Citrus Sinensis ID: 042348
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 686 | 2.2.26 [Sep-21-2011] | |||||||
| Q9C9N5 | 685 | Probable inactive leucine | no | no | 0.941 | 0.943 | 0.470 | 1e-175 | |
| C0LGS3 | 768 | Probable LRR receptor-lik | no | no | 0.940 | 0.839 | 0.338 | 2e-99 | |
| Q94C77 | 757 | Receptor protein kinase-l | no | no | 0.924 | 0.837 | 0.329 | 2e-97 | |
| Q9M9C5 | 670 | Probable leucine-rich rep | no | no | 0.829 | 0.849 | 0.327 | 1e-77 | |
| Q9LP77 | 655 | Probable inactive recepto | no | no | 0.839 | 0.879 | 0.309 | 2e-76 | |
| C0LGP9 | 784 | Probable leucine-rich rep | no | no | 0.870 | 0.761 | 0.288 | 4e-76 | |
| Q9FHK7 | 640 | Probable leucine-rich rep | no | no | 0.833 | 0.893 | 0.307 | 2e-74 | |
| C0LGQ5 | 1249 | LRR receptor-like serine/ | no | no | 0.791 | 0.434 | 0.331 | 3e-73 | |
| Q9LVM0 | 654 | Probable inactive recepto | no | no | 0.844 | 0.885 | 0.303 | 5e-73 | |
| Q9M8T0 | 627 | Probable inactive recepto | no | no | 0.867 | 0.948 | 0.308 | 2e-72 |
| >sp|Q9C9N5|Y1668_ARATH Probable inactive leucine-rich repeat receptor-like protein kinase At1g66830 OS=Arabidopsis thaliana GN=At1g66830 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 617 bits (1590), Expect = e-175, Method: Compositional matrix adjust.
Identities = 327/695 (47%), Positives = 448/695 (64%), Gaps = 49/695 (7%)
Query: 2 LVLLILSYIALMGSANDEGLALLSFKQAIRNFPEG--NNWNNSNEDPCSWNGITCR-EGQ 58
L ++ + A+ S ND+GLALLSFKQ+I+N + NWN+S+ +PCSW G+TC + +
Sbjct: 8 LCFILTHFFAIATSLNDQGLALLSFKQSIQNQSDSVFTNWNSSDSNPCSWQGVTCNYDMR 67
Query: 59 VFSLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFS 118
V S+ +PNK+L+G + +GSL ++ +NLR+N+F G LPVELF LQSL+LSGNSFS
Sbjct: 68 VVSIRLPNKRLSGSLDPSIGSLLSLRHINLRDNDFQGKLPVELFGLKGLQSLVLSGNSFS 127
Query: 119 GPVPMQIGKLKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLT 178
G VP +IG LK L LDLS+NSF+ SI S++ CK+LKT+VL++NSF+G LP G +NL
Sbjct: 128 GFVPEEIGSLKSLMTLDLSENSFNGSISLSLIPCKKLKTLVLSKNSFSGDLPTGLGSNLV 187
Query: 179 ALQKLDLSFNNLSGLIPNDIANLSRLRL-------------------LAQRVYVDLTYNN 219
L+ L+LSFN L+G IP D+ +L L+ L + +YVDL+YNN
Sbjct: 188 HLRTLNLSFNRLTGTIPEDVGSLENLKGTLDLSHNFFSGMIPTSLGNLPELLYVDLSYNN 247
Query: 220 LSGLIPQNAALLSLGPTAFIGNPFLCGPPLKVSCPSSTSDHPYPKPLPYDPSWHGGKVHH 279
LSG IP+ LL+ GP AF GNPFLCG P+K+SC S+ + P L + H H
Sbjct: 248 LSGPIPKFNVLLNAGPNAFQGNPFLCGLPIKISC-STRNTQVVPSQLYTRRANH----HS 302
Query: 280 SCAVITTVAVAVLLGICITGFLFYRQYKKASG-CKWGEKVGGCRLEEKL--MIKKEFFCF 336
+I T + GI LF +KAS + C + EKL K EF CF
Sbjct: 303 RLCIILTATGGTVAGIIFLASLFIYYLRKASARANKDQNNRTCHINEKLKKTTKPEFLCF 362
Query: 337 TRNNLD--TMSENMEQYEFVPLDSQVDFDLEQLLKASAFLLGKSTIGIVYKVALNNEEAV 394
N + T+ EN Q F+P+D +++FDL+QLLKASAFLLGKS IG+VYKV L N +
Sbjct: 363 KTGNSESETLDENKNQQVFMPMDPEIEFDLDQLLKASAFLLGKSRIGLVYKVVLENGLML 422
Query: 395 AVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLATAI 454
AVRRL + GW R KEF + EA+ KI+HPN+++L+A WS +EKLLIYDYIPNG L +AI
Sbjct: 423 AVRRLEDKGWLRLKEFLADVEAMAKIKHPNVLNLKACCWSPEEKLLIYDYIPNGDLGSAI 482
Query: 455 HGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHIS 514
G+ G +S + L+W+ RL+I++G+AKG+ ++HE SPKRYVHG + SNILLG N+EP +S
Sbjct: 483 QGRPGSVSCKQLTWTVRLKILRGIAKGLTYIHEFSPKRYVHGHINTSNILLGPNLEPKVS 542
Query: 515 DFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPE-ASKVRKPT 573
FGL R+ D + + T +P+ S SYYQAPE ASK+ KP+
Sbjct: 543 GFGLGRIVDTSSDIRSDQISPMETSSPILS------------RESYYQAPEAASKMTKPS 590
Query: 574 QKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDK 633
QKWD+YS+G+++LEM++GK P+ S E+++V W++ E KP +LDP LA D D
Sbjct: 591 QKWDVYSFGLVILEMVTGKSPV----SSEMDLVMWVESASERNKPAWYVLDPVLARDRDL 646
Query: 634 EDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRV 668
ED +V V+KI L CV K+PDKRP MR V +S +++
Sbjct: 647 EDSMVQVIKIGLACVQKNPDKRPHMRSVLESFEKL 681
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|C0LGS3|Y4372_ARATH Probable LRR receptor-like serine/threonine-protein kinase At4g37250 OS=Arabidopsis thaliana GN=At4g37250 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 363 bits (933), Expect = 2e-99, Method: Compositional matrix adjust.
Identities = 260/767 (33%), Positives = 382/767 (49%), Gaps = 122/767 (15%)
Query: 1 SLVLLILSYIALMGSANDEGLALLSFKQAIRNFPEG--NNWNNSNEDPCSWNGITCR-EG 57
S++ + + N +GL L+ FK ++ P WN +E PCSW GI+C +
Sbjct: 7 SVIFFFFCSVLSSSALNSDGLVLMKFKSSVLVDPLSLLQTWNYKHESPCSWRGISCNNDS 66
Query: 58 QVFSLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSF 117
+V +L +PN +L G IP+DLGSL + ++L NN+F+G LPV FNA L+ L LS N
Sbjct: 67 KVLTLSLPNSQLLGSIPSDLGSLLTLQSLDLSNNSFNGPLPVSFFNARELRFLDLSSNMI 126
Query: 118 SGPVPMQIGKLKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGF---- 173
SG +P IG L L L+LS N+ + +P+++ + L V L N F+G +P G+
Sbjct: 127 SGEIPSAIGDLHNLLTLNLSDNALAGKLPTNLASLRNLTVVSLENNYFSGEIPGGWRVVE 186
Query: 174 ----ATNLT-----------ALQKLDLSFNNLSGLIPNDIA-NLSRLRLLAQRVYVDLTY 217
++NL +LQ L++SFN +SG IP +I N R V VDL++
Sbjct: 187 FLDLSSNLINGSLPPDFGGYSLQYLNVSFNQISGEIPPEIGVNFPR------NVTVDLSF 240
Query: 218 NNLSGLIPQNAALLSLGPTAFIGNPFLCGPPLKVSC-----PSSTSDHPYPKPLP----- 267
NNL+G IP + L+ F GNP LCG P + C PS S+ P P
Sbjct: 241 NNLTGPIPDSPVFLNQESNFFSGNPGLCGEPTRNPCLIPSSPSIVSEADVPTSTPAIAAI 300
Query: 268 ---------YDPSWH----GGKVHHSCAVITTVAVAVLLGICITGFLFYRQYKKASGCKW 314
DP+ + VI + V + GI I +F Y+ CK
Sbjct: 301 PNTIGSNPVTDPNSQQTDPNPRTGLRPGVIIGIVVGDIAGIGILAVIFLYIYR----CKK 356
Query: 315 GEKVGGC-----RLEEKLMIKKEFF----------------CFTRNNLDTMSE------- 346
+ V R E + F C ++ T SE
Sbjct: 357 NKIVDNNNNDKQRTETDTITLSTFSSSSSSPEESRRFRKWSCLRKDPETTPSEEEDEDDE 416
Query: 347 ------NMEQY----EFVPLDSQVDFDLEQLLKASAFLLGKSTIGIVYKVALNNEEAVAV 396
N Q + V +D + + ++E LLKASA++LG + I+YK L + AV
Sbjct: 417 DEESGYNANQRSGDNKLVTVDGEKEMEIETLLKASAYILGATGSSIMYKAVLEDGRVFAV 476
Query: 397 RRLGNGGW--QRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLATAI 454
RRLG G +RFK+F+ AIGK+ HPN+V L ++W DEKL+IYD++PNGSL
Sbjct: 477 RRLGENGLSQRRFKDFEPHIRAIGKLVHPNLVRLCGFYWGTDEKLVIYDFVPNGSLVNPR 536
Query: 455 HGKAGIIS--YRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPH 512
+ K G S Y L W RL+I KG+A+G+A+LHE K++VHG+L+PSNILLG +MEP
Sbjct: 537 YRKGGGSSSPYH-LPWETRLKIAKGIARGLAYLHE---KKHVHGNLKPSNILLGHDMEPK 592
Query: 513 ISDFGLARLADIAEETPEVHWEQST---TGTPLQSSPYEFTALNSTT--------SRSYY 561
I DFGL RL + ET + S+ + +S EF+++ T + S Y
Sbjct: 593 IGDFGLERL--LTGETSYIRAGGSSRIFSSKRYTTSSREFSSIGPTPSPSPSSVGAMSPY 650
Query: 562 QAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQWIQLILEDRKPMTD 621
APE+ + KP+ KWD+Y +GVILLE+++GK+ ++ IV L +ED
Sbjct: 651 CAPESFRSLKPSPKWDVYGFGVILLELLTGKIVSVE------EIVLGNGLTVEDGHRAVR 704
Query: 622 ILDPFLAHDLD-KEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDR 667
+ D + +LD K++ ++ K+ C P KRP+M+ L+R
Sbjct: 705 MADVAIRGELDGKQEFLLDCFKLGYSCASPVPQKRPTMKESLAVLER 751
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q94C77|RPKL_ARATH Receptor protein kinase-like protein At4g34220 OS=Arabidopsis thaliana GN=At4g34220 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 357 bits (917), Expect = 2e-97, Method: Compositional matrix adjust.
Identities = 257/781 (32%), Positives = 389/781 (49%), Gaps = 147/781 (18%)
Query: 1 SLVLLILSYI-ALMGSANDEGLALLSFKQAIRNFPEG--NNWNNSNEDPCSWNGITCRE- 56
SLVL ++ + + N +G+ LL+FK +I P NWN + PC W G+TC E
Sbjct: 11 SLVLFHFLFVPTQLQALNTDGVLLLTFKYSILTDPLSVLRNWNYDDATPCLWTGVTCTEL 70
Query: 57 --------GQVFSLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQ 108
+V SL++PNK L G I DL S+ + ++L +N F+GSLP +FNA+ LQ
Sbjct: 71 GKPNTPDMFRVTSLVLPNKHLLGSITPDLFSIPYLRILDLSSNFFNGSLPDSVFNATELQ 130
Query: 109 SLILSGNSFSGPVPMQIGKLKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGP 168
S+ L N+ SG +P + + LQ+L+LS N+F+ IP +I K L V L++N+F+G
Sbjct: 131 SISLGSNNLSGDLPKSVNSVTNLQLLNLSANAFTGEIPLNISLLKNLTVVSLSKNTFSGD 190
Query: 169 LPDGFATNLTALQKLDLSFNNLSGLIPNDIA-------NLSRLRLLAQ-----------R 210
+P GF A Q LDLS N L+G +P D+ NLS ++L +
Sbjct: 191 IPSGFE----AAQILDLSSNLLNGSLPKDLGGKSLHYLNLSHNKVLGEISPNFAEKFPAN 246
Query: 211 VYVDLTYNNLSGLIPQNAALLSLGPTAFIGNPFLCGPPLKVSC--PSSTSDHP------- 261
VDL++NNL+G IP + +LL+ +F GN LCG PLK+ C PS+ S+ P
Sbjct: 247 ATVDLSFNNLTGPIPSSLSLLNQKAESFSGNQELCGKPLKILCSIPSTLSNPPNISETTS 306
Query: 262 -----YPK------PLPYDPSWHGGKVHHSCAVITTVAVAVLLGICITGFLFYRQYKKAS 310
P+ PL P+ GK + I + VA ++G+ G L Y+
Sbjct: 307 PAIAVKPRSTAPINPLTEKPN-QTGKSKLKPSTIAAITVADIVGLAFIGLLVLYVYQVRK 365
Query: 311 GCKWGEK------------------------------------VGGCRL----------- 323
++ E G C +
Sbjct: 366 RRRYPESSKFSFFKFCLEKNEAKKSKPSTTEVTVPESPEAKTTCGSCIILTGGRYDETST 425
Query: 324 -EEKLMIKKEFFCFTRNNLDTMSENMEQYEFVPLDSQVDFDLEQLLKASAFLLGKSTIGI 382
E + ++ FTR + + ++ Q + V +D + DL+ LLKASA++LG + GI
Sbjct: 426 SESDVENQQTVQAFTRTDGGQLKQS-SQTQLVTVDGETRLDLDTLLKASAYILGTTGTGI 484
Query: 383 VYKVALNNEEAVAVRRLG--NGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLL 440
VYK L N A AVRR+ + + KEF+ E AI K+RHPN+V +R + W DEKLL
Sbjct: 485 VYKAVLENGTAFAVRRIETESCAAAKPKEFEREVRAIAKLRHPNLVRIRGFCWGDDEKLL 544
Query: 441 IYDYIPNGSLATAIHGKAGIISY-------RPLSWSDRLRIIKGVAKGIAFLHEVSPKRY 493
I DY+PNGSL S PL++ RL+I +G+A+G+++++E K+
Sbjct: 545 ISDYVPNGSLLCFFTATKASSSSSSSSSLQNPLTFEARLKIARGMARGLSYINE---KKQ 601
Query: 494 VHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALN 553
VHG+++P+NILL EP I+D GL RL A E+ TTG P SSP
Sbjct: 602 VHGNIKPNNILLNAENEPIITDLGLDRLMTPARES-------HTTG-PTSSSP------- 646
Query: 554 STTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQWIQL-- 611
YQ PE S KP KWD+YS+GVILLE+++ K + S++ +I Q+ L
Sbjct: 647 -------YQPPEWSTSLKPNPKWDVYSFGVILLELLTSK-----VFSVDHDIDQFSNLSD 694
Query: 612 -ILEDRKPMTDILDPFLAHDLDK-EDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRVN 669
E+ ++D + D+ + ED ++ ++ ++CV P KRPSM+ + L+++
Sbjct: 695 SAAEENGRFLRLIDGAIRSDVARHEDAAMACFRLGIECVSSLPQKRPSMKELVQVLEKIC 754
Query: 670 I 670
+
Sbjct: 755 V 755
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|Q9M9C5|Y1680_ARATH Probable leucine-rich repeat receptor-like protein kinase At1g68400 OS=Arabidopsis thaliana GN=At1g68400 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 291 bits (746), Expect = 1e-77, Method: Compositional matrix adjust.
Identities = 223/681 (32%), Positives = 346/681 (50%), Gaps = 112/681 (16%)
Query: 22 ALLSFKQAIRNFPEGNNWNNSNEDPCSWNGITCREGQVFSLIIPNKKLTGFIPADLGSLS 81
LL+FK + + N+WN + +PC W G++C +V L++ + LTG I + +
Sbjct: 34 TLLNFKLTADSTGKLNSWNTTT-NPCQWTGVSCNRNRVTRLVLEDINLTGSISSL--TSL 90
Query: 82 AIGRV-NLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQVLDLSQNS 140
RV +L++NN SG +P L N + L+ L LS N FSG P I L L LDLS N+
Sbjct: 91 TSLRVLSLKHNNLSGPIP-NLSNLTALKLLFLSNNQFSGNFPTSITSLTRLYRLDLSFNN 149
Query: 141 FSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSGLIPNDIAN 200
FS IP + L T+ L N F+G +P+ NL+ LQ ++S NN +G IPN ++
Sbjct: 150 FSGQIPPDLTDLTHLLTLRLESNRFSGQIPN---INLSDLQDFNVSGNNFNGQIPNSLSQ 206
Query: 201 LSRLRLLAQRVYVDLTYNNLSGLIPQNAALLSLGPTAFIGNPFLCGPPLKVSCPSSTSD- 259
P+ + F NP LCG PL + C +SD
Sbjct: 207 F-----------------------PE---------SVFTQNPSLCGAPL-LKCTKLSSDP 233
Query: 260 -----------HPYPKP--LPYDP-SWHGGKVHHSCAVITTVA-VAVLLG-ICITGFL-- 301
P KP +P P S HGG ++ + I+T++ +A++LG I F+
Sbjct: 234 TKPGRPDEAKASPLNKPETVPSSPTSIHGGDKSNNTSRISTISLIAIILGDFIILSFVSL 293
Query: 302 -----FYRQY----KKASGCKWGEKVGGCRLEEKLMIKKEFFCFTRNNLDTMSENMEQYE 352
F+RQY KK S GEK+ + + T+NN + + ++ +
Sbjct: 294 LLYYCFWRQYAVNKKKHSKILEGEKI--------VYSSNPYPTSTQNNNNQNQQVGDKGK 345
Query: 353 FVPLDSQVDFDLEQLLKASAFLLGKSTIGIVYKVALNNEEAVAVRRLGNG-GWQRFKEFQ 411
V + F+LE LL+ASA +LGK G YK L + VAV+RL + KEF+
Sbjct: 346 MVFFEGTRRFELEDLLRASAEMLGKGGFGTAYKAVLEDGNEVAVKRLKDAVTVAGKKEFE 405
Query: 412 TEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDR 471
+ E +G++RH N+VSL+AY+++ +EKLL+YDY+PNGSL +HG G PL W+ R
Sbjct: 406 QQMEVLGRLRHTNLVSLKAYYFAREEKLLVYDYMPNGSLFWLLHGNRGP-GRTPLDWTTR 464
Query: 472 LRIIKGVAKGIAFLH-EVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPE 530
L+I G A+G+AF+H + HGD++ +N+LL ++ +SDFGL+ A
Sbjct: 465 LKIAAGAARGLAFIHGSCKTLKLTHGDIKSTNVLLDRSGNARVSDFGLSIFA-------- 516
Query: 531 VHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS 590
P Q+ + Y+APE RK TQK D+YS+GV+LLE+++
Sbjct: 517 ----------PSQT----------VAKSNGYRAPELIDGRKHTQKSDVYSFGVLLLEILT 556
Query: 591 GKLP-MIQIGSM--ELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDC 647
GK P M++ G +++ +W+Q ++ + + ++ D L D E+E+V +L+IA+ C
Sbjct: 557 GKCPNMVETGHSGGAVDLPRWVQSVVRE-EWTAEVFDLELMRYKDIEEEMVGLLQIAMAC 615
Query: 648 VHKSPDKRPSMRHVCDSLDRV 668
+ D RP M HV ++ +
Sbjct: 616 TAVAADHRPKMGHVVKLIEDI 636
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LP77|Y1848_ARATH Probable inactive receptor kinase At1g48480 OS=Arabidopsis thaliana GN=RKL1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 287 bits (735), Expect = 2e-76, Method: Compositional matrix adjust.
Identities = 211/681 (30%), Positives = 332/681 (48%), Gaps = 105/681 (15%)
Query: 17 NDEGLALLSFKQAI--RNFPEGNNWNNSNEDPCSWNGITCREGQVFSLIIPNKKLTGFIP 74
N + ALLS + A+ R F WN PC+W G+ C +V +L +P L+G IP
Sbjct: 34 NADRTALLSLRSAVGGRTF----RWNIKQTSPCNWAGVKCESNRVTALRLPGVALSGDIP 89
Query: 75 ADL-GSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQV 133
+ G+L+ + ++LR N SGSLP +L +SNL+ L L GN FSG +P + L +L
Sbjct: 90 EGIFGNLTQLRTLSLRLNALSGSLPKDLSTSSNLRHLYLQGNRFSGEIPEVLFSLSHLVR 149
Query: 134 LDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSGL 193
L+L+ NSF+ I S +LKT+ L N +G +PD LDL
Sbjct: 150 LNLASNSFTGEISSGFTNLTKLKTLFLENNQLSGSIPD-----------LDLPL------ 192
Query: 194 IPNDIANLSRLRLLAQRVYVDLTYNNLSGLIPQNAALLSLGPTAFIGNPFLCGPPLKVSC 253
V +++ N+L+G IP+N L +F+ LCG PLK+ C
Sbjct: 193 -----------------VQFNVSNNSLNGSIPKN--LQRFESDSFLQTS-LCGKPLKL-C 231
Query: 254 PSSTS--DHPYPKPLPYDPSWHGGKVHHSCAVITTVAVAVLLGICITGF------LFYRQ 305
P + P PS G + ++ A+A ++ C+ GF L
Sbjct: 232 PDEETVPSQPTSGGNRTPPSVEGSEEKKKKNKLSGGAIAGIVIGCVVGFALIVLILMVLC 291
Query: 306 YKKASGCKWGEKVGGCRLEE-------KLMIKKEFFCFTRNNLDTMSENMEQYE------ 352
KK++ + + +E + + + + M+ N + E
Sbjct: 292 RKKSNKRSRAVDISTIKQQEPEIPGDKEAVDNGNVYSVSAAAAAAMTGNGKASEGNGPAT 351
Query: 353 ----FVPLDSQVDFDLEQLLKASAFLLGKSTIGIVYKVALNNEEAVAVRRLGNGGWQRFK 408
F ++V FDLE LL+ASA +LGK T G YK L+ VAV+RL + K
Sbjct: 352 KKLVFFGNATKV-FDLEDLLRASAEVLGKGTFGTAYKAVLDAVTVVAVKRLKD-VMMADK 409
Query: 409 EFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSW 468
EF+ + E +G + H N+V LRAY++S DEKLL+YD++P GSL+ +HG G PL+W
Sbjct: 410 EFKEKIELVGAMDHENLVPLRAYYFSRDEKLLVYDFMPMGSLSALLHGNRG-AGRSPLNW 468
Query: 469 SDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEET 528
R RI G A+G+ +LH HG+++ SNILL K+ + +SDFGLA+L +
Sbjct: 469 DVRSRIAIGAARGLDYLHSQGTSTS-HGNIKSSNILLTKSHDAKVSDFGLAQLVGSSATN 527
Query: 529 PEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEM 588
P TG Y+APE + ++ +QK D+YS+GV+LLE+
Sbjct: 528 P-----NRATG---------------------YRAPEVTDPKRVSQKGDVYSFGVVLLEL 561
Query: 589 ISGKLPMIQIGSME-LNIVQWIQLILED--RKPMTDILDPFLAHDLDKEDEIVSVLKIAL 645
I+GK P + + E +++ +W++ + D R+ + D L+ D+E+ + ++++ L
Sbjct: 562 ITGKAPSNSVMNEEGVDLPRWVKSVARDEWRREVFD--SELLSLATDEEEMMAEMVQLGL 619
Query: 646 DCVHKSPDKRPSMRHVCDSLD 666
+C + PD+RP M V ++
Sbjct: 620 ECTSQHPDQRPEMSEVVRKME 640
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|C0LGP9|IMK3_ARATH Probable leucine-rich repeat receptor-like protein kinase IMK3 OS=Arabidopsis thaliana GN=IMK3 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 286 bits (732), Expect = 4e-76, Method: Compositional matrix adjust.
Identities = 215/746 (28%), Positives = 343/746 (45%), Gaps = 149/746 (19%)
Query: 38 NWNNSNEDPCS--WNGITCREGQVFSLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSG 95
+WN S CS W GI C +GQV + +P K L G I +G L A+ +++L +NN G
Sbjct: 80 SWNGSGFSACSGGWAGIKCAQGQVIVIQLPWKSLGGRISEKIGQLQALRKLSLHDNNLGG 139
Query: 96 SLPVELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQVLDLSQ----------------- 138
S+P+ L NL+ + L N +G +P +G +LQ LDLS
Sbjct: 140 SIPMSLGLIPNLRGVQLFNNRLTGSIPASLGVSHFLQTLDLSNNLLSEIIPPNLADSSKL 199
Query: 139 -------NSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFAT---------------- 175
NS S IP S+ + L+ + L+ N+ +GP+ D + +
Sbjct: 200 LRLNLSFNSLSGQIPVSLSRSSSLQFLALDHNNLSGPILDTWGSKSLNLRVLSLDHNSLS 259
Query: 176 --------NLTALQKLDLSFNNLSGLIPNDIANLSRLRLL------------------AQ 209
NLT LQ S N + G +P++++ L++LR + +
Sbjct: 260 GPFPFSLCNLTQLQDFSFSHNRIRGTLPSELSKLTKLRKMDISGNSVSGHIPETLGNISS 319
Query: 210 RVYVDL------------------------TYNNLSGLIPQNAALLS--LGPTAFIGNPF 243
+++DL +YNNLSG +P LLS ++F+GN
Sbjct: 320 LIHLDLSQNKLTGEIPISISDLESLNFFNVSYNNLSGPVP---TLLSQKFNSSSFVGNSL 376
Query: 244 LCGPPLKVSCPSSTSDHPYPKPLPYDPSWHGGKVHHSCAVITTVA--VAVLLGICITGFL 301
LCG + CP+ P P P H +I + A + +L+ +C+ L
Sbjct: 377 LCGYSVSTPCPT----LPSPSPEKERKPSHRNLSTKDIILIASGALLIVMLILVCVLCCL 432
Query: 302 FYRQYKKASGCKWGEKVGGCRLEEKLMIKKEFFCFTRNNLDTMSENMEQYEFVPLDSQVD 361
R+ + K GE G + T + + + V D +
Sbjct: 433 L-RKKANETKAKGGEAGPGAVAAK-----------TEKGGEAEAGGETGGKLVHFDGPMA 480
Query: 362 FDLEQLLKASAFLLGKSTIGIVYKVALNNEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIR 421
F + LL A+A ++GKST G VYK L + VAV+RL + KEF+ E +G+IR
Sbjct: 481 FTADDLLCATAEIMGKSTYGTVYKATLEDGSQVAVKRLREKITKSQKEFENEINVLGRIR 540
Query: 422 HPNIVSLRAYFWS-VDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAK 480
HPN+++LRAY+ EKL+++DY+ GSLAT +H + + ++W R+ +IKG+A+
Sbjct: 541 HPNLLALRAYYLGPKGEKLVVFDYMSRGSLATFLHARGPDVH---INWPTRMSLIKGMAR 597
Query: 481 GIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGT 540
G+ +LH + +HG+L SN+LL +N+ ISD+GL+RL A + +
Sbjct: 598 GLFYLH--THANIIHGNLTSSNVLLDENITAKISDYGLSRLMTAAAGSSVI--------- 646
Query: 541 PLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGS 600
+T Y+APE SK++K K D+YS GVI+LE+++GK P +
Sbjct: 647 -------------ATAGALGYRAPELSKLKKANTKTDVYSLGVIILELLTGKSPSEALNG 693
Query: 601 MELNIVQWIQLILEDRKPMTDILDPFLAHDLDK-EDEIVSVLKIALDCVHKSPDKRPSMR 659
++L QW+ +++ ++ D L +D++ DEI++ LK+AL CV +P RP +
Sbjct: 694 VDLP--QWVATAVKEEW-TNEVFDLELLNDVNTMGDEILNTLKLALHCVDATPSTRPEAQ 750
Query: 660 HVCDSLDRVNISTEQQFMKGEEPKFD 685
V L I E+ EP D
Sbjct: 751 QVMTQLGE--IRPEETTATTSEPLID 774
|
Can phosphorylate AGL24. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FHK7|Y5516_ARATH Probable leucine-rich repeat receptor-like protein kinase At5g05160 OS=Arabidopsis thaliana GN=At5g05160 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 280 bits (716), Expect = 2e-74, Method: Compositional matrix adjust.
Identities = 222/722 (30%), Positives = 338/722 (46%), Gaps = 150/722 (20%)
Query: 1 SLVLLILSYIALMGSANDEGLALLSFKQAIRNF------PEGNNWNNSNEDPCSWNGITC 54
S L+L+ A++ SA+ L S +QA+ NF P NWN + SW GITC
Sbjct: 12 SFFFLLLAATAVLVSAD-----LASDEQALLNFAASVPHPPKLNWNKNLSLCSSWIGITC 66
Query: 55 REGQVFSLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSG 114
E S ++ V L GS+P
Sbjct: 67 DESNPTSRVVA--------------------VRLPGVGLYGSIP---------------- 90
Query: 115 NSFSGPVPMQIGKLKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFA 174
P +GKL L+VL L NS ++PS I+ L+ + L N+F+G L
Sbjct: 91 -------PATLGKLDALKVLSLRSNSLFGTLPSDILSLPSLEYLYLQHNNFSGELTTNSL 143
Query: 175 TNLTA-LQKLDLSFNNLSGLIPNDIANLSRLRLLAQR----------------VYVDLTY 217
+++ L LDLS+N+LSG IP+ + NLS++ +L + V+L+Y
Sbjct: 144 PSISKQLVVLDLSYNSLSGNIPSGLRNLSQITVLYLQNNSFDGPIDSLDLPSVKVVNLSY 203
Query: 218 NNLSGLIPQNAALLSLGPT-AFIGNPFLCGPPLKVSCPSSTSDHPYPKPLPYDPSWHGGK 276
NNLSG IP++ L P +FIGN LCGPPL +C P P + H +
Sbjct: 204 NNLSGPIPEH---LKKSPEYSFIGNSLLCGPPLN-ACSGGAISPSSNLPRPLTENLHPVR 259
Query: 277 VHHSCAVITTVAVAVLLGICITGFLF----YRQYKKASGCKWG--EKVGGCRLEEKLMI- 329
S A I + V + + G +F ++ KK G G ++GG ++
Sbjct: 260 RRQSKAYIIAIVVGCSVAVLFLGIVFLVCLVKKTKKEEGGGEGVRTQMGGVNSKKPQDFG 319
Query: 330 -------KKEFFCFTRNNLDTMSENMEQYEFVPLDSQVDFDLEQLLKASAFLLGKSTIGI 382
K + F F R N + FDLE LLKASA +LGK + G
Sbjct: 320 SGVQDPEKNKLFFFERCNHN-------------------FDLEDLLKASAEVLGKGSFGT 360
Query: 383 VYKVALNNEEAVAVRRLGNGGWQRFKEFQTEAEAIGKI-RHPNIVSLRAYFWSVDEKLLI 441
YK L + AV V+RL + KEF+ + E +GKI +H N V L AY++S DEKLL+
Sbjct: 361 AYKAVLEDTTAVVVKRLREVVASK-KEFEQQMEIVGKINQHSNFVPLLAYYYSKDEKLLV 419
Query: 442 YDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPS 501
Y Y+ GSL +HG G R + W R++I G +K I++LH + ++VHGD++ S
Sbjct: 420 YKYMTKGSLFGIMHGNRG---DRGVDWETRMKIATGTSKAISYLHSL---KFVHGDIKSS 473
Query: 502 NILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYY 561
NILL +++EP +SD L L ++ TP T G Y
Sbjct: 474 NILLTEDLEPCLSDTSLVTLFNLPTHTPR------TIG---------------------Y 506
Query: 562 QAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIV----QWIQLILEDRK 617
APE + R+ +Q+ D+YS+GV++LEM++GK P+ Q G + +V +W++ ++ +
Sbjct: 507 NAPEVIETRRVSQRSDVYSFGVVILEMLTGKTPLTQPGLEDERVVIDLPRWVRSVVREEW 566
Query: 618 PMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRV-NISTEQQF 676
++ D L + E+E+V +L++AL CV ++P+ RP M V ++ V + QQ
Sbjct: 567 -TAEVFDVELLKFQNIEEEMVQMLQLALACVARNPESRPKMEEVARMIEDVRRLDQSQQL 625
Query: 677 MK 678
+
Sbjct: 626 QQ 627
|
Probable leucine-rich repeat receptor-like protein kinase. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|C0LGQ5|GSO1_ARATH LRR receptor-like serine/threonine-protein kinase GSO1 OS=Arabidopsis thaliana GN=GSO1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 276 bits (707), Expect = 3e-73, Method: Compositional matrix adjust.
Identities = 213/643 (33%), Positives = 312/643 (48%), Gaps = 100/643 (15%)
Query: 66 NKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQI 125
N L+G IP LG LS +G + L +N F SLP ELFN + L L L GNS +G +P +I
Sbjct: 656 NNFLSGPIPPWLGKLSQLGELKLSSNQFVESLPTELFNCTKLLVLSLDGNSLNGSIPQEI 715
Query: 126 GKLKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDL 185
G L L VL+L +N FS S+P ++ + +L + L++NS TG +P LDL
Sbjct: 716 GNLGALNVLNLDKNQFSGSLPQAMGKLSKLYELRLSRNSLTGEIPVEIGQLQDLQSALDL 775
Query: 186 SFNNLSGLIPNDIANLSRLRLLAQRVYVDLTYNNLSGLIPQNAA-LLSLG---------- 234
S+NN +G IP+ I LS+L L DL++N L+G +P + + SLG
Sbjct: 776 SYNNFTGDIPSTIGTLSKLETL------DLSHNQLTGEVPGSVGDMKSLGYLNVSFNNLG 829
Query: 235 -----------PTAFIGNPFLCGPPLKVSCPSSTSDHPYPKPLPYDPSWHGGKVHHSCAV 283
+F+GN LCG PL C S++ G S +
Sbjct: 830 GKLKKQFSRWPADSFLGNTGLCGSPLS-RCNRVRSNNK-----------QQGLSARSVVI 877
Query: 284 ITTVAVAVLLGICITGF-LFYRQYKKASGCKWGEKVGGCRLEEKLMIKKEFFCFTRNNLD 342
I+ ++ +G+ I LF++Q + +KVG +
Sbjct: 878 ISAISALTAIGLMILVIALFFKQRHD-----FFKKVG-----------------HGSTAY 915
Query: 343 TMSENMEQYEFVPL----DSQVDFDLEQLLKAS-----AFLLGKSTIGIVYKVALNNEEA 393
T S + Q PL S+ D E +++A+ F++G G VYK L N E
Sbjct: 916 TSSSSSSQATHKPLFRNGASKSDIRWEDIMEATHNLSEEFMIGSGGSGKVYKAELENGET 975
Query: 394 VAVRR-LGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDE--KLLIYDYIPNGSL 450
VAV++ L K F E + +G+IRH ++V L Y S E LLIY+Y+ NGS+
Sbjct: 976 VAVKKILWKDDLMSNKSFSREVKTLGRIRHRHLVKLMGYCSSKSEGLNLLIYEYMKNGSI 1035
Query: 451 ATAIHGKAGIISYRP--LSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKN 508
+H ++ + L W RLRI G+A+G+ +LH VH D++ SN+LL N
Sbjct: 1036 WDWLHEDKPVLEKKKKLLDWEARLRIAVGLAQGVEYLHHDCVPPIVHRDIKSSNVLLDSN 1095
Query: 509 MEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSY-YQAPEAS 567
ME H+ DFGLA+ V E T T N+ + SY Y APE +
Sbjct: 1096 MEAHLGDFGLAK----------VLTENCDTNTD----------SNTWFACSYGYIAPEYA 1135
Query: 568 KVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQWIQLILEDRKPMTD-ILDPF 626
K T+K D+YS G++L+E+++GK+P + E+++V+W++ LE D ++DP
Sbjct: 1136 YSLKATEKSDVYSMGIVLMEIVTGKMPTDSVFGAEMDMVRWVETHLEVAGSARDKLIDPK 1195
Query: 627 LAHDLD-KEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRV 668
L L +ED VL+IAL C SP +RPS R CDSL V
Sbjct: 1196 LKPLLPFEEDAACQVLEIALQCTKTSPQERPSSRQACDSLLHV 1238
|
Together with GSO2, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LVM0|Y5830_ARATH Probable inactive receptor kinase At5g58300 OS=Arabidopsis thaliana GN=At5g58300 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 276 bits (705), Expect = 5e-73, Method: Compositional matrix adjust.
Identities = 203/669 (30%), Positives = 335/669 (50%), Gaps = 90/669 (13%)
Query: 17 NDEGLALLSFKQAIRNFPEGNNWNNSNEDPCSWNGITCREG--QVFSLIIPNKKLTGFIP 74
N + ALL+F ++ + NWN++N SW G+TC V +L +P L G IP
Sbjct: 46 NSDRQALLAFAASVPHL-RRLNWNSTNHICKSWVGVTCTSDGTSVHALRLPGIGLLGPIP 104
Query: 75 AD-LGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQV 133
+ LG L ++ ++LR+N SG+LP ++ + +L + L N+FSG VP + + L +
Sbjct: 105 PNTLGKLESLRILSLRSNLLSGNLPPDIHSLPSLDYIYLQHNNFSGEVPSFVSR--QLNI 162
Query: 134 LDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSGL 193
LDLS NSF+ IP++ K+L + L N +GP+P+ + +L++L+LS N+L+G
Sbjct: 163 LDLSFNSFTGKIPATFQNLKQLTGLSLQNNKLSGPVPN---LDTVSLRRLNLSNNHLNGS 219
Query: 194 IPNDIANLSRLRLLAQRVYVDLTYNNLSGLIPQNAALLSLGPTAFIGNPFLCGPPLK--- 250
IP +AL ++F GN LCG PL+
Sbjct: 220 IP--------------------------------SALGGFPSSSFSGNTLLCGLPLQPCA 247
Query: 251 -VSCPSSTSDHPYPKPLPYDPSWHGGKVHHSCAVITTVAVAVLLGICITGFLFYRQYKKA 309
S P S + H PLP P G K + V+ ++ I G
Sbjct: 248 TSSPPPSLTPHISTPPLPPFPHKEGSK--------RKLHVSTIIPIAAGGAALLLLITVI 299
Query: 310 SGCKWGEKVGGCRLEEKLMIKKEFFCFTRNNLDTMSENMEQYEFVPLDS-QVDFDLEQLL 368
C +K + E+ ++ K + + + E+ + V + +FDLE LL
Sbjct: 300 ILCCCIKKKD--KREDSIVKVKTLTEKAKQEFGSGVQEPEKNKLVFFNGCSYNFDLEDLL 357
Query: 369 KASAFLLGKSTIGIVYKVALNNEEAVAVRRLGNGGWQRFKEFQTEAEAIGKI-RHPNIVS 427
+ASA +LGK + G YK L V V+RL + +EF+ + E I ++ HP++V
Sbjct: 358 RASAEVLGKGSYGTAYKAVLEESTTVVVKRLKEVAAGK-REFEQQMEIISRVGNHPSVVP 416
Query: 428 LRAYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHE 487
LRAY++S DEKL++ DY P G+L++ +HG G PL W R++I AKGIA LH
Sbjct: 417 LRAYYYSKDEKLMVCDYYPAGNLSSLLHGNRGS-EKTPLDWDSRVKITLSAAKGIAHLHA 475
Query: 488 VSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPY 547
++ HG+++ SN+++ + + ISDFGL TPL + P
Sbjct: 476 AGGPKFSHGNIKSSNVIMKQESDACISDFGL---------------------TPLMAVPI 514
Query: 548 EFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSME--LNI 605
+ + Y+APE + RK T K D+YS+GV++LEM++GK P +Q S + +++
Sbjct: 515 ------APMRGAGYRAPEVMETRKHTHKSDVYSFGVLILEMLTGKSP-VQSPSRDDMVDL 567
Query: 606 VQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSL 665
+W+Q ++ + +++ D L + E+E+V +L+IA+ CV + P+ RP+M V +
Sbjct: 568 PRWVQSVVREEW-TSEVFDIELMRFQNIEEEMVQMLQIAMACVAQVPEVRPTMDDVVRMI 626
Query: 666 DRVNISTEQ 674
+ + +S +
Sbjct: 627 EEIRVSDSE 635
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|Q9M8T0|Y3288_ARATH Probable inactive receptor kinase At3g02880 OS=Arabidopsis thaliana GN=At3g02880 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 274 bits (700), Expect = 2e-72, Method: Compositional matrix adjust.
Identities = 212/687 (30%), Positives = 340/687 (49%), Gaps = 92/687 (13%)
Query: 1 SLVLLILSYIALMGSA-NDEGLALLSFKQAIRNFPEGNNWNNSNEDPCSWNGITCREGQV 59
S+V L + Y+A + S + ALL+ + ++R P WN S PC+W+G+ C G+V
Sbjct: 10 SVVFLFVFYLAAVTSDLESDRRALLAVRNSVRGRPL--LWNMSASSPCNWHGVHCDAGRV 67
Query: 60 FSLIIPNKKLTGFIP-ADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFS 118
+L +P L G +P +G+L+ + ++LR N+ SG +P + N L+ L L GN+FS
Sbjct: 68 TALRLPGSGLFGSLPIGGIGNLTQLKTLSLRFNSLSGPIPSDFSNLVLLRYLYLQGNAFS 127
Query: 119 GPVPMQIGKLKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLT 178
G +P + L + ++L +N FS IP ++ RL T+ L +N +GP+P+
Sbjct: 128 GEIPSLLFTLPSIIRINLGENKFSGRIPDNVNSATRLVTLYLERNQLSGPIPE----ITL 183
Query: 179 ALQKLDLSFNNLSGLIPNDIANLSRLRLLAQRVYVDLTYNNLSGLIPQNAALLSLGPTAF 238
LQ+ ++S N L+G IP+ +++ R TAF
Sbjct: 184 PLQQFNVSSNQLNGSIPSSLSSWPR--------------------------------TAF 211
Query: 239 IGNPFLCGPPLKVSCPSSTSDHPYPKPLPYDPSWHGGKVHHSCAVITTVAVAVLLGICIT 298
GN LCG PL +C + S + P P S I + + ++G+ +
Sbjct: 212 EGN-TLCGKPLD-TC-EAESPNGGDAGGPNTPPEKKDSDKLSAGAIVGIVIGCVVGLLLL 268
Query: 299 GFLFYRQYKKASGCKWGEKVGGCRLEEKLM-------IKKEFFCFTRNNLDTMSE----N 347
+ + +K K E V +E + I KE T SE N
Sbjct: 269 LLILFCLCRKR---KKEENVPSRNVEAPVAAATSSAAIPKETVVVVPPAKATGSESGAVN 325
Query: 348 MEQYEFVPLDSQVDFDLEQLLKASAFLLGKSTIGIVYKVALNNEEAVAVRRLGNGGWQRF 407
+ FV S +FDL+ LLKASA +LGK T+G YK + + VAV+RL +
Sbjct: 326 KDLTFFV--KSFGEFDLDGLLKASAEVLGKGTVGSSYKASFEHGLVVAVKRLRDVVVPE- 382
Query: 408 KEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLS 467
KEF+ +G + H N+V+L AY++S DEKLL+++Y+ GSL+ +HG G PL+
Sbjct: 383 KEFRERLHVLGSMSHANLVTLIAYYFSRDEKLLVFEYMSKGSLSAILHGNKG-NGRTPLN 441
Query: 468 WSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEE 527
W R I G A+ I++LH HG+++ SNILL + E +SD+GLA
Sbjct: 442 WETRAGIALGAARAISYLHSRD-GTTSHGNIKSSNILLSDSYEAKVSDYGLA-------- 492
Query: 528 TPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLE 587
P+ SS ++ Y+APE + RK +QK D+YS+GV++LE
Sbjct: 493 -------------PIISSTSAPNRIDG------YRAPEITDARKISQKADVYSFGVLILE 533
Query: 588 MISGKLPM-IQIGSMELNIVQWIQLILEDRKPMTDILDPFLA-HDLDKEDEIVSVLKIAL 645
+++GK P Q+ +++ +W+Q + E + P +D+LDP L + + + I+ +LKI +
Sbjct: 534 LLTGKSPTHQQLNEEGVDLPRWVQSVTEQQTP-SDVLDPELTRYQPEGNENIIRLLKIGM 592
Query: 646 DCVHKSPDKRPSMRHVCDSLDRVNIST 672
C + PD RPSM V ++ V+ S+
Sbjct: 593 SCTAQFPDSRPSMAEVTRLIEEVSHSS 619
|
Arabidopsis thaliana (taxid: 3702) |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 686 | ||||||
| 225424079 | 713 | PREDICTED: probable inactive leucine-ric | 0.966 | 0.929 | 0.584 | 0.0 | |
| 147787085 | 713 | hypothetical protein VITISV_040575 [Viti | 0.966 | 0.929 | 0.583 | 0.0 | |
| 255574324 | 692 | ATP binding protein, putative [Ricinus c | 0.967 | 0.959 | 0.581 | 0.0 | |
| 224077204 | 699 | predicted protein [Populus trichocarpa] | 0.970 | 0.952 | 0.593 | 0.0 | |
| 255570657 | 715 | ATP binding protein, putative [Ricinus c | 0.960 | 0.921 | 0.568 | 0.0 | |
| 224111612 | 716 | predicted protein [Populus trichocarpa] | 0.956 | 0.916 | 0.559 | 0.0 | |
| 224099409 | 717 | predicted protein [Populus trichocarpa] | 0.965 | 0.923 | 0.554 | 0.0 | |
| 356573811 | 710 | PREDICTED: probable inactive leucine-ric | 0.976 | 0.943 | 0.532 | 0.0 | |
| 449458815 | 717 | PREDICTED: probable inactive leucine-ric | 0.969 | 0.927 | 0.521 | 0.0 | |
| 449503421 | 717 | PREDICTED: probable inactive leucine-ric | 0.969 | 0.927 | 0.521 | 0.0 |
| >gi|225424079|ref|XP_002282768.1| PREDICTED: probable inactive leucine-rich repeat receptor-like protein kinase At1g66830 [Vitis vinifera] gi|297737773|emb|CBI26974.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 811 bits (2096), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 408/698 (58%), Positives = 520/698 (74%), Gaps = 35/698 (5%)
Query: 11 ALMGSANDEGLALLSFKQAIRNFPEG--NNWNNSNEDPCSWNGITCREGQVFSLIIPNKK 68
AL+GS N+EG+ALLSFK+++ PE +NWN+S+E+PCSWNGITC+E +V S+ IP KK
Sbjct: 16 ALVGSLNEEGVALLSFKRSVGEDPERSLDNWNSSDENPCSWNGITCKEERVVSVSIPKKK 75
Query: 69 LTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGKL 128
L GF+P+ LGSL+ + VNLRNN F GSLPVELF A LQSL+L GN+ SG VP +IG L
Sbjct: 76 LLGFLPSALGSLTQLRHVNLRNNKFFGSLPVELFKAQGLQSLVLYGNNLSGSVPSEIGSL 135
Query: 129 KYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFN 188
KYLQ LDLSQN F+ S+P+S++QCKRLKT+ L+QN+FTG LPDGF L +L+KLDLSFN
Sbjct: 136 KYLQTLDLSQNFFNGSLPTSLLQCKRLKTLDLSQNNFTGSLPDGFGKGLISLEKLDLSFN 195
Query: 189 NLSGLIPNDIANLSRLRL-------------------LAQRVYVDLTYNNLSGLIPQNAA 229
SG IP+DI NLS L+ L ++VY+DLTYNNLSG IPQN A
Sbjct: 196 KFSGPIPSDIGNLSNLQGTVDLSHNIFSGSIPASLGDLPEKVYIDLTYNNLSGPIPQNGA 255
Query: 230 LLSLGPTAFIGNPFLCGPPLKVSCPSSTSDHP---------YPKPLPYDPSWHGGKVHHS 280
L++ GPTAFIGNP LCGPP K C T+ P YP P S G S
Sbjct: 256 LMNRGPTAFIGNPRLCGPPSKNPCSPETASSPSSIPFLPNNYPPPNSDGDSGKGKGRGLS 315
Query: 281 CAVITTVAVAVLLGICITGFLFYRQYKKASGCKWGEKVGGCRLEEKLMIKKEFFCFTRNN 340
+ + + V ++GIC+ G LF Y + C G+ G E+ +KE CF ++
Sbjct: 316 KSAVIGIVVGDVVGICLIGLLFSYCYSRMCSCGKGKDENGYGFEKGGKARKECLCFRKDE 375
Query: 341 LDTMSENMEQYEFVPLDSQVDFDLEQLLKASAFLLGKSTIGIVYKVALNNEEAVAVRRLG 400
+T+SEN+EQY+ VPLD+QV FDL++LLKASAF+LGKS IGIVYKV L + +AVRRLG
Sbjct: 376 SETLSENVEQYDLVPLDTQVAFDLDELLKASAFVLGKSGIGIVYKVVLEDGSTLAVRRLG 435
Query: 401 NGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLATAIHGKAGI 460
GG QRFKEFQTE EAIGK+RHPNIV+LRAY+WSVDEKLLIYDYIPNG+LATAIHGK G+
Sbjct: 436 EGGSQRFKEFQTEVEAIGKLRHPNIVTLRAYYWSVDEKLLIYDYIPNGNLATAIHGKPGM 495
Query: 461 ISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLAR 520
+S+RPL WS RL+I++G AKG+ +LHE SPK+YVHGDL+PSNILLG+NMEPHISDFGL R
Sbjct: 496 VSFRPLPWSVRLKIMEGTAKGLVYLHEFSPKKYVHGDLKPSNILLGQNMEPHISDFGLGR 555
Query: 521 LADIAEETPEVHWEQSTTGTPLQ----SSPYEFTALNSTTS-RSYYQAPEASKVRKPTQK 575
LA+IA +P + + T+ P Q + P E A++ST++ SYYQAPEA KV KP+QK
Sbjct: 556 LANIAGGSPTLQSSRMTSEKPPQRQQSNPPSEVGAVSSTSNLGSYYQAPEALKVVKPSQK 615
Query: 576 WDIYSYGVILLEMISGKLPMIQIGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKED 635
WD+YSYGVILLEMI+G+LP++Q+GS E+++V+WIQL +E++KP+ D+LDP+LA D DKE+
Sbjct: 616 WDVYSYGVILLEMITGRLPVVQVGSSEMDLVRWIQLCIEEKKPLADVLDPYLAQDADKEE 675
Query: 636 EIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRVNISTE 673
E+V+VLKIA+ CVH SP++RP+MRHV D LDR+ +ST+
Sbjct: 676 EMVAVLKIAMACVHSSPERRPAMRHVSDILDRLAMSTD 713
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147787085|emb|CAN73490.1| hypothetical protein VITISV_040575 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 810 bits (2093), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 407/698 (58%), Positives = 519/698 (74%), Gaps = 35/698 (5%)
Query: 11 ALMGSANDEGLALLSFKQAIRNFPEG--NNWNNSNEDPCSWNGITCREGQVFSLIIPNKK 68
A +GS N+EG+ALLSFK+++ PE +NWN+S+E+PCSWNGITC+E +V S+ IP KK
Sbjct: 16 AKVGSLNEEGVALLSFKRSVGEDPERSLDNWNSSDENPCSWNGITCKEERVVSVSIPKKK 75
Query: 69 LTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGKL 128
L GF+P+ LGSL+ + VNLRNN F GSLPVELF A LQSL+L GN+ SG VP +IG L
Sbjct: 76 LLGFLPSALGSLTQLRHVNLRNNKFFGSLPVELFKAQGLQSLVLYGNNLSGSVPSEIGSL 135
Query: 129 KYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFN 188
KYLQ LDLSQN F+ S+P+S++QCKRLKT+ L+QN+FTG LPDGF L +L+KLDLSFN
Sbjct: 136 KYLQTLDLSQNFFNGSLPTSLLQCKRLKTLXLSQNNFTGSLPDGFGKGLISLEKLDLSFN 195
Query: 189 NLSGLIPNDIANLSRLRL-------------------LAQRVYVDLTYNNLSGLIPQNAA 229
SG IP+DI NLS L+ L ++VY+DLTYNNLSG IPQN A
Sbjct: 196 KFSGPIPSDIGNLSNLQGTVDLSHNIFSGSIPASLGDLPEKVYIDLTYNNLSGPIPQNGA 255
Query: 230 LLSLGPTAFIGNPFLCGPPLKVSCPSSTSDHP---------YPKPLPYDPSWHGGKVHHS 280
L++ GPTAFIGNP LCGPP K C T+ P YP P S G S
Sbjct: 256 LMNRGPTAFIGNPRLCGPPSKNPCSPETASSPSSIPFLPNNYPPPNSDGDSGKGKGRGLS 315
Query: 281 CAVITTVAVAVLLGICITGFLFYRQYKKASGCKWGEKVGGCRLEEKLMIKKEFFCFTRNN 340
+ + + V ++GIC+ G LF Y + C G+ G E+ +KE CF ++
Sbjct: 316 KSAVIGIVVGDVVGICLIGLLFSYCYSRMCSCGKGKDENGYGFEKGGKARKECLCFRKDE 375
Query: 341 LDTMSENMEQYEFVPLDSQVDFDLEQLLKASAFLLGKSTIGIVYKVALNNEEAVAVRRLG 400
+T+SEN+EQY+ VPLD+QV FDL++LLKASAF+LGKS IGIVYKV L + +AVRRLG
Sbjct: 376 SETLSENVEQYDLVPLDTQVAFDLDELLKASAFVLGKSGIGIVYKVVLEDGSTLAVRRLG 435
Query: 401 NGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLATAIHGKAGI 460
GG QRFKEFQTE EAIGK+RHPNIV+LRAY+WSVDEKLLIYDYIPNG+LATAIHGK G+
Sbjct: 436 EGGSQRFKEFQTEVEAIGKLRHPNIVTLRAYYWSVDEKLLIYDYIPNGNLATAIHGKPGM 495
Query: 461 ISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLAR 520
+S+RPL WS RL+I++G AKG+ +LHE SPK+YVHGDL+PSNILLG+NMEPHISDFGL R
Sbjct: 496 VSFRPLPWSVRLKIMEGTAKGLVYLHEFSPKKYVHGDLKPSNILLGQNMEPHISDFGLGR 555
Query: 521 LADIAEETPEVHWEQSTTGTPLQ----SSPYEFTALNSTTS-RSYYQAPEASKVRKPTQK 575
LA+IA +P + + T+ P Q + P E A++ST++ SYYQAPEA KV KP+QK
Sbjct: 556 LANIAGGSPTLQSSRMTSEKPPQRQQSNPPSEVGAVSSTSNLGSYYQAPEALKVVKPSQK 615
Query: 576 WDIYSYGVILLEMISGKLPMIQIGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKED 635
WD+YSYGVILLEMI+G+LP++Q+GS E+++V+WIQL +E++KP+ D+LDP+LA D DKE+
Sbjct: 616 WDVYSYGVILLEMITGRLPVVQVGSSEMDLVRWIQLCIEEKKPLADVLDPYLAQDADKEE 675
Query: 636 EIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRVNISTE 673
E+V+VLKIA+ CVH SP++RP+MRHV D LDR+ +ST+
Sbjct: 676 EMVAVLKIAMACVHSSPERRPAMRHVSDILDRLAMSTD 713
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255574324|ref|XP_002528076.1| ATP binding protein, putative [Ricinus communis] gi|223532537|gb|EEF34326.1| ATP binding protein, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 808 bits (2086), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 404/695 (58%), Positives = 510/695 (73%), Gaps = 31/695 (4%)
Query: 2 LVLLILSYIALMGSANDEGLALLSFKQAIRNFPEG--NNWNNSNEDPCSWNGITCREGQV 59
L L+ SYI L S NDEGLALLSF+Q+I N G +NWN+S+++PCSW+G+ CR V
Sbjct: 5 LSFLMFSYILLANSLNDEGLALLSFRQSIENSTAGYLDNWNSSDDNPCSWHGVECRGETV 64
Query: 60 FSLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSG 119
SL IP+K L+G D L A+ +VNLRNN F GSLPVELF A L +L+LSGNSFSG
Sbjct: 65 VSLRIPHKGLSGLFHLDATKLLALRQVNLRNNYFFGSLPVELFRARGLTNLVLSGNSFSG 124
Query: 120 PVPMQIGKLKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTA 179
VP +IG LK L++LDLS+NSF+ SIPS +VQCKRLK + L++N+F G LP+GF TNL
Sbjct: 125 SVPDEIGNLKGLKILDLSENSFNGSIPSPLVQCKRLKQLYLSRNNFAGSLPNGFGTNLVM 184
Query: 180 LQKLDLSFNNLSGLIPNDIANLSRLRL-------------------LAQRVYVDLTYNNL 220
LQ LDLSFN LSGLIPND+ NLS L+ L + VY++L+YNNL
Sbjct: 185 LQILDLSFNKLSGLIPNDLGNLSSLKRGLDLSHNLFNGTIPASLGKLPELVYINLSYNNL 244
Query: 221 SGLIPQNAALLSLGPTAFIGNPFLCGPPLKVSCPSSTSDHPYPKPLPYDPSWH---GGKV 277
SGLIPQN LLS+GPTAF+GNP LCG PLK C PKP+PY+PS G
Sbjct: 245 SGLIPQNDVLLSVGPTAFVGNPLLCGLPLKSPCLMD------PKPIPYEPSQASPGGNSS 298
Query: 278 HHSCAVITTVAVAVLLGICITGFLFYRQYKKASGCKWGEKVGGCRLEEKLMIKKEFFCFT 337
S V+ + + ++G+ +T LF YK+ CK ++V GC EEK ++KE FCF
Sbjct: 299 SRSPTVVIGIVASTVVGVSLTAVLFSYWYKRTYVCKGSKRVEGCNPEEKSSVRKEMFCFR 358
Query: 338 RNNLDTMSENMEQYEFVPLDSQVDFDLEQLLKASAFLLGKSTIGIVYKVALNNEEAVAVR 397
++L+++SENMEQY F+PLDSQ+ FDLEQLLKASAFLL KS IGIVYKV L VAVR
Sbjct: 359 TDDLESLSENMEQYIFMPLDSQIKFDLEQLLKASAFLLSKSRIGIVYKVVLEKGPTVAVR 418
Query: 398 RLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLATAIHGK 457
RL +GG+QR++EFQTE EAI KI+HPNIV L AY W ++EKLLIY+Y NG L+ AIHG+
Sbjct: 419 RLEDGGFQRYREFQTEVEAIAKIKHPNIVCLLAYCWCINEKLLIYEYAQNGDLSAAIHGR 478
Query: 458 AGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFG 517
G+I ++PLSW RLRI++GVA+G++FLHE SP+RYVHG+L+PSNILLG+NMEP ISDFG
Sbjct: 479 TGMIYFKPLSWLVRLRIMQGVARGLSFLHEFSPRRYVHGNLKPSNILLGENMEPCISDFG 538
Query: 518 LARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWD 577
L+RLA EE+ V+ EQ+T GTPL SP+ FT +NS +YY+APE SK KP+QKWD
Sbjct: 539 LSRLAYTTEESTSVYLEQTTGGTPLPGSPFAFTPINSGAVMAYYEAPEVSKSSKPSQKWD 598
Query: 578 IYSYGVILLEMISGKLPMIQIGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEI 637
+YS+GVILLEMISGK P++Q + E+ +VQWIQL E KP++D+LDPFL HDLDK++E+
Sbjct: 599 VYSFGVILLEMISGKSPVMQTSASEMGLVQWIQLSTE-VKPLSDVLDPFLVHDLDKKEEM 657
Query: 638 VSVLKIALDCVHKSPDKRPSMRHVCDSLDRVNIST 672
V++L IAL CVH SPDKRPSMR+V DSL+R++ ST
Sbjct: 658 VAILNIALTCVHTSPDKRPSMRNVSDSLERLSSST 692
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224077204|ref|XP_002305177.1| predicted protein [Populus trichocarpa] gi|222848141|gb|EEE85688.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 795 bits (2054), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 411/693 (59%), Positives = 504/693 (72%), Gaps = 27/693 (3%)
Query: 4 LLILSYIALMGSANDEGLALLSFKQAIRNFPEG--NNWNNSNEDPCSWNGITCREGQVFS 61
I+ YI GS NDEGLALLSFKQ+I + +NWN+S+ +PCSW G+TCRE +VF
Sbjct: 10 FFIVHYITFAGSVNDEGLALLSFKQSIEDSTARSLDNWNSSDANPCSWYGVTCREEKVFF 69
Query: 62 LIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPV 121
L +PNK L G + D G L A+ VNLR+N SGSLPVELFNA+ L+SLILSGNSFSG V
Sbjct: 70 LRLPNKGLAGMLQLDTGKLVALSHVNLRSNYLSGSLPVELFNAAGLKSLILSGNSFSGTV 129
Query: 122 PMQIGKLKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQ 181
P +I LKYLQ LDLSQNSF+ S+PS ++QCKRLK +VL++N F G LPD NL LQ
Sbjct: 130 PEEIRNLKYLQTLDLSQNSFNGSLPSYLIQCKRLKNLVLSRNFFAGFLPDELGNNLVMLQ 189
Query: 182 KLDLSFNNLSGLIPNDIANLSRLRL-------------------LAQRVYVDLTYNNLSG 222
L+LS N+ GLIP + NLS LR L + VY++LTYNNLSG
Sbjct: 190 TLNLSHNSFRGLIPGSLGNLSSLRGVLDLSHNRFDGPIPASLGNLPELVYINLTYNNLSG 249
Query: 223 LIPQNAALLSLGPTAFIGNPFLCGPPLKVSCPSSTSDHPY--PKPLPY-DPSWHGGKVHH 279
IPQ AL+++GPTAFIGNP LCGPPLK CPSSTS HP PKPL D S G+
Sbjct: 250 AIPQTDALVNVGPTAFIGNPLLCGPPLKNQCPSSTS-HPNIDPKPLAVGDSSGKPGRGKW 308
Query: 280 SCAVITTVAVAVLLGICITGFLFYRQYKKASGCKWGEKVGGCRLEEKLMIKKEFFCFTRN 339
VI +VA + ++GIC+ F YKK GCK + G EEK M++KE FCF
Sbjct: 309 CWVVIASVA-STMVGICLVALSFCYWYKKVYGCKESIRTQGRSFEEKSMVRKEMFCFRTA 367
Query: 340 NLDTMSENMEQYEFVPLDSQVDFDLEQLLKASAFLLGKSTIGIVYKVALNNEEAVAVRRL 399
+L+++SE MEQY FVPLDS+V FDLEQLLKASAFL+GKS IGIVYKV L VAVRRL
Sbjct: 368 DLESLSETMEQYTFVPLDSKVSFDLEQLLKASAFLVGKSGIGIVYKVVLEKGLTVAVRRL 427
Query: 400 GNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLATAIHGKAG 459
+GG QRF+EFQT EAIGKIRHPNIVSL AY W ++EKLLIYDY+ NG LATAIHG+ G
Sbjct: 428 EDGGSQRFREFQTAVEAIGKIRHPNIVSLLAYCWCINEKLLIYDYVSNGDLATAIHGRTG 487
Query: 460 IISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLA 519
+ ++PLSWS RLRI+KG+AKG+AFLHE SPKRYVHG+L+ SNILLG+NMEPHISDFGL
Sbjct: 488 MTYFKPLSWSIRLRIMKGLAKGLAFLHECSPKRYVHGNLKTSNILLGENMEPHISDFGLN 547
Query: 520 RLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIY 579
A +EE+ V EQ T+GTP Q SPY T +S+ S S Y+APE+SKV KP+QKWD+Y
Sbjct: 548 CFAYTSEESIPVQGEQMTSGTPQQGSPYALTPTHSSMSGSCYEAPESSKVIKPSQKWDVY 607
Query: 580 SYGVILLEMISGKLPMIQIGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVS 639
S+GVILLE+ISGK P++Q+ +++V+WIQL +E KP +++LDPFLA D DKE E+++
Sbjct: 608 SFGVILLEIISGKSPIMQMSLSGMDLVRWIQLSIE-VKPPSEVLDPFLARDSDKEHEMIA 666
Query: 640 VLKIALDCVHKSPDKRPSMRHVCDSLDRVNIST 672
VLKIAL CVH SPDKRPSM++V ++L+R+ ST
Sbjct: 667 VLKIALACVHASPDKRPSMKNVSENLERLVSST 699
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255570657|ref|XP_002526283.1| ATP binding protein, putative [Ricinus communis] gi|223534364|gb|EEF36072.1| ATP binding protein, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 794 bits (2051), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 396/697 (56%), Positives = 509/697 (73%), Gaps = 38/697 (5%)
Query: 15 SANDEGLALLSFKQAIRNFPEGN--NWNNSNEDPCSWNGITCREGQVFSLIIPNKKLTGF 72
S N EG ALLSFKQ+I PEG+ NWN+S+E PCSWNG+TC+E +V S+ IP KKL GF
Sbjct: 19 SLNSEGFALLSFKQSIYQDPEGSLSNWNSSDETPCSWNGVTCKELKVVSVSIPKKKLFGF 78
Query: 73 IPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQ 132
+P+ LGSLS + VNLRNN F GSLP +LF A LQSL+L GNS SG +P IGKLKYLQ
Sbjct: 79 LPSSLGSLSDLRHVNLRNNMFFGSLPSQLFQAQGLQSLVLYGNSLSGSLPNDIGKLKYLQ 138
Query: 133 VLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSG 192
LDLSQNSF+ SIP SIVQC+RL+ + L+QN+F+G LPDGF + +L+KLDLSFN +G
Sbjct: 139 TLDLSQNSFNGSIPISIVQCRRLRALDLSQNNFSGSLPDGFGSGFVSLEKLDLSFNKFNG 198
Query: 193 LIPNDIANLSRLRL-------------------LAQRVYVDLTYNNLSGLIPQNAALLSL 233
IP+D+ NLS L+ L ++VY+DLTYNNLSG IPQ AL++
Sbjct: 199 SIPSDMGNLSSLQGTVDLSHNHFSGSIPASLGNLPEKVYIDLTYNNLSGPIPQTGALMNR 258
Query: 234 GPTAFIGNPFLCGPPLKVSCPSSTSDHPYPKPLPYDPSW--------HGGKVHH----SC 281
GPTAFIGNP LCGPPLK C S T + P +P+ PS HGGK S
Sbjct: 259 GPTAFIGNPGLCGPPLKNPCSSETPNANAPSSIPFLPSNYPPQDLDNHGGKSVKERGLSK 318
Query: 282 AVITTVAVAVLLGICITGFLFYRQYKKASGCKWGEKVGGCRLEEKLMIKKEFFCFTRNNL 341
+ + + V+ ++GIC+ G LF Y + C + +++ +KE CF ++
Sbjct: 319 SAVIAIIVSDVIGICLVGLLFSYCYSRVCACGKDKDESDYVFDKRGKGRKECLCFRKDES 378
Query: 342 DTMSENMEQYEFVPLDSQVDFDLEQLLKASAFLLGKSTIGIVYKVALNNEEAVAVRRLGN 401
+T+SE++EQY+ VPLD+QV FDL++LLKASAF+LGKS IGIVYKV L + +AVRRLG
Sbjct: 379 ETLSEHVEQYDLVPLDTQVTFDLDELLKASAFVLGKSGIGIVYKVVLEDGLTLAVRRLGE 438
Query: 402 GGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLATAIHGKAGII 461
GG QRFKEFQTE EAIGK+RHPNI +LRAY+WSVDEKLLIYDYIPNGSL+TA+HGK G++
Sbjct: 439 GGSQRFKEFQTEVEAIGKLRHPNIATLRAYYWSVDEKLLIYDYIPNGSLSTALHGKPGMV 498
Query: 462 SYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARL 521
S+ PLSW+ RL+IIKG+AKG+ +LHE SPK+YVHGDL+PSNILLG NMEP+ISDFGL RL
Sbjct: 499 SFTPLSWTMRLKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPYISDFGLGRL 558
Query: 522 ADIAEETPEVHWEQSTTGTPLQ----SSPYEFTALNSTTSR-SYYQAPEASKVRKPTQKW 576
A+IA +P + + T P + S+P A+ S TS SYYQAPEA KV KP+QKW
Sbjct: 559 ANIAGGSPTLQSNRITVEKPHEKQQKSAPSSEVAMVSATSMGSYYQAPEALKVVKPSQKW 618
Query: 577 DIYSYGVILLEMISGKLPMIQIGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDE 636
D+YSYGVILLEMI+G+ P++ +G+ E+++VQWIQL +E++KP+ D+LDP+LA D+DKE+E
Sbjct: 619 DVYSYGVILLEMITGRSPLVHVGTSEMDLVQWIQLCIEEQKPLADVLDPYLAPDVDKEEE 678
Query: 637 IVSVLKIALDCVHKSPDKRPSMRHVCDSLDRVNISTE 673
I++VLKIA+ CVH S ++RP+MRHV D L R+ I ++
Sbjct: 679 IIAVLKIAMACVHNSSERRPTMRHVSDVLSRLVIPSD 715
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224111612|ref|XP_002315920.1| predicted protein [Populus trichocarpa] gi|222864960|gb|EEF02091.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 790 bits (2040), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 396/708 (55%), Positives = 508/708 (71%), Gaps = 52/708 (7%)
Query: 11 ALMGSANDEGLALLSFKQAIRNFPEGN--NWNNSNEDPCSWNGITCREGQVFSLIIPNKK 68
+L+ N+EG ALLSFKQ+I PEG+ NWN+S+++PCSWNG+TC++ +V S+ IP K+
Sbjct: 16 SLVSCLNNEGYALLSFKQSIYEDPEGSLSNWNSSDDNPCSWNGVTCKDFKVMSVSIPKKR 75
Query: 69 LTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGKL 128
L GF+P+ LGSLS + VNLRNN FSGSLP ELF A LQSL+L GNS SG +P Q GKL
Sbjct: 76 LYGFLPSALGSLSDLRHVNLRNNRFSGSLPAELFQAQGLQSLVLYGNSLSGSLPNQFGKL 135
Query: 129 KYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFN 188
KYLQ LDLSQN F+ SIP+S V CKRL+ + L+QN+ TG LP GF +L +L+KLDLSFN
Sbjct: 136 KYLQTLDLSQNFFNGSIPTSFVLCKRLRALDLSQNNLTGSLPVGFGASLVSLEKLDLSFN 195
Query: 189 NLSGLIPNDIANLSRLRLLA-------------------QRVYVDLTYNNLSGLIPQNAA 229
+G IP+D+ NLS L+ A ++VY+DLTYNNLSG IPQ A
Sbjct: 196 KFNGSIPSDMGNLSSLQGTADLSHNLFTGSIPASLGNLPEKVYIDLTYNNLSGPIPQTGA 255
Query: 230 LLSLGPTAFIGNPFLCGPPLKVSCPSSTSDHPYPKPLPY--------DPSWHGGKVHHSC 281
L++ GPTAFIGNP LCGPPLK C S T P +P+ D +G K
Sbjct: 256 LMNRGPTAFIGNPGLCGPPLKNPCSSDTDGAAAPSSIPFLPNNSPPQDSDNNGRKSEKGR 315
Query: 282 AVITTVAVAVL----LGICITGFLFYRQY-------KKASGCKWGEKVGGCRLEEKLMIK 330
+ T VA++ +GIC+ G LF Y K G +G + GG + +
Sbjct: 316 GLSKTAVVAIIVSDVIGICLVGLLFSYCYSRVCQRSKDRDGNSYGFEKGGKK-------R 368
Query: 331 KEFFCFTRNNLDTMSENMEQYEFVPLDSQVDFDLEQLLKASAFLLGKSTIGIVYKVALNN 390
+E FCF ++ +T+SEN+EQY+ VPLD+QV FDL++LLKASAF+LGKS IGIVYKV L +
Sbjct: 369 RECFCFRKDESETLSENVEQYDLVPLDAQVAFDLDELLKASAFVLGKSGIGIVYKVVLED 428
Query: 391 EEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSL 450
+AVRRLG GG QRFKEFQTE EAIGK+RHPNIV LRAY+WSVDEKLLIYDYIPNGSL
Sbjct: 429 GHTLAVRRLGEGGSQRFKEFQTEVEAIGKLRHPNIVILRAYYWSVDEKLLIYDYIPNGSL 488
Query: 451 ATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNME 510
ATA+HGK G++SY PLSWSDRL+IIKG+AKG+ +LHE SPK+YVHGDL+PSN+LLG+NME
Sbjct: 489 ATALHGKPGMVSYTPLSWSDRLKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNVLLGQNME 548
Query: 511 PHISDFGLARLADIAEETPEVHWEQSTTGTPLQ-----SSPYEFTALNSTTSRSYYQAPE 565
PHISDFGL RLA IA +P + + + P + + E ++ST SYYQAPE
Sbjct: 549 PHISDFGLGRLATIAGGSPTLESNRIASEKPQERQQKGAPSSEVATVSSTNLGSYYQAPE 608
Query: 566 ASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQWIQLILEDRKPMTDILDP 625
A KV KP+QKWD+YSYGVILLEMI+G+ M+ +G+ E+ +V WIQL +E++KP+ D+LDP
Sbjct: 609 ALKVLKPSQKWDVYSYGVILLEMITGRSSMVHVGTSEMYLVHWIQLCIEEQKPLADVLDP 668
Query: 626 FLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRVNISTE 673
+LA D+DKE+EI++VLKIA+ CVH SP++RP+MRHV D +R+ +S++
Sbjct: 669 YLAPDVDKEEEIIAVLKIAMACVHSSPERRPTMRHVSDVFNRLAMSSD 716
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224099409|ref|XP_002311473.1| predicted protein [Populus trichocarpa] gi|222851293|gb|EEE88840.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 769 bits (1986), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 389/701 (55%), Positives = 504/701 (71%), Gaps = 39/701 (5%)
Query: 11 ALMGSANDEGLALLSFKQAIRNFPEGN--NWNNSNEDPCSWNGITCREGQVFSLIIPNKK 68
+L+ S N EG ALLSFKQ+I PEG+ NWN+S+++PCSWNG+TC++ +V SL IP KK
Sbjct: 16 SLVTSLNSEGYALLSFKQSINEDPEGSLSNWNSSDDNPCSWNGVTCKDLKVMSLSIPKKK 75
Query: 69 LTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGKL 128
L GF+P+ LGSLS + +NLRNN F G LP ELF A LQSL+L GNSFSG +P QIGKL
Sbjct: 76 LYGFLPSALGSLSDLRHINLRNNRFFGPLPAELFQAQGLQSLVLYGNSFSGSLPNQIGKL 135
Query: 129 KYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFN 188
KYLQ LDLSQN F+ SIP+SIVQC+R + + L+QN+FTG LP GF T L +L+KLDLSFN
Sbjct: 136 KYLQTLDLSQNFFNGSIPTSIVQCRRHRVLDLSQNNFTGSLPVGFGTGLVSLEKLDLSFN 195
Query: 189 NLSGLIPNDIANLSRLRLLA-------------------QRVYVDLTYNNLSGLIPQNAA 229
+G IP+D+ NLS L+ A ++VY+DLTYNNLSG IPQN A
Sbjct: 196 KFNGSIPSDMGNLSSLQGTADLSHNLFTGSIPASLGNLPEKVYIDLTYNNLSGPIPQNGA 255
Query: 230 LLSLGPTAFIGNPFLCGPPLKVSCPSSTSDHPYPKPLPYDP-------SWHGGKVHH--- 279
L++ GPTAFIGNP LCGPPLK CPS T+ P +P+ P S + G+
Sbjct: 256 LMNRGPTAFIGNPGLCGPPLKNPCPSDTAGASAPSAIPFLPNNSPPQDSDNSGRKSEKGR 315
Query: 280 --SCAVITTVAVAVLLGICITGFLFYRQYKKASGCKWGEKVGGCRLEEKLMIKKEFFCFT 337
S + + + V+ ++GIC+ G LF Y +A + + E+ +K F
Sbjct: 316 GLSKSAVVAIIVSDVIGICLVGLLFSYCYSRACPRRKDKDENDNGFEKGGKRRKGCLRFR 375
Query: 338 RNNLDTMSENMEQYEFVPLDSQVDFDLEQLLKASAFLLGKSTIGIVYKVALNNEEAVAVR 397
++ +T+SEN+EQ + VPLD+QV FDL++LLKASAF+LGK IGI YKV L + +AVR
Sbjct: 376 KDESETLSENVEQCDLVPLDAQVAFDLDELLKASAFVLGKGGIGIAYKVVLEDGYTLAVR 435
Query: 398 RLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLATAIHGK 457
RLG GG QRFKEFQTE EAIGK+RHPN+V+LRAY+WSVDEKLLIYDYIPNGSL TA+HGK
Sbjct: 436 RLGEGGSQRFKEFQTEVEAIGKLRHPNVVTLRAYYWSVDEKLLIYDYIPNGSLDTALHGK 495
Query: 458 AGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFG 517
G++S+ PLSWS RL+IIKG+A+G+ +LHE S K+YVHGDL+PSN+LLG+NMEPHISDFG
Sbjct: 496 PGMVSFTPLSWSVRLKIIKGIARGLVYLHEFSTKKYVHGDLKPSNVLLGQNMEPHISDFG 555
Query: 518 LARLADIAEETPEVHWEQSTTGTPLQSS-----PYEFTALNSTTSRSYYQAPEASKVRKP 572
L RLA IA +P +ST P + E ++ST SYYQAPEA KV KP
Sbjct: 556 LGRLATIAGGSPTRESNRSTLEKPQERQQKGEPSSEVATVSSTNLVSYYQAPEALKVLKP 615
Query: 573 TQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLD 632
+QKWD+YS GVILLEMI+G+ P++ +G+ E+++V WIQL +E++KP+ D+LDP+LA D+D
Sbjct: 616 SQKWDVYSCGVILLEMITGRSPVVCVGTSEMDLVHWIQLCIEEQKPLVDVLDPYLAPDVD 675
Query: 633 K-EDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRVNIST 672
K E+EIV+VLKIA+ CVH +P++RP+MRHV D +R+ IS+
Sbjct: 676 KEEEEIVAVLKIAMACVHSNPERRPTMRHVSDVFNRLVISS 716
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356573811|ref|XP_003555049.1| PREDICTED: probable inactive leucine-rich repeat receptor-like protein kinase At1g66830-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 739 bits (1908), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 377/708 (53%), Positives = 500/708 (70%), Gaps = 38/708 (5%)
Query: 2 LVLLILS---YIALMGSANDEGLALLSFKQAIRNFPEGN--NWNNSNEDPCSWNGITCRE 56
+VLL L+ ++A + S EG LL+ K++I PEG+ NWN+S++ PCSWNGITC++
Sbjct: 5 VVLLFLACNFHVAPVSSLTVEGSVLLALKKSIITDPEGSLSNWNSSDDTPCSWNGITCKD 64
Query: 57 GQVFSLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNS 116
V S+ IP +KL G +P++LGSLS + +NLRNNN G LPV LF A LQSL+L GNS
Sbjct: 65 QSVVSISIPKRKLHGVLPSELGSLSHLRHLNLRNNNLFGDLPVGLFEAQGLQSLVLYGNS 124
Query: 117 FSGPVPMQIGKLKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATN 176
SG VP +IGKL+YLQ LDLSQN ++ S+P++IVQCKRL+T+VL+ N+FTGPLPDGF
Sbjct: 125 LSGSVPNEIGKLRYLQALDLSQNFYNGSLPAAIVQCKRLRTLVLSHNNFTGPLPDGFGGG 184
Query: 177 LTALQKLDLSFNNLSGLIPNDIANLSRLRL-------------------LAQRVYVDLTY 217
L++L+KLDLSFN +GLIP+D+ LS L+ L ++VY+DLTY
Sbjct: 185 LSSLEKLDLSFNEFNGLIPSDMGKLSSLQGTVDLSHNHFSGSIPASLGNLPEKVYIDLTY 244
Query: 218 NNLSGLIPQNAALLSLGPTAFIGNPFLCGPPLKVSCPSSTSDHPYPKPLPYDPSWH---- 273
NNLSG IPQ AL++ GPTAFIGN LCGPPLK C T P P P +
Sbjct: 245 NNLSGPIPQTGALMNRGPTAFIGNSGLCGPPLKNLCAPDTHGASSPSSFPVLPDNYPPQD 304
Query: 274 --------GGKVHHSCAVITTVAVAVLLGICITGFLFYRQYKKASGCKWGEKVGGCRLEE 325
G S + + V ++GIC+ G LF Y + G ++ G ++
Sbjct: 305 SDDGFVKSGKSKRLSKGAVVGIVVGDIVGICLLGLLFSYCYSRVWGFTQDQEEKG--FDK 362
Query: 326 KLMIKKEFFCFTRNNLDTMSENMEQYEFVPLDSQVDFDLEQLLKASAFLLGKSTIGIVYK 385
++KE CF ++ +T+S++ EQY+ VPLD+QV FDL++LLKASAF+LGKS IGIVYK
Sbjct: 363 GRRLRKECLCFRKDESETLSDHDEQYDLVPLDAQVAFDLDELLKASAFVLGKSEIGIVYK 422
Query: 386 VALNNEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYI 445
V L +AVRRLG GG QRFKEFQTE EAIGK+RHPNIV+LRAY+WSVDEKLLIYDY+
Sbjct: 423 VVLEEGLNLAVRRLGEGGSQRFKEFQTEVEAIGKLRHPNIVTLRAYYWSVDEKLLIYDYV 482
Query: 446 PNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILL 505
PNGSLATAIHGKAG+ ++ PLSWS R++I+KGVAKG+ +LHE SPK+YVHGDL+P NILL
Sbjct: 483 PNGSLATAIHGKAGLATFTPLSWSVRVKIMKGVAKGLVYLHEFSPKKYVHGDLKPGNILL 542
Query: 506 GKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPE 565
G + EP ISDFGL RLA+IA +P + + + T + ++ + YQAPE
Sbjct: 543 GHSQEPCISDFGLGRLANIAGGSPTLQSNRVAAEKSQERQRSLSTEVTTSILGNGYQAPE 602
Query: 566 ASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQWIQLILEDRKPMTDILDP 625
KV KP+QKWD+YSYGVILLE+I+G+LP++Q+G+ E+++VQWIQ ++++KP++D+LD
Sbjct: 603 TLKVVKPSQKWDVYSYGVILLELITGRLPIVQVGNSEMDLVQWIQCCIDEKKPLSDVLDL 662
Query: 626 FLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRVNISTE 673
+LA D DKE+EI++VLKIA+ CVH SP+KRP MRHV D LDR++I ++
Sbjct: 663 YLAEDADKEEEIIAVLKIAIACVHSSPEKRPIMRHVLDVLDRLSIPSD 710
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449458815|ref|XP_004147142.1| PREDICTED: probable inactive leucine-rich repeat receptor-like protein kinase At1g66830-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 733 bits (1893), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 367/704 (52%), Positives = 497/704 (70%), Gaps = 39/704 (5%)
Query: 2 LVLLILS-YIALMGSANDEGLALLSFKQAIRNFPEG--NNWNNSNEDPCSWNGITCREGQ 58
L+LL S + L+ S NDEG LL+ KQ+I P+G + W++SNE PCSWNG+ C
Sbjct: 7 LILLCCSDCLVLVSSLNDEGFVLLTLKQSISLDPDGAFSYWDSSNETPCSWNGVGCLNDI 66
Query: 59 VFSLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFS 118
V S+ IP + L GF+P+ LG+LS + +NLRNN GSLP +LF+A LQSL+L GNSFS
Sbjct: 67 VVSVTIPKRNLYGFLPSSLGALSGLRHLNLRNNRLFGSLPFQLFSAQALQSLVLYGNSFS 126
Query: 119 GPVPMQIGKLKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLT 178
G VP IGKLKYLQ LDLSQN F+ S+P+SI+QC RLKT+ ++ N+FTG LP GF T+ +
Sbjct: 127 GFVPNGIGKLKYLQTLDLSQNLFNGSLPASIIQCSRLKTIDVSHNNFTGSLPHGFGTSFS 186
Query: 179 ALQKLDLSFNNLSGLIPNDIANLSRLRL-------------------LAQRVYVDLTYNN 219
L+KLDLSFN G +P+D+ NLS L+ L ++VY+DL++NN
Sbjct: 187 YLEKLDLSFNTFDGSLPSDLGNLSSLQGTFDLSHNLFSGSIPSSLGNLPEKVYIDLSHNN 246
Query: 220 LSGLIPQNAALLSLGPTAFIGNPFLCGPPLKVSCPSSTSDHPYPKPLPYDPSWHGGKVHH 279
LSG IPQN AL++ GPTAFIGNP LCG PLK C S T P LP+ P H +
Sbjct: 247 LSGPIPQNGALMNRGPTAFIGNPGLCGSPLKSKCSSGTLSASSPSLLPFLPDDHSPGISG 306
Query: 280 ---------SCAVITTVAVAVLLGICITGFLFYRQYKKASGCKWGEKVGGCRLEEKLMIK 330
S + + + + ++GIC+ G LF Y +A + +K+G +K +
Sbjct: 307 VYAEKTRGLSKSAVIAIVLGDVVGICLIGLLFSYCYSRACYPRTKDKMG--HNSDKGKGR 364
Query: 331 KEFFCFTRNNLDTMSENMEQYEFVPLDSQVDFDLEQLLKASAFLLGKSTIGIVYKVALNN 390
E CF ++ +++S+N+EQY+ VPLD+QV FDL++LLKASAF++GKS IGIVYKV L +
Sbjct: 365 NECLCFRKDESESVSQNVEQYDLVPLDAQVGFDLDELLKASAFVIGKSGIGIVYKVVLED 424
Query: 391 EEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSL 450
+AVRRLG GG QRFKEFQTE EAI K+RH N+V+LRAY+WSVDEKLLIY++IPNG+L
Sbjct: 425 GVTLAVRRLGEGGSQRFKEFQTEVEAIAKLRHSNLVTLRAYYWSVDEKLLIYEFIPNGNL 484
Query: 451 ATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNME 510
ATAIHGK G +S+ PLSWS RL+I++G+AKGI +LHE SPK+YVHGDL+P+NILL +NME
Sbjct: 485 ATAIHGKPGTVSFTPLSWSARLKIMEGIAKGIVYLHEFSPKKYVHGDLKPNNILLTQNME 544
Query: 511 PHISDFGLARLADIAEETPEVHWEQSTTGTPL-----QSSPYEFTALNSTTSRSYYQAPE 565
ISDFGLARLA+IA TP + + + PL ++ E +S+ + + YQAPE
Sbjct: 545 AKISDFGLARLANIAGGTPTLQSSRMASEKPLDPKQPKTVTSEIICSSSSNTGTCYQAPE 604
Query: 566 ASKVRKPTQKWDIYSYGVILLEMISGKLPMIQI-GSMELNIVQWIQLILEDRKPMTDILD 624
+ KV KP+QKWD+YSYG+ILLEMI+G+ P+IQ+ S E+++V WIQL +E++KP+++++D
Sbjct: 605 SLKVLKPSQKWDVYSYGMILLEMITGRFPLIQVSSSSEMDLVHWIQLCIEEKKPLSEVID 664
Query: 625 PFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRV 668
P L D DKE+E +S+LKIA+ CVH SP++RP+MRHV D+++R+
Sbjct: 665 PHLIQDADKEEEFISILKIAMSCVHGSPERRPTMRHVSDAIERL 708
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449503421|ref|XP_004161994.1| PREDICTED: probable inactive leucine-rich repeat receptor-like protein kinase At1g66830-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 733 bits (1893), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 367/704 (52%), Positives = 497/704 (70%), Gaps = 39/704 (5%)
Query: 2 LVLLILS-YIALMGSANDEGLALLSFKQAIRNFPEG--NNWNNSNEDPCSWNGITCREGQ 58
L+LL S + L+ S NDEG LL+ KQ+I P+G + W++SNE PCSWNG+ C
Sbjct: 7 LILLCCSDCLVLVSSLNDEGFVLLTLKQSISLDPDGAFSYWDSSNETPCSWNGVGCLNDI 66
Query: 59 VFSLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFS 118
V S+ IP + L GF+P+ LG+LS + +NLRNN GSLP +LF+A LQSL+L GNSFS
Sbjct: 67 VVSVTIPKRNLYGFLPSSLGALSGLRHLNLRNNRLFGSLPFQLFSAQALQSLVLYGNSFS 126
Query: 119 GPVPMQIGKLKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLT 178
G VP IGKLKYLQ LDLSQN F+ S+P+SI+QC RLKT+ ++ N+FTG LP GF T+ +
Sbjct: 127 GFVPNGIGKLKYLQTLDLSQNLFNGSLPASIIQCSRLKTIDVSHNNFTGSLPHGFGTSFS 186
Query: 179 ALQKLDLSFNNLSGLIPNDIANLSRLRL-------------------LAQRVYVDLTYNN 219
L+KLDLSFN G +P+D+ NLS L+ L ++VY+DL++NN
Sbjct: 187 YLEKLDLSFNTFDGSLPSDLGNLSSLQGTFDLSHNLFSGSIPSSLGNLPEKVYIDLSHNN 246
Query: 220 LSGLIPQNAALLSLGPTAFIGNPFLCGPPLKVSCPSSTSDHPYPKPLPYDPSWHGGKVHH 279
LSG IPQN AL++ GPTAFIGNP LCG PLK C S T P LP+ P H +
Sbjct: 247 LSGPIPQNGALMNRGPTAFIGNPGLCGSPLKSKCSSGTLSASSPSLLPFLPDDHSPGISG 306
Query: 280 ---------SCAVITTVAVAVLLGICITGFLFYRQYKKASGCKWGEKVGGCRLEEKLMIK 330
S + + + + ++GIC+ G LF Y +A + +K+G +K +
Sbjct: 307 VYAEKTRGLSKSAVIAIVLGDVVGICLIGLLFSYCYSRACYPRTKDKMG--HNSDKGKGR 364
Query: 331 KEFFCFTRNNLDTMSENMEQYEFVPLDSQVDFDLEQLLKASAFLLGKSTIGIVYKVALNN 390
E CF ++ +++S+N+EQY+ VPLD+QV FDL++LLKASAF++GKS IGIVYKV L +
Sbjct: 365 NECLCFRKDESESVSQNVEQYDLVPLDAQVGFDLDELLKASAFVIGKSGIGIVYKVVLED 424
Query: 391 EEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSL 450
+AVRRLG GG QRFKEFQTE EAI K+RH N+V+LRAY+WSVDEKLLIY++IPNG+L
Sbjct: 425 GVTLAVRRLGEGGSQRFKEFQTEVEAIAKLRHSNLVTLRAYYWSVDEKLLIYEFIPNGNL 484
Query: 451 ATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNME 510
ATAIHGK G +S+ PLSWS RL+I++G+AKGI +LHE SPK+YVHGDL+P+NILL +NME
Sbjct: 485 ATAIHGKPGTVSFTPLSWSARLKIMEGIAKGIVYLHEFSPKKYVHGDLKPNNILLTQNME 544
Query: 511 PHISDFGLARLADIAEETPEVHWEQSTTGTPL-----QSSPYEFTALNSTTSRSYYQAPE 565
ISDFGLARLA+IA TP + + + PL ++ E +S+ + + YQAPE
Sbjct: 545 AKISDFGLARLANIAGGTPTLQSSRMASEKPLDPKQPKTVTSEIICSSSSNTGTCYQAPE 604
Query: 566 ASKVRKPTQKWDIYSYGVILLEMISGKLPMIQI-GSMELNIVQWIQLILEDRKPMTDILD 624
+ KV KP+QKWD+YSYG+ILLEMI+G+ P+IQ+ S E+++V WIQL +E++KP+++++D
Sbjct: 605 SLKVLKPSQKWDVYSYGMILLEMITGRFPLIQVSSSSEMDLVHWIQLCIEEQKPLSEVID 664
Query: 625 PFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRV 668
P L D DKE+E +S+LKIA+ CVH SP++RP+MRHV D+++R+
Sbjct: 665 PHLIQDADKEEEFISILKIAMSCVHGSPERRPTMRHVSDAIERL 708
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 686 | ||||||
| TAIR|locus:2038706 | 716 | AT2G01210 [Arabidopsis thalian | 0.876 | 0.839 | 0.469 | 2.6e-141 | |
| TAIR|locus:2033000 | 702 | AT1G25320 [Arabidopsis thalian | 0.862 | 0.843 | 0.470 | 1.4e-135 | |
| TAIR|locus:2033379 | 685 | AT1G66830 [Arabidopsis thalian | 0.826 | 0.827 | 0.440 | 3.6e-121 | |
| TAIR|locus:2008793 | 719 | AT1G67510 [Arabidopsis thalian | 0.865 | 0.826 | 0.367 | 5.6e-100 | |
| TAIR|locus:2058598 | 773 | AT2G23300 [Arabidopsis thalian | 0.460 | 0.408 | 0.394 | 3e-95 | |
| TAIR|locus:2115120 | 768 | AT4G37250 [Arabidopsis thalian | 0.443 | 0.395 | 0.397 | 6.1e-95 | |
| TAIR|locus:2157182 | 751 | RLK "receptor-like kinase" [Ar | 0.475 | 0.434 | 0.378 | 2.6e-94 | |
| TAIR|locus:2053751 | 646 | AT2G42290 [Arabidopsis thalian | 0.472 | 0.501 | 0.416 | 3e-93 | |
| TAIR|locus:2095773 | 662 | AT3G57830 [Arabidopsis thalian | 0.467 | 0.484 | 0.391 | 1.9e-91 | |
| TAIR|locus:2124296 | 757 | AT4G34220 [Arabidopsis thalian | 0.374 | 0.339 | 0.372 | 4.1e-86 |
| TAIR|locus:2038706 AT2G01210 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1382 (491.5 bits), Expect = 2.6e-141, P = 2.6e-141
Identities = 296/631 (46%), Positives = 406/631 (64%)
Query: 62 LIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPV 121
L + + + G +P L L + + L N+F GSL E+ LQ+L LS N F+G +
Sbjct: 93 LNLRSNRFYGSLPIQLFHLQGLQSLVLYGNSFDGSLSEEIGKLKLLQTLDLSQNLFNGSL 152
Query: 122 PMQIGKLKYLQVLDLXXXXXXXXXXXXIVQC-KRLKTVVLNQNSFTGPLPDGFATNLTAL 180
P+ I + L+ LD+ L+ + L N F G +P NL+ L
Sbjct: 153 PLSILQCNRLKTLDVSRNNLSGPLPDGFGSAFVSLEKLDLAFNQFNGSIPSDIG-NLSNL 211
Query: 181 Q-KLDLSFNNLSGLIPNDIANLSRLRLLAQRVYVDLTYNNLSGLIPQNAALLSLGPTAFI 239
Q D S N+ +G IP + +L ++VY+DLT+NNLSG IPQ AL++ GPTAFI
Sbjct: 212 QGTADFSHNHFTGSIPPALGDLP------EKVYIDLTFNNLSGPIPQTGALMNRGPTAFI 265
Query: 240 GNPFLCGPPLKVSCPSS----TSDHPY-PKPLPYDPS--WHGGKVHHSCXXXXXXXXXXL 292
GN LCGPPLK C + +P+ P P + S + S +
Sbjct: 266 GNTGLCGPPLKDLCQGYQLGLNASYPFIPSNNPPEDSDSTNSETKQKSSGLSKSAVIAIV 325
Query: 293 L----GICITGFLFYRQYKKASGCKWGEKVGGCRLEEKLMIKKEFFCFTRNNLDTMSENM 348
L GIC+ G LF Y K C E G E K E CF ++ +T SEN+
Sbjct: 326 LCDVFGICLVGLLFTYCYSKFCACN-RENQFGVEKESKKRAS-ECLCFRKDESETPSENV 383
Query: 349 EQYEFVPLDSQVDFDLEQLLKASAFLLGKSTIGIVYKVALNNEEAVAVRRLGNGGWQRFK 408
E + VPLD+QV F+LE+LLKASAF+LGKS IGIVYKV L N +AVRRLG GG QRFK
Sbjct: 384 EHCDIVPLDAQVAFNLEELLKASAFVLGKSGIGIVYKVVLENGLTLAVRRLGEGGSQRFK 443
Query: 409 EFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSW 468
EFQTE EAIGK++HPNI SLRAY+WSVDEKLLIYDY+ NG+LATA+HGK G+++ PL+W
Sbjct: 444 EFQTEVEAIGKLKHPNIASLRAYYWSVDEKLLIYDYVSNGNLATALHGKPGMMTIAPLTW 503
Query: 469 SDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAE-E 527
S+RLRI+KG+A G+ +LHE SPK+YVHGDL+PSNIL+G++MEP ISDFGLARLA+IA
Sbjct: 504 SERLRIMKGIATGLVYLHEFSPKKYVHGDLKPSNILIGQDMEPKISDFGLARLANIAGGS 563
Query: 528 TPEVHWEQ--STTGTPLQSSPYEFTALNS-----TTSRSYYQAPEASKVRKPTQKWDIYS 580
+P + + T P + + +++S ++S SYYQAPE K+ KP+QKWD+YS
Sbjct: 564 SPTIQSNRIIQTDQQPQERQQHHHKSVSSEFTAHSSSGSYYQAPETLKMVKPSQKWDVYS 623
Query: 581 YGVILLEMISGKLPMIQIGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSV 640
YG+ILLE+I+G+ P +++G+ E+++V+W+Q+ +E++KP+ D+LDP LA + + EDEIV+V
Sbjct: 624 YGIILLELIAGRSPAVEVGTSEMDLVRWVQVCIEEKKPLCDVLDPCLAPEAETEDEIVAV 683
Query: 641 LKIALDCVHKSPDKRPSMRHVCDSLDRVNIS 671
LKIA+ CV+ SP+KRP+MRHV D+LDR+ ++
Sbjct: 684 LKIAISCVNSSPEKRPTMRHVSDTLDRLPVA 714
|
|
| TAIR|locus:2033000 AT1G25320 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1328 (472.5 bits), Expect = 1.4e-135, P = 1.4e-135
Identities = 291/619 (47%), Positives = 395/619 (63%)
Query: 62 LIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPV 121
L + + +L+G +P +L + + L N SGS+P E+ + LQ L LS NS +G +
Sbjct: 96 LNLRSNELSGNLPVELFKAQGLQSLVLYGNFLSGSIPNEIGDLKFLQILDLSRNSLNGSI 155
Query: 122 PMQIGKLKYLQVLDLXXXXXXXXXXXXIVQC-KRLKTVVLNQNSFTGPLPDGFATNLTAL 180
P + K L+ DL Q L+ + L+ N+ G +PD NLT L
Sbjct: 156 PESVLKCNRLRSFDLSQNNLTGSVPSGFGQSLASLQKLDLSSNNLIGLVPDDLG-NLTRL 214
Query: 181 Q-KLDLSFNNLSGLIPNDIANLSRLRLLAQRVYVDLTYNNLSGLIPQNAALLSLGPTAFI 239
Q LDLS N+ SG IP + NL ++VYV+L YNNLSG IPQ AL++ GPTAF+
Sbjct: 215 QGTLDLSHNSFSGSIPASLGNLP------EKVYVNLAYNNLSGPIPQTGALVNRGPTAFL 268
Query: 240 GNPFLCGPPLKVSC-P---SSTSDHPYPKPLPYDPSWHGGKVHHSCXXXXXXXXXX--LL 293
GNP LCGPPLK C P SS++ HP+ P + G K +
Sbjct: 269 GNPRLCGPPLKDPCLPDTDSSSTSHPFV-PDNNEQGGGGSKKGEGLSKTAIVAIVVCDFI 327
Query: 294 GICITGFLFYRQYKKASGCKWGEKVGGCRLEEKLMIKKEFFCFTRNNLDT-MSENME-QY 351
GICI GFLF Y K + G LE++ KK FCF R+ ++ SEN+E Q
Sbjct: 328 GICIVGFLFSCCYLKICARRNSVDEEGYVLEKEGKEKKGSFCFRRDGSESPSSENLEPQQ 387
Query: 352 EFVPLDSQVDFDLEQLLKASAFLLGKSTIGIVYKVALNNEEAVAVRRLGNGGWQRFKEFQ 411
+ V LD + DL++LLKASAF+LGK GIVYKV L + VAVRRLG GG QR KEFQ
Sbjct: 388 DLVLLDKHIALDLDELLKASAFVLGKGGNGIVYKVVLEDGLTVAVRRLGEGGSQRCKEFQ 447
Query: 412 TEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDR 471
TE EAIGK+RHPNIVSL+AY+WSV+EKLLIYDYIPNGSL A+HG G++S++PLSW R
Sbjct: 448 TEVEAIGKLRHPNIVSLKAYYWSVEEKLLIYDYIPNGSLTNALHGNPGMVSFKPLSWGVR 507
Query: 472 LRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEV 531
L+I++G+++G+ +LHE SPK+YVHG L+ SNILLG++MEPHISDFGL L+ IA
Sbjct: 508 LKIMRGISRGLVYLHEFSPKKYVHGSLKLSNILLGQDMEPHISDFGLMHLSSIAGTL--- 564
Query: 532 HWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVR-KPTQKWDIYSYGVILLEMIS 590
E +T P S+ + +S S+Y APEA+K KP+QKWD+YS+GVILLEMI+
Sbjct: 565 --ESTTVDRP--SNKTASSIGSSANLSSFYLAPEATKATVKPSQKWDVYSFGVILLEMIT 620
Query: 591 GKLPMIQIGSMELNIVQWIQLILEDRKPMTDILDPFLA-HDLDKEDEIVSVLKIALDCVH 649
G+LP++ +G E+ IV+WIQ+ ++++K M+DILDP+L +D + E+E+++VLKIA+ CV
Sbjct: 621 GRLPIVFVGKSEMEIVKWIQMCIDEKKEMSDILDPYLVPNDTEIEEEVIAVLKIAMACVS 680
Query: 650 KSPDKRPSMRHVCDSLDRV 668
SP+KRP M+H+ D+L ++
Sbjct: 681 TSPEKRPPMKHIADALTQI 699
|
|
| TAIR|locus:2033379 AT1G66830 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1192 (424.7 bits), Expect = 3.6e-121, P = 3.6e-121
Identities = 268/609 (44%), Positives = 368/609 (60%)
Query: 71 GFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGKLKY 130
G +P +L L + + L N+FSG +P E+ + +L +L LS NSF+G + + + K
Sbjct: 104 GKLPVELFGLKGLQSLVLSGNSFSGFVPEEIGSLKSLMTLDLSENSFNGSISLSLIPCKK 163
Query: 131 LQVLDLXXXXXXXXXXXXI-VQCKRLKTVVLNQNSFTGPLPD--GFATNLTALQKLDLSF 187
L+ L L + L+T+ L+ N TG +P+ G NL LDLS
Sbjct: 164 LKTLVLSKNSFSGDLPTGLGSNLVHLRTLNLSFNRLTGTIPEDVGSLENLKGT--LDLSH 221
Query: 188 NNLSGLIPNDIANLSRLRLLAQRVYVDLTYNNLSGLIPQNAALLSLGPTAFIGNPFLCGP 247
N SG+IP + NL L +YVDL+YNNLSG IP+ LL+ GP AF GNPFLCG
Sbjct: 222 NFFSGMIPTSLGNLPEL------LYVDLSYNNLSGPIPKFNVLLNAGPNAFQGNPFLCGL 275
Query: 248 PLKVSCPSSTSDHPYPKPLPYDPSWHGGKVHHS--CXXXXXXXXXXLLGICITGFLFYRQ 305
P+K+SC S+ + P L Y + HHS C + GI LF
Sbjct: 276 PIKISC-STRNTQVVPSQL-YTRRAN----HHSRLCIILTATGGT-VAGIIFLASLFIYY 328
Query: 306 YKKASG-CKWGEKVGGCRLEEKLM--IKKEFFCFTRNNLD--TMSENMEQYEFVPLDSQV 360
+KAS + C + EKL K EF CF N + T+ EN Q F+P+D ++
Sbjct: 329 LRKASARANKDQNNRTCHINEKLKKTTKPEFLCFKTGNSESETLDENKNQQVFMPMDPEI 388
Query: 361 DFDLEQLLKASAFLLGKSTIGIVYKVALNNEEAVAVRRLGNGGWQRFKEFQTEAEAIGKI 420
+FDL+QLLKASAFLLGKS IG+VYKV L N +AVRRL + GW R KEF + EA+ KI
Sbjct: 389 EFDLDQLLKASAFLLGKSRIGLVYKVVLENGLMLAVRRLEDKGWLRLKEFLADVEAMAKI 448
Query: 421 RHPNIVSLRAYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAK 480
+HPN+++L+A WS +EKLLIYDYIPNG L +AI G+ G +S + L+W+ RL+I++G+AK
Sbjct: 449 KHPNVLNLKACCWSPEEKLLIYDYIPNGDLGSAIQGRPGSVSCKQLTWTVRLKILRGIAK 508
Query: 481 GIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGT 540
G+ ++HE SPKRYVHG + SNILLG N+EP +S FGL R+ D + + +S
Sbjct: 509 GLTYIHEFSPKRYVHGHINTSNILLGPNLEPKVSGFGLGRIVDTSSDI------RSD--- 559
Query: 541 PLQSSPYEFTALNSTTSRSYYQAPEA-SKVRKPTQKWDIYSYGVILLEMISGKLPMIQIG 599
Q SP E T+ + SYYQAPEA SK+ KP+QKWD+YS+G+++LEM++GK P+
Sbjct: 560 --QISPME-TSSPILSRESYYQAPEAASKMTKPSQKWDVYSFGLVILEMVTGKSPV---- 612
Query: 600 SMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMR 659
S E+++V W++ E KP +LDP LA D D ED +V V+KI L CV K+PDKRP MR
Sbjct: 613 SSEMDLVMWVESASERNKPAWYVLDPVLARDRDLEDSMVQVIKIGLACVQKNPDKRPHMR 672
Query: 660 HVCDSLDRV 668
V +S +++
Sbjct: 673 SVLESFEKL 681
|
|
| TAIR|locus:2008793 AT1G67510 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 992 (354.3 bits), Expect = 5.6e-100, P = 5.6e-100
Identities = 232/632 (36%), Positives = 357/632 (56%)
Query: 62 LIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPV 121
L + N +L G IP L + +++ + L NN SG+LP + LQ+L LS NS SG +
Sbjct: 101 LNLHNNELYGSIPTQLFNATSLHSIFLYGNNLSGTLPPSICKLPKLQNLDLSMNSLSGTL 160
Query: 122 PMQIGKLKYLQVLDLXXXXXXXXXXXXI-VQCKRLKTVVLNQNSFTGPLPDGFATNLTAL 180
+ K K LQ L L I + L + L+ N F+G +P +
Sbjct: 161 SPDLNKCKQLQRLILSANNFSGEIPGDIWPELTNLAQLDLSANEFSGEIPKDIGELKSLS 220
Query: 181 QKLDLSFNNLSGLIPNDIANLSRLRLLAQRVYVDLTYNNLSGLIPQNAALLSLGPTAFIG 240
L+LSFN+LSG IPN + NL V +DL N+ SG IPQ+ + + GPTAF+
Sbjct: 221 GTLNLSFNHLSGQIPNSLGNLP------VTVSLDLRNNDFSGEIPQSGSFSNQGPTAFLN 274
Query: 241 NPFLCGPPLKVSCPSSTSDHPYPKPLPYD--PSWHG---GKVHHSCXXXXXXXXXXLLGI 295
NP LCG PL+ +C + + P + P + S G G + +G+
Sbjct: 275 NPKLCGFPLQKTCKDTDENSPGTRKSPENNADSRRGLSTGLI--VLISVADAASVAFIGL 332
Query: 296 CITGFLFYRQYKKASGCKWGEKVGGCRLEEKLMIKKEFFCFTR--NNLDTMSENMEQYE- 352
+ +L++++ GC G +L + K C T D+ +E E+ E
Sbjct: 333 VLV-YLYWKKKDSEGGCSC---TGNAKLGGGSVKGKSCCCITGFPKEDDSEAEGNERGEG 388
Query: 353 -----FVPLDSQVDFDLEQLLKASAFLLGKSTIGIVYKVALNNEEAVAVRRLGNGGWQRF 407
V +D F+L++LL+ASA++LGKS +GIVYKV L N VAVRRLG GG QR+
Sbjct: 389 KGDGELVAIDKGFSFELDELLRASAYVLGKSGLGIVYKVVLGNGVPVAVRRLGEGGEQRY 448
Query: 408 KEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLS 467
KEF TE +A+GK++HPN+V LRAY+W+ DEKLLI D++ NGSLA A+ G+ G S L+
Sbjct: 449 KEFVTEVQAMGKVKHPNVVKLRAYYWAPDEKLLISDFVNNGSLADALRGRNGQPS-PSLT 507
Query: 468 WSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEE 527
WS R++I KG A+G+A+LHE SP++ VHGD++PSNILL + P+ISDFGL RL I
Sbjct: 508 WSTRIKIAKGAARGLAYLHECSPRKLVHGDVKPSNILLDSSFTPYISDFGLTRLITITAA 567
Query: 528 TPEVHWEQSTTGTP-LQSSPYEFTALNSTTSRSYYQAPEASKVR-KPTQKWDIYSYGVIL 585
+ + S++ +T++ + + Y+APEA +PTQKWD+YS+GV+L
Sbjct: 568 SASSNEPSSSSAAGGFLGGALPYTSIKPSDRSNGYKAPEARLPGGRPTQKWDVYSFGVVL 627
Query: 586 LEMISGKLP-MIQIGS-------MEL-NIVQWIQLILEDRKPMTDILDPFLAHDLDKEDE 636
+E+++GK P + S +E+ ++V+W++ E+ P++D++DP L ++ + +
Sbjct: 628 MELLTGKSPDSSPLSSSSTSTVVVEVPDLVKWVRKGFEEETPLSDMVDPMLLQEVHAKQQ 687
Query: 637 IVSVLKIALDCVHKSPDKRPSMRHVCDSLDRV 668
++SV +AL C P+ RP M++V +++D++
Sbjct: 688 VLSVFHLALACTEGDPEVRPRMKNVSENIDKI 719
|
|
| TAIR|locus:2058598 AT2G23300 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 573 (206.8 bits), Expect = 3.0e-95, Sum P(2) = 3.0e-95
Identities = 136/345 (39%), Positives = 205/345 (59%)
Query: 344 MSENMEQYEFVPLDS-QVDFDLEQLLKASAFLLGKSTIGIVYKVALNNEEAVAVRRLGNG 402
+ EN ++ V +D + + ++E LLKASA++LG + I+YK L + +AVRRLG
Sbjct: 430 IGEN-KKGTLVTIDGGEKELEVETLLKASAYILGATGSSIMYKTVLEDGTVLAVRRLGEN 488
Query: 403 GW---QRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLATAIHGKAG 459
G +RFK+F+ AIGK+ HPN+V LR ++W DEKL+IYD++PNGSL A + K G
Sbjct: 489 GLSQQRRFKDFEAHIRAIGKLVHPNLVRLRGFYWGTDEKLVIYDFVPNGSLVNARYRKGG 548
Query: 460 IISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLA 519
S L W RL+I+KG+A+G+A+LH+ K++VHG+L+PSNILLG++MEP I DFGL
Sbjct: 549 S-SPCHLPWETRLKIVKGLARGLAYLHD---KKHVHGNLKPSNILLGQDMEPKIGDFGLE 604
Query: 520 RLADIAEETPEVHWEQST---TGTPLQSSPYEFTALNSTTSRSY--------YQAPEASK 568
RL +A +T S+ + L +S EF + T S S Y APE+ +
Sbjct: 605 RL--LAGDTSYNRASGSSRIFSSKRLTASSREFGTIGPTPSPSPSSVGPISPYCAPESLR 662
Query: 569 VRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQWIQLILEDRKPMTDILDPFLA 628
KP KWD++ +GVILLE+++GK+ I E+ + L +ED + D +
Sbjct: 663 NLKPNPKWDVFGFGVILLELLTGKIVSID----EVGVGNG--LTVEDGNRALIMADVAIR 716
Query: 629 HDLD-KEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRVNIST 672
+L+ KED ++ + K+ C + P KRP+M+ +R IS+
Sbjct: 717 SELEGKEDFLLGLFKLGYSCASQIPQKRPTMKEALVVFERYPISS 761
|
|
| TAIR|locus:2115120 AT4G37250 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 570 (205.7 bits), Expect = 6.1e-95, Sum P(2) = 6.1e-95
Identities = 132/332 (39%), Positives = 195/332 (58%)
Query: 352 EFVPLDSQVDFDLEQLLKASAFLLGKSTIGIVYKVALNNEEAVAVRRLGNGGW--QRFKE 409
+ V +D + + ++E LLKASA++LG + I+YK L + AVRRLG G +RFK+
Sbjct: 432 KLVTVDGEKEMEIETLLKASAYILGATGSSIMYKAVLEDGRVFAVRRLGENGLSQRRFKD 491
Query: 410 FQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLATAIHGKAGIIS--YRPLS 467
F+ AIGK+ HPN+V L ++W DEKL+IYD++PNGSL + K G S Y L
Sbjct: 492 FEPHIRAIGKLVHPNLVRLCGFYWGTDEKLVIYDFVPNGSLVNPRYRKGGGSSSPYH-LP 550
Query: 468 WSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEE 527
W RL+I KG+A+G+A+LHE K++VHG+L+PSNILLG +MEP I DFGL RL + E
Sbjct: 551 WETRLKIAKGIARGLAYLHE---KKHVHGNLKPSNILLGHDMEPKIGDFGLERL--LTGE 605
Query: 528 TPEVHWEQST---TGTPLQSSPYEFTALNSTTS--------RSYYQAPEASKVRKPTQKW 576
T + S+ + +S EF+++ T S S Y APE+ + KP+ KW
Sbjct: 606 TSYIRAGGSSRIFSSKRYTTSSREFSSIGPTPSPSPSSVGAMSPYCAPESFRSLKPSPKW 665
Query: 577 DIYSYGVILLEMISGKLPMIQIGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLD-KED 635
D+Y +GVILLE+++GK+ ++ IV L +ED + D + +LD K++
Sbjct: 666 DVYGFGVILLELLTGKIVSVE------EIVLGNGLTVEDGHRAVRMADVAIRGELDGKQE 719
Query: 636 EIVSVLKIALDCVHKSPDKRPSMRHVCDSLDR 667
++ K+ C P KRP+M+ L+R
Sbjct: 720 FLLDCFKLGYSCASPVPQKRPTMKESLAVLER 751
|
|
| TAIR|locus:2157182 RLK "receptor-like kinase" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 611 (220.1 bits), Expect = 2.6e-94, Sum P(2) = 2.6e-94
Identities = 129/341 (37%), Positives = 207/341 (60%)
Query: 339 NNLDTMSENMEQYEFVPLDSQVDFDLEQLLKASAFLLGKSTIGIVYKVALNNEEAVAVRR 398
N + + ++ V LDS+ + ++E LLKASA++LG + I+YK L + AVAVRR
Sbjct: 422 NRRSGLDDQEKKGTLVNLDSEKELEIETLLKASAYILGATGSSIMYKAVLQDGTAVAVRR 481
Query: 399 LGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLATAIHGKA 458
+ G RF++F+ + A+ K+ HPN+V +R ++W DEKL+IYD++PNGSLA A + K
Sbjct: 482 IAECGLDRFRDFEAQVRAVAKLIHPNLVRIRGFYWGSDEKLVIYDFVPNGSLANARYRKV 541
Query: 459 GIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGL 518
G S L W RL+I KG+A+G+ ++H+ K+YVHG+L+PSNILLG +MEP ++DFGL
Sbjct: 542 GS-SPCHLPWDARLKIAKGIARGLTYVHD---KKYVHGNLKPSNILLGLDMEPKVADFGL 597
Query: 519 ARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSY---YQAPEASKVRKPTQK 575
+L I + + G+ ++ EF S + S Y APE+ + KP K
Sbjct: 598 EKLL-IGDMSYRTGGSAPIFGSKRSTTSLEFGPSPSPSPSSVGLPYNAPESLRSIKPNSK 656
Query: 576 WDIYSYGVILLEMISGKLPMIQIGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLD-KE 634
WD+YS+GVILLE+++GK+ ++ EL V L+++D + + D + +L+ KE
Sbjct: 657 WDVYSFGVILLELLTGKIVVVD----ELGQVNG--LVIDDGERAIRMADSAIRAELEGKE 710
Query: 635 DEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRVNISTEQQ 675
+ +++ LK+ L C P +RP+++ L+R + + QQ
Sbjct: 711 EAVLACLKMGLACASPIPQRRPNIKEALQVLERFPVHSSQQ 751
|
|
| TAIR|locus:2053751 AT2G42290 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 607 (218.7 bits), Expect = 3.0e-93, Sum P(2) = 3.0e-93
Identities = 142/341 (41%), Positives = 207/341 (60%)
Query: 337 TRNNLDTMSENMEQYEFVPLDSQVDFDLEQLLKASAFLLGKSTIGIVYKV--ALNNEEAV 394
T + E ++ +FV D + +LE LL+ASA+++GKS GIVY+V A ++ V
Sbjct: 313 TTTVVSEFDEEGQEGKFVAFDEGFELELEDLLRASAYVIGKSRSGIVYRVVAAESSSTVV 372
Query: 395 AVRRL--GNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLAT 452
AVRRL GN W RFK+F E E+IG+I HPNIV LRAY+++ DEKLLI D+I NGSL +
Sbjct: 373 AVRRLSDGNDTW-RFKDFVNEVESIGRINHPNIVRLRAYYYAEDEKLLITDFINNGSLYS 431
Query: 453 AIHGKAGIISYRP-LSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEP 511
A+HG G + RP LSW++RL I +G A+G+ ++HE S ++YVHG+L+ S ILL + P
Sbjct: 432 ALHG--GPSNTRPTLSWAERLCIAQGTARGLMYIHEYSSRKYVHGNLKSSKILLDNELHP 489
Query: 512 HISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEF-TALNSTTSRSYYQAPEA--SK 568
H+S FGL RL + + H S T QS F T L+ + + Y APEA S
Sbjct: 490 HVSGFGLTRLVSGYPKVTD-HSLSSMT----QSIDQGFATRLSVSAPAAAYLAPEARASS 544
Query: 569 VRKPTQKWDIYSYGVILLEMISGKLPM-IQIGSMELNIVQWIQLILEDRKPMTDILDPFL 627
K + K D+YS+GVILLE+++G+LP E +V ++ ++ + + +ILDP L
Sbjct: 545 DCKLSHKCDVYSFGVILLELLTGRLPYGSSENEGEEELVNVLRKWHKEERSLAEILDPKL 604
Query: 628 AHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRV 668
++++ + +AL+C PD RP MR V + L R+
Sbjct: 605 LKQDFANKQVIATIHVALNCTEMDPDMRPRMRSVSEILGRI 645
|
|
| TAIR|locus:2095773 AT3G57830 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 588 (212.0 bits), Expect = 1.9e-91, Sum P(2) = 1.9e-91
Identities = 135/345 (39%), Positives = 210/345 (60%)
Query: 342 DTMSENMEQYEFVPLDSQVDFDLEQLLKASAFLLGKSTIGIVYKVA-----------LNN 390
D E ++ +FV +D + +LE LL+ASA+++GKS GIVY+V +
Sbjct: 321 DAADEEEKEGKFVVMDEGFELELEDLLRASAYVVGKSRSGIVYRVVAGMGSGTVAATFTS 380
Query: 391 EEAVAVRRLGNGG--WQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNG 448
VAVRRL +G W+R K+F+ E EAI +++HPNIV LRAY+++ DE+LLI DYI NG
Sbjct: 381 STVVAVRRLSDGDATWRR-KDFENEVEAISRVQHPNIVRLRAYYYAEDERLLITDYIRNG 439
Query: 449 SLATAIHGKAGIISYRP-LSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGK 507
SL +A+HG G + P LSW +RL I +G A+G+ ++HE SP++YVHG+L+ + ILL
Sbjct: 440 SLYSALHG--GPSNTLPSLSWPERLLIAQGTARGLMYIHEYSPRKYVHGNLKSTKILLDD 497
Query: 508 NMEPHISDFGLARLAD-IAEETPEVH-WEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPE 565
+ P IS FGL RL ++ + QS T L S+ T T Y APE
Sbjct: 498 ELLPRISGFGLTRLVSGYSKLIGSLSATRQSLDQTYLTSAT---TVTRITAPTVAYLAPE 554
Query: 566 A--SKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQWIQLILEDRKPMTDIL 623
A S K +QK D+YS+GV+L+E+++G+LP + +V+ ++ +++ KP+++IL
Sbjct: 555 ARASSGCKLSQKCDVYSFGVVLMELLTGRLPNASSKNNGEELVRVVRNWVKEEKPLSEIL 614
Query: 624 DPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRV 668
DP + + + ++++ + +AL+C P+ RP MR V +SL R+
Sbjct: 615 DPEILNKGHADKQVIAAIHVALNCTEMDPEVRPRMRSVSESLGRI 659
|
|
| TAIR|locus:2124296 AT4G34220 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 406 (148.0 bits), Expect = 4.1e-86, Sum P(3) = 4.1e-86
Identities = 109/293 (37%), Positives = 156/293 (53%)
Query: 1 SLVLLILSYIALMGSA-NDEGLALLSFKQAIRNFPEG--NNWNNSNEDPCSWNGITCRE- 56
SLVL ++ A N +G+ LL+FK +I P NWN + PC W G+TC E
Sbjct: 11 SLVLFHFLFVPTQLQALNTDGVLLLTFKYSILTDPLSVLRNWNYDDATPCLWTGVTCTEL 70
Query: 57 GQ--------VFSLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQ 108
G+ V SL++PNK L G I DL S+ + ++L +N F+GSLP +FNA+ LQ
Sbjct: 71 GKPNTPDMFRVTSLVLPNKHLLGSITPDLFSIPYLRILDLSSNFFNGSLPDSVFNATELQ 130
Query: 109 SLILSGNSFSGPVPMQIGKLKYLQVLDLXXXXXXXXXXXXIVQCKRLKTVVLNQNSFTGP 168
S+ L N+ SG +P + + LQ+L+L I K L V L++N+F+G
Sbjct: 131 SISLGSNNLSGDLPKSVNSVTNLQLLNLSANAFTGEIPLNISLLKNLTVVSLSKNTFSGD 190
Query: 169 LPDGFATNLTALQKLDLSFNNLSGLIPNDIA-------NLSRLRLLAQ-----------R 210
+P GF A Q LDLS N L+G +P D+ NLS ++L +
Sbjct: 191 IPSGFE----AAQILDLSSNLLNGSLPKDLGGKSLHYLNLSHNKVLGEISPNFAEKFPAN 246
Query: 211 VYVDLTYNNLSGLIPQNAALLSLGPTAFIGNPFLCGPPLKVSC--PSSTSDHP 261
VDL++NNL+G IP + +LL+ +F GN LCG PLK+ C PS+ S+ P
Sbjct: 247 ATVDLSFNNLTGPIPSSLSLLNQKAESFSGNQELCGKPLKILCSIPSTLSNPP 299
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.824 |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | GSVIVG00030403001 | SubName- Full=Chromosome chr1 scaffold_5, whole genome shotgun sequence; (695 aa) | |||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 686 | |||
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 7e-54 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-36 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 5e-36 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 4e-32 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 3e-31 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 4e-30 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 5e-30 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 3e-29 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 4e-29 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-26 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-25 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 3e-24 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-23 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-22 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 3e-22 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 6e-22 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-21 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-21 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 5e-21 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 5e-21 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-20 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-20 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 3e-20 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 3e-20 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 9e-20 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-19 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 3e-19 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 8e-19 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 3e-18 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-17 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 4e-17 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 4e-17 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 6e-17 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 8e-17 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-16 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-16 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-16 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 4e-16 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 5e-16 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 6e-16 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 8e-16 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 8e-16 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 1e-15 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-15 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-15 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 3e-15 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 4e-15 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 4e-15 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 2e-14 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-14 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-14 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 3e-14 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-13 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 2e-13 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-13 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-13 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 4e-13 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 4e-13 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 5e-13 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 5e-13 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 6e-13 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 8e-13 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 9e-13 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-12 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-12 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-12 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-12 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 3e-12 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 3e-12 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 3e-12 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 4e-12 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 4e-12 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 6e-12 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 7e-12 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 7e-12 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 8e-12 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 8e-12 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-11 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-11 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-11 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 1e-11 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-11 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-11 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 3e-11 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 3e-11 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 4e-11 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 4e-11 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 5e-11 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 6e-11 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 6e-11 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 6e-11 | |
| pfam08263 | 42 | pfam08263, LRRNT_2, Leucine rich repeat N-terminal | 8e-11 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 8e-11 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-10 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-10 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-10 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 1e-10 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-10 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-10 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-10 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 1e-10 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-10 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-10 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-10 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-10 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 3e-10 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 3e-10 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 4e-10 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 4e-10 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 4e-10 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 5e-10 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 5e-10 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 5e-10 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 6e-10 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 7e-10 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 7e-10 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 8e-10 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 9e-10 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-09 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-09 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 1e-09 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-09 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 1e-09 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 1e-09 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-09 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-09 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-09 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 3e-09 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 3e-09 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 3e-09 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 4e-09 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 4e-09 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 5e-09 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 5e-09 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 5e-09 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 6e-09 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 6e-09 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 9e-09 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-08 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-08 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-08 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-08 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-08 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-08 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-08 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 3e-08 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 3e-08 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 4e-08 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 5e-08 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 5e-08 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 5e-08 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 5e-08 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 5e-08 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 6e-08 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 6e-08 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 7e-08 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 8e-08 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-07 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-07 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 1e-07 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 1e-07 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 1e-07 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 1e-07 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-07 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-07 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-07 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-07 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-07 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-07 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-07 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 3e-07 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 3e-07 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 3e-07 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 3e-07 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 3e-07 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 4e-07 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 4e-07 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 5e-07 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 5e-07 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 5e-07 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 5e-07 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 5e-07 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 6e-07 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 7e-07 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 7e-07 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 1e-06 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 1e-06 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 1e-06 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-06 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-06 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-06 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-06 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-06 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-06 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-06 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-06 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-06 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 3e-06 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 3e-06 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 3e-06 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 3e-06 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 4e-06 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 4e-06 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 4e-06 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 4e-06 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 4e-06 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 4e-06 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 4e-06 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 5e-06 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 5e-06 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 5e-06 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 5e-06 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 6e-06 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 6e-06 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 6e-06 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 7e-06 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 7e-06 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 8e-06 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 9e-06 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 1e-05 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-05 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 1e-05 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-05 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 1e-05 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-05 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 2e-05 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-05 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-05 | |
| COG3642 | 204 | COG3642, COG3642, Mn2+-dependent serine/threonine | 2e-05 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-05 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 2e-05 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 2e-05 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-05 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 2e-05 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 3e-05 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 3e-05 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 3e-05 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 4e-05 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 4e-05 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 4e-05 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 5e-05 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 5e-05 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 5e-05 | |
| PRK09605 | 535 | PRK09605, PRK09605, bifunctional UGMP family prote | 6e-05 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 6e-05 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 7e-05 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 7e-05 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 8e-05 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 9e-05 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 9e-05 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 9e-05 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-04 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 1e-04 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 1e-04 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-04 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 2e-04 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-04 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-04 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 2e-04 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-04 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-04 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-04 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-04 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 3e-04 | |
| TIGR03724 | 199 | TIGR03724, arch_bud32, Kae1-associated kinase Bud3 | 3e-04 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 3e-04 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 3e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 4e-04 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 4e-04 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 4e-04 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 4e-04 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 4e-04 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 4e-04 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 4e-04 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 4e-04 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 4e-04 | |
| PRK14879 | 211 | PRK14879, PRK14879, serine/threonine protein kinas | 4e-04 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 6e-04 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 6e-04 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 7e-04 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 8e-04 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 9e-04 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 9e-04 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 9e-04 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 0.001 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 0.001 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 0.002 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 0.002 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 0.002 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 0.002 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 0.002 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 0.002 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 0.003 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 0.003 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 0.003 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 0.004 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 0.004 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 199 bits (507), Expect = 7e-54
Identities = 172/622 (27%), Positives = 263/622 (42%), Gaps = 104/622 (16%)
Query: 59 VFSLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFS 118
V+ L I N L G I + + ++ ++L N F G LP + F + L++L LS N FS
Sbjct: 430 VYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLP-DSFGSKRLENLDLSRNQFS 488
Query: 119 GPVPMQIGKLKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLT 178
G VP ++G L L L LS+N S IP + CK+L ++ L+ N +G +P F+ +
Sbjct: 489 GAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFS-EMP 547
Query: 179 ALQKLDLSFNNLSGLIPNDIANLSRLRLLAQRVYVDLTYNNLSGLIPQNAALLSLGPTAF 238
L +LDLS N LSG IP NL + L Q V++++N+L G +P A L++ +A
Sbjct: 548 VLSQLDLSQNQLSGEIP---KNLGNVESLVQ---VNISHNHLHGSLPSTGAFLAINASAV 601
Query: 239 IGNPFLCGPPLKVSCPSSTSDHPYPKPLPYDPSWHGGKVHHSCAVITTVAVAVLLGICIT 298
GN LCG +TS P K + PSW + T+ ++L +
Sbjct: 602 AGNIDLCG-------GDTTSGLPPCKRVRKTPSWW-------FYITCTLGAFLVLALVAF 647
Query: 299 GFLFYRQYKKASGCKWGEKVGGCRLEEKLMIKKEFFCFTRNNLDTMSENMEQ--YEFVPL 356
GF+F R RNNL+ E +E
Sbjct: 648 GFVFIR--------------------------------GRNNLELKRVENEDGTWELQFF 675
Query: 357 DSQV--DFDLEQLL--KASAFLLGKSTIGIVYK-VALNNEEAVAVRRLGNGGWQRFKEFQ 411
DS+V + +L ++ + G YK ++ N V+ + + E
Sbjct: 676 DSKVSKSITINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIA 735
Query: 412 TEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDR 471
+GK++HPNIV L S LI++YI +L+ + LSW R
Sbjct: 736 D----MGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN---------LSWERR 782
Query: 472 LRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEV 531
+I G+AK + FLH V G+L P I++ EPH+ RL
Sbjct: 783 RKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHL------RL---------- 826
Query: 532 HWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISG 591
S P S Y APE + + T+K DIY +G+IL+E+++G
Sbjct: 827 ------------SLPGLLCTDTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTG 874
Query: 592 KLPM-IQIGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHK 650
K P + G +IV+W + D I ++EIV V+ +AL C
Sbjct: 875 KSPADAEFGVHG-SIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTAT 933
Query: 651 SPDKRPSMRHVCDSLDRVNIST 672
P RP V +L+ + S+
Sbjct: 934 DPTARPCANDVLKTLESASRSS 955
|
Length = 968 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 136 bits (344), Expect = 1e-36
Identities = 63/218 (28%), Positives = 95/218 (43%), Gaps = 35/218 (16%)
Query: 375 LGKSTIGIVYKV-ALNNEEAVAVRRLGNGGWQRFKE-FQTEAEAIGKIRHPNIVSLRAYF 432
LG+ G VY + VA++ + E E E + K+ HPNIV L F
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 433 WSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKR 492
+ L+ +Y GSL + G LS + LRI+ + +G+ +LH
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEG-----KLSEDEILRILLQILEGLEYLHS---NG 112
Query: 493 YVHGDLRPSNILLGK-NMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTA 551
+H DL+P NILL N + ++DFGL++L T + ++ GTP
Sbjct: 113 IIHRDLKPENILLDSDNGKVKLADFGLSKL-----LTSDKSLLKTIVGTP---------- 157
Query: 552 LNSTTSRSYYQAPEASKVRKP-TQKWDIYSYGVILLEM 588
Y APE + ++K DI+S GVIL E+
Sbjct: 158 --------AYMAPEVLLGKGYYSEKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 136 bits (344), Expect = 5e-36
Identities = 77/297 (25%), Positives = 118/297 (39%), Gaps = 53/297 (17%)
Query: 375 LGKSTIGIVYK-VALNNEEAVAVRRL---GNGGWQRFKEFQTEAEAIGKIRHPNIVSLRA 430
LG + G VYK + VAV+ L + + + E + ++ HPNIV L
Sbjct: 7 LGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKD-QTARREIRILRRLSHPNIVRLID 65
Query: 431 YFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSP 490
F D L+ +Y G L + PLS + +I + +G+ +LH
Sbjct: 66 AFEDKDHLYLVMEYCEGGDLFDYL------SRGGPLSEDEAKKIALQILRGLEYLHS--- 116
Query: 491 KRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFT 550
+H DL+P NILL +N I+DFGLA+ + + + GTP
Sbjct: 117 NGIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSL-----TTFVGTP--------- 162
Query: 551 ALNSTTSRSYYQAPEASKVRKP-TQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQWI 609
+Y APE K D++S GVIL E+++GK P +
Sbjct: 163 ---------WYMAPEVLLGGNGYGPKVDVWSLGVILYELLTGKPP-------------FS 200
Query: 610 QLILEDRKPMTD-ILDPFLAHDLDKEDEIVSVLK-IALDCVHKSPDKRPSMRHVCDS 664
+ D+ + IL P L D K K + C++K P KRP+ +
Sbjct: 201 GENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKDLIKKCLNKDPSKRPTAEEILQH 257
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 124 bits (314), Expect = 4e-32
Identities = 71/293 (24%), Positives = 122/293 (41%), Gaps = 53/293 (18%)
Query: 374 LLGKSTIGIVYKV-ALNNEEAVAVRRLGNG-GWQRFKEFQTEAEAIGKIRHPNIVSLRAY 431
LG+ + G VY + VA++ + + + E + + K++HPNIV L
Sbjct: 6 KLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYDV 65
Query: 432 FWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPK 491
F D+ L+ +Y G L + LS + ++ + + +LH K
Sbjct: 66 FEDEDKLYLVMEYCEGGDLFDLLK------KRGRLSEDEARFYLRQILSALEYLHS---K 116
Query: 492 RYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTA 551
VH DL+P NILL ++ ++DFGLAR D E+ + GTP
Sbjct: 117 GIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKL------TTFVGTP---------- 160
Query: 552 LNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQWIQL 611
Y APE + + DI+S GVIL E+++GK P + +++ +
Sbjct: 161 --------EYMAPEVLLGKGYGKAVDIWSLGVILYELLTGKPPF----PGDDQLLELFKK 208
Query: 612 ILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPS----MRH 660
I + + PF + D E +++ + K P+KR + ++H
Sbjct: 209 IGKPKP-------PFPPPEWDISPEAKDLIR---KLLVKDPEKRLTAEEALQH 251
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 3e-31
Identities = 76/303 (25%), Positives = 127/303 (41%), Gaps = 54/303 (17%)
Query: 375 LGKSTIGIVYKVAL----NNEEAVAVRRL-GNGGWQRFKEFQTEAEAIGKIRHPNIVSLR 429
LG+ G VYK L VAV+ L + + K+F EA + K+ HPN+V L
Sbjct: 3 LGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRL- 61
Query: 430 AYFWSVDEK--LLIYDYIPNGSLATAIHGKAGIISY---RPLSWSDRLRIIKGVAKGIAF 484
+E+ L+ +Y+ G L + + LS D L +AKG+ +
Sbjct: 62 -LGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 485 LHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQS 544
L K++VH DL N L+G+++ ISDFGL+R + + TG L
Sbjct: 121 LAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDY------YRKKTGGKL-- 169
Query: 545 SPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQIGSMEL 603
P + APE+ K T K D++S+GV+L E+ + G P + + E+
Sbjct: 170 -PIRWM------------APESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEV 216
Query: 604 NIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCD 663
++ + + + P D + ++ L C P+ RP+ + +
Sbjct: 217 -----LEYLRKGYRL----PKPEYCPD--------ELYELMLSCWQLDPEDRPTFSELVE 259
Query: 664 SLD 666
L+
Sbjct: 260 RLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 4e-30
Identities = 75/299 (25%), Positives = 124/299 (41%), Gaps = 56/299 (18%)
Query: 375 LGKSTIGIVYK-----VALNNEEAVAVRRL-GNGGWQRFKEFQTEAEAIGKIRHPNIVSL 428
LG+ G VYK + VAV+ L + Q+ +EF EA + K+ HPN+V L
Sbjct: 7 LGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKL 66
Query: 429 RAYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEV 488
+ ++ +Y+ G L + + LS SD L +A+G+ +L
Sbjct: 67 LGVCTEEEPLYIVMEYMEGGDLLSYLRKNRP-----KLSLSDLLSFALQIARGMEYLES- 120
Query: 489 SPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYE 548
K ++H DL N L+G+N+ ISDFGL+R + G L P
Sbjct: 121 --KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYY-------RKRGGKL---PIR 168
Query: 549 FTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQIGSMELNIVQ 607
+ APE+ K K T K D++S+GV+L E+ + G+ P + + E+
Sbjct: 169 WM------------APESLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEV---- 212
Query: 608 WIQLILED-RKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSL 665
++ + R P P + + L C + P+ RP+ + + L
Sbjct: 213 -LEYLKNGYRLPQ-----PPNCPP--------ELYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 5e-30
Identities = 85/235 (36%), Positives = 125/235 (53%), Gaps = 15/235 (6%)
Query: 2 LVLLILSYIALMGSANDEGLALLSFKQAIRNFPEG--NNWNNSNEDPCSWNGITCRE-GQ 58
+ +L ++ +E LLSFK +I N P +NWN+S D C W GITC +
Sbjct: 13 IFMLFFLFLNFSMLHAEELELLLSFKSSI-NDPLKYLSNWNSSA-DVCLWQGITCNNSSR 70
Query: 59 VFSLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFN-ASNLQSLILSGNSF 117
V S+ + K ++G I + + L I +NL NN SG +P ++F +S+L+ L LS N+F
Sbjct: 71 VVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNF 130
Query: 118 SGPVPMQIGKLKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNL 177
+G +P G + L+ LDLS N S IP+ I LK + L N G +P TNL
Sbjct: 131 TGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIP-NSLTNL 187
Query: 178 TALQKLDLSFNNLSGLIPNDIANLSRLRLLAQRVYVDLTYNNLSGLIPQNAALLS 232
T+L+ L L+ N L G IP ++ + L+ ++ L YNNLSG IP L+
Sbjct: 188 TSLEFLTLASNQLVGQIPRELGQMKSLK------WIYLGYNNLSGEIPYEIGGLT 236
|
Length = 968 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 3e-29
Identities = 79/299 (26%), Positives = 128/299 (42%), Gaps = 55/299 (18%)
Query: 375 LGKSTIGIVYK-----VALNNEEAVAVRRL-GNGGWQRFKEFQTEAEAIGKIRHPNIVSL 428
LG+ G VYK E VAV+ L + Q+ +EF EA + K+ HPNIV L
Sbjct: 7 LGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKL 66
Query: 429 RAYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEV 488
+ +++ +Y+P G L + + LS SD L +A+G+ +L
Sbjct: 67 LGVCTEEEPLMIVMEYMPGGDLLDYLRKNRP----KELSLSDLLSFALQIARGMEYLES- 121
Query: 489 SPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYE 548
K ++H DL N L+G+N+ ISDFGL+R + G L P
Sbjct: 122 --KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYY-------KVKGGKL---PIR 169
Query: 549 FTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQIGSMELNIVQ 607
+ APE+ K K T K D++S+GV+L E+ + G+ P + + E+
Sbjct: 170 WM------------APESLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEV---- 213
Query: 608 WIQLILE-DRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSL 665
++ + + R P P + K+ L C + P+ RP+ + + L
Sbjct: 214 -LEYLKKGYRLPK-----PPNCPP--------ELYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 4e-29
Identities = 77/300 (25%), Positives = 127/300 (42%), Gaps = 57/300 (19%)
Query: 375 LGKSTIGIVYK-----VALNNEEAVAVRRLGNGGWQR-FKEFQTEAEAIGKIRHPNIVSL 428
LG+ G VYK E VAV+ L G + +EF EA + K+ HPNIV L
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66
Query: 429 RAYFWSVDEK--LLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLH 486
+ ++ +Y+P G L + L+ D L++ +AKG+ +L
Sbjct: 67 --LGVCTQGEPLYIVTEYMPGGDLLDFLRKHG-----EKLTLKDLLQMALQIAKGMEYLE 119
Query: 487 EVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSP 546
K +VH DL N L+ +N+ ISDFGL+R + + G L P
Sbjct: 120 S---KNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYY------RKRGGGKL---P 167
Query: 547 YEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQIGSMELNI 605
++ APE+ K K T K D++S+GV+L E+ + G+ P + + E+
Sbjct: 168 IKWM------------APESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEV-- 213
Query: 606 VQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSL 665
++L+ + + P DE+ ++ C P+ RP+ + + L
Sbjct: 214 ---LELLEDGYRLPR----PENCP-----DELYELML---QCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 4e-26
Identities = 64/158 (40%), Positives = 91/158 (57%), Gaps = 7/158 (4%)
Query: 69 LTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGKL 128
L+G IP ++G L+++ ++L NN +G +P L N NLQ L L N SGP+P I L
Sbjct: 224 LSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSL 283
Query: 129 KYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFN 188
+ L LDLS NS S IP ++Q + L+ + L N+FTG +P T+L LQ L L N
Sbjct: 284 QKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVAL-TSLPRLQVLQLWSN 342
Query: 189 NLSGLIPNDIANLSRLRLLAQRVYVDLTYNNLSGLIPQ 226
SG IP ++ + L +L DL+ NNL+G IP+
Sbjct: 343 KFSGEIPKNLGKHNNLTVL------DLSTNNLTGEIPE 374
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 2e-25
Identities = 62/172 (36%), Positives = 99/172 (57%), Gaps = 8/172 (4%)
Query: 54 CREGQVFSLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILS 113
C G +F LI+ + L G IP LG+ ++ RV L++N+FSG LP E + L +S
Sbjct: 377 CSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDIS 436
Query: 114 GNSFSGPVPMQIGKLKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGF 173
N+ G + + + LQ+L L++N F +P S KRL+ + L++N F+G +P
Sbjct: 437 NNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSF-GSKRLENLDLSRNQFSGAVPRKL 495
Query: 174 ATNLTALQKLDLSFNNLSGLIPNDIANLSRLRLLAQRVYVDLTYNNLSGLIP 225
+L+ L +L LS N LSG IP+++++ +L V +DL++N LSG IP
Sbjct: 496 G-SLSELMQLKLSENKLSGEIPDELSSCKKL------VSLDLSHNQLSGQIP 540
|
Length = 968 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 69/303 (22%), Positives = 121/303 (39%), Gaps = 76/303 (25%)
Query: 375 LGKSTIGIVYKV-ALNNEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFW 433
+GK G VYK + VA++ + ++ ++ E + + K +HPNIV +
Sbjct: 8 IGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYL 67
Query: 434 SVDEKLLIYDYIPNGSLATAIHGKAGI-----ISYRPLSWSDRLRIIKGVAKGIAFLHEV 488
DE ++ ++ GSL + I+Y + K + KG+ +LH
Sbjct: 68 KKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAY----------VCKELLKGLEYLHS- 116
Query: 489 SPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYE 548
+H D++ +NILL + E + DFGL+ A +++ + GTP
Sbjct: 117 --NGIIHRDIKAANILLTSDGEVKLIDFGLS--AQLSDTKA----RNTMVGTP------- 161
Query: 549 FTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQW 608
Y+ APE + K DI+S G+ +E+ GK P EL ++
Sbjct: 162 -----------YWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPY-----SELPPMKA 205
Query: 609 IQLI-------LEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPS---- 657
+ I L + + +D FL C+ K+P+KRP+
Sbjct: 206 LFKIATNGPPGLRNPEKWSDEFKDFLKK-----------------CLQKNPEKRPTAEQL 248
Query: 658 MRH 660
++H
Sbjct: 249 LKH 251
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 3e-23
Identities = 63/165 (38%), Positives = 88/165 (53%), Gaps = 9/165 (5%)
Query: 69 LTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGKL 128
L G IP L +L+++ + L +N G +P EL +L+ + L N+ SG +P +IG L
Sbjct: 176 LVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGL 235
Query: 129 KYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFN 188
L LDL N+ + IPSS+ K L+ + L QN +GP+P +L L LDLS N
Sbjct: 236 TSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSI-FSLQKLISLDLSDN 294
Query: 189 NLSGLIPNDIANLSRLRLLAQRVYVDLTYNNLSGLIPQNAALLSL 233
+LSG IP + L L +L L NN +G IP AL SL
Sbjct: 295 SLSGEIPELVIQLQNLEIL------HLFSNNFTGKIPV--ALTSL 331
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 3e-22
Identities = 61/166 (36%), Positives = 92/166 (55%), Gaps = 7/166 (4%)
Query: 62 LIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPV 121
L + + +L G IP +LG + ++ + L NN SG +P E+ ++L L L N+ +GP+
Sbjct: 193 LTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPI 252
Query: 122 PMQIGKLKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQ 181
P +G LK LQ L L QN S IP SI ++L ++ L+ NS +G +P+ L L+
Sbjct: 253 PSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPE-LVIQLQNLE 311
Query: 182 KLDLSFNNLSGLIPNDIANLSRLRLLAQRVYVDLTYNNLSGLIPQN 227
L L NN +G IP + +L RL++L L N SG IP+N
Sbjct: 312 ILHLFSNNFTGKIPVALTSLPRLQVL------QLWSNKFSGEIPKN 351
|
Length = 968 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 96.1 bits (240), Expect = 3e-22
Identities = 57/227 (25%), Positives = 100/227 (44%), Gaps = 37/227 (16%)
Query: 374 LLGKSTIGIVYKVALNNE--EAVAVR--RLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLR 429
LLG+ + G VY AL+ + E +AV+ L + + + E + ++HPNIV
Sbjct: 7 LLGRGSFGSVYL-ALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 430 AYFWSVDEK-LLIY-DYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHE 487
++ L I+ +Y+ GSL++ + + L + + + +G+A+LH
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLLK------KFGKLPEPVIRKYTRQILEGLAYLHS 119
Query: 488 VSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPY 547
VH D++ +NIL+ + ++DFG A+ E S GTP
Sbjct: 120 ---NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTG---SVRGTP------ 167
Query: 548 EFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLP 594
Y+ APE + + + DI+S G ++EM +GK P
Sbjct: 168 ------------YWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPP 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 6e-22
Identities = 71/207 (34%), Positives = 103/207 (49%), Gaps = 17/207 (8%)
Query: 40 NNSNEDPCSWNGITCREGQVFSLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPV 99
NN+ I E +L + N L+G IP D+GS S++ ++L N G +P
Sbjct: 127 NNNFTGSIPRGSIPNLE----TLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPN 182
Query: 100 ELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVV 159
L N ++L+ L L+ N G +P ++G++K L+ + L N+ S IP I L +
Sbjct: 183 SLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLD 242
Query: 160 LNQNSFTGPLPDGFATNLTALQKLDLSFNNLSGLIPNDIANLSRLRLLAQRVYVDLTYNN 219
L N+ TGP+P NL LQ L L N LSG IP I +L +L + +DL+ N+
Sbjct: 243 LVYNNLTGPIPSSLG-NLKNLQYLFLYQNKLSGPIPPSIFSLQKL------ISLDLSDNS 295
Query: 220 LSGLIP------QNAALLSLGPTAFIG 240
LSG IP QN +L L F G
Sbjct: 296 LSGEIPELVIQLQNLEILHLFSNNFTG 322
|
Length = 968 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 94.8 bits (236), Expect = 1e-21
Identities = 80/284 (28%), Positives = 129/284 (45%), Gaps = 48/284 (16%)
Query: 375 LGKSTIGIVYKVALNNEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWS 434
LG G V++ NN VAV+ L G K+F EA+ + K+RHP ++ L A
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDP-KDFLAEAQIMKKLRHPKLIQLYAVCTL 72
Query: 435 VDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYV 494
+ ++ + + GSL + G AG R L + + VA G+A+L + Y+
Sbjct: 73 EEPIYIVTELMKYGSLLEYLQGGAG----RALKLPQLIDMAAQVASGMAYLEAQN---YI 125
Query: 495 HGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNS 554
H DL N+L+G+N ++DFGLAR+ I E+ E + G P ++T
Sbjct: 126 HRDLAARNVLVGENNICKVADFGLARV--IKEDIYE-----AREGAKF---PIKWT---- 171
Query: 555 TTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQIGSMELNIVQWIQLIL 613
APEA+ + + K D++S+G++L E+++ G++P G ++Q Q+
Sbjct: 172 --------APEAALYNRFSIKSDVWSFGILLTEIVTYGRMPY--PGMTNAEVLQ--QVDQ 219
Query: 614 EDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPS 657
R P L I LDC + PD RP+
Sbjct: 220 GYRMPCPPGCPKEL-------------YDIMLDCWKEDPDDRPT 250
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 96.7 bits (239), Expect = 2e-21
Identities = 70/293 (23%), Positives = 116/293 (39%), Gaps = 38/293 (12%)
Query: 374 LLGKSTIGIVYKVALNNEEAVAVRRLGNGGWQRFKE---FQTEAEAIGKIRHP-NIVSLR 429
LG+ + G VY + + VA++ L + KE F E + + + HP NIV L
Sbjct: 7 KLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLY 64
Query: 430 AYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVS 489
+F L+ +Y+ GSL + I PLS S+ L I+ + + +LH
Sbjct: 65 DFFQDEGSLYLVMEYVDGGSLEDLLKK---IGRKGPLSESEALFILAQILSALEYLHS-- 119
Query: 490 PKRYVHGDLRPSNILLGKN-MEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYE 548
K +H D++P NILL ++ + DFGLA+L S+
Sbjct: 120 -KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLL-----------------PDPGSTSSI 161
Query: 549 FTALNSTTSRSYYQAPE---ASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNI 605
+++ Y APE + + DI+S G+ L E+++G P +
Sbjct: 162 PALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPF-EGEKNSSAT 220
Query: 606 VQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSM 658
Q +++ILE P + E + + + K P R S
Sbjct: 221 SQTLKIILELPTPSL----ASPLSPSNPELISKAASDLLKKLLAKDPKNRLSS 269
|
Length = 384 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 93.6 bits (233), Expect = 5e-21
Identities = 76/313 (24%), Positives = 120/313 (38%), Gaps = 60/313 (19%)
Query: 375 LGKSTIGIVYKVALNNE-----EAVAVRRLG-NGGWQRFKEFQTEAEAIGKIRHPNIVSL 428
LG+ G V + E VAV+ L +G Q +F+ E E + + H NIV
Sbjct: 12 LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKY 71
Query: 429 R--AYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLH 486
+ LI +Y+P+GSL + I+ + L L + KG+ +L
Sbjct: 72 KGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRL-----LLFSSQICKGMDYLG 126
Query: 487 EVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSP 546
+RY+H DL NIL+ ISDFGLA++ +
Sbjct: 127 S---QRYIHRDLAARNILVESEDLVKISDFGLAKVLP-------------------EDKD 164
Query: 547 YEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS----GKLPMIQIGSM- 601
Y + S ++ APE + K + D++S+GV L E+ + + P + M
Sbjct: 165 Y-YYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMI 223
Query: 602 ----ELNIVQWIQLILED--RKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKR 655
IV + +L++ R P P +DL K C P R
Sbjct: 224 GIAQGQMIVTRLLELLKEGERLPRPPSC-PDEVYDLMKL------------CWEAEPQDR 270
Query: 656 PSMRHVCDSLDRV 668
PS + +DR+
Sbjct: 271 PSFADLILIVDRL 283
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 93.0 bits (231), Expect = 5e-21
Identities = 77/289 (26%), Positives = 138/289 (47%), Gaps = 53/289 (18%)
Query: 385 KVALNNEEAVAVRRLGNGGWQR-FKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYD 443
K+ E VA++ L G ++ ++F +EA +G+ HPNI+ L +++ +
Sbjct: 26 KLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTE 85
Query: 444 YIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNI 503
Y+ NGSL + G + L + +++G+A G+ +L ++ YVH DL NI
Sbjct: 86 YMENGSLDAFLRKHDGQFTVIQL-----VGMLRGIASGMKYLSDMG---YVHRDLAARNI 137
Query: 504 LLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQA 563
L+ N+ +SDFGL+R + E+ PE + +T G + P +T A
Sbjct: 138 LVNSNLVCKVSDFGLSR---VLEDDPEAAY--TTRGGKI---PIRWT------------A 177
Query: 564 PEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQIGSMELNIVQWIQLILEDRK---PM 619
PEA RK T D++SYG+++ E++S G+ P ++ + ++ I+ I E + PM
Sbjct: 178 PEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDV-----IKAIEEGYRLPAPM 232
Query: 620 TDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRV 668
D ++ ++ LDC K ++RP + LD++
Sbjct: 233 ---------------DCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 2e-20
Identities = 66/236 (27%), Positives = 118/236 (50%), Gaps = 34/236 (14%)
Query: 374 LLGKSTIGIVYKVALN----NEEAVAVRRLGNGGWQRFK-EFQTEAEAIGKIRHPNIVSL 428
++G G V++ L E AVA++ L G ++ + +F +EA +G+ H NI+ L
Sbjct: 12 VIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRL 71
Query: 429 RAYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEV 488
++I +Y+ NG+L + G S L + +++G+A G+ +L ++
Sbjct: 72 EGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQL-----VGMLRGIAAGMKYLSDM 126
Query: 489 SPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYE 548
+ YVH DL NIL+ N+E +SDFGL+R + E+ PE + S P++
Sbjct: 127 N---YVHRDLAARNILVNSNLECKVSDFGLSR---VLEDDPEGTYTTSGGKIPIR----- 175
Query: 549 FTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQIGSMEL 603
+ APEA RK T D++S+G+++ E++S G+ P + + E+
Sbjct: 176 ------------WTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEV 219
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 2e-20
Identities = 75/294 (25%), Positives = 135/294 (45%), Gaps = 50/294 (17%)
Query: 375 LGKSTIGIVYKVALNNEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWS 434
LG G V++ N VA++ L + + ++FQ E +A+ ++RH +++SL A
Sbjct: 14 LGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSV 73
Query: 435 VDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYV 494
+ +I + + GSL + G + L + + + VA+G+A+L E + +
Sbjct: 74 GEPVYIITELMEKGSLLAFLRSPEG----QVLPVASLIDMACQVAEGMAYLEE---QNSI 126
Query: 495 HGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNS 554
H DL NIL+G+++ ++DFGLARL I E+ ++ + PY++T
Sbjct: 127 HRDLAARNILVGEDLVCKVADFGLARL--IKEDV------YLSSDKKI---PYKWT---- 171
Query: 555 TTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQIGSMELNIVQWIQLIL 613
APEA+ + K D++S+G++L EM + G++P + + E+ I
Sbjct: 172 --------APEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEV-----YDQIT 218
Query: 614 ED-RKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLD 666
R P + KI L+C P+ RPS + + + LD
Sbjct: 219 AGYRMPCPAKCPQE-------------IYKIMLECWAAEPEDRPSFKALREELD 259
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.4 bits (225), Expect = 3e-20
Identities = 76/291 (26%), Positives = 128/291 (43%), Gaps = 60/291 (20%)
Query: 374 LLGKSTIGIVYKVALNNE--EAVAVRR--LGNGGWQRFKEFQTEAEAIGKIRHPNIVSLR 429
L+G+ G+VYK LN E + VA+++ L + K E + + ++HPNIV
Sbjct: 7 LIGRGAFGVVYK-GLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYI 65
Query: 430 AYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVS 489
+ D +I +Y NGSL I + P S + V +G+A+LHE
Sbjct: 66 GSIETSDSLYIILEYAENGSLRQIIK------KFGPFPESLVAVYVYQVLQGLAYLHE-- 117
Query: 490 PKRYVHGDLRPSNILLGKNMEPHISDFGLA-RLADIAEETPEVHWEQSTTGTPLQSSPYE 548
+ +H D++ +NIL K+ ++DFG+A +L D++++ V GTP
Sbjct: 118 -QGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASV------VGTP------- 163
Query: 549 FTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSME--LNIV 606
Y+ APE ++ + DI+S G ++E+++G P + M IV
Sbjct: 164 -----------YWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIV 212
Query: 607 QWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPS 657
Q +D P+ + + P L L + C K P+ RP+
Sbjct: 213 Q------DDHPPLPEGISPELKDFL-------------MQCFQKDPNLRPT 244
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.5 bits (225), Expect = 3e-20
Identities = 66/222 (29%), Positives = 105/222 (47%), Gaps = 36/222 (16%)
Query: 375 LGKSTIGIVYKVALN----NEEAVAVRRL--GNGGWQRFKEFQTEAEAIGKIRHPNIVSL 428
+G G V + L E VA++ L G+ QR +F TEA +G+ HPNI+ L
Sbjct: 12 IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRL-DFLTEASIMGQFDHPNIIRL 70
Query: 429 RAYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEV 488
++I +Y+ NGSL + G + + +++G+A G+ +L E+
Sbjct: 71 EGVVTKSRPVMIITEYMENGSLDKFLRENDG-----KFTVGQLVGMLRGIASGMKYLSEM 125
Query: 489 SPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYE 548
+ YVH DL NIL+ N+ +SDFGL+R + +E T T G P
Sbjct: 126 N---YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYT------TKGG---KIPIR 173
Query: 549 FTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS 590
+T APEA RK T D++S+G+++ E++S
Sbjct: 174 WT------------APEAIAYRKFTSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 89.2 bits (222), Expect = 9e-20
Identities = 70/294 (23%), Positives = 122/294 (41%), Gaps = 64/294 (21%)
Query: 375 LGKSTIGIVYKV--ALNNEEAVAVRRL-GNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAY 431
LG+ + G+VYKV + A++++ +G + K+ E + + P +V
Sbjct: 9 LGQGSSGVVYKVRHKPTGKI-YALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGA 67
Query: 432 FWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPK 491
F+ E ++ +Y+ GSLA + K G I L+ I + + KG+ +LH + +
Sbjct: 68 FYKEGEISIVLEYMDGGSLAD-LLKKVGKIPEPVLA-----YIARQILKGLDYLH--TKR 119
Query: 492 RYVHGDLRPSNILLGKNMEPHISDFGLAR-LADIAEETPEVHWEQSTTGT-----P--LQ 543
+H D++PSN+L+ E I+DFG+++ L + ++ + GT P +Q
Sbjct: 120 HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQC------NTFVGTVTYMSPERIQ 173
Query: 544 SSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMEL 603
Y + A DI+S G+ LLE GK P + G
Sbjct: 174 GESYSYAA-------------------------DIWSLGLTLLECALGKFPFLPPGQP-- 206
Query: 604 NIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPS 657
+ +L+ + D P L + E + C+ K P KRPS
Sbjct: 207 ---SFFELMQA----ICDGPPPSLPAEE-FSPEFRDFISA---CLQKDPKKRPS 249
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 93.0 bits (231), Expect = 2e-19
Identities = 66/193 (34%), Positives = 95/193 (49%), Gaps = 31/193 (16%)
Query: 58 QVFSLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSF 117
++ SL + + L+G IP + L + ++L +NNF+G +PV L + LQ L L N F
Sbjct: 285 KLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKF 344
Query: 118 SGPVPMQIGKLKYLQVLDLSQNS--------------------FSSS----IPSSIVQCK 153
SG +P +GK L VLDLS N+ FS+S IP S+ C+
Sbjct: 345 SGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACR 404
Query: 154 RLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSGLIPNDIANLSRLRLLAQRVYV 213
L+ V L NSF+G LP F T L + LD+S NNL G I + ++ L++L
Sbjct: 405 SLRRVRLQDNSFSGELPSEF-TKLPLVYFLDISNNNLQGRINSRKWDMPSLQML------ 457
Query: 214 DLTYNNLSGLIPQ 226
L N G +P
Sbjct: 458 SLARNKFFGGLPD 470
|
Length = 968 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 88.0 bits (218), Expect = 3e-19
Identities = 80/303 (26%), Positives = 139/303 (45%), Gaps = 53/303 (17%)
Query: 374 LLGKSTIGIVY----KVALNNEEAVAVRRLGNGGWQR-FKEFQTEAEAIGKIRHPNIVSL 428
++G G V K+ E VA++ L +G ++ ++F +EA +G+ HPNI+ L
Sbjct: 11 VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 429 RAYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEV 488
++I +++ NG+L + + G + L + +++G+A G+ +L E+
Sbjct: 71 EGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQL-----VGMLRGIAAGMKYLSEM 125
Query: 489 SPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYE 548
+ YVH DL NIL+ N+ +SDFGL+R + P S+ G + P
Sbjct: 126 N---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPT---YTSSLGGKI---PIR 176
Query: 549 FTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQIGSMELNIVQ 607
+T APEA RK T D++SYG+++ E++S G+ P + + ++
Sbjct: 177 WT------------APEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDV---- 220
Query: 608 WIQLILEDRK--PMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSL 665
I I +D + P D P H L LDC K + RP + +L
Sbjct: 221 -INAIEQDYRLPPPMDC--PTALHQL------------MLDCWQKDRNARPKFGQIVSTL 265
Query: 666 DRV 668
D++
Sbjct: 266 DKM 268
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 86.6 bits (215), Expect = 8e-19
Identities = 75/284 (26%), Positives = 130/284 (45%), Gaps = 48/284 (16%)
Query: 375 LGKSTIGIVYKVALNNEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWS 434
LG G V+ N VAV+ L G + F EA+ + K+RH +V L A
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSP-EAFLQEAQIMKKLRHDKLVQLYAVCSE 72
Query: 435 VDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYV 494
+ ++ +Y+ GSL + G + L + + +A+G+A+L + Y+
Sbjct: 73 EEPIYIVTEYMSKGSLLDFLKSGEG----KKLRLPQLVDMAAQIAEGMAYLES---RNYI 125
Query: 495 HGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNS 554
H DL NIL+G+N+ I+DFGLARL + E T G P ++T
Sbjct: 126 HRDLAARNILVGENLVCKIADFGLARLIEDDEYTAR-------EGAKF---PIKWT---- 171
Query: 555 TTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQIGSMELNIVQWIQLIL 613
APEA+ + T K D++S+G++L E+++ G++P + + E +++ Q+
Sbjct: 172 --------APEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNRE--VLE--QVER 219
Query: 614 EDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPS 657
R P + +E+ ++ L C K P++RP+
Sbjct: 220 GYRMPRPP----------NCPEELYDLM---LQCWDKDPEERPT 250
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 84.9 bits (211), Expect = 3e-18
Identities = 64/299 (21%), Positives = 120/299 (40%), Gaps = 58/299 (19%)
Query: 374 LLGKSTIGIVYKVA-LNNEEAVAVRR--LGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRA 430
+GK + G VY V ++ + ++ L N + ++ E + + K+ HPNI+
Sbjct: 7 QIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYE 66
Query: 431 YFWSVDEKLL--IYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEV 488
F ++ L + +Y G L+ I K +P L + + +LH
Sbjct: 67 SF--EEKGKLCIVMEYADGGDLSQKI--KKQKKEGKPFPEEQILDWFVQLCLALKYLHS- 121
Query: 489 SPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYE 548
++ +H D++P NI L N + DFG+++ + T ++ ++ GTP
Sbjct: 122 --RKILHRDIKPQNIFLTSNGLVKLGDFGISK---VLSSTVDL--AKTVVGTP------- 167
Query: 549 FTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSME---LNI 605
YY +PE + + K DI+S G +L E+ + K P + ++ L I
Sbjct: 168 -----------YYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPF-EGENLLELALKI 215
Query: 606 VQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664
++ P+ L +VS + K P++RPS+ + S
Sbjct: 216 LK------GQYPPIPSQYSSELR-------NLVS------SLLQKDPEERPSIAQILQS 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 82.4 bits (204), Expect = 2e-17
Identities = 67/249 (26%), Positives = 102/249 (40%), Gaps = 54/249 (21%)
Query: 375 LGKSTIGIVYK-VALNNEEAVAVR--RLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAY 431
+G T G VY V L+ E +AV+ R+ + + KE E + + ++HPN+V
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVK---- 63
Query: 432 FWSV---DEKLLIY-DYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHE 487
++ V EK+ I+ +Y G+L + R L + +G+A+LH
Sbjct: 64 YYGVEVHREKVYIFMEYCSGGTLEELLEHG------RILDEHVIRVYTLQLLEGLAYLHS 117
Query: 488 VSPKRYVHGDLRPSNILLGKNMEPHISDFGLA-RLADIAEETPEVHWEQSTTGTPLQSSP 546
VH D++P+NI L N + DFG A +L + T QS GTP
Sbjct: 118 ---HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNT--TTMGEEVQSLAGTPA---- 168
Query: 547 YEFTALNSTTSRSYYQAPEASKVRKPTQKW---DIYSYGVILLEMISGKLP--------- 594
Y APE K DI+S G ++LEM +GK P
Sbjct: 169 --------------YMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQ 214
Query: 595 -MIQIGSME 602
M +G+
Sbjct: 215 IMFHVGAGH 223
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 4e-17
Identities = 80/303 (26%), Positives = 124/303 (40%), Gaps = 60/303 (19%)
Query: 375 LGKSTIGIVYK-----VALNNEEAVAVRRLGNG-GWQRFKEFQTEAEAIGKIRHPNIVSL 428
LG G VYK + VA++ L + KE EA + + HP++V L
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 429 RAYFWSVDEKLLIYDYIPNGSLATAIHGKAGII-SYRPLSWSDRLRIIKGVAKGIAFLHE 487
S + LI +P G L + I S L+W + +AKG+++L E
Sbjct: 75 LGICLS-SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQ------IAKGMSYLEE 127
Query: 488 VSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPY 547
KR VH DL N+L+ I+DFGLA+L D+ E+ E H E P
Sbjct: 128 ---KRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEK--EYHAEGGKV-------PI 175
Query: 548 EFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQIGSMELNIV 606
++ AL S R Y T K D++SYGV + E+++ G P I ++E
Sbjct: 176 KWMALESILHRIY------------THKSDVWSYGVTVWELMTFGAKPYEGIPAVE---- 219
Query: 607 QWIQLILE--DRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664
I +LE +R P I + V + + C + RP+ + + +
Sbjct: 220 --IPDLLEKGERLPQPPICT-------------IDVYMVLVKCWMIDAESRPTFKELINE 264
Query: 665 LDR 667
+
Sbjct: 265 FSK 267
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 4e-17
Identities = 76/288 (26%), Positives = 132/288 (45%), Gaps = 49/288 (17%)
Query: 375 LGKSTIGIVYKVALNNEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWS 434
LG G V+ N VAV+ L G + F EA+ + K+RH +V L A S
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSP-ESFLEEAQIMKKLRHDKLVQLYAVV-S 71
Query: 435 VDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYV 494
+ ++ +Y+ GSL + G R L + + + VA G+A++ ++ Y+
Sbjct: 72 EEPIYIVTEYMSKGSLLDFLKDGEG----RALKLPNLVDMAAQVAAGMAYIERMN---YI 124
Query: 495 HGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNS 554
H DLR +NIL+G + I+DFGLARL + E+TA
Sbjct: 125 HRDLRSANILVGDGLVCKIADFGLARLIE----------------------DNEYTARQG 162
Query: 555 TTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQIGSMELNIVQWIQLIL 613
+ APEA+ + T K D++S+G++L E+++ G++P + + E +L
Sbjct: 163 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNRE---------VL 213
Query: 614 EDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHV 661
E + + P +D +S+ ++ L C K P++RP+ ++
Sbjct: 214 EQVERGYRMPCP--------QDCPISLHELMLQCWKKDPEERPTFEYL 253
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 80.9 bits (199), Expect = 6e-17
Identities = 63/221 (28%), Positives = 107/221 (48%), Gaps = 32/221 (14%)
Query: 375 LGKSTIGIVYKVALNNEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWS 434
LG+ G V+ N VA++ L G + F EA+ + K+RH +V L A S
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVV-S 71
Query: 435 VDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYV 494
+ ++ +Y+ GSL + G+ G P + + +A G+A++ ++ YV
Sbjct: 72 EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLP----QLVDMAAQIASGMAYVERMN---YV 124
Query: 495 HGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNS 554
H DLR +NIL+G+N+ ++DFGLARL + E+TA
Sbjct: 125 HRDLRAANILVGENLVCKVADFGLARLIE----------------------DNEYTARQG 162
Query: 555 TTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLP 594
+ APEA+ + T K D++S+G++L E+ + G++P
Sbjct: 163 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 8e-17
Identities = 72/247 (29%), Positives = 109/247 (44%), Gaps = 47/247 (19%)
Query: 365 EQLLKASAFL--LGKSTIGIVYK---VALNNEE---AVAVRRLG-NGGWQRFKEFQTEAE 415
E L A FL LG+ G VYK N +VA++ L N + +EF+ EAE
Sbjct: 1 EIPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAE 60
Query: 416 AIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSL------------ATAIHGKAGIISY 463
+ ++HPNIV L ++++Y+ +G L A G + S
Sbjct: 61 LMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKS- 119
Query: 464 RPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLAD 523
L SD L I +A G+ +L S +VH DL N L+G+ + ISDFGL+R
Sbjct: 120 -SLDCSDFLHIAIQIAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDI- 174
Query: 524 IAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGV 583
+ + + QS + P++ + PEA K T + DI+S+GV
Sbjct: 175 ---YSADYYRVQSKSLLPVR-----------------WMPPEAILYGKFTTESDIWSFGV 214
Query: 584 ILLEMIS 590
+L E+ S
Sbjct: 215 VLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 2e-16
Identities = 63/221 (28%), Positives = 107/221 (48%), Gaps = 32/221 (14%)
Query: 375 LGKSTIGIVYKVALNNEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWS 434
LG G V+ N VA++ L G + F EA + +++HP +V L A +
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSP-EAFLAEANLMKQLQHPRLVRLYAVV-T 71
Query: 435 VDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYV 494
+ +I +Y+ NGSL + GI L+ + + + +A+G+AF+ K Y+
Sbjct: 72 QEPIYIITEYMENGSLVDFLKTPEGI----KLTINKLIDMAAQIAEGMAFIER---KNYI 124
Query: 495 HGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNS 554
H DLR +NIL+ + + I+DFGLARL + E T + P++
Sbjct: 125 HRDLRAANILVSETLCCKIADFGLARLIEDNEYTA-----REGAKFPIK----------- 168
Query: 555 TTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLP 594
+ APEA T K D++S+G++L E+++ G++P
Sbjct: 169 ------WTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIP 203
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 2e-16
Identities = 64/244 (26%), Positives = 110/244 (45%), Gaps = 40/244 (16%)
Query: 375 LGKSTIGIVYKVAL------NNEEAVAVRRLGNGGWQRFKE-FQTEAEAIGKIRHPNIVS 427
LG+ G V+ N++E VAV+ L ++ F+ EAE + +H NIV
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 428 LRAYFWSVDEKLLIYDYIPNGSLATAI--HGKAGIISYRP------LSWSDRLRIIKGVA 479
D +++++Y+ +G L + HG P L+ S L+I +A
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 480 KGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTG 539
G+ +L + + +VH DL N L+G ++ I DFG++R D+ T + + T
Sbjct: 133 SGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSR--DVY--TTDYYRVGGHTM 185
Query: 540 TPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQI 598
P++ P PE+ RK T + D++S+GV+L E+ + GK P +
Sbjct: 186 LPIRWMP-----------------PESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGL 228
Query: 599 GSME 602
+ E
Sbjct: 229 SNEE 232
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 3e-16
Identities = 57/166 (34%), Positives = 86/166 (51%), Gaps = 7/166 (4%)
Query: 68 KLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGK 127
KL+G IP + SL + ++L +N+ SG +P + NL+ L L N+F+G +P+ +
Sbjct: 271 KLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTS 330
Query: 128 LKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSF 187
L LQVL L N FS IP ++ + L + L+ N+ TG +P+G ++ L KL L
Sbjct: 331 LPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSS-GNLFKLILFS 389
Query: 188 NNLSGLIPNDIANLSRLRLLAQRVYVDLTYNNLSGLIPQNAALLSL 233
N+L G IP + LR V L N+ SG +P L L
Sbjct: 390 NSLEGEIPKSLGACRSLR------RVRLQDNSFSGELPSEFTKLPL 429
|
Length = 968 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 4e-16
Identities = 65/220 (29%), Positives = 98/220 (44%), Gaps = 32/220 (14%)
Query: 374 LLGKSTIGIVYKVALNNEEAVAVR--RLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAY 431
+GK G VYK L VAV+ R + K F EAE + + HPNIV L
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRK-FLQEAEILKQYDHPNIVKLIGV 60
Query: 432 FWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPK 491
++ + +P GSL T + K ++ + L L++ A G+ +L K
Sbjct: 61 CVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKL-----LQMSLDAAAGMEYLES---K 112
Query: 492 RYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTA 551
+H DL N L+G+N ISDFG++R EE ++ T L+ P ++T
Sbjct: 113 NCIHRDLAARNCLVGENNVLKISDFGMSR-----EEEGGIY----TVSDGLKQIPIKWT- 162
Query: 552 LNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISG 591
APEA + T + D++SYG++L E S
Sbjct: 163 -----------APEALNYGRYTSESDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 5e-16
Identities = 78/292 (26%), Positives = 126/292 (43%), Gaps = 52/292 (17%)
Query: 375 LGKSTIGIVYK-VALNNEEAVAVRRLGNGGWQ-RFKEFQTEAEAIGKIRHPNIVSLRAYF 432
+G +VY + L N E VA++R+ Q E + E +A+ + HPN+V F
Sbjct: 9 IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSF 68
Query: 433 WSVDEKL-LIYDYIPNGSLATAIHGKAGIISYR-PLSWSDRLRI---IKGVAKGIAFLHE 487
V ++L L+ Y+ GSL I+ P D I +K V KG+ +LH
Sbjct: 69 -VVGDELWLVMPYLSGGSLLD-------IMKSSYPRGGLDEAIIATVLKEVLKGLEYLHS 120
Query: 488 VSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQST-TGTPLQSSP 546
+H D++ NILLG++ I+DFG++ A +A+ + T GTP
Sbjct: 121 ---NGQIHRDIKAGNILLGEDGSVKIADFGVS--ASLADGGDRTRKVRKTFVGTP----- 170
Query: 547 YEFTALNSTTSRSYYQAPEA-SKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNI 605
+ APE +V K DI+S+G+ +E+ +G P + M++
Sbjct: 171 -------------CWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKV-- 215
Query: 606 VQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPS 657
+ L L++ P L D + S K+ C+ K P KRP+
Sbjct: 216 ---LMLTLQNDPPS-------LETGADYKKYSKSFRKMISLCLQKDPSKRPT 257
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 6e-16
Identities = 56/223 (25%), Positives = 101/223 (45%), Gaps = 36/223 (16%)
Query: 375 LGKSTIGIVYKVALNNEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWS 434
+G G+V+ + VA++ + G ++F EA+ + K+ HP +V L
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIREGAMSE-EDFIEEAQVMMKLSHPKLVQLYGVCTE 70
Query: 435 VDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYV 494
L+++++ +G L+ + + G S L L + V +G+A+L + +
Sbjct: 71 RSPICLVFEFMEHGCLSDYLRAQRGKFSQETL-----LGMCLDVCEGMAYLESSN---VI 122
Query: 495 HGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGT--PLQSSPYEFTAL 552
H DL N L+G+N +SDFG+ R + T S+TGT P++
Sbjct: 123 HRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT-------SSTGTKFPVK--------- 166
Query: 553 NSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLP 594
+ +PE K + K D++S+GV++ E+ S GK P
Sbjct: 167 --------WSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTP 201
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 8e-16
Identities = 81/313 (25%), Positives = 140/313 (44%), Gaps = 55/313 (17%)
Query: 361 DFDLEQLLKASAFLLGKSTIGIVYKVALNNEEA-VAVRRLGNGGWQRFKEFQTEAEAIGK 419
D L++ L AF GK + Y ++ ++ VAV+ L + K+FQ EAE +
Sbjct: 6 DIVLKRELGEGAF--GKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTN 63
Query: 420 IRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLATAI--HGKAGII--------SYRPLSWS 469
++H +IV D +++++Y+ +G L + HG +I + L S
Sbjct: 64 LQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLS 123
Query: 470 DRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETP 529
L I +A G+ +L + + +VH DL N L+G N+ I DFG++R D+ +
Sbjct: 124 QMLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR--DVY--ST 176
Query: 530 EVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMI 589
+ + T P++ P PE+ RK T + D++S+GVIL E+
Sbjct: 177 DYYRVGGHTMLPIRWMP-----------------PESIMYRKFTTESDVWSFGVILWEIF 219
Query: 590 S-GKLPMIQIGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCV 648
+ GK P Q+ + E+ I+ I + R + P KE V I L C
Sbjct: 220 TYGKQPWFQLSNTEV-----IECITQGRVLERPRVCP-------KE-----VYDIMLGCW 262
Query: 649 HKSPDKRPSMRHV 661
+ P +R +++ +
Sbjct: 263 QREPQQRLNIKEI 275
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 78.0 bits (193), Expect = 8e-16
Identities = 75/320 (23%), Positives = 120/320 (37%), Gaps = 62/320 (19%)
Query: 361 DFDLEQLLKASAFLLGKSTIGIVYKVAL---NNEEAVAV---RRLGNGGWQRFKEFQ--T 412
DF +++ G+ + V N E A+ + R+L + K
Sbjct: 2 DFKFGKII-------GEGSFSTVVLAKEKETNKEYAIKILDKRQL----IKEKKVKYVKI 50
Query: 413 EAEAIGKI-RHPNIVSLRAYFWSVDEKL-LIYDYIPNGSLATAIHGKAGIISYRPLSWSD 470
E E + ++ HP I+ L F +E L + +Y PNG L I K G + + +
Sbjct: 51 EKEVLTRLNGHPGIIKLYYTFQD-EENLYFVLEYAPNGELLQYIR-KYGSLDEKCTRF-- 106
Query: 471 RLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLAD---IAEE 527
+ + +LH K +H DL+P NILL K+M I+DFG A++ D E
Sbjct: 107 ---YAAEILLALEYLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPES 160
Query: 528 TPEVHWEQSTTGTPLQSSPYEF--TALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVIL 585
+ + F TA Y +PE + + D+++ G I+
Sbjct: 161 NKGDATNIDSQIEKNRRRFASFVGTAE--------YVSPELLNEKPAGKSSDLWALGCII 212
Query: 586 LEMISGKLPMIQIGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIAL 645
+M++GK P GS E Q IL+ P D +D I +L +
Sbjct: 213 YQMLTGKPPF--RGSNEYLT---FQKILKLEYSFPPNFPP------DAKDLIEKLLVL-- 259
Query: 646 DCVHKSPDKRPSMRHVCDSL 665
P R + D L
Sbjct: 260 -----DPQDRLGVNEGYDEL 274
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.3 bits (191), Expect = 1e-15
Identities = 82/296 (27%), Positives = 130/296 (43%), Gaps = 66/296 (22%)
Query: 375 LGKSTIGIVYK-VALNNEEAVAVR--RLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAY 431
+G T G VYK + E VA++ +L G F+ Q E + + RHPNIV AY
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLEPG--DDFEIIQQEISMLKECRHPNIV---AY 65
Query: 432 F--WSVDEKLLI-YDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEV 488
F + +KL I +Y GSL ++ PLS + + KG+A+LHE
Sbjct: 66 FGSYLRRDKLWIVMEYCGGGSLQDIYQ-----VTRGPLSELQIAYVCRETLKGLAYLHE- 119
Query: 489 SPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYE 548
+H D++ +NILL ++ + ++DFG++ A+ T + +S GTP
Sbjct: 120 --TGKIHRDIKGANILLTEDGDVKLADFGVS-----AQLTATIAKRKSFIGTP------- 165
Query: 549 FTALNSTTSRSYYQAPEASKVRKP---TQKWDIYSYGVILLEMISGKLPMIQIGSMELNI 605
Y+ APE + V + K DI++ G+ +E+ + PM +L+
Sbjct: 166 -----------YWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMF-----DLHP 209
Query: 606 VQWIQLI-LEDRKPMTDILDPFLAHDLDKE---DEIVSVLKIALDCVHKSPDKRPS 657
++ + LI + P P L DKE +K L K P KRP+
Sbjct: 210 MRALFLISKSNFPP------PKLK---DKEKWSPVFHDFIKKCLT---KDPKKRPT 253
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 1e-15
Identities = 59/185 (31%), Positives = 86/185 (46%), Gaps = 31/185 (16%)
Query: 18 DEGLALLSFKQAIRNFPEGNNWNNSNEDPCS-----WNGITCREGQVFSLIIPNKKLTGF 72
+E AL + K ++ P WN DPC W+G C+ + K F
Sbjct: 372 EEVSALQTLKSSL-GLPLRFGWNG---DPCVPQQHPWSGADCQ--------FDSTKGKWF 419
Query: 73 IPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQ 132
I + L N G +P ++ +LQS+ LSGNS G +P +G + L+
Sbjct: 420 IDG----------LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLE 469
Query: 133 VLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSG 192
VLDLS NSF+ SIP S+ Q L+ + LN NS +G +P L L + +F + +G
Sbjct: 470 VLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRL--LHRASFNFTDNAG 527
Query: 193 L--IP 195
L IP
Sbjct: 528 LCGIP 532
|
Length = 623 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 77.3 bits (191), Expect = 1e-15
Identities = 78/302 (25%), Positives = 121/302 (40%), Gaps = 84/302 (27%)
Query: 375 LGKSTIGIVYK---VALNNEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAY 431
+G+ G VYK A E A+ RL Q + E + +HPNIV Y
Sbjct: 27 IGEGASGEVYKATDRATGKEVAIKKMRLRK---QNKELIINEILIMKDCKHPNIVD---Y 80
Query: 432 FWS--VDEKL-LIYDYIPNGSLATAIHGKA-----GIISYRPLSWSDRLRIIKGVAKGIA 483
+ S V ++L ++ +Y+ GSL I I+Y + + V +G+
Sbjct: 81 YDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAY----------VCREVLQGLE 130
Query: 484 FLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQ 543
+LH + +H D++ NILL K+ ++DFG A A+ T E S GTP
Sbjct: 131 YLHS---QNVIHRDIKSDNILLSKDGSVKLADFGFA-----AQLTKEKSKRNSVVGTP-- 180
Query: 544 SSPYEFTALNSTTSRSYYQAPEASKVRKP-TQKWDIYSYGVILLEMISGKLPMIQIGSME 602
Y+ APE K RK K DI+S G++ +EM G+ P +
Sbjct: 181 ----------------YWMAPEVIK-RKDYGPKVDIWSLGIMCIEMAEGEPPY-----LR 218
Query: 603 LNIVQWIQLI-------LEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKR 655
++ + LI L++ + + FL C+ K P+KR
Sbjct: 219 EPPLRALFLITTKGIPPLKNPEKWSPEFKDFLN-----------------KCLVKDPEKR 261
Query: 656 PS 657
PS
Sbjct: 262 PS 263
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.6 bits (187), Expect = 3e-15
Identities = 51/185 (27%), Positives = 75/185 (40%), Gaps = 50/185 (27%)
Query: 419 KIRHPNIVSLRAYFWSVDEKL-LIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKG 477
+I HP IV L F + +EKL L+ +Y P G L + H S R +
Sbjct: 49 RINHPFIVKLHYAFQT-EEKLYLVLEYAPGGELFS--H------------LSKEGRFSEE 93
Query: 478 VAK--------GIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETP 529
A+ + +LH ++ DL+P NILL + ++DFGLA+
Sbjct: 94 RARFYAAEIVLALEYLHS---LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRT 150
Query: 530 EVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMI 589
+ GTP E Y APE + + D +S GV+L EM+
Sbjct: 151 -----NTFCGTP------E------------YLAPEVLLGKGYGKAVDWWSLGVLLYEML 187
Query: 590 SGKLP 594
+GK P
Sbjct: 188 TGKPP 192
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 4e-15
Identities = 61/223 (27%), Positives = 105/223 (47%), Gaps = 35/223 (15%)
Query: 375 LGKSTIGIVYKVALNNEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWS 434
LG G V+ NN VAV+ L G + F EA + ++H +V L A
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTK 72
Query: 435 VDEKLLIYDYIPNGSLATAIHGKAG--IISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKR 492
+ +I +Y+ GSL + G ++ + + +S + +A+G+A++ K
Sbjct: 73 EEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQ------IAEGMAYIER---KN 123
Query: 493 YVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTAL 552
Y+H DLR +N+L+ +++ I+DFGLAR + E+ E+TA
Sbjct: 124 YIHRDLRAANVLVSESLMCKIADFGLAR---VIEDN-------------------EYTAR 161
Query: 553 NSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLP 594
+ APEA T K D++S+G++L E+++ GK+P
Sbjct: 162 EGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIP 204
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 4e-15
Identities = 61/221 (27%), Positives = 106/221 (47%), Gaps = 32/221 (14%)
Query: 375 LGKSTIGIVYKVALNNEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWS 434
LG+ G V+ N VA++ L G + F EA+ + K+RH +V L A S
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMP-EAFLQEAQIMKKLRHDKLVPLYAVV-S 71
Query: 435 VDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYV 494
+ ++ +++ GSL + G + L + + +A G+A++ ++ Y+
Sbjct: 72 EEPIYIVTEFMGKGSLLDFLKEGDG----KYLKLPQLVDMAAQIADGMAYIERMN---YI 124
Query: 495 HGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNS 554
H DLR +NIL+G N+ I+DFGLARL + E+TA
Sbjct: 125 HRDLRAANILVGDNLVCKIADFGLARLIE----------------------DNEYTARQG 162
Query: 555 TTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLP 594
+ APEA+ + T K D++S+G++L E+++ G++P
Sbjct: 163 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.1 bits (183), Expect = 2e-14
Identities = 64/245 (26%), Positives = 104/245 (42%), Gaps = 82/245 (33%)
Query: 375 LGKSTIGIVYKVALNNE--EAVAVRRLGNGGWQRFKEFQTEAEAIG-------------K 419
LG+ T G+VYK A + + E VA+ K+ + + E G +
Sbjct: 7 LGEGTYGVVYK-ARDKKTGEIVAL-----------KKIRLDNEEEGIPSTALREISLLKE 54
Query: 420 IRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVA 479
++HPNIV L + + L+++Y L + + G +S +IK +
Sbjct: 55 LKHPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLS---------PNLIKSIM 104
Query: 480 ----KGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQ 535
+G+A+ H R +H DL+P NIL+ ++ ++DFGLAR
Sbjct: 105 YQLLRGLAYCHS---HRILHRDLKPQNILINRDGVLKLADFGLAR--------------- 146
Query: 536 STTGTPLQSSPYEFTALNSTTSRSYYQAPE--------ASKVRKPTQKWDIYSYGVILLE 587
G PL++ +E L +Y+APE ++ V DI+S G I E
Sbjct: 147 -AFGIPLRTYTHEVVTL-------WYRAPEILLGSKHYSTAV-------DIWSVGCIFAE 191
Query: 588 MISGK 592
MI+GK
Sbjct: 192 MITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 2e-14
Identities = 62/232 (26%), Positives = 104/232 (44%), Gaps = 34/232 (14%)
Query: 374 LLGKSTIGIVYKV---ALNNEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRA 430
LGK + G VYKV + N A+ LG+ + ++ E + + HPNI+S +
Sbjct: 7 KLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKE 66
Query: 431 YFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSP 490
F ++ ++ +Y P G L+ AI + + + RI + +G+ LHE
Sbjct: 67 AFLDGNKLCIVMEYAPFGDLSKAI--SKRKKKRKLIPEQEIWRIFIQLLRGLQALHE--- 121
Query: 491 KRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFT 550
++ +H DL+ +NILL N I D G++++ + + ++ GTP
Sbjct: 122 QKILHRDLKSANILLVANDLVKIGDLGISKVL-------KKNMAKTQIGTPH-------- 166
Query: 551 ALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSME 602
Y APE K R + K DI+S G +L EM + P + SM+
Sbjct: 167 ----------YMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPF-EARSMQ 207
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 2e-14
Identities = 74/297 (24%), Positives = 128/297 (43%), Gaps = 57/297 (19%)
Query: 374 LLGKSTIGIVYKVALNNEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFW 433
+GK G V ++ VAV+ L + + F EA + +RHPN+V L
Sbjct: 13 TIGKGEFGDVMLGDYRGQK-VAVKCLKDDS-TAAQAFLAEASVMTTLRHPNLVQLLGVVL 70
Query: 434 SVDEKLLIYDYIPNGSLATAIH--GKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPK 491
+ ++ +Y+ GSL + G+A I + + +L V +G+ +L E K
Sbjct: 71 QGNPLYIVTEYMAKGSLVDYLRSRGRAVI------TLAQQLGFALDVCEGMEYLEE---K 121
Query: 492 RYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTA 551
+VH DL N+L+ +++ +SDFGLA+ A Q L P ++T
Sbjct: 122 NFVHRDLAARNVLVSEDLVAKVSDFGLAKEA-----------SQGQDSGKL---PVKWT- 166
Query: 552 LNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQIGSMELNIVQWIQ 610
APEA + +K + K D++S+G++L E+ S G++P +I + +V ++
Sbjct: 167 -----------APEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--VVPHVE 213
Query: 611 LILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDR 667
P + P V K+ DC P KRP+ + + + L
Sbjct: 214 KGYRMEAP--EGCPPE-------------VYKVMKDCWELDPAKRPTFKQLREQLAL 255
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 3e-14
Identities = 74/300 (24%), Positives = 131/300 (43%), Gaps = 74/300 (24%)
Query: 374 LLGKSTIGIVYK-VALNNEEAVAVRRL-----GNGGWQRFKEFQTEAEAIGKIRHPNIVS 427
LLG + G VY+ + L++ + AV+ + G G + K+ + E + K++HPNIV
Sbjct: 7 LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66
Query: 428 LRAYFWSV--DEKLLIY-DYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAF 484
Y + ++ L I+ + +P GSLA + K G + R + G+ +
Sbjct: 67 ---YLGTEREEDNLYIFLELVPGGSLAK-LLKKYGSFPEPVIRLYTR-----QILLGLEY 117
Query: 485 LHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQS 544
LH+ + VH D++ +NIL+ N ++DFG+A+ + E + +S G+P
Sbjct: 118 LHD---RNTVHRDIKGANILVDTNGVVKLADFGMAK------QVVEFSFAKSFKGSP--- 165
Query: 545 SPYEFTALNSTTSRSYYQAPEASKVRKPTQKW----DIYSYGVILLEMISGKLP---MIQ 597
Y+ APE V + DI+S G +LEM +GK P +
Sbjct: 166 ---------------YWMAPE---VIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG 207
Query: 598 IGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPS 657
+ ++ I + ++ P+ D L + +D I L C+ + P RP+
Sbjct: 208 VAAV-FKIGR-----SKELPPIPDHLSD------EAKDFI-------LKCLQRDPSLRPT 248
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 2e-13
Identities = 73/298 (24%), Positives = 123/298 (41%), Gaps = 61/298 (20%)
Query: 375 LGKSTIGIVYKVALNNEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWS 434
LG G+V + VA++ + G EF EA+ + K+ H +V L
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMKLSHEKLVQLYGVCTK 70
Query: 435 VDEKLLIYDYIPNGSLATAI--HGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKR 492
++ +Y+ NG L + HGK S L + K V +G+A+L K+
Sbjct: 71 QRPIYIVTEYMSNGCLLNYLREHGKR-------FQPSQLLEMCKDVCEGMAYLES---KQ 120
Query: 493 YVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGT--PLQSSPYEFT 550
++H DL N L+ +SDFGL+R E T S+ G+ P++ SP
Sbjct: 121 FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT-------SSVGSKFPVRWSP---- 169
Query: 551 ALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQIGSME--LNIVQ 607
PE K + K D++++GV++ E+ S GK+P + + E + Q
Sbjct: 170 -------------PEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQ 216
Query: 608 WIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSL 665
++L P LA + V I C H+ ++RP+ + + S+
Sbjct: 217 GLRL-----------YRPHLASE--------KVYAIMYSCWHEKAEERPTFQQLLSSI 255
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 2e-13
Identities = 61/218 (27%), Positives = 101/218 (46%), Gaps = 31/218 (14%)
Query: 374 LLGKSTIGIVYKVALNNEEAVAVRRLGNGGWQRFK-EFQTEAEAIGKIRHPNIVSLRAYF 432
LLGK G V+K L ++ VAV+ Q K +F +EA + + HPNIV L
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61
Query: 433 WSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKR 492
++ + +P G + + K + + L ++ A G+A+L K
Sbjct: 62 TQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQL-----VKFALDAAAGMAYLES---KN 113
Query: 493 YVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTAL 552
+H DL N L+G+N ISDFG++R +E ++ S++G L+ P ++T
Sbjct: 114 CIHRDLAARNCLVGENNVLKISDFGMSR-----QEDDGIY---SSSG--LKQIPIKWT-- 161
Query: 553 NSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS 590
APEA + + + D++SYG++L E S
Sbjct: 162 ----------APEALNYGRYSSESDVWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 2e-13
Identities = 78/338 (23%), Positives = 138/338 (40%), Gaps = 70/338 (20%)
Query: 354 VPLDSQVDFDLEQLLKASAFLLGKSTIGIVYKVAL------NNEEAVAVRRL-GNGGWQR 406
+PLD + + ++L LG+ G V K N VAV+ L + +
Sbjct: 1 LPLDPEWELPRDRLTLGK--PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKD 58
Query: 407 FKEFQTEAEAIGKI-RHPNIVSLRAYFWSVDEKLLIYDYIPNGSL----------ATAIH 455
+ +E E + I +H NI++L ++ +Y +G+L
Sbjct: 59 LSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYAS 118
Query: 456 GKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISD 515
L+ D + VA+G+ FL + K+ +H DL N+L+ ++ I+D
Sbjct: 119 PDDPRPPEETLTQKDLVSFAYQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIAD 175
Query: 516 FGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQK 575
FGLAR DI + + + TT L P ++ A + R Y T +
Sbjct: 176 FGLAR--DIH----HIDYYRKTTNGRL---PVKWMAPEALFDRVY------------THQ 214
Query: 576 WDIYSYGVILLEMIS-GKLPMIQIGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDK- 633
D++S+GV+L E+ + G P I EL +L+ E + ++K
Sbjct: 215 SDVWSFGVLLWEIFTLGGSPYPGIPVEEL-----FKLLKE-------------GYRMEKP 256
Query: 634 ---EDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRV 668
E+ ++ DC H+ P +RP+ + + + LDR+
Sbjct: 257 QNCTQELYHLM---RDCWHEVPSQRPTFKQLVEDLDRM 291
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 70.9 bits (173), Expect = 2e-13
Identities = 58/218 (26%), Positives = 104/218 (47%), Gaps = 32/218 (14%)
Query: 394 VAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLATA 453
VAV+ L + K+F EAE + ++H +IV D +++++Y+ +G L
Sbjct: 38 VAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKF 97
Query: 454 I--HGKAGIISYR-----PLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLG 506
+ HG ++ L+ S L I + +A G+ +L + + +VH DL N L+G
Sbjct: 98 LRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYL---ASQHFVHRDLATRNCLVG 154
Query: 507 KNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEA 566
+N+ I DFG++R D+ + + + T P++ P PE+
Sbjct: 155 ENLLVKIGDFGMSR--DVY--STDYYRVGGHTMLPIRWMP-----------------PES 193
Query: 567 SKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQIGSMEL 603
RK T + D++S GV+L E+ + GK P Q+ + E+
Sbjct: 194 IMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEV 231
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 4e-13
Identities = 67/242 (27%), Positives = 108/242 (44%), Gaps = 43/242 (17%)
Query: 368 LKASAFL--LGKSTIGIVYK-----VALNNEEAVAVRRLGN-GGWQRFKEFQTEAEAIGK 419
L A F+ LG+ G +YK +++ + VA++ L + Q++ EFQ EA + +
Sbjct: 4 LSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAE 63
Query: 420 IRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLATAI-----HGKAGIIS------YRPLSW 468
+ HPNIV L ++++Y+ G L + H G S L
Sbjct: 64 LHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDH 123
Query: 469 SDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEET 528
D L I +A G+ +L S +VH DL NIL+G+ + ISD GL+R +I +
Sbjct: 124 GDFLHIAIQIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSR--EIY--S 176
Query: 529 PEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEM 588
+ + Q + P++ P PEA K + DI+S+GV+L E+
Sbjct: 177 ADYYRVQPKSLLPIRWMP-----------------PEAIMYGKFSSDSDIWSFGVVLWEI 219
Query: 589 IS 590
S
Sbjct: 220 FS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 70.0 bits (172), Expect = 4e-13
Identities = 61/228 (26%), Positives = 103/228 (45%), Gaps = 49/228 (21%)
Query: 375 LGKSTIGIVYKVALNNE--EAVAVRRL----GNGG----WQRFKEFQTEAEAIGKIRHPN 424
+G+ GIV+K A + E E VA++++ GG R E +A+ +HP
Sbjct: 8 IGEGAHGIVFK-AKDRETGETVALKKVALRRLEGGIPNQALR------EIKALQACQHPY 60
Query: 425 IVSLRAYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAF 484
+V L F +L+ +Y+P L+ + RPL + ++ + KG+A+
Sbjct: 61 VVKLLDVFPHGSGFVLVMEYMP-SDLSEVLRD-----EERPLPEAQVKSYMRMLLKGVAY 114
Query: 485 LHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQS 544
+H +H DL+P+N+L+ + I+DFGLARL EE P ++ Q T
Sbjct: 115 MHA---NGIMHRDLKPANLLISADGVLKIADFGLARLFS--EEEPRLYSHQVAT------ 163
Query: 545 SPYEFTALNSTTSRSYYQAPEA-SKVRKPTQKWDIYSYGVILLEMISG 591
+Y+APE RK D+++ G I E+++G
Sbjct: 164 --------------RWYRAPELLYGARKYDPGVDLWAVGCIFAELLNG 197
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 5e-13
Identities = 55/226 (24%), Positives = 95/226 (42%), Gaps = 39/226 (17%)
Query: 375 LGKSTIGIVYKVALNNEEAVAVRR---LGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAY 431
+GK + G+V+KV ++ V + L + +E EA + K+ I+ Y
Sbjct: 8 IGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIR---Y 64
Query: 432 FWSVDEKLLIY---DYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEV 488
+ S +K + +Y NG L + + G RPL R + G+A LH
Sbjct: 65 YESFLDKGKLNIVMEYAENGDLHKLLKMQRG----RPLPEDQVWRFFIQILLGLAHLHS- 119
Query: 489 SPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYE 548
K+ +H D++ N+ L I D G+A+L + ++ + GTP
Sbjct: 120 --KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLL-----SDNTNFANTIVGTP------- 165
Query: 549 FTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLP 594
YY +PE + + +K D+++ GV+L E +GK P
Sbjct: 166 -----------YYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHP 200
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 5e-13
Identities = 49/229 (21%), Positives = 91/229 (39%), Gaps = 39/229 (17%)
Query: 396 VRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLL-IYDYIPNGSLATAI 454
+R + F+ E ++ HPNIV+L + L +++Y+P +L +
Sbjct: 11 LRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPGRTLREVL 70
Query: 455 HGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLG-KNMEPH- 512
L + R++ V +A H + VH DL+P NI++ + PH
Sbjct: 71 AADG------ALPAGETGRLMLQVLDALACAHN---QGIVHRDLKPQNIMVSQTGVRPHA 121
Query: 513 -ISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRK 571
+ DFG+ L + T T + +P Y APE +
Sbjct: 122 KVLDFGIGTLLPGVRDADVA---TLTRTTEVLGTPT-------------YCAPEQLRGEP 165
Query: 572 PTQKWDIYSYGVILLEMISGKLPMI----------QIGSMELNIVQWIQ 610
T D+Y++G+I LE ++G+ + Q+ +++++ WI
Sbjct: 166 VTPNSDLYAWGLIFLECLTGQRVVQGASVAEILYQQLSPVDVSLPPWIA 214
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 69.3 bits (170), Expect = 6e-13
Identities = 74/308 (24%), Positives = 122/308 (39%), Gaps = 60/308 (19%)
Query: 363 DLEQLLKASAFLLGKSTIGIVYKV---ALNNEEAVAVRRLGNGGWQRFKEFQTEAEAIGK 419
DLE L + LG G+V KV AV RL K+ E + + K
Sbjct: 2 DLEYLGE-----LGAGNSGVVSKVLHRPTGKIMAVKTIRL-EINEAIQKQILRELDILHK 55
Query: 420 IRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVA 479
P IV F++ + + +Y+ GSL + G I R L +I V
Sbjct: 56 CNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILG-----KIAVAVL 110
Query: 480 KGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLAR--LADIAEETPEVHWEQST 537
KG+ +LHE + +H D++PSNIL+ + + DFG++ + +A ++
Sbjct: 111 KGLTYLHEK--HKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA---------KTF 159
Query: 538 TGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQ 597
GT S Y APE + + K DI+S G+ L+E+ +G+ P
Sbjct: 160 VGT------------------SSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPP 201
Query: 598 IGSMELNIVQWIQLILEDRKPM--TDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKR 655
I + +Q I+ + P + P ++ C+ K P +R
Sbjct: 202 ENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQDFVNL-------------CLIKDPRER 248
Query: 656 PSMRHVCD 663
PS + + +
Sbjct: 249 PSYKELLE 256
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 8e-13
Identities = 80/318 (25%), Positives = 138/318 (43%), Gaps = 74/318 (23%)
Query: 374 LLGKSTIGIVYKVALNNEEA---VAVRRLGNGGWQR-FKEFQTEAEAIGKI-RHPNIVSL 428
++G+ G V K + + A++R+ + ++F E E + K+ HPNI++L
Sbjct: 14 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 73
Query: 429 ------RAYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRP-----------LSWSDR 471
R Y + L +Y P+G+L + K+ ++ P LS
Sbjct: 74 LGACEHRGYLY------LAIEYAPHGNLLDFLR-KSRVLETDPAFAIANSTASTLSSQQL 126
Query: 472 LRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEV 531
L VA+G+ +L S K+++H DL NIL+G+N I+DFGL+R ++
Sbjct: 127 LHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEV------- 176
Query: 532 HWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS- 590
+ + T G P + A+ S Y T D++SYGV+L E++S
Sbjct: 177 -YVKKTMG----RLPVRWMAIESLNYSVY------------TTNSDVWSYGVLLWEIVSL 219
Query: 591 GKLPMIQIGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHK 650
G P + EL + +L R L L+ +DE+ +++ C +
Sbjct: 220 GGTPYCGMTCAEL----YEKLPQGYR----------LEKPLNCDDEVYDLMR---QCWRE 262
Query: 651 SPDKRPSMRHVCDSLDRV 668
P +RPS + SL+R+
Sbjct: 263 KPYERPSFAQILVSLNRM 280
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 9e-13
Identities = 75/307 (24%), Positives = 125/307 (40%), Gaps = 71/307 (23%)
Query: 374 LLGKSTIGIVYKVALN--NEEAVAVRR--LGNGGWQRFKEFQ--------TEAEAIGKIR 421
L+GK T G VY +ALN E +AV++ L R Q +E E + +
Sbjct: 8 LIGKGTYGRVY-LALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLD 66
Query: 422 HPNIVSLRAYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKG 481
H NIV + + + + +Y+P GS+ + + +Y + V +G
Sbjct: 67 HLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLR------TYGRFEEQLVRFFTEQVLEG 120
Query: 482 IAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTP 541
+A+LH K +H DL+ N+L+ + ISDFG+++ +D
Sbjct: 121 LAYLHS---KGILHRDLKADNLLVDADGICKISDFGISKKSDDI---------------- 161
Query: 542 LQSSPYEFTALNSTTSRSYYQAPEA--SKVRKPTQKWDIYSYGVILLEMISGKLP---MI 596
Y+ S ++ APE S + + K DI+S G ++LEM +G+ P
Sbjct: 162 -----YDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEE 216
Query: 597 QIGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALD----CVHKSP 652
I +M +L + P P D +++ +ALD C +P
Sbjct: 217 AIAAM-------FKLGNKRSAP------PI------PPDVSMNLSPVALDFLNACFTINP 257
Query: 653 DKRPSMR 659
D RP+ R
Sbjct: 258 DNRPTAR 264
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 1e-12
Identities = 70/294 (23%), Positives = 123/294 (41%), Gaps = 55/294 (18%)
Query: 374 LLGKSTIGIVYKVALNNEEAVAVRRLG------NGGWQRFKEFQTEAEAIGKIRHPNIVS 427
+LGK G VY N + +AV+++ + +++ Q E + + ++H NIV
Sbjct: 7 VLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV- 65
Query: 428 LRAYFWSV--DEKLLIY-DYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAF 484
Y + D + I+ +++P GS+++ ++ + PL + K + G+A+
Sbjct: 66 --QYLGTCLDDNTISIFMEFVPGGSISSILN------RFGPLPEPVFCKYTKQILDGVAY 117
Query: 485 LHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLAR-LADIAEETPEVHWEQSTTGTPLQ 543
LH VH D++ +N++L N + DFG AR LA + + +S GTP
Sbjct: 118 LHN---NCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTP-- 172
Query: 544 SSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMEL 603
Y+ APE +K DI+S G + EM +GK P+ + +
Sbjct: 173 ----------------YWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAA 216
Query: 604 NIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPS 657
+ I R M + D F A +D C+ + +RPS
Sbjct: 217 -----MFYIGAHRGLMPRLPDSFSAAAID----------FVTSCLTRDQHERPS 255
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 1e-12
Identities = 70/296 (23%), Positives = 124/296 (41%), Gaps = 57/296 (19%)
Query: 375 LGKSTIGIVYKVALNNEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWS 434
LG G+V+ + VA++ + G +F EA+ + K+ HPN+V L
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIREGAMSE-DDFIEEAKVMMKLSHPNLVQLYGVCTK 70
Query: 435 VDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYV 494
++ +Y+ NG L + + G + L L + V + + +L ++
Sbjct: 71 QRPIFIVTEYMANGCLLNYLRERKGKLGTEWL-----LDMCSDVCEAMEYLES---NGFI 122
Query: 495 HGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGT--PLQSSPYEFTAL 552
H DL N L+G++ +SDFGLAR + T S+ GT P++ +P E
Sbjct: 123 HRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT-------SSQGTKFPVKWAPPEVFDY 175
Query: 553 NSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQIGSMEL--NIVQWI 609
+ +S+S D++S+GV++ E+ S GK+P + + E+ ++
Sbjct: 176 SRFSSKS-----------------DVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGY 218
Query: 610 QLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSL 665
+L R P LA V I C H+ P+ RP+ + + L
Sbjct: 219 RL---YR--------PKLAPT--------EVYTIMYSCWHEKPEDRPAFKKLLSQL 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 2e-12
Identities = 75/306 (24%), Positives = 127/306 (41%), Gaps = 48/306 (15%)
Query: 374 LLGKSTIGIVYKVAL-----NNEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSL 428
LGK G V N E VAV++L + + ++F+ E E + ++H NIV
Sbjct: 11 QLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKY 70
Query: 429 RAYFWSVDEK--LLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLH 486
+ +S + L+ +Y+P GSL + + +R L L + KG+ +L
Sbjct: 71 KGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKL-----LLYASQICKGMEYL- 124
Query: 487 EVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSP 546
KRYVH DL NIL+ I DFGL ++ +E +V P
Sbjct: 125 --GSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKV------------REP 170
Query: 547 YEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS----GKLPMIQIGSME 602
E S ++ APE+ K + D++S+GV+L E+ + P + M
Sbjct: 171 GE--------SPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMM 222
Query: 603 LNIVQWIQLILEDRKPMTDILDP--FLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRH 660
N Q ++ + ++L L EI +++K +C + P +RPS
Sbjct: 223 GNDKQGQMIVYH----LIELLKNNGRLPAPPGCPAEIYAIMK---ECWNNDPSQRPSFSE 275
Query: 661 VCDSLD 666
+ ++
Sbjct: 276 LALQVE 281
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 2e-12
Identities = 63/219 (28%), Positives = 94/219 (42%), Gaps = 51/219 (23%)
Query: 394 VAVRRLGNGG-WQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSL-- 450
VAV+ L +FQ EA + + HPNIV L L+++Y+ G L
Sbjct: 38 VAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNE 97
Query: 451 ----------ATAIHGKAGIISYR----PLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHG 496
+ H + PLS +++L I K VA G+A+L E +++VH
Sbjct: 98 FLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSE---RKFVHR 154
Query: 497 DLRPSNILLGKNMEPHISDFGLAR---LADI--AEETPEVHWEQSTTGTPLQSSPYEFTA 551
DL N L+G+NM I+DFGL+R AD A E + P++ P E
Sbjct: 155 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAI---------PIRWMPPESIF 205
Query: 552 LNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS 590
N T+ S D+++YGV+L E+ S
Sbjct: 206 YNRYTTES-----------------DVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 3e-12
Identities = 55/230 (23%), Positives = 96/230 (41%), Gaps = 52/230 (22%)
Query: 375 LGKSTIGIVYKVALNNE--EAVAVRRLGNGGWQRFKEFQT-------EAEAIGKIRHPNI 425
+G+ T G+VYK A + E VA++++ + E + E + + ++ HPNI
Sbjct: 7 IGEGTYGVVYK-ARDKLTGEIVAIKKI-----KLRFESEGIPKTALREIKLLKELNHPNI 60
Query: 426 VSLRAYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFL 485
+ L F + L+++++ + L I + R L S + + +G+AF
Sbjct: 61 IKLLDVFRHKGDLYLVFEFM-DTDLYKLIKDRQ-----RGLPESLIKSYLYQLLQGLAFC 114
Query: 486 HEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSS 545
H +H DL+P N+L+ ++DFGLAR S
Sbjct: 115 HS---HGILHRDLKPENLLINTEGVLKLADFGLARSFG--------------------SP 151
Query: 546 PYEFTALNSTTSRSYYQAPE---ASKVRKPTQKWDIYSYGVILLEMISGK 592
+T T +Y+APE K + DI+S G I E++S +
Sbjct: 152 VRPYTHYVVT---RWYRAPELLLGDKGY--STPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 3e-12
Identities = 61/230 (26%), Positives = 108/230 (46%), Gaps = 32/230 (13%)
Query: 375 LGKSTIGIVYKVALNNEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWS 434
LG G V+ N VAV+ + G + F EA + ++H +V L A +
Sbjct: 14 LGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVV-T 71
Query: 435 VDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYV 494
+ +I +++ GSL + G S +PL + +A+G+AF+ + + Y+
Sbjct: 72 KEPIYIITEFMAKGSLLDFLKSDEG--SKQPLP--KLIDFSAQIAEGMAFIEQ---RNYI 124
Query: 495 HGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNS 554
H DLR +NIL+ ++ I+DFGLAR + E+ E+TA
Sbjct: 125 HRDLRAANILVSASLVCKIADFGLAR---VIEDN-------------------EYTAREG 162
Query: 555 TTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQIGSMEL 603
+ APEA T K D++S+G++L+E+++ G++P + + E+
Sbjct: 163 AKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEV 212
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 66.6 bits (163), Expect = 3e-12
Identities = 74/281 (26%), Positives = 111/281 (39%), Gaps = 57/281 (20%)
Query: 383 VYKVALNNEEAVAVRRLGNGGWQRFK-EFQTEAEAIGKIRHPNIVSLRAYFWSVDEKL-L 440
VY + E VAV+ L K EF EA + ++ HP IV L E L L
Sbjct: 15 VYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGV--CKGEPLML 72
Query: 441 IYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRP 500
+ + P G L + R + SD + VA G+A+L K +VH DL
Sbjct: 73 VMELAPLGPLLKYLKK------RREIPVSDLKELAHQVAMGMAYLES---KHFVHRDLAA 123
Query: 501 SNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGT--PLQSSPYEFTALNSTTSR 558
N+LL + ISDFG++R + + ++TT PL+
Sbjct: 124 RNVLLVNRHQAKISDFGMSRALGAGSD-----YYRATTAGRWPLK--------------- 163
Query: 559 SYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQIGSMELNIVQWIQLILEDRK 617
+Y APE K + K D++SYGV L E S G P ++ E ++ ++
Sbjct: 164 -WY-APECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAE--VIAMLE------- 212
Query: 618 PMTDILDPFLAHDLDKEDEI-VSVLKIALDCVHKSPDKRPS 657
L + +E + I L C P+ RP+
Sbjct: 213 ---------SGERLPRPEECPQEIYSIMLSCWKYRPEDRPT 244
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 4e-12
Identities = 64/244 (26%), Positives = 108/244 (44%), Gaps = 40/244 (16%)
Query: 375 LGKSTIGIVYKVALNN------EEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSL 428
LG+ G V+ +N + VAV+ L ++FQ EAE + ++H +IV
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 429 RAYFWSVDEKLLIYDYIPNGSLATAI--HGKAGII-------SYRPLSWSDRLRIIKGVA 479
L++++Y+ +G L + HG I + L+ L I +A
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132
Query: 480 KGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTG 539
G+ +L + +VH DL N L+G+ + I DFG++R DI + + + T
Sbjct: 133 SGMVYLASL---HFVHRDLATRNCLVGQGLVVKIGDFGMSR--DIY--STDYYRVGGRTM 185
Query: 540 TPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQI 598
P++ P PE+ RK T + DI+S+GV+L E+ + GK P Q+
Sbjct: 186 LPIRWMP-----------------PESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQL 228
Query: 599 GSME 602
+ E
Sbjct: 229 SNTE 232
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 4e-12
Identities = 75/305 (24%), Positives = 126/305 (41%), Gaps = 56/305 (18%)
Query: 357 DSQVDFDLEQLLKASAFLLGKSTIGIVYKVA-LNNEEAVAVRRLGNGGWQRFKEFQTEAE 415
+ Q DF+L Q + G T G VYK +N E A++ + + F Q E
Sbjct: 6 NPQEDFELIQRI-------GSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEII 58
Query: 416 AIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRII 475
+ +H NIV+ + D+ + ++ GSL H PLS S +
Sbjct: 59 MMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTG------PLSESQIAYVS 112
Query: 476 KGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQ 535
+ +G+ +LH K +H D++ +NILL N ++DFG++ A+ T + +
Sbjct: 113 RETLQGLYYLHS---KGKMHRDIKGANILLTDNGHVKLADFGVS-----AQITATIAKRK 164
Query: 536 STTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKP---TQKWDIYSYGVILLEMISGK 592
S GTP Y+ APE + V + Q DI++ G+ +E+ +
Sbjct: 165 SFIGTP------------------YWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQ 206
Query: 593 LPMIQIGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSP 652
PM + M L L + ++ P L + + +K+AL K+P
Sbjct: 207 PPMFDLHPMR-------ALFLMTK---SNFQPPKLKDKMKWSNSFHHFVKMALT---KNP 253
Query: 653 DKRPS 657
KRP+
Sbjct: 254 KKRPT 258
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 6e-12
Identities = 71/325 (21%), Positives = 132/325 (40%), Gaps = 75/325 (23%)
Query: 366 QLLKASAFLLGKSTIGIVYKVALNNEEAVAVRRLGNGGWQ-RFKEFQTEAEAIGKIRHPN 424
+++KA+AF L K G VAV+ L ++ +E + ++ HP+
Sbjct: 15 KVVKATAFRL-KGRAGYT---------TVAVKMLKENASSSELRDLLSEFNLLKQVNHPH 64
Query: 425 IVSLRAYFWSVDEKLLIYDYIPNGSLATAIH-----GKAGIISY-------------RPL 466
++ L LLI +Y GSL + + G + + S R L
Sbjct: 65 VIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERAL 124
Query: 467 SWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAE 526
+ D + +++G+ +L E+ VH DL N+L+ + + ISDFGL+R D+ E
Sbjct: 125 TMGDLISFAWQISRGMQYLAEMK---LVHRDLAARNVLVAEGRKMKISDFGLSR--DVYE 179
Query: 527 ETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILL 586
E V + P ++ A+ S Y T + D++S+GV+L
Sbjct: 180 EDSYVKRSKGRI-------PVKWMAIESLFDHIY------------TTQSDVWSFGVLLW 220
Query: 587 EMIS-GKLPMIQIGSMEL-NIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIV-SVLKI 643
E+++ G P I L N+++ + +++ + + +
Sbjct: 221 EIVTLGGNPYPGIAPERLFNLLK-------------------TGYRMERPENCSEEMYNL 261
Query: 644 ALDCVHKSPDKRPSMRHVCDSLDRV 668
L C + PDKRP+ + L+++
Sbjct: 262 MLTCWKQEPDKRPTFADISKELEKM 286
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 7e-12
Identities = 73/296 (24%), Positives = 123/296 (41%), Gaps = 58/296 (19%)
Query: 375 LGKSTIGIVYKVALNNEEAVAVRRL----GNGGWQRFKEFQTEAEAIGKIRHPNIVSLRA 430
LG+ G V K L N + + N Q K+ E E + P IV +
Sbjct: 9 LGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQ--KQILRELEINKSCKSPYIV--KY 64
Query: 431 YFWSVDEK----LLIYDYIPNGSLATAIHGK----AGIISYRPLSWSDRLRIIKGVAKGI 482
Y +DE + +Y GSL +I+ K G I + L +I + V KG+
Sbjct: 65 YGAFLDESSSSIGIAMEYCEGGSL-DSIYKKVKKRGGRIGEKVL-----GKIAESVLKGL 118
Query: 483 AFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPL 542
++LH ++ +H D++PSNILL + + + DFG+ +G +
Sbjct: 119 SYLHS---RKIIHRDIKPSNILLTRKGQVKLCDFGV-------------------SGELV 156
Query: 543 QSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSME 602
S FT S+Y APE + + + D++S G+ LLE+ + P G
Sbjct: 157 NSLAGTFTG------TSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPP 210
Query: 603 LNIVQWIQLILEDRKP-MTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPS 657
L ++ + I+ P + D +P + + +E +K L+ K P +RP+
Sbjct: 211 LGPIELLSYIVNMPNPELKD--EP--GNGIKWSEEFKDFIKQCLE---KDPTRRPT 259
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 65.7 bits (161), Expect = 7e-12
Identities = 65/287 (22%), Positives = 119/287 (41%), Gaps = 53/287 (18%)
Query: 374 LLGKSTIGIVYKVALNNE--EAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAY 431
LG+ + G VYK A++ E + VA++ + +E E + + P IV
Sbjct: 10 KLGEGSYGSVYK-AIHKETGQVVAIKVVPVEE--DLQEIIKEISILKQCDSPYIVKYYGS 66
Query: 432 FWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPK 491
++ + ++ +Y GS++ + I+ + L+ + I+ KG+ +LH
Sbjct: 67 YFKNTDLWIVMEYCGAGSVSDIMK-----ITNKTLTEEEIAAILYQTLKGLEYLHS---N 118
Query: 492 RYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTA 551
+ +H D++ NILL + + ++DFG++ + T + + GTP
Sbjct: 119 KKIHRDIKAGNILLNEEGQAKLADFGVS-----GQLTDTMAKRNTVIGTP---------- 163
Query: 552 LNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQWIQL 611
++ APE + K DI+S G+ +EM GK P I M +
Sbjct: 164 --------FWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMR-------AI 208
Query: 612 ILEDRKPMTDILDPFLAHDLDKE-DEIVSVLKIALDCVHKSPDKRPS 657
+ KP + DP E ++ V C+ K P++RPS
Sbjct: 209 FMIPNKPPPTLSDP---EKWSPEFNDFVKK------CLVKDPEERPS 246
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 8e-12
Identities = 68/291 (23%), Positives = 124/291 (42%), Gaps = 59/291 (20%)
Query: 375 LGKSTIGIVY-KVALNNEEAVAVRRLGNGGWQRFKEFQ-TEAEAIGKIRHPNIVSLRAYF 432
+G+ G VY + + + VA++++ N Q KE E + + +HPNIV+ +
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQM-NLQQQPKKELIINEILVMRENKHPNIVNYLDSY 85
Query: 433 WSVDEKLLIYDYIPNGSLA---TAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVS 489
DE ++ +Y+ GSL T G I+ + + + + FLH
Sbjct: 86 LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIA----------AVCRECLQALEFLHS-- 133
Query: 490 PKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEF 549
+ +H D++ NILLG + ++DFG A+ TPE + GTP
Sbjct: 134 -NQVIHRDIKSDNILLGMDGSVKLTDFGFC-----AQITPEQSKRSTMVGTP-------- 179
Query: 550 TALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQWI 609
Y+ APE + K DI+S G++ +EM+ G+ P + N ++ +
Sbjct: 180 ----------YWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPY-----LNENPLRAL 224
Query: 610 QLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALD-CVHKSPDKRPSMR 659
LI + P +L +++ ++ + L+ C+ +KR S +
Sbjct: 225 YLIATNGTP-----------ELQNPEKLSAIFRDFLNRCLEMDVEKRGSAK 264
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 8e-12
Identities = 72/288 (25%), Positives = 115/288 (39%), Gaps = 52/288 (18%)
Query: 374 LLGKSTIGIVYKVALNNEEA-------VAVRRLGNGGWQR-----FKEFQTEAEAIGK-I 420
LG G VYKV N + V G +R + +E I + +
Sbjct: 7 HLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQL 66
Query: 421 RHPNIVSLRAYFWSVDEKLLIYDYI---PNGSLATAIHGKAGIISYRPLSWSDRLRIIKG 477
RHPNIV F D ++ D I P G ++ K + + W+ I
Sbjct: 67 RHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERI-WN----IFVQ 121
Query: 478 VAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQST 537
+ + +LH+ KR VH DL P+NI+LG++ + I+DFGLA+
Sbjct: 122 MVLALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGLAK----------------- 162
Query: 538 TGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQ 597
Q P L S Y PE K +K D++++G IL +M + + P
Sbjct: 163 -----QKQPESK--LTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYS 215
Query: 598 IG--SMELNIVQWIQLILEDR---KPMTDILDPFLAHDLDKEDEIVSV 640
S+ IV+ + L + + +TD++ L D + +I+ V
Sbjct: 216 TNMLSLATKIVEAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQV 263
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 1e-11
Identities = 59/219 (26%), Positives = 95/219 (43%), Gaps = 61/219 (27%)
Query: 408 KEFQTEAEAIGKI-RHPNIVSL------RAYFWSVDEKLLIYDYIPNGSLATAI------ 454
++F E E + K+ HPNI++L R Y + L +Y P+G+L +
Sbjct: 40 RDFAGELEVLCKLGHHPNIINLLGACEHRGYLY------LAIEYAPHGNLLDFLRKSRVL 93
Query: 455 ---------HGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILL 505
+ A +S + L L VA+G+ +L + K+++H DL NIL+
Sbjct: 94 ETDPAFAIANSTASTLSSQQL-----LHFAADVARGMDYLSQ---KQFIHRDLAARNILV 145
Query: 506 GKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPE 565
G+N I+DFGL+R +E + + T G P + A+ S Y
Sbjct: 146 GENYVAKIADFGLSR----GQEV----YVKKTMG----RLPVRWMAIESLNYSVY----- 188
Query: 566 ASKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQIGSMEL 603
T D++SYGV+L E++S G P + EL
Sbjct: 189 -------TTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL 220
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 1e-11
Identities = 60/211 (28%), Positives = 90/211 (42%), Gaps = 53/211 (25%)
Query: 392 EAVAVRRLGNGGWQRFKEFQTEAEA---------IGKIRHPNIVSLRAYFWSVDEKLLIY 442
+ VA++++ K F T A + +RH NI+SL F S E +
Sbjct: 36 QNVAIKKI-------MKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDI--- 85
Query: 443 DYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSN 502
Y L T +H +++ RPL + + +G+ ++H VH DL+PSN
Sbjct: 86 -YFVTELLGTDLHR---LLTSRPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSN 138
Query: 503 ILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQ 562
IL+ +N + I DFGLAR+ D + T ST YY+
Sbjct: 139 ILINENCDLKICDFGLARIQD-----------------------PQMTGYVST---RYYR 172
Query: 563 APEASKV-RKPTQKWDIYSYGVILLEMISGK 592
APE +K + DI+S G I EM+ GK
Sbjct: 173 APEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.6 bits (163), Expect = 1e-11
Identities = 48/213 (22%), Positives = 75/213 (35%), Gaps = 29/213 (13%)
Query: 410 FQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWS 469
+ E + + P IV L F + L+ +Y+P G L L
Sbjct: 48 VRAERDILADADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNL------------LIRK 95
Query: 470 DRLR--IIKG-VAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHI--SDFGLARLADI 524
D + +A+ + L V ++H D++P NIL+ + HI +DFGL
Sbjct: 96 DVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDA--DGHIKLADFGLC-KKMN 152
Query: 525 AEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSY-------YQAPEASKVRKPTQKWD 577
+ E + S + R+ Y APE + + D
Sbjct: 153 KAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECD 212
Query: 578 IYSYGVILLEMISGKLPMIQIGSME--LNIVQW 608
+S GVIL EM+ G P E I+ W
Sbjct: 213 WWSLGVILYEMLYGFPPFYSDTLQETYNKIINW 245
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 1e-11
Identities = 85/308 (27%), Positives = 129/308 (41%), Gaps = 62/308 (20%)
Query: 357 DSQVDFDLEQLLKASAFLLGKSTIGIVYKV-ALNNEEAVAVRRLGNGGWQRFKEFQTEAE 415
+ Q D++L Q + G T G VYK L+ E AV+ + F Q E
Sbjct: 6 NPQHDYELIQRV-------GSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIF 58
Query: 416 AIGKIRHPNIVSLRAYFWSV--DEKLLI-YDYIPNGSLATAIHGKAGIISYRPLSWSDRL 472
+ + +H NIV AYF S EKL I +Y GSL H PLS
Sbjct: 59 MVKECKHCNIV---AYFGSYLSREKLWICMEYCGGGSLQDIYHVTG------PLSELQIA 109
Query: 473 RIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVH 532
+ + +G+A+LH K +H D++ +NILL N + ++DFG+A A+ T +
Sbjct: 110 YVCRETLQGLAYLHS---KGKMHRDIKGANILLTDNGDVKLADFGVA-----AKITATIA 161
Query: 533 WEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKP---TQKWDIYSYGVILLEMI 589
+S GTP Y+ APE + V K Q DI++ G+ +E+
Sbjct: 162 KRKSFIGTP------------------YWMAPEVAAVEKNGGYNQLCDIWAVGITAIELA 203
Query: 590 SGKLPMIQIGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVH 649
+ PM + M L L + ++ P L + +KI+L
Sbjct: 204 ELQPPMFDLHPMR-------ALFLMSK---SNFQPPKLKDKTKWSSTFHNFVKISLT--- 250
Query: 650 KSPDKRPS 657
K+P KRP+
Sbjct: 251 KNPKKRPT 258
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 64.3 bits (157), Expect = 2e-11
Identities = 51/206 (24%), Positives = 83/206 (40%), Gaps = 32/206 (15%)
Query: 394 VAVRRLGNGGWQR-FKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKL-LIYDYIPNGSLA 451
VAV+ L + +F EA + + H N++ R Y + L ++ + P GSL
Sbjct: 26 VAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLI--RLYGVVLTHPLMMVTELAPLGSLL 83
Query: 452 TAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEP 511
+ A ++I A G+ +L KR++H DL NILL + +
Sbjct: 84 DRLRKDALGHFLISTLCDYAVQI----ANGMRYLES---KRFIHRDLAARNILLASDDKV 136
Query: 512 HISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRK 571
I DFGL R E+ H+ P+ + APE+ + R
Sbjct: 137 KIGDFGLMRALPQNED----HY----VMEEHLKVPFAWC------------APESLRTRT 176
Query: 572 PTQKWDIYSYGVILLEMIS-GKLPMI 596
+ D++ +GV L EM + G+ P
Sbjct: 177 FSHASDVWMFGVTLWEMFTYGEEPWA 202
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 2e-11
Identities = 76/316 (24%), Positives = 124/316 (39%), Gaps = 68/316 (21%)
Query: 375 LGKSTIG--IVYKVALNNE---EAVAVRRLGNG-GWQRFKEFQTEAEAIGKIRHPNIVSL 428
LG+ G +Y N+ E VAV+ L G Q ++ E + + H NIV
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71
Query: 429 RAYFWSVDEK--LLIYDYIPNGSLATAIHGKAGIISYRP---LSWSDRLRIIKGVAKGIA 483
+ K LI +Y+P GSL Y P L+ + L + + +G+A
Sbjct: 72 KGCCSEQGGKGLQLIMEYVPLGSL----------RDYLPKHKLNLAQLLLFAQQICEGMA 121
Query: 484 FLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQ 543
+LH + Y+H DL N+LL + I DFGLA+ A ++ G
Sbjct: 122 YLHS---QHYIHRDLAARNVLLDNDRLVKIGDFGLAK----AVPEGHEYYRVREDG---- 170
Query: 544 SSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMI----SGKLP----- 594
SP ++ A E K K + D++S+GV L E++ S + P
Sbjct: 171 DSPV------------FWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFE 218
Query: 595 -MIQIGSMELNIVQWIQLILE-DRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSP 652
MI ++ +V+ I+L+ R P + E+ ++K +C
Sbjct: 219 EMIGPKQGQMTVVRLIELLERGMRLPCPK----------NCPQEVYILMK---NCWETEA 265
Query: 653 DKRPSMRHVCDSLDRV 668
RP+ R + L +
Sbjct: 266 KFRPTFRSLIPILKEM 281
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 3e-11
Identities = 67/234 (28%), Positives = 98/234 (41%), Gaps = 59/234 (25%)
Query: 375 LGKSTIGIVYKVALN--NEEAVAVRRLGNGGWQRFKEFQTEAE------AIGKI------ 420
LG+ T VYK N E VA+ KE +AE AI +I
Sbjct: 8 LGEGTYATVYK-GRNRTTGEIVAL-----------KEIHLDAEEGTPSTAIREISLMKEL 55
Query: 421 RHPNIVSLRAYFWSVDEKLLIYDYIPNG-SLATAIHGKAGIISYRPLSWSDRLRIIKGVA 479
+H NIV L + ++ +L+++Y+ HG G L + +
Sbjct: 56 KHENIVRLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRG-----ALDPNTVKSFTYQLL 110
Query: 480 KGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTG 539
KGIAF HE R +H DL+P N+L+ K E ++DFGLAR G
Sbjct: 111 KGIAFCHE---NRVLHRDLKPQNLLINKRGELKLADFGLAR----------------AFG 151
Query: 540 TPLQSSPYEFTALNSTTSRSYYQAPEA-SKVRKPTQKWDIYSYGVILLEMISGK 592
P+ + E L +Y+AP+ R + DI+S G I+ EMI+G+
Sbjct: 152 IPVNTFSNEVVTL-------WYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 3e-11
Identities = 65/257 (25%), Positives = 111/257 (43%), Gaps = 65/257 (25%)
Query: 374 LLGKSTIGIVYKVALN---NEEAVAVRRLGNGGWQR-FKEFQTEAEAIGKI-RHPNIVSL 428
++G+ G V + + + A++ L + ++F E E + K+ HPNI++L
Sbjct: 9 VIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINL 68
Query: 429 ------RAYFWSVDEKLLIYDYIPNGSLATAI---------------HGKAGIISYRPLS 467
R Y + + +Y P G+L + HG A ++ + L
Sbjct: 69 LGACENRGYLY------IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQL- 121
Query: 468 WSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEE 527
L+ VA G+ +L E K+++H DL N+L+G+N+ I+DFGL+R EE
Sbjct: 122 ----LQFASDVATGMQYLSE---KQFIHRDLAARNVLVGENLASKIADFGLSR----GEE 170
Query: 528 TPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLE 587
+ + T G P + A+ S Y T K D++S+GV+L E
Sbjct: 171 V----YVKKTMG----RLPVRWMAIESLNYSVY------------TTKSDVWSFGVLLWE 210
Query: 588 MIS-GKLPMIQIGSMEL 603
++S G P + EL
Sbjct: 211 IVSLGGTPYCGMTCAEL 227
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 4e-11
Identities = 41/127 (32%), Positives = 63/127 (49%), Gaps = 9/127 (7%)
Query: 134 LDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSGL 193
L L IP+ I + + L+++ L+ NS G +P + +T+L+ LDLS+N+ +G
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGS-ITSLEVLDLSYNSFNGS 481
Query: 194 IPNDIANLSRLRLLAQRVYVDLTYNNLSGLIPQ--NAALLSLGPTAFIGNPFLCGPPLKV 251
IP + L+ LR+L +L N+LSG +P LL F N LCG P
Sbjct: 482 IPESLGQLTSLRIL------NLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPGLR 535
Query: 252 SCPSSTS 258
+C S
Sbjct: 536 ACGPHLS 542
|
Length = 623 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 4e-11
Identities = 56/228 (24%), Positives = 96/228 (42%), Gaps = 41/228 (17%)
Query: 375 LGKSTIGIVYKVALNNEEAV-AVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSL-RAYF 432
LG G VYK A + + + ++F E + + + +HPNIV L AYF
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 433 WSVDEKLLIY-DYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPK 491
+ + KL I ++ G+L +I + R L+ + + + + + FLH
Sbjct: 73 Y--ENKLWILIEFCDGGAL-DSIMLELE----RGLTEPQIRYVCRQMLEALNFLHS---H 122
Query: 492 RYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTA 551
+ +H DL+ NILL + + ++DFG++ A+ + + GTP
Sbjct: 123 KVIHRDLKAGNILLTLDGDVKLADFGVS-----AKNKSTLQKRDTFIGTP---------- 167
Query: 552 LNSTTSRSYYQAP-----EASKVRKPTQKWDIYSYGVILLEMISGKLP 594
Y+ AP E K K DI+S G+ L+E+ + P
Sbjct: 168 --------YWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPP 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.7 bits (156), Expect = 5e-11
Identities = 67/235 (28%), Positives = 110/235 (46%), Gaps = 62/235 (26%)
Query: 375 LGKSTIGIVYKVALNNE--EAVAVRRLGNGGWQRFKEFQT-----EAEAIGKI-RHPNIV 426
LG T G VY A N E E VA++++ ++F ++ E +++ K+ HPNIV
Sbjct: 7 LGDGTFGSVYL-ARNKETGELVAIKKMK----KKFYSWEECMNLREVKSLRKLNEHPNIV 61
Query: 427 SLRAYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLR-IIKGVAKGIAFL 485
L+ F DE +++Y+ G+L + + G +P S +R II + +G+A +
Sbjct: 62 KLKEVFRENDELYFVFEYM-EGNLYQLMKDRKG----KPFS-ESVIRSIIYQILQGLAHI 115
Query: 486 HEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSS 545
H+ + H DL+P N+L+ I+DFGLAR E+ S
Sbjct: 116 HKHG---FFHRDLKPENLLVSGPEVVKIADFGLAR---------EIR-----------SR 152
Query: 546 PYEFTALNSTTSRSYYQAPE--------ASKVRKPTQKWDIYSYGVILLEMISGK 592
P +T ST R +Y+APE +S V DI++ G I+ E+ + +
Sbjct: 153 P-PYTDYVST--R-WYRAPEILLRSTSYSSPV-------DIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 6e-11
Identities = 50/201 (24%), Positives = 92/201 (45%), Gaps = 33/201 (16%)
Query: 394 VAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLATA 453
VAV+++ QR + E + +HPNIV + + + DE ++ +++ G+L
Sbjct: 47 VAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTD- 105
Query: 454 IHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHI 513
I+++ ++ + V K ++FLH + +H D++ +ILL + +
Sbjct: 106 ------IVTHTRMNEEQIATVCLAVLKALSFLHA---QGVIHRDIKSDSILLTSDGRVKL 156
Query: 514 SDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPT 573
SDFG A +++E P +S GTP +P SR Y E
Sbjct: 157 SDFGFC--AQVSKEVPR---RKSLVGTPYWMAP-------EVISRLPY-GTEV------- 196
Query: 574 QKWDIYSYGVILLEMISGKLP 594
DI+S G++++EM+ G+ P
Sbjct: 197 ---DIWSLGIMVIEMVDGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 6e-11
Identities = 65/251 (25%), Positives = 108/251 (43%), Gaps = 52/251 (20%)
Query: 411 QTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLATAIHGKAGII--SYRPLSW 468
+ E + K++HPNIV+ A F ++ +Y G L I+ + G++ + LSW
Sbjct: 47 KKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSW 106
Query: 469 SDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKN-MEPHISDFGLARLADIAEE 527
++ G+ +H+ ++ +H D++ NI L KN M + DFG+AR + + E
Sbjct: 107 ------FVQISLGLKHIHD---RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME 157
Query: 528 TPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLE 587
+ GTP YY +PE + R K DI+S G +L E
Sbjct: 158 -----LAYTCVGTP------------------YYLSPEICQNRPYNNKTDIWSLGCVLYE 194
Query: 588 MISGKLPMIQIGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDC 647
+ + K P E N + QL+L+ + + P + DL I + K+
Sbjct: 195 LCTLKHP------FEGNNLH--QLVLKICQGYFAPISPNFSRDL--RSLISQLFKV---- 240
Query: 648 VHKSPDKRPSM 658
SP RPS+
Sbjct: 241 ---SPRDRPSI 248
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 6e-11
Identities = 58/236 (24%), Positives = 101/236 (42%), Gaps = 39/236 (16%)
Query: 375 LGKSTIGIVYKVALNNEEAV--AVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYF 432
LG G VYK A N E V A + + + +++ E + + HPNIV L F
Sbjct: 13 LGDGAFGKVYK-AQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71
Query: 433 WSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKR 492
+ + ++ ++ G++ + + RPL+ + K + + +LHE +
Sbjct: 72 YYENNLWILIEFCAGGAVDAVM-----LELERPLTEPQIRVVCKQTLEALNYLHE---NK 123
Query: 493 YVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTAL 552
+H DL+ NIL + + ++DFG++ A+ T + S GTP
Sbjct: 124 IIHRDLKAGNILFTLDGDIKLADFGVS-----AKNTRTIQRRDSFIGTP----------- 167
Query: 553 NSTTSRSYYQAPE-----ASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMEL 603
Y+ APE SK R K D++S G+ L+EM + P ++ M +
Sbjct: 168 -------YWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRV 216
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|219766 pfam08263, LRRNT_2, Leucine rich repeat N-terminal domain | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 8e-11
Identities = 20/41 (48%), Positives = 27/41 (65%), Gaps = 2/41 (4%)
Query: 16 ANDEGLALLSFKQAIRNFPEGN--NWNNSNEDPCSWNGITC 54
ND+ ALL+FK ++ P G +WN S+ DPCSW G+TC
Sbjct: 1 LNDDRDALLAFKSSLNGDPSGALSSWNPSSSDPCSWTGVTC 41
|
Leucine Rich Repeats pfam00560 are short sequence motifs present in a number of proteins with diverse functions and cellular locations. Leucine Rich Repeats are often flanked by cysteine rich domains. This domain is often found at the N-terminus of tandem leucine rich repeats. Length = 42 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 8e-11
Identities = 68/237 (28%), Positives = 107/237 (45%), Gaps = 45/237 (18%)
Query: 374 LLGKSTIGIVYKVA-LNNEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYF 432
+LGK T GIVY L+ + +A++ + + + E ++H NIV Y
Sbjct: 15 VLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQ---YL 71
Query: 433 WSVDEK--LLIY-DYIPNGSLATAIHGKAGIISYRPLSWSDRLRII--KGVAKGIAFLHE 487
S E I+ + +P GSL+ + K G PL +++ I K + +G+ +LH+
Sbjct: 72 GSDSENGFFKIFMEQVPGGSLSALLRSKWG-----PLKDNEQTIIFYTKQILEGLKYLHD 126
Query: 488 VSPKRYVHGDLRPSNILLGK-NMEPHISDFGLA-RLADIAEETPEVHWEQSTTGTPLQSS 545
+ VH D++ N+L+ + ISDFG + RLA I T ++ TGT LQ
Sbjct: 127 ---NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCT------ETFTGT-LQ-- 174
Query: 546 PYEFTALNSTTSRSYYQAPEA--SKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGS 600
Y APE R DI+S G ++EM +GK P I++G
Sbjct: 175 ---------------YMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGE 216
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 68/289 (23%), Positives = 124/289 (42%), Gaps = 56/289 (19%)
Query: 394 VAVRRLGNGGWQR-FKEFQTEAEAIGKI-RHPNIVSLRAYFWSVDEKLLIYDYIPNGSLA 451
VAV+ L + ++ + +E E + I +H NI++L +I +Y G+L
Sbjct: 50 VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 109
Query: 452 TAIHGKAGI----------ISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPS 501
+ + + +++ D + VA+G+ +L + ++ +H DL
Sbjct: 110 EYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYL---ASQKCIHRDLAAR 166
Query: 502 NILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYY 561
N+L+ +N I+DFGLAR + + + + TT L P + +
Sbjct: 167 NVLVTENNVMKIADFGLAR------DVNNIDYYKKTTNGRL---PVK------------W 205
Query: 562 QAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQIGSMELNIVQWIQLILEDRKPMT 620
APEA R T + D++S+GV++ E+ + G P I EL +L+ E
Sbjct: 206 MAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL-----FKLLKE------ 254
Query: 621 DILDPFLAHDLDKEDEIVSVLKIAL-DCVHKSPDKRPSMRHVCDSLDRV 668
H +DK + L + + DC H P RP+ + + + LDR+
Sbjct: 255 -------GHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRI 296
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 75/294 (25%), Positives = 124/294 (42%), Gaps = 62/294 (21%)
Query: 375 LGKSTIGIVYKVALNNEEAV--AVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSL-RAY 431
LG G VYK A N E A + + + +++ E E + HP IV L A+
Sbjct: 20 LGDGAFGKVYK-AKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF 78
Query: 432 FWSVDEKLLIY-DYIPNGSL-ATAIHGKAGIISYRPLSWSDRLRII-KGVAKGIAFLHEV 488
+W D KL I ++ P G++ A + G+ ++++I + + + + +LH
Sbjct: 79 YW--DGKLWIMIEFCPGGAVDAIMLELDRGLTE-------PQIQVICRQMLEALQYLHS- 128
Query: 489 SPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYE 548
+ +H DL+ N+LL + + ++DFG++ A+ + S GTP
Sbjct: 129 --MKIIHRDLKAGNVLLTLDGDIKLADFGVS-----AKNVKTLQRRDSFIGTP------- 174
Query: 549 FTALNSTTSRSYYQAPEA--SKVRKPTQ---KWDIYSYGVILLEMISGKLPMIQIGSMEL 603
Y+ APE + K T K DI+S G+ L+EM + P ++ M
Sbjct: 175 -----------YWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR- 222
Query: 604 NIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPS 657
+ L + +P P L+ E LK ALD K P+ RPS
Sbjct: 223 -----VLLKIAKSEP------PTLSQPSKWSMEFRDFLKTALD---KHPETRPS 262
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 1e-10
Identities = 71/297 (23%), Positives = 117/297 (39%), Gaps = 67/297 (22%)
Query: 375 LGKSTIGIVYKVALN--NEEAVAVRRLGNGGWQRFKEFQ---TEAEAIGKIRHPNIVSLR 429
+G + G VY A + E VA++++ G Q +++Q E + ++RHPN + +
Sbjct: 23 IGHGSFGAVY-FARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYK 81
Query: 430 AYFWSVDEKLLIYDY-IPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEV 488
+ L+ +Y + + S +H K PL + I G +G+A+LH
Sbjct: 82 GCYLREHTAWLVMEYCLGSASDILEVHKK-------PLQEVEIAAICHGALQGLAYLH-- 132
Query: 489 SPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYE 548
S +R +H D++ NILL + ++DFG A L A S GTP
Sbjct: 133 SHER-IHRDIKAGNILLTEPGTVKLADFGSASLVSPA---------NSFVGTP------- 175
Query: 549 FTALNSTTSRSYYQAPE---ASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSME--L 603
Y+ APE A + K D++S G+ +E+ K P+ + +M
Sbjct: 176 -----------YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY 224
Query: 604 NIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRH 660
+I Q D D D + + C+ K P RPS
Sbjct: 225 HIAQ---------------NDSPTLSSNDWSDYFRNFVDS---CLQKIPQDRPSSEE 263
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 57/235 (24%), Positives = 96/235 (40%), Gaps = 45/235 (19%)
Query: 375 LGKSTIGIVYKVA-LNNEEAVAVRRLGNGGWQRFKEFQ---TEAEAIGKIRHPNIVSLRA 430
+G + G VY + N E VA++++ G Q +++Q E + K+RHPN + R
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 431 YFWSVDEKLLIYDY-IPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVS 489
+ L+ +Y + + S +H K PL + + G +G+A+LH
Sbjct: 83 CYLREHTAWLVMEYCLGSASDLLEVHKK-------PLQEVEIAAVTHGALQGLAYLHS-- 133
Query: 490 PKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEF 549
+H D++ NILL + + DFG A + A GTP
Sbjct: 134 -HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---------NXFVGTP-------- 175
Query: 550 TALNSTTSRSYYQAPEASKVRKPTQ---KWDIYSYGVILLEMISGKLPMIQIGSM 601
Y+ APE Q K D++S G+ +E+ K P+ + +M
Sbjct: 176 ----------YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM 220
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 1e-10
Identities = 52/225 (23%), Positives = 99/225 (44%), Gaps = 38/225 (16%)
Query: 375 LGKSTIGIVYK---VALNNEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAY 431
+G+ G V+ VA E VA++++ + + E + ++++PNIV+
Sbjct: 27 IGQGASGTVFTAIDVATGQE--VAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDS 84
Query: 432 FWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPK 491
F DE ++ +Y+ GSL +++ + + + + + + FLH
Sbjct: 85 FLVGDELFVVMEYLAGGSLTD-------VVTETCMDEAQIAAVCRECLQALEFLH---AN 134
Query: 492 RYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTA 551
+ +H D++ N+LLG + ++DFG A+ TPE + GTP
Sbjct: 135 QVIHRDIKSDNVLLGMDGSVKLTDFGFC-----AQITPEQSKRSTMVGTP---------- 179
Query: 552 LNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMI 596
Y+ APE + K DI+S G++ +EM+ G+ P +
Sbjct: 180 --------YWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYL 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 1e-10
Identities = 64/228 (28%), Positives = 93/228 (40%), Gaps = 51/228 (22%)
Query: 375 LGKSTIGIVYKV----ALNNEEAVAVRRLGNGGWQRFKEFQT--EAEAIGKIRHPNIVSL 428
LGK + G VY V A+ E ++ + G + Q EA+ + K+ HP IV
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKF 67
Query: 429 RAYFWSVDEKLLIYDYIPNGSLATAIH--GKAGIISYRP--LSWSDRLRIIKGVAKGIAF 484
A F D +I +Y L + G W +L + G+ +
Sbjct: 68 HASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLL------GVHY 121
Query: 485 LHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARL----ADIAEETPEVHWEQSTTGT 540
+H+ +R +H DL+ NI L N+ I DFG++RL D+A + TGT
Sbjct: 122 MHQ---RRILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLA---------TTFTGT 168
Query: 541 PLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEM 588
P YY +PEA K + K DI+S G IL EM
Sbjct: 169 P------------------YYMSPEALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 1e-10
Identities = 48/187 (25%), Positives = 80/187 (42%), Gaps = 34/187 (18%)
Query: 408 KEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLATAIHGKAGII--SYRP 465
+E + E + ++HPNIV + F ++ DY G L I+ + G++ +
Sbjct: 44 EESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQI 103
Query: 466 LSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIA 525
L W V +A H V ++ +H D++ NI L K+ + DFG+AR+ +
Sbjct: 104 LDWF--------VQICLALKH-VHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLN-- 152
Query: 526 EETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVIL 585
V ++ GTP YY +PE + R K DI++ G +L
Sbjct: 153 ---STVELARTCIGTP------------------YYLSPEICENRPYNNKSDIWALGCVL 191
Query: 586 LEMISGK 592
EM + K
Sbjct: 192 YEMCTLK 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 82/357 (22%), Positives = 156/357 (43%), Gaps = 71/357 (19%)
Query: 354 VPLDSQVDFDLEQLLKASAFLLGKSTIGIV-----YKVALNNEE---AVAVRRL-GNGGW 404
+PLD + +F ++L+ LG+ G V Y + + + VAV+ L N
Sbjct: 1 LPLDPKWEFPRDRLVLGKP--LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATD 58
Query: 405 QRFKEFQTEAEAIGKI-RHPNIVSLRAYFWSVDEKLLIYDYIPNGSLATAIHGK------ 457
+ + +E E + I +H NI++L +I +Y G+L + +
Sbjct: 59 KDLADLISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPD 118
Query: 458 ----AGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHI 513
+ LS+ D + VA+G+ +L +R +H DL N+L+ ++ I
Sbjct: 119 YTFDITKVPEEQLSFKDLVSCAYQVARGMEYLES---RRCIHRDLAARNVLVTEDNVMKI 175
Query: 514 SDFGLAR-LADIAEETPEVHWEQSTTG-TPLQSSPYEFTALNSTTSRSYYQAPEASKVRK 571
+DFGLAR + DI ++++++ G P++ + APEA R
Sbjct: 176 ADFGLARGVHDID------YYKKTSNGRLPVK-----------------WMAPEALFDRV 212
Query: 572 PTQKWDIYSYGVILLEMIS-GKLPMIQIGSMELNIVQWIQLILEDRKPMTDILDPFLAHD 630
T + D++S+G+++ E+ + G P I EL +L+ E H
Sbjct: 213 YTHQSDVWSFGILMWEIFTLGGSPYPGIPVEEL-----FKLLRE-------------GHR 254
Query: 631 LDKEDEIVSVLKIAL-DCVHKSPDKRPSMRHVCDSLDRVNISTEQQFMKGEEPKFDQ 686
+DK L + + +C H P +RP+ + + ++LD+V + ++++ P F+Q
Sbjct: 255 MDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAVSEEYLDLSMP-FEQ 310
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 2e-10
Identities = 44/192 (22%), Positives = 84/192 (43%), Gaps = 26/192 (13%)
Query: 411 QTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSD 470
E + +++H NIV D + +Y+P GS+A ++ +Y +
Sbjct: 54 AREIALLKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLN------NYGAFEETL 107
Query: 471 RLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPE 530
++ + KG+ +LH + +H D++ +NIL+ ISDFG+++ +
Sbjct: 108 VRNFVRQILKGLNYLHN---RGIIHRDIKGANILVDNKGGIKISDFGISKKLEA------ 158
Query: 531 VHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS 590
S + + P S ++ APE K T+K DI+S G +++EM++
Sbjct: 159 ----NSLSTKTNGARP-------SLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLT 207
Query: 591 GKLPMIQIGSME 602
GK P ++
Sbjct: 208 GKHPFPDCTQLQ 219
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 2e-10
Identities = 46/161 (28%), Positives = 66/161 (40%), Gaps = 17/161 (10%)
Query: 374 LLGKSTIGIVYKVALNNEEA-------VAVRRLGNGGW-QRFKEFQTEAEAIGKIRHPNI 425
LG G VY+ + VAV+ L G Q KEF EA + HPNI
Sbjct: 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNI 61
Query: 426 VSLRAYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRP-LSWSDRLRIIKGVAKGIAF 484
V L + + +I + + G L + + P L+ + L I VAKG +
Sbjct: 62 VKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVY 121
Query: 485 LHEVSPKRYVHGDLRPSNILLGKNMEP-----HISDFGLAR 520
L ++ ++H DL N L+ + I DFGLAR
Sbjct: 122 LEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR 159
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 76/302 (25%), Positives = 132/302 (43%), Gaps = 58/302 (19%)
Query: 389 NNEEAVAVRRLGNGGWQR-FKEFQTEAEAIGKI-RHPNIVSLRAYFWSVDEKLLIYDYIP 446
N VAV+ L + ++ + +E E + I +H NI++L +I +Y
Sbjct: 48 NRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYAS 107
Query: 447 NGSLATAIHGK---AGIISYRP-------LSWSDRLRIIKGVAKGIAFLHEVSPKRYVHG 496
G+L + + Y P LS+ D + VA+G+ +L + K+ +H
Sbjct: 108 KGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYL---ASKKCIHR 164
Query: 497 DLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGT-PLQSSPYEFTALNST 555
DL N+L+ ++ I+DFGLAR DI +++++T G P++
Sbjct: 165 DLAARNVLVTEDNVMKIADFGLAR--DIHHID---YYKKTTNGRLPVK------------ 207
Query: 556 TSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQIGSMELNIVQWIQLILE 614
+ APEA R T + D++S+GV+L E+ + G P + EL +L+ E
Sbjct: 208 -----WMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL-----FKLLKE 257
Query: 615 DRKPMTDILDPFLAHDLDKEDEIVSVLKIAL-DCVHKSPDKRPSMRHVCDSLDRVNISTE 673
H +DK + L + + DC H P +RP+ + + + LDR+ T
Sbjct: 258 -------------GHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALTS 304
Query: 674 QQ 675
Q
Sbjct: 305 NQ 306
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 2e-10
Identities = 57/231 (24%), Positives = 100/231 (43%), Gaps = 43/231 (18%)
Query: 374 LLGKSTIGIVYK-VALNNEEAVAVRRL--GNGGWQRFKEFQT---EAEAIGKIRHPNIVS 427
LLG+ G VY ++ +AV+++ + KE E + + ++H IV
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQ 68
Query: 428 LRAYF--WSVDEKLLIY-DYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAF 484
Y+ DE L I+ +Y+P GS+ K + +Y L+ + + + + +G+ +
Sbjct: 69 ---YYGCLRDDETLSIFMEYMPGGSV------KDQLKAYGALTETVTRKYTRQILEGVEY 119
Query: 485 LHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLA-RLADIAEETPEVHWEQSTTGTPLQ 543
LH VH D++ +NIL + DFG + RL I + +S TGTP
Sbjct: 120 LHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGM---KSVTGTP-- 171
Query: 544 SSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLP 594
Y+ +PE +K D++S G ++EM++ K P
Sbjct: 172 ----------------YWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPP 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 3e-10
Identities = 52/245 (21%), Positives = 108/245 (44%), Gaps = 41/245 (16%)
Query: 374 LLGKSTIGIVYKVALNNEEA----VAVR--RLGNGGWQRFKEFQTEAEAIGKIRHPNIVS 427
+LG+ G V + L+ ++ VAV+ +L + +EF +EA + HPN++
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65
Query: 428 LRAYFWSVDEK------LLIYDYIPNGSLATAIHGK--AGIISYRPLSWSDRLRIIKGVA 479
L + ++I ++ +G L + + G+ PL L+ + +A
Sbjct: 66 LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQ--TLLKFMVDIA 123
Query: 480 KGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTG 539
G+ +L S + ++H DL N +L ++M ++DFGL++ +++
Sbjct: 124 LGMEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSK---------KIYSGDYYRQ 171
Query: 540 TPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQI 598
+ P ++ A+ S R Y T K D++++GV + E+ + G+ P +
Sbjct: 172 GRIAKMPVKWIAIESLADRVY------------TSKSDVWAFGVTMWEIATRGQTPYPGV 219
Query: 599 GSMEL 603
+ E+
Sbjct: 220 ENHEI 224
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 3e-10
Identities = 66/292 (22%), Positives = 118/292 (40%), Gaps = 63/292 (21%)
Query: 375 LGKSTIGIVYKVA-LNNEEAVAVRRLGNGGWQRFKEFQ---TEAEAIGKIRHPNIVSLRA 430
+G + G VY + E VA++++ G Q +++Q E + + +I+HPN + +
Sbjct: 33 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKG 92
Query: 431 YFWSVDEKLLIYDY-IPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVS 489
+ L+ +Y + + S +H K PL + I G +G+A+LH
Sbjct: 93 CYLREHTAWLVMEYCLGSASDLLEVHKK-------PLQEVEIAAITHGALQGLAYLHS-- 143
Query: 490 PKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEF 549
+H D++ NILL + + ++DFG A +A A S GTP
Sbjct: 144 -HNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA---------NSFVGTP-------- 185
Query: 550 TALNSTTSRSYYQAPEASKVRKPTQ---KWDIYSYGVILLEMISGKLPMIQIGSMELNIV 606
Y+ APE Q K D++S G+ +E+ K P+ + +M
Sbjct: 186 ----------YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA--- 232
Query: 607 QWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALD-CVHKSPDKRPS 657
+ I ++ P + +E + +D C+ K P RP+
Sbjct: 233 --LYHIAQNESPTL------------QSNEWSDYFRNFVDSCLQKIPQDRPT 270
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 61.4 bits (150), Expect = 4e-10
Identities = 55/230 (23%), Positives = 97/230 (42%), Gaps = 47/230 (20%)
Query: 374 LLGKSTIGIVYK-VALNNEEAVAVRRLGNGGWQRFKE---FQT--EAEAIGKIRHPNIVS 427
LG+ T +VYK VA++++ G + K+ F E + + +++HPNI+
Sbjct: 7 KLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIG 66
Query: 428 LRAYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHE 487
L F L+++++ L I K I P +D + +G+ +LH
Sbjct: 67 LLDVFGHKSNINLVFEFME-TDLEKVIKDK--SIVLTP---ADIKSYMLMTLRGLEYLH- 119
Query: 488 VSPKRYV-HGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSP 546
++ H DL+P+N+L+ + ++DFGLAR + G+P
Sbjct: 120 ---SNWILHRDLKPNNLLIASDGVLKLADFGLAR----------------SFGSP----N 156
Query: 547 YEFTALNSTTSRSYYQAPE----ASKVRKPTQKWDIYSYGVILLEMISGK 592
+ T T +Y+APE A R D++S G I E++
Sbjct: 157 RKMTHQVVTR---WYRAPELLFGA---RHYGVGVDMWSVGCIFAELLLRV 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 4e-10
Identities = 64/265 (24%), Positives = 111/265 (41%), Gaps = 60/265 (22%)
Query: 410 FQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIY---DYIPNGSLATAIHGKAGIISYRPL 466
F EA + ++RH N+V L V+EK +Y +Y+ GSL + + R +
Sbjct: 46 FLAEASVMTQLRHSNLVQLLGVI--VEEKGGLYIVTEYMAKGSLVDYLRSRG-----RSV 98
Query: 467 SWSDRL-RIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIA 525
D L + V + + +L + +VH DL N+L+ ++ +SDFGL
Sbjct: 99 LGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGL------- 148
Query: 526 EETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVIL 585
T E Q T P++ + APEA + +K + K D++S+G++L
Sbjct: 149 --TKEASSTQDTGKLPVK-----------------WTAPEALREKKFSTKSDVWSFGILL 189
Query: 586 LEMIS-GKLPMIQIGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVL-KI 643
E+ S G++P +I L+D P + + +D D V+ +
Sbjct: 190 WEIYSFGRVPYPRIP-------------LKDVVPRVE-----KGYKMDAPDGCPPVVYDV 231
Query: 644 ALDCVHKSPDKRPSMRHVCDSLDRV 668
C H RPS + + L+ +
Sbjct: 232 MKQCWHLDAATRPSFLQLREQLEHI 256
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 60.9 bits (147), Expect = 4e-10
Identities = 55/225 (24%), Positives = 97/225 (43%), Gaps = 38/225 (16%)
Query: 375 LGKSTIGIVYK---VALNNEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAY 431
+G+ G VY VA E VA+R++ + + E + + ++PNIV+
Sbjct: 28 IGQGASGTVYTAMDVATGQE--VAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 432 FWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPK 491
+ DE ++ +Y+ GSL +++ + + + + + FLH
Sbjct: 86 YLVGDELWVVMEYLAGGSLTD-------VVTETCMDEGQIAAVCRECLQALEFLHS---N 135
Query: 492 RYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTA 551
+ +H D++ NILLG + ++DFG A+ TPE + GTP
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFC-----AQITPEQSKRSTMVGTP---------- 180
Query: 552 LNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMI 596
Y+ APE + K DI+S G++ +EMI G+ P +
Sbjct: 181 --------YWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYL 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 5e-10
Identities = 61/287 (21%), Positives = 113/287 (39%), Gaps = 64/287 (22%)
Query: 392 EAVAVRRLGNGGWQRFKEF-------------QTEAEAIGKIRHPNIVSLRAYFWSVDEK 438
EA RR + +KE E + ++HPNI++ +F D
Sbjct: 15 EATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMD-DNT 73
Query: 439 LLI-YDYIPNGSLATAI-HGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHG 496
LLI +Y G+L I K + + W + + ++++H+ +H
Sbjct: 74 LLIEMEYANGGTLYDKIVRQKGQLFEEEMVLW-----YLFQIVSAVSYIHKAG---ILHR 125
Query: 497 DLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTT 556
D++ NI L K + DFG++++ E ++ GTP
Sbjct: 126 DIKTLNIFLTKAGLIKLGDFGISKILG-----SEYSMAETVVGTP--------------- 165
Query: 557 SRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQWIQLILEDR 616
YY +PE + K K DI++ G +L E+++ L + LN+V I +
Sbjct: 166 ---YYMSPELCQGVKYNFKSDIWALGCVLYELLT--LKRTFDATNPLNLVVKIV-----Q 215
Query: 617 KPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCD 663
T ++ + + E++S++ + + P+KRP+ V D
Sbjct: 216 GNYTPVVSVYSS-------ELISLVH---SLLQQDPEKRPTADEVLD 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 5e-10
Identities = 57/252 (22%), Positives = 105/252 (41%), Gaps = 46/252 (18%)
Query: 374 LLGKSTIGIVYK---VALNNEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRA 430
L+G+ G VY+ V A+ + L + Q E + ++R ++
Sbjct: 8 LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPD-DDVSDIQREVALLSQLRQSQPPNITK 66
Query: 431 YF--WSVDEKL-LIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHE 487
Y+ + +L +I +Y GS+ T + KAG I+ + +S II+ V + ++H+
Sbjct: 67 YYGSYLKGPRLWIIMEYAEGGSVRTLM--KAGPIAEKYISV-----IIREVLVALKYIHK 119
Query: 488 VSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPY 547
V +H D++ +NIL+ + DFG+A A + GTP
Sbjct: 120 VG---VIHRDIKAANILVTNTGNVKLCDFGVA-----ALLNQNSSKRSTFVGTP------ 165
Query: 548 EFTALNSTTSRSYYQAPEA-SKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIV 606
Y+ APE ++ + K DI+S G+ + EM +G P + +
Sbjct: 166 ------------YWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAF----- 208
Query: 607 QWIQLILEDRKP 618
+ + LI + + P
Sbjct: 209 RAMMLIPKSKPP 220
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 5e-10
Identities = 62/254 (24%), Positives = 105/254 (41%), Gaps = 60/254 (23%)
Query: 421 RHPNIVSLRAYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAK 480
R P IVS F + + + +++ GSL I+ K G I L +I V +
Sbjct: 61 RSPYIVSFYGAFLNENNICMCMEFMDCGSL-DRIYKKGGPIPVEILG-----KIAVAVVE 114
Query: 481 GIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLA--RLADIAEETPEVHWEQSTT 538
G+ +L+ V R +H D++PSNIL+ + + DFG++ + IA +
Sbjct: 115 GLTYLYNV--HRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIA---------DTFV 163
Query: 539 GTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPM--- 595
GT S Y +PE + K T K D++S G+ ++E+ GK P
Sbjct: 164 GT------------------STYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFS 205
Query: 596 -----IQIGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALD-CVH 649
Q M I+ +Q I+++ P + L+ +D C+
Sbjct: 206 NIDDDGQDDPM--GILDLLQQIVQEPPPRL------------PSSDFPEDLRDFVDACLL 251
Query: 650 KSPDKRPSMRHVCD 663
K P +RP+ + +C
Sbjct: 252 KDPTERPTPQQLCA 265
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 6e-10
Identities = 69/300 (23%), Positives = 123/300 (41%), Gaps = 69/300 (23%)
Query: 375 LGKSTIGIVYKVALNN--EEAVAVRRLGNGGWQRFKEFQ---TEAEAIGKIRHPNIVSLR 429
+G + G VY A N+ E VAV+++ G Q +++Q E + + +++HPN + +
Sbjct: 29 IGHGSFGAVY-FATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYK 87
Query: 430 AYFWSVDEKLLIYDY-IPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEV 488
+ L+ +Y + + S +H K PL + I G +G+A+LH
Sbjct: 88 GCYLKEHTAWLVMEYCLGSASDLLEVHKK-------PLQEVEIAAITHGALQGLAYLHS- 139
Query: 489 SPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYE 548
+H D++ NILL + + ++DFG A + A S GTP
Sbjct: 140 --HNMIHRDIKAGNILLTEPGQVKLADFGSASKSSPA---------NSFVGTP------- 181
Query: 549 FTALNSTTSRSYYQAPEASKVRKPTQ---KWDIYSYGVILLEMISGKLPMIQIGSMELNI 605
Y+ APE Q K D++S G+ +E+ K P+ + +M
Sbjct: 182 -----------YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-- 228
Query: 606 VQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALD-CVHKSPDKRPS----MRH 660
+ I ++ P + +E + +D C+ K P +RP+ +RH
Sbjct: 229 ---LYHIAQNDSPTL------------QSNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 7e-10
Identities = 69/297 (23%), Positives = 129/297 (43%), Gaps = 57/297 (19%)
Query: 375 LGKSTIGIVYKVALNNEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWS 434
LG G+V+ + VA++ + G ++F EA+ + K+ HP +V L Y
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAINEGAMSE-EDFIEEAKVMMKLSHPKLVQL--YGVC 68
Query: 435 VDEKLL--IYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKR 492
+K L + +++ NG L + + G +S L L + + V +G+ +L S
Sbjct: 69 TQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDML-----LSMCQDVCEGMEYLERNS--- 120
Query: 493 YVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGT--PLQSSPYEFT 550
++H DL N L+ +SDFG+ R E T S++G P++ SP
Sbjct: 121 FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT-------SSSGAKFPVKWSP---- 169
Query: 551 ALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQIGSMELNIVQWI 609
PE K + K D++S+GV++ E+ + GK+P + + E+ +
Sbjct: 170 -------------PEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEV-----V 211
Query: 610 QLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLD 666
++I + + P LA +V ++ C H+ P+ RP+ + ++
Sbjct: 212 EMISRGFR----LYRPKLASM--------TVYEVMYSCWHEKPEGRPTFAELLRAIT 256
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 7e-10
Identities = 80/305 (26%), Positives = 122/305 (40%), Gaps = 60/305 (19%)
Query: 374 LLGKSTIGIVYKV-----ALNNEEAVAVRRL-GNGGWQRFKEFQTEAEAIGKIRHPNIVS 427
+LG G VYK N + VA++ L N + KE EA + + P +
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73
Query: 428 LRAYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPL-SWSDRLRIIKGVAKGIAFLH 486
L + +L + +P G L + I + L +W + +AKG+++L
Sbjct: 74 LLGICLTSTVQL-VTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQ------IAKGMSYLE 126
Query: 487 EVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSP 546
EV R VH DL N+L+ I+DFGLARL DI E E H + P
Sbjct: 127 EV---RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDET--EYHADGGKV-------P 174
Query: 547 YEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQIGSMELNI 605
++ AL S R + T + D++SYGV + E+++ G P I + E
Sbjct: 175 IKWMALESILHRRF------------THQSDVWSYGVTVWELMTFGAKPYDGIPARE--- 219
Query: 606 VQWIQLILE--DRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCD 663
I +LE +R P I + V I + C + RP R + D
Sbjct: 220 ---IPDLLEKGERLPQPPIC-------------TIDVYMIMVKCWMIDSECRPRFRELVD 263
Query: 664 SLDRV 668
R+
Sbjct: 264 EFSRM 268
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 8e-10
Identities = 70/238 (29%), Positives = 109/238 (45%), Gaps = 39/238 (16%)
Query: 374 LLGKSTIGIVYK-VALNNEEAV----AVRRLG-NGGWQRFKEFQTEAEAIGKIRHPNIVS 427
+LG G VYK + + E V A++ L G + EF EA + + HP++V
Sbjct: 14 VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73
Query: 428 LRAYFWSVDEKLLIYDYIPNGSLATAIH-GKAGIISYRPLSWSDRLRIIKGVAKGIAFLH 486
L S +L + +P+G L +H K I S L+W + +AKG+ +L
Sbjct: 74 LLGVCLSPTIQL-VTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQ------IAKGMMYLE 126
Query: 487 EVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSP 546
E +R VH DL N+L+ I+DFGLARL + E+ E + G + P
Sbjct: 127 E---RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEK------EYNADGGKM---P 174
Query: 547 YEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQIGSMEL 603
++ AL E RK T + D++SYGV + E+++ G P I + E+
Sbjct: 175 IKWMAL------------ECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREI 220
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 9e-10
Identities = 60/243 (24%), Positives = 100/243 (41%), Gaps = 77/243 (31%)
Query: 375 LGKSTIGIVYKVALNNE--EAVAVRRLGNGGWQRFKEFQTEAE-----AIGKI------R 421
+G+ T G+VYK A N E VA++++ TE E AI +I
Sbjct: 8 IGEGTYGVVYK-ARNKLTGEVVALKKI---------RLDTETEGVPSTAIREISLLKELN 57
Query: 422 HPNIVSLRAYFWSVDEKLLIYDYI-----------PNGSLATAIHGKAGIISYRPLSWSD 470
HPNIV L + ++ L+++++ P + + I SY
Sbjct: 58 HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPL-----IKSY------- 105
Query: 471 RLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPE 530
+ + +G+AF H R +H DL+P N+L+ ++DFGLAR
Sbjct: 106 ----LFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLAR---------- 148
Query: 531 VHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEA-SKVRKPTQKWDIYSYGVILLEMI 589
G P+++ +E L +Y+APE + + DI+S G I EM+
Sbjct: 149 ------AFGVPVRTYTHEVVTL-------WYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 195
Query: 590 SGK 592
+ +
Sbjct: 196 TRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 1e-09
Identities = 56/202 (27%), Positives = 84/202 (41%), Gaps = 38/202 (18%)
Query: 413 EAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRL 472
EA + K++HPNIV+ + F + ++ +Y G L I + G + L
Sbjct: 48 EAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRG----KLFPEDTIL 103
Query: 473 RIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVH 532
+ + G+ +HE KR +H D++ NI L +N + + DFG ARL T
Sbjct: 104 QWFVQMCLGVQHIHE---KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLL-----TSPGA 155
Query: 533 WEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGK 592
+ + GTP YY PE + K DI+S G IL E+ + K
Sbjct: 156 YACTYVGTP------------------YYVPPEIWENMPYNNKSDIWSLGCILYELCTLK 197
Query: 593 LPMIQIGSMELNIVQWIQLILE 614
P Q S W LIL+
Sbjct: 198 HPF-QANS-------WKNLILK 211
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 1e-09
Identities = 67/299 (22%), Positives = 116/299 (38%), Gaps = 66/299 (22%)
Query: 374 LLGKSTIGIVYKV-ALNNEEAVAVRRLGNGGWQRFKEF--QTEAEAIGKIRHPNIVSLRA 430
++G+ GIV+ +++ V ++++ + + Q E + + + HPNI+
Sbjct: 7 VVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYE 66
Query: 431 YFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSP 490
F +++ +Y P G+LA I R S D I+ + + LH V
Sbjct: 67 NFLEDKALMIVMEYAPGGTLAE-------YIQKRCNSLLDEDTILHFFVQILLALHHVHT 119
Query: 491 KRYVHGDLRPSNILLGKN-MEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEF 549
K +H DL+ NILL K+ M I DFG++++ + V GTP
Sbjct: 120 KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTV------VGTPC------- 166
Query: 550 TALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGK-------LPMIQIGSME 602
Y +PE + + QK DI++ G +L E+ S K LP + + M
Sbjct: 167 -----------YISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMS 215
Query: 603 LNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHV 661
P++D P L + L ++ P KRP + +
Sbjct: 216 -----------GTFAPISDRYSPDLRQ-------------LILSMLNLDPSKRPQLSQI 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 82/310 (26%), Positives = 124/310 (40%), Gaps = 64/310 (20%)
Query: 366 QLLKASAF----LLGKSTIGIVYKVALNNEE-----AVAVRRLGNGGWQRF-KEFQTEAE 415
++LK + F +LG G VYK E VA++ L + KE EA
Sbjct: 2 RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 61
Query: 416 AIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLATAI-HGKAGIISYRPLSWSDRLRI 474
+ + +P++ L + +L I +P G L + K I S L+W +
Sbjct: 62 VMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ--- 117
Query: 475 IKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWE 534
+AKG+ +L E +R VH DL N+L+ I+DFGLA+L + + E H E
Sbjct: 118 ---IAKGMNYLEE---RRLVHRDLAARNVLVKTPQHVKITDFGLAKL--LGADEKEYHAE 169
Query: 535 QSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKL 593
P ++ AL S R Y T + D++SYGV + E+++ G
Sbjct: 170 GGKV-------PIKWMALESILHRIY------------THQSDVWSYGVTVWELMTFGSK 210
Query: 594 PMIQIGSMELNIVQWIQLILE--DRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKS 651
P I + E I ILE +R P I + V I + C
Sbjct: 211 PYDGIPASE------ISSILEKGERLPQPPIC-------------TIDVYMIMVKCWMID 251
Query: 652 PDKRPSMRHV 661
D RP R +
Sbjct: 252 ADSRPKFREL 261
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 73/318 (22%), Positives = 137/318 (43%), Gaps = 68/318 (21%)
Query: 389 NNEEAVAVRRLGNGGWQR-FKEFQTEAEAIGKI-RHPNIVSLRAYFWSVDEKLLIYDYIP 446
N VAV+ L + + + +E E + I +H NI++L ++ +Y
Sbjct: 42 NKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYAS 101
Query: 447 NGSLATAIHGK----------AGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHG 496
G+L + + + L++ D + VA+G+ +L + ++ +H
Sbjct: 102 KGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYL---ASQKCIHR 158
Query: 497 DLRPSNILLGKNMEPHISDFGLARLADIAEETPEVH----WEQSTTGT-PLQSSPYEFTA 551
DL N+L+ ++ I+DFGLAR +VH ++++T G P++
Sbjct: 159 DLAARNVLVTEDNVMKIADFGLAR---------DVHNIDYYKKTTNGRLPVK-------- 201
Query: 552 LNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQIGSMELNIVQWIQ 610
+ APEA R T + D++S+GV+L E+ + G P I EL +
Sbjct: 202 ---------WMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL-----FK 247
Query: 611 LILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIAL-DCVHKSPDKRPSMRHVCDSLDRV- 668
L+ E H +DK L + + +C H P +RP+ + + + LDRV
Sbjct: 248 LLKE-------------GHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVL 294
Query: 669 NISTEQQFMKGEEPKFDQ 686
+++ +++ P F+Q
Sbjct: 295 TVTSTDEYLDLSVP-FEQ 311
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 1e-09
Identities = 50/223 (22%), Positives = 97/223 (43%), Gaps = 34/223 (15%)
Query: 375 LGKSTIGIVYK-VALNNEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFW 433
+G+ G VY + + + VA++++ + + E + + ++PNIV+ +
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 86
Query: 434 SVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRY 493
DE ++ +Y+ GSL +++ + + + + + FLH +
Sbjct: 87 VGDELWVVMEYLAGGSLTD-------VVTETCMDEGQIAAVCRECLQALDFLHS---NQV 136
Query: 494 VHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALN 553
+H D++ NILLG + ++DFG A+ TPE + GTP
Sbjct: 137 IHRDIKSDNILLGMDGSVKLTDFGFC-----AQITPEQSKRSTMVGTP------------ 179
Query: 554 STTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMI 596
Y+ APE + K DI+S G++ +EM+ G+ P +
Sbjct: 180 ------YWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYL 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 1e-09
Identities = 65/280 (23%), Positives = 109/280 (38%), Gaps = 57/280 (20%)
Query: 393 AVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLAT 452
A+ R G QR + F EA +G+ H NIV L + +++ +Y+ NG+L +
Sbjct: 37 AIHTLRAGCSDKQR-RGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDS 95
Query: 453 AIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPH 512
+ G L + ++ G+A G+ +L E+ YVH L +L+ ++
Sbjct: 96 FLRKHEG-----QLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCK 147
Query: 513 ISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYE--FTALNSTTSRSYYQAPEASKVR 570
IS F LQ E +T + S S + APEA +
Sbjct: 148 ISGFR-----------------------RLQEDKSEAIYTTM-SGKSPVLWAAPEAIQYH 183
Query: 571 KPTQKWDIYSYGVILLEMIS-GKLPMIQIGSMELNIVQWIQLILED--RKPMTDILDPFL 627
+ D++S+G+++ E++S G+ P + Q + +ED R P L
Sbjct: 184 HFSSASDVWSFGIVMWEVMSYGERPYWDMSG------QDVIKAVEDGFRLPAPRNCPNLL 237
Query: 628 AHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDR 667
H L LDC K +RP + L +
Sbjct: 238 -HQL------------MLDCWQKERGERPRFSQIHSILSK 264
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 2e-09
Identities = 61/224 (27%), Positives = 96/224 (42%), Gaps = 38/224 (16%)
Query: 374 LLGKSTIGIVYK-VALNNEEA----VAVRRLGN-GGWQRFKEFQTEAEAIGKIRHPNIVS 427
LLG G V+K + + ++ VA++ + + G Q F+E A+G + H IV
Sbjct: 14 LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVR 73
Query: 428 LRAYFWSVDEKLLIYDYIPNGSLATAIHGKAGIIS-YRPLSWSDRLRIIKGVAKGIAFLH 486
L +L + P GSL + + R L+W + +AKG+ +L
Sbjct: 74 LLGICPGASLQL-VTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQ------IAKGMYYLE 126
Query: 487 EVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSP 546
E R VH +L NILL + I+DFG+A L ++ + E T P
Sbjct: 127 E---HRMVHRNLAARNILLKSDSIVQIADFGVADLL-YPDDKKYFYSEHKT--------P 174
Query: 547 YEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS 590
++ AL S Y T + D++SYGV + EM+S
Sbjct: 175 IKWMALESILFGRY------------THQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 2e-09
Identities = 61/254 (24%), Positives = 106/254 (41%), Gaps = 49/254 (19%)
Query: 375 LGKSTIGIVYK-VALNNEEAVAVRRLGNGGWQRFKEF-----QTEAEAIGKIRHPNIVSL 428
LG+ T G VYK + VA++++ K+ E + + K++HPN+V L
Sbjct: 16 LGEGTFGEVYKARQIKTGRVVALKKILM---HNEKDGFPITALREIKILKKLKHPNVVPL 72
Query: 429 RAYFWSVDEKLLIYDYIPN-----GSLATAI----HGKAGIISYRP---LSWSDRLRIIK 476
+D + + GS+ H +G++ P L+ S +
Sbjct: 73 ------ID---MAVERPDKSKRKRGSVYMVTPYMDHDLSGLLE-NPSVKLTESQIKCYML 122
Query: 477 GVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQS 536
+ +GI +LHE +H D++ +NIL+ I+DFGLAR D P
Sbjct: 123 QLLEGINYLHE---NHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNP------- 172
Query: 537 TTGTPLQSSPYEFTALNSTTSRSYYQAPE-ASKVRKPTQKWDIYSYGVILLEMISGKLPM 595
++T L T +Y+ PE R+ T DI+ G + EM + + P+
Sbjct: 173 --KGGGGGGTRKYTNLVVT---RWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR-PI 226
Query: 596 IQIGSMELNIVQWI 609
+Q G +++ + I
Sbjct: 227 LQ-GKSDIDQLHLI 239
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 59.1 bits (144), Expect = 2e-09
Identities = 77/271 (28%), Positives = 118/271 (43%), Gaps = 89/271 (32%)
Query: 375 LGKSTIGIVYKVALN--NEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIR----------H 422
LGK GIV+K A++ +E VA++++ F F+ +A R H
Sbjct: 15 LGKGAYGIVWK-AIDRRTKEVVALKKI-------FDAFRNATDAQRTFREIMFLQELGDH 66
Query: 423 PNIVSLRAYFWSVDEK--LLIYDYIPNGSLATAIHG--KAGI--------ISYRPLSWSD 470
PNIV L + ++K L+++Y+ T +H +A I I Y+ L
Sbjct: 67 PNIVKLLNVIKAENDKDIYLVFEYM-----ETDLHAVIRANILEDVHKRYIMYQLL---- 117
Query: 471 RLRIIKGVAKGIAFLH--EVSPKRYVHGDLRPSNILLGKNMEPHI--SDFGLARLADIAE 526
K + ++H V +H DL+PSNILL N + + +DFGLAR E
Sbjct: 118 ---------KALKYIHSGNV-----IHRDLKPSNILL--NSDCRVKLADFGLARSLSELE 161
Query: 527 ETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPE---ASKVRKPTQKWDIYSYGV 583
E P E L + +Y+APE S + T+ D++S G
Sbjct: 162 ENP------------------ENPVLTDYVATRWYRAPEILLGS--TRYTKGVDMWSVGC 201
Query: 584 ILLEMISGKLPMIQIGSMELNIVQWIQLILE 614
IL EM+ GK P+ G+ LN Q ++ I+E
Sbjct: 202 ILGEMLLGK-PLFP-GTSTLN--Q-LEKIIE 227
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.4 bits (142), Expect = 3e-09
Identities = 68/308 (22%), Positives = 119/308 (38%), Gaps = 73/308 (23%)
Query: 374 LLGKSTIGIVYKVA-LNNEEAVAVRRLGNGGWQRFKEFQTEAEAIGKI-RHPNIVSLR-A 430
++G+ T G VYK + VA++ + +E + E + K HPNI + A
Sbjct: 13 VIGEGTYGKVYKARHKKTGQLVAIKIMDII-EDEEEEIKEEYNILRKYSNHPNIATFYGA 71
Query: 431 YFWSV-----DEKLLIYDYIPNGS---LATAIHGKAG-----IISYRPLSWSDRLRIIKG 477
+ D+ L+ + GS L + K I+Y I++
Sbjct: 72 FIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAY----------ILRE 121
Query: 478 VAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQST 537
+G+A+LHE + +H D++ NILL KN E + DFG++ A+ + +
Sbjct: 122 TLRGLAYLHE---NKVIHRDIKGQNILLTKNAEVKLVDFGVS-----AQLDSTLGRRNTF 173
Query: 538 TGTPLQSSPYEFTALNSTTSRSYYQAPE---ASKVRKPT--QKWDIYSYGVILLEMISGK 592
GTP Y+ APE + + + D++S G+ +E+ GK
Sbjct: 174 IGTP------------------YWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGK 215
Query: 593 LPMIQIGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSP 652
P+ + M L R P P L + + + +C+ K+
Sbjct: 216 PPLCDMHPMR-------ALFKIPRNP-----PPTLKSPENWSKKFNDFIS---ECLIKNY 260
Query: 653 DKRPSMRH 660
++RP M
Sbjct: 261 EQRPFMEE 268
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 3e-09
Identities = 75/293 (25%), Positives = 130/293 (44%), Gaps = 51/293 (17%)
Query: 374 LLGKSTIGIVYKVAL----NNEEAVAVRRLGN-GGWQRFKEFQTEAEAIGKIRHPNIVSL 428
++GK G VY L + AV+ L + ++F E + HPN++SL
Sbjct: 2 VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSL 61
Query: 429 RAYFWSVD-EKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHE 487
+ L++ Y+ +G L I + ++ P + D + VAKG+ +L
Sbjct: 62 LGICLPSEGSPLVVLPYMKHGDLRNFIRSE----THNP-TVKDLIGFGLQVAKGMEYLAS 116
Query: 488 VSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPY 547
K++VH DL N +L ++ ++DFGLAR DI ++ E + + TG L P
Sbjct: 117 ---KKFVHRDLAARNCMLDESFTVKVADFGLAR--DIYDK--EYYSVHNHTGAKL---PV 166
Query: 548 EFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLE-MISGKLPMIQIGSMELNIV 606
++ AL E+ + +K T K D++S+GV+L E M G P + S ++ +
Sbjct: 167 KWMAL------------ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITV- 213
Query: 607 QWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMR 659
+L+ R+ +L P D + ++ L C H P+ RP+
Sbjct: 214 ----YLLQGRR----LLQPEYCPD--------PLYEVMLSCWHPKPEMRPTFS 250
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 3e-09
Identities = 60/260 (23%), Positives = 109/260 (41%), Gaps = 54/260 (20%)
Query: 410 FQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWS 469
F E + K+ H N+V L + ++ + + G+L + + + +S
Sbjct: 46 FLEETAVMTKLHHKNLVRLLGVILH-NGLYIVMELMSKGNLVNFLRTRGRAL----VSVI 100
Query: 470 DRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETP 529
L+ VA+G+ +L K+ VH DL NIL+ ++ +SDFGLAR+ + +
Sbjct: 101 QLLQFSLDVAEGMEYLES---KKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNS 157
Query: 530 EVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMI 589
++ P ++T APEA K +K + K D++SYGV+L E+
Sbjct: 158 KL--------------PVKWT------------APEALKHKKFSSKSDVWSYGVLLWEVF 191
Query: 590 S-GKLPMIQIGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEI-VSVLKIALDC 647
S G+ P + M L V + ++ + ++ + V + C
Sbjct: 192 SYGRAPYPK---MSLKEV-------------KECVEK--GYRMEPPEGCPADVYVLMTSC 233
Query: 648 VHKSPDKRPSMRHVCDSLDR 667
P KRPS + + L++
Sbjct: 234 WETEPKKRPSFHKLREKLEK 253
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.9 bits (141), Expect = 4e-09
Identities = 53/206 (25%), Positives = 83/206 (40%), Gaps = 70/206 (33%)
Query: 419 KIRHPNIVSLRAYFWSVDEKL-----LIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLR 473
K+RHPNIV L+ V K ++++Y+ H G++ + +++
Sbjct: 54 KLRHPNIVRLKEI---VTSKGKGSIYMVFEYMD--------HDLTGLLDSPEVKFTESQ- 101
Query: 474 IIKGVAK----GIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETP 529
IK K G+ +LH +H D++ SNIL+ + ++DFGLAR
Sbjct: 102 -IKCYMKQLLEGLQYLHS---NGILHRDIKGSNILINNDGVLKLADFGLAR--------- 148
Query: 530 EVHWEQSTTGTPLQSSPYEFTALNSTTSRS---YYQAPE--------ASKVRKPTQKWDI 578
PY T+R +Y+ PE +V D+
Sbjct: 149 ----------------PYTKRNSADYTNRVITLWYRPPELLLGATRYGPEV-------DM 185
Query: 579 YSYGVILLEMISGKLPMIQIGSMELN 604
+S G IL E+ GK P+ Q GS EL
Sbjct: 186 WSVGCILAELFLGK-PIFQ-GSTELE 209
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 4e-09
Identities = 62/233 (26%), Positives = 97/233 (41%), Gaps = 41/233 (17%)
Query: 375 LGKSTIGIVYKVAL------NNEEAVAVRRLGNGGWQRFKE-FQTEAEAIGKIRHPNIVS 427
LG+ G VYK L +AVA++ L + +E F+ EA +++HPNIV
Sbjct: 13 LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVC 72
Query: 428 LRAYFWSVDEKLLIYDYIPNGSLATAI-----HGKAGIIS-----YRPLSWSDRLRIIKG 477
L +I+ Y + L + H G L +D + I+
Sbjct: 73 LLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQ 132
Query: 478 VAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQST 537
+A G+ FL S VH DL N+L+ + ISD GL R EV+
Sbjct: 133 IAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFR---------EVY----- 175
Query: 538 TGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS 590
++ Y + + ++ + +PEA K + DI+SYGV+L E+ S
Sbjct: 176 ------AADY-YKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 5e-09
Identities = 41/172 (23%), Positives = 67/172 (38%), Gaps = 36/172 (20%)
Query: 423 PNIVSLRAYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGI 482
P + L F S D L+ +Y+ G A+ I + P W+ + I V G+
Sbjct: 57 PYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIK----TLGGLPEDWAKQY--IAEVVLGV 110
Query: 483 AFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPL 542
LH+ + +H D++P N+L+ + ++DFGL+R E + GTP
Sbjct: 111 EDLHQ---RGIIHRDIKPENLLIDQTGHLKLTDFGLSR---NGLENKKF------VGTP- 157
Query: 543 QSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLP 594
Y APE + D +S G ++ E + G P
Sbjct: 158 -----------------DYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPP 192
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 57.6 bits (140), Expect = 5e-09
Identities = 69/292 (23%), Positives = 115/292 (39%), Gaps = 53/292 (18%)
Query: 375 LGKSTIGIVYKVALNNEEAVAVRRLGNGGWQRFKEFQ---TEAEAIGKIRHPNIVSLRAY 431
+GK + G V KV ++ + V + + G KE Q +E + +++HPNIV R Y
Sbjct: 8 IGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIV--RYY 65
Query: 432 FWSVD---EKLLIY-DYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHE 487
+D + L I +Y G LA I + + + RI+ + + H
Sbjct: 66 DRIIDRSNQTLYIVMEYCEGGDLAQLI--QKCKKERKYIEEEFIWRILTQLLLALYECHN 123
Query: 488 VSPKRYV--HGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSS 545
S H DL+P+NI L N + DFGLA++ + ++ + GTP
Sbjct: 124 RSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI--LGHDSSFAK---TYVGTP---- 174
Query: 546 PYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNI 605
YY +PE +K DI+S G ++ E+ + P
Sbjct: 175 --------------YYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPP--------FTA 212
Query: 606 VQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPS 657
+QL + ++ + E+ V+K ++ PDKRPS
Sbjct: 213 RNQLQLASKIKEGKFRRIPYR------YSSELNEVIK---SMLNVDPDKRPS 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 5e-09
Identities = 51/226 (22%), Positives = 100/226 (44%), Gaps = 34/226 (15%)
Query: 370 ASAFLLGKSTIGIV-YKVALNNEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSL 428
S +G+ + GIV + + VAV+++ QR + E + H N+V +
Sbjct: 25 DSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDM 84
Query: 429 RAYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEV 488
+ DE ++ +++ G+L I+++ ++ + V + +++LH
Sbjct: 85 YNSYLVGDELWVVMEFLEGGALTD-------IVTHTRMNEEQIATVCLSVLRALSYLHN- 136
Query: 489 SPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYE 548
+ +H D++ +ILL + +SDFG A +++E P+ +S GTP
Sbjct: 137 --QGVIHRDIKSDSILLTSDGRIKLSDFGFC--AQVSKEVPK---RKSLVGTP------- 182
Query: 549 FTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLP 594
Y+ APE + DI+S G++++EMI G+ P
Sbjct: 183 -----------YWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPP 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 56.9 bits (138), Expect = 6e-09
Identities = 45/183 (24%), Positives = 73/183 (39%), Gaps = 35/183 (19%)
Query: 413 EAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRL 472
E + ++ HP +V+L F + L+ D + G L + + S +++
Sbjct: 50 ERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHL-SQKVKFS------EEQV 102
Query: 473 RI-IKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEV 531
+ I + + +LH K +H D++P NILL + HI+DF +A T
Sbjct: 103 KFWICEIVLALEYLHS---KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLT--- 156
Query: 532 HWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISG 591
ST+GTP Y APE + + D +S GV E + G
Sbjct: 157 ---TSTSGTPG------------------YMAPEVLCRQGYSVAVDWWSLGVTAYECLRG 195
Query: 592 KLP 594
K P
Sbjct: 196 KRP 198
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 6e-09
Identities = 55/242 (22%), Positives = 96/242 (39%), Gaps = 46/242 (19%)
Query: 422 HPNIVSLRAYFWSVDEKLLIYDYIPNGSLATAI-HGKAGIISYRPLSWSDRLRIIKGVAK 480
HPN++ A F +E ++ + G L+ I H K R + + +
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQ---KRLIPERTIWKYFVQLCS 117
Query: 481 GIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGT 540
+ +H KR +H D++P+N+ + + D GL R + +T H S GT
Sbjct: 118 ALEHMHS---KRIMHRDIKPANVFITATGVVKLGDLGLGRF--FSSKTTAAH---SLVGT 169
Query: 541 PLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGS 600
P YY +PE K DI+S G +L EM + + P
Sbjct: 170 P------------------YYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYG--- 208
Query: 601 MELNIVQWIQLILE-DRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMR 659
++N+ + I + D P+ H ++ ++VS C++ P+KRP +
Sbjct: 209 DKMNLYSLCKKIEKCDYPPLPA------DHYSEELRDLVSR------CINPDPEKRPDIS 256
Query: 660 HV 661
+V
Sbjct: 257 YV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.3 bits (139), Expect = 9e-09
Identities = 39/102 (38%), Positives = 53/102 (51%), Gaps = 25/102 (24%)
Query: 494 VHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALN 553
+H DL+PSN+LL N + I DFGLAR+AD + H T E+ A
Sbjct: 128 LHRDLKPSNLLLNTNCDLKICDFGLARIADPEHD----HTGFLT----------EYVA-- 171
Query: 554 STTSRSYYQAPE---ASKVRKPTQKWDIYSYGVILLEMISGK 592
+R +Y+APE SK T+ DI+S G IL EM+S +
Sbjct: 172 ---TR-WYRAPEIMLNSK--GYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 57.2 bits (139), Expect = 1e-08
Identities = 48/182 (26%), Positives = 78/182 (42%), Gaps = 44/182 (24%)
Query: 421 RHPNIVSLRAYFWSVD----EKL-LIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLR-I 474
RH NI+ L + ++ + + L I S +PL+ D ++
Sbjct: 57 RHENIIGLLDILRPPSPEDFNDVYIVTELMET-DLHKVIK------SPQPLT-DDHIQYF 108
Query: 475 IKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWE 534
+ + +G+ +LH + +H DL+PSNIL+ N + I DFGLAR D E+
Sbjct: 109 LYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKG---- 161
Query: 535 QSTTGTPLQSSPYEFTALNSTTSRSYYQAPE----ASKVRKPTQKWDIYSYGVILLEMIS 590
+ Y T R +Y+APE +S+ K DI+S G I E+++
Sbjct: 162 --------FLTEYVVT-------R-WYRAPELLLSSSRYTKAI---DIWSVGCIFAELLT 202
Query: 591 GK 592
K
Sbjct: 203 RK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 1e-08
Identities = 78/311 (25%), Positives = 121/311 (38%), Gaps = 73/311 (23%)
Query: 366 QLLKASAFLLGKSTIGIVYKVALNNEEAVAVRRLGNGGWQRFKEFQTEAEAIG---KI-- 420
++++A+A+ L KS V KVA+ + A +E EA+ KI
Sbjct: 50 KVVEATAYGLSKS--DAVMKVAVKMLKPTAHS--------------SEREALMSELKIMS 93
Query: 421 ---RHPNIVSLRAYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKG 477
H NIV+L L+I +Y G L + K L+ D L
Sbjct: 94 HLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESF----LTLEDLLSFSYQ 149
Query: 478 VAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQST 537
VAKG+AFL + K +H DL N+LL I DFGLAR DI ++ V +
Sbjct: 150 VAKGMAFL---ASKNCIHRDLAARNVLLTHGKIVKICDFGLAR--DIMNDSNYV--VKGN 202
Query: 538 TGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKL---P 594
P++ + APE+ T + D++SYG++L E+ S P
Sbjct: 203 ARLPVK-----------------WMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYP 245
Query: 595 MIQIGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDK 654
+ + S ++ K + P A EI ++K C P K
Sbjct: 246 GMPVDSKFYKLI----------KEGYRMAQPEHA-----PAEIYDIMK---TCWDADPLK 287
Query: 655 RPSMRHVCDSL 665
RP+ + + +
Sbjct: 288 RPTFKQIVQLI 298
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.5 bits (137), Expect = 1e-08
Identities = 62/246 (25%), Positives = 100/246 (40%), Gaps = 83/246 (33%)
Query: 374 LLGKSTIGIVYKVA-LNNEEAVAVRRLGNGGWQRFKEFQTEAEAI--GKIR--------- 421
+G+ G VYK LN VA++++ E I +R
Sbjct: 6 EIGEGAYGTVYKARDLNTGRFVALKKV---------RVPLSEEGIPLSTLREIALLKQLE 56
Query: 422 ---HPNIVSLR--AYFWSVDEKL---LIYDYIPNGSLATAI--HGKAGIISYRPLSWSDR 471
HPNIV L + D +L L+++++ + LAT + K G+ +
Sbjct: 57 SFEHPNIVRLLDVCHGPRTDRELKLTLVFEHV-DQDLATYLSKCPKPGLPP-------ET 108
Query: 472 LR-IIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPE 530
++ +++ + +G+ FLH R VH DL+P NIL+ + + I+DFGLAR+
Sbjct: 109 IKDLMRQLLRGVDFLHS---HRIVHRDLKPQNILVTSDGQVKIADFGLARI--------- 156
Query: 531 VHWEQSTTGTPLQSSPYEFT-ALNSTTSRSYYQAPE-------ASKVRKPTQKWDIYSYG 582
Y F AL S +Y+APE A+ V D++S G
Sbjct: 157 ----------------YSFEMALTSVVVTLWYRAPEVLLQSSYATPV-------DMWSVG 193
Query: 583 VILLEM 588
I E+
Sbjct: 194 CIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 56.1 bits (136), Expect = 1e-08
Identities = 45/194 (23%), Positives = 79/194 (40%), Gaps = 34/194 (17%)
Query: 406 RFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRP 465
+ + TE + + + + P +V L F L+ +Y+P G LA+ + +
Sbjct: 36 QVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDLASLLE----NVGSLD 91
Query: 466 LSWSDRLRI-IKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADI 524
+ RI I + + +LH +H DL+P NIL+ N ++DFGL+++ +
Sbjct: 92 EDVA---RIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLV 145
Query: 525 AEET----PEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYS 580
+ E ++ GTP Y APE + ++ D +S
Sbjct: 146 RRQINLNDDEKE-DKRIVGTP------------------DYIAPEVILGQGHSKTVDWWS 186
Query: 581 YGVILLEMISGKLP 594
G IL E + G P
Sbjct: 187 LGCILYEFLVGIPP 200
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 2e-08
Identities = 65/246 (26%), Positives = 99/246 (40%), Gaps = 83/246 (33%)
Query: 375 LGKSTIGIVYKV-ALNNEEAVAVRRLGNGGWQRFKEFQTEAE-----AIGKI------RH 422
+G+ T G+VYK E VA++++ +TE E AI +I H
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKI---------RLETEDEGVPSTAIREISLLKELNH 57
Query: 423 PNIVSL--------RAY--FWSVDEKLLIY-DYIPNGSLATAIHGKAGIISYRPLSWSDR 471
PNIV L + Y F +D L Y D P L D
Sbjct: 58 PNIVRLLDVVHSENKLYLVFEFLDLDLKKYMDSSPLTGL-------------------DP 98
Query: 472 LRIIKG----VAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEE 527
+IK + +GIA+ H R +H DL+P N+L+ + ++DFGLAR
Sbjct: 99 -PLIKSYLYQLLQGIAYCHS---HRVLHRDLKPQNLLIDREGALKLADFGLAR------- 147
Query: 528 TPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEA-SKVRKPTQKWDIYSYGVILL 586
G P+++ +E L +Y+APE R+ + DI+S G I
Sbjct: 148 ---------AFGVPVRTYTHEVVTL-------WYRAPEILLGSRQYSTPVDIWSIGCIFA 191
Query: 587 EMISGK 592
EM++ +
Sbjct: 192 EMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 2e-08
Identities = 58/229 (25%), Positives = 99/229 (43%), Gaps = 43/229 (18%)
Query: 368 LKASAFLLGKSTIGIVYKVALNNEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVS 427
+K + + K I + KV L NE +VR E EAE + ++ +P IV
Sbjct: 11 VKKGVYKMRKKQIDVAIKV-LKNENEKSVR----------DEMMREAEIMHQLDNPYIVR 59
Query: 428 LRAYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHE 487
+ + +L+ + G L + GK I+ S+ + ++ V+ G+ +L
Sbjct: 60 MIG-VCEAEALMLVMEMASGGPLNKFLSGKKDEITV-----SNVVELMHQVSMGMKYLEG 113
Query: 488 VSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGT-PLQSSP 546
K +VH DL N+LL ISDFGL++ A + +++ + G PL+
Sbjct: 114 ---KNFVHRDLAARNVLLVNQHYAKISDFGLSK----ALGADDSYYKARSAGKWPLK--- 163
Query: 547 YEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLP 594
+ APE RK + + D++SYG+ + E S G+ P
Sbjct: 164 --------------WYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 2e-08
Identities = 66/248 (26%), Positives = 99/248 (39%), Gaps = 40/248 (16%)
Query: 359 QVDFDLEQLLKASAFLLGKSTIGIVY------KVALNNEEAVAVRRLGN-GGWQRFKEFQ 411
+V D LL+A LG G VY + E VAV+ L Q +F
Sbjct: 2 EVPRDSITLLRA----LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFL 57
Query: 412 TEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLATAI-HGKAGIISYRPLSWSD 470
EA + K H NIV L + + ++ + + G L + + + L+ D
Sbjct: 58 MEALIMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKD 117
Query: 471 RLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILL---GKNMEPHISDFGLARLADIAEE 527
L + VAKG +L E ++H D+ N LL G I+DFG+AR DI
Sbjct: 118 LLFCARDVAKGCKYLEE---NHFIHRDIAARNCLLTCKGPGRVAKIADFGMAR--DIYRA 172
Query: 528 TPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLE 587
+ + P++ P PEA T K D++S+GV+L E
Sbjct: 173 --SYYRKGGRAMLPIKWMP-----------------PEAFLDGIFTSKTDVWSFGVLLWE 213
Query: 588 MIS-GKLP 594
+ S G +P
Sbjct: 214 IFSLGYMP 221
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 3e-08
Identities = 36/124 (29%), Positives = 52/124 (41%), Gaps = 10/124 (8%)
Query: 472 LRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEV 531
L I + I ++H K +H DL+P NILLG E I D+G A + EE
Sbjct: 116 LSIFHKICATIEYVHS---KGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEE---- 168
Query: 532 HWEQSTTGTPLQSSPY-EFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS 590
+ ++ Y T Y APE ++ DIY+ GVIL +M++
Sbjct: 169 --DLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226
Query: 591 GKLP 594
P
Sbjct: 227 LSFP 230
|
Length = 932 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 3e-08
Identities = 40/139 (28%), Positives = 63/139 (45%), Gaps = 34/139 (24%)
Query: 460 IISYRPLSWSDRLRI-IKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGL 518
I+S +PLS SD +++ + + +G+ +LH +H D++P N+L+ N I DFGL
Sbjct: 94 IVSPQPLS-SDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGL 149
Query: 519 ARLADIAEE---TPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEA-SKVRKPTQ 574
AR+ + E T EV YY+APE R T
Sbjct: 150 ARVEEPDESKHMTQEV-------------------------VTQYYRAPEILMGSRHYTS 184
Query: 575 KWDIYSYGVILLEMISGKL 593
DI+S G I E++ ++
Sbjct: 185 AVDIWSVGCIFAELLGRRI 203
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 4e-08
Identities = 60/248 (24%), Positives = 100/248 (40%), Gaps = 77/248 (31%)
Query: 375 LGKSTIGIVYK---------VAL------NNEEAV---AVRRLGNGGWQRFKEFQTEAEA 416
+G+ T G+VYK VA+ + EE V A+R E
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIR---------------EISL 52
Query: 417 IGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRI-- 474
+ +++HPNIV L+ LI++++ ++ K + S + D +
Sbjct: 53 LKELQHPNIVCLQDVLMQESRLYLIFEFL-------SMDLKKYLDSLPKGQYMDAELVKS 105
Query: 475 -IKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHW 533
+ + +GI F H +R +H DL+P N+L+ ++DFGLAR
Sbjct: 106 YLYQILQGILFCHS---RRVLHRDLKPQNLLIDNKGVIKLADFGLAR------------- 149
Query: 534 EQSTTGTPLQSSPYEFTALNSTTSRSYYQAPE----ASKVRKPTQKWDIYSYGVILLEMI 589
G P++ +E L +Y+APE + + P DI+S G I EM
Sbjct: 150 ---AFGIPVRVYTHEVVTL-------WYRAPEVLLGSPRYSTPV---DIWSIGTIFAEMA 196
Query: 590 SGKLPMIQ 597
+ K P+
Sbjct: 197 TKK-PLFH 203
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 5e-08
Identities = 46/201 (22%), Positives = 89/201 (44%), Gaps = 33/201 (16%)
Query: 394 VAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLATA 453
VAV+ + QR + E + +H N+V + + +E ++ +++ G+L
Sbjct: 49 VAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTD- 107
Query: 454 IHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHI 513
I+S L+ + + V + + +LH + +H D++ +ILL + +
Sbjct: 108 ------IVSQTRLNEEQIATVCESVLQALCYLHS---QGVIHRDIKSDSILLTLDGRVKL 158
Query: 514 SDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPT 573
SDFG A I+++ P+ +S GTP Y+ APE
Sbjct: 159 SDFGFC--AQISKDVPK---RKSLVGTP------------------YWMAPEVISRTPYG 195
Query: 574 QKWDIYSYGVILLEMISGKLP 594
+ DI+S G++++EM+ G+ P
Sbjct: 196 TEVDIWSLGIMVIEMVDGEPP 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 5e-08
Identities = 58/245 (23%), Positives = 88/245 (35%), Gaps = 57/245 (23%)
Query: 375 LGKSTIGIVYKVA-LNNEEAVAVRRLGNGGWQRFKE------------FQT--EAEAIGK 419
LG+ T G V K + VA++++ F T E + + +
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76
Query: 420 IRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVA 479
I+H NI+ L + D L+ D + L + K L+ S I+ +
Sbjct: 77 IKHENIMGLVDVYVEGDFINLVMDIM-ASDLKKVVDRKI------RLTESQVKCILLQIL 129
Query: 480 KGIAFLHEVSPKRY-VHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTT 538
G+ LH K Y +H DL P+NI + I+DFGLAR
Sbjct: 130 NGLNVLH----KWYFMHRDLSPANIFINSKGICKIADFGLAR----------------RY 169
Query: 539 GTPLQSSPYEFTALNSTTSRS-------YYQAPE----ASKVRKPTQKWDIYSYGVILLE 587
G P S +Y+APE A K D++S G I E
Sbjct: 170 GYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKY---HFAVDMWSVGCIFAE 226
Query: 588 MISGK 592
+++GK
Sbjct: 227 LLTGK 231
|
Length = 335 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 5e-08
Identities = 54/244 (22%), Positives = 97/244 (39%), Gaps = 60/244 (24%)
Query: 375 LGKSTIGIVYKVALNN------EEAVAVRRL-GNGGWQRFKEFQTEAEAIGKIRHPNIVS 427
LG+ + G+VY+ E VA++ + N + EF EA + + ++V
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 428 LRAYFWSVDEKLLIYDYIPNGSLATAIHG---KAGIIS-YRPLSWSDRLRIIKGVAKGIA 483
L + L++ + + G L + + +A P + +++ +A G+A
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133
Query: 484 FLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQ 543
+L K++VH DL N ++ +++ I DFG+ R DI E
Sbjct: 134 YLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTR--DIYE----------------- 171
Query: 544 SSPYEFTALNSTTSRSYYQ------------APEASKVRKPTQKWDIYSYGVILLEMIS- 590
YY+ APE+ K T K D++S+GV+L EM +
Sbjct: 172 --------------TDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATL 217
Query: 591 GKLP 594
+ P
Sbjct: 218 AEQP 221
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 5e-08
Identities = 50/221 (22%), Positives = 98/221 (44%), Gaps = 34/221 (15%)
Query: 375 LGKSTIGIVYKVALNNE-EAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFW 433
+G+ + GIV + + + VAV+++ QR + E + +H N+V + +
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 434 SVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRY 493
DE ++ +++ G+L I+++ ++ + V K ++ LH +
Sbjct: 88 VGDELWVVMEFLEGGALTD-------IVTHTRMNEEQIAAVCLAVLKALSVLHA---QGV 137
Query: 494 VHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALN 553
+H D++ +ILL + +SDFG A+ + EV +S GTP
Sbjct: 138 IHRDIKSDSILLTHDGRVKLSDFGFC-----AQVSKEVPRRKSLVGTP------------ 180
Query: 554 STTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLP 594
Y+ APE + DI+S G++++EM+ G+ P
Sbjct: 181 ------YWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 5e-08
Identities = 54/215 (25%), Positives = 94/215 (43%), Gaps = 31/215 (14%)
Query: 375 LGKSTIGIVYK-VALNNEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFW 433
LG G VY+ V VAV+ L +EF EA + +I+HPN+V L
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCT 72
Query: 434 SVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRY 493
+I +++ G+L + + + L + ++ + +L + K +
Sbjct: 73 REPPFYIITEFMTYGNLLDYLR-ECNRQEVNAVVL---LYMATQISSAMEYLEK---KNF 125
Query: 494 VHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALN 553
+H DL N L+G+N ++DFGL+RL + +T H G P ++T
Sbjct: 126 IHRDLAARNCLVGENHLVKVADFGLSRL--MTGDTYTAH-----AGAKF---PIKWT--- 172
Query: 554 STTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEM 588
APE+ K + K D++++GV+L E+
Sbjct: 173 ---------APESLAYNKFSIKSDVWAFGVLLWEI 198
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 49.5 bits (119), Expect = 6e-08
Identities = 27/67 (40%), Positives = 36/67 (53%), Gaps = 7/67 (10%)
Query: 154 RLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSGLIPNDIANLSRLRLLAQRVYV 213
LK++ L+ N T +PDG L L+ LDLS NNL+ + P + L LR L
Sbjct: 1 NLKSLDLSNNRLTV-IPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSL------ 53
Query: 214 DLTYNNL 220
DL+ NNL
Sbjct: 54 DLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 6e-08
Identities = 34/117 (29%), Positives = 58/117 (49%), Gaps = 8/117 (6%)
Query: 409 EFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLATAI-----HGKAGIISY 463
+F E + + +++ PNI+ L A + D +I +Y+ NG L + A
Sbjct: 65 DFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADV 124
Query: 464 RPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLAR 520
+S+S + + +A G+ +L S +VH DL N L+GKN I+DFG++R
Sbjct: 125 VTISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSR 178
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 7e-08
Identities = 47/182 (25%), Positives = 79/182 (43%), Gaps = 32/182 (17%)
Query: 413 EAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRL 472
E + + ++ HP IV L F + + LI D++ G L T + + + D
Sbjct: 48 ERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEV------MFTEEDVK 101
Query: 473 RIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVH 532
+ +A + LH + ++ DL+P NILL + ++DFGL++ + +
Sbjct: 102 FYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKES--------ID 150
Query: 533 WEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGK 592
E+ Y F Y APE R TQ D +S+GV++ EM++G
Sbjct: 151 HEKKA---------YSFCGTVE------YMAPEVVNRRGHTQSADWWSFGVLMFEMLTGS 195
Query: 593 LP 594
LP
Sbjct: 196 LP 197
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 8e-08
Identities = 38/112 (33%), Positives = 48/112 (42%), Gaps = 27/112 (24%)
Query: 481 GIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGT 540
GI LH +H DL+PSNI++ + I DFGLAR T GT
Sbjct: 130 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR----------------TAGT 170
Query: 541 PLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGK 592
+PY T YY+APE + DI+S G I+ EMI G
Sbjct: 171 SFMMTPYVVT--------RYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 1e-07
Identities = 28/91 (30%), Positives = 47/91 (51%)
Query: 58 QVFSLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSF 117
++ L + KL+G IP +L S + ++L +N SG +P L L LS N
Sbjct: 500 ELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQL 559
Query: 118 SGPVPMQIGKLKYLQVLDLSQNSFSSSIPSS 148
SG +P +G ++ L +++S N S+PS+
Sbjct: 560 SGEIPKNLGNVESLVQVNISHNHLHGSLPST 590
|
Length = 968 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 53.4 bits (129), Expect = 1e-07
Identities = 53/226 (23%), Positives = 91/226 (40%), Gaps = 41/226 (18%)
Query: 375 LGKSTIGIVYKVALNNE-EAVAVRRLGNG---GWQRFKEFQTEAEAIGKIRHPNIVSLRA 430
LG G V V + ++ A++ + + + +E E + + HP IV L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 431 YFWSVDEKLL--IYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEV 488
F D+K + + +Y G L T + G+ ++ R I V +LH
Sbjct: 61 TF--KDKKYIYMLMEYCLGGELWTILR-DRGLFD----EYTARF-YIACVVLAFEYLHN- 111
Query: 489 SPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYE 548
+ ++ DL+P N+LL N + DFG A+ ++T W + GTP
Sbjct: 112 --RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKT----W--TFCGTP------- 156
Query: 549 FTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLP 594
Y APE + D +S G++L E+++G+ P
Sbjct: 157 -----------EYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPP 191
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 1e-07
Identities = 55/232 (23%), Positives = 100/232 (43%), Gaps = 37/232 (15%)
Query: 375 LGKSTIGIVYKVALN-NEEAVAVRRLG-NGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYF 432
+GK + G VYK N +E VA++ + ++ Q E + + P I +
Sbjct: 12 IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSY 71
Query: 433 WSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKR 492
+ +I +Y+ GS + K G PL + I++ + KG+ +LH +R
Sbjct: 72 LKGTKLWIIMEYLGGGSALDLL--KPG-----PLEETYIATILREILKGLDYLHS---ER 121
Query: 493 YVHGDLRPSNILLGKNMEPHISDFGLA-RLADIAEETPEVHWEQSTTGTPLQSSPYEFTA 551
+H D++ +N+LL + + ++DFG+A +L D + + GTP
Sbjct: 122 KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK------RNTFVGTP---------- 165
Query: 552 LNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMEL 603
++ APE K K DI+S G+ +E+ G+ P + M +
Sbjct: 166 --------FWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRV 209
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 1e-07
Identities = 55/234 (23%), Positives = 91/234 (38%), Gaps = 40/234 (17%)
Query: 374 LLGKSTIGIVYKVAL------NNEEAVAVRRLGNGGWQRFK-EFQTEAEAIGKIRHPNIV 426
LG+ G V+ E V V+ L + + EF+ E + K+ H N+V
Sbjct: 12 TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVV 71
Query: 427 SLRAYFWSVDEKLLIYDYIPNGSLAT---AIHGKAGIISYRPLSWSDRLRIIKGVAKGIA 483
L + +I +Y G L A K + PLS ++ + +A G+
Sbjct: 72 RLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMD 131
Query: 484 FLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQ 543
L S R+VH DL N L+ E +S L++
Sbjct: 132 HL---SNARFVHRDLAARNCLVSSQREVKVSLLSLSK----------------------- 165
Query: 544 SSPY--EFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLP 594
Y E+ L + + APEA + + K D++S+GV++ E+ + G+LP
Sbjct: 166 -DVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELP 218
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 1e-07
Identities = 55/201 (27%), Positives = 87/201 (43%), Gaps = 39/201 (19%)
Query: 465 PLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADI 524
PL+ D + VA+G+ FL + ++ +H DL NILL +N I DFGLAR DI
Sbjct: 169 PLTLEDLISYSFQVARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLAR--DI 223
Query: 525 AEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVI 584
++ V + PL+ + APE+ + T + D++S+GV+
Sbjct: 224 YKDPDYV--RKGDARLPLK-----------------WMAPESIFDKVYTTQSDVWSFGVL 264
Query: 585 LLEMISGKLPMIQIGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIA 644
L E+ S +G+ VQ + K T + P A + I
Sbjct: 265 LWEIFS-------LGASPYPGVQIDEEFCRRLKEGTRMRAPEYATP--------EIYSIM 309
Query: 645 LDCVHKSPDKRPSMRHVCDSL 665
LDC H +P+ RP+ + + L
Sbjct: 310 LDCWHNNPEDRPTFSELVEIL 330
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 53.9 bits (130), Expect = 1e-07
Identities = 51/185 (27%), Positives = 71/185 (38%), Gaps = 43/185 (23%)
Query: 415 EAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRI 474
E RHP +V+L A F + D + +Y G L IH + S R
Sbjct: 54 ETANSERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIH--TDVFSEP------RAVF 105
Query: 475 IKG-VAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHW 533
V G+ +LHE + V+ DL+ N+LL I+DFGL + E
Sbjct: 106 YAACVVLGLQYLHE---NKIVYRDLKLDNLLLDTEGFVKIADFGLCK---------EGMG 153
Query: 534 EQSTT----GTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMI 589
T GTP EF A T SY T+ D + GV++ EM+
Sbjct: 154 FGDRTSTFCGTP------EFLAPEVLTETSY------------TRAVDWWGLGVLIYEML 195
Query: 590 SGKLP 594
G+ P
Sbjct: 196 VGESP 200
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 2e-07
Identities = 57/228 (25%), Positives = 97/228 (42%), Gaps = 45/228 (19%)
Query: 374 LLGKSTIGIVYKVA-LNNEEAVAVRRLGNGGWQRFKEFQ---TEAEAIGKIRHPNIVSLR 429
+G T G V+ V +E A++ + R K+ Q E + ++ HP I+ L
Sbjct: 8 TVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRL- 66
Query: 430 AYFWSV-DEKLL--IYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLH 486
FW+ D++ L + +Y+P G L + + + S S L + + +LH
Sbjct: 67 --FWTEHDQRFLYMLMEYVPGGELFSYLR------NSGRFSNSTGLFYASEIVCALEYLH 118
Query: 487 EVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSP 546
K V+ DL+P NILL K ++DFG A+ + + T W + GTP
Sbjct: 119 S---KEIVYRDLKPENILLDKEGHIKLTDFGFAK--KLRDRT----W--TLCGTP----- 162
Query: 547 YEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLP 594
Y APE + + + D ++ G+++ EM+ G P
Sbjct: 163 -------------EYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 53.0 bits (128), Expect = 2e-07
Identities = 62/246 (25%), Positives = 110/246 (44%), Gaps = 58/246 (23%)
Query: 379 TIGIVYKVALNNE--EAVAVRRLGNGGWQRFKEFQ-------TEAEAIGKIRHPNIVSLR 429
T G+VY+ A + + E VA+++L KE + E + K++HPNIV+++
Sbjct: 17 TYGVVYR-ARDKKTGEIVALKKLKM-----EKEKEGFPITSLREINILLKLQHPNIVTVK 70
Query: 430 AYFW--SVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHE 487
++D+ ++ +Y+ + L + + P S+ ++ + G+A LH+
Sbjct: 71 EVVVGSNLDKIYMVMEYVEH-DLKSLMETMKQ-----PFLQSEVKCLMLQLLSGVAHLHD 124
Query: 488 VSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPY 547
+H DL+ SN+LL I DFGLAR G+PL+
Sbjct: 125 ---NWILHRDLKTSNLLLNNRGILKICDFGLARE----------------YGSPLK---- 161
Query: 548 EFTALNSTTSRSYYQAPE----ASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMEL 603
+T L T +Y+APE A + D++S G I E+++ K P+ G E+
Sbjct: 162 PYTQLVVTL---WYRAPELLLGAKEYSTAI---DMWSVGCIFAELLTKK-PLFP-GKSEI 213
Query: 604 NIVQWI 609
+ + I
Sbjct: 214 DQLNKI 219
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.0 bits (128), Expect = 2e-07
Identities = 69/293 (23%), Positives = 128/293 (43%), Gaps = 65/293 (22%)
Query: 374 LLGKSTIGIVYKVALNNE--EAVAVRRLG-NGGWQRFKEFQTEAEAIGKIRHPNIVSLRA 430
+GK + G VYK A++ + VA++ + ++ Q E + + + R P I
Sbjct: 8 CIGKGSFGEVYK-AIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITK--- 63
Query: 431 YFWSV--DEKL-LIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHE 487
Y+ S KL +I +Y GS + K G + +++ I++ V G+ +LHE
Sbjct: 64 YYGSFLKGSKLWIIMEYCGGGSCLDLL--KPGKLDETYIAF-----ILREVLLGLEYLHE 116
Query: 488 VSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPY 547
+ +H D++ +NILL + + ++DFG++ + T + + GTP
Sbjct: 117 ---EGKIHRDIKAANILLSEEGDVKLADFGVS-----GQLTSTMSKRNTFVGTP------ 162
Query: 548 EFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQ 607
++ APE K +K DI+S G+ +E+ G+ P+ + M +
Sbjct: 163 ------------FWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRV---- 206
Query: 608 WIQLILEDRKPMTD---ILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPS 657
+ LI ++ P + PF + VS+ C++K P +RPS
Sbjct: 207 -LFLIPKNNPPSLEGNKFSKPF--------KDFVSL------CLNKDPKERPS 244
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 52.8 bits (126), Expect = 2e-07
Identities = 61/291 (20%), Positives = 121/291 (41%), Gaps = 56/291 (19%)
Query: 375 LGKSTIGIVYKVALN-NEEAVAVRRLG-NGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYF 432
+GK + G V+K N ++ VA++ + ++ Q E + + P + +
Sbjct: 12 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71
Query: 433 WSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKR 492
+ +I +Y+ GS ++ PL + I++ + KG+ +LH ++
Sbjct: 72 LKDTKLWIIMEYLGGGS-------ALDLLEPGPLDETQIATILREILKGLDYLHS---EK 121
Query: 493 YVHGDLRPSNILLGKNMEPHISDFGLA-RLADIAEETPEVHWEQSTTGTPLQSSPYEFTA 551
+H D++ +N+LL ++ E ++DFG+A +L D + + GTP
Sbjct: 122 KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK------RNTFVGTP---------- 165
Query: 552 LNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQWIQL 611
++ APE K K DI+S G+ +E+ G+ P ++ M+ +
Sbjct: 166 --------FWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMK------VLF 211
Query: 612 ILEDRKPMTDILDPFLAHDLDKE-DEIVSVLKIALDCVHKSPDKRPSMRHV 661
++ P P L + K E V C++K P RP+ + +
Sbjct: 212 LIPKNNP------PTLEGNYSKPLKEFVEA------CLNKEPSFRPTAKEL 250
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 2e-07
Identities = 57/234 (24%), Positives = 91/234 (38%), Gaps = 45/234 (19%)
Query: 375 LGKSTIGIVYKVALNNE-EAVAVRRLGNGGWQRFKEFQTEAEA------IGKIRHPNIVS 427
LGK G V + + A ++L +R K+ + E A + K+ IVS
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDK---KRLKKRKGEQMALNEKKILEKVSSRFIVS 57
Query: 428 LRAYFWSVDEKLLIYDYIPNGSLATAI--HGKAGIISYRPLSWSDRLRIIKGVAKGIAFL 485
L F + D+ L+ + G L I G+ G R + ++ + + G+ L
Sbjct: 58 LAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQ------IICGLEHL 111
Query: 486 HEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSS 545
H+ +R V+ DL+P N+LL + ISD GLA ++ + T G
Sbjct: 112 HQ---RRIVYRDLKPENVLLDDHGNVRISDLGLA--VELKGGKK-IKGRAGTPG------ 159
Query: 546 PYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIG 599
Y APE + D ++ G L EMI+G+ P Q
Sbjct: 160 ---------------YMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRK 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.7 bits (127), Expect = 2e-07
Identities = 52/237 (21%), Positives = 90/237 (37%), Gaps = 65/237 (27%)
Query: 374 LLGKSTIGIVYKVALNNEEAVAVRRLGNGGWQRFKEFQT--EAEAIGKI----------- 420
++G+ G+V K R G K+F+ + E + K
Sbjct: 8 VVGEGAYGVVLKC----------RNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQL 57
Query: 421 RHPNIVSLRAYFWSVDEKLLIYDYIPNGSLA--TAIHGKAGIISYRPLSWSDRLRIIKGV 478
RH NIV+L+ F L+++Y+ L A G + R W +
Sbjct: 58 RHENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQ--------L 109
Query: 479 AKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTT 538
+ IA+ H +H D++P NIL+ ++ + DFG AR
Sbjct: 110 LQAIAYCHS---HNIIHRDIKPENILVSESGVLKLCDFGFAR------------------ 148
Query: 539 GTPLQSSPYEFTALNSTTSRSYYQAPE----ASKVRKPTQKWDIYSYGVILLEMISG 591
L++ P + L + +Y+APE + KP D+++ G I+ E++ G
Sbjct: 149 --ALRARPA--SPLTDYVATRWYRAPELLVGDTNYGKPV---DVWAIGCIMAELLDG 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 52.8 bits (126), Expect = 2e-07
Identities = 57/237 (24%), Positives = 92/237 (38%), Gaps = 58/237 (24%)
Query: 374 LLGKSTIGIVYKVALNNEEAVAVRRLGNGGWQRFKEFQ--------------TEAEAIGK 419
LLGK T G V + VR +G + K + TE+ +
Sbjct: 2 LLGKGTFGKV----------ILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKN 51
Query: 420 IRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKG-V 478
RHP + SL+ F + D + +Y+ G L H +S + DR R +
Sbjct: 52 TRHPFLTSLKYSFQTKDRLCFVMEYVNGGEL--FFH-----LSRERVFSEDRTRFYGAEI 104
Query: 479 AKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTT 538
+ +LH + V+ DL+ N++L K+ I+DFGL + E + ++
Sbjct: 105 VSALDYLHS---GKIVYRDLKLENLMLDKDGHIKITDFGLCK-----EGITDAATMKTFC 156
Query: 539 GTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPM 595
GTP Y APE + + D + GV++ EM+ G+LP
Sbjct: 157 GTP------------------EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.7 bits (127), Expect = 3e-07
Identities = 65/250 (26%), Positives = 99/250 (39%), Gaps = 82/250 (32%)
Query: 376 GKSTIGIVYKVALNNEEAVAVRRLGNGGWQRF--KEFQTEAE--------AIGKI----- 420
G+ T G VYK A R+ G G + + K+F+ + E A +I
Sbjct: 9 GRGTYGRVYK---------AKRKNGKDG-KEYAIKKFKGDKEQYTGISQSACREIALLRE 58
Query: 421 -RHPNIVSLRAYFWSVDEKL--LIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKG 477
+H N+VSL F +K L++DY A H II + + R+ I
Sbjct: 59 LKHENVVSLVEVFLEHADKSVYLLFDY--------AEHDLWQIIKFH--RQAKRVSIPPS 108
Query: 478 VAK--------GIAFLHEVSPKRYV-HGDLRPSNILLGKNMEPH----ISDFGLARLADI 524
+ K G+ +LH +V H DL+P+NIL+ I D GLARL +
Sbjct: 109 MVKSLLWQILNGVHYLHS----NWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFN- 163
Query: 525 AEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPE----ASKVRKPTQKWDIYS 580
PL+ L+ +Y+APE A R T+ DI++
Sbjct: 164 ---------------APLKP----LADLDPVVVTIWYRAPELLLGA---RHYTKAIDIWA 201
Query: 581 YGVILLEMIS 590
G I E+++
Sbjct: 202 IGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 3e-07
Identities = 32/118 (27%), Positives = 59/118 (50%), Gaps = 9/118 (7%)
Query: 409 EFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSL-----ATAIHGKAGIISY 463
+F E + + ++++PNI+ L S D +I +Y+ NG L I +
Sbjct: 63 DFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANN 122
Query: 464 RP-LSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLAR 520
P +S ++ L + +A G+ +L ++ +VH DL N L+G + I+DFG++R
Sbjct: 123 IPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNCLVGNHYTIKIADFGMSR 177
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 3e-07
Identities = 57/253 (22%), Positives = 103/253 (40%), Gaps = 50/253 (19%)
Query: 413 EAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLATAI---HGKAGIISYRPLSWS 469
E + + ++ HPN++ F +E ++ + G L+ I + +I R + W
Sbjct: 52 EIDLLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTV-WK 110
Query: 470 DRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETP 529
+++ V + +R +H D++P+N+ + + D GL R + +T
Sbjct: 111 YFVQLCSAV-------EHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRF--FSSKTT 161
Query: 530 EVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMI 589
H S GTP YY +PE K DI+S G +L EM
Sbjct: 162 AAH---SLVGTP------------------YYMSPERIHENGYNFKSDIWSLGCLLYEMA 200
Query: 590 SGKLPMIQIGSMELNIVQWIQLILE-DRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCV 648
+ + P ++N+ Q I + D P+ H +K E+VS+ C+
Sbjct: 201 ALQSPFY---GDKMNLFSLCQKIEQCDYPPLPT------EHYSEKLRELVSM------CI 245
Query: 649 HKSPDKRPSMRHV 661
+ PD+RP + +V
Sbjct: 246 YPDPDQRPDIGYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 3e-07
Identities = 60/267 (22%), Positives = 113/267 (42%), Gaps = 54/267 (20%)
Query: 399 LGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKL-LIYDYIPNGSLATAIHGK 457
L N + K + EA+ + +++HPNIV+ R + D L ++ + G L + +
Sbjct: 35 LRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQ 94
Query: 458 AGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFG 517
G + L + + +A + +LHE K +H DL+ N+ L + + D G
Sbjct: 95 KGKL----LPENQVVEWFVQIAMALQYLHE---KHILHRDLKTQNVFLTRTNIIKVGDLG 147
Query: 518 LARLADIAEETPEVHWEQSTT--GTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQK 575
+AR+ E + ++T GTP YY +PE + K
Sbjct: 148 IARVL-------ENQCDMASTLIGTP------------------YYMSPELFSNKPYNYK 182
Query: 576 WDIYSYGVILLEMISGKLPMIQIGSMELNIVQWIQLILEDR-KPMTDILDPFLAHDLDKE 634
D+++ G + EM + K + ++N + + I+E + PM P L
Sbjct: 183 SDVWALGCCVYEMATLKHAF---NAKDMNSL--VYRIIEGKLPPMPKDYSPELG------ 231
Query: 635 DEIVSVLKIALDCVHKSPDKRPSMRHV 661
E+++ + + K P+KRPS++ +
Sbjct: 232 -ELIATM------LSKRPEKRPSVKSI 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 3e-07
Identities = 55/234 (23%), Positives = 106/234 (45%), Gaps = 40/234 (17%)
Query: 375 LGKSTIGIVYKVALNNEEA---VAVRRLGNGGWQR--FKEFQTEAEAIGKIRHPNIVSLR 429
LG+ G V + LN +++ VAV+ + R ++F +EA + + HPN++ L
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 430 AYFWSVDEK------LLIYDYIPNGSLAT-AIHGKAGIIS-YRPLSWSDRLRIIKGVAKG 481
E ++I ++ +G L + ++ + G Y P ++ + +A G
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQM--LVKFMTDIASG 124
Query: 482 IAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTP 541
+ +L S K ++H DL N +L +NM ++DFGL++ + ++ Q
Sbjct: 125 MEYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGD-----YYRQGR---- 172
Query: 542 LQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLP 594
+ P ++ A+ S R Y T K D++S+GV + E+ + G+ P
Sbjct: 173 IAKMPVKWIAIESLADRVY------------TTKSDVWSFGVTMWEIATRGQTP 214
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 4e-07
Identities = 36/139 (25%), Positives = 66/139 (47%), Gaps = 34/139 (24%)
Query: 480 KGIAFLHEVSPKRYVHGDLRPSNILLG-KNMEPHISDFGLARLADIAEETPEVHWEQSTT 538
+G+ ++H + +H DL+P+N+ + +++ I DFGLAR+ D H+
Sbjct: 125 RGLKYIHSAN---VLHRDLKPANVFINTEDLVLKIGDFGLARIVD-------PHYSHKGY 174
Query: 539 GTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKP---TQKWDIYSYGVILLEMISGKLPM 595
L+ +Y++P + P T+ D+++ G I EM++GK
Sbjct: 175 -------------LSEGLVTKWYRSPRL--LLSPNNYTKAIDMWAAGCIFAEMLTGK--P 217
Query: 596 IQIGSMELNIVQWIQLILE 614
+ G+ EL + +QLILE
Sbjct: 218 LFAGAHEL---EQMQLILE 233
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 4e-07
Identities = 60/260 (23%), Positives = 97/260 (37%), Gaps = 59/260 (22%)
Query: 407 FKEFQTEAEAIGKIRHPNIVSLRAYFWSV-DEKLLIYDYIPNGSLATAIHGKAGIISYRP 465
F A + ++ H ++V L Y V DE +++ +Y+ G L +H + +S
Sbjct: 45 SLAFFETASLMSQLSHKHLVKL--YGVCVRDENIMVEEYVKFGPLDVFLHREKNNVS--- 99
Query: 466 LSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIA 525
L W +L + K +A + +L + K+ VHG++ NIL +AR
Sbjct: 100 LHW--KLDVAKQLASALHYLED---KKLVHGNVCGKNIL-------------VARYGLNE 141
Query: 526 EETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPE-----ASKVRKPTQKWDIYS 580
P + + S R + APE + + KW S
Sbjct: 142 GYVPFIKLSDPGIPITVLSREER-------VERIPWIAPECIRNGQASLTIAADKW---S 191
Query: 581 YGVILLEMIS-GKLPMIQIGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVS 639
+G LLE+ S G+ P+ + S E Q L PM D E+ +
Sbjct: 192 FGTTLLEICSNGEEPLSTLSSSEKERFYQDQHRL----PMPDC------------AELAN 235
Query: 640 VLKIALDCVHKSPDKRPSMR 659
++ C P KRPS R
Sbjct: 236 LIN---QCWTYDPTKRPSFR 252
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 5e-07
Identities = 58/234 (24%), Positives = 100/234 (42%), Gaps = 35/234 (14%)
Query: 375 LGKSTIGIVYKVALNNEEAVAVRRLGNGGWQRFKEFQT--EAEAIGKIRHPNIVSLRAYF 432
LG G+V+KV+ + R+L + + Q E + + + P IV F
Sbjct: 13 LGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 72
Query: 433 WSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKR 492
+S E + +++ GSL + KAG I + L ++ V KG+ +L E +
Sbjct: 73 YSDGEISICMEHMDGGSLDQVLK-KAGRIPEQILG-----KVSIAVIKGLTYLRE--KHK 124
Query: 493 YVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTAL 552
+H D++PSNIL+ E + DFG+ +G + S F
Sbjct: 125 IMHRDVKPSNILVNSRGEIKLCDFGV-------------------SGQLIDSMANSFVGT 165
Query: 553 NSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIV 606
S Y +PE + + + DI+S G+ L+EM G+ P+ + EL ++
Sbjct: 166 RS------YMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELM 213
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 5e-07
Identities = 65/251 (25%), Positives = 105/251 (41%), Gaps = 60/251 (23%)
Query: 375 LGKSTIGIVYKVA-LNNEEAVAVRRLGNGGWQRFKEFQT--------EAEAIGKIRHPNI 425
+G+ T GIVY+ + E VA++++ R + E + +RHPNI
Sbjct: 15 IGEGTYGIVYRARDTTSGEIVALKKV------RMDNERDGIPISSLREITLLLNLRHPNI 68
Query: 426 VSLR--AYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIA 483
V L+ +D L+ +Y LA+ + P S S ++ + +G+
Sbjct: 69 VELKEVVVGKHLDSIFLVMEYCEQ-DLASLLDNMP-----TPFSESQVKCLMLQLLRGLQ 122
Query: 484 FLHEVSPKRY-VHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPL 542
+LHE + +H DL+ SN+LL I+DFGLAR T G P
Sbjct: 123 YLHE----NFIIHRDLKVSNLLLTDKGCLKIADFGLAR----------------TYGLPA 162
Query: 543 QS-SPYEFTALNSTTSRSYYQAPEAS-KVRKPTQKWDIYSYGVILLEMISGK--LPMIQI 598
+ +P T +Y+APE T D+++ G IL E+++ K LP
Sbjct: 163 KPMTPKVVTL--------WYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLP---- 210
Query: 599 GSMELNIVQWI 609
G E+ + I
Sbjct: 211 GKSEIEQLDLI 221
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 5e-07
Identities = 49/183 (26%), Positives = 80/183 (43%), Gaps = 33/183 (18%)
Query: 413 EAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRL 472
E + + + P IV F+S E + +++ GSL + KAG I L
Sbjct: 49 ELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIPENILG----- 102
Query: 473 RIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVH 532
+I V +G+ +L E + +H D++PSNIL+ E + DFG+
Sbjct: 103 KISIAVLRGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGV-------------- 146
Query: 533 WEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGK 592
+G + S F +RS Y +PE + T + DI+S G+ L+EM G+
Sbjct: 147 -----SGQLIDSMANSFVG-----TRS-YMSPERLQGTHYTVQSDIWSLGLSLVEMAIGR 195
Query: 593 LPM 595
P+
Sbjct: 196 YPI 198
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 51.9 bits (125), Expect = 5e-07
Identities = 39/136 (28%), Positives = 65/136 (47%), Gaps = 34/136 (25%)
Query: 460 IISYRPLSWSDRLR-IIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGL 518
I+ + LS D ++ ++ + +G+ ++H +H DL+PSNI + ++ E I DFGL
Sbjct: 109 IVKCQKLS-DDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGL 164
Query: 519 ARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEA--SKVRKPTQKW 576
AR D E T V +R +Y+APE + + Q
Sbjct: 165 ARHTD-DEMTGYV------------------------ATR-WYRAPEIMLNWMHY-NQTV 197
Query: 577 DIYSYGVILLEMISGK 592
DI+S G I+ E+++GK
Sbjct: 198 DIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 5e-07
Identities = 41/193 (21%), Positives = 84/193 (43%), Gaps = 37/193 (19%)
Query: 407 FKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPL 466
+ + E + ++ HP+I+ + L +++ GS++ + Y
Sbjct: 47 VEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLS------KYGAF 100
Query: 467 SWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILL---GKNMEPHISDFGLA-RLA 522
+ + + + +G+++LHE + +H D++ +N+L+ G+ + I+DFG A RLA
Sbjct: 101 KEAVIINYTEQLLRGLSYLHE---NQIIHRDVKGANLLIDSTGQRLR--IADFGAAARLA 155
Query: 523 DIAEETPEVHWEQSTTGTPLQSSPYEFTA-LNSTTSRSYYQAPEASKVRKPTQKWDIYSY 581
TG EF L T + + APE + + + D++S
Sbjct: 156 ------------AKGTGAG------EFQGQLLGTIA---FMAPEVLRGEQYGRSCDVWSV 194
Query: 582 GVILLEMISGKLP 594
G +++EM + K P
Sbjct: 195 GCVIIEMATAKPP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 6e-07
Identities = 43/143 (30%), Positives = 61/143 (42%), Gaps = 31/143 (21%)
Query: 481 GIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGT 540
GI LH +H DL+PSNI++ + I DFGLAR T GT
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR----------------TAGT 178
Query: 541 PLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGS 600
+PY T YY+APE + DI+S G I+ EMI G + +
Sbjct: 179 SFMMTPYVVT--------RYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGV----LFP 226
Query: 601 MELNIVQWIQLILEDRKPMTDIL 623
+I QW ++I + P + +
Sbjct: 227 GTDHIDQWNKVIEQLGTPCPEFM 249
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 7e-07
Identities = 39/181 (21%), Positives = 71/181 (39%), Gaps = 22/181 (12%)
Query: 410 FQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWS 469
F E + ++ HPN++ LL+ ++ P G L + G+++
Sbjct: 42 FLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDV 101
Query: 470 DRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLA--RLADIAEE 527
R+ VA G+ +LH+ ++H DL N L ++ I D+GLA + +
Sbjct: 102 -LQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157
Query: 528 TPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLE 587
T + H P + A R + + T+K +I+S GV + E
Sbjct: 158 TKDCHA-----------VPLRWLAPELVEIRG-----QDLLPKDQTKKSNIWSLGVTMWE 201
Query: 588 M 588
+
Sbjct: 202 L 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 7e-07
Identities = 55/205 (26%), Positives = 84/205 (40%), Gaps = 47/205 (22%)
Query: 466 LSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIA 525
L+ D L VA+G+ FL + K VH DL N+LL + I DFGLAR DI
Sbjct: 234 LTTLDLLSFTYQVARGMEFL---ASKNCVHRDLAARNVLLAQGKIVKICDFGLAR--DIM 288
Query: 526 EETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVIL 585
++ V + +T P++ + APE+ T D++SYG++L
Sbjct: 289 HDSNYV--SKGSTFLPVK-----------------WMAPESIFDNLYTTLSDVWSYGILL 329
Query: 586 LEMIS-GKLP---MIQIGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVL 641
E+ S G P MI + I ++ D + V
Sbjct: 330 WEIFSLGGTPYPGMIVDSTFYNKIKSGYRMAKPDHAT----------QE---------VY 370
Query: 642 KIALDCVHKSPDKRPSMRHVCDSLD 666
I + C + P+KRPS H+ D ++
Sbjct: 371 DIMVKCWNSEPEKRPSFLHLSDIVE 395
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 1e-06
Identities = 28/148 (18%), Positives = 57/148 (38%), Gaps = 24/148 (16%)
Query: 383 VYKVALNNEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRH-----PNIVSLRAYFWSVDE 437
VY + +E+ V ++ + ++ + + E + + P ++ A S
Sbjct: 14 VYLLGTKDEDYV-LKINPSR--EKGADREREVAILQLLARKGLPVPKVL---ASGESDGW 67
Query: 438 KLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGD 497
L+ ++I + +S ++ I + +A+ +A LH++ HGD
Sbjct: 68 SYLLMEWIEG-------------ETLDEVSEEEKEDIAEQLAELLAKLHQLPLLVLCHGD 114
Query: 498 LRPSNILLGKNMEPHISDFGLARLADIA 525
L P NIL+ I D+ A A
Sbjct: 115 LHPGNILVDDGKILGIIDWEYAGYGPPA 142
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-06
Identities = 68/303 (22%), Positives = 117/303 (38%), Gaps = 60/303 (19%)
Query: 375 LGKSTIGIVYKVALNNEEAVAVRRLGNGGWQRFKEFQTEAEAIGKI-RHPNIVSLRAYFW 433
+GK T G VYKV + ++A ++ + +E + E + + HPN+V F+
Sbjct: 30 IGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFY 89
Query: 434 SVDEKL-----LIYDYIPNGSLATAIHG--------KAGIISYRPLSWSDRLRIIKGVAK 480
D+ + L+ + GS+ + G +ISY I+ G
Sbjct: 90 KADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISY----------ILYGALL 139
Query: 481 GIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGT 540
G+ LH R +H D++ +NILL + DFG++ A+ T ++ GT
Sbjct: 140 GLQHLHN---NRIIHRDVKGNNILLTTEGGVKLVDFGVS-----AQLTSTRLRRNTSVGT 191
Query: 541 PLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGS 600
P +P E A SY + D++S G+ +E+ G P+ +
Sbjct: 192 PFWMAP-EVIACEQQYDYSY------------DARCDVWSLGITAIELGDGDPPLFDMHP 238
Query: 601 MELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRH 660
++ L R P +L P E S C+ K + RPS+ H
Sbjct: 239 VK-------TLFKIPRNPPPTLLHP--------EKWCRSFNHFISQCLIKDFEARPSVTH 283
Query: 661 VCD 663
+ +
Sbjct: 284 LLE 286
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 1e-06
Identities = 58/235 (24%), Positives = 108/235 (45%), Gaps = 47/235 (20%)
Query: 375 LGKSTIGIVYKVALNN---EEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAY 431
+G+ T G VYK + + A++++ G E + +++HPN++SL+
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGIS--MSACREIALLRELKHPNVISLQKV 66
Query: 432 FWS-VDEKL-LIYDYIPNGSLATAIHGKAGIISYRPLSWSDR--LRIIKGVAKGIAF--- 484
F S D K+ L++DY A H II + S +++ +++ +G+ K + +
Sbjct: 67 FLSHADRKVWLLFDY--------AEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQIL 118
Query: 485 --LHEVSPKRYVHGDLRPSNIL-LGKNMEP---HISDFGLARLADIAEETPEVHWEQSTT 538
+H + +H DL+P+NIL +G+ E I+D G ARL +
Sbjct: 119 DGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFN--------------- 163
Query: 539 GTPLQSSPYEFTALNSTTSRSYYQAPE-ASKVRKPTQKWDIYSYGVILLEMISGK 592
+PL+ L+ +Y+APE R T+ DI++ G I E+++ +
Sbjct: 164 -SPLKP----LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 50.2 bits (121), Expect = 1e-06
Identities = 55/237 (23%), Positives = 91/237 (38%), Gaps = 64/237 (27%)
Query: 413 EAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRL 472
E + IRHP +V+L F L+ +Y+P G L + K+G
Sbjct: 51 EKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFS-HLRKSG------------- 96
Query: 473 RIIKGVAK--------GIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADI 524
R + VA+ + +LH V+ DL+P N+LL + I+DFG A+ +
Sbjct: 97 RFPEPVARFYAAQVVLALEYLHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAKR--V 151
Query: 525 AEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVI 584
T + GTP E Y APE + + D ++ G++
Sbjct: 152 KGRT------YTLCGTP------E------------YLAPEIILSKGYGKAVDWWALGIL 187
Query: 585 LLEMISGKLPMIQIGSMELNIVQWIQLILEDR--------KPMTDILDPFLAHDLDK 633
+ EM++G P +++ + ILE + D++ L DL K
Sbjct: 188 IYEMLAGYPPFFDDNPIQI-----YEKILEGKVRFPSFFSPDAKDLIRNLLQVDLTK 239
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-06
Identities = 40/132 (30%), Positives = 56/132 (42%), Gaps = 31/132 (23%)
Query: 481 GIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGT 540
GI LH +H DL+PSNI++ + I DFGLAR T T
Sbjct: 135 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR----------------TACT 175
Query: 541 PLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGS 600
+PY T YY+APE + DI+S G I+ E++ G + I
Sbjct: 176 NFMMTPYVVT--------RYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSV----IFQ 223
Query: 601 MELNIVQWIQLI 612
+I QW ++I
Sbjct: 224 GTDHIDQWNKVI 235
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 2e-06
Identities = 55/236 (23%), Positives = 95/236 (40%), Gaps = 37/236 (15%)
Query: 374 LLGKSTIGIV---YKVALNNEEAVAVRRLGNGGWQRFKE---FQTEAEAIGKIRHPNIVS 427
LLG+ G V Y V E A + + KE + E + + ++H IV
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQ 68
Query: 428 LRAYFWSVDEKLL--IYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFL 485
EK L +Y+P GS+ K + +Y L+ S + + + +G+++L
Sbjct: 69 YYGCLRDRAEKTLTIFMEYMPGGSV------KDQLKAYGALTESVTRKYTRQILEGMSYL 122
Query: 486 HEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSS 545
H VH D++ +NIL + DFG ++ LQ+
Sbjct: 123 HS---NMIVHRDIKGANILRDSAGNVKLGDFGASK--------------------RLQTI 159
Query: 546 PYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSM 601
T + S T Y+ +PE +K D++S G ++EM++ K P + +M
Sbjct: 160 CMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAM 215
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 2e-06
Identities = 56/252 (22%), Positives = 105/252 (41%), Gaps = 51/252 (20%)
Query: 409 EFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSW 468
+F EA + + HPNIV L ++ + + G T + + + + L
Sbjct: 39 KFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKEL-- 96
Query: 469 SDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEET 528
+++++ A G+ +L K +H DL N L+ + ISDFG++R EE
Sbjct: 97 ---IQMVENAAAGMEYLES---KHCIHRDLAARNCLVTEKNVLKISDFGMSR-----EEE 145
Query: 529 PEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEM 588
V+ ++TG ++ P ++T APEA + + + D++S+G++L E
Sbjct: 146 DGVY---ASTGG-MKQIPVKWT------------APEALNYGRYSSESDVWSFGILLWEA 189
Query: 589 IS-GKLPMIQIGSMELN--IVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIAL 645
S G +P + + + I Q ++L + P D + ++
Sbjct: 190 FSLGAVPYANLSNQQTREAIEQGVRLPCPELCP----------------DAVYRLM---E 230
Query: 646 DCVHKSPDKRPS 657
C P +RPS
Sbjct: 231 RCWEYDPGQRPS 242
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 2e-06
Identities = 60/232 (25%), Positives = 103/232 (44%), Gaps = 55/232 (23%)
Query: 375 LGKSTIGIV-YKVALNNEEAVAVRRLGNGGWQRFKEFQTEAEA---------IGKIRHPN 424
+G G V + VA+++L ++ FQ+E A + ++H N
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIKKL-------YRPFQSELFAKRAYRELRLLKHMKHEN 75
Query: 425 IVSLRAYFWSVDEKLLIYD--YIPNGSLATAIHGKAGIISYRPLSWSDRLR-IIKGVAKG 481
++ L F + D L + Y+ + T + GK ++ + LS DR++ ++ + KG
Sbjct: 76 VIGLLDVF-TPDLSLDRFHDFYLVMPFMGTDL-GK--LMKHEKLS-EDRIQFLVYQMLKG 130
Query: 482 IAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTP 541
+ ++H +H DL+P N+ + ++ E I DFGLAR D +E T V
Sbjct: 131 LKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQTD-SEMTGYV---------- 176
Query: 542 LQSSPYEFTALNSTTSRSYYQAPEAS-KVRKPTQKWDIYSYGVILLEMISGK 592
+R +Y+APE TQ DI+S G I+ EM++GK
Sbjct: 177 --------------VTR-WYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 2e-06
Identities = 54/236 (22%), Positives = 94/236 (39%), Gaps = 37/236 (15%)
Query: 374 LLGKSTIGIVY---KVALNNEEAVAVRRLGNGGWQRFKE---FQTEAEAIGKIRHPNIVS 427
LLG+ G VY E AV + + KE + E + + + H IV
Sbjct: 9 LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68
Query: 428 LRAYFWSVDEKLL--IYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFL 485
E+ L +++P GS+ K + SY L+ + + + + +G+++L
Sbjct: 69 YYGCLRDPMERTLSIFMEHMPGGSI------KDQLKSYGALTENVTRKYTRQILEGVSYL 122
Query: 486 HEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSS 545
H VH D++ +NIL + DFG ++ LQ+
Sbjct: 123 HS---NMIVHRDIKGANILRDSVGNVKLGDFGASK--------------------RLQTI 159
Query: 546 PYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSM 601
T + S T Y+ +PE +K DI+S G ++EM++ K P + +M
Sbjct: 160 CLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAM 215
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 50.1 bits (119), Expect = 2e-06
Identities = 37/113 (32%), Positives = 49/113 (43%), Gaps = 27/113 (23%)
Query: 481 GIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGT 540
GI LH +H DL+PSNI++ + I DFGLAR T GT
Sbjct: 131 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR----------------TAGT 171
Query: 541 PLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKL 593
+PY T YY+APE + DI+S G I+ EM+ K+
Sbjct: 172 SFMMTPYVVT--------RYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI 216
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 2e-06
Identities = 61/239 (25%), Positives = 101/239 (42%), Gaps = 68/239 (28%)
Query: 375 LGKSTIGIVYKVA-LNNEEAVAVRRLGNGGWQRFKEFQTEAE-----AIGKI------RH 422
+G+ T G+VYK E +A++++ + E E AI +I +H
Sbjct: 10 IGEGTYGVVYKARDRVTNETIALKKI---------RLEQEDEGVPSTAIREISLLKEMQH 60
Query: 423 PNIVSLRAYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKG----V 478
NIV L+ S L+++Y+ L H + P ++ R+IK +
Sbjct: 61 GNIVRLQDVVHSEKRLYLVFEYL---DLDLKKH-----MDSSP-DFAKNPRLIKTYLYQI 111
Query: 479 AKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEP-HISDFGLARLADIAEETPEVHWEQST 537
+GIA+ H R +H DL+P N+L+ + ++DFGLAR
Sbjct: 112 LRGIAYCHS---HRVLHRDLKPQNLLIDRRTNALKLADFGLAR----------------A 152
Query: 538 TGTPLQSSPYEFTALNSTTSRSYYQAPE----ASKVRKPTQKWDIYSYGVILLEMISGK 592
G P+++ +E L +Y+APE + P DI+S G I EM++ K
Sbjct: 153 FGIPVRTFTHEVVTL-------WYRAPEILLGSRHYSTPV---DIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 2e-06
Identities = 53/201 (26%), Positives = 84/201 (41%), Gaps = 41/201 (20%)
Query: 405 QRFKEFQTEAEAIG------KIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLATAIH--G 456
+R K+ + E+ A+ K+ +VSL + + D L+ + G L I+ G
Sbjct: 36 KRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMG 95
Query: 457 KAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDF 516
+AG R + ++ + G+ LH+ +R V+ DL+P NILL + ISD
Sbjct: 96 EAGFEEGRAVFYAAE------ICCGLEDLHQ---ERIVYRDLKPENILLDDHGHIRISDL 146
Query: 517 GLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKW 576
GLA VH + T + Y APE K + T
Sbjct: 147 GLA-----------VHVPEGQT-------------IKGRVGTVGYMAPEVVKNERYTFSP 182
Query: 577 DIYSYGVILLEMISGKLPMIQ 597
D ++ G +L EMI+G+ P Q
Sbjct: 183 DWWALGCLLYEMIAGQSPFQQ 203
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 49.6 bits (119), Expect = 3e-06
Identities = 51/201 (25%), Positives = 87/201 (43%), Gaps = 43/201 (21%)
Query: 420 IRHPNIVSLRAYFWSVDEKL----LIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRII 475
+H NI+++R ++ D + + L IH +PL+ + +R
Sbjct: 61 FKHDNIIAIRDILRPPGADFKDVYVVMDLMES-DLHHIIHSD------QPLT-EEHIRYF 112
Query: 476 KG-VAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWE 534
+ +G+ ++H + +H DL+PSN+L+ ++ E I DFG+AR +P H
Sbjct: 113 LYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLS---SSPTEH-- 164
Query: 535 QSTTGTPLQSSPYEFTALNSTTSRSYYQAPEA--SKVRKPTQKWDIYSYGVILLEMISGK 592
Y T +T +Y+APE S T D++S G I EM+ G+
Sbjct: 165 -----------KYFMTEYVAT---RWYRAPELLLSLPEY-TTAIDMWSVGCIFAEML-GR 208
Query: 593 LPMIQIGSMELNIVQWIQLIL 613
+ G N V ++LIL
Sbjct: 209 RQLFP-GK---NYVHQLKLIL 225
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 3e-06
Identities = 47/177 (26%), Positives = 80/177 (45%), Gaps = 46/177 (25%)
Query: 485 LHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARL--ADIAEETPEVHWEQSTTGTPL 542
+H V K +H D++ +NILL N + DFG +++ A ++++ ++ GTP
Sbjct: 156 VHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDV-----GRTFCGTP- 209
Query: 543 QSSPYEFTALNSTTSRSYYQAPEASKVRKP-TQKWDIYSYGVILLEMISGKLPMIQIGSM 601
YY APE + RKP ++K D++S GV+L E+++ K P
Sbjct: 210 -----------------YYVAPEIWR-RKPYSKKADMFSLGVLLYELLTLKRPFDGE--- 248
Query: 602 ELNIVQWIQLILEDR-KPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPS 657
N+ + + L R P+ + P + EIV+ L + P +RPS
Sbjct: 249 --NMEEVMHKTLAGRYDPLPPSISPEMQ-------EIVTAL------LSSDPKRRPS 290
|
Length = 496 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 3e-06
Identities = 56/212 (26%), Positives = 88/212 (41%), Gaps = 51/212 (24%)
Query: 392 EAVAVRRLGNGGWQRFKEFQTEAEA---------IGKIRHPNIVSLRAYFWSVDEKLLIY 442
E VA+++L + FQ+E A + ++H N++ L F S
Sbjct: 41 EKVAIKKLS-------RPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93
Query: 443 D-YIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPS 501
D Y+ + T + G PLS ++ + G+ ++H +H DL+P
Sbjct: 94 DFYLVMPYMQTDLQKIMG----HPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPG 146
Query: 502 NILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYY 561
N+ + ++ E I DFGLAR AD AE T V +R +Y
Sbjct: 147 NLAVNEDCELKILDFGLARHAD-AEMTGYV------------------------VTR-WY 180
Query: 562 QAPEAS-KVRKPTQKWDIYSYGVILLEMISGK 592
+APE Q DI+S G I+ EM++GK
Sbjct: 181 RAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 3e-06
Identities = 55/183 (30%), Positives = 78/183 (42%), Gaps = 18/183 (9%)
Query: 73 IPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQ 132
+P L +LS + ++L N S LP E+ S L+ L LS NS + + LK L
Sbjct: 178 LPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLS 235
Query: 133 VLDLSQNSFSSSIPSSIVQCKRLKTVVLNQN--SFTGPLPDGFATNLTALQKLDLSFNNL 190
L+LS N +P SI L+T+ L+ N S L +LT L++LDLS N+L
Sbjct: 236 GLELSNNKLED-LPESIGNLSNLETLDLSNNQISSISSLG-----SLTNLRELDLSGNSL 289
Query: 191 SGLIPNDI------ANLSRLRLLAQRVYVDLTYNNLSGLIPQNAALLSLGPTAFIGNPFL 244
S +P L L L + + + L L+ I N S P A L
Sbjct: 290 SNALPLIALLLLLLELLLNLLLTLKALELKLNSILLNNNILSNGETSS--PEALSILESL 347
Query: 245 CGP 247
Sbjct: 348 NNL 350
|
Length = 394 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 4e-06
Identities = 52/214 (24%), Positives = 85/214 (39%), Gaps = 35/214 (16%)
Query: 420 IRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVA 479
++HP +V L F + ++ + DY+ G L + + + R ++ VA
Sbjct: 53 LKHPFLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAE------VA 106
Query: 480 KGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTG 539
I +LH ++ ++ DL+P NILL ++DFGL + EET + G
Sbjct: 107 SAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEET-----TSTFCG 158
Query: 540 TPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQ-- 597
TP Y APE + + D + G +L EM+ G P
Sbjct: 159 TP------------------EYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD 200
Query: 598 IGSMELNIV-QWIQLILEDRKPMTDILDPFLAHD 630
+ M NI+ + +QL D+L L D
Sbjct: 201 VSQMYDNILHKPLQLPGGKTVAACDLLVGLLHKD 234
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.2 bits (118), Expect = 4e-06
Identities = 50/200 (25%), Positives = 81/200 (40%), Gaps = 33/200 (16%)
Query: 411 QTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSD 470
TE E + + HP + +L A F + L+ DY P G L +R L
Sbjct: 49 LTEQEILATLDHPFLPTLYASFQTETYLCLVMDYCPGGEL------------FRLLQRQP 96
Query: 471 RLRIIKGVAK--------GIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHI--SDFGLAR 520
+ + VA+ + +LH + V+ DL+P NILL ++ HI SDF L++
Sbjct: 97 GKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHES--GHIMLSDFDLSK 151
Query: 521 LADIAEETPEVHWEQST-TGTPLQSSPYEFTALNSTTSRSY-----YQAPEASKVRKPTQ 574
+D+ + + + F+ S S S+ Y APE
Sbjct: 152 QSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGS 211
Query: 575 KWDIYSYGVILLEMISGKLP 594
D ++ G++L EM+ G P
Sbjct: 212 AVDWWTLGILLYEMLYGTTP 231
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 4e-06
Identities = 52/193 (26%), Positives = 85/193 (44%), Gaps = 39/193 (20%)
Query: 465 PLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADI 524
PL+ D + VA+G+ FL + ++ +H DL NILL +N I DFGLAR DI
Sbjct: 170 PLTMEDLICYSFQVARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLAR--DI 224
Query: 525 AEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVI 584
++ V + + PL+ + APE+ + T + D++S+GV+
Sbjct: 225 YKDPDYV--RKGSARLPLK-----------------WMAPESIFDKVYTTQSDVWSFGVL 265
Query: 585 LLEMISGKLPMIQIGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIA 644
L E+ S +G+ VQ + + K T + P E+ + +I
Sbjct: 266 LWEIFS-------LGASPYPGVQINEEFCQRLKDGTRMRAP--------ENATPEIYRIM 310
Query: 645 LDCVHKSPDKRPS 657
L C P +RP+
Sbjct: 311 LACWQGDPKERPT 323
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 4e-06
Identities = 57/261 (21%), Positives = 103/261 (39%), Gaps = 50/261 (19%)
Query: 413 EAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRL 472
E + + ++ HPN++ A F +E ++ + G L+ I + RL
Sbjct: 52 EIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMI---------KHFKKQKRL 102
Query: 473 RIIKGVAKGI----AFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEET 528
K V K + L + +R +H D++P+N+ + + D GL R + +T
Sbjct: 103 IPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRF--FSSKT 160
Query: 529 PEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEM 588
H S GTP YY +PE K DI+S G +L EM
Sbjct: 161 TAAH---SLVGTP------------------YYMSPERIHENGYNFKSDIWSLGCLLYEM 199
Query: 589 ISGKLPMIQIGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCV 648
+ + P ++N+ + I + P P + +E + ++ C+
Sbjct: 200 AALQSPFY---GDKMNLYSLCKKIEQCDYP------PLPSDHYSEE-----LRQLVNMCI 245
Query: 649 HKSPDKRPSMRHVCDSLDRVN 669
+ P+KRP + +V D R++
Sbjct: 246 NPDPEKRPDITYVYDVAKRMH 266
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 4e-06
Identities = 56/230 (24%), Positives = 104/230 (45%), Gaps = 37/230 (16%)
Query: 375 LGKSTIGIVYKVALNN---EEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAY 431
+G+ T G VYK + E+ A++++ G E + +++HPN+++L+
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGIS--MSACREIALLRELKHPNVIALQKV 66
Query: 432 FWS-VDEKL-LIYDYIPNGSLATAIHGKAGIISYRPLSWSDRL--RIIKGVAKGIAFLHE 487
F S D K+ L++DY + +A + +P+ + ++ + GI +LH
Sbjct: 67 FLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH- 125
Query: 488 VSPKRYVHGDLRPSNIL-LGKNMEP---HISDFGLARLADIAEETPEVHWEQSTTGTPLQ 543
+H DL+P+NIL +G+ E I+D G ARL + +PL+
Sbjct: 126 --ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFN----------------SPLK 167
Query: 544 SSPYEFTALNSTTSRSYYQAPE-ASKVRKPTQKWDIYSYGVILLEMISGK 592
L+ +Y+APE R T+ DI++ G I E+++ +
Sbjct: 168 P----LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 4e-06
Identities = 58/235 (24%), Positives = 96/235 (40%), Gaps = 56/235 (23%)
Query: 375 LGKSTIGIVYKVALNNE--EAVAVRRLGNGGWQRFKEFQTEAEAI-----------GKIR 421
+G+ T G V+K A N E E VA++R+ + E + +++
Sbjct: 8 IGEGTYGTVFK-AKNRETHEIVALKRV---------RLDDDDEGVPSSALREICLLKELK 57
Query: 422 HPNIVSLRAYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKG 481
H NIV L S + L+++Y + L G I + S +++KG
Sbjct: 58 HKNIVRLYDVLHSDKKLTLVFEYC-DQDLKKYFDSCNGDID-PEIVKSFMFQLLKG---- 111
Query: 482 IAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTP 541
+AF H +H DL+P N+L+ KN E ++DFGLAR G P
Sbjct: 112 LAFCHS---HNVLHRDLKPQNLLINKNGELKLADFGLAR----------------AFGIP 152
Query: 542 LQSSPYEFTALNSTTSRSYYQAPEASKVRKP-TQKWDIYSYGVILLEMISGKLPM 595
++ E L +Y+ P+ K + D++S G I E+ + P+
Sbjct: 153 VRCYSAEVVTL-------WYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 4e-06
Identities = 48/184 (26%), Positives = 75/184 (40%), Gaps = 35/184 (19%)
Query: 413 EAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRL 472
E E + + HPN+V F E ++ +++ GSL ++
Sbjct: 122 EIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLA---------- 171
Query: 473 RIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLAR-LADIAEETPEV 531
+ + + GIA+LH + VH D++PSN+L+ I+DFG++R LA +
Sbjct: 172 DVARQILSGIAYLHR---RHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPC--- 225
Query: 532 HWEQSTTGTPLQSSPYEF-TALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS 590
S+ GT SP T LN Y DI+S GV +LE
Sbjct: 226 ---NSSVGTIAYMSPERINTDLNHGAYDGY--------------AGDIWSLGVSILEFYL 268
Query: 591 GKLP 594
G+ P
Sbjct: 269 GRFP 272
|
Length = 353 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 5e-06
Identities = 54/236 (22%), Positives = 94/236 (39%), Gaps = 37/236 (15%)
Query: 374 LLGKSTIGIVY---KVALNNEEAVAVRRLGNGGWQRFKE---FQTEAEAIGKIRHPNIVS 427
LLG+ G VY E AV + KE + E + + +RH IV
Sbjct: 9 LLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQ 68
Query: 428 LRAYFWSVDEKLL--IYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFL 485
+EK L +Y+P GS+ K + +Y L+ + R + + +G+++L
Sbjct: 69 YYGCLRDPEEKKLSIFVEYMPGGSI------KDQLKAYGALTENVTRRYTRQILQGVSYL 122
Query: 486 HEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSS 545
H VH D++ +NIL + DFG ++ +Q+
Sbjct: 123 HS---NMIVHRDIKGANILRDSAGNVKLGDFGASK--------------------RIQTI 159
Query: 546 PYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSM 601
T + S T Y+ +PE +K D++S ++EM++ K P + +M
Sbjct: 160 CMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAM 215
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 5e-06
Identities = 50/206 (24%), Positives = 86/206 (41%), Gaps = 33/206 (16%)
Query: 389 NNEEAVAVRRL--GNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEK--LLIYDY 444
N E VAV+ L +GG + + E E + + H NIV + LI ++
Sbjct: 31 NTGEQVAVKSLKPESGG-NHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEF 89
Query: 445 IPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNIL 504
+P+GSL + I+ + L+ + KG+ +L ++YVH DL N+L
Sbjct: 90 LPSGSLKEYLPRNKNKINLKQQ-----LKYAVQICKGMDYL---GSRQYVHRDLAARNVL 141
Query: 505 LGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAP 564
+ + I DFGL + + +E +T + S ++ AP
Sbjct: 142 VESEHQVKIGDFGLTKAIETDKEY--------------------YTVKDDLDSPVFWYAP 181
Query: 565 EASKVRKPTQKWDIYSYGVILLEMIS 590
E K D++S+GV L E+++
Sbjct: 182 ECLIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 5e-06
Identities = 49/192 (25%), Positives = 79/192 (41%), Gaps = 39/192 (20%)
Query: 408 KEFQTEAEAIGKIRHPNIVSL-RAYFW--SVDEKLLIYDYIPNGSLATAIHGKAGIISYR 464
K E + + I H I++L AY W +V + Y L T +
Sbjct: 131 KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKC----DLFTYVDRSG------ 180
Query: 465 PLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADI 524
PL + I + + + +A+LH + +H D++ NI L + + DFG A D
Sbjct: 181 PLPLEQAITIQRRLLEALAYLHG---RGIIHRDVKTENIFLDEPENAVLGDFGAACKLDA 237
Query: 525 AEETPEVH-WEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGV 583
+TP+ + W +GT +SP E AL+ Y A K DI+S G+
Sbjct: 238 HPDTPQCYGW----SGTLETNSP-ELLALDP------YCA-----------KTDIWSAGL 275
Query: 584 ILLEMISGKLPM 595
+L EM + +
Sbjct: 276 VLFEMSVKNVTL 287
|
Length = 392 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 5e-06
Identities = 59/290 (20%), Positives = 117/290 (40%), Gaps = 54/290 (18%)
Query: 375 LGKSTIGIVYKVALN-NEEAVAVRRLG-NGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYF 432
+GK + G V+K N ++ VA++ + ++ Q E + + P + +
Sbjct: 12 IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71
Query: 433 WSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKR 492
+ +I +Y+ GS + +AG P ++K + KG+ +LH ++
Sbjct: 72 LKGTKLWIIMEYLGGGSALDLL--RAG-----PFDEFQIATMLKEILKGLDYLHS---EK 121
Query: 493 YVHGDLRPSNILLGKNMEPHISDFGLA-RLADIAEETPEVHWEQSTTGTPLQSSPYEFTA 551
+H D++ +N+LL + + ++DFG+A +L D + + GTP
Sbjct: 122 KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK------RNTFVGTP---------- 165
Query: 552 LNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQWIQL 611
++ APE + K DI+S G+ +E+ G+ P + M + L
Sbjct: 166 --------FWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRV-------L 210
Query: 612 ILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHV 661
L + P L + K + C++K P RP+ + +
Sbjct: 211 FLIPKNNP-----PTLTGEFSK-----PFKEFIDACLNKDPSFRPTAKEL 250
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 6e-06
Identities = 42/146 (28%), Positives = 65/146 (44%), Gaps = 37/146 (25%)
Query: 480 KGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTG 539
+ + ++H + H DL+P NIL + + I DFGLAR+A + + W
Sbjct: 114 RALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVA-FNDTPTAIFW------ 163
Query: 540 TPLQSSPYEFTALNSTTSRSYYQAPE--ASKVRKPTQKWDIYSYGVILLEMISGKLPMIQ 597
+ Y T +Y+APE S K T DI+S G I E+++GK P+
Sbjct: 164 -----TDYVAT--------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK-PLFP 209
Query: 598 IGSMELNIVQWIQLILEDRKPMTDIL 623
G N+V + L +TD+L
Sbjct: 210 -GK---NVVHQLDL-------ITDLL 224
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 6e-06
Identities = 51/188 (27%), Positives = 80/188 (42%), Gaps = 39/188 (20%)
Query: 478 VAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQST 537
VAKG+ FL + ++ +H DL NILL +N I DFGLAR DI ++ V +
Sbjct: 188 VAKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLAR--DIYKDPDYV--RKGD 240
Query: 538 TGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQ 597
PL+ + APE R T + D++S+GV+L E+ S
Sbjct: 241 ARLPLK-----------------WMAPETIFDRVYTIQSDVWSFGVLLWEIFS------- 276
Query: 598 IGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPS 657
+G+ V+ + K T + P + + + LDC H P +RP+
Sbjct: 277 LGASPYPGVKIDEEFCRRLKEGTRMRAP--------DYTTPEMYQTMLDCWHGEPSQRPT 328
Query: 658 MRHVCDSL 665
+ + L
Sbjct: 329 FSELVEHL 336
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 6e-06
Identities = 44/184 (23%), Positives = 75/184 (40%), Gaps = 34/184 (18%)
Query: 412 TEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDR 471
TE+ + RHP + +L+ F + D + +Y G L + + + S DR
Sbjct: 44 TESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHL-SRERVFS------EDR 96
Query: 472 LRIIKG-VAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPE 530
R + + +LH V+ DL+ N++L K+ I+DFGL + E +
Sbjct: 97 ARFYGAEIVSALGYLHS---CDVVYRDLKLENLMLDKDGHIKITDFGLCK-----EGISD 148
Query: 531 VHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS 590
++ GTP Y APE + + D + GV++ EM+
Sbjct: 149 GATMKTFCGTP------------------EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMC 190
Query: 591 GKLP 594
G+LP
Sbjct: 191 GRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 7e-06
Identities = 55/229 (24%), Positives = 90/229 (39%), Gaps = 44/229 (19%)
Query: 374 LLGKSTIGIVYKVALNNEEAVA-------VRRLGNGGWQRFKEFQTEAEAIGKIRHPNIV 426
LLGK T G KV L E+A +R+ TE+ + RHP +
Sbjct: 2 LLGKGTFG---KVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLT 58
Query: 427 SLRAYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKG-VAKGIAFL 485
+L+ F + D + +Y G L H +S + +R R + + +L
Sbjct: 59 ALKYAFQTHDRLCFVMEYANGGELF--FH-----LSRERVFTEERARFYGAEIVSALEYL 111
Query: 486 HEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSS 545
H + V+ D++ N++L K+ I+DFGL + T ++ GTP
Sbjct: 112 HS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT-----MKTFCGTP---- 159
Query: 546 PYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLP 594
Y APE + + D + GV++ EM+ G+LP
Sbjct: 160 --------------EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 48.1 bits (115), Expect = 7e-06
Identities = 36/133 (27%), Positives = 58/133 (43%), Gaps = 9/133 (6%)
Query: 394 VAVRRLGNGGWQR-FKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSL-- 450
VAV+ L ++F E + + ++ PNI L +I +Y+ NG L
Sbjct: 49 VAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQ 108
Query: 451 ---ATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGK 507
+ + LS+S L + +A G+ +L +VH DL N L+GK
Sbjct: 109 FLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYL---ESLNFVHRDLATRNCLVGK 165
Query: 508 NMEPHISDFGLAR 520
N I+DFG++R
Sbjct: 166 NYTIKIADFGMSR 178
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 8e-06
Identities = 72/310 (23%), Positives = 132/310 (42%), Gaps = 58/310 (18%)
Query: 374 LLGKSTIGIVYKVALNNE----EAVAVRRLGNG--GWQRFKEFQTEAEAIGKIRHPNI-- 425
+LGK G V + L +E + VAV+ L +EF EA + + HPN+
Sbjct: 6 MLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIK 65
Query: 426 ---VSLRAYFWS-VDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDR--LRIIKGVA 479
VSLR+ + ++I ++ +G L T + I P + + +R + +A
Sbjct: 66 LIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFL--LMSRIGEEPFTLPLQTLVRFMIDIA 123
Query: 480 KGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTG 539
G+ +L S K ++H DL N +L +NM ++DFGL++ + ++ Q
Sbjct: 124 SGMEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGD-----YYRQGCA- 174
Query: 540 TPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQI 598
P ++ AL S Y T D++++GV + E+++ G+ P +
Sbjct: 175 ---SKLPVKWLALESLADNVY------------TTHSDVWAFGVTMWEIMTRGQTPYAGV 219
Query: 599 GSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSM 658
+ E+ + LI +R L D +++ ++ C P RPS
Sbjct: 220 ENSEI----YNYLIKGNR----------LKQPPDCLEDVYELM---CQCWSPEPKCRPSF 262
Query: 659 RHVCDSLDRV 668
+H+ D L+ +
Sbjct: 263 QHLRDQLELI 272
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 9e-06
Identities = 58/268 (21%), Positives = 105/268 (39%), Gaps = 71/268 (26%)
Query: 408 KEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLS 467
K+ +E E + K P I+ F+ + + +++ GSL YR +
Sbjct: 44 KQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDGGSLDV----------YRKIP 93
Query: 468 WSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEE 527
RI V KG+ +L + + +H D++PSN+L+ + + DFG++
Sbjct: 94 EHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVS-------- 142
Query: 528 TPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSY-----YQAPEASKVRKPTQKWDIYSYG 582
T L ++ +++Y Y APE + D++S G
Sbjct: 143 ----------------------TQLVNSIAKTYVGTNAYMAPERISGEQYGIHSDVWSLG 180
Query: 583 VILLEMISGKLPMIQI----GS-MELNIVQWIQLILED--RKPMTDILDPFLAHDLDKED 635
+ +E+ G+ P QI GS M L ++Q I + ED P+ + F
Sbjct: 181 ISFMELALGRFPYPQIQKNQGSLMPLQLLQCI--VDEDPPVLPVGQFSEKF--------- 229
Query: 636 EIVSVLKIALDCVHKSPDKRPSMRHVCD 663
+ C+ K P +RP+ ++ D
Sbjct: 230 -----VHFITQCMRKQPKERPAPENLMD 252
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 47.8 bits (113), Expect = 1e-05
Identities = 56/232 (24%), Positives = 90/232 (38%), Gaps = 41/232 (17%)
Query: 374 LLGKSTIGIVYKVALNNEEAVAVRRLGNGGWQRFKE-----FQTEAEAIGKIRHPNIVSL 428
++G+ G V V L N + V ++ N W+ K F+ E + + + I +L
Sbjct: 8 VIGRGAFGEVAVVKLKNADKVFAMKILNK-WEMLKRAETACFREERDVLVNGDNQWITTL 66
Query: 429 RAYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKG---VAKGIAFL 485
F + L+ DY G L T + + DRL +A+ + +
Sbjct: 67 HYAFQDENNLYLVMDYYVGGDLLTLLS-----------KFEDRLPEDMARFYLAEMVIAI 115
Query: 486 HEVSPKRYVHGDLRPSNILLGKNMEPHISDFG--LARLADIAEETPEVHWEQSTTGTPLQ 543
V YVH D++P NIL+ N ++DFG L + D ++ GTP
Sbjct: 116 DSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQS------SVAVGTPDY 169
Query: 544 SSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPM 595
SP A+ + PE D +S GV + EM+ G+ P
Sbjct: 170 ISPEILQAMEDGKGK---YGPEC----------DWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 1e-05
Identities = 42/185 (22%), Positives = 75/185 (40%), Gaps = 47/185 (25%)
Query: 413 EAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLATAI--HGKAGIISY-----RP 465
EA + + HP+++ ++ D + +G++ + H + + +Y RP
Sbjct: 107 EAMLLQNVNHPSVIRMK-------------DTLVSGAITCMVLPHYSSDLYTYLTKRSRP 153
Query: 466 LSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIA 525
L L I K + +G+ +LH +R +H D++ NI + + I D G A+ +A
Sbjct: 154 LPIDQALIIEKQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA 210
Query: 526 EETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVIL 585
F L T + APE K K DI+S G++L
Sbjct: 211 P---------------------AFLGLAGTVETN---APEVLARDKYNSKADIWSAGIVL 246
Query: 586 LEMIS 590
EM++
Sbjct: 247 FEMLA 251
|
Length = 357 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 1e-05
Identities = 41/132 (31%), Positives = 60/132 (45%), Gaps = 25/132 (18%)
Query: 464 RPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLAD 523
PL D LR VA+G+ FL + K +H D+ N+LL I DFGLAR D
Sbjct: 207 WPLDLDDLLRFSSQVAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLAR--D 261
Query: 524 IAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGV 583
I ++ V + P++ + APE+ T + D++SYG+
Sbjct: 262 IMNDSNYV--VKGNARLPVK-----------------WMAPESIFDCVYTVQSDVWSYGI 302
Query: 584 ILLEMIS-GKLP 594
+L E+ S GK P
Sbjct: 303 LLWEIFSLGKSP 314
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 1e-05
Identities = 55/220 (25%), Positives = 79/220 (35%), Gaps = 55/220 (25%)
Query: 421 RHPNIVSLRAYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKG-VA 479
+HP + L + F + D + +Y+ G L I R R +
Sbjct: 54 KHPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQ------RSGRFDEP-RARFYAAEIV 106
Query: 480 KGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTT- 538
G+ FLHE + ++ DL+ N+LL I+DFG+ + E TT
Sbjct: 107 LGLQFLHE---RGIIYRDLKLDNVLLDSEGHIKIADFGMCK---------EGILGGVTTS 154
Query: 539 ---GTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPM 595
GTP Y APE + D ++ GV+L EM++G+ P
Sbjct: 155 TFCGTP------------------DYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPF 196
Query: 596 IQIGSMELNIVQWIQLILEDR--------KPMTDILDPFL 627
EL Q ILED K IL FL
Sbjct: 197 EGDDEDEL-----FQSILEDEVRYPRWLSKEAKSILKSFL 231
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 1e-05
Identities = 34/125 (27%), Positives = 58/125 (46%), Gaps = 16/125 (12%)
Query: 409 EFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLAT----------AIHGKA 458
+F E + + +++ PNI+ L D +I +Y+ NG L +G
Sbjct: 65 DFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGND 124
Query: 459 GIISYRPL---SWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISD 515
+ L S+S L + +A G+ +L S +VH DL N L+G+N+ I+D
Sbjct: 125 AVPPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIAD 181
Query: 516 FGLAR 520
FG++R
Sbjct: 182 FGMSR 186
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 1e-05
Identities = 58/225 (25%), Positives = 98/225 (43%), Gaps = 38/225 (16%)
Query: 375 LGKSTIGIVYKVALNNE--EAVAVRRLGNGGWQRFKEFQT--EAEAIGKIRHPNIVSLRA 430
+G+ GIV A N+E E VA++++ N R +T E + + + H N+++++
Sbjct: 13 IGRGAYGIVCS-AKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKD 71
Query: 431 YFWSVDEKLLIYDYIPNGSLATAIHGKAGII-SYRPLSWSDRLR-IIKGVAKGIAFLHEV 488
+ YI + T +H II S + LS D + + + +G+ ++H
Sbjct: 72 IMPPPHREAFNDVYIVYELMDTDLHQ---IIRSSQTLS-DDHCQYFLYQLLRGLKYIHSA 127
Query: 489 SPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYE 548
+ +H DL+PSN+LL N + I DFGLAR E + E T
Sbjct: 128 N---VLHRDLKPSNLLLNANCDLKICDFGLARTTS---EKGDFMTEYVVT---------- 171
Query: 549 FTALNSTTSRSYYQAPEAS-KVRKPTQKWDIYSYGVILLEMISGK 592
+Y+APE + T D++S G I E++ K
Sbjct: 172 ----------RWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-05
Identities = 59/236 (25%), Positives = 95/236 (40%), Gaps = 39/236 (16%)
Query: 374 LLGKSTIGIVYKVALNNEEAV-AVRRLGNGGWQRFKE---FQTEAEAIGK-IRHPNIVSL 428
++GK + G V EE AV+ L + KE +E + K ++HP +V L
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61
Query: 429 RAYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEV 488
F + D+ + DYI G L + + + R ++ +A + +LH +
Sbjct: 62 HFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAE------IASALGYLHSL 115
Query: 489 SPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQST-TGTPLQSSPY 547
+ V+ DL+P NILL ++DFGL + E E + ST GTP
Sbjct: 116 N---IVYRDLKPENILLDSQGHIVLTDFGLCK------ENIEHNGTTSTFCGTP------ 160
Query: 548 EFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMEL 603
Y APE + + D + G +L EM+ G P + E+
Sbjct: 161 ------------EYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEM 204
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 2e-05
Identities = 56/235 (23%), Positives = 99/235 (42%), Gaps = 47/235 (20%)
Query: 375 LGKSTIGIVYKV---ALNNEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIR-------HPN 424
LG+ GIV + EE VA++++ N F + A+ +++ H N
Sbjct: 8 LGQGAYGIVCSARNAETSEEETVAIKKITN----VFSKKILAKRALRELKLLRHFRGHKN 63
Query: 425 IVSL---RAYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKG 481
I L F +L +Y+ + L I S +PL+ + I + G
Sbjct: 64 ITCLYDMDIVFPGNFNELYLYEELMEADLHQIIR------SGQPLTDAHFQSFIYQILCG 117
Query: 482 IAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTP 541
+ ++H + +H DL+P N+L+ + E I DFGLAR + P
Sbjct: 118 LKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLAR---------------GFSENP 159
Query: 542 LQSSPYEFTALNSTTSRSYYQAPEASKVRKP-TQKWDIYSYGVILLEMISGKLPM 595
+++ + +R +Y+APE + T+ D++S G IL E++ K P+
Sbjct: 160 GENAGF---MTEYVATR-WYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK-PV 209
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 2e-05
Identities = 43/174 (24%), Positives = 70/174 (40%), Gaps = 32/174 (18%)
Query: 421 RHPNIVSLRAYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAK 480
HP + L F + + + +Y+ G L I R ++ +
Sbjct: 54 EHPFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAE------IIC 107
Query: 481 GIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGT 540
G+ FLH+ K ++ DL+ N+LL K+ I+DFG+ + E + GT
Sbjct: 108 GLQFLHK---KGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAS-----TFCGT 159
Query: 541 PLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLP 594
P Y APE K +K + D +S+GV+L EM+ G+ P
Sbjct: 160 P------------------DYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 45.7 bits (109), Expect = 2e-05
Identities = 30/114 (26%), Positives = 45/114 (39%), Gaps = 17/114 (14%)
Query: 413 EAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRL 472
EA + K R + Y D L++ +YI L A+ R
Sbjct: 49 EARILAKAREAGVPVPIVYDVDPDNGLIVMEYIEGELLKDAL-------------EEARP 95
Query: 473 RIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAE 526
+++ V + + LH+ VHGDL SNI+L + DFGL +D E
Sbjct: 96 DLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGG-RIYFIDFGLGEFSDEVE 145
|
Length = 204 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 2e-05
Identities = 55/201 (27%), Positives = 79/201 (39%), Gaps = 41/201 (20%)
Query: 405 QRFKEFQTEAEAIG------KIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLATAIH--G 456
+R K+ + EA A+ K+ +VSL + + D L+ + G L I+ G
Sbjct: 36 KRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMG 95
Query: 457 KAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDF 516
G R + ++ + G+ LH +R V+ DL+P NILL ISD
Sbjct: 96 NPGFDEERAVFYAAEITC------GLEDLHR---ERIVYRDLKPENILLDDYGHIRISDL 146
Query: 517 GLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKW 576
GLA E PE + GT Y APE K + T
Sbjct: 147 GLA------VEIPEGETIRGRVGT------------------VGYMAPEVVKNERYTFSP 182
Query: 577 DIYSYGVILLEMISGKLPMIQ 597
D + G ++ EMI GK P Q
Sbjct: 183 DWWGLGCLIYEMIEGKSPFRQ 203
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 2e-05
Identities = 54/231 (23%), Positives = 88/231 (38%), Gaps = 41/231 (17%)
Query: 374 LLGKSTIGIVYKVALNNEEAVAVRRLGNGGWQRFKE-----FQTEAEAIGKIRHPNIVSL 428
++G+ G V V + + E + ++ N W+ K F+ E + I +L
Sbjct: 8 VIGRGAFGEVAVVKMKHTERIYAMKILNK-WEMLKRAETACFREERNVLVNGDCQWITTL 66
Query: 429 RAYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKG---VAKGIAFL 485
F + L+ DY G L T + + DRL +A+ + +
Sbjct: 67 HYAFQDENYLYLVMDYYVGGDLLTLLS-----------KFEDRLPEDMARFYIAEMVLAI 115
Query: 486 HEVSPKRYVHGDLRPSNILLGKNMEPHISDFG--LARLADIAEETPEVHWEQSTTGTPLQ 543
H + YVH D++P N+LL N ++DFG L D ++ GTP
Sbjct: 116 HSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQS------SVAVGTPDY 169
Query: 544 SSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLP 594
SP A+ + PE D +S GV + EM+ G+ P
Sbjct: 170 ISPEILQAMEDGMGK---YGPEC----------DWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 2e-05
Identities = 45/188 (23%), Positives = 81/188 (43%), Gaps = 33/188 (17%)
Query: 409 EFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLI---YDYIPNGSLATAIHGKAGIISYRP 465
+ + E A+G++ H NI+ + S +I YD+ L + ++ +A RP
Sbjct: 209 QLENEILALGRLNHENILKIEEILRSEANTYMITQKYDF----DLYSFMYDEAFDWKDRP 264
Query: 466 LSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIA 525
L R I+K + + ++H+ K+ +H D++ NI L + + + DFG A +
Sbjct: 265 LLKQTR-AIMKQLLCAVEYIHD---KKLIHRDIKLENIFLNCDGKIVLGDFGTA----MP 316
Query: 526 EETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVIL 585
E ++ GT +SP E A + + DI+S G+IL
Sbjct: 317 FEKEREAFDYGWVGTVATNSP-EILAGDGYCEIT-----------------DIWSCGLIL 358
Query: 586 LEMISGKL 593
L+M+S
Sbjct: 359 LDMLSHDF 366
|
Length = 501 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 2e-05
Identities = 57/264 (21%), Positives = 105/264 (39%), Gaps = 56/264 (21%)
Query: 413 EAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRL 472
E + ++RH N+V+L F L+++++ + L G L S
Sbjct: 50 EIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNG------LDESRVR 103
Query: 473 RIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVH 532
+ + + +GI F H +H D++P NIL+ ++ + DFG AR
Sbjct: 104 KYLFQILRGIEFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFAR------------ 148
Query: 533 WEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEA----SKVRKPTQKWDIYSYGVILLEM 588
T P + +T +T +Y+APE +K + DI++ G ++ EM
Sbjct: 149 ----TLAAPGEV----YTDYVAT---RWYRAPELLVGDTKYGRAV---DIWAVGCLVTEM 194
Query: 589 ISGKLPMIQIGSMELNIVQWIQLILE----------DRKPMTDILD-PFLAHDLDKEDEI 637
++G+ P+ G +++ + I L + P+ + P + E
Sbjct: 195 LTGE-PLFP-GDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRF 252
Query: 638 VSVLKIALD----CVHKSPDKRPS 657
+ + LD C+ PD RPS
Sbjct: 253 PKLSGLVLDLAKQCLRIDPDDRPS 276
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 2e-05
Identities = 51/208 (24%), Positives = 82/208 (39%), Gaps = 35/208 (16%)
Query: 425 IVSLRAYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRI-IKGVAKGIA 483
+V L F D + DYIP G + + + + GI D R I + I
Sbjct: 63 VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLI-RLGIFE------EDLARFYIAELTCAIE 115
Query: 484 FLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGL------------------ARLADIA 525
+H++ ++H D++P NIL+ ++ ++DFGL R D
Sbjct: 116 SVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHR-QDSM 171
Query: 526 EETPEVHWEQSTTGTPLQ---SSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYG 582
E + E PL+ ++ +S Y APE TQ D +S G
Sbjct: 172 EPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG 231
Query: 583 VILLEMISGKLPMI--QIGSMELNIVQW 608
VIL EM+ G+ P + +L ++ W
Sbjct: 232 VILYEMLVGQPPFLADTPAETQLKVINW 259
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 3e-05
Identities = 60/229 (26%), Positives = 92/229 (40%), Gaps = 43/229 (18%)
Query: 374 LLGKSTIGIVYKVALNNEEAV----AVRRLGNG---GWQRFKEFQTEAEAIGKIRHPNIV 426
LLGK T G KV L E+A A++ L TE + RHP +
Sbjct: 2 LLGKGTFG---KVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLT 58
Query: 427 SLRAYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKG-VAKGIAFL 485
+L+ F + D + +Y G L H +S + DR R + + +L
Sbjct: 59 ALKYSFQTHDRLCFVMEYANGGELF--FH-----LSRERVFSEDRARFYGAEIVSALDYL 111
Query: 486 HEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSS 545
H S K V+ DL+ N++L K+ I+DFGL + E + ++ GTP
Sbjct: 112 H--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK-----EGIKDGATMKTFCGTP---- 160
Query: 546 PYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLP 594
Y APE + + D + GV++ EM+ G+LP
Sbjct: 161 --------------EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 3e-05
Identities = 55/245 (22%), Positives = 98/245 (40%), Gaps = 69/245 (28%)
Query: 370 ASAFL----LGKSTIGIVYK--------------VALNNEEAV---AVRRLGNGGWQRFK 408
A+++L LG+ + VYK +++ EE V A+R
Sbjct: 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIR----------- 52
Query: 409 EFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSW 468
EA + ++H NIV L + + +++Y+ I G+ Y
Sbjct: 53 ----EASLLKGLKHANIVLLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPY----- 103
Query: 469 SDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEET 528
+ RL + + + +G+A++H + +H DL+P N+L+ E ++DFGLAR I
Sbjct: 104 NVRLFMFQ-LLRGLAYIHG---QHILHRDLKPQNLLISYLGELKLADFGLARAKSI---- 155
Query: 529 PEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEA-SKVRKPTQKWDIYSYGVILLE 587
P Q+ E L +Y+ P+ + DI+ G I +E
Sbjct: 156 ------------PSQTYSSEVVTL-------WYRPPDVLLGATDYSSALDIWGAGCIFIE 196
Query: 588 MISGK 592
M+ G+
Sbjct: 197 MLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 3e-05
Identities = 58/232 (25%), Positives = 94/232 (40%), Gaps = 46/232 (19%)
Query: 411 QTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSD 470
++E + H IV F S D+ LLI +Y G L I K + + P
Sbjct: 113 RSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQI--KQRLKEHLPF---- 166
Query: 471 RLRIIKGVAKGIAF------LHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADI 524
+ G+ F L EV ++ +H DL+ +NI L + DFG ++
Sbjct: 167 -----QEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQY-- 219
Query: 525 AEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVI 584
++ + S GTP YY APE + ++ ++K D++S GVI
Sbjct: 220 -SDSVSLDVASSFCGTP------------------YYLAPELWERKRYSKKADMWSLGVI 260
Query: 585 LLEMISGKLPMIQIGSMELNIVQWIQLILEDRKP------MTDILDPFLAHD 630
L E+++ P G + I+Q + D P M +LDP L+ +
Sbjct: 261 LYELLTLHRPF--KGPSQREIMQQVLYGKYDPFPCPVSSGMKALLDPLLSKN 310
|
Length = 478 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 4e-05
Identities = 47/186 (25%), Positives = 74/186 (39%), Gaps = 26/186 (13%)
Query: 410 FQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWS 469
F+ E + + P I L+ F D L+ +Y P G L + ++
Sbjct: 48 FEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFD------E 101
Query: 470 DRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETP 529
D + +A+ + +H V YVH D++P N+L+ + ++DFG A A T
Sbjct: 102 DMAQFY--LAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSA-----ARLTA 154
Query: 530 EVH-WEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEM 588
+ GTP +P T +N +Y E D +S GVI EM
Sbjct: 155 NKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTY--GVEC----------DWWSLGVIAYEM 202
Query: 589 ISGKLP 594
I G+ P
Sbjct: 203 IYGRSP 208
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 4e-05
Identities = 32/114 (28%), Positives = 48/114 (42%), Gaps = 29/114 (25%)
Query: 480 KGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTG 539
+G+ FLH R VH DL+P NIL+ + + ++DFGLAR+
Sbjct: 121 RGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARI------------------ 159
Query: 540 TPLQSSPYEFTALNSTTSRS-YYQAPEASKVRKPTQKWDIYSYGVILLEMISGK 592
Y F ++ + +Y+APE D++S G I EM K
Sbjct: 160 -------YSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 4e-05
Identities = 46/184 (25%), Positives = 73/184 (39%), Gaps = 35/184 (19%)
Query: 413 EAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLATAIH--GKAGIISYRPLSWSD 470
E E + K+ P IV+L F S L+ + G L I+ G+ G+ R + +S
Sbjct: 43 EKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSA 102
Query: 471 RLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPE 530
+ + GI LH + V+ D++P N+LL +SD GLA E +
Sbjct: 103 Q------ITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLA------VELKD 147
Query: 531 VHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS 590
GT + Y APE K + D ++ G + EM++
Sbjct: 148 GKTITQRAGT------------------NGYMAPEILKEEPYSYPVDWFAMGCSIYEMVA 189
Query: 591 GKLP 594
G+ P
Sbjct: 190 GRTP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 5e-05
Identities = 54/232 (23%), Positives = 88/232 (37%), Gaps = 55/232 (23%)
Query: 375 LGKSTIGIVYKVALN-NEEAVAVRRLGNGGWQRFKEFQ---TEAEAIGKIRHPNIVSLRA 430
LG + G V E A++ L + K+ Q E + ++ HP IV++
Sbjct: 26 LGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMC 85
Query: 431 YFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAK--------GI 482
F + + +++ G L T + KAG R VAK
Sbjct: 86 SFQDENRVYFLLEFVVGGELFTHLR-KAG-------------RFPNDVAKFYHAELVLAF 131
Query: 483 AFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPL 542
+LH K ++ DL+P N+LL ++DFG A+ + + T + GTP
Sbjct: 132 EYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAK--KVPDRT------FTLCGTP- 179
Query: 543 QSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLP 594
Y APE + + + D ++ GV+L E I+G P
Sbjct: 180 -----------------EYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPP 214
|
Length = 329 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 5e-05
Identities = 42/183 (22%), Positives = 72/183 (39%), Gaps = 35/183 (19%)
Query: 412 TEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDR 471
TE + + + +V L F + L +Y+P G T ++ G++S R
Sbjct: 50 TERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNL-GVLSED----HAR 104
Query: 472 LRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEV 531
+ + + LHE+ Y+H DL+P N L+ + ++DFGL++ V
Sbjct: 105 FYMAEMFE-AVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGI--------V 152
Query: 532 HWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISG 591
+ S G+P Y APE + + D +S G +L E + G
Sbjct: 153 TYANSVVGSP------------------DYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCG 194
Query: 592 KLP 594
P
Sbjct: 195 FPP 197
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 45.1 bits (106), Expect = 5e-05
Identities = 55/235 (23%), Positives = 97/235 (41%), Gaps = 32/235 (13%)
Query: 374 LLGKSTIGIVYKVALNNEEAVAVRRLGNGGWQRFKEFQTEAEAIGKI-RHPNIVSLRAYF 432
L+G T G VYK +A ++ + +E + E + K H NI + F
Sbjct: 13 LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAF 72
Query: 433 WS-----VDEKL-LIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLH 486
+D++L L+ ++ GS+ I G L I + + +G++ LH
Sbjct: 73 IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKG----NTLKEEWIAYICREILRGLSHLH 128
Query: 487 EVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSP 546
+ + +H D++ N+LL +N E + DFG++ A+ V + GTP +P
Sbjct: 129 Q---HKVIHRDIKGQNVLLTENAEVKLVDFGVS-----AQLDRTVGRRNTFIGTPYWMAP 180
Query: 547 YEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSM 601
E A + +Y K D++S G+ +EM G P+ + M
Sbjct: 181 -EVIACDENPDATY------------DFKSDLWSLGITAIEMAEGAPPLCDMHPM 222
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|236586 PRK09605, PRK09605, bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Score = 45.6 bits (109), Expect = 6e-05
Identities = 34/136 (25%), Positives = 61/136 (44%), Gaps = 25/136 (18%)
Query: 436 DEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVH 495
+EK ++ +YI L + G +++ V + +A LH+ VH
Sbjct: 409 EEKTIVMEYIGGKDLKDVLEG--------------NPELVRKVGEIVAKLHK---AGIVH 451
Query: 496 GDLRPSNILLGKNMEPHISDFGLARLADIAEETP-EVH-WEQSTTGTPLQSSPYEFTALN 553
GDL SN ++ + ++ DFGL + +D+ E+ ++H +QS L+S+ Y+F L
Sbjct: 452 GDLTTSNFIVRDD-RLYLIDFGLGKYSDLIEDKAVDLHVLKQS-----LESTHYDFEELW 505
Query: 554 STTSRSYYQAPEASKV 569
Y + A V
Sbjct: 506 EAFLEGYRETEGAEDV 521
|
Length = 535 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 6e-05
Identities = 46/181 (25%), Positives = 73/181 (40%), Gaps = 39/181 (21%)
Query: 417 IGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSD-RLRII 475
+ ++HP +V L F + D+ + DY+ G L + R S+ + R R
Sbjct: 50 LKNVKHPFLVGLHYSFQTADKLYFVLDYVNGGELFFHLQ--------RERSFPEPRARFY 101
Query: 476 KG-VAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWE 534
+A + +LH ++ DL+P NILL ++DFGL + +T
Sbjct: 102 AAEIASALGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKT------ 152
Query: 535 QST-TGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKL 593
ST GTP Y APE + + + D + G +L EM+ G L
Sbjct: 153 TSTFCGTP------------------EYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYG-L 193
Query: 594 P 594
P
Sbjct: 194 P 194
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 45.0 bits (107), Expect = 7e-05
Identities = 48/235 (20%), Positives = 89/235 (37%), Gaps = 44/235 (18%)
Query: 374 LLGKS----TIGIVYKVALNNEEAVAVRR--LGNGGWQRFKEFQTEAEAIGKIRHPNIVS 427
L+GK I + K N VAV++ L + + K Q E +++HPNI+
Sbjct: 5 LIGKCFEDLMIVHLAKHKPTNT-LVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILP 63
Query: 428 LRAYFWSVDEKLLIYDYIPNGSLATAI--HGKAG----IISYRPLSWSDRLRIIKGVAKG 481
F E ++ + GS + H G I++ I+K V
Sbjct: 64 YVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAF----------ILKDVLNA 113
Query: 482 IAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTP 541
+ ++H K ++H ++ S+ILL + + +S + +
Sbjct: 114 LDYIHS---KGFIHRSVKASHILLSGDGKVVLSGLRYSVSMI----------KHGKRQRV 160
Query: 542 LQSSPYEFTALNSTTSRSYYQAPEA--SKVRKPTQKWDIYSYGVILLEMISGKLP 594
+ P S+ + +PE ++ +K DIYS G+ E+ +G +P
Sbjct: 161 VHDFP------KSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVP 209
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 7e-05
Identities = 67/304 (22%), Positives = 122/304 (40%), Gaps = 55/304 (18%)
Query: 375 LGKSTIGIVYK------VALNNEEAVAVRRLGNGGWQRFK-EFQTEAEAIGKIRHPNIVS 427
LG+ + G+VY+ V E VA++ + R + EF EA + + ++V
Sbjct: 14 LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 428 LRAYFWSVDEKLLIYDYIPNGSLATAIHG----KAGIISYRPLSWSDRLRIIKGVAKGIA 483
L L+I + + G L + + P S +++ +A G+A
Sbjct: 74 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMA 133
Query: 484 FLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTG-TPL 542
+L + ++VH DL N ++ ++ I DFG+ R DI E ++ + G P+
Sbjct: 134 YL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTR--DIYETD---YYRKGGKGLLPV 185
Query: 543 QSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSME 602
+ + +PE+ K T D++S+GV+L E+ + Q S E
Sbjct: 186 R-----------------WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE 228
Query: 603 LNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVL-KIALDCVHKSPDKRPSMRHV 661
Q ++ ++E LDK D +L ++ C +P RPS +
Sbjct: 229 ----QVLRFVME-------------GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEI 271
Query: 662 CDSL 665
S+
Sbjct: 272 ISSI 275
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 8e-05
Identities = 55/234 (23%), Positives = 95/234 (40%), Gaps = 35/234 (14%)
Query: 375 LGKSTIGIVYKVALNNEEAVAVRRLGNGGWQRFKEFQT--EAEAIGKIRHPNIVSLRAYF 432
LG G+V KV + R+L + + Q E + + + P IV F
Sbjct: 13 LGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 72
Query: 433 WSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKR 492
+S E + +++ GSL + I P ++ I V +G+A+L E +
Sbjct: 73 YSDGEISICMEHMDGGSLDQVLKEAKRI----PEEILGKVSI--AVLRGLAYLRE--KHQ 124
Query: 493 YVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTAL 552
+H D++PSNIL+ E + DFG+ +G + S F
Sbjct: 125 IMHRDVKPSNILVNSRGEIKLCDFGV-------------------SGQLIDSMANSFVGT 165
Query: 553 NSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIV 606
S Y +PE + + + DI+S G+ L+E+ G+ P+ + EL +
Sbjct: 166 RS------YMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAI 213
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 9e-05
Identities = 49/176 (27%), Positives = 86/176 (48%), Gaps = 38/176 (21%)
Query: 375 LGKSTIGIVYKVALNNE--EAVAVR--RLGNGGWQRFKE-FQT----EAEAIGKIRHPNI 425
+G+ T G VYK A + + E VA++ RL N KE F E + + ++ H NI
Sbjct: 15 IGEGTYGQVYK-ARDKDTGELVALKKVRLDNE-----KEGFPITAIREIKILRQLNHRNI 68
Query: 426 VSLRAYFW----SVDEK------LLIYDYIPNGSLATAIHGKAGIISYRPLSWSDR--LR 473
V+L+ ++D K L+++Y+ H G++ + +S+
Sbjct: 69 VNLKEIVTDKQDALDFKKDKGAFYLVFEYMD--------HDLMGLLESGLVHFSEDHIKS 120
Query: 474 IIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETP 529
+K + +G+ + H+ K ++H D++ SNILL + ++DFGLARL + E P
Sbjct: 121 FMKQLLEGLNYCHK---KNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRP 173
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 9e-05
Identities = 62/232 (26%), Positives = 93/232 (40%), Gaps = 46/232 (19%)
Query: 375 LGKSTIGIVYKV---ALNNEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAY 431
LGK G VYKV A+ RL +F + E + + K P IV
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRL-ELDESKFNQIIMELDILHKAVSPYIVDFYGA 67
Query: 432 FWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRL-RIIKGVAKGIAFLHEVSP 490
F+ + +Y+ GSL ++ P D L RI V KG+ FL E
Sbjct: 68 FFIEGAVYMCMEYMDAGSL-DKLYAGGVATEGIP---EDVLRRITYAVVKGLKFLKE--E 121
Query: 491 KRYVHGDLRPSNILLGKNMEPHISDFGLA--RLADIAEETPEVHWEQSTTGTPLQSSPYE 548
+H D++P+N+L+ N + + DFG++ +A +A+ T QS
Sbjct: 122 HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAK-----------TNIGCQS---- 166
Query: 549 FTALNSTTSRSYYQAPEASKVRKPTQ------KWDIYSYGVILLEMISGKLP 594
Y APE K P Q + D++S G+ +LEM G+ P
Sbjct: 167 ------------YMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYP 206
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 9e-05
Identities = 47/186 (25%), Positives = 73/186 (39%), Gaps = 30/186 (16%)
Query: 410 FQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYR-PLSW 468
F E + + P +V L F ++ +Y+P G L + +Y P W
Sbjct: 90 FWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMS------NYDVPEKW 143
Query: 469 SDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEET 528
+ A+ + L + +H D++P N+LL K+ ++DFG D ET
Sbjct: 144 AKFY-----TAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMD---ET 195
Query: 529 PEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEM 588
V + + GTP SP L S YY ++ D +S GV L EM
Sbjct: 196 GMVRCD-TAVGTPDYISP---EVLKSQGGDGYY-----------GRECDWWSVGVFLFEM 240
Query: 589 ISGKLP 594
+ G P
Sbjct: 241 LVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 1e-04
Identities = 53/198 (26%), Positives = 76/198 (38%), Gaps = 41/198 (20%)
Query: 405 QRFKEFQTEAEAIG------KIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLATAIH--G 456
+R K+ + EA A+ K+ +VSL + + D L+ + G L I+ G
Sbjct: 36 KRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMG 95
Query: 457 KAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDF 516
G D R I A+ L ++ +R V+ DL+P NILL ISD
Sbjct: 96 NPGF---------DEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDL 146
Query: 517 GLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKW 576
GL A + PE + GT Y APE K T
Sbjct: 147 GL------AVQIPEGETVRGRVGT------------------VGYMAPEVINNEKYTFSP 182
Query: 577 DIYSYGVILLEMISGKLP 594
D + G ++ EMI G+ P
Sbjct: 183 DWWGLGCLIYEMIQGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 44.7 bits (105), Expect = 1e-04
Identities = 35/120 (29%), Positives = 54/120 (45%), Gaps = 30/120 (25%)
Query: 474 IIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHW 533
+I + +G+ ++H +H DL+PSN+ + ++ E I DFGLAR AD
Sbjct: 123 LIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQAD---------- 169
Query: 534 EQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEAS-KVRKPTQKWDIYSYGVILLEMISGK 592
E T +T +Y+APE Q DI+S G I+ E++ GK
Sbjct: 170 -------------DEMTGYVAT---RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 1e-04
Identities = 50/212 (23%), Positives = 80/212 (37%), Gaps = 39/212 (18%)
Query: 425 IVSLRAYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAF 484
+V L F D + DYIP G + + + + GI D R +A+
Sbjct: 63 VVRLYYSFQDKDNLYFVMDYIPGGDMMSLLI-RMGIFP------EDLARFY--IAELTCA 113
Query: 485 LHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETP--------------- 529
+ V ++H D++P NIL+ ++ ++DFGL ++
Sbjct: 114 VESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDF 173
Query: 530 EVHWEQSTT---GTPLQSSPYEFTA--------LNSTTSRSYYQAPEASKVRKPTQKWDI 578
W G L+ P E A +S Y APE TQ D
Sbjct: 174 SNEWGDPANCRCGDRLK--PLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDW 231
Query: 579 YSYGVILLEMISGKLPMIQIGSME--LNIVQW 608
+S GVIL EM+ G+ P + +E + ++ W
Sbjct: 232 WSVGVILYEMLVGQPPFLAQTPLETQMKVINW 263
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 1e-04
Identities = 61/247 (24%), Positives = 96/247 (38%), Gaps = 57/247 (23%)
Query: 375 LGKSTIGIVYKVALN--NEEAVAVRRLGNGGWQRFKEFQTEAEAIGKI-----RHPNIVS 427
+GK T G V+KV LN N AV+ L + E EA I HPN+V
Sbjct: 26 IGKGTYGKVFKV-LNKKNGSKAAVKIL-----DPIHDIDEEIEAEYNILKALSDHPNVVK 79
Query: 428 LRAYFWSVDEK-----LLIYDYIPNGSLATAIHG--KAG------IISYRPLSWSDRLRI 474
++ D K L+ + GS+ + G K G II+Y I
Sbjct: 80 FYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAY----------I 129
Query: 475 IKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWE 534
+ G+ LH + +H D++ +NILL + DFG++ A+ T
Sbjct: 130 LHEALMGLQHLHV---NKTIHRDVKGNNILLTTEGGVKLVDFGVS-----AQLTSTRLRR 181
Query: 535 QSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLP 594
++ GTP +P E A +Y + D++S G+ +E+ G P
Sbjct: 182 NTSVGTPFWMAP-EVIACEQQLDSTY------------DARCDVWSLGITAIELGDGDPP 228
Query: 595 MIQIGSM 601
+ + M
Sbjct: 229 LADLHPM 235
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 2e-04
Identities = 52/174 (29%), Positives = 82/174 (47%), Gaps = 16/174 (9%)
Query: 62 LIIPNKKLTGFIPADLGSLSAIGRVNL-RNNNFSGSLPVELFNASNLQSLILSGNSFSGP 120
L + + L +P+ L L ++ ++ ++ GS L N L SL L+ N
Sbjct: 52 LNLSSNTLL-LLPSSLSRLLSLDLLSPSGISSLDGSE--NLLNLLPLPSLDLNLNRLRSN 108
Query: 121 VPMQIGKLKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSF-TGPLPDGFATNLTA 179
+ ++ +L L LDL N+ + P + LK + L+ N + P P NL
Sbjct: 109 IS-ELLELTNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSDNKIESLPSPLR---NLPN 164
Query: 180 LQKLDLSFNNLSGLIPNDIANLSRLRLLAQRVYVDLTYNNLSGLIPQNAALLSL 233
L+ LDLSFN+LS +P ++NLS L L DL+ N +S L P+ L +L
Sbjct: 165 LKNLDLSFNDLSD-LPKLLSNLSNLNNL------DLSGNKISDLPPEIELLSAL 211
|
Length = 394 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 2e-04
Identities = 45/206 (21%), Positives = 75/206 (36%), Gaps = 30/206 (14%)
Query: 422 HPNIVSLRAYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKG 481
+P +V L F + LI +Y+P G + T + + + + I
Sbjct: 60 NPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLL------MKKDTFTEEETRFYIAETILA 113
Query: 482 IAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTP 541
I +H++ Y+H D++P N+LL +SDFGL + T + + P
Sbjct: 114 IDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTE--FYRILSHALP 168
Query: 542 LQSSPYEFTALN-----------------STTSRSYYQAPEASKVRKPTQKWDIYSYGVI 584
+ ++ ST Y APE ++ D +S GVI
Sbjct: 169 SNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVI 228
Query: 585 LLEMISGKLPMIQIGSME--LNIVQW 608
+ EM+ G P E I+ W
Sbjct: 229 MYEMLVGYPPFCSDNPQETYRKIINW 254
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 2e-04
Identities = 41/176 (23%), Positives = 71/176 (40%), Gaps = 40/176 (22%)
Query: 423 PNIVSLRAYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGI 482
P + L + F ++D + +Y+ G L I + ++ + I G+
Sbjct: 61 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAI------GL 114
Query: 483 AFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTT---- 538
FLH K ++ DL+ N++L I+DFG+ + E W+ TT
Sbjct: 115 FFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCK---------ENMWDGVTTKTFC 162
Query: 539 GTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLP 594
GTP Y APE + + D +++GV+L EM++G+ P
Sbjct: 163 GTP------------------DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP 200
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 2e-04
Identities = 54/211 (25%), Positives = 82/211 (38%), Gaps = 45/211 (21%)
Query: 413 EAEAIGKIRHPNIVSLRA-------YFWSVDEKL---LIYDYIPNGSLATAIHGKAGIIS 462
E E +G IR + + A F+S +KL LI +++P G + T + K
Sbjct: 41 EKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKK----- 95
Query: 463 YRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLA 522
L+ + I I +H++ ++H D++P N+LL +SDFGL
Sbjct: 96 -DTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGL 151
Query: 523 DIAEETPEVHWEQSTTGTPLQSSPYEFTALN-------------------STTSRSYYQA 563
A T E + + S P +FT N ST Y A
Sbjct: 152 KKAHRT-EFYRNLN------HSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIA 204
Query: 564 PEASKVRKPTQKWDIYSYGVILLEMISGKLP 594
PE + D +S GVI+ EM+ G P
Sbjct: 205 PEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 2e-04
Identities = 32/120 (26%), Positives = 54/120 (45%), Gaps = 30/120 (25%)
Query: 474 IIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHW 533
+I + +G+ ++H +H DL+PSN+ + ++ E I DFGLAR H
Sbjct: 125 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----------HT 170
Query: 534 EQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEAS-KVRKPTQKWDIYSYGVILLEMISGK 592
+ TG + +Y+APE Q DI+S G I+ E+++G+
Sbjct: 171 DDEMTG---------------YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 2e-04
Identities = 64/281 (22%), Positives = 104/281 (37%), Gaps = 75/281 (26%)
Query: 412 TEAEAIGKIRH-PNIVSLRAYFWSVDEKL-LIYDYIPNGSLATAIHGKAGIISYRPLSWS 469
TE + + +R P +V+L Y + D KL LI DY+ G L T H + R
Sbjct: 53 TERQVLEAVRRCPFLVTLH-YAFQTDTKLHLILDYVNGGELFT--H-----LYQREHFTE 104
Query: 470 DRLRIIKG-VAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEET 528
+R+ + + LH++ ++ D++ NILL ++DFGL++
Sbjct: 105 SEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSK-------- 153
Query: 529 PEVHWEQSTTGTPLQSSPYEFTALNSTTSRSY-----YQAPEASKVRKPTQKW----DIY 579
EF A + S+ Y APE +R + D +
Sbjct: 154 -------------------EFLAEEEERAYSFCGTIEYMAPEV--IRGGSGGHDKAVDWW 192
Query: 580 SYGVILLEMISGKLPMIQIGSMELNIVQWI-QLILEDRKPMTDILDPFLAHDLDKEDEIV 638
S GV+ E+++G P G E N I + IL+ + P + E
Sbjct: 193 SLGVLTFELLTGASPFTVDG--EQNSQSEISRRILKSKPPF--------PKTMSAE---- 238
Query: 639 SVLKIALDCVHKSPDKRPSMRHVCDSLDRVNISTEQQFMKG 679
A D + K +K P R + D + F +G
Sbjct: 239 -----ARDFIQKLLEKDPKKRLGANGADEIK---NHPFFQG 271
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 2e-04
Identities = 33/118 (27%), Positives = 54/118 (45%), Gaps = 25/118 (21%)
Query: 474 IIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHW 533
++ V+ G+ +L E +VH DL N+LL ISDFGL++ A E ++
Sbjct: 100 LVHQVSMGMKYLEE---TNFVHRDLAARNVLLVTQHYAKISDFGLSK----ALGADENYY 152
Query: 534 EQSTTGT-PLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS 590
+ T G P++ + APE K + K D++S+GV++ E S
Sbjct: 153 KAKTHGKWPVK-----------------WYAPECMNYYKFSSKSDVWSFGVLMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 2e-04
Identities = 38/172 (22%), Positives = 71/172 (41%), Gaps = 32/172 (18%)
Query: 423 PNIVSLRAYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGI 482
P + L + F +VD + +Y+ G L I + + ++ + + G+
Sbjct: 61 PFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISV------GL 114
Query: 483 AFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPL 542
FLH + ++ DL+ N++L I+DFG+ + E + ++ GTP
Sbjct: 115 FFLHR---RGIIYRDLKLDNVMLDSEGHIKIADFGMCK-----EHMVDGVTTRTFCGTP- 165
Query: 543 QSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLP 594
Y APE + + D ++YGV+L EM++G+ P
Sbjct: 166 -----------------DYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPP 200
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 3e-04
Identities = 60/263 (22%), Positives = 103/263 (39%), Gaps = 51/263 (19%)
Query: 358 SQVDFDLEQLLKASAF-----LLGKSTIGIVYKVALNNEEAVAVRRLGNGGWQRFKEFQT 412
S D DL L + ++G T G VYK +A ++ + +E +
Sbjct: 2 SLDDIDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKL 61
Query: 413 EAEAIGKI-RHPNIVSLRAYFWSV------DEKLLIYDYIPNGSLATAIHGKAG------ 459
E + K H NI + F D+ L+ ++ GS+ + G
Sbjct: 62 EINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKED 121
Query: 460 IISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLA 519
I+Y I + + +G+A LH + +H D++ N+LL +N E + DFG++
Sbjct: 122 WIAY----------ICREILRGLAHLH---AHKVIHRDIKGQNVLLTENAEVKLVDFGVS 168
Query: 520 RLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSY-YQAPEASKVRKPTQKWDI 578
A+ V + GTP +P E A + +Y Y++ DI
Sbjct: 169 -----AQLDRTVGRRNTFIGTPYWMAP-EVIACDENPDATYDYRS-------------DI 209
Query: 579 YSYGVILLEMISGKLPMIQIGSM 601
+S G+ +EM G P+ + M
Sbjct: 210 WSLGITAIEMAEGAPPLCDMHPM 232
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|234331 TIGR03724, arch_bud32, Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Score = 42.2 bits (100), Expect = 3e-04
Identities = 23/97 (23%), Positives = 42/97 (43%), Gaps = 17/97 (17%)
Query: 431 YFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSP 490
Y D K ++ +YI L I +++ + + + LH+
Sbjct: 65 YDVDPDNKTIVMEYIEGKPLKDVIE-------------EGNDELLREIGRLVGKLHKA-- 109
Query: 491 KRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEE 527
VHGDL SNI++ + + ++ DFGL + +D E+
Sbjct: 110 -GIVHGDLTTSNIIVRDD-KLYLIDFGLGKYSDEIED 144
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine [Unknown function, General]. Length = 199 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 3e-04
Identities = 42/175 (24%), Positives = 69/175 (39%), Gaps = 32/175 (18%)
Query: 420 IRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVA 479
++HP +V L F + ++ + D++ G L + + R + +A
Sbjct: 53 VKHPFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFY------AAEIA 106
Query: 480 KGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTG 539
+ +LH + V+ DL+P NILL ++DFGL + IA QS T
Sbjct: 107 SALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCK-EGIA---------QSDTT 153
Query: 540 TPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLP 594
T +P Y APE + + D + G +L EM+ G P
Sbjct: 154 TTFCGTP-------------EYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 3e-04
Identities = 33/115 (28%), Positives = 50/115 (43%), Gaps = 28/115 (24%)
Query: 481 GIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLA-RLADIAEETPEVHWEQSTTG 539
G+ LH+ +R ++ DL+P N+LL + ISD GLA L D +T + G
Sbjct: 109 GLEHLHQ---RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKT------KGYAG 159
Query: 540 TPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLP 594
TP + APE + + D ++ GV L EMI+ + P
Sbjct: 160 TP------------------GFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGP 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 38.3 bits (90), Expect = 4e-04
Identities = 27/85 (31%), Positives = 38/85 (44%), Gaps = 25/85 (29%)
Query: 106 NLQSLILSGNSFSGPVPMQIGKLKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSF 165
NL+SL LS N + L L+VLDLS N+ +S ++ +F
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTS----------------ISPEAF 44
Query: 166 TGPLPDGFATNLTALQKLDLSFNNL 190
+G L +L+ LDLS NNL
Sbjct: 45 SG---------LPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 4e-04
Identities = 28/116 (24%), Positives = 57/116 (49%), Gaps = 9/116 (7%)
Query: 413 EAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRL 472
E + ++H NIV+L + L+++Y+ + L + I+S +
Sbjct: 54 EVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYL-DKDLKQYMDDCGNIMSMHNVKI---- 108
Query: 473 RIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEET 528
+ + +G+A+ H ++ +H DL+P N+L+ + E ++DFGLAR + +T
Sbjct: 109 -FLYQILRGLAYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKT 160
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 4e-04
Identities = 41/146 (28%), Positives = 67/146 (45%), Gaps = 31/146 (21%)
Query: 457 KAGIISYRP-LSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISD 515
+ +I+ P LS+ D + VA G+ FL + K VH DL N+L+ + I D
Sbjct: 226 RDTLINESPALSYMDLVGFSYQVANGMEFL---ASKNCVHRDLAARNVLICEGKLVKICD 282
Query: 516 FGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQK 575
FGLAR DI ++ + + +T PL+ + APE+ T
Sbjct: 283 FGLAR--DIMRDSNYI--SKGSTFLPLK-----------------WMAPESIFNNLYTTL 321
Query: 576 WDIYSYGVILLEMIS------GKLPM 595
D++S+G++L E+ + +LPM
Sbjct: 322 SDVWSFGILLWEIFTLGGTPYPELPM 347
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 4e-04
Identities = 32/120 (26%), Positives = 47/120 (39%), Gaps = 29/120 (24%)
Query: 474 IIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHW 533
+++ +G+ FLH VH DL+P NIL+ + ++DFGLAR+
Sbjct: 113 LMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGQVKLADFGLARI------------ 157
Query: 534 EQSTTGTPLQSSPYEF-TALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGK 592
Y AL +Y+APE D++S G I EM K
Sbjct: 158 -------------YSCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 4e-04
Identities = 49/230 (21%), Positives = 93/230 (40%), Gaps = 45/230 (19%)
Query: 422 HPNIVSLRAYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKG 481
+P + L F + + + +++ G L I K YR ++ + G
Sbjct: 55 NPFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAE------IVCG 108
Query: 482 IAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTT--G 539
+ FLH K ++ DL+ N++L ++ I+DFG+ + + +++T G
Sbjct: 109 LQFLHS---KGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDN-------RASTFCG 158
Query: 540 TPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQ-- 597
TP Y APE + K T D +S+GV+L EM+ G+ P
Sbjct: 159 TP------------------DYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDD 200
Query: 598 ----IGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKI 643
S+ ++ + + I ++ K DIL+ D + +V ++
Sbjct: 201 EDELFESIRVDTPHYPRWITKESK---DILEKLFERDPTRRLGVVGNIRG 247
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 42.7 bits (101), Expect = 4e-04
Identities = 37/180 (20%), Positives = 82/180 (45%), Gaps = 50/180 (27%)
Query: 375 LGKSTIGIVYKVA-LNNEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIR---------HPN 424
+G+ T G V+K ++ VA++++ E + E I +R H N
Sbjct: 20 IGQGTFGEVFKARHKKTKQIVALKKV-------LMENEKEGFPITALREIKILQLLKHEN 72
Query: 425 IVSL--------------RAYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPL--SW 468
+V+L + F+ L++++ H AG++S + + +
Sbjct: 73 VVNLIEICRTKATPYNRYKGSFY------LVFEFCE--------HDLAGLLSNKNVKFTL 118
Query: 469 SDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEET 528
S+ +++K + G+ ++H + +H D++ +NIL+ K+ ++DFGLAR +++ +
Sbjct: 119 SEIKKVMKMLLNGLYYIHR---NKILHRDMKAANILITKDGILKLADFGLARAFSLSKNS 175
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 4e-04
Identities = 66/308 (21%), Positives = 118/308 (38%), Gaps = 68/308 (22%)
Query: 374 LLGKSTIGIVYK---VALNNEE-AVAVRRLGNGGWQRFKE-FQTEAEAIGKIRHPNIVSL 428
+G+ G VY+ ++ NE+ AVAV+ N +E F EA + + HP+IV L
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72
Query: 429 RAYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEV 488
+ + ++ + P G L + + + L + ++ +A+L
Sbjct: 73 IGVI-TENPVWIVMELAPLGELRSYLQVNKYSLDLASL-----ILYSYQLSTALAYLES- 125
Query: 489 SPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYE 548
KR+VH D+ N+L+ + DFGL+R + E +++ S P++
Sbjct: 126 --KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLE-----DESYYKASKGKLPIK----- 173
Query: 549 FTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQIGSMELNIVQ 607
+ APE+ R+ T D++ +GV + E++ G P Q
Sbjct: 174 ------------WMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPF-----------Q 210
Query: 608 WIQ-----LILE--DRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRH 660
++ +E +R PM P L + K C P KRP
Sbjct: 211 GVKNNDVIGRIENGERLPMPPNCPPTLYSLMTK-------------CWAYDPSKRPRFTE 257
Query: 661 VCDSLDRV 668
+ L +
Sbjct: 258 LKAQLSDI 265
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 4e-04
Identities = 64/232 (27%), Positives = 93/232 (40%), Gaps = 48/232 (20%)
Query: 375 LGKSTIGIVYKVALNNEEAV-AVRRLGNGGWQRFKEFQTEAEAIGK---------IRHPN 424
+GK T G VY+V + + A++ L KE A IG+ P
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEV---AHTIGERNILVRTLLDESPF 57
Query: 425 IVSLRAYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRI-IKGVAKGIA 483
IV L+ F + + L+ DY+ G L + K G S DR + I + +
Sbjct: 58 IVGLKFSFQTDSDLYLVTDYMSGGELFWHLQ-KEGRFS------EDRAKFYIAELVLALE 110
Query: 484 FLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQ 543
LH+ V+ DL+P NILL + DFGL++ A++ + TT T
Sbjct: 111 HLHK---YDIVYRDLKPENILLDATGHIALCDFGLSK-ANLTDN--------KTTNT--- 155
Query: 544 SSPYEFTALNSTTSRSYYQAPEASKVRKP-TQKWDIYSYGVILLEMISGKLP 594
TT Y APE K T+ D +S GV++ EM G P
Sbjct: 156 --------FCGTTE---YLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSP 196
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 4e-04
Identities = 52/209 (24%), Positives = 80/209 (38%), Gaps = 41/209 (19%)
Query: 413 EAEAIGKIRHPNIVSLRA-------YFWSVDEK---LLIYDYIPNGSLATAIHGKAGIIS 462
E E + IR + + A F+S +K LI +++P G + T + K
Sbjct: 41 EKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKK----- 95
Query: 463 YRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLA 522
LS I I +H++ ++H D++P N+LL +SDFGL
Sbjct: 96 -DTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGL 151
Query: 523 DIAEETPEVHWEQSTTGTPLQSSPYEFTALN-----------------STTSRSYYQAPE 565
A T + ++ T P S + F +N ST Y APE
Sbjct: 152 KKAHRT---EFYRNLTHNP--PSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPE 206
Query: 566 ASKVRKPTQKWDIYSYGVILLEMISGKLP 594
+ D +S GVI+ EM+ G P
Sbjct: 207 VFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.8 bits (99), Expect = 4e-04
Identities = 28/130 (21%), Positives = 52/130 (40%), Gaps = 28/130 (21%)
Query: 406 RFKEFQTEAEAIGKIRHPNIVSLRA--------YFWSVDEKLLIYDYIPNGSLATAIHGK 457
R + +T EA +I + R YF + +++ +YI L I+
Sbjct: 40 RIRRERTRREA--RI----MSRARKAGVNVPAVYFVDPENFIIVMEYIEGEPLKDLINSN 93
Query: 458 AGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFG 517
+ L + + + + + LH +HGDL SN++L + ++ DFG
Sbjct: 94 G----------MEELELSREIGRLVGKLHSA---GIIHGDLTTSNMILSGG-KIYLIDFG 139
Query: 518 LARLADIAEE 527
LA + E+
Sbjct: 140 LAEFSKDLED 149
|
Length = 211 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 42.4 bits (99), Expect = 6e-04
Identities = 29/118 (24%), Positives = 60/118 (50%), Gaps = 13/118 (11%)
Query: 413 EAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRL 472
EA + ++H NIV L + + L+++Y+ + L + G + + +
Sbjct: 53 EASLLKGLKHANIVLLHDIIHTKETLTLVFEYV-HTDLCQYMDKHPGGLH------PENV 105
Query: 473 RI-IKGVAKGIAFLHEVSPKRYV-HGDLRPSNILLGKNMEPHISDFGLARLADIAEET 528
++ + + +G++++H+ RY+ H DL+P N+L+ E ++DFGLAR + T
Sbjct: 106 KLFLFQLLRGLSYIHQ----RYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHT 159
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 6e-04
Identities = 49/212 (23%), Positives = 87/212 (41%), Gaps = 39/212 (18%)
Query: 425 IVSLRAYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLR--IIKGVAKGI 482
+V L F D + DYIP G + + + R + + L I + I
Sbjct: 63 VVKLYYSFQDKDNLYFVMDYIPGGDMMSLL--------IRMEVFPEVLARFYIAELTLAI 114
Query: 483 AFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLA-------------RLADIAEET- 528
+H++ ++H D++P NIL+ + ++DFGL + + I +++
Sbjct: 115 ESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSM 171
Query: 529 -PEVHWEQSTT---GTPLQS------SPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDI 578
P W+ + G L++ ++ +S Y APE + TQ D
Sbjct: 172 EPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDW 231
Query: 579 YSYGVILLEMISGKLPMIQIGSME--LNIVQW 608
+S GVIL EM+ G+ P + E L ++ W
Sbjct: 232 WSVGVILFEMLVGQPPFLAPTPTETQLKVINW 263
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 7e-04
Identities = 30/120 (25%), Positives = 56/120 (46%), Gaps = 34/120 (28%)
Query: 480 KGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTG 539
+G+++ H+ ++ +H DL+P N+L+ + E ++DFGLAR +
Sbjct: 114 RGLSYCHK---RKILHRDLKPQNLLINEKGELKLADFGLARAKSV--------------- 155
Query: 540 TPLQSSPYEFTALNSTTSRSYYQAPE----ASKVRKPTQKWDIYSYGVILLEMISGKLPM 595
P ++ E L +Y+ P+ +++ P W + G IL EM +G+ PM
Sbjct: 156 -PTKTYSNEVVTL-------WYRPPDVLLGSTEYSTPIDMWGV---GCILYEMATGR-PM 203
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 41.6 bits (98), Expect = 8e-04
Identities = 61/311 (19%), Positives = 128/311 (41%), Gaps = 52/311 (16%)
Query: 362 FDLEQLLKASAFLLGKSTIGIVYKVALNNEEAVAVRRLGNGGWQ-RFKEFQTEAEAIGKI 420
L LL+ F G+ GI+ EE V V+ + + + + E+ + +
Sbjct: 8 VTLSDLLQEGTF--GRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGL 65
Query: 421 RHPNIVS-LRAYFWSVDEKLLIYDYIPNGSLATAIHG--KAGIISYRPLSWSDRLRIIKG 477
H NI+ L + ++Y Y+ G+L + + + LS + +
Sbjct: 66 SHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQ 125
Query: 478 VAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQST 537
+A G+++LH+ + +H D+ N ++ + ++ I+D L+R D+
Sbjct: 126 IACGMSYLHK---RGVIHKDIAARNCVIDEELQVKITDNALSR--DLF------------ 168
Query: 538 TGTPLQSSPYEFTALNSTTSRSY-YQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPM 595
P ++ L +R + A E+ ++ + D++S+GV+L E+++ G+ P
Sbjct: 169 --------PMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPY 220
Query: 596 IQIGSMELNIVQWIQLILEDRKPMTDILDPF-LAHDLDKEDEIVSVLKIALDCVHKSPDK 654
++I E+ + D + LA ++ DE+ +V+ C P++
Sbjct: 221 VEIDPFEM---------------AAYLKDGYRLAQPINCPDELFAVM---ACCWALDPEE 262
Query: 655 RPSMRHVCDSL 665
RPS + L
Sbjct: 263 RPSFSQLVQCL 273
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 9e-04
Identities = 35/149 (23%), Positives = 62/149 (41%), Gaps = 9/149 (6%)
Query: 375 LGKSTIGIVYKVALNNEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWS 434
GK +G V + V + Q +F EA+ ++H N++
Sbjct: 8 FGKVILGEVNS-GYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTE 66
Query: 435 VDEKLLIYDYIPNGSLATAIHG--KAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKR 492
V LL+ ++ P G L + KA +++ P + R+ +A G+ LH+
Sbjct: 67 VTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQ---RMACEIALGLLHLHK---NN 120
Query: 493 YVHGDLRPSNILLGKNMEPHISDFGLARL 521
++H DL N LL ++ I D+GL+
Sbjct: 121 FIHSDLALRNCLLTADLTVKIGDYGLSHN 149
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 9e-04
Identities = 33/117 (28%), Positives = 48/117 (41%), Gaps = 34/117 (29%)
Query: 480 KGIAFLHEVSPKRYVHGDLRPSNILLGKNMEP-HISDFGLARLADIAEETPEVHWEQSTT 538
KG+A H+ +H DL+P N+L+ K I+D GL R I
Sbjct: 121 KGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSI-------------- 163
Query: 539 GTPLQSSPYEFTALNSTTSRSYYQAPE----ASKVRKPTQKWDIYSYGVILLEMISG 591
P++S +E L +Y+APE ++ P DI+S G I EM
Sbjct: 164 --PVKSYTHEIVTL-------WYRAPEVLLGSTHYSTPV---DIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 9e-04
Identities = 35/123 (28%), Positives = 51/123 (41%), Gaps = 26/123 (21%)
Query: 481 GIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGT 540
G+ FLH K V+ DL+ NILL + I+DFG+ + + + + GT
Sbjct: 108 GLQFLHS---KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK-----TCTFCGT 159
Query: 541 PLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGS 600
P Y APE +K D +S+GV+L EM+ G+ P
Sbjct: 160 P------------------DYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDE 201
Query: 601 MEL 603
EL
Sbjct: 202 EEL 204
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 0.001
Identities = 28/116 (24%), Positives = 58/116 (50%), Gaps = 9/116 (7%)
Query: 413 EAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRL 472
E + ++H NIV+L + L+++Y+ + L + I+ + +L
Sbjct: 54 EVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMHNV----KL 108
Query: 473 RIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEET 528
+ + + +G+ + H ++ +H DL+P N+L+ + E ++DFGLAR I +T
Sbjct: 109 FLFQ-LLRGLNYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT 160
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.001
Identities = 36/113 (31%), Positives = 53/113 (46%), Gaps = 24/113 (21%)
Query: 478 VAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQST 537
VAKG++FL + K +H DL NILL I DFGLAR DI ++ V +
Sbjct: 223 VAKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLAR--DIRNDSNYV--VKGN 275
Query: 538 TGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS 590
P++ + APE+ T + D++SYG++L E+ S
Sbjct: 276 ARLPVK-----------------WMAPESIFNCVYTFESDVWSYGILLWEIFS 311
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 40.8 bits (96), Expect = 0.002
Identities = 30/106 (28%), Positives = 46/106 (43%), Gaps = 30/106 (28%)
Query: 494 VHGDLRPSNILLGKNMEPHISDFGLA-RLADIAEETPEVHWEQSTTGTPLQSSPYEFTAL 552
+H D++PSNILL + + DFG++ RL D +T + G
Sbjct: 137 IHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKT-------RSAGCAA---------- 179
Query: 553 NSTTSRSYYQAPEASKVRKPTQKWDI----YSYGVILLEMISGKLP 594
Y APE P K+DI +S G+ L+E+ +G+ P
Sbjct: 180 --------YMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFP 217
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 0.002
Identities = 54/228 (23%), Positives = 101/228 (44%), Gaps = 37/228 (16%)
Query: 375 LGKSTIGIVYK------VALNNEEAVAVRRLGNGGWQRFK-EFQTEAEAIGKIRHPNIVS 427
LG+ + G+VY+ + E VAV+ + R + EF EA + ++V
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73
Query: 428 LRAYFWSVDEKLLIYDYIPNGSLAT---AIHGKAGIISYRPL-SWSDRLRIIKGVAKGIA 483
L L++ + + +G L + ++ +A RP + + +++ +A G+A
Sbjct: 74 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 133
Query: 484 FLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTG-TPL 542
+L + K++VH DL N ++ + I DFG+ R DI E ++ + G P+
Sbjct: 134 YL---NAKKFVHRDLAARNCMVAHDFTVKIGDFGMTR--DIYETD---YYRKGGKGLLPV 185
Query: 543 QSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS 590
+ + APE+ K T D++S+GV+L E+ S
Sbjct: 186 R-----------------WMAPESLKDGVFTTSSDMWSFGVVLWEITS 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 0.002
Identities = 43/182 (23%), Positives = 72/182 (39%), Gaps = 32/182 (17%)
Query: 413 EAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRL 472
E + ++ P IV L+ F S ++ L+ +I G L + + R ++ L
Sbjct: 43 ERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAEL 102
Query: 473 RIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVH 532
+ LH+ + ++ DL+P NILL + DFGL +L ++
Sbjct: 103 LC------ALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTN-- 151
Query: 533 WEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGK 592
+ GTP Y APE T+ D ++ GV+L EM++G
Sbjct: 152 ---TFCGTP------------------EYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGL 190
Query: 593 LP 594
P
Sbjct: 191 PP 192
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 0.002
Identities = 54/232 (23%), Positives = 97/232 (41%), Gaps = 59/232 (25%)
Query: 375 LGKSTIGIVYK-VALNNEEAVAVRRLGNGGWQRFKEFQTEAE------AIGK------IR 421
LG+ + VYK + + VA+ KE + E E AI + ++
Sbjct: 13 LGEGSYATVYKGRSKLTGQLVAL-----------KEIRLEHEEGAPFTAIREASLLKDLK 61
Query: 422 HPNIVSLRAYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKG 481
H NIV+L + L+++Y+ + L + G +S + RL + + + +G
Sbjct: 62 HANIVTLHDIIHTKKTLTLVFEYL-DTDLKQYMDDCGGGLSMHNV----RLFLFQ-LLRG 115
Query: 482 IAFLHEVSPKRYV-HGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGT 540
+A+ H +R V H DL+P N+L+ + E ++DFGLAR +
Sbjct: 116 LAYCH----QRRVLHRDLKPQNLLISERGELKLADFGLARAKSV---------------- 155
Query: 541 PLQSSPYEFTALNSTTSRSYYQAPEA-SKVRKPTQKWDIYSYGVILLEMISG 591
P ++ E L +Y+ P+ + + D++ G I EM +G
Sbjct: 156 PSKTYSNEVVTL-------WYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATG 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 40.0 bits (94), Expect = 0.002
Identities = 40/166 (24%), Positives = 70/166 (42%), Gaps = 44/166 (26%)
Query: 375 LGKSTIGIVYKVALNNEEA---VAVRRLGNGGWQRFKEFQTEAE---AIGKI-------- 420
+G+ + G+V+K N E VA+++ E+E I KI
Sbjct: 9 IGEGSYGVVFKC--RNRETGQIVAIKKF------------VESEDDPVIKKIALREIRML 54
Query: 421 ---RHPNIVSLRAYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRL--RII 475
+HPN+V+L F + L+++Y + L + P + L +II
Sbjct: 55 KQLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNE--------LEKNPRGVPEHLIKKII 106
Query: 476 KGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARL 521
+ + F H+ +H D++P NIL+ K + + DFG AR+
Sbjct: 107 WQTLQAVNFCHK---HNCIHRDVKPENILITKQGQIKLCDFGFARI 149
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 0.002
Identities = 32/121 (26%), Positives = 52/121 (42%), Gaps = 34/121 (28%)
Query: 478 VAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQST 537
+A G+ FLH K ++ DL+ N++L I+DFG+ + E + T
Sbjct: 110 IAIGLFFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCK---------ENIFGGKT 157
Query: 538 T----GTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKL 593
T GTP Y APE + + D +++GV+L EM++G+
Sbjct: 158 TRTFCGTP------------------DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQP 199
Query: 594 P 594
P
Sbjct: 200 P 200
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 0.003
Identities = 36/119 (30%), Positives = 52/119 (43%), Gaps = 21/119 (17%)
Query: 478 VAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFG--LARLADIAEETPEVHWEQ 535
+A+ + + V YVH D++P N+LL KN ++DFG L LAD ++
Sbjct: 108 LAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQS------N 161
Query: 536 STTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLP 594
GTP SP A+ R PE D +S GV + EM+ G+ P
Sbjct: 162 VAVGTPDYISPEILQAMEDGKGR---YGPEC----------DWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.003
Identities = 39/170 (22%), Positives = 64/170 (37%), Gaps = 35/170 (20%)
Query: 423 PNIVSLRAYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGI 482
PN+V L Y S D L+ + G L + I I W+ + + +
Sbjct: 45 PNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVV------AL 98
Query: 483 AFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPL 542
LH + V DL P+NILL + HI +R +++ +
Sbjct: 99 DALHR---EGIVCRDLNPNNILL--DDRGHIQLTYFSRWSEVEDSC-------------- 139
Query: 543 QSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGK 592
+ + Y APE + + T+ D +S G IL E+++GK
Sbjct: 140 ----------DGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGK 179
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.003
Identities = 46/184 (25%), Positives = 71/184 (38%), Gaps = 35/184 (19%)
Query: 413 EAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLATAIH--GKAGIISYRPLSWSD 470
E + + K+ +V+L + + D L+ + G L I+ G G R L ++
Sbjct: 50 EKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAA 109
Query: 471 RLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPE 530
+ G+ LH + V+ DL+P NILL ISD GLA + PE
Sbjct: 110 E------ILCGLEDLHR---ENTVYRDLKPENILLDDYGHIRISDLGLAV------KIPE 154
Query: 531 VHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS 590
+ GT Y APE ++ T D + G ++ EMI
Sbjct: 155 GESIRGRVGT------------------VGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIE 196
Query: 591 GKLP 594
G+ P
Sbjct: 197 GQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.004
Identities = 55/243 (22%), Positives = 104/243 (42%), Gaps = 36/243 (14%)
Query: 374 LLGKSTIGIVYKVA-LNNEEAVAVRRLGNG-GWQRFKEFQ-TEAEAIGKIRHPNIVSLRA 430
++G+ G+V K +E VA+++ + + KE E + + ++ NIV L+
Sbjct: 8 VVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKE 67
Query: 431 YFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSP 490
F + L+++Y+ L G+ + S+ I + K I + H+
Sbjct: 68 AFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSY------IYQLIKAIHWCHK--- 118
Query: 491 KRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFT 550
VH D++P N+L+ N + DFG AR +++E + + E T
Sbjct: 119 NDIVHRDIKPENLLISHNDVLKLCDFGFAR--NLSEGSNANYTEYVAT------------ 164
Query: 551 ALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQWIQ 610
+Y++PE + D++S G IL E+ G+ P+ G E++ + IQ
Sbjct: 165 --------RWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQ-PLFP-GESEIDQLFTIQ 214
Query: 611 LIL 613
+L
Sbjct: 215 KVL 217
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.004
Identities = 51/218 (23%), Positives = 88/218 (40%), Gaps = 41/218 (18%)
Query: 423 PNIVSLRAYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGI 482
P IV + F + D+ I D + G L + + G+ S + + + I+ G+
Sbjct: 57 PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHL-SQHGVFSEKEMRFYATEIIL-----GL 110
Query: 483 AFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPL 542
+H + V+ DL+P+NILL ++ ISD GLA D +++ P H T G
Sbjct: 111 EHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLA--CDFSKKKP--HASVGTHG--- 160
Query: 543 QSSPYEFTALNSTTSRSYYQAPEA-SKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSM 601
Y APE K D +S G +L +++ G P Q +
Sbjct: 161 ------------------YMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK 202
Query: 602 ELNIVQWIQLILEDRKP------MTDILDPFLAHDLDK 633
+ + + + L + P + +L+ L D+ K
Sbjct: 203 DKHEIDRMTLTVNVELPDSFSPELKSLLEGLLQRDVSK 240
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 686 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.98 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.98 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.97 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.97 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.97 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.97 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.96 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.95 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.95 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.95 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.95 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.95 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.95 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.94 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.94 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.93 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.91 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.89 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.88 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.87 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.86 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.86 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.85 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.85 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.84 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.84 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.83 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.82 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.82 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.82 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.81 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.81 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.81 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.77 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.76 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.74 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.74 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.73 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.73 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.71 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.7 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 99.7 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.7 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.69 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.66 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.65 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.65 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 99.63 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.63 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.61 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.61 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.6 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.59 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.58 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.56 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.5 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.49 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.46 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.39 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.37 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.37 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.34 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.34 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.34 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.33 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.32 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.32 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.25 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.25 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.25 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.23 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.21 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.18 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.18 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.16 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.16 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.15 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.14 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.12 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.08 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.08 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.08 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.05 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.04 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.02 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.01 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.01 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.0 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.0 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.88 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 98.86 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.81 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.77 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.76 | |
| PF08263 | 43 | LRRNT_2: Leucine rich repeat N-terminal domain; In | 98.72 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.67 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.66 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.64 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.63 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.62 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.49 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 98.48 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.47 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.44 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.44 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.32 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 98.28 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.24 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.21 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.12 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-65 Score=607.58 Aligned_cols=522 Identities=28% Similarity=0.479 Sum_probs=356.3
Q ss_pred CEEEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCccccCC-----------------------CCCcEEEccC
Q 042348 58 QVFSLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNA-----------------------SNLQSLILSG 114 (686)
Q Consensus 58 ~~~~l~l~~n~l~g~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~~l-----------------------~~L~~L~L~~ 114 (686)
.++.|+|++|+++|.+|..+..++.|+.|+|++|.++|.+|..+..+ ++|+.|+|++
T Consensus 405 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~~~~~L~~L~ls~ 484 (968)
T PLN00113 405 SLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGSKRLENLDLSR 484 (968)
T ss_pred CCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCcccccccceEEECcC
Confidence 45566666666666666666666666666666666655555544444 4555566666
Q ss_pred CCCCCCCcccccCCCCCCEEeccCCCCCCCCChhhhhccccccccccccccCCCCchhhhhcCcccceecccccccCCCC
Q 042348 115 NSFSGPVPMQIGKLKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSGLI 194 (686)
Q Consensus 115 N~l~g~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~ 194 (686)
|++++.+|..+..+++|+.|+|++|++++.+|..+..+++|++|+|++|+++|.+|..+. .+++|+.|||++|+++|.+
T Consensus 485 n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~~~ 563 (968)
T PLN00113 485 NQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFS-EMPVLSQLDLSQNQLSGEI 563 (968)
T ss_pred CccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHh-CcccCCEEECCCCcccccC
Confidence 666666666667777777777777777777777777777777777777777777776663 6777777777777777777
Q ss_pred chhhhcccccccccccccccccCCCCCCCcccccccccCCcccccCCCCCCCCCCCC---CCCCCCCCCCCCCCCCCCCC
Q 042348 195 PNDIANLSRLRLLAQRVYVDLTYNNLSGLIPQNAALLSLGPTAFIGNPFLCGPPLKV---SCPSSTSDHPYPKPLPYDPS 271 (686)
Q Consensus 195 p~~~~~l~~L~~l~~~~~l~l~~N~l~~~~p~~~~~~~~~~~~~~~n~~~c~~p~~~---~c~~~~~~~~~~~~~~~~~~ 271 (686)
|..+.++++|+. +|+++|+++|.+|...++.++....+.||+.+||.+... +|..
T Consensus 564 p~~l~~l~~L~~------l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~~~~c~~---------------- 621 (968)
T PLN00113 564 PKNLGNVESLVQ------VNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKR---------------- 621 (968)
T ss_pred ChhHhcCcccCE------EeccCCcceeeCCCcchhcccChhhhcCCccccCCccccCCCCCcc----------------
Confidence 777777666654 499999999999988888888888899999999864321 1110
Q ss_pred CCCCccccccceeeehhHHHHHHHHHHHHhhhhhhhhccCCCCCCCcCCcchhHHHhhhccceeeecCCccccccccccc
Q 042348 272 WHGGKVHHSCAVITTVAVAVLLGICITGFLFYRQYKKASGCKWGEKVGGCRLEEKLMIKKEFFCFTRNNLDTMSENMEQY 351 (686)
Q Consensus 272 ~~~~~~~~~~~~i~~v~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 351 (686)
........+++++++++++.+++++++++++++++ +.+...... ..+.+...
T Consensus 622 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~----------~~~~~~~~-------------- 673 (968)
T PLN00113 622 ---VRKTPSWWFYITCTLGAFLVLALVAFGFVFIRGRN-NLELKRVEN----------EDGTWELQ-------------- 673 (968)
T ss_pred ---ccccceeeeehhHHHHHHHHHHHHHHHHHHHHhhh-ccccccccc----------cccccccc--------------
Confidence 00011112222222222222222222222222211 110000000 00000000
Q ss_pred ccccCCCCcccCHHHHHHHh--hcccCccCceEEEEEEe-CCCceEEEEEcCCCCccchHHHHHHHHHHhccCCCCccee
Q 042348 352 EFVPLDSQVDFDLEQLLKAS--AFLLGKSTIGIVYKVAL-NNEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSL 428 (686)
Q Consensus 352 ~~~~~~~~~~~~~~~l~~~~--~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l 428 (686)
.........++++++..+. ..+||+|+||.||+|.. .++..||||++..... ....|++.+++++|||||++
T Consensus 674 -~~~~~~~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~~l~~l~HpnIv~~ 748 (968)
T PLN00113 674 -FFDSKVSKSITINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS----IPSSEIADMGKLQHPNIVKL 748 (968)
T ss_pred -ccccccchhhhHHHHHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc----ccHHHHHHHhhCCCCCcceE
Confidence 0000001223444444433 35799999999999987 4688999999865432 22456899999999999999
Q ss_pred eEEEEecCceeEEEeccCCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCC
Q 042348 429 RAYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKN 508 (686)
Q Consensus 429 ~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~ 508 (686)
+++|.+.+..++|||||++|+|.++++ .++|.++.+|+.|+|.||+|||..+.++|+||||||+||+++.+
T Consensus 749 ~~~~~~~~~~~lv~Ey~~~g~L~~~l~---------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~ 819 (968)
T PLN00113 749 IGLCRSEKGAYLIHEYIEGKNLSEVLR---------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGK 819 (968)
T ss_pred EEEEEcCCCCEEEEeCCCCCcHHHHHh---------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCC
Confidence 999999999999999999999999995 37899999999999999999996544799999999999999999
Q ss_pred CCeEEeecCcccccccccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHH
Q 042348 509 MEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEM 588 (686)
Q Consensus 509 ~~~kl~DfGla~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~el 588 (686)
+.+++. ||.+..... .....+|..|+|||++.+..++.++|||||||++|||
T Consensus 820 ~~~~~~-~~~~~~~~~---------------------------~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el 871 (968)
T PLN00113 820 DEPHLR-LSLPGLLCT---------------------------DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIEL 871 (968)
T ss_pred CceEEE-ecccccccc---------------------------CCCccccccccCcccccCCCCCcccchhhHHHHHHHH
Confidence 888875 665432210 0122457789999999999999999999999999999
Q ss_pred HhCCCCccccCccchhHHHHHHHHHhhcCCcccccCcccccCC-CcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 042348 589 ISGKLPMIQIGSMELNIVQWIQLILEDRKPMTDILDPFLAHDL-DKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDR 667 (686)
Q Consensus 589 ltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~-~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~ 667 (686)
+||+.||.........+.+|++..... ......+|+.+.... ...+++.++.+++.+||+.||++||||+||++.|++
T Consensus 872 ~tg~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~ 950 (968)
T PLN00113 872 LTGKSPADAEFGVHGSIVEWARYCYSD-CHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLES 950 (968)
T ss_pred HhCCCCCCcccCCCCcHHHHHHHhcCc-cchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHH
Confidence 999999965544455677776654433 233445666554332 234567788999999999999999999999999999
Q ss_pred ccccch
Q 042348 668 VNISTE 673 (686)
Q Consensus 668 i~~~~~ 673 (686)
+.....
T Consensus 951 ~~~~~~ 956 (968)
T PLN00113 951 ASRSSS 956 (968)
T ss_pred hhcccc
Confidence 865443
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-54 Score=446.43 Aligned_cols=286 Identities=39% Similarity=0.696 Sum_probs=244.6
Q ss_pred CCcccCHHHHHHHhh-----cccCccCceEEEEEEeCCCceEEEEEcCCCCccchHHHHHHHHHHhccCCCCcceeeEEE
Q 042348 358 SQVDFDLEQLLKASA-----FLLGKSTIGIVYKVALNNEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYF 432 (686)
Q Consensus 358 ~~~~~~~~~l~~~~~-----~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~ 432 (686)
....|++.++.+||. ++||+|+||.||+|.+.++..||||++.....+..++|.+|++++.+++|||+|+++|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 456789999999983 579999999999999999999999998775443145699999999999999999999999
Q ss_pred EecCc-eeEEEeccCCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCe
Q 042348 433 WSVDE-KLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEP 511 (686)
Q Consensus 433 ~~~~~-~~lV~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~ 511 (686)
.+.+. .+||||||++|+|.++|+..... .++|..|++||.++|+||+|||+.++.+||||||||+|||+|+++++
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~----~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~a 216 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE----PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNA 216 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCC----CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCE
Confidence 99984 99999999999999999987531 78999999999999999999999877789999999999999999999
Q ss_pred EEeecCcccccccccCCccccccccccCCCCCCCccccccccCC-CCCccccCcccccCCCCCCcchHHHHHHHHHHHHh
Q 042348 512 HISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNST-TSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS 590 (686)
Q Consensus 512 kl~DfGla~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt 590 (686)
||+|||+|+...... ...... .||.+|+|||++..+..++|+|||||||+|+||+|
T Consensus 217 KlsDFGLa~~~~~~~-----------------------~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElit 273 (361)
T KOG1187|consen 217 KLSDFGLAKLGPEGD-----------------------TSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELIT 273 (361)
T ss_pred EccCccCcccCCccc-----------------------cceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHh
Confidence 999999997543210 011111 68899999999999999999999999999999999
Q ss_pred CCCCccccC-ccchhHHHHHHHHHhhcCCcccccCccccc-CCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 042348 591 GKLPMIQIG-SMELNIVQWIQLILEDRKPMTDILDPFLAH-DLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRV 668 (686)
Q Consensus 591 G~~P~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~-~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i 668 (686)
|+.|.+... ..+..++.|+...+... .+.+++||.+.. ......++..+..++.+|++.+|.+||+|.||++.|+.+
T Consensus 274 gr~~~d~~~~~~~~~l~~w~~~~~~~~-~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~ 352 (361)
T KOG1187|consen 274 GRKAVDQSRPRGELSLVEWAKPLLEEG-KLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGI 352 (361)
T ss_pred CCcccCCCCCcccccHHHHHHHHHHCc-chhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhh
Confidence 999886543 34456899987777665 789999999873 333336888899999999999999999999999999776
Q ss_pred ccc
Q 042348 669 NIS 671 (686)
Q Consensus 669 ~~~ 671 (686)
...
T Consensus 353 ~~~ 355 (361)
T KOG1187|consen 353 LSL 355 (361)
T ss_pred ccc
Confidence 543
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-49 Score=389.59 Aligned_cols=257 Identities=26% Similarity=0.393 Sum_probs=215.8
Q ss_pred cCHHHHHHHhhcccCccCceEEEEEEeC-CCceEEEEEcCCC-CccchHHHHHHHHHHhccCCCCcceeeEEEEecCc-e
Q 042348 362 FDLEQLLKASAFLLGKSTIGIVYKVALN-NEEAVAVRRLGNG-GWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDE-K 438 (686)
Q Consensus 362 ~~~~~l~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~-~ 438 (686)
+.+.++.+ ...||+|..|+|||+.++ +++.+|+|.+... .....+++.+|++++++.+||+||++||.|..++. .
T Consensus 76 i~~~dle~--~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~i 153 (364)
T KOG0581|consen 76 ISLSDLER--LGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEI 153 (364)
T ss_pred cCHHHhhh--hhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceE
Confidence 34444433 346999999999999987 5788999999544 33446789999999999999999999999999995 9
Q ss_pred eEEEeccCCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCc
Q 042348 439 LLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGL 518 (686)
Q Consensus 439 ~lV~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGl 518 (686)
.++||||++|||++++... +.+++...-+|+.+|++||.|||+. ++||||||||+|||++..|++||+|||.
T Consensus 154 sI~mEYMDgGSLd~~~k~~------g~i~E~~L~~ia~~VL~GL~YLh~~--~~IIHRDIKPsNlLvNskGeVKicDFGV 225 (364)
T KOG0581|consen 154 SICMEYMDGGSLDDILKRV------GRIPEPVLGKIARAVLRGLSYLHEE--RKIIHRDIKPSNLLVNSKGEVKICDFGV 225 (364)
T ss_pred EeehhhcCCCCHHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHhhc--cCeeeccCCHHHeeeccCCCEEeccccc
Confidence 9999999999999999865 3589999999999999999999953 7899999999999999999999999999
Q ss_pred ccccccccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCcccc
Q 042348 519 ARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQI 598 (686)
Q Consensus 519 a~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~ 598 (686)
++.+... ..++.+||..|||||.+.+..|+.++||||||++++|+.+|+.||...
T Consensus 226 S~~lvnS-------------------------~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~ 280 (364)
T KOG0581|consen 226 SGILVNS-------------------------IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPP 280 (364)
T ss_pred cHHhhhh-------------------------hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCc
Confidence 9866422 224678999999999999999999999999999999999999999765
Q ss_pred CccchhHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 599 GSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 599 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
.....+..+.+..+..+..+. +... ....++.+++..||++||.+||+++|+++|
T Consensus 281 ~~~~~~~~~Ll~~Iv~~ppP~-------lP~~----~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 281 NPPYLDIFELLCAIVDEPPPR-------LPEG----EFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred CCCCCCHHHHHHHHhcCCCCC-------CCcc----cCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 444556677777777654331 1111 244578899999999999999999999887
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-47 Score=397.16 Aligned_cols=262 Identities=29% Similarity=0.498 Sum_probs=211.2
Q ss_pred ccCHHHHHHHhhcccCccCceEEEEEEeCCCceEEEEEcCCCCccc--hHHHHHHHHHHhccCCCCcceeeEEEEecC-c
Q 042348 361 DFDLEQLLKASAFLLGKSTIGIVYKVALNNEEAVAVRRLGNGGWQR--FKEFQTEAEAIGKIRHPNIVSLRAYFWSVD-E 437 (686)
Q Consensus 361 ~~~~~~l~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~-~ 437 (686)
.++..++.. ...||+|+||+||+|.++....||||++....... .++|.+|+.+|.+++|||||+++|+|.+.. .
T Consensus 37 ~i~~~~l~~--~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~ 114 (362)
T KOG0192|consen 37 EIDPDELPI--EEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGS 114 (362)
T ss_pred ecChHHhhh--hhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCc
Confidence 344444433 23499999999999999976669999997653322 568999999999999999999999999887 7
Q ss_pred eeEEEeccCCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCC-ceecCCCCCCeeecCCC-CeEEee
Q 042348 438 KLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKR-YVHGDLRPSNILLGKNM-EPHISD 515 (686)
Q Consensus 438 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~-iiHrDlkp~NILl~~~~-~~kl~D 515 (686)
.++|||||++|+|.++++.... ..+++..+++|+.|||+||.|||+ ++ ||||||||+|||++.++ ++||+|
T Consensus 115 ~~iVtEy~~~GsL~~~l~~~~~----~~l~~~~~l~~aldiArGm~YLH~---~~~iIHrDLK~~NiLv~~~~~~~KI~D 187 (362)
T KOG0192|consen 115 LCIVTEYMPGGSLSVLLHKKRK----RKLPLKVRLRIALDIARGMEYLHS---EGPIIHRDLKSDNILVDLKGKTLKIAD 187 (362)
T ss_pred eEEEEEeCCCCcHHHHHhhccc----CCCCHHHHHHHHHHHHHHHHHHhc---CCCeeecccChhhEEEcCCCCEEEECC
Confidence 9999999999999999988411 579999999999999999999999 66 99999999999999998 999999
Q ss_pred cCcccccccccCCccccccccccCCCCCCCccccccccCCCCCccccCccccc--CCCCCCcchHHHHHHHHHHHHhCCC
Q 042348 516 FGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASK--VRKPTQKWDIYSYGVILLEMISGKL 593 (686)
Q Consensus 516 fGla~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~sDVwSlGvvl~elltG~~ 593 (686)
||+++...... ...+...||+.|||||++. ...|+.|+|||||||++|||+||+.
T Consensus 188 FGlsr~~~~~~-----------------------~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~ 244 (362)
T KOG0192|consen 188 FGLSREKVISK-----------------------TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEI 244 (362)
T ss_pred Cccceeecccc-----------------------ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCC
Confidence 99998654321 1122357889999999999 5689999999999999999999999
Q ss_pred CccccCccchhHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccc
Q 042348 594 PMIQIGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRVNI 670 (686)
Q Consensus 594 P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~ 670 (686)
||..... .+.+..+...... +.+. ..+...+..++.+||+.||++||++.+++..|+.+..
T Consensus 245 Pf~~~~~-----~~~~~~v~~~~~R-p~~p----------~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~ 305 (362)
T KOG0192|consen 245 PFEDLAP-----VQVASAVVVGGLR-PPIP----------KECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMS 305 (362)
T ss_pred CCCCCCH-----HHHHHHHHhcCCC-CCCC----------ccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHH
Confidence 9965433 2223333322211 1110 1144568889999999999999999999999998753
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-46 Score=390.54 Aligned_cols=243 Identities=23% Similarity=0.398 Sum_probs=209.3
Q ss_pred hcccCccCceEEEEEEe-CCCceEEEEEcCCC---CccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCC
Q 042348 372 AFLLGKSTIGIVYKVAL-NNEEAVAVRRLGNG---GWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPN 447 (686)
Q Consensus 372 ~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~ 447 (686)
.++||+|||+.||.++. ..|+.||+|++.+. .....+...+||++.++|+|||||+++++|++.++.|+|.|+|++
T Consensus 23 g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivLELC~~ 102 (592)
T KOG0575|consen 23 GRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVLELCHR 102 (592)
T ss_pred eeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEEEecCC
Confidence 56899999999999997 78999999999773 233457789999999999999999999999999999999999999
Q ss_pred CCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccC
Q 042348 448 GSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEE 527 (686)
Q Consensus 448 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 527 (686)
++|..+++.+ +++++.++..+++||+.||.|||+ ++|||||||..|+|+++++++||+|||+|..+...+.
T Consensus 103 ~sL~el~Krr------k~ltEpEary~l~QIv~GlkYLH~---~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~E 173 (592)
T KOG0575|consen 103 GSLMELLKRR------KPLTEPEARYFLRQIVEGLKYLHS---LGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGE 173 (592)
T ss_pred ccHHHHHHhc------CCCCcHHHHHHHHHHHHHHHHHHh---cCceecccchhheeecCcCcEEecccceeeeecCccc
Confidence 9999999844 579999999999999999999999 8999999999999999999999999999998764321
Q ss_pred CccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHH
Q 042348 528 TPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQ 607 (686)
Q Consensus 528 ~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~ 607 (686)
.....+||+.|+|||++.....+..+||||+|||||.|++|++||.. .++.+
T Consensus 174 -----------------------rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFet-----k~vke 225 (592)
T KOG0575|consen 174 -----------------------RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFET-----KTVKE 225 (592)
T ss_pred -----------------------ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCccc-----chHHH
Confidence 22346778889999999998999999999999999999999999943 33445
Q ss_pred HHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 608 WIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 608 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
....+......++..+ ..+..+|+.++|+.||.+|||+.+|+.+
T Consensus 226 ty~~Ik~~~Y~~P~~l-------------s~~A~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 226 TYNKIKLNEYSMPSHL-------------SAEAKDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred HHHHHHhcCccccccc-------------CHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 5555555555544322 2246689999999999999999999876
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-47 Score=389.90 Aligned_cols=264 Identities=29% Similarity=0.459 Sum_probs=216.5
Q ss_pred ccCHHHHHHHhhcccCccCceEEEEEEeCCCceEEEEEcCCCCccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeE
Q 042348 361 DFDLEQLLKASAFLLGKSTIGIVYKVALNNEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLL 440 (686)
Q Consensus 361 ~~~~~~l~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 440 (686)
.++-+++.. .+-||+|.||+||.|.++....||+|.++..... .+.|.+|+++|++++|+|||+++|+|...+..+|
T Consensus 202 ei~r~~l~l--~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~-~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyI 278 (468)
T KOG0197|consen 202 EIPREELKL--IRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMS-PEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYI 278 (468)
T ss_pred eecHHHHHH--HHHhcCCccceEEEEEEcCCCcccceEEeccccC-hhHHHHHHHHHHhCcccCeEEEEEEEecCCceEE
Confidence 344444432 3459999999999999998889999999886443 4789999999999999999999999999889999
Q ss_pred EEeccCCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCccc
Q 042348 441 IYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLAR 520 (686)
Q Consensus 441 V~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~ 520 (686)
|||||+.|+|.++|+...+ ..+...+.+.++.|||+|++||++ +++|||||.++||||+++..+||+|||+||
T Consensus 279 VtE~m~~GsLl~yLr~~~~----~~l~~~~Ll~~a~qIaeGM~YLes---~~~IHRDLAARNiLV~~~~~vKIsDFGLAr 351 (468)
T KOG0197|consen 279 VTEYMPKGSLLDYLRTREG----GLLNLPQLLDFAAQIAEGMAYLES---KNYIHRDLAARNILVDEDLVVKISDFGLAR 351 (468)
T ss_pred EEEecccCcHHHHhhhcCC----CccchHHHHHHHHHHHHHHHHHHh---CCccchhhhhhheeeccCceEEEccccccc
Confidence 9999999999999997443 568899999999999999999999 999999999999999999999999999999
Q ss_pred ccccccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCccccC
Q 042348 521 LADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQIG 599 (686)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~ 599 (686)
...++.... .....-...|.|||.+..+.++.|||||||||+||||+| |+.||....
T Consensus 352 ~~~d~~Y~~----------------------~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~ms 409 (468)
T KOG0197|consen 352 LIGDDEYTA----------------------SEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMS 409 (468)
T ss_pred ccCCCceee----------------------cCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCC
Confidence 554433211 111122456999999999999999999999999999999 999986544
Q ss_pred ccchhHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccccch
Q 042348 600 SMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRVNISTE 673 (686)
Q Consensus 600 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~~~~ 673 (686)
. .+.++.+..+ ..++. ++.|+.++.++|..||+.+|++|||+..+...|+.+....+
T Consensus 410 n-----~ev~~~le~G-yRlp~-----------P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~~~ 466 (468)
T KOG0197|consen 410 N-----EEVLELLERG-YRLPR-----------PEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTSTE 466 (468)
T ss_pred H-----HHHHHHHhcc-CcCCC-----------CCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhccc
Confidence 3 2334443333 33221 23356689999999999999999999999999998875443
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-46 Score=367.64 Aligned_cols=192 Identities=27% Similarity=0.441 Sum_probs=171.9
Q ss_pred cCccCceEEEEEEeC-CCceEEEEEcCCC--CccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCCHH
Q 042348 375 LGKSTIGIVYKVALN-NEEAVAVRRLGNG--GWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLA 451 (686)
Q Consensus 375 iG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL~ 451 (686)
||+|+||+||+|+++ ++..||||.+... .....+.+..|+.+|+.++|||||+++++++.++..++|||||.||||.
T Consensus 18 iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVMEyC~gGDLs 97 (429)
T KOG0595|consen 18 IGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVMEYCNGGDLS 97 (429)
T ss_pred ccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEEeCCCCCHH
Confidence 999999999999976 5789999999776 4445667889999999999999999999999999999999999999999
Q ss_pred HHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCC------CCeEEeecCcccccccc
Q 042348 452 TAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKN------MEPHISDFGLARLADIA 525 (686)
Q Consensus 452 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~------~~~kl~DfGla~~~~~~ 525 (686)
++|+.++ .+++..++.++.|+|.||++||+ ++||||||||+|||++.. -.+||+|||+|+.+..+
T Consensus 98 ~yi~~~~------~l~e~t~r~Fm~QLA~alq~L~~---~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~~ 168 (429)
T KOG0595|consen 98 DYIRRRG------RLPEATARHFMQQLASALQFLHE---NNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQPG 168 (429)
T ss_pred HHHHHcC------CCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCCch
Confidence 9999874 59999999999999999999999 999999999999999764 46899999999988744
Q ss_pred cCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccC
Q 042348 526 EETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIG 599 (686)
Q Consensus 526 ~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~ 599 (686)
.. ....+|++.|||||++..++|+.|+|+||.|+++|++++|+.||....
T Consensus 169 ~~------------------------a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t 218 (429)
T KOG0595|consen 169 SM------------------------AETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAET 218 (429)
T ss_pred hH------------------------HHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccC
Confidence 31 234567777999999999999999999999999999999999996543
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-46 Score=368.34 Aligned_cols=247 Identities=23% Similarity=0.383 Sum_probs=201.0
Q ss_pred hcccCccCceEEEEEEe-CCCceEEEEEcCCCCc-------cchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEe
Q 042348 372 AFLLGKSTIGIVYKVAL-NNEEAVAVRRLGNGGW-------QRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYD 443 (686)
Q Consensus 372 ~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 443 (686)
.+.+|+|+||.|-+|.. ++|+.||||.+++... ......++|+++|++++|||||+++++|...+..|+|||
T Consensus 177 ~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~YmVlE 256 (475)
T KOG0615|consen 177 SKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSSYMVLE 256 (475)
T ss_pred eeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCceEEEEE
Confidence 45699999999999975 4799999999976321 122346799999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCC---CCeEEeecCccc
Q 042348 444 YIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKN---MEPHISDFGLAR 520 (686)
Q Consensus 444 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~---~~~kl~DfGla~ 520 (686)
||+||+|.+.+-.+ +.+.+..-+.+++|++.|+.|||+ +||+||||||+|||+..+ ..+||+|||+|+
T Consensus 257 ~v~GGeLfd~vv~n------k~l~ed~~K~~f~Qll~avkYLH~---~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK 327 (475)
T KOG0615|consen 257 YVEGGELFDKVVAN------KYLREDLGKLLFKQLLTAVKYLHS---QGIIHRDIKPENILLSNDAEDCLLKITDFGLAK 327 (475)
T ss_pred EecCccHHHHHHhc------cccccchhHHHHHHHHHHHHHHHH---cCcccccCCcceEEeccCCcceEEEecccchhh
Confidence 99999999999876 357778889999999999999999 999999999999999765 679999999999
Q ss_pred ccccccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCC---CCCcchHHHHHHHHHHHHhCCCCccc
Q 042348 521 LADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRK---PTQKWDIYSYGVILLEMISGKLPMIQ 597 (686)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~sDVwSlGvvl~elltG~~P~~~ 597 (686)
..... ......+||+.|.|||++.+.. +..++|+||+|||||-+++|.+||..
T Consensus 328 ~~g~~------------------------sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~ 383 (475)
T KOG0615|consen 328 VSGEG------------------------SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSE 383 (475)
T ss_pred ccccc------------------------eehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCccc
Confidence 76422 2345678888899999997654 34588999999999999999999965
Q ss_pred cCccchhHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 598 IGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 598 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
..... ...+.+..++...... .+.+-.++..+++.+||..||++|||+.|++++
T Consensus 384 ~~~~~----sl~eQI~~G~y~f~p~---------~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h 437 (475)
T KOG0615|consen 384 EYTDP----SLKEQILKGRYAFGPL---------QWDRISEEALDLINWMLVVDPENRPSADEALNH 437 (475)
T ss_pred ccCCc----cHHHHHhcCcccccCh---------hhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence 43322 1234455554443222 223345678899999999999999999999876
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-46 Score=352.00 Aligned_cols=253 Identities=24% Similarity=0.369 Sum_probs=205.0
Q ss_pred cccCccCceEEEEEE-eCCCceEEEEEcCCC--CccchHHHHHHHHHHhccCCCCcceeeE-EEEecCc-eeEEEeccCC
Q 042348 373 FLLGKSTIGIVYKVA-LNNEEAVAVRRLGNG--GWQRFKEFQTEAEAIGKIRHPNIVSLRA-YFWSVDE-KLLIYDYIPN 447 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~-~~~~~~~-~~lV~e~~~~ 447 (686)
+.||+|.||+|||+. ..+|..||.|.+..+ +....++...|+.+|++++|||||++++ .+..... .+||||||..
T Consensus 25 ~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivmE~c~~ 104 (375)
T KOG0591|consen 25 KKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVMELCDA 104 (375)
T ss_pred HHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHHHhhcc
Confidence 369999999999997 467999999998754 3344567899999999999999999999 4555544 7999999999
Q ss_pred CCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCC-CceecCCCCCCeeecCCCCeEEeecCccccccccc
Q 042348 448 GSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPK-RYVHGDLRPSNILLGKNMEPHISDFGLARLADIAE 526 (686)
Q Consensus 448 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~-~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~ 526 (686)
|||...++..... .+.+++..+++++.|++.||.++|+..++ -|+||||||.||+++.+|.+||+|||+++++....
T Consensus 105 GDLsqmIk~~K~q--kr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~s~~ 182 (375)
T KOG0591|consen 105 GDLSQMIKHFKKQ--KRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLSSKT 182 (375)
T ss_pred cCHHHHHHHHHhc--cccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhcchh
Confidence 9999999754322 26799999999999999999999995543 38899999999999999999999999999886432
Q ss_pred CCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHH
Q 042348 527 ETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIV 606 (686)
Q Consensus 527 ~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~ 606 (686)
+...+.+||++||+||.+.+.+|+.||||||+||++|||+.-+.||.+. ++.
T Consensus 183 -----------------------tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~-----n~~ 234 (375)
T KOG0591|consen 183 -----------------------TFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD-----NLL 234 (375)
T ss_pred -----------------------HHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc-----cHH
Confidence 2334678999999999999999999999999999999999999999543 555
Q ss_pred HHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 042348 607 QWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLD 666 (686)
Q Consensus 607 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~ 666 (686)
+..+.+..+..+ .+ ..+-....+..|+..|+..||+.||+...++..+.
T Consensus 235 ~L~~KI~qgd~~--~~---------p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~ 283 (375)
T KOG0591|consen 235 SLCKKIEQGDYP--PL---------PDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQ 283 (375)
T ss_pred HHHHHHHcCCCC--CC---------cHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHH
Confidence 555555554322 11 11234456888999999999999998655554443
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-45 Score=359.21 Aligned_cols=262 Identities=23% Similarity=0.360 Sum_probs=215.9
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCCc---cchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCC
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGGW---QRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNG 448 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~g 448 (686)
++||+|+||.||.++.. +++.+|+|.+++... .+.+....|..+|.+++||+||+++..|++.+..|+|+||+.||
T Consensus 31 kviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVld~~~GG 110 (357)
T KOG0598|consen 31 KVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVLDYLNGG 110 (357)
T ss_pred eeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEEeccCCc
Confidence 47999999999999865 578999999977532 34567889999999999999999999999999999999999999
Q ss_pred CHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCC
Q 042348 449 SLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEET 528 (686)
Q Consensus 449 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 528 (686)
.|..+|... ..+++..+.-++.+|+.||.|||+ ++||||||||+|||+|++|+++|+|||+++.....+.
T Consensus 111 eLf~hL~~e------g~F~E~~arfYlaEi~lAL~~LH~---~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~~- 180 (357)
T KOG0598|consen 111 ELFYHLQRE------GRFSEDRARFYLAEIVLALGYLHS---KGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDGD- 180 (357)
T ss_pred cHHHHHHhc------CCcchhHHHHHHHHHHHHHHHHHh---CCeeeccCCHHHeeecCCCcEEEeccccchhcccCCC-
Confidence 999999866 358999999999999999999999 9999999999999999999999999999985433221
Q ss_pred ccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHH
Q 042348 529 PEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQW 608 (686)
Q Consensus 529 ~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~ 608 (686)
.....+||+.|||||++.+..|+..+|+||+||++|||++|.+||... +...+
T Consensus 181 ----------------------~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~-----~~~~~ 233 (357)
T KOG0598|consen 181 ----------------------ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAE-----DVKKM 233 (357)
T ss_pred ----------------------ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCc-----cHHHH
Confidence 223468889999999999999999999999999999999999999543 44556
Q ss_pred HHHHHhhcCCc-ccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCC----CHHHHHHHHhcccccchhhhhccCCCC
Q 042348 609 IQLILEDRKPM-TDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRP----SMRHVCDSLDRVNISTEQQFMKGEEPK 683 (686)
Q Consensus 609 ~~~~~~~~~~~-~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RP----s~~ev~~~L~~i~~~~~~~~~~~~~~~ 683 (686)
++.+..++.+. +..++ .+..+++.+.|+.||++|- .+.+|.++----...++.-..+...|+
T Consensus 234 ~~~I~~~k~~~~p~~ls-------------~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~inW~~l~~k~l~Pp 300 (357)
T KOG0598|consen 234 YDKILKGKLPLPPGYLS-------------EEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGINWEKLLAKKLSPP 300 (357)
T ss_pred HHHHhcCcCCCCCccCC-------------HHHHHHHHHHhccCHHHhcCCCCChHHhhcCcccccCCHHHHHhcCCCCC
Confidence 66666665221 11111 2466889999999999995 566655554444567777777777777
Q ss_pred C
Q 042348 684 F 684 (686)
Q Consensus 684 ~ 684 (686)
|
T Consensus 301 F 301 (357)
T KOG0598|consen 301 F 301 (357)
T ss_pred e
Confidence 6
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-44 Score=341.25 Aligned_cols=257 Identities=19% Similarity=0.302 Sum_probs=198.8
Q ss_pred ccCccCceEEEEEEeC-CCceEEEEEcCCCCc-c-chHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCCH
Q 042348 374 LLGKSTIGIVYKVALN-NEEAVAVRRLGNGGW-Q-RFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSL 450 (686)
Q Consensus 374 ~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~-~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL 450 (686)
.+|+|+||+|||++.+ +|+.||||++..... . -.+-..+||++|++++|||+|.++.+|......++|+|||+. ++
T Consensus 9 kvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~dh-Tv 87 (396)
T KOG0593|consen 9 KVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYCDH-TV 87 (396)
T ss_pred ccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeeecch-HH
Confidence 4899999999999976 589999999976533 2 235578999999999999999999999999999999999987 44
Q ss_pred HHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCcc
Q 042348 451 ATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPE 530 (686)
Q Consensus 451 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 530 (686)
.+-+.... ..++...+.+++.|+++|+.|+|+ +++|||||||+||||+.++.+||||||+|+.+....
T Consensus 88 L~eLe~~p-----~G~~~~~vk~~l~Q~l~ai~~cHk---~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pg---- 155 (396)
T KOG0593|consen 88 LHELERYP-----NGVPSELVKKYLYQLLKAIHFCHK---NNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPG---- 155 (396)
T ss_pred HHHHHhcc-----CCCCHHHHHHHHHHHHHHhhhhhh---cCeecccCChhheEEecCCcEEeccchhhHhhcCCc----
Confidence 44444333 458899999999999999999999 999999999999999999999999999999875221
Q ss_pred ccccccccCCCCCCCccccccccCCCCCccccCcccccC-CCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHHH
Q 042348 531 VHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKV-RKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQWI 609 (686)
Q Consensus 531 ~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~ 609 (686)
...+..+.|.+|+|||.+.+ .+|+..+||||+||++.||++|.+-|.+ ..+.+..-.+
T Consensus 156 -------------------d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG--~SDiDQLy~I 214 (396)
T KOG0593|consen 156 -------------------DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPG--RSDIDQLYLI 214 (396)
T ss_pred -------------------chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCC--cchHHHHHHH
Confidence 12345678999999999877 7899999999999999999999988844 3444444444
Q ss_pred HHHHhhcC-----------CcccccCcccccCCCc----HHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 610 QLILEDRK-----------PMTDILDPFLAHDLDK----EDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 610 ~~~~~~~~-----------~~~~~~d~~l~~~~~~----~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
+..+..-. .+..+.=|.......- +....-+++++..||+.||++|++.+|++.+
T Consensus 215 ~ktLG~L~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H 284 (396)
T KOG0593|consen 215 RKTLGNLIPRHQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHH 284 (396)
T ss_pred HHHHcccCHHHHHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence 43333211 1111111111000000 1122357899999999999999999998865
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-44 Score=383.93 Aligned_cols=260 Identities=28% Similarity=0.455 Sum_probs=213.1
Q ss_pred cccCccCceEEEEEEeC------CCceEEEEEcCCCCcc-chHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEecc
Q 042348 373 FLLGKSTIGIVYKVALN------NEEAVAVRRLGNGGWQ-RFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYI 445 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~ 445 (686)
+-||+|+||.||+|+.. +...||||.++..... ...+|++|++++..++|||||+++|+|..++..++|+|||
T Consensus 492 ~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~MvFEYm 571 (774)
T KOG1026|consen 492 EELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCMVFEYM 571 (774)
T ss_pred hhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEEEEEec
Confidence 34999999999999854 3467999999887554 6789999999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcCCCccc--------cCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecC
Q 042348 446 PNGSLATAIHGKAGIIS--------YRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFG 517 (686)
Q Consensus 446 ~~gsL~~~l~~~~~~~~--------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfG 517 (686)
..|||.++|........ ..+|+..+.+.||.|||.|++||-+ +.+|||||..+|+||.++..+||+|||
T Consensus 572 ~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~---~~FVHRDLATRNCLVge~l~VKIsDfG 648 (774)
T KOG1026|consen 572 DHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSS---HHFVHRDLATRNCLVGENLVVKISDFG 648 (774)
T ss_pred ccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh---CcccccchhhhhceeccceEEEecccc
Confidence 99999999986543211 2348899999999999999999999 899999999999999999999999999
Q ss_pred cccccccccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCcc
Q 042348 518 LARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMI 596 (686)
Q Consensus 518 la~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~ 596 (686)
++|..-..+... ......-..+|||||.+..+++|++||||||||||||++| |+.||.
T Consensus 649 LsRdiYssDYYk---------------------~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~ 707 (774)
T KOG1026|consen 649 LSRDIYSSDYYK---------------------VRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYY 707 (774)
T ss_pred cchhhhhhhhhc---------------------ccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCccc
Confidence 998554332210 0111222467999999999999999999999999999999 999997
Q ss_pred ccCccchhHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccccch
Q 042348 597 QIGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRVNISTE 673 (686)
Q Consensus 597 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~~~~ 673 (686)
+..+++. ++.+..+. -+. .++.++.++++||..||+.+|++||+++||-..|+......+
T Consensus 708 glSn~EV-----Ie~i~~g~-lL~-----------~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s~ 767 (774)
T KOG1026|consen 708 GLSNQEV-----IECIRAGQ-LLS-----------CPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQASP 767 (774)
T ss_pred ccchHHH-----HHHHHcCC-ccc-----------CCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcCc
Confidence 7655442 33332222 111 234577789999999999999999999999999998765544
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-43 Score=357.57 Aligned_cols=257 Identities=21% Similarity=0.297 Sum_probs=210.8
Q ss_pred hcccCccCceEEEEEEeC-CCceEEEEEcCCCC---ccchHHHHHHHHHHhcc-CCCCcceeeEEEEecCceeEEEeccC
Q 042348 372 AFLLGKSTIGIVYKVALN-NEEAVAVRRLGNGG---WQRFKEFQTEAEAIGKI-RHPNIVSLRAYFWSVDEKLLIYDYIP 446 (686)
Q Consensus 372 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~e~~~ 446 (686)
++.||+|+|++||+|+.. +++.+|||++.+.. ....+....|-.+|.+| .||.|++|+..|.+....|+|+||++
T Consensus 78 g~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvLe~A~ 157 (604)
T KOG0592|consen 78 GKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFVLEYAP 157 (604)
T ss_pred hheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEEEEecC
Confidence 346999999999999854 58899999987642 23345678899999999 89999999999999999999999999
Q ss_pred CCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCccccccccc
Q 042348 447 NGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAE 526 (686)
Q Consensus 447 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~ 526 (686)
+|+|.++|+.. ..+++...+.++.+|+.||+|||+ +|||||||||+|||+|+||++||.|||.|+.+....
T Consensus 158 nGdll~~i~K~------Gsfde~caR~YAAeIldAleylH~---~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~ 228 (604)
T KOG0592|consen 158 NGDLLDLIKKY------GSFDETCARFYAAEILDALEYLHS---NGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQ 228 (604)
T ss_pred CCcHHHHHHHh------CcchHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeEcCCCcEEEeeccccccCChhh
Confidence 99999999976 368999999999999999999999 999999999999999999999999999999987655
Q ss_pred CCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHH
Q 042348 527 ETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIV 606 (686)
Q Consensus 527 ~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~ 606 (686)
........ ..+......+.+||..|.+||++.....++.+|+|+||||+|+|+.|++||..... .
T Consensus 229 ~~~~~~~~----------~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ne-----y 293 (604)
T KOG0592|consen 229 KSQENPVD----------PNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANE-----Y 293 (604)
T ss_pred ccccCccC----------cccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccH-----H
Confidence 43211000 00111123568999999999999999999999999999999999999999955432 2
Q ss_pred HHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 042348 607 QWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSL 665 (686)
Q Consensus 607 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L 665 (686)
..++.++.-...+++.+. ..+.+|+.+.|..||.+|+|.+||-+|.
T Consensus 294 liFqkI~~l~y~fp~~fp-------------~~a~dLv~KLLv~dp~~Rlt~~qIk~Hp 339 (604)
T KOG0592|consen 294 LIFQKIQALDYEFPEGFP-------------EDARDLIKKLLVRDPSDRLTSQQIKAHP 339 (604)
T ss_pred HHHHHHHHhcccCCCCCC-------------HHHHHHHHHHHccCccccccHHHHhhCc
Confidence 235555555444444333 3567899999999999999999998884
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=349.88 Aligned_cols=258 Identities=23% Similarity=0.313 Sum_probs=201.2
Q ss_pred ccCccCceEEEEEEe-CCCceEEEEEcCCCC--ccchHHHHHHHHHHhccCCCCcceeeEEEEec--CceeEEEeccCCC
Q 042348 374 LLGKSTIGIVYKVAL-NNEEAVAVRRLGNGG--WQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSV--DEKLLIYDYIPNG 448 (686)
Q Consensus 374 ~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~~lV~e~~~~g 448 (686)
.||+|.||.||||+. .+|+.||+|++.... .....-..+||.+|++|+||||+++.+...+. ...|+|+|||+.
T Consensus 124 kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFeYMdh- 202 (560)
T KOG0600|consen 124 KIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFEYMDH- 202 (560)
T ss_pred HhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEEecccc-
Confidence 599999999999984 578999999987654 33345578999999999999999999998877 688999999976
Q ss_pred CHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCC
Q 042348 449 SLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEET 528 (686)
Q Consensus 449 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 528 (686)
||..++.... ..+++.++..+++|++.||+|||+ ++|+|||||.+|||||.+|.+||+|||+|+++.....
T Consensus 203 DL~GLl~~p~-----vkft~~qIKc~mkQLl~Gl~~cH~---~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~- 273 (560)
T KOG0600|consen 203 DLSGLLSSPG-----VKFTEPQIKCYMKQLLEGLEYCHS---RGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGS- 273 (560)
T ss_pred hhhhhhcCCC-----cccChHHHHHHHHHHHHHHHHHhh---cCeeeccccccceEEcCCCCEEeccccceeeccCCCC-
Confidence 9999987654 469999999999999999999999 9999999999999999999999999999998765432
Q ss_pred ccccccccccCCCCCCCccccccccCCCCCccccCcccccC-CCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHH
Q 042348 529 PEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKV-RKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQ 607 (686)
Q Consensus 529 ~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~ 607 (686)
...+..+-|.+|+|||.+.+ ..|+.++|+||.||||.||++|++.|.+. .+.+..+
T Consensus 274 ---------------------~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~--tEveQl~ 330 (560)
T KOG0600|consen 274 ---------------------APYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGR--TEVEQLH 330 (560)
T ss_pred ---------------------cccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCc--cHHHHHH
Confidence 12456677999999999877 56999999999999999999999888543 3333333
Q ss_pred HHHHHHhhc---------CCcccccCcccccCCC----cHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 608 WIQLILEDR---------KPMTDILDPFLAHDLD----KEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 608 ~~~~~~~~~---------~~~~~~~d~~l~~~~~----~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
.+....... .+....+.+....... ........++|+..+|..||++|.|+.++++.
T Consensus 331 kIfklcGSP~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s 400 (560)
T KOG0600|consen 331 KIFKLCGSPTEDYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQS 400 (560)
T ss_pred HHHHHhCCCChhccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence 333332211 0001111111110000 01123357889999999999999999999865
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=374.32 Aligned_cols=253 Identities=29% Similarity=0.520 Sum_probs=212.3
Q ss_pred hcccCccCceEEEEEEeCC----CceEEEEEcCCCC-ccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccC
Q 042348 372 AFLLGKSTIGIVYKVALNN----EEAVAVRRLGNGG-WQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIP 446 (686)
Q Consensus 372 ~~~iG~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~ 446 (686)
.++||.|.||+||+|+++- ...||||.++.+. ...+.+|+.|+.||.+++||||++|.|+....+..+||.|||+
T Consensus 634 e~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTEyME 713 (996)
T KOG0196|consen 634 EKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITEYME 713 (996)
T ss_pred EEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhhhhh
Confidence 4689999999999999752 4689999998864 4456789999999999999999999999999999999999999
Q ss_pred CCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCccccccccc
Q 042348 447 NGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAE 526 (686)
Q Consensus 447 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~ 526 (686)
+|+|+.+|+.+.+ .+++.+...++++||.|+.||-+ .++|||||.++|||++.+..+|++|||+++.++++.
T Consensus 714 NGsLDsFLR~~DG-----qftviQLVgMLrGIAsGMkYLsd---m~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~ 785 (996)
T KOG0196|consen 714 NGSLDSFLRQNDG-----QFTVIQLVGMLRGIASGMKYLSD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 785 (996)
T ss_pred CCcHHHHHhhcCC-----ceEeehHHHHHHHHHHHhHHHhh---cCchhhhhhhhheeeccceEEEeccccceeecccCC
Confidence 9999999998874 58999999999999999999999 899999999999999999999999999999886543
Q ss_pred CCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCccccCccchhH
Q 042348 527 ETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQIGSMELNI 605 (686)
Q Consensus 527 ~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~~~~ 605 (686)
... .+..|. .-...|.|||.+...+++.+||||||||||||.++ |.+||..+.+.+.
T Consensus 786 ~~~-----ytt~GG---------------KIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdV-- 843 (996)
T KOG0196|consen 786 EAA-----YTTLGG---------------KIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDV-- 843 (996)
T ss_pred Ccc-----ccccCC---------------ccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHH--
Confidence 110 011111 11457999999999999999999999999999887 9999977655432
Q ss_pred HHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 042348 606 VQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRVN 669 (686)
Q Consensus 606 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~ 669 (686)
+.. +++...++. +.+++..+.+||+.||++|-.+||.+.||+..|+++-
T Consensus 844 ---Ika-Ie~gyRLPp-----------PmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklI 892 (996)
T KOG0196|consen 844 ---IKA-IEQGYRLPP-----------PMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLI 892 (996)
T ss_pred ---HHH-HHhccCCCC-----------CCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHh
Confidence 222 233333332 2346778999999999999999999999999999864
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=348.54 Aligned_cols=254 Identities=27% Similarity=0.416 Sum_probs=199.5
Q ss_pred hcccCccCceEEEEEEeCC-CceEEEEEcCCCCccchHHHHHHHHHHhccCCCCcceeeEEEEecC--ceeEEEeccCCC
Q 042348 372 AFLLGKSTIGIVYKVALNN-EEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVD--EKLLIYDYIPNG 448 (686)
Q Consensus 372 ~~~iG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~--~~~lV~e~~~~g 448 (686)
...||+|+||.||++...+ |...|||.+........+.+.+|+.+|++++|||||+++|.....+ .+++.|||+++|
T Consensus 22 ~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~~~G 101 (313)
T KOG0198|consen 22 GKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEYAPGG 101 (313)
T ss_pred hccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeeccCCC
Confidence 4579999999999998764 8899999987653333677899999999999999999999866555 589999999999
Q ss_pred CHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecC-CCCeEEeecCcccccccccC
Q 042348 449 SLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGK-NMEPHISDFGLARLADIAEE 527 (686)
Q Consensus 449 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~-~~~~kl~DfGla~~~~~~~~ 527 (686)
+|.+++...++ .+++..+.++.+||++||+|||+ ++||||||||+|||++. ++.+||+|||+++.......
T Consensus 102 sL~~~~~~~g~-----~l~E~~v~~ytr~iL~GL~ylHs---~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~ 173 (313)
T KOG0198|consen 102 SLSDLIKRYGG-----KLPEPLVRRYTRQILEGLAYLHS---KGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGT 173 (313)
T ss_pred cHHHHHHHcCC-----CCCHHHHHHHHHHHHHHHHHHHh---CCEeccCcccceEEEeCCCCeEEeccCccccccccccc
Confidence 99999987652 49999999999999999999999 99999999999999999 79999999999986553110
Q ss_pred CccccccccccCCCCCCCccccccccCCCCCccccCcccccCCC-CCCcchHHHHHHHHHHHHhCCCCccccCccchhHH
Q 042348 528 TPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRK-PTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIV 606 (686)
Q Consensus 528 ~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~ 606 (686)
. ........||+.|||||++..+. ...++|||||||++.||+||+.||... ....
T Consensus 174 ~--------------------~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~----~~~~ 229 (313)
T KOG0198|consen 174 K--------------------SDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF----FEEA 229 (313)
T ss_pred c--------------------ccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh----cchH
Confidence 0 01122456788899999998533 345999999999999999999999543 1222
Q ss_pred HHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 042348 607 QWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRV 668 (686)
Q Consensus 607 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i 668 (686)
.++-.+.... ..+.+.+ . ...+..+++.+|++.||++|||+.+++++.--.
T Consensus 230 ~~~~~ig~~~-~~P~ip~-----~-----ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~ 280 (313)
T KOG0198|consen 230 EALLLIGRED-SLPEIPD-----S-----LSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLK 280 (313)
T ss_pred HHHHHHhccC-CCCCCCc-----c-----cCHHHHHHHHHHhhcCcccCcCHHHHhhChhhh
Confidence 2222222222 1121111 1 223567899999999999999999999986543
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-43 Score=359.44 Aligned_cols=243 Identities=22% Similarity=0.402 Sum_probs=206.1
Q ss_pred ccCccCceEEEEEEe-CCCceEEEEEcCCCCccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCCHHH
Q 042348 374 LLGKSTIGIVYKVAL-NNEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLAT 452 (686)
Q Consensus 374 ~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL~~ 452 (686)
-||+|+.|.||.+.- .+++.||||++........+-+.+|+.+|+..+|+|||++++.|...++.++|||||++|+|.|
T Consensus 280 kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ggsLTD 359 (550)
T KOG0578|consen 280 KIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEGGSLTD 359 (550)
T ss_pred hhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCCCchhh
Confidence 499999999999974 4688999999988776666778999999999999999999999999999999999999999999
Q ss_pred HhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCcccc
Q 042348 453 AIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVH 532 (686)
Q Consensus 453 ~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 532 (686)
.+... .+++.++..|+++++.||+|||. ++|||||||.+|||++.+|.+||+|||++..+.....
T Consensus 360 vVt~~-------~~~E~qIA~Icre~l~aL~fLH~---~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~----- 424 (550)
T KOG0578|consen 360 VVTKT-------RMTEGQIAAICREILQGLKFLHA---RGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS----- 424 (550)
T ss_pred hhhcc-------cccHHHHHHHHHHHHHHHHHHHh---cceeeeccccceeEeccCCcEEEeeeeeeeccccccC-----
Confidence 98764 48999999999999999999999 9999999999999999999999999999987653321
Q ss_pred ccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHHHHHH
Q 042348 533 WEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQWIQLI 612 (686)
Q Consensus 533 ~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~ 612 (686)
.....+||++|||||+.....|++|+||||||++++||+-|.+||... +-.+.+..+
T Consensus 425 ------------------KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE-----~PlrAlyLI 481 (550)
T KOG0578|consen 425 ------------------KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNE-----NPLRALYLI 481 (550)
T ss_pred ------------------ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCC-----ChHHHHHHH
Confidence 223567899999999999999999999999999999999999999542 223334444
Q ss_pred HhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 613 LEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 613 ~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
.....+... . .+.....+.+++.+||+.|+++||++.|+++|
T Consensus 482 a~ng~P~lk--~--------~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 482 ATNGTPKLK--N--------PEKLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred hhcCCCCcC--C--------ccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 444332111 1 12234568899999999999999999999987
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-43 Score=350.66 Aligned_cols=258 Identities=23% Similarity=0.351 Sum_probs=201.1
Q ss_pred hcccCccCceEEEEEEe-CCCceEEEEEcCCCCccchHH--HHHHHHHHhccC-CCCcceeeEEEEecC-ceeEEEeccC
Q 042348 372 AFLLGKSTIGIVYKVAL-NNEEAVAVRRLGNGGWQRFKE--FQTEAEAIGKIR-HPNIVSLRAYFWSVD-EKLLIYDYIP 446 (686)
Q Consensus 372 ~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~--~~~E~~~l~~l~-H~nIv~l~~~~~~~~-~~~lV~e~~~ 446 (686)
.+.||.|.||.||+|+. .++..||||+++..-.. .++ -.+|+..|++++ |||||++.+++.+.+ ..++|||||+
T Consensus 15 i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fVfE~Md 93 (538)
T KOG0661|consen 15 IRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVFEFMD 93 (538)
T ss_pred HHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-HHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeeeHHhhh
Confidence 34599999999999985 46889999999765322 222 368999999998 999999999999988 8999999996
Q ss_pred CCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCccccccccc
Q 042348 447 NGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAE 526 (686)
Q Consensus 447 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~ 526 (686)
. +|+++++.++ +.+++.+++.|+.||++||+|+|. +|+.|||+||+|||+.....+||+|||+||-....
T Consensus 94 ~-NLYqLmK~R~-----r~fse~~irnim~QilqGL~hiHk---~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~Sk- 163 (538)
T KOG0661|consen 94 C-NLYQLMKDRN-----RLFSESDIRNIMYQILQGLAHIHK---HGFFHRDLKPENILISGNDVIKIADFGLAREVRSK- 163 (538)
T ss_pred h-hHHHHHhhcC-----CcCCHHHHHHHHHHHHHHHHHHHh---cCcccccCChhheEecccceeEecccccccccccC-
Confidence 5 9999999885 689999999999999999999999 99999999999999998889999999999855321
Q ss_pred CCccccccccccCCCCCCCccccccccCCCCCccccCccccc-CCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhH
Q 042348 527 ETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASK-VRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNI 605 (686)
Q Consensus 527 ~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~ 605 (686)
...+.++.|.+|+|||++. .+.|+.+.||||+|||++|+.+-++-|.+. .+.+.
T Consensus 164 -----------------------pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~--sE~Dq 218 (538)
T KOG0661|consen 164 -----------------------PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGA--SEIDQ 218 (538)
T ss_pred -----------------------CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCC--cHHHH
Confidence 2335678899999999874 567999999999999999999999888543 33333
Q ss_pred HHHHHHHHhhcCC--ccc------ccCcccccCC--C----cHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 042348 606 VQWIQLILEDRKP--MTD------ILDPFLAHDL--D----KEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSL 665 (686)
Q Consensus 606 ~~~~~~~~~~~~~--~~~------~~d~~l~~~~--~----~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L 665 (686)
.-.+..++..... +.+ .+.-.+.... . ......+..+++.+|+++||++|||++|.+++-
T Consensus 219 i~KIc~VLGtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~p 292 (538)
T KOG0661|consen 219 IYKICEVLGTPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHP 292 (538)
T ss_pred HHHHHHHhCCCccccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCc
Confidence 3333333322110 000 0000000000 0 012456788999999999999999999999873
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=353.63 Aligned_cols=241 Identities=25% Similarity=0.395 Sum_probs=207.9
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCC--CccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCC
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNG--GWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGS 449 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gs 449 (686)
+.||+|+||.||||+.+ +.+.||+|.+.+. ...+.+.+.+|++++++++|||||.++++|+...+.++|.||+.| +
T Consensus 8 e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~a~g-~ 86 (808)
T KOG0597|consen 8 EMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEYAVG-D 86 (808)
T ss_pred HHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehhhhh-h
Confidence 46999999999999876 4788999999764 334567799999999999999999999999999999999999976 9
Q ss_pred HHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCc
Q 042348 450 LATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETP 529 (686)
Q Consensus 450 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 529 (686)
|..+|... ..++++.+..|+.+++.||.|||+ ++|+|||+||.|||++..+.+|++|||+|+.+..+.
T Consensus 87 L~~il~~d------~~lpEe~v~~~a~~LVsaL~yLhs---~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t--- 154 (808)
T KOG0597|consen 87 LFTILEQD------GKLPEEQVRAIAYDLVSALYYLHS---NRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT--- 154 (808)
T ss_pred HHHHHHhc------cCCCHHHHHHHHHHHHHHHHHHHh---cCcccccCCcceeeecCCCceeechhhhhhhcccCc---
Confidence 99999876 469999999999999999999999 999999999999999999999999999999765322
Q ss_pred cccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHHH
Q 042348 530 EVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQWI 609 (686)
Q Consensus 530 ~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~ 609 (686)
...+...||+.|||||...++.|+..+|.||+||++||+++|++||.. ..+.+.+
T Consensus 155 --------------------~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a-----~si~~Lv 209 (808)
T KOG0597|consen 155 --------------------SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYA-----RSITQLV 209 (808)
T ss_pred --------------------eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchH-----HHHHHHH
Confidence 234566788889999999999999999999999999999999999943 3566667
Q ss_pred HHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 610 QLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 610 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
+.+..+..+.+. .....+..++...|.+||.+|.+..+++.|
T Consensus 210 ~~I~~d~v~~p~-------------~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 210 KSILKDPVKPPS-------------TASSSFVNFLQGLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred HHHhcCCCCCcc-------------cccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence 777666433322 223457788899999999999999999877
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-42 Score=319.81 Aligned_cols=259 Identities=23% Similarity=0.333 Sum_probs=201.5
Q ss_pred hcccCccCceEEEEEEe-CCCceEEEEEcCCCCccc--hHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCC
Q 042348 372 AFLLGKSTIGIVYKVAL-NNEEAVAVRRLGNGGWQR--FKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNG 448 (686)
Q Consensus 372 ~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~g 448 (686)
...+|+|.||.||+|+. .+|+.||||+++.....+ .....+||+.|+.++|+||+.++++|-..+...+|+|||+.
T Consensus 7 ~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEfm~t- 85 (318)
T KOG0659|consen 7 LEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEFMPT- 85 (318)
T ss_pred hhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEeccc-
Confidence 34699999999999985 468999999998754322 34678999999999999999999999999999999999965
Q ss_pred CHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCC
Q 042348 449 SLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEET 528 (686)
Q Consensus 449 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 528 (686)
||+..++... ..++..++..++.++++||+|||+ +.|+||||||.|+|++++|.+||+|||+|+.+.....
T Consensus 86 dLe~vIkd~~-----i~l~pa~iK~y~~m~LkGl~y~H~---~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~- 156 (318)
T KOG0659|consen 86 DLEVVIKDKN-----IILSPADIKSYMLMTLKGLAYCHS---KWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNR- 156 (318)
T ss_pred cHHHHhcccc-----cccCHHHHHHHHHHHHHHHHHHHh---hhhhcccCCccceEEcCCCcEEeecccchhccCCCCc-
Confidence 9999998775 579999999999999999999999 8999999999999999999999999999997653221
Q ss_pred ccccccccccCCCCCCCccccccccCCCCCccccCcccccC-CCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHH
Q 042348 529 PEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKV-RKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQ 607 (686)
Q Consensus 529 ~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~ 607 (686)
.....+-|.+|+|||.+.+ ..|+..+||||.|||+.||+-|.+-|. +..+.+...
T Consensus 157 ----------------------~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fp--G~sDidQL~ 212 (318)
T KOG0659|consen 157 ----------------------IQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFP--GDSDIDQLS 212 (318)
T ss_pred ----------------------ccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCC--CCchHHHHH
Confidence 1122367889999998876 569999999999999999999885553 233344333
Q ss_pred HHHHHHhhcC--Cccc---ccCcc-------cccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 608 WIQLILEDRK--PMTD---ILDPF-------LAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 608 ~~~~~~~~~~--~~~~---~~d~~-------l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
.+-..+.... .+++ +-|.. .....-...+....++++.+|+.+||.+|++++|++++
T Consensus 213 ~If~~LGTP~~~~WP~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 213 KIFRALGTPTPDQWPEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred HHHHHcCCCCcccCccccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 3333332211 1111 11110 00000112244467899999999999999999999876
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=348.49 Aligned_cols=259 Identities=20% Similarity=0.300 Sum_probs=204.3
Q ss_pred cccCHHHHHHHhhcccCccCceEEEEEEeCCCceEEEEEcCCCCccc---hHHHHHHHHHHhccCCCCcceeeEEEEe--
Q 042348 360 VDFDLEQLLKASAFLLGKSTIGIVYKVALNNEEAVAVRRLGNGGWQR---FKEFQTEAEAIGKIRHPNIVSLRAYFWS-- 434 (686)
Q Consensus 360 ~~~~~~~l~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~H~nIv~l~~~~~~-- 434 (686)
..++.+++.......||+|++|.||+|.+ +++.||||+++...... .+.|.+|+.+|++++|||||++++++.+
T Consensus 13 ~~i~~~~i~~~~~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~ 91 (283)
T PHA02988 13 KCIESDDIDKYTSVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIV 91 (283)
T ss_pred eecCHHHcCCCCCeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecc
Confidence 34455555444445799999999999998 57899999997643322 4678899999999999999999999977
Q ss_pred --cCceeEEEeccCCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeE
Q 042348 435 --VDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPH 512 (686)
Q Consensus 435 --~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~k 512 (686)
....++||||+++|+|.+++... ..+++....+++.|++.||+|||+. .+++||||||+||++++++.+|
T Consensus 92 ~~~~~~~lv~Ey~~~g~L~~~l~~~------~~~~~~~~~~i~~~i~~~l~~lH~~--~~~~Hrdlkp~nill~~~~~~k 163 (283)
T PHA02988 92 DDLPRLSLILEYCTRGYLREVLDKE------KDLSFKTKLDMAIDCCKGLYNLYKY--TNKPYKNLTSVSFLVTENYKLK 163 (283)
T ss_pred cCCCceEEEEEeCCCCcHHHHHhhC------CCCChhHHHHHHHHHHHHHHHHHhc--CCCCCCcCChhhEEECCCCcEE
Confidence 34678999999999999999764 3588999999999999999999972 3788999999999999999999
Q ss_pred EeecCcccccccccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccC--CCCCCcchHHHHHHHHHHHHh
Q 042348 513 ISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKV--RKPTQKWDIYSYGVILLEMIS 590 (686)
Q Consensus 513 l~DfGla~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDVwSlGvvl~ellt 590 (686)
|+|||+++...... ....++..|+|||++.+ ..++.++|||||||++|||++
T Consensus 164 l~dfg~~~~~~~~~--------------------------~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~ 217 (283)
T PHA02988 164 IICHGLEKILSSPP--------------------------FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFT 217 (283)
T ss_pred EcccchHhhhcccc--------------------------ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHH
Confidence 99999997543211 12345677999999876 679999999999999999999
Q ss_pred CCCCccccCccchhHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 042348 591 GKLPMIQIGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRVN 669 (686)
Q Consensus 591 G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~ 669 (686)
|+.||..... .+....+........ ++ ......+.+++.+||+.||++|||++|+++.|+.+.
T Consensus 218 g~~Pf~~~~~-----~~~~~~i~~~~~~~~--~~---------~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 218 GKIPFENLTT-----KEIYDLIINKNNSLK--LP---------LDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred CCCCCCCCCH-----HHHHHHHHhcCCCCC--CC---------CcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 9999954322 222333322221111 00 012346889999999999999999999999998765
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-42 Score=339.79 Aligned_cols=258 Identities=22% Similarity=0.354 Sum_probs=205.4
Q ss_pred cccCccCceEEEEEEe-CCCceEEEEEcCCCC-ccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCCH
Q 042348 373 FLLGKSTIGIVYKVAL-NNEEAVAVRRLGNGG-WQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSL 450 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL 450 (686)
..||.|..++||+|+. +.++.||||++.-.. ..+.+.+.+|+..|+.++||||++++..|..+...|+||.||.+||+
T Consensus 32 e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpfMa~GS~ 111 (516)
T KOG0582|consen 32 EVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPFMAGGSL 111 (516)
T ss_pred EEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehhhcCCcH
Confidence 3699999999999985 467999999997543 23468899999999999999999999999999999999999999999
Q ss_pred HHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCcc
Q 042348 451 ATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPE 530 (686)
Q Consensus 451 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 530 (686)
.+++...-. ..+++..+..|++++++||.|||. +|.||||||+.||||+++|.+||+|||.+..+...+. .
T Consensus 112 ldIik~~~~----~Gl~E~~Ia~iLre~LkaL~YLH~---~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~--R 182 (516)
T KOG0582|consen 112 LDIIKTYYP----DGLEEASIATILREVLKALDYLHQ---NGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGD--R 182 (516)
T ss_pred HHHHHHHcc----ccccHHHHHHHHHHHHHHHHHHHh---cCceecccccccEEEcCCCcEEEcCceeeeeecccCc--e
Confidence 999987543 358999999999999999999999 9999999999999999999999999998876654321 0
Q ss_pred ccccccccCCCCCCCccccccccCCCCCccccCcccccC--CCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHH
Q 042348 531 VHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKV--RKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQW 608 (686)
Q Consensus 531 ~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~ 608 (686)
. ....+..+||++|||||++.. ..|+.|+||||||++..||.+|..||....+...
T Consensus 183 ~-----------------~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkv----- 240 (516)
T KOG0582|consen 183 Q-----------------VTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKV----- 240 (516)
T ss_pred e-----------------eEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHH-----
Confidence 0 012256788999999999533 5699999999999999999999999976554432
Q ss_pred HHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 609 IQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 609 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
....+.+..+.....- + ...........+.+++..||++||++|||+++++++
T Consensus 241 Ll~tLqn~pp~~~t~~--~-~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 241 LLLTLQNDPPTLLTSG--L-DKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred HHHHhcCCCCCccccc--C-ChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence 2233334333222100 0 000111233468889999999999999999999876
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=356.61 Aligned_cols=277 Identities=23% Similarity=0.400 Sum_probs=213.3
Q ss_pred CcccCHHHHHHHhhcccCccCceEEEEEEeCCCceEEEEEcCCCC--ccchHHHHHHHHHHhccCCCCcceeeEEEEecC
Q 042348 359 QVDFDLEQLLKASAFLLGKSTIGIVYKVALNNEEAVAVRRLGNGG--WQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVD 436 (686)
Q Consensus 359 ~~~~~~~~l~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~ 436 (686)
.+++.++++.. ...||+|+||+||+|++.+ .||||.++... ....+.|.+|+..+++-+|.||+-+.|||..+.
T Consensus 386 ~WeIp~~ev~l--~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~ 461 (678)
T KOG0193|consen 386 EWEIPPEEVLL--GERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPP 461 (678)
T ss_pred ccccCHHHhhc--cceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCc
Confidence 35556666554 4579999999999999873 49999987653 345678999999999999999999999998877
Q ss_pred ceeEEEeccCCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeec
Q 042348 437 EKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDF 516 (686)
Q Consensus 437 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~Df 516 (686)
. .||..+|+|-+|+.++|-.+ ..+...+...|+.|||+|+.|||. ++|||||||..||++.+++.|||+||
T Consensus 462 ~-AIiTqwCeGsSLY~hlHv~e-----tkfdm~~~idIAqQiaqGM~YLHA---K~IIHrDLKSnNIFl~~~~kVkIgDF 532 (678)
T KOG0193|consen 462 L-AIITQWCEGSSLYTHLHVQE-----TKFDMNTTIDIAQQIAQGMDYLHA---KNIIHRDLKSNNIFLHEDLKVKIGDF 532 (678)
T ss_pred e-eeeehhccCchhhhhccchh-----hhhhHHHHHHHHHHHHHhhhhhhh---hhhhhhhccccceEEccCCcEEEecc
Confidence 7 99999999999999999775 468899999999999999999999 99999999999999999999999999
Q ss_pred CcccccccccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccC---CCCCCcchHHHHHHHHHHHHhCCC
Q 042348 517 GLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKV---RKPTQKWDIYSYGVILLEMISGKL 593 (686)
Q Consensus 517 Gla~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDVwSlGvvl~elltG~~ 593 (686)
|++..-..-. |. .......|...|||||++.. .+|++.+||||||+|+|||+||..
T Consensus 533 GLatvk~~w~------------g~---------~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~l 591 (678)
T KOG0193|consen 533 GLATVKTRWS------------GE---------QQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGEL 591 (678)
T ss_pred cceeeeeeec------------cc---------cccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcC
Confidence 9986422110 00 11122345667999999864 468999999999999999999999
Q ss_pred CccccCccchhHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccccch
Q 042348 594 PMIQIGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRVNISTE 673 (686)
Q Consensus 594 P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~~~~ 673 (686)
||. ....+..+. .+..+.-+++.... ...+..++.+|+..||.+++++||.+.+|+..|+++..+.-
T Consensus 592 Pys-i~~~dqIif-----mVGrG~l~pd~s~~-------~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~p 658 (678)
T KOG0193|consen 592 PYS-IQNRDQIIF-----MVGRGYLMPDLSKI-------RSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPSLP 658 (678)
T ss_pred CcC-CCChhheEE-----EecccccCccchhh-------hccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhccc
Confidence 996 322222110 11111112221111 12456688899999999999999999999999988876543
Q ss_pred hhhhccCCC
Q 042348 674 QQFMKGEEP 682 (686)
Q Consensus 674 ~~~~~~~~~ 682 (686)
+--+..++|
T Consensus 659 ki~RS~S~P 667 (678)
T KOG0193|consen 659 KINRSASEP 667 (678)
T ss_pred ccccCcCcc
Confidence 333334444
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=351.99 Aligned_cols=259 Identities=25% Similarity=0.401 Sum_probs=207.3
Q ss_pred cccCHHHHHHHhhcccCccCceEEEEEEeCCCceEEEEEcCCCCccchHHHHHHHHHHhccCCCCcceeeEEEEecCcee
Q 042348 360 VDFDLEQLLKASAFLLGKSTIGIVYKVALNNEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKL 439 (686)
Q Consensus 360 ~~~~~~~l~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 439 (686)
+++.++++.. -+.||.|+.|.||+|++. ++.||||+++.- -+.+|+-|++|+||||+.+.|+|....-++
T Consensus 119 WeiPFe~IsE--LeWlGSGaQGAVF~Grl~-netVAVKKV~el-------kETdIKHLRkLkH~NII~FkGVCtqsPcyC 188 (904)
T KOG4721|consen 119 WEIPFEEISE--LEWLGSGAQGAVFLGRLH-NETVAVKKVREL-------KETDIKHLRKLKHPNIITFKGVCTQSPCYC 188 (904)
T ss_pred ccCCHHHhhh--hhhhccCcccceeeeecc-CceehhHHHhhh-------hhhhHHHHHhccCcceeeEeeeecCCceeE
Confidence 3344444432 246999999999999997 577999998542 246789999999999999999999999999
Q ss_pred EEEeccCCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcc
Q 042348 440 LIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLA 519 (686)
Q Consensus 440 lV~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla 519 (686)
||||||+.|-|..+|+.. +.++......|..+||.|+.|||. +.|||||||.-||||..+..+||+|||.+
T Consensus 189 IiMEfCa~GqL~~VLka~------~~itp~llv~Wsk~IA~GM~YLH~---hKIIHRDLKSPNiLIs~~d~VKIsDFGTS 259 (904)
T KOG4721|consen 189 IIMEFCAQGQLYEVLKAG------RPITPSLLVDWSKGIAGGMNYLHL---HKIIHRDLKSPNILISYDDVVKISDFGTS 259 (904)
T ss_pred EeeeccccccHHHHHhcc------CccCHHHHHHHHHHhhhhhHHHHH---hhHhhhccCCCceEeeccceEEeccccch
Confidence 999999999999999876 468888999999999999999999 89999999999999999999999999999
Q ss_pred cccccccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccC
Q 042348 520 RLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIG 599 (686)
Q Consensus 520 ~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~ 599 (686)
+.+... .......||..|||||++...++++|+||||||||||||+||..||....
T Consensus 260 ~e~~~~------------------------STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVd 315 (904)
T KOG4721|consen 260 KELSDK------------------------STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVD 315 (904)
T ss_pred Hhhhhh------------------------hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccc
Confidence 865422 12235788999999999999999999999999999999999999995543
Q ss_pred ccchhHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccc----ccchhh
Q 042348 600 SMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRVN----ISTEQQ 675 (686)
Q Consensus 600 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~----~~~~~~ 675 (686)
.... + +.-...... ..-+..++..+.-|++.||+..|..||++++|+.||+=.. ..++++
T Consensus 316 ssAI-----I---wGVGsNsL~--------LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~pell~~tee~ 379 (904)
T KOG4721|consen 316 SSAI-----I---WGVGSNSLH--------LPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASPELLSTTEET 379 (904)
T ss_pred hhee-----E---EeccCCccc--------ccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCHHHhcccHHH
Confidence 3221 1 111111111 1122345566778899999999999999999999997533 344454
Q ss_pred hh
Q 042348 676 FM 677 (686)
Q Consensus 676 ~~ 677 (686)
|.
T Consensus 380 yf 381 (904)
T KOG4721|consen 380 YF 381 (904)
T ss_pred HH
Confidence 44
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=352.54 Aligned_cols=243 Identities=23% Similarity=0.358 Sum_probs=202.5
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCC----Cc-cchHHHHHHHHHHhccC-CCCcceeeEEEEecCceeEEEecc
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNG----GW-QRFKEFQTEAEAIGKIR-HPNIVSLRAYFWSVDEKLLIYDYI 445 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~-~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lV~e~~ 445 (686)
..||+|+||.||.|... ++..||+|.+... .. ...+.+.+|+.++++++ ||||++++.++......++||||+
T Consensus 23 ~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~~ivmEy~ 102 (370)
T KOG0583|consen 23 RTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKIYIVMEYC 102 (370)
T ss_pred eeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeEEEEEEec
Confidence 46999999999999754 6799999977553 11 22356678999999998 999999999999999999999999
Q ss_pred CCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCC-CCeEEeecCccccccc
Q 042348 446 PNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKN-MEPHISDFGLARLADI 524 (686)
Q Consensus 446 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~-~~~kl~DfGla~~~~~ 524 (686)
.+|+|.+++... .++.+.++.+++.|++.|++|||+ ++|+||||||+|||+|.+ +++||+|||++.....
T Consensus 103 ~gGdL~~~i~~~------g~l~E~~ar~~F~Qlisav~y~H~---~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~~ 173 (370)
T KOG0583|consen 103 SGGDLFDYIVNK------GRLKEDEARKYFRQLISAVAYCHS---RGIVHRDLKPENILLDGNEGNLKLSDFGLSAISPG 173 (370)
T ss_pred CCccHHHHHHHc------CCCChHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEecCCCCCEEEeccccccccCC
Confidence 999999999884 468889999999999999999999 999999999999999999 9999999999987631
Q ss_pred ccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCC-CC-CcchHHHHHHHHHHHHhCCCCccccCccc
Q 042348 525 AEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRK-PT-QKWDIYSYGVILLEMISGKLPMIQIGSME 602 (686)
Q Consensus 525 ~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~sDVwSlGvvl~elltG~~P~~~~~~~~ 602 (686)
.. ......+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||..
T Consensus 174 ~~-----------------------~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d----- 225 (370)
T KOG0583|consen 174 ED-----------------------GLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDD----- 225 (370)
T ss_pred CC-----------------------CcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCC-----
Confidence 10 2334667888999999999877 75 789999999999999999999955
Q ss_pred hhHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 603 LNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 603 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
.+.......+..+...++..++ ..++..++.+|+..||.+|+++.+|+++
T Consensus 226 ~~~~~l~~ki~~~~~~~p~~~~------------S~~~~~Li~~mL~~~P~~R~t~~~i~~h 275 (370)
T KOG0583|consen 226 SNVPNLYRKIRKGEFKIPSYLL------------SPEARSLIEKMLVPDPSTRITLLEILEH 275 (370)
T ss_pred ccHHHHHHHHhcCCccCCCCcC------------CHHHHHHHHHHcCCCcccCCCHHHHhhC
Confidence 3334444555555555554441 2357789999999999999999999843
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=343.35 Aligned_cols=268 Identities=22% Similarity=0.279 Sum_probs=203.7
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCCcc---chHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCC
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGGWQ---RFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNG 448 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~g 448 (686)
..||+|+||.||.|+-+ +|..+|+|++++.... ..+....|-.+|...++|+||+++..|.+.+..||||||++||
T Consensus 147 k~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiMEylPGG 226 (550)
T KOG0605|consen 147 KVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIMEYLPGG 226 (550)
T ss_pred eeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEEecCCc
Confidence 36999999999999865 5899999999886543 3456788999999999999999999999999999999999999
Q ss_pred CHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCC
Q 042348 449 SLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEET 528 (686)
Q Consensus 449 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 528 (686)
|+..+|... ..|++..+..++.+++.|++.+|. .|+|||||||+|+|||..|++||+|||++.-+......
T Consensus 227 D~mTLL~~~------~~L~e~~arfYiaE~vlAI~~iH~---~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~ 297 (550)
T KOG0605|consen 227 DMMTLLMRK------DTLTEDWARFYIAETVLAIESIHQ---LGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRI 297 (550)
T ss_pred cHHHHHHhc------CcCchHHHHHHHHHHHHHHHHHHH---cCcccccCChhheeecCCCCEeeccccccchhhhhhhh
Confidence 999999866 469999999999999999999999 99999999999999999999999999999755432211
Q ss_pred cc------ccccccccC--------CCCCCCcc----------ccccccCCCCCccccCcccccCCCCCCcchHHHHHHH
Q 042348 529 PE------VHWEQSTTG--------TPLQSSPY----------EFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVI 584 (686)
Q Consensus 529 ~~------~~~~~~~~g--------~~~~~~~~----------~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvv 584 (686)
.. ......... ++...... ......+.+||+.|||||++.+..|+..+|+||+|||
T Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~I 377 (550)
T KOG0605|consen 298 ESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCI 377 (550)
T ss_pred hhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHHH
Confidence 10 000000000 00000000 0112346899999999999999999999999999999
Q ss_pred HHHHHhCCCCccccCccchhHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCC---HHHH
Q 042348 585 LLEMISGKLPMIQIGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPS---MRHV 661 (686)
Q Consensus 585 l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs---~~ev 661 (686)
||||+.|.+||......+ ..+.+...+..+....+ .....+..++|.+|+. ||++|-. ++||
T Consensus 378 myEmLvGyPPF~s~tp~~-----T~rkI~nwr~~l~fP~~---------~~~s~eA~DLI~rll~-d~~~RLG~~G~~EI 442 (550)
T KOG0605|consen 378 MYEMLVGYPPFCSETPQE-----TYRKIVNWRETLKFPEE---------VDLSDEAKDLITRLLC-DPENRLGSKGAEEI 442 (550)
T ss_pred HHHHHhCCCCCCCCCHHH-----HHHHHHHHhhhccCCCc---------CcccHHHHHHHHHHhc-CHHHhcCcccHHHH
Confidence 999999999997654433 23344333322111111 1122467789999998 9999964 6666
Q ss_pred HHH
Q 042348 662 CDS 664 (686)
Q Consensus 662 ~~~ 664 (686)
-+|
T Consensus 443 K~H 445 (550)
T KOG0605|consen 443 KKH 445 (550)
T ss_pred hcC
Confidence 655
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=351.46 Aligned_cols=242 Identities=23% Similarity=0.366 Sum_probs=209.7
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCC---ccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCC
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGG---WQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNG 448 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~g 448 (686)
+.||+|+.|.|-.|++. +|+.+|||.+.+.. ......+++||-+|+-+.||||+++|+++.++.++|+|.||+++|
T Consensus 18 kTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEyv~gG 97 (786)
T KOG0588|consen 18 KTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEYVPGG 97 (786)
T ss_pred ccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEecCCc
Confidence 35999999999999864 79999999997652 222456889999999999999999999999999999999999999
Q ss_pred CHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCC
Q 042348 449 SLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEET 528 (686)
Q Consensus 449 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 528 (686)
-|++++..++ ++++.+..+++.||+.|+.|+|. .+|+|||+||+|+|+|..+++||+|||+|.+-..+
T Consensus 98 ELFdylv~kG------~l~e~eaa~ff~QIi~gv~yCH~---~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g--- 165 (786)
T KOG0588|consen 98 ELFDYLVRKG------PLPEREAAHFFRQILDGVSYCHA---FNICHRDLKPENLLLDVKNNIKIADFGMASLEVPG--- 165 (786)
T ss_pred hhHHHHHhhC------CCCCHHHHHHHHHHHHHHHHHhh---hcceeccCCchhhhhhcccCEeeeccceeecccCC---
Confidence 9999998774 69999999999999999999999 89999999999999999999999999999754322
Q ss_pred ccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCC-CCcchHHHHHHHHHHHHhCCCCccccCccchhHHH
Q 042348 529 PEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKP-TQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQ 607 (686)
Q Consensus 529 ~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~ 607 (686)
......+|++.|.|||++.+.+| +.++||||+|||||.|+||+.||. +.++..
T Consensus 166 ---------------------klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFd-----DdNir~ 219 (786)
T KOG0588|consen 166 ---------------------KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFD-----DDNIRV 219 (786)
T ss_pred ---------------------ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCC-----CccHHH
Confidence 23456688889999999999887 679999999999999999999994 456666
Q ss_pred HHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 042348 608 WIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSL 665 (686)
Q Consensus 608 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L 665 (686)
....+..+...++..+.+ +..+|+.+|+..||++|.|++||++|-
T Consensus 220 LLlKV~~G~f~MPs~Is~-------------eaQdLLr~ml~VDp~~RiT~~eI~kHP 264 (786)
T KOG0588|consen 220 LLLKVQRGVFEMPSNISS-------------EAQDLLRRMLDVDPSTRITTEEILKHP 264 (786)
T ss_pred HHHHHHcCcccCCCcCCH-------------HHHHHHHHHhccCccccccHHHHhhCc
Confidence 777777776666654433 566899999999999999999999984
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=320.00 Aligned_cols=230 Identities=21% Similarity=0.323 Sum_probs=200.1
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCCcc---chHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCC
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGGWQ---RFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNG 448 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~g 448 (686)
..||.|+||.|..++.+ +|..+|+|++.+.... ..+...+|.++|+.+.||+++++++.|.+.+..++||||++||
T Consensus 50 ~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvmeyv~GG 129 (355)
T KOG0616|consen 50 KTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVMEYVPGG 129 (355)
T ss_pred eeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEEeccCCc
Confidence 46999999999999976 4788999999875433 3455778999999999999999999999999999999999999
Q ss_pred CHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCC
Q 042348 449 SLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEET 528 (686)
Q Consensus 449 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 528 (686)
.|..+++.. +++++..++-++.||+.||+|||+ .+|++||+||+|||+|.+|.+||.|||.|+....
T Consensus 130 ElFS~Lrk~------~rF~e~~arFYAAeivlAleylH~---~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~---- 196 (355)
T KOG0616|consen 130 ELFSYLRKS------GRFSEPHARFYAAEIVLALEYLHS---LDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSG---- 196 (355)
T ss_pred cHHHHHHhc------CCCCchhHHHHHHHHHHHHHHHHh---cCeeeccCChHHeeeccCCcEEEEeccceEEecC----
Confidence 999999876 469999999999999999999999 8999999999999999999999999999986542
Q ss_pred ccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHH
Q 042348 529 PEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQW 608 (686)
Q Consensus 529 ~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~ 608 (686)
.+-..+||+.|+|||.+....|+.++|.|||||++|||+.|.+||..... .+.
T Consensus 197 ----------------------rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~-----~~i 249 (355)
T KOG0616|consen 197 ----------------------RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP-----IQI 249 (355)
T ss_pred ----------------------cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh-----HHH
Confidence 12346788889999999999999999999999999999999999965443 455
Q ss_pred HHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCC
Q 042348 609 IQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKR 655 (686)
Q Consensus 609 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~R 655 (686)
.+.++.++-.++..+.+ .+.+|+.+.|+.|-.+|
T Consensus 250 Y~KI~~~~v~fP~~fs~-------------~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 250 YEKILEGKVKFPSYFSS-------------DAKDLLKKLLQVDLTKR 283 (355)
T ss_pred HHHHHhCcccCCcccCH-------------HHHHHHHHHHhhhhHhh
Confidence 77777777666665554 45688889999999998
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-41 Score=352.87 Aligned_cols=259 Identities=27% Similarity=0.394 Sum_probs=198.0
Q ss_pred hcccCccCceEEEEEEe------CCCceEEEEEcCCCC-ccchHHHHHHHHHHhcc-CCCCcceeeEEEEecC-ceeEEE
Q 042348 372 AFLLGKSTIGIVYKVAL------NNEEAVAVRRLGNGG-WQRFKEFQTEAEAIGKI-RHPNIVSLRAYFWSVD-EKLLIY 442 (686)
Q Consensus 372 ~~~iG~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~-~~~lV~ 442 (686)
.+.||+|+||.||+|.. .++..||||++.... ....+.+.+|+.++.++ +||||++++++|...+ ..++||
T Consensus 12 ~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv~ 91 (338)
T cd05102 12 GKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGPLMVIV 91 (338)
T ss_pred eeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCCceEEEE
Confidence 35799999999999974 235689999987543 23346789999999999 8999999999987654 578999
Q ss_pred eccCCCCHHHHhhcCCCcc--------------------------------------------------------ccCCC
Q 042348 443 DYIPNGSLATAIHGKAGII--------------------------------------------------------SYRPL 466 (686)
Q Consensus 443 e~~~~gsL~~~l~~~~~~~--------------------------------------------------------~~~~l 466 (686)
||+++|+|.+++....... ....+
T Consensus 92 ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 171 (338)
T cd05102 92 EFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPL 171 (338)
T ss_pred ecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccccccCCC
Confidence 9999999999997532100 01358
Q ss_pred CHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCccccccccccCCCCCCCc
Q 042348 467 SWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSP 546 (686)
Q Consensus 467 ~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~g~~~~~~~ 546 (686)
++.++..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++........
T Consensus 172 ~~~~~~~~~~qi~~aL~~LH~---~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~------------------ 230 (338)
T cd05102 172 TMEDLICYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY------------------ 230 (338)
T ss_pred CHHHHHHHHHHHHHHHHHHHH---CCEECCCCccceEEEcCCCcEEEeecccccccccCcch------------------
Confidence 889999999999999999999 89999999999999999999999999999754321110
Q ss_pred cccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCccccCccchhHHHHHHHHHhhcCCcccccCc
Q 042348 547 YEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQIGSMELNIVQWIQLILEDRKPMTDILDP 625 (686)
Q Consensus 547 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 625 (686)
.......++..|+|||++.+..++.++|||||||++|||++ |..||......+ ...... .......
T Consensus 231 ---~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~----~~~~~~-~~~~~~~----- 297 (338)
T cd05102 231 ---VRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE----EFCQRL-KDGTRMR----- 297 (338)
T ss_pred ---hcccCCCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH----HHHHHH-hcCCCCC-----
Confidence 01112234567999999988899999999999999999997 999995533221 111111 1111110
Q ss_pred ccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccc
Q 042348 626 FLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRVNI 670 (686)
Q Consensus 626 ~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~ 670 (686)
.. ......+.+++.+||+.||++|||+.||++.|+++..
T Consensus 298 -~~-----~~~~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 298 -AP-----ENATPEIYRIMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred -CC-----CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 00 1123467899999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=377.12 Aligned_cols=261 Identities=28% Similarity=0.403 Sum_probs=210.0
Q ss_pred hcccCccCceEEEEEEeCC--Cc----eEEEEEcCCC-CccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEec
Q 042348 372 AFLLGKSTIGIVYKVALNN--EE----AVAVRRLGNG-GWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDY 444 (686)
Q Consensus 372 ~~~iG~G~~g~Vy~~~~~~--~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~ 444 (686)
...||+|+||.||+|.+.+ +. .||||.++.. +.++..+|.+|..+|++++|||||+++|+|.+....+|++||
T Consensus 697 ~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i~ley 776 (1025)
T KOG1095|consen 697 LRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLILLEY 776 (1025)
T ss_pred eeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEEEehh
Confidence 3579999999999998754 32 4899999775 556778999999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCc-cccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccc
Q 042348 445 IPNGSLATAIHGKAGI-ISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLAD 523 (686)
Q Consensus 445 ~~~gsL~~~l~~~~~~-~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~ 523 (686)
|++|||..+|++.+.. .....|+..+.+.++.|||+|+.||++ ++.|||||.++|+|++....+||+|||+|+.+.
T Consensus 777 M~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~---~~fvHRDLAaRNCLL~~~r~VKIaDFGlArDiy 853 (1025)
T KOG1095|consen 777 MEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLES---KHFVHRDLAARNCLLDERRVVKIADFGLARDIY 853 (1025)
T ss_pred cccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHh---CCCcCcchhhhheeecccCcEEEcccchhHhhh
Confidence 9999999999986321 112568999999999999999999999 899999999999999999999999999999443
Q ss_pred cccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCccccCccc
Q 042348 524 IAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQIGSME 602 (686)
Q Consensus 524 ~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~ 602 (686)
..+.. +. .....-...|||||.+.++.++.|+|||||||++||++| |..||....+.+
T Consensus 854 ~~~yy-----r~----------------~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~ 912 (1025)
T KOG1095|consen 854 DKDYY-----RK----------------HGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFE 912 (1025)
T ss_pred hchhe-----ec----------------cCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHH
Confidence 32211 00 000122356999999999999999999999999999999 999996544332
Q ss_pred hhHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccccch
Q 042348 603 LNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRVNISTE 673 (686)
Q Consensus 603 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~~~~ 673 (686)
. ...+..+. .+. .+..|+..++++|..||+.+|++||++..|++++..+.....
T Consensus 913 v-----~~~~~~gg-RL~-----------~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~ 966 (1025)
T KOG1095|consen 913 V-----LLDVLEGG-RLD-----------PPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAAL 966 (1025)
T ss_pred H-----HHHHHhCC-ccC-----------CCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhc
Confidence 1 22223332 211 122356678999999999999999999999999888764433
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-42 Score=340.39 Aligned_cols=243 Identities=23% Similarity=0.396 Sum_probs=203.3
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCC-CccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCCH
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNG-GWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSL 450 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL 450 (686)
..||+|.||.||||... .++.||+|.+... ...+.++.++|+.++.+++++||.++|+.|..+...+++||||.+|++
T Consensus 19 ~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~gGsv 98 (467)
T KOG0201|consen 19 ELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCGGGSV 98 (467)
T ss_pred hhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhcCcch
Confidence 46999999999999865 5789999999764 344567899999999999999999999999999999999999999999
Q ss_pred HHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCcc
Q 042348 451 ATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPE 530 (686)
Q Consensus 451 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 530 (686)
.+.+.... .+.+..+.-|++++..||.|||. ++.+|||||+.|||+..+|.+|++|||.+-.+.....
T Consensus 99 ~~lL~~~~------~~~E~~i~~ilre~l~~l~ylH~---~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~--- 166 (467)
T KOG0201|consen 99 LDLLKSGN------ILDEFEIAVILREVLKGLDYLHS---EKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK--- 166 (467)
T ss_pred hhhhccCC------CCccceeeeehHHHHHHhhhhhh---cceecccccccceeEeccCcEEEEecceeeeeechhh---
Confidence 99997653 35777888899999999999999 8999999999999999999999999999976653321
Q ss_pred ccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHHHH
Q 042348 531 VHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQWIQ 610 (686)
Q Consensus 531 ~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~ 610 (686)
.....+||++|||||++....|+.|+||||||++.+||.+|.+|+....++.. +
T Consensus 167 --------------------rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrv-----l- 220 (467)
T KOG0201|consen 167 --------------------RRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRV-----L- 220 (467)
T ss_pred --------------------ccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceE-----E-
Confidence 22467889999999999988999999999999999999999999966554321 0
Q ss_pred HHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 611 LILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 611 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
.-++.-..|.+.+. ....+.+++..||++||+.||++.+++++
T Consensus 221 ------flIpk~~PP~L~~~-----~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 221 ------FLIPKSAPPRLDGD-----FSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred ------EeccCCCCCccccc-----cCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 11122223334332 23458889999999999999999999876
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-41 Score=350.49 Aligned_cols=252 Identities=25% Similarity=0.374 Sum_probs=202.6
Q ss_pred cccCccCceEEEEEEeCCC----ce-EEEEEcCCC---CccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEec
Q 042348 373 FLLGKSTIGIVYKVALNNE----EA-VAVRRLGNG---GWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDY 444 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~~~----~~-vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~ 444 (686)
..||+|+||.||+|++... .. ||||..+.. ......+|.+|+++|++++|||||++||++......++|||+
T Consensus 163 kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ivmEl 242 (474)
T KOG0194|consen 163 KKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLVMEL 242 (474)
T ss_pred ceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEEEEe
Confidence 4699999999999987532 23 899998752 345567899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCccccccc
Q 042348 445 IPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADI 524 (686)
Q Consensus 445 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~ 524 (686)
|.||+|.++|.... ..++..++..++.+.|.||+|||+ +++|||||-++|+|++.++.+||+|||+++....
T Consensus 243 ~~gGsL~~~L~k~~-----~~v~~~ek~~~~~~AA~Gl~YLh~---k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~ 314 (474)
T KOG0194|consen 243 CNGGSLDDYLKKNK-----KSLPTLEKLRFCYDAARGLEYLHS---KNCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQ 314 (474)
T ss_pred cCCCcHHHHHHhCC-----CCCCHHHHHHHHHHHHhHHHHHHH---CCCcchhHhHHHheecCCCeEEeCccccccCCcc
Confidence 99999999999875 358999999999999999999999 9999999999999999999999999999875431
Q ss_pred ccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCccccCccch
Q 042348 525 AEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQIGSMEL 603 (686)
Q Consensus 525 ~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~~ 603 (686)
-... .....-...|+|||.+....|++++|||||||++||+++ |..||.+....
T Consensus 315 ~~~~-----------------------~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~-- 369 (474)
T KOG0194|consen 315 YVMK-----------------------KFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY-- 369 (474)
T ss_pred eeec-----------------------cccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH--
Confidence 1000 000112346999999999999999999999999999999 89899654432
Q ss_pred hHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccccc
Q 042348 604 NIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRVNIS 671 (686)
Q Consensus 604 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~~ 671 (686)
+....+.....++..- ...+..+..++.+||..+|++||+|.++.+.|+.+...
T Consensus 370 ---~v~~kI~~~~~r~~~~-----------~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~ 423 (474)
T KOG0194|consen 370 ---EVKAKIVKNGYRMPIP-----------SKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKK 423 (474)
T ss_pred ---HHHHHHHhcCccCCCC-----------CCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhc
Confidence 2233332333222110 11234566788899999999999999999999987644
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=346.17 Aligned_cols=241 Identities=22% Similarity=0.324 Sum_probs=195.1
Q ss_pred ccCccCceEEEEEEeC-CCceEEEEEcCCCC---ccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCC
Q 042348 374 LLGKSTIGIVYKVALN-NEEAVAVRRLGNGG---WQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGS 449 (686)
Q Consensus 374 ~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gs 449 (686)
+||+|+||.||++... +++.||+|.+.... ......+.+|++++++++||||+++++++...+..++||||+++|+
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~ 81 (323)
T cd05571 2 LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGE 81 (323)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCCc
Confidence 5899999999999865 68899999986532 2334567889999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCc
Q 042348 450 LATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETP 529 (686)
Q Consensus 450 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 529 (686)
|.+++... ..+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 82 L~~~l~~~------~~~~~~~~~~~~~qi~~~L~~lH~---~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~--- 149 (323)
T cd05571 82 LFFHLSRE------RVFSEDRARFYGAEIVSALGYLHS---CDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG--- 149 (323)
T ss_pred HHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC---
Confidence 99998754 458999999999999999999999 899999999999999999999999999987432111
Q ss_pred cccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHHH
Q 042348 530 EVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQWI 609 (686)
Q Consensus 530 ~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~ 609 (686)
.......||..|+|||++.+..++.++|||||||++|||++|+.||..... ....
T Consensus 150 --------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~-----~~~~ 204 (323)
T cd05571 150 --------------------ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-----EKLF 204 (323)
T ss_pred --------------------CcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCH-----HHHH
Confidence 011234578889999999988999999999999999999999999954321 1222
Q ss_pred HHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 042348 610 QLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRP-----SMRHVCDS 664 (686)
Q Consensus 610 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~ev~~~ 664 (686)
..+.......+. ....++.+++.+||+.||++|| ++.+++++
T Consensus 205 ~~~~~~~~~~p~-------------~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 205 ELILMEEIRFPR-------------TLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred HHHHcCCCCCCC-------------CCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 222222211111 1123577899999999999999 79998875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-40 Score=342.28 Aligned_cols=240 Identities=21% Similarity=0.317 Sum_probs=193.6
Q ss_pred cCccCceEEEEEEeC-CCceEEEEEcCCC---CccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCCH
Q 042348 375 LGKSTIGIVYKVALN-NEEAVAVRRLGNG---GWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSL 450 (686)
Q Consensus 375 iG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL 450 (686)
||+|+||.||+|... +++.||+|.+... .......+.+|+.++++++||||+++++++...+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 699999999999876 4788999998643 223446788999999999999999999999999999999999999999
Q ss_pred HHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCcc
Q 042348 451 ATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPE 530 (686)
Q Consensus 451 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 530 (686)
.+++... ..+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++.......
T Consensus 81 ~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH~---~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~--- 148 (312)
T cd05585 81 FHHLQRE------GRFDLSRARFYTAELLCALENLHK---FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD--- 148 (312)
T ss_pred HHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCC---
Confidence 9999764 358999999999999999999999 8999999999999999999999999999875321110
Q ss_pred ccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHHHH
Q 042348 531 VHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQWIQ 610 (686)
Q Consensus 531 ~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~ 610 (686)
......||..|+|||++.+..++.++|||||||++|||++|+.||.... ..+..+
T Consensus 149 --------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~-----~~~~~~ 203 (312)
T cd05585 149 --------------------KTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDEN-----VNEMYR 203 (312)
T ss_pred --------------------ccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCC-----HHHHHH
Confidence 1123457888999999999899999999999999999999999995432 223333
Q ss_pred HHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCC---HHHHHHH
Q 042348 611 LILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPS---MRHVCDS 664 (686)
Q Consensus 611 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs---~~ev~~~ 664 (686)
.+.......+.. ....+.+++.+||+.||++||+ +.|++.+
T Consensus 204 ~~~~~~~~~~~~-------------~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~h 247 (312)
T cd05585 204 KILQEPLRFPDG-------------FDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNH 247 (312)
T ss_pred HHHcCCCCCCCc-------------CCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcC
Confidence 333332222111 1235678999999999999985 5666654
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=346.39 Aligned_cols=262 Identities=23% Similarity=0.324 Sum_probs=208.6
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCC---ccchHHHHHHHHHHhcc-CCCCcceeeEEEEecCceeEEEeccCC
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGG---WQRFKEFQTEAEAIGKI-RHPNIVSLRAYFWSVDEKLLIYDYIPN 447 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~e~~~~ 447 (686)
.+||+|.||.|+++..+ +++.+|||.+++.. ..+.+....|.+++... +||.+++++.+|.+.++.|+||||+.|
T Consensus 374 ~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fvmey~~G 453 (694)
T KOG0694|consen 374 AVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFVMEYVAG 453 (694)
T ss_pred EEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEEEEecCC
Confidence 47999999999999976 47789999998863 34567788899998888 599999999999999999999999999
Q ss_pred CCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccC
Q 042348 448 GSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEE 527 (686)
Q Consensus 448 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 527 (686)
||+..+.+. ..+++..+.-++..|+.||+|||+ ++||+||||.+|||+|.+|++||+|||+++-....+
T Consensus 454 gdm~~~~~~-------~~F~e~rarfyaAev~l~L~fLH~---~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~g- 522 (694)
T KOG0694|consen 454 GDLMHHIHT-------DVFSEPRARFYAAEVVLGLQFLHE---NGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQG- 522 (694)
T ss_pred CcEEEEEec-------ccccHHHHHHHHHHHHHHHHHHHh---cCceeeecchhheEEcccCcEEecccccccccCCCC-
Confidence 996665553 358999999999999999999999 999999999999999999999999999998432111
Q ss_pred CccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHH
Q 042348 528 TPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQ 607 (686)
Q Consensus 528 ~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~ 607 (686)
..+++.+||+.|||||++.+..|+..+|.|||||+||||+.|..||.+.+.+ +
T Consensus 523 ----------------------~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEe-----e 575 (694)
T KOG0694|consen 523 ----------------------DRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEE-----E 575 (694)
T ss_pred ----------------------CccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHH-----H
Confidence 2345678899999999999999999999999999999999999999654332 2
Q ss_pred HHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCH-----HHHHHHHhcccccchhhhhccCCC
Q 042348 608 WIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSM-----RHVCDSLDRVNISTEQQFMKGEEP 682 (686)
Q Consensus 608 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~-----~ev~~~L~~i~~~~~~~~~~~~~~ 682 (686)
....++.+....+.. ...+.+.++.++|.++|++|-.+ .+|.++=--=...++.-..+..+|
T Consensus 576 ~FdsI~~d~~~yP~~-------------ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~~L~~r~i~P 642 (694)
T KOG0694|consen 576 VFDSIVNDEVRYPRF-------------LSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDWDDLLNRRIKP 642 (694)
T ss_pred HHHHHhcCCCCCCCc-------------ccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccCCHHHHhhccCCC
Confidence 345555554333322 23467789999999999999765 445444211123355555566666
Q ss_pred CCC
Q 042348 683 KFD 685 (686)
Q Consensus 683 ~~~ 685 (686)
+|.
T Consensus 643 Pf~ 645 (694)
T KOG0694|consen 643 PFV 645 (694)
T ss_pred CCC
Confidence 663
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=335.13 Aligned_cols=252 Identities=23% Similarity=0.243 Sum_probs=196.6
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCCc---cchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCC
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGGW---QRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNG 448 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~g 448 (686)
..||+|+||.||++... +++.||+|.+..... .....+.+|++++++++|+||+++++++.+.+..++||||+++|
T Consensus 6 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~g 85 (285)
T cd05631 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNGG 85 (285)
T ss_pred EEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEecCCC
Confidence 46999999999999864 688999999865321 22345789999999999999999999999999999999999999
Q ss_pred CHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCC
Q 042348 449 SLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEET 528 (686)
Q Consensus 449 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 528 (686)
+|.+++..... ..+++..+..++.|++.||+|||+ ++|+||||||+|||+++++.+||+|||++.......
T Consensus 86 ~L~~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~-- 156 (285)
T cd05631 86 DLKFHIYNMGN----PGFDEQRAIFYAAELCCGLEDLQR---ERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE-- 156 (285)
T ss_pred cHHHHHHhhCC----CCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC--
Confidence 99988865332 358999999999999999999999 899999999999999999999999999997543211
Q ss_pred ccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHH
Q 042348 529 PEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQW 608 (686)
Q Consensus 529 ~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~ 608 (686)
......||..|+|||++.+..++.++|||||||++|||++|+.||........ ....
T Consensus 157 ----------------------~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~-~~~~ 213 (285)
T cd05631 157 ----------------------TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVK-REEV 213 (285)
T ss_pred ----------------------eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchh-HHHH
Confidence 11234578889999999999999999999999999999999999964332111 1111
Q ss_pred HHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCC-----HHHHHHH--Hhccc
Q 042348 609 IQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPS-----MRHVCDS--LDRVN 669 (686)
Q Consensus 609 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~ev~~~--L~~i~ 669 (686)
........... . ......+.+++.+||+.||++||+ +++++++ ++.+.
T Consensus 214 ~~~~~~~~~~~----~---------~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~ 268 (285)
T cd05631 214 DRRVKEDQEEY----S---------EKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNIN 268 (285)
T ss_pred HHHhhcccccC----C---------ccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCC
Confidence 11111111110 0 012235778999999999999997 7888876 44443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=337.59 Aligned_cols=261 Identities=22% Similarity=0.318 Sum_probs=196.8
Q ss_pred cccCccCceEEEEEEeCC-----------------CceEEEEEcCCCC-ccchHHHHHHHHHHhccCCCCcceeeEEEEe
Q 042348 373 FLLGKSTIGIVYKVALNN-----------------EEAVAVRRLGNGG-WQRFKEFQTEAEAIGKIRHPNIVSLRAYFWS 434 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~ 434 (686)
..||+|+||.||++..++ +..||+|.+.... .....+|.+|++++.+++||||+++++++..
T Consensus 11 ~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 90 (304)
T cd05096 11 EKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVD 90 (304)
T ss_pred eEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEec
Confidence 469999999999997532 3369999987643 2335679999999999999999999999999
Q ss_pred cCceeEEEeccCCCCHHHHhhcCCCc-------------cccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCC
Q 042348 435 VDEKLLIYDYIPNGSLATAIHGKAGI-------------ISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPS 501 (686)
Q Consensus 435 ~~~~~lV~e~~~~gsL~~~l~~~~~~-------------~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~ 501 (686)
.+..++||||+++|+|.+++...... .....++|..+.+++.|++.||+|||+ .+|+||||||+
T Consensus 91 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~ivH~dlkp~ 167 (304)
T cd05096 91 EDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS---LNFVHRDLATR 167 (304)
T ss_pred CCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH---CCccccCcchh
Confidence 99999999999999999998653210 011357889999999999999999999 89999999999
Q ss_pred CeeecCCCCeEEeecCcccccccccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHH
Q 042348 502 NILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSY 581 (686)
Q Consensus 502 NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSl 581 (686)
|||+++++.+||+|||+++........ .......++..|+|||++....++.++|||||
T Consensus 168 Nill~~~~~~kl~DfG~~~~~~~~~~~---------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~sl 226 (304)
T cd05096 168 NCLVGENLTIKIADFGMSRNLYAGDYY---------------------RIQGRAVLPIRWMAWECILMGKFTTASDVWAF 226 (304)
T ss_pred heEEcCCccEEECCCccceecccCcee---------------------EecCcCCCCccccCHHHHhcCCCCchhhhHHH
Confidence 999999999999999999754322110 01112334667999999988889999999999
Q ss_pred HHHHHHHHh--CCCCccccCccchhHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHH
Q 042348 582 GVILLEMIS--GKLPMIQIGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMR 659 (686)
Q Consensus 582 Gvvl~ellt--G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ 659 (686)
||++|||++ +..||..... ......+............... ...+...+.+++.+||+.||++|||+.
T Consensus 227 G~~l~el~~~~~~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~li~~cl~~~p~~RPs~~ 296 (304)
T cd05096 227 GVTLWEILMLCKEQPYGELTD--EQVIENAGEFFRDQGRQVYLFR--------PPPCPQGLYELMLQCWSRDCRERPSFS 296 (304)
T ss_pred HHHHHHHHHccCCCCCCcCCH--HHHHHHHHHHhhhccccccccC--------CCCCCHHHHHHHHHHccCCchhCcCHH
Confidence 999999987 5667754322 2222222222221111000000 011234688999999999999999999
Q ss_pred HHHHHHhc
Q 042348 660 HVCDSLDR 667 (686)
Q Consensus 660 ev~~~L~~ 667 (686)
||.+.|++
T Consensus 297 ~i~~~l~~ 304 (304)
T cd05096 297 DIHAFLTE 304 (304)
T ss_pred HHHHHHhC
Confidence 99998864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-40 Score=314.95 Aligned_cols=258 Identities=21% Similarity=0.280 Sum_probs=197.1
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCCccc--hHHHHHHHHHHhccCCCCcceeeEEEEe--cCceeEEEeccCC
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGGWQR--FKEFQTEAEAIGKIRHPNIVSLRAYFWS--VDEKLLIYDYIPN 447 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~H~nIv~l~~~~~~--~~~~~lV~e~~~~ 447 (686)
+.|++|.||.||+|+.. +++.||+|+++...... .-...+||.+|.+++|||||.+..+... .+..|+|||||+.
T Consensus 82 nrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~~Eh 161 (419)
T KOG0663|consen 82 NRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVMEYVEH 161 (419)
T ss_pred hhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHHHHHh
Confidence 45999999999999865 57899999997643211 2346899999999999999999888764 4678999999976
Q ss_pred CCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccC
Q 042348 448 GSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEE 527 (686)
Q Consensus 448 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 527 (686)
||..+++... +++...+++.++.|+++|++|||. +.|+||||||+|+|+...|.+||+|||+|+.+....
T Consensus 162 -DLksl~d~m~-----q~F~~~evK~L~~QlL~glk~lH~---~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~- 231 (419)
T KOG0663|consen 162 -DLKSLMETMK-----QPFLPGEVKTLMLQLLRGLKHLHD---NWILHRDLKTSNLLLSHKGILKIADFGLAREYGSPL- 231 (419)
T ss_pred -hHHHHHHhcc-----CCCchHHHHHHHHHHHHHHHHHhh---ceeEecccchhheeeccCCcEEecccchhhhhcCCc-
Confidence 9999998764 578999999999999999999999 899999999999999999999999999999664321
Q ss_pred CccccccccccCCCCCCCccccccccCCCCCccccCcccccCC-CCCCcchHHHHHHHHHHHHhCCCCccccCccchhHH
Q 042348 528 TPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVR-KPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIV 606 (686)
Q Consensus 528 ~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~ 606 (686)
...+..+-|.+|+|||.+.+. .|+++.|+||+|||+.||+++++-|.+. .+.+..
T Consensus 232 ----------------------k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~--sE~dQl 287 (419)
T KOG0663|consen 232 ----------------------KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGK--SEIDQL 287 (419)
T ss_pred ----------------------ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCC--chHHHH
Confidence 233456778999999998774 5999999999999999999999888543 333333
Q ss_pred HHHHHHHhhc--CCcccccCcc--------------cccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 607 QWIQLILEDR--KPMTDILDPF--------------LAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 607 ~~~~~~~~~~--~~~~~~~d~~--------------l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
..+-..+... ..++...... +...+........-.+++...+.+||.+|.|+.|.+++
T Consensus 288 ~~If~llGtPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 288 DKIFKLLGTPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred HHHHHHhCCCccccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence 3333333211 0111111100 00011111112456789999999999999999999876
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=341.87 Aligned_cols=241 Identities=23% Similarity=0.343 Sum_probs=195.0
Q ss_pred ccCccCceEEEEEEeC-CCceEEEEEcCCC---CccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCC
Q 042348 374 LLGKSTIGIVYKVALN-NEEAVAVRRLGNG---GWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGS 449 (686)
Q Consensus 374 ~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gs 449 (686)
+||+|+||.||++... +++.||+|.+... .......+.+|++++++++||||+++++++...+..++||||+++|+
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g~ 81 (328)
T cd05593 2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGE 81 (328)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCCC
Confidence 5899999999999865 5889999998653 22344678899999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCc
Q 042348 450 LATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETP 529 (686)
Q Consensus 450 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 529 (686)
|.+++... ..+++.++..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 82 L~~~l~~~------~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~--- 149 (328)
T cd05593 82 LFFHLSRE------RVFSEDRTRFYGAEIVSALDYLHS---GKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA--- 149 (328)
T ss_pred HHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeEECCCCcEEEecCcCCccCCCcc---
Confidence 99988754 358999999999999999999999 899999999999999999999999999987432110
Q ss_pred cccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHHH
Q 042348 530 EVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQWI 609 (686)
Q Consensus 530 ~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~ 609 (686)
.......||..|+|||++.+..++.++|||||||++|||++|+.||..... ....
T Consensus 150 --------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~-----~~~~ 204 (328)
T cd05593 150 --------------------ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-----EKLF 204 (328)
T ss_pred --------------------cccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCH-----HHHH
Confidence 011234578889999999988899999999999999999999999954322 1222
Q ss_pred HHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 042348 610 QLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRP-----SMRHVCDS 664 (686)
Q Consensus 610 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~ev~~~ 664 (686)
..+.......+.. ....+.+++.+||+.||++|| ++.|++++
T Consensus 205 ~~~~~~~~~~p~~-------------~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 205 ELILMEDIKFPRT-------------LSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred HHhccCCccCCCC-------------CCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 2222222211111 123577899999999999997 89999876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=324.19 Aligned_cols=263 Identities=23% Similarity=0.361 Sum_probs=199.8
Q ss_pred ccCccCceEEEEEEeCCCceEEEEEcCCCCccchHHHHHHHHHHhc--cCCCCcceeeEEEEecC----ceeEEEeccCC
Q 042348 374 LLGKSTIGIVYKVALNNEEAVAVRRLGNGGWQRFKEFQTEAEAIGK--IRHPNIVSLRAYFWSVD----EKLLIYDYIPN 447 (686)
Q Consensus 374 ~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~H~nIv~l~~~~~~~~----~~~lV~e~~~~ 447 (686)
+||+|+||.||||.+.+ +.||||++... +.+.|..|-+|.+. ++|+||++++++-.... +++||+||.+.
T Consensus 217 li~~Grfg~V~KaqL~~-~~VAVKifp~~---~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh~k 292 (534)
T KOG3653|consen 217 LIGRGRFGCVWKAQLDN-RLVAVKIFPEQ---EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEFHPK 292 (534)
T ss_pred HhhcCccceeehhhccC-ceeEEEecCHH---HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeeeccC
Confidence 69999999999999975 88999999763 44668777777664 58999999999877655 78999999999
Q ss_pred CCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccC------CCCceecCCCCCCeeecCCCCeEEeecCcccc
Q 042348 448 GSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVS------PKRYVHGDLRPSNILLGKNMEPHISDFGLARL 521 (686)
Q Consensus 448 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~------~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~ 521 (686)
|+|.++|..+ .++|....+|+..+++||+|||+.. +.+|+|||||++|||+.+|+++.|+|||+|..
T Consensus 293 GsL~dyL~~n-------tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~ 365 (534)
T KOG3653|consen 293 GSLCDYLKAN-------TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALR 365 (534)
T ss_pred CcHHHHHHhc-------cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEE
Confidence 9999999875 5899999999999999999999743 34799999999999999999999999999998
Q ss_pred cccccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCC-CC-----CcchHHHHHHHHHHHHhCCCCc
Q 042348 522 ADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRK-PT-----QKWDIYSYGVILLEMISGKLPM 595 (686)
Q Consensus 522 ~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-----~~sDVwSlGvvl~elltG~~P~ 595 (686)
+..+... ......+||.+|||||++.+.. +. .+.||||+|.|||||+++..-+
T Consensus 366 ~~p~~~~---------------------~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~ 424 (534)
T KOG3653|consen 366 LEPGKPQ---------------------GDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDA 424 (534)
T ss_pred ecCCCCC---------------------cchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccc
Confidence 8754322 1223478999999999987642 22 3689999999999999965433
Q ss_pred c------------ccCccchhHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042348 596 I------------QIGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCD 663 (686)
Q Consensus 596 ~------------~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 663 (686)
. ..-...-.+.+ ++..+-.++..+.+.|.... ...+..+.+.+..||+.||+.|-|+.=|-+
T Consensus 425 ~~~~vp~Yqlpfe~evG~hPt~e~-mq~~VV~kK~RP~~p~~W~~-----h~~~~~l~et~EeCWDhDaeARLTA~Cv~e 498 (534)
T KOG3653|consen 425 DPGPVPEYQLPFEAEVGNHPTLEE-MQELVVRKKQRPKIPDAWRK-----HAGMAVLCETIEECWDHDAEARLTAGCVEE 498 (534)
T ss_pred cCCCCCcccCchhHHhcCCCCHHH-HHHHHHhhccCCCChhhhhc-----CccHHHHHHHHHHHcCCchhhhhhhHHHHH
Confidence 1 11011111222 22222222222333232222 234567889999999999999999999999
Q ss_pred HHhcccccchh
Q 042348 664 SLDRVNISTEQ 674 (686)
Q Consensus 664 ~L~~i~~~~~~ 674 (686)
++.++....+.
T Consensus 499 R~~~l~~~~~~ 509 (534)
T KOG3653|consen 499 RMAELMMLWED 509 (534)
T ss_pred HHHHHhccCCc
Confidence 98887765543
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=340.90 Aligned_cols=241 Identities=22% Similarity=0.331 Sum_probs=194.0
Q ss_pred ccCccCceEEEEEEeC-CCceEEEEEcCCC---CccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCC
Q 042348 374 LLGKSTIGIVYKVALN-NEEAVAVRRLGNG---GWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGS 449 (686)
Q Consensus 374 ~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gs 449 (686)
+||+|+||.||++... ++..||+|.+... .......+.+|++++++++||||+++++++...+..++||||+++|+
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~ 81 (323)
T cd05595 2 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGE 81 (323)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCCc
Confidence 5899999999999865 5889999998653 22334567889999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCc
Q 042348 450 LATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETP 529 (686)
Q Consensus 450 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 529 (686)
|.+++... ..+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 82 L~~~l~~~------~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~--- 149 (323)
T cd05595 82 LFFHLSRE------RVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--- 149 (323)
T ss_pred HHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEEcCCCCEEecccHHhccccCCC---
Confidence 99988754 358999999999999999999999 899999999999999999999999999987432111
Q ss_pred cccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHHH
Q 042348 530 EVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQWI 609 (686)
Q Consensus 530 ~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~ 609 (686)
.......||..|+|||++.+..++.++|||||||++|||++|+.||...... ...
T Consensus 150 --------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~-----~~~ 204 (323)
T cd05595 150 --------------------ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-----RLF 204 (323)
T ss_pred --------------------CccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHH-----HHH
Confidence 0112345788899999999889999999999999999999999999543221 122
Q ss_pred HHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 042348 610 QLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRP-----SMRHVCDS 664 (686)
Q Consensus 610 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~ev~~~ 664 (686)
..+.......+.. ....+.+++.+||+.||++|| ++.+++++
T Consensus 205 ~~~~~~~~~~p~~-------------~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 205 ELILMEEIRFPRT-------------LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred HHHhcCCCCCCCC-------------CCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence 2222222211111 123567899999999999998 88888765
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=326.70 Aligned_cols=256 Identities=25% Similarity=0.340 Sum_probs=192.1
Q ss_pred cccCccCceEEEEEEeCC-CceEEEEEcCCCCccchHHHHHHHHHHhccCCCCcceeeEEEEecC-----ceeEEEeccC
Q 042348 373 FLLGKSTIGIVYKVALNN-EEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVD-----EKLLIYDYIP 446 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~-----~~~lV~e~~~ 446 (686)
+++|.|+||.||+|.... ++.||||++-... +--.+|+.+|++++|||||++..+|.... ...+|||||+
T Consensus 30 ~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~----r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleymP 105 (364)
T KOG0658|consen 30 RLIGSGSFGVVYQAKLRETEEEVAIKKVLQDK----RYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYMP 105 (364)
T ss_pred EEEeecccceEEEEEEcCCCceeEEEEecCCC----CcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhch
Confidence 579999999999998764 6899999985432 23357999999999999999999887543 2358999998
Q ss_pred CCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCC-CCeEEeecCcccccccc
Q 042348 447 NGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKN-MEPHISDFGLARLADIA 525 (686)
Q Consensus 447 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~-~~~kl~DfGla~~~~~~ 525 (686)
. +|.+.++..... .+.++.-.++-+..||.+||+|||+ .+|+||||||+|+|+|.+ |.+||||||.|+.+..+
T Consensus 106 ~-tL~~~~r~~~~~--~~~mp~~~iKLYt~Qlfrgl~yLh~---~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~ 179 (364)
T KOG0658|consen 106 E-TLYRVIRHYTRA--NQRMPLLEIKLYTYQLFRGLAYLHS---HGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKG 179 (364)
T ss_pred H-HHHHHHHHHhhc--CCCCceeeeHHHHHHHHHHHHHHHh---cCcccCCCChheEEEcCCCCeEEeccCCcceeeccC
Confidence 7 999999853211 1457778889999999999999999 899999999999999966 89999999999988655
Q ss_pred cCCccccccccccCCCCCCCccccccccCCCCCccccCcccccC-CCCCCcchHHHHHHHHHHHHhCCCCccccCccchh
Q 042348 526 EETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKV-RKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELN 604 (686)
Q Consensus 526 ~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~ 604 (686)
+.. .+...|.+|+|||.+.+ ..|+.+.||||.|||+.||+-|++-|.+... .+
T Consensus 180 epn------------------------iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~--~d 233 (364)
T KOG0658|consen 180 EPN------------------------ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSS--VD 233 (364)
T ss_pred CCc------------------------eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCH--HH
Confidence 421 23445778999999877 5699999999999999999999998865332 22
Q ss_pred HHHHHHHHHhhc---------CCcccccCcccccCC----CcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 605 IVQWIQLILEDR---------KPMTDILDPFLAHDL----DKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 605 ~~~~~~~~~~~~---------~~~~~~~d~~l~~~~----~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
....+-.++... ....+.-.|.+.... .......+.++++.++++++|.+|.++.|++.+
T Consensus 234 QL~eIik~lG~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h 306 (364)
T KOG0658|consen 234 QLVEIIKVLGTPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH 306 (364)
T ss_pred HHHHHHHHhCCCCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence 222222222110 000111112222111 112344578899999999999999999999876
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-40 Score=336.98 Aligned_cols=239 Identities=21% Similarity=0.286 Sum_probs=195.6
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCC---ccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCC
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGG---WQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNG 448 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~g 448 (686)
..||+|+||.||+|... +++.||+|.+.... ....+.+.+|++++++++||||+++++++.+.+..++||||+++|
T Consensus 7 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~ 86 (291)
T cd05612 7 KTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGG 86 (291)
T ss_pred eeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEeCCCCC
Confidence 46999999999999876 58899999986432 223456889999999999999999999999999999999999999
Q ss_pred CHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCC
Q 042348 449 SLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEET 528 (686)
Q Consensus 449 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 528 (686)
+|.+++... ..+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 87 ~L~~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~-- 155 (291)
T cd05612 87 ELFSYLRNS------GRFSNSTGLFYASEIVCALEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT-- 155 (291)
T ss_pred CHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEEecCcchhccCCc--
Confidence 999999765 358899999999999999999999 899999999999999999999999999987543110
Q ss_pred ccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHH
Q 042348 529 PEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQW 608 (686)
Q Consensus 529 ~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~ 608 (686)
....||..|+|||++.+..++.++|||||||++|||++|+.||..... ...
T Consensus 156 ------------------------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~-----~~~ 206 (291)
T cd05612 156 ------------------------WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNP-----FGI 206 (291)
T ss_pred ------------------------ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----HHH
Confidence 123467789999999988899999999999999999999999954322 222
Q ss_pred HHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCC-----HHHHHHH
Q 042348 609 IQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPS-----MRHVCDS 664 (686)
Q Consensus 609 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~ev~~~ 664 (686)
.+.+.......+..+ ...+.+++.+||+.||.+||+ +.|++++
T Consensus 207 ~~~i~~~~~~~~~~~-------------~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 207 YEKILAGKLEFPRHL-------------DLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred HHHHHhCCcCCCccC-------------CHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 333333322222111 235778999999999999995 8888877
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=327.84 Aligned_cols=250 Identities=23% Similarity=0.392 Sum_probs=197.2
Q ss_pred hcccCccCceEEEEEEeC----CCceEEEEEcCCCC-ccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccC
Q 042348 372 AFLLGKSTIGIVYKVALN----NEEAVAVRRLGNGG-WQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIP 446 (686)
Q Consensus 372 ~~~iG~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~ 446 (686)
...||+|+||.||+|.+. .+..||+|.++... ......+.+|+..+++++||||+++++++...+..++||||++
T Consensus 10 ~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 89 (266)
T cd05064 10 ERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMS 89 (266)
T ss_pred eeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEEEEeCC
Confidence 346999999999999753 35689999987653 2334578999999999999999999999999999999999999
Q ss_pred CCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCccccccccc
Q 042348 447 NGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAE 526 (686)
Q Consensus 447 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~ 526 (686)
+|+|.+++.... ..+++.+++.++.|++.||+|||+ ++++||||||+||+++.++.+|++|||.+.......
T Consensus 90 ~~~L~~~l~~~~-----~~l~~~~~~~~~~~i~~al~~lH~---~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~ 161 (266)
T cd05064 90 NGALDSFLRKHE-----GQLVAGQLMGMLPGLASGMKYLSE---MGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEA 161 (266)
T ss_pred CCcHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHH---CCEeeccccHhhEEEcCCCcEEECCCcccccccccc
Confidence 999999997643 358999999999999999999999 899999999999999999999999999875422110
Q ss_pred CCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCccccCccchhH
Q 042348 527 ETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQIGSMELNI 605 (686)
Q Consensus 527 ~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~~~~ 605 (686)
. .......++..|+|||.+.+..++.++|||||||++||+++ |+.||......
T Consensus 162 ~----------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~---- 215 (266)
T cd05064 162 I----------------------YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ---- 215 (266)
T ss_pred h----------------------hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH----
Confidence 0 00011233567999999988999999999999999999875 99999543221
Q ss_pred HHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 042348 606 VQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRV 668 (686)
Q Consensus 606 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i 668 (686)
..++.+... ...+ . .......+.+++.+||+.+|++||++.||.+.|+++
T Consensus 216 -~~~~~~~~~-~~~~---~--------~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 216 -DVIKAVEDG-FRLP---A--------PRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred -HHHHHHHCC-CCCC---C--------CCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 122222221 1111 0 112334678899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=341.17 Aligned_cols=239 Identities=20% Similarity=0.288 Sum_probs=195.1
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCC---ccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCC
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGG---WQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNG 448 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~g 448 (686)
+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|+.++++++||||+++++++...+..++||||+++|
T Consensus 24 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~ 103 (329)
T PTZ00263 24 ETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGG 103 (329)
T ss_pred EEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEEcCCCCC
Confidence 46999999999999876 57899999986532 233456889999999999999999999999999999999999999
Q ss_pred CHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCC
Q 042348 449 SLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEET 528 (686)
Q Consensus 449 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 528 (686)
+|.+++... ..+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 104 ~L~~~l~~~------~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-- 172 (329)
T PTZ00263 104 ELFTHLRKA------GRFPNDVAKFYHAELVLAFEYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT-- 172 (329)
T ss_pred hHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHEEECCCCCEEEeeccCceEcCCCc--
Confidence 999999764 357889999999999999999999 899999999999999999999999999997543111
Q ss_pred ccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHH
Q 042348 529 PEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQW 608 (686)
Q Consensus 529 ~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~ 608 (686)
....||..|+|||++.+..++.++|||||||++|||++|+.||..... .+.
T Consensus 173 ------------------------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~-----~~~ 223 (329)
T PTZ00263 173 ------------------------FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP-----FRI 223 (329)
T ss_pred ------------------------ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCH-----HHH
Confidence 123567789999999988899999999999999999999999954321 222
Q ss_pred HHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCC-----HHHHHHH
Q 042348 609 IQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPS-----MRHVCDS 664 (686)
Q Consensus 609 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~ev~~~ 664 (686)
...+.......+..+ ...+.+++.+||+.||++||+ +++++.+
T Consensus 224 ~~~i~~~~~~~p~~~-------------~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 224 YEKILAGRLKFPNWF-------------DGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred HHHHhcCCcCCCCCC-------------CHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 333333322222211 124678999999999999997 6777766
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=323.01 Aligned_cols=246 Identities=23% Similarity=0.409 Sum_probs=197.4
Q ss_pred cccCccCceEEEEEEeCCCceEEEEEcCCCCccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCCHHH
Q 042348 373 FLLGKSTIGIVYKVALNNEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLAT 452 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL~~ 452 (686)
..||+|+||.||++...++..+|+|.+..... ..+++.+|++++++++||||+++++++...+..++||||+++|+|.+
T Consensus 10 ~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~ 88 (256)
T cd05114 10 KELGSGQFGVVHLGKWRAQIKVAIKAINEGAM-SEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLN 88 (256)
T ss_pred eEecCCcCceEEEEEeccCceEEEEecccCCc-cHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCCCcHHH
Confidence 35999999999999998888899998865432 34678999999999999999999999999999999999999999999
Q ss_pred HhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCcccc
Q 042348 453 AIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVH 532 (686)
Q Consensus 453 ~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 532 (686)
+++... ..+++..+..++.|++.||+|||+ ++|+||||||+||++++++.+||+|||.++.......
T Consensus 89 ~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~----- 155 (256)
T cd05114 89 YLRQRQ-----GKLSKDMLLSMCQDVCEGMEYLER---NSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY----- 155 (256)
T ss_pred HHHhCc-----cCCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcceEEEcCCCeEEECCCCCccccCCCce-----
Confidence 997643 348899999999999999999999 8999999999999999999999999999875432110
Q ss_pred ccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCccccCccchhHHHHHHH
Q 042348 533 WEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQIGSMELNIVQWIQL 611 (686)
Q Consensus 533 ~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~ 611 (686)
.......++..|+|||++.+..++.++||||||+++|||++ |+.||..... .+.+..
T Consensus 156 -----------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~-----~~~~~~ 213 (256)
T cd05114 156 -----------------TSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN-----YEVVEM 213 (256)
T ss_pred -----------------eccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH-----HHHHHH
Confidence 00111223456999999988889999999999999999999 8999954322 222333
Q ss_pred HHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 042348 612 ILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLD 666 (686)
Q Consensus 612 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~ 666 (686)
+....... .+. .....+.+++.+||+.+|++||++.|+++.|.
T Consensus 214 i~~~~~~~----~~~--------~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 214 ISRGFRLY----RPK--------LASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred HHCCCCCC----CCC--------CCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 33222111 111 11235789999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=337.69 Aligned_cols=241 Identities=21% Similarity=0.309 Sum_probs=193.5
Q ss_pred ccCccCceEEEEEEe----CCCceEEEEEcCCCC----ccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEecc
Q 042348 374 LLGKSTIGIVYKVAL----NNEEAVAVRRLGNGG----WQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYI 445 (686)
Q Consensus 374 ~iG~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~ 445 (686)
.||+|+||.||+++. ..++.||||.+.... ......+..|++++++++||||+++++++...+..++||||+
T Consensus 3 ~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 82 (323)
T cd05584 3 VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEYL 82 (323)
T ss_pred eeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeCC
Confidence 699999999999975 357889999986531 223356788999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccc
Q 042348 446 PNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIA 525 (686)
Q Consensus 446 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~ 525 (686)
++|+|.+++... ..+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 83 ~~~~L~~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 153 (323)
T cd05584 83 SGGELFMHLERE------GIFMEDTACFYLSEISLALEHLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHE 153 (323)
T ss_pred CCchHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEeeCcCCeecccC
Confidence 999999999754 357888899999999999999999 89999999999999999999999999998743211
Q ss_pred cCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhH
Q 042348 526 EETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNI 605 (686)
Q Consensus 526 ~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~ 605 (686)
. .......||..|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 154 ~-----------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~----- 205 (323)
T cd05584 154 G-----------------------TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENR----- 205 (323)
T ss_pred C-----------------------CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCH-----
Confidence 1 011234578889999999988899999999999999999999999954322
Q ss_pred HHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 042348 606 VQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRP-----SMRHVCDS 664 (686)
Q Consensus 606 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~ev~~~ 664 (686)
...+..+.......+.. ....+.+++.+||+.||++|| ++.+++++
T Consensus 206 ~~~~~~~~~~~~~~~~~-------------~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 206 KKTIDKILKGKLNLPPY-------------LTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred HHHHHHHHcCCCCCCCC-------------CCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence 22233333332222211 123577899999999999999 78888775
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=325.33 Aligned_cols=251 Identities=21% Similarity=0.311 Sum_probs=195.2
Q ss_pred ccCccCceEEEEEEeC-CCceEEEEEcCCCCc--------------cchHHHHHHHHHHhccCCCCcceeeEEEEec--C
Q 042348 374 LLGKSTIGIVYKVALN-NEEAVAVRRLGNGGW--------------QRFKEFQTEAEAIGKIRHPNIVSLRAYFWSV--D 436 (686)
Q Consensus 374 ~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------------~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~ 436 (686)
-||+|.||.|-+|+.. +++.||||++.+... ...+...+||.+|++++|||||+++.+..+. +
T Consensus 104 eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEvLDDP~s~ 183 (576)
T KOG0585|consen 104 EIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEVLDDPESD 183 (576)
T ss_pred hhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEeecCcccC
Confidence 4899999999999865 688999999865321 1235788999999999999999999998875 5
Q ss_pred ceeEEEeccCCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeec
Q 042348 437 EKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDF 516 (686)
Q Consensus 437 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~Df 516 (686)
..|||+|||..|.+...-... ..+++.+++++++++..||+|||. ++||||||||+|+|++++|++||+||
T Consensus 184 ~~YlVley~s~G~v~w~p~d~------~els~~~Ar~ylrDvv~GLEYLH~---QgiiHRDIKPsNLLl~~~g~VKIsDF 254 (576)
T KOG0585|consen 184 KLYLVLEYCSKGEVKWCPPDK------PELSEQQARKYLRDVVLGLEYLHY---QGIIHRDIKPSNLLLSSDGTVKISDF 254 (576)
T ss_pred ceEEEEEeccCCccccCCCCc------ccccHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheEEcCCCcEEeecc
Confidence 789999999988876532211 238999999999999999999999 99999999999999999999999999
Q ss_pred CcccccccccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCC----CCCcchHHHHHHHHHHHHhCC
Q 042348 517 GLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRK----PTQKWDIYSYGVILLEMISGK 592 (686)
Q Consensus 517 Gla~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDVwSlGvvl~elltG~ 592 (686)
|.+.....+..... .......+||+.|+|||...++. .+.+.||||+||+||.|+.|+
T Consensus 255 GVs~~~~~~~~~~~------------------d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~ 316 (576)
T KOG0585|consen 255 GVSNEFPQGSDEGS------------------DDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQ 316 (576)
T ss_pred ceeeecccCCcccc------------------HHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhcc
Confidence 99976543311100 02234478899999999886632 467899999999999999999
Q ss_pred CCccccCccchhHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 042348 593 LPMIQIGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDR 667 (686)
Q Consensus 593 ~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~ 667 (686)
.||... ...+....+....-..++ .++....+.+|+.++|++||++|.+..+|..|.--
T Consensus 317 ~PF~~~-----~~~~l~~KIvn~pL~fP~-----------~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwv 375 (576)
T KOG0585|consen 317 LPFFDD-----FELELFDKIVNDPLEFPE-----------NPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWV 375 (576)
T ss_pred CCcccc-----hHHHHHHHHhcCcccCCC-----------cccccHHHHHHHHHHhhcChhheeehhhheeccee
Confidence 999432 233444455444322221 11344567899999999999999999999887633
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-40 Score=335.83 Aligned_cols=244 Identities=23% Similarity=0.355 Sum_probs=206.0
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCC--CccchHHHHHHHHHHhccCCCCcceeeEEEEecCc-eeEEEeccCCC
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNG--GWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDE-KLLIYDYIPNG 448 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~-~~lV~e~~~~g 448 (686)
+.+|+|+||.++.++.+ +...+++|.+... ....++...+|+.++++++|||||.+.+.|..++. .+|||+||+||
T Consensus 10 ~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~Y~eGg 89 (426)
T KOG0589|consen 10 RQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVMEYCEGG 89 (426)
T ss_pred hhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEEeecCCC
Confidence 46999999999998865 4678999988654 33445578999999999999999999999999988 89999999999
Q ss_pred CHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCC
Q 042348 449 SLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEET 528 (686)
Q Consensus 449 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 528 (686)
++.+.|.+..+ ..++++.+.+|+.|++.|+.|||+ +.|+|||||+.||++..+..+||+|||+|+.+....
T Consensus 90 ~l~~~i~~~k~----~~f~E~~i~~~~~Q~~~av~ylH~---~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~-- 160 (426)
T KOG0589|consen 90 DLAQLIKEQKG----VLFPEERILKWFVQILLAVNYLHE---NRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED-- 160 (426)
T ss_pred CHHHHHHHHhh----ccccHHHHHHHHHHHHHHHHHHHh---hhhhcccchhhhhhccccCceeecchhhhhhcCCch--
Confidence 99999998764 468999999999999999999998 899999999999999999999999999999876432
Q ss_pred ccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHH
Q 042348 529 PEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQW 608 (686)
Q Consensus 529 ~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~ 608 (686)
......+||+.||.||.+.+.+|+.|+|||||||++|||++-+++|... +....
T Consensus 161 ---------------------~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~-----~m~~L 214 (426)
T KOG0589|consen 161 ---------------------SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKAS-----NMSEL 214 (426)
T ss_pred ---------------------hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCcc-----chHHH
Confidence 1223567888999999999999999999999999999999999999543 33344
Q ss_pred HHHHHhhc-CCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 609 IQLILEDR-KPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 609 ~~~~~~~~-~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
+..+.... .+++ .....++..++..|++.+|+.||++.+++.+
T Consensus 215 i~ki~~~~~~Plp-------------~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 215 ILKINRGLYSPLP-------------SMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred HHHHhhccCCCCC-------------ccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 45554443 2221 2234568889999999999999999999887
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-39 Score=341.32 Aligned_cols=256 Identities=25% Similarity=0.337 Sum_probs=197.4
Q ss_pred hcccCccCceEEEEEEe------CCCceEEEEEcCCCC-ccchHHHHHHHHHHhcc-CCCCcceeeEEEEecCceeEEEe
Q 042348 372 AFLLGKSTIGIVYKVAL------NNEEAVAVRRLGNGG-WQRFKEFQTEAEAIGKI-RHPNIVSLRAYFWSVDEKLLIYD 443 (686)
Q Consensus 372 ~~~iG~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~e 443 (686)
.+.||+|+||.||+|.. .++..||||+++... ....+.+.+|++++..+ +||||++++++|...+..++|||
T Consensus 40 ~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~~lv~E 119 (375)
T cd05104 40 GKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPTLVITE 119 (375)
T ss_pred hheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcceeeeh
Confidence 45799999999999963 235689999987542 23446788999999999 89999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCCcc--------------------------------------------------------------
Q 042348 444 YIPNGSLATAIHGKAGII-------------------------------------------------------------- 461 (686)
Q Consensus 444 ~~~~gsL~~~l~~~~~~~-------------------------------------------------------------- 461 (686)
||++|+|.++++......
T Consensus 120 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (375)
T cd05104 120 YCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYIDQDV 199 (375)
T ss_pred hccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccceeccccc
Confidence 999999999997543110
Q ss_pred -------ccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCcccccc
Q 042348 462 -------SYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWE 534 (686)
Q Consensus 462 -------~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 534 (686)
....+++..+.+++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++........
T Consensus 200 ~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~------ 270 (375)
T cd05104 200 TSEILEEDELALDTEDLLSFSYQVAKGMSFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY------ 270 (375)
T ss_pred HHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCchhhEEEECCCcEEEecCccceeccCcccc------
Confidence 01257899999999999999999999 89999999999999999999999999999755322110
Q ss_pred ccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCccccCccchhHHHHHHHHH
Q 042348 535 QSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQIGSMELNIVQWIQLIL 613 (686)
Q Consensus 535 ~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~ 613 (686)
.......++..|+|||++.+..++.++|||||||++|||++ |..||....... .... . .
T Consensus 271 ---------------~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~-~~~~---~-~ 330 (375)
T cd05104 271 ---------------VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS-KFYK---M-I 330 (375)
T ss_pred ---------------cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH-HHHH---H-H
Confidence 00111234567999999998899999999999999999998 888985432211 1111 1 1
Q ss_pred hhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 042348 614 EDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDR 667 (686)
Q Consensus 614 ~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~ 667 (686)
....... .+. ....++.+++.+||+.||++||++.||++.|++
T Consensus 331 ~~~~~~~---~~~--------~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~ 373 (375)
T cd05104 331 KEGYRML---SPE--------CAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ 373 (375)
T ss_pred HhCccCC---CCC--------CCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence 1111100 010 112367899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=336.70 Aligned_cols=241 Identities=21% Similarity=0.297 Sum_probs=192.9
Q ss_pred ccCccCceEEEEEEeC-CCceEEEEEcCCC---CccchHHHHHHHHHHhcc-CCCCcceeeEEEEecCceeEEEeccCCC
Q 042348 374 LLGKSTIGIVYKVALN-NEEAVAVRRLGNG---GWQRFKEFQTEAEAIGKI-RHPNIVSLRAYFWSVDEKLLIYDYIPNG 448 (686)
Q Consensus 374 ~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~e~~~~g 448 (686)
.||+|+||.||+|... +++.||||.+... .....+.+..|..++..+ +||||+++++++...+..++||||+++|
T Consensus 2 ~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~g 81 (320)
T cd05590 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNGG 81 (320)
T ss_pred eeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCCc
Confidence 5899999999999875 5789999998653 223345677899998877 6999999999999999999999999999
Q ss_pred CHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCC
Q 042348 449 SLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEET 528 (686)
Q Consensus 449 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 528 (686)
+|.+++... ..+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~L~~~i~~~------~~l~~~~~~~~~~ql~~~L~~lH~---~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~-- 150 (320)
T cd05590 82 DLMFHIQKS------RRFDEARARFYAAEITSALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG-- 150 (320)
T ss_pred hHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC--
Confidence 999998764 358999999999999999999999 899999999999999999999999999987432111
Q ss_pred ccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHH
Q 042348 529 PEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQW 608 (686)
Q Consensus 529 ~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~ 608 (686)
.......||..|+|||++.+..++.++|||||||++|||++|+.||..... ...
T Consensus 151 ---------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~-----~~~ 204 (320)
T cd05590 151 ---------------------KTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENE-----DDL 204 (320)
T ss_pred ---------------------CcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH-----HHH
Confidence 011234578889999999988899999999999999999999999954322 222
Q ss_pred HHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCH------HHHHHH
Q 042348 609 IQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSM------RHVCDS 664 (686)
Q Consensus 609 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~------~ev~~~ 664 (686)
...+.......+.. ....+.+++.+||+.||++||++ ++++++
T Consensus 205 ~~~i~~~~~~~~~~-------------~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h 253 (320)
T cd05590 205 FEAILNDEVVYPTW-------------LSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRH 253 (320)
T ss_pred HHHHhcCCCCCCCC-------------CCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcC
Confidence 33333322221111 12357789999999999999998 566554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=300.03 Aligned_cols=243 Identities=26% Similarity=0.336 Sum_probs=202.0
Q ss_pred hcccCccCceEEEEEEeC-CCceEEEEEcCCCC---ccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCC
Q 042348 372 AFLLGKSTIGIVYKVALN-NEEAVAVRRLGNGG---WQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPN 447 (686)
Q Consensus 372 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~ 447 (686)
+..||+|.||.||.|+.+ ++-.||+|++.+.. .....++.+|+++-+.++||||+++|++|.+....|+++||.++
T Consensus 27 gr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLilEya~~ 106 (281)
T KOG0580|consen 27 GRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLILEYAPR 106 (281)
T ss_pred cccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEEEecCC
Confidence 457999999999999876 56789999986642 22346789999999999999999999999999999999999999
Q ss_pred CCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccC
Q 042348 448 GSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEE 527 (686)
Q Consensus 448 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 527 (686)
|++...|.+... ..+++.....++.|+|.||.|+|. ++||||||||+|+|++.++..||+|||-+-....
T Consensus 107 gel~k~L~~~~~----~~f~e~~~a~Yi~q~A~Al~y~h~---k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~--- 176 (281)
T KOG0580|consen 107 GELYKDLQEGRM----KRFDEQRAATYIKQLANALLYCHL---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS--- 176 (281)
T ss_pred chHHHHHHhccc----ccccccchhHHHHHHHHHHHHhcc---CCcccCCCCHHHhccCCCCCeeccCCCceeecCC---
Confidence 999999986654 468888889999999999999999 9999999999999999999999999998754321
Q ss_pred CccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHH
Q 042348 528 TPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQ 607 (686)
Q Consensus 528 ~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~ 607 (686)
......+||..|.+||+..+..++..+|+|++|++.||++.|.+||..... .+
T Consensus 177 ----------------------~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~-----~e 229 (281)
T KOG0580|consen 177 ----------------------NKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSH-----SE 229 (281)
T ss_pred ----------------------CCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhh-----HH
Confidence 112345788999999999999999999999999999999999999965432 23
Q ss_pred HHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 608 WIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 608 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
..+.+..-+..++.. ......+++.+|+.++|.+|.+..|++++
T Consensus 230 tYkrI~k~~~~~p~~-------------is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 230 TYKRIRKVDLKFPST-------------ISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred HHHHHHHccccCCcc-------------cChhHHHHHHHHhccCccccccHHHHhhh
Confidence 344444433322221 12256789999999999999999999876
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=339.28 Aligned_cols=239 Identities=21% Similarity=0.265 Sum_probs=193.8
Q ss_pred cccCccCceEEEEEEeCC--CceEEEEEcCCC---CccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCC
Q 042348 373 FLLGKSTIGIVYKVALNN--EEAVAVRRLGNG---GWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPN 447 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~~--~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~ 447 (686)
..||+|+||.||+|.... +..||+|++... .....+.+.+|+.+++.++||||+++++++.+.+..++||||+++
T Consensus 36 ~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~Ey~~~ 115 (340)
T PTZ00426 36 RTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIG 115 (340)
T ss_pred EEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEEEeCCCC
Confidence 469999999999998643 368999988543 223345688999999999999999999999999999999999999
Q ss_pred CCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccC
Q 042348 448 GSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEE 527 (686)
Q Consensus 448 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 527 (686)
|+|.+++... ..+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 116 g~L~~~i~~~------~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~-- 184 (340)
T PTZ00426 116 GEFFTFLRRN------KRFPNDVGCFYAAQIVLIFEYLQS---LNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR-- 184 (340)
T ss_pred CcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEecCCCCeecCCC--
Confidence 9999999765 358999999999999999999999 89999999999999999999999999999754311
Q ss_pred CccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHH
Q 042348 528 TPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQ 607 (686)
Q Consensus 528 ~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~ 607 (686)
.....||..|+|||++.+..++.++|||||||++|||++|+.||..... ..
T Consensus 185 ------------------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~-----~~ 235 (340)
T PTZ00426 185 ------------------------TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEP-----LL 235 (340)
T ss_pred ------------------------cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCH-----HH
Confidence 1123567789999999888899999999999999999999999954322 12
Q ss_pred HHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 042348 608 WIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRP-----SMRHVCDS 664 (686)
Q Consensus 608 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~ev~~~ 664 (686)
..+.+.......+..+ ...+.+++.+|++.||++|+ +++|++++
T Consensus 236 ~~~~i~~~~~~~p~~~-------------~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 236 IYQKILEGIIYFPKFL-------------DNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred HHHHHhcCCCCCCCCC-------------CHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 2233333222211111 12467899999999999995 88888876
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=315.65 Aligned_cols=275 Identities=23% Similarity=0.301 Sum_probs=212.8
Q ss_pred ccCccCceEEEEEEeCC-CceEEEEEcCCCCcc---chHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCC
Q 042348 374 LLGKSTIGIVYKVALNN-EEAVAVRRLGNGGWQ---RFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGS 449 (686)
Q Consensus 374 ~iG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gs 449 (686)
.||.|.-|+||.++..+ +...|+|++.+.... ...+.+.|-+||+.++||.++.+|+.|+.++..++|||||+||+
T Consensus 84 ~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~meyCpGGd 163 (459)
T KOG0610|consen 84 RLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVMEYCPGGD 163 (459)
T ss_pred HcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEecCCCcc
Confidence 69999999999999875 478999999875433 34568889999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCc
Q 042348 450 LATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETP 529 (686)
Q Consensus 450 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 529 (686)
|..+++.+.+ +.+++..+.-++.+|+-||+|||- .|||.|||||+||||.++|++.|+||.++..........
T Consensus 164 L~~LrqkQp~----~~fse~~aRFYaAEvl~ALEYLHm---lGivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt~~ 236 (459)
T KOG0610|consen 164 LHSLRQKQPG----KRFSESAARFYAAEVLLALEYLHM---LGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPTLV 236 (459)
T ss_pred HHHHHhhCCC----CccchhhHHHHHHHHHHHHHHHHh---hceeeccCCcceeEEecCCcEEeeeccccccCCCCCeee
Confidence 9999998765 679999999999999999999999 899999999999999999999999999987653211000
Q ss_pred cccc----------cc--ccc-------C-C-------------CCCCCccccccccCCCCCccccCcccccCCCCCCcc
Q 042348 530 EVHW----------EQ--STT-------G-T-------------PLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKW 576 (686)
Q Consensus 530 ~~~~----------~~--~~~-------g-~-------------~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~s 576 (686)
.... .. ..+ + + |...+.......++.+||-.|.|||++.+...+.++
T Consensus 237 ~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgsAV 316 (459)
T KOG0610|consen 237 KSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGSAV 316 (459)
T ss_pred ccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCchh
Confidence 0000 00 000 0 0 000001111345678999999999999999999999
Q ss_pred hHHHHHHHHHHHHhCCCCccccCccchhHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCC
Q 042348 577 DIYSYGVILLEMISGKLPMIQIGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRP 656 (686)
Q Consensus 577 DVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 656 (686)
|+|+|||++|||+.|+.||.+.+..+. ...++......++. ......+.+||.+.|.+||.+|.
T Consensus 317 DWWtfGIflYEmLyG~TPFKG~~~~~T-----l~NIv~~~l~Fp~~-----------~~vs~~akDLIr~LLvKdP~kRl 380 (459)
T KOG0610|consen 317 DWWTFGIFLYEMLYGTTPFKGSNNKET-----LRNIVGQPLKFPEE-----------PEVSSAAKDLIRKLLVKDPSKRL 380 (459)
T ss_pred hHHHHHHHHHHHHhCCCCcCCCCchhh-----HHHHhcCCCcCCCC-----------CcchhHHHHHHHHHhccChhhhh
Confidence 999999999999999999977655432 34444433222211 12345678999999999999998
Q ss_pred C----HHHHHHH--Hhccccc
Q 042348 657 S----MRHVCDS--LDRVNIS 671 (686)
Q Consensus 657 s----~~ev~~~--L~~i~~~ 671 (686)
. +.||-+| .+.++.+
T Consensus 381 g~~rGA~eIK~HpFF~gVnWa 401 (459)
T KOG0610|consen 381 GSKRGAAEIKRHPFFEGVNWA 401 (459)
T ss_pred ccccchHHhhcCccccCCChh
Confidence 8 8888776 4555543
|
|
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=335.85 Aligned_cols=241 Identities=22% Similarity=0.306 Sum_probs=193.5
Q ss_pred ccCccCceEEEEEEeC-CCceEEEEEcCCCC---ccchHHHHHHHHHHhcc-CCCCcceeeEEEEecCceeEEEeccCCC
Q 042348 374 LLGKSTIGIVYKVALN-NEEAVAVRRLGNGG---WQRFKEFQTEAEAIGKI-RHPNIVSLRAYFWSVDEKLLIYDYIPNG 448 (686)
Q Consensus 374 ~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~e~~~~g 448 (686)
+||+|+||.||+|+.. +++.||+|.+.... ....+.+..|.+++..+ +||||+++++++...+..++||||+++|
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 81 (321)
T cd05591 2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNGG 81 (321)
T ss_pred ccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCCC
Confidence 5899999999999876 47899999986532 23345677899998876 7999999999999999999999999999
Q ss_pred CHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCC
Q 042348 449 SLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEET 528 (686)
Q Consensus 449 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 528 (686)
+|.+++... ..+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++.......
T Consensus 82 ~L~~~l~~~------~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~- 151 (321)
T cd05591 82 DLMFQIQRS------RKFDEPRSRFYAAEVTLALMFLHR---HGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV- 151 (321)
T ss_pred cHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeecccceecccCCc-
Confidence 999998754 358899999999999999999999 8999999999999999999999999999874321110
Q ss_pred ccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHH
Q 042348 529 PEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQW 608 (686)
Q Consensus 529 ~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~ 608 (686)
......||..|+|||++.+..++.++|||||||++|||++|+.||..... ...
T Consensus 152 ----------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~-----~~~ 204 (321)
T cd05591 152 ----------------------TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNE-----DDL 204 (321)
T ss_pred ----------------------cccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCH-----HHH
Confidence 11234578889999999988999999999999999999999999954332 222
Q ss_pred HHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCC-------CHHHHHHH
Q 042348 609 IQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRP-------SMRHVCDS 664 (686)
Q Consensus 609 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-------s~~ev~~~ 664 (686)
...+.......+.. ...++.+++.+||+.||++|| ++.+++++
T Consensus 205 ~~~i~~~~~~~p~~-------------~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 205 FESILHDDVLYPVW-------------LSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred HHHHHcCCCCCCCC-------------CCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 33333332211111 123577899999999999999 78888766
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=338.78 Aligned_cols=242 Identities=23% Similarity=0.324 Sum_probs=193.9
Q ss_pred ccCccCceEEEEEEeC-CCceEEEEEcCCC---CccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCC
Q 042348 374 LLGKSTIGIVYKVALN-NEEAVAVRRLGNG---GWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGS 449 (686)
Q Consensus 374 ~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gs 449 (686)
.||+|+||.||++... +++.||+|.+... .......+..|++++..++||||+++++++...+..++||||+++|+
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~ 81 (325)
T cd05594 2 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGE 81 (325)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCCc
Confidence 5899999999999864 6889999998653 22334567889999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCc
Q 042348 450 LATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETP 529 (686)
Q Consensus 450 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 529 (686)
|.+++... ..+++..+..++.|++.||+|||+. ++|+||||||+|||++.++.+||+|||+++......
T Consensus 82 L~~~l~~~------~~l~~~~~~~~~~qi~~aL~~lH~~--~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~--- 150 (325)
T cd05594 82 LFFHLSRE------RVFSEDRARFYGAEIVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG--- 150 (325)
T ss_pred HHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCC---
Confidence 99988754 3589999999999999999999952 589999999999999999999999999987432111
Q ss_pred cccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHHH
Q 042348 530 EVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQWI 609 (686)
Q Consensus 530 ~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~ 609 (686)
.......||..|+|||++.+..++.++|||||||++|||+||+.||..... ....
T Consensus 151 --------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~-----~~~~ 205 (325)
T cd05594 151 --------------------ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-----EKLF 205 (325)
T ss_pred --------------------cccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCH-----HHHH
Confidence 011234578889999999988999999999999999999999999954322 1222
Q ss_pred HHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 042348 610 QLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRP-----SMRHVCDS 664 (686)
Q Consensus 610 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~ev~~~ 664 (686)
..+.......+.. ...++.+++.+||+.||++|+ ++.+++++
T Consensus 206 ~~i~~~~~~~p~~-------------~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 206 ELILMEEIRFPRT-------------LSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred HHHhcCCCCCCCC-------------CCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 2222222222111 123577899999999999996 89999876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-39 Score=340.53 Aligned_cols=257 Identities=26% Similarity=0.334 Sum_probs=197.4
Q ss_pred hcccCccCceEEEEEEeC------CCceEEEEEcCCCC-ccchHHHHHHHHHHhcc-CCCCcceeeEEEEecCceeEEEe
Q 042348 372 AFLLGKSTIGIVYKVALN------NEEAVAVRRLGNGG-WQRFKEFQTEAEAIGKI-RHPNIVSLRAYFWSVDEKLLIYD 443 (686)
Q Consensus 372 ~~~iG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~e 443 (686)
.+.||+|+||.||+|... ++..||||++.... ......+.+|+++++.+ +|+|||+++++|...+..++|||
T Consensus 43 ~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~~lv~e 122 (374)
T cd05106 43 GKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPVLVITE 122 (374)
T ss_pred hheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCeEEeHh
Confidence 457999999999998742 23579999997543 23345688999999999 89999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCCc---------------------------------------------------------------
Q 042348 444 YIPNGSLATAIHGKAGI--------------------------------------------------------------- 460 (686)
Q Consensus 444 ~~~~gsL~~~l~~~~~~--------------------------------------------------------------- 460 (686)
|+++|+|.++++.....
T Consensus 123 y~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 202 (374)
T cd05106 123 YCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSKDEED 202 (374)
T ss_pred hccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccccchhc
Confidence 99999999998643210
Q ss_pred -cccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCccccccccccC
Q 042348 461 -ISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTG 539 (686)
Q Consensus 461 -~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~g 539 (686)
.....+++.++.+|+.||+.||+|||+ ++|+||||||+|||+++++.+||+|||+++........
T Consensus 203 ~~~~~~l~~~~~~~i~~qi~~aL~yLH~---~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~----------- 268 (374)
T cd05106 203 TEDSWPLDLDDLLRFSSQVAQGMDFLAS---KNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNY----------- 268 (374)
T ss_pred cCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcce-----------
Confidence 011357889999999999999999999 89999999999999999999999999999754321100
Q ss_pred CCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCccccCccchhHHHHHHHHHhhcCC
Q 042348 540 TPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQIGSMELNIVQWIQLILEDRKP 618 (686)
Q Consensus 540 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~ 618 (686)
.......++..|+|||++.+..++.++|||||||++|||++ |+.||....... . ..........
T Consensus 269 ----------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~-~----~~~~~~~~~~ 333 (374)
T cd05106 269 ----------VVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS-K----FYKMVKRGYQ 333 (374)
T ss_pred ----------eeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH-H----HHHHHHcccC
Confidence 00111234567999999988889999999999999999997 999995533211 1 1111111111
Q ss_pred cccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 042348 619 MTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRV 668 (686)
Q Consensus 619 ~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i 668 (686)
.. .+. ....++.+++.+||+.||++|||+.+|++.|+++
T Consensus 334 ~~---~~~--------~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~ 372 (374)
T cd05106 334 MS---RPD--------FAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQ 372 (374)
T ss_pred cc---CCC--------CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 00 010 0124678899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=317.63 Aligned_cols=241 Identities=22% Similarity=0.350 Sum_probs=203.3
Q ss_pred cccCccCceEEEEEEe-CCCceEEEEEcCCC---CccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCC
Q 042348 373 FLLGKSTIGIVYKVAL-NNEEAVAVRRLGNG---GWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNG 448 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~g 448 (686)
+.||+|.||.|-+|.. ..|+.||||.+++. +.++.-.+.+||+||+.++||||+.+|.+|+..+...+||||..+|
T Consensus 59 etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivMEYaS~G 138 (668)
T KOG0611|consen 59 ETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVMEYASGG 138 (668)
T ss_pred HHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEEEecCCc
Confidence 4699999999999975 67999999999765 4455567889999999999999999999999999999999999999
Q ss_pred CHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCC
Q 042348 449 SLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEET 528 (686)
Q Consensus 449 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 528 (686)
.|+|++.++ +.|++.+...+++||..|+.|+|. ++++|||||.+|||+|.++++||+|||++.++....
T Consensus 139 eLYDYiSer------~~LsErEaRhfFRQIvSAVhYCHk---nrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~k-- 207 (668)
T KOG0611|consen 139 ELYDYISER------GSLSEREARHFFRQIVSAVHYCHK---NRVVHRDLKLENILLDQNNNIKIADFGLSNLYADKK-- 207 (668)
T ss_pred cHHHHHHHh------ccccHHHHHHHHHHHHHHHHHHhh---ccceecccchhheeecCCCCeeeeccchhhhhcccc--
Confidence 999999987 469999999999999999999999 999999999999999999999999999998775432
Q ss_pred ccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCC-CCcchHHHHHHHHHHHHhCCCCccccCccchhHHH
Q 042348 529 PEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKP-TQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQ 607 (686)
Q Consensus 529 ~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~ 607 (686)
..+..+|++-|.+||...+.+| ++.+|-||+||+||.|+.|..||++. +...
T Consensus 208 ----------------------fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~-----Dhk~ 260 (668)
T KOG0611|consen 208 ----------------------FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGR-----DHKR 260 (668)
T ss_pred ----------------------HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCc-----hHHH
Confidence 3445667777999999999887 67899999999999999999999543 3334
Q ss_pred HHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 042348 608 WIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSL 665 (686)
Q Consensus 608 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L 665 (686)
.++.+..+...-++ .+....-|+.+||..||++|.|+.+|..+.
T Consensus 261 lvrQIs~GaYrEP~--------------~PSdA~gLIRwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 261 LVRQISRGAYREPE--------------TPSDASGLIRWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred HHHHhhcccccCCC--------------CCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence 45555444322111 112344688899999999999999999885
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=332.91 Aligned_cols=240 Identities=23% Similarity=0.329 Sum_probs=189.2
Q ss_pred ccCccCceEEEEEEeC-CCceEEEEEcCCCC---ccchHHHHHHHHHHhcc-CCCCcceeeEEEEecCceeEEEeccCCC
Q 042348 374 LLGKSTIGIVYKVALN-NEEAVAVRRLGNGG---WQRFKEFQTEAEAIGKI-RHPNIVSLRAYFWSVDEKLLIYDYIPNG 448 (686)
Q Consensus 374 ~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~e~~~~g 448 (686)
.||+|+||.||+|... +++.||+|.++... ....+.+..|..++... +||||+++++++...+..++||||+++|
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~gg 81 (316)
T cd05592 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNGG 81 (316)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence 5899999999999875 47789999986531 22334566677777654 8999999999999999999999999999
Q ss_pred CHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCC
Q 042348 449 SLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEET 528 (686)
Q Consensus 449 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 528 (686)
+|.+++... ..+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++......
T Consensus 82 ~L~~~~~~~------~~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-- 150 (316)
T cd05592 82 DLMFHIQSS------GRFDEARARFYAAEIICGLQFLHK---KGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-- 150 (316)
T ss_pred cHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--
Confidence 999998754 358899999999999999999999 899999999999999999999999999987432111
Q ss_pred ccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHH
Q 042348 529 PEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQW 608 (686)
Q Consensus 529 ~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~ 608 (686)
.......||..|+|||++.+..++.++|||||||++|||++|+.||..... .+.
T Consensus 151 ---------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~-----~~~ 204 (316)
T cd05592 151 ---------------------GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE-----DEL 204 (316)
T ss_pred ---------------------CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCH-----HHH
Confidence 011234578889999999988899999999999999999999999954332 122
Q ss_pred HHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHH-HHHH
Q 042348 609 IQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMR-HVCD 663 (686)
Q Consensus 609 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~-ev~~ 663 (686)
...+.......+.. ...++.+++.+||+.||++||++. ++.+
T Consensus 205 ~~~i~~~~~~~~~~-------------~~~~~~~ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 205 FDSILNDRPHFPRW-------------ISKEAKDCLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred HHHHHcCCCCCCCC-------------CCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 22232222111111 123467899999999999999875 5544
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=333.22 Aligned_cols=258 Identities=21% Similarity=0.267 Sum_probs=195.6
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCC-ccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCCH
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGG-WQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSL 450 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL 450 (686)
..||+|+||.||++... ++..||+|.+.... ....+.+.+|++++++++||||+++++++...+..++||||+++|+|
T Consensus 11 ~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 90 (331)
T cd06649 11 SELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL 90 (331)
T ss_pred EeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeecCCCCcH
Confidence 36999999999999876 57889999886542 23346799999999999999999999999999999999999999999
Q ss_pred HHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCcc
Q 042348 451 ATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPE 530 (686)
Q Consensus 451 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 530 (686)
.+++... ..+++..+..++.|++.||+|||+. .+|+||||||+||+++.++.+||+|||+++......
T Consensus 91 ~~~l~~~------~~~~~~~~~~~~~~i~~~l~~lH~~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~---- 158 (331)
T cd06649 91 DQVLKEA------KRIPEEILGKVSIAVLRGLAYLREK--HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM---- 158 (331)
T ss_pred HHHHHHc------CCCCHHHHHHHHHHHHHHHHHHhhc--CCEEcCCCChhhEEEcCCCcEEEccCcccccccccc----
Confidence 9999764 3588999999999999999999982 259999999999999999999999999987542111
Q ss_pred ccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHHHH
Q 042348 531 VHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQWIQ 610 (686)
Q Consensus 531 ~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~ 610 (686)
.....||..|+|||++.+..++.++|||||||++|||+||+.||......+ +...+.
T Consensus 159 ---------------------~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~--~~~~~~ 215 (331)
T cd06649 159 ---------------------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKE--LEAIFG 215 (331)
T ss_pred ---------------------cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHhc
Confidence 112356778999999998899999999999999999999999995432211 111111
Q ss_pred HHHh-hcCCcccc----------------------------cCcccc---cCCCcHHHHHHHHHHHHhccccCCCCCCCH
Q 042348 611 LILE-DRKPMTDI----------------------------LDPFLA---HDLDKEDEIVSVLKIALDCVHKSPDKRPSM 658 (686)
Q Consensus 611 ~~~~-~~~~~~~~----------------------------~d~~l~---~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~ 658 (686)
.... ........ .+.... ..........++.+++.+||+.||++|||+
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~ 295 (331)
T cd06649 216 RPVVDGEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADL 295 (331)
T ss_pred ccccccccCCccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCH
Confidence 0000 00000000 000000 000001123468899999999999999999
Q ss_pred HHHHHHH
Q 042348 659 RHVCDSL 665 (686)
Q Consensus 659 ~ev~~~L 665 (686)
.|++++-
T Consensus 296 ~ell~h~ 302 (331)
T cd06649 296 KMLMNHT 302 (331)
T ss_pred HHHhcCh
Confidence 9999874
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-39 Score=335.06 Aligned_cols=246 Identities=20% Similarity=0.340 Sum_probs=192.6
Q ss_pred ccCccCceEEEEEEeC-CCceEEEEEcCCC---CccchHHHHHHHHHHhcc-CCCCcceeeEEEEecCceeEEEeccCCC
Q 042348 374 LLGKSTIGIVYKVALN-NEEAVAVRRLGNG---GWQRFKEFQTEAEAIGKI-RHPNIVSLRAYFWSVDEKLLIYDYIPNG 448 (686)
Q Consensus 374 ~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~e~~~~g 448 (686)
+||+|+||.||+|... +++.||+|.+... .....+.+.+|+.++.++ +||||+++++++...+..++||||+++|
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~~ 81 (329)
T cd05618 2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGG 81 (329)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCCC
Confidence 5899999999999875 5788999998753 223345678899988877 8999999999999999999999999999
Q ss_pred CHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCC
Q 042348 449 SLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEET 528 (686)
Q Consensus 449 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 528 (686)
+|..++... ..+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++......
T Consensus 82 ~L~~~~~~~------~~l~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~-- 150 (329)
T cd05618 82 DLMFHMQRQ------RKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG-- 150 (329)
T ss_pred CHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCC--
Confidence 999988654 358999999999999999999999 899999999999999999999999999987432111
Q ss_pred ccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCcc---chhH
Q 042348 529 PEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSM---ELNI 605 (686)
Q Consensus 529 ~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~---~~~~ 605 (686)
.......||..|+|||++.+..++.++|||||||++|||++|+.||...... ....
T Consensus 151 ---------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~ 209 (329)
T cd05618 151 ---------------------DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNT 209 (329)
T ss_pred ---------------------CccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCccccc
Confidence 0112345788899999999999999999999999999999999999532211 1111
Q ss_pred HHHHHH-HHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCC------HHHHHHH
Q 042348 606 VQWIQL-ILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPS------MRHVCDS 664 (686)
Q Consensus 606 ~~~~~~-~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs------~~ev~~~ 664 (686)
..++.. +......++. .....+.+++.+||+.||++||+ +.+++++
T Consensus 210 ~~~~~~~i~~~~~~~p~-------------~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05618 210 EDYLFQVILEKQIRIPR-------------SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 262 (329)
T ss_pred HHHHHHHHhcCCCCCCC-------------CCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence 222222 2222211111 11235678999999999999998 4677655
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=314.33 Aligned_cols=243 Identities=21% Similarity=0.397 Sum_probs=203.9
Q ss_pred ccCccCceEEEEEEeC-CCceEEEEEcCCCCccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCCHHH
Q 042348 374 LLGKSTIGIVYKVALN-NEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLAT 452 (686)
Q Consensus 374 ~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL~~ 452 (686)
.||+|+||.|||+.++ .|..||||.+... .+.+++.+|+.+|++++.|++|++||.|......++|||||..|++.+
T Consensus 40 KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAGSiSD 117 (502)
T KOG0574|consen 40 KLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAGSISD 117 (502)
T ss_pred HhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCCcHHH
Confidence 5999999999999865 6899999999764 356789999999999999999999999999999999999999999999
Q ss_pred HhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCcccc
Q 042348 453 AIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVH 532 (686)
Q Consensus 453 ~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 532 (686)
+++.++ ++|++.++..+++..++||+|||. ..-||||||+.|||++.+|.+||+|||.|..+.+..
T Consensus 118 I~R~R~-----K~L~E~EIs~iL~~TLKGL~YLH~---~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM------ 183 (502)
T KOG0574|consen 118 IMRARR-----KPLSEQEISAVLRDTLKGLQYLHD---LKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM------ 183 (502)
T ss_pred HHHHhc-----CCccHHHHHHHHHHHHhHHHHHHH---HHHHHhhcccccEEEcccchhhhhhccccchhhhhH------
Confidence 999876 689999999999999999999999 667999999999999999999999999997664322
Q ss_pred ccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHHHHHH
Q 042348 533 WEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQWIQLI 612 (686)
Q Consensus 533 ~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~ 612 (686)
...+...||++|||||++..-.|+.++||||+|++..||..|++||....+... +
T Consensus 184 -----------------AKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRA--------I 238 (502)
T KOG0574|consen 184 -----------------AKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRA--------I 238 (502)
T ss_pred -----------------HhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccce--------e
Confidence 233456788899999999999999999999999999999999999965444321 0
Q ss_pred HhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 613 LEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 613 ~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
+.- +..-.|.+. .++....++.+++.+||-+.|++|-|+.+++++
T Consensus 239 FMI----PT~PPPTF~---KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 239 FMI----PTKPPPTFK---KPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred Eec----cCCCCCCCC---ChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 000 000011111 123445678899999999999999999999887
|
|
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=332.25 Aligned_cols=240 Identities=22% Similarity=0.329 Sum_probs=190.0
Q ss_pred ccCccCceEEEEEEeC-CCceEEEEEcCCCC---ccchHHHHHHHHHHhcc-CCCCcceeeEEEEecCceeEEEeccCCC
Q 042348 374 LLGKSTIGIVYKVALN-NEEAVAVRRLGNGG---WQRFKEFQTEAEAIGKI-RHPNIVSLRAYFWSVDEKLLIYDYIPNG 448 (686)
Q Consensus 374 ~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~e~~~~g 448 (686)
.||+|+||.||+|... +++.||||.++... ......+..|..++... +||||+++++++.+.+..++||||+++|
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~g 81 (316)
T cd05619 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNGG 81 (316)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCCC
Confidence 5899999999999876 47889999986531 22345567788888765 8999999999999999999999999999
Q ss_pred CHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCC
Q 042348 449 SLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEET 528 (686)
Q Consensus 449 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 528 (686)
+|.+++... ..+++.++..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~L~~~l~~~------~~~~~~~~~~~~~qi~~al~~LH~---~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 151 (316)
T cd05619 82 DLMFHIQSC------HKFDLPRATFYAAEIICGLQFLHS---KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA- 151 (316)
T ss_pred cHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC-
Confidence 999999754 358899999999999999999999 8999999999999999999999999999874321110
Q ss_pred ccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHH
Q 042348 529 PEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQW 608 (686)
Q Consensus 529 ~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~ 608 (686)
......||..|+|||++.+..++.++|||||||++|||++|+.||..... .+.
T Consensus 152 ----------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~-----~~~ 204 (316)
T cd05619 152 ----------------------KTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDE-----EEL 204 (316)
T ss_pred ----------------------ceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCH-----HHH
Confidence 11234577889999999988999999999999999999999999954322 122
Q ss_pred HHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHH-HHHH
Q 042348 609 IQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMR-HVCD 663 (686)
Q Consensus 609 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~-ev~~ 663 (686)
.+.+.......+.. ....+.+++.+||+.||++||++. ++.+
T Consensus 205 ~~~i~~~~~~~~~~-------------~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 205 FQSIRMDNPCYPRW-------------LTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred HHHHHhCCCCCCcc-------------CCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 22222221111111 123567899999999999999997 6654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=327.58 Aligned_cols=258 Identities=19% Similarity=0.272 Sum_probs=191.7
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCCc-cchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCCH
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGGW-QRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSL 450 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL 450 (686)
..||+|+||.||+|... ++..||+|.+..... .....+.+|++++++++||||+++++++...+..++||||++ |+|
T Consensus 11 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-~~l 89 (288)
T cd07871 11 DKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLD-SDL 89 (288)
T ss_pred eEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCCC-cCH
Confidence 46999999999999875 578999999865422 233567899999999999999999999999999999999997 499
Q ss_pred HHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCcc
Q 042348 451 ATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPE 530 (686)
Q Consensus 451 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 530 (686)
.+++.... ..+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 90 ~~~l~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~--- 158 (288)
T cd07871 90 KQYLDNCG-----NLMSMHNVKIFMFQLLRGLSYCHK---RKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK--- 158 (288)
T ss_pred HHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc---
Confidence 99887543 357899999999999999999999 8999999999999999999999999999875431110
Q ss_pred ccccccccCCCCCCCccccccccCCCCCccccCcccccC-CCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHHH
Q 042348 531 VHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKV-RKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQWI 609 (686)
Q Consensus 531 ~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~ 609 (686)
......++..|+|||.+.+ ..++.++||||+||++|||+||+.||......+ ....+
T Consensus 159 --------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~--~~~~~ 216 (288)
T cd07871 159 --------------------TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKE--ELHLI 216 (288)
T ss_pred --------------------cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHH
Confidence 1122356778999998865 568999999999999999999999995433211 11111
Q ss_pred HHHHhhcC--Ccccc---------cCcccccCCC---cHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 610 QLILEDRK--PMTDI---------LDPFLAHDLD---KEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 610 ~~~~~~~~--~~~~~---------~d~~l~~~~~---~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
........ .++.+ ..+....... ......+..+++.+||+.||.+|||++|++++
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 217 FRLLGTPTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred HHHhCCCChHHhhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 11111000 00000 0000000000 00112357799999999999999999999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=326.25 Aligned_cols=248 Identities=31% Similarity=0.532 Sum_probs=190.5
Q ss_pred cccCccCceEEEEEEeC-----CCceEEEEEcCCCC-ccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccC
Q 042348 373 FLLGKSTIGIVYKVALN-----NEEAVAVRRLGNGG-WQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIP 446 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~ 446 (686)
..||.|.||.||+|.+. .+..|+||.++... ....+.|.+|++.+++++||||++++|++...+..++||||++
T Consensus 5 ~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~~ 84 (259)
T PF07714_consen 5 KQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYCP 84 (259)
T ss_dssp EEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--T
T ss_pred eEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccccc
Confidence 46999999999999987 25689999996543 3346889999999999999999999999998888999999999
Q ss_pred CCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCccccccccc
Q 042348 447 NGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAE 526 (686)
Q Consensus 447 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~ 526 (686)
+|+|.++++.... ..+++..+.+|+.||+.||+|||+ ++++||||+++||++++++.+||+|||+++......
T Consensus 85 ~g~L~~~L~~~~~----~~~~~~~~~~i~~~i~~~l~~Lh~---~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~ 157 (259)
T PF07714_consen 85 GGSLDDYLKSKNK----EPLSEQQRLSIAIQIAEALSYLHS---NNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKS 157 (259)
T ss_dssp TEBHHHHHHHTCT----TTSBHHHHHHHHHHHHHHHHHHHH---TTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSS
T ss_pred ccccccccccccc----cccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccc
Confidence 9999999998622 468999999999999999999999 899999999999999999999999999998652111
Q ss_pred CCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCccccCccchhH
Q 042348 527 ETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQIGSMELNI 605 (686)
Q Consensus 527 ~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~~~~ 605 (686)
.. ...........|+|||.+....++.++||||||+++||+++ |+.||.....
T Consensus 158 ~~---------------------~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~----- 211 (259)
T PF07714_consen 158 KY---------------------KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDN----- 211 (259)
T ss_dssp SE---------------------EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCH-----
T ss_pred cc---------------------cccccccccccccccccccccccccccccccccccccccccccccccccccc-----
Confidence 10 01112234567999999988889999999999999999999 7888854322
Q ss_pred HHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 042348 606 VQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSL 665 (686)
Q Consensus 606 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L 665 (686)
.+........... .. .......+.+++.+||+.+|++||+++++++.|
T Consensus 212 ~~~~~~~~~~~~~--~~----------~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 212 EEIIEKLKQGQRL--PI----------PDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp HHHHHHHHTTEET--TS----------BTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ccccccccccccc--ee----------ccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 2223333222211 10 011234577999999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=335.54 Aligned_cols=245 Identities=20% Similarity=0.268 Sum_probs=196.7
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCC---ccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCC
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGG---WQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNG 448 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~g 448 (686)
..||+|+||.||+|... +++.||||++.... ....+.+.+|++++.+++||||+++++++...+..++||||+++|
T Consensus 7 ~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~g~ 86 (333)
T cd05600 7 TQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYVPGG 86 (333)
T ss_pred EEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999976 47899999986532 233456889999999999999999999999999999999999999
Q ss_pred CHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCC
Q 042348 449 SLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEET 528 (686)
Q Consensus 449 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 528 (686)
+|.+++... ..+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++....
T Consensus 87 ~L~~~l~~~------~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~---- 153 (333)
T cd05600 87 DFRTLLNNL------GVLSEDHARFYMAEMFEAVDALHE---LGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT---- 153 (333)
T ss_pred CHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEEEeCcCCccccc----
Confidence 999999754 358899999999999999999999 8999999999999999999999999999875431
Q ss_pred ccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHH
Q 042348 529 PEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQW 608 (686)
Q Consensus 529 ~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~ 608 (686)
......||..|+|||++.+..++.++|||||||++|||++|+.||......+ .
T Consensus 154 ----------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~-----~ 206 (333)
T cd05600 154 ----------------------YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNE-----T 206 (333)
T ss_pred ----------------------ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHH-----H
Confidence 1123457788999999998899999999999999999999999995432211 1
Q ss_pred HHHHHhhcCCc--ccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 609 IQLILEDRKPM--TDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 609 ~~~~~~~~~~~--~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
...+....... +...++. .....++.+++.+||..+|++||++.|++++
T Consensus 207 ~~~i~~~~~~~~~~~~~~~~-------~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 207 WENLKYWKETLQRPVYDDPR-------FNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred HHHHHhccccccCCCCCccc-------cccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 12221111110 1111110 1123467789999999999999999999987
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=348.52 Aligned_cols=257 Identities=21% Similarity=0.278 Sum_probs=203.7
Q ss_pred hcccCccCceEEEEEEeCCC-ceEEEEEcCCCCccchHHHHHHHHHHhccC-CCCcceeeEEE-Ee---c---CceeEEE
Q 042348 372 AFLLGKSTIGIVYKVALNNE-EAVAVRRLGNGGWQRFKEFQTEAEAIGKIR-HPNIVSLRAYF-WS---V---DEKLLIY 442 (686)
Q Consensus 372 ~~~iG~G~~g~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~-~~---~---~~~~lV~ 442 (686)
.++|.+|||+.||.|....+ ..+|+|++-..++...+...+||++|++|+ |+|||.+++.. .. . -+.+|.|
T Consensus 42 ~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~EvllLm 121 (738)
T KOG1989|consen 42 EKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEVLLLM 121 (738)
T ss_pred EEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEEEeeh
Confidence 45799999999999998776 999999998777788889999999999996 99999999943 21 1 2568999
Q ss_pred eccCCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCccccc
Q 042348 443 DYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLA 522 (686)
Q Consensus 443 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~ 522 (686)
|||.+|+|-|++..+.. ..|++.++++|+.|+++|+++||.+. .+|||||||-+||||+.++..||||||.|.--
T Consensus 122 EyC~gg~Lvd~mn~Rlq----~~lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLCDFGSatt~ 196 (738)
T KOG1989|consen 122 EYCKGGSLVDFMNTRLQ----TRLTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLCDFGSATTK 196 (738)
T ss_pred hhccCCcHHHHHHHHHh----ccCChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeCcccccccc
Confidence 99999999999987653 45999999999999999999999976 47999999999999999999999999988632
Q ss_pred ccccCCccccccccccCCCCCCCcccc---ccccCCCCCccccCcccc---cCCCCCCcchHHHHHHHHHHHHhCCCCcc
Q 042348 523 DIAEETPEVHWEQSTTGTPLQSSPYEF---TALNSTTSRSYYQAPEAS---KVRKPTQKWDIYSYGVILLEMISGKLPMI 596 (686)
Q Consensus 523 ~~~~~~~~~~~~~~~~g~~~~~~~~~~---~~~~~~~gt~~y~aPE~~---~~~~~~~~sDVwSlGvvl~elltG~~P~~ 596 (686)
..... ..++. ...-...-|+.|+|||++ .+..+++|+|||||||+||-|+....||.
T Consensus 197 ~~~~~-----------------~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe 259 (738)
T KOG1989|consen 197 ILSPT-----------------SAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFE 259 (738)
T ss_pred cCCCc-----------------cHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcC
Confidence 11100 00111 111223457889999986 45678999999999999999999999995
Q ss_pred ccCccchhHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccc
Q 042348 597 QIGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRVNI 670 (686)
Q Consensus 597 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~ 670 (686)
..+.-. ++.+...++. .+.....+.+||..||+.||++||++-||++.+.++..
T Consensus 260 ~sg~la---------Ilng~Y~~P~-----------~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~ 313 (738)
T KOG1989|consen 260 ESGKLA---------ILNGNYSFPP-----------FPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELAN 313 (738)
T ss_pred cCccee---------EEeccccCCC-----------CccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhc
Confidence 543211 1222222211 12356678899999999999999999999999988763
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=332.52 Aligned_cols=241 Identities=24% Similarity=0.331 Sum_probs=193.2
Q ss_pred ccCccCceEEEEEEeC-CCceEEEEEcCCCC---ccchHHHHHHHHHHhcc-CCCCcceeeEEEEecCceeEEEeccCCC
Q 042348 374 LLGKSTIGIVYKVALN-NEEAVAVRRLGNGG---WQRFKEFQTEAEAIGKI-RHPNIVSLRAYFWSVDEKLLIYDYIPNG 448 (686)
Q Consensus 374 ~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~e~~~~g 448 (686)
.||+|+||.||+|... +++.||||.+.... ......+..|++++..+ +||||+++++++...+..++||||+++|
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 81 (318)
T cd05570 2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNGG 81 (318)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence 5899999999999876 47889999987532 23345677899999888 7999999999999999999999999999
Q ss_pred CHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCC
Q 042348 449 SLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEET 528 (686)
Q Consensus 449 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 528 (686)
+|.+++... ..+++..+..++.|++.||+|||+ ++|+||||||+||++++++.+||+|||+++......
T Consensus 82 ~L~~~~~~~------~~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-- 150 (318)
T cd05570 82 DLMFHIQRS------GRFDEPRARFYAAEIVLGLQFLHE---RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG-- 150 (318)
T ss_pred CHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHh---CCeEccCCCHHHeEECCCCcEEecccCCCeecCcCC--
Confidence 999998754 358999999999999999999999 899999999999999999999999999986422111
Q ss_pred ccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHH
Q 042348 529 PEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQW 608 (686)
Q Consensus 529 ~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~ 608 (686)
.......||..|+|||++.+..++.++|||||||++|||++|+.||..... ...
T Consensus 151 ---------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~-----~~~ 204 (318)
T cd05570 151 ---------------------VTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDE-----DEL 204 (318)
T ss_pred ---------------------CcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCH-----HHH
Confidence 011223567889999999999999999999999999999999999954321 122
Q ss_pred HHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCH-----HHHHHH
Q 042348 609 IQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSM-----RHVCDS 664 (686)
Q Consensus 609 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~-----~ev~~~ 664 (686)
...+.......+. .....+.+++.+||+.||++||++ .+++++
T Consensus 205 ~~~i~~~~~~~~~-------------~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 205 FQSILEDEVRYPR-------------WLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred HHHHHcCCCCCCC-------------cCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 2223222211111 112357799999999999999999 888765
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=337.17 Aligned_cols=237 Identities=24% Similarity=0.355 Sum_probs=190.3
Q ss_pred ccCccCceEEEEEEe----CCCceEEEEEcCCCC--ccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCC
Q 042348 374 LLGKSTIGIVYKVAL----NNEEAVAVRRLGNGG--WQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPN 447 (686)
Q Consensus 374 ~iG~G~~g~Vy~~~~----~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~ 447 (686)
.||+|+||.||++.. .+++.||+|++.... ......+..|++++++++||||+++++++...+..++||||+++
T Consensus 3 ~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 82 (318)
T cd05582 3 VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLRG 82 (318)
T ss_pred eeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCCC
Confidence 589999999999875 357899999986532 12335677899999999999999999999999999999999999
Q ss_pred CCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccC
Q 042348 448 GSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEE 527 (686)
Q Consensus 448 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 527 (686)
|+|.+++... ..+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++.......
T Consensus 83 ~~L~~~l~~~------~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~ 153 (318)
T cd05582 83 GDLFTRLSKE------VMFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK 153 (318)
T ss_pred CcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC
Confidence 9999999654 358999999999999999999999 8999999999999999999999999999875432110
Q ss_pred CccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHH
Q 042348 528 TPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQ 607 (686)
Q Consensus 528 ~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~ 607 (686)
......||..|+|||.+.+..++.++|||||||++|||++|+.||..... ..
T Consensus 154 -----------------------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~-----~~ 205 (318)
T cd05582 154 -----------------------KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDR-----KE 205 (318)
T ss_pred -----------------------ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCH-----HH
Confidence 11234577889999999888899999999999999999999999954322 12
Q ss_pred HHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHH
Q 042348 608 WIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRH 660 (686)
Q Consensus 608 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~e 660 (686)
....+......++.. ....+.+++.+||+.||++||++.+
T Consensus 206 ~~~~i~~~~~~~p~~-------------~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 206 TMTMILKAKLGMPQF-------------LSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred HHHHHHcCCCCCCCC-------------CCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 222333222222111 1235678999999999999999555
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=325.47 Aligned_cols=248 Identities=22% Similarity=0.264 Sum_probs=192.8
Q ss_pred cCccCceEEEEEEeC-CCceEEEEEcCCCCc---cchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCCH
Q 042348 375 LGKSTIGIVYKVALN-NEEAVAVRRLGNGGW---QRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSL 450 (686)
Q Consensus 375 iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL 450 (686)
||+|+||+||++... +++.||+|.+..... ...+.+..|++++++++||||+++.+++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 699999999999865 678999999865322 2335678899999999999999999999999999999999999999
Q ss_pred HHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCcc
Q 042348 451 ATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPE 530 (686)
Q Consensus 451 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 530 (686)
.+++...... ...+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++.......
T Consensus 81 ~~~~~~~~~~--~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~--- 152 (280)
T cd05608 81 RYHIYNVDEE--NPGFPEPRACFYTAQIISGLEHLHQ---RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--- 152 (280)
T ss_pred HHHHHhcccc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc---
Confidence 9888543211 1468999999999999999999999 8999999999999999999999999999875432211
Q ss_pred ccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHHHH
Q 042348 531 VHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQWIQ 610 (686)
Q Consensus 531 ~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~ 610 (686)
......||..|+|||++.+..++.++|||||||++|||++|+.||....... .......
T Consensus 153 --------------------~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~-~~~~~~~ 211 (280)
T cd05608 153 --------------------KTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV-ENKELKQ 211 (280)
T ss_pred --------------------cccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcch-hHHHHHH
Confidence 1122356778999999999999999999999999999999999995433211 1111111
Q ss_pred HHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 042348 611 LILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRP-----SMRHVCDS 664 (686)
Q Consensus 611 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~ev~~~ 664 (686)
......... .......+.+++.+||+.||++|| ++++++++
T Consensus 212 ~~~~~~~~~-------------~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 212 RILNDSVTY-------------PDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred hhcccCCCC-------------cccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 111111000 011234577899999999999999 66777765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=334.71 Aligned_cols=246 Identities=19% Similarity=0.325 Sum_probs=193.6
Q ss_pred ccCccCceEEEEEEeC-CCceEEEEEcCCCC---ccchHHHHHHHHHHhcc-CCCCcceeeEEEEecCceeEEEeccCCC
Q 042348 374 LLGKSTIGIVYKVALN-NEEAVAVRRLGNGG---WQRFKEFQTEAEAIGKI-RHPNIVSLRAYFWSVDEKLLIYDYIPNG 448 (686)
Q Consensus 374 ~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~e~~~~g 448 (686)
+||+|+||.||++... +++.||+|.++... ....+.+..|..++.++ +||||+++++++.+.+..++||||+++|
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~g 81 (329)
T cd05588 2 VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSGG 81 (329)
T ss_pred eEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 5899999999999875 57899999987532 23345688999999998 7999999999999999999999999999
Q ss_pred CHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCC
Q 042348 449 SLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEET 528 (686)
Q Consensus 449 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 528 (686)
+|.+++... ..+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++......
T Consensus 82 ~L~~~~~~~------~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~-- 150 (329)
T cd05588 82 DLMFHMQRQ------RKLPEEHARFYSAEISLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG-- 150 (329)
T ss_pred CHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEECcCccccccccCC--
Confidence 999988654 358999999999999999999999 899999999999999999999999999986321110
Q ss_pred ccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCcc---chhH
Q 042348 529 PEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSM---ELNI 605 (686)
Q Consensus 529 ~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~---~~~~ 605 (686)
.......||..|+|||++.+..++.++|||||||++|||++|+.||...... ....
T Consensus 151 ---------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~ 209 (329)
T cd05588 151 ---------------------DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNT 209 (329)
T ss_pred ---------------------CccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccc
Confidence 0112345788899999999989999999999999999999999999532211 1112
Q ss_pred HHHHHHHH-hhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCC------HHHHHHH
Q 042348 606 VQWIQLIL-EDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPS------MRHVCDS 664 (686)
Q Consensus 606 ~~~~~~~~-~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs------~~ev~~~ 664 (686)
..+..... ......+.. ....+.+++.+||+.||++||+ +.|++++
T Consensus 210 ~~~~~~~~~~~~~~~p~~-------------~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05588 210 EDYLFQVILEKQIRIPRS-------------LSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH 262 (329)
T ss_pred hHHHHHHHHcCCCCCCCC-------------CCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence 22222222 221111111 1235778999999999999997 6777765
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=330.95 Aligned_cols=259 Identities=20% Similarity=0.303 Sum_probs=191.3
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCCc-cchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCCH
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGGW-QRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSL 450 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL 450 (686)
..||+|+||.||+|... +++.||||.+..... .....+.+|+.++++++||||+++++++.+.+..++||||++ ++|
T Consensus 11 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-~~l 89 (303)
T cd07869 11 EKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYVH-TDL 89 (303)
T ss_pred eeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEECCC-cCH
Confidence 36999999999999976 578999999875432 223467889999999999999999999999999999999995 688
Q ss_pred HHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCcc
Q 042348 451 ATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPE 530 (686)
Q Consensus 451 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 530 (686)
.+++.... ..+++..+..++.|++.||+|||+ ++|+||||||+|||+++++.+||+|||+++......
T Consensus 90 ~~~~~~~~-----~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~---- 157 (303)
T cd07869 90 CQYMDKHP-----GGLHPENVKLFLFQLLRGLSYIHQ---RYILHRDLKPQNLLISDTGELKLADFGLARAKSVPS---- 157 (303)
T ss_pred HHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECCCCcceeccCCC----
Confidence 88887543 358899999999999999999999 899999999999999999999999999987432111
Q ss_pred ccccccccCCCCCCCccccccccCCCCCccccCcccccC-CCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHHH
Q 042348 531 VHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKV-RKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQWI 609 (686)
Q Consensus 531 ~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~ 609 (686)
.......+|..|+|||++.+ ..++.++|||||||++|||++|+.||.........+ ..+
T Consensus 158 -------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~-~~~ 217 (303)
T cd07869 158 -------------------HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQL-ERI 217 (303)
T ss_pred -------------------ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHH-HHH
Confidence 01122456778999998865 458899999999999999999999996543221111 111
Q ss_pred HHHHhhcC--Cccc-----ccCcccccC---------CCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 610 QLILEDRK--PMTD-----ILDPFLAHD---------LDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 610 ~~~~~~~~--~~~~-----~~d~~l~~~---------~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
........ .... ..++..... .........+.+++.+||+.||++|||+.|++++
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h 288 (303)
T cd07869 218 FLVLGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSH 288 (303)
T ss_pred HHHhCCCChhhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcC
Confidence 11111000 0000 000000000 0000012356789999999999999999999864
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=347.98 Aligned_cols=250 Identities=21% Similarity=0.280 Sum_probs=197.7
Q ss_pred hcccCccCceEEEEEEeC-C-CceEEEEEcCCCCccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCC
Q 042348 372 AFLLGKSTIGIVYKVALN-N-EEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGS 449 (686)
Q Consensus 372 ~~~iG~G~~g~Vy~~~~~-~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gs 449 (686)
...||+|+||.||+|... + +..||+|.+..........+.+|+.+++.++|||||++++++...+..++||||+++|+
T Consensus 72 ~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~gg~ 151 (478)
T PTZ00267 72 TTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGD 151 (478)
T ss_pred EEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCCCCC
Confidence 357999999999999754 3 56788888765554445678889999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCc
Q 042348 450 LATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETP 529 (686)
Q Consensus 450 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 529 (686)
|.++++..... ..++++.++..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++........
T Consensus 152 L~~~l~~~~~~--~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~- 225 (478)
T PTZ00267 152 LNKQIKQRLKE--HLPFQEYEVGLLFYQIVLALDEVHS---RKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSL- 225 (478)
T ss_pred HHHHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCcCHHhEEECCCCcEEEEeCcCceecCCcccc-
Confidence 99988653211 1468899999999999999999999 89999999999999999999999999999865321100
Q ss_pred cccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHHH
Q 042348 530 EVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQWI 609 (686)
Q Consensus 530 ~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~ 609 (686)
.......||..|+|||++.+..++.++|||||||++|||++|+.||..... .+.+
T Consensus 226 --------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~-----~~~~ 280 (478)
T PTZ00267 226 --------------------DVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ-----REIM 280 (478)
T ss_pred --------------------ccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH-----HHHH
Confidence 112234678889999999988999999999999999999999999954321 2223
Q ss_pred HHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 610 QLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 610 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
..+..+... +. . ......+.+++.+||+.||++||++.+++.+
T Consensus 281 ~~~~~~~~~------~~-~-----~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~ 323 (478)
T PTZ00267 281 QQVLYGKYD------PF-P-----CPVSSGMKALLDPLLSKNPALRPTTQQLLHT 323 (478)
T ss_pred HHHHhCCCC------CC-C-----ccCCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence 333332211 00 0 0122357889999999999999999998754
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=315.18 Aligned_cols=261 Identities=23% Similarity=0.348 Sum_probs=199.5
Q ss_pred ccCccCceEEEEEEeC-CCceEEEEEcCC--CCccchHHHHHHHHHHhccCCCCcceeeEEEEe-----cCceeEEEecc
Q 042348 374 LLGKSTIGIVYKVALN-NEEAVAVRRLGN--GGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWS-----VDEKLLIYDYI 445 (686)
Q Consensus 374 ~iG~G~~g~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~-----~~~~~lV~e~~ 445 (686)
.||+|+||.|.++... +|+.||||++.. ......++..+|+++|+.++|+||+.+.+.+.. -+..|+|+|+|
T Consensus 29 ~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~elM 108 (359)
T KOG0660|consen 29 PIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFELM 108 (359)
T ss_pred cccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehhHH
Confidence 5999999999999865 689999999973 455566888999999999999999999999875 35679999999
Q ss_pred CCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccc
Q 042348 446 PNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIA 525 (686)
Q Consensus 446 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~ 525 (686)
+-||...++.. +.|+...+..++.|+++||.|+|+ .+|+|||+||+|+|++.+...||+|||+|+.....
T Consensus 109 -etDL~~iik~~------~~L~d~H~q~f~YQiLrgLKyiHS---AnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~ 178 (359)
T KOG0660|consen 109 -ETDLHQIIKSQ------QDLTDDHAQYFLYQILRGLKYIHS---ANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKF 178 (359)
T ss_pred -hhHHHHHHHcC------ccccHHHHHHHHHHHHHhcchhhc---ccccccccchhheeeccCCCEEeccccceeecccc
Confidence 56999999875 359999999999999999999999 89999999999999999999999999999976532
Q ss_pred cCCccccccccccCCCCCCCccccccccCCCCCccccCccccc-CCCCCCcchHHHHHHHHHHHHhCCCCccccCccchh
Q 042348 526 EETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASK-VRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELN 604 (686)
Q Consensus 526 ~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~ 604 (686)
.. ....+..+.|.+|+|||.+. ...|+.+.||||.|||+.||++|+.-|.+. +..+
T Consensus 179 ~~---------------------~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~--d~v~ 235 (359)
T KOG0660|consen 179 FE---------------------DGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGK--DYVH 235 (359)
T ss_pred Cc---------------------ccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCC--chHH
Confidence 10 12345678899999999874 478999999999999999999999988432 2222
Q ss_pred HHHHHHHHHhhcCC-----------------cccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH--H
Q 042348 605 IVQWIQLILEDRKP-----------------MTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS--L 665 (686)
Q Consensus 605 ~~~~~~~~~~~~~~-----------------~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~--L 665 (686)
....+...+....+ ++..-...+...+ +......++++.+||..||.+|+|++|.+++ |
T Consensus 236 Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~f--p~a~p~AidLlekmL~fdP~kRita~eAL~hPYl 313 (359)
T KOG0660|consen 236 QLQLILELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIF--PNANPLAIDLLEKMLVFDPKKRITAEEALAHPYL 313 (359)
T ss_pred HHHHHHHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHc--CCCCHHHHHHHHHHhccCccccCCHHHHhcChhh
Confidence 22222221111000 0000000000000 1122357899999999999999999999987 4
Q ss_pred hccc
Q 042348 666 DRVN 669 (686)
Q Consensus 666 ~~i~ 669 (686)
....
T Consensus 314 ~~~h 317 (359)
T KOG0660|consen 314 APYH 317 (359)
T ss_pred hhhc
Confidence 4444
|
|
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=332.12 Aligned_cols=241 Identities=21% Similarity=0.298 Sum_probs=190.4
Q ss_pred ccCccCceEEEEEEeC-CCceEEEEEcCCCC---ccchHHHHHHHHHHhcc-CCCCcceeeEEEEecCceeEEEeccCCC
Q 042348 374 LLGKSTIGIVYKVALN-NEEAVAVRRLGNGG---WQRFKEFQTEAEAIGKI-RHPNIVSLRAYFWSVDEKLLIYDYIPNG 448 (686)
Q Consensus 374 ~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~e~~~~g 448 (686)
.||+|+||.||+|... +++.||+|.++... ......+..|..++... +||||+++++++.+.+..++||||+++|
T Consensus 2 ~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g 81 (316)
T cd05620 2 VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNGG 81 (316)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCCC
Confidence 5899999999999876 57899999986532 22345567788888765 8999999999999999999999999999
Q ss_pred CHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCC
Q 042348 449 SLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEET 528 (686)
Q Consensus 449 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 528 (686)
+|.+++... ..+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++......
T Consensus 82 ~L~~~i~~~------~~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-- 150 (316)
T cd05620 82 DLMFHIQDK------GRFDLYRATFYAAEIVCGLQFLHS---KGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD-- 150 (316)
T ss_pred cHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEeCccCCCeecccCC--
Confidence 999998764 358899999999999999999999 899999999999999999999999999986322111
Q ss_pred ccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHH
Q 042348 529 PEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQW 608 (686)
Q Consensus 529 ~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~ 608 (686)
.......||..|+|||++.+..++.++|||||||++|||++|+.||..... ...
T Consensus 151 ---------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~-----~~~ 204 (316)
T cd05620 151 ---------------------NRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE-----DEL 204 (316)
T ss_pred ---------------------CceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH-----HHH
Confidence 011234578889999999998999999999999999999999999954322 122
Q ss_pred HHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHH-HHHHH
Q 042348 609 IQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMR-HVCDS 664 (686)
Q Consensus 609 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~-ev~~~ 664 (686)
...+.......+.. ...++.+++.+||+.||++||++. ++.++
T Consensus 205 ~~~~~~~~~~~~~~-------------~~~~~~~li~~~l~~dP~~R~~~~~~~~~h 248 (316)
T cd05620 205 FESIRVDTPHYPRW-------------ITKESKDILEKLFERDPTRRLGVVGNIRGH 248 (316)
T ss_pred HHHHHhCCCCCCCC-------------CCHHHHHHHHHHccCCHHHcCCChHHHHcC
Confidence 22222221111111 123567899999999999999985 56533
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=317.66 Aligned_cols=246 Identities=24% Similarity=0.401 Sum_probs=197.0
Q ss_pred cccCccCceEEEEEEeCCCceEEEEEcCCCCccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCCHHH
Q 042348 373 FLLGKSTIGIVYKVALNNEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLAT 452 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL~~ 452 (686)
..||+|+||.||+|...++..+|+|.+..... ..+++.+|+.++++++||||+++++++...+..++||||+++|+|.+
T Consensus 10 ~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~ 88 (256)
T cd05113 10 KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLN 88 (256)
T ss_pred eEecCcccceEEEEEecCCCcEEEEEcCCCcc-cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCCCcHHH
Confidence 35999999999999988777899999875433 34679999999999999999999999998889999999999999999
Q ss_pred HhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCcccc
Q 042348 453 AIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVH 532 (686)
Q Consensus 453 ~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 532 (686)
++.... ..+++..++.++.|++.||+|||+ ++++|+||||+||++++++.+||+|||.++.......
T Consensus 89 ~i~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~----- 155 (256)
T cd05113 89 YLREHG-----KRFQPSQLLEMCKDVCEGMAYLES---KQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY----- 155 (256)
T ss_pred HHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCCEEECCCccceecCCCce-----
Confidence 997643 358999999999999999999999 8999999999999999999999999999875432110
Q ss_pred ccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCccccCccchhHHHHHHH
Q 042348 533 WEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQIGSMELNIVQWIQL 611 (686)
Q Consensus 533 ~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~ 611 (686)
.......++..|+|||+..+..++.++|||||||++|||++ |+.||...... .....
T Consensus 156 -----------------~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~-----~~~~~ 213 (256)
T cd05113 156 -----------------TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS-----ETVEK 213 (256)
T ss_pred -----------------eecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHH-----HHHHH
Confidence 00112234567999999988889999999999999999999 99998543321 11222
Q ss_pred HHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 042348 612 ILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLD 666 (686)
Q Consensus 612 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~ 666 (686)
+....... .+ ......+.+++.+||+.+|++||++.+|++.|+
T Consensus 214 ~~~~~~~~----~~--------~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 214 VSQGLRLY----RP--------HLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred HhcCCCCC----CC--------CCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 22221110 00 012346789999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=320.11 Aligned_cols=249 Identities=27% Similarity=0.451 Sum_probs=199.5
Q ss_pred cccCccCceEEEEEEeCCCceEEEEEcCCCCccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCCHHH
Q 042348 373 FLLGKSTIGIVYKVALNNEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLAT 452 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL~~ 452 (686)
+.||+|+||.||+|...++..||+|.+..... ..+.+.+|+.++++++|+||+++++++...+..++||||+++|+|.+
T Consensus 12 ~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 90 (261)
T cd05072 12 KKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTM-SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLD 90 (261)
T ss_pred eecCCcCCceEEEEEecCCceEEEEEccCCch-hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCCCCcHHH
Confidence 46999999999999988888899999865432 35788999999999999999999999999999999999999999999
Q ss_pred HhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCcccc
Q 042348 453 AIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVH 532 (686)
Q Consensus 453 ~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 532 (686)
+++...+ ..+++..++.++.|++.||+|||+ .+++||||||+||++++++.++|+|||+++........
T Consensus 91 ~l~~~~~----~~~~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~---- 159 (261)
T cd05072 91 FLKSDEG----GKVLLPKLIDFSAQIAEGMAYIER---KNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT---- 159 (261)
T ss_pred HHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEecCCCcEEECCCccceecCCCcee----
Confidence 9976532 458899999999999999999999 89999999999999999999999999999765321110
Q ss_pred ccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCccccCccchhHHHHHHH
Q 042348 533 WEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQIGSMELNIVQWIQL 611 (686)
Q Consensus 533 ~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~ 611 (686)
......++..|+|||+.....++.++|||||||++|||+| |+.||...... .. ...
T Consensus 160 ------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~--~~---~~~ 216 (261)
T cd05072 160 ------------------AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS--DV---MSA 216 (261)
T ss_pred ------------------ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH--HH---HHH
Confidence 0112234567999999988889999999999999999999 99999543221 11 111
Q ss_pred HHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 042348 612 ILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRV 668 (686)
Q Consensus 612 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i 668 (686)
.... ..... . .....++.+++.+|++.+|++||+++++.+.|+++
T Consensus 217 ~~~~-~~~~~-----~------~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 217 LQRG-YRMPR-----M------ENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred HHcC-CCCCC-----C------CCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 1111 11110 0 01224578899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=323.09 Aligned_cols=255 Identities=26% Similarity=0.413 Sum_probs=200.5
Q ss_pred hcccCccCceEEEEEEeCC------CceEEEEEcCCCCcc-chHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEec
Q 042348 372 AFLLGKSTIGIVYKVALNN------EEAVAVRRLGNGGWQ-RFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDY 444 (686)
Q Consensus 372 ~~~iG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~ 444 (686)
.+.||+|+||.||+|...+ +..||||.+...... ..+.+.+|++++++++||||+++++++...+..++||||
T Consensus 10 ~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 89 (280)
T cd05049 10 KRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPIMVFEY 89 (280)
T ss_pred HhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeEEEEec
Confidence 3469999999999998643 478999998765443 356899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCC--------ccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeec
Q 042348 445 IPNGSLATAIHGKAG--------IISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDF 516 (686)
Q Consensus 445 ~~~gsL~~~l~~~~~--------~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~Df 516 (686)
+++++|.+++..... ......+++.++..++.|++.||+|||+ ++++||||||+||+++.++.+||+||
T Consensus 90 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~~~kl~d~ 166 (280)
T cd05049 90 MEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLAS---QHFVHRDLATRNCLVGYDLVVKIGDF 166 (280)
T ss_pred CCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhh---CCeeccccccceEEEcCCCeEEECCc
Confidence 999999999976532 1112458899999999999999999999 89999999999999999999999999
Q ss_pred CcccccccccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCc
Q 042348 517 GLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPM 595 (686)
Q Consensus 517 Gla~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~ 595 (686)
|+++........ .......++..|+|||++.+..++.++|||||||++|||++ |+.||
T Consensus 167 g~~~~~~~~~~~---------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~ 225 (280)
T cd05049 167 GMSRDVYTTDYY---------------------RVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPW 225 (280)
T ss_pred ccceecccCcce---------------------ecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCC
Confidence 998754321100 00112234567999999999999999999999999999999 99998
Q ss_pred cccCccchhHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 042348 596 IQIGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDR 667 (686)
Q Consensus 596 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~ 667 (686)
...... +.+..+..+... . .. ......+.+++.+||+.||++||++.||++.|++
T Consensus 226 ~~~~~~-----~~~~~~~~~~~~--~-~~---------~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 226 YGLSNE-----EVIECITQGRLL--Q-RP---------RTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred CCCCHH-----HHHHHHHcCCcC--C-CC---------CCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 543322 122222222111 0 00 1123467899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=298.70 Aligned_cols=266 Identities=24% Similarity=0.324 Sum_probs=204.3
Q ss_pred cccCccCceEEEEEE-eCCCceEEEEEcCCCCccchHHHHHHHHHHhccCCCCcceeeEEEEecC-----ceeEEEeccC
Q 042348 373 FLLGKSTIGIVYKVA-LNNEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVD-----EKLLIYDYIP 446 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~-----~~~lV~e~~~ 446 (686)
+.+|+|||+-||.++ ..++..+|+|++......+.+..++|++.-++++||||++++++..... +.|++++|..
T Consensus 27 ~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yll~Pyy~ 106 (302)
T KOG2345|consen 27 RLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYLLLPYYK 106 (302)
T ss_pred eeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEEEeehhc
Confidence 369999999999998 5568899999998877777888999999999999999999999876543 4799999999
Q ss_pred CCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCccccccccc
Q 042348 447 NGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAE 526 (686)
Q Consensus 447 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~ 526 (686)
.|+|.+.+....... ..+++.+++.|+.+|++||++||+..+ +++||||||.|||+.+++.+++.|||.+.......
T Consensus 107 ~Gsl~d~i~~~k~kg--~~~sE~~iL~if~gic~gL~~lH~~~~-~yAH~DiKP~NILls~~~~~vl~D~GS~~~a~i~i 183 (302)
T KOG2345|consen 107 RGSLLDEIERLKIKG--NFVSEAQILWIFLGICRGLEALHEKEP-PYAHRDIKPANILLSDSGLPVLMDLGSATQAPIQI 183 (302)
T ss_pred cccHHHHHHHHhhcC--CccCHHHHHHHHHHHHHHHHHHhccCC-cccccCCCcceeEecCCCceEEEeccCccccceEe
Confidence 999999998654221 468999999999999999999999553 59999999999999999999999999987654322
Q ss_pred CCccccccccccCCCCCCCccccccccCCCCCccccCccccc---CCCCCCcchHHHHHHHHHHHHhCCCCccccCccch
Q 042348 527 ETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASK---VRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMEL 603 (686)
Q Consensus 527 ~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~ 603 (686)
.... ...+.........|..|+|||.+. +...++++|||||||++|+|+.|..||......+.
T Consensus 184 ~~~~--------------~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~Gg 249 (302)
T KOG2345|consen 184 EGSR--------------QALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGG 249 (302)
T ss_pred echH--------------HHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCC
Confidence 1110 001112233445678899999874 34578999999999999999999999944322221
Q ss_pred hHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 042348 604 NIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRVN 669 (686)
Q Consensus 604 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~ 669 (686)
.+ ...+..+.+.-. ......+.+.+++..|++.||.+||++.+++.+++.+.
T Consensus 250 Sl-------------aLAv~n~q~s~P-~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 250 SL-------------ALAVQNAQISIP-NSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred eE-------------EEeeeccccccC-CCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 11 111111111100 11114457889999999999999999999999988753
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=328.71 Aligned_cols=259 Identities=22% Similarity=0.300 Sum_probs=208.5
Q ss_pred hcccCccCceEEEEEEeCCCceEEEEEcCCCCcc-chHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCCH
Q 042348 372 AFLLGKSTIGIVYKVALNNEEAVAVRRLGNGGWQ-RFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSL 450 (686)
Q Consensus 372 ~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL 450 (686)
.+.||+|.||+|..+....+..||||.++..... .+++|.+|+++|.+++|||||+++|+|..++.+++|+|||++|+|
T Consensus 543 ~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYmEnGDL 622 (807)
T KOG1094|consen 543 KEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYMENGDL 622 (807)
T ss_pred hhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHHhcCcH
Confidence 4579999999999999998899999999876443 458899999999999999999999999999999999999999999
Q ss_pred HHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCcc
Q 042348 451 ATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPE 530 (686)
Q Consensus 451 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 530 (686)
.+++.++... .+.-....+|+.|||.|++||.+ -++|||||.++|+|+|.++++||+|||+++-+-.++..
T Consensus 623 nqFl~aheap----t~~t~~~vsi~tqiasgmaYLes---~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy-- 693 (807)
T KOG1094|consen 623 NQFLSAHELP----TAETAPGVSICTQIASGMAYLES---LNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYY-- 693 (807)
T ss_pred HHHHHhccCc----ccccchhHHHHHHHHHHHHHHHh---hchhhccccccceeecCcccEEecCcccccccccCCce--
Confidence 9999877431 23445567899999999999999 78999999999999999999999999999865433221
Q ss_pred ccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHh--CCCCccccCccchhHHHH
Q 042348 531 VHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS--GKLPMIQIGSMELNIVQW 608 (686)
Q Consensus 531 ~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt--G~~P~~~~~~~~~~~~~~ 608 (686)
......+-...|||||.+.-+++++++|||+|||++||+++ ...||.+..++ +.++-
T Consensus 694 -------------------~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e--~vven 752 (807)
T KOG1094|consen 694 -------------------RVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDE--QVVEN 752 (807)
T ss_pred -------------------eeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHH--HHHHh
Confidence 11112233567999999999999999999999999999887 78899655432 23333
Q ss_pred HHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 042348 609 IQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRV 668 (686)
Q Consensus 609 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i 668 (686)
......+..+..-.. .+..+..++++++.+||..+-++||+++++...|++.
T Consensus 753 ~~~~~~~~~~~~~l~--------~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 753 AGEFFRDQGRQVVLS--------RPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred hhhhcCCCCcceecc--------CCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 333333332211111 1234566889999999999999999999999998764
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=322.57 Aligned_cols=249 Identities=24% Similarity=0.291 Sum_probs=193.7
Q ss_pred cCccCceEEEEEEeC-CCceEEEEEcCCCCc---cchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCCH
Q 042348 375 LGKSTIGIVYKVALN-NEEAVAVRRLGNGGW---QRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSL 450 (686)
Q Consensus 375 iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL 450 (686)
||+|+||.||++... +++.||+|.+..... .....+..|++++++++||||+++++++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 699999999999865 588999999864321 2234566799999999999999999999999999999999999999
Q ss_pred HHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCcc
Q 042348 451 ATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPE 530 (686)
Q Consensus 451 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 530 (686)
.+++..... ..+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~~~~----~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~---- 149 (277)
T cd05607 81 KYHIYNVGE----RGLEMERVIHYSAQITCGILHLHS---MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---- 149 (277)
T ss_pred HHHHHhccc----cCCCHHHHHHHHHHHHHHHHHHHH---CCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc----
Confidence 998865432 458899999999999999999999 899999999999999999999999999987543211
Q ss_pred ccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHHHH
Q 042348 531 VHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQWIQ 610 (686)
Q Consensus 531 ~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~ 610 (686)
......|+..|+|||++.+..++.++|||||||++|||++|+.||...... ........
T Consensus 150 --------------------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~-~~~~~~~~ 208 (277)
T cd05607 150 --------------------TITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEK-VAKEELKR 208 (277)
T ss_pred --------------------eeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcch-hhHHHHHH
Confidence 011234677899999998888999999999999999999999999543221 11112222
Q ss_pred HHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 042348 611 LILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDR 667 (686)
Q Consensus 611 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~ 667 (686)
.......... ......++.+++.+||+.||++||+++|+++.+..
T Consensus 209 ~~~~~~~~~~------------~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~ 253 (277)
T cd05607 209 RTLEDEVKFE------------HQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRK 253 (277)
T ss_pred Hhhccccccc------------cccCCHHHHHHHHHHhccCHhhCCCCccchhhhhc
Confidence 2221111100 00122357899999999999999999877655544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=331.52 Aligned_cols=241 Identities=23% Similarity=0.332 Sum_probs=189.3
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCC---ccchHHHHHHHHHH---hccCCCCcceeeEEEEecCceeEEEecc
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGG---WQRFKEFQTEAEAI---GKIRHPNIVSLRAYFWSVDEKLLIYDYI 445 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l---~~l~H~nIv~l~~~~~~~~~~~lV~e~~ 445 (686)
..||+|+||.||+|... +++.||||.++... ....+.+.+|++++ ++++||||+++++++...+..++||||+
T Consensus 5 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~E~~ 84 (324)
T cd05589 5 AVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVMEYA 84 (324)
T ss_pred EEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEEEcCC
Confidence 46999999999999865 58899999986532 22335566676655 5678999999999999999999999999
Q ss_pred CCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccc
Q 042348 446 PNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIA 525 (686)
Q Consensus 446 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~ 525 (686)
++|+|..+++. ..+++..+..++.|++.||+|||+ ++|+||||||+||++++++.+||+|||+++.....
T Consensus 85 ~~~~L~~~~~~-------~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05589 85 AGGDLMMHIHT-------DVFSEPRAVFYAACVVLGLQYLHE---NKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF 154 (324)
T ss_pred CCCcHHHHhhc-------CCCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCcEEeCcccCCccCCCC
Confidence 99999998864 358999999999999999999999 89999999999999999999999999998642211
Q ss_pred cCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhH
Q 042348 526 EETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNI 605 (686)
Q Consensus 526 ~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~ 605 (686)
. .......|+..|+|||.+.+..++.++|||||||++|||++|+.||.....
T Consensus 155 ~-----------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~----- 206 (324)
T cd05589 155 G-----------------------DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDE----- 206 (324)
T ss_pred C-----------------------CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCH-----
Confidence 1 011234577889999999988999999999999999999999999954322
Q ss_pred HHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 042348 606 VQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRP-----SMRHVCDS 664 (686)
Q Consensus 606 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~ev~~~ 664 (686)
.+....+.......+.. ....+.+++.+||+.||++|| ++.+++++
T Consensus 207 ~~~~~~i~~~~~~~p~~-------------~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~ 257 (324)
T cd05589 207 EEVFDSIVNDEVRYPRF-------------LSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ 257 (324)
T ss_pred HHHHHHHHhCCCCCCCC-------------CCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence 12223333322221111 123567899999999999999 46666654
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=327.83 Aligned_cols=259 Identities=19% Similarity=0.273 Sum_probs=193.5
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCC--ccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCC
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGG--WQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGS 449 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gs 449 (686)
..||+|+||.||+++.. +++.||+|++.... ....+.+.+|+.++++++||||+++++++...+..++||||++++.
T Consensus 7 ~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 86 (287)
T cd07848 7 GVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEKNM 86 (287)
T ss_pred EEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEecCCCCH
Confidence 46999999999999986 57889999986542 2234668899999999999999999999999999999999999877
Q ss_pred HHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCc
Q 042348 450 LATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETP 529 (686)
Q Consensus 450 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 529 (686)
+..+.... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++.......
T Consensus 87 l~~~~~~~------~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-- 155 (287)
T cd07848 87 LELLEEMP------NGVPPEKVRSYIYQLIKAIHWCHK---NDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN-- 155 (287)
T ss_pred HHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccCccccccccc--
Confidence 76654332 358999999999999999999999 8999999999999999999999999999976532111
Q ss_pred cccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHHH
Q 042348 530 EVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQWI 609 (686)
Q Consensus 530 ~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~ 609 (686)
.......||..|+|||++.+..++.++|||||||++|||++|+.||......+ ....+
T Consensus 156 --------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~--~~~~~ 213 (287)
T cd07848 156 --------------------ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEID--QLFTI 213 (287)
T ss_pred --------------------ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHH--HHHHH
Confidence 01122456778999999988889999999999999999999999996533211 11111
Q ss_pred HHHHh-----------hcCCcccccCcccccCCC-----cHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 610 QLILE-----------DRKPMTDILDPFLAHDLD-----KEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 610 ~~~~~-----------~~~~~~~~~d~~l~~~~~-----~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
..... ..........+....... .......+.+++.+||+.||++|||++|++++
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h 284 (287)
T cd07848 214 QKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH 284 (287)
T ss_pred HHhhCCCCHHHHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 11100 000000000000000000 00123458899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=322.96 Aligned_cols=255 Identities=28% Similarity=0.441 Sum_probs=199.2
Q ss_pred cccCccCceEEEEEEeCC------CceEEEEEcCCCCc-cchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEecc
Q 042348 373 FLLGKSTIGIVYKVALNN------EEAVAVRRLGNGGW-QRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYI 445 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~ 445 (686)
..||+|+||.||+|.... ...||+|.+..... ....+|.+|++++++++||||+++++++...+..+++|||+
T Consensus 11 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~ 90 (283)
T cd05048 11 EELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYL 90 (283)
T ss_pred hcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEEEEecC
Confidence 369999999999998643 25799999875432 33456899999999999999999999999989999999999
Q ss_pred CCCCHHHHhhcCCCcc----------ccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEee
Q 042348 446 PNGSLATAIHGKAGII----------SYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISD 515 (686)
Q Consensus 446 ~~gsL~~~l~~~~~~~----------~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~D 515 (686)
++|+|.+++....... ....+++.++..++.|++.||+|||+ ++++||||||+||++++++.+||+|
T Consensus 91 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nil~~~~~~~~L~d 167 (283)
T cd05048 91 AHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSS---HHFVHRDLAARNCLVGEGLTVKISD 167 (283)
T ss_pred CCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccccceEEEcCCCcEEECC
Confidence 9999999997642211 11458899999999999999999999 8999999999999999999999999
Q ss_pred cCcccccccccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCC
Q 042348 516 FGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLP 594 (686)
Q Consensus 516 fGla~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P 594 (686)
||+++........ .......++..|+|||.+.+..++.++|||||||++|||++ |..|
T Consensus 168 fg~~~~~~~~~~~---------------------~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p 226 (283)
T cd05048 168 FGLSRDIYSADYY---------------------RVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQP 226 (283)
T ss_pred Ccceeeccccccc---------------------cccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCC
Confidence 9999754321110 01112334667999999988889999999999999999998 9999
Q ss_pred ccccCccchhHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 042348 595 MIQIGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRV 668 (686)
Q Consensus 595 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i 668 (686)
|...... ++ ...+.... . ... ......++.+++.+||+.||++||+++||+++|+++
T Consensus 227 ~~~~~~~--~~---~~~i~~~~-~-~~~----------~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05048 227 YYGFSNQ--EV---IEMIRSRQ-L-LPC----------PEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW 283 (283)
T ss_pred CCCCCHH--HH---HHHHHcCC-c-CCC----------cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence 9643322 11 22222211 1 110 112345788999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=332.61 Aligned_cols=236 Identities=22% Similarity=0.343 Sum_probs=186.9
Q ss_pred ccCccCceEEEEEEeC-CCceEEEEEcCCCC---ccchHHHHHHHH-HHhccCCCCcceeeEEEEecCceeEEEeccCCC
Q 042348 374 LLGKSTIGIVYKVALN-NEEAVAVRRLGNGG---WQRFKEFQTEAE-AIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNG 448 (686)
Q Consensus 374 ~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~g 448 (686)
.||+|+||.||+|... +++.||+|.+.... .....++..|.. +++.++||||+++++++...+..++||||+++|
T Consensus 2 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g 81 (323)
T cd05575 2 VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNGG 81 (323)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCCC
Confidence 5899999999999875 58899999986532 122344555555 567899999999999999999999999999999
Q ss_pred CHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCC
Q 042348 449 SLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEET 528 (686)
Q Consensus 449 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 528 (686)
+|.+++... ..+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~L~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH~---~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~-- 150 (323)
T cd05575 82 ELFFHLQRE------RSFPEPRARFYAAEIASALGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS-- 150 (323)
T ss_pred CHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC--
Confidence 999998754 358899999999999999999999 899999999999999999999999999986432111
Q ss_pred ccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHH
Q 042348 529 PEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQW 608 (686)
Q Consensus 529 ~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~ 608 (686)
.......||..|+|||++.+..++.++|||||||++|||++|+.||.... ..+.
T Consensus 151 ---------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~-----~~~~ 204 (323)
T cd05575 151 ---------------------KTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRD-----TAEM 204 (323)
T ss_pred ---------------------CccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCC-----HHHH
Confidence 01123457888999999999899999999999999999999999995432 2222
Q ss_pred HHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHH
Q 042348 609 IQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMR 659 (686)
Q Consensus 609 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ 659 (686)
...+........ + . ....+.+++.+||+.||++||++.
T Consensus 205 ~~~i~~~~~~~~----~----~-----~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 205 YDNILNKPLRLK----P----N-----ISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred HHHHHcCCCCCC----C----C-----CCHHHHHHHHHHhhcCHHhCCCCC
Confidence 333333221111 1 1 123577899999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-38 Score=317.59 Aligned_cols=250 Identities=27% Similarity=0.435 Sum_probs=203.5
Q ss_pred hcccCccCceEEEEEEeCCCceEEEEEcCCCCccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCCHH
Q 042348 372 AFLLGKSTIGIVYKVALNNEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLA 451 (686)
Q Consensus 372 ~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL~ 451 (686)
.+.||+|+||.||+|...++..+++|.+.........++.+|+.+++.++||||+++++++...+..++||||+++++|.
T Consensus 11 ~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 90 (261)
T cd05148 11 ERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLL 90 (261)
T ss_pred hhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeecccCCHH
Confidence 34699999999999998889999999998766555678999999999999999999999999999999999999999999
Q ss_pred HHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCccc
Q 042348 452 TAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEV 531 (686)
Q Consensus 452 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 531 (686)
+++....+ ..+++..+..++.|++.||+|||+ ++|+||||||+||++++++.+||+|||.+........
T Consensus 91 ~~~~~~~~----~~~~~~~~~~~~~~i~~al~~lH~---~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~---- 159 (261)
T cd05148 91 AFLRSPEG----QVLPVASLIDMACQVAEGMAYLEE---QNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY---- 159 (261)
T ss_pred HHHhcCCC----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccCcceEEEcCCceEEEccccchhhcCCccc----
Confidence 99986543 458999999999999999999999 8999999999999999999999999999976532110
Q ss_pred cccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCccccCccchhHHHHHH
Q 042348 532 HWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQIGSMELNIVQWIQ 610 (686)
Q Consensus 532 ~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~~~~~~~~~ 610 (686)
......++..|+|||......++.++||||||+++|+|++ |+.||..... . +.+.
T Consensus 160 -------------------~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~--~---~~~~ 215 (261)
T cd05148 160 -------------------LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNN--H---EVYD 215 (261)
T ss_pred -------------------cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCH--H---HHHH
Confidence 0112234567999999988889999999999999999998 8999954321 1 1122
Q ss_pred HHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 042348 611 LILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRV 668 (686)
Q Consensus 611 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i 668 (686)
........ . . .......+.+++.+||+.||++|||+.++++.|+.+
T Consensus 216 ~~~~~~~~-~---~--------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 216 QITAGYRM-P---C--------PAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred HHHhCCcC-C---C--------CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 22211110 0 0 012234678999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-38 Score=322.20 Aligned_cols=257 Identities=25% Similarity=0.390 Sum_probs=201.9
Q ss_pred cccCccCceEEEEEEeC------CCceEEEEEcCCCCccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccC
Q 042348 373 FLLGKSTIGIVYKVALN------NEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIP 446 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~ 446 (686)
+.||+|+||.||++... ++..+|+|.+........+.+.+|++++++++||||+++++++...+..++||||++
T Consensus 11 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 90 (288)
T cd05093 11 RELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMK 90 (288)
T ss_pred cccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEcCC
Confidence 46999999999999742 345689999877655556789999999999999999999999999999999999999
Q ss_pred CCCHHHHhhcCCCc-------cccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcc
Q 042348 447 NGSLATAIHGKAGI-------ISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLA 519 (686)
Q Consensus 447 ~gsL~~~l~~~~~~-------~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla 519 (686)
+++|.+++...... .....+++..++.++.|++.||+|||+ ++++||||||+||++++++.+||+|||++
T Consensus 91 ~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~ 167 (288)
T cd05093 91 HGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLLVKIGDFGMS 167 (288)
T ss_pred CCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEccCCcEEeccCCcc
Confidence 99999999754310 111358999999999999999999999 89999999999999999999999999998
Q ss_pred cccccccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCcccc
Q 042348 520 RLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQI 598 (686)
Q Consensus 520 ~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~ 598 (686)
+........ .......++..|+|||++.+..++.++|||||||++|||+| |+.||...
T Consensus 168 ~~~~~~~~~---------------------~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~ 226 (288)
T cd05093 168 RDVYSTDYY---------------------RVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQL 226 (288)
T ss_pred ccccCCcee---------------------ecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 754321100 01112234567999999988889999999999999999999 89998543
Q ss_pred CccchhHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccc
Q 042348 599 GSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRVNI 670 (686)
Q Consensus 599 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~ 670 (686)
... .....+..+... .. .. ....++.+++.+||+.||.+|||+.|+.+.|+++..
T Consensus 227 ~~~-----~~~~~i~~~~~~--~~-----~~-----~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~ 281 (288)
T cd05093 227 SNN-----EVIECITQGRVL--QR-----PR-----TCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAK 281 (288)
T ss_pred CHH-----HHHHHHHcCCcC--CC-----CC-----CCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence 321 112222222111 00 00 122358899999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-38 Score=317.18 Aligned_cols=249 Identities=25% Similarity=0.381 Sum_probs=198.6
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCCccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCCHH
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLA 451 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL~ 451 (686)
+.||+|+||.||+|... .+..||+|.+.... ....++.+|++++++++||||+++++++...+..++||||+++++|.
T Consensus 12 ~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 90 (263)
T cd05052 12 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLL 90 (263)
T ss_pred eecCCcccceEEEEEEecCCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCCCCcHH
Confidence 46999999999999865 47889999987543 34567899999999999999999999999999999999999999999
Q ss_pred HHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCccc
Q 042348 452 TAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEV 531 (686)
Q Consensus 452 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 531 (686)
+++..... ..+++..++.++.|++.||+|||+ ++++||||||+||++++++.+||+|||+++.......
T Consensus 91 ~~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~---- 159 (263)
T cd05052 91 DYLRECNR----QEVNAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY---- 159 (263)
T ss_pred HHHHhCCC----CCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCcEEeCCCcccccccccee----
Confidence 99976432 458999999999999999999999 8999999999999999999999999999975532110
Q ss_pred cccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCccccCccchhHHHHHH
Q 042348 532 HWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQIGSMELNIVQWIQ 610 (686)
Q Consensus 532 ~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~~~~~~~~~ 610 (686)
........+..|+|||.+.+..++.++|||||||++|||++ |..||..... .+...
T Consensus 160 ------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~-----~~~~~ 216 (263)
T cd05052 160 ------------------TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-----SQVYE 216 (263)
T ss_pred ------------------eccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH-----HHHHH
Confidence 00011223456999999988899999999999999999998 9999854321 12222
Q ss_pred HHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 042348 611 LILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRV 668 (686)
Q Consensus 611 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i 668 (686)
..... ... + . ......++.+++.+||+.+|++||++.|+++.|+.+
T Consensus 217 ~~~~~-~~~-~-----~-----~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 217 LLEKG-YRM-E-----R-----PEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred HHHCC-CCC-C-----C-----CCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 22211 110 0 0 011234688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-38 Score=317.40 Aligned_cols=249 Identities=29% Similarity=0.467 Sum_probs=199.7
Q ss_pred cccCccCceEEEEEEeCCCceEEEEEcCCCCccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCCHHH
Q 042348 373 FLLGKSTIGIVYKVALNNEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLAT 452 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL~~ 452 (686)
..||+|++|.||+|...+++.||+|.++.... ..+++.+|++++++++||||+++++++...+..++||||+++++|.+
T Consensus 12 ~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 90 (261)
T cd05068 12 RKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTM-DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLE 90 (261)
T ss_pred EEecccCCccEEEEEecCCeEEEEEeeCCCcc-cHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecccCCcHHH
Confidence 46999999999999988788899999876432 34679999999999999999999999999999999999999999999
Q ss_pred HhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCcccc
Q 042348 453 AIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVH 532 (686)
Q Consensus 453 ~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 532 (686)
++....+ ..+++..+..++.|++.||+|||+ ++|+||||||+||++++++.+||+|||+++........
T Consensus 91 ~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~---- 159 (261)
T cd05068 91 YLQGGAG----RALKLPQLIDMAAQVASGMAYLEA---QNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE---- 159 (261)
T ss_pred HHhccCC----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCcceEEEcCCCCEEECCcceEEEccCCccc----
Confidence 9976542 468999999999999999999999 89999999999999999999999999999866421100
Q ss_pred ccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCccccCccchhHHHHHHH
Q 042348 533 WEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQIGSMELNIVQWIQL 611 (686)
Q Consensus 533 ~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~ 611 (686)
.......+..|+|||+..+..++.++||||||+++|||+| |+.||...... .....
T Consensus 160 ------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-----~~~~~ 216 (261)
T cd05068 160 ------------------AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNA-----EVLQQ 216 (261)
T ss_pred ------------------ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHH-----HHHHH
Confidence 0011122346999999988889999999999999999999 99998543211 11112
Q ss_pred HHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 042348 612 ILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRV 668 (686)
Q Consensus 612 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i 668 (686)
+... .... . .......+.+++.+|++.+|++||++.++++.|+++
T Consensus 217 ~~~~-~~~~--~---------~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 217 VDQG-YRMP--C---------PPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred HHcC-CCCC--C---------CCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 2111 1110 0 011234688999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=334.25 Aligned_cols=242 Identities=23% Similarity=0.341 Sum_probs=188.1
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCCc-cchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCCH
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGGW-QRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSL 450 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL 450 (686)
+.||+|+||.||+|... +++.||||.+..... ...+.+.+|++++++++|+||+++++++...+..++||||+++|+|
T Consensus 80 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 159 (353)
T PLN00034 80 NRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSL 159 (353)
T ss_pred hhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCCCCcc
Confidence 46999999999999865 588999999865432 2346789999999999999999999999999999999999999998
Q ss_pred HHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCcc
Q 042348 451 ATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPE 530 (686)
Q Consensus 451 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 530 (686)
.+. ...++..+..++.||+.||+|||+ ++|+||||||+|||+++++.+||+|||+++.......
T Consensus 160 ~~~----------~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~--- 223 (353)
T PLN00034 160 EGT----------HIADEQFLADVARQILSGIAYLHR---RHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD--- 223 (353)
T ss_pred ccc----------ccCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEcccccceecccccc---
Confidence 653 235677888999999999999999 8999999999999999999999999999986532110
Q ss_pred ccccccccCCCCCCCccccccccCCCCCccccCcccccC-----CCCCCcchHHHHHHHHHHHHhCCCCccccCccchhH
Q 042348 531 VHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKV-----RKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNI 605 (686)
Q Consensus 531 ~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~ 605 (686)
......||..|+|||++.. ...+.++|||||||++|||++|+.||...... +.
T Consensus 224 --------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~--~~ 281 (353)
T PLN00034 224 --------------------PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQG--DW 281 (353)
T ss_pred --------------------cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc--cH
Confidence 1123457888999998743 23456899999999999999999999632211 11
Q ss_pred HHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 606 VQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 606 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
............+ . . ......++.+++.+||+.||++||++.|++++
T Consensus 282 ~~~~~~~~~~~~~--~-~---------~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 282 ASLMCAICMSQPP--E-A---------PATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred HHHHHHHhccCCC--C-C---------CCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1111111111110 0 0 01123467899999999999999999999987
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=328.87 Aligned_cols=253 Identities=26% Similarity=0.375 Sum_probs=197.4
Q ss_pred cccCccCceEEEEEEeC-CCc----eEEEEEcCCCC-ccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccC
Q 042348 373 FLLGKSTIGIVYKVALN-NEE----AVAVRRLGNGG-WQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIP 446 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~ 446 (686)
..||+|+||.||+|.+. ++. .||+|.+.... ....+++.+|+.+++.++||||+++++++... ..++|+||++
T Consensus 13 ~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~v~e~~~ 91 (316)
T cd05108 13 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMP 91 (316)
T ss_pred eeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-CceeeeecCC
Confidence 46999999999999864 333 48999987543 23456789999999999999999999999764 5789999999
Q ss_pred CCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCccccccccc
Q 042348 447 NGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAE 526 (686)
Q Consensus 447 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~ 526 (686)
+|+|.+++.... ..+++..++.++.||+.||+|||+ ++|+||||||+||++++++.+||+|||+++......
T Consensus 92 ~g~l~~~l~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~---~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 163 (316)
T cd05108 92 FGCLLDYVREHK-----DNIGSQYLLNWCVQIAKGMNYLEE---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADE 163 (316)
T ss_pred CCCHHHHHHhcc-----ccCCHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheEecCCCcEEEccccccccccCCC
Confidence 999999998654 358899999999999999999999 899999999999999999999999999998664322
Q ss_pred CCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCccccCccchhH
Q 042348 527 ETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQIGSMELNI 605 (686)
Q Consensus 527 ~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~~~~ 605 (686)
.. .......++..|+|||++.+..++.++|||||||++|||++ |+.||......
T Consensus 164 ~~---------------------~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~---- 218 (316)
T cd05108 164 KE---------------------YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS---- 218 (316)
T ss_pred cc---------------------eeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH----
Confidence 10 00111223567999999998899999999999999999998 99998543221
Q ss_pred HHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccccc
Q 042348 606 VQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRVNIST 672 (686)
Q Consensus 606 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~~~ 672 (686)
+. ..........+. + ..+...+.+++.+||+.+|++||++.+++..+..+....
T Consensus 219 -~~-~~~~~~~~~~~~---~--------~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~ 272 (316)
T cd05108 219 -EI-SSILEKGERLPQ---P--------PICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 272 (316)
T ss_pred -HH-HHHHhCCCCCCC---C--------CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence 11 122222111110 0 112235778999999999999999999999998876443
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=329.36 Aligned_cols=239 Identities=25% Similarity=0.448 Sum_probs=199.0
Q ss_pred cCccCceEEEEEEeC-CCceEEEEEcCCCCccc---hHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCCH
Q 042348 375 LGKSTIGIVYKVALN-NEEAVAVRRLGNGGWQR---FKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSL 450 (686)
Q Consensus 375 iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL 450 (686)
||.|+||.||.++.. +.+.||||++.....+. ..++.+|++.|.+++|||+|.+.|+|......++|||||- ||-
T Consensus 34 IGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYCl-GSA 112 (948)
T KOG0577|consen 34 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYCL-GSA 112 (948)
T ss_pred hcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHHh-ccH
Confidence 999999999999864 57889999997654433 4578899999999999999999999999999999999994 588
Q ss_pred HHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCcc
Q 042348 451 ATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPE 530 (686)
Q Consensus 451 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 530 (686)
.|++.-.. +++.+.++..|..+.+.||+|||+ .+.||||||+.|||+.+.|.+||+|||.|.+..+
T Consensus 113 sDlleVhk-----KplqEvEIAAi~~gaL~gLaYLHS---~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P------ 178 (948)
T KOG0577|consen 113 SDLLEVHK-----KPLQEVEIAAITHGALQGLAYLHS---HNRIHRDIKAGNILLSEPGLVKLADFGSASIMAP------ 178 (948)
T ss_pred HHHHHHHh-----ccchHHHHHHHHHHHHHHHHHHHH---hhHHhhhccccceEecCCCeeeeccccchhhcCc------
Confidence 88886554 679999999999999999999999 8999999999999999999999999999976543
Q ss_pred ccccccccCCCCCCCccccccccCCCCCccccCccccc---CCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHH
Q 042348 531 VHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASK---VRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQ 607 (686)
Q Consensus 531 ~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~ 607 (686)
.++.+||++|||||++. .+.|+-|+||||+|++..||.-.++|+..++.+ .
T Consensus 179 ---------------------AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAM-----S 232 (948)
T KOG0577|consen 179 ---------------------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-----S 232 (948)
T ss_pred ---------------------hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHH-----H
Confidence 24678899999999874 478999999999999999999999998654432 2
Q ss_pred HHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 042348 608 WIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSL 665 (686)
Q Consensus 608 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L 665 (686)
....+..+..|. + ...+....+..++..||++-|.+|||..+++.+-
T Consensus 233 ALYHIAQNesPt-------L----qs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~ 279 (948)
T KOG0577|consen 233 ALYHIAQNESPT-------L----QSNEWSDYFRNFVDSCLQKIPQERPTSEELLKHR 279 (948)
T ss_pred HHHHHHhcCCCC-------C----CCchhHHHHHHHHHHHHhhCcccCCcHHHHhhcc
Confidence 233333333322 1 1234455688889999999999999999988764
|
|
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-38 Score=322.38 Aligned_cols=258 Identities=26% Similarity=0.418 Sum_probs=203.2
Q ss_pred cccCccCceEEEEEEeC------CCceEEEEEcCCCCccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccC
Q 042348 373 FLLGKSTIGIVYKVALN------NEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIP 446 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~ 446 (686)
..||+|+||.||+|... ++..+++|.+........+.+.+|++++++++||||+++++++...+..++||||++
T Consensus 11 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 90 (291)
T cd05094 11 RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMK 90 (291)
T ss_pred eeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEEEecCC
Confidence 36999999999999743 345689999877665556789999999999999999999999999999999999999
Q ss_pred CCCHHHHhhcCCCc----------cccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeec
Q 042348 447 NGSLATAIHGKAGI----------ISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDF 516 (686)
Q Consensus 447 ~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~Df 516 (686)
+++|.+++...... .....+++..++.++.|++.||+|||+ ++|+||||||+||+++.++.++|+||
T Consensus 91 ~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~df 167 (291)
T cd05094 91 HGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLAS---QHFVHRDLATRNCLVGANLLVKIGDF 167 (291)
T ss_pred CCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEccCCcEEECCC
Confidence 99999999764310 111348999999999999999999999 89999999999999999999999999
Q ss_pred CcccccccccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCc
Q 042348 517 GLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPM 595 (686)
Q Consensus 517 Gla~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~ 595 (686)
|+++....... ........++..|+|||++.+..++.++|||||||++|||+| |+.||
T Consensus 168 g~a~~~~~~~~---------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~ 226 (291)
T cd05094 168 GMSRDVYSTDY---------------------YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPW 226 (291)
T ss_pred CcccccCCCce---------------------eecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 99975432110 001122345677999999988889999999999999999999 99998
Q ss_pred cccCccchhHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccccc
Q 042348 596 IQIGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRVNIS 671 (686)
Q Consensus 596 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~~ 671 (686)
...... ..+........ ... .......+.+++.+||+.+|++||++.+|++.|+++...
T Consensus 227 ~~~~~~-----~~~~~~~~~~~--~~~----------~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 227 FQLSNT-----EVIECITQGRV--LER----------PRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred CCCCHH-----HHHHHHhCCCC--CCC----------CccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 543221 11222222111 110 011234678999999999999999999999999998643
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=332.10 Aligned_cols=247 Identities=21% Similarity=0.288 Sum_probs=192.5
Q ss_pred cccCccCceEEEEEEe----CCCceEEEEEcCCC----CccchHHHHHHHHHHhcc-CCCCcceeeEEEEecCceeEEEe
Q 042348 373 FLLGKSTIGIVYKVAL----NNEEAVAVRRLGNG----GWQRFKEFQTEAEAIGKI-RHPNIVSLRAYFWSVDEKLLIYD 443 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~----~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~e 443 (686)
..||+|+||.||+++. .+++.||+|.+... .....+.+..|+.++.++ +||||+++++++...+..++|||
T Consensus 6 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (332)
T cd05614 6 KVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLHLILD 85 (332)
T ss_pred EEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEEEEEe
Confidence 4699999999999875 35788999998642 122345678899999999 59999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccc
Q 042348 444 YIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLAD 523 (686)
Q Consensus 444 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~ 523 (686)
|+++|+|.+++... ..+++.++..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 86 ~~~~g~L~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~ 156 (332)
T cd05614 86 YVSGGEMFTHLYQR------DNFSEDEVRFYSGEIILALEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEFL 156 (332)
T ss_pred CCCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHeEECCCCCEEEeeCcCCcccc
Confidence 99999999999764 358999999999999999999999 899999999999999999999999999987543
Q ss_pred cccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCC-CCCCcchHHHHHHHHHHHHhCCCCccccCccc
Q 042348 524 IAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVR-KPTQKWDIYSYGVILLEMISGKLPMIQIGSME 602 (686)
Q Consensus 524 ~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~ 602 (686)
.... .......||..|+|||++.+. .++.++|||||||++|||+||+.||.......
T Consensus 157 ~~~~----------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 214 (332)
T cd05614 157 SEEK----------------------ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERN 214 (332)
T ss_pred ccCC----------------------CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCC
Confidence 2111 011234578889999998765 47899999999999999999999995433221
Q ss_pred hhHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 042348 603 LNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRP-----SMRHVCDS 664 (686)
Q Consensus 603 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~ev~~~ 664 (686)
. .......+.....+.... ....+.+++.+||+.||++|| ++++++++
T Consensus 215 ~-~~~~~~~~~~~~~~~~~~-------------~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 215 T-QSEVSRRILKCDPPFPSF-------------IGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred C-HHHHHHHHhcCCCCCCCC-------------CCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 1 112222222222111111 123567899999999999999 67788765
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=309.59 Aligned_cols=265 Identities=21% Similarity=0.280 Sum_probs=199.6
Q ss_pred ccCccCceEEEEEEeC-CCceEEEEEcCCCCc--cchHHHHHHHHHHhccCCCC-cceeeEEEEecC------ceeEEEe
Q 042348 374 LLGKSTIGIVYKVALN-NEEAVAVRRLGNGGW--QRFKEFQTEAEAIGKIRHPN-IVSLRAYFWSVD------EKLLIYD 443 (686)
Q Consensus 374 ~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~n-Iv~l~~~~~~~~------~~~lV~e 443 (686)
.||+|+||+||+|+.. +|+.||+|++..... .......+|+.++++++|+| ||++++++...+ ..++|+|
T Consensus 18 klGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l~lvfe 97 (323)
T KOG0594|consen 18 KLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKLYLVFE 97 (323)
T ss_pred HhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceEEEEEE
Confidence 4999999999999865 688999999876433 23356789999999999999 999999999877 6789999
Q ss_pred ccCCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccc
Q 042348 444 YIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLAD 523 (686)
Q Consensus 444 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~ 523 (686)
|++. +|..++....... ..++...++.++.|++.||+|||+ ++|+||||||+||||+++|.+||+|||+|+...
T Consensus 98 ~~d~-DL~~ymd~~~~~~--~g~~~~~ik~~m~Qll~gl~~~H~---~~IlHRDLKPQNlLi~~~G~lKlaDFGlAra~~ 171 (323)
T KOG0594|consen 98 FLDR-DLKKYMDSLPKKP--QGLPPRLIKSFMRQLLRGLAFLHS---HGILHRDLKPQNLLISSSGVLKLADFGLARAFS 171 (323)
T ss_pred eecc-cHHHHHHhccccc--cCCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCcceEEECCCCcEeeeccchHHHhc
Confidence 9954 9999998765211 246778899999999999999999 999999999999999999999999999998543
Q ss_pred cccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCC-CCCCcchHHHHHHHHHHHHhCCCCccccCccc
Q 042348 524 IAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVR-KPTQKWDIYSYGVILLEMISGKLPMIQIGSME 602 (686)
Q Consensus 524 ~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~ 602 (686)
... ...+..++|.+|+|||++.+. .|++..||||+||++.||++++.-|.+...
T Consensus 172 ip~-----------------------~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se-- 226 (323)
T KOG0594|consen 172 IPM-----------------------RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSE-- 226 (323)
T ss_pred CCc-----------------------ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcH--
Confidence 211 123456778899999999886 699999999999999999999988854432
Q ss_pred hhHHHHHHHHHhhc--CCccccc---Ccc--cccCCCc----H---HHHHHHHHHHHhccccCCCCCCCHHHHHHH--Hh
Q 042348 603 LNIVQWIQLILEDR--KPMTDIL---DPF--LAHDLDK----E---DEIVSVLKIALDCVHKSPDKRPSMRHVCDS--LD 666 (686)
Q Consensus 603 ~~~~~~~~~~~~~~--~~~~~~~---d~~--l~~~~~~----~---~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~--L~ 666 (686)
.+....+-..+... ..++... +-. ....... . .......+++.+|++++|.+|.|++.++++ +.
T Consensus 227 ~~ql~~If~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~ 306 (323)
T KOG0594|consen 227 IDQLFRIFRLLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFS 306 (323)
T ss_pred HHHHHHHHHHcCCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhc
Confidence 22222222222211 1111111 100 0000000 0 011357899999999999999999999988 55
Q ss_pred ccc
Q 042348 667 RVN 669 (686)
Q Consensus 667 ~i~ 669 (686)
.+.
T Consensus 307 ~~~ 309 (323)
T KOG0594|consen 307 ELP 309 (323)
T ss_pred ccc
Confidence 543
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=329.54 Aligned_cols=192 Identities=24% Similarity=0.327 Sum_probs=165.5
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCC-CccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCCH
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNG-GWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSL 450 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL 450 (686)
..||+|+||.||++... ++..+|+|.+... .......+.+|++++++++||||++++++|...+..++||||+++|+|
T Consensus 11 ~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 90 (333)
T cd06650 11 SELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL 90 (333)
T ss_pred ccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEecCCCCcH
Confidence 46999999999999876 5788999988654 223346789999999999999999999999999999999999999999
Q ss_pred HHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCcc
Q 042348 451 ATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPE 530 (686)
Q Consensus 451 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 530 (686)
.+++... ..+++..+..++.|++.||+|||+. .+|+||||||+|||++.++.+||+|||++.......
T Consensus 91 ~~~l~~~------~~~~~~~~~~~~~~l~~~l~~lH~~--~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~---- 158 (333)
T cd06650 91 DQVLKKA------GRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM---- 158 (333)
T ss_pred HHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc----
Confidence 9999754 3588899999999999999999972 369999999999999999999999999987543211
Q ss_pred ccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccc
Q 042348 531 VHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQ 597 (686)
Q Consensus 531 ~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~ 597 (686)
.....|+..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 159 ---------------------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~ 204 (333)
T cd06650 159 ---------------------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPP 204 (333)
T ss_pred ---------------------cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 1123567789999999988899999999999999999999999954
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=336.28 Aligned_cols=258 Identities=26% Similarity=0.316 Sum_probs=198.4
Q ss_pred hcccCccCceEEEEEEeCC------CceEEEEEcCCCC-ccchHHHHHHHHHHhccC-CCCcceeeEEEEecCceeEEEe
Q 042348 372 AFLLGKSTIGIVYKVALNN------EEAVAVRRLGNGG-WQRFKEFQTEAEAIGKIR-HPNIVSLRAYFWSVDEKLLIYD 443 (686)
Q Consensus 372 ~~~iG~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lV~e 443 (686)
...||+|+||.||+|.... +..||||++.... ....+.+.+|+++++++. |||||++++++...+..++|||
T Consensus 42 ~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E 121 (400)
T cd05105 42 GRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPIYIITE 121 (400)
T ss_pred hheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCceEEEEE
Confidence 3579999999999997531 3469999996542 233467899999999996 9999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCCc---------------------------------------------------------------
Q 042348 444 YIPNGSLATAIHGKAGI--------------------------------------------------------------- 460 (686)
Q Consensus 444 ~~~~gsL~~~l~~~~~~--------------------------------------------------------------- 460 (686)
||++|+|.++++.....
T Consensus 122 y~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 201 (400)
T cd05105 122 YCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKEASKYS 201 (400)
T ss_pred ecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhhhhhhhh
Confidence 99999999998753210
Q ss_pred ---------------------------cccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEE
Q 042348 461 ---------------------------ISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHI 513 (686)
Q Consensus 461 ---------------------------~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl 513 (686)
.....+++.++..++.|++.||+|||+ ++|+||||||+||++++++.+||
T Consensus 202 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dikp~Nill~~~~~~kL 278 (400)
T cd05105 202 DIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLAS---KNCVHRDLAARNVLLAQGKIVKI 278 (400)
T ss_pred hcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHhEEEeCCCEEEE
Confidence 001347889999999999999999999 89999999999999999999999
Q ss_pred eecCcccccccccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHh-CC
Q 042348 514 SDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GK 592 (686)
Q Consensus 514 ~DfGla~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~ 592 (686)
+|||+++........ .......++..|+|||.+.+..++.++|||||||++|||++ |.
T Consensus 279 ~DfGla~~~~~~~~~---------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~ 337 (400)
T cd05105 279 CDFGLARDIMHDSNY---------------------VSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGG 337 (400)
T ss_pred EeCCcceeccccccc---------------------cccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCC
Confidence 999999755321110 01112345667999999988889999999999999999997 99
Q ss_pred CCccccCccchhHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 042348 593 LPMIQIGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRVN 669 (686)
Q Consensus 593 ~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~ 669 (686)
.||........ +........... . .......+.+++.+||+.||++||++.+|.+.|+++.
T Consensus 338 ~P~~~~~~~~~-----~~~~~~~~~~~~--~---------~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~ 398 (400)
T cd05105 338 TPYPGMIVDST-----FYNKIKSGYRMA--K---------PDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398 (400)
T ss_pred CCCcccchhHH-----HHHHHhcCCCCC--C---------CccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence 99854322111 111111111110 0 0112346789999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=317.40 Aligned_cols=251 Identities=28% Similarity=0.490 Sum_probs=199.0
Q ss_pred hcccCccCceEEEEEEeCC----CceEEEEEcCCCC-ccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccC
Q 042348 372 AFLLGKSTIGIVYKVALNN----EEAVAVRRLGNGG-WQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIP 446 (686)
Q Consensus 372 ~~~iG~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~ 446 (686)
...||+|+||.||+|.... ...||||.+.... .....+|.+|+.++++++||||+++++++...+..++||||++
T Consensus 9 ~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 88 (266)
T cd05033 9 EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITEYME 88 (266)
T ss_pred eeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEEEEcCC
Confidence 3469999999999998742 4579999987543 2334678999999999999999999999999999999999999
Q ss_pred CCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCccccccccc
Q 042348 447 NGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAE 526 (686)
Q Consensus 447 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~ 526 (686)
+++|.+++.... ..+++.++.+++.|++.||+|||+ ++|+||||||+||++++++.++|+|||+++......
T Consensus 89 ~~~L~~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~ 160 (266)
T cd05033 89 NGSLDKFLREND-----GKFTVGQLVGMLRGIASGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSE 160 (266)
T ss_pred CCCHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCCEEECccchhhcccccc
Confidence 999999997654 358999999999999999999999 899999999999999999999999999998664111
Q ss_pred CCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCccccCccchhH
Q 042348 527 ETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQIGSMELNI 605 (686)
Q Consensus 527 ~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~~~~ 605 (686)
.. .......++..|+|||.+.+..++.++||||||+++|||++ |..||......
T Consensus 161 ~~---------------------~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~---- 215 (266)
T cd05033 161 AT---------------------YTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ---- 215 (266)
T ss_pred cc---------------------eeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH----
Confidence 10 00011223567999999988889999999999999999998 99998543221
Q ss_pred HHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 042348 606 VQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRV 668 (686)
Q Consensus 606 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i 668 (686)
+....+... ..... .......+.+++.+||+.+|++||++.||+++|+++
T Consensus 216 -~~~~~~~~~-~~~~~-----------~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 216 -DVIKAVEDG-YRLPP-----------PMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred -HHHHHHHcC-CCCCC-----------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 112222211 11110 011234678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=302.19 Aligned_cols=247 Identities=25% Similarity=0.401 Sum_probs=199.5
Q ss_pred hcccCccCceEEEEEEeC-CCceEEEEEcCCCC-----cc---chHHHHHHHHHHhcc-CCCCcceeeEEEEecCceeEE
Q 042348 372 AFLLGKSTIGIVYKVALN-NEEAVAVRRLGNGG-----WQ---RFKEFQTEAEAIGKI-RHPNIVSLRAYFWSVDEKLLI 441 (686)
Q Consensus 372 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~---~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV 441 (686)
++++|+|..++|.++..+ ++...|+|++.... .. -.+.-.+|+.+|+++ .||+|+++.++|+++...++|
T Consensus 22 keilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~FlV 101 (411)
T KOG0599|consen 22 KEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAFVFLV 101 (411)
T ss_pred HHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchhhhh
Confidence 457999999999887654 57888999875321 11 123456899999999 699999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccc
Q 042348 442 YDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARL 521 (686)
Q Consensus 442 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~ 521 (686)
+|.|+.|.|.|++.+. ..+++.+..+|++|+.+|++|||. ++||||||||+|||+|++.++||+|||.|..
T Consensus 102 Fdl~prGELFDyLts~------VtlSEK~tR~iMrqlfegVeylHa---~~IVHRDLKpENILlddn~~i~isDFGFa~~ 172 (411)
T KOG0599|consen 102 FDLMPRGELFDYLTSK------VTLSEKETRRIMRQLFEGVEYLHA---RNIVHRDLKPENILLDDNMNIKISDFGFACQ 172 (411)
T ss_pred hhhcccchHHHHhhhh------eeecHHHHHHHHHHHHHHHHHHHH---hhhhhcccChhheeeccccceEEeccceeec
Confidence 9999999999999876 468999999999999999999999 8999999999999999999999999999998
Q ss_pred cccccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccC------CCCCCcchHHHHHHHHHHHHhCCCCc
Q 042348 522 ADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKV------RKPTQKWDIYSYGVILLEMISGKLPM 595 (686)
Q Consensus 522 ~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~sDVwSlGvvl~elltG~~P~ 595 (686)
+..++ .....+||++|.|||.+.. ..|+..+|+||+||+||.|+.|.+||
T Consensus 173 l~~Ge------------------------kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPF 228 (411)
T KOG0599|consen 173 LEPGE------------------------KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPF 228 (411)
T ss_pred cCCch------------------------hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCch
Confidence 77554 2345678889999998743 35888999999999999999999999
Q ss_pred cccCccchhHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 042348 596 IQIGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSL 665 (686)
Q Consensus 596 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L 665 (686)
..... .-..+.+..++... -.| ...+......+++.+||+.||.+|.|++|++++=
T Consensus 229 wHRkQ-----mlMLR~ImeGkyqF---~sp------eWadis~~~KdLIsrlLqVdp~~Ritake~LaHp 284 (411)
T KOG0599|consen 229 WHRKQ-----MLMLRMIMEGKYQF---RSP------EWADISATVKDLISRLLQVDPTKRITAKEALAHP 284 (411)
T ss_pred hHHHH-----HHHHHHHHhccccc---CCc------chhhccccHHHHHHHHHeeCchhcccHHHHhcCh
Confidence 54221 11233334443222 122 2233445678999999999999999999999873
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-40 Score=301.10 Aligned_cols=246 Identities=23% Similarity=0.327 Sum_probs=199.5
Q ss_pred hcccCccCceEEEEEEe-CCCceEEEEEcCCC--CccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCC
Q 042348 372 AFLLGKSTIGIVYKVAL-NNEEAVAVRRLGNG--GWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNG 448 (686)
Q Consensus 372 ~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~g 448 (686)
.+.||+|.|+.||++.. .+|+.+|+|.+... ...+.+++.+|+++-+.++|||||++.+.+.+....|+|+|+|.|+
T Consensus 16 ~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe~m~G~ 95 (355)
T KOG0033|consen 16 KEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGG 95 (355)
T ss_pred HHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEecccch
Confidence 34799999999999864 46888888877543 3345678999999999999999999999999999999999999999
Q ss_pred CHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeec---CCCCeEEeecCcccccccc
Q 042348 449 SLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLG---KNMEPHISDFGLARLADIA 525 (686)
Q Consensus 449 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~---~~~~~kl~DfGla~~~~~~ 525 (686)
+|..-|-.+ ..+++..+-.++.||+++|+|+|. ++|||||+||+|+++. ...-+||+|||+|..+..+
T Consensus 96 dl~~eIV~R------~~ySEa~aSH~~rQiLeal~yCH~---n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g 166 (355)
T KOG0033|consen 96 ELFEDIVAR------EFYSEADASHCIQQILEALAYCHS---NGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDG 166 (355)
T ss_pred HHHHHHHHH------HHHHHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeeeeccCCCceeecccceEEEeCCc
Confidence 998777654 247888899999999999999999 9999999999999995 3346899999999876522
Q ss_pred cCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhH
Q 042348 526 EETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNI 605 (686)
Q Consensus 526 ~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~ 605 (686)
......+||++|||||++...+|+..+|||+.|||||-|+.|..||.+...
T Consensus 167 ------------------------~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~----- 217 (355)
T KOG0033|consen 167 ------------------------EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ----- 217 (355)
T ss_pred ------------------------cccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccH-----
Confidence 123457889999999999999999999999999999999999999965322
Q ss_pred HHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 606 VQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 606 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
....+.+..+...++. |.+. ...++..+|+.+||..||.+|.|+.|.+++
T Consensus 218 ~rlye~I~~g~yd~~~---~~w~------~is~~Ak~LvrrML~~dP~kRIta~EAL~H 267 (355)
T KOG0033|consen 218 HRLYEQIKAGAYDYPS---PEWD------TVTPEAKSLIRRMLTVNPKKRITADEALKH 267 (355)
T ss_pred HHHHHHHhccccCCCC---cccC------cCCHHHHHHHHHHhccChhhhccHHHHhCC
Confidence 2335555555433321 1111 123356789999999999999999988765
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=335.68 Aligned_cols=254 Identities=21% Similarity=0.250 Sum_probs=189.8
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCCccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCCHH
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLA 451 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL~ 451 (686)
+.||+|+||.||++... +++.||+|.... ..+.+|++++++++|||||++++++......++|||++. ++|.
T Consensus 98 ~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~-~~L~ 170 (391)
T PHA03212 98 ETFTPGAEGFAFACIDNKTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYK-TDLY 170 (391)
T ss_pred EEEcCCCCeEEEEEEECCCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecCC-CCHH
Confidence 46999999999999865 578899997532 457899999999999999999999999999999999995 7898
Q ss_pred HHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCccc
Q 042348 452 TAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEV 531 (686)
Q Consensus 452 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 531 (686)
+++... ..+++.+++.|+.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+|+.......
T Consensus 171 ~~l~~~------~~l~~~~~~~i~~qi~~aL~ylH~---~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~---- 237 (391)
T PHA03212 171 CYLAAK------RNIAICDILAIERSVLRAIQYLHE---NRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA---- 237 (391)
T ss_pred HHHHhc------CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHhEEEcCCCCEEEEeCCcccccccccc----
Confidence 888654 358899999999999999999999 8999999999999999999999999999974321110
Q ss_pred cccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccch--hHHHHH
Q 042348 532 HWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMEL--NIVQWI 609 (686)
Q Consensus 532 ~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~--~~~~~~ 609 (686)
.......||..|+|||++.+..++.++|||||||++|||+||+.||........ +....+
T Consensus 238 ------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l 299 (391)
T PHA03212 238 ------------------NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQI 299 (391)
T ss_pred ------------------cccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHH
Confidence 011234678889999999988999999999999999999999988743221110 000111
Q ss_pred HHHHhhcCCcccc--c-------------------CcccccCC-CcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 610 QLILEDRKPMTDI--L-------------------DPFLAHDL-DKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 610 ~~~~~~~~~~~~~--~-------------------d~~l~~~~-~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
..+.......+.. . .+...... .......++.+++.+||+.||++|||++|++++
T Consensus 300 ~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~h 376 (391)
T PHA03212 300 KLIIRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDF 376 (391)
T ss_pred HHHHHHhcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 1111100000000 0 00000000 001223468899999999999999999999864
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=315.45 Aligned_cols=265 Identities=24% Similarity=0.352 Sum_probs=206.7
Q ss_pred cccCccCceEEEEEEeCCCceEEEEEcCCCCccchHHHHHHHHHHhc--cCCCCcceeeEEEEecC----ceeEEEeccC
Q 042348 373 FLLGKSTIGIVYKVALNNEEAVAVRRLGNGGWQRFKEFQTEAEAIGK--IRHPNIVSLRAYFWSVD----EKLLIYDYIP 446 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~H~nIv~l~~~~~~~~----~~~lV~e~~~ 446 (686)
+.||+|.||+||+|.++ |+.||||++...++ +.+.+|.++.+. |+|+||+.+++.-..++ ..+||.+|-+
T Consensus 217 e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srdE---~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTdYHe 292 (513)
T KOG2052|consen 217 EIIGKGRFGEVWRGRWR-GEDVAVKIFSSRDE---RSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTDYHE 292 (513)
T ss_pred EEecCccccceeecccc-CCceEEEEecccch---hhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeeeccc
Confidence 57999999999999998 77899999976533 567778777765 49999999999876543 4689999999
Q ss_pred CCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHc-----cCCCCceecCCCCCCeeecCCCCeEEeecCcccc
Q 042348 447 NGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHE-----VSPKRYVHGDLRPSNILLGKNMEPHISDFGLARL 521 (686)
Q Consensus 447 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~-----~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~ 521 (686)
.|||+|+|... .++....++++..+|.||+|||. ...+.|.|||||+.|||+.+++.+.|+|+|+|-.
T Consensus 293 ~GSL~DyL~r~-------tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~ 365 (513)
T KOG2052|consen 293 HGSLYDYLNRN-------TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 365 (513)
T ss_pred CCcHHHHHhhc-------cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEE
Confidence 99999999864 58899999999999999999995 3345799999999999999999999999999976
Q ss_pred cccccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCC------CCCcchHHHHHHHHHHHHhC----
Q 042348 522 ADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRK------PTQKWDIYSYGVILLEMISG---- 591 (686)
Q Consensus 522 ~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------~~~~sDVwSlGvvl~elltG---- 591 (686)
........ -...+..+||..|||||++...- --..+||||||.|+||+..+
T Consensus 366 h~~~t~~i-------------------di~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~g 426 (513)
T KOG2052|consen 366 HDSDTDTI-------------------DIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESG 426 (513)
T ss_pred ecccCCcc-------------------cCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcC
Confidence 54332111 12446789999999999986532 12469999999999999862
Q ss_pred ------CCCccccCccchhHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 042348 592 ------KLPMIQIGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSL 665 (686)
Q Consensus 592 ------~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L 665 (686)
+.||.+.-+.+..+.+..+.+. .+-+.|.+.......+.+..+.++|..||..||.-|-|+-.|-+.|
T Consensus 427 gi~eey~~Pyyd~Vp~DPs~eeMrkVVC------v~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl 500 (513)
T KOG2052|consen 427 GIVEEYQLPYYDVVPSDPSFEEMRKVVC------VQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTL 500 (513)
T ss_pred CEehhhcCCcccCCCCCCCHHHHhccee------ecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHH
Confidence 4577665554443333221111 1123344445555667889999999999999999999999999999
Q ss_pred hcccccch
Q 042348 666 DRVNISTE 673 (686)
Q Consensus 666 ~~i~~~~~ 673 (686)
.++....|
T Consensus 501 ~~l~~~~e 508 (513)
T KOG2052|consen 501 AKLSNSDE 508 (513)
T ss_pred HHHhcChh
Confidence 99876444
|
|
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=313.21 Aligned_cols=248 Identities=23% Similarity=0.361 Sum_probs=194.4
Q ss_pred ccCccCceEEEEEEeC-CCceEEEEEcCCCC-ccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCCHH
Q 042348 374 LLGKSTIGIVYKVALN-NEEAVAVRRLGNGG-WQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLA 451 (686)
Q Consensus 374 ~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL~ 451 (686)
.||+|+||.||+|... +++.||+|.+.... ......+.+|++++++++||||+++++++...+..++||||+++++|.
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 81 (252)
T cd05084 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFL 81 (252)
T ss_pred ccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcHH
Confidence 5899999999999875 68889999876532 233467899999999999999999999999999999999999999999
Q ss_pred HHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCccc
Q 042348 452 TAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEV 531 (686)
Q Consensus 452 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 531 (686)
+++.... ..+++.+++.++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++........
T Consensus 82 ~~~~~~~-----~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~--- 150 (252)
T cd05084 82 TFLRTEG-----PRLKVKELIQMVENAAAGMEYLES---KHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYA--- 150 (252)
T ss_pred HHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEEcCCCcEEECccccCccccccccc---
Confidence 9997543 358899999999999999999999 89999999999999999999999999998754321100
Q ss_pred cccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCccccCccchhHHHHHH
Q 042348 532 HWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQIGSMELNIVQWIQ 610 (686)
Q Consensus 532 ~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~~~~~~~~~ 610 (686)
. .......+..|+|||.+.+..++.++|||||||++|||++ |..||....... ..
T Consensus 151 -----~-------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~------~~ 206 (252)
T cd05084 151 -----S-------------TGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQ------TR 206 (252)
T ss_pred -----c-------------cCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHH------HH
Confidence 0 0001122346999999988889999999999999999998 888885432211 11
Q ss_pred HHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 042348 611 LILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDR 667 (686)
Q Consensus 611 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~ 667 (686)
.......+. . . .......+.+++.+||+.+|++|||+.||.+.|++
T Consensus 207 ~~~~~~~~~-~-~---------~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~ 252 (252)
T cd05084 207 EAIEQGVRL-P-C---------PELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQS 252 (252)
T ss_pred HHHHcCCCC-C-C---------cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhC
Confidence 111111110 0 0 01123468899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-38 Score=321.93 Aligned_cols=247 Identities=23% Similarity=0.251 Sum_probs=194.3
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCCc---cchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCC
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGGW---QRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNG 448 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~g 448 (686)
..||+|+||.||++... +++.||+|.+..... .....+.+|+.++++++||||+++++++...+..++||||+++|
T Consensus 6 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 85 (285)
T cd05605 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGG 85 (285)
T ss_pred EEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEeccCCC
Confidence 46999999999999865 588999999865322 22345778999999999999999999999999999999999999
Q ss_pred CHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCC
Q 042348 449 SLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEET 528 (686)
Q Consensus 449 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 528 (686)
+|.+++..... ..+++..+..++.|++.||+|||+ .+|+||||||+||++++++.++|+|||+++.......
T Consensus 86 ~L~~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~- 157 (285)
T cd05605 86 DLKFHIYNMGN----PGFDEERAVFYAAEITCGLEDLHR---ERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET- 157 (285)
T ss_pred cHHHHHHhcCc----CCCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCc-
Confidence 99998865432 458999999999999999999999 8999999999999999999999999999875432110
Q ss_pred ccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHH
Q 042348 529 PEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQW 608 (686)
Q Consensus 529 ~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~ 608 (686)
.....|+..|+|||++.+..++.++||||+||++|||++|+.||....... ..+.
T Consensus 158 -----------------------~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~--~~~~ 212 (285)
T cd05605 158 -----------------------IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKV--KREE 212 (285)
T ss_pred -----------------------cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhh--HHHH
Confidence 112356778999999988889999999999999999999999996432211 1111
Q ss_pred HHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 042348 609 IQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRP-----SMRHVCDS 664 (686)
Q Consensus 609 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~ev~~~ 664 (686)
+........ .... ......+.+++.+||+.||++|| ++.+++++
T Consensus 213 ~~~~~~~~~---~~~~---------~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 213 VERRVKEDQ---EEYS---------EKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred HHHHhhhcc---cccC---------cccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 111111111 0000 11233577899999999999999 88888776
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-38 Score=319.21 Aligned_cols=239 Identities=21% Similarity=0.334 Sum_probs=186.3
Q ss_pred ccCccCceEEEEEEeCC-------------------------CceEEEEEcCCCCccchHHHHHHHHHHhccCCCCccee
Q 042348 374 LLGKSTIGIVYKVALNN-------------------------EEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSL 428 (686)
Q Consensus 374 ~iG~G~~g~Vy~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l 428 (686)
.||+|+||.||+|.... ...|++|.+..........|.+|+.++++++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 48999999999987421 13588998876544445678899999999999999999
Q ss_pred eEEEEecCceeEEEeccCCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCC
Q 042348 429 RAYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKN 508 (686)
Q Consensus 429 ~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~ 508 (686)
++++......++||||+++|+|..++.... ..+++..+..++.|++.||+|||+ ++|+||||||+||+++++
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~Nill~~~ 153 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEK-----GRVPVAWKITVAQQLASALSYLED---KNLVHGNVCAKNILLARL 153 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHc---CCccCCCCCcccEEEecc
Confidence 999999999999999999999999997543 358899999999999999999999 899999999999999764
Q ss_pred C-------CeEEeecCcccccccccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccC-CCCCCcchHHH
Q 042348 509 M-------EPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKV-RKPTQKWDIYS 580 (686)
Q Consensus 509 ~-------~~kl~DfGla~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS 580 (686)
+ .+|++|||++...... ....++..|+|||.+.+ ..++.++||||
T Consensus 154 ~~~~~~~~~~kl~d~g~~~~~~~~---------------------------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~s 206 (274)
T cd05076 154 GLAEGTSPFIKLSDPGVSFTALSR---------------------------EERVERIPWIAPECVPGGNSLSTAADKWS 206 (274)
T ss_pred CcccCccceeeecCCccccccccc---------------------------cccccCCcccCchhhcCCCCCCcHHHHHH
Confidence 3 3799999987532211 11234566999998865 56899999999
Q ss_pred HHHHHHHHH-hCCCCccccCccchhHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHH
Q 042348 581 YGVILLEMI-SGKLPMIQIGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMR 659 (686)
Q Consensus 581 lGvvl~ell-tG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ 659 (686)
|||++||++ +|+.||......+ ... ........+.. ....+.+++.+||+.+|++|||+.
T Consensus 207 lG~~l~el~~~g~~p~~~~~~~~--~~~----~~~~~~~~~~~-------------~~~~~~~li~~cl~~~p~~Rps~~ 267 (274)
T cd05076 207 FGTTLLEICFDGEVPLKERTPSE--KER----FYEKKHRLPEP-------------SCKELATLISQCLTYEPTQRPSFR 267 (274)
T ss_pred HHHHHHHHHhCCCCCccccChHH--HHH----HHHhccCCCCC-------------CChHHHHHHHHHcccChhhCcCHH
Confidence 999999995 6999985433221 111 11111111110 112577899999999999999999
Q ss_pred HHHHHHh
Q 042348 660 HVCDSLD 666 (686)
Q Consensus 660 ev~~~L~ 666 (686)
+|++.|.
T Consensus 268 ~il~~L~ 274 (274)
T cd05076 268 TILRDLT 274 (274)
T ss_pred HHHHhhC
Confidence 9998873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=328.49 Aligned_cols=242 Identities=21% Similarity=0.321 Sum_probs=190.9
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCC---CccchHHHHHHHHHHhccCC-CCcceeeEEEEecCceeEEEeccCC
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNG---GWQRFKEFQTEAEAIGKIRH-PNIVSLRAYFWSVDEKLLIYDYIPN 447 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H-~nIv~l~~~~~~~~~~~lV~e~~~~ 447 (686)
..||+|+||.||+|... +++.||||.+... .....+.+..|++++..++| ++|+++++++...+..++||||+++
T Consensus 6 ~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 85 (324)
T cd05587 6 MVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNG 85 (324)
T ss_pred EEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEcCCCC
Confidence 46999999999999876 4678999998653 22344678889999999976 5688999999999999999999999
Q ss_pred CCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccC
Q 042348 448 GSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEE 527 (686)
Q Consensus 448 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 527 (686)
|+|.+++... ..+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 86 g~L~~~~~~~------~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~- 155 (324)
T cd05587 86 GDLMYHIQQV------GKFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG- 155 (324)
T ss_pred CcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCC-
Confidence 9999998754 358899999999999999999999 899999999999999999999999999986422111
Q ss_pred CccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHH
Q 042348 528 TPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQ 607 (686)
Q Consensus 528 ~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~ 607 (686)
.......||..|+|||++.+..++.++|||||||++|||+||+.||..... ..
T Consensus 156 ----------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~-----~~ 208 (324)
T cd05587 156 ----------------------KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE-----DE 208 (324)
T ss_pred ----------------------CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH-----HH
Confidence 011234578889999999998999999999999999999999999954322 12
Q ss_pred HHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCH-----HHHHHH
Q 042348 608 WIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSM-----RHVCDS 664 (686)
Q Consensus 608 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~-----~ev~~~ 664 (686)
....+.......+.. ...++.+++.+||+.||++|++. .++.++
T Consensus 209 ~~~~i~~~~~~~~~~-------------~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 257 (324)
T cd05587 209 LFQSIMEHNVSYPKS-------------LSKEAVSICKGLLTKHPAKRLGCGPTGERDIREH 257 (324)
T ss_pred HHHHHHcCCCCCCCC-------------CCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 223333222221111 12357789999999999999986 566554
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=313.21 Aligned_cols=248 Identities=24% Similarity=0.379 Sum_probs=193.8
Q ss_pred cCccCceEEEEEEeC---CCceEEEEEcCCCCc-cchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCCH
Q 042348 375 LGKSTIGIVYKVALN---NEEAVAVRRLGNGGW-QRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSL 450 (686)
Q Consensus 375 iG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL 450 (686)
||+|+||.||+|.+. ++..||+|.+..... ...+.+.+|+.++++++||||+++++++. .+..++||||+++|+|
T Consensus 3 ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~L 81 (257)
T cd05115 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGPL 81 (257)
T ss_pred cCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCCH
Confidence 899999999999764 345799999876532 23456899999999999999999999885 4578999999999999
Q ss_pred HHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCcc
Q 042348 451 ATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPE 530 (686)
Q Consensus 451 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 530 (686)
.+++.... ..+++..+++++.|++.||+|||+ ++++||||||+||+++.++.+||+|||+++.........
T Consensus 82 ~~~l~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~- 152 (257)
T cd05115 82 NKFLSGKK-----DEITVSNVVELMHQVSMGMKYLEG---KNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYY- 152 (257)
T ss_pred HHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHh---cCeeecccchheEEEcCCCcEEeccCCccccccCCccce-
Confidence 99997543 458999999999999999999999 899999999999999999999999999997553221100
Q ss_pred ccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCccccCccchhHHHHH
Q 042348 531 VHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQIGSMELNIVQWI 609 (686)
Q Consensus 531 ~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~~~~~~~~ 609 (686)
.......++..|+|||.+....++.++|||||||++||+++ |+.||...... ...
T Consensus 153 -------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-----~~~ 208 (257)
T cd05115 153 -------------------KARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP-----EVM 208 (257)
T ss_pred -------------------eccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH-----HHH
Confidence 00011223456999999988889999999999999999996 99999543321 122
Q ss_pred HHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 042348 610 QLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRV 668 (686)
Q Consensus 610 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i 668 (686)
..+...... . .+ ..+..++.+++.+||+.+|++||++.+|.+.|+.+
T Consensus 209 ~~~~~~~~~--~-~~---------~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 209 SFIEQGKRL--D-CP---------AECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred HHHHCCCCC--C-CC---------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 222222111 0 11 11234677899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=317.97 Aligned_cols=255 Identities=20% Similarity=0.363 Sum_probs=197.4
Q ss_pred cccCccCceEEEEEEeCC----CceEEEEEcCCC--CccchHHHHHHHHHHhccCCCCcceeeEEEEecCc------eeE
Q 042348 373 FLLGKSTIGIVYKVALNN----EEAVAVRRLGNG--GWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDE------KLL 440 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~~----~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~------~~l 440 (686)
+.||+|+||.||+|.... +..||+|+++.. .......+.+|++.++.++||||+++++++...+. .++
T Consensus 5 ~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~ 84 (273)
T cd05035 5 KILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPMV 84 (273)
T ss_pred cccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCcccEE
Confidence 469999999999998643 367999998753 23345678999999999999999999999876554 699
Q ss_pred EEeccCCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCccc
Q 042348 441 IYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLAR 520 (686)
Q Consensus 441 V~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~ 520 (686)
||||+++|+|.+++...........+++..+..++.|++.||+|||+ ++|+||||||+||++++++.+||+|||+++
T Consensus 85 v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~ 161 (273)
T cd05035 85 ILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSN---RNFIHRDLAARNCMLREDMTVCVADFGLSK 161 (273)
T ss_pred EEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCeeccccchheEEECCCCeEEECCcccee
Confidence 99999999999998654322222468999999999999999999999 899999999999999999999999999998
Q ss_pred ccccccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCccccC
Q 042348 521 LADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQIG 599 (686)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~ 599 (686)
........ .......++..|+|||++.+..++.++|||||||++|||++ |..||....
T Consensus 162 ~~~~~~~~---------------------~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~ 220 (273)
T cd05035 162 KIYSGDYY---------------------RQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVE 220 (273)
T ss_pred eccccccc---------------------cccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCC
Confidence 65422110 00011223456999999988889999999999999999999 888985432
Q ss_pred ccchhHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 042348 600 SMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRV 668 (686)
Q Consensus 600 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i 668 (686)
.. +........... .. ......++.+++.+||+.||++||++.|+++.|+++
T Consensus 221 ~~-----~~~~~~~~~~~~--~~----------~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 221 NH-----EIYDYLRHGNRL--KQ----------PEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred HH-----HHHHHHHcCCCC--CC----------CcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 21 122222222111 00 011334688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=329.74 Aligned_cols=241 Identities=23% Similarity=0.318 Sum_probs=187.2
Q ss_pred ccCccCceEEEEEEeC-CCceEEEEEcCCCC---ccchHHHHHHHH-HHhccCCCCcceeeEEEEecCceeEEEeccCCC
Q 042348 374 LLGKSTIGIVYKVALN-NEEAVAVRRLGNGG---WQRFKEFQTEAE-AIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNG 448 (686)
Q Consensus 374 ~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~g 448 (686)
.||+|+||.||+|... +++.||+|.+.... ......+..|.. +++.++||||+++++++...+..++||||+++|
T Consensus 2 ~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~~ 81 (325)
T cd05602 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGG 81 (325)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCCC
Confidence 5899999999999876 46789999986532 122234444444 567889999999999999999999999999999
Q ss_pred CHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCC
Q 042348 449 SLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEET 528 (686)
Q Consensus 449 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 528 (686)
+|.+++... ..+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~L~~~~~~~------~~~~~~~~~~~~~qi~~~L~~lH~---~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~-- 150 (325)
T cd05602 82 ELFYHLQRE------RCFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN-- 150 (325)
T ss_pred cHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEEccCCCCcccccCC--
Confidence 999999764 347888889999999999999999 899999999999999999999999999987432111
Q ss_pred ccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHH
Q 042348 529 PEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQW 608 (686)
Q Consensus 529 ~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~ 608 (686)
.......||..|+|||++.+..++.++|||||||++|||++|+.||..... .+.
T Consensus 151 ---------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-----~~~ 204 (325)
T cd05602 151 ---------------------GTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT-----AEM 204 (325)
T ss_pred ---------------------CCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCH-----HHH
Confidence 011234578889999999998999999999999999999999999954322 222
Q ss_pred HHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 609 IQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 609 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
...+....... .+ .....+.+++.+||+.||.+||++.+.+..
T Consensus 205 ~~~i~~~~~~~----~~---------~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ 247 (325)
T cd05602 205 YDNILNKPLQL----KP---------NITNSARHLLEGLLQKDRTKRLGAKDDFME 247 (325)
T ss_pred HHHHHhCCcCC----CC---------CCCHHHHHHHHHHcccCHHHCCCCCCCHHH
Confidence 23332221111 11 112357789999999999999998754433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=317.90 Aligned_cols=255 Identities=21% Similarity=0.336 Sum_probs=194.2
Q ss_pred cccCccCceEEEEEEeCCCc---eEEEEEcCCC--CccchHHHHHHHHHHhccCCCCcceeeEEEEec------CceeEE
Q 042348 373 FLLGKSTIGIVYKVALNNEE---AVAVRRLGNG--GWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSV------DEKLLI 441 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~~~~---~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~------~~~~lV 441 (686)
..||+|+||.||+|...+.. .||+|.++.. .....+.+.+|++++++++||||+++++++... ...++|
T Consensus 5 ~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v 84 (272)
T cd05075 5 KTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVI 84 (272)
T ss_pred cccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcEEE
Confidence 46999999999999876432 5899988653 233456789999999999999999999987532 246899
Q ss_pred EeccCCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccc
Q 042348 442 YDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARL 521 (686)
Q Consensus 442 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~ 521 (686)
|||+++|+|.+++...........+++..+..++.|++.||+|||+ ++|+||||||+||++++++.+||+|||+++.
T Consensus 85 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 161 (272)
T cd05075 85 LPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSS---KSFIHRDLAARNCMLNENMNVCVADFGLSKK 161 (272)
T ss_pred EEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhheEEcCCCCEEECCCCcccc
Confidence 9999999999988543221122458999999999999999999999 8999999999999999999999999999986
Q ss_pred cccccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCccccCc
Q 042348 522 ADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQIGS 600 (686)
Q Consensus 522 ~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~ 600 (686)
....... .......++..|+|||+..+..++.++|||||||++|||++ |+.||.....
T Consensus 162 ~~~~~~~---------------------~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~ 220 (272)
T cd05075 162 IYNGDYY---------------------RQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN 220 (272)
T ss_pred cCcccce---------------------ecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 5422110 00011233556999999998889999999999999999999 8889854322
Q ss_pred cchhHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 042348 601 MELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRV 668 (686)
Q Consensus 601 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i 668 (686)
. ........+. ... .. ......+.+++.+||+.||++|||+.++++.|+++
T Consensus 221 --~---~~~~~~~~~~-~~~--~~---------~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 221 --S---EIYDYLRQGN-RLK--QP---------PDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred --H---HHHHHHHcCC-CCC--CC---------CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 1 1122222211 110 00 11233578999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=317.81 Aligned_cols=255 Identities=19% Similarity=0.302 Sum_probs=201.0
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCC---CccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCC
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNG---GWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNG 448 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~g 448 (686)
..||+|+||.||+|... +++.||||.+... .......+.+|++++++++||||+++++++...+..++||||+++|
T Consensus 8 ~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~ 87 (267)
T cd08228 8 KKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLELADAG 87 (267)
T ss_pred eeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEEecCCC
Confidence 36999999999999865 6889999987542 2233456889999999999999999999999999999999999999
Q ss_pred CHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCC
Q 042348 449 SLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEET 528 (686)
Q Consensus 449 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 528 (686)
+|.+++...... ...+++..+..++.|++.||+|||+ ++++||||||+||+++.++.++|+|||++........
T Consensus 88 ~L~~~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~- 161 (267)
T cd08228 88 DLSQMIKYFKKQ--KRLIPERTVWKYFVQLCSAVEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT- 161 (267)
T ss_pred cHHHHHHHhhhc--cCCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCCHHHEEEcCCCCEEECccccceeccchhH-
Confidence 999988643211 1357889999999999999999999 8999999999999999999999999999876532110
Q ss_pred ccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHH
Q 042348 529 PEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQW 608 (686)
Q Consensus 529 ~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~ 608 (686)
......++..|+|||.+.+..++.++||||||+++|||++|+.||...... ...+
T Consensus 162 ----------------------~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~---~~~~ 216 (267)
T cd08228 162 ----------------------AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN---LFSL 216 (267)
T ss_pred ----------------------HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccccc---HHHH
Confidence 011234566799999998888999999999999999999999998543222 2222
Q ss_pred HHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 042348 609 IQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRVN 669 (686)
Q Consensus 609 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~ 669 (686)
...+..... +.. ........+.+++.+||+.+|++||++.+|++.+++++
T Consensus 217 ~~~~~~~~~--~~~---------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 217 CQKIEQCDY--PPL---------PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred HHHHhcCCC--CCC---------ChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 222221111 110 01123356889999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=313.69 Aligned_cols=245 Identities=24% Similarity=0.424 Sum_probs=195.5
Q ss_pred cccCccCceEEEEEEeCCCceEEEEEcCCCCccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCCHHH
Q 042348 373 FLLGKSTIGIVYKVALNNEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLAT 452 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL~~ 452 (686)
+.||+|+||.||+|...++..+|+|.+..... ...++.+|++++++++||||+++++++...+..++||||+++++|.+
T Consensus 10 ~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 88 (256)
T cd05059 10 KELGSGQFGVVHLGKWRGKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLN 88 (256)
T ss_pred hhhccCCCceEEEeEecCCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCCCCHHH
Confidence 46999999999999988777899999865432 33578899999999999999999999999999999999999999999
Q ss_pred HhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCcccc
Q 042348 453 AIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVH 532 (686)
Q Consensus 453 ~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 532 (686)
++.... ..+++..+..++.|++.||+|||+ ++++||||||+||++++++.+||+|||+++........
T Consensus 89 ~l~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~---- 156 (256)
T cd05059 89 YLRERK-----GKLGTEWLLDMCSDVCEAMEYLES---NGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT---- 156 (256)
T ss_pred HHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHhhEEECCCCcEEECCcccceeccccccc----
Confidence 997653 358999999999999999999999 89999999999999999999999999998754321100
Q ss_pred ccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCccccCccchhHHHHHHH
Q 042348 533 WEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQIGSMELNIVQWIQL 611 (686)
Q Consensus 533 ~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~ 611 (686)
......++..|+|||.+.+..++.++||||||+++|||++ |+.||...... .. ...
T Consensus 157 ------------------~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~---~~~ 213 (256)
T cd05059 157 ------------------SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS--EV---VES 213 (256)
T ss_pred ------------------ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHH--HH---HHH
Confidence 0011123456999999988889999999999999999999 89998543221 11 112
Q ss_pred HHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 042348 612 ILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSL 665 (686)
Q Consensus 612 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L 665 (686)
.... .... .+ .....++.+++.+||+.+|++|||+.|+++.|
T Consensus 214 ~~~~-~~~~---~~--------~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 214 VSAG-YRLY---RP--------KLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred HHcC-CcCC---CC--------CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 2111 1100 00 11234688999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-39 Score=327.59 Aligned_cols=252 Identities=25% Similarity=0.366 Sum_probs=209.8
Q ss_pred hcccCccCceEEEEEEeCC-CceEEEEEcCCCCccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCCH
Q 042348 372 AFLLGKSTIGIVYKVALNN-EEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSL 450 (686)
Q Consensus 372 ~~~iG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL 450 (686)
.+.||.|.||.||.|.|+. .-.||||.++...+ ..++|+.|+.+|+.++|||+|+++|+|......|||.|||..|+|
T Consensus 272 khKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtM-eveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~yGNL 350 (1157)
T KOG4278|consen 272 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMCYGNL 350 (1157)
T ss_pred eeccCCCcccceeeeeeeccceeeehhhhhhcch-hHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecccCccH
Confidence 3569999999999999875 56799999987654 468999999999999999999999999999999999999999999
Q ss_pred HHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCcc
Q 042348 451 ATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPE 530 (686)
Q Consensus 451 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 530 (686)
.+||++... ..++.-..+.++.||+.|++||.. +++|||||.++|+|+.++..+|++|||+++++..+..+.
T Consensus 351 LdYLRecnr----~ev~avvLlyMAtQIsSaMeYLEk---knFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYTA- 422 (1157)
T KOG4278|consen 351 LDYLRECNR----SEVPAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYTA- 422 (1157)
T ss_pred HHHHHHhch----hhcchhHHHHHHHHHHHHHHHHHH---hhhhhhhhhhhhccccccceEEeeccchhhhhcCCceec-
Confidence 999998653 457777789999999999999999 899999999999999999999999999999886433211
Q ss_pred ccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCccccCccchhHHHHH
Q 042348 531 VHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQIGSMELNIVQWI 609 (686)
Q Consensus 531 ~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~~~~~~~~ 609 (686)
.....=.+.|.|||.+....++.|+|||+|||+|||+.| |-.||.+. ++. .+
T Consensus 423 ---------------------HAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGi-----dlS-qV 475 (1157)
T KOG4278|consen 423 ---------------------HAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGI-----DLS-QV 475 (1157)
T ss_pred ---------------------ccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCc-----cHH-HH
Confidence 011111346999999999999999999999999999998 88998543 222 23
Q ss_pred HHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccc
Q 042348 610 QLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRVNI 670 (686)
Q Consensus 610 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~ 670 (686)
...+.....|.. ++.|+..+++||..||+++|.+||++.|+-+.++.+-.
T Consensus 476 Y~LLEkgyRM~~-----------PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~ 525 (1157)
T KOG4278|consen 476 YGLLEKGYRMDG-----------PEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFS 525 (1157)
T ss_pred HHHHhccccccC-----------CCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhc
Confidence 444444443321 23467789999999999999999999999999998753
|
|
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-38 Score=327.96 Aligned_cols=242 Identities=21% Similarity=0.325 Sum_probs=191.0
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCC---ccchHHHHHHHHHHhcc-CCCCcceeeEEEEecCceeEEEeccCC
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGG---WQRFKEFQTEAEAIGKI-RHPNIVSLRAYFWSVDEKLLIYDYIPN 447 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~e~~~~ 447 (686)
..||+|+||.||+|... +++.||||.+.... ....+.+..|..++..+ +|++|+++++++...+..++||||+++
T Consensus 6 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 85 (323)
T cd05616 6 MVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVMEYVNG 85 (323)
T ss_pred EEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999876 46789999986532 22334567788888877 689999999999999999999999999
Q ss_pred CCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccC
Q 042348 448 GSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEE 527 (686)
Q Consensus 448 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 527 (686)
|+|.+++... ..+++.++..++.|++.||+|||+ ++|+||||||+|||+++++.+||+|||+++......
T Consensus 86 g~L~~~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~- 155 (323)
T cd05616 86 GDLMYQIQQV------GRFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG- 155 (323)
T ss_pred CCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCEEecCCCHHHeEECCCCcEEEccCCCceecCCCC-
Confidence 9999998754 358899999999999999999999 899999999999999999999999999987432111
Q ss_pred CccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHH
Q 042348 528 TPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQ 607 (686)
Q Consensus 528 ~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~ 607 (686)
.......||..|+|||++.+..++.++|||||||++|||+||+.||..... ..
T Consensus 156 ----------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~-----~~ 208 (323)
T cd05616 156 ----------------------VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE-----DE 208 (323)
T ss_pred ----------------------CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCH-----HH
Confidence 011234578889999999999999999999999999999999999954322 12
Q ss_pred HHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCH-----HHHHHH
Q 042348 608 WIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSM-----RHVCDS 664 (686)
Q Consensus 608 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~-----~ev~~~ 664 (686)
..+.+.......+. ....++.+++.+||+.||++|++. .++.++
T Consensus 209 ~~~~i~~~~~~~p~-------------~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h 257 (323)
T cd05616 209 LFQSIMEHNVAYPK-------------SMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 257 (323)
T ss_pred HHHHHHhCCCCCCC-------------cCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcC
Confidence 22333322221111 112357789999999999999985 555543
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=329.23 Aligned_cols=236 Identities=22% Similarity=0.344 Sum_probs=185.7
Q ss_pred ccCccCceEEEEEEeC-CCceEEEEEcCCCC---ccchHHHHHHHH-HHhccCCCCcceeeEEEEecCceeEEEeccCCC
Q 042348 374 LLGKSTIGIVYKVALN-NEEAVAVRRLGNGG---WQRFKEFQTEAE-AIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNG 448 (686)
Q Consensus 374 ~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~g 448 (686)
+||+|+||.||+|+.. +++.||+|.+.... .....++..|.. +++.++||||+++++++.+.+..++||||+++|
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 81 (321)
T cd05603 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGG 81 (321)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence 5899999999999875 57889999986532 122344555654 578899999999999999999999999999999
Q ss_pred CHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCC
Q 042348 449 SLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEET 528 (686)
Q Consensus 449 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 528 (686)
+|...+... ..+++..+..++.||+.||+|||+ ++|+||||||+||+++.++.+||+|||+++......
T Consensus 82 ~L~~~l~~~------~~~~~~~~~~~~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-- 150 (321)
T cd05603 82 ELFFHLQRE------RCFLEPRARFYAAEVASAIGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE-- 150 (321)
T ss_pred CHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC--
Confidence 999888654 357888999999999999999999 899999999999999999999999999987421111
Q ss_pred ccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHH
Q 042348 529 PEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQW 608 (686)
Q Consensus 529 ~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~ 608 (686)
.......||..|+|||++.+..++.++|||||||++|||++|+.||.... ....
T Consensus 151 ---------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~-----~~~~ 204 (321)
T cd05603 151 ---------------------ETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD-----VSQM 204 (321)
T ss_pred ---------------------CccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCC-----HHHH
Confidence 01123457888999999988889999999999999999999999995432 2222
Q ss_pred HHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHH
Q 042348 609 IQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMR 659 (686)
Q Consensus 609 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ 659 (686)
...+.......+. .....+.+++.+||+.||++||++.
T Consensus 205 ~~~i~~~~~~~~~-------------~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 205 YDNILHKPLQLPG-------------GKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred HHHHhcCCCCCCC-------------CCCHHHHHHHHHHccCCHhhcCCCC
Confidence 3333322111110 1223577899999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=315.02 Aligned_cols=239 Identities=23% Similarity=0.359 Sum_probs=187.4
Q ss_pred ccCccCceEEEEEEeCC-------------CceEEEEEcCCCCccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeE
Q 042348 374 LLGKSTIGIVYKVALNN-------------EEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLL 440 (686)
Q Consensus 374 ~iG~G~~g~Vy~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 440 (686)
.||+|+||.||+|.... ...|++|.+..........+.+|+.++++++||||+++++++......++
T Consensus 2 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~l 81 (262)
T cd05077 2 HLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIM 81 (262)
T ss_pred ccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCEE
Confidence 48999999999998532 23588998876544445678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCC-------eEE
Q 042348 441 IYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNME-------PHI 513 (686)
Q Consensus 441 V~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~-------~kl 513 (686)
||||+++|+|..+++... ..+++..+.+++.||+.||+|||+ ++|+||||||+|||++.++. +++
T Consensus 82 v~e~~~~~~l~~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~~~~~~~~~l 153 (262)
T cd05077 82 VEEFVEFGPLDLFMHRKS-----DVLTTPWKFKVAKQLASALSYLED---KDLVHGNVCTKNILLAREGIDGECGPFIKL 153 (262)
T ss_pred EEecccCCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHhhh---CCeECCCCCcccEEEecCCccCCCCceeEe
Confidence 999999999999987543 358999999999999999999999 89999999999999987664 899
Q ss_pred eecCcccccccccCCccccccccccCCCCCCCccccccccCCCCCccccCccccc-CCCCCCcchHHHHHHHHHHHH-hC
Q 042348 514 SDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASK-VRKPTQKWDIYSYGVILLEMI-SG 591 (686)
Q Consensus 514 ~DfGla~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDVwSlGvvl~ell-tG 591 (686)
+|||++...... ....++..|+|||.+. +..++.++|||||||++|||+ +|
T Consensus 154 ~d~g~~~~~~~~---------------------------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~ 206 (262)
T cd05077 154 SDPGIPITVLSR---------------------------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNG 206 (262)
T ss_pred CCCCCCccccCc---------------------------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCC
Confidence 999988643211 1223566799999886 466899999999999999998 58
Q ss_pred CCCccccCccchhHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 042348 592 KLPMIQIGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLD 666 (686)
Q Consensus 592 ~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~ 666 (686)
+.||......+ .......... ...+ ...++.+++.+||+.||++||++.+|++.++
T Consensus 207 ~~p~~~~~~~~------~~~~~~~~~~---~~~~----------~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 207 EIPLKDKTLAE------KERFYEGQCM---LVTP----------SCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred CCCCCCcchhH------HHHHHhcCcc---CCCC----------ChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 88874322111 1111111111 1111 1235788999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-38 Score=327.56 Aligned_cols=246 Identities=19% Similarity=0.322 Sum_probs=192.7
Q ss_pred ccCccCceEEEEEEeC-CCceEEEEEcCCCC---ccchHHHHHHHHHHhcc-CCCCcceeeEEEEecCceeEEEeccCCC
Q 042348 374 LLGKSTIGIVYKVALN-NEEAVAVRRLGNGG---WQRFKEFQTEAEAIGKI-RHPNIVSLRAYFWSVDEKLLIYDYIPNG 448 (686)
Q Consensus 374 ~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~e~~~~g 448 (686)
.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.++.++ +||||+++++++...+..++||||+++|
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 81 (327)
T cd05617 2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNGG 81 (327)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCCC
Confidence 5899999999999875 57889999997532 23345688999999988 6999999999999999999999999999
Q ss_pred CHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCC
Q 042348 449 SLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEET 528 (686)
Q Consensus 449 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 528 (686)
+|.+++... ..+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~L~~~~~~~------~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-- 150 (327)
T cd05617 82 DLMFHMQRQ------RKLPEEHARFYAAEICIALNFLHE---RGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG-- 150 (327)
T ss_pred cHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEeCCCCEEEeccccceeccCCC--
Confidence 999988654 358999999999999999999999 899999999999999999999999999987422110
Q ss_pred ccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCcc-chhHHH
Q 042348 529 PEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSM-ELNIVQ 607 (686)
Q Consensus 529 ~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~-~~~~~~ 607 (686)
.......||..|+|||++.+..++.++|||||||++|||++|+.||...... ......
T Consensus 151 ---------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~ 209 (327)
T cd05617 151 ---------------------DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTED 209 (327)
T ss_pred ---------------------CceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHH
Confidence 0112345788899999999999999999999999999999999999543221 112222
Q ss_pred HHHHHHhhc-CCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCH------HHHHHH
Q 042348 608 WIQLILEDR-KPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSM------RHVCDS 664 (686)
Q Consensus 608 ~~~~~~~~~-~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~------~ev~~~ 664 (686)
++....... ...+.. ....+.+++.+||+.||++|+++ .++.++
T Consensus 210 ~~~~~~~~~~~~~p~~-------------~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 260 (327)
T cd05617 210 YLFQVILEKPIRIPRF-------------LSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSH 260 (327)
T ss_pred HHHHHHHhCCCCCCCC-------------CCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcC
Confidence 222222221 111111 12346789999999999999985 466555
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=311.53 Aligned_cols=246 Identities=27% Similarity=0.387 Sum_probs=195.8
Q ss_pred ccCccCceEEEEEEeCCCceEEEEEcCCCCcc-chHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCCHHH
Q 042348 374 LLGKSTIGIVYKVALNNEEAVAVRRLGNGGWQ-RFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLAT 452 (686)
Q Consensus 374 ~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL~~ 452 (686)
+||+|+||.||+|...++..+|+|.+...... ....+.+|++++++++||||+++++++...+..++||||+++++|.+
T Consensus 2 ~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 81 (250)
T cd05085 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLS 81 (250)
T ss_pred ccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHHH
Confidence 58999999999999888899999998765322 23468899999999999999999999999999999999999999999
Q ss_pred HhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCcccc
Q 042348 453 AIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVH 532 (686)
Q Consensus 453 ~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 532 (686)
++.... ..+++..+..++.|++.||.|+|+ ++++||||||+||++++++.+||+|||++.........
T Consensus 82 ~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~---- 149 (250)
T cd05085 82 FLRKKK-----DELKTKQLVKFALDAAAGMAYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYS---- 149 (250)
T ss_pred HHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccChheEEEcCCCeEEECCCccceeccccccc----
Confidence 987543 357899999999999999999999 89999999999999999999999999998743321100
Q ss_pred ccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCccccCccchhHHHHHHH
Q 042348 533 WEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQIGSMELNIVQWIQL 611 (686)
Q Consensus 533 ~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~ 611 (686)
......++..|+|||+..+..++.++||||||+++||+++ |..||...... .....
T Consensus 150 ------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~-----~~~~~ 206 (250)
T cd05085 150 ------------------SSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ-----QAREQ 206 (250)
T ss_pred ------------------cCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH-----HHHHH
Confidence 0011122456999999988889999999999999999998 99999543211 11111
Q ss_pred HHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 042348 612 ILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLD 666 (686)
Q Consensus 612 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~ 666 (686)
.... ... .. .......+.+++.+|++.+|++||++.|+++.|.
T Consensus 207 ~~~~-~~~-~~----------~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 207 VEKG-YRM-SC----------PQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred HHcC-CCC-CC----------CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 1111 110 00 0112346889999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=317.87 Aligned_cols=258 Identities=25% Similarity=0.407 Sum_probs=196.2
Q ss_pred cccCccCceEEEEEEeC-----CCceEEEEEcCCCCccchHHHHHHHHHHhccCCCCcceeeEEEEec--CceeEEEecc
Q 042348 373 FLLGKSTIGIVYKVALN-----NEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSV--DEKLLIYDYI 445 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~~lV~e~~ 445 (686)
..||+|+||.||++... ++..||+|.+........+.+.+|++++++++||||+++++++... ...++||||+
T Consensus 10 ~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~ 89 (284)
T cd05081 10 QQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYL 89 (284)
T ss_pred eeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEEEEEec
Confidence 46999999999999753 4778999999776655567899999999999999999999987643 4678999999
Q ss_pred CCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccc
Q 042348 446 PNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIA 525 (686)
Q Consensus 446 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~ 525 (686)
++|+|.+++.... ..+++..+..++.|++.||+|||+ ++|+||||||+||++++++.+||+|||+++.....
T Consensus 90 ~~~~L~~~l~~~~-----~~l~~~~~~~~~~~l~~aL~~LH~---~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 161 (284)
T cd05081 90 PYGSLRDYLQKHR-----ERLDHRKLLLYASQICKGMEYLGS---KRYVHRDLATRNILVESENRVKIGDFGLTKVLPQD 161 (284)
T ss_pred CCCCHHHHHHhcC-----cCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHhhEEECCCCeEEECCCcccccccCC
Confidence 9999999997543 358999999999999999999999 89999999999999999999999999999865422
Q ss_pred cCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccch--
Q 042348 526 EETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMEL-- 603 (686)
Q Consensus 526 ~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~-- 603 (686)
.... .......++..|+|||++.+..++.++|||||||++|||++|..|+........
T Consensus 162 ~~~~--------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~ 221 (284)
T cd05081 162 KEYY--------------------KVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRM 221 (284)
T ss_pred Ccce--------------------eecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhh
Confidence 1100 000111234459999999888899999999999999999998877532211000
Q ss_pred --------hHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 042348 604 --------NIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRVN 669 (686)
Q Consensus 604 --------~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~ 669 (686)
................. ........+.+++.+||+.+|++|||+.||++.|+.++
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~~ 284 (284)
T cd05081 222 MGNDKQGQMIVYHLIELLKNNGRLP-----------APPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAIR 284 (284)
T ss_pred cccccccccchHHHHHHHhcCCcCC-----------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhcC
Confidence 00000011111110000 01112346889999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=326.33 Aligned_cols=252 Identities=23% Similarity=0.344 Sum_probs=206.5
Q ss_pred hhcccCccCceEEEEEEeCC---C--ceEEEEEcCCC-CccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEec
Q 042348 371 SAFLLGKSTIGIVYKVALNN---E--EAVAVRRLGNG-GWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDY 444 (686)
Q Consensus 371 ~~~~iG~G~~g~Vy~~~~~~---~--~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~ 444 (686)
.+.+||.|-||.||+|.+.+ | -.||||..+.. ...+.+.|..|..+|++++|||||+++|+|.+ ...++|||.
T Consensus 393 l~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~WivmEL 471 (974)
T KOG4257|consen 393 LKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWIVMEL 471 (974)
T ss_pred HHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeEEEec
Confidence 35689999999999998643 2 36899998874 44556789999999999999999999999964 578999999
Q ss_pred cCCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCccccccc
Q 042348 445 IPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADI 524 (686)
Q Consensus 445 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~ 524 (686)
++-|.|..+++.+. ..|+......++.||+.||+|||+ ...|||||..+|||+.....+||+|||+++.++.
T Consensus 472 ~~~GELr~yLq~nk-----~sL~l~tL~ly~~Qi~talaYLeS---krfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed 543 (974)
T KOG4257|consen 472 APLGELREYLQQNK-----DSLPLRTLTLYCYQICTALAYLES---KRFVHRDIAARNILVSSPQCVKLADFGLSRYLED 543 (974)
T ss_pred ccchhHHHHHHhcc-----ccchHHHHHHHHHHHHHHHHHHHh---hchhhhhhhhhheeecCcceeeecccchhhhccc
Confidence 99999999998765 468888999999999999999999 8999999999999999999999999999998875
Q ss_pred ccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCccccCccch
Q 042348 525 AEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQIGSMEL 603 (686)
Q Consensus 525 ~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~~ 603 (686)
..... . +...-...|||||.+.-..++.++|||-|||+|||+++ |..||....+.+.
T Consensus 544 ~~yYk-----a-----------------S~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDV 601 (974)
T KOG4257|consen 544 DAYYK-----A-----------------SRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDV 601 (974)
T ss_pred cchhh-----c-----------------cccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccce
Confidence 54311 1 11112456999999999999999999999999999998 9999976655442
Q ss_pred hHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccc
Q 042348 604 NIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRVNI 670 (686)
Q Consensus 604 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~ 670 (686)
+-. ++.+... +.++.|+..++.++.+||+++|.+||.+.|+...|..+..
T Consensus 602 -----I~~-iEnGeRl-----------P~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 602 -----IGH-IENGERL-----------PCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred -----EEE-ecCCCCC-----------CCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 111 1111111 1223466688999999999999999999999999988764
|
|
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=330.22 Aligned_cols=242 Identities=21% Similarity=0.323 Sum_probs=189.2
Q ss_pred ccCccCceEEEEEEeC-CCceEEEEEcCCCC---ccchHHHHHHHH-HHhccCCCCcceeeEEEEecCceeEEEeccCCC
Q 042348 374 LLGKSTIGIVYKVALN-NEEAVAVRRLGNGG---WQRFKEFQTEAE-AIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNG 448 (686)
Q Consensus 374 ~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~g 448 (686)
.||+|+||.||+|... +++.||+|.+.... .....++..|.. +++.++||||+++++++...+..++||||+++|
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~~ 81 (325)
T cd05604 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGG 81 (325)
T ss_pred ceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCCC
Confidence 5899999999999865 58899999986531 223345556655 467789999999999999999999999999999
Q ss_pred CHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCC
Q 042348 449 SLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEET 528 (686)
Q Consensus 449 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 528 (686)
+|..++... ..+++..+..++.||+.||+|||+ ++|+||||||+|||+++++.+||+|||+++......
T Consensus 82 ~L~~~l~~~------~~~~~~~~~~~~~qi~~al~~lH~---~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~-- 150 (325)
T cd05604 82 ELFFHLQRE------RSFPEPRARFYAAEIASALGYLHS---INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS-- 150 (325)
T ss_pred CHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCC--
Confidence 999988754 458999999999999999999999 899999999999999999999999999986432111
Q ss_pred ccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHH
Q 042348 529 PEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQW 608 (686)
Q Consensus 529 ~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~ 608 (686)
.......||..|+|||++.+..++.++|||||||++|||++|+.||..... .+.
T Consensus 151 ---------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~-----~~~ 204 (325)
T cd05604 151 ---------------------DTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDV-----AEM 204 (325)
T ss_pred ---------------------CCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCH-----HHH
Confidence 011234578889999999998999999999999999999999999954321 222
Q ss_pred HHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 042348 609 IQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSL 665 (686)
Q Consensus 609 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L 665 (686)
...+...... +.+ .....+.+++.+|++.+|.+||++++.++.+
T Consensus 205 ~~~~~~~~~~----~~~---------~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i 248 (325)
T cd05604 205 YDNILHKPLV----LRP---------GASLTAWSILEELLEKDRQRRLGAKEDFLEI 248 (325)
T ss_pred HHHHHcCCcc----CCC---------CCCHHHHHHHHHHhccCHHhcCCCCCCHHHH
Confidence 3333322111 111 1123567899999999999999987444443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=327.28 Aligned_cols=258 Identities=28% Similarity=0.401 Sum_probs=196.6
Q ss_pred hcccCccCceEEEEEEeC------CCceEEEEEcCCCC-ccchHHHHHHHHHHhcc-CCCCcceeeEEEEec-CceeEEE
Q 042348 372 AFLLGKSTIGIVYKVALN------NEEAVAVRRLGNGG-WQRFKEFQTEAEAIGKI-RHPNIVSLRAYFWSV-DEKLLIY 442 (686)
Q Consensus 372 ~~~iG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~-~~~~lV~ 442 (686)
.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.++.++ +|+||++++++|... ...+++|
T Consensus 12 ~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~~~~v~ 91 (337)
T cd05054 12 GKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGPLMVIV 91 (337)
T ss_pred hcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCCEEEEE
Confidence 357999999999999642 24689999987542 23345688899999999 899999999988754 5678999
Q ss_pred eccCCCCHHHHhhcCCCc-------------------------------------------------------cccCCCC
Q 042348 443 DYIPNGSLATAIHGKAGI-------------------------------------------------------ISYRPLS 467 (686)
Q Consensus 443 e~~~~gsL~~~l~~~~~~-------------------------------------------------------~~~~~l~ 467 (686)
||+++|+|.+++...... .....++
T Consensus 92 ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 171 (337)
T cd05054 92 EYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLT 171 (337)
T ss_pred ecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHhhcCCC
Confidence 999999999998653210 0013689
Q ss_pred HHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCccccccccccCCCCCCCcc
Q 042348 468 WSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPY 547 (686)
Q Consensus 468 ~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~g~~~~~~~~ 547 (686)
|..+..++.||+.||+|||+ ++|+||||||+||++++++.+||+|||+++.+......
T Consensus 172 ~~~~~~~~~qi~~aL~~lH~---~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~------------------- 229 (337)
T cd05054 172 LEDLISYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY------------------- 229 (337)
T ss_pred HHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEEeCCCcEEEeccccchhcccCcch-------------------
Confidence 99999999999999999999 89999999999999999999999999999865322110
Q ss_pred ccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCccccCccchhHHHHHHHHHhhcCCcccccCcc
Q 042348 548 EFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQIGSMELNIVQWIQLILEDRKPMTDILDPF 626 (686)
Q Consensus 548 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 626 (686)
.......++..|+|||++.+..++.++|||||||++|||++ |..||......+ .+ .......... .. +
T Consensus 230 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~-~~----~~~~~~~~~~--~~-~- 298 (337)
T cd05054 230 --VRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE-EF----CRRLKEGTRM--RA-P- 298 (337)
T ss_pred --hhccCCCCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH-HH----HHHHhccCCC--CC-C-
Confidence 01112334567999999999999999999999999999998 999995432211 11 1111111110 00 0
Q ss_pred cccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 042348 627 LAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRVN 669 (686)
Q Consensus 627 l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~ 669 (686)
.....++.+++.+||+.+|++||++.||+++|+++-
T Consensus 299 -------~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~ 334 (337)
T cd05054 299 -------EYATPEIYSIMLDCWHNNPEDRPTFSELVEILGDLL 334 (337)
T ss_pred -------ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 112346789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=315.53 Aligned_cols=251 Identities=25% Similarity=0.366 Sum_probs=194.0
Q ss_pred cccCccCceEEEEEEeC-CCc----eEEEEEcCCCC-ccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccC
Q 042348 373 FLLGKSTIGIVYKVALN-NEE----AVAVRRLGNGG-WQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIP 446 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~ 446 (686)
+.||+|+||.||+|.+. ++. .+++|.+.... .....++..|+..+++++||||+++++++. ....++++||++
T Consensus 13 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~i~e~~~ 91 (279)
T cd05111 13 KLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQLVTQLSP 91 (279)
T ss_pred cccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEEEEEeCC
Confidence 46999999999999864 333 47888875432 223467888999999999999999999875 455789999999
Q ss_pred CCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCccccccccc
Q 042348 447 NGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAE 526 (686)
Q Consensus 447 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~ 526 (686)
+|+|.+++.... ..+++..+..|+.||+.||+|||+ ++++||||||+||++++++.+||+|||+++......
T Consensus 92 ~gsL~~~l~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~ 163 (279)
T cd05111 92 LGSLLDHVRQHR-----DSLDPQRLLNWCVQIAKGMYYLEE---HRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDD 163 (279)
T ss_pred CCcHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEEcCCccceeccCCC
Confidence 999999997654 458999999999999999999999 899999999999999999999999999998653221
Q ss_pred CCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCccccCccchhH
Q 042348 527 ETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQIGSMELNI 605 (686)
Q Consensus 527 ~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~~~~ 605 (686)
.. .......++..|+|||++.+..++.++|||||||++||+++ |+.||...... ..
T Consensus 164 ~~---------------------~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~--~~ 220 (279)
T cd05111 164 KK---------------------YFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH--EV 220 (279)
T ss_pred cc---------------------cccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHH--HH
Confidence 10 00112335567999999988889999999999999999998 99999543221 11
Q ss_pred HHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccc
Q 042348 606 VQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRVNI 670 (686)
Q Consensus 606 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~ 670 (686)
. .......... .+. .+...+.+++.+||..+|++|||+.|+++.|+.+..
T Consensus 221 ~----~~~~~~~~~~---~~~--------~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 221 P----DLLEKGERLA---QPQ--------ICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred H----HHHHCCCcCC---CCC--------CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 1 1122211111 111 122356788999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=312.68 Aligned_cols=248 Identities=29% Similarity=0.486 Sum_probs=196.9
Q ss_pred hcccCccCceEEEEEEeCCCceEEEEEcCCCCccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCCHH
Q 042348 372 AFLLGKSTIGIVYKVALNNEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLA 451 (686)
Q Consensus 372 ~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL~ 451 (686)
...||+|+||.||+|...++..||+|.+..... ..+.+.+|+.++++++|+||+++++++. .+..++||||+++++|.
T Consensus 11 ~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~~~L~ 88 (260)
T cd05070 11 IKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMSKGSLL 88 (260)
T ss_pred hheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecCCCcHH
Confidence 346999999999999988888899999876433 3467999999999999999999999875 45689999999999999
Q ss_pred HHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCccc
Q 042348 452 TAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEV 531 (686)
Q Consensus 452 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 531 (686)
++++.... ..+++.+++.++.|++.||+|||+ ++|+||||||+||++++++.++|+|||++.........
T Consensus 89 ~~~~~~~~----~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~--- 158 (260)
T cd05070 89 DFLKDGEG----RALKLPNLVDMAAQVAAGMAYIER---MNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT--- 158 (260)
T ss_pred HHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEEeCCceEEeCCceeeeeccCcccc---
Confidence 99976432 458999999999999999999999 89999999999999999999999999999765322110
Q ss_pred cccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCccccCccchhHHHHHH
Q 042348 532 HWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQIGSMELNIVQWIQ 610 (686)
Q Consensus 532 ~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~~~~~~~~~ 610 (686)
......++..|+|||...+..++.++||||||+++|||++ |+.||..... .+...
T Consensus 159 -------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~-----~~~~~ 214 (260)
T cd05070 159 -------------------ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN-----REVLE 214 (260)
T ss_pred -------------------cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCH-----HHHHH
Confidence 0011223456999999988889999999999999999999 8899854322 11222
Q ss_pred HHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 042348 611 LILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDR 667 (686)
Q Consensus 611 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~ 667 (686)
..... .... . .......+.+++.+|++.+|++|||+.++.+.|++
T Consensus 215 ~~~~~-~~~~------~-----~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 215 QVERG-YRMP------C-----PQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred HHHcC-CCCC------C-----CCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 22211 1110 0 01123468899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=320.39 Aligned_cols=258 Identities=22% Similarity=0.274 Sum_probs=187.4
Q ss_pred cccCccCceEEEEEEeC--CCceEEEEEcCCCC--ccchHHHHHHHHHHhcc---CCCCcceeeEEEEe-----cCceeE
Q 042348 373 FLLGKSTIGIVYKVALN--NEEAVAVRRLGNGG--WQRFKEFQTEAEAIGKI---RHPNIVSLRAYFWS-----VDEKLL 440 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~--~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~H~nIv~l~~~~~~-----~~~~~l 440 (686)
..||+|+||.||+|+.. ++..||+|++.... ......+.+|+.+++++ +||||+++++++.. ....++
T Consensus 7 ~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~~~~l 86 (290)
T cd07862 7 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTL 86 (290)
T ss_pred eEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCCcEEE
Confidence 36999999999999863 46789999886432 22234566788777766 69999999999863 345799
Q ss_pred EEeccCCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCccc
Q 042348 441 IYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLAR 520 (686)
Q Consensus 441 V~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~ 520 (686)
||||++ ++|.+++..... ..+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++
T Consensus 87 v~e~~~-~~l~~~~~~~~~----~~~~~~~~~~i~~qi~~aL~~lH~---~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~ 158 (290)
T cd07862 87 VFEHVD-QDLTTYLDKVPE----PGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLAR 158 (290)
T ss_pred EEccCC-CCHHHHHHhCCC----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEcCCCCEEEccccceE
Confidence 999996 699999875432 358999999999999999999999 899999999999999999999999999997
Q ss_pred ccccccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCc
Q 042348 521 LADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGS 600 (686)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~ 600 (686)
...... ......||..|+|||.+.+..++.++|||||||++|||++|+.||.....
T Consensus 159 ~~~~~~------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~ 214 (290)
T cd07862 159 IYSFQM------------------------ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD 214 (290)
T ss_pred eccCCc------------------------ccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCH
Confidence 543211 11234567789999999888899999999999999999999999965332
Q ss_pred cchhHHHHHHHHHhhcC--Ccc-------cccCcccccCCC--cHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 601 MELNIVQWIQLILEDRK--PMT-------DILDPFLAHDLD--KEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 601 ~~~~~~~~~~~~~~~~~--~~~-------~~~d~~l~~~~~--~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
. +....+........ ... ..+.+....... .......+.+++.+||+.||++|||+.|++++
T Consensus 215 ~--~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h 287 (290)
T cd07862 215 V--DQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 287 (290)
T ss_pred H--HHHHHHHHHhCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence 1 11111111110000 000 000000000000 00122356789999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=329.18 Aligned_cols=260 Identities=20% Similarity=0.324 Sum_probs=190.2
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCC--CccchHHHHHHHHHHhccCCCCcceeeEEEEecC-----ceeEEEec
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNG--GWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVD-----EKLLIYDY 444 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~-----~~~lV~e~ 444 (686)
..||+|+||.||+|... ++..||||++... ......++.+|++++++++||||+++++++.... ..++||||
T Consensus 6 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv~e~ 85 (338)
T cd07859 6 EVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFEL 85 (338)
T ss_pred EEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEEEEec
Confidence 46999999999999865 5889999998643 2233456889999999999999999999986442 47999999
Q ss_pred cCCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCccccccc
Q 042348 445 IPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADI 524 (686)
Q Consensus 445 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~ 524 (686)
|. ++|.+++... ..+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 86 ~~-~~L~~~l~~~------~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~ 155 (338)
T cd07859 86 ME-SDLHQVIKAN------DDLTPEHHQFFLYQLLRALKYIHT---ANVFHRDLKPKNILANADCKLKICDFGLARVAFN 155 (338)
T ss_pred CC-CCHHHHHHhc------ccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEccCcccccccc
Confidence 95 6999988754 358999999999999999999999 8999999999999999999999999999975432
Q ss_pred ccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccC--CCCCCcchHHHHHHHHHHHHhCCCCccccCccc
Q 042348 525 AEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKV--RKPTQKWDIYSYGVILLEMISGKLPMIQIGSME 602 (686)
Q Consensus 525 ~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~ 602 (686)
..... .......||..|+|||++.+ ..++.++|||||||++|||+||+.||.....
T Consensus 156 ~~~~~--------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~-- 213 (338)
T cd07859 156 DTPTA--------------------IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNV-- 213 (338)
T ss_pred ccCcc--------------------ccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCCh--
Confidence 11100 11123567888999999865 6789999999999999999999999954322
Q ss_pred hhHHHHHHHHHhhcC----------Ccccc---cCcccccCCC--cHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 603 LNIVQWIQLILEDRK----------PMTDI---LDPFLAHDLD--KEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 603 ~~~~~~~~~~~~~~~----------~~~~~---~d~~l~~~~~--~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
......+........ ..... +.+....... .......+.+++.+||+.||++|||+.|++++
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 214 VHQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred HHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 111111111110000 00000 0000000000 00112356799999999999999999999977
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=332.01 Aligned_cols=247 Identities=21% Similarity=0.296 Sum_probs=194.3
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCC---ccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCC
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGG---WQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNG 448 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~g 448 (686)
..||+|+||.||++... +++.||+|+++... ....+.+.+|+.+++.++||||+++++++.+.+..++||||+++|
T Consensus 7 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 86 (330)
T cd05601 7 SLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQPGG 86 (330)
T ss_pred EEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEECCCCCC
Confidence 46999999999999865 58899999987532 223456889999999999999999999999999999999999999
Q ss_pred CHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCC
Q 042348 449 SLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEET 528 (686)
Q Consensus 449 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 528 (686)
+|.+++.... ..+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++.+.....
T Consensus 87 ~L~~~l~~~~-----~~l~~~~~~~~~~qi~~aL~~lH~---~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~- 157 (330)
T cd05601 87 DLLSLLNRYE-----DQFDEDMAQFYLAELVLAIHSVHQ---MGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM- 157 (330)
T ss_pred CHHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeEcccCchHheEECCCCCEEeccCCCCeECCCCCc-
Confidence 9999998653 358999999999999999999999 8999999999999999999999999999976542211
Q ss_pred ccccccccccCCCCCCCccccccccCCCCCccccCccccc------CCCCCCcchHHHHHHHHHHHHhCCCCccccCccc
Q 042348 529 PEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASK------VRKPTQKWDIYSYGVILLEMISGKLPMIQIGSME 602 (686)
Q Consensus 529 ~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~ 602 (686)
.......||..|+|||++. ...++.++|||||||++|||++|+.||.....
T Consensus 158 ---------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~-- 214 (330)
T cd05601 158 ---------------------VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTS-- 214 (330)
T ss_pred ---------------------eeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCH--
Confidence 0112235678899999986 45678999999999999999999999954322
Q ss_pred hhHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 603 LNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 603 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
...+..+....... .. + .. ......+.+++.+|++ +|++||++.+++++
T Consensus 215 ---~~~~~~i~~~~~~~-~~--~---~~---~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 215 ---AKTYNNIMNFQRFL-KF--P---ED---PKVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred ---HHHHHHHHcCCCcc-CC--C---CC---CCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 12223332221111 00 0 00 0122357788889997 99999999999876
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=317.47 Aligned_cols=254 Identities=21% Similarity=0.349 Sum_probs=195.6
Q ss_pred cccCccCceEEEEEEeC------CCceEEEEEcCCCC-ccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEecc
Q 042348 373 FLLGKSTIGIVYKVALN------NEEAVAVRRLGNGG-WQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYI 445 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~ 445 (686)
..||+|+||.||+|... .+..||||.+.... .....++.+|+.++++++||||+++++++...+..++||||+
T Consensus 12 ~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~~ 91 (277)
T cd05062 12 RELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELM 91 (277)
T ss_pred eeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCeEEEEecC
Confidence 46999999999998753 24679999986532 233457889999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcCCCcc----ccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccc
Q 042348 446 PNGSLATAIHGKAGII----SYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARL 521 (686)
Q Consensus 446 ~~gsL~~~l~~~~~~~----~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~ 521 (686)
++|+|.+++....... ....+++..+..++.|++.||+|||+ ++++||||||+||++++++.++|+|||+++.
T Consensus 92 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~~vH~dlkp~Nil~~~~~~~~l~dfg~~~~ 168 (277)
T cd05062 92 TRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRD 168 (277)
T ss_pred CCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCcchheEEEcCCCCEEECCCCCccc
Confidence 9999999997543211 01346888999999999999999999 8999999999999999999999999999875
Q ss_pred cccccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCccccCc
Q 042348 522 ADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQIGS 600 (686)
Q Consensus 522 ~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~ 600 (686)
....... .......++..|+|||++.+..++.++|||||||++|||++ |..||.....
T Consensus 169 ~~~~~~~---------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~ 227 (277)
T cd05062 169 IYETDYY---------------------RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN 227 (277)
T ss_pred cCCccee---------------------ecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 4321110 00011234567999999988889999999999999999999 7888854322
Q ss_pred cchhHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 042348 601 MELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDR 667 (686)
Q Consensus 601 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~ 667 (686)
............ ... . ......+.+++.+||+.+|++|||+.|+++.|++
T Consensus 228 -----~~~~~~~~~~~~--~~~-----~-----~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 228 -----EQVLRFVMEGGL--LDK-----P-----DNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred -----HHHHHHHHcCCc--CCC-----C-----CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 122222222211 110 0 1123467899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=333.94 Aligned_cols=246 Identities=25% Similarity=0.388 Sum_probs=201.8
Q ss_pred hcccCccCceEEEEEEeCC-CceEEEEEcCCCCccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCCH
Q 042348 372 AFLLGKSTIGIVYKVALNN-EEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSL 450 (686)
Q Consensus 372 ~~~iG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL 450 (686)
.-++|+|.||+||.|+..+ ...+|||-+........+.+..||.+-++++|.|||+++|.+..+++.-|.||-++||||
T Consensus 580 rvVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSL 659 (1226)
T KOG4279|consen 580 RVVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSL 659 (1226)
T ss_pred eEEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcH
Confidence 3479999999999998654 567999999887777778899999999999999999999999999999999999999999
Q ss_pred HHHhhcCCCccccCCC--CHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeec-CCCCeEEeecCcccccccccC
Q 042348 451 ATAIHGKAGIISYRPL--SWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLG-KNMEPHISDFGLARLADIAEE 527 (686)
Q Consensus 451 ~~~l~~~~~~~~~~~l--~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~-~~~~~kl~DfGla~~~~~~~~ 527 (686)
.++++..=| ++ ++.++--+-+||++||.|||+ +.|||||||-+|||++ -.|.+||+|||.++.+..-.
T Consensus 660 SsLLrskWG-----PlKDNEstm~fYtkQILeGLkYLHe---n~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgin- 730 (1226)
T KOG4279|consen 660 SSLLRSKWG-----PLKDNESTMNFYTKQILEGLKYLHE---NKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGIN- 730 (1226)
T ss_pred HHHHHhccC-----CCccchhHHHHHHHHHHHHhhhhhh---cceeeccccCCcEEEeeccceEEecccccchhhccCC-
Confidence 999987643 45 778888999999999999999 8999999999999997 57899999999998653111
Q ss_pred CccccccccccCCCCCCCccccccccCCCCCccccCcccccCC--CCCCcchHHHHHHHHHHHHhCCCCccccCccchhH
Q 042348 528 TPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVR--KPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNI 605 (686)
Q Consensus 528 ~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~ 605 (686)
..+....||..|||||++..+ .|+.++|||||||++.||.||++||...++...-
T Consensus 731 ----------------------P~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAA- 787 (1226)
T KOG4279|consen 731 ----------------------PCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAA- 787 (1226)
T ss_pred ----------------------ccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHh-
Confidence 123456789999999999764 4899999999999999999999999766543321
Q ss_pred HHHHHHH-HhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 606 VQWIQLI-LEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 606 ~~~~~~~-~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
.++.. ++..++ -+++-..+...++.+|+.+||.+||+++++++.
T Consensus 788 --MFkVGmyKvHP~-------------iPeelsaeak~FilrcFepd~~~R~sA~~LL~D 832 (1226)
T KOG4279|consen 788 --MFKVGMYKVHPP-------------IPEELSAEAKNFILRCFEPDPCDRPSAKDLLQD 832 (1226)
T ss_pred --hhhhcceecCCC-------------CcHHHHHHHHHHHHHHcCCCcccCccHHHhccC
Confidence 11111 111111 123445678899999999999999999999754
|
|
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=315.97 Aligned_cols=254 Identities=27% Similarity=0.442 Sum_probs=196.4
Q ss_pred cccCccCceEEEEEEe-----CCCceEEEEEcCCCC-ccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccC
Q 042348 373 FLLGKSTIGIVYKVAL-----NNEEAVAVRRLGNGG-WQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIP 446 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~ 446 (686)
..||+|+||.||+|.. .++..|++|.+.... ......+.+|++++++++||||+++++++...+..++||||++
T Consensus 11 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 90 (283)
T cd05090 11 EELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLN 90 (283)
T ss_pred eeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEEEEEcCC
Confidence 4699999999999974 245789999997533 2334678999999999999999999999999999999999999
Q ss_pred CCCHHHHhhcCCCc-----------cccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEee
Q 042348 447 NGSLATAIHGKAGI-----------ISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISD 515 (686)
Q Consensus 447 ~gsL~~~l~~~~~~-----------~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~D 515 (686)
+++|.+++...... .....+++.++..++.|++.||+|||+ ++|+||||||+||++++++.+||+|
T Consensus 91 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~nili~~~~~~kl~d 167 (283)
T cd05090 91 QGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSS---HFFVHKDLAARNILIGEQLHVKISD 167 (283)
T ss_pred CCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---cCeehhccccceEEEcCCCcEEecc
Confidence 99999998643210 001358899999999999999999999 8999999999999999999999999
Q ss_pred cCcccccccccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCC
Q 042348 516 FGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLP 594 (686)
Q Consensus 516 fGla~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P 594 (686)
||+++........ .......++..|+|||++.+..++.++|||||||++|||++ |..|
T Consensus 168 fg~~~~~~~~~~~---------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p 226 (283)
T cd05090 168 LGLSREIYSADYY---------------------RVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQP 226 (283)
T ss_pred ccccccccCCcce---------------------ecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCC
Confidence 9999755322110 01112234567999999988889999999999999999999 9999
Q ss_pred ccccCccchhHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 042348 595 MIQIGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDR 667 (686)
Q Consensus 595 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~ 667 (686)
|..... ..+ .... ..... ... . ......+.+++.+||+.||++||++.+|.++|..
T Consensus 227 ~~~~~~--~~~---~~~~-~~~~~-~~~-~---------~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 227 YYGFSN--QEV---IEMV-RKRQL-LPC-S---------EDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred CCCCCH--HHH---HHHH-HcCCc-CCC-C---------CCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 854321 111 1222 11111 110 0 1123457789999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=312.51 Aligned_cols=247 Identities=24% Similarity=0.335 Sum_probs=193.3
Q ss_pred ccCccCceEEEEEEeC---CCceEEEEEcCCCC--ccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCC
Q 042348 374 LLGKSTIGIVYKVALN---NEEAVAVRRLGNGG--WQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNG 448 (686)
Q Consensus 374 ~iG~G~~g~Vy~~~~~---~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~g 448 (686)
.||+|+||.||+|.++ ++..+|+|++.... ....+++.+|+.++++++||||+++++++. .+..++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 4899999999999653 46789999986543 223567899999999999999999999885 45678999999999
Q ss_pred CHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCC
Q 042348 449 SLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEET 528 (686)
Q Consensus 449 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 528 (686)
+|.+++... ..+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++........
T Consensus 81 ~L~~~l~~~------~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~ 151 (257)
T cd05116 81 PLNKFLQKN------KHVTEKNITELVHQVSMGMKYLEE---TNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENY 151 (257)
T ss_pred cHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchhhEEEcCCCeEEECCCccccccCCCCCe
Confidence 999999754 358899999999999999999999 89999999999999999999999999999765322110
Q ss_pred ccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCccccCccchhHHH
Q 042348 529 PEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQIGSMELNIVQ 607 (686)
Q Consensus 529 ~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~~~~~~ 607 (686)
. .......++..|+|||.+....++.++|||||||++|||++ |+.||...... .
T Consensus 152 ~--------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-----~ 206 (257)
T cd05116 152 Y--------------------KAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN-----E 206 (257)
T ss_pred e--------------------eecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-----H
Confidence 0 00111223467999999988889999999999999999998 99999543221 2
Q ss_pred HHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 042348 608 WIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDR 667 (686)
Q Consensus 608 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~ 667 (686)
+.+.+..... .+. . .....++.+++.+||+.||++||++.+|.+.|++
T Consensus 207 ~~~~i~~~~~--~~~-----~-----~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 207 VTQMIESGER--MEC-----P-----QRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred HHHHHHCCCC--CCC-----C-----CCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 2222222211 110 0 0123467799999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=314.31 Aligned_cols=255 Identities=21% Similarity=0.327 Sum_probs=201.4
Q ss_pred cccCccCceEEEEEEe-CCCceEEEEEcCCC---CccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCC
Q 042348 373 FLLGKSTIGIVYKVAL-NNEEAVAVRRLGNG---GWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNG 448 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~g 448 (686)
..||+|+||.||++.. .++..++||.+... ......++.+|+.+++.++||||+++++++...+..++||||++++
T Consensus 8 ~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~ 87 (267)
T cd08229 8 KKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAG 87 (267)
T ss_pred hhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEEecCCC
Confidence 4699999999999986 47889999987643 2233457889999999999999999999999999999999999999
Q ss_pred CHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCC
Q 042348 449 SLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEET 528 (686)
Q Consensus 449 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 528 (686)
+|.+++...... ...+++..+..++.|++.||+|||+ ++++|+||||+||+++.++.++|+|||++........
T Consensus 88 ~L~~~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~- 161 (267)
T cd08229 88 DLSRMIKHFKKQ--KRLIPEKTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT- 161 (267)
T ss_pred CHHHHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEECcchhhhccccCCc-
Confidence 999998743211 1468999999999999999999999 8999999999999999999999999999875532110
Q ss_pred ccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHH
Q 042348 529 PEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQW 608 (686)
Q Consensus 529 ~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~ 608 (686)
......++..|+|||++.+..++.++||||||+++|||++|..||..... +....
T Consensus 162 ----------------------~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---~~~~~ 216 (267)
T cd08229 162 ----------------------AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM---NLYSL 216 (267)
T ss_pred ----------------------ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccc---hHHHH
Confidence 01123466779999999888899999999999999999999999954322 12222
Q ss_pred HHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 042348 609 IQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRVN 669 (686)
Q Consensus 609 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~ 669 (686)
.........+ .. ........+.+++.+||+.+|++|||+.+|++.++++.
T Consensus 217 ~~~~~~~~~~-------~~----~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 217 CKKIEQCDYP-------PL----PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred hhhhhcCCCC-------CC----CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 2222211110 00 11123446889999999999999999999999998864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=319.44 Aligned_cols=265 Identities=23% Similarity=0.301 Sum_probs=195.5
Q ss_pred cccCccCceEEEEEEe-----CCCceEEEEEcCCCCc-cchHHHHHHHHHHhccCCCCcceeeEEEEec--CceeEEEec
Q 042348 373 FLLGKSTIGIVYKVAL-----NNEEAVAVRRLGNGGW-QRFKEFQTEAEAIGKIRHPNIVSLRAYFWSV--DEKLLIYDY 444 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~~lV~e~ 444 (686)
..||+|+||.||++.. .++..||+|.+..... .....+.+|++++++++||||+++++++... ...++||||
T Consensus 10 ~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~ 89 (283)
T cd05080 10 RVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEY 89 (283)
T ss_pred eecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEEecC
Confidence 4699999999988653 3567899999876432 3356788999999999999999999998754 357899999
Q ss_pred cCCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCccccccc
Q 042348 445 IPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADI 524 (686)
Q Consensus 445 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~ 524 (686)
+++|+|.+++... .+++.++..++.|++.||+|||+ ++|+||||||+||++++++.+||+|||+++....
T Consensus 90 ~~~~~l~~~~~~~-------~l~~~~~~~i~~~l~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 159 (283)
T cd05080 90 VPLGSLRDYLPKH-------KLNLAQLLLFAQQICEGMAYLHS---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 159 (283)
T ss_pred CCCCCHHHHHHHc-------CCCHHHHHHHHHHHHHHHHHHHH---CCeeccccChheEEEcCCCcEEEeecccccccCC
Confidence 9999999999653 48999999999999999999999 8999999999999999999999999999986542
Q ss_pred ccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchh
Q 042348 525 AEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELN 604 (686)
Q Consensus 525 ~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~ 604 (686)
..... .......++..|+|||.+....++.++||||||+++|||+||+.||........+
T Consensus 160 ~~~~~--------------------~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~ 219 (283)
T cd05080 160 GHEYY--------------------RVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEE 219 (283)
T ss_pred cchhh--------------------ccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhh
Confidence 21100 0011123345699999998888999999999999999999999998543221111
Q ss_pred HHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 042348 605 IVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRVN 669 (686)
Q Consensus 605 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~ 669 (686)
........ .......+..+...... .......++.+++.+||+.+|++|||+++|++.|+++.
T Consensus 220 ~~~~~~~~-~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 220 MIGPKQGQ-MTVVRLIELLERGMRLP-CPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hhcccccc-cchhhhhhhhhcCCCCC-CCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 10000000 00000000011100000 01123457889999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=341.84 Aligned_cols=249 Identities=23% Similarity=0.304 Sum_probs=196.0
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCC--CccchHHHHHHHHHHhccCCCCcceeeEEEEecC--------ceeEE
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNG--GWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVD--------EKLLI 441 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~--------~~~lV 441 (686)
..||+|+||.||+|... +++.||||.+... .......+.+|+..+..++|+||+++++.+...+ ..++|
T Consensus 38 ~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~~~i~lV 117 (496)
T PTZ00283 38 RVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVLMIALV 117 (496)
T ss_pred EEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccceEEEEE
Confidence 46999999999999854 6899999998653 2334567889999999999999999988776433 25799
Q ss_pred EeccCCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccc
Q 042348 442 YDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARL 521 (686)
Q Consensus 442 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~ 521 (686)
|||+++|+|.++++..... ...+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++.
T Consensus 118 ~Ey~~~gsL~~~l~~~~~~--~~~l~e~~~~~i~~qll~aL~~lH~---~~IiHrDLKP~NILl~~~~~vkL~DFGls~~ 192 (496)
T PTZ00283 118 LDYANAGDLRQEIKSRAKT--NRTFREHEAGLLFIQVLLAVHHVHS---KHMIHRDIKSANILLCSNGLVKLGDFGFSKM 192 (496)
T ss_pred EeCCCCCcHHHHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEeCCCCEEEEecccCee
Confidence 9999999999999754321 1468999999999999999999999 8999999999999999999999999999986
Q ss_pred cccccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCcc
Q 042348 522 ADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSM 601 (686)
Q Consensus 522 ~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~ 601 (686)
+...... .......||..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 193 ~~~~~~~---------------------~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~--- 248 (496)
T PTZ00283 193 YAATVSD---------------------DVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGE--- 248 (496)
T ss_pred ccccccc---------------------cccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC---
Confidence 5422110 0112346788899999999989999999999999999999999999542
Q ss_pred chhHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 602 ELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 602 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
+....+......... .+.+ ....++.+++.+||+.||++||++.+++++
T Consensus 249 --~~~~~~~~~~~~~~~---~~~~---------~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 249 --NMEEVMHKTLAGRYD---PLPP---------SISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred --CHHHHHHHHhcCCCC---CCCC---------CCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 222333333332211 0111 123467889999999999999999999875
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=331.36 Aligned_cols=246 Identities=20% Similarity=0.282 Sum_probs=193.2
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCC---CccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCC
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNG---GWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNG 448 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~g 448 (686)
..||+|+||.||++... +++.||+|.+... .......+.+|+.+++.++||||+++++++.+.+..++||||+++|
T Consensus 49 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~Ey~~gg 128 (370)
T cd05596 49 KVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGG 128 (370)
T ss_pred EEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEcCCCCC
Confidence 46999999999999875 5789999998642 1223345788999999999999999999999999999999999999
Q ss_pred CHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCC
Q 042348 449 SLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEET 528 (686)
Q Consensus 449 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 528 (686)
+|.+++... .+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 129 ~L~~~l~~~-------~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~- 197 (370)
T cd05596 129 DLVNLMSNY-------DIPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGM- 197 (370)
T ss_pred cHHHHHHhc-------CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCCc-
Confidence 999998643 47888899999999999999999 8999999999999999999999999999975432110
Q ss_pred ccccccccccCCCCCCCccccccccCCCCCccccCcccccCC----CCCCcchHHHHHHHHHHHHhCCCCccccCccchh
Q 042348 529 PEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVR----KPTQKWDIYSYGVILLEMISGKLPMIQIGSMELN 604 (686)
Q Consensus 529 ~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~ 604 (686)
.......||..|+|||++.+. .++.++|||||||++|||++|+.||.....
T Consensus 198 ---------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~---- 252 (370)
T cd05596 198 ---------------------VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL---- 252 (370)
T ss_pred ---------------------ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCH----
Confidence 011234578889999988653 478999999999999999999999954322
Q ss_pred HHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCC--CCCHHHHHHH
Q 042348 605 IVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDK--RPSMRHVCDS 664 (686)
Q Consensus 605 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~--RPs~~ev~~~ 664 (686)
......+........ . + .. ......+.+++.+||+.+|++ ||++.|++++
T Consensus 253 -~~~~~~i~~~~~~~~-~--~---~~---~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 253 -VGTYSKIMDHKNSLT-F--P---DD---IEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred -HHHHHHHHcCCCcCC-C--C---Cc---CCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 222333333221110 0 0 00 012346778999999999988 9999999877
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=313.26 Aligned_cols=252 Identities=27% Similarity=0.470 Sum_probs=198.4
Q ss_pred hcccCccCceEEEEEEeCC-C---ceEEEEEcCCCC-ccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccC
Q 042348 372 AFLLGKSTIGIVYKVALNN-E---EAVAVRRLGNGG-WQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIP 446 (686)
Q Consensus 372 ~~~iG~G~~g~Vy~~~~~~-~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~ 446 (686)
.+.||+|+||.||+|.... + ..+|+|.+.... ....+.+..|++++++++||||+++++++...+..++||||++
T Consensus 10 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 89 (268)
T cd05063 10 QKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITEYME 89 (268)
T ss_pred eeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEEEEcCC
Confidence 3579999999999998752 2 379999987542 3345678999999999999999999999999999999999999
Q ss_pred CCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCccccccccc
Q 042348 447 NGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAE 526 (686)
Q Consensus 447 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~ 526 (686)
+++|.+++.... ..+++.++..++.|++.||+|||+ .+++||||||+||++++++.+||+|||++.......
T Consensus 90 ~~~L~~~~~~~~-----~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~ 161 (268)
T cd05063 90 NGALDKYLRDHD-----GEFSSYQLVGMLRGIAAGMKYLSD---MNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDP 161 (268)
T ss_pred CCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEEcCCCcEEECCCccceeccccc
Confidence 999999997643 358999999999999999999999 899999999999999999999999999987553221
Q ss_pred CCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCccccCccchhH
Q 042348 527 ETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQIGSMELNI 605 (686)
Q Consensus 527 ~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~~~~ 605 (686)
... ........+..|+|||++....++.++|||||||++|||++ |+.||.....
T Consensus 162 ~~~--------------------~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~----- 216 (268)
T cd05063 162 EGT--------------------YTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN----- 216 (268)
T ss_pred ccc--------------------eeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH-----
Confidence 100 00011122456999999988889999999999999999998 9999954322
Q ss_pred HHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 042348 606 VQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRV 668 (686)
Q Consensus 606 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i 668 (686)
.+....+... ...+. ..+....+.+++.+||+.+|++||++.+|++.|+++
T Consensus 217 ~~~~~~i~~~-~~~~~-----------~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 217 HEVMKAINDG-FRLPA-----------PMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred HHHHHHHhcC-CCCCC-----------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 1222222221 11111 011234678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=316.74 Aligned_cols=254 Identities=27% Similarity=0.377 Sum_probs=197.2
Q ss_pred cccCccCceEEEEEEeCC------CceEEEEEcCCCCcc-chHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEecc
Q 042348 373 FLLGKSTIGIVYKVALNN------EEAVAVRRLGNGGWQ-RFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYI 445 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~ 445 (686)
..||+|+||.||+|...+ +..||+|++...... ..+.+.+|+.++++++||||+++++++...+..++++||+
T Consensus 11 ~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~~e~~ 90 (283)
T cd05091 11 EELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYC 90 (283)
T ss_pred HHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEEEEEcC
Confidence 468999999999998632 478999999754332 2456889999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcCCCc----------cccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEee
Q 042348 446 PNGSLATAIHGKAGI----------ISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISD 515 (686)
Q Consensus 446 ~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~D 515 (686)
++++|.+++...... .....+++..+..++.|++.||+|||+ ++|+||||||+||++++++.+||+|
T Consensus 91 ~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~---~gi~H~dlkp~Nil~~~~~~~kl~D 167 (283)
T cd05091 91 SHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSS---HHVVHKDLATRNVLVFDKLNVKISD 167 (283)
T ss_pred CCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---cCccccccchhheEecCCCceEecc
Confidence 999999998643110 011358889999999999999999999 8999999999999999999999999
Q ss_pred cCcccccccccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCC
Q 042348 516 FGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLP 594 (686)
Q Consensus 516 fGla~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P 594 (686)
||+++........ .......++..|+|||++.+..++.++|||||||++|||++ |..|
T Consensus 168 fg~~~~~~~~~~~---------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p 226 (283)
T cd05091 168 LGLFREVYAADYY---------------------KLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 226 (283)
T ss_pred cccccccccchhe---------------------eeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCC
Confidence 9998755322110 01112334567999999988889999999999999999998 8888
Q ss_pred ccccCccchhHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 042348 595 MIQIGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDR 667 (686)
Q Consensus 595 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~ 667 (686)
|..... .++...+...... .. ..+....+.+++.+||+.+|++||++++|+..|+.
T Consensus 227 ~~~~~~-----~~~~~~i~~~~~~--~~----------~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 227 YCGYSN-----QDVIEMIRNRQVL--PC----------PDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred CCCCCH-----HHHHHHHHcCCcC--CC----------CCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 854322 2223333222111 00 01233457899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=310.87 Aligned_cols=248 Identities=29% Similarity=0.463 Sum_probs=196.1
Q ss_pred cccCccCceEEEEEEeCCCceEEEEEcCCCCccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCCHHH
Q 042348 373 FLLGKSTIGIVYKVALNNEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLAT 452 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL~~ 452 (686)
..||+|+||.||+|...++..||+|.+..... ..+++.+|++++++++||||+++++++. .+..++||||+++|+|.+
T Consensus 12 ~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~~~L~~ 89 (262)
T cd05071 12 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMSKGSLLD 89 (262)
T ss_pred eecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcCCCCcHHH
Confidence 35899999999999987777899999875432 3467899999999999999999999874 456799999999999999
Q ss_pred HhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCcccc
Q 042348 453 AIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVH 532 (686)
Q Consensus 453 ~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 532 (686)
++....+ ..+++..+..++.|++.||+|||+ ++++||||||+||++++++.++|+|||.++........
T Consensus 90 ~~~~~~~----~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~---- 158 (262)
T cd05071 90 FLKGEMG----KYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT---- 158 (262)
T ss_pred HHhhccc----cCCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcccEEEcCCCcEEeccCCceeeccccccc----
Confidence 9976432 357899999999999999999999 89999999999999999999999999999765422110
Q ss_pred ccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCccccCccchhHHHHHHH
Q 042348 533 WEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQIGSMELNIVQWIQL 611 (686)
Q Consensus 533 ~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~ 611 (686)
......++..|+|||+..+..++.++|||||||++|||+| |+.||......+ ....
T Consensus 159 ------------------~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~-----~~~~ 215 (262)
T cd05071 159 ------------------ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-----VLDQ 215 (262)
T ss_pred ------------------cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHH-----HHHH
Confidence 0012234567999999988889999999999999999999 888885432211 1112
Q ss_pred HHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 042348 612 ILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRV 668 (686)
Q Consensus 612 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i 668 (686)
.... .... ........+.+++.+|++.+|++||++.++.+.|++.
T Consensus 216 ~~~~-~~~~-----------~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 216 VERG-YRMP-----------CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred HhcC-CCCC-----------CccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 2111 1110 0112345688999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=332.19 Aligned_cols=269 Identities=19% Similarity=0.287 Sum_probs=193.6
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCC---ccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCC
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGG---WQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNG 448 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~g 448 (686)
..||+|+||.||+|... +++.||||++.... ......+.+|++++++++||||+++++++.+.+..++||||+++|
T Consensus 7 ~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~~~gg 86 (381)
T cd05626 7 KTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGG 86 (381)
T ss_pred EEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEecCCCC
Confidence 46999999999999865 57899999986532 233456889999999999999999999999999999999999999
Q ss_pred CHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCC
Q 042348 449 SLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEET 528 (686)
Q Consensus 449 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 528 (686)
+|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++........
T Consensus 87 ~L~~~l~~~------~~~~e~~~~~~~~qi~~aL~~LH~---~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~ 157 (381)
T cd05626 87 DMMSLLIRM------EVFPEVLARFYIAELTLAIESVHK---MGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNS 157 (381)
T ss_pred cHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCcHHHEEECCCCCEEEeeCcCCccccccccc
Confidence 999999764 358899999999999999999999 89999999999999999999999999998754321110
Q ss_pred cccc---------------cccc---ccCCCC---C--CC-ccccccccCCCCCccccCcccccCCCCCCcchHHHHHHH
Q 042348 529 PEVH---------------WEQS---TTGTPL---Q--SS-PYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVI 584 (686)
Q Consensus 529 ~~~~---------------~~~~---~~g~~~---~--~~-~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvv 584 (686)
.... +... ..+... . .. ..........+||..|+|||++.+..++.++|||||||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~i 237 (381)
T cd05626 158 KYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVI 237 (381)
T ss_pred ccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhH
Confidence 0000 0000 000000 0 00 000001134578999999999988889999999999999
Q ss_pred HHHHHhCCCCccccCccchhHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHh--ccccCCCCCCCHHHHH
Q 042348 585 LLEMISGKLPMIQIGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALD--CVHKSPDKRPSMRHVC 662 (686)
Q Consensus 585 l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~--cl~~dP~~RPs~~ev~ 662 (686)
+|||+||+.||......+. ...+........ ..... ....++.+++.+ |+..+|..||++.|++
T Consensus 238 l~elltG~~Pf~~~~~~~~-----~~~i~~~~~~~~------~~~~~---~~s~~~~dli~~ll~~~~~~~~R~~~~~~l 303 (381)
T cd05626 238 LFEMLVGQPPFLAPTPTET-----QLKVINWENTLH------IPPQV---KLSPEAVDLITKLCCSAEERLGRNGADDIK 303 (381)
T ss_pred HHHHHhCCCCCcCCCHHHH-----HHHHHccccccC------CCCCC---CCCHHHHHHHHHHccCcccccCCCCHHHHh
Confidence 9999999999965332211 111211111100 00000 012345567766 5666777799999998
Q ss_pred HH
Q 042348 663 DS 664 (686)
Q Consensus 663 ~~ 664 (686)
++
T Consensus 304 ~h 305 (381)
T cd05626 304 AH 305 (381)
T ss_pred cC
Confidence 87
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=311.53 Aligned_cols=255 Identities=20% Similarity=0.328 Sum_probs=202.1
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCC---CccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCC
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNG---GWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNG 448 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~g 448 (686)
+.||+|+||.||+|... +++.||+|.++.. .....+.+.+|++++++++|+||+++++++...+..++||||+++|
T Consensus 8 ~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 87 (267)
T cd08224 8 KKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLELADAG 87 (267)
T ss_pred eeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEecCCCC
Confidence 46999999999999976 7889999988642 2233567899999999999999999999999999999999999999
Q ss_pred CHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCC
Q 042348 449 SLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEET 528 (686)
Q Consensus 449 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 528 (686)
+|.+++...... ...+++.++..++.|++.||+|||+ .+|+||||||+||+++.++.++|+|||+++.......
T Consensus 88 ~L~~~l~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~- 161 (267)
T cd08224 88 DLSRMIKHFKKQ--KRLIPERTIWKYFVQLCSALEHMHS---KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT- 161 (267)
T ss_pred CHHHHHHHhccc--CCCcCHHHHHHHHHHHHHHHHHHHh---CCEecCCcChhhEEECCCCcEEEeccceeeeccCCCc-
Confidence 999998653211 1458999999999999999999999 8999999999999999999999999999875532211
Q ss_pred ccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHH
Q 042348 529 PEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQW 608 (686)
Q Consensus 529 ~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~ 608 (686)
......++..|+|||.+.+..++.++|||||||++|+|++|+.||.... .+..+.
T Consensus 162 ----------------------~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~~ 216 (267)
T cd08224 162 ----------------------AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK---MNLYSL 216 (267)
T ss_pred ----------------------ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCC---ccHHHH
Confidence 0112345667999999988889999999999999999999999985432 222222
Q ss_pred HHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 042348 609 IQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRVN 669 (686)
Q Consensus 609 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~ 669 (686)
......... ... ........+.+++.+||+.+|++||++.+|++.|++++
T Consensus 217 ~~~~~~~~~--~~~---------~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 217 CKKIEKCDY--PPL---------PADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred HhhhhcCCC--CCC---------ChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 222221111 000 01123346789999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=315.57 Aligned_cols=239 Identities=23% Similarity=0.356 Sum_probs=187.0
Q ss_pred ccCccCceEEEEEEeCC--------CceEEEEEcCCCCccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEecc
Q 042348 374 LLGKSTIGIVYKVALNN--------EEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYI 445 (686)
Q Consensus 374 ~iG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~ 445 (686)
.||+|+||.||+|.... ...|++|.+........+.+.+|+.++++++||||+++++++..++..++||||+
T Consensus 2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~ 81 (258)
T cd05078 2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYV 81 (258)
T ss_pred CCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEecC
Confidence 58999999999997642 2348888886654445567899999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCC--------eEEeecC
Q 042348 446 PNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNME--------PHISDFG 517 (686)
Q Consensus 446 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~--------~kl~DfG 517 (686)
++|+|.++++... ..+++..++.++.||+.||+|||+ ++|+||||||+||+++.++. ++++|||
T Consensus 82 ~~g~L~~~l~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g 153 (258)
T cd05078 82 KFGSLDTYLKKNK-----NLINISWKLEVAKQLAWALHFLED---KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPG 153 (258)
T ss_pred CCCcHHHHHhcCC-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCccceEEEecccccccCCCceEEecccc
Confidence 9999999998654 358999999999999999999999 89999999999999987765 5888888
Q ss_pred cccccccccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccC-CCCCCcchHHHHHHHHHHHHhCC-CCc
Q 042348 518 LARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKV-RKPTQKWDIYSYGVILLEMISGK-LPM 595 (686)
Q Consensus 518 la~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvvl~elltG~-~P~ 595 (686)
++...... ....++..|+|||++.+ ..++.++|||||||++|||++|. .||
T Consensus 154 ~~~~~~~~---------------------------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~ 206 (258)
T cd05078 154 ISITVLPK---------------------------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPL 206 (258)
T ss_pred cccccCCc---------------------------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCCh
Confidence 87533211 12345667999999876 45799999999999999999985 555
Q ss_pred cccCccchhHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 042348 596 IQIGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLD 666 (686)
Q Consensus 596 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~ 666 (686)
....... .. .........+. ....++.+++.+||+.||++|||++++++.|+
T Consensus 207 ~~~~~~~-----~~-~~~~~~~~~~~-------------~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 207 SALDSQK-----KL-QFYEDRHQLPA-------------PKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred hhccHHH-----HH-HHHHccccCCC-------------CCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 3322111 11 11111111111 11235789999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=311.14 Aligned_cols=249 Identities=24% Similarity=0.393 Sum_probs=198.0
Q ss_pred ccCccCceEEEEEEeCC--C--ceEEEEEcCCCCc-cchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCC
Q 042348 374 LLGKSTIGIVYKVALNN--E--EAVAVRRLGNGGW-QRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNG 448 (686)
Q Consensus 374 ~iG~G~~g~Vy~~~~~~--~--~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~g 448 (686)
.||+|++|.||+|.+.+ + ..||||.+..... ...+.+.+|++++++++||||+++++++.. ...++||||+++|
T Consensus 2 ~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~~ 80 (257)
T cd05040 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPLG 80 (257)
T ss_pred cCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCCC
Confidence 58999999999998753 2 3689999987655 556789999999999999999999999988 8899999999999
Q ss_pred CHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCC
Q 042348 449 SLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEET 528 (686)
Q Consensus 449 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 528 (686)
+|.+++..... ..+++..+..++.|++.||+|||+ ++++||||||+||+++.++.+||+|||+++........
T Consensus 81 ~L~~~l~~~~~----~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~ 153 (257)
T cd05040 81 SLLDRLRKDAL----GHFLISTLCDYAVQIANGMRYLES---KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDH 153 (257)
T ss_pred cHHHHHHhccc----ccCcHHHHHHHHHHHHHHHHHHHh---CCccccccCcccEEEecCCEEEeccccccccccccccc
Confidence 99999986532 358999999999999999999999 89999999999999999999999999999866432110
Q ss_pred ccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCccccCccchhHHH
Q 042348 529 PEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQIGSMELNIVQ 607 (686)
Q Consensus 529 ~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~~~~~~ 607 (686)
. .......++..|+|||++.+..++.++|||||||++|||++ |+.||...... +
T Consensus 154 ~--------------------~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-----~ 208 (257)
T cd05040 154 Y--------------------VMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGS-----Q 208 (257)
T ss_pred e--------------------ecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHH-----H
Confidence 0 01112345677999999988889999999999999999999 99998543221 1
Q ss_pred HHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 042348 608 WIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLD 666 (686)
Q Consensus 608 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~ 666 (686)
..+.......... .+ ......+.+++.+|++.+|++||++.|+++.|.
T Consensus 209 ~~~~~~~~~~~~~---~~--------~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 209 ILKKIDKEGERLE---RP--------EACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred HHHHHHhcCCcCC---CC--------ccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 1222221111100 00 112346889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=327.84 Aligned_cols=257 Identities=24% Similarity=0.307 Sum_probs=198.5
Q ss_pred hcccCccCceEEEEEEeC------CCceEEEEEcCCCCc-cchHHHHHHHHHHhccC-CCCcceeeEEEEecCceeEEEe
Q 042348 372 AFLLGKSTIGIVYKVALN------NEEAVAVRRLGNGGW-QRFKEFQTEAEAIGKIR-HPNIVSLRAYFWSVDEKLLIYD 443 (686)
Q Consensus 372 ~~~iG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lV~e 443 (686)
...||+|+||.||+|.+. .+..||||+++.... ...+.+.+|++++.++. |||||++++++...+..++|||
T Consensus 42 ~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~~iv~E 121 (401)
T cd05107 42 GRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPIYIITE 121 (401)
T ss_pred hhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCcEEEEe
Confidence 457999999999999864 245799999976422 22457889999999997 9999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCCc---------------------------------------------------------------
Q 042348 444 YIPNGSLATAIHGKAGI--------------------------------------------------------------- 460 (686)
Q Consensus 444 ~~~~gsL~~~l~~~~~~--------------------------------------------------------------- 460 (686)
|+++|+|.++++.....
T Consensus 122 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 201 (401)
T cd05107 122 YCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMKGTVKY 201 (401)
T ss_pred ccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcchhhhhh
Confidence 99999999999754210
Q ss_pred -----------------------------cccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCe
Q 042348 461 -----------------------------ISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEP 511 (686)
Q Consensus 461 -----------------------------~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~ 511 (686)
.....+++..+.+|+.|++.||+|||+ ++|+||||||+|||+++++.+
T Consensus 202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrdlkp~NiLl~~~~~~ 278 (401)
T cd05107 202 ADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLAS---KNCVHRDLAARNVLICEGKLV 278 (401)
T ss_pred hhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhc---CCcCcccCCcceEEEeCCCEE
Confidence 011347888899999999999999999 899999999999999999999
Q ss_pred EEeecCcccccccccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHh-
Q 042348 512 HISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS- 590 (686)
Q Consensus 512 kl~DfGla~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt- 590 (686)
||+|||+++........ .......++..|+|||.+....++.++|||||||++|||++
T Consensus 279 kL~DfGla~~~~~~~~~---------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~ 337 (401)
T cd05107 279 KICDFGLARDIMRDSNY---------------------ISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTL 337 (401)
T ss_pred EEEecCcceeccccccc---------------------ccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHc
Confidence 99999999754321110 00112345677999999988889999999999999999998
Q ss_pred CCCCccccCccchhHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 042348 591 GKLPMIQIGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRV 668 (686)
Q Consensus 591 G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i 668 (686)
|..||......+ ............. .+ ......+.+++.+||+.+|++||+++||++.|+++
T Consensus 338 g~~P~~~~~~~~-----~~~~~~~~~~~~~---~p--------~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~ 399 (401)
T cd05107 338 GGTPYPELPMNE-----QFYNAIKRGYRMA---KP--------AHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL 399 (401)
T ss_pred CCCCCCCCCchH-----HHHHHHHcCCCCC---CC--------CCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 899985432211 1111111111110 01 01234678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-37 Score=310.41 Aligned_cols=252 Identities=25% Similarity=0.420 Sum_probs=192.0
Q ss_pred ccCccCceEEEEEEeCC----CceEEEEEcCCC-CccchHHHHHHHHHHhccCCCCcceeeEEEEe-cCceeEEEeccCC
Q 042348 374 LLGKSTIGIVYKVALNN----EEAVAVRRLGNG-GWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWS-VDEKLLIYDYIPN 447 (686)
Q Consensus 374 ~iG~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~-~~~~~lV~e~~~~ 447 (686)
.||+|+||.||+|...+ ...||+|++... .....+.+.+|+.+++.++||||+++++++.. ++..++||||+++
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~ 81 (262)
T cd05058 2 VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMKH 81 (262)
T ss_pred cccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCCC
Confidence 58999999999998532 357999998543 33345678899999999999999999998764 4567999999999
Q ss_pred CCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccC
Q 042348 448 GSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEE 527 (686)
Q Consensus 448 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 527 (686)
|+|.+++.... ..+++..+..++.|++.||+|||+ .+++||||||+||++++++.+||+|||+++.......
T Consensus 82 ~~L~~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~ 153 (262)
T cd05058 82 GDLRNFIRSET-----HNPTVKDLIGFGLQVAKGMEYLAS---KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEY 153 (262)
T ss_pred CCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCccccccccCCcc
Confidence 99999997643 346788889999999999999999 8999999999999999999999999999875432110
Q ss_pred CccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhC-CCCccccCccchhHH
Q 042348 528 TPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISG-KLPMIQIGSMELNIV 606 (686)
Q Consensus 528 ~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG-~~P~~~~~~~~~~~~ 606 (686)
.. ........++..|+|||.+.+..++.++|||||||++|||++| ..||.... ..
T Consensus 154 ~~-------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~-----~~ 209 (262)
T cd05058 154 YS-------------------VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVD-----SF 209 (262)
T ss_pred ee-------------------ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCC-----HH
Confidence 00 0001122345679999999888899999999999999999995 55553321 11
Q ss_pred HHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 042348 607 QWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRVN 669 (686)
Q Consensus 607 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~ 669 (686)
.............. + ...+..+.+++.+||+.+|++||++.||++.|+++.
T Consensus 210 ~~~~~~~~~~~~~~----~--------~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 210 DITVYLLQGRRLLQ----P--------EYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred HHHHHHhcCCCCCC----C--------CcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 22222222211100 0 011236789999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=314.80 Aligned_cols=248 Identities=26% Similarity=0.351 Sum_probs=193.7
Q ss_pred cccCccCceEEEEEEe-CCCceEEEEEcCCCCccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCCHH
Q 042348 373 FLLGKSTIGIVYKVAL-NNEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLA 451 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL~ 451 (686)
..||+|+||.||+|.. .+++.||+|++..........+.+|+.++++++||||+++++++...+..++||||+++++|.
T Consensus 15 ~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~~~~~L~ 94 (267)
T cd06646 15 QRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQ 94 (267)
T ss_pred heeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCCCCCcHH
Confidence 4699999999999986 467889999987654445567889999999999999999999999999999999999999999
Q ss_pred HHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCccc
Q 042348 452 TAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEV 531 (686)
Q Consensus 452 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 531 (686)
++++.. ..+++..+..++.|++.||+|||+ ++|+||||||+||++++++.++|+|||+++.......
T Consensus 95 ~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~---- 161 (267)
T cd06646 95 DIYHVT------GPLSELQIAYVCRETLQGLAYLHS---KGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA---- 161 (267)
T ss_pred HHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEECcCccceeeccccc----
Confidence 998754 358899999999999999999999 8999999999999999999999999999975532110
Q ss_pred cccccccCCCCCCCccccccccCCCCCccccCccccc---CCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHH
Q 042348 532 HWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASK---VRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQW 608 (686)
Q Consensus 532 ~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~ 608 (686)
......++..|+|||.+. ...++.++|||||||++|||++|+.||......+.
T Consensus 162 -------------------~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~----- 217 (267)
T cd06646 162 -------------------KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA----- 217 (267)
T ss_pred -------------------ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhh-----
Confidence 011234667799999874 34578899999999999999999999854322111
Q ss_pred HHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 042348 609 IQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSL 665 (686)
Q Consensus 609 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L 665 (686)
........ ...+.... .......+.+++.+||+.+|++||++++++++|
T Consensus 218 ~~~~~~~~-----~~~~~~~~---~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 218 LFLMSKSN-----FQPPKLKD---KTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred heeeecCC-----CCCCCCcc---ccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 00000000 00011100 011234678999999999999999999998764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=310.11 Aligned_cols=249 Identities=28% Similarity=0.412 Sum_probs=195.5
Q ss_pred ccCccCceEEEEEEeCC----CceEEEEEcCCCCc-cchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCC
Q 042348 374 LLGKSTIGIVYKVALNN----EEAVAVRRLGNGGW-QRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNG 448 (686)
Q Consensus 374 ~iG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~g 448 (686)
.||+|+||.||+|.... +..+|+|.+..... ...+++.+|+.++++++||||+++++++. .+..++||||+++|
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~~ 80 (257)
T cd05060 2 ELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPLG 80 (257)
T ss_pred ccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCCC
Confidence 58999999999997532 26899999876543 24467899999999999999999999876 45689999999999
Q ss_pred CHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCC
Q 042348 449 SLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEET 528 (686)
Q Consensus 449 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 528 (686)
+|.+++... ..+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||+++........
T Consensus 81 ~L~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~ 151 (257)
T cd05060 81 PLLKYLKKR------REIPVSDLKELAHQVAMGMAYLES---KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDY 151 (257)
T ss_pred cHHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHhh---cCeeccCcccceEEEcCCCcEEeccccccceeecCCcc
Confidence 999999765 358999999999999999999999 89999999999999999999999999999865422210
Q ss_pred ccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCccccCccchhHHH
Q 042348 529 PEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQIGSMELNIVQ 607 (686)
Q Consensus 529 ~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~~~~~~ 607 (686)
. .......++..|+|||...+..++.++|||||||++|||++ |+.||..... ..+.
T Consensus 152 ~--------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~--~~~~- 208 (257)
T cd05060 152 Y--------------------RATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG--AEVI- 208 (257)
T ss_pred c--------------------ccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH--HHHH-
Confidence 0 00111223456999999988889999999999999999998 9999954322 1222
Q ss_pred HHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 042348 608 WIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRVN 669 (686)
Q Consensus 608 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~ 669 (686)
..+... .... . .......+.+++.+||+.+|++||++.++++.|+++.
T Consensus 209 --~~~~~~-~~~~---~--------~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 209 --AMLESG-ERLP---R--------PEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred --HHHHcC-CcCC---C--------CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 222111 1110 0 0112346789999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=309.87 Aligned_cols=247 Identities=28% Similarity=0.458 Sum_probs=195.4
Q ss_pred cccCccCceEEEEEEeCCCceEEEEEcCCCCccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCCHHH
Q 042348 373 FLLGKSTIGIVYKVALNNEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLAT 452 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL~~ 452 (686)
..||+|++|.||+|....+..+|+|.+..... ..+.+.+|++++++++||||+++++++. .+..++||||+++|+|.+
T Consensus 12 ~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~ 89 (260)
T cd05069 12 VKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTM-MPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMGKGSLLD 89 (260)
T ss_pred eeecCcCCCeEEEEEEcCCceEEEEEcccCCc-cHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCCCCCHHH
Confidence 35999999999999988777899998865432 3467899999999999999999999875 456899999999999999
Q ss_pred HhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCcccc
Q 042348 453 AIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVH 532 (686)
Q Consensus 453 ~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 532 (686)
+++.... ..+++..+..++.|++.||+|||+ .+++||||||+||++++++.++|+|||+++........
T Consensus 90 ~~~~~~~----~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~---- 158 (260)
T cd05069 90 FLKEGDG----KYLKLPQLVDMAAQIADGMAYIER---MNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT---- 158 (260)
T ss_pred HHhhCCC----CCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCeEEECCCccceEccCCccc----
Confidence 9976432 358999999999999999999999 89999999999999999999999999999765322110
Q ss_pred ccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCccccCccchhHHHHHHH
Q 042348 533 WEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQIGSMELNIVQWIQL 611 (686)
Q Consensus 533 ~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~ 611 (686)
......++..|+|||+..+..++.++|||||||++|||+| |+.||...... .. ...
T Consensus 159 ------------------~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~~---~~~ 215 (260)
T cd05069 159 ------------------ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNR--EV---LEQ 215 (260)
T ss_pred ------------------ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH--HH---HHH
Confidence 0011234567999999988889999999999999999999 89998543221 11 122
Q ss_pred HHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 042348 612 ILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDR 667 (686)
Q Consensus 612 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~ 667 (686)
.... .... . .......+.+++.+||+.||++||++++|++.|++
T Consensus 216 ~~~~-~~~~------~-----~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 216 VERG-YRMP------C-----PQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred HHcC-CCCC------C-----CcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 2111 1110 0 01123468899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=315.21 Aligned_cols=247 Identities=22% Similarity=0.236 Sum_probs=192.7
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCCc---cchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCC
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGGW---QRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNG 448 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~g 448 (686)
..||+|+||.||++... +++.||+|.+..... .....+.+|++++++++|+||+++.+++..++..++||||++++
T Consensus 6 ~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 85 (285)
T cd05632 6 RVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGG 85 (285)
T ss_pred EEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEeccCc
Confidence 46999999999999875 578999999865322 22345788999999999999999999999999999999999999
Q ss_pred CHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCC
Q 042348 449 SLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEET 528 (686)
Q Consensus 449 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 528 (686)
+|.+++..... ..+++..+..++.|++.||+|||+ ++|+||||||+||++++++.+||+|||++.......
T Consensus 86 ~L~~~~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~---~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~-- 156 (285)
T cd05632 86 DLKFHIYNMGN----PGFEEERALFYAAEILCGLEDLHR---ENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE-- 156 (285)
T ss_pred cHHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEECCCCCEEEecCCcceecCCCC--
Confidence 99998875432 358999999999999999999999 899999999999999999999999999986542111
Q ss_pred ccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHH
Q 042348 529 PEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQW 608 (686)
Q Consensus 529 ~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~ 608 (686)
......|+..|+|||++.+..++.++|||||||++|||++|+.||....... .....
T Consensus 157 ----------------------~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~-~~~~~ 213 (285)
T cd05632 157 ----------------------SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKV-KREEV 213 (285)
T ss_pred ----------------------cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHH-HHHHH
Confidence 0112356788999999988889999999999999999999999995432211 11111
Q ss_pred HHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCC-----HHHHHHH
Q 042348 609 IQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPS-----MRHVCDS 664 (686)
Q Consensus 609 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~ev~~~ 664 (686)
.......... ..+ .....+.+++.+||+.||++||+ +.+++++
T Consensus 214 ~~~~~~~~~~----~~~---------~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 214 DRRVLETEEV----YSA---------KFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred HHhhhccccc----cCc---------cCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 1111111111 111 12235678999999999999999 5666665
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=319.00 Aligned_cols=258 Identities=25% Similarity=0.399 Sum_probs=200.1
Q ss_pred hcccCccCceEEEEEEeC--------CCceEEEEEcCCC-CccchHHHHHHHHHHhcc-CCCCcceeeEEEEecCceeEE
Q 042348 372 AFLLGKSTIGIVYKVALN--------NEEAVAVRRLGNG-GWQRFKEFQTEAEAIGKI-RHPNIVSLRAYFWSVDEKLLI 441 (686)
Q Consensus 372 ~~~iG~G~~g~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV 441 (686)
...||+|+||.||+|+.. ++..||+|.+... .....+++.+|+.+++.+ +||||+++++++...+..++|
T Consensus 20 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv 99 (304)
T cd05101 20 GKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVI 99 (304)
T ss_pred cceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecCCceEEE
Confidence 457999999999999742 2357999988653 233456789999999999 899999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCCc----------cccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCe
Q 042348 442 YDYIPNGSLATAIHGKAGI----------ISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEP 511 (686)
Q Consensus 442 ~e~~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~ 511 (686)
|||+++|+|.+++...... .....+++.++..++.|++.||+|||+ ++|+||||||+||++++++.+
T Consensus 100 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~givH~dlkp~Nili~~~~~~ 176 (304)
T cd05101 100 VEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLAS---QKCIHRDLAARNVLVTENNVM 176 (304)
T ss_pred EecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHH---CCeeecccccceEEEcCCCcE
Confidence 9999999999999764321 011358899999999999999999999 899999999999999999999
Q ss_pred EEeecCcccccccccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHh-
Q 042348 512 HISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS- 590 (686)
Q Consensus 512 kl~DfGla~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt- 590 (686)
||+|||+++........ .......++..|+|||++.+..++.++||||||+++|||++
T Consensus 177 kl~D~g~~~~~~~~~~~---------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~ 235 (304)
T cd05101 177 KIADFGLARDVNNIDYY---------------------KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTL 235 (304)
T ss_pred EECCCccceeccccccc---------------------ccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcC
Confidence 99999999865322110 00111234567999999988889999999999999999998
Q ss_pred CCCCccccCccchhHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccc
Q 042348 591 GKLPMIQIGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRVNI 670 (686)
Q Consensus 591 G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~ 670 (686)
|..||.... ..++...+.... ... .+ ......+.+++.+||+.+|++||++.|+++.|+++..
T Consensus 236 g~~p~~~~~-----~~~~~~~~~~~~-~~~---~~--------~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~ 298 (304)
T cd05101 236 GGSPYPGIP-----VEELFKLLKEGH-RMD---KP--------ANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILT 298 (304)
T ss_pred CCCCcccCC-----HHHHHHHHHcCC-cCC---CC--------CCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHH
Confidence 788884322 222233222221 110 00 1233468889999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=309.75 Aligned_cols=245 Identities=23% Similarity=0.380 Sum_probs=197.6
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCC--CccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCC
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNG--GWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGS 449 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gs 449 (686)
+.||+|++|.||+|... +++.|++|.+... .....+.+.+|++++++++||||+++++++...+..++||||+++++
T Consensus 6 ~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 85 (256)
T cd08529 6 NKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAENGD 85 (256)
T ss_pred EEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeCCCCc
Confidence 46999999999999875 5789999988643 33445778999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCc
Q 042348 450 LATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETP 529 (686)
Q Consensus 450 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 529 (686)
|.++++...+ ..+++..+..++.|++.||+|||+ ++++||||||+||++++++.++|+|||+++.......
T Consensus 86 L~~~l~~~~~----~~~~~~~~~~i~~~l~~al~~lH~---~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~-- 156 (256)
T cd08529 86 LHKLLKMQRG----RPLPEDQVWRFFIQILLGLAHLHS---KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN-- 156 (256)
T ss_pred HHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEeCCCCEEEcccccceeccCccc--
Confidence 9999986532 468999999999999999999999 8999999999999999999999999999876542211
Q ss_pred cccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHHH
Q 042348 530 EVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQWI 609 (686)
Q Consensus 530 ~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~ 609 (686)
......++..|+|||+..+..++.++|||||||++|||++|+.||..... ....
T Consensus 157 ---------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~~ 210 (256)
T cd08529 157 ---------------------FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ-----GALI 210 (256)
T ss_pred ---------------------hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH-----HHHH
Confidence 01123456779999999988899999999999999999999999954331 1112
Q ss_pred HHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 610 QLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 610 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
........ ... . ......+.+++.+||+.+|++||++.+++++
T Consensus 211 ~~~~~~~~--~~~-----~-----~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 211 LKIIRGVF--PPV-----S-----QMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred HHHHcCCC--CCC-----c-----cccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 22222211 110 0 0123468899999999999999999999865
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=323.65 Aligned_cols=236 Identities=22% Similarity=0.326 Sum_probs=188.1
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCC---CccchHHHHHHHHHHhccC-CCCcceeeEEEEecCceeEEEeccCC
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNG---GWQRFKEFQTEAEAIGKIR-HPNIVSLRAYFWSVDEKLLIYDYIPN 447 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lV~e~~~~ 447 (686)
..||+|+||.||+|... +++.||+|.+... .....+.+..|..++..+. |++|+++++++...+..++||||+++
T Consensus 6 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~Ey~~~ 85 (323)
T cd05615 6 MVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVMEYVNG 85 (323)
T ss_pred EEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEcCCCC
Confidence 47999999999999865 5889999998653 2233456788999998885 57888999999999999999999999
Q ss_pred CCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccC
Q 042348 448 GSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEE 527 (686)
Q Consensus 448 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 527 (686)
|+|.+++... ..+++.++..++.|++.||+|||+ ++|+||||||+|||+++++.+||+|||+++......
T Consensus 86 g~L~~~i~~~------~~l~~~~~~~i~~qi~~al~~lH~---~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~- 155 (323)
T cd05615 86 GDLMYHIQQV------GKFKEPQAVFYAAEISVGLFFLHR---RGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG- 155 (323)
T ss_pred CcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeccccccccCCCC-
Confidence 9999998754 358999999999999999999999 899999999999999999999999999987432111
Q ss_pred CccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHH
Q 042348 528 TPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQ 607 (686)
Q Consensus 528 ~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~ 607 (686)
.......||..|+|||++.+..++.++|||||||++|||++|+.||..... ..
T Consensus 156 ----------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~-----~~ 208 (323)
T cd05615 156 ----------------------VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE-----DE 208 (323)
T ss_pred ----------------------ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCH-----HH
Confidence 011234578889999999988899999999999999999999999954322 12
Q ss_pred HHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCH
Q 042348 608 WIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSM 658 (686)
Q Consensus 608 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~ 658 (686)
..+.+.......+.. ....+.+++.+||+.+|++|++.
T Consensus 209 ~~~~i~~~~~~~p~~-------------~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 209 LFQSIMEHNVSYPKS-------------LSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred HHHHHHhCCCCCCcc-------------CCHHHHHHHHHHcccCHhhCCCC
Confidence 233333322221111 12356789999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=332.31 Aligned_cols=268 Identities=20% Similarity=0.284 Sum_probs=199.6
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCC---ccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCC
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGG---WQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNG 448 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~g 448 (686)
..||+|+||.||+|... +++.||||++.... ......+..|++++..++||||+++++++.+.+..++||||+++|
T Consensus 7 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 86 (350)
T cd05573 7 KVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEYMPGG 86 (350)
T ss_pred EEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEcCCCCC
Confidence 46999999999999976 68899999986532 233467889999999999999999999999999999999999999
Q ss_pred CHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCC
Q 042348 449 SLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEET 528 (686)
Q Consensus 449 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 528 (686)
+|.+++... ..+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++........
T Consensus 87 ~L~~~l~~~------~~l~~~~~~~i~~qi~~aL~~LH~---~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~ 157 (350)
T cd05573 87 DLMNLLIRK------DVFPEETARFYIAELVLALDSVHK---LGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDR 157 (350)
T ss_pred CHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCcc
Confidence 999999865 358999999999999999999999 89999999999999999999999999999866433210
Q ss_pred ccccccccc------cCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccc
Q 042348 529 PEVHWEQST------TGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSME 602 (686)
Q Consensus 529 ~~~~~~~~~------~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~ 602 (686)
......... ...................||..|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~-- 235 (350)
T cd05573 158 EYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTL-- 235 (350)
T ss_pred cccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCH--
Confidence 000000000 000000000001122345688999999999999999999999999999999999999955332
Q ss_pred hhHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCC-HHHHHHH
Q 042348 603 LNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPS-MRHVCDS 664 (686)
Q Consensus 603 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-~~ev~~~ 664 (686)
......+........ -|. . ......+.+++.+|++ ||++||+ +.|++++
T Consensus 236 ---~~~~~~i~~~~~~~~---~p~---~---~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 236 ---QETYNKIINWKESLR---FPP---D---PPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred ---HHHHHHHhccCCccc---CCC---C---CCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 112222222111100 000 0 0023457788999997 9999999 9999987
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=318.05 Aligned_cols=256 Identities=25% Similarity=0.383 Sum_probs=197.2
Q ss_pred cccCccCceEEEEEEeC------CCceEEEEEcCCCC-ccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEecc
Q 042348 373 FLLGKSTIGIVYKVALN------NEEAVAVRRLGNGG-WQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYI 445 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~ 445 (686)
..||+|+||.||+|... ....+++|.+.... .....++.+|+.++++++||||+++++.+...+..++||||+
T Consensus 6 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 85 (290)
T cd05045 6 KTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYA 85 (290)
T ss_pred ccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEEEEec
Confidence 46999999999999753 23568888886543 233567899999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcCCCc------------------cccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecC
Q 042348 446 PNGSLATAIHGKAGI------------------ISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGK 507 (686)
Q Consensus 446 ~~gsL~~~l~~~~~~------------------~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~ 507 (686)
++|+|.+++...... .....+++..+..++.|++.||+|||+ ++|+||||||+||++++
T Consensus 86 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~ivH~dikp~nill~~ 162 (290)
T cd05045 86 KYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAE---MKLVHRDLAARNVLVAE 162 (290)
T ss_pred CCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHH---CCeehhhhhhheEEEcC
Confidence 999999998753211 112458899999999999999999999 89999999999999999
Q ss_pred CCCeEEeecCcccccccccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHH
Q 042348 508 NMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLE 587 (686)
Q Consensus 508 ~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~e 587 (686)
++.+||+|||+++........ .......++..|+|||++.+..++.++||||||+++||
T Consensus 163 ~~~~kl~dfg~~~~~~~~~~~---------------------~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~e 221 (290)
T cd05045 163 GRKMKISDFGLSRDVYEEDSY---------------------VKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWE 221 (290)
T ss_pred CCcEEeccccccccccCccch---------------------hcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHH
Confidence 999999999998754322110 00011223456999999988889999999999999999
Q ss_pred HHh-CCCCccccCccchhHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 042348 588 MIS-GKLPMIQIGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLD 666 (686)
Q Consensus 588 llt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~ 666 (686)
|+| |+.||..... ..+ ... ........ . .......+.+++.+||+.+|++||++.|+++.|+
T Consensus 222 l~t~g~~p~~~~~~--~~~---~~~-~~~~~~~~------~-----~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~ 284 (290)
T cd05045 222 IVTLGGNPYPGIAP--ERL---FNL-LKTGYRME------R-----PENCSEEMYNLMLTCWKQEPDKRPTFADISKELE 284 (290)
T ss_pred HHhcCCCCCCCCCH--HHH---HHH-HhCCCCCC------C-----CCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHH
Confidence 999 9999854321 111 111 11111100 0 0112346788999999999999999999999999
Q ss_pred ccc
Q 042348 667 RVN 669 (686)
Q Consensus 667 ~i~ 669 (686)
++-
T Consensus 285 ~~~ 287 (290)
T cd05045 285 KMM 287 (290)
T ss_pred HHH
Confidence 864
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-37 Score=309.56 Aligned_cols=252 Identities=28% Similarity=0.440 Sum_probs=200.1
Q ss_pred ccCccCceEEEEEEeCC----CceEEEEEcCCCCccc-hHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCC
Q 042348 374 LLGKSTIGIVYKVALNN----EEAVAVRRLGNGGWQR-FKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNG 448 (686)
Q Consensus 374 ~iG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~g 448 (686)
.||+|+||.||+|.... +..|++|.+....... .+.+.+|++.+.+++|+||+++++++......++||||++++
T Consensus 2 ~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 81 (262)
T cd00192 2 KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGG 81 (262)
T ss_pred ccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccCC
Confidence 58999999999998764 7789999997654332 678999999999999999999999999999999999999999
Q ss_pred CHHHHhhcCCCc---cccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccc
Q 042348 449 SLATAIHGKAGI---ISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIA 525 (686)
Q Consensus 449 sL~~~l~~~~~~---~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~ 525 (686)
+|.+++...... .....+++..+..++.|++.||+|||+ ++++||||||+||++++++.+||+|||.+......
T Consensus 82 ~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 158 (262)
T cd00192 82 DLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDD 158 (262)
T ss_pred cHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHc---CCcccCccCcceEEECCCCcEEEcccccccccccc
Confidence 999999875210 001468999999999999999999999 89999999999999999999999999999865432
Q ss_pred cCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCccccCccchh
Q 042348 526 EETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQIGSMELN 604 (686)
Q Consensus 526 ~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~~~ 604 (686)
... .......++..|+|||.+....++.++||||+|+++|||++ |..||.....
T Consensus 159 ~~~---------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---- 213 (262)
T cd00192 159 DYY---------------------RKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN---- 213 (262)
T ss_pred ccc---------------------ccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH----
Confidence 210 01122345677999999988889999999999999999999 6999955421
Q ss_pred HHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 042348 605 IVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLD 666 (686)
Q Consensus 605 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~ 666 (686)
........... .. ..+ .....++.+++.+||+.+|++|||+.|++++|+
T Consensus 214 -~~~~~~~~~~~-~~---~~~--------~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 214 -EEVLEYLRKGY-RL---PKP--------EYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred -HHHHHHHHcCC-CC---CCC--------ccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 11222222211 10 000 112346889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=313.27 Aligned_cols=254 Identities=26% Similarity=0.416 Sum_probs=198.5
Q ss_pred cccCccCceEEEEEEeC------CCceEEEEEcCCCCccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccC
Q 042348 373 FLLGKSTIGIVYKVALN------NEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIP 446 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~ 446 (686)
..||+|+||.||++... ++..+++|.+..........+.+|++++++++|+||+++++++...+..++||||++
T Consensus 11 ~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 90 (280)
T cd05092 11 WELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMR 90 (280)
T ss_pred cccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEEEEecCC
Confidence 46999999999999642 356799999877665666789999999999999999999999999999999999999
Q ss_pred CCCHHHHhhcCCCc---------cccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecC
Q 042348 447 NGSLATAIHGKAGI---------ISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFG 517 (686)
Q Consensus 447 ~gsL~~~l~~~~~~---------~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfG 517 (686)
+|+|.+++...... .....+++..++.++.|++.||+|||+ ++++||||||+||++++++.+||+|||
T Consensus 91 ~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~~i~H~dlkp~nil~~~~~~~kL~dfg 167 (280)
T cd05092 91 HGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLAS---LHFVHRDLATRNCLVGQGLVVKIGDFG 167 (280)
T ss_pred CCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHH---CCeecccccHhhEEEcCCCCEEECCCC
Confidence 99999999754311 011358999999999999999999999 899999999999999999999999999
Q ss_pred cccccccccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCcc
Q 042348 518 LARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMI 596 (686)
Q Consensus 518 la~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~ 596 (686)
+++........ .......++..|+|||++.+..++.++|||||||++|||++ |+.||.
T Consensus 168 ~~~~~~~~~~~---------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~ 226 (280)
T cd05092 168 MSRDIYSTDYY---------------------RVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWY 226 (280)
T ss_pred ceeEcCCCcee---------------------ecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCc
Confidence 98754321100 00112233567999999988889999999999999999998 999985
Q ss_pred ccCccchhHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 042348 597 QIGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDR 667 (686)
Q Consensus 597 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~ 667 (686)
..... +.+......... . .+ ......+.+++.+||+.||++||++.||.+.|++
T Consensus 227 ~~~~~-----~~~~~~~~~~~~--~--~~--------~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 227 QLSNT-----EAIECITQGREL--E--RP--------RTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred cCCHH-----HHHHHHHcCccC--C--CC--------CCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 43321 112222222111 0 00 0122357799999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=315.56 Aligned_cols=257 Identities=23% Similarity=0.374 Sum_probs=196.7
Q ss_pred hcccCccCceEEEEEEe-----CCCceEEEEEcCCCC-ccchHHHHHHHHHHhccCCCCcceeeEEEEec--CceeEEEe
Q 042348 372 AFLLGKSTIGIVYKVAL-----NNEEAVAVRRLGNGG-WQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSV--DEKLLIYD 443 (686)
Q Consensus 372 ~~~iG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~~lV~e 443 (686)
...||+|+||.||++.. .++..||+|.++... ......+.+|++++++++||||+++++++... ...++|||
T Consensus 9 ~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e 88 (284)
T cd05079 9 IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIME 88 (284)
T ss_pred ceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceEEEEE
Confidence 34699999999999974 347789999987542 33346799999999999999999999998875 56789999
Q ss_pred ccCCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccc
Q 042348 444 YIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLAD 523 (686)
Q Consensus 444 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~ 523 (686)
|+++++|.+++.... ..+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++.+.
T Consensus 89 ~~~g~~L~~~l~~~~-----~~~~~~~~~~i~~~i~~aL~~lH~---~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05079 89 FLPSGSLKEYLPRNK-----NKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIE 160 (284)
T ss_pred ccCCCCHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccchheEEEcCCCCEEECCCccccccc
Confidence 999999999997543 358999999999999999999999 999999999999999999999999999998654
Q ss_pred cccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCc---
Q 042348 524 IAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGS--- 600 (686)
Q Consensus 524 ~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~--- 600 (686)
...... .......++..|+|||++.+..++.++|||||||++|||+|++.|+.....
T Consensus 161 ~~~~~~--------------------~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~ 220 (284)
T cd05079 161 TDKEYY--------------------TVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFL 220 (284)
T ss_pred cCccce--------------------eecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhh
Confidence 221100 011123455679999999888899999999999999999998776522111
Q ss_pred -------cchhHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 042348 601 -------MELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRV 668 (686)
Q Consensus 601 -------~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i 668 (686)
.+......+... ....... ........+.+++.+||+.+|++||++.++++.|+++
T Consensus 221 ~~~~~~~~~~~~~~~~~~~-~~~~~~~-----------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 221 KMIGPTHGQMTVTRLVRVL-EEGKRLP-----------RPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred hhcccccccccHHHHHHHH-HcCccCC-----------CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 011111111111 1111100 0011334688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=315.40 Aligned_cols=253 Identities=27% Similarity=0.392 Sum_probs=196.5
Q ss_pred cccCccCceEEEEEEeC-CCc----eEEEEEcCCCC-ccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccC
Q 042348 373 FLLGKSTIGIVYKVALN-NEE----AVAVRRLGNGG-WQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIP 446 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~ 446 (686)
+.||+|+||.||+|.+. ++. .||+|.+.... ....+++.+|+.+++.++||||+++++++.. ...+++|||++
T Consensus 13 ~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l~~~~~~ 91 (279)
T cd05109 13 KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQLVTQLMP 91 (279)
T ss_pred eecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEEEEEcCC
Confidence 46999999999999853 343 48999986543 2334678899999999999999999999975 45789999999
Q ss_pred CCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCccccccccc
Q 042348 447 NGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAE 526 (686)
Q Consensus 447 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~ 526 (686)
+|+|.++++... ..+++..++.++.|++.||+|||+ ++|+||||||+||++++++.+||+|||+++......
T Consensus 92 ~g~l~~~l~~~~-----~~~~~~~~~~~~~qi~~~L~~lH~---~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~ 163 (279)
T cd05109 92 YGCLLDYVRENK-----DRIGSQDLLNWCVQIAKGMSYLEE---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDE 163 (279)
T ss_pred CCCHHHHHhhcc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccceEEEcCCCcEEECCCCceeeccccc
Confidence 999999997653 358999999999999999999999 899999999999999999999999999998664221
Q ss_pred CCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCccccCccchhH
Q 042348 527 ETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQIGSMELNI 605 (686)
Q Consensus 527 ~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~~~~ 605 (686)
.. .......++..|+|||...+..++.++|||||||++|||++ |..||..... ..+
T Consensus 164 ~~---------------------~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--~~~ 220 (279)
T cd05109 164 TE---------------------YHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA--REI 220 (279)
T ss_pred ce---------------------eecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH--HHH
Confidence 10 00111223456999999988889999999999999999998 8999854322 112
Q ss_pred HHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccccc
Q 042348 606 VQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRVNIST 672 (686)
Q Consensus 606 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~~~ 672 (686)
..+ ......... .......+.+++.+||+.||++||++.++++.|+++....
T Consensus 221 ~~~----~~~~~~~~~-----------~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05109 221 PDL----LEKGERLPQ-----------PPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP 272 (279)
T ss_pred HHH----HHCCCcCCC-----------CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence 222 111111110 0112346788999999999999999999999998876544
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=316.27 Aligned_cols=256 Identities=26% Similarity=0.399 Sum_probs=198.4
Q ss_pred hcccCccCceEEEEEEeCC------CceEEEEEcCCC-CccchHHHHHHHHHHhcc-CCCCcceeeEEEEecCceeEEEe
Q 042348 372 AFLLGKSTIGIVYKVALNN------EEAVAVRRLGNG-GWQRFKEFQTEAEAIGKI-RHPNIVSLRAYFWSVDEKLLIYD 443 (686)
Q Consensus 372 ~~~iG~G~~g~Vy~~~~~~------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~e 443 (686)
...||+|+||.||++.... ...+|+|.+... ......++.+|+.++.++ +|+||+++++++...+..++|||
T Consensus 17 ~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~li~e 96 (293)
T cd05053 17 GKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVE 96 (293)
T ss_pred eeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCeEEEEE
Confidence 3469999999999998642 357999998753 223345688999999999 89999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCC----------ccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEE
Q 042348 444 YIPNGSLATAIHGKAG----------IISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHI 513 (686)
Q Consensus 444 ~~~~gsL~~~l~~~~~----------~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl 513 (686)
|+++|+|.++++.... ......+++..+++++.|++.||+|||+ ++|+||||||+||++++++.+||
T Consensus 97 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~dlkp~Nil~~~~~~~kL 173 (293)
T cd05053 97 YAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLAS---KKCIHRDLAARNVLVTEDHVMKI 173 (293)
T ss_pred eCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCccccccceeeEEEcCCCeEEe
Confidence 9999999999975321 0112468999999999999999999999 89999999999999999999999
Q ss_pred eecCcccccccccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHh-CC
Q 042348 514 SDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GK 592 (686)
Q Consensus 514 ~DfGla~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~ 592 (686)
+|||+++.+...... .......++..|+|||++.+..++.++|||||||++|||++ |.
T Consensus 174 ~Dfg~~~~~~~~~~~---------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~ 232 (293)
T cd05053 174 ADFGLARDIHHIDYY---------------------RKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGG 232 (293)
T ss_pred Cccccccccccccce---------------------eccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCC
Confidence 999999865422110 00111223456999999988889999999999999999998 99
Q ss_pred CCccccCccchhHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 042348 593 LPMIQIGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRV 668 (686)
Q Consensus 593 ~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i 668 (686)
.||...... +........ ... .. .......+.+++.+||+.||++|||+.|+++.|+++
T Consensus 233 ~p~~~~~~~-----~~~~~~~~~-~~~-~~----------~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~ 291 (293)
T cd05053 233 SPYPGIPVE-----ELFKLLKEG-YRM-EK----------PQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM 291 (293)
T ss_pred CCCCCCCHH-----HHHHHHHcC-CcC-CC----------CCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHh
Confidence 998543221 112222111 110 00 011234688999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-37 Score=316.17 Aligned_cols=260 Identities=21% Similarity=0.298 Sum_probs=194.7
Q ss_pred cccCccCceEEEEEEeCC---------------CceEEEEEcCCC-CccchHHHHHHHHHHhccCCCCcceeeEEEEecC
Q 042348 373 FLLGKSTIGIVYKVALNN---------------EEAVAVRRLGNG-GWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVD 436 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~~---------------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~ 436 (686)
+.||+|+||.||++...+ ...||+|.+... .......|.+|++++++++||||+++++++...+
T Consensus 11 ~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~ 90 (295)
T cd05097 11 EKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDD 90 (295)
T ss_pred hccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEcCCC
Confidence 469999999999987542 235899998754 2233457999999999999999999999999999
Q ss_pred ceeEEEeccCCCCHHHHhhcCCCc------cccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCC
Q 042348 437 EKLLIYDYIPNGSLATAIHGKAGI------ISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNME 510 (686)
Q Consensus 437 ~~~lV~e~~~~gsL~~~l~~~~~~------~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~ 510 (686)
..++||||+++++|.+++...... .....+++..++.++.|++.||+|||+ ++++||||||+||++++++.
T Consensus 91 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~Nill~~~~~ 167 (295)
T cd05097 91 PLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLAS---LNFVHRDLATRNCLVGNHYT 167 (295)
T ss_pred ccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHh---cCeeccccChhhEEEcCCCc
Confidence 999999999999999999653210 011247899999999999999999999 89999999999999999999
Q ss_pred eEEeecCcccccccccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHh
Q 042348 511 PHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS 590 (686)
Q Consensus 511 ~kl~DfGla~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt 590 (686)
+||+|||+++........ .......++..|+|||+.....++.++|||||||++|||++
T Consensus 168 ~kl~dfg~~~~~~~~~~~---------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~ 226 (295)
T cd05097 168 IKIADFGMSRNLYSGDYY---------------------RIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226 (295)
T ss_pred EEecccccccccccCcce---------------------eccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHH
Confidence 999999998754321100 01112234567999999988889999999999999999998
Q ss_pred --CCCCccccCccchhHHHHHHHHHhhc-CCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 042348 591 --GKLPMIQIGSMELNIVQWIQLILEDR-KPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDR 667 (686)
Q Consensus 591 --G~~P~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~ 667 (686)
|..||..... ......+....... ........ ......+.+++.+||+.||++||++.+|++.|++
T Consensus 227 ~~~~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 227 LCKEQPYSLLSD--EQVIENTGEFFRNQGRQIYLSQT---------PLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred cCCCCCCcccCh--HHHHHHHHHhhhhccccccCCCC---------CCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 6667744322 11222111111111 10000000 0123468899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=309.97 Aligned_cols=243 Identities=25% Similarity=0.415 Sum_probs=193.4
Q ss_pred cccCccCceEEEEEEeCCCceEEEEEcCCCCccchHHHHHHHHHHhccCCCCcceeeEEEE-ecCceeEEEeccCCCCHH
Q 042348 373 FLLGKSTIGIVYKVALNNEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFW-SVDEKLLIYDYIPNGSLA 451 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~-~~~~~~lV~e~~~~gsL~ 451 (686)
..||+|+||.||++... +..||+|.+.... ..+.+.+|+.++++++|+||+++++++. ..+..++||||+++++|.
T Consensus 12 ~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~L~ 88 (256)
T cd05082 12 QTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLV 88 (256)
T ss_pred eeecccCCCeEEEEEEc-CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCCCCcHH
Confidence 46999999999999876 6779999986543 3467899999999999999999999765 446789999999999999
Q ss_pred HHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCccc
Q 042348 452 TAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEV 531 (686)
Q Consensus 452 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 531 (686)
+++..... ..+++..++.++.|++.||+|||+ ++++||||||+||++++++.+||+|||+++......
T Consensus 89 ~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~----- 156 (256)
T cd05082 89 DYLRSRGR----SVLGGDCLLKFSLDVCEAMEYLEA---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ----- 156 (256)
T ss_pred HHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHh---CCEeccccchheEEEcCCCcEEecCCccceeccccC-----
Confidence 99976542 358899999999999999999999 899999999999999999999999999987432111
Q ss_pred cccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCccccCccchhHHHHHH
Q 042348 532 HWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQIGSMELNIVQWIQ 610 (686)
Q Consensus 532 ~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~~~~~~~~~ 610 (686)
.....+..|+|||++.+..++.++|||||||++|||++ |+.||.... ..+...
T Consensus 157 ---------------------~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~-----~~~~~~ 210 (256)
T cd05082 157 ---------------------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP-----LKDVVP 210 (256)
T ss_pred ---------------------CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCC-----HHHHHH
Confidence 01122346999999988889999999999999999998 999985322 222222
Q ss_pred HHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 042348 611 LILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRV 668 (686)
Q Consensus 611 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i 668 (686)
.+..+..+ ... ......+.+++.+|++.+|++|||+.++++.|+++
T Consensus 211 ~~~~~~~~--~~~----------~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 211 RVEKGYKM--DAP----------DGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred HHhcCCCC--CCC----------CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 22221110 100 11234678999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=321.58 Aligned_cols=199 Identities=26% Similarity=0.400 Sum_probs=159.2
Q ss_pred cccCccCceEEEEEEeC---CCceEEEEEcCCCCccchHHHHHHHHHHhccCCCCcceeeEEEEec--CceeEEEeccCC
Q 042348 373 FLLGKSTIGIVYKVALN---NEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSV--DEKLLIYDYIPN 447 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~~lV~e~~~~ 447 (686)
..||+|+||.||+|... +++.||+|.+..... ...+.+|++++++++||||+++++++... ...++||||+.
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~- 83 (317)
T cd07868 7 CKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE- 83 (317)
T ss_pred cccccCCCeEEEEEEEccCCCCceEEEEEECCCCC--cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC-
Confidence 46999999999999864 457899999865432 24578899999999999999999998653 45789999995
Q ss_pred CCHHHHhhcCCCc---cccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeee----cCCCCeEEeecCccc
Q 042348 448 GSLATAIHGKAGI---ISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILL----GKNMEPHISDFGLAR 520 (686)
Q Consensus 448 gsL~~~l~~~~~~---~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl----~~~~~~kl~DfGla~ 520 (686)
++|.+++...... .....+++..+..++.|++.||+|||+ ++|+||||||+|||+ +.++.+||+|||+++
T Consensus 84 ~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07868 84 HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEecCCCCcCcEEEeecCcee
Confidence 5888887643211 111358899999999999999999999 899999999999999 456789999999998
Q ss_pred ccccccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccC-CCCCCcchHHHHHHHHHHHHhCCCCccc
Q 042348 521 LADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKV-RKPTQKWDIYSYGVILLEMISGKLPMIQ 597 (686)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvvl~elltG~~P~~~ 597 (686)
........ ........+|..|+|||++.+ ..++.++||||+||++|||++|+.||..
T Consensus 161 ~~~~~~~~--------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~ 218 (317)
T cd07868 161 LFNSPLKP--------------------LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred ccCCCCcc--------------------ccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccC
Confidence 65322110 011224567888999999876 4589999999999999999999999954
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=312.18 Aligned_cols=254 Identities=25% Similarity=0.338 Sum_probs=195.3
Q ss_pred cccCccCceEEEEEEeCC------CceEEEEEcCCCC-ccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEecc
Q 042348 373 FLLGKSTIGIVYKVALNN------EEAVAVRRLGNGG-WQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYI 445 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~ 445 (686)
+.||+|++|.||+|...+ +..||+|.+.... ......|.+|+.++++++|+||+++++++.+.+..++||||+
T Consensus 12 ~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 91 (277)
T cd05036 12 RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFILLELM 91 (277)
T ss_pred eECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcEEEEecC
Confidence 469999999999998753 5678999886543 233456899999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcCCCc-cccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCC---CeEEeecCcccc
Q 042348 446 PNGSLATAIHGKAGI-ISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNM---EPHISDFGLARL 521 (686)
Q Consensus 446 ~~gsL~~~l~~~~~~-~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~---~~kl~DfGla~~ 521 (686)
++++|.++++..... .....+++..+.+++.||+.||+|||+ ++++||||||+||+++.++ .+||+|||+++.
T Consensus 92 ~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~nil~~~~~~~~~~kl~dfg~~~~ 168 (277)
T cd05036 92 AGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEE---NHFIHRDIAARNCLLTCKGPGRVAKIADFGMARD 168 (277)
T ss_pred CCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchheEEEeccCCCcceEeccCccccc
Confidence 999999999765321 111358999999999999999999999 8999999999999998654 599999999986
Q ss_pred cccccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCccccCc
Q 042348 522 ADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQIGS 600 (686)
Q Consensus 522 ~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~ 600 (686)
....... ........+..|+|||++.+..++.++|||||||++|||++ |+.||.....
T Consensus 169 ~~~~~~~---------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~ 227 (277)
T cd05036 169 IYRASYY---------------------RKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTN 227 (277)
T ss_pred cCCccce---------------------ecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 5321100 00011122356999999988889999999999999999997 9999954322
Q ss_pred cchhHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 042348 601 MELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDR 667 (686)
Q Consensus 601 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~ 667 (686)
. .....+...... . .. ......+.+++.+|++.+|++||++.+|+++|++
T Consensus 228 ~-----~~~~~~~~~~~~-~--~~---------~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~~ 277 (277)
T cd05036 228 Q-----EVMEFVTGGGRL-D--PP---------KGCPGPVYRIMTDCWQHTPEDRPNFATILERIQY 277 (277)
T ss_pred H-----HHHHHHHcCCcC-C--CC---------CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhhC
Confidence 1 112222221111 0 00 1123467899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=333.97 Aligned_cols=256 Identities=17% Similarity=0.189 Sum_probs=189.7
Q ss_pred cccCccCceEEEEEEeCC-CceEEEEEcCCCCccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCCHH
Q 042348 373 FLLGKSTIGIVYKVALNN-EEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLA 451 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL~ 451 (686)
..||+|+||.||++.... ++.||||.... ..+.+|++++++++|+|||++++++...+..++|||++. ++|.
T Consensus 175 ~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~-~~L~ 247 (461)
T PHA03211 175 RALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYR-SDLY 247 (461)
T ss_pred EEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEccC-CCHH
Confidence 469999999999998764 67899996432 346789999999999999999999999999999999994 7999
Q ss_pred HHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCccc
Q 042348 452 TAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEV 531 (686)
Q Consensus 452 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 531 (686)
+++.... ..++|.+++.|+.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++........
T Consensus 248 ~~l~~~~-----~~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~--- 316 (461)
T PHA03211 248 TYLGARL-----RPLGLAQVTAVARQLLSAIDYIHG---EGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWST--- 316 (461)
T ss_pred HHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHH---CCEEECcCCHHHEEECCCCCEEEcccCCceeccccccc---
Confidence 9887543 368999999999999999999999 89999999999999999999999999999865321110
Q ss_pred cccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCcc------chhH
Q 042348 532 HWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSM------ELNI 605 (686)
Q Consensus 532 ~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~------~~~~ 605 (686)
.......||..|+|||++.+..++.++|||||||++|||++|..|+...... ...+
T Consensus 317 ------------------~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l 378 (461)
T PHA03211 317 ------------------PFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQI 378 (461)
T ss_pred ------------------ccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHH
Confidence 0112346788999999999999999999999999999999988766332211 1112
Q ss_pred HHHHHHHHhhcCCcccccCcccc---------------cCCCcH---HHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 606 VQWIQLILEDRKPMTDILDPFLA---------------HDLDKE---DEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 606 ~~~~~~~~~~~~~~~~~~d~~l~---------------~~~~~~---~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
...++................+. ...... .....+.+++.+||+.||.+|||+.|++++
T Consensus 379 ~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 379 LRIIRQAQVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred HHHHHhhccccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 22221110000000000000000 000000 011257789999999999999999999876
|
|
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=307.78 Aligned_cols=244 Identities=28% Similarity=0.498 Sum_probs=197.8
Q ss_pred cccCccCceEEEEEEeCCCceEEEEEcCCCCccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCCHHH
Q 042348 373 FLLGKSTIGIVYKVALNNEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLAT 452 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL~~ 452 (686)
..||+|+||.||+|... ++.||+|.+..... ..+++.+|+.++++++|+||+++++++...+..++||||+++++|.+
T Consensus 12 ~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~ 89 (256)
T cd05039 12 ATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVD 89 (256)
T ss_pred eeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCCCcHHH
Confidence 46999999999999876 78899999976543 45789999999999999999999999999899999999999999999
Q ss_pred HhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCcccc
Q 042348 453 AIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVH 532 (686)
Q Consensus 453 ~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 532 (686)
++..... ..+++..+..++.|++.||+|||+ ++++||||||+||+++.++.+||+|||.++.......
T Consensus 90 ~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~----- 157 (256)
T cd05039 90 YLRSRGR----AVITLAQQLGFALDVCEGMEYLEE---KNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD----- 157 (256)
T ss_pred HHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHh---CCccchhcccceEEEeCCCCEEEcccccccccccccc-----
Confidence 9976542 358999999999999999999999 8999999999999999999999999999975521110
Q ss_pred ccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCccccCccchhHHHHHHH
Q 042348 533 WEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQIGSMELNIVQWIQL 611 (686)
Q Consensus 533 ~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~ 611 (686)
....+..|+|||++....++.++||||||+++||+++ |+.||...... ++ ...
T Consensus 158 ---------------------~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~---~~~ 211 (256)
T cd05039 158 ---------------------SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--DV---VPH 211 (256)
T ss_pred ---------------------cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHH--HH---HHH
Confidence 1122446999999988889999999999999999998 99998543221 11 111
Q ss_pred HHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 042348 612 ILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRV 668 (686)
Q Consensus 612 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i 668 (686)
. ...... .. + ......+.+++.+||..+|++||++.|+++.|+++
T Consensus 212 ~-~~~~~~-~~--~--------~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 212 V-EKGYRM-EA--P--------EGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred H-hcCCCC-CC--c--------cCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 1 111110 00 0 11234678999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=313.71 Aligned_cols=254 Identities=27% Similarity=0.486 Sum_probs=198.1
Q ss_pred hcccCccCceEEEEEEeCC-C---ceEEEEEcCCC-CccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccC
Q 042348 372 AFLLGKSTIGIVYKVALNN-E---EAVAVRRLGNG-GWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIP 446 (686)
Q Consensus 372 ~~~iG~G~~g~Vy~~~~~~-~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~ 446 (686)
.+.||+|+||.||+|.... + ..||||.+... ......+|..|+.++++++||||+++++++...+..++||||++
T Consensus 9 ~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~ 88 (269)
T cd05065 9 EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITEFME 88 (269)
T ss_pred EeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEEecCC
Confidence 3569999999999998653 2 36999998764 33345689999999999999999999999999999999999999
Q ss_pred CCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCccccccccc
Q 042348 447 NGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAE 526 (686)
Q Consensus 447 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~ 526 (686)
+|+|.+++.... ..+++.+++.++.|++.||+|||+ ++++||||||+||+++.++.+||+|||+++......
T Consensus 89 ~~~L~~~l~~~~-----~~~~~~~~~~i~~~l~~al~~lH~---~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~ 160 (269)
T cd05065 89 NGALDSFLRQND-----GQFTVIQLVGMLRGIAAGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 160 (269)
T ss_pred CCcHHHHHhhCC-----CCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccChheEEEcCCCcEEECCCccccccccCc
Confidence 999999997653 358999999999999999999999 899999999999999999999999999987654322
Q ss_pred CCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCccccCccchhH
Q 042348 527 ETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQIGSMELNI 605 (686)
Q Consensus 527 ~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~~~~ 605 (686)
..... ........+..|+|||++.+..++.++|||||||++||+++ |..||..... .+.
T Consensus 161 ~~~~~------------------~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~--~~~ 220 (269)
T cd05065 161 SDPTY------------------TSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN--QDV 220 (269)
T ss_pred ccccc------------------ccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCH--HHH
Confidence 11000 00011112456999999998899999999999999999887 9999954322 122
Q ss_pred HHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 042348 606 VQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRV 668 (686)
Q Consensus 606 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i 668 (686)
..+ +... ...+. ..+.+..+.+++.+||+.+|++||++.+|+..|+++
T Consensus 221 ~~~---i~~~-~~~~~-----------~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 221 INA---IEQD-YRLPP-----------PMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred HHH---HHcC-CcCCC-----------cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 222 2111 11110 012234577899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=311.92 Aligned_cols=255 Identities=21% Similarity=0.291 Sum_probs=189.8
Q ss_pred ccCccCceEEEEEEeCC---CceEEEEEcCCCC-ccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCC
Q 042348 374 LLGKSTIGIVYKVALNN---EEAVAVRRLGNGG-WQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGS 449 (686)
Q Consensus 374 ~iG~G~~g~Vy~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gs 449 (686)
.||+|+||.||+|...+ +..+|+|.++... ......+.+|+.++++++||||+++++++.+....++||||+++|+
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGD 81 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCc
Confidence 48999999999998653 3578999886543 2334578899999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCc
Q 042348 450 LATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETP 529 (686)
Q Consensus 450 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 529 (686)
|.++++..... .....++..+..++.|++.||+|||+ ++++||||||+||+++.++.+||+|||+++........
T Consensus 82 L~~~l~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~- 156 (269)
T cd05087 82 LKGYLRSCRKA-ELMTPDPTTLQRMACEIALGLLHLHK---NNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYY- 156 (269)
T ss_pred HHHHHHHhhhc-ccccccHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEECCccccccccCccee-
Confidence 99999754321 11346778888999999999999999 89999999999999999999999999998643211100
Q ss_pred cccccccccCCCCCCCccccccccCCCCCccccCcccccCC-------CCCCcchHHHHHHHHHHHHh-CCCCccccCcc
Q 042348 530 EVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVR-------KPTQKWDIYSYGVILLEMIS-GKLPMIQIGSM 601 (686)
Q Consensus 530 ~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~ 601 (686)
.......++..|+|||++... .++.++|||||||++|||++ |+.||......
T Consensus 157 --------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~ 216 (269)
T cd05087 157 --------------------VTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDE 216 (269)
T ss_pred --------------------ecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChH
Confidence 011123456779999987542 35789999999999999996 99999543322
Q ss_pred chhHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 042348 602 ELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLD 666 (686)
Q Consensus 602 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~ 666 (686)
+. .. ...... .....++.+... ....+.+++.+|+ .+|++|||+.||+..|+
T Consensus 217 ~~--~~---~~~~~~--~~~~~~~~~~~~-----~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 217 QV--LT---YTVREQ--QLKLPKPRLKLP-----LSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred HH--HH---HHhhcc--cCCCCCCccCCC-----CChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 11 11 111111 111122222111 1234677888998 68999999999998875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=310.43 Aligned_cols=252 Identities=25% Similarity=0.403 Sum_probs=194.4
Q ss_pred ccCccCceEEEEEEeCC-Cc--eEEEEEcCCCC-ccchHHHHHHHHHHhcc-CCCCcceeeEEEEecCceeEEEeccCCC
Q 042348 374 LLGKSTIGIVYKVALNN-EE--AVAVRRLGNGG-WQRFKEFQTEAEAIGKI-RHPNIVSLRAYFWSVDEKLLIYDYIPNG 448 (686)
Q Consensus 374 ~iG~G~~g~Vy~~~~~~-~~--~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~e~~~~g 448 (686)
+||+|+||.||+|...+ +. .+++|.++... ....+.+.+|++++.++ +||||+++++++...+..++||||+++|
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 81 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHG 81 (270)
T ss_pred cCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCCC
Confidence 58999999999998754 33 57888887532 33446788999999999 8999999999999999999999999999
Q ss_pred CHHHHhhcCCCc----------cccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCc
Q 042348 449 SLATAIHGKAGI----------ISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGL 518 (686)
Q Consensus 449 sL~~~l~~~~~~----------~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGl 518 (686)
+|.+++...... .....+++.++..++.|++.||+|||+ ++++||||||+||++++++.+||+|||+
T Consensus 82 ~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nili~~~~~~kl~dfgl 158 (270)
T cd05047 82 NLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGL 158 (270)
T ss_pred cHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccccceEEEcCCCeEEECCCCC
Confidence 999999764311 011358899999999999999999999 8999999999999999999999999999
Q ss_pred ccccccccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCccc
Q 042348 519 ARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQ 597 (686)
Q Consensus 519 a~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~ 597 (686)
++...... .......+..|+|||++....++.++|||||||++|||++ |..||..
T Consensus 159 ~~~~~~~~------------------------~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~ 214 (270)
T cd05047 159 SRGQEVYV------------------------KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG 214 (270)
T ss_pred ccccchhh------------------------hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccc
Confidence 85321100 0001122456999999988889999999999999999997 9999954
Q ss_pred cCccchhHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 042348 598 IGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRVN 669 (686)
Q Consensus 598 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~ 669 (686)
... .......... .... . . ......+.+++.+||+.+|.+|||+.|+++.|+++-
T Consensus 215 ~~~-----~~~~~~~~~~-~~~~-~-----~-----~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 215 MTC-----AELYEKLPQG-YRLE-K-----P-----LNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred cCH-----HHHHHHHhCC-CCCC-C-----C-----CcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 321 1112222111 1100 0 0 012235789999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=324.07 Aligned_cols=244 Identities=23% Similarity=0.369 Sum_probs=201.1
Q ss_pred cCccCceEEEEEEeCCC-ceEEEEEcCCCCccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCCHHHH
Q 042348 375 LGKSTIGIVYKVALNNE-EAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLATA 453 (686)
Q Consensus 375 iG~G~~g~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL~~~ 453 (686)
||.|+||.||||..++. ...|-|.+...+....++|.-||+||+.++||+||++++.|...+..+++.|||.||..+.+
T Consensus 40 LGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~GGAVDai 119 (1187)
T KOG0579|consen 40 LGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGGGAVDAI 119 (1187)
T ss_pred hcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCCchHhHH
Confidence 79999999999987653 44567888887777889999999999999999999999999999999999999999999999
Q ss_pred hhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCccccc
Q 042348 454 IHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHW 533 (686)
Q Consensus 454 l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 533 (686)
+-+-+ +.|++.++.-+++|+++||.|||+ ++|||||||+.|||+.-+|.++|+|||.+......
T Consensus 120 mlEL~-----r~LtE~QIqvvc~q~ldALn~LHs---~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t-------- 183 (1187)
T KOG0579|consen 120 MLELG-----RVLTEDQIQVVCYQVLDALNWLHS---QNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKST-------- 183 (1187)
T ss_pred HHHhc-----cccchHHHHHHHHHHHHHHHHHhh---cchhhhhccccceEEEecCcEeeecccccccchhH--------
Confidence 98765 679999999999999999999999 89999999999999999999999999987543211
Q ss_pred cccccCCCCCCCccccccccCCCCCccccCcccc-----cCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHH
Q 042348 534 EQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEAS-----KVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQW 608 (686)
Q Consensus 534 ~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~ 608 (686)
.....+..||++|||||+. ...+|+.++||||||++|.||..+.+|-.....+ ..
T Consensus 184 ---------------~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpM-----RV 243 (1187)
T KOG0579|consen 184 ---------------RQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPM-----RV 243 (1187)
T ss_pred ---------------HhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchH-----HH
Confidence 1223456788899999975 3568999999999999999999999997543332 22
Q ss_pred HHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 609 IQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 609 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
+-.+....+| .++. +......+.+++.+||.+||..||++.++++|
T Consensus 244 llKiaKSePP--TLlq--------PS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 244 LLKIAKSEPP--TLLQ--------PSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred HHHHhhcCCC--cccC--------cchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence 3333333222 1122 22344578899999999999999999999876
|
|
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=313.43 Aligned_cols=254 Identities=22% Similarity=0.379 Sum_probs=197.5
Q ss_pred cccCccCceEEEEEEeCC------CceEEEEEcCCCC-ccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEecc
Q 042348 373 FLLGKSTIGIVYKVALNN------EEAVAVRRLGNGG-WQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYI 445 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~ 445 (686)
..||+|+||.||+|...+ +..||+|.+.... ......+.+|+.+++.++||||+++++++......++||||+
T Consensus 12 ~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 91 (277)
T cd05032 12 RELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTLVVMELM 91 (277)
T ss_pred eEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcEEEEecC
Confidence 469999999999998642 3689999986543 233457889999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcCCCcc----ccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccc
Q 042348 446 PNGSLATAIHGKAGII----SYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARL 521 (686)
Q Consensus 446 ~~gsL~~~l~~~~~~~----~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~ 521 (686)
++|+|.+++....... ....+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++.
T Consensus 92 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~di~p~nill~~~~~~kl~dfg~~~~ 168 (277)
T cd05032 92 AKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTRD 168 (277)
T ss_pred CCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccChheEEEcCCCCEEECCcccchh
Confidence 9999999997543211 11347899999999999999999999 8999999999999999999999999999875
Q ss_pred cccccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCccccCc
Q 042348 522 ADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQIGS 600 (686)
Q Consensus 522 ~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~ 600 (686)
....... .......++..|+|||.+.+..++.++|||||||++||++| |+.||.....
T Consensus 169 ~~~~~~~---------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 227 (277)
T cd05032 169 IYETDYY---------------------RKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN 227 (277)
T ss_pred hccCccc---------------------ccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCH
Confidence 4322110 00112234667999999988889999999999999999998 9999854322
Q ss_pred cchhHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 042348 601 MELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDR 667 (686)
Q Consensus 601 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~ 667 (686)
... ....... .. .... . .....+.+++.+||+.+|++|||+.|+++.|++
T Consensus 228 --~~~---~~~~~~~-~~-~~~~-----~-----~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 228 --EEV---LKFVIDG-GH-LDLP-----E-----NCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred --HHH---HHHHhcC-CC-CCCC-----C-----CCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 111 2222211 11 1110 0 123468899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-37 Score=315.56 Aligned_cols=257 Identities=23% Similarity=0.370 Sum_probs=197.2
Q ss_pred cccCccCceEEEEEEeCC-C--ceEEEEEcCCC-CccchHHHHHHHHHHhcc-CCCCcceeeEEEEecCceeEEEeccCC
Q 042348 373 FLLGKSTIGIVYKVALNN-E--EAVAVRRLGNG-GWQRFKEFQTEAEAIGKI-RHPNIVSLRAYFWSVDEKLLIYDYIPN 447 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~~-~--~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~e~~~~ 447 (686)
.+||+|+||.||+|...+ + ..+++|.++.. .....+.+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus 8 ~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 87 (297)
T cd05089 8 DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEYAPY 87 (297)
T ss_pred eeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEEEecCC
Confidence 469999999999998754 3 34788888743 233446789999999999 799999999999999999999999999
Q ss_pred CCHHHHhhcCCCcc----------ccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecC
Q 042348 448 GSLATAIHGKAGII----------SYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFG 517 (686)
Q Consensus 448 gsL~~~l~~~~~~~----------~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfG 517 (686)
|+|.++++...... ....+++..+..++.|++.||+|||+ ++|+||||||+||++++++.+||+|||
T Consensus 88 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kl~dfg 164 (297)
T cd05089 88 GNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSE---KQFIHRDLAARNVLVGENLASKIADFG 164 (297)
T ss_pred CcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCcCCcceEEECCCCeEEECCcC
Confidence 99999997643110 11358899999999999999999999 899999999999999999999999999
Q ss_pred cccccccccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCcc
Q 042348 518 LARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMI 596 (686)
Q Consensus 518 la~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~ 596 (686)
++....... .......+..|+|||+..+..++.++|||||||++|||++ |..||.
T Consensus 165 ~~~~~~~~~------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~ 220 (297)
T cd05089 165 LSRGEEVYV------------------------KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYC 220 (297)
T ss_pred CCcccccee------------------------ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCC
Confidence 986321100 0001112346999999988889999999999999999998 999995
Q ss_pred ccCccchhHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccccch
Q 042348 597 QIGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRVNISTE 673 (686)
Q Consensus 597 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~~~~ 673 (686)
..... +........... ... ......+.+++.+||+.+|.+||++.++++.|+.+....+
T Consensus 221 ~~~~~-----~~~~~~~~~~~~-------~~~-----~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~ 280 (297)
T cd05089 221 GMTCA-----ELYEKLPQGYRM-------EKP-----RNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARK 280 (297)
T ss_pred CCCHH-----HHHHHHhcCCCC-------CCC-----CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence 43221 122222211100 000 1122457899999999999999999999999988775443
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=307.96 Aligned_cols=247 Identities=28% Similarity=0.457 Sum_probs=196.8
Q ss_pred cccCccCceEEEEEEeCCCceEEEEEcCCCCccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCCHHH
Q 042348 373 FLLGKSTIGIVYKVALNNEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLAT 452 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL~~ 452 (686)
..||+|+||.||+|...+++.||+|.+..... ...++.+|+.++++++|+||+++++++. .+..++||||+++++|.+
T Consensus 12 ~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~ 89 (260)
T cd05067 12 KKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYMENGSLVD 89 (260)
T ss_pred eeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcCCCCCHHH
Confidence 46999999999999988889999999875443 3467999999999999999999999874 567899999999999999
Q ss_pred HhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCcccc
Q 042348 453 AIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVH 532 (686)
Q Consensus 453 ~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 532 (686)
++....+ ..+++.++..++.|++.||+|||+ .+++||||||+||++++++.++|+|||++.........
T Consensus 90 ~~~~~~~----~~~~~~~~~~i~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~---- 158 (260)
T cd05067 90 FLKTPEG----IKLTINKLIDMAAQIAEGMAFIER---KNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYT---- 158 (260)
T ss_pred HHHhcCC----CCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHHhEEEcCCCCEEEccCcceeecCCCCcc----
Confidence 9876443 458999999999999999999999 89999999999999999999999999998765421110
Q ss_pred ccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCccccCccchhHHHHHHH
Q 042348 533 WEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQIGSMELNIVQWIQL 611 (686)
Q Consensus 533 ~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~ 611 (686)
......++..|+|||++....++.++||||||+++||+++ |+.||...... +....
T Consensus 159 ------------------~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-----~~~~~ 215 (260)
T cd05067 159 ------------------AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNP-----EVIQN 215 (260)
T ss_pred ------------------cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChH-----HHHHH
Confidence 0112234567999999988889999999999999999999 99999543221 11222
Q ss_pred HHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 042348 612 ILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDR 667 (686)
Q Consensus 612 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~ 667 (686)
.... ... .. . .....++.+++.+||+.+|++||+++++.+.|+.
T Consensus 216 ~~~~-~~~-~~-----~-----~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 216 LERG-YRM-PR-----P-----DNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred HHcC-CCC-CC-----C-----CCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 2111 111 00 0 1122468899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=312.03 Aligned_cols=247 Identities=22% Similarity=0.364 Sum_probs=195.4
Q ss_pred cccCccCceEEEEEEeCC-CceEEEEEcCCCCccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCCHH
Q 042348 373 FLLGKSTIGIVYKVALNN-EEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLA 451 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL~ 451 (686)
..||+|+||.||+|.... +..+++|.+........+.+.+|+++++.++||||+++++++...+..++||||+++++|.
T Consensus 11 ~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~~~l~ 90 (282)
T cd06643 11 GELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVD 90 (282)
T ss_pred hhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCCCcHH
Confidence 469999999999998764 6788999987665556678899999999999999999999999999999999999999999
Q ss_pred HHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCccc
Q 042348 452 TAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEV 531 (686)
Q Consensus 452 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 531 (686)
.++.... ..+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++.......
T Consensus 91 ~~~~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~---~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~----- 157 (282)
T cd06643 91 AVMLELE-----RPLTEPQIRVVCKQTLEALNYLHE---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI----- 157 (282)
T ss_pred HHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCcccEEEccCCCEEEccccccccccccc-----
Confidence 9887543 468999999999999999999999 899999999999999999999999999987542111
Q ss_pred cccccccCCCCCCCccccccccCCCCCccccCccccc-----CCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHH
Q 042348 532 HWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASK-----VRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIV 606 (686)
Q Consensus 532 ~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~ 606 (686)
.......++..|+|||++. +..++.++|||||||++|||++|+.||......
T Consensus 158 ------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~----- 214 (282)
T cd06643 158 ------------------QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPM----- 214 (282)
T ss_pred ------------------cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHH-----
Confidence 0112234677899999873 345788999999999999999999998543221
Q ss_pred HHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 042348 607 QWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSL 665 (686)
Q Consensus 607 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L 665 (686)
..+........+ ....+ .....++.+++.+||+.||++||++.+++++-
T Consensus 215 ~~~~~~~~~~~~--~~~~~--------~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 263 (282)
T cd06643 215 RVLLKIAKSEPP--TLAQP--------SRWSSEFKDFLKKCLEKNVDARWTTTQLLQHP 263 (282)
T ss_pred HHHHHHhhcCCC--CCCCc--------cccCHHHHHHHHHHccCChhhCcCHHHHhcCC
Confidence 112222221111 11111 11224678999999999999999999998663
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-37 Score=316.62 Aligned_cols=253 Identities=26% Similarity=0.338 Sum_probs=197.5
Q ss_pred hcccCccCceEEEEEEeC------CCceEEEEEcCCCC-ccchHHHHHHHHHHhcc-CCCCcceeeEEEEecCceeEEEe
Q 042348 372 AFLLGKSTIGIVYKVALN------NEEAVAVRRLGNGG-WQRFKEFQTEAEAIGKI-RHPNIVSLRAYFWSVDEKLLIYD 443 (686)
Q Consensus 372 ~~~iG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~e 443 (686)
.+.||+|+||.||++... .+..||||.++... ....+.+.+|+++++++ +||||+++++++...+..++|||
T Consensus 40 ~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e 119 (302)
T cd05055 40 GKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITE 119 (302)
T ss_pred cceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCceEEEEE
Confidence 457999999999999742 24579999987543 23345789999999999 79999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccc
Q 042348 444 YIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLAD 523 (686)
Q Consensus 444 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~ 523 (686)
|+++|+|.++++.... ..+++.++..++.|++.||+|||+ ++|+||||||+||+++.++.++++|||+++...
T Consensus 120 ~~~~~~L~~~i~~~~~----~~l~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~~ 192 (302)
T cd05055 120 YCCYGDLLNFLRRKRE----SFLTLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNVLLTHGKIVKICDFGLARDIM 192 (302)
T ss_pred cCCCCcHHHHHHhCCC----CCCCHHHHHHHHHHHHHHHHHHHH---CCeehhhhccceEEEcCCCeEEECCCccccccc
Confidence 9999999999976432 248999999999999999999999 899999999999999999999999999997543
Q ss_pred cccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCccccCccc
Q 042348 524 IAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQIGSME 602 (686)
Q Consensus 524 ~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~ 602 (686)
..... .......++..|+|||.+.+..++.++|||||||++|||++ |+.||......+
T Consensus 193 ~~~~~---------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~ 251 (302)
T cd05055 193 NDSNY---------------------VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS 251 (302)
T ss_pred CCCce---------------------eecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH
Confidence 21100 00112234567999999988889999999999999999998 999985433211
Q ss_pred hhHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 042348 603 LNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRV 668 (686)
Q Consensus 603 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i 668 (686)
. ............ .+ .....++.+++.+||+.+|++||++.|+++.|+++
T Consensus 252 -~----~~~~~~~~~~~~---~~--------~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 252 -K----FYKLIKEGYRMA---QP--------EHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred -H----HHHHHHcCCcCC---CC--------CCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 1 111111111110 00 01123678999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=316.15 Aligned_cols=261 Identities=23% Similarity=0.340 Sum_probs=197.2
Q ss_pred cccCccCceEEEEEEeCC-----------------CceEEEEEcCCCC-ccchHHHHHHHHHHhccCCCCcceeeEEEEe
Q 042348 373 FLLGKSTIGIVYKVALNN-----------------EEAVAVRRLGNGG-WQRFKEFQTEAEAIGKIRHPNIVSLRAYFWS 434 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~ 434 (686)
..||+|+||.||+|.... +..||+|.+.... ....+.+.+|++++++++||||+++++++..
T Consensus 11 ~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 90 (296)
T cd05051 11 EKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTV 90 (296)
T ss_pred ccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEEEEEEec
Confidence 469999999999987643 2458999987643 2345678999999999999999999999999
Q ss_pred cCceeEEEeccCCCCHHHHhhcCCCc-----cccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCC
Q 042348 435 VDEKLLIYDYIPNGSLATAIHGKAGI-----ISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNM 509 (686)
Q Consensus 435 ~~~~~lV~e~~~~gsL~~~l~~~~~~-----~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~ 509 (686)
.+..++||||+++++|.+++...... .....+++..++.++.|++.||+|||+ ++|+||||||+||+++.++
T Consensus 91 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~---~~i~H~dlkp~Nili~~~~ 167 (296)
T cd05051 91 DPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLES---LNFVHRDLATRNCLVGKNY 167 (296)
T ss_pred CCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHH---cCccccccchhceeecCCC
Confidence 99999999999999999999765311 011368999999999999999999999 8999999999999999999
Q ss_pred CeEEeecCcccccccccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHH
Q 042348 510 EPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMI 589 (686)
Q Consensus 510 ~~kl~DfGla~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ell 589 (686)
.++|+|||+++........ .......++..|+|||++.+..++.++|||||||++|||+
T Consensus 168 ~~~l~dfg~~~~~~~~~~~---------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~ 226 (296)
T cd05051 168 TIKIADFGMSRNLYSSDYY---------------------RVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEIL 226 (296)
T ss_pred ceEEccccceeecccCcce---------------------eecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHH
Confidence 9999999998754322110 0111233456799999998888999999999999999999
Q ss_pred h--CCCCccccCccchhHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 042348 590 S--GKLPMIQIGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDR 667 (686)
Q Consensus 590 t--G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~ 667 (686)
+ |..||..... ......+............... ......++.+++.+||+.||++|||+.||++.|++
T Consensus 227 ~~~~~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 227 TLCREQPYEHLTD--QQVIENAGHFFRDDGRQIYLPR--------PPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred hcCCCCCCCCcCh--HHHHHHHHhccccccccccCCC--------ccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 8 6778743321 1122222111111100000000 01123468899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=309.08 Aligned_cols=251 Identities=28% Similarity=0.498 Sum_probs=197.2
Q ss_pred cccCccCceEEEEEEeC----CCceEEEEEcCCCC-ccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCC
Q 042348 373 FLLGKSTIGIVYKVALN----NEEAVAVRRLGNGG-WQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPN 447 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~ 447 (686)
+.||+|+||.||+|... .+..+|+|.++... ....+.+.+|+.++++++||||+++++++...+..++||||+++
T Consensus 10 ~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 89 (267)
T cd05066 10 KVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMEN 89 (267)
T ss_pred eeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEcCCC
Confidence 47999999999999864 23479999986543 23346789999999999999999999999999999999999999
Q ss_pred CCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccC
Q 042348 448 GSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEE 527 (686)
Q Consensus 448 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 527 (686)
++|.+++.... ..+++.++..++.|++.||+|||+ ++++||||||+||+++.++.++|+|||+++.......
T Consensus 90 ~~L~~~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd05066 90 GSLDAFLRKHD-----GQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE 161 (267)
T ss_pred CCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHH---CCEeehhhchhcEEECCCCeEEeCCCCcccccccccc
Confidence 99999997654 358999999999999999999999 8999999999999999999999999999986542211
Q ss_pred CccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCccccCccchhHH
Q 042348 528 TPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQIGSMELNIV 606 (686)
Q Consensus 528 ~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~~~~~ 606 (686)
.. .......++..|+|||++.+..++.++|||||||++||+++ |+.||...... +.
T Consensus 162 ~~--------------------~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~--~~- 218 (267)
T cd05066 162 AA--------------------YTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ--DV- 218 (267)
T ss_pred ee--------------------eecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH--HH-
Confidence 00 00011222456999999998889999999999999999887 99999543221 11
Q ss_pred HHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 042348 607 QWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRV 668 (686)
Q Consensus 607 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i 668 (686)
...+... ...+. .......+.+++.+|++.+|++||++.++++.|+++
T Consensus 219 --~~~~~~~-~~~~~-----------~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 219 --IKAIEEG-YRLPA-----------PMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred --HHHHhCC-CcCCC-----------CCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 2222211 11110 011234577999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=316.56 Aligned_cols=259 Identities=25% Similarity=0.388 Sum_probs=198.9
Q ss_pred hcccCccCceEEEEEEeC--------CCceEEEEEcCCCC-ccchHHHHHHHHHHhcc-CCCCcceeeEEEEecCceeEE
Q 042348 372 AFLLGKSTIGIVYKVALN--------NEEAVAVRRLGNGG-WQRFKEFQTEAEAIGKI-RHPNIVSLRAYFWSVDEKLLI 441 (686)
Q Consensus 372 ~~~iG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV 441 (686)
.+.||+|+||.||++... +...+|+|.+.... .....++..|+++++++ +||||+++++++...+..++|
T Consensus 23 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv 102 (307)
T cd05098 23 GKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVI 102 (307)
T ss_pred eeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 346999999999999753 23469999987542 33446788999999999 799999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCCc----------cccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCe
Q 042348 442 YDYIPNGSLATAIHGKAGI----------ISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEP 511 (686)
Q Consensus 442 ~e~~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~ 511 (686)
|||+++|+|.+++...... .....+++.++++++.|++.||+|||+ ++++||||||+||+++.++.+
T Consensus 103 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp~Nill~~~~~~ 179 (307)
T cd05098 103 VEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVM 179 (307)
T ss_pred EecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHHheEEcCCCcE
Confidence 9999999999999764321 011358999999999999999999999 899999999999999999999
Q ss_pred EEeecCcccccccccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHh-
Q 042348 512 HISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS- 590 (686)
Q Consensus 512 kl~DfGla~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt- 590 (686)
||+|||+++........ .......++..|+|||++.+..++.++|||||||++|||++
T Consensus 180 kL~dfg~a~~~~~~~~~---------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~ 238 (307)
T cd05098 180 KIADFGLARDIHHIDYY---------------------KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTL 238 (307)
T ss_pred EECCCcccccccccchh---------------------hccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcC
Confidence 99999998754321100 00011123456999999988889999999999999999998
Q ss_pred CCCCccccCccchhHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccc
Q 042348 591 GKLPMIQIGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRVNI 670 (686)
Q Consensus 591 G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~ 670 (686)
|+.||.... ..+..... ...... +. ......++.+++.+||+.+|++||++.+|++.|+++..
T Consensus 239 g~~p~~~~~-----~~~~~~~~-~~~~~~-~~----------~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~ 301 (307)
T cd05098 239 GGSPYPGVP-----VEELFKLL-KEGHRM-DK----------PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILA 301 (307)
T ss_pred CCCCCCcCC-----HHHHHHHH-HcCCCC-CC----------CCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHH
Confidence 888884322 11222222 111111 10 01123467789999999999999999999999999765
Q ss_pred c
Q 042348 671 S 671 (686)
Q Consensus 671 ~ 671 (686)
.
T Consensus 302 ~ 302 (307)
T cd05098 302 L 302 (307)
T ss_pred H
Confidence 4
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=327.81 Aligned_cols=246 Identities=19% Similarity=0.268 Sum_probs=190.3
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCC---CccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCC
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNG---GWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNG 448 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~g 448 (686)
..||+|+||.||++... +++.||+|.+... .......+.+|+.+++.++||||+++++++.+.+..++||||+++|
T Consensus 49 ~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg 128 (370)
T cd05621 49 KVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGG 128 (370)
T ss_pred EEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEcCCCCC
Confidence 46999999999999876 4788999998642 1223356789999999999999999999999999999999999999
Q ss_pred CHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCC
Q 042348 449 SLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEET 528 (686)
Q Consensus 449 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 528 (686)
+|.+++... .+++..+..++.||+.||+|||+ ++|+||||||+|||+++++.+||+|||+|+.......
T Consensus 129 ~L~~~l~~~-------~~~~~~~~~~~~qil~aL~~LH~---~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~- 197 (370)
T cd05621 129 DLVNLMSNY-------DVPEKWAKFYTAEVVLALDAIHS---MGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGM- 197 (370)
T ss_pred cHHHHHHhc-------CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEEecccceecccCCc-
Confidence 999999643 47888999999999999999999 8999999999999999999999999999976532110
Q ss_pred ccccccccccCCCCCCCccccccccCCCCCccccCcccccCC----CCCCcchHHHHHHHHHHHHhCCCCccccCccchh
Q 042348 529 PEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVR----KPTQKWDIYSYGVILLEMISGKLPMIQIGSMELN 604 (686)
Q Consensus 529 ~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~ 604 (686)
.......||..|+|||++.+. .++.++||||+||++|||++|+.||.....
T Consensus 198 ---------------------~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~---- 252 (370)
T cd05621 198 ---------------------VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSL---- 252 (370)
T ss_pred ---------------------eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCH----
Confidence 011234678889999998654 378999999999999999999999954322
Q ss_pred HHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCC--CCCHHHHHHH
Q 042348 605 IVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDK--RPSMRHVCDS 664 (686)
Q Consensus 605 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~--RPs~~ev~~~ 664 (686)
......+........ . ... ......+.+++.+|++.++.+ ||++.|++++
T Consensus 253 -~~~~~~i~~~~~~~~-~-----p~~---~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 253 -VGTYSKIMDHKNSLN-F-----PED---VEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred -HHHHHHHHhCCcccC-C-----CCc---ccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 222333332221110 0 000 011234667888888765543 8999999987
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=310.61 Aligned_cols=246 Identities=24% Similarity=0.357 Sum_probs=192.3
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCCccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCCHH
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLA 451 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL~ 451 (686)
..||+|+||.||+|... ++..|++|.+........+.+.+|+.++++++|+||+++++++...+..++||||+++++|.
T Consensus 14 ~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 93 (268)
T cd06624 14 VVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLS 93 (268)
T ss_pred EEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCCHH
Confidence 36999999999999865 57789999987766566678999999999999999999999999999999999999999999
Q ss_pred HHhhcCCCccccCCC--CHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecC-CCCeEEeecCcccccccccCC
Q 042348 452 TAIHGKAGIISYRPL--SWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGK-NMEPHISDFGLARLADIAEET 528 (686)
Q Consensus 452 ~~l~~~~~~~~~~~l--~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~-~~~~kl~DfGla~~~~~~~~~ 528 (686)
+++.... ..+ ++..+..++.|++.||+|||+ ++|+||||||+||+++. ++.++|+|||++........
T Consensus 94 ~~l~~~~-----~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~- 164 (268)
T cd06624 94 ALLRSKW-----GPLKDNEQTIIFYTKQILEGLKYLHD---NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP- 164 (268)
T ss_pred HHHHHhc-----ccCCCcHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCeEEEecchhheecccCCC-
Confidence 9998643 234 788899999999999999999 89999999999999986 67999999999875432110
Q ss_pred ccccccccccCCCCCCCccccccccCCCCCccccCcccccCCC--CCCcchHHHHHHHHHHHHhCCCCccccCccchhHH
Q 042348 529 PEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRK--PTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIV 606 (686)
Q Consensus 529 ~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~ 606 (686)
......++..|+|||++.... ++.++||||||+++|+|++|+.||........ .
T Consensus 165 ----------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~--~ 220 (268)
T cd06624 165 ----------------------CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA--A 220 (268)
T ss_pred ----------------------ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhh--h
Confidence 011224567799999986543 78999999999999999999999954322111 1
Q ss_pred HHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 607 QWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 607 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
.+..........++ .....++.+++.+||+.+|++|||+.|++++
T Consensus 221 ~~~~~~~~~~~~~~-------------~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 221 MFKVGMFKIHPEIP-------------ESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred HhhhhhhccCCCCC-------------cccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 11111111111111 1122357789999999999999999999865
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=306.45 Aligned_cols=246 Identities=25% Similarity=0.416 Sum_probs=196.2
Q ss_pred cccCccCceEEEEEEeCCCceEEEEEcCCCCccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCCHHH
Q 042348 373 FLLGKSTIGIVYKVALNNEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLAT 452 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL~~ 452 (686)
..||+|+||.||++...++..+|+|.+..... ...++.+|++++++++||||+++++++......++||||+++++|.+
T Consensus 10 ~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~ 88 (256)
T cd05112 10 QEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSD 88 (256)
T ss_pred eeecCcccceEEEEEEeCCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCCCcHHH
Confidence 46999999999999887788899999875433 34678999999999999999999999999999999999999999999
Q ss_pred HhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCcccc
Q 042348 453 AIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVH 532 (686)
Q Consensus 453 ~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 532 (686)
++.... ..+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||+++.......
T Consensus 89 ~~~~~~-----~~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~----- 155 (256)
T cd05112 89 YLRAQR-----GKFSQETLLGMCLDVCEGMAYLES---SNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY----- 155 (256)
T ss_pred HHHhCc-----cCCCHHHHHHHHHHHHHHHHHHHH---CCccccccccceEEEcCCCeEEECCCcceeecccCcc-----
Confidence 997654 357899999999999999999999 8999999999999999999999999999875432110
Q ss_pred ccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCccccCccchhHHHHHHH
Q 042348 533 WEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQIGSMELNIVQWIQL 611 (686)
Q Consensus 533 ~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~ 611 (686)
.......++..|+|||.+.+..++.++||||||+++|||++ |+.||..... ......
T Consensus 156 -----------------~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-----~~~~~~ 213 (256)
T cd05112 156 -----------------TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN-----SEVVET 213 (256)
T ss_pred -----------------cccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCH-----HHHHHH
Confidence 00111223457999999988889999999999999999998 9999854321 122222
Q ss_pred HHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 042348 612 ILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLD 666 (686)
Q Consensus 612 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~ 666 (686)
....... ..+.. ....+.+++.+||+.+|++||++.|+++.|.
T Consensus 214 ~~~~~~~----~~~~~--------~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 214 INAGFRL----YKPRL--------ASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred HhCCCCC----CCCCC--------CCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 2211111 11111 1246889999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=316.00 Aligned_cols=257 Identities=25% Similarity=0.385 Sum_probs=196.7
Q ss_pred cccCccCceEEEEEEeC-CCc--eEEEEEcCCC-CccchHHHHHHHHHHhcc-CCCCcceeeEEEEecCceeEEEeccCC
Q 042348 373 FLLGKSTIGIVYKVALN-NEE--AVAVRRLGNG-GWQRFKEFQTEAEAIGKI-RHPNIVSLRAYFWSVDEKLLIYDYIPN 447 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~e~~~~ 447 (686)
..||+|+||.||+|... ++. .+++|.+... ......++.+|++++.++ +||||+++++++...+..++||||+++
T Consensus 13 ~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 92 (303)
T cd05088 13 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 92 (303)
T ss_pred eeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEEEEeCCC
Confidence 46999999999999865 343 4688877653 233446788999999999 899999999999999999999999999
Q ss_pred CCHHHHhhcCCCcc----------ccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecC
Q 042348 448 GSLATAIHGKAGII----------SYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFG 517 (686)
Q Consensus 448 gsL~~~l~~~~~~~----------~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfG 517 (686)
|+|.++++...... ....+++.+++.++.|++.||+|||+ ++|+||||||+|||+++++.+||+|||
T Consensus 93 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dlkp~Nili~~~~~~kl~dfg 169 (303)
T cd05088 93 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFG 169 (303)
T ss_pred CcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEecCCCcEEeCccc
Confidence 99999997543110 11358899999999999999999999 899999999999999999999999999
Q ss_pred cccccccccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCcc
Q 042348 518 LARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMI 596 (686)
Q Consensus 518 la~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~ 596 (686)
+++...... .......+..|+|||++.+..++.++|||||||++|||+| |..||.
T Consensus 170 ~~~~~~~~~------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~ 225 (303)
T cd05088 170 LSRGQEVYV------------------------KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYC 225 (303)
T ss_pred cCcccchhh------------------------hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcc
Confidence 986321100 0011122456999999988889999999999999999998 999995
Q ss_pred ccCccchhHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccccch
Q 042348 597 QIGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRVNISTE 673 (686)
Q Consensus 597 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~~~~ 673 (686)
..... +...... ...... .. ......+.+++.+||+.+|++||++.++++.|+++.....
T Consensus 226 ~~~~~-----~~~~~~~-~~~~~~------~~-----~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~ 285 (303)
T cd05088 226 GMTCA-----ELYEKLP-QGYRLE------KP-----LNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 285 (303)
T ss_pred cCChH-----HHHHHHh-cCCcCC------CC-----CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhh
Confidence 43221 1122111 110000 00 0122357889999999999999999999999998765444
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=329.37 Aligned_cols=268 Identities=19% Similarity=0.277 Sum_probs=191.7
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCC---ccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCC
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGG---WQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNG 448 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~g 448 (686)
+.||+|+||.||+|+.. +++.||+|.+.... ......+.+|++++++++|||||++++++.+.+..++|||||++|
T Consensus 7 ~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~~~gg 86 (382)
T cd05625 7 KTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGG 86 (382)
T ss_pred EEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeCCCCC
Confidence 46999999999999865 57889999986532 223456889999999999999999999999999999999999999
Q ss_pred CHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCC
Q 042348 449 SLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEET 528 (686)
Q Consensus 449 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 528 (686)
+|.+++... ..+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++.+......
T Consensus 87 ~L~~~l~~~------~~~~e~~~~~~~~qi~~al~~lH~---~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~ 157 (382)
T cd05625 87 DMMSLLIRM------GIFPEDLARFYIAELTCAVESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 157 (382)
T ss_pred cHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEEeECCCCccccccccc
Confidence 999999754 357889999999999999999999 89999999999999999999999999998643211100
Q ss_pred ccc----cccc------cccCCCC-----------C---CCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHH
Q 042348 529 PEV----HWEQ------STTGTPL-----------Q---SSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVI 584 (686)
Q Consensus 529 ~~~----~~~~------~~~g~~~-----------~---~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvv 584 (686)
... .... ...+.+. . ............+||..|+|||++.+..++.++|||||||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvi 237 (382)
T cd05625 158 KYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI 237 (382)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHH
Confidence 000 0000 0000000 0 00000011224578999999999998899999999999999
Q ss_pred HHHHHhCCCCccccCccchhHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCC---HHHH
Q 042348 585 LLEMISGKLPMIQIGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPS---MRHV 661 (686)
Q Consensus 585 l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs---~~ev 661 (686)
+|||++|+.||...... +....+......... |. . .....+..+++.+|+ .+|++|++ +.|+
T Consensus 238 l~elltG~~Pf~~~~~~-----~~~~~i~~~~~~~~~---p~---~---~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei 302 (382)
T cd05625 238 LYEMLVGQPPFLAQTPL-----ETQMKVINWQTSLHI---PP---Q---AKLSPEASDLIIKLC-RGPEDRLGKNGADEI 302 (382)
T ss_pred HHHHHhCCCCCCCCCHH-----HHHHHHHccCCCcCC---CC---c---ccCCHHHHHHHHHHc-cCHhHcCCCCCHHHH
Confidence 99999999999543321 112222221111100 00 0 011224556666665 59999987 8887
Q ss_pred HHH
Q 042348 662 CDS 664 (686)
Q Consensus 662 ~~~ 664 (686)
+++
T Consensus 303 ~~h 305 (382)
T cd05625 303 KAH 305 (382)
T ss_pred hcC
Confidence 765
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-37 Score=324.85 Aligned_cols=269 Identities=19% Similarity=0.227 Sum_probs=191.8
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCC---ccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCC
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGG---WQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNG 448 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~g 448 (686)
..||+|+||.||++... +++.||||.+.... ......+..|+.++.+++||||+++++++.+.+..++||||+++|
T Consensus 7 ~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E~~~gg 86 (363)
T cd05628 7 KVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLPGG 86 (363)
T ss_pred EEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEcCCCCC
Confidence 46999999999999865 57899999986532 223356788999999999999999999999999999999999999
Q ss_pred CHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCC
Q 042348 449 SLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEET 528 (686)
Q Consensus 449 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 528 (686)
+|.+++... ..+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++........
T Consensus 87 ~L~~~l~~~------~~l~~~~~~~~~~qi~~aL~~lH~---~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~ 157 (363)
T cd05628 87 DMMTLLMKK------DTLTEEETQFYIAETVLAIDSIHQ---LGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRT 157 (363)
T ss_pred cHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCCEEEeeccCcccccccccc
Confidence 999999764 358999999999999999999999 89999999999999999999999999999865432111
Q ss_pred ccccccccc------cCCCCC-CCc-----cccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCcc
Q 042348 529 PEVHWEQST------TGTPLQ-SSP-----YEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMI 596 (686)
Q Consensus 529 ~~~~~~~~~------~g~~~~-~~~-----~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~ 596 (686)
......... ...... ... .........+||..|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~ 237 (363)
T cd05628 158 EFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237 (363)
T ss_pred cccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCC
Confidence 000000000 000000 000 00001124578999999999998899999999999999999999999995
Q ss_pred ccCccchhHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccc--cCCCCCCCHHHHHHH
Q 042348 597 QIGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVH--KSPDKRPSMRHVCDS 664 (686)
Q Consensus 597 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~--~dP~~RPs~~ev~~~ 664 (686)
..... .....+........ +.+. .. ...++.+++.+++. .++..||++.||+++
T Consensus 238 ~~~~~-----~~~~~i~~~~~~~~--~p~~----~~---~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 238 SETPQ-----ETYKKVMNWKETLI--FPPE----VP---ISEKAKDLILRFCCEWEHRIGAPGVEEIKTN 293 (363)
T ss_pred CCCHH-----HHHHHHHcCcCccc--CCCc----CC---CCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence 43321 22222322211110 1110 01 11234455555332 344467999999887
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=314.06 Aligned_cols=261 Identities=23% Similarity=0.341 Sum_probs=195.3
Q ss_pred cccCccCceEEEEEEeC-----------------CCceEEEEEcCCCC-ccchHHHHHHHHHHhccCCCCcceeeEEEEe
Q 042348 373 FLLGKSTIGIVYKVALN-----------------NEEAVAVRRLGNGG-WQRFKEFQTEAEAIGKIRHPNIVSLRAYFWS 434 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-----------------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~ 434 (686)
+.||+|+||.||++... +...||+|.+.... .....++.+|++++++++|+||+++++++..
T Consensus 11 ~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~ 90 (296)
T cd05095 11 EKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCIT 90 (296)
T ss_pred eeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec
Confidence 46999999999998532 23468999987542 2334679999999999999999999999999
Q ss_pred cCceeEEEeccCCCCHHHHhhcCCCcc-----ccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCC
Q 042348 435 VDEKLLIYDYIPNGSLATAIHGKAGII-----SYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNM 509 (686)
Q Consensus 435 ~~~~~lV~e~~~~gsL~~~l~~~~~~~-----~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~ 509 (686)
.+..++||||+++|+|.+++....... ....+++.++..++.|++.||+|||+ ++++||||||+||+++.++
T Consensus 91 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dlkp~Nili~~~~ 167 (296)
T cd05095 91 SDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSS---LNFVHRDLATRNCLVGKNY 167 (296)
T ss_pred CCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCeecccCChheEEEcCCC
Confidence 999999999999999999997643211 11357889999999999999999999 8999999999999999999
Q ss_pred CeEEeecCcccccccccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHH
Q 042348 510 EPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMI 589 (686)
Q Consensus 510 ~~kl~DfGla~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ell 589 (686)
.++|+|||+++.+...... .......++..|+|||...++.++.++|||||||++|||+
T Consensus 168 ~~~l~dfg~~~~~~~~~~~---------------------~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~ 226 (296)
T cd05095 168 TIKIADFGMSRNLYSGDYY---------------------RIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEIL 226 (296)
T ss_pred CEEeccCcccccccCCcce---------------------eccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHH
Confidence 9999999998754321100 0001122345699999988888999999999999999999
Q ss_pred h--CCCCccccCccchhHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 042348 590 S--GKLPMIQIGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDR 667 (686)
Q Consensus 590 t--G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~ 667 (686)
+ |..||...... ............... ....+. ...+...+.+++.+||+.||++||++.||++.|++
T Consensus 227 ~~~~~~p~~~~~~~--~~~~~~~~~~~~~~~--~~~~~~------~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 227 TLCKEQPYSQLSDE--QVIENTGEFFRDQGR--QVYLPK------PALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred HhCCCCCccccChH--HHHHHHHHHHhhccc--cccCCC------CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 8 77888543221 111111111111100 000000 01123568899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=317.91 Aligned_cols=264 Identities=24% Similarity=0.397 Sum_probs=201.3
Q ss_pred hcccCccCceEEEEEEeC--------CCceEEEEEcCCCC-ccchHHHHHHHHHHhcc-CCCCcceeeEEEEecCceeEE
Q 042348 372 AFLLGKSTIGIVYKVALN--------NEEAVAVRRLGNGG-WQRFKEFQTEAEAIGKI-RHPNIVSLRAYFWSVDEKLLI 441 (686)
Q Consensus 372 ~~~iG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV 441 (686)
...||+|+||.||+|... ....+|+|.+.... ......+.+|+++++++ +||||+++++++...+..++|
T Consensus 17 ~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 96 (314)
T cd05099 17 GKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEGPLYVI 96 (314)
T ss_pred eeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCCceEEE
Confidence 457999999999999742 24568999987542 23356788999999999 699999999999998999999
Q ss_pred EeccCCCCHHHHhhcCCCc----------cccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCe
Q 042348 442 YDYIPNGSLATAIHGKAGI----------ISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEP 511 (686)
Q Consensus 442 ~e~~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~ 511 (686)
|||+++|+|.+++...... .....+++.++.+++.|++.||+|||+ ++|+||||||+||+++.++.+
T Consensus 97 ~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp~Nill~~~~~~ 173 (314)
T cd05099 97 VEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLES---RRCIHRDLAARNVLVTEDNVM 173 (314)
T ss_pred EecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHH---CCeeeccccceeEEEcCCCcE
Confidence 9999999999999764311 112458999999999999999999999 899999999999999999999
Q ss_pred EEeecCcccccccccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHh-
Q 042348 512 HISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS- 590 (686)
Q Consensus 512 kl~DfGla~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt- 590 (686)
||+|||+++........ .......++..|+|||++.+..++.++|||||||++|||++
T Consensus 174 kL~Dfg~~~~~~~~~~~---------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~ 232 (314)
T cd05099 174 KIADFGLARGVHDIDYY---------------------KKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTL 232 (314)
T ss_pred EEccccccccccccccc---------------------cccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhC
Confidence 99999999755321110 00011123356999999988889999999999999999999
Q ss_pred CCCCccccCccchhHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccc
Q 042348 591 GKLPMIQIGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRVNI 670 (686)
Q Consensus 591 G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~ 670 (686)
|..||..... .......... ... +. ......++.+++.+||+.+|++||++.|+++.|+++..
T Consensus 233 g~~p~~~~~~-----~~~~~~~~~~-~~~-~~----------~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~ 295 (314)
T cd05099 233 GGSPYPGIPV-----EELFKLLREG-HRM-DK----------PSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLA 295 (314)
T ss_pred CCCCCCCCCH-----HHHHHHHHcC-CCC-CC----------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence 8889844321 1112222211 111 10 01123367789999999999999999999999999875
Q ss_pred cchhhh
Q 042348 671 STEQQF 676 (686)
Q Consensus 671 ~~~~~~ 676 (686)
.....+
T Consensus 296 ~~~~~~ 301 (314)
T cd05099 296 AVSEEY 301 (314)
T ss_pred HhcCCc
Confidence 544444
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=321.00 Aligned_cols=259 Identities=27% Similarity=0.378 Sum_probs=195.5
Q ss_pred hcccCccCceEEEEEEe------CCCceEEEEEcCCCC-ccchHHHHHHHHHHhcc-CCCCcceeeEEEEec-CceeEEE
Q 042348 372 AFLLGKSTIGIVYKVAL------NNEEAVAVRRLGNGG-WQRFKEFQTEAEAIGKI-RHPNIVSLRAYFWSV-DEKLLIY 442 (686)
Q Consensus 372 ~~~iG~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~-~~~~lV~ 442 (686)
.+.||+|+||.||+|.. .+++.||||+++... ......+.+|+.++.++ +||||+++++++... ...++||
T Consensus 12 ~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv~ 91 (343)
T cd05103 12 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIV 91 (343)
T ss_pred cccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCceEEEE
Confidence 45799999999999973 346789999997543 23345788999999999 789999999988754 4578999
Q ss_pred eccCCCCHHHHhhcCCCcc-------------------------------------------------------------
Q 042348 443 DYIPNGSLATAIHGKAGII------------------------------------------------------------- 461 (686)
Q Consensus 443 e~~~~gsL~~~l~~~~~~~------------------------------------------------------------- 461 (686)
||+++|+|.++++......
T Consensus 92 ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (343)
T cd05103 92 EFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQEDL 171 (343)
T ss_pred eccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhhhhhhh
Confidence 9999999999997542100
Q ss_pred ccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCccccccccccCCC
Q 042348 462 SYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTP 541 (686)
Q Consensus 462 ~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~g~~ 541 (686)
....+++..+.+++.|++.||+|||+ ++|+||||||+||++++++.+||+|||+++........
T Consensus 172 ~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~------------- 235 (343)
T cd05103 172 YKKVLTLEDLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY------------- 235 (343)
T ss_pred hhccCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCccCeEEEcCCCcEEEEecccccccccCcch-------------
Confidence 01247888999999999999999999 89999999999999999999999999998754321100
Q ss_pred CCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCccccCccchhHHHHHHHHHhhcCCcc
Q 042348 542 LQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQIGSMELNIVQWIQLILEDRKPMT 620 (686)
Q Consensus 542 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 620 (686)
.......++..|+|||.+.+..++.++||||||+++|||++ |..||....... . .... .......
T Consensus 236 --------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-~---~~~~-~~~~~~~- 301 (343)
T cd05103 236 --------VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-E---FCRR-LKEGTRM- 301 (343)
T ss_pred --------hhcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH-H---HHHH-HhccCCC-
Confidence 00111234556999999988889999999999999999997 999985432211 1 1111 1111110
Q ss_pred cccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccc
Q 042348 621 DILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRVNI 670 (686)
Q Consensus 621 ~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~ 670 (686)
.. +. ....++.+++.+||+.+|++|||+.||+++|+.+..
T Consensus 302 ~~--~~--------~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 302 RA--PD--------YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred CC--CC--------CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 00 00 012357899999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=328.93 Aligned_cols=268 Identities=20% Similarity=0.292 Sum_probs=196.3
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCC---ccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCC
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGG---WQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNG 448 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~g 448 (686)
+.||+|+||.||+|+.. +++.||||++.... ......+.+|+.++..++||||+++++++.+.+..++||||+++|
T Consensus 7 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g 86 (364)
T cd05599 7 KVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEYLPGG 86 (364)
T ss_pred EEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEECCCCCc
Confidence 46999999999999875 57899999986532 223456788999999999999999999999999999999999999
Q ss_pred CHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCC
Q 042348 449 SLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEET 528 (686)
Q Consensus 449 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 528 (686)
+|.+++... ..+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++.+......
T Consensus 87 ~L~~~l~~~------~~l~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~ 157 (364)
T cd05599 87 DMMTLLMKK------DTFTEEETRFYIAETILAIDSIHK---LGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRT 157 (364)
T ss_pred HHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEeecccceeccccccc
Confidence 999999764 358999999999999999999999 89999999999999999999999999999865432211
Q ss_pred cccccccc--------ccCCCCCCCc-------cccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCC
Q 042348 529 PEVHWEQS--------TTGTPLQSSP-------YEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKL 593 (686)
Q Consensus 529 ~~~~~~~~--------~~g~~~~~~~-------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~ 593 (686)
........ ....+..... .........+||+.|+|||++....++.++|||||||++|||++|+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~ 237 (364)
T cd05599 158 EFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYP 237 (364)
T ss_pred cccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCC
Confidence 00000000 0000000000 00001123568999999999998899999999999999999999999
Q ss_pred CccccCccchhHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCC---HHHHHHH
Q 042348 594 PMIQIGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPS---MRHVCDS 664 (686)
Q Consensus 594 P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs---~~ev~~~ 664 (686)
||...... +....+........ . + ... .....+.+++.+|+. +|.+|++ +.|++++
T Consensus 238 Pf~~~~~~-----~~~~~i~~~~~~~~-~--~---~~~---~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 238 PFCSDNPQ-----ETYRKIINWKETLQ-F--P---DEV---PLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH 296 (364)
T ss_pred CCCCCCHH-----HHHHHHHcCCCccC-C--C---CCC---CCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence 99543321 12222222211111 0 0 000 112356688888886 9999997 8888775
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=312.95 Aligned_cols=247 Identities=22% Similarity=0.262 Sum_probs=193.3
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCCcc---chHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCC
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGGWQ---RFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNG 448 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~g 448 (686)
..||+|+||.||++... +++.||||.+...... ....+.+|+.++++++|+||+++++.+.+.+..++||||++++
T Consensus 6 ~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g~ 85 (285)
T cd05630 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGG 85 (285)
T ss_pred EEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEecCCC
Confidence 46999999999999875 5789999998653222 2345778999999999999999999999999999999999999
Q ss_pred CHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCC
Q 042348 449 SLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEET 528 (686)
Q Consensus 449 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 528 (686)
+|.+++..... ..+++.++..++.|++.||+|||+ .+|+||||||+||++++++.++|+|||++.......
T Consensus 86 ~L~~~l~~~~~----~~l~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~-- 156 (285)
T cd05630 86 DLKFHIYHMGE----AGFEEGRAVFYAAEICCGLEDLHQ---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ-- 156 (285)
T ss_pred cHHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc--
Confidence 99999865432 358999999999999999999999 899999999999999999999999999986543111
Q ss_pred ccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHH
Q 042348 529 PEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQW 608 (686)
Q Consensus 529 ~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~ 608 (686)
......|+..|+|||++.+..++.++|||||||++|||++|+.||........ ...
T Consensus 157 ----------------------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~--~~~ 212 (285)
T cd05630 157 ----------------------TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK--REE 212 (285)
T ss_pred ----------------------cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccch--HHH
Confidence 01123567889999999988899999999999999999999999964322110 011
Q ss_pred HHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCC-----HHHHHHH
Q 042348 609 IQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPS-----MRHVCDS 664 (686)
Q Consensus 609 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~ev~~~ 664 (686)
........ ... ... .....+.+++.+||+.||++||| +.|++++
T Consensus 213 ~~~~~~~~---~~~----~~~-----~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h 261 (285)
T cd05630 213 VERLVKEV---QEE----YSE-----KFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEH 261 (285)
T ss_pred HHhhhhhh---hhh----cCc-----cCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence 11111110 000 001 12235778999999999999999 8888875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=305.96 Aligned_cols=248 Identities=29% Similarity=0.484 Sum_probs=198.7
Q ss_pred cccCccCceEEEEEEeCCCceEEEEEcCCCCccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCCHHH
Q 042348 373 FLLGKSTIGIVYKVALNNEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLAT 452 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL~~ 452 (686)
..||+|+||.||+|..+++..||||.+..... ..+++.+|+.++++++|+||+++++++......++||||+++++|.+
T Consensus 12 ~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~ 90 (261)
T cd05034 12 RKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM-SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLD 90 (261)
T ss_pred eeeccCcceEEEEEEEcCCceEEEEEecCCcc-CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEeccCCCCHHH
Confidence 46999999999999988888899999875433 34679999999999999999999999998899999999999999999
Q ss_pred HhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCcccc
Q 042348 453 AIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVH 532 (686)
Q Consensus 453 ~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 532 (686)
++....+ ..+++.++..++.|++.||+|||+ ++++||||||+||++++++.+||+|||+++........
T Consensus 91 ~i~~~~~----~~~~~~~~~~~~~~i~~al~~lh~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~---- 159 (261)
T cd05034 91 FLKSGEG----KKLRLPQLVDMAAQIAEGMAYLES---RNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYT---- 159 (261)
T ss_pred HHhcccc----CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcchheEEEcCCCCEEECccccceeccchhhh----
Confidence 9986542 458999999999999999999999 89999999999999999999999999998765421100
Q ss_pred ccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCccccCccchhHHHHHHH
Q 042348 533 WEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQIGSMELNIVQWIQL 611 (686)
Q Consensus 533 ~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~ 611 (686)
......++..|+|||.+.+..++.++|||||||++||+++ |+.||...... .....
T Consensus 160 ------------------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~-----~~~~~ 216 (261)
T cd05034 160 ------------------AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR-----EVLEQ 216 (261)
T ss_pred ------------------hhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-----HHHHH
Confidence 0011123456999999988889999999999999999999 99999543211 11222
Q ss_pred HHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 042348 612 ILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDR 667 (686)
Q Consensus 612 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~ 667 (686)
+.... ... .+ ......+.+++.+|++.+|++||+++++.+.|+.
T Consensus 217 ~~~~~-~~~---~~--------~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 217 VERGY-RMP---RP--------PNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred HHcCC-CCC---CC--------CCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 22111 100 00 0113467899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=320.26 Aligned_cols=260 Identities=25% Similarity=0.381 Sum_probs=200.3
Q ss_pred hcccCccCceEEEEEEeC--------CCceEEEEEcCCCC-ccchHHHHHHHHHHhcc-CCCCcceeeEEEEecCceeEE
Q 042348 372 AFLLGKSTIGIVYKVALN--------NEEAVAVRRLGNGG-WQRFKEFQTEAEAIGKI-RHPNIVSLRAYFWSVDEKLLI 441 (686)
Q Consensus 372 ~~~iG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV 441 (686)
...||+|+||.||+|... .+..||+|.+.... ....+++.+|+++++++ +||||+++++++...+..++|
T Consensus 17 ~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 96 (334)
T cd05100 17 GKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVL 96 (334)
T ss_pred cceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCCceEEE
Confidence 457999999999999742 12368999887542 23456789999999999 899999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCCc----------cccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCe
Q 042348 442 YDYIPNGSLATAIHGKAGI----------ISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEP 511 (686)
Q Consensus 442 ~e~~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~ 511 (686)
|||+++|+|.+++...... .....+++.+++.++.|++.||+|||+ ++|+||||||+||+++.++.+
T Consensus 97 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~givH~dlkp~Nill~~~~~~ 173 (334)
T cd05100 97 VEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLAS---QKCIHRDLAARNVLVTEDNVM 173 (334)
T ss_pred EecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccceEEEcCCCcE
Confidence 9999999999999764311 112458899999999999999999999 899999999999999999999
Q ss_pred EEeecCcccccccccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHh-
Q 042348 512 HISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS- 590 (686)
Q Consensus 512 kl~DfGla~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt- 590 (686)
||+|||+++........ .......++..|+|||++.+..++.++|||||||++|||++
T Consensus 174 kL~Dfg~~~~~~~~~~~---------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~ 232 (334)
T cd05100 174 KIADFGLARDVHNIDYY---------------------KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTL 232 (334)
T ss_pred EECCcccceeccccccc---------------------ccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhc
Confidence 99999999755321100 00111223456999999998889999999999999999998
Q ss_pred CCCCccccCccchhHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccc
Q 042348 591 GKLPMIQIGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRVNI 670 (686)
Q Consensus 591 G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~ 670 (686)
|..||.... ..+....+.... . .+.. .....++.+++.+||+.+|++||++.|+++.|+++..
T Consensus 233 g~~p~~~~~-----~~~~~~~~~~~~-~-~~~~----------~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~ 295 (334)
T cd05100 233 GGSPYPGIP-----VEELFKLLKEGH-R-MDKP----------ANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLT 295 (334)
T ss_pred CCCCCCCCC-----HHHHHHHHHcCC-C-CCCC----------CCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhh
Confidence 888885432 222222222211 1 1100 1123467899999999999999999999999999874
Q ss_pred cc
Q 042348 671 ST 672 (686)
Q Consensus 671 ~~ 672 (686)
..
T Consensus 296 ~~ 297 (334)
T cd05100 296 VT 297 (334)
T ss_pred hc
Confidence 33
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=328.44 Aligned_cols=266 Identities=21% Similarity=0.281 Sum_probs=193.3
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCC---ccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCC
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGG---WQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNG 448 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~g 448 (686)
+.||+|+||.||++... +++.||||.+.... ....+.+.+|++++++++||||+++++++.+.+..++||||+++|
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E~~~gg 86 (377)
T cd05629 7 KVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEFLPGG 86 (377)
T ss_pred EEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEeCCCCC
Confidence 46999999999999865 68899999986432 223456889999999999999999999999999999999999999
Q ss_pred CHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCC
Q 042348 449 SLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEET 528 (686)
Q Consensus 449 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 528 (686)
+|.+++... ..+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++.+......
T Consensus 87 ~L~~~l~~~------~~~~~~~~~~~~~ql~~aL~~LH~---~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 157 (377)
T cd05629 87 DLMTMLIKY------DTFSEDVTRFYMAECVLAIEAVHK---LGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDS 157 (377)
T ss_pred cHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEEeeccccccccccccc
Confidence 999999754 358899999999999999999999 89999999999999999999999999999744221110
Q ss_pred ccccccccccCCCCCC--------------------------CccccccccCCCCCccccCcccccCCCCCCcchHHHHH
Q 042348 529 PEVHWEQSTTGTPLQS--------------------------SPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYG 582 (686)
Q Consensus 529 ~~~~~~~~~~g~~~~~--------------------------~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG 582 (686)
.. +.....+..... ...........+||..|+|||++.+..++.++||||||
T Consensus 158 ~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG 235 (377)
T cd05629 158 AY--YQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLG 235 (377)
T ss_pred cc--ccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecc
Confidence 00 000000000000 00000011135689999999999988999999999999
Q ss_pred HHHHHHHhCCCCccccCccchhHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCC---CCHH
Q 042348 583 VILLEMISGKLPMIQIGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKR---PSMR 659 (686)
Q Consensus 583 vvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~R---Ps~~ 659 (686)
|++|||+||+.||...... .....+........ . | .. .....++.+++.+|++ +|.+| +++.
T Consensus 236 vil~elltG~~Pf~~~~~~-----~~~~~i~~~~~~~~-~--p---~~---~~~s~~~~dli~~lL~-~~~~r~~r~~~~ 300 (377)
T cd05629 236 AIMFECLIGWPPFCSENSH-----ETYRKIINWRETLY-F--P---DD---IHLSVEAEDLIRRLIT-NAENRLGRGGAH 300 (377)
T ss_pred hhhhhhhcCCCCCCCCCHH-----HHHHHHHccCCccC-C--C---CC---CCCCHHHHHHHHHHhc-CHhhcCCCCCHH
Confidence 9999999999999543321 11222222111110 0 0 00 0112356788889997 67665 5999
Q ss_pred HHHHH
Q 042348 660 HVCDS 664 (686)
Q Consensus 660 ev~~~ 664 (686)
|++++
T Consensus 301 ~~l~h 305 (377)
T cd05629 301 EIKSH 305 (377)
T ss_pred HHhcC
Confidence 98887
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=313.99 Aligned_cols=244 Identities=21% Similarity=0.373 Sum_probs=195.7
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCCccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCCHH
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLA 451 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL~ 451 (686)
..||+|+||.||+|... +++.|++|.+........+.+.+|+.+++.++||||+++++++...+..++||||+++++|.
T Consensus 26 ~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (296)
T cd06654 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT 105 (296)
T ss_pred EEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecccCCCCHH
Confidence 35999999999999864 67899999987665555677899999999999999999999999999999999999999999
Q ss_pred HHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCccc
Q 042348 452 TAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEV 531 (686)
Q Consensus 452 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 531 (686)
+++... .+++.++..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++........
T Consensus 106 ~~~~~~-------~~~~~~~~~i~~ql~~aL~~LH~---~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~---- 171 (296)
T cd06654 106 DVVTET-------CMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS---- 171 (296)
T ss_pred HHHHhc-------CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCEEECccccchhcccccc----
Confidence 998642 47899999999999999999999 8999999999999999999999999999875432110
Q ss_pred cccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHHHHH
Q 042348 532 HWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQWIQL 611 (686)
Q Consensus 532 ~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~ 611 (686)
......++..|+|||.+.+..++.++|||||||++|||++|+.||....... .+..
T Consensus 172 -------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~----~~~~- 227 (296)
T cd06654 172 -------------------KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR----ALYL- 227 (296)
T ss_pred -------------------ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHH----hHHH-
Confidence 0112346678999999988888999999999999999999999995433211 1111
Q ss_pred HHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 612 ILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 612 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
......+ ..-. .......+.+++.+||+.+|++||++.|++++
T Consensus 228 ~~~~~~~--~~~~--------~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 228 IATNGTP--ELQN--------PEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred HhcCCCC--CCCC--------ccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 1111111 1000 11123457789999999999999999999875
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=310.91 Aligned_cols=258 Identities=19% Similarity=0.292 Sum_probs=200.1
Q ss_pred hcccCccCceEEEEEEeCC-----CceEEEEEcCCC-CccchHHHHHHHHHHhccCCCCcceeeEEEEe-cCceeEEEec
Q 042348 372 AFLLGKSTIGIVYKVALNN-----EEAVAVRRLGNG-GWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWS-VDEKLLIYDY 444 (686)
Q Consensus 372 ~~~iG~G~~g~Vy~~~~~~-----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~-~~~~~lV~e~ 444 (686)
..+||+|+||.||+|...+ +..|++|++... .....+.+.+|+.++++++||||+++++++.. ....++++||
T Consensus 11 ~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~~ 90 (280)
T cd05043 11 SDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPPFVLYPY 90 (280)
T ss_pred eeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCCEEEEEc
Confidence 3579999999999999765 678999988754 23335678899999999999999999998876 4678999999
Q ss_pred cCCCCHHHHhhcCCCc--cccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCccccc
Q 042348 445 IPNGSLATAIHGKAGI--ISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLA 522 (686)
Q Consensus 445 ~~~gsL~~~l~~~~~~--~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~ 522 (686)
+++|+|.+++...... .....+++..+..++.|++.||+|||+ ++++||||||+||++++++.+||+|||+++.+
T Consensus 91 ~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kl~d~g~~~~~ 167 (280)
T cd05043 91 MNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK---RGVIHKDIAARNCVIDEELQVKITDNALSRDL 167 (280)
T ss_pred CCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCHhhEEEcCCCcEEECCCCCcccc
Confidence 9999999999754311 011358999999999999999999999 89999999999999999999999999999865
Q ss_pred ccccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCccccCcc
Q 042348 523 DIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQIGSM 601 (686)
Q Consensus 523 ~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~ 601 (686)
....... ......++..|+|||++.+..++.++|||||||++||+++ |+.||.....
T Consensus 168 ~~~~~~~---------------------~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~- 225 (280)
T cd05043 168 FPMDYHC---------------------LGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP- 225 (280)
T ss_pred cCCceEE---------------------eCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH-
Confidence 3221100 0011233556999999988889999999999999999999 9999954322
Q ss_pred chhHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccc
Q 042348 602 ELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRVNI 670 (686)
Q Consensus 602 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~ 670 (686)
.++......+ ..... + ......+.+++.+||+.||++|||+.|+++.|+.+..
T Consensus 226 ----~~~~~~~~~~-~~~~~---~--------~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 226 ----FEMAAYLKDG-YRLAQ---P--------INCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred ----HHHHHHHHcC-CCCCC---C--------CcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 1222222111 11110 0 1123467899999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=327.27 Aligned_cols=255 Identities=22% Similarity=0.325 Sum_probs=191.3
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCC--CccchHHHHHHHHHHhccCCCCcceeeEEEEecC-----ceeEEEec
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNG--GWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVD-----EKLLIYDY 444 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~-----~~~lV~e~ 444 (686)
+.||+|+||.||++... +++.||||++... .....+++.+|+++++.++||||+++++++...+ ..++||||
T Consensus 6 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~ 85 (372)
T cd07853 6 RPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVTEL 85 (372)
T ss_pred ceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEEeec
Confidence 46999999999999864 6889999998653 2234467889999999999999999999998776 78999999
Q ss_pred cCCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCccccccc
Q 042348 445 IPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADI 524 (686)
Q Consensus 445 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~ 524 (686)
+. ++|.+++... ..+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 86 ~~-~~l~~~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~ 155 (372)
T cd07853 86 MQ-SDLHKIIVSP------QPLSSDHVKVFLYQILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEP 155 (372)
T ss_pred cc-cCHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHHEEECCCCCEEeccccceeeccc
Confidence 96 5888887654 458999999999999999999999 8999999999999999999999999999975432
Q ss_pred ccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCC-CCCCcchHHHHHHHHHHHHhCCCCccccCccch
Q 042348 525 AEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVR-KPTQKWDIYSYGVILLEMISGKLPMIQIGSMEL 603 (686)
Q Consensus 525 ~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~ 603 (686)
... .......++..|+|||.+.+. .++.++|||||||++|||++|+.||......
T Consensus 156 ~~~----------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-- 211 (372)
T cd07853 156 DES----------------------KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPI-- 211 (372)
T ss_pred Ccc----------------------ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHH--
Confidence 111 011223467789999998764 4799999999999999999999999543321
Q ss_pred hHHHHHHHHHh-------------------hcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 604 NIVQWIQLILE-------------------DRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 604 ~~~~~~~~~~~-------------------~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
.....+..... ........... .. . .......++.+++.+||+.||++|||+.|++++
T Consensus 212 ~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~-~-~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 212 QQLDLITDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPV-LY-T-LSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHHHHHHHHcCCCCHHHHHHhhHHHHHHHHhCCCCCCchHH-hc-c-cCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 11111111100 00000000000 00 0 001123467899999999999999999999876
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=304.88 Aligned_cols=248 Identities=28% Similarity=0.399 Sum_probs=196.8
Q ss_pred ccCccCceEEEEEEeCCCceEEEEEcCCCCcc-chHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCCHHH
Q 042348 374 LLGKSTIGIVYKVALNNEEAVAVRRLGNGGWQ-RFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLAT 452 (686)
Q Consensus 374 ~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL~~ 452 (686)
.||+|+||.||++...+++.|++|.+...... ....+.+|++++++++|+||+++++++...+..++||||+++++|.+
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~ 81 (251)
T cd05041 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLT 81 (251)
T ss_pred ccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHHH
Confidence 58999999999999877899999998765433 45679999999999999999999999999999999999999999999
Q ss_pred HhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCcccc
Q 042348 453 AIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVH 532 (686)
Q Consensus 453 ~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 532 (686)
++.... ..+++..+..++.+++.||+|||+ ++++||||||+||+++.++.+||+|||+++.........
T Consensus 82 ~l~~~~-----~~~~~~~~~~~~~~~~~~l~~lH~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~--- 150 (251)
T cd05041 82 FLRKKK-----NRLTVKKLLQMSLDAAAGMEYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTV--- 150 (251)
T ss_pred HHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHh---CCEehhhcCcceEEEcCCCcEEEeeccccccccCCccee---
Confidence 997643 357899999999999999999999 899999999999999999999999999987543111000
Q ss_pred ccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCccccCccchhHHHHHHH
Q 042348 533 WEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQIGSMELNIVQWIQL 611 (686)
Q Consensus 533 ~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~ 611 (686)
.......+..|+|||.+.+..++.++|||||||++|||+| |..||....... ....
T Consensus 151 ------------------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~-----~~~~ 207 (251)
T cd05041 151 ------------------SDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ-----TRER 207 (251)
T ss_pred ------------------ccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHH-----HHHH
Confidence 0001122456999999988889999999999999999999 888885433211 1111
Q ss_pred HHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 042348 612 ILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDR 667 (686)
Q Consensus 612 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~ 667 (686)
. ....... . .......+.+++.+||+.+|++||++.|+++.|+.
T Consensus 208 ~-~~~~~~~---~--------~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~~ 251 (251)
T cd05041 208 I-ESGYRMP---A--------PQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQI 251 (251)
T ss_pred H-hcCCCCC---C--------CccCCHHHHHHHHHHhccChhhCcCHHHHHHHhhC
Confidence 1 1111100 0 01123468899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=317.13 Aligned_cols=258 Identities=19% Similarity=0.298 Sum_probs=190.8
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCCc-cchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCCH
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGGW-QRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSL 450 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL 450 (686)
..||+|+||.||+|... +++.||+|.++.... .....+.+|++++++++||||+++++++...+..++||||+++ +|
T Consensus 12 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l 90 (309)
T cd07872 12 EKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLDK-DL 90 (309)
T ss_pred EEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeCCCC-CH
Confidence 36999999999999875 577899999865422 2234678899999999999999999999999999999999975 88
Q ss_pred HHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCcc
Q 042348 451 ATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPE 530 (686)
Q Consensus 451 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 530 (686)
.+++.... ..+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++.......
T Consensus 91 ~~~~~~~~-----~~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--- 159 (309)
T cd07872 91 KQYMDDCG-----NIMSMHNVKIFLYQILRGLAYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK--- 159 (309)
T ss_pred HHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECccccceecCCCcc---
Confidence 88886543 357899999999999999999999 8999999999999999999999999999875321110
Q ss_pred ccccccccCCCCCCCccccccccCCCCCccccCcccccC-CCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHHH
Q 042348 531 VHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKV-RKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQWI 609 (686)
Q Consensus 531 ~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~ 609 (686)
......+|..|+|||.+.+ ..++.++|||||||++|||+||+.||...... +....+
T Consensus 160 --------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~--~~~~~~ 217 (309)
T cd07872 160 --------------------TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVE--DELHLI 217 (309)
T ss_pred --------------------ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH--HHHHHH
Confidence 0112345778999998865 56899999999999999999999999544322 111111
Q ss_pred HHHHhhcC--Cccccc------C---cccccCC---CcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 610 QLILEDRK--PMTDIL------D---PFLAHDL---DKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 610 ~~~~~~~~--~~~~~~------d---~~l~~~~---~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
........ .++.+. + +...... .......++.+++.+||+.||++|||+.|++++
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 286 (309)
T cd07872 218 FRLLGTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKH 286 (309)
T ss_pred HHHhCCCCHHHHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcC
Confidence 11111000 000000 0 0000000 000123357799999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=307.28 Aligned_cols=237 Identities=26% Similarity=0.414 Sum_probs=187.4
Q ss_pred ccCccCceEEEEEEeCCCc-----------eEEEEEcCCCCccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEE
Q 042348 374 LLGKSTIGIVYKVALNNEE-----------AVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIY 442 (686)
Q Consensus 374 ~iG~G~~g~Vy~~~~~~~~-----------~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 442 (686)
.||+|+||.||+|...+.. .|++|.+...... ...+.+|+.++++++||||+++++++.. +..++||
T Consensus 2 ~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~ 79 (259)
T cd05037 2 HLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVE 79 (259)
T ss_pred cccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEE
Confidence 5899999999999876433 5778877654333 5789999999999999999999999988 7789999
Q ss_pred eccCCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCC-------CeEEee
Q 042348 443 DYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNM-------EPHISD 515 (686)
Q Consensus 443 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~-------~~kl~D 515 (686)
||+++|+|.+++.... ..+++..++.++.|++.||+|||+ ++|+||||||+||+++.++ .+||+|
T Consensus 80 e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~D 151 (259)
T cd05037 80 EYVKFGPLDVFLHREK-----NNVSLHWKLDVAKQLASALHYLED---KKLVHGNVCGKNILVARYGLNEGYVPFIKLSD 151 (259)
T ss_pred EcCCCCcHHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHhh---CCeecccCccceEEEecCccccCCceeEEeCC
Confidence 9999999999998653 258999999999999999999999 8999999999999999887 799999
Q ss_pred cCcccccccccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCC--CCCCcchHHHHHHHHHHHHh-CC
Q 042348 516 FGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVR--KPTQKWDIYSYGVILLEMIS-GK 592 (686)
Q Consensus 516 fGla~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDVwSlGvvl~ellt-G~ 592 (686)
||+++..... ....++..|+|||++.+. .++.++|||||||++|||++ |.
T Consensus 152 fg~a~~~~~~---------------------------~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~ 204 (259)
T cd05037 152 PGIPITVLSR---------------------------EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGE 204 (259)
T ss_pred CCcccccccc---------------------------cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCC
Confidence 9998754321 012234569999998776 78999999999999999999 57
Q ss_pred CCccccCccchhHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 042348 593 LPMIQIGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLD 666 (686)
Q Consensus 593 ~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~ 666 (686)
.||......+ ...+. ....... .+ ....+.+++.+||+.+|++|||+.||++.|+
T Consensus 205 ~p~~~~~~~~--~~~~~----~~~~~~~---~~----------~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 205 EPLSTLSSSE--KERFY----QDQHRLP---MP----------DCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred CCcccCCchh--HHHHH----hcCCCCC---CC----------CchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 7774432111 11111 1111100 00 0146789999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=310.27 Aligned_cols=253 Identities=25% Similarity=0.392 Sum_probs=195.3
Q ss_pred ccCccCceEEEEEEeCC-------CceEEEEEcCCCC-ccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEecc
Q 042348 374 LLGKSTIGIVYKVALNN-------EEAVAVRRLGNGG-WQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYI 445 (686)
Q Consensus 374 ~iG~G~~g~Vy~~~~~~-------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~ 445 (686)
.||+|+||.||+|...+ +..+|+|.+.... ......+.+|+.++++++||||+++++++...+..++||||+
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELM 81 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEecc
Confidence 58999999999998643 2578999886543 234567899999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcCCCcc-ccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCC-----CeEEeecCcc
Q 042348 446 PNGSLATAIHGKAGII-SYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNM-----EPHISDFGLA 519 (686)
Q Consensus 446 ~~gsL~~~l~~~~~~~-~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~-----~~kl~DfGla 519 (686)
++++|.+++....... ....+++.+++.++.|++.||+|||+ .+++|+||||+||+++.++ .++++|||++
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~ 158 (269)
T cd05044 82 EGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA 158 (269)
T ss_pred CCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHh---CCcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence 9999999997543211 12347899999999999999999999 8999999999999999877 8999999998
Q ss_pred cccccccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCcccc
Q 042348 520 RLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQI 598 (686)
Q Consensus 520 ~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~ 598 (686)
+........ .......++..|+|||++.+..++.++|||||||++|||+| |+.||...
T Consensus 159 ~~~~~~~~~---------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~ 217 (269)
T cd05044 159 RDIYKSDYY---------------------RKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPAL 217 (269)
T ss_pred ccccccccc---------------------ccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCccc
Confidence 754322110 00011233567999999998899999999999999999998 99998543
Q ss_pred CccchhHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 042348 599 GSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDR 667 (686)
Q Consensus 599 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~ 667 (686)
.. .+. ...+.... ... ........+.+++.+||+.+|++||++.+|++.|++
T Consensus 218 ~~--~~~---~~~~~~~~-~~~-----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 218 NN--QEV---LQHVTAGG-RLQ-----------KPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred CH--HHH---HHHHhcCC-ccC-----------CcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 22 111 11111111 100 001123467899999999999999999999999864
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=328.84 Aligned_cols=268 Identities=19% Similarity=0.236 Sum_probs=193.0
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCC---ccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCC
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGG---WQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNG 448 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~g 448 (686)
..||+|+||.||+++.. +++.||||.+.... ......+.+|++++++++||||+++++.+.+.+..++||||+++|
T Consensus 7 ~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g 86 (376)
T cd05598 7 KTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGG 86 (376)
T ss_pred EEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999865 57899999986532 123456889999999999999999999999999999999999999
Q ss_pred CHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCC
Q 042348 449 SLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEET 528 (686)
Q Consensus 449 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 528 (686)
+|.+++... ..+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+|..+......
T Consensus 87 ~L~~~i~~~------~~~~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~ 157 (376)
T cd05598 87 DMMSLLIRL------GIFEEDLARFYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 157 (376)
T ss_pred cHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHEEECCCCCEEEEeCCCCccccccccc
Confidence 999999764 357888999999999999999999 89999999999999999999999999998643211100
Q ss_pred ccc-----------ccccccc-C-----CCCCCC---ccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHH
Q 042348 529 PEV-----------HWEQSTT-G-----TPLQSS---PYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEM 588 (686)
Q Consensus 529 ~~~-----------~~~~~~~-g-----~~~~~~---~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~el 588 (686)
... ....... . .+.... ...........||..|+|||++.+..++.++|||||||++|||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyel 237 (376)
T cd05598 158 KYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEM 237 (376)
T ss_pred cccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeeh
Confidence 000 0000000 0 000000 0000111245789999999999998999999999999999999
Q ss_pred HhCCCCccccCccchhHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCC---CHHHHHHH
Q 042348 589 ISGKLPMIQIGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRP---SMRHVCDS 664 (686)
Q Consensus 589 ltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RP---s~~ev~~~ 664 (686)
++|+.||......+ ....+....... . .+.. ......+.+++.+|+ .+|.+|+ ++.|++++
T Consensus 238 l~G~~Pf~~~~~~~-----~~~~i~~~~~~~-~--~~~~------~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 238 LVGQPPFLADTPAE-----TQLKVINWETTL-H--IPSQ------AKLSREASDLILRLC-CGAEDRLGKNGADEIKAH 301 (376)
T ss_pred hhCCCCCCCCCHHH-----HHHHHhccCccc-c--CCCC------CCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence 99999996543221 112222111110 0 0000 011234556777765 5999999 89999877
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=323.34 Aligned_cols=266 Identities=24% Similarity=0.387 Sum_probs=209.5
Q ss_pred hcccCccCceEEEEEEeCC--C--ceEEEEEcCCCCcc-chHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccC
Q 042348 372 AFLLGKSTIGIVYKVALNN--E--EAVAVRRLGNGGWQ-RFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIP 446 (686)
Q Consensus 372 ~~~iG~G~~g~Vy~~~~~~--~--~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~ 446 (686)
.+.||+|.||.|++|.|.. | ..||||.++..... ...+|.+|+.+|.+|+|||++++||+..+ ....+|||.++
T Consensus 115 ~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELap 193 (1039)
T KOG0199|consen 115 YELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELAP 193 (1039)
T ss_pred HHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhcc
Confidence 3569999999999998763 3 46899999876443 67899999999999999999999999987 77899999999
Q ss_pred CCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCccccccccc
Q 042348 447 NGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAE 526 (686)
Q Consensus 447 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~ 526 (686)
.|||.+.|+.... ..|.......++.|||.|+.||.+ +++|||||..+|+|+-..-.+||+|||+.+.+..++
T Consensus 194 lGSLldrLrka~~----~~llv~~Lcdya~QiA~aM~YLes---krlvHRDLAARNlllasprtVKI~DFGLmRaLg~ne 266 (1039)
T KOG0199|consen 194 LGSLLDRLRKAKK----AILLVSRLCDYAMQIAKAMQYLES---KRLVHRDLAARNLLLASPRTVKICDFGLMRALGENE 266 (1039)
T ss_pred cchHHHHHhhccc----cceeHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhhhheecccceeeeecccceeccCCCC
Confidence 9999999998321 457788899999999999999999 999999999999999998999999999999887665
Q ss_pred CCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCccccCccchhH
Q 042348 527 ETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQIGSMELNI 605 (686)
Q Consensus 527 ~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~~~~ 605 (686)
...... ....-.+.|+|||.+....++.++|||+|||++|||+| |..||.+.... .+
T Consensus 267 d~Yvm~--------------------p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~--qI 324 (1039)
T KOG0199|consen 267 DMYVMA--------------------PQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGI--QI 324 (1039)
T ss_pred cceEec--------------------CCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHH--HH
Confidence 432110 11122456999999999999999999999999999999 88999654332 22
Q ss_pred HHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH--hcccccchhhhhccCCC
Q 042348 606 VQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSL--DRVNISTEQQFMKGEEP 682 (686)
Q Consensus 606 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L--~~i~~~~~~~~~~~~~~ 682 (686)
.+ .+ +.+..+ ...+.|.+.+++++..||..+|++|||+..|.+.+ .+.+.......+...+|
T Consensus 325 L~---~i-D~~erL-----------pRPk~csedIY~imk~cWah~paDRptFsair~~~~l~eaqp~~a~~~~d~~ep 388 (1039)
T KOG0199|consen 325 LK---NI-DAGERL-----------PRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVLAEAQPAVARETYDSIEP 388 (1039)
T ss_pred HH---hc-cccccC-----------CCCCCChHHHHHHHHHhccCCccccccHHHHHHhHHHHhcCCceeeeeccccCC
Confidence 22 21 121111 12345778899999999999999999999998443 33344444444444444
|
|
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=311.85 Aligned_cols=255 Identities=22% Similarity=0.343 Sum_probs=195.8
Q ss_pred cccCccCceEEEEEEeC------CCceEEEEEcCCCC-ccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEecc
Q 042348 373 FLLGKSTIGIVYKVALN------NEEAVAVRRLGNGG-WQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYI 445 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~ 445 (686)
..||+|+||.||+|... .+..||+|.+.... ......+.+|+.++++++||||+++++++...+..++||||+
T Consensus 12 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 91 (288)
T cd05061 12 RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELM 91 (288)
T ss_pred eeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEeCC
Confidence 46999999999998753 24579999886543 223356889999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcCCCcc----ccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccc
Q 042348 446 PNGSLATAIHGKAGII----SYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARL 521 (686)
Q Consensus 446 ~~gsL~~~l~~~~~~~----~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~ 521 (686)
++|+|.+++....... .....++..+..++.|++.||+|||+ ++|+||||||+||++++++.++|+|||+++.
T Consensus 92 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dikp~nili~~~~~~~L~Dfg~~~~ 168 (288)
T cd05061 92 AHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRD 168 (288)
T ss_pred CCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCCcCCCCChheEEEcCCCcEEECcCCcccc
Confidence 9999999997532110 11345778889999999999999999 8999999999999999999999999999875
Q ss_pred cccccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCccccCc
Q 042348 522 ADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQIGS 600 (686)
Q Consensus 522 ~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~ 600 (686)
....... .......++..|+|||.+.+..++.++|||||||++|||++ |..||.....
T Consensus 169 ~~~~~~~---------------------~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~ 227 (288)
T cd05061 169 IYETDYY---------------------RKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN 227 (288)
T ss_pred ccccccc---------------------cccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 4321110 00011223556999999988889999999999999999999 7888854322
Q ss_pred cchhHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 042348 601 MELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRV 668 (686)
Q Consensus 601 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i 668 (686)
.+........... . . .......+.+++.+||+.||++|||+.++++.|++.
T Consensus 228 -----~~~~~~~~~~~~~--~-----~-----~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~ 278 (288)
T cd05061 228 -----EQVLKFVMDGGYL--D-----Q-----PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278 (288)
T ss_pred -----HHHHHHHHcCCCC--C-----C-----CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence 1222222222111 0 0 011234688999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=325.64 Aligned_cols=241 Identities=22% Similarity=0.284 Sum_probs=185.8
Q ss_pred cCccCceEEEEEEeC-CCceEEEEEcCCCCc---cchHHHHHHHHHHhcc---CCCCcceeeEEEEecCceeEEEeccCC
Q 042348 375 LGKSTIGIVYKVALN-NEEAVAVRRLGNGGW---QRFKEFQTEAEAIGKI---RHPNIVSLRAYFWSVDEKLLIYDYIPN 447 (686)
Q Consensus 375 iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l---~H~nIv~l~~~~~~~~~~~lV~e~~~~ 447 (686)
||+|+||.||+|+.. +++.||||++..... .....+..|..++.+. +||||+++++++...+..++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 699999999999865 588999999864321 2233455677777665 699999999999999999999999999
Q ss_pred CCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccC
Q 042348 448 GSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEE 527 (686)
Q Consensus 448 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 527 (686)
|+|.+++... ..+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 81 g~L~~~l~~~------~~~~~~~~~~~~~qil~al~~LH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~- 150 (330)
T cd05586 81 GELFWHLQKE------GRFSEDRAKFYIAELVLALEHLHK---YDIVYRDLKPENILLDATGHIALCDFGLSKANLTDN- 150 (330)
T ss_pred ChHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC-
Confidence 9999998754 358999999999999999999999 899999999999999999999999999987432111
Q ss_pred CccccccccccCCCCCCCccccccccCCCCCccccCcccccCC-CCCCcchHHHHHHHHHHHHhCCCCccccCccchhHH
Q 042348 528 TPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVR-KPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIV 606 (686)
Q Consensus 528 ~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~ 606 (686)
.......||..|+|||++.+. .++.++|||||||++|||++|+.||..... .
T Consensus 151 ----------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~-----~ 203 (330)
T cd05586 151 ----------------------KTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDT-----Q 203 (330)
T ss_pred ----------------------CCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCH-----H
Confidence 011234578889999998754 479999999999999999999999954321 2
Q ss_pred HHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCC----HHHHHHH
Q 042348 607 QWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPS----MRHVCDS 664 (686)
Q Consensus 607 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs----~~ev~~~ 664 (686)
+....+.......+. . .....+.+++.+||+.||++||+ +.|++++
T Consensus 204 ~~~~~i~~~~~~~~~---~---------~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h 253 (330)
T cd05586 204 QMYRNIAFGKVRFPK---N---------VLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEH 253 (330)
T ss_pred HHHHHHHcCCCCCCC---c---------cCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcC
Confidence 222333222211110 0 11235678999999999999984 5555553
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=322.94 Aligned_cols=257 Identities=23% Similarity=0.298 Sum_probs=188.6
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCC--CccchHHHHHHHHHHhccCCCCcceeeEEEEecC------ceeEEEe
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNG--GWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVD------EKLLIYD 443 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~------~~~lV~e 443 (686)
..||+|+||.||++... ++..||||.+... .......+.+|+.+++.++||||+++++++...+ ..++|||
T Consensus 27 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e 106 (359)
T cd07876 27 KPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVME 106 (359)
T ss_pred EEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccceeEEEEe
Confidence 46999999999999865 5889999998653 2233567889999999999999999999986543 4699999
Q ss_pred ccCCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccc
Q 042348 444 YIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLAD 523 (686)
Q Consensus 444 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~ 523 (686)
|+++ +|.+.++ ..+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++...
T Consensus 107 ~~~~-~l~~~~~--------~~~~~~~~~~~~~qi~~~L~~LH~---~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~ 174 (359)
T cd07876 107 LMDA-NLCQVIH--------MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAC 174 (359)
T ss_pred CCCc-CHHHHHh--------ccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEecCCCccccc
Confidence 9965 6766664 247888999999999999999999 899999999999999999999999999987432
Q ss_pred cccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccch
Q 042348 524 IAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMEL 603 (686)
Q Consensus 524 ~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~ 603 (686)
... ......+|..|+|||++.+..++.++|||||||++|||++|+.||......+.
T Consensus 175 ~~~------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~ 230 (359)
T cd07876 175 TNF------------------------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQ 230 (359)
T ss_pred cCc------------------------cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 111 11234567889999999998999999999999999999999999964322110
Q ss_pred -------------hH----HHHHHHHHhhcCCccc-----ccCccccc-C-CCcHHHHHHHHHHHHhccccCCCCCCCHH
Q 042348 604 -------------NI----VQWIQLILEDRKPMTD-----ILDPFLAH-D-LDKEDEIVSVLKIALDCVHKSPDKRPSMR 659 (686)
Q Consensus 604 -------------~~----~~~~~~~~~~~~~~~~-----~~d~~l~~-~-~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ 659 (686)
.. ...+............ ........ . .........+.+++.+||+.||++|||+.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~ 310 (359)
T cd07876 231 WNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVD 310 (359)
T ss_pred HHHHHHhcCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHH
Confidence 00 0001111111111000 00000000 0 00001234578999999999999999999
Q ss_pred HHHHHH
Q 042348 660 HVCDSL 665 (686)
Q Consensus 660 ev~~~L 665 (686)
|++++-
T Consensus 311 e~l~hp 316 (359)
T cd07876 311 EALRHP 316 (359)
T ss_pred HHhcCc
Confidence 999873
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=310.02 Aligned_cols=243 Identities=23% Similarity=0.354 Sum_probs=191.3
Q ss_pred cccCccCceEEEEEEe-CCCceEEEEEcCCC-CccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCCH
Q 042348 373 FLLGKSTIGIVYKVAL-NNEEAVAVRRLGNG-GWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSL 450 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL 450 (686)
..||+|+||.||+|.. .+++.||+|.+... .....+.+.+|++++++++||||+++++++...+..++||||+++++|
T Consensus 7 ~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l 86 (279)
T cd06619 7 EILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDGGSL 86 (279)
T ss_pred eeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCCCCCh
Confidence 4699999999999986 46788999998654 223345788999999999999999999999999999999999999999
Q ss_pred HHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCcc
Q 042348 451 ATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPE 530 (686)
Q Consensus 451 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 530 (686)
..+. .+++..+..++.|++.||+|||+ .+|+|+||||+||+++.++.++|+|||++.......
T Consensus 87 ~~~~----------~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~---- 149 (279)
T cd06619 87 DVYR----------KIPEHVLGRIAVAVVKGLTYLWS---LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI---- 149 (279)
T ss_pred HHhh----------cCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc----
Confidence 7542 36788899999999999999999 899999999999999999999999999987543111
Q ss_pred ccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchh--HHHH
Q 042348 531 VHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELN--IVQW 608 (686)
Q Consensus 531 ~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~--~~~~ 608 (686)
.....+|..|+|||++.+..++.++|||||||++|||++|+.||......... ....
T Consensus 150 ---------------------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 208 (279)
T cd06619 150 ---------------------AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQL 208 (279)
T ss_pred ---------------------ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHH
Confidence 11235677899999999888999999999999999999999999543322111 1111
Q ss_pred HHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 609 IQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 609 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
.+....... +.+.. .....++.+++.+||+.+|++||+++|++++
T Consensus 209 ~~~~~~~~~-------~~~~~----~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 209 LQCIVDEDP-------PVLPV----GQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred HHHHhccCC-------CCCCC----CcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 121111111 11100 1122357899999999999999999999876
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=309.07 Aligned_cols=248 Identities=24% Similarity=0.338 Sum_probs=194.0
Q ss_pred hcccCccCceEEEEEEeC-CCceEEEEEcCCCCccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCCH
Q 042348 372 AFLLGKSTIGIVYKVALN-NEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSL 450 (686)
Q Consensus 372 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL 450 (686)
...||+|+||.||+|... +++.||+|.++.........+.+|+.+++.++||||+++++++...+..++||||+++++|
T Consensus 14 ~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L 93 (267)
T cd06645 14 IQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSL 93 (267)
T ss_pred HHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccCCCcH
Confidence 346999999999999865 5889999998765544556788999999999999999999999999999999999999999
Q ss_pred HHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCcc
Q 042348 451 ATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPE 530 (686)
Q Consensus 451 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 530 (686)
.+++... ..+++.+++.++.|++.||+|||+ .+++||||||+||+++.++.++|+|||++.......
T Consensus 94 ~~~~~~~------~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~---- 160 (267)
T cd06645 94 QDIYHVT------GPLSESQIAYVSRETLQGLYYLHS---KGKMHRDIKGANILLTDNGHVKLADFGVSAQITATI---- 160 (267)
T ss_pred HHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECcceeeeEccCcc----
Confidence 9998754 358999999999999999999999 899999999999999999999999999987543111
Q ss_pred ccccccccCCCCCCCccccccccCCCCCccccCccccc---CCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHH
Q 042348 531 VHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASK---VRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQ 607 (686)
Q Consensus 531 ~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~ 607 (686)
.......|+..|+|||++. ...++.++|||||||++|||++|+.||........
T Consensus 161 -------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~---- 217 (267)
T cd06645 161 -------------------AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA---- 217 (267)
T ss_pred -------------------cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhh----
Confidence 0112335677899999874 45688999999999999999999999854332111
Q ss_pred HHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 608 WIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 608 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
+......... . +...... .....+.+++.+||+.+|++||++.+|+++
T Consensus 218 -~~~~~~~~~~-~----~~~~~~~---~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 218 -LFLMTKSNFQ-P----PKLKDKM---KWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred -HHhhhccCCC-C----CcccccC---CCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 1111111111 0 1010000 112357789999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=317.69 Aligned_cols=244 Identities=26% Similarity=0.360 Sum_probs=202.9
Q ss_pred cccCccCceEEEEEEeCC-CceEEEEEcCCCCcc---chHHHHHHHHHHhccC-CCCcceeeEEEEecCceeEEEeccCC
Q 042348 373 FLLGKSTIGIVYKVALNN-EEAVAVRRLGNGGWQ---RFKEFQTEAEAIGKIR-HPNIVSLRAYFWSVDEKLLIYDYIPN 447 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lV~e~~~~ 447 (686)
..||+|.||.||+++.+. |+.+|+|.+.+.... ....+.+|+.+|+++. |||||.+++.|++....++|||+|.|
T Consensus 41 ~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lvmEL~~G 120 (382)
T KOG0032|consen 41 RELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLVMELCEG 120 (382)
T ss_pred hhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEEEEecCC
Confidence 469999999999999775 899999999765432 3468999999999998 99999999999999999999999999
Q ss_pred CCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCC----CCeEEeecCcccccc
Q 042348 448 GSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKN----MEPHISDFGLARLAD 523 (686)
Q Consensus 448 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~----~~~kl~DfGla~~~~ 523 (686)
|.|.+.+... .+++.++..++.|++.|++|||+ .+|+||||||+|+|+... +.+|++|||+|....
T Consensus 121 GeLfd~i~~~-------~~sE~da~~~~~~il~av~~lH~---~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~ 190 (382)
T KOG0032|consen 121 GELFDRIVKK-------HYSERDAAGIIRQILEAVKYLHS---LGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIK 190 (382)
T ss_pred chHHHHHHHc-------cCCHHHHHHHHHHHHHHHHHHHh---CCceeccCCHHHeeeccccCCCCcEEEeeCCCceEcc
Confidence 9999999765 28999999999999999999999 899999999999999633 579999999998765
Q ss_pred cccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccch
Q 042348 524 IAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMEL 603 (686)
Q Consensus 524 ~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~ 603 (686)
.. ......+||+.|+|||++....|+..+||||+||++|.|++|..||........
T Consensus 191 ~~------------------------~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~ 246 (382)
T KOG0032|consen 191 PG------------------------ERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEI 246 (382)
T ss_pred CC------------------------ceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHH
Confidence 41 123456889999999999999999999999999999999999999966543332
Q ss_pred hHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 604 NIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 604 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
...+...... ..++. .+.......+++.+|+..||.+|+|+.++++|
T Consensus 247 -----~~~i~~~~~~---f~~~~------w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 247 -----FLAILRGDFD---FTSEP------WDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred -----HHHHHcCCCC---CCCCC------ccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 1233333321 11111 12234567789999999999999999999997
|
|
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=318.12 Aligned_cols=262 Identities=21% Similarity=0.272 Sum_probs=191.8
Q ss_pred cccCcc--CceEEEEEEeC-CCceEEEEEcCCCC--ccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCC
Q 042348 373 FLLGKS--TIGIVYKVALN-NEEAVAVRRLGNGG--WQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPN 447 (686)
Q Consensus 373 ~~iG~G--~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~ 447 (686)
.+||+| +|++||++... +++.||+|++.... ....+.+.+|+++++.++||||+++++++..++..++||||+++
T Consensus 4 ~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~ 83 (327)
T cd08227 4 TVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAY 83 (327)
T ss_pred hhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccCC
Confidence 368999 78999999865 68899999987542 22235677899999999999999999999999999999999999
Q ss_pred CCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccC
Q 042348 448 GSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEE 527 (686)
Q Consensus 448 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 527 (686)
|+|.+++..... ..+++..++.++.|++.||+|||+ ++|+||||||+||+++.++.++++||+.+........
T Consensus 84 ~~l~~~~~~~~~----~~l~~~~~~~i~~qi~~~L~~LH~---~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~ 156 (327)
T cd08227 84 GSAKDLICTHFM----DGMSELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQ 156 (327)
T ss_pred CcHHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCChhhEEEecCCcEEEcccchhhccccccc
Confidence 999999975432 358999999999999999999999 8999999999999999999999999987643321110
Q ss_pred CccccccccccCCCCCCCccccccccCCCCCccccCcccccC--CCCCCcchHHHHHHHHHHHHhCCCCccccCccchhH
Q 042348 528 TPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKV--RKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNI 605 (686)
Q Consensus 528 ~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~ 605 (686)
.. .... .......++..|+|||++.+ ..++.++|||||||++|||++|+.||........
T Consensus 157 ~~-----~~~~-----------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-- 218 (327)
T cd08227 157 RL-----RVVH-----------DFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM-- 218 (327)
T ss_pred cc-----cccc-----------cccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHH--
Confidence 00 0000 00112345667999999875 4589999999999999999999999954322111
Q ss_pred HHHHHHHHhhcCCccccc-------------------Cccccc----------------CCCcHHHHHHHHHHHHhcccc
Q 042348 606 VQWIQLILEDRKPMTDIL-------------------DPFLAH----------------DLDKEDEIVSVLKIALDCVHK 650 (686)
Q Consensus 606 ~~~~~~~~~~~~~~~~~~-------------------d~~l~~----------------~~~~~~~~~~l~~l~~~cl~~ 650 (686)
........ ..... +..... ..........+.+++.+||+.
T Consensus 219 ---~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 293 (327)
T cd08227 219 ---LLEKLNGT--VPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQR 293 (327)
T ss_pred ---HHHHhcCC--ccccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhh
Confidence 11111100 00000 000000 000111234688999999999
Q ss_pred CCCCCCCHHHHHHH
Q 042348 651 SPDKRPSMRHVCDS 664 (686)
Q Consensus 651 dP~~RPs~~ev~~~ 664 (686)
||++|||++|++++
T Consensus 294 dP~~Rpt~~ell~~ 307 (327)
T cd08227 294 NPDARPSASTLLNH 307 (327)
T ss_pred CchhcCCHHHHhcC
Confidence 99999999999875
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=308.14 Aligned_cols=251 Identities=22% Similarity=0.335 Sum_probs=196.4
Q ss_pred hcccCccCceEEEEEEeCC----CceEEEEEcCCCC-ccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccC
Q 042348 372 AFLLGKSTIGIVYKVALNN----EEAVAVRRLGNGG-WQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIP 446 (686)
Q Consensus 372 ~~~iG~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~ 446 (686)
...||+|+||.||+|...+ ...|+||...... ....+.+.+|+.++++++||||+++++++.+ +..++||||++
T Consensus 11 ~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv~e~~~ 89 (270)
T cd05056 11 GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIVMELAP 89 (270)
T ss_pred eeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEEEEcCC
Confidence 3479999999999998643 2468999887654 3445679999999999999999999999875 56789999999
Q ss_pred CCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCccccccccc
Q 042348 447 NGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAE 526 (686)
Q Consensus 447 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~ 526 (686)
+|+|.+++.... ..+++..++.++.|++.||+|||+ .+++||||||+||+++.++.+||+|||+++......
T Consensus 90 ~~~L~~~l~~~~-----~~~~~~~~~~~~~~l~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 161 (270)
T cd05056 90 LGELRSYLQVNK-----YSLDLASLILYSYQLSTALAYLES---KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDES 161 (270)
T ss_pred CCcHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccChheEEEecCCCeEEccCceeeeccccc
Confidence 999999997643 358999999999999999999999 899999999999999999999999999987654221
Q ss_pred CCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCccccCccchhH
Q 042348 527 ETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQIGSMELNI 605 (686)
Q Consensus 527 ~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~~~~ 605 (686)
.. ......++..|+|||.+....++.++|||||||++||+++ |+.||......+ .
T Consensus 162 ~~----------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~--~ 217 (270)
T cd05056 162 YY----------------------KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNND--V 217 (270)
T ss_pred ce----------------------ecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHH--H
Confidence 00 0011123456999999988889999999999999999996 999995443221 1
Q ss_pred HHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccc
Q 042348 606 VQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRVNI 670 (686)
Q Consensus 606 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~ 670 (686)
....... .... . .......+.+++.+|+..+|++|||+.++++.|+++..
T Consensus 218 ---~~~~~~~-~~~~------~-----~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~ 267 (270)
T cd05056 218 ---IGRIENG-ERLP------M-----PPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ 267 (270)
T ss_pred ---HHHHHcC-CcCC------C-----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 1111111 1110 0 01123467889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=310.39 Aligned_cols=258 Identities=26% Similarity=0.379 Sum_probs=199.4
Q ss_pred cccCccCceEEEEEEeC-----CCceEEEEEcCCCCcc-chHHHHHHHHHHhccCCCCcceeeEEEEe--cCceeEEEec
Q 042348 373 FLLGKSTIGIVYKVALN-----NEEAVAVRRLGNGGWQ-RFKEFQTEAEAIGKIRHPNIVSLRAYFWS--VDEKLLIYDY 444 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~~~~~~--~~~~~lV~e~ 444 (686)
..||+|+||.||+|.+. ++..||||.+...... ..+.|.+|++++++++||||+++++++.. ....++||||
T Consensus 10 ~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~ 89 (284)
T cd05038 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEY 89 (284)
T ss_pred eeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceEEEEec
Confidence 46999999999999864 3678999999765433 45789999999999999999999999887 5578999999
Q ss_pred cCCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCccccccc
Q 042348 445 IPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADI 524 (686)
Q Consensus 445 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~ 524 (686)
+++++|.+++.... ..+++..+..++.|++.||+|||+ ++++||||||+||+++.++.++|+|||++.....
T Consensus 90 ~~~~~l~~~l~~~~-----~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 161 (284)
T cd05038 90 LPSGSLRDYLQRHR-----DQINLKRLLLFSSQICKGMDYLGS---QRYIHRDLAARNILVESEDLVKISDFGLAKVLPE 161 (284)
T ss_pred CCCCCHHHHHHhCc-----cccCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEccccccccccc
Confidence 99999999998654 358999999999999999999999 8999999999999999999999999999986542
Q ss_pred ccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchh
Q 042348 525 AEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELN 604 (686)
Q Consensus 525 ~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~ 604 (686)
..... .......++..|+|||...+..++.++||||||+++|||+||+.|+.........
T Consensus 162 ~~~~~--------------------~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~ 221 (284)
T cd05038 162 DKDYY--------------------YVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLR 221 (284)
T ss_pred CCcce--------------------eccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcc
Confidence 21100 0011123345699999998888999999999999999999999998543221110
Q ss_pred ---------HHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 042348 605 ---------IVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRVN 669 (686)
Q Consensus 605 ---------~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~ 669 (686)
................ ....+..++.+++.+||+.+|++|||+.||++.|+++.
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i~ 284 (284)
T cd05038 222 MIGIAQGQMIVTRLLELLKEGERLP-----------RPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRLR 284 (284)
T ss_pred ccccccccccHHHHHHHHHcCCcCC-----------CCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhcC
Confidence 0111111111111100 01122356889999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=307.25 Aligned_cols=247 Identities=27% Similarity=0.486 Sum_probs=196.4
Q ss_pred cccCccCceEEEEEEeCCCceEEEEEcCCCCccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCCHHH
Q 042348 373 FLLGKSTIGIVYKVALNNEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLAT 452 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL~~ 452 (686)
+.||+|+||.||++...++..+|+|.+.... ...+.+.+|++++++++|+||+++++++.. ...+++|||+++|+|.+
T Consensus 12 ~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~ 89 (260)
T cd05073 12 KKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLD 89 (260)
T ss_pred eEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeCCCCcHHH
Confidence 4699999999999998878889999887543 234678999999999999999999999887 77899999999999999
Q ss_pred HhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCcccc
Q 042348 453 AIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVH 532 (686)
Q Consensus 453 ~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 532 (686)
++....+ ..+++..++.++.|++.||+|||+ .+++||||||+||+++.++.+||+|||.+.........
T Consensus 90 ~~~~~~~----~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~---- 158 (260)
T cd05073 90 FLKSDEG----SKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT---- 158 (260)
T ss_pred HHHhCCc----cccCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCCcceeeccCCCcc----
Confidence 9976532 357899999999999999999999 89999999999999999999999999998754321110
Q ss_pred ccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCccccCccchhHHHHHHH
Q 042348 533 WEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQIGSMELNIVQWIQL 611 (686)
Q Consensus 533 ~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~ 611 (686)
......++..|+|||++....++.++|||||||++|+++| |+.||...... .... .
T Consensus 159 ------------------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~--~~~~---~ 215 (260)
T cd05073 159 ------------------AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP--EVIR---A 215 (260)
T ss_pred ------------------cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHH--HHHH---H
Confidence 0111234566999999988889999999999999999999 99998543221 1111 1
Q ss_pred HHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 042348 612 ILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDR 667 (686)
Q Consensus 612 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~ 667 (686)
. ....... . ......++.+++.+|++.+|++||++.++.+.|+.
T Consensus 216 ~-~~~~~~~-~----------~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 216 L-ERGYRMP-R----------PENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred H-hCCCCCC-C----------cccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 1 1111110 0 01123468899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=312.02 Aligned_cols=254 Identities=28% Similarity=0.424 Sum_probs=196.6
Q ss_pred cccCccCceEEEEEEeC------CCceEEEEEcCCCCc-cchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEecc
Q 042348 373 FLLGKSTIGIVYKVALN------NEEAVAVRRLGNGGW-QRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYI 445 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~ 445 (686)
..||+|+||.||+|... ++..||+|.+..... ...+++.+|+.++++++||||+++++++...+..++||||+
T Consensus 11 ~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 90 (288)
T cd05050 11 RDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYM 90 (288)
T ss_pred ccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccEEEEecC
Confidence 35899999999999863 467899999875432 33467899999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcCCCc----------------cccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCC
Q 042348 446 PNGSLATAIHGKAGI----------------ISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNM 509 (686)
Q Consensus 446 ~~gsL~~~l~~~~~~----------------~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~ 509 (686)
++|+|.+++...... .....+++.+++.++.|++.||+|||+ ++++||||||+||++++++
T Consensus 91 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~---~~i~H~dl~p~nil~~~~~ 167 (288)
T cd05050 91 AYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSE---RKFVHRDLATRNCLVGENM 167 (288)
T ss_pred CCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCeecccccHhheEecCCC
Confidence 999999999753211 011357889999999999999999999 8999999999999999999
Q ss_pred CeEEeecCcccccccccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHH
Q 042348 510 EPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMI 589 (686)
Q Consensus 510 ~~kl~DfGla~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ell 589 (686)
.++|+|||+++........ ........+..|+|||.+.+..++.++|||||||++|||+
T Consensus 168 ~~~l~dfg~~~~~~~~~~~---------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~ 226 (288)
T cd05050 168 VVKIADFGLSRNIYSADYY---------------------KASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIF 226 (288)
T ss_pred ceEECccccceecccCccc---------------------cccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHH
Confidence 9999999998754321100 0011122345699999998888999999999999999999
Q ss_pred h-CCCCccccCccchhHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 042348 590 S-GKLPMIQIGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDR 667 (686)
Q Consensus 590 t-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~ 667 (686)
+ |..||..... .+....+..... ... ......++.+++.+||+.+|++|||+.|+++.|++
T Consensus 227 ~~~~~p~~~~~~-----~~~~~~~~~~~~--~~~----------~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 227 SYGMQPYYGMAH-----EEVIYYVRDGNV--LSC----------PDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred hCCCCCCCCCCH-----HHHHHHHhcCCC--CCC----------CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 8 8888854322 222222222211 000 01123468899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=322.27 Aligned_cols=256 Identities=21% Similarity=0.297 Sum_probs=197.5
Q ss_pred hcccCccCceEEEEEEeC-CCceEEEEEcCCCCccchHHHHHHHHHHhccC-C-----CCcceeeEEEEecCceeEEEec
Q 042348 372 AFLLGKSTIGIVYKVALN-NEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIR-H-----PNIVSLRAYFWSVDEKLLIYDY 444 (686)
Q Consensus 372 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H-----~nIv~l~~~~~~~~~~~lV~e~ 444 (686)
.++||+|.||.|.||... +++.||||+++... .-..+...|+.+|..++ | -|+|+++++|...++.+||+|.
T Consensus 191 ~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciVfEL 269 (586)
T KOG0667|consen 191 LEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIVFEL 269 (586)
T ss_pred EEEecccccceeEEEEecCCCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeeeehh
Confidence 457999999999999855 58999999998753 23466788999999996 4 3899999999999999999999
Q ss_pred cCCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCC--CCeEEeecCccccc
Q 042348 445 IPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKN--MEPHISDFGLARLA 522 (686)
Q Consensus 445 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~--~~~kl~DfGla~~~ 522 (686)
+. .+|.++++.+.- ..++...+..|+.||+.||.+||+ .+|||+||||+||||.+- ..+||+|||.|.+.
T Consensus 270 L~-~NLYellK~n~f----~Glsl~~ir~~~~Qil~~L~~L~~---l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~ 341 (586)
T KOG0667|consen 270 LS-TNLYELLKNNKF----RGLSLPLVRKFAQQILTALLFLHE---LGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFE 341 (586)
T ss_pred hh-hhHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCChhheeeccCCcCceeEEeccccccc
Confidence 94 599999997753 679999999999999999999999 899999999999999743 37999999999865
Q ss_pred ccccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccc
Q 042348 523 DIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSME 602 (686)
Q Consensus 523 ~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~ 602 (686)
... ......+.+|+|||++.+.+|+.+.||||||||+.||++|.+-|.+. .+
T Consensus 342 ~q~--------------------------vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~--ne 393 (586)
T KOG0667|consen 342 SQR--------------------------VYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGD--NE 393 (586)
T ss_pred CCc--------------------------ceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCC--CH
Confidence 422 12445677899999999999999999999999999999998777443 33
Q ss_pred hhHHHHHHHHHhh--------cCCcccccCc---------------------------------ccccCCC------cHH
Q 042348 603 LNIVQWIQLILED--------RKPMTDILDP---------------------------------FLAHDLD------KED 635 (686)
Q Consensus 603 ~~~~~~~~~~~~~--------~~~~~~~~d~---------------------------------~l~~~~~------~~~ 635 (686)
.+....+..++.- .......++. ....... ...
T Consensus 394 ~DQl~~I~e~lG~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~ 473 (586)
T KOG0667|consen 394 YDQLARIIEVLGLPPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKA 473 (586)
T ss_pred HHHHHHHHHHhCCCCHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccc
Confidence 3333333333221 0000000110 0000000 012
Q ss_pred HHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 636 EIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 636 ~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
.-..+++++.+||+.||.+|+|..|+++|
T Consensus 474 ~~~~F~dflk~~L~~dP~~R~tp~qal~H 502 (586)
T KOG0667|consen 474 DDKLFIDFLKRCLEWDPAERITPAQALNH 502 (586)
T ss_pred cHHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence 33458899999999999999999999987
|
|
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=307.07 Aligned_cols=255 Identities=20% Similarity=0.316 Sum_probs=187.3
Q ss_pred ccCccCceEEEEEEeCC---CceEEEEEcCCCC-ccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCC
Q 042348 374 LLGKSTIGIVYKVALNN---EEAVAVRRLGNGG-WQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGS 449 (686)
Q Consensus 374 ~iG~G~~g~Vy~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gs 449 (686)
.||+|+||.||+|...+ ...+++|.+.... ......+.+|+.+++.++||||+++++++...+..++||||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 48999999999997543 3468888876442 2334568899999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCc
Q 042348 450 LATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETP 529 (686)
Q Consensus 450 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 529 (686)
|.+++....... ....++.....++.|++.||+|||+ ++|+||||||+||++++++.+||+|||+++........
T Consensus 82 L~~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~- 156 (269)
T cd05042 82 LKNYLRSNRGMV-AQMAQKDVLQRMACEVASGLLWLHQ---ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYY- 156 (269)
T ss_pred HHHHHHhccccc-cccccHHHHHHHHHHHHHHHHHHHh---cCEecccccHhheEecCCCcEEEeccccccccccchhe-
Confidence 999997654211 1235678889999999999999999 89999999999999999999999999998643221100
Q ss_pred cccccccccCCCCCCCccccccccCCCCCccccCccccc-------CCCCCCcchHHHHHHHHHHHHh-CCCCccccCcc
Q 042348 530 EVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASK-------VRKPTQKWDIYSYGVILLEMIS-GKLPMIQIGSM 601 (686)
Q Consensus 530 ~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~ 601 (686)
.......++..|+|||+.. ...++.++|||||||++|||++ |..||......
T Consensus 157 --------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~ 216 (269)
T cd05042 157 --------------------ITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDE 216 (269)
T ss_pred --------------------eccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHH
Confidence 0011223456699999864 2356889999999999999999 78888543221
Q ss_pred chhHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 042348 602 ELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLD 666 (686)
Q Consensus 602 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~ 666 (686)
+ .......... ....++.+.. .....+.+++..|+ .||++|||++||++.|.
T Consensus 217 ~-----~~~~~~~~~~--~~~~~~~~~~-----~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 217 Q-----VLKQVVREQD--IKLPKPQLDL-----KYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred H-----HHHHHhhccC--ccCCCCcccc-----cCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 1 1112121111 1111222211 12234567778888 59999999999998873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=326.10 Aligned_cols=256 Identities=19% Similarity=0.240 Sum_probs=190.4
Q ss_pred cccCccCceEEEEEEeC---CCceEEEEEcCCCCccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCC
Q 042348 373 FLLGKSTIGIVYKVALN---NEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGS 449 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gs 449 (686)
..||+|+||.||++... .+..||+|.+... +.+.+|++++++++|||||++++++...+..++||||+. ++
T Consensus 98 ~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~ 171 (392)
T PHA03207 98 SSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYK-CD 171 (392)
T ss_pred EeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEehhcC-CC
Confidence 46999999999999754 3568999988653 345689999999999999999999999999999999995 68
Q ss_pred HHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCc
Q 042348 450 LATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETP 529 (686)
Q Consensus 450 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 529 (686)
|.+++... ..+++.+++.|+.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++........
T Consensus 172 l~~~l~~~------~~l~~~~~~~i~~ql~~aL~~LH~---~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~- 241 (392)
T PHA03207 172 LFTYVDRS------GPLPLEQAITIQRRLLEALAYLHG---RGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDT- 241 (392)
T ss_pred HHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEccCccccccCccccc-
Confidence 98888433 468999999999999999999999 89999999999999999999999999999755422110
Q ss_pred cccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccc--hhHHH
Q 042348 530 EVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSME--LNIVQ 607 (686)
Q Consensus 530 ~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~--~~~~~ 607 (686)
.......||..|+|||++.+..++.++|||||||++|||++|+.||....... ..+..
T Consensus 242 --------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~ 301 (392)
T PHA03207 242 --------------------PQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRS 301 (392)
T ss_pred --------------------ccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHH
Confidence 01123467889999999998899999999999999999999999995543221 11111
Q ss_pred HHHHHHhhcCCcccc---------------cCccc--ccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 608 WIQLILEDRKPMTDI---------------LDPFL--AHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 608 ~~~~~~~~~~~~~~~---------------~d~~l--~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
.+............. ..+.. ............+.+++.+||..||++|||+.|++.+
T Consensus 302 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 302 IIRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred HHHHhccCccccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 111100000000000 00000 0000000112356788999999999999999999887
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-37 Score=331.56 Aligned_cols=256 Identities=21% Similarity=0.310 Sum_probs=184.1
Q ss_pred hcccCccCceEEEEEEeC-CCceEEEEEcCCCCccchHHHHHHHHHHhccCCCCcceeeEEEEec--------CceeEEE
Q 042348 372 AFLLGKSTIGIVYKVALN-NEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSV--------DEKLLIY 442 (686)
Q Consensus 372 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--------~~~~lV~ 442 (686)
...||+|+||.||+|... +++.||||++.... ....+|+.++++++|||||++++++... ...++||
T Consensus 71 ~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~lvm 146 (440)
T PTZ00036 71 GNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVM 146 (440)
T ss_pred eEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEEEEE
Confidence 347999999999999875 57899999885432 2345799999999999999999987542 1356899
Q ss_pred eccCCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCC-CeEEeecCcccc
Q 042348 443 DYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNM-EPHISDFGLARL 521 (686)
Q Consensus 443 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~-~~kl~DfGla~~ 521 (686)
||+++ +|.+++..... ....+++..+..++.||+.||+|||+ ++|+||||||+|||++.++ .+||+|||+|+.
T Consensus 147 E~~~~-~l~~~~~~~~~--~~~~l~~~~~~~~~~qi~~gL~yLH~---~~IiHrDLKp~NILl~~~~~~vkL~DFGla~~ 220 (440)
T PTZ00036 147 EFIPQ-TVHKYMKHYAR--NNHALPLFLVKLYSYQLCRALAYIHS---KFICHRDLKPQNLLIDPNTHTLKLCDFGSAKN 220 (440)
T ss_pred ecCCc-cHHHHHHHHhh--cCCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCcCHHHEEEcCCCCceeeeccccchh
Confidence 99975 77777653211 11468999999999999999999999 8999999999999999665 699999999985
Q ss_pred cccccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccC-CCCCCcchHHHHHHHHHHHHhCCCCccccCc
Q 042348 522 ADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKV-RKPTQKWDIYSYGVILLEMISGKLPMIQIGS 600 (686)
Q Consensus 522 ~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvvl~elltG~~P~~~~~~ 600 (686)
+..... .....+|..|+|||++.+ ..++.++|||||||++|||++|+.||.....
T Consensus 221 ~~~~~~------------------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~ 276 (440)
T PTZ00036 221 LLAGQR------------------------SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSS 276 (440)
T ss_pred ccCCCC------------------------cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh
Confidence 532211 112456778999998865 4689999999999999999999999965432
Q ss_pred cchhHHHHHHHHHhhc---------C-----CcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 601 MELNIVQWIQLILEDR---------K-----PMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 601 ~~~~~~~~~~~~~~~~---------~-----~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
.+ .+...++ ..... . ..+......+.... +.....++.+++.+||++||.+|||+.|++++
T Consensus 277 ~~-~~~~i~~-~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~-p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 277 VD-QLVRIIQ-VLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVF-PKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred HH-HHHHHHH-HhCCCCHHHHHHhchhhhcccCCccCchhHHHHh-ccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 21 1111111 11000 0 00000000000000 00123468899999999999999999999866
|
|
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=309.77 Aligned_cols=246 Identities=21% Similarity=0.346 Sum_probs=194.3
Q ss_pred cccCccCceEEEEEEeCC-CceEEEEEcCCCCccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCCHH
Q 042348 373 FLLGKSTIGIVYKVALNN-EEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLA 451 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL~ 451 (686)
..||+|+||.||+|.... +..|++|.+........+.+.+|+.++++++||||+++++++...+..++||||+++++|.
T Consensus 18 ~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~ 97 (292)
T cd06644 18 GELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVD 97 (292)
T ss_pred heecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecCCCCcHH
Confidence 369999999999998764 7899999997766566678999999999999999999999999999999999999999999
Q ss_pred HHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCccc
Q 042348 452 TAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEV 531 (686)
Q Consensus 452 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 531 (686)
.++.... ..+++..+..++.|++.||+|||+ ++++||||||+||+++.++.+||+|||++.......
T Consensus 98 ~~~~~~~-----~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~----- 164 (292)
T cd06644 98 AIMLELD-----RGLTEPQIQVICRQMLEALQYLHS---MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL----- 164 (292)
T ss_pred HHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHhc---CCeeecCCCcceEEEcCCCCEEEccCccceeccccc-----
Confidence 8886543 358999999999999999999999 899999999999999999999999999886432110
Q ss_pred cccccccCCCCCCCccccccccCCCCCccccCccccc-----CCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHH
Q 042348 532 HWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASK-----VRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIV 606 (686)
Q Consensus 532 ~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~ 606 (686)
.......++..|+|||++. ...++.++|||||||++|||++|+.||..... .
T Consensus 165 ------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~-----~ 221 (292)
T cd06644 165 ------------------QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP-----M 221 (292)
T ss_pred ------------------cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccH-----H
Confidence 0011234567799999874 34578899999999999999999999854322 1
Q ss_pred HHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 607 QWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 607 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
..+........+ .... ......++.+++.+||+.+|++||++.|++++
T Consensus 222 ~~~~~~~~~~~~--~~~~--------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 222 RVLLKIAKSEPP--TLSQ--------PSKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred HHHHHHhcCCCc--cCCC--------CcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 112222211111 1100 11123457889999999999999999999875
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=305.88 Aligned_cols=254 Identities=19% Similarity=0.307 Sum_probs=187.8
Q ss_pred ccCccCceEEEEEEeCCC---ceEEEEEcCCCC-ccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCC
Q 042348 374 LLGKSTIGIVYKVALNNE---EAVAVRRLGNGG-WQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGS 449 (686)
Q Consensus 374 ~iG~G~~g~Vy~~~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gs 449 (686)
.||+|+||.||++...++ ..+++|.+.... ....+.+.+|+.+++.++||||+++++++......++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 489999999999975433 346677765432 2345689999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCc
Q 042348 450 LATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETP 529 (686)
Q Consensus 450 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 529 (686)
|.++++..... ....++..+..++.||+.||+|||+ .+++||||||+|||++.++.+||+|||++........
T Consensus 82 L~~~l~~~~~~--~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~-- 154 (268)
T cd05086 82 LKSYLSQEQWH--RRNSQLLLLQRMACEIAAGVTHMHK---HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDY-- 154 (268)
T ss_pred HHHHHHhhhcc--cccccHHHHHHHHHHHHHHHHHHHH---CCeeccCCccceEEEcCCccEEecccccccccCcchh--
Confidence 99999864321 1346777888999999999999999 8999999999999999999999999998863221100
Q ss_pred cccccccccCCCCCCCccccccccCCCCCccccCcccccC-------CCCCCcchHHHHHHHHHHHHh-CCCCccccCcc
Q 042348 530 EVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKV-------RKPTQKWDIYSYGVILLEMIS-GKLPMIQIGSM 601 (686)
Q Consensus 530 ~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~ 601 (686)
........++..|+|||++.. ..++.++|||||||++|||++ |..||.....
T Consensus 155 -------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~- 214 (268)
T cd05086 155 -------------------IETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD- 214 (268)
T ss_pred -------------------hhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH-
Confidence 001122345677999998743 245789999999999999997 5667743322
Q ss_pred chhHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 042348 602 ELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLD 666 (686)
Q Consensus 602 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~ 666 (686)
.+.+.....+. .....++.+.... ...+.+++..|| .+|++||+++||++.|.
T Consensus 215 ----~~~~~~~~~~~--~~~~~~~~~~~~~-----~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 215 ----REVLNHVIKDQ--QVKLFKPQLELPY-----SERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred ----HHHHHHHHhhc--ccccCCCccCCCC-----cHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 12222222221 1223333332222 235667888899 67999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=306.52 Aligned_cols=251 Identities=24% Similarity=0.371 Sum_probs=195.4
Q ss_pred cccCccCceEEEEEEeCCCceEEEEEcCCCCc------cchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccC
Q 042348 373 FLLGKSTIGIVYKVALNNEEAVAVRRLGNGGW------QRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIP 446 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~ 446 (686)
..||+|+||.||+|...+++.+|+|.+..... .....+.+|++++++++|+||+++++++.+.+..++||||++
T Consensus 6 ~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 85 (265)
T cd06631 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFMEFVP 85 (265)
T ss_pred ceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEEecCC
Confidence 46999999999999988889999998864321 123568899999999999999999999999999999999999
Q ss_pred CCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCccccccccc
Q 042348 447 NGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAE 526 (686)
Q Consensus 447 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~ 526 (686)
+++|.+++... ..+++..+..++.|++.||+|||+ .+|+|+||||+||++++++.++|+|||+++......
T Consensus 86 ~~~L~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 156 (265)
T cd06631 86 GGSISSILNRF------GPLPEPVFCKYTKQILDGVAYLHN---NCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVG 156 (265)
T ss_pred CCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHhEEECCCCeEEeccchhhHhhhhcc
Confidence 99999999754 357899999999999999999999 899999999999999999999999999987543211
Q ss_pred CCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHH
Q 042348 527 ETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIV 606 (686)
Q Consensus 527 ~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~ 606 (686)
..... ........++..|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 157 ~~~~~-----------------~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~---- 215 (265)
T cd06631 157 LHGTH-----------------SNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLA---- 215 (265)
T ss_pred ccccc-----------------cccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHH----
Confidence 10000 001123457788999999998889999999999999999999999995432111
Q ss_pred HHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 607 QWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 607 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
.............. +.. .....+.+++.+||+.+|++||++.|++++
T Consensus 216 -~~~~~~~~~~~~~~-----~~~-----~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 262 (265)
T cd06631 216 -AMFYIGAHRGLMPR-----LPD-----SFSAAAIDFVTSCLTRDQHERPSALQLLRH 262 (265)
T ss_pred -HHHHhhhccCCCCC-----CCC-----CCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 11111111111111 111 123457889999999999999999999753
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=340.73 Aligned_cols=274 Identities=23% Similarity=0.253 Sum_probs=199.7
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCC---ccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCC
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGG---WQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNG 448 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~g 448 (686)
..||+|+||.||+|... +++.||+|++.... ....+++.+|++++++++||||+++++++.+.+..++||||+++|
T Consensus 8 ~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVMEY~eGG 87 (932)
T PRK13184 8 RLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMPYIEGY 87 (932)
T ss_pred EEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEEcCCCC
Confidence 46999999999999875 58899999986532 122457899999999999999999999999999999999999999
Q ss_pred CHHHHhhcCCCc-----cccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccc
Q 042348 449 SLATAIHGKAGI-----ISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLAD 523 (686)
Q Consensus 449 sL~~~l~~~~~~-----~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~ 523 (686)
+|.+++...... .....+++..+++++.||+.||+|||+ ++|+||||||+||+++.++.+||+|||+++...
T Consensus 88 SL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs---~GIIHRDLKPeNILLd~dg~vKLiDFGLAk~i~ 164 (932)
T PRK13184 88 TLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHS---KGVLHRDLKPDNILLGLFGEVVILDWGAAIFKK 164 (932)
T ss_pred CHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHH---CCccccCCchheEEEcCCCCEEEEecCcceecc
Confidence 999998642110 001346778889999999999999999 899999999999999999999999999998763
Q ss_pred cccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccch
Q 042348 524 IAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMEL 603 (686)
Q Consensus 524 ~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~ 603 (686)
........ ......+. ...........+||..|+|||++.+..++.++|||||||++|||+||+.||........
T Consensus 165 ~~~~~~~~-l~~~~~~s----~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki 239 (932)
T PRK13184 165 LEEEDLLD-IDVDERNI----CYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKI 239 (932)
T ss_pred cccccccc-cccccccc----cccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhh
Confidence 21110000 00000000 00001122345789999999999998999999999999999999999999954322111
Q ss_pred hHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCC-CHHHHHHHHhccc
Q 042348 604 NIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRP-SMRHVCDSLDRVN 669 (686)
Q Consensus 604 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-s~~ev~~~L~~i~ 669 (686)
. . ......+....+ .......+.+++.+|++.||++|| +++++.+.|+...
T Consensus 240 ~-----~---~~~i~~P~~~~p-------~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~l 291 (932)
T PRK13184 240 S-----Y---RDVILSPIEVAP-------YREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHL 291 (932)
T ss_pred h-----h---hhhccChhhccc-------cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 0 0 000000000000 011234577899999999999995 6777888887753
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=322.28 Aligned_cols=248 Identities=19% Similarity=0.269 Sum_probs=190.8
Q ss_pred hcccCccCceEEEEEEeC-CCceEEEEEcCCC---CccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCC
Q 042348 372 AFLLGKSTIGIVYKVALN-NEEAVAVRRLGNG---GWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPN 447 (686)
Q Consensus 372 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~ 447 (686)
...||+|+||.||++... +++.||+|.+... .......+.+|+.+++.++||||+++++++...+..++||||+++
T Consensus 48 ~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~g 127 (371)
T cd05622 48 VKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPG 127 (371)
T ss_pred EEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCCCC
Confidence 346999999999999876 5788999998542 122335578899999999999999999999999999999999999
Q ss_pred CCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccC
Q 042348 448 GSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEE 527 (686)
Q Consensus 448 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 527 (686)
|+|.+++... .+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 128 g~L~~~~~~~-------~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~ 197 (371)
T cd05622 128 GDLVNLMSNY-------DVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM 197 (371)
T ss_pred CcHHHHHHhc-------CCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCCc
Confidence 9999998643 47888899999999999999999 8999999999999999999999999999976532110
Q ss_pred CccccccccccCCCCCCCccccccccCCCCCccccCcccccCC----CCCCcchHHHHHHHHHHHHhCCCCccccCccch
Q 042348 528 TPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVR----KPTQKWDIYSYGVILLEMISGKLPMIQIGSMEL 603 (686)
Q Consensus 528 ~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~ 603 (686)
.......||..|+|||++... .++.++|||||||++|||++|+.||....
T Consensus 198 ----------------------~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~---- 251 (371)
T cd05622 198 ----------------------VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS---- 251 (371)
T ss_pred ----------------------ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCC----
Confidence 011234678889999998653 37899999999999999999999995432
Q ss_pred hHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCC--CCCHHHHHHHH
Q 042348 604 NIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDK--RPSMRHVCDSL 665 (686)
Q Consensus 604 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~--RPs~~ev~~~L 665 (686)
.......+....... ...+. ......+.+++.+|+..++.+ ||++.|++++.
T Consensus 252 -~~~~~~~i~~~~~~~-~~~~~--------~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 252 -LVGTYSKIMNHKNSL-TFPDD--------NDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred -HHHHHHHHHcCCCcc-cCCCc--------CCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 122233333322111 11000 112235678889999844433 78999998875
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=304.58 Aligned_cols=248 Identities=21% Similarity=0.328 Sum_probs=194.3
Q ss_pred hcccCccCceEEEEEEeC-CCceEEEEEcCCCC-----ccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEecc
Q 042348 372 AFLLGKSTIGIVYKVALN-NEEAVAVRRLGNGG-----WQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYI 445 (686)
Q Consensus 372 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~ 445 (686)
...||+|++|.||++... +++.||+|.+.... ....+.+.+|++++++++||||+++++++...+..++||||+
T Consensus 7 ~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 86 (263)
T cd06625 7 GKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFMEYM 86 (263)
T ss_pred cceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEEEEEC
Confidence 347999999999999864 58899999876432 122356889999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccc
Q 042348 446 PNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIA 525 (686)
Q Consensus 446 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~ 525 (686)
++++|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+||++++++.++|+|||+++.....
T Consensus 87 ~~~~l~~~~~~~------~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~ 157 (263)
T cd06625 87 PGGSVKDQLKAY------GALTETVTRKYTRQILEGVEYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTI 157 (263)
T ss_pred CCCcHHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccceecccc
Confidence 999999998754 358889999999999999999999 89999999999999999999999999998754321
Q ss_pred cCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhH
Q 042348 526 EETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNI 605 (686)
Q Consensus 526 ~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~ 605 (686)
.... .......++..|+|||.+.+..++.++||||||+++|||++|+.||......
T Consensus 158 ~~~~--------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~---- 213 (263)
T cd06625 158 CSSG--------------------TGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAM---- 213 (263)
T ss_pred cccc--------------------ccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchH----
Confidence 1000 0001234566799999999888999999999999999999999999543221
Q ss_pred HHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 606 VQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 606 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
............ +.+. ......+.+++.+||..+|++|||+.|++++
T Consensus 214 -~~~~~~~~~~~~------~~~~-----~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 214 -AAIFKIATQPTN------PQLP-----SHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred -HHHHHHhccCCC------CCCC-----ccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 111111111110 0011 1122357789999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=313.59 Aligned_cols=243 Identities=20% Similarity=0.331 Sum_probs=194.3
Q ss_pred ccCccCceEEEEEEeC-CCceEEEEEcCCCCccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCCHHH
Q 042348 374 LLGKSTIGIVYKVALN-NEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLAT 452 (686)
Q Consensus 374 ~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL~~ 452 (686)
.||+|+||.||++... ++..||||.+........+.+.+|+.++++++||||+++++.+...+..++||||+++++|.+
T Consensus 29 ~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~ 108 (292)
T cd06658 29 KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTD 108 (292)
T ss_pred cccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcHHH
Confidence 5899999999999865 578999999876555556778999999999999999999999999999999999999999999
Q ss_pred HhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCcccc
Q 042348 453 AIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVH 532 (686)
Q Consensus 453 ~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 532 (686)
++.. ..+++.++..++.||+.||+|||+ ++|+||||||+||++++++.++|+|||++........
T Consensus 109 ~~~~-------~~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~----- 173 (292)
T cd06658 109 IVTH-------TRMNEEQIATVCLSVLRALSYLHN---QGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP----- 173 (292)
T ss_pred HHhc-------CCCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc-----
Confidence 8854 247899999999999999999999 8999999999999999999999999999875431110
Q ss_pred ccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHHHHHH
Q 042348 533 WEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQWIQLI 612 (686)
Q Consensus 533 ~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~ 612 (686)
......++..|+|||...+..++.++|||||||++|||++|+.||...... ..+...
T Consensus 174 ------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~-----~~~~~~ 230 (292)
T cd06658 174 ------------------KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPL-----QAMRRI 230 (292)
T ss_pred ------------------cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHH
Confidence 011234677899999998888999999999999999999999999543221 111111
Q ss_pred HhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 613 LEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 613 ~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
.... . +.... .......+.+++.+||+.||++|||+.|++++
T Consensus 231 ~~~~---~----~~~~~---~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 231 RDNL---P----PRVKD---SHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred HhcC---C----Ccccc---ccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 1111 1 10100 01122357788999999999999999999976
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=309.48 Aligned_cols=245 Identities=24% Similarity=0.384 Sum_probs=189.9
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCCccchHHHHHHHHHHhcc-CCCCcceeeEEEEec------CceeEEEec
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGGWQRFKEFQTEAEAIGKI-RHPNIVSLRAYFWSV------DEKLLIYDY 444 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~------~~~~lV~e~ 444 (686)
..||+|+||.||+|... +++.||+|.+.... .....+..|+.++.++ +||||+++++++... ...++||||
T Consensus 12 ~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~ 90 (272)
T cd06637 12 ELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEF 90 (272)
T ss_pred HheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEEEEEEc
Confidence 46999999999999865 57889999986543 3346788999999999 799999999998753 357899999
Q ss_pred cCCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCccccccc
Q 042348 445 IPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADI 524 (686)
Q Consensus 445 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~ 524 (686)
+++|+|.+++..... ..+++..+..++.|++.||+|||+ ++|+||||||+||++++++.++|+|||+++....
T Consensus 91 ~~~~~L~~~l~~~~~----~~l~~~~~~~~~~qi~~~l~~LH~---~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~~ 163 (272)
T cd06637 91 CGAGSVTDLIKNTKG----NTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR 163 (272)
T ss_pred CCCCcHHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHEEECCCCCEEEccCCCceeccc
Confidence 999999999986432 458999999999999999999999 8999999999999999999999999999875432
Q ss_pred ccCCccccccccccCCCCCCCccccccccCCCCCccccCccccc-----CCCCCCcchHHHHHHHHHHHHhCCCCccccC
Q 042348 525 AEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASK-----VRKPTQKWDIYSYGVILLEMISGKLPMIQIG 599 (686)
Q Consensus 525 ~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDVwSlGvvl~elltG~~P~~~~~ 599 (686)
... ......|+..|+|||++. +..++.++|||||||++|||++|+.||....
T Consensus 164 ~~~-----------------------~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~ 220 (272)
T cd06637 164 TVG-----------------------RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH 220 (272)
T ss_pred ccc-----------------------cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccC
Confidence 110 112334677899999885 3457889999999999999999999995432
Q ss_pred ccchhHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 600 SMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 600 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
... ... .... .......+. .....+.+++.+||..+|++|||+.|++++
T Consensus 221 ~~~----~~~-~~~~--~~~~~~~~~---------~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 269 (272)
T cd06637 221 PMR----ALF-LIPR--NPAPRLKSK---------KWSKKFQSFIESCLVKNHSQRPTTEQLMKH 269 (272)
T ss_pred HHH----HHH-HHhc--CCCCCCCCC---------CcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence 211 111 1111 111111111 122357899999999999999999999864
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=310.86 Aligned_cols=244 Identities=21% Similarity=0.398 Sum_probs=195.7
Q ss_pred cccCccCceEEEEEEe-CCCceEEEEEcCCCCccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCCHH
Q 042348 373 FLLGKSTIGIVYKVAL-NNEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLA 451 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL~ 451 (686)
..||.|++|.||+|.. .+++.|++|.+........+.+.+|+.+++.++||||+++++++...+..++||||+++++|.
T Consensus 25 ~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 104 (296)
T cd06655 25 EKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLT 104 (296)
T ss_pred EEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecCCCcHH
Confidence 3599999999999985 468899999987655555678899999999999999999999999999999999999999999
Q ss_pred HHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCccc
Q 042348 452 TAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEV 531 (686)
Q Consensus 452 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 531 (686)
+++.. ..+++.++..++.|++.||+|||+ ++++||||||+||+++.++.+||+|||++........
T Consensus 105 ~~~~~-------~~l~~~~~~~i~~~l~~al~~LH~---~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~---- 170 (296)
T cd06655 105 DVVTE-------TCMDEAQIAAVCRECLQALEFLHA---NQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS---- 170 (296)
T ss_pred HHHHh-------cCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccchhcccccc----
Confidence 99864 348999999999999999999999 8999999999999999999999999999875432211
Q ss_pred cccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHHHHH
Q 042348 532 HWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQWIQL 611 (686)
Q Consensus 532 ~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~ 611 (686)
......++..|+|||.+.+..++.++|||||||++|+|++|+.||....... ....
T Consensus 171 -------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~-----~~~~ 226 (296)
T cd06655 171 -------------------KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR-----ALYL 226 (296)
T ss_pred -------------------cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-----HHHH
Confidence 0112345678999999988889999999999999999999999995433211 1111
Q ss_pred HHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 612 ILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 612 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
......+ ....+ ......+.+++.+||+.||++||++.+++.+
T Consensus 227 ~~~~~~~--~~~~~--------~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 227 IATNGTP--ELQNP--------EKLSPIFRDFLNRCLEMDVEKRGSAKELLQH 269 (296)
T ss_pred HHhcCCc--ccCCc--------ccCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 1111111 00000 1122357789999999999999999999865
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=305.39 Aligned_cols=244 Identities=25% Similarity=0.407 Sum_probs=195.3
Q ss_pred cccCccCceEEEEEEeCC-CceEEEEEcCCCCccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCCHH
Q 042348 373 FLLGKSTIGIVYKVALNN-EEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLA 451 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL~ 451 (686)
..||+|+||.||+|...+ +..+++|.+..... .+++.+|++++++++||||+++++++...+..++++||+++++|.
T Consensus 9 ~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~ 86 (256)
T cd06612 9 EKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVS 86 (256)
T ss_pred hhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCCCCcHH
Confidence 369999999999999875 78999999865432 578999999999999999999999999999999999999999999
Q ss_pred HHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCccc
Q 042348 452 TAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEV 531 (686)
Q Consensus 452 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 531 (686)
+++.... ..+++..+..++.|++.||+|||+ .+++||||+|+||++++++.+||+|||++........
T Consensus 87 ~~l~~~~-----~~l~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~---- 154 (256)
T cd06612 87 DIMKITN-----KTLTEEEIAAILYQTLKGLEYLHS---NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA---- 154 (256)
T ss_pred HHHHhCc-----cCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEECCCCcEEEcccccchhcccCcc----
Confidence 9997543 468999999999999999999999 8999999999999999999999999999876532210
Q ss_pred cccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHHHHH
Q 042348 532 HWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQWIQL 611 (686)
Q Consensus 532 ~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~ 611 (686)
......++..|+|||++.+..++.++|||||||++|+|++|+.||........ ...
T Consensus 155 -------------------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~-----~~~ 210 (256)
T cd06612 155 -------------------KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRA-----IFM 210 (256)
T ss_pred -------------------ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhh-----hhh
Confidence 01123356679999999888899999999999999999999999954322111 111
Q ss_pred HHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 612 ILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 612 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
.... . . +.+. ........+.+++.+||+.||++|||+.||+++
T Consensus 211 ~~~~--~-~----~~~~---~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~ 253 (256)
T cd06612 211 IPNK--P-P----PTLS---DPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQH 253 (256)
T ss_pred hccC--C-C----CCCC---chhhcCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence 0000 0 0 0000 011123467889999999999999999999863
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=303.72 Aligned_cols=248 Identities=27% Similarity=0.407 Sum_probs=197.4
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCCccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCCHH
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLA 451 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL~ 451 (686)
..||+|+||.||+|... +++.+++|.+........+.+.+|++++++++||||+++++++...+..+++|||+++++|.
T Consensus 9 ~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~~~~l~ 88 (262)
T cd06613 9 QRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQ 88 (262)
T ss_pred EEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCCCCCcHH
Confidence 36899999999999875 46789999987665556678999999999999999999999999999999999999999999
Q ss_pred HHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCccc
Q 042348 452 TAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEV 531 (686)
Q Consensus 452 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 531 (686)
+++.... ..+++.++..++.|++.||+|||+ ++|+||||||+||++++++.+||+|||++........
T Consensus 89 ~~~~~~~-----~~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~---- 156 (262)
T cd06613 89 DIYQVTR-----GPLSELQIAYVCRETLKGLAYLHE---TGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA---- 156 (262)
T ss_pred HHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHh---CCceecCCChhhEEECCCCCEEECccccchhhhhhhh----
Confidence 9987653 358899999999999999999999 8999999999999999999999999999875432110
Q ss_pred cccccccCCCCCCCccccccccCCCCCccccCcccccCC---CCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHH
Q 042348 532 HWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVR---KPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQW 608 (686)
Q Consensus 532 ~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~ 608 (686)
......++..|+|||.+... .++.++|||||||++|||+||+.||........
T Consensus 157 -------------------~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~----- 212 (262)
T cd06613 157 -------------------KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRA----- 212 (262)
T ss_pred -------------------ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH-----
Confidence 11123456779999998776 789999999999999999999999954332211
Q ss_pred HHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 609 IQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 609 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
............. +. .......++.+++.+||+.+|++|||+.+|+.+
T Consensus 213 ~~~~~~~~~~~~~-----~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 260 (262)
T cd06613 213 LFLISKSNFPPPK-----LK---DKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH 260 (262)
T ss_pred HHHHHhccCCCcc-----cc---chhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 1111111101000 00 112234568899999999999999999999753
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=304.44 Aligned_cols=245 Identities=23% Similarity=0.342 Sum_probs=195.4
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCC-CccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCCH
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNG-GWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSL 450 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL 450 (686)
..||+|+||.||++... ++..+|+|.++.. .....+.+.+|+.++++++||||+++++++...+..++||||+++|+|
T Consensus 6 ~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l 85 (255)
T cd08219 6 RVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDL 85 (255)
T ss_pred EEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCCCCcH
Confidence 46999999999999865 5788999988543 233456788999999999999999999999999999999999999999
Q ss_pred HHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCcc
Q 042348 451 ATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPE 530 (686)
Q Consensus 451 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 530 (686)
.+++....+ ..+++..++.++.|++.||+|||+ ++|+|+||||+||++++++.++++|||.++.......
T Consensus 86 ~~~~~~~~~----~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~--- 155 (255)
T cd08219 86 MQKIKLQRG----KLFPEDTILQWFVQMCLGVQHIHE---KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA--- 155 (255)
T ss_pred HHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEECCCCcEEEcccCcceeeccccc---
Confidence 999875432 457899999999999999999999 8999999999999999999999999999875532110
Q ss_pred ccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHHHH
Q 042348 531 VHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQWIQ 610 (686)
Q Consensus 531 ~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~ 610 (686)
......++..|+|||++.+..++.++||||||+++|+|++|+.||..... .....
T Consensus 156 --------------------~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~-----~~~~~ 210 (255)
T cd08219 156 --------------------YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSW-----KNLIL 210 (255)
T ss_pred --------------------ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCH-----HHHHH
Confidence 01123466779999999888899999999999999999999999954321 12222
Q ss_pred HHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 611 LILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 611 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
........ . +. ......+.+++.+||+.||++||++.+++..
T Consensus 211 ~~~~~~~~--~-~~---------~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 211 KVCQGSYK--P-LP---------SHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred HHhcCCCC--C-CC---------cccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 22222111 0 00 0122357789999999999999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=308.64 Aligned_cols=254 Identities=24% Similarity=0.354 Sum_probs=200.0
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCC-ccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCCH
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGG-WQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSL 450 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL 450 (686)
+.||+|+||+||++... ++..||+|.+.... ....+.+.+|+++++.++||||+++++++...+..++||||+++++|
T Consensus 11 ~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 90 (284)
T cd06620 11 SDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSL 90 (284)
T ss_pred HHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEecCCCCCH
Confidence 46999999999999865 57889999876532 23356789999999999999999999999999999999999999999
Q ss_pred HHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCcc
Q 042348 451 ATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPE 530 (686)
Q Consensus 451 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 530 (686)
.+++... ..+++..+..++.+++.||.|||+. .+++||||||+||++++++.++|+|||++.......
T Consensus 91 ~~~~~~~------~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~---- 158 (284)
T cd06620 91 DRIYKKG------GPIPVEILGKIAVAVVEGLTYLYNV--HRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI---- 158 (284)
T ss_pred HHHHHhc------cCCCHHHHHHHHHHHHHHHHHHHHh--cCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc----
Confidence 9998764 3589999999999999999999962 479999999999999999999999999986432110
Q ss_pred ccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccc------hh
Q 042348 531 VHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSME------LN 604 (686)
Q Consensus 531 ~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~------~~ 604 (686)
.....++..|+|||++.+..++.++|||||||++||++||+.||......+ ..
T Consensus 159 ---------------------~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~ 217 (284)
T cd06620 159 ---------------------ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMG 217 (284)
T ss_pred ---------------------cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhH
Confidence 012356778999999988889999999999999999999999996543211 11
Q ss_pred HHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccc
Q 042348 605 IVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRVNI 670 (686)
Q Consensus 605 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~ 670 (686)
+..++........+ .+ ........+.+++.+|++.||++|||+.|++++..-++.
T Consensus 218 ~~~~~~~~~~~~~~-------~~----~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~ 272 (284)
T cd06620 218 ILDLLQQIVQEPPP-------RL----PSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQA 272 (284)
T ss_pred HHHHHHHHhhccCC-------CC----CchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence 22333333222111 00 011133467899999999999999999999988655443
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=312.44 Aligned_cols=244 Identities=21% Similarity=0.383 Sum_probs=195.1
Q ss_pred cccCccCceEEEEEEe-CCCceEEEEEcCCCCccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCCHH
Q 042348 373 FLLGKSTIGIVYKVAL-NNEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLA 451 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL~ 451 (686)
..||+|+||.||++.. .+++.||+|.+........+.+.+|+.+++.++||||+++++++...+..++||||+++++|.
T Consensus 25 ~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 104 (297)
T cd06656 25 EKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT 104 (297)
T ss_pred eeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecccCCCCHH
Confidence 4699999999999986 468899999997655555677899999999999999999999999999999999999999999
Q ss_pred HHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCccc
Q 042348 452 TAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEV 531 (686)
Q Consensus 452 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 531 (686)
+++... .+++.++..++.|++.||+|||+ .+++||||||+||+++.++.++|+|||++........
T Consensus 105 ~~~~~~-------~~~~~~~~~~~~~l~~~L~~LH~---~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~---- 170 (297)
T cd06656 105 DVVTET-------CMDEGQIAAVCRECLQALDFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS---- 170 (297)
T ss_pred HHHHhC-------CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEECcCccceEccCCcc----
Confidence 998642 47889999999999999999999 8999999999999999999999999999875432211
Q ss_pred cccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHHHHH
Q 042348 532 HWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQWIQL 611 (686)
Q Consensus 532 ~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~ 611 (686)
......++..|+|||.+.+..++.++|||||||++|++++|+.||........ ...
T Consensus 171 -------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~-----~~~ 226 (297)
T cd06656 171 -------------------KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA-----LYL 226 (297)
T ss_pred -------------------CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchh-----eee
Confidence 01123456779999999888899999999999999999999999954322111 000
Q ss_pred HHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 612 ILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 612 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
......+ .... .......+.+++.+||+.+|++||++.+++++
T Consensus 227 ~~~~~~~--~~~~--------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (297)
T cd06656 227 IATNGTP--ELQN--------PERLSAVFRDFLNRCLEMDVDRRGSAKELLQH 269 (297)
T ss_pred eccCCCC--CCCC--------ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1111100 0000 11122356789999999999999999999884
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=313.00 Aligned_cols=258 Identities=21% Similarity=0.275 Sum_probs=193.9
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCC-ccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCCH
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGG-WQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSL 450 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL 450 (686)
+.||+|+||.||++... ++..+|+|.+.... .....++.+|++++++++||||+++++++...+..++||||+++++|
T Consensus 7 ~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~~~~L 86 (308)
T cd06615 7 GELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL 86 (308)
T ss_pred eeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeeccCCCcH
Confidence 46999999999999865 57788999886542 22345688999999999999999999999999999999999999999
Q ss_pred HHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCcc
Q 042348 451 ATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPE 530 (686)
Q Consensus 451 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 530 (686)
.++++.. ..+++..+..++.|++.||+|||+. .+++||||||+||+++.++.+||+|||++.......
T Consensus 87 ~~~l~~~------~~~~~~~~~~~~~~i~~~l~~lH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~---- 154 (308)
T cd06615 87 DQVLKKA------GRIPENILGKISIAVLRGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM---- 154 (308)
T ss_pred HHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhh--CCEEECCCChHHEEEecCCcEEEccCCCcccccccc----
Confidence 9999764 3588999999999999999999972 379999999999999999999999999986442110
Q ss_pred ccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHHHH
Q 042348 531 VHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQWIQ 610 (686)
Q Consensus 531 ~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~ 610 (686)
.....++..|+|||.+.+..++.++|||||||++|||++|+.||...... ....+..
T Consensus 155 ---------------------~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~--~~~~~~~ 211 (308)
T cd06615 155 ---------------------ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAK--ELEAMFG 211 (308)
T ss_pred ---------------------cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchh--hHHHhhc
Confidence 11235677899999998888999999999999999999999998543211 1111111
Q ss_pred HHHhhcCCcc-------------------cccCcccc---cCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 042348 611 LILEDRKPMT-------------------DILDPFLA---HDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSL 665 (686)
Q Consensus 611 ~~~~~~~~~~-------------------~~~d~~l~---~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L 665 (686)
.......... +..+.... ...........+.+++.+||+.+|++||++.||+++.
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~ 288 (308)
T cd06615 212 RPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHP 288 (308)
T ss_pred CccccccccCCcccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 0000000000 00000000 0000011234588999999999999999999999883
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=308.43 Aligned_cols=242 Identities=24% Similarity=0.396 Sum_probs=194.1
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCC-ccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCCH
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGG-WQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSL 450 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL 450 (686)
+.||+|+||.||+|... ++..||+|.+.... ....+.+.+|++++++++||||+++++++...+..++||||+++++|
T Consensus 10 ~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 89 (277)
T cd06642 10 ERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSA 89 (277)
T ss_pred HHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccCCCcH
Confidence 46999999999999865 57789999886543 23456789999999999999999999999999999999999999999
Q ss_pred HHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCcc
Q 042348 451 ATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPE 530 (686)
Q Consensus 451 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 530 (686)
.+++.. ..+++..+..++.|++.||+|||+ ++++|+||+|+||++++++.++|+|||+++.......
T Consensus 90 ~~~~~~-------~~~~~~~~~~~~~~i~~~l~~lH~---~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~--- 156 (277)
T cd06642 90 LDLLKP-------GPLEETYIATILREILKGLDYLHS---ERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI--- 156 (277)
T ss_pred HHHhhc-------CCCCHHHHHHHHHHHHHHHHHHhc---CCeeccCCChheEEEeCCCCEEEccccccccccCcch---
Confidence 999864 358899999999999999999999 8999999999999999999999999999875532110
Q ss_pred ccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHHHH
Q 042348 531 VHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQWIQ 610 (686)
Q Consensus 531 ~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~ 610 (686)
......++..|+|||++.+..++.++|||||||++|||++|+.||....... ...
T Consensus 157 --------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~-----~~~ 211 (277)
T cd06642 157 --------------------KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMR-----VLF 211 (277)
T ss_pred --------------------hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhh-----HHh
Confidence 0112345677999999998889999999999999999999999985432211 111
Q ss_pred HHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 611 LILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 611 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
...... .+.+. ......+.+++.+||+.+|++||++.+++++
T Consensus 212 ~~~~~~-------~~~~~-----~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 212 LIPKNS-------PPTLE-----GQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred hhhcCC-------CCCCC-----cccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 111111 11111 1233467899999999999999999999986
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=313.65 Aligned_cols=199 Identities=26% Similarity=0.404 Sum_probs=158.7
Q ss_pred cccCccCceEEEEEEeC---CCceEEEEEcCCCCccchHHHHHHHHHHhccCCCCcceeeEEEEe--cCceeEEEeccCC
Q 042348 373 FLLGKSTIGIVYKVALN---NEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWS--VDEKLLIYDYIPN 447 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~--~~~~~lV~e~~~~ 447 (686)
..||+|+||.||+|... ++..||+|.+..... ...+.+|++++++++||||+++++++.. ....++||||++
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~- 83 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI--SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE- 83 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCCC--cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC-
Confidence 46999999999999865 346899999875432 2467899999999999999999999864 456789999996
Q ss_pred CCHHHHhhcCCCc---cccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeee----cCCCCeEEeecCccc
Q 042348 448 GSLATAIHGKAGI---ISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILL----GKNMEPHISDFGLAR 520 (686)
Q Consensus 448 gsL~~~l~~~~~~---~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl----~~~~~~kl~DfGla~ 520 (686)
++|.+++...... .....+++..+..++.|++.||+|||+ ++|+||||||+||++ +.++.+||+|||+++
T Consensus 84 ~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 84 HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 4888887533211 111358899999999999999999999 899999999999999 566799999999998
Q ss_pred ccccccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccC-CCCCCcchHHHHHHHHHHHHhCCCCccc
Q 042348 521 LADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKV-RKPTQKWDIYSYGVILLEMISGKLPMIQ 597 (686)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvvl~elltG~~P~~~ 597 (686)
........ ........+|..|+|||++.+ ..++.++|||||||++|||+||+.||..
T Consensus 161 ~~~~~~~~--------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~ 218 (317)
T cd07867 161 LFNSPLKP--------------------LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred ccCCCccc--------------------ccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccc
Confidence 65422110 011223456888999999876 4589999999999999999999999954
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=321.67 Aligned_cols=255 Identities=24% Similarity=0.293 Sum_probs=188.3
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCC--CccchHHHHHHHHHHhccCCCCcceeeEEEEecC------ceeEEEe
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNG--GWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVD------EKLLIYD 443 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~------~~~lV~e 443 (686)
+.||+|+||.||++... .++.||||++... .......+.+|+.+++.++||||+++++++.... ..++|||
T Consensus 23 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e 102 (355)
T cd07874 23 KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVME 102 (355)
T ss_pred EEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccceeEEEhh
Confidence 46999999999999864 5788999998753 2233467889999999999999999999986543 4699999
Q ss_pred ccCCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccc
Q 042348 444 YIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLAD 523 (686)
Q Consensus 444 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~ 523 (686)
|+++ +|.+.+. ..+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 103 ~~~~-~l~~~~~--------~~l~~~~~~~~~~qi~~aL~~LH~---~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~ 170 (355)
T cd07874 103 LMDA-NLCQVIQ--------MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 170 (355)
T ss_pred hhcc-cHHHHHh--------hcCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEECCCCCEEEeeCcccccCC
Confidence 9965 6777664 247889999999999999999999 899999999999999999999999999997543
Q ss_pred cccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccch
Q 042348 524 IAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMEL 603 (686)
Q Consensus 524 ~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~ 603 (686)
... ......+|..|+|||++.+..++.++|||||||++|||++|+.||......+.
T Consensus 171 ~~~------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~ 226 (355)
T cd07874 171 TSF------------------------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ 226 (355)
T ss_pred Ccc------------------------ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 211 11234567889999999988899999999999999999999999954321110
Q ss_pred hHHHH------------------HHHHHhhcCCcccccCcccc------cCC-CcHHHHHHHHHHHHhccccCCCCCCCH
Q 042348 604 NIVQW------------------IQLILEDRKPMTDILDPFLA------HDL-DKEDEIVSVLKIALDCVHKSPDKRPSM 658 (686)
Q Consensus 604 ~~~~~------------------~~~~~~~~~~~~~~~d~~l~------~~~-~~~~~~~~l~~l~~~cl~~dP~~RPs~ 658 (686)
.... +...............+... .+. ........+.+++.+||+.||++|||+
T Consensus 227 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~ 305 (355)
T cd07874 227 -WNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISV 305 (355)
T ss_pred -HHHHHHHhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCH
Confidence 0000 01111111000000000000 000 001123457899999999999999999
Q ss_pred HHHHHH
Q 042348 659 RHVCDS 664 (686)
Q Consensus 659 ~ev~~~ 664 (686)
.|++++
T Consensus 306 ~ell~h 311 (355)
T cd07874 306 DEALQH 311 (355)
T ss_pred HHHhcC
Confidence 999987
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-36 Score=305.63 Aligned_cols=251 Identities=27% Similarity=0.399 Sum_probs=197.4
Q ss_pred cccCccCceEEEEEEeCC-C----ceEEEEEcCCCCc-cchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccC
Q 042348 373 FLLGKSTIGIVYKVALNN-E----EAVAVRRLGNGGW-QRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIP 446 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~~-~----~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~ 446 (686)
+.||+|+||.||+|.... + ..+|+|.+..... ....++.+|+.++++++||||+++++++.. ...++||||++
T Consensus 13 ~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~ 91 (279)
T cd05057 13 KVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQLITQLMP 91 (279)
T ss_pred ceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEEEEecCC
Confidence 469999999999998643 3 2589998866532 344678899999999999999999999987 78899999999
Q ss_pred CCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCccccccccc
Q 042348 447 NGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAE 526 (686)
Q Consensus 447 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~ 526 (686)
+|+|.+++.... ..+++..+..++.|++.||+|||+ ++|+||||||+||++++++.+||+|||+++......
T Consensus 92 ~g~L~~~l~~~~-----~~~~~~~~~~~~~qi~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~ 163 (279)
T cd05057 92 LGCLLDYVRNHK-----DNIGSQYLLNWCVQIAKGMSYLEE---KRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDE 163 (279)
T ss_pred CCcHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCEEecccCcceEEEcCCCeEEECCCcccccccCcc
Confidence 999999998654 358999999999999999999999 899999999999999999999999999998654221
Q ss_pred CCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCccccCccchhH
Q 042348 527 ETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQIGSMELNI 605 (686)
Q Consensus 527 ~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~~~~ 605 (686)
... ......++..|+|||.+....++.++|||||||++||+++ |+.||.....
T Consensus 164 ~~~---------------------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~----- 217 (279)
T cd05057 164 KEY---------------------HAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA----- 217 (279)
T ss_pred cce---------------------ecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCH-----
Confidence 100 0011123456999999988889999999999999999999 9999954322
Q ss_pred HHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccc
Q 042348 606 VQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRVNI 670 (686)
Q Consensus 606 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~ 670 (686)
.++.+.+.... ... .+ ..+...+.+++.+||..+|++||++.++++.|+++..
T Consensus 218 ~~~~~~~~~~~-~~~---~~--------~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05057 218 VEIPDLLEKGE-RLP---QP--------PICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR 270 (279)
T ss_pred HHHHHHHhCCC-CCC---CC--------CCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 12222222211 110 00 0122357789999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=308.66 Aligned_cols=246 Identities=22% Similarity=0.373 Sum_probs=195.7
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCCccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCCHH
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLA 451 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL~ 451 (686)
..||.|+||.||++... ++..||+|.+........+.+.+|++++++++||||+++++++...+..++||||+++++|.
T Consensus 11 ~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 90 (280)
T cd06611 11 GELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCDGGALD 90 (280)
T ss_pred HHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeeccCCCcHH
Confidence 35999999999999875 57899999987665556678999999999999999999999999999999999999999999
Q ss_pred HHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCccc
Q 042348 452 TAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEV 531 (686)
Q Consensus 452 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 531 (686)
+++.... ..+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.++|+|||++........
T Consensus 91 ~~~~~~~-----~~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~---- 158 (280)
T cd06611 91 SIMLELE-----RGLTEPQIRYVCRQMLEALNFLHS---HKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ---- 158 (280)
T ss_pred HHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEECCCCCEEEccCccchhhccccc----
Confidence 9987643 458999999999999999999999 8999999999999999999999999998865431110
Q ss_pred cccccccCCCCCCCccccccccCCCCCccccCccccc-----CCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHH
Q 042348 532 HWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASK-----VRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIV 606 (686)
Q Consensus 532 ~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~ 606 (686)
......++..|+|||.+. ...++.++||||||+++|||++|+.||..... .
T Consensus 159 -------------------~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~-----~ 214 (280)
T cd06611 159 -------------------KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNP-----M 214 (280)
T ss_pred -------------------ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCH-----H
Confidence 111234677799999874 34578899999999999999999999954322 1
Q ss_pred HHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 607 QWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 607 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
..+........+. ... .......+.+++.+||+.+|++||++.+++++
T Consensus 215 ~~~~~~~~~~~~~--~~~--------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 215 RVLLKILKSEPPT--LDQ--------PSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred HHHHHHhcCCCCC--cCC--------cccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 1122222221110 000 01122357789999999999999999999876
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=319.74 Aligned_cols=185 Identities=24% Similarity=0.355 Sum_probs=157.5
Q ss_pred hcccCccCceEEEEEEeC-CCceEEEEEcCCCCccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCCH
Q 042348 372 AFLLGKSTIGIVYKVALN-NEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSL 450 (686)
Q Consensus 372 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL 450 (686)
...||+|+||.||+|... ++..||+|..... ....|+.++++++||||+++++++...+..++||||+. ++|
T Consensus 71 ~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l 143 (357)
T PHA03209 71 IKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYS-SDL 143 (357)
T ss_pred EEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEccC-CcH
Confidence 346999999999999876 4678999975432 34569999999999999999999999999999999994 689
Q ss_pred HHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCcc
Q 042348 451 ATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPE 530 (686)
Q Consensus 451 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 530 (686)
.+++.... ..+++..+..|+.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 144 ~~~l~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~---- 211 (357)
T PHA03209 144 YTYLTKRS-----RPLPIDQALIIEKQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP---- 211 (357)
T ss_pred HHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEecCccccccccCc----
Confidence 98887543 468999999999999999999999 899999999999999999999999999987432110
Q ss_pred ccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCc
Q 042348 531 VHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPM 595 (686)
Q Consensus 531 ~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~ 595 (686)
......||..|+|||++.+..++.++|||||||++|||+++..|+
T Consensus 212 --------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 212 --------------------AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred --------------------ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 112345778899999999889999999999999999999966555
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=310.37 Aligned_cols=254 Identities=28% Similarity=0.411 Sum_probs=196.3
Q ss_pred cccCccCceEEEEEEeC-CCc----eEEEEEcCCCCc-cchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccC
Q 042348 373 FLLGKSTIGIVYKVALN-NEE----AVAVRRLGNGGW-QRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIP 446 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~ 446 (686)
+.||+|+||.||+|... ++. .||+|.+..... ....++.+|+.++++++||||+++++++... ..++++||++
T Consensus 13 ~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~v~e~~~ 91 (303)
T cd05110 13 KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQLVTQLMP 91 (303)
T ss_pred cccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-CceeeehhcC
Confidence 46999999999999864 343 478888865432 2234688999999999999999999998754 5679999999
Q ss_pred CCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCccccccccc
Q 042348 447 NGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAE 526 (686)
Q Consensus 447 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~ 526 (686)
+|+|.+++.... ..+++..+..++.|++.||+|||+ ++|+||||||+||++++++.+||+|||+++......
T Consensus 92 ~g~l~~~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~ 163 (303)
T cd05110 92 HGCLLDYVHEHK-----DNIGSQLLLNWCVQIAKGMMYLEE---RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDE 163 (303)
T ss_pred CCCHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHhh---cCeeccccccceeeecCCCceEEccccccccccCcc
Confidence 999999997653 358899999999999999999999 899999999999999999999999999998654221
Q ss_pred CCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCccccCccchhH
Q 042348 527 ETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQIGSMELNI 605 (686)
Q Consensus 527 ~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~~~~ 605 (686)
.. .......++..|+|||++.+..++.++|||||||++|||++ |+.||..... ...
T Consensus 164 ~~---------------------~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~--~~~ 220 (303)
T cd05110 164 KE---------------------YNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT--REI 220 (303)
T ss_pred cc---------------------cccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH--HHH
Confidence 10 00112234567999999988889999999999999999998 8999854321 112
Q ss_pred HHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccccch
Q 042348 606 VQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRVNISTE 673 (686)
Q Consensus 606 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~~~~ 673 (686)
..+ ......... + ..+...+.+++.+||..+|++||++.++++.|+++.....
T Consensus 221 ~~~----~~~~~~~~~---~--------~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~~ 273 (303)
T cd05110 221 PDL----LEKGERLPQ---P--------PICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDPQ 273 (303)
T ss_pred HHH----HHCCCCCCC---C--------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhchh
Confidence 221 222111110 0 1122457789999999999999999999999999865544
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=312.23 Aligned_cols=243 Identities=19% Similarity=0.333 Sum_probs=194.5
Q ss_pred ccCccCceEEEEEEeC-CCceEEEEEcCCCCccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCCHHH
Q 042348 374 LLGKSTIGIVYKVALN-NEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLAT 452 (686)
Q Consensus 374 ~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL~~ 452 (686)
.||+|+||.||++... ++..||+|.+........+.+.+|+.+++.++||||+++++++...+..++||||+++++|.+
T Consensus 28 ~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L~~ 107 (297)
T cd06659 28 KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTD 107 (297)
T ss_pred hcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCHHH
Confidence 5999999999999865 588999999876554556778899999999999999999999999999999999999999999
Q ss_pred HhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCcccc
Q 042348 453 AIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVH 532 (686)
Q Consensus 453 ~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 532 (686)
++.. ..+++..+..++.|++.||+|||+ ++++||||||+||+++.++.+||+|||++........
T Consensus 108 ~~~~-------~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~----- 172 (297)
T cd06659 108 IVSQ-------TRLNEEQIATVCESVLQALCYLHS---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP----- 172 (297)
T ss_pred HHhh-------cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHeEEccCCcEEEeechhHhhcccccc-----
Confidence 8754 348899999999999999999999 8999999999999999999999999999875432110
Q ss_pred ccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHHHHHH
Q 042348 533 WEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQWIQLI 612 (686)
Q Consensus 533 ~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~ 612 (686)
......++..|+|||++.+..++.++|||||||++|||++|+.||...... ......
T Consensus 173 ------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-----~~~~~~ 229 (297)
T cd06659 173 ------------------KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPV-----QAMKRL 229 (297)
T ss_pred ------------------cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHH
Confidence 111234677899999998888999999999999999999999999543211 111111
Q ss_pred HhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 613 LEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 613 ~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
......... . .......+.+++.+||+.+|++||++.+++++
T Consensus 230 ~~~~~~~~~-------~---~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 230 RDSPPPKLK-------N---AHKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred hccCCCCcc-------c---cCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 111110000 0 00112357789999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=320.02 Aligned_cols=241 Identities=22% Similarity=0.358 Sum_probs=195.7
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCC----CCccchHHHHHHHHHHhccCCCCcceeeEEEEecCc--eeEEEecc
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGN----GGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDE--KLLIYDYI 445 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~----~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~--~~lV~e~~ 445 (686)
.+||+|+|-+||||... +|..||--.++. ......++|..|+.+|+.|+|||||++|.++.+... ..+|+|.|
T Consensus 46 evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL~ 125 (632)
T KOG0584|consen 46 EVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITELF 125 (632)
T ss_pred hhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeecc
Confidence 46999999999999865 466665332221 223345789999999999999999999999987655 67899999
Q ss_pred CCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecC-CCCeEEeecCccccccc
Q 042348 446 PNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGK-NMEPHISDFGLARLADI 524 (686)
Q Consensus 446 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~-~~~~kl~DfGla~~~~~ 524 (686)
..|+|..|+.+. +.++...++.|++||++||.|||+..| +|||||||-+||+|+. .|.+||+|+|+|.....
T Consensus 126 TSGtLr~Y~kk~------~~vn~kaik~W~RQILkGL~yLHs~~P-PIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~ 198 (632)
T KOG0584|consen 126 TSGTLREYRKKH------RRVNIKAIKSWCRQILKGLVYLHSQDP-PIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK 198 (632)
T ss_pred cCCcHHHHHHHh------ccCCHHHHHHHHHHHHHHhhhhhcCCC-CccccccccceEEEcCCcCceeecchhHHHHhhc
Confidence 999999999876 458889999999999999999999875 8999999999999984 58999999999987653
Q ss_pred ccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchh
Q 042348 525 AEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELN 604 (686)
Q Consensus 525 ~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~ 604 (686)
.. ..+..||+.|||||++. ..|++.+||||||++|+||+|+..||.....
T Consensus 199 s~-------------------------aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n---- 248 (632)
T KOG0584|consen 199 SH-------------------------AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTN---- 248 (632)
T ss_pred cc-------------------------cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCC----
Confidence 22 22356788899999987 7899999999999999999999999965543
Q ss_pred HHHHHHHHHhhcCCc--ccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 605 IVQWIQLILEDRKPM--TDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 605 ~~~~~~~~~~~~~~~--~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
..+.++.+..+.+|. ..+-| .++.+++.+|+.. .++|||+.|++++
T Consensus 249 ~AQIYKKV~SGiKP~sl~kV~d-------------Pevr~fIekCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 249 PAQIYKKVTSGIKPAALSKVKD-------------PEVREFIEKCLAT-KSERLSAKELLKD 296 (632)
T ss_pred HHHHHHHHHcCCCHHHhhccCC-------------HHHHHHHHHHhcC-chhccCHHHHhhC
Confidence 345566666655431 11112 2577899999999 9999999999875
|
|
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=312.92 Aligned_cols=248 Identities=23% Similarity=0.330 Sum_probs=193.5
Q ss_pred hcccCccCceEEEEEEeCCCceEEEEEcCC--CCccchHHHHHHHHHHhcc-CCCCcceeeEEEEecCceeEEEeccCCC
Q 042348 372 AFLLGKSTIGIVYKVALNNEEAVAVRRLGN--GGWQRFKEFQTEAEAIGKI-RHPNIVSLRAYFWSVDEKLLIYDYIPNG 448 (686)
Q Consensus 372 ~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~e~~~~g 448 (686)
...||+||.+.||++...+.+.+|+|++.. .+.+....|.+|+..|.++ .|.+||++++|-..++..|+||||= ..
T Consensus 366 lk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE~G-d~ 444 (677)
T KOG0596|consen 366 LKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVMECG-DI 444 (677)
T ss_pred HHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEeecc-cc
Confidence 346999999999999998888899988754 3555677899999999999 5999999999999999999999986 45
Q ss_pred CHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCC
Q 042348 449 SLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEET 528 (686)
Q Consensus 449 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 528 (686)
||..+|...... ...| .++.+..|++.|+.++|. .||||.||||.|+|+- .|.+||+|||+|..+..+...
T Consensus 445 DL~kiL~k~~~~----~~~~-~lk~ywkqML~aV~~IH~---~gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~DTTs 515 (677)
T KOG0596|consen 445 DLNKILKKKKSI----DPDW-FLKFYWKQMLLAVKTIHQ---HGIVHSDLKPANFLLV-KGRLKLIDFGIANAIQPDTTS 515 (677)
T ss_pred cHHHHHHhccCC----CchH-HHHHHHHHHHHHHHHHHH---hceeecCCCcccEEEE-eeeEEeeeechhcccCccccc
Confidence 999999987642 2334 678899999999999999 9999999999999995 579999999999876543211
Q ss_pred ccccccccccCCCCCCCccccccccCCCCCccccCcccccCCC-----------CCCcchHHHHHHHHHHHHhCCCCccc
Q 042348 529 PEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRK-----------PTQKWDIYSYGVILLEMISGKLPMIQ 597 (686)
Q Consensus 529 ~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----------~~~~sDVwSlGvvl~elltG~~P~~~ 597 (686)
......+||+.||+||.+.... +++++||||+|||||+|+.|+.||..
T Consensus 516 ---------------------I~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~ 574 (677)
T KOG0596|consen 516 ---------------------IVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQ 574 (677)
T ss_pred ---------------------eeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHH
Confidence 1234578899999999875432 56899999999999999999999943
Q ss_pred cCccchhHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 598 IGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 598 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
. ...+.. +..+.||...-.+.......+++++|..||++||.+||++.|++++
T Consensus 575 ~-------~n~~aK-------l~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 575 I-------INQIAK-------LHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred H-------HHHHHH-------HHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 2 111111 2222333221111111122238899999999999999999999987
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=312.86 Aligned_cols=258 Identities=20% Similarity=0.297 Sum_probs=191.0
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCC-ccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCCH
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGG-WQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSL 450 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL 450 (686)
..||+|+||.||+|... +++.||+|.+.... ......+.+|+.++++++||||+++++++...+..++||||++ ++|
T Consensus 12 ~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~-~~l 90 (301)
T cd07873 12 DKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD-KDL 90 (301)
T ss_pred eEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEeccc-cCH
Confidence 35999999999999875 57889999986432 2233567889999999999999999999999999999999997 599
Q ss_pred HHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCcc
Q 042348 451 ATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPE 530 (686)
Q Consensus 451 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 530 (686)
.+++.... ..+++..+..++.|++.||+|||+ ++|+||||||+||++++++.+||+|||+++.......
T Consensus 91 ~~~l~~~~-----~~~~~~~~~~~~~qi~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~--- 159 (301)
T cd07873 91 KQYLDDCG-----NSINMHNVKLFLFQLLRGLNYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK--- 159 (301)
T ss_pred HHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC---
Confidence 99887653 358899999999999999999999 8999999999999999999999999999874321110
Q ss_pred ccccccccCCCCCCCccccccccCCCCCccccCcccccC-CCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHHH
Q 042348 531 VHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKV-RKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQWI 609 (686)
Q Consensus 531 ~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~ 609 (686)
......++..|+|||.+.+ ..++.++|||||||++|||+||+.||...... .....+
T Consensus 160 --------------------~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~--~~~~~~ 217 (301)
T cd07873 160 --------------------TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVE--EQLHFI 217 (301)
T ss_pred --------------------cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHH
Confidence 0112344677999998765 45788999999999999999999999643321 111111
Q ss_pred HHHHhhc--CCcccccC---------cccccCC---CcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 610 QLILEDR--KPMTDILD---------PFLAHDL---DKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 610 ~~~~~~~--~~~~~~~d---------~~l~~~~---~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
....... ..+..+.+ +...... ........+.+++.+||+.||.+|||+.|++++
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h 286 (301)
T cd07873 218 FRILGTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKH 286 (301)
T ss_pred HHHcCCCChhhchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 1111100 00000000 0000000 000122356789999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=300.91 Aligned_cols=245 Identities=22% Similarity=0.365 Sum_probs=193.8
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCC--ccchHHHHHHHHHHhccCCCCcceeeEEEEecC-ceeEEEeccCCC
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGG--WQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVD-EKLLIYDYIPNG 448 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~-~~~lV~e~~~~g 448 (686)
..||+|++|.||++... +++.||+|++.... ....+.+.+|++++++++|+|++++++.+...+ ..++||||++++
T Consensus 6 ~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~ 85 (257)
T cd08223 6 RVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGG 85 (257)
T ss_pred EEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecccCCC
Confidence 46899999999999865 46789999986532 233467889999999999999999999876544 578999999999
Q ss_pred CHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCC
Q 042348 449 SLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEET 528 (686)
Q Consensus 449 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 528 (686)
+|.+++..... ..+++.++..++.|++.||+|||+ ++++||||||+||+++.++.++|+|||+++.......
T Consensus 86 ~l~~~l~~~~~----~~l~~~~~~~~~~~l~~~l~~lH~---~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~- 157 (257)
T cd08223 86 DLYHKLKEQKG----KLLPENQVVEWFVQIAMALQYLHE---KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD- 157 (257)
T ss_pred cHHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCchhEEEecCCcEEEecccceEEecccCC-
Confidence 99999976432 458999999999999999999999 8999999999999999999999999999976532110
Q ss_pred ccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHH
Q 042348 529 PEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQW 608 (686)
Q Consensus 529 ~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~ 608 (686)
......++..|+|||++.+..++.++||||||+++|||++|+.||.... ....
T Consensus 158 ----------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~-----~~~~ 210 (257)
T cd08223 158 ----------------------MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKD-----MNSL 210 (257)
T ss_pred ----------------------ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC-----HHHH
Confidence 0112345677999999998889999999999999999999999985322 1222
Q ss_pred HHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 609 IQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 609 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
......+.. .. . .......+.+++.+|++.+|++||++.+++++
T Consensus 211 ~~~~~~~~~--~~-----~-----~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 211 VYRIIEGKL--PP-----M-----PKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred HHHHHhcCC--CC-----C-----ccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 222222211 11 0 01123467899999999999999999999865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=302.56 Aligned_cols=249 Identities=23% Similarity=0.369 Sum_probs=194.1
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCCcc---------chHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEE
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGGWQ---------RFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIY 442 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---------~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 442 (686)
..||+|++|.||+|... +++.||+|.+...... ..+.+.+|+.++++++||||+++++++...+..++||
T Consensus 6 ~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (267)
T cd06628 6 ALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHLNIFL 85 (267)
T ss_pred ceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCccEEEE
Confidence 46999999999999864 5788999988653221 1246889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCccccc
Q 042348 443 DYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLA 522 (686)
Q Consensus 443 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~ 522 (686)
||+++++|.+++... ..+++..+..++.|++.||+|||+ .+++||||||+||++++++.++|+|||.++..
T Consensus 86 e~~~~~~L~~~l~~~------~~l~~~~~~~~~~~l~~~l~~lH~---~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~ 156 (267)
T cd06628 86 EYVPGGSVAALLNNY------GAFEETLVRNFVRQILKGLNYLHN---RGIIHRDIKGANILVDNKGGIKISDFGISKKL 156 (267)
T ss_pred EecCCCCHHHHHHhc------cCccHHHHHHHHHHHHHHHHHHHh---cCcccccCCHHHEEEcCCCCEEecccCCCccc
Confidence 999999999999764 358899999999999999999999 89999999999999999999999999999866
Q ss_pred ccccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccc
Q 042348 523 DIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSME 602 (686)
Q Consensus 523 ~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~ 602 (686)
......... ........++..|+|||.+.+..++.++|||||||++|||++|+.||......
T Consensus 157 ~~~~~~~~~-----------------~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~- 218 (267)
T cd06628 157 EANSLSTKT-----------------NGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL- 218 (267)
T ss_pred ccccccCCc-----------------cccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH-
Confidence 422110000 00111234677899999998888999999999999999999999999543221
Q ss_pred hhHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 603 LNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 603 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
..+....... .+.+. ......+.+++.+||+.||++||++.||+++
T Consensus 219 ----~~~~~~~~~~-------~~~~~-----~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 264 (267)
T cd06628 219 ----QAIFKIGENA-------SPEIP-----SNISSEAIDFLEKTFEIDHNKRPTAAELLKH 264 (267)
T ss_pred ----HHHHHHhccC-------CCcCC-----cccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence 1111111110 11111 1123467789999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=320.29 Aligned_cols=255 Identities=23% Similarity=0.300 Sum_probs=188.1
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCC--CccchHHHHHHHHHHhccCCCCcceeeEEEEec------CceeEEEe
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNG--GWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSV------DEKLLIYD 443 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~------~~~~lV~e 443 (686)
..||+|+||.||++... .++.||||++... .......+.+|+.+++.++||||+++++++... ...++|||
T Consensus 30 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~~~lv~e 109 (364)
T cd07875 30 KPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVME 109 (364)
T ss_pred EEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccCeEEEEEe
Confidence 46999999999999865 5788999998653 223346788999999999999999999988643 34699999
Q ss_pred ccCCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccc
Q 042348 444 YIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLAD 523 (686)
Q Consensus 444 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~ 523 (686)
|+++ +|.+.+. ..+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++...
T Consensus 110 ~~~~-~l~~~~~--------~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~ 177 (364)
T cd07875 110 LMDA-NLCQVIQ--------MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 177 (364)
T ss_pred CCCC-CHHHHHH--------hcCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEEECCCCcEEEEeCCCccccC
Confidence 9964 7777774 247889999999999999999999 899999999999999999999999999997543
Q ss_pred cccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccch
Q 042348 524 IAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMEL 603 (686)
Q Consensus 524 ~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~ 603 (686)
... ......+|..|+|||++.+..++.++|||||||++|||++|+.||......+
T Consensus 178 ~~~------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~- 232 (364)
T cd07875 178 TSF------------------------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHID- 232 (364)
T ss_pred CCC------------------------cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHH-
Confidence 111 1123456788999999999999999999999999999999999995432211
Q ss_pred hHHHHH------------------HHHHhhcCCccccc-C---ccccc--CC-CcHHHHHHHHHHHHhccccCCCCCCCH
Q 042348 604 NIVQWI------------------QLILEDRKPMTDIL-D---PFLAH--DL-DKEDEIVSVLKIALDCVHKSPDKRPSM 658 (686)
Q Consensus 604 ~~~~~~------------------~~~~~~~~~~~~~~-d---~~l~~--~~-~~~~~~~~l~~l~~~cl~~dP~~RPs~ 658 (686)
.....+ .............. + +.... +. ........+.+++.+||+.||++|||+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~ 312 (364)
T cd07875 233 QWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISV 312 (364)
T ss_pred HHHHHHHhcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCH
Confidence 010000 00011110000000 0 00000 00 000122357899999999999999999
Q ss_pred HHHHHH
Q 042348 659 RHVCDS 664 (686)
Q Consensus 659 ~ev~~~ 664 (686)
.|++++
T Consensus 313 ~e~L~h 318 (364)
T cd07875 313 DEALQH 318 (364)
T ss_pred HHHhcC
Confidence 999987
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=316.45 Aligned_cols=249 Identities=20% Similarity=0.262 Sum_probs=188.9
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCC---CccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCC
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNG---GWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNG 448 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~g 448 (686)
..||+|+||.||++... +++.||+|.+... .....+.+.+|+.++..++|+||+++++++.+.+..++||||+++|
T Consensus 7 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~ 86 (331)
T cd05597 7 KVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMDYYVGG 86 (331)
T ss_pred EEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEecCCCC
Confidence 46999999999999865 5789999998642 2223456889999999999999999999999999999999999999
Q ss_pred CHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCC
Q 042348 449 SLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEET 528 (686)
Q Consensus 449 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 528 (686)
+|.+++.... ..+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||++........
T Consensus 87 ~L~~~l~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~- 157 (331)
T cd05597 87 DLLTLLSKFE-----DRLPEDMARFYLAEMVLAIDSVHQ---LGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT- 157 (331)
T ss_pred cHHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCC-
Confidence 9999997543 358899999999999999999999 8999999999999999999999999999875432111
Q ss_pred ccccccccccCCCCCCCccccccccCCCCCccccCcccccC-----CCCCCcchHHHHHHHHHHHHhCCCCccccCccch
Q 042348 529 PEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKV-----RKPTQKWDIYSYGVILLEMISGKLPMIQIGSMEL 603 (686)
Q Consensus 529 ~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~ 603 (686)
.......||..|+|||++.. ..++.++|||||||++|||++|+.||....
T Consensus 158 ---------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~---- 212 (331)
T cd05597 158 ---------------------VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAES---- 212 (331)
T ss_pred ---------------------ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCC----
Confidence 01112357888999999863 457889999999999999999999995432
Q ss_pred hHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccC--CCCCCCHHHHHHH
Q 042348 604 NIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKS--PDKRPSMRHVCDS 664 (686)
Q Consensus 604 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~d--P~~RPs~~ev~~~ 664 (686)
..+....+...... ... .+.. ......+.+++.+|+..+ +..||++.+++++
T Consensus 213 -~~~~~~~i~~~~~~-~~~-~~~~------~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 213 -LVETYGKIMNHKEH-FQF-PPDV------TDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred -HHHHHHHHHcCCCc-ccC-CCcc------CCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 12222233222111 110 0000 012234667777766543 3347899999888
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=308.05 Aligned_cols=258 Identities=22% Similarity=0.267 Sum_probs=187.2
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCCc--cchHHHHHHHHHHhcc---CCCCcceeeEEEEec-----CceeEE
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGGW--QRFKEFQTEAEAIGKI---RHPNIVSLRAYFWSV-----DEKLLI 441 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~H~nIv~l~~~~~~~-----~~~~lV 441 (686)
..||+|+||.||+|... +++.||+|.+..... .....+.+|+.+++++ +||||+++++++... ...++|
T Consensus 6 ~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~~~lv 85 (288)
T cd07863 6 AEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETKVTLV 85 (288)
T ss_pred eEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCceEEEE
Confidence 35999999999999875 588999998865321 1224566788777765 699999999998653 347899
Q ss_pred EeccCCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccc
Q 042348 442 YDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARL 521 (686)
Q Consensus 442 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~ 521 (686)
|||++ ++|.+++..... ..+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++.
T Consensus 86 ~e~~~-~~l~~~~~~~~~----~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~kl~dfg~~~~ 157 (288)
T cd07863 86 FEHVD-QDLRTYLDKVPP----PGLPAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGQVKLADFGLARI 157 (288)
T ss_pred Ecccc-cCHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECccCcccc
Confidence 99997 589998876432 358999999999999999999999 8999999999999999999999999999975
Q ss_pred cccccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCcc
Q 042348 522 ADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSM 601 (686)
Q Consensus 522 ~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~ 601 (686)
..... ......+|..|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 158 ~~~~~------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~ 213 (288)
T cd07863 158 YSCQM------------------------ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA 213 (288)
T ss_pred ccCcc------------------------cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHH
Confidence 53211 011234677899999998888999999999999999999999998543221
Q ss_pred chhHHHHHHHHHhhc--CCccc-------ccCcccccCC--CcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 602 ELNIVQWIQLILEDR--KPMTD-------ILDPFLAHDL--DKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 602 ~~~~~~~~~~~~~~~--~~~~~-------~~d~~l~~~~--~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
+ .+.. +....... ..+.. .+.+...... ..+.....+.+++.+||+.||++|||+.|++.+
T Consensus 214 ~-~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h 285 (288)
T cd07863 214 D-QLGK-IFDLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH 285 (288)
T ss_pred H-HHHH-HHHHhCCCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 1 1111 11111000 00000 0000000000 001123457799999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=301.33 Aligned_cols=242 Identities=26% Similarity=0.447 Sum_probs=191.4
Q ss_pred hcccCccCceEEEEEEeCCCceEEEEEcCCCCccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCCHH
Q 042348 372 AFLLGKSTIGIVYKVALNNEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLA 451 (686)
Q Consensus 372 ~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL~ 451 (686)
...||+|+||.||++.. .++.||+|.+.... ..+.+.+|+.++++++||||+++++++... ..++||||+++++|.
T Consensus 11 ~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~~~~L~ 86 (254)
T cd05083 11 GEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMSKGNLV 86 (254)
T ss_pred eeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCCCCCHH
Confidence 34799999999999975 56789999986532 346789999999999999999999998654 579999999999999
Q ss_pred HHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCccc
Q 042348 452 TAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEV 531 (686)
Q Consensus 452 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 531 (686)
+++..... ..+++..+..++.|++.||+|||+ ++++||||||+||+++.++.+||+|||+++......
T Consensus 87 ~~l~~~~~----~~~~~~~~~~~~~qi~~al~~lH~---~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~----- 154 (254)
T cd05083 87 NFLRTRGR----ALVSVIQLLQFSLDVAEGMEYLES---KKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV----- 154 (254)
T ss_pred HHHHhcCc----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCcEEECCCccceeccccC-----
Confidence 99976532 358899999999999999999999 899999999999999999999999999987432110
Q ss_pred cccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCccccCccchhHHHHHH
Q 042348 532 HWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQIGSMELNIVQWIQ 610 (686)
Q Consensus 532 ~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~~~~~~~~~ 610 (686)
.....+..|+|||.+.+..++.++|||||||++|||++ |+.||..... .....
T Consensus 155 ---------------------~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-----~~~~~ 208 (254)
T cd05083 155 ---------------------DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSL-----KEVKE 208 (254)
T ss_pred ---------------------CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCH-----HHHHH
Confidence 01112345999999988889999999999999999998 9999854322 12222
Q ss_pred HHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 042348 611 LILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDR 667 (686)
Q Consensus 611 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~ 667 (686)
..... ... + + .......+.+++.+||+.+|++||+++++++.|++
T Consensus 209 ~~~~~-~~~-~---~-------~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 209 CVEKG-YRM-E---P-------PEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred HHhCC-CCC-C---C-------CCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 22111 111 0 0 01123467799999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-36 Score=306.31 Aligned_cols=259 Identities=21% Similarity=0.288 Sum_probs=190.2
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCC--ccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCC
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGG--WQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGS 449 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gs 449 (686)
..||+|++|.||+|... ++..||+|.+.... ....+.+.+|+.++++++||||+++++++..++..++||||++ ++
T Consensus 6 ~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~ 84 (285)
T cd07861 6 EKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFLS-MD 84 (285)
T ss_pred eEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecCC-CC
Confidence 35899999999999875 58899999986432 2234678899999999999999999999999999999999997 68
Q ss_pred HHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCc
Q 042348 450 LATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETP 529 (686)
Q Consensus 450 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 529 (686)
|.+++...... ..+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++.......
T Consensus 85 l~~~~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~-- 156 (285)
T cd07861 85 LKKYLDSLPKG---QYMDAELVKSYLYQILQGILFCHS---RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR-- 156 (285)
T ss_pred HHHHHhcCCCC---CcCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEEcCCCcEEECcccceeecCCCcc--
Confidence 98888654321 458999999999999999999999 8999999999999999999999999999875431110
Q ss_pred cccccccccCCCCCCCccccccccCCCCCccccCcccccC-CCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHH
Q 042348 530 EVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKV-RKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQW 608 (686)
Q Consensus 530 ~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~ 608 (686)
......++..|+|||.+.+ ..++.++|||||||++|||+||+.||....... .....
T Consensus 157 ---------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~-~~~~~ 214 (285)
T cd07861 157 ---------------------VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEID-QLFRI 214 (285)
T ss_pred ---------------------cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH-HHHHH
Confidence 0112345677999998765 457899999999999999999999995432211 11111
Q ss_pred HHHHHh--------------hcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 609 IQLILE--------------DRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 609 ~~~~~~--------------~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
...... ................ ......++.+++.+||+.||++|||+.+|+++
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 215 FRILGTPTEDVWPGVTSLPDYKNTFPKWKKGSLRSA--VKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred HHHhCCCChhhhhcchhhHHHHhhccccCcchhHHh--cCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 000000 0000000000000000 00123456789999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-36 Score=304.79 Aligned_cols=253 Identities=24% Similarity=0.377 Sum_probs=195.7
Q ss_pred ccCccCceEEEEEEeC------CCceEEEEEcCCCCcc-chHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccC
Q 042348 374 LLGKSTIGIVYKVALN------NEEAVAVRRLGNGGWQ-RFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIP 446 (686)
Q Consensus 374 ~iG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~ 446 (686)
.||+|+||.||+|+.. +...|++|.+...... ..+.+.+|++++++++|+||+++++++.+.+..++||||++
T Consensus 12 ~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 91 (275)
T cd05046 12 TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTD 91 (275)
T ss_pred eecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcceEEEEecC
Confidence 5899999999999864 2457999988664433 35679999999999999999999999999899999999999
Q ss_pred CCCHHHHhhcCCCcc---ccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccc
Q 042348 447 NGSLATAIHGKAGII---SYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLAD 523 (686)
Q Consensus 447 ~gsL~~~l~~~~~~~---~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~ 523 (686)
+|+|.+++....... ....+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.++++|||+++...
T Consensus 92 ~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dlkp~Nili~~~~~~~l~~~~~~~~~~ 168 (275)
T cd05046 92 LGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSN---ARFVHRDLAARNCLVSSQREVKVSLLSLSKDVY 168 (275)
T ss_pred CCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhh---cCcccCcCccceEEEeCCCcEEEcccccccccC
Confidence 999999997654211 01258999999999999999999999 899999999999999999999999999986432
Q ss_pred cccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCccccCccc
Q 042348 524 IAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQIGSME 602 (686)
Q Consensus 524 ~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~ 602 (686)
.... .......++..|+|||.+.+..++.++||||||+++|+|++ |..||.....
T Consensus 169 ~~~~----------------------~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~-- 224 (275)
T cd05046 169 NSEY----------------------YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD-- 224 (275)
T ss_pred cccc----------------------cccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccch--
Confidence 1110 01112234566999999988888999999999999999999 8888843221
Q ss_pred hhHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 042348 603 LNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDR 667 (686)
Q Consensus 603 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~ 667 (686)
. ..+........... . + ......+.+++.+||+.+|++||++.|+++.|.+
T Consensus 225 ~---~~~~~~~~~~~~~~--~-~--------~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~~ 275 (275)
T cd05046 225 E---EVLNRLQAGKLELP--V-P--------EGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE 275 (275)
T ss_pred H---HHHHHHHcCCcCCC--C-C--------CCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhcC
Confidence 1 12222221111110 0 0 1123468899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=302.63 Aligned_cols=243 Identities=21% Similarity=0.371 Sum_probs=195.6
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCC-ccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCCH
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGG-WQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSL 450 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL 450 (686)
..||.|+||.||+|... ++..||+|.+.... ......+.+|+.++++++||||+++++++.+.+..++||||+++|+|
T Consensus 10 ~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 89 (277)
T cd06640 10 ERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSA 89 (277)
T ss_pred hhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecCCCCcH
Confidence 45999999999999875 57889999886542 33456789999999999999999999999999999999999999999
Q ss_pred HHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCcc
Q 042348 451 ATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPE 530 (686)
Q Consensus 451 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 530 (686)
.+++.. ..+++..+..++.|++.||+|||+ .+++|+||+|+||+++.++.++|+|||++........
T Consensus 90 ~~~i~~-------~~l~~~~~~~~~~~l~~~l~~lh~---~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~--- 156 (277)
T cd06640 90 LDLLRA-------GPFDEFQIATMLKEILKGLDYLHS---EKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI--- 156 (277)
T ss_pred HHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHh---CCccCcCCChhhEEEcCCCCEEEcccccceeccCCcc---
Confidence 999864 247889999999999999999999 8999999999999999999999999999875432110
Q ss_pred ccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHHHH
Q 042348 531 VHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQWIQ 610 (686)
Q Consensus 531 ~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~ 610 (686)
......++..|+|||++.+..++.++|||||||++|||+||+.||....... ...
T Consensus 157 --------------------~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~-----~~~ 211 (277)
T cd06640 157 --------------------KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMR-----VLF 211 (277)
T ss_pred --------------------ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHh-----Hhh
Confidence 0112345677999999988889999999999999999999999985432211 111
Q ss_pred HHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 042348 611 LILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSL 665 (686)
Q Consensus 611 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L 665 (686)
....... +. ........+.+++.+||+.+|++||++.+++.+-
T Consensus 212 ~~~~~~~-------~~-----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 254 (277)
T cd06640 212 LIPKNNP-------PT-----LTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHK 254 (277)
T ss_pred hhhcCCC-------CC-----CchhhhHHHHHHHHHHcccCcccCcCHHHHHhCh
Confidence 1111100 11 1123455788999999999999999999998874
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=299.97 Aligned_cols=246 Identities=19% Similarity=0.309 Sum_probs=197.4
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCC--CccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCC
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNG--GWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGS 449 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gs 449 (686)
+.||.|+||.||.++.. ++..+++|.+... .....+++.+|++++++++|+||+++++++.+.+..++||||+++|+
T Consensus 6 ~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~~~~~ 85 (256)
T cd08221 6 RVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGT 85 (256)
T ss_pred eEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEecCCCc
Confidence 47999999999998854 5788999987643 23445678999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCc
Q 042348 450 LATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETP 529 (686)
Q Consensus 450 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 529 (686)
|.+++....+ ..+++.++..++.|++.||+|||+ .+++||||||+||++++++.+||+|||+++.......
T Consensus 86 L~~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~-- 156 (256)
T cd08221 86 LYDKIVRQKG----QLFEEEMVLWYLFQIVSAVSYIHK---AGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS-- 156 (256)
T ss_pred HHHHHHhccc----cCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCChHhEEEeCCCCEEECcCcceEEcccccc--
Confidence 9999976532 458999999999999999999999 8999999999999999999999999999876532210
Q ss_pred cccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHHH
Q 042348 530 EVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQWI 609 (686)
Q Consensus 530 ~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~ 609 (686)
......++..|+|||...+..++.++||||||+++|||++|+.||.... ..+..
T Consensus 157 ---------------------~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~-----~~~~~ 210 (256)
T cd08221 157 ---------------------MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATN-----PLNLV 210 (256)
T ss_pred ---------------------cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCC-----HHHHH
Confidence 1112346778999999988888999999999999999999999995422 22223
Q ss_pred HHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 042348 610 QLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSL 665 (686)
Q Consensus 610 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L 665 (686)
..+...... .. . ......+.+++.+||+.+|++||++.|+++++
T Consensus 211 ~~~~~~~~~--~~-~---------~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 211 VKIVQGNYT--PV-V---------SVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred HHHHcCCCC--CC-c---------cccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 333222111 10 0 11234577899999999999999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=329.82 Aligned_cols=254 Identities=20% Similarity=0.240 Sum_probs=183.3
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCCccchHHHHHHHHHHhccCC------CCcceeeEEEEec-CceeEEEec
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRH------PNIVSLRAYFWSV-DEKLLIYDY 444 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H------~nIv~l~~~~~~~-~~~~lV~e~ 444 (686)
..||+|+||.||+|... .++.||||+++.... ..+.+..|+.++.+++| .+++++++++... ++.++|||+
T Consensus 135 ~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~-~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~~iv~~~ 213 (467)
T PTZ00284 135 SLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPK-YTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMCIVMPK 213 (467)
T ss_pred EEEEeccCEEEEEEEEcCCCeEEEEEEEecchh-hHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceEEEEEec
Confidence 46999999999999865 578899999865321 22455667777777654 4588999988765 467899999
Q ss_pred cCCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCC---------------
Q 042348 445 IPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNM--------------- 509 (686)
Q Consensus 445 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~--------------- 509 (686)
+ +++|.+++... ..+++..+..|+.||+.||+|||+. .+||||||||+|||++.++
T Consensus 214 ~-g~~l~~~l~~~------~~l~~~~~~~i~~qi~~aL~yLH~~--~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~ 284 (467)
T PTZ00284 214 Y-GPCLLDWIMKH------GPFSHRHLAQIIFQTGVALDYFHTE--LHLMHTDLKPENILMETSDTVVDPVTNRALPPDP 284 (467)
T ss_pred c-CCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHhc--CCeecCCCCHHHEEEecCCcccccccccccCCCC
Confidence 8 77899988754 3589999999999999999999971 3899999999999998765
Q ss_pred -CeEEeecCcccccccccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHH
Q 042348 510 -EPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEM 588 (686)
Q Consensus 510 -~~kl~DfGla~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~el 588 (686)
.+||+|||.+..... .....+||..|+|||++.+..++.++|||||||++|||
T Consensus 285 ~~vkl~DfG~~~~~~~--------------------------~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~el 338 (467)
T PTZ00284 285 CRVRICDLGGCCDERH--------------------------SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYEL 338 (467)
T ss_pred ceEEECCCCccccCcc--------------------------ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHH
Confidence 499999998753211 11234678889999999999999999999999999999
Q ss_pred HhCCCCccccCccchhHHHHHHHHHhh--------------------cCCcccccCcccc----cC--CCcHHHHHHHHH
Q 042348 589 ISGKLPMIQIGSMELNIVQWIQLILED--------------------RKPMTDILDPFLA----HD--LDKEDEIVSVLK 642 (686)
Q Consensus 589 ltG~~P~~~~~~~~~~~~~~~~~~~~~--------------------~~~~~~~~d~~l~----~~--~~~~~~~~~l~~ 642 (686)
++|+.||..... .+....+...... ........++... .. .........+.+
T Consensus 339 ltG~~pf~~~~~--~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 416 (467)
T PTZ00284 339 YTGKLLYDTHDN--LEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCD 416 (467)
T ss_pred HhCCCCCCCCCh--HHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHH
Confidence 999999954332 1222212111100 0000000011000 00 000011235779
Q ss_pred HHHhccccCCCCCCCHHHHHHH
Q 042348 643 IALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 643 l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
|+.+||++||++|||++|+++|
T Consensus 417 li~~mL~~dP~~R~ta~e~L~H 438 (467)
T PTZ00284 417 LIYGLLHYDRQKRLNARQMTTH 438 (467)
T ss_pred HHHHhCCcChhhCCCHHHHhcC
Confidence 9999999999999999999975
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=316.30 Aligned_cols=249 Identities=20% Similarity=0.259 Sum_probs=190.4
Q ss_pred cccCccCceEEEEEEeCC-CceEEEEEcCCCC---ccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCC
Q 042348 373 FLLGKSTIGIVYKVALNN-EEAVAVRRLGNGG---WQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNG 448 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~g 448 (686)
..||+|+||.||++.... ++.+|+|.+.... ......+..|+.++..++|+||+++++++.+.+..++||||+++|
T Consensus 7 ~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ey~~~g 86 (332)
T cd05623 7 KVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDYYVGG 86 (332)
T ss_pred EEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEeccCCC
Confidence 469999999999998764 6789999986421 122345888999999999999999999999999999999999999
Q ss_pred CHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCC
Q 042348 449 SLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEET 528 (686)
Q Consensus 449 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 528 (686)
+|.+++.... ..+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 87 ~L~~~l~~~~-----~~l~~~~~~~~~~qi~~al~~lH~---~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~- 157 (332)
T cd05623 87 DLLTLLSKFE-----DRLPEDMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT- 157 (332)
T ss_pred cHHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEeecchheecccCCc-
Confidence 9999997643 358999999999999999999999 8999999999999999999999999999875432110
Q ss_pred ccccccccccCCCCCCCccccccccCCCCCccccCccccc-----CCCCCCcchHHHHHHHHHHHHhCCCCccccCccch
Q 042348 529 PEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASK-----VRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMEL 603 (686)
Q Consensus 529 ~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~ 603 (686)
.......||..|+|||++. ...++.++|||||||++|||++|+.||....
T Consensus 158 ---------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~---- 212 (332)
T cd05623 158 ---------------------VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAES---- 212 (332)
T ss_pred ---------------------ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCC----
Confidence 0112345788899999885 3468899999999999999999999995432
Q ss_pred hHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCC--CCCHHHHHHH
Q 042348 604 NIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDK--RPSMRHVCDS 664 (686)
Q Consensus 604 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~--RPs~~ev~~~ 664 (686)
..+....+........ +... .......+.+++.+|+..++++ |+++.|++++
T Consensus 213 -~~~~~~~i~~~~~~~~--~p~~------~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 213 -LVETYGKIMNHKERFQ--FPAQ------VTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred -HHHHHHHHhCCCcccc--CCCc------cccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 2233333333221110 0000 0112335677888877654444 6899999888
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=337.79 Aligned_cols=248 Identities=21% Similarity=0.353 Sum_probs=188.4
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCC--CccchHHHHHHHHHHhccCCCCcceeeEEEEec--CceeEEEeccCC
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNG--GWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSV--DEKLLIYDYIPN 447 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~~lV~e~~~~ 447 (686)
..||+|+||.||++... .+..||+|.+... .......|..|+.++++++|||||+++++|... +..++||||+++
T Consensus 19 ~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyIVMEY~~g 98 (1021)
T PTZ00266 19 KKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDA 98 (1021)
T ss_pred EEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEEEEeCCCC
Confidence 36999999999999875 4678899988653 223356789999999999999999999998654 467999999999
Q ss_pred CCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCC----CCceecCCCCCCeeecC----------------
Q 042348 448 GSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSP----KRYVHGDLRPSNILLGK---------------- 507 (686)
Q Consensus 448 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~----~~iiHrDlkp~NILl~~---------------- 507 (686)
|+|.++|...... ...+++..++.|+.||+.||+|||+... ++||||||||+|||++.
T Consensus 99 GSL~~lL~k~~~~--~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~n~n 176 (1021)
T PTZ00266 99 GDLSRNIQKCYKM--FGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLN 176 (1021)
T ss_pred CcHHHHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccccccccC
Confidence 9999999753211 1468999999999999999999998321 35999999999999964
Q ss_pred -CCCeEEeecCcccccccccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccC--CCCCCcchHHHHHHH
Q 042348 508 -NMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKV--RKPTQKWDIYSYGVI 584 (686)
Q Consensus 508 -~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDVwSlGvv 584 (686)
...+||+|||+++.+.... ......||+.|+|||++.+ ..++.++||||||||
T Consensus 177 g~~iVKLsDFGlAr~l~~~s------------------------~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~I 232 (1021)
T PTZ00266 177 GRPIAKIGDFGLSKNIGIES------------------------MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCI 232 (1021)
T ss_pred CCCceEEccCCccccccccc------------------------cccccCCCccccCHHHHhccCCCCCchhHHHHHHHH
Confidence 2358999999997543211 1123457888999998854 458999999999999
Q ss_pred HHHHHhCCCCccccCccchhHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042348 585 LLEMISGKLPMIQIGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCD 663 (686)
Q Consensus 585 l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 663 (686)
+|||+||+.||..... ....+..+ ......+ + ......+.+++..||+.+|++||++.|++.
T Consensus 233 LYELLTGk~PF~~~~~----~~qli~~l-k~~p~lp------i------~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 233 IYELCSGKTPFHKANN----FSQLISEL-KRGPDLP------I------KGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred HHHHHHCCCCCCcCCc----HHHHHHHH-hcCCCCC------c------CCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 9999999999954322 11222222 1111110 0 011245788999999999999999999984
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=303.40 Aligned_cols=255 Identities=23% Similarity=0.376 Sum_probs=193.5
Q ss_pred cccCccCceEEEEEEeC----CCceEEEEEcCCC--CccchHHHHHHHHHHhccCCCCcceeeEEEEecC------ceeE
Q 042348 373 FLLGKSTIGIVYKVALN----NEEAVAVRRLGNG--GWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVD------EKLL 440 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~----~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~------~~~l 440 (686)
..||+|+||.||+|... ++..||||.+... .....+++.+|++++++++||||+++++++...+ ..++
T Consensus 5 ~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~ 84 (273)
T cd05074 5 RMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMV 84 (273)
T ss_pred hcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccceEE
Confidence 46999999999999854 3678999998654 2234567889999999999999999999986543 2378
Q ss_pred EEeccCCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCccc
Q 042348 441 IYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLAR 520 (686)
Q Consensus 441 V~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~ 520 (686)
++||+++|+|.+++...........+++..++.++.|++.||+|||+ ++|+||||||+||++++++.+||+|||+++
T Consensus 85 ~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~nili~~~~~~kl~dfg~~~ 161 (273)
T cd05074 85 ILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSS---KNFIHRDLAARNCMLNENMTVCVADFGLSK 161 (273)
T ss_pred EEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccchhhEEEcCCCCEEECcccccc
Confidence 99999999999887643211112357899999999999999999999 899999999999999999999999999988
Q ss_pred ccccccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCccccC
Q 042348 521 LADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQIG 599 (686)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~ 599 (686)
........ .......++..|++||.+....++.++|||||||++|||++ |+.||....
T Consensus 162 ~~~~~~~~---------------------~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~ 220 (273)
T cd05074 162 KIYSGDYY---------------------RQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVE 220 (273)
T ss_pred cccCCcce---------------------ecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCC
Confidence 55321100 00011223456999999988889999999999999999999 888885432
Q ss_pred ccchhHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 042348 600 SMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRV 668 (686)
Q Consensus 600 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i 668 (686)
. .+. ...+.... .... . ......+.+++.+||+.+|++||++.|+++.|+++
T Consensus 221 ~--~~~---~~~~~~~~-~~~~--~---------~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 221 N--SEI---YNYLIKGN-RLKQ--P---------PDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred H--HHH---HHHHHcCC-cCCC--C---------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 2 111 11111111 1110 0 11234688999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=306.07 Aligned_cols=249 Identities=30% Similarity=0.465 Sum_probs=194.9
Q ss_pred cccCccCceEEEEEEeCC-CceEEEEEcCCCCccch--HHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCC
Q 042348 373 FLLGKSTIGIVYKVALNN-EEAVAVRRLGNGGWQRF--KEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGS 449 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~--~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gs 449 (686)
+.||+|+||.||++.... ++.+|+|.+........ ....+|+.++++++||||+++++++...+..++||||+++++
T Consensus 5 ~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~~~~~ 84 (260)
T PF00069_consen 5 KKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYCPGGS 84 (260)
T ss_dssp EEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEETTEB
T ss_pred EEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccccccc
Confidence 469999999999999775 56899999977644332 234569999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCc
Q 042348 450 LATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETP 529 (686)
Q Consensus 450 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 529 (686)
|.+++... ..+++..+..++.|+++||+|||+ .+|+||||||+||++++++.++|+|||.+.......
T Consensus 85 L~~~l~~~------~~~~~~~~~~~~~qi~~~L~~Lh~---~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~--- 152 (260)
T PF00069_consen 85 LQDYLQKN------KPLSEEEILKIAYQILEALAYLHS---KGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENN--- 152 (260)
T ss_dssp HHHHHHHH------SSBBHHHHHHHHHHHHHHHHHHHH---TTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTT---
T ss_pred cccccccc------cccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccc---
Confidence 99999832 468999999999999999999999 899999999999999999999999999987541100
Q ss_pred cccccccccCCCCCCCccccccccCCCCCccccCccccc-CCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHH
Q 042348 530 EVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASK-VRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQW 608 (686)
Q Consensus 530 ~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~ 608 (686)
.......++..|+|||++. +..++.++||||+|+++|+|++|..||..... .+....
T Consensus 153 --------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~--~~~~~~ 210 (260)
T PF00069_consen 153 --------------------ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNS--DDQLEI 210 (260)
T ss_dssp --------------------SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSH--HHHHHH
T ss_pred --------------------cccccccccccccccccccccccccccccccccccccccccccccccccccc--hhhhhh
Confidence 1223455677899999998 78899999999999999999999999965411 111122
Q ss_pred HHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 609 IQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 609 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
.......... ... .........+.+++.+||+.||++||++.+++++
T Consensus 211 ~~~~~~~~~~--~~~-------~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~ 257 (260)
T PF00069_consen 211 IEKILKRPLP--SSS-------QQSREKSEELRDLIKKMLSKDPEQRPSAEELLKH 257 (260)
T ss_dssp HHHHHHTHHH--HHT-------TSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred hhhccccccc--ccc-------cccchhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 2222111000 000 0000012578899999999999999999999864
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=321.32 Aligned_cols=266 Identities=20% Similarity=0.271 Sum_probs=193.6
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCC---ccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCC
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGG---WQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNG 448 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~g 448 (686)
..||+|+||.||++... +++.||+|.+.... ......+..|+.++.+++||||+++++++.+.+..++||||+++|
T Consensus 7 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~~~gg 86 (360)
T cd05627 7 KVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLPGG 86 (360)
T ss_pred EEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCCc
Confidence 46999999999999875 57899999986432 223456888999999999999999999999999999999999999
Q ss_pred CHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCC
Q 042348 449 SLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEET 528 (686)
Q Consensus 449 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 528 (686)
+|.+++... ..+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++........
T Consensus 87 ~L~~~l~~~------~~l~~~~~~~~~~qi~~~L~~lH~---~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~ 157 (360)
T cd05627 87 DMMTLLMKK------DTLSEEATQFYIAETVLAIDAIHQ---LGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRT 157 (360)
T ss_pred cHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEeeccCCccccccccc
Confidence 999999764 358999999999999999999999 99999999999999999999999999999865432111
Q ss_pred ccccccccccCCCC---------CCCc-----cccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCC
Q 042348 529 PEVHWEQSTTGTPL---------QSSP-----YEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLP 594 (686)
Q Consensus 529 ~~~~~~~~~~g~~~---------~~~~-----~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P 594 (686)
... .......+. .... .........+||..|+|||++.+..++.++|||||||++|||+||+.|
T Consensus 158 ~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~P 235 (360)
T cd05627 158 EFY--RNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235 (360)
T ss_pred ccc--cccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCC
Confidence 000 000000000 0000 000112245789999999999999999999999999999999999999
Q ss_pred ccccCccchhHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCC---HHHHHHH
Q 042348 595 MIQIGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPS---MRHVCDS 664 (686)
Q Consensus 595 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs---~~ev~~~ 664 (686)
|...... .....+....... .+.+. .. ...++.+++.+|+ .||.+|++ +.|++++
T Consensus 236 f~~~~~~-----~~~~~i~~~~~~~--~~p~~----~~---~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~h 293 (360)
T cd05627 236 FCSETPQ-----ETYRKVMNWKETL--VFPPE----VP---ISEKAKDLILRFC-TDSENRIGSNGVEEIKSH 293 (360)
T ss_pred CCCCCHH-----HHHHHHHcCCCce--ecCCC----CC---CCHHHHHHHHHhc-cChhhcCCCCCHHHHhcC
Confidence 9543322 2222222211110 01110 00 1224567777766 49999985 6777666
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=316.80 Aligned_cols=251 Identities=23% Similarity=0.332 Sum_probs=186.4
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCC--ccchHHHHHHHHHHhccCCCCcceeeEEEEec------CceeEEEe
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGG--WQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSV------DEKLLIYD 443 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~------~~~~lV~e 443 (686)
..||+|+||.||+|... +++.||||.+.... ....+.+.+|++++++++||||+++++++... ...+++||
T Consensus 21 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~ 100 (343)
T cd07878 21 TPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTN 100 (343)
T ss_pred eecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCcEEEEee
Confidence 46999999999999864 57899999986532 22345678899999999999999999988643 34689999
Q ss_pred ccCCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccc
Q 042348 444 YIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLAD 523 (686)
Q Consensus 444 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~ 523 (686)
++ +++|.+++.. ..+++..+..++.|++.||+|||+ ++|+||||||+||++++++.+||+|||+++...
T Consensus 101 ~~-~~~l~~~~~~-------~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~ 169 (343)
T cd07878 101 LM-GADLNNIVKC-------QKLSDEHVQFLIYQLLRGLKYIHS---AGIIHRDLKPSNVAVNEDCELRILDFGLARQAD 169 (343)
T ss_pred cC-CCCHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHH---CCeecccCChhhEEECCCCCEEEcCCccceecC
Confidence 98 7899988753 358999999999999999999999 899999999999999999999999999997543
Q ss_pred cccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccC-CCCCCcchHHHHHHHHHHHHhCCCCccccCccc
Q 042348 524 IAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKV-RKPTQKWDIYSYGVILLEMISGKLPMIQIGSME 602 (686)
Q Consensus 524 ~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~ 602 (686)
.. .....+|..|+|||++.+ ..++.++|||||||++|||++|+.||......
T Consensus 170 ~~--------------------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~- 222 (343)
T cd07878 170 DE--------------------------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYI- 222 (343)
T ss_pred CC--------------------------cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHH-
Confidence 11 112356778999999876 56899999999999999999999999543211
Q ss_pred hhHHHHHHHHHhhcCCcccccCc-----------ccccCCCc------HHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 603 LNIVQWIQLILEDRKPMTDILDP-----------FLAHDLDK------EDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 603 ~~~~~~~~~~~~~~~~~~~~~d~-----------~l~~~~~~------~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
+....+..... .+..+.... .+...... ......+.+++.+||+.||++|||+.|++++
T Consensus 223 -~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 223 -DQLKRIMEVVG--TPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred -HHHHHHHHHhC--CCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 11111111100 000000000 00000000 0011246789999999999999999999977
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=300.57 Aligned_cols=245 Identities=20% Similarity=0.362 Sum_probs=196.6
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCC--CccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCC
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNG--GWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGS 449 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gs 449 (686)
+.||+|+||.||++... +++.||+|++... .....+++.+|+.++++++||||+++++++...+..++||||+++++
T Consensus 6 ~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 85 (256)
T cd08218 6 KKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGD 85 (256)
T ss_pred EEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecCCCCc
Confidence 46999999999999865 5789999988643 23344678999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCc
Q 042348 450 LATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETP 529 (686)
Q Consensus 450 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 529 (686)
|.+++..... ..+++.++..++.|++.||+|||+ ++++|+||+|+||+++.++.++|+|||++........
T Consensus 86 l~~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~-- 156 (256)
T cd08218 86 LYKKINAQRG----VLFPEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE-- 156 (256)
T ss_pred HHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh--
Confidence 9999976432 357899999999999999999999 8999999999999999999999999999875432110
Q ss_pred cccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHHH
Q 042348 530 EVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQWI 609 (686)
Q Consensus 530 ~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~ 609 (686)
......++..|+|||+..+..++.++|||||||++|+|++|+.||.... ....+
T Consensus 157 ---------------------~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~-----~~~~~ 210 (256)
T cd08218 157 ---------------------LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGN-----MKNLV 210 (256)
T ss_pred ---------------------hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCC-----HHHHH
Confidence 0112345667999999988889999999999999999999999985322 22223
Q ss_pred HHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 610 QLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 610 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
.....+..+. . .......+.+++.+||+.+|++||++.||+++
T Consensus 211 ~~~~~~~~~~-------~-----~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 211 LKIIRGSYPP-------V-----SSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred HHHhcCCCCC-------C-----cccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 3333222110 0 01123467899999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=308.41 Aligned_cols=259 Identities=21% Similarity=0.273 Sum_probs=190.2
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCCc--cchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCC
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGGW--QRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGS 449 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gs 449 (686)
..||+|+||.||+|... +|+.||+|++..... .....+.+|++++++++||||+++++++.+.+..++|+||++ ++
T Consensus 6 ~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~ 84 (284)
T cd07839 6 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYCD-QD 84 (284)
T ss_pred EEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecCC-CC
Confidence 36899999999999875 588999999865322 223567889999999999999999999999999999999996 58
Q ss_pred HHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCc
Q 042348 450 LATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETP 529 (686)
Q Consensus 450 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 529 (686)
|.+++.... ..+++..++.++.||++||+|||+ ++|+||||||+||+++.++.+||+|||+++.......
T Consensus 85 l~~~~~~~~-----~~~~~~~~~~~~~qi~~al~~LH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~-- 154 (284)
T cd07839 85 LKKYFDSCN-----GDIDPEIVKSFMFQLLKGLAFCHS---HNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR-- 154 (284)
T ss_pred HHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC--
Confidence 888876543 358999999999999999999999 8999999999999999999999999999875432110
Q ss_pred cccccccccCCCCCCCccccccccCCCCCccccCcccccCC-CCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHH
Q 042348 530 EVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVR-KPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQW 608 (686)
Q Consensus 530 ~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~ 608 (686)
......++..|+|||++.+. .++.++|||||||++|||+||+.|+.........+ ..
T Consensus 155 ---------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~-~~ 212 (284)
T cd07839 155 ---------------------CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQL-KR 212 (284)
T ss_pred ---------------------CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHH-HH
Confidence 01123456779999988664 47899999999999999999999974433222111 11
Q ss_pred HHHHHhhcC-----CcccccCc----ccccCCC----cHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 609 IQLILEDRK-----PMTDILDP----FLAHDLD----KEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 609 ~~~~~~~~~-----~~~~~~d~----~l~~~~~----~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
+........ ......+. ....... .......+.+++.+||+.||++|||+.|++++
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 213 IFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred HHHHhCCCChHHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 111110000 00000000 0000000 01123467789999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=315.39 Aligned_cols=249 Identities=20% Similarity=0.252 Sum_probs=190.6
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCC---CccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCC
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNG---GWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNG 448 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~g 448 (686)
+.||+|+||.||+++.. +++.||+|.+... .......+.+|+.++..++|+||+++++++.+.+..++||||+++|
T Consensus 7 ~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~Ey~~gg 86 (331)
T cd05624 7 KVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMDYYVGG 86 (331)
T ss_pred EEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999876 5788999998652 1223345888999999999999999999999999999999999999
Q ss_pred CHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCC
Q 042348 449 SLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEET 528 (686)
Q Consensus 449 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 528 (686)
+|.+++.... ..+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 87 ~L~~~l~~~~-----~~l~~~~~~~~~~qi~~~L~~lH~---~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~- 157 (331)
T cd05624 87 DLLTLLSKFE-----DRLPEDMARFYIAEMVLAIHSIHQ---LHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT- 157 (331)
T ss_pred cHHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCc-
Confidence 9999998643 358899999999999999999999 8999999999999999999999999999975432111
Q ss_pred ccccccccccCCCCCCCccccccccCCCCCccccCcccccC-----CCCCCcchHHHHHHHHHHHHhCCCCccccCccch
Q 042348 529 PEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKV-----RKPTQKWDIYSYGVILLEMISGKLPMIQIGSMEL 603 (686)
Q Consensus 529 ~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~ 603 (686)
.......||..|+|||++.+ ..++.++|||||||++|||++|+.||.....
T Consensus 158 ---------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~--- 213 (331)
T cd05624 158 ---------------------VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESL--- 213 (331)
T ss_pred ---------------------eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCH---
Confidence 01112457888999998865 4678999999999999999999999954322
Q ss_pred hHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCC--CCCHHHHHHH
Q 042348 604 NIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDK--RPSMRHVCDS 664 (686)
Q Consensus 604 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~--RPs~~ev~~~ 664 (686)
.+....+........ +.+.. .....++.+++.+|+..++++ |+++++++++
T Consensus 214 --~~~~~~i~~~~~~~~--~p~~~------~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 214 --VETYGKIMNHEERFQ--FPSHI------TDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred --HHHHHHHHcCCCccc--CCCcc------ccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 222233322211110 01101 112345778888888866544 4688888776
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=302.30 Aligned_cols=243 Identities=23% Similarity=0.385 Sum_probs=195.7
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCC-ccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCCH
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGG-WQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSL 450 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL 450 (686)
..||.|++|.||+|... +++.||+|.+.... ......+.+|++++++++|+||+++++++......++|+||+++++|
T Consensus 7 ~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 86 (274)
T cd06609 7 ECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSC 86 (274)
T ss_pred hhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEeeCCCcH
Confidence 36899999999999875 57899999986543 33456788999999999999999999999999999999999999999
Q ss_pred HHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCcc
Q 042348 451 ATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPE 530 (686)
Q Consensus 451 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 530 (686)
.+++... .+++..+..++.|++.||+|||+ ++++||||+|+||++++++.++|+|||+++.......
T Consensus 87 ~~~~~~~-------~~~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~--- 153 (274)
T cd06609 87 LDLLKPG-------KLDETYIAFILREVLLGLEYLHE---EGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS--- 153 (274)
T ss_pred HHHHhhc-------CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEcccccceeeccccc---
Confidence 9998753 58999999999999999999999 8999999999999999999999999999986643210
Q ss_pred ccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHHHH
Q 042348 531 VHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQWIQ 610 (686)
Q Consensus 531 ~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~ 610 (686)
......++..|+|||++.+..++.++|||||||++|||+||+.||...... ....
T Consensus 154 --------------------~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~-----~~~~ 208 (274)
T cd06609 154 --------------------KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPM-----RVLF 208 (274)
T ss_pred --------------------ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchH-----HHHH
Confidence 111234566799999998888999999999999999999999999543321 1111
Q ss_pred HHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 611 LILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 611 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
.+..... .. +... .....+.+++.+||..+|++||++++++++
T Consensus 209 ~~~~~~~--~~-----~~~~----~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 209 LIPKNNP--PS-----LEGN----KFSKPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred HhhhcCC--CC-----Cccc----ccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 1111111 11 1000 023357789999999999999999999875
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=303.08 Aligned_cols=258 Identities=20% Similarity=0.307 Sum_probs=192.4
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCC--ccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCC
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGG--WQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGS 449 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gs 449 (686)
..||+|++|.||+|... +++.||+|++.... ....+.+.+|+.++++++||||+++++++...+..++||||+++++
T Consensus 7 ~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~ 86 (286)
T cd07847 7 SKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHTV 86 (286)
T ss_pred eeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEeccCccH
Confidence 36899999999999876 58899999886432 1223568899999999999999999999999999999999999998
Q ss_pred HHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCc
Q 042348 450 LATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETP 529 (686)
Q Consensus 450 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 529 (686)
|..++... ..+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++........
T Consensus 87 l~~~~~~~------~~~~~~~~~~~~~ql~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~-- 155 (286)
T cd07847 87 LNELEKNP------RGVPEHLIKKIIWQTLQAVNFCHK---HNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD-- 155 (286)
T ss_pred HHHHHhCC------CCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCChhhEEEcCCCcEEECccccceecCCCcc--
Confidence 88877543 358999999999999999999999 8999999999999999999999999999986542211
Q ss_pred cccccccccCCCCCCCccccccccCCCCCccccCcccccC-CCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHH
Q 042348 530 EVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKV-RKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQW 608 (686)
Q Consensus 530 ~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~ 608 (686)
......++..|+|||++.+ ..++.++|||||||++|||++|+.||......+ ....
T Consensus 156 ---------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~--~~~~ 212 (286)
T cd07847 156 ---------------------DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVD--QLYL 212 (286)
T ss_pred ---------------------cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHH--HHHH
Confidence 0112235667999999865 457899999999999999999999996443221 1111
Q ss_pred HHHHHhhc-----------CCcccccCcccccCCCc----HHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 609 IQLILEDR-----------KPMTDILDPFLAHDLDK----EDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 609 ~~~~~~~~-----------~~~~~~~d~~l~~~~~~----~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
+....... ........+........ ......+.+++.+||+.+|++||++.|++.+
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 213 IRKTLGDLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred HHHHhCCCChHHhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 11111100 00000000000000000 0123467899999999999999999999764
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=303.78 Aligned_cols=241 Identities=22% Similarity=0.321 Sum_probs=200.4
Q ss_pred ccCccCceEEEEEEeC-CCceEEEEEcCCCCcc--chHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCCH
Q 042348 374 LLGKSTIGIVYKVALN-NEEAVAVRRLGNGGWQ--RFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSL 450 (686)
Q Consensus 374 ~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL 450 (686)
.||+|.|..|-.|++- +|+.||||++.+.... ....+.+|++.|+.++|||||++|.+.......|+|+|.=++|+|
T Consensus 25 TlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLELGD~GDl 104 (864)
T KOG4717|consen 25 TLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILELGDGGDL 104 (864)
T ss_pred hhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEecCCchH
Confidence 5999999999998753 7999999999775333 345688999999999999999999999999999999999999999
Q ss_pred HHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeee-cCCCCeEEeecCcccccccccCCc
Q 042348 451 ATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILL-GKNMEPHISDFGLARLADIAEETP 529 (686)
Q Consensus 451 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl-~~~~~~kl~DfGla~~~~~~~~~~ 529 (686)
+++|-++. ..+.+....+++.||+.|+.|+|. -.+|||||||+||.+ .+-|-+||.|||++-.+.+++
T Consensus 105 ~DyImKHe-----~Gl~E~La~kYF~QI~~AI~YCHq---LHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~--- 173 (864)
T KOG4717|consen 105 FDYIMKHE-----EGLNEDLAKKYFAQIVHAISYCHQ---LHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGK--- 173 (864)
T ss_pred HHHHHhhh-----ccccHHHHHHHHHHHHHHHHHHhh---hhhhcccCCcceeEEeeecCceEeeeccccccCCCcc---
Confidence 99998765 468999999999999999999999 789999999999876 577899999999997665443
Q ss_pred cccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCC-CcchHHHHHHHHHHHHhCCCCccccCccchhHHHH
Q 042348 530 EVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPT-QKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQW 608 (686)
Q Consensus 530 ~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~ 608 (686)
..+..+|+..|-|||.+.+..|+ +++||||+|||||.|++|+.||....+.+.
T Consensus 174 ---------------------kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSET----- 227 (864)
T KOG4717|consen 174 ---------------------KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSET----- 227 (864)
T ss_pred ---------------------hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhh-----
Confidence 34567888899999999998875 679999999999999999999976554432
Q ss_pred HHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 609 IQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 609 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
.-.++.-+..++ .....++.+|+.+||..||.+|.+.+||+..
T Consensus 228 LTmImDCKYtvP-------------shvS~eCrdLI~sMLvRdPkkRAslEeI~s~ 270 (864)
T KOG4717|consen 228 LTMIMDCKYTVP-------------SHVSKECRDLIQSMLVRDPKKRASLEEIVST 270 (864)
T ss_pred hhhhhcccccCc-------------hhhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence 222222222222 2244578899999999999999999998754
|
|
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=303.21 Aligned_cols=244 Identities=21% Similarity=0.350 Sum_probs=195.4
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCCccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCCHH
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLA 451 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL~ 451 (686)
..||+|++|.||++... +++.+++|++........+.+.+|+.++++++||||+++++++...+..++|+||+++++|.
T Consensus 25 ~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L~ 104 (285)
T cd06648 25 VKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALT 104 (285)
T ss_pred eEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCCCHH
Confidence 46999999999999864 67889999986655455567889999999999999999999999999999999999999999
Q ss_pred HHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCccc
Q 042348 452 TAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEV 531 (686)
Q Consensus 452 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 531 (686)
+++... .+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.++|+|||.+........
T Consensus 105 ~~~~~~-------~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~---- 170 (285)
T cd06648 105 DIVTHT-------RMNEEQIATVCLAVLKALSFLHA---QGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP---- 170 (285)
T ss_pred HHHHhC-------CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChhhEEEcCCCcEEEcccccchhhccCCc----
Confidence 998752 47899999999999999999999 8999999999999999999999999998864421110
Q ss_pred cccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHHHHH
Q 042348 532 HWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQWIQL 611 (686)
Q Consensus 532 ~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~ 611 (686)
......|+..|+|||...+..++.++|||||||++|||++|+.||..... ......
T Consensus 171 -------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~-----~~~~~~ 226 (285)
T cd06648 171 -------------------RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP-----LQAMKR 226 (285)
T ss_pred -------------------ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCH-----HHHHHH
Confidence 01123467789999999888899999999999999999999999854221 222222
Q ss_pred HHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 612 ILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 612 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
......+ . .... ......+.+++.+||+.+|++||++.+++++
T Consensus 227 ~~~~~~~--~-----~~~~---~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 269 (285)
T cd06648 227 IRDNLPP--K-----LKNL---HKVSPRLRSFLDRMLVRDPAQRATAAELLNH 269 (285)
T ss_pred HHhcCCC--C-----Cccc---ccCCHHHHHHHHHHcccChhhCcCHHHHccC
Confidence 2222111 0 0000 0123468899999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=304.10 Aligned_cols=248 Identities=25% Similarity=0.384 Sum_probs=193.1
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCC-CccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCCH
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNG-GWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSL 450 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL 450 (686)
..||+|+||.||++... ++..||+|.+... .......+.+|+.++++++||||+++++++...+..++||||+++++|
T Consensus 7 ~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l 86 (286)
T cd06622 7 DELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMDAGSL 86 (286)
T ss_pred hhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeecCCCCH
Confidence 46999999999999876 6889999988653 223346789999999999999999999999999999999999999999
Q ss_pred HHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCcc
Q 042348 451 ATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPE 530 (686)
Q Consensus 451 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 530 (686)
..++..... ...+++..+..++.|++.||.|||+. .+|+||||||+||+++.++.+||+|||++.......
T Consensus 87 ~~~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~---- 157 (286)
T cd06622 87 DKLYAGGVA---TEGIPEDVLRRITYAVVKGLKFLKEE--HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL---- 157 (286)
T ss_pred HHHHHhccc---cCCCCHHHHHHHHHHHHHHHHHHHhc--CCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc----
Confidence 999876421 13689999999999999999999962 489999999999999999999999999987542111
Q ss_pred ccccccccCCCCCCCccccccccCCCCCccccCcccccCC------CCCCcchHHHHHHHHHHHHhCCCCccccCccchh
Q 042348 531 VHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVR------KPTQKWDIYSYGVILLEMISGKLPMIQIGSMELN 604 (686)
Q Consensus 531 ~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~ 604 (686)
.....++..|+|||.+.+. .++.++|||||||++|||++|+.||..... ..
T Consensus 158 ---------------------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~--~~ 214 (286)
T cd06622 158 ---------------------AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETY--AN 214 (286)
T ss_pred ---------------------cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcch--hh
Confidence 1122356679999988543 358899999999999999999999954322 11
Q ss_pred HHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 605 IVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 605 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
....+..+.....+ . +. ......+.+++.+||+.+|++||++.+++++
T Consensus 215 ~~~~~~~~~~~~~~--~-~~---------~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 215 IFAQLSAIVDGDPP--T-LP---------SGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred HHHHHHHHhhcCCC--C-CC---------cccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 11112222221111 0 11 1133467789999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=319.26 Aligned_cols=252 Identities=26% Similarity=0.384 Sum_probs=205.6
Q ss_pred hhcccCccCceEEEEEEe-CCC----ceEEEEEcCCC-CccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEec
Q 042348 371 SAFLLGKSTIGIVYKVAL-NNE----EAVAVRRLGNG-GWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDY 444 (686)
Q Consensus 371 ~~~~iG~G~~g~Vy~~~~-~~~----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~ 444 (686)
..++||+|+||+||||.+ ++| .+||+|++... ..+..+++.+|+-+|.+++|||+++++|+|.... ..||++|
T Consensus 700 k~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~ 778 (1177)
T KOG1025|consen 700 KDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQL 778 (1177)
T ss_pred hhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHh
Confidence 356899999999999975 333 47899988654 3445678999999999999999999999998765 8899999
Q ss_pred cCCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCccccccc
Q 042348 445 IPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADI 524 (686)
Q Consensus 445 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~ 524 (686)
|+.|.|.++++..+ ..+-....+.|..|||+|+.|||+ +++|||||-.+|||+.+-..+||.|||+|+.+..
T Consensus 779 mP~G~LlDyvr~hr-----~~igsq~lLnw~~QIAkgM~YLe~---qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~ 850 (1177)
T KOG1025|consen 779 MPLGCLLDYVREHR-----DNIGSQDLLNWCYQIAKGMKYLEE---QRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAP 850 (1177)
T ss_pred cccchHHHHHHHhh-----ccccHHHHHHHHHHHHHHHHHHHh---cchhhhhhhhhheeecCCCeEEEEecchhhccCc
Confidence 99999999999876 457888999999999999999999 8999999999999999999999999999998876
Q ss_pred ccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCccccCccch
Q 042348 525 AEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQIGSMEL 603 (686)
Q Consensus 525 ~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~~ 603 (686)
.+..... ....-.+.|||-|.+....|+.++|||||||++||++| |..|+.....++
T Consensus 851 d~~ey~~---------------------~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~e- 908 (1177)
T KOG1025|consen 851 DEKEYSA---------------------PGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEE- 908 (1177)
T ss_pred ccccccc---------------------cccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHH-
Confidence 5432110 01111345999999999999999999999999999999 999996544332
Q ss_pred hHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 042348 604 NIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRVN 669 (686)
Q Consensus 604 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~ 669 (686)
+...++....+. .++.+...+..++.+||..|++.||+++++...+.++.
T Consensus 909 -----I~dlle~geRLs-----------qPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~a 958 (1177)
T KOG1025|consen 909 -----IPDLLEKGERLS-----------QPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMA 958 (1177)
T ss_pred -----hhHHHhccccCC-----------CCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHh
Confidence 333333332211 23346678899999999999999999999999887754
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=301.65 Aligned_cols=245 Identities=23% Similarity=0.274 Sum_probs=189.9
Q ss_pred cCccCceEEEEEEeC-CCceEEEEEcCCCC---ccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCCH
Q 042348 375 LGKSTIGIVYKVALN-NEEAVAVRRLGNGG---WQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSL 450 (686)
Q Consensus 375 iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL 450 (686)
||+|+||+||++... +++.||+|.+.... ......+..|++++++++||||+++++++...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 699999999999765 58899999886432 22234577899999999999999999999999999999999999999
Q ss_pred HHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCcc
Q 042348 451 ATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPE 530 (686)
Q Consensus 451 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 530 (686)
.+++..... ..+++.++..++.|++.||.|||+ .+++||||||+||++++++.++|+|||.+.......
T Consensus 81 ~~~l~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~---- 149 (277)
T cd05577 81 KYHIYNVGE----PGFPEARAIFYAAQIICGLEHLHQ---RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK---- 149 (277)
T ss_pred HHHHHHcCc----CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEccCcchhhhccCC----
Confidence 999976542 358999999999999999999999 899999999999999999999999999987543211
Q ss_pred ccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHHHH
Q 042348 531 VHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQWIQ 610 (686)
Q Consensus 531 ~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~ 610 (686)
......++..|+|||++.+..++.++|||||||++|+|++|+.||....... .......
T Consensus 150 --------------------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~ 208 (277)
T cd05577 150 --------------------KIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKV-EKEELKR 208 (277)
T ss_pred --------------------ccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccc-cHHHHHh
Confidence 0112345667999999988889999999999999999999999995433211 1111111
Q ss_pred HHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 042348 611 LILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRP-----SMRHVCDS 664 (686)
Q Consensus 611 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~ev~~~ 664 (686)
.......... ......+.+++.+||+.||++|| ++.+++++
T Consensus 209 ~~~~~~~~~~-------------~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h 254 (277)
T cd05577 209 RTLEMAVEYP-------------DKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREH 254 (277)
T ss_pred ccccccccCC-------------ccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhC
Confidence 1111100110 01133577999999999999999 55556554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=301.36 Aligned_cols=251 Identities=18% Similarity=0.303 Sum_probs=194.1
Q ss_pred cccCccCceEEEEEEe-CCCceEEEEEcCCCC------ccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEecc
Q 042348 373 FLLGKSTIGIVYKVAL-NNEEAVAVRRLGNGG------WQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYI 445 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~ 445 (686)
..||+|++|.||++.. .+++.||+|.+.... ....+.+.+|++++++++|+||+++++++.+.+..++||||+
T Consensus 6 ~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~ 85 (268)
T cd06630 6 QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEWM 85 (268)
T ss_pred ceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEEEecc
Confidence 4699999999999985 468899999886432 112467899999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCC-CeEEeecCccccccc
Q 042348 446 PNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNM-EPHISDFGLARLADI 524 (686)
Q Consensus 446 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~-~~kl~DfGla~~~~~ 524 (686)
++++|.+++... ..+++..+..++.|++.||+|||+ ++++||||||+||+++.++ .+||+|||.+.....
T Consensus 86 ~~~~L~~~l~~~------~~~~~~~~~~~~~ql~~al~~LH~---~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~ 156 (268)
T cd06630 86 AGGSVSHLLSKY------GAFKEAVIINYTEQLLRGLSYLHE---NQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAA 156 (268)
T ss_pred CCCcHHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEccccccccccc
Confidence 999999999754 358899999999999999999999 8999999999999998776 599999999876543
Q ss_pred ccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchh
Q 042348 525 AEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELN 604 (686)
Q Consensus 525 ~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~ 604 (686)
...... .......++..|+|||.+.+..++.++||||+|+++|+|++|+.||.......
T Consensus 157 ~~~~~~-------------------~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~-- 215 (268)
T cd06630 157 KGTGAG-------------------EFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSN-- 215 (268)
T ss_pred ccccCC-------------------ccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcc--
Confidence 211000 00112346778999999988889999999999999999999999995432211
Q ss_pred HHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 605 IVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 605 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
....+......... +.. .......+.+++.+|++.+|++||++.|++++
T Consensus 216 ~~~~~~~~~~~~~~------~~~-----~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~ 264 (268)
T cd06630 216 HLALIFKIASATTA------PSI-----PEHLSPGLRDVTLRCLELQPEDRPPSRELLKH 264 (268)
T ss_pred hHHHHHHHhccCCC------CCC-----chhhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence 11111111111100 000 11223467889999999999999999999854
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=318.73 Aligned_cols=264 Identities=25% Similarity=0.328 Sum_probs=196.6
Q ss_pred hcccCccCceEEEEEEe-CCCceEEEEEcCCC-CccchHHHHHHHHHHhccCCCCcceeeEEEEecC------ceeEEEe
Q 042348 372 AFLLGKSTIGIVYKVAL-NNEEAVAVRRLGNG-GWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVD------EKLLIYD 443 (686)
Q Consensus 372 ~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~------~~~lV~e 443 (686)
.+.||+|+||.||+|+. .+|+.||||.++.. ....++...+|+++|++++|+|||+++++-.+.. ...+|||
T Consensus 18 ~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmE 97 (732)
T KOG4250|consen 18 DERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVME 97 (732)
T ss_pred hhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEEe
Confidence 34799999999999994 57999999999764 3445677889999999999999999999866543 5689999
Q ss_pred ccCCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeec--CCC--CeEEeecCcc
Q 042348 444 YIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLG--KNM--EPHISDFGLA 519 (686)
Q Consensus 444 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~--~~~--~~kl~DfGla 519 (686)
||.+|||...+...... ..|++.+.+.++.+++.||.|||+ ++||||||||.||++- .+| .-||+|||.|
T Consensus 98 yC~gGsL~~~L~~PEN~---~GLpE~e~l~lL~d~~~al~~LrE---n~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 98 YCSGGSLRKVLNSPENA---YGLPESEFLDLLSDLVSALRHLRE---NGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA 171 (732)
T ss_pred ecCCCcHHHHhcCcccc---cCCCHHHHHHHHHHHHHHHHHHHH---cCceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence 99999999999876532 569999999999999999999999 9999999999999984 334 4699999999
Q ss_pred cccccccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccC-CCCCCcchHHHHHHHHHHHHhCCCCcccc
Q 042348 520 RLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKV-RKPTQKWDIYSYGVILLEMISGKLPMIQI 598 (686)
Q Consensus 520 ~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvvl~elltG~~P~~~~ 598 (686)
|-++++. ...+.+||..|.+||.+.. ..|+..+|.|||||++|+++||..||...
T Consensus 172 rel~d~s------------------------~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~ 227 (732)
T KOG4250|consen 172 RELDDNS------------------------LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPF 227 (732)
T ss_pred ccCCCCC------------------------eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcC
Confidence 9776442 3457789999999999985 78999999999999999999999999665
Q ss_pred CccchhHHHHHHHHHhhcC-CcccccCcccccC------C-----CcHHHHHHHHHHHHhccccCCCCCC--CHHHHHHH
Q 042348 599 GSMELNIVQWIQLILEDRK-PMTDILDPFLAHD------L-----DKEDEIVSVLKIALDCVHKSPDKRP--SMRHVCDS 664 (686)
Q Consensus 599 ~~~~~~~~~~~~~~~~~~~-~~~~~~d~~l~~~------~-----~~~~~~~~l~~l~~~cl~~dP~~RP--s~~ev~~~ 664 (686)
.....+. +.+..+...++ ...-..++...+. . -.......+.+.+..+|..+|++|- ...+....
T Consensus 228 ~~pk~~~-~~~~~~~tkkp~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~ 306 (732)
T KOG4250|consen 228 GGPKNNK-EIMWHIITKKPSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAE 306 (732)
T ss_pred CCccccc-hhhhhhhccCCCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHH
Confidence 5432211 11111211111 1100011111000 0 0122344566777788888999997 54444444
Q ss_pred Hh
Q 042348 665 LD 666 (686)
Q Consensus 665 L~ 666 (686)
+.
T Consensus 307 ~~ 308 (732)
T KOG4250|consen 307 VD 308 (732)
T ss_pred HH
Confidence 43
|
|
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=305.67 Aligned_cols=249 Identities=22% Similarity=0.338 Sum_probs=188.6
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCCccchHHHHHHHHHHhcc-CCCCcceeeEEEEe-----cCceeEEEecc
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGGWQRFKEFQTEAEAIGKI-RHPNIVSLRAYFWS-----VDEKLLIYDYI 445 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~-----~~~~~lV~e~~ 445 (686)
..||+|+||.||++... +++.+|+|.+.... ....++..|+.+++++ +||||+++++++.. .+..++||||+
T Consensus 24 ~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~ 102 (286)
T cd06638 24 ETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELC 102 (286)
T ss_pred eeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEEEEeec
Confidence 35999999999999875 57889999876532 2235688899999999 69999999998853 34679999999
Q ss_pred CCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccc
Q 042348 446 PNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIA 525 (686)
Q Consensus 446 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~ 525 (686)
++++|.++++..... ...+++..+..++.|++.||.|||+ .+|+||||||+||++++++.+||+|||+++.....
T Consensus 103 ~~~~L~~~l~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~ 177 (286)
T cd06638 103 NGGSVTDLVKGFLKR--GERMEEPIIAYILHEALMGLQHLHV---NKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTST 177 (286)
T ss_pred CCCCHHHHHHHhhcc--CccccHHHHHHHHHHHHHHHHHHHh---CCccccCCCHHhEEECCCCCEEEccCCceeecccC
Confidence 999999988643211 1458899999999999999999999 89999999999999999999999999998755321
Q ss_pred cCCccccccccccCCCCCCCccccccccCCCCCccccCcccccC-----CCCCCcchHHHHHHHHHHHHhCCCCccccCc
Q 042348 526 EETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKV-----RKPTQKWDIYSYGVILLEMISGKLPMIQIGS 600 (686)
Q Consensus 526 ~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDVwSlGvvl~elltG~~P~~~~~~ 600 (686)
.. ......|+..|+|||++.. ..++.++|||||||++|||++|+.||.....
T Consensus 178 ~~-----------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~ 234 (286)
T cd06638 178 RL-----------------------RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHP 234 (286)
T ss_pred CC-----------------------ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCch
Confidence 10 1112346778999998753 4578899999999999999999999954322
Q ss_pred cchhHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 042348 601 MELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSL 665 (686)
Q Consensus 601 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L 665 (686)
.. . ....... ......++. .....+.+++.+||+.||++|||+.||+++.
T Consensus 235 ~~----~-~~~~~~~--~~~~~~~~~--------~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 235 MR----A-LFKIPRN--PPPTLHQPE--------LWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred hH----H-Hhhcccc--CCCcccCCC--------CcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 11 1 1111111 001111111 1123578899999999999999999998864
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=299.73 Aligned_cols=246 Identities=21% Similarity=0.337 Sum_probs=187.2
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCC-----ccchHHHHHHHHHHhccCCCCcceeeEEEEec--CceeEEEec
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGG-----WQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSV--DEKLLIYDY 444 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~~lV~e~ 444 (686)
..||+|+||.||+|... ++..|++|.+.... ......+.+|+.++++++||||+++++++... +..+++|||
T Consensus 8 ~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l~~e~ 87 (266)
T cd06651 8 KLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEY 87 (266)
T ss_pred ceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEEEEeC
Confidence 47999999999999865 58899999875431 12345688999999999999999999998763 567899999
Q ss_pred cCCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCccccccc
Q 042348 445 IPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADI 524 (686)
Q Consensus 445 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~ 524 (686)
+++++|.+++... ..+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++....
T Consensus 88 ~~~~~L~~~l~~~------~~l~~~~~~~~~~qi~~~l~~LH~---~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd06651 88 MPGGSVKDQLKAY------GALTESVTRKYTRQILEGMSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQT 158 (266)
T ss_pred CCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEccCCCcccccc
Confidence 9999999999754 348899999999999999999999 8999999999999999999999999999875432
Q ss_pred ccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchh
Q 042348 525 AEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELN 604 (686)
Q Consensus 525 ~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~ 604 (686)
..... .......++..|+|||.+.+..++.++|||||||++|||++|+.||.....
T Consensus 159 ~~~~~--------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~---- 214 (266)
T cd06651 159 ICMSG--------------------TGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEA---- 214 (266)
T ss_pred ccccC--------------------CccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccch----
Confidence 11000 011123467789999999888899999999999999999999999954321
Q ss_pred HHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 605 IVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 605 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
...+....... . .+.+. ......+.+++ +||..+|++||+++||+++
T Consensus 215 -~~~~~~~~~~~-~-----~~~~~-----~~~~~~~~~li-~~~~~~p~~Rp~~~eil~h 261 (266)
T cd06651 215 -MAAIFKIATQP-T-----NPQLP-----SHISEHARDFL-GCIFVEARHRPSAEELLRH 261 (266)
T ss_pred -HHHHHHHhcCC-C-----CCCCc-----hhcCHHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence 11111111110 0 11111 01122344555 6888999999999999764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=305.88 Aligned_cols=259 Identities=22% Similarity=0.319 Sum_probs=189.4
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCCc-cchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCCH
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGGW-QRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSL 450 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL 450 (686)
..||+|++|.||+|... +++.||+|.+..... .....+.+|++++++++||||+++++++...+..++||||++ ++|
T Consensus 11 ~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~L 89 (291)
T cd07844 11 DKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLD-TDL 89 (291)
T ss_pred EEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEecCC-CCH
Confidence 36999999999999876 578999999865322 223457789999999999999999999999999999999997 499
Q ss_pred HHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCcc
Q 042348 451 ATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPE 530 (686)
Q Consensus 451 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 530 (686)
.+++.... ..+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++.......
T Consensus 90 ~~~~~~~~-----~~~~~~~~~~~~~ql~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~--- 158 (291)
T cd07844 90 KQYMDDCG-----GGLSMHNVRLFLFQLLRGLAYCHQ---RRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK--- 158 (291)
T ss_pred HHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCHHHEEEcCCCCEEECccccccccCCCCc---
Confidence 99887653 358899999999999999999999 8999999999999999999999999999864321110
Q ss_pred ccccccccCCCCCCCccccccccCCCCCccccCcccccC-CCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHHH
Q 042348 531 VHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKV-RKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQWI 609 (686)
Q Consensus 531 ~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~ 609 (686)
......++..|+|||++.+ ..++.++||||+||++|||++|+.||........ ....+
T Consensus 159 --------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~-~~~~~ 217 (291)
T cd07844 159 --------------------TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVED-QLHKI 217 (291)
T ss_pred --------------------cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHH-HHHHH
Confidence 0011234667999998865 4578999999999999999999999954332111 11111
Q ss_pred HHHHhhcCC--cccc-------------c-CcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 610 QLILEDRKP--MTDI-------------L-DPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 610 ~~~~~~~~~--~~~~-------------~-d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
........+ .... . ...+............+.+++.+||+.+|++|||+.|++++
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~ 288 (291)
T cd07844 218 FRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH 288 (291)
T ss_pred HHhcCCCChhhhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence 111100000 0000 0 00000000000112457789999999999999999998753
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=296.12 Aligned_cols=247 Identities=30% Similarity=0.474 Sum_probs=196.2
Q ss_pred cccCccCceEEEEEEeCC-----CceEEEEEcCCCCcc-chHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccC
Q 042348 373 FLLGKSTIGIVYKVALNN-----EEAVAVRRLGNGGWQ-RFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIP 446 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~ 446 (686)
..||+|+||.||++...+ +..||+|.+...... ..+.+..|++.+.+++|+||+++++++...+..+++|||++
T Consensus 5 ~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~~~ 84 (258)
T smart00219 5 KKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEYME 84 (258)
T ss_pred ceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEeccC
Confidence 468999999999998764 378999999765433 56789999999999999999999999999999999999999
Q ss_pred CCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCccccccccc
Q 042348 447 NGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAE 526 (686)
Q Consensus 447 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~ 526 (686)
+++|.+++..... ..+++.++..++.|++.||+|||+ .+++||||||+||++++++.++|+|||+++......
T Consensus 85 ~~~l~~~~~~~~~----~~~~~~~~~~~~~ql~~~l~~lh~---~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (258)
T smart00219 85 GGDLLDYLRKNRP----KELSLSDLLSFALQIARGMEYLES---KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD 157 (258)
T ss_pred CCCHHHHHHhhhh----ccCCHHHHHHHHHHHHHHHHHHhc---CCeeecccccceEEEccCCeEEEcccCCceeccccc
Confidence 9999999976532 128999999999999999999999 899999999999999999999999999997654321
Q ss_pred CCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCccccCccchhH
Q 042348 527 ETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQIGSMELNI 605 (686)
Q Consensus 527 ~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~~~~ 605 (686)
.. ......++..|+|||.+.+..++.++||||+|+++|||++ |+.||.... .
T Consensus 158 ~~----------------------~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~-----~ 210 (258)
T smart00219 158 YY----------------------KKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMS-----N 210 (258)
T ss_pred cc----------------------ccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC-----H
Confidence 10 0001124567999999988889999999999999999999 788884421 1
Q ss_pred HHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 042348 606 VQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSL 665 (686)
Q Consensus 606 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L 665 (686)
....+........ . .+ .....++.+++.+|+..+|++|||+.|+++.|
T Consensus 211 ~~~~~~~~~~~~~--~--~~--------~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 211 EEVLEYLKKGYRL--P--KP--------ENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred HHHHHHHhcCCCC--C--CC--------CcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 2222222222111 0 00 11234688899999999999999999998764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=297.99 Aligned_cols=243 Identities=25% Similarity=0.371 Sum_probs=193.1
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCC-----ccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccC
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGG-----WQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIP 446 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~ 446 (686)
..||+|++|.||+|... ++..|++|.+.... ....+.+.+|+.++++++|+||+++++++...+..++||||++
T Consensus 6 ~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (258)
T cd06632 6 ELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLELVP 85 (258)
T ss_pred ceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEEEecC
Confidence 46999999999999876 68899999875432 2234678999999999999999999999999999999999999
Q ss_pred CCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCccccccccc
Q 042348 447 NGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAE 526 (686)
Q Consensus 447 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~ 526 (686)
+++|.+++... ..+++..+..++.|++.||+|||+ .+|+|+||||+||+++.++.+||+|||++.......
T Consensus 86 ~~~L~~~~~~~------~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~ 156 (258)
T cd06632 86 GGSLAKLLKKY------GSFPEPVIRLYTRQILLGLEYLHD---RNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS 156 (258)
T ss_pred CCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccceeccccc
Confidence 99999999754 358899999999999999999999 899999999999999999999999999987543211
Q ss_pred CCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCC-CCCcchHHHHHHHHHHHHhCCCCccccCccchhH
Q 042348 527 ETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRK-PTQKWDIYSYGVILLEMISGKLPMIQIGSMELNI 605 (686)
Q Consensus 527 ~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~ 605 (686)
......++..|+|||.+.... ++.++|||||||++|+|++|+.||.....
T Consensus 157 ------------------------~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~----- 207 (258)
T cd06632 157 ------------------------FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG----- 207 (258)
T ss_pred ------------------------cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcH-----
Confidence 011234567799999987766 89999999999999999999999954321
Q ss_pred HHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 606 VQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 606 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
.......... ..... +.+ .....+.+++.+||+.+|++||++.+++.+
T Consensus 208 ~~~~~~~~~~-~~~~~-~~~---------~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 208 VAAVFKIGRS-KELPP-IPD---------HLSDEAKDFILKCLQRDPSLRPTAAELLEH 255 (258)
T ss_pred HHHHHHHHhc-ccCCC-cCC---------CcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence 1111111110 11111 111 122356789999999999999999999864
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=306.90 Aligned_cols=266 Identities=25% Similarity=0.300 Sum_probs=198.7
Q ss_pred cccCccCceEEEEEEeCC-CceEEEEEcCCCCcc---chHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCC
Q 042348 373 FLLGKSTIGIVYKVALNN-EEAVAVRRLGNGGWQ---RFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNG 448 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~g 448 (686)
..||+|++|.||+|...+ ++.||+|.+...... ..+.+..|++++++++||||+++++++...+..++||||+.++
T Consensus 7 ~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 86 (316)
T cd05574 7 KLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDYCPGG 86 (316)
T ss_pred eeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEEecCCC
Confidence 369999999999998764 889999998764322 4457889999999999999999999999999999999999999
Q ss_pred CHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCC
Q 042348 449 SLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEET 528 (686)
Q Consensus 449 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 528 (686)
+|.+++....+ ..+++..+..++.|++.||+|||+ .+++||||||+||+++.++.++|+|||++.........
T Consensus 87 ~L~~~~~~~~~----~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~ 159 (316)
T cd05574 87 ELFRLLQRQPG----KCLSEEVARFYAAEVLLALEYLHL---LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPP 159 (316)
T ss_pred CHHHHHHhCCC----CccCHHHHHHHHHHHHHHHHHHHH---CCeeccCCChHHeEEcCCCCEEEeecchhhcccccccc
Confidence 99999975432 468999999999999999999999 89999999999999999999999999998765432211
Q ss_pred ccccccccccCCCC-------C--CCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccC
Q 042348 529 PEVHWEQSTTGTPL-------Q--SSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIG 599 (686)
Q Consensus 529 ~~~~~~~~~~g~~~-------~--~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~ 599 (686)
... .....+.. . .............||..|+|||++.+..++.++||||||+++|+|++|+.||....
T Consensus 160 ~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~ 236 (316)
T cd05574 160 VSK---ALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN 236 (316)
T ss_pred ccc---ccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence 000 00000000 0 00000012234567889999999988889999999999999999999999995433
Q ss_pred ccchhHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCC----HHHHHHH
Q 042348 600 SMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPS----MRHVCDS 664 (686)
Q Consensus 600 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs----~~ev~~~ 664 (686)
... ....+......... .......+.+++.+||+.||++||+ +.|++++
T Consensus 237 ~~~-----~~~~~~~~~~~~~~-----------~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~ 289 (316)
T cd05574 237 RDE-----TFSNILKKEVTFPG-----------SPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH 289 (316)
T ss_pred hHH-----HHHHHhcCCccCCC-----------ccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence 211 11222211111110 0012346889999999999999999 6666654
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=299.19 Aligned_cols=251 Identities=25% Similarity=0.391 Sum_probs=193.7
Q ss_pred cccCccCceEEEEEEeCC--CceEEEEEcCCC----------CccchHHHHHHHHHHhc-cCCCCcceeeEEEEecCcee
Q 042348 373 FLLGKSTIGIVYKVALNN--EEAVAVRRLGNG----------GWQRFKEFQTEAEAIGK-IRHPNIVSLRAYFWSVDEKL 439 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~~--~~~vavK~~~~~----------~~~~~~~~~~E~~~l~~-l~H~nIv~l~~~~~~~~~~~ 439 (686)
..||+|+||.||+|.... ++.+|+|.+... ......++..|+.++.+ ++||||+++++++...+..+
T Consensus 6 ~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 85 (269)
T cd08528 6 EHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLENDRLY 85 (269)
T ss_pred hhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccCCeEE
Confidence 369999999999999765 678999987532 12233557788988875 79999999999999999999
Q ss_pred EEEeccCCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcc
Q 042348 440 LIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLA 519 (686)
Q Consensus 440 lV~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla 519 (686)
+||||+++++|.+++...... ...+++..+++++.|++.||.|||+. .+++||||||+||+++.++.+||+|||.+
T Consensus 86 lv~e~~~~~~l~~~l~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~--~~i~H~dl~~~nil~~~~~~~~l~dfg~~ 161 (269)
T cd08528 86 IVMDLIEGAPLGEHFNSLKEK--KQRFTEERIWNIFVQMVLALRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGLA 161 (269)
T ss_pred EEEecCCCCcHHHHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHhccC--CceeecCCCHHHEEECCCCcEEEecccce
Confidence 999999999999988542111 14589999999999999999999951 57999999999999999999999999999
Q ss_pred cccccccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccC
Q 042348 520 RLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIG 599 (686)
Q Consensus 520 ~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~ 599 (686)
....... ......++..|+|||...+..++.++||||||+++|||++|+.||....
T Consensus 162 ~~~~~~~------------------------~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~ 217 (269)
T cd08528 162 KQKQPES------------------------KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTN 217 (269)
T ss_pred eeccccc------------------------ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccC
Confidence 7543221 0112345677999999998889999999999999999999999984322
Q ss_pred ccchhHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 042348 600 SMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDR 667 (686)
Q Consensus 600 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~ 667 (686)
.............. ... .......+.+++.+||+.||++||++.|+.+++++
T Consensus 218 -----~~~~~~~~~~~~~~--~~~---------~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~~ 269 (269)
T cd08528 218 -----MLSLATKIVEAVYE--PLP---------EGMYSEDVTDVITSCLTPDAEARPDIIQVSAMISD 269 (269)
T ss_pred -----HHHHHHHHhhccCC--cCC---------cccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhcC
Confidence 12222222222111 000 00122467889999999999999999999998863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=303.93 Aligned_cols=241 Identities=25% Similarity=0.447 Sum_probs=189.9
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCC---ccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCC
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGG---WQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNG 448 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~g 448 (686)
..||+|+||.||+|... +++.||+|.+.... ....+++.+|++++++++||||+++++++...+..++||||++ |
T Consensus 21 ~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-g 99 (307)
T cd06607 21 REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCL-G 99 (307)
T ss_pred eeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEHHhhC-C
Confidence 46999999999999875 58899999886432 2334568899999999999999999999999999999999996 6
Q ss_pred CHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCC
Q 042348 449 SLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEET 528 (686)
Q Consensus 449 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 528 (686)
++.+++.... ..+++..+..++.|++.||.|||+ .+|+||||+|+||++++++.++|+|||++......
T Consensus 100 ~l~~~~~~~~-----~~l~~~~~~~~~~ql~~~L~~LH~---~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~--- 168 (307)
T cd06607 100 SASDILEVHK-----KPLQEVEIAAICHGALQGLAYLHS---HERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA--- 168 (307)
T ss_pred CHHHHHHHcc-----cCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcccEEECCCCCEEEeecCcceecCCC---
Confidence 7877776433 358999999999999999999999 89999999999999999999999999998654211
Q ss_pred ccccccccccCCCCCCCccccccccCCCCCccccCccccc---CCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhH
Q 042348 529 PEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASK---VRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNI 605 (686)
Q Consensus 529 ~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~ 605 (686)
....++..|+|||++. ...++.++||||||+++|||+||+.||......
T Consensus 169 ------------------------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~---- 220 (307)
T cd06607 169 ------------------------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM---- 220 (307)
T ss_pred ------------------------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHH----
Confidence 1223566799999874 356889999999999999999999998543211
Q ss_pred HHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 042348 606 VQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSL 665 (686)
Q Consensus 606 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L 665 (686)
...........+ . .........+.+++.+||+.+|++||++.+|+.+.
T Consensus 221 -~~~~~~~~~~~~--~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 268 (307)
T cd06607 221 -SALYHIAQNDSP--T---------LSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHR 268 (307)
T ss_pred -HHHHHHhcCCCC--C---------CCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence 111111111111 0 01112345688999999999999999999998763
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=302.44 Aligned_cols=239 Identities=21% Similarity=0.313 Sum_probs=193.2
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCC---ccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCC
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGG---WQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNG 448 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~g 448 (686)
..||+|+||.||++... +++.||+|.+.... ....+.+.+|++++++++||||+++++++...+..++||||++++
T Consensus 7 ~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~ 86 (290)
T cd05580 7 KTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGG 86 (290)
T ss_pred EEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEecCCCC
Confidence 46999999999999875 57899999886532 223467889999999999999999999999999999999999999
Q ss_pred CHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCC
Q 042348 449 SLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEET 528 (686)
Q Consensus 449 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 528 (686)
+|.+++... ..+++..+..++.|++.||+|||+ ++|+||||+|+||+++.++.+||+|||+++.....
T Consensus 87 ~L~~~~~~~------~~l~~~~~~~~~~qil~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~--- 154 (290)
T cd05580 87 ELFSHLRKS------GRFPEPVARFYAAQVVLALEYLHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR--- 154 (290)
T ss_pred CHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC---
Confidence 999999765 358999999999999999999999 89999999999999999999999999998754321
Q ss_pred ccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHH
Q 042348 529 PEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQW 608 (686)
Q Consensus 529 ~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~ 608 (686)
.....++..|+|||.+.+..++.++||||||+++|+|++|+.||..... ...
T Consensus 155 -----------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~ 206 (290)
T cd05580 155 -----------------------TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP-----IQI 206 (290)
T ss_pred -----------------------CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH-----HHH
Confidence 0123456779999999888889999999999999999999999954331 112
Q ss_pred HHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 042348 609 IQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRP-----SMRHVCDS 664 (686)
Q Consensus 609 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~ev~~~ 664 (686)
.+.+.......+.. ....+.+++.+||+.||++|| +++|++++
T Consensus 207 ~~~~~~~~~~~~~~-------------~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~ 254 (290)
T cd05580 207 YEKILEGKVRFPSF-------------FSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNH 254 (290)
T ss_pred HHHHhcCCccCCcc-------------CCHHHHHHHHHHccCCHHHccCcccCCHHHHHcC
Confidence 22222222222111 123577899999999999999 77777654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=299.92 Aligned_cols=242 Identities=21% Similarity=0.250 Sum_probs=184.3
Q ss_pred ccCccCceEEEEEEeC-CCceEEEEEcCCCCc---cchHHHHHHHHHHh---ccCCCCcceeeEEEEecCceeEEEeccC
Q 042348 374 LLGKSTIGIVYKVALN-NEEAVAVRRLGNGGW---QRFKEFQTEAEAIG---KIRHPNIVSLRAYFWSVDEKLLIYDYIP 446 (686)
Q Consensus 374 ~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~---~l~H~nIv~l~~~~~~~~~~~lV~e~~~ 446 (686)
+||+|+||.||++... +++.+|+|.+..... .....+.+|..++. ..+||||+.+++++...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999875 578999998865321 11223444544433 3479999999999999999999999999
Q ss_pred CCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCccccccccc
Q 042348 447 NGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAE 526 (686)
Q Consensus 447 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~ 526 (686)
+|+|.+++... ..+++..+..++.|++.||+|||+ ++|+||||||+||++++++.++|+|||++.......
T Consensus 81 ~~~L~~~i~~~------~~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~ 151 (279)
T cd05633 81 GGDLHYHLSQH------GVFSEKEMRFYATEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK 151 (279)
T ss_pred CCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC
Confidence 99999998754 358999999999999999999999 899999999999999999999999999986432111
Q ss_pred CCccccccccccCCCCCCCccccccccCCCCCccccCcccccC-CCCCCcchHHHHHHHHHHHHhCCCCccccCccchhH
Q 042348 527 ETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKV-RKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNI 605 (686)
Q Consensus 527 ~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~ 605 (686)
.....|+..|+|||.+.+ ..++.++|||||||++|||++|+.||.........
T Consensus 152 -------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~- 205 (279)
T cd05633 152 -------------------------PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH- 205 (279)
T ss_pred -------------------------ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH-
Confidence 012346778999998864 56899999999999999999999999544322211
Q ss_pred HHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 042348 606 VQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRP-----SMRHVCDS 664 (686)
Q Consensus 606 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~ev~~~ 664 (686)
.+...... . +..+. .....++.+++.+||+.||++|| +++|++++
T Consensus 206 --~~~~~~~~---~----~~~~~-----~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 206 --EIDRMTLT---V----NVELP-----DSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred --HHHHHhhc---C----CcCCc-----cccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 11111100 0 01111 11234677899999999999999 69999887
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=300.84 Aligned_cols=256 Identities=22% Similarity=0.324 Sum_probs=194.5
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCCc-cchHHHHHHHHHHhccCCCCcceeeEEEEec--CceeEEEeccCCC
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGGW-QRFKEFQTEAEAIGKIRHPNIVSLRAYFWSV--DEKLLIYDYIPNG 448 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~~lV~e~~~~g 448 (686)
..||.|++|.||++... +++.+|+|.+..... ....++.+|++++++++||||++++++|... +..++||||++++
T Consensus 7 ~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~ 86 (287)
T cd06621 7 SRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGG 86 (287)
T ss_pred EEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEecCCC
Confidence 36899999999999975 578899999875432 3456789999999999999999999998654 3679999999999
Q ss_pred CHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCC
Q 042348 449 SLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEET 528 (686)
Q Consensus 449 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 528 (686)
+|.+++..... ....+++..+..++.|++.||+|||+ .+++|+||+|+||+++.++.++|+|||++........
T Consensus 87 ~L~~~l~~~~~--~~~~l~~~~~~~i~~~i~~~L~~lH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~- 160 (287)
T cd06621 87 SLDSIYKKVKK--RGGRIGEKVLGKIAESVLKGLSYLHS---RKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLA- 160 (287)
T ss_pred CHHHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEecCCeEEEeecccccccccccc-
Confidence 99998764221 11458899999999999999999999 8999999999999999999999999999864421110
Q ss_pred ccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHH
Q 042348 529 PEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQW 608 (686)
Q Consensus 529 ~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~ 608 (686)
....++..|+|||.+.+..++.++|||||||++|||++|+.||...........+.
T Consensus 161 ------------------------~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~ 216 (287)
T cd06621 161 ------------------------GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIEL 216 (287)
T ss_pred ------------------------ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHH
Confidence 11234567999999988889999999999999999999999996543211112222
Q ss_pred HHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 609 IQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 609 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
......... ....+. .. ........+.+++.+||+.+|++|||+.|++++
T Consensus 217 ~~~~~~~~~--~~~~~~-~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~ 266 (287)
T cd06621 217 LSYIVNMPN--PELKDE-PG---NGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH 266 (287)
T ss_pred HHHHhcCCc--hhhccC-CC---CCCchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence 222222111 111000 00 001123567899999999999999999999985
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=302.45 Aligned_cols=244 Identities=20% Similarity=0.338 Sum_probs=193.8
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCCccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCCHH
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLA 451 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL~ 451 (686)
..||+|+||.||++... ++..||||.+..........+.+|+.++++++|+||+++++++...+..++||||+++++|.
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 105 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence 35999999999999874 68899999986655455567899999999999999999999999999999999999999999
Q ss_pred HHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCccc
Q 042348 452 TAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEV 531 (686)
Q Consensus 452 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 531 (686)
+++.. ..+++..+..++.|++.||+|||+ ++++||||||+||++++++.++|+|||++........
T Consensus 106 ~~~~~-------~~~~~~~~~~~~~ql~~~l~~lH~---~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~---- 171 (292)
T cd06657 106 DIVTH-------TRMNEEQIAAVCLAVLKALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP---- 171 (292)
T ss_pred HHHhc-------CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEcccccceecccccc----
Confidence 98753 247899999999999999999999 8999999999999999999999999998864431110
Q ss_pred cccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHHHHH
Q 042348 532 HWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQWIQL 611 (686)
Q Consensus 532 ~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~ 611 (686)
......++..|+|||.+.+..++.++|||||||++|||++|+.||..... . ..+..
T Consensus 172 -------------------~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~--~---~~~~~ 227 (292)
T cd06657 172 -------------------RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP--L---KAMKM 227 (292)
T ss_pred -------------------cccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--H---HHHHH
Confidence 01123467789999999888889999999999999999999999854221 1 11111
Q ss_pred HHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 612 ILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 612 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
........ +... ......+.+++.+||+.+|.+||++.+++++
T Consensus 228 ~~~~~~~~-------~~~~---~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 228 IRDNLPPK-------LKNL---HKVSPSLKGFLDRLLVRDPAQRATAAELLKH 270 (292)
T ss_pred HHhhCCcc-------cCCc---ccCCHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence 11111110 0000 0122356788999999999999999999875
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=305.35 Aligned_cols=258 Identities=22% Similarity=0.327 Sum_probs=191.8
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCCcc--chHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCC
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGGWQ--RFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGS 449 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gs 449 (686)
+.||+|+||.||+|... +++.||+|++...... ..+.+.+|++++++++||||+++++++...+..++||||+++++
T Consensus 7 ~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 86 (286)
T cd07846 7 GLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTV 86 (286)
T ss_pred eeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEecCCccH
Confidence 46999999999999986 4789999988653222 34568899999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCc
Q 042348 450 LATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETP 529 (686)
Q Consensus 450 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 529 (686)
|.++.... ..+++.+++.++.|++.||+|||+ .+++||||+|+||++++++.++|+|||++........
T Consensus 87 l~~~~~~~------~~~~~~~~~~~~~~i~~~l~~LH~---~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~-- 155 (286)
T cd07846 87 LDDLEKYP------NGLDESRVRKYLFQILRGIEFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE-- 155 (286)
T ss_pred HHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcc--
Confidence 98877643 348999999999999999999999 8999999999999999999999999999875432110
Q ss_pred cccccccccCCCCCCCccccccccCCCCCccccCcccccC-CCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHH
Q 042348 530 EVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKV-RKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQW 608 (686)
Q Consensus 530 ~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~ 608 (686)
......++..|+|||+..+ ..++.++|||||||++|||++|+.||..... .+....
T Consensus 156 ---------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~--~~~~~~ 212 (286)
T cd07846 156 ---------------------VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSD--IDQLYH 212 (286)
T ss_pred ---------------------ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCch--HHHHHH
Confidence 1112345677999998865 4578899999999999999999999854321 111111
Q ss_pred HHHHHhh-----------cCCcccccCcccccCC----CcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 609 IQLILED-----------RKPMTDILDPFLAHDL----DKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 609 ~~~~~~~-----------~~~~~~~~d~~l~~~~----~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
+...... .........+...... ..+.....+.+++.+||+.+|++||++.+++++
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 213 IIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred HHHHhCCCchhhHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 1110000 0000000000000000 001123468899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-36 Score=284.68 Aligned_cols=268 Identities=23% Similarity=0.335 Sum_probs=210.0
Q ss_pred CHHHHHHHhhcccCccCceEEEEEE-eCCCceEEEEEcCCCCccchHHHHHHHHHHhcc-CCCCcceeeEEEEecCceeE
Q 042348 363 DLEQLLKASAFLLGKSTIGIVYKVA-LNNEEAVAVRRLGNGGWQRFKEFQTEAEAIGKI-RHPNIVSLRAYFWSVDEKLL 440 (686)
Q Consensus 363 ~~~~l~~~~~~~iG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~l 440 (686)
.++++.+-+.++||+|+|+.|--+. ..++..+|||++.+.....+.+..+|++++.+. .|+||+.++++|+++...|+
T Consensus 74 ~F~d~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYL 153 (463)
T KOG0607|consen 74 KFEDMYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYL 153 (463)
T ss_pred hHHHHHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEE
Confidence 3567777788999999999998875 678999999999887666778899999999999 59999999999999999999
Q ss_pred EEeccCCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCC---CeEEeecC
Q 042348 441 IYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNM---EPHISDFG 517 (686)
Q Consensus 441 V~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~---~~kl~DfG 517 (686)
|||-|.||+|..+|+++ +.+++.++.++.++|+.||.|||. +||.|||+||+|||..+.. -+||+||.
T Consensus 154 VfEKm~GGplLshI~~~------~~F~E~EAs~vvkdia~aLdFlH~---kgIAHRDlKPENiLC~~pn~vsPvKiCDfD 224 (463)
T KOG0607|consen 154 VFEKMRGGPLLSHIQKR------KHFNEREASRVVKDIASALDFLHT---KGIAHRDLKPENILCESPNKVSPVKICDFD 224 (463)
T ss_pred EEecccCchHHHHHHHh------hhccHHHHHHHHHHHHHHHHHHhh---cCcccccCCccceeecCCCCcCceeeeccc
Confidence 99999999999999877 468999999999999999999999 9999999999999997544 47999998
Q ss_pred cccccccccCCccccccccccCCCCCCCccccccccCCCCCccccCccccc-----CCCCCCcchHHHHHHHHHHHHhCC
Q 042348 518 LARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASK-----VRKPTQKWDIYSYGVILLEMISGK 592 (686)
Q Consensus 518 la~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDVwSlGvvl~elltG~ 592 (686)
++.-...... -+...|| ...+.+|+..|||||+.. ...|+.++|.||||||+|-|++|.
T Consensus 225 LgSg~k~~~~-------~spastP---------~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGY 288 (463)
T KOG0607|consen 225 LGSGIKLNND-------CSPASTP---------ELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGY 288 (463)
T ss_pred cccccccCCC-------CCCCCCc---------cccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCC
Confidence 8754332211 1122222 344568888999999753 235899999999999999999999
Q ss_pred CCccccCccc-----hh-----HHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHH
Q 042348 593 LPMIQIGSME-----LN-----IVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVC 662 (686)
Q Consensus 593 ~P~~~~~~~~-----~~-----~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~ 662 (686)
.||.+.-..+ .. ....+..+..++..+++ + .......+..+++...+..+|.+|-++.+++
T Consensus 289 pPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQEGkYeFPd---k------dWahIS~eakdlisnLlvrda~~rlsa~~vl 359 (463)
T KOG0607|consen 289 PPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPD---K------DWAHISSEAKDLISNLLVRDAKQRLSAAQVL 359 (463)
T ss_pred CCccCccCCcCCccCCCccHHHHHHHHHHHhccCCcCCh---h------hhHHhhHHHHHHHHHHHhccHHhhhhhhhcc
Confidence 9995533221 11 22334444444433322 1 1122334566888888999999999999998
Q ss_pred HH
Q 042348 663 DS 664 (686)
Q Consensus 663 ~~ 664 (686)
++
T Consensus 360 nh 361 (463)
T KOG0607|consen 360 NH 361 (463)
T ss_pred CC
Confidence 74
|
|
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=302.94 Aligned_cols=258 Identities=20% Similarity=0.285 Sum_probs=190.3
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCC--ccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCC
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGG--WQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGS 449 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gs 449 (686)
..||+|++|.||+|... +++.||||++.... ......+.+|++++++++||||+++++++.+.+..++||||+. ++
T Consensus 6 ~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~ 84 (284)
T cd07860 6 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QD 84 (284)
T ss_pred eeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeeccc-cC
Confidence 35899999999999875 58899999886532 2233578899999999999999999999999999999999995 68
Q ss_pred HHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCc
Q 042348 450 LATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETP 529 (686)
Q Consensus 450 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 529 (686)
|.+++..... ..+++..+..++.|++.||+|||+ ++++||||||+||++++++.+||+|||+++.......
T Consensus 85 l~~~~~~~~~----~~l~~~~~~~~~~~i~~~l~~lh~---~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~-- 155 (284)
T cd07860 85 LKKFMDASPL----SGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR-- 155 (284)
T ss_pred HHHHHHhCCC----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc--
Confidence 9998876432 458999999999999999999999 8999999999999999999999999999875432110
Q ss_pred cccccccccCCCCCCCccccccccCCCCCccccCcccccCCC-CCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHH
Q 042348 530 EVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRK-PTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQW 608 (686)
Q Consensus 530 ~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~ 608 (686)
......++..|+|||.+.+.. ++.++|||||||++|||+||+.||...... ....+.
T Consensus 156 ---------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~-~~~~~~ 213 (284)
T cd07860 156 ---------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI-DQLFRI 213 (284)
T ss_pred ---------------------ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH-HHHHHH
Confidence 011223466799999886644 688999999999999999999999543221 111111
Q ss_pred HHHHHhh--------------cCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 609 IQLILED--------------RKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 609 ~~~~~~~--------------~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
+...... ...........+... .......+.+++.+||+.||++|||++|++++
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 214 FRTLGTPDEVVWPGVTSLPDYKPSFPKWARQDFSKV--VPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred HHHhCCCChhhhhhhhHHHHHHhhcccccccCHHHH--cccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 1100000 000000000000000 00112356789999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=303.84 Aligned_cols=244 Identities=22% Similarity=0.382 Sum_probs=194.8
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCCccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCCHH
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLA 451 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL~ 451 (686)
..||+|+||.||++... ++..|++|.+........+.+.+|+.++++++||||+++++++...+..++|+||+++++|.
T Consensus 25 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 104 (293)
T cd06647 25 EKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLT 104 (293)
T ss_pred eEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecCCCCcHH
Confidence 46999999999999854 57889999987655455577899999999999999999999999999999999999999999
Q ss_pred HHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCccc
Q 042348 452 TAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEV 531 (686)
Q Consensus 452 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 531 (686)
+++... .+++.++..++.|++.||+|||+ ++++||||||+||+++.++.++|+|||++........
T Consensus 105 ~~~~~~-------~l~~~~~~~i~~~l~~al~~LH~---~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~---- 170 (293)
T cd06647 105 DVVTET-------CMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS---- 170 (293)
T ss_pred HHHhhc-------CCCHHHHHHHHHHHHHHHHHHHh---CCEeeccCCHHHEEEcCCCCEEEccCcceeccccccc----
Confidence 998653 47899999999999999999999 8999999999999999999999999998875432111
Q ss_pred cccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHHHHH
Q 042348 532 HWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQWIQL 611 (686)
Q Consensus 532 ~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~ 611 (686)
......++..|+|||.+....++.++|||||||++||+++|+.||........ +..
T Consensus 171 -------------------~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~-----~~~ 226 (293)
T cd06647 171 -------------------KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA-----LYL 226 (293)
T ss_pred -------------------ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhh-----eee
Confidence 01123466779999999888899999999999999999999999954322111 111
Q ss_pred HHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 612 ILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 612 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
......+. .. ........+.+++.+||+.+|++||++.+++.+
T Consensus 227 ~~~~~~~~-------~~---~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 227 IATNGTPE-------LQ---NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred hhcCCCCC-------CC---CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11111110 00 011123457789999999999999999999877
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=295.11 Aligned_cols=244 Identities=23% Similarity=0.363 Sum_probs=194.1
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCC--ccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCC
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGG--WQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGS 449 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gs 449 (686)
..||+|+||.||++... +++.+|+|.+.... ....+.+.+|++++++++||||+++++.+...+..++||||+++++
T Consensus 6 ~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 85 (256)
T cd08220 6 RVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGT 85 (256)
T ss_pred EEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecCCCCC
Confidence 46999999999999864 57889999986542 2345678999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCC-CCeEEeecCcccccccccCC
Q 042348 450 LATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKN-MEPHISDFGLARLADIAEET 528 (686)
Q Consensus 450 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~-~~~kl~DfGla~~~~~~~~~ 528 (686)
|.+++....+ ..+++..+.+++.|++.||+|||+ ++++||||||+||+++++ +.+||+|||.++.......
T Consensus 86 L~~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~- 157 (256)
T cd08220 86 LAEYIQKRCN----SLLDEDTILHFFVQILLALHHVHT---KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK- 157 (256)
T ss_pred HHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc-
Confidence 9999986542 458999999999999999999999 899999999999999855 4589999999976532211
Q ss_pred ccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHH
Q 042348 529 PEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQW 608 (686)
Q Consensus 529 ~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~ 608 (686)
.....++..|+|||.+.+..++.++||||||+++|+|++|+.||..... ...
T Consensus 158 -----------------------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~-----~~~ 209 (256)
T cd08220 158 -----------------------AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANL-----PAL 209 (256)
T ss_pred -----------------------ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCch-----HHH
Confidence 1123456679999999888899999999999999999999999954322 122
Q ss_pred HHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 609 IQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 609 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
+........ ....+ .....+.+++.+||+.+|++|||+.|++++
T Consensus 210 ~~~~~~~~~--~~~~~----------~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 210 VLKIMSGTF--APISD----------RYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred HHHHHhcCC--CCCCC----------CcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 222222211 11101 123357799999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=298.34 Aligned_cols=242 Identities=22% Similarity=0.409 Sum_probs=193.9
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCC-ccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCCH
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGG-WQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSL 450 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL 450 (686)
..||+|+||.||+|... ++..||+|.+.... ....+.+.+|+.++++++||||+++++++..++..++||||+++++|
T Consensus 10 ~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l 89 (277)
T cd06641 10 EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSA 89 (277)
T ss_pred eeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCCCCcH
Confidence 46999999999999864 57899999876432 23346788999999999999999999999999999999999999999
Q ss_pred HHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCcc
Q 042348 451 ATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPE 530 (686)
Q Consensus 451 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 530 (686)
.+++.. ..+++..+..++.|++.|++|||+ ++++|+||||+||+++.++.++|+|||++........
T Consensus 90 ~~~i~~-------~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~--- 156 (277)
T cd06641 90 LDLLEP-------GPLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI--- 156 (277)
T ss_pred HHHHhc-------CCCCHHHHHHHHHHHHHHHHHHcc---CCeecCCCCHHhEEECCCCCEEEeecccceecccchh---
Confidence 999864 348899999999999999999999 8999999999999999999999999999875432110
Q ss_pred ccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHHHH
Q 042348 531 VHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQWIQ 610 (686)
Q Consensus 531 ~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~ 610 (686)
......++..|+|||.+.+..++.++|||||||++|+|++|..||..... .....
T Consensus 157 --------------------~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~-----~~~~~ 211 (277)
T cd06641 157 --------------------KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHP-----MKVLF 211 (277)
T ss_pred --------------------hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccch-----HHHHH
Confidence 01123456779999999888889999999999999999999999854221 11122
Q ss_pred HHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 611 LILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 611 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
.+.....+ .++ ......+.+++.+||+.+|++||++.+++++
T Consensus 212 ~~~~~~~~---~~~---------~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 212 LIPKNNPP---TLE---------GNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred HHhcCCCC---CCC---------cccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 22111111 011 1123457789999999999999999999996
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=303.70 Aligned_cols=248 Identities=24% Similarity=0.381 Sum_probs=189.4
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCCccchHHHHHHHHHHhcc-CCCCcceeeEEEEec-----CceeEEEecc
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGGWQRFKEFQTEAEAIGKI-RHPNIVSLRAYFWSV-----DEKLLIYDYI 445 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~-----~~~~lV~e~~ 445 (686)
..||+|+||.||++... +++.+|+|.+..... ....+.+|+.++.++ +||||+++++++... +..++||||+
T Consensus 28 ~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~lv~ey~ 106 (291)
T cd06639 28 ETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD-VDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELC 106 (291)
T ss_pred EEeecCCCeEEEEEEECCCCCEEEEEEeccccc-HHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEEEEEEC
Confidence 36899999999999874 578999999865422 235678899999999 899999999998754 3579999999
Q ss_pred CCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccc
Q 042348 446 PNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIA 525 (686)
Q Consensus 446 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~ 525 (686)
++|+|.++++..... ...+++..++.++.|++.||+|||+ .+++||||||+||++++++.+||+|||+++.....
T Consensus 107 ~~~sL~~~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~nili~~~~~~kl~dfg~~~~~~~~ 181 (291)
T cd06639 107 NGGSVTELVKGLLIC--GQRLDEAMISYILYGALLGLQHLHN---NRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTST 181 (291)
T ss_pred CCCcHHHHHHHhhhc--CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCCCCEEEeecccchhcccc
Confidence 999999998643211 1468999999999999999999999 89999999999999999999999999998754321
Q ss_pred cCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCC-----CCCCcchHHHHHHHHHHHHhCCCCccccCc
Q 042348 526 EETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVR-----KPTQKWDIYSYGVILLEMISGKLPMIQIGS 600 (686)
Q Consensus 526 ~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDVwSlGvvl~elltG~~P~~~~~~ 600 (686)
.. ......++..|+|||.+... .++.++|||||||++|||++|+.||.....
T Consensus 182 ~~-----------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~ 238 (291)
T cd06639 182 RL-----------------------RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHP 238 (291)
T ss_pred cc-----------------------cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcH
Confidence 10 01123466779999987543 368999999999999999999999954321
Q ss_pred cchhHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 601 MELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 601 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
. ..+...... ......++ +.....+.+++.+||+.+|++||++.|++++
T Consensus 239 ~-----~~~~~~~~~--~~~~~~~~--------~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 239 V-----KTLFKIPRN--PPPTLLHP--------EKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred H-----HHHHHHhcC--CCCCCCcc--------cccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 1 111111111 11111111 1223468899999999999999999999875
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=298.55 Aligned_cols=249 Identities=24% Similarity=0.352 Sum_probs=199.0
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCC-ccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCCH
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGG-WQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSL 450 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL 450 (686)
+.||+|++|.||++... +++.|++|++.... ....+++.+|++++++++||||+++++++...+..++|+||+++++|
T Consensus 7 ~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 86 (265)
T cd06605 7 GELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSL 86 (265)
T ss_pred HHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecCCCcH
Confidence 46999999999999876 57889999987653 23456789999999999999999999999999999999999999999
Q ss_pred HHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCcc
Q 042348 451 ATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPE 530 (686)
Q Consensus 451 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 530 (686)
.+++.... ..+++..+.+++.|++.||+|||+. .+++||||||+||++++++.++|+|||.+........
T Consensus 87 ~~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~lH~~--~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~--- 156 (265)
T cd06605 87 DKILKEVQ-----GRIPERILGKIAVAVLKGLTYLHEK--HKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA--- 156 (265)
T ss_pred HHHHHHcc-----CCCCHHHHHHHHHHHHHHHHHHcCC--CCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh---
Confidence 99997653 3588999999999999999999982 4799999999999999999999999999875432110
Q ss_pred ccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHHHH
Q 042348 531 VHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQWIQ 610 (686)
Q Consensus 531 ~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~ 610 (686)
....++..|+|||.+.+..++.++||||||+++|+|++|+.||.............++
T Consensus 157 ----------------------~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 214 (265)
T cd06605 157 ----------------------KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQ 214 (265)
T ss_pred ----------------------hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHH
Confidence 0134566799999998889999999999999999999999999654322223333343
Q ss_pred HHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 611 LILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 611 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
.......+. +. .......+.+++.+||..+|++|||+.|++.+
T Consensus 215 ~~~~~~~~~-------~~----~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 215 YIVNEPPPR-------LP----SGKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred HHhcCCCCC-------CC----hhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 333322111 00 01123457899999999999999999999865
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=295.99 Aligned_cols=242 Identities=20% Similarity=0.291 Sum_probs=192.6
Q ss_pred cCccCceEEEEEEeCC-CceEEEEEcCCCC---ccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCCH
Q 042348 375 LGKSTIGIVYKVALNN-EEAVAVRRLGNGG---WQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSL 450 (686)
Q Consensus 375 iG~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL 450 (686)
||.|++|.||++.... ++.||+|.+.... ....+.+.+|+.++++++||||+++++++.+++..++||||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 6999999999999764 7899999986532 22346789999999999999999999999999999999999999999
Q ss_pred HHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCcc
Q 042348 451 ATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPE 530 (686)
Q Consensus 451 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 530 (686)
.+++... ..+++..+..++.|++.||+|||+ ++++|+||||+||+++.++.++|+|||+++.......
T Consensus 81 ~~~l~~~------~~l~~~~~~~~~~~i~~~l~~lH~---~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~--- 148 (262)
T cd05572 81 WTILRDR------GLFDEYTARFYIACVVLAFEYLHN---RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQK--- 148 (262)
T ss_pred HHHHhhc------CCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEEcCCCCEEEeeCCcccccCcccc---
Confidence 9999764 348899999999999999999999 8999999999999999999999999999876532210
Q ss_pred ccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHHHH
Q 042348 531 VHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQWIQ 610 (686)
Q Consensus 531 ~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~ 610 (686)
.....++..|+|||.+.+..++.++||||||+++|||++|+.||..... +......
T Consensus 149 ---------------------~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~~ 204 (262)
T cd05572 149 ---------------------TWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDE---DPMEIYN 204 (262)
T ss_pred ---------------------cccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCC---CHHHHHH
Confidence 0122456679999999888899999999999999999999999955432 1222233
Q ss_pred HHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCC-----HHHHHH
Q 042348 611 LILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPS-----MRHVCD 663 (686)
Q Consensus 611 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~ev~~ 663 (686)
.+....... . .. ......+.+++.+||+.+|++||+ ++|+++
T Consensus 205 ~~~~~~~~~-~-----~~-----~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 205 DILKGNGKL-E-----FP-----NYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred HHhccCCCC-C-----CC-----cccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 333211110 0 00 011346889999999999999999 666655
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=302.42 Aligned_cols=259 Identities=20% Similarity=0.268 Sum_probs=188.0
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCCcc-chHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCCH
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGGWQ-RFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSL 450 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL 450 (686)
..||+|+||.||+|... ++..||+|++...... ....+.+|+.++++++|+||+++++++...+..++||||+. ++|
T Consensus 11 ~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~-~~l 89 (291)
T cd07870 11 EKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYMH-TDL 89 (291)
T ss_pred EEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEeccc-CCH
Confidence 36999999999999864 5889999998654322 23467889999999999999999999999999999999995 688
Q ss_pred HHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCcc
Q 042348 451 ATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPE 530 (686)
Q Consensus 451 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 530 (686)
.+++.... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++.......
T Consensus 90 ~~~~~~~~-----~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~--- 158 (291)
T cd07870 90 AQYMIQHP-----GGLHPYNVRLFMFQLLRGLAYIHG---QHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ--- 158 (291)
T ss_pred HHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEEcCCCcEEEeccccccccCCCCC---
Confidence 77775443 347888899999999999999999 8999999999999999999999999999874321110
Q ss_pred ccccccccCCCCCCCccccccccCCCCCccccCcccccC-CCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHHH
Q 042348 531 VHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKV-RKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQWI 609 (686)
Q Consensus 531 ~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~ 609 (686)
......++..|+|||++.+ ..++.++|||||||++|||++|+.||.........+.+.
T Consensus 159 --------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~- 217 (291)
T cd07870 159 --------------------TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKI- 217 (291)
T ss_pred --------------------CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHH-
Confidence 0112235677999999875 357889999999999999999999996443221111111
Q ss_pred HHHHh-----------hcCCc-ccccC----cccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 610 QLILE-----------DRKPM-TDILD----PFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 610 ~~~~~-----------~~~~~-~~~~d----~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
..... ..... ..... +.+............+.+++.+|++.||++|||+.|++.+
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h 288 (291)
T cd07870 218 WTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH 288 (291)
T ss_pred HHHcCCCChhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence 00000 00000 00000 0000000000113457789999999999999999998754
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=297.89 Aligned_cols=250 Identities=24% Similarity=0.369 Sum_probs=191.6
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCCc----------cchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEE
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGGW----------QRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLI 441 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----------~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 441 (686)
+.||+|+||.||+|... +++.||+|.++.... ...+.+..|+.++++++||||+++++++...+..++|
T Consensus 7 ~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 86 (272)
T cd06629 7 ELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEYLSIF 86 (272)
T ss_pred ceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCceEEE
Confidence 46999999999999864 588999998753211 0124578899999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccc
Q 042348 442 YDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARL 521 (686)
Q Consensus 442 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~ 521 (686)
|||+++++|.++++.. ..+++..+..++.|++.||.|||+ ++++||||||+||+++.++.++|+|||+++.
T Consensus 87 ~e~~~~~~L~~~l~~~------~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~ 157 (272)
T cd06629 87 LEYVPGGSIGSCLRTY------GRFEEQLVRFFTEQVLEGLAYLHS---KGILHRDLKADNLLVDADGICKISDFGISKK 157 (272)
T ss_pred EecCCCCcHHHHHhhc------cCCCHHHHHHHHHHHHHHHHHHhh---CCeeecCCChhhEEEcCCCeEEEeecccccc
Confidence 9999999999999765 358899999999999999999999 8999999999999999999999999999875
Q ss_pred cccccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCC--CCCcchHHHHHHHHHHHHhCCCCccccC
Q 042348 522 ADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRK--PTQKWDIYSYGVILLEMISGKLPMIQIG 599 (686)
Q Consensus 522 ~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDVwSlGvvl~elltG~~P~~~~~ 599 (686)
....... .......++..|+|||.+.... ++.++||||||+++||+++|+.||....
T Consensus 158 ~~~~~~~---------------------~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~ 216 (272)
T cd06629 158 SDDIYDN---------------------DQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEE 216 (272)
T ss_pred ccccccc---------------------cccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcc
Confidence 4311100 0112234677899999987654 7899999999999999999999994322
Q ss_pred ccchhHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 600 SMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 600 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
.. .. ........ ....+++... ......+.+++.+||+.+|++||++.||+++
T Consensus 217 ~~----~~-~~~~~~~~--~~~~~~~~~~-----~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 217 AI----AA-MFKLGNKR--SAPPIPPDVS-----MNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred hH----HH-HHHhhccc--cCCcCCcccc-----ccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 11 11 11111111 0111111111 1123468889999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-35 Score=296.19 Aligned_cols=247 Identities=21% Similarity=0.313 Sum_probs=188.8
Q ss_pred hcccCccCceEEEEEEeC-CCceEEEEEcCCCC-----ccchHHHHHHHHHHhccCCCCcceeeEEEEec--CceeEEEe
Q 042348 372 AFLLGKSTIGIVYKVALN-NEEAVAVRRLGNGG-----WQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSV--DEKLLIYD 443 (686)
Q Consensus 372 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~~lV~e 443 (686)
.+.||+|+||.||+|... ++..||||.+.... ....+.+.+|+.++++++||||+++++++.+. ...++|||
T Consensus 7 ~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e 86 (265)
T cd06652 7 GKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFME 86 (265)
T ss_pred eeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEEEEE
Confidence 347999999999999875 58899999875321 12345788999999999999999999998764 45789999
Q ss_pred ccCCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccc
Q 042348 444 YIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLAD 523 (686)
Q Consensus 444 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~ 523 (686)
|+++++|.+++... ..+++..+++++.|++.||+|||+ .+|+|+||||+||+++.++.++|+|||+++...
T Consensus 87 ~~~~~~L~~~l~~~------~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~ 157 (265)
T cd06652 87 HMPGGSIKDQLKSY------GALTENVTRKYTRQILEGVSYLHS---NMIVHRDIKGANILRDSVGNVKLGDFGASKRLQ 157 (265)
T ss_pred ecCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEecCCCCEEECcCccccccc
Confidence 99999999998754 347888999999999999999999 899999999999999999999999999987543
Q ss_pred cccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccch
Q 042348 524 IAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMEL 603 (686)
Q Consensus 524 ~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~ 603 (686)
...... .......++..|+|||.+.+..++.++|||||||++|||++|+.||......
T Consensus 158 ~~~~~~--------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-- 215 (265)
T cd06652 158 TICLSG--------------------TGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAM-- 215 (265)
T ss_pred cccccc--------------------cccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchH--
Confidence 211000 0112234677899999998888999999999999999999999999543111
Q ss_pred hHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 604 NIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 604 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
.. +...... +.. +.. .......+.+++.+|+. +|++||++.||+++
T Consensus 216 --~~-~~~~~~~--~~~----~~~-----~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 216 --AA-IFKIATQ--PTN----PVL-----PPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred --HH-HHHHhcC--CCC----CCC-----chhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 11 1111111 100 101 11223457788888984 99999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=304.67 Aligned_cols=258 Identities=21% Similarity=0.296 Sum_probs=191.6
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCCcc-----chHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccC
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGGWQ-----RFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIP 446 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~ 446 (686)
..||+|++|.||+|... +++.||||.+...... ....+..|++++++++|+||+++++++.+.+..++||||+
T Consensus 6 ~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~- 84 (298)
T cd07841 6 KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVFEFM- 84 (298)
T ss_pred eeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEEccc-
Confidence 36999999999999865 5889999998754322 2345678999999999999999999999999999999999
Q ss_pred CCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCccccccccc
Q 042348 447 NGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAE 526 (686)
Q Consensus 447 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~ 526 (686)
+|+|.+++.... ..+++..+..++.||++||+|||+ ++|+||||||+||+++.++.++|+|||+++......
T Consensus 85 ~~~L~~~i~~~~-----~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~ 156 (298)
T cd07841 85 ETDLEKVIKDKS-----IVLTPADIKSYMLMTLRGLEYLHS---NWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN 156 (298)
T ss_pred CCCHHHHHhccC-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCChhhEEEcCCCCEEEccceeeeeccCCC
Confidence 899999997643 258999999999999999999999 899999999999999999999999999997653221
Q ss_pred CCccccccccccCCCCCCCccccccccCCCCCccccCcccccC-CCCCCcchHHHHHHHHHHHHhCCCCccccCccchhH
Q 042348 527 ETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKV-RKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNI 605 (686)
Q Consensus 527 ~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~ 605 (686)
. ......++..|+|||.+.+ ..++.++|||||||++|||++|..||...... +.
T Consensus 157 ~-----------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~--~~ 211 (298)
T cd07841 157 R-----------------------KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDI--DQ 211 (298)
T ss_pred c-----------------------cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccH--HH
Confidence 0 0112234567999998854 45789999999999999999998777543221 11
Q ss_pred HHHHHHHHhhc--------CCcccccCcccccCCC----cHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 606 VQWIQLILEDR--------KPMTDILDPFLAHDLD----KEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 606 ~~~~~~~~~~~--------~~~~~~~d~~l~~~~~----~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
........... ................ .......+.+++.+||+.+|++|||+.|++++
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 212 LGKIFEALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred HHHHHHHcCCCchhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 11111110000 0000000000000000 01123568899999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=302.81 Aligned_cols=245 Identities=24% Similarity=0.370 Sum_probs=188.9
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCCccchHHHHHHHHHHhcc-CCCCcceeeEEEEe------cCceeEEEec
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGGWQRFKEFQTEAEAIGKI-RHPNIVSLRAYFWS------VDEKLLIYDY 444 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~------~~~~~lV~e~ 444 (686)
..||+|+||.||+|... +++.+|+|.+.... ....++..|+.+++++ +||||+++++++.. .+..++||||
T Consensus 22 ~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~ 100 (282)
T cd06636 22 EVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEF 100 (282)
T ss_pred eeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEEEEEEe
Confidence 46999999999999874 57889999886543 2345788999999999 79999999999863 3567999999
Q ss_pred cCCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCccccccc
Q 042348 445 IPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADI 524 (686)
Q Consensus 445 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~ 524 (686)
+++|+|.+++..... ..+++..+..++.|++.||+|||+ ++|+||||||+||++++++.++|+|||++.....
T Consensus 101 ~~~~~L~~~~~~~~~----~~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dl~~~nili~~~~~~~l~dfg~~~~~~~ 173 (282)
T cd06636 101 CGAGSVTDLVKNTKG----NALKEDWIAYICREILRGLAHLHA---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR 173 (282)
T ss_pred CCCCcHHHHHHHccC----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCcchhhhhc
Confidence 999999999976432 357888899999999999999999 8999999999999999999999999999875431
Q ss_pred ccCCccccccccccCCCCCCCccccccccCCCCCccccCccccc-----CCCCCCcchHHHHHHHHHHHHhCCCCccccC
Q 042348 525 AEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASK-----VRKPTQKWDIYSYGVILLEMISGKLPMIQIG 599 (686)
Q Consensus 525 ~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDVwSlGvvl~elltG~~P~~~~~ 599 (686)
... ......++..|+|||.+. ...++.++|||||||++|||++|+.||....
T Consensus 174 ~~~-----------------------~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~ 230 (282)
T cd06636 174 TVG-----------------------RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMH 230 (282)
T ss_pred ccc-----------------------CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccC
Confidence 110 112234677899999875 3467889999999999999999999995432
Q ss_pred ccchhHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 600 SMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 600 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
.... ....... .... . ........+.+++.+||+.||.+||++.|++++
T Consensus 231 ~~~~-----~~~~~~~--~~~~-----~----~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~ 279 (282)
T cd06636 231 PMRA-----LFLIPRN--PPPK-----L----KSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH 279 (282)
T ss_pred HHhh-----hhhHhhC--CCCC-----C----cccccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence 2111 1111111 0000 0 011233468899999999999999999999753
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-35 Score=302.39 Aligned_cols=263 Identities=17% Similarity=0.263 Sum_probs=195.2
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCCc---cchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCC
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGGW---QRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNG 448 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~g 448 (686)
+.||+|+||.||++... .++.|++|.+..... ...+.+.+|+++++.++||||+++++++...+..++||||++++
T Consensus 7 ~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~ 86 (305)
T cd05609 7 KLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYVEGG 86 (305)
T ss_pred eEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEecCCCC
Confidence 46999999999999876 468899999865432 23456889999999999999999999999999999999999999
Q ss_pred CHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCC
Q 042348 449 SLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEET 528 (686)
Q Consensus 449 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 528 (686)
+|.+++... ..+++..+..++.|++.||+|||+ ++++||||||+||+++.++.+||+|||+++........
T Consensus 87 ~L~~~l~~~------~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~ 157 (305)
T cd05609 87 DCATLLKNI------GALPVDMARMYFAETVLALEYLHN---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTT 157 (305)
T ss_pred cHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCchHHEEECCCCCEEEeeCCCccccCcCccc
Confidence 999999754 358999999999999999999999 89999999999999999999999999998743211100
Q ss_pred ccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHH
Q 042348 529 PEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQW 608 (686)
Q Consensus 529 ~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~ 608 (686)
. . ..+.. ... ..........++..|+|||.+....++.++|||||||++|||++|+.||..... .+.
T Consensus 158 ~-~-----~~~~~-~~~-~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~-----~~~ 224 (305)
T cd05609 158 N-L-----YEGHI-EKD-TREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP-----EEL 224 (305)
T ss_pred c-c-----ccccc-ccc-hhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----HHH
Confidence 0 0 00000 000 000011123567789999999888899999999999999999999999954321 122
Q ss_pred HHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 042348 609 IQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDR 667 (686)
Q Consensus 609 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~ 667 (686)
...........+. .. ......+.+++.+||+.+|++||++.++.+.|+.
T Consensus 225 ~~~~~~~~~~~~~-----~~-----~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 225 FGQVISDDIEWPE-----GD-----EALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred HHHHHhcccCCCC-----cc-----ccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 2332222111111 00 0122357899999999999999996555555544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=296.43 Aligned_cols=250 Identities=22% Similarity=0.329 Sum_probs=193.7
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCC--ccchHHHHHHHHHHhccCCCCcceeeEEEEec--CceeEEEeccCC
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGG--WQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSV--DEKLLIYDYIPN 447 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~~lV~e~~~~ 447 (686)
..||.|+||.||++... ++..||+|.+.... ....+++..|++++++++||||+++++++... ...+++|||+++
T Consensus 6 ~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e~~~~ 85 (265)
T cd08217 6 ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEG 85 (265)
T ss_pred eeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEehhccC
Confidence 36899999999999864 57889999886532 33346788999999999999999999988643 457899999999
Q ss_pred CCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccC--CCCceecCCCCCCeeecCCCCeEEeecCcccccccc
Q 042348 448 GSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVS--PKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIA 525 (686)
Q Consensus 448 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~--~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~ 525 (686)
++|.+++...... ...+++..++.++.|++.||+|||..+ ..+++||||||+||++++++.+||+|||++......
T Consensus 86 ~~L~~~l~~~~~~--~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~~~~ 163 (265)
T cd08217 86 GDLAQLIQKCKKE--RKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHD 163 (265)
T ss_pred CCHHHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccccCC
Confidence 9999999754211 146899999999999999999999221 189999999999999999999999999999865422
Q ss_pred cCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhH
Q 042348 526 EETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNI 605 (686)
Q Consensus 526 ~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~ 605 (686)
.. ......++..|+|||.+....++.++||||||+++|+|++|+.||.....
T Consensus 164 ~~-----------------------~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~----- 215 (265)
T cd08217 164 SS-----------------------FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ----- 215 (265)
T ss_pred cc-----------------------cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH-----
Confidence 11 01123456779999999888899999999999999999999999954321
Q ss_pred HHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 606 VQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 606 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
....+.+.... ... +. ......+.+++.+|++.+|++||++.+|+++
T Consensus 216 ~~~~~~~~~~~--~~~-~~---------~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 216 LQLASKIKEGK--FRR-IP---------YRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred HHHHHHHhcCC--CCC-Cc---------cccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 12222222111 111 11 1223467899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=299.87 Aligned_cols=259 Identities=23% Similarity=0.327 Sum_probs=194.3
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCC--ccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCC
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGG--WQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGS 449 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gs 449 (686)
..||+|++|.||+|... +++.||+|++.... ......+.+|+.++++++||||+++++++...+..++||||+ +++
T Consensus 6 ~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~-~~~ 84 (286)
T cd07832 6 GRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM-PSD 84 (286)
T ss_pred eecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc-CCC
Confidence 46899999999999875 68899999987643 223467899999999999999999999999999999999999 999
Q ss_pred HHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCc
Q 042348 450 LATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETP 529 (686)
Q Consensus 450 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 529 (686)
|.+++.... ..+++.++..++.|++.||+|||+ .+++|+||||+||+++.++.++|+|||++........
T Consensus 85 L~~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~-- 154 (286)
T cd07832 85 LSEVLRDEE-----RPLPEAQVKSYMRMLLKGVAYMHA---NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP-- 154 (286)
T ss_pred HHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC--
Confidence 999987644 468999999999999999999999 8999999999999999999999999999875542211
Q ss_pred cccccccccCCCCCCCccccccccCCCCCccccCcccccCC-CCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHH
Q 042348 530 EVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVR-KPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQW 608 (686)
Q Consensus 530 ~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~ 608 (686)
.......++..|+|||.+.+. .++.++||||+|+++|||+||+.||..... ......
T Consensus 155 --------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~--~~~~~~ 212 (286)
T cd07832 155 --------------------RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGEND--IEQLAI 212 (286)
T ss_pred --------------------CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCH--HHHHHH
Confidence 011223567789999988654 468999999999999999999877744322 111111
Q ss_pred HHHHHhhcCC-----cccccCc---ccccCCC------cHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 609 IQLILEDRKP-----MTDILDP---FLAHDLD------KEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 609 ~~~~~~~~~~-----~~~~~d~---~l~~~~~------~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
+......... ..+..+. ....... .++....+.+++.+||+.+|++||++++++++
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 213 VFRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred HHHHcCCCChHHHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 1111110000 0000000 0000000 01123578899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=285.28 Aligned_cols=263 Identities=24% Similarity=0.338 Sum_probs=213.7
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCCc---cchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCC
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGGW---QRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNG 448 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~g 448 (686)
++||+|.||.|-.++-+ +++.+|+|++++.-. .+...-..|-++|+..+||.+..+-..|+..+..++||||..||
T Consensus 174 KvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMeyanGG 253 (516)
T KOG0690|consen 174 KVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVMEYANGG 253 (516)
T ss_pred HHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEEEEccCc
Confidence 36999999999999855 688999999987532 33445678999999999999999999999999999999999999
Q ss_pred CHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCC
Q 042348 449 SLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEET 528 (686)
Q Consensus 449 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 528 (686)
.|.-+|... +.+++....-+-.+|+.||.|||+ ++||.||||.+|.|+|.||++||.|||+++---..
T Consensus 254 eLf~HLsre------r~FsE~RtRFYGaEIvsAL~YLHs---~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~--- 321 (516)
T KOG0690|consen 254 ELFFHLSRE------RVFSEDRTRFYGAEIVSALGYLHS---RNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKY--- 321 (516)
T ss_pred eEeeehhhh------hcccchhhhhhhHHHHHHhhhhhh---CCeeeeechhhhheeccCCceEeeecccchhcccc---
Confidence 999988765 468888888899999999999999 99999999999999999999999999999732111
Q ss_pred ccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHH
Q 042348 529 PEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQW 608 (686)
Q Consensus 529 ~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~ 608 (686)
| ......+||+.|.|||++....|+.++|.|.+|||||||++|+.||..... ...
T Consensus 322 ----------g----------~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh-----~kL 376 (516)
T KOG0690|consen 322 ----------G----------DTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDH-----EKL 376 (516)
T ss_pred ----------c----------ceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccch-----hHH
Confidence 1 223457888899999999999999999999999999999999999965432 233
Q ss_pred HHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHHHhcccccchhhhhccCCCC
Q 042348 609 IQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRP-----SMRHVCDSLDRVNISTEQQFMKGEEPK 683 (686)
Q Consensus 609 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~ev~~~L~~i~~~~~~~~~~~~~~~ 683 (686)
+..++.+.-..+..+.+ +...|+...|.+||.+|- .++||.++=--....++..+++.-+|+
T Consensus 377 FeLIl~ed~kFPr~ls~-------------eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~~~~~Kki~PP 443 (516)
T KOG0690|consen 377 FELILMEDLKFPRTLSP-------------EAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWEATYRKKIEPP 443 (516)
T ss_pred HHHHHhhhccCCccCCH-------------HHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCCHHHHHHhccCCC
Confidence 44455444444333222 355778889999999994 467777665555677888899999998
Q ss_pred CC
Q 042348 684 FD 685 (686)
Q Consensus 684 ~~ 685 (686)
|.
T Consensus 444 fK 445 (516)
T KOG0690|consen 444 FK 445 (516)
T ss_pred CC
Confidence 84
|
|
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=301.60 Aligned_cols=259 Identities=20% Similarity=0.307 Sum_probs=193.7
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCC--CccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCC
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNG--GWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGS 449 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gs 449 (686)
..||+|++|.||+|... +++.||+|.++.. .....+.+.+|++++++++|+||+++++++...+..++||||++++.
T Consensus 7 ~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~ 86 (288)
T cd07833 7 GVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVERTL 86 (288)
T ss_pred EEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEecCCCCH
Confidence 46899999999999876 4789999988653 22334678999999999999999999999999999999999999877
Q ss_pred HHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCc
Q 042348 450 LATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETP 529 (686)
Q Consensus 450 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 529 (686)
+..+.... ..+++.++..++.|++.||+|||+ ++++||||||+||++++++.+||+|||++........
T Consensus 87 l~~~~~~~------~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~-- 155 (288)
T cd07833 87 LELLEASP------GGLPPDAVRSYIWQLLQAIAYCHS---HNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA-- 155 (288)
T ss_pred HHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc--
Confidence 77665443 348999999999999999999999 8999999999999999999999999999876543211
Q ss_pred cccccccccCCCCCCCccccccccCCCCCccccCcccccCC-CCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHH
Q 042348 530 EVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVR-KPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQW 608 (686)
Q Consensus 530 ~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~ 608 (686)
.......++..|+|||++.+. .++.++||||||+++|+|++|+.||...... +....
T Consensus 156 --------------------~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~--~~~~~ 213 (288)
T cd07833 156 --------------------SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDI--DQLYL 213 (288)
T ss_pred --------------------ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHH
Confidence 011123456779999999887 7899999999999999999999998543221 11111
Q ss_pred HHHHHhhcC----------------CcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 609 IQLILEDRK----------------PMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 609 ~~~~~~~~~----------------~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
......... ...+..++.............++.+++.+||+.+|++||++++++++
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 214 IQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred HHHHhCCCCHHHhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 111110000 00000000000000011124568899999999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-35 Score=295.82 Aligned_cols=255 Identities=26% Similarity=0.403 Sum_probs=198.1
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCC-ccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCCH
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGG-WQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSL 450 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL 450 (686)
+.||.|+||.||+|... ++..+++|++.... ....+.+.+|++.++.++|+||+++++.+...+..++||||+++++|
T Consensus 7 ~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~l 86 (267)
T cd06610 7 EVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSL 86 (267)
T ss_pred eeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEeccCCCcH
Confidence 46899999999999865 57889999986543 23457789999999999999999999999999999999999999999
Q ss_pred HHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCcc
Q 042348 451 ATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPE 530 (686)
Q Consensus 451 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 530 (686)
.++++.... ...+++..+..++.|++.||+|||+ .+++||||||+||++++++.++|+|||++..+.......
T Consensus 87 ~~~~~~~~~---~~~~~~~~~~~~~~ql~~al~~lh~---~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~- 159 (267)
T cd06610 87 LDIMKSSYP---RGGLDEAIIATVLKEVLKGLEYLHS---NGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRT- 159 (267)
T ss_pred HHHHHHhcc---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcccc-
Confidence 999976421 1358999999999999999999999 899999999999999999999999999997664322110
Q ss_pred ccccccccCCCCCCCccccccccCCCCCccccCcccccCC-CCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHHH
Q 042348 531 VHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVR-KPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQWI 609 (686)
Q Consensus 531 ~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~ 609 (686)
........++..|+|||++... .++.++|||||||++|||++|+.||....... ..
T Consensus 160 ------------------~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~-----~~ 216 (267)
T cd06610 160 ------------------RKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK-----VL 216 (267)
T ss_pred ------------------ccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh-----hH
Confidence 0011233567789999998776 78999999999999999999999995443221 11
Q ss_pred HHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 610 QLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 610 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
........+ .+............+.+++.+||+.||++||++.|++++
T Consensus 217 ~~~~~~~~~-------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 217 MLTLQNDPP-------SLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred HHHhcCCCC-------CcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 112111111 111111111234567899999999999999999999874
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=298.75 Aligned_cols=243 Identities=23% Similarity=0.376 Sum_probs=192.0
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCC-CccchHHHHHHHHHHhccC---CCCcceeeEEEEecCceeEEEeccCC
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNG-GWQRFKEFQTEAEAIGKIR---HPNIVSLRAYFWSVDEKLLIYDYIPN 447 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~---H~nIv~l~~~~~~~~~~~lV~e~~~~ 447 (686)
+.||+|+||.||+|... +++.||+|.+... ......++.+|+.++++++ |||++++++++......++||||+++
T Consensus 7 ~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e~~~~ 86 (277)
T cd06917 7 ELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYAEG 86 (277)
T ss_pred hheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEecCCC
Confidence 46999999999999864 6889999998654 2334567889999999996 99999999999999999999999999
Q ss_pred CCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccC
Q 042348 448 GSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEE 527 (686)
Q Consensus 448 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 527 (686)
++|.+++... .+++..+..++.|++.||+|||+ .+|+||||+|+||++++++.++|+|||++........
T Consensus 87 ~~L~~~~~~~-------~l~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06917 87 GSVRTLMKAG-------PIAEKYISVIIREVLVALKYIHK---VGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS 156 (277)
T ss_pred CcHHHHHHcc-------CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCcc
Confidence 9999998642 58899999999999999999999 8999999999999999999999999999876542211
Q ss_pred CccccccccccCCCCCCCccccccccCCCCCccccCcccccC-CCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHH
Q 042348 528 TPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKV-RKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIV 606 (686)
Q Consensus 528 ~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~ 606 (686)
......|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||..... .
T Consensus 157 -----------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~-----~ 208 (277)
T cd06917 157 -----------------------KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDA-----F 208 (277)
T ss_pred -----------------------ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCCh-----h
Confidence 0112346778999998865 4468999999999999999999999954321 1
Q ss_pred HHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 607 QWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 607 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
......... ..+.+.. ......+.+++.+||+.||++||++.|++++
T Consensus 209 ~~~~~~~~~-------~~~~~~~----~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 209 RAMMLIPKS-------KPPRLED----NGYSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred hhhhccccC-------CCCCCCc----ccCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 111111111 0011111 1123468899999999999999999999874
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=295.58 Aligned_cols=235 Identities=18% Similarity=0.309 Sum_probs=182.5
Q ss_pred cCccCceEEEEEEeC-CCceEEEEEcCCCCccchHHHHHHHHHHhcc-CCCCcceeeEEEEecCceeEEEeccCCCCHHH
Q 042348 375 LGKSTIGIVYKVALN-NEEAVAVRRLGNGGWQRFKEFQTEAEAIGKI-RHPNIVSLRAYFWSVDEKLLIYDYIPNGSLAT 452 (686)
Q Consensus 375 iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL~~ 452 (686)
||+|+||.||++... ++..+|+|.+....... . |+.....+ +||||+++++++...+..++||||+++|+|.+
T Consensus 24 lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~---~--e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~ 98 (267)
T PHA03390 24 LIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA---I--EPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFD 98 (267)
T ss_pred ecCCCceEEEEEEEcCCCcEEEEEEEehhhcch---h--hHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEcCCCCcHHH
Confidence 699999999999865 57889999886532221 1 22222222 79999999999999999999999999999999
Q ss_pred HhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCC-CeEEeecCcccccccccCCccc
Q 042348 453 AIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNM-EPHISDFGLARLADIAEETPEV 531 (686)
Q Consensus 453 ~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~-~~kl~DfGla~~~~~~~~~~~~ 531 (686)
++... ..+++.++..++.|++.||+|||+ .+++||||||+||+++.++ .++|+|||+++.....
T Consensus 99 ~l~~~------~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~------ 163 (267)
T PHA03390 99 LLKKE------GKLSEAEVKKIIRQLVEALNDLHK---HNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP------ 163 (267)
T ss_pred HHHhc------CCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC------
Confidence 99764 358999999999999999999999 8999999999999999988 9999999998754311
Q ss_pred cccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHHHHH
Q 042348 532 HWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQWIQL 611 (686)
Q Consensus 532 ~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~ 611 (686)
....++..|+|||++.+..++.++|||||||++|||++|+.||........+...+...
T Consensus 164 ---------------------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~ 222 (267)
T PHA03390 164 ---------------------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKR 222 (267)
T ss_pred ---------------------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHh
Confidence 11235667999999998889999999999999999999999996443333233333222
Q ss_pred HHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCC-HHHHHHH
Q 042348 612 ILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPS-MRHVCDS 664 (686)
Q Consensus 612 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-~~ev~~~ 664 (686)
. ....+.. ......+.+++.+||+.+|++||+ ++|++++
T Consensus 223 ~-~~~~~~~-------------~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h 262 (267)
T PHA03390 223 Q-QKKLPFI-------------KNVSKNANDFVQSMLKYNINYRLTNYNEIIKH 262 (267)
T ss_pred h-cccCCcc-------------cccCHHHHHHHHHHhccChhhCCchHHHHhcC
Confidence 2 1111111 112345788999999999999996 6888753
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=300.72 Aligned_cols=244 Identities=24% Similarity=0.438 Sum_probs=191.7
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCC---ccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCC
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGG---WQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNG 448 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~g 448 (686)
..||+|+||.||++... ++..||+|.+.... .....++.+|++++++++|||++++++++...+..++||||++ |
T Consensus 31 ~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-g 109 (317)
T cd06635 31 REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCL-G 109 (317)
T ss_pred heeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeCCC-C
Confidence 46999999999999865 57899999986432 2234578899999999999999999999999999999999996 5
Q ss_pred CHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCC
Q 042348 449 SLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEET 528 (686)
Q Consensus 449 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 528 (686)
+|.+++.... ..+++.++..++.|++.||.|||+ ++|+||||+|+||+++.++.+||+|||++......
T Consensus 110 ~l~~~~~~~~-----~~l~~~~~~~i~~~i~~~l~~lH~---~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~--- 178 (317)
T cd06635 110 SASDLLEVHK-----KPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA--- 178 (317)
T ss_pred CHHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcccEEECCCCCEEEecCCCccccCCc---
Confidence 8888776443 458999999999999999999999 89999999999999999999999999988643211
Q ss_pred ccccccccccCCCCCCCccccccccCCCCCccccCccccc---CCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhH
Q 042348 529 PEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASK---VRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNI 605 (686)
Q Consensus 529 ~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~ 605 (686)
....++..|+|||++. ...++.++|||||||++|||++|+.||......
T Consensus 179 ------------------------~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~---- 230 (317)
T cd06635 179 ------------------------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM---- 230 (317)
T ss_pred ------------------------ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHH----
Confidence 1234566799999873 456899999999999999999999998543211
Q ss_pred HHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 042348 606 VQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRV 668 (686)
Q Consensus 606 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i 668 (686)
...........+.. ........+.+++.+||+.+|++||++.++++++...
T Consensus 231 -~~~~~~~~~~~~~~-----------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~ 281 (317)
T cd06635 231 -SALYHIAQNESPTL-----------QSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVL 281 (317)
T ss_pred -HHHHHHHhccCCCC-----------CCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhh
Confidence 11222222211110 0112234578999999999999999999999876443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=293.86 Aligned_cols=250 Identities=24% Similarity=0.334 Sum_probs=195.0
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCCc--cchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCC
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGGW--QRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGS 449 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gs 449 (686)
..||+|+||.||+|... +++.|++|.+..... ...+.+..|+.++++++|+||+++++++...+..++|+||+++++
T Consensus 6 ~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 85 (264)
T cd06626 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCSGGT 85 (264)
T ss_pred eEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecCCCCc
Confidence 46999999999999865 678999999876543 256789999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCc
Q 042348 450 LATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETP 529 (686)
Q Consensus 450 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 529 (686)
|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+||++++++.+||+|||++..........
T Consensus 86 L~~~~~~~------~~~~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~ 156 (264)
T cd06626 86 LEELLEHG------RILDEHVIRVYTLQLLEGLAYLHS---HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTM 156 (264)
T ss_pred HHHHHhhc------CCCChHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcc
Confidence 99999764 347889999999999999999999 899999999999999999999999999987654322100
Q ss_pred cccccccccCCCCCCCccccccccCCCCCccccCcccccCCC---CCCcchHHHHHHHHHHHHhCCCCccccCccchhHH
Q 042348 530 EVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRK---PTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIV 606 (686)
Q Consensus 530 ~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~ 606 (686)
. .......++..|+|||++.+.. ++.++||||||+++||+++|+.||.......
T Consensus 157 ~-------------------~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~---- 213 (264)
T cd06626 157 G-------------------EEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEF---- 213 (264)
T ss_pred c-------------------ccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchH----
Confidence 0 0011234567799999987765 8899999999999999999999995432111
Q ss_pred HHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 607 QWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 607 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
...........+ .+... ......+.+++.+||+.+|++||++.|++.+
T Consensus 214 ~~~~~~~~~~~~-------~~~~~---~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~ 261 (264)
T cd06626 214 QIMFHVGAGHKP-------PIPDS---LQLSPEGKDFLDRCLESDPKKRPTASELLQH 261 (264)
T ss_pred HHHHHHhcCCCC-------CCCcc---cccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 111111111111 01000 1113456789999999999999999998753
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=300.65 Aligned_cols=247 Identities=19% Similarity=0.284 Sum_probs=186.9
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCCc-cchHHHHHHHHH-HhccCCCCcceeeEEEEecCceeEEEeccCCCC
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGGW-QRFKEFQTEAEA-IGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGS 449 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~-l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gs 449 (686)
..||+|+||.||++... +++.||+|++..... ....++..|+.. ++..+||||+++++++...+..++||||++ |+
T Consensus 7 ~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~ 85 (283)
T cd06617 7 EELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVMD-TS 85 (283)
T ss_pred EEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhhc-cc
Confidence 36899999999999876 589999999875422 223456667665 566689999999999999999999999996 68
Q ss_pred HHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCC-CceecCCCCCCeeecCCCCeEEeecCcccccccccCC
Q 042348 450 LATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPK-RYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEET 528 (686)
Q Consensus 450 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~-~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 528 (686)
|.+++...... ...+++..+..++.|++.||+|||+ + +++||||||+||+++.++.+||+|||+++......
T Consensus 86 l~~~l~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~---~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-- 158 (283)
T cd06617 86 LDKFYKKVYDK--GLTIPEDILGKIAVSIVKALEYLHS---KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSV-- 158 (283)
T ss_pred HHHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHhh---cCCeecCCCCHHHEEECCCCCEEEeeccccccccccc--
Confidence 98888653221 1468999999999999999999998 6 89999999999999999999999999987543111
Q ss_pred ccccccccccCCCCCCCccccccccCCCCCccccCcccccC----CCCCCcchHHHHHHHHHHHHhCCCCccccCccchh
Q 042348 529 PEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKV----RKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELN 604 (686)
Q Consensus 529 ~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~ 604 (686)
..+...++..|+|||.+.+ ..++.++|||||||++|||++|+.||........
T Consensus 159 ----------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~- 215 (283)
T cd06617 159 ----------------------AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQ- 215 (283)
T ss_pred ----------------------ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHH-
Confidence 0112345677999998764 4568899999999999999999999954322111
Q ss_pred HHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 605 IVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 605 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
.......... ..... .....++.+++.+||+.+|++||++.+++++
T Consensus 216 ---~~~~~~~~~~--~~~~~---------~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 261 (283)
T cd06617 216 ---QLKQVVEEPS--PQLPA---------EKFSPEFQDFVNKCLKKNYKERPNYPELLQH 261 (283)
T ss_pred ---HHHHHHhcCC--CCCCc---------cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1112211111 11100 1123467899999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=297.26 Aligned_cols=246 Identities=25% Similarity=0.394 Sum_probs=196.7
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCCccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCCHH
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLA 451 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL~ 451 (686)
..||+|++|.||+|... ++..|++|.+..... ..+.+.+|++.+++++|+||+++++++...+..++|+||+++++|.
T Consensus 25 ~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 103 (286)
T cd06614 25 EKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLT 103 (286)
T ss_pred HhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccCCCcHH
Confidence 36999999999999987 578899999876543 4567899999999999999999999999999999999999999999
Q ss_pred HHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCccc
Q 042348 452 TAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEV 531 (686)
Q Consensus 452 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 531 (686)
+++.... ..+++..+..++.|++.||+|||+ .+|+|+||||+||+++.++.++|+|||++........
T Consensus 104 ~~l~~~~-----~~l~~~~~~~i~~~i~~~L~~lH~---~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~---- 171 (286)
T cd06614 104 DIITQNF-----VRMNEPQIAYVCREVLQGLEYLHS---QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS---- 171 (286)
T ss_pred HHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCChhhEEEcCCCCEEECccchhhhhccchh----
Confidence 9998753 368999999999999999999999 8999999999999999999999999998865432110
Q ss_pred cccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHHHHH
Q 042348 532 HWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQWIQL 611 (686)
Q Consensus 532 ~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~ 611 (686)
......++..|+|||.+.+..++.++|||||||++|+|++|+.||...... .....
T Consensus 172 -------------------~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~-----~~~~~ 227 (286)
T cd06614 172 -------------------KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPL-----RALFL 227 (286)
T ss_pred -------------------hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHH-----HHHHH
Confidence 011223566799999998888999999999999999999999998533221 11111
Q ss_pred HHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 042348 612 ILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSL 665 (686)
Q Consensus 612 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L 665 (686)
..... .....+ .......+.+++.+||+.+|.+||++.+++++-
T Consensus 228 ~~~~~--~~~~~~--------~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~ 271 (286)
T cd06614 228 ITTKG--IPPLKN--------PEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHP 271 (286)
T ss_pred HHhcC--CCCCcc--------hhhCCHHHHHHHHHHhccChhhCcCHHHHhhCh
Confidence 11111 111111 111234678899999999999999999998753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=337.58 Aligned_cols=249 Identities=25% Similarity=0.357 Sum_probs=198.2
Q ss_pred hcccCccCceEEEEEEe-CCCceEEEEEcCCC--CccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCC
Q 042348 372 AFLLGKSTIGIVYKVAL-NNEEAVAVRRLGNG--GWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNG 448 (686)
Q Consensus 372 ~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~g 448 (686)
+..||.|.||.||-+.. ++|+..|||-++.. .....+...+|+.++..++|||+|+++|+-.+.+..+|.||||++|
T Consensus 1240 g~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~G 1319 (1509)
T KOG4645|consen 1240 GNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGG 1319 (1509)
T ss_pred ccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhccC
Confidence 45799999999999874 56888999977543 3344567889999999999999999999999999999999999999
Q ss_pred CHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCC
Q 042348 449 SLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEET 528 (686)
Q Consensus 449 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 528 (686)
+|.+.+...+ -.++.....+..|++.|++|||+ .|||||||||.||+++.+|.+|++|||.|..+......
T Consensus 1320 sLa~ll~~gr------i~dE~vt~vyt~qll~gla~LH~---~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~ 1390 (1509)
T KOG4645|consen 1320 SLASLLEHGR------IEDEMVTRVYTKQLLEGLAYLHE---HGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQT 1390 (1509)
T ss_pred cHHHHHHhcc------hhhhhHHHHHHHHHHHHHHHHHh---cCceecCCCccceeeecCCcEEeecccceeEecCchhc
Confidence 9999997653 35666667788999999999999 99999999999999999999999999999876533110
Q ss_pred ccccccccccCCCCCCCccccccccCCCCCccccCcccccCCC---CCCcchHHHHHHHHHHHHhCCCCccccCccchhH
Q 042348 529 PEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRK---PTQKWDIYSYGVILLEMISGKLPMIQIGSMELNI 605 (686)
Q Consensus 529 ~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~ 605 (686)
.+ .......||+.|||||++.+.. -..++||||+|||++||+||++||...+..
T Consensus 1391 ----------------~~---~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne---- 1447 (1509)
T KOG4645|consen 1391 ----------------MP---GELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE---- 1447 (1509)
T ss_pred ----------------CC---HHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch----
Confidence 00 2345678899999999997643 467899999999999999999999665432
Q ss_pred HHHHHHHHhhcCC-cccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 042348 606 VQWIQLILEDRKP-MTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSL 665 (686)
Q Consensus 606 ~~~~~~~~~~~~~-~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L 665 (686)
.+.+..+..+..| +++ .-..+-.+++..||+.||++|.++.|++++=
T Consensus 1448 ~aIMy~V~~gh~Pq~P~-------------~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~ 1495 (1509)
T KOG4645|consen 1448 WAIMYHVAAGHKPQIPE-------------RLSSEGRDFLEHCLEQDPKMRWTASQLLEHA 1495 (1509)
T ss_pred hHHHhHHhccCCCCCch-------------hhhHhHHHHHHHHHhcCchhhhHHHHHHHhh
Confidence 2223333333322 221 1233456899999999999999999888763
|
|
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=300.01 Aligned_cols=258 Identities=22% Similarity=0.281 Sum_probs=190.1
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCCc--cchHHHHHHHHHHhccCCCCcceeeEEEEec--CceeEEEeccCC
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGGW--QRFKEFQTEAEAIGKIRHPNIVSLRAYFWSV--DEKLLIYDYIPN 447 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~~lV~e~~~~ 447 (686)
+.||+|+||.||+|... +++.+++|.++.... .....+.+|+.++++++||||+++++++... +..++||||++
T Consensus 11 ~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~e~~~- 89 (293)
T cd07843 11 NRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVE- 89 (293)
T ss_pred hhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEehhcC-
Confidence 46999999999999976 578899999865432 2234577899999999999999999999877 88999999997
Q ss_pred CCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccC
Q 042348 448 GSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEE 527 (686)
Q Consensus 448 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 527 (686)
++|.+++.... ..+++..++.++.|++.||+|||+ ++++||||||+||+++.++.+||+|||+++.......
T Consensus 90 ~~L~~~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~ 161 (293)
T cd07843 90 HDLKSLMETMK-----QPFLQSEVKCLMLQLLSGVAHLHD---NWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLK 161 (293)
T ss_pred cCHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCcEEEeecCceeeccCCcc
Confidence 59999987643 358999999999999999999999 8999999999999999999999999999875542210
Q ss_pred CccccccccccCCCCCCCccccccccCCCCCccccCcccccCC-CCCCcchHHHHHHHHHHHHhCCCCccccCccchhHH
Q 042348 528 TPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVR-KPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIV 606 (686)
Q Consensus 528 ~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~ 606 (686)
......++..|+|||.+.+. .++.++||||||+++|||++|+.||......+ ..
T Consensus 162 -----------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~--~~ 216 (293)
T cd07843 162 -----------------------PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEID--QL 216 (293)
T ss_pred -----------------------ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHH--HH
Confidence 01123346679999988654 46899999999999999999999995433211 11
Q ss_pred HHHHHHHhh---------------c-CCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 607 QWIQLILED---------------R-KPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 607 ~~~~~~~~~---------------~-~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
..+...... . ..........+............+.+++.+||+.+|++|||+.|++++
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 217 NKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred HHHHHHhCCCchHHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 111110000 0 000000000000111100023457789999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=277.13 Aligned_cols=245 Identities=21% Similarity=0.339 Sum_probs=190.6
Q ss_pred ccCccCceEEEEEEeC-CCceEEEEEcCCC-CccchHHHHHHHHHHhccC-CCCcceeeEEEEecCceeEEEeccCCCCH
Q 042348 374 LLGKSTIGIVYKVALN-NEEAVAVRRLGNG-GWQRFKEFQTEAEAIGKIR-HPNIVSLRAYFWSVDEKLLIYDYIPNGSL 450 (686)
Q Consensus 374 ~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lV~e~~~~gsL 450 (686)
.||.|..|.|++++.+ +|..+|||.+... +..+.+++...++++.+-+ .|+||+.+|||..+...++.||.|.- -+
T Consensus 99 dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs~-C~ 177 (391)
T KOG0983|consen 99 DLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMST-CA 177 (391)
T ss_pred hhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHHH-HH
Confidence 4899999999999976 4788999998764 4455677888888877764 89999999999999999999999842 45
Q ss_pred HHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCcc
Q 042348 451 ATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPE 530 (686)
Q Consensus 451 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 530 (686)
+.++..-. +++++.-+-++...+++||.||.+. ++|||||+||+|||+|+.|++|++|||++-.+-+...
T Consensus 178 ekLlkrik-----~piPE~ilGk~tva~v~AL~YLKeK--H~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkA--- 247 (391)
T KOG0983|consen 178 EKLLKRIK-----GPIPERILGKMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKA--- 247 (391)
T ss_pred HHHHHHhc-----CCchHHhhhhhHHHHHHHHHHHHHh--cceeecccCccceEEccCCCEEeecccccceeecccc---
Confidence 55554432 5688888889999999999999974 6899999999999999999999999999976653321
Q ss_pred ccccccccCCCCCCCccccccccCCCCCccccCcccccC---CCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHH
Q 042348 531 VHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKV---RKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQ 607 (686)
Q Consensus 531 ~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~ 607 (686)
.+...|.+.|||||.+.- ..|+.++||||||++++||.||+.||.....+-.
T Consensus 248 ---------------------htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe---- 302 (391)
T KOG0983|consen 248 ---------------------HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFE---- 302 (391)
T ss_pred ---------------------cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHH----
Confidence 122345556999998854 4689999999999999999999999966443322
Q ss_pred HHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 608 WIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 608 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
....++.+..+ .+.... .....+.+++..||.+|+.+||...+++++
T Consensus 303 ~ltkvln~ePP-------~L~~~~---gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 303 VLTKVLNEEPP-------LLPGHM---GFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred HHHHHHhcCCC-------CCCccc---CcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 22333333222 121111 133467889999999999999999999887
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=300.96 Aligned_cols=262 Identities=18% Similarity=0.242 Sum_probs=189.8
Q ss_pred cCccCceEEEEEEeCCCceEEEEEcCCC--CccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCCHHH
Q 042348 375 LGKSTIGIVYKVALNNEEAVAVRRLGNG--GWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLAT 452 (686)
Q Consensus 375 iG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL~~ 452 (686)
+|.|+++.||++.. +++.||||++... .....+.+.+|++++++++||||+++++++...+..+++|||+++|+|.+
T Consensus 10 ~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 88 (314)
T cd08216 10 FEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCED 88 (314)
T ss_pred hcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHH
Confidence 44555555555544 5889999998654 33445689999999999999999999999999999999999999999999
Q ss_pred HhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCcccc
Q 042348 453 AIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVH 532 (686)
Q Consensus 453 ~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 532 (686)
++..... ..+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||.+...........
T Consensus 89 ~l~~~~~----~~~~~~~~~~~~~~l~~~L~~LH~---~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~-- 159 (314)
T cd08216 89 LLKTHFP----EGLPELAIAFILKDVLNALDYIHS---KGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQR-- 159 (314)
T ss_pred HHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCcceEEEecCCceEEecCccceeecccccccc--
Confidence 9986532 358899999999999999999999 8999999999999999999999999998875532211000
Q ss_pred ccccccCCCCCCCccccccccCCCCCccccCcccccC--CCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHHHH
Q 042348 533 WEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKV--RKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQWIQ 610 (686)
Q Consensus 533 ~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~ 610 (686)
.. ........++..|+|||++.. ..++.++|||||||++|||++|+.||........ . ..
T Consensus 160 ---~~-----------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~-~---~~ 221 (314)
T cd08216 160 ---VV-----------HDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQM-L---LE 221 (314)
T ss_pred ---cc-----------ccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHH-H---HH
Confidence 00 011123445678999999865 3588999999999999999999999964332111 1 11
Q ss_pred HHHhhcCC-------------ccc----ccCcccc---cCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 611 LILEDRKP-------------MTD----ILDPFLA---HDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 611 ~~~~~~~~-------------~~~----~~d~~l~---~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
........ ... ..++... ...........+.+++.+||+.||++|||+.|++++
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 222 KVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred HHhccCccccccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 11100000 000 0000000 000111233467889999999999999999999886
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=297.68 Aligned_cols=248 Identities=25% Similarity=0.381 Sum_probs=191.0
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCCccchHHHHHHHHHHhcc-CCCCcceeeEEEEecC------ceeEEEec
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGGWQRFKEFQTEAEAIGKI-RHPNIVSLRAYFWSVD------EKLLIYDY 444 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~------~~~lV~e~ 444 (686)
..||+|++|.||+|... +++.+++|.+..... ..+++.+|+.+++++ +|+||+++++++.... ..++||||
T Consensus 12 ~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~ 90 (275)
T cd06608 12 EVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMEL 90 (275)
T ss_pred eeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEEEEEEc
Confidence 46999999999999975 577899999876543 346789999999999 7999999999997655 37999999
Q ss_pred cCCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCccccccc
Q 042348 445 IPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADI 524 (686)
Q Consensus 445 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~ 524 (686)
+++++|.+++...... ...+++..+..++.|++.||+|||+ .+++||||+|+||++++++.+||+|||++.....
T Consensus 91 ~~~~~L~~~~~~~~~~--~~~~~~~~~~~~~~ql~~al~~lH~---~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~ 165 (275)
T cd06608 91 CGGGSVTDLVKGLRKK--GKRLKEEWIAYILRETLRGLAYLHE---NKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDS 165 (275)
T ss_pred CCCCcHHHHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHHHEEEccCCeEEECCCccceeccc
Confidence 9999999998753211 1468999999999999999999999 8999999999999999999999999999875432
Q ss_pred ccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccC-----CCCCCcchHHHHHHHHHHHHhCCCCccccC
Q 042348 525 AEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKV-----RKPTQKWDIYSYGVILLEMISGKLPMIQIG 599 (686)
Q Consensus 525 ~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDVwSlGvvl~elltG~~P~~~~~ 599 (686)
... ......++..|+|||++.. ..++.++|||||||++|||++|+.||....
T Consensus 166 ~~~-----------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 222 (275)
T cd06608 166 TLG-----------------------RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMH 222 (275)
T ss_pred chh-----------------------hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccc
Confidence 110 1122346778999998753 346889999999999999999999995432
Q ss_pred ccchhHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 600 SMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 600 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
... ....+... ...... ........+.+++.+||..||++|||+.|++++
T Consensus 223 ~~~-----~~~~~~~~--~~~~~~--------~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~ 272 (275)
T cd06608 223 PMR-----ALFKIPRN--PPPTLK--------SPENWSKKFNDFISECLIKNYEQRPFMEELLEH 272 (275)
T ss_pred hHH-----HHHHhhcc--CCCCCC--------chhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 211 11111111 111111 111233467899999999999999999999863
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=294.55 Aligned_cols=242 Identities=20% Similarity=0.245 Sum_probs=184.3
Q ss_pred ccCccCceEEEEEEeC-CCceEEEEEcCCCCcc---chHHHHHHHH---HHhccCCCCcceeeEEEEecCceeEEEeccC
Q 042348 374 LLGKSTIGIVYKVALN-NEEAVAVRRLGNGGWQ---RFKEFQTEAE---AIGKIRHPNIVSLRAYFWSVDEKLLIYDYIP 446 (686)
Q Consensus 374 ~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~---~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~ 446 (686)
+||+|+||.||++... +++.||+|.+...... ....+..|.. .++...||||+++++++...+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999864 5789999988653211 1122344443 4445579999999999999999999999999
Q ss_pred CCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCccccccccc
Q 042348 447 NGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAE 526 (686)
Q Consensus 447 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~ 526 (686)
+|+|.+++... ..+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++......
T Consensus 81 g~~L~~~l~~~------~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~ 151 (278)
T cd05606 81 GGDLHYHLSQH------GVFSEAEMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK 151 (278)
T ss_pred CCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC
Confidence 99999988654 358999999999999999999999 899999999999999999999999999986442110
Q ss_pred CCccccccccccCCCCCCCccccccccCCCCCccccCcccccCC-CCCCcchHHHHHHHHHHHHhCCCCccccCccchhH
Q 042348 527 ETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVR-KPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNI 605 (686)
Q Consensus 527 ~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~ 605 (686)
.....|+..|+|||.+.++ .++.++||||+||++|||++|+.||........
T Consensus 152 -------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~-- 204 (278)
T cd05606 152 -------------------------PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-- 204 (278)
T ss_pred -------------------------CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccch--
Confidence 0123467789999998754 689999999999999999999999965422211
Q ss_pred HHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 042348 606 VQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRP-----SMRHVCDS 664 (686)
Q Consensus 606 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~ev~~~ 664 (686)
............. +.. .....+.+++.+|+..+|++|| ++.+++++
T Consensus 205 ~~~~~~~~~~~~~--------~~~-----~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 205 HEIDRMTLTMAVE--------LPD-----SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred HHHHHHhhccCCC--------CCC-----cCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence 1111111111111 111 1124678899999999999999 99999875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=301.88 Aligned_cols=261 Identities=20% Similarity=0.251 Sum_probs=191.1
Q ss_pred cCcc--CceEEEEEEeC-CCceEEEEEcCCCC--ccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCC
Q 042348 375 LGKS--TIGIVYKVALN-NEEAVAVRRLGNGG--WQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGS 449 (686)
Q Consensus 375 iG~G--~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gs 449 (686)
||+| +||+||++... +++.||+|.+.... ....+.+.+|+.+++.++||||++++++|...+..++||||+.+++
T Consensus 6 ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~~ 85 (328)
T cd08226 6 IGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGS 85 (328)
T ss_pred hCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCCC
Confidence 5666 99999999874 68999999986532 2334678899999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCc
Q 042348 450 LATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETP 529 (686)
Q Consensus 450 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 529 (686)
|.+++..... ..+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.++++||+.+..........
T Consensus 86 l~~~l~~~~~----~~~~~~~~~~~~~qi~~aL~~lH~---~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~ 158 (328)
T cd08226 86 ANSLLKTYFP----EGMSEALIGNILFGALRGLNYLHQ---NGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKA 158 (328)
T ss_pred HHHHHHhhcc----cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccc
Confidence 9999876432 358899999999999999999999 899999999999999999999999998654332111100
Q ss_pred cccccccccCCCCCCCccccccccCCCCCccccCcccccCC--CCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHH
Q 042348 530 EVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVR--KPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQ 607 (686)
Q Consensus 530 ~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~ 607 (686)
. ... .......++..|+|||++.+. .++.++|||||||++|||++|+.||........
T Consensus 159 ~-----~~~-----------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~---- 218 (328)
T cd08226 159 K-----VVY-----------DFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQM---- 218 (328)
T ss_pred c-----ccc-----------cccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHH----
Confidence 0 000 001112345569999998763 478999999999999999999999954322111
Q ss_pred HHHHHHhhcCCcc-----------------------------------cccCcccccCCCcHHHHHHHHHHHHhccccCC
Q 042348 608 WIQLILEDRKPMT-----------------------------------DILDPFLAHDLDKEDEIVSVLKIALDCVHKSP 652 (686)
Q Consensus 608 ~~~~~~~~~~~~~-----------------------------------~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP 652 (686)
...........+ ...+..+. ..........+.+++.+||+.||
T Consensus 219 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dP 296 (328)
T cd08226 219 -LLQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLR-TPSSKTFSPAFQNLVELCLQQDP 296 (328)
T ss_pred -HHHHhcCCCCCCccccccchhhhhhccchhhhhcccccchhcccccccccccccc-chhhhhhhHHHHHHHHHHccCCc
Confidence 111111000000 00000000 01112345678999999999999
Q ss_pred CCCCCHHHHHHH
Q 042348 653 DKRPSMRHVCDS 664 (686)
Q Consensus 653 ~~RPs~~ev~~~ 664 (686)
++|||+.|++++
T Consensus 297 ~~Rpta~e~l~~ 308 (328)
T cd08226 297 EKRPSASSLLSH 308 (328)
T ss_pred ccCCCHHHHhhC
Confidence 999999999866
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-35 Score=294.30 Aligned_cols=245 Identities=23% Similarity=0.392 Sum_probs=194.1
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCC--ccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCC
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGG--WQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGS 449 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gs 449 (686)
+.||+|+||.||+|... ++..||+|.+.... ....+.+.+|+.++++++|+||+++++++...+..++|+||+++++
T Consensus 6 ~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 85 (257)
T cd08225 6 KKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGD 85 (257)
T ss_pred EEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecCCCCc
Confidence 46999999999999876 47889999986532 2334678899999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCC-CeEEeecCcccccccccCC
Q 042348 450 LATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNM-EPHISDFGLARLADIAEET 528 (686)
Q Consensus 450 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~-~~kl~DfGla~~~~~~~~~ 528 (686)
|.+++....+ ..+++..+..++.|++.||+|||+ .+++|+||||+||++++++ .+||+|||.+........
T Consensus 86 L~~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~- 157 (257)
T cd08225 86 LMKRINRQRG----VLFSEDQILSWFVQISLGLKHIHD---RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME- 157 (257)
T ss_pred HHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEEcCCCCeEEecccccchhccCCcc-
Confidence 9999976432 357999999999999999999999 8999999999999999885 469999999875532110
Q ss_pred ccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHH
Q 042348 529 PEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQW 608 (686)
Q Consensus 529 ~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~ 608 (686)
......|+..|+|||+..+..++.++|||||||++|||++|+.||.... ..++
T Consensus 158 ----------------------~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----~~~~ 210 (257)
T cd08225 158 ----------------------LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN-----LHQL 210 (257)
T ss_pred ----------------------cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc-----HHHH
Confidence 0112346777999999988889999999999999999999999985322 2222
Q ss_pred HHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 609 IQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 609 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
+....... ... ..+ .....+.+++.+||+.+|++|||+.|++++
T Consensus 211 ~~~~~~~~--~~~-~~~---------~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 211 VLKICQGY--FAP-ISP---------NFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred HHHHhccc--CCC-CCC---------CCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 33222221 111 111 122357889999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=295.97 Aligned_cols=242 Identities=21% Similarity=0.260 Sum_probs=193.2
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCCc---cchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCC
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGGW---QRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNG 448 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~g 448 (686)
+.||.|+||.||+|... ++..||+|.+..... ...+.+.+|++++++++||||+++++++...+..++||||++++
T Consensus 6 ~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 85 (258)
T cd05578 6 RVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLGG 85 (258)
T ss_pred EEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeCCCCC
Confidence 46999999999999876 588999999865322 34567899999999999999999999999999999999999999
Q ss_pred CHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCC
Q 042348 449 SLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEET 528 (686)
Q Consensus 449 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 528 (686)
+|.+++... ..+++..+..++.|++.||+|||+ ++++|+||||+||++++++.++|+|||.+.......
T Consensus 86 ~L~~~l~~~------~~l~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-- 154 (258)
T cd05578 86 DLRYHLSQK------VKFSEEQVKFWICEIVLALEYLHS---KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT-- 154 (258)
T ss_pred CHHHHHHhc------CCcCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc--
Confidence 999999764 358899999999999999999999 899999999999999999999999999987543221
Q ss_pred ccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHH
Q 042348 529 PEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQW 608 (686)
Q Consensus 529 ~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~ 608 (686)
......++..|+|||.+.+..++.++||||||+++|+|++|+.||....... ....
T Consensus 155 ----------------------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--~~~~ 210 (258)
T cd05578 155 ----------------------LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTI--RDQI 210 (258)
T ss_pred ----------------------cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccH--HHHH
Confidence 0112345667999999988889999999999999999999999996543321 1111
Q ss_pred HHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCH--HHHH
Q 042348 609 IQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSM--RHVC 662 (686)
Q Consensus 609 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~--~ev~ 662 (686)
...........+ + .....+.+++.+||+.||.+||++ +|++
T Consensus 211 ~~~~~~~~~~~~----~---------~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 211 RAKQETADVLYP----A---------TWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred HHHhccccccCc----c---------cCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 111111111111 1 122467899999999999999999 6654
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-35 Score=299.50 Aligned_cols=249 Identities=20% Similarity=0.293 Sum_probs=188.6
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCC-ccchHHHHHHHHHHhccC-CCCcceeeEEEEecCceeEEEeccCCCC
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGG-WQRFKEFQTEAEAIGKIR-HPNIVSLRAYFWSVDEKLLIYDYIPNGS 449 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lV~e~~~~gs 449 (686)
..||+|+||.||++... +++.||+|.+.... ......+.+|+.++.++. ||||+++++++...+..+++|||+.. +
T Consensus 10 ~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~~-~ 88 (288)
T cd06616 10 GEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMDI-S 88 (288)
T ss_pred HHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEecccC-C
Confidence 36999999999999865 57899999986542 234567889999999996 99999999999999999999999864 5
Q ss_pred HHHHh---hcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCccccccccc
Q 042348 450 LATAI---HGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAE 526 (686)
Q Consensus 450 L~~~l---~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~ 526 (686)
+.++. ..... ..+++..+..++.|++.||+|||+. .+++||||||+||+++.++.+||+|||+++......
T Consensus 89 l~~l~~~~~~~~~----~~l~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 162 (288)
T cd06616 89 LDKFYKYVYEVLK----SVIPEEILGKIAVATVKALNYLKEE--LKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSI 162 (288)
T ss_pred HHHHHHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhhc--CCeeccCCCHHHEEEccCCcEEEeecchhHHhccCC
Confidence 55543 22211 4689999999999999999999972 389999999999999999999999999987543211
Q ss_pred CCccccccccccCCCCCCCccccccccCCCCCccccCcccccCC---CCCCcchHHHHHHHHHHHHhCCCCccccCccch
Q 042348 527 ETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVR---KPTQKWDIYSYGVILLEMISGKLPMIQIGSMEL 603 (686)
Q Consensus 527 ~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~ 603 (686)
. .....++..|+|||++.+. .++.++|||||||++|||++|+.||....
T Consensus 163 ~------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~---- 214 (288)
T cd06616 163 A------------------------KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN---- 214 (288)
T ss_pred c------------------------cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc----
Confidence 0 1122456779999998765 68999999999999999999999995432
Q ss_pred hHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 604 NIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 604 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
...+.+........+ .+.... ......++.+++.+||+.+|++|||+.+|+++
T Consensus 215 ~~~~~~~~~~~~~~~-------~~~~~~-~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 215 SVFDQLTQVVKGDPP-------ILSNSE-EREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred hHHHHHhhhcCCCCC-------cCCCcC-CCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111222222111111 111110 01234468899999999999999999999876
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=296.69 Aligned_cols=265 Identities=22% Similarity=0.291 Sum_probs=198.6
Q ss_pred cccCccCceEEEEEEe----CCCceEEEEEcCCCCc----cchHHHHHHHHHHhcc-CCCCcceeeEEEEecCceeEEEe
Q 042348 373 FLLGKSTIGIVYKVAL----NNEEAVAVRRLGNGGW----QRFKEFQTEAEAIGKI-RHPNIVSLRAYFWSVDEKLLIYD 443 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~----~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~e 443 (686)
..||+|+||.||++.. .+|..||+|++..... ...+.+.+|++++.++ +|+||+++++++..+...++|||
T Consensus 6 ~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (290)
T cd05613 6 KVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHLILD 85 (290)
T ss_pred eeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEEEEEe
Confidence 4699999999999986 3678999999865321 2235688999999999 69999999999999889999999
Q ss_pred ccCCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccc
Q 042348 444 YIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLAD 523 (686)
Q Consensus 444 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~ 523 (686)
|+++++|.+++... ..+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||+++...
T Consensus 86 ~~~~~~L~~~l~~~------~~l~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 156 (290)
T cd05613 86 YINGGELFTHLSQR------ERFKEQEVQIYSGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFH 156 (290)
T ss_pred cCCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEECCCCCEEEeeCccceecc
Confidence 99999999999764 358899999999999999999999 899999999999999999999999999987543
Q ss_pred cccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCC--CCCCcchHHHHHHHHHHHHhCCCCccccCcc
Q 042348 524 IAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVR--KPTQKWDIYSYGVILLEMISGKLPMIQIGSM 601 (686)
Q Consensus 524 ~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDVwSlGvvl~elltG~~P~~~~~~~ 601 (686)
..... ......|+..|+|||.+... .++.++||||||+++|+|++|+.||.....
T Consensus 157 ~~~~~----------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~- 213 (290)
T cd05613 157 EDEVE----------------------RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGE- 213 (290)
T ss_pred ccccc----------------------ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCc-
Confidence 22110 01123467789999998653 468899999999999999999999953322
Q ss_pred chhHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH--Hhcccccchh
Q 042348 602 ELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRP-----SMRHVCDS--LDRVNISTEQ 674 (686)
Q Consensus 602 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~ev~~~--L~~i~~~~~~ 674 (686)
................+.+.. ....+.+++.+||+.||++|| ++.+++.+ ++++. ++.
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~--~~~ 278 (290)
T cd05613 214 KNSQAEISRRILKSEPPYPQE-------------MSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKIN--WDD 278 (290)
T ss_pred cccHHHHHHHhhccCCCCCcc-------------CCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCC--HHH
Confidence 112222233322222222111 123567899999999999997 67777765 33333 343
Q ss_pred hhhccCCCCC
Q 042348 675 QFMKGEEPKF 684 (686)
Q Consensus 675 ~~~~~~~~~~ 684 (686)
...+..+++|
T Consensus 279 ~~~~~~~~~~ 288 (290)
T cd05613 279 LAAKKVPAPF 288 (290)
T ss_pred HhhccCCCCC
Confidence 3344444444
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=296.73 Aligned_cols=255 Identities=22% Similarity=0.294 Sum_probs=190.9
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCC--ccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCC
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGG--WQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGS 449 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gs 449 (686)
+.||.|++|.||+|... ++..||+|++.... ......+.+|++++++++||||+++++++.+.+..++||||++ ++
T Consensus 5 ~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~~-~~ 83 (283)
T cd07835 5 EKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFLD-LD 83 (283)
T ss_pred eEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEeccC-cC
Confidence 46899999999999865 68899999986542 2223568899999999999999999999999999999999995 69
Q ss_pred HHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCc
Q 042348 450 LATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETP 529 (686)
Q Consensus 450 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 529 (686)
|.+++..... ..+++..++.++.|++.||+|||+ ++++||||+|+||+++.++.++|+|||+++.......
T Consensus 84 l~~~~~~~~~----~~~~~~~~~~~~~~i~~~L~~lH~---~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~-- 154 (283)
T cd07835 84 LKKYMDSSPL----TGLDPPLIKSYLYQLLQGIAYCHS---HRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR-- 154 (283)
T ss_pred HHHHHhhCCC----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc--
Confidence 9999876532 358999999999999999999999 8999999999999999999999999999875432110
Q ss_pred cccccccccCCCCCCCccccccccCCCCCccccCcccccCC-CCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHH
Q 042348 530 EVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVR-KPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQW 608 (686)
Q Consensus 530 ~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~ 608 (686)
......++..|+|||++.+. .++.++||||||+++|||++|+.||....... .+...
T Consensus 155 ---------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-~~~~~ 212 (283)
T cd07835 155 ---------------------TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEID-QLFRI 212 (283)
T ss_pred ---------------------ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHH
Confidence 01122346679999987654 57899999999999999999999995432211 11111
Q ss_pred HHHHHhhcCCcc-----------------cccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 609 IQLILEDRKPMT-----------------DILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 609 ~~~~~~~~~~~~-----------------~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
.+.. ..+.. ....+.... ........+.+++.+||+.+|++|||++|++++
T Consensus 213 ~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 213 FRTL---GTPDEDVWPGVTSLPDYKPTFPKWARQDLSK--VVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred HHHh---CCCChHHhhhhhhchhhhhhcccccccchhh--hcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 1110 00000 000000000 001122467899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=294.56 Aligned_cols=252 Identities=20% Similarity=0.323 Sum_probs=195.1
Q ss_pred cCccCceEEEEEEeCC-CceEEEEEcCCCCc---cchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCCH
Q 042348 375 LGKSTIGIVYKVALNN-EEAVAVRRLGNGGW---QRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSL 450 (686)
Q Consensus 375 iG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL 450 (686)
||+|+||.||++.... ++.+++|.+..... ...+.+.+|++++++++||||+++++.+...+..++||||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 6899999999999874 88999999865433 3456788999999999999999999999999999999999999999
Q ss_pred HHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCcc
Q 042348 451 ATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPE 530 (686)
Q Consensus 451 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 530 (686)
.+++... ..+++..+..++.|++.||+|||+ ++++||||+|+||++++++.++|+|||++...........
T Consensus 81 ~~~l~~~------~~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 151 (265)
T cd05579 81 ASLLENV------GSLDEDVARIYIAEIVLALEYLHS---NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINL 151 (265)
T ss_pred HHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---cCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccc
Confidence 9999764 358999999999999999999999 8999999999999999999999999999875432211000
Q ss_pred ccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHHHH
Q 042348 531 VHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQWIQ 610 (686)
Q Consensus 531 ~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~ 610 (686)
...........++..|+|||......++.++||||||+++||+++|+.||..... .....
T Consensus 152 ---------------~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~-----~~~~~ 211 (265)
T cd05579 152 ---------------NDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETP-----EEIFQ 211 (265)
T ss_pred ---------------ccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH-----HHHHH
Confidence 0000111233456779999999888889999999999999999999999954322 12222
Q ss_pred HHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 042348 611 LILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLD 666 (686)
Q Consensus 611 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~ 666 (686)
.........+... .....+.+++.+||+.+|++|||+.++.+.|+
T Consensus 212 ~~~~~~~~~~~~~-----------~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 212 NILNGKIEWPEDV-----------EVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred HHhcCCcCCCccc-----------cCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 2222211111100 01346789999999999999999966655554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=297.55 Aligned_cols=254 Identities=18% Similarity=0.193 Sum_probs=179.0
Q ss_pred cccCccCceEEEEEEeCCC----ceEEEEEcCCCCccch-----------HHHHHHHHHHhccCCCCcceeeEEEEecC-
Q 042348 373 FLLGKSTIGIVYKVALNNE----EAVAVRRLGNGGWQRF-----------KEFQTEAEAIGKIRHPNIVSLRAYFWSVD- 436 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~~~----~~vavK~~~~~~~~~~-----------~~~~~E~~~l~~l~H~nIv~l~~~~~~~~- 436 (686)
+.||+|+||.||+|...+. ..+|+|.......... .....+...+..++|+||+++++++....
T Consensus 18 ~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~ 97 (294)
T PHA02882 18 KLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGCGSFKRC 97 (294)
T ss_pred eEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEeeeEecC
Confidence 4699999999999987643 4556665432211110 11223344566778999999999876543
Q ss_pred ---ceeEEEeccCCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEE
Q 042348 437 ---EKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHI 513 (686)
Q Consensus 437 ---~~~lV~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl 513 (686)
..++++|++. .++.+.+... ...++..+..|+.|++.||+|||+ ++|+||||||+|||++.++.++|
T Consensus 98 ~~~~~~~~~~~~~-~~~~~~~~~~------~~~~~~~~~~i~~qi~~~l~~lH~---~~iiHrDiKp~Nill~~~~~~~l 167 (294)
T PHA02882 98 RMYYRFILLEKLV-ENTKEIFKRI------KCKNKKLIKNIMKDMLTTLEYIHE---HGISHGDIKPENIMVDGNNRGYI 167 (294)
T ss_pred CceEEEEEEehhc-cCHHHHHHhh------ccCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCcEEE
Confidence 3478888874 3676666543 235788899999999999999999 89999999999999999999999
Q ss_pred eecCcccccccccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCC
Q 042348 514 SDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKL 593 (686)
Q Consensus 514 ~DfGla~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~ 593 (686)
+|||+|+.......... ..........||..|+|||++.+..++.++|||||||++|||++|+.
T Consensus 168 ~DFGla~~~~~~~~~~~----------------~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~ 231 (294)
T PHA02882 168 IDYGIASHFIIHGKHIE----------------YSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKL 231 (294)
T ss_pred EEcCCceeeccCCcccc----------------cccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 99999986643221100 00011123468889999999999999999999999999999999999
Q ss_pred CccccCccchhH----HHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 042348 594 PMIQIGSMELNI----VQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLD 666 (686)
Q Consensus 594 P~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~ 666 (686)
||.......... .+++..+...... .......+.+++..|++.+|++||++.++.+.++
T Consensus 232 P~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 232 PWKGFGHNGNLIHAAKCDFIKRLHEGKIK--------------IKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred CCCccccchHHHHHhHHHHHHHhhhhhhc--------------cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 996553222111 1111111111100 0112346889999999999999999999998763
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=296.52 Aligned_cols=242 Identities=25% Similarity=0.280 Sum_probs=193.1
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCCc---cchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCC
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGGW---QRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNG 448 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~g 448 (686)
.+||+|+||.||-++.+ +|+.+|.|.+.+... .......+|-.+|.+++.+.||.+-..|++.+..++|+..|.||
T Consensus 191 RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLtlMNGG 270 (591)
T KOG0986|consen 191 RVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLTLMNGG 270 (591)
T ss_pred EEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEEeecCC
Confidence 47999999999998765 688999988754321 22345788999999999999999999999999999999999999
Q ss_pred CHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCC
Q 042348 449 SLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEET 528 (686)
Q Consensus 449 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 528 (686)
||.-+|...+. ..+++..+.-++.+|+.||++||. .+||.||+||+|||+|+.|+++|+|.|+|.-+..+.
T Consensus 271 DLkfHiyn~g~----~gF~e~ra~FYAAEi~cGLehlH~---~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~-- 341 (591)
T KOG0986|consen 271 DLKFHIYNHGN----PGFDEQRARFYAAEIICGLEHLHR---RRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGK-- 341 (591)
T ss_pred ceeEEeeccCC----CCCchHHHHHHHHHHHhhHHHHHh---cceeeccCChhheeeccCCCeEeeccceEEecCCCC--
Confidence 99999987653 469999999999999999999999 899999999999999999999999999998665332
Q ss_pred ccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHH
Q 042348 529 PEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQW 608 (686)
Q Consensus 529 ~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~ 608 (686)
.....+||.+|||||++....|+...|.||+||++|||+.|+.||........ -.+.
T Consensus 342 ----------------------~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk-~eEv 398 (591)
T KOG0986|consen 342 ----------------------PIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVK-REEV 398 (591)
T ss_pred ----------------------ccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhh-HHHH
Confidence 23456899999999999999999999999999999999999999955332211 0111
Q ss_pred HHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHH
Q 042348 609 IQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMR 659 (686)
Q Consensus 609 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ 659 (686)
-+.+......++ +...++..++....|++||++|-..+
T Consensus 399 drr~~~~~~ey~-------------~kFS~eakslc~~LL~Kdp~~RLGcr 436 (591)
T KOG0986|consen 399 DRRTLEDPEEYS-------------DKFSEEAKSLCEGLLTKDPEKRLGCR 436 (591)
T ss_pred HHHHhcchhhcc-------------cccCHHHHHHHHHHHccCHHHhccCC
Confidence 122222221111 12233566777788999999996543
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=290.75 Aligned_cols=242 Identities=21% Similarity=0.257 Sum_probs=185.2
Q ss_pred ccCccCceEEEEEEeC-CCceEEEEEcCCCCc---cchHHHHHHHHHH-hccCCCCcceeeEEEEecCceeEEEeccCCC
Q 042348 374 LLGKSTIGIVYKVALN-NEEAVAVRRLGNGGW---QRFKEFQTEAEAI-GKIRHPNIVSLRAYFWSVDEKLLIYDYIPNG 448 (686)
Q Consensus 374 ~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l-~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~g 448 (686)
.||+|+||.||+|... +++.||+|.+..... .....+..|..++ ...+|+||+++++++...+..++||||++++
T Consensus 3 ~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 82 (260)
T cd05611 3 PISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNGG 82 (260)
T ss_pred cCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCCC
Confidence 4899999999999875 578999999865432 1223344555544 4558999999999999999999999999999
Q ss_pred CHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCC
Q 042348 449 SLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEET 528 (686)
Q Consensus 449 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 528 (686)
+|.+++... ..+++..+..++.|++.||.|||+ .+++||||+|+||++++++.+||+|||+++.....
T Consensus 83 ~L~~~l~~~------~~~~~~~~~~i~~qi~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--- 150 (260)
T cd05611 83 DCASLIKTL------GGLPEDWAKQYIAEVVLGVEDLHQ---RGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLEN--- 150 (260)
T ss_pred CHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEeecccceecccc---
Confidence 999999754 358899999999999999999999 89999999999999999999999999998743210
Q ss_pred ccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHH
Q 042348 529 PEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQW 608 (686)
Q Consensus 529 ~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~ 608 (686)
....++..|+|||.+.+..++.++||||||+++|||++|..||..... ...
T Consensus 151 ------------------------~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~~~ 201 (260)
T cd05611 151 ------------------------KKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETP-----DAV 201 (260)
T ss_pred ------------------------ccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCH-----HHH
Confidence 122355679999999888889999999999999999999999954322 112
Q ss_pred HHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 042348 609 IQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSL 665 (686)
Q Consensus 609 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L 665 (686)
................ ......+.+++.+||+.+|++||++.++.+.|
T Consensus 202 ~~~~~~~~~~~~~~~~---------~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l 249 (260)
T cd05611 202 FDNILSRRINWPEEVK---------EFCSPEAVDLINRLLCMDPAKRLGANGYQEIK 249 (260)
T ss_pred HHHHHhcccCCCCccc---------ccCCHHHHHHHHHHccCCHHHccCCCcHHHHH
Confidence 2222222111111000 11234678999999999999999776554433
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=291.11 Aligned_cols=248 Identities=25% Similarity=0.431 Sum_probs=198.6
Q ss_pred cccCccCceEEEEEEeCC-CceEEEEEcCCCCc-cchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCCH
Q 042348 373 FLLGKSTIGIVYKVALNN-EEAVAVRRLGNGGW-QRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSL 450 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL 450 (686)
+.||+|++|.||+|.... ++.|+||++..... ...+.+.+|++.+.+++|+||+++++++...+..++||||+++++|
T Consensus 7 ~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 86 (264)
T cd06623 7 KVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMDGGSL 86 (264)
T ss_pred eeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEecCCCcH
Confidence 469999999999998774 88999999876543 3457899999999999999999999999999999999999999999
Q ss_pred HHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCcc
Q 042348 451 ATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPE 530 (686)
Q Consensus 451 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 530 (686)
.+++... ..+++..+..++.|+++||+|||+. .+++||||+|+||+++.++.++|+|||.+.........
T Consensus 87 ~~~l~~~------~~l~~~~~~~~~~~l~~~l~~lh~~--~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~-- 156 (264)
T cd06623 87 ADLLKKV------GKIPEPVLAYIARQILKGLDYLHTK--RHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ-- 156 (264)
T ss_pred HHHHHHc------CCCCHHHHHHHHHHHHHHHHHHhcc--CCCccCCCCHHHEEECCCCCEEEccCccceecccCCCc--
Confidence 9999764 3589999999999999999999973 47999999999999999999999999998765322110
Q ss_pred ccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHHHH
Q 042348 531 VHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQWIQ 610 (686)
Q Consensus 531 ~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~ 610 (686)
.....++..|+|||.+.+..++.++||||||+++|||+||+.||..... ....+...
T Consensus 157 ---------------------~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~--~~~~~~~~ 213 (264)
T cd06623 157 ---------------------CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQ--PSFFELMQ 213 (264)
T ss_pred ---------------------ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccc--cCHHHHHH
Confidence 0123456679999999888899999999999999999999999965432 11222222
Q ss_pred HHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 611 LILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 611 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
.+.....+ . .+ .. .....+.+++.+||+.+|++||++.|++++
T Consensus 214 ~~~~~~~~--~-~~----~~----~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 214 AICDGPPP--S-LP----AE----EFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred HHhcCCCC--C-CC----cc----cCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 22221111 0 11 11 023468899999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=295.75 Aligned_cols=251 Identities=22% Similarity=0.287 Sum_probs=194.5
Q ss_pred cccCccCceEEEEEEeC----CCceEEEEEcCCCC----ccchHHHHHHHHHHhcc-CCCCcceeeEEEEecCceeEEEe
Q 042348 373 FLLGKSTIGIVYKVALN----NEEAVAVRRLGNGG----WQRFKEFQTEAEAIGKI-RHPNIVSLRAYFWSVDEKLLIYD 443 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~----~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~e 443 (686)
..||+|++|.||++... ++..||||.++... ....+.+.+|+.++.++ +||||+++++.+...+..++|||
T Consensus 6 ~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~e 85 (288)
T cd05583 6 RVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLHLILD 85 (288)
T ss_pred EEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEEEEEe
Confidence 46999999999998743 46789999886432 12335688999999999 69999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccc
Q 042348 444 YIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLAD 523 (686)
Q Consensus 444 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~ 523 (686)
|+++|+|.+++... ..+++..+..++.|+++||+|||+ .+++||||||+||+++.++.++|+|||+++...
T Consensus 86 ~~~~~~L~~~~~~~------~~~~~~~~~~~~~ql~~~l~~lH~---~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 156 (288)
T cd05583 86 YVNGGELFTHLYQR------EHFTESEVRVYIAEIVLALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFL 156 (288)
T ss_pred cCCCCcHHHHHhhc------CCcCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEEECccccccc
Confidence 99999999998754 358899999999999999999999 899999999999999999999999999987543
Q ss_pred cccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCC--CCCcchHHHHHHHHHHHHhCCCCccccCcc
Q 042348 524 IAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRK--PTQKWDIYSYGVILLEMISGKLPMIQIGSM 601 (686)
Q Consensus 524 ~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDVwSlGvvl~elltG~~P~~~~~~~ 601 (686)
..... ......++..|+|||...+.. .+.++||||||+++|||++|+.||......
T Consensus 157 ~~~~~----------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~ 214 (288)
T cd05583 157 AEEEE----------------------RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQ 214 (288)
T ss_pred ccccc----------------------ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCccc
Confidence 22110 011234567799999987654 788999999999999999999999533221
Q ss_pred chhHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 042348 602 ELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRV 668 (686)
Q Consensus 602 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i 668 (686)
.......+.......+.+.. ....+.+++.+||+.||++|||+.++.+.|+..
T Consensus 215 -~~~~~~~~~~~~~~~~~~~~-------------~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~ 267 (288)
T cd05583 215 -NSQSEISRRILKSKPPFPKT-------------MSAEARDFIQKLLEKDPKKRLGANGADEIKNHP 267 (288)
T ss_pred -chHHHHHHHHHccCCCCCcc-------------cCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence 11122223332222222111 123567899999999999999998887777664
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=323.09 Aligned_cols=257 Identities=25% Similarity=0.372 Sum_probs=185.4
Q ss_pred ccCccCceEEEEEEeC-CCceEEEEEcCCCC-ccchHHHHHHHHHHhccCCCCcceeeEEEEe-----------------
Q 042348 374 LLGKSTIGIVYKVALN-NEEAVAVRRLGNGG-WQRFKEFQTEAEAIGKIRHPNIVSLRAYFWS----------------- 434 (686)
Q Consensus 374 ~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~----------------- 434 (686)
+||+||||.|||++.+ ||+.+|||++.... ........+|+..+++|+|||||+++..+.+
T Consensus 486 lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei~~~~~~~ 565 (1351)
T KOG1035|consen 486 LLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEIVASDSES 565 (1351)
T ss_pred HhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccccccchhh
Confidence 6999999999999976 79999999997653 2334568899999999999999999876511
Q ss_pred --------------------------------------c-----------------------------------------
Q 042348 435 --------------------------------------V----------------------------------------- 435 (686)
Q Consensus 435 --------------------------------------~----------------------------------------- 435 (686)
.
T Consensus 566 ~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~~~~~d~~ 645 (1351)
T KOG1035|consen 566 RSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEGSVILDDT 645 (1351)
T ss_pred hcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCCccccCcc
Confidence 0
Q ss_pred -----------------------CceeEEEeccCCCCHHHHhhcCCCccccCCC-CHHHHHHHHHHHHHHHHHHHccCCC
Q 042348 436 -----------------------DEKLLIYDYIPNGSLATAIHGKAGIISYRPL-SWSDRLRIIKGVAKGIAFLHEVSPK 491 (686)
Q Consensus 436 -----------------------~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~l-~~~~~~~i~~~ia~gL~~LH~~~~~ 491 (686)
-..||-||||+.-.+.++++.+. .. .....++++++|+.||+|+|+ +
T Consensus 646 ~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~------~~~~~d~~wrLFreIlEGLaYIH~---~ 716 (1351)
T KOG1035|consen 646 SESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNH------FNSQRDEAWRLFREILEGLAYIHD---Q 716 (1351)
T ss_pred hhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcc------cchhhHHHHHHHHHHHHHHHHHHh---C
Confidence 01367799999888888887653 11 356678999999999999999 8
Q ss_pred CceecCCCCCCeeecCCCCeEEeecCcccccccccC---CccccccccccCCCCCCCccccccccCCCCCccccCccccc
Q 042348 492 RYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEE---TPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASK 568 (686)
Q Consensus 492 ~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~---~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 568 (686)
|||||||||.||++|++..+||+|||+|+....... .....+.. ..|+ .....++.+||.-|+|||.+.
T Consensus 717 giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~-~~g~-------~~~~~Ts~VGTalYvAPEll~ 788 (1351)
T KOG1035|consen 717 GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTN-RAGS-------NDGDLTSQVGTALYVAPELLS 788 (1351)
T ss_pred ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCcccc-ccCC-------CCcccccccceeeeecHHHhc
Confidence 999999999999999999999999999987331110 00000000 0111 112456789999999999987
Q ss_pred CC---CCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHHHHHHHhhcCCcc-cccCcccccCCCcHHHHHHHHHHH
Q 042348 569 VR---KPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQWIQLILEDRKPMT-DILDPFLAHDLDKEDEIVSVLKIA 644 (686)
Q Consensus 569 ~~---~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~d~~l~~~~~~~~~~~~l~~l~ 644 (686)
+. .|+.|+|+||+|||++||+. ||.. .++ -...+.....+.-|.+ +..+ +....-.+++
T Consensus 789 ~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~T--sME--Ra~iL~~LR~g~iP~~~~f~~----------~~~~~e~slI 851 (1351)
T KOG1035|consen 789 DTSSNKYNSKIDMYSLGIVLFEMLY---PFGT--SME--RASILTNLRKGSIPEPADFFD----------PEHPEEASLI 851 (1351)
T ss_pred ccccccccchhhhHHHHHHHHHHhc---cCCc--hHH--HHHHHHhcccCCCCCCccccc----------ccchHHHHHH
Confidence 64 49999999999999999986 5522 122 2222222222222211 1111 2233445889
Q ss_pred HhccccCCCCCCCHHHHHHH
Q 042348 645 LDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 645 ~~cl~~dP~~RPs~~ev~~~ 664 (686)
.++++.||.+|||+.|++..
T Consensus 852 ~~Ll~hdP~kRPtA~eLL~s 871 (1351)
T KOG1035|consen 852 RWLLSHDPSKRPTATELLNS 871 (1351)
T ss_pred HHHhcCCCccCCCHHHHhhc
Confidence 99999999999999999764
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=293.29 Aligned_cols=256 Identities=19% Similarity=0.254 Sum_probs=188.0
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCC-ccchHHHHHHHHHHhccC-CCCcceeeEEEEec--CceeEEEeccCC
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGG-WQRFKEFQTEAEAIGKIR-HPNIVSLRAYFWSV--DEKLLIYDYIPN 447 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~--~~~~lV~e~~~~ 447 (686)
..||+|+||.||+|... ++..||+|+++... ........+|+.++.++. |+||+++++++.+. +..++||||++
T Consensus 5 ~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~~- 83 (282)
T cd07831 5 GKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELMD- 83 (282)
T ss_pred eeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEecCC-
Confidence 45899999999999865 57899999986532 222234557999999985 99999999999987 88999999996
Q ss_pred CCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccC
Q 042348 448 GSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEE 527 (686)
Q Consensus 448 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 527 (686)
|+|.+.+.... ..+++.++..++.|++.||+|||+ .+++||||||+||+++. +.+||+|||+++.......
T Consensus 84 ~~l~~~l~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~ 154 (282)
T cd07831 84 MNLYELIKGRK-----RPLPEKRVKSYMYQLLKSLDHMHR---NGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP 154 (282)
T ss_pred ccHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCceecccCHHHEEEcC-CCeEEEecccccccccCCC
Confidence 58888887543 358999999999999999999999 89999999999999999 9999999999975532110
Q ss_pred CccccccccccCCCCCCCccccccccCCCCCccccCcccccC-CCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHH
Q 042348 528 TPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKV-RKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIV 606 (686)
Q Consensus 528 ~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~ 606 (686)
.....++..|+|||++.. ..++.++|||||||++|||++|+.||..... .+..
T Consensus 155 ------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~--~~~~ 208 (282)
T cd07831 155 ------------------------YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNE--LDQI 208 (282)
T ss_pred ------------------------cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCH--HHHH
Confidence 012345677999997644 5578999999999999999999999954332 1222
Q ss_pred HHHHHHHhhcCC-------cccccCcccccCCC------cHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 607 QWIQLILEDRKP-------MTDILDPFLAHDLD------KEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 607 ~~~~~~~~~~~~-------~~~~~d~~l~~~~~------~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
............ .....+........ .......+.+++.+||+++|++||++.+++++
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 209 AKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred HHHHHHcCCCCHHHHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 222221111000 00000000000000 01234678899999999999999999999864
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=298.55 Aligned_cols=258 Identities=24% Similarity=0.319 Sum_probs=188.2
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCCc--cchHHHHHHHHHHhccCCCCcceeeEEEEec--CceeEEEeccCC
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGGW--QRFKEFQTEAEAIGKIRHPNIVSLRAYFWSV--DEKLLIYDYIPN 447 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~~lV~e~~~~ 447 (686)
..||+|+||.||+|... +++.||+|.+..... .....+.+|+.++++++|+||+++++++... +..++||||+.
T Consensus 13 ~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~- 91 (309)
T cd07845 13 NRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCE- 91 (309)
T ss_pred eeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEEecCC-
Confidence 36999999999999875 588999999864322 1223567899999999999999999998765 45799999996
Q ss_pred CCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccC
Q 042348 448 GSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEE 527 (686)
Q Consensus 448 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 527 (686)
++|.+++.... ..+++.++..++.|++.||+|||+ .+++||||||+||++++++.+||+|||+++.......
T Consensus 92 ~~l~~~l~~~~-----~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~~ 163 (309)
T cd07845 92 QDLASLLDNMP-----TPFSESQVKCLMLQLLRGLQYLHE---NFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAK 163 (309)
T ss_pred CCHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECccceeeecCCccC
Confidence 58988887543 468999999999999999999999 8999999999999999999999999999976542110
Q ss_pred CccccccccccCCCCCCCccccccccCCCCCccccCcccccC-CCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHH
Q 042348 528 TPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKV-RKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIV 606 (686)
Q Consensus 528 ~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~ 606 (686)
......++..|+|||.+.+ ..++.++|||||||++|||++|+.||..... ....
T Consensus 164 -----------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~--~~~~ 218 (309)
T cd07845 164 -----------------------PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSE--IEQL 218 (309)
T ss_pred -----------------------CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCH--HHHH
Confidence 0111233567999998865 4578999999999999999999999954322 1111
Q ss_pred HHHHHHHhhcC--CcccccC------cccccC-CC-----cHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 607 QWIQLILEDRK--PMTDILD------PFLAHD-LD-----KEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 607 ~~~~~~~~~~~--~~~~~~d------~~l~~~-~~-----~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
..+........ ......+ ..+... .. .......+.+++.+||+.||++|||+.|++++
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 219 DLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred HHHHHhcCCCChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 11111111000 0000000 000000 00 00123457789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=287.18 Aligned_cols=245 Identities=25% Similarity=0.417 Sum_probs=197.7
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCCccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCCHH
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLA 451 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL~ 451 (686)
..||+|++|.||++... ++..+++|++........+.+.+|++.+++++|+||+++++++...+..++++||+++++|.
T Consensus 6 ~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~ 85 (253)
T cd05122 6 EKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLK 85 (253)
T ss_pred eeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCCCcHH
Confidence 46999999999999976 67889999997765555678999999999999999999999999999999999999999999
Q ss_pred HHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCccc
Q 042348 452 TAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEV 531 (686)
Q Consensus 452 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 531 (686)
+++.... ..+++..+..++.|++.||+|||+ ++++||||+|+||++++++.++|+|||.+........
T Consensus 86 ~~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~---- 153 (253)
T cd05122 86 DLLKSTN-----QTLTESQIAYVCKELLKGLEYLHS---NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA---- 153 (253)
T ss_pred HHHhhcC-----CCCCHHHHHHHHHHHHHHHHHhhc---CCEecCCCCHHHEEEccCCeEEEeecccccccccccc----
Confidence 9997653 368999999999999999999999 8999999999999999999999999999875542210
Q ss_pred cccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHHHHH
Q 042348 532 HWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQWIQL 611 (686)
Q Consensus 532 ~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~ 611 (686)
.....++..|+|||.+.+..++.++||||||+++|+|++|+.||...... .....
T Consensus 154 --------------------~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-----~~~~~ 208 (253)
T cd05122 154 --------------------RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPM-----KALFK 208 (253)
T ss_pred --------------------ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchH-----HHHHH
Confidence 11234566799999998888999999999999999999999999543221 11111
Q ss_pred HHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 612 ILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 612 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
... .......++ ......+.+++.+||+.||++|||+.|++++
T Consensus 209 ~~~--~~~~~~~~~--------~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 209 IAT--NGPPGLRNP--------EKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred HHh--cCCCCcCcc--------cccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 111 111111111 0013467899999999999999999999864
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=280.08 Aligned_cols=268 Identities=24% Similarity=0.284 Sum_probs=194.5
Q ss_pred cccCccCceEEEEEEeCC-----CceEEEEEcCCCCcc--chHHHHHHHHHHhccCCCCcceeeEEEEe-cCceeEEEec
Q 042348 373 FLLGKSTIGIVYKVALNN-----EEAVAVRRLGNGGWQ--RFKEFQTEAEAIGKIRHPNIVSLRAYFWS-VDEKLLIYDY 444 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~nIv~l~~~~~~-~~~~~lV~e~ 444 (686)
..||+|.||.||||.-.+ ...+|+|+++..... -.....+|+.+++.++||||+.+..+|.. +...++++||
T Consensus 30 g~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~l~fdY 109 (438)
T KOG0666|consen 30 GKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKVWLLFDY 109 (438)
T ss_pred ceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEEEEehh
Confidence 359999999999996432 237899999764221 12457899999999999999999999988 6778999999
Q ss_pred cCCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCC----CCeEEeecCccc
Q 042348 445 IPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKN----MEPHISDFGLAR 520 (686)
Q Consensus 445 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~----~~~kl~DfGla~ 520 (686)
.+. ||.++|+..+.... +.++...+..|+.||++|+.|||+ +=|+||||||.|||+..+ |.+||+|||+|+
T Consensus 110 AEh-DL~~II~fHr~~~~-~~lp~~mvKsilwQil~Gv~YLH~---NWvlHRDLKPaNIlvmgdgperG~VKIaDlGlaR 184 (438)
T KOG0666|consen 110 AEH-DLWHIIKFHRASKA-KQLPRSMVKSILWQILDGVHYLHS---NWVLHRDLKPANILVMGDGPERGRVKIADLGLAR 184 (438)
T ss_pred hhh-hHHHHHHHhccchh-ccCCHHHHHHHHHHHHhhhHHHhh---hheeeccCCcceEEEeccCCccCeeEeecccHHH
Confidence 976 99999987664433 579999999999999999999999 789999999999999877 899999999999
Q ss_pred ccccccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccC-CCCCCcchHHHHHHHHHHHHhCCCCccccC
Q 042348 521 LADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKV-RKPTQKWDIYSYGVILLEMISGKLPMIQIG 599 (686)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvvl~elltG~~P~~~~~ 599 (686)
++...-. ........+-|.+|+|||.+.+ ..||.+.||||.|||+.||+|-++-|....
T Consensus 185 ~~~~plk--------------------pl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E 244 (438)
T KOG0666|consen 185 LFNNPLK--------------------PLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGRE 244 (438)
T ss_pred Hhhcccc--------------------ccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchh
Confidence 8753211 1123345667999999999887 469999999999999999999887774321
Q ss_pred cc----chhHHHHHHHHHhhcCCcccccCcccccCCCc-----------------HH-------HHHHHHHHHHhccccC
Q 042348 600 SM----ELNIVQWIQLILEDRKPMTDILDPFLAHDLDK-----------------ED-------EIVSVLKIALDCVHKS 651 (686)
Q Consensus 600 ~~----~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~-----------------~~-------~~~~l~~l~~~cl~~d 651 (686)
.. ..-....+.++++--....+..-|.+..-+.. .. .....++|+.++|.+|
T Consensus 245 ~k~~~~~Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yD 324 (438)
T KOG0666|consen 245 EKIKTKNPFQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYD 324 (438)
T ss_pred hhcccCCCchHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccC
Confidence 11 00111222222221000000000111000000 00 1112678999999999
Q ss_pred CCCCCCHHHHHHHH
Q 042348 652 PDKRPSMRHVCDSL 665 (686)
Q Consensus 652 P~~RPs~~ev~~~L 665 (686)
|.+|.|+.+.+++.
T Consensus 325 P~kRIta~qAleh~ 338 (438)
T KOG0666|consen 325 PIKRITAEQALEHP 338 (438)
T ss_pred chhhccHHHHhccc
Confidence 99999999998875
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=303.64 Aligned_cols=240 Identities=22% Similarity=0.337 Sum_probs=196.6
Q ss_pred ccCccCceEEEEEEeC-CCceEEEEEcCCCC--ccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCCH
Q 042348 374 LLGKSTIGIVYKVALN-NEEAVAVRRLGNGG--WQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSL 450 (686)
Q Consensus 374 ~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL 450 (686)
.||+|.|+.|..|... ++..||||.+.+.. ......+.+|+++|+.++|||||+++.+.......|+||||+.+|.+
T Consensus 63 tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~eya~~ge~ 142 (596)
T KOG0586|consen 63 TIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVMEYASGGEL 142 (596)
T ss_pred eeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEEeccCchh
Confidence 5999999999999865 58899999997753 23345588999999999999999999999999999999999999999
Q ss_pred HHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCcc
Q 042348 451 ATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPE 530 (686)
Q Consensus 451 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 530 (686)
++++.... ......+..++.|+..|++|||+ +.|||||||++|||++.++++||+|||++.++....
T Consensus 143 ~~yl~~~g------r~~e~~ar~~F~q~vsaveYcH~---k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~---- 209 (596)
T KOG0586|consen 143 FDYLVKHG------RMKEKEARAKFRQIVSAVEYCHS---KNIVHRDLKAENILLDENMNIKIADFGFSTFFDYGL---- 209 (596)
T ss_pred HHHHHhcc------cchhhhhhhhhHHHHHHHHHHhh---cceeccccchhhcccccccceeeeccccceeecccc----
Confidence 99998774 35568889999999999999999 899999999999999999999999999998876432
Q ss_pred ccccccccCCCCCCCccccccccCCCCCccccCcccccCCCC-CCcchHHHHHHHHHHHHhCCCCccccCccchhHHHHH
Q 042348 531 VHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKP-TQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQWI 609 (686)
Q Consensus 531 ~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~ 609 (686)
.....+|++.|.|||++.+.+| ++.+|+||+|+++|-|+.|..||++.. +...-
T Consensus 210 --------------------~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~-----lk~Lr 264 (596)
T KOG0586|consen 210 --------------------MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQN-----LKELR 264 (596)
T ss_pred --------------------cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcc-----ccccc
Confidence 2345677788999999998775 689999999999999999999995432 11112
Q ss_pred HHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 610 QLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 610 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
...+.++..++..+ ..++.+++++++..+|.+|++++++.++
T Consensus 265 ~rvl~gk~rIp~~m-------------s~dce~lLrk~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 265 PRVLRGKYRIPFYM-------------SCDCEDLLRKFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred chheeeeeccccee-------------echhHHHHHHhhccCccccCCHHHhhhh
Confidence 22222222221111 1135689999999999999999998765
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=294.93 Aligned_cols=258 Identities=22% Similarity=0.287 Sum_probs=192.2
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCC--ccchHHHHHHHHHHhccCCCCcceeeEEEEec--CceeEEEeccCC
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGG--WQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSV--DEKLLIYDYIPN 447 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~~lV~e~~~~ 447 (686)
..||+|++|.||+|... +++.+|+|++.... ......+.+|++++++++|||++++++++... +..++||||+++
T Consensus 5 ~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~ 84 (287)
T cd07840 5 AQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMDH 84 (287)
T ss_pred EEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEeccccc
Confidence 35899999999999876 47899999997652 23345688999999999999999999999988 789999999974
Q ss_pred CCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccC
Q 042348 448 GSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEE 527 (686)
Q Consensus 448 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 527 (686)
+|.+++.... ..+++..++.++.|++.||+|||+ .+++|+||||+||++++++.+||+|||++........
T Consensus 85 -~l~~~~~~~~-----~~~~~~~~~~i~~~i~~al~~LH~---~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~ 155 (287)
T cd07840 85 -DLTGLLDSPE-----VKFTESQIKCYMKQLLEGLQYLHS---NGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS 155 (287)
T ss_pred -cHHHHHhccC-----CCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHHeEEcCCCCEEEccccceeeccCCCc
Confidence 8999887653 358999999999999999999999 8999999999999999999999999999976543211
Q ss_pred CccccccccccCCCCCCCccccccccCCCCCccccCcccccC-CCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHH
Q 042348 528 TPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKV-RKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIV 606 (686)
Q Consensus 528 ~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~ 606 (686)
.......++..|+|||.+.+ ..++.++||||||+++|||+||+.||...... ...
T Consensus 156 ----------------------~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~--~~~ 211 (287)
T cd07840 156 ----------------------ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTEL--EQL 211 (287)
T ss_pred ----------------------ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChH--HHH
Confidence 00112334667999997764 45789999999999999999999999544321 111
Q ss_pred HHHHHHHhhc--CCcccccC--------------cccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 607 QWIQLILEDR--KPMTDILD--------------PFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 607 ~~~~~~~~~~--~~~~~~~d--------------~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
..+....... ..+....+ ..+.... ...+...+.+++.+||+.+|++||++.+++++
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 212 EKIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFF-KHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred HHHHHHhCCCchhhccccccchhhhhccccccchhHHHHHh-cccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 1111111000 00000000 0000000 00124568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=295.38 Aligned_cols=259 Identities=22% Similarity=0.262 Sum_probs=188.5
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCC--ccchHHHHHHHHHHhccC-CCCcceeeEEEEecCc-----eeEEEe
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGG--WQRFKEFQTEAEAIGKIR-HPNIVSLRAYFWSVDE-----KLLIYD 443 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~-----~~lV~e 443 (686)
..||+|+||.||+|... +++.||+|.+.... ......+.+|+.++++++ ||||+++++++...+. .++|||
T Consensus 7 ~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~lv~e 86 (295)
T cd07837 7 EKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLVFE 86 (295)
T ss_pred eEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEEEEee
Confidence 46999999999999875 58899999876532 223357888999999995 6999999999987665 799999
Q ss_pred ccCCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecC-CCCeEEeecCccccc
Q 042348 444 YIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGK-NMEPHISDFGLARLA 522 (686)
Q Consensus 444 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~-~~~~kl~DfGla~~~ 522 (686)
|+++ +|.+++...... ....+++..++.++.||+.||+|||+ ++|+||||||+||+++. ++.+||+|||+++..
T Consensus 87 ~~~~-~l~~~~~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~~ 161 (295)
T cd07837 87 YLDS-DLKKFMDSNGRG-PGRPLPAKTIKSFMYQLLKGVAHCHK---HGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAF 161 (295)
T ss_pred ccCc-CHHHHHHHhccc-CCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEecCCCeEEEeecccceec
Confidence 9985 899888754321 11468999999999999999999999 89999999999999998 889999999998754
Q ss_pred ccccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccC-CCCCCcchHHHHHHHHHHHHhCCCCccccCcc
Q 042348 523 DIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKV-RKPTQKWDIYSYGVILLEMISGKLPMIQIGSM 601 (686)
Q Consensus 523 ~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~ 601 (686)
..... ......++..|+|||++.+ ..++.++||||||+++|||++|+.||......
T Consensus 162 ~~~~~-----------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~ 218 (295)
T cd07837 162 SIPVK-----------------------SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSEL 218 (295)
T ss_pred CCCcc-----------------------ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHH
Confidence 21110 0112234667999998765 45799999999999999999999999543221
Q ss_pred chhHHHHHHHHHhh-cCCcccccC-----------ccccc-CC--CcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 602 ELNIVQWIQLILED-RKPMTDILD-----------PFLAH-DL--DKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 602 ~~~~~~~~~~~~~~-~~~~~~~~d-----------~~l~~-~~--~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
. . ...+... ..+...... +.... .. ..+....++.+++.+||+.||++||++.|++.+
T Consensus 219 ~----~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 219 Q----Q-LLHIFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred H----H-HHHHHHHhCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 1 1 1111111 000000000 00000 00 001123467899999999999999999999864
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=302.71 Aligned_cols=254 Identities=23% Similarity=0.305 Sum_probs=188.3
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCC--CccchHHHHHHHHHHhccCCCCcceeeEEEEec------CceeEEEe
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNG--GWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSV------DEKLLIYD 443 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~------~~~~lV~e 443 (686)
..||+|+||.||+|... +++.||+|.+... .......+.+|+.++++++||||+++++++... ...++|||
T Consensus 22 ~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e 101 (353)
T cd07850 22 KPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVME 101 (353)
T ss_pred EEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCcEEEEEe
Confidence 46999999999999865 6889999998643 223345678899999999999999999998644 34699999
Q ss_pred ccCCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccc
Q 042348 444 YIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLAD 523 (686)
Q Consensus 444 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~ 523 (686)
|+. ++|.+.+.. .+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++...
T Consensus 102 ~~~-~~l~~~~~~--------~l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~ 169 (353)
T cd07850 102 LMD-ANLCQVIQM--------DLDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 169 (353)
T ss_pred ccC-CCHHHHHhh--------cCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEccCccceeCC
Confidence 995 588888753 37888999999999999999999 899999999999999999999999999997543
Q ss_pred cccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccch
Q 042348 524 IAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMEL 603 (686)
Q Consensus 524 ~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~ 603 (686)
... ......++..|+|||.+.+..++.++|||||||++|+|++|+.||.......
T Consensus 170 ~~~------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~- 224 (353)
T cd07850 170 TSF------------------------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHID- 224 (353)
T ss_pred CCC------------------------CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHH-
Confidence 211 0112345677999999998899999999999999999999999995432111
Q ss_pred hHHHHHH-------------------HHHhhcC-----CcccccCcccccCCC---cHHHHHHHHHHHHhccccCCCCCC
Q 042348 604 NIVQWIQ-------------------LILEDRK-----PMTDILDPFLAHDLD---KEDEIVSVLKIALDCVHKSPDKRP 656 (686)
Q Consensus 604 ~~~~~~~-------------------~~~~~~~-----~~~~~~d~~l~~~~~---~~~~~~~l~~l~~~cl~~dP~~RP 656 (686)
....+. ....... +..+.+......... .......+.+++.+||+.||++||
T Consensus 225 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~ 303 (353)
T cd07850 225 -QWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRI 303 (353)
T ss_pred -HHHHHHHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCc
Confidence 000000 0000000 000000000000000 112344678999999999999999
Q ss_pred CHHHHHHH
Q 042348 657 SMRHVCDS 664 (686)
Q Consensus 657 s~~ev~~~ 664 (686)
|+.|++++
T Consensus 304 t~~eiL~~ 311 (353)
T cd07850 304 SVDDALQH 311 (353)
T ss_pred CHHHHhcC
Confidence 99999876
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-34 Score=286.06 Aligned_cols=242 Identities=25% Similarity=0.441 Sum_probs=194.8
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCCc--cchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCC
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGGW--QRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGS 449 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gs 449 (686)
..||+|++|.||++... +++.|++|.+..... ...+.+.+|++++++++|||++++++++.+.+..++||||+++++
T Consensus 6 ~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~ 85 (254)
T cd06627 6 DLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAENGS 85 (254)
T ss_pred eEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecCCCCc
Confidence 46999999999999865 578899999876543 345679999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCc
Q 042348 450 LATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETP 529 (686)
Q Consensus 450 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 529 (686)
|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.++|+|||.+.........
T Consensus 86 L~~~~~~~------~~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~- 155 (254)
T cd06627 86 LRQIIKKF------GPFPESLVAVYVYQVLQGLAYLHE---QGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD- 155 (254)
T ss_pred HHHHHHhc------cCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEECCCCCEEEeccccceecCCCccc-
Confidence 99998765 358999999999999999999999 89999999999999999999999999999865432210
Q ss_pred cccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHHH
Q 042348 530 EVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQWI 609 (686)
Q Consensus 530 ~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~ 609 (686)
.....++..|+|||...+..++.++||||+|+++|+|++|+.||..... .....
T Consensus 156 ----------------------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~----~~~~~ 209 (254)
T cd06627 156 ----------------------DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP----MAALF 209 (254)
T ss_pred ----------------------ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH----HHHHH
Confidence 1123456679999998887789999999999999999999999954331 11111
Q ss_pred HHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042348 610 QLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCD 663 (686)
Q Consensus 610 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 663 (686)
. .... .... +.+ .....+.+++.+||..+|++||++.|++.
T Consensus 210 ~-~~~~--~~~~-~~~---------~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 210 R-IVQD--DHPP-LPE---------GISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred H-Hhcc--CCCC-CCC---------CCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 1 1111 1111 111 11235778999999999999999999975
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=293.28 Aligned_cols=259 Identities=24% Similarity=0.324 Sum_probs=191.4
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCCc-cchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCCH
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGGW-QRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSL 450 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL 450 (686)
+.||.|++|.||+|... ++..||||.+..... .....+.+|+.++++++||||+++++++...+..++||||+++ +|
T Consensus 6 ~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l 84 (284)
T cd07836 6 EKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMDK-DL 84 (284)
T ss_pred eeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCCc-cH
Confidence 46899999999999975 588999999876432 2345678899999999999999999999999999999999975 89
Q ss_pred HHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCcc
Q 042348 451 ATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPE 530 (686)
Q Consensus 451 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 530 (686)
.+++..... ...+++..+..++.|++.||+|||+ .+++||||||+||++++++.++|+|||+++.......
T Consensus 85 ~~~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~--- 155 (284)
T cd07836 85 KKYMDTHGV---RGALDPNTVKSFTYQLLKGIAFCHE---NRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN--- 155 (284)
T ss_pred HHHHHhcCC---CCCcCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc---
Confidence 988875432 1358999999999999999999999 8999999999999999999999999999875432110
Q ss_pred ccccccccCCCCCCCccccccccCCCCCccccCcccccC-CCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHHH
Q 042348 531 VHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKV-RKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQWI 609 (686)
Q Consensus 531 ~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~ 609 (686)
......++..|++||++.+ ..++.++|||||||++|||++|+.||......+ ....+
T Consensus 156 --------------------~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~--~~~~~ 213 (284)
T cd07836 156 --------------------TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNED--QLLKI 213 (284)
T ss_pred --------------------ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHH--HHHHH
Confidence 0112345677999998765 457899999999999999999999996543221 11111
Q ss_pred HHHHhhc--------CCcccccCcccccCC-C-----cHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 610 QLILEDR--------KPMTDILDPFLAHDL-D-----KEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 610 ~~~~~~~--------~~~~~~~d~~l~~~~-~-----~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
....... ...... ........ . .+.....+.+++.+|++.||++||++.|++++
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 281 (284)
T cd07836 214 FRIMGTPTESTWPGISQLPEY-KPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH 281 (284)
T ss_pred HHHhCCCChhhHHHHhcCchh-cccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 1100000 000000 00000000 0 01123457799999999999999999999854
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=301.51 Aligned_cols=271 Identities=21% Similarity=0.251 Sum_probs=193.1
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCCccc--------------hHHHHHHHHHHhccCCCCcceeeEEEEecCc
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGGWQR--------------FKEFQTEAEAIGKIRHPNIVSLRAYFWSVDE 437 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--------------~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~ 437 (686)
.+||+|+||.||+|... +++.||||.+....... ...+.+|++++++++||||+++++++...+.
T Consensus 15 ~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 94 (335)
T PTZ00024 15 AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEGDF 94 (335)
T ss_pred hcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecCCc
Confidence 46999999999999865 58899999886532211 1247789999999999999999999999999
Q ss_pred eeEEEeccCCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecC
Q 042348 438 KLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFG 517 (686)
Q Consensus 438 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfG 517 (686)
.++||||++ |+|.+++... ..+++.....++.|++.||+|||+ .+|+||||||+||+++.++.++|+|||
T Consensus 95 ~~lv~e~~~-~~l~~~l~~~------~~~~~~~~~~~~~ql~~aL~~LH~---~~i~H~dl~~~nill~~~~~~kl~dfg 164 (335)
T PTZ00024 95 INLVMDIMA-SDLKKVVDRK------IRLTESQVKCILLQILNGLNVLHK---WYFMHRDLSPANIFINSKGICKIADFG 164 (335)
T ss_pred EEEEEeccc-cCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHHeEECCCCCEEECCcc
Confidence 999999996 6999998654 358899999999999999999999 899999999999999999999999999
Q ss_pred cccccccccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCC-CCCCcchHHHHHHHHHHHHhCCCCcc
Q 042348 518 LARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVR-KPTQKWDIYSYGVILLEMISGKLPMI 596 (686)
Q Consensus 518 la~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlGvvl~elltG~~P~~ 596 (686)
+++................. ..........++..|+|||.+.+. .++.++|||||||++|||++|+.||.
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~ 235 (335)
T PTZ00024 165 LARRYGYPPYSDTLSKDETM---------QRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFP 235 (335)
T ss_pred ceeecccccccccccccccc---------cccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 99865422211100000000 000111233457789999998764 46899999999999999999999996
Q ss_pred ccCccchhHHHHHHHHHhhcCC--ccccc-----CcccccCCC-----cHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 597 QIGSMELNIVQWIQLILEDRKP--MTDIL-----DPFLAHDLD-----KEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 597 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~-----d~~l~~~~~-----~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
..... +....+......... ++... .+....... .......+.+++.+||+.+|++||++.|++.+
T Consensus 236 ~~~~~--~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~ 313 (335)
T PTZ00024 236 GENEI--DQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKH 313 (335)
T ss_pred CCCHH--HHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence 44322 112222111111000 00000 000000000 01123457899999999999999999999864
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=278.68 Aligned_cols=247 Identities=21% Similarity=0.338 Sum_probs=194.3
Q ss_pred hcccCccCceEEEEEEeC-CCceEEEEEcCCCCccchHHHHHHHHHHhcc-CCCCcceeeEEEEec----CceeEEEecc
Q 042348 372 AFLLGKSTIGIVYKVALN-NEEAVAVRRLGNGGWQRFKEFQTEAEAIGKI-RHPNIVSLRAYFWSV----DEKLLIYDYI 445 (686)
Q Consensus 372 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~----~~~~lV~e~~ 445 (686)
..+||-|-.|.|-.+..+ +++.+|+|++... ....+|+++--+. .|||||.++++|... ....+|||+|
T Consensus 67 ~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~m 141 (400)
T KOG0604|consen 67 WQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECM 141 (400)
T ss_pred hhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeecc
Confidence 357999999999988765 6888999998543 4567888887666 699999999998742 4568999999
Q ss_pred CCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeec---CCCCeEEeecCccccc
Q 042348 446 PNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLG---KNMEPHISDFGLARLA 522 (686)
Q Consensus 446 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~---~~~~~kl~DfGla~~~ 522 (686)
+||.|...+.+++. ..+++.++-.|++||+.|+.|||+ .+|.||||||+|+|.. .|..+||+|||+|+.-
T Consensus 142 eGGeLfsriq~~g~----~afTErea~eI~~qI~~Av~~lH~---~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t 214 (400)
T KOG0604|consen 142 EGGELFSRIQDRGD----QAFTEREASEIMKQIGLAVRYLHS---MNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKET 214 (400)
T ss_pred cchHHHHHHHHccc----ccchHHHHHHHHHHHHHHHHHHHh---cchhhccCChhheeeecCCCCcceEeccccccccc
Confidence 99999999998764 579999999999999999999999 8999999999999996 4567999999999853
Q ss_pred ccccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccc
Q 042348 523 DIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSME 602 (686)
Q Consensus 523 ~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~ 602 (686)
... ......+-|++|.|||++...+|+..+|+||+||+||-|++|.+||.+.....
T Consensus 215 ~~~------------------------~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~a 270 (400)
T KOG0604|consen 215 QEP------------------------GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA 270 (400)
T ss_pred CCC------------------------ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCcc
Confidence 321 11233456888999999999999999999999999999999999996654422
Q ss_pred hhHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 603 LNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 603 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
.. ...-.++..+...++ +| ......+...++++.+|..+|++|.|+.|+.++
T Consensus 271 is-pgMk~rI~~gqy~FP---~p------EWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h 322 (400)
T KOG0604|consen 271 IS-PGMKRRIRTGQYEFP---EP------EWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH 322 (400)
T ss_pred CC-hhHHhHhhccCccCC---Ch------hHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence 11 111122222222211 11 223455677899999999999999999999876
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=303.60 Aligned_cols=265 Identities=22% Similarity=0.324 Sum_probs=191.4
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCC-ccchHHHHHHHHHHhccCCCCcceeeEEEEecC-----ceeEEEecc
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGG-WQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVD-----EKLLIYDYI 445 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~-----~~~lV~e~~ 445 (686)
..||+|+||.||+|... +++.||+|.+.... ......+.+|+.++++++||||+++++++.... ..++||||+
T Consensus 11 ~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 90 (336)
T cd07849 11 SYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYIVQELM 90 (336)
T ss_pred EEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEEEEehhc
Confidence 46999999999999864 68899999986432 223456888999999999999999999876543 479999999
Q ss_pred CCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccc
Q 042348 446 PNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIA 525 (686)
Q Consensus 446 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~ 525 (686)
+ ++|.+++.. ..+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++.....
T Consensus 91 ~-~~l~~~~~~-------~~l~~~~~~~i~~ql~~aL~~LH~---~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~ 159 (336)
T cd07849 91 E-TDLYKLIKT-------QHLSNDHIQYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPE 159 (336)
T ss_pred c-cCHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEECcccceeecccc
Confidence 6 488888754 358999999999999999999999 89999999999999999999999999998755322
Q ss_pred cCCccccccccccCCCCCCCccccccccCCCCCccccCcccccC-CCCCCcchHHHHHHHHHHHHhCCCCccccCccchh
Q 042348 526 EETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKV-RKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELN 604 (686)
Q Consensus 526 ~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~ 604 (686)
.... .......++..|+|||.+.+ ..++.++|||||||++|||++|+.||..... ..
T Consensus 160 ~~~~--------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~--~~ 217 (336)
T cd07849 160 HDHT--------------------GFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDY--LH 217 (336)
T ss_pred cccc--------------------CCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH--HH
Confidence 1100 01123456788999998654 5689999999999999999999999954221 11
Q ss_pred HHHHHHHHHhhcC--CcccccCcc-------cc--cCCC----cHHHHHHHHHHHHhccccCCCCCCCHHHHHHH--Hhc
Q 042348 605 IVQWIQLILEDRK--PMTDILDPF-------LA--HDLD----KEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS--LDR 667 (686)
Q Consensus 605 ~~~~~~~~~~~~~--~~~~~~d~~-------l~--~~~~----~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~--L~~ 667 (686)
....+........ ....+.+.. .. .... .+....++.+++.+||+.+|++|||+.|++++ ++.
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~ 297 (336)
T cd07849 218 QLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQ 297 (336)
T ss_pred HHHHHHHHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccc
Confidence 1111111111000 000000000 00 0000 00123457899999999999999999999998 665
Q ss_pred ccc
Q 042348 668 VNI 670 (686)
Q Consensus 668 i~~ 670 (686)
...
T Consensus 298 ~~~ 300 (336)
T cd07849 298 YHD 300 (336)
T ss_pred cCC
Confidence 543
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-34 Score=296.49 Aligned_cols=262 Identities=18% Similarity=0.267 Sum_probs=188.1
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCC--ccchHHHHHHHHHHhccCCCCcceeeEEEEecCc--------eeEE
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGG--WQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDE--------KLLI 441 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~--------~~lV 441 (686)
..||+|+||.||+|... +++.||||.+.... ......+.+|++++++++||||+++++++...+. .++|
T Consensus 18 ~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv 97 (310)
T cd07865 18 AKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLV 97 (310)
T ss_pred EEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCceEEEE
Confidence 46999999999999875 58899999885432 1223456789999999999999999999876543 4999
Q ss_pred EeccCCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccc
Q 042348 442 YDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARL 521 (686)
Q Consensus 442 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~ 521 (686)
|||+. ++|.+++.... ..+++.++..++.|++.||+|||+ ++++||||||+||+++.++.+||+|||++..
T Consensus 98 ~e~~~-~~l~~~l~~~~-----~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 168 (310)
T cd07865 98 FEFCE-HDLAGLLSNKN-----VKFTLSEIKKVMKMLLNGLYYIHR---NKILHRDMKAANILITKDGILKLADFGLARA 168 (310)
T ss_pred EcCCC-cCHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEECCCCcEEECcCCCccc
Confidence 99996 58888886543 358999999999999999999999 8999999999999999999999999999986
Q ss_pred cccccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCC-CCCCcchHHHHHHHHHHHHhCCCCccccCc
Q 042348 522 ADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVR-KPTQKWDIYSYGVILLEMISGKLPMIQIGS 600 (686)
Q Consensus 522 ~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlGvvl~elltG~~P~~~~~~ 600 (686)
......... .......++..|+|||.+.+. .++.++||||||+++|||+||+.||.....
T Consensus 169 ~~~~~~~~~-------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~ 229 (310)
T cd07865 169 FSLSKNSKP-------------------NRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTE 229 (310)
T ss_pred ccCCcccCC-------------------CCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCH
Confidence 543221100 011223456789999987654 478899999999999999999999854322
Q ss_pred cchhHHHHHHHHHhhcCC--cccc-----cC---------cccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 601 MELNIVQWIQLILEDRKP--MTDI-----LD---------PFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 601 ~~~~~~~~~~~~~~~~~~--~~~~-----~d---------~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
......+........+ .+.. .+ ...............+.+++.+||..||++|||++|++++
T Consensus 230 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 230 --QHQLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred --HHHHHHHHHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 1122222222111000 0000 00 0000000000012356789999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=294.69 Aligned_cols=256 Identities=22% Similarity=0.302 Sum_probs=187.4
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCCc--cchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCC
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGGW--QRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGS 449 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gs 449 (686)
..||+|++|.||+|... +++.||+|.+..... ...+.+.+|++++++++||||+++++++...+..++||||++ ++
T Consensus 8 ~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~ 86 (294)
T PLN00009 8 EKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYLD-LD 86 (294)
T ss_pred EEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEeccc-cc
Confidence 36899999999999875 678999999865422 233568899999999999999999999999999999999995 58
Q ss_pred HHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecC-CCCeEEeecCcccccccccCC
Q 042348 450 LATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGK-NMEPHISDFGLARLADIAEET 528 (686)
Q Consensus 450 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~-~~~~kl~DfGla~~~~~~~~~ 528 (686)
|.+++..... ..+++..+..++.||+.||+|||+ ++++||||||+||+++. ++.+||+|||++........
T Consensus 87 l~~~~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~- 158 (294)
T PLN00009 87 LKKHMDSSPD----FAKNPRLIKTYLYQILRGIAYCHS---HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR- 158 (294)
T ss_pred HHHHHHhCCC----CCcCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCcceEEEECCCCEEEEcccccccccCCCcc-
Confidence 8888765432 236788889999999999999999 89999999999999985 55799999999975432110
Q ss_pred ccccccccccCCCCCCCccccccccCCCCCccccCcccccC-CCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHH
Q 042348 529 PEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKV-RKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQ 607 (686)
Q Consensus 529 ~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~ 607 (686)
......++..|+|||++.+ ..++.++|||||||++|+|+||+.||......+ .
T Consensus 159 ----------------------~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~-~--- 212 (294)
T PLN00009 159 ----------------------TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEID-E--- 212 (294)
T ss_pred ----------------------ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-H---
Confidence 0112345677999998866 457899999999999999999999995432211 1
Q ss_pred HHHHHHhh-cCCcccccC------------cccccCC---CcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 608 WIQLILED-RKPMTDILD------------PFLAHDL---DKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 608 ~~~~~~~~-~~~~~~~~d------------~~l~~~~---~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
+...... ..+.....+ +...... ..+.....+.+++.+|++.+|++||++.+++++
T Consensus 213 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 213 -LFKIFRILGTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred -HHHHHHHhCCCChhhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1111110 001000000 0000000 001122357789999999999999999999864
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-34 Score=299.81 Aligned_cols=283 Identities=24% Similarity=0.345 Sum_probs=199.5
Q ss_pred hcccCccCceEEEEEEeC-CCceEEEEEcCCC--CccchHHHHHHHHHHhcc-CCCCcceeeEEEEecC--ceeEEEecc
Q 042348 372 AFLLGKSTIGIVYKVALN-NEEAVAVRRLGNG--GWQRFKEFQTEAEAIGKI-RHPNIVSLRAYFWSVD--EKLLIYDYI 445 (686)
Q Consensus 372 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~--~~~lV~e~~ 445 (686)
...||+|+||.||+|... +++.+|+|++... .......+.+|+.+++++ +||||+++++++...+ ..++||||+
T Consensus 12 ~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~lv~e~~ 91 (337)
T cd07852 12 LQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYM 91 (337)
T ss_pred hHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEEEeccc
Confidence 346999999999999876 5788999988542 223345677899999999 9999999999987543 579999999
Q ss_pred CCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccc
Q 042348 446 PNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIA 525 (686)
Q Consensus 446 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~ 525 (686)
+ ++|..++... .+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++.....
T Consensus 92 ~-~~L~~~~~~~-------~~~~~~~~~i~~qi~~~L~~LH~---~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~ 160 (337)
T cd07852 92 E-TDLHAVIRAN-------ILEDVHKRYIMYQLLKALKYIHS---GNVIHRDLKPSNILLNSDCRVKLADFGLARSLSEL 160 (337)
T ss_pred c-cCHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccchhccccc
Confidence 7 5999988653 47889999999999999999999 89999999999999999999999999999865422
Q ss_pred cCCccccccccccCCCCCCCccccccccCCCCCccccCcccccC-CCCCCcchHHHHHHHHHHHHhCCCCccccCccchh
Q 042348 526 EETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKV-RKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELN 604 (686)
Q Consensus 526 ~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~ 604 (686)
.... +. .......++..|+|||.+.+ ..++.++||||||+++|||+||+.||......+
T Consensus 161 ~~~~---------~~---------~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~-- 220 (337)
T cd07852 161 EENP---------EN---------PVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLN-- 220 (337)
T ss_pred cccc---------cC---------cchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHH--
Confidence 2100 00 01123456788999998754 457899999999999999999999995432211
Q ss_pred HHHHHHHHHhhcC---------C-cccccCcccccCC-----CcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH--Hhc
Q 042348 605 IVQWIQLILEDRK---------P-MTDILDPFLAHDL-----DKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS--LDR 667 (686)
Q Consensus 605 ~~~~~~~~~~~~~---------~-~~~~~d~~l~~~~-----~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~--L~~ 667 (686)
....+........ . ....++....... .......++.+++.+||+.||++|||+.+++++ ++.
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~ 300 (337)
T cd07852 221 QLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQ 300 (337)
T ss_pred HHHHHHHHhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhh
Confidence 1111100000000 0 0000000000000 000123467899999999999999999999987 666
Q ss_pred ccccch-hhhhccCCCCCC
Q 042348 668 VNISTE-QQFMKGEEPKFD 685 (686)
Q Consensus 668 i~~~~~-~~~~~~~~~~~~ 685 (686)
+....+ ....+...|+|+
T Consensus 301 ~~~~~~~~~~~~~~~~~~~ 319 (337)
T cd07852 301 FHNPSDEPVLPYPITIPLD 319 (337)
T ss_pred hccCCCCCCCCCCccCCcc
Confidence 654333 344444455554
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=286.19 Aligned_cols=247 Identities=23% Similarity=0.382 Sum_probs=197.3
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCCc--cchHHHHHHHHHHhccCCCCcceeeEEEEec--CceeEEEeccCC
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGGW--QRFKEFQTEAEAIGKIRHPNIVSLRAYFWSV--DEKLLIYDYIPN 447 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~~lV~e~~~~ 447 (686)
+.||+|++|.||+|... ++..|++|.+..... ...+.+.+|+.++++++||||+++++.+... +..++||||+++
T Consensus 6 ~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~ 85 (260)
T cd06606 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSG 85 (260)
T ss_pred eEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEEecCC
Confidence 46999999999999976 688999999866532 3457899999999999999999999999988 889999999999
Q ss_pred CCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccC
Q 042348 448 GSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEE 527 (686)
Q Consensus 448 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 527 (686)
++|.+++... ..+++..+..++.|++.||+|||+ .+++|+||+|+||+++.++.++|+|||.+........
T Consensus 86 ~~L~~~~~~~------~~~~~~~~~~~~~~l~~~l~~lh~---~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 156 (260)
T cd06606 86 GSLSSLLKKF------GKLPEPVIRKYTRQILEGLAYLHS---NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIET 156 (260)
T ss_pred CcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEcccccEEecccccc
Confidence 9999999764 268999999999999999999999 8999999999999999999999999999886543221
Q ss_pred CccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHH
Q 042348 528 TPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQ 607 (686)
Q Consensus 528 ~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~ 607 (686)
. .......++..|+|||...+..++.++||||||+++|+|++|+.||..... ...
T Consensus 157 ~---------------------~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~----~~~ 211 (260)
T cd06606 157 G---------------------EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGN----PMA 211 (260)
T ss_pred c---------------------ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc----hHH
Confidence 0 001223456779999999888899999999999999999999999955431 111
Q ss_pred HHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 608 WIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 608 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
........ ..... +. ......+.+++.+|++.+|++||++.|++.+
T Consensus 212 ~~~~~~~~-~~~~~-----~~-----~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 212 ALYKIGSS-GEPPE-----IP-----EHLSEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred HHHhcccc-CCCcC-----CC-----cccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 11111110 11111 10 1123468889999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=293.88 Aligned_cols=243 Identities=23% Similarity=0.414 Sum_probs=190.0
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCC---CccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCC
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNG---GWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNG 448 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~g 448 (686)
..||+|+||.||+|... ++..+|+|.+... .....+++.+|+++++.++|+|++++++++......++||||+. |
T Consensus 21 ~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~ 99 (308)
T cd06634 21 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-G 99 (308)
T ss_pred HheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEccC-C
Confidence 45999999999999865 5788999988642 22334568899999999999999999999999999999999996 6
Q ss_pred CHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCC
Q 042348 449 SLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEET 528 (686)
Q Consensus 449 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 528 (686)
++.+++.... ..+++.++..++.|++.||+|||+ ++++||||||+||+++.++.++|+|||++......
T Consensus 100 ~l~~~~~~~~-----~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~--- 168 (308)
T cd06634 100 SASDLLEVHK-----KPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--- 168 (308)
T ss_pred CHHHHHHHcC-----CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHhEEECCCCcEEECCcccceeecCc---
Confidence 8888776443 358899999999999999999999 89999999999999999999999999998754311
Q ss_pred ccccccccccCCCCCCCccccccccCCCCCccccCccccc---CCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhH
Q 042348 529 PEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASK---VRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNI 605 (686)
Q Consensus 529 ~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~ 605 (686)
....++..|+|||.+. ...++.++|||||||++|||++|+.||......
T Consensus 169 ------------------------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~---- 220 (308)
T cd06634 169 ------------------------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM---- 220 (308)
T ss_pred ------------------------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHH----
Confidence 1224566799999874 356788999999999999999999998543211
Q ss_pred HHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 042348 606 VQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDR 667 (686)
Q Consensus 606 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~ 667 (686)
...........+ .. ........+.+++.+||+.+|++||++.+++++-..
T Consensus 221 -~~~~~~~~~~~~--~~---------~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~ 270 (308)
T cd06634 221 -SALYHIAQNESP--AL---------QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFV 270 (308)
T ss_pred -HHHHHHhhcCCC--Cc---------CcccccHHHHHHHHHHhhCCcccCCCHHHHhhCccc
Confidence 111122211111 00 011233457789999999999999999999987543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=318.16 Aligned_cols=264 Identities=20% Similarity=0.205 Sum_probs=179.9
Q ss_pred cccCccCceEEEEEEeCC--CceEEEE------------------EcCCCCccchHHHHHHHHHHhccCCCCcceeeEEE
Q 042348 373 FLLGKSTIGIVYKVALNN--EEAVAVR------------------RLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYF 432 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~~--~~~vavK------------------~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~ 432 (686)
..||+|+||.||++..+. +..+++| .+.. .......+.+|+.++++++|||||++++++
T Consensus 154 ~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~ 232 (501)
T PHA03210 154 DDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKA-GSRAAIQLENEILALGRLNHENILKIEEIL 232 (501)
T ss_pred eEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhc-chHHHHHHHHHHHHHHhCCCCCcCcEeEEE
Confidence 469999999999987542 2222222 1111 112235688999999999999999999999
Q ss_pred EecCceeEEEeccCCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeE
Q 042348 433 WSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPH 512 (686)
Q Consensus 433 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~k 512 (686)
...+..++|+|++. ++|.+++....... .......++..|+.|++.||+|||+ ++||||||||+|||++.++.+|
T Consensus 233 ~~~~~~~lv~e~~~-~~l~~~l~~~~~~~-~~~~~~~~~~~i~~ql~~aL~yLH~---~gIiHrDLKP~NILl~~~~~vk 307 (501)
T PHA03210 233 RSEANTYMITQKYD-FDLYSFMYDEAFDW-KDRPLLKQTRAIMKQLLCAVEYIHD---KKLIHRDIKLENIFLNCDGKIV 307 (501)
T ss_pred EECCeeEEEEeccc-cCHHHHHhhccccc-cccccHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEE
Confidence 99999999999994 57877775432111 1223456678899999999999999 8999999999999999999999
Q ss_pred EeecCcccccccccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCC
Q 042348 513 ISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGK 592 (686)
Q Consensus 513 l~DfGla~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~ 592 (686)
|+|||+++.+..... .......||..|+|||++.+..++.++|||||||++|||++|.
T Consensus 308 L~DFGla~~~~~~~~----------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~ 365 (501)
T PHA03210 308 LGDFGTAMPFEKERE----------------------AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHD 365 (501)
T ss_pred EEeCCCceecCcccc----------------------cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCC
Confidence 999999986542211 0112346788899999999999999999999999999999988
Q ss_pred CCccccC-cc-chhHHHHHHHHHhhcCCcccc-------cCc-ccccCCC-cH------HHHHHHHHHHHhccccCCCCC
Q 042348 593 LPMIQIG-SM-ELNIVQWIQLILEDRKPMTDI-------LDP-FLAHDLD-KE------DEIVSVLKIALDCVHKSPDKR 655 (686)
Q Consensus 593 ~P~~~~~-~~-~~~~~~~~~~~~~~~~~~~~~-------~d~-~l~~~~~-~~------~~~~~l~~l~~~cl~~dP~~R 655 (686)
.++.... .. ...+.+.+.........+++. ++. .+..... .. .....+.+++.+||+.||++|
T Consensus 366 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~R 445 (501)
T PHA03210 366 FCPIGDGGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLR 445 (501)
T ss_pred CCCccCCCCCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccC
Confidence 6543221 11 111211111110000000000 000 0000000 00 011246677889999999999
Q ss_pred CCHHHHHHH
Q 042348 656 PSMRHVCDS 664 (686)
Q Consensus 656 Ps~~ev~~~ 664 (686)
||+.|++++
T Consensus 446 psa~elL~h 454 (501)
T PHA03210 446 PGAAELLAL 454 (501)
T ss_pred cCHHHHhhC
Confidence 999999876
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=279.85 Aligned_cols=252 Identities=20% Similarity=0.296 Sum_probs=192.9
Q ss_pred ccCccCceEEEEEEeC-CCceEEEEEcCCCCc-cchHHHHHHHHHHhcc-CCCCcceeeEEEEecCceeEEEeccCCCCH
Q 042348 374 LLGKSTIGIVYKVALN-NEEAVAVRRLGNGGW-QRFKEFQTEAEAIGKI-RHPNIVSLRAYFWSVDEKLLIYDYIPNGSL 450 (686)
Q Consensus 374 ~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL 450 (686)
.||.|+||+|+|-.++ .|+.+|||+++.... .+.+++..|.+...+- +.||||++||.+...+..++.||.|+ .||
T Consensus 71 ~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd-~Sl 149 (361)
T KOG1006|consen 71 EIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMD-ISL 149 (361)
T ss_pred HhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHh-hhH
Confidence 3999999999998765 689999999976543 5567899999876665 78999999999999999999999994 476
Q ss_pred HHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCcc
Q 042348 451 ATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPE 530 (686)
Q Consensus 451 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 530 (686)
+.+...-- ......+++.-.-.|....++||.||-+. ..|||||+||+|||+|..|.+||+|||++-.+..+-
T Consensus 150 DklYk~vy-~vq~~~ipE~Ilg~ItvatV~AL~yLK~~--lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~Si---- 222 (361)
T KOG1006|consen 150 DKLYKRVY-SVQKSRIPENILGHITVATVDALDYLKEE--LKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSI---- 222 (361)
T ss_pred HHHHHHHH-HHHhccCcHhhhhheeeeehhHHHHHHHH--hhhhhccCChhheEEecCCCEeeecccchHhHHHHH----
Confidence 65543110 00114688888888999999999999874 579999999999999999999999999987654221
Q ss_pred ccccccccCCCCCCCccccccccCCCCCccccCcccccC--CCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHH
Q 042348 531 VHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKV--RKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQW 608 (686)
Q Consensus 531 ~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~ 608 (686)
..+...|...|||||.+.. ..|+-+|||||+|++|||+.||+.||....+ +.+.
T Consensus 223 --------------------AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s----vfeq 278 (361)
T KOG1006|consen 223 --------------------AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS----VFEQ 278 (361)
T ss_pred --------------------HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH----HHHH
Confidence 1123455667999998854 3489999999999999999999999965433 4444
Q ss_pred HHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 609 IQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 609 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
+..+..+..+... .+...-.....+.+++..|+.+|-.+||...++.++
T Consensus 279 l~~Vv~gdpp~l~-------~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 279 LCQVVIGDPPILL-------FDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred HHHHHcCCCCeec-------CcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 5555555443211 111111234468889999999999999999988654
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=293.61 Aligned_cols=240 Identities=23% Similarity=0.436 Sum_probs=188.2
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCCc---cchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCC
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGGW---QRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNG 448 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~g 448 (686)
..||+|+||.||+|... ++..|++|.+..... .....+.+|++++++++|||++++++++.+.+..++||||+. |
T Consensus 27 ~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~ 105 (313)
T cd06633 27 HEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCL-G 105 (313)
T ss_pred eeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEecCC-C
Confidence 35999999999999864 578899999864322 234568899999999999999999999999999999999995 5
Q ss_pred CHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCC
Q 042348 449 SLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEET 528 (686)
Q Consensus 449 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 528 (686)
++.+++.... ..+++.++..++.|++.||+|||+ ++++||||||+||++++++.+||+|||++.....
T Consensus 106 ~l~~~l~~~~-----~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~---- 173 (313)
T cd06633 106 SASDLLEVHK-----KPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP---- 173 (313)
T ss_pred CHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChhhEEECCCCCEEEeecCCCcccCC----
Confidence 8888876543 468999999999999999999999 8999999999999999999999999998753210
Q ss_pred ccccccccccCCCCCCCccccccccCCCCCccccCccccc---CCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhH
Q 042348 529 PEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASK---VRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNI 605 (686)
Q Consensus 529 ~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~ 605 (686)
.....++..|+|||++. ...++.++|||||||++|||++|+.||......
T Consensus 174 -----------------------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~---- 226 (313)
T cd06633 174 -----------------------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM---- 226 (313)
T ss_pred -----------------------CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH----
Confidence 11234567799999974 356888999999999999999999998543221
Q ss_pred HHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 606 VQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 606 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
........... ..... ......+.+++.+||+.+|++||++.+++.+
T Consensus 227 -~~~~~~~~~~~--~~~~~---------~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 227 -SALYHIAQNDS--PTLQS---------NEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred -HHHHHHHhcCC--CCCCc---------cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11222221111 11111 1112357789999999999999999999875
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-34 Score=292.37 Aligned_cols=258 Identities=22% Similarity=0.304 Sum_probs=193.4
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCCcc--chHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCC
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGGWQ--RFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGS 449 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gs 449 (686)
..||.|++|.||++... +++.+++|++...... ....+.+|+.++++++|+||+++++++...+..++||||+++ +
T Consensus 5 ~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~-~ 83 (283)
T cd05118 5 GKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMDT-D 83 (283)
T ss_pred eeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccCC-C
Confidence 35899999999999875 6888999998654322 346788999999999999999999999999999999999975 8
Q ss_pred HHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCc
Q 042348 450 LATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETP 529 (686)
Q Consensus 450 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 529 (686)
|.+++.... ..+++..+..++.|++.||+|||+ ++|+|+||||+||++++++.++|+|||.+........
T Consensus 84 l~~~l~~~~-----~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~-- 153 (283)
T cd05118 84 LYKLIKDRQ-----RGLPESLIKSYLYQLLQGLAFCHS---HGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR-- 153 (283)
T ss_pred HHHHHHhhc-----ccCCHHHHHHHHHHHHHHHHHHHH---CCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcc--
Confidence 988887643 368999999999999999999999 8999999999999999999999999999875542210
Q ss_pred cccccccccCCCCCCCccccccccCCCCCccccCcccccCC-CCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHH
Q 042348 530 EVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVR-KPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQW 608 (686)
Q Consensus 530 ~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~ 608 (686)
......++..|+|||.+.+. .++.++||||||+++|+|+||+.||...... +....
T Consensus 154 ---------------------~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~--~~~~~ 210 (283)
T cd05118 154 ---------------------PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEI--DQLFK 210 (283)
T ss_pred ---------------------cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHH
Confidence 01123456679999998776 7899999999999999999999999543321 11111
Q ss_pred HHHHHhhcCC--cccccC------ccccc--CC----CcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 609 IQLILEDRKP--MTDILD------PFLAH--DL----DKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 609 ~~~~~~~~~~--~~~~~d------~~l~~--~~----~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
+........+ .....+ ..... .. ..+....++.+++.+||+.||.+||++.+++.+
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 211 IFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred HHHHcCCCchHhcccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 1111000000 000000 00000 00 011234578899999999999999999999864
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=298.57 Aligned_cols=267 Identities=21% Similarity=0.274 Sum_probs=191.2
Q ss_pred cccCccCceEEEEEEeCC---CceEEEEEcCCCC---ccchHHHHHHHHHHhccCCCCcceeeEEEEec--CceeEEEec
Q 042348 373 FLLGKSTIGIVYKVALNN---EEAVAVRRLGNGG---WQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSV--DEKLLIYDY 444 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~~---~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~~lV~e~ 444 (686)
..||+|+||.||+|.... +..||+|.+.... ....+.+.+|+.++++++||||+++++++... +..++||||
T Consensus 6 ~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~ 85 (316)
T cd07842 6 GCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYLLFDY 85 (316)
T ss_pred EEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEEEEeC
Confidence 359999999999998754 7899999987632 23346678899999999999999999999988 788999999
Q ss_pred cCCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecC----CCCeEEeecCccc
Q 042348 445 IPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGK----NMEPHISDFGLAR 520 (686)
Q Consensus 445 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~----~~~~kl~DfGla~ 520 (686)
+++ +|.+++....... ...+++..+..++.|++.||+|||+ ++|+||||||+||+++. ++.+||+|||+++
T Consensus 86 ~~~-~l~~~~~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~ 160 (316)
T cd07842 86 AEH-DLWQIIKFHRQAK-RVSIPPSMVKSLLWQILNGVHYLHS---NWVLHRDLKPANILVMGEGPERGVVKIGDLGLAR 160 (316)
T ss_pred CCc-CHHHHHHhhccCC-CcCcCHHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEEcCCCCccceEEECCCcccc
Confidence 975 7777765432111 1368899999999999999999999 89999999999999999 8999999999998
Q ss_pred ccccccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccC-CCCCCcchHHHHHHHHHHHHhCCCCccccC
Q 042348 521 LADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKV-RKPTQKWDIYSYGVILLEMISGKLPMIQIG 599 (686)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvvl~elltG~~P~~~~~ 599 (686)
........ ........++..|+|||++.+ ..++.++|||||||++|||++|+.||....
T Consensus 161 ~~~~~~~~--------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~ 220 (316)
T cd07842 161 LFNAPLKP--------------------LADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGRE 220 (316)
T ss_pred ccCCCccc--------------------ccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCc
Confidence 65322110 011123456778999998766 457899999999999999999999996543
Q ss_pred ccc--------hhHHHHHHHHHhhc-------CCcccccC---cccccCCC---cH-------HHHHHHHHHHHhccccC
Q 042348 600 SME--------LNIVQWIQLILEDR-------KPMTDILD---PFLAHDLD---KE-------DEIVSVLKIALDCVHKS 651 (686)
Q Consensus 600 ~~~--------~~~~~~~~~~~~~~-------~~~~~~~d---~~l~~~~~---~~-------~~~~~l~~l~~~cl~~d 651 (686)
... ..+...+....... ....+..+ ........ .. .....+.+++.+||+.|
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~ 300 (316)
T cd07842 221 AKIKKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYD 300 (316)
T ss_pred ccccccchhHHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCC
Confidence 321 01111111100000 00000000 00000000 00 12345889999999999
Q ss_pred CCCCCCHHHHHHH
Q 042348 652 PDKRPSMRHVCDS 664 (686)
Q Consensus 652 P~~RPs~~ev~~~ 664 (686)
|++|||+.|++++
T Consensus 301 P~~Rps~~eil~~ 313 (316)
T cd07842 301 PTKRITAEEALEH 313 (316)
T ss_pred cccCcCHHHHhcC
Confidence 9999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=319.90 Aligned_cols=269 Identities=26% Similarity=0.379 Sum_probs=207.4
Q ss_pred CcccCHHHHHHHhhcccCccCceEEEEEEeC--------CCceEEEEEcCCCC-ccchHHHHHHHHHHhcc-CCCCccee
Q 042348 359 QVDFDLEQLLKASAFLLGKSTIGIVYKVALN--------NEEAVAVRRLGNGG-WQRFKEFQTEAEAIGKI-RHPNIVSL 428 (686)
Q Consensus 359 ~~~~~~~~l~~~~~~~iG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l 428 (686)
..+++-+.+ ...+.+|+|.||.|++|... ....||||.++... ..+.+.+..|+++|+.+ +|+||+.+
T Consensus 290 ~~e~~~~~l--~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~l 367 (609)
T KOG0200|consen 290 KWEIPRENL--KLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNL 367 (609)
T ss_pred ceeechhhc--cccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhh
Confidence 445555554 23348999999999999743 13579999998653 34567899999999999 69999999
Q ss_pred eEEEEecCceeEEEeccCCCCHHHHhhcCC---Cccc-----c--CCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCC
Q 042348 429 RAYFWSVDEKLLIYDYIPNGSLATAIHGKA---GIIS-----Y--RPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDL 498 (686)
Q Consensus 429 ~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~---~~~~-----~--~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDl 498 (686)
+|+|...+..++|+||+..|+|.++++..+ .... . ..++..+.+.++.|||.|++||++ .++|||||
T Consensus 368 lG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~---~~~vHRDL 444 (609)
T KOG0200|consen 368 LGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLAS---VPCVHRDL 444 (609)
T ss_pred eeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhh---CCccchhh
Confidence 999999999999999999999999999876 1100 0 138999999999999999999999 89999999
Q ss_pred CCCCeeecCCCCeEEeecCcccccccccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchH
Q 042348 499 RPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDI 578 (686)
Q Consensus 499 kp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV 578 (686)
.++|||+.++..+||+|||+|+.....+.... ....+ . -...|||||.+....|+.|+||
T Consensus 445 AaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~----~~~~~---------------~-LP~kWmApEsl~~~~ft~kSDV 504 (609)
T KOG0200|consen 445 AARNVLITKNKVIKIADFGLARDHYNKDYYRT----KSSAG---------------T-LPVKWMAPESLFDRVFTSKSDV 504 (609)
T ss_pred hhhhEEecCCCEEEEccccceeccCCCCceEe----cCCCC---------------c-cceeecCHHHhccCcccccchh
Confidence 99999999999999999999985543221100 00000 0 1345999999999999999999
Q ss_pred HHHHHHHHHHHh-CCCCccccCccchhHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCC
Q 042348 579 YSYGVILLEMIS-GKLPMIQIGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPS 657 (686)
Q Consensus 579 wSlGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs 657 (686)
|||||+|||++| |..||..... ..++ ++ .++.+..+. .+..+..++.++|..||+.+|++||+
T Consensus 505 WSfGI~L~EifsLG~~PYp~~~~-~~~l---~~-~l~~G~r~~-----------~P~~c~~eiY~iM~~CW~~~p~~RP~ 568 (609)
T KOG0200|consen 505 WSFGILLWEIFTLGGTPYPGIPP-TEEL---LE-FLKEGNRME-----------QPEHCSDEIYDLMKSCWNADPEDRPT 568 (609)
T ss_pred hHHHHHHHHHhhCCCCCCCCCCc-HHHH---HH-HHhcCCCCC-----------CCCCCCHHHHHHHHHHhCCCcccCCC
Confidence 999999999999 8999954221 1122 22 222222211 11224557889999999999999999
Q ss_pred HHHHHHHHhcc
Q 042348 658 MRHVCDSLDRV 668 (686)
Q Consensus 658 ~~ev~~~L~~i 668 (686)
+.|+++.++..
T Consensus 569 F~~~~~~~~~~ 579 (609)
T KOG0200|consen 569 FSECVEFFEKH 579 (609)
T ss_pred HHHHHHHHHHH
Confidence 99999999884
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=288.86 Aligned_cols=255 Identities=22% Similarity=0.282 Sum_probs=189.6
Q ss_pred cccCccCceEEEEEEeCC-CceEEEEEcCCCCc--cchHHHHHHHHHHhcc---CCCCcceeeEEEEecCc-----eeEE
Q 042348 373 FLLGKSTIGIVYKVALNN-EEAVAVRRLGNGGW--QRFKEFQTEAEAIGKI---RHPNIVSLRAYFWSVDE-----KLLI 441 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~H~nIv~l~~~~~~~~~-----~~lV 441 (686)
..||+|+||.||+|.... +..||+|++..... .....+.+|+.+++++ +||||+++++++...+. .+++
T Consensus 5 ~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~l~ 84 (287)
T cd07838 5 AEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTLV 84 (287)
T ss_pred EEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCceeEEE
Confidence 468999999999999874 88999999864322 2234566788877666 59999999999998876 8999
Q ss_pred EeccCCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccc
Q 042348 442 YDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARL 521 (686)
Q Consensus 442 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~ 521 (686)
|||+. ++|.+++..... ..+++..++.++.|++.||+|||+ .+++|+||||+||++++++.+||+|||++..
T Consensus 85 ~e~~~-~~l~~~l~~~~~----~~l~~~~~~~~~~~i~~al~~LH~---~~i~h~~l~~~nili~~~~~~~l~dfg~~~~ 156 (287)
T cd07838 85 FEHVD-QDLATYLSKCPK----PGLPPETIKDLMRQLLRGVDFLHS---HRIVHRDLKPQNILVTSDGQVKIADFGLARI 156 (287)
T ss_pred ehhcc-cCHHHHHHHccC----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChhhEEEccCCCEEEeccCccee
Confidence 99997 589998875432 358999999999999999999999 8999999999999999999999999999876
Q ss_pred cccccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCcc
Q 042348 522 ADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSM 601 (686)
Q Consensus 522 ~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~ 601 (686)
...... .....++..|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 157 ~~~~~~------------------------~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~ 212 (287)
T cd07838 157 YSFEMA------------------------LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEA 212 (287)
T ss_pred ccCCcc------------------------cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChH
Confidence 532211 11223566799999999888999999999999999999999998543321
Q ss_pred chhHHHHHHHHHhhcCC-------cc-----cccCcccccCC--CcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 602 ELNIVQWIQLILEDRKP-------MT-----DILDPFLAHDL--DKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 602 ~~~~~~~~~~~~~~~~~-------~~-----~~~d~~l~~~~--~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
+....+...... .. ........... ........+.+++.+||+.||++||++.|++.+
T Consensus 213 -----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~ 284 (287)
T cd07838 213 -----DQLDKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH 284 (287)
T ss_pred -----HHHHHHHHHcCCCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence 112222211000 00 00000000000 001223567799999999999999999999854
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=300.71 Aligned_cols=259 Identities=20% Similarity=0.343 Sum_probs=190.5
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCC--ccchHHHHHHHHHHhccCCCCcceeeEEEEe----cCceeEEEecc
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGG--WQRFKEFQTEAEAIGKIRHPNIVSLRAYFWS----VDEKLLIYDYI 445 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~----~~~~~lV~e~~ 445 (686)
..||+|+||.||+|... ++..||+|++.... ....+.+.+|+.++++++||||+++++++.. ....++||||+
T Consensus 11 ~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~ 90 (334)
T cd07855 11 ENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMDLM 90 (334)
T ss_pred eeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEEEEEehh
Confidence 36999999999999865 58899999986532 2334678889999999999999999998764 34579999999
Q ss_pred CCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccc
Q 042348 446 PNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIA 525 (686)
Q Consensus 446 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~ 525 (686)
. |+|.+++... ..+++..+..++.|++.||+|||+ ++|+||||||+||++++++.+||+|||+++.....
T Consensus 91 ~-~~l~~~~~~~------~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 160 (334)
T cd07855 91 E-SDLHHIIHSD------QPLTEEHIRYFLYQLLRGLKYIHS---ANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSS 160 (334)
T ss_pred h-hhHHHHhccC------CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEecccccceeeccc
Confidence 5 6999998754 358999999999999999999999 89999999999999999999999999999755322
Q ss_pred cCCccccccccccCCCCCCCccccccccCCCCCccccCcccccC-CCCCCcchHHHHHHHHHHHHhCCCCccccCccchh
Q 042348 526 EETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKV-RKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELN 604 (686)
Q Consensus 526 ~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~ 604 (686)
.... ........++..|+|||.+.. ..++.++|||||||++|||++|+.||...... .
T Consensus 161 ~~~~-------------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~--~ 219 (334)
T cd07855 161 PTEH-------------------KYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYV--H 219 (334)
T ss_pred CcCC-------------------CcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChH--H
Confidence 1100 001122356778999998765 45899999999999999999999999543221 1
Q ss_pred HHHHHHHHHhhcCCcccccCcc-----------c--ccCCC----cHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 605 IVQWIQLILEDRKPMTDILDPF-----------L--AHDLD----KEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 605 ~~~~~~~~~~~~~~~~~~~d~~-----------l--~~~~~----~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
....+..... .+..+..+.. . ..... .......+.+++.+||+.+|++||++.+++.+
T Consensus 220 ~~~~~~~~~g--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 220 QLKLILSVLG--SPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred HHHHHHHHhC--CChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 1111111100 0000000000 0 00000 01124568899999999999999999999886
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-34 Score=294.44 Aligned_cols=248 Identities=21% Similarity=0.336 Sum_probs=188.7
Q ss_pred hcccCccCceEEEEEEeCC-CceEEEEEcCCCCc-cchHHHHHHHHHHhccC-CCCcceeeEEEEecCceeEEEeccCCC
Q 042348 372 AFLLGKSTIGIVYKVALNN-EEAVAVRRLGNGGW-QRFKEFQTEAEAIGKIR-HPNIVSLRAYFWSVDEKLLIYDYIPNG 448 (686)
Q Consensus 372 ~~~iG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lV~e~~~~g 448 (686)
...||+|+||.||+|...+ ++.||||.+..... ....++..|+.++.+.. ||||+++++++......++||||++ +
T Consensus 20 ~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~-~ 98 (296)
T cd06618 20 LGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELMS-T 98 (296)
T ss_pred eeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEeeccC-c
Confidence 3479999999999999875 88999999875432 23456777888777774 9999999999999999999999985 5
Q ss_pred CHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCC
Q 042348 449 SLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEET 528 (686)
Q Consensus 449 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 528 (686)
++.+++.... ..+++..+..++.|++.||+|||+. .+|+||||+|+||++++++.+||+|||++..+.....
T Consensus 99 ~l~~l~~~~~-----~~l~~~~~~~i~~~i~~~l~~lH~~--~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~- 170 (296)
T cd06618 99 CLDKLLKRIQ-----GPIPEDILGKMTVAIVKALHYLKEK--HGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKA- 170 (296)
T ss_pred CHHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhh--CCEecCCCcHHHEEEcCCCCEEECccccchhccCCCc-
Confidence 7877776533 3689999999999999999999962 4899999999999999999999999999875432110
Q ss_pred ccccccccccCCCCCCCccccccccCCCCCccccCcccccCCC----CCCcchHHHHHHHHHHHHhCCCCccccCccchh
Q 042348 529 PEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRK----PTQKWDIYSYGVILLEMISGKLPMIQIGSMELN 604 (686)
Q Consensus 529 ~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~ 604 (686)
.....++..|+|||.+.+.. ++.++||||||+++|||++|+.||......
T Consensus 171 -----------------------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--- 224 (296)
T cd06618 171 -----------------------KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE--- 224 (296)
T ss_pred -----------------------ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH---
Confidence 01223566799999987553 789999999999999999999999542211
Q ss_pred HHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 042348 605 IVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSL 665 (686)
Q Consensus 605 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L 665 (686)
.+..........+... .. .....++.+++.+||+.||++||++.+++++-
T Consensus 225 -~~~~~~~~~~~~~~~~--~~--------~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~ 274 (296)
T cd06618 225 -FEVLTKILQEEPPSLP--PN--------EGFSPDFCSFVDLCLTKDHRKRPKYRELLQHP 274 (296)
T ss_pred -HHHHHHHhcCCCCCCC--CC--------CCCCHHHHHHHHHHccCChhhCCCHHHHhcCh
Confidence 1112222222111100 00 01234678999999999999999999998773
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=283.68 Aligned_cols=236 Identities=25% Similarity=0.355 Sum_probs=190.5
Q ss_pred cCccCceEEEEEEeC-CCceEEEEEcCCCCc---cchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCCH
Q 042348 375 LGKSTIGIVYKVALN-NEEAVAVRRLGNGGW---QRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSL 450 (686)
Q Consensus 375 iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL 450 (686)
||+|+||.||++... +++.+++|.+..... .....+..|+.++++++||||+++++.+..++..++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999876 488999999866432 2345789999999999999999999999999999999999999999
Q ss_pred HHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCcc
Q 042348 451 ATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPE 530 (686)
Q Consensus 451 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 530 (686)
.+++... ..+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++........
T Consensus 81 ~~~l~~~------~~l~~~~~~~~~~qi~~~l~~lh~---~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~--- 148 (250)
T cd05123 81 FSHLSKE------GRFSEERARFYAAEIVLALEYLHS---LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS--- 148 (250)
T ss_pred HHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcceEEEcCCCcEEEeecCcceecccCCC---
Confidence 9999765 358999999999999999999999 8999999999999999999999999999876532210
Q ss_pred ccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHHHH
Q 042348 531 VHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQWIQ 610 (686)
Q Consensus 531 ~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~ 610 (686)
......++..|+|||...+...+.++|+||||+++||+++|+.||..... .....
T Consensus 149 --------------------~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~-----~~~~~ 203 (250)
T cd05123 149 --------------------RTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR-----KEIYE 203 (250)
T ss_pred --------------------cccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-----HHHHH
Confidence 01223456679999999888889999999999999999999999954322 22222
Q ss_pred HHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHH
Q 042348 611 LILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRH 660 (686)
Q Consensus 611 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~e 660 (686)
.......+.+... ...+.+++.+||..||++||++.+
T Consensus 204 ~~~~~~~~~~~~~-------------~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 204 KILKDPLRFPEFL-------------SPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred HHhcCCCCCCCCC-------------CHHHHHHHHHHhcCCHhhCCCccc
Confidence 3222222222111 235778999999999999999943
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-34 Score=299.09 Aligned_cols=267 Identities=20% Similarity=0.316 Sum_probs=195.6
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCC--CccchHHHHHHHHHHhccCCCCcceeeEEEEec-----CceeEEEec
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNG--GWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSV-----DEKLLIYDY 444 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~-----~~~~lV~e~ 444 (686)
..||+|+||.||+|... ++..||||.+... .......+.+|+.++++++||||+++++++... ...++||||
T Consensus 11 ~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~e~ 90 (337)
T cd07858 11 KPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYEL 90 (337)
T ss_pred EEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEEEEEeC
Confidence 36999999999999864 5889999998653 223345678899999999999999999988654 347999999
Q ss_pred cCCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCccccccc
Q 042348 445 IPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADI 524 (686)
Q Consensus 445 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~ 524 (686)
+. ++|.+++... ..+++..+..++.|++.||+|||+ ++++||||||+||+++.++.+||+|||+++....
T Consensus 91 ~~-~~L~~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~ 160 (337)
T cd07858 91 MD-TDLHQIIRSS------QTLSDDHCQYFLYQLLRGLKYIHS---ANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE 160 (337)
T ss_pred CC-CCHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECcCccccccCC
Confidence 95 6899888754 358999999999999999999999 8999999999999999999999999999975432
Q ss_pred ccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccC-CCCCCcchHHHHHHHHHHHHhCCCCccccCccch
Q 042348 525 AEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKV-RKPTQKWDIYSYGVILLEMISGKLPMIQIGSMEL 603 (686)
Q Consensus 525 ~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~ 603 (686)
... ......++..|+|||.+.. ..++.++|||||||++|+|++|+.||..... .
T Consensus 161 ~~~-----------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~--~ 215 (337)
T cd07858 161 KGD-----------------------FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDY--V 215 (337)
T ss_pred Ccc-----------------------cccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCh--H
Confidence 110 0112345667999998764 4689999999999999999999999954321 1
Q ss_pred hHHHHHHHHHhhcCC--c---------------ccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH--
Q 042348 604 NIVQWIQLILEDRKP--M---------------TDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS-- 664 (686)
Q Consensus 604 ~~~~~~~~~~~~~~~--~---------------~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~-- 664 (686)
.....+........+ . ....++.... ..+.....+.+++.+||+.+|++|||++|++++
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~ 293 (337)
T cd07858 216 HQLKLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFAR--LFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPY 293 (337)
T ss_pred HHHHHHHHHhCCCChHHhhhcCchhhhHHHHhcCcccccCHHH--HcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcc
Confidence 111111111110000 0 0000000000 001233467899999999999999999999998
Q ss_pred Hhcccccchhhh
Q 042348 665 LDRVNISTEQQF 676 (686)
Q Consensus 665 L~~i~~~~~~~~ 676 (686)
++.+.......+
T Consensus 294 ~~~~~~~~~~~~ 305 (337)
T cd07858 294 LASLHDPSDEPV 305 (337)
T ss_pred hhhhcCcccCcc
Confidence 777665544333
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=285.27 Aligned_cols=245 Identities=24% Similarity=0.350 Sum_probs=195.6
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCC--ccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCC
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGG--WQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGS 449 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gs 449 (686)
+.||+|++|.||++... +++.+++|.+.... .....++.+|++++++++|+||+++++++......++||||+++++
T Consensus 6 ~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~ 85 (256)
T cd08530 6 KKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYAPFGD 85 (256)
T ss_pred eeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhcCCCC
Confidence 46999999999999765 57889999986532 2334578899999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCc
Q 042348 450 LATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETP 529 (686)
Q Consensus 450 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 529 (686)
|.+++...... ...+++..+..++.|++.||+|||+ .+++||||+|+||++++++.+||+|||+++......
T Consensus 86 L~~~~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lh~---~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~--- 157 (256)
T cd08530 86 LSKAISKRKKK--RKLIPEQEIWRIFIQLLRGLQALHE---QKILHRDLKSANILLVANDLVKIGDLGISKVLKKNM--- 157 (256)
T ss_pred HHHHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEEecCCcEEEeeccchhhhccCC---
Confidence 99998763211 1468999999999999999999999 899999999999999999999999999997654321
Q ss_pred cccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHHH
Q 042348 530 EVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQWI 609 (686)
Q Consensus 530 ~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~ 609 (686)
.....++..|+|||...+..++.++|+||||+++|||++|+.||...... ...
T Consensus 158 ----------------------~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~-----~~~ 210 (256)
T cd08530 158 ----------------------AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ-----DLR 210 (256)
T ss_pred ----------------------cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----HHH
Confidence 01123566799999998888999999999999999999999999543221 111
Q ss_pred HHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 610 QLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 610 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
....... .... .......+.+++.+|++.+|++||++.|++++
T Consensus 211 ~~~~~~~--~~~~----------~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 211 YKVQRGK--YPPI----------PPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred HHHhcCC--CCCC----------chhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 1211111 1111 11234568899999999999999999999865
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=295.88 Aligned_cols=264 Identities=23% Similarity=0.335 Sum_probs=198.5
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCC--ccchHHHHHHHHHHhccCCCCcceeeEEEEecC-----ceeEEEec
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGG--WQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVD-----EKLLIYDY 444 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~-----~~~lV~e~ 444 (686)
..||+|++|.||+|... ++..||||++.... ....+.+.+|+.++++++||||+++++++...+ ..++||||
T Consensus 6 ~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~ 85 (330)
T cd07834 6 KPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIVTEL 85 (330)
T ss_pred eeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEEEecc
Confidence 46999999999999976 48899999987643 334567899999999999999999999998775 78999999
Q ss_pred cCCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCccccccc
Q 042348 445 IPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADI 524 (686)
Q Consensus 445 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~ 524 (686)
++ ++|.+++... ..+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.++|+|||++.....
T Consensus 86 ~~-~~l~~~l~~~------~~l~~~~~~~i~~~l~~~l~~LH~---~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~ 155 (330)
T cd07834 86 ME-TDLHKVIKSP------QPLTDDHIQYFLYQILRGLKYLHS---ANVIHRDLKPSNILVNSNCDLKICDFGLARGVDP 155 (330)
T ss_pred hh-hhHHHHHhCC------CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEcccCceEeecc
Confidence 97 5899988754 368999999999999999999999 8999999999999999999999999999986543
Q ss_pred ccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCC-CCCCcchHHHHHHHHHHHHhCCCCccccCccch
Q 042348 525 AEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVR-KPTQKWDIYSYGVILLEMISGKLPMIQIGSMEL 603 (686)
Q Consensus 525 ~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~ 603 (686)
..... .......++..|+|||.+.+. .++.++||||||+++|+|++|+.||......+
T Consensus 156 ~~~~~--------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~- 214 (330)
T cd07834 156 DEDEK--------------------GFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYID- 214 (330)
T ss_pred ccccc--------------------ccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHH-
Confidence 21100 011233457779999999877 78999999999999999999999995543211
Q ss_pred hHHHHHHHHHhhcC-CcccccC----cc----cc---cCC--C----cHHHHHHHHHHHHhccccCCCCCCCHHHHHHH-
Q 042348 604 NIVQWIQLILEDRK-PMTDILD----PF----LA---HDL--D----KEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS- 664 (686)
Q Consensus 604 ~~~~~~~~~~~~~~-~~~~~~d----~~----l~---~~~--~----~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~- 664 (686)
....+..... +..+... .. +. ... . .......+.+++.+||+.+|++||++.+++++
T Consensus 215 ----~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~ 290 (330)
T cd07834 215 ----QLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHP 290 (330)
T ss_pred ----HHHHHHHhcCCCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCc
Confidence 1111111100 0000000 00 00 000 0 01123467899999999999999999999986
Q ss_pred -Hhccccc
Q 042348 665 -LDRVNIS 671 (686)
Q Consensus 665 -L~~i~~~ 671 (686)
++.++..
T Consensus 291 ~~~~~~~~ 298 (330)
T cd07834 291 YLAQLHDP 298 (330)
T ss_pred cHHhhccc
Confidence 6666543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=284.31 Aligned_cols=247 Identities=21% Similarity=0.328 Sum_probs=189.7
Q ss_pred hcccCccCceEEEEEEeC-CCceEEEEEcCCC-----CccchHHHHHHHHHHhccCCCCcceeeEEEEec--CceeEEEe
Q 042348 372 AFLLGKSTIGIVYKVALN-NEEAVAVRRLGNG-----GWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSV--DEKLLIYD 443 (686)
Q Consensus 372 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~~lV~e 443 (686)
.+.||+|+||.||+|... ++..||+|.+... .......+.+|++++++++|+||+++++++.+. +..++|||
T Consensus 7 ~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e 86 (264)
T cd06653 7 GKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVE 86 (264)
T ss_pred eeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEEEEE
Confidence 347999999999999865 5889999987432 123345788999999999999999999998765 35789999
Q ss_pred ccCCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccc
Q 042348 444 YIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLAD 523 (686)
Q Consensus 444 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~ 523 (686)
|+++++|.+++... ..+++..+.+++.|++.||+|||+ .+++||||||+||+++.++.++|+|||+++...
T Consensus 87 ~~~~~~L~~~~~~~------~~l~~~~~~~~~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~ 157 (264)
T cd06653 87 YMPGGSIKDQLKAY------GALTENVTRRYTRQILQGVSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRIQ 157 (264)
T ss_pred eCCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECccccccccc
Confidence 99999999998754 347889999999999999999999 899999999999999999999999999997543
Q ss_pred cccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccch
Q 042348 524 IAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMEL 603 (686)
Q Consensus 524 ~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~ 603 (686)
...... .......++..|+|||.+.+..++.++|||||||++|||++|+.||......
T Consensus 158 ~~~~~~--------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-- 215 (264)
T cd06653 158 TICMSG--------------------TGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAM-- 215 (264)
T ss_pred cccccC--------------------ccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHH--
Confidence 211000 0112234677899999998888899999999999999999999999543211
Q ss_pred hHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 604 NIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 604 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
..+...... +....+.+ .....+.+++.+|++ +|.+||++.+++.+
T Consensus 216 ---~~~~~~~~~--~~~~~~p~---------~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~ 261 (264)
T cd06653 216 ---AAIFKIATQ--PTKPMLPD---------GVSDACRDFLKQIFV-EEKRRPTAEFLLRH 261 (264)
T ss_pred ---HHHHHHHcC--CCCCCCCc---------ccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence 112222111 11111111 122457789999999 57999999998764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=290.04 Aligned_cols=258 Identities=24% Similarity=0.369 Sum_probs=190.3
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCCc-cchHHHHHHHHHHhccC-CCCcceeeEEEEecCceeEEEeccCCCC
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGGW-QRFKEFQTEAEAIGKIR-HPNIVSLRAYFWSVDEKLLIYDYIPNGS 449 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lV~e~~~~gs 449 (686)
..||+|++|.||+|... +++.|+||++..... .......+|+..+++++ ||||+++++++...+..++||||+ +|+
T Consensus 5 ~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~ 83 (283)
T cd07830 5 KQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM-EGN 83 (283)
T ss_pred eeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC-CCC
Confidence 46999999999999986 478899999865422 22234567999999998 999999999999999999999999 889
Q ss_pred HHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCc
Q 042348 450 LATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETP 529 (686)
Q Consensus 450 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 529 (686)
|.+++....+ ..+++..+..++.|++.||+|||+ ++++|+||||+||++++++.++|+|||+++......
T Consensus 84 l~~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~--- 153 (283)
T cd07830 84 LYQLMKDRKG----KPFSESVIRSIIYQILQGLAHIHK---HGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP--- 153 (283)
T ss_pred HHHHHHhccc----ccCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCCEEEeecccceeccCCC---
Confidence 9999876542 368999999999999999999999 899999999999999999999999999987543211
Q ss_pred cccccccccCCCCCCCccccccccCCCCCccccCccccc-CCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHH
Q 042348 530 EVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASK-VRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQW 608 (686)
Q Consensus 530 ~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~ 608 (686)
......++..|+|||++. ...++.++||||||+++|||++|+.||......+ ....
T Consensus 154 ---------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~--~~~~ 210 (283)
T cd07830 154 ---------------------PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEID--QLYK 210 (283)
T ss_pred ---------------------CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHH--HHHH
Confidence 011234567799999874 4557999999999999999999999985432211 1111
Q ss_pred HHHHHhhc--------CCcccccCcccccCCC------cHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 609 IQLILEDR--------KPMTDILDPFLAHDLD------KEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 609 ~~~~~~~~--------~~~~~~~d~~l~~~~~------~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
........ .......+..+..... .......+.+++.+||+.+|++||+++|++.+
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 211 ICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred HHHhcCCCChhhhhhHhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 11100000 0000000000000000 00113468899999999999999999999764
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=289.17 Aligned_cols=262 Identities=21% Similarity=0.293 Sum_probs=197.8
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCC---CccchHHHHHHHHHHhccC-CCCcceeeEEEEecCceeEEEeccCC
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNG---GWQRFKEFQTEAEAIGKIR-HPNIVSLRAYFWSVDEKLLIYDYIPN 447 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lV~e~~~~ 447 (686)
..||+|+||.||++... ++..||+|.+... .....+.+.+|++++++++ ||||+++++++...+..++||||+++
T Consensus 7 ~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 86 (280)
T cd05581 7 KIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLEYAPN 86 (280)
T ss_pred eeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEEcCCCC
Confidence 35899999999999875 6889999998653 2233466889999999998 99999999999999999999999999
Q ss_pred CCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccC
Q 042348 448 GSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEE 527 (686)
Q Consensus 448 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 527 (686)
++|.+++... ..+++..+..|+.|++.||+|||+ .+++|+||||+||+++.++.++++|||++........
T Consensus 87 ~~L~~~l~~~------~~l~~~~~~~i~~ql~~~l~~Lh~---~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~ 157 (280)
T cd05581 87 GELLQYIRKY------GSLDEKCTRFYAAEILLALEYLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSS 157 (280)
T ss_pred CcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEecCCccccccCCccc
Confidence 9999999765 358999999999999999999999 8999999999999999999999999999986543221
Q ss_pred CccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHH
Q 042348 528 TPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQ 607 (686)
Q Consensus 528 ~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~ 607 (686)
......... .................++..|+|||......++.++||||||++++++++|+.||..... ..
T Consensus 158 ~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-----~~ 229 (280)
T cd05581 158 PESNKGDAT---NIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE-----YL 229 (280)
T ss_pred cccCCCCCc---cccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccH-----HH
Confidence 100000000 0000000111222344567889999998888899999999999999999999999954331 11
Q ss_pred HHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCH----HHHHHH
Q 042348 608 WIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSM----RHVCDS 664 (686)
Q Consensus 608 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~----~ev~~~ 664 (686)
..+.........+.. ....+.+++.+||+.+|++||++ +|++++
T Consensus 230 ~~~~~~~~~~~~~~~-------------~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~ 277 (280)
T cd05581 230 TFQKILKLEYSFPPN-------------FPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH 277 (280)
T ss_pred HHHHHHhcCCCCCCc-------------cCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence 122222222111111 12357799999999999999999 777653
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=283.58 Aligned_cols=247 Identities=21% Similarity=0.393 Sum_probs=197.2
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCCc--cchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCC
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGGW--QRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGS 449 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gs 449 (686)
..||+|+||.||++... ++..+++|++..... ...+.+.+|++++++++|||++++++.+...+..++|+||+++++
T Consensus 6 ~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~~~~~ 85 (258)
T cd08215 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYADGGD 85 (258)
T ss_pred eeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEecCCCc
Confidence 46899999999999876 578999999876433 445678999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCc
Q 042348 450 LATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETP 529 (686)
Q Consensus 450 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 529 (686)
|.+++..... ....+++..+..++.+++.||+|||+ .+++|+||+|+||++++++.++|+|||.+........
T Consensus 86 L~~~l~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lh~---~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~-- 158 (258)
T cd08215 86 LSQKIKKQKK--EGKPFPEEQILDWFVQLCLALKYLHS---RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVD-- 158 (258)
T ss_pred HHHHHHHhhc--cCCCcCHHHHHHHHHHHHHHHHHHHh---CCEecccCChHHeEEcCCCcEEECCccceeecccCcc--
Confidence 9999986531 11468999999999999999999999 8999999999999999999999999999875532210
Q ss_pred cccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHHH
Q 042348 530 EVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQWI 609 (686)
Q Consensus 530 ~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~ 609 (686)
......++..|+|||...+..++.++||||+|+++|+|++|+.||.... ..+..
T Consensus 159 ---------------------~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~-----~~~~~ 212 (258)
T cd08215 159 ---------------------LAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN-----LLELA 212 (258)
T ss_pred ---------------------eecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCc-----HHHHH
Confidence 0112345667999999988889999999999999999999999984432 12222
Q ss_pred HHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 610 QLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 610 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
....... ... +.. .....+.+++.+||..+|++||++.|++++
T Consensus 213 ~~~~~~~--~~~-----~~~-----~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 213 LKILKGQ--YPP-----IPS-----QYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred HHHhcCC--CCC-----CCC-----CCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 2222211 111 110 122457889999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=290.49 Aligned_cols=259 Identities=22% Similarity=0.300 Sum_probs=189.0
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCC--ccchHHHHHHHHHHhccCCCCcceeeEEEEecC----------cee
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGG--WQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVD----------EKL 439 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~----------~~~ 439 (686)
..||+|+||.||+|... +++.||+|+++... ......+.+|++++++++||||+++++++.+.. ..+
T Consensus 13 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~ 92 (302)
T cd07864 13 GQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFY 92 (302)
T ss_pred eeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhccccCCcEE
Confidence 46999999999999976 47899999986532 222356788999999999999999999987654 789
Q ss_pred EEEeccCCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcc
Q 042348 440 LIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLA 519 (686)
Q Consensus 440 lV~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla 519 (686)
+|+||+++ ++.+.+.... ..+++..+..++.|++.||+|||+ .+|+||||||+||++++++.+||+|||++
T Consensus 93 lv~e~~~~-~l~~~l~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~kl~dfg~~ 163 (302)
T cd07864 93 LVFEYMDH-DLMGLLESGL-----VHFSEDHIKSFMKQLLEGLNYCHK---KNFLHRDIKCSNILLNNKGQIKLADFGLA 163 (302)
T ss_pred EEEcccCc-cHHHHHhcCC-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCcEEeCccccc
Confidence 99999976 7777776542 358999999999999999999999 89999999999999999999999999999
Q ss_pred cccccccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccC-CCCCCcchHHHHHHHHHHHHhCCCCcccc
Q 042348 520 RLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKV-RKPTQKWDIYSYGVILLEMISGKLPMIQI 598 (686)
Q Consensus 520 ~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvvl~elltG~~P~~~~ 598 (686)
......... ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||...
T Consensus 164 ~~~~~~~~~----------------------~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~ 221 (302)
T cd07864 164 RLYNSEESR----------------------PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQAN 221 (302)
T ss_pred ccccCCccc----------------------ccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence 765432110 0011234567999998764 45789999999999999999999999543
Q ss_pred CccchhHHHHHHHHHhhcCC--ccccc--------Cccccc--C--CCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 599 GSMELNIVQWIQLILEDRKP--MTDIL--------DPFLAH--D--LDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 599 ~~~~~~~~~~~~~~~~~~~~--~~~~~--------d~~l~~--~--~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
.. ......+........+ .+++. ++.... . .........+.+++.+||+.+|++||++.+++++
T Consensus 222 ~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 222 QE--LAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred Ch--HHHHHHHHHHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 21 1222222222211110 00000 000000 0 0000123468899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=297.25 Aligned_cols=255 Identities=24% Similarity=0.337 Sum_probs=187.3
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCC--ccchHHHHHHHHHHhccCCCCcceeeEEEEecC------ceeEEEe
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGG--WQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVD------EKLLIYD 443 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~------~~~lV~e 443 (686)
..||+|+||.||+|... +++.||||++.... ......+.+|+.++++++||||+++++++.... ..++|+|
T Consensus 21 ~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e 100 (342)
T cd07879 21 KQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMP 100 (342)
T ss_pred EEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCceEEEEec
Confidence 46999999999999864 68899999986532 222356889999999999999999999987543 4589999
Q ss_pred ccCCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccc
Q 042348 444 YIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLAD 523 (686)
Q Consensus 444 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~ 523 (686)
|+.. +|..++. ..+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++...
T Consensus 101 ~~~~-~l~~~~~--------~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~ 168 (342)
T cd07879 101 YMQT-DLQKIMG--------HPLSEDKVQYLVYQMLCGLKYIHS---AGIIHRDLKPGNLAVNEDCELKILDFGLARHAD 168 (342)
T ss_pred cccc-CHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCCCCcCCC
Confidence 9964 7777652 348899999999999999999999 899999999999999999999999999987432
Q ss_pred cccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccC-CCCCCcchHHHHHHHHHHHHhCCCCccccCccc
Q 042348 524 IAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKV-RKPTQKWDIYSYGVILLEMISGKLPMIQIGSME 602 (686)
Q Consensus 524 ~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~ 602 (686)
.. .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||......
T Consensus 169 ~~--------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~- 221 (342)
T cd07879 169 AE--------------------------MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL- 221 (342)
T ss_pred CC--------------------------CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHH-
Confidence 11 012345667999999866 46899999999999999999999999543211
Q ss_pred hhHHHHHHHHHhhcC-Ccccc------------cC--ccc-ccCCC--cHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 603 LNIVQWIQLILEDRK-PMTDI------------LD--PFL-AHDLD--KEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 603 ~~~~~~~~~~~~~~~-~~~~~------------~d--~~l-~~~~~--~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
. .+..+..... +.+.. .. +.. ..... .+.....+.+++.+||+.||++||++.|++.+
T Consensus 222 -~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h 297 (342)
T cd07879 222 -D---QLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEH 297 (342)
T ss_pred -H---HHHHHHHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 1 1111111000 00000 00 000 00000 00122357799999999999999999999976
Q ss_pred --Hhcccc
Q 042348 665 --LDRVNI 670 (686)
Q Consensus 665 --L~~i~~ 670 (686)
++.++.
T Consensus 298 ~~f~~~~~ 305 (342)
T cd07879 298 PYFDSFRD 305 (342)
T ss_pred cchhhccc
Confidence 666654
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=286.41 Aligned_cols=258 Identities=26% Similarity=0.343 Sum_probs=192.6
Q ss_pred cccCccCceEEEEEEeCC-CceEEEEEcCCCC--ccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCC
Q 042348 373 FLLGKSTIGIVYKVALNN-EEAVAVRRLGNGG--WQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGS 449 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gs 449 (686)
..||+|++|.||+|...+ ++.||+|.+.... ....+.+..|+.++++++|+||+++++++.+.+..++||||++ ++
T Consensus 5 ~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~-~~ 83 (282)
T cd07829 5 EKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD-MD 83 (282)
T ss_pred hcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcC-cC
Confidence 358999999999998764 8899999987653 2334678899999999999999999999999999999999997 59
Q ss_pred HHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCc
Q 042348 450 LATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETP 529 (686)
Q Consensus 450 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 529 (686)
|.+++.... ..+++..+..++.|++.||+|||+ ++|+||||+|+||++++++.+||+|||+++.......
T Consensus 84 l~~~i~~~~-----~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-- 153 (282)
T cd07829 84 LKKYLDKRP-----GPLSPNLIKSIMYQLLRGLAYCHS---HRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-- 153 (282)
T ss_pred HHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc--
Confidence 999998653 358999999999999999999999 8999999999999999999999999999875432110
Q ss_pred cccccccccCCCCCCCccccccccCCCCCccccCcccccCC-CCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHH
Q 042348 530 EVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVR-KPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQW 608 (686)
Q Consensus 530 ~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~ 608 (686)
......++..|+|||.+.+. .++.++|||||||++||+++|+.||...... .....
T Consensus 154 ---------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~--~~~~~ 210 (282)
T cd07829 154 ---------------------TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEI--DQLFK 210 (282)
T ss_pred ---------------------ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHH--HHHHH
Confidence 01122335669999998766 7899999999999999999999998543211 11111
Q ss_pred HHHHHhhcC--------Cc---ccccCcccccCC--CcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 609 IQLILEDRK--------PM---TDILDPFLAHDL--DKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 609 ~~~~~~~~~--------~~---~~~~d~~l~~~~--~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
+........ .. ...+........ ..+.....+.+++.+||+.+|++||++.+++.+
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 211 IFQILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred HHHHhCCCcHHHHHhhcccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence 111111000 00 000000000000 000113468899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=248.13 Aligned_cols=254 Identities=21% Similarity=0.286 Sum_probs=190.2
Q ss_pred ccCccCceEEEEEEeC-CCceEEEEEcCCCC--ccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCCH
Q 042348 374 LLGKSTIGIVYKVALN-NEEAVAVRRLGNGG--WQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSL 450 (686)
Q Consensus 374 ~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL 450 (686)
.||+|.||+||||+.. +++.||+|+++-.+ ..-.....+||-+++.++|+|||++++....++...+|+|||. .+|
T Consensus 9 kigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~cd-qdl 87 (292)
T KOG0662|consen 9 KIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCD-QDL 87 (292)
T ss_pred hhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHhh-HHH
Confidence 5999999999999855 57899999986542 2334678999999999999999999999999999999999995 489
Q ss_pred HHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCcc
Q 042348 451 ATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPE 530 (686)
Q Consensus 451 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 530 (686)
..+...-. ..++.+.+..++.|+++||.|+|+ +++.|||+||.|.||+.+|+.|++|||+|+.+..
T Consensus 88 kkyfdsln-----g~~d~~~~rsfmlqllrgl~fchs---hnvlhrdlkpqnllin~ngelkladfglarafgi------ 153 (292)
T KOG0662|consen 88 KKYFDSLN-----GDLDPEIVRSFMLQLLRGLGFCHS---HNVLHRDLKPQNLLINRNGELKLADFGLARAFGI------ 153 (292)
T ss_pred HHHHHhcC-----CcCCHHHHHHHHHHHHhhhhhhhh---hhhhhccCCcceEEeccCCcEEecccchhhhcCC------
Confidence 99887765 358889999999999999999999 8999999999999999999999999999985532
Q ss_pred ccccccccCCCCCCCccccccccCCCCCccccCcccccCCC-CCCcchHHHHHHHHHHHHh-CCCCccccCccchhHHHH
Q 042348 531 VHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRK-PTQKWDIYSYGVILLEMIS-GKLPMIQIGSMELNIVQW 608 (686)
Q Consensus 531 ~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~~~~~~~ 608 (686)
|. ...+..+-|.+|++|.++.+.+ |++..|+||-||++.|+.. |++-|.+. +- .+.
T Consensus 154 ----------pv-------rcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~-dv----ddq 211 (292)
T KOG0662|consen 154 ----------PV-------RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN-DV----DDQ 211 (292)
T ss_pred ----------ce-------EeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCC-cH----HHH
Confidence 11 1223445688999999998754 8999999999999999998 55445322 11 122
Q ss_pred HHHHHhhc--------CCcccccCcccccCCC----cHHHH----HHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 609 IQLILEDR--------KPMTDILDPFLAHDLD----KEDEI----VSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 609 ~~~~~~~~--------~~~~~~~d~~l~~~~~----~~~~~----~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
.+.+...- ..+....|...-..+. ..... ..-.+++.+.+.-+|.+|.++++.+++
T Consensus 212 lkrif~~lg~p~ed~wps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 212 LKRIFRLLGTPTEDQWPSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred HHHHHHHhCCCccccCCccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 22222211 1111222221111111 11111 123477888888999999999988765
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=295.08 Aligned_cols=250 Identities=20% Similarity=0.256 Sum_probs=185.5
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCC--ccchHHHHHHHHHHhccCCCCcceeeEEEEecC------ceeEEEe
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGG--WQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVD------EKLLIYD 443 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~------~~~lV~e 443 (686)
..||+|+||.||++... ++..||||++.... ......+.+|++++++++||||+++++++.... ..++|||
T Consensus 21 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e 100 (343)
T cd07880 21 KQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMP 100 (343)
T ss_pred EEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccceEEEEEe
Confidence 36999999999999854 68899999986432 222356889999999999999999999987654 3589999
Q ss_pred ccCCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccc
Q 042348 444 YIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLAD 523 (686)
Q Consensus 444 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~ 523 (686)
|+ +++|.+++.. ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.++|+|||++....
T Consensus 101 ~~-~~~l~~~~~~-------~~l~~~~~~~i~~qi~~al~~LH~---~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~ 169 (343)
T cd07880 101 FM-GTDLGKLMKH-------EKLSEDRIQFLVYQMLKGLKYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQTD 169 (343)
T ss_pred cC-CCCHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccccccc
Confidence 99 7799988864 358999999999999999999999 899999999999999999999999999987543
Q ss_pred cccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccC-CCCCCcchHHHHHHHHHHHHhCCCCccccCccc
Q 042348 524 IAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKV-RKPTQKWDIYSYGVILLEMISGKLPMIQIGSME 602 (686)
Q Consensus 524 ~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~ 602 (686)
... ....++..|+|||.+.+ ..++.++|||||||++|++++|+.||......
T Consensus 170 ~~~--------------------------~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~- 222 (343)
T cd07880 170 SEM--------------------------TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHL- 222 (343)
T ss_pred cCc--------------------------cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-
Confidence 111 12234667999998865 45889999999999999999999999543221
Q ss_pred hhHHHHHHHHHhhcCCcccccCcc---------------cc-cCC--CcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 603 LNIVQWIQLILEDRKPMTDILDPF---------------LA-HDL--DKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 603 ~~~~~~~~~~~~~~~~~~~~~d~~---------------l~-~~~--~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
.....+..........+... .. ... ........+.+++.+|++.||++|||+.+++++
T Consensus 223 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~ 298 (343)
T cd07880 223 ----DQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAH 298 (343)
T ss_pred ----HHHHHHHHhcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 11111111100000000000 00 000 001122357899999999999999999999854
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=313.78 Aligned_cols=246 Identities=21% Similarity=0.262 Sum_probs=198.0
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCCc---cchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCC
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGGW---QRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNG 448 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~g 448 (686)
.+||+|+||.|..++++ +++.+|+|++.+... .+..-|..|-.+|..-+.+.||.++-.|.+.++.|+|||||+||
T Consensus 81 KvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlVMdY~pGG 160 (1317)
T KOG0612|consen 81 KVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLVMDYMPGG 160 (1317)
T ss_pred HHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEEEecccCc
Confidence 47999999999999976 578899999977322 33356889999999999999999999999999999999999999
Q ss_pred CHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCC
Q 042348 449 SLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEET 528 (686)
Q Consensus 449 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 528 (686)
||-.++.... ++++..+.-++..|+.||.-||+ .|+|||||||+|||+|.+|++||+|||.+-.+..++.
T Consensus 161 DlltLlSk~~------~~pE~~ArFY~aEiVlAldslH~---mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG~- 230 (1317)
T KOG0612|consen 161 DLLTLLSKFD------RLPEDWARFYTAEIVLALDSLHS---MGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADGT- 230 (1317)
T ss_pred hHHHHHhhcC------CChHHHHHHHHHHHHHHHHHHHh---ccceeccCCcceeEecccCcEeeccchhHHhcCCCCc-
Confidence 9999997653 58899899999999999999999 8999999999999999999999999999876653332
Q ss_pred ccccccccccCCCCCCCccccccccCCCCCccccCcccccC-----CCCCCcchHHHHHHHHHHHHhCCCCccccCccch
Q 042348 529 PEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKV-----RKPTQKWDIYSYGVILLEMISGKLPMIQIGSMEL 603 (686)
Q Consensus 529 ~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~ 603 (686)
-.....+||+.|++||++.. +.|++.+|.||+||++|||+.|..||.. .
T Consensus 231 ---------------------V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYa-----d 284 (1317)
T KOG0612|consen 231 ---------------------VRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYA-----D 284 (1317)
T ss_pred ---------------------EEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchH-----H
Confidence 12345688999999998742 5689999999999999999999999943 3
Q ss_pred hHHHHHHHHHhhcCC--cccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCC---HHHHHHHHh
Q 042348 604 NIVQWIQLILEDRKP--MTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPS---MRHVCDSLD 666 (686)
Q Consensus 604 ~~~~~~~~~~~~~~~--~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs---~~ev~~~L~ 666 (686)
.+++-+..+...+.. +++.. +...+..+|+.+.+ -+|+.|-. +.++-.|--
T Consensus 285 slveTY~KIm~hk~~l~FP~~~-----------~VSeeakdLI~~ll-~~~e~RLgrngiedik~HpF 340 (1317)
T KOG0612|consen 285 SLVETYGKIMNHKESLSFPDET-----------DVSEEAKDLIEALL-CDREVRLGRNGIEDIKNHPF 340 (1317)
T ss_pred HHHHHHHHHhchhhhcCCCccc-----------ccCHHHHHHHHHHh-cChhhhcccccHHHHHhCcc
Confidence 455556666554221 11111 12334556666654 57888887 999888753
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-33 Score=289.72 Aligned_cols=267 Identities=21% Similarity=0.256 Sum_probs=188.7
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCCc--cchHHHHHHHHHHhccCCCCcceeeEEEEecC--------ceeEE
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGGW--QRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVD--------EKLLI 441 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~--------~~~lV 441 (686)
..||+|+||.||+|... +++.+|+|++..... .....+.+|++++++++||||+++++++.... ..++|
T Consensus 14 ~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~lv 93 (311)
T cd07866 14 GKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMV 93 (311)
T ss_pred EEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccccCceEEEE
Confidence 36999999999999865 578899998854322 12346788999999999999999999876543 35999
Q ss_pred EeccCCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccc
Q 042348 442 YDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARL 521 (686)
Q Consensus 442 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~ 521 (686)
|||+.+ +|...+.... ..+++..+..++.|+++||+|||+ ++|+||||||+||++++++.++|+|||+++.
T Consensus 94 ~~~~~~-~l~~~~~~~~-----~~~~~~~~~~i~~~l~~al~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 164 (311)
T cd07866 94 TPYMDH-DLSGLLENPS-----VKLTESQIKCYMLQLLEGINYLHE---NHILHRDIKAANILIDNQGILKIADFGLARP 164 (311)
T ss_pred EecCCc-CHHHHHhccc-----cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECcCccchh
Confidence 999964 7877776543 358999999999999999999999 8999999999999999999999999999986
Q ss_pred cccccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccC-CCCCCcchHHHHHHHHHHHHhCCCCccccCc
Q 042348 522 ADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKV-RKPTQKWDIYSYGVILLEMISGKLPMIQIGS 600 (686)
Q Consensus 522 ~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvvl~elltG~~P~~~~~~ 600 (686)
.......... + ............++..|+|||.+.+ ..++.++|||||||++|||++|+.||.....
T Consensus 165 ~~~~~~~~~~-------~-----~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~ 232 (311)
T cd07866 165 YDGPPPNPKG-------G-----GGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSD 232 (311)
T ss_pred ccCCCccccc-------C-----CcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCH
Confidence 5432211000 0 0000112234466788999998765 4578999999999999999999999954332
Q ss_pred cchhHHHHHHHHHhhcCC--------ccccc--------CcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 601 MELNIVQWIQLILEDRKP--------MTDIL--------DPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 601 ~~~~~~~~~~~~~~~~~~--------~~~~~--------d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
. ...+.+........+ ..... .+.+.... ......+.+++.+||+.||++|||+.|++.+
T Consensus 233 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~ 308 (311)
T cd07866 233 I--DQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERF--GKLGPEGLDLLSKLLSLDPYKRLTASDALEH 308 (311)
T ss_pred H--HHHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHc--ccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence 1 111111111110000 00000 00000000 0112457899999999999999999999764
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=283.25 Aligned_cols=246 Identities=27% Similarity=0.357 Sum_probs=187.4
Q ss_pred cccCccCceEEEEEEeCC-CceEEEEEcCC---C--CccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccC
Q 042348 373 FLLGKSTIGIVYKVALNN-EEAVAVRRLGN---G--GWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIP 446 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~~-~~~vavK~~~~---~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~ 446 (686)
..||+|+||.||++.... +..+++|.++. . ......++..|+.++++++||||+++++++.+.+..++||||++
T Consensus 6 ~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (260)
T cd08222 6 QRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIITEYCE 85 (260)
T ss_pred eeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEEEeCC
Confidence 469999999999998654 33455555432 1 12233467789999999999999999999999999999999999
Q ss_pred CCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCccccccccc
Q 042348 447 NGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAE 526 (686)
Q Consensus 447 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~ 526 (686)
+++|.+++...... ...+++.+++.++.|++.||+|||+ .+++|+||||+||++++ +.++|+|||+++......
T Consensus 86 ~~~l~~~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~ 159 (260)
T cd08222 86 GRDLDCKLEELKHT--GKTLSENQVCEWFIQLLLGVHYMHQ---RRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSC 159 (260)
T ss_pred CCCHHHHHHHHhhc--ccccCHHHHHHHHHHHHHHHHHHHH---cCccccCCChhheEeec-CCEeecccCceeecCCCc
Confidence 99999998753211 1468999999999999999999999 89999999999999975 569999999987653211
Q ss_pred CCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHH
Q 042348 527 ETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIV 606 (686)
Q Consensus 527 ~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~ 606 (686)
. ......++..|+|||...+..++.++||||||+++|+|++|..||.... ..
T Consensus 160 ~-----------------------~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~-----~~ 211 (260)
T cd08222 160 D-----------------------LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN-----FL 211 (260)
T ss_pred c-----------------------cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc-----HH
Confidence 1 0112345667999999988888999999999999999999999984321 22
Q ss_pred HHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 607 QWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 607 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
...........+ . . ......++.+++.+||+.+|++||++.|++++
T Consensus 212 ~~~~~~~~~~~~--~-----~-----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 212 SVVLRIVEGPTP--S-----L-----PETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred HHHHHHHcCCCC--C-----C-----cchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 222222222111 1 0 11233467889999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=313.68 Aligned_cols=141 Identities=23% Similarity=0.396 Sum_probs=126.1
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCCc---cchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCC
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGGW---QRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNG 448 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~g 448 (686)
..||+|+||.||+|... +++.||||++..... .....+..|+.+++.++||||+++++++...+..++||||++++
T Consensus 10 ~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmEy~~g~ 89 (669)
T cd05610 10 KPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVMEYLIGG 89 (669)
T ss_pred EEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEeCCCCC
Confidence 36999999999999876 588999999865422 22467889999999999999999999999999999999999999
Q ss_pred CHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCccccc
Q 042348 449 SLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLA 522 (686)
Q Consensus 449 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~ 522 (686)
+|.+++... ..+++..++.|+.||+.||+|||+ ++||||||||+|||++.++.+||+|||+++..
T Consensus 90 ~L~~li~~~------~~l~~~~~~~i~~qil~aL~yLH~---~gIiHrDLKP~NILl~~~g~vkL~DFGls~~~ 154 (669)
T cd05610 90 DVKSLLHIY------GYFDEEMAVKYISEVALALDYLHR---HGIIHRDLKPDNMLISNEGHIKLTDFGLSKVT 154 (669)
T ss_pred CHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCccHHHEEEcCCCCEEEEeCCCCccc
Confidence 999999754 357889999999999999999999 89999999999999999999999999999743
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-33 Score=291.91 Aligned_cols=259 Identities=23% Similarity=0.283 Sum_probs=186.5
Q ss_pred cccCccCceEEEEEEeC-C--CceEEEEEcCCC--CccchHHHHHHHHHHhcc-CCCCcceeeEEEEec----CceeEEE
Q 042348 373 FLLGKSTIGIVYKVALN-N--EEAVAVRRLGNG--GWQRFKEFQTEAEAIGKI-RHPNIVSLRAYFWSV----DEKLLIY 442 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~--~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~----~~~~lV~ 442 (686)
..||+|+||.||++... . +..||+|++... .....+.+.+|+++++++ +||||+++++++... ...++++
T Consensus 6 ~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~ 85 (332)
T cd07857 6 KELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNELYLYE 85 (332)
T ss_pred EEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcEEEEE
Confidence 46999999999999865 3 678999998643 222245688899999999 599999999976433 4568899
Q ss_pred eccCCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCccccc
Q 042348 443 DYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLA 522 (686)
Q Consensus 443 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~ 522 (686)
||+. ++|.+++... ..+++..++.++.|++.||+|||+ .+|+||||||+||++++++.+||+|||+++..
T Consensus 86 e~~~-~~L~~~l~~~------~~~~~~~~~~~~~qi~~aL~~LH~---~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~ 155 (332)
T cd07857 86 ELME-ADLHQIIRSG------QPLTDAHFQSFIYQILCGLKYIHS---ANVLHRDLKPGNLLVNADCELKICDFGLARGF 155 (332)
T ss_pred eccc-CCHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHeEEcCCCCEEeCcCCCceec
Confidence 9985 6999998654 458999999999999999999999 89999999999999999999999999999865
Q ss_pred ccccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccC-CCCCCcchHHHHHHHHHHHHhCCCCccccCcc
Q 042348 523 DIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKV-RKPTQKWDIYSYGVILLEMISGKLPMIQIGSM 601 (686)
Q Consensus 523 ~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~ 601 (686)
....... ........||..|+|||++.+ ..++.++|||||||++|+|++|+.||......
T Consensus 156 ~~~~~~~-------------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~ 216 (332)
T cd07857 156 SENPGEN-------------------AGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYV 216 (332)
T ss_pred ccccccc-------------------cccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHH
Confidence 4221100 001123457788999998765 46899999999999999999999998543211
Q ss_pred chhHHHHHHHHHhhcC-----------------CcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 602 ELNIVQWIQLILEDRK-----------------PMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 602 ~~~~~~~~~~~~~~~~-----------------~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
.....+........ .....-...+... .......+.+++.+|++.||++|||+.|++.+
T Consensus 217 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~ 292 (332)
T cd07857 217 --DQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESI--FPNANPLALDLLEKLLAFDPTKRISVEEALEH 292 (332)
T ss_pred --HHHHHHHHHhCCCCHHHHHhhhhhhHHHHHHhccccCCcchHhh--CCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 11111111100000 0000000000000 00113467899999999999999999999765
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-33 Score=293.45 Aligned_cols=255 Identities=23% Similarity=0.356 Sum_probs=185.8
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCCccchHHHHHHHHHHhccCCCCcceeeEEEEec--------------Cc
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSV--------------DE 437 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--------------~~ 437 (686)
..||.|+||.||+|... ++..||+|.+........+.+.+|++++++++||||+++++++... ..
T Consensus 11 ~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 90 (342)
T cd07854 11 RPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNS 90 (342)
T ss_pred EEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccccccccce
Confidence 46999999999999865 5789999998766555567789999999999999999999876654 34
Q ss_pred eeEEEeccCCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeec-CCCCeEEeec
Q 042348 438 KLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLG-KNMEPHISDF 516 (686)
Q Consensus 438 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~-~~~~~kl~Df 516 (686)
.++||||++ ++|.+++.. ..+++..++.++.|++.||+|||+ .+|+||||||+||+++ +++.+|++||
T Consensus 91 ~~lv~e~~~-~~L~~~~~~-------~~l~~~~~~~~~~qi~~aL~~LH~---~givH~dikp~Nili~~~~~~~kl~df 159 (342)
T cd07854 91 VYIVQEYME-TDLANVLEQ-------GPLSEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANVFINTEDLVLKIGDF 159 (342)
T ss_pred EEEEeeccc-ccHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEcCCCceEEECCc
Confidence 689999997 599888853 248899999999999999999999 8999999999999997 4567899999
Q ss_pred CcccccccccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccC-CCCCCcchHHHHHHHHHHHHhCCCCc
Q 042348 517 GLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKV-RKPTQKWDIYSYGVILLEMISGKLPM 595 (686)
Q Consensus 517 Gla~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvvl~elltG~~P~ 595 (686)
|+++......... .......++..|+|||.+.. ..++.++|||||||++|||++|+.||
T Consensus 160 g~~~~~~~~~~~~--------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf 219 (342)
T cd07854 160 GLARIVDPHYSHK--------------------GYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLF 219 (342)
T ss_pred ccceecCCccccc--------------------cccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCC
Confidence 9987543211000 01112345777999997654 56889999999999999999999999
Q ss_pred cccCccchhHHHHHHHHHhhcCCccc---------ccCcccc-----cCCCc----HHHHHHHHHHHHhccccCCCCCCC
Q 042348 596 IQIGSMELNIVQWIQLILEDRKPMTD---------ILDPFLA-----HDLDK----EDEIVSVLKIALDCVHKSPDKRPS 657 (686)
Q Consensus 596 ~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~d~~l~-----~~~~~----~~~~~~l~~l~~~cl~~dP~~RPs 657 (686)
......+. ........ +... ....... ..... .....++.+++.+||+.||++|||
T Consensus 220 ~~~~~~~~-----~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t 293 (342)
T cd07854 220 AGAHELEQ-----MQLILESV-PVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLT 293 (342)
T ss_pred CCCCHHHH-----HHHHHHhc-CCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccC
Confidence 54332111 11111100 0000 0000000 00000 012245778999999999999999
Q ss_pred HHHHHHH
Q 042348 658 MRHVCDS 664 (686)
Q Consensus 658 ~~ev~~~ 664 (686)
+.|++.+
T Consensus 294 ~~ell~h 300 (342)
T cd07854 294 AEEALMH 300 (342)
T ss_pred HHHHhCC
Confidence 9999865
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=289.22 Aligned_cols=259 Identities=24% Similarity=0.347 Sum_probs=188.9
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCC--CccchHHHHHHHHHHhccCCCCcceeeEEEEe-cCceeEEEeccCCC
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNG--GWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWS-VDEKLLIYDYIPNG 448 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~-~~~~~lV~e~~~~g 448 (686)
..||+|+||.||++... ++..||||++... .....+.+.+|++++++++||||+++++++.. .+..++||||+ ++
T Consensus 16 ~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~e~~-~~ 94 (328)
T cd07856 16 QPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTELL-GT 94 (328)
T ss_pred EeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEeehh-cc
Confidence 46999999999999865 6889999987542 22234678899999999999999999999876 45789999999 56
Q ss_pred CHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCC
Q 042348 449 SLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEET 528 (686)
Q Consensus 449 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 528 (686)
+|.++++.. .+++..+..++.|++.||+|||+ .+|+||||||+||++++++.++|+|||.++.....
T Consensus 95 ~L~~~~~~~-------~~~~~~~~~~~~ql~~aL~~LH~---~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~--- 161 (328)
T cd07856 95 DLHRLLTSR-------PLEKQFIQYFLYQILRGLKYVHS---AGVVHRDLKPSNILINENCDLKICDFGLARIQDPQ--- 161 (328)
T ss_pred CHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEeECCCCCEEeCccccccccCCC---
Confidence 999888642 47888889999999999999999 89999999999999999999999999998743211
Q ss_pred ccccccccccCCCCCCCccccccccCCCCCccccCcccccC-CCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHH
Q 042348 529 PEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKV-RKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQ 607 (686)
Q Consensus 529 ~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~ 607 (686)
.....++..|+|||.+.+ ..++.++|||||||++|||+||+.||...... ....
T Consensus 162 -----------------------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~--~~~~ 216 (328)
T cd07856 162 -----------------------MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHV--NQFS 216 (328)
T ss_pred -----------------------cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHH
Confidence 012244667999998765 56899999999999999999999999543221 1111
Q ss_pred HHHHHHhhc----------CCcccccCcc-cccCCCc----HHHHHHHHHHHHhccccCCCCCCCHHHHHHH--Hhcccc
Q 042348 608 WIQLILEDR----------KPMTDILDPF-LAHDLDK----EDEIVSVLKIALDCVHKSPDKRPSMRHVCDS--LDRVNI 670 (686)
Q Consensus 608 ~~~~~~~~~----------~~~~~~~d~~-l~~~~~~----~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~--L~~i~~ 670 (686)
.+....... ....+.+... ....... +.....+.+++.+||+.+|++||++.+++.+ ++..+.
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~ 296 (328)
T cd07856 217 IITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHD 296 (328)
T ss_pred HHHHHhCCCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccC
Confidence 111110000 0000000000 0000000 0123468899999999999999999999877 544443
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-33 Score=292.10 Aligned_cols=251 Identities=21% Similarity=0.318 Sum_probs=184.4
Q ss_pred cccCccCceEEEEEEe-CCCceEEEEEcCCCC--ccchHHHHHHHHHHhccCCCCcceeeEEEEec------CceeEEEe
Q 042348 373 FLLGKSTIGIVYKVAL-NNEEAVAVRRLGNGG--WQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSV------DEKLLIYD 443 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~------~~~~lV~e 443 (686)
..||+|+||.||+|.. .+++.||+|++.... ....+.+.+|+.++++++||||+++++++... ...+++++
T Consensus 23 ~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~~ 102 (345)
T cd07877 23 SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTH 102 (345)
T ss_pred EEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccccEEEEeh
Confidence 3599999999999985 468899999987532 22345688899999999999999999988643 34678888
Q ss_pred ccCCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccc
Q 042348 444 YIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLAD 523 (686)
Q Consensus 444 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~ 523 (686)
++ +++|.+++.. ..+++..+..++.|++.||+|||+ .+|+||||||+||++++++.+||+|||+++...
T Consensus 103 ~~-~~~L~~~~~~-------~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~ 171 (345)
T cd07877 103 LM-GADLNNIVKC-------QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD 171 (345)
T ss_pred hc-ccCHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEcCCCCEEEeccccccccc
Confidence 87 7899988864 248999999999999999999999 899999999999999999999999999987432
Q ss_pred cccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccC-CCCCCcchHHHHHHHHHHHHhCCCCccccCccc
Q 042348 524 IAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKV-RKPTQKWDIYSYGVILLEMISGKLPMIQIGSME 602 (686)
Q Consensus 524 ~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~ 602 (686)
.. .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||.......
T Consensus 172 ~~--------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~ 225 (345)
T cd07877 172 DE--------------------------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID 225 (345)
T ss_pred cc--------------------------ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 11 112345677999998765 568899999999999999999999995432211
Q ss_pred hhHHHHHHHHHhhcCCcccccC---------------cccccCCC--cHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 603 LNIVQWIQLILEDRKPMTDILD---------------PFLAHDLD--KEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 603 ~~~~~~~~~~~~~~~~~~~~~d---------------~~l~~~~~--~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
.+ ..+..... .+...... ........ .......+.+++.+|++.||++||++.+++++
T Consensus 226 -~~-~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 226 -QL-KLILRLVG--TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred -HH-HHHHHHhC--CCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 11 11111000 00000000 00000000 00112357799999999999999999999877
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-33 Score=277.71 Aligned_cols=220 Identities=21% Similarity=0.237 Sum_probs=173.4
Q ss_pred cCceEEEEEEeC-CCceEEEEEcCCCCccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCCHHHHhhc
Q 042348 378 STIGIVYKVALN-NEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLATAIHG 456 (686)
Q Consensus 378 G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~ 456 (686)
|.+|.||++... +++.+|+|++.... .+.+|...+....||||+++++++...+..++||||+++|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 889999999875 57899999986642 234556666666799999999999999999999999999999999875
Q ss_pred CCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCcccccccc
Q 042348 457 KAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQS 536 (686)
Q Consensus 457 ~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~ 536 (686)
. ..+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.++++|||.+.......
T Consensus 79 ~------~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~---------- 139 (237)
T cd05576 79 F------LNIPEECVKRWAAEMVVALDALHR---EGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC---------- 139 (237)
T ss_pred h------cCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCCCCEEEecccchhcccccc----------
Confidence 4 348999999999999999999999 899999999999999999999999999876443211
Q ss_pred ccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHHHHHHHhhc
Q 042348 537 TTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQWIQLILEDR 616 (686)
Q Consensus 537 ~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~ 616 (686)
....++..|+|||...+..++.++||||+|+++|||++|+.|+....... ...
T Consensus 140 ----------------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~-----------~~~ 192 (237)
T cd05576 140 ----------------DGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI-----------NTH 192 (237)
T ss_pred ----------------ccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc-----------ccc
Confidence 11223456999999988889999999999999999999998873211100 000
Q ss_pred CCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHH
Q 042348 617 KPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMR 659 (686)
Q Consensus 617 ~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ 659 (686)
.. . .+. ......+.+++.+|++.||++||++.
T Consensus 193 ~~---~---~~~-----~~~~~~~~~li~~~l~~dp~~R~~~~ 224 (237)
T cd05576 193 TT---L---NIP-----EWVSEEARSLLQQLLQFNPTERLGAG 224 (237)
T ss_pred cc---c---CCc-----ccCCHHHHHHHHHHccCCHHHhcCCC
Confidence 00 0 000 01123577899999999999999973
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=268.17 Aligned_cols=262 Identities=19% Similarity=0.300 Sum_probs=194.4
Q ss_pred ccCccCceEEEEEEeC-CCceEEEEEcCCC--CccchHHHHHHHHHHhccCCCCcceeeEEEEec--------CceeEEE
Q 042348 374 LLGKSTIGIVYKVALN-NEEAVAVRRLGNG--GWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSV--------DEKLLIY 442 (686)
Q Consensus 374 ~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--------~~~~lV~ 442 (686)
.||+|.||+||+|+.. +++.||+|++-.. ...-.....+|+++|..++|+|++.++..|... ...++||
T Consensus 24 kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~ylVf 103 (376)
T KOG0669|consen 24 KIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRATFYLVF 103 (376)
T ss_pred hcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccceeeeeH
Confidence 5999999999999865 4777888865321 112234578999999999999999999988643 2369999
Q ss_pred eccCCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCccccc
Q 042348 443 DYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLA 522 (686)
Q Consensus 443 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~ 522 (686)
++|+. +|..++.... ..++..++.+++.++..||.|+|. ..|+|||+||+|+||+.++.+||+|||+|+.+
T Consensus 104 ~~ceh-DLaGlLsn~~-----vr~sls~Ikk~Mk~Lm~GL~~iHr---~kilHRDmKaaNvLIt~dgilklADFGlar~f 174 (376)
T KOG0669|consen 104 DFCEH-DLAGLLSNRK-----VRFSLSEIKKVMKGLMNGLYYIHR---NKILHRDMKAANVLITKDGILKLADFGLARAF 174 (376)
T ss_pred HHhhh-hHHHHhcCcc-----ccccHHHHHHHHHHHHHHHHHHHH---hhHHhhcccHhhEEEcCCceEEeeccccccce
Confidence 99976 9999997654 468999999999999999999999 89999999999999999999999999999876
Q ss_pred ccccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccC-CCCCCcchHHHHHHHHHHHHhCCCCccccCcc
Q 042348 523 DIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKV-RKPTQKWDIYSYGVILLEMISGKLPMIQIGSM 601 (686)
Q Consensus 523 ~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~ 601 (686)
...+.... ...+..+-|.+|++||.+.+ ..|+++.|||+-||||.||.||.+-+.+. .
T Consensus 175 s~~~n~~k-------------------prytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgn--t 233 (376)
T KOG0669|consen 175 STSKNVVK-------------------PRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGN--T 233 (376)
T ss_pred ecccccCC-------------------CCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCC--h
Confidence 54332110 12345667899999998876 56999999999999999999999877432 3
Q ss_pred chhHHHHHHHHHhhc--CCcccccC----------cccccCCC-cHHHHH------HHHHHHHhccccCCCCCCCHHHHH
Q 042348 602 ELNIVQWIQLILEDR--KPMTDILD----------PFLAHDLD-KEDEIV------SVLKIALDCVHKSPDKRPSMRHVC 662 (686)
Q Consensus 602 ~~~~~~~~~~~~~~~--~~~~~~~d----------~~l~~~~~-~~~~~~------~l~~l~~~cl~~dP~~RPs~~ev~ 662 (686)
+......+....... ..++++.. |-..+... .++.+. ...+++..++..||.+|+++.+++
T Consensus 234 eqqql~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~al 313 (376)
T KOG0669|consen 234 EQQQLHLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQAL 313 (376)
T ss_pred HHHHHHHHHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhh
Confidence 333344444443321 11111111 10000000 011111 467899999999999999999998
Q ss_pred HHH
Q 042348 663 DSL 665 (686)
Q Consensus 663 ~~L 665 (686)
.+-
T Consensus 314 nh~ 316 (376)
T KOG0669|consen 314 NHD 316 (376)
T ss_pred chh
Confidence 774
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=287.71 Aligned_cols=255 Identities=21% Similarity=0.292 Sum_probs=196.9
Q ss_pred cCHHHHHHHh-hcccCccCceEEEEEEeC-CCceEEEEEcCCCC--ccchHHHHHHHHHHhccCCCCcceeeEEEEecCc
Q 042348 362 FDLEQLLKAS-AFLLGKSTIGIVYKVALN-NEEAVAVRRLGNGG--WQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDE 437 (686)
Q Consensus 362 ~~~~~l~~~~-~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~ 437 (686)
.++.++.+.. .++||+|.||+||-|..+ +|+.||||.+.+.. .....++.+|+.||++++||.||.+...|+..+.
T Consensus 558 vd~stvYQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~er 637 (888)
T KOG4236|consen 558 VDISTVYQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPER 637 (888)
T ss_pred hhHHHHHHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCce
Confidence 3444444432 578999999999999865 69999999987642 2233678999999999999999999999999999
Q ss_pred eeEEEeccCCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCC---CCeEEe
Q 042348 438 KLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKN---MEPHIS 514 (686)
Q Consensus 438 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~---~~~kl~ 514 (686)
.|+|||-+.|.-|+-+|.... ..|++..-+-++.||+.||.|||. ++|+|+||||+|||+.+. -++||+
T Consensus 638 vFVVMEKl~GDMLEMILSsEk-----gRL~er~TkFlvtQIL~ALr~LH~---knIvHCDLKPENVLLas~~~FPQvKlC 709 (888)
T KOG4236|consen 638 VFVVMEKLHGDMLEMILSSEK-----GRLPERITKFLVTQILVALRYLHF---KNIVHCDLKPENVLLASASPFPQVKLC 709 (888)
T ss_pred EEEEehhhcchHHHHHHHhhc-----ccchHHHHHHHHHHHHHHHHHhhh---cceeeccCCchheeeccCCCCCceeec
Confidence 999999995433444444433 468888888999999999999999 999999999999999643 379999
Q ss_pred ecCcccccccccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCC
Q 042348 515 DFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLP 594 (686)
Q Consensus 515 DfGla~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P 594 (686)
|||.|+++.... ...+.+||+.|.|||++....|+..-|+||.|||+|--++|..|
T Consensus 710 DFGfARiIgEks------------------------FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFP 765 (888)
T KOG4236|consen 710 DFGFARIIGEKS------------------------FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFP 765 (888)
T ss_pred cccceeecchhh------------------------hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEeccccc
Confidence 999999876432 23456788889999999999999999999999999999999999
Q ss_pred ccccCccchhHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 595 MIQIGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 595 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
|- ++.++-+.++....-- . .....+.....++++...|+..-.+|-|..+-+.+
T Consensus 766 FN----EdEdIndQIQNAaFMy-------P-----p~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh 819 (888)
T KOG4236|consen 766 FN----EDEDINDQIQNAAFMY-------P-----PNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSH 819 (888)
T ss_pred CC----CccchhHHhhcccccc-------C-----CCchhhcCHHHHHHHHHHHHHHHHHhcchHhhccc
Confidence 93 2334444333321110 0 01122333457788888888888899888765544
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-33 Score=293.56 Aligned_cols=248 Identities=21% Similarity=0.309 Sum_probs=187.3
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCC--CccchHHHHHHHHHHhccCCCCcceeeEEEEecCc------eeEEEe
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNG--GWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDE------KLLIYD 443 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~------~~lV~e 443 (686)
..||+|++|.||+|... ++..||||++... .....+.+.+|+.++++++||||+++++++...+. .++|+|
T Consensus 21 ~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e 100 (343)
T cd07851 21 SPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTH 100 (343)
T ss_pred EEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccEEEEEe
Confidence 46999999999999876 5788999998653 22234567789999999999999999998876654 899999
Q ss_pred ccCCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccc
Q 042348 444 YIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLAD 523 (686)
Q Consensus 444 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~ 523 (686)
|+ +++|.+++.. ..+++..+..++.|++.||+|||+ .+|+||||||+||++++++.++|+|||++....
T Consensus 101 ~~-~~~L~~~~~~-------~~l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~ 169 (343)
T cd07851 101 LM-GADLNNIVKC-------QKLSDDHIQFLVYQILRGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLARHTD 169 (343)
T ss_pred cC-CCCHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEcccccccccc
Confidence 99 6799998864 358999999999999999999999 899999999999999999999999999987543
Q ss_pred cccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccC-CCCCCcchHHHHHHHHHHHHhCCCCccccCccc
Q 042348 524 IAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKV-RKPTQKWDIYSYGVILLEMISGKLPMIQIGSME 602 (686)
Q Consensus 524 ~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~ 602 (686)
.. .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||......
T Consensus 170 ~~--------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~- 222 (343)
T cd07851 170 DE--------------------------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHI- 222 (343)
T ss_pred cc--------------------------ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH-
Confidence 11 112345667999998755 46789999999999999999999999543221
Q ss_pred hhHHHHHHHHHhhcCCcc-cccC-------------------cccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHH
Q 042348 603 LNIVQWIQLILEDRKPMT-DILD-------------------PFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVC 662 (686)
Q Consensus 603 ~~~~~~~~~~~~~~~~~~-~~~d-------------------~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~ 662 (686)
..+..+........ ...+ +...... ......+.+++.+||+.+|++|||+.||+
T Consensus 223 ----~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~s~~l~dli~~~l~~~P~~Rpt~~ell 296 (343)
T cd07851 223 ----DQLKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVF--SGANPLAIDLLEKMLVLDPDKRITAAEAL 296 (343)
T ss_pred ----HHHHHHHHhcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHh--ccCCHHHHHHHHHhCCCChhhCCCHHHHh
Confidence 11111111110000 0000 0000000 01234688999999999999999999998
Q ss_pred HH
Q 042348 663 DS 664 (686)
Q Consensus 663 ~~ 664 (686)
++
T Consensus 297 ~h 298 (343)
T cd07851 297 AH 298 (343)
T ss_pred cC
Confidence 75
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=268.79 Aligned_cols=257 Identities=19% Similarity=0.280 Sum_probs=203.6
Q ss_pred cccCccCceEEEEEEeC------CCceEEEEEcCCC-CccchHHHHHHHHHHhccCCCCcceeeEEEEec-CceeEEEec
Q 042348 373 FLLGKSTIGIVYKVALN------NEEAVAVRRLGNG-GWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSV-DEKLLIYDY 444 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~-~~~~lV~e~ 444 (686)
.++-+|.||.||+|.+. +.+.|.||.++.. +.-....+..|.-.+..+.|||+..+.+++... +..+++|.+
T Consensus 290 ~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~V~y~~ 369 (563)
T KOG1024|consen 290 CLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPFVLYPA 369 (563)
T ss_pred hhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcceEEEec
Confidence 46789999999999554 4566788888654 334456789999999999999999999998765 567999999
Q ss_pred cCCCCHHHHhhcCCCc--cccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCccccc
Q 042348 445 IPNGSLATAIHGKAGI--ISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLA 522 (686)
Q Consensus 445 ~~~gsL~~~l~~~~~~--~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~ 522 (686)
+.-|+|..++...++. ...+.++-.+...++.|++.|++|||. ++|||.||.++|.+||+..++||+|=.+++.+
T Consensus 370 ~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~---~~ViHkDiAaRNCvIdd~LqVkltDsaLSRDL 446 (563)
T KOG1024|consen 370 TGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHN---HGVIHKDIAARNCVIDDQLQVKLTDSALSRDL 446 (563)
T ss_pred cCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHh---cCcccchhhhhcceehhheeEEeccchhcccc
Confidence 9999999999833221 122567788889999999999999999 99999999999999999999999999999977
Q ss_pred ccccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCccccCcc
Q 042348 523 DIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQIGSM 601 (686)
Q Consensus 523 ~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~ 601 (686)
-+.+..- .|. .......||+||.+....|+.++|||||||+||||+| |+.||...++.
T Consensus 447 FP~DYhc--------LGD-------------nEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPf 505 (563)
T KOG1024|consen 447 FPGDYHC--------LGD-------------NENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPF 505 (563)
T ss_pred Ccccccc--------cCC-------------CCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHH
Confidence 6544321 111 1122346999999999999999999999999999999 99999655443
Q ss_pred chhHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccc
Q 042348 602 ELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRVNI 670 (686)
Q Consensus 602 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~ 670 (686)
+ +...+.++..+.. +-.++.++..+|.-||+.+|++||+++|++.-|.+...
T Consensus 506 E------m~~ylkdGyRlaQ-----------P~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~ 557 (563)
T KOG1024|consen 506 E------MEHYLKDGYRLAQ-----------PFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHT 557 (563)
T ss_pred H------HHHHHhccceecC-----------CCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHH
Confidence 3 2344444443322 12355678899999999999999999999999987653
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=278.16 Aligned_cols=257 Identities=25% Similarity=0.342 Sum_probs=192.1
Q ss_pred cccCccCceEEEEEEe-CCCceEEEEEcCCC-Ccc------chHHHHHHHHHHhccCCCCcceeeEEEEec-CceeEEEe
Q 042348 373 FLLGKSTIGIVYKVAL-NNEEAVAVRRLGNG-GWQ------RFKEFQTEAEAIGKIRHPNIVSLRAYFWSV-DEKLLIYD 443 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~------~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~-~~~~lV~e 443 (686)
++||+|+|++|||+.. ...+-||||+-... ++. ..+...+|.+|-+.++||.||++|+||.-+ +..+-|+|
T Consensus 469 hLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsFCTVLE 548 (775)
T KOG1151|consen 469 HLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSFCTVLE 548 (775)
T ss_pred HHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccceeeee
Confidence 4799999999999974 45678899875321 221 134567899999999999999999999754 56789999
Q ss_pred ccCCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeec---CCCCeEEeecCccc
Q 042348 444 YIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLG---KNMEPHISDFGLAR 520 (686)
Q Consensus 444 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~---~~~~~kl~DfGla~ 520 (686)
||+|-+|+-+|+.. +.+++.++..|+.||+.||.||.+.. .+|||-||||.|||+. ..|.+||.|||+++
T Consensus 549 YceGNDLDFYLKQh------klmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeIKITDFGLSK 621 (775)
T KOG1151|consen 549 YCEGNDLDFYLKQH------KLMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEIKITDFGLSK 621 (775)
T ss_pred ecCCCchhHHHHhh------hhhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccceeEeeecchhh
Confidence 99999999999876 46899999999999999999999866 4899999999999995 45789999999999
Q ss_pred ccccccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCC----CCCCcchHHHHHHHHHHHHhCCCCcc
Q 042348 521 LADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVR----KPTQKWDIYSYGVILLEMISGKLPMI 596 (686)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDVwSlGvvl~elltG~~P~~ 596 (686)
+++......... +..+....||++|.+||.+.-+ +.+.|+||||.|||+|..+.|+.||.
T Consensus 622 IMdddSy~~vdG----------------meLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFG 685 (775)
T KOG1151|consen 622 IMDDDSYNSVDG----------------MELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFG 685 (775)
T ss_pred hccCCccCcccc----------------eeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCC
Confidence 997654322111 1234456889999999987533 47889999999999999999999994
Q ss_pred ccCccchhHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 597 QIGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 597 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
..... .++.+. ..++.. .++ .-+..+....+...++.+||++.-++|....++..+
T Consensus 686 hnqsQ-QdILqe-NTIlkA----tEV------qFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~d 741 (775)
T KOG1151|consen 686 HNQSQ-QDILQE-NTILKA----TEV------QFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACD 741 (775)
T ss_pred CchhH-HHHHhh-hchhcc----eec------cCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccC
Confidence 43221 111111 011111 010 000111223356688999999999999998887654
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=293.39 Aligned_cols=246 Identities=23% Similarity=0.370 Sum_probs=198.9
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCCccchHHHHHHHHHHhcc-CCCCcceeeEEEEe-----cCceeEEEecc
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGGWQRFKEFQTEAEAIGKI-RHPNIVSLRAYFWS-----VDEKLLIYDYI 445 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~-----~~~~~lV~e~~ 445 (686)
++||.|.+|.||+++.. +++.+|+|+....... .++.+.|.++++.. +|||++.++|+|.. ++..++|||||
T Consensus 25 evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~-deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLVMEfC 103 (953)
T KOG0587|consen 25 EVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDE-EEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLVMEFC 103 (953)
T ss_pred EEEeeccceeEEEEeeeecCceeeeEeecCCccc-cHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEEEeecc
Confidence 47999999999999854 5778888887654333 36788899999988 79999999999974 46789999999
Q ss_pred CCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccc
Q 042348 446 PNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIA 525 (686)
Q Consensus 446 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~ 525 (686)
.+||..|+++...+ ..+.|..+..|++.++.||.+||. +.++|||||=.|||++.++.+|+.|||++..++..
T Consensus 104 ~gGSVTDLVKn~~g----~rl~E~~IaYI~re~lrgl~HLH~---nkviHRDikG~NiLLT~e~~VKLvDFGvSaQldsT 176 (953)
T KOG0587|consen 104 GGGSVTDLVKNTKG----NRLKEEWIAYILREILRGLAHLHN---NKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDST 176 (953)
T ss_pred CCccHHHHHhhhcc----cchhhHHHHHHHHHHHHHHHHHhh---cceeeecccCceEEEeccCcEEEeeeeeeeeeecc
Confidence 99999999987654 579999999999999999999999 89999999999999999999999999999876532
Q ss_pred cCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCC-----CCCCcchHHHHHHHHHHHHhCCCCccccCc
Q 042348 526 EETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVR-----KPTQKWDIYSYGVILLEMISGKLPMIQIGS 600 (686)
Q Consensus 526 ~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDVwSlGvvl~elltG~~P~~~~~~ 600 (686)
- ...+..+||++|||||++... .|+..+|+||+|++..||.-|.+|+.++.+
T Consensus 177 ~-----------------------grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHP 233 (953)
T KOG0587|consen 177 V-----------------------GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHP 233 (953)
T ss_pred c-----------------------ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcch
Confidence 2 223456788899999998643 367899999999999999999999966554
Q ss_pred cchhHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 601 MELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 601 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
... .+ .++..-.|.+.. ++....++.+++..||.+|-++||++.+++++
T Consensus 234 mra--------LF----~IpRNPPPkLkr---p~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 234 MRA--------LF----LIPRNPPPKLKR---PKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred hhh--------hc----cCCCCCCccccc---hhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 321 11 112222233322 23456678899999999999999999998876
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.4e-33 Score=272.95 Aligned_cols=235 Identities=22% Similarity=0.329 Sum_probs=187.8
Q ss_pred hcccCccCceEEEEEEeCC-CceEEEEEcCCCCc---cchHHHHHHHHHHhcc-CCCCcceeeEEEEecCceeEEEeccC
Q 042348 372 AFLLGKSTIGIVYKVALNN-EEAVAVRRLGNGGW---QRFKEFQTEAEAIGKI-RHPNIVSLRAYFWSVDEKLLIYDYIP 446 (686)
Q Consensus 372 ~~~iG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~e~~~ 446 (686)
-.+||+|+||.|..+..+. .+.+|||++++.-. .+.+--..|-++|+.- +-|.++.++.+|+..+..|+||||+.
T Consensus 354 l~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFVMEyvn 433 (683)
T KOG0696|consen 354 LMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFVMEYVN 433 (683)
T ss_pred EEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeEEEEec
Confidence 3579999999999998764 57899999977522 2233345677888776 57899999999999999999999999
Q ss_pred CCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCccccccccc
Q 042348 447 NGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAE 526 (686)
Q Consensus 447 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~ 526 (686)
||+|...|+.-+ .+.++.+.-+|.+||-||-|||+ ++||.||||..||++|.+|++||+|||+++-.-...
T Consensus 434 GGDLMyhiQQ~G------kFKEp~AvFYAaEiaigLFFLh~---kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~~ 504 (683)
T KOG0696|consen 434 GGDLMYHIQQVG------KFKEPVAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFDG 504 (683)
T ss_pred CchhhhHHHHhc------ccCCchhhhhhHHHHHHhhhhhc---CCeeeeeccccceEeccCCceEeeecccccccccCC
Confidence 999999998763 47788889999999999999999 999999999999999999999999999997322111
Q ss_pred CCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHH
Q 042348 527 ETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIV 606 (686)
Q Consensus 527 ~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~ 606 (686)
..+...+||+.|+|||.+..++|+..+|.|||||+||||+.|+.||.+.+.+
T Consensus 505 -----------------------~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~----- 556 (683)
T KOG0696|consen 505 -----------------------VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED----- 556 (683)
T ss_pred -----------------------cceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHH-----
Confidence 1234568888999999999999999999999999999999999999654332
Q ss_pred HHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCC
Q 042348 607 QWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRP 656 (686)
Q Consensus 607 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 656 (686)
+.++.+....-..+. ....+...+....+.+.|.+|-
T Consensus 557 elF~aI~ehnvsyPK-------------slSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 557 ELFQAIMEHNVSYPK-------------SLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred HHHHHHHHccCcCcc-------------cccHHHHHHHHHHhhcCCcccc
Confidence 234444443322222 1223556777788889999994
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.1e-33 Score=272.46 Aligned_cols=252 Identities=23% Similarity=0.311 Sum_probs=195.7
Q ss_pred ccCccCceEEEEEEeC-CCceEEEEEcCCCCccchHHHHHHHHHHhccC-C-C----CcceeeEEEEecCceeEEEeccC
Q 042348 374 LLGKSTIGIVYKVALN-NEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIR-H-P----NIVSLRAYFWSVDEKLLIYDYIP 446 (686)
Q Consensus 374 ~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H-~----nIv~l~~~~~~~~~~~lV~e~~~ 446 (686)
.+|+|.||.|-.+... .+..||||+++.... ..+...-|++++.++. + | -+|.+.++|.-.++.++|+|.+
T Consensus 96 ~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~k-YreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghiCivfell- 173 (415)
T KOG0671|consen 96 LLGEGTFGKVVECWDRETKEHVALKIIKNVDK-YREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHICIVFELL- 173 (415)
T ss_pred hhcCCcccceEEEeecCCCceehHHHHHHHHH-HhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCceEEEEecc-
Confidence 5899999999998755 468899999976432 2356778999999993 2 2 3788889999999999999999
Q ss_pred CCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecC-------------------
Q 042348 447 NGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGK------------------- 507 (686)
Q Consensus 447 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~------------------- 507 (686)
|-|+.+++..+.- .+++...+..|+.|++++++|||+ .+++|-||||+|||+.+
T Consensus 174 G~S~~dFlk~N~y----~~fpi~~ir~m~~QL~~sv~fLh~---~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r~~ 246 (415)
T KOG0671|consen 174 GLSTFDFLKENNY----IPFPIDHIRHMGYQLLESVAFLHD---LKLTHTDLKPENILFVSSEYFKTYNPKKKVCFIRPL 246 (415)
T ss_pred ChhHHHHhccCCc----cccchHHHHHHHHHHHHHHHHHHh---cceeecCCChheEEEeccceEEEeccCCccceeccC
Confidence 6699999987653 679999999999999999999999 89999999999999931
Q ss_pred -CCCeEEeecCcccccccccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHH
Q 042348 508 -NMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILL 586 (686)
Q Consensus 508 -~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ 586 (686)
+..+|++|||.|++.... .+..+.|..|+|||++.+-.++.++||||+||||.
T Consensus 247 ks~~I~vIDFGsAtf~~e~--------------------------hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ 300 (415)
T KOG0671|consen 247 KSTAIKVIDFGSATFDHEH--------------------------HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILV 300 (415)
T ss_pred CCcceEEEecCCcceeccC--------------------------cceeeeccccCCchheeccCcCCccCceeeeeEEE
Confidence 345899999999864422 23457788999999999999999999999999999
Q ss_pred HHHhCCCCccccCccchhHHHHHHHHHhhcCCcccccCcc--------------------------------cccCCCcH
Q 042348 587 EMISGKLPMIQIGSMELNIVQWIQLILEDRKPMTDILDPF--------------------------------LAHDLDKE 634 (686)
Q Consensus 587 elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~--------------------------------l~~~~~~~ 634 (686)
|+.||..-|.... +.+....++.++.. .| ..++... -.......
T Consensus 301 ElytG~~LFqtHe--n~EHLaMMerIlGp-~P-~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d 376 (415)
T KOG0671|consen 301 ELYTGETLFQTHE--NLEHLAMMERILGP-IP-SRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDD 376 (415)
T ss_pred EeeccceecccCC--cHHHHHHHHHhhCC-Cc-HHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCc
Confidence 9999999996544 22333444444331 11 0000000 00011223
Q ss_pred HHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 635 DEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 635 ~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
.+..++.+|+.+||..||.+|+|+.|++.+
T Consensus 377 ~e~~~LfDLl~~mL~fDP~~RiTl~EAL~H 406 (415)
T KOG0671|consen 377 LEHVQLFDLLRRMLEFDPARRITLREALSH 406 (415)
T ss_pred HHHhHHHHHHHHHHccCccccccHHHHhcC
Confidence 566789999999999999999999999865
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-32 Score=287.33 Aligned_cols=232 Identities=22% Similarity=0.295 Sum_probs=184.3
Q ss_pred ccCccCceEEEEEEeC-CCceEEEEEcCCCCccchHHHHHHHHHHhcc-CCCCcceeeEEEEecCceeEEEeccCCCCHH
Q 042348 374 LLGKSTIGIVYKVALN-NEEAVAVRRLGNGGWQRFKEFQTEAEAIGKI-RHPNIVSLRAYFWSVDEKLLIYDYIPNGSLA 451 (686)
Q Consensus 374 ~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL~ 451 (686)
-+|.|+|+.|-++... +++..+||++.... .+-.+|+.++... +||||+++.+.+.+..+.++|||.+.+|-+.
T Consensus 329 ~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~g~ell 404 (612)
T KOG0603|consen 329 ELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLDGGELL 404 (612)
T ss_pred ccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeeehhccccHHH
Confidence 4899999999998754 57789999997652 3346678777766 7999999999999999999999999999888
Q ss_pred HHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeee-cCCCCeEEeecCcccccccccCCcc
Q 042348 452 TAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILL-GKNMEPHISDFGLARLADIAEETPE 530 (686)
Q Consensus 452 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl-~~~~~~kl~DfGla~~~~~~~~~~~ 530 (686)
+.+.... ....++..|+.+|+.|+.|||+ +|+|||||||+|||+ ++.++++|+|||.++.....-
T Consensus 405 ~ri~~~~-------~~~~e~~~w~~~lv~Av~~LH~---~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~~---- 470 (612)
T KOG0603|consen 405 RRIRSKP-------EFCSEASQWAAELVSAVDYLHE---QGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERSC---- 470 (612)
T ss_pred HHHHhcc-------hhHHHHHHHHHHHHHHHHHHHh---cCeeecCCChhheeecCCCCcEEEEEechhhhCchhh----
Confidence 8776542 2226778899999999999999 999999999999999 589999999999998654321
Q ss_pred ccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHHHH
Q 042348 531 VHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQWIQ 610 (686)
Q Consensus 531 ~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~ 610 (686)
...+-|..|.|||+.....|++++|+||||++||+|++|+.||...... .+...
T Consensus 471 ----------------------~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~----~ei~~ 524 (612)
T KOG0603|consen 471 ----------------------DTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG----IEIHT 524 (612)
T ss_pred ----------------------cccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch----HHHHH
Confidence 1123366799999999999999999999999999999999999654433 11111
Q ss_pred HHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 611 LILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 611 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
.+... +.. ........+|+..||+.||.+||+|.++..+
T Consensus 525 ~i~~~--~~s-------------~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h 563 (612)
T KOG0603|consen 525 RIQMP--KFS-------------ECVSDEAKDLLQQLLQVDPALRLGADEIGAH 563 (612)
T ss_pred hhcCC--ccc-------------cccCHHHHHHHHHhccCChhhCcChhhhccC
Confidence 11111 111 1223356789999999999999999999766
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-32 Score=244.41 Aligned_cols=201 Identities=21% Similarity=0.270 Sum_probs=162.9
Q ss_pred hcccCccCceEEEEEEeC-CCceEEEEEcCCC-CccchHHHHHHHHHHhcc-CCCCcceeeEEEEecCceeEEEeccCCC
Q 042348 372 AFLLGKSTIGIVYKVALN-NEEAVAVRRLGNG-GWQRFKEFQTEAEAIGKI-RHPNIVSLRAYFWSVDEKLLIYDYIPNG 448 (686)
Q Consensus 372 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~e~~~~g 448 (686)
..-||+|++|.|-+-++. +|...|+|++... ..+..++..+|+.+..+. ..|.+|+++|.+......++.||.|+ -
T Consensus 51 i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M~-t 129 (282)
T KOG0984|consen 51 IEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELMD-T 129 (282)
T ss_pred hhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHhh-h
Confidence 345999999999888754 6899999999764 445567788899886665 79999999999999999999999995 4
Q ss_pred CHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCC
Q 042348 449 SLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEET 528 (686)
Q Consensus 449 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 528 (686)
||+.+-.+--.. ...+++..+-+|+..+..||.|||+. ..+||||+||+|||++.+|++|+||||++-.+..+..
T Consensus 130 Sldkfy~~v~~~--g~~ipE~vlGkIa~Svv~al~~L~~k--L~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiA- 204 (282)
T KOG0984|consen 130 SLDKFYRKVLKK--GGTIPEDVLGKIAVSVVHALEFLHSK--LSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSIA- 204 (282)
T ss_pred hHHHHHHHHHhc--CCcCchHHhhHhHHHHHHHHHHHHHH--hhhhhccCCcceEEEccCCcEEEcccccceeehhhhH-
Confidence 887776542111 14688899999999999999999985 4699999999999999999999999999987653321
Q ss_pred ccccccccccCCCCCCCccccccccCCCCCccccCcccccC----CCCCCcchHHHHHHHHHHHHhCCCCccccCcc
Q 042348 529 PEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKV----RKPTQKWDIYSYGVILLEMISGKLPMIQIGSM 601 (686)
Q Consensus 529 ~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~ 601 (686)
.+-..|...|||||.+.. ..|+-|+||||+|+++.||.+++.||......
T Consensus 205 -----------------------kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tp 258 (282)
T KOG0984|consen 205 -----------------------KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTP 258 (282)
T ss_pred -----------------------HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCH
Confidence 111234456999998754 36899999999999999999999999765543
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-33 Score=296.00 Aligned_cols=247 Identities=26% Similarity=0.370 Sum_probs=188.9
Q ss_pred hhcccCccCce-EEEEEEeCCCceEEEEEcCCCCccchHHHHHHHHHHhcc-CCCCcceeeEEEEecCceeEEEeccCCC
Q 042348 371 SAFLLGKSTIG-IVYKVALNNEEAVAVRRLGNGGWQRFKEFQTEAEAIGKI-RHPNIVSLRAYFWSVDEKLLIYDYIPNG 448 (686)
Q Consensus 371 ~~~~iG~G~~g-~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~e~~~~g 448 (686)
..+++|.|+.| .||+|.+. ++.||||++-... ..-..+||..|+.- +|||||++++.-.+.+..||..|.|..
T Consensus 513 ~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e~---~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~~- 587 (903)
T KOG1027|consen 513 PKEILGYGSNGTVVFRGVYE-GREVAVKRLLEEF---FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCAC- 587 (903)
T ss_pred cHHHcccCCCCcEEEEEeeC-CceehHHHHhhHh---HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhhh-
Confidence 34578999887 57999987 6899999986532 24567999999988 699999999999999999999999955
Q ss_pred CHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecC---C--CCeEEeecCcccccc
Q 042348 449 SLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGK---N--MEPHISDFGLARLAD 523 (686)
Q Consensus 449 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~---~--~~~kl~DfGla~~~~ 523 (686)
+|.+++....... ....-.....++.|++.||++||+ -+||||||||.||||+. + ..++|+|||+++.+.
T Consensus 588 sL~dlie~~~~d~--~~~~~i~~~~~l~q~~~GlaHLHs---l~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~ 662 (903)
T KOG1027|consen 588 SLQDLIESSGLDV--EMQSDIDPISVLSQIASGLAHLHS---LKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA 662 (903)
T ss_pred hHHHHHhccccch--hhcccccHHHHHHHHHHHHHHHHh---cccccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence 9999998751110 111113457789999999999999 78999999999999975 3 478999999999876
Q ss_pred cccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhC-CCCccccCccc
Q 042348 524 IAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISG-KLPMIQIGSME 602 (686)
Q Consensus 524 ~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG-~~P~~~~~~~~ 602 (686)
.+.. .+.......||.+|+|||++....-+.++||||+|||+|+.++| ++||......+
T Consensus 663 ~~~s--------------------S~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~ 722 (903)
T KOG1027|consen 663 GGKS--------------------SFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ 722 (903)
T ss_pred CCcc--------------------hhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhh
Confidence 4432 12334566789999999999988888899999999999999995 99995433333
Q ss_pred hhHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 603 LNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 603 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
.+ ++.+...+..+ . ...++ +..+|+.+|+.++|..||++.+|+.|
T Consensus 723 ~N-------Il~~~~~L~~L-~-------~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~H 767 (903)
T KOG1027|consen 723 AN-------ILTGNYTLVHL-E-------PLPDC--EAKDLISRMLNPDPQLRPSATDVLNH 767 (903)
T ss_pred hh-------hhcCccceeee-c-------cCchH--HHHHHHHHhcCCCcccCCCHHHHhCC
Confidence 22 22222222111 0 11122 56799999999999999999999876
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.7e-31 Score=262.77 Aligned_cols=238 Identities=25% Similarity=0.383 Sum_probs=191.0
Q ss_pred CceEEEEEEeCC-CceEEEEEcCCCCccc-hHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCCHHHHhhc
Q 042348 379 TIGIVYKVALNN-EEAVAVRRLGNGGWQR-FKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLATAIHG 456 (686)
Q Consensus 379 ~~g~Vy~~~~~~-~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~ 456 (686)
+||.||+|...+ ++.+++|++....... .+.+.+|++.+++++|+||+++++++......+++|||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 589999999874 8899999997765444 67899999999999999999999999999999999999999999999876
Q ss_pred CCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCcccccccc
Q 042348 457 KAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQS 536 (686)
Q Consensus 457 ~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~ 536 (686)
.. .+++..+..++.+++.+++|||+ .+++|+||+|+||++++++.++|+|||.+.......
T Consensus 81 ~~------~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---------- 141 (244)
T smart00220 81 RG------RLSEDEARFYARQILSALEYLHS---NGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---------- 141 (244)
T ss_pred cc------CCCHHHHHHHHHHHHHHHHHHHH---cCeecCCcCHHHeEECCCCcEEEccccceeeecccc----------
Confidence 43 38899999999999999999999 899999999999999999999999999998654321
Q ss_pred ccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHHHHHHHhhc
Q 042348 537 TTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQWIQLILEDR 616 (686)
Q Consensus 537 ~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~ 616 (686)
......++..|++||......++.++||||||+++|++++|..||...... ...........
T Consensus 142 --------------~~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~----~~~~~~~~~~~ 203 (244)
T smart00220 142 --------------LLTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQL----LELFKKIGKPK 203 (244)
T ss_pred --------------ccccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH----HHHHHHHhccC
Confidence 112234566799999998888899999999999999999999999542211 11222221111
Q ss_pred CCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042348 617 KPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCD 663 (686)
Q Consensus 617 ~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 663 (686)
...... .......+.+++.+|+..+|++||++.++++
T Consensus 204 ~~~~~~----------~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 204 PPFPPP----------EWKISPEAKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred CCCccc----------cccCCHHHHHHHHHHccCCchhccCHHHHhh
Confidence 111000 0002346888999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-31 Score=284.45 Aligned_cols=256 Identities=21% Similarity=0.293 Sum_probs=173.7
Q ss_pred hcccCccCceEEEEEEe-----------------CCCceEEEEEcCCCCccchHH--------------HHHHHHHHhcc
Q 042348 372 AFLLGKSTIGIVYKVAL-----------------NNEEAVAVRRLGNGGWQRFKE--------------FQTEAEAIGKI 420 (686)
Q Consensus 372 ~~~iG~G~~g~Vy~~~~-----------------~~~~~vavK~~~~~~~~~~~~--------------~~~E~~~l~~l 420 (686)
.+.||+|+||.||+|.. ..++.||||++........++ +..|+.++.++
T Consensus 150 ~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~~l~~l 229 (507)
T PLN03224 150 RDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAYMCAKI 229 (507)
T ss_pred eeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHHHHHHh
Confidence 35799999999999964 235679999986543222223 34577777778
Q ss_pred CCCCc-----ceeeEEEEe--------cCceeEEEeccCCCCHHHHhhcCCCc------------------cccCCCCHH
Q 042348 421 RHPNI-----VSLRAYFWS--------VDEKLLIYDYIPNGSLATAIHGKAGI------------------ISYRPLSWS 469 (686)
Q Consensus 421 ~H~nI-----v~l~~~~~~--------~~~~~lV~e~~~~gsL~~~l~~~~~~------------------~~~~~l~~~ 469 (686)
+|.++ ++++++|.. .+..++||||+++|+|.++++...+. .....++|.
T Consensus 230 ~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~~~~ 309 (507)
T PLN03224 230 KRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRDIN 309 (507)
T ss_pred hcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccCCHH
Confidence 66654 677887753 35679999999999999999854211 011245788
Q ss_pred HHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCccccccccccCCCCCCCcccc
Q 042348 470 DRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEF 549 (686)
Q Consensus 470 ~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~ 549 (686)
.+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++........
T Consensus 310 ~~~~i~~ql~~aL~~lH~---~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~--------------------- 365 (507)
T PLN03224 310 VIKGVMRQVLTGLRKLHR---IGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF--------------------- 365 (507)
T ss_pred HHHHHHHHHHHHHHHHHH---CCeecCCCchHhEEECCCCcEEEEeCcCccccccCCcc---------------------
Confidence 899999999999999999 89999999999999999999999999999754321100
Q ss_pred ccccCCCCCccccCcccccCCC--------------------C--CCcchHHHHHHHHHHHHhCCC-CccccCccchh--
Q 042348 550 TALNSTTSRSYYQAPEASKVRK--------------------P--TQKWDIYSYGVILLEMISGKL-PMIQIGSMELN-- 604 (686)
Q Consensus 550 ~~~~~~~gt~~y~aPE~~~~~~--------------------~--~~~sDVwSlGvvl~elltG~~-P~~~~~~~~~~-- 604 (686)
......+|+.|+|||.+.... + ..+.||||+||++|||++|.. ||........+
T Consensus 366 -~~~~g~~tp~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~ 444 (507)
T PLN03224 366 -NPLYGMLDPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELR 444 (507)
T ss_pred -CccccCCCcceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHh
Confidence 001123366799999875322 1 235799999999999999885 66432111111
Q ss_pred -----HHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCC---CCCCCHHHHHHH
Q 042348 605 -----IVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSP---DKRPSMRHVCDS 664 (686)
Q Consensus 605 -----~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP---~~RPs~~ev~~~ 664 (686)
...|. ........+ ... ........+++.++|..+| .+|+|++|+++|
T Consensus 445 ~~~~~~~~~r-~~~~~~~~~-~~~----------d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 445 QYDNDLNRWR-MYKGQKYDF-SLL----------DRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred hccchHHHHH-hhcccCCCc-ccc----------cccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 11111 010010000 001 1122356788999998766 689999999876
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-31 Score=292.96 Aligned_cols=257 Identities=19% Similarity=0.230 Sum_probs=161.2
Q ss_pred cccCccCceEEEEEEeCC-----CceEEEEEcCCCCccchHHHHHHHHHHhccCCCCcceeeEE------EEecCceeEE
Q 042348 373 FLLGKSTIGIVYKVALNN-----EEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAY------FWSVDEKLLI 441 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~------~~~~~~~~lV 441 (686)
+.||+|+||.||+|...+ +..||||++...... +.+..| .+....+.+++.++.. .......++|
T Consensus 138 ~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~LV 213 (566)
T PLN03225 138 KKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSKKEDEYWLV 213 (566)
T ss_pred EEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccccCCceEEE
Confidence 479999999999998754 688999988653221 111111 1222223333332222 2345678999
Q ss_pred EeccCCCCHHHHhhcCCCcc--------------ccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecC
Q 042348 442 YDYIPNGSLATAIHGKAGII--------------SYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGK 507 (686)
Q Consensus 442 ~e~~~~gsL~~~l~~~~~~~--------------~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~ 507 (686)
|||+++++|.++++...... .........+..|+.|++.||+|||+ ++|+||||||+|||+++
T Consensus 214 ~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~---~gIiHRDLKP~NILl~~ 290 (566)
T PLN03225 214 WRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHS---TGIVHRDVKPQNIIFSE 290 (566)
T ss_pred EEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHH---CCEEeCcCCHHHEEEeC
Confidence 99999999999997542100 00011234466899999999999999 89999999999999985
Q ss_pred -CCCeEEeecCcccccccccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCC----------------
Q 042348 508 -NMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVR---------------- 570 (686)
Q Consensus 508 -~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---------------- 570 (686)
++.+||+|||+|+.+..... .......+++.|+|||.+...
T Consensus 291 ~~~~~KL~DFGlA~~l~~~~~----------------------~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~s 348 (566)
T PLN03225 291 GSGSFKIIDLGAAADLRVGIN----------------------YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALS 348 (566)
T ss_pred CCCcEEEEeCCCccccccccc----------------------cCCcccccCCCccChHHhhccCCCCCCcccccccccc
Confidence 57999999999985532211 011234567779999955321
Q ss_pred ------CCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHHHHHHHhhcCCc---ccccCcccccC----CCc-HHH
Q 042348 571 ------KPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQWIQLILEDRKPM---TDILDPFLAHD----LDK-EDE 636 (686)
Q Consensus 571 ------~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~d~~l~~~----~~~-~~~ 636 (686)
.++.++|||||||++|||+++..|+.. +...+...+....... .....+....+ +.. ...
T Consensus 349 p~l~~~~~~~k~DVwSlGviL~el~~~~~~~~~------~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 422 (566)
T PLN03225 349 PVLWQLNLPDRFDIYSAGLIFLQMAFPNLRSDS------NLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLD 422 (566)
T ss_pred chhccccCCCCcccHHHHHHHHHHHhCcCCCch------HHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhcccc
Confidence 234567999999999999998776521 1111111111111000 00011100000 000 001
Q ss_pred HHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 637 IVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 637 ~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
.....+++.+||+.||++|||++|+++|
T Consensus 423 ~~~~~dLi~~mL~~dP~kR~ta~e~L~H 450 (566)
T PLN03225 423 GGAGWELLKSMMRFKGRQRISAKAALAH 450 (566)
T ss_pred chHHHHHHHHHccCCcccCCCHHHHhCC
Confidence 1234589999999999999999999987
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-32 Score=272.81 Aligned_cols=242 Identities=20% Similarity=0.299 Sum_probs=195.7
Q ss_pred ccCccCceEEEEEEeCCCc-eEEEEEcCCCC---ccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCC
Q 042348 374 LLGKSTIGIVYKVALNNEE-AVAVRRLGNGG---WQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGS 449 (686)
Q Consensus 374 ~iG~G~~g~Vy~~~~~~~~-~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gs 449 (686)
.||-|+||.|-.+..+... .+|+|.+++.. ....+....|-++|...+.|.||++|-.|.+.++.|+.||-|-||.
T Consensus 427 TLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaClGGE 506 (732)
T KOG0614|consen 427 TLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEACLGGE 506 (732)
T ss_pred hcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhhcCch
Confidence 4899999999999887544 37888876643 2334567789999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCc
Q 042348 450 LATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETP 529 (686)
Q Consensus 450 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 529 (686)
|...++.++ .++.....-++..+.+|++|||+ ++||.|||||+|.++|.+|.+||.|||+|+.+..+..+
T Consensus 507 lWTiLrdRg------~Fdd~tarF~~acv~EAfeYLH~---k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~KT- 576 (732)
T KOG0614|consen 507 LWTILRDRG------SFDDYTARFYVACVLEAFEYLHR---KGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRKT- 576 (732)
T ss_pred hhhhhhhcC------CcccchhhhhHHHHHHHHHHHHh---cCceeccCChhheeeccCCceEEeehhhHHHhccCCce-
Confidence 999999874 57778888899999999999999 99999999999999999999999999999988755432
Q ss_pred cccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHHH
Q 042348 530 EVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQWI 609 (686)
Q Consensus 530 ~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~ 609 (686)
-..+||+.|.|||.+.....+.++|.||+|+++|||++|.+||...+++. ..
T Consensus 577 -----------------------wTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmk-----tY 628 (732)
T KOG0614|consen 577 -----------------------WTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMK-----TY 628 (732)
T ss_pred -----------------------eeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHH-----HH
Confidence 24678888999999998888999999999999999999999997655433 23
Q ss_pred HHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCC-----HHHHHHH
Q 042348 610 QLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPS-----MRHVCDS 664 (686)
Q Consensus 610 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~ev~~~ 664 (686)
..++.+-..+ ++ | ........+++.+....+|.+|-. +.+|-+|
T Consensus 629 n~ILkGid~i-~~--P--------r~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH 677 (732)
T KOG0614|consen 629 NLILKGIDKI-EF--P--------RRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKH 677 (732)
T ss_pred HHHHhhhhhh-hc--c--------cccchhHHHHHHHHHhcCcHhhhccccCChHHHHhh
Confidence 4444432111 10 0 011224557788888899999965 6666665
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.5e-31 Score=252.00 Aligned_cols=267 Identities=20% Similarity=0.318 Sum_probs=201.7
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCC---CccchHHHHHHHHHHhcc-CCCCcceeeEEEEecCceeEEEeccCC
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNG---GWQRFKEFQTEAEAIGKI-RHPNIVSLRAYFWSVDEKLLIYDYIPN 447 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~e~~~~ 447 (686)
.+||+|+|..|..+++. +.+.+|+|++++. ...+.+-.+.|-.+..+. +||.+|-++.+|......++|.||++|
T Consensus 256 ~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffvieyv~g 335 (593)
T KOG0695|consen 256 RVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVIEYVNG 335 (593)
T ss_pred eeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEEEEecC
Confidence 47999999999999876 4678999998763 333445567788888777 799999999999999999999999999
Q ss_pred CCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccC
Q 042348 448 GSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEE 527 (686)
Q Consensus 448 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 527 (686)
|+|.-+++.. +.|+++.+.-+..+|+.||.|||+ +|||.||||..|+|+|..|++||.|||+++---...
T Consensus 336 gdlmfhmqrq------rklpeeharfys~ei~lal~flh~---rgiiyrdlkldnvlldaeghikltdygmcke~l~~g- 405 (593)
T KOG0695|consen 336 GDLMFHMQRQ------RKLPEEHARFYSAEICLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGPG- 405 (593)
T ss_pred cceeeehhhh------hcCcHHHhhhhhHHHHHHHHHHhh---cCeeeeeccccceEEccCCceeecccchhhcCCCCC-
Confidence 9998888765 469999999999999999999999 999999999999999999999999999997321111
Q ss_pred CccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccC--ccchhH
Q 042348 528 TPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIG--SMELNI 605 (686)
Q Consensus 528 ~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~--~~~~~~ 605 (686)
..++..+||+.|+|||.+.+..|...+|.|++||+|+||+.|+.||+-.+ +.+.+-
T Consensus 406 ----------------------d~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~nt 463 (593)
T KOG0695|consen 406 ----------------------DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNT 463 (593)
T ss_pred ----------------------cccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccch
Confidence 12345788889999999999999999999999999999999999995432 233333
Q ss_pred HHHH-HHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCC------HHHHHHHHhcccccchhhhhc
Q 042348 606 VQWI-QLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPS------MRHVCDSLDRVNISTEQQFMK 678 (686)
Q Consensus 606 ~~~~-~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs------~~ev~~~L~~i~~~~~~~~~~ 678 (686)
.++. +.++...-.++..+ ..+...++...|.+||.+|-. ++++..+----...++.--++
T Consensus 464 edylfqvilekqiriprsl-------------svkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idwd~leqk 530 (593)
T KOG0695|consen 464 EDYLFQVILEKQIRIPRSL-------------SVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDWDLLEQK 530 (593)
T ss_pred hHHHHHHHhhhccccccee-------------ehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCHHHHhhc
Confidence 3333 33333332222211 123446777889999999843 334433311112344444456
Q ss_pred cCCCCC
Q 042348 679 GEEPKF 684 (686)
Q Consensus 679 ~~~~~~ 684 (686)
+..|+|
T Consensus 531 ~v~ppf 536 (593)
T KOG0695|consen 531 QVLPPF 536 (593)
T ss_pred ccCCCC
Confidence 666766
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-30 Score=236.17 Aligned_cols=252 Identities=19% Similarity=0.289 Sum_probs=191.5
Q ss_pred ccCccCceEEEEEE-eCCCceEEEEEcCCCCccchHHHHHHHHHHhccC-CCCcceeeEEEEecC--ceeEEEeccCCCC
Q 042348 374 LLGKSTIGIVYKVA-LNNEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIR-HPNIVSLRAYFWSVD--EKLLIYDYIPNGS 449 (686)
Q Consensus 374 ~iG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~--~~~lV~e~~~~gs 449 (686)
.+|+|.+++||.|. ..+.+.++||.++.. ..+.+.+|+.+|..++ ||||+++++...+.. ...+|+||+.+.+
T Consensus 45 k~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~v~n~D 121 (338)
T KOG0668|consen 45 KVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFEYVNNTD 121 (338)
T ss_pred HHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhhhhcccc
Confidence 48999999999997 456788999999763 3467889999999997 999999999998764 4589999999988
Q ss_pred HHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecC-CCCeEEeecCcccccccccCC
Q 042348 450 LATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGK-NMEPHISDFGLARLADIAEET 528 (686)
Q Consensus 450 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~-~~~~kl~DfGla~~~~~~~~~ 528 (686)
...+. ..|+-.++..++.+++.||.|+|+ .||+|||+||.|++||. .-.++|+|+|+|.++.++..
T Consensus 122 fk~ly---------~tl~d~dIryY~~elLkALdyCHS---~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~e- 188 (338)
T KOG0668|consen 122 FKQLY---------PTLTDYDIRYYIYELLKALDYCHS---MGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE- 188 (338)
T ss_pred HHHHh---------hhhchhhHHHHHHHHHHHHhHHHh---cCcccccCCcceeeechhhceeeeeecchHhhcCCCce-
Confidence 87765 457788899999999999999999 99999999999999995 45799999999998765432
Q ss_pred ccccccccccCCCCCCCccccccccCCCCCccccCcccccC-CCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHH
Q 042348 529 PEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKV-RKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQ 607 (686)
Q Consensus 529 ~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~ 607 (686)
-+..+.+.+|.-||.+.. +.|+..-|+|||||++..|+..+.||....+....++.
T Consensus 189 -----------------------YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVk 245 (338)
T KOG0668|consen 189 -----------------------YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVK 245 (338)
T ss_pred -----------------------eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHH
Confidence 123455667999998865 56889999999999999999999999655544444444
Q ss_pred HHHHHHhhc-----CCcccccCccccc---CC------------CcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 608 WIQLILEDR-----KPMTDILDPFLAH---DL------------DKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 608 ~~~~~~~~~-----~~~~~~~d~~l~~---~~------------~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
.+...-.+. ....-.+||.... .. ...-...+.++++.+.|.+|-.+|+|++|...+
T Consensus 246 IakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H 322 (338)
T KOG0668|consen 246 IAKVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH 322 (338)
T ss_pred HHHHhChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence 332211100 0000112222211 00 000122467899999999999999999998876
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.4e-32 Score=252.28 Aligned_cols=259 Identities=24% Similarity=0.372 Sum_probs=190.8
Q ss_pred ccCccCceEEEEEEeC-CCceEEEEEcCCC--CccchHHHHHHHHHHhccCCCCcceeeEEEEec-----CceeEEEecc
Q 042348 374 LLGKSTIGIVYKVALN-NEEAVAVRRLGNG--GWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSV-----DEKLLIYDYI 445 (686)
Q Consensus 374 ~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~-----~~~~lV~e~~ 445 (686)
-||-|+||.||.+... +|+.||.|++... +....+++.+|+++|..++|.|++..++...-. ++.|+++|.|
T Consensus 60 PIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TELm 139 (449)
T KOG0664|consen 60 PIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTELM 139 (449)
T ss_pred cccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHHHH
Confidence 5899999999999865 6899999998653 334457889999999999999999999887643 3568899999
Q ss_pred CCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccc
Q 042348 446 PNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIA 525 (686)
Q Consensus 446 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~ 525 (686)
. .+|..+|-.. +.++...++-++.||++||.|||+ .+|.||||||.|.|++++-..||+|||+|+..+..
T Consensus 140 Q-SDLHKIIVSP------Q~Ls~DHvKVFlYQILRGLKYLHs---A~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d 209 (449)
T KOG0664|consen 140 Q-SDLHKIIVSP------QALTPDHVKVFVYQILRGLKYLHT---ANILHRDIKPGNLLVNSNCILKICDFGLARTWDQR 209 (449)
T ss_pred H-hhhhheeccC------CCCCcchhhhhHHHHHhhhHHHhh---cchhhccCCCccEEeccCceEEecccccccccchh
Confidence 4 5898888765 568889999999999999999999 89999999999999999999999999999976544
Q ss_pred cCCccccccccccCCCCCCCccccccccCCCCCccccCcccccC-CCCCCcchHHHHHHHHHHHHhCCCCccccCccchh
Q 042348 526 EETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKV-RKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELN 604 (686)
Q Consensus 526 ~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~ 604 (686)
+. ...+..+-|.+|+|||.+.+ ..|+.+.||||.||++.||+-++.-|...+.-+
T Consensus 210 ~~----------------------~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~Piq-- 265 (449)
T KOG0664|consen 210 DR----------------------LNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIE-- 265 (449)
T ss_pred hh----------------------hhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHH--
Confidence 32 12223345778999999987 569999999999999999999888885443321
Q ss_pred HHHHHHHHHhhc----------CCccccc-----Ccccc---cCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 042348 605 IVQWIQLILEDR----------KPMTDIL-----DPFLA---HDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLD 666 (686)
Q Consensus 605 ~~~~~~~~~~~~----------~~~~~~~-----d~~l~---~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~ 666 (686)
..+.+-..+... .....++ .|.+. ........-.+...+.+.++..||++|.+..+.+.++.
T Consensus 266 QL~lItdLLGTPs~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~ 345 (449)
T KOG0664|consen 266 QLQMIIDLLGTPSQEAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY 345 (449)
T ss_pred HHHHHHHHhCCCcHHHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence 111111111100 0000000 01110 00011112234557778899999999999999988764
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-30 Score=265.74 Aligned_cols=219 Identities=22% Similarity=0.310 Sum_probs=170.1
Q ss_pred ccCccCceEEEEEEeC-CCceEEEEEcCCCCcc---chHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCC
Q 042348 374 LLGKSTIGIVYKVALN-NEEAVAVRRLGNGGWQ---RFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGS 449 (686)
Q Consensus 374 ~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gs 449 (686)
-||-|+||+|.+++.. +...+|+|.+++.+.- .......|-.||...+.+.||+||-.|.+++..|+||||++|||
T Consensus 636 ~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdYIPGGD 715 (1034)
T KOG0608|consen 636 TIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGD 715 (1034)
T ss_pred eecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEeccCCcc
Confidence 4999999999998754 4567899998775432 23456789999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCc
Q 042348 450 LATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETP 529 (686)
Q Consensus 450 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 529 (686)
+..+|-..+ .+.+..+.-++.++..|+++.|. .|+|||||||+|||||.||++||.|||++.-+.......
T Consensus 716 mMSLLIrmg------IFeE~LARFYIAEltcAiesVHk---mGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdsk 786 (1034)
T KOG0608|consen 716 MMSLLIRMG------IFEEDLARFYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK 786 (1034)
T ss_pred HHHHHHHhc------cCHHHHHHHHHHHHHHHHHHHHh---ccceecccCccceEEccCCceeeeeccccccceeccccc
Confidence 999987653 47788888889999999999999 899999999999999999999999999987443221110
Q ss_pred ----cccccccccCCC------------CC-C--CccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHh
Q 042348 530 ----EVHWEQSTTGTP------------LQ-S--SPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS 590 (686)
Q Consensus 530 ----~~~~~~~~~g~~------------~~-~--~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt 590 (686)
..+.+...+.-+ .. . ...........+||..|+|||++....|+..+|.||.|||||||+.
T Consensus 787 YYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~ 866 (1034)
T KOG0608|consen 787 YYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLV 866 (1034)
T ss_pred cccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhh
Confidence 000000000000 00 0 0000111234689999999999999999999999999999999999
Q ss_pred CCCCccccCcc
Q 042348 591 GKLPMIQIGSM 601 (686)
Q Consensus 591 G~~P~~~~~~~ 601 (686)
|+.||......
T Consensus 867 g~~pf~~~tp~ 877 (1034)
T KOG0608|consen 867 GQPPFLADTPG 877 (1034)
T ss_pred CCCCccCCCCC
Confidence 99999655443
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-29 Score=242.09 Aligned_cols=251 Identities=25% Similarity=0.330 Sum_probs=185.1
Q ss_pred ccCccCceEEEEEEe-CCCceEEEEEcCCC--CccchHHHHHHHHHHhccCCCCcceeeEEEEec------CceeEEEec
Q 042348 374 LLGKSTIGIVYKVAL-NNEEAVAVRRLGNG--GWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSV------DEKLLIYDY 444 (686)
Q Consensus 374 ~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~------~~~~lV~e~ 444 (686)
.+|.|.- .|-.+.. -.+++||+|++... .....++..+|...+..+.|+||++++.+|.-. .+.|+||||
T Consensus 24 p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e~ 102 (369)
T KOG0665|consen 24 PIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVMEL 102 (369)
T ss_pred ccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHHh
Confidence 3677776 4444432 24788999987543 344557788999999999999999999998643 356999999
Q ss_pred cCCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCccccccc
Q 042348 445 IPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADI 524 (686)
Q Consensus 445 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~ 524 (686)
| .++|...++. .++-.++..|+.|++.|++|||+ .+|+||||||+||++..+..+||.|||+|+....
T Consensus 103 m-~~nl~~vi~~--------elDH~tis~i~yq~~~~ik~lhs---~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~ 170 (369)
T KOG0665|consen 103 M-DANLCQVILM--------ELDHETISYILYQMLCGIKHLHS---AGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDT 170 (369)
T ss_pred h-hhHHHHHHHH--------hcchHHHHHHHHHHHHHHHHHHh---cceeecccCcccceecchhheeeccchhhcccCc
Confidence 9 4699998873 36778889999999999999999 9999999999999999999999999999974331
Q ss_pred ccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchh
Q 042348 525 AEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELN 604 (686)
Q Consensus 525 ~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~ 604 (686)
. ...+..+.|.+|.|||++.+..|.+.+||||.||++.||++|+.-|.+ ...
T Consensus 171 ~------------------------~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g----~d~ 222 (369)
T KOG0665|consen 171 D------------------------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPG----KDH 222 (369)
T ss_pred c------------------------cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecC----chH
Confidence 1 123456778899999999998899999999999999999999998842 223
Q ss_pred HHHHHHHHHhhcCCcc--------------------------ccc-CcccccCCCc-HHHHHHHHHHHHhccccCCCCCC
Q 042348 605 IVQWIQLILEDRKPMT--------------------------DIL-DPFLAHDLDK-EDEIVSVLKIALDCVHKSPDKRP 656 (686)
Q Consensus 605 ~~~~~~~~~~~~~~~~--------------------------~~~-d~~l~~~~~~-~~~~~~l~~l~~~cl~~dP~~RP 656 (686)
+.+|.+.+..-+.+-. +.+ |..+...... ........+++.+||..||++|.
T Consensus 223 idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Ri 302 (369)
T KOG0665|consen 223 IDQWNKIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRI 302 (369)
T ss_pred HHHHHHHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcc
Confidence 3333332222111100 000 0000000000 11223466889999999999999
Q ss_pred CHHHHHHHH
Q 042348 657 SMRHVCDSL 665 (686)
Q Consensus 657 s~~ev~~~L 665 (686)
+++++++|=
T Consensus 303 sv~daL~HP 311 (369)
T KOG0665|consen 303 SVDDALRHP 311 (369)
T ss_pred cHHHHhcCC
Confidence 999999873
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.8e-28 Score=235.64 Aligned_cols=211 Identities=31% Similarity=0.514 Sum_probs=180.6
Q ss_pred cCccCceEEEEEEeCC-CceEEEEEcCCCCcc-chHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCCHHH
Q 042348 375 LGKSTIGIVYKVALNN-EEAVAVRRLGNGGWQ-RFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLAT 452 (686)
Q Consensus 375 iG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL~~ 452 (686)
||+|.+|.||++...+ ++.+++|.+...... ..+.+.+|++.++.++|++|+++++++......+++|||+++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999865 889999999765432 34679999999999999999999999999999999999999999999
Q ss_pred HhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecC-CCCeEEeecCcccccccccCCccc
Q 042348 453 AIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGK-NMEPHISDFGLARLADIAEETPEV 531 (686)
Q Consensus 453 ~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~-~~~~kl~DfGla~~~~~~~~~~~~ 531 (686)
++.... ..+++..+..++.+++++++|||+ .+++|+||+|.||+++. ++.++|+|||.+........
T Consensus 81 ~~~~~~-----~~~~~~~~~~~~~~l~~~l~~lh~---~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~---- 148 (215)
T cd00180 81 LLKENE-----GKLSEDEILRILLQILEGLEYLHS---NGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS---- 148 (215)
T ss_pred HHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc----
Confidence 997642 258899999999999999999999 89999999999999999 89999999999875542210
Q ss_pred cccccccCCCCCCCccccccccCCCCCccccCcccccCC-CCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHHHH
Q 042348 532 HWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVR-KPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQWIQ 610 (686)
Q Consensus 532 ~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~ 610 (686)
......+...|++||..... .++.++|+|++|++++++
T Consensus 149 -------------------~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------- 187 (215)
T cd00180 149 -------------------LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------- 187 (215)
T ss_pred -------------------hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------
Confidence 01122345569999998776 788999999999999999
Q ss_pred HHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 042348 611 LILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSL 665 (686)
Q Consensus 611 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L 665 (686)
..+.+++.+|++.+|++||++.++++++
T Consensus 188 ---------------------------~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 ---------------------------PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred ---------------------------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 2466889999999999999999998753
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-28 Score=229.67 Aligned_cols=247 Identities=18% Similarity=0.320 Sum_probs=187.6
Q ss_pred hcccCccCceEEEEEEeCC-CceEEEEEcCCCCccchHHHHHHHHHHhcc-CCCCcceeeEE-EEecCceeEEEeccCCC
Q 042348 372 AFLLGKSTIGIVYKVALNN-EEAVAVRRLGNGGWQRFKEFQTEAEAIGKI-RHPNIVSLRAY-FWSVDEKLLIYDYIPNG 448 (686)
Q Consensus 372 ~~~iG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~-~~~~~~~~lV~e~~~~g 448 (686)
...+|+|.||.+-.++++. .+.+++|.+.... ...++|.+|...--.| .|.||+.-|+. |+..+.+++++||++.|
T Consensus 29 ~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~aP~g 107 (378)
T KOG1345|consen 29 NKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQEFAPRG 107 (378)
T ss_pred HHHhcccceeeEEeeeccCCceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeeccCccc
Confidence 3469999999999999874 6788999887643 3457899998876666 59999987765 66778889999999999
Q ss_pred CHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeee-c-CCCCeEEeecCccccccccc
Q 042348 449 SLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILL-G-KNMEPHISDFGLARLADIAE 526 (686)
Q Consensus 449 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl-~-~~~~~kl~DfGla~~~~~~~ 526 (686)
||..-+... .+-+....+++.|++.|+.|||+ +++||||||.+|||| + +..++||+|||+.+..+...
T Consensus 108 dL~snv~~~-------GigE~~~K~v~~ql~SAi~fMHs---knlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV 177 (378)
T KOG1345|consen 108 DLRSNVEAA-------GIGEANTKKVFAQLLSAIEFMHS---KNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTV 177 (378)
T ss_pred hhhhhcCcc-------cccHHHHHHHHHHHHHHHHHhhc---cchhhcccccceEEEecCCccEEEeeecccccccCcee
Confidence 999988653 36778889999999999999999 999999999999999 3 34589999999987432111
Q ss_pred CCccccccccccCCCCCCCccccccccCCCCCccccCcccccCC-----CCCCcchHHHHHHHHHHHHhCCCCccccCcc
Q 042348 527 ETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVR-----KPTQKWDIYSYGVILLEMISGKLPMIQIGSM 601 (686)
Q Consensus 527 ~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDVwSlGvvl~elltG~~P~~~~~~~ 601 (686)
....-+..|.+||..... ...+.+|||.||+++|.++||+.||.....+
T Consensus 178 --------------------------~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~ 231 (378)
T KOG1345|consen 178 --------------------------KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIM 231 (378)
T ss_pred --------------------------hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhcc
Confidence 011123348999976432 3578899999999999999999999876667
Q ss_pred chhHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 042348 602 ELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSL 665 (686)
Q Consensus 602 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L 665 (686)
+....+|.+-.-+.....++.+.+ ......++..+-+..+|++|--..++.+..
T Consensus 232 d~~Y~~~~~w~~rk~~~~P~~F~~----------fs~~a~r~Fkk~lt~~~~drcki~~~kk~r 285 (378)
T KOG1345|consen 232 DKPYWEWEQWLKRKNPALPKKFNP----------FSEKALRLFKKSLTPRFKDRCKIWTAKKMR 285 (378)
T ss_pred CchHHHHHHHhcccCccCchhhcc----------cCHHHHHHHHHhcCCcccccchhHHHHHHH
Confidence 777777766554443344444433 223567788888999999995555554443
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.9e-28 Score=243.07 Aligned_cols=126 Identities=22% Similarity=0.291 Sum_probs=106.0
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCCccchHHHHHHHHHHhccC-----C---CCcceeeEEEEe----cCcee
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIR-----H---PNIVSLRAYFWS----VDEKL 439 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----H---~nIv~l~~~~~~----~~~~~ 439 (686)
..||.|.|++||++... ..+.||+|+.+... ...+....||++|++++ | .+||++++.|.. +.+.+
T Consensus 84 rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq-hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpNG~HVC 162 (590)
T KOG1290|consen 84 RKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ-HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPNGQHVC 162 (590)
T ss_pred EeccccccceeEEEeeccCCeEEEEEEEehhh-HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCCCcEEE
Confidence 35999999999999754 56789999987643 23466789999999983 3 479999999985 45789
Q ss_pred EEEeccCCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeec
Q 042348 440 LIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLG 506 (686)
Q Consensus 440 lV~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~ 506 (686)
+|+|++ |.+|..+|....- +.++...+++|++||+.||.|||..+ +|||-||||+|||+.
T Consensus 163 MVfEvL-GdnLLklI~~s~Y----rGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 163 MVFEVL-GDNLLKLIKYSNY----RGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLC 222 (590)
T ss_pred EEehhh-hhHHHHHHHHhCC----CCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeee
Confidence 999999 6689999986643 67999999999999999999999864 799999999999993
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.1e-29 Score=255.45 Aligned_cols=190 Identities=23% Similarity=0.316 Sum_probs=163.1
Q ss_pred cccCccCceEEEEEEeCC-CceEEEEEcCCCC-----cc---chHHHHHHHHHHhccC---CCCcceeeEEEEecCceeE
Q 042348 373 FLLGKSTIGIVYKVALNN-EEAVAVRRLGNGG-----WQ---RFKEFQTEAEAIGKIR---HPNIVSLRAYFWSVDEKLL 440 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~~-~~~vavK~~~~~~-----~~---~~~~~~~E~~~l~~l~---H~nIv~l~~~~~~~~~~~l 440 (686)
..+|+|+||.|+.+.++. ...|+||.+.+.. +. ..-..-.||.||..++ |+||++++++|++++.+|+
T Consensus 567 q~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEddd~yyl 646 (772)
T KOG1152|consen 567 QPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDDDYYYL 646 (772)
T ss_pred eeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecCCeeEE
Confidence 359999999999998874 5678999886531 11 1123567999999997 9999999999999999999
Q ss_pred EEecc-CCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcc
Q 042348 441 IYDYI-PNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLA 519 (686)
Q Consensus 441 V~e~~-~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla 519 (686)
+||-- ++-+|+++|..+ ..+++.++..|++||+.|+++||+ .+|||||||-+|+.++.+|-+||+|||.|
T Consensus 647 ~te~hg~gIDLFd~IE~k------p~m~E~eAk~IFkQV~agi~hlh~---~~ivhrdikdenvivd~~g~~klidfgsa 717 (772)
T KOG1152|consen 647 ETEVHGEGIDLFDFIEFK------PRMDEPEAKLIFKQVVAGIKHLHD---QGIVHRDIKDENVIVDSNGFVKLIDFGSA 717 (772)
T ss_pred EecCCCCCcchhhhhhcc------CccchHHHHHHHHHHHhccccccc---cCceecccccccEEEecCCeEEEeeccch
Confidence 99986 567999999876 468999999999999999999999 89999999999999999999999999998
Q ss_pred cccccccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCC-CCcchHHHHHHHHHHHHhCCCCcc
Q 042348 520 RLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKP-TQKWDIYSYGVILLEMISGKLPMI 596 (686)
Q Consensus 520 ~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDVwSlGvvl~elltG~~P~~ 596 (686)
.+...+ .....+||.+|.|||++.+.+| +..-|||++|++||.++....||.
T Consensus 718 a~~ksg-------------------------pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 718 AYTKSG-------------------------PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred hhhcCC-------------------------CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 755422 2345789999999999999887 667899999999999999999984
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.7e-29 Score=261.63 Aligned_cols=245 Identities=24% Similarity=0.353 Sum_probs=194.3
Q ss_pred ccCccCceEEEEEEeC-CCceEEEEEcCCCCccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCCHHH
Q 042348 374 LLGKSTIGIVYKVALN-NEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLAT 452 (686)
Q Consensus 374 ~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL~~ 452 (686)
.+|.|.||.|||++.. .++..|||.++-....+..-.++|+-+++..+|||||.++|.|...+..++.||||.+|+|++
T Consensus 22 rvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEycgggslQd 101 (829)
T KOG0576|consen 22 RVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYCGGGSLQD 101 (829)
T ss_pred eecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEecCCCcccc
Confidence 5999999999999864 688999999987766667778899999999999999999999999999999999999999999
Q ss_pred HhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCcccc
Q 042348 453 AIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVH 532 (686)
Q Consensus 453 ~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 532 (686)
+-+.. .++++.++....+...+||+|||+ .+=+|||||=.||++++.|.+|++|||.+..+....
T Consensus 102 iy~~T------gplselqiayvcRetl~gl~ylhs---~gk~hRdiKGanilltd~gDvklaDfgvsaqitati------ 166 (829)
T KOG0576|consen 102 IYHVT------GPLSELQIAYVCRETLQGLKYLHS---QGKIHRDIKGANILLTDEGDVKLADFGVSAQITATI------ 166 (829)
T ss_pred eeeec------ccchhHHHHHHHhhhhccchhhhc---CCcccccccccceeecccCceeecccCchhhhhhhh------
Confidence 88765 479999999999999999999999 888999999999999999999999999886543211
Q ss_pred ccccccCCCCCCCccccccccCCCCCccccCcccc---cCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHHH
Q 042348 533 WEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEAS---KVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQWI 609 (686)
Q Consensus 533 ~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~ 609 (686)
....+..||++|||||+. ..+.|..++|||+.|++..|+---+.|........ ..
T Consensus 167 -----------------~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr-----~l 224 (829)
T KOG0576|consen 167 -----------------AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMR-----AL 224 (829)
T ss_pred -----------------hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHH-----HH
Confidence 122356778889999986 34679999999999999999988887753322211 11
Q ss_pred HHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042348 610 QLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCD 663 (686)
Q Consensus 610 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 663 (686)
...-..... .|.+..... ....+.++++.|+-++|.+||+++.++.
T Consensus 225 ~LmTkS~~q-----pp~lkDk~k---ws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 225 FLMTKSGFQ-----PPTLKDKTK---WSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred HHhhccCCC-----CCcccCCcc---chHHHHHHHHHHhcCCCccCCChhhhee
Confidence 111111111 112221112 2345678888999999999999988765
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.3e-28 Score=241.85 Aligned_cols=279 Identities=20% Similarity=0.303 Sum_probs=195.2
Q ss_pred hcccCccCceEEEEEEeC----CCceEEEEEcCCCCccchHHHHHHHHHHhcc-CCCCcceeeEEEEecCceeEEEeccC
Q 042348 372 AFLLGKSTIGIVYKVALN----NEEAVAVRRLGNGGWQRFKEFQTEAEAIGKI-RHPNIVSLRAYFWSVDEKLLIYDYIP 446 (686)
Q Consensus 372 ~~~iG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~e~~~ 446 (686)
.+.||+|.|++||++... ..+.||+|.+...+. ..+...|++.|..+ -+.||+++.+++..++...+|+||++
T Consensus 41 v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~--p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp~~~ 118 (418)
T KOG1167|consen 41 VNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS--PSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLPYFE 118 (418)
T ss_pred hccccccchhhhhhhhHhhhccccceEeeeecccccC--chHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEecccC
Confidence 356999999999999754 357899999876533 35789999999999 59999999999999999999999999
Q ss_pred CCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecC-CCCeEEeecCcccccccc
Q 042348 447 NGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGK-NMEPHISDFGLARLADIA 525 (686)
Q Consensus 447 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~-~~~~kl~DfGla~~~~~~ 525 (686)
.....++.. .++..++..+++.+..||+++|. +|||||||||+|+|.+. .+.-.|.|||+|...+..
T Consensus 119 H~~f~~l~~---------~l~~~~i~~Yl~~ll~Al~~~h~---~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~ 186 (418)
T KOG1167|consen 119 HDRFRDLYR---------SLSLAEIRWYLRNLLKALAHLHK---NGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGY 186 (418)
T ss_pred ccCHHHHHh---------cCCHHHHHHHHHHHHHHhhhhhc---cCccccCCCccccccccccCCceEEechhHHHHHhh
Confidence 999988874 47788999999999999999999 99999999999999984 456789999999843211
Q ss_pred cCCccccc----cccc-cCC----------CCCCC------ccccccccCCCCCccccCcccccC-CCCCCcchHHHHHH
Q 042348 526 EETPEVHW----EQST-TGT----------PLQSS------PYEFTALNSTTSRSYYQAPEASKV-RKPTQKWDIYSYGV 583 (686)
Q Consensus 526 ~~~~~~~~----~~~~-~g~----------~~~~~------~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGv 583 (686)
........ .... .|. ..+.. ...........||++|+|||++.. ...++++||||.||
T Consensus 187 ~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GV 266 (418)
T KOG1167|consen 187 QQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGV 266 (418)
T ss_pred hhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccc
Confidence 10000000 0000 000 00000 000112345789999999999865 45689999999999
Q ss_pred HHHHHHhCCCCccccCccchhHHHHHHHH--------H--hhc------CC---cccc------cC-ccccc-C------
Q 042348 584 ILLEMISGKLPMIQIGSMELNIVQWIQLI--------L--EDR------KP---MTDI------LD-PFLAH-D------ 630 (686)
Q Consensus 584 vl~elltG~~P~~~~~~~~~~~~~~~~~~--------~--~~~------~~---~~~~------~d-~~l~~-~------ 630 (686)
|++-+++++.||.....+-..+.+.+... . .+. .. ..+. ++ ..+.. +
T Consensus 267 I~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~ 346 (418)
T KOG1167|consen 267 ILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTER 346 (418)
T ss_pred eeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceee
Confidence 99999999999966554433333222110 0 011 00 0000 00 00000 0
Q ss_pred -CCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 631 -LDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 631 -~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
...+.....+++++.+|++.||.+|.|+++.+++
T Consensus 347 ~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH 381 (418)
T KOG1167|consen 347 EIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH 381 (418)
T ss_pred ccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence 0001122368899999999999999999999887
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.1e-28 Score=245.73 Aligned_cols=256 Identities=18% Similarity=0.223 Sum_probs=193.3
Q ss_pred ccCccCceEEEEEEeC-CCceEEEEEcCCCCccchHHHHHHHHHHhccC------CCCcceeeEEEEecCceeEEEeccC
Q 042348 374 LLGKSTIGIVYKVALN-NEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIR------HPNIVSLRAYFWSVDEKLLIYDYIP 446 (686)
Q Consensus 374 ~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------H~nIv~l~~~~~~~~~~~lV~e~~~ 446 (686)
..|+|-|++|.+|... .|..||||++...... .+.=+.|+++|++|. --|+++++-.|...++.+||+|-+
T Consensus 439 ~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M-~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHLClVFE~L- 516 (752)
T KOG0670|consen 439 YTGKGVFSTVVRARDQARGQEVAIKIIRNNEVM-HKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHLCLVFEPL- 516 (752)
T ss_pred ccccceeeeeeeccccCCCCeeEEEEeecchHH-hhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcceeEEEehhh-
Confidence 4799999999999865 4779999999775322 244578999999994 358999999999999999999988
Q ss_pred CCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCC-CCeEEeecCcccccccc
Q 042348 447 NGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKN-MEPHISDFGLARLADIA 525 (686)
Q Consensus 447 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~-~~~kl~DfGla~~~~~~ 525 (686)
.-+|.++|...+.. ..|....+..++.|+.-||..|-. -+|+|.||||.|||+++. ..+||||||.|......
T Consensus 517 slNLRevLKKyG~n---vGL~ikaVRsYaqQLflALklLK~---c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~~en 590 (752)
T KOG0670|consen 517 SLNLREVLKKYGRN---VGLHIKAVRSYAQQLFLALKLLKK---CGVLHADIKPDNILVNESKNILKLCDFGSASFASEN 590 (752)
T ss_pred hchHHHHHHHhCcc---cceeehHHHHHHHHHHHHHHHHHh---cCeeecccCccceEeccCcceeeeccCccccccccc
Confidence 45999999876533 458889999999999999999999 789999999999999865 56899999999877655
Q ss_pred cCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhH
Q 042348 526 EETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNI 605 (686)
Q Consensus 526 ~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~ 605 (686)
+.++ +.-+.+|.|||.+.+-.|+...|+||.||+||||.||+.-|.+..+.. +
T Consensus 591 eitP-------------------------YLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~--M 643 (752)
T KOG0670|consen 591 EITP-------------------------YLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQ--M 643 (752)
T ss_pred cccH-------------------------HHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHH--H
Confidence 4332 223457999999999999999999999999999999999996544322 2
Q ss_pred HHHHHHHH--------hhcCCccc--------------------------ccCc------ccccC--C--CcHHHHHHHH
Q 042348 606 VQWIQLIL--------EDRKPMTD--------------------------ILDP------FLAHD--L--DKEDEIVSVL 641 (686)
Q Consensus 606 ~~~~~~~~--------~~~~~~~~--------------------------~~d~------~l~~~--~--~~~~~~~~l~ 641 (686)
..++..+- ....-... .+.| .+... . .......++.
T Consensus 644 Lrl~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~r 723 (752)
T KOG0670|consen 644 LRLFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLR 723 (752)
T ss_pred HHHHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHH
Confidence 22221110 00000000 0111 00000 0 1123456788
Q ss_pred HHHHhccccCCCCCCCHHHHHHH
Q 042348 642 KIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 642 ~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
+|+..|+..||++|.|..|.+.|
T Consensus 724 dLLdkml~LdP~KRit~nqAL~H 746 (752)
T KOG0670|consen 724 DLLDKMLILDPEKRITVNQALKH 746 (752)
T ss_pred HHHHHHhccChhhcCCHHHHhcC
Confidence 99999999999999999998865
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-26 Score=229.32 Aligned_cols=195 Identities=32% Similarity=0.474 Sum_probs=167.2
Q ss_pred cccCccCceEEEEEEeCC-CceEEEEEcCCCCcc-chHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCCH
Q 042348 373 FLLGKSTIGIVYKVALNN-EEAVAVRRLGNGGWQ-RFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSL 450 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL 450 (686)
..||.|++|.||++...+ ++.+++|.+...... ..+.+.+|++.+++++|+|++++++++...+..++++||+++++|
T Consensus 5 ~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L 84 (225)
T smart00221 5 KKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEGGDL 84 (225)
T ss_pred eEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCCCCH
Confidence 468999999999999875 789999999876544 567899999999999999999999999999999999999999999
Q ss_pred HHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCcc
Q 042348 451 ATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPE 530 (686)
Q Consensus 451 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 530 (686)
.+++..... .+++..+..++.+++.++.|||+ .+++|+||+|+||+++.++.++|+|||.+........
T Consensus 85 ~~~~~~~~~-----~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~--- 153 (225)
T smart00221 85 FDYLRKKGG-----KLSEEEARFYLRQILEALEYLHS---LGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA--- 153 (225)
T ss_pred HHHHHhccc-----CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc---
Confidence 999986531 27899999999999999999999 8999999999999999999999999999886543210
Q ss_pred ccccccccCCCCCCCccccccccCCCCCccccCcccc-cCCCCCCcchHHHHHHHHHHHHhCCCCccc
Q 042348 531 VHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEAS-KVRKPTQKWDIYSYGVILLEMISGKLPMIQ 597 (686)
Q Consensus 531 ~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~sDVwSlGvvl~elltG~~P~~~ 597 (686)
.......++..|++||.. ....++.++|||+||++++||++|+.||..
T Consensus 154 -------------------~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 154 -------------------ALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred -------------------ccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 001123445679999998 667788899999999999999999999944
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.9e-27 Score=273.95 Aligned_cols=213 Identities=16% Similarity=0.190 Sum_probs=143.2
Q ss_pred hccCC-CCcceeeEEEE-------ecCceeEEEeccCCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccC
Q 042348 418 GKIRH-PNIVSLRAYFW-------SVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVS 489 (686)
Q Consensus 418 ~~l~H-~nIv~l~~~~~-------~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~ 489 (686)
+.++| +||++++++|. ..+..+.+|||+ +++|.++|.... ..+++.+++.|+.||++||+|||+
T Consensus 27 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~al~~lH~-- 98 (793)
T PLN00181 27 KSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD-----RSVDAFECFHVFRQIVEIVNAAHS-- 98 (793)
T ss_pred chhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc-----ccccHHHHHHHHHHHHHHHHHHHh--
Confidence 34556 68888888872 334567788987 669999997543 468999999999999999999999
Q ss_pred CCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCc----ccccc--------------ccccCCCCCCCcccccc
Q 042348 490 PKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETP----EVHWE--------------QSTTGTPLQSSPYEFTA 551 (686)
Q Consensus 490 ~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~----~~~~~--------------~~~~g~~~~~~~~~~~~ 551 (686)
++|+||||||+|||++..+.+|++|||++.......... +.... ....+++. ...
T Consensus 99 -~gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~------~~~ 171 (793)
T PLN00181 99 -QGIVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPF------PMK 171 (793)
T ss_pred -CCeeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCC------ccc
Confidence 899999999999999776666666666554322111000 00000 00001110 001
Q ss_pred ccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHHHHHHHhhcCCcccccCcccccCC
Q 042348 552 LNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQWIQLILEDRKPMTDILDPFLAHDL 631 (686)
Q Consensus 552 ~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 631 (686)
.....||..|||||++.+..++.++|||||||+||||++|..|+.... ..+....... ..+..
T Consensus 172 ~~~~~gt~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~-------~~~~~~~~~~------~~~~~---- 234 (793)
T PLN00181 172 QILAMEMSWYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS-------RTMSSLRHRV------LPPQI---- 234 (793)
T ss_pred ccccCCCcceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH-------HHHHHHHHhh------cChhh----
Confidence 122467899999999999999999999999999999999988873211 1111111110 11110
Q ss_pred CcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 632 DKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 632 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
.........++.+||+++|.+||+|.|++++
T Consensus 235 --~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h 265 (793)
T PLN00181 235 --LLNWPKEASFCLWLLHPEPSCRPSMSELLQS 265 (793)
T ss_pred --hhcCHHHHHHHHHhCCCChhhCcChHHHhhc
Confidence 0112235577889999999999999999875
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.1e-26 Score=273.72 Aligned_cols=226 Identities=37% Similarity=0.606 Sum_probs=162.9
Q ss_pred hcCCChhHHHHHHHHHHhccCCCCC--CCCCCCCCCCcceeeeEec-CCCEEEEEeCCCCccccCCcCcCCCCCCCEEEc
Q 042348 12 LMGSANDEGLALLSFKQAIRNFPEG--NNWNNSNEDPCSWNGITCR-EGQVFSLIIPNKKLTGFIPADLGSLSAIGRVNL 88 (686)
Q Consensus 12 ~~~~~~~~~~~l~~~k~~~~~~~~~--~~w~~~~~~~c~w~gv~c~-~~~~~~l~l~~n~l~g~~p~~l~~l~~L~~L~L 88 (686)
.+.+..+|..||+.||+++. +|.. .+|+. +.++|.|.||+|+ .++|+.|+|++|+++|.+|..|..+++|+.|+|
T Consensus 23 ~~~~~~~~~~~l~~~~~~~~-~~~~~~~~w~~-~~~~c~w~gv~c~~~~~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~L 100 (968)
T PLN00113 23 FSMLHAEELELLLSFKSSIN-DPLKYLSNWNS-SADVCLWQGITCNNSSRVVSIDLSGKNISGKISSAIFRLPYIQTINL 100 (968)
T ss_pred ccCCCHHHHHHHHHHHHhCC-CCcccCCCCCC-CCCCCcCcceecCCCCcEEEEEecCCCccccCChHHhCCCCCCEEEC
Confidence 44456689999999999994 4543 67864 4689999999997 478999999999999999999999999999999
Q ss_pred cCCCCcccCCcccc-CCCCCcEEEccCCCCCCCCcccccCCCCCCEEeccCCCCCCCCChhhhhccccccccccccccCC
Q 042348 89 RNNNFSGSLPVELF-NASNLQSLILSGNSFSGPVPMQIGKLKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTG 167 (686)
Q Consensus 89 ~~N~l~g~~p~~~~-~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 167 (686)
++|+++|.+|..+. ++++|++|+|++|+++|.+|. +.+++|++|+|++|.+++.+|..++.+++|++|+|++|.+++
T Consensus 101 s~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~--~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~ 178 (968)
T PLN00113 101 SNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVG 178 (968)
T ss_pred CCCccCCcCChHHhccCCCCCEEECcCCccccccCc--cccCCCCEEECcCCcccccCChHHhcCCCCCEEECccCcccc
Confidence 99999999998766 888888888888888776664 446667777777777766666666666677777777766666
Q ss_pred CCchhhhhcCcccceecccccccCCCCchhhhcccccccc------------------cccccccccCCCCCCCcccccc
Q 042348 168 PLPDGFATNLTALQKLDLSFNNLSGLIPNDIANLSRLRLL------------------AQRVYVDLTYNNLSGLIPQNAA 229 (686)
Q Consensus 168 ~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l------------------~~~~~l~l~~N~l~~~~p~~~~ 229 (686)
.+|..+. ++++|++|+|++|++++.+|..++++++|+.| .++..|++++|++++.+|..+.
T Consensus 179 ~~p~~~~-~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~ 257 (968)
T PLN00113 179 KIPNSLT-NLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLG 257 (968)
T ss_pred cCChhhh-hCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccCCcCChhHhcCCCCCEEECcCceeccccChhHh
Confidence 6666553 56666666666666666666666666655443 1122346666666665554432
Q ss_pred -cccCCcccccCCC
Q 042348 230 -LLSLGPTAFIGNP 242 (686)
Q Consensus 230 -~~~~~~~~~~~n~ 242 (686)
+.++..+.+.+|.
T Consensus 258 ~l~~L~~L~L~~n~ 271 (968)
T PLN00113 258 NLKNLQYLFLYQNK 271 (968)
T ss_pred CCCCCCEEECcCCe
Confidence 3334444444443
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.8e-26 Score=215.72 Aligned_cols=168 Identities=21% Similarity=0.275 Sum_probs=126.4
Q ss_pred CCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccC
Q 042348 448 GSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEE 527 (686)
Q Consensus 448 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 527 (686)
|+|.++++.+. ..+++.++..|+.|++.||+|||+ ++ ||+|||++.++.+|+ ||+++.....
T Consensus 1 GsL~~~l~~~~-----~~l~~~~~~~i~~qi~~~L~~lH~---~~------kp~Nil~~~~~~~~~--fG~~~~~~~~-- 62 (176)
T smart00750 1 VSLADILEVRG-----RPLNEEEIWAVCLQCLRALRELHR---QA------KSGNILLTWDGLLKL--DGSVAFKTPE-- 62 (176)
T ss_pred CcHHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHh---cC------CcccEeEcCccceee--ccceEeeccc--
Confidence 78999998643 469999999999999999999999 55 999999999999999 9998754321
Q ss_pred CccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHH
Q 042348 528 TPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQ 607 (686)
Q Consensus 528 ~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~ 607 (686)
...||..|+|||++.+..++.++|||||||++|||+||+.||.........
T Consensus 63 --------------------------~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~--- 113 (176)
T smart00750 63 --------------------------QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAI--- 113 (176)
T ss_pred --------------------------cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHH---
Confidence 113567899999999999999999999999999999999999543322222
Q ss_pred HHHHHHhhcCCcccccCcccccCCCcHHHH--HHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 042348 608 WIQLILEDRKPMTDILDPFLAHDLDKEDEI--VSVLKIALDCVHKSPDKRPSMRHVCDSLDRVN 669 (686)
Q Consensus 608 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~--~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~ 669 (686)
............. .+. ....... .++.+++.+||+.+|++||++.|+++++..+.
T Consensus 114 -~~~~~~~~~~~~~-~~~-----~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~ 170 (176)
T smart00750 114 -LEILLNGMPADDP-RDR-----SNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALF 170 (176)
T ss_pred -HHHHHHHhccCCc-ccc-----ccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHH
Confidence 2222221111100 000 0011111 25889999999999999999999999997764
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.6e-25 Score=207.53 Aligned_cols=256 Identities=21% Similarity=0.358 Sum_probs=189.9
Q ss_pred cccCHHHHHHHhhcccCccCceEEEEEEeCCCceEEEEEcCCCCc--cchHHHHHHHHHHhccCCCCcceeeEEEEecCc
Q 042348 360 VDFDLEQLLKASAFLLGKSTIGIVYKVALNNEEAVAVRRLGNGGW--QRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDE 437 (686)
Q Consensus 360 ~~~~~~~l~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~ 437 (686)
..++..++..-+ .|.+...|+.|+|+++. ..+++|++..... .-.++|..|.-.|+-+.||||..++|.|.....
T Consensus 185 ~gid~~~lnl~t--kl~e~hsgelwrgrwqg-ndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppn 261 (448)
T KOG0195|consen 185 TGIDVSSLNLIT--KLAESHSGELWRGRWQG-NDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPN 261 (448)
T ss_pred cCcchhhhhhhh--hhccCCCcccccccccC-cchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCC
Confidence 344555544333 37888899999999984 4466677654322 223679999999999999999999999999999
Q ss_pred eeEEEeccCCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEe--e
Q 042348 438 KLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHIS--D 515 (686)
Q Consensus 438 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~--D 515 (686)
..++..||+.|||+..+|+..+ -..+-.++.+++.++|+|++|||+..+ -|.---|.+..+++|++.+++|+ |
T Consensus 262 lv~isq~mp~gslynvlhe~t~----vvvd~sqav~faldiargmaflhslep-~ipr~~lns~hvmidedltarismad 336 (448)
T KOG0195|consen 262 LVIISQYMPFGSLYNVLHEQTS----VVVDHSQAVRFALDIARGMAFLHSLEP-MIPRFYLNSKHVMIDEDLTARISMAD 336 (448)
T ss_pred ceEeeeeccchHHHHHHhcCcc----EEEecchHHHHHHHHHhhHHHHhhcch-hhhhhhcccceEEecchhhhheeccc
Confidence 9999999999999999998765 357778999999999999999999753 24444688999999999988875 3
Q ss_pred cCcccccccccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCC---CCcchHHHHHHHHHHHHhCC
Q 042348 516 FGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKP---TQKWDIYSYGVILLEMISGK 592 (686)
Q Consensus 516 fGla~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~sDVwSlGvvl~elltG~ 592 (686)
--++... ....-.+.||+||.++..+- -.++|+|||.+++|||.|..
T Consensus 337 ~kfsfqe------------------------------~gr~y~pawmspealqrkped~n~raadmwsfaillwel~tre 386 (448)
T KOG0195|consen 337 TKFSFQE------------------------------VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTRE 386 (448)
T ss_pred ceeeeec------------------------------cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccc
Confidence 2222100 01122456999999876543 35799999999999999999
Q ss_pred CCccccCccchhHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 042348 593 LPMIQIGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRVN 669 (686)
Q Consensus 593 ~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~ 669 (686)
.||....+.+.... ..++ -+.+.+... ....+.+++.-|+..||.+||.+..|+-.|+++.
T Consensus 387 vpfadlspmecgmk----iale-------glrv~ippg-----is~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 387 VPFADLSPMECGMK----IALE-------GLRVHIPPG-----ISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred cccccCCchhhhhh----hhhc-------cccccCCCC-----ccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 99977666543211 1111 111212111 2235678888999999999999999999999874
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=6e-23 Score=212.87 Aligned_cols=163 Identities=21% Similarity=0.211 Sum_probs=121.9
Q ss_pred cccCccCceEEEEEEeC--CCceEEEEEcCCC-----CccchHHHHHHHHHHhccCCCCcce-eeEEEEecCceeEEEec
Q 042348 373 FLLGKSTIGIVYKVALN--NEEAVAVRRLGNG-----GWQRFKEFQTEAEAIGKIRHPNIVS-LRAYFWSVDEKLLIYDY 444 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~--~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~H~nIv~-l~~~~~~~~~~~lV~e~ 444 (686)
..||+|+||+||+|... +++.||||++... .....+.|.+|+++|++++|+||++ +++ .+..++||||
T Consensus 24 ~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~----~~~~~LVmE~ 99 (365)
T PRK09188 24 AVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA----TGKDGLVRGW 99 (365)
T ss_pred cEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE----cCCcEEEEEc
Confidence 46999999999999865 4677899986532 1123456899999999999999985 443 2567999999
Q ss_pred cCCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCC-CCCCeeecCCCCeEEeecCcccccc
Q 042348 445 IPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDL-RPSNILLGKNMEPHISDFGLARLAD 523 (686)
Q Consensus 445 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDl-kp~NILl~~~~~~kl~DfGla~~~~ 523 (686)
+++++|... .. .. ...++.++++||+|||+ ++|+|||| ||+|||++.++.+||+|||+|+.+.
T Consensus 100 ~~G~~L~~~-~~---------~~---~~~~~~~i~~aL~~lH~---~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~ 163 (365)
T PRK09188 100 TEGVPLHLA-RP---------HG---DPAWFRSAHRALRDLHR---AGITHNDLAKPQNWLMGPDGEAAVIDFQLASVFR 163 (365)
T ss_pred cCCCCHHHh-Cc---------cc---hHHHHHHHHHHHHHHHH---CCCeeCCCCCcceEEEcCCCCEEEEECccceecc
Confidence 999999732 11 01 14678999999999999 89999999 9999999999999999999998764
Q ss_pred cccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCC
Q 042348 524 IAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVR 570 (686)
Q Consensus 524 ~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 570 (686)
...... +. ..........++..|+|||++...
T Consensus 164 ~~~~~~-----------~~----~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 164 RRGALY-----------RI----AAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred cCcchh-----------hh----hhhhhhhhhhccCccCCcccCChh
Confidence 321100 00 001122356677889999987643
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.1e-21 Score=202.38 Aligned_cols=263 Identities=18% Similarity=0.175 Sum_probs=188.2
Q ss_pred cccCccCceEEEEEEeCCC--ceEEEEEcCCCCccchHHHHHHHHHHhccCC----CCcceeeEEE-EecCceeEEEecc
Q 042348 373 FLLGKSTIGIVYKVALNNE--EAVAVRRLGNGGWQRFKEFQTEAEAIGKIRH----PNIVSLRAYF-WSVDEKLLIYDYI 445 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~~~--~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H----~nIv~l~~~~-~~~~~~~lV~e~~ 445 (686)
..||+|+||.||+|..... ..+|+|............+..|+.++..+.. +++..+++.. ......++||+.+
T Consensus 24 ~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~iVM~l~ 103 (322)
T KOG1164|consen 24 KKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFIVMSLL 103 (322)
T ss_pred eeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEEEEecc
Confidence 4699999999999987653 4788887765433322367889999998863 6999999999 4777889999998
Q ss_pred CCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCC-----CCeEEeecCccc
Q 042348 446 PNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKN-----MEPHISDFGLAR 520 (686)
Q Consensus 446 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~-----~~~kl~DfGla~ 520 (686)
|.+|.++...... +.++..++.+|+.|++.+|++||+ .|++||||||+|+++... ..+.|.|||+|+
T Consensus 104 -G~sL~dl~~~~~~----~~fs~~T~l~ia~q~l~~l~~lH~---~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar 175 (322)
T KOG1164|consen 104 -GPSLEDLRKRNPP----GRFSRKTVLRIAIQNLNALEDLHS---KGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLAR 175 (322)
T ss_pred -CccHHHHHHhCCC----CCcCHhHHHHHHHHHHHHHHHHHh---cCcccCCcCHHHeeecCCCCcccceEEEEecCCCc
Confidence 7899998865541 569999999999999999999999 999999999999999754 468999999998
Q ss_pred ccccccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCc
Q 042348 521 LADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGS 600 (686)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~ 600 (686)
........... ..+. ........||..|.++....+...+.+.|+||++.++.|+..|..||.....
T Consensus 176 ~~~~~~~~~~~-------~~~~------r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~ 242 (322)
T KOG1164|consen 176 RFKYVGDSGGN-------LRPP------RPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEM 242 (322)
T ss_pred cccccCCCCcc-------cccC------CCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccc
Confidence 43321111000 0000 0011345689999999999999999999999999999999999999955432
Q ss_pred cchhHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 042348 601 MELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRVN 669 (686)
Q Consensus 601 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~ 669 (686)
... ...+......... .. . ... ...++.+++..+-..+..++|....+...++...
T Consensus 243 ~~~--~~~~~~~~~~~~~-----~~-~--~~~---~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~ 298 (322)
T KOG1164|consen 243 TDL--KSKFEKDPRKLLT-----DR-F--GDL---KPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVF 298 (322)
T ss_pred cch--HHHHHHHhhhhcc-----cc-c--cCC---ChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHH
Confidence 211 1111111111100 00 0 001 1223444555555589999999999999887654
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.1e-20 Score=197.94 Aligned_cols=260 Identities=27% Similarity=0.380 Sum_probs=192.3
Q ss_pred ccCccCceEEEEEEeCCCceEEEEEcCCCCcc---chHHHHHHHHHHhccCCC-CcceeeEEEEecCceeEEEeccCCCC
Q 042348 374 LLGKSTIGIVYKVALNNEEAVAVRRLGNGGWQ---RFKEFQTEAEAIGKIRHP-NIVSLRAYFWSVDEKLLIYDYIPNGS 449 (686)
Q Consensus 374 ~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H~-nIv~l~~~~~~~~~~~lV~e~~~~gs 449 (686)
.||.|+||.||++... ..+++|.+...... ....+.+|+.+++.+.|+ +|+++++++......+++++|+.+++
T Consensus 7 ~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 84 (384)
T COG0515 7 KLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGS 84 (384)
T ss_pred eecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecCCCCc
Confidence 5899999999999887 77899998765332 357799999999999988 79999999977777899999999999
Q ss_pred HHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCC-CeEEeecCcccccccccCC
Q 042348 450 LATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNM-EPHISDFGLARLADIAEET 528 (686)
Q Consensus 450 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~-~~kl~DfGla~~~~~~~~~ 528 (686)
+.+++...... ..++......++.|++.+++|+|+ .+++|||+||+||+++... .++++|||.++........
T Consensus 85 l~~~~~~~~~~---~~~~~~~~~~~~~~~~~~l~~~H~---~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 158 (384)
T COG0515 85 LEDLLKKIGRK---GPLSESEALFILAQILSALEYLHS---KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST 158 (384)
T ss_pred HHHHHHhcccc---cCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcc
Confidence 99777654311 258889999999999999999999 8899999999999999888 7999999999854322211
Q ss_pred ccccccccccCCCCCCCccccccccCCCCCccccCcccccC---CCCCCcchHHHHHHHHHHHHhCCCCccccCccchhH
Q 042348 529 PEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKV---RKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNI 605 (686)
Q Consensus 529 ~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~ 605 (686)
.... .......||..|+|||...+ ..++...|+||+|++++++++|..||...... ...
T Consensus 159 ~~~~-----------------~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~-~~~ 220 (384)
T COG0515 159 SSIP-----------------ALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS-SAT 220 (384)
T ss_pred cccc-----------------ccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc-ccH
Confidence 0000 12345677889999999987 57889999999999999999999997543321 001
Q ss_pred HHHHHHHHhhcCC-cccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 606 VQWIQLILEDRKP-MTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 606 ~~~~~~~~~~~~~-~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
......+.....+ ......+... ......+.+++.+|+..+|..|.++.+....
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 221 SQTLKIILELPTPSLASPLSPSNP-----ELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred HHHHHHHHhcCCcccccccCcccc-----chhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 1111111111111 1111111000 1123457788899999999999998887764
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.86 E-value=9.1e-23 Score=225.52 Aligned_cols=254 Identities=19% Similarity=0.226 Sum_probs=180.6
Q ss_pred hcccCccCceEEEEEEeC-CCceEEEEEcC----CC-Ccc-chHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEec
Q 042348 372 AFLLGKSTIGIVYKVALN-NEEAVAVRRLG----NG-GWQ-RFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDY 444 (686)
Q Consensus 372 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~----~~-~~~-~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~ 444 (686)
..++|.|++|.|+.+... .....+.|.+. .. ... ....+..|..+-..++|||++..+..+.+.....-+|||
T Consensus 323 ~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE~ 402 (601)
T KOG0590|consen 323 GRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSMEY 402 (601)
T ss_pred cceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhhc
Confidence 457999999977776543 23333333322 11 111 112266788888889999999888877777666666999
Q ss_pred cCCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCccccccc
Q 042348 445 IPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADI 524 (686)
Q Consensus 445 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~ 524 (686)
|++ ||..++... ..++..++..++.|+..|++|+|+ .||.|||+|++|+++..++.+||+|||.+....-
T Consensus 403 ~~~-Dlf~~~~~~------~~~~~~e~~c~fKqL~~Gv~y~h~---~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~ 472 (601)
T KOG0590|consen 403 CPY-DLFSLVMSN------GKLTPLEADCFFKQLLRGVKYLHS---MGLAHRDLKLENLLVTENGILKIIDFGAASVFRY 472 (601)
T ss_pred ccH-HHHHHHhcc------cccchhhhhHHHHHHHHHHHHHHh---cCceeccCccccEEEecCCceEEeecCcceeecc
Confidence 999 999999765 247888899999999999999999 8999999999999999999999999999876542
Q ss_pred ccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCC-cchHHHHHHHHHHHHhCCCCccccCccch
Q 042348 525 AEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQ-KWDIYSYGVILLEMISGKLPMIQIGSMEL 603 (686)
Q Consensus 525 ~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~sDVwSlGvvl~elltG~~P~~~~~~~~~ 603 (686)
.... ........+|+..|+|||++.+.+|.+ ..||||.|+++..|++|+.||......+.
T Consensus 473 ~~e~-------------------~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~ 533 (601)
T KOG0590|consen 473 PWEK-------------------NIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDN 533 (601)
T ss_pred Ccch-------------------hhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCcccccccccc
Confidence 2211 012334567888899999999988865 58999999999999999999965544332
Q ss_pred hHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042348 604 NIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCD 663 (686)
Q Consensus 604 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 663 (686)
.. .......... ....+. .-......+...++.+||+.||.+|.|+++|++
T Consensus 534 ~~---~~~~~~~~~~--~~~~~~----~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 534 SF---KTNNYSDQRN--IFEGPN----RLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred ch---hhhccccccc--cccChH----HHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 21 0000000000 000000 001223445678899999999999999999975
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.2e-20 Score=182.53 Aligned_cols=202 Identities=20% Similarity=0.297 Sum_probs=168.4
Q ss_pred hcccCccCceEEEEEE-eCCCceEEEEEcCCCCccchHHHHHHHHHHhcc-CCCCcceeeEEEEecCceeEEEeccCCCC
Q 042348 372 AFLLGKSTIGIVYKVA-LNNEEAVAVRRLGNGGWQRFKEFQTEAEAIGKI-RHPNIVSLRAYFWSVDEKLLIYDYIPNGS 449 (686)
Q Consensus 372 ~~~iG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~e~~~~gs 449 (686)
+..||+|+||+++.|+ +-+++.||||.-...+. ..++..|.+..+.| ..++|...+-+..++.+-.+|+|.+ |.|
T Consensus 33 GkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~--APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL-GPS 109 (449)
T KOG1165|consen 33 GKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE--APQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL-GPS 109 (449)
T ss_pred ccccccCcceeeecccccccCceEEEEeccccCC--cchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh-CcC
Confidence 4579999999999997 45689999998765432 35788899988888 4699999998888888899999999 789
Q ss_pred HHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCC-----CCeEEeecCccccccc
Q 042348 450 LATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKN-----MEPHISDFGLARLADI 524 (686)
Q Consensus 450 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~-----~~~kl~DfGla~~~~~ 524 (686)
|+|+..-.+ +.++..++..||.|++.-++|+|+ +.+|.|||||+|+||... ..+.++|||+|+.+.+
T Consensus 110 LEDLFD~Cg-----R~FSvKTV~miA~Qmi~rie~vH~---k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrD 181 (449)
T KOG1165|consen 110 LEDLFDLCG-----RRFSVKTVAMIAKQMITRIEYVHE---KDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRD 181 (449)
T ss_pred HHHHHHHhc-----CcccHHhHHHHHHHHHHHHHHHHh---cceeecccCccceeecCCCCCCCceEEEEeccchhhhcC
Confidence 999887554 679999999999999999999999 899999999999999643 3589999999998765
Q ss_pred ccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCc
Q 042348 525 AEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGS 600 (686)
Q Consensus 525 ~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~ 600 (686)
........+ ....+..||..||+--...+.+-+.+-|.-|+|-|+.+.+-|..||.+...
T Consensus 182 p~TkqHIPY----------------rE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA 241 (449)
T KOG1165|consen 182 PKTKQHIPY----------------REHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKA 241 (449)
T ss_pred ccccccCcc----------------ccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccC
Confidence 443322222 233456789999999999999999999999999999999999999976543
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.85 E-value=2e-21 Score=185.47 Aligned_cols=138 Identities=18% Similarity=0.175 Sum_probs=107.8
Q ss_pred cccCccCceEEEEEEeCCCceEEEEEcCCCCcc--c-------hHH-----------------HHHHHHHHhccCCCCcc
Q 042348 373 FLLGKSTIGIVYKVALNNEEAVAVRRLGNGGWQ--R-------FKE-----------------FQTEAEAIGKIRHPNIV 426 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~-------~~~-----------------~~~E~~~l~~l~H~nIv 426 (686)
..||+|+||.||+|...+|+.||||+++..... . ..+ ...|++.+.++.|+++.
T Consensus 3 ~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v~ 82 (190)
T cd05147 3 GCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGIP 82 (190)
T ss_pred CccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCCC
Confidence 369999999999999888999999998653211 0 112 23599999999888775
Q ss_pred eeeEEEEecCceeEEEeccCCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHH-HccCCCCceecCCCCCCeee
Q 042348 427 SLRAYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFL-HEVSPKRYVHGDLRPSNILL 505 (686)
Q Consensus 427 ~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~L-H~~~~~~iiHrDlkp~NILl 505 (686)
....+.. ...++||||++++++....... ..+++.++..++.|++.+|+|+ |+ .+|+||||||+||++
T Consensus 83 ~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~------~~~~~~~~~~i~~qi~~~L~~l~H~---~giiHrDlkP~NIli 151 (190)
T cd05147 83 CPEPILL--KSHVLVMEFIGDDGWAAPRLKD------APLSESKARELYLQVIQIMRILYQD---CRLVHADLSEYNLLY 151 (190)
T ss_pred CCcEEEe--cCCEEEEEEeCCCCCcchhhhc------CCCCHHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEE
Confidence 4433322 2348999999988776543222 3588899999999999999999 68 799999999999999
Q ss_pred cCCCCeEEeecCccccc
Q 042348 506 GKNMEPHISDFGLARLA 522 (686)
Q Consensus 506 ~~~~~~kl~DfGla~~~ 522 (686)
+ ++.++|+|||+|...
T Consensus 152 ~-~~~v~LiDFG~a~~~ 167 (190)
T cd05147 152 H-DGKLYIIDVSQSVEH 167 (190)
T ss_pred E-CCcEEEEEccccccC
Confidence 8 478999999999743
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=8e-21 Score=175.75 Aligned_cols=199 Identities=20% Similarity=0.314 Sum_probs=163.2
Q ss_pred ccCccCceEEEEEE-eCCCceEEEEEcCCCCccchHHHHHHHHHHhccCC-CCcceeeEEEEecCceeEEEeccCCCCHH
Q 042348 374 LLGKSTIGIVYKVA-LNNEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRH-PNIVSLRAYFWSVDEKLLIYDYIPNGSLA 451 (686)
Q Consensus 374 ~iG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H-~nIv~l~~~~~~~~~~~lV~e~~~~gsL~ 451 (686)
.||.|+||.+|.|. ..+|+.||||.-.... ...++..|.++...++| ..|..+..|..+..+-.+|||.+ |.||+
T Consensus 22 kiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a--~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdLL-GPsLE 98 (341)
T KOG1163|consen 22 KIGSGSFGDIYLGISITSGEEVAIKLESSKA--KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDLL-GPSLE 98 (341)
T ss_pred eecCCchhheeeeeeccCCceEEEEeecccC--CCcchhHHHHHHHHhccCCCCchhhhhccccccceeeeecc-CccHH
Confidence 59999999999997 5679999999875532 22467889999999975 78888888888889999999999 78999
Q ss_pred HHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecC---CCCeEEeecCcccccccccCC
Q 042348 452 TAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGK---NMEPHISDFGLARLADIAEET 528 (686)
Q Consensus 452 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~---~~~~kl~DfGla~~~~~~~~~ 528 (686)
++..-.. +.++..+++-++-|++.-++|+|. ++.|||||||+|+|..- ...+.++|||+|+.+.+....
T Consensus 99 dLfnfC~-----R~ftmkTvLMLaDQml~RiEyvH~---r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~ 170 (341)
T KOG1163|consen 99 DLFNFCS-----RRFTMKTVLMLADQMLSRIEYVHL---RNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTR 170 (341)
T ss_pred HHHHHHh-----hhhhHHhHHHHHHHHHHHHHHHHh---hccccccCCccceeeccccccceEEEEeccchhhhcccccc
Confidence 9987554 578999999999999999999999 89999999999999963 346889999999977543322
Q ss_pred ccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccC
Q 042348 529 PEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIG 599 (686)
Q Consensus 529 ~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~ 599 (686)
....+ .....-+||..|.+--...+.+-+.+.|+-|+|.+|.+.--|..||.+..
T Consensus 171 ~HIpy----------------re~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglk 225 (341)
T KOG1163|consen 171 QHIPY----------------REDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLK 225 (341)
T ss_pred ccCcc----------------ccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccc
Confidence 11111 22335678889999888777777899999999999999999999996654
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=6.3e-21 Score=183.67 Aligned_cols=164 Identities=16% Similarity=0.171 Sum_probs=125.9
Q ss_pred hcccCccCceEEEEEEeCCCceEEEEEcCCCCccchH---H------HHHHHHHHhccCCCCcceeeEEEEec-------
Q 042348 372 AFLLGKSTIGIVYKVALNNEEAVAVRRLGNGGWQRFK---E------FQTEAEAIGKIRHPNIVSLRAYFWSV------- 435 (686)
Q Consensus 372 ~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~---~------~~~E~~~l~~l~H~nIv~l~~~~~~~------- 435 (686)
.+++|.|+||.||.+.. ++..+|||.+......... . +.+|++.+.++.|++|....+++...
T Consensus 36 ~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~~~~~~~ 114 (232)
T PRK10359 36 IKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAERKTLRY 114 (232)
T ss_pred EEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecccccccc
Confidence 45799999999999766 4668999999754322211 2 68999999999999999999987644
Q ss_pred -CceeEEEeccCCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEe
Q 042348 436 -DEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHIS 514 (686)
Q Consensus 436 -~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~ 514 (686)
+..++||||++|.+|.++.. ++. ....+++.+++.+|+ .+++|||+||+||++++++ ++|+
T Consensus 115 ~~~~~lvmEyi~G~tL~~~~~----------~~~----~~~~~i~~~l~~lH~---~gi~H~Dikp~Nili~~~g-i~li 176 (232)
T PRK10359 115 AHTYIMLIEYIEGVELNDMPE----------ISE----DVKAKIKASIESLHQ---HGMVSGDPHKGNFIVSKNG-LRII 176 (232)
T ss_pred cCCeEEEEEEECCccHHHhhh----------ccH----HHHHHHHHHHHHHHH---cCCccCCCChHHEEEeCCC-EEEE
Confidence 35789999999999988732 222 245699999999999 9999999999999999988 9999
Q ss_pred ecCcccccccccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHH
Q 042348 515 DFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMI 589 (686)
Q Consensus 515 DfGla~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ell 589 (686)
|||..+........ ..+.....|..++|+||||+++....
T Consensus 177 Dfg~~~~~~e~~a~-----------------------------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 177 DLSGKRCTAQRKAK-----------------------------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred ECCCcccccchhhH-----------------------------------HHHHHHhHhcccccccceeEeehHHH
Confidence 99987644211100 01223344667899999999987654
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.2e-20 Score=198.93 Aligned_cols=219 Identities=25% Similarity=0.373 Sum_probs=165.0
Q ss_pred HhccCCCCcceeeEEEEecCceeEEEeccCCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCc-ee
Q 042348 417 IGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRY-VH 495 (686)
Q Consensus 417 l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~i-iH 495 (686)
|+.+.|.|+.+++|.+.+....++|.+||..|+|.|.+.... ..++|--...++++|+.||+|+|+ .+| .|
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~-----~~~d~~F~~s~~rdi~~Gl~ylh~---s~i~~h 72 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNED-----IKLDYFFILSFIRDISKGLAYLHN---SPIGYH 72 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccc-----cCccHHHHHHHHHHHHHHHHHHhc---Ccceee
Confidence 467899999999999999999999999999999999998743 568999999999999999999998 444 99
Q ss_pred cCCCCCCeeecCCCCeEEeecCcccccccccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCC----
Q 042348 496 GDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRK---- 571 (686)
Q Consensus 496 rDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---- 571 (686)
+.++++|.++|....+||+|||+..+........ .........-|.|||.+....
T Consensus 73 g~l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~---------------------~~~~~~~~~lw~aPellr~~~~~~~ 131 (484)
T KOG1023|consen 73 GALKSSNCLVDSRWVLKLTDFGLNSLLEETAEPE---------------------AHHPIRKALLWTAPELLRGALSQSL 131 (484)
T ss_pred eeeccccceeeeeEEEEechhhhccccccccccc---------------------ccchhHHHHhccCHHHhcccccccc
Confidence 9999999999999999999999987664310000 000011223499999886631
Q ss_pred ---CCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhcc
Q 042348 572 ---PTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCV 648 (686)
Q Consensus 572 ---~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl 648 (686)
.+.+.||||||++++|+++.+.||......... .+.+..+..+. ...+.|.+.... +....+..++.+||
T Consensus 132 ~~~~~~~gdiYs~~ii~~ei~~r~~~~~~~~~~~~~-~eii~~~~~~~---~~~~rP~i~~~~---e~~~~l~~l~~~cw 204 (484)
T KOG1023|consen 132 ESALTQKGDIYSFGIIMYEILFRSGPFDLRNLVEDP-DEIILRVKKGG---SNPFRPSIELLN---ELPPELLLLVARCW 204 (484)
T ss_pred cccccccCCeehHHHHHHHHHhccCccccccccCCh-HHHHHHHHhcC---CCCcCcchhhhh---hcchHHHHHHHHhc
Confidence 467899999999999999999999764443332 23333333311 112222222111 22336889999999
Q ss_pred ccCCCCCCCHHHHHHHHhccccc
Q 042348 649 HKSPDKRPSMRHVCDSLDRVNIS 671 (686)
Q Consensus 649 ~~dP~~RPs~~ev~~~L~~i~~~ 671 (686)
..+|++||++++|-..++.+...
T Consensus 205 ~e~P~~rPs~~~i~~~~~~~~~~ 227 (484)
T KOG1023|consen 205 EEIPEKRPSIEQIRSKLLTINKG 227 (484)
T ss_pred ccChhhCccHHHHHhhhhhhccc
Confidence 99999999999999999887653
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.9e-22 Score=175.80 Aligned_cols=177 Identities=31% Similarity=0.482 Sum_probs=157.9
Q ss_pred CCCEEEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCccccCCCCCcEEEccCCCCCCCCcccccCCCCCCEEe
Q 042348 56 EGQVFSLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQVLD 135 (686)
Q Consensus 56 ~~~~~~l~l~~n~l~g~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ 135 (686)
.+.++.|-|++|+|+ .+|+.+..|.+|+.|++++|+|+ .+|..++++++|+.|+++-|++. .+|..||.++.|++||
T Consensus 32 ~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levld 108 (264)
T KOG0617|consen 32 MSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLD 108 (264)
T ss_pred hhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhhh
Confidence 357889999999999 68899999999999999999999 89999999999999999999998 8999999999999999
Q ss_pred ccCCCCC-CCCChhhhhccccccccccccccCCCCchhhhhcCcccceecccccccCCCCchhhhccccccccccccccc
Q 042348 136 LSQNSFS-SSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSGLIPNDIANLSRLRLLAQRVYVD 214 (686)
Q Consensus 136 ls~N~l~-~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~~~~~l~ 214 (686)
|++|++. ..+|..|..+..|+.|+|++|.|. .+|..++ +|++|+.|.|.+|.+- ..|.+++.|..|+.| .
T Consensus 109 ltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg-~lt~lqil~lrdndll-~lpkeig~lt~lrel------h 179 (264)
T KOG0617|consen 109 LTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVG-KLTNLQILSLRDNDLL-SLPKEIGDLTRLREL------H 179 (264)
T ss_pred ccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhh-hhcceeEEeeccCchh-hCcHHHHHHHHHHHH------h
Confidence 9999987 468999999999999999999998 7898885 8999999999999998 469999999999877 8
Q ss_pred ccCCCCCCCcccccccccC---CcccccCCCCC
Q 042348 215 LTYNNLSGLIPQNAALLSL---GPTAFIGNPFL 244 (686)
Q Consensus 215 l~~N~l~~~~p~~~~~~~~---~~~~~~~n~~~ 244 (686)
+.+|+++..+|+...+.-. .....+.|||.
T Consensus 180 iqgnrl~vlppel~~l~l~~~k~v~r~E~NPwv 212 (264)
T KOG0617|consen 180 IQGNRLTVLPPELANLDLVGNKQVMRMEENPWV 212 (264)
T ss_pred cccceeeecChhhhhhhhhhhHHHHhhhhCCCC
Confidence 9999999998887653322 23345677776
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=3.7e-21 Score=202.11 Aligned_cols=225 Identities=21% Similarity=0.298 Sum_probs=177.1
Q ss_pred ccCccCceEEEEEE----eCCCceEEEEEcCCCCccc--hHHHHHHHHHHhccC-CCCcceeeEEEEecCceeEEEeccC
Q 042348 374 LLGKSTIGIVYKVA----LNNEEAVAVRRLGNGGWQR--FKEFQTEAEAIGKIR-HPNIVSLRAYFWSVDEKLLIYDYIP 446 (686)
Q Consensus 374 ~iG~G~~g~Vy~~~----~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lV~e~~~ 446 (686)
++|.|.||.|+.++ ...+..+|+|..++..... ......|..++..++ ||.+|++...++.+...+++++|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 37999999999864 2346678888876542211 124567888888886 9999999999999999999999999
Q ss_pred CCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCccccccccc
Q 042348 447 NGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAE 526 (686)
Q Consensus 447 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~ 526 (686)
+|+|...+.... .+++.....+...++-|++++|+ .+|+|||+|++||+++.+|++++.|||+++..-..+
T Consensus 81 gg~lft~l~~~~------~f~~~~~~~~~aelaLald~lh~---l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~ 151 (612)
T KOG0603|consen 81 GGDLFTRLSKEV------MFDELDVAFYLAELALALDHLHK---LGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK 151 (612)
T ss_pred cchhhhccccCC------chHHHHHHHHHHHHHHHHhhcch---hHHHHhcccccceeecccCccccCCchhhhHhHhhh
Confidence 999999887653 46777788888899999999999 899999999999999999999999999998653222
Q ss_pred CCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHH
Q 042348 527 ETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIV 606 (686)
Q Consensus 527 ~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~ 606 (686)
..+||+-|||||++. .....+|.||||++++||+||..||..
T Consensus 152 ---------------------------~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~--------- 193 (612)
T KOG0603|consen 152 ---------------------------IACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG--------- 193 (612)
T ss_pred ---------------------------hcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch---------
Confidence 126788899999998 457789999999999999999999954
Q ss_pred HHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCH
Q 042348 607 QWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSM 658 (686)
Q Consensus 607 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~ 658 (686)
+....+...+..++. .......+++..++..+|..|--.
T Consensus 194 ~~~~~Il~~~~~~p~-------------~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 194 DTMKRILKAELEMPR-------------ELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred HHHHHHhhhccCCch-------------hhhHHHHHHHHHHHhhCHHHHhcc
Confidence 223444443333332 223345577778888999999654
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=6.5e-20 Score=172.53 Aligned_cols=194 Identities=16% Similarity=0.186 Sum_probs=136.3
Q ss_pred cccCccCceEEEEEEeCCCceEEEEEcCCCCccc----hHHHHHHHHHHhccC-CCCcceeeEEEEecCceeEEEeccCC
Q 042348 373 FLLGKSTIGIVYKVALNNEEAVAVRRLGNGGWQR----FKEFQTEAEAIGKIR-HPNIVSLRAYFWSVDEKLLIYDYIPN 447 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~----~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lV~e~~~~ 447 (686)
..|++|+||+||.+.. .+..++.+.+.....-. ...+.+|+++|+++. |++|++++++ +..+++|||+.|
T Consensus 8 ~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~G 82 (218)
T PRK12274 8 EPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLAG 82 (218)
T ss_pred eeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeecC
Confidence 4699999999997766 57778888776654321 125889999999995 5889999886 457999999999
Q ss_pred CCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCC-CCCCeeecCCCCeEEeecCccccccccc
Q 042348 448 GSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDL-RPSNILLGKNMEPHISDFGLARLADIAE 526 (686)
Q Consensus 448 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDl-kp~NILl~~~~~~kl~DfGla~~~~~~~ 526 (686)
.+|.+.+.. ....++.|++.+|+++|+ +||+|||| ||+|||++.++.++|+|||+|.......
T Consensus 83 ~~L~~~~~~-------------~~~~~~~qi~~~L~~lH~---~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~ 146 (218)
T PRK12274 83 AAMYQRPPR-------------GDLAYFRAARRLLQQLHR---CGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRA 146 (218)
T ss_pred ccHHhhhhh-------------hhHHHHHHHHHHHHHHHH---CcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcc
Confidence 998754321 113578899999999999 99999999 7999999999999999999998543211
Q ss_pred CCccccccccccCCCCCCCccccccccCCCCCccccCcccccCC-CCC-CcchHHHHHHHHHHHHhCCCCccc
Q 042348 527 ETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVR-KPT-QKWDIYSYGVILLEMISGKLPMIQ 597 (686)
Q Consensus 527 ~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~-~~sDVwSlGvvl~elltG~~P~~~ 597 (686)
........+. ...........+..|++|+...-. ..+ ...+.++-|.-+|.++|+..|...
T Consensus 147 ~~~r~L~~rD----------l~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 147 RWMRLLARED----------LRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred hHHHHHHHHH----------HHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence 0000000000 000000012245567777744321 223 467888999999999999988743
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.1e-19 Score=174.29 Aligned_cols=138 Identities=19% Similarity=0.264 Sum_probs=109.3
Q ss_pred ccCccCceEEEEEEeCCCceEEEEEcCCCCcc--c------------------------hHHHHHHHHHHhccCCCCcce
Q 042348 374 LLGKSTIGIVYKVALNNEEAVAVRRLGNGGWQ--R------------------------FKEFQTEAEAIGKIRHPNIVS 427 (686)
Q Consensus 374 ~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~------------------------~~~~~~E~~~l~~l~H~nIv~ 427 (686)
.||+|++|.||+|...+|+.||||+++..... . ...+..|.+.+.++.|++|..
T Consensus 4 ~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (190)
T cd05145 4 CISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGVPV 83 (190)
T ss_pred eeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCCCC
Confidence 59999999999999878999999998654211 0 112457899999999998865
Q ss_pred eeEEEEecCceeEEEeccCCCCHHHH-hhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeec
Q 042348 428 LRAYFWSVDEKLLIYDYIPNGSLATA-IHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLG 506 (686)
Q Consensus 428 l~~~~~~~~~~~lV~e~~~~gsL~~~-l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~ 506 (686)
...+... ..++||||++++++... +.. ..++..+..+++.|++.++.++|+. .+|+||||||+||+++
T Consensus 84 p~~~~~~--~~~lVmE~~~g~~~~~~~l~~-------~~~~~~~~~~i~~~l~~~l~~lH~~--~givHrDlkP~NIll~ 152 (190)
T cd05145 84 PEPILLK--KNVLVMEFIGDDGSPAPRLKD-------VPLEEEEAEELYEQVVEQMRRLYQE--AGLVHGDLSEYNILYH 152 (190)
T ss_pred ceEEEec--CCEEEEEEecCCCchhhhhhh-------ccCCHHHHHHHHHHHHHHHHHHHHh--CCEecCCCChhhEEEE
Confidence 5444332 34899999998865443 322 2467888999999999999999973 5899999999999998
Q ss_pred CCCCeEEeecCcccccc
Q 042348 507 KNMEPHISDFGLARLAD 523 (686)
Q Consensus 507 ~~~~~kl~DfGla~~~~ 523 (686)
++.++|+|||+++...
T Consensus 153 -~~~~~liDFG~a~~~~ 168 (190)
T cd05145 153 -DGKPYIIDVSQAVELD 168 (190)
T ss_pred -CCCEEEEEcccceecC
Confidence 8899999999998654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.7e-19 Score=173.63 Aligned_cols=134 Identities=18% Similarity=0.210 Sum_probs=105.6
Q ss_pred cccCccCceEEEEEEeCCCceEEEEEcCCCCccchHHHHHHHHHHhcc-----CCCCcceeeEEEEecC---cee-EEEe
Q 042348 373 FLLGKSTIGIVYKVALNNEEAVAVRRLGNGGWQRFKEFQTEAEAIGKI-----RHPNIVSLRAYFWSVD---EKL-LIYD 443 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~H~nIv~l~~~~~~~~---~~~-lV~e 443 (686)
..||+|+||.||. .++....+||++........+.+.+|+++++++ +||||++++|++.++. ..+ +|+|
T Consensus 8 ~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~e 85 (210)
T PRK10345 8 SPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIAD 85 (210)
T ss_pred ceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEec
Confidence 4799999999996 443333478988765444567899999999999 5799999999999874 333 7899
Q ss_pred c--cCCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHH-HHHHccCCCCceecCCCCCCeeecC----CCCeEEee-
Q 042348 444 Y--IPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGI-AFLHEVSPKRYVHGDLRPSNILLGK----NMEPHISD- 515 (686)
Q Consensus 444 ~--~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL-~~LH~~~~~~iiHrDlkp~NILl~~----~~~~kl~D- 515 (686)
| +++|+|.+++... .+++. ..++.+++.++ +|||+ ++|+||||||+|||++. +..++|+|
T Consensus 86 ~~G~~~~tL~~~l~~~-------~~~e~--~~~~~~~L~~l~~yLh~---~~IvhrDlKp~NILl~~~~~~~~~~~LiDg 153 (210)
T PRK10345 86 FDGKPSITLTEFAEQC-------RYEED--VAQLRQLLKKLKRYLLD---NRIVTMELKPQNILCQRISESEVIPVVCDN 153 (210)
T ss_pred CCCCcchhHHHHHHcc-------cccHh--HHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEeccCCCCCcEEEEEC
Confidence 9 5689999999652 24444 36688888888 99999 99999999999999974 34799999
Q ss_pred cCccc
Q 042348 516 FGLAR 520 (686)
Q Consensus 516 fGla~ 520 (686)
||...
T Consensus 154 ~G~~~ 158 (210)
T PRK10345 154 IGEST 158 (210)
T ss_pred CCCcc
Confidence 55443
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.6e-19 Score=201.27 Aligned_cols=137 Identities=36% Similarity=0.626 Sum_probs=86.0
Q ss_pred CChhHHHHHHHHHHhccCCCCCCCCCCCCCCCc-----ceeeeEecCCCEEEEEeCCCCccccCCcCcCCCCCCCEEEcc
Q 042348 15 SANDEGLALLSFKQAIRNFPEGNNWNNSNEDPC-----SWNGITCREGQVFSLIIPNKKLTGFIPADLGSLSAIGRVNLR 89 (686)
Q Consensus 15 ~~~~~~~~l~~~k~~~~~~~~~~~w~~~~~~~c-----~w~gv~c~~~~~~~l~l~~n~l~g~~p~~l~~l~~L~~L~L~ 89 (686)
....|..||+.+|+.+. .+...+|+ ++|| .|.||.|..... + ....++.|+|+
T Consensus 369 t~~~~~~aL~~~k~~~~-~~~~~~W~---g~~C~p~~~~w~Gv~C~~~~~----------~--------~~~~v~~L~L~ 426 (623)
T PLN03150 369 TLLEEVSALQTLKSSLG-LPLRFGWN---GDPCVPQQHPWSGADCQFDST----------K--------GKWFIDGLGLD 426 (623)
T ss_pred cCchHHHHHHHHHHhcC-CcccCCCC---CCCCCCcccccccceeeccCC----------C--------CceEEEEEECC
Confidence 34568999999999985 34335685 3677 699999952110 0 00124455666
Q ss_pred CCCCcccCCccccCCCCCcEEEccCCCCCCCCcccccCCCCCCEEeccCCCCCCCCChhhhhccccccccccccccCCCC
Q 042348 90 NNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPL 169 (686)
Q Consensus 90 ~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 169 (686)
+|.++|.+|.++.++++|+.|+|++|+|+|.+|..++.+++|+.|+|++|+|+|.+|..++++++|+.|+|++|+|+|.+
T Consensus 427 ~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~i 506 (623)
T PLN03150 427 NQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRV 506 (623)
T ss_pred CCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccccC
Confidence 66666666666666666666666666666666666666677777777777776666666655555555555555555555
Q ss_pred chhh
Q 042348 170 PDGF 173 (686)
Q Consensus 170 p~~~ 173 (686)
|..+
T Consensus 507 P~~l 510 (623)
T PLN03150 507 PAAL 510 (623)
T ss_pred ChHH
Confidence 5443
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.4e-20 Score=207.08 Aligned_cols=250 Identities=20% Similarity=0.286 Sum_probs=173.7
Q ss_pred cccCccCceEEEEEEeCCCceEEEEEcCCCC-ccchHHHHHHHHH--HhccCCCCcceeeEEEEecCceeEEEeccCCCC
Q 042348 373 FLLGKSTIGIVYKVALNNEEAVAVRRLGNGG-WQRFKEFQTEAEA--IGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGS 449 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~--l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gs 449 (686)
+.+|+++|=.|.+++.+.|. |+||++-+.. .-..+.|.++++- ...++|||++++.-+-....-.|+|=+|..+ +
T Consensus 29 ~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqyvkh-n 106 (1431)
T KOG1240|consen 29 ENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQYVKH-N 106 (1431)
T ss_pred cccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHHHhh-h
Confidence 45999999999999999887 8899885543 3334444443333 4555899999998877777778899999965 9
Q ss_pred HHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCc
Q 042348 450 LATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETP 529 (686)
Q Consensus 450 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 529 (686)
|+|.+..+ ..|...+.+-|+.|++.||..+|. .+|+|||||.+||||..-.-+.|+||..-|..--.+..+
T Consensus 107 LyDRlSTR------PFL~~iEKkWiaFQLL~al~qcH~---~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNP 177 (1431)
T KOG1240|consen 107 LYDRLSTR------PFLVLIEKKWIAFQLLKALSQCHK---LGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNP 177 (1431)
T ss_pred hhhhhccc------hHHHHHHHHHHHHHHHHHHHHHHH---cCccccccccceEEEeeechhhhhcccccCCccCCCCCc
Confidence 99998765 347777888899999999999999 899999999999999999999999998665322111111
Q ss_pred cccccccccCCCCCCCccccccccCCCCCccccCcccccCC----------C-CCCcchHHHHHHHHHHHHh-CCCCccc
Q 042348 530 EVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVR----------K-PTQKWDIYSYGVILLEMIS-GKLPMIQ 597 (686)
Q Consensus 530 ~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------~-~~~~sDVwSlGvvl~ellt-G~~P~~~ 597 (686)
. .+.+.. ........|+|||.+... . .+++.||||+|||+.||++ |++||.-
T Consensus 178 a---------------df~fFF-DTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L 241 (1431)
T KOG1240|consen 178 A---------------DFTFFF-DTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL 241 (1431)
T ss_pred c---------------cceEEE-ecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH
Confidence 0 011111 112223359999976431 1 5788999999999999999 7888821
Q ss_pred cCccchhHHHHHHHHHhhcCCcccccCcc-cccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 042348 598 IGSMELNIVQWIQLILEDRKPMTDILDPF-LAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDR 667 (686)
Q Consensus 598 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~-l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~ 667 (686)
.+... ...+. ..++. +.... +-..+..++..|++.||++|-++++.++.-..
T Consensus 242 --------SQL~a-Yr~~~-----~~~~e~~Le~I----ed~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG 294 (1431)
T KOG1240|consen 242 --------SQLLA-YRSGN-----ADDPEQLLEKI----EDVSLRNLILSMIQRDPSKRLSAEDYLQKYRG 294 (1431)
T ss_pred --------HHHHh-HhccC-----ccCHHHHHHhC----cCccHHHHHHHHHccCchhccCHHHHHHhhhc
Confidence 11110 00010 01110 00000 11146689999999999999999999887444
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.3e-18 Score=172.83 Aligned_cols=229 Identities=20% Similarity=0.267 Sum_probs=142.5
Q ss_pred cccCccCceEEEEEEeCC-CceEEEEEcCCC---CccchHHHHHHHHHHhccCC----------CCcceeeEEEEe----
Q 042348 373 FLLGKSTIGIVYKVALNN-EEAVAVRRLGNG---GWQRFKEFQTEAEAIGKIRH----------PNIVSLRAYFWS---- 434 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H----------~nIv~l~~~~~~---- 434 (686)
..||.|+++.||.++..+ ++.+|||.+... .....+++.+|.-....+.+ -.++.-++...-
T Consensus 18 ~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~~~ 97 (288)
T PF14531_consen 18 RIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPGKP 97 (288)
T ss_dssp EEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETTS-
T ss_pred cccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcCCC
Confidence 469999999999999874 889999987432 23345667777766555432 222222222221
Q ss_pred -----cC--------ceeEEEeccCCCCHHHHhhc---CCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCC
Q 042348 435 -----VD--------EKLLIYDYIPNGSLATAIHG---KAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDL 498 (686)
Q Consensus 435 -----~~--------~~~lV~e~~~~gsL~~~l~~---~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDl 498 (686)
.. ..+++|+-+ .+||.+++.. .... ...+....++.+..|+++.+++||+ .|++|+||
T Consensus 98 ~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~--~~~l~~~arl~lT~Q~I~lvA~Lh~---~GlVHgdi 171 (288)
T PF14531_consen 98 PFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQT--HSPLAFAARLSLTVQMIRLVANLHS---YGLVHGDI 171 (288)
T ss_dssp SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTT--SHHHHHHHHHHHHHHHHHHHHHHHH---TTEEEST-
T ss_pred cceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccc--cchhHHHHHHHHHHHHHHHHHHHhh---cceEeccc
Confidence 11 236678877 5688888653 1110 1234456667888999999999999 99999999
Q ss_pred CCCCeeecCCCCeEEeecCcccccccccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccC--------C
Q 042348 499 RPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKV--------R 570 (686)
Q Consensus 499 kp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~ 570 (686)
||+|++++.+|.++|+||+.......... ....+..|.+||.... -
T Consensus 172 ~~~nfll~~~G~v~Lg~F~~~~r~g~~~~--------------------------~~~~~~~~~PPe~~~~~~~~~~~~~ 225 (288)
T PF14531_consen 172 KPENFLLDQDGGVFLGDFSSLVRAGTRYR--------------------------CSEFPVAFTPPELESCAGQFGQNNA 225 (288)
T ss_dssp SGGGEEE-TTS-EEE--GGGEEETTEEEE--------------------------GGGS-TTTS-HHHHHHHTSCHHSEE
T ss_pred ceeeEEEcCCCCEEEcChHHHeecCceee--------------------------ccCCCcccCChhhhhhhcccCcccc
Confidence 99999999999999999987764332110 0112345889996633 2
Q ss_pred CCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhcccc
Q 042348 571 KPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHK 650 (686)
Q Consensus 571 ~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~ 650 (686)
.++.+.|.|++|+++|.|.+|..||........... .+.. .. +-++.+..|+..+|++
T Consensus 226 ~~t~~~DaW~LG~~ly~lWC~~lPf~~~~~~~~~~~-------------------~f~~--C~-~~Pe~v~~LI~~lL~~ 283 (288)
T PF14531_consen 226 PYTFATDAWQLGITLYSLWCGRLPFGLSSPEADPEW-------------------DFSR--CR-DMPEPVQFLIRGLLQR 283 (288)
T ss_dssp EE-HHHHHHHHHHHHHHHHHSS-STCCCGGGSTSGG-------------------GGTT--SS----HHHHHHHHHHT-S
T ss_pred eeeeccCHHHHHHHHHHHHHccCCCCCCCccccccc-------------------cchh--cC-CcCHHHHHHHHHHccC
Confidence 478899999999999999999999954322211000 1111 11 3455688899999999
Q ss_pred CCCCC
Q 042348 651 SPDKR 655 (686)
Q Consensus 651 dP~~R 655 (686)
||++|
T Consensus 284 ~~~~R 288 (288)
T PF14531_consen 284 NPEDR 288 (288)
T ss_dssp SGGGS
T ss_pred CcccC
Confidence 99988
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=4.5e-18 Score=168.32 Aligned_cols=201 Identities=20% Similarity=0.307 Sum_probs=139.3
Q ss_pred CCCCcceeeEEEEe---------------------------cCceeEEEeccCCCCHHHHhhcCCCccccCCCCHHHHHH
Q 042348 421 RHPNIVSLRAYFWS---------------------------VDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLR 473 (686)
Q Consensus 421 ~H~nIv~l~~~~~~---------------------------~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~ 473 (686)
+|||||++.++|.+ +...|+||.-++. +|.+++-.+ ..+.....-
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~-------~~s~r~~~~ 345 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTR-------HRSYRTGRV 345 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcC-------CCchHHHHH
Confidence 59999999998854 2235899998865 999998764 355666777
Q ss_pred HHHHHHHHHHHHHccCCCCceecCCCCCCeeec--CCC--CeEEeecCcccccccccCCccccccccccCCCCCCCcccc
Q 042348 474 IIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLG--KNM--EPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEF 549 (686)
Q Consensus 474 i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~--~~~--~~kl~DfGla~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~ 549 (686)
|+.|+++|..|||. ++|.|||+|++|||+. +|+ ...|+|||++-.-+..+ -...+ +
T Consensus 346 ~laQlLEav~hL~~---hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hG--lqlpy--------------~- 405 (598)
T KOG4158|consen 346 ILAQLLEAVTHLHK---HGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHG--LQLPY--------------E- 405 (598)
T ss_pred HHHHHHHHHHHHHH---ccchhhcccccceEEEecCCCCcEEEEcccceeeeccccc--ccccc--------------c-
Confidence 89999999999999 9999999999999994 444 46889999875322110 00000 0
Q ss_pred ccccCCCCCccccCcccccCCC------CCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHHHHHHHhhcCCccccc
Q 042348 550 TALNSTTSRSYYQAPEASKVRK------PTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQWIQLILEDRKPMTDIL 623 (686)
Q Consensus 550 ~~~~~~~gt~~y~aPE~~~~~~------~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 623 (686)
...-...|...-||||+....+ --.|+|.|+.|.+.||+++...||...+..-.+...+-+. +-.++++-
T Consensus 406 S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~---qLPalp~~- 481 (598)
T KOG4158|consen 406 SDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQES---QLPALPSR- 481 (598)
T ss_pred cccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhh---hCCCCccc-
Confidence 1112334566789999876532 2458999999999999999999997755544433331111 11122222
Q ss_pred CcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 042348 624 DPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSL 665 (686)
Q Consensus 624 d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L 665 (686)
+...+.+++...|+.||++|++..-....|
T Consensus 482 ------------vpp~~rqlV~~lL~r~pskRvsp~iAANvl 511 (598)
T KOG4158|consen 482 ------------VPPVARQLVFDLLKRDPSKRVSPNIAANVL 511 (598)
T ss_pred ------------CChHHHHHHHHHhcCCccccCCccHHHhHH
Confidence 223466888899999999999876555544
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.7e-17 Score=162.42 Aligned_cols=133 Identities=20% Similarity=0.364 Sum_probs=113.0
Q ss_pred ccCccCceEEEEEEeCCCceEEEEEcCCCCcc--------chHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEecc
Q 042348 374 LLGKSTIGIVYKVALNNEEAVAVRRLGNGGWQ--------RFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYI 445 (686)
Q Consensus 374 ~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~ 445 (686)
.||+|++|.||+|.. .+..|++|........ ....+.+|++++..+.|++|+....++...+..++||||+
T Consensus 3 ~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 81 (211)
T PRK14879 3 LIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEYI 81 (211)
T ss_pred ccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEEe
Confidence 589999999999987 5677889976543211 1245788999999999999988888887788889999999
Q ss_pred CCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccc
Q 042348 446 PNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARL 521 (686)
Q Consensus 446 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~ 521 (686)
+|++|.+++... .+ .+..++.+++.+|+++|+ .+++|||++|+||+++ ++.++|+|||.++.
T Consensus 82 ~G~~L~~~~~~~---------~~-~~~~i~~~i~~~l~~lH~---~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 82 EGEPLKDLINSN---------GM-EELELSREIGRLVGKLHS---AGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred CCcCHHHHHHhc---------cH-HHHHHHHHHHHHHHHHHh---CCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 999999998642 12 788999999999999999 8999999999999999 78999999999874
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.5e-17 Score=164.30 Aligned_cols=137 Identities=15% Similarity=0.160 Sum_probs=106.6
Q ss_pred hcccCccCceEEEEEE--eCCCceEEEEEcCCCCcc------------------------chHHHHHHHHHHhccCCC--
Q 042348 372 AFLLGKSTIGIVYKVA--LNNEEAVAVRRLGNGGWQ------------------------RFKEFQTEAEAIGKIRHP-- 423 (686)
Q Consensus 372 ~~~iG~G~~g~Vy~~~--~~~~~~vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l~H~-- 423 (686)
...||+|++|.||+|. ..+|+.||+|.+...... ....+..|++.+.++.+.
T Consensus 33 ~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~~~i 112 (237)
T smart00090 33 GGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYEAGV 112 (237)
T ss_pred CCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 3469999999999998 567999999988643210 012356899999999753
Q ss_pred CcceeeEEEEecCceeEEEeccCCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCC-ceecCCCCCC
Q 042348 424 NIVSLRAYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKR-YVHGDLRPSN 502 (686)
Q Consensus 424 nIv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~-iiHrDlkp~N 502 (686)
.+.+++++ ...++||||+++++|....... ..+...+...++.|++.++++||+ .+ |+||||||+|
T Consensus 113 ~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~------~~~~~~~~~~i~~qi~~~l~~LH~---~g~iiH~Dikp~N 179 (237)
T smart00090 113 PVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD------VEPEEEEEFELYDDILEEMRKLYK---EGELVHGDLSEYN 179 (237)
T ss_pred CCCeeeEe----cCceEEEEEecCCccccccccc------CCcchHHHHHHHHHHHHHHHHHHh---cCCEEeCCCChhh
Confidence 34444443 2458999999998887654322 234556678999999999999999 88 9999999999
Q ss_pred eeecCCCCeEEeecCccccc
Q 042348 503 ILLGKNMEPHISDFGLARLA 522 (686)
Q Consensus 503 ILl~~~~~~kl~DfGla~~~ 522 (686)
|+++ ++.++|+|||.+...
T Consensus 180 Ili~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 180 ILVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred EEEE-CCCEEEEEChhhhcc
Confidence 9999 889999999998743
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.7e-17 Score=159.40 Aligned_cols=130 Identities=22% Similarity=0.370 Sum_probs=107.2
Q ss_pred ccCccCceEEEEEEeCCCceEEEEEcCCCCc--------cchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEecc
Q 042348 374 LLGKSTIGIVYKVALNNEEAVAVRRLGNGGW--------QRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYI 445 (686)
Q Consensus 374 ~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~ 445 (686)
+||+|+||.||+|.+ ++..|++|....... ....++.+|++++..++|+++.....++...+..++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999985 467899998643211 11356778999999999887766666666677789999999
Q ss_pred CCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccc
Q 042348 446 PNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARL 521 (686)
Q Consensus 446 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~ 521 (686)
+|++|.+++.... . .++.+++.+|++||+ .+++|||++|.||+++ ++.++++|||+++.
T Consensus 80 ~g~~l~~~~~~~~------~-------~~~~~i~~~l~~lH~---~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGN------D-------ELLREIGRLVGKLHK---AGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcH------H-------HHHHHHHHHHHHHHH---CCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 9999999875421 0 789999999999999 8999999999999999 88999999999874
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.7e-17 Score=186.87 Aligned_cols=189 Identities=19% Similarity=0.273 Sum_probs=148.6
Q ss_pred hcccCccCceEEEEEEeCCCceEEEEEcCCCCccchHHHHHHHHHHhccC---CCCcceeeEEEEecCceeEEEeccCCC
Q 042348 372 AFLLGKSTIGIVYKVALNNEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIR---HPNIVSLRAYFWSVDEKLLIYDYIPNG 448 (686)
Q Consensus 372 ~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---H~nIv~l~~~~~~~~~~~lV~e~~~~g 448 (686)
...||+|+||.||+|...+|+.||+|.-+....-+ |--=.+++.||+ -+-|..+...+.-.+.-++|+||.+.|
T Consensus 703 ~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE---fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~ey~~~G 779 (974)
T KOG1166|consen 703 SKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE---FYICLQVMERLKPQMLPSIMHISSAHVFQNASVLVSEYSPYG 779 (974)
T ss_pred EeeeccccceEEEEeecCCCcEEEEEeecCCCcee---eeehHHHHHhhchhhhcchHHHHHHHccCCcceeeeeccccc
Confidence 45699999999999998889999999876543222 111122333333 345556666666677889999999999
Q ss_pred CHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeec-------CCCCeEEeecCcccc
Q 042348 449 SLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLG-------KNMEPHISDFGLARL 521 (686)
Q Consensus 449 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~-------~~~~~kl~DfGla~~ 521 (686)
+|.+++... +.++|..++.+..|+++-+++||. .+|||+||||+|.||. +...++|+|||.+-.
T Consensus 780 tlld~~N~~------~~m~e~lv~~~~~qml~ive~lH~---~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siD 850 (974)
T KOG1166|consen 780 TLLDLINTN------KVMDEYLVMFFSCQMLRIVEHLHA---MGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSID 850 (974)
T ss_pred cHHHhhccC------CCCCchhhhHHHHHHHHHHHHHHh---cceecccCCcceeEeecccCCCCcccceEEEeccccee
Confidence 999999843 568999999999999999999999 8999999999999994 234689999999875
Q ss_pred cccccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCC
Q 042348 522 ADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKL 593 (686)
Q Consensus 522 ~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~ 593 (686)
+..-... +......+|-.+--+|+..+..++..+|-|.+..+++-|+.|+.
T Consensus 851 m~lfp~~---------------------~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 851 MKLFPDG---------------------TKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred eeEcCCC---------------------cEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 5422111 23345566778999999999999999999999999999999983
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.71 E-value=6.5e-17 Score=180.16 Aligned_cols=133 Identities=25% Similarity=0.387 Sum_probs=108.5
Q ss_pred hcccCccCceEEEEEEeCCCceEEEEEcCCC-Cc------cchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEec
Q 042348 372 AFLLGKSTIGIVYKVALNNEEAVAVRRLGNG-GW------QRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDY 444 (686)
Q Consensus 372 ~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~-~~------~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~ 444 (686)
.+.||+|+||.||+|.+.+...++.+++... .. ...+++.+|++++.+++|++++....++...+..++||||
T Consensus 338 ~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~E~ 417 (535)
T PRK09605 338 DHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIVMEY 417 (535)
T ss_pred cceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEEEEe
Confidence 4579999999999998765443332222221 11 1235688999999999999999988888887888999999
Q ss_pred cCCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCccccc
Q 042348 445 IPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLA 522 (686)
Q Consensus 445 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~ 522 (686)
+++++|.+++. ....++.+++.+|+|||+ .+++||||||+||++ +++.++|+|||+++..
T Consensus 418 ~~g~~L~~~l~--------------~~~~~~~~i~~~L~~lH~---~giiHrDlkp~NILl-~~~~~~liDFGla~~~ 477 (535)
T PRK09605 418 IGGKDLKDVLE--------------GNPELVRKVGEIVAKLHK---AGIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS 477 (535)
T ss_pred cCCCcHHHHHH--------------HHHHHHHHHHHHHHHHHh---CCCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence 99999998874 346789999999999999 899999999999999 6789999999999754
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.70 E-value=1e-16 Score=155.01 Aligned_cols=132 Identities=17% Similarity=0.140 Sum_probs=105.1
Q ss_pred hcccCccCceEEEEEEeCCCceEEEEEcCCCCc--c--------------------chHHHHHHHHHHhccCCC--Ccce
Q 042348 372 AFLLGKSTIGIVYKVALNNEEAVAVRRLGNGGW--Q--------------------RFKEFQTEAEAIGKIRHP--NIVS 427 (686)
Q Consensus 372 ~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~--------------------~~~~~~~E~~~l~~l~H~--nIv~ 427 (686)
.+.||+|+||.||++...+|+.||||++..... . ....+..|+.++.++.|+ .+++
T Consensus 20 ~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~v~~ 99 (198)
T cd05144 20 GNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFPVPK 99 (198)
T ss_pred CCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCCCCc
Confidence 457999999999999988899999998654220 0 012367899999999887 4444
Q ss_pred eeEEEEecCceeEEEeccCCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecC
Q 042348 428 LRAYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGK 507 (686)
Q Consensus 428 l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~ 507 (686)
.++ ....++||||+++++|.++... .....++.+++.++.++|+ .+|+||||||+||++++
T Consensus 100 ~~~----~~~~~lv~e~~~g~~L~~~~~~------------~~~~~~~~~i~~~l~~lh~---~gi~H~Dl~p~Nill~~ 160 (198)
T cd05144 100 PID----WNRHAVVMEYIDGVELYRVRVL------------EDPEEVLDEILEEIVKAYK---HGIIHGDLSEFNILVDD 160 (198)
T ss_pred eee----cCCceEEEEEeCCcchhhcccc------------ccHHHHHHHHHHHHHHHHH---CCCCcCCCCcccEEEcC
Confidence 443 2456899999999998765321 2346788999999999999 89999999999999999
Q ss_pred CCCeEEeecCccccc
Q 042348 508 NMEPHISDFGLARLA 522 (686)
Q Consensus 508 ~~~~kl~DfGla~~~ 522 (686)
++.++|+|||++...
T Consensus 161 ~~~~~liDfg~~~~~ 175 (198)
T cd05144 161 DEKIYIIDWPQMVST 175 (198)
T ss_pred CCcEEEEECCccccC
Confidence 999999999999644
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.9e-18 Score=178.47 Aligned_cols=194 Identities=23% Similarity=0.243 Sum_probs=153.4
Q ss_pred eeEecCCCEEEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCccccCCCCCcEEEccCCCCCCCCcccccCCCC
Q 042348 51 GITCREGQVFSLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGKLKY 130 (686)
Q Consensus 51 gv~c~~~~~~~l~l~~n~l~g~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~ 130 (686)
|++-.-..+..|+|..|+++..-.+++.+|++|+.|+||+|.|+..-+..+.-.++|++|+|++|+|+..-+..|..|..
T Consensus 263 G~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~ 342 (873)
T KOG4194|consen 263 GAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQ 342 (873)
T ss_pred cceeeecccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHH
Confidence 44333356778888888888877788888888888888888888777788888888888888888888767777888888
Q ss_pred CCEEeccCCCCCCCCChhhhhccccccccccccccCCCCchh--hhhcCcccceecccccccCCCCchhhhccccccccc
Q 042348 131 LQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDG--FATNLTALQKLDLSFNNLSGLIPNDIANLSRLRLLA 208 (686)
Q Consensus 131 L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~--~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~ 208 (686)
|++|+|++|.++..-...|..+.+|+.|+|++|.+++.|.++ .+.+|++|+.|+|.+|+|..+.-..|..|.+|..|
T Consensus 343 Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~L- 421 (873)
T KOG4194|consen 343 LEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHL- 421 (873)
T ss_pred hhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCceeeecchhhhccCccccee-
Confidence 888888888888666777888888888888888888766542 23568888888888888887767778887777655
Q ss_pred ccccccccCCCCCCCcccccccccCCcccccCCCCCCCCCCC
Q 042348 209 QRVYVDLTYNNLSGLIPQNAALLSLGPTAFIGNPFLCGPPLK 250 (686)
Q Consensus 209 ~~~~l~l~~N~l~~~~p~~~~~~~~~~~~~~~n~~~c~~p~~ 250 (686)
||.+|-+..+-|..+.-..+..+-+..-.++|++.+.
T Consensus 422 -----dL~~NaiaSIq~nAFe~m~Lk~Lv~nSssflCDCql~ 458 (873)
T KOG4194|consen 422 -----DLGDNAIASIQPNAFEPMELKELVMNSSSFLCDCQLK 458 (873)
T ss_pred -----cCCCCcceeecccccccchhhhhhhcccceEEeccHH
Confidence 9999999988888877667777777788889988653
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.1e-17 Score=172.85 Aligned_cols=180 Identities=24% Similarity=0.344 Sum_probs=130.1
Q ss_pred ceeEEEeccCCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeec
Q 042348 437 EKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDF 516 (686)
Q Consensus 437 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~Df 516 (686)
..++.|++|...+|.+||..+... ...++...+.++.|++.|++| ++.+|||+||.||+...+..+||.||
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~---e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDF 400 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTG---EERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDF 400 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcc---cccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhh
Confidence 468999999999999999865432 457888899999999999999 47899999999999999999999999
Q ss_pred CcccccccccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCc
Q 042348 517 GLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPM 595 (686)
Q Consensus 517 Gla~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~ 595 (686)
|+......... + .......+..+||..||+||.+.+..|+.|+||||||++++|+++ =..++
T Consensus 401 gl~ts~~~~~~-------------~----~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~ 463 (516)
T KOG1033|consen 401 GLVTSQDKDET-------------V----APAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQF 463 (516)
T ss_pred hheeecccCCc-------------c----cchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHH
Confidence 99875543320 0 011234456788999999999999999999999999999999998 22233
Q ss_pred cccCccchhHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHH
Q 042348 596 IQIGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVC 662 (686)
Q Consensus 596 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~ 662 (686)
.... ....+.. ..++|....+.. .-..++.+++...|.+||++.++.
T Consensus 464 er~~--------t~~d~r~------g~ip~~~~~d~p------~e~~ll~~lls~~p~~RP~~~~~~ 510 (516)
T KOG1033|consen 464 ERIA--------TLTDIRD------GIIPPEFLQDYP------EEYTLLQQLLSPSPEERPSAIEVA 510 (516)
T ss_pred HHHH--------hhhhhhc------CCCChHHhhcCc------HHHHHHHHhcCCCcccCchHHHHh
Confidence 1110 0111111 112221111111 234678899999999999555543
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.69 E-value=4e-18 Score=168.68 Aligned_cols=193 Identities=23% Similarity=0.322 Sum_probs=151.0
Q ss_pred CCEEEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCccccCCCCCcEEEccC-CCCCCCCcccccCCCCCCEEe
Q 042348 57 GQVFSLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSG-NSFSGPVPMQIGKLKYLQVLD 135 (686)
Q Consensus 57 ~~~~~l~l~~n~l~g~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~-N~l~g~~p~~~~~l~~L~~L~ 135 (686)
...+.|+|..|+|+...|..|+.+++|++||||+|+|+.+-|.+|.++++|..|-|-+ |+|+...-..|++|.+|+.|.
T Consensus 67 ~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrLl 146 (498)
T KOG4237|consen 67 PETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFGGLSSLQRLL 146 (498)
T ss_pred CcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhhhHHHHHHHh
Confidence 4678899999999988888999999999999999999988999999999988876666 999865556788888777777
Q ss_pred ccCCCCCCCCChhhhhccccccccccccccC-------------------------------------------------
Q 042348 136 LSQNSFSSSIPSSIVQCKRLKTVVLNQNSFT------------------------------------------------- 166 (686)
Q Consensus 136 ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~------------------------------------------------- 166 (686)
+.-|++.-.....|..+++|..|.|.+|.+.
T Consensus 147 lNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCnL~wla~~~a~~~ietsgarc~ 226 (498)
T KOG4237|consen 147 LNANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCNLPWLADDLAMNPIETSGARCV 226 (498)
T ss_pred cChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccccccccchhhhHHhhchhhcccceec
Confidence 7777776555555665655555555544432
Q ss_pred ------------------------------------CCCchhhhhcCcccceecccccccCCCCchhhhcccccccc---
Q 042348 167 ------------------------------------GPLPDGFATNLTALQKLDLSFNNLSGLIPNDIANLSRLRLL--- 207 (686)
Q Consensus 167 ------------------------------------~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l--- 207 (686)
+.-|...+..|++|+.|||++|+++++-+.+|..+..++.|
T Consensus 227 ~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~ 306 (498)
T KOG4237|consen 227 SPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLT 306 (498)
T ss_pred chHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhhhhcchhhhhhhhcC
Confidence 01122223578999999999999999999999988887655
Q ss_pred ---------------cccccccccCCCCCCCcccccc-cccCCcccccCCCCCCCCCC
Q 042348 208 ---------------AQRVYVDLTYNNLSGLIPQNAA-LLSLGPTAFIGNPFLCGPPL 249 (686)
Q Consensus 208 ---------------~~~~~l~l~~N~l~~~~p~~~~-~~~~~~~~~~~n~~~c~~p~ 249 (686)
..+..|+|..|+|+..-|..++ ...+..+.+.+|||.|.+.+
T Consensus 307 ~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~CnC~l 364 (498)
T KOG4237|consen 307 RNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNCNCRL 364 (498)
T ss_pred cchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCcccCccch
Confidence 2456789999999998887765 44567788999999998754
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.66 E-value=1.1e-16 Score=176.59 Aligned_cols=212 Identities=21% Similarity=0.295 Sum_probs=139.1
Q ss_pred hcccCccCceEEEEEEeCC-CceEEEEEcCCCCccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCCH
Q 042348 372 AFLLGKSTIGIVYKVALNN-EEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSL 450 (686)
Q Consensus 372 ~~~iG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL 450 (686)
.++|..|+||.||.++++. .+..|+| +.+... +.+- ++.....|.+| ||-
T Consensus 88 IklisngAygavylvrh~~trqrfa~k-iNkq~l-----ilRn--ilt~a~npfvv---------------------gDc 138 (1205)
T KOG0606|consen 88 IKLISNGAYGAVYLVRHKETRQRFAMK-INKQNL-----ILRN--ILTFAGNPFVV---------------------GDC 138 (1205)
T ss_pred eEeeccCCCCceeeeeccccccchhhc-ccccch-----hhhc--cccccCCccee---------------------chh
Confidence 3468999999999998774 4567773 333211 1110 33333344433 444
Q ss_pred HHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCcc
Q 042348 451 ATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPE 530 (686)
Q Consensus 451 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 530 (686)
...+... ..++.. ++.+++|||+ .+|+|||+||+|.+|..-|++|+.|||+++..-..-..
T Consensus 139 ~tllk~~------g~lPvd--------mvla~Eylh~---ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~at-- 199 (1205)
T KOG0606|consen 139 ATLLKNI------GPLPVD--------MVLAVEYLHS---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLAT-- 199 (1205)
T ss_pred hhhcccC------CCCcch--------hhHHhHhhcc---CCeecCCCCCCcceeeecccccccchhhhhhhhhhccc--
Confidence 4444432 223322 2789999999 99999999999999999999999999999854321110
Q ss_pred ccccccccCCCCCCCcc-cc---ccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHH
Q 042348 531 VHWEQSTTGTPLQSSPY-EF---TALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIV 606 (686)
Q Consensus 531 ~~~~~~~~g~~~~~~~~-~~---~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~ 606 (686)
..+.... .. ......+||+.|+|||++..+.|+..+|+|++|+|+||.+.|+.||.....++
T Consensus 200 ----------nl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpee---- 265 (1205)
T KOG0606|consen 200 ----------NLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE---- 265 (1205)
T ss_pred ----------hhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHH----
Confidence 0000000 00 11234588999999999999999999999999999999999999996654433
Q ss_pred HHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCC
Q 042348 607 QWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRP 656 (686)
Q Consensus 607 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 656 (686)
.+..++.+...+++- |.. ...+..+++.+.|+.+|..|-
T Consensus 266 -lfg~visd~i~wpE~-dea---------~p~Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 266 -LFGQVISDDIEWPEE-DEA---------LPPEAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred -HHhhhhhhhcccccc-CcC---------CCHHHHHHHHHHHHhChHhhc
Confidence 233333333333332 221 223566788889999999994
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.65 E-value=5.1e-18 Score=149.26 Aligned_cols=161 Identities=29% Similarity=0.456 Sum_probs=141.4
Q ss_pred cCCCCCCCEEEccCCCCcccCCccccCCCCCcEEEccCCCCCCCCcccccCCCCCCEEeccCCCCCCCCChhhhhccccc
Q 042348 77 LGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQVLDLSQNSFSSSIPSSIVQCKRLK 156 (686)
Q Consensus 77 l~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~ 156 (686)
+-+++.++.|-||+|+++ .+|+.+.++.+|+.|++++|+++ .+|..++.|+.|+.|+++.|++. .+|..|+.++.|+
T Consensus 29 Lf~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~le 105 (264)
T KOG0617|consen 29 LFNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALE 105 (264)
T ss_pred ccchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhh
Confidence 556788899999999999 88999999999999999999998 89999999999999999999998 8999999999999
Q ss_pred cccccccccCC-CCchhhhhcCcccceecccccccCCCCchhhhcccccccccccccccccCCCCCCCcccccccccCCc
Q 042348 157 TVVLNQNSFTG-PLPDGFATNLTALQKLDLSFNNLSGLIPNDIANLSRLRLLAQRVYVDLTYNNLSGLIPQNAALLSLGP 235 (686)
Q Consensus 157 ~L~L~~N~l~~-~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~~~~~l~l~~N~l~~~~p~~~~~~~~~~ 235 (686)
.|+|.+|+++. .+|..|+ .++.|+.|+|++|.|. .+|.++++|++|+.| .+..|.+-..+-+...+..+..
T Consensus 106 vldltynnl~e~~lpgnff-~m~tlralyl~dndfe-~lp~dvg~lt~lqil------~lrdndll~lpkeig~lt~lre 177 (264)
T KOG0617|consen 106 VLDLTYNNLNENSLPGNFF-YMTTLRALYLGDNDFE-ILPPDVGKLTNLQIL------SLRDNDLLSLPKEIGDLTRLRE 177 (264)
T ss_pred hhhccccccccccCCcchh-HHHHHHHHHhcCCCcc-cCChhhhhhcceeEE------eeccCchhhCcHHHHHHHHHHH
Confidence 99999999974 5788887 7999999999999999 678899999998866 8899998876666556666666
Q ss_pred ccccCCCCCCCCC
Q 042348 236 TAFIGNPFLCGPP 248 (686)
Q Consensus 236 ~~~~~n~~~c~~p 248 (686)
+-..||....-||
T Consensus 178 lhiqgnrl~vlpp 190 (264)
T KOG0617|consen 178 LHIQGNRLTVLPP 190 (264)
T ss_pred HhcccceeeecCh
Confidence 7778887654444
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.65 E-value=1.5e-15 Score=150.31 Aligned_cols=137 Identities=20% Similarity=0.200 Sum_probs=107.4
Q ss_pred HhhcccC-ccCceEEEEEEeCCCceEEEEEcCCCC-------------ccchHHHHHHHHHHhccCCCCc--ceeeEEEE
Q 042348 370 ASAFLLG-KSTIGIVYKVALNNEEAVAVRRLGNGG-------------WQRFKEFQTEAEAIGKIRHPNI--VSLRAYFW 433 (686)
Q Consensus 370 ~~~~~iG-~G~~g~Vy~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~E~~~l~~l~H~nI--v~l~~~~~ 433 (686)
....+|| .|+.|+||++... +..++||++.... ......+.+|++++.+++|++| ++.+++..
T Consensus 34 ~~~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~ 112 (239)
T PRK01723 34 QQARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARV 112 (239)
T ss_pred hcCceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeee
Confidence 4456798 8999999999886 6678998875321 1223567889999999998875 67777754
Q ss_pred ecCc----eeEEEeccCC-CCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCC
Q 042348 434 SVDE----KLLIYDYIPN-GSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKN 508 (686)
Q Consensus 434 ~~~~----~~lV~e~~~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~ 508 (686)
.... .++||||+++ .+|.+++... .++.. .+.+++.+|++||+ +||+||||||.|||++.+
T Consensus 113 ~~~~~~~~~~lV~e~l~G~~~L~~~l~~~-------~l~~~----~~~~i~~~l~~lH~---~GI~HrDlkp~NILv~~~ 178 (239)
T PRK01723 113 VRHGLFYRADILIERIEGARDLVALLQEA-------PLSEE----QWQAIGQLIARFHD---AGVYHADLNAHNILLDPD 178 (239)
T ss_pred eecCcceeeeEEEEecCCCCCHHHHHhcC-------CCCHH----HHHHHHHHHHHHHH---CCCCCCCCCchhEEEcCC
Confidence 4322 2599999997 6999988642 24433 36789999999999 999999999999999998
Q ss_pred CCeEEeecCcccc
Q 042348 509 MEPHISDFGLARL 521 (686)
Q Consensus 509 ~~~kl~DfGla~~ 521 (686)
+.++|+|||.+..
T Consensus 179 ~~v~LIDfg~~~~ 191 (239)
T PRK01723 179 GKFWLIDFDRGEL 191 (239)
T ss_pred CCEEEEECCCccc
Confidence 8999999998864
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.63 E-value=6.7e-17 Score=167.11 Aligned_cols=164 Identities=21% Similarity=0.286 Sum_probs=112.5
Q ss_pred CEEEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCccccCCCCCcEEEccCCCCCCCCcccccCCCCCCEEecc
Q 042348 58 QVFSLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQVLDLS 137 (686)
Q Consensus 58 ~~~~l~l~~n~l~g~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls 137 (686)
.+..|+|++|.++..--..|.+|.+|..|.|+.|+++...+..|.+|++|+.|+|..|++.-.--..|.+|++|+.|.|.
T Consensus 174 ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnrN~irive~ltFqgL~Sl~nlklq 253 (873)
T KOG4194|consen 174 NIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITTLPQRSFKRLPKLESLDLNRNRIRIVEGLTFQGLPSLQNLKLQ 253 (873)
T ss_pred CceEEeeccccccccccccccccchheeeecccCcccccCHHHhhhcchhhhhhccccceeeehhhhhcCchhhhhhhhh
Confidence 67888888888888777888888888888888888884445556668888888888888863225566777777777777
Q ss_pred CCCCCCCCChhhhhccccccccccccccCCCCchhhhhcCcccceecccccccCCCCchhhhcccccccccccccccccC
Q 042348 138 QNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSGLIPNDIANLSRLRLLAQRVYVDLTY 217 (686)
Q Consensus 138 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~~~~~l~l~~ 217 (686)
.|.++..-.+.|..|.++++|+|+.|+++. +-.++.-+|++|+.||||+|.|..+-++.+.-+++|..| ||++
T Consensus 254 rN~I~kL~DG~Fy~l~kme~l~L~~N~l~~-vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~L------dLs~ 326 (873)
T KOG4194|consen 254 RNDISKLDDGAFYGLEKMEHLNLETNRLQA-VNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKEL------DLSS 326 (873)
T ss_pred hcCcccccCcceeeecccceeecccchhhh-hhcccccccchhhhhccchhhhheeecchhhhcccceeE------eccc
Confidence 777665556666666666677777666663 322222356666666666666666666666666666544 6666
Q ss_pred CCCCCCccccc
Q 042348 218 NNLSGLIPQNA 228 (686)
Q Consensus 218 N~l~~~~p~~~ 228 (686)
|+++...++.+
T Consensus 327 N~i~~l~~~sf 337 (873)
T KOG4194|consen 327 NRITRLDEGSF 337 (873)
T ss_pred cccccCChhHH
Confidence 66665555443
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.63 E-value=9.7e-18 Score=166.14 Aligned_cols=173 Identities=28% Similarity=0.442 Sum_probs=153.0
Q ss_pred CEEEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCccccCCCCCcEEEccCCCCCCCCcccccCCCCCCEEecc
Q 042348 58 QVFSLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQVLDLS 137 (686)
Q Consensus 58 ~~~~l~l~~n~l~g~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls 137 (686)
.+..++..+|+++ .+|++++++.+|..|++.+|++. .+|++.-+++.|+.||..+|.++ .+|+.++.|.+|..|||.
T Consensus 138 ~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~-~l~~~~i~m~~L~~ld~~~N~L~-tlP~~lg~l~~L~~LyL~ 214 (565)
T KOG0472|consen 138 DLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLK-ALPENHIAMKRLKHLDCNSNLLE-TLPPELGGLESLELLYLR 214 (565)
T ss_pred hhhhhhccccccc-cCchHHHHHHHHHHhhccccchh-hCCHHHHHHHHHHhcccchhhhh-cCChhhcchhhhHHHHhh
Confidence 4556778899998 58889999999999999999998 66666667999999999999997 899999999999999999
Q ss_pred CCCCCCCCChhhhhccccccccccccccCCCCchhhhhcCcccceecccccccCCCCchhhhcccccccccccccccccC
Q 042348 138 QNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSGLIPNDIANLSRLRLLAQRVYVDLTY 217 (686)
Q Consensus 138 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~~~~~l~l~~ 217 (686)
.|++. .+| +|.+|..|.+|+++.|++. .+|.+...+|.+|..|||.+|+++ ..|+.+.-|.+|.. ||+|+
T Consensus 215 ~Nki~-~lP-ef~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLrsL~r------LDlSN 284 (565)
T KOG0472|consen 215 RNKIR-FLP-EFPGCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLRSLER------LDLSN 284 (565)
T ss_pred hcccc-cCC-CCCccHHHHHHHhcccHHH-hhHHHHhcccccceeeeccccccc-cCchHHHHhhhhhh------hcccC
Confidence 99998 688 8999999999999999998 799999889999999999999999 56998888877765 49999
Q ss_pred CCCCCCcccccccccCCcccccCCCCC
Q 042348 218 NNLSGLIPQNAALLSLGPTAFIGNPFL 244 (686)
Q Consensus 218 N~l~~~~p~~~~~~~~~~~~~~~n~~~ 244 (686)
|.+++.+++...+ .+....+.|||.-
T Consensus 285 N~is~Lp~sLgnl-hL~~L~leGNPlr 310 (565)
T KOG0472|consen 285 NDISSLPYSLGNL-HLKFLALEGNPLR 310 (565)
T ss_pred CccccCCcccccc-eeeehhhcCCchH
Confidence 9999988876665 7777888899853
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.61 E-value=3.9e-15 Score=137.15 Aligned_cols=133 Identities=21% Similarity=0.202 Sum_probs=112.8
Q ss_pred ccCccCceEEEEEEeCCCceEEEEEcCCCCccchHHHHHHHHHHhccCC--CCcceeeEEEEecCceeEEEeccCCCCHH
Q 042348 374 LLGKSTIGIVYKVALNNEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRH--PNIVSLRAYFWSVDEKLLIYDYIPNGSLA 451 (686)
Q Consensus 374 ~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H--~nIv~l~~~~~~~~~~~lV~e~~~~gsL~ 451 (686)
.||+|.++.||++...+ ..+++|....... ...+.+|+.++..++| .+++++++++...+..+++|||++++.+.
T Consensus 5 ~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~~ 81 (155)
T cd05120 5 LLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETLD 81 (155)
T ss_pred ecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeecc
Confidence 58999999999999865 6799999866433 4678999999999976 59999999988888899999999887665
Q ss_pred HHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCccccc
Q 042348 452 TAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLA 522 (686)
Q Consensus 452 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~ 522 (686)
.+ +......++.+++.+|+++|.....+++|+|++|+||++++++.++++|||.++..
T Consensus 82 ~~-------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~ 139 (155)
T cd05120 82 EV-------------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG 139 (155)
T ss_pred cC-------------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence 43 44566788999999999999854347999999999999999899999999998743
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.61 E-value=6.5e-17 Score=168.05 Aligned_cols=166 Identities=30% Similarity=0.479 Sum_probs=120.8
Q ss_pred CCcCcCCCCCCCEEEccCCCCcccCCccccCCCCCcEEEccCCCCCCCCcccccCCCCCCEEeccCCCCCCCCChhhhhc
Q 042348 73 IPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQVLDLSQNSFSSSIPSSIVQC 152 (686)
Q Consensus 73 ~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l 152 (686)
+|+++..|.+|..+|||.|.+. .+|..+.++++|+.|+||+|+|+ .+....+...+|++|+||.|+|+ .+|..++.|
T Consensus 214 ~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~it-eL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL 290 (1255)
T KOG0444|consen 214 IPTSLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKIT-ELNMTEGEWENLETLNLSRNQLT-VLPDAVCKL 290 (1255)
T ss_pred CCCchhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCcee-eeeccHHHHhhhhhhccccchhc-cchHHHhhh
Confidence 6677777777777777777776 67777777777777777777776 55556666677777777777777 677777777
Q ss_pred cccccccccccccC-CCCchhhhhcCcccceecccccccCCCCchhhhcccccccccccccccccCCCCCCCcccccccc
Q 042348 153 KRLKTVVLNQNSFT-GPLPDGFATNLTALQKLDLSFNNLSGLIPNDIANLSRLRLLAQRVYVDLTYNNLSGLIPQNAALL 231 (686)
Q Consensus 153 ~~L~~L~L~~N~l~-~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~~~~~l~l~~N~l~~~~p~~~~~~ 231 (686)
++|+.|.+.+|+|+ ..||++++ .|.+|+.+..++|.|. .+|+.+..|..|+.| .|++|+|-..+....-+.
T Consensus 291 ~kL~kLy~n~NkL~FeGiPSGIG-KL~~Levf~aanN~LE-lVPEglcRC~kL~kL------~L~~NrLiTLPeaIHlL~ 362 (1255)
T KOG0444|consen 291 TKLTKLYANNNKLTFEGIPSGIG-KLIQLEVFHAANNKLE-LVPEGLCRCVKLQKL------KLDHNRLITLPEAIHLLP 362 (1255)
T ss_pred HHHHHHHhccCcccccCCccchh-hhhhhHHHHhhccccc-cCchhhhhhHHHHHh------cccccceeechhhhhhcC
Confidence 77777777777765 23677774 6777777777777777 667777777777766 899999986544333455
Q ss_pred cCCcccccCCCCCCCCCC
Q 042348 232 SLGPTAFIGNPFLCGPPL 249 (686)
Q Consensus 232 ~~~~~~~~~n~~~c~~p~ 249 (686)
.+..+++..||.+.-||-
T Consensus 363 ~l~vLDlreNpnLVMPPK 380 (1255)
T KOG0444|consen 363 DLKVLDLRENPNLVMPPK 380 (1255)
T ss_pred CcceeeccCCcCccCCCC
Confidence 677788889988865553
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.60 E-value=7.9e-17 Score=178.49 Aligned_cols=248 Identities=23% Similarity=0.290 Sum_probs=183.0
Q ss_pred ccCccCceEEEEEEeCC--CceEEEEEcCCCC--ccchHHHHHHHHHHhccC-CCCcceeeEEEEecCceeEEEeccCCC
Q 042348 374 LLGKSTIGIVYKVALNN--EEAVAVRRLGNGG--WQRFKEFQTEAEAIGKIR-HPNIVSLRAYFWSVDEKLLIYDYIPNG 448 (686)
Q Consensus 374 ~iG~G~~g~Vy~~~~~~--~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lV~e~~~~g 448 (686)
-||+|+|+.|-...... ...+|+|.+.... ....++...|..+-+.+. |+|++++++.....+..+++++|..++
T Consensus 27 ~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~~s~g~ 106 (601)
T KOG0590|consen 27 SIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLSYSDGG 106 (601)
T ss_pred cccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccccCccccc
Confidence 38999999998876533 4556777665442 222344556888888886 999999999999999999999999999
Q ss_pred CHHHHh-hcCCCccccCCCCHHHHHHHHHHHHHHHHHHH-ccCCCCceecCCCCCCeeecCCC-CeEEeecCcccccccc
Q 042348 449 SLATAI-HGKAGIISYRPLSWSDRLRIIKGVAKGIAFLH-EVSPKRYVHGDLRPSNILLGKNM-EPHISDFGLARLADIA 525 (686)
Q Consensus 449 sL~~~l-~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH-~~~~~~iiHrDlkp~NILl~~~~-~~kl~DfGla~~~~~~ 525 (686)
++.+.+ +... ...+......++.|+..++.|+| . .++.||||||+|.+++..+ ..+++|||+|..+...
T Consensus 107 ~~f~~i~~~~~-----~~~~~~~~~~~~~ql~s~l~~~H~~---~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~ 178 (601)
T KOG0590|consen 107 SLFSKISHPDS-----TGTSSSSASRYLPQLNSGLSYLHPE---NGVTHRDIKPSNSLLDESGSALKIADFGLATAYRNK 178 (601)
T ss_pred ccccccccCCc-----cCCCCcchhhhhhhhccCccccCcc---cccccCCCCCccchhccCCCcccCCCchhhcccccc
Confidence 999988 4332 13556677889999999999999 7 8999999999999999999 9999999999866541
Q ss_pred cCCccccccccccCCCCCCCccccccccCCCC-CccccCcccccCC-CCCCcchHHHHHHHHHHHHhCCCCccccCccch
Q 042348 526 EETPEVHWEQSTTGTPLQSSPYEFTALNSTTS-RSYYQAPEASKVR-KPTQKWDIYSYGVILLEMISGKLPMIQIGSMEL 603 (686)
Q Consensus 526 ~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~ 603 (686)
.... .......| +..|+|||...+. ...+..|+||.|+++.-+++|..|+........
T Consensus 179 ~g~~--------------------~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~ 238 (601)
T KOG0590|consen 179 NGAE--------------------RSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDG 238 (601)
T ss_pred CCcc--------------------eeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccc
Confidence 1100 12234455 7889999998874 457889999999999999999999966555444
Q ss_pred hHHHHHHHHHh-hcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042348 604 NIVQWIQLILE-DRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCD 663 (686)
Q Consensus 604 ~~~~~~~~~~~-~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 663 (686)
....|...... ...++ ..-.....++..+++..+|+.|.+.+++..
T Consensus 239 ~~~~~~~~~~~~~~~~~--------------~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 239 RYSSWKSNKGRFTQLPW--------------NSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred cceeecccccccccCcc--------------ccCChhhhhcccccccCCchhccccccccc
Confidence 33333322100 00000 111224567788899999999999888754
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.59 E-value=1.1e-16 Score=166.44 Aligned_cols=155 Identities=32% Similarity=0.456 Sum_probs=137.0
Q ss_pred CCEEEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCccccCCCCCcEEEccCCCCCC-CCcccccCCCCCCEEe
Q 042348 57 GQVFSLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSG-PVPMQIGKLKYLQVLD 135 (686)
Q Consensus 57 ~~~~~l~l~~n~l~g~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g-~~p~~~~~l~~L~~L~ 135 (686)
.+++.|.|...+|. .+|..++.|.+|++|.+++|++. .+-.++..|+.|+.+++.+|+|.. -||..+..|..|++||
T Consensus 32 t~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LRsv~~R~N~LKnsGiP~diF~l~dLt~lD 109 (1255)
T KOG0444|consen 32 TQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLI-SVHGELSDLPRLRSVIVRDNNLKNSGIPTDIFRLKDLTILD 109 (1255)
T ss_pred hheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhH-hhhhhhccchhhHHHhhhccccccCCCCchhcccccceeee
Confidence 57888999888887 68999999999999999999998 788899999999999999999874 4888899999999999
Q ss_pred ccCCCCCCCCChhhhhccccccccccccccCCCCchhhhhcCcccceecccccccCCCCchhhhcccccccccccccccc
Q 042348 136 LSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSGLIPNDIANLSRLRLLAQRVYVDL 215 (686)
Q Consensus 136 ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~~~~~l~l 215 (686)
||+|+|. ..|..+..-+++.+|+||+|++. .||..++.+|+-|-.||||+|+|... |..+..|..|+.| +|
T Consensus 110 LShNqL~-EvP~~LE~AKn~iVLNLS~N~Ie-tIPn~lfinLtDLLfLDLS~NrLe~L-PPQ~RRL~~LqtL------~L 180 (1255)
T KOG0444|consen 110 LSHNQLR-EVPTNLEYAKNSIVLNLSYNNIE-TIPNSLFINLTDLLFLDLSNNRLEML-PPQIRRLSMLQTL------KL 180 (1255)
T ss_pred cchhhhh-hcchhhhhhcCcEEEEcccCccc-cCCchHHHhhHhHhhhccccchhhhc-CHHHHHHhhhhhh------hc
Confidence 9999999 79999999999999999999998 79999888999999999999999965 5566777777665 89
Q ss_pred cCCCCCC
Q 042348 216 TYNNLSG 222 (686)
Q Consensus 216 ~~N~l~~ 222 (686)
|+|.|..
T Consensus 181 s~NPL~h 187 (1255)
T KOG0444|consen 181 SNNPLNH 187 (1255)
T ss_pred CCChhhH
Confidence 9998753
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.58 E-value=1.1e-14 Score=139.66 Aligned_cols=135 Identities=19% Similarity=0.214 Sum_probs=97.5
Q ss_pred cccCccCceEEEEEEeCCCceEEEEEcCCCCcc--chHH----------------------HHHHHHHHhccCCCC--cc
Q 042348 373 FLLGKSTIGIVYKVALNNEEAVAVRRLGNGGWQ--RFKE----------------------FQTEAEAIGKIRHPN--IV 426 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~----------------------~~~E~~~l~~l~H~n--Iv 426 (686)
..||+|+||.||+|...+++.||||++...... .... ...|.+.+.++.+.. +.
T Consensus 3 ~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~ 82 (187)
T cd05119 3 GPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPVP 82 (187)
T ss_pred cccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCCC
Confidence 469999999999999888999999987643211 1111 135666666664433 44
Q ss_pred eeeEEEEecCceeEEEeccCCCCHHHH-hhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeee
Q 042348 427 SLRAYFWSVDEKLLIYDYIPNGSLATA-IHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILL 505 (686)
Q Consensus 427 ~l~~~~~~~~~~~lV~e~~~~gsL~~~-l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl 505 (686)
+.+++ ...++||||++++++... +... ... .+...++.+++.++.++|.. .+|+||||||+||++
T Consensus 83 ~~~~~----~~~~lv~e~~~g~~~~~~~l~~~-------~~~-~~~~~~~~~~~~~l~~lh~~--~~ivH~Dl~p~Nili 148 (187)
T cd05119 83 KPIDL----NRHVLVMEFIGGDGIPAPRLKDV-------RLL-EDPEELYDQILELMRKLYRE--AGLVHGDLSEYNILV 148 (187)
T ss_pred ceEec----CCCEEEEEEeCCCCccChhhhhh-------hhc-ccHHHHHHHHHHHHHHHhhc--cCcCcCCCChhhEEE
Confidence 45443 346899999998654321 1111 011 56788999999999999973 579999999999999
Q ss_pred cCCCCeEEeecCccccc
Q 042348 506 GKNMEPHISDFGLARLA 522 (686)
Q Consensus 506 ~~~~~~kl~DfGla~~~ 522 (686)
+ ++.++++|||.+...
T Consensus 149 ~-~~~~~liDfg~a~~~ 164 (187)
T cd05119 149 D-DGKVYIIDVPQAVEI 164 (187)
T ss_pred E-CCcEEEEECcccccc
Confidence 9 899999999999744
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.56 E-value=4e-16 Score=169.84 Aligned_cols=184 Identities=30% Similarity=0.413 Sum_probs=141.3
Q ss_pred CCCEEEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCccccCCCCCcEEEccCCCCCCCCcccccCCCCCCEEe
Q 042348 56 EGQVFSLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQVLD 135 (686)
Q Consensus 56 ~~~~~~l~l~~n~l~g~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ 135 (686)
+..+++++++.|++++ +|.+++.+.+|+.|+..+|+|. .+|.++...++|+.|...+|.++ .+|+...++++|++||
T Consensus 240 p~nl~~~dis~n~l~~-lp~wi~~~~nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~~~nel~-yip~~le~~~sL~tLd 316 (1081)
T KOG0618|consen 240 PLNLQYLDISHNNLSN-LPEWIGACANLEALNANHNRLV-ALPLRISRITSLVSLSAAYNELE-YIPPFLEGLKSLRTLD 316 (1081)
T ss_pred cccceeeecchhhhhc-chHHHHhcccceEecccchhHH-hhHHHHhhhhhHHHHHhhhhhhh-hCCCcccccceeeeee
Confidence 4578889999999996 5699999999999999999986 67766666666666666666665 5565566666666666
Q ss_pred ccCCCCC-------------------------------------------------CCCChhhhhccccccccccccccC
Q 042348 136 LSQNSFS-------------------------------------------------SSIPSSIVQCKRLKTVVLNQNSFT 166 (686)
Q Consensus 136 ls~N~l~-------------------------------------------------~~~p~~~~~l~~L~~L~L~~N~l~ 166 (686)
|..|+|. ...-+.+.+..+|+.|+|++|+|.
T Consensus 317 L~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~ 396 (1081)
T KOG0618|consen 317 LQSNNLPSLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLN 396 (1081)
T ss_pred ehhccccccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchhhhccccceeeeeecccccc
Confidence 6666665 222223445568899999999998
Q ss_pred CCCchhhhhcCcccceecccccccCCCCchhhhcccccccc----------------cccccccccCCCCCC-Ccccccc
Q 042348 167 GPLPDGFATNLTALQKLDLSFNNLSGLIPNDIANLSRLRLL----------------AQRVYVDLTYNNLSG-LIPQNAA 229 (686)
Q Consensus 167 ~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l----------------~~~~~l~l~~N~l~~-~~p~~~~ 229 (686)
.+|+....+|..|++|+||+|+|+. +|..+.++..|++| +++.++|+|+|+|+. .+|....
T Consensus 397 -~fpas~~~kle~LeeL~LSGNkL~~-Lp~tva~~~~L~tL~ahsN~l~~fPe~~~l~qL~~lDlS~N~L~~~~l~~~~p 474 (1081)
T KOG0618|consen 397 -SFPASKLRKLEELEELNLSGNKLTT-LPDTVANLGRLHTLRAHSNQLLSFPELAQLPQLKVLDLSCNNLSEVTLPEALP 474 (1081)
T ss_pred -cCCHHHHhchHHhHHHhcccchhhh-hhHHHHhhhhhHHHhhcCCceeechhhhhcCcceEEecccchhhhhhhhhhCC
Confidence 7899888899999999999999995 67888888887654 467789999999984 4555555
Q ss_pred cccCCcccccCCCCC
Q 042348 230 LLSLGPTAFIGNPFL 244 (686)
Q Consensus 230 ~~~~~~~~~~~n~~~ 244 (686)
..++..+++.||.++
T Consensus 475 ~p~LkyLdlSGN~~l 489 (1081)
T KOG0618|consen 475 SPNLKYLDLSGNTRL 489 (1081)
T ss_pred CcccceeeccCCccc
Confidence 577888899999974
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.50 E-value=1.5e-15 Score=150.87 Aligned_cols=152 Identities=32% Similarity=0.461 Sum_probs=132.9
Q ss_pred CEEEEEeCCCCccccCCcCcCCCCCCCE-EEccCCCCcccCCccccCCCCCcEEEccCCCCCCCCcccccCCCCCCEEec
Q 042348 58 QVFSLIIPNKKLTGFIPADLGSLSAIGR-VNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQVLDL 136 (686)
Q Consensus 58 ~~~~l~l~~n~l~g~~p~~l~~l~~L~~-L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l 136 (686)
-|+.++++.|+|. .+|..+..+..+.+ +.+++|.++ .+|..++.+++|..|+|++|-+. .+|..++.+..|+.||+
T Consensus 389 ~Vt~VnfskNqL~-elPk~L~~lkelvT~l~lsnn~is-fv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~Lnl 465 (565)
T KOG0472|consen 389 IVTSVNFSKNQLC-ELPKRLVELKELVTDLVLSNNKIS-FVPLELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNL 465 (565)
T ss_pred ceEEEecccchHh-hhhhhhHHHHHHHHHHHhhcCccc-cchHHHHhhhcceeeecccchhh-hcchhhhhhhhhheecc
Confidence 3889999999998 68988888877644 567777776 89999999999999999999998 89999999999999999
Q ss_pred cCCCCCCCCChhhhhccccccccccccccCCCCchhhhhcCcccceecccccccCCCCchhhhccccccccccccccccc
Q 042348 137 SQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSGLIPNDIANLSRLRLLAQRVYVDLT 216 (686)
Q Consensus 137 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~~~~~l~l~ 216 (686)
|.|+|. .+|..+..+..|+.+-.++|++...-|+.+ .++.+|.+|||.+|.+. .||..+++|.+|+.| +++
T Consensus 466 S~NrFr-~lP~~~y~lq~lEtllas~nqi~~vd~~~l-~nm~nL~tLDL~nNdlq-~IPp~LgnmtnL~hL------eL~ 536 (565)
T KOG0472|consen 466 SFNRFR-MLPECLYELQTLETLLASNNQIGSVDPSGL-KNMRNLTTLDLQNNDLQ-QIPPILGNMTNLRHL------ELD 536 (565)
T ss_pred cccccc-cchHHHhhHHHHHHHHhccccccccChHHh-hhhhhcceeccCCCchh-hCChhhccccceeEE------Eec
Confidence 999998 899999888889988888899984444445 58999999999999999 578899999999877 999
Q ss_pred CCCCC
Q 042348 217 YNNLS 221 (686)
Q Consensus 217 ~N~l~ 221 (686)
+|.|+
T Consensus 537 gNpfr 541 (565)
T KOG0472|consen 537 GNPFR 541 (565)
T ss_pred CCccC
Confidence 99999
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.49 E-value=1.3e-13 Score=148.48 Aligned_cols=140 Identities=22% Similarity=0.313 Sum_probs=101.1
Q ss_pred cccCccCceEEEEEEeCCCceEEEEEcCCCCccch----------------------------------------HHHHH
Q 042348 373 FLLGKSTIGIVYKVALNNEEAVAVRRLGNGGWQRF----------------------------------------KEFQT 412 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~----------------------------------------~~~~~ 412 (686)
.-||.|++|.||+|++.+|+.||||+.+....... -+|.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 35999999999999999999999999865321100 12555
Q ss_pred HHHHHhccC----CCCcceeeEEEE-ecCceeEEEeccCCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHH-HHHHHH
Q 042348 413 EAEAIGKIR----HPNIVSLRAYFW-SVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAK-GIAFLH 486 (686)
Q Consensus 413 E~~~l~~l~----H~nIv~l~~~~~-~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~-gL~~LH 486 (686)
|++.+.++. |.+-+.+-.++. .....++||||++|++|.++..... ... .+.+++..++. .+..+|
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~-----~~~---~~~~ia~~~~~~~l~ql~ 274 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDE-----AGL---DRKALAENLARSFLNQVL 274 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHh-----cCC---CHHHHHHHHHHHHHHHHH
Confidence 666666652 322233333332 2345799999999999998765321 112 24556776666 467889
Q ss_pred ccCCCCceecCCCCCCeeecCCCCeEEeecCcccccc
Q 042348 487 EVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLAD 523 (686)
Q Consensus 487 ~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~ 523 (686)
. .|++|+|+||.||++++++.++++|||++..+.
T Consensus 275 ~---~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 275 R---DGFFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred h---CCceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 8 899999999999999999999999999998665
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.46 E-value=6.3e-14 Score=136.16 Aligned_cols=211 Identities=19% Similarity=0.293 Sum_probs=141.0
Q ss_pred HHHhccCCCCcceeeEEEEecC-----ceeEEEeccCCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccC
Q 042348 415 EAIGKIRHPNIVSLRAYFWSVD-----EKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVS 489 (686)
Q Consensus 415 ~~l~~l~H~nIv~l~~~~~~~~-----~~~lV~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~ 489 (686)
.-+-++.|.|||+++.|+.+.+ ...++.|||..|++..+|++.... ...+......+|+-||..||.|||++.
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~--~~a~~~~~wkkw~tqIlsal~yLhs~~ 196 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKN--QKALFQKAWKKWCTQILSALSYLHSCD 196 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHh--hhhhhHHHHHHHHHHHHhhhhhhhccC
Confidence 4455668999999999987654 358899999999999999865432 256778888999999999999999988
Q ss_pred CCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccC
Q 042348 490 PKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKV 569 (686)
Q Consensus 490 ~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 569 (686)
| +|+|+++.-+-|++..++-+|+.----........ .+. ........+-.+|.|||+-..
T Consensus 197 P-piihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~----------~~~---------~~Ek~~~~~~~g~~a~~sg~~ 256 (458)
T KOG1266|consen 197 P-PIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVN----------STR---------EAEKSVNTSLPGFSAPESGTT 256 (458)
T ss_pred C-ccccCCcchhheeecCCceEEecccCccccchhhh----------hhh---------HhhhhccccCCccccCCcCcc
Confidence 4 89999999999999988877765321111000000 000 001112234567999998877
Q ss_pred CCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccc
Q 042348 570 RKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVH 649 (686)
Q Consensus 570 ~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~ 649 (686)
...+.++|||+||...+||..+..--....+ ......-+...... .-+ ... ..++.+|++
T Consensus 257 tn~~~a~dIy~fgmcAlemailEiq~tnseS-~~~~ee~ia~~i~~------len-----~lq--------r~~i~kcl~ 316 (458)
T KOG1266|consen 257 TNTTGASDIYKFGMCALEMAILEIQSTNSES-KVEVEENIANVIIG------LEN-----GLQ--------RGSITKCLE 316 (458)
T ss_pred cccccchhhhhhhHHHHHHHHheeccCCCcc-eeehhhhhhhheee------ccC-----ccc--------cCcCccccc
Confidence 7788899999999999999987753211111 10011111111110 000 000 145668999
Q ss_pred cCCCCCCCHHHHHHHHhc
Q 042348 650 KSPDKRPSMRHVCDSLDR 667 (686)
Q Consensus 650 ~dP~~RPs~~ev~~~L~~ 667 (686)
..|..||+|++++.|.-.
T Consensus 317 ~eP~~rp~ar~llfHpll 334 (458)
T KOG1266|consen 317 GEPNGRPDARLLLFHPLL 334 (458)
T ss_pred CCCCCCcchhhhhcCcee
Confidence 999999999999877543
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.39 E-value=4.5e-13 Score=141.76 Aligned_cols=248 Identities=19% Similarity=0.176 Sum_probs=173.7
Q ss_pred hhcccCc--cCceEEEEEEe---CCCceEEEEEcCC--CCccchHHHHHHHHHHhcc-CCCCcceeeEEEEecCceeEEE
Q 042348 371 SAFLLGK--STIGIVYKVAL---NNEEAVAVRRLGN--GGWQRFKEFQTEAEAIGKI-RHPNIVSLRAYFWSVDEKLLIY 442 (686)
Q Consensus 371 ~~~~iG~--G~~g~Vy~~~~---~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~ 442 (686)
....+|. |.+|.||.+.. .++..+|+|+-+. .......+-.+|+...+++ .|+|.++.+..+...+..++-+
T Consensus 118 ~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lfiqt 197 (524)
T KOG0601|consen 118 ISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILFIQT 197 (524)
T ss_pred cccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcceeee
Confidence 3456899 99999999876 3577889988433 2223334456777777777 5999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHH----HHHHHHccCCCCceecCCCCCCeeecCC-CCeEEeecC
Q 042348 443 DYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAK----GIAFLHEVSPKRYVHGDLRPSNILLGKN-MEPHISDFG 517 (686)
Q Consensus 443 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~----gL~~LH~~~~~~iiHrDlkp~NILl~~~-~~~kl~DfG 517 (686)
|++. .+|..+.+... ..++....+.+..+... ||.++|+ .+++|-|+||.||+...+ ..+++.|||
T Consensus 198 E~~~-~sl~~~~~~~~-----~~~p~~~l~~~~~~~~~~~~~al~~~hs---~~~~~~~~kp~~i~~~~~~~s~~~~df~ 268 (524)
T KOG0601|consen 198 ELCG-ESLQSYCHTPC-----NFLPDNLLWNSLRDWLSRDVTALSHLHS---NNIVHDDLKPANIFTTSDWTSCKLTDFG 268 (524)
T ss_pred cccc-chhHHhhhccc-----ccCCchhhhhHHhhhhhcccccccccCC---CcccccccchhheecccccceeecCCcc
Confidence 9995 78888887654 34666777788888888 9999999 899999999999999999 889999999
Q ss_pred cccccccccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccc
Q 042348 518 LARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQ 597 (686)
Q Consensus 518 la~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~ 597 (686)
+...+....-.... .......+..-|++||...+ -++.+.|+||+|.+..+..++..+...
T Consensus 269 ~v~~i~~~~~~~~~------------------~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~ 329 (524)
T KOG0601|consen 269 LVSKISDGNFSSVF------------------KVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSV 329 (524)
T ss_pred eeEEccCCccccce------------------eeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccC
Confidence 98877644321110 00111133445999998864 568899999999999999998776532
Q ss_pred cCccchhHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042348 598 IGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCD 663 (686)
Q Consensus 598 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 663 (686)
..... |.+. +....-.+.++. -..++...+..|++.+|-.|++.+.+..
T Consensus 330 g~~~~-----W~~~--r~~~ip~e~~~~----------~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 330 GKNSS-----WSQL--RQGYIPLEFCEG----------GSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred CCCCC-----cccc--ccccCchhhhcC----------cchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 21111 1100 000000011100 0112334777899999999998776543
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.37 E-value=1.7e-14 Score=149.44 Aligned_cols=148 Identities=32% Similarity=0.515 Sum_probs=100.7
Q ss_pred EEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCccccCCCCCcEEEccCCCCCCCCcccccCCCCCCEEeccCCCC
Q 042348 62 LIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQVLDLSQNSF 141 (686)
Q Consensus 62 l~l~~n~l~g~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l 141 (686)
+.|..|.+. .+|..+.+|..|+.|||+.|+++ .+|..++.|+ |+.|.+++|+++ .+|+.++.+..|..||.+.|.+
T Consensus 103 liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei 178 (722)
T KOG0532|consen 103 LILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEI 178 (722)
T ss_pred HHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeEEEecCccc-cCCcccccchhHHHhhhhhhhh
Confidence 444455555 46667777777777777777776 6777777766 777777777775 6777777777777777777777
Q ss_pred CCCCChhhhhccccccccccccccCCCCchhhhhcCcccceecccccccCCCCchhhhcccccccccccccccccCCCCC
Q 042348 142 SSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSGLIPNDIANLSRLRLLAQRVYVDLTYNNLS 221 (686)
Q Consensus 142 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~~~~~l~l~~N~l~ 221 (686)
. .+|..++.+.+|+.|.+..|++. .+|.+.. .| .|..||+|+|+++ .||-.|.+|+.|+.| -|.+|-|+
T Consensus 179 ~-slpsql~~l~slr~l~vrRn~l~-~lp~El~-~L-pLi~lDfScNkis-~iPv~fr~m~~Lq~l------~LenNPLq 247 (722)
T KOG0532|consen 179 Q-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELC-SL-PLIRLDFSCNKIS-YLPVDFRKMRHLQVL------QLENNPLQ 247 (722)
T ss_pred h-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHh-CC-ceeeeecccCcee-ecchhhhhhhhheee------eeccCCCC
Confidence 6 56777777777777777777776 5666664 33 4677777777777 457777777666654 67777776
Q ss_pred CCc
Q 042348 222 GLI 224 (686)
Q Consensus 222 ~~~ 224 (686)
..+
T Consensus 248 SPP 250 (722)
T KOG0532|consen 248 SPP 250 (722)
T ss_pred CCh
Confidence 543
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.37 E-value=8.8e-13 Score=148.35 Aligned_cols=159 Identities=27% Similarity=0.329 Sum_probs=92.4
Q ss_pred CEEEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCc---cccC-------------C-CCCcEEEccCCCCCCC
Q 042348 58 QVFSLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPV---ELFN-------------A-SNLQSLILSGNSFSGP 120 (686)
Q Consensus 58 ~~~~l~l~~n~l~g~~p~~l~~l~~L~~L~L~~N~l~g~~p~---~~~~-------------l-~~L~~L~L~~N~l~g~ 120 (686)
.++.|+|++|+|+. +|.. +++|+.|+|++|+|++ +|. .+.. + .+|+.|+|++|+|+ .
T Consensus 283 ~L~~L~Ls~N~Lt~-LP~~---p~~L~~LdLS~N~L~~-Lp~lp~~L~~L~Ls~N~L~~LP~lp~~Lq~LdLS~N~Ls-~ 356 (788)
T PRK15387 283 GLCKLWIFGNQLTS-LPVL---PPGLQELSVSDNQLAS-LPALPSELCKLWAYNNQLTSLPTLPSGLQELSVSDNQLA-S 356 (788)
T ss_pred hcCEEECcCCcccc-cccc---ccccceeECCCCcccc-CCCCcccccccccccCccccccccccccceEecCCCccC-C
Confidence 34556666666663 3432 3556666666666663 222 1111 1 36778888888887 4
Q ss_pred CcccccCCCCCCEEeccCCCCCCCCChhhhhccccccccccccccCCCCchhhhhcCcccceecccccccCCCCchhhhc
Q 042348 121 VPMQIGKLKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSGLIPNDIAN 200 (686)
Q Consensus 121 ~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 200 (686)
+|.. ..+|+.|++++|.|+ .+|.. ..+|+.|+|++|+|+ .+|.. .++|+.|+|++|+|++ +|..+.
T Consensus 357 LP~l---p~~L~~L~Ls~N~L~-~LP~l---~~~L~~LdLs~N~Lt-~LP~l----~s~L~~LdLS~N~Lss-IP~l~~- 422 (788)
T PRK15387 357 LPTL---PSELYKLWAYNNRLT-SLPAL---PSGLKELIVSGNRLT-SLPVL----PSELKELMVSGNRLTS-LPMLPS- 422 (788)
T ss_pred CCCC---Ccccceehhhccccc-cCccc---ccccceEEecCCccc-CCCCc----ccCCCEEEccCCcCCC-CCcchh-
Confidence 5543 245666777777777 35543 246777777777777 35542 3567777777777775 454332
Q ss_pred ccccccccccccccccCCCCCCCcccccccccCCcccccCCCCC
Q 042348 201 LSRLRLLAQRVYVDLTYNNLSGLIPQNAALLSLGPTAFIGNPFL 244 (686)
Q Consensus 201 l~~L~~l~~~~~l~l~~N~l~~~~p~~~~~~~~~~~~~~~n~~~ 244 (686)
+|+ +|++++|+|+.++.....+..+..+.+.+|++.
T Consensus 423 --~L~------~L~Ls~NqLt~LP~sl~~L~~L~~LdLs~N~Ls 458 (788)
T PRK15387 423 --GLL------SLSVYRNQLTRLPESLIHLSSETTVNLEGNPLS 458 (788)
T ss_pred --hhh------hhhhccCcccccChHHhhccCCCeEECCCCCCC
Confidence 222 347777777743323334455556666777654
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.34 E-value=3.5e-12 Score=144.46 Aligned_cols=146 Identities=26% Similarity=0.430 Sum_probs=106.7
Q ss_pred EecCCCEEEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCccccCCCCCcEEEccCCCCCCCCcccccCCCCCC
Q 042348 53 TCREGQVFSLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQ 132 (686)
Q Consensus 53 ~c~~~~~~~l~l~~n~l~g~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~ 132 (686)
.|.....+.|+|++++|+. +|..+. ++|+.|+|++|+|+ .+|..+. ++|+.|+|++|+|+ .+|..+. .+|+
T Consensus 174 ~Cl~~~~~~L~L~~~~Lts-LP~~Ip--~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~ 244 (754)
T PRK15370 174 DCLKNNKTELRLKILGLTT-IPACIP--EQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQ 244 (754)
T ss_pred hhcccCceEEEeCCCCcCc-CCcccc--cCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccc-cCChhhh--cccc
Confidence 3555677889999999885 676664 57889999999998 6776654 58999999999988 5676553 4788
Q ss_pred EEeccCCCCCCCCChhhhhccccccccccccccCCCCchhhhhcCcccceecccccccCCCCchhhhccccccccccccc
Q 042348 133 VLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSGLIPNDIANLSRLRLLAQRVY 212 (686)
Q Consensus 133 ~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~~~~~ 212 (686)
.|+|++|+++ .+|..+. .+|+.|+|++|+|+ .+|..+. ++|+.|+|++|+|++. |..+. ++|. .
T Consensus 245 ~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~---~sL~~L~Ls~N~Lt~L-P~~lp--~sL~------~ 308 (754)
T PRK15370 245 EMELSINRIT-ELPERLP--SALQSLDLFHNKIS-CLPENLP---EELRYLSVYDNSIRTL-PAHLP--SGIT------H 308 (754)
T ss_pred EEECcCCccC-cCChhHh--CCCCEEECcCCccC-ccccccC---CCCcEEECCCCccccC-cccch--hhHH------H
Confidence 8999999888 6777664 57888899988888 5776553 5788888888888864 43332 1232 3
Q ss_pred ccccCCCCCCC
Q 042348 213 VDLTYNNLSGL 223 (686)
Q Consensus 213 l~l~~N~l~~~ 223 (686)
|++++|+|+..
T Consensus 309 L~Ls~N~Lt~L 319 (754)
T PRK15370 309 LNVQSNSLTAL 319 (754)
T ss_pred HHhcCCccccC
Confidence 36666666653
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.34 E-value=1.2e-12 Score=148.20 Aligned_cols=119 Identities=28% Similarity=0.440 Sum_probs=80.7
Q ss_pred CCEEEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCccccCCCCCcEEEccCCCCCCCCcccccCCCCCCEEec
Q 042348 57 GQVFSLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQVLDL 136 (686)
Q Consensus 57 ~~~~~l~l~~n~l~g~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l 136 (686)
..+..|+|++|++. .+|..+. ++|+.|+|++|+|+ .+|..+. ++|+.|+|++|+|+ .+|..+. ++|+.|++
T Consensus 241 ~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt-~LP~~lp--~sL~~L~L 311 (754)
T PRK15370 241 DTIQEMELSINRIT-ELPERLP--SALQSLDLFHNKIS-CLPENLP--EELRYLSVYDNSIR-TLPAHLP--SGITHLNV 311 (754)
T ss_pred ccccEEECcCCccC-cCChhHh--CCCCEEECcCCccC-ccccccC--CCCcEEECCCCccc-cCcccch--hhHHHHHh
Confidence 36788999999998 5777664 57999999999998 6787664 58999999999998 4565443 35666666
Q ss_pred cCCCCCCCCChhhhhccccccccccccccCCCCchhhhhcCcccceecccccccC
Q 042348 137 SQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLS 191 (686)
Q Consensus 137 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~ 191 (686)
++|+|++ +|..+. ++|+.|++++|.|++ +|..+ .++|+.|+|++|+|+
T Consensus 312 s~N~Lt~-LP~~l~--~sL~~L~Ls~N~Lt~-LP~~l---~~sL~~L~Ls~N~L~ 359 (754)
T PRK15370 312 QSNSLTA-LPETLP--PGLKTLEAGENALTS-LPASL---PPELQVLDVSKNQIT 359 (754)
T ss_pred cCCcccc-CCcccc--ccceeccccCCcccc-CChhh---cCcccEEECCCCCCC
Confidence 6666663 444332 456666666666653 55443 245666666666665
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.34 E-value=2.5e-12 Score=144.69 Aligned_cols=161 Identities=28% Similarity=0.342 Sum_probs=107.0
Q ss_pred CCCEEEEEeCCCCccccC--CcCcCC--------------CCCCCEEEccCCCCcccCCccccCCCCCcEEEccCCCCCC
Q 042348 56 EGQVFSLIIPNKKLTGFI--PADLGS--------------LSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSG 119 (686)
Q Consensus 56 ~~~~~~l~l~~n~l~g~~--p~~l~~--------------l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g 119 (686)
...+++|+|++|+|+... |..+.. .++|+.|+|++|+|+ .+|. .+++|+.|+|++|+|++
T Consensus 241 p~~Lk~LdLs~N~LtsLP~lp~sL~~L~Ls~N~L~~Lp~lp~~L~~L~Ls~N~Lt-~LP~---~p~~L~~LdLS~N~L~~ 316 (788)
T PRK15387 241 PPELRTLEVSGNQLTSLPVLPPGLLELSIFSNPLTHLPALPSGLCKLWIFGNQLT-SLPV---LPPGLQELSVSDNQLAS 316 (788)
T ss_pred CCCCcEEEecCCccCcccCcccccceeeccCCchhhhhhchhhcCEEECcCCccc-cccc---cccccceeECCCCcccc
Confidence 367777788877776653 222221 245778899999998 5665 34789999999999985
Q ss_pred CCcc---cccC----------C----CCCCEEeccCCCCCCCCChhhhhccccccccccccccCCCCchhhhhcCcccce
Q 042348 120 PVPM---QIGK----------L----KYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQK 182 (686)
Q Consensus 120 ~~p~---~~~~----------l----~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~ 182 (686)
+|. .+.. + .+|+.|+|++|+|++ +|.. ..+|+.|++++|+|+ .+|.. ..+|+.
T Consensus 317 -Lp~lp~~L~~L~Ls~N~L~~LP~lp~~Lq~LdLS~N~Ls~-LP~l---p~~L~~L~Ls~N~L~-~LP~l----~~~L~~ 386 (788)
T PRK15387 317 -LPALPSELCKLWAYNNQLTSLPTLPSGLQELSVSDNQLAS-LPTL---PSELYKLWAYNNRLT-SLPAL----PSGLKE 386 (788)
T ss_pred -CCCCcccccccccccCccccccccccccceEecCCCccCC-CCCC---Ccccceehhhccccc-cCccc----ccccce
Confidence 443 2111 1 368888888888884 5643 356778888888888 46752 357899
Q ss_pred ecccccccCCCCchhhhcccccccccccccccccCCCCCCCcccccccccCCcccccCCCC
Q 042348 183 LDLSFNNLSGLIPNDIANLSRLRLLAQRVYVDLTYNNLSGLIPQNAALLSLGPTAFIGNPF 243 (686)
Q Consensus 183 L~Ls~N~l~~~~p~~~~~l~~L~~l~~~~~l~l~~N~l~~~~p~~~~~~~~~~~~~~~n~~ 243 (686)
|+|++|+|++ +|... ++| ..|++++|+|++. |... .++..+.+.+|..
T Consensus 387 LdLs~N~Lt~-LP~l~---s~L------~~LdLS~N~LssI-P~l~--~~L~~L~Ls~NqL 434 (788)
T PRK15387 387 LIVSGNRLTS-LPVLP---SEL------KELMVSGNRLTSL-PMLP--SGLLSLSVYRNQL 434 (788)
T ss_pred EEecCCcccC-CCCcc---cCC------CEEEccCCcCCCC-Ccch--hhhhhhhhccCcc
Confidence 9999999996 45433 233 3459999999974 5432 2333445555553
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.33 E-value=1.2e-13 Score=143.18 Aligned_cols=172 Identities=24% Similarity=0.366 Sum_probs=151.0
Q ss_pred CEEEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCccccCCCCCcEEEccCCCCCCCCcccccCCCCCCEEecc
Q 042348 58 QVFSLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQVLDLS 137 (686)
Q Consensus 58 ~~~~l~l~~n~l~g~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls 137 (686)
..+..+|+.|++. .+|..+..+..|+.|.|..|.|. .+|..+.++..|++|||+.|+++ .+|..++.|+ |+.|-++
T Consensus 76 dt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvli~s 151 (722)
T KOG0532|consen 76 DTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVLIVS 151 (722)
T ss_pred chhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeEEEe
Confidence 3466899999999 68999999999999999999998 89999999999999999999998 8999999988 9999999
Q ss_pred CCCCCCCCChhhhhccccccccccccccCCCCchhhhhcCcccceecccccccCCCCchhhhcccccccccccccccccC
Q 042348 138 QNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSGLIPNDIANLSRLRLLAQRVYVDLTY 217 (686)
Q Consensus 138 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~~~~~l~l~~ 217 (686)
+|+++ .+|..++.+..|..|+.+.|.+. .+|..++ +|.+|+.|++..|++... |.++..|+ |..||+|+
T Consensus 152 NNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~-~l~slr~l~vrRn~l~~l-p~El~~Lp-------Li~lDfSc 220 (722)
T KOG0532|consen 152 NNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLG-YLTSLRDLNVRRNHLEDL-PEELCSLP-------LIRLDFSC 220 (722)
T ss_pred cCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhh-hHHHHHHHHHhhhhhhhC-CHHHhCCc-------eeeeeccc
Confidence 99999 79999999999999999999998 6888885 899999999999999965 55665554 34569999
Q ss_pred CCCCCCcccccccccCCcccccCCCCC
Q 042348 218 NNLSGLIPQNAALLSLGPTAFIGNPFL 244 (686)
Q Consensus 218 N~l~~~~p~~~~~~~~~~~~~~~n~~~ 244 (686)
|+++.++-....+..+..+.+++||..
T Consensus 221 Nkis~iPv~fr~m~~Lq~l~LenNPLq 247 (722)
T KOG0532|consen 221 NKISYLPVDFRKMRHLQVLQLENNPLQ 247 (722)
T ss_pred CceeecchhhhhhhhheeeeeccCCCC
Confidence 999975545555677888889999875
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.32 E-value=1.1e-11 Score=116.63 Aligned_cols=128 Identities=24% Similarity=0.250 Sum_probs=95.5
Q ss_pred ccCccCceEEEEEEeCCCceEEEEEcCCCCccchHHHHHHHHHHhccCCCCcc-eeeEEEEecCceeEEEeccCCCCHHH
Q 042348 374 LLGKSTIGIVYKVALNNEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIV-SLRAYFWSVDEKLLIYDYIPNGSLAT 452 (686)
Q Consensus 374 ~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv-~l~~~~~~~~~~~lV~e~~~~gsL~~ 452 (686)
.++.|.++.||++... +..|++|....... ....+..|+.++..+.+.+++ +++.+. ....++||||+++.++.+
T Consensus 5 ~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l~~ 80 (170)
T cd05151 5 PLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSELLT 80 (170)
T ss_pred ecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcccc
Confidence 4789999999999876 67899998765432 224568899999998665544 455443 344689999999987764
Q ss_pred HhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccC--CCCceecCCCCCCeeecCCCCeEEeecCccc
Q 042348 453 AIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVS--PKRYVHGDLRPSNILLGKNMEPHISDFGLAR 520 (686)
Q Consensus 453 ~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~--~~~iiHrDlkp~NILl~~~~~~kl~DfGla~ 520 (686)
.- . ....++.+++++|+.||+.. +.+++|+|++|.||+++ ++.++++|||.+.
T Consensus 81 ~~-----------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 81 ED-----------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred cc-----------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 30 0 11345789999999999832 22369999999999999 6689999999886
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.32 E-value=5e-12 Score=137.55 Aligned_cols=141 Identities=16% Similarity=0.249 Sum_probs=92.7
Q ss_pred ccCccCceEEEEEEeCC-CceEEEEEcCCCCcc---------------------------------c-h------HHHHH
Q 042348 374 LLGKSTIGIVYKVALNN-EEAVAVRRLGNGGWQ---------------------------------R-F------KEFQT 412 (686)
Q Consensus 374 ~iG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~---------------------------------~-~------~~~~~ 412 (686)
-||+|++|.||+|++.+ |+.||||+.+..-.. + . -+|.+
T Consensus 126 PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~~ 205 (537)
T PRK04750 126 PLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLMR 205 (537)
T ss_pred hhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHHH
Confidence 59999999999999987 999999998753110 0 0 12445
Q ss_pred HHHHHhccC----CCCcceeeEEEEe-cCceeEEEeccCCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHc
Q 042348 413 EAEAIGKIR----HPNIVSLRAYFWS-VDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHE 487 (686)
Q Consensus 413 E~~~l~~l~----H~nIv~l~~~~~~-~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~ 487 (686)
|+..+.+++ +.+.+.+-.++++ ....++||||++|+.+.++-.-.........+....+..++.|+ +.
T Consensus 206 Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi-------f~ 278 (537)
T PRK04750 206 EAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV-------FR 278 (537)
T ss_pred HHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH-------Hh
Confidence 555555552 4444444444443 35678999999999998753211100000112222233333343 34
Q ss_pred cCCCCceecCCCCCCeeecCCC----CeEEeecCccccccc
Q 042348 488 VSPKRYVHGDLRPSNILLGKNM----EPHISDFGLARLADI 524 (686)
Q Consensus 488 ~~~~~iiHrDlkp~NILl~~~~----~~kl~DfGla~~~~~ 524 (686)
.|++|+|+||.||+++.++ .+++.|||++..++.
T Consensus 279 ---~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 279 ---DGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred ---CCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 7899999999999999888 999999999987754
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.25 E-value=8.7e-12 Score=140.63 Aligned_cols=119 Identities=34% Similarity=0.539 Sum_probs=103.7
Q ss_pred CCcEEEccCCCCCCCCcccccCCCCCCEEeccCCCCCCCCChhhhhccccccccccccccCCCCchhhhhcCcccceecc
Q 042348 106 NLQSLILSGNSFSGPVPMQIGKLKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDL 185 (686)
Q Consensus 106 ~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L 185 (686)
.++.|+|++|.++|.+|..++.|++|+.|+|++|.|+|.+|..+..+++|+.|+|++|+|+|.+|..+. +|++|+.|||
T Consensus 419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~-~L~~L~~L~L 497 (623)
T PLN03150 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLG-QLTSLRILNL 497 (623)
T ss_pred EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHh-cCCCCCEEEC
Confidence 478999999999999999999999999999999999999999999999999999999999999999885 8999999999
Q ss_pred cccccCCCCchhhhcccccccccccccccccCCCCCCCcccccccccCCcccccCCCCCCCCCCCCCC
Q 042348 186 SFNNLSGLIPNDIANLSRLRLLAQRVYVDLTYNNLSGLIPQNAALLSLGPTAFIGNPFLCGPPLKVSC 253 (686)
Q Consensus 186 s~N~l~~~~p~~~~~l~~L~~l~~~~~l~l~~N~l~~~~p~~~~~~~~~~~~~~~n~~~c~~p~~~~c 253 (686)
++|+|+|.+|..++.+. + ......+.+|+.+|+.|....|
T Consensus 498 s~N~l~g~iP~~l~~~~-~---------------------------~~~~l~~~~N~~lc~~p~l~~C 537 (623)
T PLN03150 498 NGNSLSGRVPAALGGRL-L---------------------------HRASFNFTDNAGLCGIPGLRAC 537 (623)
T ss_pred cCCcccccCChHHhhcc-c---------------------------cCceEEecCCccccCCCCCCCC
Confidence 99999999999887531 0 0112457788999987765555
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.25 E-value=6.3e-11 Score=112.00 Aligned_cols=134 Identities=13% Similarity=0.130 Sum_probs=97.5
Q ss_pred ccCccCceEEEEEEeCC-------CceEEEEEcCCCC------------c----------cchHHH----HHHHHHHhcc
Q 042348 374 LLGKSTIGIVYKVALNN-------EEAVAVRRLGNGG------------W----------QRFKEF----QTEAEAIGKI 420 (686)
Q Consensus 374 ~iG~G~~g~Vy~~~~~~-------~~~vavK~~~~~~------------~----------~~~~~~----~~E~~~l~~l 420 (686)
.||.|.-+.||.|...+ +..+|||..+... . ...+.+ ++|++.|.++
T Consensus 4 ~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~rl 83 (197)
T cd05146 4 CISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKRM 83 (197)
T ss_pred ccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 58999999999997653 4789999763210 0 001223 3899999999
Q ss_pred CC--CCcceeeEEEEecCceeEEEeccCCCCHHH-HhhcCCCccccCCCCHHHHHHHHHHHHHHHHHH-HccCCCCceec
Q 042348 421 RH--PNIVSLRAYFWSVDEKLLIYDYIPNGSLAT-AIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFL-HEVSPKRYVHG 496 (686)
Q Consensus 421 ~H--~nIv~l~~~~~~~~~~~lV~e~~~~gsL~~-~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~L-H~~~~~~iiHr 496 (686)
.. -++.+.+++ ...++||||+.++.+.. .+.. ..++..+...+..+++.+|..| |. .+|||+
T Consensus 84 ~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd-------~~~~~~~~~~i~~~i~~~l~~l~H~---~glVHG 149 (197)
T cd05146 84 QKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD-------AKLNDEEMKNAYYQVLSMMKQLYKE---CNLVHA 149 (197)
T ss_pred HHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc-------cccCHHHHHHHHHHHHHHHHHHHHh---CCeecC
Confidence 53 566777764 56789999997654422 1221 1244556678889999999999 78 899999
Q ss_pred CCCCCCeeecCCCCeEEeecCccccc
Q 042348 497 DLRPSNILLGKNMEPHISDFGLARLA 522 (686)
Q Consensus 497 Dlkp~NILl~~~~~~kl~DfGla~~~ 522 (686)
||++.||+++ ++.++|+|||.+-..
T Consensus 150 DLs~~NIL~~-~~~v~iIDF~qav~~ 174 (197)
T cd05146 150 DLSEYNMLWH-DGKVWFIDVSQSVEP 174 (197)
T ss_pred CCCHHHEEEE-CCcEEEEECCCceeC
Confidence 9999999997 468999999988643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.25 E-value=1.3e-10 Score=124.36 Aligned_cols=168 Identities=17% Similarity=0.223 Sum_probs=124.1
Q ss_pred eCCCceEEEEEcCCCCccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCCHHHHhhcCCCccccCCCC
Q 042348 388 LNNEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLS 467 (686)
Q Consensus 388 ~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~l~ 467 (686)
..++.+|.|...+...........+-++.|+.++||||+++++.+...+..|+|+|-+. .|..++.+ +.
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~---------l~ 102 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE---------LG 102 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH---------hH
Confidence 34577788877766544333456778899999999999999999999999999999984 57777754 33
Q ss_pred HHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCccccccccccCCCCCCCcc
Q 042348 468 WSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPY 547 (686)
Q Consensus 468 ~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~g~~~~~~~~ 547 (686)
...+...+.||+.||.|||+. .+++|++|.-+.|+++..|+.||++|-++........ +.
T Consensus 103 ~~~v~~Gl~qIl~AL~FL~~d--~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-------------~~----- 162 (690)
T KOG1243|consen 103 KEEVCLGLFQILAALSFLNDD--CNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-------------PA----- 162 (690)
T ss_pred HHHHHHHHHHHHHHHHHHhcc--CCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-------------cc-----
Confidence 455667889999999999964 4799999999999999999999999988753321110 00
Q ss_pred ccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCC
Q 042348 548 EFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKL 593 (686)
Q Consensus 548 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~ 593 (686)
....--..|..|+.+.... ...|.|-||++++|++.|..
T Consensus 163 -----~~~~~~~s~~~P~~~~~s~--~s~D~~~Lg~li~el~ng~~ 201 (690)
T KOG1243|consen 163 -----KSLYLIESFDDPEEIDPSE--WSIDSWGLGCLIEELFNGSL 201 (690)
T ss_pred -----ccchhhhcccChhhcCccc--cchhhhhHHHHHHHHhCccc
Confidence 0000011266676554322 34699999999999999943
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.23 E-value=4e-11 Score=145.13 Aligned_cols=105 Identities=28% Similarity=0.323 Sum_probs=68.4
Q ss_pred CCEEEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCccccCCCCCcEEEccCCCCCCCCcccccCCCCCCEEec
Q 042348 57 GQVFSLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQVLDL 136 (686)
Q Consensus 57 ~~~~~l~l~~n~l~g~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l 136 (686)
..++.|+|++|+|. .+|..+..+++|+.|+|++|...+.+| .+..+++|+.|+|++|..-..+|..++.+++|+.|++
T Consensus 611 ~~L~~L~L~~s~l~-~L~~~~~~l~~Lk~L~Ls~~~~l~~ip-~ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L 688 (1153)
T PLN03210 611 ENLVKLQMQGSKLE-KLWDGVHSLTGLRNIDLRGSKNLKEIP-DLSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDM 688 (1153)
T ss_pred cCCcEEECcCcccc-ccccccccCCCCCEEECCCCCCcCcCC-ccccCCcccEEEecCCCCccccchhhhccCCCCEEeC
Confidence 46677777777776 356667777777777777665444666 3667777777777776655567777777777777777
Q ss_pred cCCCCCCCCChhhhhccccccccccccc
Q 042348 137 SQNSFSSSIPSSIVQCKRLKTVVLNQNS 164 (686)
Q Consensus 137 s~N~l~~~~p~~~~~l~~L~~L~L~~N~ 164 (686)
++|..-+.+|..+ ++++|+.|+|++|.
T Consensus 689 ~~c~~L~~Lp~~i-~l~sL~~L~Lsgc~ 715 (1153)
T PLN03210 689 SRCENLEILPTGI-NLKSLYRLNLSGCS 715 (1153)
T ss_pred CCCCCcCccCCcC-CCCCCCEEeCCCCC
Confidence 7654333555544 45555555555543
|
syringae 6; Provisional |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.21 E-value=2.5e-10 Score=103.82 Aligned_cols=130 Identities=25% Similarity=0.373 Sum_probs=100.5
Q ss_pred ccCccCceEEEEEEeCCCceEEEEE-cCCCC-c------cchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEecc
Q 042348 374 LLGKSTIGIVYKVALNNEEAVAVRR-LGNGG-W------QRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYI 445 (686)
Q Consensus 374 ~iG~G~~g~Vy~~~~~~~~~vavK~-~~~~~-~------~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~ 445 (686)
++++|+-+.+|.+.+.+ ..+++|. +++.- . -...+-.+|++++.+++--.|..-+=+..+.+...++|||+
T Consensus 3 ~i~~GAEa~i~~~~~~g-~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I 81 (204)
T COG3642 3 LIKQGAEAIIYLTDFLG-LPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI 81 (204)
T ss_pred hhhCCcceeEEeeeccC-cceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence 57899999999997754 3455653 33321 1 11345778999999997666665555677788889999999
Q ss_pred CCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccc
Q 042348 446 PNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARL 521 (686)
Q Consensus 446 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~ 521 (686)
+|-.|.+.+... ...++..+-.-+.-||. .+|||+||.++||++..+. +.++|||++.+
T Consensus 82 ~G~~lkd~l~~~-------------~~~~~r~vG~~vg~lH~---~givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 82 EGELLKDALEEA-------------RPDLLREVGRLVGKLHK---AGIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred CChhHHHHHHhc-------------chHHHHHHHHHHHHHHh---cCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 999999888643 24577778888889999 9999999999999997654 99999999974
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.18 E-value=3.3e-12 Score=133.56 Aligned_cols=187 Identities=22% Similarity=0.251 Sum_probs=127.2
Q ss_pred CCCEEEEEeCCCCccccCCcCcCCCCC---CCEEEccCCCCcc----cCCccccCC-CCCcEEEccCCCCCCC----Ccc
Q 042348 56 EGQVFSLIIPNKKLTGFIPADLGSLSA---IGRVNLRNNNFSG----SLPVELFNA-SNLQSLILSGNSFSGP----VPM 123 (686)
Q Consensus 56 ~~~~~~l~l~~n~l~g~~p~~l~~l~~---L~~L~L~~N~l~g----~~p~~~~~l-~~L~~L~L~~N~l~g~----~p~ 123 (686)
..+++.|+|++|.+.+..+..+..+.. |+.|++++|++++ .+...+..+ ++|+.|+|++|.+++. ++.
T Consensus 80 ~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~ 159 (319)
T cd00116 80 GCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAK 159 (319)
T ss_pred cCceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHH
Confidence 358999999999998777776766666 9999999999873 234455666 8999999999999853 344
Q ss_pred cccCCCCCCEEeccCCCCCCC----CChhhhhccccccccccccccCCCCchh---hhhcCcccceecccccccCCCCch
Q 042348 124 QIGKLKYLQVLDLSQNSFSSS----IPSSIVQCKRLKTVVLNQNSFTGPLPDG---FATNLTALQKLDLSFNNLSGLIPN 196 (686)
Q Consensus 124 ~~~~l~~L~~L~ls~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~p~~---~~~~l~~L~~L~Ls~N~l~~~~p~ 196 (686)
.+..++.|+.|+|++|.+++. ++..+..+++|++|+|++|.+++.-... ....+++|++|++++|.+++....
T Consensus 160 ~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~~~~~ 239 (319)
T cd00116 160 ALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAA 239 (319)
T ss_pred HHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCchHHHH
Confidence 566778999999999999853 3344556679999999999987432222 124678899999999999864333
Q ss_pred hhhc-ccccccccccccccccCCCCC--CC--cccc-cccccCCcccccCCCCC
Q 042348 197 DIAN-LSRLRLLAQRVYVDLTYNNLS--GL--IPQN-AALLSLGPTAFIGNPFL 244 (686)
Q Consensus 197 ~~~~-l~~L~~l~~~~~l~l~~N~l~--~~--~p~~-~~~~~~~~~~~~~n~~~ 244 (686)
.+.. +.. ....+..|++++|.++ +. +... ..+.++..+.+.+|...
T Consensus 240 ~l~~~~~~--~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~ 291 (319)
T cd00116 240 ALASALLS--PNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFG 291 (319)
T ss_pred HHHHHHhc--cCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCc
Confidence 3332 110 1123345588888886 22 1111 12234555666666543
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.18 E-value=2e-10 Score=113.19 Aligned_cols=141 Identities=19% Similarity=0.254 Sum_probs=110.1
Q ss_pred ccCccCceEEEEEEeCCCceEEEEEcCCCCc-cchHHHHHHHHHHhccCC--CCcceeeEEEEecC---ceeEEEeccCC
Q 042348 374 LLGKSTIGIVYKVALNNEEAVAVRRLGNGGW-QRFKEFQTEAEAIGKIRH--PNIVSLRAYFWSVD---EKLLIYDYIPN 447 (686)
Q Consensus 374 ~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H--~nIv~l~~~~~~~~---~~~lV~e~~~~ 447 (686)
.|+.|..+.||++...+|..+++|....... ....++..|+++++.+.+ ..+.+++.+..... ..++||||+++
T Consensus 5 ~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~G 84 (223)
T cd05154 5 QLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVDG 84 (223)
T ss_pred ecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeCC
Confidence 4899999999999987778899999765432 134578999999999975 44677777766542 56899999999
Q ss_pred CCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccC--------------------------------------
Q 042348 448 GSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVS-------------------------------------- 489 (686)
Q Consensus 448 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~-------------------------------------- 489 (686)
.++.+.+.. ..++..++..++.+++++|++||+..
T Consensus 85 ~~l~~~~~~-------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (223)
T cd05154 85 RVLRDRLLR-------PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAM 157 (223)
T ss_pred EecCCCCCC-------CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHH
Confidence 888776531 13677788888899999999998521
Q ss_pred ---------------CCCceecCCCCCCeeecC--CCCeEEeecCcccc
Q 042348 490 ---------------PKRYVHGDLRPSNILLGK--NMEPHISDFGLARL 521 (686)
Q Consensus 490 ---------------~~~iiHrDlkp~NILl~~--~~~~kl~DfGla~~ 521 (686)
+..++|+|+.|.||+++. ++.+.|+||+.+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 158 ERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 245799999999999998 56689999998863
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.16 E-value=5.2e-12 Score=121.25 Aligned_cols=138 Identities=31% Similarity=0.381 Sum_probs=100.1
Q ss_pred cCcCCCCCCCEEEccCCCCcccCCccccCCCCCcEEEccCCCCCCCCcccccCCCCCCEEeccCCCCCCCCChhhhhccc
Q 042348 75 ADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQVLDLSQNSFSSSIPSSIVQCKR 154 (686)
Q Consensus 75 ~~l~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~ 154 (686)
..+.....|+.||||+|.|+ .+..+..-+|.++.|+||+|.+. .+. .+..|++|+.||||+|.|+ .+.++-..+.+
T Consensus 278 ~~~dTWq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~-~v~-nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGN 353 (490)
T KOG1259|consen 278 VSADTWQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIR-TVQ-NLAELPQLQLLDLSGNLLA-ECVGWHLKLGN 353 (490)
T ss_pred EecchHhhhhhccccccchh-hhhhhhhhccceeEEecccccee-eeh-hhhhcccceEeecccchhH-hhhhhHhhhcC
Confidence 34455677888899999887 77777777888899999999886 443 3788888999999998888 56777778888
Q ss_pred cccccccccccCCCCchhhhhcCcccceecccccccCCCC-chhhhcccccccccccccccccCCCCCCCcc
Q 042348 155 LKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSGLI-PNDIANLSRLRLLAQRVYVDLTYNNLSGLIP 225 (686)
Q Consensus 155 L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~l~~~~~l~l~~N~l~~~~p 225 (686)
++.|.|+.|.+.. + +++ ..|.+|..||+++|++...- -..+++|+-| ..+.|.+|.+++++.
T Consensus 354 IKtL~La~N~iE~-L-SGL-~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCL------E~l~L~~NPl~~~vd 416 (490)
T KOG1259|consen 354 IKTLKLAQNKIET-L-SGL-RKLYSLVNLDLSSNQIEELDEVNHIGNLPCL------ETLRLTGNPLAGSVD 416 (490)
T ss_pred EeeeehhhhhHhh-h-hhh-HhhhhheeccccccchhhHHHhcccccccHH------HHHhhcCCCccccch
Confidence 8888888888762 2 233 36788888888888887421 1123444433 344788888877644
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.16 E-value=4.7e-12 Score=132.34 Aligned_cols=180 Identities=21% Similarity=0.217 Sum_probs=126.8
Q ss_pred CCEEEEEeCCCCcc------ccCCcCcCCCCCCCEEEccCCCCcccCCccccCCCC---CcEEEccCCCCCC----CCcc
Q 042348 57 GQVFSLIIPNKKLT------GFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASN---LQSLILSGNSFSG----PVPM 123 (686)
Q Consensus 57 ~~~~~l~l~~n~l~------g~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~~l~~---L~~L~L~~N~l~g----~~p~ 123 (686)
..++.|+++++.+. ..++..+..+++|+.|+|++|.+.+..+..+..+.+ |+.|++++|++++ .+..
T Consensus 51 ~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~ 130 (319)
T cd00116 51 PSLKELCLSLNETGRIPRGLQSLLQGLTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAK 130 (319)
T ss_pred CCceEEeccccccCCcchHHHHHHHHHHhcCceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHH
Confidence 45888999888887 234566778899999999999998767766665555 9999999999983 3444
Q ss_pred cccCC-CCCCEEeccCCCCCCC----CChhhhhccccccccccccccCCC----CchhhhhcCcccceecccccccCCCC
Q 042348 124 QIGKL-KYLQVLDLSQNSFSSS----IPSSIVQCKRLKTVVLNQNSFTGP----LPDGFATNLTALQKLDLSFNNLSGLI 194 (686)
Q Consensus 124 ~~~~l-~~L~~L~ls~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~~l~~L~~L~Ls~N~l~~~~ 194 (686)
.+..+ ++|+.|+|++|.+++. ++..+..+.+|+.|+|++|.+++. ++..+ ..+++|+.|+|++|.+++..
T Consensus 131 ~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l-~~~~~L~~L~L~~n~i~~~~ 209 (319)
T cd00116 131 GLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGL-KANCNLEVLDLNNNGLTDEG 209 (319)
T ss_pred HHHhCCCCceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHHHHH-HhCCCCCEEeccCCccChHH
Confidence 56677 8999999999999853 334556677899999999999853 22223 24569999999999998553
Q ss_pred chh----hhcccccccccccccccccCCCCCCCccccc--c----cccCCcccccCCCC
Q 042348 195 PND----IANLSRLRLLAQRVYVDLTYNNLSGLIPQNA--A----LLSLGPTAFIGNPF 243 (686)
Q Consensus 195 p~~----~~~l~~L~~l~~~~~l~l~~N~l~~~~p~~~--~----~~~~~~~~~~~n~~ 243 (686)
... +..+++| .+|++++|.++....... . ...+..+.+.+|..
T Consensus 210 ~~~l~~~~~~~~~L------~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i 262 (319)
T cd00116 210 ASALAETLASLKSL------EVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDI 262 (319)
T ss_pred HHHHHHHhcccCCC------CEEecCCCcCchHHHHHHHHHHhccCCCceEEEccCCCC
Confidence 332 3334444 455999999886222111 1 13455566666643
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.15 E-value=4.3e-12 Score=138.94 Aligned_cols=179 Identities=27% Similarity=0.356 Sum_probs=138.7
Q ss_pred CCEEEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCccccCCCCCcEEEccCCCCCCCCcccccCCCCCCEEec
Q 042348 57 GQVFSLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQVLDL 136 (686)
Q Consensus 57 ~~~~~l~l~~n~l~g~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l 136 (686)
..++.|+.+.|.|+...+.. .-.+|+.+++++|+++ .+|.++..+.+|+.|+..+|+|+ .+|..+....+|+.|.+
T Consensus 219 ~~l~~L~a~~n~l~~~~~~p--~p~nl~~~dis~n~l~-~lp~wi~~~~nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~ 294 (1081)
T KOG0618|consen 219 PSLTALYADHNPLTTLDVHP--VPLNLQYLDISHNNLS-NLPEWIGACANLEALNANHNRLV-ALPLRISRITSLVSLSA 294 (1081)
T ss_pred cchheeeeccCcceeecccc--ccccceeeecchhhhh-cchHHHHhcccceEecccchhHH-hhHHHHhhhhhHHHHHh
Confidence 45667777778877433322 2357899999999999 67889999999999999999996 89999999999999999
Q ss_pred cCCCCCCCCChhhhhccccccccccccccCCCCchhhh------------------------------------------
Q 042348 137 SQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFA------------------------------------------ 174 (686)
Q Consensus 137 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~------------------------------------------ 174 (686)
..|.++ -+|....++++|++|+|..|+|. .+|+.++
T Consensus 295 ~~nel~-yip~~le~~~sL~tLdL~~N~L~-~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Lt 372 (1081)
T KOG0618|consen 295 AYNELE-YIPPFLEGLKSLRTLDLQSNNLP-SLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLT 372 (1081)
T ss_pred hhhhhh-hCCCcccccceeeeeeehhcccc-ccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCccc
Confidence 999999 68888888999999999999987 5565442
Q ss_pred -------hcCcccceecccccccCCCCchhhhcccccccccccccccccCCCCCCCcccccccccCCcccccCCCCCCCC
Q 042348 175 -------TNLTALQKLDLSFNNLSGLIPNDIANLSRLRLLAQRVYVDLTYNNLSGLIPQNAALLSLGPTAFIGNPFLCGP 247 (686)
Q Consensus 175 -------~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~~~~~l~l~~N~l~~~~p~~~~~~~~~~~~~~~n~~~c~~ 247 (686)
.+.++|+.|+|++|+|...+...+.++..|+.| +||+|.|+..+-....+..+..+...+|..+|-|
T Consensus 373 d~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL------~LSGNkL~~Lp~tva~~~~L~tL~ahsN~l~~fP 446 (1081)
T KOG0618|consen 373 DSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEEL------NLSGNKLTTLPDTVANLGRLHTLRAHSNQLLSFP 446 (1081)
T ss_pred ccchhhhccccceeeeeecccccccCCHHHHhchHHhHHH------hcccchhhhhhHHHHhhhhhHHHhhcCCceeech
Confidence 356788999999999997766677777777665 8999999876543334444445555566666654
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.14 E-value=1.6e-10 Score=139.97 Aligned_cols=190 Identities=22% Similarity=0.257 Sum_probs=115.3
Q ss_pred eeeeEecCCCEEEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCccccCCCCCcEEEccCCCCCCCCcccccCC
Q 042348 49 WNGITCREGQVFSLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGKL 128 (686)
Q Consensus 49 w~gv~c~~~~~~~l~l~~n~l~g~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l 128 (686)
|.|+.+ -.+++.|+|+++...+.+| .++.+++|+.|+|++|.....+|..+.++++|+.|+|++|..-+.+|..+ ++
T Consensus 627 ~~~~~~-l~~Lk~L~Ls~~~~l~~ip-~ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i-~l 703 (1153)
T PLN03210 627 WDGVHS-LTGLRNIDLRGSKNLKEIP-DLSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI-NL 703 (1153)
T ss_pred cccccc-CCCCCEEECCCCCCcCcCC-ccccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcC-CC
Confidence 666532 3467788887766555666 47777888888888776656777777777788888877764434566543 44
Q ss_pred CCCCEEecc---------------------CCCCCCCCChhh------------------------------hhcccccc
Q 042348 129 KYLQVLDLS---------------------QNSFSSSIPSSI------------------------------VQCKRLKT 157 (686)
Q Consensus 129 ~~L~~L~ls---------------------~N~l~~~~p~~~------------------------------~~l~~L~~ 157 (686)
++|+.|+|+ +|.++ .+|..+ ..+++|+.
T Consensus 704 ~sL~~L~Lsgc~~L~~~p~~~~nL~~L~L~~n~i~-~lP~~~~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~sL~~ 782 (1153)
T PLN03210 704 KSLYRLNLSGCSRLKSFPDISTNISWLDLDETAIE-EFPSNLRLENLDELILCEMKSEKLWERVQPLTPLMTMLSPSLTR 782 (1153)
T ss_pred CCCCEEeCCCCCCccccccccCCcCeeecCCCccc-cccccccccccccccccccchhhccccccccchhhhhccccchh
Confidence 444444444 44433 233221 11246777
Q ss_pred ccccccccCCCCchhhhhcCcccceecccccccCCCCchhhhcccccccc---------------cccccccccCCCCCC
Q 042348 158 VVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSGLIPNDIANLSRLRLL---------------AQRVYVDLTYNNLSG 222 (686)
Q Consensus 158 L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l---------------~~~~~l~l~~N~l~~ 222 (686)
|+|++|...+.+|..+ .++++|+.|+|++|..-+.+|..+ ++++|+.| .++..|+|++|.++.
T Consensus 783 L~Ls~n~~l~~lP~si-~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~~~nL~~L~Ls~n~i~~ 860 (1153)
T PLN03210 783 LFLSDIPSLVELPSSI-QNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPDISTNISDLNLSRTGIEE 860 (1153)
T ss_pred eeCCCCCCccccChhh-hCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCccccccccccccCEeECCCCCCcc
Confidence 8888887777788887 488899999998875444566543 34443322 124456777777765
Q ss_pred CcccccccccCCcccccCCCCC
Q 042348 223 LIPQNAALLSLGPTAFIGNPFL 244 (686)
Q Consensus 223 ~~p~~~~~~~~~~~~~~~n~~~ 244 (686)
.+.....+.++..+.+.+++.+
T Consensus 861 iP~si~~l~~L~~L~L~~C~~L 882 (1153)
T PLN03210 861 VPWWIEKFSNLSFLDMNGCNNL 882 (1153)
T ss_pred ChHHHhcCCCCCEEECCCCCCc
Confidence 4333333444555555554433
|
syringae 6; Provisional |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.12 E-value=5.7e-11 Score=126.02 Aligned_cols=241 Identities=20% Similarity=0.208 Sum_probs=168.1
Q ss_pred ccCccCceEEEEEEeC--CCceEEEEEcCCCCccchH--HHHHHHHHHhcc-CCCCcceeeEEEEecCceeEEEeccCCC
Q 042348 374 LLGKSTIGIVYKVALN--NEEAVAVRRLGNGGWQRFK--EFQTEAEAIGKI-RHPNIVSLRAYFWSVDEKLLIYDYIPNG 448 (686)
Q Consensus 374 ~iG~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~~~--~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~e~~~~g 448 (686)
-||.|.|+.||+...+ ++..+++|.+......... .-..|+.+...+ .|.++++++..+......++--|||+++
T Consensus 272 ~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~~~~~ 351 (524)
T KOG0601|consen 272 KISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLEFCEGG 351 (524)
T ss_pred EccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCchhhhcCc
Confidence 4899999999997654 5678899987665332222 234566666666 5999999888888888888999999999
Q ss_pred CHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCC-CCeEEeecCcccccccccC
Q 042348 449 SLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKN-MEPHISDFGLARLADIAEE 527 (686)
Q Consensus 449 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~-~~~kl~DfGla~~~~~~~~ 527 (686)
++...+.-. ..++...++++..|++.++.++|+ +.++|+|+||+||++..+ +..++.|||++..+.....
T Consensus 352 s~~l~~~~~------~~~d~~~~~~~~~q~~~~l~~i~s---~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~~~ 422 (524)
T KOG0601|consen 352 SSSLRSVTS------QMLDEDPRLRLTAQILTALNVIHS---KLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFSSG 422 (524)
T ss_pred chhhhhHHH------HhcCcchhhhhHHHHHhccccccc---hhhhcccccccceeeccchhhhhccccccccccceecc
Confidence 988776322 457888899999999999999999 899999999999999876 7889999998863221110
Q ss_pred CccccccccccCCCCCCCccccccccCCCCCccc-cCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHH
Q 042348 528 TPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYY-QAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIV 606 (686)
Q Consensus 528 ~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y-~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~ 606 (686)
.....+..| .+++......+..++|+||||..+.|.+++..-- ... .
T Consensus 423 -------------------------~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls-~~~------~ 470 (524)
T KOG0601|consen 423 -------------------------VFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLS-ESG------V 470 (524)
T ss_pred -------------------------cccccccccccchhhccccccccccccccccccccccccCcccC-ccc------c
Confidence 000112224 3555556667888999999999999999987432 111 0
Q ss_pred HHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 042348 607 QWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRVN 669 (686)
Q Consensus 607 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~ 669 (686)
+|. .+..+..+ ... .....+..+...+...++..||.+.++..+.+..+
T Consensus 471 ~~~-~i~~~~~p-------~~~------~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~ 519 (524)
T KOG0601|consen 471 QSL-TIRSGDTP-------NLP------GLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFYR 519 (524)
T ss_pred cce-eeeccccc-------CCC------chHHhhhhhhhhhcCCccccchhhhhhcccchhhh
Confidence 110 00111111 010 11134556677788899999999998877766544
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.08 E-value=1.1e-10 Score=108.12 Aligned_cols=126 Identities=26% Similarity=0.286 Sum_probs=39.2
Q ss_pred cCCCCCCCEEEccCCCCcccCCcccc-CCCCCcEEEccCCCCCCCCcccccCCCCCCEEeccCCCCCCCCChhh-hhccc
Q 042348 77 LGSLSAIGRVNLRNNNFSGSLPVELF-NASNLQSLILSGNSFSGPVPMQIGKLKYLQVLDLSQNSFSSSIPSSI-VQCKR 154 (686)
Q Consensus 77 l~~l~~L~~L~L~~N~l~g~~p~~~~-~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~-~~l~~ 154 (686)
+.+...++.|+|++|.|+ .+. .++ .+.+|+.|+|++|.++ .++ .+..++.|+.|++++|+++ .++..+ ..+++
T Consensus 15 ~~n~~~~~~L~L~~n~I~-~Ie-~L~~~l~~L~~L~Ls~N~I~-~l~-~l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp~ 89 (175)
T PF14580_consen 15 YNNPVKLRELNLRGNQIS-TIE-NLGATLDKLEVLDLSNNQIT-KLE-GLPGLPRLKTLDLSNNRIS-SISEGLDKNLPN 89 (175)
T ss_dssp -----------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS----S-CHHHHHH-TT
T ss_pred cccccccccccccccccc-ccc-chhhhhcCCCEEECCCCCCc-ccc-CccChhhhhhcccCCCCCC-ccccchHHhCCc
Confidence 444556677777777776 332 344 4667777777777776 343 4666777777777777777 344444 35777
Q ss_pred cccccccccccCCCCchhhhhcCcccceecccccccCCCC---chhhhcccccccc
Q 042348 155 LKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSGLI---PNDIANLSRLRLL 207 (686)
Q Consensus 155 L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~---p~~~~~l~~L~~l 207 (686)
|++|+|++|++...---.....+++|+.|+|.+|.++... .-.+..+++|+.|
T Consensus 90 L~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~~~YR~~vi~~lP~Lk~L 145 (175)
T PF14580_consen 90 LQELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVCEKKNYRLFVIYKLPSLKVL 145 (175)
T ss_dssp --EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGGGSTTHHHHHHHH-TT-SEE
T ss_pred CCEEECcCCcCCChHHhHHHHcCCCcceeeccCCcccchhhHHHHHHHHcChhhee
Confidence 7777777777763211122246777788888888776431 1134445555433
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.08 E-value=1.3e-09 Score=98.48 Aligned_cols=139 Identities=23% Similarity=0.297 Sum_probs=103.6
Q ss_pred ccCccCceEEEEEEeCCCceEEEE-EcCCCC-------ccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEecc
Q 042348 374 LLGKSTIGIVYKVALNNEEAVAVR-RLGNGG-------WQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYI 445 (686)
Q Consensus 374 ~iG~G~~g~Vy~~~~~~~~~vavK-~~~~~~-------~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~ 445 (686)
+|-+|+-+.|+++.+. |+...|| ++.+.- .-..++..+|++.+.+++--.|.--.-++.+...-.++|||+
T Consensus 14 likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME~~ 92 (229)
T KOG3087|consen 14 LIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYMEFI 92 (229)
T ss_pred eeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEEec
Confidence 5788999999999987 5555555 343321 112456788999999997656665555677788889999999
Q ss_pred CC-CCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCC---CeEEeecCccc
Q 042348 446 PN-GSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNM---EPHISDFGLAR 520 (686)
Q Consensus 446 ~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~---~~kl~DfGla~ 520 (686)
++ -++.+++..... ...........+.+|-..+.-||. ++|||+||..+||++..++ .+.++|||++.
T Consensus 93 ~g~~~vk~~i~~~~~----~~~~d~~~~~~~~~iG~~igklH~---ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~ 164 (229)
T KOG3087|consen 93 DGASTVKDFILSTME----DESEDEGLAELARRIGELIGKLHD---NDIIHGDLTTSNILLRSDGNQITPILIDFGLSS 164 (229)
T ss_pred cchhHHHHHHHHHcc----CcccchhHHHHHHHHHHHHHHhhh---CCeecccccccceEEecCCCcCceEEEeecchh
Confidence 76 378888876432 112223336788999999999999 9999999999999997655 45899999985
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.08 E-value=1.1e-10 Score=125.70 Aligned_cols=173 Identities=35% Similarity=0.478 Sum_probs=116.1
Q ss_pred CEEEEEeCCCCccccCCcCcCCCC-CCCEEEccCCCCcccCCccccCCCCCcEEEccCCCCCCCCcccccCCCCCCEEec
Q 042348 58 QVFSLIIPNKKLTGFIPADLGSLS-AIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQVLDL 136 (686)
Q Consensus 58 ~~~~l~l~~n~l~g~~p~~l~~l~-~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l 136 (686)
.++.|++.+|.++ .+|+....+. +|+.|++++|++. .+|..+.++++|+.|++++|+++ .+|...+.+++|+.|++
T Consensus 117 ~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L~~L~l 193 (394)
T COG4886 117 NLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDL 193 (394)
T ss_pred ceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCchhh-hhhhhhhhhhhhhheec
Confidence 4677777777777 4666666664 7778888888777 66666777788888888888877 66666667777888888
Q ss_pred cCCCCCCCCChhhhhccccccccccccccCCCCchhhhhcCcccceecccccccCCCCchhhhccccccccccccccccc
Q 042348 137 SQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSGLIPNDIANLSRLRLLAQRVYVDLT 216 (686)
Q Consensus 137 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~~~~~l~l~ 216 (686)
++|+++ .+|..+..+..|+.|.+++|++. .++..+ .++.++..|.+++|++... +..++.+++|+. |+++
T Consensus 194 s~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~-~~~~~l~~l~l~~n~~~~~-~~~~~~l~~l~~------L~~s 263 (394)
T COG4886 194 SGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSL-SNLKNLSGLELSNNKLEDL-PESIGNLSNLET------LDLS 263 (394)
T ss_pred cCCccc-cCchhhhhhhhhhhhhhcCCcce-ecchhh-hhcccccccccCCceeeec-cchhccccccce------eccc
Confidence 888877 67766666666777777777543 344444 3667777777777777643 445555555543 4788
Q ss_pred CCCCCCCcccccccccCCcccccCCCCC
Q 042348 217 YNNLSGLIPQNAALLSLGPTAFIGNPFL 244 (686)
Q Consensus 217 ~N~l~~~~p~~~~~~~~~~~~~~~n~~~ 244 (686)
+|.++-..+ .....++..+.+.+|...
T Consensus 264 ~n~i~~i~~-~~~~~~l~~L~~s~n~~~ 290 (394)
T COG4886 264 NNQISSISS-LGSLTNLRELDLSGNSLS 290 (394)
T ss_pred ccccccccc-ccccCccCEEeccCcccc
Confidence 888875544 444445555556666544
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.05 E-value=1.1e-10 Score=130.07 Aligned_cols=261 Identities=19% Similarity=0.244 Sum_probs=162.7
Q ss_pred ccCccCceEEEEEEeC-CCceEEEEEcCCC---CccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCC
Q 042348 374 LLGKSTIGIVYKVALN-NEEAVAVRRLGNG---GWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGS 449 (686)
Q Consensus 374 ~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gs 449 (686)
-+-+|.++.++.+.-. .|...++|..... ...+.+....+-.++-..+||-+++....+......++|++|..+++
T Consensus 811 p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~~~~~~~~ 890 (1205)
T KOG0606|consen 811 PSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVGHYLNGGD 890 (1205)
T ss_pred cccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhhHHhccCC
Confidence 4667888888876532 2222233322211 11122333344444444566777766555556678899999999999
Q ss_pred HHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCc
Q 042348 450 LATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETP 529 (686)
Q Consensus 450 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 529 (686)
|...++... ..+..-.......+..+++|||. ..++|||+||.|+++..++..++.|||............
T Consensus 891 ~~Skl~~~~------~~saepaRs~i~~~vqs~e~L~s---~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~ 961 (1205)
T KOG0606|consen 891 LPSKLHNSG------CLSAEPARSPILERVQSLESLHS---SLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTT 961 (1205)
T ss_pred chhhhhcCC------CcccccccchhHHHHhhhhcccc---chhhcccccccchhhcccCCcccCccccccccccccCcC
Confidence 999998764 24444445566778889999999 669999999999999999999999999544322110000
Q ss_pred cccccccccCCCCCCCccc---------cccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCc
Q 042348 530 EVHWEQSTTGTPLQSSPYE---------FTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGS 600 (686)
Q Consensus 530 ~~~~~~~~~g~~~~~~~~~---------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~ 600 (686)
... .....|++....... ........+|..|.+||...+......+|+|+.|++++|.++|..||.....
T Consensus 962 ~~s-g~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~tp 1040 (1205)
T KOG0606|consen 962 DLS-GPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAETP 1040 (1205)
T ss_pred Ccc-cccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcch
Confidence 000 001111111111100 1123356789999999999999889999999999999999999999954433
Q ss_pred cchhHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHH
Q 042348 601 MELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMR 659 (686)
Q Consensus 601 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ 659 (686)
.. .++.+.....+++.. ......+..+++.+.+..+|.+|-.|.
T Consensus 1041 q~-----~f~ni~~~~~~~p~g----------~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1041 QQ-----IFENILNRDIPWPEG----------PEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred hh-----hhhccccCCCCCCCC----------ccccChhhhhhhhhhhccCchhccCcc
Confidence 22 123333332222211 111223455677777888999997665
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.04 E-value=1.2e-10 Score=107.93 Aligned_cols=122 Identities=33% Similarity=0.466 Sum_probs=41.0
Q ss_pred ccCCCCcccCCccccCCCCCcEEEccCCCCCCCCccccc-CCCCCCEEeccCCCCCCCCChhhhhccccccccccccccC
Q 042348 88 LRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIG-KLKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFT 166 (686)
Q Consensus 88 L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~-~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 166 (686)
|..|.|. .+| .+.+..+++.|+|++|.|+ .|. .++ .+.+|+.||||+|.++ .++ .+..+++|+.|+|++|+++
T Consensus 4 lt~~~i~-~~~-~~~n~~~~~~L~L~~n~I~-~Ie-~L~~~l~~L~~L~Ls~N~I~-~l~-~l~~L~~L~~L~L~~N~I~ 77 (175)
T PF14580_consen 4 LTANMIE-QIA-QYNNPVKLRELNLRGNQIS-TIE-NLGATLDKLEVLDLSNNQIT-KLE-GLPGLPRLKTLDLSNNRIS 77 (175)
T ss_dssp ------------------------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS---
T ss_pred ccccccc-ccc-ccccccccccccccccccc-ccc-chhhhhcCCCEEECCCCCCc-ccc-CccChhhhhhcccCCCCCC
Confidence 4445554 344 3456678999999999998 453 566 5889999999999999 454 4778999999999999999
Q ss_pred CCCchhhhhcCcccceecccccccCCCCchhhhcccccccccccccccccCCCCC
Q 042348 167 GPLPDGFATNLTALQKLDLSFNNLSGLIPNDIANLSRLRLLAQRVYVDLTYNNLS 221 (686)
Q Consensus 167 ~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~~~~~l~l~~N~l~ 221 (686)
.+.+.+...+++|+.|+|++|+|... ..+..|..++.|..|++.+|.++
T Consensus 78 -~i~~~l~~~lp~L~~L~L~~N~I~~l-----~~l~~L~~l~~L~~L~L~~NPv~ 126 (175)
T PF14580_consen 78 -SISEGLDKNLPNLQELYLSNNKISDL-----NELEPLSSLPKLRVLSLEGNPVC 126 (175)
T ss_dssp -S-CHHHHHH-TT--EEE-TTS---SC-----CCCGGGGG-TT--EEE-TT-GGG
T ss_pred -ccccchHHhCCcCCEEECcCCcCCCh-----HHhHHHHcCCCcceeeccCCccc
Confidence 57665545689999999999999853 33444444555566677777655
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.02 E-value=1.1e-10 Score=125.74 Aligned_cols=158 Identities=37% Similarity=0.508 Sum_probs=135.5
Q ss_pred CEEEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCccccCCCCCcEEEccCCCCCCCCcccccCCCCCCEEecc
Q 042348 58 QVFSLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQVLDLS 137 (686)
Q Consensus 58 ~~~~l~l~~n~l~g~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls 137 (686)
.++.|++++|.+. .+|..+..++.|+.|++++|+++ .+|...+.+++|+.|++++|+++ .+|..+..+..|+.|+++
T Consensus 141 nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~ 217 (394)
T COG4886 141 NLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLS 217 (394)
T ss_pred hcccccccccchh-hhhhhhhccccccccccCCchhh-hhhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhc
Confidence 7999999999999 46788999999999999999999 78877778999999999999998 888887778889999999
Q ss_pred CCCCCCCCChhhhhccccccccccccccCCCCchhhhhcCcccceecccccccCCCCchhhhcccccccccccccccccC
Q 042348 138 QNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSGLIPNDIANLSRLRLLAQRVYVDLTY 217 (686)
Q Consensus 138 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~~~~~l~l~~ 217 (686)
+|.+. .++..+..+.++..|.+.+|++. .++... +.+++|+.|++++|+++...+ ++.+.+|+. +++++
T Consensus 218 ~N~~~-~~~~~~~~~~~l~~l~l~~n~~~-~~~~~~-~~l~~l~~L~~s~n~i~~i~~--~~~~~~l~~------L~~s~ 286 (394)
T COG4886 218 NNSII-ELLSSLSNLKNLSGLELSNNKLE-DLPESI-GNLSNLETLDLSNNQISSISS--LGSLTNLRE------LDLSG 286 (394)
T ss_pred CCcce-ecchhhhhcccccccccCCceee-eccchh-ccccccceecccccccccccc--ccccCccCE------EeccC
Confidence 99755 57788999999999999999987 334444 588999999999999996544 666666654 49999
Q ss_pred CCCCCCcccccc
Q 042348 218 NNLSGLIPQNAA 229 (686)
Q Consensus 218 N~l~~~~p~~~~ 229 (686)
|.++..+|....
T Consensus 287 n~~~~~~~~~~~ 298 (394)
T COG4886 287 NSLSNALPLIAL 298 (394)
T ss_pred ccccccchhhhc
Confidence 999988886654
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.01 E-value=5.5e-09 Score=104.66 Aligned_cols=140 Identities=17% Similarity=0.155 Sum_probs=100.5
Q ss_pred ccCccCceEEEEEEeCCCceEEEEEcCCCCccc-h----------HHHHHHHHHHhccCCCC--cceeeEEEEec-----
Q 042348 374 LLGKSTIGIVYKVALNNEEAVAVRRLGNGGWQR-F----------KEFQTEAEAIGKIRHPN--IVSLRAYFWSV----- 435 (686)
Q Consensus 374 ~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-~----------~~~~~E~~~l~~l~H~n--Iv~l~~~~~~~----- 435 (686)
++-.-....|+++.+. |+.+.||+........ . ..+.+|.+.+.++...+ .+..+++....
T Consensus 29 ~v~~~~~rrvvr~~~~-g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~ 107 (268)
T PRK15123 29 VFRELEGRRTLRFELA-GKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPAT 107 (268)
T ss_pred EEecCCCceEEEEEEC-CEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCcc
Confidence 3433334446677664 6789999875433211 1 14789999999885433 33456666432
Q ss_pred CceeEEEeccCCC-CHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecC-------
Q 042348 436 DEKLLIYDYIPNG-SLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGK------- 507 (686)
Q Consensus 436 ~~~~lV~e~~~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~------- 507 (686)
...++|||++++- +|.+++..... ...+...+..++.+++..++-||. .||+|+|++++|||++.
T Consensus 108 ~~s~LVte~l~~~~sL~~~~~~~~~----~~~~~~~~~~ll~~la~~i~~LH~---~Gi~HgDL~~~NiLl~~~~~~~~~ 180 (268)
T PRK15123 108 RTSFIITEDLAPTISLEDYCADWAT----NPPDPRLKRMLIKRVATMVRDMHA---AGINHRDCYICHFLLHLPFPGREE 180 (268)
T ss_pred ceeEEEEeeCCCCccHHHHHHhhcc----cCCCHHHHHHHHHHHHHHHHHHHH---CcCccCCCChhhEEEeccccCCCC
Confidence 3468999999876 89999853211 234566778999999999999999 99999999999999975
Q ss_pred CCCeEEeecCcccc
Q 042348 508 NMEPHISDFGLARL 521 (686)
Q Consensus 508 ~~~~kl~DfGla~~ 521 (686)
++.+.++||+.++.
T Consensus 181 ~~~~~LIDl~r~~~ 194 (268)
T PRK15123 181 DLKLSVIDLHRAQI 194 (268)
T ss_pred CceEEEEECCcccc
Confidence 46899999998753
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.01 E-value=1.2e-10 Score=116.31 Aligned_cols=123 Identities=25% Similarity=0.242 Sum_probs=75.4
Q ss_pred CCCccccCCcCcCCCCCCCEEEccCCCCcccCCccccCCCCCcEEEccCCCCCCCCcccccCCCCCCEEeccC-CCCCCC
Q 042348 66 NKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQVLDLSQ-NSFSSS 144 (686)
Q Consensus 66 ~n~l~g~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~-N~l~~~ 144 (686)
+.+|+ .+|..+. .....++|..|+|+-..|.+|+.+++|+.||||+|+|+-+-|++|.+|.+|..|-+.+ |+++..
T Consensus 55 ~~GL~-eVP~~LP--~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l 131 (498)
T KOG4237|consen 55 GKGLT-EVPANLP--PETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDL 131 (498)
T ss_pred CCCcc-cCcccCC--CcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhh
Confidence 33444 3555443 3445677777777755556667777777777777777766666777776666655554 666643
Q ss_pred CChhhhhccccccccccccccCCCCchhhhhcCcccceecccccccCC
Q 042348 145 IPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSG 192 (686)
Q Consensus 145 ~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~ 192 (686)
.-..|.+|.+|+.|.+.-|++. -++...+..|++|..|.|-+|.+..
T Consensus 132 ~k~~F~gL~slqrLllNan~i~-Cir~~al~dL~~l~lLslyDn~~q~ 178 (498)
T KOG4237|consen 132 PKGAFGGLSSLQRLLLNANHIN-CIRQDALRDLPSLSLLSLYDNKIQS 178 (498)
T ss_pred hhhHhhhHHHHHHHhcChhhhc-chhHHHHHHhhhcchhcccchhhhh
Confidence 3445666666666666666666 3444444566666666666666653
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.00 E-value=2.8e-09 Score=100.54 Aligned_cols=124 Identities=24% Similarity=0.274 Sum_probs=83.8
Q ss_pred EEEEEEeCCCceEEEEEcCCCCc--------------------------cchHHHHHHHHHHhccCCC--CcceeeEEEE
Q 042348 382 IVYKVALNNEEAVAVRRLGNGGW--------------------------QRFKEFQTEAEAIGKIRHP--NIVSLRAYFW 433 (686)
Q Consensus 382 ~Vy~~~~~~~~~vavK~~~~~~~--------------------------~~~~~~~~E~~~l~~l~H~--nIv~l~~~~~ 433 (686)
.||.|...++..+|||..+.... .......+|.+.|.++..- ++.+.+++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 38999999999999997643100 0123467899999999765 566776542
Q ss_pred ecCceeEEEeccC--CCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHH-HHccCCCCceecCCCCCCeeecCCCC
Q 042348 434 SVDEKLLIYDYIP--NGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAF-LHEVSPKRYVHGDLRPSNILLGKNME 510 (686)
Q Consensus 434 ~~~~~~lV~e~~~--~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~-LH~~~~~~iiHrDlkp~NILl~~~~~ 510 (686)
..++||||++ |..+..+.... ++......++.+++..+.. +|. .||+|+|+.+.||+++++ .
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~~--------~~~~~~~~~~~~il~~~~~~~~~---~givHGDLs~~NIlv~~~-~ 144 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDVD--------LSPEEPKELLEEILEEIIKMLHK---AGIVHGDLSEYNILVDDG-K 144 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHCG--------GGGSTHHHHHHHHHHHHHHHHHC---TTEEESS-STTSEEEETT-C
T ss_pred ---CCEEEEEecCCCccchhhHHhcc--------ccchhHHHHHHHHHHHHHHHHHh---cCceecCCChhhEEeecc-e
Confidence 4579999998 55554443321 2244567788888886666 568 899999999999999887 9
Q ss_pred eEEeecCcccc
Q 042348 511 PHISDFGLARL 521 (686)
Q Consensus 511 ~kl~DfGla~~ 521 (686)
+.++|||.+..
T Consensus 145 ~~iIDf~qav~ 155 (188)
T PF01163_consen 145 VYIIDFGQAVD 155 (188)
T ss_dssp EEE--GTTEEE
T ss_pred EEEEecCccee
Confidence 99999998863
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.00 E-value=4.9e-11 Score=114.69 Aligned_cols=132 Identities=24% Similarity=0.248 Sum_probs=109.5
Q ss_pred CCEEEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCccccCCCCCcEEEccCCCCCCCCcccccCCCCCCEEec
Q 042348 57 GQVFSLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQVLDL 136 (686)
Q Consensus 57 ~~~~~l~l~~n~l~g~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l 136 (686)
..+++|+|++|.++ .+..++.-++.++.|++|+|.|. .+.. +..|++|+.||||+|.++ .+-..-.+|-+.+.|.|
T Consensus 284 q~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~-~v~n-La~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~L 359 (490)
T KOG1259|consen 284 QELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIR-TVQN-LAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLKL 359 (490)
T ss_pred hhhhhccccccchh-hhhhhhhhccceeEEecccccee-eehh-hhhcccceEeecccchhH-hhhhhHhhhcCEeeeeh
Confidence 35788999999998 68888999999999999999997 4443 888999999999999998 56666678899999999
Q ss_pred cCCCCCCCCChhhhhccccccccccccccCCCCchhhhhcCcccceecccccccCCCC
Q 042348 137 SQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSGLI 194 (686)
Q Consensus 137 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~ 194 (686)
++|.+.. + ..+..+.+|..|++++|++...-.-.-.++|+.|++|.|-+|.+.+.+
T Consensus 360 a~N~iE~-L-SGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~v 415 (490)
T KOG1259|consen 360 AQNKIET-L-SGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGSV 415 (490)
T ss_pred hhhhHhh-h-hhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccccc
Confidence 9999873 2 457888999999999999973211111258999999999999999764
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.88 E-value=7.2e-08 Score=100.33 Aligned_cols=171 Identities=22% Similarity=0.258 Sum_probs=128.3
Q ss_pred ceEEEEEEeC-CCceEEEEEcCCCCccchHHHHHHHHHHhccCCCCcceeeEEEEe----cCceeEEEeccCC-CCHHHH
Q 042348 380 IGIVYKVALN-NEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWS----VDEKLLIYDYIPN-GSLATA 453 (686)
Q Consensus 380 ~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~----~~~~~lV~e~~~~-gsL~~~ 453 (686)
-.+.||+... +|..|++||++....+.......-++.++++.|+|||++.++|.. +...++||+|.++ ++|.++
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 3578898754 799999999955433333334456889999999999999999873 3457899999985 577776
Q ss_pred hhcCCCc---------cccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCccccccc
Q 042348 454 IHGKAGI---------ISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADI 524 (686)
Q Consensus 454 l~~~~~~---------~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~ 524 (686)
-...... ......++..++.++.|+..||.++|+ .|..-+-|.|.+|+++.+.+++|+..|....+..
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHs---sGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHS---SGLACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHh---cCceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 5432211 112457788999999999999999999 8999999999999999999999998887765542
Q ss_pred ccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCC
Q 042348 525 AEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKL 593 (686)
Q Consensus 525 ~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~ 593 (686)
+.. |.+.. -.+-|.=.||.+++.|.||..
T Consensus 446 d~~-------------------------------------~~le~---~Qq~D~~~lG~ll~aLAt~~~ 474 (655)
T KOG3741|consen 446 DPT-------------------------------------EPLES---QQQNDLRDLGLLLLALATGTE 474 (655)
T ss_pred CCC-------------------------------------cchhH---HhhhhHHHHHHHHHHHhhccc
Confidence 210 11111 235688999999999999963
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=98.86 E-value=4e-10 Score=114.09 Aligned_cols=164 Identities=20% Similarity=0.263 Sum_probs=83.9
Q ss_pred CEEEEEeCCCCccccCC--cCcCCCCCCCEEEccCCCCcccCCccc-cCCCCCcEEEccCCCCCC-CCcccccCCCCCCE
Q 042348 58 QVFSLIIPNKKLTGFIP--ADLGSLSAIGRVNLRNNNFSGSLPVEL-FNASNLQSLILSGNSFSG-PVPMQIGKLKYLQV 133 (686)
Q Consensus 58 ~~~~l~l~~n~l~g~~p--~~l~~l~~L~~L~L~~N~l~g~~p~~~-~~l~~L~~L~L~~N~l~g-~~p~~~~~l~~L~~ 133 (686)
.++.|+|+.|-+....| .-...|++|+.|+|+.|++.-...... ..++.|+.|.|+.+.|+- .+-..+..+++|+.
T Consensus 147 ~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~~lK~L~l~~CGls~k~V~~~~~~fPsl~~ 226 (505)
T KOG3207|consen 147 NVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLSHLKQLVLNSCGLSWKDVQWILLTFPSLEV 226 (505)
T ss_pred cceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhhhhheEEeccCCCCHHHHHHHHHhCCcHHH
Confidence 45566666665554333 223455666666666666542222111 134556666666666652 12233345666677
Q ss_pred EeccCCCCCCCCChhhhhccccccccccccccCCCCchhhhhcCcccceecccccccCCCCchhhhcccccccccccccc
Q 042348 134 LDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSGLIPNDIANLSRLRLLAQRVYV 213 (686)
Q Consensus 134 L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~~~~~l 213 (686)
|+|.+|...+.--....-+..|+.|+|++|++-..-.......|+.|..|+++.+.++..--.+...+.....++.+.+|
T Consensus 227 L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L~~Lnls~tgi~si~~~d~~s~~kt~~f~kL~~L 306 (505)
T KOG3207|consen 227 LYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPGLNQLNLSSTGIASIAEPDVESLDKTHTFPKLEYL 306 (505)
T ss_pred hhhhcccccceecchhhhhhHHhhccccCCcccccccccccccccchhhhhccccCcchhcCCCccchhhhcccccceee
Confidence 77766642222233334455677777777766532111112356666666666666654322222223333445556677
Q ss_pred cccCCCCC
Q 042348 214 DLTYNNLS 221 (686)
Q Consensus 214 ~l~~N~l~ 221 (686)
+++.|++.
T Consensus 307 ~i~~N~I~ 314 (505)
T KOG3207|consen 307 NISENNIR 314 (505)
T ss_pred ecccCccc
Confidence 77777774
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.81 E-value=3.5e-08 Score=95.39 Aligned_cols=133 Identities=21% Similarity=0.238 Sum_probs=97.5
Q ss_pred HhhcccCccCceEEEEEEeCCCceEEEEEcCCC--------------------Cc--cchHHHHHHHHHHhccCCC--Cc
Q 042348 370 ASAFLLGKSTIGIVYKVALNNEEAVAVRRLGNG--------------------GW--QRFKEFQTEAEAIGKIRHP--NI 425 (686)
Q Consensus 370 ~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~--------------------~~--~~~~~~~~E~~~l~~l~H~--nI 425 (686)
+.+..||-|.-+.||.|..+.|.++|||.=+.+ ++ ..+...++|.++|.++.-. .|
T Consensus 94 ~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~V 173 (304)
T COG0478 94 AIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKV 173 (304)
T ss_pred hhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCC
Confidence 456789999999999999999999999942211 11 1234577899999999655 67
Q ss_pred ceeeEEEEecCceeEEEeccCCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeee
Q 042348 426 VSLRAYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILL 505 (686)
Q Consensus 426 v~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl 505 (686)
.+.+++ +.-.+||||++|--|...- ++......|+..|+.-+.-.-. .||||+|+.+=||++
T Consensus 174 P~P~~~----nRHaVvMe~ieG~eL~~~r-----------~~~en~~~il~~il~~~~~~~~---~GiVHGDlSefNIlV 235 (304)
T COG0478 174 PKPIAW----NRHAVVMEYIEGVELYRLR-----------LDVENPDEILDKILEEVRKAYR---RGIVHGDLSEFNILV 235 (304)
T ss_pred CCcccc----ccceeeeehcccceeeccc-----------CcccCHHHHHHHHHHHHHHHHH---cCccccCCchheEEE
Confidence 776654 5668999999886665432 2233344455555555555555 799999999999999
Q ss_pred cCCCCeEEeecCccc
Q 042348 506 GKNMEPHISDFGLAR 520 (686)
Q Consensus 506 ~~~~~~kl~DfGla~ 520 (686)
++||.+.++||--+.
T Consensus 236 ~~dg~~~vIDwPQ~v 250 (304)
T COG0478 236 TEDGDIVVIDWPQAV 250 (304)
T ss_pred ecCCCEEEEeCcccc
Confidence 999999999997553
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.77 E-value=3.8e-09 Score=80.41 Aligned_cols=59 Identities=32% Similarity=0.446 Sum_probs=30.3
Q ss_pred CCCEEEccCCCCcccCCccccCCCCCcEEEccCCCCCCCCcccccCCCCCCEEeccCCC
Q 042348 82 AIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQVLDLSQNS 140 (686)
Q Consensus 82 ~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~ 140 (686)
+|++|+|++|+|+...+..|.++++|++|+|++|+++...|..|..+++|++|++++|+
T Consensus 2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~ 60 (61)
T PF13855_consen 2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNN 60 (61)
T ss_dssp TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSS
T ss_pred cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCc
Confidence 44555555555553333444555555555555555554444455555555555555554
|
... |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.76 E-value=3.5e-07 Score=92.94 Aligned_cols=263 Identities=16% Similarity=0.181 Sum_probs=154.6
Q ss_pred ccCccCceEEEEEEeCCCceEEEEEcCCCCccchHHHHHHHHHHhcc-CCCCcceeeEEE----E--ecC-ceeEEEecc
Q 042348 374 LLGKSTIGIVYKVALNNEEAVAVRRLGNGGWQRFKEFQTEAEAIGKI-RHPNIVSLRAYF----W--SVD-EKLLIYDYI 445 (686)
Q Consensus 374 ~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~----~--~~~-~~~lV~e~~ 445 (686)
-||+|+-+.+|-.---.+ -+-|+......... .+-+..|... .||-+-.=+.+= . +.+ ..-++|..+
T Consensus 18 ~LgqGgea~ly~l~e~~d--~VAKIYh~Pppa~~---aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflmP~v 92 (637)
T COG4248 18 PLGQGGEADLYTLGEVRD--QVAKIYHAPPPAAQ---AQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLMPKV 92 (637)
T ss_pred cccCCccceeeecchhhc--hhheeecCCCchHH---HHHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEecccC
Confidence 489999999996432111 23355554322211 1223333333 566544311111 1 112 245677777
Q ss_pred CCC-CHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCccccccc
Q 042348 446 PNG-SLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADI 524 (686)
Q Consensus 446 ~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~ 524 (686)
++. -+..++........+....|.-.++.++.+|.+.+-||+ .|.+-+|+.++|+|+.+++.+.|.|-..-.+..
T Consensus 93 ~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~---~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi~~- 168 (637)
T COG4248 93 SGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHE---HGHVVGDVNQNSFLVSDDSKVVLVDSDSFQINA- 168 (637)
T ss_pred CCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHh---cCCcccccCccceeeecCceEEEEcccceeecc-
Confidence 653 344444443333344668999999999999999999999 899999999999999999999999843222111
Q ss_pred ccCCccccccccccCCCCCCCccccccccCCCCCccccCccccc-----CCCCCCcchHHHHHHHHHHHHhC-CCCcccc
Q 042348 525 AEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASK-----VRKPTQKWDIYSYGVILLEMISG-KLPMIQI 598 (686)
Q Consensus 525 ~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDVwSlGvvl~elltG-~~P~~~~ 598 (686)
+ | +.....+|...|.+||.-. +-.-+...|-|.+||++++++.| ++||.+.
T Consensus 169 n-------------g----------~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI 225 (637)
T COG4248 169 N-------------G----------TLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGI 225 (637)
T ss_pred C-------------C----------ceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcc
Confidence 0 0 1112235566799999643 33457789999999999999986 9999543
Q ss_pred Cc-------cchhHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhcccc--CCCCCCCHHHHHHHHhccc
Q 042348 599 GS-------MELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHK--SPDKRPSMRHVCDSLDRVN 669 (686)
Q Consensus 599 ~~-------~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~--dP~~RPs~~ev~~~L~~i~ 669 (686)
.. .+.++.........+..+ . ..+ .............+..+..+|+.. ++.-|||++..+..|..+.
T Consensus 226 ~~~~~ap~p~E~~Ia~g~f~ya~~~~~--g-~~p-~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~ 301 (637)
T COG4248 226 PLISDAPNPLETDIAHGRFAYASDQRR--G-LKP-PPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALR 301 (637)
T ss_pred cccCCCCCcchhhhhcceeeechhccC--C-CCC-CCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHH
Confidence 21 111111100000000000 0 000 001111222334566677778865 3678999999999988776
Q ss_pred ccc
Q 042348 670 IST 672 (686)
Q Consensus 670 ~~~ 672 (686)
.+.
T Consensus 302 ~~L 304 (637)
T COG4248 302 QQL 304 (637)
T ss_pred Hhh
Confidence 543
|
|
| >PF08263 LRRNT_2: Leucine rich repeat N-terminal domain; InterPro: IPR013210 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape [] | Back alignment and domain information |
|---|
Probab=98.72 E-value=1.1e-08 Score=71.31 Aligned_cols=40 Identities=50% Similarity=1.106 Sum_probs=28.6
Q ss_pred ChhHHHHHHHHHHhccCCCCC--CCCCCCC-CCCcceeeeEec
Q 042348 16 ANDEGLALLSFKQAIRNFPEG--NNWNNSN-EDPCSWNGITCR 55 (686)
Q Consensus 16 ~~~~~~~l~~~k~~~~~~~~~--~~w~~~~-~~~c~w~gv~c~ 55 (686)
+++|+.||+.||+++..+|.. .+|+.++ .+||+|.||+|+
T Consensus 1 ~~~d~~aLl~~k~~l~~~~~~~l~~W~~~~~~~~C~W~GV~Cd 43 (43)
T PF08263_consen 1 PNQDRQALLAFKKSLNNDPSGVLSSWNPSSDSDPCSWSGVTCD 43 (43)
T ss_dssp -HHHHHHHHHHHHCTT-SC-CCCTT--TT--S-CCCSTTEEE-
T ss_pred CcHHHHHHHHHHHhcccccCcccccCCCcCCCCCeeeccEEeC
Confidence 367999999999999866633 7899874 799999999995
|
LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. This domain is often found at the N terminus of tandem leucine rich repeats.; PDB: 3RGZ_A 3RJ0_A 3RIZ_A 3RGX_A 1OGQ_A. |
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.67 E-value=1.7e-08 Score=76.75 Aligned_cols=60 Identities=33% Similarity=0.445 Sum_probs=56.1
Q ss_pred CEEEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCccccCCCCCcEEEccCCCC
Q 042348 58 QVFSLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSF 117 (686)
Q Consensus 58 ~~~~l~l~~n~l~g~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l 117 (686)
+++.|+|++|+|+...+..|..+++|++|++++|+|+...|..|.++++|++|+|++|+|
T Consensus 2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 678999999999987778999999999999999999988888999999999999999985
|
... |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.66 E-value=6.7e-08 Score=104.79 Aligned_cols=149 Identities=20% Similarity=0.350 Sum_probs=96.4
Q ss_pred HHHHHHHhh-cccCccCceEEEEEEeCCCceEEEEEcCCCCccc------------------------------h-----
Q 042348 364 LEQLLKASA-FLLGKSTIGIVYKVALNNEEAVAVRRLGNGGWQR------------------------------F----- 407 (686)
Q Consensus 364 ~~~l~~~~~-~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~------------------------------~----- 407 (686)
++++..... .-|+.++-|.||+|++.+|+.||||+.+.+-... .
T Consensus 121 iee~F~eF~~~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~ 200 (517)
T COG0661 121 IEELFSEFEPEPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEK 200 (517)
T ss_pred HHHHHHHcCCCchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHH
Confidence 344444433 4588999999999999999999999875431110 0
Q ss_pred -----HHHHHHHHHHhccC-----CCCcceeeEEEE-ecCceeEEEeccCCCCHHHHhhcCCCccccCCCCHHHHHHHHH
Q 042348 408 -----KEFQTEAEAIGKIR-----HPNIVSLRAYFW-SVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIK 476 (686)
Q Consensus 408 -----~~~~~E~~~l~~l~-----H~nIv~l~~~~~-~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~ 476 (686)
-++.+|...+.+++ .++| ++=.+|+ -.....++|||++|-.+.+...-.. ..++. ..++.
T Consensus 201 ~l~~ElDy~~EA~n~~~~~~nf~~~~~v-~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-----~g~d~---k~ia~ 271 (517)
T COG0661 201 RLREELDYRREAANAERFRENFKDDPDV-YVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-----AGIDR---KELAE 271 (517)
T ss_pred HHHHHhCHHHHHHHHHHHHHHcCCCCCe-EeceeehhccCCcEEEEEeeCCEecccHHHHHh-----cCCCH---HHHHH
Confidence 12445666666552 3333 2222333 2467799999999998888843222 12332 23333
Q ss_pred HHHHH-HHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCccccccc
Q 042348 477 GVAKG-IAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADI 524 (686)
Q Consensus 477 ~ia~g-L~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~ 524 (686)
.++++ +..+-. .|++|.|..|.||+++.++.+.+.|||+...+++
T Consensus 272 ~~~~~f~~q~~~---dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 272 LLVRAFLRQLLR---DGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred HHHHHHHHHHHh---cCccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 33332 222222 5899999999999999999999999999876654
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.64 E-value=2.7e-07 Score=89.42 Aligned_cols=107 Identities=25% Similarity=0.303 Sum_probs=84.9
Q ss_pred hHHHHHHHHHHhccCC--CCcceeeEEEEecC----ceeEEEeccCCC-CHHHHhhcCCCccccCCCCHHHHHHHHHHHH
Q 042348 407 FKEFQTEAEAIGKIRH--PNIVSLRAYFWSVD----EKLLIYDYIPNG-SLATAIHGKAGIISYRPLSWSDRLRIIKGVA 479 (686)
Q Consensus 407 ~~~~~~E~~~l~~l~H--~nIv~l~~~~~~~~----~~~lV~e~~~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia 479 (686)
...+.+|.+.+.++.. =.+++.+++..... ..++|+|++++. +|.+++.... ..+......++.+++
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~------~~~~~~~~~ll~~l~ 128 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE------QLDPSQRRELLRALA 128 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc------ccchhhHHHHHHHHH
Confidence 3467889998888853 34556677766532 348999999874 8999987632 245567789999999
Q ss_pred HHHHHHHccCCCCceecCCCCCCeeecCCC---CeEEeecCccccc
Q 042348 480 KGIAFLHEVSPKRYVHGDLRPSNILLGKNM---EPHISDFGLARLA 522 (686)
Q Consensus 480 ~gL~~LH~~~~~~iiHrDlkp~NILl~~~~---~~kl~DfGla~~~ 522 (686)
..++-||+ .||+|+|+++.|||++.+. .+.++||+-++..
T Consensus 129 ~~i~~lH~---~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 129 RLIAKLHD---AGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHHHHHH---CcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 99999999 9999999999999999876 8999999987643
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.63 E-value=8.8e-07 Score=84.03 Aligned_cols=138 Identities=17% Similarity=0.083 Sum_probs=103.0
Q ss_pred CccCceEEEEEEeCCCceEEEEEcCCC---C---ccchHHHHHHHHHHhccCC--CCcceeeEEEEec----CceeEEEe
Q 042348 376 GKSTIGIVYKVALNNEEAVAVRRLGNG---G---WQRFKEFQTEAEAIGKIRH--PNIVSLRAYFWSV----DEKLLIYD 443 (686)
Q Consensus 376 G~G~~g~Vy~~~~~~~~~vavK~~~~~---~---~~~~~~~~~E~~~l~~l~H--~nIv~l~~~~~~~----~~~~lV~e 443 (686)
|+||.+-|++..+.+. .+-+|+-... + ......|.+|+..+.++.. -.+.+.+.+.... ..-+||+|
T Consensus 27 ~rgG~SgV~r~~~~g~-~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVTe 105 (216)
T PRK09902 27 RRNGMSGVQCVERNGK-KLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVTE 105 (216)
T ss_pred CCCCcceEEEEEeCCc-EEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEEE
Confidence 7889999999887644 6888987521 1 2245679999999999953 2355555222222 13489999
Q ss_pred ccCC-CCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCC--eEEeecCccc
Q 042348 444 YIPN-GSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNME--PHISDFGLAR 520 (686)
Q Consensus 444 ~~~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~--~kl~DfGla~ 520 (686)
-+++ -||.+++....- .+.+...+..++.+++..++-||+ .|+.|+|+-+.||+++.++. ++++||--++
T Consensus 106 ~L~g~~~L~~~l~~~~~----~~~~~~~k~~il~~va~~ia~LH~---~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 106 DMAGFISIADWYAQHAV----SPYSDEVRQAMLKAVALAFKKMHS---VNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred eCCCCccHHHHHhcCCc----CCcchHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 8854 589998865421 345777788999999999999999 99999999999999986666 9999998765
Q ss_pred c
Q 042348 521 L 521 (686)
Q Consensus 521 ~ 521 (686)
.
T Consensus 179 ~ 179 (216)
T PRK09902 179 R 179 (216)
T ss_pred h
Confidence 3
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.62 E-value=2.2e-09 Score=114.83 Aligned_cols=161 Identities=29% Similarity=0.349 Sum_probs=106.3
Q ss_pred CcCcCCCCCCCEEEccCCCCc---ccCC-------------------------ccccC---CCCCcEEEccCCCCCCCCc
Q 042348 74 PADLGSLSAIGRVNLRNNNFS---GSLP-------------------------VELFN---ASNLQSLILSGNSFSGPVP 122 (686)
Q Consensus 74 p~~l~~l~~L~~L~L~~N~l~---g~~p-------------------------~~~~~---l~~L~~L~L~~N~l~g~~p 122 (686)
|-.|.-+.+|++|.|.+..|+ |..+ .++.+ ...|.+.+.++|.|. .+.
T Consensus 102 pi~ifpF~sLr~LElrg~~L~~~~GL~~lr~qLe~LIC~~Sl~Al~~v~ascggd~~ns~~Wn~L~~a~fsyN~L~-~mD 180 (1096)
T KOG1859|consen 102 PISIFPFRSLRVLELRGCDLSTAKGLQELRHQLEKLICHNSLDALRHVFASCGGDISNSPVWNKLATASFSYNRLV-LMD 180 (1096)
T ss_pred CceeccccceeeEEecCcchhhhhhhHHHHHhhhhhhhhccHHHHHHHHHHhccccccchhhhhHhhhhcchhhHH-hHH
Confidence 556777888888888887775 2111 01111 123556667777776 677
Q ss_pred ccccCCCCCCEEeccCCCCCCCCChhhhhccccccccccccccCCCCchhhhhcCcccceecccccccCCCCchhhhccc
Q 042348 123 MQIGKLKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSGLIPNDIANLS 202 (686)
Q Consensus 123 ~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 202 (686)
.++.-++.|+.|||++|+++. .. .+..|+.|++|||+.|+|+ .+|.--...+ .|+.|+|++|.++.. ..+.+|.
T Consensus 181 ~SLqll~ale~LnLshNk~~~-v~-~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc-~L~~L~lrnN~l~tL--~gie~Lk 254 (1096)
T KOG1859|consen 181 ESLQLLPALESLNLSHNKFTK-VD-NLRRLPKLKHLDLSYNCLR-HVPQLSMVGC-KLQLLNLRNNALTTL--RGIENLK 254 (1096)
T ss_pred HHHHHHHHhhhhccchhhhhh-hH-HHHhcccccccccccchhc-cccccchhhh-hheeeeecccHHHhh--hhHHhhh
Confidence 777778888888888888884 32 7788888888888888887 5654322233 388888888888853 2455555
Q ss_pred ccccccccccccccCCCCCCCc--ccccccccCCcccccCCCCCCCC
Q 042348 203 RLRLLAQRVYVDLTYNNLSGLI--PQNAALLSLGPTAFIGNPFLCGP 247 (686)
Q Consensus 203 ~L~~l~~~~~l~l~~N~l~~~~--p~~~~~~~~~~~~~~~n~~~c~~ 247 (686)
+|+. |||++|-|++-- -..-.+..+..+++.|||.-|.+
T Consensus 255 sL~~------LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c~p 295 (1096)
T KOG1859|consen 255 SLYG------LDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCCAP 295 (1096)
T ss_pred hhhc------cchhHhhhhcchhhhHHHHHHHHHHHhhcCCccccCH
Confidence 5554 499999887531 11122344566788899987754
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.49 E-value=5.3e-08 Score=105.10 Aligned_cols=159 Identities=20% Similarity=0.244 Sum_probs=99.2
Q ss_pred HHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCccccccccccCCCCCCCccccccccC
Q 042348 475 IKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNS 554 (686)
Q Consensus 475 ~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~ 554 (686)
+.++++||.|+|.. .++||++|.|++|.+++.+..||+.|+.+.........+ ...+.....--
T Consensus 105 l~~v~dgl~flh~s--Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p--------------~~~yd~~lp~~ 168 (700)
T KOG2137|consen 105 LGNVADGLAFLHRS--AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYP--------------FSEYDPPLPLL 168 (700)
T ss_pred hhcccchhhhhccC--cceeecccchhheeeccCcceeeccchhhhccCCCCccc--------------cccCCCCCChh
Confidence 45566999999974 579999999999999999999999999876443211100 01111111111
Q ss_pred CCCCccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCccccCccchhHHHHHHHHHhhcCCcccccCcccccCCCc
Q 042348 555 TTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQIGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDK 633 (686)
Q Consensus 555 ~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 633 (686)
......|.|||++.....+.++|+||+||++|.+.. |+.-+...+.... .-...... +....+ ..
T Consensus 169 ~~~~~~f~apE~~~~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~----~~~~~~~~--------~~~~~~--~s 234 (700)
T KOG2137|consen 169 LQPHLNFLAPEYLLGTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLS----YSFSRNLL--------NAGAFG--YS 234 (700)
T ss_pred hccCcccccchhhccccccccccceeeeeEEEEEecCCcchhhccCCcch----hhhhhccc--------cccccc--cc
Confidence 222456999999998888999999999999999995 4443322211110 00000000 000000 01
Q ss_pred HHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042348 634 EDEIVSVLKIALDCVHKSPDKRPSMRHVCD 663 (686)
Q Consensus 634 ~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 663 (686)
...+.++.+-+.+++..++..||++.++..
T Consensus 235 ~~~p~el~~~l~k~l~~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 235 NNLPSELRESLKKLLNGDSAVRPTLDLLLS 264 (700)
T ss_pred ccCcHHHHHHHHHHhcCCcccCcchhhhhc
Confidence 123345667777889999999997776543
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=98.48 E-value=3e-08 Score=100.81 Aligned_cols=160 Identities=23% Similarity=0.250 Sum_probs=114.4
Q ss_pred CCCEEEEEeCCCCccccCCcC-cCCCCCCCEEEccCCCCcc-cCCccccCCCCCcEEEccCCCCCCCCcccccCCCCCCE
Q 042348 56 EGQVFSLIIPNKKLTGFIPAD-LGSLSAIGRVNLRNNNFSG-SLPVELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQV 133 (686)
Q Consensus 56 ~~~~~~l~l~~n~l~g~~p~~-l~~l~~L~~L~L~~N~l~g-~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~ 133 (686)
-.+++.|+|+.|+|.-..... -..++.|+.|.|+.+.|+- .+-.-+..+|+|..|+|..|..-+.-......+..|+.
T Consensus 171 Lp~Le~LNls~Nrl~~~~~s~~~~~l~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~ 250 (505)
T KOG3207|consen 171 LPSLENLNLSSNRLSNFISSNTTLLLSHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQE 250 (505)
T ss_pred cccchhcccccccccCCccccchhhhhhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhh
Confidence 468999999999998654443 2367899999999999971 12233456799999999999643344445566789999
Q ss_pred EeccCCCCCCCCC--hhhhhccccccccccccccCCC-Cchh----hhhcCcccceecccccccCCCCchhhhccccccc
Q 042348 134 LDLSQNSFSSSIP--SSIVQCKRLKTVVLNQNSFTGP-LPDG----FATNLTALQKLDLSFNNLSGLIPNDIANLSRLRL 206 (686)
Q Consensus 134 L~ls~N~l~~~~p--~~~~~l~~L~~L~L~~N~l~~~-~p~~----~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 206 (686)
|||++|++- ..+ ...+.++.|..|+++.+.++.. +|+. ....+++|++|+++.|++.. +..+.+++.
T Consensus 251 LdLs~N~li-~~~~~~~~~~l~~L~~Lnls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~~-----w~sl~~l~~ 324 (505)
T KOG3207|consen 251 LDLSNNNLI-DFDQGYKVGTLPGLNQLNLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIRD-----WRSLNHLRT 324 (505)
T ss_pred ccccCCccc-ccccccccccccchhhhhccccCcchhcCCCccchhhhcccccceeeecccCcccc-----ccccchhhc
Confidence 999999987 344 4567889999999999988732 2332 12468899999999999974 334455555
Q ss_pred ccccccccccCCCCC
Q 042348 207 LAQRVYVDLTYNNLS 221 (686)
Q Consensus 207 l~~~~~l~l~~N~l~ 221 (686)
++++..|....|.|+
T Consensus 325 l~nlk~l~~~~n~ln 339 (505)
T KOG3207|consen 325 LENLKHLRITLNYLN 339 (505)
T ss_pred cchhhhhhccccccc
Confidence 544444455555554
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.47 E-value=2.2e-06 Score=84.18 Aligned_cols=141 Identities=17% Similarity=0.157 Sum_probs=84.6
Q ss_pred ccCccCceEEEEEEeCCCceEEEEEcCCCCccchHHHHHHHHHHhccCCCC--cceeeEEEEecCceeEEEeccCCCC-H
Q 042348 374 LLGKSTIGIVYKVALNNEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPN--IVSLRAYFWSVDEKLLIYDYIPNGS-L 450 (686)
Q Consensus 374 ~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n--Iv~l~~~~~~~~~~~lV~e~~~~gs-L 450 (686)
.||+|..+.||+. .+..+++|...... ......+|.++++.+..-. +.+.+++....+...+|||+++|.+ +
T Consensus 8 ~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~~ 82 (226)
T TIGR02172 8 QTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRSF 82 (226)
T ss_pred eecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccch
Confidence 5899999999984 24467788876533 2355788999999986433 4677878777777889999998863 2
Q ss_pred HHHhhcCC-----------------CccccCCCCHHHHH-HHHH----------HHHH-HHHHHHccC-CCCceecCCCC
Q 042348 451 ATAIHGKA-----------------GIISYRPLSWSDRL-RIIK----------GVAK-GIAFLHEVS-PKRYVHGDLRP 500 (686)
Q Consensus 451 ~~~l~~~~-----------------~~~~~~~l~~~~~~-~i~~----------~ia~-gL~~LH~~~-~~~iiHrDlkp 500 (686)
...+.... .............. ++-. .+.. ..++|.... ...++|+|+.|
T Consensus 83 ~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~~ 162 (226)
T TIGR02172 83 SRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQI 162 (226)
T ss_pred hhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCCC
Confidence 21111000 00000001111100 0000 0001 122222211 23578999999
Q ss_pred CCeeecCCCCeEEeecCccc
Q 042348 501 SNILLGKNMEPHISDFGLAR 520 (686)
Q Consensus 501 ~NILl~~~~~~kl~DfGla~ 520 (686)
.||++++++ +.++||+.+.
T Consensus 163 ~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 163 GNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CcEEEcCCC-cEEEechhcC
Confidence 999999887 9999999875
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.44 E-value=3e-08 Score=85.03 Aligned_cols=133 Identities=18% Similarity=0.251 Sum_probs=89.5
Q ss_pred EEEEeCCCCccccCCc---CcCCCCCCCEEEccCCCCcccCCcccc-CCCCCcEEEccCCCCCCCCcccccCCCCCCEEe
Q 042348 60 FSLIIPNKKLTGFIPA---DLGSLSAIGRVNLRNNNFSGSLPVELF-NASNLQSLILSGNSFSGPVPMQIGKLKYLQVLD 135 (686)
Q Consensus 60 ~~l~l~~n~l~g~~p~---~l~~l~~L~~L~L~~N~l~g~~p~~~~-~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ 135 (686)
-.++|++..|- .++. .+.....|+..+|++|.|. ..|..|. ..+.+++|+|++|.|+ .+|.++..++.|+.|+
T Consensus 30 h~ldLssc~lm-~i~davy~l~~~~el~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~lN 106 (177)
T KOG4579|consen 30 HFLDLSSCQLM-YIADAVYMLSKGYELTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSLN 106 (177)
T ss_pred hhcccccchhh-HHHHHHHHHhCCceEEEEecccchhh-hCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhcc
Confidence 34555555543 2333 3444556666788888887 5666655 3457888888888887 7888888888888888
Q ss_pred ccCCCCCCCCChhhhhccccccccccccccCCCCchhhhhcCcccceecccccccCCCCchhh
Q 042348 136 LSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSGLIPNDI 198 (686)
Q Consensus 136 ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 198 (686)
++.|.|. ..|..+..|.+|..|+..+|.+. +||-..+ .-..+-..+|.+|.+.+.-|..+
T Consensus 107 l~~N~l~-~~p~vi~~L~~l~~Lds~~na~~-eid~dl~-~s~~~al~~lgnepl~~~~~~kl 166 (177)
T KOG4579|consen 107 LRFNPLN-AEPRVIAPLIKLDMLDSPENARA-EIDVDLF-YSSLPALIKLGNEPLGDETKKKL 166 (177)
T ss_pred cccCccc-cchHHHHHHHhHHHhcCCCCccc-cCcHHHh-ccccHHHHHhcCCcccccCcccc
Confidence 8888887 67777777888888888888876 6665543 22233334566777776655443
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.44 E-value=6.1e-09 Score=111.54 Aligned_cols=126 Identities=26% Similarity=0.269 Sum_probs=76.1
Q ss_pred EEEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCccccCCCCCcEEEccCCCCCCCCccc-ccCCCCCCEEecc
Q 042348 59 VFSLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQ-IGKLKYLQVLDLS 137 (686)
Q Consensus 59 ~~~l~l~~n~l~g~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~-~~~l~~L~~L~ls 137 (686)
+...+.+.|.|+ .+..++.-|+.|+.|||++|++. ... .+..++.|++|||++|.|. .+|.. ...+. |+.|.|+
T Consensus 166 L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~-~v~-~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc~-L~~L~lr 240 (1096)
T KOG1859|consen 166 LATASFSYNRLV-LMDESLQLLPALESLNLSHNKFT-KVD-NLRRLPKLKHLDLSYNCLR-HVPQLSMVGCK-LQLLNLR 240 (1096)
T ss_pred HhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhh-hhH-HHHhcccccccccccchhc-cccccchhhhh-heeeeec
Confidence 444555566666 35566666777777777777776 232 5666777777777777776 45532 22233 7777777
Q ss_pred CCCCCCCCChhhhhccccccccccccccCCCCchhhhhcCcccceecccccccC
Q 042348 138 QNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLS 191 (686)
Q Consensus 138 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~ 191 (686)
+|.++.. ..+.+|.+|..|||++|-|++.-.-.+...|..|..|+|.+|.+-
T Consensus 241 nN~l~tL--~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~ 292 (1096)
T KOG1859|consen 241 NNALTTL--RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLC 292 (1096)
T ss_pred ccHHHhh--hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccc
Confidence 7776632 235566777777777776664332222334566677777777664
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.32 E-value=1.1e-07 Score=81.72 Aligned_cols=132 Identities=23% Similarity=0.323 Sum_probs=78.1
Q ss_pred CCEEEccCCCCcccCCcccc---CCCCCcEEEccCCCCCCCCccccc-CCCCCCEEeccCCCCCCCCChhhhhccccccc
Q 042348 83 IGRVNLRNNNFSGSLPVELF---NASNLQSLILSGNSFSGPVPMQIG-KLKYLQVLDLSQNSFSSSIPSSIVQCKRLKTV 158 (686)
Q Consensus 83 L~~L~L~~N~l~g~~p~~~~---~l~~L~~L~L~~N~l~g~~p~~~~-~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L 158 (686)
+..++|++.+|- .++.... ....|+..+|++|.|. .+|..|. +++.++.|+|++|.++ .+|..+..++.|+.|
T Consensus 29 ~h~ldLssc~lm-~i~davy~l~~~~el~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~l 105 (177)
T KOG4579|consen 29 LHFLDLSSCQLM-YIADAVYMLSKGYELTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSL 105 (177)
T ss_pred hhhcccccchhh-HHHHHHHHHhCCceEEEEecccchhh-hCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhc
Confidence 445666666663 4444433 3344555677777776 4444443 4457777777777777 577777777777777
Q ss_pred cccccccCCCCchhhhhcCcccceecccccccCCCCchhhhcccccccccccccccccCCCCCCCccc
Q 042348 159 VLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSGLIPNDIANLSRLRLLAQRVYVDLTYNNLSGLIPQ 226 (686)
Q Consensus 159 ~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~~~~~l~l~~N~l~~~~p~ 226 (686)
+++.|.|. ..|.-++ .|.+|-.||..+|.+.- ||-++- .+++..+ .++.+|-+.+.-+.
T Consensus 106 Nl~~N~l~-~~p~vi~-~L~~l~~Lds~~na~~e-id~dl~-~s~~~al-----~~lgnepl~~~~~~ 164 (177)
T KOG4579|consen 106 NLRFNPLN-AEPRVIA-PLIKLDMLDSPENARAE-IDVDLF-YSSLPAL-----IKLGNEPLGDETKK 164 (177)
T ss_pred ccccCccc-cchHHHH-HHHhHHHhcCCCCcccc-CcHHHh-ccccHHH-----HHhcCCcccccCcc
Confidence 77777776 4555554 47777777777777663 343322 1222111 25566666654443
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.28 E-value=3.9e-07 Score=98.54 Aligned_cols=126 Identities=28% Similarity=0.298 Sum_probs=72.0
Q ss_pred CCEEEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCccccCCCCCcEEEccCCCCCCCCcccccCCCCCCEEec
Q 042348 57 GQVFSLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQVLDL 136 (686)
Q Consensus 57 ~~~~~l~l~~n~l~g~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l 136 (686)
..+..|+|.+|+|.+.. ..+..+.+|++|+|++|.|+...+ +..++.|+.|++++|.++ .+. .+..+.+|+.+++
T Consensus 95 ~~l~~l~l~~n~i~~i~-~~l~~~~~L~~L~ls~N~I~~i~~--l~~l~~L~~L~l~~N~i~-~~~-~~~~l~~L~~l~l 169 (414)
T KOG0531|consen 95 KSLEALDLYDNKIEKIE-NLLSSLVNLQVLDLSFNKITKLEG--LSTLTLLKELNLSGNLIS-DIS-GLESLKSLKLLDL 169 (414)
T ss_pred cceeeeeccccchhhcc-cchhhhhcchheeccccccccccc--hhhccchhhheeccCcch-hcc-CCccchhhhcccC
Confidence 45666777777776532 225666777777777777764333 345555777777777775 222 3445667777777
Q ss_pred cCCCCCCCCChh-hhhccccccccccccccCCCCchhhhhcCcccceecccccccC
Q 042348 137 SQNSFSSSIPSS-IVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLS 191 (686)
Q Consensus 137 s~N~l~~~~p~~-~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~ 191 (686)
++|.++. +... ...+.+|+.+++.+|.+.- +. .+ ..+..+..+++..|.++
T Consensus 170 ~~n~i~~-ie~~~~~~~~~l~~l~l~~n~i~~-i~-~~-~~~~~l~~~~l~~n~i~ 221 (414)
T KOG0531|consen 170 SYNRIVD-IENDELSELISLEELDLGGNSIRE-IE-GL-DLLKKLVLLSLLDNKIS 221 (414)
T ss_pred Ccchhhh-hhhhhhhhccchHHHhccCCchhc-cc-ch-HHHHHHHHhhcccccce
Confidence 7777663 3322 4566667777777776652 21 11 12333444455555554
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.24 E-value=1.2e-05 Score=80.39 Aligned_cols=75 Identities=16% Similarity=0.177 Sum_probs=54.4
Q ss_pred cCccCc-eEEEEEEeCCCceEEEEEcCCCCccchHHHHHHHHHHhccC-CCCcceeeEEEEecCceeEEEeccCCCCHHH
Q 042348 375 LGKSTI-GIVYKVALNNEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIR-HPNIVSLRAYFWSVDEKLLIYDYIPNGSLAT 452 (686)
Q Consensus 375 iG~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lV~e~~~~gsL~~ 452 (686)
|-.|.. ..||+....+ ..+.||+..... .....+|+++++.+. +--+.+++++....+..++|||+++|.++..
T Consensus 6 ~~~g~~~~~v~~~~~~~-~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~ 81 (244)
T cd05150 6 VTEGQSGATVYRLDGKN-PGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAA 81 (244)
T ss_pred cCCCCCcCeEEEEcCCC-CcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhH
Confidence 334444 7899997654 678888876543 245778999988883 4446678887776667899999999987764
Q ss_pred H
Q 042348 453 A 453 (686)
Q Consensus 453 ~ 453 (686)
.
T Consensus 82 ~ 82 (244)
T cd05150 82 L 82 (244)
T ss_pred h
Confidence 4
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.21 E-value=8.7e-06 Score=88.17 Aligned_cols=141 Identities=20% Similarity=0.300 Sum_probs=89.2
Q ss_pred cccCccCceEEEEEEeCCCceEEEEEcCCCCcc-------------------------------------chHHHHHHHH
Q 042348 373 FLLGKSTIGIVYKVALNNEEAVAVRRLGNGGWQ-------------------------------------RFKEFQTEAE 415 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-------------------------------------~~~~~~~E~~ 415 (686)
.-||.-+.|.||+|++++|+.||||+-+.+-.. ..-+|.+|++
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 458999999999999999999999986543111 0012455555
Q ss_pred HHhcc----CCCCc---ceeeEEEEe-cCceeEEEeccCCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHc
Q 042348 416 AIGKI----RHPNI---VSLRAYFWS-VDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHE 487 (686)
Q Consensus 416 ~l~~l----~H~nI---v~l~~~~~~-~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~ 487 (686)
-..++ .|-+. |.+=.++++ -..+.|+||||+|..+.|.-.-.. ..++...+ +..+.++.. +.
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~-----~gi~~~~i---~~~l~~~~~--~q 316 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDK-----RGISPHDI---LNKLVEAYL--EQ 316 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHH-----cCCCHHHH---HHHHHHHHH--HH
Confidence 44444 35551 112222332 356799999999987766533221 23454433 333333222 11
Q ss_pred cCCCCceecCCCCCCeeecC----CCCeEEeecCcccccc
Q 042348 488 VSPKRYVHGDLRPSNILLGK----NMEPHISDFGLARLAD 523 (686)
Q Consensus 488 ~~~~~iiHrDlkp~NILl~~----~~~~kl~DfGla~~~~ 523 (686)
.-..|.+|+|=.|.||++.. ++.+.+-|||+...+.
T Consensus 317 If~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 317 IFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred HHhcCCccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 11157999999999999983 6789999999987654
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.12 E-value=2.3e-05 Score=75.42 Aligned_cols=135 Identities=20% Similarity=0.232 Sum_probs=92.1
Q ss_pred ccCccCceEEEEEEeCCCceEEEEEcCCCCcc-------------------chHH-----HHHHHHHHhccC--CCCcce
Q 042348 374 LLGKSTIGIVYKVALNNEEAVAVRRLGNGGWQ-------------------RFKE-----FQTEAEAIGKIR--HPNIVS 427 (686)
Q Consensus 374 ~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-------------------~~~~-----~~~E~~~l~~l~--H~nIv~ 427 (686)
.|+.|.-+.||+|...++..+|||+++..... ..++ ..+|..-|.++. +-.+.+
T Consensus 55 ~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP~ 134 (268)
T COG1718 55 CISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVPE 134 (268)
T ss_pred eecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCCC
Confidence 47888899999999888999999987543211 0111 346777777773 444555
Q ss_pred eeEEEEecCceeEEEeccCCCC-HHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeec
Q 042348 428 LRAYFWSVDEKLLIYDYIPNGS-LATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLG 506 (686)
Q Consensus 428 l~~~~~~~~~~~lV~e~~~~gs-L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~ 506 (686)
-+++. .-.+||||+.... -.-.|. ..++...+...+..++++.+.-|-.. .++||+||..=|||+.
T Consensus 135 Pi~~~----~nVLvMEfIg~~g~pAP~Lk-------Dv~~e~~e~~~~~~~~v~~~~~l~~~--a~LVHgDLSEyNiL~~ 201 (268)
T COG1718 135 PIAFR----NNVLVMEFIGDDGLPAPRLK-------DVPLELEEAEGLYEDVVEYMRRLYKE--AGLVHGDLSEYNILVH 201 (268)
T ss_pred ceeec----CCeEEEEeccCCCCCCCCcc-------cCCcCchhHHHHHHHHHHHHHHHHHh--cCcccccchhhheEEE
Confidence 55443 4579999995431 111111 12233335677788888888777653 5799999999999999
Q ss_pred CCCCeEEeecCccccc
Q 042348 507 KNMEPHISDFGLARLA 522 (686)
Q Consensus 507 ~~~~~kl~DfGla~~~ 522 (686)
++.+.|+|||-|-..
T Consensus 202 -~~~p~iID~~QaV~~ 216 (268)
T COG1718 202 -DGEPYIIDVSQAVTI 216 (268)
T ss_pred -CCeEEEEECcccccc
Confidence 889999999988643
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 686 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 4e-33 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 1e-32 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 8e-27 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 9e-27 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-26 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 3e-25 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-24 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 3e-24 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 4e-19 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 5e-19 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 5e-19 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 1e-18 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-18 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-18 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 3e-18 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 3e-18 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-18 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 3e-18 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 3e-18 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 3e-18 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 3e-18 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 4e-18 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 4e-18 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 4e-18 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 4e-18 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 5e-18 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 5e-18 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 7e-18 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 7e-18 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 7e-18 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 7e-18 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 8e-18 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-17 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-17 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 1e-17 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 1e-17 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 1e-17 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-17 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-17 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-17 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-17 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-17 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 3e-17 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 3e-17 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 3e-17 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 3e-17 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 3e-17 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 3e-17 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 5e-17 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 5e-17 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 9e-17 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-16 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-16 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 1e-16 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-16 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-16 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-16 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 3e-16 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-16 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 3e-16 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 3e-16 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 8e-16 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 3e-15 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 3e-15 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 3e-15 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 5e-15 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 5e-15 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 6e-15 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 8e-15 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-14 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-14 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-14 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 3e-14 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 3e-14 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 3e-14 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 6e-14 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 6e-14 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 7e-14 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 8e-14 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 1e-13 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 1e-13 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 1e-13 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-13 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-13 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-13 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-13 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 4e-13 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 5e-13 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 6e-13 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 6e-13 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 7e-13 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 8e-13 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 8e-13 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 8e-13 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 8e-13 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 9e-13 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 9e-13 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 9e-13 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-12 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-12 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-12 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-12 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 1e-12 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-12 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 1e-12 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-12 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-12 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 3e-12 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-12 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-12 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 5e-12 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 6e-12 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 7e-12 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 9e-12 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 9e-12 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 9e-12 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-11 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-11 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-11 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-11 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-11 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 2e-11 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-11 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-11 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-11 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-11 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-11 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-11 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-11 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 3e-11 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 5e-11 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 7e-11 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 8e-11 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 9e-11 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 9e-11 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 1e-10 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-10 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-10 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-10 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-10 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-10 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-10 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-10 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-10 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-10 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-10 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-10 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-10 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-10 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-10 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-10 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-10 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-10 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-10 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-10 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-10 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-10 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 2e-10 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-10 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-10 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-10 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-10 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-10 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-10 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-10 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 2e-10 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-10 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-10 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-10 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 2e-10 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 2e-10 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-10 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-10 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-10 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-10 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-10 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-10 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 2e-10 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 2e-10 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-10 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-10 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 2e-10 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-10 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-10 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 3e-10 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 3e-10 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 3e-10 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 3e-10 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 3e-10 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-10 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 4e-10 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 4e-10 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-10 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 4e-10 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 4e-10 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 4e-10 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 5e-10 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 5e-10 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 5e-10 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 5e-10 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 5e-10 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 5e-10 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 7e-10 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 7e-10 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 8e-10 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 8e-10 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 8e-10 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 8e-10 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 9e-10 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 9e-10 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 9e-10 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 9e-10 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 9e-10 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 9e-10 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-09 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-09 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-09 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-09 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 1e-09 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-09 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-09 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-09 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-09 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-09 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 1e-09 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 1e-09 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 2e-09 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 2e-09 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-09 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-09 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-09 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-09 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-09 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 2e-09 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-09 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-09 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 3e-09 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 3e-09 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-09 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 3e-09 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 3e-09 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 4e-09 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 4e-09 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 7e-09 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 9e-09 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-08 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-08 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-08 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-08 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 1e-08 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 1e-08 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 1e-08 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 1e-08 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-08 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 1e-08 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-08 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-08 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 1e-08 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-08 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-08 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-08 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 2e-08 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-08 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-08 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 2e-08 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-08 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 2e-08 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 2e-08 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 3e-08 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 3e-08 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 3e-08 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 3e-08 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 3e-08 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 3e-08 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 3e-08 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 3e-08 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 3e-08 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 3e-08 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 3e-08 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 3e-08 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-08 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 4e-08 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 4e-08 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 4e-08 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-08 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 4e-08 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 4e-08 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 4e-08 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 4e-08 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-08 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 4e-08 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 4e-08 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 4e-08 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 4e-08 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 4e-08 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 4e-08 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 4e-08 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 4e-08 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 4e-08 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 5e-08 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 5e-08 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 5e-08 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-08 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 5e-08 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 5e-08 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-08 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 5e-08 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 6e-08 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 6e-08 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 6e-08 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 6e-08 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 6e-08 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 6e-08 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 6e-08 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 6e-08 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 6e-08 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 7e-08 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 7e-08 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-08 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 7e-08 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 7e-08 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-08 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 7e-08 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 7e-08 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 7e-08 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 8e-08 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 8e-08 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-08 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-08 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 9e-08 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 9e-08 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 9e-08 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 9e-08 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 9e-08 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 9e-08 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 9e-08 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-07 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-07 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-07 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 1e-07 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 1e-07 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 1e-07 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 1e-07 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 1e-07 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-07 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-07 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-07 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 1e-07 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 1e-07 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-07 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-07 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-07 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-07 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 2e-07 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-07 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-07 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-07 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-07 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-07 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 2e-07 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 2e-07 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-07 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-07 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 2e-07 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-07 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-07 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-07 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-07 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-07 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 2e-07 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 2e-07 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 2e-07 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 2e-07 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-07 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-07 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 2e-07 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-07 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-07 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-07 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-07 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 2e-07 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 3e-07 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 3e-07 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 3e-07 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 3e-07 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 3e-07 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 3e-07 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 3e-07 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-07 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 3e-07 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 3e-07 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 3e-07 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 3e-07 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 3e-07 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 3e-07 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 3e-07 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 3e-07 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 3e-07 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 3e-07 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 3e-07 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 3e-07 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 3e-07 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 3e-07 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 3e-07 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 3e-07 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 3e-07 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 3e-07 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 3e-07 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 3e-07 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-07 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 4e-07 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 4e-07 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-07 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 4e-07 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 4e-07 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 4e-07 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 4e-07 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 4e-07 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 4e-07 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 4e-07 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 4e-07 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-07 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 4e-07 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 4e-07 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 4e-07 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 4e-07 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 4e-07 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 4e-07 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 4e-07 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 4e-07 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 4e-07 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 4e-07 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 4e-07 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 4e-07 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 4e-07 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 4e-07 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 4e-07 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-07 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 4e-07 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 4e-07 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 4e-07 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 4e-07 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 4e-07 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 4e-07 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-07 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 4e-07 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 4e-07 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 4e-07 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-07 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 4e-07 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-07 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-07 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 5e-07 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 5e-07 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 5e-07 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 5e-07 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 5e-07 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-07 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 5e-07 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 5e-07 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 5e-07 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-07 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 5e-07 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 5e-07 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 5e-07 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 5e-07 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-07 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 5e-07 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 5e-07 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 6e-07 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 6e-07 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 6e-07 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-07 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 6e-07 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-07 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 6e-07 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 6e-07 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 6e-07 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 6e-07 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 6e-07 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 7e-07 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 7e-07 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 7e-07 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 7e-07 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 7e-07 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 7e-07 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 8e-07 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 8e-07 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 8e-07 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-07 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 8e-07 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 8e-07 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 8e-07 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 8e-07 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 8e-07 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 8e-07 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 8e-07 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 8e-07 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 9e-07 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 9e-07 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 9e-07 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 9e-07 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 9e-07 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 9e-07 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 9e-07 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 9e-07 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 9e-07 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-07 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 9e-07 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 9e-07 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-06 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-06 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 1e-06 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-06 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 1e-06 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-06 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-06 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 1e-06 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-06 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-06 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 1e-06 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 1e-06 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-06 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-06 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 1e-06 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 1e-06 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 1e-06 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 1e-06 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-06 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 1e-06 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 1e-06 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 1e-06 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 1e-06 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-06 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-06 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-06 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 2e-06 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-06 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-06 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-06 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 2e-06 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-06 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-06 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-06 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 2e-06 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 2e-06 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-06 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-06 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 3e-06 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 3e-06 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 3e-06 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-06 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 3e-06 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 3e-06 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 3e-06 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 3e-06 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 3e-06 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 3e-06 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 3e-06 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 3e-06 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 3e-06 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 4e-06 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 4e-06 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 4e-06 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 4e-06 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 4e-06 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 4e-06 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 4e-06 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 4e-06 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-06 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 4e-06 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 4e-06 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 4e-06 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-06 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 4e-06 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 4e-06 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 4e-06 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-06 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 5e-06 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 5e-06 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 6e-06 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 6e-06 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 6e-06 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 6e-06 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 6e-06 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 6e-06 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 7e-06 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 7e-06 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 7e-06 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 7e-06 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 7e-06 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 7e-06 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 7e-06 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 7e-06 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 7e-06 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 7e-06 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 7e-06 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 7e-06 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 8e-06 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 8e-06 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 8e-06 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 8e-06 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-06 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 8e-06 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 9e-06 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 9e-06 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 9e-06 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 9e-06 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-05 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 1e-05 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 1e-05 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 1e-05 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 1e-05 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-05 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 1e-05 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 1e-05 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-05 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-05 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-05 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 1e-05 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 1e-05 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 1e-05 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 1e-05 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 1e-05 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 1e-05 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 2e-05 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 2e-05 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-05 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 2e-05 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-05 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-05 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 2e-05 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 2e-05 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-05 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 2e-05 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-05 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 2e-05 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 2e-05 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 2e-05 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-05 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 2e-05 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 2e-05 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-05 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-05 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 2e-05 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-05 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-05 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-05 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 2e-05 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-05 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-05 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-05 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-05 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-05 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-05 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-05 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-05 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 3e-05 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-05 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 3e-05 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 3e-05 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-05 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 3e-05 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 3e-05 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 3e-05 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 3e-05 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 4e-05 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-05 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-05 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 4e-05 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 4e-05 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 4e-05 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 4e-05 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 4e-05 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 4e-05 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 4e-05 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 4e-05 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 4e-05 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 4e-05 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 4e-05 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 4e-05 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 4e-05 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 4e-05 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 4e-05 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 5e-05 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 5e-05 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 5e-05 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 5e-05 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 5e-05 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 5e-05 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 5e-05 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 5e-05 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 5e-05 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 5e-05 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 6e-05 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 6e-05 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 6e-05 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 6e-05 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 6e-05 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 6e-05 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 6e-05 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 7e-05 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 7e-05 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 7e-05 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 7e-05 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 8e-05 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 8e-05 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 8e-05 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 9e-05 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 9e-05 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 1e-04 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 1e-04 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-04 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 1e-04 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 1e-04 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-04 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 1e-04 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-04 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-04 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-04 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 1e-04 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 1e-04 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 1e-04 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 1e-04 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 1e-04 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-04 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-04 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 1e-04 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 1e-04 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 1e-04 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 1e-04 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 1e-04 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 1e-04 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 1e-04 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 1e-04 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-04 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-04 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-04 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-04 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-04 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-04 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-04 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-04 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-04 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-04 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-04 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-04 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-04 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-04 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-04 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-04 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-04 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-04 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-04 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 2e-04 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-04 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-04 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-04 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-04 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-04 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-04 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-04 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-04 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 2e-04 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-04 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-04 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-04 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-04 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-04 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-04 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-04 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-04 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-04 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 3e-04 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 3e-04 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-04 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-04 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-04 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 3e-04 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 3e-04 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-04 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-04 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 3e-04 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 3e-04 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 3e-04 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 3e-04 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 3e-04 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 3e-04 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 3e-04 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 3e-04 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-04 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-04 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-04 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 4e-04 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 4e-04 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 4e-04 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 4e-04 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 4e-04 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 4e-04 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-04 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 4e-04 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 5e-04 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-04 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 5e-04 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 5e-04 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 5e-04 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 5e-04 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 5e-04 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 6e-04 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 6e-04 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 6e-04 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 6e-04 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 6e-04 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 6e-04 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 6e-04 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 7e-04 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 7e-04 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 7e-04 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 7e-04 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 8e-04 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 8e-04 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 8e-04 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 8e-04 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 8e-04 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 8e-04 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 8e-04 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 8e-04 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 9e-04 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 9e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 255 bits (653), Expect = 2e-79
Identities = 101/327 (30%), Positives = 166/327 (50%), Gaps = 35/327 (10%)
Query: 349 EQYEFVPLDSQVDFDLEQLLKA-----SAFLLGKSTIGIVYKVALNNEEAVAVRRLGNGG 403
E+ V L F L +L A + +LG+ G VYK L + VAV+RL
Sbjct: 7 EEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEER 66
Query: 404 WQRFK-EFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLATAIHGKAGIIS 462
Q + +FQTE E I H N++ LR + + E+LL+Y Y+ NGS+A+ + + S
Sbjct: 67 TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPE--S 124
Query: 463 YRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLA 522
PL W R RI G A+G+A+LH+ + +H D++ +NILL + E + DFGLA+L
Sbjct: 125 QPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 184
Query: 523 DIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYG 582
D ++T + TA+ T + APE K ++K D++ YG
Sbjct: 185 D-YKDT------------------HVTTAVRGTIG---HIAPEYLSTGKSSEKTDVFGYG 222
Query: 583 VILLEMISGKLPM---IQIGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVS 639
V+LLE+I+G+ ++ ++ W++ +L+++K ++D L + E E+
Sbjct: 223 VMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE-ALVDVDLQGNYKDE-EVEQ 280
Query: 640 VLKIALDCVHKSPDKRPSMRHVCDSLD 666
++++AL C SP +RP M V L+
Sbjct: 281 LIQVALLCTQSSPMERPKMSEVVRMLE 307
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 244 bits (626), Expect = 1e-75
Identities = 93/312 (29%), Positives = 148/312 (47%), Gaps = 38/312 (12%)
Query: 362 FDLEQLLKA-----SAFLLGKSTIGIVYKVALNNEEAVAVRRLGNGGWQRFKEFQTEAEA 416
L L +A FL+G G VYK L + VA++R Q +EF+TE E
Sbjct: 29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIET 88
Query: 417 IGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIK 476
+ RHP++VSL + +E +LIY Y+ NG+L ++G +SW RL I
Sbjct: 89 LSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDL--PTMSMSWEQRLEICI 146
Query: 477 GVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQS 536
G A+G+ +LH + +H D++ NILL +N P I+DFG+++ ++T H S
Sbjct: 147 GAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQT---H--LS 198
Query: 537 TT--GTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLP 594
T GT Y PE + T+K D+YS+GV+L E++ +
Sbjct: 199 TVVKGTL------------------GYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSA 240
Query: 595 MIQ-IGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPD 653
++Q + +N+ +W + + + I+DP LA + E + A+ C+ S +
Sbjct: 241 IVQSLPREMVNLAEWAVESHNNGQ-LEQIVDPNLADKIRPE-SLRKFGDTAVKCLALSSE 298
Query: 654 KRPSMRHVCDSL 665
RPSM V L
Sbjct: 299 DRPSMGDVLWKL 310
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 239 bits (612), Expect = 9e-74
Identities = 96/319 (30%), Positives = 155/319 (48%), Gaps = 45/319 (14%)
Query: 361 DFDLEQLLKASAFLLGKSTIGIVYKVALNNEEAVAVRRLGNG----GWQRFKEFQTEAEA 416
+FD E+ + +G+ G+VYK +NN VAV++L + ++F E +
Sbjct: 26 NFD-ERPISVGGNKMGEGGFGVVYKGYVNNTT-VAVKKLAAMVDITTEELKQQFDQEIKV 83
Query: 417 IGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIK 476
+ K +H N+V L + D+ L+Y Y+PNGSL + G PLSW R +I +
Sbjct: 84 MAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDG---TPPLSWHMRCKIAQ 140
Query: 477 GVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQS 536
G A GI FLHE ++H D++ +NILL + ISDFGLAR ++ +T +
Sbjct: 141 GAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQT---V--MT 192
Query: 537 T--TGTPLQSSPYEFTALNSTTSRSY-YQAPEASKVR-KPTQKWDIYSYGVILLEMISGK 592
+ GT Y APEA +R + T K DIYS+GV+LLE+I+G
Sbjct: 193 SRIVGT-------------------TAYMAPEA--LRGEITPKSDIYSFGVVLLEIITGL 231
Query: 593 LPMIQIGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSP 652
+ ++ + I ++ K + D +D + D D + ++ +A C+H+
Sbjct: 232 PA-VDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMN-DAD-STSVEAMYSVASQCLHEKK 288
Query: 653 DKRPSMRHVCDSLDRVNIS 671
+KRP ++ V L + S
Sbjct: 289 NKRPDIKKVQQLLQEMTAS 307
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 195 bits (499), Expect = 3e-57
Identities = 56/218 (25%), Positives = 100/218 (45%), Gaps = 17/218 (7%)
Query: 17 NDEGLALLSFKQAIRNFPEGNNWNNSNE-DPCSWNGITC----REGQVFSLIIPNKKLTG 71
+ ALL K+ + N ++W + + +W G+ C + +V +L + L
Sbjct: 5 PQDKQALLQIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPK 64
Query: 72 --FIPADLGSLSAIGRVNLRN-NNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGKL 128
IP+ L +L + + + NN G +P + + L L ++ + SG +P + ++
Sbjct: 65 PYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQI 124
Query: 129 KYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTAL-QKLDLSF 187
K L LD S N+ S ++P SI L + + N +G +PD + + + L + +S
Sbjct: 125 KTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYG-SFSKLFTSMTISR 183
Query: 188 NNLSGLIPNDIANLSRLRLLAQRVYVDLTYNNLSGLIP 225
N L+G IP ANL+ L + DL+ N L G
Sbjct: 184 NRLTGKIPPTFANLN-LAFV------DLSRNMLEGDAS 214
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 163 bits (416), Expect = 2e-45
Identities = 48/187 (25%), Positives = 72/187 (38%), Gaps = 35/187 (18%)
Query: 68 KLTGFIPADLGSLSAIGRV-NLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIG 126
+++G IP GS S + + N +G +P N NL + LS N G + G
Sbjct: 160 RISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANL-NLAFVDLSRNMLEGDASVLFG 218
Query: 127 KLKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLS 186
K Q + L++NS + + L LDL
Sbjct: 219 SDKNTQKIHLAKNSLAFDLGKVG--------------------------LSKNLNGLDLR 252
Query: 187 FNNLSGLIPNDIANLSRLRLLAQRVYVDLTYNNLSGLIPQNAALLSLGPTAFIGNPFLCG 246
N + G +P + L L L ++++NNL G IPQ L +A+ N LCG
Sbjct: 253 NNRIYGTLPQGLTQLKFLHSL------NVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCG 306
Query: 247 PPLKVSC 253
PL +C
Sbjct: 307 SPLP-AC 312
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 187 bits (477), Expect = 4e-54
Identities = 74/338 (21%), Positives = 124/338 (36%), Gaps = 56/338 (16%)
Query: 357 DSQVDFDLEQLLKASAFL-----LGKSTIGIVYKVALNNEEAVAVRRLGNGGWQRFKEFQ 411
S VD E L S L + G V+K L NE VAV+ Q + + +
Sbjct: 9 SSGVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEY-VAVKIFPIQDKQSW-QNE 66
Query: 412 TEAEAIGKIRHPNIVSLRAY----FWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLS 467
E ++ ++H NI+ + LI + GSL+ + +S
Sbjct: 67 YEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA-------NVVS 119
Query: 468 WSDRLRIIKGVAKGIAFLHEVSPK-------RYVHGDLRPSNILLGKNMEPHISDFGLAR 520
W++ I + +A+G+A+LHE P H D++ N+LL N+ I+DFGLA
Sbjct: 120 WNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLAL 179
Query: 521 LADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPE-----ASKVRKPTQK 575
+ + + H GT Y APE + R +
Sbjct: 180 KFEAGKSAGDTH---GQVGTRR------------------YMAPEVLEGAINFQRDAFLR 218
Query: 576 WDIYSYGVILLEMISGKLPMIQI-GSMELNIVQWI--QLILEDRKPM--TDILDPFLAHD 630
D+Y+ G++L E+ S L + I LED + + P L
Sbjct: 219 IDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDY 278
Query: 631 LDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRV 668
K + + + +C + R S V + + ++
Sbjct: 279 WQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQM 316
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 183 bits (466), Expect = 4e-49
Identities = 66/251 (26%), Positives = 112/251 (44%), Gaps = 43/251 (17%)
Query: 14 GSANDEGLALLSFKQAIRNFPEGNNWNNSNEDPCSWNGITCREGQVFSLIIPNKKLTGF- 72
S E L+SFK + + +W+++ +PC+++G+TCR+ +V S+ + +K L
Sbjct: 8 QSLYREIHQLISFKDVLPDKNLLPDWSSNK-NPCTFDGVTCRDDKVTSIDLSSKPLNVGF 66
Query: 73 --IPADLGSLS-----------------AIGR------VNLRNNNFSGSLP--VELFNAS 105
+ + L SL+ ++L N+ SG + L + S
Sbjct: 67 SAVSSSLLSLTGLESLFLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCS 126
Query: 106 NLQSLILSGNSFSGPVPMQIG-KLKYLQVLDLSQNSFSSSIPSSIVQ---CKRLKTVVLN 161
L+ L +S N+ P + G KL L+VLDLS NS S + V C LK + ++
Sbjct: 127 GLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAIS 186
Query: 162 QNSFTGPLPDGFATNLTALQKLDLSFNNLSGLIPNDIANLSRLRLLAQRVYVDLTYNNLS 221
N +G + L+ LD+S NN S IP + + S L+ L D++ N LS
Sbjct: 187 GNKISGDVDVS---RCVNLEFLDVSSNNFSTGIP-FLGDCSALQHL------DISGNKLS 236
Query: 222 GLIPQNAALLS 232
G + + +
Sbjct: 237 GDFSRAISTCT 247
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 8e-48
Identities = 57/208 (27%), Positives = 82/208 (39%), Gaps = 31/208 (14%)
Query: 54 CREGQVFSLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILS 113
+ + G L LS N+ + + G N ++ L +S
Sbjct: 581 DGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMS 640
Query: 114 GNSFSGPVPMQIGKLKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGF 173
N SG +P +IG + YL +L+L N S SIP +
Sbjct: 641 YNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEV------------------------ 676
Query: 174 ATNLTALQKLDLSFNNLSGLIPNDIANLSRLRLLAQRVYVDLTYNNLSGLIPQNAALLSL 233
+L L LDLS N L G IP ++ L+ L +DL+ NNLSG IP+ +
Sbjct: 677 -GDLRGLNILDLSSNKLDGRIPQAMSALTML------TEIDLSNNNLSGPIPEMGQFETF 729
Query: 234 GPTAFIGNPFLCGPPLKVSCPSSTSDHP 261
P F+ NP LCG PL PS+ +
Sbjct: 730 PPAKFLNNPGLCGYPLPRCDPSNADGYA 757
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 3e-46
Identities = 58/160 (36%), Positives = 82/160 (51%), Gaps = 9/160 (5%)
Query: 68 KLTGFIPADLG--SLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQI 125
+G I +L + + + L+NN F+G +P L N S L SL LS N SG +P +
Sbjct: 379 NFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSL 438
Query: 126 GKLKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDL 185
G L L+ L L N IP ++ K L+T++L+ N TG +P G + N T L + L
Sbjct: 439 GSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLS-NCTNLNWISL 497
Query: 186 SFNNLSGLIPNDIANLSRLRLLAQRVYVDLTYNNLSGLIP 225
S N L+G IP I L L +L L+ N+ SG IP
Sbjct: 498 SNNRLTGEIPKWIGRLENLAIL------KLSNNSFSGNIP 531
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 172 bits (439), Expect = 2e-45
Identities = 55/173 (31%), Positives = 79/173 (45%), Gaps = 7/173 (4%)
Query: 61 SLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGP 120
L + N TG IP L + S + ++L N SG++P L + S L+ L L N G
Sbjct: 398 ELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGE 457
Query: 121 VPMQIGKLKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTAL 180
+P ++ +K L+ L L N + IPS + C L + L+ N TG +P L L
Sbjct: 458 IPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIG-RLENL 516
Query: 181 QKLDLSFNNLSGLIPNDIANLSRLRLLAQRVYVDLTYNNLSGLIPQNAALLSL 233
L LS N+ SG IP ++ + L L DL N +G IP S
Sbjct: 517 AILKLSNNSFSGNIPAELGDCRSLIWL------DLNTNLFNGTIPAAMFKQSG 563
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 5e-44
Identities = 53/167 (31%), Positives = 80/167 (47%), Gaps = 11/167 (6%)
Query: 61 SLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGP 120
L I K++G + + + +++ +NNFS +P L + S LQ L +SGN SG
Sbjct: 182 HLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIP-FLGDCSALQHLDISGNKLSGD 238
Query: 121 VPMQIGKLKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTAL 180
I L++L++S N F IP K L+ + L +N FTG +PD + L
Sbjct: 239 FSRAISTCTELKLLNISSNQFVGPIPPLP--LKSLQYLSLAENKFTGEIPDFLSGACDTL 296
Query: 181 QKLDLSFNNLSGLIPNDIANLSRLRLLAQRVYVDLTYNNLSGLIPQN 227
LDLS N+ G +P + S L L L+ NN SG +P +
Sbjct: 297 TGLDLSGNHFYGAVPPFFGSCSLLESL------ALSSNNFSGELPMD 337
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 1e-42
Identities = 47/166 (28%), Positives = 74/166 (44%), Gaps = 11/166 (6%)
Query: 68 KLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGK 127
L+G IP+ LGSLS + + L N G +P EL L++LIL N +G +P +
Sbjct: 429 YLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSN 488
Query: 128 LKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSF 187
L + LS N + IP I + + L + L+ NSF+G +P + +L LDL+
Sbjct: 489 CTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAEL-GDCRSLIWLDLNT 547
Query: 188 NNLSGLIPNDIANLSRLRLLAQRVYVDLTYNNLSGLIPQNAALLSL 233
N +G IP + S + N ++G +
Sbjct: 548 NLFNGTIPAAMFKQSG----------KIAANFIAGKRYVYIKNDGM 583
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 161 bits (411), Expect = 7e-42
Identities = 58/169 (34%), Positives = 85/169 (50%), Gaps = 10/169 (5%)
Query: 61 SLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGP 120
L I KL+G + + + + +N+ +N F G +P +LQ L L+ N F+G
Sbjct: 227 HLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIP--PLPLKSLQYLSLAENKFTGE 284
Query: 121 VPMQI-GKLKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTA 179
+P + G L LDLS N F ++P C L+++ L+ N+F+G LP +
Sbjct: 285 IPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRG 344
Query: 180 LQKLDLSFNNLSGLIPNDIANLS-RLRLLAQRVYVDLTYNNLSGLIPQN 227
L+ LDLSFN SG +P + NLS L L DL+ NN SG I N
Sbjct: 345 LKVLDLSFNEFSGELPESLTNLSASLLTL------DLSSNNFSGPILPN 387
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 2e-38
Identities = 53/160 (33%), Positives = 78/160 (48%), Gaps = 8/160 (5%)
Query: 68 KLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELF-NASNLQSLILSGNSFSGPVPMQIG 126
+ G IP L ++ ++L N F+G +P L L L LSGN F G VP G
Sbjct: 258 QFVGPIPP--LPLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFG 315
Query: 127 KLKYLQVLDLSQNSFSSSIP-SSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDL 185
L+ L LS N+FS +P ++++ + LK + L+ N F+G LP+ +L LDL
Sbjct: 316 SCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDL 375
Query: 186 SFNNLSGLIPNDIANLSRLRLLAQRVYVDLTYNNLSGLIP 225
S NN SG I ++ + L + L N +G IP
Sbjct: 376 SSNNFSGPILPNLCQNPKNTL----QELYLQNNGFTGKIP 411
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 2e-38
Identities = 46/179 (25%), Positives = 73/179 (40%), Gaps = 27/179 (15%)
Query: 68 KLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGK 127
L G IP +L + + + L N+ +G +P L N +NL + LS N +G +P IG+
Sbjct: 453 MLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGR 512
Query: 128 LKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFA------------- 174
L+ L +L LS NSFS +IP+ + C+ L + LN N F G +P
Sbjct: 513 LENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAG 572
Query: 175 ------TNLTALQKLDLSFN--NLSGLIPNDIANLSRLRLLAQRVYVDLTYNNLSGLIP 225
N ++ + N G+ + LS ++T G
Sbjct: 573 KRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPC------NITSRVYGGHTS 625
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 60.3 bits (147), Expect = 1e-09
Identities = 18/74 (24%), Positives = 31/74 (41%), Gaps = 8/74 (10%)
Query: 160 LNQNSFTGPLPDGFATNLTALQKLDLSFNNLSGLIPNDIANLSRLRLLAQRVYVDLTYNN 219
N + +LT L+ L LS ++++G + + L L DL+ N+
Sbjct: 60 KPLNVGFSAVSSSLL-SLTGLESLFLSNSHINGSVS-GFKCSASLTSL------DLSRNS 111
Query: 220 LSGLIPQNAALLSL 233
LSG + +L S
Sbjct: 112 LSGPVTTLTSLGSC 125
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 4e-45
Identities = 69/355 (19%), Positives = 119/355 (33%), Gaps = 64/355 (18%)
Query: 352 EFVPLDSQVDFDLEQLLKASAFLLGKSTIGIVYKVALNNEEAVAVRRLGNGGWQRFKEFQ 411
E + +D D +LL+ L+G+ G VYK +L+ VAV+ + + F
Sbjct: 2 EAAASEPSLDLDNLKLLE----LIGRGRYGAVYKGSLDERP-VAVKVFS---FANRQNFI 53
Query: 412 TEAE--AIGKIRHPNIVSL-----RAYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYR 464
E + + H NI R E LL+ +Y PNGSL +
Sbjct: 54 NEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSL-------H 106
Query: 465 PLSWSDRLRIIKGVAKGIAFLHEVSPKR------YVHGDLRPSNILLGKNMEPHISDFGL 518
W R+ V +G+A+LH P+ H DL N+L+ + ISDFGL
Sbjct: 107 TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGL 166
Query: 519 ARLADIAEETPEVHWEQSTT---GTPLQSSPYEFTALNSTTSRSYYQAPE-------ASK 568
+ + + GT Y APE
Sbjct: 167 SMRLTGNRLVRPGEEDNAAISEVGTIR------------------YMAPEVLEGAVNLRD 208
Query: 569 VRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQWIQLILEDRKP--MTDI---- 622
++ D+Y+ G+I E+ + S+ + + + M +
Sbjct: 209 XESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSRE 268
Query: 623 -LDPFLAHDLDKEDEIVSVL-KIALDCVHKSPDKRPSMRHVCDSLDRVNISTEQQ 675
P + V L + DC + + R + + + + + + E+
Sbjct: 269 KQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWERN 323
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 2e-44
Identities = 66/310 (21%), Positives = 112/310 (36%), Gaps = 33/310 (10%)
Query: 375 LGKSTIGIVYKVALN-NEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFW 433
LGK G KV E + ++ L + + F E + + + HPN++ +
Sbjct: 18 LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77
Query: 434 SVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRY 493
I +YI G+L I WS R+ K +A G+A+LH
Sbjct: 78 KDKRLNFITEYIKGGTLRGIIKSMDS-----QYPWSQRVSFAKDIASGMAYLHS---MNI 129
Query: 494 VHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALN 553
+H DL N L+ +N ++DFGLARL + PE +
Sbjct: 130 IHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPE---------GLRSLKKPDRKKRY 180
Query: 554 STTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQWIQLIL 613
+ Y+ APE R +K D++S+G++L E+I ++ ++ L
Sbjct: 181 TVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFL 240
Query: 614 EDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRVNISTE 673
+ P I + C P+KRPS + L+ + +
Sbjct: 241 --DRYCPPNCPPSFF-------------PITVRCCDLDPEKRPSFVKLEHWLETLRMHLA 285
Query: 674 QQFMKGEEPK 683
G + +
Sbjct: 286 GHLPLGPQLE 295
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 4e-42
Identities = 71/309 (22%), Positives = 126/309 (40%), Gaps = 54/309 (17%)
Query: 375 LGKSTIGIVYKVALNNEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWS 434
+G+ G+V K ++ VA++++ + K F E + ++ HPNIV L
Sbjct: 16 VGRGAFGVVCKAKWRAKD-VAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGA--C 70
Query: 435 VDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYV 494
++ L+ +Y GSL +HG + + + + ++G+A+LH + PK +
Sbjct: 71 LNPVCLVMEYAEGGSLYNVLHGAEPLP---YYTAAHAMSWCLQCSQGVAYLHSMQPKALI 127
Query: 495 HGDLRPSNILLGKNME-PHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALN 553
H DL+P N+LL I DFG A DI + G+
Sbjct: 128 HRDLKPPNLLLVAGGTVLKICDFGTAC--DIQTHM------TNNKGSAA----------- 168
Query: 554 STTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQWIQLIL 613
+ APE + ++K D++S+G+IL E+I+ + P +IG I+ +
Sbjct: 169 -------WMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGT 221
Query: 614 EDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRVNISTE 673
R P+ L + + C K P +RPSM + + +
Sbjct: 222 --RPPLIKNLPKPIE-------------SLMTRCWSKDPSQRPSMEEIVKIMTHL----M 262
Query: 674 QQFMKGEEP 682
+ F +EP
Sbjct: 263 RYFPGADEP 271
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 2e-39
Identities = 65/308 (21%), Positives = 120/308 (38%), Gaps = 65/308 (21%)
Query: 375 LGKSTIGIVYKVALNNEEAVAVRRLGNGGWQ----RFKEFQTEAEAIGKIRHPNIVSLRA 430
+G G VY+ +E VAV+ + + + + EA+ ++HPNI++LR
Sbjct: 15 IGIGGFGKVYRAFWIGDE-VAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRG 73
Query: 431 YFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSP 490
L+ ++ G L + GK + + +A+G+ +LH+ +
Sbjct: 74 VCLKEPNLCLVMEFARGGPLNRVLSGK-------RIPPDILVNWAVQIARGMNYLHDEAI 126
Query: 491 KRYVHGDLRPSNILLGKNMEPH--------ISDFGLARLADIAEETPEVHWEQSTTGTPL 542
+H DL+ SNIL+ + +E I+DFGLAR + S G
Sbjct: 127 VPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKM-------SAAGAYA 179
Query: 543 QSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSME 602
+ APE + ++ D++SYGV+L E+++G++P
Sbjct: 180 ------------------WMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVP-----FRG 216
Query: 603 LNIVQWIQLILED--RKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRH 660
++ + + + P+ A K+ DC + P RPS +
Sbjct: 217 IDGLAVAYGVAMNKLALPIPSTCPEPFA-------------KLMEDCWNPDPHSRPSFTN 263
Query: 661 VCDSLDRV 668
+ D L +
Sbjct: 264 ILDQLTTI 271
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 3e-39
Identities = 74/310 (23%), Positives = 125/310 (40%), Gaps = 67/310 (21%)
Query: 375 LGKSTIGIVYKVA-LNNEEAVAVRRLGNGGWQ-------RFKEFQTEAEAIGKIRHPNIV 426
+GK G+V+K + ++ VA++ L G + +F+EFQ E + + HPNIV
Sbjct: 27 IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 427 SLRAYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLH 486
L + ++ +++P G L + KA P+ WS +LR++ +A GI ++
Sbjct: 87 KLYGL--MHNPPRMVMEFVPCGDLYHRLLDKA-----HPIKWSVKLRLMLDIALGIEYMQ 139
Query: 487 EVSPKRYVHGDLRPSNILLGKNMEPH-----ISDFGLARLADIAEETPEVHWEQSTTGTP 541
+P VH DLR NI L E ++DFGL++ VH G
Sbjct: 140 NQNPP-IVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ--------SVHSVSGLLGNF 190
Query: 542 LQSSPYEFTALNSTTSRSYYQAPEASKVRKP--TQKWDIYSYGVILLEMISGKLPMIQIG 599
+ APE + T+K D YS+ +IL +++G+ P
Sbjct: 191 ------------------QWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPF---D 229
Query: 600 SMELNIVQWIQLILED--RKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPS 657
+++I +I E+ R + + P L + C P KRP
Sbjct: 230 EYSYGKIKFINMIREEGLRPTIPEDCPPRLR-------------NVIELCWSGDPKKRPH 276
Query: 658 MRHVCDSLDR 667
++ L
Sbjct: 277 FSYIVKELSE 286
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 7e-39
Identities = 76/298 (25%), Positives = 120/298 (40%), Gaps = 50/298 (16%)
Query: 375 LGKSTIGIVYKVALNNEEAVAVRRLGNGGW--QRFKEFQTEAEAIGKIRHPNIVSLRAYF 432
+G + G V++ + + VAV+ L + +R EF E + ++RHPNIV
Sbjct: 45 IGAGSFGTVHRAEWHGSD-VAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103
Query: 433 WSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKR 492
++ +Y+ GSL +H L RL + VAKG+ +LH +P
Sbjct: 104 TQPPNLSIVTEYLSRGSLYRLLHKSGAR---EQLDERRRLSMAYDVAKGMNYLHNRNPP- 159
Query: 493 YVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTAL 552
VH +L+ N+L+ K + DFGL+R + +S GTP
Sbjct: 160 IVHRNLKSPNLLVDKKYTVKVCDFGLSR-----LKASTFLSSKSAAGTPE---------- 204
Query: 553 NSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQWIQLI 612
+ APE + +K D+YS+GVIL E+ + + P LN Q + +
Sbjct: 205 --------WMAPEVLRDEPSNEKSDVYSFGVILWELATLQQP-----WGNLNPAQVVAAV 251
Query: 613 LED--RKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRV 668
R + L+P +A I C P KRPS + D L +
Sbjct: 252 GFKCKRLEIPRNLNPQVA-------------AIIEGCWTNEPWKRPSFATIMDLLRPL 296
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 2e-38
Identities = 64/297 (21%), Positives = 122/297 (41%), Gaps = 47/297 (15%)
Query: 375 LGKSTIGIVYKVALNNEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWS 434
+G + G VYK + + AV + + Q+ + F+ E + K RH NI+ Y S
Sbjct: 32 IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY--S 89
Query: 435 VDEKL-LIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRY 493
+L ++ + SL +H + I + A+G+ +LH K
Sbjct: 90 TAPQLAIVTQWCEGSSLYHHLHASE-----TKFEMKKLIDIARQTARGMDYLHA---KSI 141
Query: 494 VHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALN 553
+H DL+ +NI L ++ I DFGLA H + +G+ L
Sbjct: 142 IHRDLKSNNIFLHEDNTVKIGDFGLAT---EKSRWSGSHQFEQLSGSIL----------- 187
Query: 554 STTSRSYYQAPEA--SKVRKP-TQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQWIQ 610
+ APE + P + + D+Y++G++L E+++G+LP I + + I++
Sbjct: 188 -------WMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD-QIIE--M 237
Query: 611 LILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDR 667
+ P + + K + ++ +C+ K D+RPS + ++
Sbjct: 238 VGRGSLSPDL----SKVRSNCPKR-----MKRLMAECLKKKRDERPSFPRILAEIEE 285
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 5e-38
Identities = 51/302 (16%), Positives = 111/302 (36%), Gaps = 61/302 (20%)
Query: 375 LGKSTIGIVYKVALNNEEAVAVRRLGNGGW--QRFKEFQTEAEAIGKIRHPNIVSLRAYF 432
L ++ G ++K + + V+ L W ++ ++F E + HPN++ +
Sbjct: 18 LNENHSGELWKGRWQGND-IVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGAC 76
Query: 433 WSVDEKLL--IYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSP 490
S I ++P GSL +H + S ++ +A+G+AFLH + P
Sbjct: 77 QSPPAPHPTLITHWMPYGSLYNVLHEGTN----FVVDQSQAVKFALDMARGMAFLHTLEP 132
Query: 491 KRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFT 550
L ++++ ++M IS + P
Sbjct: 133 L-IPRHALNSRSVMIDEDMTARISMADVKFSFQ----------SPGRMYAPA-------- 173
Query: 551 ALNSTTSRSYYQAPEA---SKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQ 607
+ APEA + D++S+ V+L E+++ ++P +L+ ++
Sbjct: 174 ----------WVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVP-----FADLSNME 218
Query: 608 WIQLILED--RKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSL 665
+ + R + + P ++ K+ C+++ P KRP + L
Sbjct: 219 IGMKVALEGLRPTIPPGISPHVS-------------KLMKICMNEDPAKRPKFDMIVPIL 265
Query: 666 DR 667
++
Sbjct: 266 EK 267
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 3e-37
Identities = 59/305 (19%), Positives = 107/305 (35%), Gaps = 56/305 (18%)
Query: 375 LGKSTIGIVYKVALNNEEAVAVRRLGNGGW--QRFKEFQTEAEAIGKIRHPNIVSLRAYF 432
+GK G VY + E VA+R + + K F+ E A + RH N+V
Sbjct: 41 IGKGRFGQVYHGRWHGE--VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGAC 98
Query: 433 WSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKR 492
S +I +L + + L + +I + + KG+ +LH K
Sbjct: 99 MSPPHLAIITSLCKGRTLYSVVRDAK-----IVLDVNKTRQIAQEIVKGMGYLHA---KG 150
Query: 493 YVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTAL 552
+H DL+ N+ N + I+DFGL ++ + + + G
Sbjct: 151 ILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLC---------- 199
Query: 553 NSTTSRSYYQAPEASKVRKP---------TQKWDIYSYGVILLEMISGKLPMIQIGSMEL 603
+ APE + P ++ D+++ G I E+ + + P
Sbjct: 200 --------HLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPF-----KTQ 246
Query: 604 NIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCD 663
I + KP + KE + I L C ++RP+ + D
Sbjct: 247 PAEAIIWQMGTGMKP------NLSQIGMGKE-----ISDILLFCWAFEQEERPTFTKLMD 295
Query: 664 SLDRV 668
L+++
Sbjct: 296 MLEKL 300
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 8e-35
Identities = 70/361 (19%), Positives = 125/361 (34%), Gaps = 58/361 (16%)
Query: 342 DTMSENMEQYEFVPLDSQVDF-----DLEQLLKASAFLLGKSTIGIVYKVALNNEEAVAV 396
+++ + +EQ + S + +Q+ +GK G V+ E+ VAV
Sbjct: 9 ESLRDLIEQSQSSGSGSGLPLLVQRTIAKQIQMVK--QIGKGRYGEVWMGKWRGEK-VAV 65
Query: 397 RRLGNGGWQRFKEFQTEAE--AIGKIRHPNIVSLRAY----FWSVDEKLLIYDYIPNGSL 450
+ + E E +RH NI+ A S + LI DY NGSL
Sbjct: 66 KVFF---TTEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSL 122
Query: 451 ATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRY-----VHGDLRPSNILL 505
+ L L++ G+ LH H DL+ NIL+
Sbjct: 123 YDYLKST-------TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILV 175
Query: 506 GKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPE 565
KN I+D GLA ++ + GT Y PE
Sbjct: 176 KKNGTCCIADLGLAVKFISDTNEVDIP-PNTRVGTKR------------------YMPPE 216
Query: 566 -----ASKVRKP-TQKWDIYSYGVILLEMISGKLPMIQIGSMEL--NIVQWIQLILEDRK 617
++ D+YS+G+IL E+ + + +L + + ED +
Sbjct: 217 VLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMR 276
Query: 618 PM--TDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRVNISTEQQ 675
+ L P + ++ + + K+ +C +P R + V +L +++ S + +
Sbjct: 277 EIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQDIK 336
Query: 676 F 676
Sbjct: 337 L 337
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 4e-34
Identities = 64/323 (19%), Positives = 117/323 (36%), Gaps = 63/323 (19%)
Query: 374 LLGKSTIGIVYKVALNNEEAVAVRRLGNGGWQRFKEFQTEAE--AIGKIRHPNIVSLRAY 431
+GK G V++ + E VAV+ + K + E E +RH NI+ A
Sbjct: 15 CVGKGRYGEVWRGSWQGEN-VAVKIFS---SRDEKSWFRETELYNTVMLRHENILGFIAS 70
Query: 432 FWSVDEK----LLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHE 487
+ LI Y GSL + L LRI+ +A G+A LH
Sbjct: 71 DMTSRHSSTQLWLITHYHEMGSLYDYLQLT-------TLDTVSCLRIVLSIASGLAHLHI 123
Query: 488 VSPKRY-----VHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPL 542
H DL+ NIL+ KN + I+D GLA + + +V GT
Sbjct: 124 EIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVG-NNPRVGTKR 182
Query: 543 QSSPYEFTALNSTTSRSYYQAPE------ASKVRKPTQKWDIYSYGVILLEMISGKLPMI 596
Y APE ++ DI+++G++L E+ +
Sbjct: 183 ------------------YMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNG 224
Query: 597 QIGSMEL----------NIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALD 646
+ + + +++ D+ P + + + + S+ K+ +
Sbjct: 225 IVEDYKPPFYDVVPNDPSFEDMRKVVCVDQ------QRPNIPNRWFSDPTLTSLAKLMKE 278
Query: 647 CVHKSPDKRPSMRHVCDSLDRVN 669
C +++P R + + +L +++
Sbjct: 279 CWYQNPSARLTALRIKKTLTKID 301
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 2e-33
Identities = 66/326 (20%), Positives = 126/326 (38%), Gaps = 65/326 (19%)
Query: 374 LLGKSTIGIVYKVALNNEEAVAVRRLGNGGWQRFKEFQTEAE--AIGKIRHPNIVSLRA- 430
+GK G V++ EE VAV+ + + + EAE +RH NI+ A
Sbjct: 49 SIGKGRFGEVWRGKWRGEE-VAVKIFS---SREERSWFREAEIYQTVMLRHENILGFIAA 104
Query: 431 ---YFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHE 487
+ + L+ DY +GSL ++ ++ +++ A G+A LH
Sbjct: 105 DNKDNGTWTQLWLVSDYHEHGSLFDYLNR-------YTVTVEGMIKLALSTASGLAHLHM 157
Query: 488 VSPKRY-----VHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPL 542
H DL+ NIL+ KN I+D GLA D A +T ++ GT
Sbjct: 158 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIA-PNHRVGTKR 216
Query: 543 QSSPYEFTALNSTTSRSYYQAPE------ASKVRKPTQKWDIYSYGVILLEMISG----- 591
Y APE K + ++ DIY+ G++ E+
Sbjct: 217 ------------------YMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGG 258
Query: 592 -----KLPMIQIGSMELNIVQWIQLILEDRK-PMTDILDPFLAHDLDKEDEIVSVLKIAL 645
+LP + + ++ + +++ E + P +I + + + + + + KI
Sbjct: 259 IHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRP--NIPNRWQSCEALRV-----MAKIMR 311
Query: 646 DCVHKSPDKRPSMRHVCDSLDRVNIS 671
+C + + R + + +L +++
Sbjct: 312 ECWYANGAARLTALRIKKTLSQLSQQ 337
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 5e-33
Identities = 41/167 (24%), Positives = 68/167 (40%), Gaps = 4/167 (2%)
Query: 68 KLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGK 127
L S + ++L + S+L +LIL+GN
Sbjct: 39 PLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSG 98
Query: 128 LKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTG-PLPDGFATNLTALQKLDLS 186
L LQ L + + +S I K LK + + N LP+ F+ NLT L+ LDLS
Sbjct: 99 LSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFS-NLTNLEHLDLS 157
Query: 187 FNNLSGLIPNDIANLSRLRLLAQRVYVDLTYNNLSGLIPQNAALLSL 233
N + + D+ L ++ LL + +DL+ N ++ + P + L
Sbjct: 158 SNKIQSIYCTDLRVLHQMPLL--NLSLDLSLNPMNFIQPGAFKEIRL 202
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 1e-30
Identities = 31/158 (19%), Positives = 54/158 (34%), Gaps = 8/158 (5%)
Query: 69 LTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQI-GK 127
G +++ ++L N + L+ L ++ +
Sbjct: 361 FKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLS 419
Query: 128 LKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSF 187
L+ L LD+S + L+ + + NSF T L L LDLS
Sbjct: 420 LRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQ 479
Query: 188 NNLSGLIPNDIANLSRLRLLAQRVYVDLTYNNLSGLIP 225
L L P +LS L++L ++++NN L
Sbjct: 480 CQLEQLSPTAFNSLSSLQVL------NMSHNNFFSLDT 511
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 1e-29
Identities = 31/162 (19%), Positives = 56/162 (34%), Gaps = 11/162 (6%)
Query: 66 NKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQI 125
IP +L + ++L N F+ LQ L LS
Sbjct: 16 ELNFYK-IPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAY 72
Query: 126 GKLKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDL 185
L +L L L+ N S + L+ +V + + +L L++L++
Sbjct: 73 QSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIG-HLKTLKELNV 131
Query: 186 SFNNLSGL-IPNDIANLSRLRLLAQRVYVDLTYNNLSGLIPQ 226
+ N + +P +NL+ L L DL+ N + +
Sbjct: 132 AHNLIQSFKLPEYFSNLTNLEHL------DLSSNKIQSIYCT 167
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 4e-27
Identities = 29/167 (17%), Positives = 59/167 (35%), Gaps = 5/167 (2%)
Query: 68 KLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELF-NASNLQSLILSGNSFSGPVPMQIG 126
LS++ + + N+F + ++F NL L LS P
Sbjct: 432 HTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFN 491
Query: 127 KLKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLS 186
L LQVL++S N+F S L+ + + N ++L L+L+
Sbjct: 492 SLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLT 551
Query: 187 FNNLSGLIPNDIANLSRLRLLAQRVYVDLTYNNLSGLIPQNAALLSL 233
N+ + + S L+ + + + + + P + + +
Sbjct: 552 QNDFAC----TCEHQSFLQWIKDQRQLLVEVERMECATPSDKQGMPV 594
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 5e-27
Identities = 35/170 (20%), Positives = 58/170 (34%), Gaps = 14/170 (8%)
Query: 61 SLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGN--SFS 118
L + N K F L SL L + G + +L+ L LS N SF
Sbjct: 308 HLELVNCKFGQFPTLKLKSLK-----RLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFK 362
Query: 119 GPVPMQIGKLKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLT 178
G L+ LDLS N ++ S+ + ++L+ + ++ +L
Sbjct: 363 GCCSQSDFGTTSLKYLDLSFNGV-ITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLR 421
Query: 179 ALQKLDLSFNNLSGLIPNDIANLSRLRLLAQRVYVDLTYNNLSGLIPQNA 228
L LD+S + LS L +L + N+ +
Sbjct: 422 NLIYLDISHTHTRVAFNGIFNGLSSLEVL------KMAGNSFQENFLPDI 465
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 1e-20
Identities = 38/178 (21%), Positives = 63/178 (35%), Gaps = 13/178 (7%)
Query: 68 KLTGFIPADLGSLSAIGRVNLRNNNF-SGSLPVELFNASNLQSLILSGNSFSGPVPMQIG 126
L +G L + +N+ +N S LP N +NL+ L LS N +
Sbjct: 111 NLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLR 170
Query: 127 KLKYLQV----LDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQK 182
L + + LDLS N + P + + RL + L N + + L L+
Sbjct: 171 VLHQMPLLNLSLDLSLNPMNFIQPGAF-KEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEV 229
Query: 183 LDLS------FNNLSGLIPNDIANLSRLRLLAQR-VYVDLTYNNLSGLIPQNAALLSL 233
L NL + + L L + R Y+D +++ L + S
Sbjct: 230 HRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSF 287
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 3e-17
Identities = 30/173 (17%), Positives = 57/173 (32%), Gaps = 20/173 (11%)
Query: 66 NKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQ----SLILSGNSFSGPV 121
N + +P +L+ + ++L +N +L + SL LS N + +
Sbjct: 134 NLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF-I 192
Query: 122 PMQIGKLKYLQVLDLSQNSFSSSIPSSIVQ---CKRLKTVVLNQNSFTGPLPDGFATNLT 178
K L L L N S ++ + +Q + +VL + G L + L
Sbjct: 193 QPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALE 252
Query: 179 ALQKLDLSFNNLSGL------IPNDIANLSRLRLLAQRVYVDLTYNNLSGLIP 225
L L + L+ L I + L+ + L + +
Sbjct: 253 GLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSF------SLVSVTIERVKD 299
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 4e-16
Identities = 25/189 (13%), Positives = 54/189 (28%), Gaps = 27/189 (14%)
Query: 68 KLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNA-SNLQSLILSGNSFSGPVPMQ-- 124
+ P + + ++ LRNN S ++ + L+ L F ++
Sbjct: 188 PMNFIQPGAFKEIR-LHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKF 246
Query: 125 -IGKLKYLQVLDLSQNSFSS------SIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNL 177
L+ L L + + + I + + L + +
Sbjct: 247 DKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSY---N 303
Query: 178 TALQKLDLSFNNLSGLIPNDIANLSRLRLLAQR-------------VYVDLTYNNLSGLI 224
Q L+L + +L RL + + ++DL+ N LS
Sbjct: 304 FGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKG 363
Query: 225 PQNAALLSL 233
+ +
Sbjct: 364 CCSQSDFGT 372
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 7e-33
Identities = 22/168 (13%), Positives = 56/168 (33%), Gaps = 22/168 (13%)
Query: 68 KLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGK 127
+ N + ++ N +L + + +P +
Sbjct: 217 PFVAENICEAWENE-----NSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKA 271
Query: 128 LKYLQVLDLSQNSFSS--------SIPSSIVQCKRLKTVVLNQNSF-TGPLPDGFATNLT 178
L +Q+++++ N S + ++++ + + N+ T P+ +
Sbjct: 272 LPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQ-KMK 330
Query: 179 ALQKLDLSFNNLSGLIPNDIANLSRLRLLAQRVYVDLTYNNLSGLIPQ 226
L L+ +N L G +P + +L L +L YN ++ +
Sbjct: 331 KLGMLECLYNQLEGKLP-AFGSEIKLASL------NLAYNQITEIPAN 371
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 1e-32
Identities = 39/174 (22%), Positives = 56/174 (32%), Gaps = 16/174 (9%)
Query: 68 KLTGF-IPADLGSLSAIGRVNLRNNNFSG-------SLPVELFNASNLQSLILSGNSFSG 119
KL D S+S + ++ N L F N+ S+ LS N S
Sbjct: 388 KLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISK 447
Query: 120 PVPMQIGKLKYLQVLDLSQNSFSS-------SIPSSIVQCKRLKTVVLNQNSFTGPLPDG 172
L ++L N + + L ++ L N T D
Sbjct: 448 FPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTKLSDDF 507
Query: 173 FATNLTALQKLDLSFNNLSGLIPNDIANLSRLRLLAQRVYVDLTYNNLSGLIPQ 226
AT L L +DLS+N+ S P N S L+ R D N P+
Sbjct: 508 RATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPE 560
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 1e-32
Identities = 34/237 (14%), Positives = 76/237 (32%), Gaps = 32/237 (13%)
Query: 1 SLVLLILSYIALMGSANDEGLALLSFKQAIRNFPEGNNWNNSNEDPCSWNGITCREGQVF 60
L + + E + + W+ + +
Sbjct: 207 KLRQFYMGNSPFVAENICEAWENENS----------EYAQQYKTEDLKWDNLK----DLT 252
Query: 61 SLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNF--------SGSLPVELFNASNLQSLIL 112
+ + N +P L +L + +N+ N + +Q + +
Sbjct: 253 DVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYI 312
Query: 113 SGNSF-SGPVPMQIGKLKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPD 171
N+ + PV + K+K L +L+ N +P+ +L ++ L N T +P
Sbjct: 313 GYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLPA-FGSEIKLASLNLAYNQITE-IPA 370
Query: 172 GFATNLTALQKLDLSFNNLSGLIPN-DIANLSRLRLLAQRVYVDLTYNNLSGLIPQN 227
F ++ L + N L + D ++S + + D +YN + + +N
Sbjct: 371 NFCGFTEQVENLSFAHNKLKYIPNIFDAKSVSVMSAI------DFSYNEIGSVDGKN 421
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 7e-30
Identities = 30/252 (11%), Positives = 72/252 (28%), Gaps = 37/252 (14%)
Query: 1 SLVLLILSYIALMGSANDEGLALLSFKQAIRNFPEGNNWNNSNEDPCSWNGITCREGQVF 60
L +L L + G +S + + +
Sbjct: 106 ELEVLALGSHGEKVNERLFGPKGISANMSDEQK---QKMRMHYQKTFVDYDPREDFSDLI 162
Query: 61 SLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGP 120
I + I ++ +NN + + + + L+ + + F
Sbjct: 163 KDCINSDPQQKSIKKSSRITLKDTQIGQLSNNIT-FVSKAVMRLTKLRQFYMGNSPFVAE 221
Query: 121 -------------------VPMQIGKLKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLN 161
++ LK L +++ + +P+ + ++ + +
Sbjct: 222 NICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVA 281
Query: 162 QNSFTG--PLPDGF-----ATNLTALQKLDLSFNNLSGL-IPNDIANLSRLRLLAQRVYV 213
N L D + A +Q + + +NNL + + + +L +L
Sbjct: 282 CNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGML------ 335
Query: 214 DLTYNNLSGLIP 225
+ YN L G +P
Sbjct: 336 ECLYNQLEGKLP 347
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 1e-28
Identities = 25/170 (14%), Positives = 53/170 (31%), Gaps = 15/170 (8%)
Query: 64 IPNKKLTGFIPADLGSLSAIGRVNLRNNNF-SGSLPVELFNASNLQSLILSGNSFSGPVP 122
K AD I + + NN + + L L L N G +P
Sbjct: 288 GEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLP 347
Query: 123 MQIGKLKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQK 182
G L L+L+ N + + ++++ + N A +++ +
Sbjct: 348 -AFGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKYIPNIFDAKSVSVMSA 406
Query: 183 LDLSFNNLSGL-------IPNDIANLSRLRLLAQRVYVDLTYNNLSGLIP 225
+D S+N + + + + + +L+ N +S
Sbjct: 407 IDFSYNEIGSVDGKNFDPLDPTPFKGINVSSI------NLSNNQISKFPK 450
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 3e-28
Identities = 35/203 (17%), Positives = 57/203 (28%), Gaps = 33/203 (16%)
Query: 64 IPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSG---- 119
+ K + + +NL NN S S L S+ L GN +
Sbjct: 417 VDGKNFDP-LDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKN 475
Query: 120 ---PVPMQIGKLKYLQVLDLSQNSFSSSIPSSIV--QCKRLKTVVLNQNSFTGPLPDGFA 174
L +DL N + + L + L+ NSF+ P
Sbjct: 476 SLKDENENFKNTYLLTSIDLRFNKLTK-LSDDFRATTLPYLVGIDLSYNSFSK-FPTQPL 533
Query: 175 TNLTALQKL------DLSFNNLSGLIPNDIANLSRLRLLAQRVYVDLTYNNLSGLIP--- 225
N + L+ D N P I L L + N++ +
Sbjct: 534 -NSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQL------QIGSNDIRKVNEKIT 586
Query: 226 QNAALLSLGPTAFIGNPFLCGPP 248
N ++L + NP +
Sbjct: 587 PNISVLDIK-----DNPNISIDL 604
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 2e-27
Identities = 29/234 (12%), Positives = 61/234 (26%), Gaps = 50/234 (21%)
Query: 18 DEGLALLSFKQAIR---------NFPEGNNWNNSNEDPCSWN---GITCREGQVFSLIIP 65
+ LAL A+ G NWN N++ W G++
Sbjct: 30 KDYLALKEIWDALNGKNWSQQGFGTQPGANWN-FNKELDMWGAQPGVSLNS--------- 79
Query: 66 NKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGP----V 121
G ++ + +L SG +P + + L+ L L +
Sbjct: 80 -----------NGRVTGL---SLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFG 125
Query: 122 PMQIGKLKYLQVLDLSQNSFSSSIPSSI--VQCKRLKTVVLNQNSFTGPLPDGFATNLTA 179
P I + + + + L +N + +
Sbjct: 126 PKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSS-RITLK 184
Query: 180 LQKLDLSFNNLSGLIPNDIANLSRLRLLAQRVYVDLTYNNLSGLIPQNAALLSL 233
++ NN++ + + L++LR + + A
Sbjct: 185 DTQIGQLSNNITF-VSKAVMRLTKLRQF------YMGNSPFVAENICEAWENEN 231
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 1e-24
Identities = 29/166 (17%), Positives = 49/166 (29%), Gaps = 21/166 (12%)
Query: 64 IPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELF--NASNLQSLILSGNSFSGPV 121
IP L + + + ++LR N + L + L + LS NSFS
Sbjct: 472 IPKNSLKD-ENENFKNTYLLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSK-F 528
Query: 122 PMQIGKLKYLQVL------DLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFAT 175
P Q L+ D N P I C L + + N + +
Sbjct: 529 PTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRK-VNEKI-- 585
Query: 176 NLTALQKLDLSFNNLSGLIPNDIANLSRLRLLAQRVYVDLTYNNLS 221
+ LD+ N + + + + L Y+
Sbjct: 586 -TPNISVLDIKDNPNISIDLSYVCPYIEAGMY------MLFYDKTQ 624
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 9e-21
Identities = 25/144 (17%), Positives = 44/144 (30%), Gaps = 14/144 (9%)
Query: 68 KLTGFIPADL--GSLSAIGRVNLRNNNFSGSLPVELFNASNLQSL------ILSGNSFSG 119
KLT + D +L + ++L N+FS P + N+S L+ GN
Sbjct: 499 KLTK-LSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLR 556
Query: 120 PVPMQIGKLKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTA 179
P I L L + N + I + + + N
Sbjct: 557 EWPEGITLCPSLTQLQIGSNDI-RKVNEKI--TPNISVLDIKDNPNISIDLSYVC-PYIE 612
Query: 180 LQKLDLSFNNLSGLIPNDIANLSR 203
L ++ + D ++ R
Sbjct: 613 AGMYMLFYDKTQDIRGCDALDIKR 636
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 8e-30
Identities = 39/161 (24%), Positives = 62/161 (38%), Gaps = 7/161 (4%)
Query: 68 KLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGK 127
++ P L + +NL++N S +NL L L NS K
Sbjct: 60 TISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVK 119
Query: 128 LKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFAT-NLTALQKLDLS 186
K L LDLS N SS+ + VQ + L+ ++L+ N + ++L+KL+LS
Sbjct: 120 QKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELS 179
Query: 187 FNNLSGLIPNDIANLSRLRLLAQRVYVDLTYNNLSGLIPQN 227
N + P + RL L L L + +
Sbjct: 180 SNQIKEFSPGCFHAIGRLFGL------FLNNVQLGPSLTEK 214
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 1e-29
Identities = 38/183 (20%), Positives = 64/183 (34%), Gaps = 9/183 (4%)
Query: 47 CSWNGITCREGQVFS----LIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELF 102
CS +T + + L + + +L A+ S + +++ N S P
Sbjct: 11 CSHLKLTQVPDDLPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQ 70
Query: 103 NASNLQSLILSGNSFSGPVPMQIGKLKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQ 162
L+ L L N S L L L NS + V+ K L T+ L+
Sbjct: 71 KLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSH 130
Query: 163 NSFTGPLPDGFATNLTALQKLDLSFNNLSGLIPNDIANLSRLRLLAQRVYVDLTYNNLSG 222
N + L LQ+L LS N + L ++ + L ++L+ N +
Sbjct: 131 NGLSSTKLGTQV-QLENLQELLLSNNKIQALKSEELDIFANSSL----KKLELSSNQIKE 185
Query: 223 LIP 225
P
Sbjct: 186 FSP 188
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 2e-29
Identities = 42/193 (21%), Positives = 69/193 (35%), Gaps = 19/193 (9%)
Query: 68 KLTGFIPADLGSLSAIGRVNLRNNNFSG--SLPVELFNASNLQSLILSGNSFSGPVPMQI 125
K + ++ R+ LR S P NL L LS N+ + +
Sbjct: 441 KYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDML 500
Query: 126 GKLKYLQVLDLSQNSFSS--------SIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNL 177
L+ L++LDL N+ + + L + L N F + F +L
Sbjct: 501 EGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVF-KDL 559
Query: 178 TALQKLDLSFNNLSGLIPNDIANLSRLRLLAQRVYVDLTYNNLSGLIPQ--NAALLSLGP 235
L+ +DL NNL+ L + N L+ L +L N ++ + + A +L
Sbjct: 560 FELKIIDLGLNNLNTLPASVFNNQVSLKSL------NLQKNLITSVEKKVFGPAFRNLTE 613
Query: 236 TAFIGNPFLCGPP 248
NPF C
Sbjct: 614 LDMRFNPFDCTCE 626
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 7e-29
Identities = 36/163 (22%), Positives = 56/163 (34%), Gaps = 8/163 (4%)
Query: 68 KLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSG--PVPMQI 125
+ + ++L +N S + NLQ L+LS N + I
Sbjct: 108 SIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDI 167
Query: 126 GKLKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGF--ATNLTALQKL 183
L+ L+LS N P RL + LN L + T+++ L
Sbjct: 168 FANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNL 227
Query: 184 DLSFNNLSGLIPNDIANLSRLRLLAQRVYVDLTYNNLSGLIPQ 226
LS + LS L L +DL+YNNL+ +
Sbjct: 228 SLSNSQLSTTSNTTFLGLKWTNL----TMLDLSYNNLNVVGND 266
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 6e-26
Identities = 33/178 (18%), Positives = 55/178 (30%), Gaps = 10/178 (5%)
Query: 60 FSLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSG 119
I L L + +N+ +N+ G NL+ L LS + S
Sbjct: 308 TKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSL 367
Query: 120 ----PVPMQIGKLKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFAT 175
L +L+L++N S + L+ + L N L
Sbjct: 368 RTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWR 427
Query: 176 NLTALQKLDLSFNNLSGLIPNDIANLSRLRLLAQRVYVDLTYNNLSGLIPQNAALLSL 233
L + ++ LS+N L N A + L+ L L L + + L
Sbjct: 428 GLENIFEIYLSYNKYLQLTRNSFALVPSLQRL------MLRRVALKNVDSSPSPFQPL 479
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 8e-26
Identities = 33/182 (18%), Positives = 65/182 (35%), Gaps = 19/182 (10%)
Query: 68 KLTGFIPADLG---SLSAIGRVNLRNNNFSGSLPVELFN--ASNLQSLILSGNSFSGPVP 122
+L + L + ++I ++L N+ S + +NL L LS N+ +
Sbjct: 206 QLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGN 265
Query: 123 MQIGKLKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPL--------PDGFA 174
L L+ L N+ S+ ++ + L ++ + D
Sbjct: 266 DSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSF 325
Query: 175 TNLTALQKLDLSFNNLSGLIPNDIANLSRLRLLAQRVYVDLTYNNLSGLIPQNAALLSLG 234
L L+ L++ N++ G+ N L L+ L L+ + S N +SL
Sbjct: 326 QWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYL------SLSNSFTSLRTLTNETFVSLA 379
Query: 235 PT 236
+
Sbjct: 380 HS 381
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 8e-26
Identities = 31/173 (17%), Positives = 52/173 (30%), Gaps = 18/173 (10%)
Query: 68 KLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGN---------SFS 118
L L + L NN L N++ L L + S
Sbjct: 259 NLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLP 318
Query: 119 GPVPMQIGKLKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVL--NQNSFTGPLPDGFA-T 175
LK L+ L++ N + LK + L + S + F
Sbjct: 319 KIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSL 378
Query: 176 NLTALQKLDLSFNNLSGLIPNDIANLSRLRLLAQRVYVDLTYNNLSGLIPQNA 228
+ L L+L+ N +S + + + L L +L DL N + +
Sbjct: 379 AHSPLHILNLTKNKISKIESDAFSWLGHLEVL------DLGLNEIGQELTGQE 425
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-23
Identities = 37/183 (20%), Positives = 62/183 (33%), Gaps = 11/183 (6%)
Query: 61 SLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFS--------GSLPVELFNASNLQSLIL 112
L + N + L L + ++L++NN + G L S+L L L
Sbjct: 484 ILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNL 543
Query: 113 SGNSFSGPVPMQIGKLKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDG 172
N F L L+++DL N+ ++ S LK++ L +N T
Sbjct: 544 ESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKV 603
Query: 173 FATNLTALQKLDLSFNNLSGLIPNDIANLSRLRLLAQRVYVDLTYNNLSGLIP--QNAAL 230
F L +LD+ FN + IA +L+ + L P +
Sbjct: 604 FGPAFRNLTELDMRFNPFDCTCES-IAWFVNWINETHTNIPELSSHYLCNTPPHYHGFPV 662
Query: 231 LSL 233
Sbjct: 663 RLF 665
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 2e-09
Identities = 20/77 (25%), Positives = 33/77 (42%), Gaps = 11/77 (14%)
Query: 151 QCK-RLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSGLIPNDIANLSRLRLLAQ 209
+C + + T +PD TN+T L+L+ N L L + S+L L
Sbjct: 1 KCTVSHEVADCSHLKLTQ-VPDDLPTNIT---VLNLTHNQLRRLPAANFTRYSQLTSL-- 54
Query: 210 RVYVDLTYNNLSGLIPQ 226
D+ +N +S L P+
Sbjct: 55 ----DVGFNTISKLEPE 67
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 121 bits (304), Expect = 2e-29
Identities = 81/311 (26%), Positives = 140/311 (45%), Gaps = 55/311 (17%)
Query: 375 LGKSTIGIVYKVALNNEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWS 434
LG+ G V+ N VA++ L G + F EA+ + K+RH +V L A
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAV--- 247
Query: 435 VDEK--LLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKR 492
V E+ ++ +Y+ GSL + G+ G + L + + +A G+A++
Sbjct: 248 VSEEPIYIVTEYMSKGSLLDFLKGETG----KYLRLPQLVDMAAQIASGMAYVER---MN 300
Query: 493 YVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTAL 552
YVH DLR +NIL+G+N+ ++DFGLARL + + T P ++T
Sbjct: 301 YVHRDLRAANILVGENLVCKVADFGLARLIE----------DNEYTARQGAKFPIKWT-- 348
Query: 553 NSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQIGSMELNIVQWIQL 611
APEA+ + T K D++S+G++L E+ + G++P + + E+ +
Sbjct: 349 ----------APEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV-----LDQ 393
Query: 612 ILED-RKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRVNI 670
+ R P P + S+ + C K P++RP+ ++ L+
Sbjct: 394 VERGYRMPC-----PPECPE--------SLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 440
Query: 671 STEQQFMKGEE 681
STE Q+ GE
Sbjct: 441 STEPQYQPGEN 451
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 2e-28
Identities = 34/206 (16%), Positives = 68/206 (33%), Gaps = 28/206 (13%)
Query: 61 SLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFS-------GSLPVELFNASNLQSLILS 113
++ + ++ F + S I + L NN + N L ++ L
Sbjct: 677 TVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLR 736
Query: 114 GNSFSG-PVPMQIGKLKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQ------NSFT 166
N + + L YL +D+S N FSS P+ + +LK + N
Sbjct: 737 FNKLTSLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRIL 795
Query: 167 GPLPDGFATNLTALQKLDLSFNNLSGLIPNDIANLSRLRLLAQRVYVDLTYNNLSGL-IP 225
P G +L +L + N++ + + +L +L D+ N + +
Sbjct: 796 RQWPTGIT-TCPSLIQLQIGSNDIRK-VDEKL--TPQLYIL------DIADNPNISIDVT 845
Query: 226 QNAALLSLGPTAFIGN--PFLCGPPL 249
+ G + + + G
Sbjct: 846 SVCPYIEAGMYVLLYDKTQDIRGCDA 871
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 1e-26
Identities = 27/184 (14%), Positives = 58/184 (31%), Gaps = 20/184 (10%)
Query: 61 SLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSG---------SLPVELFNASNLQSLI 111
+ + N +P L L + +N+ N L + +Q
Sbjct: 495 DVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFY 554
Query: 112 LSGNSFSG-PVPMQIGKLKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLP 170
+ N+ P + K+ L +LD N + +L + L+ N +P
Sbjct: 555 MGYNNLEEFPASASLQKMVKLGLLDCVHNKVRH--LEAFGTNVKLTDLKLDYNQIEE-IP 611
Query: 171 DGFATNLTALQKLDLSFNNLSGLIPN-DIANLSRLRLLAQRVYVDLTYNNLSGLIPQNAA 229
+ F ++ L S N L + + ++ + + D +YN + +
Sbjct: 612 EDFCAFTDQVEGLGFSHNKLKYIPNIFNAKSVYVMGSV------DFSYNKIGSEGRNISC 665
Query: 230 LLSL 233
+
Sbjct: 666 SMDD 669
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 3e-26
Identities = 37/171 (21%), Positives = 57/171 (33%), Gaps = 14/171 (8%)
Query: 68 KLTGF-IPADLGSLSAIGRVNLRNNNFSG-----SLPVELFNASNLQSLILSGNSFSGPV 121
KL + S+ +G V+ N S ++ + N ++ LS N
Sbjct: 630 KLKYIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFP 689
Query: 122 PMQIGKLKYLQVLDLSQNSFSS-------SIPSSIVQCKRLKTVVLNQNSFTGPLPDGFA 174
+ + LS N +S + L T+ L N T D A
Sbjct: 690 TELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLTSLSDDFRA 749
Query: 175 TNLTALQKLDLSFNNLSGLIPNDIANLSRLRLLAQRVYVDLTYNNLSGLIP 225
T L L +D+S+N S P N S+L+ R D N + P
Sbjct: 750 TTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWP 799
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 5e-25
Identities = 26/181 (14%), Positives = 48/181 (26%), Gaps = 22/181 (12%)
Query: 61 SLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGP 120
+ N T A + N + + N +L + L
Sbjct: 452 IIYFANSPFTYDNIAVDWEDA-----NSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQ 506
Query: 121 VPMQIGKLKYLQVLDLSQNSFSS---------SIPSSIVQCKRLKTVVLNQNSFTGPLPD 171
+P + L LQ L+++ N S + +++ + N+
Sbjct: 507 LPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPAS 566
Query: 172 GFATNLTALQKLDLSFNNLSGLIPNDIANLSRLRLLAQRVYVDLTYNNLSGLIPQNAALL 231
+ L LD N + L +L L L YN + + A
Sbjct: 567 ASLQKMVKLGLLDCVHNKVRHL--EAFGTNVKLTDL------KLDYNQIEEIPEDFCAFT 618
Query: 232 S 232
Sbjct: 619 D 619
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 108 bits (270), Expect = 2e-24
Identities = 27/169 (15%), Positives = 47/169 (27%), Gaps = 8/169 (4%)
Query: 60 FSLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVE--LFNASNLQSLILSGNSF 117
K + D + I + NN P L L L N
Sbjct: 527 GISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKLGLLDCVHNKV 585
Query: 118 SGPVPMQIGKLKYLQVLDLSQNSFSSSIPSSIVQ-CKRLKTVVLNQNSFTGPLPDGFATN 176
G L L L N IP +++ + + N A +
Sbjct: 586 RHLEA--FGTNVKLTDLKLDYNQIEE-IPEDFCAFTDQVEGLGFSHNKLKYIPNIFNAKS 642
Query: 177 LTALQKLDLSFNNLSGLIPNDIANLSRLRLLAQRVYVDLTYNNLSGLIP 225
+ + +D S+N + N ++ + + V L+YN +
Sbjct: 643 VYVMGSVDFSYNKIGSEGRNISCSMDDYKGI-NASTVTLSYNEIQKFPT 690
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 6e-24
Identities = 24/163 (14%), Positives = 52/163 (31%), Gaps = 22/163 (13%)
Query: 71 GFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGKLKY 130
FI + L+ + + N+ F+ + + + + LK
Sbjct: 438 TFISKAIQRLTKLQIIYFANSPFTY-DNIAVD----WEDANSDYAKQYENEELSWSNLKD 492
Query: 131 LQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGP---------LPDGFATNLTALQ 181
L ++L + +P + L+++ + N L D +Q
Sbjct: 493 LTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDE-DTGPKIQ 551
Query: 182 KLDLSFNNLSGLIPN-DIANLSRLRLLAQRVYVDLTYNNLSGL 223
+ +NNL + + + +L LL D +N + L
Sbjct: 552 IFYMGYNNLEEFPASASLQKMVKLGLL------DCVHNKVRHL 588
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 4e-23
Identities = 35/288 (12%), Positives = 74/288 (25%), Gaps = 82/288 (28%)
Query: 18 DEGLALLSFKQAIR------------NFPEGNNWNNSNEDPCSWNGITC----REGQVFS 61
+ AL + +A+ N NWN N++ W G+V
Sbjct: 269 KDYKALKAIWEALDGKNWRYYSGTINNTIHSLNWN-FNKELDMWGDQPGVDLDNNGRVTG 327
Query: 62 LIIPNKKLTGFIPADLGSLSAI-------------------------GRVNLRNNNFSGS 96
L + G +P +G L+ + ++
Sbjct: 328 LSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHY 387
Query: 97 LPVELFNASNLQSLILSGNSFSG----------------------------PVPMQIGKL 128
+ L L L ++ + + I +L
Sbjct: 388 KKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITFISKAIQRL 447
Query: 129 KYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFN 188
LQ++ + + F+ + + + ++ NL L ++L
Sbjct: 448 TKLQIIYFANSPFTYDNIAVD-----WEDANSDYAKQYENEELSWS-NLKDLTDVELYNC 501
Query: 189 NLSGLIPNDIANLSRLRLLAQRVYVDLTYNNLSGLIPQNAALLSLGPT 236
+P+ + +L L+ L ++ N A L
Sbjct: 502 PNMTQLPDFLYDLPELQSL------NIACNRGISAAQLKADWTRLADD 543
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 79.9 bits (197), Expect = 1e-15
Identities = 26/144 (18%), Positives = 47/144 (32%), Gaps = 14/144 (9%)
Query: 68 KLTGFIPADL--GSLSAIGRVNLRNNNFSGSLPVELFNASNLQSL------ILSGNSFSG 119
KLT + D +L + +++ N FS S P + N+S L++ GN
Sbjct: 739 KLTS-LSDDFRATTLPYLSNMDVSYNCFS-SFPTQPLNSSQLKAFGIRHQRDAEGNRILR 796
Query: 120 PVPMQIGKLKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTA 179
P I L L + N + + +L + + N + A
Sbjct: 797 QWPTGITTCPSLIQLQIGSNDI-RKVDEKL--TPQLYILDIADNPNISIDVTSVCPYIEA 853
Query: 180 LQKLDLSFNNLSGLIPNDIANLSR 203
L ++ + D + R
Sbjct: 854 GM-YVLLYDKTQDIRGCDALGIER 876
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 2e-28
Identities = 81/311 (26%), Positives = 140/311 (45%), Gaps = 55/311 (17%)
Query: 375 LGKSTIGIVYKVALNNEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWS 434
LG+ G V+ N VA++ L G + F EA+ + K+RH +V L A
Sbjct: 275 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAV--- 330
Query: 435 VDEK--LLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKR 492
V E+ ++ +Y+ GSL + G+ G + L + + +A G+A++
Sbjct: 331 VSEEPIYIVTEYMSKGSLLDFLKGETG----KYLRLPQLVDMAAQIASGMAYVER---MN 383
Query: 493 YVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTAL 552
YVH DLR +NIL+G+N+ ++DFGLARL + + T P ++T
Sbjct: 384 YVHRDLRAANILVGENLVCKVADFGLARLIE----------DNEYTARQGAKFPIKWT-- 431
Query: 553 NSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQIGSMELNIVQWIQL 611
APEA+ + T K D++S+G++L E+ + G++P + + E+ +
Sbjct: 432 ----------APEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV-----LDQ 476
Query: 612 ILED-RKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRVNI 670
+ R P P + S+ + C K P++RP+ ++ L+
Sbjct: 477 VERGYRMPC-----PPECPE--------SLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 523
Query: 671 STEQQFMKGEE 681
STE Q+ GE
Sbjct: 524 STEPQYQPGEN 534
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 4e-27
Identities = 29/166 (17%), Positives = 55/166 (33%), Gaps = 5/166 (3%)
Query: 68 KLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGK 127
L L + ++L + L +L+L+ N +
Sbjct: 44 VLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSG 103
Query: 128 LKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSF 187
K L+ L Q SS + K L+++ L N + L+ LD
Sbjct: 104 PKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGF-PTEKLKVLDFQN 162
Query: 188 NNLSGLIPNDIANLSRLRLLAQRVYVDLTYNNLSGLIPQNAALLSL 233
N + L D+++L + L ++L N+++G+ P
Sbjct: 163 NAIHYLSKEDMSSLQQATNL----SLNLNGNDIAGIEPGAFDSAVF 204
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 8e-26
Identities = 36/168 (21%), Positives = 60/168 (35%), Gaps = 9/168 (5%)
Query: 68 KLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELF-NASNLQSLILSGN--SFSGPVPMQ 124
K + ++ ++++ N L N NL+ L LS + S +Q
Sbjct: 312 KFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQ 371
Query: 125 IGKLKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLD 184
+ L +LQ L+LS N S + +C +L+ + L NL L+ L+
Sbjct: 372 LRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLN 431
Query: 185 LSFNNLSGLIPNDIANLSRLRLLAQRVYVDLTYNNLSGLIPQNAALLS 232
LS + L L L+ L +L N+ Q L
Sbjct: 432 LSHSLLDISSEQLFDGLPALQHL------NLQGNHFPKGNIQKTNSLQ 473
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 8e-24
Identities = 37/207 (17%), Positives = 61/207 (29%), Gaps = 33/207 (15%)
Query: 71 GFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSG-PVPMQIGKLK 129
L +LS + +NL N L+ L L+ L
Sbjct: 366 DCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLH 425
Query: 130 YLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTG--PLPDGFATNLTALQKLDLSF 187
L+VL+LS + S L+ + L N F L L+ L LSF
Sbjct: 426 LLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSF 485
Query: 188 NNLSGLIPNDIANLSRLRLLAQRVYVDLTYNNLSGLIP-------------QNAALLSLG 234
+LS + + +L + + DL++N L+ + + +
Sbjct: 486 CDLSSIDQHAFTSLKMMNHV------DLSHNRLTSSSIEALSHLKGIYLNLASNHISIIL 539
Query: 235 PTAFI-----------GNPFLCGPPLK 250
P+ NP C
Sbjct: 540 PSLLPILSQQRTINLRQNPLDCTCSNI 566
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 9e-24
Identities = 27/154 (17%), Positives = 47/154 (30%), Gaps = 9/154 (5%)
Query: 73 IPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQ 132
IP L ++ + N NL L L+ L
Sbjct: 27 IPGTL--PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLD 84
Query: 133 VLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSG 192
L L+ N +++ K LK + Q + + N L+ L L N++S
Sbjct: 85 TLVLTANPLIFMAETALSGPKALKHLFFIQTGISS-IDFIPLHNQKTLESLYLGSNHISS 143
Query: 193 LIPNDIANLSRLRLLAQRVYVDLTYNNLSGLIPQ 226
+ +L++L D N + L +
Sbjct: 144 IKLPKGFPTEKLKVL------DFQNNAIHYLSKE 171
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 5e-23
Identities = 41/163 (25%), Positives = 69/163 (42%), Gaps = 10/163 (6%)
Query: 66 NKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQI 125
++ ++ + L +S + +NL+ + F S LQ L L+ S +P +
Sbjct: 240 DEDISPAVFEGLCEMS-VESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSE-LPSGL 297
Query: 126 GKLKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDL 185
L L+ L LS N F + S L + + N+ L G NL L++LDL
Sbjct: 298 VGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDL 357
Query: 186 SFNNL--SGLIPNDIANLSRLRLLAQRVYVDLTYNNLSGLIPQ 226
S +++ S + NLS L+ L +L+YN L +
Sbjct: 358 SHDDIETSDCCNLQLRNLSHLQSL------NLSYNEPLSLKTE 394
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 6e-22
Identities = 39/166 (23%), Positives = 68/166 (40%), Gaps = 10/166 (6%)
Query: 69 LTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGKL 128
G + + SL ++ + + S ++ L +++S+ L + F
Sbjct: 219 FKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCE-MSVESINLQKHYFFNISSNTFHCF 277
Query: 129 KYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFN 188
LQ LDL+ S +PS +V LK +VL+ N F L A+N +L L + N
Sbjct: 278 SGLQELDLTATHL-SELPSGLVGLSTLKKLVLSANKFEN-LCQISASNFPSLTHLSIKGN 335
Query: 189 NLSGLI-PNDIANLSRLRLLAQRVYVDLTYNNLSGLIPQNAALLSL 233
+ + NL LR L DL+++++ N L +L
Sbjct: 336 TKRLELGTGCLENLENLREL------DLSHDDIETSDCCNLQLRNL 375
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 3e-20
Identities = 18/161 (11%), Positives = 48/161 (29%), Gaps = 8/161 (4%)
Query: 68 KLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGK 127
++ L + + + L +N+ S + F L+ L N+ +
Sbjct: 116 GISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSS 175
Query: 128 LKYLQV--LDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFA-TNLTALQKLD 184
L+ L+L+ N + I +++ + G + + +L
Sbjct: 176 LQQATNLSLNLNGNDIAG-IEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGT 234
Query: 185 LSFNNLSGLIPNDIANLSRLRLLAQRVYVDLTYNNLSGLIP 225
+ + P L + + ++L + +
Sbjct: 235 FEDMDDEDISPAVFEGLCEMSVE----SINLQKHYFFNISS 271
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 3e-16
Identities = 31/135 (22%), Positives = 52/135 (38%), Gaps = 5/135 (3%)
Query: 61 SLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVE---LFNASNLQSLILSGNSF 117
L + + L L A+ +NL+ N+F + L L+ L+LS
Sbjct: 429 VLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDL 488
Query: 118 SGPVPMQIGKLKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNL 177
S LK + +DLS N +SS ++ K + + L N + LP L
Sbjct: 489 SSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLP-IL 546
Query: 178 TALQKLDLSFNNLSG 192
+ + ++L N L
Sbjct: 547 SQQRTINLRQNPLDC 561
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 6e-27
Identities = 73/304 (24%), Positives = 132/304 (43%), Gaps = 51/304 (16%)
Query: 375 LGKSTIGIVYKVALNNEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWS 434
LG G V+ N VAV+ + G + F EA + ++H +V L A +
Sbjct: 196 LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSV-EAFLAEANVMKTLQHDKLVKLHAVV-T 253
Query: 435 VDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYV 494
+ +I +++ GSL + G + +A+G+AF+ + + Y+
Sbjct: 254 KEPIYIITEFMAKGSLLDFLKSDEG----SKQPLPKLIDFSAQIAEGMAFIEQ---RNYI 306
Query: 495 HGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNS 554
H DLR +NIL+ ++ I+DFGLAR+ + E T + G P ++T
Sbjct: 307 HRDLRAANILVSASLVCKIADFGLARVIEDNEYT-------AREGAKF---PIKWT---- 352
Query: 555 TTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQIGSMELNIVQWIQLIL 613
APEA T K D++S+G++L+E+++ G++P + + E+ I+ +
Sbjct: 353 --------APEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEV-----IRALE 399
Query: 614 ED-RKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRVNIST 672
R P P + + I + C P++RP+ ++ LD +T
Sbjct: 400 RGYRMPR-----PENCPE--------ELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTAT 446
Query: 673 EQQF 676
E Q+
Sbjct: 447 ESQY 450
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 7e-27
Identities = 34/166 (20%), Positives = 61/166 (36%), Gaps = 2/166 (1%)
Query: 68 KLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGK 127
L + S + ++L +L +LIL+GN P
Sbjct: 43 PLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSG 102
Query: 128 LKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSF 187
L L+ L + +S I Q LK + + N + +NLT L +DLS+
Sbjct: 103 LTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSY 162
Query: 188 NNLSGLIPNDIANLSRLRLLAQRVYVDLTYNNLSGLIPQNAALLSL 233
N + + ND+ L + + +D++ N + + Q + L
Sbjct: 163 NYIQTITVNDLQFLRENPQV--NLSLDMSLNPIDFIQDQAFQGIKL 206
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 4e-24
Identities = 32/140 (22%), Positives = 48/140 (34%), Gaps = 8/140 (5%)
Query: 87 NLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQ-IGKLKYLQVLDLSQNSFSSSI 145
+L N + LQ L ++ L+ L LD+S +
Sbjct: 382 DLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDF 440
Query: 146 PSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSGLIPNDIANLSRLR 205
+ L T+ + NSF N T L LDLS L + L RL+
Sbjct: 441 DGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQ 500
Query: 206 LLAQRVYVDLTYNNLSGLIP 225
LL ++++NNL L
Sbjct: 501 LL------NMSHNNLLFLDS 514
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-23
Identities = 38/168 (22%), Positives = 64/168 (38%), Gaps = 11/168 (6%)
Query: 66 NKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQI 125
++KL+ +P D+ S + ++L N N S LQ L LS
Sbjct: 20 DQKLSK-VPDDIPS--STKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAW 76
Query: 126 GKLKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDL 185
L +L L L+ N S P S L+ +V + L L+KL++
Sbjct: 77 HGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPI-GQLITLKKLNV 135
Query: 186 SFNNLSGL-IPNDIANLSRLRLLAQRVYVDLTYNNLSGLIPQNAALLS 232
+ N + +P +NL+ L + DL+YN + + + L
Sbjct: 136 AHNFIHSCKLPAYFSNLTNLVHV------DLSYNYIQTITVNDLQFLR 177
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-23
Identities = 30/156 (19%), Positives = 52/156 (33%), Gaps = 9/156 (5%)
Query: 68 KLTGFIPAD-LGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQI- 125
L SL + +++ N ++L +L ++GNSF +
Sbjct: 410 TLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVF 469
Query: 126 GKLKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDL 185
L LDLS+ RL+ + ++ N+ L L +L LD
Sbjct: 470 ANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLF-LDSSHYNQLYSLSTLDC 528
Query: 186 SFNNLSGLIPNDIANLSRLRLLAQRVYVDLTYNNLS 221
SFN + L +LT N+++
Sbjct: 529 SFNRIETSKGILQHFPKSLAFF------NLTNNSVA 558
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 7e-18
Identities = 36/227 (15%), Positives = 69/227 (30%), Gaps = 25/227 (11%)
Query: 48 SWNGITCREGQVFS-------LIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVE 100
S I E + + LI+ + F P L+++ + +
Sbjct: 64 SRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFP 123
Query: 101 LFNASNLQSLILSGNSFSG-PVPMQIGKLKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVV 159
+ L+ L ++ N +P L L +DLS N + + + + V
Sbjct: 124 IGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVN 183
Query: 160 ----LNQNSFTGPLPDGFATNLTALQKLDLSFNNLSGLIPND-IANLSRLRLLAQRVYVD 214
++ N + D + L +L L N S I + NL+ L +
Sbjct: 184 LSLDMSLNPIDF-IQDQAFQGIK-LHELTLRGNFNSSNIMKTCLQNLAGLHVH------R 235
Query: 215 LTYNNLSGLIPQNAALLSLGPTAFIGNPFLCGPPLKVSCPSSTSDHP 261
L L P+ G + +++ + SD
Sbjct: 236 LILGEFKDERN----LEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDI 278
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 2e-16
Identities = 35/170 (20%), Positives = 60/170 (35%), Gaps = 14/170 (8%)
Query: 66 NKKLTGFIPADLGSLSAIGRVNLR--NNNFSGSLPVELFNASNLQSLILSGNSFSGPVPM 123
+ L F P+ + L + R N V+ +N+ ++ L+G S
Sbjct: 244 ERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYLED- 302
Query: 124 QIGKLKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKL 183
+ K Q L + + P+ LK++ L N + L +L L
Sbjct: 303 -VPKHFKWQSLSIIRCQLKQ-FPTL--DLPFLKSLTLTMNKGSISFKK---VALPSLSYL 355
Query: 184 DLSFNNLSGLIPNDIANLSRLRLLAQRVYVDLTYNNLSGLIPQNAALLSL 233
DLS N LS ++L L ++DL++N + L L
Sbjct: 356 DLSRNALSFSGCCSYSDLGTNSLR----HLDLSFNGAIIMSANFMGLEEL 401
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 1e-14
Identities = 30/189 (15%), Positives = 50/189 (26%), Gaps = 35/189 (18%)
Query: 72 FIPADLGSLSAIGRVNLRNNNFSGSLPVELFNA-SNLQSLILSGNSFSGPVPMQIGKLKY 130
FI + + LR N S ++ + L L F ++I +
Sbjct: 195 FIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSI 254
Query: 131 LQ--------VLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFAT------- 175
++ L+ + S + + L S
Sbjct: 255 MEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYLEDVPKHFKWQSLSI 314
Query: 176 -----------NLTALQKLDLSFNNLSGLIPNDIANLSRLRLLAQRVYVDLTYNNLSGLI 224
+L L+ L L+ N S I L L L DL+ N LS
Sbjct: 315 IRCQLKQFPTLDLPFLKSLTLTMNKGS--ISFKKVALPSLSYL------DLSRNALSFSG 366
Query: 225 PQNAALLSL 233
+ + L
Sbjct: 367 CCSYSDLGT 375
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 5e-12
Identities = 22/128 (17%), Positives = 38/128 (29%), Gaps = 10/128 (7%)
Query: 48 SWNGITCREGQVFS-------LIIPNKKLTGFIPAD-LGSLSAIGRVNLRNNNFSGSLPV 99
S+ +F L + ++ + + + ++L +
Sbjct: 432 SYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLE-QISW 490
Query: 100 ELF-NASNLQSLILSGNSFSGPVPMQIGKLKYLQVLDLSQNSFSSSIPSSIVQCKRLKTV 158
+F LQ L +S N+ +L L LD S N +S K L
Sbjct: 491 GVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFF 550
Query: 159 VLNQNSFT 166
L NS
Sbjct: 551 NLTNNSVA 558
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 1e-08
Identities = 15/78 (19%), Positives = 28/78 (35%), Gaps = 2/78 (2%)
Query: 68 KLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELF-NASNLQSLILSGNSFSGPVPMQIG 126
+L +L + +N+ +NN L + +L +L S N +
Sbjct: 484 QLEQISWGVFDTLHRLQLLNMSHNNLL-FLDSSHYNQLYSLSTLDCSFNRIETSKGILQH 542
Query: 127 KLKYLQVLDLSQNSFSSS 144
K L +L+ NS +
Sbjct: 543 FPKSLAFFNLTNNSVACI 560
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 67/319 (21%), Positives = 122/319 (38%), Gaps = 59/319 (18%)
Query: 375 LGKSTIGIVYK-----VALNNEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLR 429
LGK G V + N VAV++L + G + ++FQ E + + + IV R
Sbjct: 31 LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 90
Query: 430 AYFWSVDEK--LLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHE 487
+ + L+ +Y+P+G L + + L L + KG+ +L
Sbjct: 91 GVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRL-----LLYSSQICKGMEYLGS 145
Query: 488 VSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPY 547
+R VH DL NIL+ I+DFGLA+L + ++ V SP
Sbjct: 146 ---RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVV-----REPG---QSPI 194
Query: 548 EFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQIGSMELNIV 606
+ APE+ +++ D++S+GV+L E+ +
Sbjct: 195 FWY------------APESLSDNIFSRQSDVWSFGVVLYELFTYCDKSC-------SPSA 235
Query: 607 QWIQLILEDRKPMT--DILDPFLAHDLDKEDEI--------VSVLKIALDCVHKSPDKRP 656
++++++ +R +L +L +E + V ++ C SP RP
Sbjct: 236 EFLRMMGCERDVPALSRLL------ELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRP 289
Query: 657 SMRHVCDSLDRVNISTEQQ 675
S + LD + +
Sbjct: 290 SFSALGPQLDMLWSGSRGC 308
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 4e-26
Identities = 66/304 (21%), Positives = 122/304 (40%), Gaps = 51/304 (16%)
Query: 375 LGKSTIGIVYK-VALNNEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFW 433
LG G VY+ V VAV+ L + +EF EA + +I+HPN+V L
Sbjct: 228 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGVCT 286
Query: 434 SVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRY 493
+I +++ G+L + + +S L + ++ + +L + K +
Sbjct: 287 REPPFYIITEFMTYGNLLDYLRECNR----QEVSAVVLLYMATQISSAMEYLEK---KNF 339
Query: 494 VHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALN 553
+H +L N L+G+N ++DFGL+RL T + G P ++T
Sbjct: 340 IHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYT-------AHAGAKF---PIKWT--- 386
Query: 554 STTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQIGSMELNIVQWIQLI 612
APE+ K + K D++++GV+L E+ + G P I ++ +L+
Sbjct: 387 ---------APESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV-----YELL 432
Query: 613 LED-RKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRVNIS 671
+D R P + V ++ C +P RPS + + + +
Sbjct: 433 EKDYRMER-----PEGCPE--------KVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 479
Query: 672 TEQQ 675
+
Sbjct: 480 SSIS 483
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 5e-26
Identities = 61/299 (20%), Positives = 108/299 (36%), Gaps = 53/299 (17%)
Query: 375 LGKSTIGIVYK-VALNNEEAVAVRRL--GNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAY 431
+G+ G V+ + VAV+ + +F EA + + HPNIV L
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLK-AKFLQEARILKQYSHPNIVRLIGV 180
Query: 432 FWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPK 491
++ + + G T + + L L+++ A G+ +L K
Sbjct: 181 CTQKQPIYIVMELVQGGDFLTFLRTEG-----ARLRVKTLLQMVGDAAAGMEYLES---K 232
Query: 492 RYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTA 551
+H DL N L+ + ISDFG++R L+ P ++T
Sbjct: 233 CCIHRDLAARNCLVTEKNVLKISDFGMSRE---------EADGVYAASGGLRQVPVKWT- 282
Query: 552 LNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQIGSMELNIVQWIQ 610
APEA + + + D++S+G++L E S G P ++ +
Sbjct: 283 -----------APEALNYGRYSSESDVWSFGILLWETFSLGASPY---PNLSNQQT--RE 326
Query: 611 LILED-RKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRV 668
+ + R P P L D +V ++ C P +RPS + L +
Sbjct: 327 FVEKGGRLPC-----PELCPD--------AVFRLMEQCWAYEPGQRPSFSTIYQELQSI 372
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 6e-26
Identities = 70/295 (23%), Positives = 125/295 (42%), Gaps = 51/295 (17%)
Query: 375 LGKSTIGIVYKVALNNEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWS 434
+G G+V+ N++ VA++ + G ++F EAE + K+ HP +V L
Sbjct: 16 IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE-EDFIEEAEVMMKLSHPKLVQLYGVCLE 74
Query: 435 VDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYV 494
L+ +++ +G L+ + + G+ + L L + V +G+A+L E +
Sbjct: 75 QAPICLVTEFMEHGCLSDYLRTQRGLFAAETL-----LGMCLDVCEGMAYLEE---ACVI 126
Query: 495 HGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNS 554
H DL N L+G+N +SDFG+ R + T S+TGT P ++
Sbjct: 127 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-------SSTGTKF---PVKWA---- 172
Query: 555 TTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQIGSMELNIVQWIQLIL 613
+PE + + K D++S+GV++ E+ S GK+P + E+ ++ I
Sbjct: 173 --------SPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV-----VEDIS 219
Query: 614 ED-RKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDR 667
R P LA V +I C + P+ RP+ + L
Sbjct: 220 TGFRLYK-----PRLAST--------HVYQIMNHCWRERPEDRPAFSRLLRQLAE 261
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 7e-26
Identities = 80/312 (25%), Positives = 138/312 (44%), Gaps = 57/312 (18%)
Query: 375 LGKSTIGIVYKVALNNEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWS 434
LG G V+ N VAV+ L G F EA + +++H +V L A
Sbjct: 21 LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLVRLYA---V 76
Query: 435 VDEK--LLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKR 492
V ++ +I +Y+ NGSL + +G L+ + L + +A+G+AF+ E +
Sbjct: 77 VTQEPIYIITEYMENGSLVDFLKTPSG----IKLTINKLLDMAAQIAEGMAFIEE---RN 129
Query: 493 YVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTAL 552
Y+H DLR +NIL+ + I+DFGLARL + E T + G P ++T
Sbjct: 130 YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT-------AREGAKF---PIKWT-- 177
Query: 553 NSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQIGSMELNIVQWIQL 611
APEA T K D++S+G++L E+++ G++P + + E+ IQ
Sbjct: 178 ----------APEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEV-----IQN 222
Query: 612 ILED-RKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRVNI 670
+ R P + + ++ C + P+ RP+ ++ L+
Sbjct: 223 LERGYRMVR-----PDNCPE--------ELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269
Query: 671 STEQQFMKGEEP 682
+TE Q+ +P
Sbjct: 270 ATEGQYQ--PQP 279
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 3e-25
Identities = 63/293 (21%), Positives = 115/293 (39%), Gaps = 58/293 (19%)
Query: 374 LLGKSTIGIVYKVALNNEE--AVAVR--RLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLR 429
+G+ + VYK L+ E VA + + F+ EAE + ++HPNIV
Sbjct: 33 EIGRGSFKTVYK-GLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 91
Query: 430 AYFWSVDEK---LLIY-DYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFL 485
+ S + +++ + + +G+L T + ++ + + + KG+ FL
Sbjct: 92 DSWESTVKGKKCIVLVTELMTSGTLKTYLK------RFKVMKIKVLRSWCRQILKGLQFL 145
Query: 486 HEVSPKRYVHGDLRPSNILL-GKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQS 544
H +P +H DL+ NI + G I D GLA L + ++ GTP
Sbjct: 146 HTRTPP-IIHRDLKCDNIFITGPTGSVKIGDLGLATLK-------RASFAKAVIGTP--- 194
Query: 545 SPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELN 604
+ APE + K + D+Y++G+ +LEM + + P + +
Sbjct: 195 ---------------EFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNA--- 235
Query: 605 IVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPS 657
Q + + KP E V +I C+ ++ D+R S
Sbjct: 236 -AQIYRRVTSGVKP------ASFDKVAIPE-----VKEIIEGCIRQNKDERYS 276
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 4e-25
Identities = 69/313 (22%), Positives = 123/313 (39%), Gaps = 50/313 (15%)
Query: 375 LGKSTIGIVYK-----VALNNEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLR 429
LGK G V + N E VAV++L + + ++F+ E E + ++H NIV +
Sbjct: 18 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 430 AYFWSVDEK--LLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHE 487
+S + LI +Y+P GSL + I + L L+ + KG+ +L
Sbjct: 78 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGMEYLGT 132
Query: 488 VSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPY 547
KRY+H DL NIL+ I DFGL ++ +E +V SP
Sbjct: 133 ---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKV-----KEPG---ESPI 181
Query: 548 EFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQ 607
+ APE+ K + D++S+GV+L E+ + + +
Sbjct: 182 FWY------------APESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMR--- 226
Query: 608 WIQLILEDRKPMTDILDPFLAHDLDK-------EDEIVSVLKIALDCVHKSPDKRPSMRH 660
+ ++ L L + + I +C + + ++RPS R
Sbjct: 227 -----MIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRD 281
Query: 661 VCDSLDRVNISTE 673
+ +D++ +
Sbjct: 282 LALRVDQIRDNMA 294
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 5e-25
Identities = 69/294 (23%), Positives = 126/294 (42%), Gaps = 51/294 (17%)
Query: 375 LGKSTIGIVYKVALNNEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWS 434
LG G+V + VAV+ + G EF EA+ + K+ HP +V
Sbjct: 16 LGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSE-DEFFQEAQTMMKLSHPKLVKFYGVCSK 74
Query: 435 VDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYV 494
++ +YI NG L + + L S L + V +G+AFL +++
Sbjct: 75 EYPIYIVTEYISNGCLLNYLRSHG-----KGLEPSQLLEMCYDVCEGMAFLES---HQFI 126
Query: 495 HGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNS 554
H DL N L+ +++ +SDFG+ R + ++ S+ GT P +++
Sbjct: 127 HRDLAARNCLVDRDLCVKVSDFGMTR--YVLDDQ-----YVSSVGTKF---PVKWS---- 172
Query: 555 TTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQIGSMELNIVQWIQLIL 613
APE K + K D++++G+++ E+ S GK+P + E+ + +
Sbjct: 173 --------APEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEV-----VLKVS 219
Query: 614 ED-RKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLD 666
+ R P LA D ++ +I C H+ P+KRP+ + + S++
Sbjct: 220 QGHRLYR-----PHLASD--------TIYQIMYSCWHELPEKRPTFQQLLSSIE 260
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 7e-25
Identities = 64/295 (21%), Positives = 114/295 (38%), Gaps = 51/295 (17%)
Query: 375 LGKSTIGIVYKVALNNEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWS 434
LG G+V + VA++ + G EF EA+ + + H +V L
Sbjct: 32 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLVQLYGVCTK 90
Query: 435 VDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYV 494
+I +Y+ NG L + L + K V + + +L K+++
Sbjct: 91 QRPIFIITEYMANGCLLNYLREMRH-----RFQTQQLLEMCKDVCEAMEYLES---KQFL 142
Query: 495 HGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNS 554
H DL N L+ +SDFGL+R + ++ S+ G+ P ++
Sbjct: 143 HRDLAARNCLVNDQGVVKVSDFGLSR--YVLDDEYT-----SSVGSKF---PVRWS---- 188
Query: 555 TTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQIGSMELNIVQWIQLIL 613
PE K + K DI+++GV++ E+ S GK+P + + E + I
Sbjct: 189 --------PPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSET-----AEHIA 235
Query: 614 ED-RKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDR 667
+ R P LA + V I C H+ D+RP+ + + ++
Sbjct: 236 QGLRLYR-----PHLASE--------KVYTIMYSCWHEKADERPTFKILLSNILD 277
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 66/305 (21%), Positives = 116/305 (38%), Gaps = 54/305 (17%)
Query: 374 LLGKSTIGIVYKV-ALNNEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYF 432
LG+ V V L++ A++R+ Q +E Q EA+ HPNI+ L AY
Sbjct: 36 KLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYC 95
Query: 433 W----SVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEV 488
+ E L+ + G+L I + L+ L ++ G+ +G+ +H
Sbjct: 96 LRERGAKHEAWLLLPFFKRGTLWNEI--ERLKDKGNFLTEDQILWLLLGICRGLEAIHA- 152
Query: 489 SPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADI----AEETPEVHWEQSTTGTPLQS 544
K Y H DL+P+NILLG +P + D G A I + + + + T
Sbjct: 153 --KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTI--- 207
Query: 545 SPYEFTALNSTTSRSYYQAPEASKVRK---PTQKWDIYSYGVILLEMISGKLPMIQIGSM 601
Y+APE V+ ++ D++S G +L M+ G+ P +
Sbjct: 208 ---------------SYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPY-DMVFQ 251
Query: 602 ELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPS---- 657
+ + V + + P + L L + S++ P +RP
Sbjct: 252 KGDSVALA-VQNQLSIPQSPRHSSAL-WQL-----LNSMMT-------VDPHQRPHIPLL 297
Query: 658 MRHVC 662
+ +
Sbjct: 298 LSQLE 302
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 1e-24
Identities = 79/301 (26%), Positives = 129/301 (42%), Gaps = 55/301 (18%)
Query: 375 LGKSTIGIVYKVALN----NEEAVAVRRL--GNGGWQRFKEFQTEAEAIGKIRHPNIVSL 428
+G G V L E +VA++ L G QR ++F EA +G+ HPNI+ L
Sbjct: 53 VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR-RDFLGEASIMGQFDHPNIIRL 111
Query: 429 RAYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEV 488
+++ +Y+ NGSL + + + + +++G+A G+ +L +
Sbjct: 112 EGVVTKSKPVMIVTEYMENGSLDSFLRKHDA-----QFTVIQLVGMLRGIASGMKYLSD- 165
Query: 489 SPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYE 548
YVH DL NIL+ N+ +SDFGL R+ + E +T G + P
Sbjct: 166 --MGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAY-----TTRGGKI---PIR 215
Query: 549 FTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQIGSMELNIVQ 607
+T +PEA RK T D++SYG++L E++S G+ P M V
Sbjct: 216 WT------------SPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY---WEMSNQDV- 259
Query: 608 WIQLILED-RKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLD 666
I+ + E R P P ++ ++ LDC K + RP + LD
Sbjct: 260 -IKAVDEGYRLPP-----PMDCPA--------ALYQLMLDCWQKDRNNRPKFEQIVSILD 305
Query: 667 R 667
+
Sbjct: 306 K 306
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 67/313 (21%), Positives = 108/313 (34%), Gaps = 66/313 (21%)
Query: 374 LLGKSTIGIVYKV---ALNNEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRA 430
LG+ G+V++ + A+ RL N R ++ E +A+ K+ HP IV
Sbjct: 12 CLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAR-EKVMREVKALAKLEHPGIVRYFN 70
Query: 431 YF-------WSVDEKLLIYDYI-----PNGSLATAIHGKAGIISYRPLSWSDRLRIIKGV 478
+ +Y YI +L ++G+ I S L I +
Sbjct: 71 AWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTI---EERERSVCLHIFLQI 127
Query: 479 AKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLAR-------LADIAEETPEV 531
A+ + FLH K +H DL+PSNI + + DFGL + P
Sbjct: 128 AEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAY 184
Query: 532 HWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISG 591
GT Y +PE + K DI+S G+IL E++
Sbjct: 185 ARHTGQVGTK------------------LYMSPEQIHGNSYSHKVDIFSLGLILFELLY- 225
Query: 592 KLPMIQIGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKS 651
P ME + + + P P E +V D + S
Sbjct: 226 --PF--STQMERVRT--LTDVRNLKFP------PLFTQKYPCEYVMVQ------DMLSPS 267
Query: 652 PDKRPSMRHVCDS 664
P +RP ++ ++
Sbjct: 268 PMERPEAINIIEN 280
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 62/312 (19%), Positives = 116/312 (37%), Gaps = 48/312 (15%)
Query: 374 LLGKSTIGIVYKV-ALNNEEAVAVRRLGNGGWQRFKE---FQTEAEAIGKIRHPNIVSLR 429
+G+ VY+ L + VA++++ K E + + ++ HPN++
Sbjct: 39 KIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYY 98
Query: 430 AYFWSVDEKLLIY-DYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEV 488
A F D +L I + G L+ I K R + + + + +H
Sbjct: 99 ASFIE-DNELNIVLELADAGDLSRMI--KHFKKQKRLIPERTVWKYFVQLCSALEHMHS- 154
Query: 489 SPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYE 548
+R +H D++P+N+ + + D GL R S GTP
Sbjct: 155 --RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAA-----HSLVGTP------- 200
Query: 549 FTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQW 608
YY +PE K DI+S G +L EM + + P ++N+
Sbjct: 201 -----------YYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPF---YGDKMNLYSL 246
Query: 609 IQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRV 668
+ I + P + + +L ++V++ C++ P+KRP + +V D R+
Sbjct: 247 CKKIEQCDYP--PLPSDHYSEEL---RQLVNM------CINPDPEKRPDVTYVYDVAKRM 295
Query: 669 NISTEQQFMKGE 680
+ T
Sbjct: 296 HACTASSLEHHH 307
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-24
Identities = 68/313 (21%), Positives = 121/313 (38%), Gaps = 50/313 (15%)
Query: 375 LGKSTIGIVYK-----VALNNEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLR 429
LGK G V + N E VAV++L + + ++F+ E E + ++H NIV +
Sbjct: 49 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 108
Query: 430 AYFWSVDEK--LLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHE 487
+S + LI +Y+P GSL + I + L L+ + KG+ +L
Sbjct: 109 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGMEYLGT 163
Query: 488 VSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPY 547
KRY+H DL NIL+ I DFGL ++ +E +V P
Sbjct: 164 ---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKV-----KEPGES---PI 212
Query: 548 EFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQ 607
+ APE+ K + D++S+GV+L E+ + + +
Sbjct: 213 FWY------------APESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMR--- 257
Query: 608 WIQLILEDRKPMTDILDPFLAHDLDK-------EDEIVSVLKIALDCVHKSPDKRPSMRH 660
+ ++ L L + + I +C + + ++RPS R
Sbjct: 258 -----MIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRD 312
Query: 661 VCDSLDRVNISTE 673
+ +D++
Sbjct: 313 LALRVDQIRDQMA 325
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 75/294 (25%), Positives = 131/294 (44%), Gaps = 49/294 (16%)
Query: 383 VYKVALNNEEAVAVRRLGNGGWQRFK-EFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLI 441
+V + VA++ L G +R + +F +EA +G+ HPNI+ L +++
Sbjct: 69 RLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIV 128
Query: 442 YDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPS 501
+Y+ NGSL T + G + + +++GV G+ +L + YVH DL
Sbjct: 129 TEYMENGSLDTFLRTHDG-----QFTIMQLVGMLRGVGAGMRYLSD---LGYVHRDLAAR 180
Query: 502 NILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYY 561
N+L+ N+ +SDFGL+R + ++ + +TTG + P +T
Sbjct: 181 NVLVDSNLVCKVSDFGLSR--VLEDDPDAAY---TTTGGKI---PIRWT----------- 221
Query: 562 QAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQIGSMELNIVQWIQLILED-RKPM 619
APEA R + D++S+GV++ E+++ G+ P +M V I + E R P
Sbjct: 222 -APEAIAFRTFSSASDVWSFGVVMWEVLAYGERPY---WNMTNRDV--ISSVEEGYRLPA 275
Query: 620 TDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRVNISTE 673
P ++ ++ LDC HK +RP + LD + S E
Sbjct: 276 -----PMGCPH--------ALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPE 316
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 3e-24
Identities = 59/328 (17%), Positives = 117/328 (35%), Gaps = 72/328 (21%)
Query: 339 NNLDTMSENMEQYEFVPLDSQVDFDLEQLLKASAFLLGKSTIGIVYKV-ALNNEEAVAVR 397
+ ++ME+Y + +G+ + G V + + ++
Sbjct: 14 GTENLYFQSMEKYVRLQK------------------IGEGSFGKAILVKSTEDGRQYVIK 55
Query: 398 --RLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIY-DYIPNGSLATAI 454
+ + +E + E + ++HPNIV R F + L I DY G L I
Sbjct: 56 EINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEE-NGSLYIVMDYCEGGDLFKRI 114
Query: 455 HGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHIS 514
+ + G L + + +H+ ++ +H D++ NI L K+ +
Sbjct: 115 NAQKG----VLFQEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTVQLG 167
Query: 515 DFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQ 574
DFG+AR+ + V ++ GTP YY +PE + +
Sbjct: 168 DFGIARVLN-----STVELARACIGTP------------------YYLSPEICENKPYNN 204
Query: 575 KWDIYSYGVILLEMISGKLPMIQIGSMELNIVQWIQLILEDR-KPMTDILDPFLAHDLDK 633
K DI++ G +L E+ + K L + I+ P++
Sbjct: 205 KSDIWALGCVLYELCTLKHAFEAGSMKNL-----VLKIISGSFPPVSLHYSY-------- 251
Query: 634 EDEIVSVLKIALDCVHKSPDKRPSMRHV 661
++ S++ ++P RPS+ +
Sbjct: 252 --DLRSLVS---QLFKRNPRDRPSVNSI 274
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 6e-24
Identities = 62/306 (20%), Positives = 109/306 (35%), Gaps = 59/306 (19%)
Query: 375 LGKSTIGIVYK----VALNNEEAVAVRRLGNG---GWQRFKEFQTEAEAIGKIRHPNIVS 427
LG + G+V + +VAV+ L + +F E A+ + H N++
Sbjct: 26 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 428 LRAYFWSVDEKL-LIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLH 486
L + + ++ + P GSL + G L R VA+G+ +L
Sbjct: 86 LYGV--VLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTL-----SRYAVQVAEGMGYLE 138
Query: 487 EVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSP 546
KR++H DL N+LL I DFGL R ++ + P
Sbjct: 139 S---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDH-----YVMQEHRKV---P 187
Query: 547 YEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQIGSMELNI 605
+ + APE+ K R + D + +GV L EM + G+ P + +
Sbjct: 188 FAWC------------APESLKTRTFSHASDTWMFGVTLWEMFTYGQEPW---IGLNGSQ 232
Query: 606 VQWIQLILED--RKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCD 663
+ + I ++ R P + + + + C P+ RP+ + D
Sbjct: 233 I--LHKIDKEGERLPRPEDCPQ-------------DIYNVMVQCWAHKPEDRPTFVALRD 277
Query: 664 SLDRVN 669
L
Sbjct: 278 FLLEAQ 283
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 6e-24
Identities = 66/295 (22%), Positives = 109/295 (36%), Gaps = 53/295 (17%)
Query: 381 GIVYK---VALNNEEAVAVRRLGNGGWQRFKE-FQTEAEAIGKIRHPNIVSLRAYFWSVD 436
VY LN + A+ + + + F+ E ++ H NIVS+ +
Sbjct: 25 STVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSM--IDVDEE 82
Query: 437 EKL--LIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYV 494
+ L+ +YI +L+ I PLS + + GI H+ R V
Sbjct: 83 DDCYYLVMEYIEGPTLSEYIESHG------PLSVDTAINFTNQILDGIKHAHD---MRIV 133
Query: 495 HGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNS 554
H D++P NIL+ N I DFG+A+ T GT
Sbjct: 134 HRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQT----NHVLGTV------------- 176
Query: 555 TTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQWIQLILE 614
Y +PE +K + DIYS G++L EM+ G+ P G ++I I+ I +
Sbjct: 177 -----QYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPF--NGETAVSIA--IKHIQD 227
Query: 615 DRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRP-SMRHVCDSLDRV 668
+T + + L ++ L K R +++ + D L V
Sbjct: 228 SVPNVTTDVRKDIPQSL---SNVI------LRATEKDKANRYKTIQEMKDDLSSV 273
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 6e-24
Identities = 69/304 (22%), Positives = 111/304 (36%), Gaps = 62/304 (20%)
Query: 375 LGKSTIGIVYK-----VALNNEEAVAVRRLGNG-GWQRFKEFQTEAEAIGKIRHPNIVSL 428
LG G VYK + VA++ L + KE EA + + +P++ L
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 429 RAYFWSV---DEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFL 485
+ LI +P G L + I + L L +AKG+ +L
Sbjct: 83 LG----ICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYL-----LNWCVQIAKGMNYL 133
Query: 486 HEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSS 545
+ +R VH DL N+L+ I+DFGLA+L E+ E G +
Sbjct: 134 ED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK------EYHAEGGKV--- 181
Query: 546 PYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQIGSMELN 604
P ++ A E+ R T + D++SYGV + E+++ G P I + E+
Sbjct: 182 PIKWM------------ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI- 228
Query: 605 IVQWIQLILE-DRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCD 663
++ + +R P I V I C D RP R +
Sbjct: 229 ----SSILEKGERLPQPPICTI-------------DVYMIMRKCWMIDADSRPKFRELII 271
Query: 664 SLDR 667
+
Sbjct: 272 EFSK 275
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 7e-24
Identities = 62/313 (19%), Positives = 107/313 (34%), Gaps = 60/313 (19%)
Query: 375 LGKSTIGIVYK-----VALNNEEAVAVRRL-GNGGWQRFKEFQTEAEAIGKIRHPNIVSL 428
LG+ G V N E VAV+ L G + + E E + + H NIV
Sbjct: 29 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 429 RA--YFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLH 486
+ + LI +++P+GSL + I+ + L+ + KG+ +L
Sbjct: 89 KGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQ-----LKYAVQICKGMDYLG 143
Query: 487 EVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSP 546
++YVH DL N+L+ + I DFGL + + +E V P
Sbjct: 144 S---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTV-----KDDRDS---P 192
Query: 547 YEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQIGSMELNI 605
+ APE K D++S+GV L E+++ + I
Sbjct: 193 VFWY------------APECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMI 240
Query: 606 VQW---------IQLILED-RKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKR 655
+ + E R P V ++ C P R
Sbjct: 241 GPTHGQMTVTRLVNTLKEGKRLPCPPNCPD-------------EVYQLMRKCWEFQPSNR 287
Query: 656 PSMRHVCDSLDRV 668
S +++ + + +
Sbjct: 288 TSFQNLIEGFEAL 300
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 9e-24
Identities = 65/309 (21%), Positives = 111/309 (35%), Gaps = 57/309 (18%)
Query: 375 LGKSTIGIVYKVALN---NEEAVAVRRLGNG-GWQRFKEFQTEAEAIGKIRHPNIVSLRA 430
LG G V + + VA++ L G +E EA+ + ++ +P IV L
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 431 YFWSVDEK--LLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEV 488
+ +L+ + G L + GK + S+ ++ V+ G+ +L E
Sbjct: 78 V---CQAEALMLVMEMAGGGPLHKFLVGKRE-----EIPVSNVAELLHQVSMGMKYLEE- 128
Query: 489 SPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYE 548
K +VH DL N+LL ISDFGL++ + + + P +
Sbjct: 129 --KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSY-----YTARSAGKW---PLK 178
Query: 549 FTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQIGSMELNIVQ 607
+ APE RK + + D++SYGV + E +S G+ P M+ V
Sbjct: 179 WY------------APECINFRKFSSRSDVWSYGVTMWEALSYGQKPY---KKMKGPEV- 222
Query: 608 WIQLILED-RKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLD 666
+ I + R P + + DC + RP V +
Sbjct: 223 -MAFIEQGKRMECPPECPP-------------ELYALMSDCWIYKWEDRPDFLTVEQRMR 268
Query: 667 RVNISTEQQ 675
S +
Sbjct: 269 ACYYSLASK 277
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 9e-24
Identities = 61/313 (19%), Positives = 108/313 (34%), Gaps = 61/313 (19%)
Query: 375 LGKSTIGIVYKVALNNEEA---VAVRRL--GNGGWQRFKEFQTEAEAIGKIRHPNIVSLR 429
LG G V K ++ VAV+ L E EA + ++ +P IV +
Sbjct: 25 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84
Query: 430 AYFWSVDEK--LLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHE 487
+ + +L+ + G L + R + + + ++ V+ G+ +L E
Sbjct: 85 GI---CEAESWMLVMEMAELGPLNKYLQQN------RHVKDKNIIELVHQVSMGMKYLEE 135
Query: 488 VSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPY 547
+VH DL N+LL ISDFGL++ E ++ T P
Sbjct: 136 ---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY-----YKAQTHGKW---PV 184
Query: 548 EFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQIGSMELNIV 606
++ APE K + K D++S+GV++ E S G+ P M+ + V
Sbjct: 185 KWY------------APECINYYKFSSKSDVWSFGVLMWEAFSYGQKPY---RGMKGSEV 229
Query: 607 QWIQLILED-RKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSL 665
++ + R + + C + RP V L
Sbjct: 230 --TAMLEKGERMGCPAGCPR-------------EMYDLMNLCWTYDVENRPGFAAVELRL 274
Query: 666 DR--VNISTEQQF 676
++ E
Sbjct: 275 RNYYYDVVNEGHH 287
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 1e-23
Identities = 64/300 (21%), Positives = 120/300 (40%), Gaps = 65/300 (21%)
Query: 375 LGKSTIGIVYKVALNNEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWS 434
+GK G V + VAV+ + N + F EA + ++RH N+V L
Sbjct: 201 IGKGEFGDVMLGDYRGNK-VAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLG---- 253
Query: 435 V--DEKLLIY---DYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVS 489
V +EK +Y +Y+ GSL + + L L+ V + + +L
Sbjct: 254 VIVEEKGGLYIVTEYMAKGSLVDYLRSRGR----SVLGGDCLLKFSLDVCEAMEYLEG-- 307
Query: 490 PKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEF 549
+VH DL N+L+ ++ +SDFGL + + + + L P ++
Sbjct: 308 -NNFVHRDLAARNVLVSEDNVAKVSDFGLTK--EASS---------TQDTGKL---PVKW 352
Query: 550 TALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQIGSMELNIVQW 608
T APEA + +K + K D++S+G++L E+ S G++P +I ++
Sbjct: 353 T------------APEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV----- 395
Query: 609 IQLILED-RKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDR 667
+ + + + P +V + +C H RP+ + + L+
Sbjct: 396 VPRVEKGYKMDA-----PDGCPP--------AVYDVMKNCWHLDAATRPTFLQLREQLEH 442
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 66/304 (21%), Positives = 120/304 (39%), Gaps = 51/304 (16%)
Query: 375 LGKSTIGIVYKVALNNEE-AVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFW 433
LG G VY+ VAV+ L + +EF EA + +I+HPN+V L
Sbjct: 21 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 434 SVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRY 493
+I +++ G+L + + +S L + ++ + +L K +
Sbjct: 80 REPPFYIITEFMTYGNLLDYLRECNR----QEVSAVVLLYMATQISSAMEYL---EKKNF 132
Query: 494 VHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALN 553
+H DL N L+G+N ++DFGL+RL T + G P ++T
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT-------AHAGAKF---PIKWT--- 179
Query: 554 STTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQIGSMELNIVQWIQLI 612
APE+ K + K D++++GV+L E+ + G P I ++ +L+
Sbjct: 180 ---------APESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV-----YELL 225
Query: 613 LED-RKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRVNIS 671
+D R P + V ++ C +P RPS + + + +
Sbjct: 226 EKDYRMER-----PEGCPE--------KVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 272
Query: 672 TEQQ 675
+
Sbjct: 273 SSIS 276
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 2e-23
Identities = 65/315 (20%), Positives = 112/315 (35%), Gaps = 57/315 (18%)
Query: 375 LGKSTIGIVYK---VALNNEEAVAVRRLGNGGWQRFK-EFQTEAEAIGKIRHPNIVSLRA 430
LG G V + + VA++ L G + E EA+ + ++ +P IV L
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403
Query: 431 YFWSVDEK--LLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEV 488
+ +L+ + G L + GK + S+ ++ V+ G+ +L E
Sbjct: 404 V---CQAEALMLVMEMAGGGPLHKFLVGKRE-----EIPVSNVAELLHQVSMGMKYLEE- 454
Query: 489 SPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYE 548
K +VH +L N+LL ISDFGL++ + + + P +
Sbjct: 455 --KNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSY-----YTARSAGKW---PLK 504
Query: 549 FTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQIGSMELNIVQ 607
+ APE RK + + D++SYGV + E +S G+ P M+ V
Sbjct: 505 WY------------APECINFRKFSSRSDVWSYGVTMWEALSYGQKPY---KKMKGPEV- 548
Query: 608 WIQLILED-RKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLD 666
+ I + R P + + DC + RP V +
Sbjct: 549 -MAFIEQGKRMECPPECPP-------------ELYALMSDCWIYKWEDRPDFLTVEQRMR 594
Query: 667 RVNISTEQQFMKGEE 681
S + G
Sbjct: 595 ACYYSLASKVEGGSA 609
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 3e-23
Identities = 65/324 (20%), Positives = 114/324 (35%), Gaps = 70/324 (21%)
Query: 375 LGKSTIGIVYKVALNN-----EEAVAVRRL-GNGGWQRFKEFQTEAEAIGKIRHPNIVSL 428
LG+ G V + E VAV+ L + G Q ++ E + + + H +I+
Sbjct: 39 LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98
Query: 429 RAYFWSVDEK--LLIYDYIPNGSLATAIHGKAGIISY---RPLSWSDRLRIIKGVAKGIA 483
+ L+ +Y+P GSL Y + + L + + +G+A
Sbjct: 99 KGCCEDAGAASLQLVMEYVPLGSL----------RDYLPRHSIGLAQLLLFAQQICEGMA 148
Query: 484 FLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQ 543
+LH + Y+H DL N+LL + I DFGLA+ E +
Sbjct: 149 YLHA---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEY-----YRVREDGDS- 199
Query: 544 SSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQIGSME 602
P + APE K K D++S+GV L E+++ +
Sbjct: 200 --PVFWY------------APECLKEYKFYYASDVWSFGVTLYELLTHCDSS-------Q 238
Query: 603 LNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEI-----------VSVLKIALDCVHKS 651
++++LI + MT L + E V + +C
Sbjct: 239 SPPTKFLELIGIAQGQMT-------VLRLTELLERGERLPRPDKCPAEVYHLMKNCWETE 291
Query: 652 PDKRPSMRHVCDSLDRVNISTEQQ 675
RP+ ++ L V+ + Q
Sbjct: 292 ASFRPTFENLIPILKTVHEKYQGQ 315
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 4e-23
Identities = 63/305 (20%), Positives = 113/305 (37%), Gaps = 62/305 (20%)
Query: 375 LGKSTIGIVYK-----VALNNEEAVAVRRL-GNGGWQRFKEFQTEAEAIGKIRHPNIVSL 428
LG G V+K + + V ++ + G Q F+ AIG + H +IV L
Sbjct: 21 LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 80
Query: 429 RAYFWSV---DEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFL 485
+ L+ Y+P GSL + G + + L L +AKG+ +L
Sbjct: 81 LG----LCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLL-----LNWGVQIAKGMYYL 131
Query: 486 HEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSS 545
E VH +L N+LL + ++DFG+A L ++ + +
Sbjct: 132 EE---HGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDK------QLLYSEAKT--- 179
Query: 546 PYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQIGSMELN 604
P ++ A E+ K T + D++SYGV + E+++ G P + E+
Sbjct: 180 PIKWM------------ALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEV- 226
Query: 605 IVQWIQLILED-RKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCD 663
L+ + R I V + + C + RP+ + + +
Sbjct: 227 ----PDLLEKGERLAQPQICTI-------------DVYMVMVKCWMIDENIRPTFKELAN 269
Query: 664 SLDRV 668
R+
Sbjct: 270 EFTRM 274
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 5e-23
Identities = 58/307 (18%), Positives = 108/307 (35%), Gaps = 78/307 (25%)
Query: 374 LLGKSTIGIVYKVA-LNNEEAVAVR--RLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRA 430
L+G G V+K + + ++ + N ++ + E +A+ K+ H NIV
Sbjct: 18 LIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN------EKAEREVKALAKLDHVNIVHYNG 71
Query: 431 YF---------------WSVDEKLLIY-DYIPNGSLATAIHGKAGIISYRPLSWSDRLRI 474
+ S + L I ++ G+L I + G L L +
Sbjct: 72 CWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRG----EKLDKVLALEL 127
Query: 475 IKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWE 534
+ + KG+ ++H K+ ++ DL+PSNI L + I DFGL +
Sbjct: 128 FEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKR------ 178
Query: 535 QSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLP 594
+ GT Y +PE + ++ D+Y+ G+IL E++
Sbjct: 179 TRSKGTL------------------RYMSPEQISSQDYGKEVDLYALGLILAELLHVCDT 220
Query: 595 MIQIGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDK 654
+ ++ ++DI D L K + K P+
Sbjct: 221 AFETSKFFTDLR---------DGIISDIFDKKEKTLLQK-------------LLSKKPED 258
Query: 655 RPSMRHV 661
RP+ +
Sbjct: 259 RPNTSEI 265
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 6e-23
Identities = 70/334 (20%), Positives = 126/334 (37%), Gaps = 64/334 (19%)
Query: 352 EFVPLDSQVDFDLEQLLKASAFLLGKSTIGIVY----KVALNNEEAVAVRRL-GNGGWQR 406
V S + +++ F G VY + AV+ L
Sbjct: 17 HVVIGPSSLIVHFNEVIGRGHF-------GCVYHGTLLDNDGKKIHCAVKSLNRITDIGE 69
Query: 407 FKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLL-IYDYIPNGSLATAIHGKAGIISYRP 465
+F TE + HPN++SL + L + Y+ +G L I +
Sbjct: 70 VSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNET-----HN 124
Query: 466 LSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIA 525
+ D + VAKG+ +L K++VH DL N +L + ++DFGLAR D+
Sbjct: 125 PTVKDLIGFGLQVAKGMKYLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLAR--DMY 179
Query: 526 EETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVIL 585
++ + TG L P ++ A E+ + +K T K D++S+GV+L
Sbjct: 180 DKEYYS--VHNKTGAKL---PVKWM------------ALESLQTQKFTTKSDVWSFGVLL 222
Query: 586 LEMIS-GKLPMIQIGSMELNIVQWIQLILEDR---KPMTDILDPFLAHDLDKEDEIVSVL 641
E+++ G P + + ++ +L+ R +P D + V+
Sbjct: 223 WELMTRGAPPYPDVNTFDI-----TVYLLQGRRLLQPE------------YCPDPLYEVM 265
Query: 642 KIALDCVHKSPDKRPSMRHVCDSLDRVNISTEQQ 675
L C H + RPS + + + + +
Sbjct: 266 ---LKCWHPKAEMRPSFSELVSRISAIFSTFIGE 296
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 7e-23
Identities = 60/292 (20%), Positives = 113/292 (38%), Gaps = 44/292 (15%)
Query: 374 LLGKSTIGIVYKVALNNEEAVAVRR--LGNGGWQRFKEFQTEAEAIGKIRHPN--IVSLR 429
+G V++V ++ A++ L Q ++ E + K++ + I+ L
Sbjct: 16 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 75
Query: 430 AYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVS 489
Y + ++ + N L + + + + +R K + + + +H+
Sbjct: 76 DYEITDQYIYMVMEC-GNIDLNSWLK------KKKSIDPWERKSYWKNMLEAVHTIHQ-- 126
Query: 490 PKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEF 549
VH DL+P+N L+ M + DFG+A + +T V + S GT P E
Sbjct: 127 -HGIVHSDLKPANFLIVDGM-LKLIDFGIANQ--MQPDTTSVV-KDSQVGTVNYMPP-E- 179
Query: 550 TALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQWI 609
A+ + K + K D++S G IL M GK P QI N + +
Sbjct: 180 -AIKDMS----SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII----NQISKL 230
Query: 610 QLILEDRKPMT--DILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMR 659
I++ + DI + ++ VLK C+ + P +R S+
Sbjct: 231 HAIIDPNHEIEFPDIPEK----------DLQDVLK---CCLKRDPKQRISIP 269
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 7e-23
Identities = 36/181 (19%), Positives = 62/181 (34%), Gaps = 21/181 (11%)
Query: 54 CREGQVFSLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILS 113
+ +L + + L P LS + + + LP + + L++L L+
Sbjct: 78 ATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLA 135
Query: 114 GNSFSGPVPMQIGKLKYLQVLDLSQNSFSSSIPSSIVQC---------KRLKTVVLNQNS 164
N +P I L L+ L + + +P + L+++ L
Sbjct: 136 RNPLRA-LPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTG 194
Query: 165 FTGPLPDGFATNLTALQKLDLSFNNLSGLIPNDIANLSRLRLLAQRVYVDLTYNNLSGLI 224
LP A NL L+ L + + LS L I +L +L L DL
Sbjct: 195 IRS-LPASIA-NLQNLKSLKIRNSPLSAL-GPAIHHLPKLEEL------DLRGCTALRNY 245
Query: 225 P 225
P
Sbjct: 246 P 246
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 7e-22
Identities = 41/165 (24%), Positives = 63/165 (38%), Gaps = 21/165 (12%)
Query: 73 IPADLGSLSAIGRV---------NLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPM 123
+P L S A G L SLP + N NL+SL + + S +
Sbjct: 166 LPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGP 223
Query: 124 QIGKLKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVL-NQNSFTGPLPDGFATNLTALQK 182
I L L+ LDL + + P LK ++L + ++ LP LT L+K
Sbjct: 224 AIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLT-LPLDIH-RLTQLEK 281
Query: 183 LDLSFNNLSGLIPNDIANLSRLRLLAQRVYVDLTYNNLSGLIPQN 227
LDL +P+ IA L ++ L +L + Q+
Sbjct: 282 LDLRGCVNLSRLPSLIAQLPANCII-------LVPPHLQAQLDQH 319
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 1e-20
Identities = 32/161 (19%), Positives = 59/161 (36%), Gaps = 20/161 (12%)
Query: 73 IPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGK----- 127
+P + + + + L N +LP + + + L+ L + +P +
Sbjct: 119 LPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASG 177
Query: 128 ----LKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKL 183
L LQ L L S +P+SI + LK++ + + + L +L L++L
Sbjct: 178 EHQGLVNLQSLRLEWTGIRS-LPASIANLQNLKSLKIRNSPLSA-LGPAIH-HLPKLEEL 234
Query: 184 DLSFNNLSGLIPNDIANLSRLRLLAQRVYVDLT-YNNLSGL 223
DL P + L+ L L +NL L
Sbjct: 235 DLRGCTALRNYPPIFGGRAPLKRL------ILKDCSNLLTL 269
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 2e-14
Identities = 26/103 (25%), Positives = 44/103 (42%), Gaps = 1/103 (0%)
Query: 61 SLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGP 120
SL I N L+ + + L + ++LR + P + L+ LIL S
Sbjct: 210 SLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLT 268
Query: 121 VPMQIGKLKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQN 163
+P+ I +L L+ LDL S +PS I Q +++ +
Sbjct: 269 LPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPH 311
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 8e-13
Identities = 23/150 (15%), Positives = 44/150 (29%), Gaps = 30/150 (20%)
Query: 95 GSLPVELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQVLDLSQNSFSS----------- 143
GS ++S ++L G++ P + + + D ++ +
Sbjct: 2 GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIE 61
Query: 144 --------SIPSSIVQCKRLKTVVLN--QNSFTGPLPDGFATNLTALQKLDLSFNNLSGL 193
+ + + V L PD L+ LQ + + L L
Sbjct: 62 TRTGRALKATADLLEDATQPGRVALELRSVPLPQ-FPDQAF-RLSHLQHMTIDAAGLMEL 119
Query: 194 IPNDIANLSRLRLLAQRVYVDLTYNNLSGL 223
P+ + + L L L N L L
Sbjct: 120 -PDTMQQFAGLETL------TLARNPLRAL 142
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 98.0 bits (245), Expect = 8e-23
Identities = 65/300 (21%), Positives = 121/300 (40%), Gaps = 65/300 (21%)
Query: 375 LGKSTIGIVYKVALNNEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWS 434
+GK G V + VAV+ + N + F EA + ++RH N+V L
Sbjct: 29 IGKGEFGDVMLGDYRGNK-VAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLG---- 81
Query: 435 V--DEKLLIY---DYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVS 489
V +EK +Y +Y+ GSL + + L L+ V + + +L
Sbjct: 82 VIVEEKGGLYIVTEYMAKGSLVDYLRSRGR----SVLGGDCLLKFSLDVCEAMEYL---E 134
Query: 490 PKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEF 549
+VH DL N+L+ ++ +SDFGL + + + + L P ++
Sbjct: 135 GNNFVHRDLAARNVLVSEDNVAKVSDFGLTK--EASS---------TQDTGKL---PVKW 180
Query: 550 TALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQIGSMELNIVQW 608
T APEA + +K + K D++S+G++L E+ S G++P +I ++
Sbjct: 181 T------------APEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV----- 223
Query: 609 IQLILED-RKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDR 667
+ + + + P +V ++ +C H RPS + + L+
Sbjct: 224 VPRVEKGYKMDA-----PDGCPP--------AVYEVMKNCWHLDAAMRPSFLQLREQLEH 270
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 9e-23
Identities = 62/298 (20%), Positives = 111/298 (37%), Gaps = 56/298 (18%)
Query: 383 VYKVALNNEEAVAVRRLGNGGWQRFK-EFQTEAEAIGKIRHPNIVSLRAYFWSVDEK--L 439
+Y N AVA++ N + +F EA + + HP+IV L + E
Sbjct: 35 IYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGV---ITENPVW 91
Query: 440 LIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLR 499
+I + G L + + + + L + ++ +A+L KR+VH D+
Sbjct: 92 IIMELCTLGELRSFLQVRKYSLDLASL-----ILYAYQLSTALAYLES---KRFVHRDIA 143
Query: 500 PSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRS 559
N+L+ N + DFGL+R + + T + L P ++
Sbjct: 144 ARNVLVSSNDCVKLGDFGLSR--YMEDST-----YYKASKGKL---PIKWM--------- 184
Query: 560 YYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQIGSMELNIVQWIQLILE-DRK 617
APE+ R+ T D++ +GV + E++ G P ++ N V I I +R
Sbjct: 185 ---APESINFRRFTSASDVWMFGVCMWEILMHGVKPF---QGVKNNDV--IGRIENGERL 236
Query: 618 PMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRVNISTEQQ 675
PM P ++ + C P +RP + L + + Q
Sbjct: 237 PMPPNCPP-------------TLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEKAQ 281
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 1e-22
Identities = 74/307 (24%), Positives = 134/307 (43%), Gaps = 54/307 (17%)
Query: 375 LGKSTIGIVYKVALNN-----EEAVAVRRLGNGGWQRFK-EFQTEAEAIGKIRHPNIVSL 428
+G G VYK L E VA++ L G ++ + +F EA +G+ H NI+ L
Sbjct: 52 IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRL 111
Query: 429 RAYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEV 488
++I +Y+ NG+L + K G S + +++G+A G+ +L
Sbjct: 112 EGVISKYKPMMIITEYMENGALDKFLREKDG-----EFSVLQLVGMLRGIAAGMKYLAN- 165
Query: 489 SPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYE 548
YVH DL NIL+ N+ +SDFGL+R+ + E +T+G + P
Sbjct: 166 --MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA-----TYTTSGGKI---PIR 215
Query: 549 FTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQIGSMELNIVQ 607
+T APEA RK T D++S+G+++ E+++ G+ P + + V
Sbjct: 216 WT------------APEAISYRKFTSASDVWSFGIVMWEVMTYGERPY---WELSNHEV- 259
Query: 608 WIQLILED-RKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLD 666
++ I + R P P ++ ++ + C + +RP + LD
Sbjct: 260 -MKAINDGFRLPT-----PMDCPS--------AIYQLMMQCWQQERARRPKFADIVSILD 305
Query: 667 RVNISTE 673
++ + +
Sbjct: 306 KLIRAPD 312
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 1e-22
Identities = 61/298 (20%), Positives = 103/298 (34%), Gaps = 57/298 (19%)
Query: 374 LLGKSTIGIVYKVALNNEEAVAVRRLGNGGWQRFKEFQTEAEAIGKI-RHPNIVSLRAYF 432
+LG G + + + VAV+R+ + F E + + + HPN++
Sbjct: 31 VLGHGAEGTIVYRGMFDNRDVAVKRILP---ECFSFADREVQLLRESDEHPNVIRYFCTE 87
Query: 433 WSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKR 492
+ + + +L + K + + +++ G+A LH
Sbjct: 88 KDRQFQYIAIELCA-ATLQEYVEQKDFAHLGL-----EPITLLQQTTSGLAHLHS---LN 138
Query: 493 YVHGDLRPSNILL-----GKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPY 547
VH DL+P NIL+ ++ ISDFGL + L +
Sbjct: 139 IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKK--------------------LAVGRH 178
Query: 548 EFTALNSTTSRSYYQAPE---ASKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQIGSMEL 603
F+ + + APE PT DI+S G + +IS G P + +
Sbjct: 179 SFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQA 238
Query: 604 NIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHV 661
NI+ D L P D+ + I + P KRPS +HV
Sbjct: 239 NILL--------GACSLDCLHPEKHEDVIARELIEK-------MIAMDPQKRPSAKHV 281
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 2e-22
Identities = 60/328 (18%), Positives = 113/328 (34%), Gaps = 69/328 (21%)
Query: 344 MSENMEQYEFVPLDSQVDFDLEQLLKASAFLLGKSTIGIVYKVALNNEEAVAVR---RLG 400
M E YE + +G + G K+ ++ + V G
Sbjct: 1 MPSRAEDYEVLYT------------------IGTGSYGRCQKIRRKSDGKILVWKELDYG 42
Query: 401 NGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLL--IYDYIPNGSLATAIHGKA 458
+ + +E + +++HPNIV L + +Y G LA+ I
Sbjct: 43 SMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVI--TK 100
Query: 459 GIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRY--VHGDLRPSNILLGKNMEPHISDF 516
G + L LR++ + + H S + +H DL+P+N+ L + DF
Sbjct: 101 GTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDF 160
Query: 517 GLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKW 576
GLAR+ + + + ++ GTP YY +PE +K
Sbjct: 161 GLARILN-----HDTSFAKTFVGTP------------------YYMSPEQMNRMSYNEKS 197
Query: 577 DIYSYGVILLEMISGKLPMIQIGSMELNIVQWIQLILEDR-KPMTDILDPFLAHDLDKED 635
DI+S G +L E+ + P + + I E + + +
Sbjct: 198 DIWSLGCLLYELCALMPPF-----TAFSQKELAGKIREGKFRRIPYRYSD---------- 242
Query: 636 EIVSVLKIALDCVHKSPDKRPSMRHVCD 663
E+ ++ ++ RPS+ + +
Sbjct: 243 ELNEIIT---RMLNLKDYHRPSVEEILE 267
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 99.1 bits (247), Expect = 2e-22
Identities = 61/303 (20%), Positives = 112/303 (36%), Gaps = 66/303 (21%)
Query: 374 LLGKSTIGIVYKVALNNEEAVAVRR--LGNGGWQRFKEFQTEAEAIGKIRHPN--IVSLR 429
+G V++V ++ A++ L Q ++ E + K++ + I+ L
Sbjct: 63 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 122
Query: 430 AYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVS 489
Y + D+ + + N L + + + + +R K + + + +H+
Sbjct: 123 DYEIT-DQYIYMVMECGNIDLNSWLK------KKKSIDPWERKSYWKNMLEAVHTIHQ-- 173
Query: 490 PKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEF 549
VH DL+P+N L+ M + DFG+A + +T V + S G
Sbjct: 174 -HGIVHSDLKPANFLIVDGM-LKLIDFGIANQ--MQPDTTSVV-KDSQVGAV-------- 220
Query: 550 TALNSTTSRSYYQAPEA-----------SKVRKPTQKWDIYSYGVILLEMISGKLPMIQI 598
Y PEA K + K D++S G IL M GK P QI
Sbjct: 221 ----------NYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI 270
Query: 599 GSMELNIVQWIQLILEDRKPMT--DILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRP 656
N + + I++ + DI + ++ VLK C+ + P +R
Sbjct: 271 I----NQISKLHAIIDPNHEIEFPDIPEK----------DLQDVLK---CCLKRDPKQRI 313
Query: 657 SMR 659
S+
Sbjct: 314 SIP 316
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 2e-22
Identities = 64/309 (20%), Positives = 124/309 (40%), Gaps = 53/309 (17%)
Query: 375 LGKSTIGIVYK----VALNNEEAVAVRRLGNGGWQR-FKEFQTEAEAIGKIRHPNIVSLR 429
+GK G+VY N A++ L + + F E + + HPN+++L
Sbjct: 29 IGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALI 88
Query: 430 AYFWSVDE-KLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEV 488
+ ++ Y+ +G L I + + L + VA+G+ +L
Sbjct: 89 GIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDL-----ISFGLQVARGMEYL--- 140
Query: 489 SPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYE 548
+ +++VH DL N +L ++ ++DFGLAR DI + E + Q L P +
Sbjct: 141 AEQKFVHRDLAARNCMLDESFTVKVADFGLAR--DILDR--EYYSVQQHRHARL---PVK 193
Query: 549 FTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQIGSMELNIVQ 607
+T A E+ + + T K D++S+GV+L E+++ G P I +L
Sbjct: 194 WT------------ALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDL---- 237
Query: 608 WIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVL-KIALDCVHKSPDKRPSMRHVCDSLD 666
+ + R+ L + + L ++ C P RP+ R + ++
Sbjct: 238 -THFLAQGRR-------------LPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVE 283
Query: 667 RVNISTEQQ 675
++ +
Sbjct: 284 QIVSALLGD 292
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 3e-22
Identities = 74/325 (22%), Positives = 126/325 (38%), Gaps = 88/325 (27%)
Query: 375 LGKSTIGIVYKVALNN------EEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSL 428
LG+ G V+ N + VAV+ L + K+FQ EAE + ++H +IV
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 429 RAYFWSVDEK--LLIYDYIPNGSL----------ATAIHGKAGIISYRPLSWSDRLRIIK 476
D +++++Y+ +G L A + + L S L I
Sbjct: 83 YGV--CGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 140
Query: 477 GVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQS 536
+A G+ +L + + +VH DL N L+G N+ I DFG++R D+
Sbjct: 141 QIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR--DV------------ 183
Query: 537 TTGTPLQSSPYEFTALNSTTSRSYYQ------------APEASKVRKPTQKWDIYSYGVI 584
S YY+ PE+ RK T + D++S+GVI
Sbjct: 184 -------------------YSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVI 224
Query: 585 LLEMIS-GKLPMIQIGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEI-VSVLK 642
L E+ + GK P Q+ + E+ I+ I + R L++ V
Sbjct: 225 LWEIFTYGKQPWFQLSNTEV-----IECITQGRV-------------LERPRVCPKEVYD 266
Query: 643 IALDCVHKSPDKRPSMRHVCDSLDR 667
+ L C + P +R +++ + L
Sbjct: 267 VMLGCWQREPQQRLNIKEIYKILHA 291
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 3e-22
Identities = 60/292 (20%), Positives = 113/292 (38%), Gaps = 44/292 (15%)
Query: 374 LLGKSTIGIVYKVALNNEEAVAVRR--LGNGGWQRFKEFQTEAEAIGKIRHPN--IVSLR 429
+G V++V ++ A++ L Q ++ E + K++ + I+ L
Sbjct: 35 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 94
Query: 430 AYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVS 489
Y + ++ + N L + + + + +R K + + + +H+
Sbjct: 95 DYEITDQYIYMVMEC-GNIDLNSWLK------KKKSIDPWERKSYWKNMLEAVHTIHQ-- 145
Query: 490 PKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEF 549
VH DL+P+N L+ M + DFG+A + +T V + S GT P E
Sbjct: 146 -HGIVHSDLKPANFLIVDGM-LKLIDFGIANQ--MQPDTTSVV-KDSQVGTVNYMPP-E- 198
Query: 550 TALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQWI 609
A+ + K + K D++S G IL M GK P QI N + +
Sbjct: 199 -AIKDMS----SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII----NQISKL 249
Query: 610 QLILEDRKPMT--DILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMR 659
I++ + DI + ++ VLK C+ + P +R S+
Sbjct: 250 HAIIDPNHEIEFPDIPEK----------DLQDVLK---CCLKRDPKQRISIP 288
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 4e-22
Identities = 69/304 (22%), Positives = 111/304 (36%), Gaps = 62/304 (20%)
Query: 375 LGKSTIGIVYK-----VALNNEEAVAVRRLGNG-GWQRFKEFQTEAEAIGKIRHPNIVSL 428
LG G VYK + VA++ L + KE EA + + +P++ L
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 429 RAYFWSV---DEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFL 485
+ LI +P G L + I + L L +AKG+ +L
Sbjct: 83 LG----ICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYL-----LNWCVQIAKGMNYL 133
Query: 486 HEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSS 545
+ +R VH DL N+L+ I+DFGLA+L E+ E G +
Sbjct: 134 ED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK------EYHAEGGKV--- 181
Query: 546 PYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQIGSMELN 604
P ++ A E+ R T + D++SYGV + E+++ G P I + E+
Sbjct: 182 PIKWM------------ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI- 228
Query: 605 IVQWIQLILED-RKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCD 663
++ + R P I V I + C D RP R +
Sbjct: 229 ----SSILEKGERLPQPPICTI-------------DVYMIMVKCWMIDADSRPKFRELII 271
Query: 664 SLDR 667
+
Sbjct: 272 EFSK 275
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 4e-22
Identities = 56/294 (19%), Positives = 99/294 (33%), Gaps = 65/294 (22%)
Query: 374 LLGKSTIGIVYKVALNNE--EAVAVRRLGNGGWQRFKEF-QTEAEAIGKIRHPNIVSLRA 430
+G+ + G V++ + + AV+++ R + F E A + P IV
Sbjct: 65 RVGRGSFGEVHR-MKDKQTGFQCAVKKV------RLEVFRVEELVACAGLSSPRIVP--- 114
Query: 431 YFWSV--DEKLLIY-DYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHE 487
+ +V + I+ + + GSL I L L + +G+ +LH
Sbjct: 115 LYGAVREGPWVNIFMELLEGGSLGQLIK------QMGCLPEDRALYYLGQALEGLEYLHT 168
Query: 488 VSPKRYVHGDLRPSNILLGKN-MEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSP 546
+R +HGD++ N+LL + + DFG A + GT
Sbjct: 169 ---RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTE----- 220
Query: 547 YEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIV 606
+ APE + K DI+S ++L M++G P Q
Sbjct: 221 -------------THMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRG----- 262
Query: 607 QWIQLILEDRKPMTDILDPF--LAHD-LDKEDEIVSVLKIALDCVHKSPDKRPS 657
I + P+ +I L + + + K P R S
Sbjct: 263 PLCLKIASEPPPIREIPPSCAPLTAQAIQE-------------GLRKEPVHRAS 303
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 5e-22
Identities = 48/247 (19%), Positives = 88/247 (35%), Gaps = 40/247 (16%)
Query: 361 DFDLEQLLKASAF---LLGKST-----IGIVYKVALNNEEAVAVRRLGNGGWQRFKE-FQ 411
D+ + + L F +L + + K L + + + F+
Sbjct: 32 DYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFK 91
Query: 412 TEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLATAI--HGKAGIISYRPLSWS 469
E + I I++ ++ + DE +IY+Y+ N S+ +
Sbjct: 92 NELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQ 151
Query: 470 DRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETP 529
IIK V +++H + K H D++PSNIL+ KN +SDFG +
Sbjct: 152 VIKCIIKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYM------V 203
Query: 530 EVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPE--ASKVRKPTQKWDIYSYGVILLE 587
+ + + GT + PE +++ K DI+S G+ L
Sbjct: 204 DKKI-KGSRGTY------------------EFMPPEFFSNESSYNGAKVDIWSLGICLYV 244
Query: 588 MISGKLP 594
M +P
Sbjct: 245 MFYNVVP 251
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 5e-22
Identities = 36/186 (19%), Positives = 60/186 (32%), Gaps = 19/186 (10%)
Query: 71 GFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSG-PVPMQIGKLK 129
G +++ ++L N ++ L+ L ++ L+
Sbjct: 363 GCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLR 421
Query: 130 YLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNN 189
L LD+S + L+ + + NSF T L L LDLS
Sbjct: 422 NLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQ 481
Query: 190 LSGLIPNDIANLSRLRLLAQRVYVDLTYNNLSGLIPQNAALLS------LGPTAFIGNPF 243
L L P +LS L++L ++ N L + L+ L NP+
Sbjct: 482 LEQLSPTAFNSLSSLQVL------NMASNQLKSVPDGIFDRLTSLQKIWLH-----TNPW 530
Query: 244 LCGPPL 249
C P
Sbjct: 531 DCSCPR 536
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 95.6 bits (238), Expect = 8e-21
Identities = 41/168 (24%), Positives = 71/168 (42%), Gaps = 6/168 (3%)
Query: 68 KLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELF-NASNLQSLILSGNSFSGPVPMQIG 126
L S + ++L ++ + + S+L +LIL+GN
Sbjct: 39 PLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPIQSLALGAFS 97
Query: 127 KLKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFT-GPLPDGFATNLTALQKLDL 185
L LQ L + + +S I K LK + + N LP+ F+ NLT L+ LDL
Sbjct: 98 GLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFS-NLTNLEHLDL 156
Query: 186 SFNNLSGLIPNDIANLSRLRLLAQRVYVDLTYNNLSGLIPQNAALLSL 233
S N + + D+ L ++ LL + +DL+ N ++ + P + L
Sbjct: 157 SSNKIQSIYCTDLRVLHQMPLL--NLSLDLSLNPMNFIQPGAFKEIRL 202
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 92.9 bits (231), Expect = 7e-20
Identities = 35/170 (20%), Positives = 60/170 (35%), Gaps = 14/170 (8%)
Query: 61 SLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGN--SFS 118
L + N K F L SL R+ +N + + +L+ L LS N SF
Sbjct: 308 HLELVNCKFGQFPTLKLKSLK---RLTFTSNKGGNAFS--EVDLPSLEFLDLSRNGLSFK 362
Query: 119 GPVPMQIGKLKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLT 178
G L+ LDLS N ++ S+ + ++L+ + ++ +L
Sbjct: 363 GCCSQSDFGTTSLKYLDLSFNGV-ITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLR 421
Query: 179 ALQKLDLSFNNLSGLIPNDIANLSRLRLLAQRVYVDLTYNNLSGLIPQNA 228
L LD+S + LS L +L + N+ +
Sbjct: 422 NLIYLDISHTHTRVAFNGIFNGLSSLEVL------KMAGNSFQENFLPDI 465
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 3e-19
Identities = 32/162 (19%), Positives = 58/162 (35%), Gaps = 11/162 (6%)
Query: 66 NKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQI 125
IP +L + ++L N F+ LQ L LS
Sbjct: 16 ELNFYK-IPDNLPF--STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAY 72
Query: 126 GKLKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDL 185
L +L L L+ N S + L+ +V + + L + +L L++L++
Sbjct: 73 QSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLAS-LENFPIGHLKTLKELNV 131
Query: 186 SFNNLSGL-IPNDIANLSRLRLLAQRVYVDLTYNNLSGLIPQ 226
+ N + +P +NL+ L L DL+ N + +
Sbjct: 132 AHNLIQSFKLPEYFSNLTNLEHL------DLSSNKIQSIYCT 167
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 61.7 bits (150), Expect = 4e-10
Identities = 34/143 (23%), Positives = 49/143 (34%), Gaps = 27/143 (18%)
Query: 62 LIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNA-SNLQSLILSGNSFSGP 120
L I + LS++ + + N+F + ++F NL L LS
Sbjct: 426 LDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQL 485
Query: 121 VPMQIGKLKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTAL 180
P L LQVL+++ N S +PDG LT+L
Sbjct: 486 SPTAFNSLSSLQVLNMASNQLKS-------------------------VPDGIFDRLTSL 520
Query: 181 QKLDLSFNNLSGLIPNDIANLSR 203
QK+ L N I LSR
Sbjct: 521 QKIWLHTNPWDC-SCPRIDYLSR 542
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 6e-09
Identities = 39/253 (15%), Positives = 62/253 (24%), Gaps = 65/253 (25%)
Query: 48 SWNGIT-CREGQVFS-------LIIPNKKLTGFIPADLGSLS----AIGRVNLRNNNFSG 95
+ N I + + FS L + + K+ DL L ++L N +
Sbjct: 132 AHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN- 190
Query: 96 SLPVELFNASNLQSLILSGNSFSGPVP-MQIGKLKYLQVLDLSQNSFSSS---------- 144
+ F L L L N S V I L L+V L F +
Sbjct: 191 FIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSA 250
Query: 145 -----------------------IPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQ 181
I + + L + + L+
Sbjct: 251 LEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLE 310
Query: 182 KLDLSFNNLSGLIP----------NDIANLSRLRLLAQRVYVDLTYNNLSGLIPQNAALL 231
++ F L N N L ++DL+ N LS
Sbjct: 311 LVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLS--------FK 362
Query: 232 SLGPTAFIGNPFL 244
+ G L
Sbjct: 363 GCCSQSDFGTTSL 375
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 7e-22
Identities = 62/316 (19%), Positives = 119/316 (37%), Gaps = 69/316 (21%)
Query: 374 LLGKSTIGIVYKV-ALNNEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYF 432
+LG+ G V K + A++++ ++ +E + + H +V A +
Sbjct: 13 VLGQGAFGQVVKARNALDSRYYAIKKI-RHTEEKLSTILSEVMLLASLNHQYVVRYYAAW 71
Query: 433 ----------WSVDEKLLIY---DYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVA 479
+V +K ++ +Y NG+L IH + R W R+ + +
Sbjct: 72 LERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIH-SENLNQQRDEYW----RLFRQIL 126
Query: 480 KGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWE----- 534
+ ++++H + +H DL+P NI + ++ I DFGLA+ + + ++ +
Sbjct: 127 EALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGS 183
Query: 535 ----QSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPT--QKWDIYSYGVILLEM 588
S GT Y A E +K D+YS G+I EM
Sbjct: 184 SDNLTSAIGTA------------------MYVATEVLD-GTGHYNEKIDMYSLGIIFFEM 224
Query: 589 ISGKLPMIQIGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCV 648
I G +NI++ + R + F + + E +I+ +
Sbjct: 225 IYPFST----GMERVNILKKL------RSVSIEFPPDFDDNKMKVEKKIIR------LLI 268
Query: 649 HKSPDKRPSMRHVCDS 664
P+KRP R + +S
Sbjct: 269 DHDPNKRPGARTLLNS 284
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 8e-22
Identities = 60/323 (18%), Positives = 115/323 (35%), Gaps = 86/323 (26%)
Query: 375 LGKSTIGIVYKVALNNEE----AVAVRRL--GNGGWQRFKEFQTEAEAIGKIRHPNIVSL 428
LGK G V + L E+ VAV+ L +EF EA + + HP++ L
Sbjct: 31 LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKL 90
Query: 429 ------RAYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGI 482
+ ++I ++ +G L + + L +R + +A G+
Sbjct: 91 VGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGM 150
Query: 483 AFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPL 542
+L S + ++H DL N +L ++M ++DFGL+R I
Sbjct: 151 EYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSR--KIYSG--------------- 190
Query: 543 QSSPYEFTALNSTTSRSYYQ------------APEASKVRKPTQKWDIYSYGVILLEMIS 590
YY+ A E+ T D++++GV + E+++
Sbjct: 191 ----------------DYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMT 234
Query: 591 -GKLPMIQIGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDK----EDEIVSVLKIAL 645
G+ P I + E+ ++ + L + +E+ ++
Sbjct: 235 RGQTPYAGIENAEI-----YNYLIGGNR-------------LKQPPECMEEVYDLM---Y 273
Query: 646 DCVHKSPDKRPSMRHVCDSLDRV 668
C P +RPS + L+ +
Sbjct: 274 QCWSADPKQRPSFTCLRMELENI 296
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 9e-22
Identities = 67/310 (21%), Positives = 115/310 (37%), Gaps = 60/310 (19%)
Query: 375 LGKSTIGIVYKVALNNEEA----VAVRRLGNGGWQRFK-EFQTEAEAIGKIRHPNIVSLR 429
LG+ G VY+ N + VAV+ K +F +EA + + HP+IV L
Sbjct: 20 LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 79
Query: 430 AYFWSVDEK--LLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHE 487
++E+ +I + P G L + + L + + K +A+L
Sbjct: 80 GI---IEEEPTWIIMELYPYGELGHYLERNKNSLKVLTL-----VLYSLQICKAMAYLES 131
Query: 488 VSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPY 547
VH D+ NIL+ + DFGL+R I +E + T L P
Sbjct: 132 ---INCVHRDIAVRNILVASPECVKLGDFGLSR--YIEDED-----YYKASVTRL---PI 178
Query: 548 EFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQIGSMELNIV 606
++ +PE+ R+ T D++ + V + E++S GK P + + ++
Sbjct: 179 KWM------------SPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDV--- 223
Query: 607 QWIQLILE-DRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSL 665
I ++ + DR P P L + + C P RP + SL
Sbjct: 224 --IGVLEKGDRLPK-----PDLCPP--------VLYTLMTRCWDYDPSDRPRFTELVCSL 268
Query: 666 DRVNISTEQQ 675
V +
Sbjct: 269 SDVYQMEKDI 278
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 1e-21
Identities = 71/322 (22%), Positives = 120/322 (37%), Gaps = 83/322 (25%)
Query: 375 LGKSTIGIVYKVALNN------EEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSL 428
LG+ G V+ +N + VAV+ L ++FQ EAE + ++H +IV
Sbjct: 49 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 429 RAYFWSVDEKLLIYDYIPNGSL---------ATAIHGKAGIISYRPLSWSDRLRIIKGVA 479
L++++Y+ +G L + ++ PL L + VA
Sbjct: 109 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 168
Query: 480 KGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTG 539
G+ +L +VH DL N L+G+ + I DFG++R DI
Sbjct: 169 AGMVYLAG---LHFVHRDLATRNCLVGQGLVVKIGDFGMSR--DIYST------------ 211
Query: 540 TPLQSSPYEFTALNSTTSRSYYQ------------APEASKVRKPTQKWDIYSYGVILLE 587
YY+ PE+ RK T + D++S+GV+L E
Sbjct: 212 -------------------DYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWE 252
Query: 588 MIS-GKLPMIQIGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVL-KIAL 645
+ + GK P Q+ + E I I + R+ L++ + I
Sbjct: 253 IFTYGKQPWYQLSNTEA-----IDCITQGRE-------------LERPRACPPEVYAIMR 294
Query: 646 DCVHKSPDKRPSMRHVCDSLDR 667
C + P +R S++ V L
Sbjct: 295 GCWQREPQQRHSIKDVHARLQA 316
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 95.6 bits (238), Expect = 1e-21
Identities = 56/239 (23%), Positives = 93/239 (38%), Gaps = 50/239 (20%)
Query: 374 LLGKSTIGIVYKVA-LNNEEAVAVRRLGNGGWQRFKE-FQTEAEAIGKIRHPNIVSLRAY 431
+LG+ V++ + A++ N + R + E E + K+ H NIV L A
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 432 FWSVDEKL--LIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVS 489
+ LI ++ P GSL T + + + L S+ L +++ V G+ L E
Sbjct: 76 EEETTTRHKVLIMEFCPCGSLYTVLEEPS---NAYGLPESEFLIVLRDVVGGMNHLRE-- 130
Query: 490 PKRYVHGDLRPSNILLGKNMEPH----ISDFGLARLADIAEETPEVHWEQSTT--GTPLQ 543
VH +++P NI+ + ++DFG AR + EQ + GT
Sbjct: 131 -NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE--------DDEQFVSLYGTE-- 179
Query: 544 SSPYEFTALNSTTSRSYYQAPE---ASKVRKPTQKW-----DIYSYGVILLEMISGKLP 594
Y P+ + +RK QK D++S GV +G LP
Sbjct: 180 ----------------EYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 1e-21
Identities = 61/319 (19%), Positives = 119/319 (37%), Gaps = 79/319 (24%)
Query: 375 LGKSTIGIVYKVALNNEE----AVAVRRL--GNGGWQRFKEFQTEAEAIGKIRHPNIVSL 428
LG+ G V + L E+ VAV+ + N + +EF +EA + HPN++ L
Sbjct: 42 LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRL 101
Query: 429 -----RAYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIA 483
+ + ++I ++ G L T + + + L+ + +A G+
Sbjct: 102 LGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGME 161
Query: 484 FLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQ 543
+L S + ++H DL N +L +M ++DFGL++ I
Sbjct: 162 YL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSK--KIYSG---------------- 200
Query: 544 SSPYEFTALNSTTSRSYYQ------------APEASKVRKPTQKWDIYSYGVILLEMIS- 590
YY+ A E+ R T K D++++GV + E+ +
Sbjct: 201 ---------------DYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATR 245
Query: 591 GKLPMIQIGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVL-KIALDCVH 649
G P + + E+ +L + L + ++ + L +I C
Sbjct: 246 GMTPYPGVQNHEM-----YDYLLHGHR-------------LKQPEDCLDELYEIMYSCWR 287
Query: 650 KSPDKRPSMRHVCDSLDRV 668
P RP+ + L+++
Sbjct: 288 TDPLDRPTFSVLRLQLEKL 306
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 1e-21
Identities = 74/319 (23%), Positives = 123/319 (38%), Gaps = 78/319 (24%)
Query: 374 LLGKSTIGIVYKVALNNEEA---VAVRRLGNGGWQR-FKEFQTEAEAIGKI-RHPNIVSL 428
++G+ G V K + + A++R+ + ++F E E + K+ HPNI++L
Sbjct: 32 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 91
Query: 429 RAYFWSVDEK--LLIYDYIPNGSL----------ATAIHGKAGIISYRPLSWSDRLRIIK 476
L +Y P+G+L T + LS L
Sbjct: 92 LG--ACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149
Query: 477 GVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPE----VH 532
VA+G+ +L S K+++H DL NIL+G+N I+DFGL+R ++ + V
Sbjct: 150 DVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVR 206
Query: 533 WEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-G 591
W A E+ T D++SYGV+L E++S G
Sbjct: 207 W----------------------------MAIESLNYSVYTTNSDVWSYGVLLWEIVSLG 238
Query: 592 KLPMIQIGSMELNIVQWIQLILEDR---KPMTDILDPFLAHDLDKEDEIVSVLKIALDCV 648
P + EL + + + KP+ + D E V + C
Sbjct: 239 GTPYCGMTCAEL-----YEKLPQGYRLEKPL----------NCDDE-----VYDLMRQCW 278
Query: 649 HKSPDKRPSMRHVCDSLDR 667
+ P +RPS + SL+R
Sbjct: 279 REKPYERPSFAQILVSLNR 297
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 96.4 bits (240), Expect = 1e-21
Identities = 69/311 (22%), Positives = 123/311 (39%), Gaps = 57/311 (18%)
Query: 375 LGKSTIGIVY----KVALNNEEAVAVRRL-GNGGWQRFKEFQTEAEAIGKIRHPNIVSLR 429
+G+ G VY + AV+ L +F TE + HPN++SL
Sbjct: 97 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 156
Query: 430 AYFWSVDEKLL-IYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEV 488
+ L + Y+ +G L I + + D + VAKG+ FL
Sbjct: 157 GICLRSEGSPLVVLPYMKHGDLRNFIRNET-----HNPTVKDLIGFGLQVAKGMKFLAS- 210
Query: 489 SPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYE 548
K++VH DL N +L + ++DFGLAR D+ ++ + + TG L P +
Sbjct: 211 --KKFVHRDLAARNCMLDEKFTVKVADFGLAR--DMYDKEFDSV--HNKTGAKL---PVK 261
Query: 549 FTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQIGSMELNIVQ 607
+ A E+ + +K T K D++S+GV+L E+++ G P + + ++
Sbjct: 262 WM------------ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI---- 305
Query: 608 WIQLILEDR---KPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664
+L+ R +P D + V+ L C H + RPS +
Sbjct: 306 -TVYLLQGRRLLQPE------------YCPDPLYEVM---LKCWHPKAEMRPSFSELVSR 349
Query: 665 LDRVNISTEQQ 675
+ + + +
Sbjct: 350 ISAIFSTFIGE 360
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 1e-21
Identities = 48/228 (21%), Positives = 85/228 (37%), Gaps = 41/228 (17%)
Query: 374 LLGKSTIGIVYK---VALNNEEAVAVRRLGNGGWQRFKE-FQTEAEAIGKIRHPNIVSLR 429
L+G+ +G VY+ A+ + F+ Q EA G+++ P++V +
Sbjct: 41 LVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPI- 99
Query: 430 AYFWSVDEKLLIY---DYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLH 486
+ + + L Y I LA + + PL+ + I++ + + H
Sbjct: 100 -HDFGEIDGQL-YVDMRLINGVDLAAMLRRQG------PLAPPRAVAIVRQIGSALDAAH 151
Query: 487 EVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSP 546
H D++P NIL+ + ++ DFG+A
Sbjct: 152 A---AGATHRDVKPENILVSADDFAYLVDFGIASATT------------DEK-------- 188
Query: 547 YEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLP 594
T L +T YY APE T + DIY+ +L E ++G P
Sbjct: 189 --LTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPP 234
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 95.9 bits (238), Expect = 2e-21
Identities = 38/324 (11%), Positives = 75/324 (23%), Gaps = 76/324 (23%)
Query: 374 LLGKSTIGIVYKVA-LNNEEAVAV---RRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLR 429
L +V+ V + E A+ + A ++ + R
Sbjct: 69 PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128
Query: 430 AYF--------------------------WSVDEKLLIYDYIPNGSLATAIHGKAGIISY 463
++V LL+ + L + +
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPA-ASVDLELLFSTLDFVYVF 187
Query: 464 R-PLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLA 522
R + + + A L K VHG P N+ + + + D
Sbjct: 188 RGDEGILALHILTAQLIRLAANLQS---KGLVHGHFTPDNLFIMPDGRLMLGDVSALWKV 244
Query: 523 DIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKP--TQKWDIYS 580
+ P+ Y E T + +
Sbjct: 245 GTR---------GPASSVPV-----------------TYAPREFLNASTATFTHALNAWQ 278
Query: 581 YGVILLEMISGKLPMIQIGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSV 640
G+ + + LP + ++ R P TD L L D + ++
Sbjct: 279 LGLSIYRVWCLFLPF----GLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLP--DFVKTL 332
Query: 641 LKIALDCVHKSPDKRPS----MRH 660
+ L+ +R M
Sbjct: 333 IGRFLN---FDRRRRLLPLEAMET 353
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 2e-21
Identities = 60/321 (18%), Positives = 106/321 (33%), Gaps = 92/321 (28%)
Query: 375 LGKSTIGIVYK--------VALNNEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIV 426
LG+ T ++K +E V ++ L + F A + K+ H ++V
Sbjct: 16 LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 427 SLRAYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLH 486
DE +L+ +++ GSL T + ++ +L + K +A + FL
Sbjct: 76 LNYGVCVCGDENILVQEFVKFGSLDTYLKKNKN-----CINILWKLEVAKQLAAAMHFLE 130
Query: 487 EVSPKRYVHGDLRPSNILLGKNMEPH--------ISDFGLARLADIAEETPEVHWEQSTT 538
E +HG++ NILL + + +SD G++ + +
Sbjct: 131 E---NTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISI--TVLPK----------- 174
Query: 539 GTPLQSSPYEFTALNSTTSRSYYQ------APEASKVRKP-TQKWDIYSYGVILLEMIS- 590
Q PE + K D +S+G L E+ S
Sbjct: 175 --------------------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSG 214
Query: 591 GKLPMIQIGSMELNIVQWIQLILEDR----KPMTDILDPFLAHDLDKEDEIVSVLKIALD 646
G P+ + S +Q EDR P + + +
Sbjct: 215 GDKPLSALDSQRK-----LQFY-EDRHQLPAPKAA-----------------ELANLINN 251
Query: 647 CVHKSPDKRPSMRHVCDSLDR 667
C+ PD RPS R + L+
Sbjct: 252 CMDYEPDHRPSFRAIIRDLNS 272
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 3e-21
Identities = 44/222 (19%), Positives = 88/222 (39%), Gaps = 37/222 (16%)
Query: 381 GIVYK---VALNNEEAVAVRRLGNGGWQRFKE-FQTEAEAIGKIRHPNIVSLRAYFWSVD 436
V+ + + + AV V R F F+ EA+ + HP IV++ +
Sbjct: 26 SEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET 85
Query: 437 EKLLIY----DYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKR 492
+ +Y+ +L +H + P++ + +I + + F H+
Sbjct: 86 PAGPLPYIVMEYVDGVTLRDIVH------TEGPMTPKRAIEVIADACQALNFSHQ---NG 136
Query: 493 YVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTAL 552
+H D++P+NI++ + DFG+AR + + V + GT
Sbjct: 137 IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNS--VTQTAAVIGTA----------- 183
Query: 553 NSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLP 594
Y +PE ++ + D+YS G +L E+++G+ P
Sbjct: 184 -------QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 94.3 bits (234), Expect = 5e-21
Identities = 39/302 (12%), Positives = 86/302 (28%), Gaps = 48/302 (15%)
Query: 374 LLGKSTIGIVYKV------ALNNEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVS 427
LLG+ VY+ N++ ++ F E + +
Sbjct: 72 LLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMK 131
Query: 428 LRAYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHE 487
+ + +L+ + G+L AI+ + + + + I +H+
Sbjct: 132 FYSAHLFQNGSVLVGELYSYGTLLNAIN-LYKNTPEKVMPQGLVISFAMRMLYMIEQVHD 190
Query: 488 VSPKRYVHGDLRPSNILLGKNMEPH-----------ISDFGLARLADIAEETPEVHWEQS 536
+HGD++P N +LG + D G + + + +
Sbjct: 191 ---CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFT---A 244
Query: 537 TTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMI 596
T +Q E + + D + + M+ G +
Sbjct: 245 KCETS------------------GFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKV 286
Query: 597 QIGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEI-VSVLKIALDCVHKSPDKR 655
+ E + R P D+ + F L+ D + L + + K +
Sbjct: 287 KNEGGECKPEGLFR-----RLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQH 341
Query: 656 PS 657
+
Sbjct: 342 YT 343
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 96.5 bits (240), Expect = 6e-21
Identities = 60/298 (20%), Positives = 110/298 (36%), Gaps = 56/298 (18%)
Query: 383 VYKVALNNEEAVAVRRLGNGGWQRFK-EFQTEAEAIGKIRHPNIVSLRAYFWSVDEK--L 439
+Y N AVA++ N + +F EA + + HP+IV L + E
Sbjct: 410 IYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGV---ITENPVW 466
Query: 440 LIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLR 499
+I + G L + + + L + + ++ +A+L KR+VH D+
Sbjct: 467 IIMELCTLGELRSFLQVRKF-----SLDLASLILYAYQLSTALAYLES---KRFVHRDIA 518
Query: 500 PSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRS 559
N+L+ N + DFGL+R + + T + L P ++
Sbjct: 519 ARNVLVSSNDCVKLGDFGLSR--YMEDST-----YYKASKGKL---PIKWM--------- 559
Query: 560 YYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQIGSMELNIVQWIQLILED-RK 617
APE+ R+ T D++ +GV + E++ G P + + ++ I I R
Sbjct: 560 ---APESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV-----IGRIENGERL 611
Query: 618 PMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRVNISTEQQ 675
PM P ++ + C P +RP + L + + Q
Sbjct: 612 PMPPNCPP-------------TLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEKLQ 656
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 95.3 bits (237), Expect = 2e-20
Identities = 48/298 (16%), Positives = 95/298 (31%), Gaps = 75/298 (25%)
Query: 381 GIVYK---VALNNEEAVAVRRLGNGGWQRFKE-FQTEAEAIGKIRHPNIVSLRAY--FWS 434
G +Y +N V ++ L + G + E + + ++ HP+IV + +
Sbjct: 94 GWIYLALDRNVNGRP-VVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTD 152
Query: 435 VDEKLLIY---DYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPK 491
+ Y +Y+ SL + L ++ + + + +++LH
Sbjct: 153 RHGDPVGYIVMEYVGGQSLKRSKGQ--------KLPVAEAIAYLLEILPALSYLHS---I 201
Query: 492 RYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTA 551
V+ DL+P NI+L + + + D G + ++ GTP
Sbjct: 202 GLVYNDLKPENIMLTEE-QLKLIDLGAVSRIN---SFGYLY------GTP---------- 241
Query: 552 LNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQWIQL 611
+QAPE + PT DIY+ G L + L
Sbjct: 242 --------GFQAPEIVR-TGPTVATDIYTVGRTLAALTLDLPTRNGRYVDGLP------- 285
Query: 612 ILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRP-SMRHVCDSLDRV 668
+ P+ D + ++ + P +R + + L V
Sbjct: 286 ---EDDPVLKTYDSY--------GRLL------RRAIDPDPRQRFTTAEEMSAQLTGV 326
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 92.3 bits (229), Expect = 2e-20
Identities = 52/264 (19%), Positives = 83/264 (31%), Gaps = 52/264 (19%)
Query: 409 EFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLI-YDYIPNGSLATAIHGKAGIISYRPLS 467
+ + N V S L I +L ++ + +
Sbjct: 107 APSVKIRRMDPFSTKNTVGQLQPS-SPKVYLYIQMQLCRKENLKDWMNRRCSL---EDRE 162
Query: 468 WSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEE 527
L I +A+ + FLH K +H DL+PSNI + + DFGL D EE
Sbjct: 163 HGVCLHIFIQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEE 219
Query: 528 TPEVHWEQSTT-------GTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYS 580
V GT Y +PE + K DI+S
Sbjct: 220 EQTVLTPMPAYATHTGQVGTK------------------LYMSPEQIHGNNYSHKVDIFS 261
Query: 581 YGVILLEMISGKLPMIQIGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSV 640
G+IL E++ ME +++I + R +E +V
Sbjct: 262 LGLILFELLYSFST-----QMER-----VRIITDVRNL---KFPLLFTQKYPQEHMMVQ- 307
Query: 641 LKIALDCVHKSPDKRPSMRHVCDS 664
D + SP +RP + ++
Sbjct: 308 -----DMLSPSPTERPEATDIIEN 326
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 93.0 bits (231), Expect = 2e-20
Identities = 56/237 (23%), Positives = 93/237 (39%), Gaps = 46/237 (19%)
Query: 374 LLGKSTIGIVYKVA-LNNEEAVAVRRLGNGGWQRFKE-FQTEAEAIGKIRHPNIVSLRAY 431
+LG+ V++ + A++ N + R + E E + K+ H NIV L A
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 432 FWSVDEKL--LIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVS 489
+ LI ++ P GSL T + + + L S+ L +++ V G+ L E
Sbjct: 76 EEETTTRHKVLIMEFCPCGSLYTVLEEPS---NAYGLPESEFLIVLRDVVGGMNHLRE-- 130
Query: 490 PKRYVHGDLRPSNILLGKNMEPH----ISDFGLARLADIAEETPEVHWEQSTTGTPLQSS 545
VH +++P NI+ + ++DFG AR + E+ S GT
Sbjct: 131 -NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQF------VSLYGTE---- 179
Query: 546 PYEFTALNSTTSRSYYQAPE---ASKVRKPTQKW-----DIYSYGVILLEMISGKLP 594
Y P+ + +RK QK D++S GV +G LP
Sbjct: 180 --------------EYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 90.3 bits (225), Expect = 4e-20
Identities = 68/325 (20%), Positives = 118/325 (36%), Gaps = 89/325 (27%)
Query: 375 LGKSTIGIVYKVALNN------EEAVAVRRLGNGGWQRFK-EFQTEAEAIGKIRHPNIVS 427
LG+ G VYK L +AVA++ L + + EF+ EA +++HPN+V
Sbjct: 17 LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 76
Query: 428 LRAYFWSVDEK--LLIYDYIPNGSL----------ATAIHGKAGIISYRPLSWSDRLRII 475
L ++ +I+ Y +G L + L D + ++
Sbjct: 77 LLGV--VTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 134
Query: 476 KGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQ 535
+A G+ +L S VH DL N+L+ + ISD GL R ++
Sbjct: 135 AQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFR--EVYAA-------- 181
Query: 536 STTGTPLQSSPYEFTALNSTTSRSYYQ------------APEASKVRKPTQKWDIYSYGV 583
YY+ APEA K + DI+SYGV
Sbjct: 182 -----------------------DYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGV 218
Query: 584 ILLEMIS-GKLPMIQIGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVL- 641
+L E+ S G P + ++ +++I L D+ + +
Sbjct: 219 VLWEVFSYGLQPYCGYSNQDV-----VEMIRNR-------------QVLPCPDDCPAWVY 260
Query: 642 KIALDCVHKSPDKRPSMRHVCDSLD 666
+ ++C ++ P +RP + + L
Sbjct: 261 ALMIECWNEFPSRRPRFKDIHSRLR 285
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 5e-20
Identities = 64/318 (20%), Positives = 108/318 (33%), Gaps = 79/318 (24%)
Query: 375 LGKSTIGIVYKVALNN------EEAVAVRRLGNGGWQR-FKEFQTEAEAIGKIRHPNIVS 427
LG G VY+ ++ VAV+ L ++ +F EA I K H NIV
Sbjct: 38 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 428 LRAYFWSVDEKLLIYDYIPNGSLATAIHGKAGIIS-YRPLSWSDRLRIIKGVAKGIAFLH 486
+ ++ + + G L + + S L+ D L + + +A G +L
Sbjct: 98 CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL- 156
Query: 487 EVSPKRYVHGDLRPSNILLGKNMEPH---ISDFGLARLADIAEETPEVHWEQSTTGTPLQ 543
++H D+ N LL I DFG+AR DI
Sbjct: 157 --EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR--DIYRA---------------- 196
Query: 544 SSPYEFTALNSTTSRSYYQ------------APEASKVRKPTQKWDIYSYGVILLEMIS- 590
SYY+ PEA T K D +S+GV+L E+ S
Sbjct: 197 ---------------SYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSL 241
Query: 591 GKLPMIQIGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVL-KIALDCVH 649
G +P + E+ ++ + + +D + +I C
Sbjct: 242 GYMPYPSKSNQEV-----LEFVTSGGR-------------MDPPKNCPGPVYRIMTQCWQ 283
Query: 650 KSPDKRPSMRHVCDSLDR 667
P+ RP+ + + ++
Sbjct: 284 HQPEDRPNFAIILERIEY 301
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 90.3 bits (224), Expect = 5e-20
Identities = 42/206 (20%), Positives = 61/206 (29%), Gaps = 23/206 (11%)
Query: 40 NNSNEDPCSWNGITCREGQVFSLIIPNKKLTGFIPADLGSLSAIGRVNLR----NNNFSG 95
N + + L + N A L L + L+ S
Sbjct: 104 NLEVTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSL 162
Query: 96 SLPVELFNA-SNLQSLILSGNSFSGPVPMQI----GKLKYLQVLDLSQNSFSS---SIPS 147
+ E L +L LS N G + K LQVL L + +
Sbjct: 163 NFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSA 222
Query: 148 SIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSGLIPNDIANLSRLRLL 207
+L+ + L+ NS + L L+LSF L + A LS L
Sbjct: 223 LAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQVPKGLPAKLSVL--- 279
Query: 208 AQRVYVDLTYNNLSGLIPQNAALLSL 233
DL+YN L P L +
Sbjct: 280 ------DLSYNRLDR-NPSPDELPQV 298
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 67.2 bits (164), Expect = 3e-12
Identities = 29/159 (18%), Positives = 44/159 (27%), Gaps = 28/159 (17%)
Query: 61 SLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVE----LFNASNLQSLILSGN- 115
L I F + A+ ++L +N G + LQ L L
Sbjct: 153 VLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAG 212
Query: 116 --SFSGPVPMQIGKLKYLQVLDLSQNSFSSSIPSSI-VQCKRLKTVVLNQNSFTGPLPDG 172
+ SG LQ LDLS NS + + +L ++ L+ +P G
Sbjct: 213 METPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQ-VPKG 271
Query: 173 -------------------FATNLTALQKLDLSFNNLSG 192
L + L L N
Sbjct: 272 LPAKLSVLDLSYNRLDRNPSPDELPQVGNLSLKGNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 64.5 bits (157), Expect = 2e-11
Identities = 22/159 (13%), Positives = 49/159 (30%), Gaps = 14/159 (8%)
Query: 87 NLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVP---MQIGKLKYLQVLDLSQNSFSS 143
+ ++ + +L+ L + + +++ + LQ L L +
Sbjct: 50 KRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTG 109
Query: 144 SIPSSIVQC--KRLKTVVLNQNSFTGP---LPDGFATNLTALQKLDLSFNNLSGLIPNDI 198
+ P +++ L + L S+ L + L+ L ++ + +
Sbjct: 110 TAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQV 169
Query: 199 ANLSRLRLLAQRVYVDLTYNNLSGLIPQNAALLSLGPTA 237
L L DL+ N G +AL L
Sbjct: 170 RVFPALSTL------DLSDNPELGERGLISALCPLKFPT 202
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 61.1 bits (148), Expect = 3e-10
Identities = 24/103 (23%), Positives = 38/103 (36%), Gaps = 6/103 (5%)
Query: 67 KKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELF-NASNLQSLILSGNSFSGPVPMQI 125
+ +G A + + ++L +N+ + S L SL LS VP +
Sbjct: 214 ETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQ-VPKGL 272
Query: 126 GKLKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGP 168
L VLDLS N PS + ++ + L N F
Sbjct: 273 --PAKLSVLDLSYNRLDR-NPSPD-ELPQVGNLSLKGNPFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 46.4 bits (110), Expect = 2e-05
Identities = 29/145 (20%), Positives = 43/145 (29%), Gaps = 8/145 (5%)
Query: 1 SLVLLILSYIALMGSANDEGLALLSFKQAIRNFPEGNNWNNSNEDPCSWNGITCREGQVF 60
+L L LS +G ++ N + CS Q+
Sbjct: 174 ALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSAL--AAARVQLQ 231
Query: 61 SLIIPNKKLTGFIPADLGS-LSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSG 119
L + + L A S + +NL +P L + L L LS N
Sbjct: 232 GLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLP--AKLSVLDLSYNRLDR 288
Query: 120 PVPMQIGKLKYLQVLDLSQNSFSSS 144
P +L + L L N F S
Sbjct: 289 -NP-SPDELPQVGNLSLKGNPFLDS 311
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 90.7 bits (226), Expect = 6e-20
Identities = 31/168 (18%), Positives = 70/168 (41%), Gaps = 18/168 (10%)
Query: 58 QVFSLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSF 117
+ ++ +T + L +I ++ + + S+ + +NL+ L L+GN
Sbjct: 23 EGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVA-SIQ-GIEYLTNLEYLNLNGNQI 78
Query: 118 SGPVPMQIGKLKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNL 177
+ P + L L L + N + S++ L+ + LN+++ + P NL
Sbjct: 79 TDISP--LSNLVKLTNLYIGTNKITD--ISALQNLTNLRELYLNEDNISDISPLA---NL 131
Query: 178 TALQKLDLSFNNLSGLIPNDIANLSRLRLLAQRVYVDLTYNNLSGLIP 225
T + L+L N+ + ++N++ L L +T + + + P
Sbjct: 132 TKMYSLNLGANHNLSDLSP-LSNMTGLNYL------TVTESKVKDVTP 172
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 3e-19
Identities = 34/161 (21%), Positives = 64/161 (39%), Gaps = 17/161 (10%)
Query: 61 SLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGP 120
++T P + +++ + + + NN + P L N S L L + N S
Sbjct: 203 YFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISDI 258
Query: 121 VPMQIGKLKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTAL 180
+ L L++L++ N S S + +L ++ LN N + LT L
Sbjct: 259 NA--VKDLTKLKMLNVGSNQISD--ISVLNNLSQLNSLFLNNNQLGNEDMEVIG-GLTNL 313
Query: 181 QKLDLSFNNLSGLIPNDIANLSRLRLLAQRVYVDLTYNNLS 221
L LS N+++ + P +A+LS++ D +
Sbjct: 314 TTLFLSQNHITDIRP--LASLSKMDSA------DFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 6e-19
Identities = 35/165 (21%), Positives = 65/165 (39%), Gaps = 17/165 (10%)
Query: 61 SLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGP 120
SL + ++ P L SL+++ N + P + N + L SL + N +
Sbjct: 181 SLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDL 236
Query: 121 VPMQIGKLKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTAL 180
P + L L L++ N S +++ +LK + + N + NL+ L
Sbjct: 237 SP--LANLSQLTWLEIGTNQISD--INAVKDLTKLKMLNVGSNQISDI--SVLN-NLSQL 289
Query: 181 QKLDLSFNNLSGLIPNDIANLSRLRLLAQRVYVDLTYNNLSGLIP 225
L L+ N L I L+ L + L+ N+++ + P
Sbjct: 290 NSLFLNNNQLGNEDMEVIGGLTNLT------TLFLSQNHITDIRP 328
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 86.8 bits (216), Expect = 1e-18
Identities = 36/184 (19%), Positives = 72/184 (39%), Gaps = 23/184 (12%)
Query: 47 CSWNGITCREG-----QVFSLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVEL 101
+ + +G + L + ++T P L +L + + + N + + L
Sbjct: 51 VAGEKVASIQGIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKIT-DIS-AL 106
Query: 102 FNASNLQSLILSGNSFSGPVPMQIGKLKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLN 161
N +NL+ L L+ ++ S P + L + L+L N S S + L + +
Sbjct: 107 QNLTNLRELYLNEDNISDISP--LANLTKMYSLNLGANHNLS-DLSPLSNMTGLNYLTVT 163
Query: 162 QNSFTGPLPDGFATNLTALQKLDLSFNNLSGLIPNDIANLSRLRLLAQRVYVDLTYNNLS 221
++ P NLT L L L++N + + P +A+L+ L N ++
Sbjct: 164 ESKVKDVTPIA---NLTDLYSLSLNYNQIEDISP--LASLTSLHYF------TAYVNQIT 212
Query: 222 GLIP 225
+ P
Sbjct: 213 DITP 216
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 83.7 bits (208), Expect = 1e-17
Identities = 34/173 (19%), Positives = 70/173 (40%), Gaps = 19/173 (10%)
Query: 61 SLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGP 120
+L + P L+ R L+ + + + E ++ L+++G +
Sbjct: 4 TLATLPAPINQIFP--DADLAEGIRAVLQKASVTDVVTQE--ELESITKLVVAGEKVASI 59
Query: 121 VPMQIGKLKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTAL 180
I L L+ L+L+ N + P + +L + + N T NLT L
Sbjct: 60 QG--IEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITDI--SALQ-NLTNL 112
Query: 181 QKLDLSFNNLSGLIPNDIANLSRLRLLAQRVYVDLTYNNLSGLIPQNAALLSL 233
++L L+ +N+S + P +ANL+++ L +L N+ + + + L
Sbjct: 113 RELYLNEDNISDISP--LANLTKMYSL------NLGANHNLSDLSPLSNMTGL 157
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 60.6 bits (148), Expect = 5e-10
Identities = 18/119 (15%), Positives = 41/119 (34%), Gaps = 15/119 (12%)
Query: 107 LQSLILSGNSFSGPVPMQIGKLKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFT 166
+L + P L L + S + + + + + +V+
Sbjct: 2 AATLATLPAPINQIFP--DADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVA 57
Query: 167 GPLPDGFATNLTALQKLDLSFNNLSGLIPNDIANLSRLRLLAQRVYVDLTYNNLSGLIP 225
LT L+ L+L+ N ++ + P ++NL +L L + N ++ +
Sbjct: 58 SIQGIE---YLTNLEYLNLNGNQITDISP--LSNLVKLTNL------YIGTNKITDISA 105
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 7e-20
Identities = 69/323 (21%), Positives = 109/323 (33%), Gaps = 63/323 (19%)
Query: 375 LGKSTIGIVYK------VALNNEEAVAVRRLGNGGWQR-FKEFQTEAEAIGKI-RHPNIV 426
LG G V + + + VAV+ L + +E + + + H NIV
Sbjct: 31 LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90
Query: 427 SLRAYFWSVDEKLLIYDYIPNGSL------------ATAIHGKAGIISYRPLSWSDRLRI 474
+L L+I +Y G L + L D L
Sbjct: 91 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 150
Query: 475 IKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWE 534
VAKG+AFL + K +H DL NILL I DFGLAR DI +
Sbjct: 151 SYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLAR--DIKND----SNY 201
Query: 535 QSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKL 593
L P ++ APE+ T + D++SYG+ L E+ S G
Sbjct: 202 VVKGNARL---PVKWM------------APESIFNCVYTFESDVWSYGIFLWELFSLGSS 246
Query: 594 PMIQIGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEI-VSVLKIALDCVHKSP 652
P + ++ ++I E + + + I C P
Sbjct: 247 PYPGMPVDS----KFYKMIKE-------------GFRMLSPEHAPAEMYDIMKTCWDADP 289
Query: 653 DKRPSMRHVCDSLDRVNISTEQQ 675
KRP+ + + +++ +
Sbjct: 290 LKRPTFKQIVQLIEKQISESTNH 312
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 8e-20
Identities = 60/232 (25%), Positives = 99/232 (42%), Gaps = 47/232 (20%)
Query: 374 LLGKSTIGIVYKVALNNE--EAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAY 431
+LGK T GIVY + +A++ + + + E ++H NIV Y
Sbjct: 29 VLGKGTYGIVYA-GRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQ---Y 84
Query: 432 FWSV--DEKLLIY-DYIPNGSLATAIHGKAGIISYRPLSWSDRL--RIIKGVAKGIAFLH 486
S + + I+ + +P GSL+ + K G PL +++ K + +G+ +LH
Sbjct: 85 LGSFSENGFIKIFMEQVPGGSLSALLRSKWG-----PLKDNEQTIGFYTKQILEGLKYLH 139
Query: 487 EVSPKRYVHGDLRPSNILLG-KNMEPHISDFGLA-RLADIAEETPEVHWEQSTTGTPLQS 544
+ + VH D++ N+L+ + ISDFG + RLA I T ++ TGT
Sbjct: 140 D---NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCT------ETFTGTL--- 187
Query: 545 SPYEFTALNSTTSRSYYQAPEASKVRKP--TQKWDIYSYGVILLEMISGKLP 594
Y APE + DI+S G ++EM +GK P
Sbjct: 188 ---------------QYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPP 224
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 9e-20
Identities = 64/318 (20%), Positives = 118/318 (37%), Gaps = 79/318 (24%)
Query: 375 LGKSTIGIVYKVALNN------EEAVAVRRLGNGGWQR-FKEFQTEAEAIGKIRHPNIVS 427
LG+ + G+VY+ E VA++ + R EF EA + + ++V
Sbjct: 33 LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92
Query: 428 LRAYFWSVDEKLLIYDYIPNGSLAT----AIHGKAGIISYRPLSWSDRLRIIKGVAKGIA 483
L L+I + + G L + A P S S +++ +A G+A
Sbjct: 93 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA 152
Query: 484 FLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQ 543
+L+ ++VH DL N ++ ++ I DFG+ R DI E
Sbjct: 153 YLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTR--DIYET---------------- 191
Query: 544 SSPYEFTALNSTTSRSYYQ------------APEASKVRKPTQKWDIYSYGVILLEMIS- 590
YY+ +PE+ K T D++S+GV+L E+ +
Sbjct: 192 ---------------DYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATL 236
Query: 591 GKLPMIQIGSMELNIVQWIQLILEDRKPMTDILD-PFLAHDLDKEDEIVSVLKIALDCVH 649
+ P + + ++ ++ ++E +LD P D + ++ C
Sbjct: 237 AEQPYQGLSNEQV-----LRFVMEGG-----LLDKPDNCPD--------MLFELMRMCWQ 278
Query: 650 KSPDKRPSMRHVCDSLDR 667
+P RPS + S+
Sbjct: 279 YNPKMRPSFLEIISSIKE 296
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 9e-20
Identities = 57/312 (18%), Positives = 103/312 (33%), Gaps = 84/312 (26%)
Query: 374 LLGKSTIGIVYKVALNNE--EAVAVRR--LGNGGWQRFKEFQTEAEAIGKI-RHPNIVSL 428
+G G V+K + A++R G + E A + +H ++V
Sbjct: 18 KIGSGEFGSVFKC-VKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVR- 75
Query: 429 RAYF--WSVDEKLLIY-DYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFL 485
YF W+ D+ +LI +Y GSLA AI ++ ++ V +G+ ++
Sbjct: 76 --YFSAWAEDDHMLIQNEYCNGGSLADAI--SENYRIMSYFKEAELKDLLLQVGRGLRYI 131
Query: 486 HEVSPKRYVHGDLRPSNILLGKNMEPH-------------------ISDFGLARLADIAE 526
H VH D++PSNI + + P+ I D G
Sbjct: 132 HS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSP- 187
Query: 527 ETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKP-TQKWDIYSYGVIL 585
Q G + A E + K DI++ + +
Sbjct: 188 --------QVEEGDS------------------RFLANEVLQENYTHLPKADIFALALTV 221
Query: 586 LEMISGKLPMIQIGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIAL 645
+ + P+ + G W ++ + +L E +LK+
Sbjct: 222 VCAAGAE-PLPRNGDQ------WHEIRQGRLPRIPQVLSQ----------EFTELLKV-- 262
Query: 646 DCVHKSPDKRPS 657
+H P++RPS
Sbjct: 263 -MIHPDPERRPS 273
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 1e-19
Identities = 57/289 (19%), Positives = 89/289 (30%), Gaps = 59/289 (20%)
Query: 374 LLGKSTIGIVYKV-ALNNEEAVAVRRLGNGGWQRFKEFQTEAEAIG---KIRHPNIVSLR 429
LG + G V+KV + + AV+R + + AE +HP V L
Sbjct: 64 RLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLE 123
Query: 430 AYFWSVDEKLLIY-DYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEV 488
W L + + SL G L + ++ +A LH
Sbjct: 124 -QAWEEGGILYLQTELC-GPSLQQHCE-AWG----ASLPEAQVWGYLRDTLLALAHLHS- 175
Query: 489 SPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYE 548
+ VH D++P+NI LG + DFGL A + G P
Sbjct: 176 --QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAG------EVQEGDP------- 220
Query: 549 FTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQW 608
Y APE + D++S G+ +LE+ + + Q
Sbjct: 221 -----------RYMAPELLQ-GSYGTAADVFSLGLTILEVACNMELPHGGEGWQ-QLRQG 267
Query: 609 IQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPS 657
T L E+ SVL + + P R +
Sbjct: 268 Y-----LPPEFTAGLSS----------ELRSVLVM---MLEPDPKLRAT 298
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 1e-19
Identities = 49/228 (21%), Positives = 86/228 (37%), Gaps = 42/228 (18%)
Query: 374 LLGKSTIGIVYKVA-LNNEEAVAV-----RRLGNGGWQRFKEFQTEAEAIGKIRHPNIVS 427
LGK ++++ + +E A L QR K E + H ++V
Sbjct: 22 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPH-QREK-MSMEISIHRSLAHQHVVG 79
Query: 428 LRAYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHE 487
+F D ++ + SL + + L+ + ++ + G +LH
Sbjct: 80 FHGFFEDNDFVFVVLELCRRRSLLELHKRR------KALTEPEARYYLRQIVLGCQYLHR 133
Query: 488 VSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTT-GTPLQSSP 546
R +H DL+ N+ L +++E I DFGLA + E + GTP
Sbjct: 134 ---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER------KKVLCGTP----- 179
Query: 547 YEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLP 594
N Y APE + + + D++S G I+ ++ GK P
Sbjct: 180 ------N-------YIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP 214
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 90.1 bits (223), Expect = 1e-19
Identities = 32/211 (15%), Positives = 70/211 (33%), Gaps = 27/211 (12%)
Query: 391 EEAVAVRRLGN----GGWQRFKEFQTEAEAIGKIRHPNIVSLRAYF--WSVDEKLLIYDY 444
EE + +R L + F + + + ++ +R V + +Y
Sbjct: 122 EEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLY-P 180
Query: 445 IPNGSLATAI-HGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNI 503
+L T + +++ L RL++ V + +A LH VH LRP +I
Sbjct: 181 RMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGLVHTYLRPVDI 237
Query: 504 LLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQA 563
+L + ++ F ++ + P +R +
Sbjct: 238 VLDQRGGVFLTGFEHLVRDGA---------RVVSSVSRGFEPPE-------LEARRATIS 281
Query: 564 PEASKVRKPTQKWDIYSYGVILLEMISGKLP 594
+ T +D ++ G+++ + LP
Sbjct: 282 YHRDRRTLMTFSFDAWALGLVIYWIWCADLP 312
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 92.6 bits (230), Expect = 1e-19
Identities = 33/189 (17%), Positives = 63/189 (33%), Gaps = 18/189 (9%)
Query: 47 CSWNGITCREGQVFS-------LIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPV 99
+ +T QV L++ + + L + + L + ++
Sbjct: 11 YRFCNLT----QVPQVLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDK 66
Query: 100 ELF-NASNLQSLILSGNSFSGPVPMQIGKLKYLQVLDLSQNSFSSSI--PSSIVQCKRLK 156
E F N NL+ L L + P L +L L L S ++ K L
Sbjct: 67 EAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALT 126
Query: 157 TVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSGLIPNDIANLSRLRLLAQRVYVDLT 216
+ L++N L +L+ +D S N + + +++ L L + L
Sbjct: 127 RLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLS----FFSLA 182
Query: 217 YNNLSGLIP 225
N+L +
Sbjct: 183 ANSLYSRVS 191
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 82.5 bits (204), Expect = 2e-16
Identities = 56/292 (19%), Positives = 92/292 (31%), Gaps = 30/292 (10%)
Query: 48 SWNGITCREGQVFS---LIIPNKKLTGF-IPADLGSLSAIGRVNLRNNNFSGSLPVELFN 103
S N + + + + +L I L + + + L N FS + +
Sbjct: 389 SGNKLVTLPKINLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPS 448
Query: 104 A-SNLQSLILSGNSFSGPVPMQI-----GKLKYLQVLDLSQNSFSSSIPSSIVQCKRLKT 157
+L+ L L N ++ L +LQVL L+ N +S P L+
Sbjct: 449 ENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRG 508
Query: 158 VVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSGLIPNDIANLSRLRLLAQRVYVDLTY 217
+ LN N T + N L+ LD+S N L P+ +LS +D+T+
Sbjct: 509 LSLNSNRLTVLSHNDLPAN---LEILDISRNQLLAPNPDVFVSLS---------VLDITH 556
Query: 218 NNLSGLIPQNAALLSLGPTAFIGNPFLCGPPLKVSC--PSSTSDHP--YPKPLPYDPSWH 273
N L + N + GPP + C P S S D
Sbjct: 557 NKFICECE----LSTFINWLNHTNVTIAGPPADIYCVYPDSFSGVSLFSLSTEGCDEEEV 612
Query: 274 GGKVHHSCAVITTVAVAVLLGICITGFLFYRQYKKASGCKWGEKVGGCRLEE 325
+ S ++ TV + + L +T F
Sbjct: 613 LKSLKFSLFIVCTVTLTLFLMTILTVTKFRGFCFICYKTAQRLVFKDHPQGT 664
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 82.5 bits (204), Expect = 2e-16
Identities = 36/180 (20%), Positives = 60/180 (33%), Gaps = 16/180 (8%)
Query: 47 CSWNGITCREGQVFSLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELF---N 103
S NG T FS ++ L I +N F
Sbjct: 211 VSGNGWTVDITGNFS-----NAISKSQAFSLILAHHIMGAGFGFHNIK-DPDQNTFAGLA 264
Query: 104 ASNLQSLILSGNSFSGPVPMQIGKLKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQN 163
S+++ L LS LK L+VL+L+ N + + L+ + L+ N
Sbjct: 265 RSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYN 324
Query: 164 SFTGPLPDGFATNLTALQKLDLSFNNLSGLIPNDIANLSRLRLLAQRVYVDLTYNNLSGL 223
L L + +DL N+++ + L +L+ L DL N L+ +
Sbjct: 325 LLGE-LYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTL------DLRDNALTTI 377
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 79.5 bits (196), Expect = 2e-15
Identities = 35/146 (23%), Positives = 52/146 (35%), Gaps = 14/146 (9%)
Query: 86 VNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQVLDLSQNSFSSSI 145
R N + +P L + + L+LS N L+ LQ+L+L +I
Sbjct: 9 AFYRFCNLT-QVPQVL---NTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTI 64
Query: 146 PSSIVQ-CKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLS--GLIPNDIANLS 202
+ L+ + L + PD F L L +L L F LS L NL
Sbjct: 65 DKEAFRNLPNLRILDLGSSKIYFLHPDAFQ-GLFHLFELRLYFCGLSDAVLKDGYFRNLK 123
Query: 203 RLRLLAQRVYVDLTYNNLSGLIPQNA 228
L L DL+ N + L +
Sbjct: 124 ALTRL------DLSKNQIRSLYLHPS 143
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 68.7 bits (168), Expect = 4e-12
Identities = 35/178 (19%), Positives = 57/178 (32%), Gaps = 16/178 (8%)
Query: 62 LIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFS-GSLPVELF-NASNLQSLILSGNSFSG 119
L + + K+ P L + + L S L F N L L LS N
Sbjct: 78 LDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRS 137
Query: 120 -PVPMQIGKLKYLQVLDLSQNSFSSSIPSSI--VQCKRLKTVVLNQNSFTGPLPDGFATN 176
+ GKL L+ +D S N + +Q K L L NS + +
Sbjct: 138 LYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKC 197
Query: 177 LTALQKLDLSFNNLS---------GLIPNDIANLS--RLRLLAQRVYVDLTYNNLSGL 223
+ + + L ++S G N I+ L L + ++N+
Sbjct: 198 MNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDP 255
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 65.6 bits (160), Expect = 3e-11
Identities = 33/182 (18%), Positives = 60/182 (32%), Gaps = 21/182 (11%)
Query: 61 SLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGP 120
L + + + +L + +NL N + + NLQ L LS N
Sbjct: 270 HLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGEL 329
Query: 121 VPMQIGKLKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTAL 180
L + +DL +N + + ++L+T+ L N+ T + ++
Sbjct: 330 YSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALT------TIHFIPSI 383
Query: 181 QKLDLSFNNLSGLIPNDIA----NLSRLRL-----------LAQRVYVDLTYNNLSGLIP 225
+ LS N L L ++ +LS RL + + L N S
Sbjct: 384 PDIFLSGNKLVTLPKINLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSG 443
Query: 226 QN 227
Sbjct: 444 DQ 445
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 2e-19
Identities = 68/355 (19%), Positives = 117/355 (32%), Gaps = 89/355 (25%)
Query: 344 MSENMEQYEFVPLDSQVDFDLE------QLLKASAFLLGKSTIGIVYKVALNN------E 391
M++ Y F S + E L++ LG G VY+ ++
Sbjct: 46 MTDYNPNYCFAGKTSSISDLKEVPRKNITLIRG----LGHGAFGEVYEGQVSGMPNDPSP 101
Query: 392 EAVAVRRLGNGGWQR-FKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSL 450
VAV+ L ++ +F EA I K H NIV + ++ + + G L
Sbjct: 102 LQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDL 161
Query: 451 ATAI-HGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNM 509
+ + + L+ D L + + +A G +L ++H D+ N LL
Sbjct: 162 KSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL---EENHFIHRDIAARNCLLTCPG 218
Query: 510 EPH---ISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQ---- 562
I DFG+AR DI YY+
Sbjct: 219 PGRVAKIGDFGMAR--DIYRA-------------------------------GYYRKGGC 245
Query: 563 --------APEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQIGSMELNIVQWIQLIL 613
PEA T K D +S+GV+L E+ S G +P + E+ ++ +
Sbjct: 246 AMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV-----LEFVT 300
Query: 614 EDRKPMTDILDPFLAHDLDKEDEIVSVL-KIALDCVHKSPDKRPSMRHVCDSLDR 667
+D + +I C P+ RP+ + + ++
Sbjct: 301 SG-------------GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEY 342
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 87.6 bits (218), Expect = 3e-19
Identities = 42/181 (23%), Positives = 73/181 (40%), Gaps = 43/181 (23%)
Query: 420 IRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVA 479
++HP+I+ L YF + L+ + NG + + + +P S ++ + +
Sbjct: 68 LKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRV-----KPFSENEARHFMHQII 122
Query: 480 KGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQS--- 536
G+ +LH +H DL SN+LL +NM I+DFGLA +
Sbjct: 123 TGMLYLHS---HGILHRDLTLSNLLLTRNMNIKIADFGLA-----------TQLKMPHEK 168
Query: 537 --TT-GTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKL 593
T GTP N Y +PE + + D++S G + ++ G+
Sbjct: 169 HYTLCGTP-----------N-------YISPEIATRSAHGLESDVWSLGCMFYTLLIGRP 210
Query: 594 P 594
P
Sbjct: 211 P 211
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 3e-19
Identities = 42/173 (24%), Positives = 66/173 (38%), Gaps = 19/173 (10%)
Query: 61 SLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGP 120
L + N +++ P L L+ + + L N S P L + L +L L+ N
Sbjct: 247 DLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDI 302
Query: 121 VPMQIGKLKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTAL 180
P I LK L L L N+ S P + +L+ + N + NLT +
Sbjct: 303 SP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSDVSSLA---NLTNI 355
Query: 181 QKLDLSFNNLSGLIPNDIANLSRLRLLAQRVYVDLTYNNLSGLIPQNAALLSL 233
L N +S L P +ANL+R+ L L + A +S+
Sbjct: 356 NWLSAGHNQISDLTP--LANLTRITQL------GLNDQAWTNAPVNYKANVSI 400
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 9e-18
Identities = 40/165 (24%), Positives = 69/165 (41%), Gaps = 20/165 (12%)
Query: 61 SLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGP 120
L + + ++ L L+++ +++ N + P+ N + L+ L +S N S
Sbjct: 138 RLELSSNTISDISA--LSGLTSLQQLSF-GNQVTDLKPLA--NLTTLERLDISSNKVSDI 192
Query: 121 VPMQIGKLKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTAL 180
+ KL L+ L + N S P + L + LN N A +LT L
Sbjct: 193 SV--LAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLA-SLTNL 245
Query: 181 QKLDLSFNNLSGLIPNDIANLSRLRLLAQRVYVDLTYNNLSGLIP 225
LDL+ N +S L P ++ L++L L L N +S + P
Sbjct: 246 TDLDLANNQISNLAP--LSGLTKLTEL------KLGANQISNISP 282
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 1e-17
Identities = 29/165 (17%), Positives = 59/165 (35%), Gaps = 19/165 (11%)
Query: 61 SLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGP 120
+ I + + +L+ + L N + ++ + + +L
Sbjct: 6 ATITQDTPINQIFT--DTALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKSI 61
Query: 121 VPMQIGKLKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTAL 180
+ L L ++ S N + P + +L +++N N P NLT L
Sbjct: 62 DG--VEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITPLA---NLTNL 114
Query: 181 QKLDLSFNNLSGLIPNDIANLSRLRLLAQRVYVDLTYNNLSGLIP 225
L L N ++ + P + NL+ L L +L+ N +S +
Sbjct: 115 TGLTLFNNQITDIDP--LKNLTNLNRL------ELSSNTISDISA 151
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 2e-16
Identities = 36/163 (22%), Positives = 58/163 (35%), Gaps = 11/163 (6%)
Query: 61 SLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGP 120
L + +++ P L L+A+ + L N P+ N NL L L N+ S
Sbjct: 269 ELKLGANQISNISP--LAGLTALTNLELNENQLEDISPIS--NLKNLTYLTLYFNNISDI 324
Query: 121 VPMQIGKLKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTAL 180
P + L LQ L N S SS+ + + N + P NLT +
Sbjct: 325 SP--VSSLTKLQRLFFYNNKVSD--VSSLANLTNINWLSAGHNQISDLTPLA---NLTRI 377
Query: 181 QKLDLSFNNLSGLIPNDIANLSRLRLLAQRVYVDLTYNNLSGL 223
+L L+ + N AN+S + + +S
Sbjct: 378 TQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGALIAPATISDG 420
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 6e-16
Identities = 39/165 (23%), Positives = 66/165 (40%), Gaps = 20/165 (12%)
Query: 61 SLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGP 120
+++ N ++ P L +L+ + + L NN + P L N +NL L LS N+ S
Sbjct: 94 DILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDI 149
Query: 121 VPMQIGKLKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTAL 180
+ L LQ L N + P + L+ + ++ N + A LT L
Sbjct: 150 SA--LSGLTSLQQLSFG-NQVTDLKP--LANLTTLERLDISSNKVSD--ISVLA-KLTNL 201
Query: 181 QKLDLSFNNLSGLIPNDIANLSRLRLLAQRVYVDLTYNNLSGLIP 225
+ L + N +S + P + L+ L L L N L +
Sbjct: 202 ESLIATNNQISDITP--LGILTNLDEL------SLNGNQLKDIGT 238
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 2e-14
Identities = 34/184 (18%), Positives = 60/184 (32%), Gaps = 28/184 (15%)
Query: 61 SLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGP 120
+L + +L P + +L + + L NN S PV + + LQ L N S
Sbjct: 291 NLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISPVS--SLTKLQRLFFYNNKVSDV 346
Query: 121 VPMQIGKLKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTAL 180
+ L + L N S P + R+ + LN ++T P + N++
Sbjct: 347 SS--LANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTN-APVNYKANVSIP 401
Query: 181 QKLDLSFNNLSGLIPNDIANLSRLRLL-----------------AQRVYVDLTYNNLSGL 223
+ L + P I++ +Q V + SG
Sbjct: 402 NTVKNVTGAL--IAPATISDGGSYTEPDITWNLPSYTNEVSYTFSQPVTIGKGTTTFSGT 459
Query: 224 IPQN 227
+ Q
Sbjct: 460 VTQP 463
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 3e-19
Identities = 74/347 (21%), Positives = 133/347 (38%), Gaps = 90/347 (25%)
Query: 375 LGKSTIGIVYK--------VALNNEEAVAVRRLGNGGWQR-FKEFQTEAEAIGKI-RHPN 424
LG+ G V VAV+ L + ++ + +E E + I +H N
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 425 IVSLRAYFWSVDEKLLIYDYIPNGSL----------ATAIHGKAGIISYRPLSWSDRLRI 474
I++L +I +Y G+L + +++ D +
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 475 IKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWE 534
+A+G+ +L + ++ +H DL N+L+ +N I+DFGLAR DI
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR--DINNI------- 210
Query: 535 QSTTGTPLQSSPYEFTALNSTTSRSYYQ------------APEASKVRKPTQKWDIYSYG 582
YY+ APEA R T + D++S+G
Sbjct: 211 ------------------------DYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFG 246
Query: 583 VILLEMIS-GKLPMIQIGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVL 641
V++ E+ + G P I EL +L+ E H +DK + L
Sbjct: 247 VLMWEIFTLGGSPYPGIPVEEL-----FKLLKE-------------GHRMDKPANCTNEL 288
Query: 642 -KIALDCVHKSPDKRPSMRHVCDSLDRV-NISTEQQFMKGEEPKFDQ 686
+ DC H P +RP+ + + + LDR+ ++T ++++ +P +Q
Sbjct: 289 YMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTNEEYLDLSQP-LEQ 334
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 3e-19
Identities = 61/239 (25%), Positives = 91/239 (38%), Gaps = 66/239 (27%)
Query: 374 LLGKSTIGIVYKV-ALNNEEAVAVRRLGNGGWQRFKE----------FQTEAEAIGKIRH 422
LGK G VY ++ +A++ L FK + E E +RH
Sbjct: 16 PLGKGKFGNVYLAREKQSKFILALKVL-------FKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 423 PNIVSLRAYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRL------RIIK 476
PNI+ L YF LI +Y P G++ YR L + I
Sbjct: 69 PNILRLYGYFHDATRVYLILEYAPLGTV------------YRELQKLSKFDEQRTATYIT 116
Query: 477 GVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQS 536
+A +++ H KR +H D++P N+LLG E I+DFG + A ++
Sbjct: 117 ELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP--------SSRRT 165
Query: 537 TT-GTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLP 594
GT Y PE + R +K D++S GV+ E + GK P
Sbjct: 166 DLCGTL------------------DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 206
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 3e-19
Identities = 77/359 (21%), Positives = 134/359 (37%), Gaps = 96/359 (26%)
Query: 354 VPLDSQVDFDLEQL-LKASAFLLGKSTIGIVYK--------VALNNEEAVAVRRLGNGGW 404
+P D + +F ++L L LG+ G V VAV+ L +
Sbjct: 70 LPEDPKWEFPRDKLTLGK---PLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDAT 126
Query: 405 QR-FKEFQTEAEAIGKI-RHPNIVSLRAYFWSVDEK--LLIYDYIPNGSL---------- 450
++ + +E E + I +H NI++L + +I +Y G+L
Sbjct: 127 EKDLSDLVSEMEMMKMIGKHKNIINLLG--ACTQDGPLYVIVEYASKGNLREYLRARRPP 184
Query: 451 ATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNME 510
+ +++ D + +A+G+ +L ++ +H DL N+L+ +N
Sbjct: 185 GMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVLVTENNV 241
Query: 511 PHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQ-------- 562
I+DFGLAR DI YY+
Sbjct: 242 MKIADFGLAR--DINNI-------------------------------DYYKKTTNGRLP 268
Query: 563 ----APEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQIGSMELNIVQWIQLILEDRK 617
APEA R T + D++S+GV++ E+ + G P I EL +L+ E
Sbjct: 269 VKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL-----FKLLKE--- 320
Query: 618 PMTDILDPFLAHDLDKEDEIVSVL-KIALDCVHKSPDKRPSMRHVCDSLDRVNISTEQQ 675
H +DK + L + DC H P +RP+ + + + LDR+ T +
Sbjct: 321 ----------GHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTNE 369
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 90.3 bits (224), Expect = 3e-19
Identities = 29/162 (17%), Positives = 60/162 (37%), Gaps = 17/162 (10%)
Query: 62 LIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPV 121
+ + L + + S + ++L N S +L + L+ L LS N +
Sbjct: 15 EKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETL 74
Query: 122 PMQIGKLKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQ 181
+ L L+ LDL+ N ++ ++T+ N+ + + +
Sbjct: 75 D--LESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNISR-VSCS---RGQGKK 123
Query: 182 KLDLSFNNLSGLIPNDIANLSRLRLLAQRVYVDLTYNNLSGL 223
+ L+ N ++ L D SR++ L DL N + +
Sbjct: 124 NIYLANNKITMLRDLDEGCRSRVQYL------DLKLNEIDTV 159
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 81.8 bits (202), Expect = 2e-16
Identities = 30/158 (18%), Positives = 65/158 (41%), Gaps = 16/158 (10%)
Query: 76 DLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQVLD 135
DL SLS + ++L NN EL ++++L + N+ S + + + + +
Sbjct: 75 DLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNISR---VSCSRGQGKKNIY 126
Query: 136 LSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSGLIP 195
L+ N + R++ + L N A + L+ L+L +N + +
Sbjct: 127 LANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYD-VK 185
Query: 196 NDIANLSRLRLLAQRVYVDLTYNNLSGLIPQNAALLSL 233
+ ++L+ L DL+ N L+ + P+ + +
Sbjct: 186 GQV-VFAKLKTL------DLSSNKLAFMGPEFQSAAGV 216
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 76.8 bits (189), Expect = 6e-15
Identities = 22/128 (17%), Positives = 48/128 (37%), Gaps = 14/128 (10%)
Query: 96 SLPVELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQVLDLSQNSFSSSIPSSIVQCKRL 155
++ N + + ++ +S + ++ LDLS N S + + +L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 156 KTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSGLIPNDIANLSRLRLLAQRVYVDL 215
+ + L+ N L +L+ L+ LDL+ N + ++ + L
Sbjct: 61 ELLNLSSNVLYETLD--LE-SLSTLRTLDLNNNYVQ-----ELLVGPSIETL------HA 106
Query: 216 TYNNLSGL 223
NN+S +
Sbjct: 107 ANNNISRV 114
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 67.9 bits (166), Expect = 4e-12
Identities = 26/163 (15%), Positives = 51/163 (31%), Gaps = 8/163 (4%)
Query: 73 IPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQ 132
S + +NL+ N + ++ + L++L LS N + + + +
Sbjct: 161 FAELAASSDTLEHLNLQYNFIY-DVKGQVVF-AKLKTLDLSSNKLAF-MGPEFQSAAGVT 217
Query: 133 VLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSG 192
+ L N I ++ + L+ L N F F + +Q + +
Sbjct: 218 WISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAK--QTVKK 274
Query: 193 LIPNDIANLSRLRLLAQRVYV--DLTYNNLSGLIPQNAALLSL 233
L + + L Y DL LI +L
Sbjct: 275 LTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHAL 317
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 66.4 bits (162), Expect = 1e-11
Identities = 24/181 (13%), Positives = 46/181 (25%), Gaps = 37/181 (20%)
Query: 73 IPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQ 132
+ + S + + ++LRNN + L + NL+ L GN F K +
Sbjct: 206 MGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDF-FSKNQR 263
Query: 133 VLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLT-------------- 178
V +++ + + +C LP FA L
Sbjct: 264 VQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCE-DLPAPFADRLIALKRKEHALLSGQG 322
Query: 179 --------------ALQKLDLSFNNLSGLIPNDIANLSRLRLLAQRVYVDLTYNNLSGLI 224
+++D +I L + L +
Sbjct: 323 SETERLECERENQARQREIDALKEQYRTVIDQVTLRKQAKITL------EQKKKALDEQV 376
Query: 225 P 225
Sbjct: 377 S 377
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 55.6 bits (134), Expect = 3e-08
Identities = 19/189 (10%), Positives = 42/189 (22%), Gaps = 33/189 (17%)
Query: 73 IPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQ 132
I L + +LR N F + F + N + ++ + +
Sbjct: 229 IEKALRFSQNLEHFDLRGNGFHCGTLRDFF-SKNQRVQTVAKQTVKKLTGQNEEECTVPT 287
Query: 133 VLDLSQNSFS----------------------------SSIPSSIVQCKRLKTVVLNQNS 164
+ + R + + +
Sbjct: 288 LGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQ 347
Query: 165 FTGPLPDGFATNLTALQKLDLSFNNLSGLIPNDIANLSRLRLLAQRVYVDLTYNNLSGLI 224
+ + D A L+ L + N + L Q+ + L
Sbjct: 348 YRT-VIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQ---AVGQIELQHAT 403
Query: 225 PQNAALLSL 233
+ + L L
Sbjct: 404 EEQSPLQLL 412
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 46.0 bits (109), Expect = 3e-05
Identities = 8/51 (15%), Positives = 20/51 (39%), Gaps = 6/51 (11%)
Query: 176 NLTALQKLDLSFNNLSGLIPNDIANLSRLRLLAQRVYVDLTYNNLSGLIPQ 226
N + ++ ++L + + + ++ L DL+ N LS +
Sbjct: 8 NGNRYKIEKVTDSSLKQALASLRQSAWNVKEL------DLSGNPLSQISAA 52
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 90.5 bits (224), Expect = 5e-19
Identities = 61/308 (19%), Positives = 108/308 (35%), Gaps = 61/308 (19%)
Query: 375 LGKSTIGIVYKVALNNE--EAVAVRRLGNGGWQRFKE-FQTEAEAIGKIRHPNIVSLRAY 431
LG G V + ++ + E VA+++ + +E + E + + K+ HPN+VS R
Sbjct: 22 LGTGGFGYVLR-WIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREV 80
Query: 432 F------WSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFL 485
D LL +Y G L ++ + L ++ ++ + +L
Sbjct: 81 PDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFE---NCCGLKEGPIRTLLSDISSALRYL 137
Query: 486 HEVSPKRYVHGDLRPSNILLGKNMEPH---ISDFGLARLADIAEETPEVHWEQSTT--GT 540
HE R +H DL+P NI+L + I D G A+ D E T GT
Sbjct: 138 HE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELD--------QGELCTEFVGT 186
Query: 541 PLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLP------ 594
Y APE + +K T D +S+G + E I+G P
Sbjct: 187 L------------------QYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQ 228
Query: 595 ----MIQIGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHK 650
++ + + K + + P + ++ L+ L
Sbjct: 229 PVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILA-GKLERWLQCMLMW--- 284
Query: 651 SPDKRPSM 658
+R +
Sbjct: 285 HQRQRGTD 292
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 5e-19
Identities = 49/228 (21%), Positives = 86/228 (37%), Gaps = 42/228 (18%)
Query: 374 LLGKSTIGIVYKVA-LNNEEAVAV-----RRLGNGGWQRFKEFQTEAEAIGKIRHPNIVS 427
LGK ++++ + +E A L QR K E + H ++V
Sbjct: 48 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPH-QREK-MSMEISIHRSLAHQHVVG 105
Query: 428 LRAYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHE 487
+F D ++ + SL + + L+ + ++ + G +LH
Sbjct: 106 FHGFFEDNDFVFVVLELCRRRSLLELHKRR------KALTEPEARYYLRQIVLGCQYLHR 159
Query: 488 VSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTT-GTPLQSSP 546
R +H DL+ N+ L +++E I DFGLA + E + GTP
Sbjct: 160 ---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER------KKVLCGTP----- 205
Query: 547 YEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLP 594
N Y APE + + + D++S G I+ ++ GK P
Sbjct: 206 ------N-------YIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP 240
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 6e-19
Identities = 29/162 (17%), Positives = 60/162 (37%), Gaps = 17/162 (10%)
Query: 62 LIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPV 121
+ + L + + S + ++L N S +L + L+ L LS N +
Sbjct: 15 EKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETL 74
Query: 122 PMQIGKLKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQ 181
+ L L+ LDL+ N ++ ++T+ N+ + + +
Sbjct: 75 D--LESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNISR-VSCS---RGQGKK 123
Query: 182 KLDLSFNNLSGLIPNDIANLSRLRLLAQRVYVDLTYNNLSGL 223
+ L+ N ++ L D SR++ L DL N + +
Sbjct: 124 NIYLANNKITMLRDLDEGCRSRVQYL------DLKLNEIDTV 159
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 5e-17
Identities = 32/158 (20%), Positives = 65/158 (41%), Gaps = 16/158 (10%)
Query: 76 DLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQVLD 135
DL SLS + ++L NN EL ++++L + N+ S V G+ + +
Sbjct: 75 DLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNISR-VSCSRGQG--KKNIY 126
Query: 136 LSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSGLIP 195
L+ N + R++ + L N A + L+ L+L +N + +
Sbjct: 127 LANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYD-VK 185
Query: 196 NDIANLSRLRLLAQRVYVDLTYNNLSGLIPQNAALLSL 233
+ ++L+ L DL+ N L+ + P+ + +
Sbjct: 186 GQV-VFAKLKTL------DLSSNKLAFMGPEFQSAAGV 216
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 7e-15
Identities = 22/128 (17%), Positives = 48/128 (37%), Gaps = 14/128 (10%)
Query: 96 SLPVELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQVLDLSQNSFSSSIPSSIVQCKRL 155
++ N + + ++ +S + ++ LDLS N S + + +L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 156 KTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSGLIPNDIANLSRLRLLAQRVYVDL 215
+ + L+ N L +L+ L+ LDL+ N + ++ + L
Sbjct: 61 ELLNLSSNVLYETLD--LE-SLSTLRTLDLNNNYVQ-----ELLVGPSIETL------HA 106
Query: 216 TYNNLSGL 223
NN+S +
Sbjct: 107 ANNNISRV 114
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 6e-12
Identities = 21/161 (13%), Positives = 45/161 (27%), Gaps = 14/161 (8%)
Query: 73 IPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQ 132
S + +NL+ N + ++ + L++L LS N + + + +
Sbjct: 161 FAELAASSDTLEHLNLQYNFIY-DVKGQVVF-AKLKTLDLSSNKLAF-MGPEFQSAAGVT 217
Query: 133 VLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSG 192
+ L N I ++ + L+ L N F + L+ +
Sbjct: 218 WISLRNNKLVL-IEKALRFSQNLEHFDLRGNGF----------HCGTLRDFFSKNQRVQT 266
Query: 193 LIPNDIANLSRLRLLAQRVYVDLTYNNLSGLIPQNAALLSL 233
+ + L+ V Y L
Sbjct: 267 VAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRL 307
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 6e-19
Identities = 39/187 (20%), Positives = 73/187 (39%), Gaps = 21/187 (11%)
Query: 73 IPADLGSLSAIGRVNLRNNNFSGSLPVELF-NASNLQSLILSGNSFSGPVPMQIGKLKYL 131
+ ++ L + ++ +++N +F + NL L +S L L
Sbjct: 93 MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSL 152
Query: 132 QVLDLSQNSFSSSIPSSI-VQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNL 190
+VL ++ NSF + I + + L + L+Q L +L++LQ L++S NN
Sbjct: 153 EVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQ-LSPTAFNSLSSLQVLNMSHNNF 211
Query: 191 SGLIPNDIANLSRLRLLAQRVYVDLTYNNLSGL-------IPQNAALLSLGPTAFIGNPF 243
L L+ L++L D + N++ P + A L+L N F
Sbjct: 212 FSLDTFPYKCLNSLQVL------DYSLNHIMTSKKQELQHFPSSLAFLNLT-----QNDF 260
Query: 244 LCGPPLK 250
C +
Sbjct: 261 ACTCEHQ 267
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 6e-15
Identities = 31/147 (21%), Positives = 50/147 (34%), Gaps = 15/147 (10%)
Query: 85 RVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQVLDLSQN--SFS 142
+ + + S+P + S+ L L N KL L L LS N SF
Sbjct: 11 EIRCNSKGLT-SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFK 67
Query: 143 SSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSGLIPNDI-ANL 201
S LK + L+ N + F L L+ LD +NL + + +L
Sbjct: 68 GCCSQSDFGTTSLKYLDLSFNGVIT-MSSNF-LGLEQLEHLDFQHSNLKQMSEFSVFLSL 125
Query: 202 SRLRLLAQRVYVDLTYNNLSGLIPQNA 228
L L D+++ + +
Sbjct: 126 RNLIYL------DISHTHTR-VAFNGI 145
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 7e-19
Identities = 72/354 (20%), Positives = 135/354 (38%), Gaps = 74/354 (20%)
Query: 343 TMSENMEQYEFVPLDSQVDFDLEQL-LKASAFLLGKSTIGIVYK------VALNNEEAVA 395
+S +++ ++ + D + +F + L L + LG+ G V K VA
Sbjct: 2 PLSLSVDAFK-ILEDPKWEFPRKNLVLGKT---LGEGEFGKVVKATAFHLKGRAGYTTVA 57
Query: 396 VRRLGNGGWQR-FKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSL---- 450
V+ L ++ +E + ++ HP+++ L LLI +Y GSL
Sbjct: 58 VKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFL 117
Query: 451 --------------ATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHG 496
+ R L+ D + +++G+ +L + + VH
Sbjct: 118 RESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYL---AEMKLVHR 174
Query: 497 DLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTT 556
DL NIL+ + + ISDFGL+R D+ EE + + P ++
Sbjct: 175 DLAARNILVAEGRKMKISDFGLSR--DVYEE----DSYVKRSQGRI---PVKWM------ 219
Query: 557 SRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQIGSMELNIVQWIQLILED 615
A E+ T + D++S+GV+L E+++ G P I L L+
Sbjct: 220 ------AIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERL-----FNLLKT- 267
Query: 616 RKPMTDILDPFLAHDLDKEDEIVSVL-KIALDCVHKSPDKRPSMRHVCDSLDRV 668
H +++ D + ++ L C + PDKRP + L+++
Sbjct: 268 ------------GHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKM 309
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 8e-19
Identities = 54/234 (23%), Positives = 90/234 (38%), Gaps = 56/234 (23%)
Query: 374 LLGKSTIGIVYKV-ALNNEEAVAV-----RRLGNGGWQRFKEFQTEAEAIGKIRHPNIVS 427
LGK G VY N+ +A+ +L G + + + E E +RHPNI+
Sbjct: 21 PLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVE--HQLRREIEIQSHLRHPNILR 78
Query: 428 LRAYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRL------RIIKGVAKG 481
+ YF L+ ++ P G L Y+ L R ++ +A
Sbjct: 79 MYNYFHDRKRIYLMLEFAPRGEL------------YKELQKHGRFDEQRSATFMEELADA 126
Query: 482 IAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTT-GT 540
+ + HE ++ +H D++P N+L+G E I+DFG + A + T GT
Sbjct: 127 LHYCHE---RKVIHRDIKPENLLMGYKGELKIADFGWSVHAP--------SLRRRTMCGT 175
Query: 541 PLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLP 594
Y PE + + +K D++ GV+ E + G P
Sbjct: 176 L------------------DYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPP 211
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 2e-18
Identities = 70/322 (21%), Positives = 119/322 (36%), Gaps = 62/322 (19%)
Query: 375 LGKSTIGIVYKVALNN------EEAVAVRRLGNGGWQR-FKEFQTEAEAIGKI-RHPNIV 426
LG+ G V + VAV+ L G + +E + + I H N+V
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 427 SLRAYFWSVDEKL-LIYDYIPNGSL----------ATAIHGKAGIISYRPLSWSDRLRII 475
+L L +I ++ G+L + L+ +
Sbjct: 95 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 476 KGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQ 535
VAKG+ FL + ++ +H DL NILL + I DFGLAR DI ++
Sbjct: 155 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR--DIYKD----PDYV 205
Query: 536 STTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLP 594
L P ++ APE R T + D++S+GV+L E+ S G P
Sbjct: 206 RKGDARL---PLKWM------------APETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250
Query: 595 MIQIGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVL-KIALDCVHKSPD 653
++++ ++ + + E + D + + LDC H P
Sbjct: 251 Y---PGVKID-EEFCRRLKE-------------GTRMRAPDYTTPEMYQTMLDCWHGEPS 293
Query: 654 KRPSMRHVCDSLDRVNISTEQQ 675
+RP+ + + L + + QQ
Sbjct: 294 QRPTFSELVEHLGNLLQANAQQ 315
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 2e-18
Identities = 69/323 (21%), Positives = 109/323 (33%), Gaps = 83/323 (25%)
Query: 375 LGKSTIGIVYK------VALNNEEAVAVRRLGNGGWQR-FKEFQTEAEAIGKI-RHPNIV 426
LG G V + + VAV+ L + + +E + + + +H NIV
Sbjct: 54 LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 427 SLRAYFWSVDEKLLIYDYIPNGSL--------ATAIHGKAGIISYRPLSWSDRLRIIKGV 478
+L L+I +Y G L A I+ S D L V
Sbjct: 114 NLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQV 173
Query: 479 AKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTT 538
A+G+AFL K +H D+ N+LL I DFGLAR DI +
Sbjct: 174 AQGMAFLAS---KNCIHRDVAARNVLLTNGHVAKIGDFGLAR--DIMND----------- 217
Query: 539 GTPLQSSPYEFTALNSTTSRSYYQ------------APEASKVRKPTQKWDIYSYGVILL 586
S Y APE+ T + D++SYG++L
Sbjct: 218 --------------------SNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLW 257
Query: 587 EMIS-GKLPMIQIGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEI-VSVLKIA 644
E+ S G P I ++ +L+ + + + + ++ I
Sbjct: 258 EIFSLGLNPYPGILVNS----KFYKLVKD-------------GYQMAQPAFAPKNIYSIM 300
Query: 645 LDCVHKSPDKRPSMRHVCDSLDR 667
C P RP+ + +C L
Sbjct: 301 QACWALEPTHRPTFQQICSFLQE 323
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 87.0 bits (215), Expect = 2e-18
Identities = 37/255 (14%), Positives = 74/255 (29%), Gaps = 43/255 (16%)
Query: 391 EEAVAVRRLGN----GGWQRFKEFQTEAEAIGKIRHPNIVSLRAYF--WSVDEKLLIYDY 444
EE + +R L + F + + + ++ +R V + +Y
Sbjct: 127 EEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPR 186
Query: 445 IPNGSLATAIHGKAGIIS-YRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNI 503
+L T S ++ L RL++ V + +A LH VH LRP +I
Sbjct: 187 -MQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGLVHTYLRPVDI 242
Query: 504 LLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQA 563
+L + ++ F + +P + P A
Sbjct: 243 VLDQRGGVFLTGFEHLVRDGASAVSP---------IGRGFAPP-------------ETTA 280
Query: 564 PEASKVRKPTQKW-----DIYSYGVILLEMISGKLPMIQIGSMELNIVQWIQLILEDRKP 618
+ D ++ G+ + + LP + + + I K
Sbjct: 281 ERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPN-----TDDAALGGSEWIFRSCKN 335
Query: 619 MTDILDPFLAHDLDK 633
+ + L L
Sbjct: 336 IPQPVRALLEGFLRY 350
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 85.6 bits (212), Expect = 3e-18
Identities = 51/233 (21%), Positives = 88/233 (37%), Gaps = 27/233 (11%)
Query: 374 LLGKSTIGIVYKV-ALNNEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIR-HPNIVSLRAY 431
+L + VY+ + + A++RL + ++ + E + K+ HPNIV +
Sbjct: 35 VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94
Query: 432 FWSVDEK-------LLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAF 484
E+ L+ + G L + S PLS L+I + +
Sbjct: 95 ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKME---SRGPLSCDTVLKIFYQTCRAVQH 151
Query: 485 LHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQS 544
+H P +H DL+ N+LL + DFG A P+ W + +
Sbjct: 152 MHRQKPP-IIHRDLKVENLLLSNQGTIKLCDFGSAT---TISHYPDYSW------SAQRR 201
Query: 545 SPYEFTALNSTTSRSYYQAPE--ASKVRKP-TQKWDIYSYGVILLEMISGKLP 594
+ E +TT Y+ PE P +K DI++ G IL + + P
Sbjct: 202 ALVEEEITRNTT--PMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP 252
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 87.5 bits (217), Expect = 3e-18
Identities = 40/162 (24%), Positives = 60/162 (37%), Gaps = 12/162 (7%)
Query: 66 NKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELF-NASNLQSLILSGNSFSGPVPMQ 124
++ T IP+ L +A+ ++L N + + +NLQ LIL + +
Sbjct: 14 SRSFT-SIPSGL--TAAMKSLDLSFNKIT-YIGHGDLRACANLQVLILKSSRINTIEGDA 69
Query: 125 IGKLKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLD 184
L L+ LDLS N SS S LK + L N + NLT LQ L
Sbjct: 70 FYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLR 129
Query: 185 LSFNNLSGLIP-NDIANLSRLRLLAQRVYVDLTYNNLSGLIP 225
+ I D A L+ L L ++ +L
Sbjct: 130 IGNVETFSEIRRIDFAGLTSLNEL------EIKALSLRNYQS 165
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 1e-17
Identities = 36/168 (21%), Positives = 74/168 (44%), Gaps = 11/168 (6%)
Query: 68 KLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELF-NASNLQSLILSGNSFSGPVPMQIG 126
K+T DL + + + + L+++ + ++ + F + +L+ L LS N S G
Sbjct: 37 KITYIGHGDLRACANLQVLILKSSRIN-TIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFG 95
Query: 127 KLKYLQVLDLSQNSFSS-SIPSSIVQCKRLKTVVL-NQNSFTGPLPDGFATNLTALQKLD 184
L L+ L+L N + + + S L+T+ + N +F+ FA LT+L +L+
Sbjct: 96 PLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFA-GLTSLNELE 154
Query: 185 LSFNNLSGLIPNDIANLSRLRLLAQRVYVDLTYNNLSGLIPQNAALLS 232
+ +L + ++ + L L + + L+ A +LS
Sbjct: 155 IKALSLRNYQSQSLKSIRDIHHL------TLHLSESAFLLEIFADILS 196
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 8e-15
Identities = 39/186 (20%), Positives = 70/186 (37%), Gaps = 34/186 (18%)
Query: 74 PADLGSLSAIGRVNLRNNNFSGSLPVELF---NASNLQSLILSGNSFSGPVPMQIGKLKY 130
A G+ ++ + L N+ S+ NL SL +S N+F P+P +
Sbjct: 354 SACKGAWPSLQTLVLSQNHLR-SMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEK 411
Query: 131 LQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNL 190
++ L+LS + + I Q L+ + ++ N+ F+ L LQ+L +S N L
Sbjct: 412 MRFLNLSSTGIRV-VKTCIPQ--TLEVLDVSNNNLDS-----FSLFLPRLQELYISRNKL 463
Query: 191 SGLIPNDIANLSRLRLLAQRVYVDLTYNNLSGLIPQNA-------ALLSLGPTAFIGNPF 243
L + L ++ ++ N L +P + L NP+
Sbjct: 464 KTLPDA--SLFPVLLVM------KISRNQLK-SVPDGIFDRLTSLQKIWLH-----TNPW 509
Query: 244 LCGPPL 249
C P
Sbjct: 510 DCSCPR 515
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 72.5 bits (178), Expect = 2e-13
Identities = 20/162 (12%), Positives = 47/162 (29%), Gaps = 10/162 (6%)
Query: 76 DLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQVLD 135
+ + G + + + ++ L + + L+ ++ +
Sbjct: 257 EFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRIT 316
Query: 136 LSQNSFSSSIPSSIVQCKRLKTVVLNQNSFT--GPLPDGFATNLTALQKLDLSFNNLSGL 193
+ + S K L+ + L++N +LQ L LS N+L +
Sbjct: 317 VENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSM 376
Query: 194 --IPNDIANLSRLRLLAQRVYVDLTYNNLSGLIPQNAALLSL 233
+ L L L D++ N + +
Sbjct: 377 QKTGEILLTLKNLTSL------DISRNTFHPMPDSCQWPEKM 412
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 4e-11
Identities = 21/176 (11%), Positives = 50/176 (28%), Gaps = 13/176 (7%)
Query: 61 SLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGP 120
L + + L F + L + S L IL +
Sbjct: 200 YLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVE-- 257
Query: 121 VPMQIGKLKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTAL 180
+ D + + V+ ++ + + Q + L +
Sbjct: 258 ----FDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLF-YDLSTVYSLLEKV 312
Query: 181 QKLDLSFNNLSGLIPNDIANLSRLRLLAQRVYVDLTYNNLSGLIPQNAALLSLGPT 236
+++ + + + + + +L L L DL+ N + +N+A P+
Sbjct: 313 KRITVENSKVFLVPCSFSQHLKSLEFL------DLSENLMVEEYLKNSACKGAWPS 362
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 1e-09
Identities = 24/164 (14%), Positives = 59/164 (35%), Gaps = 4/164 (2%)
Query: 73 IPADLGSLSAIGRVNLRNNNFSGSLPVELF-NASNLQSLILSGNSFSGPVPMQIGKLKYL 131
+ + +L+ + + + N + F ++L L + S + ++ +
Sbjct: 115 VTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDI 174
Query: 132 QVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTG--PLPDGFATNLTALQKLDLSFNN 189
L L + + + ++ + L + P + ++KL +
Sbjct: 175 HHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSV 234
Query: 190 LSGLIPNDIANLSRLRL-LAQRVYVDLTYNNLSGLIPQNAALLS 232
L+ N++ L R L L++ + D T N L P + ++S
Sbjct: 235 LTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVS 278
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 59.0 bits (143), Expect = 3e-09
Identities = 19/189 (10%), Positives = 60/189 (31%), Gaps = 19/189 (10%)
Query: 66 NKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNA-SNLQSLILSGNSFSGPVPMQ 124
+ + D L+++ + ++ + + + + ++ L L + + + +
Sbjct: 133 VETFSEIRRIDFAGLTSLNELEIKALSLR-NYQSQSLKSIRDIHHLTLHLSESAFLLEIF 191
Query: 125 IGKLKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFA---------T 175
L ++ L+L + + S + + + + + F
Sbjct: 192 ADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYIL 251
Query: 176 NLTALQKLDLSFNNLSGLIPNDIANLSRLRLLAQRVYVDLTYNNLSGLIPQNAALLSLGP 235
L+ ++ D + N L P++ +S L + V + ++ L
Sbjct: 252 ELSEVEFDDCTLNGLGDFNPSESDVVSELGKVET---VTIRRLHIPQF-----YLFYDLS 303
Query: 236 TAFIGNPFL 244
T + +
Sbjct: 304 TVYSLLEKV 312
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 2e-06
Identities = 16/112 (14%), Positives = 37/112 (33%), Gaps = 23/112 (20%)
Query: 73 IPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGKLKY-- 130
+P + +NL + + + L+ L +S N+ + + +L+
Sbjct: 402 MPDSCQWPEKMRFLNLSSTGIR-VVKTCIP--QTLEVLDVSNNNLDS-FSLFLPRLQELY 457
Query: 131 -----------------LQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSF 165
L V+ +S+N S + L+ + L+ N +
Sbjct: 458 ISRNKLKTLPDASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPW 509
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 2e-05
Identities = 19/99 (19%), Positives = 30/99 (30%), Gaps = 10/99 (10%)
Query: 47 CSWNGITCREGQVFS----LIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELF 102
S GI + + L + N L L L + + N +LP
Sbjct: 417 LSSTGIRVVKTCIPQTLEVLDVSNNNLD-SFSLFLPRLQ---ELYISRNKLK-TLPDASL 471
Query: 103 NASNLQSLILSGNSFSGPVPMQIGKLKYLQVLDLSQNSF 141
L + +S N +L LQ + L N +
Sbjct: 472 -FPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPW 509
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 3e-18
Identities = 27/182 (14%), Positives = 57/182 (31%), Gaps = 17/182 (9%)
Query: 63 IIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVP 122
+ P + I ++L V++ E +N + + ++
Sbjct: 3 VKPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPA 62
Query: 123 MQIGKLKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQK 182
+ + +++L+L+ + ++ + + N+ LP N+ L
Sbjct: 63 ALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRY-LPPHVFQNVPLLTV 121
Query: 183 LDLSFNNLSGLIPNDIANLSRLRLLAQRVYVDLTYNNLSGLIPQNAALLSLGPTAFIGNP 242
L L N+LS L N +L L ++ NNL + F
Sbjct: 122 LVLERNDLSSLPRGIFHNTPKLTTL------SMSNNNLE----------RIEDDTFQATT 165
Query: 243 FL 244
L
Sbjct: 166 SL 167
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 7e-17
Identities = 33/161 (20%), Positives = 54/161 (33%), Gaps = 12/161 (7%)
Query: 64 IPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELF-NASNLQSLILSGNSFSGPVP 122
GF L + V +N+ LP L + ++ L L+
Sbjct: 31 QTQDVYFGFEDITLNNQK---IVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIEEIDT 86
Query: 123 MQIGKLKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQK 182
+Q L + N+ P L +VL +N + LP G N L
Sbjct: 87 YAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSS-LPRGIFHNTPKLTT 145
Query: 183 LDLSFNNLSGLIPNDIANLSRLRLLAQRVYVDLTYNNLSGL 223
L +S NNL + + + L+ L L+ N L+ +
Sbjct: 146 LSMSNNNLERIEDDTFQATTSLQNL------QLSSNRLTHV 180
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 9e-17
Identities = 41/175 (23%), Positives = 69/175 (39%), Gaps = 15/175 (8%)
Query: 61 SLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELF-NASNLQSLILSGNSFSG 119
+ N + A L S + +NL + + F A +Q L + N+
Sbjct: 49 IVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRY 107
Query: 120 PVPMQIGKLKYLQVLDLSQNSFSSSIPSSI-VQCKRLKTVVLNQNSFTGPLPDGFATNLT 178
P + L VL L +N SS+P I +L T+ ++ N+ + D T
Sbjct: 108 LPPHVFQNVPLLTVLVLERNDL-SSLPRGIFHNTPKLTTLSMSNNNLER-IEDDTFQATT 165
Query: 179 ALQKLDLSFNNLSGLIPNDIANLSRLRLLAQRVYVDLTYNNLSGLIPQNAALLSL 233
+LQ L LS N L+ + + I +L +++YN LS + A+ L
Sbjct: 166 SLQNLQLSSNRLTHVDLSLIPSLFHA---------NVSYNLLS-TLAIPIAVEEL 210
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 9e-15
Identities = 31/152 (20%), Positives = 59/152 (38%), Gaps = 21/152 (13%)
Query: 73 IPAD-LGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGKLKYL 131
I D + +++ + L +N + + + L +L +S N S + +
Sbjct: 156 IEDDTFQATTSLQNLQLSSNRLT-HVDLSLI--PSLFHANVSYNLLS-----TLAIPIAV 207
Query: 132 QVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLS 191
+ LD S NS + + + L + L N+ T N L ++DLS+N L
Sbjct: 208 EELDASHNSINV-VRGPV--NVELTILKLQHNNLTDT--AWLL-NYPGLVEVDLSYNELE 261
Query: 192 GLIPNDIANLSRLRLLAQRVYVDLTYNNLSGL 223
++ + + RL L ++ N L L
Sbjct: 262 KIMYHPFVKMQRLERL------YISNNRLVAL 287
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 2e-13
Identities = 30/162 (18%), Positives = 55/162 (33%), Gaps = 15/162 (9%)
Query: 87 NLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQVLDLSQNSFSSSIP 146
L++NN + L N L + LS N + K++ L+ L +S N + +
Sbjct: 232 KLQHNNLT-DTAW-LLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LN 288
Query: 147 SSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSGLIPNDIANLSRLRL 206
LK + L+ N + L+ L L N++ L ++ L+
Sbjct: 289 LYGQPIPTLKVLDLSHNHLLH-VERNQP-QFDRLENLYLDHNSIVTL---KLSTHHTLKN 343
Query: 207 LAQRVYVDLTYNNLSGLIPQNAALLSLGPTAFIGNPFLCGPP 248
L L++N+ A ++ A C
Sbjct: 344 L------TLSHNDWDC-NSLRALFRNVARPAVDDADQHCKID 378
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 4e-06
Identities = 12/72 (16%), Positives = 28/72 (38%), Gaps = 4/72 (5%)
Query: 73 IPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQ 132
+ + + ++L +N+ + L++L L NS +++ L+
Sbjct: 287 LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV---TLKLSTHHTLK 342
Query: 133 VLDLSQNSFSSS 144
L LS N + +
Sbjct: 343 NLTLSHNDWDCN 354
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 4e-18
Identities = 62/294 (21%), Positives = 120/294 (40%), Gaps = 69/294 (23%)
Query: 375 LGKSTIGIVYKVALNNE--EAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVS-LRAY 431
+G+ + GIV A VAV+ + QR + E + +H N+V ++Y
Sbjct: 53 IGEGSTGIVCL-AREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSY 111
Query: 432 FWSVDEKL-LIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSP 490
V E+L ++ +++ G+L I+S L+ + + V + +A+LH
Sbjct: 112 L--VGEELWVLMEFLQGGALTD-------IVSQVRLNEEQIATVCEAVLQALAYLHA--- 159
Query: 491 KRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFT 550
+ +H D++ +ILL + +SDFG A+ + +V +S GTP
Sbjct: 160 QGVIHRDIKSDSILLTLDGRVKLSDFGFC-----AQISKDVPKRKSLVGTP--------- 205
Query: 551 ALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQWIQ 610
Y+ APE + DI+S G++++EM+ G+ P + VQ ++
Sbjct: 206 ---------YWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPY-----FSDSPVQAMK 251
Query: 611 LI-------LEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPS 657
+ L++ ++ +L FL + + P +R +
Sbjct: 252 RLRDSPPPKLKNSHKVSPVLRDFLER-----------------MLVRDPQERAT 288
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 5e-18
Identities = 77/328 (23%), Positives = 143/328 (43%), Gaps = 61/328 (18%)
Query: 344 MSENMEQYEFVPLDSQVDFDLEQLLKASAFLLGKSTIGIVYKVALNNE--EAVAVRRLGN 401
MSE+ + ++ D++L++++ G +V A E VA++R+
Sbjct: 1 MSEDSSALPW-SINRD-DYELQEVI-------GSGATAVVQA-AYCAPKKEKVAIKRINL 50
Query: 402 GGWQ-RFKEFQTEAEAIGKIRHPNIVSLRAYFWS--VDEKL-LIYDYIPNGSLATAIHGK 457
Q E E +A+ + HPNIVS Y+ S V ++L L+ + GS+ I
Sbjct: 51 EKCQTSMDELLKEIQAMSQCHHPNIVS---YYTSFVVKDELWLVMKLLSGGSVLDIIKHI 107
Query: 458 AGIISYRPLSWSDRL--RIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISD 515
++ + I++ V +G+ +LH+ +H D++ NILLG++ I+D
Sbjct: 108 VAKGEHKSGVLDESTIATILREVLEGLEYLHK---NGQIHRDVKAGNILLGEDGSVQIAD 164
Query: 516 FGLARLADIAEETPEVHWEQSTT--GTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKP- 572
FG++ A +A + T GTP + APE + +
Sbjct: 165 FGVS--AFLATGGDITRNKVRKTFVGTP------------------CWMAPEVMEQVRGY 204
Query: 573 TQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQWIQLILEDRKPM--TDILDPFLAHD 630
K DI+S+G+ +E+ +G P + M++ + L L++ P T + D +
Sbjct: 205 DFKADIWSFGITAIELATGAAPYHKYPPMKV-----LMLTLQNDPPSLETGVQDKEMLKK 259
Query: 631 LDKE-DEIVSVLKIALDCVHKSPDKRPS 657
K +++S+ C+ K P+KRP+
Sbjct: 260 YGKSFRKMISL------CLQKDPEKRPT 281
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 7e-18
Identities = 80/383 (20%), Positives = 125/383 (32%), Gaps = 81/383 (21%)
Query: 313 KWGEKVGGCRLEEKLMIKKEFFCFTRNNLDTMSENMEQYEFVPLDSQVDFDLEQL-LKAS 371
K+ ++ R E +L + + ++ + + +Y D + +F E L
Sbjct: 2 KYKKQF---RYESQLQMVQVT---GSSDNEYFYVDFREY---EYDLKWEFPRENLEFGK- 51
Query: 372 AFLLGKSTIGIVYK------VALNNEEAVAVRRLGNGGWQR-FKEFQTEAEAIGKI-RHP 423
+LG G V VAV+ L + +E + + ++ H
Sbjct: 52 --VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHE 109
Query: 424 NIVSLRAYFWSVDEKLLIYDYIPNGSL-----------------ATAIHGKAGIISYRPL 466
NIV+L LI++Y G L L
Sbjct: 110 NIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVL 169
Query: 467 SWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAE 526
++ D L VAKG+ FL K VH DL N+L+ I DFGLAR DI
Sbjct: 170 TFEDLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLAR--DIMS 224
Query: 527 ETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILL 586
+ L P ++ APE+ T K D++SYG++L
Sbjct: 225 D----SNYVVRGNARL---PVKWM------------APESLFEGIYTIKSDVWSYGILLW 265
Query: 587 EMIS-GKLPMIQIGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVL-KIA 644
E+ S G P I + +LI +D+ + I
Sbjct: 266 EIFSLGVNPYPGIPVDA----NFYKLIQN-------------GFKMDQPFYATEEIYIIM 308
Query: 645 LDCVHKSPDKRPSMRHVCDSLDR 667
C KRPS ++ L
Sbjct: 309 QSCWAFDSRKRPSFPNLTSFLGC 331
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 7e-18
Identities = 86/355 (24%), Positives = 142/355 (40%), Gaps = 69/355 (19%)
Query: 344 MSENMEQYEFVPLDSQVDFDLEQL-LKASAFLLGKSTIGIVYK--------VALNNEEAV 394
M + +YE +P D + + ++L L LG+ G V N V
Sbjct: 49 MLAGVSEYE-LPEDPRWELPRDRLVLGK---PLGEGAFGQVVLAEAIGLDKDKPNRVTKV 104
Query: 395 AVRRLGNGGWQR-FKEFQTEAEAIGKI-RHPNIVSLRAYFWSVDEKLLIYDYIPNGSL-- 450
AV+ L + ++ + +E E + I +H NI++L +I +Y G+L
Sbjct: 105 AVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLRE 164
Query: 451 --------ATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSN 502
LS D + VA+G+ +L + K+ +H DL N
Sbjct: 165 YLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARN 221
Query: 503 ILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQ 562
+L+ ++ I+DFGLAR DI + + TT L P ++
Sbjct: 222 VLVTEDNVMKIADFGLAR--DIHHI----DYYKKTTNGRL---PVKWM------------ 260
Query: 563 APEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQIGSMELNIVQWIQLILEDRKPMTD 621
APEA R T + D++S+GV+L E+ + G P + EL +L+ E
Sbjct: 261 APEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL-----FKLLKEG------ 309
Query: 622 ILDPFLAHDLDKEDEIVSVL-KIALDCVHKSPDKRPSMRHVCDSLDRVNISTEQQ 675
H +DK + L + DC H P +RP+ + + + LDR+ T Q
Sbjct: 310 -------HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQ 357
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 1e-17
Identities = 66/294 (22%), Positives = 123/294 (41%), Gaps = 69/294 (23%)
Query: 375 LGKSTIGIVYKVALNNE--EAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVS-LRAY 431
+G+ G VY A++ + VA+R++ + + E + + ++PNIV+ L +Y
Sbjct: 28 IGQGASGTVYT-AMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 432 FWSVDEKL-LIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSP 490
V ++L ++ +Y+ GSL +++ + + + + + FLH
Sbjct: 87 L--VGDELWVVMEYLAGGSLTD-------VVTETCMDEGQIAAVCRECLQALEFLHS--- 134
Query: 491 KRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFT 550
+ +H D++ NILLG + ++DFG A+ TPE + GTP
Sbjct: 135 NQVIHRDIKSDNILLGMDGSVKLTDFGFC-----AQITPEQSKRSTMVGTP--------- 180
Query: 551 ALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQWIQ 610
Y+ APE + K DI+S G++ +EMI G+ P + N ++ +
Sbjct: 181 ---------YWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPY-----LNENPLRALY 226
Query: 611 LI-------LEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPS 657
LI L++ + ++ I FL C+ +KR S
Sbjct: 227 LIATNGTPELQNPEKLSAIFRDFLNR-----------------CLEMDVEKRGS 263
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 84.6 bits (209), Expect = 1e-17
Identities = 59/327 (18%), Positives = 104/327 (31%), Gaps = 80/327 (24%)
Query: 376 GKSTIGIVYKVALNNE--EAVAVRR--LGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAY 431
G + V A E V VRR L + Q E HPNIV Y
Sbjct: 36 GFEDLMTVNL-ARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVP---Y 91
Query: 432 FWS--VDEKL-LIYDYIPNGSLATAIHGKAG------IISYRPLSWSDRLRIIKGVAKGI 482
+ D +L ++ ++ GS I I+Y I++GV K +
Sbjct: 92 RATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAY----------ILQGVLKAL 141
Query: 483 AFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFG-LARLADIAEETPEVH-WEQSTTGT 540
++H YVH ++ S+IL+ + + ++S + + VH + + +
Sbjct: 142 DYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKV 198
Query: 541 PLQSSPYEFTALNSTTSRSYYQAPE--ASKVRKPTQKWDIYSYGVILLEMISGKLPMIQI 598
+ +PE ++ K DIYS G+ E+ +G +P +
Sbjct: 199 L------------------PWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDM 240
Query: 599 GSME--LNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALD---------- 646
+ + L + L D + + L +
Sbjct: 241 PATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSH 300
Query: 647 ----------------CVHKSPDKRPS 657
C+ ++PD RPS
Sbjct: 301 PYHRTFSPHFHHFVEQCLQRNPDARPS 327
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 85.4 bits (211), Expect = 2e-17
Identities = 27/182 (14%), Positives = 57/182 (31%), Gaps = 17/182 (9%)
Query: 63 IIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVP 122
+ P + I ++L V++ E +N + + ++
Sbjct: 9 VKPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPA 68
Query: 123 MQIGKLKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQK 182
+ + +++L+L+ + ++ + + N+ LP N+ L
Sbjct: 69 ALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRY-LPPHVFQNVPLLTV 127
Query: 183 LDLSFNNLSGLIPNDIANLSRLRLLAQRVYVDLTYNNLSGLIPQNAALLSLGPTAFIGNP 242
L L N+LS L N +L L ++ NNL + F
Sbjct: 128 LVLERNDLSSLPRGIFHNTPKLTTL------SMSNNNLE----------RIEDDTFQATT 171
Query: 243 FL 244
L
Sbjct: 172 SL 173
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 82.3 bits (203), Expect = 2e-16
Identities = 33/161 (20%), Positives = 54/161 (33%), Gaps = 12/161 (7%)
Query: 64 IPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELF-NASNLQSLILSGNSFSGPVP 122
GF L + V +N+ LP L + ++ L L+
Sbjct: 37 QTQDVYFGFEDITLNNQK---IVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIEEIDT 92
Query: 123 MQIGKLKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQK 182
+Q L + N+ P L +VL +N + LP G N L
Sbjct: 93 YAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSS-LPRGIFHNTPKLTT 151
Query: 183 LDLSFNNLSGLIPNDIANLSRLRLLAQRVYVDLTYNNLSGL 223
L +S NNL + + + L+ L L+ N L+ +
Sbjct: 152 LSMSNNNLERIEDDTFQATTSLQNL------QLSSNRLTHV 186
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 81.5 bits (201), Expect = 3e-16
Identities = 41/175 (23%), Positives = 69/175 (39%), Gaps = 15/175 (8%)
Query: 61 SLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELF-NASNLQSLILSGNSFSG 119
+ N + A L S + +NL + + F A +Q L + N+
Sbjct: 55 IVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRY 113
Query: 120 PVPMQIGKLKYLQVLDLSQNSFSSSIPSSI-VQCKRLKTVVLNQNSFTGPLPDGFATNLT 178
P + L VL L +N SS+P I +L T+ ++ N+ + D T
Sbjct: 114 LPPHVFQNVPLLTVLVLERNDL-SSLPRGIFHNTPKLTTLSMSNNNLER-IEDDTFQATT 171
Query: 179 ALQKLDLSFNNLSGLIPNDIANLSRLRLLAQRVYVDLTYNNLSGLIPQNAALLSL 233
+LQ L LS N L+ + + I +L +++YN LS + A+ L
Sbjct: 172 SLQNLQLSSNRLTHVDLSLIPSLFHA---------NVSYNLLS-TLAIPIAVEEL 216
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 77.3 bits (190), Expect = 7e-15
Identities = 31/152 (20%), Positives = 59/152 (38%), Gaps = 21/152 (13%)
Query: 73 IPAD-LGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGKLKYL 131
I D + +++ + L +N + + + L +L +S N S + +
Sbjct: 162 IEDDTFQATTSLQNLQLSSNRLT-HVDLSLI--PSLFHANVSYNLLS-----TLAIPIAV 213
Query: 132 QVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLS 191
+ LD S NS + + + L + L N+ T N L ++DLS+N L
Sbjct: 214 EELDASHNSINV-VRGPV--NVELTILKLQHNNLTDT--AWLL-NYPGLVEVDLSYNELE 267
Query: 192 GLIPNDIANLSRLRLLAQRVYVDLTYNNLSGL 223
++ + + RL L ++ N L L
Sbjct: 268 KIMYHPFVKMQRLERL------YISNNRLVAL 293
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 72.3 bits (177), Expect = 2e-13
Identities = 31/177 (17%), Positives = 59/177 (33%), Gaps = 15/177 (8%)
Query: 87 NLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQVLDLSQNSFSSSIP 146
L++NN + L N L + LS N + K++ L+ L +S N + +
Sbjct: 238 KLQHNNLT-DTAW-LLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LN 294
Query: 147 SSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSGLIPNDIANLSRLRL 206
LK + L+ N + L+ L L N++ L ++ L+
Sbjct: 295 LYGQPIPTLKVLDLSHNHLLH-VERNQP-QFDRLENLYLDHNSIVTL---KLSTHHTLKN 349
Query: 207 LAQRVYVDLTYNNLSGLIPQNAALLSLGPTAFIGNPFLCGPPLKVSCPSSTSDHPYP 263
L L++N+ A ++ A C ++ + P
Sbjct: 350 L------TLSHNDWDC-NSLRALFRNVARPAVDDADQHCKIDYQLEHGLCCKESDKP 399
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 49.2 bits (117), Expect = 3e-06
Identities = 24/173 (13%), Positives = 54/173 (31%), Gaps = 12/173 (6%)
Query: 73 IPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQ 132
+ + + ++L +N+ + L++L L NS +++ L+
Sbjct: 293 LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV---TLKLSTHHTLK 348
Query: 133 VLDLSQNSFS-SSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLS 191
L LS N + +S+ + R +Q+ L S
Sbjct: 349 NLTLSHNDWDCNSLRALFRNVARPAVDDADQHCKID-------YQLEHGLCCKESDKPYL 401
Query: 192 GLIPNDIANLSRLRLLAQRVYVDLTYNNLSGLIPQNAALLSLGPTAFIGNPFL 244
+ IA S + + + + ++ + + + G GN L
Sbjct: 402 DRLLQYIALTSVVEKVQRAQGRCSATDTINSVQSLSHYITQQGGVPLQGNEQL 454
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 43.0 bits (101), Expect = 3e-04
Identities = 23/168 (13%), Positives = 48/168 (28%), Gaps = 11/168 (6%)
Query: 73 IPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQI-GKLKYL 131
+ + + + L +N+ +L + L++L LS N + + +
Sbjct: 316 VERNQPQFDRLENLYLDHNSIV-TLKLSTH--HTLKNLTLSHNDWDCNSLRALFRNVARP 372
Query: 132 QVLDLSQNSFSSSIPSSIVQC----KRLKTVVLNQNSFTGPL--PDGFATNLTALQKLDL 185
V D Q+ + C K +L + T + +A ++
Sbjct: 373 AVDDADQHCKIDYQLEHGLCCKESDKPYLDRLLQYIALTSVVEKVQRAQGRCSATDTINS 432
Query: 186 SFNNLSGLIPNDIANLSRLRLLAQRVY-VDLTYNNLSGLIPQNAALLS 232
+ + L L V + L+ Q LL
Sbjct: 433 VQSLSHYITQQGGVPLQGNEQLEAEVNELRAEVQQLTNEQIQQEQLLQ 480
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 84.5 bits (209), Expect = 2e-17
Identities = 64/312 (20%), Positives = 113/312 (36%), Gaps = 62/312 (19%)
Query: 374 LLGKSTIGIVYKVALNNEEAVAVRRLGNGGWQRFKEFQTEAEAIGKI-RHPNIVSLRAYF 432
+LG + G V VAV+R+ E + + + HPN++
Sbjct: 22 ILGYGSSGTVVFQGSFQGRPVAVKRMLI---DFCDIALMEIKLLTESDDHPNVIRYYCSE 78
Query: 433 WSVDEKLLIYDYIPNGSLATAIHGK-AGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPK 491
+ + + N +L + K + + + + +++ +A G+A LH
Sbjct: 79 TTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS---L 134
Query: 492 RYVHGDLRPSNILLGKNMEPH-------------ISDFGLARLADIAEETPEVHWEQSTT 538
+ +H DL+P NIL+ + ISDFGL + D + + + + +
Sbjct: 135 KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNL-NNPS 193
Query: 539 GTPLQSSPYEFTALNSTTSRSYYQAPE-------ASKVRKPTQKWDIYSYGVILLEMIS- 590
GT ++APE R+ T+ DI+S G + ++S
Sbjct: 194 GTS------------------GWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235
Query: 591 GKLPMIQIGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHK 650
GK P S E NI++ L++ K + D A DL +
Sbjct: 236 GKHPFGDKYSRESNIIR-GIFSLDEMKCLHDRSLIAEATDLIS------------QMIDH 282
Query: 651 SPDKRPSMRHVC 662
P KRP+ V
Sbjct: 283 DPLKRPTAMKVL 294
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 83.3 bits (206), Expect = 2e-17
Identities = 44/264 (16%), Positives = 84/264 (31%), Gaps = 66/264 (25%)
Query: 375 LGKSTIGIVYKVA-LNNEEAVAV-----RRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSL 428
+G+ + G+V A+ ++ + + +TE + K+ HPNI L
Sbjct: 34 IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93
Query: 429 RAYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRL---------------- 472
+ L+ + G L ++ + + +
Sbjct: 94 YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGS 153
Query: 473 ------------------RIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLG--KNMEPH 512
I++ + + +LH + H D++P N L K+ E
Sbjct: 154 IHGFRESLDFVQREKLISNIMRQIFSALHYLHN---QGICHRDIKPENFLFSTNKSFEIK 210
Query: 513 ISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPE--ASKVR 570
+ DFGL++ + GTP Y+ APE +
Sbjct: 211 LVDFGLSKEFYKLNNGEYYGM-TTKAGTP------------------YFVAPEVLNTTNE 251
Query: 571 KPTQKWDIYSYGVILLEMISGKLP 594
K D +S GV+L ++ G +P
Sbjct: 252 SYGPKCDAWSAGVLLHLLLMGAVP 275
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 3e-17
Identities = 81/379 (21%), Positives = 134/379 (35%), Gaps = 117/379 (30%)
Query: 341 LDTMSENMEQYEFVPLDSQVDFDLE------QLLKASAFLLGKSTIGIVYKVALNN---- 390
LD + N L + LE + ++ +G+ G V++
Sbjct: 19 LDRLHPNPMYQRMPLLLNPKLLSLEYPRNNIEYVR----DIGEGAFGRVFQARAPGLLPY 74
Query: 391 --EEAVAVRRL-GNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEK--LLIYDYI 445
VAV+ L +FQ EA + + +PNIV L K L+++Y+
Sbjct: 75 EPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGV--CAVGKPMCLLFEYM 132
Query: 446 PNGSL------------------ATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHE 487
G L + + PLS +++L I + VA G+A+L E
Sbjct: 133 AYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE 192
Query: 488 VSPKRYVHGDL--RPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSS 545
+++VH DL R N L+G+NM I+DFGL+R +I
Sbjct: 193 ---RKFVHRDLATR--NCLVGENMVVKIADFGLSR--NIYSA------------------ 227
Query: 546 PYEFTALNSTTSRSYYQ------------APEASKVRKPTQKWDIYSYGVILLEMIS-GK 592
YY+ PE+ + T + D+++YGV+L E+ S G
Sbjct: 228 -------------DYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL 274
Query: 593 LPMIQIGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDK----EDEIVSVLKIALDCV 648
P + E+ I + + + L E+ +++ C
Sbjct: 275 QPYYGMAHEEV-----IYYVRD-------------GNILACPENCPLELYNLM---RLCW 313
Query: 649 HKSPDKRPSMRHVCDSLDR 667
K P RPS + L R
Sbjct: 314 SKLPADRPSFCSIHRILQR 332
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 8e-17
Identities = 61/299 (20%), Positives = 114/299 (38%), Gaps = 79/299 (26%)
Query: 375 LGKSTIGIVYKVA-LNNEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFW 433
LG+ + G VYK + VA++++ +E E + + P++V Y+
Sbjct: 37 LGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPHVVK---YYG 91
Query: 434 S--VDEKL-LIYDYIPNGSLATAIHGKAGI-----ISYRPLSWSDRLRIIKGVAKGIAFL 485
S + L ++ +Y GS++ I + I+ I++ KG+ +L
Sbjct: 92 SYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIAT----------ILQSTLKGLEYL 141
Query: 486 HEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSS 545
H R +H D++ NILL ++DFG+A + T + + GTP
Sbjct: 142 HF---MRKIHRDIKAGNILLNTEGHAKLADFGVA-----GQLTDTMAKRNTVIGTP---- 189
Query: 546 PYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNI 605
++ APE + DI+S G+ +EM GK P +++
Sbjct: 190 --------------FWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPY-----ADIHP 230
Query: 606 VQWIQLI-------LEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPS 657
++ I +I + +D F+ C+ KSP++R +
Sbjct: 231 MRAIFMIPTNPPPTFRKPELWSDNFTDFVKQ-----------------CLVKSPEQRAT 272
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 3e-16
Identities = 53/222 (23%), Positives = 84/222 (37%), Gaps = 38/222 (17%)
Query: 48 SWNGITCREGQVFS-------LIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVE 100
N I E F+ L + + LT LS + + LRNN S+P
Sbjct: 107 GRNSIRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIE-SIPSY 165
Query: 101 LFNA-SNLQSLILSGN---------SFSGPVPMQIGKLKYLQVLDLSQNSFSSSIPSSIV 150
FN +L L L +F G L L+ L+L + +P+ +
Sbjct: 166 AFNRVPSLMRLDLGELKKLEYISEGAFEG--------LFNLKYLNLGMCNIKD-MPN-LT 215
Query: 151 QCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSGLIPNDIANLSRLRLLAQR 210
L+ + ++ N F P F L++L+KL + + +S + N L+ L L
Sbjct: 216 PLVGLEELEMSGNHFPEIRPGSF-HGLSSLKKLWVMNSQVSLIERNAFDGLASLVEL--- 271
Query: 211 VYVDLTYNNLSGLIPQNA--ALLSLGPTAFIGNPFLCGPPLK 250
+L +NNLS L P + L L NP+ C +
Sbjct: 272 ---NLAHNNLSSL-PHDLFTPLRYLVELHLHHNPWNCDCDIL 309
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 70.2 bits (172), Expect = 7e-13
Identities = 33/144 (22%), Positives = 51/144 (35%), Gaps = 10/144 (6%)
Query: 85 RVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQVLDLSQNSFSSS 144
+V S +P + SN + L L N+ L +L+VL L +NS
Sbjct: 58 KVVCTRRGLS-EVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQI 114
Query: 145 IPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSGLIPNDIANLSRL 204
+ L T+ L N T +P G L+ L++L L N + + + L
Sbjct: 115 EVGAFNGLASLNTLELFDNWLTV-IPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSL 173
Query: 205 RLLAQRVYVDLTYNNLSGLIPQNA 228
L DL I + A
Sbjct: 174 MRL------DLGELKKLEYISEGA 191
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 52.1 bits (125), Expect = 3e-07
Identities = 21/114 (18%), Positives = 38/114 (33%), Gaps = 20/114 (17%)
Query: 131 LQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNL 190
+ ++ S +P I + + L +N+ D F +L L+ L L N++
Sbjct: 56 FSKVVCTRRGLSE-VPQGIP--SNTRYLNLMENNIQMIQADTFR-HLHHLEVLQLGRNSI 111
Query: 191 SGLIPNDIANLSRLRLLAQRVYVDLTYNNLSGLIPQNAALLSLGPTAFIGNPFL 244
+ L+ L L +L N L+ + AF L
Sbjct: 112 RQIEVGAFNGLASLNTL------ELFDNWLT----------VIPSGAFEYLSKL 149
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 81.4 bits (201), Expect = 3e-16
Identities = 50/223 (22%), Positives = 91/223 (40%), Gaps = 35/223 (15%)
Query: 375 LGKSTIGIVYK-VALNNEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFW 433
LG G+V++ A + + + + E + + +RHP +V+L F
Sbjct: 165 LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFE 224
Query: 434 SVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRY 493
+E ++IY+++ G L + + +S + + ++ V KG+ +HE Y
Sbjct: 225 DDNEMVMIYEFMSGGELFEKVADEHNKMSED-----EAVEYMRQVCKGLCHMHE---NNY 276
Query: 494 VHGDLRPSNILLGKNMEPHI--SDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTA 551
VH DL+P NI+ + DFGL D + + TTGT
Sbjct: 277 VHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSV------KVTTGTA---------- 320
Query: 552 LNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLP 594
+ APE ++ + D++S GV+ ++SG P
Sbjct: 321 --------EFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSP 355
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 4e-16
Identities = 53/231 (22%), Positives = 86/231 (37%), Gaps = 44/231 (19%)
Query: 375 LGKSTIGIVYKV---ALNNEEAV---AVRRLGNGGWQRFKE-FQTEAEAIGKIRHPNIVS 427
LG IV K + E A R+ +E + E + ++ H N+++
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 428 LRAYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHE 487
L + + + +LI + + G L + LS + IK + G+ +LH
Sbjct: 80 LHDVYENRTDVVLILELVSGGELFDF------LAQKESLSEEEATSFIKQILDGVNYLHT 133
Query: 488 VSPKRYVHGDLRPSNILLGKNMEPH----ISDFGLARLADIAEETPEVHWEQSTTGTPLQ 543
K+ H DL+P NI+L P + DFGLA + E + GTP
Sbjct: 134 ---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNI------FGTP-- 182
Query: 544 SSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLP 594
+ APE + D++S GVI ++SG P
Sbjct: 183 ----------------EFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 79.8 bits (197), Expect = 5e-16
Identities = 53/222 (23%), Positives = 85/222 (38%), Gaps = 38/222 (17%)
Query: 48 SWNGITCREGQVFS-------LIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVE 100
S N I E F+ L + + +LT LS + + LRNN S+P
Sbjct: 96 SRNHIRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIE-SIPSY 154
Query: 101 LFNA-SNLQSLILSGN---------SFSGPVPMQIGKLKYLQVLDLSQNSFSSSIPSSIV 150
FN +L+ L L +F G L L+ L+L+ + IP+ +
Sbjct: 155 AFNRIPSLRRLDLGELKRLSYISEGAFEG--------LSNLRYLNLAMCNLRE-IPN-LT 204
Query: 151 QCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSGLIPNDIANLSRLRLLAQR 210
+L + L+ N + + G L LQKL + + + + N NL L +
Sbjct: 205 PLIKLDELDLSGNHLSA-IRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEI--- 260
Query: 211 VYVDLTYNNLSGLIPQNA--ALLSLGPTAFIGNPFLCGPPLK 250
+L +NNL+ L P + L L NP+ C +
Sbjct: 261 ---NLAHNNLTLL-PHDLFTPLHHLERIHLHHNPWNCNCDIL 298
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 1e-09
Identities = 26/139 (18%), Positives = 45/139 (32%), Gaps = 34/139 (24%)
Query: 85 RVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQVLDLSQNSFSSS 144
+V N +P + +N + L L N L++L++L LS+N +
Sbjct: 47 KVICVRKNLR-EVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRT- 102
Query: 145 IPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSGLIPNDIANLSRL 204
+ G L L L+L N L+ + LS+L
Sbjct: 103 ------------------------IEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKL 138
Query: 205 RLLAQRVYVDLTYNNLSGL 223
+ L L N + +
Sbjct: 139 KEL------WLRNNPIESI 151
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 7e-16
Identities = 30/166 (18%), Positives = 61/166 (36%), Gaps = 20/166 (12%)
Query: 61 SLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGP 120
+ + N +T + I + + N + + P + SNL+ L + G +
Sbjct: 48 YITLANINVTDLTG--IEYAHNIKDLTINNIHATNYNP--ISGLSNLERLRIMGKDVTSD 103
Query: 121 VPMQIGKLKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTG---PLPDGFATNL 177
+ L L +LD+S ++ SI + I ++ ++ L+ N PL L
Sbjct: 104 KIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMPL-----KTL 158
Query: 178 TALQKLDLSFNNLSGLIPNDIANLSRLRLLAQRVYVDLTYNNLSGL 223
L+ L++ F+ + I + +L L + G
Sbjct: 159 PELKSLNIQFDGVHDYRG--IEDFPKLNQL------YAFSQTIGGK 196
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 1e-12
Identities = 25/155 (16%), Positives = 54/155 (34%), Gaps = 14/155 (9%)
Query: 79 SLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQVLDLSQ 138
+ A L ++ + + ++L + L+ + + I ++ L ++
Sbjct: 21 TFKAYLNGLLGQSSTA---NITEAQMNSLTYITLANINVTDLTG--IEYAHNIKDLTINN 75
Query: 139 NSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSGLIPNDI 198
++ + I L+ + + T + LT+L LD+S + I I
Sbjct: 76 IHATNY--NPISGLSNLERLRIMGKDVTSDKIPNLS-GLTSLTLLDISHSAHDDSILTKI 132
Query: 199 ANLSRLRLLAQRVYVDLTYNNLSGLIPQNAALLSL 233
L ++ + DL+YN I L L
Sbjct: 133 NTLPKVNSI------DLSYNGAITDIMPLKTLPEL 161
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 4e-10
Identities = 18/125 (14%), Positives = 49/125 (39%), Gaps = 15/125 (12%)
Query: 105 SNLQSLILSGNSFSGPVPMQIGKLKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNS 164
S ++ + S + ++ L + L+ + + + I +K + +N
Sbjct: 20 STFKAYLNGLLGQSSTANITEAQMNSLTYITLANINVTDL--TGIEYAHNIKDLTINNIH 77
Query: 165 FT--GPLPDGFATNLTALQKLDLSFNNLSGLIPNDIANLSRLRLLAQRVYVDLTYNNLSG 222
T P+ + L+ L++L + +++ +++ L+ L LL D++++
Sbjct: 78 ATNYNPI-----SGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLL------DISHSAHDD 126
Query: 223 LIPQN 227
I
Sbjct: 127 SILTK 131
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 7e-16
Identities = 38/219 (17%), Positives = 69/219 (31%), Gaps = 39/219 (17%)
Query: 61 SLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNA-SNLQSLILSGNSFSG 119
+ + +++ A + + + L +N + + F + L+ L LS N+
Sbjct: 36 RIFLHGNRISHVPAASFRACRNLTILWLHSNVLA-RIDAAAFTGLALLEQLDLSDNAQLR 94
Query: 120 PVPMQI-GKLKYLQVLDLSQNSFSSSIPSSI-VQCKRLKTVVLNQNSFTGPLPDGFATNL 177
V L L L L + + + L+ + L N+ LPD +L
Sbjct: 95 SVDPATFHGLGRLHTLHLDRCGLQE-LGPGLFRGLAALQYLYLQDNALQA-LPDDTFRDL 152
Query: 178 TALQKLDLSFNNLSGLIPNDIANLSRLRLLAQRVYVDLTYNNLSGLIPQNA--------- 228
L L L N +S + L L L L N ++ + +A
Sbjct: 153 GNLTHLFLHGNRISSVPERAFRGLHSLDRL------LLHQNRVAH-VHPHAFRDLGRLMT 205
Query: 229 ------ALLSLGPTAFI-----------GNPFLCGPPLK 250
L +L A NP++C +
Sbjct: 206 LYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRAR 244
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 1e-12
Identities = 28/143 (19%), Positives = 48/143 (33%), Gaps = 10/143 (6%)
Query: 86 VNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQVLDLSQNSFSSSI 145
+ ++PV + + Q + L GN S + L +L L N +
Sbjct: 16 TSCPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARID 72
Query: 146 PSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSGLIPNDIANLSRLR 205
++ L+ + L+ N+ + L L L L L L P L+ L+
Sbjct: 73 AAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQ 132
Query: 206 LLAQRVYVDLTYNNLSGLIPQNA 228
L L N L +P +
Sbjct: 133 YL------YLQDNALQ-ALPDDT 148
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 8e-16
Identities = 67/324 (20%), Positives = 131/324 (40%), Gaps = 75/324 (23%)
Query: 344 MSENMEQYEFVPLDSQVDFDLEQLLKASAFLLGKSTIGIVYKVALNNE--EAVAVRRLGN 401
+ + + + D + F + + GK + G V+K ++N + VA++ +
Sbjct: 6 VQSGLPGMQNLKADPEELFTKLEKI-------GKGSFGEVFK-GIDNRTQKVVAIKIIDL 57
Query: 402 GGWQ-RFKEFQTEAEAIGKIRHPNIVSLRAYFWS--VDEKL-LIYDYIPNGSLATAIHGK 457
+ ++ Q E + + P + Y+ S D KL +I +Y+ GS +
Sbjct: 58 EEAEDEIEDIQQEITVLSQCDSPYVTK---YYGSYLKDTKLWIIMEYLGGGSALDLLEPG 114
Query: 458 A---GIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHIS 514
I+ I++ + KG+ +LH ++ +H D++ +N+LL ++ E ++
Sbjct: 115 PLDETQIAT----------ILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLA 161
Query: 515 DFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQ 574
DFG+A + T + GTP ++ APE K
Sbjct: 162 DFGVA-----GQLTDTQIKRNTFVGTP------------------FWMAPEVIKQSAYDS 198
Query: 575 KWDIYSYGVILLEMISGKLPMIQIGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKE 634
K DI+S G+ +E+ G+ P ++ M++ + LI ++ P L + K
Sbjct: 199 KADIWSLGITAIELARGEPPHSELHPMKV-----LFLIPKNNPPT-------LEGNYSKP 246
Query: 635 -DEIVSVLKIALDCVHKSPDKRPS 657
E V C++K P RP+
Sbjct: 247 LKEFVEA------CLNKEPSFRPT 264
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 8e-16
Identities = 56/232 (24%), Positives = 89/232 (38%), Gaps = 46/232 (19%)
Query: 375 LGKSTIGIVYKV---ALNNEEAV---AVRRLGNGGWQRFKE-FQTEAEAIGKIRHPNIVS 427
LG IV K + E A R+ +E + E + ++ HPNI++
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79
Query: 428 LRAYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHE 487
L + + + +LI + + G L + LS + IK + G+ +LH
Sbjct: 80 LHDVYENRTDVVLILELVSGGELFDF------LAQKESLSEEEATSFIKQILDGVNYLHT 133
Query: 488 VSPKRYVHGDLRPSNILLGKNMEPH----ISDFGLARLADIAEETPEVHWEQSTTGTPLQ 543
K+ H DL+P NI+L P + DFGLA + E + GTP
Sbjct: 134 ---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNI------FGTP-- 182
Query: 544 SSPYEFTALNSTTSRSYYQAPEASKVRKP-TQKWDIYSYGVILLEMISGKLP 594
+ APE +P + D++S GVI ++SG P
Sbjct: 183 ----------------EFVAPEIVN-YEPLGLEADMWSIGVITYILLSGASP 217
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 79.4 bits (196), Expect = 9e-16
Identities = 32/189 (16%), Positives = 60/189 (31%), Gaps = 11/189 (5%)
Query: 61 SLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELF-NASNLQSLILSGNSFSG 119
+ + + L + + + + F S+L L L N F
Sbjct: 34 YVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQ 93
Query: 120 PVPMQI-GKLKYLQVLDLSQNSFSSS-IPSSIVQC-KRLKTVVLNQNSFTGPLPDGFATN 176
+ L L+VL L+Q + + + + + L+ +VL N+ P F N
Sbjct: 94 -LETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLN 152
Query: 177 LTALQKLDLSFNNLSGLIPNDIANLSRLRLLAQRVYVDLTYNNLSGLIPQNAALLSLGPT 236
+ LDL+FN + + D+ N + L+ L + L
Sbjct: 153 MRRFHVLDLTFNKVKSICEEDLLNFQGKHFT----LLRLSSITLQDM--NEYWLGWEKCG 206
Query: 237 AFIGNPFLC 245
N +
Sbjct: 207 NPFKNTSIT 215
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 77.1 bits (190), Expect = 5e-15
Identities = 46/205 (22%), Positives = 72/205 (35%), Gaps = 22/205 (10%)
Query: 48 SWNGITCREGQVFSLIIPNKKLTGFIPAD----LGSLSAIGRVNLRNNNFSGSLPVELFN 103
S NG + F I K+ I ++ S + N F G
Sbjct: 220 SGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKG------LE 273
Query: 104 ASNLQSLILSGNSFSGPVPMQI-GKLKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQ 162
AS +++ LS + + + L+ L L+QN + ++ L + L+Q
Sbjct: 274 ASGVKTCDLSKSKIFA-LLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQ 332
Query: 163 NSFTGPLPDGFATNLTALQKLDLSFNNLSGLIPNDIANLSRLRLLAQRVYVDLTYNNLSG 222
N + NL L+ LDLS+N++ L L L+ L L N L
Sbjct: 333 NFLGS-IDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKEL------ALDTNQLKS 385
Query: 223 LIPQNA--ALLSLGPTAFIGNPFLC 245
+P L SL NP+ C
Sbjct: 386 -VPDGIFDRLTSLQKIWLHTNPWDC 409
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 69.4 bits (170), Expect = 1e-12
Identities = 29/127 (22%), Positives = 52/127 (40%), Gaps = 10/127 (7%)
Query: 105 SNLQSLILSGNSFSGPVPMQIGKLKYLQVLDLSQNSFSSSIPSSI-VQCKRLKTVVLNQN 163
+++ + LS NS + +L+ LQ L + Q + I ++ L + L+ N
Sbjct: 30 AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYN 89
Query: 164 SFTGPLPDGFATNLTALQKLDLSFNNL-SGLIPNDI-ANLSRLRLLAQRVYVDLTYNNLS 221
F L G L L+ L L+ NL ++ + L+ L +L L NN+
Sbjct: 90 QFLQ-LETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEML------VLRDNNIK 142
Query: 222 GLIPQNA 228
+ P +
Sbjct: 143 KIQPASF 149
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 56.3 bits (136), Expect = 2e-08
Identities = 31/207 (14%), Positives = 59/207 (28%), Gaps = 59/207 (28%)
Query: 68 KLTGFIPADL-GSLSAIGRVNLRNNNFSGSLPVELF-----------NASNLQSLILSGN 115
+ PA ++ ++L N S+ E S++ ++
Sbjct: 140 NIKKIQPASFFLNMRRFHVLDLTFNKVK-SICEEDLLNFQGKHFTLLRLSSITLQDMNEY 198
Query: 116 SFSGPVPMQIGKLKYLQVLDLSQNSFSSSIP----------------------------- 146
K + LDLS N F S+
Sbjct: 199 WLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGH 258
Query: 147 ---SSIVQC-------KRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSGLIPN 196
+KT L+++ L ++ T L++L L+ N ++ + N
Sbjct: 259 TNFKDPDNFTFKGLEASGVKTCDLSKSKIFA-LLKSVFSHFTDLEQLTLAQNEINKIDDN 317
Query: 197 DIANLSRLRLLAQRVYVDLTYNNLSGL 223
L+ L L +L+ N L +
Sbjct: 318 AFWGLTHLLKL------NLSQNFLGSI 338
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 1e-15
Identities = 30/176 (17%), Positives = 64/176 (36%), Gaps = 35/176 (19%)
Query: 73 IPAD-LGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGKLKYL 131
I L + + + + + ++ NL SL ++ + + + + L YL
Sbjct: 191 IRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYL 250
Query: 132 QVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLS 191
+ L+LS N S+ + + L LQ++ L L+
Sbjct: 251 RFLNLSYNPIST----------------IEGSMLHE---------LLRLQEIQLVGGQLA 285
Query: 192 GLIPNDIANLSRLRLLAQRVYVDLTYNNLSGLIPQNA--ALLSLGPTAFIGNPFLC 245
+ P L+ LR+L +++ N L+ + ++ ++ +L NP C
Sbjct: 286 VVEPYAFRGLNYLRVL------NVSGNQLT-TLEESVFHSVGNLETLILDSNPLAC 334
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 1e-15
Identities = 36/159 (22%), Positives = 62/159 (38%), Gaps = 20/159 (12%)
Query: 86 VNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQVLDLSQNSFSSSI 145
V F ++P + + + L L N + +L+ L+L++N S+
Sbjct: 16 VLCHRKRFV-AVPEGIP--TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVE 72
Query: 146 PSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSGLIPNDIANLSRLR 205
P + L+T+ L N +P G T L+ L KLD+S N + L+ +L L+
Sbjct: 73 PGAFNNLFNLRTLGLRSNRLKL-IPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLK 131
Query: 206 LLAQRVYVDLTYNNLSGLIPQNAALLSLGPTAFIGNPFL 244
L ++ N+L + AF G L
Sbjct: 132 SL------EVGDNDLV----------YISHRAFSGLNSL 154
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 6e-15
Identities = 33/165 (20%), Positives = 65/165 (39%), Gaps = 11/165 (6%)
Query: 61 SLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELF-NASNLQSLILSGNSFSG 119
L + ++ + S + + L N S ++ F N NL++L L N
Sbjct: 36 LLDLGKNRIKTLNQDEFASFPHLEELELNENIVS-AVEPGAFNNLFNLRTLGLRSNRLKL 94
Query: 120 PVPMQIGKLKYLQVLDLSQNSFSSSIPSSIVQ-CKRLKTVVLNQNSFTGPLPDGFATNLT 178
L L LD+S+N + + Q LK++ + N + + L
Sbjct: 95 IPLGVFTGLSNLTKLDISENKIVI-LLDYMFQDLYNLKSLEVGDNDLVY-ISHRAFSGLN 152
Query: 179 ALQKLDLSFNNLSGLIPNDIANLSRLRLLAQRVYVDLTYNNLSGL 223
+L++L L NL+ + +++L L +L L + N++ +
Sbjct: 153 SLEQLTLEKCNLTSIPTEALSHLHGLIVL------RLRHLNINAI 191
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 7e-15
Identities = 34/189 (17%), Positives = 68/189 (35%), Gaps = 17/189 (8%)
Query: 48 SWNGITCREGQVFS-------LIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVE 100
+ N ++ E F+ L + + +L LS + ++++ N L
Sbjct: 64 NENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIV-ILLDY 122
Query: 101 LF-NASNLQSLILSGNSFSGPVPMQIGKLKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVV 159
+F + NL+SL + N L L+ L L + + +S ++ L +
Sbjct: 123 MFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLR 182
Query: 160 LNQNSFTGPLPDGFATNLTALQKLDLSFNNLSGLIPNDIANLSRLRLLAQRVYVDLTYNN 219
L + + D L L+ L++S + + L L +T+ N
Sbjct: 183 LRHLNINA-IRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSL------SITHCN 235
Query: 220 LSGLIPQNA 228
L+ +P A
Sbjct: 236 LTA-VPYLA 243
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 1e-14
Identities = 37/181 (20%), Positives = 65/181 (35%), Gaps = 24/181 (13%)
Query: 66 NKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELF-NASNLQSLILSGNSFSGPVPMQ 124
K+ +P + + ++L N +L + F + +L+ L L+ N S P
Sbjct: 20 RKRFV-AVPEGI--PTETRLLDLGKNRIK-TLNQDEFASFPHLEELELNENIVSAVEPGA 75
Query: 125 IGKLKYLQVLDLSQNSFSSSIPSSIVQ-CKRLKTVVLNQNSFTGPLPDGFATNLTALQKL 183
L L+ L L N IP + L + +++N L D +L L+ L
Sbjct: 76 FNNLFNLRTLGLRSNRLKL-IPLGVFTGLSNLTKLDISENKIVI-LLDYMFQDLYNLKSL 133
Query: 184 DLSFNNLSGLIPNDIANLSRLRLLAQRVYVDLTYNNLSGLIPQNAALLSLGPTAFIGNPF 243
++ N+L + + L+ L L L NL+ S+ A
Sbjct: 134 EVGDNDLVYISHRAFSGLNSLEQL------TLEKCNLT----------SIPTEALSHLHG 177
Query: 244 L 244
L
Sbjct: 178 L 178
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 2e-15
Identities = 61/229 (26%), Positives = 91/229 (39%), Gaps = 45/229 (19%)
Query: 375 LGKSTIGIVYKVA-LNNEEAVAV-----RRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSL 428
LGK + G V + AV R++ + E + + ++ HPNI+ L
Sbjct: 34 LGKGSFGEVILCKDKITGQECAVKVISKRQVKQK--TDKESLLREVQLLKQLDHPNIMKL 91
Query: 429 RAYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEV 488
+F L+ + G L IIS + S D RII+ V GI ++H+
Sbjct: 92 YEFFEDKGYFYLVGEVYTGGELFDE------IISRKRFSEVDAARIIRQVLSGITYMHK- 144
Query: 489 SPKRYVHGDLRPSNILL---GKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSS 545
+ VH DL+P N+LL K+ I DFGL+ + + GT
Sbjct: 145 --NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE------ASKKMKDKIGTA---- 192
Query: 546 PYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLP 594
YY APE +K D++S GVIL ++SG P
Sbjct: 193 --------------YYIAPEVLH-GTYDEKCDVWSTGVILYILLSGCPP 226
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 2e-15
Identities = 68/304 (22%), Positives = 111/304 (36%), Gaps = 82/304 (26%)
Query: 375 LGKSTIGIVYKVALNNE--EAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLR-AY 431
LG G VYK A N E A + + + +++ E E + HP IV L AY
Sbjct: 27 LGDGAFGKVYK-AKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAY 85
Query: 432 FWSVDEKL-LIYDYIPNGSLATAIHGKAGI-----ISYRPLSWSDRLRIIKGVAKGIAFL 485
+ D KL ++ ++ P G++ + I + + + + + FL
Sbjct: 86 Y--HDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQV----------VCRQMLEALNFL 133
Query: 486 HEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSS 545
H KR +H DL+ N+L+ + ++DFG++ A+ + S GTP
Sbjct: 134 HS---KRIIHRDLKAGNVLMTLEGDIRLADFGVS-----AKNLKTLQKRDSFIGTP---- 181
Query: 546 PYEFTALNSTTSRSYYQAPEASKVRKPTQ-----KWDIYSYGVILLEMISGKLPMIQIGS 600
Y+ APE K DI+S G+ L+EM + P
Sbjct: 182 --------------YWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPH----- 222
Query: 601 MELNIVQWIQLI-------LEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPD 653
ELN ++ + I L + FL + K+P+
Sbjct: 223 HELNPMRVLLKIAKSDPPTLLTPSKWSVEFRDFLKI-----------------ALDKNPE 265
Query: 654 KRPS 657
RPS
Sbjct: 266 TRPS 269
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 2e-15
Identities = 52/180 (28%), Positives = 73/180 (40%), Gaps = 14/180 (7%)
Query: 68 KLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGK 127
L F A L + + ++NL + L V+ L +L LS N +P+
Sbjct: 42 LLYTFSLATLMPYTRLTQLNLDRAELT-KLQVD-GTLPVLGTLDLSHNQLQS-LPLLGQT 98
Query: 128 LKYLQVLDLSQNSFSSSIPSSI-VQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLS 186
L L VLD+S N +S +P L+ + L N LP G T L+KL L+
Sbjct: 99 LPALTVLDVSFNRLTS-LPLGALRGLGELQELYLKGNELKT-LPPGLLTPTPKLEKLSLA 156
Query: 187 FNNLSGLIPNDIANLSRLRLLAQRVYVDLTYNNLSGLIPQNA-ALLSLGPTAFIGNPFLC 245
NNL+ L + L L L L N+L IP+ L GNP+LC
Sbjct: 157 NNNLTELPAGLLNGLENLDTL------LLQENSLYT-IPKGFFGSHLLPFAFLHGNPWLC 209
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 6e-12
Identities = 36/138 (26%), Positives = 51/138 (36%), Gaps = 13/138 (9%)
Query: 86 VNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQVLDLSQNSFSSSI 145
VN N + +LP +L + L LS N + L L+L + + +
Sbjct: 15 VNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAEL-TKL 70
Query: 146 PSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSGLIPNDIANLSRLR 205
L T+ L+ N LP L AL LD+SFN L+ L + L L+
Sbjct: 71 QVD-GTLPVLGTLDLSHNQLQS-LPLLGQ-TLPALTVLDVSFNRLTSLPLGALRGLGELQ 127
Query: 206 LLAQRVYVDLTYNNLSGL 223
L L N L L
Sbjct: 128 EL------YLKGNELKTL 139
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 77.6 bits (191), Expect = 2e-15
Identities = 47/194 (24%), Positives = 76/194 (39%), Gaps = 31/194 (15%)
Query: 66 NKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELF--NASNLQSLILSGN-------- 115
++L +P L S ++L +NN S L E +NL SL+LS N
Sbjct: 27 KQQLP-NVPQSL--PSYTALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLNFISSE 82
Query: 116 SFSGPVPMQIGKLKYLQVLDLSQNSFSSSIPSSIVQ-CKRLKTVVLNQNSFTGPLPDGFA 174
+F + L+ LDLS N + + + + L+ ++L N +
Sbjct: 83 AFVP--------VPNLRYLDLSSNHLHT-LDEFLFSDLQALEVLLLYNNHIVV-VDRNAF 132
Query: 175 TNLTALQKLDLSFNNLSGLIPNDIANLSRLRLLAQRVYVDLTYNNLSGLIPQNAALLSLG 234
++ LQKL LS N +S I + ++L L +DL+ N L L + L
Sbjct: 133 EDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLM---LLDLSSNKLKKLPLTDLQKLPAW 189
Query: 235 PTAFI---GNPFLC 245
+ NP C
Sbjct: 190 VKNGLYLHNNPLEC 203
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 2e-15
Identities = 44/182 (24%), Positives = 79/182 (43%), Gaps = 40/182 (21%)
Query: 419 KIRHPNIVSLRAYFWSVDEKLLIY---DYIPNGSLATAIHGKAGIISYRPLSWSDRLRII 475
K+ HPN+V L + +Y + + G + + + +PLS
Sbjct: 92 KLDHPNVVKLVE-VLDDPNEDHLYMVFELVNQGPVME-------VPTLKPLSEDQARFYF 143
Query: 476 KGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQ 535
+ + KGI +LH ++ +H D++PSN+L+G++ I+DFG++ E
Sbjct: 144 QDLIKGIEYLHY---QKIIHRDIKPSNLLVGEDGHIKIADFGVS-----NEFKGSDALLS 195
Query: 536 STTGTPLQSSPYEFTALNSTTSRSYYQAPEA-SKVRKP--TQKWDIYSYGVILLEMISGK 592
+T GTP + APE+ S+ RK + D+++ GV L + G+
Sbjct: 196 NTVGTP------------------AFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237
Query: 593 LP 594
P
Sbjct: 238 CP 239
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 2e-15
Identities = 44/229 (19%), Positives = 86/229 (37%), Gaps = 37/229 (16%)
Query: 375 LGKSTIGIVYKV---ALNNEEAV---AVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSL 428
+GK +V + + AV V + + ++ + EA ++HP+IV L
Sbjct: 32 IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91
Query: 429 RAYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEV 488
+ S ++++++ L I +A S + ++ + + + + H+
Sbjct: 92 LETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFV--YSEAVASHYMRQILEALRYCHD- 148
Query: 489 SPKRYVHGDLRPSNILLGKNMEPH---ISDFGLARLADIAEETPEVHWEQSTTGTPLQSS 545
+H D++P +LL + FG+A + E GTP
Sbjct: 149 --NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAI--QLGESGLVAG---GRVGTP---- 197
Query: 546 PYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLP 594
++ APE K + D++ GVIL ++SG LP
Sbjct: 198 --------------HFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLP 232
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 2e-15
Identities = 57/229 (24%), Positives = 85/229 (37%), Gaps = 46/229 (20%)
Query: 375 LGKSTIGIVYKVA-LNNEEAVAV-----RRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSL 428
LG G V A+ + + E + + HPNI+ L
Sbjct: 45 LGSGAYGEVLLCRDKVTHVERAIKIIRKTSVST---SSNSKLLEEVAVLKLLDHPNIMKL 101
Query: 429 RAYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEV 488
+F L+ + G L II + D IIK V G+ +LH+
Sbjct: 102 YDFFEDKRNYYLVMECYKGGELFDE------IIHRMKFNEVDAAVIIKQVLSGVTYLHK- 154
Query: 489 SPKRYVHGDLRPSNILL---GKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSS 545
VH DL+P N+LL K+ I DFGL+ + E ++ GT
Sbjct: 155 --HNIVHRDLKPENLLLESKEKDALIKIVDFGLSA---VFENQKKMK---ERLGTA---- 202
Query: 546 PYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLP 594
YY APE + +K +K D++S GVIL +++G P
Sbjct: 203 --------------YYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPP 236
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 78.8 bits (194), Expect = 2e-15
Identities = 37/173 (21%), Positives = 63/173 (36%), Gaps = 31/173 (17%)
Query: 61 SLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGP 120
+L + +LT +P L + + + S L L + GN +
Sbjct: 85 TLEVSGNQLT-SLPVLPPGLLELSIFSNPLTHLPALP-------SGLCKLWIFGNQLTS- 135
Query: 121 VPMQIGKLKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTAL 180
+P+ L+ L +S N +S +P+ + +L N T LP + L
Sbjct: 136 LPVLPPGLQEL---SVSDNQLAS-LPALPSELCKLW---AYNNQLTS-LPM----LPSGL 183
Query: 181 QKLDLSFNNLSGLIPNDIANLSRLRLLAQRVYVDLTYNNLSGLIPQNAALLSL 233
Q+L +S N L+ L P + L +L N L+ L + L L
Sbjct: 184 QELSVSDNQLASL-PTLPSELYKLWAY---------NNRLTSLPALPSGLKEL 226
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 75.7 bits (186), Expect = 2e-14
Identities = 40/187 (21%), Positives = 69/187 (36%), Gaps = 33/187 (17%)
Query: 48 SWNGITCREGQVFSLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNL 107
+ + L I +LT +P L + ++ +N + SLP S L
Sbjct: 112 PLTHLPALPSGLCKLWIFGNQLT-SLPVLPPGLQEL---SVSDNQLA-SLPALP---SEL 163
Query: 108 QSLILSGNSFSGPVPMQIGKLKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTG 167
L N + +PM L Q L +S N +S +P+ + +L N T
Sbjct: 164 CKLWAYNNQLTS-LPMLPSGL---QELSVSDNQLAS-LPTLPSELYKLW---AYNNRLT- 214
Query: 168 PLPDGFATNLTALQKLDLSFNNLSGLIPNDIANLSRLRL-----------LAQRVYVDLT 216
LP + L++L +S N L+ L P + L L + + + + +
Sbjct: 215 SLPA----LPSGLKELIVSGNRLTSL-PVLPSELKELMVSGNRLTSLPMLPSGLLSLSVY 269
Query: 217 YNNLSGL 223
N L+ L
Sbjct: 270 RNQLTRL 276
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 62.2 bits (151), Expect = 3e-10
Identities = 22/129 (17%), Positives = 43/129 (33%), Gaps = 22/129 (17%)
Query: 105 SNLQSLILSGNSFSGPVPMQIGKLKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNS 164
+ L + + + +P + + L + N+ +S +P+ + + L+ ++ N
Sbjct: 40 NGNAVLNVGESGLTT-LPDCLPAH--ITTLVIPDNNLTS-LPALPPELRTLE---VSGNQ 92
Query: 165 FTGPLPDGFATNLTALQKLDLSFNNLSGLIPNDIANLSRLRLLAQRVYVDLTYNNLSGLI 224
T LP L L +L L L +L + N L+ L
Sbjct: 93 LTS-LPVLP-PGLLELSIFSNPLTHLPALPS----GLCKL---------WIFGNQLTSLP 137
Query: 225 PQNAALLSL 233
L L
Sbjct: 138 VLPPGLQEL 146
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 51.8 bits (124), Expect = 6e-07
Identities = 24/154 (15%), Positives = 48/154 (31%), Gaps = 10/154 (6%)
Query: 61 SLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGP 120
L++ +LT +P L +++ N + LP L + S+ ++ L GN S
Sbjct: 245 ELMVSGNRLTS-LPMLPSGLL---SLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSER 299
Query: 121 VPMQIGKLKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVV---LNQNSFTGPLPDGFATNL 177
+ ++ F + S+ + + L L P P
Sbjct: 300 TLQALREITSAPGYSGPIIRFDMAGASAPRETRALHLAAADWLVPAREGEPAPADRWHMF 359
Query: 178 TALQKLDLSFNNLSGLIPNDIANLSRLRLLAQRV 211
D L L ++ N + ++
Sbjct: 360 GQEDNADAFSLFLDRL--SETENFIKDAGFKAQI 391
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 3e-15
Identities = 38/173 (21%), Positives = 63/173 (36%), Gaps = 28/173 (16%)
Query: 61 SLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGP 120
SL+ LT +P SL ++ N S LP L+ L +S N
Sbjct: 95 SLVASCNSLT-ELPELPQSLKSLLVDNNNLKALS-DLP------PLLEYLGVSNNQLEK- 145
Query: 121 VPMQIGKLKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTAL 180
+P ++ +L+++D+ NS +P L+ + N LP+ NL L
Sbjct: 146 LP-ELQNSSFLKIIDVDNNSLKK-LPDLPPS---LEFIAAGNNQLEE-LPE--LQNLPFL 197
Query: 181 QKLDLSFNNLSGLIPNDIANLSRLRLLAQRVYVDLTYNNLSGLIPQNAALLSL 233
+ N+L L P+ +L + N L +P+ L L
Sbjct: 198 TAIYADNNSLKKL-PDLPLSLESI---------VAGNNILE-ELPELQNLPFL 239
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 4e-15
Identities = 36/190 (18%), Positives = 69/190 (36%), Gaps = 41/190 (21%)
Query: 72 FIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGKLKY- 130
FI S + + ++N + +PVE N + + + + P G+ +
Sbjct: 2 FINPRNVSNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREM 60
Query: 131 ------------LQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLT 178
L+L+ SS+P L+++V + NS T LP+ +L
Sbjct: 61 AVSRLRDCLDRQAHELELNNLGL-SSLPELP---PHLESLVASCNSLT-ELPELP-QSLK 114
Query: 179 ALQKLDLSFNNLSGLIPN---------------DIANLSRLRLLAQRVYVDLTYNNLSGL 223
+L + + LS L P ++ N S L+++ D+ N+L L
Sbjct: 115 SLLVDNNNLKALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKII------DVDNNSLKKL 168
Query: 224 IPQNAALLSL 233
+L +
Sbjct: 169 PDLPPSLEFI 178
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 2e-14
Identities = 36/173 (20%), Positives = 66/173 (38%), Gaps = 25/173 (14%)
Query: 61 SLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGP 120
L + N +L +P +L + S + +++ NN+ LP +L+ + N
Sbjct: 135 YLGVSNNQLE-KLP-ELQNSSFLKIIDVDNNSLK-KLPDLP---PSLEFIAAGNNQLEE- 187
Query: 121 VPMQIGKLKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTAL 180
+P ++ L +L + NS +P + + + V N LP+ NL L
Sbjct: 188 LP-ELQNLPFLTAIYADNNSLKK-LPDLPLSLESI---VAGNNILEE-LPE--LQNLPFL 239
Query: 181 QKLDLSFNNLSGLIPNDIANLSRLRLLAQRVYVDLTYNNLSGLIPQNAALLSL 233
+ N L L P+ +L L ++ N L+ L +L L
Sbjct: 240 TTIYADNNLLKTL-PDLPPSLEAL---------NVRDNYLTDLPELPQSLTFL 282
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 1e-13
Identities = 36/173 (20%), Positives = 65/173 (37%), Gaps = 29/173 (16%)
Query: 61 SLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGP 120
S++ N L +L +L + + NN +LP +L++L + N +
Sbjct: 219 SIVAGNNILE--ELPELQNLPFLTTIYADNNLLK-TLPDLP---PSLEALNVRDNYLTD- 271
Query: 121 VPMQIGKLKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTAL 180
+P L +L V + + S P+ L + + N L D +L
Sbjct: 272 LPELPQSLTFLDVSENIFSGLSELPPN-------LYYLNASSNEIRS-LCD----LPPSL 319
Query: 181 QKLDLSFNNLSGLIPNDIANLSRLRLLAQRVYVDLTYNNLSGLIPQNAALLSL 233
++L++S N L L P L RL ++N+L+ + L L
Sbjct: 320 EELNVSNNKLIEL-PALPPRLERL---------IASFNHLAEVPELPQNLKQL 362
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 3e-11
Identities = 32/173 (18%), Positives = 60/173 (34%), Gaps = 32/173 (18%)
Query: 61 SLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGP 120
+L + + LT +P SL+ + + S P NL L S N
Sbjct: 261 ALNVRDNYLTD-LPELPQSLTFLDVSENIFSGLSELPP-------NLYYLNASSNEIRSL 312
Query: 121 VPMQIGKLKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTAL 180
L+ L++S N +P+ RL+ ++ + N +P+ L
Sbjct: 313 ----CDLPPSLEELNVSNNKLIE-LPALP---PRLERLIASFNHLAE-VPEL----PQNL 359
Query: 181 QKLDLSFNNLSGLIPNDIANLSRLRLLAQRVYV----------DLTYNNLSGL 223
++L + +N L P+ ++ LR+ + V + N L
Sbjct: 360 KQLHVEYNPLREF-PDIPESVEDLRMNSHLAEVPELPQNLKQLHVETNPLREF 411
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 5e-10
Identities = 28/188 (14%), Positives = 55/188 (29%), Gaps = 40/188 (21%)
Query: 50 NGITCREGQVFSLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQS 109
+G++ ++ L + ++ + SL +N+ NN LP L+
Sbjct: 290 SGLSELPPNLYYLNASSNEIRS-LCDLPPSLE---ELNVSNNKLI-ELPALP---PRLER 341
Query: 110 LILSGNSFSGPVPMQIGKLKYLQVLDLSQNSFSSSIPSSIVQ----------------CK 153
LI S N + VP LK L + N P +
Sbjct: 342 LIASFNHLAE-VPELPQNLK---QLHVEYNPLRE-FPDIPESVEDLRMNSHLAEVPELPQ 396
Query: 154 RLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSGLIPNDIANLSRLRLLAQRVYV 213
LK + + N PD +++ L ++ + +L
Sbjct: 397 NLKQLHVETNPLRE-FPD----IPESVEDLRMNSERVVDPYEFAHETTDKLEDD------ 445
Query: 214 DLTYNNLS 221
+++
Sbjct: 446 VFEHHHHH 453
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 4e-15
Identities = 40/170 (23%), Positives = 62/170 (36%), Gaps = 16/170 (9%)
Query: 75 ADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQVL 134
+ LS I + + N + ++P L +L L L GN + + L L L
Sbjct: 168 QGMKKLSYI---RIADTNIT-TIPQGLP--PSLTELHLDGNKITKVDAASLKGLNNLAKL 221
Query: 135 DLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSGLI 194
LS NS S+ S+ L+ + LN N +P G A + +Q + L NN+S +
Sbjct: 222 GLSFNSISAVDNGSLANTPHLRELHLNNNKLVK-VPGGLA-DHKYIQVVYLHNNNISAIG 279
Query: 195 PNDIANLSRLRLLAQRVYVDLTYNNLSGLIPQNAALLSLGPTAFIGNPFL 244
ND A V L N + + P+ F
Sbjct: 280 SNDFCPPGYNTKKASYSGVSLFSNPVQ--------YWEIQPSTFRCVYVR 321
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 6e-15
Identities = 37/207 (17%), Positives = 72/207 (34%), Gaps = 35/207 (16%)
Query: 48 SWNGITCREGQVFS-------LIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVE 100
N I+ F+ L + +L +P + + + + N + +
Sbjct: 84 INNKISKISPGAFAPLVKLERLYLSKNQLKE-LPEKM--PKTLQELRVHENEIT-KVRKS 139
Query: 101 LF-NASNLQSLILSGNSF-SGPVPMQI-GKLKYLQVLDLSQNSFSSSIPSSIVQCKRLKT 157
+F + + + L N S + +K L + ++ + ++ IP + L
Sbjct: 140 VFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITT-IPQGLPP--SLTE 196
Query: 158 VVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSGLIPNDIANLSRLRLLAQRVYVDLTY 217
+ L+ N T + L L KL LSFN++S + +AN LR L L
Sbjct: 197 LHLDGNKITK-VDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLREL------HLNN 249
Query: 218 NNLSGLIPQNAALLSLGPTAFIGNPFL 244
N L + P + ++
Sbjct: 250 NKLVKV-----------PGGLADHKYI 265
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 4e-12
Identities = 40/169 (23%), Positives = 66/169 (39%), Gaps = 24/169 (14%)
Query: 66 NKKLTGF---IPADLGSLSAIGRVNLRNNNFSGSLPVELF-NASNLQSLILSGNSFSGPV 121
+ L +P D L +L+NN + + F N NL +LIL N S
Sbjct: 40 DLGLEKVPKDLPPDTALL------DLQNNKIT-EIKDGDFKNLKNLHTLILINNKISKIS 92
Query: 122 PMQIGKLKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQ 181
P L L+ L LS+N +P + K L+ + +++N T + L +
Sbjct: 93 PGAFAPLVKLERLYLSKNQL-KELPEKMP--KTLQELRVHENEITK-VRKSVFNGLNQMI 148
Query: 182 KLDLSFNNL-SGLIPNDI-ANLSRLRLLAQRVYVDLTYNNLSGLIPQNA 228
++L N L S I N + +L + + N++ IPQ
Sbjct: 149 VVELGTNPLKSSGIENGAFQGMKKLSYI------RIADTNITT-IPQGL 190
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 9e-10
Identities = 27/129 (20%), Positives = 47/129 (36%), Gaps = 10/129 (7%)
Query: 68 KLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELF-NASNLQSLILSGNSFSGPVPMQIG 126
K+T A L L+ + ++ L N+ S ++ N +L+ L L+ N VP +
Sbjct: 203 KITKVDAASLKGLNNLAKLGLSFNSIS-AVDNGSLANTPHLRELHLNNNKLVK-VPGGLA 260
Query: 127 KLKYLQVLDLSQNSFSS------SIPSSIVQCKRLKTVVLNQNSFT-GPLPDGFATNLTA 179
KY+QV+ L N+ S+ P + V L N + +
Sbjct: 261 DHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYV 320
Query: 180 LQKLDLSFN 188
+ L
Sbjct: 321 RAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 7e-06
Identities = 24/99 (24%), Positives = 36/99 (36%), Gaps = 11/99 (11%)
Query: 130 YLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNN 189
+L+V+ S +P + + L N T F NL L L L N
Sbjct: 32 HLRVVQCSDLGLEK-VPKDLP--PDTALLDLQNNKITEIKDGDFK-NLKNLHTLILINNK 87
Query: 190 LSGLIPNDIANLSRLRLLAQRVYVDLTYNNLSGLIPQNA 228
+S + P A L +L L L+ N L +P+
Sbjct: 88 ISKISPGAFAPLVKLERL------YLSKNQLK-ELPEKM 119
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 4e-15
Identities = 57/237 (24%), Positives = 86/237 (36%), Gaps = 51/237 (21%)
Query: 375 LGKSTIGIVYKVA-LNNEEAVAV-----RRLGNGGWQRF--------KEFQTEAEAIGKI 420
LG G V N A+ + G + +E E + +
Sbjct: 44 LGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL 103
Query: 421 RHPNIVSLRAYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAK 480
HPNI+ L F L+ ++ G L II+ D I+K +
Sbjct: 104 DHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQ------IINRHKFDECDAANIMKQILS 157
Query: 481 GIAFLHEVSPKRYVHGDLRPSNILL---GKNMEPHISDFGLARLADIAEETPEVHWEQST 537
GI +LH+ VH D++P NILL + I DFGL+ + ++
Sbjct: 158 GICYLHK---HNIVHRDIKPENILLENKNSLLNIKIVDFGLSS---FFSKDYKLR---DR 208
Query: 538 TGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLP 594
GT YY APE K +K +K D++S GVI+ ++ G P
Sbjct: 209 LGTA------------------YYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPP 246
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 6e-15
Identities = 53/236 (22%), Positives = 87/236 (36%), Gaps = 51/236 (21%)
Query: 375 LGKSTIGIVYKVA-LNNEEAVAV-----RRLGNGGWQRFKE---FQTEAEAIGKIRHPNI 425
LG G V + VA+ R+ G + +TE E + K+ HP I
Sbjct: 143 LGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 202
Query: 426 VSLRAYFWSVDEKL-LIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAF 484
+ ++ +F E ++ + + G L ++ + L + + + +
Sbjct: 203 IKIKNFF--DAEDYYIVLELMEGGELFDK------VVGNKRLKEATCKLYFYQMLLAVQY 254
Query: 485 LHEVSPKRYVHGDLRPSNILLGKNMEPH---ISDFGLARLADIAEETPEVHWEQSTTGTP 541
LHE +H DL+P N+LL E I+DFG +++ E ++ GTP
Sbjct: 255 LHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG------ETSLMRTLCGTP 305
Query: 542 LQSSPYEFTALNSTTSRSYYQAPE--ASKVRKP-TQKWDIYSYGVILLEMISGKLP 594
Y APE S + D +S GVIL +SG P
Sbjct: 306 ------------------TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 343
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 6e-15
Identities = 47/230 (20%), Positives = 86/230 (37%), Gaps = 49/230 (21%)
Query: 375 LGKSTIGIVYKV---ALNNEEAV---AVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSL 428
LG G+V++ A + + E + ++ HP +++L
Sbjct: 59 LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLD-----KYTVKNEISIMNQLHHPKLINL 113
Query: 429 RAYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEV 488
F E +LI +++ G L I + +S + + ++ +G+ +HE
Sbjct: 114 HDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEA-----EVINYMRQACEGLKHMHE- 167
Query: 489 SPKRYVHGDLRPSNILLGKNMEPH---ISDFGLARLADIAEETPEVHWEQSTTGTPLQSS 545
VH D++P NI+ + + I DFGLA + E + TT T
Sbjct: 168 --HSIVHLDIKPENIMC-ETKKASSVKIIDFGLATKLNPDEIV------KVTTATA---- 214
Query: 546 PYEFTALNSTTSRSYYQAPEASKVRKP-TQKWDIYSYGVILLEMISGKLP 594
+ APE R+P D+++ GV+ ++SG P
Sbjct: 215 --------------EFAAPEIVD-REPVGFYTDMWAIGVLGYVLLSGLSP 249
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 74.5 bits (184), Expect = 7e-15
Identities = 58/229 (25%), Positives = 92/229 (40%), Gaps = 46/229 (20%)
Query: 375 LGKSTIGIVYKV---ALNNEEAV---AVRRLGNGGWQRFKE-FQTEAEAIGKIRHPNIVS 427
LG IV K E A RRL + +E + E + +IRHPNI++
Sbjct: 13 LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 428 LRAYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHE 487
L F + + +LI + + G L + L+ + + +K + G+ +LH
Sbjct: 73 LHDIFENKTDVVLILELVSGGELFDF------LAEKESLTEDEATQFLKQILDGVHYLHS 126
Query: 488 VSPKRYVHGDLRPSNILLGKNMEPH----ISDFGLARLADIAEETPEVHWEQSTTGTPLQ 543
KR H DL+P NI+L P+ + DFG+A + E + GTP
Sbjct: 127 ---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNI------FGTP-- 175
Query: 544 SSPYEFTALNSTTSRSYYQAPEASKVRKP-TQKWDIYSYGVILLEMISG 591
+ APE +P + D++S GVI ++SG
Sbjct: 176 ----------------EFVAPEIVN-YEPLGLEADMWSIGVITYILLSG 207
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 1e-14
Identities = 63/311 (20%), Positives = 117/311 (37%), Gaps = 86/311 (27%)
Query: 375 LGKSTIGIVYKVALNNE--EAVAVRRLGNGGWQRFKEFQTEAEAIGKI-RHPNIVS---- 427
+G T G VYK + + + A++ + G +E + E + K H NI +
Sbjct: 32 VGNGTYGQVYK-GRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGA 89
Query: 428 -LRAYFWSVDEKL-LIYDYIPNGSLATAIHGKAG------IISYRPLSWSDRLRIIKGVA 479
++ +D++L L+ ++ GS+ I G I+Y I + +
Sbjct: 90 FIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY----------ICREIL 139
Query: 480 KGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTG 539
+G++ LH+ + +H D++ N+LL +N E + DFG++ A+ V + G
Sbjct: 140 RGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVS-----AQLDRTVGRRNTFIG 191
Query: 540 TPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQ-----KWDIYSYGVILLEMISGKLP 594
TP Y+ APE + K D++S G+ +EM G P
Sbjct: 192 TP------------------YWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP 233
Query: 595 MIQIGSMELNIVQWIQLILEDRKPM------TDILDPFLAHDLDKEDEIVSVLKIALDCV 648
+ + M + LI + P + F+ C+
Sbjct: 234 LCDMHPMRA-----LFLIPRNPAPRLKSKKWSKKFQSFIES-----------------CL 271
Query: 649 HKSPDKRPSMR 659
K+ +RP+
Sbjct: 272 VKNHSQRPATE 282
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 1e-14
Identities = 54/232 (23%), Positives = 90/232 (38%), Gaps = 46/232 (19%)
Query: 375 LGKSTIGIVYKV---ALNNEEAV---AVRRLGNGGWQRFKE-FQTEAEAIGKIRHPNIVS 427
LG +V K + + A RR + +E + E + +I+HPN+++
Sbjct: 19 LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 428 LRAYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHE 487
L + + + +LI + + G L + L+ + +K + G+ +LH
Sbjct: 79 LHEVYENKTDVILILELVAGGELFDF------LAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 488 VSPKRYVHGDLRPSNILLGKNMEPH----ISDFGLARLADIAEETPEVHWEQSTTGTPLQ 543
+ H DL+P NI+L P I DFGLA D E + GTP
Sbjct: 133 ---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNI------FGTP-- 181
Query: 544 SSPYEFTALNSTTSRSYYQAPEASKVRKP-TQKWDIYSYGVILLEMISGKLP 594
+ APE +P + D++S GVI ++SG P
Sbjct: 182 ----------------EFVAPEIVN-YEPLGLEADMWSIGVITYILLSGASP 216
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 76.2 bits (187), Expect = 1e-14
Identities = 42/203 (20%), Positives = 69/203 (33%), Gaps = 35/203 (17%)
Query: 31 RNFPEGNNWNNSNEDPCSWNGITCREGQVFSLIIPNKKLTGFIPADLGSLSAIGRVNLRN 90
+ G N N + C Q L + L+ +P +L I + +
Sbjct: 38 KQALPGENRNEAVSLLKE-----CLINQFSELQLNRLNLS-SLPDNLPPQ--ITVLEITQ 89
Query: 91 NNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQVLDLSQNSFSSSIPSSIV 150
N SLP ++L+ L N S +P LK+L D+ N + +P
Sbjct: 90 NALI-SLPELP---ASLEYLDACDNRLST-LPELPASLKHL---DVDNNQLTM-LPELPA 140
Query: 151 QCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSGLIPNDIANLSRLRLLAQR 210
+ + + N T LP+ T+L+ L + N L+ L P +L L
Sbjct: 141 LLEYIN---ADNNQLTM-LPE----LPTSLEVLSVRNNQLTFL-PELPESLEAL------ 185
Query: 211 VYVDLTYNNLSGLIPQNAALLSL 233
D++ N L L
Sbjct: 186 ---DVSTNLLESLPAVPVRNHHS 205
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 20/146 (13%), Positives = 40/146 (27%), Gaps = 12/146 (8%)
Query: 73 IPADLGSL----SAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGKL 128
+PA R N + +P + + ++IL N S + + +
Sbjct: 195 LPAVPVRNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQ 253
Query: 129 KYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLS-- 186
+ FS S + L V F + A + + +
Sbjct: 254 TAQPDYHGPRIYFSMSDGQQNTLHRPLADAVTAW--FPENKQSDVSQIWHAFEHEEHANT 311
Query: 187 -FNNLSGLIPNDIANLSRLRLLAQRV 211
L L +D + ++V
Sbjct: 312 FSAFLDRL--SDTVSARNTSGFREQV 335
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 42.3 bits (99), Expect = 4e-04
Identities = 23/111 (20%), Positives = 41/111 (36%), Gaps = 24/111 (21%)
Query: 120 PVPMQIGKLKYLQVLDLSQNSFS---SSIPSSIVQC----KRLKTVVLNQNSFTGPLPDG 172
+ + I LSQNSF S + ++ N+N L +
Sbjct: 2 SIMLPINNN-----FSLSQNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKEC 56
Query: 173 FATNLTALQKLDLSFNNLSGLIPNDIANLSRLRLLAQRVYVDLTYNNLSGL 223
+ +L L+ NLS L P+++ ++ +L ++T N L L
Sbjct: 57 L---INQFSELQLNRLNLSSL-PDNL--PPQITVL------EITQNALISL 95
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 2e-14
Identities = 43/183 (23%), Positives = 71/183 (38%), Gaps = 37/183 (20%)
Query: 422 HPNIVSLRAYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKG 481
H N++ L +F D L+++ + GS+ + IH + R + + +++ VA
Sbjct: 70 HRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKR------RHFNELEASVVVQDVASA 123
Query: 482 IAFLHEVSPKRYVHGDLRPSNILLGKNMEPH---ISDFGLARLADIAEETPEVHWEQSTT 538
+ FLH K H DL+P NIL + I DF L + + + + T
Sbjct: 124 LDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLT 180
Query: 539 --GTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKW-----DIYSYGVILLEMISG 591
G+ Y APE + D++S GVIL ++SG
Sbjct: 181 PCGSA------------------EYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSG 222
Query: 592 KLP 594
P
Sbjct: 223 YPP 225
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 2e-14
Identities = 63/229 (27%), Positives = 91/229 (39%), Gaps = 46/229 (20%)
Query: 375 LGKSTIGIVYKVA-LNNEEAVAV-----RRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSL 428
LGK + G V K ++ AV N + E E + K+ HPNI+ L
Sbjct: 30 LGKGSFGEVLKCKDRITQQEYAVKVINKASAKN---KDTSTILREVELLKKLDHPNIMKL 86
Query: 429 RAYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEV 488
++ + G L II + S D RIIK V GI ++H+
Sbjct: 87 FEILEDSSSFYIVGELYTGGELFDE------IIKRKRFSEHDAARIIKQVFSGITYMHK- 139
Query: 489 SPKRYVHGDLRPSNILL---GKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSS 545
VH DL+P NILL K+ + I DFGL+ ++ ++ GT
Sbjct: 140 --HNIVHRDLKPENILLESKEKDCDIKIIDFGLST---CFQQNTKMK---DRIGTA---- 187
Query: 546 PYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLP 594
YY APE + +K D++S GVIL ++SG P
Sbjct: 188 --------------YYIAPEVLR-GTYDEKCDVWSAGVILYILLSGTPP 221
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 2e-14
Identities = 57/251 (22%), Positives = 85/251 (33%), Gaps = 80/251 (31%)
Query: 374 LLGKSTIGIVYKVALNNE--EAVAV--------RRLGNGGWQRFKEFQTEAEAIGKIRHP 423
LLG+ + G V K L++E AV RR+ NG KE Q + ++RH
Sbjct: 12 LLGEGSYGKV-KEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQL----LRRLRHK 66
Query: 424 NIVSLRAY-FWSVDEKLLIY--------------DYIPNGSL--ATAIHGKAGIISYRPL 466
N++ L +EK +Y D +P A +I
Sbjct: 67 NVIQL--VDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLID---- 120
Query: 467 SWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAE 526
G+ +LH + VH D++P N+LL IS G+A
Sbjct: 121 --------------GLEYLHS---QGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFA 163
Query: 527 ETPEVHWEQSTT-GTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKP--TQKWDIYSYGV 583
T+ G+P +Q PE + K DI+S GV
Sbjct: 164 ADDTCR----TSQGSP------------------AFQPPEIANGLDTFSGFKVDIWSAGV 201
Query: 584 ILLEMISGKLP 594
L + +G P
Sbjct: 202 TLYNITTGLYP 212
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 2e-14
Identities = 55/229 (24%), Positives = 93/229 (40%), Gaps = 47/229 (20%)
Query: 375 LGKSTIGIVYKV---ALNNEEAV---AVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSL 428
LG G V+K A + A R + + +E + E + ++ H N++ L
Sbjct: 97 LGGGRFGQVHKCEETATGLKLAAKIIKTRGM-----KDKEEVKNEISVMNQLDHANLIQL 151
Query: 429 RAYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEV 488
F S ++ +L+ +Y+ G L I ++ ++ D + +K + +GI +H+
Sbjct: 152 YDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTEL-----DTILFMKQICEGIRHMHQ- 205
Query: 489 SPKRYVHGDLRPSNILLGKNMEPH---ISDFGLARLADIAEETPEVHWEQSTTGTPLQSS 545
+H DL+P NIL N + I DFGLAR E+ + GTP
Sbjct: 206 --MYILHLDLKPENILC-VNRDAKQIKIIDFGLARRYKPREKL------KVNFGTP---- 252
Query: 546 PYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLP 594
+ APE + D++S GVI ++SG P
Sbjct: 253 --------------EFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSP 287
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 3e-14
Identities = 63/229 (27%), Positives = 89/229 (38%), Gaps = 46/229 (20%)
Query: 375 LGKSTIGIVYKVA-LNNEEAVAV-----RRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSL 428
LGK + G V K ++ AV N + E E + K+ HPNI+ L
Sbjct: 30 LGKGSFGEVLKCKDRITQQEYAVKVINKASAKN---KDTSTILREVELLKKLDHPNIMKL 86
Query: 429 RAYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEV 488
++ + G L II + S D RIIK V GI ++H+
Sbjct: 87 FEILEDSSSFYIVGELYTGGELFDE------IIKRKRFSEHDAARIIKQVFSGITYMHK- 139
Query: 489 SPKRYVHGDLRPSNILL---GKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSS 545
VH DL+P NILL K+ + I DFGL+ + + GT
Sbjct: 140 --HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM------KDRIGTA---- 187
Query: 546 PYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLP 594
YY APE + +K D++S GVIL ++SG P
Sbjct: 188 --------------YYIAPEVLR-GTYDEKCDVWSAGVILYILLSGTPP 221
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 3e-14
Identities = 68/339 (20%), Positives = 127/339 (37%), Gaps = 73/339 (21%)
Query: 336 FTRNNLDTMSENMEQYEFVPLDSQVDFDLEQLLKASAFLLGKSTIGIVYKVALN-NEEAV 394
+ ++ ++Y+ DLE L + +G T G V+K+ +
Sbjct: 5 SSGKQTGYLTIGGQRYQAEI------NDLENLGE-----MGSGTCGQVWKMRFRKTGHVI 53
Query: 395 AVRRL-GNGGWQRFKEFQTEAEAIGK-IRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLAT 452
AV+++ +G + K + + + K P IV F + + + + +
Sbjct: 54 AVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-GTCAEK 112
Query: 453 AIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPH 512
G I R L ++ + K + +L E +H D++PSNILL + +
Sbjct: 113 LKKRMQGPIPERILG-----KMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGQIK 165
Query: 513 ISDFGL-ARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRK 571
+ DFG+ RL D + + G Y APE
Sbjct: 166 LCDFGISGRLVDDKAKD-------RSAGCA------------------AYMAPERIDPPD 200
Query: 572 PTQ-----KWDIYSYGVILLEMISGKLPMIQIGS-MELNIVQWIQLILEDRKPMTDILDP 625
PT+ + D++S G+ L+E+ +G+ P + E+ + +L++ +P P
Sbjct: 201 PTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEV-----LTKVLQE-EP------P 248
Query: 626 FLAHDLDKEDEIVSVLKIALDCVHKSPDKRPS----MRH 660
L + + S +K DC+ K KRP + H
Sbjct: 249 LLPGHMGFSGDFQSFVK---DCLTKDHRKRPKYNKLLEH 284
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 72.9 bits (179), Expect = 3e-14
Identities = 30/288 (10%), Positives = 68/288 (23%), Gaps = 76/288 (26%)
Query: 374 LLGKSTIGIVYK---VALNNEEAVAVRRLGNGGWQRFKE-FQTEAEAIGKIRHPNIVSLR 429
G ++ AL+ + A+ + + + +I P + +
Sbjct: 38 FHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVL 97
Query: 430 AYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVS 489
+ L++ ++I GSL S +R ++ +A H
Sbjct: 98 DVVHTRAGGLVVAEWIRGGSLQEVADT--------SPSPVGAIRAMQSLAAAADAAHRAG 149
Query: 490 PKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEF 549
PS + +S G LA
Sbjct: 150 ---VALSIDHPSRVR--------VSIDGDVVLAY-------------------------P 173
Query: 550 TALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQWI 609
+ + DI G L ++ + P+ + + +
Sbjct: 174 ATMPDANPQD-----------------DIRGIGASLYALLVNRWPL--PEAGVRSGLAPA 214
Query: 610 QLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPS 657
+ + +D + + +A V R +
Sbjct: 215 ERDTAGQPIEPADIDRDIPFQIS---------AVAARSVQGDGGIRSA 253
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 4e-14
Identities = 36/225 (16%), Positives = 67/225 (29%), Gaps = 48/225 (21%)
Query: 48 SWNGITCREGQVFS-------LIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVE 100
N I+ F L++ N K++ L + ++ + N+ +P
Sbjct: 62 QNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLV-EIPPN 120
Query: 101 LFNASNLQSLILSGNSFSGPVPMQIGKLKYLQVLDLSQNSF-SSSIPSSIVQCKRLKTVV 159
L S+L L + N L+ + +++ N +S +L +
Sbjct: 121 LP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLR 178
Query: 160 LNQNSFTGPLPDGFAT--------------------NLTALQKLDLSFNNLSGLIPNDIA 199
+++ TG D T + L +L L N + + ++
Sbjct: 179 ISEAKLTGIPKDLPETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLS 238
Query: 200 NLSRLRLLAQRVYVDLTYNNLSGLIPQNAALLSLGPTAFIGNPFL 244
L LR L L N LS + P L
Sbjct: 239 FLPTLREL------HLDNNKLSRV-----------PAGLPDLKLL 266
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 1e-13
Identities = 29/158 (18%), Positives = 50/158 (31%), Gaps = 13/158 (8%)
Query: 87 NLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQVLDLSQNSFSSSIP 146
+ + +P +L L L L N + + L L L N
Sbjct: 178 RISEAKLT-GIPKDLP--ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIEN 234
Query: 147 SSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSGLIPNDIANLSRLRL 206
S+ L+ + L+ N + +P G +L LQ + L NN++ + ND +
Sbjct: 235 GSLSFLPTLRELHLDNNKLSR-VPAGLP-DLKLLQVVYLHTNNITKVGVNDFCPVGFGVK 292
Query: 207 LAQRVYVDLTYNNLSGLIPQNAALLSLGPTAFIGNPFL 244
A + L N + + P F
Sbjct: 293 RAYYNGISLFNNPVP--------YWEVQPATFRCVTDR 322
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 3e-11
Identities = 36/168 (21%), Positives = 65/168 (38%), Gaps = 23/168 (13%)
Query: 66 NKKLTGF---IPADLGSLSAIGRVNLRNNNFSGSLPVELF-NASNLQSLILSGNSFSGPV 121
+ L I D L +L+NN+ S L + F +L +L+L N S
Sbjct: 42 DLGLKAVPKEISPDTTLL------DLQNNDIS-ELRKDDFKGLQHLYALVLVNNKISKIH 94
Query: 122 PMQIGKLKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQ 181
L+ LQ L +S+N IP ++ L + ++ N +P G + L +
Sbjct: 95 EKAFSPLRKLQKLYISKNHL-VEIPPNLP--SSLVELRIHDNRIRK-VPKGVFSGLRNMN 150
Query: 182 KLDLSFNNLSGL-IPNDIANLSRLRLLAQRVYVDLTYNNLSGLIPQNA 228
+++ N L + +L L ++ L+G IP++
Sbjct: 151 CIEMGGNPLENSGFEPGAFDGLKLNYL------RISEAKLTG-IPKDL 191
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 6e-08
Identities = 24/124 (19%), Positives = 40/124 (32%), Gaps = 12/124 (9%)
Query: 74 PADLGSLSAIGRVNLRNNNFSGSLPVELF-NASNLQSLILSGNSFSGPVPMQIGKLKYLQ 132
DL S + R+ L +N + L+ L L N S VP + LK LQ
Sbjct: 210 LEDLLRYSKLYRLGLGHNQIR-MIENGSLSFLPTLRELHLDNNKLSR-VPAGLPDLKLLQ 267
Query: 133 VLDLSQNSFSSSIPSSI-------VQCKRLKTVVLNQNSFT-GPLPDGFATNLTALQKLD 184
V+ L N+ + + + V+ + L N + +T +
Sbjct: 268 VVYLHTNNITK-VGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQ 326
Query: 185 LSFN 188
Sbjct: 327 FGNY 330
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 1e-05
Identities = 20/94 (21%), Positives = 36/94 (38%), Gaps = 10/94 (10%)
Query: 130 YLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNN 189
+L+V+ S + +P I + L N + D F L L L L N
Sbjct: 34 HLRVVQCSDLGLKA-VPKEIS--PDTTLLDLQNNDISELRKDDFK-GLQHLYALVLVNNK 89
Query: 190 LSGLIPNDIANLSRLRLLAQRVYVDLTYNNLSGL 223
+S + + L +L+ L ++ N+L +
Sbjct: 90 ISKIHEKAFSPLRKLQKL------YISKNHLVEI 117
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 4e-14
Identities = 41/171 (23%), Positives = 73/171 (42%), Gaps = 12/171 (7%)
Query: 68 KLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELF-NASNLQSLILSGNSFSGPVPMQI- 125
L S + ++L ++ + + S+L +LIL+GN + +
Sbjct: 39 PLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPIQS-LALGAF 96
Query: 126 GKLKYLQVLDLSQNSFSSSIPSSI-VQCKRLKTVVLNQNSFTG-PLPDGFATNLTALQKL 183
L LQ L + + +S+ + K LK + + N LP+ F+ NLT L+ L
Sbjct: 97 SGLSSLQKLVAVETN-LASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFS-NLTNLEHL 154
Query: 184 DLSFNNLSGLIPNDIANLSRLRLLAQRVYVDLTYNNLSGLIPQNA-ALLSL 233
DLS N + + D+ L ++ LL +DL+ N ++ I A + L
Sbjct: 155 DLSSNKIQSIYCTDLRVLHQMPLLNLS--LDLSLNPMNF-IQPGAFKEIRL 202
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 1e-10
Identities = 35/145 (24%), Positives = 53/145 (36%), Gaps = 12/145 (8%)
Query: 85 RVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQVLDLSQNSFSSS 144
NF +P L + ++L LS N LQVLDLS+ +
Sbjct: 11 TYQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQT- 66
Query: 145 IPSSI-VQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSGLIPNDIANLSR 203
I L T++L N L G + L++LQKL NL+ L I +L
Sbjct: 67 IEDGAYQSLSHLSTLILTGNPIQS-LALGAFSGLSSLQKLVAVETNLASLENFPIGHLKT 125
Query: 204 LRLLAQRVYVDLTYNNLSGLIPQNA 228
L+ L ++ +N +
Sbjct: 126 LKEL------NVAHNLIQSFKLPEY 144
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 1e-07
Identities = 34/176 (19%), Positives = 64/176 (36%), Gaps = 20/176 (11%)
Query: 47 CSWNGITCREGQVFS-------LIIPNKKLTGFIPADL-GSLSAIGRVNLRNNNFSGSLP 98
S I E + LI+ + + LS++ ++ N + SL
Sbjct: 59 LSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLA-SLE 116
Query: 99 VELF-NASNLQSLILSGNSF-SGPVPMQIGKLKYLQVLDLSQNSFSSSIPSSIVQ-CKRL 155
+ L+ L ++ N S +P L L+ LDLS N S I + ++ ++
Sbjct: 117 NFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQS-IYCTDLRVLHQM 175
Query: 156 KTVV----LNQNSFTGPLPDGFATNLTALQKLDLSFNNLSGLIPNDIANLSRLRLL 207
+ L+ N + G + L++L L N L + L+ L+ +
Sbjct: 176 PLLNLSLDLSLNPMNF-IQPGAFKEIR-LKELALDTNQLKSVPDGIFDRLTSLQKI 229
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 5e-14
Identities = 54/231 (23%), Positives = 87/231 (37%), Gaps = 49/231 (21%)
Query: 375 LGKSTIGIVYKVALNNE--EAVAV-----RRLGNGGWQRFKEFQTEAEAIGKIRHPNIVS 427
+GK V K+A + VA+ +L Q+ E + + HPNIV
Sbjct: 23 IGKGNFAKV-KLARHILTGREVAIKIIDKTQLNPTSLQKLF---REVRIMKILNHPNIVK 78
Query: 428 LRAYFWSVDEKLLIYDYIPNGSLATAI--HGKAGIISYRPLSWSDRLRIIKGVAKGIAFL 485
L + LI +Y G + + HG+ + + + + + +
Sbjct: 79 LFEVIETEKTLYLIMEYASGGEVFDYLVAHGR--------MKEKEARSKFRQIVSAVQYC 130
Query: 486 HEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTT-GTPLQS 544
H+ KR VH DL+ N+LL +M I+DFG + + + G P +
Sbjct: 131 HQ---KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKL-------DAFCGAPPYA 180
Query: 545 SPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPM 595
+P F Y PE D++S GVIL ++SG LP
Sbjct: 181 APELF-------QGKKYDGPEV----------DVWSLGVILYTLVSGSLPF 214
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 6e-14
Identities = 55/229 (24%), Positives = 85/229 (37%), Gaps = 43/229 (18%)
Query: 375 LGKSTIGIVYKV-ALNNEEAVAV-----RRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSL 428
LG G V+ V ++ + R ++ + E E + + HPNI+ +
Sbjct: 30 LGSGAFGDVHLVEERSSGLERVIKTINKDRSQV----PMEQIEAEIEVLKSLDHPNIIKI 85
Query: 429 RAYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEV 488
F ++ + G L I LS ++K + +A+ H
Sbjct: 86 FEVFEDYHNMYIVMETCEGGELLERIVSAQARGKA--LSEGYVAELMKQMMNALAYFHS- 142
Query: 489 SPKRYVHGDLRPSNILL---GKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSS 545
+ VH DL+P NIL + I DFGLA L E + + GT
Sbjct: 143 --QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHS------TNAAGTA---- 190
Query: 546 PYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLP 594
Y APE K R T K DI+S GV++ +++G LP
Sbjct: 191 --------------LYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLP 224
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 7e-14
Identities = 55/240 (22%), Positives = 95/240 (39%), Gaps = 63/240 (26%)
Query: 375 LGKSTIGIVYKVALNNE--EAVAVRR-LGNGGWQRFK--EFQTEAEAIGKIRHPNIVSLR 429
G+ T G V +VA+++ + + RF+ E Q + + + HPNIV L+
Sbjct: 31 AGQGTFGTVQL-GKEKSTGMSVAIKKVIQD---PRFRNRELQ-IMQDLAVLHHPNIVQLQ 85
Query: 430 AYFWSVDEK-------LLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKG----V 478
+YF+++ E+ ++ +Y+P +H +Y + +IK +
Sbjct: 86 SYFYTLGERDRRDIYLNVVMEYVP-----DTLH--RCCRNYYRRQVAPPPILIKVFLFQL 138
Query: 479 AKGIAFLHEVSPKRYVHGDLRPSNILL-GKNMEPHISDFGLARLADIAEE-TPEVHWEQS 536
+ I LH S H D++P N+L+ + + DFG A+ +E +
Sbjct: 139 IRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYI----- 192
Query: 537 TTGTPLQSSPYEFTALNSTTSRSYYQAPE----ASKVRKPTQKWDIYSYGVILLEMISGK 592
SR YY+APE T DI+S G I EM+ G+
Sbjct: 193 -------------------CSR-YYRAPELIFGNQ---HYTTAVDIWSVGCIFAEMMLGE 229
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 71.0 bits (175), Expect = 1e-13
Identities = 55/229 (24%), Positives = 90/229 (39%), Gaps = 45/229 (19%)
Query: 375 LGKSTIGIVYKVA-LNNEEAVAV-----RRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSL 428
LGK +V + A ++L + F++ + EA K++HPNIV L
Sbjct: 14 LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSA---RDFQKLEREARICRKLQHPNIVRL 70
Query: 429 RAYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEV 488
L++D + G L I++ S +D I+ + + IA+ H
Sbjct: 71 HDSIQEESFHYLVFDLVTGGELFED------IVAREFYSEADASHCIQQILESIAYCHS- 123
Query: 489 SPKRYVHGDLRPSNILLGKNMEPH---ISDFGLARLADIAEETPEVHWEQSTTGTPLQSS 545
VH +L+P N+LL + ++DFGLA + +E GTP
Sbjct: 124 --NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGF------AGTP---- 171
Query: 546 PYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLP 594
Y +PE K ++ DI++ GVIL ++ G P
Sbjct: 172 --------------GYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 206
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 71.8 bits (176), Expect = 1e-13
Identities = 73/355 (20%), Positives = 130/355 (36%), Gaps = 88/355 (24%)
Query: 359 QVDFDLEQLLKASAFL-------------------LGKSTIGIVYKVALN-NEEAVAVRR 398
+++ D +Q + AFL LG G+V+KV+ + +A +
Sbjct: 6 ELELDEQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKL 65
Query: 399 L-GNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLATAIHGK 457
+ + E + + + P IV F+S E + +++ GSL + K
Sbjct: 66 IHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLD-QVLKK 124
Query: 458 AGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFG 517
AG I + L ++ V KG+ +L E + +H D++PSNIL+ E + DFG
Sbjct: 125 AGRIPEQILG-----KVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFG 177
Query: 518 LA-RLAD-IAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQK 575
++ +L D +A S GT Y +PE + + +
Sbjct: 178 VSGQLIDSMA---------NSFVGTR------------------SYMSPERLQGTHYSVQ 210
Query: 576 WDIYSYGVILLEMISGKLPMIQIGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKED 635
DI+S G+ L+EM G+ P+ + EL ++ Q+ + + P + D
Sbjct: 211 SDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMD 270
Query: 636 EIVSVLKIAL--------------------------DCVHKSPDKRPS----MRH 660
+ L C+ K+P +R M H
Sbjct: 271 SRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 325
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 1e-13
Identities = 46/183 (25%), Positives = 76/183 (41%), Gaps = 16/183 (8%)
Query: 68 KLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNA-SNLQSLILSGNSFSGPVPMQI- 125
KL+ L+ + + L +N +LP +F NL++L ++ N +P+ +
Sbjct: 48 KLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKLQA-LPIGVF 105
Query: 126 GKLKYLQVLDLSQNSFSSSIPSSI-VQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLD 184
+L L L L +N S +P + +L + L N LP G LT+L++L
Sbjct: 106 DQLVNLAELRLDRNQLKS-LPPRVFDSLTKLTYLSLGYNELQS-LPKGVFDKLTSLKELR 163
Query: 185 LSFNNLSGLIPNDIANLSRLRLLAQRVYVDLTYNNLSGLIPQNA--ALLSLGPTAFIGNP 242
L N L + L+ L+ L L N L +P+ A +L L NP
Sbjct: 164 LYNNQLKRVPEGAFDKLTELKTL------KLDNNQLKR-VPEGAFDSLEKLKMLQLQENP 216
Query: 243 FLC 245
+ C
Sbjct: 217 WDC 219
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 5e-11
Identities = 37/144 (25%), Positives = 62/144 (43%), Gaps = 13/144 (9%)
Query: 86 VNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQVLDLSQNSFSSSI 145
V+ + + ++P + ++ + L L N S +L L++L L+ N + +
Sbjct: 21 VDCSSKKLT-AIPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQT-L 76
Query: 146 PSSI-VQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSGLIPNDIANLSRL 204
P+ I + K L+T+ + N LP G L L +L L N L L P +L++L
Sbjct: 77 PAGIFKELKNLETLWVTDNKLQA-LPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKL 135
Query: 205 RLLAQRVYVDLTYNNLSGLIPQNA 228
L L YN L L P+
Sbjct: 136 TYL------SLGYNELQSL-PKGV 152
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 2e-13
Identities = 53/236 (22%), Positives = 87/236 (36%), Gaps = 51/236 (21%)
Query: 375 LGKSTIGIVYKVA-LNNEEAVAV-----RRLGNGGWQRFKE---FQTEAEAIGKIRHPNI 425
LG G V + VA+ R+ G + +TE E + K+ HP I
Sbjct: 18 LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 426 VSLRAYFWSVDEKL-LIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAF 484
+ ++ +F E ++ + + G L ++ + L + + + +
Sbjct: 78 IKIKNFF--DAEDYYIVLELMEGGELFDK------VVGNKRLKEATCKLYFYQMLLAVQY 129
Query: 485 LHEVSPKRYVHGDLRPSNILLGKNMEPH---ISDFGLARLADIAEETPEVHWEQSTTGTP 541
LHE +H DL+P N+LL E I+DFG +++ E ++ GTP
Sbjct: 130 LHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG------ETSLMRTLCGTP 180
Query: 542 LQSSPYEFTALNSTTSRSYYQAPE--ASKVRKP-TQKWDIYSYGVILLEMISGKLP 594
Y APE S + D +S GVIL +SG P
Sbjct: 181 ------------------TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 218
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 2e-13
Identities = 28/180 (15%), Positives = 64/180 (35%), Gaps = 21/180 (11%)
Query: 68 KLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNA-SNLQSLILSGNSFSGPVPMQI- 125
++T +DL + + L +N + ++ + F++ +L+ L LS N S +
Sbjct: 63 RITYISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGSLEHLDLSYNYLSN-LSSSWF 120
Query: 126 GKLKYLQVLDLSQNSFSSSIPSSIVQ-CKRLKTVVLNQNSFTGPLPDGFATNLTALQKLD 184
L L L+L N + + +S+ +L+ + + + LT L++L+
Sbjct: 121 KPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELE 180
Query: 185 LSFNNLSGLIPNDIANLSRLRLLAQRVYVDLTYNNLSGLIPQNAALLSLGPTAFIGNPFL 244
+ ++L P + ++ + L L L +
Sbjct: 181 IDASDLQSYEPKSLKSIQNVSHL------ILHMKQHI----------LLLEIFVDVTSSV 224
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 2e-12
Identities = 35/198 (17%), Positives = 76/198 (38%), Gaps = 14/198 (7%)
Query: 48 SWNGITCREGQVFS-------LIIPNKKLTGFIPADL-GSLSAIGRVNLRNNNFSGSLPV 99
+ NGI E FS L + L+ + + LS++ +NL N +
Sbjct: 84 TSNGINTIEEDSFSSLGSLEHLDLSYNYLS-NLSSSWFKPLSSLTFLNLLGNPYKTLGET 142
Query: 100 ELFNA-SNLQSLILSGNSFSGPVPMQI-GKLKYLQVLDLSQNSFSSSIPSSIVQCKRLKT 157
LF+ + LQ L + + + L +L+ L++ + S P S+ + +
Sbjct: 143 SLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSH 202
Query: 158 VVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSGLIPNDIANLS--RLRLLAQRVYVDL 215
++L+ L + F ++++ L+L +L ++++ L V +
Sbjct: 203 LILHMKQHIL-LLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKI 261
Query: 216 TYNNLSGLIPQNAALLSL 233
T +L ++ + L
Sbjct: 262 TDESLFQVMKLLNQISGL 279
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 67.5 bits (165), Expect = 3e-12
Identities = 35/208 (16%), Positives = 66/208 (31%), Gaps = 22/208 (10%)
Query: 48 SWNGITCREGQVFS-------LIIPNKKLTGFIPADL-GSLSAIGRVNLRNNNFSGSLPV 99
S N IT L++ + + I D SL ++ ++L N S +L
Sbjct: 60 SNNRITYISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGSLEHLDLSYNYLS-NLSS 117
Query: 100 ELF-NASNLQSLILSGNSFSGPVPMQI-GKLKYLQVLDLSQNSFSSSIPSSIVQ-CKRLK 156
F S+L L L GN + + L LQ+L + + I L+
Sbjct: 118 SWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLE 177
Query: 157 TVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSGLIPNDIANLSRLRLLAQRVYVDLT 216
+ ++ + ++ + L L L+ + S + L +L
Sbjct: 178 ELEIDASDLQS-YEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECL------ELR 230
Query: 217 YNNLSGLIPQNAALLSLGPTAFIGNPFL 244
+L + L + + I
Sbjct: 231 DTDLDTF--HFSELSTGETNSLIKKFTF 256
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 64.8 bits (158), Expect = 3e-11
Identities = 23/164 (14%), Positives = 54/164 (32%), Gaps = 18/164 (10%)
Query: 66 NKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELF-NASNLQSLILSGNSFSGPVPMQ 124
T D L+ + + + ++ S + + N+ LIL + +
Sbjct: 159 MDTFTKIQRKDFAGLTFLEELEIDASDLQ-SYEPKSLKSIQNVSHLILHMKQHILLLEIF 217
Query: 125 IGKLKYLQVLDLSQNSFS----SSIPS----SIVQCKRLKTVVLNQNSFTGPLPDGFATN 176
+ ++ L+L S + + S+++ + V + S +
Sbjct: 218 VDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLN-Q 275
Query: 177 LTALQKLDLSFNNLSGLIPNDIANLSRLRLLAQRVYVDLTYNNL 220
++ L +L+ S N L + L+ L+ + L N
Sbjct: 276 ISGLLELEFSRNQLKSVPDGIFDRLTSLQ------KIWLHTNPW 313
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 4e-10
Identities = 38/167 (22%), Positives = 67/167 (40%), Gaps = 17/167 (10%)
Query: 66 NKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELF-NASNLQSLILSGNSFSGPVPMQ 124
+ L IP+ L A+ ++L NN + + NLQ+L+L+ N + +
Sbjct: 40 SGSLN-SIPSGL--TEAVKSLDLSNNRIT-YISNSDLQRCVNLQALVLTSNGINT-IEED 94
Query: 125 I-GKLKYLQVLDLSQNSFSSSIPSSI-VQCKRLKTVVLNQNSFTGPLPDGFATNLTALQK 182
L L+ LDLS N S++ SS L + L N + ++LT LQ
Sbjct: 95 SFSSLGSLEHLDLSYNYL-SNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQI 153
Query: 183 LDLSFNN-LSGLIPNDIANLSRLRLLAQRVYVDLTYNNLSGLIPQNA 228
L + + + + D A L+ L L ++ ++L +
Sbjct: 154 LRVGNMDTFTKIQRKDFAGLTFLEEL------EIDASDLQS-YEPKS 193
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 9e-05
Identities = 20/106 (18%), Positives = 38/106 (35%), Gaps = 11/106 (10%)
Query: 123 MQIGKLKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQK 182
M + + S S + + C R + S +P G +
Sbjct: 1 MPHTLWMVWVLGVIISLSKEESSNQASLSCDRNGICKGSSGSLNS-IPSGLTEAVK---S 56
Query: 183 LDLSFNNLSGLIPNDIANLSRLRLLAQRVYVDLTYNNLSGLIPQNA 228
LDLS N ++ + +D+ L+ L LT N ++ I +++
Sbjct: 57 LDLSNNRITYISNSDLQRCVNLQAL------VLTSNGIN-TIEEDS 95
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 2e-13
Identities = 51/231 (22%), Positives = 83/231 (35%), Gaps = 50/231 (21%)
Query: 374 LLGKSTIGIVYK-VALNNEEAVAV-----RRLGNGGWQRFKEFQTEAEAIGKIRHPNIVS 427
+LG V+ + A+ + E + KI+H NIV+
Sbjct: 16 VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFR-----DSSLENEIAVLKKIKHENIVT 70
Query: 428 LRAYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHE 487
L + S L+ + G L I+ + D +I+ V + +LHE
Sbjct: 71 LEDIYESTTHYYLVMQLVSGGELFDR------ILERGVYTEKDASLVIQQVLSAVKYLHE 124
Query: 488 VSPKRYVHGDLRPSNILLGKNMEPH----ISDFGLARLADIAEETPEVHWEQSTTGTPLQ 543
VH DL+P N+L E + I+DFGL+++ E + + GTP
Sbjct: 125 ---NGIVHRDLKPENLLY-LTPEENSKIMITDFGLSKM-----EQNGIM--STACGTP-- 171
Query: 544 SSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLP 594
Y APE + ++ D +S GVI ++ G P
Sbjct: 172 ----------------GYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPP 206
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 70.3 bits (173), Expect = 2e-13
Identities = 64/245 (26%), Positives = 99/245 (40%), Gaps = 78/245 (31%)
Query: 375 LGKSTIGIVYKVALN--NEEAVAVRRLGNGGWQRFKEFQTEAE------AIGKI------ 420
LG T VYK LN VA+ KE + ++E AI +I
Sbjct: 13 LGNGTYATVYK-GLNKTTGVYVAL-----------KEVKLDSEEGTPSTAIREISLMKEL 60
Query: 421 RHPNIVSLRAYFWSVDEKL-LIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVA 479
+H NIV L + + KL L+++++ N L + + + R L + +
Sbjct: 61 KHENIVRLYDVIHT-ENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLL 118
Query: 480 KGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEE--TPEV--HWEQ 535
+G+AF HE + +H DL+P N+L+ K + + DFGLAR I + EV W
Sbjct: 119 QGLAFCHE---NKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLW-- 173
Query: 536 STTGTPLQSSPYEFTALNSTTSRSYYQAPE--------ASKVRKPTQKWDIYSYGVILLE 587
Y+AP+ ++ + DI+S G IL E
Sbjct: 174 -------------------------YRAPDVLMGSRTYSTSI-------DIWSCGCILAE 201
Query: 588 MISGK 592
MI+GK
Sbjct: 202 MITGK 206
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 4e-13
Identities = 48/224 (21%), Positives = 82/224 (36%), Gaps = 38/224 (16%)
Query: 375 LGKSTIGIVYKVA-LNNEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFW 433
+G+ + G V A +++ + F+ E E + + HPNI+ L F
Sbjct: 17 IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFE 76
Query: 434 SVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRY 493
+ L+ + G L ++ R SD RI+K V +A+ H+
Sbjct: 77 DNTDIYLVMELCTGGELFER------VVHKRVFRESDAARIMKDVLSAVAYCHK---LNV 127
Query: 494 VHGDLRPSNILL---GKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFT 550
H DL+P N L + + DFGLA ++ GTP
Sbjct: 128 AHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK------PGKMMRTKVGTP--------- 172
Query: 551 ALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLP 594
YY +P+ + + D +S GV++ ++ G P
Sbjct: 173 ---------YYVSPQVLE-GLYGPECDEWSAGVMMYVLLCGYPP 206
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 4e-13
Identities = 57/238 (23%), Positives = 102/238 (42%), Gaps = 65/238 (27%)
Query: 375 LGKSTIGIVYKVALNNE--EAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYF 432
+G + G+VY+ A + E VA++++ +RFK E + + K+ H NIV LR +F
Sbjct: 62 IGNGSFGVVYQ-AKLCDSGELVAIKKVLQD--KRFK--NRELQIMRKLDHCNIVRLRYFF 116
Query: 433 WSVDEKL------LIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKG----VAKGI 482
+S EK L+ DY+P ++ + + + L + +K + + +
Sbjct: 117 YSSGEKKDEVYLNLVLDYVPE-TVYRVA--RHYSRAKQTLP----VIYVKLYMYQLFRSL 169
Query: 483 AFLHEVSPKRYVHGDLRPSNILLGKNMEPH---ISDFGLARLADIAEE-TPEVHWEQSTT 538
A++H H D++P N+LL + + + DFG A+ E +
Sbjct: 170 AYIHS---FGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVSYI------- 217
Query: 539 GTPLQSSPYEFTALNSTTSRSYYQAPE----ASKVRKPTQKWDIYSYGVILLEMISGK 592
SR YY+APE A+ T D++S G +L E++ G+
Sbjct: 218 -----------------CSR-YYRAPELIFGATDY---TSSIDVWSAGCVLAELLLGQ 254
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 5e-13
Identities = 43/179 (24%), Positives = 73/179 (40%), Gaps = 36/179 (20%)
Query: 420 IRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVA 479
+HPNI++L+ + ++ + + G L I + + S + ++ +
Sbjct: 73 GQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQ------KFFSEREASAVLFTIT 126
Query: 480 KGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPH----ISDFGLARLADIAEETPEVHWEQ 535
K + +LH + VH DL+PSNIL I DFG A+ ++ E
Sbjct: 127 KTVEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAK---------QLRAEN 174
Query: 536 STTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLP 594
TP +TA + APE + + DI+S GV+L M++G P
Sbjct: 175 GLLMTPC------YTA--------NFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTP 219
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 6e-13
Identities = 43/242 (17%), Positives = 83/242 (34%), Gaps = 66/242 (27%)
Query: 375 LGKSTIGIVYKVALNNE--EAVAV-----RRLGNGGWQRFKEFQT---EAEAIGKIRHPN 424
LG G V A++ E + V V ++ W + E + ++ H N
Sbjct: 32 LGSGAFGFV-WTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHAN 90
Query: 425 IVSL------RAYFWSVDEKLL----IYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRI 474
I+ + + +F V EK ++ +I H + L I
Sbjct: 91 IIKVLDIFENQGFFQLVMEKHGSGLDLFAFI-------DRHPR--------LDEPLASYI 135
Query: 475 IKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAE--ETPEVH 532
+ + + +L K +H D++ NI++ ++ + DFG A + + T
Sbjct: 136 FRQLVSAVGYLRL---KDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYT---- 188
Query: 533 WEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGK 592
GT +P + Y+ PE +++S GV L ++ +
Sbjct: 189 ----FCGTIEYCAPEVL-------MGNPYRGPEL----------EMWSLGVTLYTLVFEE 227
Query: 593 LP 594
P
Sbjct: 228 NP 229
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 6e-13
Identities = 47/224 (20%), Positives = 90/224 (40%), Gaps = 38/224 (16%)
Query: 375 LGKSTIGIVYK-VALNNEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFW 433
LG+ GIV++ V ++++ + + G + + E + RH NI+ L F
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQ-VLVKKEISILNIARHRNILHLHESFE 71
Query: 434 SVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRY 493
S++E ++I+++I + I+ A ++ R + + + V + + FLH
Sbjct: 72 SMEELVMIFEFISGLDIFERINTSAFELNER-----EIVSYVHQVCEALQFLHS---HNI 123
Query: 494 VHGDLRPSNILLGKNMEPH---ISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFT 550
H D+RP NI+ + I +FG AR + + P
Sbjct: 124 GHFDIRPENIIY-QTRRSSTIKIIEFGQARQLKPGDNF------RLLFTAP--------- 167
Query: 551 ALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLP 594
Y APE + + D++S G ++ ++SG P
Sbjct: 168 ---------EYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINP 202
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 7e-13
Identities = 46/179 (25%), Positives = 75/179 (41%), Gaps = 39/179 (21%)
Query: 422 HPNIVSLRAYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKG 481
HPNI+ L+ + + L++D + G L + LS + +I++ + +
Sbjct: 83 HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL------TEKVTLSEKETRKIMRALLEV 136
Query: 482 IAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTP 541
I LH+ VH DL+P NILL +M ++DFG + D E+ EV GTP
Sbjct: 137 ICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREV------CGTP 187
Query: 542 LQSSPYEFTALNSTTSRSYYQAPE------ASKVRKPTQKWDIYSYGVILLEMISGKLP 594
Y APE ++ D++S GVI+ +++G P
Sbjct: 188 ------------------SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 69.6 bits (170), Expect = 8e-13
Identities = 51/208 (24%), Positives = 83/208 (39%), Gaps = 47/208 (22%)
Query: 464 RPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLAD 523
L+ + VAKG+ FL + ++ +H DL NILL + I DFGLAR D
Sbjct: 188 DFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR--D 242
Query: 524 IAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGV 583
I ++ V L P ++ APE R T + D++S+GV
Sbjct: 243 IYKDPDYV----RKGDARL---PLKWM------------APETIFDRVYTIQSDVWSFGV 283
Query: 584 ILLEMIS-GKLP--MIQIGSMELNIVQWIQLILEDRKPMTDILD-PFLAHDLDKEDEIVS 639
+L E+ S G P ++I ++ + + E + + P
Sbjct: 284 LLWEIFSLGASPYPGVKIDE------EFCRRLKEGTR-----MRAPDYTTP--------E 324
Query: 640 VLKIALDCVHKSPDKRPSMRHVCDSLDR 667
+ + LDC H P +RP+ + + L
Sbjct: 325 MYQTMLDCWHGEPSQRPTFSELVEHLGN 352
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 9e-13
Identities = 55/231 (23%), Positives = 91/231 (39%), Gaps = 46/231 (19%)
Query: 375 LGKSTIGIVYKV---ALNNEEAV---AVRRLGNGGWQRFKEFQTEAEAIGKIRH-PNIVS 427
LG+ +V + + E A RR G E E + + P +++
Sbjct: 37 LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQ---DCRAEILHEIAVLELAKSCPRVIN 93
Query: 428 LRAYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHE 487
L + + E +LI +Y G + + + +S +D +R+IK + +G+ +LH+
Sbjct: 94 LHEVYENTSEIILILEYAAGGEIFSLCLPE----LAEMVSENDVIRLIKQILEGVYYLHQ 149
Query: 488 VSPKRYVHGDLRPSNILLGKNMEPH---ISDFGLARLADIAEETPEVHWEQSTTGTPLQS 544
VH DL+P NILL I DFG++R A E E+ GTP
Sbjct: 150 ---NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREI------MGTP--- 197
Query: 545 SPYEFTALNSTTSRSYYQAPEASKVRKP-TQKWDIYSYGVILLEMISGKLP 594
Y APE P T D+++ G+I +++ P
Sbjct: 198 ---------------EYLAPEILN-YDPITTATDMWNIGIIAYMLLTHTSP 232
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 1e-12
Identities = 56/229 (24%), Positives = 90/229 (39%), Gaps = 45/229 (19%)
Query: 375 LGKSTIGIVYKVA-LNNEEAVAV-----RRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSL 428
LGK +V + A ++L + F++ + EA K++HPNIV L
Sbjct: 37 LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSA---RDFQKLEREARICRKLQHPNIVRL 93
Query: 429 RAYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEV 488
L++D + G L I + Y S +D I+ + + IA+ H
Sbjct: 94 HDSIQEESFHYLVFDLVTGGELFEDIVARE---FY---SEADASHCIQQILESIAYCHS- 146
Query: 489 SPKRYVHGDLRPSNILLGKNMEPH---ISDFGLARLADIAEETPEVHWEQSTTGTPLQSS 545
VH +L+P N+LL + ++DFGLA + +E GTP
Sbjct: 147 --NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGF------AGTP---- 194
Query: 546 PYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLP 594
Y +PE K ++ DI++ GVIL ++ G P
Sbjct: 195 --------------GYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 229
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 1e-12
Identities = 29/160 (18%), Positives = 59/160 (36%), Gaps = 24/160 (15%)
Query: 76 DLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQVLD 135
D+ + + ++ N L + + L +L S N + + + + K L L+
Sbjct: 143 DVSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNKITE---LDVSQNKLLNRLN 197
Query: 136 LSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTG-PLPDGFATNLTALQKLDLSFNNLSGLI 194
N+ + + + Q +L + + N T + T LT L D S N L+ L
Sbjct: 198 CDTNNITK-LD--LNQNIQLTFLDCSSNKLTEIDV-----TPLTQLTYFDCSVNPLTELD 249
Query: 195 PNDIANLSRLRLLAQRVYVDLTYNNLSGL-IPQNAALLSL 233
+ ++ L+ L +L + + N L+
Sbjct: 250 VSTLSKLTTL---------HCIQTDLLEIDLTHNTQLIYF 280
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 2e-12
Identities = 28/196 (14%), Positives = 68/196 (34%), Gaps = 33/196 (16%)
Query: 50 NGITCREGQVFSLIIPNKKLTGFI----------PADLGSLSAIGRVNLRNNNFSGSLPV 99
N + + Q F+ P+ + L+ + ++ N++ + +
Sbjct: 1 NTLKAGQTQSFNDWFPDDNFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSIT-DMT- 58
Query: 100 ELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVV 159
+ + L LI + N+ + + + + L L N ++ + + +L +
Sbjct: 59 GIEKLTGLTKLICTSNNITT---LDLSQNTNLTYLACDSNKLTN-LD--VTPLTKLTYLN 112
Query: 160 LNQNSFTGPLPDGFATNLTALQKLDLSFNNLSGLIPNDIANLSRLRLLAQRVYVDLTYNN 219
+ N T L + L L+ + N L+ + D+++ ++L L D N
Sbjct: 113 CDTNKLT-KLDV---SQNPLLTYLNCARNTLTEI---DVSHNTQLTEL------DCHLNK 159
Query: 220 LSGLIP--QNAALLSL 233
+ L +L
Sbjct: 160 KITKLDVTPQTQLTTL 175
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 2e-11
Identities = 22/160 (13%), Positives = 48/160 (30%), Gaps = 23/160 (14%)
Query: 76 DLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQVLD 135
D+ L+ + + N + L V S L +L + + L
Sbjct: 228 DVTPLTQLTYFDCSVNPLT-ELDVSTL--SKLTTLHCIQTDLLE---IDLTHNTQLIYFQ 281
Query: 136 LSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSGLIP 195
+ + +L + T L + L L L+ L+ L
Sbjct: 282 AEGCRKIKELD--VTHNTQLYLLDCQAAGIT-ELD---LSQNPKLVYLYLNNTELTEL-- 333
Query: 196 NDIANLSRLRLLAQRVYVDLTYNNLSGL--IPQNAALLSL 233
D+++ ++L+ L ++ + + AL +
Sbjct: 334 -DVSHNTKLKSL------SCVNAHIQDFSSVGKIPALNNN 366
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 1e-10
Identities = 30/210 (14%), Positives = 60/210 (28%), Gaps = 21/210 (10%)
Query: 47 CSWNGITCREGQVFS----LIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELF 102
CS N +T + S L L DL + + L ++
Sbjct: 240 CSVNPLTELDVSTLSKLTTLHCIQTDLLEI---DLTHNTQLIYFQAEGCRKIKEL--DVT 294
Query: 103 NASNLQSLILSGNSFSGPVPMQIGKLKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQ 162
+ + L L + + + + L L L+ + + S +LK++
Sbjct: 295 HNTQLYLLDCQAAGIT---ELDLSQNPKLVYLYLNNTELTE-LDVS--HNTKLKSLSCVN 348
Query: 163 NSFTGPLPDGFATNLTALQKLDLSFNNLSGLIPNDIANLSRLRLLAQRVYVDLTYNNLSG 222
+ AL + + + N S L + +D N ++
Sbjct: 349 AHIQD-FSS--VGKIPALNNNFEAEGQTITMPKETLTNNS-LTIAVSPDLLDQFGNPMN- 403
Query: 223 LIPQNAALLSLGPTAFIGNPFLCGPPLKVS 252
+ P + + T I L V+
Sbjct: 404 IEPGDGGVYDQ-ATNTITWENLSTDNPAVT 432
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 1e-12
Identities = 48/232 (20%), Positives = 87/232 (37%), Gaps = 50/232 (21%)
Query: 374 LLGKSTIGIVYK-VALNNEEAVAVRRLGNGGWQRFKEFQTEAEAIGKI-RHPNIVSLRAY 431
+LG G V + + A++ L + + E + + P+IV +
Sbjct: 36 VLGLGVNGKVLECFHRRTGQKCALKLL-----YDSPKARQEVDHHWQASGGPHIVCILDV 90
Query: 432 FWSVDEK----LLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHE 487
+ ++ L+I + + G L + I + G ++ + + I++ + I FLH
Sbjct: 91 YENMHHGKRCLLIIMECMEGGELFSRIQER-GDQAF---TEREAAEIMRDIGTAIQFLHS 146
Query: 488 VSPKRYVHGDLRPSNILL---GKNMEPHISDFGLARLADIAEETPEVHWEQSTT--GTPL 542
H D++P N+L K+ ++DFG A+ E T TP
Sbjct: 147 ---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK---------ETTQNALQTPCYTP- 193
Query: 543 QSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLP 594
YY APE K + D++S GVI+ ++ G P
Sbjct: 194 -----------------YYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPP 228
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 1e-12
Identities = 47/176 (26%), Positives = 73/176 (41%), Gaps = 35/176 (19%)
Query: 422 HPNIVSLRAYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKG 481
HPNIV L F L+ + + G L I K + S ++ I++ +
Sbjct: 65 HPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKK------KHFSETEASYIMRKLVSA 118
Query: 482 IAFLHEVSPKRYVHGDLRPSNILL---GKNMEPHISDFGLARLADIAEETPEVHWEQSTT 538
++ +H+ VH DL+P N+L N+E I DFG ARL P+ ++
Sbjct: 119 VSHMHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKP-----PDNQPLKTPC 170
Query: 539 GTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLP 594
T +Y APE + D++S GVIL M+SG++P
Sbjct: 171 FTL------------------HYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVP 208
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 1e-12
Identities = 52/230 (22%), Positives = 88/230 (38%), Gaps = 46/230 (20%)
Query: 375 LGKSTIGIVYK-VALNNEEAVAV-----RRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSL 428
LGK +V + V + + A ++L Q+ + EA ++HPNIV L
Sbjct: 19 LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLE---REARICRLLKHPNIVRL 75
Query: 429 RAYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEV 488
LI+D + G L I++ S +D I+ + + + H+
Sbjct: 76 HDSISEEGHHYLIFDLVTGGELFED------IVAREYYSEADASHCIQQILEAVLHCHQ- 128
Query: 489 SPKRYVHGDLRPSNILLGKNMEPH----ISDFGLARLADIAEETPEVHWEQSTTGTPLQS 544
VH +L+P N+LL + ++DFGLA + + W GTP
Sbjct: 129 --MGVVHRNLKPENLLL-ASKLKGAAVKLADFGLAIEVE----GEQQAW-FGFAGTP--- 177
Query: 545 SPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLP 594
Y +PE + + D+++ GVIL ++ G P
Sbjct: 178 ---------------GYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPP 212
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 69.1 bits (169), Expect = 2e-12
Identities = 35/173 (20%), Positives = 62/173 (35%), Gaps = 12/173 (6%)
Query: 64 IPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNA-SNLQSLILSGNSFSGPVP 122
+ + S + N + + + + + S L S N + V
Sbjct: 283 VVSDVFGFPQSYIYEIFSNMNIKNFTVSG-TRMVHMLCPSKISPFLHLDFSNNLLTDTVF 341
Query: 123 MQIGKLKYLQVLDLSQNSFSS--SIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTAL 180
G L L+ L L N I Q K L+ + ++QNS + G + +L
Sbjct: 342 ENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSL 401
Query: 181 QKLDLSFNNLSGLIPNDIANLSRLRLLAQRVYVDLTYNNLSGLIPQNAALLSL 233
L++S N L+ I + R+++L DL N + + Q L +L
Sbjct: 402 LSLNMSSNILTDTIFRCL--PPRIKVL------DLHSNKIKSIPKQVVKLEAL 446
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 68.0 bits (166), Expect = 4e-12
Identities = 40/168 (23%), Positives = 63/168 (37%), Gaps = 8/168 (4%)
Query: 66 NKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQI 125
L +P DL +N+ N S ++ + S L+ LI+S N
Sbjct: 9 KNGLI-HVPKDLSQ--KTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVF 65
Query: 126 GKLKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDL 185
+ L+ LDLS N I LK + L+ N+F N++ L+ L L
Sbjct: 66 KFNQELEYLDLSHNKLVK-ISCH--PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGL 122
Query: 186 SFNNLSGLIPNDIANLSRLRLLAQRVYVDLTYNNLSGLIPQNAALLSL 233
S +L IA+L+ ++L + GL Q+ SL
Sbjct: 123 STTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGL--QDFNTESL 168
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 63.7 bits (155), Expect = 9e-11
Identities = 29/206 (14%), Positives = 57/206 (27%), Gaps = 15/206 (7%)
Query: 30 IRNFPEGNNWNNSNEDPCSWNGITCREGQVFSLIIPNKKLTGFIPADLGSLSAIGRVNLR 89
I+ E N + + I I + + + ++
Sbjct: 197 IKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLV-WHTTVWYFSIS 255
Query: 90 NNNFSGSLPVELFNASN-----LQSLILSGNSFSGPVPMQIGKLKYLQVLDLSQNSFSSS 144
N G L F+ S L + + F P + + + + +
Sbjct: 256 NVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMV 315
Query: 145 IPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSGL--IPNDIANLS 202
+ + + N T +LT L+ L L N L L I +
Sbjct: 316 HMLCPSKISPFLHLDFSNNLLTD-TVFENCGHLTELETLILQMNQLKELSKIAEMTTQMK 374
Query: 203 RLRLLAQRVYVDLTYNNLSGLIPQNA 228
L+ L D++ N++S +
Sbjct: 375 SLQQL------DISQNSVSYDEKKGD 394
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 62.6 bits (152), Expect = 2e-10
Identities = 38/159 (23%), Positives = 64/159 (40%), Gaps = 15/159 (9%)
Query: 66 NKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLP--VELF-NASNLQSLILSGNSFSGPVP 122
N LT + + G L+ + + L+ N L E+ +LQ L +S NS S
Sbjct: 333 NNLLTDTVFENCGHLTELETLILQMNQLK-ELSKIAEMTTQMKSLQQLDISQNSVSYDEK 391
Query: 123 MQI-GKLKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQ 181
K L L++S N + +I + R+K + L+ N +P L ALQ
Sbjct: 392 KGDCSWTKSLLSLNMSSNILTDTIFRCLPP--RIKVLDLHSNKIKS-IPKQVV-KLEALQ 447
Query: 182 KLDLSFNNLSGLIPNDIANLSRLRLLAQRVYVDLTYNNL 220
+L+++ N L + L+ L+ + L N
Sbjct: 448 ELNVASNQLKSVPDGIFDRLTSLQKI------WLHTNPW 480
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 52.9 bits (127), Expect = 2e-07
Identities = 31/188 (16%), Positives = 63/188 (33%), Gaps = 20/188 (10%)
Query: 48 SWNGITCREGQVFS-------LIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVE 100
S N I+ LII + ++ + + ++L +N +
Sbjct: 29 SQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV-KISCH 87
Query: 101 LFNASNLQSLILSGNSF-SGPVPMQIGKLKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVV 159
NL+ L LS N+F + P+ + G + L+ L LS S I K ++
Sbjct: 88 PT--VNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLL 145
Query: 160 LNQNSFTGPLPDGFATNLTALQKLDLSFNNLSGLIPNDIANLSRLRLLAQRVYVDLTYNN 219
+ ++ L L + + I ++S + +L +N
Sbjct: 146 VLGETYGEKEDPEG---LQDFNTESLHIVFPTNKEFHFILDVSVKTVA------NLELSN 196
Query: 220 LSGLIPQN 227
+ ++ N
Sbjct: 197 IKCVLEDN 204
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 46.0 bits (109), Expect = 3e-05
Identities = 20/105 (19%), Positives = 43/105 (40%), Gaps = 4/105 (3%)
Query: 62 LIIPNKKLTGFIPADL-GSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGP 120
L I ++ ++ +N+ +N + ++ L ++ L L N
Sbjct: 379 LDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIKS- 435
Query: 121 VPMQIGKLKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSF 165
+P Q+ KL+ LQ L+++ N S + L+ + L+ N +
Sbjct: 436 IPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTNPW 480
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 3e-12
Identities = 54/235 (22%), Positives = 103/235 (43%), Gaps = 60/235 (25%)
Query: 375 LGKSTIGIVYKVALNNEEAVAVRRLGNGGWQRFKEFQT-EAEAIGKIRHPNIVSLRAYFW 433
+G + G+V++ L + VA++++ + K F+ E + + ++HPN+V L+A+F+
Sbjct: 48 IGNGSFGVVFQAKLVESDEVAIKKV-----LQDKRFKNRELQIMRIVKHPNVVDLKAFFY 102
Query: 434 SVDEKL------LIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKG----VAKGIA 483
S +K L+ +Y+P ++ A Y L + + +IK + + +A
Sbjct: 103 SNGDKKDEVFLNLVLEYVPE-TVYRASR------HYAKLKQTMPMLLIKLYMYQLLRSLA 155
Query: 484 FLHEVSPKRYVHGDLRPSNILLGKNMEP-HISDFGLARLADIAEE-TPEVHWEQSTTGTP 541
++H H D++P N+LL + DFG A++ E +
Sbjct: 156 YIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYI---------- 202
Query: 542 LQSSPYEFTALNSTTSRSYYQAPE----ASKVRKPTQKWDIYSYGVILLEMISGK 592
SR YY+APE A+ T DI+S G ++ E++ G+
Sbjct: 203 --------------CSR-YYRAPELIFGATNY---TTNIDIWSTGCVMAELMQGQ 239
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 67.1 bits (164), Expect = 5e-12
Identities = 63/306 (20%), Positives = 108/306 (35%), Gaps = 91/306 (29%)
Query: 375 LGKSTIGIVYKVALNNE--EAVAVRRLGNGGWQR---FKEFQTEAEAIGKIRHPNIVSLR 429
+G + G VY A + E VA++++ G Q +++ E + K+RHPN +
Sbjct: 62 IGHGSFGAVYF-ARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTI--- 117
Query: 430 AYFWS--VDEKL-LIYDYIPNGSLATAIHGKAGI-----ISYRPLSWSDRLRIIKGVAKG 481
Y + L+ +Y GS + + I+ + G +G
Sbjct: 118 QYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAA----------VTHGALQG 166
Query: 482 IAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTP 541
+A+LH +H D++ NILL + + DFG A + P S GTP
Sbjct: 167 LAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSA-----SIMAP----ANSFVGTP 214
Query: 542 LQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQ---KWDIYSYGVILLEMISGKLPMIQI 598
Y+ APE Q K D++S G+ +E+ K P+ +
Sbjct: 215 ------------------YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 256
Query: 599 GSMELNIVQWIQLI-------LEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKS 651
+M + I L+ ++ F+ C+ K
Sbjct: 257 NAMSA-----LYHIAQNESPALQSGH-WSEYFRNFVDS-----------------CLQKI 293
Query: 652 PDKRPS 657
P RP+
Sbjct: 294 PQDRPT 299
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 6e-12
Identities = 61/331 (18%), Positives = 122/331 (36%), Gaps = 59/331 (17%)
Query: 344 MSENMEQYEFVPLDSQVDFDLEQLLKASAFLLGKSTIGIVYKVALN-NEEAVAVRRL-GN 401
MS + + DF E L +G+ G V K+ + + +AV+R+
Sbjct: 1 MSIESSGKLKISPEQHWDFTAEDLKDLG--EIGRGAYGSVNKMVHKPSGQIMAVKRIRST 58
Query: 402 GGWQRFKEFQTEAEAIGK-IRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLATAIHGKAGI 460
+ K+ + + + + P IV + + + + + + S
Sbjct: 59 VDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELM-STSFDKFYK-YVYS 116
Query: 461 ISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGL-A 519
+ + +I K + L E + +H D++PSNILL ++ + DFG+
Sbjct: 117 VLDDVIPEEILGKITLATVKALNHLKEN--LKIIHRDIKPSNILLDRSGNIKLCDFGISG 174
Query: 520 RLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPE---ASKVRKP-TQK 575
+L D +T G Y APE S R+ +
Sbjct: 175 QLVDSIAKT-------RDAGCR------------------PYMAPERIDPSASRQGYDVR 209
Query: 576 WDIYSYGVILLEMISGKLPMIQIGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKE- 634
D++S G+ L E+ +G+ P + S+ + +++ P P L++ ++E
Sbjct: 210 SDVWSLGITLYELATGRFPYPKWNSV----FDQLTQVVKG-DP------PQLSNSEEREF 258
Query: 635 -DEIVSVLKIALDCVHKSPDKRPS----MRH 660
++ + + C+ K KRP ++H
Sbjct: 259 SPSFINFVNL---CLTKDESKRPKYKELLKH 286
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 7e-12
Identities = 55/240 (22%), Positives = 90/240 (37%), Gaps = 45/240 (18%)
Query: 361 DFDLEQLLKASAFLLGKSTIGIVYKV-ALNNEEAVAVRRLGNGGWQRFKEFQ---TEAEA 416
DF K +LG+ + V L A++ L + + E +
Sbjct: 31 DFKF---GK----ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDV 83
Query: 417 IGKIRHPNIVSLRAYFWSVDEKL-LIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRI- 474
+ ++ HP V L F DEKL Y NG L I K G R
Sbjct: 84 MSRLDHPFFVKLYFTFQD-DEKLYFGLSYAKNGELLKYIR-KIGSFD------ETCTRFY 135
Query: 475 IKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWE 534
+ + +LH K +H DL+P NILL ++M I+DFG A++ + +
Sbjct: 136 TAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARAN-- 190
Query: 535 QSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLP 594
S GT + Y +PE + + D+++ G I+ ++++G P
Sbjct: 191 -SFVGTA------Q------------YVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 66.8 bits (163), Expect = 1e-11
Identities = 64/269 (23%), Positives = 101/269 (37%), Gaps = 63/269 (23%)
Query: 342 DTMSENMEQYEFVPLD-SQVDFDLE---QLLKASAFLLGKSTIGIVYKVALNNE--EAVA 395
MS++ +F ++ F + Q LK +G GIV A + VA
Sbjct: 37 YNMSKSKVDNQFYSVEVGDSTFTVLKRYQNLKP----IGSGAQGIVCA-AYDAVLDRNVA 91
Query: 396 VRRLGNGGWQRFKEFQTEAEA---------IGKIRHPNIVSLRAYFWSVDEKLLIYD-YI 445
+++L + FQ + A + + H NI+SL F D Y+
Sbjct: 92 IKKL-------SRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYL 144
Query: 446 PNGSLATAIHGKAGIISYRPLSWSDRLR-IIKGVAKGIAFLHEVSPKRYVHGDLRPSNIL 504
+ + + L +R+ ++ + GI LH +H DL+PSNI+
Sbjct: 145 VMELMDANLCQ----VIQMELD-HERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIV 196
Query: 505 LGKNMEPHISDFGLARLADIAEE-TPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQA 563
+ + I DFGLAR A + TP V +R YY+A
Sbjct: 197 VKSDCTLKILDFGLARTAGTSFMMTPYV------------------------VTR-YYRA 231
Query: 564 PEASKVRKPTQKWDIYSYGVILLEMISGK 592
PE + DI+S G I+ EM+ K
Sbjct: 232 PEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 64.9 bits (159), Expect = 1e-11
Identities = 54/230 (23%), Positives = 96/230 (41%), Gaps = 46/230 (20%)
Query: 374 LLGKSTIGIVYKVALNNE--EAVAV-----RRLGNGGWQRFKEFQTEAEAIGKIRHPNIV 426
LG T G V K+ + VAV +++ + + + E + + RHP+I+
Sbjct: 18 TLGVGTFGKV-KIGEHQLTGHKVAVKILNRQKIRSLD--VVGKIKREIQNLKLFRHPHII 74
Query: 427 SLRAYFWSVDEKLLIYDYIPNGSLATAI--HGKAGIISYRPLSWSDRLRIIKGVAKGIAF 484
L + + ++ +Y+ G L I HG+ + + R+ + + + +
Sbjct: 75 KLYQVISTPTDFFMVMEYVSGGELFDYICKHGR--------VEEMEARRLFQQILSAVDY 126
Query: 485 LHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQS 544
H VH DL+P N+LL +M I+DFGL+ + + +++ G+P +
Sbjct: 127 CHR---HMVVHRDLKPENVLLDAHMNAKIADFGLS-----NMMSDG-EFLRTSCGSPNYA 177
Query: 545 SPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLP 594
+P S Y PE DI+S GVIL ++ G LP
Sbjct: 178 APEVI-------SGRLYAGPEV----------DIWSCGVILYALLCGTLP 210
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 66.8 bits (163), Expect = 1e-11
Identities = 29/146 (19%), Positives = 56/146 (38%), Gaps = 9/146 (6%)
Query: 66 NKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSF----SGPV 121
T + +L + + L+ N + N+ SL S S
Sbjct: 362 QNVFTDSVFQGCSTLKRLQTLILQRNGLK-NFFKVALMTKNMSSLETLDVSLNSLNSHAY 420
Query: 122 PMQIGKLKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQ 181
+ + VL+LS N + S+ + ++K + L+ N +P T+L ALQ
Sbjct: 421 DRTCAWAESILVLNLSSNMLTGSVFRCLPP--KVKVLDLHNNRIMS-IPKDV-THLQALQ 476
Query: 182 KLDLSFNNLSGLIPNDIANLSRLRLL 207
+L+++ N L + L+ L+ +
Sbjct: 477 ELNVASNQLKSVPDGVFDRLTSLQYI 502
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 58.0 bits (140), Expect = 6e-09
Identities = 44/171 (25%), Positives = 67/171 (39%), Gaps = 12/171 (7%)
Query: 66 NKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELF-NASNLQSLILSGNSFSGPVPMQ 124
N+ LT +P DL ++L N+ S L + S L+ L LS N +
Sbjct: 40 NRNLT-HVPKDL--PPRTKALSLSQNSIS-ELRMPDISFLSELRVLRLSHNRIRS-LDFH 94
Query: 125 I-GKLKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTG-PLPDGFATNLTALQK 182
+ + L+ LD+S N + I + L+ + L+ N F P+ F NLT L
Sbjct: 95 VFLFNQDLEYLDVSHNRLQN-ISCCPM--ASLRHLDLSFNDFDVLPVCKEFG-NLTKLTF 150
Query: 183 LDLSFNNLSGLIPNDIANLSRLRLLAQRVYVDLTYNNLSGLIPQNAALLSL 233
L LS L +A+L +L V + L N +L L
Sbjct: 151 LGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHL 201
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 56.0 bits (135), Expect = 3e-08
Identities = 28/148 (18%), Positives = 63/148 (42%), Gaps = 8/148 (5%)
Query: 79 SLSAIGRVNLRNNNFSGSLPVELFNA-SNLQSLILSGNSFSGPVPMQIGKLKYLQVLDLS 137
+L ++ +++N F L++ + + +LS + + L+ +
Sbjct: 303 ALKSLMIEHVKNQVFL-FSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFT 361
Query: 138 QNSFSSSIPSSIVQCKRLKTVVLNQNSFTG-PLPDGFATNLTALQKLDLSFNNLSGLIPN 196
QN F+ S+ KRL+T++L +N N+++L+ LD+S N+L+ +
Sbjct: 362 QNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYD 421
Query: 197 DIANLSRLRLLAQRVYVDLTYNNLSGLI 224
+ ++L+ N L+G +
Sbjct: 422 RTCA-----WAESILVLNLSSNMLTGSV 444
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 43.7 bits (103), Expect = 2e-04
Identities = 20/80 (25%), Positives = 37/80 (46%), Gaps = 5/80 (6%)
Query: 87 NLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQVLDLSQNSFSSSIP 146
NL +N +GS+ L ++ L L N +P + L+ LQ L+++ N S+P
Sbjct: 434 NLSSNMLTGSVFRCL--PPKVKVLDLHNNRIMS-IPKDVTHLQALQELNVASNQL-KSVP 489
Query: 147 SSIVQ-CKRLKTVVLNQNSF 165
+ L+ + L+ N +
Sbjct: 490 DGVFDRLTSLQYIWLHDNPW 509
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 1e-11
Identities = 46/179 (25%), Positives = 76/179 (42%), Gaps = 39/179 (21%)
Query: 422 HPNIVSLRAYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKG 481
HP+I++L + S L++D + G L + LS + I++ + +
Sbjct: 159 HPHIITLIDSYESSSFMFLVFDLMRKGELFDYL------TEKVALSEKETRSIMRSLLEA 212
Query: 482 IAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTP 541
++FLH VH DL+P NILL NM+ +SDFG + + E+ E+ GTP
Sbjct: 213 VSFLHA---NNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLREL------CGTP 263
Query: 542 LQSSPYEFTALNSTTSRSYYQAPE------ASKVRKPTQKWDIYSYGVILLEMISGKLP 594
Y APE ++ D+++ GVIL +++G P
Sbjct: 264 ------------------GYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPP 304
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 64.5 bits (158), Expect = 2e-11
Identities = 55/229 (24%), Positives = 85/229 (37%), Gaps = 43/229 (18%)
Query: 374 LLGKSTIGIVYKVALNNE--EAVAV-----RRLGNGGWQRFKEFQTEAEAIGK-IRHPNI 425
LG+ G V ++A+N EAVAV +R + KE I K + H N+
Sbjct: 14 TLGEGAYGEV-QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIC-----INKMLNHENV 67
Query: 426 VSLRAYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFL 485
V + + + L +Y G L I + D R + G+ +L
Sbjct: 68 VKFYGHRREGNIQYLFLEYCSGGELFDRI------EPDIGMPEPDAQRFFHQLMAGVVYL 121
Query: 486 HEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSS 545
H H D++P N+LL + ISDFGLA + GT +
Sbjct: 122 HG---IGITHRDIKPENLLLDERDNLKISDFGLATV---FRYNNRERLLNKMCGTLPYVA 175
Query: 546 PYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLP 594
P R + A D++S G++L M++G+LP
Sbjct: 176 PELL-------KRREFHAEPV----------DVWSCGIVLTAMLAGELP 207
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 64.5 bits (158), Expect = 2e-11
Identities = 60/244 (24%), Positives = 94/244 (38%), Gaps = 81/244 (33%)
Query: 375 LGKSTIGIVYKVALNNEEAVAVRRLGNGGWQRFKEFQTEAEAIG-------------KIR 421
+G+ T G+VYK + VA+ K + +AE G ++
Sbjct: 29 VGEGTYGVVYKAKDSQGRIVAL-----------KRIRLDAEDEGIPSTAIREISLLKELH 77
Query: 422 HPNIVSLRAYFWSVDEKL-LIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAK 480
HPNIVSL S + L L+++++ L + L S + + +
Sbjct: 78 HPNIVSLIDVIHS-ERCLTLVFEFMEK-DLKKVLDENKT-----GLQDSQIKIYLYQLLR 130
Query: 481 GIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEE--TPEV--HWEQS 536
G+A H+ R +H DL+P N+L+ + ++DFGLAR I T EV W
Sbjct: 131 GVAHCHQ---HRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLW--- 184
Query: 537 TTGTPLQSSPYEFTALNSTTSRSYYQAPE--------ASKVRKPTQKWDIYSYGVILLEM 588
Y+AP+ ++ V DI+S G I EM
Sbjct: 185 ------------------------YRAPDVLMGSKKYSTSV-------DIWSIGCIFAEM 213
Query: 589 ISGK 592
I+GK
Sbjct: 214 ITGK 217
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 2e-11
Identities = 55/217 (25%), Positives = 88/217 (40%), Gaps = 41/217 (18%)
Query: 374 LLGKSTIGIVYKVA-LNNEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYF 432
LG+ IVY+ ++ A++ L K +TE + ++ HPNI+ L+ F
Sbjct: 60 ELGRGATSIVYRCKQKGTQKPYALKVLKKT--VDKKIVRTEIGVLLRLSHPNIIKLKEIF 117
Query: 433 WSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKR 492
+ E L+ + + G L I K Y S D +K + + +A+LHE
Sbjct: 118 ETPTEISLVLELVTGGELFDRIVEKG---YY---SERDAADAVKQILEAVAYLHE---NG 168
Query: 493 YVHGDLRPSNILLGKNMEPH----ISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYE 548
VH DL+P N+L P I+DFGL+++ + V GTP
Sbjct: 169 IVHRDLKPENLLY-ATPAPDAPLKIADFGLSKIVEHQVLMKTV------CGTP------- 214
Query: 549 FTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVIL 585
Y APE + + D++S G+I
Sbjct: 215 -----------GYCAPEILRGCAYGPEVDMWSVGIIT 240
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 65.2 bits (159), Expect = 3e-11
Identities = 40/240 (16%), Positives = 86/240 (35%), Gaps = 45/240 (18%)
Query: 375 LGKSTIGIVYKVALNNE--EAVAVRRLGNGGWQRFKEFQTEAEAIGKIR---------HP 423
+G + G V + A + VA++++ + F+ + +R H
Sbjct: 61 IGTGSYGHVCE-AYDKLEKRVVAIKKI-------LRVFEDLIDCKRILREIAILNRLNHD 112
Query: 424 NIVSLRAYFWSVDEKL-----LIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGV 478
++V + D + ++ + + + L+ ++ +
Sbjct: 113 HVVKVLDIVIPKDVEKFDELYVVLEI-----ADSDFK--KLFRTPVYLTELHIKTLLYNL 165
Query: 479 AKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTT 538
G+ ++H +H DL+P+N L+ ++ + DFGLAR D E
Sbjct: 166 LVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPRE 222
Query: 539 GTPLQSSPYEFTALNST-----TSRSYYQAPE---ASKVRKPTQKWDIYSYGVILLEMIS 590
+ L +R +Y+APE + T+ D++S G I E+++
Sbjct: 223 DDMNLVTFPHTKNLKRQLTGHVVTR-WYRAPELILLQE--NYTEAIDVWSIGCIFAELLN 279
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 63.7 bits (156), Expect = 4e-11
Identities = 55/251 (21%), Positives = 93/251 (37%), Gaps = 84/251 (33%)
Query: 375 LGKSTIGIVYKVALNNE--EAVAVRRLGNGGWQRFKEFQTEAEAIG-------------K 419
+G+ T G V+K A N E E VA+ K + + + G +
Sbjct: 10 IGEGTYGTVFK-AKNRETHEIVAL-----------KRVRLDDDDEGVPSSALREICLLKE 57
Query: 420 IRHPNIVSLRAYFWSVDEKL-LIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGV 478
++H NIV L S D+KL L++++ L G L + +
Sbjct: 58 LKHKNIVRLHDVLHS-DKKLTLVFEFCDQ-DLKKYFDSCNG-----DLDPEIVKSFLFQL 110
Query: 479 AKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEE--TPEV--HWE 534
KG+ F H + +H DL+P N+L+ +N E +++FGLAR I + EV W
Sbjct: 111 LKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLW- 166
Query: 535 QSTTGTPLQSSPYEFTALNSTTSRSYYQAPE--------ASKVRKPTQKWDIYSYGVILL 586
Y+ P+ ++ + D++S G I
Sbjct: 167 --------------------------YRPPDVLFGAKLYSTSI-------DMWSAGCIFA 193
Query: 587 EMISGKLPMIQ 597
E+ + P+
Sbjct: 194 ELANAGRPLFP 204
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 64.4 bits (157), Expect = 4e-11
Identities = 50/230 (21%), Positives = 91/230 (39%), Gaps = 47/230 (20%)
Query: 375 LGKSTIGIVYKVA-LNNEEAVAVRRLGNGGWQRFKEFQTEAEAIGKI-RHPNIVSLRAYF 432
LG G V ++ +E A++ L Q + + E E + + P+IV + +
Sbjct: 70 LGLGINGKVLQIFNKRTQEKFALKML-----QDCPKARREVELHWRASQCPHIVRIVDVY 124
Query: 433 ----WSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEV 488
L++ + + G L + I + G ++ + + I+K + + I +LH
Sbjct: 125 ENLYAGRKCLLIVMECLDGGELFSRIQDR-GDQAF---TEREASEIMKSIGEAIQYLHS- 179
Query: 489 SPKRYVHGDLRPSNILLGKNMEPH----ISDFGLARLADIAEETPEVHWEQSTTGTPLQS 544
H D++P N+L + P+ ++DFG A+ E T + TP
Sbjct: 180 --INIAHRDVKPENLLY-TSKRPNAILKLTDFGFAK-----ETTSHNSL-TTPCYTP--- 227
Query: 545 SPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLP 594
YY APE K + D++S GVI+ ++ G P
Sbjct: 228 ---------------YYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 262
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 63.7 bits (156), Expect = 4e-11
Identities = 48/244 (19%), Positives = 89/244 (36%), Gaps = 80/244 (32%)
Query: 375 LGKSTIGIVYKVALNNE--EAVAVRRLGNGGWQRFKEFQTEAEAIG-------------K 419
+G+ + G+V+K N + + VA+ K+F + +
Sbjct: 11 IGEGSYGVVFK-CRNRDTGQIVAI-----------KKFLESEDDPVIKKIALREIRMLKQ 58
Query: 420 IRHPNIVSLRAYFWSVDEKL-LIYDYIPNGSLATAIHGKAGIISYRPLSWSDRL--RIIK 476
++HPN+V+L F +L L+++Y H + + L I
Sbjct: 59 LKHPNLVNLLEVFRR-KRRLHLVFEYCD--------HTVLHELDRYQRGVPEHLVKSITW 109
Query: 477 GVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEE--TPEV--H 532
+ + F H+ +H D++P NIL+ K+ + DFG ARL + EV
Sbjct: 110 QTLQAVNFCHK---HNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATR 166
Query: 533 WEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPE----ASKVRKPTQKWDIYSYGVILLEM 588
W Y++PE ++ P D+++ G + E+
Sbjct: 167 W---------------------------YRSPELLVGDTQYGPPV---DVWAIGCVFAEL 196
Query: 589 ISGK 592
+SG
Sbjct: 197 LSGV 200
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 4e-11
Identities = 57/235 (24%), Positives = 96/235 (40%), Gaps = 50/235 (21%)
Query: 375 LGKSTIGIVYKVALNNE--EAVAVRRLGNGGWQRFKEFQTEAEAIGKIR---------HP 423
LG+ G+V A + E VA++++ F A+ +R H
Sbjct: 19 LGEGAYGVVCS-ATHKPTGEIVAIKKIEP--------FDKPLFALRTLREIKILKHFKHE 69
Query: 424 NIVSLRAYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLR-IIKGVAKGI 482
NI+++ + YI + T +H +IS + LS D ++ I + +
Sbjct: 70 NIITIFNIQRPDSFENFNEVYIIQELMQTDLHR---VISTQMLS-DDHIQYFIYQTLRAV 125
Query: 483 AFLH--EVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGT 540
LH V +H DL+PSN+L+ N + + DFGLAR+ D + Q +
Sbjct: 126 KVLHGSNV-----IHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMV 180
Query: 541 PLQSSPYEFTALNSTTSRSYYQAPE---ASKVRKPTQKWDIYSYGVILLEMISGK 592
+ T R +Y+APE S K ++ D++S G IL E+ +
Sbjct: 181 -----EFVAT-------R-WYRAPEVMLTSA--KYSRAMDVWSCGCILAELFLRR 220
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 4e-11
Identities = 27/171 (15%), Positives = 57/171 (33%), Gaps = 30/171 (17%)
Query: 66 NKKLTGFIPADL-GSLSAIGRVNLRNNNFSGSLPVELF-NASNLQSLILSGNSFSG-PVP 122
+ L + + +LS + + +RN + + L+ L + P
Sbjct: 65 DVTLQ-QLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKMFPDL 123
Query: 123 MQIGKLKYLQVLDLSQNSFSSSIPSSIVQ--CKRLKTVVLNQN--------SFTGP---- 168
++ +L+++ N + +SIP + Q C T+ L N +F G
Sbjct: 124 TKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTSVQGYAFNGTKLDA 183
Query: 169 -----------LPDG-FATNLTALQKLDLSFNNLSGLIPNDIANLSRLRLL 207
+ F + LD+S +++ L + +L L
Sbjct: 184 VYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTALPSKGLEHLKELIAR 234
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 8e-10
Identities = 17/125 (13%), Positives = 38/125 (30%), Gaps = 6/125 (4%)
Query: 105 SNLQSLILSGNSFSGPVPMQIGKLKYLQVLDLSQNSFSSSIPSSI-VQCKRLKTVVLNQN 163
+ Q+L L L + + +S + + S ++ + +
Sbjct: 31 PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNT 90
Query: 164 SFTGPLPDGFATNLTALQKLDLSFNNLSGLIPNDIANLSRLRLLAQRVYVDLTYNNLSGL 223
+ L L+ L + L +L+++ +++T N
Sbjct: 91 RNLTYIDPDALKELPLLKFLGIFNTGLK-----MFPDLTKVYSTDIFFILEITDNPYMTS 145
Query: 224 IPQNA 228
IP NA
Sbjct: 146 IPVNA 150
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 5e-11
Identities = 36/195 (18%), Positives = 75/195 (38%), Gaps = 56/195 (28%)
Query: 342 DTMSENMEQYEFVPLDSQVDFDLEQLLKASAFLLGKSTIGIVYKVALNNE--EAVAVRRL 399
+ ++ME+YE +L + G+ + G+V K N + VA+
Sbjct: 18 NLYFQSMEKYE----------NLGLV--------GEGSYGMVMK-CRNKDTGRIVAI--- 55
Query: 400 GNGGWQRFKEFQTEAEAIG-------------KIRHPNIVSLRAYFWSVDEKL-LIYDYI 445
K+F + ++RH N+V+L ++ L+++++
Sbjct: 56 --------KKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKK-KKRWYLVFEFV 106
Query: 446 PNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILL 505
+ ++ + L + + + + GI F H +H D++P NIL+
Sbjct: 107 DH-TILDDLELFPN-----GLDYQVVQKYLFQIINGIGFCHS---HNIIHRDIKPENILV 157
Query: 506 GKNMEPHISDFGLAR 520
++ + DFG AR
Sbjct: 158 SQSGVVKLCDFGFAR 172
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 63.0 bits (154), Expect = 6e-11
Identities = 61/318 (19%), Positives = 119/318 (37%), Gaps = 78/318 (24%)
Query: 363 DLEQLLKASAFLLGKSTIGIVYKVALN-NEEAVAVRRL-GNGGWQRFKEFQTEAEAIGK- 419
DLE +++ LG+ G+V K+ + + +AV+R+ Q K + + +
Sbjct: 8 DLEPIME-----LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRT 62
Query: 420 IRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLA---TAIHGKAGIISYRPLSWSDRLRIIK 476
+ P V+ + + + + + + SL + K I L +I
Sbjct: 63 VDCPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILG-----KIAV 116
Query: 477 GVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGL-ARLAD-IAEETPEVHWE 534
+ K + LH +H D++PSN+L+ + + DFG+ L D +A++
Sbjct: 117 SIVKALEHLHSK--LSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDI------ 168
Query: 535 QSTTGTPLQSSPYEFTALNSTTSRSYYQAPE---ASKVRKP-TQKWDIYSYGVILLEMIS 590
G Y APE +K + K DI+S G+ ++E+
Sbjct: 169 --DAGCK------------------PYMAPERINPELNQKGYSVKSDIWSLGITMIELAI 208
Query: 591 GKLPMIQIGS-MELNIVQWIQLILEDRKPMTDILDPFLAHDLDKE---DEIVSVLKIALD 646
+ P G+ + ++ ++E+ P L + E V
Sbjct: 209 LRFPYDSWGTPFQQ-----LKQVVEEPSPQ-----------LPADKFSAEFVDFTS---Q 249
Query: 647 CVHKSPDKRPS----MRH 660
C+ K+ +RP+ M+H
Sbjct: 250 CLKKNSKERPTYPELMQH 267
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 62.9 bits (154), Expect = 6e-11
Identities = 57/244 (23%), Positives = 95/244 (38%), Gaps = 81/244 (33%)
Query: 375 LGKSTIGIVYKVALNNEEAVAVRRLGNGGWQRFKEFQTEAEAIG-------------KIR 421
+G+ T G+VYK N E A+ K+ + E E G +++
Sbjct: 10 IGEGTYGVVYKAQNNYGETFAL-----------KKIRLEKEDEGIPSTTIREISILKELK 58
Query: 422 HPNIVSLRAYFWSVDEKL-LIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAK 480
H NIV L + ++L L+++++ L + G L + +
Sbjct: 59 HSNIVKLYDVIHT-KKRLVLVFEHLDQ-DLKKLLDVCEG-----GLESVTAKSFLLQLLN 111
Query: 481 GIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEE--TPEV--HWEQS 536
GIA+ H+ +R +H DL+P N+L+ + E I+DFGLAR I T E+ W
Sbjct: 112 GIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLW--- 165
Query: 537 TTGTPLQSSPYEFTALNSTTSRSYYQAPE--------ASKVRKPTQKWDIYSYGVILLEM 588
Y+AP+ ++ + DI+S G I EM
Sbjct: 166 ------------------------YRAPDVLMGSKKYSTTI-------DIWSVGCIFAEM 194
Query: 589 ISGK 592
++G
Sbjct: 195 VNGT 198
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 6e-11
Identities = 58/250 (23%), Positives = 94/250 (37%), Gaps = 73/250 (29%)
Query: 373 FLLGKSTIGIVYKVALNNE----EAVAVRRLGNGGWQRFKEFQTEAEAIGKI------RH 422
+G+ T G VYK A + + A+++ + A +I +H
Sbjct: 27 CKVGRGTYGHVYK-AKRKDGKDDKDYALKQ--------IEGTGISMSACREIALLRELKH 77
Query: 423 PNIVSLRAYFWS-VDEKL-LIYDYIPNGSLATAIH---GKAGIISYRPLSWSDRLRIIKG 477
PN++SL+ F S D K+ L++DY + L I L ++
Sbjct: 78 PNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQ 136
Query: 478 VAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPH----ISDFGLARLADI-----AEET 528
+ GI +LH +H DL+P+NIL+ I+D G ARL + A+
Sbjct: 137 ILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLD 193
Query: 529 PEV--HWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPE----ASKVRKPTQKWDIYSYG 582
P V W Y+APE A R T+ DI++ G
Sbjct: 194 PVVVTFW---------------------------YRAPELLLGA---RHYTKAIDIWAIG 223
Query: 583 VILLEMISGK 592
I E+++ +
Sbjct: 224 CIFAELLTSE 233
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 6e-11
Identities = 55/229 (24%), Positives = 85/229 (37%), Gaps = 43/229 (18%)
Query: 374 LLGKSTIGIVYKVALNNE--EAVAV-----RRLGNGGWQRFKEFQTEAEAIGK-IRHPNI 425
LG+ G V ++A+N EAVAV +R + KE I K + H N+
Sbjct: 14 TLGEGAYGEV-QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIC-----INKMLNHENV 67
Query: 426 VSLRAYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFL 485
V + + + L +Y G L I + D R + G+ +L
Sbjct: 68 VKFYGHRREGNIQYLFLEYCSGGELFDRI------EPDIGMPEPDAQRFFHQLMAGVVYL 121
Query: 486 HEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSS 545
H H D++P N+LL + ISDFGLA + GT +
Sbjct: 122 HG---IGITHRDIKPENLLLDERDNLKISDFGLATV---FRYNNRERLLNKMCGTLPYVA 175
Query: 546 PYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLP 594
P R + A D++S G++L M++G+LP
Sbjct: 176 PELL-------KRREFHAEPV----------DVWSCGIVLTAMLAGELP 207
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 8e-11
Identities = 58/233 (24%), Positives = 94/233 (40%), Gaps = 57/233 (24%)
Query: 375 LGKSTIGIVYKVALNNE--EAVAVRRLGNGGWQRFKEFQTEAEAIGKIR---------HP 423
+G G V A++ VA+++L FQ+E A R H
Sbjct: 33 VGSGAYGAVCS-AVDGRTGAKVAIKKLYR-------PFQSELFAKRAYRELRLLKHMRHE 84
Query: 424 NIVSLRAYFWSVDEKLLIYD-YIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGI 482
N++ L F + D Y+ + T + ++ + L ++ + KG+
Sbjct: 85 NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGK---LMKHEKLGEDRIQFLVYQMLKGL 141
Query: 483 AFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPL 542
++H +H DL+P N+ + ++ E I DFGLAR AD +E T V
Sbjct: 142 RYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQAD-SEMTGYV----------- 186
Query: 543 QSSPYEFTALNSTTSRSYYQAPE---ASKVRKPTQKWDIYSYGVILLEMISGK 592
+R +Y+APE + TQ DI+S G I+ EMI+GK
Sbjct: 187 -------------VTR-WYRAPEVILNWM--RYTQTVDIWSVGCIMAEMITGK 223
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 64.1 bits (156), Expect = 8e-11
Identities = 49/245 (20%), Positives = 89/245 (36%), Gaps = 56/245 (22%)
Query: 415 EAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRI 474
+ P IV + F + D+ I D + G L + + G+ S +R
Sbjct: 244 SLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS-QHGVFS------EADMRF 296
Query: 475 -IKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHW 533
+ G+ +H + V+ DL+P+NILL ++ ISD GLA +
Sbjct: 297 YAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLAC---------DFSK 344
Query: 534 EQSTT--GTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKP-TQKWDIYSYGVILLEMIS 590
++ GT Y APE + D +S G +L +++
Sbjct: 345 KKPHASVGTH------------------GYMAPEVLQKGVAYDSSADWFSLGCMLFKLLR 386
Query: 591 GKLPMIQIGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHK 650
G P Q + + + + ++ L + D P E+ S+L+ L +
Sbjct: 387 GHSPFRQHKTKDKHEID--RMTLTMAVELPDSFSP----------ELRSLLEGLL---QR 431
Query: 651 SPDKR 655
++R
Sbjct: 432 DVNRR 436
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 9e-11
Identities = 40/151 (26%), Positives = 64/151 (42%), Gaps = 21/151 (13%)
Query: 77 LGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQVLDL 136
+ L+ + + L++N + L L N + + L LSGN I L+ ++ LDL
Sbjct: 59 VQYLNNLIGLELKDNQIT-DLA-PLKNLTKITELELSGNPLKNVSA--IAGLQSIKTLDL 114
Query: 137 SQNSFSSSIPSSIVQCKRLKTVVLNQNSFT--GPLPDGFATNLTALQKLDLSFNNLSGLI 194
+ + P + L+ + L+ N T PL LT LQ L + +S L
Sbjct: 115 TSTQITDVTP--LAGLSNLQVLYLDLNQITNISPL-----AGLTNLQYLSIGNAQVSDLT 167
Query: 195 PNDIANLSRLRLLAQRVYVDLTYNNLSGLIP 225
P +ANLS+L L N +S + P
Sbjct: 168 P--LANLSKLTTL------KADDNKISDISP 190
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 3e-10
Identities = 27/163 (16%), Positives = 60/163 (36%), Gaps = 19/163 (11%)
Query: 63 IIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVP 122
I + P +L+ ++ +N + V + + +L G +
Sbjct: 3 ITQPTAINVIFP--DPALANAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGVTTIEG 58
Query: 123 MQIGKLKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQK 182
+ L L L+L N + + + ++ + L+ N L +++
Sbjct: 59 --VQYLNNLIGLELKDNQITD--LAPLKNLTKITELELSGNPLKNVSAIA---GLQSIKT 111
Query: 183 LDLSFNNLSGLIPNDIANLSRLRLLAQRVYVDLTYNNLSGLIP 225
LDL+ ++ + P +A LS L++L L N ++ + P
Sbjct: 112 LDLTSTQITDVTP--LAGLSNLQVL------YLDLNQITNISP 146
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 5e-10
Identities = 40/200 (20%), Positives = 75/200 (37%), Gaps = 34/200 (17%)
Query: 47 CSWNGITCREG-----QVFSLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVEL 101
G+T EG + L + + ++T P L +L+ I + L N ++ +
Sbjct: 48 AFGTGVTTIEGVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLK-NVS-AI 103
Query: 102 FNASNLQSLILSGNSFSGPVPMQIGKLKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLN 161
++++L L+ + P + L LQVL L N ++ S + L+ + +
Sbjct: 104 AGLQSIKTLDLTSTQITDVTP--LAGLSNLQVLYLDLNQITNI--SPLAGLTNLQYLSIG 159
Query: 162 QNSFTG--PLPDGFATNLTALQKLDLSFNNLSGLIP--------------NDIANLSRLR 205
+ PL NL+ L L N +S + P N I+++S L
Sbjct: 160 NAQVSDLTPL-----ANLSKLTTLKADDNKISDISPLASLPNLIEVHLKNNQISDVSPLA 214
Query: 206 LLAQRVYVDLTYNNLSGLIP 225
+ V LT ++
Sbjct: 215 NTSNLFIVTLTNQTITNQPV 234
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 2e-08
Identities = 33/163 (20%), Positives = 57/163 (34%), Gaps = 15/163 (9%)
Query: 61 SLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGP 120
+L + + ++T P L LS + + L N + ++ L +NLQ L + S
Sbjct: 111 TLDLTSTQITDVTP--LAGLSNLQVLYLDLNQIT-NIS-PLAGLTNLQYLSIGNAQVSDL 166
Query: 121 VPMQIGKLKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTG--PLPDGFATNLT 178
P + L L L N S S + L V L N + PL N +
Sbjct: 167 TP--LANLSKLTTLKADDNKISDI--SPLASLPNLIEVHLKNNQISDVSPL-----ANTS 217
Query: 179 ALQKLDLSFNNLSGLIPNDIANLSRLRLLAQRVYVDLTYNNLS 221
L + L+ ++ NL ++ + +S
Sbjct: 218 NLFIVTLTNQTITNQPVFYNNNLVVPNVVKGPSGAPIAPATIS 260
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 62.6 bits (153), Expect = 1e-10
Identities = 51/244 (20%), Positives = 96/244 (39%), Gaps = 81/244 (33%)
Query: 375 LGKSTIGIVYKV-ALNNEEAVAVRRLGNGGWQRFKEFQTEAE------AIGKI------R 421
LG+ T VYK + + VA+ KE + E E AI ++ +
Sbjct: 10 LGEGTYATVYKGKSKLTDNLVAL-----------KEIRLEHEEGAPCTAIREVSLLKDLK 58
Query: 422 HPNIVSLRAYFWSVDEKL-LIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAK 480
H NIV+L + ++ L L+++Y+ L + ++ + + + +
Sbjct: 59 HANIVTLHDIIHT-EKSLTLVFEYLDK-DLKQYLDDCGN-----IINMHNVKLFLFQLLR 111
Query: 481 GIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEE--TPEV--HWEQS 536
G+A+ H ++ +H DL+P N+L+ + E ++DFGLAR I + EV W
Sbjct: 112 GLAYCHR---QKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLW--- 165
Query: 537 TTGTPLQSSPYEFTALNSTTSRSYYQAPE--------ASKVRKPTQKWDIYSYGVILLEM 588
Y+ P+ ++++ D++ G I EM
Sbjct: 166 ------------------------YRPPDILLGSTDYSTQI-------DMWGVGCIFYEM 194
Query: 589 ISGK 592
+G+
Sbjct: 195 ATGR 198
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 2e-10
Identities = 34/179 (18%), Positives = 66/179 (36%), Gaps = 42/179 (23%)
Query: 422 HPNIVSLRAYFWSVDEK--LLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVA 479
PNI++L + L+++++ N Y+ L+ D + +
Sbjct: 90 GPNIITLADIVKDPVSRTPALVFEHVNNTDFKQL---------YQTLTDYDIRFYMYEIL 140
Query: 480 KGIAFLHEVSPKRYVHGDLRPSNILL-GKNMEPHISDFGLARLADIAEE-TPEVHWEQST 537
K + + H +H D++P N+++ ++ + + D+GLA +E V
Sbjct: 141 KALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRV------ 191
Query: 538 TGTPLQSSPYEFTALNSTTSRSYYQAPEA-SKVRKPTQKWDIYSYGVILLEMISGKLPM 595
SR Y++ PE + D++S G +L MI K P
Sbjct: 192 ------------------ASR-YFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 231
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 2e-10
Identities = 38/167 (22%), Positives = 71/167 (42%), Gaps = 23/167 (13%)
Query: 61 SLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGP 120
+ K +T + L++I ++ N++ S+ + N+ L L+GN +
Sbjct: 28 KDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQ-GIQYLPNVTKLFLNGNKLTDI 83
Query: 121 VPMQIGKLKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFT--GPLPDGFATNLT 178
P + LK L L L +N SS+ K+LK++ L N + L +L
Sbjct: 84 KP--LANLKNLGWLFLDENKVKDL--SSLKDLKKLKSLSLEHNGISDINGL-----VHLP 134
Query: 179 ALQKLDLSFNNLSGLIPNDIANLSRLRLLAQRVYVDLTYNNLSGLIP 225
L+ L L N ++ + ++ L++L L L N +S ++P
Sbjct: 135 QLESLYLGNNKITDITV--LSRLTKLDTL------SLEDNQISDIVP 173
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 2e-07
Identities = 25/123 (20%), Positives = 42/123 (34%), Gaps = 19/123 (15%)
Query: 105 SNLQSLILSGNSFSGPVPMQIGKLKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNS 164
+ L S + V +L + + + + S I + + LN N
Sbjct: 24 AETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSV--QGIQYLPNVTKLFLNGNK 79
Query: 165 FT--GPLPDGFATNLTALQKLDLSFNNLSGLIPNDIANLSRLRLLAQRVYVDLTYNNLSG 222
T PL NL L L L N + L + +L +L+ L L +N +S
Sbjct: 80 LTDIKPL-----ANLKNLGWLFLDENKVKDLSS--LKDLKKLKSL------SLEHNGISD 126
Query: 223 LIP 225
+
Sbjct: 127 ING 129
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 2e-07
Identities = 42/192 (21%), Positives = 68/192 (35%), Gaps = 29/192 (15%)
Query: 61 SLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGP 120
+I N + + L + ++ L N + P L N NL L L N
Sbjct: 50 QIIANNSDIKSVQG--IQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKDL 105
Query: 121 VPMQIGKLKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTG--PLPDGFATNLT 178
+ LK L+ L L N S + +V +L+++ L N T L + LT
Sbjct: 106 SS--LKDLKKLKSLSLEHNGISD--INGLVHLPQLESLYLGNNKITDITVL-----SRLT 156
Query: 179 ALQKLDLSFNNLSGLIP--------------NDIANLSRLRLLAQRVYVDLTYNNLSGLI 224
L L L N +S ++P N I++L L L ++L
Sbjct: 157 KLDTLSLEDNQISDIVPLAGLTKLQNLYLSKNHISDLRALAGLKNLDVLELFSQECLNKP 216
Query: 225 PQNAALLSLGPT 236
+ + L + T
Sbjct: 217 INHQSNLVVPNT 228
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 3e-07
Identities = 30/147 (20%), Positives = 52/147 (35%), Gaps = 13/147 (8%)
Query: 77 LGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQVLDL 136
L L + ++L +N S + L + L+SL L N + + +L L L L
Sbjct: 108 LKDLKKLKSLSLEHNGIS-DING-LVHLPQLESLYLGNNKITDITV--LSRLTKLDTLSL 163
Query: 137 SQNSFSSSIPSSIVQCKRLKTVVLNQNSFT--GPLPDGFATNLTALQKLDLSFNNLSGLI 194
N S + +L+ + L++N + L L L L+L
Sbjct: 164 EDNQISD--IVPLAGLTKLQNLYLSKNHISDLRAL-----AGLKNLDVLELFSQECLNKP 216
Query: 195 PNDIANLSRLRLLAQRVYVDLTYNNLS 221
N +NL + +T +S
Sbjct: 217 INHQSNLVVPNTVKNTDGSLVTPEIIS 243
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 6e-05
Identities = 16/97 (16%), Positives = 34/97 (35%), Gaps = 17/97 (17%)
Query: 127 KLKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFT--GPLPDGFATNLTALQKLD 184
+L + S + + + + ++ N + + L + KL
Sbjct: 22 AFAETIKDNLKKKSVTD--AVTQNELNSIDQIIANNSDIKSVQGI-----QYLPNVTKLF 74
Query: 185 LSFNNLSGLIPNDIANLSRLRLLAQRVYVDLTYNNLS 221
L+ N L+ DI L+ L+ L ++ L N +
Sbjct: 75 LNGNKLT-----DIKPLANLKNL---GWLFLDENKVK 103
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 62.1 bits (151), Expect = 2e-10
Identities = 44/266 (16%), Positives = 93/266 (34%), Gaps = 89/266 (33%)
Query: 375 LGKSTIGIVYKVALNNE--EAVAVRRLGNGGWQRFKEFQT---EAEAIGKIRHPNIVSLR 429
LG + GIV + + E + A++++ ++ + E + + + H NI+ L
Sbjct: 15 LGTGSFGIVCE-VFDIESGKRFALKKV-------LQDPRYKNRELDIMKVLDHVNIIKLV 66
Query: 430 AYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRL----------------R 473
YF++ ++ P+ ++ + + +
Sbjct: 67 DYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHK 126
Query: 474 IIKGVAK-------------------GIAFLHEVSPKRYVHGDLRPSNILLGKNMEPH-- 512
++K + + F+H + H D++P N+L+ N + +
Sbjct: 127 VLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL---GICHRDIKPQNLLV--NSKDNTL 181
Query: 513 -ISDFGLARLADIAEE-TPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPE----A 566
+ DFG A+ +E + SR +Y+APE A
Sbjct: 182 KLCDFGSAKKLIPSEPSVAYI------------------------CSR-FYRAPELMLGA 216
Query: 567 SKVRKPTQKWDIYSYGVILLEMISGK 592
+ + T D++S G + E+I GK
Sbjct: 217 T---EYTPSIDLWSIGCVFGELILGK 239
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 62.5 bits (152), Expect = 3e-10
Identities = 57/251 (22%), Positives = 91/251 (36%), Gaps = 59/251 (23%)
Query: 412 TEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDR 471
E + + K+ +VSL + + D L+ + G L I+ G + R
Sbjct: 233 NEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIY-HMGQAGFPE----AR 287
Query: 472 LRI-IKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHI--SDFGLARLADIAEET 528
+ G+ LH +R V+ DL+P NILL + HI SD GLA
Sbjct: 288 AVFYAAEICCGLEDLHR---ERIVYRDLKPENILL--DDHGHIRISDLGLAV-------- 334
Query: 529 PEVHWEQSTT---GTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVIL 585
V Q+ GT Y APE K + T D ++ G +L
Sbjct: 335 -HVPEGQTIKGRVGTV------------------GYMAPEVVKNERYTFSPDWWALGCLL 375
Query: 586 LEMISGKLPMIQIGSMELNIVQWI-QLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIA 644
EMI+G+ P + + + +L+ E + ++ P + S+
Sbjct: 376 YEMIAGQSPF--QQRKKKIKREEVERLVKEVPEEYSERFSP----------QARSLCSQL 423
Query: 645 LDCVHKSPDKR 655
L K P +R
Sbjct: 424 L---CKDPAER 431
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 61.7 bits (149), Expect = 3e-10
Identities = 21/102 (20%), Positives = 34/102 (33%), Gaps = 6/102 (5%)
Query: 144 SIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSGLIPNDIANLSR 203
+ + L + + L L L+ L + + L + P+ R
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPR 81
Query: 204 LRLLAQRVYVDLTYNNLSGLIPQNAALLSLGPTAFIGNPFLC 245
L L +L++N L L + LSL GNP C
Sbjct: 82 LSRL------NLSFNALESLSWKTVQGLSLQELVLSGNPLHC 117
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 51.7 bits (123), Expect = 4e-07
Identities = 18/95 (18%), Positives = 32/95 (33%), Gaps = 2/95 (2%)
Query: 73 IPADLGSLSAIGRVNLRNNNFSGSLPVELF-NASNLQSLILSGNSFSGPVPMQIGKLKYL 131
L + + + N L + L++L + + P L
Sbjct: 23 SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRL 82
Query: 132 QVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFT 166
L+LS N+ S+ VQ L+ +VL+ N
Sbjct: 83 SRLNLSFNAL-ESLSWKTVQGLSLQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 44.3 bits (104), Expect = 8e-05
Identities = 20/112 (17%), Positives = 33/112 (29%), Gaps = 26/112 (23%)
Query: 96 SLPVELFNASNLQSLILSGNSFSGPVP-MQIGKLKYLQVLDLSQNSFSSSIPSSIVQCKR 154
L A NL L + + + L L+ L + ++
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRF----------- 70
Query: 155 LKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSGLIPNDIANLSRLRL 206
+ ++F L +L+LSFN L L + LS L
Sbjct: 71 -----VAPDAFHF---------TPRLSRLNLSFNALESLSWKTVQGLSLQEL 108
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 3e-10
Identities = 67/258 (25%), Positives = 108/258 (41%), Gaps = 55/258 (21%)
Query: 359 QVDFDLE---QLLKASAFLLGKSTIGIVYKVALNNE--EAVAVRRLGNGGWQRFKEFQTE 413
+VD + +L+K LGK GIV+K +++ E VAV+++ + FQ
Sbjct: 2 RVDRHVLRKYELVK----KLGKGAYGIVWK-SIDRRTGEVVAVKKIFDA-------FQNS 49
Query: 414 AEAIGKIR----------HPNIVSLRAYFW--SVDEKLLIYDYIPNGSLATAIHGKAGII 461
+A R H NIV+L + + L++DY+ T +H +I
Sbjct: 50 TDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYME-----TDLHA---VI 101
Query: 462 SYRPLSWSDRLR-IIKGVAKGIAFLH--EVSPKRYVHGDLRPSNILLGKNMEPHISDFGL 518
L + ++ + K I +LH + +H D++PSNILL ++DFGL
Sbjct: 102 RANILE-PVHKQYVVYQLIKVIKYLHSGGL-----LHRDMKPSNILLNAECHVKVADFGL 155
Query: 519 ARLADIAEETPEVHWEQSTTGTPLQSSPYEF-TALNSTTSRSYYQAPE---ASKVRKPTQ 574
+R T T +T R +Y+APE S K T+
Sbjct: 156 SRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVAT--R-WYRAPEILLGST--KYTK 210
Query: 575 KWDIYSYGVILLEMISGK 592
D++S G IL E++ GK
Sbjct: 211 GIDMWSLGCILGEILCGK 228
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 3e-10
Identities = 57/235 (24%), Positives = 99/235 (42%), Gaps = 57/235 (24%)
Query: 375 LGKSTIGIVYKVALNNE--EAVAVRRLGNGGWQRFKEFQTEAEAIGKIR---------HP 423
+G+ G+V A +N VA++++ F+ + +R H
Sbjct: 35 IGEGAYGMVCS-AYDNLNKVRVAIKKISP--------FEHQTYCQRTLREIKILLRFRHE 85
Query: 424 NIVSLRAYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLR-IIKGVAKGI 482
NI+ + + + + YI + T ++ ++ + LS +D + + + +G+
Sbjct: 86 NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYK---LLKTQHLS-NDHICYFLYQILRGL 141
Query: 483 AFLH--EVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGT 540
++H V +H DL+PSN+LL + I DFGLAR+AD + E T
Sbjct: 142 KYIHSANV-----LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT-- 194
Query: 541 PLQSSPYEFTALNSTTSRSYYQAPE---ASKVRKPTQKWDIYSYGVILLEMISGK 592
R +Y+APE SK T+ DI+S G IL EM+S +
Sbjct: 195 -----------------R-WYRAPEIMLNSK--GYTKSIDIWSVGCILAEMLSNR 229
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 3e-10
Identities = 58/266 (21%), Positives = 104/266 (39%), Gaps = 63/266 (23%)
Query: 345 SENMEQYEFVPLD-SQVDFDLE---QLLKASAFLLGKSTIGIVYKVALNNE--EAVAVRR 398
+ E+ F + ++ +++ Q L +G G V A + + VAV++
Sbjct: 7 HHSQERPTFYRQELNKTIWEVPERYQNLSP----VGSGAYGSVCA-AFDTKTGLRVAVKK 61
Query: 399 LGNGGWQRFKEFQTEAEAIGKIR---------HPNIVSLRAYFWSVDEKLLIYD-YIPNG 448
L FQ+ A R H N++ L F D Y+
Sbjct: 62 LSR-------PFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTH 114
Query: 449 SLATAIHGKAGIISYRPLSWSDRLR-IIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGK 507
+ ++ I+ + L+ D ++ +I + +G+ ++H +H DL+PSN+ + +
Sbjct: 115 LMGADLNN---IVKCQKLT-DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNE 167
Query: 508 NMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEA- 566
+ E I DFGLAR E T V +R +Y+APE
Sbjct: 168 DCELKILDFGLARHTA-DEMTGYV------------------------ATR-WYRAPEIM 201
Query: 567 SKVRKPTQKWDIYSYGVILLEMISGK 592
Q DI+S G I+ E+++G+
Sbjct: 202 LNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 62.1 bits (151), Expect = 3e-10
Identities = 56/230 (24%), Positives = 98/230 (42%), Gaps = 46/230 (20%)
Query: 374 LLGKSTIGIVYKVALNNE--EAVAV-----RRLGNGGWQRFKEFQTEAEAIGKIRHPNIV 426
LG T G V KV + VAV +++ + + + E + + RHP+I+
Sbjct: 23 TLGVGTFGKV-KVGKHELTGHKVAVKILNRQKIRSLD--VVGKIRREIQNLKLFRHPHII 79
Query: 427 SLRAYFWSVDEKLLIYDYIPNGSLATAI--HGKAGIISYRPLSWSDRLRIIKGVAKGIAF 484
L + + ++ +Y+ G L I +G+ L + R+ + + G+ +
Sbjct: 80 KLYQVISTPSDIFMVMEYVSGGELFDYICKNGR--------LDEKESRRLFQQILSGVDY 131
Query: 485 LHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQS 544
H VH DL+P N+LL +M I+DFGL+ + + + +++ G+P +
Sbjct: 132 CHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNM------MSDGEFLRTSCGSPNYA 182
Query: 545 SPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLP 594
+P S Y PE DI+S GVIL ++ G LP
Sbjct: 183 APEVI-------SGRLYAGPEV----------DIWSSGVILYALLCGTLP 215
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 3e-10
Identities = 55/282 (19%), Positives = 110/282 (39%), Gaps = 89/282 (31%)
Query: 344 MSENMEQYEFVPLDSQVDFDLEQLLKASAFLLGKSTIGIVYKVALNNE--EAVAVRRLGN 401
M++ + E D + E+L K +G+ T G V+K A + + + VA++++
Sbjct: 1 MAKQYDSVECPFCDEVSKY--EKLAK-----IGQGTFGEVFK-ARHRKTGQKVALKKV-- 50
Query: 402 GGWQRFKEFQTEAE-----AIGKI------RHPNIVSLR-------AYFWSVDEKL-LIY 442
+ E E A+ +I +H N+V+L + + + L++
Sbjct: 51 -------LMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVF 103
Query: 443 DYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAK----GIAFLHEVSPKRYVHGDL 498
D+ H AG++S + ++ IK V + G+ ++H + +H D+
Sbjct: 104 DFCE--------HDLAGLLSNVLVKFTLSE--IKRVMQMLLNGLYYIHR---NKILHRDM 150
Query: 499 RPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSR 558
+ +N+L+ ++ ++DFGLAR S P +T T
Sbjct: 151 KAANVLITRDGVLKLADFGLARA----------------FSLAKNSQPNRYTNRVVTL-- 192
Query: 559 SYYQAPE--------ASKVRKPTQKWDIYSYGVILLEMISGK 592
+Y+ PE + D++ G I+ EM +
Sbjct: 193 -WYRPPELLLGERDYGPPI-------DLWGAGCIMAEMWTRS 226
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 61.3 bits (149), Expect = 4e-10
Identities = 75/304 (24%), Positives = 113/304 (37%), Gaps = 70/304 (23%)
Query: 361 DFDLEQLLKASAFLLGKSTIGIVYKVALNNEEAV-AVRRLGNGGWQRFKEF---QTEAEA 416
+F+ LK LLGK T G V V A++ L E TE
Sbjct: 149 EFEY---LK----LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRV 201
Query: 417 IGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIK 476
+ RHP + +L+ F + D + +Y G L + + + S DR R
Sbjct: 202 LQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLS-RERVFS------EDRARFYG 254
Query: 477 G-VAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQ 535
+ + +LH S K V+ DL+ N++L K+ I+DFGL + E +
Sbjct: 255 AEIVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK---------EGIKDG 303
Query: 536 STT----GTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISG 591
+T GTP E Y APE + + D + GV++ EM+ G
Sbjct: 304 ATMKTFCGTP------E------------YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG 345
Query: 592 KLPMIQIGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKS 651
+LP +L +LIL + L P E S+L L K
Sbjct: 346 RLPFYNQDHEKL-----FELILMEEIRFPRTLGP----------EAKSLLSGLL---KKD 387
Query: 652 PDKR 655
P +R
Sbjct: 388 PKQR 391
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 60.7 bits (148), Expect = 4e-10
Identities = 57/250 (22%), Positives = 86/250 (34%), Gaps = 88/250 (35%)
Query: 375 LGKSTIGIVYKVALNNE--EAVAVRRLGNGGWQRFKEFQTEAEAIG-------------K 419
LG+ T G VYK A++ E VA+ K + E E G +
Sbjct: 42 LGEGTYGEVYK-AIDTVTNETVAI-----------KRIRLEHEEEGVPGTAIREVSLLKE 89
Query: 420 IRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVA 479
++H NI+ L++ LI++Y N L + +S + +
Sbjct: 90 LQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMD------KNPDVSMRVIKSFLYQLI 142
Query: 480 KGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPH-----ISDFGLARLADIAEE--TPEV- 531
G+ F H +R +H DL+P N+LL + I DFGLAR I T E+
Sbjct: 143 NGVNFCHS---RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEII 199
Query: 532 -HWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPE--------ASKVRKPTQKWDIYSYG 582
W Y+ PE ++ V DI+S
Sbjct: 200 TLW---------------------------YRPPEILLGSRHYSTSV-------DIWSIA 225
Query: 583 VILLEMISGK 592
I EM+
Sbjct: 226 CIWAEMLMKT 235
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 5e-10
Identities = 59/232 (25%), Positives = 86/232 (37%), Gaps = 55/232 (23%)
Query: 375 LGKSTIGIVYKVALNNE--EAVAVRRLGNGGWQRFKEFQTEAEAIGKIR---------HP 423
+G GIV A + VA+++L + FQ + A R H
Sbjct: 33 IGSGAQGIVCA-AYDAILERNVAIKKL-------SRPFQNQTHAKRAYRELVLMKCVNHK 84
Query: 424 NIVSLRAYFWSVDEKLLIYD-YIPNGSLATAIHGKAGIISYRPLSWSDRLR-IIKGVAKG 481
NI+ L F D YI + + + L +R+ ++ + G
Sbjct: 85 NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQ----VIQMELD-HERMSYLLYQMLCG 139
Query: 482 IAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEE-TPEVHWEQSTTGT 540
I LH +H DL+PSNI++ + I DFGLAR A + TP V
Sbjct: 140 IKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYV--------- 187
Query: 541 PLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGK 592
+R YY+APE + DI+S G I+ EMI G
Sbjct: 188 ---------------VTR-YYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 6e-10
Identities = 34/145 (23%), Positives = 55/145 (37%), Gaps = 13/145 (8%)
Query: 105 SNLQSLILSGNSFSGPVPMQI-GKLKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQN 163
L L+ N F+ I KL L+ ++ S N + + + ++L N
Sbjct: 32 QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSN 91
Query: 164 SFTGPLPDGFATNLTALQKLDLSFNNLSGLIPNDI-ANLSRLRLLAQRVYVDLTYNNLSG 222
+ L +L+ L L N ++ + ND LS +RLL L N ++
Sbjct: 92 RLEN-VQHKMFKGLESLKTLMLRSNRITCV-GNDSFIGLSSVRLL------SLYDNQITT 143
Query: 223 LIPQNA--ALLSLGPTAFIGNPFLC 245
+ A L SL + NPF C
Sbjct: 144 -VAPGAFDTLHSLSTLNLLANPFNC 167
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 5e-05
Identities = 20/82 (24%), Positives = 31/82 (37%), Gaps = 10/82 (12%)
Query: 143 SSIPSSI-VQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSGLIPNDIANL 201
+ IP I L+ LN N FT G L L+K++ S N ++ +
Sbjct: 24 NKIPEHIPQYTAELR---LNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGA 80
Query: 202 SRLRLLAQRVYVDLTYNNLSGL 223
S + + LT N L +
Sbjct: 81 SGVNEI------LLTSNRLENV 96
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 1e-09
Identities = 50/238 (21%), Positives = 98/238 (41%), Gaps = 63/238 (26%)
Query: 374 LLGKSTIGIVYKVALNNE--EAVAV-----RRLGNGGWQRFKEFQTEAEAIGKIRHPNIV 426
LG+ + G V K+A + + + VA+ + L + E + +RHP+I+
Sbjct: 16 TLGEGSFGKV-KLATHYKTQQKVALKFISRQLLKKSDMH--MRVEREISYLKLLRHPHII 72
Query: 427 SLRAY-FWSVDEKLLI---------YDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIK 476
L Y + +++ +DYI + ++ + R +
Sbjct: 73 KL--YDVITTPTDIVMVIEYAGGELFDYI-------VEKKR--------MTEDEGRRFFQ 115
Query: 477 GVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQS 536
+ I + H + VH DL+P N+LL N+ I+DFGL+ + + ++ ++
Sbjct: 116 QIICAIEYCHR---HKIVHRDLKPENLLLDDNLNVKIADFGLSNIM------TDGNFLKT 166
Query: 537 TTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLP 594
+ G+P ++P + Y PE D++S G++L M+ G+LP
Sbjct: 167 SCGSPNYAAPEVI-------NGKLYAGPEV----------DVWSCGIVLYVMLVGRLP 207
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 60.2 bits (146), Expect = 1e-09
Identities = 53/245 (21%), Positives = 83/245 (33%), Gaps = 58/245 (23%)
Query: 419 KIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLATAIHG---KAGIISYRPLSWSDRLRI- 474
K+ IVSL F + + L+ + G + I+ R
Sbjct: 241 KVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQ------EPRAIFY 294
Query: 475 IKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWE 534
+ G+ LH+ + ++ DL+P N+LL + ISD GLA E+
Sbjct: 295 TAQIVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAV---------ELKAG 342
Query: 535 QSTT----GTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS 590
Q+ T GTP + APE + D ++ GV L EMI+
Sbjct: 343 QTKTKGYAGTP------------------GFMAPELLLGEEYDFSVDYFALGVTLYEMIA 384
Query: 591 GKLPMIQIGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHK 650
+ P G ++ + Q +LE D P + L K
Sbjct: 385 ARGPFRARG-EKVENKELKQRVLEQAVTYPDKFSP----------ASKDFCEALL---QK 430
Query: 651 SPDKR 655
P+KR
Sbjct: 431 DPEKR 435
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 1e-09
Identities = 48/242 (19%), Positives = 89/242 (36%), Gaps = 55/242 (22%)
Query: 419 KIRHPNIVSLRAYFWSVDEKL-LIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRI-IK 476
+ HP +V+L F +E + ++ D + G L + + + +++ I
Sbjct: 71 GLEHPFLVNLWYSFQD-EEDMFMVVDLLLGGDLRYHL-QQNVHFK------EETVKLFIC 122
Query: 477 GVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQS 536
+ + +L +R +H D++P NILL ++ HI+DF +A P +
Sbjct: 123 ELVMALDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAA------MLPRETQITT 173
Query: 537 TTGTPLQSSPYEFTALNSTTSRSYYQAPE--ASKVRKP-TQKWDIYSYGVILLEMISGKL 593
GT Y APE +S+ + D +S GV E++ G+
Sbjct: 174 MAGTK------------------PYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRR 215
Query: 594 PMIQIGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPD 653
P + + + E+VS+LK L+ +PD
Sbjct: 216 PY--HIRSSTSSKEIVHTFETTVVTYPSAWSQ----------EMVSLLKKLLE---PNPD 260
Query: 654 KR 655
+R
Sbjct: 261 QR 262
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 1e-09
Identities = 44/242 (18%), Positives = 95/242 (39%), Gaps = 46/242 (19%)
Query: 375 LGKSTIGIVYKVALNNE--EAVAVRRLGNGGWQRFKEFQTEAEAIGKIR---------HP 423
+G+ + G VY A + + VA++++ + F+ + +R
Sbjct: 34 IGRGSYGYVYL-AYDKNTEKNVAIKKV-------NRMFEDLIDCKRILREITILNRLKSD 85
Query: 424 NIVSLRAYFWSVDEKL-----LIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLR-IIKG 477
I+ L D ++ + + + + L+ + ++ I+
Sbjct: 86 YIIRLYDLIIPDDLLKFDELYIVLEIAD-----SDLK--KLFKTPIFLT-EEHIKTILYN 137
Query: 478 VAKGIAFLH--EVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQ 535
+ G F+H + +H DL+P+N LL ++ + DFGLAR + ++T V+ +
Sbjct: 138 LLLGENFIHESGI-----IHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLE 192
Query: 536 STTGTPLQSSPYEFTALNSTTSRSYYQAPE---ASKVRKPTQKWDIYSYGVILLEMISGK 592
+ + + +R +Y+APE + T+ DI+S G I E+++
Sbjct: 193 ENEEPGPHNKNLKKQLTSHVVTR-WYRAPELILLQE--NYTKSIDIWSTGCIFAELLNML 249
Query: 593 LP 594
Sbjct: 250 QS 251
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 1e-09
Identities = 58/241 (24%), Positives = 86/241 (35%), Gaps = 62/241 (25%)
Query: 375 LGKSTIGIVYKVALNNEEAVAVRRLGNGGWQRFKE--FQTEAEAIGKIR---------HP 423
+ + G V + VA++R+ N +R HP
Sbjct: 30 ISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHP 89
Query: 424 NIVSLRAYFWSVDEKL-----LIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLR-IIKG 477
NI+ LR F +E L+ + + LA IH + +IS ++ +
Sbjct: 90 NILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVIS------PQHIQYFMYH 142
Query: 478 VAKGIAFLH--EVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEE-TPEVHWE 534
+ G+ LH V VH DL P NILL N + I DF LAR T V
Sbjct: 143 ILLGLHVLHEAGV-----VHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYV--- 194
Query: 535 QSTTGTPLQSSPYEFTALNSTTSRSYYQAPE---ASKVRKPTQKWDIYSYGVILLEMISG 591
T R +Y+APE K T+ D++S G ++ EM +
Sbjct: 195 ---------------------THR-WYRAPELVMQFK--GFTKLVDMWSAGCVMAEMFNR 230
Query: 592 K 592
K
Sbjct: 231 K 231
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 59.1 bits (144), Expect = 1e-09
Identities = 54/275 (19%), Positives = 97/275 (35%), Gaps = 95/275 (34%)
Query: 344 MSENMEQYEFVPLDSQVDFDLEQLLKASAFLLGKSTIGIVYKVALNNE--EAVAVRRLGN 401
+ ++YE L+ L G+ VYK A + + VA++++
Sbjct: 5 VKSRAKRYEK----------LDFL--------GEGQFATVYK-ARDKNTNQIVAIKKI-- 43
Query: 402 GGWQRFKEFQTEAE-----AIGKI------RHPNIVSLRAYFWSVDEKL-LIYDYIPNGS 449
+ + A+ +I HPNI+ L F + L++D++
Sbjct: 44 ----KLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGH-KSNISLVFDFMET-D 97
Query: 450 LATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNM 509
L I + L+ S + +G+ +LH+ +H DL+P+N+LL +N
Sbjct: 98 LEVIIKDNSL-----VLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENG 149
Query: 510 EPHISDFGLARLADIAEE--TPEV--HWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPE 565
++DFGLA+ T +V W Y+APE
Sbjct: 150 VLKLADFGLAKSFGSPNRAYTHQVVTRW---------------------------YRAPE 182
Query: 566 --------ASKVRKPTQKWDIYSYGVILLEMISGK 592
V D+++ G IL E++
Sbjct: 183 LLFGARMYGVGV-------DMWAVGCILAELLLRV 210
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 2e-09
Identities = 60/232 (25%), Positives = 97/232 (41%), Gaps = 56/232 (24%)
Query: 375 LGKSTIGIVYKVALNNE--EAVAVRRLGNGGWQRFKEFQTEAEA---------IGKIRHP 423
+G G V A++ E VA+++L FQ+E A + ++H
Sbjct: 32 VGSGAYGSVCS-AIDKRSGEKVAIKKLSR-------PFQSEIFAKRAYRELLLLKHMQHE 83
Query: 424 NIVSLRAYFWSVDEKLLIYD-YIPNGSLATAIHGKAGIISYRPLSWSDRLR-IIKGVAKG 481
N++ L F YD Y+ + T + I S ++++ ++ + KG
Sbjct: 84 NVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQK----IMGLKFS-EEKIQYLVYQMLKG 138
Query: 482 IAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTP 541
+ ++H VH DL+P N+ + ++ E I DFGLAR AD AE T V
Sbjct: 139 LKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHAD-AEMTGYV---------- 184
Query: 542 LQSSPYEFTALNSTTSRSYYQAPEA-SKVRKPTQKWDIYSYGVILLEMISGK 592
+R +Y+APE Q DI+S G I+ EM++GK
Sbjct: 185 --------------VTR-WYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 58.6 bits (142), Expect = 3e-09
Identities = 43/198 (21%), Positives = 65/198 (32%), Gaps = 49/198 (24%)
Query: 410 FQTEAEAIGKIRHPNIVSLRAYFWSVDEKL-LIYDYIPNGSLATAIHGKAGIISYRPLSW 468
F+ E + + I L F + L L+ +Y G L T + I
Sbjct: 108 FREERDVLVNGDRRWITQLHFAFQD-ENYLYLVMEYYVGGDLLTLLSKFGERIP------ 160
Query: 469 SDRLRI-IKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHI--SDFGLARLADIA 525
++ R + + I +H YVH D++P NILL + HI +DFG
Sbjct: 161 AEMARFYLAEIVMAIDSVHR---LGYVHRDIKPDNILL--DRCGHIRLADFGSCLKLRAD 215
Query: 526 EETPEVHWEQSTT--GTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIY---- 579
+S GTP + Y +PE + Y
Sbjct: 216 GTV------RSLVAVGTP------D------------YLSPEILQAVGGGPGTGSYGPEC 251
Query: 580 ---SYGVILLEMISGKLP 594
+ GV EM G+ P
Sbjct: 252 DWWALGVFAYEMFYGQTP 269
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 58.0 bits (141), Expect = 3e-09
Identities = 57/254 (22%), Positives = 85/254 (33%), Gaps = 90/254 (35%)
Query: 375 LGKSTIGIVYKVALNNE--EAVAVR--RLGN--GGWQRF-----------KEFQTEAEAI 417
+G G VYK A + VA++ R+ N GG + +
Sbjct: 17 IGVGAYGTVYK-ARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAF---- 71
Query: 418 GKIRHPNIVSLR----AYFWSVDEKL-LIYDYIPNGSLATAIHGKAGIISYRPLSWSDRL 472
HPN+V L + K+ L+++++ + P
Sbjct: 72 ---EHPNVVRLMDVCATSRTDREIKVTLVFEHVD--------QDLRTYLDKAPPPGLP-A 119
Query: 473 RIIKGVA----KGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEE- 527
IK + +G+ FLH VH DL+P NIL+ ++DFGLAR+
Sbjct: 120 ETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMAL 176
Query: 528 TPEV--HWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPE-------ASKVRKPTQKWDI 578
TP V W Y+APE A+ V D+
Sbjct: 177 TPVVVTLW---------------------------YRAPEVLLQSTYATPV-------DM 202
Query: 579 YSYGVILLEMISGK 592
+S G I EM K
Sbjct: 203 WSVGCIFAEMFRRK 216
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 59.0 bits (142), Expect = 3e-09
Identities = 29/156 (18%), Positives = 57/156 (36%), Gaps = 15/156 (9%)
Query: 83 IGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQVLDLSQNSFS 142
++ + F V ++++ L L+ + + +L + LDLS N
Sbjct: 419 AAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLTVLCH--LEQLLLVTHLDLSHNRLR 476
Query: 143 SSIPSSIVQCKRLKTVVLNQNSFT--GPLPDGFATNLTALQKLDLSFNNLSGLIPNDIAN 200
+ +P ++ + L+ + + N+ + NL LQ+L L N L I
Sbjct: 477 A-LPPALAALRCLEVLQASDNALENVDGVA-----NLPRLQELLLCNNRLQQS--AAIQP 528
Query: 201 LSRLRLLAQRVYVDLTYNNLSGLIPQNAALLSLGPT 236
L L ++L N+L L + P+
Sbjct: 529 LVSCPRLVL---LNLQGNSLCQEEGIQERLAEMLPS 561
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 43.6 bits (102), Expect = 2e-04
Identities = 31/192 (16%), Positives = 61/192 (31%), Gaps = 24/192 (12%)
Query: 37 NNWNNSNEDPCSWNGITCREGQVFSLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGS 96
+ P W + + Q+F + +K T + ++L S + + N +
Sbjct: 329 KECVLLKDRPECWCRDSATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLT 387
Query: 97 LPVELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQVLDLSQNSFSSSI-----PSSIVQ 151
+ + + L + FS LK + + + S ++
Sbjct: 388 IILLMRALDPLLYEKETLQYFS--------TLKAVDPMRAAYLDDLRSKFLLENSVLKME 439
Query: 152 CKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSGLIPNDIANLSRLRLLAQRV 211
++ + L T L + LDLS N L +P +A L L +L
Sbjct: 440 YADVRVLHLAHKDLTVL---CHLEQLLLVTHLDLSHNRLRA-LPPALAALRCLEVL---- 491
Query: 212 YVDLTYNNLSGL 223
+ N L +
Sbjct: 492 --QASDNALENV 501
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 57.9 bits (141), Expect = 4e-09
Identities = 65/258 (25%), Positives = 106/258 (41%), Gaps = 81/258 (31%)
Query: 361 DFDLEQLLKASAFLLGKSTIGIVYKVALNNEEAVAVRRLGNGGWQRF------------- 407
F+L LK +LG+ + G KV L V+++ ++
Sbjct: 25 QFEL---LK----VLGQGSFG---KVFL-------VKKISGSDARQLYAMKVLKKATLKV 67
Query: 408 -KEFQTEAE--AIGKIRHPNIVSLRAYFWSVDEKL-LIYDYIPNGSLATAIHGKAGIISY 463
+T+ E + ++ HP IV L F + + KL LI D++ G L T + K + +
Sbjct: 68 RDRVRTKMERDILVEVNHPFIVKLHYAFQT-EGKLYLILDFLRGGDLFTRLS-KEVMFT- 124
Query: 464 RPLSWSDRLRI-IKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHI--SDFGLAR 520
+ ++ + +A + LH ++ DL+P NILL + E HI +DFGL++
Sbjct: 125 -----EEDVKFYLAELALALDHLHS---LGIIYRDLKPENILL--DEEGHIKLTDFGLSK 174
Query: 521 LADIAEETPEVHWEQSTT----GTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKW 576
E + GT E Y APE R TQ
Sbjct: 175 ---------ESIDHEKKAYSFCGTV------E------------YMAPEVVNRRGHTQSA 207
Query: 577 DIYSYGVILLEMISGKLP 594
D +S+GV++ EM++G LP
Sbjct: 208 DWWSFGVLMFEMLTGTLP 225
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 4e-09
Identities = 52/232 (22%), Positives = 83/232 (35%), Gaps = 52/232 (22%)
Query: 374 LLGKSTIGIVYKVALNNE--EAVAV-----RRLGNGGWQRFKEFQTEAEAIGKIRHPNIV 426
+G G+ ++ + E VAV + QR E +RHPNIV
Sbjct: 27 DIGSGNFGVA-RLMRDKLTKELVAVKYIERGAAIDENVQR------EIINHRSLRHPNIV 79
Query: 427 SLRAYFWSVDEKLLIYDYIPNGSLATAI--HGKAGIISYRPLSWSDRLRIIKGVAKGIAF 484
+ + +I +Y G L I G+ S + + + G+++
Sbjct: 80 RFKEVILTPTHLAIIMEYASGGELYERICNAGR--------FSEDEARFFFQQLLSGVSY 131
Query: 485 LHEVSPKRYVHGDLRPSNILLGKNMEPH--ISDFGLARLADIAEETPEVHWEQSTTGTPL 542
H + H DL+ N LL + P I DFG ++ + + + +ST GTP
Sbjct: 132 CHS---MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP------KSTVGTPA 182
Query: 543 QSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLP 594
+P R Y A D++S GV L M+ G P
Sbjct: 183 YIAPEVL-------LRQEYDGKIA----------DVWSCGVTLYVMLVGAYP 217
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 58.1 bits (140), Expect = 7e-09
Identities = 55/242 (22%), Positives = 91/242 (37%), Gaps = 64/242 (26%)
Query: 421 RHPNIVSLRAYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKG-VA 479
+ P + L + F ++D + +Y+ G L I + G +A
Sbjct: 400 KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQ-QVGRFK------EPHAVFYAAEIA 452
Query: 480 KGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHI--SDFGLARLADIAEETPEVHWEQST 537
G+ FL K ++ DL+ N++L + E HI +DFG+ + E W+ T
Sbjct: 453 IGLFFLQS---KGIIYRDLKLDNVML--DSEGHIKIADFGMCK---------ENIWDGVT 498
Query: 538 T----GTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKL 593
T GTP + Y APE + + D +++GV+L EM++G+
Sbjct: 499 TKTFCGTP------D------------YIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQA 540
Query: 594 PMIQIGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPD 653
P EL Q I+E + E V++ K + K P
Sbjct: 541 PFEGEDEDEL-----FQSIMEHNVAYPKSMSK----------EAVAICKGLM---TKHPG 582
Query: 654 KR 655
KR
Sbjct: 583 KR 584
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 7e-09
Identities = 25/140 (17%), Positives = 47/140 (33%), Gaps = 22/140 (15%)
Query: 88 LRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQVLDLSQNSFSSSIPS 147
R + P +N L S + V +L +Q + ++ S +
Sbjct: 4 QRPTPINQVFPDP--GLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQS--LA 57
Query: 148 SIVQCKRLKTVVLNQNSFT--GPLPDGFATNLTALQKLDLSFNNLSGLIPNDIANLSRLR 205
+ LK + L+ N + PL +LT L++L ++ N L ++ +
Sbjct: 58 GMQFFTNLKELHLSHNQISDLSPL-----KDLTKLEELSVNRNRLK-----NLNGIPSAC 107
Query: 206 LLAQRVYVDLTYNNLSGLIP 225
L + L N L
Sbjct: 108 L----SRLFLDNNELRDTDS 123
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 8e-08
Identities = 36/165 (21%), Positives = 61/165 (36%), Gaps = 20/165 (12%)
Query: 61 SLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGP 120
+ + +T + LS + N N+N SL + +NL+ L LS N S
Sbjct: 23 KQNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQ-SLA-GMQFFTNLKELHLSHNQISDL 78
Query: 121 VPMQIGKLKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTAL 180
P + L L+ L +++N + + + L + L+ N D +L L
Sbjct: 79 SP--LKDLTKLEELSVNRNRLKNL---NGIPSACLSRLFLDNNELRDT--DSLI-HLKNL 130
Query: 181 QKLDLSFNNLSGLIPNDIANLSRLRLLAQRVYVDLTYNNLSGLIP 225
+ L + N L I L L L +DL N ++
Sbjct: 131 EILSIRNNKLK-----SIVMLGFLSKL---EVLDLHGNEITNTGG 167
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 9e-07
Identities = 24/133 (18%), Positives = 45/133 (33%), Gaps = 14/133 (10%)
Query: 77 LGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQVLDL 136
L L+ + +++ N + ++ L L L N + LK L++L +
Sbjct: 81 LKDLTKLEELSVNRNRLKN---LNGIPSACLSRLFLDNNELRDTDS--LIHLKNLEILSI 135
Query: 137 SQNSFSSSIPSSIVQCKRLKTVVLNQNSFT--GPLPDGFATNLTALQKLDLSFNNLSGLI 194
N S + +L+ + L+ N T G L T L + +DL+
Sbjct: 136 RNNKLKS--IVMLGFLSKLEVLDLHGNEITNTGGL-----TRLKKVNWIDLTGQKCVNEP 188
Query: 195 PNDIANLSRLRLL 207
L +
Sbjct: 189 VKYQPELYITNTV 201
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 57.1 bits (138), Expect = 1e-08
Identities = 61/249 (24%), Positives = 97/249 (38%), Gaps = 58/249 (23%)
Query: 361 DFDLEQLLKASAFLLGKSTIGIVYKVALNNEEAV-AVRRLGNGGWQRFKE---FQTEAEA 416
DF++ LK ++G+ G V V L N + V A++ L + E F+ E +
Sbjct: 75 DFEI---LK----VIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDV 127
Query: 417 IGKIRHPNIVSLRAYFWSVDEKL-LIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRI- 474
+ I +L F D L L+ DY G L T + + + R
Sbjct: 128 LVNGDSKWITTLHYAFQD-DNNLYLVMDYYVGGDLLTLLSKFEDRLP------EEMARFY 180
Query: 475 IKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHI--SDFGLARLADIAEETPEVH 532
+ + I +H+ YVH D++P NIL+ N HI +DFG + E
Sbjct: 181 LAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMN--GHIRLADFGSCL------KLMEDG 229
Query: 533 WEQSTT--GTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKW-----DIYSYGVIL 585
QS+ GTP + Y +PE + + + D +S GV +
Sbjct: 230 TVQSSVAVGTP------D------------YISPEILQAMEGGKGRYGPECDWWSLGVCM 271
Query: 586 LEMISGKLP 594
EM+ G+ P
Sbjct: 272 YEMLYGETP 280
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 1e-08
Identities = 52/246 (21%), Positives = 82/246 (33%), Gaps = 70/246 (28%)
Query: 374 LLGKSTIGIVY---------KVA---LNNEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIR 421
LLGK G V+ +VA + + L + E +
Sbjct: 38 LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSV-TCPLEVALLWKVGAGGG 96
Query: 422 HPNIVSLRAYFWSVDEKLLI----------YDYIPNGSLATAIHGKAGIISYRPLSWSDR 471
HP ++ L +F + + +L+ +DYI G L
Sbjct: 97 HPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYI-------TEKGP--------LGEGPS 141
Query: 472 LRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILL-GKNMEPHISDFGLARLADIAEETPE 530
V I H + VH D++ NIL+ + + DFG L
Sbjct: 142 RCFFGQVVAAIQHCHS---RGVVHRDIKDENILIDLRRGCAKLIDFGSGAL--------- 189
Query: 531 VHWEQSTT--GTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEM 588
+H E T GT + S P E+ SR Y A A ++S G++L +M
Sbjct: 190 LHDEPYTDFDGTRVYSPP-EWI------SRHQYHALPA----------TVWSLGILLYDM 232
Query: 589 ISGKLP 594
+ G +P
Sbjct: 233 VCGDIP 238
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 1e-08
Identities = 40/160 (25%), Positives = 54/160 (33%), Gaps = 26/160 (16%)
Query: 108 QSLILSGNSFSGPVPMQIGKLKYLQVLDLSQNSFSSSIPSSIVQC-KRLKTVVLNQNSFT 166
+ L L + L L L+L N + + + + L T+ L N
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQT-LSAGVFDDLTELGTLGLANNQLA 96
Query: 167 GPLPDGFATNLTALQKLDLSFNNLSGLIPNDI----ANLSRLRL---------------L 207
LP G +LT L KL L N L L P+ + L LRL L
Sbjct: 97 S-LPLGVFDHLTQLDKLYLGGNQLKSL-PSGVFDRLTKLKELRLNTNQLQSIPAGAFDKL 154
Query: 208 AQRVYVDLTYNNLSGLIPQNA--ALLSLGPTAFIGNPFLC 245
+ L+ N L +P A L L GN F C
Sbjct: 155 TNLQTLSLSTNQLQS-VPHGAFDRLGKLQTITLFGNQFDC 193
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 1e-08
Identities = 54/246 (21%), Positives = 94/246 (38%), Gaps = 63/246 (25%)
Query: 421 RHPNIVSLRAYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKG-VA 479
HP +V L + F + + +Y+ G L + + + + R ++
Sbjct: 111 NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQ-RQRKLP------EEHARFYSAEIS 163
Query: 480 KGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHI--SDFGLARLADIAEETPEVHWEQST 537
+ +LHE + ++ DL+ N+LL + E HI +D+G+ + E T
Sbjct: 164 LALNYLHE---RGIIYRDLKLDNVLL--DSEGHIKLTDYGMCK---------EGLRPGDT 209
Query: 538 T----GTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKL 593
T GTP Y APE + D ++ GV++ EM++G+
Sbjct: 210 TSTFCGTP------N------------YIAPEILRGEDYGFSVDWWALGVLMFEMMAGRS 251
Query: 594 PMIQIGSMEL----NIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVH 649
P +GS + Q+ILE + + L + SVLK L+
Sbjct: 252 PFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSV----------KAASVLKSFLN--- 298
Query: 650 KSPDKR 655
K P +R
Sbjct: 299 KDPKER 304
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 1e-08
Identities = 44/182 (24%), Positives = 68/182 (37%), Gaps = 46/182 (25%)
Query: 420 IRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKG-V 478
HP + + F + + + +Y+ G L I R +
Sbjct: 75 WEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQ-SCHKFD------LSRATFYAAEI 127
Query: 479 AKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHI--SDFGLARLADIAEETPEVHWEQS 536
G+ FLH K V+ DL+ NILL + + HI +DFG+ + E +
Sbjct: 128 ILGLQFLHS---KGIVYRDLKLDNILL--DKDGHIKIADFGMCK---------ENMLGDA 173
Query: 537 TT----GTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGK 592
T GTP + Y APE +K D +S+GV+L EM+ G+
Sbjct: 174 KTNTFCGTP------D------------YIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ 215
Query: 593 LP 594
P
Sbjct: 216 SP 217
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 1e-08
Identities = 46/191 (24%), Positives = 68/191 (35%), Gaps = 65/191 (34%)
Query: 421 RHPNIVSLR----AYFWSVDEKL-LIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRII 475
HPN+V L + KL L+++++ + P I
Sbjct: 72 EHPNVVRLFDVCTVSRTDRETKLTLVFEHVD--------QDLTTYLDKVPEPGVP-TETI 122
Query: 476 KGVA----KGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEE-TPE 530
K + +G+ FLH R VH DL+P NIL+ + + ++DFGLAR+ T
Sbjct: 123 KDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSV 179
Query: 531 V--HWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPE-------ASKVRKPTQKWDIYSY 581
V W Y+APE A+ V D++S
Sbjct: 180 VVTLW---------------------------YRAPEVLLQSSYATPV-------DLWSV 205
Query: 582 GVILLEMISGK 592
G I EM K
Sbjct: 206 GCIFAEMFRRK 216
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 1e-08
Identities = 54/246 (21%), Positives = 94/246 (38%), Gaps = 63/246 (25%)
Query: 421 RHPNIVSLRAYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKG-VA 479
HP +V L + F + + +Y+ G L + + + + R ++
Sbjct: 68 NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQ-RQRKLP------EEHARFYSAEIS 120
Query: 480 KGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHI--SDFGLARLADIAEETPEVHWEQST 537
+ +LHE + ++ DL+ N+LL + E HI +D+G+ + E T
Sbjct: 121 LALNYLHE---RGIIYRDLKLDNVLL--DSEGHIKLTDYGMCK---------EGLRPGDT 166
Query: 538 T----GTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKL 593
T GTP Y APE + D ++ GV++ EM++G+
Sbjct: 167 TSTFCGTP------N------------YIAPEILRGEDYGFSVDWWALGVLMFEMMAGRS 208
Query: 594 PMIQIGSMEL----NIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVH 649
P +GS + Q+ILE + + L + SVLK L +
Sbjct: 209 PFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSV----------KAASVLKSFL---N 255
Query: 650 KSPDKR 655
K P +R
Sbjct: 256 KDPKER 261
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 56.0 bits (135), Expect = 1e-08
Identities = 44/232 (18%), Positives = 73/232 (31%), Gaps = 44/232 (18%)
Query: 48 SWNGITCREGQVFS-------LIIPNKKLTGFIPAD-LGSLSAIGRVNLRNNNFSGSLPV 99
+ + FS + I + I AD +L + + + N +
Sbjct: 38 VLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINP 97
Query: 100 ELF-NASNLQSLILSGNSFSGPVPMQIGKLKYLQVLDLSQNSFSSSIPSSIVQ--CKRLK 156
E F N NLQ L++S + +LD+ N +I +
Sbjct: 98 EAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESV 157
Query: 157 TVVLNQN--------SFTGP---------------LPDGFATNLTALQKLDLSFNNLSGL 193
+ LN+N +F G LP+ + LD+S + L
Sbjct: 158 ILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSL 217
Query: 194 IPNDIANLSRLRLLAQRVYVDLTYNNLSGLIPQNAALLSLGPTAFIGNPFLC 245
+ NL +LR + NL L P L++L A + P C
Sbjct: 218 PSYGLENLKKLRA--------RSTYNLKKL-PTLEKLVAL-MEASLTYPSHC 259
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 53.7 bits (129), Expect = 9e-08
Identities = 22/155 (14%), Positives = 50/155 (32%), Gaps = 25/155 (16%)
Query: 106 NLQSLILSGNSFSGPVPMQIGKLKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSF 165
+ + + + + +P + + L + L+ + ++QN
Sbjct: 10 SNRVFLCQESKVTE-IPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDV 66
Query: 166 TGPLPDGFATNLTALQKLDLS-FNNLSGLIPNDIANLSRLRLLAQRVYVDLTYNNLSGL- 223
+ +NL L ++ + NNL + P NL L+ L ++ + L
Sbjct: 67 LEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYL------LISNTGIKHLP 120
Query: 224 --------------IPQNAALLSLGPTAFIGNPFL 244
I N + ++ +F+G F
Sbjct: 121 DVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFE 155
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 55.7 bits (135), Expect = 2e-08
Identities = 48/245 (19%), Positives = 95/245 (38%), Gaps = 68/245 (27%)
Query: 375 LGKSTIGIVYKVALNNE--EAVAVRRLGNGGWQRFKEFQTEAEA---------IGKIRHP 423
LG G+V+ A++N+ + VA++++ I ++ H
Sbjct: 19 LGCGGNGLVFS-AVDNDCDKRVAIKKIV---------LTDPQSVKHALREIKIIRRLDHD 68
Query: 424 NIVSLRAYFWSVDEKLLIYD---------YIPNGSLATAIHGKAGIISYRPLSWSDRLR- 473
NIV + +L YI + T + ++ PL + R
Sbjct: 69 NIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLAN---VLEQGPLL-EEHARL 124
Query: 474 IIKGVAKGIAFLH--EVSPKRYVHGDLRPSNILL-GKNMEPHISDFGLARLADIAEETPE 530
+ + +G+ ++H V +H DL+P+N+ + +++ I DFGLAR+ D P
Sbjct: 125 FMYQLLRGLKYIHSANV-----LHRDLKPANLFINTEDLVLKIGDFGLARIMD-----PH 174
Query: 531 VHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPE---ASKVRKPTQKWDIYSYGVILLE 587
+ + T + +Y++P + T+ D+++ G I E
Sbjct: 175 YSHKGHLSE-------GLVT-------K-WYRSPRLLLSPN--NYTKAIDMWAAGCIFAE 217
Query: 588 MISGK 592
M++GK
Sbjct: 218 MLTGK 222
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 55.6 bits (135), Expect = 2e-08
Identities = 55/245 (22%), Positives = 92/245 (37%), Gaps = 66/245 (26%)
Query: 419 KIRHPNIVSLRAYFWSVDEKL-LIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRI-IK 476
+++HP IV L F + KL LI +Y+ G L + + GI D +
Sbjct: 77 EVKHPFIVDLIYAFQT-GGKLYLILEYLSGGELFMQLE-REGIFM------EDTACFYLA 128
Query: 477 GVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHI--SDFGLARLADIAEETPEVHWE 534
++ + LH+ K ++ DL+P NI+L N + H+ +DFGL + E +
Sbjct: 129 EISMALGHLHQ---KGIIYRDLKPENIML--NHQGHVKLTDFGLCK---------ESIHD 174
Query: 535 QSTT----GTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS 590
+ T GT E Y APE + D +S G ++ +M++
Sbjct: 175 GTVTHTFCGTI------E------------YMAPEILMRSGHNRAVDWWSLGALMYDMLT 216
Query: 591 GKLPMIQIGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHK 650
G P + I IL+ + + L E +LK L +
Sbjct: 217 GAPPFTGENRKKT-----IDKILKCKLNLPPYLTQ----------EARDLLKKLL---KR 258
Query: 651 SPDKR 655
+ R
Sbjct: 259 NAASR 263
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 56.3 bits (135), Expect = 2e-08
Identities = 30/149 (20%), Positives = 52/149 (34%), Gaps = 15/149 (10%)
Query: 61 SLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGP 120
L + K+ L L + ++L +N S + L + L+SL L N +
Sbjct: 91 WLFLDENKIKDLSS--LKDLKKLKSLSLEHNGIS-DING-LVHLPQLESLYLGNNKITDI 146
Query: 121 VPMQIGKLKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFT--GPLPDGFATNLT 178
+ +L L L L N S + +L+ + L++N + L L
Sbjct: 147 TV--LSRLTKLDTLSLEDNQISDI--VPLAGLTKLQNLYLSKNHISDLRAL-----AGLK 197
Query: 179 ALQKLDLSFNNLSGLIPNDIANLSRLRLL 207
L L+L N +NL +
Sbjct: 198 NLDVLELFSQECLNKPINHQSNLVVPNTV 226
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 55.5 bits (133), Expect = 4e-08
Identities = 44/209 (21%), Positives = 72/209 (34%), Gaps = 30/209 (14%)
Query: 47 CSWNGITCREGQ-----VFSLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVEL 101
+T Q + +I N + + L + ++ L N + P L
Sbjct: 28 LKKKSVTDAVTQNELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNGNKLTDIKP--L 83
Query: 102 FNASNLQSLILSGNSFSGPVPMQIGKLKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLN 161
N NL L L N + LK L+ L L N S I + +V +L+++ L
Sbjct: 84 TNLKNLGWLFLDENKIKDLSS--LKDLKKLKSLSLEHNGI-SDI-NGLVHLPQLESLYLG 139
Query: 162 QNSFTGPLPDGFATNLTALQKLDLSFNNLSGLIP--------------NDIANLSRLRLL 207
N T + LT L L L N +S ++P N I++L L L
Sbjct: 140 NNKITD--ITVLS-RLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKNHISDLRALAGL 196
Query: 208 AQRVYVDLTYNNLSGLIPQNAALLSLGPT 236
++L + + L + T
Sbjct: 197 KNLDVLELFSQECLNKPINHQSNLVVPNT 225
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 49.3 bits (117), Expect = 3e-06
Identities = 19/123 (15%), Positives = 38/123 (30%), Gaps = 19/123 (15%)
Query: 107 LQSLILSGNSFSGPVPMQIGKLKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFT 166
+ I P +L + S + ++ + + + ++ N +
Sbjct: 1 MGETITVSTPIKQIFP--DDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIK 56
Query: 167 --GPLPDGFATNLTALQKLDLSFNNLSGLIPNDIANLSRLRLLAQRVYVDLTYNNLSGLI 224
+ L + KL L+ N L+ + P + NL L L L N + L
Sbjct: 57 SVQGI-----QYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWL------FLDENKIKDLS 103
Query: 225 PQN 227
Sbjct: 104 SLK 106
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 55.7 bits (135), Expect = 2e-08
Identities = 44/191 (23%), Positives = 78/191 (40%), Gaps = 46/191 (24%)
Query: 411 QTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSD 470
TE+ + RHP + +L+ F + D + +Y G L + + + + +
Sbjct: 53 VTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLS-RERVFT------EE 105
Query: 471 RLRIIKG-VAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHI--SDFGLARLADIAEE 527
R R + + +LH + V+ D++ N++L K + HI +DFGL +
Sbjct: 106 RARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDK--DGHIKITDFGLCK------- 153
Query: 528 TPEVHWEQSTT----GTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGV 583
E + +T GTP E Y APE + + D + GV
Sbjct: 154 --EGISDGATMKTFCGTP------E------------YLAPEVLEDNDYGRAVDWWGLGV 193
Query: 584 ILLEMISGKLP 594
++ EM+ G+LP
Sbjct: 194 VMYEMMCGRLP 204
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 55.3 bits (134), Expect = 3e-08
Identities = 55/242 (22%), Positives = 91/242 (37%), Gaps = 64/242 (26%)
Query: 421 RHPNIVSLRAYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKG-VA 479
+ P + L + F ++D + +Y+ G L I + G +A
Sbjct: 79 KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQ-QVGRFK------EPHAVFYAAEIA 131
Query: 480 KGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHI--SDFGLARLADIAEETPEVHWEQST 537
G+ FL K ++ DL+ N++L + E HI +DFG+ + E W+ T
Sbjct: 132 IGLFFLQS---KGIIYRDLKLDNVML--DSEGHIKIADFGMCK---------ENIWDGVT 177
Query: 538 T----GTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKL 593
T GTP + Y APE + + D +++GV+L EM++G+
Sbjct: 178 TKTFCGTP------D------------YIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQA 219
Query: 594 PMIQIGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPD 653
P EL Q I+E + E V++ K + K P
Sbjct: 220 PFEGEDEDEL-----FQSIMEHNVAYPKSMSK----------EAVAICKGLM---TKHPG 261
Query: 654 KR 655
KR
Sbjct: 262 KR 263
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 4e-08
Identities = 45/242 (18%), Positives = 78/242 (32%), Gaps = 64/242 (26%)
Query: 374 LLGKSTIGIVYKVALNNE--EAVAV-----RRLGNGGWQRFKE-FQTEAEAIGKIRH--P 423
LLG G V + VA+ R+ + G E + K+
Sbjct: 50 LLGSGGFGSV-YSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 108
Query: 424 NIVSLRAYFWSVDEKLLI----------YDYIPNGSLATAIHGKAGIISYRPLSWSDRLR 473
++ L +F D +LI +D+I G L
Sbjct: 109 GVIRLLDWFERPDSFVLILERPEPVQDLFDFI-------TERGA--------LQEELARS 153
Query: 474 IIKGVAKGIAFLHEVSPKRYVHGDLRPSNILL-GKNMEPHISDFGLARLADIAEETPEVH 532
V + + H +H D++ NIL+ E + DFG + ++T
Sbjct: 154 FFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSG---ALLKDTVYTD 207
Query: 533 WEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGK 592
++ GT + S P E+ Y A ++S G++L +M+ G
Sbjct: 208 FD----GTRVYSPP-EWI------RYHRYHGRSA----------AVWSLGILLYDMVCGD 246
Query: 593 LP 594
+P
Sbjct: 247 IP 248
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 6e-08
Identities = 50/255 (19%), Positives = 94/255 (36%), Gaps = 73/255 (28%)
Query: 361 DFDLEQLLKASAFLLGKSTIGIVYKVAL-NNEEAVAVRRLGNGGWQRFKE---FQTEAEA 416
D+++ +K ++G+ G V V + + A++ L + + F E +
Sbjct: 70 DYEV---VK----VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDI 122
Query: 417 IGKIRHPNIVSLRAYFWSVDEKL-LIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRII 475
+ P +V L F D L ++ +Y+P G L ++ +
Sbjct: 123 MAFANSPWVVQLFYAFQD-DRYLYMVMEYMPGGDL---------------VNLMSNYDVP 166
Query: 476 KGVAK--------GIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHI--SDFGLARLADIA 525
+ A+ + +H ++H D++P N+LL K+ H+ +DFG
Sbjct: 167 EKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKS--GHLKLADFGTCM----- 216
Query: 526 EETPEVHWEQSTT--GTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKW----DIY 579
+ + + T GTP + Y +PE K + + D +
Sbjct: 217 -KMNKEGMVRCDTAVGTP------D------------YISPEVLKSQGGDGYYGRECDWW 257
Query: 580 SYGVILLEMISGKLP 594
S GV L EM+ G P
Sbjct: 258 SVGVFLYEMLVGDTP 272
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 8e-08
Identities = 50/184 (27%), Positives = 72/184 (39%), Gaps = 48/184 (26%)
Query: 419 KIRHPNIVSLRAYFWSVDEKL-LIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRI-IK 476
++HP +V L F + +KL + DYI G L + + R R
Sbjct: 95 NVKHPFLVGLHFSFQT-ADKLYFVLDYINGGELFYHLQ-RERCFL------EPRARFYAA 146
Query: 477 GVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHI--SDFGLARLADIAEETPEVHWE 534
+A + +LH V+ DL+P NILL + + HI +DFGL + E
Sbjct: 147 EIASALGYLHS---LNIVYRDLKPENILL--DSQGHIVLTDFGLCK---------ENIEH 192
Query: 535 QSTT----GTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS 590
STT GTP E Y APE + + D + G +L EM+
Sbjct: 193 NSTTSTFCGTP------E------------YLAPEVLHKQPYDRTVDWWCLGAVLYEMLY 234
Query: 591 GKLP 594
G P
Sbjct: 235 GLPP 238
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 9e-08
Identities = 53/242 (21%), Positives = 83/242 (34%), Gaps = 64/242 (26%)
Query: 421 RHPNIVSLRAYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKG-VA 479
HP + L F + D + +++ G L I K+ R R +
Sbjct: 82 NHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQ-KSRRFD------EARARFYAAEII 134
Query: 480 KGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHI--SDFGLARLADIAEETPEVHWEQST 537
+ FLH+ K ++ DL+ N+LL + E H +DFG+ + E T
Sbjct: 135 SALMFLHD---KGIIYRDLKLDNVLL--DHEGHCKLADFGMCK---------EGICNGVT 180
Query: 538 T----GTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKL 593
T GTP + Y APE + D ++ GV+L EM+ G
Sbjct: 181 TATFCGTP------D------------YIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHA 222
Query: 594 PMIQIGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPD 653
P +L + IL D L + +LK + K+P
Sbjct: 223 PFEAENEDDL-----FEAILNDEVVYPTWLHE----------DATGILKSFM---TKNPT 264
Query: 654 KR 655
R
Sbjct: 265 MR 266
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 1e-07
Identities = 35/116 (30%), Positives = 51/116 (43%), Gaps = 11/116 (9%)
Query: 132 QVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLS 191
L L N F+ +P + K L + L+ N + L + +N+T L L LS+N L
Sbjct: 34 TELYLDGNQFTL-VPKELSNYKHLTLIDLSNNRIST-LSNQSFSNMTQLLTLILSYNRLR 91
Query: 192 GLIPNDIANLSRLRLLAQRVYVDLTYNNLSGLIPQNA--ALLSLGPTAFIGNPFLC 245
+ P L LRLL L N++S +P+ A L +L A NP C
Sbjct: 92 CIPPRTFDGLKSLRLL------SLHGNDISV-VPEGAFNDLSALSHLAIGANPLYC 140
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 2e-04
Identities = 30/118 (25%), Positives = 47/118 (39%), Gaps = 28/118 (23%)
Query: 73 IPADLGSLSAIGRVNLRNNNFSGSLPVELF-NASNLQSLILSGNSFSGPVPMQIGKLKYL 131
+P +L + + ++L NN S +L + F N + L +LILS N P LK L
Sbjct: 46 VPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQLLTLILSYNRLRCIPPRTFDGLKSL 104
Query: 132 QVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNN 189
++L L N + V P+G +L+AL L + N
Sbjct: 105 RLLSLHGN--------------DISVV-----------PEGAFNDLSALSHLAI-GAN 136
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 1e-07
Identities = 29/162 (17%), Positives = 59/162 (36%), Gaps = 19/162 (11%)
Query: 77 LGSLSAIGRVNLRNNNFSGSLPVELFNA----SNLQSLILSGNSFSGPVPMQIGK-LKY- 130
L L V L + + + ++ +A L L L N + + L+
Sbjct: 24 LPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP 83
Query: 131 ---LQVLDLSQNSFS----SSIPSSIVQCKRLKTVVLNQNSFTGP----LPDGFATNLTA 179
+Q L L + + S++ L+ + L+ N L +G
Sbjct: 84 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCR 143
Query: 180 LQKLDLSFNNLSGLIPNDIANLSRLRLLAQRVYVDLTYNNLS 221
L+KL L + +LS +A++ LR + ++ N+++
Sbjct: 144 LEKLQLEYCSLSAASCEPLASV--LRAKPDFKELTVSNNDIN 183
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 9e-07
Identities = 39/218 (17%), Positives = 68/218 (31%), Gaps = 52/218 (23%)
Query: 48 SWNGITCREGQVFS--LIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFS----GSLPVEL 101
N + L P+ K+ +++L+N + G L L
Sbjct: 64 RSNELGDVGVHCVLQGLQTPSCKIQ--------------KLSLQNCCLTGAGCGVLSSTL 109
Query: 102 FNASNLQSLILSGNSFSGPVPMQIGKL-----KYLQVLDLSQNSFSS----SIPSSIVQC 152
LQ L LS N + + L+ L L S S+ + S +
Sbjct: 110 RTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAK 169
Query: 153 KRLKTVVLNQNSFTGP----LPDGFATNLTALQKLDLSFNNLS----GLIPNDIANLSRL 204
K + ++ N L G + L+ L L ++ + +A+ + L
Sbjct: 170 PDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASL 229
Query: 205 RLLAQRVYVDLTYNNLS---------GLIPQNAALLSL 233
R L L N L GL+ ++ L +L
Sbjct: 230 REL------ALGSNKLGDVGMAELCPGLLHPSSRLRTL 261
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 2e-06
Identities = 27/130 (20%), Positives = 47/130 (36%), Gaps = 19/130 (14%)
Query: 105 SNLQSLILSGNSFSGPVPMQIGK-LKYLQVLDLSQNSFS----SSIPSSIVQCKRLKTVV 159
++QSL + S ++ L+ QV+ L + I S++ L +
Sbjct: 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 62
Query: 160 LNQNSFTGP----LPDGFATNLTALQKLDLSFNNLS----GLIPNDIANLSRLRLLAQRV 211
L N + G T +QKL L L+ G++ + + L L+ L
Sbjct: 63 LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQEL---- 118
Query: 212 YVDLTYNNLS 221
L+ N L
Sbjct: 119 --HLSDNLLG 126
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 4e-06
Identities = 35/211 (16%), Positives = 65/211 (30%), Gaps = 43/211 (20%)
Query: 48 SWNGITCREGQVFSLIIP-NKKLT---------------GFIPADLGSLSAIGRVNLRNN 91
G+T + I+ L P L S + + +
Sbjct: 207 ESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWEC 266
Query: 92 NFSGSLPVELFNA----SNLQSLILSGNSFSGPVPMQIGKL-----KYLQVLDLSQNSFS 142
+ +L +L+ L L+GN + + L+ L + SF+
Sbjct: 267 GITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFT 326
Query: 143 S----SIPSSIVQCKRLKTVVLNQNSFTGP----LPDGFATNLTALQKLDLSFNNLSGLI 194
+ S + Q + L + ++ N L G + L+ L L+ ++S
Sbjct: 327 AACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSS 386
Query: 195 PNDIA----NLSRLRLLAQRVYVDLTYNNLS 221
+ +A LR L DL+ N L
Sbjct: 387 CSSLAATLLANHSLREL------DLSNNCLG 411
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 8e-05
Identities = 21/122 (17%), Positives = 45/122 (36%), Gaps = 17/122 (13%)
Query: 87 NLRNNNFSGSLPVELFNA----SNLQSLILSGNSFSGPVPMQIGK-LKY----LQVLDLS 137
+++ +F+ + + L L +S N ++ + L L+VL L+
Sbjct: 319 WVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLA 378
Query: 138 QNSFS----SSIPSSIVQCKRLKTVVLNQNSFTGP----LPDGFATNLTALQKLDLSFNN 189
S SS+ ++++ L+ + L+ N L + L++L L
Sbjct: 379 DCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIY 438
Query: 190 LS 191
S
Sbjct: 439 WS 440
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 2e-07
Identities = 34/166 (20%), Positives = 65/166 (39%), Gaps = 30/166 (18%)
Query: 375 LGKSTIGIVYKVA-LNNEEAVAVRRLGNGGWQRFKEFQTEAEAIGKI-RHPNIVSLRAYF 432
LG G V ++ +E A++ L Q + + E E + + P+IV + +
Sbjct: 26 LGLGINGKVLQIFNKRTQEKFALKML-----QDCPKARREVELHWRASQCPHIVRIVDVY 80
Query: 433 ----WSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEV 488
L++ + + G L + I + G ++ + + I+K + + I +LH
Sbjct: 81 ENLYAGRKCLLIVMECLDGGELFSRIQDR-GDQAF---TEREASEIMKSIGEAIQYLHS- 135
Query: 489 SPKRYVHGDLRPSNILL---GKNMEPHISDFGLARLADIAEETPEV 531
H D++P N+L N ++DFG A E
Sbjct: 136 --INIAHRDVKPENLLYTSKRPNAILKLTDFGFA---------KET 170
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 5e-07
Identities = 52/247 (21%), Positives = 90/247 (36%), Gaps = 67/247 (27%)
Query: 421 RHPNIVSLRAYFWSVDEKL-LIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRI-IKGV 478
+ P +V+L F + + KL LI DYI G L T + + + ++I + +
Sbjct: 117 QSPFLVTLHYAFQT-ETKLHLILDYINGGELFTHLS-QRERFT------EHEVQIYVGEI 168
Query: 479 AKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHI--SDFGLARLADIAEETPEVHWEQS 536
+ LH+ ++ D++ NILL + H+ +DFGL++ V E
Sbjct: 169 VLALEHLHK---LGIIYRDIKLENILL--DSNGHVVLTDFGLSKE--------FVADETE 215
Query: 537 TT----GTPLQSSPYEFTALNSTTSRSYYQAPE-ASKVRKPTQK---WDIYSYGVILLEM 588
GT E Y AP+ K W +S GV++ E+
Sbjct: 216 RAYDFCGTI------E------------YMAPDIVRGGDSGHDKAVDW--WSLGVLMYEL 255
Query: 589 ISGKLPMIQIGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCV 648
++G P G + + + IL+ P + +++ L
Sbjct: 256 LTGASPFTVDGEKN-SQAEISRRILKSEPPYPQEMSA----------LAKDLIQRLL--- 301
Query: 649 HKSPDKR 655
K P KR
Sbjct: 302 MKDPKKR 308
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 5e-07
Identities = 22/92 (23%), Positives = 37/92 (40%), Gaps = 7/92 (7%)
Query: 132 QVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLS 191
+ L QN+ P + K+L+ + L+ N + L L +L L L N ++
Sbjct: 35 TEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISE-LAPDAFQGLRSLNSLVLYGNKIT 93
Query: 192 GLIPNDIANLSRLRLLAQRVYVDLTYNNLSGL 223
L + L L+LL L N ++ L
Sbjct: 94 ELPKSLFEGLFSLQLL------LLNANKINCL 119
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 5e-07
Identities = 55/309 (17%), Positives = 105/309 (33%), Gaps = 58/309 (18%)
Query: 338 RNNLDTMSENMEQYEFVPLDSQVDFDLEQLLKASAFLLGKSTIGIVYKVAL-NNEEAVAV 396
+ L E+ + P + D +K LG + G V V + A+
Sbjct: 16 KEFLAKAKEDFLKKWETPSQNTAQLDQFDRIK----TLGTGSFGRVMLVKHKESGNHYAM 71
Query: 397 RRLGNGGWQRFKEFQ---TEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLATA 453
+ L + K+ + E + + P +V L F ++ +Y+ G + +
Sbjct: 72 KILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSH 131
Query: 454 IHGKAGIISYRPLSWSDRLRIIKG-VAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPH 512
+ + G S R + +LH ++ DL+P N+L+ +
Sbjct: 132 LR-RIGRFS------EPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQ 181
Query: 513 ISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKP 572
++DFG A+ W + GTP APE +
Sbjct: 182 VTDFGFAK------RVKGRTW--TLCGTP------------------EALAPEIILSKGY 215
Query: 573 TQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQWIQLILEDR--------KPMTDILD 624
+ D ++ GV++ EM +G P +++ + I+ + + D+L
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQPIQI-----YEKIVSGKVRFPSHFSSDLKDLLR 270
Query: 625 PFLAHDLDK 633
L DL K
Sbjct: 271 NLLQVDLTK 279
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 8e-07
Identities = 28/147 (19%), Positives = 51/147 (34%), Gaps = 18/147 (12%)
Query: 87 NLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQI---GKLKYLQVLDLSQNSFSS 143
+ + L + L LS N+ +I ++ L++L L +N
Sbjct: 31 HGMIPPIEK-MDATLSTLKACKHLALSTNNIE-----KISSLSGMENLRILSLGRNLIKK 84
Query: 144 SIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSGLIPNDIANLSR 203
I + L+ + ++ N G L L+ L +S N ++ +I L+
Sbjct: 85 -IENLDAVADTLEELWISYNQIA--SLSGIE-KLVNLRVLYMSNNKITNW--GEIDKLAA 138
Query: 204 LRLLAQRVYVDLTYNNLSGLIPQNAAL 230
L L + L N L +N A
Sbjct: 139 LDKL---EDLLLAGNPLYNDYKENNAT 162
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 51.4 bits (122), Expect = 9e-07
Identities = 88/637 (13%), Positives = 173/637 (27%), Gaps = 214/637 (33%)
Query: 133 VLDLSQNSFSSS-------IPSSIVQCKRLKTVVLNQNS-----FTGPLPDGFATNLTAL 180
V D+ ++ S ++ RL +L++ F L
Sbjct: 38 VQDMPKSILSKEEIDHIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVE----------EVL 87
Query: 181 QKLDLSFNNLSGLIPNDIANLSRLRLLAQRVYV---DLTYNNLSGLIPQN---------- 227
+ + F + + I R + R+Y+ D YN+ N
Sbjct: 88 RI-NYKF------LMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKL 140
Query: 228 -AALLSLGPTAFIGNPFLCGPPLKVSCPSSTSDHPYPKPLPYDPSWHG-GKVHHSCAVIT 285
ALL L P + + G G GK T
Sbjct: 141 RQALLELRPAKNV---LIDGVL-------------------------GSGK--------T 164
Query: 286 TVAVAVLLGICITGFLFYRQYKKASGCKWGEKVGGCRLEEKLMIKKEFFCFT-RNNLDTM 344
VA+ V L + + ++ + W + C E ++ + + N +
Sbjct: 165 WVALDVCLSYKVQCKMDFKIF-------W-LNLKNCNSPETVLEMLQKLLYQIDPNWTSR 216
Query: 345 SENMEQYEFVPLDSQVDFDLEQLLKASAFLLGKSTIGIVYKVAL------NNEEAVAVRR 398
S++ L ++ L+ L K Y+ L N +A
Sbjct: 217 SDHSSNI---KLRIH---SIQAELRR--LLKSKP-----YENCLLVLLNVQNAKA----- 258
Query: 399 LGNGGWQRFKEFQ------------TEAEAIGKIRHPNIVSLRAYFWSVDEKL-LIYDY- 444
W F T+ + H ++ + DE L+ Y
Sbjct: 259 -----WNAF-NLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTL-TPDEVKSLLLKYL 311
Query: 445 -IPNGSL---ATAIHGKA-GII--SYR--PLSW-------SDRL-RIIKGVAKGIAFLHE 487
L + + II S R +W D+L II+ + L+
Sbjct: 312 DCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIE------SSLNV 365
Query: 488 VSPKRYVHGDLRPSNILLGKNMEPHISDFGLARL-ADIAEETPEVHWEQSTTGTPLQSSP 546
+ P + R + A I + W +
Sbjct: 366 LEPA-----EYRK-----------MFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVV-- 407
Query: 547 YEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIV 606
+N S K K + S I LE+ K+ + ++ +IV
Sbjct: 408 -----VNKLHKYSL-----VEKQPKEST----ISIPSIYLEL---KVKLENEYALHRSIV 450
Query: 607 QWIQLILEDRKPMTDILDP--------FLAHDL---DKEDEIVSVLKIALDC------VH 649
+ D++ P + H L + + + + LD +
Sbjct: 451 D--HYNIPKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHPERMTLFRMVFLDFRFLEQKIR 508
Query: 650 KSPDKRPSMRHVCDSLDRVNISTEQQFMKGEEPKFDQ 686
+ + ++L ++ + ++ +PK+++
Sbjct: 509 HDSTAWNASGSILNTLQQLKFY--KPYICDNDPKYER 543
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 48.3 bits (114), Expect = 8e-06
Identities = 66/432 (15%), Positives = 123/432 (28%), Gaps = 143/432 (33%)
Query: 339 NNLDT-MSENMEQYE---FVPLDSQV-DFDLEQLLKASAFLLGKSTIGIVYKVALNNEEA 393
+++D E+ QY+ V D+ V +FD + + +L K I + +
Sbjct: 5 HHMDFETGEHQYQYKDILSVFEDAFVDNFDCKDVQDMPKSILSKEEIDHIIMSK-DAVSG 63
Query: 394 VAVRRL-------GNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIP 446
RL Q+F + ++ N Y + +
Sbjct: 64 T--LRLFWTLLSKQEEMVQKF---------VEEVLRIN------YKFLMSP----IKTEQ 102
Query: 447 NG-SLATAIHGKAGIISYRPLSWSD----------RLRIIKGVAKGIAFLHEVSPKRYV- 494
S+ T ++ I R ++D RL+ + + L E+ P + V
Sbjct: 103 RQPSMMTRMY-----IEQRDRLYNDNQVFAKYNVSRLQPYLKLRQA---LLELRPAKNVL 154
Query: 495 -HG--------------------DLRPSNIL---LGKNMEP-----------HISDFGLA 519
G I L P + D
Sbjct: 155 IDGVLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWT 214
Query: 520 RLADIAEETP-EVHWEQSTTGTPLQSSPYE--------------FTALN-------STTS 557
+D + +H Q+ L+S PYE + A N +T
Sbjct: 215 SRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRF 274
Query: 558 RSYYQAPEASKVRKPTQKWDIYSYGV-------IL---LEMISGKLP--MIQIGSMELNI 605
+ A+ + D +S + +L L+ LP ++ L+
Sbjct: 275 KQVTDFLSAATTTHISL--DHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLS- 331
Query: 606 VQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSL 665
+I E + D + + DK I ++ +L+ + P R + D L
Sbjct: 332 -----IIAESIRDGLATWDNWKHVNCDKLTTI---IESSLNVL--EPA---EYRKMFDRL 378
Query: 666 ----DRVNISTE 673
+I T
Sbjct: 379 SVFPPSAHIPTI 390
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 47.2 bits (111), Expect = 2e-05
Identities = 67/436 (15%), Positives = 137/436 (31%), Gaps = 110/436 (25%)
Query: 2 LVLLILSYIALMGSANDEGLALLSFKQAIRNFPEGNNWNNS-----N-EDPCSWNG---- 51
L + ++ + +++ L + S + +R + + N N ++ +WN
Sbjct: 206 LYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLS 265
Query: 52 ----ITCREGQVFSLIIPNKK--------LTGFIPADLGSLSAIGRVNLRNNNFSGSLPV 99
+T R QV + P ++ SL ++ R LP
Sbjct: 266 CKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLL-KYLDCR----PQDLPR 320
Query: 100 ELFNASNLQ-SLILSGNSFSGPVPMQIGKLKYLQVLDLSQNSFSSSIPSSIVQCKRLKTV 158
E+ + + S+I S K++ + ++ I SS+ L+
Sbjct: 321 EVLTTNPRRLSII--AESIRDG-LATWDNWKHVNC-----DKLTTIIESSL---NVLEPA 369
Query: 159 VLNQNSFT--GPLPDGFATNLTALQKLDLSFNNLSGLIPNDIANLSRLRLLAQRVYVDLT 216
+ F P ++ L L + ++ + N L ++ + T
Sbjct: 370 EY-RKMFDRLSVFPPS--AHIPT-ILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKEST 425
Query: 217 YNNLSGLIPQNAALLSLGPTAFIGNPFLCGPPLKVSCPSSTSDH-----PYPKPLPYDPS 271
+ IP + L LKV + + H Y P +D
Sbjct: 426 IS-----IPS----IYL--------------ELKVKLENEYALHRSIVDHYNIPKTFDSD 462
Query: 272 ------------WHGGKVHHSCAVITTVAVAVLLGICITGFLFYR--QYK-KASGCKWGE 316
H G HH + + + + FL +R + K + W
Sbjct: 463 DLIPPYLDQYFYSHIG--HHLKNIEHPERMTLFRMV----FLDFRFLEQKIRHDSTAWNA 516
Query: 317 KVGGCRLEEKLMIKKEFFCFTRNNLDTMSENMEQYEFVPLDSQVDFDLEQLLKASAFLLG 376
++L K + C +N +YE + +++ +DF L K L+
Sbjct: 517 SGSILNTLQQLKFYKPYIC----------DNDPKYERL-VNAILDF----LPKIEENLIC 561
Query: 377 KSTIGIVYKVALNNEE 392
++ ++AL E+
Sbjct: 562 SKYTDLL-RIALMAED 576
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 2e-06
Identities = 45/163 (27%), Positives = 68/163 (41%), Gaps = 23/163 (14%)
Query: 66 NKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNA-SNLQSLILSGNSFSGPVPMQ 124
K +T + + L++I ++ N++ S+ N++ L L GN
Sbjct: 28 KKSVTDAVTQN--ELNSIDQIIANNSDIK-SVQG--IQYLPNVRYLALGGNKLH-----D 77
Query: 125 IG---KLKYLQVLDLSQNSFSSSIPSSIVQC-KRLKTVVLNQNSFTGPLPDGFATNLTAL 180
I +L L L L+ N S +P+ + LK +VL +N LPDG LT L
Sbjct: 78 ISALKELTNLTYLILTGNQLQS-LPNGVFDKLTNLKELVLVENQLQS-LPDGVFDKLTNL 135
Query: 181 QKLDLSFNNLSGLIPNDIANLSRLRLLAQRVYVDLTYNNLSGL 223
L+L+ N L L L+ L L DL+YN L L
Sbjct: 136 TYLNLAHNQLQSLPKGVFDKLTNLTEL------DLSYNQLQSL 172
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 8e-06
Identities = 43/176 (24%), Positives = 72/176 (40%), Gaps = 26/176 (14%)
Query: 29 AIRNFPEGNNWNNSNEDPCSWNGITCREG-----QVFSLIIPNKKLTGFIPADLG---SL 80
++ + N N+ ++ + + I +G V L + KL D+ L
Sbjct: 30 SVTDAVTQNELNSIDQIIANNSDIKSVQGIQYLPNVRYLALGGNKLH-----DISALKEL 84
Query: 81 SAIGRVNLRNNNFSGSLPVELFNA-SNLQSLILSGNSFSGPVPMQI-GKLKYLQVLDLSQ 138
+ + + L N SLP +F+ +NL+ L+L N +P + KL L L+L+
Sbjct: 85 TNLTYLILTGNQLQ-SLPNGVFDKLTNLKELVLVENQLQS-LPDGVFDKLTNLTYLNLAH 142
Query: 139 NSFSSSIPS----SIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNL 190
N S +P + L + L+ N LP+G LT L+ L L N L
Sbjct: 143 NQLQS-LPKGVFDKLTN---LTELDLSYNQLQS-LPEGVFDKLTQLKDLRLYQNQL 193
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 48.2 bits (115), Expect = 3e-06
Identities = 42/146 (28%), Positives = 56/146 (38%), Gaps = 17/146 (11%)
Query: 105 SNLQSLILSGNSFSGPVPMQIGKLKYLQVLDLSQN---SFSSSIPSSIVQCKRLKTVVLN 161
+N Q L L N + P L L+ L L N + + S+ Q L + L
Sbjct: 40 TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQ---LTVLDLG 96
Query: 162 QNSFTGPLPDGFATNLTALQKLDLSFNNLSGLIPNDIANLSRLRLLAQRVYVDLTYNNLS 221
N T LP L L++L + N L+ +P I L+ L L L N L
Sbjct: 97 TNQLTV-LPSAVFDRLVHLKELFMCCNKLTE-LPRGIERLTHLTHL------ALDQNQLK 148
Query: 222 GLIPQNA--ALLSLGPTAFIGNPFLC 245
IP A L SL GNP+ C
Sbjct: 149 S-IPHGAFDRLSSLTHAYLFGNPWDC 173
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 48.3 bits (116), Expect = 4e-06
Identities = 50/217 (23%), Positives = 86/217 (39%), Gaps = 49/217 (22%)
Query: 419 KIRHPNIVSLRAYFWSVDEKL-LIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRI-IK 476
+ HP I+ + F +++ +I DYI G L + + K+ + +
Sbjct: 62 IVTHPFIIRMWGTFQD-AQQIFMIMDYIEGGELFSLLR-KSQRFP------NPVAKFYAA 113
Query: 477 GVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHI--SDFGLARLADIAEETPEVHWE 534
V + +LH K ++ DL+P NILL K HI +DFG A+ P+V +
Sbjct: 114 EVCLALEYLHS---KDIIYRDLKPENILLDK--NGHIKITDFGFAK------YVPDVTY- 161
Query: 535 QSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLP 594
+ GTP + Y APE + + D +S+G+++ EM++G P
Sbjct: 162 -TLCGTP------D------------YIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTP 202
Query: 595 MIQIGSMELNIVQWIQLILEDRKPMTDILDPFLAHDL 631
+M+ + IL + DL
Sbjct: 203 FYDSNTMKT-----YEKILNAELRFPPFFNE-DVKDL 233
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336 | Back alignment and structure |
|---|
Score = 48.0 bits (114), Expect = 6e-06
Identities = 32/168 (19%), Positives = 63/168 (37%), Gaps = 12/168 (7%)
Query: 48 SWNGITCREGQVFSLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPV-ELFNASN 106
W + E +L + K L P G L + G + R P+ E F+
Sbjct: 38 RWYRLASDESLWQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFR 94
Query: 107 LQSLILSGNSFSGPVPMQIGK-LKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQ-NS 164
+Q + LS + I LQ L L S I +++ + L + L+ +
Sbjct: 95 VQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSG 154
Query: 165 FTGPLPDGFATNLTALQKLDLSF------NNLSGLIPNDIANLSRLRL 206
F+ ++ + L +L+LS+ ++ + + +++L L
Sbjct: 155 FSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNL 202
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336 | Back alignment and structure |
|---|
Score = 41.8 bits (98), Expect = 5e-04
Identities = 39/215 (18%), Positives = 63/215 (29%), Gaps = 47/215 (21%)
Query: 39 WNNSNEDPCSWNGITCR--------EGQVFSLIIPNKKLTGFIPADLGSLSAIGRVNLRN 90
W D W + G++ S + + D +++
Sbjct: 39 WYRLASDESLWQTLDLTGKNLHPDVTGRLLSQGVIAFRCPRSF-MDQPLAEHFSPFRVQH 97
Query: 91 NNFSG------SLPVELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQVLDLSQ-NSFSS 143
+ S +L L S LQ+L L G S P+ + K L L+LS + FS
Sbjct: 98 MDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSE 157
Query: 144 SIPSSIVQ-CKRLKTV-------------------------VLNQNSFTGPLPDG----F 173
+++ C RL + LN + + L
Sbjct: 158 FALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTL 217
Query: 174 ATNLTALQKLDLSF-NNLSGLIPNDIANLSRLRLL 207
L LDLS L + L+ L+ L
Sbjct: 218 VRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHL 252
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 8e-06
Identities = 19/103 (18%), Positives = 30/103 (29%), Gaps = 14/103 (13%)
Query: 123 MQIGKLKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFT--GPLPDGFATNLTAL 180
Q + LDL I + + + + N P L L
Sbjct: 13 AQYTNAVRDRELDLRGYK-IPVIENLGATLDQFDAIDFSDNEIRKLDGFP-----LLRRL 66
Query: 181 QKLDLSFNNLSGLIPNDIANLSRLRLLAQRVYVDLTYNNLSGL 223
+ L ++ N + + L L L LT N+L L
Sbjct: 67 KTLLVNNNRICRIGEGLDQALPDLTEL------ILTNNSLVEL 103
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 9e-06
Identities = 30/138 (21%), Positives = 57/138 (41%), Gaps = 26/138 (18%)
Query: 77 LGSLSAIGRVNLRNNNFSG----SLPVELFNASNLQSLILSGNSFSGPVPMQ-----IGK 127
+ S I +L+ + + S+ L +++ ++LSGN+ G + I
Sbjct: 1 MARFS-IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTI-GTEAARWLSENIAS 58
Query: 128 LKYLQVLDLSQNSFS----------SSIPSSIVQCKRLKTVVLNQNSFTG----PLPDGF 173
K L++ + S + ++++C +L TV L+ N+F PL D
Sbjct: 59 KKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFL 118
Query: 174 ATNLTALQKLDLSFNNLS 191
+ + T L+ L L N L
Sbjct: 119 SKH-TPLEHLYLHNNGLG 135
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 43.2 bits (102), Expect = 2e-04
Identities = 24/135 (17%), Positives = 42/135 (31%), Gaps = 21/135 (15%)
Query: 77 LGSLSAIGRVNLRNNNF-----SGSLPVELFNASNLQSLILSGNSFSGPVPMQ-----IG 126
S + V + N L L L+ L L N+F + +
Sbjct: 183 FQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTF-THLGSSALAIALK 241
Query: 127 KLKYLQVLDLSQNSFSS----SIPSSIVQC--KRLKTVVLNQNSFTGP----LPDGFATN 176
L+ L L+ S+ ++ + + L+T+ L N L
Sbjct: 242 SWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEK 301
Query: 177 LTALQKLDLSFNNLS 191
+ L L+L+ N S
Sbjct: 302 MPDLLFLELNGNRFS 316
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 9e-06
Identities = 50/237 (21%), Positives = 85/237 (35%), Gaps = 62/237 (26%)
Query: 374 LLGKSTIGIVYKVA-LNNEEAVAVRRLGNGGWQRFKE-FQTEAEAIGKIRH------PNI 425
++GK + G V K + VA++ + N +RF E + +R N+
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMVRNE--KRFHRQAAEEIRILEHLRKQDKDNTMNV 161
Query: 426 VSLRAYFW------SVDEKLLI--YDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKG 477
+ + F E L + Y+ I ++ S +
Sbjct: 162 IHMLENFTFRNHICMTFELLSMNLYELIKKNK-------------FQGFSLPLVRKFAHS 208
Query: 478 VAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHIS--DFGLARLADIAEETPEVHWEQ 535
+ + + LH+ R +H DL+P NILL + I DFG + E
Sbjct: 209 ILQCLDALHK---NRIIHCDLKPENILLKQQGRSGIKVIDFGSSCY------------EH 253
Query: 536 STTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGK 592
T +Q SR +Y+APE + D++S G IL E+++G
Sbjct: 254 QRVYTYIQ-------------SR-FYRAPEVILGARYGMPIDMWSLGCILAELLTGY 296
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 2e-05
Identities = 31/216 (14%), Positives = 58/216 (26%), Gaps = 44/216 (20%)
Query: 48 SWNGITCREGQVFS--LIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNA- 104
N + + L + +NLR NN + EL
Sbjct: 146 RGNDLGIKSSDELIQILAAIPANVN--------------SLNLRGNNLASKNCAELAKFL 191
Query: 105 ----SNLQSLILSGNSFSGPVPMQIGKL-----KYLQVLDLSQNSFSSS----IPSSIVQ 151
+++ SL LS N ++ + ++ L+L N +
Sbjct: 192 ASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDS 251
Query: 152 CKRLKTVVLNQNSFTGPLPDGFA------TNLTALQKLDLSFNN--------LSGLIPND 197
K L+TV L+ + + N+ + +D + +S LI
Sbjct: 252 LKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHSIPISNLIREL 311
Query: 198 IANLSRLRLLAQRVYVDLTYNNLSGLIPQNAALLSL 233
LL Q + + + L
Sbjct: 312 SGKADVPSLLNQCLIFAQKHQTNIEDLNIPDELRES 347
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 1e-04
Identities = 34/206 (16%), Positives = 69/206 (33%), Gaps = 37/206 (17%)
Query: 48 SWNGITCREGQVFS--LIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNA- 104
S N ++ + L +T ++L N+FS E A
Sbjct: 88 SGNFLSYKSSDELVKTLAAIPFTIT--------------VLDLGWNDFSSKSSSEFKQAF 133
Query: 105 ----SNLQSLILSGNSFSGPVPMQIGKL-----KYLQVLDLSQNSFSSSIPSSIVQC--- 152
+++ SL L GN ++ ++ + L+L N+ +S + + +
Sbjct: 134 SNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLAS 193
Query: 153 --KRLKTVVLNQNSFT----GPLPDGFATNLTALQKLDLSFNNLSGLIPNDIANLSRLRL 206
+ ++ L+ N L F++ + L+L N L G ++ L
Sbjct: 194 IPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLL--KDS 251
Query: 207 LAQRVYVDLTYNNLSGLIPQNAALLS 232
L V L Y+ + + + L
Sbjct: 252 LKHLQTVYLDYDIVKNMSKEQCKALG 277
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 43.2 bits (102), Expect = 2e-04
Identities = 28/134 (20%), Positives = 50/134 (37%), Gaps = 19/134 (14%)
Query: 77 LGSLSAIGRVNLRNNNFSGSLPVELFNA-----SNLQSLILSGNSFSGPVPMQIGKL--- 128
+ ++L NN VEL A +++ SL LSGNS ++ ++
Sbjct: 18 TSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAA 77
Query: 129 --KYLQVLDLSQNSFSSSIPSSIVQ-----CKRLKTVVLNQNSFTG----PLPDGFATNL 177
+ L+LS N S +V+ + + L N F+ F+
Sbjct: 78 IPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLP 137
Query: 178 TALQKLDLSFNNLS 191
++ L+L N+L
Sbjct: 138 ASITSLNLRGNDLG 151
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 7e-04
Identities = 27/157 (17%), Positives = 51/157 (32%), Gaps = 34/157 (21%)
Query: 105 SNLQSLILSGNSFSGPVPMQIGKL-----KYLQVLDLSQNSFSSSIPSSI-----VQCKR 154
+ SL LS N+ +++ + + L+LS NS +
Sbjct: 22 HGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPAN 81
Query: 155 LKTVVLNQNSFTGP----LPDGFATNLTALQKLDLSFNNLSGLIPNDIANL-----SRLR 205
+ ++ L+ N + L A + LDL +N+ S ++ + +
Sbjct: 82 VTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASIT 141
Query: 206 LLAQRVYVDLTYNNL---------SGLIPQNAALLSL 233
L +L N+L L A + SL
Sbjct: 142 SL------NLRGNDLGIKSSDELIQILAAIPANVNSL 172
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 46.5 bits (110), Expect = 3e-05
Identities = 26/159 (16%), Positives = 52/159 (32%), Gaps = 20/159 (12%)
Query: 69 LTGFIPADLGSLSAIGRVNLRNNNFSG----SLPVELFNASNLQSLILSGNSFSGPVPMQ 124
L I ++ + L S +P+ A+ ++ L L
Sbjct: 253 LNEDIGMPEKYMNLVFPRKLCRLGLSYMGPNEMPILFPFAAQIRKLDLLYALLETEDHCT 312
Query: 125 -IGKLKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDG----------- 172
I K L+VL+ + CK+LK + + + + + D
Sbjct: 313 LIQKCPNLEVLETRNVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIA 372
Query: 173 FATNLTALQKLDLSFNNLS--GL--IPNDIANLSRLRLL 207
A L+ + + ++++ L I + NL RL+
Sbjct: 373 LAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLV 411
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 45.5 bits (108), Expect = 4e-05
Identities = 27/117 (23%), Positives = 47/117 (40%), Gaps = 25/117 (21%)
Query: 482 IAFLHEVSPKRYVHGDLRPSNILLGKNMEP--HISDFGLA-RLADIAEETPEVHWEQST- 537
+ FLHE YVHG++ NI + + ++ +G A R + V +S
Sbjct: 172 LEFLHE---NEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPH 228
Query: 538 TGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLP 594
G EF +++ K P+++ D+ S G +L+ + G LP
Sbjct: 229 EGDL------EFISMD------------LHKGCGPSRRSDLQSLGYCMLKWLYGFLP 267
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 7e-05
Identities = 30/117 (25%), Positives = 51/117 (43%), Gaps = 25/117 (21%)
Query: 482 IAFLHEVSPKRYVHGDLRPSNILLGKNMEP--HISDFGLA-RLADIAEETPEVHWEQ-ST 537
+ ++HE YVHGD++ +N+LLG +++D+GL+ R +
Sbjct: 164 LEYIHE---NEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGH 220
Query: 538 TGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLP 594
GT EFT+L+ A K +++ D+ G +L + GKLP
Sbjct: 221 NGTI------EFTSLD------------AHKGVALSRRSDVEILGYCMLRWLCGKLP 259
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 44.9 bits (106), Expect = 7e-05
Identities = 26/153 (16%), Positives = 49/153 (32%), Gaps = 25/153 (16%)
Query: 463 YRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLA 522
Y+ L +II+ V +G+ +LH + R +H D++P NILL N + A
Sbjct: 140 YQGLPLPCVKKIIQQVLQGLDYLH--TKCRIIHTDIKPENILLSVNEQYIRRLAAEATEW 197
Query: 523 -----------DIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRS------------ 559
++ P + + + +
Sbjct: 198 QRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTR 257
Query: 560 YYQAPEASKVRKPTQKWDIYSYGVILLEMISGK 592
Y++ E DI+S + E+ +G
Sbjct: 258 QYRSLEVLIGSGYNTPADIWSTACMAFELATGD 290
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 44.8 bits (106), Expect = 7e-05
Identities = 28/117 (23%), Positives = 50/117 (42%), Gaps = 25/117 (21%)
Query: 482 IAFLHEVSPKRYVHGDLRPSNILLGKNMEP--HISDFGLA-RLADIAEETPEVHWE-QST 537
+ ++HE YVHGD++ SN+LL ++ D+GLA R +
Sbjct: 165 LEYIHE---HEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCH 221
Query: 538 TGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLP 594
GT EFT+++ A P+++ D+ G +++ ++G LP
Sbjct: 222 DGTI------EFTSID------------AHNGVAPSRRGDLEILGYCMIQWLTGHLP 260
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 9e-05
Identities = 26/136 (19%), Positives = 48/136 (35%), Gaps = 34/136 (25%)
Query: 463 YRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPH------ISDF 516
+R + +I K + G+ ++H +H D++P N+L+ P I+D
Sbjct: 125 HRGIPLIYVKQISKQLLLGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADL 182
Query: 517 GLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKW 576
G A W +Q+ Y++PE
Sbjct: 183 GNAC------------WYDEHYTNSIQT--------------REYRSPEVLLGAPWGCGA 216
Query: 577 DIYSYGVILLEMISGK 592
DI+S ++ E+I+G
Sbjct: 217 DIWSTACLIFELITGD 232
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* Length = 540 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 1e-04
Identities = 26/121 (21%), Positives = 48/121 (39%), Gaps = 19/121 (15%)
Query: 406 RFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRP 465
R EA + ++ I + + +D K ++ YI I
Sbjct: 382 RKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMSYINGKLAKDVI----------- 430
Query: 466 LSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIA 525
D L I + + + LH+ +H DL SN + K++ +I DFGL +++++
Sbjct: 431 ---EDNLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDKDL--YIIDFGLGKISNLD 482
Query: 526 E 526
E
Sbjct: 483 E 483
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 43.7 bits (102), Expect = 1e-04
Identities = 30/216 (13%), Positives = 61/216 (28%), Gaps = 47/216 (21%)
Query: 349 EQYEFVPLDSQVDFD-LEQLLKASAFLLGKSTIGIVYKVALNNEE-AVAVRRLGNGGWQR 406
Q VP + + L++ K +G+ G V++ ++ A+ + +
Sbjct: 6 SQKGPVPFSHCLPTEKLQRCEK-----IGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVN 60
Query: 407 FKEFQTEAEAIGKI---------------RHPNIVSLRAYF--WSVDEKLLIYDYI---- 445
+T E + +I R + L + LL+ +
Sbjct: 61 GSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNS 120
Query: 446 PNGSLATAIHGKAGIISY-----------------RPLSWSDRLRIIKGVAKGIAFLHEV 488
GS + + S + I+ + +A
Sbjct: 121 TKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEAS 180
Query: 489 SPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADI 524
R+ H DL N+LL K + + + I
Sbjct: 181 L--RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTI 214
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 2e-04
Identities = 22/93 (23%), Positives = 37/93 (39%), Gaps = 14/93 (15%)
Query: 133 VLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFT--GPLPDGFATNLTALQKLDLSFNNL 190
VLD S+++ + + + L+ + T LP L L+KL+LS N +
Sbjct: 23 VLDNSRSN-EGKLEGLTDEFEELEFLSTINVGLTSIANLP-----KLNKLKKLELSDNRV 76
Query: 191 SGLIPNDIANLSRLRLLAQRVYVDLTYNNLSGL 223
SG + L L +L+ N + L
Sbjct: 77 SGGLEVLAEKCPNLTHL------NLSGNKIKDL 103
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 2e-04
Identities = 61/332 (18%), Positives = 119/332 (35%), Gaps = 70/332 (21%)
Query: 374 LLGKSTIGIVYKVA-LNNEEAVAVRRLGNGGWQRFKE-FQTEAEAIGKIRH-----PNIV 426
+G T G V ++N++ AV+ + N +++ + EA+ + KI++ NIV
Sbjct: 42 KMGDGTFGRVLLCQHIDNKKYYAVKVVRNI--KKYTRSAKIEADILKKIQNDDINNNNIV 99
Query: 427 SLRAYFWS------VDEKLLI--YDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGV 478
F + E L Y+ I + Y D +
Sbjct: 100 KYHGKFMYYDHMCLIFEPLGPSLYEIITRNN-------------YNGFHIEDIKLYCIEI 146
Query: 479 AKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTT 538
K + +L ++ H DL+P NILL +P+ + + +++ +ST
Sbjct: 147 LKALNYLRKM---SLTHTDLKPENILL---DDPYFEKSLITVRRVTDGKKIQIYRTKSTG 200
Query: 539 ------GTPLQSSPYEFTALNSTTSRSYYQAPEASKV---RKPTQKWDIYSYGVILLEMI 589
G + ++ S + Y+APE V D++S+G +L E+
Sbjct: 201 IKLIDFG----CATFKSDYHGSIINTRQYRAPE---VILNLGWDVSSDMWSFGCVLAELY 253
Query: 590 SGKLPMIQIGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDK-----EDEIVSVLKIA 644
+G + + + L + M I+ P + L + + V+ ++
Sbjct: 254 TGS-LLFR-THEHME-----HLAM-----MESIIQPIPKNMLYEATKTNGSKYVNKDELK 301
Query: 645 LDCVHKSPDKRPSMRHVCDSLDRVNISTEQQF 676
L + S++HV L I + F
Sbjct: 302 LAWPENASSIN-SIKHVKKCLPLYKIIKHELF 332
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 41.3 bits (97), Expect = 2e-04
Identities = 22/93 (23%), Positives = 35/93 (37%), Gaps = 14/93 (15%)
Query: 133 VLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFT--GPLPDGFATNLTALQKLDLSFNNL 190
VLD +++ I + L+ + L LP L L+KL+LS N +
Sbjct: 30 VLDNCKSN-DGKIEGLTAEFVNLEFLSLINVGLISVSNLP-----KLPKLKKLELSENRI 83
Query: 191 SGLIPNDIANLSRLRLLAQRVYVDLTYNNLSGL 223
G + L L L +L+ N L +
Sbjct: 84 FGGLDMLAEKLPNLTHL------NLSGNKLKDI 110
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 40.5 bits (95), Expect = 5e-04
Identities = 19/66 (28%), Positives = 30/66 (45%), Gaps = 1/66 (1%)
Query: 75 ADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQ-IGKLKYLQV 133
++L L + ++ L N G L + NL L LSGN ++ + KL+ L+
Sbjct: 65 SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKS 124
Query: 134 LDLSQN 139
LDL
Sbjct: 125 LDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 40.5 bits (95), Expect = 5e-04
Identities = 16/77 (20%), Positives = 30/77 (38%), Gaps = 8/77 (10%)
Query: 155 LKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSGLIPNDIANLSRLRLLAQRVYVD 214
++ +VL+ +G L+ L L L ++NL +L L ++
Sbjct: 26 VRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-----SVSNLPKLPKL---KKLE 77
Query: 215 LTYNNLSGLIPQNAALL 231
L+ N + G + A L
Sbjct: 78 LSENRIFGGLDMLAEKL 94
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 43.0 bits (101), Expect = 3e-04
Identities = 21/161 (13%), Positives = 52/161 (32%), Gaps = 18/161 (11%)
Query: 79 SLSAIGRVNLRNNNFSGSLPVELF-NASNLQSLILSG--------------NSFSGPVPM 123
+ R + N P + ++S+ L G + P
Sbjct: 39 EIERWCRRKVFIGNCYAVSPATVIRRFPKVRSVELKGKPHFADFNLVPDGWGGYVYPWIE 98
Query: 124 QIGK-LKYLQVLDLSQNSFSSSIPSSIVQ-CKRLKTVVLNQ-NSFTGPLPDGFATNLTAL 180
+ +L+ + L + + I + K K +VL+ F+ A L
Sbjct: 99 AMSSSYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNL 158
Query: 181 QKLDLSFNNLSGLIPNDIANLSRLRLLAQRVYVDLTYNNLS 221
++LDL +++ + + +++ + + + +S
Sbjct: 159 KELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLASEVS 199
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 42.2 bits (98), Expect = 4e-04
Identities = 27/195 (13%), Positives = 67/195 (34%), Gaps = 31/195 (15%)
Query: 23 LLSFKQAIRNFPEGNNWNNSNEDPC-SWNGITCREGQVFSLIIPNKKLT--GFIPADLGS 79
++ K+ +F + E+ SW + + ++ L + S
Sbjct: 131 IVENKEKFAHFEGLFWGDIDFEEQEISW----IEQVDLSPVLDAMPLLNNLKIKGTNNLS 186
Query: 80 LSAIGRVNLR-----NNNFSGSLPVELFNA--SNLQSLILSGNS--FSGPVPMQI----- 125
+ R NL+ + S+ ++ + NL+ L+L + M +
Sbjct: 187 IGKKPRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLF 246
Query: 126 --GKLKYLQVLDLSQNSFSSSIPSSIVQC---KRLKTVVLNQNSFTG----PLPDGFATN 176
+ L+ L + + + ++ +L+T+ ++ T L D
Sbjct: 247 SKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVD-K 305
Query: 177 LTALQKLDLSFNNLS 191
+ L+ +++ +N LS
Sbjct: 306 IKHLKFINMKYNYLS 320
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 5e-04
Identities = 62/278 (22%), Positives = 106/278 (38%), Gaps = 72/278 (25%)
Query: 374 LLGKSTIGIVYKVA-LNNEEAVAVRRLGNGGWQRF-KEFQTEAEAIGKIRHP------NI 425
L+GK + G V K +E VA++ + N + F + Q E + + I
Sbjct: 61 LIGKGSFGQVVKAYDRVEQEWVAIKIIKNK--KAFLNQAQIEVRLLELMNKHDTEMKYYI 118
Query: 426 VSLRAYFWS------VDEKLLI--YDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKG 477
V L+ +F V E L YD + N ++R +S + + +
Sbjct: 119 VHLKRHFMFRNHLCLVFEMLSYNLYDLLRN-------------TNFRGVSLNLTRKFAQQ 165
Query: 478 VAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHIS--DFGLARLADIAEETPEVHWEQ 535
+ + FL +H DL+P NILL I DFG + + +
Sbjct: 166 MCTALLFLAT-PELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG------QRIY-- 216
Query: 536 STTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPM 595
+Q SR +Y++PE D++S G IL+EM +G+ P+
Sbjct: 217 ----QYIQ-------------SR-FYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE-PL 257
Query: 596 IQIGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDK 633
G+ E++ Q+ + ++L AH LD+
Sbjct: 258 FS-GANEVD-----QMNK-----IVEVLGIPPAHILDQ 284
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 5e-04
Identities = 21/107 (19%), Positives = 44/107 (41%), Gaps = 9/107 (8%)
Query: 108 QSLILSGNSFSGPVPMQI-GKLKYLQVLDLSQNSFSSSIPSSIV-QCKRLKTVVLNQNSF 165
L+L+ N + G+L +L L+L +N + I + ++ + L +N
Sbjct: 32 TELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTG-IEPNAFEGASHIQELQLGENKI 90
Query: 166 TGPLPDGFATNLTALQKLDLSFNNLSGLIP----NDIANLSRLRLLA 208
+ + L L+ L+L N +S + + +L+ L L +
Sbjct: 91 KE-ISNKMFLGLHQLKTLNLYDNQISC-VMPGSFEHLNSLTSLNLAS 135
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 40.4 bits (95), Expect = 7e-04
Identities = 23/82 (28%), Positives = 31/82 (37%), Gaps = 10/82 (12%)
Query: 143 SSIPSSI-VQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSGLIPNDIANL 201
IP I + L LN N DG L L KL+L N L+G+ PN
Sbjct: 21 KEIPRDIPLHTTELL---LNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGA 77
Query: 202 SRLRLLAQRVYVDLTYNNLSGL 223
S ++ L L N + +
Sbjct: 78 SHIQEL------QLGENKIKEI 93
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 Length = 185 | Back alignment and structure |
|---|
Score = 40.0 bits (94), Expect = 8e-04
Identities = 22/144 (15%), Positives = 43/144 (29%), Gaps = 23/144 (15%)
Query: 86 VNLRN-NNFSGSLPVELFNA----SNLQSLILSGNSFSGPVPMQIGKL----KYLQVLDL 136
VNL N N A + ++ + G + PV + ++ L+ L++
Sbjct: 41 VNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNV 100
Query: 137 SQNSFSS----SIPSSIVQCKRLKTVVL--NQNSFTGP----LPDGFATNLTALQKLDLS 186
N S ++ ++ L + + + + N T L K
Sbjct: 101 ESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKN-TTLLKFGYH 159
Query: 187 FNNLSGLIPNDIA---NLSRLRLL 207
F + A N +R
Sbjct: 160 FTQQGPRLRASNAMMNNNDLVRKR 183
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 686 | |||
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.96 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.95 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 99.94 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 99.94 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 99.94 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.94 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.93 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.92 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.9 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.89 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.88 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.88 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.88 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.87 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.86 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.86 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.86 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.85 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.85 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.85 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.85 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.85 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.83 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.83 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.83 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.83 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.83 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.82 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.82 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 99.82 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.82 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 99.82 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.82 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.82 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 99.81 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 99.81 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.81 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.81 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.81 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.81 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 99.81 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.8 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.8 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.8 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.8 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 99.8 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.8 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.8 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.8 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.8 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 99.79 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.79 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 99.79 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.79 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 99.79 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.79 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.79 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.78 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.78 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 99.78 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.78 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.77 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.77 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.77 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.77 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.77 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.77 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.76 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.76 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.76 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.76 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.75 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 99.75 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.75 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.75 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.75 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.74 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.74 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.74 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.73 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.72 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.72 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 99.71 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 99.71 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.71 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.7 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.7 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.7 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.7 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.69 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.69 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.69 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.69 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.68 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.67 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.67 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.67 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.67 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.67 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.67 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 99.66 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.66 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.66 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.66 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.65 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.65 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.64 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.64 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.64 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.64 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.64 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 99.63 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.63 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.62 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.61 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.61 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.61 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.59 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.58 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.58 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.57 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.57 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.57 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.56 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.56 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.56 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.56 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.55 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.55 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.53 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.52 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.51 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.5 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.5 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.49 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.49 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.45 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.39 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.34 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.34 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.27 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.18 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.16 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.16 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.05 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.05 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 98.99 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.99 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 98.95 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 98.91 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.88 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 98.73 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 98.71 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 98.64 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.63 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.63 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.55 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 98.53 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.51 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.48 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.46 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.41 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.36 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.35 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.34 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.27 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.02 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.99 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.83 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.7 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.63 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.48 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 97.39 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.35 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.32 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.3 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.29 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.22 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.22 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.16 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 97.16 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 97.06 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 97.04 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.03 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 97.0 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.97 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 96.94 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.91 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.85 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 96.84 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.78 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 96.54 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 96.44 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 96.27 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.21 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 93.5 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 86.09 | |
| 2k1k_A | 38 | Ephrin type-A receptor 1; EPHA1, receptor tyrosine | 81.83 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 81.65 |
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-54 Score=449.53 Aligned_cols=257 Identities=26% Similarity=0.414 Sum_probs=204.6
Q ss_pred cccCccCceEEEEEEeC------CCceEEEEEcCCCCccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccC
Q 042348 373 FLLGKSTIGIVYKVALN------NEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIP 446 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~ 446 (686)
+.||+|+||.||+|++. +++.||||+++.......++|.+|+++|++++|||||+++|+|.+.+..++|||||+
T Consensus 47 ~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~~ 126 (329)
T 4aoj_A 47 WELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMR 126 (329)
T ss_dssp EEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred EEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCC
Confidence 46999999999999864 367899999988776677889999999999999999999999999999999999999
Q ss_pred CCCHHHHhhcCCCc---------cccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecC
Q 042348 447 NGSLATAIHGKAGI---------ISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFG 517 (686)
Q Consensus 447 ~gsL~~~l~~~~~~---------~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfG 517 (686)
+|+|.++++..... ....+++|.++++|+.|||.||+|||+ ++||||||||+|||+++++.+||+|||
T Consensus 127 ~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDLKp~NILl~~~~~~Ki~DFG 203 (329)
T 4aoj_A 127 HGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAG---LHFVHRDLATRNCLVGQGLVVKIGDFG 203 (329)
T ss_dssp TCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTTEEEECCCC
T ss_pred CCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHhhEEECCCCcEEEcccc
Confidence 99999999865321 112469999999999999999999999 899999999999999999999999999
Q ss_pred cccccccccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCcc
Q 042348 518 LARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMI 596 (686)
Q Consensus 518 la~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~ 596 (686)
+|+........ .......||+.|||||++.+..|+.++|||||||++|||+| |+.||.
T Consensus 204 la~~~~~~~~~---------------------~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~ 262 (329)
T 4aoj_A 204 MSRDIYSTDYY---------------------RVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWY 262 (329)
T ss_dssp -------------------------------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTC
T ss_pred cceeccCCCcc---------------------eecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCC
Confidence 99865432210 11234568889999999999999999999999999999999 899996
Q ss_pred ccCccchhHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccc
Q 042348 597 QIGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRVNI 670 (686)
Q Consensus 597 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~ 670 (686)
.... .+.+..+..+... . .| ..+..++.+++.+||+.||++||||+||+++|+.+..
T Consensus 263 ~~~~-----~~~~~~i~~g~~~-~---~p--------~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~ 319 (329)
T 4aoj_A 263 QLSN-----TEAIDCITQGREL-E---RP--------RACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQ 319 (329)
T ss_dssp SSCH-----HHHHHHHHHTCCC-C---CC--------TTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CCCH-----HHHHHHHHcCCCC-C---Cc--------ccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhh
Confidence 5432 2223333333211 1 00 1123468899999999999999999999999998764
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-55 Score=446.64 Aligned_cols=257 Identities=26% Similarity=0.398 Sum_probs=208.6
Q ss_pred cccCccCceEEEEEEeC------CCceEEEEEcCCCCccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccC
Q 042348 373 FLLGKSTIGIVYKVALN------NEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIP 446 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~ 446 (686)
+.||+|+||.||+|++. ++..||||+++.......++|.+|+++|++++|||||+++|+|.+.+..++|||||+
T Consensus 19 ~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~~ 98 (299)
T 4asz_A 19 RELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMK 98 (299)
T ss_dssp EEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred eEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEcCC
Confidence 46999999999999864 367899999988766667889999999999999999999999999999999999999
Q ss_pred CCCHHHHhhcCCC-------ccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcc
Q 042348 447 NGSLATAIHGKAG-------IISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLA 519 (686)
Q Consensus 447 ~gsL~~~l~~~~~-------~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla 519 (686)
+|||.++|+.... ......++|.++++|+.|||.||+|||+ ++||||||||+|||+++++.+||+|||+|
T Consensus 99 ~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDlKp~NILl~~~~~~Ki~DFGla 175 (299)
T 4asz_A 99 HGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLLVKIGDFGMS 175 (299)
T ss_dssp TCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCSCH
T ss_pred CCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCccCHhhEEECCCCcEEECCcccc
Confidence 9999999986431 1112469999999999999999999999 89999999999999999999999999999
Q ss_pred cccccccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCcccc
Q 042348 520 RLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQI 598 (686)
Q Consensus 520 ~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~ 598 (686)
+........ .......||+.|||||++.+..|+.++|||||||++|||+| |+.||...
T Consensus 176 ~~~~~~~~~---------------------~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~ 234 (299)
T 4asz_A 176 RDVYSTDYY---------------------RVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQL 234 (299)
T ss_dssp HHHTGGGCE---------------------EETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred eecCCCCce---------------------eecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Confidence 865432210 11123457889999999999999999999999999999999 89999654
Q ss_pred CccchhHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccc
Q 042348 599 GSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRVNI 670 (686)
Q Consensus 599 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~ 670 (686)
.. .+.+..+..+..+. . | ..+..++.+++.+||+.||++|||++||++.|+++..
T Consensus 235 ~~-----~~~~~~i~~~~~~~--~--p--------~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~ 289 (299)
T 4asz_A 235 SN-----NEVIECITQGRVLQ--R--P--------RTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAK 289 (299)
T ss_dssp CH-----HHHHHHHHHTCCCC--C--C--------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CH-----HHHHHHHHcCCCCC--C--C--------ccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 32 22333443332210 0 0 1123468899999999999999999999999998753
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-54 Score=442.27 Aligned_cols=256 Identities=26% Similarity=0.374 Sum_probs=207.0
Q ss_pred cccCccCceEEEEEEeC------CCceEEEEEcCCCC-ccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEecc
Q 042348 373 FLLGKSTIGIVYKVALN------NEEAVAVRRLGNGG-WQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYI 445 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~ 445 (686)
+.||+|+||.||+|.+. +++.||||+++... ....++|.+|+.++++++|||||+++|+|.+.+..++|||||
T Consensus 32 ~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~lV~Ey~ 111 (308)
T 4gt4_A 32 EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYC 111 (308)
T ss_dssp EEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred eEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEEEEEcC
Confidence 35999999999999863 46789999997643 334578999999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcCCCc----------cccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEee
Q 042348 446 PNGSLATAIHGKAGI----------ISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISD 515 (686)
Q Consensus 446 ~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~D 515 (686)
++|||.++|+..... .....++|.++++|+.|||.||+|||+ ++||||||||+|||+++++.+||+|
T Consensus 112 ~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDLK~~NILl~~~~~~Ki~D 188 (308)
T 4gt4_A 112 SHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSS---HHVVHKDLATRNVLVYDKLNVKISD 188 (308)
T ss_dssp SSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECC
T ss_pred CCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCCCCCCccccceEECCCCCEEECC
Confidence 999999999764321 112469999999999999999999999 8999999999999999999999999
Q ss_pred cCcccccccccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCC
Q 042348 516 FGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLP 594 (686)
Q Consensus 516 fGla~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P 594 (686)
||+|+........ .......||+.|||||++.+..|+.++|||||||++|||+| |+.|
T Consensus 189 FGlar~~~~~~~~---------------------~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~P 247 (308)
T 4gt4_A 189 LGLFREVYAADYY---------------------KLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 247 (308)
T ss_dssp SCCBCGGGGGGCB---------------------CSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred cccceeccCCCce---------------------eEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCC
Confidence 9999866433210 11234568889999999999999999999999999999999 8999
Q ss_pred ccccCccchhHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 042348 595 MIQIGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRVN 669 (686)
Q Consensus 595 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~ 669 (686)
|..... .+.+..+..+... .. +.+++..+.+++.+||+.||++||||.||+++|+.+.
T Consensus 248 f~~~~~-----~~~~~~i~~~~~~--~~----------p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~ 305 (308)
T 4gt4_A 248 YCGYSN-----QDVVEMIRNRQVL--PC----------PDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWG 305 (308)
T ss_dssp TTTCCH-----HHHHHHHHTTCCC--CC----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred CCCCCH-----HHHHHHHHcCCCC--CC----------cccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhcc
Confidence 965432 2223333333211 10 1123446889999999999999999999999998764
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-54 Score=438.50 Aligned_cols=254 Identities=25% Similarity=0.444 Sum_probs=198.9
Q ss_pred cccCccCceEEEEEEeCCCceEEEEEcCCC--CccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCCH
Q 042348 373 FLLGKSTIGIVYKVALNNEEAVAVRRLGNG--GWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSL 450 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL 450 (686)
+.||+|+||+||+|++.+ .||||+++.. .....++|.+|+++|++++|||||+++|++. .+..++|||||++|+|
T Consensus 42 ~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~-~~~~~iVmEy~~gGsL 118 (307)
T 3omv_A 42 TRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMT-KDNLAIVTQWCEGSSL 118 (307)
T ss_dssp EECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEECCSSCBH
T ss_pred eEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-CCeEEEEEEcCCCCCH
Confidence 469999999999998764 5999998653 3344578999999999999999999999885 4678999999999999
Q ss_pred HHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCcc
Q 042348 451 ATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPE 530 (686)
Q Consensus 451 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 530 (686)
.++|+... ..++|.++..|+.|||.||+|||+ ++||||||||+|||+++++.+||+|||+|+........
T Consensus 119 ~~~l~~~~-----~~l~~~~~~~i~~qia~gL~yLH~---~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~-- 188 (307)
T 3omv_A 119 YKHLHVQE-----TKFQMFQLIDIARQTAQGMDYLHA---KNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGS-- 188 (307)
T ss_dssp HHHHHTSC-----CCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCCSSSEEEETTEEEEECCCSSCBC---------
T ss_pred HHHHhhcC-----CCCCHHHHHHHHHHHHHHHHHHHH---CCccCCccCHHHEEECCCCcEEEeeccCceecccCCcc--
Confidence 99998654 469999999999999999999999 89999999999999999999999999999865432210
Q ss_pred ccccccccCCCCCCCccccccccCCCCCccccCcccccC---CCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHH
Q 042348 531 VHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKV---RKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQ 607 (686)
Q Consensus 531 ~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~ 607 (686)
......+||+.|||||++.+ ..|+.++|||||||++|||+||+.||.......
T Consensus 189 -------------------~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~----- 244 (307)
T 3omv_A 189 -------------------QQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRD----- 244 (307)
T ss_dssp ------------------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH-----
T ss_pred -------------------eeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHH-----
Confidence 12234578999999999854 468999999999999999999999996543221
Q ss_pred HHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccc
Q 042348 608 WIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRVNI 670 (686)
Q Consensus 608 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~ 670 (686)
.+..........+.. .. ....+...+.+++.+||+.||++||||.||+++|+.++.
T Consensus 245 ~~~~~~~~~~~~p~~-----~~--~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~ 300 (307)
T 3omv_A 245 QIIFMVGRGYASPDL-----SK--LYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQH 300 (307)
T ss_dssp HHHHHHHTTCCCCCS-----TT--SCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHT
T ss_pred HHHHHHhcCCCCCCc-----cc--ccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 122222222111111 00 011234568899999999999999999999999988763
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-53 Score=435.86 Aligned_cols=243 Identities=19% Similarity=0.324 Sum_probs=203.3
Q ss_pred ccCccCceEEEEEEeC-CCceEEEEEcCCCCccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCCHHH
Q 042348 374 LLGKSTIGIVYKVALN-NEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLAT 452 (686)
Q Consensus 374 ~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL~~ 452 (686)
.||+|+||.||+|... +|+.||||++........+.+.+|+++|++++|||||+++++|.+.+..|+|||||++|+|.+
T Consensus 81 ~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~ 160 (346)
T 4fih_A 81 KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTD 160 (346)
T ss_dssp EEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCCTTEEHHH
T ss_pred EeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHH
Confidence 5999999999999975 689999999976655566789999999999999999999999999999999999999999999
Q ss_pred HhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCcccc
Q 042348 453 AIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVH 532 (686)
Q Consensus 453 ~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 532 (686)
++.. ..+++.++..|+.||+.||+|||+ ++||||||||+|||++.++.+||+|||+|+.+....
T Consensus 161 ~l~~-------~~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~------ 224 (346)
T 4fih_A 161 IVTH-------TRMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV------ 224 (346)
T ss_dssp HHHH-------SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS------
T ss_pred HHHc-------CCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEECCCCCEEEecCcCceecCCCC------
Confidence 9975 348999999999999999999999 999999999999999999999999999998664321
Q ss_pred ccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHHHHHH
Q 042348 533 WEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQWIQLI 612 (686)
Q Consensus 533 ~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~ 612 (686)
......+||+.|||||++.+..|+.++|||||||++|||++|+.||..... .+.+..+
T Consensus 225 -----------------~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~-----~~~~~~i 282 (346)
T 4fih_A 225 -----------------PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP-----LKAMKMI 282 (346)
T ss_dssp -----------------CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-----HHHHHHH
T ss_pred -----------------CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH-----HHHHHHH
Confidence 122356789999999999999999999999999999999999999954322 2223333
Q ss_pred HhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 613 LEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 613 ~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
.....+.... ......++.+++.+||+.||++|||+.|++++
T Consensus 283 ~~~~~~~~~~----------~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~H 324 (346)
T 4fih_A 283 RDNLPPRLKN----------LHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 324 (346)
T ss_dssp HHSSCCCCSC----------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred HcCCCCCCCc----------cccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 3332111110 01123467899999999999999999999876
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-53 Score=435.71 Aligned_cols=245 Identities=20% Similarity=0.353 Sum_probs=197.9
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCC--CccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCC
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNG--GWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGS 449 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gs 449 (686)
+.||+|+||.||+|+.. +++.||||++... .....+++.+|+++|++++|||||++++++.+.+..|+|||||++|+
T Consensus 30 ~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmEy~~gg~ 109 (350)
T 4b9d_A 30 QKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGD 109 (350)
T ss_dssp EEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCB
T ss_pred EEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEeCCCCCc
Confidence 36999999999999875 6899999998654 33345779999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCc
Q 042348 450 LATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETP 529 (686)
Q Consensus 450 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 529 (686)
|.++|....+ ..+++.+++.|+.||+.||+|||+ ++||||||||+|||+++++.+||+|||+|+.+....
T Consensus 110 L~~~i~~~~~----~~~~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~--- 179 (350)
T 4b9d_A 110 LFKRINAQKG----VLFQEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV--- 179 (350)
T ss_dssp HHHHHHHTTT----CCCCHHHHHHHHHHHHHHHHHHHH---TTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHH---
T ss_pred HHHHHHHcCC----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCCEEEcccccceeecCCc---
Confidence 9999976543 457899999999999999999999 999999999999999999999999999998664321
Q ss_pred cccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHHH
Q 042348 530 EVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQWI 609 (686)
Q Consensus 530 ~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~ 609 (686)
......+||+.|||||++.+..|+.++|||||||++|||+||+.||.... ..+.+
T Consensus 180 --------------------~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~-----~~~~~ 234 (350)
T 4b9d_A 180 --------------------ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGS-----MKNLV 234 (350)
T ss_dssp --------------------HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS-----HHHHH
T ss_pred --------------------ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC-----HHHHH
Confidence 11234568889999999999999999999999999999999999995432 23344
Q ss_pred HHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 610 QLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 610 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
..+..+..+. ... ....++.+++.+||++||++|||+.|++++
T Consensus 235 ~~i~~~~~~~---~~~---------~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 277 (350)
T 4b9d_A 235 LKIISGSFPP---VSL---------HYSYDLRSLVSQLFKRNPRDRPSVNSILEK 277 (350)
T ss_dssp HHHHHTCCCC---CCT---------TSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHcCCCCC---CCc---------cCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 4555443221 011 112357799999999999999999999875
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-52 Score=428.77 Aligned_cols=250 Identities=21% Similarity=0.245 Sum_probs=201.3
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCCccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCCHH
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLA 451 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL~ 451 (686)
..||+|+||.||+|+.. +|+.||||+++.... ..+|+.++++++|||||++++++.+.+..|+|||||++|+|.
T Consensus 64 ~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~ 138 (336)
T 4g3f_A 64 PRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLG 138 (336)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTTCBHH
T ss_pred cEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcHH
Confidence 35999999999999975 589999999965422 257999999999999999999999999999999999999999
Q ss_pred HHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCC-CeEEeecCcccccccccCCcc
Q 042348 452 TAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNM-EPHISDFGLARLADIAEETPE 530 (686)
Q Consensus 452 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~-~~kl~DfGla~~~~~~~~~~~ 530 (686)
++++.. ..+++.++..|+.||+.||+|||+ ++||||||||+|||++.++ ++||+|||+|+.+........
T Consensus 139 ~~l~~~------~~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~ 209 (336)
T 4g3f_A 139 QLIKQM------GCLPEDRALYYLGQALEGLEYLHT---RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKS 209 (336)
T ss_dssp HHHHHH------SSCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCCGGGEEECTTSCCEEECCCTTCEEC--------
T ss_pred HHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccc
Confidence 999865 469999999999999999999999 9999999999999999987 699999999997654321100
Q ss_pred ccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHHHH
Q 042348 531 VHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQWIQ 610 (686)
Q Consensus 531 ~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~ 610 (686)
.......+||+.|||||++.+..|+.++|||||||++|||+||+.||........ ..
T Consensus 210 ------------------~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~-----~~ 266 (336)
T 4g3f_A 210 ------------------LLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPL-----CL 266 (336)
T ss_dssp ----------------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCC-----HH
T ss_pred ------------------eecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH-----HH
Confidence 0112345789999999999999999999999999999999999999965443332 23
Q ss_pred HHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 042348 611 LILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRVN 669 (686)
Q Consensus 611 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~ 669 (686)
.+.....+..++ .+ .....+.+++.+||++||++|||+.|++++|....
T Consensus 267 ~i~~~~~~~~~~-~~---------~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l 315 (336)
T 4g3f_A 267 KIASEPPPIREI-PP---------SCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKAL 315 (336)
T ss_dssp HHHHSCCGGGGS-CT---------TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHcCCCCchhc-Cc---------cCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHH
Confidence 333333222211 11 12245778999999999999999999999987754
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-52 Score=429.75 Aligned_cols=264 Identities=23% Similarity=0.252 Sum_probs=198.1
Q ss_pred cccCccCceEEEEEEeCCCceEEEEEcCCCCccchHHHHHHHHHHhccCCCCcceeeEEEEecC----ceeEEEeccCCC
Q 042348 373 FLLGKSTIGIVYKVALNNEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVD----EKLLIYDYIPNG 448 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~----~~~lV~e~~~~g 448 (686)
+.||+|+||+||+|++. |+.||||++...... ...++.|+..+.+++|||||+++++|.+.+ ..++|||||++|
T Consensus 9 ~~iG~G~fG~Vy~~~~~-g~~VAvK~l~~~~~~-~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~~~g 86 (303)
T 3hmm_A 9 ESIGKGRFGEVWRGKWR-GEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHG 86 (303)
T ss_dssp EEEEECSSSEEEEEEET-TEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTC
T ss_pred EEEeeCCCeEEEEEEEC-CEEEEEEEECccchh-hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecCCCCC
Confidence 46999999999999984 789999999754322 123445667778899999999999998764 469999999999
Q ss_pred CHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccC-----CCCceecCCCCCCeeecCCCCeEEeecCcccccc
Q 042348 449 SLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVS-----PKRYVHGDLRPSNILLGKNMEPHISDFGLARLAD 523 (686)
Q Consensus 449 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~-----~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~ 523 (686)
+|.++++.. .++|..+.+|+.|++.||+|||+.. .++||||||||+|||+++++++||+|||+|+...
T Consensus 87 sL~~~l~~~-------~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~ 159 (303)
T 3hmm_A 87 SLFDYLNRY-------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHD 159 (303)
T ss_dssp BHHHHHHHC-------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEE
T ss_pred cHHHHHHhC-------CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCcccc
Confidence 999999753 5899999999999999999999831 1389999999999999999999999999998765
Q ss_pred cccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCC------CCCCcchHHHHHHHHHHHHhCCCCccc
Q 042348 524 IAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVR------KPTQKWDIYSYGVILLEMISGKLPMIQ 597 (686)
Q Consensus 524 ~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~sDVwSlGvvl~elltG~~P~~~ 597 (686)
...... .......+||+.|||||++.+. .++.++|||||||++|||+||+.||..
T Consensus 160 ~~~~~~-------------------~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~ 220 (303)
T 3hmm_A 160 SATDTI-------------------DIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI 220 (303)
T ss_dssp TTTTEE-------------------SCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTB
T ss_pred CCCCce-------------------eeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCc
Confidence 322110 0112345789999999998754 367899999999999999999887633
Q ss_pred cCcc----------chhHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 042348 598 IGSM----------ELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDR 667 (686)
Q Consensus 598 ~~~~----------~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~ 667 (686)
.... ..........+... ..+|.+.......+....+.+++.+||+.||++||||.||++.|++
T Consensus 221 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~------~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~ 294 (303)
T 3hmm_A 221 HEDYQLPYYDLVPSDPSVEEMRKVVCEQ------KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 294 (303)
T ss_dssp CCCCCCTTTTTSCSSCCHHHHHHHHTTS------CCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHH
T ss_pred cccccccchhcccccchHHHHHHHHhcc------cCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHH
Confidence 2211 11122222222211 1222222222233566788999999999999999999999999998
Q ss_pred ccc
Q 042348 668 VNI 670 (686)
Q Consensus 668 i~~ 670 (686)
+..
T Consensus 295 l~~ 297 (303)
T 3hmm_A 295 LSQ 297 (303)
T ss_dssp HHH
T ss_pred HHH
Confidence 864
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-52 Score=423.79 Aligned_cols=242 Identities=19% Similarity=0.274 Sum_probs=203.2
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCC---CccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCC
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNG---GWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNG 448 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~g 448 (686)
+.||+|+||+||+|+.. +++.||||++... .....+.+.+|+++|++++|||||++++++.+.+..|+|||||++|
T Consensus 38 ~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmEy~~gG 117 (311)
T 4aw0_A 38 KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNG 117 (311)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCTTE
T ss_pred EEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCC
Confidence 46999999999999875 6889999999653 2234567999999999999999999999999999999999999999
Q ss_pred CHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCC
Q 042348 449 SLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEET 528 (686)
Q Consensus 449 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 528 (686)
+|.+++... ..+++.++..|+.||+.||+|||+ ++||||||||+|||++.++.+||+|||+|+.+......
T Consensus 118 ~L~~~i~~~------~~l~e~~~~~~~~qi~~al~ylH~---~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~ 188 (311)
T 4aw0_A 118 ELLKYIRKI------GSFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ 188 (311)
T ss_dssp EHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTC
T ss_pred CHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCc
Confidence 999999865 469999999999999999999999 99999999999999999999999999999876432210
Q ss_pred ccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHH
Q 042348 529 PEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQW 608 (686)
Q Consensus 529 ~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~ 608 (686)
......+||+.|||||++.+..|+.++||||+||++|||+||+.||.... ..+.
T Consensus 189 ---------------------~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~-----~~~~ 242 (311)
T 4aw0_A 189 ---------------------ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN-----EGLI 242 (311)
T ss_dssp ---------------------CCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHH
T ss_pred ---------------------ccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC-----HHHH
Confidence 12335678999999999999999999999999999999999999995432 2333
Q ss_pred HHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHH
Q 042348 609 IQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVC 662 (686)
Q Consensus 609 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~ 662 (686)
+..+......+++.+ ..++.+++.+||++||++|||++|+.
T Consensus 243 ~~~i~~~~~~~p~~~-------------s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 243 FAKIIKLEYDFPEKF-------------FPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp HHHHHHTCCCCCTTC-------------CHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred HHHHHcCCCCCCccc-------------CHHHHHHHHHHccCCHhHCcChHHHc
Confidence 455555543332211 12577899999999999999999864
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-51 Score=418.23 Aligned_cols=241 Identities=24% Similarity=0.375 Sum_probs=193.0
Q ss_pred ccCccCceEEEEEEeC-CCceEEEEEcCCC--CccchHHHHHHHHHHhccCCCCcceeeEEEEe----cCceeEEEeccC
Q 042348 374 LLGKSTIGIVYKVALN-NEEAVAVRRLGNG--GWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWS----VDEKLLIYDYIP 446 (686)
Q Consensus 374 ~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~----~~~~~lV~e~~~ 446 (686)
.||+|+||.||+|... ++..||||++... .....++|.+|+++|++++|||||+++++|.+ .+..++|||||+
T Consensus 33 ~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvmEy~~ 112 (290)
T 3fpq_A 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMT 112 (290)
T ss_dssp EEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEEECCC
T ss_pred EEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEEeCCC
Confidence 5999999999999875 5789999998653 33345679999999999999999999999875 345799999999
Q ss_pred CCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCC--ceecCCCCCCeeec-CCCCeEEeecCcccccc
Q 042348 447 NGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKR--YVHGDLRPSNILLG-KNMEPHISDFGLARLAD 523 (686)
Q Consensus 447 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~--iiHrDlkp~NILl~-~~~~~kl~DfGla~~~~ 523 (686)
+|+|.++++.. ..+++..+..|+.||+.||+|||+ ++ ||||||||+|||++ .++.+||+|||+|+...
T Consensus 113 gg~L~~~l~~~------~~l~~~~~~~~~~qi~~aL~ylH~---~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~ 183 (290)
T 3fpq_A 113 SGTLKTYLKRF------KVMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp SCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred CCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCCCEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence 99999999864 469999999999999999999999 66 99999999999998 47999999999997532
Q ss_pred cccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccch
Q 042348 524 IAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMEL 603 (686)
Q Consensus 524 ~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~ 603 (686)
.. .....+||+.|||||++.+ .|+.++|||||||++|||+||+.||.....
T Consensus 184 ~~-------------------------~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~--- 234 (290)
T 3fpq_A 184 AS-------------------------FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN--- 234 (290)
T ss_dssp TT-------------------------SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS---
T ss_pred CC-------------------------ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCc---
Confidence 11 1224578899999998865 699999999999999999999999954322
Q ss_pred hHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 604 NIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 604 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
.......+.....+ ..+++ . ...++.+++.+||+.||++|||++|+++|
T Consensus 235 -~~~~~~~i~~~~~~--~~~~~----~-----~~~~~~~li~~~L~~dP~~R~s~~e~l~H 283 (290)
T 3fpq_A 235 -AAQIYRRVTSGVKP--ASFDK----V-----AIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp -HHHHHHHHTTTCCC--GGGGG----C-----CCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred -HHHHHHHHHcCCCC--CCCCc----c-----CCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 12222232222111 11111 1 12357789999999999999999999864
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-51 Score=436.89 Aligned_cols=244 Identities=20% Similarity=0.332 Sum_probs=203.8
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCCccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCCHH
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLA 451 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL~ 451 (686)
..||+|+||.||+|... +|+.||||++........+.+.+|+.+|++++|||||+++++|.+.+..|+|||||++|+|.
T Consensus 157 ~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~~gG~L~ 236 (423)
T 4fie_A 157 IKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 236 (423)
T ss_dssp EEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHH
T ss_pred eEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCCCCCcHH
Confidence 35999999999999975 58999999997766666678999999999999999999999999999999999999999999
Q ss_pred HHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCccc
Q 042348 452 TAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEV 531 (686)
Q Consensus 452 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 531 (686)
+++... .+++.++..|+.||+.||+|||+ ++||||||||+|||++.++.+||+|||+|+.+....
T Consensus 237 ~~i~~~-------~l~e~~~~~~~~qil~aL~ylH~---~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~----- 301 (423)
T 4fie_A 237 DIVTHT-------RMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV----- 301 (423)
T ss_dssp HHHHHS-------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSC-----
T ss_pred HHHhcc-------CCCHHHHHHHHHHHHHHHHHHHH---CCeecccCCHHHEEEcCCCCEEEecCccceECCCCC-----
Confidence 999743 48999999999999999999999 999999999999999999999999999998664321
Q ss_pred cccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHHHHH
Q 042348 532 HWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQWIQL 611 (686)
Q Consensus 532 ~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~ 611 (686)
......+||+.|||||++.+..|+.++|||||||++|||++|+.||..... .+.+..
T Consensus 302 ------------------~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~-----~~~~~~ 358 (423)
T 4fie_A 302 ------------------PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP-----LKAMKM 358 (423)
T ss_dssp ------------------CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-----HHHHHH
T ss_pred ------------------ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH-----HHHHHH
Confidence 112346789999999999999999999999999999999999999954322 222333
Q ss_pred HHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 612 ILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 612 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
+.....+..... .....++.+++.+||+.||++|||+.|+++|
T Consensus 359 i~~~~~~~~~~~----------~~~s~~~~dli~~~L~~dP~~R~ta~ell~H 401 (423)
T 4fie_A 359 IRDNLPPRLKNL----------HKVSPSLKGFLDRLLVRDPAQRATAAELLKH 401 (423)
T ss_dssp HHHSCCCCCSCT----------TSSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred HHcCCCCCCccc----------ccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 333322111100 0112357789999999999999999999886
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-51 Score=412.76 Aligned_cols=240 Identities=23% Similarity=0.348 Sum_probs=188.8
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCC---ccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCC
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGG---WQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNG 448 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~g 448 (686)
+.||+|+||+||+|... +++.||||++.... ....+.+.+|+++|++++|||||++++++.+.+..++||||| +|
T Consensus 19 ~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~-~g 97 (275)
T 3hyh_A 19 KTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYA-GN 97 (275)
T ss_dssp EEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC-CE
T ss_pred EEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEeCC-CC
Confidence 46999999999999865 68999999986532 233467999999999999999999999999999999999999 68
Q ss_pred CHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCC
Q 042348 449 SLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEET 528 (686)
Q Consensus 449 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 528 (686)
+|.+++... ..+++.++..++.||+.||+|||+ ++|+||||||+|||+++++.+||+|||+|+......
T Consensus 98 ~L~~~l~~~------~~l~e~~~~~~~~qi~~al~ylH~---~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~-- 166 (275)
T 3hyh_A 98 ELFDYIVQR------DKMSEQEARRFFQQIISAVEYCHR---HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN-- 166 (275)
T ss_dssp EHHHHHHHS------CSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCTTTEEECTTCCEEECCSSCC---------
T ss_pred CHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCChHHeEECCCCCEEEeecCCCeecCCCC--
Confidence 999999765 469999999999999999999999 999999999999999999999999999998654221
Q ss_pred ccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCC-CCcchHHHHHHHHHHHHhCCCCccccCccchhHHH
Q 042348 529 PEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKP-TQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQ 607 (686)
Q Consensus 529 ~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~ 607 (686)
.....+||+.|||||++.+..| +.++||||+||++|||+||+.||... +...
T Consensus 167 ----------------------~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~-----~~~~ 219 (275)
T 3hyh_A 167 ----------------------FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDE-----SIPV 219 (275)
T ss_dssp ------------------------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCS-----SHHH
T ss_pred ----------------------ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCC-----CHHH
Confidence 1224578899999999988776 58999999999999999999999543 2233
Q ss_pred HHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 608 WIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 608 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
..+.+.......++.+ ..++.+++.+||+.||++|||++|++++
T Consensus 220 ~~~~i~~~~~~~p~~~-------------s~~~~~li~~~L~~dP~~R~s~~eil~h 263 (275)
T 3hyh_A 220 LFKNISNGVYTLPKFL-------------SPGAAGLIKRMLIVNPLNRISIHEIMQD 263 (275)
T ss_dssp HHHHHHHTCCCCCTTS-------------CHHHHHHHHHHSCSSGGGSCCHHHHHHC
T ss_pred HHHHHHcCCCCCCCCC-------------CHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 4445544443332221 2357789999999999999999999874
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-52 Score=422.72 Aligned_cols=261 Identities=23% Similarity=0.340 Sum_probs=202.2
Q ss_pred cccCccCceEEEEEEeC----CCceEEEEEcCCCC--ccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccC
Q 042348 373 FLLGKSTIGIVYKVALN----NEEAVAVRRLGNGG--WQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIP 446 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~----~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~ 446 (686)
+.||+|+||+||+|+.. +++.||||.++... .....++.+|+++|++++|||||++++++.+.+..|+|||||+
T Consensus 30 ~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy~~ 109 (304)
T 3ubd_A 30 KVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLR 109 (304)
T ss_dssp EEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEEEECCCT
T ss_pred EEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEEcCC
Confidence 46999999999999863 46789999997542 2234568899999999999999999999999999999999999
Q ss_pred CCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCccccccccc
Q 042348 447 NGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAE 526 (686)
Q Consensus 447 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~ 526 (686)
+|+|.+++... ..+++.++..++.||+.||+|||+ ++||||||||+|||+++++.+||+|||+|+......
T Consensus 110 gg~L~~~l~~~------~~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~ 180 (304)
T 3ubd_A 110 GGDLFTRLSKE------VMFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE 180 (304)
T ss_dssp TCEEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECTTSCEEEESSEEEEC-----
T ss_pred CCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHeEEcCCCCEEecccccceeccCCC
Confidence 99999999865 469999999999999999999999 999999999999999999999999999998543221
Q ss_pred CCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHH
Q 042348 527 ETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIV 606 (686)
Q Consensus 527 ~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~ 606 (686)
......+||+.|||||++.+..|+.++||||+||++|||+||+.||.... ..
T Consensus 181 -----------------------~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~-----~~ 232 (304)
T 3ubd_A 181 -----------------------KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKD-----RK 232 (304)
T ss_dssp -----------------------CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS-----HH
T ss_pred -----------------------ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcC-----HH
Confidence 11234678999999999999999999999999999999999999995432 23
Q ss_pred HHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCH-----HHHHHH--Hhcccccchhhhhcc
Q 042348 607 QWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSM-----RHVCDS--LDRVNISTEQQFMKG 679 (686)
Q Consensus 607 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~-----~ev~~~--L~~i~~~~~~~~~~~ 679 (686)
+.+..+.....+.++.+ ..++.+++.+||++||++|||+ +|+++| ++.+ .++.-..+.
T Consensus 233 ~~~~~i~~~~~~~p~~~-------------s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~i--dw~~l~~~~ 297 (304)
T 3ubd_A 233 ETMTMILKAKLGMPQFL-------------SPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTI--DWNKLYRRE 297 (304)
T ss_dssp HHHHHHHHCCCCCCTTS-------------CHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTC--CHHHHHTTC
T ss_pred HHHHHHHcCCCCCCCcC-------------CHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccCC--CHHHHHhCC
Confidence 33445555443332221 2357789999999999999985 566654 3333 233334445
Q ss_pred CCCCCC
Q 042348 680 EEPKFD 685 (686)
Q Consensus 680 ~~~~~~ 685 (686)
-.|+|.
T Consensus 298 ~~pP~~ 303 (304)
T 3ubd_A 298 IHPPFK 303 (304)
T ss_dssp SCCSSC
T ss_pred CCcCcC
Confidence 567763
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-52 Score=432.22 Aligned_cols=259 Identities=26% Similarity=0.352 Sum_probs=204.8
Q ss_pred hcccCccCceEEEEEEeCC------CceEEEEEcCCCCc-cchHHHHHHHHHHhccCC-CCcceeeEEEEec-CceeEEE
Q 042348 372 AFLLGKSTIGIVYKVALNN------EEAVAVRRLGNGGW-QRFKEFQTEAEAIGKIRH-PNIVSLRAYFWSV-DEKLLIY 442 (686)
Q Consensus 372 ~~~iG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H-~nIv~l~~~~~~~-~~~~lV~ 442 (686)
.+.||+|+||.||+|.+.. ++.||||++..... ...++|.+|+++|++++| ||||+++|+|... +..++||
T Consensus 69 ~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~~~~iV~ 148 (353)
T 4ase_A 69 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIV 148 (353)
T ss_dssp EEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEEE
T ss_pred eeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCCEEEEEE
Confidence 3569999999999998643 35799999976533 345679999999999965 9999999999765 5689999
Q ss_pred eccCCCCHHHHhhcCCCc----------cccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeE
Q 042348 443 DYIPNGSLATAIHGKAGI----------ISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPH 512 (686)
Q Consensus 443 e~~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~k 512 (686)
|||++|+|.++|+..... .....++|.++..|+.|||.||+|||+ ++||||||||+|||+++++.+|
T Consensus 149 Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~---~~iiHRDLK~~NILl~~~~~vK 225 (353)
T 4ase_A 149 EFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVK 225 (353)
T ss_dssp ECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEE
T ss_pred EcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhh---CCeecCccCccceeeCCCCCEE
Confidence 999999999999864321 012458999999999999999999999 8999999999999999999999
Q ss_pred EeecCcccccccccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHh-C
Q 042348 513 ISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-G 591 (686)
Q Consensus 513 l~DfGla~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G 591 (686)
|+|||+|+.+..... ........||+.|||||++.+..|+.++|||||||++|||+| |
T Consensus 226 i~DFGlar~~~~~~~---------------------~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G 284 (353)
T 4ase_A 226 ICDFGLARDIYKDPD---------------------YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLG 284 (353)
T ss_dssp ECCCGGGSCTTTCTT---------------------SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTS
T ss_pred ECcchhhhhcccCCC---------------------ceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCC
Confidence 999999986543221 012234567889999999999999999999999999999998 9
Q ss_pred CCCccccCccchhHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccc
Q 042348 592 KLPMIQIGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRVNI 670 (686)
Q Consensus 592 ~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~ 670 (686)
+.||......+ .+...+....... . | ..+..++.+++.+||+.||++|||+.||+++|+++..
T Consensus 285 ~~Pf~~~~~~~-----~~~~~i~~g~~~~-~--p--------~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq 347 (353)
T 4ase_A 285 ASPYPGVKIDE-----EFCRRLKEGTRMR-A--P--------DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 347 (353)
T ss_dssp CCSSTTCCCSH-----HHHHHHHHTCCCC-C--C--------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCCCHHH-----HHHHHHHcCCCCC-C--C--------ccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHH
Confidence 99996543322 1222222221111 0 0 1123467899999999999999999999999998754
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-49 Score=404.44 Aligned_cols=260 Identities=23% Similarity=0.364 Sum_probs=187.1
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCC-ccchHHHHHHHHHHhccCCCCcceeeEEEEecCc------------e
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGG-WQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDE------------K 438 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~------------~ 438 (686)
+.||+|+||+||+|+.. +++.||||+++... ....+++.+|+++|++++|||||++++++.+.+. .
T Consensus 11 ~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~~~~~l 90 (299)
T 4g31_A 11 QCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYL 90 (299)
T ss_dssp EEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC----------CEEE
T ss_pred eEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccCCCcEE
Confidence 46999999999999875 68899999986543 2345679999999999999999999999976543 6
Q ss_pred eEEEeccCCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCc
Q 042348 439 LLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGL 518 (686)
Q Consensus 439 ~lV~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGl 518 (686)
|+|||||++|+|.+++...... ...++..++.|+.||+.||+|||+ ++||||||||+|||++.++.+||+|||+
T Consensus 91 ~ivmE~~~gg~L~~~l~~~~~~---~~~~~~~~~~i~~qi~~al~ylH~---~~IiHRDlKp~NILl~~~~~vKl~DFGl 164 (299)
T 4g31_A 91 YIQMQLCRKENLKDWMNGRCTI---EERERSVCLHIFLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGL 164 (299)
T ss_dssp EEEEECCCSCCHHHHHHTCCSG---GGSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCCC
T ss_pred EEEEecCCCCcHHHHHHhcCCC---ChhHHHHHHHHHHHHHHHHHHHHH---CcCccccCcHHHeEECCCCcEEEccCcc
Confidence 8999999999999999876432 345677789999999999999999 9999999999999999999999999999
Q ss_pred ccccccccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCcccc
Q 042348 519 ARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQI 598 (686)
Q Consensus 519 a~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~ 598 (686)
|+.+.......... ++ .......+..+||+.|||||++.+..|+.++|||||||++|||++ ||...
T Consensus 165 a~~~~~~~~~~~~~-------~~----~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~ 230 (299)
T 4g31_A 165 VTAMDQDEEEQTVL-------TP----MPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQ 230 (299)
T ss_dssp C-------------------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSH
T ss_pred ceecCCCccccccc-------cc----cccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCc
Confidence 99776433211100 00 001122345679999999999999999999999999999999996 77321
Q ss_pred CccchhHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH--Hhcc
Q 042348 599 GSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS--LDRV 668 (686)
Q Consensus 599 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~--L~~i 668 (686)
.+....+..+.... .+.. .........+++.+||+.||++|||+.|++++ ++++
T Consensus 231 ----~~~~~~~~~~~~~~--~p~~----------~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~ 286 (299)
T 4g31_A 231 ----MERVRTLTDVRNLK--FPPL----------FTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDL 286 (299)
T ss_dssp ----HHHHHHHHHHHTTC--CCHH----------HHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC
T ss_pred ----cHHHHHHHHHhcCC--CCCC----------CcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCC
Confidence 11222222222211 1111 11223346689999999999999999999874 4444
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-47 Score=401.25 Aligned_cols=259 Identities=21% Similarity=0.332 Sum_probs=195.4
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCC--ccchHHHHHHHHHHhccCCCCcceeeEEEEec------CceeEEEe
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGG--WQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSV------DEKLLIYD 443 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~------~~~~lV~e 443 (686)
..||+|+||.||+|... +|+.||||+++... ....+.+.+|+++|++++|||||++++++... +..|+|||
T Consensus 60 ~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~~ivmE 139 (398)
T 4b99_A 60 ETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLD 139 (398)
T ss_dssp EEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCEEEEEE
T ss_pred EEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEEEEEEe
Confidence 46999999999999875 68999999997542 23456788999999999999999999998643 56799999
Q ss_pred ccCCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccc
Q 042348 444 YIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLAD 523 (686)
Q Consensus 444 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~ 523 (686)
||+ |+|.+++... ..+++.++..|+.||+.||+|||+ ++||||||||+|||++.++.+||+|||+|+.+.
T Consensus 140 ~~~-g~L~~~i~~~------~~l~~~~~~~~~~qil~al~ylH~---~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~ 209 (398)
T 4b99_A 140 LME-SDLHQIIHSS------QPLTLEHVRYFLYQLLRGLKYMHS---AQVIHRDLKPSNLLVNENCELKIGDFGMARGLC 209 (398)
T ss_dssp CCS-EEHHHHHTSS------SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTCCEEECCCTTCBCC-
T ss_pred CCC-CCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CcCcCCCcCccccccCCCCCEEEeecceeeecc
Confidence 995 7899999765 469999999999999999999999 999999999999999999999999999998664
Q ss_pred cccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCC-CCCCcchHHHHHHHHHHHHhCCCCccccCccc
Q 042348 524 IAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVR-KPTQKWDIYSYGVILLEMISGKLPMIQIGSME 602 (686)
Q Consensus 524 ~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~ 602 (686)
...... .......+||+.|||||++.+. .++.++||||+||++|||++|+.||.... .
T Consensus 210 ~~~~~~-------------------~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~--~ 268 (398)
T 4b99_A 210 TSPAEH-------------------QYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKN--Y 268 (398)
T ss_dssp -------------------------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSS--H
T ss_pred cCcccc-------------------ccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCC--H
Confidence 321100 0123456889999999998775 56999999999999999999999995432 2
Q ss_pred hhHHHHHHHHHhhcCCcccccCcc-----------ccc-CCCc-----HHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 603 LNIVQWIQLILEDRKPMTDILDPF-----------LAH-DLDK-----EDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 603 ~~~~~~~~~~~~~~~~~~~~~d~~-----------l~~-~~~~-----~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
.+....+...... +........ +.. .... +....++.+|+.+||+.||++|||+.|+++|
T Consensus 269 ~~~l~~I~~~~g~--p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 345 (398)
T 4b99_A 269 VHQLQLIMMVLGT--PSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH 345 (398)
T ss_dssp HHHHHHHHHHHCC--CCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred HHHHHHHHHhcCC--CChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 2222222222111 111100000 000 0000 0112357899999999999999999999886
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=393.86 Aligned_cols=213 Identities=20% Similarity=0.304 Sum_probs=165.0
Q ss_pred cccCccCceEEEEEEeC----CCceEEEEEcCCCCccchHHHHHHHHHHhcc-CCCCcceeeEEEEecCceeEEEeccCC
Q 042348 373 FLLGKSTIGIVYKVALN----NEEAVAVRRLGNGGWQRFKEFQTEAEAIGKI-RHPNIVSLRAYFWSVDEKLLIYDYIPN 447 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~e~~~~ 447 (686)
+.||+|+||+||+|+.+ +++.||||++.... ...++.+|+++|+++ +|||||++++++.+.+..++|||||++
T Consensus 27 ~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvmE~~~g 104 (361)
T 4f9c_A 27 DKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMPYLEH 104 (361)
T ss_dssp EEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEEECCCC
T ss_pred EEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEEeCCCc
Confidence 46999999999999753 46789999986643 345788999999998 699999999999999999999999999
Q ss_pred CCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCC-CCeEEeecCccccccccc
Q 042348 448 GSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKN-MEPHISDFGLARLADIAE 526 (686)
Q Consensus 448 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~-~~~kl~DfGla~~~~~~~ 526 (686)
|+|.+++. .+++.++..++.|++.||+|||+ ++||||||||+|||++.+ +.+||+|||+|+......
T Consensus 105 ~~L~~~~~---------~l~~~~~~~~~~qll~al~ylH~---~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~ 172 (361)
T 4f9c_A 105 ESFLDILN---------SLSFQEVREYMLNLFKALKRIHQ---FGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTK 172 (361)
T ss_dssp CCHHHHHT---------TCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCS
T ss_pred ccHHHHHc---------CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCcc
Confidence 99999983 48999999999999999999999 999999999999999876 799999999998664322
Q ss_pred CCccccccccc----c-CCCCCCCccccccccCCCCCccccCcccccCC-CCCCcchHHHHHHHHHHHHhCCCCccccC
Q 042348 527 ETPEVHWEQST----T-GTPLQSSPYEFTALNSTTSRSYYQAPEASKVR-KPTQKWDIYSYGVILLEMISGKLPMIQIG 599 (686)
Q Consensus 527 ~~~~~~~~~~~----~-g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlGvvl~elltG~~P~~~~~ 599 (686)
........... . ..............+..+||+.|+|||++.+. .|+.++||||+||++|||+||+.||....
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~ 251 (361)
T 4f9c_A 173 IELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKAS 251 (361)
T ss_dssp CGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCS
T ss_pred ccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCC
Confidence 11000000000 0 00000000011223456899999999998775 58999999999999999999999996543
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=408.22 Aligned_cols=243 Identities=21% Similarity=0.251 Sum_probs=195.7
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCCc---cchHHH---HHHHHHHhccCCCCcceeeEEEEecCceeEEEecc
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGGW---QRFKEF---QTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYI 445 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~---~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~ 445 (686)
.+||+|+||.||+|+.. +|+.||||++.+... .....+ ..++.+++.++|||||+++++|.+.+..|+|||||
T Consensus 195 k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~lylVmEy~ 274 (689)
T 3v5w_A 195 RIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLM 274 (689)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred EEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEEEEEecC
Confidence 46999999999999876 589999999864311 112223 34467778889999999999999999999999999
Q ss_pred CCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccc
Q 042348 446 PNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIA 525 (686)
Q Consensus 446 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~ 525 (686)
+||+|.++|... ..+++..+..|+.||+.||+|||+ ++||||||||+|||++.+|++||+|||+|+.+...
T Consensus 275 ~GGdL~~~l~~~------~~l~E~~a~~y~~qIl~aL~yLH~---~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~ 345 (689)
T 3v5w_A 275 NGGDLHYHLSQH------GVFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK 345 (689)
T ss_dssp CSCBHHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred CCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCchHHeEEeCCCCEEecccceeeecCCC
Confidence 999999999865 469999999999999999999999 99999999999999999999999999999865321
Q ss_pred cCCccccccccccCCCCCCCccccccccCCCCCccccCcccccC-CCCCCcchHHHHHHHHHHHHhCCCCccccCccchh
Q 042348 526 EETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKV-RKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELN 604 (686)
Q Consensus 526 ~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~ 604 (686)
.....+||+.|||||++.. ..|+.++||||+||++|||++|+.||......+
T Consensus 346 -------------------------~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~-- 398 (689)
T 3v5w_A 346 -------------------------KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD-- 398 (689)
T ss_dssp -------------------------CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCC--
T ss_pred -------------------------CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH--
Confidence 1234578999999999964 579999999999999999999999996543322
Q ss_pred HHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCC-----HHHHHHH
Q 042348 605 IVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPS-----MRHVCDS 664 (686)
Q Consensus 605 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~ev~~~ 664 (686)
.......+.......+..+ ..++.+++.+||++||++|++ +.||.+|
T Consensus 399 ~~~i~~~i~~~~~~~p~~~-------------S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~H 450 (689)
T 3v5w_A 399 KHEIDRMTLTMAVELPDSF-------------SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 450 (689)
T ss_dssp HHHHHHHHHHCCCCCCTTS-------------CHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTS
T ss_pred HHHHHHhhcCCCCCCCccC-------------CHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcC
Confidence 2233344444433322221 235779999999999999998 6788766
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=410.21 Aligned_cols=246 Identities=22% Similarity=0.344 Sum_probs=204.2
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCCccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCCHH
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLA 451 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL~ 451 (686)
+.||+|+||.||+|... +|+.||+|.+........+.+.+|+++|++++|||||+++++|.+.+..++|||||++|+|.
T Consensus 163 ~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~~gg~L~ 242 (573)
T 3uto_A 163 EELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELF 242 (573)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECCCCCBHH
T ss_pred EEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeecCCCcHH
Confidence 46999999999999875 68999999997766666678999999999999999999999999999999999999999999
Q ss_pred HHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCC--CCeEEeecCcccccccccCCc
Q 042348 452 TAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKN--MEPHISDFGLARLADIAEETP 529 (686)
Q Consensus 452 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~--~~~kl~DfGla~~~~~~~~~~ 529 (686)
+++.... ..+++.++..++.||+.||+|||+ ++|+||||||+|||++.+ +.+||+|||+|+.+....
T Consensus 243 ~~i~~~~-----~~l~e~~~~~~~~qi~~al~ylH~---~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~--- 311 (573)
T 3uto_A 243 EKVADEH-----NKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ--- 311 (573)
T ss_dssp HHHTCTT-----SCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS---
T ss_pred HHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChhhccccCCCCCCEEEeeccceeEccCCC---
Confidence 9997654 358999999999999999999999 999999999999999854 899999999998764321
Q ss_pred cccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHHH
Q 042348 530 EVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQWI 609 (686)
Q Consensus 530 ~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~ 609 (686)
.....+||+.|||||++.+..|+.++||||+||++|||++|+.||..... .+.+
T Consensus 312 ---------------------~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~-----~~~~ 365 (573)
T 3uto_A 312 ---------------------SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND-----DETL 365 (573)
T ss_dssp ---------------------EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH-----HHHH
T ss_pred ---------------------ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH-----HHHH
Confidence 12235688899999999999999999999999999999999999954332 2233
Q ss_pred HHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 610 QLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 610 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
..+........... . .. ...++.+|+.+||+.||++|||+.|+++|
T Consensus 366 ~~i~~~~~~~~~~~---~-~~-----~s~~~~dli~~~L~~dp~~R~t~~e~l~H 411 (573)
T 3uto_A 366 RNVKSCDWNMDDSA---F-SG-----ISEDGKDFIRKLLLADPNTRMTIHQALEH 411 (573)
T ss_dssp HHHHTTCCCCCSGG---G-TT-----SCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred HHHHhCCCCCCccc---c-cC-----CCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 44444332221111 1 11 12357789999999999999999999986
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-44 Score=374.77 Aligned_cols=271 Identities=31% Similarity=0.525 Sum_probs=220.8
Q ss_pred cccCccCceEEEEEEeCCCceEEEEEcCCCCccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCCHHH
Q 042348 373 FLLGKSTIGIVYKVALNNEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLAT 452 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL~~ 452 (686)
..||+|+||.||+|...+++.||||++........+.+.+|++++++++||||+++++++...+..++||||+++|+|.+
T Consensus 45 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 124 (321)
T 2qkw_B 45 FLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKR 124 (321)
T ss_dssp CCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEECCTTCBTGG
T ss_pred ceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcCCCCcHHH
Confidence 46999999999999988899999999987666667889999999999999999999999999999999999999999999
Q ss_pred HhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCcccc
Q 042348 453 AIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVH 532 (686)
Q Consensus 453 ~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 532 (686)
++...... ...+++.++..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++........
T Consensus 125 ~l~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~---- 195 (321)
T 2qkw_B 125 HLYGSDLP--TMSMSWEQRLEICIGAARGLHYLHT---RAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQT---- 195 (321)
T ss_dssp GSSSSCCC--SCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCC----
T ss_pred HHhccCCC--ccccCHHHHHHHHHHHHHHHHHhcC---CCeecCCCCHHHEEECCCCCEEEeeccccccccccccc----
Confidence 99765321 1458999999999999999999999 89999999999999999999999999999754321110
Q ss_pred ccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccc-hhHHHHHHH
Q 042348 533 WEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSME-LNIVQWIQL 611 (686)
Q Consensus 533 ~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~-~~~~~~~~~ 611 (686)
.......||..|+|||++.+..++.++|||||||++|||+||+.||......+ .....|...
T Consensus 196 -----------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~ 258 (321)
T 2qkw_B 196 -----------------HLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVE 258 (321)
T ss_dssp -----------------CCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHH
T ss_pred -----------------ccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhh
Confidence 01123456788999999988889999999999999999999999996544322 234444433
Q ss_pred HHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccccc
Q 042348 612 ILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRVNIS 671 (686)
Q Consensus 612 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~~ 671 (686)
... .......+++.+.... ..+....+.+++.+||+.||++|||+.|++++|+.+...
T Consensus 259 ~~~-~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~ 316 (321)
T 2qkw_B 259 SHN-NGQLEQIVDPNLADKI-RPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL 316 (321)
T ss_dssp HHT-TTCCCSSSSSSCTTCS-CHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred ccc-cccHHHhcChhhcccc-CHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhc
Confidence 322 2334445555443322 356778899999999999999999999999999987543
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=371.60 Aligned_cols=271 Identities=32% Similarity=0.575 Sum_probs=216.2
Q ss_pred cccCccCceEEEEEEeCCCceEEEEEcCCCCc-cchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCCHH
Q 042348 373 FLLGKSTIGIVYKVALNNEEAVAVRRLGNGGW-QRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLA 451 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL~ 451 (686)
..||+|+||.||+|...+++.||||++..... .....+.+|++++++++||||+++++++...+..++||||+++|+|.
T Consensus 36 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 115 (326)
T 3uim_A 36 NILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVA 115 (326)
T ss_dssp TEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSCCEEEEECCTTCBHH
T ss_pred eeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEecCCceEEEEEeccCCCHH
Confidence 47999999999999988899999999976432 22347899999999999999999999999999999999999999999
Q ss_pred HHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCccc
Q 042348 452 TAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEV 531 (686)
Q Consensus 452 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 531 (686)
+++...... ...+++..+..|+.|++.||+|||+.+..+|+||||||+|||++.++.+||+|||+++.......
T Consensus 116 ~~l~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~---- 189 (326)
T 3uim_A 116 SCLRERPES--QPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT---- 189 (326)
T ss_dssp HHHHCCSTT--CCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCEECCSSSS----
T ss_pred HHHHhcccc--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCccccccCcccc----
Confidence 999876432 14599999999999999999999992212999999999999999999999999999986542221
Q ss_pred cccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCcccc---CccchhHHHH
Q 042348 532 HWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQI---GSMELNIVQW 608 (686)
Q Consensus 532 ~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~---~~~~~~~~~~ 608 (686)
.......||..|+|||++.+..++.++|||||||++|||+||+.||... .........|
T Consensus 190 ------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 251 (326)
T 3uim_A 190 ------------------HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDW 251 (326)
T ss_dssp ------------------CEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHH
T ss_pred ------------------cccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHH
Confidence 1122345788999999998888999999999999999999999999421 1223334444
Q ss_pred HHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 042348 609 IQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRVN 669 (686)
Q Consensus 609 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~ 669 (686)
+...... .......+..+.... .......+.+++.+||+.||++|||+.||+++|+...
T Consensus 252 ~~~~~~~-~~~~~~~~~~~~~~~-~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~ 310 (326)
T 3uim_A 252 VKGLLKE-KKLEALVDVDLQGNY-KDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDG 310 (326)
T ss_dssp HTTTTSS-CCSTTSSCTTCTTSC-CHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSS
T ss_pred HHHHhhc-hhhhhhcChhhcccc-CHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcc
Confidence 4333322 233444444443332 3567788999999999999999999999999998754
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=366.32 Aligned_cols=267 Identities=24% Similarity=0.382 Sum_probs=207.7
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCCccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCCHH
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLA 451 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL~ 451 (686)
+.||+|+||.||+|... +++.||+|++........+.+.+|++++++++||||+++++++.+.+..++||||+++|+|.
T Consensus 16 ~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 95 (310)
T 3s95_A 16 EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLR 95 (310)
T ss_dssp EEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCTTCBHH
T ss_pred ceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEecCCCcHH
Confidence 46999999999999975 58899999987766666788999999999999999999999999999999999999999999
Q ss_pred HHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCccc
Q 042348 452 TAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEV 531 (686)
Q Consensus 452 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 531 (686)
+++.... ..+++.++..|+.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++...........
T Consensus 96 ~~l~~~~-----~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 167 (310)
T 3s95_A 96 GIIKSMD-----SQYPWSQRVSFAKDIASGMAYLHS---MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEG 167 (310)
T ss_dssp HHHHHCC-----TTSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEECTTSCEEECCCTTCEECC--------
T ss_pred HHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCcCeEEECCCCCEEEeecccceecccccccccc
Confidence 9998754 468999999999999999999999 89999999999999999999999999999876533221100
Q ss_pred cccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHHHHH
Q 042348 532 HWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQWIQL 611 (686)
Q Consensus 532 ~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~ 611 (686)
.. .. ............||..|+|||++.+..++.++|||||||++|||++|..||................
T Consensus 168 ~~---~~------~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~ 238 (310)
T 3s95_A 168 LR---SL------KKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRG 238 (310)
T ss_dssp ---------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHH
T ss_pred cc---cc------cccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhc
Confidence 00 00 0000011224578999999999999999999999999999999999999985543322211111111
Q ss_pred HHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccccc
Q 042348 612 ILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRVNIS 671 (686)
Q Consensus 612 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~~ 671 (686)
...... +. .....+.+++.+||+.||++|||+.|+++.|+.++..
T Consensus 239 ~~~~~~--~~-------------~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~ 283 (310)
T 3s95_A 239 FLDRYC--PP-------------NCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMH 283 (310)
T ss_dssp HHHHTC--CT-------------TCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cccccC--CC-------------CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 111110 00 1112477899999999999999999999999988643
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-43 Score=365.25 Aligned_cols=241 Identities=21% Similarity=0.327 Sum_probs=200.4
Q ss_pred cccCccCceEEEEEEe-CCCceEEEEEcCCC--CccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCC
Q 042348 373 FLLGKSTIGIVYKVAL-NNEEAVAVRRLGNG--GWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGS 449 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gs 449 (686)
..||+|+||.||+|.. .+++.||||++... .....+.+.+|++++++++||||+++++++...+..++||||+++|+
T Consensus 21 ~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~~~ 100 (328)
T 3fe3_A 21 KTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGE 100 (328)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTCB
T ss_pred EEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEECCCCCc
Confidence 4699999999999997 57899999998654 23345678899999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCc
Q 042348 450 LATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETP 529 (686)
Q Consensus 450 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 529 (686)
|.+++... ..+++.++..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 101 L~~~l~~~------~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~--- 168 (328)
T 3fe3_A 101 VFDYLVAH------GRMKEKEARSKFRQIVSAVQYCHQ---KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG--- 168 (328)
T ss_dssp HHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC---
T ss_pred HHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCC---
Confidence 99999765 358999999999999999999999 899999999999999999999999999997553221
Q ss_pred cccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCC-CcchHHHHHHHHHHHHhCCCCccccCccchhHHHH
Q 042348 530 EVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPT-QKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQW 608 (686)
Q Consensus 530 ~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~ 608 (686)
......||+.|+|||++.+..++ .++|||||||++|||++|+.||.... ....
T Consensus 169 ---------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~-----~~~~ 222 (328)
T 3fe3_A 169 ---------------------KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN-----LKEL 222 (328)
T ss_dssp ---------------------GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHH
T ss_pred ---------------------ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCC-----HHHH
Confidence 12345678899999999887765 79999999999999999999995432 2333
Q ss_pred HHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 609 IQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 609 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
...+..+....+.. ....+.+++.+||+.||++|||+.|++++
T Consensus 223 ~~~i~~~~~~~p~~-------------~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 223 RERVLRGKYRIPFY-------------MSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp HHHHHHCCCCCCTT-------------SCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred HHHHHhCCCCCCCC-------------CCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 44444443332221 12357789999999999999999999876
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=362.82 Aligned_cols=243 Identities=22% Similarity=0.321 Sum_probs=200.3
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCC---CccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCC
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNG---GWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNG 448 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~g 448 (686)
..||+|+||.||+|+.. +++.||+|.+... .......+.+|++++++++||||+++++++.+.+..++||||+++|
T Consensus 11 ~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~E~~~gg 90 (337)
T 1o6l_A 11 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 90 (337)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECCTTC
T ss_pred EEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEEeCCCCC
Confidence 46999999999999876 5889999998653 2234567889999999999999999999999999999999999999
Q ss_pred CHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCC
Q 042348 449 SLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEET 528 (686)
Q Consensus 449 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 528 (686)
+|.+++... ..+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 91 ~L~~~l~~~------~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~-- 159 (337)
T 1o6l_A 91 ELFFHLSRE------RVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-- 159 (337)
T ss_dssp BHHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT--
T ss_pred cHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCcCCHHHEEECCCCCEEEeeccchhhcccCC--
Confidence 999999754 358999999999999999999999 899999999999999999999999999997532111
Q ss_pred ccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHH
Q 042348 529 PEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQW 608 (686)
Q Consensus 529 ~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~ 608 (686)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ...
T Consensus 160 ---------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-----~~~ 213 (337)
T 1o6l_A 160 ---------------------ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-----ERL 213 (337)
T ss_dssp ---------------------CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH-----HHH
T ss_pred ---------------------CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCH-----HHH
Confidence 112245678899999999999999999999999999999999999954322 223
Q ss_pred HHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHHH
Q 042348 609 IQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRP-----SMRHVCDSL 665 (686)
Q Consensus 609 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~ev~~~L 665 (686)
...+.......+.. ...++.+++.+||+.||++|| ++.||+++-
T Consensus 214 ~~~i~~~~~~~p~~-------------~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~ 262 (337)
T 1o6l_A 214 FELILMEEIRFPRT-------------LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHR 262 (337)
T ss_dssp HHHHHHCCCCCCTT-------------SCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSG
T ss_pred HHHHHcCCCCCCCC-------------CCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCC
Confidence 33444333222211 123577899999999999999 899998873
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-43 Score=359.67 Aligned_cols=244 Identities=22% Similarity=0.371 Sum_probs=200.5
Q ss_pred cccCccCceEEEEEEe-CCCceEEEEEcCCCCccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCCHH
Q 042348 373 FLLGKSTIGIVYKVAL-NNEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLA 451 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL~ 451 (686)
..||+|+||.||+|.. .+++.||||++........+.+.+|+.++++++||||+++++++...+..++||||+++|+|.
T Consensus 26 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (297)
T 3fxz_A 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT 105 (297)
T ss_dssp EEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHH
T ss_pred eeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECCCCCCHH
Confidence 3699999999999986 468899999987655555678999999999999999999999999999999999999999999
Q ss_pred HHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCccc
Q 042348 452 TAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEV 531 (686)
Q Consensus 452 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 531 (686)
+++... .+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 106 ~~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~---- 171 (297)
T 3fxz_A 106 DVVTET-------CMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS---- 171 (297)
T ss_dssp HHHHHS-------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC----
T ss_pred HHHhhc-------CCCHHHHHHHHHHHHHHHHHHHh---CCceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc----
Confidence 999753 48999999999999999999999 8999999999999999999999999999976542211
Q ss_pred cccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHHHHH
Q 042348 532 HWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQWIQL 611 (686)
Q Consensus 532 ~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~ 611 (686)
......||..|+|||++.+..++.++|||||||++|||++|+.||...... .....
T Consensus 172 -------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-----~~~~~ 227 (297)
T 3fxz_A 172 -------------------KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL-----RALYL 227 (297)
T ss_dssp -------------------CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-----HHHHH
T ss_pred -------------------ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHH
Confidence 122346788899999999999999999999999999999999999543221 11222
Q ss_pred HHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 612 ILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 612 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
......+.. .. .......+.+++.+||+.||++|||+.|++++
T Consensus 228 ~~~~~~~~~--~~--------~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 270 (297)
T 3fxz_A 228 IATNGTPEL--QN--------PEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 270 (297)
T ss_dssp HHHHCSCCC--SC--------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred HHhCCCCCC--CC--------ccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 222221111 01 11123457799999999999999999999875
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=369.65 Aligned_cols=259 Identities=22% Similarity=0.319 Sum_probs=201.6
Q ss_pred cccCccCceEEEEEEeCCCceEEEEEcCCCCccchHHHHHHHHHHhccCCCCcceeeEEEEecCc----eeEEEeccCCC
Q 042348 373 FLLGKSTIGIVYKVALNNEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDE----KLLIYDYIPNG 448 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~----~~lV~e~~~~g 448 (686)
..||+|+||.||+|+.. ++.||||++..... ....+..|+.++++++|||||++++++..... .++||||+++|
T Consensus 30 ~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e~~~~g 107 (322)
T 3soc_A 30 EVKARGRFGCVWKAQLL-NEYVAVKIFPIQDK-QSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKG 107 (322)
T ss_dssp EEEECSTTCEEEEEEET-TEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTC
T ss_pred heecccCceEEEEEEEC-CCEEEEEEeecCch-HHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEEecCCCC
Confidence 46999999999999876 78999999975432 23456779999999999999999999987654 59999999999
Q ss_pred CHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCC----------CceecCCCCCCeeecCCCCeEEeecCc
Q 042348 449 SLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPK----------RYVHGDLRPSNILLGKNMEPHISDFGL 518 (686)
Q Consensus 449 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~----------~iiHrDlkp~NILl~~~~~~kl~DfGl 518 (686)
+|.++++.. .+++..+..++.|++.||+|||+ . +|+||||||+|||++.++.+||+|||+
T Consensus 108 ~L~~~l~~~-------~~~~~~~~~i~~qi~~al~~LH~---~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~ 177 (322)
T 3soc_A 108 SLSDFLKAN-------VVSWNELCHIAETMARGLAYLHE---DIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGL 177 (322)
T ss_dssp BHHHHHHHC-------CBCHHHHHHHHHHHHHHHHHHTC---CEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred CHHHHHHhc-------CCCHHHHHHHHHHHHHHHHHHHh---hccccccccCCCEEeCCCChHhEEECCCCeEEEccCCc
Confidence 999999753 48999999999999999999999 7 999999999999999999999999999
Q ss_pred ccccccccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCC-----CCCCcchHHHHHHHHHHHHhCCC
Q 042348 519 ARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVR-----KPTQKWDIYSYGVILLEMISGKL 593 (686)
Q Consensus 519 a~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDVwSlGvvl~elltG~~ 593 (686)
++........ .......||..|+|||++.+. .++.++|||||||++|||+||+.
T Consensus 178 a~~~~~~~~~---------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~ 236 (322)
T 3soc_A 178 ALKFEAGKSA---------------------GDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCT 236 (322)
T ss_dssp CEEECTTSCC---------------------CCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBT
T ss_pred ccccccccCc---------------------cccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCC
Confidence 9866432211 112235678899999998763 45678899999999999999999
Q ss_pred CccccCccch-----------hHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHH
Q 042348 594 PMIQIGSMEL-----------NIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVC 662 (686)
Q Consensus 594 P~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~ 662 (686)
||........ ....+..... ... ..+.+............+.+++.+||+.||++|||+.||+
T Consensus 237 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~-----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell 310 (322)
T 3soc_A 237 AADGPVDEYMLPFEEEIGQHPSLEDMQEVVV-HKK-----KRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVG 310 (322)
T ss_dssp TSSSCCCCCCCTTHHHHCSSCCHHHHHHHHT-TSC-----CCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred CCCCCcchhccchhhhhccCCchhhhhhhhh-ccc-----CCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHH
Confidence 9965332211 1111111111 111 1111111122234566799999999999999999999999
Q ss_pred HHHhcccc
Q 042348 663 DSLDRVNI 670 (686)
Q Consensus 663 ~~L~~i~~ 670 (686)
+.|+++..
T Consensus 311 ~~L~~l~~ 318 (322)
T 3soc_A 311 ERITQMQR 318 (322)
T ss_dssp HHHHHHHH
T ss_pred HHHHHHHH
Confidence 99999864
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=359.79 Aligned_cols=245 Identities=20% Similarity=0.328 Sum_probs=201.7
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCCccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCCHH
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLA 451 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL~ 451 (686)
..||+|+||.||+|... +|+.||||++........+.+.+|+.++++++||||+++++++...+..++||||+++|+|.
T Consensus 51 ~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~ 130 (321)
T 2c30_A 51 VKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALT 130 (321)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCCSCBHH
T ss_pred EEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCCCCCHH
Confidence 36999999999999976 68999999997766666678999999999999999999999999999999999999999999
Q ss_pred HHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCccc
Q 042348 452 TAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEV 531 (686)
Q Consensus 452 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 531 (686)
+++.. ..+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++.......
T Consensus 131 ~~l~~-------~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~---- 196 (321)
T 2c30_A 131 DIVSQ-------VRLNEEQIATVCEAVLQALAYLHA---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP---- 196 (321)
T ss_dssp HHHTT-------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC----
T ss_pred HHHHh-------cCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCcc----
Confidence 99864 358999999999999999999999 8999999999999999999999999999976542211
Q ss_pred cccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHHHHH
Q 042348 532 HWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQWIQL 611 (686)
Q Consensus 532 ~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~ 611 (686)
......||..|+|||++.+..++.++|||||||++|||++|+.||..... ......
T Consensus 197 -------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~-----~~~~~~ 252 (321)
T 2c30_A 197 -------------------KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSP-----VQAMKR 252 (321)
T ss_dssp -------------------CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-----HHHHHH
T ss_pred -------------------ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHH
Confidence 11234678889999999988999999999999999999999999954322 122222
Q ss_pred HHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 042348 612 ILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSL 665 (686)
Q Consensus 612 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L 665 (686)
+.....+. ... .......+.+++.+||+.||++|||+.|++++-
T Consensus 253 ~~~~~~~~--~~~--------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp 296 (321)
T 2c30_A 253 LRDSPPPK--LKN--------SHKVSPVLRDFLERMLVRDPQERATAQELLDHP 296 (321)
T ss_dssp HHHSSCCC--CTT--------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSG
T ss_pred HhcCCCCC--cCc--------cccCCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 22221111 000 011223577899999999999999999999863
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-42 Score=355.74 Aligned_cols=279 Identities=32% Similarity=0.526 Sum_probs=218.5
Q ss_pred cccCHHHHHHHhh-----------cccCccCceEEEEEEeCCCceEEEEEcCCCC----ccchHHHHHHHHHHhccCCCC
Q 042348 360 VDFDLEQLLKASA-----------FLLGKSTIGIVYKVALNNEEAVAVRRLGNGG----WQRFKEFQTEAEAIGKIRHPN 424 (686)
Q Consensus 360 ~~~~~~~l~~~~~-----------~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~H~n 424 (686)
..|++.++.+++. +.||+|+||.||+|.. +++.||||++.... ....+.+.+|+.++++++|||
T Consensus 13 ~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 91 (307)
T 2nru_A 13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHEN 91 (307)
T ss_dssp EECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTT
T ss_pred CcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCC
Confidence 3455666665542 4699999999999987 57889999986532 233567999999999999999
Q ss_pred cceeeEEEEecCceeEEEeccCCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCee
Q 042348 425 IVSLRAYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNIL 504 (686)
Q Consensus 425 Iv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NIL 504 (686)
|+++++++.+.+..++||||+++|+|.+++...... ..+++..+..++.|++.||+|||+ ++|+||||||+||+
T Consensus 92 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dlkp~Nil 165 (307)
T 2nru_A 92 LVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGT---PPLSWHMRCKIAQGAANGINFLHE---NHHIHRDIKSANIL 165 (307)
T ss_dssp BCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGC---CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEE
T ss_pred eEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCC---CCCCHHHHHHHHHHHHHHHHHHhc---CCeecCCCCHHHEE
Confidence 999999999999999999999999999999754321 468999999999999999999999 89999999999999
Q ss_pred ecCCCCeEEeecCcccccccccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHH
Q 042348 505 LGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVI 584 (686)
Q Consensus 505 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvv 584 (686)
++.++.+||+|||+++........ .......||..|+|||.+.+ .++.++||||||++
T Consensus 166 i~~~~~~kl~Dfg~~~~~~~~~~~---------------------~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~i 223 (307)
T 2nru_A 166 LDEAFTAKISDFGLARASEKFAQT---------------------VMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVV 223 (307)
T ss_dssp ECTTCCEEECCCTTCEECCSCSSC---------------------EECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHH
T ss_pred EcCCCcEEEeeccccccccccccc---------------------ccccccCCCcCcCChHHhcC-CCCccchhHHHHHH
Confidence 999999999999999765422110 11223467888999998865 57999999999999
Q ss_pred HHHHHhCCCCccccCccchhHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 585 LLEMISGKLPMIQIGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 585 l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
+|||++|+.||....... ....+..........+.+.+++.+.. ........+.+++.+||+.||++|||+.||+++
T Consensus 224 l~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~ 300 (307)
T 2nru_A 224 LLEIITGLPAVDEHREPQ-LLLDIKEEIEDEEKTIEDYIDKKMND--ADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL 300 (307)
T ss_dssp HHHHHHCCCSBCTTBSSS-BTTHHHHHHHTTSCCHHHHSCSSCSC--CCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred HHHHHHCCCCcccCcchH-HHHHHHHHhhhhhhhhhhhccccccc--cchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 999999999996543322 22233333333333334444443321 234566789999999999999999999999999
Q ss_pred Hhcccc
Q 042348 665 LDRVNI 670 (686)
Q Consensus 665 L~~i~~ 670 (686)
|+++..
T Consensus 301 L~~l~~ 306 (307)
T 2nru_A 301 LQEMTA 306 (307)
T ss_dssp HHHHC-
T ss_pred HHHHhc
Confidence 999864
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=360.06 Aligned_cols=253 Identities=28% Similarity=0.407 Sum_probs=196.2
Q ss_pred cccCccCceEEEEEEeCCCceEEEEEcCCCC--ccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCCH
Q 042348 373 FLLGKSTIGIVYKVALNNEEAVAVRRLGNGG--WQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSL 450 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL 450 (686)
..||+|+||.||+|+. +++.||||++.... ....+++.+|++++++++||||+++++++...+..++||||+++|+|
T Consensus 43 ~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L 121 (309)
T 3p86_A 43 EKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSL 121 (309)
T ss_dssp EEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEECCTTCBH
T ss_pred eEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEecCCCCcH
Confidence 4699999999999987 47889999987643 23346789999999999999999999999999999999999999999
Q ss_pred HHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCC--ceecCCCCCCeeecCCCCeEEeecCcccccccccCC
Q 042348 451 ATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKR--YVHGDLRPSNILLGKNMEPHISDFGLARLADIAEET 528 (686)
Q Consensus 451 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~--iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 528 (686)
.+++...... ..+++..++.++.|++.||+|||+ ++ |+||||||+||+++.++.+||+|||+++......
T Consensus 122 ~~~l~~~~~~---~~~~~~~~~~i~~qi~~aL~~LH~---~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~-- 193 (309)
T 3p86_A 122 YRLLHKSGAR---EQLDERRRLSMAYDVAKGMNYLHN---RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTF-- 193 (309)
T ss_dssp HHHHHSTTHH---HHSCHHHHHHHHHHHHHHHHHHHT---SSSCCCCTTCCGGGEEECTTCCEEECCCC-----------
T ss_pred HHHHhhcCCC---CCCCHHHHHHHHHHHHHHHHHHHc---CCCCEECCCCChhhEEEeCCCcEEECCCCCCccccccc--
Confidence 9999865321 248999999999999999999999 78 9999999999999999999999999997543211
Q ss_pred ccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHH
Q 042348 529 PEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQW 608 (686)
Q Consensus 529 ~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~ 608 (686)
.......||..|+|||.+.+..++.++|||||||++|||++|+.||...... +.
T Consensus 194 ---------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~-----~~ 247 (309)
T 3p86_A 194 ---------------------LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPA-----QV 247 (309)
T ss_dssp -----------------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHH-----HH
T ss_pred ---------------------cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----HH
Confidence 1112345788899999999999999999999999999999999999543322 11
Q ss_pred HHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccccc
Q 042348 609 IQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRVNIS 671 (686)
Q Consensus 609 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~~ 671 (686)
.......... ... .. .....+.+++.+||+.||++|||+.|+++.|+.+...
T Consensus 248 ~~~~~~~~~~-~~~-----~~-----~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~ 299 (309)
T 3p86_A 248 VAAVGFKCKR-LEI-----PR-----NLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS 299 (309)
T ss_dssp HHHHHHSCCC-CCC-----CT-----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred HHHHHhcCCC-CCC-----Cc-----cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 2222111111 110 01 1223578999999999999999999999999987643
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=368.72 Aligned_cols=257 Identities=25% Similarity=0.391 Sum_probs=204.6
Q ss_pred cccCccCceEEEEEEeC--------CCceEEEEEcCCCC-ccchHHHHHHHHHHhcc-CCCCcceeeEEEEecCceeEEE
Q 042348 373 FLLGKSTIGIVYKVALN--------NEEAVAVRRLGNGG-WQRFKEFQTEAEAIGKI-RHPNIVSLRAYFWSVDEKLLIY 442 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~ 442 (686)
..||+|+||.||+|... ++..||||.++... ....+++.+|+++++++ +||||+++++++...+..++||
T Consensus 87 ~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~ 166 (370)
T 2psq_A 87 KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIV 166 (370)
T ss_dssp EEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSSSCEEEE
T ss_pred eEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCCCEEEEE
Confidence 46999999999999852 34579999997653 33456799999999999 8999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCCc----------cccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeE
Q 042348 443 DYIPNGSLATAIHGKAGI----------ISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPH 512 (686)
Q Consensus 443 e~~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~k 512 (686)
||+++|+|.+++...... .....+++.+++.++.||+.||+|||+ ++|+||||||+|||++.++.+|
T Consensus 167 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~k 243 (370)
T 2psq_A 167 EYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVLVTENNVMK 243 (370)
T ss_dssp ECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEE
T ss_pred EcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCeeccccchhhEEECCCCCEE
Confidence 999999999999865321 112358999999999999999999999 8999999999999999999999
Q ss_pred EeecCcccccccccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHh-C
Q 042348 513 ISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-G 591 (686)
Q Consensus 513 l~DfGla~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G 591 (686)
|+|||+++........ .......+|..|+|||++.+..++.++|||||||++|||+| |
T Consensus 244 l~DFG~a~~~~~~~~~---------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g 302 (370)
T 2psq_A 244 IADFGLARDINNIDYY---------------------KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLG 302 (370)
T ss_dssp ECCCSSCEETTCCCTT---------------------CTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTS
T ss_pred EccccCCcccCcccce---------------------ecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCC
Confidence 9999999865422110 11123445778999999999999999999999999999999 9
Q ss_pred CCCccccCccchhHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccc
Q 042348 592 KLPMIQIGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRVNI 670 (686)
Q Consensus 592 ~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~ 670 (686)
+.||......+ + ...+...... . . .......+.+++.+||+.||++||++.|+++.|+++..
T Consensus 303 ~~p~~~~~~~~--~---~~~~~~~~~~--~-----~-----~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~ 364 (370)
T 2psq_A 303 GSPYPGIPVEE--L---FKLLKEGHRM--D-----K-----PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 364 (370)
T ss_dssp CCSSTTCCGGG--H---HHHHHTTCCC--C-----C-----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCCCHHH--H---HHHHhcCCCC--C-----C-----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 99996543222 1 2222222111 0 0 01123468899999999999999999999999999763
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=351.66 Aligned_cols=250 Identities=24% Similarity=0.402 Sum_probs=205.7
Q ss_pred cccCccCceEEEEEEeCCCceEEEEEcCCCCccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCCHHH
Q 042348 373 FLLGKSTIGIVYKVALNNEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLAT 452 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL~~ 452 (686)
..||+|+||.||+|...+++.||+|++..... ..+++.+|++++++++||||+++++++.+.+..++||||+++|+|.+
T Consensus 16 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 94 (269)
T 4hcu_A 16 QEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSD 94 (269)
T ss_dssp EEEEECSSCEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHH
T ss_pred heecCCCccEEEEEEecCCCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCCCCcHHH
Confidence 36999999999999998888999999976543 34679999999999999999999999999999999999999999999
Q ss_pred HhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCcccc
Q 042348 453 AIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVH 532 (686)
Q Consensus 453 ~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 532 (686)
++.... ..+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++.......
T Consensus 95 ~l~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~----- 161 (269)
T 4hcu_A 95 YLRTQR-----GLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY----- 161 (269)
T ss_dssp HHHTTT-----TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHH-----
T ss_pred HHHhcC-----cccCHHHHHHHHHHHHHHHHHHHh---CCeecCCcchheEEEcCCCCEEecccccccccccccc-----
Confidence 997654 458999999999999999999999 8999999999999999999999999999986542211
Q ss_pred ccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCccccCccchhHHHHHHH
Q 042348 533 WEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQIGSMELNIVQWIQL 611 (686)
Q Consensus 533 ~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~ 611 (686)
.......+|..|+|||.+.+..++.++||||||+++|||++ |+.||...... .....
T Consensus 162 -----------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~-----~~~~~ 219 (269)
T 4hcu_A 162 -----------------TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS-----EVVED 219 (269)
T ss_dssp -----------------HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-----HHHHH
T ss_pred -----------------ccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHH-----HHHHH
Confidence 11123445677999999988899999999999999999999 99999543321 22233
Q ss_pred HHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccc
Q 042348 612 ILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRVNI 670 (686)
Q Consensus 612 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~ 670 (686)
+....... .+ ......+.+++.+||+.||++|||+.|++++|+++..
T Consensus 220 ~~~~~~~~----~~--------~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~ 266 (269)
T 4hcu_A 220 ISTGFRLY----KP--------RLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 266 (269)
T ss_dssp HHTTCCCC----CC--------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HhcCccCC----CC--------CcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence 32221111 11 0112357889999999999999999999999998864
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=362.07 Aligned_cols=256 Identities=26% Similarity=0.442 Sum_probs=204.2
Q ss_pred cccCccCceEEEEEEeC----CCceEEEEEcCCC-CccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCC
Q 042348 373 FLLGKSTIGIVYKVALN----NEEAVAVRRLGNG-GWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPN 447 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~ 447 (686)
..||+|+||.||+|... .+..||||++... .....+.+.+|++++++++||||+++++++.+.+..++||||+++
T Consensus 55 ~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 134 (325)
T 3kul_A 55 KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMEN 134 (325)
T ss_dssp EEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEEEECCTT
T ss_pred eEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEEeeCCCC
Confidence 46999999999999974 3456999999765 334456799999999999999999999999999999999999999
Q ss_pred CCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccC
Q 042348 448 GSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEE 527 (686)
Q Consensus 448 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 527 (686)
|+|.++++... ..+++.++..|+.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 135 ~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 206 (325)
T 3kul_A 135 GSLDTFLRTHD-----GQFTIMQLVGMLRGVGAGMRYLSD---LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPD 206 (325)
T ss_dssp CBHHHHHHTTT-----TCSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCSSCEECC----
T ss_pred CcHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCcceEEECCCCCEEECCCCcccccccCcc
Confidence 99999997654 358999999999999999999999 8999999999999999999999999999987643221
Q ss_pred CccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCccccCccchhHH
Q 042348 528 TPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQIGSMELNIV 606 (686)
Q Consensus 528 ~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~~~~~ 606 (686)
.. .......+|..|+|||++.+..++.++|||||||++|||++ |+.||......
T Consensus 207 ~~--------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~----- 261 (325)
T 3kul_A 207 AA--------------------YTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNR----- 261 (325)
T ss_dssp CC--------------------EECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHH-----
T ss_pred ce--------------------eeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHH-----
Confidence 10 11123345778999999988889999999999999999999 99999544322
Q ss_pred HHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccccch
Q 042348 607 QWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRVNISTE 673 (686)
Q Consensus 607 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~~~~ 673 (686)
.....+...... . . .......+.+++.+||+.||++|||+.||++.|+.+....+
T Consensus 262 ~~~~~~~~~~~~-~--~---------~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~ 316 (325)
T 3kul_A 262 DVISSVEEGYRL-P--A---------PMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPE 316 (325)
T ss_dssp HHHHHHHTTCCC-C--C---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC
T ss_pred HHHHHHHcCCCC-C--C---------CCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCcc
Confidence 222222222111 1 0 01123467899999999999999999999999999875443
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=349.90 Aligned_cols=251 Identities=24% Similarity=0.407 Sum_probs=205.3
Q ss_pred cccCccCceEEEEEEeCCCceEEEEEcCCCCccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCCHHH
Q 042348 373 FLLGKSTIGIVYKVALNNEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLAT 452 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL~~ 452 (686)
..||+|+||.||+|...++..||||.+..... ..+++.+|++++++++||||+++++++...+..++||||+++++|.+
T Consensus 14 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 92 (268)
T 3sxs_A 14 KELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLN 92 (268)
T ss_dssp EEEEEETTEEEEEEEETTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHH
T ss_pred eeeccCCCceEEEEEecCceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccCCCcHHH
Confidence 46999999999999999888999999976543 34679999999999999999999999999999999999999999999
Q ss_pred HhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCcccc
Q 042348 453 AIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVH 532 (686)
Q Consensus 453 ~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 532 (686)
++.... ..+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++.......
T Consensus 93 ~l~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~----- 159 (268)
T 3sxs_A 93 YLRSHG-----KGLEPSQLLEMCYDVCEGMAFLES---HQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY----- 159 (268)
T ss_dssp HHHHHG-----GGCCHHHHHHHHHHHHHHHHHHHH---TTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCE-----
T ss_pred HHHHcC-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCcceEEECCCCCEEEccCccceecchhhh-----
Confidence 997653 358999999999999999999999 8999999999999999999999999999986542211
Q ss_pred ccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCccccCccchhHHHHHHH
Q 042348 533 WEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQIGSMELNIVQWIQL 611 (686)
Q Consensus 533 ~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~ 611 (686)
.......+|..|+|||.+.+..++.++||||||+++|||+| |+.||...... .....
T Consensus 160 -----------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-----~~~~~ 217 (268)
T 3sxs_A 160 -----------------VSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNS-----EVVLK 217 (268)
T ss_dssp -----------------EECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHH-----HHHHH
T ss_pred -----------------hcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChH-----HHHHH
Confidence 11123345677999999988889999999999999999999 99999543322 12222
Q ss_pred HHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccccc
Q 042348 612 ILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRVNIS 671 (686)
Q Consensus 612 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~~ 671 (686)
........ .+. .....+.+++.+||+.||++|||+.|++++|+.+...
T Consensus 218 ~~~~~~~~----~~~--------~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (268)
T 3sxs_A 218 VSQGHRLY----RPH--------LASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK 265 (268)
T ss_dssp HHTTCCCC----CCT--------TSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred HHcCCCCC----CCC--------cChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence 22221111 110 1123577899999999999999999999999998754
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=378.97 Aligned_cols=257 Identities=27% Similarity=0.482 Sum_probs=209.3
Q ss_pred cccCccCceEEEEEEeCCCceEEEEEcCCCCccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCCHHH
Q 042348 373 FLLGKSTIGIVYKVALNNEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLAT 452 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL~~ 452 (686)
+.||+|+||.||+|...++..||||+++... ...+.|.+|+++|++++|||||++++++. .+..++|||||++|+|.+
T Consensus 194 ~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~~~g~L~~ 271 (454)
T 1qcf_A 194 KKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMAKGSLLD 271 (454)
T ss_dssp EEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCCTTCBHHH
T ss_pred EEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeecCCCcHHH
Confidence 4699999999999999888899999997654 34678999999999999999999999986 667899999999999999
Q ss_pred HhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCcccc
Q 042348 453 AIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVH 532 (686)
Q Consensus 453 ~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 532 (686)
+++...+ ..+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 272 ~l~~~~~----~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~----- 339 (454)
T 1qcf_A 272 FLKSDEG----SKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY----- 339 (454)
T ss_dssp HHHSHHH----HTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHH-----
T ss_pred HHHhccC----CCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCce-----
Confidence 9986432 358899999999999999999999 8999999999999999999999999999986542211
Q ss_pred ccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCccccCccchhHHHHHHH
Q 042348 533 WEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQIGSMELNIVQWIQL 611 (686)
Q Consensus 533 ~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~ 611 (686)
.......+|..|+|||++....++.++|||||||++|||+| |+.||...... +....
T Consensus 340 -----------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~-----~~~~~ 397 (454)
T 1qcf_A 340 -----------------TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP-----EVIRA 397 (454)
T ss_dssp -----------------HTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-----HHHHH
T ss_pred -----------------eccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHH-----HHHHH
Confidence 11122345677999999988899999999999999999999 99999643322 22222
Q ss_pred HHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccccchhhhh
Q 042348 612 ILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRVNISTEQQFM 677 (686)
Q Consensus 612 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~~~~~~~~ 677 (686)
+..+ ..... + ......+.+++.+||+.||++|||+.+|++.|+.+....+.++.
T Consensus 398 i~~~-~~~~~---~--------~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~~~~~~ 451 (454)
T 1qcf_A 398 LERG-YRMPR---P--------ENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTATESQYE 451 (454)
T ss_dssp HHHT-CCCCC---C--------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSSCCSSB
T ss_pred HHcC-CCCCC---C--------CCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhccccccc
Confidence 2222 11110 0 11234688999999999999999999999999999877766653
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-42 Score=365.06 Aligned_cols=247 Identities=20% Similarity=0.312 Sum_probs=196.7
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCC---ccchHHHHHHHHHHhcc-CCCCcceeeEEEEecCceeEEEeccCC
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGG---WQRFKEFQTEAEAIGKI-RHPNIVSLRAYFWSVDEKLLIYDYIPN 447 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~e~~~~ 447 (686)
..||+|+||.||+|+.. +++.||||+++... ....+.+.+|..++.++ +|||||++++++.+.+..++||||+++
T Consensus 58 ~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV~E~~~g 137 (396)
T 4dc2_A 58 RVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 137 (396)
T ss_dssp EEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred EEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEEEEcCCC
Confidence 46999999999999976 47889999986532 22345688999999887 899999999999999999999999999
Q ss_pred CCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccC
Q 042348 448 GSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEE 527 (686)
Q Consensus 448 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 527 (686)
|+|.+++... ..+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+|+......
T Consensus 138 g~L~~~l~~~------~~l~~~~~~~~~~qi~~aL~~LH~---~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~- 207 (396)
T 4dc2_A 138 GDLMFHMQRQ------RKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG- 207 (396)
T ss_dssp CBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT-
T ss_pred CcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCEEeccCCHHHEEECCCCCEEEeecceeeecccCC-
Confidence 9999999764 358999999999999999999999 899999999999999999999999999997432111
Q ss_pred CccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccc----h
Q 042348 528 TPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSME----L 603 (686)
Q Consensus 528 ~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~----~ 603 (686)
......+||+.|+|||++.+..++.++|||||||++|||++|+.||......+ .
T Consensus 208 ----------------------~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~ 265 (396)
T 4dc2_A 208 ----------------------DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQN 265 (396)
T ss_dssp ----------------------CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------C
T ss_pred ----------------------CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchh
Confidence 11234578889999999999999999999999999999999999995432211 1
Q ss_pred hHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCH------HHHHHH
Q 042348 604 NIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSM------RHVCDS 664 (686)
Q Consensus 604 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~------~ev~~~ 664 (686)
......+.+.......+.. ....+.+++.+||+.||++||++ .||+++
T Consensus 266 ~~~~~~~~i~~~~~~~p~~-------------~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~H 319 (396)
T 4dc2_A 266 TEDYLFQVILEKQIRIPRS-------------LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 319 (396)
T ss_dssp CHHHHHHHHHHCCCCCCTT-------------SCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHS
T ss_pred hHHHHHHHHhccccCCCCc-------------CCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcC
Confidence 1122233333333222221 12357789999999999999996 566655
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=364.29 Aligned_cols=242 Identities=21% Similarity=0.285 Sum_probs=196.4
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCC---CccchHHHHHHHHHHhcc-CCCCcceeeEEEEecCceeEEEeccCC
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNG---GWQRFKEFQTEAEAIGKI-RHPNIVSLRAYFWSVDEKLLIYDYIPN 447 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~e~~~~ 447 (686)
..||+|+||.||+|+.. +++.||||++... .....+.+.+|.+++..+ +||||+++++++.+.+..++||||+++
T Consensus 29 ~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~g 108 (353)
T 3txo_A 29 RVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNG 108 (353)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCCS
T ss_pred EEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999876 5889999998653 223346688999999998 799999999999999999999999999
Q ss_pred CCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccC
Q 042348 448 GSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEE 527 (686)
Q Consensus 448 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 527 (686)
|+|.+++... ..+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+|+......
T Consensus 109 g~L~~~l~~~------~~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~- 178 (353)
T 3txo_A 109 GDLMFHIQKS------RRFDEARARFYAAEIISALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNG- 178 (353)
T ss_dssp CBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC---
T ss_pred CcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCCcccCCCHHHEEECCCCCEEEccccceeecccCC-
Confidence 9999999765 358999999999999999999999 899999999999999999999999999997432111
Q ss_pred CccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHH
Q 042348 528 TPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQ 607 (686)
Q Consensus 528 ~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~ 607 (686)
......+||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+
T Consensus 179 ----------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~-----~~ 231 (353)
T 3txo_A 179 ----------------------VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENE-----DD 231 (353)
T ss_dssp -----------------------------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HH
T ss_pred ----------------------ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCH-----HH
Confidence 112345688899999999888899999999999999999999999954332 23
Q ss_pred HHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCH------HHHHHH
Q 042348 608 WIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSM------RHVCDS 664 (686)
Q Consensus 608 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~------~ev~~~ 664 (686)
....+.......+..+ ...+.+++.+||+.||++||++ .|++++
T Consensus 232 ~~~~i~~~~~~~p~~~-------------~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~h 281 (353)
T 3txo_A 232 LFEAILNDEVVYPTWL-------------HEDATGILKSFMTKNPTMRLGSLTQGGEHAILRH 281 (353)
T ss_dssp HHHHHHHCCCCCCTTS-------------CHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTS
T ss_pred HHHHHHcCCCCCCCCC-------------CHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhC
Confidence 3444444433322211 2357789999999999999998 777765
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=355.65 Aligned_cols=258 Identities=24% Similarity=0.341 Sum_probs=197.7
Q ss_pred cccCccCceEEEEEEeCCCceEEEEEcCCCCccchHHHHHHHHHHhc--cCCCCcceeeEEEEec----CceeEEEeccC
Q 042348 373 FLLGKSTIGIVYKVALNNEEAVAVRRLGNGGWQRFKEFQTEAEAIGK--IRHPNIVSLRAYFWSV----DEKLLIYDYIP 446 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~H~nIv~l~~~~~~~----~~~~lV~e~~~ 446 (686)
..||+|+||.||+|.. +++.||||++... ....+..|.+++.. ++||||+++++++... ...++||||++
T Consensus 14 ~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv~e~~~ 89 (301)
T 3q4u_A 14 ECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHE 89 (301)
T ss_dssp EEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEEECCCT
T ss_pred EeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEehhhcc
Confidence 4699999999999988 5889999998653 33556667777666 7999999999997653 45789999999
Q ss_pred CCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHH--------ccCCCCceecCCCCCCeeecCCCCeEEeecCc
Q 042348 447 NGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLH--------EVSPKRYVHGDLRPSNILLGKNMEPHISDFGL 518 (686)
Q Consensus 447 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH--------~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGl 518 (686)
+|+|.++++. ..+++..+..++.|++.||+||| + ++|+||||||+|||++.++.+||+|||+
T Consensus 90 ~g~L~~~l~~-------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~---~~ivH~Dlkp~Nill~~~~~~kl~Dfg~ 159 (301)
T 3q4u_A 90 MGSLYDYLQL-------TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGK---PAIAHRDLKSKNILVKKNGQCCIADLGL 159 (301)
T ss_dssp TCBHHHHHTT-------CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCB---CEEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred CCCHHHHHhh-------cccCHHHHHHHHHHHHHHHHHHHHhhhhccCC---CCeecCCCChHhEEEcCCCCEEEeeCCC
Confidence 9999999954 35899999999999999999999 7 8999999999999999999999999999
Q ss_pred ccccccccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCC------CCCCcchHHHHHHHHHHHHhC-
Q 042348 519 ARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVR------KPTQKWDIYSYGVILLEMISG- 591 (686)
Q Consensus 519 a~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~sDVwSlGvvl~elltG- 591 (686)
++......... ........||..|+|||++.+. .++.++|||||||++|||+||
T Consensus 160 a~~~~~~~~~~-------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~ 220 (301)
T 3q4u_A 160 AVMHSQSTNQL-------------------DVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRM 220 (301)
T ss_dssp CEEEETTTTEE-------------------ECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTB
T ss_pred eeecccccccc-------------------cccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhh
Confidence 98654322100 0111234678899999998776 445799999999999999999
Q ss_pred ---------CCCccccCccchhHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHH
Q 042348 592 ---------KLPMIQIGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVC 662 (686)
Q Consensus 592 ---------~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~ 662 (686)
+.||............... ......... .+............+.+++.+||+.||++|||+.||+
T Consensus 221 ~~~~~~~~~~~pf~~~~~~~~~~~~~~~-~~~~~~~~~-----~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~ 294 (301)
T 3q4u_A 221 VSNGIVEDYKPPFYDVVPNDPSFEDMRK-VVCVDQQRP-----NIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIK 294 (301)
T ss_dssp CBTTBCCCCCCTTTTTSCSSCCHHHHHH-HHTTSCCCC-----CCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHH
T ss_pred cCccccccccccccccCCCCcchhhhhH-HHhccCCCC-----CCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHH
Confidence 8888654433332222222 221111111 1111111234667899999999999999999999999
Q ss_pred HHHhccc
Q 042348 663 DSLDRVN 669 (686)
Q Consensus 663 ~~L~~i~ 669 (686)
+.|++|.
T Consensus 295 ~~L~~i~ 301 (301)
T 3q4u_A 295 KTLTKID 301 (301)
T ss_dssp HHHHHHC
T ss_pred HHHhccC
Confidence 9999863
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=354.19 Aligned_cols=239 Identities=22% Similarity=0.333 Sum_probs=199.2
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCC---ccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCC
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGG---WQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNG 448 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~g 448 (686)
..||+|+||.||+|+.. +++.||+|.+.... ....+.+.+|+.+++.++||||+++++++.+.+..++||||+++|
T Consensus 12 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~gg 91 (318)
T 1fot_A 12 RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGG 91 (318)
T ss_dssp EEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred EEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEEeCCCCC
Confidence 46999999999999876 68899999986532 233567889999999999999999999999999999999999999
Q ss_pred CHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCC
Q 042348 449 SLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEET 528 (686)
Q Consensus 449 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 528 (686)
+|.+++... ..+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 92 ~L~~~l~~~------~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~--- 159 (318)
T 1fot_A 92 ELFSLLRKS------QRFPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV--- 159 (318)
T ss_dssp BHHHHHHHT------SSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC---
T ss_pred CHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChheEEEcCCCCEEEeecCcceecCCc---
Confidence 999999865 358999999999999999999999 89999999999999999999999999999854311
Q ss_pred ccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHH
Q 042348 529 PEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQW 608 (686)
Q Consensus 529 ~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~ 608 (686)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ...
T Consensus 160 -----------------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-----~~~ 211 (318)
T 1fot_A 160 -----------------------TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT-----MKT 211 (318)
T ss_dssp -----------------------BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH-----HHH
T ss_pred -----------------------cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH-----HHH
Confidence 1234678889999999999999999999999999999999999954322 233
Q ss_pred HHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 042348 609 IQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRP-----SMRHVCDS 664 (686)
Q Consensus 609 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~ev~~~ 664 (686)
...+.......+..+ ..++.+++.+||+.||++|| ++.|++++
T Consensus 212 ~~~i~~~~~~~p~~~-------------~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h 259 (318)
T 1fot_A 212 YEKILNAELRFPPFF-------------NEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 259 (318)
T ss_dssp HHHHHHCCCCCCTTS-------------CHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred HHHHHhCCCCCCCCC-------------CHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence 444444432222111 23577899999999999999 88998876
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-42 Score=365.52 Aligned_cols=253 Identities=27% Similarity=0.478 Sum_probs=193.4
Q ss_pred cccCccCceEEEEEEeC----CCceEEEEEcCCC-CccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCC
Q 042348 373 FLLGKSTIGIVYKVALN----NEEAVAVRRLGNG-GWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPN 447 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~ 447 (686)
..||+|+||.||+|+.. ++..||||+++.. .....++|.+|+.++++++||||+++++++...+..++||||+++
T Consensus 51 ~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 130 (373)
T 2qol_A 51 KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMEN 130 (373)
T ss_dssp EEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTT
T ss_pred eEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEEEeCCCC
Confidence 47999999999999865 5678999999764 333456799999999999999999999999999999999999999
Q ss_pred CCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccC
Q 042348 448 GSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEE 527 (686)
Q Consensus 448 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 527 (686)
|+|.++++... ..+++.++..|+.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 131 ~sL~~~l~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 202 (373)
T 2qol_A 131 GSLDSFLRKHD-----AQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPE 202 (373)
T ss_dssp CBHHHHHHTTT-----TCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC-----------
T ss_pred CcHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCcceEEEcCCCCEEECcCccccccccCCc
Confidence 99999998654 468999999999999999999999 8999999999999999999999999999986643211
Q ss_pred CccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCccccCccchhHH
Q 042348 528 TPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQIGSMELNIV 606 (686)
Q Consensus 528 ~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~~~~~ 606 (686)
.. .......++..|+|||++.+..++.++|||||||++|||++ |+.||......
T Consensus 203 ~~--------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~----- 257 (373)
T 2qol_A 203 AA--------------------YTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ----- 257 (373)
T ss_dssp -------------------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHH-----
T ss_pred cc--------------------eeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHH-----
Confidence 00 01112234667999999998899999999999999999998 99999544321
Q ss_pred HHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccc
Q 042348 607 QWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRVNI 670 (686)
Q Consensus 607 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~ 670 (686)
+....+.... .... .......+.+++.+||+.||++||++.||++.|+++..
T Consensus 258 ~~~~~i~~~~-~~~~-----------~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~ 309 (373)
T 2qol_A 258 DVIKAVDEGY-RLPP-----------PMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR 309 (373)
T ss_dssp HHHHHHHTTE-ECCC-----------CTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHcCC-CCCC-----------CccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHh
Confidence 1222222221 1000 01123468899999999999999999999999998753
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=348.44 Aligned_cols=249 Identities=24% Similarity=0.368 Sum_probs=201.9
Q ss_pred cccCccCceEEEEEEeCCCceEEEEEcCCCCccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCCHHH
Q 042348 373 FLLGKSTIGIVYKVALNNEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLAT 452 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL~~ 452 (686)
..||+|+||.||++...++..||||++..... ..+++.+|++++++++||||+++++++.+.+..++||||+++|+|.+
T Consensus 30 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 108 (283)
T 3gen_A 30 KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLN 108 (283)
T ss_dssp EECC---CEEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCCTTCBHHH
T ss_pred hhcCCCCCceEEEEEEcCCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEeccCCCcHHH
Confidence 46999999999999999888999999976543 34779999999999999999999999999999999999999999999
Q ss_pred HhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCcccc
Q 042348 453 AIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVH 532 (686)
Q Consensus 453 ~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 532 (686)
++.... ..+++.++..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++.......
T Consensus 109 ~l~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~----- 175 (283)
T 3gen_A 109 YLREMR-----HRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY----- 175 (283)
T ss_dssp HHHCGG-----GCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHH-----
T ss_pred HHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCccceEEEcCCCCEEEcccccccccccccc-----
Confidence 998643 458999999999999999999999 8999999999999999999999999999986542211
Q ss_pred ccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCccccCccchhHHHHHHH
Q 042348 533 WEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQIGSMELNIVQWIQL 611 (686)
Q Consensus 533 ~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~ 611 (686)
.......+|..|+|||.+.+..++.++||||||+++|||+| |+.||...... .....
T Consensus 176 -----------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~-----~~~~~ 233 (283)
T 3gen_A 176 -----------------TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS-----ETAEH 233 (283)
T ss_dssp -----------------HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHH-----HHHHH
T ss_pred -----------------ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChh-----HHHHH
Confidence 11123345677999999988889999999999999999998 99999543322 22222
Q ss_pred HHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 042348 612 ILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRVN 669 (686)
Q Consensus 612 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~ 669 (686)
+........ + ......+.+++.+||+.||++|||+.|++++|+++.
T Consensus 234 ~~~~~~~~~----~--------~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~ 279 (283)
T 3gen_A 234 IAQGLRLYR----P--------HLASEKVYTIMYSCWHEKADERPTFKILLSNILDVM 279 (283)
T ss_dssp HHTTCCCCC----C--------TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HhcccCCCC----C--------CcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHh
Confidence 222211110 1 011235778999999999999999999999999875
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=354.49 Aligned_cols=243 Identities=21% Similarity=0.287 Sum_probs=190.6
Q ss_pred cccCccCceEEEEEEe----CCCceEEEEEcCCCC----ccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEec
Q 042348 373 FLLGKSTIGIVYKVAL----NNEEAVAVRRLGNGG----WQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDY 444 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~ 444 (686)
..||+|+||.||+++. .+++.||+|+++... ......+.+|++++++++||||+++++++...+..++||||
T Consensus 23 ~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 102 (327)
T 3a62_A 23 RVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEY 102 (327)
T ss_dssp EEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred EEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEEEEEEeC
Confidence 4699999999999987 468899999997642 22345688999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCccccccc
Q 042348 445 IPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADI 524 (686)
Q Consensus 445 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~ 524 (686)
+++|+|.+++... ..+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 103 ~~~~~L~~~l~~~------~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 173 (327)
T 3a62_A 103 LSGGELFMQLERE------GIFMEDTACFYLAEISMALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIH 173 (327)
T ss_dssp CTTEEHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCTTTEEECTTSCEEECCCSCC-----
T ss_pred CCCCcHHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHh---CCEEcccCCHHHeEECCCCcEEEEeCCccccccc
Confidence 9999999999754 358999999999999999999999 8999999999999999999999999999875322
Q ss_pred ccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchh
Q 042348 525 AEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELN 604 (686)
Q Consensus 525 ~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~ 604 (686)
.. .......||..|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 174 ~~-----------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~---- 226 (327)
T 3a62_A 174 DG-----------------------TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENR---- 226 (327)
T ss_dssp ----------------------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH----
T ss_pred CC-----------------------ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCH----
Confidence 11 112234678889999999988899999999999999999999999954322
Q ss_pred HHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHHH
Q 042348 605 IVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRP-----SMRHVCDSL 665 (686)
Q Consensus 605 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~ev~~~L 665 (686)
...+..+.......+.. ....+.+++.+||+.||++|| ++.|++++-
T Consensus 227 -~~~~~~i~~~~~~~p~~-------------~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp 278 (327)
T 3a62_A 227 -KKTIDKILKCKLNLPPY-------------LTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHP 278 (327)
T ss_dssp -HHHHHHHHHTCCCCCTT-------------SCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSG
T ss_pred -HHHHHHHHhCCCCCCCC-------------CCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCC
Confidence 22334444433222211 123577899999999999999 778888763
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=355.66 Aligned_cols=259 Identities=25% Similarity=0.401 Sum_probs=200.3
Q ss_pred cccCccCceEEEEEEe-----CCCceEEEEEcCCCCccchHHHHHHHHHHhccCCCCcceeeEEEEec--CceeEEEecc
Q 042348 373 FLLGKSTIGIVYKVAL-----NNEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSV--DEKLLIYDYI 445 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~~lV~e~~ 445 (686)
..||+|+||.||+|++ .+++.||||++........+.+.+|++++++++||||+++++++... ...++||||+
T Consensus 16 ~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~ 95 (295)
T 3ugc_A 16 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYL 95 (295)
T ss_dssp EEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCEEEEECC
T ss_pred heeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceEEEEEeC
Confidence 4699999999999984 25789999999877666667899999999999999999999998654 5689999999
Q ss_pred CCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccc
Q 042348 446 PNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIA 525 (686)
Q Consensus 446 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~ 525 (686)
++|+|.+++.... ..+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++.....
T Consensus 96 ~~~~L~~~l~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 167 (295)
T 3ugc_A 96 PYGSLRDYLQKHK-----ERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQD 167 (295)
T ss_dssp TTCBHHHHHHHCG-----GGCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCCSCC-----
T ss_pred CCCCHHHHHHhcc-----cccCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHhhEEEcCCCeEEEccCcccccccCC
Confidence 9999999998754 358999999999999999999999 89999999999999999999999999999866432
Q ss_pred cCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCcc----
Q 042348 526 EETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSM---- 601 (686)
Q Consensus 526 ~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~---- 601 (686)
.... .......++..|+|||.+.+..++.++||||||+++|||+||..|+......
T Consensus 168 ~~~~--------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~ 227 (295)
T 3ugc_A 168 KEFF--------------------KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRM 227 (295)
T ss_dssp ----------------------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHH
T ss_pred ccee--------------------eeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhh
Confidence 2100 1112334567799999999889999999999999999999999998432111
Q ss_pred ------chhHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccc
Q 042348 602 ------ELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRVNI 670 (686)
Q Consensus 602 ------~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~ 670 (686)
................... .......++.+++.+||+.||++|||+.|+++.|+++..
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~ 291 (295)
T 3ugc_A 228 IGNDKQGQMIVFHLIELLKNNGRLP-----------RPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 291 (295)
T ss_dssp HCTTCCTHHHHHHHHHHHHTTCCCC-----------CCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hcCccccchhHHHHHHHHhccCcCC-----------CCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHH
Confidence 0011111111111111110 011223468899999999999999999999999998864
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-42 Score=360.62 Aligned_cols=242 Identities=22% Similarity=0.330 Sum_probs=198.0
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCC---ccchHHHHHHHHHHhcc-CCCCcceeeEEEEecCceeEEEeccCC
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGG---WQRFKEFQTEAEAIGKI-RHPNIVSLRAYFWSVDEKLLIYDYIPN 447 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~e~~~~ 447 (686)
..||+|+||.||+|+.. +++.||||+++... ....+.+..|.+++.++ +||||+++++++.+.+..++||||+++
T Consensus 23 ~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~g 102 (345)
T 1xjd_A 23 KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNG 102 (345)
T ss_dssp EEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred EEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999976 58899999986532 23346688899999987 999999999999999999999999999
Q ss_pred CCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccC
Q 042348 448 GSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEE 527 (686)
Q Consensus 448 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 527 (686)
|+|.+++... ..+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 103 g~L~~~l~~~------~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~- 172 (345)
T 1xjd_A 103 GDLMYHIQSC------HKFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD- 172 (345)
T ss_dssp CBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT-
T ss_pred CcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCChhhEEECCCCCEEEeEChhhhhcccCC-
Confidence 9999999764 358999999999999999999999 899999999999999999999999999997532111
Q ss_pred CccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHH
Q 042348 528 TPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQ 607 (686)
Q Consensus 528 ~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~ 607 (686)
......+||..|+|||++.+..++.++|||||||++|||++|+.||..... ..
T Consensus 173 ----------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-----~~ 225 (345)
T 1xjd_A 173 ----------------------AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE-----EE 225 (345)
T ss_dssp ----------------------CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HH
T ss_pred ----------------------CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCH-----HH
Confidence 112345688899999999999999999999999999999999999954322 22
Q ss_pred HHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHH-HHHHH
Q 042348 608 WIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMR-HVCDS 664 (686)
Q Consensus 608 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~-ev~~~ 664 (686)
....+.......+.. ....+.+++.+||+.||++||++. ||.++
T Consensus 226 ~~~~i~~~~~~~p~~-------------~s~~~~~li~~lL~~dp~~R~~~~~~i~~h 270 (345)
T 1xjd_A 226 LFHSIRMDNPFYPRW-------------LEKEAKDLLVKLFVREPEKRLGVRGDIRQH 270 (345)
T ss_dssp HHHHHHHCCCCCCTT-------------SCHHHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred HHHHHHhCCCCCCcc-------------cCHHHHHHHHHHhcCCHhHcCCChHHHHcC
Confidence 333443333222211 123577899999999999999997 76654
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=358.94 Aligned_cols=245 Identities=22% Similarity=0.281 Sum_probs=199.5
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCCcc------chHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEecc
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGGWQ------RFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYI 445 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~ 445 (686)
..||+|+||.||+|... +++.||+|.+...... ..+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 18 ~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~~ 97 (361)
T 2yab_A 18 EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVLILELV 97 (361)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred eEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEEEEEEcC
Confidence 46999999999999876 5889999998654221 3467999999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCC----CeEEeecCcccc
Q 042348 446 PNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNM----EPHISDFGLARL 521 (686)
Q Consensus 446 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~----~~kl~DfGla~~ 521 (686)
++|+|.+++... ..+++..+..++.||+.||+|||+ ++|+||||||+|||++.++ .+||+|||+++.
T Consensus 98 ~gg~L~~~l~~~------~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~ 168 (361)
T 2yab_A 98 SGGELFDFLAQK------ESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE 168 (361)
T ss_dssp CSCBHHHHHTTC------SCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEE
T ss_pred CCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEeCCCCCccCEEEEecCCceE
Confidence 999999999764 458999999999999999999999 8999999999999998777 799999999986
Q ss_pred cccccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCcc
Q 042348 522 ADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSM 601 (686)
Q Consensus 522 ~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~ 601 (686)
..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 169 ~~~~~------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~- 223 (361)
T 2yab_A 169 IEDGV------------------------EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK- 223 (361)
T ss_dssp CCTTC------------------------CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH-
T ss_pred cCCCC------------------------ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH-
Confidence 54221 11234678889999999988999999999999999999999999955322
Q ss_pred chhHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 602 ELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 602 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
.+....+........ +.... .....+.+++.+||+.||++|||+.|++++
T Consensus 224 ----~~~~~~i~~~~~~~~----~~~~~-----~~s~~~~~li~~~L~~dP~~R~t~~e~l~h 273 (361)
T 2yab_A 224 ----QETLANITAVSYDFD----EEFFS-----QTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (361)
T ss_dssp ----HHHHHHHHTTCCCCC----HHHHT-----TSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ----HHHHHHHHhcCCCCC----chhcc-----CCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 222333333322211 11111 112357789999999999999999999875
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=360.54 Aligned_cols=244 Identities=20% Similarity=0.298 Sum_probs=197.5
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCC---ccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCC
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGG---WQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNG 448 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~g 448 (686)
..||+|+||.||+|... +++.||+|.+.... ....+.+.+|++++++++|||||++++++.+.+..++||||+++|
T Consensus 21 ~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~gg 100 (384)
T 4fr4_A 21 RAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGG 100 (384)
T ss_dssp EEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTE
T ss_pred EEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecCCCC
Confidence 46999999999999876 47889999986432 234567889999999999999999999999999999999999999
Q ss_pred CHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCC
Q 042348 449 SLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEET 528 (686)
Q Consensus 449 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 528 (686)
+|.+++... ..+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 101 ~L~~~l~~~------~~l~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~-- 169 (384)
T 4fr4_A 101 DLRYHLQQN------VHFKEETVKLFICELVMALDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET-- 169 (384)
T ss_dssp EHHHHHHTT------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTC--
T ss_pred cHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHHeEECCCCCEEEeccceeeeccCCC--
Confidence 999999864 358999999999999999999999 899999999999999999999999999998654221
Q ss_pred ccccccccccCCCCCCCccccccccCCCCCccccCcccccC---CCCCCcchHHHHHHHHHHHHhCCCCccccCccchhH
Q 042348 529 PEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKV---RKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNI 605 (686)
Q Consensus 529 ~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~ 605 (686)
......||..|+|||++.. ..++.++|||||||++|||++|+.||....... .
T Consensus 170 ----------------------~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~--~ 225 (384)
T 4fr4_A 170 ----------------------QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTS--S 225 (384)
T ss_dssp ----------------------CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSC--H
T ss_pred ----------------------ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCcc--H
Confidence 1234568889999999864 458999999999999999999999996443322 2
Q ss_pred HHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCC-HHHHHHH
Q 042348 606 VQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPS-MRHVCDS 664 (686)
Q Consensus 606 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-~~ev~~~ 664 (686)
...+..+.......+.. ....+.+++.+||+.||++||+ +.+|.++
T Consensus 226 ~~~~~~~~~~~~~~p~~-------------~s~~~~~li~~lL~~dP~~R~s~~~~l~~h 272 (384)
T 4fr4_A 226 KEIVHTFETTVVTYPSA-------------WSQEMVSLLKKLLEPNPDQRFSQLSDVQNF 272 (384)
T ss_dssp HHHHHHHHHCCCCCCTT-------------SCHHHHHHHHHHSCSSGGGSCCSHHHHHTS
T ss_pred HHHHHHHhhcccCCCCc-------------CCHHHHHHHHHHhcCCHhHhcccHHHHHcC
Confidence 22333333322222211 1235789999999999999998 6776654
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=350.13 Aligned_cols=256 Identities=26% Similarity=0.346 Sum_probs=200.5
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCC---CccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCC
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNG---GWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNG 448 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~g 448 (686)
..||+|+||.||+|... +++.||+|.+... .....+.+.+|+.++++++||||+++++++...+..++||||+++|
T Consensus 17 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~ 96 (294)
T 4eqm_A 17 DKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGP 96 (294)
T ss_dssp EEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEEECCCSC
T ss_pred EEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEEeCCCCC
Confidence 46999999999999865 5889999998543 2233567899999999999999999999999999999999999999
Q ss_pred CHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCC
Q 042348 449 SLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEET 528 (686)
Q Consensus 449 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 528 (686)
+|.+++... ..+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++.......
T Consensus 97 ~L~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 166 (294)
T 4eqm_A 97 TLSEYIESH------GPLSVDTAINFTNQILDGIKHAHD---MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSL- 166 (294)
T ss_dssp BHHHHHHHH------CSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCSSSTTC------
T ss_pred CHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEEeCCCccccccccc-
Confidence 999999764 358999999999999999999999 8999999999999999999999999999986542211
Q ss_pred ccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHH
Q 042348 529 PEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQW 608 (686)
Q Consensus 529 ~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~ 608 (686)
.......||..|+|||.+.+..++.++|||||||++|||+||+.||...... ..
T Consensus 167 ---------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~-----~~ 220 (294)
T 4eqm_A 167 ---------------------TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAV-----SI 220 (294)
T ss_dssp -----------------------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHH-----HH
T ss_pred ---------------------cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH-----HH
Confidence 1122345788899999999999999999999999999999999999543321 11
Q ss_pred HHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCC-CHHHHHHHHhcccccc
Q 042348 609 IQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRP-SMRHVCDSLDRVNIST 672 (686)
Q Consensus 609 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-s~~ev~~~L~~i~~~~ 672 (686)
.........+ .. ..... ......+.+++.+||+.||++|| +++++.+.|+.+....
T Consensus 221 ~~~~~~~~~~--~~-~~~~~-----~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~ 277 (294)
T 4eqm_A 221 AIKHIQDSVP--NV-TTDVR-----KDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHEN 277 (294)
T ss_dssp HHHHHSSCCC--CH-HHHSC-----TTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSS
T ss_pred HHHHhhccCC--Cc-chhcc-----cCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhc
Confidence 2222222111 10 00000 11234678899999999999998 8999999999876433
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=355.76 Aligned_cols=247 Identities=20% Similarity=0.309 Sum_probs=196.9
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCC---ccchHHHHHHHHHHhcc-CCCCcceeeEEEEecCceeEEEeccCC
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGG---WQRFKEFQTEAEAIGKI-RHPNIVSLRAYFWSVDEKLLIYDYIPN 447 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~e~~~~ 447 (686)
..||+|+||.||+|+.. +++.||+|++.... ....+.+.+|..++.++ +||||+++++++.+.+..++||||+++
T Consensus 15 ~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~e~~~g 94 (345)
T 3a8x_A 15 RVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 94 (345)
T ss_dssp EEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred EEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999976 57899999997542 23345688999999988 899999999999999999999999999
Q ss_pred CCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccC
Q 042348 448 GSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEE 527 (686)
Q Consensus 448 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 527 (686)
|+|.+++... ..+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 95 g~L~~~l~~~------~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~- 164 (345)
T 3a8x_A 95 GDLMFHMQRQ------RKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG- 164 (345)
T ss_dssp CBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTT-
T ss_pred CcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEECCCCCEEEEeccccccccCCC-
Confidence 9999999764 358999999999999999999999 899999999999999999999999999997532111
Q ss_pred CccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccc----h
Q 042348 528 TPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSME----L 603 (686)
Q Consensus 528 ~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~----~ 603 (686)
.......||..|+|||++.+..++.++|||||||++|||++|+.||...+... .
T Consensus 165 ----------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~ 222 (345)
T 3a8x_A 165 ----------------------DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQN 222 (345)
T ss_dssp ----------------------CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------
T ss_pred ----------------------CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccc
Confidence 11234568889999999999999999999999999999999999995432211 1
Q ss_pred hHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCH------HHHHHH
Q 042348 604 NIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSM------RHVCDS 664 (686)
Q Consensus 604 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~------~ev~~~ 664 (686)
......+.+.......+.. ....+.+++.+||+.||++||++ .|++++
T Consensus 223 ~~~~~~~~i~~~~~~~p~~-------------~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~h 276 (345)
T 3a8x_A 223 TEDYLFQVILEKQIRIPRS-------------LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 276 (345)
T ss_dssp CHHHHHHHHHHCCCCCCTT-------------SCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTS
T ss_pred cHHHHHHHHHcCCCCCCCC-------------CCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcC
Confidence 1112223333332222211 12357789999999999999996 566655
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=358.12 Aligned_cols=240 Identities=17% Similarity=0.234 Sum_probs=199.8
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCC---ccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCC
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGG---WQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNG 448 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~g 448 (686)
..||+|+||.||+|+.. +++.||||.+.... ....+.+.+|++++++++||||+++++++.+.+..++||||+++|
T Consensus 47 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~gg 126 (350)
T 1rdq_E 47 KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGG 126 (350)
T ss_dssp EEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTC
T ss_pred EEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCCCCC
Confidence 46999999999999976 58899999986532 233567889999999999999999999999999999999999999
Q ss_pred CHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCC
Q 042348 449 SLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEET 528 (686)
Q Consensus 449 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 528 (686)
+|.+++... ..+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 127 ~L~~~l~~~------~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~--- 194 (350)
T 1rdq_E 127 EMFSHLRRI------GRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--- 194 (350)
T ss_dssp BHHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC---
T ss_pred cHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCccceEEECCCCCEEEcccccceeccCC---
Confidence 999999864 358999999999999999999999 89999999999999999999999999999854321
Q ss_pred ccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHH
Q 042348 529 PEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQW 608 (686)
Q Consensus 529 ~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~ 608 (686)
.....||..|+|||++.+..++.++|||||||++|||++|+.||.... ..+.
T Consensus 195 -----------------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~-----~~~~ 246 (350)
T 1rdq_E 195 -----------------------TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ-----PIQI 246 (350)
T ss_dssp -----------------------BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHH
T ss_pred -----------------------cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCC-----HHHH
Confidence 123457888999999999999999999999999999999999995432 2233
Q ss_pred HHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCC-----HHHHHHHH
Q 042348 609 IQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPS-----MRHVCDSL 665 (686)
Q Consensus 609 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~ev~~~L 665 (686)
...+.......+.. ....+.+++.+||+.||++||+ +.||+++-
T Consensus 247 ~~~i~~~~~~~p~~-------------~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~ 295 (350)
T 1rdq_E 247 YEKIVSGKVRFPSH-------------FSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHK 295 (350)
T ss_dssp HHHHHHCCCCCCTT-------------CCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSG
T ss_pred HHHHHcCCCCCCCC-------------CCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCc
Confidence 44444443322211 1235779999999999999998 88887763
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=367.61 Aligned_cols=252 Identities=22% Similarity=0.341 Sum_probs=202.0
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCC-ccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCCH
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGG-WQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSL 450 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL 450 (686)
..||+|+||.||+|... +++.||||.++... ....++|.+|++++++++||||+++++++...+..++||||+++|+|
T Consensus 120 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L 199 (377)
T 3cbl_A 120 EQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 199 (377)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBH
T ss_pred eEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEcCCCCCH
Confidence 46999999999999986 68899999987643 23345789999999999999999999999999999999999999999
Q ss_pred HHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCcc
Q 042348 451 ATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPE 530 (686)
Q Consensus 451 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 530 (686)
.++++... ..+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++........
T Consensus 200 ~~~l~~~~-----~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~-- 269 (377)
T 3cbl_A 200 LTFLRTEG-----ARLRVKTLLQMVGDAAAGMEYLES---KCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYA-- 269 (377)
T ss_dssp HHHHHHHG-----GGCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEE--
T ss_pred HHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHH---CCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCcee--
Confidence 99998643 358999999999999999999999 89999999999999999999999999999754321100
Q ss_pred ccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCccccCccchhHHHHH
Q 042348 531 VHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQIGSMELNIVQWI 609 (686)
Q Consensus 531 ~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~~~~~~~~ 609 (686)
.......++..|+|||.+.+..++.++|||||||++|||+| |+.||......+ . .
T Consensus 270 -------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~--~---~ 325 (377)
T 3cbl_A 270 -------------------ASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQ--T---R 325 (377)
T ss_dssp -------------------CCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHH--H---H
T ss_pred -------------------ecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--H---H
Confidence 00011223567999999988889999999999999999999 999995543221 1 1
Q ss_pred HHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccc
Q 042348 610 QLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRVNI 670 (686)
Q Consensus 610 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~ 670 (686)
..+..+ .... .+ ......+.+++.+||+.||++|||+.+|++.|+++..
T Consensus 326 ~~~~~~-~~~~---~~--------~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~ 374 (377)
T 3cbl_A 326 EFVEKG-GRLP---CP--------ELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRK 374 (377)
T ss_dssp HHHHTT-CCCC---CC--------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHcC-CCCC---CC--------CCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHh
Confidence 222222 1111 00 1123467889999999999999999999999998763
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-41 Score=349.97 Aligned_cols=265 Identities=20% Similarity=0.262 Sum_probs=206.5
Q ss_pred cccCccCceEEEEEEeCC-CceEEEEEcCCCC-ccchHHHHHHHHHHhccCCCCcceeeEEEEecC--ceeEEEeccCCC
Q 042348 373 FLLGKSTIGIVYKVALNN-EEAVAVRRLGNGG-WQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVD--EKLLIYDYIPNG 448 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~--~~~lV~e~~~~g 448 (686)
..||+|+||.||+|.... ++.||||++.... ....+.+.+|++++++++||||+++++++...+ ..++||||+++|
T Consensus 15 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~ 94 (319)
T 4euu_A 15 DILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCG 94 (319)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEECCTTC
T ss_pred EEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEEeCCCCC
Confidence 469999999999999764 8899999997543 234567889999999999999999999998765 679999999999
Q ss_pred CHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeee----cCCCCeEEeecCccccccc
Q 042348 449 SLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILL----GKNMEPHISDFGLARLADI 524 (686)
Q Consensus 449 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl----~~~~~~kl~DfGla~~~~~ 524 (686)
+|.+++...... ..+++.+++.++.|++.||+|||+ ++|+||||||+|||+ +.++.+||+|||+++....
T Consensus 95 ~L~~~l~~~~~~---~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~~ 168 (319)
T 4euu_A 95 SLYTVLEEPSNA---YGLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED 168 (319)
T ss_dssp BHHHHHHSGGGT---TCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEECCT
T ss_pred CHHHHHHHhccc---cCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEEeccCCCCceEEEccCCCceecCC
Confidence 999999875421 348999999999999999999999 899999999999999 7788899999999986543
Q ss_pred ccCCccccccccccCCCCCCCccccccccCCCCCccccCccccc--------CCCCCCcchHHHHHHHHHHHHhCCCCcc
Q 042348 525 AEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASK--------VRKPTQKWDIYSYGVILLEMISGKLPMI 596 (686)
Q Consensus 525 ~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~sDVwSlGvvl~elltG~~P~~ 596 (686)
.. ......||..|+|||++. +..++.++|||||||++|||+||+.||.
T Consensus 169 ~~------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~ 224 (319)
T 4euu_A 169 DE------------------------QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFR 224 (319)
T ss_dssp TC------------------------CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEE
T ss_pred CC------------------------ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 21 112345788899999875 5678999999999999999999999996
Q ss_pred ccCccchhHHHHHHHHHhhcCCc-cc-c---cC------cccc-cCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 597 QIGSMELNIVQWIQLILEDRKPM-TD-I---LD------PFLA-HDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 597 ~~~~~~~~~~~~~~~~~~~~~~~-~~-~---~d------~~l~-~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
...... ...+.+..+....... .. . .. +.+. ...........+.+++.+||+.||++|||++|++++
T Consensus 225 ~~~~~~-~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h 303 (319)
T 4euu_A 225 PFEGPR-RNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303 (319)
T ss_dssp CTTCGG-GCHHHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHH
T ss_pred CCCccc-hhHHHHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhc
Confidence 544322 2233344444432210 00 0 00 0000 011124566678899999999999999999999999
Q ss_pred Hhcc
Q 042348 665 LDRV 668 (686)
Q Consensus 665 L~~i 668 (686)
..+.
T Consensus 304 ~~d~ 307 (319)
T 4euu_A 304 TSDI 307 (319)
T ss_dssp HHHH
T ss_pred cHHH
Confidence 8764
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=356.83 Aligned_cols=242 Identities=21% Similarity=0.310 Sum_probs=198.1
Q ss_pred cccCccCceEEEEEEeCC-CceEEEEEcCCCC---ccchHHHHHHHHHHhcc-CCCCcceeeEEEEecCceeEEEeccCC
Q 042348 373 FLLGKSTIGIVYKVALNN-EEAVAVRRLGNGG---WQRFKEFQTEAEAIGKI-RHPNIVSLRAYFWSVDEKLLIYDYIPN 447 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~e~~~~ 447 (686)
..||+|+||.||+|+... ++.||||++.... ....+.+..|.+++..+ +||||+++++++.+.+..++||||+++
T Consensus 26 ~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~g 105 (353)
T 2i0e_A 26 MVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNG 105 (353)
T ss_dssp EEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEEEECCCS
T ss_pred EEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEEEeCCCC
Confidence 469999999999999864 7889999986532 23456788999999988 899999999999999999999999999
Q ss_pred CCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccC
Q 042348 448 GSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEE 527 (686)
Q Consensus 448 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 527 (686)
|+|.+++... ..+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 106 g~L~~~l~~~------~~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~- 175 (353)
T 2i0e_A 106 GDLMYHIQQV------GRFKEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG- 175 (353)
T ss_dssp CBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT-
T ss_pred CcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCEEeccCCHHHEEEcCCCcEEEEeCCcccccccCC-
Confidence 9999999764 358999999999999999999999 899999999999999999999999999997432111
Q ss_pred CccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHH
Q 042348 528 TPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQ 607 (686)
Q Consensus 528 ~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~ 607 (686)
......+||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+
T Consensus 176 ----------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~-----~~ 228 (353)
T 2i0e_A 176 ----------------------VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE-----DE 228 (353)
T ss_dssp ----------------------CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HH
T ss_pred ----------------------cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCH-----HH
Confidence 112345688899999999999999999999999999999999999954322 23
Q ss_pred HHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCC-----HHHHHHH
Q 042348 608 WIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPS-----MRHVCDS 664 (686)
Q Consensus 608 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~ev~~~ 664 (686)
..+.+.......+.. ...++.+++.+||+.||++||+ +.||+++
T Consensus 229 ~~~~i~~~~~~~p~~-------------~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h 277 (353)
T 2i0e_A 229 LFQSIMEHNVAYPKS-------------MSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 277 (353)
T ss_dssp HHHHHHHCCCCCCTT-------------SCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred HHHHHHhCCCCCCCC-------------CCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 344444443322211 1235778999999999999995 4677665
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-42 Score=374.77 Aligned_cols=259 Identities=29% Similarity=0.470 Sum_probs=205.6
Q ss_pred cccCccCceEEEEEEeCCCceEEEEEcCCCCccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCCHHH
Q 042348 373 FLLGKSTIGIVYKVALNNEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLAT 452 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL~~ 452 (686)
..||+|+||.||+|...++..||||+++.... ..++|.+|+++|++++||||+++++++.. +..++||||+++|+|.+
T Consensus 190 ~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~~gsL~~ 267 (452)
T 1fmk_A 190 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLD 267 (452)
T ss_dssp EEEEECSSCEEEEEEETTTEEEEEEECCTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTCBHHH
T ss_pred eeecCCCCeEEEEEEECCCceEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhhcCCCHHH
Confidence 46999999999999998888899999976543 35789999999999999999999999866 77899999999999999
Q ss_pred HhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCcccc
Q 042348 453 AIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVH 532 (686)
Q Consensus 453 ~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 532 (686)
++....+ ..+++.++..++.|++.||+|||+ ++|+||||||+|||+++++.+||+|||+++.......
T Consensus 268 ~l~~~~~----~~~~~~~~~~i~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~----- 335 (452)
T 1fmk_A 268 FLKGETG----KYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY----- 335 (452)
T ss_dssp HHSHHHH----TTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCTTC------------
T ss_pred HHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChhhEEECCCCCEEECCCccceecCCCce-----
Confidence 9975322 358999999999999999999999 8999999999999999999999999999986542211
Q ss_pred ccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCccccCccchhHHHHHHH
Q 042348 533 WEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQIGSMELNIVQWIQL 611 (686)
Q Consensus 533 ~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~ 611 (686)
.......++..|+|||.+.+..++.++|||||||++|||+| |+.||...... +....
T Consensus 336 -----------------~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~-----~~~~~ 393 (452)
T 1fmk_A 336 -----------------TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR-----EVLDQ 393 (452)
T ss_dssp ------------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-----HHHHH
T ss_pred -----------------ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHH-----HHHHH
Confidence 01112345677999999988899999999999999999999 99999543321 22222
Q ss_pred HHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccccchhhhhcc
Q 042348 612 ILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRVNISTEQQFMKG 679 (686)
Q Consensus 612 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~~~~~~~~~~ 679 (686)
+..+. ... . .......+.+++.+||+.||++|||+.+|++.|+.+....+.++..+
T Consensus 394 i~~~~-~~~--~---------~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~~~~~~~ 449 (452)
T 1fmk_A 394 VERGY-RMP--C---------PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPG 449 (452)
T ss_dssp HHTTC-CCC--C---------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCCCCCCS
T ss_pred HHcCC-CCC--C---------CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCCcccccc
Confidence 22221 111 0 01123467899999999999999999999999999987777766544
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=354.69 Aligned_cols=245 Identities=20% Similarity=0.295 Sum_probs=199.9
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCCccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCCHH
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLA 451 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL~ 451 (686)
..||+|+||.||+|... +++.||+|.+.... .....+.+|+.++++++||||+++++++.+.+..++||||+++|+|.
T Consensus 11 ~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~ 89 (321)
T 1tki_A 11 EDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIF 89 (321)
T ss_dssp EEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBHH
T ss_pred eEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeCCCCCHH
Confidence 46999999999999876 57889999987543 33467889999999999999999999999999999999999999999
Q ss_pred HHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecC--CCCeEEeecCcccccccccCCc
Q 042348 452 TAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGK--NMEPHISDFGLARLADIAEETP 529 (686)
Q Consensus 452 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~--~~~~kl~DfGla~~~~~~~~~~ 529 (686)
+++.... ..+++.++..++.|++.||+|||+ ++|+||||||+|||++. ++.+||+|||+++......
T Consensus 90 ~~l~~~~-----~~~~~~~~~~i~~qi~~al~~lH~---~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~--- 158 (321)
T 1tki_A 90 ERINTSA-----FELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD--- 158 (321)
T ss_dssp HHHTSSS-----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC---
T ss_pred HHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHH---CCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC---
Confidence 9997653 358999999999999999999999 89999999999999987 7899999999998654221
Q ss_pred cccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHHH
Q 042348 530 EVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQWI 609 (686)
Q Consensus 530 ~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~ 609 (686)
......||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+.+
T Consensus 159 ---------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-----~~~~ 212 (321)
T 1tki_A 159 ---------------------NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN-----QQII 212 (321)
T ss_dssp ---------------------EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH-----HHHH
T ss_pred ---------------------ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCH-----HHHH
Confidence 11234567789999999988889999999999999999999999954322 2233
Q ss_pred HHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 610 QLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 610 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
..+......... .... ....++.+++.+||+.||++|||+.|++++
T Consensus 213 ~~i~~~~~~~~~----~~~~-----~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h 258 (321)
T 1tki_A 213 ENIMNAEYTFDE----EAFK-----EISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp HHHHHTCCCCCH----HHHT-----TSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred HHHHcCCCCCCh----hhhc-----cCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 344433322111 0000 122467899999999999999999999986
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=361.18 Aligned_cols=246 Identities=24% Similarity=0.322 Sum_probs=196.8
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCCccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCCHH
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLA 451 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL~ 451 (686)
+.||+|+||.||+|... +++.||+|++........+.+.+|++++++++||||+++++++...+..++||||+++|+|.
T Consensus 95 ~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L~ 174 (373)
T 2x4f_A 95 EILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELF 174 (373)
T ss_dssp EECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEEH
T ss_pred eEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHH
Confidence 46999999999999875 58899999998766566678999999999999999999999999999999999999999999
Q ss_pred HHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeee--cCCCCeEEeecCcccccccccCCc
Q 042348 452 TAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILL--GKNMEPHISDFGLARLADIAEETP 529 (686)
Q Consensus 452 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl--~~~~~~kl~DfGla~~~~~~~~~~ 529 (686)
+++.... ..+++..+..++.||+.||+|||+ ++|+||||||+|||+ +.++.+||+|||+++......
T Consensus 175 ~~l~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~--- 243 (373)
T 2x4f_A 175 DRIIDES-----YNLTELDTILFMKQICEGIRHMHQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE--- 243 (373)
T ss_dssp HHHHHTG-----GGCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC---
T ss_pred HHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc---
Confidence 9987543 358999999999999999999999 899999999999999 567889999999998654221
Q ss_pred cccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHHH
Q 042348 530 EVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQWI 609 (686)
Q Consensus 530 ~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~ 609 (686)
......||..|+|||++.+..++.++|||||||++|||++|+.||..... ...+
T Consensus 244 ---------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~-----~~~~ 297 (373)
T 2x4f_A 244 ---------------------KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDND-----AETL 297 (373)
T ss_dssp ---------------------BCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSH-----HHHH
T ss_pred ---------------------ccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH-----HHHH
Confidence 11234578889999999988899999999999999999999999954332 2223
Q ss_pred HHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 610 QLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 610 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
..+......... +.. ......+.+++.+||+.||++|||+.|++++
T Consensus 298 ~~i~~~~~~~~~---~~~------~~~~~~~~~li~~~L~~dp~~Rps~~e~l~h 343 (373)
T 2x4f_A 298 NNILACRWDLED---EEF------QDISEEAKEFISKLLIKEKSWRISASEALKH 343 (373)
T ss_dssp HHHHHTCCCSCS---GGG------TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred HHHHhccCCCCh---hhh------ccCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 333333222111 100 0122467899999999999999999999985
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=352.39 Aligned_cols=246 Identities=21% Similarity=0.304 Sum_probs=198.9
Q ss_pred hcccCccCceEEEEEEeC-CCceEEEEEcCCCCc------cchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEec
Q 042348 372 AFLLGKSTIGIVYKVALN-NEEAVAVRRLGNGGW------QRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDY 444 (686)
Q Consensus 372 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~ 444 (686)
...||+|+||.||+|... +++.||+|.+..... ...+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 95 (326)
T 2y0a_A 16 GEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILEL 95 (326)
T ss_dssp EEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEEc
Confidence 346999999999999876 588999999865322 1356799999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCC----CeEEeecCccc
Q 042348 445 IPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNM----EPHISDFGLAR 520 (686)
Q Consensus 445 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~----~~kl~DfGla~ 520 (686)
+++|+|.+++... ..+++..+..++.|++.||+|||+ ++|+||||||+||+++.++ .+||+|||+++
T Consensus 96 ~~~~~L~~~l~~~------~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~ 166 (326)
T 2y0a_A 96 VAGGELFDFLAEK------ESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166 (326)
T ss_dssp CCSCBHHHHHTTS------SCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred CCCCCHHHHHHhc------CCcCHHHHHHHHHHHHHHHHHHHH---CCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCe
Confidence 9999999999754 458999999999999999999999 8999999999999999887 89999999998
Q ss_pred ccccccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCc
Q 042348 521 LADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGS 600 (686)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~ 600 (686)
...... ......||..|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 167 ~~~~~~------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 222 (326)
T 2y0a_A 167 KIDFGN------------------------EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK 222 (326)
T ss_dssp ECCTTS------------------------CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH
T ss_pred ECCCCC------------------------ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCH
Confidence 654221 11234578889999999988999999999999999999999999954322
Q ss_pred cchhHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 601 MELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 601 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
. +....+......... .... .....+.+++.+||+.||++|||+.|++++
T Consensus 223 ~-----~~~~~~~~~~~~~~~----~~~~-----~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 223 Q-----ETLANVSAVNYEFED----EYFS-----NTSALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp H-----HHHHHHHHTCCCCCH----HHHT-----TSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred H-----HHHHHHHhcCCCcCc----cccc-----cCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 1 222222222211111 0000 112357789999999999999999999986
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=351.51 Aligned_cols=258 Identities=24% Similarity=0.332 Sum_probs=196.1
Q ss_pred cccCccCceEEEEEEeCCCceEEEEEcCCCCc--cchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCCH
Q 042348 373 FLLGKSTIGIVYKVALNNEEAVAVRRLGNGGW--QRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSL 450 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL 450 (686)
..||+|+||.||+|...+++.||+|++..... ...+.+.+|++++++++||||+++++++.+.+..++||||++ |+|
T Consensus 27 ~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~-~~l 105 (311)
T 3niz_A 27 EKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFME-KDL 105 (311)
T ss_dssp EEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEECCS-EEH
T ss_pred hhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcCCC-CCH
Confidence 36999999999999998899999999865422 234678899999999999999999999999999999999997 588
Q ss_pred HHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCcc
Q 042348 451 ATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPE 530 (686)
Q Consensus 451 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 530 (686)
.+++.... ..+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 106 ~~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~--- 174 (311)
T 3niz_A 106 KKVLDENK-----TGLQDSQIKIYLYQLLRGVAHCHQ---HRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVR--- 174 (311)
T ss_dssp HHHHHTCT-----TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC---
T ss_pred HHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCchHhEEECCCCCEEEccCcCceecCCCcc---
Confidence 88887654 458999999999999999999999 8999999999999999999999999999986532111
Q ss_pred ccccccccCCCCCCCccccccccCCCCCccccCcccccC-CCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHHH
Q 042348 531 VHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKV-RKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQWI 609 (686)
Q Consensus 531 ~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~ 609 (686)
......+|..|+|||++.+ ..++.++|||||||++|||++|+.||......+ ....+
T Consensus 175 --------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--~~~~i 232 (311)
T 3niz_A 175 --------------------SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDD--QLPKI 232 (311)
T ss_dssp -----------------------CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTT--HHHHH
T ss_pred --------------------cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHH--HHHHH
Confidence 1123456888999999876 568999999999999999999999996544332 22222
Q ss_pred HHHHhhcCC--cccccC------cccc--cCCCc----HHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 610 QLILEDRKP--MTDILD------PFLA--HDLDK----EDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 610 ~~~~~~~~~--~~~~~d------~~l~--~~~~~----~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
........+ +....+ .... ..... +....++.+++.+||+.||++|||++|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 301 (311)
T 3niz_A 233 FSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH 301 (311)
T ss_dssp HHHHCCCCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHHCCCChHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 222221111 000000 0000 00000 0122467899999999999999999999874
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-42 Score=363.60 Aligned_cols=259 Identities=23% Similarity=0.306 Sum_probs=204.1
Q ss_pred cccCccCceEEEEEEeC------CCceEEEEEcCCC-CccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEecc
Q 042348 373 FLLGKSTIGIVYKVALN------NEEAVAVRRLGNG-GWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYI 445 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~ 445 (686)
..||+|+||.||+|... ++..||||++... ......++.+|+.++++++|||||++++++...+..++||||+
T Consensus 77 ~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~ 156 (367)
T 3l9p_A 77 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELM 156 (367)
T ss_dssp EECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred eEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCEEEEEeC
Confidence 46999999999999853 3568999999754 3344567899999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcCCCcc-ccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCC---CeEEeecCcccc
Q 042348 446 PNGSLATAIHGKAGII-SYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNM---EPHISDFGLARL 521 (686)
Q Consensus 446 ~~gsL~~~l~~~~~~~-~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~---~~kl~DfGla~~ 521 (686)
++|+|.+++....... ....+++.+++.++.||+.||+|||+ ++|+||||||+|||++.++ .+||+|||+++.
T Consensus 157 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~~~~kL~DFG~a~~ 233 (367)
T 3l9p_A 157 AGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARD 233 (367)
T ss_dssp TTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEECCCHHHHH
T ss_pred CCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChhhEEEecCCCCceEEECCCccccc
Confidence 9999999998653211 11358999999999999999999999 8999999999999999555 599999999986
Q ss_pred cccccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCccccCc
Q 042348 522 ADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQIGS 600 (686)
Q Consensus 522 ~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~ 600 (686)
....... .......+|..|+|||++.+..++.++|||||||++|||+| |+.||.....
T Consensus 234 ~~~~~~~---------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~ 292 (367)
T 3l9p_A 234 IYRAGYY---------------------RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN 292 (367)
T ss_dssp HHHHSSC---------------------TTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred ccccccc---------------------ccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 5432211 01122346778999999988899999999999999999998 9999954322
Q ss_pred cchhHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccccc
Q 042348 601 MELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRVNIST 672 (686)
Q Consensus 601 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~~~ 672 (686)
.+....+........ .......+.+++.+||+.||++|||+.||+++|+.+....
T Consensus 293 -----~~~~~~i~~~~~~~~------------~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~ 347 (367)
T 3l9p_A 293 -----QEVLEFVTSGGRMDP------------PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP 347 (367)
T ss_dssp -----HHHHHHHHTTCCCCC------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred -----HHHHHHHHcCCCCCC------------CccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhCh
Confidence 122233332221100 0112235789999999999999999999999999886543
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=364.57 Aligned_cols=246 Identities=22% Similarity=0.292 Sum_probs=198.3
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCC--ccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCC
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGG--WQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGS 449 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gs 449 (686)
..||+|+||.||+|... +++.||+|.+.... ....+.+.+|++++++++|||||++++++.+.+..++|||||++|+
T Consensus 17 ~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~ 96 (444)
T 3soa_A 17 EELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGE 96 (444)
T ss_dssp EEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEECCCBCCB
T ss_pred EEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEEeCCCCC
Confidence 46999999999999864 68899999986543 2334678999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeec---CCCCeEEeecCccccccccc
Q 042348 450 LATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLG---KNMEPHISDFGLARLADIAE 526 (686)
Q Consensus 450 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~---~~~~~kl~DfGla~~~~~~~ 526 (686)
|.+.+... ..+++..+..++.||+.||+|||+ ++|+||||||+|||++ .++.+||+|||+++......
T Consensus 97 L~~~i~~~------~~~~e~~~~~i~~qil~aL~~lH~---~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~ 167 (444)
T 3soa_A 97 LFEDIVAR------EYYSEADASHCIQQILEAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ 167 (444)
T ss_dssp HHHHHHHC------SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTC
T ss_pred HHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCC
Confidence 99999865 358999999999999999999999 8999999999999998 46789999999997554221
Q ss_pred CCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHH
Q 042348 527 ETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIV 606 (686)
Q Consensus 527 ~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~ 606 (686)
.......||+.|+|||++.+..++.++||||+||++|+|++|+.||..... .
T Consensus 168 -----------------------~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~-----~ 219 (444)
T 3soa_A 168 -----------------------QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQ-----H 219 (444)
T ss_dssp -----------------------CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSH-----H
T ss_pred -----------------------ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccH-----H
Confidence 112245678899999999988999999999999999999999999954322 2
Q ss_pred HHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 607 QWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 607 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
.....+..+....+. +.. ......+.+++.+||+.||++|||+.|++++
T Consensus 220 ~~~~~i~~~~~~~~~---~~~------~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 220 RLYQQIKAGAYDFPS---PEW------DTVTPEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp HHHHHHHHTCCCCCT---TTT------TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHHhCCCCCCc---ccc------ccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 223334333322211 111 1122357899999999999999999999886
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=356.06 Aligned_cols=252 Identities=26% Similarity=0.375 Sum_probs=195.9
Q ss_pred cccCccCceEEEEEEeC-CCc----eEEEEEcCCC-CccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccC
Q 042348 373 FLLGKSTIGIVYKVALN-NEE----AVAVRRLGNG-GWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIP 446 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~ 446 (686)
..||+|+||.||+|... +++ .||+|.+... .....+++.+|+.++++++||||+++++++... ..++||||++
T Consensus 21 ~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~v~e~~~ 99 (327)
T 3poz_A 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMP 99 (327)
T ss_dssp EEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS-SEEEEEECCT
T ss_pred eEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-CeEEEEEecC
Confidence 46999999999999864 333 4688888653 234457899999999999999999999999875 4789999999
Q ss_pred CCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCccccccccc
Q 042348 447 NGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAE 526 (686)
Q Consensus 447 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~ 526 (686)
+|+|.+++.... ..+++..++.|+.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 100 ~g~L~~~l~~~~-----~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 171 (327)
T 3poz_A 100 FGCLLDYVREHK-----DNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 171 (327)
T ss_dssp TCBHHHHHHHST-----TSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTTC
T ss_pred CCcHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCChheEEECCCCCEEEccCcceeEccCCc
Confidence 999999998754 468999999999999999999999 899999999999999999999999999998764322
Q ss_pred CCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCccccCccchhH
Q 042348 527 ETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQIGSMELNI 605 (686)
Q Consensus 527 ~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~~~~ 605 (686)
.. .......+|..|+|||++.+..++.++|||||||++|||+| |+.||....... +
T Consensus 172 ~~---------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~ 228 (327)
T 3poz_A 172 KE---------------------YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--I 228 (327)
T ss_dssp C----------------------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--H
T ss_pred cc---------------------ccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH--H
Confidence 11 11123345778999999999999999999999999999999 999996543322 1
Q ss_pred HHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccccc
Q 042348 606 VQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRVNIS 671 (686)
Q Consensus 606 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~~ 671 (686)
. ........... .......+.+++.+||+.||++||++.|++++|+++...
T Consensus 229 ~----~~~~~~~~~~~-----------~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~ 279 (327)
T 3poz_A 229 S----SILEKGERLPQ-----------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp H----HHHHTTCCCCC-----------CTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred H----HHHHcCCCCCC-----------CccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence 1 11222111110 011234678899999999999999999999999987654
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=356.42 Aligned_cols=246 Identities=23% Similarity=0.326 Sum_probs=199.1
Q ss_pred hcccCccCceEEEEEEeC-CCceEEEEEcCCCC--ccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCC
Q 042348 372 AFLLGKSTIGIVYKVALN-NEEAVAVRRLGNGG--WQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNG 448 (686)
Q Consensus 372 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~g 448 (686)
...||+|+||.||+|... +++.||+|.+.... ....+.+.+|++++++++||||+++++++.+.+..++||||+++|
T Consensus 34 ~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e~~~gg 113 (362)
T 2bdw_A 34 KEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGG 113 (362)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred eeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCC
Confidence 346999999999999875 58899999986542 234567899999999999999999999999999999999999999
Q ss_pred CHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCC---CCeEEeecCcccccccc
Q 042348 449 SLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKN---MEPHISDFGLARLADIA 525 (686)
Q Consensus 449 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~---~~~kl~DfGla~~~~~~ 525 (686)
+|.+++... ..+++.++..++.||+.||+|||+ ++|+||||||+|||++.+ +.+||+|||+++.....
T Consensus 114 ~L~~~l~~~------~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~ 184 (362)
T 2bdw_A 114 ELFEDIVAR------EFYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 184 (362)
T ss_dssp BHHHHHTTC------SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTC
T ss_pred CHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCC
Confidence 999999765 358999999999999999999999 899999999999999865 45999999999755421
Q ss_pred cCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhH
Q 042348 526 EETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNI 605 (686)
Q Consensus 526 ~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~ 605 (686)
. ......||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 185 ~------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~----- 235 (362)
T 2bdw_A 185 E------------------------AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ----- 235 (362)
T ss_dssp C------------------------SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----
T ss_pred c------------------------ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-----
Confidence 1 11234678889999999988999999999999999999999999954322
Q ss_pred HHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 606 VQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 606 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
......+.......+. +.. ......+.+++.+||+.||++|||+.|++++
T Consensus 236 ~~~~~~i~~~~~~~~~---~~~------~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 236 HRLYAQIKAGAYDYPS---PEW------DTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp HHHHHHHHHTCCCCCT---TGG------GGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred HHHHHHHHhCCCCCCc---ccc------cCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 2223333333222111 100 1123467899999999999999999999876
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=369.42 Aligned_cols=245 Identities=24% Similarity=0.417 Sum_probs=200.2
Q ss_pred cccCccCceEEEEEEeCCCceEEEEEcCCCCccchHHHHHHHHHHhccCCCCcceeeEEEEecC-ceeEEEeccCCCCHH
Q 042348 373 FLLGKSTIGIVYKVALNNEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVD-EKLLIYDYIPNGSLA 451 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~-~~~lV~e~~~~gsL~ 451 (686)
..||+|+||.||+|... ++.||||.++... ..+.|.+|+++|++++|||||++++++...+ ..++|||||++|+|.
T Consensus 199 ~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~g~L~ 275 (450)
T 1k9a_A 199 QTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLV 275 (450)
T ss_dssp EEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECCTTCBHH
T ss_pred eeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEecCCCcHH
Confidence 46999999999999986 6789999997653 4578999999999999999999999987765 789999999999999
Q ss_pred HHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCccc
Q 042348 452 TAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEV 531 (686)
Q Consensus 452 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 531 (686)
+++..... ..+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 276 ~~l~~~~~----~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~----- 343 (450)
T 1k9a_A 276 DYLRSRGR----SVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ----- 343 (450)
T ss_dssp HHHHHHCT----TTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTSCEEECCCTTCEECC--------
T ss_pred HHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHhhEEECCCCCEEEeeCCCcccccccc-----
Confidence 99986532 347999999999999999999999 899999999999999999999999999997432111
Q ss_pred cccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCccccCccchhHHHHHH
Q 042348 532 HWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQIGSMELNIVQWIQ 610 (686)
Q Consensus 532 ~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~~~~~~~~~ 610 (686)
....++..|+|||.+.+..++.++|||||||++|||+| |+.||......+ . ..
T Consensus 344 ---------------------~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~--~---~~ 397 (450)
T 1k9a_A 344 ---------------------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--V---VP 397 (450)
T ss_dssp ------------------------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT--H---HH
T ss_pred ---------------------cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--H---HH
Confidence 11234667999999999999999999999999999999 999996543322 1 22
Q ss_pred HHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccc
Q 042348 611 LILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRVNI 670 (686)
Q Consensus 611 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~ 670 (686)
.+..+. .+. . ...+...+.+++.+||+.||++|||+.|+++.|+.+..
T Consensus 398 ~i~~~~-~~~------~-----p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~ 445 (450)
T 1k9a_A 398 RVEKGY-KMD------A-----PDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRT 445 (450)
T ss_dssp HHHTTC-CCC------C-----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHcCC-CCC------C-----CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 222221 110 0 01123468899999999999999999999999998864
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-41 Score=359.18 Aligned_cols=258 Identities=25% Similarity=0.367 Sum_probs=205.1
Q ss_pred cccCccCceEEEEEEeC--------CCceEEEEEcCCCC-ccchHHHHHHHHHHhcc-CCCCcceeeEEEEecCceeEEE
Q 042348 373 FLLGKSTIGIVYKVALN--------NEEAVAVRRLGNGG-WQRFKEFQTEAEAIGKI-RHPNIVSLRAYFWSVDEKLLIY 442 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~ 442 (686)
..||+|+||.||+|... .+..||||++.... ....+++.+|+++++++ +|||||++++++...+..++||
T Consensus 75 ~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~ 154 (382)
T 3tt0_A 75 KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIV 154 (382)
T ss_dssp EEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred eEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccCCceEEEE
Confidence 46999999999999852 23579999997643 33457799999999999 9999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCCc----------cccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeE
Q 042348 443 DYIPNGSLATAIHGKAGI----------ISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPH 512 (686)
Q Consensus 443 e~~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~k 512 (686)
||+++|+|.+++...... .....+++.+++.|+.|++.||+|||+ ++|+||||||+|||++.++.+|
T Consensus 155 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~k 231 (382)
T 3tt0_A 155 EYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMK 231 (382)
T ss_dssp ECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEE
T ss_pred EecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCcceEEEcCCCcEE
Confidence 999999999999865421 111358999999999999999999999 8999999999999999999999
Q ss_pred EeecCcccccccccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHh-C
Q 042348 513 ISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-G 591 (686)
Q Consensus 513 l~DfGla~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G 591 (686)
|+|||+++........ .......+|..|+|||++.+..++.++|||||||++|||++ |
T Consensus 232 L~DFG~a~~~~~~~~~---------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g 290 (382)
T 3tt0_A 232 IADFGLARDIHHIDYY---------------------KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLG 290 (382)
T ss_dssp ECSCSCCCCSSCCCTT---------------------CCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTS
T ss_pred EcccCccccccccccc---------------------ccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCC
Confidence 9999999865432110 11123445778999999999999999999999999999999 9
Q ss_pred CCCccccCccchhHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccccc
Q 042348 592 KLPMIQIGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRVNIS 671 (686)
Q Consensus 592 ~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~~ 671 (686)
+.||..... .+....+........ + .....++.+++.+||+.||++|||+.||+++|+++...
T Consensus 291 ~~p~~~~~~-----~~~~~~~~~~~~~~~----~--------~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 353 (382)
T 3tt0_A 291 GSPYPGVPV-----EELFKLLKEGHRMDK----P--------SNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 353 (382)
T ss_dssp CCSSTTCCH-----HHHHHHHHTTCCCCC----C--------SSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCCCH-----HHHHHHHHcCCCCCC----C--------ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 999954322 222333322211100 0 01223678999999999999999999999999998643
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-42 Score=361.99 Aligned_cols=259 Identities=26% Similarity=0.352 Sum_probs=202.0
Q ss_pred cccCccCceEEEEEEe------CCCceEEEEEcCCCC-ccchHHHHHHHHHHhcc-CCCCcceeeEEEEecCc-eeEEEe
Q 042348 373 FLLGKSTIGIVYKVAL------NNEEAVAVRRLGNGG-WQRFKEFQTEAEAIGKI-RHPNIVSLRAYFWSVDE-KLLIYD 443 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~-~~lV~e 443 (686)
..||+|+||.||+|.+ .+++.||||++.... ....+.+.+|++++.++ +||||+++++++...+. .++|||
T Consensus 28 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~~iv~e 107 (359)
T 3vhe_A 28 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVE 107 (359)
T ss_dssp EEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEEEE
T ss_pred eeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCCceEEEEE
Confidence 4699999999999974 245789999997643 33456799999999999 79999999999987654 899999
Q ss_pred ccCCCCHHHHhhcCCCcc------------------------------------------------------------cc
Q 042348 444 YIPNGSLATAIHGKAGII------------------------------------------------------------SY 463 (686)
Q Consensus 444 ~~~~gsL~~~l~~~~~~~------------------------------------------------------------~~ 463 (686)
|+++|+|.++++...... ..
T Consensus 108 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 187 (359)
T 3vhe_A 108 FCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYK 187 (359)
T ss_dssp CCTTEEHHHHHHTTTTSBCSCC------------------------------------------------------CTTT
T ss_pred ecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhcccccchhc
Confidence 999999999998754210 01
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCccccccccccCCCCC
Q 042348 464 RPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQ 543 (686)
Q Consensus 464 ~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~g~~~~ 543 (686)
..+++..+..|+.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++........
T Consensus 188 ~~l~~~~~~~~~~ql~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~--------------- 249 (359)
T 3vhe_A 188 DFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY--------------- 249 (359)
T ss_dssp TCBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTC---------------
T ss_pred cccCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCcEEEEeccceeeecccccc---------------
Confidence 228999999999999999999999 89999999999999999999999999999865322110
Q ss_pred CCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCccccCccchhHHHHHHHHHhhcCCcccc
Q 042348 544 SSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQIGSMELNIVQWIQLILEDRKPMTDI 622 (686)
Q Consensus 544 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 622 (686)
.......+|..|+|||++.+..++.++|||||||++|||+| |+.||......+. +........... .
T Consensus 250 ------~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~-----~~~~~~~~~~~~-~ 317 (359)
T 3vhe_A 250 ------VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE-----FCRRLKEGTRMR-A 317 (359)
T ss_dssp ------EEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH-----HHHHHHHTCCCC-C
T ss_pred ------hhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHH-----HHHHHHcCCCCC-C
Confidence 11223456788999999998899999999999999999999 9999965433221 111222211110 0
Q ss_pred cCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccccc
Q 042348 623 LDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRVNIS 671 (686)
Q Consensus 623 ~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~~ 671 (686)
+ .....++.+++.+||+.||++|||+.||+++|+++..+
T Consensus 318 --~--------~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 356 (359)
T 3vhe_A 318 --P--------DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 356 (359)
T ss_dssp --C--------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --C--------CCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHH
Confidence 0 01123578899999999999999999999999987643
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-42 Score=357.48 Aligned_cols=247 Identities=24% Similarity=0.337 Sum_probs=196.4
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCC-ccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCCH
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGG-WQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSL 450 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL 450 (686)
..||+|+||.||+|... +++.||||.+.... ....+.+.+|+.++++++||||+++++++.+.+..++||||+++|+|
T Consensus 13 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L 92 (323)
T 3tki_A 13 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL 92 (323)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCTTEEG
T ss_pred eEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEcCCCCcH
Confidence 46999999999999876 68899999986542 22346789999999999999999999999999999999999999999
Q ss_pred HHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCcc
Q 042348 451 ATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPE 530 (686)
Q Consensus 451 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 530 (686)
.+++... ..+++.++..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++.+......
T Consensus 93 ~~~l~~~------~~~~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~-- 161 (323)
T 3tki_A 93 FDRIEPD------IGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE-- 161 (323)
T ss_dssp GGGSBTT------TBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE--
T ss_pred HHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCccccccchHHEEEeCCCCEEEEEeeccceeccCCcc--
Confidence 9999754 358999999999999999999999 89999999999999999999999999999865422110
Q ss_pred ccccccccCCCCCCCccccccccCCCCCccccCcccccCCCC-CCcchHHHHHHHHHHHHhCCCCccccCccchhHHHHH
Q 042348 531 VHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKP-TQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQWI 609 (686)
Q Consensus 531 ~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~ 609 (686)
.......||..|+|||++.+..+ +.++|||||||++|||++|+.||............+
T Consensus 162 -------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~- 221 (323)
T 3tki_A 162 -------------------RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW- 221 (323)
T ss_dssp -------------------CCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHH-
T ss_pred -------------------cccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHH-
Confidence 11234567889999999987665 779999999999999999999996554433222221
Q ss_pred HHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 610 QLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 610 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
....... .+ .......+.+++.+||+.||++|||+.|++++
T Consensus 222 ---~~~~~~~----~~-------~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 222 ---KEKKTYL----NP-------WKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp ---HTTCTTS----TT-------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ---hcccccC----Cc-------cccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 1111111 00 01122357789999999999999999999876
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-41 Score=341.49 Aligned_cols=250 Identities=24% Similarity=0.393 Sum_probs=205.0
Q ss_pred cccCccCceEEEEEEeCCCceEEEEEcCCCCccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCCHHH
Q 042348 373 FLLGKSTIGIVYKVALNNEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLAT 452 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL~~ 452 (686)
..||+|+||.||+|...+++.||+|.+..... ..+++.+|++++++++||||+++++++.+.+..++||||+++++|.+
T Consensus 14 ~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 92 (267)
T 3t9t_A 14 QEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSD 92 (267)
T ss_dssp EEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCTTCBHHH
T ss_pred eEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCCCCcHHH
Confidence 46999999999999998888999999976543 34689999999999999999999999999999999999999999999
Q ss_pred HhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCcccc
Q 042348 453 AIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVH 532 (686)
Q Consensus 453 ~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 532 (686)
++.... ..+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++.......
T Consensus 93 ~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~----- 159 (267)
T 3t9t_A 93 YLRTQR-----GLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY----- 159 (267)
T ss_dssp HHHHTT-----TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHH-----
T ss_pred HHhhCc-----ccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCchheEEECCCCCEEEcccccccccccccc-----
Confidence 998654 358999999999999999999999 8999999999999999999999999999986532110
Q ss_pred ccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCccccCccchhHHHHHHH
Q 042348 533 WEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQIGSMELNIVQWIQL 611 (686)
Q Consensus 533 ~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~ 611 (686)
.......++..|+|||.+.+..++.++||||||+++|||++ |+.||..... ......
T Consensus 160 -----------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-----~~~~~~ 217 (267)
T 3t9t_A 160 -----------------TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN-----SEVVED 217 (267)
T ss_dssp -----------------HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-----HHHHHH
T ss_pred -----------------cccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCH-----HHHHHH
Confidence 11123345677999999988889999999999999999999 8999954322 122233
Q ss_pred HHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccc
Q 042348 612 ILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRVNI 670 (686)
Q Consensus 612 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~ 670 (686)
+....... .+ ......+.+++.+||+.||++|||+.|++++|+++..
T Consensus 218 i~~~~~~~----~~--------~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (267)
T 3t9t_A 218 ISTGFRLY----KP--------RLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 264 (267)
T ss_dssp HHTTCCCC----CC--------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HhcCCcCC----CC--------ccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 32221111 01 0112357789999999999999999999999998864
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-41 Score=357.69 Aligned_cols=266 Identities=15% Similarity=0.192 Sum_probs=200.4
Q ss_pred cccCccCceEEEEEEeCC------CceEEEEEcCCCCccc-----------hHHHHHHHHHHhccCCCCcceeeEEEEec
Q 042348 373 FLLGKSTIGIVYKVALNN------EEAVAVRRLGNGGWQR-----------FKEFQTEAEAIGKIRHPNIVSLRAYFWSV 435 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~-----------~~~~~~E~~~l~~l~H~nIv~l~~~~~~~ 435 (686)
..||+|+||.||+|.... ++.||||++....... ...+..|+..+..++||||+++++++...
T Consensus 41 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~ 120 (364)
T 3op5_A 41 LPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHD 120 (364)
T ss_dssp EECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEEEEEEEE
T ss_pred EEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEEeeeeec
Confidence 469999999999998765 3789999986543211 12244566677788899999999999875
Q ss_pred ----CceeEEEeccCCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeec--CCC
Q 042348 436 ----DEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLG--KNM 509 (686)
Q Consensus 436 ----~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~--~~~ 509 (686)
...++||||+ +++|.+++.... ..+++..++.|+.||+.||+|||+ ++|+||||||+|||++ .++
T Consensus 121 ~~~~~~~~lv~e~~-g~~L~~~~~~~~-----~~l~~~~~~~i~~qi~~~l~~lH~---~~iiHrDlkp~Nill~~~~~~ 191 (364)
T 3op5_A 121 KNGKSYRFMIMDRF-GSDLQKIYEANA-----KRFSRKTVLQLSLRILDILEYIHE---HEYVHGDIKASNLLLNYKNPD 191 (364)
T ss_dssp ETTEEEEEEEEECE-EEEHHHHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEESSCTT
T ss_pred cCCcceEEEEEeCC-CCCHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeEEecCCHHHEEEecCCCC
Confidence 4479999999 999999998753 469999999999999999999999 8999999999999999 889
Q ss_pred CeEEeecCcccccccccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHH
Q 042348 510 EPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMI 589 (686)
Q Consensus 510 ~~kl~DfGla~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ell 589 (686)
.+||+|||+++.+......... .........||..|+|||++.+..++.++|||||||++|||+
T Consensus 192 ~~kl~DFG~a~~~~~~~~~~~~----------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~ 255 (364)
T 3op5_A 192 QVYLVDYGLAYRYCPEGVHKAY----------------AADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWL 255 (364)
T ss_dssp CEEECCCTTCEESSGGGCCCCS----------------SCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred eEEEEECCcceecccCCccccc----------------ccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHH
Confidence 9999999999876543221100 001123456888999999999999999999999999999999
Q ss_pred hCCCCccccCccchhHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 042348 590 SGKLPMIQIGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRVN 669 (686)
Q Consensus 590 tG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~ 669 (686)
||+.||....... ............ ...+.+++.+... ....++.+++..||+.||++||++.+|++.|+++.
T Consensus 256 ~g~~Pf~~~~~~~-~~~~~~~~~~~~--~~~~~~~~~~~~~----~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~ 328 (364)
T 3op5_A 256 TGHLPWEDNLKDP-KYVRDSKIRYRE--NIASLMDKCFPAA----NAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGL 328 (364)
T ss_dssp HSCCTTGGGTTCH-HHHHHHHHHHHH--CHHHHHHHHSCTT----CCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred hCCCCccccccCH-HHHHHHHHHhhh--hHHHHHHHhcccc----cCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Confidence 9999996533322 222222221111 2223333322111 12346889999999999999999999999998865
Q ss_pred c
Q 042348 670 I 670 (686)
Q Consensus 670 ~ 670 (686)
.
T Consensus 329 ~ 329 (364)
T 3op5_A 329 K 329 (364)
T ss_dssp H
T ss_pred H
Confidence 3
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=357.33 Aligned_cols=250 Identities=18% Similarity=0.274 Sum_probs=197.8
Q ss_pred hcccCccCceEEEEEEeC-CCceEEEEEcCCC-----CccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEecc
Q 042348 372 AFLLGKSTIGIVYKVALN-NEEAVAVRRLGNG-----GWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYI 445 (686)
Q Consensus 372 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~ 445 (686)
...||+|+||.||+|... +++.||||.+... .....+.+.+|+.++++++||||+++++++.+.+..++|||||
T Consensus 29 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~ 108 (351)
T 3c0i_A 29 CEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFM 108 (351)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred eeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEeCC
Confidence 357999999999999875 5889999998532 1123577999999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCC---eEEeecCccccc
Q 042348 446 PNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNME---PHISDFGLARLA 522 (686)
Q Consensus 446 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~---~kl~DfGla~~~ 522 (686)
++|+|.+++...... ...+++..+..++.||+.||+|||+ ++|+||||||+|||++.++. +||+|||+++..
T Consensus 109 ~g~~L~~~l~~~~~~--~~~~~~~~~~~i~~qi~~al~~lH~---~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~ 183 (351)
T 3c0i_A 109 DGADLCFEIVKRADA--GFVYSEAVASHYMRQILEALRYCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQL 183 (351)
T ss_dssp SSCBHHHHHHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECSSSTTCCEEECCCTTCEEC
T ss_pred CCCCHHHHHHHhccc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCChHHeEEecCCCCCcEEEecCcceeEe
Confidence 999999888653211 1358999999999999999999999 89999999999999986654 999999999865
Q ss_pred ccccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccc
Q 042348 523 DIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSME 602 (686)
Q Consensus 523 ~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~ 602 (686)
..... ......||..|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 184 ~~~~~-----------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~--- 237 (351)
T 3c0i_A 184 GESGL-----------------------VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK--- 237 (351)
T ss_dssp CTTSC-----------------------BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH---
T ss_pred cCCCe-----------------------eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH---
Confidence 42210 1123467889999999998899999999999999999999999995421
Q ss_pred hhHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 603 LNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 603 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
......+........ +.... .....+.+++.+||+.||++|||+.|++++
T Consensus 238 ---~~~~~~i~~~~~~~~----~~~~~-----~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 287 (351)
T 3c0i_A 238 ---ERLFEGIIKGKYKMN----PRQWS-----HISESAKDLVRRMLMLDPAERITVYEALNH 287 (351)
T ss_dssp ---HHHHHHHHHTCCCCC----HHHHT-----TSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ---HHHHHHHHcCCCCCC----ccccc-----cCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 122333333322211 10000 112367899999999999999999999875
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=351.73 Aligned_cols=253 Identities=24% Similarity=0.367 Sum_probs=198.1
Q ss_pred cccCccCceEEEEEEeC-CCce----EEEEEcCCCC-ccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccC
Q 042348 373 FLLGKSTIGIVYKVALN-NEEA----VAVRRLGNGG-WQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIP 446 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~----vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~ 446 (686)
..||+|+||.||+|... +++. ||+|.+.... ....+.+.+|+.++++++||||+++++++. .+..++||||++
T Consensus 19 ~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~ 97 (325)
T 3kex_A 19 KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQLVTQYLP 97 (325)
T ss_dssp EEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEEEEECCT
T ss_pred eeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEEEEEeCC
Confidence 46999999999999865 3443 7888875432 334467889999999999999999999886 567899999999
Q ss_pred CCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCccccccccc
Q 042348 447 NGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAE 526 (686)
Q Consensus 447 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~ 526 (686)
+|+|.+++.... ..+++..+..|+.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 98 ~~~L~~~l~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 169 (325)
T 3kex_A 98 LGSLLDHVRQHR-----GALGPQLLLNWGVQIAKGMYYLEE---HGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDD 169 (325)
T ss_dssp TCBSHHHHHSSG-----GGSCTTHHHHHHHHHHHHHHHHHH---TTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCCT
T ss_pred CCCHHHHHHHcc-----ccCCHHHHHHHHHHHHHHHHHHHh---CCCCCCccchheEEECCCCeEEECCCCcccccCccc
Confidence 999999998653 358999999999999999999999 899999999999999999999999999998764322
Q ss_pred CCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCccccCccchhH
Q 042348 527 ETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQIGSMELNI 605 (686)
Q Consensus 527 ~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~~~~ 605 (686)
.. .......+|..|+|||++.+..++.++|||||||++|||+| |+.||......+ .
T Consensus 170 ~~---------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~ 226 (325)
T 3kex_A 170 KQ---------------------LLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE--V 226 (325)
T ss_dssp TC---------------------CC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTH--H
T ss_pred cc---------------------ccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHH--H
Confidence 11 11123456778999999998899999999999999999999 999996543222 1
Q ss_pred HHHHHHHHhhcC-CcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccccch
Q 042348 606 VQWIQLILEDRK-PMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRVNISTE 673 (686)
Q Consensus 606 ~~~~~~~~~~~~-~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~~~~ 673 (686)
...+..... ..... ....+.+++.+||+.||++|||+.|++++|+++.....
T Consensus 227 ---~~~~~~~~~~~~~~~-------------~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~~~ 279 (325)
T 3kex_A 227 ---PDLLEKGERLAQPQI-------------CTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARDPP 279 (325)
T ss_dssp ---HHHHHTTCBCCCCTT-------------BCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTSHH
T ss_pred ---HHHHHcCCCCCCCCc-------------CcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcch
Confidence 122222111 11111 11235689999999999999999999999999865443
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=358.39 Aligned_cols=246 Identities=20% Similarity=0.287 Sum_probs=200.3
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCCccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCCHH
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLA 451 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL~ 451 (686)
+.||+|+||.||+|... +++.||+|.+..........+.+|++++++++||||+++++++.+.+..++||||+++|+|.
T Consensus 57 ~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~~gg~L~ 136 (387)
T 1kob_A 57 EELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELF 136 (387)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBHH
T ss_pred EEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcCCCCcHH
Confidence 46999999999999875 58899999997765555667999999999999999999999999999999999999999999
Q ss_pred HHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecC--CCCeEEeecCcccccccccCCc
Q 042348 452 TAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGK--NMEPHISDFGLARLADIAEETP 529 (686)
Q Consensus 452 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~--~~~~kl~DfGla~~~~~~~~~~ 529 (686)
+++.... ..+++.++..++.||+.||+|||+ ++|+||||||+|||++. ++.+||+|||+++......
T Consensus 137 ~~l~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~--- 205 (387)
T 1kob_A 137 DRIAAED-----YKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE--- 205 (387)
T ss_dssp HHTTCTT-----CCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS---
T ss_pred HHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccchHHeEEecCCCCceEEEecccceecCCCc---
Confidence 9997653 358999999999999999999999 89999999999999974 5789999999998654221
Q ss_pred cccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHHH
Q 042348 530 EVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQWI 609 (686)
Q Consensus 530 ~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~ 609 (686)
......||..|+|||++.+..++.++|||||||++|||++|+.||..... ....
T Consensus 206 ---------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~-----~~~~ 259 (387)
T 1kob_A 206 ---------------------IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD-----LETL 259 (387)
T ss_dssp ---------------------CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH-----HHHH
T ss_pred ---------------------ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCH-----HHHH
Confidence 11223578889999999998999999999999999999999999954322 2223
Q ss_pred HHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 610 QLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 610 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
..+......... ... .....++.+++.+||+.||++|||+.|++++
T Consensus 260 ~~i~~~~~~~~~----~~~-----~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 260 QNVKRCDWEFDE----DAF-----SSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp HHHHHCCCCCCS----STT-----TTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred HHHHhCCCCCCc----ccc-----ccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 333332221111 000 0122367899999999999999999999986
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-41 Score=343.10 Aligned_cols=246 Identities=28% Similarity=0.484 Sum_probs=194.8
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCCccc-------hHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEec
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGGWQR-------FKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDY 444 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-------~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~ 444 (686)
..||+|+||.||+|... +++.||||++....... .+.+.+|++++++++||||+++++++.+.. ++||||
T Consensus 25 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~lv~e~ 102 (287)
T 4f0f_A 25 KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP--RMVMEF 102 (287)
T ss_dssp EECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--EEEEEC
T ss_pred hccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--eEEEEe
Confidence 46999999999999875 68899999986543221 267899999999999999999999986544 799999
Q ss_pred cCCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCC--ceecCCCCCCeeecCCCC-----eEEeecC
Q 042348 445 IPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKR--YVHGDLRPSNILLGKNME-----PHISDFG 517 (686)
Q Consensus 445 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~--iiHrDlkp~NILl~~~~~-----~kl~DfG 517 (686)
+++|+|.+++.... ..+++..+..++.|++.||+|||+ ++ |+||||||+||+++.++. +||+|||
T Consensus 103 ~~~~~L~~~l~~~~-----~~~~~~~~~~~~~~l~~~l~~lH~---~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg 174 (287)
T 4f0f_A 103 VPCGDLYHRLLDKA-----HPIKWSVKLRLMLDIALGIEYMQN---QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFG 174 (287)
T ss_dssp CTTCBHHHHHHCTT-----SCCCHHHHHHHHHHHHHHHHHHHT---SSSCCBCSCCSGGGEEESCCCTTCSCCEEECCCT
T ss_pred cCCCCHHHHHhccc-----CCccHHHHHHHHHHHHHHHHHHHh---CCCCeecCCCCcceEEEeccCCCCceeEEeCCCC
Confidence 99999999987654 469999999999999999999999 78 999999999999988776 9999999
Q ss_pred cccccccccCCccccccccccCCCCCCCccccccccCCCCCccccCccccc--CCCCCCcchHHHHHHHHHHHHhCCCCc
Q 042348 518 LARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASK--VRKPTQKWDIYSYGVILLEMISGKLPM 595 (686)
Q Consensus 518 la~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~sDVwSlGvvl~elltG~~P~ 595 (686)
+++..... .....||..|+|||++. ...++.++|||||||++|||++|+.||
T Consensus 175 ~~~~~~~~--------------------------~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf 228 (287)
T 4f0f_A 175 LSQQSVHS--------------------------VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPF 228 (287)
T ss_dssp TCBCCSSC--------------------------EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTT
T ss_pred cccccccc--------------------------ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCC
Confidence 98743211 12345678899999983 455789999999999999999999999
Q ss_pred cccCccchhHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 042348 596 IQIGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRV 668 (686)
Q Consensus 596 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i 668 (686)
......... ........... .. ... .....+.+++.+||+.||++|||+.|+++.|+++
T Consensus 229 ~~~~~~~~~---~~~~~~~~~~~-~~-----~~~-----~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 229 DEYSYGKIK---FINMIREEGLR-PT-----IPE-----DCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp TTCCCCHHH---HHHHHHHSCCC-CC-----CCT-----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred ccccccHHH---HHHHHhccCCC-CC-----CCc-----ccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 654433321 12222222111 11 111 1234678999999999999999999999999875
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=352.24 Aligned_cols=259 Identities=15% Similarity=0.161 Sum_probs=203.9
Q ss_pred cccCccCceEEEEEEe-CCCceEEEEEcCCCCccchHHHHHHHHHHhcc-CCCCcceeeEEEEecCceeEEEeccCCCCH
Q 042348 373 FLLGKSTIGIVYKVAL-NNEEAVAVRRLGNGGWQRFKEFQTEAEAIGKI-RHPNIVSLRAYFWSVDEKLLIYDYIPNGSL 450 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL 450 (686)
..||+|+||.||+|.. .+++.||||.+..... .+.+.+|+++++++ +||||+++++++...+..++||||+ +++|
T Consensus 15 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~L 91 (330)
T 2izr_A 15 KKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL-GPSL 91 (330)
T ss_dssp EECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC-CCBH
T ss_pred EEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC-CCCH
Confidence 4699999999999986 4688999999865432 35689999999999 9999999999999999999999999 9999
Q ss_pred HHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCC-----eEEeecCcccccccc
Q 042348 451 ATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNME-----PHISDFGLARLADIA 525 (686)
Q Consensus 451 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~-----~kl~DfGla~~~~~~ 525 (686)
.+++.... ..+++..+..|+.|++.||+|||+ ++|+||||||+|||++.++. +||+|||+++.....
T Consensus 92 ~~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~LH~---~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~ 163 (330)
T 2izr_A 92 EDLFDLCD-----RTFSLKTVLMIAIQLISRMEYVHS---KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDP 163 (330)
T ss_dssp HHHHHHTT-----TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCT
T ss_pred HHHHHHcC-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecC
Confidence 99998653 469999999999999999999999 89999999999999998887 999999999876432
Q ss_pred cCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhH
Q 042348 526 EETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNI 605 (686)
Q Consensus 526 ~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~ 605 (686)
...... .........||..|+|||++.+..++.++|||||||++|||++|+.||...... +.
T Consensus 164 ~~~~~~----------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~--~~ 225 (330)
T 2izr_A 164 ETKKHI----------------PYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKAD--TL 225 (330)
T ss_dssp TTCCBC----------------CCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCS--SH
T ss_pred CCCccc----------------cccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccc--cH
Confidence 211000 001223567889999999999999999999999999999999999999654332 22
Q ss_pred HHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 042348 606 VQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRVN 669 (686)
Q Consensus 606 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~ 669 (686)
.+.+..+.....+... ..+.. ... ++.+++.+||+.||.+||++.+|++.|+++.
T Consensus 226 ~~~~~~i~~~~~~~~~---~~~~~-----~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~ 280 (330)
T 2izr_A 226 KERYQKIGDTKRATPI---EVLCE-----NFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLF 280 (330)
T ss_dssp HHHHHHHHHHHHHSCH---HHHTT-----TCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred HHHHHHHHhhhccCCH---HHHhc-----cCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHH
Confidence 2333333222111110 00000 012 6889999999999999999999999998764
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=356.31 Aligned_cols=260 Identities=27% Similarity=0.393 Sum_probs=204.5
Q ss_pred cccCccCceEEEEEEeC------CCceEEEEEcCCCC-ccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEecc
Q 042348 373 FLLGKSTIGIVYKVALN------NEEAVAVRRLGNGG-WQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYI 445 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~ 445 (686)
..||+|+||.||+|... +++.||||.++... ....+.+.+|+.++++++||||+++++++...+..++||||+
T Consensus 53 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 132 (343)
T 1luf_A 53 RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYM 132 (343)
T ss_dssp EEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred eeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCceEEEEecC
Confidence 46999999999999875 34789999997653 333567999999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcCCCcc------------------ccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecC
Q 042348 446 PNGSLATAIHGKAGII------------------SYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGK 507 (686)
Q Consensus 446 ~~gsL~~~l~~~~~~~------------------~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~ 507 (686)
++|+|.+++....... ....+++.+++.|+.||+.||+|||+ ++|+||||||+||+++.
T Consensus 133 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl~~~ 209 (343)
T 1luf_A 133 AYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGE 209 (343)
T ss_dssp TTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECG
T ss_pred CCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEECC
Confidence 9999999998642110 01468999999999999999999999 89999999999999999
Q ss_pred CCCeEEeecCcccccccccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHH
Q 042348 508 NMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLE 587 (686)
Q Consensus 508 ~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~e 587 (686)
++.+||+|||+++........ .......+|..|+|||.+.+..++.++|||||||++||
T Consensus 210 ~~~~kl~Dfg~~~~~~~~~~~---------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~e 268 (343)
T 1luf_A 210 NMVVKIADFGLSRNIYSADYY---------------------KADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWE 268 (343)
T ss_dssp GGCEEECCCSCHHHHTGGGCB---------------------C----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHH
T ss_pred CCeEEEeecCCCcccccCccc---------------------cccCCCcccceecChhhhccCCcCcccccHHHHHHHHH
Confidence 999999999999865432210 01123456778999999988889999999999999999
Q ss_pred HHh-CCCCccccCccchhHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 042348 588 MIS-GKLPMIQIGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLD 666 (686)
Q Consensus 588 llt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~ 666 (686)
|+| |+.||..... .+....+...... .. . ......+.+++.+||+.||++|||+.|++++|+
T Consensus 269 l~t~g~~p~~~~~~-----~~~~~~~~~~~~~--~~-~---------~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~ 331 (343)
T 1luf_A 269 IFSYGLQPYYGMAH-----EEVIYYVRDGNIL--AC-P---------ENCPLELYNLMRLCWSKLPADRPSFCSIHRILQ 331 (343)
T ss_dssp HHTTTCCTTTTSCH-----HHHHHHHHTTCCC--CC-C---------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHhcCCCcCCCCCh-----HHHHHHHhCCCcC--CC-C---------CCCCHHHHHHHHHHcccCcccCCCHHHHHHHHH
Confidence 999 9999954332 1222333222211 00 0 112236789999999999999999999999999
Q ss_pred cccccch
Q 042348 667 RVNISTE 673 (686)
Q Consensus 667 ~i~~~~~ 673 (686)
++....+
T Consensus 332 ~~~~~~~ 338 (343)
T 1luf_A 332 RMCERAE 338 (343)
T ss_dssp HTTC---
T ss_pred HHHhhhh
Confidence 9876544
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-41 Score=344.63 Aligned_cols=258 Identities=23% Similarity=0.329 Sum_probs=194.5
Q ss_pred cccCccCceEEEEEEeCCCceEEEEEcCCCCc--cchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCCH
Q 042348 373 FLLGKSTIGIVYKVALNNEEAVAVRRLGNGGW--QRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSL 450 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL 450 (686)
..||+|+||.||+|...+++.||+|++..... ...+.+.+|++++++++||||+++++++...+..++||||+++ +|
T Consensus 8 ~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l 86 (288)
T 1ob3_A 8 EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DL 86 (288)
T ss_dssp EEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSE-EH
T ss_pred hhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEecCC-CH
Confidence 46999999999999998899999999865432 2346788999999999999999999999999999999999975 99
Q ss_pred HHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCcc
Q 042348 451 ATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPE 530 (686)
Q Consensus 451 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 530 (686)
.+++.... ..+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++......
T Consensus 87 ~~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~---- 154 (288)
T 1ob3_A 87 KKLLDVCE-----GGLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV---- 154 (288)
T ss_dssp HHHHHTST-----TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred HHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEEeECccccccCccc----
Confidence 99997654 458999999999999999999999 899999999999999999999999999997653211
Q ss_pred ccccccccCCCCCCCccccccccCCCCCccccCcccccC-CCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHHH
Q 042348 531 VHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKV-RKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQWI 609 (686)
Q Consensus 531 ~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~ 609 (686)
.......+|..|+|||++.+ ..++.++|||||||++|||++|+.||...... +....+
T Consensus 155 -------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--~~~~~~ 213 (288)
T 1ob3_A 155 -------------------RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEA--DQLMRI 213 (288)
T ss_dssp --------------------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHH
T ss_pred -------------------cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHH
Confidence 01123456788999999876 45899999999999999999999999654322 111111
Q ss_pred HHHHhhcC--Cccc-----ccCcccccC--C----CcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 610 QLILEDRK--PMTD-----ILDPFLAHD--L----DKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 610 ~~~~~~~~--~~~~-----~~d~~l~~~--~----~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
........ .+.. ..++..... . ........+.+++.+||+.||++|||+.|++++
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 281 (288)
T 1ob3_A 214 FRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (288)
T ss_dssp HHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHCCCChhhchhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 11111100 0000 001110000 0 001123467899999999999999999999864
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=374.66 Aligned_cols=251 Identities=25% Similarity=0.383 Sum_probs=205.1
Q ss_pred cccCccCceEEEEEEeCC-CceEEEEEcCCCCccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCCHH
Q 042348 373 FLLGKSTIGIVYKVALNN-EEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLA 451 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL~ 451 (686)
..||+|+||.||+|.+.. +..||||.++.... ..++|.+|+++|++++|||||+++++|...+..++|||||++|+|.
T Consensus 226 ~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~~~g~L~ 304 (495)
T 1opk_A 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLL 304 (495)
T ss_dssp EESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHH
T ss_pred eEecCCCCeEEEEEEEcCCCeEEEEEEecCccc-chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEccCCCCHH
Confidence 469999999999999875 78999999976543 4578999999999999999999999999999999999999999999
Q ss_pred HHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCccc
Q 042348 452 TAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEV 531 (686)
Q Consensus 452 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 531 (686)
+++..... ..+++..++.|+.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 305 ~~l~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~---- 373 (495)
T 1opk_A 305 DYLRECNR----QEVSAVVLLYMATQISSAMEYLEK---KNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTY---- 373 (495)
T ss_dssp HHHHHSCT----TTSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCE----
T ss_pred HHHHhcCc----CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChhhEEECCCCcEEEeecccceeccCCce----
Confidence 99986432 458999999999999999999999 8999999999999999999999999999986532110
Q ss_pred cccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCccccCccchhHHHHHH
Q 042348 532 HWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQIGSMELNIVQWIQ 610 (686)
Q Consensus 532 ~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~~~~~~~~~ 610 (686)
.......++..|+|||++.+..++.++|||||||++|||+| |+.||....... +. .
T Consensus 374 ------------------~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~--~~---~ 430 (495)
T 1opk_A 374 ------------------TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ--VY---E 430 (495)
T ss_dssp ------------------ECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG--HH---H
T ss_pred ------------------eecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHH--HH---H
Confidence 11122345678999999988889999999999999999999 999996543322 11 2
Q ss_pred HHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccc
Q 042348 611 LILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRVNI 670 (686)
Q Consensus 611 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~ 670 (686)
.+ ....... . .......+.+++.+||+.||++|||+.||++.|+.+..
T Consensus 431 ~~-~~~~~~~---~--------~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~ 478 (495)
T 1opk_A 431 LL-EKDYRME---R--------PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 478 (495)
T ss_dssp HH-HTTCCCC---C--------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred HH-HcCCCCC---C--------CCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence 22 2211110 0 01123467899999999999999999999999999753
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=347.21 Aligned_cols=251 Identities=21% Similarity=0.320 Sum_probs=191.6
Q ss_pred cccCccCceEEEEEEeCC----CceEEEEEcCCCC-ccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCC
Q 042348 373 FLLGKSTIGIVYKVALNN----EEAVAVRRLGNGG-WQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPN 447 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~ 447 (686)
..||+|+||.||+|.... +..||+|.+.... ....+.+.+|+.++++++||||+++++++ ..+..++||||+++
T Consensus 21 ~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e~~~~ 99 (281)
T 1mp8_A 21 RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTL 99 (281)
T ss_dssp EEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-CSSSCEEEEECCTT
T ss_pred eEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEE-ccCccEEEEecCCC
Confidence 469999999999998743 4579999987643 33456799999999999999999999998 45678999999999
Q ss_pred CCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccC
Q 042348 448 GSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEE 527 (686)
Q Consensus 448 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 527 (686)
|+|.+++.... ..+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++.......
T Consensus 100 ~~L~~~l~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 171 (281)
T 1mp8_A 100 GELRSFLQVRK-----YSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY 171 (281)
T ss_dssp EEHHHHHHHTT-----TTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECC------------
T ss_pred CCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHHEEECCCCCEEECccccccccCcccc
Confidence 99999998653 358999999999999999999999 8999999999999999999999999999986542211
Q ss_pred CccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCccccCccchhHH
Q 042348 528 TPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQIGSMELNIV 606 (686)
Q Consensus 528 ~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~~~~~ 606 (686)
.......+|..|+|||.+.+..++.++|||||||++|||++ |..||......+ .
T Consensus 172 ----------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~--~- 226 (281)
T 1mp8_A 172 ----------------------YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND--V- 226 (281)
T ss_dssp -----------------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--H-
T ss_pred ----------------------cccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHH--H-
Confidence 01112345677999999988889999999999999999997 999996543322 1
Q ss_pred HHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccccc
Q 042348 607 QWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRVNIS 671 (686)
Q Consensus 607 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~~ 671 (686)
...+...... . .. ......+.+++.+||+.||++|||+.|+++.|+++...
T Consensus 227 --~~~i~~~~~~--~-~~---------~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 277 (281)
T 1mp8_A 227 --IGRIENGERL--P-MP---------PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 277 (281)
T ss_dssp --HHHHHTTCCC--C-CC---------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --HHHHHcCCCC--C-CC---------CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 2222222111 0 01 11224677899999999999999999999999998643
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=353.24 Aligned_cols=258 Identities=22% Similarity=0.353 Sum_probs=191.5
Q ss_pred hcccCccCceEEEEEEeCCC----ceEEEEEcCCC--CccchHHHHHHHHHHhccCCCCcceeeEEEEecCce------e
Q 042348 372 AFLLGKSTIGIVYKVALNNE----EAVAVRRLGNG--GWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEK------L 439 (686)
Q Consensus 372 ~~~iG~G~~g~Vy~~~~~~~----~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~------~ 439 (686)
...||+|+||.||+|..... ..||||.+... .....+++.+|++++++++||||+++++++...+.. +
T Consensus 28 ~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 107 (323)
T 3qup_A 28 GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPM 107 (323)
T ss_dssp EEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-------CEE
T ss_pred eceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccccCCCccE
Confidence 34799999999999987643 27999999764 334467899999999999999999999999877655 9
Q ss_pred EEEeccCCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcc
Q 042348 440 LIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLA 519 (686)
Q Consensus 440 lV~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla 519 (686)
+||||+++|+|.+++...........+++.++..|+.|++.||+|||+ ++|+||||||+||++++++.+||+|||++
T Consensus 108 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~---~~ivH~Dikp~NIli~~~~~~kl~Dfg~a 184 (323)
T 3qup_A 108 VILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSS---RNFIHRDLAARNCMLAEDMTVCVADFGLS 184 (323)
T ss_dssp EEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC-
T ss_pred EEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHc---CCcccCCCCcceEEEcCCCCEEEeecccc
Confidence 999999999999999754321112358999999999999999999999 89999999999999999999999999999
Q ss_pred cccccccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCcccc
Q 042348 520 RLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQI 598 (686)
Q Consensus 520 ~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~ 598 (686)
+........ .......++..|+|||.+.+..++.++|||||||++|||++ |+.||...
T Consensus 185 ~~~~~~~~~---------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~ 243 (323)
T 3qup_A 185 RKIYSGDYY---------------------RQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGI 243 (323)
T ss_dssp -------------------------------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred ccccccccc---------------------cccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCcccc
Confidence 865432210 01122345677999999998899999999999999999999 99999654
Q ss_pred CccchhHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccc
Q 042348 599 GSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRVNI 670 (686)
Q Consensus 599 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~ 670 (686)
...+ . .......... .. . ......+.+++.+||+.||++|||+.|+++.|+++..
T Consensus 244 ~~~~--~---~~~~~~~~~~-~~--~---------~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~ 298 (323)
T 3qup_A 244 ENAE--I---YNYLIGGNRL-KQ--P---------PECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILG 298 (323)
T ss_dssp CGGG--H---HHHHHTTCCC-CC--C---------TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ChHH--H---HHHHhcCCCC-CC--C---------CccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 3322 1 2222222111 00 0 1122468899999999999999999999999998753
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=350.12 Aligned_cols=263 Identities=25% Similarity=0.313 Sum_probs=199.1
Q ss_pred hcccCccCceEEEEEEeCCCceEEEEEcCCCCccchHHHHHHHHHHhcc--CCCCcceeeEEEEec----CceeEEEecc
Q 042348 372 AFLLGKSTIGIVYKVALNNEEAVAVRRLGNGGWQRFKEFQTEAEAIGKI--RHPNIVSLRAYFWSV----DEKLLIYDYI 445 (686)
Q Consensus 372 ~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~H~nIv~l~~~~~~~----~~~~lV~e~~ 445 (686)
...||+|+||.||+|+.. ++.||||++... ....+..|.+++..+ +||||+++++++... ...++||||+
T Consensus 42 ~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~ 117 (337)
T 3mdy_A 42 VKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYH 117 (337)
T ss_dssp EEEEEEETTEEEEEEEET-TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEEEECCC
T ss_pred EeEeecCCCeEEEEEEEC-CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEEEEecc
Confidence 357999999999999886 889999998543 234455566666554 899999999999887 6789999999
Q ss_pred CCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCC--------CceecCCCCCCeeecCCCCeEEeecC
Q 042348 446 PNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPK--------RYVHGDLRPSNILLGKNMEPHISDFG 517 (686)
Q Consensus 446 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~--------~iiHrDlkp~NILl~~~~~~kl~DfG 517 (686)
++|+|.++++.. .+++..+..++.|++.||+|||+ + +|+||||||+|||++.++.+||+|||
T Consensus 118 ~~g~L~~~l~~~-------~~~~~~~~~i~~~i~~~l~~lH~---~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg 187 (337)
T 3mdy_A 118 ENGSLYDYLKST-------TLDAKSMLKLAYSSVSGLCHLHT---EIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 187 (337)
T ss_dssp TTCBHHHHHHHC-------CBCHHHHHHHHHHHHHHHHHHHS---CBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCT
T ss_pred CCCcHHHHhhcc-------CCCHHHHHHHHHHHHHHHHHHHH---hhhhhccCCCEEecccchHHEEECCCCCEEEEeCC
Confidence 999999999653 48999999999999999999998 6 99999999999999999999999999
Q ss_pred cccccccccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCc------chHHHHHHHHHHHHhC
Q 042348 518 LARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQK------WDIYSYGVILLEMISG 591 (686)
Q Consensus 518 la~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~------sDVwSlGvvl~elltG 591 (686)
+++......... ........||..|+|||++.+..++.+ +|||||||++|||+||
T Consensus 188 ~a~~~~~~~~~~-------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg 248 (337)
T 3mdy_A 188 LAVKFISDTNEV-------------------DIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARR 248 (337)
T ss_dssp TCEECC----------------------------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTT
T ss_pred Cceeeccccccc-------------------cCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhc
Confidence 997654322110 011224568889999999987776665 9999999999999999
Q ss_pred ----------CCCccccCccchhHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHH
Q 042348 592 ----------KLPMIQIGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHV 661 (686)
Q Consensus 592 ----------~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev 661 (686)
+.||............. ........ ..+.............++.+++.+||+.||++|||+.||
T Consensus 249 ~~~~~~~~~~~~p~~~~~~~~~~~~~~-~~~~~~~~-----~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~el 322 (337)
T 3mdy_A 249 CVSGGIVEEYQLPYHDLVPSDPSYEDM-REIVCIKK-----LRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRV 322 (337)
T ss_dssp BCBTTBCCCCCCTTTTTSCSSCCHHHH-HHHHTTSC-----CCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred cCcccccccccccHhhhcCCCCchhhh-HHHHhhhc-----cCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHH
Confidence 66664433322222222 22111111 111111112233567789999999999999999999999
Q ss_pred HHHHhcccccch
Q 042348 662 CDSLDRVNISTE 673 (686)
Q Consensus 662 ~~~L~~i~~~~~ 673 (686)
+++|+++..+.+
T Consensus 323 l~~L~~l~~~~~ 334 (337)
T 3mdy_A 323 KKTLAKMSESQD 334 (337)
T ss_dssp HHHHHHHHHTTT
T ss_pred HHHHHHHHhhcc
Confidence 999999876543
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=367.82 Aligned_cols=263 Identities=23% Similarity=0.309 Sum_probs=197.7
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCC---CccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCC
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNG---GWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNG 448 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~g 448 (686)
..||+|+||.||+|... +++.||||++... .......+.+|++++++++||||+++++++...+..++|||||++|
T Consensus 154 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~~ 233 (446)
T 4ejn_A 154 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 233 (446)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEECCCSSC
T ss_pred EEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEEeeCCCC
Confidence 47999999999999865 5889999998643 2233456789999999999999999999999999999999999999
Q ss_pred CHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCC
Q 042348 449 SLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEET 528 (686)
Q Consensus 449 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 528 (686)
+|.+++... ..+++..+..++.|++.||+|||+. ++|+||||||+|||++.++.+||+|||+|+......
T Consensus 234 ~L~~~l~~~------~~~~~~~~~~~~~qi~~aL~~LH~~--~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-- 303 (446)
T 4ejn_A 234 ELFFHLSRE------RVFSEDRARFYGAEIVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG-- 303 (446)
T ss_dssp BHHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHH--TCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC----
T ss_pred cHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHhhc--CCEEECCCCHHHEEECCCCCEEEccCCCceeccCCC--
Confidence 999999764 4689999999999999999999952 589999999999999999999999999997532111
Q ss_pred ccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHH
Q 042348 529 PEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQW 608 (686)
Q Consensus 529 ~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~ 608 (686)
.......||..|+|||++.+..++.++|||||||++|||++|+.||..... ...
T Consensus 304 ---------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-----~~~ 357 (446)
T 4ejn_A 304 ---------------------ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-----EKL 357 (446)
T ss_dssp ------------------------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHH
T ss_pred ---------------------cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH-----HHH
Confidence 112345688899999999999999999999999999999999999954322 223
Q ss_pred HHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHHHhcccccchhhhhccCCCC
Q 042348 609 IQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRP-----SMRHVCDSLDRVNISTEQQFMKGEEPK 683 (686)
Q Consensus 609 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~ev~~~L~~i~~~~~~~~~~~~~~~ 683 (686)
...+.......+..+ ...+.+++.+||+.||++|| ++.|++++----...++....+.-.|+
T Consensus 358 ~~~i~~~~~~~p~~~-------------~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~~~~~~~~~~~~pp 424 (446)
T 4ejn_A 358 FELILMEEIRFPRTL-------------GPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPP 424 (446)
T ss_dssp HHHHHHCCCCCCTTS-------------CHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHHHHTTCSCCS
T ss_pred HHHHHhCCCCCCccC-------------CHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCCCHHHHhhCcCCCC
Confidence 334443333222211 23577899999999999999 999998863222223333333444444
Q ss_pred C
Q 042348 684 F 684 (686)
Q Consensus 684 ~ 684 (686)
|
T Consensus 425 ~ 425 (446)
T 4ejn_A 425 F 425 (446)
T ss_dssp C
T ss_pred c
Confidence 4
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-41 Score=346.62 Aligned_cols=249 Identities=25% Similarity=0.463 Sum_probs=194.6
Q ss_pred cccCccCceEEEEEEeCCCceEEEEEcCCCCccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCCHHH
Q 042348 373 FLLGKSTIGIVYKVALNNEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLAT 452 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL~~ 452 (686)
..||+|+||.||+|... ++.||||.+... ...+.+.+|++++++++||||+++++++. +..++||||+++|+|.+
T Consensus 14 ~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~~~~~L~~ 88 (307)
T 2eva_A 14 EVVGRGAFGVVCKAKWR-AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAEGGSLYN 88 (307)
T ss_dssp EEEECCSSSEEEEEEET-TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECCTTCBHHH
T ss_pred eEeecCCCceEEEEEEC-CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcCCCCCHHH
Confidence 46999999999999886 678999999754 34578999999999999999999999876 45899999999999999
Q ss_pred HhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCC-eEEeecCcccccccccCCccc
Q 042348 453 AIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNME-PHISDFGLARLADIAEETPEV 531 (686)
Q Consensus 453 ~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~-~kl~DfGla~~~~~~~~~~~~ 531 (686)
++...... ..+++..++.++.|+++||+|||+..+++|+||||||+||+++.++. +||+|||+++.....
T Consensus 89 ~l~~~~~~---~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~------ 159 (307)
T 2eva_A 89 VLHGAEPL---PYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH------ 159 (307)
T ss_dssp HHHCSSSE---ECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-------------
T ss_pred HHhccCCC---CccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc------
Confidence 99865421 35789999999999999999999965568999999999999998887 799999999754311
Q ss_pred cccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHHHHH
Q 042348 532 HWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQWIQL 611 (686)
Q Consensus 532 ~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~ 611 (686)
.....||..|+|||++.+..++.++|||||||++|||+||+.||........ .....
T Consensus 160 --------------------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~---~~~~~ 216 (307)
T 2eva_A 160 --------------------MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAF---RIMWA 216 (307)
T ss_dssp -------------------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHH---HHHHH
T ss_pred --------------------cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHH---HHHHH
Confidence 1123467889999999998999999999999999999999999965433221 11112
Q ss_pred HHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccc
Q 042348 612 ILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRVNI 670 (686)
Q Consensus 612 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~ 670 (686)
......+ .. .. .....+.+++.+||+.||++|||+.|+++.|+.+..
T Consensus 217 ~~~~~~~--~~-----~~-----~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 263 (307)
T 2eva_A 217 VHNGTRP--PL-----IK-----NLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMR 263 (307)
T ss_dssp HHTTCCC--CC-----BT-----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGG
T ss_pred HhcCCCC--Cc-----cc-----ccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence 2221111 10 01 122357789999999999999999999999998763
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=356.30 Aligned_cols=265 Identities=26% Similarity=0.301 Sum_probs=202.2
Q ss_pred hcccCccCceEEEEEEe------CCCceEEEEEcCCC-CccchHHHHHHHHHHhcc-CCCCcceeeEEEEecCceeEEEe
Q 042348 372 AFLLGKSTIGIVYKVAL------NNEEAVAVRRLGNG-GWQRFKEFQTEAEAIGKI-RHPNIVSLRAYFWSVDEKLLIYD 443 (686)
Q Consensus 372 ~~~iG~G~~g~Vy~~~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~e 443 (686)
...||+|+||.||+|.. .++..||||.+... .....+.+.+|+.+++++ +||||+++++++...+..++|||
T Consensus 50 ~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e 129 (344)
T 1rjb_A 50 GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFE 129 (344)
T ss_dssp EEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred eeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCccEEEEe
Confidence 45799999999999986 23568999999754 233457899999999999 89999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCCcc-----------------ccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeec
Q 042348 444 YIPNGSLATAIHGKAGII-----------------SYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLG 506 (686)
Q Consensus 444 ~~~~gsL~~~l~~~~~~~-----------------~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~ 506 (686)
|+++|+|.+++....... ....+++..++.++.|++.||+|||+ ++|+||||||+||+++
T Consensus 130 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIll~ 206 (344)
T 1rjb_A 130 YCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVT 206 (344)
T ss_dssp CCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH---TTEEETTCSGGGEEEE
T ss_pred cCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChhhEEEc
Confidence 999999999998754210 01248999999999999999999999 8999999999999999
Q ss_pred CCCCeEEeecCcccccccccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHH
Q 042348 507 KNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILL 586 (686)
Q Consensus 507 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ 586 (686)
.++.+||+|||+++........ .......+|..|+|||.+.+..++.++|||||||++|
T Consensus 207 ~~~~~kL~Dfg~~~~~~~~~~~---------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ 265 (344)
T 1rjb_A 207 HGKVVKICDFGLARDIMSDSNY---------------------VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLW 265 (344)
T ss_dssp TTTEEEECCCGGGSCGGGCTTS---------------------EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHH
T ss_pred CCCcEEeCCCccCcccccCccc---------------------eeccCccCccCccCHHHhccCCCChhHhHHHHHHHHH
Confidence 9999999999999865432210 1112334577899999998889999999999999999
Q ss_pred HHHh-CCCCccccCccchhHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 042348 587 EMIS-GKLPMIQIGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSL 665 (686)
Q Consensus 587 ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L 665 (686)
||+| |+.||....... . +........... .. ......+.+++.+||+.||++|||+.|++++|
T Consensus 266 el~t~g~~p~~~~~~~~-~----~~~~~~~~~~~~--~~---------~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l 329 (344)
T 1rjb_A 266 EIFSLGVNPYPGIPVDA-N----FYKLIQNGFKMD--QP---------FYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL 329 (344)
T ss_dssp HHTTTSCCSSTTCCCSH-H----HHHHHHTTCCCC--CC---------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHcCCCCCcccCCcHH-H----HHHHHhcCCCCC--CC---------CCCCHHHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence 9998 999996543322 1 122222211110 00 01224678899999999999999999999999
Q ss_pred hcccccchhhh
Q 042348 666 DRVNISTEQQF 676 (686)
Q Consensus 666 ~~i~~~~~~~~ 676 (686)
+.+....+++.
T Consensus 330 ~~~~~~~~~~~ 340 (344)
T 1rjb_A 330 GCQLADAEEAM 340 (344)
T ss_dssp HHHC-------
T ss_pred HHHHHHHHHHH
Confidence 99876655443
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=363.01 Aligned_cols=245 Identities=20% Similarity=0.268 Sum_probs=196.9
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCC---ccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCC
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGG---WQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNG 448 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~g 448 (686)
..||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+.+++.++|||||++++++.+.+..++|||||++|
T Consensus 75 ~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~gg 154 (410)
T 3v8s_A 75 KVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGG 154 (410)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTE
T ss_pred EEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCC
Confidence 46999999999999976 47899999986521 122345889999999999999999999999999999999999999
Q ss_pred CHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCC
Q 042348 449 SLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEET 528 (686)
Q Consensus 449 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 528 (686)
+|.++++.. .+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+|+.......
T Consensus 155 ~L~~~l~~~-------~~~e~~~~~~~~qi~~aL~~LH~---~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~- 223 (410)
T 3v8s_A 155 DLVNLMSNY-------DVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM- 223 (410)
T ss_dssp EHHHHHHHC-------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSE-
T ss_pred cHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeeECCCCCEEEeccceeEeeccCCc-
Confidence 999999753 48999999999999999999999 8999999999999999999999999999986542210
Q ss_pred ccccccccccCCCCCCCccccccccCCCCCccccCcccccCCC----CCCcchHHHHHHHHHHHHhCCCCccccCccchh
Q 042348 529 PEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRK----PTQKWDIYSYGVILLEMISGKLPMIQIGSMELN 604 (686)
Q Consensus 529 ~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~ 604 (686)
......+||+.|+|||++.+.. ++.++|||||||++|||++|+.||.....
T Consensus 224 ---------------------~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~---- 278 (410)
T 3v8s_A 224 ---------------------VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL---- 278 (410)
T ss_dssp ---------------------EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSH----
T ss_pred ---------------------ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCCh----
Confidence 1223457888999999987655 78999999999999999999999964322
Q ss_pred HHHHHHHHHhhc--CCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCC--CCCHHHHHHHH
Q 042348 605 IVQWIQLILEDR--KPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDK--RPSMRHVCDSL 665 (686)
Q Consensus 605 ~~~~~~~~~~~~--~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~--RPs~~ev~~~L 665 (686)
......+.... ...+. ++ .....+.+++.+||+.+|.+ ||++.||++|-
T Consensus 279 -~~~~~~i~~~~~~~~~p~--~~---------~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp 331 (410)
T 3v8s_A 279 -VGTYSKIMNHKNSLTFPD--DN---------DISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 331 (410)
T ss_dssp -HHHHHHHHTHHHHCCCCT--TC---------CCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSG
T ss_pred -hhHHHHHHhccccccCCC--cc---------cccHHHHHHHHHHccChhhhCCCCCHHHHhcCc
Confidence 22233333321 11111 00 01235778999999999988 99999999883
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=347.99 Aligned_cols=248 Identities=22% Similarity=0.308 Sum_probs=197.0
Q ss_pred cccCccCceEEEEEEeCC-C-------ceEEEEEcCCCCccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEec
Q 042348 373 FLLGKSTIGIVYKVALNN-E-------EAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDY 444 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~~-~-------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~ 444 (686)
..||+|+||.||+|.... + ..||+|.+........+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 14 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 93 (289)
T 4fvq_A 14 ESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEF 93 (289)
T ss_dssp EEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred eeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCCEEEEEC
Confidence 469999999999998653 2 46999999776666678899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCC--------eEEeec
Q 042348 445 IPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNME--------PHISDF 516 (686)
Q Consensus 445 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~--------~kl~Df 516 (686)
+++|+|.+++.... ..+++..+..++.|++.||+|||+ ++|+||||||+|||++.++. +||+||
T Consensus 94 ~~~~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Df 165 (289)
T 4fvq_A 94 VKFGSLDTYLKKNK-----NCINILWKLEVAKQLAAAMHFLEE---NTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDP 165 (289)
T ss_dssp CTTCBHHHHHHHTG-----GGCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEEECCBGGGTBCCEEEECCC
T ss_pred CCCCCHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHhh---CCeECCCcCcceEEEecCCcccccccceeeeccC
Confidence 99999999998654 348999999999999999999999 89999999999999998887 999999
Q ss_pred CcccccccccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccC-CCCCCcchHHHHHHHHHHHHhCCCCc
Q 042348 517 GLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKV-RKPTQKWDIYSYGVILLEMISGKLPM 595 (686)
Q Consensus 517 Gla~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvvl~elltG~~P~ 595 (686)
|+++...... ...+|..|+|||.+.+ ..++.++|||||||++|||++|..|+
T Consensus 166 g~~~~~~~~~---------------------------~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~ 218 (289)
T 4fvq_A 166 GISITVLPKD---------------------------ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKP 218 (289)
T ss_dssp CSCTTTSCHH---------------------------HHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred cccccccCcc---------------------------ccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCC
Confidence 9986442111 1234667999999987 67899999999999999999965554
Q ss_pred cccCccchhHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccccch
Q 042348 596 IQIGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRVNISTE 673 (686)
Q Consensus 596 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~~~~ 673 (686)
....... . ............... ...+.+++.+||+.||++|||+.|++++|+++.....
T Consensus 219 ~~~~~~~----~-~~~~~~~~~~~~~~~-------------~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~~ 278 (289)
T 4fvq_A 219 LSALDSQ----R-KLQFYEDRHQLPAPK-------------AAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDL 278 (289)
T ss_dssp TTTSCHH----H-HHHHHHTTCCCCCCS-------------SCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC----
T ss_pred ccccchH----H-HHHHhhccCCCCCCC-------------CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCC
Confidence 3222111 1 111122222222111 1246689999999999999999999999999876544
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-41 Score=357.16 Aligned_cols=257 Identities=25% Similarity=0.410 Sum_probs=193.4
Q ss_pred cccCccCceEEEEEEeCC----CceEEEEEcCCC-CccchHHHHHHHHHHhccCCCCcceeeEEEEe-cCceeEEEeccC
Q 042348 373 FLLGKSTIGIVYKVALNN----EEAVAVRRLGNG-GWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWS-VDEKLLIYDYIP 446 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~-~~~~~lV~e~~~ 446 (686)
+.||+|+||.||+|...+ +..||||.+... .....++|.+|+.++++++||||+++++++.. .+..++||||++
T Consensus 95 ~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~e~~~ 174 (373)
T 3c1x_A 95 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMK 174 (373)
T ss_dssp EEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEEECCT
T ss_pred cEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEEECCC
Confidence 479999999999998642 246899998654 33456789999999999999999999998764 457899999999
Q ss_pred CCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCccccccccc
Q 042348 447 NGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAE 526 (686)
Q Consensus 447 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~ 526 (686)
+|+|.+++.... ..+++.++..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 175 ~g~L~~~l~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~ 246 (373)
T 3c1x_A 175 HGDLRNFIRNET-----HNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 246 (373)
T ss_dssp TCBHHHHHHCTT-----CCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred CCCHHHHHhhcc-----cCCCHHHHHHHHHHHHHHHHHHHH---CCEecCccchheEEECCCCCEEEeeccccccccccc
Confidence 999999998654 458899999999999999999999 899999999999999999999999999998654221
Q ss_pred CCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCccccCccchhH
Q 042348 527 ETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQIGSMELNI 605 (686)
Q Consensus 527 ~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~~~~ 605 (686)
... ........+|..|+|||.+.+..++.++|||||||++|||+| |..||......+.
T Consensus 247 ~~~-------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~-- 305 (373)
T 3c1x_A 247 FDS-------------------VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI-- 305 (373)
T ss_dssp ------------------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCH--
T ss_pred ccc-------------------ccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHH--
Confidence 100 011123445778999999998999999999999999999999 6777754433221
Q ss_pred HHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccccch
Q 042348 606 VQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRVNISTE 673 (686)
Q Consensus 606 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~~~~ 673 (686)
. .......... .+ ......+.+++.+||+.||++|||+.|+++.|+++.....
T Consensus 306 ~---~~~~~~~~~~----~p--------~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~ 358 (373)
T 3c1x_A 306 T---VYLLQGRRLL----QP--------EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 358 (373)
T ss_dssp H---HHHHTTCCCC----CC--------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred H---HHHHcCCCCC----CC--------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcc
Confidence 1 1222221111 11 1122367899999999999999999999999999865444
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=343.92 Aligned_cols=259 Identities=16% Similarity=0.215 Sum_probs=204.3
Q ss_pred cccCccCceEEEEEEe-CCCceEEEEEcCCCCccchHHHHHHHHHHhcc-CCCCcceeeEEEEecCceeEEEeccCCCCH
Q 042348 373 FLLGKSTIGIVYKVAL-NNEEAVAVRRLGNGGWQRFKEFQTEAEAIGKI-RHPNIVSLRAYFWSVDEKLLIYDYIPNGSL 450 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL 450 (686)
..||+|+||.||+|.. .+++.||||.+.... ..+.+.+|+++++++ +|+||+++++++......++||||+ +++|
T Consensus 16 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L 92 (298)
T 1csn_A 16 RRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSL 92 (298)
T ss_dssp EEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CCBH
T ss_pred EEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec-CCCH
Confidence 4699999999999986 568899999986543 235688999999999 8999999999999999999999999 9999
Q ss_pred HHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCC-----eEEeecCcccccccc
Q 042348 451 ATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNME-----PHISDFGLARLADIA 525 (686)
Q Consensus 451 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~-----~kl~DfGla~~~~~~ 525 (686)
.+++.... ..+++..+..++.|++.||+|||+ ++|+||||||+||+++.++. +||+|||+++.....
T Consensus 93 ~~~l~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~ 164 (298)
T 1csn_A 93 EDLLDLCG-----RKFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDP 164 (298)
T ss_dssp HHHHHHTT-----TCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCT
T ss_pred HHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEeccCCCCCCCeEEEEECccccccccc
Confidence 99998653 458999999999999999999999 89999999999999987776 999999999876533
Q ss_pred cCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhH
Q 042348 526 EETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNI 605 (686)
Q Consensus 526 ~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~ 605 (686)
...... .........||..|+|||.+.+..++.++|||||||++|||++|+.||........
T Consensus 165 ~~~~~~----------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~-- 226 (298)
T 1csn_A 165 VTKQHI----------------PYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATN-- 226 (298)
T ss_dssp TTCCBC----------------CCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCH--
T ss_pred cccccc----------------cccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhcccc--
Confidence 211100 00122345688899999999998999999999999999999999999965432221
Q ss_pred HHHHHHHHhhc--CCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccc
Q 042348 606 VQWIQLILEDR--KPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRVNI 670 (686)
Q Consensus 606 ~~~~~~~~~~~--~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~ 670 (686)
......+.... .+.... .. .....+.+++.+||+.||++||++.+|++.|+++..
T Consensus 227 ~~~~~~~~~~~~~~~~~~~-----~~-----~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~ 283 (298)
T 1csn_A 227 KQKYERIGEKKQSTPLREL-----CA-----GFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLE 283 (298)
T ss_dssp HHHHHHHHHHHHHSCHHHH-----TT-----TSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHhhccCccHHHH-----Hh-----hCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHH
Confidence 11122222111 111110 00 122468899999999999999999999999998764
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=355.98 Aligned_cols=240 Identities=21% Similarity=0.340 Sum_probs=193.1
Q ss_pred cccCccCceEEEEEEe-CCCceEEEEEcCCCC---ccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCC
Q 042348 373 FLLGKSTIGIVYKVAL-NNEEAVAVRRLGNGG---WQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNG 448 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~g 448 (686)
+.||+|+||.||+|.. .+++.||||++.... ......+.+|+.+++.++||||+++++++...+..++||||+ +|
T Consensus 15 ~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~-~g 93 (336)
T 3h4j_B 15 ETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEYA-GG 93 (336)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCC-CE
T ss_pred EEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEECC-CC
Confidence 4699999999999997 468899999986431 122357899999999999999999999999999999999999 78
Q ss_pred CHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCC
Q 042348 449 SLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEET 528 (686)
Q Consensus 449 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 528 (686)
+|.+++... ..+++.++..++.|++.||+|||+ ++|+||||||+|||+++++.+||+|||+++......
T Consensus 94 ~l~~~l~~~------~~l~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~-- 162 (336)
T 3h4j_B 94 ELFDYIVEK------KRMTEDEGRRFFQQIICAIEYCHR---HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN-- 162 (336)
T ss_dssp EHHHHHHHH------CSCCHHHHHHHHHHHHHHHHHHHH---HTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB--
T ss_pred cHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCchhhEEEcCCCCEEEEEeccceeccCCc--
Confidence 999998764 358999999999999999999999 899999999999999999999999999997654221
Q ss_pred ccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCC-CCcchHHHHHHHHHHHHhCCCCccccCccchhHHH
Q 042348 529 PEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKP-TQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQ 607 (686)
Q Consensus 529 ~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~ 607 (686)
......||+.|+|||++.+..+ ++++|||||||++|||++|+.||........
T Consensus 163 ----------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~---- 216 (336)
T 3h4j_B 163 ----------------------FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL---- 216 (336)
T ss_dssp ----------------------TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC----
T ss_pred ----------------------ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH----
Confidence 1123467888999999988776 7899999999999999999999954322111
Q ss_pred HHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 608 WIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 608 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
. ...... ..... ......+.+++.+||+.||.+|||+.|++++
T Consensus 217 ------~--~~i~~~-~~~~p-----~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 259 (336)
T 3h4j_B 217 ------F--KKVNSC-VYVMP-----DFLSPGAQSLIRRMIVADPMQRITIQEIRRD 259 (336)
T ss_dssp ------B--CCCCSS-CCCCC-----TTSCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred ------H--HHHHcC-CCCCc-----ccCCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 0 000000 00000 1122357789999999999999999999876
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-41 Score=345.48 Aligned_cols=243 Identities=21% Similarity=0.356 Sum_probs=188.8
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCCc--------------------------cchHHHHHHHHHHhccCCCCc
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGGW--------------------------QRFKEFQTEAEAIGKIRHPNI 425 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------------------------~~~~~~~~E~~~l~~l~H~nI 425 (686)
..||+|+||.||+|... +++.||||++..... ...+.+.+|++++++++||||
T Consensus 19 ~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 98 (298)
T 2zv2_A 19 DEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNV 98 (298)
T ss_dssp EEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHTCCCTTB
T ss_pred eEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHhCCCCCC
Confidence 46999999999999865 578999999865321 113568899999999999999
Q ss_pred ceeeEEEEe--cCceeEEEeccCCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCe
Q 042348 426 VSLRAYFWS--VDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNI 503 (686)
Q Consensus 426 v~l~~~~~~--~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NI 503 (686)
+++++++.+ .+..++||||+++|+|.+++.. ..+++.++..++.|++.||+|||+ ++|+||||||+||
T Consensus 99 v~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-------~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Ni 168 (298)
T 2zv2_A 99 VKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL-------KPLSEDQARFYFQDLIKGIEYLHY---QKIIHRDIKPSNL 168 (298)
T ss_dssp CCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS-------SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGE
T ss_pred CeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc-------CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHE
Confidence 999999987 5678999999999999886542 468999999999999999999999 8999999999999
Q ss_pred eecCCCCeEEeecCcccccccccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCC---CCCcchHHH
Q 042348 504 LLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRK---PTQKWDIYS 580 (686)
Q Consensus 504 Ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~sDVwS 580 (686)
|++.++.+||+|||+++...... .......||..|+|||.+.+.. ++.++||||
T Consensus 169 l~~~~~~~kl~Dfg~~~~~~~~~-----------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~s 225 (298)
T 2zv2_A 169 LVGEDGHIKIADFGVSNEFKGSD-----------------------ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWA 225 (298)
T ss_dssp EECTTSCEEECCCTTCEECSSSS-----------------------CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHH
T ss_pred EECCCCCEEEecCCCcccccccc-----------------------ccccCCcCCccccChhhhccCCCCCCCchhhhHh
Confidence 99999999999999998654221 0112346788899999997655 378899999
Q ss_pred HHHHHHHHHhCCCCccccCccchhHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHH
Q 042348 581 YGVILLEMISGKLPMIQIGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRH 660 (686)
Q Consensus 581 lGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~e 660 (686)
|||++|||++|+.||.... .......+.......+. . ......+.+++.+||+.||++|||+.|
T Consensus 226 lG~~l~~l~~g~~pf~~~~-----~~~~~~~~~~~~~~~~~--~---------~~~~~~l~~li~~~l~~dp~~R~s~~e 289 (298)
T 2zv2_A 226 MGVTLYCFVFGQCPFMDER-----IMCLHSKIKSQALEFPD--Q---------PDIAEDLKDLITRMLDKNPESRIVVPE 289 (298)
T ss_dssp HHHHHHHHHHSSCSSCCSS-----HHHHHHHHHHCCCCCCS--S---------SCCCHHHHHHHHHHTCSCTTTSCCHHH
T ss_pred HHHHHHHHHHCCCCCCCcc-----HHHHHHHHhcccCCCCC--c---------cccCHHHHHHHHHHhhcChhhCCCHHH
Confidence 9999999999999995432 12222333222211111 0 011235789999999999999999999
Q ss_pred HHHH
Q 042348 661 VCDS 664 (686)
Q Consensus 661 v~~~ 664 (686)
++++
T Consensus 290 ~l~h 293 (298)
T 2zv2_A 290 IKLH 293 (298)
T ss_dssp HTTC
T ss_pred HhcC
Confidence 9764
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-41 Score=354.82 Aligned_cols=245 Identities=22% Similarity=0.297 Sum_probs=189.4
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCCc---cchHHHHHHHHH-HhccCCCCcceeeEEEEecCceeEEEeccCC
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGGW---QRFKEFQTEAEA-IGKIRHPNIVSLRAYFWSVDEKLLIYDYIPN 447 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~-l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~ 447 (686)
..||+|+||.||+|+.. +++.||||++..... .....+.+|..+ ++.++||||+++++++.+.+..++||||+++
T Consensus 44 ~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~g 123 (373)
T 2r5t_A 44 KVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 123 (373)
T ss_dssp EEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEEEECCCS
T ss_pred EEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999976 478899999865432 233456777776 5778999999999999999999999999999
Q ss_pred CCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccC
Q 042348 448 GSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEE 527 (686)
Q Consensus 448 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 527 (686)
|+|.+++... ..+++..+..++.||+.||+|||+ ++|+||||||+|||++.++++||+|||+++......
T Consensus 124 g~L~~~l~~~------~~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~- 193 (373)
T 2r5t_A 124 GELFYHLQRE------RCFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN- 193 (373)
T ss_dssp CBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCC-
T ss_pred CcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEECCCCCEEEeeCccccccccCC-
Confidence 9999999764 358899999999999999999999 899999999999999999999999999997532111
Q ss_pred CccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHH
Q 042348 528 TPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQ 607 (686)
Q Consensus 528 ~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~ 607 (686)
......+||..|+|||++.+..++.++|||||||++|||++|+.||..... .+
T Consensus 194 ----------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~-----~~ 246 (373)
T 2r5t_A 194 ----------------------STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT-----AE 246 (373)
T ss_dssp ----------------------CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBH-----HH
T ss_pred ----------------------CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH-----HH
Confidence 112345678899999999999999999999999999999999999954322 23
Q ss_pred HHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 042348 608 WIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDR 667 (686)
Q Consensus 608 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~ 667 (686)
....+.......... ....+.+++.+||+.||++||++.+.++.+.+
T Consensus 247 ~~~~i~~~~~~~~~~-------------~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~ 293 (373)
T 2r5t_A 247 MYDNILNKPLQLKPN-------------ITNSARHLLEGLLQKDRTKRLGAKDDFMEIKS 293 (373)
T ss_dssp HHHHHHHSCCCCCSS-------------SCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHT
T ss_pred HHHHHHhcccCCCCC-------------CCHHHHHHHHHHcccCHHhCCCCCCCHHHHhC
Confidence 334444432222111 12357789999999999999998654444433
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-41 Score=349.13 Aligned_cols=263 Identities=24% Similarity=0.308 Sum_probs=190.6
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCC-ccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCCH
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGG-WQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSL 450 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL 450 (686)
..||+|+||.||+|... +++.||||++.... ....+.+.+|++++++++||||+++++++...+..++||||++ |+|
T Consensus 11 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~-~~L 89 (317)
T 2pmi_A 11 EKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFMD-NDL 89 (317)
T ss_dssp --------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEECCC-CBH
T ss_pred eEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEecC-CCH
Confidence 36999999999999875 58899999986543 2334678899999999999999999999999999999999997 699
Q ss_pred HHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCcc
Q 042348 451 ATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPE 530 (686)
Q Consensus 451 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 530 (686)
.+++...........+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 90 ~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~--- 163 (317)
T 2pmi_A 90 KKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHE---NKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVN--- 163 (317)
T ss_dssp HHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCSSCEETTSCCC---
T ss_pred HHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCChHHeEEcCCCCEEECcCccceecCCCcc---
Confidence 9998754322222458999999999999999999999 8999999999999999999999999999986532110
Q ss_pred ccccccccCCCCCCCccccccccCCCCCccccCcccccC-CCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHHH
Q 042348 531 VHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKV-RKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQWI 609 (686)
Q Consensus 531 ~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~ 609 (686)
......+|..|+|||++.+ ..++.++|||||||++|||++|+.||...... .....+
T Consensus 164 --------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--~~~~~i 221 (317)
T 2pmi_A 164 --------------------TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDE--EQLKLI 221 (317)
T ss_dssp --------------------CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHH
T ss_pred --------------------cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH--HHHHHH
Confidence 1123456888999999876 46899999999999999999999999654322 222222
Q ss_pred HHHHhhcCC--ccc-----ccCcccccCC-----------CcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 610 QLILEDRKP--MTD-----ILDPFLAHDL-----------DKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 610 ~~~~~~~~~--~~~-----~~d~~l~~~~-----------~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
......... +.. ...+.+.... ........+.+++.+||+.||++|||+.|++++
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h 294 (317)
T 2pmi_A 222 FDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH 294 (317)
T ss_dssp HHHHCSCCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred HHHhCCCChhHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence 222111000 000 0000000000 000122368899999999999999999999875
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=378.15 Aligned_cols=259 Identities=29% Similarity=0.469 Sum_probs=209.4
Q ss_pred cccCccCceEEEEEEeCCCceEEEEEcCCCCccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCCHHH
Q 042348 373 FLLGKSTIGIVYKVALNNEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLAT 452 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL~~ 452 (686)
..||+|+||.||+|.+.++..||||+++.... ..++|.+|+++|++++||||+++++++.+ +..++|||||++|+|.+
T Consensus 273 ~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~~~gsL~~ 350 (535)
T 2h8h_A 273 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLD 350 (535)
T ss_dssp EEEEECSSEEEEEEEETTTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTEEHHH
T ss_pred eecccCCCeEEEEEEECCCceEEEEEeCCCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehhcCCcHHH
Confidence 46999999999999998888899999976543 35789999999999999999999999866 67899999999999999
Q ss_pred HhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCcccc
Q 042348 453 AIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVH 532 (686)
Q Consensus 453 ~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 532 (686)
+++...+ ..+++.+++.|+.||+.||+|||+ ++|+||||||+|||+++++.+||+|||+++.......
T Consensus 351 ~l~~~~~----~~l~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~----- 418 (535)
T 2h8h_A 351 FLKGETG----KYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY----- 418 (535)
T ss_dssp HHSHHHH----TTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHH-----
T ss_pred HHhhcCC----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCce-----
Confidence 9975322 358999999999999999999999 8999999999999999999999999999986542210
Q ss_pred ccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCccccCccchhHHHHHHH
Q 042348 533 WEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQIGSMELNIVQWIQL 611 (686)
Q Consensus 533 ~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~ 611 (686)
.......++..|+|||++....++.++|||||||++|||+| |+.||...... +....
T Consensus 419 -----------------~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~-----~~~~~ 476 (535)
T 2h8h_A 419 -----------------TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR-----EVLDQ 476 (535)
T ss_dssp -----------------HTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHH-----HHHHH
T ss_pred -----------------ecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-----HHHHH
Confidence 11122345678999999988899999999999999999999 99999543321 22222
Q ss_pred HHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccccchhhhhcc
Q 042348 612 ILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRVNISTEQQFMKG 679 (686)
Q Consensus 612 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~~~~~~~~~~ 679 (686)
+..+ ..+. . ...+...+.+++.+||+.||++|||+.+|++.|+.+....+.++..+
T Consensus 477 i~~~-~~~~--~---------~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~~~~~~~ 532 (535)
T 2h8h_A 477 VERG-YRMP--C---------PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPG 532 (535)
T ss_dssp HHTT-CCCC--C---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCCSCSSCC-
T ss_pred HHcC-CCCC--C---------CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhccCcccCcc
Confidence 2222 1111 0 01123467899999999999999999999999999987777766544
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-41 Score=340.52 Aligned_cols=244 Identities=25% Similarity=0.422 Sum_probs=187.9
Q ss_pred cccCccCceEEEEEEeCCCceEEEEEcCCCCc----cchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCC
Q 042348 373 FLLGKSTIGIVYKVALNNEEAVAVRRLGNGGW----QRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNG 448 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~g 448 (686)
..||+|+||.||+|... ++.||||.+..... ...+.+.+|++++++++||||+++++++...+..++||||++++
T Consensus 13 ~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 91 (271)
T 3dtc_A 13 EIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGG 91 (271)
T ss_dssp EEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEEECCTTE
T ss_pred eeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEEcCCCC
Confidence 46999999999999976 78899999865422 23467899999999999999999999999999999999999999
Q ss_pred CHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCC---ceecCCCCCCeeecC--------CCCeEEeecC
Q 042348 449 SLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKR---YVHGDLRPSNILLGK--------NMEPHISDFG 517 (686)
Q Consensus 449 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~---iiHrDlkp~NILl~~--------~~~~kl~DfG 517 (686)
+|.+++.. ..+++..+..++.|++.||+|||+ ++ |+||||||+||+++. ++.+||+|||
T Consensus 92 ~L~~~~~~-------~~~~~~~~~~i~~~l~~~l~~lH~---~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg 161 (271)
T 3dtc_A 92 PLNRVLSG-------KRIPPDILVNWAVQIARGMNYLHD---EAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFG 161 (271)
T ss_dssp EHHHHHTS-------SCCCHHHHHHHHHHHHHHHHHHHH---SSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCC
T ss_pred CHHHHhhc-------CCCCHHHHHHHHHHHHHHHHHHHh---CCCCceeecCCchHHEEEecccccccccCcceEEccCC
Confidence 99999864 358999999999999999999999 67 999999999999986 6789999999
Q ss_pred cccccccccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccc
Q 042348 518 LARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQ 597 (686)
Q Consensus 518 la~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~ 597 (686)
+++...... .....||..|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus 162 ~~~~~~~~~-------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~ 216 (271)
T 3dtc_A 162 LAREWHRTT-------------------------KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRG 216 (271)
T ss_dssp C--------------------------------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTT
T ss_pred ccccccccc-------------------------ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 997543211 1123567889999999888899999999999999999999999965
Q ss_pred cCccchhHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 042348 598 IGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRV 668 (686)
Q Consensus 598 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i 668 (686)
..... ........... .. .. ......+.+++.+||+.||++|||+.|++++|+++
T Consensus 217 ~~~~~-----~~~~~~~~~~~-~~-----~~-----~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 217 IDGLA-----VAYGVAMNKLA-LP-----IP-----STCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp SCHHH-----HHHHHHTSCCC-CC-----CC-----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred CCHHH-----HHHhhhcCCCC-CC-----CC-----cccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 33211 11222222111 00 00 11224678999999999999999999999999875
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=352.70 Aligned_cols=248 Identities=25% Similarity=0.353 Sum_probs=180.7
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCCccchHHHHHHHHHHhccC-CCCcceeeEEEEecCceeEEEeccCCCCH
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIR-HPNIVSLRAYFWSVDEKLLIYDYIPNGSL 450 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lV~e~~~~gsL 450 (686)
+.||+|+||.||+|... +++.||||++... ....+.+|+.+++++. ||||+++++++.+.+..++||||+++|+|
T Consensus 17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L 93 (325)
T 3kn6_A 17 KPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGEL 93 (325)
T ss_dssp CCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcH
Confidence 46999999999999976 5889999998653 3467889999999997 99999999999999999999999999999
Q ss_pred HHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCC---CeEEeecCcccccccccC
Q 042348 451 ATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNM---EPHISDFGLARLADIAEE 527 (686)
Q Consensus 451 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~---~~kl~DfGla~~~~~~~~ 527 (686)
.+++... ..+++.++..|+.|++.||+|||+ ++|+||||||+|||++.++ .+||+|||+++.......
T Consensus 94 ~~~l~~~------~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~ 164 (325)
T 3kn6_A 94 FERIKKK------KHFSETEASYIMRKLVSAVSHMHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ 164 (325)
T ss_dssp HHHHHHC------SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC---
T ss_pred HHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC
Confidence 9999865 468999999999999999999999 8999999999999997665 799999999985542211
Q ss_pred CccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCcc--chhH
Q 042348 528 TPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSM--ELNI 605 (686)
Q Consensus 528 ~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~--~~~~ 605 (686)
......||..|+|||++.+..++.++|||||||++|||++|+.||...... ....
T Consensus 165 -----------------------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~ 221 (325)
T 3kn6_A 165 -----------------------PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSA 221 (325)
T ss_dssp ------------------------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCH
T ss_pred -----------------------cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccH
Confidence 112345688899999999999999999999999999999999999653321 1122
Q ss_pred HHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 606 VQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 606 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
.+....+..+...... +.. .....++.+++.+||+.||++|||+.|++++
T Consensus 222 ~~~~~~i~~~~~~~~~---~~~------~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 271 (325)
T 3kn6_A 222 VEIMKKIKKGDFSFEG---EAW------KNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN 271 (325)
T ss_dssp HHHHHHHTTTCCCCCS---HHH------HTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred HHHHHHHHcCCCCCCc---ccc------cCCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence 2333333222211110 000 1123467899999999999999999999765
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=348.72 Aligned_cols=256 Identities=21% Similarity=0.321 Sum_probs=194.5
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCC-ccchHHHHHHHHHHhccCCCCcceeeEEEEecCc-------------
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGG-WQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDE------------- 437 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~------------- 437 (686)
..||+|+||.||+|+.. +++.||||++.... ....+.+.+|++++++++||||+++++++.+.+.
T Consensus 12 ~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~ 91 (332)
T 3qd2_B 12 QCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLK 91 (332)
T ss_dssp EEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHHHC----
T ss_pred eEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhhhhhhhc
Confidence 46999999999999986 68999999986533 3345779999999999999999999999866442
Q ss_pred --------------------------------------------eeEEEeccCCCCHHHHhhcCCCccccCCCCHHHHHH
Q 042348 438 --------------------------------------------KLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLR 473 (686)
Q Consensus 438 --------------------------------------------~~lV~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~ 473 (686)
.++|||||++|+|.+++...... ...++..++.
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~---~~~~~~~~~~ 168 (332)
T 3qd2_B 92 DESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSL---EDREHGVCLH 168 (332)
T ss_dssp ----------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSG---GGSCHHHHHH
T ss_pred cccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCc---cchhhHHHHH
Confidence 79999999999999999876432 3467778999
Q ss_pred HHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCccccccccccCCCCCCCcccccccc
Q 042348 474 IIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALN 553 (686)
Q Consensus 474 i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~ 553 (686)
++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++............ . .........
T Consensus 169 i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~-------~----~~~~~~~~~ 234 (332)
T 3qd2_B 169 IFIQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVL-------T----PMPAYATHT 234 (332)
T ss_dssp HHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC-------------------------CCC
T ss_pred HHHHHHHHHHHHHh---CCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhcccc-------c----ccccccccc
Confidence 99999999999999 899999999999999999999999999998765432111000 0 000011223
Q ss_pred CCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHHHHHHHhhcCCcccccCcccccCCCc
Q 042348 554 STTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDK 633 (686)
Q Consensus 554 ~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 633 (686)
...||..|+|||++.+..++.++|||||||++|||++|..|+.. ............ .+. ..
T Consensus 235 ~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~-------~~~~~~~~~~~~--~~~----------~~ 295 (332)
T 3qd2_B 235 GQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME-------RVRIITDVRNLK--FPL----------LF 295 (332)
T ss_dssp SCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH-------HHHHHHHHHTTC--CCH----------HH
T ss_pred ccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH-------HHHHHHHhhccC--CCc----------cc
Confidence 45789999999999999999999999999999999999887621 111112211111 110 01
Q ss_pred HHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 634 EDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 634 ~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
......+.+++.+||+.||++|||+.|++++
T Consensus 296 ~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 296 TQKYPQEHMMVQDMLSPSPTERPEATDIIEN 326 (332)
T ss_dssp HHHCHHHHHHHHHHHCSSGGGSCCHHHHHHS
T ss_pred ccCChhHHHHHHHHccCCCCcCCCHHHHhhc
Confidence 2233457889999999999999999999874
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-41 Score=354.77 Aligned_cols=244 Identities=23% Similarity=0.355 Sum_probs=184.5
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCCccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCCHH
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLA 451 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL~ 451 (686)
..||+|+||.||+|... +++.||||++.... ..+.+.+|++++++++||||+++++++...+..++||||+++|+|.
T Consensus 59 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~ 136 (349)
T 2w4o_A 59 SELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELF 136 (349)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHH
T ss_pred eEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCCCCCHH
Confidence 46999999999999986 47889999987643 3467889999999999999999999999999999999999999999
Q ss_pred HHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecC---CCCeEEeecCcccccccccCC
Q 042348 452 TAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGK---NMEPHISDFGLARLADIAEET 528 (686)
Q Consensus 452 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~---~~~~kl~DfGla~~~~~~~~~ 528 (686)
+++... ..+++.++..++.|++.||+|||+ ++|+||||||+|||++. ++.+||+|||+++......
T Consensus 137 ~~l~~~------~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~-- 205 (349)
T 2w4o_A 137 DRIVEK------GYYSERDAADAVKQILEAVAYLHE---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV-- 205 (349)
T ss_dssp HHHTTC------SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEESSSSTTCCEEECCCC-----------
T ss_pred HHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCcccEEEecCCCCCCEEEccCccccccCccc--
Confidence 999765 358999999999999999999999 89999999999999975 8899999999998653211
Q ss_pred ccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHH
Q 042348 529 PEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQW 608 (686)
Q Consensus 529 ~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~ 608 (686)
......||..|+|||++.+..++.++|||||||++|||++|+.||....... ..
T Consensus 206 ----------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~----~~ 259 (349)
T 2w4o_A 206 ----------------------LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQ----FM 259 (349)
T ss_dssp -----------------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHH----HH
T ss_pred ----------------------ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccH----HH
Confidence 1123457888999999999899999999999999999999999995543221 12
Q ss_pred HHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 609 IQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 609 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
...+........ .+.. ......+.+++.+||+.||++|||+.|++++
T Consensus 260 ~~~i~~~~~~~~---~~~~------~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 260 FRRILNCEYYFI---SPWW------DEVSLNAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp HHHHHTTCCCCC---TTTT------TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred HHHHHhCCCccC---Cchh------hhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 223333222111 1100 1123467899999999999999999999886
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-41 Score=361.76 Aligned_cols=247 Identities=19% Similarity=0.248 Sum_probs=197.5
Q ss_pred cccCccCceEEEEEEeCC-CceEEEEEcCCCC---ccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCC
Q 042348 373 FLLGKSTIGIVYKVALNN-EEAVAVRRLGNGG---WQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNG 448 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~g 448 (686)
..||+|+||.||+|+... ++.||||++.... ......+.+|+.++.+++||||++++++|.+.+..++|||||++|
T Consensus 80 ~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~Ey~~gg 159 (437)
T 4aw2_A 80 KVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGG 159 (437)
T ss_dssp EEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCTTC
T ss_pred EEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEEecCCCC
Confidence 469999999999999864 7889999986521 122345889999999999999999999999999999999999999
Q ss_pred CHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCC
Q 042348 449 SLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEET 528 (686)
Q Consensus 449 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 528 (686)
+|.+++.... ..+++..+..++.|++.||+|||+ ++||||||||+|||++.++.+||+|||+|+.......
T Consensus 160 ~L~~~l~~~~-----~~l~e~~~~~~~~qi~~aL~~LH~---~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~- 230 (437)
T 4aw2_A 160 DLLTLLSKFE-----DRLPEEMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT- 230 (437)
T ss_dssp BHHHHHHTTT-----TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSC-
T ss_pred cHHHHHHHcc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeeEcCCCCEEEcchhhhhhcccCCC-
Confidence 9999998643 468999999999999999999999 8999999999999999999999999999976542211
Q ss_pred ccccccccccCCCCCCCccccccccCCCCCccccCccccc-----CCCCCCcchHHHHHHHHHHHHhCCCCccccCccch
Q 042348 529 PEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASK-----VRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMEL 603 (686)
Q Consensus 529 ~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~ 603 (686)
......+||+.|+|||++. ...++.++|||||||++|||++|+.||.....
T Consensus 231 ---------------------~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~--- 286 (437)
T 4aw2_A 231 ---------------------VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL--- 286 (437)
T ss_dssp ---------------------EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSH---
T ss_pred ---------------------cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCCh---
Confidence 1122357889999999986 56789999999999999999999999964332
Q ss_pred hHHHHHHHHHhhc--CCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCC--CCCHHHHHHH
Q 042348 604 NIVQWIQLILEDR--KPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDK--RPSMRHVCDS 664 (686)
Q Consensus 604 ~~~~~~~~~~~~~--~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~--RPs~~ev~~~ 664 (686)
.+....+.... ...+... . .....+.+++.+||..+|++ ||+++|++++
T Consensus 287 --~~~~~~i~~~~~~~~~p~~~-----~-----~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 287 --VETYGKIMNHKERFQFPTQV-----T-----DVSENAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp --HHHHHHHHTHHHHCCCCSSC-----C-----CSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred --hHHHHhhhhccccccCCccc-----c-----cCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 22233333221 1111110 0 11235778999999988888 9999999987
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-41 Score=344.52 Aligned_cols=261 Identities=24% Similarity=0.361 Sum_probs=208.4
Q ss_pred ccCccCceEEEEEEeC---CCceEEEEEcCCCC-ccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCC
Q 042348 374 LLGKSTIGIVYKVALN---NEEAVAVRRLGNGG-WQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGS 449 (686)
Q Consensus 374 ~iG~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gs 449 (686)
.||+|+||.||+|... ++..||||.+.... ....+++.+|++++++++||||+++++++ ..+..++||||+++++
T Consensus 17 ~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~~ 95 (287)
T 1u59_A 17 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGP 95 (287)
T ss_dssp EEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEEECCTTEE
T ss_pred cccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEEEeCCCCC
Confidence 6999999999999854 57789999997653 34457799999999999999999999999 5567899999999999
Q ss_pred HHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCc
Q 042348 450 LATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETP 529 (686)
Q Consensus 450 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 529 (686)
|.+++.... ..+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++........
T Consensus 96 L~~~l~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~- 166 (287)
T 1u59_A 96 LHKFLVGKR-----EEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSY- 166 (287)
T ss_dssp HHHHHTTCT-----TTSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCE-
T ss_pred HHHHHHhCC-----ccCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCchheEEEcCCCCEEECcccceeeeccCcce-
Confidence 999997543 468999999999999999999999 89999999999999999999999999999865422110
Q ss_pred cccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCccccCccchhHHHH
Q 042348 530 EVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQIGSMELNIVQW 608 (686)
Q Consensus 530 ~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~~~~~~~ 608 (686)
........+|..|+|||.+.+..++.++||||||+++|||+| |+.||...... +.
T Consensus 167 -------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-----~~ 222 (287)
T 1u59_A 167 -------------------YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP-----EV 222 (287)
T ss_dssp -------------------ECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH-----HH
T ss_pred -------------------eeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH-----HH
Confidence 011123345778999999988889999999999999999999 99999554322 12
Q ss_pred HHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccccchhhhhccC
Q 042348 609 IQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRVNISTEQQFMKGE 680 (686)
Q Consensus 609 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~~~~~~~~~~~ 680 (686)
...+...... . .. ......+.+++.+||+.||++||++.|++++|+++..+.......+.
T Consensus 223 ~~~i~~~~~~--~-~~---------~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~~~~~ 282 (287)
T 1u59_A 223 MAFIEQGKRM--E-CP---------PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEGHH 282 (287)
T ss_dssp HHHHHTTCCC--C-CC---------TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTTCSSCC
T ss_pred HHHHhcCCcC--C-CC---------CCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCcccCCc
Confidence 2222222111 0 01 11234688999999999999999999999999999877766555443
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-41 Score=349.72 Aligned_cols=257 Identities=24% Similarity=0.379 Sum_probs=203.5
Q ss_pred cccCccCceEEEEEEe------CCCceEEEEEcCCCC-ccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEecc
Q 042348 373 FLLGKSTIGIVYKVAL------NNEEAVAVRRLGNGG-WQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYI 445 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~ 445 (686)
..||+|+||.||+|.. .++..||||.+.... ....+.+.+|++++++++||||+++++++...+..++||||+
T Consensus 29 ~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 108 (314)
T 2ivs_A 29 KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYA 108 (314)
T ss_dssp EEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred eeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCceEEEEeec
Confidence 4699999999999986 235789999997643 344577899999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcCCCcc------------------ccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecC
Q 042348 446 PNGSLATAIHGKAGII------------------SYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGK 507 (686)
Q Consensus 446 ~~gsL~~~l~~~~~~~------------------~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~ 507 (686)
++|+|.+++....... ....+++.++..++.|++.||+|||+ ++|+||||||+||+++.
T Consensus 109 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dikp~NIli~~ 185 (314)
T 2ivs_A 109 KYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE---MKLVHRDLAARNILVAE 185 (314)
T ss_dssp TTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEET
T ss_pred CCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHH---CCCcccccchheEEEcC
Confidence 9999999998653210 11348999999999999999999999 89999999999999999
Q ss_pred CCCeEEeecCcccccccccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHH
Q 042348 508 NMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLE 587 (686)
Q Consensus 508 ~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~e 587 (686)
++.+||+|||+++........ .......+|..|+|||.+.+..++.++|||||||++||
T Consensus 186 ~~~~kl~Dfg~~~~~~~~~~~---------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e 244 (314)
T 2ivs_A 186 GRKMKISDFGLSRDVYEEDSY---------------------VKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWE 244 (314)
T ss_dssp TTEEEECCCTTCEECTTTSCE---------------------ECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHH
T ss_pred CCCEEEccccccccccccccc---------------------eeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHH
Confidence 999999999999865422110 11123345778999999988889999999999999999
Q ss_pred HHh-CCCCccccCccchhHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 042348 588 MIS-GKLPMIQIGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLD 666 (686)
Q Consensus 588 llt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~ 666 (686)
|+| |+.||....... + ...+...... . .. ......+.+++.+||+.||++|||+.|++++|+
T Consensus 245 l~t~g~~p~~~~~~~~--~---~~~~~~~~~~--~-~~---------~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~ 307 (314)
T 2ivs_A 245 IVTLGGNPYPGIPPER--L---FNLLKTGHRM--E-RP---------DNCSEEMYRLMLQCWKQEPDKRPVFADISKDLE 307 (314)
T ss_dssp HHTTSCCSSTTCCGGG--H---HHHHHTTCCC--C-CC---------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHhCCCCCCCCCCHHH--H---HHHhhcCCcC--C-CC---------ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 999 999996543322 1 1222221111 0 00 112246789999999999999999999999999
Q ss_pred cccc
Q 042348 667 RVNI 670 (686)
Q Consensus 667 ~i~~ 670 (686)
++..
T Consensus 308 ~~~~ 311 (314)
T 2ivs_A 308 KMMV 311 (314)
T ss_dssp HHHH
T ss_pred HHHh
Confidence 8753
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-41 Score=343.94 Aligned_cols=257 Identities=20% Similarity=0.280 Sum_probs=194.0
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCC--ccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCC
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGG--WQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGS 449 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gs 449 (686)
+.||+|+||.||+|... +++.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++||||+++ +
T Consensus 8 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~ 86 (292)
T 3o0g_A 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-D 86 (292)
T ss_dssp EEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSE-E
T ss_pred eEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEecCCC-C
Confidence 46999999999999976 58899999986542 23346788999999999999999999999999999999999975 6
Q ss_pred HHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCc
Q 042348 450 LATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETP 529 (686)
Q Consensus 450 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 529 (686)
+.+.+.... ..+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++......
T Consensus 87 l~~~~~~~~-----~~l~~~~~~~~~~ql~~~l~~lH~---~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~--- 155 (292)
T 3o0g_A 87 LKKYFDSCN-----GDLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV--- 155 (292)
T ss_dssp HHHHHHHTT-----TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCC---
T ss_pred HHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccceecCCcc---
Confidence 666665433 469999999999999999999999 899999999999999999999999999998653211
Q ss_pred cccccccccCCCCCCCccccccccCCCCCccccCcccccCCC-CCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHH
Q 042348 530 EVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRK-PTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQW 608 (686)
Q Consensus 530 ~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~ 608 (686)
.......+|..|+|||++.+.. ++.++|||||||++|||++|..||........ ....
T Consensus 156 --------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~-~~~~ 214 (292)
T 3o0g_A 156 --------------------RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD-QLKR 214 (292)
T ss_dssp --------------------SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHH-HHHH
T ss_pred --------------------ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHH-HHHH
Confidence 1112346688899999987765 89999999999999999999998744333222 1221
Q ss_pred HHHHHhhcCCcccccCc---------c--c----ccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 609 IQLILEDRKPMTDILDP---------F--L----AHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 609 ~~~~~~~~~~~~~~~d~---------~--l----~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
+...... +..+.... . . ............+.+++.+||+.||++|||++|++++
T Consensus 215 i~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 283 (292)
T 3o0g_A 215 IFRLLGT--PTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp HHHHHCC--CCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHhCC--CChhhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 2111111 00000000 0 0 0000001123467799999999999999999999864
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=357.70 Aligned_cols=273 Identities=20% Similarity=0.280 Sum_probs=200.8
Q ss_pred cccCcc--CceEEEEEEeC-CCceEEEEEcCCCC--ccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCC
Q 042348 373 FLLGKS--TIGIVYKVALN-NEEAVAVRRLGNGG--WQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPN 447 (686)
Q Consensus 373 ~~iG~G--~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~ 447 (686)
..||+| +||.||+|+.. +++.||||++.... ....+.+.+|++++++++|||||++++++.+.+..++|||||++
T Consensus 31 ~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 110 (389)
T 3gni_B 31 TVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAY 110 (389)
T ss_dssp EEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred ecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEEEEccCC
Confidence 469999 99999999976 68999999986542 23346788999999999999999999999999999999999999
Q ss_pred CCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccC
Q 042348 448 GSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEE 527 (686)
Q Consensus 448 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 527 (686)
|+|.+++..... ..+++..+..|+.||+.||+|||+ ++|+||||||+|||++.++.+||+|||.+........
T Consensus 111 ~~L~~~l~~~~~----~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~~~ 183 (389)
T 3gni_B 111 GSAKDLICTHFM----DGMNELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQ 183 (389)
T ss_dssp CBHHHHHHHTCT----TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCGGGCEECEETTE
T ss_pred CCHHHHHhhhcc----cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEcccccceeeccccc
Confidence 999999986532 458999999999999999999999 8999999999999999999999999999875532211
Q ss_pred CccccccccccCCCCCCCccccccccCCCCCccccCcccccC--CCCCCcchHHHHHHHHHHHHhCCCCccccCccchhH
Q 042348 528 TPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKV--RKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNI 605 (686)
Q Consensus 528 ~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~ 605 (686)
... .. ........||..|+|||++.+ ..++.++|||||||++|||++|+.||.........
T Consensus 184 ~~~-----~~-----------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~- 246 (389)
T 3gni_B 184 RQR-----VV-----------HDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQML- 246 (389)
T ss_dssp ECS-----CB-----------CCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHH-
T ss_pred ccc-----cc-----------ccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHH-
Confidence 000 00 011223467888999999987 57899999999999999999999999654333211
Q ss_pred HHHHHHHHhh----cC-C----------------ccccc---Ccc-----cccCCCcHHHHHHHHHHHHhccccCCCCCC
Q 042348 606 VQWIQLILED----RK-P----------------MTDIL---DPF-----LAHDLDKEDEIVSVLKIALDCVHKSPDKRP 656 (686)
Q Consensus 606 ~~~~~~~~~~----~~-~----------------~~~~~---d~~-----l~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 656 (686)
.......... .. + ..+.. .+. .............+.+++.+||+.||++||
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp 326 (389)
T 3gni_B 247 LEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARP 326 (389)
T ss_dssp HHC--------------------------------------------------------CCHHHHHHHHHHTCSCTTTSC
T ss_pred HHHhcCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCC
Confidence 1100000000 00 0 00000 000 000000111234588999999999999999
Q ss_pred CHHHHHHH--Hhccc
Q 042348 657 SMRHVCDS--LDRVN 669 (686)
Q Consensus 657 s~~ev~~~--L~~i~ 669 (686)
|+.|++++ ++.+.
T Consensus 327 ta~ell~hp~f~~~~ 341 (389)
T 3gni_B 327 SASTLLNHSFFKQIK 341 (389)
T ss_dssp CHHHHTTSGGGGGC-
T ss_pred CHHHHhcCHHHHHHh
Confidence 99999977 55554
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=338.78 Aligned_cols=246 Identities=20% Similarity=0.316 Sum_probs=198.0
Q ss_pred cccCccCceEEEEEEeCCCceEEEEEcCCCC--ccchHHHHHHHHHHhccCCCCcceeeEEEEec--CceeEEEeccCCC
Q 042348 373 FLLGKSTIGIVYKVALNNEEAVAVRRLGNGG--WQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSV--DEKLLIYDYIPNG 448 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~~lV~e~~~~g 448 (686)
..||+|+||.||+|... ++.||||++.... ....+.+.+|+.++++++||||+++++++.+. +..++||||+++|
T Consensus 16 ~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~ 94 (271)
T 3kmu_A 16 TKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYG 94 (271)
T ss_dssp EEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEECCTTC
T ss_pred HHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeeecccCCC
Confidence 46999999999999986 7889999987643 33456799999999999999999999999887 6789999999999
Q ss_pred CHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCC--ceecCCCCCCeeecCCCCeEEeecCccccccccc
Q 042348 449 SLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKR--YVHGDLRPSNILLGKNMEPHISDFGLARLADIAE 526 (686)
Q Consensus 449 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~--iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~ 526 (686)
+|.+++..... ..+++..+..|+.|++.||+|||+ ++ |+||||||+||+++.++.++|+|||++.....
T Consensus 95 ~L~~~l~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~---~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~-- 165 (271)
T 3kmu_A 95 SLYNVLHEGTN----FVVDQSQAVKFALDMARGMAFLHT---LEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS-- 165 (271)
T ss_dssp BHHHHHHSCSS----CCCCHHHHHHHHHHHHHHHHHHTT---SSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC--
T ss_pred cHHHHHhhccc----CCCCHHHHHHHHHHHHHHHHHHhc---CCCceecCCCccceEEEcCCcceeEEeccceeeecc--
Confidence 99999987542 358999999999999999999999 77 99999999999999999999999988653211
Q ss_pred CCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCC---cchHHHHHHHHHHHHhCCCCccccCccch
Q 042348 527 ETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQ---KWDIYSYGVILLEMISGKLPMIQIGSMEL 603 (686)
Q Consensus 527 ~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~sDVwSlGvvl~elltG~~P~~~~~~~~~ 603 (686)
....+|..|+|||.+.+..++. ++|||||||++|||++|+.||......
T Consensus 166 --------------------------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-- 217 (271)
T 3kmu_A 166 --------------------------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNM-- 217 (271)
T ss_dssp --------------------------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHH--
T ss_pred --------------------------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChH--
Confidence 1234677899999988765544 799999999999999999999543322
Q ss_pred hHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccc
Q 042348 604 NIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRVNI 670 (686)
Q Consensus 604 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~ 670 (686)
............ .. ... .....+.+++.+||+.||++|||+.|+++.|+++..
T Consensus 218 ---~~~~~~~~~~~~-~~-----~~~-----~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 218 ---EIGMKVALEGLR-PT-----IPP-----GISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp ---HHHHHHHHSCCC-CC-----CCT-----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred ---HHHHHHHhcCCC-CC-----CCC-----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 112222222111 11 111 122357899999999999999999999999998864
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=364.05 Aligned_cols=241 Identities=25% Similarity=0.378 Sum_probs=198.6
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCC---ccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCC
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGG---WQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNG 448 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~g 448 (686)
..||+|+||.||+|... +|+.||||++.... ....+.+.+|+.+++.++||||+++++++...+..++||||+++|
T Consensus 22 ~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~gg 101 (476)
T 2y94_A 22 DTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGG 101 (476)
T ss_dssp EEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSSE
T ss_pred EEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCC
Confidence 46999999999999976 68999999986532 123467899999999999999999999999999999999999999
Q ss_pred CHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCC
Q 042348 449 SLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEET 528 (686)
Q Consensus 449 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 528 (686)
+|.+++... ..+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 102 ~L~~~l~~~------~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~-- 170 (476)
T 2y94_A 102 ELFDYICKN------GRLDEKESRRLFQQILSGVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE-- 170 (476)
T ss_dssp EHHHHTTSS------SSCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTC--
T ss_pred cHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCCCcccccHHHEEEecCCCeEEEeccchhhccccc--
Confidence 999999754 458999999999999999999999 899999999999999999999999999998654221
Q ss_pred ccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCC-CCcchHHHHHHHHHHHHhCCCCccccCccchhHHH
Q 042348 529 PEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKP-TQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQ 607 (686)
Q Consensus 529 ~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~ 607 (686)
......||+.|+|||++.+..+ +.++|||||||++|||++|+.||..... ..
T Consensus 171 ----------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~-----~~ 223 (476)
T 2y94_A 171 ----------------------FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHV-----PT 223 (476)
T ss_dssp ----------------------CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSS-----HH
T ss_pred ----------------------cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCH-----HH
Confidence 1123467888999999988765 6899999999999999999999954322 22
Q ss_pred HHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 608 WIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 608 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
....+..+....+.. ....+.+++.+||+.||++|||+.|++++
T Consensus 224 ~~~~i~~~~~~~p~~-------------~s~~~~~Li~~~L~~dP~~Rpt~~eil~h 267 (476)
T 2y94_A 224 LFKKICDGIFYTPQY-------------LNPSVISLLKHMLQVDPMKRATIKDIREH 267 (476)
T ss_dssp HHHHHHTTCCCCCTT-------------CCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred HHHHHhcCCcCCCcc-------------CCHHHHHHHHHHcCCCchhCcCHHHHHhC
Confidence 333443332222111 12357789999999999999999999975
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=353.16 Aligned_cols=246 Identities=23% Similarity=0.293 Sum_probs=191.0
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCCccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCCHH
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLA 451 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL~ 451 (686)
..||+|+||.||+++.. +++.||||++..... ..+.+.+|+.++++++||||+++++++.+.+..++||||+++|+|.
T Consensus 26 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~ 104 (361)
T 3uc3_A 26 KDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELY 104 (361)
T ss_dssp EEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHH
T ss_pred EEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeCCCCCHH
Confidence 46999999999999976 688999999976432 2367889999999999999999999999999999999999999999
Q ss_pred HHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCC--eEEeecCcccccccccCCc
Q 042348 452 TAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNME--PHISDFGLARLADIAEETP 529 (686)
Q Consensus 452 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~--~kl~DfGla~~~~~~~~~~ 529 (686)
+++... ..+++..+..++.|++.||+|||+ ++|+||||||+|||++.++. +||+|||+++......
T Consensus 105 ~~l~~~------~~~~~~~~~~i~~ql~~~L~~LH~---~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~--- 172 (361)
T 3uc3_A 105 ERICNA------GRFSEDEARFFFQQLLSGVSYCHS---MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--- 172 (361)
T ss_dssp HHHHHH------SSCCHHHHHHHHHHHHHHHHHHHH---TTCCSCCCCGGGEEECSSSSCCEEECCCCCC----------
T ss_pred HHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCceEEEeecCccccccccC---
Confidence 999754 358999999999999999999999 89999999999999987765 9999999987432111
Q ss_pred cccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCc-chHHHHHHHHHHHHhCCCCccccCccchhHHHH
Q 042348 530 EVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQK-WDIYSYGVILLEMISGKLPMIQIGSMELNIVQW 608 (686)
Q Consensus 530 ~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~ 608 (686)
......||..|+|||++.+..++.+ +|||||||++|||++|+.||...... ......
T Consensus 173 ---------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~-~~~~~~ 230 (361)
T 3uc3_A 173 ---------------------QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP-RDYRKT 230 (361)
T ss_dssp -----------------------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----C-CCHHHH
T ss_pred ---------------------CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccH-HHHHHH
Confidence 1123457888999999988777655 89999999999999999999654332 223334
Q ss_pred HHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 609 IQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 609 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
++.+.......+... .....+.+++.+||+.||++|||+.|++++
T Consensus 231 ~~~~~~~~~~~~~~~-----------~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 231 IQRILSVKYSIPDDI-----------RISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp HHHHHTTCCCCCTTS-----------CCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHHhcCCCCCCCcC-----------CCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 444443332221110 012357789999999999999999999987
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-41 Score=342.67 Aligned_cols=256 Identities=29% Similarity=0.463 Sum_probs=203.1
Q ss_pred cccCccCceEEEEEEeCCCceEEEEEcCCCCccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCCHHH
Q 042348 373 FLLGKSTIGIVYKVALNNEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLAT 452 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL~~ 452 (686)
..||+|+||.||+|...++..||||.+.... ...+.+.+|++++++++||||+++++++. .+..++||||+++++|.+
T Consensus 19 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~ 96 (279)
T 1qpc_A 19 ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYMENGSLVD 96 (279)
T ss_dssp EEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCTTCBHHH
T ss_pred eeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEecCCCCCHHH
Confidence 4699999999999999888899999997654 23578999999999999999999999986 456899999999999999
Q ss_pred HhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCcccc
Q 042348 453 AIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVH 532 (686)
Q Consensus 453 ~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 532 (686)
++....+ ..+++..+..++.|++.||+|||+ ++|+||||||+||++++++.+||+|||+++.......
T Consensus 97 ~l~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~----- 164 (279)
T 1qpc_A 97 FLKTPSG----IKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY----- 164 (279)
T ss_dssp HTTSHHH----HTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE-----
T ss_pred HHhcCCC----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHhhEEEcCCCCEEECCCcccccccCccc-----
Confidence 9975421 258999999999999999999999 8999999999999999999999999999986542211
Q ss_pred ccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCccccCccchhHHHHHHH
Q 042348 533 WEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQIGSMELNIVQWIQL 611 (686)
Q Consensus 533 ~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~ 611 (686)
.......++..|+|||.+.+..++.++||||||+++|||++ |+.||...... +....
T Consensus 165 -----------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-----~~~~~ 222 (279)
T 1qpc_A 165 -----------------TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP-----EVIQN 222 (279)
T ss_dssp -----------------ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-----HHHHH
T ss_pred -----------------ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHH-----HHHHH
Confidence 11122345677999999988889999999999999999999 99999543221 22222
Q ss_pred HHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccccchhhh
Q 042348 612 ILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRVNISTEQQF 676 (686)
Q Consensus 612 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~~~~~~~ 676 (686)
+....... .+ ......+.+++.+||+.||++|||+.++++.|+++......++
T Consensus 223 ~~~~~~~~----~~--------~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~ 275 (279)
T 1qpc_A 223 LERGYRMV----RP--------DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEGQY 275 (279)
T ss_dssp HHTTCCCC----CC--------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC----
T ss_pred HhcccCCC----Cc--------ccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhccCCC
Confidence 22221110 00 1122467899999999999999999999999999876555444
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=352.26 Aligned_cols=267 Identities=21% Similarity=0.289 Sum_probs=205.0
Q ss_pred cccCccCceEEEEEEe----CCCceEEEEEcCCCC----ccchHHHHHHHHHHhcc-CCCCcceeeEEEEecCceeEEEe
Q 042348 373 FLLGKSTIGIVYKVAL----NNEEAVAVRRLGNGG----WQRFKEFQTEAEAIGKI-RHPNIVSLRAYFWSVDEKLLIYD 443 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~e 443 (686)
+.||+|+||.||+++. .+++.||||+++... ....+.+.+|+++++++ +||||+++++++...+..++|||
T Consensus 60 ~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e 139 (355)
T 1vzo_A 60 KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILD 139 (355)
T ss_dssp EEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEEEEC
T ss_pred EEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCceEEEEee
Confidence 4699999999999987 368899999987532 22345678899999999 69999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccc
Q 042348 444 YIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLAD 523 (686)
Q Consensus 444 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~ 523 (686)
|+++|+|.+++... ..+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 140 ~~~~~~L~~~l~~~------~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~ 210 (355)
T 1vzo_A 140 YINGGELFTHLSQR------ERFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFV 210 (355)
T ss_dssp CCCSCBHHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred cCCCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCcEEEeeCCCCeecc
Confidence 99999999999764 358999999999999999999999 899999999999999999999999999998653
Q ss_pred cccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccC--CCCCCcchHHHHHHHHHHHHhCCCCccccCcc
Q 042348 524 IAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKV--RKPTQKWDIYSYGVILLEMISGKLPMIQIGSM 601 (686)
Q Consensus 524 ~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~ 601 (686)
.... .......||..|+|||++.+ ..++.++|||||||++|||++|+.||......
T Consensus 211 ~~~~----------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~ 268 (355)
T 1vzo_A 211 ADET----------------------ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEK 268 (355)
T ss_dssp GGGG----------------------GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSC
T ss_pred cCCC----------------------CcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCcc
Confidence 2211 11223457888999999875 34789999999999999999999999644322
Q ss_pred chhHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHHHhcccccchhhh
Q 042348 602 ELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRP-----SMRHVCDSLDRVNISTEQQF 676 (686)
Q Consensus 602 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~ev~~~L~~i~~~~~~~~ 676 (686)
. ..............+.+. .....+.+++.+||+.||++|| ++.|++++.---...++.-.
T Consensus 269 ~-~~~~~~~~~~~~~~~~~~-------------~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~~~~~l~ 334 (355)
T 1vzo_A 269 N-SQAEISRRILKSEPPYPQ-------------EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLA 334 (355)
T ss_dssp C-CHHHHHHHHHHCCCCCCT-------------TSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHHHHH
T ss_pred c-hHHHHHHHHhccCCCCCc-------------ccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcCChhHhh
Confidence 2 223333333333222211 1123577899999999999999 99999988644433333333
Q ss_pred hccCCCCC
Q 042348 677 MKGEEPKF 684 (686)
Q Consensus 677 ~~~~~~~~ 684 (686)
.+...|+|
T Consensus 335 ~~~~~~p~ 342 (355)
T 1vzo_A 335 AKKVPAPF 342 (355)
T ss_dssp TTCSCCSC
T ss_pred hccCCCCC
Confidence 33333333
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=367.27 Aligned_cols=247 Identities=23% Similarity=0.263 Sum_probs=200.3
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCC---ccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCC
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGG---WQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNG 448 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~g 448 (686)
..||+|+||.||+|... +++.||||++.... ......+.+|++++++++|||||++++++.+.+..++||||+++|
T Consensus 190 ~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmEy~~gg 269 (576)
T 2acx_A 190 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGG 269 (576)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred EEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEEEcCCCC
Confidence 46999999999999875 68999999986532 223456889999999999999999999999999999999999999
Q ss_pred CHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCC
Q 042348 449 SLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEET 528 (686)
Q Consensus 449 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 528 (686)
+|.+++..... ..+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 270 ~L~~~l~~~~~----~~l~e~~~~~i~~qIl~aL~yLH~---~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~-- 340 (576)
T 2acx_A 270 DLKFHIYHMGQ----AGFPEARAVFYAAEICCGLEDLHR---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ-- 340 (576)
T ss_dssp BHHHHHHSSSS----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTC--
T ss_pred cHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHH---CCEeccCCchheEEEeCCCCeEEEecccceecccCc--
Confidence 99999986542 358999999999999999999999 899999999999999999999999999998654221
Q ss_pred ccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHH
Q 042348 529 PEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQW 608 (686)
Q Consensus 529 ~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~ 608 (686)
.....+||+.|+|||++.+..++.++|||||||++|||++|+.||....... .....
T Consensus 341 ----------------------~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~-~~~~i 397 (576)
T 2acx_A 341 ----------------------TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI-KREEV 397 (576)
T ss_dssp ----------------------CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCC-CHHHH
T ss_pred ----------------------cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccch-hHHHH
Confidence 1123468889999999998889999999999999999999999996543221 11222
Q ss_pred HHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 042348 609 IQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRP-----SMRHVCDS 664 (686)
Q Consensus 609 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~ev~~~ 664 (686)
...+.......... ....+.+++.+||+.||++|| ++.||++|
T Consensus 398 ~~~i~~~~~~~p~~-------------~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 398 ERLVKEVPEEYSER-------------FSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp HHHHHHCCCCCCTT-------------SCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred HHHhhcccccCCcc-------------CCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence 22232222221111 123577899999999999999 78888876
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-41 Score=347.97 Aligned_cols=258 Identities=26% Similarity=0.315 Sum_probs=204.0
Q ss_pred cccCccCceEEEEEEe------CCCceEEEEEcCCCCc-cchHHHHHHHHHHhcc-CCCCcceeeEEEEecCceeEEEec
Q 042348 373 FLLGKSTIGIVYKVAL------NNEEAVAVRRLGNGGW-QRFKEFQTEAEAIGKI-RHPNIVSLRAYFWSVDEKLLIYDY 444 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~e~ 444 (686)
..||+|+||.||+|.. .+++.||||.+..... ...+.+.+|+++++++ +||||+++++++...+..++||||
T Consensus 29 ~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~ 108 (313)
T 1t46_A 29 KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEY 108 (313)
T ss_dssp EEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCCcEEEEec
Confidence 4699999999999985 3467899999976532 3457799999999999 999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCc------------cccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeE
Q 042348 445 IPNGSLATAIHGKAGI------------ISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPH 512 (686)
Q Consensus 445 ~~~gsL~~~l~~~~~~------------~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~k 512 (686)
+++|+|.+++...... .....+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+|
T Consensus 109 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~k 185 (313)
T 1t46_A 109 CCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITK 185 (313)
T ss_dssp CTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEETTTEEE
T ss_pred CCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCccceEEEcCCCCEE
Confidence 9999999999865421 011258999999999999999999999 8999999999999999999999
Q ss_pred EeecCcccccccccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHh-C
Q 042348 513 ISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-G 591 (686)
Q Consensus 513 l~DfGla~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G 591 (686)
|+|||+++........ .......+|..|+|||.+.+..++.++||||||+++|||+| |
T Consensus 186 l~Dfg~~~~~~~~~~~---------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g 244 (313)
T 1t46_A 186 ICDFGLARDIKNDSNY---------------------VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLG 244 (313)
T ss_dssp ECCCGGGSCTTSCTTS---------------------EECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTT
T ss_pred Eccccccccccccccc---------------------eeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCC
Confidence 9999999865432110 11123345778999999988899999999999999999999 9
Q ss_pred CCCccccCccchhHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccc
Q 042348 592 KLPMIQIGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRVNI 670 (686)
Q Consensus 592 ~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~ 670 (686)
+.||........ ............ .. ......+.+++.+||+.||++|||+.|++++|+++..
T Consensus 245 ~~p~~~~~~~~~-----~~~~~~~~~~~~--~~---------~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 307 (313)
T 1t46_A 245 SSPYPGMPVDSK-----FYKMIKEGFRML--SP---------EHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307 (313)
T ss_dssp CCSSTTCCSSHH-----HHHHHHHTCCCC--CC---------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCcccchhH-----HHHHhccCCCCC--Cc---------ccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHH
Confidence 999965432221 112222211100 00 1122467899999999999999999999999998754
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-41 Score=377.75 Aligned_cols=254 Identities=25% Similarity=0.361 Sum_probs=200.7
Q ss_pred ccCccCceEEEEEEeC---CCceEEEEEcCCCC-ccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCC
Q 042348 374 LLGKSTIGIVYKVALN---NEEAVAVRRLGNGG-WQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGS 449 (686)
Q Consensus 374 ~iG~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gs 449 (686)
.||+|+||.||+|.+. ++..||||+++... ....++|.+|+++|++++|||||++++++.. +..++|||||++|+
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~ 421 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 421 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence 5899999999999864 45679999997653 3356789999999999999999999999976 56899999999999
Q ss_pred HHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCc
Q 042348 450 LATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETP 529 (686)
Q Consensus 450 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 529 (686)
|.+++.... ..+++..+..|+.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++.........
T Consensus 422 L~~~l~~~~-----~~l~~~~~~~i~~qi~~~L~~LH~---~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 493 (613)
T 2ozo_A 422 LHKFLVGKR-----EEIPVSNVAELLHQVSMGMKYLEE---KNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYY 493 (613)
T ss_dssp HHHHHTTCT-----TTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC------
T ss_pred HHHHHhhcc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCcee
Confidence 999997653 468999999999999999999999 899999999999999999999999999998654322100
Q ss_pred cccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCccccCccchhHHHH
Q 042348 530 EVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQIGSMELNIVQW 608 (686)
Q Consensus 530 ~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~~~~~~~ 608 (686)
.......++..|+|||++.+..++.++|||||||++|||+| |+.||......+ .
T Consensus 494 --------------------~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~-----~ 548 (613)
T 2ozo_A 494 --------------------TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE-----V 548 (613)
T ss_dssp ----------------------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHH-----H
T ss_pred --------------------eeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHH-----H
Confidence 01112234677999999998899999999999999999998 999996543322 2
Q ss_pred HHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccccch
Q 042348 609 IQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRVNISTE 673 (686)
Q Consensus 609 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~~~~ 673 (686)
...+..+. .+. . ...+..++.+++.+||+.||++||++.+|++.|+.+-...+
T Consensus 549 ~~~i~~~~-~~~--~---------p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~ 601 (613)
T 2ozo_A 549 MAFIEQGK-RME--C---------PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA 601 (613)
T ss_dssp HHHHHTTC-CCC--C---------CTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHS
T ss_pred HHHHHcCC-CCC--C---------CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhc
Confidence 22222221 110 0 01123468899999999999999999999999998754433
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=364.90 Aligned_cols=250 Identities=20% Similarity=0.271 Sum_probs=200.9
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCC---ccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCC
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGG---WQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNG 448 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~g 448 (686)
.+||+|+||.||+|+.. +++.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++||||+++|
T Consensus 191 ~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE~~~gg 270 (543)
T 3c4z_A 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGG 270 (543)
T ss_dssp EEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTC
T ss_pred EEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEEEeccCC
Confidence 46999999999999985 58999999986532 123467889999999999999999999999999999999999999
Q ss_pred CHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCC
Q 042348 449 SLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEET 528 (686)
Q Consensus 449 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 528 (686)
+|.+++...... ...+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 271 ~L~~~l~~~~~~--~~~l~e~~~~~~~~qi~~aL~~LH~---~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~~- 344 (543)
T 3c4z_A 271 DIRYHIYNVDED--NPGFQEPRAIFYTAQIVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQT- 344 (543)
T ss_dssp BHHHHHHTSSTT--SCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCC-
T ss_pred CHHHHHHHhhcc--cccccHHHHHHHHHHHHHHHHHHHH---cCCcccCCChHHEEEeCCCCEEEeecceeeeccCCCc-
Confidence 999999764321 1468999999999999999999999 8999999999999999999999999999986542211
Q ss_pred ccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHH
Q 042348 529 PEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQW 608 (686)
Q Consensus 529 ~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~ 608 (686)
......||+.|+|||++.+..++.++|||||||++|||+||+.||...... ......
T Consensus 345 ----------------------~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~-~~~~~~ 401 (543)
T 3c4z_A 345 ----------------------KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEK-VENKEL 401 (543)
T ss_dssp ----------------------CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCC-CCHHHH
T ss_pred ----------------------ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccc-hhHHHH
Confidence 112346788999999999999999999999999999999999999654321 122333
Q ss_pred HHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCH-----HHHHHH
Q 042348 609 IQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSM-----RHVCDS 664 (686)
Q Consensus 609 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~-----~ev~~~ 664 (686)
.+.+.......+.. ....+.+++.+||+.||++||++ .||.++
T Consensus 402 ~~~i~~~~~~~p~~-------------~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~H 449 (543)
T 3c4z_A 402 KQRVLEQAVTYPDK-------------FSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTH 449 (543)
T ss_dssp HHHHHHCCCCCCTT-------------SCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTS
T ss_pred HHHHhhcccCCCcc-------------cCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcC
Confidence 44444433222211 12357789999999999999975 566654
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-41 Score=352.27 Aligned_cols=265 Identities=15% Similarity=0.188 Sum_probs=196.9
Q ss_pred cccCccCceEEEEEEeC----CCceEEEEEcCCCCcc-----------chHHHHHHHHHHhccCCCCcceeeEEEEe---
Q 042348 373 FLLGKSTIGIVYKVALN----NEEAVAVRRLGNGGWQ-----------RFKEFQTEAEAIGKIRHPNIVSLRAYFWS--- 434 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~H~nIv~l~~~~~~--- 434 (686)
..||+|+||.||+|... ++..||||++...... ....+.+|+..++.++||||+++++++..
T Consensus 43 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~~~~~~~ 122 (345)
T 2v62_A 43 KKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFK 122 (345)
T ss_dssp EEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEEEEEESS
T ss_pred eeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecccccccC
Confidence 46999999999999976 5678999998654321 12346788899999999999999999988
Q ss_pred -cCceeEEEeccCCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCC--Ce
Q 042348 435 -VDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNM--EP 511 (686)
Q Consensus 435 -~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~--~~ 511 (686)
.+..++||||+ +++|.+++... ..+++.+++.|+.||+.||+|||+ ++|+||||||+|||++.++ .+
T Consensus 123 ~~~~~~lv~e~~-~~~L~~~l~~~------~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~ 192 (345)
T 2v62_A 123 GRSYRFMVMERL-GIDLQKISGQN------GTFKKSTVLQLGIRMLDVLEYIHE---NEYVHGDIKAANLLLGYKNPDQV 192 (345)
T ss_dssp SCEEEEEEEECE-EEEHHHHCBGG------GBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEESSSTTSE
T ss_pred CCcEEEEEEecc-CCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCcCHHHEEEccCCCCcE
Confidence 67789999999 99999999764 358999999999999999999999 8999999999999999887 99
Q ss_pred EEeecCcccccccccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhC
Q 042348 512 HISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISG 591 (686)
Q Consensus 512 kl~DfGla~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG 591 (686)
||+|||+++.+........ ..........||..|+|||++.+..++.++|||||||++|||+||
T Consensus 193 kL~Dfg~a~~~~~~~~~~~----------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g 256 (345)
T 2v62_A 193 YLADYGLSYRYCPNGNHKQ----------------YQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCG 256 (345)
T ss_dssp EECCCTTCEESSGGGCCCC----------------CCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHS
T ss_pred EEEeCCCceeccccccccc----------------chhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhC
Confidence 9999999987654321100 000122345688899999999998999999999999999999999
Q ss_pred CCCccccCccchhHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccc
Q 042348 592 KLPMIQIGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRVNI 670 (686)
Q Consensus 592 ~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~ 670 (686)
+.||.................... .+........ ......++.+++.+||+.||++||++.+|++.|+++..
T Consensus 257 ~~pf~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 328 (345)
T 2v62_A 257 KLPWEQNLKDPVAVQTAKTNLLDE---LPQSVLKWAP----SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI 328 (345)
T ss_dssp SCTTGGGTTCHHHHHHHHHHHHHT---TTHHHHHHSC----TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred CCCccccccccHHHHHHHHhhccc---ccHHHHhhcc----ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence 999965333322222222222111 1111110000 00123468899999999999999999999999998764
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=346.07 Aligned_cols=254 Identities=26% Similarity=0.463 Sum_probs=197.5
Q ss_pred cccCccCceEEEEEEeCC-----CceEEEEEcCCCC-ccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccC
Q 042348 373 FLLGKSTIGIVYKVALNN-----EEAVAVRRLGNGG-WQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIP 446 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~ 446 (686)
+.||+|+||.||+|.... +..||||.+.... ......+.+|++++++++||||+++++++...+..++||||++
T Consensus 50 ~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 129 (333)
T 1mqb_A 50 KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYME 129 (333)
T ss_dssp EEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred cEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEEEEeCCC
Confidence 479999999999998653 2359999997643 3345678999999999999999999999999999999999999
Q ss_pred CCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCccccccccc
Q 042348 447 NGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAE 526 (686)
Q Consensus 447 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~ 526 (686)
+|+|.+++.... ..+++.+++.++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++......
T Consensus 130 ~~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 201 (333)
T 1mqb_A 130 NGALDKFLREKD-----GEFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 201 (333)
T ss_dssp TEEHHHHHHHTT-----TCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC--------
T ss_pred CCcHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChheEEECCCCcEEECCCCcchhhcccc
Confidence 999999998653 468999999999999999999999 899999999999999999999999999998654321
Q ss_pred CCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCccccCccchhH
Q 042348 527 ETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQIGSMELNI 605 (686)
Q Consensus 527 ~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~~~~ 605 (686)
... .......+|..|+|||.+.+..++.++|||||||++|||++ |+.||......
T Consensus 202 ~~~--------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~---- 257 (333)
T 1mqb_A 202 EAT--------------------YTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH---- 257 (333)
T ss_dssp -----------------------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH----
T ss_pred ccc--------------------cccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHH----
Confidence 100 01112345678999999998899999999999999999999 99999543321
Q ss_pred HHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccccc
Q 042348 606 VQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRVNIS 671 (686)
Q Consensus 606 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~~ 671 (686)
+....+..... ... . ......+.+++.+||+.||++||++.|+++.|+++...
T Consensus 258 -~~~~~~~~~~~-~~~--~---------~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~ 310 (333)
T 1mqb_A 258 -EVMKAINDGFR-LPT--P---------MDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 310 (333)
T ss_dssp -HHHHHHHTTCC-CCC--C---------TTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred -HHHHHHHCCCc-CCC--c---------ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 22222222211 110 0 11234578899999999999999999999999987643
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=344.82 Aligned_cols=257 Identities=23% Similarity=0.370 Sum_probs=199.5
Q ss_pred cccCccCceEEEEEEe-----CCCceEEEEEcCCC-CccchHHHHHHHHHHhccCCCCcceeeEEEEec--CceeEEEec
Q 042348 373 FLLGKSTIGIVYKVAL-----NNEEAVAVRRLGNG-GWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSV--DEKLLIYDY 444 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~-----~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~~lV~e~ 444 (686)
..||+|+||.||+|.+ .+++.||||++... .....+.+.+|++++++++||||+++++++... +..++||||
T Consensus 27 ~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~ 106 (302)
T 4e5w_A 27 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEF 106 (302)
T ss_dssp EEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCEEEEEEC
T ss_pred hccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceEEEEEEe
Confidence 4699999999999984 35789999999754 333457899999999999999999999999876 668999999
Q ss_pred cCCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCccccccc
Q 042348 445 IPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADI 524 (686)
Q Consensus 445 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~ 524 (686)
+++|+|.+++.... ..+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++....
T Consensus 107 ~~~~~L~~~l~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 178 (302)
T 4e5w_A 107 LPSGSLKEYLPKNK-----NKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIET 178 (302)
T ss_dssp CTTCBHHHHHHHHT-----TTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEECCT
T ss_pred CCCCcHHHHHHhcc-----ccCCHHHHHHHHHHHHHHHHHhhc---CCcccCCCchheEEEcCCCCEEECcccccccccC
Confidence 99999999996543 458999999999999999999999 8999999999999999999999999999986643
Q ss_pred ccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccC-----
Q 042348 525 AEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIG----- 599 (686)
Q Consensus 525 ~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~----- 599 (686)
.... ........+|..|+|||.+.+..++.++||||||+++|||+||+.|+....
T Consensus 179 ~~~~--------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~ 238 (302)
T 4e5w_A 179 DKEY--------------------YTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLK 238 (302)
T ss_dssp TCCE--------------------EECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHH
T ss_pred CCcc--------------------eeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhh
Confidence 2210 011223456778999999988889999999999999999999999873221
Q ss_pred -----ccchhHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 042348 600 -----SMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRVN 669 (686)
Q Consensus 600 -----~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~ 669 (686)
................ .... . .......+.+++.+||+.||++|||+.|+++.|+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~-~~~~--~---------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 239 MIGPTHGQMTVTRLVNTLKEG-KRLP--C---------PPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp HHCSCCGGGHHHHHHHHHHTT-CCCC--C---------CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ccCCcccccCHHHHHHHHhcc-CCCC--C---------CCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 0111111222222111 1110 0 0112346889999999999999999999999998763
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=345.10 Aligned_cols=257 Identities=21% Similarity=0.294 Sum_probs=194.4
Q ss_pred ccCccCceEEEEEEeC-CCceEEEEEcCCCCccchHHHHHHHHHHhcc-CCCCcceeeEEEEecCceeEEEeccCCCCHH
Q 042348 374 LLGKSTIGIVYKVALN-NEEAVAVRRLGNGGWQRFKEFQTEAEAIGKI-RHPNIVSLRAYFWSVDEKLLIYDYIPNGSLA 451 (686)
Q Consensus 374 ~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL~ 451 (686)
.||+|+||.||+|... +++.||||++........+.+.+|++++.++ +||||+++++++.+.+..++||||+++|+|.
T Consensus 20 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 99 (316)
T 2ac3_A 20 VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSIL 99 (316)
T ss_dssp CCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTCBHH
T ss_pred eecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcCCCCcHH
Confidence 6999999999999864 6889999999776555567899999999995 7999999999999999999999999999999
Q ss_pred HHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCC---eEEeecCcccccccccCC
Q 042348 452 TAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNME---PHISDFGLARLADIAEET 528 (686)
Q Consensus 452 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~---~kl~DfGla~~~~~~~~~ 528 (686)
+++... ..+++..+..++.|++.||+|||+ ++|+||||||+||+++.++. +||+|||+++........
T Consensus 100 ~~l~~~------~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~ 170 (316)
T 2ac3_A 100 SHIHKR------RHFNELEASVVVQDVASALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDC 170 (316)
T ss_dssp HHHHHH------SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC--------
T ss_pred HHHhcc------CCCCHHHHHHHHHHHHHHHHHHHh---CCceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCcc
Confidence 999764 358999999999999999999999 89999999999999998776 999999999765422210
Q ss_pred ccccccccccCCCCCCCccccccccCCCCCccccCcccccC-----CCCCCcchHHHHHHHHHHHHhCCCCccccCccch
Q 042348 529 PEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKV-----RKPTQKWDIYSYGVILLEMISGKLPMIQIGSMEL 603 (686)
Q Consensus 529 ~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~ 603 (686)
... .........||..|+|||++.+ ..++.++|||||||++|||++|+.||......+.
T Consensus 171 ~~~----------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~ 234 (316)
T 2ac3_A 171 SPI----------------STPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDC 234 (316)
T ss_dssp ---------------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCS
T ss_pred ccc----------------cccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccc
Confidence 000 0011223467889999999864 4578999999999999999999999965432210
Q ss_pred ----------hHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 604 ----------NIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 604 ----------~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
........+.......+.. .. ......+.+++.+||+.||++|||+.|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~i~~~~~~~~~~---~~------~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 235 GWDRGEACPACQNMLFESIQEGKYEFPDK---DW------AHISCAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp CC----CCHHHHHHHHHHHHHCCCCCCHH---HH------TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred cccccccchhHHHHHHHHHhccCcccCch---hc------ccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 0111222222222111110 00 0112357899999999999999999999885
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=349.58 Aligned_cols=261 Identities=25% Similarity=0.341 Sum_probs=204.0
Q ss_pred hcccCccCceEEEEEEeCCCceEEEEEcCCCCccchHHHHHHHHHHhc--cCCCCcceeeEEEEecC----ceeEEEecc
Q 042348 372 AFLLGKSTIGIVYKVALNNEEAVAVRRLGNGGWQRFKEFQTEAEAIGK--IRHPNIVSLRAYFWSVD----EKLLIYDYI 445 (686)
Q Consensus 372 ~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~H~nIv~l~~~~~~~~----~~~lV~e~~ 445 (686)
...||+|+||.||+|... ++.||||.+... ....+.+|++++.. ++||||+++++++...+ ..++||||+
T Consensus 47 ~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~ 122 (342)
T 1b6c_B 47 QESIGKGRFGEVWRGKWR-GEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYH 122 (342)
T ss_dssp EEEEEEETTEEEEEEEET-TEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEEEEECCC
T ss_pred EeeecCCCCcEEEEEEEc-CccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeEEEEeec
Confidence 357999999999999984 889999998653 34667889998887 79999999999998876 789999999
Q ss_pred CCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHH--------ccCCCCceecCCCCCCeeecCCCCeEEeecC
Q 042348 446 PNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLH--------EVSPKRYVHGDLRPSNILLGKNMEPHISDFG 517 (686)
Q Consensus 446 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH--------~~~~~~iiHrDlkp~NILl~~~~~~kl~DfG 517 (686)
++|+|.+++... .+++.+++.++.|++.||+||| + ++|+||||||+||+++.++.+||+|||
T Consensus 123 ~~g~L~~~l~~~-------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~---~~ivH~Dlkp~NIll~~~~~~kL~Dfg 192 (342)
T 1b6c_B 123 EHGSLFDYLNRY-------TVTVEGMIKLALSTASGLAHLHMEIVGTQGK---PAIAHRDLKSKNILVKKNGTCCIADLG 192 (342)
T ss_dssp TTCBHHHHHHHC-------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCB---CEEECSCCSGGGEEECTTSCEEECCCT
T ss_pred CCCcHHHHHhcc-------CccHHHHHHHHHHHHHHHHHHHHHHhhhccc---CCeeeCCCCHHHEEECCCCCEEEEECC
Confidence 999999999753 4899999999999999999999 7 899999999999999999999999999
Q ss_pred cccccccccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCC------CCCcchHHHHHHHHHHHHhC
Q 042348 518 LARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRK------PTQKWDIYSYGVILLEMISG 591 (686)
Q Consensus 518 la~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------~~~~sDVwSlGvvl~elltG 591 (686)
+++......... ........||..|+|||.+.+.. ++.++|||||||++|||+||
T Consensus 193 ~~~~~~~~~~~~-------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg 253 (342)
T 1b6c_B 193 LAVRHDSATDTI-------------------DIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARR 253 (342)
T ss_dssp TCEEEETTTTEE-------------------EECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred Cceecccccccc-------------------ccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhc
Confidence 998654322100 00123446788999999987652 33689999999999999999
Q ss_pred ----------CCCccccCccchhHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHH
Q 042348 592 ----------KLPMIQIGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHV 661 (686)
Q Consensus 592 ----------~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev 661 (686)
+.||............+........ ..+.+.......+....+.+++.+||+.||++|||+.||
T Consensus 254 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i 327 (342)
T 1b6c_B 254 CSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQK------LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRI 327 (342)
T ss_dssp BCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSC------CCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHH
T ss_pred cCcCCcccccccCccccCcCcccHHHHHHHHHHHH------hCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHH
Confidence 7888654443333333333332221 111111111223566789999999999999999999999
Q ss_pred HHHHhccccc
Q 042348 662 CDSLDRVNIS 671 (686)
Q Consensus 662 ~~~L~~i~~~ 671 (686)
+++|+++...
T Consensus 328 ~~~L~~i~~~ 337 (342)
T 1b6c_B 328 KKTLSQLSQQ 337 (342)
T ss_dssp HHHHHHHHHT
T ss_pred HHHHHHHHHH
Confidence 9999998643
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-41 Score=347.70 Aligned_cols=254 Identities=20% Similarity=0.324 Sum_probs=191.2
Q ss_pred cccCccCceEEEEEEe-CCCceEEEEEcCCCCc---cchHHHHHHHHHHhccCCCCcceeeEEEEecCce----eEEEec
Q 042348 373 FLLGKSTIGIVYKVAL-NNEEAVAVRRLGNGGW---QRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEK----LLIYDY 444 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~----~lV~e~ 444 (686)
..||+|+||.||+|.. .+++.||||++..... .....+.+|++++++++||||+++++++...... ++||||
T Consensus 18 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~lv~e~ 97 (311)
T 3ork_A 18 EILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEY 97 (311)
T ss_dssp EEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEEEEEEEC
T ss_pred EEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcccEEEEec
Confidence 4699999999999996 4688999999976422 2345789999999999999999999999876544 999999
Q ss_pred cCCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCccccccc
Q 042348 445 IPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADI 524 (686)
Q Consensus 445 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~ 524 (686)
+++|+|.++++.. ..+++.++..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++....
T Consensus 98 ~~g~~L~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~ 168 (311)
T 3ork_A 98 VDGVTLRDIVHTE------GPMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIAD 168 (311)
T ss_dssp CCEEEHHHHHHHH------CSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEETTSCEEECCCSCC-----
T ss_pred CCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCCCcCCCCHHHEEEcCCCCEEEeeccCcccccc
Confidence 9999999999764 358999999999999999999999 8999999999999999999999999999986543
Q ss_pred ccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchh
Q 042348 525 AEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELN 604 (686)
Q Consensus 525 ~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~ 604 (686)
.... ........||..|+|||++.+..++.++|||||||++|||+||+.||......
T Consensus 169 ~~~~--------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~--- 225 (311)
T 3ork_A 169 SGNS--------------------VTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV--- 225 (311)
T ss_dssp ---------------------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH---
T ss_pred cccc--------------------cccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH---
Confidence 2210 01122346788899999999999999999999999999999999999543321
Q ss_pred HHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHH-HHHhccc
Q 042348 605 IVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVC-DSLDRVN 669 (686)
Q Consensus 605 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~-~~L~~i~ 669 (686)
.................. ......+.+++.+||+.||++||++.+++ +.+.++.
T Consensus 226 --~~~~~~~~~~~~~~~~~~---------~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 280 (311)
T 3ork_A 226 --SVAYQHVREDPIPPSARH---------EGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 280 (311)
T ss_dssp --HHHHHHHHCCCCCHHHHS---------TTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred --HHHHHHhcCCCCCccccc---------CCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHh
Confidence 122222222211111000 01223577899999999999999766554 5555543
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=351.43 Aligned_cols=241 Identities=24% Similarity=0.434 Sum_probs=194.3
Q ss_pred cccCccCceEEEEEEe-CCCceEEEEEcCCCC---ccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCC
Q 042348 373 FLLGKSTIGIVYKVAL-NNEEAVAVRRLGNGG---WQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNG 448 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~g 448 (686)
..||+|+||.||+|.. .+++.||||++.... ....+++.+|++++++++||||+++++++...+..++||||+. |
T Consensus 60 ~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~-g 138 (348)
T 1u5q_A 60 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-G 138 (348)
T ss_dssp EEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCS-E
T ss_pred eEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEEecCC-C
Confidence 4699999999999986 468899999986542 2234678999999999999999999999999999999999997 6
Q ss_pred CHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCC
Q 042348 449 SLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEET 528 (686)
Q Consensus 449 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 528 (686)
+|.+++.... ..+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 139 ~l~~~l~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~--- 207 (348)
T 1u5q_A 139 SASDLLEVHK-----KPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--- 207 (348)
T ss_dssp EHHHHHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB---
T ss_pred CHHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEeeccCceecCCC---
Confidence 8888886543 468999999999999999999999 89999999999999999999999999999754311
Q ss_pred ccccccccccCCCCCCCccccccccCCCCCccccCccccc---CCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhH
Q 042348 529 PEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASK---VRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNI 605 (686)
Q Consensus 529 ~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~ 605 (686)
....||..|+|||++. ...++.++|||||||++|||++|+.||.....
T Consensus 208 ------------------------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~----- 258 (348)
T 1u5q_A 208 ------------------------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA----- 258 (348)
T ss_dssp ------------------------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-----
T ss_pred ------------------------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh-----
Confidence 1245788899999874 56789999999999999999999999954322
Q ss_pred HHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 042348 606 VQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSL 665 (686)
Q Consensus 606 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L 665 (686)
...+..+.....+. ... ......+.+++.+||+.||++|||+.|++++.
T Consensus 259 ~~~~~~~~~~~~~~--~~~---------~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~ 307 (348)
T 1u5q_A 259 MSALYHIAQNESPA--LQS---------GHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR 307 (348)
T ss_dssp HHHHHHHHHSCCCC--CCC---------TTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCH
T ss_pred HHHHHHHHhcCCCC--CCC---------CCCCHHHHHHHHHHcccChhhCcCHHHHhhCh
Confidence 12223333332211 101 01123577899999999999999999998763
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=357.69 Aligned_cols=246 Identities=17% Similarity=0.214 Sum_probs=195.8
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCC---ccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCC
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGG---WQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNG 448 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~g 448 (686)
+.||+|+||.||+++.. +++.||||++.... ....+.+.+|..++.+++||||+++++++.+.+..++||||+++|
T Consensus 67 ~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVmE~~~gg 146 (412)
T 2vd5_A 67 KVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGG 146 (412)
T ss_dssp EEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred EEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEcCCCCC
Confidence 46999999999999975 68999999986532 123345889999999999999999999999999999999999999
Q ss_pred CHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCC
Q 042348 449 SLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEET 528 (686)
Q Consensus 449 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 528 (686)
+|.+++.... ..+++..+..++.||+.||+|||+ ++|+||||||+|||++.++++||+|||+++.......
T Consensus 147 ~L~~~l~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~---~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~~- 217 (412)
T 2vd5_A 147 DLLTLLSKFG-----ERIPAEMARFYLAEIVMAIDSVHR---LGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGT- 217 (412)
T ss_dssp BHHHHHHHHS-----SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSC-
T ss_pred cHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccCHHHeeecCCCCEEEeechhheeccCCCc-
Confidence 9999997643 358999999999999999999999 8999999999999999999999999999986542211
Q ss_pred ccccccccccCCCCCCCccccccccCCCCCccccCccccc-------CCCCCCcchHHHHHHHHHHHHhCCCCccccCcc
Q 042348 529 PEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASK-------VRKPTQKWDIYSYGVILLEMISGKLPMIQIGSM 601 (686)
Q Consensus 529 ~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~ 601 (686)
......+||..|+|||++. ...++.++|||||||++|||++|+.||......
T Consensus 218 ---------------------~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~ 276 (412)
T 2vd5_A 218 ---------------------VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTA 276 (412)
T ss_dssp ---------------------EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH
T ss_pred ---------------------cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHH
Confidence 1122357888999999986 356899999999999999999999999653322
Q ss_pred chhHHHHHHHHHhhc--CCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCC---CCHHHHHHH
Q 042348 602 ELNIVQWIQLILEDR--KPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKR---PSMRHVCDS 664 (686)
Q Consensus 602 ~~~~~~~~~~~~~~~--~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~R---Ps~~ev~~~ 664 (686)
+....+.... ...+. .+ .. ...++.+++.+||+ +|++| |+++|+++|
T Consensus 277 -----~~~~~i~~~~~~~~~p~-~~----~~-----~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 277 -----ETYGKIVHYKEHLSLPL-VD----EG-----VPEEARDFIQRLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp -----HHHHHHHTHHHHCCCC---------C-----CCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred -----HHHHHHHhcccCcCCCc-cc----cC-----CCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence 2223333211 11111 00 01 12357789999999 99998 689999877
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-41 Score=350.75 Aligned_cols=259 Identities=25% Similarity=0.373 Sum_probs=203.1
Q ss_pred cccCccCceEEEEEEe-----CCCceEEEEEcCCCCccchHHHHHHHHHHhccCCCCcceeeEEEEe--cCceeEEEecc
Q 042348 373 FLLGKSTIGIVYKVAL-----NNEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWS--VDEKLLIYDYI 445 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~--~~~~~lV~e~~ 445 (686)
..||+|+||.||+|++ .+++.||||++........+.+.+|++++++++||||+++++++.. .+..++||||+
T Consensus 29 ~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~ 108 (327)
T 3lxl_A 29 SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYL 108 (327)
T ss_dssp EEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEEEEEECC
T ss_pred hhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEEEEEeec
Confidence 4699999999999984 3578999999987766666789999999999999999999999874 45688999999
Q ss_pred CCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccc
Q 042348 446 PNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIA 525 (686)
Q Consensus 446 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~ 525 (686)
++|+|.+++.... ..+++..++.|+.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++.....
T Consensus 109 ~~~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~ 180 (327)
T 3lxl_A 109 PSGCLRDFLQRHR-----ARLDASRLLLYSSQICKGMEYLGS---RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLD 180 (327)
T ss_dssp TTCBHHHHHHHHG-----GGCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCGGGCEECCTT
T ss_pred CCCCHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCChhhEEECCCCCEEEcccccceecccC
Confidence 9999999998643 358999999999999999999999 89999999999999999999999999999865432
Q ss_pred cCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccc---
Q 042348 526 EETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSME--- 602 (686)
Q Consensus 526 ~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~--- 602 (686)
... ........+|..|+|||.+.+..++.++|||||||++|||++|+.||.......
T Consensus 181 ~~~--------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~ 240 (327)
T 3lxl_A 181 KDY--------------------YVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRM 240 (327)
T ss_dssp CSE--------------------EECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHH
T ss_pred Ccc--------------------ceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhh
Confidence 210 011223456778999999988889999999999999999999999985422110
Q ss_pred -------hhHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccccc
Q 042348 603 -------LNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRVNIS 671 (686)
Q Consensus 603 -------~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~~ 671 (686)
......... ........ ........+.+++.+||+.||++|||+.|++++|+.+...
T Consensus 241 ~~~~~~~~~~~~~~~~-~~~~~~~~-----------~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 304 (327)
T 3lxl_A 241 MGCERDVPALSRLLEL-LEEGQRLP-----------APPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSG 304 (327)
T ss_dssp CC----CCHHHHHHHH-HHTTCCCC-----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC---
T ss_pred cccccccccHHHHHHH-hhcccCCC-----------CCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhh
Confidence 001111111 11111100 0112234688999999999999999999999999998643
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=356.09 Aligned_cols=246 Identities=20% Similarity=0.343 Sum_probs=188.4
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCCccchHHHHHHHHHHhcc-CCCCcceeeEEEEe----cCceeEEEeccC
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGGWQRFKEFQTEAEAIGKI-RHPNIVSLRAYFWS----VDEKLLIYDYIP 446 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~----~~~~~lV~e~~~ 446 (686)
.+||+|+||.||++... +++.||||++.. ...+.+|+.++.++ +||||+++++++.. .+..++|||||+
T Consensus 68 ~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~ 142 (400)
T 1nxk_A 68 QVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLD 142 (400)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCC
T ss_pred ceeeeccCeEEEEEEECCCCCEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeCC
Confidence 36999999999999876 588999999853 24678899987554 89999999999876 566899999999
Q ss_pred CCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecC---CCCeEEeecCcccccc
Q 042348 447 NGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGK---NMEPHISDFGLARLAD 523 (686)
Q Consensus 447 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~---~~~~kl~DfGla~~~~ 523 (686)
+|+|.+++..... ..+++.++..|+.||+.||+|||+ ++|+||||||+|||++. ++.+||+|||+++...
T Consensus 143 gg~L~~~l~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~ 215 (400)
T 1nxk_A 143 GGELFSRIQDRGD----QAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT 215 (400)
T ss_dssp SEEHHHHHHCC-------CCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred CCcHHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCcCcceEEEecCCCCccEEEEecccccccC
Confidence 9999999987532 458999999999999999999999 89999999999999997 7899999999998543
Q ss_pred cccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccch
Q 042348 524 IAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMEL 603 (686)
Q Consensus 524 ~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~ 603 (686)
... ......||..|+|||++.+..++.++|||||||++|||++|+.||........
T Consensus 216 ~~~------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~ 271 (400)
T 1nxk_A 216 SHN------------------------SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI 271 (400)
T ss_dssp -----------------------------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSS
T ss_pred CCC------------------------ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccc
Confidence 211 11234678889999999999999999999999999999999999965433221
Q ss_pred hHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 604 NIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 604 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
. ......+..+...... +.. .....++.+++.+||+.||++|||+.|++++
T Consensus 272 ~-~~~~~~i~~~~~~~~~---~~~------~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 272 S-PGMKTRIRMGQYEFPN---PEW------SEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp C-CSHHHHHHHTCCCCCT---TTT------TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred c-HHHHHHHHcCcccCCC---ccc------ccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0 0011222222211111 100 1123467899999999999999999999986
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-40 Score=335.17 Aligned_cols=244 Identities=21% Similarity=0.295 Sum_probs=198.0
Q ss_pred cccCccCceEEEEEEeCC-CceEEEEEcCCCCccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCCHH
Q 042348 373 FLLGKSTIGIVYKVALNN-EEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLA 451 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL~ 451 (686)
..||+|+||.||+|.... +..||+|++........+.+.+|++++++++||||+++++++.+.+..++||||+++++|.
T Consensus 15 ~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 94 (277)
T 3f3z_A 15 NTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELF 94 (277)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHH
T ss_pred eEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEeccCCCcHH
Confidence 469999999999998764 6789999987765556788999999999999999999999999999999999999999999
Q ss_pred HHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeee---cCCCCeEEeecCcccccccccCC
Q 042348 452 TAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILL---GKNMEPHISDFGLARLADIAEET 528 (686)
Q Consensus 452 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl---~~~~~~kl~DfGla~~~~~~~~~ 528 (686)
+++... ..+++..+..++.|++.||+|||+ ++|+||||||+||++ +.++.+||+|||++.......
T Consensus 95 ~~~~~~------~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~-- 163 (277)
T 3f3z_A 95 ERVVHK------RVFRESDAARIMKDVLSAVAYCHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK-- 163 (277)
T ss_dssp HHHHHH------CSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTS--
T ss_pred HHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCcc--
Confidence 998764 458999999999999999999999 899999999999999 788999999999997654221
Q ss_pred ccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHH
Q 042348 529 PEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQW 608 (686)
Q Consensus 529 ~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~ 608 (686)
......||..|+|||.+.+. ++.++||||||+++|||++|+.||...... ..
T Consensus 164 ----------------------~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-----~~ 215 (277)
T 3f3z_A 164 ----------------------MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDS-----EV 215 (277)
T ss_dssp ----------------------CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-----HH
T ss_pred ----------------------chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHH-----HH
Confidence 11234577889999998654 899999999999999999999999553321 22
Q ss_pred HHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 609 IQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 609 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
...+.......+... . ......+.+++.+||+.||++|||+.|++++
T Consensus 216 ~~~~~~~~~~~~~~~---~------~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h 262 (277)
T 3f3z_A 216 MLKIREGTFTFPEKD---W------LNVSPQAESLIRRLLTKSPKQRITSLQALEH 262 (277)
T ss_dssp HHHHHHCCCCCCHHH---H------TTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred HHHHHhCCCCCCchh---h------hcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 233333322211100 0 0122467899999999999999999999864
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=339.83 Aligned_cols=255 Identities=25% Similarity=0.417 Sum_probs=197.7
Q ss_pred cccCccCceEEEEEEeCC----CceEEEEEcCCC-CccchHHHHHHHHHHhccCCCCcceeeEEEEe-cCceeEEEeccC
Q 042348 373 FLLGKSTIGIVYKVALNN----EEAVAVRRLGNG-GWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWS-VDEKLLIYDYIP 446 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~-~~~~~lV~e~~~ 446 (686)
..||+|+||.||+|...+ ...||+|.+... .....+.+.+|+.++++++||||+++++++.. .+..++||||++
T Consensus 31 ~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~ 110 (298)
T 3f66_A 31 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMK 110 (298)
T ss_dssp EEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEEECCT
T ss_pred ceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEEEeCCC
Confidence 469999999999998643 236899998764 33445779999999999999999999998654 567899999999
Q ss_pred CCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCccccccccc
Q 042348 447 NGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAE 526 (686)
Q Consensus 447 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~ 526 (686)
+|+|.+++.... ..+++.++..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++......
T Consensus 111 ~~~L~~~l~~~~-----~~~~~~~~~~i~~ql~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 182 (298)
T 3f66_A 111 HGDLRNFIRNET-----HNPTVKDLIGFGLQVAKGMKYLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 182 (298)
T ss_dssp TCBHHHHHHCTT-----CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGG
T ss_pred CCCHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCchheEEECCCCCEEECcccccccccccc
Confidence 999999997654 458999999999999999999999 899999999999999999999999999998654322
Q ss_pred CCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCccccCccchhH
Q 042348 527 ETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQIGSMELNI 605 (686)
Q Consensus 527 ~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~~~~ 605 (686)
... ........+|..|+|||.+.+..++.++||||||+++|||++ |..||......+ .
T Consensus 183 ~~~-------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~--~ 241 (298)
T 3f66_A 183 YYS-------------------VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD--I 241 (298)
T ss_dssp GCB-------------------C-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTT--H
T ss_pred hhc-------------------cccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHH--H
Confidence 110 011223456778999999988899999999999999999999 555554332222 1
Q ss_pred HHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccccc
Q 042348 606 VQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRVNIS 671 (686)
Q Consensus 606 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~~ 671 (686)
........... .+ ......+.+++.+||+.||++|||+.|+++.|+++...
T Consensus 242 ---~~~~~~~~~~~----~~--------~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 292 (298)
T 3f66_A 242 ---TVYLLQGRRLL----QP--------EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 292 (298)
T ss_dssp ---HHHHHTTCCCC----CC--------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred ---HHHHhcCCCCC----CC--------ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 12222222111 01 01123578899999999999999999999999997643
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=340.40 Aligned_cols=256 Identities=22% Similarity=0.367 Sum_probs=200.1
Q ss_pred cccCccCceEEEEEEeCC----CceEEEEEcCCCC-ccchHHHHHHHHHHhccCCCCcceeeEEEEecCce-eEEEeccC
Q 042348 373 FLLGKSTIGIVYKVALNN----EEAVAVRRLGNGG-WQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEK-LLIYDYIP 446 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~-~lV~e~~~ 446 (686)
+.||+|+||.||+|...+ +..||+|.+.... ....+.+.+|+.++++++||||+++++++.+.+.. ++||||+.
T Consensus 27 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~ 106 (298)
T 3pls_A 27 RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMC 106 (298)
T ss_dssp EEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEECCCT
T ss_pred ceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEEeccc
Confidence 579999999999998543 2369999987643 34457799999999999999999999999877665 99999999
Q ss_pred CCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCccccccccc
Q 042348 447 NGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAE 526 (686)
Q Consensus 447 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~ 526 (686)
+|+|.+++.... ..+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++......
T Consensus 107 ~~~L~~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 178 (298)
T 3pls_A 107 HGDLLQFIRSPQ-----RNPTVKDLISFGLQVARGMEYLAE---QKFVHRDLAARNCMLDESFTVKVADFGLARDILDRE 178 (298)
T ss_dssp TCBHHHHHHCTT-----CCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGG
T ss_pred CCCHHHHHhccc-----cCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCc
Confidence 999999998754 468999999999999999999999 899999999999999999999999999998654321
Q ss_pred CCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHH
Q 042348 527 ETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIV 606 (686)
Q Consensus 527 ~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~ 606 (686)
... ........+|..|+|||.+.+..++.++||||||+++|||++|..|+...... ....
T Consensus 179 ~~~-------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~-~~~~ 238 (298)
T 3pls_A 179 YYS-------------------VQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDP-FDLT 238 (298)
T ss_dssp GGC-------------------SCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCG-GGHH
T ss_pred ccc-------------------cccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCH-HHHH
Confidence 100 01122345678899999999999999999999999999999966665332221 1111
Q ss_pred HHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccccc
Q 042348 607 QWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRVNIS 671 (686)
Q Consensus 607 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~~ 671 (686)
......... .. . ......+.+++.+||+.||++|||+.|+++.|+++...
T Consensus 239 ---~~~~~~~~~-~~--~---------~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~ 288 (298)
T 3pls_A 239 ---HFLAQGRRL-PQ--P---------EYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSA 288 (298)
T ss_dssp ---HHHHTTCCC-CC--C---------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---HHhhcCCCC-CC--C---------ccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 122222111 00 0 01123578999999999999999999999999997643
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=348.79 Aligned_cols=257 Identities=24% Similarity=0.380 Sum_probs=202.6
Q ss_pred cccCccCceEEEEEEeC--------CCceEEEEEcCCCC-ccchHHHHHHHHHHhcc-CCCCcceeeEEEEecCceeEEE
Q 042348 373 FLLGKSTIGIVYKVALN--------NEEAVAVRRLGNGG-WQRFKEFQTEAEAIGKI-RHPNIVSLRAYFWSVDEKLLIY 442 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~ 442 (686)
..||+|+||.||+|... ++..||||++.... ....+++.+|+++++++ +||||+++++++...+..++||
T Consensus 41 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~ 120 (334)
T 2pvf_A 41 KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIV 120 (334)
T ss_dssp EEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCCEEEE
T ss_pred eEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccCCceEEEE
Confidence 46999999999999863 46789999997643 33456789999999999 8999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCCc----------cccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeE
Q 042348 443 DYIPNGSLATAIHGKAGI----------ISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPH 512 (686)
Q Consensus 443 e~~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~k 512 (686)
||+++|+|.+++...... .....+++.+++.++.|++.||+|||+ ++|+||||||+||+++.++.+|
T Consensus 121 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~k 197 (334)
T 2pvf_A 121 EYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVLVTENNVMK 197 (334)
T ss_dssp ECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEE
T ss_pred ECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCccceEEEcCCCCEE
Confidence 999999999999865421 011348999999999999999999999 8999999999999999999999
Q ss_pred EeecCcccccccccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHh-C
Q 042348 513 ISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-G 591 (686)
Q Consensus 513 l~DfGla~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G 591 (686)
|+|||+++........ .......+|..|+|||++.+..++.++|||||||++|||++ |
T Consensus 198 L~Dfg~~~~~~~~~~~---------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g 256 (334)
T 2pvf_A 198 IADFGLARDINNIDYY---------------------KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLG 256 (334)
T ss_dssp ECCCTTCEECTTTSSE---------------------ECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTS
T ss_pred Eccccccccccccccc---------------------cccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCC
Confidence 9999999865422110 11123345678999999988889999999999999999999 9
Q ss_pred CCCccccCccchhHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccc
Q 042348 592 KLPMIQIGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRVNI 670 (686)
Q Consensus 592 ~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~ 670 (686)
+.||..... .+....+...... . .. ......+.+++.+||+.||++|||+.|+++.|+++..
T Consensus 257 ~~p~~~~~~-----~~~~~~~~~~~~~-~--~~---------~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~ 318 (334)
T 2pvf_A 257 GSPYPGIPV-----EELFKLLKEGHRM-D--KP---------ANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 318 (334)
T ss_dssp CCSSTTCCH-----HHHHHHHHHTCCC-C--CC---------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCcCcCCH-----HHHHHHHhcCCCC-C--CC---------ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 999954322 1222222222111 0 00 1122367889999999999999999999999999864
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=356.27 Aligned_cols=266 Identities=20% Similarity=0.250 Sum_probs=206.2
Q ss_pred cccCccCceEEEEEEeCC-CceEEEEEcCCCC-ccchHHHHHHHHHHhccCCCCcceeeEEEEecC--ceeEEEeccCCC
Q 042348 373 FLLGKSTIGIVYKVALNN-EEAVAVRRLGNGG-WQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVD--EKLLIYDYIPNG 448 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~--~~~lV~e~~~~g 448 (686)
..||+|+||.||+|.... ++.||||++.... ....+.+.+|++++++++||||+++++++...+ ..++||||+++|
T Consensus 15 ~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~~~~g 94 (396)
T 4eut_A 15 DILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCG 94 (396)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEECCCTTE
T ss_pred EEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEEecCCCC
Confidence 469999999999999764 8899999997543 233567889999999999999999999998765 679999999999
Q ss_pred CHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeee----cCCCCeEEeecCccccccc
Q 042348 449 SLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILL----GKNMEPHISDFGLARLADI 524 (686)
Q Consensus 449 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl----~~~~~~kl~DfGla~~~~~ 524 (686)
+|.+++...... ..+++..++.++.|++.||+|||+ ++|+||||||+|||+ +.++.+||+|||+++....
T Consensus 95 ~L~~~l~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~~ 168 (396)
T 4eut_A 95 SLYTVLEEPSNA---YGLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED 168 (396)
T ss_dssp EHHHHTTSGGGT---TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEECCC
T ss_pred CHHHHHHhhhcc---cCCCHHHHHHHHHHHHHHHHHHHH---CCEEECCcCHHHEEEeecCCCceeEEEecCCCceEccC
Confidence 999999865321 348999999999999999999999 899999999999999 7778899999999986543
Q ss_pred ccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccC--------CCCCCcchHHHHHHHHHHHHhCCCCcc
Q 042348 525 AEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKV--------RKPTQKWDIYSYGVILLEMISGKLPMI 596 (686)
Q Consensus 525 ~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~sDVwSlGvvl~elltG~~P~~ 596 (686)
.. ......||..|+|||++.+ ..++.++|||||||++|||++|+.||.
T Consensus 169 ~~------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~ 224 (396)
T 4eut_A 169 DE------------------------QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFR 224 (396)
T ss_dssp GG------------------------GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEE
T ss_pred CC------------------------ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence 21 1123457888999998764 457889999999999999999999996
Q ss_pred ccCccchhHHHHHHHHHhhcCCc-cccc----C------cccc-cCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 597 QIGSMELNIVQWIQLILEDRKPM-TDIL----D------PFLA-HDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 597 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~----d------~~l~-~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
....... ..+.+..+..+..+. ...+ + ..+. ...-.......+.+++.+||+.||++||++.|+++.
T Consensus 225 ~~~~~~~-~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~ 303 (396)
T 4eut_A 225 PFEGPRR-NKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303 (396)
T ss_dssp CTTCTTT-CHHHHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHH
T ss_pred CCCcccc-hHHHHHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHH
Confidence 5443222 223344444332210 0000 0 0000 011124566778899999999999999999999999
Q ss_pred Hhccc
Q 042348 665 LDRVN 669 (686)
Q Consensus 665 L~~i~ 669 (686)
++++.
T Consensus 304 l~~il 308 (396)
T 4eut_A 304 TSDIL 308 (396)
T ss_dssp HHHHH
T ss_pred HHHHh
Confidence 98864
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-40 Score=342.29 Aligned_cols=246 Identities=21% Similarity=0.272 Sum_probs=199.1
Q ss_pred hcccCccCceEEEEEEeC-CCceEEEEEcCCCCc------cchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEec
Q 042348 372 AFLLGKSTIGIVYKVALN-NEEAVAVRRLGNGGW------QRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDY 444 (686)
Q Consensus 372 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~ 444 (686)
...||+|+||.||+|... +++.||||.+..... ...+++.+|+.++++++||||+++++++.+.+..++||||
T Consensus 17 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 96 (321)
T 2a2a_A 17 GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILEL 96 (321)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred eeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEEc
Confidence 346999999999999976 588999999865322 1356799999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCC----CeEEeecCccc
Q 042348 445 IPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNM----EPHISDFGLAR 520 (686)
Q Consensus 445 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~----~~kl~DfGla~ 520 (686)
+++++|.+++... ..+++..+..++.|++.||+|||+ ++|+||||||+||+++.++ .+||+|||+++
T Consensus 97 ~~~~~L~~~l~~~------~~~~~~~~~~i~~qi~~aL~~lH~---~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~ 167 (321)
T 2a2a_A 97 VSGGELFDFLAQK------ESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167 (321)
T ss_dssp CCSCBHHHHHHTC------SCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCTTSSSCCEEECCCTTCE
T ss_pred CCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChHHEEEecCCCCcCCEEEccCccce
Confidence 9999999999764 358999999999999999999999 8999999999999999887 79999999997
Q ss_pred ccccccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCc
Q 042348 521 LADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGS 600 (686)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~ 600 (686)
...... ......||..|+|||.+.+..++.++|||||||++|||++|+.||.....
T Consensus 168 ~~~~~~------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 223 (321)
T 2a2a_A 168 EIEDGV------------------------EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK 223 (321)
T ss_dssp ECCTTC------------------------CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH
T ss_pred ecCccc------------------------cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCH
Confidence 654221 11234578889999999988999999999999999999999999954322
Q ss_pred cchhHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 601 MELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 601 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
.+....+....... ++..... ....+.+++.+||+.||++|||+.|++++
T Consensus 224 -----~~~~~~i~~~~~~~----~~~~~~~-----~~~~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 224 -----QETLANITSVSYDF----DEEFFSH-----TSELAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp -----HHHHHHHHTTCCCC----CHHHHTT-----CCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred -----HHHHHHHHhccccc----Chhhhcc-----cCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 12223332222111 1111111 12357899999999999999999999986
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=351.21 Aligned_cols=262 Identities=16% Similarity=0.197 Sum_probs=203.3
Q ss_pred cccCccCceEEEEEEeCC---------CceEEEEEcCCCCccchHHHHHHHHHHhccCCCCcce---------------e
Q 042348 373 FLLGKSTIGIVYKVALNN---------EEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVS---------------L 428 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~---------------l 428 (686)
..||+|+||.||+|.... ++.||||.+... +.+.+|++++++++||||++ +
T Consensus 48 ~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i~~~ 122 (352)
T 2jii_A 48 SFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPTC 122 (352)
T ss_dssp EEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTTCSCCCC
T ss_pred EEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCccCccch
Confidence 469999999999998764 789999998653 46889999999999999988 6
Q ss_pred eEEEEe-cCceeEEEeccCCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecC
Q 042348 429 RAYFWS-VDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGK 507 (686)
Q Consensus 429 ~~~~~~-~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~ 507 (686)
++++.. .+..++||||+ +++|.+++..... ..+++.+++.|+.||+.||+|||+ ++|+||||||+|||++.
T Consensus 123 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~----~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dikp~NIl~~~ 194 (352)
T 2jii_A 123 MGFGVHQDKYRFLVLPSL-GRSLQSALDVSPK----HVLSERSVLQVACRLLDALEFLHE---NEYVHGNVTAENIFVDP 194 (352)
T ss_dssp CEEEEETTTEEEEEEECC-CEEHHHHHHHSGG----GCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCCGGGEEEET
T ss_pred hhccccCCcEEEEEecCC-CcCHHHHHHhCCc----CCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCHHHEEEcC
Confidence 777776 67789999999 9999999986522 469999999999999999999999 89999999999999999
Q ss_pred CC--CeEEeecCcccccccccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHH
Q 042348 508 NM--EPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVIL 585 (686)
Q Consensus 508 ~~--~~kl~DfGla~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl 585 (686)
++ .+||+|||+++.+......... .........||..|+|||.+.+..++.++|||||||++
T Consensus 195 ~~~~~~kl~Dfg~a~~~~~~~~~~~~----------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il 258 (352)
T 2jii_A 195 EDQSQVTLAGYGFAFRYCPSGKHVAY----------------VEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCM 258 (352)
T ss_dssp TEEEEEEECCGGGCBCSSGGGCCCCC----------------CTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHH
T ss_pred CCCceEEEecCcceeeccCCCccccc----------------cccccccccCCccccCHHHHccCCCCchhhHHHHHHHH
Confidence 98 8999999999876543221100 00112334678899999999998999999999999999
Q ss_pred HHHHhCCCCccccCccchhHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 042348 586 LEMISGKLPMIQIGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSL 665 (686)
Q Consensus 586 ~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L 665 (686)
|||++|+.||.........+............ ...++... .......+.+++.+||+.||++|||+.||++.|
T Consensus 259 ~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L 331 (352)
T 2jii_A 259 LKWLYGFLPWTNCLPNTEDIMKQKQKFVDKPG---PFVGPCGH----WIRPSETLQKYLKVVMALTYEEKPPYAMLRNNL 331 (352)
T ss_dssp HHHHHSCCTTGGGTTCHHHHHHHHHHHHHSCC---CEECTTSC----EECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHH
T ss_pred HHHHhCCCCcccCCcCHHHHHHHHHhccCChh---hhhhhccc----cCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHH
Confidence 99999999997654333333333333322221 11111100 001124688999999999999999999999999
Q ss_pred hcccc
Q 042348 666 DRVNI 670 (686)
Q Consensus 666 ~~i~~ 670 (686)
+++..
T Consensus 332 ~~~~~ 336 (352)
T 2jii_A 332 EALLQ 336 (352)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 98764
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=336.37 Aligned_cols=240 Identities=25% Similarity=0.377 Sum_probs=194.6
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCC---ccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCC
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGG---WQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNG 448 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~g 448 (686)
..||+|+||.||+|... ++..||||++.... ......+.+|+.++++++||||+++++++.+.+..++||||+++|
T Consensus 15 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 94 (279)
T 3fdn_A 15 RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLG 94 (279)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCTTE
T ss_pred eEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEEecCCCC
Confidence 46999999999999876 46789999985432 122456889999999999999999999999999999999999999
Q ss_pred CHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCC
Q 042348 449 SLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEET 528 (686)
Q Consensus 449 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 528 (686)
+|.+++... ..+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||++.......
T Consensus 95 ~l~~~l~~~------~~~~~~~~~~~~~qi~~~l~~LH~---~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~-- 163 (279)
T 3fdn_A 95 TVYRELQKL------SKFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR-- 163 (279)
T ss_dssp EHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHT---TTCEECCCCGGGEEECTTSCEEECSCCEESCC------
T ss_pred cHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHh---CCEecccCChHhEEEcCCCCEEEEeccccccCCccc--
Confidence 999999764 358999999999999999999999 899999999999999999999999999986433211
Q ss_pred ccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHH
Q 042348 529 PEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQW 608 (686)
Q Consensus 529 ~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~ 608 (686)
.....||..|+|||.+.+..++.++||||||+++|||++|+.||..... ...
T Consensus 164 -----------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~ 215 (279)
T 3fdn_A 164 -----------------------RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY-----QET 215 (279)
T ss_dssp ---------------------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH-----HHH
T ss_pred -----------------------ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcH-----HHH
Confidence 1234567889999999998999999999999999999999999954322 222
Q ss_pred HHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 609 IQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 609 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
...+.......++. ....+.+++.+||+.||++|||+.|++++
T Consensus 216 ~~~~~~~~~~~~~~-------------~~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 216 YKRISRVEFTFPDF-------------VTEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp HHHHHHTCCCCCTT-------------SCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred HHHHHhCCCCCCCc-------------CCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 23333322222211 12357789999999999999999999987
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=346.13 Aligned_cols=258 Identities=22% Similarity=0.355 Sum_probs=201.2
Q ss_pred cccCccCceEEEEEEeC-----CCceEEEEEcCCCC-ccchHHHHHHHHHHhccCCCCcceeeEEEEec--CceeEEEec
Q 042348 373 FLLGKSTIGIVYKVALN-----NEEAVAVRRLGNGG-WQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSV--DEKLLIYDY 444 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~~lV~e~ 444 (686)
..||+|+||.||++.+. +++.||||++.... ....+.+.+|++++++++||||+++++++.+. ...++||||
T Consensus 37 ~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~ 116 (318)
T 3lxp_A 37 RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEY 116 (318)
T ss_dssp EEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEEEECC
T ss_pred heecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEEEEec
Confidence 46999999999998753 57889999997653 23456799999999999999999999999874 567999999
Q ss_pred cCCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCccccccc
Q 042348 445 IPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADI 524 (686)
Q Consensus 445 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~ 524 (686)
+++|+|.+++... .+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++....
T Consensus 117 ~~~~~L~~~l~~~-------~~~~~~~~~i~~~l~~~l~~LH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 186 (318)
T 3lxp_A 117 VPLGSLRDYLPRH-------SIGLAQLLLFAQQICEGMAYLHA---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 186 (318)
T ss_dssp CTTCBHHHHGGGS-------CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCGGGCEECCT
T ss_pred ccCCcHHHHHhhC-------CCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCchheEEEcCCCCEEECCccccccccc
Confidence 9999999999753 48999999999999999999999 8999999999999999999999999999986643
Q ss_pred ccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccc--
Q 042348 525 AEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSME-- 602 (686)
Q Consensus 525 ~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~-- 602 (686)
.... ........+|..|+|||.+.+..++.++||||||+++|||+||+.||.......
T Consensus 187 ~~~~--------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~ 246 (318)
T 3lxp_A 187 GHEY--------------------YRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLE 246 (318)
T ss_dssp TCSE--------------------EEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHH
T ss_pred cccc--------------------cccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhh
Confidence 2110 011223456778999999988889999999999999999999999995432110
Q ss_pred --------hhHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccccc
Q 042348 603 --------LNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRVNIST 672 (686)
Q Consensus 603 --------~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~~~ 672 (686)
..... +........... . .......+.+++.+||+.||++|||+.|+++.|+++....
T Consensus 247 ~~~~~~~~~~~~~-~~~~~~~~~~~~------~-----~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~ 312 (318)
T 3lxp_A 247 LIGIAQGQMTVLR-LTELLERGERLP------R-----PDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKY 312 (318)
T ss_dssp HHCSCCHHHHHHH-HHHHHHTTCCCC------C-----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred hhcccccchhHHH-HHHHHhcccCCC------C-----CccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhh
Confidence 01111 111111111100 0 0112346889999999999999999999999999886433
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=337.55 Aligned_cols=250 Identities=23% Similarity=0.357 Sum_probs=198.1
Q ss_pred cccCccCceEEEEEEeCC----CceEEEEEcCCC-CccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCC
Q 042348 373 FLLGKSTIGIVYKVALNN----EEAVAVRRLGNG-GWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPN 447 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~ 447 (686)
..||+|+||.||+|.... +..||||.+... .....+.+.+|+.++++++||||+++++++.+ +..++||||+++
T Consensus 18 ~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~ 96 (281)
T 3cc6_A 18 RILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWIIMELYPY 96 (281)
T ss_dssp EEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEEEEECCTT
T ss_pred EEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEEEEecCCC
Confidence 469999999999998643 346999999765 33445779999999999999999999999864 567899999999
Q ss_pred CCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccC
Q 042348 448 GSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEE 527 (686)
Q Consensus 448 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 527 (686)
++|.+++.... ..+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++.......
T Consensus 97 ~~L~~~l~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 168 (281)
T 3cc6_A 97 GELGHYLERNK-----NSLKVLTLVLYSLQICKAMAYLES---INCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDY 168 (281)
T ss_dssp CBHHHHHHHHT-----TTCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEEEETTEEEECCCCGGGCC-----
T ss_pred CCHHHHHHhcc-----ccCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEECCCCcEEeCccCCCcccccccc
Confidence 99999997643 458999999999999999999999 8999999999999999999999999999986542211
Q ss_pred CccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCccccCccchhHH
Q 042348 528 TPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQIGSMELNIV 606 (686)
Q Consensus 528 ~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~~~~~ 606 (686)
.......+|..|+|||.+.+..++.++||||||+++|||+| |+.||......+ ..
T Consensus 169 ----------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~--~~ 224 (281)
T 3cc6_A 169 ----------------------YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD--VI 224 (281)
T ss_dssp --------------------------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG--HH
T ss_pred ----------------------cccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHH--HH
Confidence 01122345678999999988889999999999999999998 999996443322 22
Q ss_pred HHHHHHHhhcC-CcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccccc
Q 042348 607 QWIQLILEDRK-PMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRVNIS 671 (686)
Q Consensus 607 ~~~~~~~~~~~-~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~~ 671 (686)
........ +... .....+.+++.+||+.||++|||+.|++++|+++...
T Consensus 225 ---~~~~~~~~~~~~~-------------~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 274 (281)
T 3cc6_A 225 ---GVLEKGDRLPKPD-------------LCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQM 274 (281)
T ss_dssp ---HHHHHTCCCCCCT-------------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---HHHhcCCCCCCCC-------------CCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHh
Confidence 12222211 1111 1123578899999999999999999999999998654
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=346.10 Aligned_cols=254 Identities=25% Similarity=0.363 Sum_probs=195.6
Q ss_pred cccCccCceEEEEEEeC-CCc----eEEEEEcCCC-CccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccC
Q 042348 373 FLLGKSTIGIVYKVALN-NEE----AVAVRRLGNG-GWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIP 446 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~ 446 (686)
..||+|+||.||+|... +++ .||+|.+... .....+++.+|+.++++++||||+++++++.... .++|+||++
T Consensus 21 ~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~v~~~~~ 99 (327)
T 3lzb_A 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMP 99 (327)
T ss_dssp EEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEEEECCCS
T ss_pred EEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceEEEEecC
Confidence 46999999999999864 344 3578877543 3345678999999999999999999999998754 889999999
Q ss_pred CCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCccccccccc
Q 042348 447 NGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAE 526 (686)
Q Consensus 447 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~ 526 (686)
+|+|.+++.... ..+++..++.|+.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 100 ~g~L~~~l~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~ 171 (327)
T 3lzb_A 100 FGCLLDYVREHK-----DNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 171 (327)
T ss_dssp SCBHHHHHHHTT-----TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCTTC--------
T ss_pred CCcHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHhh---CCCcCCCCCHHHEEEcCCCCEEEccCcceeEccCcc
Confidence 999999998754 458999999999999999999999 899999999999999999999999999998654322
Q ss_pred CCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCccccCccchhH
Q 042348 527 ETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQIGSMELNI 605 (686)
Q Consensus 527 ~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~~~~ 605 (686)
.. .......+|..|+|||.+.+..++.++|||||||++|||++ |+.||......+ +
T Consensus 172 ~~---------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~--~ 228 (327)
T 3lzb_A 172 KE---------------------YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--I 228 (327)
T ss_dssp -----------------------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--H
T ss_pred cc---------------------ccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH--H
Confidence 11 11122345778999999999999999999999999999999 999996543332 1
Q ss_pred HHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccccch
Q 042348 606 VQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRVNISTE 673 (686)
Q Consensus 606 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~~~~ 673 (686)
. ..+... ..... . ......+.+++.+||+.||++||++.|+++.|+++.....
T Consensus 229 ~---~~~~~~-~~~~~--~---------~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 281 (327)
T 3lzb_A 229 S---SILEKG-ERLPQ--P---------PICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDPQ 281 (327)
T ss_dssp H---HHHHTT-CCCCC--C---------TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTSHH
T ss_pred H---HHHHcC-CCCCC--C---------ccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhCcC
Confidence 1 112111 11110 0 1122357889999999999999999999999999875543
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=340.73 Aligned_cols=254 Identities=24% Similarity=0.444 Sum_probs=189.8
Q ss_pred cccCccCceEEEEEEeCCCceEEEEEcCCCC--ccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCCH
Q 042348 373 FLLGKSTIGIVYKVALNNEEAVAVRRLGNGG--WQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSL 450 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL 450 (686)
..||+|+||.||+|.... .||||.++... ....+.+.+|++++++++||||+++++++ ..+..++||||+++++|
T Consensus 30 ~~lG~G~~g~Vy~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e~~~~~~L 106 (289)
T 3og7_A 30 QRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQWCEGSSL 106 (289)
T ss_dssp EEEEECSSEEEEEEESSS--EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEECCCEEEH
T ss_pred eEecCCCCeEEEEEEEcC--ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEEecCCCcH
Confidence 469999999999998653 59999986543 33456799999999999999999999965 55678999999999999
Q ss_pred HHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCcc
Q 042348 451 ATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPE 530 (686)
Q Consensus 451 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 530 (686)
.+++.... ..+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++........
T Consensus 107 ~~~l~~~~-----~~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-- 176 (289)
T 3og7_A 107 YHHLHASE-----TKFEMKKLIDIARQTARGMDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGS-- 176 (289)
T ss_dssp HHHHTTC--------CCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTTEEEECCCC-------------
T ss_pred HHHHhhcc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCcccccCccceEEECCCCCEEEccceecccccccccc--
Confidence 99997654 468999999999999999999999 89999999999999999999999999999754321110
Q ss_pred ccccccccCCCCCCCccccccccCCCCCccccCccccc---CCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHH
Q 042348 531 VHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASK---VRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQ 607 (686)
Q Consensus 531 ~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~ 607 (686)
.......||..|+|||.+. +..++.++||||||+++|||++|+.||......+ .
T Consensus 177 -------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~----~ 233 (289)
T 3og7_A 177 -------------------HQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD----Q 233 (289)
T ss_dssp --------------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHH----H
T ss_pred -------------------ccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHH----H
Confidence 1112345788899999886 5678889999999999999999999996543322 1
Q ss_pred HHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccc
Q 042348 608 WIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRVNI 670 (686)
Q Consensus 608 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~ 670 (686)
......... .... ... . .......+.+++.+||+.||++|||+.|+++.|+++..
T Consensus 234 ~~~~~~~~~-~~~~-~~~-~-----~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 234 IIEMVGRGS-LSPD-LSK-V-----RSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp HHHHHHHTS-CCCC-TTS-S-----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred HHHHhcccc-cCcc-hhh-c-----cccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 122222221 1111 000 0 01223468899999999999999999999999998764
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-40 Score=338.70 Aligned_cols=254 Identities=21% Similarity=0.297 Sum_probs=194.0
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCCc---cchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCC
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGGW---QRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNG 448 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~g 448 (686)
..||+|+||.||+|... +++.||||.+..... ...+.+.+|+.++++++||||+++++++...+..++||||++++
T Consensus 40 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~ 119 (309)
T 2h34_A 40 RLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGV 119 (309)
T ss_dssp EEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCCCE
T ss_pred EEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEEEecCCC
Confidence 46999999999999975 688999999875422 22467899999999999999999999999999999999999999
Q ss_pred CHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCC
Q 042348 449 SLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEET 528 (686)
Q Consensus 449 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 528 (686)
+|.+++... ..+++.++..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++.......
T Consensus 120 ~L~~~l~~~------~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~- 189 (309)
T 2h34_A 120 DLAAMLRRQ------GPLAPPRAVAIVRQIGSALDAAHA---AGATHRDVKPENILVSADDFAYLVDFGIASATTDEKL- 189 (309)
T ss_dssp EHHHHHHHH------CSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSCCC----------
T ss_pred CHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CcCCcCCCChHHEEEcCCCCEEEecCccCcccccccc-
Confidence 999999764 358999999999999999999999 8999999999999999999999999999975542211
Q ss_pred ccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHH
Q 042348 529 PEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQW 608 (686)
Q Consensus 529 ~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~ 608 (686)
.......+|..|+|||.+.+..++.++||||||+++|||++|+.||..... ..
T Consensus 190 ---------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~ 242 (309)
T 2h34_A 190 ---------------------TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQL------SV 242 (309)
T ss_dssp ----------------------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHH------HH
T ss_pred ---------------------ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchH------HH
Confidence 111234578889999999988999999999999999999999999954221 12
Q ss_pred HHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCC-CHHHHHHHHhcccccc
Q 042348 609 IQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRP-SMRHVCDSLDRVNIST 672 (686)
Q Consensus 609 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-s~~ev~~~L~~i~~~~ 672 (686)
+........+......+ .....+.+++.+||+.||++|| +++++++.|++.....
T Consensus 243 ~~~~~~~~~~~~~~~~~---------~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~ 298 (309)
T 2h34_A 243 MGAHINQAIPRPSTVRP---------GIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATA 298 (309)
T ss_dssp HHHHHHSCCCCGGGTST---------TCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC--
T ss_pred HHHHhccCCCCccccCC---------CCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhh
Confidence 22222222221111111 1123577899999999999999 9999999999876443
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=342.96 Aligned_cols=259 Identities=20% Similarity=0.318 Sum_probs=195.5
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCC---CccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCC
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNG---GWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNG 448 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~g 448 (686)
..||+|+||.||+|... +++.||||++... .....+.+.+|+.++++++||||+++++++...+..++||||+++|
T Consensus 38 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 117 (310)
T 2wqm_A 38 KKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAG 117 (310)
T ss_dssp EEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCCSC
T ss_pred EeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEEecCCCC
Confidence 46999999999999864 6889999998753 2334567899999999999999999999999999999999999999
Q ss_pred CHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCC
Q 042348 449 SLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEET 528 (686)
Q Consensus 449 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 528 (686)
+|.+++...... ...+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++.......
T Consensus 118 ~L~~~l~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~~~- 191 (310)
T 2wqm_A 118 DLSRMIKHFKKQ--KRLIPERTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT- 191 (310)
T ss_dssp BHHHHHHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCC------------
T ss_pred CHHHHHHHhccc--ccCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCcHHHEEEcCCCCEEEEeccceeeecCCCc-
Confidence 999999752110 1468999999999999999999999 8999999999999999999999999999876542211
Q ss_pred ccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHH
Q 042348 529 PEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQW 608 (686)
Q Consensus 529 ~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~ 608 (686)
......++..|+|||.+.+..++.++||||||+++|||++|+.||...... ....
T Consensus 192 ----------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~ 246 (310)
T 2wqm_A 192 ----------------------AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN---LYSL 246 (310)
T ss_dssp -----------------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CC---HHHH
T ss_pred ----------------------cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchh---HHHH
Confidence 112345677899999999889999999999999999999999999543222 2222
Q ss_pred HHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccccch
Q 042348 609 IQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRVNISTE 673 (686)
Q Consensus 609 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~~~~ 673 (686)
...+.....+ .... ......+.+++.+||+.||++|||+.+|++.|+++.+...
T Consensus 247 ~~~~~~~~~~--~~~~---------~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~ 300 (310)
T 2wqm_A 247 CKKIEQCDYP--PLPS---------DHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTA 300 (310)
T ss_dssp HHHHHTTCSC--CCCT---------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred HHHhhcccCC--CCcc---------cccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhh
Confidence 3333222111 1100 1122357899999999999999999999999999986544
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=342.47 Aligned_cols=240 Identities=21% Similarity=0.197 Sum_probs=187.8
Q ss_pred hcccCccCceEEEEEEeC-CCceEEEEEcCCCC--ccchHHHHHHHHHHhcc-CCCCcceeeEEEEecCceeEEEeccCC
Q 042348 372 AFLLGKSTIGIVYKVALN-NEEAVAVRRLGNGG--WQRFKEFQTEAEAIGKI-RHPNIVSLRAYFWSVDEKLLIYDYIPN 447 (686)
Q Consensus 372 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~e~~~~ 447 (686)
...||+|+||+||+|... +++.||||++.... .....++..|+..+.++ +||||+++++++.+.+..++||||+ +
T Consensus 62 ~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~e~~-~ 140 (311)
T 3p1a_A 62 LSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-G 140 (311)
T ss_dssp EEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC-C
T ss_pred eheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEEecc-C
Confidence 346999999999999986 68999999986532 23334566677666666 8999999999999999999999999 7
Q ss_pred CCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccC
Q 042348 448 GSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEE 527 (686)
Q Consensus 448 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 527 (686)
++|.+++.... ..++|..+..|+.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 141 ~~L~~~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~- 211 (311)
T 3p1a_A 141 PSLQQHCEAWG-----ASLPEAQVWGYLRDTLLALAHLHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG- 211 (311)
T ss_dssp CBHHHHHHHHC-----SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECGGGCEEECCCTTCEECC----
T ss_pred CCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEccceeeeecccCC-
Confidence 79999987654 469999999999999999999999 899999999999999999999999999987553221
Q ss_pred CccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHH
Q 042348 528 TPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQ 607 (686)
Q Consensus 528 ~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~ 607 (686)
......||..|+|||++.+ .++.++|||||||++|||++|..|+.... .
T Consensus 212 -----------------------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~----~--- 260 (311)
T 3p1a_A 212 -----------------------AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE----G--- 260 (311)
T ss_dssp --------------------------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH----H---
T ss_pred -----------------------CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc----H---
Confidence 1123457888999999876 78999999999999999999977663211 0
Q ss_pred HHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 608 WIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 608 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
........ ..+..... ....+.+++.+||+.||++|||+.|++++
T Consensus 261 -~~~~~~~~------~~~~~~~~-----~~~~l~~li~~~L~~dP~~Rpt~~ell~h 305 (311)
T 3p1a_A 261 -WQQLRQGY------LPPEFTAG-----LSSELRSVLVMMLEPDPKLRATAEALLAL 305 (311)
T ss_dssp -HHHHTTTC------CCHHHHTT-----SCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred -HHHHhccC------CCcccccC-----CCHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence 11111111 11111111 22468899999999999999999999864
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=338.96 Aligned_cols=243 Identities=22% Similarity=0.373 Sum_probs=177.0
Q ss_pred cccCccCceEEEEEEe-CCCceEEEEEcCCCC---ccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCC
Q 042348 373 FLLGKSTIGIVYKVAL-NNEEAVAVRRLGNGG---WQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNG 448 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~g 448 (686)
..||+|+||.||+|.. .+++.||||.+.... ....+.+.+|+.++++++||||+++++++.+.+..++||||++++
T Consensus 17 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 96 (278)
T 3cok_A 17 NLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNG 96 (278)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEEECCTTE
T ss_pred eeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEEecCCCC
Confidence 4699999999999987 468899999986432 122467899999999999999999999999999999999999999
Q ss_pred CHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCC
Q 042348 449 SLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEET 528 (686)
Q Consensus 449 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 528 (686)
+|.+++.... ..+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||++........
T Consensus 97 ~L~~~l~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~- 167 (278)
T 3cok_A 97 EMNRYLKNRV-----KPFSENEARHFMHQIITGMLYLHS---HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHE- 167 (278)
T ss_dssp EHHHHHHTCS-----SCCCHHHHHHHHHHHHHHHHHHHH---TTEECSSCCGGGEEECTTCCEEECCCTTCEECC-----
T ss_pred cHHHHHhhcc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCC-
Confidence 9999998654 468999999999999999999999 8999999999999999999999999999976532111
Q ss_pred ccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHH
Q 042348 529 PEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQW 608 (686)
Q Consensus 529 ~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~ 608 (686)
......||..|+|||.+.+..++.++||||||+++|||++|+.||........
T Consensus 168 ----------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~----- 220 (278)
T 3cok_A 168 ----------------------KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT----- 220 (278)
T ss_dssp ----------------------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-------
T ss_pred ----------------------cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH-----
Confidence 11124567889999999988899999999999999999999999954332211
Q ss_pred HHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 609 IQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 609 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
....... +..... .....+.+++.+||+.||++|||+.|++++
T Consensus 221 ~~~~~~~--------~~~~~~-----~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 263 (278)
T 3cok_A 221 LNKVVLA--------DYEMPS-----FLSIEAKDLIHQLLRRNPADRLSLSSVLDH 263 (278)
T ss_dssp ---CCSS--------CCCCCT-----TSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred HHHHhhc--------ccCCcc-----ccCHHHHHHHHHHcccCHhhCCCHHHHhcC
Confidence 0000000 000111 122357799999999999999999999875
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=342.95 Aligned_cols=258 Identities=21% Similarity=0.348 Sum_probs=192.7
Q ss_pred hcccCccCceEEEEEEeC----CCceEEEEEcCCC--CccchHHHHHHHHHHhccCCCCcceeeEEEEecCc-----eeE
Q 042348 372 AFLLGKSTIGIVYKVALN----NEEAVAVRRLGNG--GWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDE-----KLL 440 (686)
Q Consensus 372 ~~~iG~G~~g~Vy~~~~~----~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~-----~~l 440 (686)
...||+|+||.||+|... .+..||||.+... .....+.+.+|+.++++++||||+++++++...+. .++
T Consensus 39 ~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 118 (313)
T 3brb_A 39 GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMV 118 (313)
T ss_dssp EEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-------CEEE
T ss_pred ccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCCcccEE
Confidence 346999999999999764 2457999998754 23345679999999999999999999999987653 499
Q ss_pred EEeccCCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCccc
Q 042348 441 IYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLAR 520 (686)
Q Consensus 441 V~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~ 520 (686)
||||+++|+|.+++...........+++..++.++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++
T Consensus 119 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dikp~NIli~~~~~~kl~Dfg~~~ 195 (313)
T 3brb_A 119 ILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSN---RNFLHRDLAARNCMLRDDMTVCVADFGLSK 195 (313)
T ss_dssp EEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHT---TTCCCCCCSGGGEEECTTSCEEECSCSCC-
T ss_pred EEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCcEEEeecCcce
Confidence 99999999999999643322222569999999999999999999999 899999999999999999999999999998
Q ss_pred ccccccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCccccC
Q 042348 521 LADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQIG 599 (686)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~ 599 (686)
........ .......++..|+|||.+.+..++.++||||||+++|||++ |..||....
T Consensus 196 ~~~~~~~~---------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~ 254 (313)
T 3brb_A 196 KIYSGDYY---------------------RQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQ 254 (313)
T ss_dssp ------------------------------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred eccccccc---------------------CcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCC
Confidence 65432110 01122345678999999998899999999999999999999 889985543
Q ss_pred ccchhHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccc
Q 042348 600 SMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRVNI 670 (686)
Q Consensus 600 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~ 670 (686)
... . ........... .. ......+.+++.+||+.||++|||+.+++++|+++..
T Consensus 255 ~~~--~---~~~~~~~~~~~-------~~-----~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~ 308 (313)
T 3brb_A 255 NHE--M---YDYLLHGHRLK-------QP-----EDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLE 308 (313)
T ss_dssp GGG--H---HHHHHTTCCCC-------CB-----TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHH--H---HHHHHcCCCCC-------CC-----ccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 322 1 22222221110 00 1122468899999999999999999999999998754
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=339.10 Aligned_cols=252 Identities=25% Similarity=0.382 Sum_probs=204.3
Q ss_pred cccCccCceEEEEEEeCC-CceEEEEEcCCCCccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCCHH
Q 042348 373 FLLGKSTIGIVYKVALNN-EEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLA 451 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL~ 451 (686)
..||+|+||.||+|.... +..||+|.+.... ...+.+.+|++++++++||||+++++++.+.+..++||||+++++|.
T Consensus 19 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~ 97 (288)
T 3kfa_A 19 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLL 97 (288)
T ss_dssp EESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTEEHH
T ss_pred eecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEcCCCCcHH
Confidence 469999999999999864 7889999997643 34578999999999999999999999999999999999999999999
Q ss_pred HHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCccc
Q 042348 452 TAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEV 531 (686)
Q Consensus 452 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 531 (686)
+++..... ..+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++.......
T Consensus 98 ~~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~---- 166 (288)
T 3kfa_A 98 DYLRECNR----QEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY---- 166 (288)
T ss_dssp HHHHHCCT----TTSCHHHHHHHHHHHHHHHHHHHH---HTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSS----
T ss_pred HHHHhccc----CCccHhHHHHHHHHHHHHHHHHHH---CCccCCCCCcceEEEcCCCCEEEccCccceeccCCcc----
Confidence 99986542 468999999999999999999999 8999999999999999999999999999986542211
Q ss_pred cccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCccccCccchhHHHHHH
Q 042348 532 HWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQIGSMELNIVQWIQ 610 (686)
Q Consensus 532 ~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~~~~~~~~~ 610 (686)
.......+|..|+|||.+.+..++.++||||||+++|+|++ |..||....... .. .
T Consensus 167 ------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~--~~---~ 223 (288)
T 3kfa_A 167 ------------------TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ--VY---E 223 (288)
T ss_dssp ------------------EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG--HH---H
T ss_pred ------------------ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--HH---H
Confidence 11122345677999999988899999999999999999999 999995543222 11 1
Q ss_pred HHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccccc
Q 042348 611 LILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRVNIS 671 (686)
Q Consensus 611 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~~ 671 (686)
..... .... .. ......+.+++.+||+.||++|||+.|+++.|+.+...
T Consensus 224 ~~~~~-~~~~--~~---------~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~ 272 (288)
T 3kfa_A 224 LLEKD-YRME--RP---------EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 272 (288)
T ss_dssp HHHTT-CCCC--CC---------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHhcc-CCCC--CC---------CCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHh
Confidence 11111 1100 00 11224678999999999999999999999999987643
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=348.46 Aligned_cols=245 Identities=20% Similarity=0.274 Sum_probs=194.5
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCCccchHHHHHHHHHHhcc-CCCCcceeeEEEEecCceeEEEeccCCCCH
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGGWQRFKEFQTEAEAIGKI-RHPNIVSLRAYFWSVDEKLLIYDYIPNGSL 450 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL 450 (686)
..||+|+||.||++... +++.||||.+..... ...+|++++.++ +||||+++++++.+.+..++||||+++|+|
T Consensus 28 ~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L 103 (342)
T 2qr7_A 28 EDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGEL 103 (342)
T ss_dssp EEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred EEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCCCCCcH
Confidence 46999999999999876 588999999965432 346788999888 799999999999999999999999999999
Q ss_pred HHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCC-C---CeEEeecCccccccccc
Q 042348 451 ATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKN-M---EPHISDFGLARLADIAE 526 (686)
Q Consensus 451 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~-~---~~kl~DfGla~~~~~~~ 526 (686)
.+++... ..+++.++..++.||+.||+|||+ ++|+||||||+|||+.++ + .+||+|||+++......
T Consensus 104 ~~~i~~~------~~~~~~~~~~~~~qi~~al~~lH~---~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~ 174 (342)
T 2qr7_A 104 LDKILRQ------KFFSEREASAVLFTITKTVEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN 174 (342)
T ss_dssp HHHHHTC------TTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTT
T ss_pred HHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCC
Confidence 9999765 358999999999999999999999 899999999999998533 3 49999999998654221
Q ss_pred CCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHH
Q 042348 527 ETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIV 606 (686)
Q Consensus 527 ~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~ 606 (686)
. ......||..|+|||++.+..++.++|||||||++|||++|+.||..... ....
T Consensus 175 ~-----------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~--~~~~ 229 (342)
T 2qr7_A 175 G-----------------------LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPD--DTPE 229 (342)
T ss_dssp C-----------------------CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTT--SCHH
T ss_pred C-----------------------ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCc--CCHH
Confidence 1 11234678889999999887789999999999999999999999964322 2223
Q ss_pred HHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 607 QWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 607 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
+....+..+......... ......+.+++.+||+.||++|||+.|++++
T Consensus 230 ~~~~~i~~~~~~~~~~~~---------~~~s~~~~~li~~~L~~dP~~R~t~~~il~h 278 (342)
T 2qr7_A 230 EILARIGSGKFSLSGGYW---------NSVSDTAKDLVSKMLHVDPHQRLTAALVLRH 278 (342)
T ss_dssp HHHHHHHHCCCCCCSTTT---------TTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred HHHHHHccCCcccCcccc---------ccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 334444433322211100 1122357789999999999999999999876
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=345.95 Aligned_cols=267 Identities=23% Similarity=0.325 Sum_probs=201.0
Q ss_pred cccCccCceEEEEEEe-CCCceEEEEEcCCCCccchHHHHHHHHHHhccCCCCcceeeEEEEe----cCceeEEEeccCC
Q 042348 373 FLLGKSTIGIVYKVAL-NNEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWS----VDEKLLIYDYIPN 447 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~----~~~~~lV~e~~~~ 447 (686)
..||+|+||.||++.. .+++.||||++........+.+.+|++++++++||||+++++++.. ....++||||+++
T Consensus 35 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~ 114 (317)
T 2buj_A 35 QKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKR 114 (317)
T ss_dssp EEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEEEECCTT
T ss_pred EEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEEEEeCCC
Confidence 4699999999999997 4688999999876655667789999999999999999999999973 3467999999999
Q ss_pred CCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccC
Q 042348 448 GSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEE 527 (686)
Q Consensus 448 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 527 (686)
|+|.+++...... ...+++.++..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++.......
T Consensus 115 ~~L~~~l~~~~~~--~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~ 189 (317)
T 2buj_A 115 GTLWNEIERLKDK--GNFLTEDQILWLLLGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVE 189 (317)
T ss_dssp CBHHHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCSSCEESCEEEE
T ss_pred CcHHHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEcCCCCEEEEecCcchhcccccc
Confidence 9999999763111 1468999999999999999999999 8999999999999999999999999999875532211
Q ss_pred CccccccccccCCCCCCCccccccccCCCCCccccCcccccCCC---CCCcchHHHHHHHHHHHHhCCCCccccCccchh
Q 042348 528 TPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRK---PTQKWDIYSYGVILLEMISGKLPMIQIGSMELN 604 (686)
Q Consensus 528 ~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~ 604 (686)
.... ...........||..|+|||.+.+.. ++.++|||||||++|||++|+.||.........
T Consensus 190 ~~~~--------------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~ 255 (317)
T 2buj_A 190 GSRQ--------------ALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDS 255 (317)
T ss_dssp SHHH--------------HHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSC
T ss_pred cccc--------------cccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccch
Confidence 0000 00001112334678899999987554 689999999999999999999999542211111
Q ss_pred HHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccccch
Q 042348 605 IVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRVNISTE 673 (686)
Q Consensus 605 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~~~~ 673 (686)
.... .......+. .......+.+++.+||+.||++|||+.|++++|+.+.....
T Consensus 256 ~~~~----~~~~~~~~~-----------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~ 309 (317)
T 2buj_A 256 VALA----VQNQLSIPQ-----------SPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAP 309 (317)
T ss_dssp HHHH----HHCC--CCC-----------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCCC
T ss_pred hhHH----hhccCCCCc-----------cccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCCC
Confidence 1111 111111110 01122368899999999999999999999999999875444
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-40 Score=373.96 Aligned_cols=242 Identities=21% Similarity=0.315 Sum_probs=199.5
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCC---CccchHHHHHHHHHHhcc-CCCCcceeeEEEEecCceeEEEeccCC
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNG---GWQRFKEFQTEAEAIGKI-RHPNIVSLRAYFWSVDEKLLIYDYIPN 447 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~e~~~~ 447 (686)
..||+|+||.||+|+.. +++.||||+++.. .....+.+..|.+++..+ +||||+++++++.+.+..++||||+++
T Consensus 347 ~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV~E~~~g 426 (674)
T 3pfq_A 347 MVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNG 426 (674)
T ss_dssp EESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEEEECCCS
T ss_pred EEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEEEeCcCC
Confidence 47999999999999976 5788999998653 223446788999999988 799999999999999999999999999
Q ss_pred CCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccC
Q 042348 448 GSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEE 527 (686)
Q Consensus 448 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 527 (686)
|+|.++++.. ..+++..+..|+.||+.||+|||+ ++||||||||+|||++.++++||+|||+|+......
T Consensus 427 g~L~~~l~~~------~~~~~~~~~~~~~qi~~aL~~LH~---~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~- 496 (674)
T 3pfq_A 427 GDLMYHIQQV------GRFKEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG- 496 (674)
T ss_dssp CBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHH---TSEECCCCCSTTEEECSSSCEEECCCTTCEECCCTT-
T ss_pred CcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHh---CCeEeccCChhhEEEcCCCcEEEeecceeeccccCC-
Confidence 9999999865 358999999999999999999999 899999999999999999999999999998532211
Q ss_pred CccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHH
Q 042348 528 TPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQ 607 (686)
Q Consensus 528 ~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~ 607 (686)
.......||+.|+|||++.+..|+.++|||||||++|||++|+.||..... .+
T Consensus 497 ----------------------~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~-----~~ 549 (674)
T 3pfq_A 497 ----------------------VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE-----DE 549 (674)
T ss_dssp ----------------------CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HH
T ss_pred ----------------------cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCH-----HH
Confidence 112345688899999999999999999999999999999999999954322 33
Q ss_pred HHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCH-----HHHHHH
Q 042348 608 WIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSM-----RHVCDS 664 (686)
Q Consensus 608 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~-----~ev~~~ 664 (686)
..+.+......++.. ...++.+++.+||+.||++||++ +||.++
T Consensus 550 ~~~~i~~~~~~~p~~-------------~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h 598 (674)
T 3pfq_A 550 LFQSIMEHNVAYPKS-------------MSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 598 (674)
T ss_dssp HHHHHHSSCCCCCTT-------------SCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSS
T ss_pred HHHHHHhCCCCCCcc-------------CCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcC
Confidence 345555443333221 12357789999999999999998 666654
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-40 Score=335.91 Aligned_cols=247 Identities=24% Similarity=0.336 Sum_probs=191.6
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCC-ccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCCH
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGG-WQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSL 450 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL 450 (686)
+.||+|+||.||++... ++..||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++||||+++|+|
T Consensus 28 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L 107 (285)
T 3is5_A 28 RKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGEL 107 (285)
T ss_dssp EEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCSCCBH
T ss_pred ceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEeCCCCcH
Confidence 46999999999999875 57899999986542 33457899999999999999999999999999999999999999999
Q ss_pred HHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeee---cCCCCeEEeecCcccccccccC
Q 042348 451 ATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILL---GKNMEPHISDFGLARLADIAEE 527 (686)
Q Consensus 451 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl---~~~~~~kl~DfGla~~~~~~~~ 527 (686)
.+++...... ...+++..+..|+.|++.||+|||+ ++|+||||||+||++ +.++.+||+|||+++......
T Consensus 108 ~~~l~~~~~~--~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~- 181 (285)
T 3is5_A 108 LERIVSAQAR--GKALSEGYVAELMKQMMNALAYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDE- 181 (285)
T ss_dssp HHHHHHHHHH--TCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC------
T ss_pred HHHHHhhhhc--ccCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCCCHHHEEEecCCCCCCEEEEeeecceecCCcc-
Confidence 9998653211 1468999999999999999999999 899999999999999 456789999999997654221
Q ss_pred CccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHH
Q 042348 528 TPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQ 607 (686)
Q Consensus 528 ~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~ 607 (686)
......||..|+|||.+. ..++.++||||||+++|||++|+.||...... .
T Consensus 182 -----------------------~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~-----~ 232 (285)
T 3is5_A 182 -----------------------HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLE-----E 232 (285)
T ss_dssp ----------------------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-----H
T ss_pred -----------------------cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHH-----H
Confidence 112345678899999886 56899999999999999999999999543321 1
Q ss_pred HHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 608 WIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 608 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
................. .....+.+++.+||+.||++|||+.|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~----------~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 279 (285)
T 3is5_A 233 VQQKATYKEPNYAVECR----------PLTPQAVDLLKQMLTKDPERRPSAAQVLHH 279 (285)
T ss_dssp HHHHHHHCCCCCCC--C----------CCCHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred HHhhhccCCcccccccC----------cCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 12222222111111000 012357789999999999999999999864
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=374.97 Aligned_cols=250 Identities=23% Similarity=0.304 Sum_probs=197.6
Q ss_pred cccCccCceEEEEEEeC---CCceEEEEEcCCCCc--cchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCC
Q 042348 373 FLLGKSTIGIVYKVALN---NEEAVAVRRLGNGGW--QRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPN 447 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~ 447 (686)
+.||+|+||.||+|.+. .++.||||+++.... ...+++.+|++++++++|||||++++++. .+..++|||||++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCCEEEEEEccCC
Confidence 36999999999999653 457899999976432 33578999999999999999999999996 4568999999999
Q ss_pred CCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccC
Q 042348 448 GSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEE 527 (686)
Q Consensus 448 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 527 (686)
|+|.+++... ..+++..+..|+.||+.||+|||+ ++||||||||+|||++.++.+||+|||+++.+.....
T Consensus 454 g~L~~~l~~~------~~l~~~~~~~i~~qi~~~L~yLH~---~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~ 524 (635)
T 4fl3_A 454 GPLNKYLQQN------RHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 524 (635)
T ss_dssp EEHHHHHHHC------TTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC---
T ss_pred CCHHHHHhhC------CCCCHHHHHHHHHHHHHHHHHHHH---CCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcc
Confidence 9999999754 458999999999999999999999 8999999999999999999999999999987643221
Q ss_pred CccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCccccCccchhHH
Q 042348 528 TPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQIGSMELNIV 606 (686)
Q Consensus 528 ~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~~~~~ 606 (686)
.. .......+|..|+|||++.+..++.++|||||||++|||++ |+.||......
T Consensus 525 ~~--------------------~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~----- 579 (635)
T 4fl3_A 525 YY--------------------KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS----- 579 (635)
T ss_dssp ------------------------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-----
T ss_pred cc--------------------ccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH-----
Confidence 00 11122345678999999998899999999999999999998 99999554322
Q ss_pred HHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 042348 607 QWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRVN 669 (686)
Q Consensus 607 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~ 669 (686)
+....+.... ... . ......++.+++.+||+.||++||++.+|++.|+++-
T Consensus 580 ~~~~~i~~~~-~~~-~----------p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~ 630 (635)
T 4fl3_A 580 EVTAMLEKGE-RMG-C----------PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 630 (635)
T ss_dssp HHHHHHHTTC-CCC-C----------CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred HHHHHHHcCC-CCC-C----------CCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 1222222221 110 0 0112346889999999999999999999999998764
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=351.04 Aligned_cols=246 Identities=21% Similarity=0.317 Sum_probs=190.3
Q ss_pred cccCccCceEEEEEEeCCCceEEEEEcCCC--CccchHHHHHHHHHHhccCC--CCcceeeEEEEecCceeEEEeccCCC
Q 042348 373 FLLGKSTIGIVYKVALNNEEAVAVRRLGNG--GWQRFKEFQTEAEAIGKIRH--PNIVSLRAYFWSVDEKLLIYDYIPNG 448 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H--~nIv~l~~~~~~~~~~~lV~e~~~~g 448 (686)
..||+|+||.||++...+++.||||++... .....+.+.+|+.++.+++| |||+++++++...+..++||| +.+|
T Consensus 15 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e-~~~~ 93 (343)
T 3dbq_A 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNI 93 (343)
T ss_dssp EEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC-CCSE
T ss_pred EEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEEe-CCCC
Confidence 469999999999999988999999998653 33345678999999999976 999999999999999999999 5588
Q ss_pred CHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCC
Q 042348 449 SLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEET 528 (686)
Q Consensus 449 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 528 (686)
+|.+++... ..+++.++..|+.|++.||+|||+ ++|+||||||+|||++ ++.+||+|||+++........
T Consensus 94 ~L~~~l~~~------~~~~~~~~~~i~~qi~~al~~lH~---~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~~ 163 (343)
T 3dbq_A 94 DLNSWLKKK------KSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTS 163 (343)
T ss_dssp EHHHHHHHS------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC------
T ss_pred CHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEEE-CCcEEEeecccccccCccccc
Confidence 999999865 468999999999999999999999 8999999999999997 578999999999865432110
Q ss_pred ccccccccccCCCCCCCccccccccCCCCCccccCcccccC-----------CCCCCcchHHHHHHHHHHHHhCCCCccc
Q 042348 529 PEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKV-----------RKPTQKWDIYSYGVILLEMISGKLPMIQ 597 (686)
Q Consensus 529 ~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDVwSlGvvl~elltG~~P~~~ 597 (686)
.......||..|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 164 ---------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 222 (343)
T 3dbq_A 164 ---------------------VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ 222 (343)
T ss_dssp ---------------------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred ---------------------ccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchh
Confidence 11224567889999999854 6789999999999999999999999954
Q ss_pred cCccchhHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 042348 598 IGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSL 665 (686)
Q Consensus 598 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L 665 (686)
.... .............. . .. .. ....+.+++.+||+.||++|||+.|++++-
T Consensus 223 ~~~~----~~~~~~~~~~~~~~-~-~~----~~-----~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp 275 (343)
T 3dbq_A 223 IINQ----ISKLHAIIDPNHEI-E-FP----DI-----PEKDLQDVLKCCLKRDPKQRISIPELLAHP 275 (343)
T ss_dssp CCSH----HHHHHHHHCTTSCC-C-CC----CC-----SCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred hhhH----HHHHHHHhcCCccc-C-Cc----cc-----CCHHHHHHHHHHcCCChhHCCCHHHHHhCc
Confidence 3221 11222222211110 0 00 00 123577899999999999999999998773
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-40 Score=337.22 Aligned_cols=242 Identities=19% Similarity=0.306 Sum_probs=197.8
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCC---ccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCC
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGG---WQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNG 448 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~g 448 (686)
..||+|+||.||++... +++.||+|.+.... ....+.+.+|+.++++++||||+++++++.+.+..++||||++++
T Consensus 21 ~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 100 (294)
T 2rku_A 21 RFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRR 100 (294)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTC
T ss_pred EEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEEecCCCC
Confidence 46999999999999976 47889999986532 234567889999999999999999999999999999999999999
Q ss_pred CHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCC
Q 042348 449 SLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEET 528 (686)
Q Consensus 449 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 528 (686)
+|.+++... ..+++.++..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++.......
T Consensus 101 ~L~~~~~~~------~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~- 170 (294)
T 2rku_A 101 SLLELHKRR------KALTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE- 170 (294)
T ss_dssp BHHHHHHHH------CSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTC-
T ss_pred CHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEcCCCCEEEEeccCceecccCcc-
Confidence 999998754 358999999999999999999999 8999999999999999999999999999976532211
Q ss_pred ccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHH
Q 042348 529 PEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQW 608 (686)
Q Consensus 529 ~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~ 608 (686)
......||..|+|||.+.+..++.++||||||+++|||++|+.||..... .+.
T Consensus 171 ----------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-----~~~ 223 (294)
T 2rku_A 171 ----------------------RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL-----KET 223 (294)
T ss_dssp ----------------------CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH-----HHH
T ss_pred ----------------------ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----HHH
Confidence 11234567889999999988899999999999999999999999954322 122
Q ss_pred HHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 609 IQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 609 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
...+.......+.. ....+.+++.+||+.||++|||+.|++++
T Consensus 224 ~~~~~~~~~~~~~~-------------~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 224 YLRIKKNEYSIPKH-------------INPVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp HHHHHTTCCCCCTT-------------SCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred HHHHhhccCCCccc-------------cCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 22222222221111 12357789999999999999999999876
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-40 Score=357.89 Aligned_cols=254 Identities=23% Similarity=0.275 Sum_probs=188.5
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCC--CccchHHHHHHHHHHhccCCCCcceeeEEEEecC------ceeEEEe
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNG--GWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVD------EKLLIYD 443 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~------~~~lV~e 443 (686)
..||+|+||.||+|... +++.||||++... .....+++.+|+.++++++|||||++++++...+ ..++|||
T Consensus 68 ~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~E 147 (464)
T 3ttj_A 68 KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVME 147 (464)
T ss_dssp EEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEE
T ss_pred EEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCeEEEEEe
Confidence 46999999999999865 5889999999654 3334567889999999999999999999997653 4699999
Q ss_pred ccCCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccc
Q 042348 444 YIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLAD 523 (686)
Q Consensus 444 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~ 523 (686)
||++ +|.+.+. ..+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+|+...
T Consensus 148 ~~~~-~l~~~~~--------~~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 215 (464)
T 3ttj_A 148 LMDA-NLCQVIQ--------MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 215 (464)
T ss_dssp CCSE-EHHHHHT--------SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCCC----
T ss_pred CCCC-CHHHHHh--------hcCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChHhEEEeCCCCEEEEEEEeeeecC
Confidence 9975 5766664 248899999999999999999999 899999999999999999999999999998553
Q ss_pred cccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccch
Q 042348 524 IAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMEL 603 (686)
Q Consensus 524 ~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~ 603 (686)
... .....+||..|+|||++.+..|+.++|||||||++|||++|+.||..... .
T Consensus 216 ~~~------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~--~ 269 (464)
T 3ttj_A 216 TSF------------------------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDY--I 269 (464)
T ss_dssp -CC------------------------CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH--H
T ss_pred CCc------------------------ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCH--H
Confidence 211 12345678899999999999999999999999999999999999954332 1
Q ss_pred hHHHHHHHHHh-------------------hcCCcc-----cccCcccccCCC--cHHHHHHHHHHHHhccccCCCCCCC
Q 042348 604 NIVQWIQLILE-------------------DRKPMT-----DILDPFLAHDLD--KEDEIVSVLKIALDCVHKSPDKRPS 657 (686)
Q Consensus 604 ~~~~~~~~~~~-------------------~~~~~~-----~~~d~~l~~~~~--~~~~~~~l~~l~~~cl~~dP~~RPs 657 (686)
+....+..... ...... ..+...+..... ......++.+++.+||+.||++|||
T Consensus 270 ~~~~~i~~~lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t 349 (464)
T 3ttj_A 270 DQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRIS 349 (464)
T ss_dssp HHHHHHHHHHCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCC
T ss_pred HHHHHHHHhcCCCCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCC
Confidence 11111111110 000000 000000000000 0112456889999999999999999
Q ss_pred HHHHHHH
Q 042348 658 MRHVCDS 664 (686)
Q Consensus 658 ~~ev~~~ 664 (686)
++|++++
T Consensus 350 a~e~L~H 356 (464)
T 3ttj_A 350 VDDALQH 356 (464)
T ss_dssp HHHHHTS
T ss_pred HHHHhcC
Confidence 9999987
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=343.32 Aligned_cols=259 Identities=25% Similarity=0.343 Sum_probs=201.9
Q ss_pred cccCccCceEEEEEEe------CCCceEEEEEcCCCCc-cchHHHHHHHHHHhcc-CCCCcceeeEEEEecC-ceeEEEe
Q 042348 373 FLLGKSTIGIVYKVAL------NNEEAVAVRRLGNGGW-QRFKEFQTEAEAIGKI-RHPNIVSLRAYFWSVD-EKLLIYD 443 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~-~~~lV~e 443 (686)
+.||+|+||.||+|.. .+++.||||.+..... ...+.+.+|++++.++ +||||+++++++...+ ..++|||
T Consensus 33 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~~lv~e 112 (316)
T 2xir_A 33 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVE 112 (316)
T ss_dssp EEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEEEE
T ss_pred eEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCCceEEEEE
Confidence 4699999999999974 3467899999976532 3456789999999999 7999999999988765 4899999
Q ss_pred ccCCCCHHHHhhcCCCcc----------ccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEE
Q 042348 444 YIPNGSLATAIHGKAGII----------SYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHI 513 (686)
Q Consensus 444 ~~~~gsL~~~l~~~~~~~----------~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl 513 (686)
|+++|+|.+++....... ....+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||
T Consensus 113 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dikp~Nil~~~~~~~kl 189 (316)
T 2xir_A 113 FCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKI 189 (316)
T ss_dssp CCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEE
T ss_pred cCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHh---CCcccccCccceEEECCCCCEEE
Confidence 999999999998754210 01237899999999999999999999 89999999999999999999999
Q ss_pred eecCcccccccccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHh-CC
Q 042348 514 SDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GK 592 (686)
Q Consensus 514 ~DfGla~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~ 592 (686)
+|||+++........ .......+|..|+|||.+.+..++.++|||||||++|||+| |+
T Consensus 190 ~Dfg~~~~~~~~~~~---------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~ 248 (316)
T 2xir_A 190 CDFGLARDIYKDPDY---------------------VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA 248 (316)
T ss_dssp CCCGGGSCTTTCTTS---------------------EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred CCCccccccccCccc---------------------eeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCC
Confidence 999999865422110 11223445778999999988899999999999999999998 99
Q ss_pred CCccccCccchhHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccccc
Q 042348 593 LPMIQIGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRVNIS 671 (686)
Q Consensus 593 ~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~~ 671 (686)
.||........ ......... ... . .. .....+.+++.+||+.||++|||+.|++++|+++...
T Consensus 249 ~p~~~~~~~~~----~~~~~~~~~-~~~-~-----~~-----~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 311 (316)
T 2xir_A 249 SPYPGVKIDEE----FCRRLKEGT-RMR-A-----PD-----YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 311 (316)
T ss_dssp CSSTTCCCSHH----HHHHHHHTC-CCC-C-----CT-----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCcccchhHH----HHHHhccCc-cCC-C-----CC-----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhh
Confidence 99965433221 112222221 110 0 00 1123578899999999999999999999999998643
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-40 Score=344.34 Aligned_cols=242 Identities=19% Similarity=0.311 Sum_probs=198.1
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCC---CccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCC
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNG---GWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNG 448 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~g 448 (686)
+.||+|+||.||++... +++.||+|.+... .....+.+.+|+.++++++||||+++++++.+.+..++||||++++
T Consensus 47 ~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 126 (335)
T 2owb_A 47 RFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRR 126 (335)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTC
T ss_pred EEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEecCCCC
Confidence 46999999999999976 4788999998653 2234567899999999999999999999999999999999999999
Q ss_pred CHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCC
Q 042348 449 SLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEET 528 (686)
Q Consensus 449 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 528 (686)
+|.+++... ..+++.++..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++.......
T Consensus 127 ~L~~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~- 196 (335)
T 2owb_A 127 SLLELHKRR------KALTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE- 196 (335)
T ss_dssp BHHHHHHHH------CSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTC-
T ss_pred CHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHH---CCCEecCCCchhEEEcCCCCEEEeeccCceecccCcc-
Confidence 999998754 358999999999999999999999 8999999999999999999999999999986542211
Q ss_pred ccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHH
Q 042348 529 PEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQW 608 (686)
Q Consensus 529 ~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~ 608 (686)
......||..|+|||++.+..++.++||||||+++|||++|+.||..... .+.
T Consensus 197 ----------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-----~~~ 249 (335)
T 2owb_A 197 ----------------------RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL-----KET 249 (335)
T ss_dssp ----------------------CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH-----HHH
T ss_pred ----------------------cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCH-----HHH
Confidence 11234577889999999988899999999999999999999999954322 122
Q ss_pred HHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 609 IQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 609 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
...+.......... ....+.+++.+||+.||++|||+.|++++
T Consensus 250 ~~~~~~~~~~~~~~-------------~~~~~~~li~~~l~~dp~~Rps~~ell~~ 292 (335)
T 2owb_A 250 YLRIKKNEYSIPKH-------------INPVAASLIQKMLQTDPTARPTINELLND 292 (335)
T ss_dssp HHHHHHTCCCCCTT-------------SCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred HHHHhcCCCCCCcc-------------CCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 22233332222211 11357789999999999999999999875
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-40 Score=342.65 Aligned_cols=258 Identities=21% Similarity=0.336 Sum_probs=203.2
Q ss_pred cccCccCceEEEEEEeC------CCceEEEEEcCCCC-ccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEecc
Q 042348 373 FLLGKSTIGIVYKVALN------NEEAVAVRRLGNGG-WQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYI 445 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~ 445 (686)
..||+|+||.||+|... +++.||||.+.... .....++.+|++++++++||||+++++++.+.+..++||||+
T Consensus 31 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 110 (322)
T 1p4o_A 31 RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELM 110 (322)
T ss_dssp EEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred eEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCccEEEEEeC
Confidence 46999999999999764 36789999997643 234557899999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcCCCc----cccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccc
Q 042348 446 PNGSLATAIHGKAGI----ISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARL 521 (686)
Q Consensus 446 ~~gsL~~~l~~~~~~----~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~ 521 (686)
++|+|.+++...... .....+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++.
T Consensus 111 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~NIli~~~~~~kl~Dfg~~~~ 187 (322)
T 1p4o_A 111 TRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRD 187 (322)
T ss_dssp TTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCSGGGEEECTTCCEEECCTTCCCG
T ss_pred CCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCCccCCCccceEEEcCCCeEEECcCccccc
Confidence 999999999753210 001357899999999999999999999 8999999999999999999999999999986
Q ss_pred cccccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCccccCc
Q 042348 522 ADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQIGS 600 (686)
Q Consensus 522 ~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~ 600 (686)
....... .......+|..|+|||.+.+..++.++|||||||++|||++ |+.||.....
T Consensus 188 ~~~~~~~---------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~ 246 (322)
T 1p4o_A 188 IYETDYY---------------------RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN 246 (322)
T ss_dssp GGGGGCE---------------------EGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH
T ss_pred ccccccc---------------------ccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCH
Confidence 5432110 11122345778999999988889999999999999999999 8999854322
Q ss_pred cchhHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccccc
Q 042348 601 MELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRVNIS 671 (686)
Q Consensus 601 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~~ 671 (686)
.+....+...... .. .......+.+++.+||+.||++|||+.|++++|+++...
T Consensus 247 -----~~~~~~~~~~~~~--~~----------~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~ 300 (322)
T 1p4o_A 247 -----EQVLRFVMEGGLL--DK----------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 300 (322)
T ss_dssp -----HHHHHHHHTTCCC--CC----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCT
T ss_pred -----HHHHHHHHcCCcC--CC----------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhcc
Confidence 1222222222111 10 011223578899999999999999999999999987543
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=333.43 Aligned_cols=245 Identities=23% Similarity=0.331 Sum_probs=197.3
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCC--CccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCC
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNG--GWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGS 449 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gs 449 (686)
+.||+|+||.||+|... +++.||+|++... .....+.+.+|+.++++++||||+++++++...+..++||||+++|+
T Consensus 12 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~ 91 (284)
T 3kk8_A 12 EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGE 91 (284)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred hhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEecCCCCC
Confidence 46999999999999875 5889999998654 23345678899999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCC---eEEeecCccccccccc
Q 042348 450 LATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNME---PHISDFGLARLADIAE 526 (686)
Q Consensus 450 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~---~kl~DfGla~~~~~~~ 526 (686)
|.+.+... ..+++..+..++.|++.||+|||+ ++|+||||||+||+++.++. +||+|||++.......
T Consensus 92 l~~~~~~~------~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~ 162 (284)
T 3kk8_A 92 LFEDIVAR------EFYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE 162 (284)
T ss_dssp HHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSC
T ss_pred HHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCc
Confidence 99988765 358999999999999999999999 89999999999999986655 9999999997553221
Q ss_pred CCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHH
Q 042348 527 ETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIV 606 (686)
Q Consensus 527 ~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~ 606 (686)
......||..|+|||.+.+..++.++||||||+++|+|++|+.||..... .
T Consensus 163 ------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~-----~ 213 (284)
T 3kk8_A 163 ------------------------AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ-----H 213 (284)
T ss_dssp ------------------------BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----H
T ss_pred ------------------------cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCch-----h
Confidence 11234578889999999999999999999999999999999999954322 1
Q ss_pred HHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 607 QWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 607 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
.....+.......+. +.. ......+.+++.+||+.||++|||+.|++++
T Consensus 214 ~~~~~~~~~~~~~~~---~~~------~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (284)
T 3kk8_A 214 RLYAQIKAGAYDYPS---PEW------DTVTPEAKSLIDSMLTVNPKKRITADQALKV 262 (284)
T ss_dssp HHHHHHHHTCCCCCT---TTT------TTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred HHHHHHHhccccCCc---hhh------cccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 222333332221111 100 1122357799999999999999999999885
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=344.53 Aligned_cols=259 Identities=25% Similarity=0.411 Sum_probs=202.4
Q ss_pred cccCccCceEEEEEEe-----CCCceEEEEEcCCCCccchHHHHHHHHHHhccCCCCcceeeEEEEecC--ceeEEEecc
Q 042348 373 FLLGKSTIGIVYKVAL-----NNEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVD--EKLLIYDYI 445 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~--~~~lV~e~~ 445 (686)
..||+|+||.||++++ .+++.||||++........+.+.+|++++++++||||+++++++...+ ..++||||+
T Consensus 47 ~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~ 126 (326)
T 2w1i_A 47 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYL 126 (326)
T ss_dssp EEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCEEEECCC
T ss_pred eeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceEEEEECC
Confidence 4699999999999984 357899999998766666678999999999999999999999987654 679999999
Q ss_pred CCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccc
Q 042348 446 PNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIA 525 (686)
Q Consensus 446 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~ 525 (686)
++|+|.+++.... ..+++.++..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++.....
T Consensus 127 ~~~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~~ 198 (326)
T 2w1i_A 127 PYGSLRDYLQKHK-----ERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQD 198 (326)
T ss_dssp TTCBHHHHHHHST-----TSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEECCSS
T ss_pred CCCCHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHh---CCEeccCCCcceEEEcCCCcEEEecCcchhhcccc
Confidence 9999999998754 358999999999999999999999 89999999999999999999999999999866432
Q ss_pred cCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCcc----
Q 042348 526 EETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSM---- 601 (686)
Q Consensus 526 ~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~---- 601 (686)
... ........++..|+|||.+.+..++.++||||||+++|||+||..||......
T Consensus 199 ~~~--------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~ 258 (326)
T 2w1i_A 199 KEY--------------------YKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRM 258 (326)
T ss_dssp CSE--------------------EECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHH
T ss_pred ccc--------------------cccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHh
Confidence 110 00112234567799999998888999999999999999999999998432100
Q ss_pred ------chhHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccc
Q 042348 602 ------ELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRVNI 670 (686)
Q Consensus 602 ------~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~ 670 (686)
.......+........... . ......++.+++.+||+.||++|||+.||++.|+++..
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~------~-----~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~ 322 (326)
T 2w1i_A 259 IGNDKQGQMIVFHLIELLKNNGRLP------R-----PDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 322 (326)
T ss_dssp HCTTCCTHHHHHHHHHHHHTTCCCC------C-----CTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hccccchhhhHHHHHHHhhcCCCCC------C-----CCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 0001111111111111110 0 01123468899999999999999999999999998864
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-40 Score=336.59 Aligned_cols=247 Identities=23% Similarity=0.339 Sum_probs=194.4
Q ss_pred ccCccCceEEEEEEeC-CCceEEEEEcCCCCccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCCHHH
Q 042348 374 LLGKSTIGIVYKVALN-NEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLAT 452 (686)
Q Consensus 374 ~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL~~ 452 (686)
+||+|+||.||+|... +++.||||.+........+.+.+|+.++++++||||+++++++...+..++||||+++++|.+
T Consensus 29 ~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 108 (295)
T 2clq_A 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSA 108 (295)
T ss_dssp EEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEEHHH
T ss_pred EEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCHHH
Confidence 6999999999999864 578999999977655556789999999999999999999999999999999999999999999
Q ss_pred HhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecC-CCCeEEeecCcccccccccCCccc
Q 042348 453 AIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGK-NMEPHISDFGLARLADIAEETPEV 531 (686)
Q Consensus 453 ~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~-~~~~kl~DfGla~~~~~~~~~~~~ 531 (686)
++....+. ..+++..+..++.|++.||+|||+ ++|+||||||+||+++. ++.+||+|||+++.......
T Consensus 109 ~l~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~---- 178 (295)
T 2clq_A 109 LLRSKWGP---LKDNEQTIGFYTKQILEGLKYLHD---NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP---- 178 (295)
T ss_dssp HHHHTTCC---CTTCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-------
T ss_pred HHHhhccC---CCccHHHHHHHHHHHHHHHHHHHh---CCEEccCCChhhEEEECCCCCEEEeecccccccCCCCC----
Confidence 99865321 356788999999999999999999 89999999999999987 89999999999976532110
Q ss_pred cccccccCCCCCCCccccccccCCCCCccccCcccccCCC--CCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHHH
Q 042348 532 HWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRK--PTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQWI 609 (686)
Q Consensus 532 ~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~ 609 (686)
......||..|+|||.+.+.. ++.++||||||+++|||++|+.||.......... .
T Consensus 179 -------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~---~ 236 (295)
T 2clq_A 179 -------------------CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAM---F 236 (295)
T ss_dssp ---------------------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHH---H
T ss_pred -------------------cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHH---H
Confidence 112345788899999986543 7899999999999999999999996543322111 1
Q ss_pred HHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 610 QLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 610 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
........ +.+.. .....+.+++.+||+.||++||++.|++++
T Consensus 237 ~~~~~~~~-------~~~~~-----~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 279 (295)
T 2clq_A 237 KVGMFKVH-------PEIPE-----SMSAEAKAFILKCFEPDPDKRACANDLLVD 279 (295)
T ss_dssp HHHHHCCC-------CCCCT-----TSCHHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred hhcccccc-------ccccc-----cCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 11111110 11111 122357789999999999999999999865
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-40 Score=351.45 Aligned_cols=245 Identities=21% Similarity=0.330 Sum_probs=191.4
Q ss_pred cccCccCceEEEEEEeCCCceEEEEEcCCC--CccchHHHHHHHHHHhccC--CCCcceeeEEEEecCceeEEEeccCCC
Q 042348 373 FLLGKSTIGIVYKVALNNEEAVAVRRLGNG--GWQRFKEFQTEAEAIGKIR--HPNIVSLRAYFWSVDEKLLIYDYIPNG 448 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~--H~nIv~l~~~~~~~~~~~lV~e~~~~g 448 (686)
..||+|+||.||++...+++.||||++... .....+.+.+|+.++++++ ||||+++++++...+..++||| +.++
T Consensus 62 ~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E-~~~~ 140 (390)
T 2zmd_A 62 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNI 140 (390)
T ss_dssp EEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEE-CCSE
T ss_pred EEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEEe-cCCC
Confidence 469999999999999888999999998653 3344577999999999996 5999999999999999999999 5688
Q ss_pred CHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCC
Q 042348 449 SLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEET 528 (686)
Q Consensus 449 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 528 (686)
+|.+++... ..+++.++..|+.||+.||+|||+ ++|+||||||+|||++ ++.+||+|||+++........
T Consensus 141 ~L~~~l~~~------~~~~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~ 210 (390)
T 2zmd_A 141 DLNSWLKKK------KSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTS 210 (390)
T ss_dssp EHHHHHHHC------SSCCHHHHHHHHHHHHHHHHHHHT---TTCCCCCCCGGGEEES-SSCEEECCCSSSCCC------
T ss_pred CHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCcc
Confidence 999999865 358899999999999999999999 8999999999999995 589999999999865432110
Q ss_pred ccccccccccCCCCCCCccccccccCCCCCccccCcccccC-----------CCCCCcchHHHHHHHHHHHHhCCCCccc
Q 042348 529 PEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKV-----------RKPTQKWDIYSYGVILLEMISGKLPMIQ 597 (686)
Q Consensus 529 ~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDVwSlGvvl~elltG~~P~~~ 597 (686)
.......||+.|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 211 ---------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~ 269 (390)
T 2zmd_A 211 ---------------------VVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ 269 (390)
T ss_dssp ------------------------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred ---------------------ccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchh
Confidence 11234568889999999865 3689999999999999999999999954
Q ss_pred cCccchhHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 598 IGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 598 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
.... ...+..+....... . . + .. ....+.+++.+||+.||++|||+.|++++
T Consensus 270 ~~~~----~~~~~~~~~~~~~~-~-~-~---~~-----~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 270 IINQ----ISKLHAIIDPNHEI-E-F-P---DI-----PEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp CCCH----HHHHHHHHCTTSCC-C-C-C---CC-----SCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hhHH----HHHHHHHhCccccC-C-C-C---cc-----chHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 3221 12222333221110 0 0 0 00 12357789999999999999999999876
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-40 Score=336.51 Aligned_cols=245 Identities=22% Similarity=0.369 Sum_probs=197.7
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCCccchHHHHHHHHHHhccCCCCcceeeEEEEe----------------c
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWS----------------V 435 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~----------------~ 435 (686)
+.||+|+||.||+|... +++.||+|++.... +.+.+|++++++++||||+++++++.. .
T Consensus 17 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 92 (284)
T 2a19_B 17 ELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKT 92 (284)
T ss_dssp EEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---------CCEE
T ss_pred eeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccccccccCc
Confidence 46999999999999986 68999999986543 467899999999999999999999865 3
Q ss_pred CceeEEEeccCCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEee
Q 042348 436 DEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISD 515 (686)
Q Consensus 436 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~D 515 (686)
...++||||+++|+|.+++..... ..+++..+..++.|++.||+|||+ ++|+||||||+||++++++.+||+|
T Consensus 93 ~~~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~D 165 (284)
T 2a19_B 93 KCLFIQMEFCDKGTLEQWIEKRRG----EKLDKVLALELFEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGD 165 (284)
T ss_dssp EEEEEEECCCCSCBHHHHHHHGGG----SCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECC
T ss_pred ceEEEEEeccCCCCHHHHHhhccC----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCHHHEEEcCCCCEEECc
Confidence 457999999999999999976432 468999999999999999999999 8999999999999999999999999
Q ss_pred cCcccccccccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCc
Q 042348 516 FGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPM 595 (686)
Q Consensus 516 fGla~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~ 595 (686)
||+++....... .....+|..|+|||.+.+..++.++||||||+++|||++|..|+
T Consensus 166 fg~~~~~~~~~~------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~ 221 (284)
T 2a19_B 166 FGLVTSLKNDGK------------------------RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTA 221 (284)
T ss_dssp CTTCEESSCCSC------------------------CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSH
T ss_pred chhheecccccc------------------------ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcc
Confidence 999976542211 12235678899999999888999999999999999999999998
Q ss_pred cccCccchhHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccccchh
Q 042348 596 IQIGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRVNISTEQ 674 (686)
Q Consensus 596 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~~~~~ 674 (686)
... .......... ..... ....+.+++.+||+.||++|||+.|++++|+.+....+.
T Consensus 222 ~~~-------~~~~~~~~~~--~~~~~-------------~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~~ 278 (284)
T 2a19_B 222 FET-------SKFFTDLRDG--IISDI-------------FDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEK 278 (284)
T ss_dssp HHH-------HHHHHHHHTT--CCCTT-------------SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC----
T ss_pred hhH-------HHHHHHhhcc--ccccc-------------CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCCc
Confidence 321 1112222111 11111 112467899999999999999999999999998866553
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=345.79 Aligned_cols=235 Identities=17% Similarity=0.270 Sum_probs=193.1
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCCc--------cchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEe
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGGW--------QRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYD 443 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 443 (686)
..||+|+||.||+|... +++.||||++..... ...+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 30 ~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e 109 (335)
T 3dls_A 30 SPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVME 109 (335)
T ss_dssp EECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred eEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCEEEEEEE
Confidence 46999999999999864 688999999865421 133467889999999999999999999999999999999
Q ss_pred ccCCC-CHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCccccc
Q 042348 444 YIPNG-SLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLA 522 (686)
Q Consensus 444 ~~~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~ 522 (686)
|+.+| +|.+++... ..+++..+..|+.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++..
T Consensus 110 ~~~~g~~l~~~~~~~------~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~ 180 (335)
T 3dls_A 110 KHGSGLDLFAFIDRH------PRLDEPLASYIFRQLVSAVGYLRL---KDIIHRDIKDENIVIAEDFTIKLIDFGSAAYL 180 (335)
T ss_dssp CCTTSCBHHHHHHTC------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred eCCCCccHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHh---CCeEEeccCHHHEEEcCCCcEEEeecccceEC
Confidence 99777 999999865 358999999999999999999999 89999999999999999999999999999865
Q ss_pred ccccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCC-CCcchHHHHHHHHHHHHhCCCCccccCcc
Q 042348 523 DIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKP-TQKWDIYSYGVILLEMISGKLPMIQIGSM 601 (686)
Q Consensus 523 ~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDVwSlGvvl~elltG~~P~~~~~~~ 601 (686)
.... ......||..|+|||++.+..+ +.++|||||||++|||++|+.||......
T Consensus 181 ~~~~------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~ 236 (335)
T 3dls_A 181 ERGK------------------------LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET 236 (335)
T ss_dssp CTTC------------------------CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG
T ss_pred CCCC------------------------ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH
Confidence 4221 1123457888999999988776 78999999999999999999999542110
Q ss_pred chhHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 602 ELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 602 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
.......+. .....+.+++.+||+.||++|||+.|++++
T Consensus 237 -----------~~~~~~~~~-------------~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 237 -----------VEAAIHPPY-------------LVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp -----------TTTCCCCSS-------------CCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred -----------HhhccCCCc-------------ccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000000000 012357899999999999999999999987
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-40 Score=345.54 Aligned_cols=270 Identities=24% Similarity=0.319 Sum_probs=194.5
Q ss_pred cccCccCceEEEEEEeCCCceEEEEEcCCCCccchHHHHHHHHH--HhccCCCCcceeeEEEEec-----CceeEEEecc
Q 042348 373 FLLGKSTIGIVYKVALNNEEAVAVRRLGNGGWQRFKEFQTEAEA--IGKIRHPNIVSLRAYFWSV-----DEKLLIYDYI 445 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~--l~~l~H~nIv~l~~~~~~~-----~~~~lV~e~~ 445 (686)
..||+|+||.||+|+. +++.||||++.... ...+..|.++ +..++||||+++++++... ...++||||+
T Consensus 19 ~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~ 94 (336)
T 3g2f_A 19 ELIGRGRYGAVYKGSL-DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYY 94 (336)
T ss_dssp EEEEECSSEEEEEEEE-TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEEECCC
T ss_pred eecccCCCeEEEEEEE-CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEEEEecC
Confidence 4699999999999987 57899999986532 2344444444 5568999999999866532 2468999999
Q ss_pred CCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCC---------CceecCCCCCCeeecCCCCeEEeec
Q 042348 446 PNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPK---------RYVHGDLRPSNILLGKNMEPHISDF 516 (686)
Q Consensus 446 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~---------~iiHrDlkp~NILl~~~~~~kl~Df 516 (686)
++|+|.+++... ..++..+..|+.|++.||+|||+ . +|+||||||+|||++.++.+||+||
T Consensus 95 ~~g~L~~~l~~~-------~~~~~~~~~i~~qi~~~L~~LH~---~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DF 164 (336)
T 3g2f_A 95 PNGSLXKYLSLH-------TSDWVSSCRLAHSVTRGLAYLHT---ELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDF 164 (336)
T ss_dssp TTCBHHHHHHHC-------CBCHHHHHHHHHHHHHHHHHHHC---CBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCC
T ss_pred CCCcHHHHHhhc-------ccchhHHHHHHHHHHHHHHHHHh---hhccccccccceeecccccceEEEcCCCcEEEeec
Confidence 999999999754 35899999999999999999999 6 9999999999999999999999999
Q ss_pred CcccccccccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccC-------CCCCCcchHHHHHHHHHHHH
Q 042348 517 GLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKV-------RKPTQKWDIYSYGVILLEMI 589 (686)
Q Consensus 517 Gla~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~sDVwSlGvvl~ell 589 (686)
|+++.+........ ...........||..|+|||++.+ ..++.++|||||||++|||+
T Consensus 165 G~a~~~~~~~~~~~---------------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell 229 (336)
T 3g2f_A 165 GLSMRLTGNRLVRP---------------GEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIF 229 (336)
T ss_dssp TTCEECSSSSCC------------------------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHH
T ss_pred cceeecccccccCc---------------cccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHH
Confidence 99987653221100 000112234568899999999876 35667899999999999999
Q ss_pred hCCCCccccCccch------------hHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCC
Q 042348 590 SGKLPMIQIGSMEL------------NIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPS 657 (686)
Q Consensus 590 tG~~P~~~~~~~~~------------~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs 657 (686)
+|..||........ .................. +.... .........+.+++.+||+.||++|||
T Consensus 230 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~---~~~~~~~~~l~~li~~cl~~dP~~Rps 305 (336)
T 3g2f_A 230 MRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPK-FPEAW---KENSLAVRSLKETIEDCWDQDAEARLT 305 (336)
T ss_dssp TTBGGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCC-CCTTC---CCCSHHHHHHHHHHHHHSCSSGGGSCC
T ss_pred hcCCcCCCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCC-CCccc---ccccchHHHHHHHHHHHhcCChhhCcc
Confidence 99888743322110 001111111111111111 11111 112345667999999999999999999
Q ss_pred HHHHHHHHhcccccchhh
Q 042348 658 MRHVCDSLDRVNISTEQQ 675 (686)
Q Consensus 658 ~~ev~~~L~~i~~~~~~~ 675 (686)
+.|+++.|+++...+++.
T Consensus 306 ~~e~l~~L~~ll~~~~~~ 323 (336)
T 3g2f_A 306 AQXAEERMAELMMIWERN 323 (336)
T ss_dssp HHHHHHHHHHHHHCCCC-
T ss_pred hHHHHHHHHHHHHHHHhc
Confidence 999999999988665543
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=348.41 Aligned_cols=261 Identities=26% Similarity=0.332 Sum_probs=203.8
Q ss_pred hcccCccCceEEEEEEeCC-C-----ceEEEEEcCCCC-ccchHHHHHHHHHHhcc-CCCCcceeeEEEEecCceeEEEe
Q 042348 372 AFLLGKSTIGIVYKVALNN-E-----EAVAVRRLGNGG-WQRFKEFQTEAEAIGKI-RHPNIVSLRAYFWSVDEKLLIYD 443 (686)
Q Consensus 372 ~~~iG~G~~g~Vy~~~~~~-~-----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~e 443 (686)
...||+|+||.||+|.... + ..||+|.+.... ....+.+.+|+++++++ +||||+++++++...+..++|||
T Consensus 51 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e 130 (333)
T 2i1m_A 51 GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITE 130 (333)
T ss_dssp EEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred eeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCceEEEEe
Confidence 3579999999999998653 2 479999997653 33456799999999999 89999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCCc--------cccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEee
Q 042348 444 YIPNGSLATAIHGKAGI--------ISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISD 515 (686)
Q Consensus 444 ~~~~gsL~~~l~~~~~~--------~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~D 515 (686)
|+++|+|.+++...... .....+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|
T Consensus 131 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~D 207 (333)
T 2i1m_A 131 YCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLAS---KNCIHRDVAARNVLLTNGHVAKIGD 207 (333)
T ss_dssp CCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGCEEEGGGEEEBCC
T ss_pred cCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhc---CCcccCCcccceEEECCCCeEEECc
Confidence 99999999999754210 001358999999999999999999999 8999999999999999999999999
Q ss_pred cCcccccccccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCC
Q 042348 516 FGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLP 594 (686)
Q Consensus 516 fGla~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P 594 (686)
||+++........ .......+|..|+|||.+.+..++.++|||||||++|||+| |..|
T Consensus 208 fg~~~~~~~~~~~---------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p 266 (333)
T 2i1m_A 208 FGLARDIMNDSNY---------------------IVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP 266 (333)
T ss_dssp CGGGCCGGGCTTS---------------------EECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCS
T ss_pred cccccccccccce---------------------eecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCC
Confidence 9999865422110 11123345678999999988889999999999999999999 9999
Q ss_pred ccccCccchhHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccccc
Q 042348 595 MIQIGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRVNIST 672 (686)
Q Consensus 595 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~~~ 672 (686)
|........ +........... .+ ......+.+++.+||+.||++|||+.||++.|+++....
T Consensus 267 ~~~~~~~~~-----~~~~~~~~~~~~---~~--------~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~ 328 (333)
T 2i1m_A 267 YPGILVNSK-----FYKLVKDGYQMA---QP--------AFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQED 328 (333)
T ss_dssp STTCCSSHH-----HHHHHHHTCCCC---CC--------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CcccchhHH-----HHHHHhcCCCCC---CC--------CCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHhh
Confidence 965432221 122222221110 00 011235788999999999999999999999999876543
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=345.48 Aligned_cols=252 Identities=22% Similarity=0.281 Sum_probs=195.0
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCCccchHHHHHHHHHHhccC-----CCCcceeeEEEEecCceeEEEeccC
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIR-----HPNIVSLRAYFWSVDEKLLIYDYIP 446 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----H~nIv~l~~~~~~~~~~~lV~e~~~ 446 (686)
..||+|+||.||+|... +++.||||++.... ...+.+..|+++++++. ||||+++++++...+..++||||+
T Consensus 41 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~- 118 (360)
T 3llt_A 41 RKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIK-KYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFEPL- 118 (360)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEECSCH-HHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEEEEEECCC-
T ss_pred EEEcccCCeEEEEEEECCCCeEEEEEEeccch-hhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCeeEEEEcCC-
Confidence 46999999999999974 67899999997532 33466788999999986 999999999999999999999999
Q ss_pred CCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecC-------------------
Q 042348 447 NGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGK------------------- 507 (686)
Q Consensus 447 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~------------------- 507 (686)
+++|.+++..... ..+++..+..++.||+.||+|||+ ++|+||||||+|||++.
T Consensus 119 ~~~L~~~~~~~~~----~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~ 191 (360)
T 3llt_A 119 GPSLYEIITRNNY----NGFHIEDIKLYCIEILKALNYLRK---MSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKI 191 (360)
T ss_dssp CCBHHHHHHHTTT----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCTTCCEEEEEEECTTTCCEE
T ss_pred CCCHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCcccEEEccccccccccchhcccccccc
Confidence 9999999986542 358999999999999999999999 89999999999999975
Q ss_pred ------CCCeEEeecCcccccccccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHH
Q 042348 508 ------NMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSY 581 (686)
Q Consensus 508 ------~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSl 581 (686)
++.+||+|||+++..... .....||..|+|||++.+..++.++|||||
T Consensus 192 ~~~~~~~~~~kl~DFG~a~~~~~~--------------------------~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 245 (360)
T 3llt_A 192 QIYRTKSTGIKLIDFGCATFKSDY--------------------------HGSIINTRQYRAPEVILNLGWDVSSDMWSF 245 (360)
T ss_dssp EEEEESCCCEEECCCTTCEETTSC--------------------------CCSCCSCGGGCCHHHHTTCCCCTTHHHHHH
T ss_pred cccccCCCCEEEEeccCceecCCC--------------------------CcCccCcccccCcHHHcCCCCCCccchHHH
Confidence 789999999999753311 123456888999999999999999999999
Q ss_pred HHHHHHHHhCCCCccccCccchhHHHHHHHHHhhcCCcccc-------------cC-----cccccCCCcHH--------
Q 042348 582 GVILLEMISGKLPMIQIGSMELNIVQWIQLILEDRKPMTDI-------------LD-----PFLAHDLDKED-------- 635 (686)
Q Consensus 582 Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------------~d-----~~l~~~~~~~~-------- 635 (686)
||++|||++|+.||...... +....+.... .+.+.. ++ ...........
T Consensus 246 G~il~ell~g~~pf~~~~~~--~~~~~~~~~~---~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~ 320 (360)
T 3llt_A 246 GCVLAELYTGSLLFRTHEHM--EHLAMMESII---QPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKC 320 (360)
T ss_dssp HHHHHHHHHSSCSCCCSSHH--HHHHHHHHHT---CCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTC
T ss_pred HHHHHHHHHCCCCCCCCcHH--HHHHHHHHhc---CCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhc
Confidence 99999999999999653322 2222221111 111100 00 00000000000
Q ss_pred -------HHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 636 -------EIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 636 -------~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
....+.+++.+||+.||++|||+.|++++
T Consensus 321 ~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~h 356 (360)
T 3llt_A 321 LPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKH 356 (360)
T ss_dssp CCHHHHCCCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred ccccccchHHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 01457799999999999999999999864
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=337.34 Aligned_cols=244 Identities=23% Similarity=0.332 Sum_probs=195.5
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCCccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCCHH
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLA 451 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL~ 451 (686)
..||+|+||.||++... +++.||+|.+........+.+.+|+.++++++||||+++++++.+.+..++||||+++++|.
T Consensus 15 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 94 (304)
T 2jam_A 15 EVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELF 94 (304)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHH
T ss_pred eeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcCCCccHH
Confidence 46999999999999876 68899999997654444567899999999999999999999999999999999999999999
Q ss_pred HHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeee---cCCCCeEEeecCcccccccccCC
Q 042348 452 TAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILL---GKNMEPHISDFGLARLADIAEET 528 (686)
Q Consensus 452 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl---~~~~~~kl~DfGla~~~~~~~~~ 528 (686)
+++... ..+++..+..++.|++.||+|||+ ++|+||||||+||++ +.++.+||+|||+++......
T Consensus 95 ~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~-- 163 (304)
T 2jam_A 95 DRILER------GVYTEKDASLVIQQVLSAVKYLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI-- 163 (304)
T ss_dssp HHHHHH------SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCBT--
T ss_pred HHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCCc--
Confidence 998754 358999999999999999999999 899999999999999 788999999999987432110
Q ss_pred ccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHH
Q 042348 529 PEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQW 608 (686)
Q Consensus 529 ~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~ 608 (686)
.....||..|+|||.+.+..++.++|||||||++|||++|+.||..... ...
T Consensus 164 -----------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-----~~~ 215 (304)
T 2jam_A 164 -----------------------MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETE-----SKL 215 (304)
T ss_dssp -----------------------THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCH-----HHH
T ss_pred -----------------------cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-----HHH
Confidence 1123467789999999998999999999999999999999999954322 122
Q ss_pred HHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 609 IQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 609 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
...+............ ......+.+++.+||+.||++|||+.|++++
T Consensus 216 ~~~i~~~~~~~~~~~~---------~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (304)
T 2jam_A 216 FEKIKEGYYEFESPFW---------DDISESAKDFICHLLEKDPNERYTCEKALSH 262 (304)
T ss_dssp HHHHHHCCCCCCTTTT---------TTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred HHHHHcCCCCCCcccc---------ccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 3333333222111100 1122467899999999999999999999875
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-40 Score=340.24 Aligned_cols=258 Identities=21% Similarity=0.307 Sum_probs=193.5
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCCc--cchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCC
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGGW--QRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGS 449 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gs 449 (686)
..||+|+||.||+|... +++.||||++..... ...+.+.+|++++++++||||+++++++...+..++||||+++++
T Consensus 9 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 88 (311)
T 4agu_A 9 GKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTV 88 (311)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSEEH
T ss_pred eEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEEeCCCch
Confidence 46999999999999976 488999999865432 224668899999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCc
Q 042348 450 LATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETP 529 (686)
Q Consensus 450 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 529 (686)
|.+++... ..+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++.......
T Consensus 89 l~~~~~~~------~~~~~~~~~~i~~~l~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-- 157 (311)
T 4agu_A 89 LHELDRYQ------RGVPEHLVKSITWQTLQAVNFCHK---HNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD-- 157 (311)
T ss_dssp HHHHHHTS------SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECC------
T ss_pred HHHHHhhh------cCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCccc--
Confidence 99988754 358999999999999999999999 8999999999999999999999999999986542211
Q ss_pred cccccccccCCCCCCCccccccccCCCCCccccCcccccC-CCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHH
Q 042348 530 EVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKV-RKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQW 608 (686)
Q Consensus 530 ~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~ 608 (686)
......+|..|+|||.+.+ ..++.++|||||||++|||++|+.||...... +....
T Consensus 158 ---------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~ 214 (311)
T 4agu_A 158 ---------------------YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDV--DQLYL 214 (311)
T ss_dssp -----------------------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHH
T ss_pred ---------------------ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH--HHHHH
Confidence 1123456788999999876 66899999999999999999999999554322 12222
Q ss_pred HHHHHhhcC-----------Ccc--cccCcccccCC--CcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 609 IQLILEDRK-----------PMT--DILDPFLAHDL--DKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 609 ~~~~~~~~~-----------~~~--~~~d~~l~~~~--~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
+........ ... ...++...... ........+.+++.+||+.||++|||++|++++
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 215 IRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp HHHHHCSCCHHHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred HHHHhcccccccccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 222111100 000 00000000000 001123457899999999999999999999987
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=335.59 Aligned_cols=260 Identities=17% Similarity=0.202 Sum_probs=198.5
Q ss_pred cccCccCceEEEEEEe-CCCceEEEEEcCCCCccchHHHHHHHHHHhccCCCCcceeeEEE-EecCceeEEEeccCCCCH
Q 042348 373 FLLGKSTIGIVYKVAL-NNEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYF-WSVDEKLLIYDYIPNGSL 450 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~-~~~~~~~lV~e~~~~gsL 450 (686)
..||+|+||.||+|.. .+++.||||.+..... ..++.+|++++++++|++++..+.++ ...+..++||||+ +++|
T Consensus 15 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L 91 (296)
T 4hgt_A 15 RKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSL 91 (296)
T ss_dssp EEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCBH
T ss_pred eeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEcc-CCCH
Confidence 4699999999999986 5688999998755432 24688999999999988877776666 5566779999999 9999
Q ss_pred HHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeee---cCCCCeEEeecCcccccccccC
Q 042348 451 ATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILL---GKNMEPHISDFGLARLADIAEE 527 (686)
Q Consensus 451 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl---~~~~~~kl~DfGla~~~~~~~~ 527 (686)
.+++.... ..+++..+..++.|++.||+|||+ ++|+||||||+|||+ +.++.+||+|||+++.......
T Consensus 92 ~~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~ 163 (296)
T 4hgt_A 92 EDLFNFCS-----RKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART 163 (296)
T ss_dssp HHHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTT
T ss_pred HHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCccc
Confidence 99998543 459999999999999999999999 899999999999999 7889999999999987653322
Q ss_pred CccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccch--hH
Q 042348 528 TPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMEL--NI 605 (686)
Q Consensus 528 ~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~--~~ 605 (686)
.... .........||..|+|||.+.+..++.++|||||||++|||++|+.||........ .+
T Consensus 164 ~~~~----------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~ 227 (296)
T 4hgt_A 164 HQHI----------------PYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKY 227 (296)
T ss_dssp CCBC----------------CCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHH
T ss_pred CccC----------------CCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhh
Confidence 1100 00122345678899999999999999999999999999999999999965433221 11
Q ss_pred HHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccccc
Q 042348 606 VQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRVNIS 671 (686)
Q Consensus 606 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~~ 671 (686)
......... .+... ... .....+.+++.+||+.||++|||+.+|++.|+++...
T Consensus 228 ~~~~~~~~~--~~~~~-----~~~-----~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~ 281 (296)
T 4hgt_A 228 ERISEKKMS--TPIEV-----LCK-----GYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 281 (296)
T ss_dssp HHHHHHHHH--SCHHH-----HTT-----TSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHH
T ss_pred hhhhccccc--chhhh-----hhc-----cCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHH
Confidence 111111111 01000 000 0123688999999999999999999999999987643
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=337.46 Aligned_cols=258 Identities=21% Similarity=0.252 Sum_probs=192.5
Q ss_pred cccCccCceEEEEEEe-CCCceEEEEEcCCCC-----ccchHHHHHHHHHHhccC---CCCcceeeEEEEecC-----ce
Q 042348 373 FLLGKSTIGIVYKVAL-NNEEAVAVRRLGNGG-----WQRFKEFQTEAEAIGKIR---HPNIVSLRAYFWSVD-----EK 438 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~---H~nIv~l~~~~~~~~-----~~ 438 (686)
..||+|+||.||+|.. .+++.||||++.... ......+.+|++++++++ ||||+++++++.... ..
T Consensus 15 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~~~~~~~ 94 (308)
T 3g33_A 15 AEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKV 94 (308)
T ss_dssp EEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCSSSEEEE
T ss_pred EEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCCCCceeE
Confidence 4699999999999996 468899999985321 112356778888877775 999999999998765 47
Q ss_pred eEEEeccCCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCc
Q 042348 439 LLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGL 518 (686)
Q Consensus 439 ~lV~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGl 518 (686)
++||||+. |+|.+++..... ..+++.++..|+.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+
T Consensus 95 ~lv~e~~~-~~L~~~~~~~~~----~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~ 166 (308)
T 3g33_A 95 TLVFEHVD-QDLRTYLDKAPP----PGLPAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGTVKLADFGL 166 (308)
T ss_dssp EEEEECCC-CBHHHHHHTCCT----TCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCTTTEEECTTSCEEECSCSC
T ss_pred EEEehhhh-cCHHHHHhhccC----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCEEEeeCcc
Confidence 99999996 699999987643 348999999999999999999999 8999999999999999999999999999
Q ss_pred ccccccccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCcccc
Q 042348 519 ARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQI 598 (686)
Q Consensus 519 a~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~ 598 (686)
++...... ......||..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 167 a~~~~~~~------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 222 (308)
T 3g33_A 167 ARIYSYQM------------------------ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGN 222 (308)
T ss_dssp TTTSTTCC------------------------CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCS
T ss_pred ccccCCCc------------------------ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCC
Confidence 97553211 112345688899999999899999999999999999999999999553
Q ss_pred CccchhHHHHHHHHHhhcC--CcccccC---cccccC-CCc-----HHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 599 GSMELNIVQWIQLILEDRK--PMTDILD---PFLAHD-LDK-----EDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 599 ~~~~~~~~~~~~~~~~~~~--~~~~~~d---~~l~~~-~~~-----~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
... +....+........ .+..... ...... ... .+....+.+++.+||+.||++|||+.|++++
T Consensus 223 ~~~--~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 297 (308)
T 3g33_A 223 SEA--DQLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH 297 (308)
T ss_dssp SHH--HHHHHHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CHH--HHHHHHHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence 322 22222222111100 0000000 000000 000 0123467899999999999999999999875
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=344.06 Aligned_cols=257 Identities=18% Similarity=0.268 Sum_probs=194.4
Q ss_pred hcccCccCceEEEEEEeC-CCceEEEEEcCCC-----CccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEecc
Q 042348 372 AFLLGKSTIGIVYKVALN-NEEAVAVRRLGNG-----GWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYI 445 (686)
Q Consensus 372 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~ 445 (686)
...||+|+||.||+|... +++.||+|++... .....+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 31 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 110 (345)
T 3hko_A 31 KGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELC 110 (345)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEEEEeCC
Confidence 357999999999999875 5788999998543 2344578999999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcCCCc----------------------------------cccCCCCHHHHHHHHHHHHHHHHHHHccCCC
Q 042348 446 PNGSLATAIHGKAGI----------------------------------ISYRPLSWSDRLRIIKGVAKGIAFLHEVSPK 491 (686)
Q Consensus 446 ~~gsL~~~l~~~~~~----------------------------------~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~ 491 (686)
++|+|.+++...... .....+++..+..|+.|++.||+|||+ +
T Consensus 111 ~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~ 187 (345)
T 3hko_A 111 HGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHN---Q 187 (345)
T ss_dssp CSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHHH---T
T ss_pred CCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH---C
Confidence 999999999621100 000124567788999999999999999 8
Q ss_pred CceecCCCCCCeeecCCC--CeEEeecCcccccccccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccC
Q 042348 492 RYVHGDLRPSNILLGKNM--EPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKV 569 (686)
Q Consensus 492 ~iiHrDlkp~NILl~~~~--~~kl~DfGla~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 569 (686)
+|+||||||+||+++.++ .+||+|||+++......... ........||..|+|||.+.+
T Consensus 188 ~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~-------------------~~~~~~~~gt~~y~aPE~~~~ 248 (345)
T 3hko_A 188 GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGE-------------------YYGMTTKAGTPYFVAPEVLNT 248 (345)
T ss_dssp TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC---------------------------CCCGGGCCHHHHTC
T ss_pred CccccCCChhhEEEecCCCceEEEeeccccccccccCccc-------------------cccccccCCCccccCchhhcc
Confidence 999999999999998776 89999999998654322110 011234567888999999865
Q ss_pred --CCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhc
Q 042348 570 --RKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDC 647 (686)
Q Consensus 570 --~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~c 647 (686)
..++.++|||||||++|||++|+.||...... +....+........ .+.. ......+.+++.+|
T Consensus 249 ~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-----~~~~~~~~~~~~~~---~~~~------~~~~~~~~~li~~~ 314 (345)
T 3hko_A 249 TNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDA-----DTISQVLNKKLCFE---NPNY------NVLSPLARDLLSNL 314 (345)
T ss_dssp SSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-----HHHHHHHHCCCCTT---SGGG------GGSCHHHHHHHHHH
T ss_pred CCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCChH-----HHHHHHHhcccccC---Cccc------ccCCHHHHHHHHHH
Confidence 67899999999999999999999999544322 22333333322211 1111 11224678999999
Q ss_pred cccCCCCCCCHHHHHHH
Q 042348 648 VHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 648 l~~dP~~RPs~~ev~~~ 664 (686)
|+.||++||++.|++++
T Consensus 315 l~~~p~~Rps~~~~l~h 331 (345)
T 3hko_A 315 LNRNVDERFDAMRALQH 331 (345)
T ss_dssp SCSCTTTSCCHHHHHHS
T ss_pred cCCChhHCCCHHHHhcC
Confidence 99999999999999875
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-40 Score=337.30 Aligned_cols=252 Identities=23% Similarity=0.317 Sum_probs=197.9
Q ss_pred ccCccCceEEEEEEeC---CCceEEEEEcCCCC--ccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCC
Q 042348 374 LLGKSTIGIVYKVALN---NEEAVAVRRLGNGG--WQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNG 448 (686)
Q Consensus 374 ~iG~G~~g~Vy~~~~~---~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~g 448 (686)
.||+|+||.||+|... .++.||||.+.... ....+++.+|++++++++||||+++++++ ..+..++||||++++
T Consensus 24 ~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~ 102 (291)
T 1xbb_A 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELG 102 (291)
T ss_dssp EEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEEEEECCTTE
T ss_pred ccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEEEEEeCCCC
Confidence 6999999999999643 36789999997643 22356799999999999999999999999 567789999999999
Q ss_pred CHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCC
Q 042348 449 SLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEET 528 (686)
Q Consensus 449 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 528 (686)
+|.+++... ..+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++........
T Consensus 103 ~L~~~l~~~------~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 173 (291)
T 1xbb_A 103 PLNKYLQQN------RHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 173 (291)
T ss_dssp EHHHHHHHC------TTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSE
T ss_pred CHHHHHHhC------cCCCHHHHHHHHHHHHHHHHHHHh---CCeEcCCCCcceEEEeCCCcEEEccCCcceeeccCCCc
Confidence 999999864 358999999999999999999999 89999999999999999999999999999865432210
Q ss_pred ccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCccccCccchhHHH
Q 042348 529 PEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQIGSMELNIVQ 607 (686)
Q Consensus 529 ~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~~~~~~ 607 (686)
........++..|+|||.+.+..++.++||||||+++|||+| |+.||...... .
T Consensus 174 --------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-----~ 228 (291)
T 1xbb_A 174 --------------------YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS-----E 228 (291)
T ss_dssp --------------------EEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-----H
T ss_pred --------------------ccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHH-----H
Confidence 011122345678999999988889999999999999999999 99999553321 1
Q ss_pred HHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccccc
Q 042348 608 WIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRVNIST 672 (686)
Q Consensus 608 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~~~ 672 (686)
....+...... . .. ......+.+++.+||+.||++||++.|+++.|+++-...
T Consensus 229 ~~~~~~~~~~~--~-~~---------~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~ 281 (291)
T 1xbb_A 229 VTAMLEKGERM--G-CP---------AGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 281 (291)
T ss_dssp HHHHHHTTCCC--C-CC---------TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHcCCCC--C-CC---------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHH
Confidence 12222222111 0 00 112346889999999999999999999999999876433
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=334.12 Aligned_cols=260 Identities=17% Similarity=0.198 Sum_probs=198.8
Q ss_pred cccCccCceEEEEEEe-CCCceEEEEEcCCCCccchHHHHHHHHHHhccCCCCcceeeEEE-EecCceeEEEeccCCCCH
Q 042348 373 FLLGKSTIGIVYKVAL-NNEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYF-WSVDEKLLIYDYIPNGSL 450 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~-~~~~~~~lV~e~~~~gsL 450 (686)
..||+|+||.||+|.. .+++.||||++..... .+++.+|+.++++++|++++..+.++ ...+..++||||+ +++|
T Consensus 15 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L 91 (296)
T 3uzp_A 15 RKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSL 91 (296)
T ss_dssp EEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCBH
T ss_pred EEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec-CCCH
Confidence 4699999999999996 5688999999865432 25689999999999988877666665 4566779999999 9999
Q ss_pred HHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeee---cCCCCeEEeecCcccccccccC
Q 042348 451 ATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILL---GKNMEPHISDFGLARLADIAEE 527 (686)
Q Consensus 451 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl---~~~~~~kl~DfGla~~~~~~~~ 527 (686)
.+++.... ..+++..+..++.|++.||+|||+ ++|+||||||+||++ +.++.+||+|||+++.......
T Consensus 92 ~~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~ 163 (296)
T 3uzp_A 92 EDLFNFCS-----RKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART 163 (296)
T ss_dssp HHHHHHTT-----TCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTT
T ss_pred HHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccccc
Confidence 99997543 468999999999999999999999 899999999999999 4888999999999987653322
Q ss_pred CccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccc-hhHH
Q 042348 528 TPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSME-LNIV 606 (686)
Q Consensus 528 ~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~-~~~~ 606 (686)
.... .........||..|+|||.+.+..++.++|||||||++|||++|+.||....... ....
T Consensus 164 ~~~~----------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~ 227 (296)
T 3uzp_A 164 HQHI----------------PYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKY 227 (296)
T ss_dssp CCBC----------------CCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHH
T ss_pred cccc----------------ccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhh
Confidence 1100 0011234567889999999999899999999999999999999999996543221 1111
Q ss_pred HHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccc
Q 042348 607 QWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRVNI 670 (686)
Q Consensus 607 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~ 670 (686)
..+...... .+... +.. .....+.+++.+||+.||++|||+.+|++.|+++..
T Consensus 228 ~~~~~~~~~-~~~~~-----~~~-----~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 280 (296)
T 3uzp_A 228 ERISEKKMS-TPIEV-----LCK-----GYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 280 (296)
T ss_dssp HHHHHHHHH-SCHHH-----HTT-----TSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHH
T ss_pred hhhcccccC-CchHH-----HHh-----hCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHH
Confidence 111111111 11000 000 112357899999999999999999999999998754
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-40 Score=348.06 Aligned_cols=247 Identities=23% Similarity=0.341 Sum_probs=196.3
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCC-CccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCCH
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNG-GWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSL 450 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL 450 (686)
..||+|+||.||+|... ++..||+|++... .....+.+.+|+.++++++||||+++++++...+..++||||+++|+|
T Consensus 39 ~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 118 (360)
T 3eqc_A 39 SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL 118 (360)
T ss_dssp EEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECCCTTCBH
T ss_pred eeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEECCCCCCH
Confidence 46999999999999976 5889999998764 233456789999999999999999999999999999999999999999
Q ss_pred HHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCC-CceecCCCCCCeeecCCCCeEEeecCcccccccccCCc
Q 042348 451 ATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPK-RYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETP 529 (686)
Q Consensus 451 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~-~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 529 (686)
.+++... ..+++..+..++.|++.||+|||+ . +|+||||||+||+++.++.+||+|||+++......
T Consensus 119 ~~~l~~~------~~~~~~~~~~i~~~i~~~l~~lh~---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--- 186 (360)
T 3eqc_A 119 DQVLKKA------GRIPEQILGKVSIAVIKGLTYLRE---KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--- 186 (360)
T ss_dssp HHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHH---HHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHC---
T ss_pred HHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---hCCEEcCCccHHHEEECCCCCEEEEECCCCccccccc---
Confidence 9999765 358999999999999999999998 5 89999999999999999999999999997543211
Q ss_pred cccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHH---
Q 042348 530 EVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIV--- 606 (686)
Q Consensus 530 ~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~--- 606 (686)
.....||..|+|||++.+..++.++|||||||++|||++|+.||......+....
T Consensus 187 ----------------------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~ 244 (360)
T 3eqc_A 187 ----------------------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGC 244 (360)
T ss_dssp --------------------------CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-
T ss_pred ----------------------ccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcc
Confidence 1234567889999999999999999999999999999999999965432221100
Q ss_pred ----------------------------------HHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCC
Q 042348 607 ----------------------------------QWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSP 652 (686)
Q Consensus 607 ----------------------------------~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP 652 (686)
........... + ..........+.+++.+||+.||
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~----~~~~~~~~~~~~~li~~~L~~dP 313 (360)
T 3eqc_A 245 QVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPP-------P----KLPSGVFSLEFQDFVNKCLIKNP 313 (360)
T ss_dssp -----------------------------CCCHHHHHHHHHHSCC-------C----CCCTTTSCHHHHHHHHHHHCSST
T ss_pred cccccCCCCCCCcccCCCcccccccCCCCcccchhhhhHHhccCC-------C----CCCcccccHHHHHHHHHHhhcCh
Confidence 00000000000 0 00001123468899999999999
Q ss_pred CCCCCHHHHHHH
Q 042348 653 DKRPSMRHVCDS 664 (686)
Q Consensus 653 ~~RPs~~ev~~~ 664 (686)
++|||+.|++++
T Consensus 314 ~~Rpt~~ell~h 325 (360)
T 3eqc_A 314 AERADLKQLMVH 325 (360)
T ss_dssp TTSCCHHHHHTS
T ss_pred hhCCCHHHHhhC
Confidence 999999999876
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=331.93 Aligned_cols=247 Identities=24% Similarity=0.337 Sum_probs=197.6
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCC-ccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCCH
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGG-WQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSL 450 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL 450 (686)
..||+|+||.||+|... +++.||||.+.... ....+.+.+|+.++++++||||+++++++.+.+..++||||+++++|
T Consensus 13 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 92 (276)
T 2yex_A 13 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL 92 (276)
T ss_dssp EEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEG
T ss_pred EEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEecCCCcH
Confidence 46999999999999876 68899999986432 23456789999999999999999999999999999999999999999
Q ss_pred HHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCcc
Q 042348 451 ATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPE 530 (686)
Q Consensus 451 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 530 (686)
.+++... ..+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||++.........
T Consensus 93 ~~~l~~~------~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~-- 161 (276)
T 2yex_A 93 FDRIEPD------IGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE-- 161 (276)
T ss_dssp GGGSBTT------TBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE--
T ss_pred HHHHhhc------cCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcch--
Confidence 9998754 358999999999999999999999 89999999999999999999999999999865422110
Q ss_pred ccccccccCCCCCCCccccccccCCCCCccccCcccccCCCC-CCcchHHHHHHHHHHHHhCCCCccccCccchhHHHHH
Q 042348 531 VHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKP-TQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQWI 609 (686)
Q Consensus 531 ~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~ 609 (686)
.......||..|+|||.+.+..+ +.++||||||+++|||++|+.||............+
T Consensus 162 -------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~- 221 (276)
T 2yex_A 162 -------------------RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW- 221 (276)
T ss_dssp -------------------CCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHH-
T ss_pred -------------------hcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHh-
Confidence 11223457888999999987665 779999999999999999999996654333222221
Q ss_pred HHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 610 QLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 610 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
....... .+ .......+.+++.+||+.||++|||+.|++++
T Consensus 222 ---~~~~~~~----~~-------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (276)
T 2yex_A 222 ---KEKKTYL----NP-------WKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (276)
T ss_dssp ---HTTCTTS----TT-------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ---hhccccc----Cc-------hhhcCHHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence 1111110 00 01122357789999999999999999999874
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-40 Score=346.92 Aligned_cols=248 Identities=15% Similarity=0.181 Sum_probs=195.9
Q ss_pred cccCccCceEEEEEE------eCCCceEEEEEcCCCCccchHHHHHHHHHHhccC---CCCcceeeEEEEecCceeEEEe
Q 042348 373 FLLGKSTIGIVYKVA------LNNEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIR---HPNIVSLRAYFWSVDEKLLIYD 443 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~------~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---H~nIv~l~~~~~~~~~~~lV~e 443 (686)
..||+|+||.||+|. ..+++.||||++.... ..++..|++++.+++ |+||+++++++...+..++|||
T Consensus 71 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~~lv~e 147 (365)
T 3e7e_A 71 HLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGE 147 (365)
T ss_dssp EEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCEEEEEC
T ss_pred EEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCCcEEEEe
Confidence 469999999999994 4468899999997643 456778888888886 9999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecC-----------CCCeE
Q 042348 444 YIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGK-----------NMEPH 512 (686)
Q Consensus 444 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~-----------~~~~k 512 (686)
||++|+|.+++...... ....+++..++.|+.||+.||+|||+ ++||||||||+|||++. ++.+|
T Consensus 148 ~~~~g~L~~~l~~~~~~-~~~~l~~~~~~~i~~qi~~~L~~lH~---~~ivHrDiKp~NIll~~~~~~~~~~~~~~~~~k 223 (365)
T 3e7e_A 148 LYSYGTLLNAINLYKNT-PEKVMPQGLVISFAMRMLYMIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLA 223 (365)
T ss_dssp CCCSCBHHHHHHHHHTS-TTCSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECGGGTCC------CTTEE
T ss_pred ccCCCcHHHHHHHhhcc-cccCCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEEecccccCccccccccCCEE
Confidence 99999999999753211 11469999999999999999999999 89999999999999998 89999
Q ss_pred EeecCcccccccccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCC
Q 042348 513 ISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGK 592 (686)
Q Consensus 513 l~DfGla~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~ 592 (686)
|+|||+|+.+...... .......||..|+|||++.+..++.++|||||||++|||+||+
T Consensus 224 l~DFG~a~~~~~~~~~---------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~ 282 (365)
T 3e7e_A 224 LIDLGQSIDMKLFPKG---------------------TIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGT 282 (365)
T ss_dssp ECCCTTCEEGGGSCTT---------------------EEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSS
T ss_pred EeeCchhhhhhccCCC---------------------ceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCC
Confidence 9999999765422110 1223456888999999999999999999999999999999999
Q ss_pred CCccccCccchhHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCC-CCHHHHHHHHhcccc
Q 042348 593 LPMIQIGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKR-PSMRHVCDSLDRVNI 670 (686)
Q Consensus 593 ~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~R-Ps~~ev~~~L~~i~~ 670 (686)
.||........ .....+. .. . ....+.+++..|++.+|.+| |+++++.+.|+++..
T Consensus 283 ~pf~~~~~~~~--------------~~~~~~~----~~-~---~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~ 339 (365)
T 3e7e_A 283 YMKVKNEGGEC--------------KPEGLFR----RL-P---HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQ 339 (365)
T ss_dssp CCCEEEETTEE--------------EECSCCT----TC-S---SHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHH
T ss_pred CccccCCCCce--------------eechhcc----cc-C---cHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHH
Confidence 99954322111 0011111 11 1 12346678889999999999 678888888887643
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=331.93 Aligned_cols=249 Identities=22% Similarity=0.335 Sum_probs=197.5
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCCc------cchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEecc
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGGW------QRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYI 445 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~ 445 (686)
..||+|+||.||+|... +++.||+|.+..... ...+.+.+|+.++++++||||+++++++...+..++||||+
T Consensus 11 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 90 (283)
T 3bhy_A 11 EELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELV 90 (283)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred HhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEEEEEeec
Confidence 46999999999999986 588999999865321 23577999999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCC----CeEEeecCcccc
Q 042348 446 PNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNM----EPHISDFGLARL 521 (686)
Q Consensus 446 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~----~~kl~DfGla~~ 521 (686)
++++|.+++... ..+++.++..++.|++.||+|||+ ++|+||||||+||+++.++ .+||+|||+++.
T Consensus 91 ~~~~L~~~l~~~------~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~ 161 (283)
T 3bhy_A 91 SGGELFDFLAEK------ESLTEDEATQFLKQILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK 161 (283)
T ss_dssp CSCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred CCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCChHHEEEecCCCCCCceEEEeccccee
Confidence 999999999754 458999999999999999999999 8999999999999998877 899999999976
Q ss_pred cccccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCcc
Q 042348 522 ADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSM 601 (686)
Q Consensus 522 ~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~ 601 (686)
..... ......+|..|+|||.+.+..++.++||||||+++|||++|+.||......
T Consensus 162 ~~~~~------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~ 217 (283)
T 3bhy_A 162 IEAGN------------------------EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQ 217 (283)
T ss_dssp CC--------------------------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHH
T ss_pred ccCCC------------------------cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchH
Confidence 53221 112345678899999999889999999999999999999999999553321
Q ss_pred chhHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH--Hhcc
Q 042348 602 ELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS--LDRV 668 (686)
Q Consensus 602 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~--L~~i 668 (686)
.....+....... ++.... .....+.+++.+||+.||++|||+.|++++ ++.+
T Consensus 218 -----~~~~~~~~~~~~~----~~~~~~-----~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 272 (283)
T 3bhy_A 218 -----ETLTNISAVNYDF----DEEYFS-----NTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAI 272 (283)
T ss_dssp -----HHHHHHHTTCCCC----CHHHHT-----TCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHH
T ss_pred -----HHHHHhHhcccCC----cchhcc-----cCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHH
Confidence 1222222221111 111111 112357899999999999999999999985 4444
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=344.34 Aligned_cols=256 Identities=19% Similarity=0.299 Sum_probs=190.9
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCCcc-chHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCCH
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGGWQ-RFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSL 450 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL 450 (686)
..||+|+||.||+|... +++.||||++...... ....+.+|++++++++||||+++++++...+..++||||++ |+|
T Consensus 8 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l 86 (324)
T 3mtl_A 8 DKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD-KDL 86 (324)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEECCS-EEH
T ss_pred EEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecccc-cCH
Confidence 46999999999999976 6889999998654322 22345689999999999999999999999999999999997 599
Q ss_pred HHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCcc
Q 042348 451 ATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPE 530 (686)
Q Consensus 451 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 530 (686)
.+++.... ..+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++......
T Consensus 87 ~~~~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~---- 154 (324)
T 3mtl_A 87 KQYLDDCG-----NIINMHNVKLFLFQLLRGLAYCHR---QKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT---- 154 (324)
T ss_dssp HHHHHHTT-----TCCCHHHHHHHHHHHHHHHHHHHH---TTEEESSCCGGGEEECTTCCEEECSSSEEECC--------
T ss_pred HHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCcCHHHEEECCCCCEEEccCcccccccCCc----
Confidence 99988654 458999999999999999999999 899999999999999999999999999997543211
Q ss_pred ccccccccCCCCCCCccccccccCCCCCccccCcccccC-CCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHHH
Q 042348 531 VHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKV-RKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQWI 609 (686)
Q Consensus 531 ~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~ 609 (686)
.......+|..|+|||++.+ ..++.++|||||||++|||++|+.||..... .+....+
T Consensus 155 -------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~--~~~~~~i 213 (324)
T 3mtl_A 155 -------------------KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTV--EEQLHFI 213 (324)
T ss_dssp ---------------------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHH
T ss_pred -------------------cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHH
Confidence 11123456888999999876 5689999999999999999999999965432 2222223
Q ss_pred HHHHhhcCCcccccCccccc---------C--CC-----cHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 610 QLILEDRKPMTDILDPFLAH---------D--LD-----KEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 610 ~~~~~~~~~~~~~~d~~l~~---------~--~~-----~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
...... +........... . .. .......+.+++.+||+.||++|||+.|++++
T Consensus 214 ~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 282 (324)
T 3mtl_A 214 FRILGT--PTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKH 282 (324)
T ss_dssp HHHHCC--CCTTTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred HHHhCC--CChHhchhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 222221 111111100000 0 00 00122457899999999999999999999886
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-40 Score=341.79 Aligned_cols=257 Identities=25% Similarity=0.388 Sum_probs=198.4
Q ss_pred cccCccCceEEEEEEeC-CCce--EEEEEcCCC-CccchHHHHHHHHHHhcc-CCCCcceeeEEEEecCceeEEEeccCC
Q 042348 373 FLLGKSTIGIVYKVALN-NEEA--VAVRRLGNG-GWQRFKEFQTEAEAIGKI-RHPNIVSLRAYFWSVDEKLLIYDYIPN 447 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~--vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~e~~~~ 447 (686)
..||+|+||.||+|... ++.. ||||.+... .....+.+.+|+++++++ +||||+++++++.+.+..++||||+++
T Consensus 31 ~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 110 (327)
T 1fvr_A 31 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 110 (327)
T ss_dssp EEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCTT
T ss_pred eeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEEEecCCC
Confidence 46999999999999865 4554 599988653 233456789999999999 899999999999999999999999999
Q ss_pred CCHHHHhhcCCCc----------cccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecC
Q 042348 448 GSLATAIHGKAGI----------ISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFG 517 (686)
Q Consensus 448 gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfG 517 (686)
|+|.+++...... .....+++.+++.++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||
T Consensus 111 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~~~~~kL~Dfg 187 (327)
T 1fvr_A 111 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFG 187 (327)
T ss_dssp CBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCEEECCTT
T ss_pred CCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCccceEEEcCCCeEEEcccC
Confidence 9999999865300 011468999999999999999999999 899999999999999999999999999
Q ss_pred cccccccccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCcc
Q 042348 518 LARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMI 596 (686)
Q Consensus 518 la~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~ 596 (686)
+++...... ......++..|+|||.+.+..++.++|||||||++|||+| |+.||.
T Consensus 188 ~~~~~~~~~------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~ 243 (327)
T 1fvr_A 188 LSRGQEVYV------------------------KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYC 243 (327)
T ss_dssp CEESSCEEC------------------------CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred cCccccccc------------------------cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCC
Confidence 987432111 0112334667999999988889999999999999999998 999995
Q ss_pred ccCccchhHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccccch
Q 042348 597 QIGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRVNISTE 673 (686)
Q Consensus 597 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~~~~ 673 (686)
..... .....+.... ... .. ......+.+++.+||+.||++|||+.|++++|+++.....
T Consensus 244 ~~~~~-----~~~~~~~~~~-~~~------~~-----~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 303 (327)
T 1fvr_A 244 GMTCA-----ELYEKLPQGY-RLE------KP-----LNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 303 (327)
T ss_dssp TCCHH-----HHHHHGGGTC-CCC------CC-----TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred CCcHH-----HHHHHhhcCC-CCC------CC-----CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhc
Confidence 43221 1122221111 100 00 0122467899999999999999999999999998765444
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-40 Score=342.85 Aligned_cols=255 Identities=23% Similarity=0.280 Sum_probs=186.4
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCCc--cchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCC
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGGW--QRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGS 449 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gs 449 (686)
..||+|+||.||+|... +++.||||++..... ...+.+.+|++++++++||||+++++++.+.+..++||||++ |+
T Consensus 40 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~ 118 (329)
T 3gbz_A 40 TKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAE-ND 118 (329)
T ss_dssp EEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEEECCS-EE
T ss_pred EEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEEecCC-CC
Confidence 46999999999999865 688999999975432 224567899999999999999999999999999999999997 59
Q ss_pred HHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeec-----CCCCeEEeecCccccccc
Q 042348 450 LATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLG-----KNMEPHISDFGLARLADI 524 (686)
Q Consensus 450 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~-----~~~~~kl~DfGla~~~~~ 524 (686)
|.+++... ..+++..+..|+.|++.||+|||+ ++|+||||||+|||++ .++.+||+|||+++....
T Consensus 119 L~~~~~~~------~~~~~~~~~~i~~ql~~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~ 189 (329)
T 3gbz_A 119 LKKYMDKN------PDVSMRVIKSFLYQLINGVNFCHS---RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGI 189 (329)
T ss_dssp HHHHHHHC------TTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC-
T ss_pred HHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHh---CCEECCCCCHHHEEEecCCCCccceEEECcCCCccccCC
Confidence 99999865 358999999999999999999999 8999999999999994 455699999999986542
Q ss_pred ccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCC-CCCCcchHHHHHHHHHHHHhCCCCccccCccch
Q 042348 525 AEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVR-KPTQKWDIYSYGVILLEMISGKLPMIQIGSMEL 603 (686)
Q Consensus 525 ~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~ 603 (686)
... ......+|..|+|||++.+. .++.++|||||||++|||++|+.||......
T Consensus 190 ~~~-----------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-- 244 (329)
T 3gbz_A 190 PIR-----------------------QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEI-- 244 (329)
T ss_dssp ---------------------------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--
T ss_pred ccc-----------------------ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHH--
Confidence 211 11234567889999998774 4899999999999999999999999553321
Q ss_pred hHHHHHHHHHhhcCCcccccC-----cccccCC------CcH-----HHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 604 NIVQWIQLILEDRKPMTDILD-----PFLAHDL------DKE-----DEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 604 ~~~~~~~~~~~~~~~~~~~~d-----~~l~~~~------~~~-----~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
+....+..... .+...... +...... ... ....++.+++.+||+.||++|||+.|++++
T Consensus 245 ~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 319 (329)
T 3gbz_A 245 DQLFKIFEVLG--LPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEH 319 (329)
T ss_dssp HHHHHHHHHHC--CCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHHHhC--CCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCC
Confidence 11111111111 11000000 0000000 000 022467899999999999999999999874
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-40 Score=335.16 Aligned_cols=245 Identities=24% Similarity=0.403 Sum_probs=192.2
Q ss_pred cccCccCceEEEEEEeCCCceEEEEEcCCCCccchHHHHHHHHHHhccCCCCcceeeEEEEec-CceeEEEeccCCCCHH
Q 042348 373 FLLGKSTIGIVYKVALNNEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSV-DEKLLIYDYIPNGSLA 451 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~-~~~~lV~e~~~~gsL~ 451 (686)
..||+|+||.||++... ++.||||.+.... ..+.+.+|++++++++||||+++++++... +..++||||+++|+|.
T Consensus 27 ~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~ 103 (278)
T 1byg_A 27 QTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLV 103 (278)
T ss_dssp EEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHH
T ss_pred eEEecCCCceEEEEEEc-CCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecCCCCCHH
Confidence 46999999999999875 7899999997643 457799999999999999999999997654 4789999999999999
Q ss_pred HHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCccc
Q 042348 452 TAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEV 531 (686)
Q Consensus 452 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 531 (686)
+++..... ..+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++......
T Consensus 104 ~~l~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~----- 171 (278)
T 1byg_A 104 DYLRSRGR----SVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ----- 171 (278)
T ss_dssp HHHHHHHH----HHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC-------------
T ss_pred HHHHhccc----ccCCHHHHHHHHHHHHHHHHHHHh---CCccccCCCcceEEEeCCCcEEEeeccccccccccc-----
Confidence 99975431 248899999999999999999999 899999999999999999999999999987543211
Q ss_pred cccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCccccCccchhHHHHHH
Q 042348 532 HWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQIGSMELNIVQWIQ 610 (686)
Q Consensus 532 ~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~~~~~~~~~ 610 (686)
....++..|+|||.+.+..++.++||||||+++|||+| |+.||......+ . ..
T Consensus 172 ---------------------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~--~---~~ 225 (278)
T 1byg_A 172 ---------------------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--V---VP 225 (278)
T ss_dssp -------------------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG--H---HH
T ss_pred ---------------------cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH--H---HH
Confidence 11234667999999988889999999999999999998 999996543222 1 11
Q ss_pred HHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccc
Q 042348 611 LILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRVNI 670 (686)
Q Consensus 611 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~ 670 (686)
.+.... . +... ......+.+++.+||+.||++|||+.|+++.|+++..
T Consensus 226 ~~~~~~-~------~~~~-----~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~ 273 (278)
T 1byg_A 226 RVEKGY-K------MDAP-----DGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 273 (278)
T ss_dssp HHTTTC-C------CCCC-----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHhcCC-C------CCCc-----ccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHh
Confidence 221111 1 0010 1123467889999999999999999999999999864
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-40 Score=350.13 Aligned_cols=280 Identities=24% Similarity=0.308 Sum_probs=189.6
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCC--CccchHHHHHHHHHHhccC-CCCcceeeEEEEecC--ceeEEEeccC
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNG--GWQRFKEFQTEAEAIGKIR-HPNIVSLRAYFWSVD--EKLLIYDYIP 446 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~--~~~lV~e~~~ 446 (686)
..||+|+||.||+|... +++.||||++... .....+++.+|+.++.++. ||||+++++++...+ ..++|||||+
T Consensus 15 ~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~ 94 (388)
T 3oz6_A 15 KKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYME 94 (388)
T ss_dssp EC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEEEEECCS
T ss_pred EEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEEEecccC
Confidence 46999999999999865 6889999998653 3344567889999999997 999999999998654 6799999997
Q ss_pred CCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCccccccccc
Q 042348 447 NGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAE 526 (686)
Q Consensus 447 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~ 526 (686)
|+|.+++... .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+|+......
T Consensus 95 -~~L~~~~~~~-------~~~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 163 (388)
T 3oz6_A 95 -TDLHAVIRAN-------ILEPVHKQYVVYQLIKVIKYLHS---GGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIR 163 (388)
T ss_dssp -EEHHHHHHHT-------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEESSSCC
T ss_pred -cCHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHeEEcCCCCEEecCCcccccccccc
Confidence 6999999753 58999999999999999999999 899999999999999999999999999998764321
Q ss_pred CCccccccccccCCCCCCCccccccccCCCCCccccCcccccC-CCCCCcchHHHHHHHHHHHHhCCCCccccCccchhH
Q 042348 527 ETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKV-RKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNI 605 (686)
Q Consensus 527 ~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~ 605 (686)
....... ....................+||..|+|||++.+ ..++.++|||||||++|||++|+.||...... +.
T Consensus 164 ~~~~~~~--~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~--~~ 239 (388)
T 3oz6_A 164 RVTNNIP--LSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTM--NQ 239 (388)
T ss_dssp CCCCCGG--GCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HH
T ss_pred ccccccc--ccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHH--HH
Confidence 1100000 0000000000001122345688999999999876 67899999999999999999999999654321 11
Q ss_pred HHHHHHHHhhcCCccccc----Cc------------------ccccCC-----------CcHHHHHHHHHHHHhccccCC
Q 042348 606 VQWIQLILEDRKPMTDIL----DP------------------FLAHDL-----------DKEDEIVSVLKIALDCVHKSP 652 (686)
Q Consensus 606 ~~~~~~~~~~~~~~~~~~----d~------------------~l~~~~-----------~~~~~~~~l~~l~~~cl~~dP 652 (686)
...+..... .+..+.+ .+ .....+ ........+.+++.+||+.||
T Consensus 240 ~~~i~~~~~--~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP 317 (388)
T 3oz6_A 240 LERIIGVID--FPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNP 317 (388)
T ss_dssp HHHHHHHHC--CCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSG
T ss_pred HHHHHHhcC--CCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCc
Confidence 111111111 0100000 00 000000 000123467899999999999
Q ss_pred CCCCCHHHHHHH--Hhccc
Q 042348 653 DKRPSMRHVCDS--LDRVN 669 (686)
Q Consensus 653 ~~RPs~~ev~~~--L~~i~ 669 (686)
++|||+.|++++ +..+.
T Consensus 318 ~~R~t~~e~l~Hp~~~~~~ 336 (388)
T 3oz6_A 318 NKRISANDALKHPFVSIFH 336 (388)
T ss_dssp GGSCCHHHHTTSTTTTTTC
T ss_pred ccCCCHHHHhCCHHHHHhc
Confidence 999999999988 55554
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=343.46 Aligned_cols=256 Identities=21% Similarity=0.299 Sum_probs=193.0
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCCcc-----chHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccC
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGGWQ-----RFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIP 446 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~ 446 (686)
..||+|+||.||+|... +++.||||++...... ..+.+.+|++++++++||||+++++++.+.+..++||||++
T Consensus 16 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 95 (346)
T 1ua2_A 16 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFME 95 (346)
T ss_dssp EEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCS
T ss_pred eEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceEEEEEcCC
Confidence 46999999999999975 5889999998753221 12468899999999999999999999999999999999997
Q ss_pred CCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCccccccccc
Q 042348 447 NGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAE 526 (686)
Q Consensus 447 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~ 526 (686)
+ +|.+++.... ..+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++......
T Consensus 96 ~-~l~~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 166 (346)
T 1ua2_A 96 T-DLEVIIKDNS-----LVLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN 166 (346)
T ss_dssp E-EHHHHHTTCC-----SSCCSSHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC
T ss_pred C-CHHHHHHhcC-----cCCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCCHHHEEEcCCCCEEEEecccceeccCCc
Confidence 5 8999887654 468899999999999999999999 899999999999999999999999999998653211
Q ss_pred CCccccccccccCCCCCCCccccccccCCCCCccccCcccccCC-CCCCcchHHHHHHHHHHHHhCCCCccccCccchhH
Q 042348 527 ETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVR-KPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNI 605 (686)
Q Consensus 527 ~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~ 605 (686)
. ......+|..|+|||++.+. .++.++|||||||++|||++|..||...... +.
T Consensus 167 ~-----------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~--~~ 221 (346)
T 1ua2_A 167 R-----------------------AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDL--DQ 221 (346)
T ss_dssp C-----------------------CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--HH
T ss_pred c-----------------------cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHH--HH
Confidence 1 11234578889999998654 5899999999999999999999998543321 11
Q ss_pred HHHHHHHHhh-cCCc----cccc---CcccccC---CCc----HHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 042348 606 VQWIQLILED-RKPM----TDIL---DPFLAHD---LDK----EDEIVSVLKIALDCVHKSPDKRPSMRHVCDSL 665 (686)
Q Consensus 606 ~~~~~~~~~~-~~~~----~~~~---d~~l~~~---~~~----~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L 665 (686)
+..+... ..+. .+.. +...... ... ......+.+++.+||+.||++|||+.|++++-
T Consensus 222 ---~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~ 293 (346)
T 1ua2_A 222 ---LTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMK 293 (346)
T ss_dssp ---HHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSG
T ss_pred ---HHHHHHHcCCCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcCh
Confidence 2222221 1110 0000 0000000 000 11234688999999999999999999999863
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=338.95 Aligned_cols=247 Identities=22% Similarity=0.306 Sum_probs=196.2
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCC--CccchHHHHHHHHHHhcc-CCCCcceeeEEEEecCceeEEEeccCCC
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNG--GWQRFKEFQTEAEAIGKI-RHPNIVSLRAYFWSVDEKLLIYDYIPNG 448 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~e~~~~g 448 (686)
+.||+|+||.||+|... +++.||||.+... .......+.+|+.++.++ +||||+++++++...+..++||||+++|
T Consensus 35 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv~e~~~~~ 114 (327)
T 3lm5_A 35 KELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGG 114 (327)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCTTE
T ss_pred ceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEEEEecCCC
Confidence 56999999999999876 5889999998653 233457899999999999 5699999999999999999999999999
Q ss_pred CHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecC---CCCeEEeecCcccccccc
Q 042348 449 SLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGK---NMEPHISDFGLARLADIA 525 (686)
Q Consensus 449 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~---~~~~kl~DfGla~~~~~~ 525 (686)
+|.+++..... ..+++.++..++.|++.||+|||+ ++|+||||||+||+++. ++.+||+|||+++.....
T Consensus 115 ~L~~~~~~~~~----~~~~~~~~~~i~~ql~~~L~~LH~---~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~ 187 (327)
T 3lm5_A 115 EIFSLCLPELA----EMVSENDVIRLIKQILEGVYYLHQ---NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHA 187 (327)
T ss_dssp EGGGGGSSCC-----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC---
T ss_pred cHHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHH---CCeecCcCChHHEEEecCCCCCcEEEeeCccccccCCc
Confidence 99999865432 468999999999999999999999 89999999999999987 789999999999865422
Q ss_pred cCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhH
Q 042348 526 EETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNI 605 (686)
Q Consensus 526 ~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~ 605 (686)
. ......||..|+|||++.+..++.++|||||||++|||++|+.||......+
T Consensus 188 ~------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--- 240 (327)
T 3lm5_A 188 C------------------------ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQE--- 240 (327)
T ss_dssp ------------------------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---
T ss_pred c------------------------ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH---
Confidence 1 1123457888999999999999999999999999999999999995533221
Q ss_pred HHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 606 VQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 606 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
....+............ ......+.+++.+||+.||++|||+.|++++
T Consensus 241 --~~~~i~~~~~~~~~~~~---------~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 241 --TYLNISQVNVDYSEETF---------SSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp --HHHHHHHTCCCCCTTTT---------TTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred --HHHHHHhcccccCchhh---------cccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 12222222111111000 1123357789999999999999999999876
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=345.80 Aligned_cols=253 Identities=22% Similarity=0.325 Sum_probs=189.3
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCC--CccchHHHHHHHHHHhccCCCCcceeeEEEEecC------ceeEEEe
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNG--GWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVD------EKLLIYD 443 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~------~~~lV~e 443 (686)
..||+|+||.||+|... +++.||||++... .....+++.+|++++++++||||+++++++...+ ..++|||
T Consensus 31 ~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~e 110 (367)
T 1cm8_A 31 QPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMP 110 (367)
T ss_dssp EEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEE
T ss_pred EEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCceEEEEEe
Confidence 46999999999999874 6899999998653 2233567899999999999999999999998653 4599999
Q ss_pred ccCCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccc
Q 042348 444 YIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLAD 523 (686)
Q Consensus 444 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~ 523 (686)
|+ +++|.+++.. ..+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++...
T Consensus 111 ~~-~~~L~~~~~~-------~~l~~~~~~~~~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 179 (367)
T 1cm8_A 111 FM-GTDLGKLMKH-------EKLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQAD 179 (367)
T ss_dssp CC-SEEHHHHHHH-------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred cC-CCCHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCcCHHHEEEcCCCCEEEEeeecccccc
Confidence 99 8899999975 248999999999999999999999 899999999999999999999999999998543
Q ss_pred cccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccC-CCCCCcchHHHHHHHHHHHHhCCCCccccCccc
Q 042348 524 IAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKV-RKPTQKWDIYSYGVILLEMISGKLPMIQIGSME 602 (686)
Q Consensus 524 ~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~ 602 (686)
.. .....+|..|+|||++.+ ..++.++||||+||++|||++|+.||.....
T Consensus 180 ~~--------------------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-- 231 (367)
T 1cm8_A 180 SE--------------------------MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDH-- 231 (367)
T ss_dssp SS--------------------------CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH--
T ss_pred cc--------------------------cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCH--
Confidence 11 123467888999999876 6799999999999999999999999954332
Q ss_pred hhHHHHHHHHHhhc-CCccc-------------------ccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHH
Q 042348 603 LNIVQWIQLILEDR-KPMTD-------------------ILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVC 662 (686)
Q Consensus 603 ~~~~~~~~~~~~~~-~~~~~-------------------~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~ 662 (686)
.+. +..+.... .+..+ .....+.... ......+.+++.+||+.||++|||+.|++
T Consensus 232 ~~~---l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ll~~mL~~dP~~R~t~~e~l 306 (367)
T 1cm8_A 232 LDQ---LKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASIL--TNASPLAVNLLEKMLVLDAEQRVTAGEAL 306 (367)
T ss_dssp HHH---HHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTC--TTCCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred HHH---HHHHHHhcCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHC--CCCCHHHHHHHHHHccCChhHCCCHHHHh
Confidence 111 11111110 00000 0000000000 11234678999999999999999999999
Q ss_pred HH--Hhccc
Q 042348 663 DS--LDRVN 669 (686)
Q Consensus 663 ~~--L~~i~ 669 (686)
++ ++.+.
T Consensus 307 ~hp~f~~~~ 315 (367)
T 1cm8_A 307 AHPYFESLH 315 (367)
T ss_dssp HSGGGTTTC
T ss_pred cChHHHhhc
Confidence 86 45544
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=330.75 Aligned_cols=241 Identities=24% Similarity=0.365 Sum_probs=190.2
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCC---ccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCC
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGG---WQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNG 448 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~g 448 (686)
..||+|+||.||+|... +++.||||.+.... ....+.+.+|+.++++++||||+++++++...+..++||||++++
T Consensus 17 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 96 (276)
T 2h6d_A 17 DTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGG 96 (276)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCSC
T ss_pred eeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEEeccCCC
Confidence 46999999999999976 68899999986532 223467899999999999999999999999999999999999999
Q ss_pred CHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCC
Q 042348 449 SLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEET 528 (686)
Q Consensus 449 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 528 (686)
+|.+++... ..+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||++.......
T Consensus 97 ~L~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~-- 165 (276)
T 2h6d_A 97 ELFDYICKH------GRVEEMEARRLFQQILSAVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE-- 165 (276)
T ss_dssp BHHHHHHHH------CSCCHHHHHHHHHHHHHHHHHHHH---HCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC----
T ss_pred cHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCChhhEEECCCCCEEEeecccccccCCCc--
Confidence 999999764 358999999999999999999999 899999999999999999999999999997653221
Q ss_pred ccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCC-CCcchHHHHHHHHHHHHhCCCCccccCccchhHHH
Q 042348 529 PEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKP-TQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQ 607 (686)
Q Consensus 529 ~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~ 607 (686)
......+|..|+|||.+.+..+ +.++||||||+++|||++|+.||..... ..
T Consensus 166 ----------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-----~~ 218 (276)
T 2h6d_A 166 ----------------------FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHV-----PT 218 (276)
T ss_dssp ---------------------------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSH-----HH
T ss_pred ----------------------ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcH-----HH
Confidence 0122356778999999987665 6899999999999999999999954321 22
Q ss_pred HHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 608 WIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 608 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
....+.......+.. ....+.+++.+||+.||++|||+.|++++
T Consensus 219 ~~~~~~~~~~~~~~~-------------~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 219 LFKKIRGGVFYIPEY-------------LNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp HHHHHHHCCCCCCTT-------------SCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred HHHHhhcCcccCchh-------------cCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 233333322221111 12357789999999999999999999985
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=331.96 Aligned_cols=240 Identities=21% Similarity=0.333 Sum_probs=196.2
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCC---ccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCC
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGG---WQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNG 448 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~g 448 (686)
..||+|+||.||+|... +++.||||.+.... ....+.+.+|++++++++||||+++++++.+.+..++||||+++|
T Consensus 20 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 99 (284)
T 2vgo_A 20 RPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRG 99 (284)
T ss_dssp EEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTE
T ss_pred heecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEEEeCCCC
Confidence 46999999999999876 57789999985431 122467899999999999999999999999999999999999999
Q ss_pred CHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCC
Q 042348 449 SLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEET 528 (686)
Q Consensus 449 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 528 (686)
+|.+++... ..+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||++.......
T Consensus 100 ~L~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~-- 168 (284)
T 2vgo_A 100 ELYKELQKH------GRFDEQRSATFMEELADALHYCHE---RKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR-- 168 (284)
T ss_dssp EHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECTTCCEEECCCTTCEECSSSC--
T ss_pred cHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEEcCCCCEEEecccccccCcccc--
Confidence 999999764 358999999999999999999999 899999999999999999999999999986543111
Q ss_pred ccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHH
Q 042348 529 PEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQW 608 (686)
Q Consensus 529 ~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~ 608 (686)
.....|+..|+|||.+.+..++.++||||||+++|||++|+.||...... ..
T Consensus 169 -----------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----~~ 220 (284)
T 2vgo_A 169 -----------------------RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHT-----ET 220 (284)
T ss_dssp -----------------------BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH-----HH
T ss_pred -----------------------cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHh-----HH
Confidence 12345678899999999988999999999999999999999999543321 22
Q ss_pred HHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 609 IQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 609 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
...+.......+.. ....+.+++.+||+.||++|||+.|++++
T Consensus 221 ~~~~~~~~~~~~~~-------------~~~~~~~li~~~l~~~p~~Rps~~~ll~h 263 (284)
T 2vgo_A 221 HRRIVNVDLKFPPF-------------LSDGSKDLISKLLRYHPPQRLPLKGVMEH 263 (284)
T ss_dssp HHHHHTTCCCCCTT-------------SCHHHHHHHHHHSCSSGGGSCCHHHHHTC
T ss_pred HHHHhccccCCCCc-------------CCHHHHHHHHHHhhcCHhhCCCHHHHhhC
Confidence 22333222211111 12357789999999999999999999875
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=337.38 Aligned_cols=246 Identities=23% Similarity=0.365 Sum_probs=194.0
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCCccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCCHH
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLA 451 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL~ 451 (686)
..||+|+||.||+|... +++.||+|.+........+.+.+|++++++++||||+++++++...+..++||||+++++|.
T Consensus 25 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~ 104 (302)
T 2j7t_A 25 GELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVD 104 (302)
T ss_dssp EEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECCTTEEHH
T ss_pred ceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeCCCCcHH
Confidence 36999999999999986 48899999998766666788999999999999999999999999999999999999999999
Q ss_pred HHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCccc
Q 042348 452 TAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEV 531 (686)
Q Consensus 452 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 531 (686)
+++.... ..+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||++.......
T Consensus 105 ~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~----- 171 (302)
T 2j7t_A 105 AIMLELD-----RGLTEPQIQVVCRQMLEALNFLHS---KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL----- 171 (302)
T ss_dssp HHHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH-----
T ss_pred HHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHHHEEECCCCCEEEEECCCCccccccc-----
Confidence 9987643 458999999999999999999999 899999999999999999999999999986432111
Q ss_pred cccccccCCCCCCCccccccccCCCCCccccCcccc-----cCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHH
Q 042348 532 HWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEAS-----KVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIV 606 (686)
Q Consensus 532 ~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~ 606 (686)
.......||..|+|||.+ ....++.++||||||+++|||++|+.||......
T Consensus 172 ------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----- 228 (302)
T 2j7t_A 172 ------------------QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM----- 228 (302)
T ss_dssp ------------------HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHH-----
T ss_pred ------------------cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHH-----
Confidence 011234567889999987 4667899999999999999999999999543321
Q ss_pred HHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 607 QWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 607 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
...........+ .... .......+.+++.+||+.||++|||+.|++++
T Consensus 229 ~~~~~~~~~~~~--~~~~--------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 276 (302)
T 2j7t_A 229 RVLLKIAKSDPP--TLLT--------PSKWSVEFRDFLKIALDKNPETRPSAAQLLEH 276 (302)
T ss_dssp HHHHHHHHSCCC--CCSS--------GGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred HHHHHHhccCCc--ccCC--------ccccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 222222222211 1111 11123467899999999999999999999875
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=330.62 Aligned_cols=242 Identities=24% Similarity=0.382 Sum_probs=191.4
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCC--CccchHHHHHHHHHHhccCCCCcceeeEEEEec----CceeEEEecc
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNG--GWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSV----DEKLLIYDYI 445 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~----~~~~lV~e~~ 445 (686)
..||+|+||.||+|... ++..||+|.+... .....+.+.+|+.++++++||||+++++++... ...++||||+
T Consensus 32 ~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~ 111 (290)
T 1t4h_A 32 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELM 111 (290)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECC
T ss_pred eeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEEEEec
Confidence 36999999999999875 5778999998653 233456789999999999999999999998763 4579999999
Q ss_pred CCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCC--ceecCCCCCCeeec-CCCCeEEeecCccccc
Q 042348 446 PNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKR--YVHGDLRPSNILLG-KNMEPHISDFGLARLA 522 (686)
Q Consensus 446 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~--iiHrDlkp~NILl~-~~~~~kl~DfGla~~~ 522 (686)
++|+|.+++... ..+++..+..|+.|++.||+|||+ ++ |+||||||+||+++ .++.+||+|||++...
T Consensus 112 ~~~~L~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH~---~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~ 182 (290)
T 1t4h_A 112 TSGTLKTYLKRF------KVMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 182 (290)
T ss_dssp CSCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred CCCCHHHHHHHc------cCCCHHHHHHHHHHHHHHHHHHHc---CCCCEEECCCCHHHEEEECCCCCEEEeeCCCcccc
Confidence 999999999764 358999999999999999999999 77 99999999999997 7899999999999643
Q ss_pred ccccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccc
Q 042348 523 DIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSME 602 (686)
Q Consensus 523 ~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~ 602 (686)
... ......||..|+|||.+. ..++.++|||||||++|+|++|+.||......
T Consensus 183 ~~~-------------------------~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~- 235 (290)
T 1t4h_A 183 RAS-------------------------FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNA- 235 (290)
T ss_dssp CTT-------------------------SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH-
T ss_pred ccc-------------------------ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcH-
Confidence 311 112345678899999887 45899999999999999999999999553322
Q ss_pred hhHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 603 LNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 603 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
............+ ...+ .. ....+.+++.+||+.||++|||+.|++++
T Consensus 236 ---~~~~~~~~~~~~~--~~~~----~~-----~~~~l~~li~~~l~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 236 ---AQIYRRVTSGVKP--ASFD----KV-----AIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp ---HHHHHHHTTTCCC--GGGG----GC-----CCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ---HHHHHHHhccCCc--cccC----CC-----CCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 1222222222111 1111 11 12357899999999999999999999864
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-40 Score=354.11 Aligned_cols=246 Identities=21% Similarity=0.307 Sum_probs=185.4
Q ss_pred hcccCccCceEEEEEEeC-CCceEEEEEcCCCC--------ccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEE
Q 042348 372 AFLLGKSTIGIVYKVALN-NEEAVAVRRLGNGG--------WQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIY 442 (686)
Q Consensus 372 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 442 (686)
.+.||+|+||.||+|... +++.||||++.... ......+.+|++++++++||||+++++++. .+..++||
T Consensus 140 ~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~~~~lv~ 218 (419)
T 3i6u_A 140 SKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-AEDYYIVL 218 (419)
T ss_dssp EEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-SSEEEEEE
T ss_pred EeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCceEEEE
Confidence 346999999999999875 57899999986431 112235889999999999999999999975 45679999
Q ss_pred eccCCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCC---CCeEEeecCcc
Q 042348 443 DYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKN---MEPHISDFGLA 519 (686)
Q Consensus 443 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~---~~~kl~DfGla 519 (686)
||+++|+|.+++... ..+++..+..++.|++.||+|||+ ++|+||||||+|||++.+ +.+||+|||++
T Consensus 219 e~~~~g~L~~~l~~~------~~~~~~~~~~i~~qi~~~l~~LH~---~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a 289 (419)
T 3i6u_A 219 ELMEGGELFDKVVGN------KRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHS 289 (419)
T ss_dssp ECCTTCBGGGGTSSS------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSSSCCEEECCSSTT
T ss_pred EcCCCCcHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEecCCCcceEEEeecccc
Confidence 999999999998754 468999999999999999999999 899999999999999754 45999999999
Q ss_pred cccccccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccC---CCCCCcchHHHHHHHHHHHHhCCCCcc
Q 042348 520 RLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKV---RKPTQKWDIYSYGVILLEMISGKLPMI 596 (686)
Q Consensus 520 ~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDVwSlGvvl~elltG~~P~~ 596 (686)
+...... ......||..|+|||++.+ ..++.++|||||||++|||++|+.||.
T Consensus 290 ~~~~~~~------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~ 345 (419)
T 3i6u_A 290 KILGETS------------------------LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFS 345 (419)
T ss_dssp TSCC-----------------------------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred eecCCCc------------------------cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCC
Confidence 8654221 1123467888999999853 568889999999999999999999996
Q ss_pred ccCccchhHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 597 QIGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 597 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
....... +. ..+........ +.... .....+.+++.+||+.||++|||+.|++++
T Consensus 346 ~~~~~~~-~~---~~i~~~~~~~~----~~~~~-----~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 346 EHRTQVS-LK---DQITSGKYNFI----PEVWA-----EVSEKALDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp CCSSSCC-HH---HHHHTTCCCCC----HHHHT-----TSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCcchHH-HH---HHHhcCCCCCC----chhhc-----ccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 5433221 11 11122211110 10000 123467899999999999999999999986
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=341.30 Aligned_cols=258 Identities=23% Similarity=0.307 Sum_probs=198.7
Q ss_pred cccCccCceEEEEEEe------CCCceEEEEEcCCC-CccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEecc
Q 042348 373 FLLGKSTIGIVYKVAL------NNEEAVAVRRLGNG-GWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYI 445 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~ 445 (686)
..||+|+||.||+|.. .++..||||.+... ......++.+|+.++++++||||+++++++...+..++||||+
T Consensus 36 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 115 (327)
T 2yfx_A 36 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELM 115 (327)
T ss_dssp EECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred EEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCcEEEEecC
Confidence 4699999999999984 24678999999754 3344567899999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcCCCcc-ccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecC---CCCeEEeecCcccc
Q 042348 446 PNGSLATAIHGKAGII-SYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGK---NMEPHISDFGLARL 521 (686)
Q Consensus 446 ~~gsL~~~l~~~~~~~-~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~---~~~~kl~DfGla~~ 521 (686)
++|+|.+++....... ....+++.+++.++.|++.||+|||+ ++|+||||||+||+++. +..+||+|||+++.
T Consensus 116 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~---~~i~H~dlkp~NIli~~~~~~~~~kl~Dfg~~~~ 192 (327)
T 2yfx_A 116 AGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARD 192 (327)
T ss_dssp TTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEECCCHHHHH
T ss_pred CCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhh---CCeecCcCCHhHEEEecCCCcceEEECccccccc
Confidence 9999999998654211 11358999999999999999999999 89999999999999984 44699999999975
Q ss_pred cccccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCccccCc
Q 042348 522 ADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQIGS 600 (686)
Q Consensus 522 ~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~ 600 (686)
....... .......+|..|+|||.+.+..++.++||||||+++|||+| |+.||.....
T Consensus 193 ~~~~~~~---------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~ 251 (327)
T 2yfx_A 193 IYRASYY---------------------RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN 251 (327)
T ss_dssp HHC---------------------------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred ccccccc---------------------ccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCH
Confidence 5322110 01122345778999999988889999999999999999998 9999954322
Q ss_pred cchhHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccccc
Q 042348 601 MELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRVNIS 671 (686)
Q Consensus 601 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~~ 671 (686)
......+....... .. ......+.+++.+||+.||++||++.|++++|+.+...
T Consensus 252 -----~~~~~~~~~~~~~~---~~---------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 305 (327)
T 2yfx_A 252 -----QEVLEFVTSGGRMD---PP---------KNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 305 (327)
T ss_dssp -----HHHHHHHHTTCCCC---CC---------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred -----HHHHHHHhcCCCCC---CC---------CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcC
Confidence 12222222221110 00 11223678899999999999999999999999987643
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=355.57 Aligned_cols=244 Identities=25% Similarity=0.375 Sum_probs=196.4
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCC--CccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCC
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNG--GWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGS 449 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gs 449 (686)
..||+|+||.||+|... +++.||||++... .......+.+|++++++++||||+++++++.+.+..++|||||++|+
T Consensus 28 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~ 107 (486)
T 3mwu_A 28 CMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGE 107 (486)
T ss_dssp EEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred EEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEEcCCCCc
Confidence 46999999999999876 6889999998542 22345678999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeec---CCCCeEEeecCccccccccc
Q 042348 450 LATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLG---KNMEPHISDFGLARLADIAE 526 (686)
Q Consensus 450 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~---~~~~~kl~DfGla~~~~~~~ 526 (686)
|.+.+... ..+++..+..|+.|++.||+|||+ ++|+||||||+|||++ .++.+||+|||+++......
T Consensus 108 L~~~~~~~------~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~ 178 (486)
T 3mwu_A 108 LFDEIIKR------KRFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT 178 (486)
T ss_dssp HHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC-
T ss_pred HHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCC
Confidence 99998765 358999999999999999999999 8999999999999995 55679999999997654221
Q ss_pred CCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHH
Q 042348 527 ETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIV 606 (686)
Q Consensus 527 ~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~ 606 (686)
......||+.|+|||++.+ .++.++||||+||++|+|++|+.||..... .
T Consensus 179 ------------------------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~-----~ 228 (486)
T 3mwu_A 179 ------------------------KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE-----Y 228 (486)
T ss_dssp ---------------------------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSH-----H
T ss_pred ------------------------ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----H
Confidence 1123467889999999875 589999999999999999999999954322 2
Q ss_pred HHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 607 QWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 607 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
+....+......... +.. ......+.+++.+||+.||++|||+.|++++
T Consensus 229 ~~~~~i~~~~~~~~~---~~~------~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 229 DILKRVETGKYAFDL---PQW------RTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp HHHHHHHHTCCCSCS---GGG------GGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred HHHHHHHhCCCCCCC---ccc------CCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 223333333222110 111 1122457899999999999999999999986
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=340.62 Aligned_cols=262 Identities=18% Similarity=0.268 Sum_probs=195.9
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCCc--cchHHHHHHHHHHhccCCCCcceeeEEEEec--------CceeEE
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGGW--QRFKEFQTEAEAIGKIRHPNIVSLRAYFWSV--------DEKLLI 441 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--------~~~~lV 441 (686)
..||+|+||.||+|... +++.||||++..... .....+.+|++++++++||||+++++++... +..++|
T Consensus 23 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv 102 (351)
T 3mi9_A 23 AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLV 102 (351)
T ss_dssp EECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------CEEEEE
T ss_pred EEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCCceEEEE
Confidence 46999999999999974 688999999865432 2345788999999999999999999999874 457999
Q ss_pred EeccCCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccc
Q 042348 442 YDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARL 521 (686)
Q Consensus 442 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~ 521 (686)
|||+++ +|.+.+.... ..+++.++..|+.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++.
T Consensus 103 ~e~~~~-~l~~~l~~~~-----~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~ 173 (351)
T 3mi9_A 103 FDFCEH-DLAGLLSNVL-----VKFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLARA 173 (351)
T ss_dssp EECCSE-EHHHHHHCTT-----SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EeccCC-CHHHHHhhcc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCCEEEccchhccc
Confidence 999975 8888877654 458999999999999999999999 8999999999999999999999999999986
Q ss_pred cccccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccC-CCCCCcchHHHHHHHHHHHHhCCCCccccCc
Q 042348 522 ADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKV-RKPTQKWDIYSYGVILLEMISGKLPMIQIGS 600 (686)
Q Consensus 522 ~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvvl~elltG~~P~~~~~~ 600 (686)
......... .......||..|+|||++.+ ..++.++|||||||++|||+||+.||.....
T Consensus 174 ~~~~~~~~~-------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~ 234 (351)
T 3mi9_A 174 FSLAKNSQP-------------------NRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTE 234 (351)
T ss_dssp CCCCSSSSC-------------------CCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred ccccccccc-------------------cccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCCh
Confidence 643221100 12234567889999998876 4589999999999999999999999965332
Q ss_pred cchhHHHHHHHHHhhcCC--cccccCccc-------cc-CCCcHHH------HHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 601 MELNIVQWIQLILEDRKP--MTDILDPFL-------AH-DLDKEDE------IVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 601 ~~~~~~~~~~~~~~~~~~--~~~~~d~~l-------~~-~~~~~~~------~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
......+........+ .....+... .. .....+. ...+.+++.+||+.||++|||+.|++++
T Consensus 235 --~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 235 --QHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp --HHHHHHHHHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred --HHHHHHHHHHhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 2222222222221110 000000000 00 0000111 2347899999999999999999999986
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=339.00 Aligned_cols=258 Identities=21% Similarity=0.326 Sum_probs=193.2
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCCc--cchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCC
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGGW--QRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGS 449 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gs 449 (686)
..||+|+||.||+|... +++.||||++..... ...+.+.+|++++++++||||+++++++.+.+..++||||+++++
T Consensus 31 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 110 (331)
T 4aaa_A 31 GLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTI 110 (331)
T ss_dssp EEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSEEH
T ss_pred eEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEecCCcch
Confidence 46999999999999976 488999999855432 234568899999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCc
Q 042348 450 LATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETP 529 (686)
Q Consensus 450 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 529 (686)
|.+++... ..+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++.......
T Consensus 111 l~~~~~~~------~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-- 179 (331)
T 4aaa_A 111 LDDLELFP------NGLDYQVVQKYLFQIINGIGFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE-- 179 (331)
T ss_dssp HHHHHHST------TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCTTC----------
T ss_pred HHHHHhhc------cCCCHHHHHHHHHHHHHHHHHHHH---CCEEccCcChheEEEcCCCcEEEEeCCCceeecCCcc--
Confidence 99887654 358999999999999999999999 8999999999999999999999999999976542211
Q ss_pred cccccccccCCCCCCCccccccccCCCCCccccCcccccCC-CCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHH
Q 042348 530 EVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVR-KPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQW 608 (686)
Q Consensus 530 ~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~ 608 (686)
......||..|+|||.+.+. .++.++|||||||++|||++|+.||......+ ....
T Consensus 180 ---------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~ 236 (331)
T 4aaa_A 180 ---------------------VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDID--QLYH 236 (331)
T ss_dssp -------------------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHH
T ss_pred ---------------------ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHH--HHHH
Confidence 11234567889999998775 78999999999999999999999995543221 1111
Q ss_pred HHHHH-----------hhcCCcccccCcccccCCCc----HHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 609 IQLIL-----------EDRKPMTDILDPFLAHDLDK----EDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 609 ~~~~~-----------~~~~~~~~~~d~~l~~~~~~----~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
+.... ...........+.+...... +.....+.+++.+||+.||++|||+.|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 307 (331)
T 4aaa_A 237 IMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH 307 (331)
T ss_dssp HHHHHCSCCHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred HHHHhCCCChhhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 11111 11000011111111111000 1123468899999999999999999999876
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-39 Score=355.76 Aligned_cols=244 Identities=23% Similarity=0.351 Sum_probs=193.0
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCC--ccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCC
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGG--WQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGS 449 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gs 449 (686)
..||+|+||.||+|... ++..||||.+.... ......+.+|+.++++++|||||++++++.+.+..++|||||++|+
T Consensus 43 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~ 122 (494)
T 3lij_A 43 KKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGE 122 (494)
T ss_dssp EEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCCSCB
T ss_pred eEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCc
Confidence 46999999999999976 57899999986542 2335678999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecC---CCCeEEeecCccccccccc
Q 042348 450 LATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGK---NMEPHISDFGLARLADIAE 526 (686)
Q Consensus 450 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~---~~~~kl~DfGla~~~~~~~ 526 (686)
|.+.+... ..+++..+..|+.||+.||+|||+ ++|+||||||+|||++. ++.+||+|||+++......
T Consensus 123 L~~~~~~~------~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~ 193 (494)
T 3lij_A 123 LFDEIIHR------MKFNEVDAAVIIKQVLSGVTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK 193 (494)
T ss_dssp HHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTB
T ss_pred HHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCc
Confidence 99988765 358999999999999999999999 89999999999999976 4559999999998654221
Q ss_pred CCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHH
Q 042348 527 ETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIV 606 (686)
Q Consensus 527 ~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~ 606 (686)
......||+.|+|||++. ..++.++||||+||++|+|++|+.||..... .
T Consensus 194 ------------------------~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-----~ 243 (494)
T 3lij_A 194 ------------------------KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTD-----Q 243 (494)
T ss_dssp ------------------------CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----H
T ss_pred ------------------------cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCH-----H
Confidence 112346788899999886 5689999999999999999999999954332 2
Q ss_pred HHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 607 QWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 607 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
+....+........ .+... .....+.+++.+||+.||++|||+.|++++
T Consensus 244 ~~~~~i~~~~~~~~---~~~~~------~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 292 (494)
T 3lij_A 244 EILRKVEKGKYTFD---SPEWK------NVSEGAKDLIKQMLQFDSQRRISAQQALEH 292 (494)
T ss_dssp HHHHHHHHTCCCCC---SGGGT------TSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred HHHHHHHhCCCCCC---chhcc------cCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence 23333333332211 11111 122357799999999999999999999875
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=357.58 Aligned_cols=244 Identities=26% Similarity=0.388 Sum_probs=198.2
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCC---ccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCC
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGG---WQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNG 448 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~g 448 (686)
..||+|+||.||+|... +++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++||||+.+|
T Consensus 32 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~ 111 (484)
T 3nyv_A 32 RVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGG 111 (484)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred eEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecCCCC
Confidence 46999999999999976 68899999985432 334577999999999999999999999999999999999999999
Q ss_pred CHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeee---cCCCCeEEeecCcccccccc
Q 042348 449 SLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILL---GKNMEPHISDFGLARLADIA 525 (686)
Q Consensus 449 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl---~~~~~~kl~DfGla~~~~~~ 525 (686)
+|.+++... ..+++..+..|+.|++.||+|||+ ++|+||||||+|||+ +.++.+||+|||+++.....
T Consensus 112 ~L~~~~~~~------~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~ 182 (484)
T 3nyv_A 112 ELFDEIISR------KRFSEVDAARIIRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS 182 (484)
T ss_dssp BHHHHHHTC------SCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCC
T ss_pred CHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccc
Confidence 999999765 358999999999999999999999 899999999999999 56789999999999865422
Q ss_pred cCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhH
Q 042348 526 EETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNI 605 (686)
Q Consensus 526 ~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~ 605 (686)
. ......||+.|+|||++.+ .++.++||||+||++|+|++|+.||.....
T Consensus 183 ~------------------------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~----- 232 (484)
T 3nyv_A 183 K------------------------KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANE----- 232 (484)
T ss_dssp C------------------------SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----
T ss_pred c------------------------ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCH-----
Confidence 1 1123457888999999876 689999999999999999999999954332
Q ss_pred HHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 606 VQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 606 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
.+....+........ .+.. ......+.+++.+||+.||++|||+.|++++
T Consensus 233 ~~~~~~i~~~~~~~~---~~~~------~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 282 (484)
T 3nyv_A 233 YDILKKVEKGKYTFE---LPQW------KKVSESAKDLIRKMLTYVPSMRISARDALDH 282 (484)
T ss_dssp HHHHHHHHHCCCCCC---SGGG------GGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHHcCCCCCC---Cccc------ccCCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence 222333333322211 0111 1123467899999999999999999999875
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-39 Score=341.17 Aligned_cols=245 Identities=23% Similarity=0.395 Sum_probs=195.8
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCCc--------cchHHHHHHHHHHhcc-CCCCcceeeEEEEecCceeEEE
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGGW--------QRFKEFQTEAEAIGKI-RHPNIVSLRAYFWSVDEKLLIY 442 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~ 442 (686)
..||+|+||.||+|... +|+.||||++..... ...+.+.+|+.+++++ +||||+++++++...+..++||
T Consensus 100 ~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~ 179 (365)
T 2y7j_A 100 DVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVF 179 (365)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSSEEEEEE
T ss_pred eEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCCEEEEEE
Confidence 57999999999999986 689999999865421 1135678999999999 7999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCccccc
Q 042348 443 DYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLA 522 (686)
Q Consensus 443 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~ 522 (686)
||+++++|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||++..+
T Consensus 180 e~~~g~~L~~~l~~~------~~l~~~~~~~i~~qi~~~L~~LH~---~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~ 250 (365)
T 2y7j_A 180 DLMRKGELFDYLTEK------VALSEKETRSIMRSLLEAVSFLHA---NNIVHRDLKPENILLDDNMQIRLSDFGFSCHL 250 (365)
T ss_dssp CCCTTCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EeCCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEEEecCccccc
Confidence 999999999999754 358999999999999999999999 89999999999999999999999999999765
Q ss_pred ccccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccC------CCCCCcchHHHHHHHHHHHHhCCCCcc
Q 042348 523 DIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKV------RKPTQKWDIYSYGVILLEMISGKLPMI 596 (686)
Q Consensus 523 ~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~sDVwSlGvvl~elltG~~P~~ 596 (686)
.... ......||..|+|||++.+ ..++.++|||||||++|||++|+.||.
T Consensus 251 ~~~~------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~ 306 (365)
T 2y7j_A 251 EPGE------------------------KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFW 306 (365)
T ss_dssp CTTC------------------------CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSC
T ss_pred CCCc------------------------ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCC
Confidence 4221 1123467888999998753 358899999999999999999999995
Q ss_pred ccCccchhHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 597 QIGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 597 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
.... ......+........ .+... .....+.+++.+||+.||++|||+.|++++
T Consensus 307 ~~~~-----~~~~~~i~~~~~~~~---~~~~~------~~~~~~~~li~~~L~~dP~~Rps~~ell~h 360 (365)
T 2y7j_A 307 HRRQ-----ILMLRMIMEGQYQFS---SPEWD------DRSSTVKDLISRLLQVDPEARLTAEQALQH 360 (365)
T ss_dssp CSSH-----HHHHHHHHHTCCCCC---HHHHS------SSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCCH-----HHHHHHHHhCCCCCC---Ccccc------cCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 4321 122222332221111 01000 112357899999999999999999999874
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-41 Score=356.09 Aligned_cols=239 Identities=16% Similarity=0.175 Sum_probs=182.4
Q ss_pred cccCccCceEEEEEEe-CCCceEEEEEcCCC---CccchHHHHHHH---HHHhccCCCCcceee-------EEEEecCc-
Q 042348 373 FLLGKSTIGIVYKVAL-NNEEAVAVRRLGNG---GWQRFKEFQTEA---EAIGKIRHPNIVSLR-------AYFWSVDE- 437 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~---~~l~~l~H~nIv~l~-------~~~~~~~~- 437 (686)
..||+|+||.||+|.. .+++.||||++... .....+.+.+|+ +++++++|||||+++ +++...+.
T Consensus 79 ~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~ 158 (377)
T 3byv_A 79 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKK 158 (377)
T ss_dssp EEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEECTTSC
T ss_pred ceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhhccCCc
Confidence 4699999999999996 46899999998632 333457789999 555666899999998 66665532
Q ss_pred ----------------eeEEEeccCCCCHHHHhhcCCCccc-cCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCC
Q 042348 438 ----------------KLLIYDYIPNGSLATAIHGKAGIIS-YRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRP 500 (686)
Q Consensus 438 ----------------~~lV~e~~~~gsL~~~l~~~~~~~~-~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp 500 (686)
.++||||+ +|+|.+++........ ...+++..+..|+.||+.||+|||+ ++|+||||||
T Consensus 159 ~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrDikp 234 (377)
T 3byv_A 159 KMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGLVHTYLRP 234 (377)
T ss_dssp SEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHH---TTEECSCCCG
T ss_pred cccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHh---CCeecCCCCH
Confidence 78999999 6899999986421100 1234568889999999999999999 8999999999
Q ss_pred CCeeecCCCCeEEeecCcccccccccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCC----------
Q 042348 501 SNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVR---------- 570 (686)
Q Consensus 501 ~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---------- 570 (686)
+|||++.++.+||+|||+|+.... ......| ..|+|||++.+.
T Consensus 235 ~NIll~~~~~~kL~DFG~a~~~~~--------------------------~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~ 287 (377)
T 3byv_A 235 VDIVLDQRGGVFLTGFEHLVRDGA--------------------------RVVSSVS-RGFEPPELEARRATISYHRDRR 287 (377)
T ss_dssp GGEEECTTCCEEECCGGGCEETTC--------------------------EEECCCC-TTCCCHHHHHHHTSTHHHHCCE
T ss_pred HHEEEcCCCCEEEEechhheecCC--------------------------cccCCCC-cCccChhhhccccccccccccc
Confidence 999999999999999999984321 1122345 679999999877
Q ss_pred -CCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccc
Q 042348 571 -KPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVH 649 (686)
Q Consensus 571 -~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~ 649 (686)
.++.++|||||||++|||++|+.||........ ...+... . . .....+.+++.+||+
T Consensus 288 ~~~~~~~DvwSlG~il~elltg~~Pf~~~~~~~~---------------~~~~~~~-~-~-----~~~~~~~~li~~~L~ 345 (377)
T 3byv_A 288 TLMTFSFDAWALGLVIYWIWCADLPITKDAALGG---------------SEWIFRS-C-K-----NIPQPVRALLEGFLR 345 (377)
T ss_dssp EECCHHHHHHHHHHHHHHHHHSSCCC------CC---------------SGGGGSS-C-C-----CCCHHHHHHHHHHTC
T ss_pred ccCChhhhHHHHHHHHHHHHHCCCCCcccccccc---------------hhhhhhh-c-c-----CCCHHHHHHHHHHcC
Confidence 799999999999999999999999954322110 1111110 0 0 112357889999999
Q ss_pred cCCCCCCCHHHHHHH
Q 042348 650 KSPDKRPSMRHVCDS 664 (686)
Q Consensus 650 ~dP~~RPs~~ev~~~ 664 (686)
.||++|||+.|++++
T Consensus 346 ~dp~~Rpt~~e~l~h 360 (377)
T 3byv_A 346 YPKEDRLLPLQAMET 360 (377)
T ss_dssp SSGGGCCCHHHHHTS
T ss_pred CCchhCCCHHHHhhC
Confidence 999999999999874
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-39 Score=333.53 Aligned_cols=244 Identities=24% Similarity=0.394 Sum_probs=193.8
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCCccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCCHH
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLA 451 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL~ 451 (686)
..||+|+||.||+|... +++.||||.+.... ..+.+.+|+.++++++||||+++++++...+..++||||+++|+|.
T Consensus 35 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 112 (314)
T 3com_A 35 EKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVS 112 (314)
T ss_dssp EECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEHH
T ss_pred eeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecCCCCCHH
Confidence 46999999999999876 48899999987643 3467899999999999999999999999999999999999999999
Q ss_pred HHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCccc
Q 042348 452 TAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEV 531 (686)
Q Consensus 452 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 531 (686)
+++.... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++........
T Consensus 113 ~~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~---- 180 (314)
T 3com_A 113 DIIRLRN-----KTLTEDEIATILQSTLKGLEYLHF---MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA---- 180 (314)
T ss_dssp HHHHHHT-----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBS----
T ss_pred HHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHh---CCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhcc----
Confidence 9997433 468999999999999999999999 8999999999999999999999999999976532211
Q ss_pred cccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHHHHH
Q 042348 532 HWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQWIQL 611 (686)
Q Consensus 532 ~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~ 611 (686)
......||..|+|||.+.+..++.++||||||+++|||++|+.||...... .....
T Consensus 181 -------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----~~~~~ 236 (314)
T 3com_A 181 -------------------KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPM-----RAIFM 236 (314)
T ss_dssp -------------------CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHH-----HHHHH
T ss_pred -------------------ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChH-----HHHHH
Confidence 112345778899999999888999999999999999999999999543321 11112
Q ss_pred HHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 612 ILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 612 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
......+ ....+ ......+.+++.+||+.||++|||+.|++++
T Consensus 237 ~~~~~~~--~~~~~--------~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (314)
T 3com_A 237 IPTNPPP--TFRKP--------ELWSDNFTDFVKQCLVKSPEQRATATQLLQH 279 (314)
T ss_dssp HHHSCCC--CCSSG--------GGSCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred HhcCCCc--ccCCc--------ccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 2222111 11011 1122467899999999999999999999875
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-39 Score=331.15 Aligned_cols=243 Identities=23% Similarity=0.401 Sum_probs=198.4
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCC-ccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCCH
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGG-WQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSL 450 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL 450 (686)
..||+|+||.||+|... +++.||||.+.... ....+.+.+|+.++++++||||+++++++...+..++||||+++++|
T Consensus 28 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 107 (303)
T 3a7i_A 28 EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSA 107 (303)
T ss_dssp EEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEH
T ss_pred hhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEeCCCCcH
Confidence 46999999999999865 58899999986543 33457899999999999999999999999999999999999999999
Q ss_pred HHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCcc
Q 042348 451 ATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPE 530 (686)
Q Consensus 451 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 530 (686)
.+++.. ..+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||++........
T Consensus 108 ~~~~~~-------~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~--- 174 (303)
T 3a7i_A 108 LDLLEP-------GPLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI--- 174 (303)
T ss_dssp HHHHTT-------SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBC---
T ss_pred HHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCChheEEECCCCCEEEeecccceecCcccc---
Confidence 999864 358999999999999999999999 8999999999999999999999999999976542211
Q ss_pred ccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHHHH
Q 042348 531 VHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQWIQ 610 (686)
Q Consensus 531 ~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~ 610 (686)
......||..|+|||.+.+..++.++||||||+++|||++|+.||...... ....
T Consensus 175 --------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----~~~~ 229 (303)
T 3a7i_A 175 --------------------KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPM-----KVLF 229 (303)
T ss_dssp --------------------CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-----HHHH
T ss_pred --------------------ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHH-----HHHH
Confidence 112345788899999999889999999999999999999999999543221 1122
Q ss_pred HHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 042348 611 LILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSL 665 (686)
Q Consensus 611 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L 665 (686)
.+.....+ .+... ....+.+++.+||+.||++|||+.|++++.
T Consensus 230 ~~~~~~~~-------~~~~~-----~~~~l~~li~~~l~~dp~~Rps~~~ll~~~ 272 (303)
T 3a7i_A 230 LIPKNNPP-------TLEGN-----YSKPLKEFVEACLNKEPSFRPTAKELLKHK 272 (303)
T ss_dssp HHHHSCCC-------CCCSS-----CCHHHHHHHHHHCCSSGGGSCCHHHHTTCH
T ss_pred HhhcCCCC-------CCccc-----cCHHHHHHHHHHcCCChhhCcCHHHHhhCh
Confidence 22222111 11111 123578999999999999999999998864
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=332.67 Aligned_cols=252 Identities=20% Similarity=0.305 Sum_probs=196.7
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCC--ccchHHHHHHHHHHhccCCCCcceeeEEEEe--cCceeEEEeccCC
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGG--WQRFKEFQTEAEAIGKIRHPNIVSLRAYFWS--VDEKLLIYDYIPN 447 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~--~~~~~lV~e~~~~ 447 (686)
..||+|+||.||++... +++.||+|.+.... ....+.+.+|++++++++||||+++++++.. .+..++||||+++
T Consensus 12 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~ 91 (279)
T 2w5a_A 12 YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEG 91 (279)
T ss_dssp EEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEEEECCTT
T ss_pred hhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEEEeCCCC
Confidence 46999999999999876 68899999986542 3345678999999999999999999998864 5678999999999
Q ss_pred CCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCC-----ceecCCCCCCeeecCCCCeEEeecCccccc
Q 042348 448 GSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKR-----YVHGDLRPSNILLGKNMEPHISDFGLARLA 522 (686)
Q Consensus 448 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~-----iiHrDlkp~NILl~~~~~~kl~DfGla~~~ 522 (686)
|+|.+++...... ...+++..+..++.|++.||+|||+ ++ |+||||||+||+++.++.+||+|||+++..
T Consensus 92 ~~L~~~l~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~---~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~~~ 166 (279)
T 2w5a_A 92 GDLASVITKGTKE--RQYLDEEFVLRVMTQLTLALKECHR---RSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL 166 (279)
T ss_dssp EEHHHHHHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHH---HC------CCCCCSGGGEEECSSSCEEECCCCHHHHC
T ss_pred CCHHHHHHhhccc--CCCCCHHHHHHHHHHHHHHHHHHhc---ccCCCCeeEEeccchhhEEEcCCCCEEEecCchheee
Confidence 9999999754211 1358999999999999999999999 66 999999999999999999999999999865
Q ss_pred ccccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccc
Q 042348 523 DIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSME 602 (686)
Q Consensus 523 ~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~ 602 (686)
..... ......||..|+|||.+.+..++.++||||||+++|||++|+.||.....
T Consensus 167 ~~~~~-----------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-- 221 (279)
T 2w5a_A 167 NHDTS-----------------------FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ-- 221 (279)
T ss_dssp ---CH-----------------------HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSH--
T ss_pred ccccc-----------------------cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCH--
Confidence 42110 11123467789999999988899999999999999999999999954432
Q ss_pred hhHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 042348 603 LNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRVN 669 (686)
Q Consensus 603 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~ 669 (686)
......+.....+ . +. . .....+.+++.+||+.||++|||+.||++++....
T Consensus 222 ---~~~~~~i~~~~~~--~-~~----~-----~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~ 273 (279)
T 2w5a_A 222 ---KELAGKIREGKFR--R-IP----Y-----RYSDELNEIITRMLNLKDYHRPSVEEILENPLILE 273 (279)
T ss_dssp ---HHHHHHHHHTCCC--C-CC----T-----TSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCG
T ss_pred ---HHHHHHHhhcccc--c-CC----c-----ccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhh
Confidence 1222233332211 1 01 0 12236788999999999999999999998776543
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=351.13 Aligned_cols=264 Identities=21% Similarity=0.293 Sum_probs=181.3
Q ss_pred hcccCccCceEEEEEEeC---CCceEEEEEcCCCCccchHHHHHHHHHHhccCCCCcceeeEEEEe--cCceeEEEeccC
Q 042348 372 AFLLGKSTIGIVYKVALN---NEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWS--VDEKLLIYDYIP 446 (686)
Q Consensus 372 ~~~iG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~--~~~~~lV~e~~~ 446 (686)
+..||+|+||.||+|... +++.||||++..... ...+.+|++++++++|||||++++++.. ....++||||++
T Consensus 26 g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~ 103 (405)
T 3rgf_A 26 GCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 103 (405)
T ss_dssp SCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC--CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEECCS
T ss_pred CcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC--CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeCCC
Confidence 346999999999999975 478899999976432 3578899999999999999999999965 567899999996
Q ss_pred CCCHHHHhhcCCCc---cccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeee----cCCCCeEEeecCcc
Q 042348 447 NGSLATAIHGKAGI---ISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILL----GKNMEPHISDFGLA 519 (686)
Q Consensus 447 ~gsL~~~l~~~~~~---~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl----~~~~~~kl~DfGla 519 (686)
|+|.+++...... .....+++..++.|+.||+.||+|||+ ++|+||||||+|||+ +.++.+||+|||+|
T Consensus 104 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a 179 (405)
T 3rgf_A 104 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFA 179 (405)
T ss_dssp -EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECCSSTTTTCEEECCTTCC
T ss_pred -CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCEeCCCcCHHHeEEecCCCCCCcEEEEECCCc
Confidence 5888887632210 011358999999999999999999999 899999999999999 67889999999999
Q ss_pred cccccccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCC-CCCCcchHHHHHHHHHHHHhCCCCcccc
Q 042348 520 RLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVR-KPTQKWDIYSYGVILLEMISGKLPMIQI 598 (686)
Q Consensus 520 ~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlGvvl~elltG~~P~~~~ 598 (686)
+........ ........||..|+|||++.+. .++.++|||||||++|||++|+.||...
T Consensus 180 ~~~~~~~~~--------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 239 (405)
T 3rgf_A 180 RLFNSPLKP--------------------LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 239 (405)
T ss_dssp C------------------------------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCC
T ss_pred eecCCCCcc--------------------cccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCc
Confidence 865422110 0122345678899999998774 5899999999999999999999999543
Q ss_pred Cccc-------hhHHHHHHHHHhhcCCcccccCccccc-----------------CCCcHH--------HHHHHHHHHHh
Q 042348 599 GSME-------LNIVQWIQLILEDRKPMTDILDPFLAH-----------------DLDKED--------EIVSVLKIALD 646 (686)
Q Consensus 599 ~~~~-------~~~~~~~~~~~~~~~~~~~~~d~~l~~-----------------~~~~~~--------~~~~l~~l~~~ 646 (686)
.... .+....+..... .+..... +.+.. ...... ....+.+++.+
T Consensus 240 ~~~~~~~~~~~~~~l~~i~~~~g--~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~ 316 (405)
T 3rgf_A 240 QEDIKTSNPYHHDQLDRIFNVMG--FPADKDW-EDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQK 316 (405)
T ss_dssp C------CCCCHHHHHHHHHHHC--CCCTTTC-GGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHH
T ss_pred cccccccccchHHHHHHHHHhhC--CCChhhc-chhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHH
Confidence 3210 111111111111 0100000 00000 000000 02357799999
Q ss_pred ccccCCCCCCCHHHHHHH
Q 042348 647 CVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 647 cl~~dP~~RPs~~ev~~~ 664 (686)
||+.||++|||+.|++++
T Consensus 317 ~L~~dP~~R~ta~e~L~h 334 (405)
T 3rgf_A 317 LLTMDPIKRITSEQAMQD 334 (405)
T ss_dssp HSCSSGGGSCCHHHHHTS
T ss_pred HccCCcccCCCHHHHhcC
Confidence 999999999999999987
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-40 Score=336.37 Aligned_cols=254 Identities=24% Similarity=0.385 Sum_probs=191.6
Q ss_pred cccCccCceEEEEEEeC--CCc--eEEEEEcCCC---CccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEecc
Q 042348 373 FLLGKSTIGIVYKVALN--NEE--AVAVRRLGNG---GWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYI 445 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~--~~~--~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~ 445 (686)
..||+|+||.||+|.+. ++. .||||.++.. .....+++.+|++++++++||||+++++++...+ .++||||+
T Consensus 24 ~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~e~~ 102 (291)
T 1u46_A 24 EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MKMVTELA 102 (291)
T ss_dssp EECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CEEEEECC
T ss_pred eeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ceeeEecc
Confidence 46999999999999863 233 6899988654 2234577899999999999999999999998654 88999999
Q ss_pred CCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccc
Q 042348 446 PNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIA 525 (686)
Q Consensus 446 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~ 525 (686)
++|+|.+++.... ..+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++.....
T Consensus 103 ~~~~L~~~l~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 174 (291)
T 1u46_A 103 PLGSLLDRLRKHQ-----GHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQN 174 (291)
T ss_dssp TTCBHHHHHHHHG-----GGSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-
T ss_pred cCCCHHHHHHhcc-----CCcCHHHHHHHHHHHHHHHHHHHh---CCcccCCCchheEEEcCCCCEEEcccccccccccc
Confidence 9999999998653 358999999999999999999999 89999999999999999999999999999865432
Q ss_pred cCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCccccCccchh
Q 042348 526 EETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQIGSMELN 604 (686)
Q Consensus 526 ~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~~~ 604 (686)
... ........+|..|+|||.+.+..++.++||||||+++|||++ |+.||.....
T Consensus 175 ~~~--------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---- 230 (291)
T 1u46_A 175 DDH--------------------YVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG---- 230 (291)
T ss_dssp CCE--------------------EEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH----
T ss_pred ccc--------------------hhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCH----
Confidence 210 011123445778999999988888999999999999999999 9999954432
Q ss_pred HHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccccc
Q 042348 605 IVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRVNIS 671 (686)
Q Consensus 605 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~~ 671 (686)
.+....+......... .......+.+++.+||+.||++|||+.++++.|+++...
T Consensus 231 -~~~~~~~~~~~~~~~~-----------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 285 (291)
T 1u46_A 231 -SQILHKIDKEGERLPR-----------PEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPT 285 (291)
T ss_dssp -HHHHHHHHTSCCCCCC-----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred -HHHHHHHHccCCCCCC-----------CcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCcc
Confidence 2223333322211110 011234688999999999999999999999999988743
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=330.65 Aligned_cols=240 Identities=20% Similarity=0.255 Sum_probs=190.2
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCC--CccchHHHHHHHHHHhcc-CCCCcceeeEEEEecCceeEEEeccCCC
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNG--GWQRFKEFQTEAEAIGKI-RHPNIVSLRAYFWSVDEKLLIYDYIPNG 448 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~e~~~~g 448 (686)
..||+|+||.||+|... +++.||||++... ......++.+|+..+.++ +||||+++++++.+.+..++||||+++|
T Consensus 17 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 96 (289)
T 1x8b_A 17 EKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGG 96 (289)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEEECCTTC
T ss_pred hhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEEecCCC
Confidence 46999999999999976 6899999998653 233456788999999999 9999999999999999999999999999
Q ss_pred CHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCC-------------------C
Q 042348 449 SLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKN-------------------M 509 (686)
Q Consensus 449 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~-------------------~ 509 (686)
+|.+++...... ...+++..+..|+.|++.||+|||+ ++|+||||||+||+++.+ .
T Consensus 97 ~L~~~l~~~~~~--~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~ 171 (289)
T 1x8b_A 97 SLADAISENYRI--MSYFKEAELKDLLLQVGRGLRYIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKV 171 (289)
T ss_dssp BHHHHHHHHHHH--TCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEC--------------------CC
T ss_pred cHHHHHHhhccc--ccCCCHHHHHHHHHHHHHHHHHHHh---CCEeecCCCHHHEEEcCCCCCcccccccccccccCCce
Confidence 999999764211 1358999999999999999999999 899999999999999844 4
Q ss_pred CeEEeecCcccccccccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCC-CCCCcchHHHHHHHHHHH
Q 042348 510 EPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVR-KPTQKWDIYSYGVILLEM 588 (686)
Q Consensus 510 ~~kl~DfGla~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlGvvl~el 588 (686)
.+||+|||.++..... ....||..|+|||.+.+. .++.++|||||||++|||
T Consensus 172 ~~kl~Dfg~~~~~~~~---------------------------~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l 224 (289)
T 1x8b_A 172 MFKIGDLGHVTRISSP---------------------------QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCA 224 (289)
T ss_dssp CEEECCCTTCEETTCS---------------------------CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHH
T ss_pred EEEEcccccccccCCc---------------------------cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHH
Confidence 7999999998755321 123467789999998765 567899999999999999
Q ss_pred HhCCCCccccCccchhHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 589 ISGKLPMIQIGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 589 ltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
++|..|+... .. ...+..... .. +... ....+.+++.+||+.||++|||+.|++++
T Consensus 225 ~~~~~~~~~~-----~~---~~~~~~~~~--~~-----~~~~-----~~~~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 225 AGAEPLPRNG-----DQ---WHEIRQGRL--PR-----IPQV-----LSQEFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp TTCCCCCSSS-----HH---HHHHHTTCC--CC-----CSSC-----CCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred hcCCCCCcch-----hH---HHHHHcCCC--CC-----CCcc-----cCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 9999776321 11 112222211 11 1111 12357889999999999999999999875
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-39 Score=334.64 Aligned_cols=253 Identities=19% Similarity=0.276 Sum_probs=192.7
Q ss_pred cccCccCceEEEEEEe-CCCceEEEEEcCCCCccchHHHHHHHHHHhccC-CCCcceeeEEEEe--cCceeEEEeccCCC
Q 042348 373 FLLGKSTIGIVYKVAL-NNEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIR-HPNIVSLRAYFWS--VDEKLLIYDYIPNG 448 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~--~~~~~lV~e~~~~g 448 (686)
+.||+|+||.||+|.. .+++.||||.+... ..+.+.+|++++++++ ||||+++++++.. ....++||||++++
T Consensus 42 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~ 118 (330)
T 3nsz_A 42 RKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNT 118 (330)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEECCCCC
T ss_pred EEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEeccCch
Confidence 4699999999999986 46889999999753 3467899999999997 9999999999988 56789999999999
Q ss_pred CHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCC-CeEEeecCcccccccccC
Q 042348 449 SLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNM-EPHISDFGLARLADIAEE 527 (686)
Q Consensus 449 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~-~~kl~DfGla~~~~~~~~ 527 (686)
+|.+++. .+++.++..++.|++.||+|||+ ++|+||||||+|||++.++ .+||+|||+++.......
T Consensus 119 ~l~~~~~---------~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~ 186 (330)
T 3nsz_A 119 DFKQLYQ---------TLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE 186 (330)
T ss_dssp CHHHHGG---------GCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTCC
T ss_pred hHHHHHH---------hCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCCc
Confidence 9999884 37899999999999999999999 8999999999999999776 899999999986542211
Q ss_pred CccccccccccCCCCCCCccccccccCCCCCccccCcccccC-CCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHH
Q 042348 528 TPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKV-RKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIV 606 (686)
Q Consensus 528 ~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~ 606 (686)
.....+|..|+|||.+.+ ..++.++|||||||++|||++|+.||.........+.
T Consensus 187 ------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~ 242 (330)
T 3nsz_A 187 ------------------------YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV 242 (330)
T ss_dssp ------------------------CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHH
T ss_pred ------------------------cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHH
Confidence 123456778999999877 6789999999999999999999999955433322222
Q ss_pred HHHHHH---------HhhcCCcccccC--------cc---cccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 607 QWIQLI---------LEDRKPMTDILD--------PF---LAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 607 ~~~~~~---------~~~~~~~~~~~d--------~~---l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
...... ...........+ .. .............+.+++.+||+.||++|||++|++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 320 (330)
T 3nsz_A 243 RIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320 (330)
T ss_dssp HHHHHHCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred HHHHhcCCchhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 111110 000000000000 00 00000011123568899999999999999999999875
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-39 Score=354.45 Aligned_cols=244 Identities=23% Similarity=0.333 Sum_probs=193.7
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCCc-------------cchHHHHHHHHHHhccCCCCcceeeEEEEecCce
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGGW-------------QRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEK 438 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~ 438 (686)
..||+|+||.||+|... +++.||||++..... ...+.+.+|+.++++++||||+++++++.+.+..
T Consensus 42 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 121 (504)
T 3q5i_A 42 RKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYF 121 (504)
T ss_dssp EEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred eEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEE
Confidence 46999999999999976 578999999865321 2346789999999999999999999999999999
Q ss_pred eEEEeccCCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCC---CeEEee
Q 042348 439 LLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNM---EPHISD 515 (686)
Q Consensus 439 ~lV~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~---~~kl~D 515 (686)
++|||||++|+|.+++... ..+++..+..|+.||+.||+|||+ ++|+||||||+|||++.++ .+||+|
T Consensus 122 ~lv~e~~~gg~L~~~l~~~------~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~D 192 (504)
T 3q5i_A 122 YLVTEFYEGGELFEQIINR------HKFDECDAANIMKQILSGICYLHK---HNIVHRDIKPENILLENKNSLLNIKIVD 192 (504)
T ss_dssp EEEEECCTTCBHHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESSTTCCSSEEECC
T ss_pred EEEEecCCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCcHHHEEEecCCCCccEEEEE
Confidence 9999999999999998764 358999999999999999999999 8999999999999998775 699999
Q ss_pred cCcccccccccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCc
Q 042348 516 FGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPM 595 (686)
Q Consensus 516 fGla~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~ 595 (686)
||+++...... ......||+.|+|||++. ..++.++||||+||++|+|++|+.||
T Consensus 193 fg~a~~~~~~~------------------------~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf 247 (504)
T 3q5i_A 193 FGLSSFFSKDY------------------------KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPF 247 (504)
T ss_dssp CTTCEECCTTS------------------------CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred CCCCEEcCCCC------------------------ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCC
Confidence 99998654221 112346788899999987 46899999999999999999999999
Q ss_pred cccCccchhHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 596 IQIGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 596 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
..... .+.+..+......... +.. ......+.+++.+||+.||.+|||+.|++++
T Consensus 248 ~~~~~-----~~~~~~i~~~~~~~~~---~~~------~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h 302 (504)
T 3q5i_A 248 GGQND-----QDIIKKVEKGKYYFDF---NDW------KNISDEAKELIKLMLTYDYNKRCTAEEALNS 302 (504)
T ss_dssp CCSSH-----HHHHHHHHHCCCCCCH---HHH------TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCCCH-----HHHHHHHHcCCCCCCc---ccc------CCCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 54332 2223333333221110 000 0112357899999999999999999999876
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=355.14 Aligned_cols=209 Identities=19% Similarity=0.308 Sum_probs=149.7
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCC--CccchHHHHHHHHHHhccCCCCcceeeEEEEec-----CceeEEEec
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNG--GWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSV-----DEKLLIYDY 444 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~-----~~~~lV~e~ 444 (686)
..||+|+||.||+|... +++.||||++... .....+++.+|+++|++++|||||++++++... +..++||||
T Consensus 59 ~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~ 138 (458)
T 3rp9_A 59 HLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEI 138 (458)
T ss_dssp CC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEECC
T ss_pred eEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceEEEEEec
Confidence 46999999999999865 6889999998653 333457789999999999999999999999543 568999999
Q ss_pred cCCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCccccccc
Q 042348 445 IPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADI 524 (686)
Q Consensus 445 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~ 524 (686)
+ +|+|.+++... ..+++..+..|+.||+.||+|||+ ++||||||||+|||++.++.+||+|||+|+....
T Consensus 139 ~-~~~L~~~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~---~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~ 208 (458)
T 3rp9_A 139 A-DSDFKKLFRTP------VYLTELHIKTLLYNLLVGVKYVHS---AGILHRDLKPANCLVNQDCSVKVCDFGLARTVDY 208 (458)
T ss_dssp C-SEEHHHHHHSS------CCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTS
T ss_pred c-ccchhhhcccC------CCCCHHHHHHHHHHHHHHHHHHHh---CCcCCCCCChhhEEECCCCCEeecccccchhccC
Confidence 8 57999999764 459999999999999999999999 8999999999999999999999999999987653
Q ss_pred ccCCccccccc-cccC---CCCCCCccccccccCCCCCccccCcccc-cCCCCCCcchHHHHHHHHHHHHhC
Q 042348 525 AEETPEVHWEQ-STTG---TPLQSSPYEFTALNSTTSRSYYQAPEAS-KVRKPTQKWDIYSYGVILLEMISG 591 (686)
Q Consensus 525 ~~~~~~~~~~~-~~~g---~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~sDVwSlGvvl~elltG 591 (686)
........... .... ................+||..|+|||++ ....++.++|||||||++|||++|
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 209 PENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp CTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred ccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 32110000000 0000 0000000001233456789999999976 556799999999999999999993
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=348.46 Aligned_cols=260 Identities=18% Similarity=0.245 Sum_probs=199.6
Q ss_pred cccCccCceEEEEEEe-CCCceEEEEEcCCCCccchHHHHHHHHHHhccCC-CCcceeeEEEEecCceeEEEeccCCCCH
Q 042348 373 FLLGKSTIGIVYKVAL-NNEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRH-PNIVSLRAYFWSVDEKLLIYDYIPNGSL 450 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H-~nIv~l~~~~~~~~~~~lV~e~~~~gsL 450 (686)
..||+|+||.||+|.. .+++.||||++..... ..++.+|+++++.++| ++|+.+..++...+..++||||+ +++|
T Consensus 13 ~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~-g~sL 89 (483)
T 3sv0_A 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSL 89 (483)
T ss_dssp CCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC-CCBH
T ss_pred EEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC-CCCH
Confidence 3699999999999986 4688999998765432 2468899999999976 56666666777778889999999 9999
Q ss_pred HHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeee---cCCCCeEEeecCcccccccccC
Q 042348 451 ATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILL---GKNMEPHISDFGLARLADIAEE 527 (686)
Q Consensus 451 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl---~~~~~~kl~DfGla~~~~~~~~ 527 (686)
.+++.... ..+++.+++.|+.||+.||+|||+ ++||||||||+|||+ +.++.+||+|||+++.+.....
T Consensus 90 ~~ll~~~~-----~~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 161 (483)
T 3sv0_A 90 EDLFNFCS-----RKLSLKTVLMLADQMINRVEFVHS---KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST 161 (483)
T ss_dssp HHHHHHTT-----TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTT
T ss_pred HHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCcc
Confidence 99998543 469999999999999999999999 899999999999999 6889999999999987653321
Q ss_pred CccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHH
Q 042348 528 TPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQ 607 (686)
Q Consensus 528 ~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~ 607 (686)
.... .+.......||..|+|||++.+..++.++|||||||++|||++|+.||........ ..
T Consensus 162 ~~~~----------------~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~--~~ 223 (483)
T 3sv0_A 162 HQHI----------------PYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK--KQ 223 (483)
T ss_dssp CCBC----------------CCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSH--HH
T ss_pred cccc----------------ccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhH--HH
Confidence 1100 01122346788999999999999999999999999999999999999965443221 11
Q ss_pred HHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 042348 608 WIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRVN 669 (686)
Q Consensus 608 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~ 669 (686)
.+..+..... ..... .+.. ....++.+++..||+.+|++||++.+|++.|+++.
T Consensus 224 ~~~~i~~~~~--~~~~~-~l~~-----~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~ 277 (483)
T 3sv0_A 224 KYEKISEKKV--ATSIE-ALCR-----GYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLF 277 (483)
T ss_dssp HHHHHHHHHH--HSCHH-HHHT-----TSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred HHHHHhhccc--cccHH-HHhc-----CCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence 1222211110 00000 0000 11246889999999999999999999999998874
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-39 Score=346.58 Aligned_cols=191 Identities=20% Similarity=0.298 Sum_probs=164.6
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCCccchHHHHHHHHHHhcc------CCCCcceeeEEEEecCceeEEEecc
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGGWQRFKEFQTEAEAIGKI------RHPNIVSLRAYFWSVDEKLLIYDYI 445 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l------~H~nIv~l~~~~~~~~~~~lV~e~~ 445 (686)
..||+|+||.||+|... +++.||||++.... ...+++.+|+++++.+ .|+||+++++++...+..++||||+
T Consensus 103 ~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~ 181 (429)
T 3kvw_A 103 KVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK-RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELL 181 (429)
T ss_dssp EEEEESSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEEEEECCC
T ss_pred EEcccCccEEEEEEEECCCCcEEEEEEECCcc-chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEEEEEecc
Confidence 47999999999999865 47899999997642 2345678899888887 5779999999999999999999999
Q ss_pred CCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCC--eEEeecCcccccc
Q 042348 446 PNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNME--PHISDFGLARLAD 523 (686)
Q Consensus 446 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~--~kl~DfGla~~~~ 523 (686)
. ++|.+++..... ..+++..+..|+.||+.||+|||+ ++|+||||||+|||++.++. +||+|||+++...
T Consensus 182 ~-~~L~~~l~~~~~----~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~ 253 (429)
T 3kvw_A 182 S-MNLYELIKKNKF----QGFSLPLVRKFAHSILQCLDALHK---NRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEH 253 (429)
T ss_dssp C-CBHHHHHHHTTT----CCCCHHHHHHHHHHHHHHHHHHHH---HTEECSCCSGGGEEESSTTSCCEEECCCTTCEETT
T ss_pred C-CCHHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEEccCCCcceEEeecccceecC
Confidence 5 699999986542 458999999999999999999999 89999999999999999887 9999999997532
Q ss_pred cccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCcccc
Q 042348 524 IAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQI 598 (686)
Q Consensus 524 ~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~ 598 (686)
.. .....||..|+|||++.+..++.++|||||||++|||+||+.||...
T Consensus 254 ~~--------------------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~ 302 (429)
T 3kvw_A 254 QR--------------------------VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGE 302 (429)
T ss_dssp CC--------------------------CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred Cc--------------------------ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCC
Confidence 11 12346788899999999989999999999999999999999999654
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=335.00 Aligned_cols=255 Identities=21% Similarity=0.287 Sum_probs=196.6
Q ss_pred cccCccCceEEEEEEe--CCCceEEEEEcCCCCccchHHHHHHHHHHhccCCC------CcceeeEEEEecCceeEEEec
Q 042348 373 FLLGKSTIGIVYKVAL--NNEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHP------NIVSLRAYFWSVDEKLLIYDY 444 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~------nIv~l~~~~~~~~~~~lV~e~ 444 (686)
..||+|+||.||+|.. .+++.||||++.... ...+.+.+|++++++++|+ +|+++++++...+..++||||
T Consensus 20 ~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~ 98 (339)
T 1z57_A 20 DTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD-RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFEL 98 (339)
T ss_dssp EEEEEETTEEEEEEEETTTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEEEEEEEC
T ss_pred EEEecCCCeEEEEEEecCCCCcEEEEEEEecCC-chhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcEEEEEcC
Confidence 4699999999999986 357899999997543 3346788999999998765 499999999999999999999
Q ss_pred cCCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecC-----------------
Q 042348 445 IPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGK----------------- 507 (686)
Q Consensus 445 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~----------------- 507 (686)
+ +++|.+++..... ..+++..+..++.|++.||+|||+ ++|+||||||+|||++.
T Consensus 99 ~-~~~l~~~l~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~ 170 (339)
T 1z57_A 99 L-GLSTYDFIKENGF----LPFRLDHIRKMAYQICKSVNFLHS---NKLTHTDLKPENILFVQSDYTEAYNPKIKRDERT 170 (339)
T ss_dssp C-CCBHHHHHHHTTT----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESCCCEEEEEC----CEEEE
T ss_pred C-CCCHHHHHHhcCC----CCCcHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHEEEeccccccccCCcccccccc
Confidence 9 8899999986542 368999999999999999999999 89999999999999987
Q ss_pred --CCCeEEeecCcccccccccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHH
Q 042348 508 --NMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVIL 585 (686)
Q Consensus 508 --~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl 585 (686)
++.+||+|||+++..... .....||..|+|||++.+..++.++|||||||++
T Consensus 171 ~~~~~~kl~Dfg~~~~~~~~--------------------------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il 224 (339)
T 1z57_A 171 LINPDIKVVDFGSATYDDEH--------------------------HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCIL 224 (339)
T ss_dssp ESCCCEEECCCSSCEETTSC--------------------------CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHH
T ss_pred ccCCCceEeeCcccccCccc--------------------------cccccCCccccChHHhhCCCCCcchhhHHHHHHH
Confidence 678999999999753311 1234578889999999998999999999999999
Q ss_pred HHHHhCCCCccccCccchhHHHHHHHHHhhcCC-------ccc---------------------ccCcccccCCCcHHHH
Q 042348 586 LEMISGKLPMIQIGSMELNIVQWIQLILEDRKP-------MTD---------------------ILDPFLAHDLDKEDEI 637 (686)
Q Consensus 586 ~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~-------~~~---------------------~~d~~l~~~~~~~~~~ 637 (686)
|||++|+.||...... +....+......... ... ...+............
T Consensus 225 ~el~~g~~pf~~~~~~--~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (339)
T 1z57_A 225 IEYYLGFTVFPTHDSK--EHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEH 302 (339)
T ss_dssp HHHHHSSCSCCCSCHH--HHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHH
T ss_pred HHHHhCCCCCCCCChH--HHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhH
Confidence 9999999999654322 222222222111000 000 0000000011123456
Q ss_pred HHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 638 VSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 638 ~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
..+.+++.+||+.||++|||+.|++++
T Consensus 303 ~~l~~li~~~L~~dP~~Rpt~~ell~h 329 (339)
T 1z57_A 303 ERLFDLIQKMLEYDPAKRITLREALKH 329 (339)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred HHHHHHHHHHhCcCcccccCHHHHhcC
Confidence 678999999999999999999999876
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=328.85 Aligned_cols=245 Identities=20% Similarity=0.291 Sum_probs=191.5
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCC----ccchHHHHHHHHHHhccCCCCcceeeEEEE--ecCceeEEEecc
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGG----WQRFKEFQTEAEAIGKIRHPNIVSLRAYFW--SVDEKLLIYDYI 445 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~--~~~~~~lV~e~~ 445 (686)
..||+|+||.||++... +++.||+|.+.... ....+.+.+|++++++++||||+++++++. +.+..++||||+
T Consensus 11 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~ 90 (305)
T 2wtk_C 11 DLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYC 90 (305)
T ss_dssp CEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEEEEEECC
T ss_pred eEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEEEEehhc
Confidence 46999999999999975 57899999987532 233567999999999999999999999985 445789999999
Q ss_pred CCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccc
Q 042348 446 PNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIA 525 (686)
Q Consensus 446 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~ 525 (686)
+++ |.+++..... ..+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++.....
T Consensus 91 ~~~-l~~~~~~~~~----~~~~~~~~~~~~~qi~~al~~LH~---~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~ 162 (305)
T 2wtk_C 91 VCG-MQEMLDSVPE----KRFPVCQAHGYFCQLIDGLEYLHS---QGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPF 162 (305)
T ss_dssp SEE-HHHHHHHSTT----CSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECCTT
T ss_pred cCC-HHHHHHhCcc----cccCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCcccEEEcCCCcEEeeccccccccCcc
Confidence 876 7777765432 468999999999999999999999 89999999999999999999999999999865422
Q ss_pred cCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCC--CCCcchHHHHHHHHHHHHhCCCCccccCccch
Q 042348 526 EETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRK--PTQKWDIYSYGVILLEMISGKLPMIQIGSMEL 603 (686)
Q Consensus 526 ~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~ 603 (686)
... .......||..|+|||++.+.. ++.++||||||+++|||++|+.||....
T Consensus 163 ~~~---------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---- 217 (305)
T 2wtk_C 163 AAD---------------------DTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN---- 217 (305)
T ss_dssp CSS---------------------CEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSS----
T ss_pred ccc---------------------cccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCch----
Confidence 110 1112345788899999987644 3779999999999999999999995432
Q ss_pred hHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 604 NIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 604 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
.......+......... .....+.+++.+||+.||++|||+.|++++
T Consensus 218 -~~~~~~~i~~~~~~~~~-------------~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 218 -IYKLFENIGKGSYAIPG-------------DCGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp -HHHHHHHHHHCCCCCCS-------------SSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred -HHHHHHHHhcCCCCCCC-------------ccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 22223333333222111 112357789999999999999999999976
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=346.58 Aligned_cols=248 Identities=13% Similarity=0.057 Sum_probs=174.2
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCCc---cchHHHHHHHHHHhcc--CCCCcceee-------EEEEecC---
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGGW---QRFKEFQTEAEAIGKI--RHPNIVSLR-------AYFWSVD--- 436 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l--~H~nIv~l~-------~~~~~~~--- 436 (686)
..||+|+||.||+|... +++.||||++..... ...+.+.+|+.+++.+ +||||++++ +++...+
T Consensus 68 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~~~~~~ 147 (371)
T 3q60_A 68 EPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPP 147 (371)
T ss_dssp EEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEETTSCS
T ss_pred eeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheecCCCCC
Confidence 46999999999999975 688999999977532 3345677885544444 699988755 4554332
Q ss_pred --------------ceeEEEeccCCCCHHHHhhcCCCccccCCCCHHHH------HHHHHHHHHHHHHHHccCCCCceec
Q 042348 437 --------------EKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDR------LRIIKGVAKGIAFLHEVSPKRYVHG 496 (686)
Q Consensus 437 --------------~~~lV~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~------~~i~~~ia~gL~~LH~~~~~~iiHr 496 (686)
..++|||||+ |+|.+++.... ..+++..+ ..++.||+.||+|||+ ++|+||
T Consensus 148 ~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-----~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~---~~ivHr 218 (371)
T 3q60_A 148 FAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD-----FVYVFRGDEGILALHILTAQLIRLAANLQS---KGLVHG 218 (371)
T ss_dssp SSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH-----HSCCCCHHHHHHHHHHHHHHHHHHHHHHHH---TTEEET
T ss_pred eeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc-----cccchhhhhhhhhHHHHHHHHHHHHHHHHH---CCCccC
Confidence 3799999998 89999998653 23566666 7888999999999999 899999
Q ss_pred CCCCCCeeecCCCCeEEeecCcccccccccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccC--CCCCC
Q 042348 497 DLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKV--RKPTQ 574 (686)
Q Consensus 497 Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~ 574 (686)
||||+|||++.++.+||+|||+|+...... ....+|..|+|||++.+ ..++.
T Consensus 219 Dikp~NIll~~~~~~kL~DFG~a~~~~~~~--------------------------~~~~~t~~y~aPE~~~~~~~~~~~ 272 (371)
T 3q60_A 219 HFTPDNLFIMPDGRLMLGDVSALWKVGTRG--------------------------PASSVPVTYAPREFLNASTATFTH 272 (371)
T ss_dssp TCSGGGEEECTTSCEEECCGGGEEETTCEE--------------------------EGGGSCGGGCCHHHHTCSEEECCH
T ss_pred cCCHHHEEECCCCCEEEEecceeeecCCCc--------------------------cCccCCcCCcChhhccCCCCCcCc
Confidence 999999999999999999999998543211 12334578999999987 67999
Q ss_pred cchHHHHHHHHHHHHhCCCCccccCccchhHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCC
Q 042348 575 KWDIYSYGVILLEMISGKLPMIQIGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDK 654 (686)
Q Consensus 575 ~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~ 654 (686)
++|||||||++|||+||+.||.......... ................. ........+.+++.+||+.||++
T Consensus 273 ~~DiwSlG~il~elltg~~Pf~~~~~~~~~~--------~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~ 343 (371)
T 3q60_A 273 ALNAWQLGLSIYRVWCLFLPFGLVTPGIKGS--------WKRPSLRVPGTDSLAFG-SCTPLPDFVKTLIGRFLNFDRRR 343 (371)
T ss_dssp HHHHHHHHHHHHHHHHSSCSTTBCCTTCTTC--------CCBCCTTSCCCCSCCCT-TSSCCCHHHHHHHHHHTCSSTTT
T ss_pred cccHHHHHHHHHHHHhCCCCCCCcCcccccc--------hhhhhhhhccccccchh-hccCCCHHHHHHHHHHcCCChhh
Confidence 9999999999999999999996543221100 00000000000000000 00112346889999999999999
Q ss_pred CCCHHHHHHH
Q 042348 655 RPSMRHVCDS 664 (686)
Q Consensus 655 RPs~~ev~~~ 664 (686)
|||+.|++++
T Consensus 344 Rpt~~e~l~h 353 (371)
T 3q60_A 344 RLLPLEAMET 353 (371)
T ss_dssp CCCHHHHTTS
T ss_pred CCCHHHHhcC
Confidence 9999999864
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-39 Score=337.91 Aligned_cols=260 Identities=19% Similarity=0.264 Sum_probs=181.9
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCCccchHHHHHHHHHHhccC-CCCcceeeEEEEe--------cCceeEEE
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIR-HPNIVSLRAYFWS--------VDEKLLIY 442 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~--------~~~~~lV~ 442 (686)
..||+|+||.||+|... +++.||||++........+.+.+|+.++.++. ||||+++++++.. ....++||
T Consensus 34 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~ 113 (337)
T 3ll6_A 34 RVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLT 113 (337)
T ss_dssp EEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEEEEEEE
T ss_pred EEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCceEEEEE
Confidence 46999999999999975 68899999986665556678999999999996 9999999999953 23478999
Q ss_pred eccCCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCC--ceecCCCCCCeeecCCCCeEEeecCccc
Q 042348 443 DYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKR--YVHGDLRPSNILLGKNMEPHISDFGLAR 520 (686)
Q Consensus 443 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~--iiHrDlkp~NILl~~~~~~kl~DfGla~ 520 (686)
||+. |+|.+++...... ..+++.+++.|+.|++.||+|||+ ++ |+||||||+|||++.++.+||+|||+++
T Consensus 114 e~~~-g~L~~~l~~~~~~---~~~~~~~~~~i~~qi~~~l~~LH~---~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~ 186 (337)
T 3ll6_A 114 ELCK-GQLVEFLKKMESR---GPLSCDTVLKIFYQTCRAVQHMHR---QKPPIIHRDLKVENLLLSNQGTIKLCDFGSAT 186 (337)
T ss_dssp ECCS-EEHHHHHHHHHTT---CSCCHHHHHHHHHHHHHHHHHHHT---SSSCCBCCCCCGGGCEECTTSCEEBCCCTTCB
T ss_pred EecC-CCHHHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHh---CCCCEEEccCCcccEEECCCCCEEEecCccce
Confidence 9995 7999988752211 469999999999999999999999 77 9999999999999999999999999998
Q ss_pred ccccccCCccccccccccCCCCCCCccccccccCCCCCccccCcccc---cCCCCCCcchHHHHHHHHHHHHhCCCCccc
Q 042348 521 LADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEAS---KVRKPTQKWDIYSYGVILLEMISGKLPMIQ 597 (686)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~sDVwSlGvvl~elltG~~P~~~ 597 (686)
............. ............+|..|+|||++ .+..++.++|||||||++|||++|+.||..
T Consensus 187 ~~~~~~~~~~~~~-----------~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~ 255 (337)
T 3ll6_A 187 TISHYPDYSWSAQ-----------RRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFED 255 (337)
T ss_dssp CCSSCC------------------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC--
T ss_pred eccccCccccccc-----------ccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcc
Confidence 7653221100000 00000111234578889999998 566789999999999999999999999953
Q ss_pred cCccchhHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccc
Q 042348 598 IGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRVNI 670 (686)
Q Consensus 598 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~ 670 (686)
..... .......... ... ....+.+++.+||+.||++|||+.|++++|+.+..
T Consensus 256 ~~~~~---------~~~~~~~~~~------~~~-----~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~ 308 (337)
T 3ll6_A 256 GAKLR---------IVNGKYSIPP------HDT-----QYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAA 308 (337)
T ss_dssp -------------------CCCCT------TCC-----SSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hhHHH---------hhcCcccCCc------ccc-----cchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 22111 1111111000 000 11236689999999999999999999999998764
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-39 Score=340.86 Aligned_cols=251 Identities=23% Similarity=0.294 Sum_probs=186.2
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCC--CccchHHHHHHHHHHhccCCCCcceeeEEEEecC------ceeEEEe
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNG--GWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVD------EKLLIYD 443 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~------~~~lV~e 443 (686)
..||+|+||.||+|... +++.||||++... .....+.+.+|+.++++++||||+++++++...+ ..++|||
T Consensus 31 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~lv~e 110 (371)
T 2xrw_A 31 KPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVME 110 (371)
T ss_dssp EEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCEEEEEEE
T ss_pred eeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccceEEEEE
Confidence 46999999999999865 5889999998653 2334567889999999999999999999998665 6799999
Q ss_pred ccCCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccc
Q 042348 444 YIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLAD 523 (686)
Q Consensus 444 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~ 523 (686)
|++ |+|.+.+. ..+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 111 ~~~-~~l~~~~~--------~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~ 178 (371)
T 2xrw_A 111 LMD-ANLCQVIQ--------MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 178 (371)
T ss_dssp CCS-EEHHHHHH--------SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCCCC-----
T ss_pred cCC-CCHHHHHh--------hccCHHHHHHHHHHHHHHHHHHHH---CCeecccCCHHHEEEcCCCCEEEEEeecccccc
Confidence 997 58888885 248899999999999999999999 899999999999999999999999999997543
Q ss_pred cccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccch
Q 042348 524 IAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMEL 603 (686)
Q Consensus 524 ~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~ 603 (686)
... ......||..|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 179 ~~~------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-- 232 (371)
T 2xrw_A 179 TSF------------------------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHI-- 232 (371)
T ss_dssp -----------------------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH--
T ss_pred ccc------------------------ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHH--
Confidence 211 112346788899999999989999999999999999999999999653321
Q ss_pred hHHHHHHHHHhhc-CCcccc--------------------------cCcccccCCC--cHHHHHHHHHHHHhccccCCCC
Q 042348 604 NIVQWIQLILEDR-KPMTDI--------------------------LDPFLAHDLD--KEDEIVSVLKIALDCVHKSPDK 654 (686)
Q Consensus 604 ~~~~~~~~~~~~~-~~~~~~--------------------------~d~~l~~~~~--~~~~~~~l~~l~~~cl~~dP~~ 654 (686)
..+..+.... .+.++. +......... .......+.+++.+||+.||++
T Consensus 233 ---~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~ 309 (371)
T 2xrw_A 233 ---DQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASK 309 (371)
T ss_dssp ---HHHHHHHC-CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGG
T ss_pred ---HHHHHHHHHhCCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhh
Confidence 1112221110 000000 0000000000 1123557889999999999999
Q ss_pred CCCHHHHHHH
Q 042348 655 RPSMRHVCDS 664 (686)
Q Consensus 655 RPs~~ev~~~ 664 (686)
|||++|++++
T Consensus 310 R~t~~e~l~h 319 (371)
T 2xrw_A 310 RISVDEALQH 319 (371)
T ss_dssp SCCHHHHHHS
T ss_pred CCCHHHHhCC
Confidence 9999999986
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=335.85 Aligned_cols=261 Identities=25% Similarity=0.402 Sum_probs=180.4
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCC-ccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCCH
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGG-WQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSL 450 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL 450 (686)
..||+|+||.||+|... +++.||||++.... ....+++.+|+.++++++||||+++++++...+..++||||+++|+|
T Consensus 21 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 100 (303)
T 2vwi_A 21 EVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSV 100 (303)
T ss_dssp EECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEECCTTCBH
T ss_pred heeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEehhccCCch
Confidence 46999999999999864 67899999986542 23356788999999999999999999999999999999999999999
Q ss_pred HHHhhcCC--CccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCC
Q 042348 451 ATAIHGKA--GIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEET 528 (686)
Q Consensus 451 ~~~l~~~~--~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 528 (686)
.+++.... +......+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++........
T Consensus 101 ~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 177 (303)
T 2vwi_A 101 LDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK---NGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDI 177 (303)
T ss_dssp HHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTCCEEECCCHHHHHCC-----
T ss_pred HHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCCCCCCCChhhEEEcCCCCEEEEeccchheeccCCCc
Confidence 99987411 00011458999999999999999999999 89999999999999999999999999999865432210
Q ss_pred ccccccccccCCCCCCCccccccccCCCCCccccCcccccC-CCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHH
Q 042348 529 PEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKV-RKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQ 607 (686)
Q Consensus 529 ~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~ 607 (686)
.. ........||..|+|||.+.+ ..++.++||||||+++|||++|+.||........
T Consensus 178 ~~------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---- 235 (303)
T 2vwi_A 178 TR------------------NKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKV---- 235 (303)
T ss_dssp ----------------------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH----
T ss_pred cc------------------hhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhH----
Confidence 00 011123457888999999865 5689999999999999999999999965433221
Q ss_pred HHHHHHhhcCCc-cc-ccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 608 WIQLILEDRKPM-TD-ILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 608 ~~~~~~~~~~~~-~~-~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
.........+. .. ..++.... .....+.+++.+||+.||++|||+.|++++
T Consensus 236 -~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 288 (303)
T 2vwi_A 236 -LMLTLQNDPPSLETGVQDKEMLK-----KYGKSFRKMISLCLQKDPEKRPTAAELLRH 288 (303)
T ss_dssp -HHHHHTSSCCCTTC-----CCCC-----CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred -HHHHhccCCCccccccccchhhh-----hhhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 11122221111 00 01111111 122357889999999999999999999875
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-39 Score=343.55 Aligned_cols=257 Identities=19% Similarity=0.220 Sum_probs=193.7
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCCccchHHHHHHHHHHhccC--------CCCcceeeEEEE----ecCcee
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIR--------HPNIVSLRAYFW----SVDEKL 439 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--------H~nIv~l~~~~~----~~~~~~ 439 (686)
..||+|+||.||+|... +++.||||++.... ...+.+.+|++++++++ |+||+++++++. .....+
T Consensus 43 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~ 121 (397)
T 1wak_A 43 RKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAE-HYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHIC 121 (397)
T ss_dssp EEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEETTEEEEE
T ss_pred EEeeecCCeeEEEEEecCCCeEEEEEEEecCC-cchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCCCCceEE
Confidence 46999999999999864 57899999997542 33467889999999995 788999999998 456789
Q ss_pred EEEeccCCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCC-CceecCCCCCCeeecCCC---------
Q 042348 440 LIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPK-RYVHGDLRPSNILLGKNM--------- 509 (686)
Q Consensus 440 lV~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~-~iiHrDlkp~NILl~~~~--------- 509 (686)
+||||+ +++|.+.+..... ..+++..++.|+.||+.||+|||+ + +|+||||||+|||++.++
T Consensus 122 lv~e~~-~~~l~~~~~~~~~----~~~~~~~~~~i~~qi~~aL~~lH~---~~givHrDikp~NIll~~~~~~~~~~~~~ 193 (397)
T 1wak_A 122 MVFEVL-GHHLLKWIIKSNY----QGLPLPCVKKIIQQVLQGLDYLHT---KCRIIHTDIKPENILLSVNEQYIRRLAAE 193 (397)
T ss_dssp EEECCC-CCBHHHHHHHTTT----SCCCHHHHHHHHHHHHHHHHHHHH---TTCEECCCCSGGGEEECCCHHHHHHHHHH
T ss_pred EEEecc-CccHHHHHHhccc----CCCCHHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHeeEeccchhhhhhhhh
Confidence 999999 5677666654432 468999999999999999999999 8 999999999999999775
Q ss_pred ----------------------------------------CeEEeecCcccccccccCCccccccccccCCCCCCCcccc
Q 042348 510 ----------------------------------------EPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEF 549 (686)
Q Consensus 510 ----------------------------------------~~kl~DfGla~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~ 549 (686)
.+||+|||+++.....
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~------------------------ 249 (397)
T 1wak_A 194 ATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH------------------------ 249 (397)
T ss_dssp HC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC------------------------
T ss_pred hHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc------------------------
Confidence 8999999999765321
Q ss_pred ccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccc----hhHHHHHHHHHhhc--------C
Q 042348 550 TALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSME----LNIVQWIQLILEDR--------K 617 (686)
Q Consensus 550 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~----~~~~~~~~~~~~~~--------~ 617 (686)
.....||..|+|||++.+..++.++|||||||++|||+||+.||....... .+....+....... .
T Consensus 250 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~ 327 (397)
T 1wak_A 250 --FTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGK 327 (397)
T ss_dssp --SCSCCSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCT
T ss_pred --CccCCCCCcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhccc
Confidence 123457888999999999899999999999999999999999996544322 11111111111110 0
Q ss_pred CcccccCcc--c----------------ccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 618 PMTDILDPF--L----------------AHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 618 ~~~~~~d~~--l----------------~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
...+.+... + ............+.+++.+||+.||++|||+.|++++
T Consensus 328 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 392 (397)
T 1wak_A 328 YSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392 (397)
T ss_dssp TGGGTBCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred ccccccCCccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence 000000000 0 0001124456678999999999999999999999864
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=333.31 Aligned_cols=247 Identities=18% Similarity=0.284 Sum_probs=179.8
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCCc-cc-hHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCC
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGGW-QR-FKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGS 449 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~-~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gs 449 (686)
..||+|+||.||+|... +++.||||++..... .. .+.+.++...++.++||||+++++++.+.+..++||||++ |+
T Consensus 13 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~~-~~ 91 (290)
T 3fme_A 13 MELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELMD-TS 91 (290)
T ss_dssp EEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEECCS-EE
T ss_pred HhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEehhc-cc
Confidence 46999999999999974 688999999976422 22 2334455556888899999999999999999999999997 58
Q ss_pred HHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCC-CceecCCCCCCeeecCCCCeEEeecCcccccccccCC
Q 042348 450 LATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPK-RYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEET 528 (686)
Q Consensus 450 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~-~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 528 (686)
|.+++..... ....+++..+..|+.|++.||+|||+ + +|+||||||+||+++.++.+||+|||+++.......
T Consensus 92 l~~~l~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 165 (290)
T 3fme_A 92 LDKFYKQVID--KGQTIPEDILGKIAVSIVKALEHLHS---KLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVA- 165 (290)
T ss_dssp HHHHHHHHHH--TTCCCCHHHHHHHHHHHHHHHHHHHH---HSCCCCCCCSGGGCEECTTCCEEBCCC------------
T ss_pred hHHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHhh---cCCeecCCCCHHHEEECCCCCEEEeecCCccccccccc-
Confidence 8888764211 01469999999999999999999999 7 999999999999999999999999999976542211
Q ss_pred ccccccccccCCCCCCCccccccccCCCCCccccCcccc----cCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchh
Q 042348 529 PEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEAS----KVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELN 604 (686)
Q Consensus 529 ~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~ 604 (686)
.....||..|+|||.+ .+..++.++|||||||++|||+||+.||........
T Consensus 166 -----------------------~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~- 221 (290)
T 3fme_A 166 -----------------------KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQ- 221 (290)
T ss_dssp ---------------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHH-
T ss_pred -----------------------ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHH-
Confidence 1123567789999995 556789999999999999999999999964333222
Q ss_pred HHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 605 IVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 605 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
.+........+ .... ......+.+++.+||+.||++|||+.|++++
T Consensus 222 ---~~~~~~~~~~~--~~~~---------~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~h 267 (290)
T 3fme_A 222 ---QLKQVVEEPSP--QLPA---------DKFSAEFVDFTSQCLKKNSKERPTYPELMQH 267 (290)
T ss_dssp ---HHHHHHHSCCC--CCCT---------TTSCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred ---HHHHHhccCCC--Cccc---------ccCCHHHHHHHHHHhhcChhhCcCHHHHHhC
Confidence 12222222111 1100 1122357899999999999999999999874
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=326.88 Aligned_cols=245 Identities=24% Similarity=0.367 Sum_probs=195.7
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCC---------ccchHHHHHHHHHHhccC-CCCcceeeEEEEecCceeEE
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGG---------WQRFKEFQTEAEAIGKIR-HPNIVSLRAYFWSVDEKLLI 441 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---------~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lV 441 (686)
..||+|+||.||+|... +++.||||.+.... ....+.+.+|+++++++. ||||+++++++...+..++|
T Consensus 23 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv 102 (298)
T 1phk_A 23 EILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLV 102 (298)
T ss_dssp EEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred eeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccCCeEEEE
Confidence 46999999999999976 57899999986532 112356889999999995 99999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccc
Q 042348 442 YDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARL 521 (686)
Q Consensus 442 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~ 521 (686)
|||+++++|.+++... ..+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++.
T Consensus 103 ~e~~~~~~L~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 173 (298)
T 1phk_A 103 FDLMKKGELFDYLTEK------VTLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQ 173 (298)
T ss_dssp EECCTTCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EeccCCCcHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEcCCCcEEEecccchhh
Confidence 9999999999999764 358999999999999999999999 8999999999999999999999999999976
Q ss_pred cccccCCccccccccccCCCCCCCccccccccCCCCCccccCccccc------CCCCCCcchHHHHHHHHHHHHhCCCCc
Q 042348 522 ADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASK------VRKPTQKWDIYSYGVILLEMISGKLPM 595 (686)
Q Consensus 522 ~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~sDVwSlGvvl~elltG~~P~ 595 (686)
..... ......+|..|+|||++. ...++.++||||||+++|||++|+.||
T Consensus 174 ~~~~~------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~ 229 (298)
T 1phk_A 174 LDPGE------------------------KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF 229 (298)
T ss_dssp CCTTC------------------------CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred cCCCc------------------------ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCC
Confidence 54221 112345678899999874 456889999999999999999999999
Q ss_pred cccCccchhHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 596 IQIGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 596 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
..... ......+........ .+. .......+.+++.+||+.||++|||+.|++++
T Consensus 230 ~~~~~-----~~~~~~~~~~~~~~~---~~~------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (298)
T 1phk_A 230 WHRKQ-----MLMLRMIMSGNYQFG---SPE------WDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 284 (298)
T ss_dssp CCSSH-----HHHHHHHHHTCCCCC---TTT------GGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred cCccH-----HHHHHHHhcCCcccC---ccc------ccccCHHHHHHHHHHccCCcccCCCHHHHHhC
Confidence 54322 122233333222111 110 01223468899999999999999999999864
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=341.27 Aligned_cols=251 Identities=21% Similarity=0.327 Sum_probs=176.7
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCC--CccchHHHHHHHHHHhccCCCCcceeeEEEEec------CceeEEEe
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNG--GWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSV------DEKLLIYD 443 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~------~~~~lV~e 443 (686)
..||+|+||.||+|... +++.||||++... .....+++.+|++++++++||||+++++++... ...++|||
T Consensus 35 ~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~~lv~e 114 (367)
T 2fst_X 35 SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTH 114 (367)
T ss_dssp EECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEE
T ss_pred eEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCeEEEEec
Confidence 46999999999999864 6889999999653 233456788999999999999999999999754 56799999
Q ss_pred ccCCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccc
Q 042348 444 YIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLAD 523 (686)
Q Consensus 444 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~ 523 (686)
|+ +++|.+++.. ..+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 115 ~~-~~~L~~~~~~-------~~l~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~ 183 (367)
T 2fst_X 115 LM-GADLNNIVKC-------QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTA 183 (367)
T ss_dssp CC-CEECC------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECC--------
T ss_pred cc-CCCHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHhhEEECCCCCEEEeecccccccc
Confidence 99 7899998864 358999999999999999999999 899999999999999999999999999997543
Q ss_pred cccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccC-CCCCCcchHHHHHHHHHHHHhCCCCccccCccc
Q 042348 524 IAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKV-RKPTQKWDIYSYGVILLEMISGKLPMIQIGSME 602 (686)
Q Consensus 524 ~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~ 602 (686)
.. .....||..|+|||++.+ ..++.++|||||||++|||++|+.||.....
T Consensus 184 ~~--------------------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-- 235 (367)
T 2fst_X 184 DE--------------------------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH-- 235 (367)
T ss_dssp ---------------------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSH--
T ss_pred cc--------------------------CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--
Confidence 11 123467888999999876 6789999999999999999999999954332
Q ss_pred hhHHHHHHHHHhhcCCcccccCcc-----------ccc--CCCc----HHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 603 LNIVQWIQLILEDRKPMTDILDPF-----------LAH--DLDK----EDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 603 ~~~~~~~~~~~~~~~~~~~~~d~~-----------l~~--~~~~----~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
.+....+...... +..+..... +.. .... ......+.+++.+||+.||++|||+.|++++
T Consensus 236 ~~~l~~i~~~~g~--p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 236 IDQLKLILRLVGT--PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp HHHHHHHHHHHCS--CCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHHHHhCC--CCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 2222222221111 100000000 000 0000 0112457899999999999999999999987
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=333.25 Aligned_cols=245 Identities=24% Similarity=0.369 Sum_probs=189.4
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCCccchHHHHHHHHHHhcc-CCCCcceeeEEEEe------cCceeEEEec
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGGWQRFKEFQTEAEAIGKI-RHPNIVSLRAYFWS------VDEKLLIYDY 444 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~------~~~~~lV~e~ 444 (686)
..||+|+||.||+|... +++.||||++.... ...+.+.+|+.+++++ +||||+++++++.. .+..++||||
T Consensus 30 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~ 108 (326)
T 2x7f_A 30 ELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEF 108 (326)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEEEEEEC
T ss_pred EEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEEEEEEc
Confidence 46999999999999974 68899999986543 2347789999999999 89999999999987 4578999999
Q ss_pred cCCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCccccccc
Q 042348 445 IPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADI 524 (686)
Q Consensus 445 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~ 524 (686)
+++|+|.+++..... ..+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||++.....
T Consensus 109 ~~~~~L~~~l~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 181 (326)
T 2x7f_A 109 CGAGSVTDLIKNTKG----NTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR 181 (326)
T ss_dssp CTTEEHHHHHHHSGG----GCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTCCEEECCCTTTC----
T ss_pred CCCCcHHHHHHhccc----CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCcHHHEEEcCCCCEEEeeCcCceecCc
Confidence 999999999986532 468999999999999999999999 8999999999999999999999999999875532
Q ss_pred ccCCccccccccccCCCCCCCccccccccCCCCCccccCccccc-----CCCCCCcchHHHHHHHHHHHHhCCCCccccC
Q 042348 525 AEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASK-----VRKPTQKWDIYSYGVILLEMISGKLPMIQIG 599 (686)
Q Consensus 525 ~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDVwSlGvvl~elltG~~P~~~~~ 599 (686)
... ......||..|+|||.+. +..++.++|||||||++|||++|+.||....
T Consensus 182 ~~~-----------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 238 (326)
T 2x7f_A 182 TVG-----------------------RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH 238 (326)
T ss_dssp --------------------------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred Ccc-----------------------ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCc
Confidence 110 112345788899999986 5668999999999999999999999995433
Q ss_pred ccchhHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 600 SMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 600 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
.. .....+..... .....+ .....+.+++.+||+.||++||++.|++++
T Consensus 239 ~~-----~~~~~~~~~~~--~~~~~~---------~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 287 (326)
T 2x7f_A 239 PM-----RALFLIPRNPA--PRLKSK---------KWSKKFQSFIESCLVKNHSQRPATEQLMKH 287 (326)
T ss_dssp HH-----HHHHHHHHSCC--CCCSCS---------CSCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HH-----HHHHHhhcCcc--ccCCcc---------ccCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 21 11122222211 111111 112367889999999999999999999885
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-39 Score=334.85 Aligned_cols=245 Identities=21% Similarity=0.320 Sum_probs=188.5
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCCc--------cchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEe
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGGW--------QRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYD 443 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 443 (686)
..||+|+||.||+|... +++.||||.+..... .....+.+|++++++++||||+++++++...+ .++|||
T Consensus 16 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~~lv~e 94 (322)
T 2ycf_A 16 KTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED-YYIVLE 94 (322)
T ss_dssp EEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-EEEEEE
T ss_pred eEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-eEEEEe
Confidence 46999999999999875 578999999865321 22346889999999999999999999987654 899999
Q ss_pred ccCCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCC---eEEeecCccc
Q 042348 444 YIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNME---PHISDFGLAR 520 (686)
Q Consensus 444 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~---~kl~DfGla~ 520 (686)
|+++|+|.+++... ..+++..+..++.|++.||+|||+ ++|+||||||+||+++.++. +||+|||+++
T Consensus 95 ~~~~~~L~~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~ 165 (322)
T 2ycf_A 95 LMEGGELFDKVVGN------KRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK 165 (322)
T ss_dssp CCTTEETHHHHSTT------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSSSCCEEECCCTTCE
T ss_pred cCCCCcHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEecCCCCCeEEEccCccce
Confidence 99999999998754 468999999999999999999999 89999999999999987654 9999999998
Q ss_pred ccccccCCccccccccccCCCCCCCccccccccCCCCCccccCccccc---CCCCCCcchHHHHHHHHHHHHhCCCCccc
Q 042348 521 LADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASK---VRKPTQKWDIYSYGVILLEMISGKLPMIQ 597 (686)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDVwSlGvvl~elltG~~P~~~ 597 (686)
...... ......||..|+|||++. ...++.++|||||||++|||++|+.||..
T Consensus 166 ~~~~~~------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 221 (322)
T 2ycf_A 166 ILGETS------------------------LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSE 221 (322)
T ss_dssp ECCCCH------------------------HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCS
T ss_pred eccccc------------------------ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcc
Confidence 653211 111234677899999863 56789999999999999999999999965
Q ss_pred cCccchhHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 598 IGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 598 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
..... .+.. .+....... .+.... .....+.+++.+||+.||++|||+.|++++
T Consensus 222 ~~~~~-~~~~---~~~~~~~~~----~~~~~~-----~~~~~~~~li~~~l~~dP~~Rps~~~~l~h 275 (322)
T 2ycf_A 222 HRTQV-SLKD---QITSGKYNF----IPEVWA-----EVSEKALDLVKKLLVVDPKARFTTEEALRH 275 (322)
T ss_dssp TTCSS-CHHH---HHHHTCCCC----CHHHHT-----TSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred cchHH-HHHH---HHHhCcccc----Cchhhh-----hcCHHHHHHHHHHcccCHhhCCCHHHHhhC
Confidence 43322 1111 111221111 011101 122467899999999999999999999865
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=345.01 Aligned_cols=212 Identities=24% Similarity=0.334 Sum_probs=160.9
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCC--CccchHHHHHHHHHHhccCCCCcceeeEEEEec-----CceeEEEec
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNG--GWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSV-----DEKLLIYDY 444 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~-----~~~~lV~e~ 444 (686)
..||+|+||.||+|... +++.||||++... .....+++.+|++++++++||||+++++++... +..++||||
T Consensus 32 ~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~ 111 (432)
T 3n9x_A 32 HLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEI 111 (432)
T ss_dssp EEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEEEC
T ss_pred EEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeEEEEEec
Confidence 46999999999999875 5788999999753 333456789999999999999999999999876 568999999
Q ss_pred cCCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCccccccc
Q 042348 445 IPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADI 524 (686)
Q Consensus 445 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~ 524 (686)
++ |+|.+++... ..+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+|+....
T Consensus 112 ~~-~~L~~~~~~~------~~l~~~~~~~i~~qil~aL~~LH~---~givHrDlkp~NILl~~~~~~kL~DFGla~~~~~ 181 (432)
T 3n9x_A 112 AD-SDLKKLFKTP------IFLTEEHIKTILYNLLLGENFIHE---SGIIHRDLKPANCLLNQDCSVKVCDFGLARTINS 181 (432)
T ss_dssp CS-EEHHHHHHSS------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEEC--
T ss_pred CC-cCHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCHHHeEECCCCCEEEccCCCcccccc
Confidence 96 6999999764 458999999999999999999999 8999999999999999999999999999987653
Q ss_pred ccCCccccccccccCCCCCCCccccccccCCCCCccccCcccc-cCCCCCCcchHHHHHHHHHHHHhCCCCc
Q 042348 525 AEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEAS-KVRKPTQKWDIYSYGVILLEMISGKLPM 595 (686)
Q Consensus 525 ~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~sDVwSlGvvl~elltG~~P~ 595 (686)
.......... .....+..............+||..|+|||++ ....++.++|||||||++|||++|..||
T Consensus 182 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~ 252 (432)
T 3n9x_A 182 EKDTNIVNDL-EENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH 252 (432)
T ss_dssp ------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred cccccccccc-cccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence 3211000000 00000000000001223567889999999986 5567999999999999999999865554
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-39 Score=363.67 Aligned_cols=251 Identities=21% Similarity=0.304 Sum_probs=198.5
Q ss_pred hcccCccCceEEEEEEeCC----CceEEEEEcCCCC-ccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccC
Q 042348 372 AFLLGKSTIGIVYKVALNN----EEAVAVRRLGNGG-WQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIP 446 (686)
Q Consensus 372 ~~~iG~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~ 446 (686)
...||+|+||.||+|.... +..||||++.... ....+.+.+|+.++++++||||+++++++. .+..++||||++
T Consensus 395 ~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~lv~E~~~ 473 (656)
T 2j0j_A 395 GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCT 473 (656)
T ss_dssp EEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCT
T ss_pred eeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceEEEEEcCC
Confidence 4579999999999998743 4579999987643 333467999999999999999999999984 567899999999
Q ss_pred CCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCccccccccc
Q 042348 447 NGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAE 526 (686)
Q Consensus 447 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~ 526 (686)
+|+|.+++.... ..+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 474 ~g~L~~~l~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~~~ 545 (656)
T 2j0j_A 474 LGELRSFLQVRK-----FSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 545 (656)
T ss_dssp TCBHHHHHHHTT-----TTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC--
T ss_pred CCcHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCccccccchHhEEEeCCCCEEEEecCCCeecCCCc
Confidence 999999998653 358999999999999999999999 899999999999999999999999999998654221
Q ss_pred CCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCccccCccchhH
Q 042348 527 ETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQIGSMELNI 605 (686)
Q Consensus 527 ~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~~~~ 605 (686)
. .......+|..|+|||++.+..++.++|||||||++|||++ |..||......
T Consensus 546 ~----------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~---- 599 (656)
T 2j0j_A 546 Y----------------------YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN---- 599 (656)
T ss_dssp ------------------------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH----
T ss_pred c----------------------eeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHH----
Confidence 1 01122345678999999988899999999999999999997 99999543322
Q ss_pred HHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccc
Q 042348 606 VQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRVNI 670 (686)
Q Consensus 606 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~ 670 (686)
+....+...... . .. ......+.+++.+||+.||++|||+.||++.|+++..
T Consensus 600 -~~~~~i~~~~~~-~--~~---------~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~ 651 (656)
T 2j0j_A 600 -DVIGRIENGERL-P--MP---------PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 651 (656)
T ss_dssp -HHHHHHHHTCCC-C--CC---------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -HHHHHHHcCCCC-C--CC---------ccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 222233222211 0 00 1122467899999999999999999999999998753
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=332.07 Aligned_cols=255 Identities=22% Similarity=0.307 Sum_probs=193.5
Q ss_pred cccCccCceEEEEEEeCCCceEEEEEcCCCC--ccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCCH
Q 042348 373 FLLGKSTIGIVYKVALNNEEAVAVRRLGNGG--WQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSL 450 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL 450 (686)
..||+|+||.||+|...+ .||+|.+.... ....+.+.+|+.++++++||||+++++++.+.+..++||||+++++|
T Consensus 39 ~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L 116 (319)
T 2y4i_B 39 ELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTL 116 (319)
T ss_dssp CBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECBCCCSEEH
T ss_pred eEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEeecccCCcH
Confidence 469999999999998864 49999986532 23346688999999999999999999999999999999999999999
Q ss_pred HHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCcc
Q 042348 451 ATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPE 530 (686)
Q Consensus 451 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 530 (686)
.+++.... ..+++..+..++.|++.||+|||+ ++|+||||||+||+++ ++.+||+|||+++.........
T Consensus 117 ~~~l~~~~-----~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~- 186 (319)
T 2y4i_B 117 YSVVRDAK-----IVLDVNKTRQIAQEIVKGMGYLHA---KGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGR- 186 (319)
T ss_dssp HHHTTSSC-----CCCCSHHHHHHHHHHHHHHHHHHH---TTCCCCCCCSTTEEEC---CCEECCCSCCC----------
T ss_pred HHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCChhhEEEe-CCCEEEeecCCccccccccccc-
Confidence 99997653 468999999999999999999999 8999999999999998 6799999999987553221100
Q ss_pred ccccccccCCCCCCCccccccccCCCCCccccCcccccC---------CCCCCcchHHHHHHHHHHHHhCCCCccccCcc
Q 042348 531 VHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKV---------RKPTQKWDIYSYGVILLEMISGKLPMIQIGSM 601 (686)
Q Consensus 531 ~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---------~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~ 601 (686)
.........||..|+|||.+.. ..++.++|||||||++|||++|+.||......
T Consensus 187 -----------------~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~ 249 (319)
T 2y4i_B 187 -----------------REDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAE 249 (319)
T ss_dssp ------------------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHH
T ss_pred -----------------cccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 0011223457888999998864 45788999999999999999999999543321
Q ss_pred chhHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccccc
Q 042348 602 ELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRVNIST 672 (686)
Q Consensus 602 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~~~ 672 (686)
...........+ ..... . ....+.+++.+||+.||++|||+.|+++.|+++....
T Consensus 250 -----~~~~~~~~~~~~--~~~~~----~-----~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~ 304 (319)
T 2y4i_B 250 -----AIIWQMGTGMKP--NLSQI----G-----MGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRN 304 (319)
T ss_dssp -----HHHHHHHTTCCC--CCCCS----S-----CCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC----
T ss_pred -----HHHHHhccCCCC--CCCcC----C-----CCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhh
Confidence 122222222211 11110 0 1124778999999999999999999999999987544
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-39 Score=332.59 Aligned_cols=256 Identities=21% Similarity=0.334 Sum_probs=186.7
Q ss_pred cccCccCceEEEEEEeCC-CceEEEEEcCCCCccchHHHHHHHHHHhccCCCCcceeeEEEE--------------ecCc
Q 042348 373 FLLGKSTIGIVYKVALNN-EEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFW--------------SVDE 437 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~--------------~~~~ 437 (686)
..||+|+||.||+|.... ++.||||++........+++.+|++++++++||||+++++++. ..+.
T Consensus 17 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~ 96 (320)
T 2i6l_A 17 KPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNS 96 (320)
T ss_dssp EECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----CCSCSE
T ss_pred EEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccccccccCc
Confidence 469999999999999864 8899999997766666778999999999999999999999874 3356
Q ss_pred eeEEEeccCCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeec-CCCCeEEeec
Q 042348 438 KLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLG-KNMEPHISDF 516 (686)
Q Consensus 438 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~-~~~~~kl~Df 516 (686)
.++||||++ |+|.+++.. ..+++..+..++.|++.||+|||+ ++|+||||||+||+++ +++.+||+||
T Consensus 97 ~~lv~e~~~-~~L~~~~~~-------~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~kl~Df 165 (320)
T 2i6l_A 97 VYIVQEYME-TDLANVLEQ-------GPLLEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANLFINTEDLVLKIGDF 165 (320)
T ss_dssp EEEEEECCS-EEHHHHHTT-------CCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTTEEEECCC
T ss_pred eeEEeeccC-CCHHHHhhc-------CCccHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCeEEEccC
Confidence 799999997 699999864 358999999999999999999999 8999999999999997 5679999999
Q ss_pred CcccccccccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccC-CCCCCcchHHHHHHHHHHHHhCCCCc
Q 042348 517 GLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKV-RKPTQKWDIYSYGVILLEMISGKLPM 595 (686)
Q Consensus 517 Gla~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvvl~elltG~~P~ 595 (686)
|+++......... .......+|..|+|||.+.+ ..++.++|||||||++|||++|+.||
T Consensus 166 g~~~~~~~~~~~~--------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf 225 (320)
T 2i6l_A 166 GLARIMDPHYSHK--------------------GHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLF 225 (320)
T ss_dssp TTCBCC----------------------------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSS
T ss_pred ccccccCCCcccc--------------------cccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCC
Confidence 9998654221100 01123345778999998765 67899999999999999999999999
Q ss_pred cccCccchhHHHHHHHHHhhcCCccc------------ccCcccccCCCc-----HHHHHHHHHHHHhccccCCCCCCCH
Q 042348 596 IQIGSMELNIVQWIQLILEDRKPMTD------------ILDPFLAHDLDK-----EDEIVSVLKIALDCVHKSPDKRPSM 658 (686)
Q Consensus 596 ~~~~~~~~~~~~~~~~~~~~~~~~~~------------~~d~~l~~~~~~-----~~~~~~l~~l~~~cl~~dP~~RPs~ 658 (686)
...... .....+......... ............ ......+.+++.+||+.||++|||+
T Consensus 226 ~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~ 300 (320)
T 2i6l_A 226 AGAHEL-----EQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTA 300 (320)
T ss_dssp CCSSHH-----HHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCH
T ss_pred CCCCHH-----HHHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCH
Confidence 654321 112222221110000 000000000000 0123468899999999999999999
Q ss_pred HHHHHH
Q 042348 659 RHVCDS 664 (686)
Q Consensus 659 ~ev~~~ 664 (686)
.|++++
T Consensus 301 ~ell~h 306 (320)
T 2i6l_A 301 EEALSH 306 (320)
T ss_dssp HHHHTS
T ss_pred HHHhCC
Confidence 999875
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=341.26 Aligned_cols=261 Identities=20% Similarity=0.333 Sum_probs=188.2
Q ss_pred cccCccCceEEEEEEeCCCceEEEEEcCCCCccchHHHHHHHHHHhccCCCCcceeeEEEEecCc------eeEEEeccC
Q 042348 373 FLLGKSTIGIVYKVALNNEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDE------KLLIYDYIP 446 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~------~~lV~e~~~ 446 (686)
..||+|+||.||+|+...+..||+|++.... ....+|++++++++||||+++++++...+. .++||||++
T Consensus 46 ~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~----~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~e~~~ 121 (394)
T 4e7w_A 46 KVIGNGSFGVVFQAKLVESDEVAIKKVLQDK----RFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVP 121 (394)
T ss_dssp EEEEEETTEEEEEEEETTTEEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEEECCS
T ss_pred EEEeeCCCeEEEEEEECCCCeEEEEEEecCc----chHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEeeccC
Confidence 4699999999999998877779999885432 223479999999999999999999976543 789999998
Q ss_pred CCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeec-CCCCeEEeecCcccccccc
Q 042348 447 NGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLG-KNMEPHISDFGLARLADIA 525 (686)
Q Consensus 447 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~-~~~~~kl~DfGla~~~~~~ 525 (686)
++.+....+.... ...+++..+..++.|++.||+|||+ ++|+||||||+|||++ .++.+||+|||+|+.....
T Consensus 122 ~~l~~~~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~ 195 (394)
T 4e7w_A 122 ETVYRASRHYAKL---KQTMPMLLIKLYMYQLLRSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAG 195 (394)
T ss_dssp EEHHHHHHHHHHT---TSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred ccHHHHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCC
Confidence 7544333321110 1468999999999999999999999 8999999999999999 7999999999999865422
Q ss_pred cCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCC-CCCCcchHHHHHHHHHHHHhCCCCccccCccchh
Q 042348 526 EETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVR-KPTQKWDIYSYGVILLEMISGKLPMIQIGSMELN 604 (686)
Q Consensus 526 ~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~ 604 (686)
.. .....+|..|+|||++.+. .++.++|||||||++|||++|+.||......+ .
T Consensus 196 ~~------------------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~-~ 250 (394)
T 4e7w_A 196 EP------------------------NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGID-Q 250 (394)
T ss_dssp CC------------------------CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-H
T ss_pred CC------------------------CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-H
Confidence 11 1234568889999998764 58999999999999999999999996543221 1
Q ss_pred HHHHHHHHHhh---------cCCcccccCcccccCC----CcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH--Hhccc
Q 042348 605 IVQWIQLILED---------RKPMTDILDPFLAHDL----DKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS--LDRVN 669 (686)
Q Consensus 605 ~~~~~~~~~~~---------~~~~~~~~d~~l~~~~----~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~--L~~i~ 669 (686)
+...+. .... .....+..-+...... .......++.+++.+||+.||++|||+.|++++ +++++
T Consensus 251 l~~i~~-~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 329 (394)
T 4e7w_A 251 LVEIIK-VLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELR 329 (394)
T ss_dssp HHHHHH-HHCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTT
T ss_pred HHHHHH-HhCCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhc
Confidence 111111 1100 0000000000000000 000123468899999999999999999999987 55543
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=344.97 Aligned_cols=257 Identities=22% Similarity=0.334 Sum_probs=186.2
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCCccchHHHHHHHHHHhccCCCCcceeeEEEEecC------ceeEEEecc
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVD------EKLLIYDYI 445 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~------~~~lV~e~~ 445 (686)
+.||+|+||.||+|... +++.||||++.... ..+.+|++++++++|||||+++++|.... ..++||||+
T Consensus 60 ~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~ 135 (420)
T 1j1b_A 60 KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV 135 (420)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEEEECC
T ss_pred eEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEeehhcc
Confidence 46999999999999986 58999999986532 23457999999999999999999986532 257999999
Q ss_pred CCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCC-CCeEEeecCccccccc
Q 042348 446 PNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKN-MEPHISDFGLARLADI 524 (686)
Q Consensus 446 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~-~~~kl~DfGla~~~~~ 524 (686)
++ +|.+.+..... ....+++..+..++.||+.||+|||+ ++|+||||||+|||++.+ +.+||+|||+++.+..
T Consensus 136 ~~-~l~~~~~~~~~--~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~ 209 (420)
T 1j1b_A 136 PE-TVYRVARHYSR--AKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR 209 (420)
T ss_dssp CE-EHHHHHHHHHH--TTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred cc-cHHHHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChhhEEEeCCCCeEEeccchhhhhccc
Confidence 75 67666543110 01469999999999999999999999 899999999999999965 5689999999986542
Q ss_pred ccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCC-CCCCcchHHHHHHHHHHHHhCCCCccccCccch
Q 042348 525 AEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVR-KPTQKWDIYSYGVILLEMISGKLPMIQIGSMEL 603 (686)
Q Consensus 525 ~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~ 603 (686)
... .....+|..|+|||++.+. .++.++|||||||++|||++|+.||......+
T Consensus 210 ~~~------------------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~- 264 (420)
T 1j1b_A 210 GEP------------------------NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD- 264 (420)
T ss_dssp TCC------------------------CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-
T ss_pred CCC------------------------ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH-
Confidence 211 1234568889999998764 78999999999999999999999996543211
Q ss_pred hHHHHHHHH--------HhhcCCcccccCcccccCC----CcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 604 NIVQWIQLI--------LEDRKPMTDILDPFLAHDL----DKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 604 ~~~~~~~~~--------~~~~~~~~~~~d~~l~~~~----~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
.+...+... ........+..-+.+.... .......++.+|+.+||+.||++|||+.|++++
T Consensus 265 ~l~~i~~~lg~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h 337 (420)
T 1j1b_A 265 QLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 337 (420)
T ss_dssp HHHHHHHHHCSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHHhCCCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence 122222110 0000001111011110000 000123468899999999999999999999876
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-38 Score=333.06 Aligned_cols=257 Identities=23% Similarity=0.341 Sum_probs=193.9
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCC-ccchHHHHHHHHHHhccCCCCcceeeEEEEec-----CceeEEEecc
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGG-WQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSV-----DEKLLIYDYI 445 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~-----~~~~lV~e~~ 445 (686)
..||+|+||.||+|... +++.||||++.... ....+.+.+|++++++++||||+++++++... ...++||||+
T Consensus 33 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~e~~ 112 (364)
T 3qyz_A 33 SYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM 112 (364)
T ss_dssp EEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEECC
T ss_pred EEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEEEEEccc
Confidence 46999999999999865 57889999997543 23346789999999999999999999999765 3679999999
Q ss_pred CCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccc
Q 042348 446 PNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIA 525 (686)
Q Consensus 446 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~ 525 (686)
+ |+|.+++... .+++.++..|+.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 113 ~-~~L~~~l~~~-------~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 181 (364)
T 3qyz_A 113 E-TDLYKLLKTQ-------HLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 181 (364)
T ss_dssp S-EEHHHHHHHC-------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECCGG
T ss_pred C-cCHHHHHHhC-------CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChHhEEECCCCCEEEEeCcceEecCCC
Confidence 7 5999998653 48999999999999999999999 89999999999999999999999999999866432
Q ss_pred cCCccccccccccCCCCCCCccccccccCCCCCccccCcccccC-CCCCCcchHHHHHHHHHHHHhCCCCccccCccchh
Q 042348 526 EETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKV-RKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELN 604 (686)
Q Consensus 526 ~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~ 604 (686)
.... .......||..|+|||++.+ ..++.++|||||||++|||++|+.||......+
T Consensus 182 ~~~~--------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-- 239 (364)
T 3qyz_A 182 HDHT--------------------GFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD-- 239 (364)
T ss_dssp GCBC--------------------CTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGG--
T ss_pred CCcc--------------------ccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHH--
Confidence 2100 11234567889999998654 558999999999999999999999996543322
Q ss_pred HHHHHHHHHhhcCCcccccCc-----------cc--ccCCCc----HHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 605 IVQWIQLILEDRKPMTDILDP-----------FL--AHDLDK----EDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 605 ~~~~~~~~~~~~~~~~~~~d~-----------~l--~~~~~~----~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
....+...... +..+.... .. ...... ......+.+++.+||+.||++|||+.|++++
T Consensus 240 ~~~~i~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 314 (364)
T 3qyz_A 240 QLNHILGILGS--PSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 314 (364)
T ss_dssp HHHHHHHHHCS--CCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHHHHHhCC--CCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 22222111111 00000000 00 000000 0112457899999999999999999999986
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=336.99 Aligned_cols=254 Identities=23% Similarity=0.314 Sum_probs=191.1
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCC--ccchHHHHHHHHHHhccCCCCcceeeEEEEecCce------eEEEe
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGG--WQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEK------LLIYD 443 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~------~lV~e 443 (686)
..||+|+||.||+|... +++.||||++.... ....+.+.+|+.++++++||||+++++++...+.. ++|||
T Consensus 48 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e 127 (371)
T 4exu_A 48 THVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMP 127 (371)
T ss_dssp EEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCCEEEEE
T ss_pred eEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccceeEEEEEc
Confidence 46999999999999865 58899999997642 23356788999999999999999999999877654 99999
Q ss_pred ccCCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccc
Q 042348 444 YIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLAD 523 (686)
Q Consensus 444 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~ 523 (686)
|+. ++|.+++. ..+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 128 ~~~-~~l~~~~~--------~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~ 195 (371)
T 4exu_A 128 FMQ-TDLQKIMG--------MEFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLARHAD 195 (371)
T ss_dssp CCC-EEHHHHTT--------SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECSTTCC----
T ss_pred ccc-ccHHHHhh--------cCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCcCHHHeEECCCCCEEEEecCcccccc
Confidence 997 68988874 348999999999999999999999 899999999999999999999999999997543
Q ss_pred cccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccC-CCCCCcchHHHHHHHHHHHHhCCCCccccCccc
Q 042348 524 IAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKV-RKPTQKWDIYSYGVILLEMISGKLPMIQIGSME 602 (686)
Q Consensus 524 ~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~ 602 (686)
.. .....+|..|+|||++.+ ..++.++|||||||++|||++|+.||......
T Consensus 196 ~~--------------------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~- 248 (371)
T 4exu_A 196 AE--------------------------MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL- 248 (371)
T ss_dssp ------------------------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH-
T ss_pred cC--------------------------cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChH-
Confidence 21 123456788999999877 67899999999999999999999999543321
Q ss_pred hhHHHHHHHHHhhc-CCcccccCcc-----------cccCC--C----cHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 603 LNIVQWIQLILEDR-KPMTDILDPF-----------LAHDL--D----KEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 603 ~~~~~~~~~~~~~~-~~~~~~~d~~-----------l~~~~--~----~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
+.+..+.... .+..+..+.. +.... . .......+.+++.+||+.||++|||+.|++++
T Consensus 249 ----~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 249 ----DQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp ----HHHHHHHHHHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred ----HHHHHHHHHhCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 1111221110 0000000000 00000 0 00123468899999999999999999999987
Q ss_pred --Hhccc
Q 042348 665 --LDRVN 669 (686)
Q Consensus 665 --L~~i~ 669 (686)
++.+.
T Consensus 325 p~f~~~~ 331 (371)
T 4exu_A 325 PFFEPFR 331 (371)
T ss_dssp GGGTTTC
T ss_pred cccccCC
Confidence 44443
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=346.01 Aligned_cols=253 Identities=24% Similarity=0.305 Sum_probs=185.8
Q ss_pred cccCccCceEEEEEEeCCCceEEEEEcCCCCccchHHHHHHHHHHhcc-CCCCcceeeEEEEecCceeEEEeccCCCCHH
Q 042348 373 FLLGKSTIGIVYKVALNNEEAVAVRRLGNGGWQRFKEFQTEAEAIGKI-RHPNIVSLRAYFWSVDEKLLIYDYIPNGSLA 451 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL~ 451 (686)
.+||+|+||+||.+...+|+.||||++... ..+.+.+|++++.++ +|||||++++++.+.+..++|||||. |+|.
T Consensus 21 ~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-gsL~ 96 (434)
T 2rio_A 21 KILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LNLQ 96 (434)
T ss_dssp EEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-EEHH
T ss_pred CeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-CCHH
Confidence 469999999998777778999999998653 235678999999987 89999999999999999999999995 6999
Q ss_pred HHhhcCCCcccc-CCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCC-------------CCeEEeecC
Q 042348 452 TAIHGKAGIISY-RPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKN-------------MEPHISDFG 517 (686)
Q Consensus 452 ~~l~~~~~~~~~-~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~-------------~~~kl~DfG 517 (686)
+++......... ...++..+..|+.||+.||+|||+ ++|+||||||+|||++.+ +.+||+|||
T Consensus 97 ~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG 173 (434)
T 2rio_A 97 DLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFG 173 (434)
T ss_dssp HHHHTC------------CCHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCCT
T ss_pred HHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEecCcccccccccCCCceEEEEcccc
Confidence 999865421110 112445668899999999999999 899999999999999754 489999999
Q ss_pred cccccccccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccC-------CCCCCcchHHHHHHHHHHHHh
Q 042348 518 LARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKV-------RKPTQKWDIYSYGVILLEMIS 590 (686)
Q Consensus 518 la~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~sDVwSlGvvl~ellt 590 (686)
+++......... ........||..|+|||++.+ ..++.++|||||||++|||+|
T Consensus 174 ~a~~~~~~~~~~-------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt 234 (434)
T 2rio_A 174 LCKKLDSGQSSF-------------------RTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILS 234 (434)
T ss_dssp TCEECCC---------------------------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHT
T ss_pred cceecCCCCccc-------------------eeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHh
Confidence 998765322100 011224567889999999865 568999999999999999999
Q ss_pred -CCCCccccCccchhHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 591 -GKLPMIQIGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 591 -G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
|+.||....... ..+.......... ..........++.+++.+||+.||++|||+.||+++
T Consensus 235 ~g~~Pf~~~~~~~-------~~i~~~~~~~~~~------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 296 (434)
T 2rio_A 235 KGKHPFGDKYSRE-------SNIIRGIFSLDEM------KCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRH 296 (434)
T ss_dssp TSCCTTCSTTTHH-------HHHHHTCCCCCCC------TTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CCCCCCCCchhhH-------HHHhcCCCCcccc------cccccccchHHHHHHHHHHhhCChhhCCCHHHHHhC
Confidence 999995433221 1122222211111 111223455678899999999999999999999874
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=336.12 Aligned_cols=256 Identities=24% Similarity=0.290 Sum_probs=186.8
Q ss_pred cccCccCceEEEEEEeCCCceEEEEEcCCCCcc-----------chHHHHHHHHHHhccCCCCcceeeEEEEecC-----
Q 042348 373 FLLGKSTIGIVYKVALNNEEAVAVRRLGNGGWQ-----------RFKEFQTEAEAIGKIRHPNIVSLRAYFWSVD----- 436 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~----- 436 (686)
..||+|+||.||+|...++..||||++...... ..+.+.+|++++++++||||+++++++...+
T Consensus 28 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 107 (362)
T 3pg1_A 28 RFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMH 107 (362)
T ss_dssp EEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEECCTTTCC
T ss_pred EEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEeccCCCcc
Confidence 469999999999999888999999998543211 1367899999999999999999999996533
Q ss_pred ceeEEEeccCCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeec
Q 042348 437 EKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDF 516 (686)
Q Consensus 437 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~Df 516 (686)
..++||||++ |+|.+++.... ..+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+||
T Consensus 108 ~~~lv~e~~~-~~l~~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Df 178 (362)
T 3pg1_A 108 KLYLVTELMR-TDLAQVIHDQR-----IVISPQHIQYFMYHILLGLHVLHE---AGVVHRDLHPGNILLADNNDITICDF 178 (362)
T ss_dssp EEEEEEECCS-EEHHHHHHCTT-----SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCT
T ss_pred eEEEEEccCC-CCHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHH---CcCEecCCChHHEEEcCCCCEEEEec
Confidence 4699999997 69999887654 468999999999999999999999 89999999999999999999999999
Q ss_pred CcccccccccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccC-CCCCCcchHHHHHHHHHHHHhCCCCc
Q 042348 517 GLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKV-RKPTQKWDIYSYGVILLEMISGKLPM 595 (686)
Q Consensus 517 Gla~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvvl~elltG~~P~ 595 (686)
|+++...... ......+|..|+|||++.+ ..++.++|||||||++|||++|+.||
T Consensus 179 g~~~~~~~~~------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf 234 (362)
T 3pg1_A 179 NLAREDTADA------------------------NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALF 234 (362)
T ss_dssp TC---------------------------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred Cccccccccc------------------------ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCC
Confidence 9997433211 1123456788999998876 67899999999999999999999999
Q ss_pred cccCccchhHHHHHHHHHhhcCCcc-----------cccCcccccCCC------cHHHHHHHHHHHHhccccCCCCCCCH
Q 042348 596 IQIGSMELNIVQWIQLILEDRKPMT-----------DILDPFLAHDLD------KEDEIVSVLKIALDCVHKSPDKRPSM 658 (686)
Q Consensus 596 ~~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~d~~l~~~~~------~~~~~~~l~~l~~~cl~~dP~~RPs~ 658 (686)
...... .....+...... .... +........... .......+.+++.+||+.||++|||+
T Consensus 235 ~~~~~~--~~~~~i~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~ 311 (362)
T 3pg1_A 235 RGSTFY--NQLNKIVEVVGT-PKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRIST 311 (362)
T ss_dssp CCSSHH--HHHHHHHHHHCC-CCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCH
T ss_pred CCCCHH--HHHHHHHHHcCC-CChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCH
Confidence 553321 111111111100 0000 000000000000 00113457899999999999999999
Q ss_pred HHHHHH
Q 042348 659 RHVCDS 664 (686)
Q Consensus 659 ~ev~~~ 664 (686)
.|++++
T Consensus 312 ~ell~h 317 (362)
T 3pg1_A 312 EQALRH 317 (362)
T ss_dssp HHHHTS
T ss_pred HHHHcC
Confidence 999986
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=334.95 Aligned_cols=256 Identities=20% Similarity=0.246 Sum_probs=196.6
Q ss_pred cccCccCceEEEEEEeCCCceEEEEEcCCCCccc-----------------hHHHHHHHHHHhccCCCCcceeeEEEEec
Q 042348 373 FLLGKSTIGIVYKVALNNEEAVAVRRLGNGGWQR-----------------FKEFQTEAEAIGKIRHPNIVSLRAYFWSV 435 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-----------------~~~~~~E~~~l~~l~H~nIv~l~~~~~~~ 435 (686)
..||+|+||.||+|.. +++.||||.+....... .+.+.+|++++++++||||+++++++.+.
T Consensus 37 ~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 115 (348)
T 2pml_X 37 RTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNY 115 (348)
T ss_dssp EEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCSEEEESS
T ss_pred EEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEEEEEeeC
Confidence 4699999999999999 89999999986432111 17899999999999999999999999999
Q ss_pred CceeEEEeccCCCCHHHH------hhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCC
Q 042348 436 DEKLLIYDYIPNGSLATA------IHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNM 509 (686)
Q Consensus 436 ~~~~lV~e~~~~gsL~~~------l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~ 509 (686)
+..++||||+++|+|.++ +.... ...+++..+..++.|++.||+|||+. ++|+||||||+||+++.++
T Consensus 116 ~~~~lv~e~~~~~~L~~~~~~~~~l~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~--~~i~H~dl~p~Nil~~~~~ 189 (348)
T 2pml_X 116 DEVYIIYEYMENDSILKFDEYFFVLDKNY----TCFIPIQVIKCIIKSVLNSFSYIHNE--KNICHRDVKPSNILMDKNG 189 (348)
T ss_dssp SEEEEEEECCTTCBSSEESSSEESSCSSS----CCCCCHHHHHHHHHHHHHHHHHHHHT--SCEECCCCCGGGEEECTTS
T ss_pred CeEEEEEeccCCCcHHHHHHHhhhhhhcc----ccCCCHHHHHHHHHHHHHHHHHHhcc--CCEeecCCChHhEEEcCCC
Confidence 999999999999999999 54421 15699999999999999999999962 5899999999999999999
Q ss_pred CeEEeecCcccccccccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCC-CCCC-cchHHHHHHHHHH
Q 042348 510 EPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVR-KPTQ-KWDIYSYGVILLE 587 (686)
Q Consensus 510 ~~kl~DfGla~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~sDVwSlGvvl~e 587 (686)
.+||+|||+++..... ......||..|+|||.+.+. .++. ++|||||||++||
T Consensus 190 ~~kl~dfg~~~~~~~~-------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~ 244 (348)
T 2pml_X 190 RVKLSDFGESEYMVDK-------------------------KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYV 244 (348)
T ss_dssp CEEECCCTTCEECBTT-------------------------EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHH
T ss_pred cEEEeccccccccccc-------------------------cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHH
Confidence 9999999999765321 11234567889999999877 5666 9999999999999
Q ss_pred HHhCCCCccccCccchhHHHHHHHHHhhcCCcccccCcccccC------CCcHHHHHHHHHHHHhccccCCCCCCCHHHH
Q 042348 588 MISGKLPMIQIGSMELNIVQWIQLILEDRKPMTDILDPFLAHD------LDKEDEIVSVLKIALDCVHKSPDKRPSMRHV 661 (686)
Q Consensus 588 lltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~------~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev 661 (686)
|++|+.||...... ......+.......+.......... .........+.+++.+||+.||++|||+.|+
T Consensus 245 l~~g~~pf~~~~~~----~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~ 320 (348)
T 2pml_X 245 MFYNVVPFSLKISL----VELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDA 320 (348)
T ss_dssp HHHSSCSSCCSSCS----HHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHH
T ss_pred HHhCCCCCCCCCcH----HHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHH
Confidence 99999999654331 1222222222221111000000000 0001123467899999999999999999999
Q ss_pred HHH
Q 042348 662 CDS 664 (686)
Q Consensus 662 ~~~ 664 (686)
+++
T Consensus 321 l~h 323 (348)
T 2pml_X 321 LKH 323 (348)
T ss_dssp HTS
T ss_pred hcC
Confidence 985
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=325.21 Aligned_cols=258 Identities=22% Similarity=0.368 Sum_probs=187.4
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCCccchHHHHHHHHHHhccCCCCcceeeEEEEe-------------cCce
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWS-------------VDEK 438 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~-------------~~~~ 438 (686)
..||+|+||.||+|... +++.||||.+... ....+.+.+|+.++++++||||+++++++.+ .+..
T Consensus 12 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 90 (303)
T 1zy4_A 12 AVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTL 90 (303)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------CEEEE
T ss_pred heeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcccccCCce
Confidence 46999999999999975 6889999998543 2345678999999999999999999999865 3457
Q ss_pred eEEEeccCCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCc
Q 042348 439 LLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGL 518 (686)
Q Consensus 439 ~lV~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGl 518 (686)
++||||+++|+|.+++.... ..+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dlkp~Nil~~~~~~~kl~dfg~ 162 (303)
T 1zy4_A 91 FIQMEYCENGTLYDLIHSEN-----LNQQRDEYWRLFRQILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGL 162 (303)
T ss_dssp EEEEECCCSCBHHHHHHHSC-----GGGCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred EEEEecCCCCCHHHhhhccc-----cccchHHHHHHHHHHHHHHHHHHh---CCeecccCCHHhEEEcCCCCEEEeeCcc
Confidence 99999999999999998643 357889999999999999999999 8999999999999999999999999999
Q ss_pred ccccccccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCC-CCCCcchHHHHHHHHHHHHhCCCCccc
Q 042348 519 ARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVR-KPTQKWDIYSYGVILLEMISGKLPMIQ 597 (686)
Q Consensus 519 a~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlGvvl~elltG~~P~~~ 597 (686)
++............. .. .+..........||..|+|||.+.+. .++.++|||||||++|||++ ||..
T Consensus 163 ~~~~~~~~~~~~~~~----~~-----~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~ 230 (303)
T 1zy4_A 163 AKNVHRSLDILKLDS----QN-----LPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFST 230 (303)
T ss_dssp CSCTTC----------------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSS
T ss_pred hhhcccccchhcccc----cc-----ccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCC
Confidence 986543211000000 00 00000122345678889999998764 68999999999999999998 5522
Q ss_pred cCccchhHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 598 IGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 598 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
. .+...............+..+. ......+.+++.+||+.||++|||+.|++++
T Consensus 231 ~----~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 231 G----MERVNILKKLRSVSIEFPPDFD---------DNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp H----HHHHHHHHHHHSTTCCCCTTCC---------TTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred c----hhHHHHHHhccccccccCcccc---------ccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 1 1112222332222221111111 1123457789999999999999999999986
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=329.07 Aligned_cols=256 Identities=23% Similarity=0.270 Sum_probs=192.1
Q ss_pred cccCccCceEEEEEEe--CCCceEEEEEcCCCC--ccchHHHHHHHHHHhcc---CCCCcceeeEEEE-----ecCceeE
Q 042348 373 FLLGKSTIGIVYKVAL--NNEEAVAVRRLGNGG--WQRFKEFQTEAEAIGKI---RHPNIVSLRAYFW-----SVDEKLL 440 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~--~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~H~nIv~l~~~~~-----~~~~~~l 440 (686)
..||+|+||.||+|.. .+++.||||++.... ......+.+|+.+++++ +||||+++++++. .....++
T Consensus 17 ~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~l 96 (326)
T 1blx_A 17 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTL 96 (326)
T ss_dssp EEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEEE
T ss_pred eeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCCCceEEE
Confidence 4699999999999997 357899999886432 12234677888887776 8999999999997 4567899
Q ss_pred EEeccCCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCccc
Q 042348 441 IYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLAR 520 (686)
Q Consensus 441 V~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~ 520 (686)
||||++ |+|.+++..... ..+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++
T Consensus 97 v~e~~~-~~L~~~l~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~---~gi~H~dlkp~Nili~~~~~~kl~Dfg~~~ 168 (326)
T 1blx_A 97 VFEHVD-QDLTTYLDKVPE----PGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLAR 168 (326)
T ss_dssp EEECCS-CBHHHHHHHSCT----TCSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred EEecCC-CCHHHHHHhccc----CCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHHHeEEcCCCCEEEecCcccc
Confidence 999997 699999986542 358999999999999999999999 899999999999999999999999999997
Q ss_pred ccccccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCc
Q 042348 521 LADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGS 600 (686)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~ 600 (686)
...... ......+|..|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 169 ~~~~~~------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 224 (326)
T 1blx_A 169 IYSFQM------------------------ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD 224 (326)
T ss_dssp CCCGGG------------------------GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred cccCCC------------------------CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCH
Confidence 553211 11234567889999999988999999999999999999999999964332
Q ss_pred cchhHHHHHHHHHhhcC--Ccccc-------cC----cccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 601 MELNIVQWIQLILEDRK--PMTDI-------LD----PFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 601 ~~~~~~~~~~~~~~~~~--~~~~~-------~d----~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
......+........ .+... +. ..+... .......+.+++.+||+.||++|||+.|++++
T Consensus 225 --~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 297 (326)
T 1blx_A 225 --VDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKF--VTDIDELGKDLLLKCLTFNPAKRISAYSALSH 297 (326)
T ss_dssp --HHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGT--CCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred --HHHHHHHHHHcCCCCcccCccccccchhhhcccCcchhhhc--cccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 112211111111000 00000 00 000000 01123457799999999999999999999965
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=337.50 Aligned_cols=256 Identities=22% Similarity=0.307 Sum_probs=186.2
Q ss_pred cccCccCceEEEEEEe-CCCceEEEEEcCCCCccchHHHHHHHHHHhccCCCCcceeeEEEEec----------------
Q 042348 373 FLLGKSTIGIVYKVAL-NNEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSV---------------- 435 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~---------------- 435 (686)
..||+|+||.||+|.. .+++.||||++.... ....+|++++++++|||||++++++...
T Consensus 13 ~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~ 88 (383)
T 3eb0_A 13 KTLGTGSFGIVCEVFDIESGKRFALKKVLQDP----RYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNK 88 (383)
T ss_dssp EEEECC-CEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHTTCCCTTBCCEEEEEEEC----------------
T ss_pred EEEEeccCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHHcCCCCccchhheeeecCccccccccccccccc
Confidence 4699999999999986 468999999986532 2335799999999999999999998543
Q ss_pred ----------------------CceeEEEeccCCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCc
Q 042348 436 ----------------------DEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRY 493 (686)
Q Consensus 436 ----------------------~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~i 493 (686)
...++||||++ |+|.+.+..... ....+++..+..++.|++.||+|||+ ++|
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~---~gi 162 (383)
T 3eb0_A 89 LGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIR--SGRSIPMNLISIYIYQLFRAVGFIHS---LGI 162 (383)
T ss_dssp ---------------------CCEEEEEECCCS-EEHHHHHHHHHH--TTCCCCHHHHHHHHHHHHHHHHHHHT---TTE
T ss_pred ccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHH---CcC
Confidence 23789999998 588877764211 01469999999999999999999999 899
Q ss_pred eecCCCCCCeeec-CCCCeEEeecCcccccccccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCC-C
Q 042348 494 VHGDLRPSNILLG-KNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVR-K 571 (686)
Q Consensus 494 iHrDlkp~NILl~-~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~ 571 (686)
+||||||+|||++ .++.+||+|||+|+....... .....+|..|+|||.+.+. .
T Consensus 163 ~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~------------------------~~~~~~t~~y~aPE~~~~~~~ 218 (383)
T 3eb0_A 163 CHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP------------------------SVAYICSRFYRAPELMLGATE 218 (383)
T ss_dssp ECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC------------------------CCCCCCCSSCCCHHHHTTCSS
T ss_pred ccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC------------------------CcCcccCCCccCHHHhcCCCC
Confidence 9999999999998 688999999999986543221 1234567789999998764 4
Q ss_pred CCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHHHHHHHhh---------cCCcccccCcccccCC----CcHHHHH
Q 042348 572 PTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQWIQLILED---------RKPMTDILDPFLAHDL----DKEDEIV 638 (686)
Q Consensus 572 ~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~d~~l~~~~----~~~~~~~ 638 (686)
++.++||||+||++|||++|+.||......+ .+...+ ..... .....+..-+...... .......
T Consensus 219 ~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~~~~i~-~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (383)
T 3eb0_A 219 YTPSIDLWSIGCVFGELILGKPLFSGETSID-QLVRII-QIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPS 296 (383)
T ss_dssp CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHH-HHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCH
T ss_pred CCcchhhhhHHHHHHHHHhCCCCCCCCChHH-HHHHHH-HHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCH
Confidence 8999999999999999999999996543221 111111 11110 0000000000000000 0011234
Q ss_pred HHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 639 SVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 639 ~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
.+.+++.+||+.||++|||+.|++++
T Consensus 297 ~~~~li~~~L~~dP~~R~t~~e~l~h 322 (383)
T 3eb0_A 297 LAIDLLEQILRYEPDLRINPYEAMAH 322 (383)
T ss_dssp HHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHHHccCChhhCCCHHHHhcC
Confidence 58899999999999999999999875
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-38 Score=334.52 Aligned_cols=193 Identities=24% Similarity=0.323 Sum_probs=162.9
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCCccchHHHHHHHHHHhccC-CC-----CcceeeEEEEecCceeEEEecc
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIR-HP-----NIVSLRAYFWSVDEKLLIYDYI 445 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~-----nIv~l~~~~~~~~~~~lV~e~~ 445 (686)
..||+|+||.||+|... +++.||||++.... ....++..|+++++.++ |+ +|+++++++...+..++||||+
T Consensus 60 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~ 138 (382)
T 2vx3_A 60 SLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK-AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEML 138 (382)
T ss_dssp EEEEEETTEEEEEEEETTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEEEEEECC
T ss_pred EEEeecCCEEEEEEEEcCCCcEEEEEEEeccH-HHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceEEEEecC
Confidence 46999999999999876 57889999997542 33467788999998885 55 4999999999999999999999
Q ss_pred CCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeec--CCCCeEEeecCcccccc
Q 042348 446 PNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLG--KNMEPHISDFGLARLAD 523 (686)
Q Consensus 446 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~--~~~~~kl~DfGla~~~~ 523 (686)
+ |+|.+++..... ..+++..+..++.|++.||+|||+.. .+|+||||||+|||++ .++.+||+|||+++...
T Consensus 139 ~-~~L~~~l~~~~~----~~~~~~~~~~i~~qi~~al~~lH~~~-~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~~ 212 (382)
T 2vx3_A 139 S-YNLYDLLRNTNF----RGVSLNLTRKFAQQMCTALLFLATPE-LSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG 212 (382)
T ss_dssp C-CBHHHHHHHTTT----SCCCHHHHHHHHHHHHHHHHHHTSTT-TCEECCCCSGGGEEESSTTSCCEEECCCTTCEETT
T ss_pred C-CCHHHHHhhcCc----CCCCHHHHHHHHHHHHHHHHHhccCC-CCEEcCCCCcccEEEecCCCCcEEEEeccCceecc
Confidence 6 599999986542 45899999999999999999999421 6899999999999994 57889999999997653
Q ss_pred cccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCcccc
Q 042348 524 IAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQI 598 (686)
Q Consensus 524 ~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~ 598 (686)
.. .....||..|+|||++.+..++.++|||||||++|||+||+.||...
T Consensus 213 ~~--------------------------~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~ 261 (382)
T 2vx3_A 213 QR--------------------------IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGA 261 (382)
T ss_dssp CC--------------------------CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cc--------------------------cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 11 12345678899999999999999999999999999999999999654
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-38 Score=321.27 Aligned_cols=244 Identities=25% Similarity=0.373 Sum_probs=194.2
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCC--ccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCC
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGG--WQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGS 449 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gs 449 (686)
..||+|+||.||+|... +++.||||++.... ....+.+.+|++++++++||||+++++++...+..++||||+++++
T Consensus 28 ~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 107 (287)
T 2wei_A 28 CMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGE 107 (287)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred EEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEEEccCCCC
Confidence 46999999999999976 68899999986532 2345789999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCC---CCeEEeecCccccccccc
Q 042348 450 LATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKN---MEPHISDFGLARLADIAE 526 (686)
Q Consensus 450 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~---~~~kl~DfGla~~~~~~~ 526 (686)
|.+++... ..+++.++..++.|++.||+|||+ ++|+||||||+||+++.+ +.+||+|||+++......
T Consensus 108 L~~~l~~~------~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~ 178 (287)
T 2wei_A 108 LFDEIIKR------KRFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT 178 (287)
T ss_dssp HHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCS
T ss_pred HHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCChhhEEEecCCCcccEEEeccCcceeecCCC
Confidence 99988754 358999999999999999999999 899999999999999754 479999999997653221
Q ss_pred CCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHH
Q 042348 527 ETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIV 606 (686)
Q Consensus 527 ~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~ 606 (686)
. .....+|..|+|||.+.+ .++.++||||||+++|+|++|+.||..... .
T Consensus 179 ~------------------------~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-----~ 228 (287)
T 2wei_A 179 K------------------------MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE-----Y 228 (287)
T ss_dssp S------------------------CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----H
T ss_pred c------------------------cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCH-----H
Confidence 1 112345778999998875 489999999999999999999999955322 1
Q ss_pred HHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 607 QWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 607 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
.....+........ .+.. ......+.+++.+||+.||++|||+.|++++
T Consensus 229 ~~~~~~~~~~~~~~---~~~~------~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 277 (287)
T 2wei_A 229 DILKRVETGKYAFD---LPQW------RTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (287)
T ss_dssp HHHHHHHHCCCCCC---SGGG------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred HHHHHHHcCCCCCC---chhh------hhcCHHHHHHHHHHcccChhhCcCHHHHhcC
Confidence 22333333322111 0000 0122357899999999999999999999985
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-38 Score=334.22 Aligned_cols=264 Identities=20% Similarity=0.266 Sum_probs=181.3
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCCccchHHHHHHHHHHhccCCCCcceeeEEEEecCc-------eeEEEec
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDE-------KLLIYDY 444 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~-------~~lV~e~ 444 (686)
..||+|+||.||+|... +++.||||++.... .....+.+|++.++.++||||+++++++...+. .++||||
T Consensus 29 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~lv~e~ 107 (360)
T 3e3p_A 29 RMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEY 107 (360)
T ss_dssp ----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEEEEEEEC
T ss_pred EEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeEEEEeec
Confidence 36999999999999975 58899999885542 223567788889999999999999999976544 7899999
Q ss_pred cCCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHH--ccCCCCceecCCCCCCeeecC-CCCeEEeecCcccc
Q 042348 445 IPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLH--EVSPKRYVHGDLRPSNILLGK-NMEPHISDFGLARL 521 (686)
Q Consensus 445 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH--~~~~~~iiHrDlkp~NILl~~-~~~~kl~DfGla~~ 521 (686)
+++ +|.+.+..... ....+++..+..++.|++.||+||| + ++|+||||||+|||++. ++.+||+|||+++.
T Consensus 108 ~~~-~l~~~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~~ 181 (360)
T 3e3p_A 108 VPD-TLHRCCRNYYR--RQVAPPPILIKVFLFQLIRSIGCLHLPS---VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKK 181 (360)
T ss_dssp CSC-BHHHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHTSTT---TCCBCSCCCGGGEEEETTTTEEEECCCTTCBC
T ss_pred ccc-cHHHHHHHHhh--cccCCCHHHHHHHHHHHHHHHHHHhCCC---CCeecCcCCHHHEEEeCCCCcEEEeeCCCcee
Confidence 976 55544432110 0146899999999999999999999 7 89999999999999996 89999999999986
Q ss_pred cccccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCC-CCCCcchHHHHHHHHHHHHhCCCCccccCc
Q 042348 522 ADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVR-KPTQKWDIYSYGVILLEMISGKLPMIQIGS 600 (686)
Q Consensus 522 ~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlGvvl~elltG~~P~~~~~~ 600 (686)
...... .....||..|+|||++.+. .++.++|||||||++|||++|+.||.....
T Consensus 182 ~~~~~~------------------------~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~ 237 (360)
T 3e3p_A 182 LSPSEP------------------------NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNS 237 (360)
T ss_dssp CCTTSC------------------------CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred cCCCCC------------------------cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCCh
Confidence 542211 1234568889999998664 489999999999999999999999965432
Q ss_pred cchhHHHHHHHHHhhc--------CCcccccCcccccCCC--------cHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 601 MELNIVQWIQLILEDR--------KPMTDILDPFLAHDLD--------KEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 601 ~~~~~~~~~~~~~~~~--------~~~~~~~d~~l~~~~~--------~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
.. ....+....... .+.....+........ .......+.+++.+||+.||++|||+.|++++
T Consensus 238 ~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 315 (360)
T 3e3p_A 238 AG--QLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH 315 (360)
T ss_dssp HH--HHHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred HH--HHHHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 21 111111111000 0000000000000000 01134578899999999999999999999987
Q ss_pred --Hhccc
Q 042348 665 --LDRVN 669 (686)
Q Consensus 665 --L~~i~ 669 (686)
++++.
T Consensus 316 p~f~~~~ 322 (360)
T 3e3p_A 316 PYFDELH 322 (360)
T ss_dssp GGGGGGG
T ss_pred ccccccC
Confidence 45543
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-38 Score=330.62 Aligned_cols=255 Identities=20% Similarity=0.260 Sum_probs=194.1
Q ss_pred cccCccCceEEEEEEeC-CC-ceEEEEEcCCCCccchHHHHHHHHHHhccCCCC------cceeeEEEEecCceeEEEec
Q 042348 373 FLLGKSTIGIVYKVALN-NE-EAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPN------IVSLRAYFWSVDEKLLIYDY 444 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n------Iv~l~~~~~~~~~~~lV~e~ 444 (686)
..||+|+||.||+|... ++ ..||||++.... ...+.+.+|++++++++|++ ++.+++++...+..++||||
T Consensus 25 ~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~ 103 (355)
T 2eu9_A 25 GNLGEGTFGKVVECLDHARGKSQVALKIIRNVG-KYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFEL 103 (355)
T ss_dssp EEEEEETTEEEEEEEETTTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEEEEEEEC
T ss_pred EEeeccCCeEEEEEEecCCCceEEEEEEEcccc-cchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeEEEEEec
Confidence 46999999999999875 33 689999997542 33467889999999997765 99999999999999999999
Q ss_pred cCCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeee-------------------
Q 042348 445 IPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILL------------------- 505 (686)
Q Consensus 445 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl------------------- 505 (686)
+ +++|.+++..... ..+++.++..++.||+.||+|||+ ++|+||||||+|||+
T Consensus 104 ~-~~~l~~~l~~~~~----~~~~~~~~~~i~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~ 175 (355)
T 2eu9_A 104 L-GKNTFEFLKENNF----QPYPLPHVRHMAYQLCHALRFLHE---NQLTHTDLKPENILFVNSEFETLYNEHKSCEEKS 175 (355)
T ss_dssp C-CCBHHHHHHHTTT----CCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEESCCCEEEEECCC-CCCEEE
T ss_pred c-CCChHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEecccccccccccccccccc
Confidence 9 6677777765432 468999999999999999999999 899999999999999
Q ss_pred cCCCCeEEeecCcccccccccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHH
Q 042348 506 GKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVIL 585 (686)
Q Consensus 506 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl 585 (686)
+.++.+||+|||+++..... .....||..|+|||++.+..++.++|||||||++
T Consensus 176 ~~~~~~kl~Dfg~~~~~~~~--------------------------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il 229 (355)
T 2eu9_A 176 VKNTSIRVADFGSATFDHEH--------------------------HTTIVATRHYRPPEVILELGWAQPCDVWSIGCIL 229 (355)
T ss_dssp ESCCCEEECCCTTCEETTSC--------------------------CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHH
T ss_pred cCCCcEEEeecCcccccccc--------------------------ccCCcCCCcccCCeeeecCCCCCccchHHHHHHH
Confidence 56789999999999753211 1234578889999999999999999999999999
Q ss_pred HHHHhCCCCccccCccchhHHHHHHHHHhhcCC-------ccc---------------------ccCcccccCCCcHHHH
Q 042348 586 LEMISGKLPMIQIGSMELNIVQWIQLILEDRKP-------MTD---------------------ILDPFLAHDLDKEDEI 637 (686)
Q Consensus 586 ~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~-------~~~---------------------~~d~~l~~~~~~~~~~ 637 (686)
|||++|+.||...... .....+......... ... ...+............
T Consensus 230 ~el~~g~~pf~~~~~~--~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (355)
T 2eu9_A 230 FEYYRGFTLFQTHENR--EHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEH 307 (355)
T ss_dssp HHHHHSSCSCCCSSHH--HHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHH
T ss_pred HHHHhCCCCCCCCCHH--HHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhH
Confidence 9999999999654322 222222222111000 000 0000000011122345
Q ss_pred HHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 638 VSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 638 ~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
..+.+++.+||+.||++|||+.|++++
T Consensus 308 ~~l~~li~~~L~~dP~~Rpt~~e~l~h 334 (355)
T 2eu9_A 308 VQLFDLMRRMLEFDPAQRITLAEALLH 334 (355)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred HHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 678899999999999999999999875
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=329.58 Aligned_cols=245 Identities=21% Similarity=0.310 Sum_probs=189.0
Q ss_pred cccCccCceEEEEEEeCCCceEEEEEcCCC--CccchHHHHHHHHHHhccC--CCCcceeeEEEEecCceeEEEeccCCC
Q 042348 373 FLLGKSTIGIVYKVALNNEEAVAVRRLGNG--GWQRFKEFQTEAEAIGKIR--HPNIVSLRAYFWSVDEKLLIYDYIPNG 448 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~--H~nIv~l~~~~~~~~~~~lV~e~~~~g 448 (686)
..||+|+||.||++...+++.||||.+... .....+.+.+|++++.+++ ||||+++++++...+..++||| +.++
T Consensus 34 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e-~~~~ 112 (313)
T 3cek_A 34 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNI 112 (313)
T ss_dssp EEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEEEC-CCSE
T ss_pred EEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEEEe-cCCC
Confidence 369999999999999888999999998653 2334577899999999997 5999999999999999999999 5688
Q ss_pred CHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCC
Q 042348 449 SLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEET 528 (686)
Q Consensus 449 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 528 (686)
+|.+++... ..+++..+..++.|++.||+|||+ ++|+||||||+||++++ +.+||+|||+++........
T Consensus 113 ~L~~~l~~~------~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~~~~ 182 (313)
T 3cek_A 113 DLNSWLKKK------KSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTS 182 (313)
T ss_dssp EHHHHHHHC------SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEET-TEEEECCCSSSCC-------
T ss_pred cHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcccEEEEC-CeEEEeeccccccccCcccc
Confidence 999999865 358999999999999999999999 89999999999999964 89999999999865432110
Q ss_pred ccccccccccCCCCCCCccccccccCCCCCccccCcccccC-----------CCCCCcchHHHHHHHHHHHHhCCCCccc
Q 042348 529 PEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKV-----------RKPTQKWDIYSYGVILLEMISGKLPMIQ 597 (686)
Q Consensus 529 ~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDVwSlGvvl~elltG~~P~~~ 597 (686)
.......||..|+|||.+.+ ..++.++|||||||++|||++|+.||..
T Consensus 183 ---------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 241 (313)
T 3cek_A 183 ---------------------VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ 241 (313)
T ss_dssp ----------------------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred ---------------------ccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhh
Confidence 01123457888999999865 4688899999999999999999999954
Q ss_pred cCccchhHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 598 IGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 598 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
..... ..+.......... . .... ....+.+++.+||+.||++||++.|++++
T Consensus 242 ~~~~~----~~~~~~~~~~~~~-~-----~~~~-----~~~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 242 IINQI----SKLHAIIDPNHEI-E-----FPDI-----PEKDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp CCSHH----HHHHHHHCTTSCC-C-----CCCC-----SCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHH----HHHHHHHhccccc-C-----Cccc-----chHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 33221 1122222211110 0 0000 12357789999999999999999999876
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=329.77 Aligned_cols=255 Identities=21% Similarity=0.265 Sum_probs=190.5
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCC--ccchHHHHHHHHHHhccCCCCcceeeEEEEecCc------eeEEEe
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGG--WQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDE------KLLIYD 443 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~------~~lV~e 443 (686)
..||+|+||.||+|... +++.||||++.... ....+++.+|+.++++++||||+++++++...+. .++|||
T Consensus 30 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e 109 (353)
T 3coi_A 30 THVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMP 109 (353)
T ss_dssp EEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEE
T ss_pred eeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccceeEEEEec
Confidence 46999999999999875 58899999986542 2334678899999999999999999999987654 499999
Q ss_pred ccCCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccc
Q 042348 444 YIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLAD 523 (686)
Q Consensus 444 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~ 523 (686)
|++ |+|.+++. ..+++..+..++.||+.||+|||+ ++|+||||||+||+++.++.+||+|||+++...
T Consensus 110 ~~~-~~l~~~~~--------~~~~~~~~~~i~~qi~~al~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 177 (353)
T 3coi_A 110 FMQ-TDLQKIMG--------LKFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLARHAD 177 (353)
T ss_dssp CCS-EEGGGTTT--------SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECTTCCEEECSTTCTTC--
T ss_pred ccc-CCHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEeECCCCcEEEeecccccCCC
Confidence 997 68888774 348999999999999999999999 899999999999999999999999999997543
Q ss_pred cccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccC-CCCCCcchHHHHHHHHHHHHhCCCCccccCccc
Q 042348 524 IAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKV-RKPTQKWDIYSYGVILLEMISGKLPMIQIGSME 602 (686)
Q Consensus 524 ~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~ 602 (686)
.. .....+|..|+|||.+.+ ..++.++|||||||++|||++|+.||......
T Consensus 178 ~~--------------------------~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~- 230 (353)
T 3coi_A 178 AE--------------------------MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL- 230 (353)
T ss_dssp --------------------------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHH-
T ss_pred CC--------------------------ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-
Confidence 11 123456788999999876 67899999999999999999999999653321
Q ss_pred hhHHHHHHHHHhhcC-----------------CcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH-
Q 042348 603 LNIVQWIQLILEDRK-----------------PMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS- 664 (686)
Q Consensus 603 ~~~~~~~~~~~~~~~-----------------~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~- 664 (686)
+....+........ .......+.+... .......+.+++.+||+.||++|||+.|++++
T Consensus 231 -~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp 307 (353)
T 3coi_A 231 -DQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQL--FPRASPQAADLLEKMLELDVDKRLTAAQALTHP 307 (353)
T ss_dssp -HHHHHHHHHHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTT--CTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSG
T ss_pred -HHHHHHHHHhCCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHh--cCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCc
Confidence 11111111110000 0000000000000 01223468899999999999999999999976
Q ss_pred -Hhccc
Q 042348 665 -LDRVN 669 (686)
Q Consensus 665 -L~~i~ 669 (686)
++.+.
T Consensus 308 ~f~~~~ 313 (353)
T 3coi_A 308 FFEPFR 313 (353)
T ss_dssp GGTTTC
T ss_pred chhhcc
Confidence 44443
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=331.24 Aligned_cols=245 Identities=19% Similarity=0.317 Sum_probs=167.4
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCCccchHHHHHHH-HHHhccCCCCcceeeEEEEe----cCceeEEEeccC
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGGWQRFKEFQTEA-EAIGKIRHPNIVSLRAYFWS----VDEKLLIYDYIP 446 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~-~~l~~l~H~nIv~l~~~~~~----~~~~~lV~e~~~ 446 (686)
.+||+|+||.||+|... +++.||||++... ....+|+ ..++.+.||||+++++++.. ....++||||++
T Consensus 35 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~ 109 (336)
T 3fhr_A 35 QVLGLGVNGKVLECFHRRTGQKCALKLLYDS-----PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECME 109 (336)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEESS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCT
T ss_pred eeeeeCCCeEEEEEEECCCCCEEEEEEecCc-----HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEEEeccC
Confidence 36999999999999976 5889999998653 2223333 34566799999999999986 445799999999
Q ss_pred CCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecC---CCCeEEeecCcccccc
Q 042348 447 NGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGK---NMEPHISDFGLARLAD 523 (686)
Q Consensus 447 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~---~~~~kl~DfGla~~~~ 523 (686)
+|+|.+++..... ..+++.++..++.|++.||+|||+ ++|+||||||+||+++. ++.+||+|||+++...
T Consensus 110 gg~L~~~l~~~~~----~~l~~~~~~~i~~ql~~~l~~LH~---~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~ 182 (336)
T 3fhr_A 110 GGELFSRIQERGD----QAFTEREAAEIMRDIGTAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETT 182 (336)
T ss_dssp TEEHHHHHHTC-C----CCCBHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC-
T ss_pred CCCHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEEecCCCceEEEeccccceecc
Confidence 9999999987542 469999999999999999999999 89999999999999976 4559999999997543
Q ss_pred cccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccch
Q 042348 524 IAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMEL 603 (686)
Q Consensus 524 ~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~ 603 (686)
... .....+|..|+|||++.+..++.++|||||||++|||++|+.||........
T Consensus 183 ~~~-------------------------~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~ 237 (336)
T 3fhr_A 183 QNA-------------------------LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAI 237 (336)
T ss_dssp ----------------------------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC--------
T ss_pred ccc-------------------------cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhh
Confidence 211 1233567789999999888899999999999999999999999954432211
Q ss_pred hHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 604 NIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 604 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
. ............... .+ ........+.+++.+||+.||++|||+.|++++
T Consensus 238 ~-~~~~~~~~~~~~~~~---~~------~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 288 (336)
T 3fhr_A 238 S-PGMKRRIRLGQYGFP---NP------EWSEVSEDAKQLIRLLLKTDPTERLTITQFMNH 288 (336)
T ss_dssp --------------CCC---TT------TSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred h-hhHHHhhhccccccC---ch------hhccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0 000111111110000 00 001123467899999999999999999999985
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-38 Score=334.90 Aligned_cols=257 Identities=18% Similarity=0.235 Sum_probs=192.2
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCCccchHHHHHHHHHHhccC-----------CCCcceeeEEEEecC----
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIR-----------HPNIVSLRAYFWSVD---- 436 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------H~nIv~l~~~~~~~~---- 436 (686)
..||+|+||.||+|... +++.||||.+.... ...+.+.+|++++++++ ||||+++++++...+
T Consensus 25 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 103 (373)
T 1q8y_A 25 RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGV 103 (373)
T ss_dssp EEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEE
T ss_pred EeeeecCCeEEEEEEecCCCcEEEEEEecCCc-cchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhccCCCCc
Confidence 46999999999999864 68899999997542 33467889999999886 899999999998654
Q ss_pred ceeEEEeccCCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCC-CceecCCCCCCeeec------CCC
Q 042348 437 EKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPK-RYVHGDLRPSNILLG------KNM 509 (686)
Q Consensus 437 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~-~iiHrDlkp~NILl~------~~~ 509 (686)
..++||||+ +++|.+++..... ..+++..+..++.||+.||+|||+ + +|+||||||+|||++ ..+
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~~~~----~~~~~~~~~~i~~qi~~aL~~lH~---~~~ivH~Dikp~NIll~~~~~~~~~~ 175 (373)
T 1q8y_A 104 HVVMVFEVL-GENLLALIKKYEH----RGIPLIYVKQISKQLLLGLDYMHR---RCGIIHTDIKPENVLMEIVDSPENLI 175 (373)
T ss_dssp EEEEEECCC-CEEHHHHHHHTTT----SCCCHHHHHHHHHHHHHHHHHHHH---TTCEECSCCSGGGEEEEEEETTTTEE
T ss_pred eEEEEEecC-CCCHHHHHHHhhc----cCCcHHHHHHHHHHHHHHHHHHHh---cCCEEecCCChHHeEEeccCCCcCcc
Confidence 679999999 8999999986542 458999999999999999999999 8 999999999999994 445
Q ss_pred CeEEeecCcccccccccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHH
Q 042348 510 EPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMI 589 (686)
Q Consensus 510 ~~kl~DfGla~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ell 589 (686)
.+||+|||+++..... .....||..|+|||++.+..++.++|||||||++|||+
T Consensus 176 ~~kl~Dfg~a~~~~~~--------------------------~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~ 229 (373)
T 1q8y_A 176 QIKIADLGNACWYDEH--------------------------YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELI 229 (373)
T ss_dssp EEEECCCTTCEETTBC--------------------------CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHH
T ss_pred eEEEcccccccccCCC--------------------------CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHH
Confidence 7999999999765321 12335688899999999989999999999999999999
Q ss_pred hCCCCccccCccch-hHHHHHHHHHhhcCCcccc-----------cCc-----------------ccc-cCCCcHHHHHH
Q 042348 590 SGKLPMIQIGSMEL-NIVQWIQLILEDRKPMTDI-----------LDP-----------------FLA-HDLDKEDEIVS 639 (686)
Q Consensus 590 tG~~P~~~~~~~~~-~~~~~~~~~~~~~~~~~~~-----------~d~-----------------~l~-~~~~~~~~~~~ 639 (686)
||+.||........ .....+..+.......+.. ++. .+. ...........
T Consensus 230 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (373)
T 1q8y_A 230 TGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKE 309 (373)
T ss_dssp HSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHH
T ss_pred hCCCCCCCCcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHH
Confidence 99999965432110 0011111111110000000 000 000 00112345678
Q ss_pred HHHHHHhccccCCCCCCCHHHHHHH
Q 042348 640 VLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 640 l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
+.+++.+||+.||++|||+.|++++
T Consensus 310 ~~~li~~~L~~dP~~Rpt~~ell~h 334 (373)
T 1q8y_A 310 ISDFLSPMLQLDPRKRADAGGLVNH 334 (373)
T ss_dssp HHHHHGGGGCSSTTTCBCHHHHHTC
T ss_pred HHHHHHHHhccCccccCCHHHHhhC
Confidence 8999999999999999999999986
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-38 Score=339.82 Aligned_cols=245 Identities=24% Similarity=0.349 Sum_probs=183.1
Q ss_pred cccCccCceEEEEEEeCCCceEEEEEcCCCCccchHHHHHHHHHHhcc-CCCCcceeeEEEEecCceeEEEeccCCCCHH
Q 042348 373 FLLGKSTIGIVYKVALNNEEAVAVRRLGNGGWQRFKEFQTEAEAIGKI-RHPNIVSLRAYFWSVDEKLLIYDYIPNGSLA 451 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL~ 451 (686)
.+||+|+||+||.....+++.||||++..... ..+.+|+++++++ +|||||++++++.+.+..++|||||+ |+|.
T Consensus 30 ~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~-g~L~ 105 (432)
T 3p23_A 30 DVLGHGAEGTIVYRGMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQ 105 (432)
T ss_dssp EEEEECGGGCEEEEEESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS-EEHH
T ss_pred CeeecCcCEEEEEEEEeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC-CCHH
Confidence 47999999997666666789999999966432 3467899999999 79999999999999999999999996 6999
Q ss_pred HHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecC-----CCCeEEeecCccccccccc
Q 042348 452 TAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGK-----NMEPHISDFGLARLADIAE 526 (686)
Q Consensus 452 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~-----~~~~kl~DfGla~~~~~~~ 526 (686)
+++.... ..+.+..+..++.||+.||+|||+ ++|+||||||+|||++. ...+||+|||+|+......
T Consensus 106 ~~l~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~ 177 (432)
T 3p23_A 106 EYVEQKD-----FAHLGLEPITLLQQTTSGLAHLHS---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGR 177 (432)
T ss_dssp HHHHSSS-----CCCCSSCHHHHHHHHHHHHHHHHH---TTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC----
T ss_pred HHHHhcC-----CCccchhHHHHHHHHHHHHHHHHH---CcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCC
Confidence 9998764 235556678999999999999999 89999999999999953 3368899999998664322
Q ss_pred CCccccccccccCCCCCCCccccccccCCCCCccccCccccc---CCCCCCcchHHHHHHHHHHHHh-CCCCccccCccc
Q 042348 527 ETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASK---VRKPTQKWDIYSYGVILLEMIS-GKLPMIQIGSME 602 (686)
Q Consensus 527 ~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~ 602 (686)
.. ........||..|+|||++. ...++.++|||||||++|||+| |..||.......
T Consensus 178 ~~--------------------~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~ 237 (432)
T 3p23_A 178 HS--------------------FSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ 237 (432)
T ss_dssp ----------------------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHH
T ss_pred cc--------------------eeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHH
Confidence 10 01123456888999999987 4567889999999999999999 999984322211
Q ss_pred hhHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 603 LNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 603 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
.. ........ .... ........+.+++.+||+.||++|||+.||+++
T Consensus 238 ------~~-~~~~~~~~-~~~~-------~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~h 284 (432)
T 3p23_A 238 ------AN-ILLGACSL-DCLH-------PEKHEDVIARELIEKMIAMDPQKRPSAKHVLKH 284 (432)
T ss_dssp ------HH-HHTTCCCC-TTSC-------TTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ------HH-HHhccCCc-cccC-------ccccccHHHHHHHHHHHhCCHhhCCCHHHHHhC
Confidence 11 11111111 1111 111234457789999999999999999999864
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=328.99 Aligned_cols=270 Identities=21% Similarity=0.279 Sum_probs=195.0
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCC-ccchHHHHHHHHHHhccCCCCcceeeEEEEec-----CceeEEEecc
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGG-WQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSV-----DEKLLIYDYI 445 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~-----~~~~lV~e~~ 445 (686)
..||+|+||.||+|... +++.||||++.... .....++.+|++++++++||||+++++++... ...++||||+
T Consensus 17 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~ 96 (353)
T 2b9h_A 17 SLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELM 96 (353)
T ss_dssp EEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEEEEECCC
T ss_pred eEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEEEEEecc
Confidence 46999999999999976 58899999996543 23346788999999999999999999998764 6789999999
Q ss_pred CCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccc
Q 042348 446 PNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIA 525 (686)
Q Consensus 446 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~ 525 (686)
. |+|.+++.. ..+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++.....
T Consensus 97 ~-~~L~~~~~~-------~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~ 165 (353)
T 2b9h_A 97 Q-TDLHRVIST-------QMLSDDHIQYFIYQTLRAVKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDES 165 (353)
T ss_dssp S-EEHHHHHHH-------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECC--
T ss_pred C-ccHHHHHhh-------cCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEEcCCCcEEEEecccccccccc
Confidence 7 699999875 358999999999999999999999 89999999999999999999999999999876532
Q ss_pred cCCccccccccccCCCCCCCccccccccCCCCCccccCcccccC-CCCCCcchHHHHHHHHHHHHhCCCCccccCccchh
Q 042348 526 EETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKV-RKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELN 604 (686)
Q Consensus 526 ~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~ 604 (686)
...... ..+ .........||..|+|||++.+ ..++.++|||||||++|||++|+.||...... .
T Consensus 166 ~~~~~~-----~~~--------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~ 230 (353)
T 2b9h_A 166 AADNSE-----PTG--------QQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYR--H 230 (353)
T ss_dssp ---------------------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH--H
T ss_pred cccccC-----ccc--------cccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcH--H
Confidence 211000 000 0011234567899999998754 67899999999999999999999999654321 1
Q ss_pred HHHHHHHHHhhcCCccccc----Ccc-------ccc-CCCc-----HHHHHHHHHHHHhccccCCCCCCCHHHHHHH--H
Q 042348 605 IVQWIQLILEDRKPMTDIL----DPF-------LAH-DLDK-----EDEIVSVLKIALDCVHKSPDKRPSMRHVCDS--L 665 (686)
Q Consensus 605 ~~~~~~~~~~~~~~~~~~~----d~~-------l~~-~~~~-----~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~--L 665 (686)
....+...... ....... .+. +.. .... ......+.+++.+||+.||++|||+.|++++ +
T Consensus 231 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~ 309 (353)
T 2b9h_A 231 QLLLIFGIIGT-PHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYL 309 (353)
T ss_dssp HHHHHHHHHCC-CCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred HHHHHHHHhCC-CchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccc
Confidence 11111111111 0000000 000 000 0000 0123467899999999999999999999986 4
Q ss_pred hccc
Q 042348 666 DRVN 669 (686)
Q Consensus 666 ~~i~ 669 (686)
+.+.
T Consensus 310 ~~~~ 313 (353)
T 2b9h_A 310 QTYH 313 (353)
T ss_dssp TTTC
T ss_pred cccC
Confidence 4443
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-38 Score=326.49 Aligned_cols=234 Identities=19% Similarity=0.274 Sum_probs=189.7
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCCcc------chHHHHHHHHHHhccC--CCCcceeeEEEEecCceeEEEe
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGGWQ------RFKEFQTEAEAIGKIR--HPNIVSLRAYFWSVDEKLLIYD 443 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~--H~nIv~l~~~~~~~~~~~lV~e 443 (686)
..||+|+||.||+|... +++.||||.+...... ..+.+.+|+.++++++ ||||+++++++...+..++|||
T Consensus 49 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~~~~lv~e 128 (320)
T 3a99_A 49 PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILE 128 (320)
T ss_dssp EECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEEEE
T ss_pred EEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCCcEEEEEE
Confidence 46999999999999864 6889999998654221 2345778999999996 5999999999999999999999
Q ss_pred ccCC-CCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeec-CCCCeEEeecCcccc
Q 042348 444 YIPN-GSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLG-KNMEPHISDFGLARL 521 (686)
Q Consensus 444 ~~~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~-~~~~~kl~DfGla~~ 521 (686)
|+.+ ++|.+++... ..+++..+..++.|++.||+|||+ ++|+||||||+|||++ +++.+||+|||+++.
T Consensus 129 ~~~~~~~L~~~l~~~------~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~ 199 (320)
T 3a99_A 129 RPEPVQDLFDFITER------GALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGAL 199 (320)
T ss_dssp CCSSEEEHHHHHHHH------CSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred cCCCCccHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHH---CCcEeCCCCHHHEEEeCCCCCEEEeeCccccc
Confidence 9976 8999999764 358999999999999999999999 8999999999999999 788999999999986
Q ss_pred cccccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCC-CCcchHHHHHHHHHHHHhCCCCccccCc
Q 042348 522 ADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKP-TQKWDIYSYGVILLEMISGKLPMIQIGS 600 (686)
Q Consensus 522 ~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDVwSlGvvl~elltG~~P~~~~~~ 600 (686)
..... .....||..|+|||++.+..+ +.++|||||||++|||++|+.||....
T Consensus 200 ~~~~~-------------------------~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~- 253 (320)
T 3a99_A 200 LKDTV-------------------------YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE- 253 (320)
T ss_dssp CCSSC-------------------------BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-
T ss_pred ccccc-------------------------ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh-
Confidence 54211 123457888999999876665 688999999999999999999994321
Q ss_pred cchhHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 601 MELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 601 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
........... . ....+.+++.+||+.||++|||+.|++++
T Consensus 254 ----------~~~~~~~~~~~--------~-----~~~~~~~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 254 ----------EIIRGQVFFRQ--------R-----VSSECQHLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp ----------HHHHCCCCCSS--------C-----CCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ----------hhhcccccccc--------c-----CCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11112111111 1 12357789999999999999999999885
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-38 Score=324.28 Aligned_cols=234 Identities=22% Similarity=0.328 Sum_probs=184.6
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCCc------cchHHHHHHHHHHhcc----CCCCcceeeEEEEecCceeEE
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGGW------QRFKEFQTEAEAIGKI----RHPNIVSLRAYFWSVDEKLLI 441 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l----~H~nIv~l~~~~~~~~~~~lV 441 (686)
..||+|+||.||+|... +++.||||++..... .....+.+|+.++.++ +||||+++++++...+..++|
T Consensus 37 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~~~~~~~v 116 (312)
T 2iwi_A 37 PLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLV 116 (312)
T ss_dssp EEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-----CEEE
T ss_pred eEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEecCCeEEEE
Confidence 46999999999999864 678999999965432 1234567899999998 899999999999999999999
Q ss_pred Eec-cCCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeec-CCCCeEEeecCcc
Q 042348 442 YDY-IPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLG-KNMEPHISDFGLA 519 (686)
Q Consensus 442 ~e~-~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~-~~~~~kl~DfGla 519 (686)
||| +.+++|.+++... ..+++..+..++.|++.||+|||+ ++|+||||||+||+++ .++.+||+|||++
T Consensus 117 ~e~~~~~~~L~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~kl~dfg~~ 187 (312)
T 2iwi_A 117 LERPLPAQDLFDYITEK------GPLGEGPSRCFFGQVVAAIQHCHS---RGVVHRDIKDENILIDLRRGCAKLIDFGSG 187 (312)
T ss_dssp EECCSSEEEHHHHHHHH------CSCCHHHHHHHHHHHHHHHHHHHH---HTEECCCCSGGGEEEETTTTEEEECCCSSC
T ss_pred EEecCCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChhhEEEeCCCCeEEEEEcchh
Confidence 999 7899999999764 358999999999999999999999 8999999999999999 8899999999999
Q ss_pred cccccccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCC-CCcchHHHHHHHHHHHHhCCCCcccc
Q 042348 520 RLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKP-TQKWDIYSYGVILLEMISGKLPMIQI 598 (686)
Q Consensus 520 ~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDVwSlGvvl~elltG~~P~~~~ 598 (686)
+...... .....||..|+|||++.+..+ +.++|||||||++|||++|+.||...
T Consensus 188 ~~~~~~~-------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 242 (312)
T 2iwi_A 188 ALLHDEP-------------------------YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERD 242 (312)
T ss_dssp EECCSSC-------------------------BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH
T ss_pred hhcccCc-------------------------ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCCh
Confidence 8654211 123456788999999876665 45899999999999999999999431
Q ss_pred CccchhHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 599 GSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 599 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
. ........... .....+.+++.+||+.||++|||+.|++++
T Consensus 243 ~-----------~~~~~~~~~~~-------------~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 243 Q-----------EILEAELHFPA-------------HVSPDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp H-----------HHHHTCCCCCT-------------TSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred H-----------HHhhhccCCcc-------------cCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1 11112111111 112357789999999999999999999985
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=323.66 Aligned_cols=251 Identities=19% Similarity=0.279 Sum_probs=172.9
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCC-ccchHHHHHHHH-HHhccCCCCcceeeEEEEecCceeEEEeccCCCC
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGG-WQRFKEFQTEAE-AIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGS 449 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~-~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gs 449 (686)
..||+|+||.||+|... +++.||||++.... .....++..|+. +++.++||||+++++++...+..++||||+++ +
T Consensus 28 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e~~~~-~ 106 (327)
T 3aln_A 28 GEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMST-S 106 (327)
T ss_dssp CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEECCCSE-E
T ss_pred heeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEeecCC-C
Confidence 36999999999999975 68899999987642 233445666666 77778999999999999999999999999975 8
Q ss_pred HHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCC-CceecCCCCCCeeecCCCCeEEeecCcccccccccCC
Q 042348 450 LATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPK-RYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEET 528 (686)
Q Consensus 450 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~-~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 528 (686)
|.+++...... ....+++..+..++.|++.||+|||+ + +|+||||||+||+++.++.+||+|||+++.......
T Consensus 107 l~~~~~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~---~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~- 181 (327)
T 3aln_A 107 FDKFYKYVYSV-LDDVIPEEILGKITLATVKALNHLKE---NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIA- 181 (327)
T ss_dssp HHHHHHHHHHT-TCCCCCHHHHHHHHHHHHHHHHHHHH---HHSCCCSCCCGGGEEEETTTEEEECCCSSSCC-------
T ss_pred hHHHHHHHHhh-hcccCcHHHHHHHHHHHHHHHHHHhc---cCCEeECCCCHHHEEEcCCCCEEEccCCCceecccccc-
Confidence 88877631100 01468999999999999999999999 7 999999999999999999999999999976532210
Q ss_pred ccccccccccCCCCCCCccccccccCCCCCccccCcccc----cCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchh
Q 042348 529 PEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEAS----KVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELN 604 (686)
Q Consensus 529 ~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~ 604 (686)
.....||..|+|||++ .+..++.++|||||||++|||++|+.||........
T Consensus 182 -----------------------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~- 237 (327)
T 3aln_A 182 -----------------------KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD- 237 (327)
T ss_dssp -----------------------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC------
T ss_pred -----------------------cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH-
Confidence 1123567889999998 456789999999999999999999999954322110
Q ss_pred HHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 605 IVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 605 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
.+...... ..+.+... ........+.+++.+||+.||++|||+.|++++
T Consensus 238 ---~~~~~~~~-------~~~~~~~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 286 (327)
T 3aln_A 238 ---QLTQVVKG-------DPPQLSNS-EEREFSPSFINFVNLCLTKDESKRPKYKELLKH 286 (327)
T ss_dssp -----CCCCCS-------CCCCCCCC-SSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred ---HHHHHhcC-------CCCCCCCc-ccccCCHHHHHHHHHHhhCChhhCcCHHHHHhC
Confidence 00000000 00111100 001123468899999999999999999999875
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-37 Score=319.23 Aligned_cols=245 Identities=19% Similarity=0.316 Sum_probs=175.0
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCCcc-c-hHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCC
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGGWQ-R-FKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGS 449 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~-~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gs 449 (686)
..||+|+||.||+|... +++.||||.+...... . .+.+..+..+++.++||||+++++++...+..++||||+ ++.
T Consensus 31 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~ 109 (318)
T 2dyl_A 31 GEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-GTC 109 (318)
T ss_dssp EEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCC-SEE
T ss_pred ceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEecc-CCc
Confidence 36999999999999986 6889999998654322 2 233445556788889999999999999999999999999 556
Q ss_pred HHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCC-CceecCCCCCCeeecCCCCeEEeecCcccccccccCC
Q 042348 450 LATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPK-RYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEET 528 (686)
Q Consensus 450 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~-~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 528 (686)
+..+..... ..+++..+..++.|++.||+|||+ + +|+||||||+||+++.++.+||+|||+++.......
T Consensus 110 ~~~l~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~- 180 (318)
T 2dyl_A 110 AEKLKKRMQ-----GPIPERILGKMTVAIVKALYYLKE---KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKA- 180 (318)
T ss_dssp HHHHHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHH---HHCCCCCCCCGGGEEECTTSCEEECCCTTC---------
T ss_pred HHHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHh---hCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCCcc-
Confidence 666554332 468999999999999999999998 6 899999999999999999999999999975532211
Q ss_pred ccccccccccCCCCCCCccccccccCCCCCccccCccccc-----CCCCCCcchHHHHHHHHHHHHhCCCCccccCccch
Q 042348 529 PEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASK-----VRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMEL 603 (686)
Q Consensus 529 ~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~ 603 (686)
.....+|..|+|||.+. ...++.++|||||||++|||++|+.||......
T Consensus 181 -----------------------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-- 235 (318)
T 2dyl_A 181 -----------------------KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD-- 235 (318)
T ss_dssp -----------------------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSH--
T ss_pred -----------------------ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc--
Confidence 11235677899999984 456899999999999999999999999643222
Q ss_pred hHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 604 NIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 604 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
............+... ... .....+.+++.+||+.||++||++.|++++
T Consensus 236 --~~~~~~~~~~~~~~~~-------~~~---~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (318)
T 2dyl_A 236 --FEVLTKVLQEEPPLLP-------GHM---GFSGDFQSFVKDCLTKDHRKRPKYNKLLEH 284 (318)
T ss_dssp --HHHHHHHHHSCCCCCC-------SSS---CCCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred --HHHHHHHhccCCCCCC-------ccC---CCCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 1223333333221110 000 112357789999999999999999999875
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-36 Score=309.38 Aligned_cols=228 Identities=13% Similarity=0.127 Sum_probs=177.1
Q ss_pred cccCccCceEEEEEEeCC-CceEEEEEcCCCCc---cchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCC
Q 042348 373 FLLGKSTIGIVYKVALNN-EEAVAVRRLGNGGW---QRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNG 448 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~g 448 (686)
..||+|+||.||+|.... ++.||||.+..... ...+.+.+|+.++++++||||+++++++...+..++||||++++
T Consensus 37 ~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~ 116 (286)
T 3uqc_A 37 IFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGG 116 (286)
T ss_dssp EEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCCEE
T ss_pred EEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEEEecCCC
Confidence 369999999999999764 88999999976532 23467999999999999999999999999999999999999999
Q ss_pred CHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCC
Q 042348 449 SLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEET 528 (686)
Q Consensus 449 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 528 (686)
+|.+++... ....++.+|+.|++.||+|||+ ++|+||||||+|||++.++.+||+++|
T Consensus 117 ~L~~~l~~~--------~~~~~~~~i~~ql~~aL~~lH~---~givH~Dikp~NIll~~~g~~kl~~~~----------- 174 (286)
T 3uqc_A 117 SLQEVADTS--------PSPVGAIRAMQSLAAAADAAHR---AGVALSIDHPSRVRVSIDGDVVLAYPA----------- 174 (286)
T ss_dssp EHHHHHTTC--------CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEEETTSCEEECSCC-----------
T ss_pred CHHHHHhcC--------CChHHHHHHHHHHHHHHHHHHH---CCCccCCCCcccEEEcCCCCEEEEecc-----------
Confidence 999999532 3455788999999999999999 899999999999999999999998544
Q ss_pred ccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHH
Q 042348 529 PEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQW 608 (686)
Q Consensus 529 ~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~ 608 (686)
|++| ++.++|||||||++|||+||+.||...........
T Consensus 175 --------------------------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~-- 213 (286)
T 3uqc_A 175 --------------------------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAP-- 213 (286)
T ss_dssp --------------------------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEE--
T ss_pred --------------------------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHH--
Confidence 4443 58899999999999999999999965433211000
Q ss_pred HHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccccch
Q 042348 609 IQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRVNISTE 673 (686)
Q Consensus 609 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~~~~ 673 (686)
............. ... ......+.+++.+||+.||++| |+.|+++.|+++.....
T Consensus 214 ~~~~~~~~~~~~~----~~~-----~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~~ 268 (286)
T 3uqc_A 214 AERDTAGQPIEPA----DID-----RDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVAD 268 (286)
T ss_dssp CCBCTTSCBCCHH----HHC-----TTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC---
T ss_pred HHHHhccCCCChh----hcc-----cCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccCC
Confidence 0000000000000 000 1123457899999999999999 99999999999875443
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-37 Score=342.16 Aligned_cols=255 Identities=24% Similarity=0.278 Sum_probs=191.0
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCC-CccchHHHHHHHHHHhccCCCCcceeeEEEEe------cCceeEEEec
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNG-GWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWS------VDEKLLIYDY 444 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~------~~~~~lV~e~ 444 (686)
..||+|+||.||+|... +++.||||++... .....+.+.+|++++++++||||+++++++.. .+..++||||
T Consensus 20 ~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~~LVmEy 99 (676)
T 3qa8_A 20 ERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEY 99 (676)
T ss_dssp CCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSCCCEEEC
T ss_pred EEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeEEEEEEe
Confidence 46999999999999874 5889999998764 33445679999999999999999999999765 5677999999
Q ss_pred cCCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCC---eEEeecCcccc
Q 042348 445 IPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNME---PHISDFGLARL 521 (686)
Q Consensus 445 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~---~kl~DfGla~~ 521 (686)
+++|+|.+++...... ..+++..+..|+.|++.||+|||+ .+|+||||||+||+++.++. +||+|||+++.
T Consensus 100 ~~ggsL~~~L~~~~~~---~~lse~~i~~I~~QLl~aL~yLHs---~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~~ 173 (676)
T 3qa8_A 100 CEGGDLRKYLNQFENC---CGLKEGPIRTLLSDISSALRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKE 173 (676)
T ss_dssp CSSCBHHHHHHSSSCT---TCCCSSHHHHHHHHHHHHHHHHHH---TTBCCCCCCSTTEEEECCSSSCEEEECSCCCCCB
T ss_pred CCCCCHHHHHHhcccC---CCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHeEeecCCCceeEEEcccccccc
Confidence 9999999999875421 358999999999999999999999 89999999999999997765 89999999986
Q ss_pred cccccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCcc
Q 042348 522 ADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSM 601 (686)
Q Consensus 522 ~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~ 601 (686)
..... ......||..|+|||.+.+..++.++|||||||++|||++|+.||.....
T Consensus 174 ~~~~~------------------------~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~- 228 (676)
T 3qa8_A 174 LDQGE------------------------LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQ- 228 (676)
T ss_dssp TTSCC------------------------CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCH-
T ss_pred ccccc------------------------ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccc-
Confidence 54221 11234678889999999999999999999999999999999999954211
Q ss_pred chhHHHHHHHHHhhc---CCcccccC------cccc-cCCCcHHHHHHHHHHHHhccccCCCCCCCHHHH
Q 042348 602 ELNIVQWIQLILEDR---KPMTDILD------PFLA-HDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHV 661 (686)
Q Consensus 602 ~~~~~~~~~~~~~~~---~~~~~~~d------~~l~-~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev 661 (686)
...|........ ....+... ..+. ...........+.+++.+||+.||++|||+.|+
T Consensus 229 ---~~~~~~~i~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~el 295 (676)
T 3qa8_A 229 ---PVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQN 295 (676)
T ss_dssp ---HHHSSTTCC------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTC
T ss_pred ---hhhhhhhhhcccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHH
Confidence 111110000000 00000000 0000 000112345678899999999999999999873
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-36 Score=345.56 Aligned_cols=233 Identities=19% Similarity=0.251 Sum_probs=185.0
Q ss_pred cccCccCceEEEEEEeC--CCceEEEEEcCCCC-ccchHHHHHHHHHHhccCCCCcceeeEEEEecCc-----eeEEEec
Q 042348 373 FLLGKSTIGIVYKVALN--NEEAVAVRRLGNGG-WQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDE-----KLLIYDY 444 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~--~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~-----~~lV~e~ 444 (686)
..||+|+||.||+|... +++.||||++.... ......+.+|++++++++|||||++++++...+. .++||||
T Consensus 86 ~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~lv~E~ 165 (681)
T 2pzi_A 86 GCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEY 165 (681)
T ss_dssp EEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEEEEEEEC
T ss_pred EEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCceeEEEEEe
Confidence 46999999999999975 58899999986543 3345678999999999999999999999998766 6999999
Q ss_pred cCCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCccccccc
Q 042348 445 IPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADI 524 (686)
Q Consensus 445 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~ 524 (686)
+++++|.+++.. .+++.+++.|+.||+.||+|||+ ++||||||||+|||++.+ .+||+|||+++....
T Consensus 166 ~~g~~L~~~~~~--------~l~~~~~~~~~~qi~~aL~~lH~---~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~ 233 (681)
T 2pzi_A 166 VGGQSLKRSKGQ--------KLPVAEAIAYLLEILPALSYLHS---IGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINS 233 (681)
T ss_dssp CCCEECC----C--------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECSS-CEEECCCTTCEETTC
T ss_pred CCCCcHHHHHhC--------CCCHHHHHHHHHHHHHHHHHHHH---CCCeecccChHHeEEeCC-cEEEEecccchhccc
Confidence 999999987653 48999999999999999999999 899999999999999886 899999999975432
Q ss_pred ccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchh
Q 042348 525 AEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELN 604 (686)
Q Consensus 525 ~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~ 604 (686)
. ....||..|+|||++.+. ++.++|||||||++|||++|..||.......
T Consensus 234 ~---------------------------~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~-- 283 (681)
T 2pzi_A 234 F---------------------------GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDG-- 283 (681)
T ss_dssp C---------------------------SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSS--
T ss_pred C---------------------------CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCccccccc--
Confidence 1 234578889999998765 4889999999999999999998884321110
Q ss_pred HHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCC-HHHHHHHHhccc
Q 042348 605 IVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPS-MRHVCDSLDRVN 669 (686)
Q Consensus 605 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-~~ev~~~L~~i~ 669 (686)
.. ...........+.+++.+||+.||++||+ ++++.+.|..+.
T Consensus 284 --------------~~--------~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 327 (681)
T 2pzi_A 284 --------------LP--------EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVL 327 (681)
T ss_dssp --------------CC--------TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred --------------cc--------ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence 00 00011122346789999999999999995 666666676553
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-36 Score=307.42 Aligned_cols=222 Identities=20% Similarity=0.338 Sum_probs=173.2
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCCccchHHHHHHHHHH-hccCCCCcceeeEEEEe----cCceeEEEeccC
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGGWQRFKEFQTEAEAI-GKIRHPNIVSLRAYFWS----VDEKLLIYDYIP 446 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l-~~l~H~nIv~l~~~~~~----~~~~~lV~e~~~ 446 (686)
.+||+|+||.||+|... +++.||+|++.. ...+.+|+.++ +..+||||+++++++.. .+..++||||++
T Consensus 24 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~ 98 (299)
T 3m2w_A 24 QVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLD 98 (299)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECCCC
T ss_pred cccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEeecC
Confidence 46999999999999874 688999999854 25678899988 55599999999999987 667899999999
Q ss_pred CCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecC---CCCeEEeecCcccccc
Q 042348 447 NGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGK---NMEPHISDFGLARLAD 523 (686)
Q Consensus 447 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~---~~~~kl~DfGla~~~~ 523 (686)
+|+|.+++..... ..+++..+..++.|++.||+|||+ ++|+||||||+||+++. ++.+||+|||+++...
T Consensus 99 ~~~L~~~l~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~ 171 (299)
T 3m2w_A 99 GGELFSRIQDRGD----QAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT 171 (299)
T ss_dssp SCBHHHHHHHCTT----CCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECT
T ss_pred CCcHHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEecCCCCCcEEEeccccccccc
Confidence 9999999987542 468999999999999999999999 89999999999999998 7899999999986322
Q ss_pred cccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccch
Q 042348 524 IAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMEL 603 (686)
Q Consensus 524 ~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~ 603 (686)
+..++.++|||||||++|||+||+.||........
T Consensus 172 ---------------------------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~ 206 (299)
T 3m2w_A 172 ---------------------------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI 206 (299)
T ss_dssp ---------------------------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC------
T ss_pred ---------------------------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhh
Confidence 12357789999999999999999999954322110
Q ss_pred hHHHHHHHHHhhcCCcccccCcccccCCCc---HHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 604 NIVQWIQLILEDRKPMTDILDPFLAHDLDK---EDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 604 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~---~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
..... ........ .... .....++.+++.+||+.||++|||+.|++++
T Consensus 207 ---------~~~~~--~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h 257 (299)
T 3m2w_A 207 ---------SPGMK--TRIRMGQY--EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 257 (299)
T ss_dssp ----------CCSC--CSSCTTCC--SSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ---------hHHHH--HHHhhccc--cCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 00000 00000000 0000 1123468899999999999999999999985
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=326.55 Aligned_cols=239 Identities=16% Similarity=0.135 Sum_probs=173.5
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCCc---cchHHHHHHHHHHhccCC-CCcce--------------------
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGGW---QRFKEFQTEAEAIGKIRH-PNIVS-------------------- 427 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H-~nIv~-------------------- 427 (686)
++||+|+||.||+|... +++.||||++..... ...+.+.+|+.+++.++| +|...
T Consensus 84 ~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (413)
T 3dzo_A 84 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKK 163 (413)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEECCC--
T ss_pred cccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcccCCCC
Confidence 47999999999999954 688999999874322 235789999999999987 32211
Q ss_pred -eeEEEEe-----cCceeEEEeccCCCCHHHHhhcCCC-ccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCC
Q 042348 428 -LRAYFWS-----VDEKLLIYDYIPNGSLATAIHGKAG-IISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRP 500 (686)
Q Consensus 428 -l~~~~~~-----~~~~~lV~e~~~~gsL~~~l~~~~~-~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp 500 (686)
+..++.. ....+++|+++ +++|.+++..... ......+++..++.|+.|++.||+|||+ ++|+||||||
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~iiHrDiKp 239 (413)
T 3dzo_A 164 KMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGLVHTYLRP 239 (413)
T ss_dssp -------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH---TTEECSCCCG
T ss_pred ccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCccc
Confidence 1111111 12356777766 6899999852100 0001458899999999999999999999 8999999999
Q ss_pred CCeeecCCCCeEEeecCcccccccccCCccccccccccCCCCCCCccccccccCCCCCccccCcccc----------cCC
Q 042348 501 SNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEAS----------KVR 570 (686)
Q Consensus 501 ~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~ 570 (686)
+|||++.++.+||+|||+++..... .....| ..|+|||++ ...
T Consensus 240 ~NILl~~~~~~kL~DFG~a~~~~~~--------------------------~~~~~g-~~y~aPE~~~~~~~~~~~~~~~ 292 (413)
T 3dzo_A 240 VDIVLDQRGGVFLTGFEHLVRDGAS--------------------------AVSPIG-RGFAPPETTAERMLPFGQHHPT 292 (413)
T ss_dssp GGEEECTTCCEEECCGGGCEETTEE--------------------------ECCCCC-TTTCCHHHHHHHTSTTGGGCCE
T ss_pred ceEEEecCCeEEEEeccceeecCCc--------------------------cccCCC-CceeCchhhhccccccccccCc
Confidence 9999999999999999998754321 122345 679999998 555
Q ss_pred CCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhcccc
Q 042348 571 KPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHK 650 (686)
Q Consensus 571 ~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~ 650 (686)
.++.++|||||||++|||+||+.||......+. ...++. .... ....+.+++.+||+.
T Consensus 293 ~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~---------------~~~~~~----~~~~---~~~~~~~li~~~l~~ 350 (413)
T 3dzo_A 293 LMTFAFDTWTLGLAIYWIWCADLPNTDDAALGG---------------SEWIFR----SCKN---IPQPVRALLEGFLRY 350 (413)
T ss_dssp EECHHHHHHHHHHHHHHHHHSSCCCCTTGGGSC---------------SGGGGS----SCCC---CCHHHHHHHHHHTCS
T ss_pred CCCchhhHHHHHHHHHHHHHCCCCCCCcchhhh---------------HHHHHh----hccc---CCHHHHHHHHHHccC
Confidence 688999999999999999999999954322111 111111 0001 124588999999999
Q ss_pred CCCCCCCHHHHHHH
Q 042348 651 SPDKRPSMRHVCDS 664 (686)
Q Consensus 651 dP~~RPs~~ev~~~ 664 (686)
||++||++.|++++
T Consensus 351 dP~~Rpt~~~~l~~ 364 (413)
T 3dzo_A 351 PKEDRLLPLQAMET 364 (413)
T ss_dssp SGGGSCCHHHHTTS
T ss_pred ChhhCcCHHHHHhC
Confidence 99999998888654
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=311.26 Aligned_cols=238 Identities=15% Similarity=0.165 Sum_probs=177.6
Q ss_pred hcccCccCceEEEEEEeCCCceEEEEEcCCCC--------ccchHHHHHHHHHHhccC---------CCCcceeeEEEE-
Q 042348 372 AFLLGKSTIGIVYKVALNNEEAVAVRRLGNGG--------WQRFKEFQTEAEAIGKIR---------HPNIVSLRAYFW- 433 (686)
Q Consensus 372 ~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~---------H~nIv~l~~~~~- 433 (686)
...||+|+||.||+|+. +++.||||++.... ....+.+.+|++++++++ |||||++.+.+.
T Consensus 25 ~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~~~~~~ 103 (336)
T 2vuw_A 25 CEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCV 103 (336)
T ss_dssp CEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEEEEEEE
T ss_pred eeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhcceeEe
Confidence 45799999999999998 67999999986542 223477899999999886 777777766643
Q ss_pred ----------------e-------------cCceeEEEeccCCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHH
Q 042348 434 ----------------S-------------VDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAF 484 (686)
Q Consensus 434 ----------------~-------------~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~ 484 (686)
+ .+..++|||||++|++.+.+.. ..+++.+++.|+.||+.||+|
T Consensus 104 ~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-------~~~~~~~~~~i~~qi~~aL~~ 176 (336)
T 2vuw_A 104 QGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-------KLSSLATAKSILHQLTASLAV 176 (336)
T ss_dssp ESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-------TCCCHHHHHHHHHHHHHHHHH
T ss_pred cCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-------cCCCHHHHHHHHHHHHHHHHH
Confidence 2 6788999999999977666643 348999999999999999999
Q ss_pred HH-ccCCCCceecCCCCCCeeecCCC--------------------CeEEeecCcccccccccCCccccccccccCCCCC
Q 042348 485 LH-EVSPKRYVHGDLRPSNILLGKNM--------------------EPHISDFGLARLADIAEETPEVHWEQSTTGTPLQ 543 (686)
Q Consensus 485 LH-~~~~~~iiHrDlkp~NILl~~~~--------------------~~kl~DfGla~~~~~~~~~~~~~~~~~~~g~~~~ 543 (686)
|| + ++|+||||||+|||++.++ .+||+|||+|+.....
T Consensus 177 lH~~---~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------------------ 235 (336)
T 2vuw_A 177 AEAS---LRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------------------ 235 (336)
T ss_dssp HHHH---HCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------------------
T ss_pred HHHh---CCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------------------
Confidence 99 8 8999999999999999887 8999999999865421
Q ss_pred CCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHH-HHHHHhCCCCccccCccchhHHHHHHHHHhhcCCcccc
Q 042348 544 SSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVI-LLEMISGKLPMIQIGSMELNIVQWIQLILEDRKPMTDI 622 (686)
Q Consensus 544 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvv-l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 622 (686)
...||..|+|||++.+.. +.++||||+|++ .+++++|..||.... ............. .....
T Consensus 236 ----------~~~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~----~~~~~~~~~~~~~-~~~~~ 299 (336)
T 2vuw_A 236 ----------IVVFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVL----WLHYLTDKMLKQM-TFKTK 299 (336)
T ss_dssp ----------EEECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHH----HHHHHHHHHHHTC-CCSSC
T ss_pred ----------cEEEeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchh----hhhHHHHhhhhhh-ccCcc
Confidence 125677899999998766 889999998777 788889999983210 0011111222111 11110
Q ss_pred cCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHH-HH
Q 042348 623 LDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVC-DS 664 (686)
Q Consensus 623 ~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~-~~ 664 (686)
..+ ........++.+++.+||++| |++|++ ++
T Consensus 300 ~~~-----~~~~~~s~~~~dli~~~L~~d-----sa~e~l~~H 332 (336)
T 2vuw_A 300 CNT-----PAMKQIKRKIQEFHRTMLNFS-----SATDLLCQH 332 (336)
T ss_dssp CCS-----HHHHHHHHHHHHHHHHGGGSS-----SHHHHHHHC
T ss_pred cch-----hhhhhcCHHHHHHHHHHhccC-----CHHHHHhcC
Confidence 000 012345667899999999976 999988 54
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-33 Score=288.47 Aligned_cols=233 Identities=28% Similarity=0.531 Sum_probs=183.2
Q ss_pred CChhHHHHHHHHHHhccCCCCC-CCCCCCCCCCcc--eeeeEecC----CCEEEEEeCCCCccc--cCCcCcCCCCCCCE
Q 042348 15 SANDEGLALLSFKQAIRNFPEG-NNWNNSNEDPCS--WNGITCRE----GQVFSLIIPNKKLTG--FIPADLGSLSAIGR 85 (686)
Q Consensus 15 ~~~~~~~~l~~~k~~~~~~~~~-~~w~~~~~~~c~--w~gv~c~~----~~~~~l~l~~n~l~g--~~p~~l~~l~~L~~ 85 (686)
+..+|..||++||+++. +|.. .+|+. +.+||. |.||+|+. ++|+.|+|++|+++| .+|..|+.+++|++
T Consensus 3 c~~~~~~aL~~~k~~~~-~~~~l~~W~~-~~~~C~~~w~gv~C~~~~~~~~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~ 80 (313)
T 1ogq_A 3 CNPQDKQALLQIKKDLG-NPTTLSSWLP-TTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNF 80 (313)
T ss_dssp SCHHHHHHHHHHHHHTT-CCGGGTTCCT-TSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTCSE
T ss_pred CCHHHHHHHHHHHHhcC-CcccccCCCC-CCCCCcCCCcceEeCCCCCCceEEEEECCCCCccCCcccChhHhCCCCCCe
Confidence 56789999999999995 4433 68875 468998 99999985 789999999999999 89999999999999
Q ss_pred EEccC-CCCcccCCccccCCCCCcEEEccCCCCCCCCcccccCCCCCCEEeccCCCCCCCCChhhhhccccccccccccc
Q 042348 86 VNLRN-NNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNS 164 (686)
Q Consensus 86 L~L~~-N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~ 164 (686)
|+|++ |.+.+.+|..|.++++|++|+|++|++++.+|..|+.+++|++|+|++|.+++.+|..+..+++|++|+|++|+
T Consensus 81 L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~ 160 (313)
T 1ogq_A 81 LYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNR 160 (313)
T ss_dssp EEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSC
T ss_pred eeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCCcCChHHhcCCCCCeEECcCCc
Confidence 99995 99999999999999999999999999998899999999999999999999988888888888888888888888
Q ss_pred cCCCCchhhhhcCc-ccceecccccccCCCCchhhhcc-----------------------cccccc-------------
Q 042348 165 FTGPLPDGFATNLT-ALQKLDLSFNNLSGLIPNDIANL-----------------------SRLRLL------------- 207 (686)
Q Consensus 165 l~~~~p~~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l-----------------------~~L~~l------------- 207 (686)
+++.+|..+. .++ +|+.|+|++|++++.+|..+..+ ++|+.|
T Consensus 161 l~~~~p~~l~-~l~~~L~~L~L~~N~l~~~~~~~~~~l~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~ 239 (313)
T 1ogq_A 161 ISGAIPDSYG-SFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK 239 (313)
T ss_dssp CEEECCGGGG-CCCTTCCEEECCSSEEEEECCGGGGGCCCSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGG
T ss_pred ccCcCCHHHh-hhhhcCcEEECcCCeeeccCChHHhCCcccEEECcCCcccCcCCHHHhcCCCCCEEECCCCceeeecCc
Confidence 8877887764 455 66666666666665555444332 222111
Q ss_pred ----------------------------cccccccccCCCCCCCcccccccccCCcccccCCCCCCCCCCC
Q 042348 208 ----------------------------AQRVYVDLTYNNLSGLIPQNAALLSLGPTAFIGNPFLCGPPLK 250 (686)
Q Consensus 208 ----------------------------~~~~~l~l~~N~l~~~~p~~~~~~~~~~~~~~~n~~~c~~p~~ 250 (686)
+++.+|++++|+++|.+|....+.++....+.+|+++||.|+.
T Consensus 240 ~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~~~l~~L~~l~l~~N~~lc~~p~~ 310 (313)
T 1ogq_A 240 VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSPLP 310 (313)
T ss_dssp CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSSEEESTTSS
T ss_pred ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCCCCccccccChHHhcCCCCccCCCCC
Confidence 1233455666666666665555666677778888888887664
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=7e-31 Score=292.75 Aligned_cols=185 Identities=11% Similarity=0.031 Sum_probs=129.5
Q ss_pred cCccCceEEEEEE-eCCCceEEEEEcCCCC----------ccchHHHHHHHHHHhcc-CCCCcceeeEEEEecCceeEEE
Q 042348 375 LGKSTIGIVYKVA-LNNEEAVAVRRLGNGG----------WQRFKEFQTEAEAIGKI-RHPNIVSLRAYFWSVDEKLLIY 442 (686)
Q Consensus 375 iG~G~~g~Vy~~~-~~~~~~vavK~~~~~~----------~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~ 442 (686)
.+.|+.|.++.++ .-.|+.++||.+.... ....++|.+|+++|+++ .|+||+++++++++++..||||
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM 321 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM 321 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence 4566777666654 3347889999986531 12345799999999999 7999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCccccc
Q 042348 443 DYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLA 522 (686)
Q Consensus 443 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~ 522 (686)
||++||+|.++|.... +++.. +|+.||+.||+|+|+ +|||||||||+|||+++++.+||+|||+|+..
T Consensus 322 Eyv~G~~L~d~i~~~~------~l~~~---~I~~QIl~AL~ylH~---~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~ 389 (569)
T 4azs_A 322 EKLPGRLLSDMLAAGE------EIDRE---KILGSLLRSLAALEK---QGFWHDDVRPWNVMVDARQHARLIDFGSIVTT 389 (569)
T ss_dssp ECCCSEEHHHHHHTTC------CCCHH---HHHHHHHHHHHHHHH---TTCEESCCCGGGEEECTTSCEEECCCTTEESC
T ss_pred ecCCCCcHHHHHHhCC------CCCHH---HHHHHHHHHHHHHHH---CCceeccCchHhEEECCCCCEEEeecccCeeC
Confidence 9999999999998653 45543 589999999999999 99999999999999999999999999999865
Q ss_pred ccccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCc
Q 042348 523 DIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPM 595 (686)
Q Consensus 523 ~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~ 595 (686)
.... ......+||++|+|||++.+ .+..++|+||+|++++++.++..|+
T Consensus 390 ~~~~-----------------------~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~~ 438 (569)
T 4azs_A 390 PQDC-----------------------SWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSNW 438 (569)
T ss_dssp C--------------------------CCSHHHHHHHHHHHHHHC------------------CCCCTTHHHH
T ss_pred CCCC-----------------------ccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccchh
Confidence 4321 11234568899999999875 4677899999999988887665544
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.95 E-value=3.7e-28 Score=281.38 Aligned_cols=217 Identities=18% Similarity=0.283 Sum_probs=185.4
Q ss_pred CChhHHHHHHHHHHhccCCCCCCCCCCCC----CCC--cce------------eeeEec-CCCEEEEEeCCCCccccCCc
Q 042348 15 SANDEGLALLSFKQAIRNFPEGNNWNNSN----EDP--CSW------------NGITCR-EGQVFSLIIPNKKLTGFIPA 75 (686)
Q Consensus 15 ~~~~~~~~l~~~k~~~~~~~~~~~w~~~~----~~~--c~w------------~gv~c~-~~~~~~l~l~~n~l~g~~p~ 75 (686)
...+|..||+.||+++. +| +|+.++ .+| |.| .||+|+ .++|+.|+|++|+|+|.+|+
T Consensus 266 ~~~~d~~ALl~~k~~l~-~~---~W~~~~~~~~~~~~~C~W~~~~~~~~w~~~~GV~C~~~~~V~~L~Ls~~~L~G~ip~ 341 (876)
T 4ecn_A 266 EYIKDYKALKAIWEALD-GK---NWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPD 341 (876)
T ss_dssp HHHHHHHHHHHHHHHTT-GG---GCCCCCSSCSSCCCCCSCCCSSCGGGTTCCTTEEECTTSCEEEEECTTTCCEEEECG
T ss_pred cchHHHHHHHHHHHHcC-CC---CCCcCCCcccccCCccccccccccccccCcCceEecCCCCEEEEECccCCCCCcCch
Confidence 34579999999999994 34 687664 467 999 999998 58999999999999999999
Q ss_pred CcCCCCCCCEEEc-cCCCCccc----------------------------------------------------------
Q 042348 76 DLGSLSAIGRVNL-RNNNFSGS---------------------------------------------------------- 96 (686)
Q Consensus 76 ~l~~l~~L~~L~L-~~N~l~g~---------------------------------------------------------- 96 (686)
.|++|++|+.|+| ++|.++|.
T Consensus 342 ~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~l~~~~l~~~~~~~~i~~~~ 421 (876)
T 4ecn_A 342 AIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDS 421 (876)
T ss_dssp GGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHTCTTSCCCCCCC
T ss_pred HHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhHHHHHHhhhCcccccccccc
Confidence 9999999999999 88866554
Q ss_pred ------------------CCccccCCCCCcEEEccCCCCCC-----------------CCccccc--CCCCCCEEeccCC
Q 042348 97 ------------------LPVELFNASNLQSLILSGNSFSG-----------------PVPMQIG--KLKYLQVLDLSQN 139 (686)
Q Consensus 97 ------------------~p~~~~~l~~L~~L~L~~N~l~g-----------------~~p~~~~--~l~~L~~L~ls~N 139 (686)
+|.+|+++++|++|+|++|+|+| .+|..++ ++++|++|+|++|
T Consensus 422 ~l~l~~l~l~~~~N~L~~IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N 501 (876)
T 4ecn_A 422 RISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNC 501 (876)
T ss_dssp CCCCCTTTTTCCSCEEEEECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESC
T ss_pred ccchhhceeccccCcccchhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcCC
Confidence 88899999999999999999998 3999988 9999999999999
Q ss_pred CCCCCCChhhhhccccccccccccc-cCC-CCchhhhhcCc-------ccceecccccccCCCCch--hhhccccccccc
Q 042348 140 SFSSSIPSSIVQCKRLKTVVLNQNS-FTG-PLPDGFATNLT-------ALQKLDLSFNNLSGLIPN--DIANLSRLRLLA 208 (686)
Q Consensus 140 ~l~~~~p~~~~~l~~L~~L~L~~N~-l~~-~~p~~~~~~l~-------~L~~L~Ls~N~l~~~~p~--~~~~l~~L~~l~ 208 (686)
++.+.+|..+.++++|+.|+|++|+ ++| .+|..+. .++ +|+.|+|++|+++ .+|. .++++++|+.|
T Consensus 502 ~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~-~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~L~~L- 578 (876)
T 4ecn_A 502 PNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWT-RLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKLGLL- 578 (876)
T ss_dssp TTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHH-HHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCTTCCEE-
T ss_pred CCCccChHHHhCCCCCCEEECcCCCCcccccchHHHH-hhhhcccccCCccEEEeeCCcCC-ccCChhhhhcCCCCCEE-
Confidence 9999999999999999999999998 998 8898774 555 9999999999999 7787 88888887765
Q ss_pred ccccccccCCCCCCCcccccccccCCcccccCCCCC
Q 042348 209 QRVYVDLTYNNLSGLIPQNAALLSLGPTAFIGNPFL 244 (686)
Q Consensus 209 ~~~~l~l~~N~l~~~~p~~~~~~~~~~~~~~~n~~~ 244 (686)
+|++|+++ .+|....+.++..+.+.+|...
T Consensus 579 -----~Ls~N~l~-~lp~~~~L~~L~~L~Ls~N~l~ 608 (876)
T 4ecn_A 579 -----DCVHNKVR-HLEAFGTNVKLTDLKLDYNQIE 608 (876)
T ss_dssp -----ECTTSCCC-BCCCCCTTSEESEEECCSSCCS
T ss_pred -----ECCCCCcc-cchhhcCCCcceEEECcCCccc
Confidence 78888887 5664444555556666666544
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=9.9e-28 Score=279.01 Aligned_cols=192 Identities=37% Similarity=0.585 Sum_probs=157.3
Q ss_pred CCEEEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCccccCCCCCcEEEccCCCCCCCCcccc-----------
Q 042348 57 GQVFSLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQI----------- 125 (686)
Q Consensus 57 ~~~~~l~l~~n~l~g~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~----------- 125 (686)
..++.|+|++|+++|.+|..++.+++|+.|+|++|+++|.+|..+.++++|+.|+|++|+++|.+|..+
T Consensus 490 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~~~~~~ 569 (768)
T 3rgz_A 490 TNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANF 569 (768)
T ss_dssp TTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEECCGGGGGCTTCCEEECCSSEEESBCCGGGGTTTTCBCCST
T ss_pred CCCCEEEccCCccCCcCChHHhcCCCCCEEECCCCcccCcCCHHHcCCCCCCEEECCCCccCCcCChHHhcccchhhhhc
Confidence 456777777777777777777777777777777777777777777777777777777777776666543
Q ss_pred -----------------------------------------------------------cCCCCCCEEeccCCCCCCCCC
Q 042348 126 -----------------------------------------------------------GKLKYLQVLDLSQNSFSSSIP 146 (686)
Q Consensus 126 -----------------------------------------------------------~~l~~L~~L~ls~N~l~~~~p 146 (686)
+.+++|+.|||++|+++|.+|
T Consensus 570 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip 649 (768)
T 3rgz_A 570 IAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIP 649 (768)
T ss_dssp TCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCC
T ss_pred cccccccccccccccccccccccccccccccchhhhccccccccccccceecccCchhhhccccccEEECcCCcccccCC
Confidence 234667888888888888888
Q ss_pred hhhhhccccccccccccccCCCCchhhhhcCcccceecccccccCCCCchhhhcccccccccccccccccCCCCCCCccc
Q 042348 147 SSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSGLIPNDIANLSRLRLLAQRVYVDLTYNNLSGLIPQ 226 (686)
Q Consensus 147 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~~~~~l~l~~N~l~~~~p~ 226 (686)
..++.+++|+.|+|++|+++|.+|..+. ++++|+.||||+|+++|.+|..++++++|+.| |+++|+|+|.+|+
T Consensus 650 ~~l~~l~~L~~L~Ls~N~l~g~ip~~l~-~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L------~ls~N~l~g~iP~ 722 (768)
T 3rgz_A 650 KEIGSMPYLFILNLGHNDISGSIPDEVG-DLRGLNILDLSSNKLDGRIPQAMSALTMLTEI------DLSNNNLSGPIPE 722 (768)
T ss_dssp GGGGGCTTCCEEECCSSCCCSCCCGGGG-GCTTCCEEECCSSCCEECCCGGGGGCCCCSEE------ECCSSEEEEECCS
T ss_pred HHHhccccCCEEeCcCCccCCCCChHHh-CCCCCCEEECCCCcccCcCChHHhCCCCCCEE------ECcCCcccccCCC
Confidence 8888888888888888888888888874 78888888888888888888888888777655 9999999999999
Q ss_pred ccccccCCcccccCCCCCCCCCCCCCCCCC
Q 042348 227 NAALLSLGPTAFIGNPFLCGPPLKVSCPSS 256 (686)
Q Consensus 227 ~~~~~~~~~~~~~~n~~~c~~p~~~~c~~~ 256 (686)
..++.++....|.|||.+||+|+. +|...
T Consensus 723 ~~~~~~~~~~~~~gN~~Lcg~~l~-~C~~~ 751 (768)
T 3rgz_A 723 MGQFETFPPAKFLNNPGLCGYPLP-RCDPS 751 (768)
T ss_dssp SSSGGGSCGGGGCSCTEEESTTSC-CCCSC
T ss_pred chhhccCCHHHhcCCchhcCCCCc-CCCCC
Confidence 999999999999999999999986 78654
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.1e-27 Score=278.48 Aligned_cols=220 Identities=29% Similarity=0.399 Sum_probs=158.2
Q ss_pred hhcCCChhHHHHHHHHHHhccCCCCC-CCCCCCCCCCcceeeeEecCCCEEEEEeCCCCcccc---CC------------
Q 042348 11 ALMGSANDEGLALLSFKQAIRNFPEG-NNWNNSNEDPCSWNGITCREGQVFSLIIPNKKLTGF---IP------------ 74 (686)
Q Consensus 11 ~~~~~~~~~~~~l~~~k~~~~~~~~~-~~w~~~~~~~c~w~gv~c~~~~~~~l~l~~n~l~g~---~p------------ 74 (686)
++.++.++|+.||++||+++. +|.. .+|+. +.+||+|.||+|+.++|+.|+|+++.+.|. +|
T Consensus 5 ~~~~~~~~~~~all~~k~~~~-~~~~l~~W~~-~~~~C~w~gv~C~~~~v~~L~L~~~~l~g~~~~l~~~l~~L~~L~~l 82 (768)
T 3rgz_A 5 SPSQSLYREIHQLISFKDVLP-DKNLLPDWSS-NKNPCTFDGVTCRDDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESL 82 (768)
T ss_dssp ---CCHHHHHHHHHHHHTTCS-CTTSSTTCCT-TSCGGGSTTEEEETTEEEEEECTTSCCCEEHHHHHHHTTTCTTCCEE
T ss_pred ccccCCHHHHHHHHHHHhhCC-CcccccCCCC-CCCCcCCcceEECCCcEEEEECCCCCcCCccCccChhHhccCccccc
Confidence 345567789999999999996 4534 78974 578999999999989999999999999987 44
Q ss_pred -----------cCcCCCCCCCEEEccCCCCcccCCc--cccCCCCCcEEEccCCCCCCCCcccc-cCCCCCCEEeccCCC
Q 042348 75 -----------ADLGSLSAIGRVNLRNNNFSGSLPV--ELFNASNLQSLILSGNSFSGPVPMQI-GKLKYLQVLDLSQNS 140 (686)
Q Consensus 75 -----------~~l~~l~~L~~L~L~~N~l~g~~p~--~~~~l~~L~~L~L~~N~l~g~~p~~~-~~l~~L~~L~ls~N~ 140 (686)
..|+.+++|++|+|++|.++|.+|. .++++++|++|+|++|.+++.+|..+ .++++|++|+|++|.
T Consensus 83 ~~~~~~~~~l~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~n~ 162 (768)
T 3rgz_A 83 FLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANS 162 (768)
T ss_dssp ECTTSCEEECCCCCCCCTTCCEEECCSSEEEEEGGGGGGGGGCTTCCEEECCSSEEECCSSCCSCCCCTTCSEEECCSSC
T ss_pred CCcCCCcCCCchhhccCCCCCEEECCCCcCCCcCCChHHHhCCCCCCEEECcCCccCCcCCHHHhccCCCCCEEECCCCc
Confidence 5677778888888888888888887 78888888888888888887777765 678888888888888
Q ss_pred CCCCCChh---hhhccccccccccccccCCCCchhhhhcCcccceecccccccCCCCchhhhcccccccccccccccccC
Q 042348 141 FSSSIPSS---IVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSGLIPNDIANLSRLRLLAQRVYVDLTY 217 (686)
Q Consensus 141 l~~~~p~~---~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~~~~~l~l~~ 217 (686)
+++..|.. +.++++|++|+|++|++++.+|. ..+++|++|+|++|++++.+|. ++++++|+.| ++++
T Consensus 163 l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~---~~l~~L~~L~Ls~n~l~~~~~~-l~~l~~L~~L------~Ls~ 232 (768)
T 3rgz_A 163 ISGANVVGWVLSDGCGELKHLAISGNKISGDVDV---SRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHL------DISG 232 (768)
T ss_dssp CEEETHHHHHHTTCCTTCCEEECCSSEEESCCBC---TTCTTCCEEECCSSCCCSCCCB-CTTCCSCCEE------ECCS
T ss_pred cCCcCChhhhhhccCCCCCEEECCCCcccccCCc---ccCCcCCEEECcCCcCCCCCcc-cccCCCCCEE------ECcC
Confidence 87777665 56666677777776666665543 3566667777777776666665 5555555443 6666
Q ss_pred CCCCCCcccccc-cccCCcccccCCC
Q 042348 218 NNLSGLIPQNAA-LLSLGPTAFIGNP 242 (686)
Q Consensus 218 N~l~~~~p~~~~-~~~~~~~~~~~n~ 242 (686)
|++++.+|..+. +.++..+.+.+|.
T Consensus 233 n~l~~~~~~~l~~l~~L~~L~Ls~n~ 258 (768)
T 3rgz_A 233 NKLSGDFSRAISTCTELKLLNISSNQ 258 (768)
T ss_dssp SCCCSCHHHHTTTCSSCCEEECCSSC
T ss_pred CcCCCcccHHHhcCCCCCEEECCCCc
Confidence 666655554332 3334444444443
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=99.94 E-value=1e-27 Score=272.62 Aligned_cols=217 Identities=19% Similarity=0.361 Sum_probs=188.4
Q ss_pred hhHHHHHHHHHHhccCCCCC---------CCCCCCCCCCcce---eeeEecC-CCEEEEEeCCCCccccCCcCcCCCCCC
Q 042348 17 NDEGLALLSFKQAIRNFPEG---------NNWNNSNEDPCSW---NGITCRE-GQVFSLIIPNKKLTGFIPADLGSLSAI 83 (686)
Q Consensus 17 ~~~~~~l~~~k~~~~~~~~~---------~~w~~~~~~~c~w---~gv~c~~-~~~~~l~l~~n~l~g~~p~~l~~l~~L 83 (686)
..|..||..+++++..+.+. .+|+.+ .++|.| .||+|+. ++|+.|+|++|+|+|.+|+.|++|++|
T Consensus 29 ~~d~~aL~~~~~~~~~~~w~~~~~~~~~~~~W~~~-~~~c~w~~~~GV~C~~~~~V~~L~L~~~~l~g~lp~~l~~L~~L 107 (636)
T 4eco_A 29 IKDYLALKEIWDALNGKNWSQQGFGTQPGANWNFN-KELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTEL 107 (636)
T ss_dssp HHHHHHHHHHHHHTTGGGCCCCC------CCCCCS-SCGGGTTCCTTEEECTTCCEEEEECTTSCCEEEECGGGGGCTTC
T ss_pred HHHHHHHHHHHHHcCCCCcccCCcCCccCCCCCCC-CCcccccCCCCeEEcCCCCEEEEEecCcccCCcCChHHhcCccc
Confidence 35899999999998654433 368864 789999 9999964 699999999999999999999999999
Q ss_pred CEEEccCCC-----------------------------------------------------------------------
Q 042348 84 GRVNLRNNN----------------------------------------------------------------------- 92 (686)
Q Consensus 84 ~~L~L~~N~----------------------------------------------------------------------- 92 (686)
+.|+|++|.
T Consensus 108 ~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~~~~l~l~l~~~~l~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~l~~l~ 187 (636)
T 4eco_A 108 EVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQ 187 (636)
T ss_dssp CEEESCCGGGGGTCCSBSTTSBCTTCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHHCTTSCCCCCCCCCCCCTTT
T ss_pred eEEECcCCccccCCccccccccccCchHHHHHHHHhhHHHhhhccCchhhHHHHHHHHhhcCccccccccccccchhhhh
Confidence 999999884
Q ss_pred -------CcccCCccccCCCCCcEEEccCCCCCCC-----------------Cccccc--CCCCCCEEeccCCCCCCCCC
Q 042348 93 -------FSGSLPVELFNASNLQSLILSGNSFSGP-----------------VPMQIG--KLKYLQVLDLSQNSFSSSIP 146 (686)
Q Consensus 93 -------l~g~~p~~~~~l~~L~~L~L~~N~l~g~-----------------~p~~~~--~l~~L~~L~ls~N~l~~~~p 146 (686)
|+| +|.+++++++|++|+|++|.|+|. +|..++ ++++|++|+|++|.+.+.+|
T Consensus 188 l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p 266 (636)
T 4eco_A 188 IGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLP 266 (636)
T ss_dssp TTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCC
T ss_pred hccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccCh
Confidence 445 899999999999999999999986 999999 99999999999999999999
Q ss_pred hhhhhccccccccccccc-cCC-CCchhhhhcC------cccceecccccccCCCCch--hhhccccccccccccccccc
Q 042348 147 SSIVQCKRLKTVVLNQNS-FTG-PLPDGFATNL------TALQKLDLSFNNLSGLIPN--DIANLSRLRLLAQRVYVDLT 216 (686)
Q Consensus 147 ~~~~~l~~L~~L~L~~N~-l~~-~~p~~~~~~l------~~L~~L~Ls~N~l~~~~p~--~~~~l~~L~~l~~~~~l~l~ 216 (686)
..+.++++|++|+|++|+ ++| .+|..+. .+ ++|++|+|++|+++ .+|. .++++++|+.| +++
T Consensus 267 ~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~-~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L~~L------~L~ 338 (636)
T 4eco_A 267 TFLKALPEMQLINVACNRGISGEQLKDDWQ-ALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLGML------ECL 338 (636)
T ss_dssp TTTTTCSSCCEEECTTCTTSCHHHHHHHHH-HHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTCCEE------ECC
T ss_pred HHHhcCCCCCEEECcCCCCCccccchHHHH-hhhccccCCCCCEEECCCCcCC-ccCchhhhccCCCCCEE------eCc
Confidence 999999999999999999 998 8998885 55 99999999999999 7787 89988888765 888
Q ss_pred CCCCCCCcccccccccCCcccccCCCC
Q 042348 217 YNNLSGLIPQNAALLSLGPTAFIGNPF 243 (686)
Q Consensus 217 ~N~l~~~~p~~~~~~~~~~~~~~~n~~ 243 (686)
+|+++|.+|....+.++..+.+.+|..
T Consensus 339 ~N~l~g~ip~~~~l~~L~~L~L~~N~l 365 (636)
T 4eco_A 339 YNQLEGKLPAFGSEIKLASLNLAYNQI 365 (636)
T ss_dssp SCCCEEECCCCEEEEEESEEECCSSEE
T ss_pred CCcCccchhhhCCCCCCCEEECCCCcc
Confidence 999888888444455566666666643
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.94 E-value=3.4e-27 Score=245.99 Aligned_cols=220 Identities=18% Similarity=0.231 Sum_probs=189.2
Q ss_pred CCChhHHHHHHHHHHhccCCCCC--CCCC---CCCCCCcceeeeEec----------CCCEEEEEeCCCCccccCCcCcC
Q 042348 14 GSANDEGLALLSFKQAIRNFPEG--NNWN---NSNEDPCSWNGITCR----------EGQVFSLIIPNKKLTGFIPADLG 78 (686)
Q Consensus 14 ~~~~~~~~~l~~~k~~~~~~~~~--~~w~---~~~~~~c~w~gv~c~----------~~~~~~l~l~~n~l~g~~p~~l~ 78 (686)
....+|..||+.||+.+..++.. ..|. ..+.++|.|.|+.|. ..+++.|+|++|+++ .+|..++
T Consensus 23 ~~~~~~~~aLl~~k~~~~~~~~~~~~~w~~~~~~~~~~~~~~g~~~~~~~~~l~~~~~~~l~~L~L~~n~l~-~lp~~l~ 101 (328)
T 4fcg_A 23 TALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQAF 101 (328)
T ss_dssp CCCCCHHHHHHHHHHHHHHCCTTHHHHHHHHTTTCTTSCCSHHHHHHHHHHHHHHHTSTTCCEEEEESSCCS-SCCSCGG
T ss_pred ccCchHHHHHHHHHHhccCCchhhhhhhcccccccccccccCCcchhhhHHHHhcccccceeEEEccCCCch-hcChhhh
Confidence 34567899999999999777755 5674 345688999999995 378999999999999 7899999
Q ss_pred CCCCCCEEEccCCCCcccCCccccCCCCCcEEEccCCCCCCCCcccccCCCCCCEEeccCCCCCCCCChhhhh-------
Q 042348 79 SLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQVLDLSQNSFSSSIPSSIVQ------- 151 (686)
Q Consensus 79 ~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~------- 151 (686)
.+++|++|+|++|.|+ .+|..+.++++|++|+|++|+++ .+|..++.+++|++|+|++|++.+.+|..+..
T Consensus 102 ~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~~~~~~~ 179 (328)
T 4fcg_A 102 RLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEH 179 (328)
T ss_dssp GGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTCCCCCSCSEEEC-CCCE
T ss_pred hCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCccccChhHhhccchhhh
Confidence 9999999999999999 89999999999999999999999 88999999999999999999999999988765
Q ss_pred --ccccccccccccccCCCCchhhhhcCcccceecccccccCCCCchhhhcccccccccccccccccCCCCCCCccccc-
Q 042348 152 --CKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSGLIPNDIANLSRLRLLAQRVYVDLTYNNLSGLIPQNA- 228 (686)
Q Consensus 152 --l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~~~~~l~l~~N~l~~~~p~~~- 228 (686)
+++|++|+|++|+++ .+|..+ ..+++|++|+|++|++++ +|..+..+++|+.| ++++|++.+.+|..+
T Consensus 180 ~~l~~L~~L~L~~n~l~-~lp~~l-~~l~~L~~L~L~~N~l~~-l~~~l~~l~~L~~L------~Ls~n~~~~~~p~~~~ 250 (328)
T 4fcg_A 180 QGLVNLQSLRLEWTGIR-SLPASI-ANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEEL------DLRGCTALRNYPPIFG 250 (328)
T ss_dssp EESTTCCEEEEEEECCC-CCCGGG-GGCTTCCEEEEESSCCCC-CCGGGGGCTTCCEE------ECTTCTTCCBCCCCTT
T ss_pred ccCCCCCEEECcCCCcC-cchHhh-cCCCCCCEEEccCCCCCc-CchhhccCCCCCEE------ECcCCcchhhhHHHhc
Confidence 999999999999999 788887 489999999999999997 45568887777655 999999998888754
Q ss_pred ccccCCcccccCCCCCC
Q 042348 229 ALLSLGPTAFIGNPFLC 245 (686)
Q Consensus 229 ~~~~~~~~~~~~n~~~c 245 (686)
.+.++..+.+.+|....
T Consensus 251 ~l~~L~~L~L~~n~~~~ 267 (328)
T 4fcg_A 251 GRAPLKRLILKDCSNLL 267 (328)
T ss_dssp CCCCCCEEECTTCTTCC
T ss_pred CCCCCCEEECCCCCchh
Confidence 35566667777776543
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.2e-26 Score=257.05 Aligned_cols=188 Identities=18% Similarity=0.239 Sum_probs=145.1
Q ss_pred hcccCccCceEEEEEEeCCCceEEEEEcCCCCcc--------chHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEe
Q 042348 372 AFLLGKSTIGIVYKVALNNEEAVAVRRLGNGGWQ--------RFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYD 443 (686)
Q Consensus 372 ~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 443 (686)
.+.||+|+||.||++... +..+++|+....... ..+++.+|++++++++||||+++..++...+..++|||
T Consensus 341 ~~~LG~G~fg~Vy~~~~~-~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE 419 (540)
T 3en9_A 341 EHLIGKGAEADIKRDSYL-DFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMS 419 (540)
T ss_dssp -------CCEEEEEEECS-SCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEE
T ss_pred CCEEeeCCCEEEEEEEEC-CCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEE
Confidence 457999999999999544 677888876442211 13458999999999999999977777778888899999
Q ss_pred ccCCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccc
Q 042348 444 YIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLAD 523 (686)
Q Consensus 444 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~ 523 (686)
|+++|+|.+++.. +..|+.|++.||+|||+ ++|+||||||+|||++. .+||+|||+++...
T Consensus 420 ~~~ggsL~~~l~~--------------~~~i~~qi~~aL~~LH~---~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~ 480 (540)
T 3en9_A 420 YINGKLAKDVIED--------------NLDIAYKIGEIVGKLHK---NDVIHNDLTTSNFIFDK--DLYIIDFGLGKISN 480 (540)
T ss_dssp CCCSEEHHHHSTT--------------CTHHHHHHHHHHHHHHH---TTEECTTCCTTSEEESS--SEEECCCTTCEECC
T ss_pred CCCCCCHHHHHHH--------------HHHHHHHHHHHHHHHHH---CcCccCCCCHHHEEECC--eEEEEECccCEECC
Confidence 9999999999864 45799999999999999 89999999999999998 99999999998765
Q ss_pred cccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccC--CCCCCcchHHHHHHHHHHHHhCCCCc
Q 042348 524 IAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKV--RKPTQKWDIYSYGVILLEMISGKLPM 595 (686)
Q Consensus 524 ~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDVwSlGvvl~elltG~~P~ 595 (686)
........ .........||..|+|||++.. ..|+..+|+||..+-.++-+.++.+|
T Consensus 481 ~~~~~~~~----------------~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 481 LDEDKAVD----------------LIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp CHHHHHHH----------------HHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred Cccccccc----------------hhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 32210000 0001124567889999999976 56788899999999999988888776
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.92 E-value=1.3e-24 Score=220.13 Aligned_cols=183 Identities=22% Similarity=0.270 Sum_probs=145.4
Q ss_pred CEEEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCccccCCCCCcEEEccCCCCCCCCcccccCCCCCCEEecc
Q 042348 58 QVFSLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQVLDLS 137 (686)
Q Consensus 58 ~~~~l~l~~n~l~g~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls 137 (686)
.++.|+|++|++++..+..|..+++|++|+|++|.|+...+..|.++++|++|+|++|++++..+..|..+++|++|+|+
T Consensus 38 ~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~ 117 (270)
T 2o6q_A 38 DTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLD 117 (270)
T ss_dssp TCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECC
T ss_pred CCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECC
Confidence 46778888888887766788888888888888888885555556788888888888888886666677888888888888
Q ss_pred CCCCCCCCChhhhhccccccccccccccCCCCchhhhhcCcccceecccccccCCCCchhhhcccccccccccccccccC
Q 042348 138 QNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSGLIPNDIANLSRLRLLAQRVYVDLTY 217 (686)
Q Consensus 138 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~~~~~l~l~~ 217 (686)
+|.+++..|..+..+++|++|+|++|++++ +|...+..+++|+.|+|++|++++..+..+.++++|+.| ++++
T Consensus 118 ~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L------~L~~ 190 (270)
T 2o6q_A 118 RNQLKSLPPRVFDSLTKLTYLSLGYNELQS-LPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTL------KLDN 190 (270)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCCCC-CCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEE------ECCS
T ss_pred CCccCeeCHHHhCcCcCCCEEECCCCcCCc-cCHhHccCCcccceeEecCCcCcEeChhHhccCCCcCEE------ECCC
Confidence 888887777778888888888888888884 555544578888889999888888777777777777655 8999
Q ss_pred CCCCCCccccc-ccccCCcccccCCCCCCCC
Q 042348 218 NNLSGLIPQNA-ALLSLGPTAFIGNPFLCGP 247 (686)
Q Consensus 218 N~l~~~~p~~~-~~~~~~~~~~~~n~~~c~~ 247 (686)
|++++.++..+ .+.++..+.+.+||+.|.+
T Consensus 191 N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c 221 (270)
T 2o6q_A 191 NQLKRVPEGAFDSLEKLKMLQLQENPWDCTC 221 (270)
T ss_dssp SCCSCCCTTTTTTCTTCCEEECCSSCBCCSS
T ss_pred CcCCcCCHHHhccccCCCEEEecCCCeeCCC
Confidence 99988766544 3566777888899988854
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.90 E-value=1.1e-23 Score=210.86 Aligned_cols=191 Identities=23% Similarity=0.293 Sum_probs=163.6
Q ss_pred CCcceeeeEecCCCEEEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCccccCCCCCcEEEccCCCCCCCCccc
Q 042348 45 DPCSWNGITCREGQVFSLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQ 124 (686)
Q Consensus 45 ~~c~w~gv~c~~~~~~~l~l~~n~l~g~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~ 124 (686)
+||.|.|++|.. ..+.++++++.++ .+|..+. ++|+.|+|++|.+++..|..|.++++|++|+|++|.+++..|..
T Consensus 3 ~Cp~~~gC~C~~-~~~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~ 78 (251)
T 3m19_A 3 TCETVTGCTCNE-GKKEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGV 78 (251)
T ss_dssp -CHHHHSSEEEG-GGTEEECTTCCCS-SCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTT
T ss_pred cCCCCCceEcCC-CCeEEecCCCCcc-ccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhH
Confidence 467899999963 2357899999998 4777665 68999999999999888888999999999999999999888888
Q ss_pred ccCCCCCCEEeccCCCCCCCCChhhhhccccccccccccccCCCCchhhhhcCcccceecccccccCCCCchhhhccccc
Q 042348 125 IGKLKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSGLIPNDIANLSRL 204 (686)
Q Consensus 125 ~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 204 (686)
|..+++|++|+|++|++++..+..+..+++|++|+|++|++++ +|...+..+++|+.|+|++|+|++..+..+..+++|
T Consensus 79 ~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L 157 (251)
T 3m19_A 79 FDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKS-LPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNL 157 (251)
T ss_dssp TTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCC-CCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTC
T ss_pred hccCCcCCEEECCCCcccccChhHhcccCCCCEEEcCCCcCCC-cChhHhccCCcccEEECcCCcCCccCHHHcCcCcCC
Confidence 9999999999999999998777888999999999999999995 555554689999999999999998888788888887
Q ss_pred ccccccccccccCCCCCCCccccc-ccccCCcccccCCCCCCC
Q 042348 205 RLLAQRVYVDLTYNNLSGLIPQNA-ALLSLGPTAFIGNPFLCG 246 (686)
Q Consensus 205 ~~l~~~~~l~l~~N~l~~~~p~~~-~~~~~~~~~~~~n~~~c~ 246 (686)
+.| +|++|++++.++..+ .+.++..+.+.+|++.|.
T Consensus 158 ~~L------~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 194 (251)
T 3m19_A 158 QTL------SLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCS 194 (251)
T ss_dssp CEE------ECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCTT
T ss_pred CEE------ECCCCcCCccCHHHHhCCCCCCEEEeeCCceeCC
Confidence 765 999999998887554 456777888999999874
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=7.4e-23 Score=207.95 Aligned_cols=190 Identities=24% Similarity=0.234 Sum_probs=158.4
Q ss_pred CCEEEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCccccCCCCCcEEEccCCCCCCCCcccccCCCCCCEEec
Q 042348 57 GQVFSLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQVLDL 136 (686)
Q Consensus 57 ~~~~~l~l~~n~l~g~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l 136 (686)
..++.|+|++|++++..+..|.++++|++|+|++|++++..+..|.++++|++|+|++|.+++..+..|..+++|++|++
T Consensus 28 ~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l 107 (276)
T 2z62_A 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA 107 (276)
T ss_dssp TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEEC
T ss_pred CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEEC
Confidence 35899999999999988889999999999999999999877888999999999999999999888889999999999999
Q ss_pred cCCCCCCCCChhhhhccccccccccccccCC-CCchhhhhcCcccceecccccccCCCCchhhhccccccccc-------
Q 042348 137 SQNSFSSSIPSSIVQCKRLKTVVLNQNSFTG-PLPDGFATNLTALQKLDLSFNNLSGLIPNDIANLSRLRLLA------- 208 (686)
Q Consensus 137 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~------- 208 (686)
++|.+++..+..+..+++|++|+|++|++++ .+|..+ ..+++|++|+|++|++++..+..+..+.+|+.+.
T Consensus 108 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~-~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls~ 186 (276)
T 2z62_A 108 VETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYF-SNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSL 186 (276)
T ss_dssp TTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGG-GGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCEEEECCS
T ss_pred CCCCccccCchhcccCCCCCEEECcCCccceecCchhh-ccCCCCCEEECCCCCCCcCCHHHhhhhhhccccceeeecCC
Confidence 9999998777789999999999999999986 357777 4899999999999999998888888877765321
Q ss_pred --------------ccccccccCCCCCCCccccc-ccccCCcccccCCCCCCCC
Q 042348 209 --------------QRVYVDLTYNNLSGLIPQNA-ALLSLGPTAFIGNPFLCGP 247 (686)
Q Consensus 209 --------------~~~~l~l~~N~l~~~~p~~~-~~~~~~~~~~~~n~~~c~~ 247 (686)
++..|++++|++++.++..+ .+.++..+.+.+|++.|.+
T Consensus 187 n~l~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c 240 (276)
T 2z62_A 187 NPMNFIQPGAFKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSC 240 (276)
T ss_dssp SCCCEECTTSSCSCCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCCCT
T ss_pred CcccccCccccCCCcccEEECCCCceeecCHhHhcccccccEEEccCCcccccC
Confidence 34556677777776655443 3455566667777777654
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.88 E-value=8.6e-23 Score=208.66 Aligned_cols=181 Identities=27% Similarity=0.277 Sum_probs=160.4
Q ss_pred CCEEEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCccccCCCCCcEEEccCCCCCCCCcccccCCCCCCEEec
Q 042348 57 GQVFSLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQVLDL 136 (686)
Q Consensus 57 ~~~~~l~l~~n~l~g~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l 136 (686)
..++.|+|++|.+++..|..|..+++|+.|+|++|.|++..+ . ..+++|++|+|++|+++ .+|..+..+++|++|+|
T Consensus 31 ~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~-~-~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l 107 (290)
T 1p9a_G 31 KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQV-D-GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDV 107 (290)
T ss_dssp TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEEC-C-SCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEEC
T ss_pred CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccC-C-CCCCcCCEEECCCCcCC-cCchhhccCCCCCEEEC
Confidence 478899999999999999999999999999999999995433 3 78999999999999998 78989999999999999
Q ss_pred cCCCCCCCCChhhhhccccccccccccccCCCCchhhhhcCcccceecccccccCCCCchhhhccccccccccccccccc
Q 042348 137 SQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSGLIPNDIANLSRLRLLAQRVYVDLT 216 (686)
Q Consensus 137 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~~~~~l~l~ 216 (686)
++|++++..|..|..+++|++|+|++|++++ +|...+..+++|+.|+|++|+|++..+..+..+++|+.| +|+
T Consensus 108 ~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L------~L~ 180 (290)
T 1p9a_G 108 SFNRLTSLPLGALRGLGELQELYLKGNELKT-LPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTL------LLQ 180 (290)
T ss_dssp CSSCCCCCCSSTTTTCTTCCEEECTTSCCCC-CCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEE------ECC
T ss_pred CCCcCcccCHHHHcCCCCCCEEECCCCCCCc-cChhhcccccCCCEEECCCCcCCccCHHHhcCcCCCCEE------ECC
Confidence 9999998778889999999999999999995 565555689999999999999998877777888887765 999
Q ss_pred CCCCCCCcccccccccCCcccccCCCCCCCC
Q 042348 217 YNNLSGLIPQNAALLSLGPTAFIGNPFLCGP 247 (686)
Q Consensus 217 ~N~l~~~~p~~~~~~~~~~~~~~~n~~~c~~ 247 (686)
+|+|+..++..+....+..+.+.+|||.|.+
T Consensus 181 ~N~l~~ip~~~~~~~~L~~l~L~~Np~~C~c 211 (290)
T 1p9a_G 181 ENSLYTIPKGFFGSHLLPFAFLHGNPWLCNC 211 (290)
T ss_dssp SSCCCCCCTTTTTTCCCSEEECCSCCBCCSG
T ss_pred CCcCCccChhhcccccCCeEEeCCCCccCcC
Confidence 9999977666666777788889999999864
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=2.1e-23 Score=211.88 Aligned_cols=128 Identities=16% Similarity=0.216 Sum_probs=106.6
Q ss_pred cccCccCceEEEEEEeCCCceEEEEEcCCCCc------------------cchHHHHHHHHHHhccCCCCcceeeEEEEe
Q 042348 373 FLLGKSTIGIVYKVALNNEEAVAVRRLGNGGW------------------QRFKEFQTEAEAIGKIRHPNIVSLRAYFWS 434 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~ 434 (686)
..||+|+||.||+|...+++.||||.++.... .....+.+|++++++++ | +++.+++..
T Consensus 96 ~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~~~~~~ 172 (282)
T 1zar_A 96 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVPKVYAW 172 (282)
T ss_dssp EEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSCCEEEE
T ss_pred CEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcCeEEec
Confidence 57999999999999997789999999864321 12456899999999999 4 666665543
Q ss_pred cCceeEEEeccCCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEe
Q 042348 435 VDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHIS 514 (686)
Q Consensus 435 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~ 514 (686)
+..++||||+++|+|.+ +.. .....++.|++.||+|||+ ++|+||||||+|||++ ++.+||+
T Consensus 173 -~~~~lvmE~~~g~~L~~-l~~------------~~~~~i~~qi~~~l~~lH~---~giiHrDlkp~NILl~-~~~vkl~ 234 (282)
T 1zar_A 173 -EGNAVLMELIDAKELYR-VRV------------ENPDEVLDMILEEVAKFYH---RGIVHGDLSQYNVLVS-EEGIWII 234 (282)
T ss_dssp -ETTEEEEECCCCEEGGG-CCC------------SCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEE-TTEEEEC
T ss_pred -cceEEEEEecCCCcHHH-cch------------hhHHHHHHHHHHHHHHHHH---CCCEeCCCCHHHEEEE-CCcEEEE
Confidence 56799999999999998 421 2345799999999999999 8999999999999999 9999999
Q ss_pred ecCcccc
Q 042348 515 DFGLARL 521 (686)
Q Consensus 515 DfGla~~ 521 (686)
|||+|+.
T Consensus 235 DFG~a~~ 241 (282)
T 1zar_A 235 DFPQSVE 241 (282)
T ss_dssp CCTTCEE
T ss_pred ECCCCeE
Confidence 9999973
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.88 E-value=2.4e-22 Score=201.06 Aligned_cols=172 Identities=22% Similarity=0.247 Sum_probs=152.2
Q ss_pred ceeeeEecC-----------CCEEEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCccccCCCCCcEEEccCCC
Q 042348 48 SWNGITCRE-----------GQVFSLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNS 116 (686)
Q Consensus 48 ~w~gv~c~~-----------~~~~~l~l~~n~l~g~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~ 116 (686)
.|..|.|.. ..++.|+|++|++++..+..|..+++|++|+|++|.|++..|..|.++++|++|+|++|+
T Consensus 15 ~~~~l~~~~~~l~~~p~~~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~ 94 (251)
T 3m19_A 15 GKKEVDCQGKSLDSVPSGIPADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQ 94 (251)
T ss_dssp GGTEEECTTCCCSSCCSCCCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSC
T ss_pred CCeEEecCCCCccccCCCCCCCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECCCCc
Confidence 356677752 468899999999999999999999999999999999998888889999999999999999
Q ss_pred CCCCCcccccCCCCCCEEeccCCCCCCCCChhhhhccccccccccccccCCCCchhhhhcCcccceecccccccCCCCch
Q 042348 117 FSGPVPMQIGKLKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSGLIPN 196 (686)
Q Consensus 117 l~g~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~ 196 (686)
+++..+..|..+++|++|+|++|++++..+..+..+++|++|+|++|++++ +|...+..+++|++|+|++|+|++.+|.
T Consensus 95 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-~~~~~~~~l~~L~~L~L~~N~l~~~~~~ 173 (251)
T 3m19_A 95 LASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQS-IPAGAFDKLTNLQTLSLSTNQLQSVPHG 173 (251)
T ss_dssp CCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCC-CCTTTTTTCTTCCEEECCSSCCSCCCTT
T ss_pred ccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCc-cCHHHcCcCcCCCEEECCCCcCCccCHH
Confidence 998778889999999999999999997777778999999999999999995 5554346899999999999999999888
Q ss_pred hhhcccccccccccccccccCCCCCCCccc
Q 042348 197 DIANLSRLRLLAQRVYVDLTYNNLSGLIPQ 226 (686)
Q Consensus 197 ~~~~l~~L~~l~~~~~l~l~~N~l~~~~p~ 226 (686)
.+..+++|+.| ++++|.+++....
T Consensus 174 ~~~~l~~L~~L------~l~~N~~~c~~~~ 197 (251)
T 3m19_A 174 AFDRLGKLQTI------TLFGNQFDCSRCE 197 (251)
T ss_dssp TTTTCTTCCEE------ECCSCCBCTTSTT
T ss_pred HHhCCCCCCEE------EeeCCceeCCccc
Confidence 88888887755 9999999987443
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=2.6e-22 Score=204.88 Aligned_cols=188 Identities=21% Similarity=0.246 Sum_probs=112.8
Q ss_pred CEEEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCccccCCCCCcEEEccCCC-CCCCCcccccCCCCCCEEec
Q 042348 58 QVFSLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNS-FSGPVPMQIGKLKYLQVLDL 136 (686)
Q Consensus 58 ~~~~l~l~~n~l~g~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~-l~g~~p~~~~~l~~L~~L~l 136 (686)
.++.|+|++|.+++..+..|..+++|++|+|++|.+++..|..|.++++|++|+|++|. ++...|..|..+++|++|+|
T Consensus 33 ~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~l 112 (285)
T 1ozn_A 33 ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHL 112 (285)
T ss_dssp TCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEEC
T ss_pred CceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCEEEC
Confidence 56667777777766655666666777777777776666666666666666677666665 55444666666666666666
Q ss_pred cCCCCCCCCChhhhhccccccccccccccCCCCchhhhhcCcccceecccccccCCCCchhhhcccccccc---------
Q 042348 137 SQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSGLIPNDIANLSRLRLL--------- 207 (686)
Q Consensus 137 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l--------- 207 (686)
++|.+++..|..+..+++|++|+|++|++++ +|...+..+++|+.|+|++|++++..+..+..+++|+.|
T Consensus 113 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~-~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~ 191 (285)
T 1ozn_A 113 DRCGLQELGPGLFRGLAALQYLYLQDNALQA-LPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAH 191 (285)
T ss_dssp TTSCCCCCCTTTTTTCTTCCEEECCSSCCCC-CCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCE
T ss_pred CCCcCCEECHhHhhCCcCCCEEECCCCcccc-cCHhHhccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCcccc
Confidence 6666666556666666666666666666663 333322456666666666666665555555555554433
Q ss_pred ---------cccccccccCCCCCCCccccc-ccccCCcccccCCCCCCC
Q 042348 208 ---------AQRVYVDLTYNNLSGLIPQNA-ALLSLGPTAFIGNPFLCG 246 (686)
Q Consensus 208 ---------~~~~~l~l~~N~l~~~~p~~~-~~~~~~~~~~~~n~~~c~ 246 (686)
+++..|++++|++++.++..+ .+.++..+.+.+|++.|.
T Consensus 192 ~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 240 (285)
T 1ozn_A 192 VHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCD 240 (285)
T ss_dssp ECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECS
T ss_pred cCHhHccCcccccEeeCCCCcCCcCCHHHcccCcccCEEeccCCCccCC
Confidence 112234666666665544422 234455555666666654
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.86 E-value=4e-22 Score=210.12 Aligned_cols=179 Identities=21% Similarity=0.269 Sum_probs=149.7
Q ss_pred CCCcceeeeEec-------------CCCEEEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCccccCCCCCcEE
Q 042348 44 EDPCSWNGITCR-------------EGQVFSLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSL 110 (686)
Q Consensus 44 ~~~c~w~gv~c~-------------~~~~~~l~l~~n~l~g~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L 110 (686)
..+|.|.|+ |+ ...++.|+|++|++++..+..|..+++|+.|+|++|++++..|..|.++++|++|
T Consensus 27 ~~~C~~~~~-c~~~~~~l~~iP~~~~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 105 (353)
T 2z80_A 27 SLSCDRNGI-CKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHL 105 (353)
T ss_dssp CCEECTTSE-EECCSTTCSSCCTTCCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEE
T ss_pred CCCCCCCeE-eeCCCCCcccccccccccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEE
Confidence 467999988 65 1378999999999998777799999999999999999998888899999999999
Q ss_pred EccCCCCCCCCcccccCCCCCCEEeccCCCCCCCCC-hhhhhccccccccccccc-cCCCCchhhhhcCcccceeccccc
Q 042348 111 ILSGNSFSGPVPMQIGKLKYLQVLDLSQNSFSSSIP-SSIVQCKRLKTVVLNQNS-FTGPLPDGFATNLTALQKLDLSFN 188 (686)
Q Consensus 111 ~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~~~~p-~~~~~l~~L~~L~L~~N~-l~~~~p~~~~~~l~~L~~L~Ls~N 188 (686)
+|++|++++..+..|+.+++|++|+|++|++++..+ ..+..+++|++|+|++|+ ++ .++...+..+++|++|+|++|
T Consensus 106 ~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~-~~~~~~~~~l~~L~~L~l~~n 184 (353)
T 2z80_A 106 DLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFT-KIQRKDFAGLTFLEELEIDAS 184 (353)
T ss_dssp ECCSSCCSSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCC-EECTTTTTTCCEEEEEEEEET
T ss_pred ECCCCcCCcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCcccc-ccCHHHccCCCCCCEEECCCC
Confidence 999999996666669999999999999999995433 478899999999999995 55 454443468999999999999
Q ss_pred ccCCCCchhhhcccccccc------------------cccccccccCCCCCCCc
Q 042348 189 NLSGLIPNDIANLSRLRLL------------------AQRVYVDLTYNNLSGLI 224 (686)
Q Consensus 189 ~l~~~~p~~~~~l~~L~~l------------------~~~~~l~l~~N~l~~~~ 224 (686)
++++..|..+.++++|+.| +.+..|++++|++++..
T Consensus 185 ~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~ 238 (353)
T 2z80_A 185 DLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFH 238 (353)
T ss_dssp TCCEECTTTTTTCSEEEEEEEECSCSTTHHHHHHHHTTTEEEEEEESCBCTTCC
T ss_pred CcCccCHHHHhccccCCeecCCCCccccchhhhhhhcccccEEECCCCcccccc
Confidence 9999889888888777553 34566777777777643
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.86 E-value=1.8e-21 Score=188.77 Aligned_cols=170 Identities=25% Similarity=0.291 Sum_probs=142.4
Q ss_pred CcceeeeEecC-----------CCEEEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCccccCCCCCcEEEccC
Q 042348 46 PCSWNGITCRE-----------GQVFSLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSG 114 (686)
Q Consensus 46 ~c~w~gv~c~~-----------~~~~~l~l~~n~l~g~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~ 114 (686)
.|+|.+|.|.. .+++.|+|++|++++..+..|..+++|++|+|++|+|++..+..|.++++|++|+|++
T Consensus 6 ~C~~~~v~c~~~~l~~~p~~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~ 85 (208)
T 2o6s_A 6 SCSGTTVECYSQGRTSVPTGIPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLST 85 (208)
T ss_dssp EEETTEEECCSSCCSSCCSCCCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred EECCCEEEecCCCccCCCCCCCCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCC
Confidence 47899999973 3588999999999987777789999999999999999966666678999999999999
Q ss_pred CCCCCCCcccccCCCCCCEEeccCCCCCCCCChhhhhccccccccccccccCCCCchhhhhcCcccceecccccccCCCC
Q 042348 115 NSFSGPVPMQIGKLKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSGLI 194 (686)
Q Consensus 115 N~l~g~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~ 194 (686)
|++++..+..|..+++|++|+|++|++++..+..+..+++|+.|+|++|++++ +|...+..+++|+.|+|++|.+.+..
T Consensus 86 n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~-~~~~~~~~l~~L~~L~l~~N~~~~~~ 164 (208)
T 2o6s_A 86 NQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKS-VPDGVFDRLTSLQYIWLHDNPWDCTC 164 (208)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSC-CCTTTTTTCTTCCEEECCSCCBCCCT
T ss_pred CcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccce-eCHHHhccCCCccEEEecCCCeecCC
Confidence 99997666678899999999999999997777778899999999999999995 55554468999999999999888653
Q ss_pred chhhhcccccccccccccccccCCCCCCCcccccc
Q 042348 195 PNDIANLSRLRLLAQRVYVDLTYNNLSGLIPQNAA 229 (686)
Q Consensus 195 p~~~~~l~~L~~l~~~~~l~l~~N~l~~~~p~~~~ 229 (686)
| +|+ +|+++.|+++|.+|....
T Consensus 165 ~-------~l~------~L~~~~n~~~g~ip~~~~ 186 (208)
T 2o6s_A 165 P-------GIR------YLSEWINKHSGVVRNSAG 186 (208)
T ss_dssp T-------TTH------HHHHHHHHCTTTBBCTTS
T ss_pred C-------CHH------HHHHHHHhCCceeeccCc
Confidence 3 343 448999999999987543
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.86 E-value=1.6e-21 Score=212.77 Aligned_cols=198 Identities=22% Similarity=0.232 Sum_probs=156.2
Q ss_pred eeeeEecC-----------CCEEEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCccccCCCCCcEEEccCCCC
Q 042348 49 WNGITCRE-----------GQVFSLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSF 117 (686)
Q Consensus 49 w~gv~c~~-----------~~~~~l~l~~n~l~g~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l 117 (686)
|..|.|.. ..++.|+|++|+|++..|..|.++++|+.|+|++|+|++..|..|.++++|++|+|++|++
T Consensus 56 ~~~v~c~~~~l~~iP~~~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l 135 (452)
T 3zyi_A 56 FSKVVCTRRGLSEVPQGIPSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWL 135 (452)
T ss_dssp SCEEECCSSCCSSCCSCCCTTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCC
T ss_pred CcEEEECCCCcCccCCCCCCCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCcC
Confidence 56788863 3688999999999999999999999999999999999988889999999999999999999
Q ss_pred CCCCcccccCCCCCCEEeccCCCCCCCCChhh-------------------------hhccccccccccccccCCCCchh
Q 042348 118 SGPVPMQIGKLKYLQVLDLSQNSFSSSIPSSI-------------------------VQCKRLKTVVLNQNSFTGPLPDG 172 (686)
Q Consensus 118 ~g~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~-------------------------~~l~~L~~L~L~~N~l~~~~p~~ 172 (686)
++..+..|..+++|++|+|++|++++..+..+ ..+++|++|+|++|++++ +|.
T Consensus 136 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~-~~~- 213 (452)
T 3zyi_A 136 TVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKD-MPN- 213 (452)
T ss_dssp SBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSS-CCC-
T ss_pred CccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCcccc-ccc-
Confidence 97777779999999999999999885544344 445556666666666663 342
Q ss_pred hhhcCcccceecccccccCCCCchhhhcccccccc------------------cccccccccCCCCCCCcccccc-cccC
Q 042348 173 FATNLTALQKLDLSFNNLSGLIPNDIANLSRLRLL------------------AQRVYVDLTYNNLSGLIPQNAA-LLSL 233 (686)
Q Consensus 173 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l------------------~~~~~l~l~~N~l~~~~p~~~~-~~~~ 233 (686)
+ ..+++|+.|+|++|+|++..|..+.++++|+.| +++..|||++|+|++.++..+. +.++
T Consensus 214 ~-~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L 292 (452)
T 3zyi_A 214 L-TPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYL 292 (452)
T ss_dssp C-TTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTTCTTC
T ss_pred c-cccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhccccCC
Confidence 2 356777777788888887778777777766543 3456778999999887776543 5567
Q ss_pred CcccccCCCCCCCCCC
Q 042348 234 GPTAFIGNPFLCGPPL 249 (686)
Q Consensus 234 ~~~~~~~n~~~c~~p~ 249 (686)
..+.+.+|||.|.+.+
T Consensus 293 ~~L~L~~Np~~CdC~~ 308 (452)
T 3zyi_A 293 VELHLHHNPWNCDCDI 308 (452)
T ss_dssp CEEECCSSCEECSTTT
T ss_pred CEEEccCCCcCCCCCc
Confidence 7788899999998754
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.85 E-value=1.2e-21 Score=203.93 Aligned_cols=179 Identities=20% Similarity=0.257 Sum_probs=160.7
Q ss_pred CCEEEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCccccCCCCCcEEEccCCCCCCCCcccccC---------
Q 042348 57 GQVFSLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGK--------- 127 (686)
Q Consensus 57 ~~~~~l~l~~n~l~g~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~--------- 127 (686)
.++++|+|++|.++ .+|..++.+++|++|+|++|+|+ .+|..+.++++|++|+|++|++.+.+|..++.
T Consensus 104 ~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~~~~~~~~~ 181 (328)
T 4fcg_A 104 SHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQG 181 (328)
T ss_dssp TTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTCCCCCSCSEEEC-CCCEEE
T ss_pred CCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCccccChhHhhccchhhhcc
Confidence 57899999999999 89999999999999999999999 88999999999999999999999999988765
Q ss_pred CCCCCEEeccCCCCCCCCChhhhhccccccccccccccCCCCchhhhhcCcccceecccccccCCCCchhhhcccccccc
Q 042348 128 LKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSGLIPNDIANLSRLRLL 207 (686)
Q Consensus 128 l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l 207 (686)
+++|++|+|++|.++ .+|..+..+++|++|+|++|++++ +|..+ ..+++|+.|+|++|.+.+.+|..++++++|+.|
T Consensus 182 l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~-l~~~l-~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L 258 (328)
T 4fcg_A 182 LVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAI-HHLPKLEELDLRGCTALRNYPPIFGGRAPLKRL 258 (328)
T ss_dssp STTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCC-CCGGG-GGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEE
T ss_pred CCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCc-Cchhh-ccCCCCCEEECcCCcchhhhHHHhcCCCCCCEE
Confidence 999999999999999 899999999999999999999995 77766 489999999999999999999999988888765
Q ss_pred cccccccccCCCCCCCccccc-ccccCCcccccCCCCCCC
Q 042348 208 AQRVYVDLTYNNLSGLIPQNA-ALLSLGPTAFIGNPFLCG 246 (686)
Q Consensus 208 ~~~~~l~l~~N~l~~~~p~~~-~~~~~~~~~~~~n~~~c~ 246 (686)
++++|++.+.+|... .+.++..+.+.+|+....
T Consensus 259 ------~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~ 292 (328)
T 4fcg_A 259 ------ILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSR 292 (328)
T ss_dssp ------ECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCC
T ss_pred ------ECCCCCchhhcchhhhcCCCCCEEeCCCCCchhh
Confidence 999999999988654 456677778888876643
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.85 E-value=5.9e-21 Score=187.99 Aligned_cols=162 Identities=25% Similarity=0.294 Sum_probs=134.2
Q ss_pred CCCCcceeeeEecCCCEEEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCccccCCCCCcEEEccCCCCCCCCc
Q 042348 43 NEDPCSWNGITCREGQVFSLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVP 122 (686)
Q Consensus 43 ~~~~c~w~gv~c~~~~~~~l~l~~n~l~g~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p 122 (686)
+...|+|.+|.|.. ++++ .+|..+. ++|+.|+|++|+|++..|..|.++++|+.|+|++|+|++..+
T Consensus 15 ~~~~Cs~~~v~c~~----------~~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~ 81 (229)
T 3e6j_A 15 SQCSCSGTTVDCRS----------KRHA-SVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPV 81 (229)
T ss_dssp TTCEEETTEEECTT----------SCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCT
T ss_pred CCCEEeCCEeEccC----------CCcC-ccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcCh
Confidence 35789999999964 3444 4565554 889999999999998888889999999999999999986556
Q ss_pred ccccCCCCCCEEeccCCCCCCCCChhhhhccccccccccccccCCCCchhhhhcCcccceecccccccCCCCchhhhccc
Q 042348 123 MQIGKLKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSGLIPNDIANLS 202 (686)
Q Consensus 123 ~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 202 (686)
..|..+++|+.|+|++|++++..+..+..+++|+.|+|++|+|+ .+|..+ ..+++|++|+|++|+|++..+..+..++
T Consensus 82 ~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~-~~l~~L~~L~L~~N~l~~~~~~~~~~l~ 159 (229)
T 3e6j_A 82 GVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGI-ERLTHLTHLALDQNQLKSIPHGAFDRLS 159 (229)
T ss_dssp TTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTG-GGCTTCSEEECCSSCCCCCCTTTTTTCT
T ss_pred hhcccCCCcCEEECCCCcCCccChhHhCcchhhCeEeccCCccc-ccCccc-ccCCCCCEEECCCCcCCccCHHHHhCCC
Confidence 66789999999999999999777777888999999999999998 788877 4889999999999999988777787777
Q ss_pred ccccccccccccccCCCCCCCcc
Q 042348 203 RLRLLAQRVYVDLTYNNLSGLIP 225 (686)
Q Consensus 203 ~L~~l~~~~~l~l~~N~l~~~~p 225 (686)
+|+.| ++++|.+.+..+
T Consensus 160 ~L~~L------~l~~N~~~c~c~ 176 (229)
T 3e6j_A 160 SLTHA------YLFGNPWDCECR 176 (229)
T ss_dssp TCCEE------ECTTSCBCTTBG
T ss_pred CCCEE------EeeCCCccCCcc
Confidence 77655 888888887655
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.85 E-value=3.2e-21 Score=209.58 Aligned_cols=198 Identities=22% Similarity=0.236 Sum_probs=153.5
Q ss_pred eeeeEecC-----------CCEEEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCccccCCCCCcEEEccCCCC
Q 042348 49 WNGITCRE-----------GQVFSLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSF 117 (686)
Q Consensus 49 w~gv~c~~-----------~~~~~l~l~~n~l~g~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l 117 (686)
|..|.|.. ..++.|+|++|++++..+..|.++++|+.|+|++|.|++..|..|.++++|++|+|++|+|
T Consensus 45 ~~~v~c~~~~l~~iP~~~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l 124 (440)
T 3zyj_A 45 FSKVICVRKNLREVPDGISTNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRL 124 (440)
T ss_dssp SCEEECCSCCCSSCCSCCCTTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSSCC
T ss_pred CCEEEeCCCCcCcCCCCCCCCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCCcC
Confidence 66888873 3578899999999998889999999999999999999987788899999999999999999
Q ss_pred CCCCcccccCCCCCCEEeccCCCCCCCCChhh-------------------------hhccccccccccccccCCCCchh
Q 042348 118 SGPVPMQIGKLKYLQVLDLSQNSFSSSIPSSI-------------------------VQCKRLKTVVLNQNSFTGPLPDG 172 (686)
Q Consensus 118 ~g~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~-------------------------~~l~~L~~L~L~~N~l~~~~p~~ 172 (686)
++..+..|..+++|+.|+|++|.+++..+..+ .++++|++|+|++|+++ .+|.
T Consensus 125 ~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~-~~~~- 202 (440)
T 3zyj_A 125 TTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIPN- 202 (440)
T ss_dssp SSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCS-SCCC-
T ss_pred CeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCc-cccc-
Confidence 86666678889999999999988875544444 44555556666666665 3443
Q ss_pred hhhcCcccceecccccccCCCCchhhhcccccccc------------------cccccccccCCCCCCCccccc-ccccC
Q 042348 173 FATNLTALQKLDLSFNNLSGLIPNDIANLSRLRLL------------------AQRVYVDLTYNNLSGLIPQNA-ALLSL 233 (686)
Q Consensus 173 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l------------------~~~~~l~l~~N~l~~~~p~~~-~~~~~ 233 (686)
+ ..+++|+.|+|++|++++..|..+.++++|+.| +++..|||++|+|++.++..+ .+.++
T Consensus 203 ~-~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L 281 (440)
T 3zyj_A 203 L-TPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHL 281 (440)
T ss_dssp C-TTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSSCTTC
T ss_pred c-CCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhccccCC
Confidence 2 356777778888888887778788777776544 346678999999998777654 35667
Q ss_pred CcccccCCCCCCCCCC
Q 042348 234 GPTAFIGNPFLCGPPL 249 (686)
Q Consensus 234 ~~~~~~~n~~~c~~p~ 249 (686)
..+.+.+|||.|++.+
T Consensus 282 ~~L~L~~Np~~CdC~l 297 (440)
T 3zyj_A 282 ERIHLHHNPWNCNCDI 297 (440)
T ss_dssp CEEECCSSCEECSSTT
T ss_pred CEEEcCCCCccCCCCc
Confidence 7788999999997653
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=3.6e-21 Score=196.39 Aligned_cols=182 Identities=26% Similarity=0.283 Sum_probs=152.4
Q ss_pred EecCCCEEEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCccccCCCCCcEEEccCCCCCCCCcccccCCCCCC
Q 042348 53 TCREGQVFSLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQ 132 (686)
Q Consensus 53 ~c~~~~~~~l~l~~n~l~g~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~ 132 (686)
+|.....+.++.++++++. +|..+ .++|++|+|++|.+++..+..|.++++|++|+|++|.+++..|..|..+++|+
T Consensus 7 ~C~~~~~~~~~c~~~~l~~-ip~~~--~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~ 83 (285)
T 1ozn_A 7 VCYNEPKVTTSCPQQGLQA-VPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLE 83 (285)
T ss_dssp EEECSSSCEEECCSSCCSS-CCTTC--CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCC
T ss_pred eECCCCCeEEEcCcCCccc-CCcCC--CCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCC
Confidence 4665555778888999885 56544 47899999999999987778899999999999999999988899999999999
Q ss_pred EEeccCCC-CCCCCChhhhhccccccccccccccCCCCchhhhhcCcccceecccccccCCCCchhhhcccccccccccc
Q 042348 133 VLDLSQNS-FSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSGLIPNDIANLSRLRLLAQRV 211 (686)
Q Consensus 133 ~L~ls~N~-l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~~~~ 211 (686)
+|+|++|. ++...|..+..+++|++|+|++|++++..|..+ ..+++|++|+|++|++++..+..++.+++|+.|
T Consensus 84 ~L~l~~n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~-~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L---- 158 (285)
T 1ozn_A 84 QLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLF-RGLAALQYLYLQDNALQALPDDTFRDLGNLTHL---- 158 (285)
T ss_dssp EEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTT-TTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE----
T ss_pred EEeCCCCCCccccCHHHhcCCcCCCEEECCCCcCCEECHhHh-hCCcCCCEEECCCCcccccCHhHhccCCCccEE----
Confidence 99999998 887668899999999999999999997556555 589999999999999999888888888887765
Q ss_pred cccccCCCCCCCccccc-ccccCCcccccCCCCC
Q 042348 212 YVDLTYNNLSGLIPQNA-ALLSLGPTAFIGNPFL 244 (686)
Q Consensus 212 ~l~l~~N~l~~~~p~~~-~~~~~~~~~~~~n~~~ 244 (686)
++++|++++.++..+ .+.++..+.+.+|...
T Consensus 159 --~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~ 190 (285)
T 1ozn_A 159 --FLHGNRISSVPERAFRGLHSLDRLLLHQNRVA 190 (285)
T ss_dssp --ECCSSCCCEECTTTTTTCTTCCEEECCSSCCC
T ss_pred --ECCCCcccccCHHHhcCccccCEEECCCCccc
Confidence 899998887666533 3556666677777543
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.85 E-value=8.2e-21 Score=192.30 Aligned_cols=181 Identities=27% Similarity=0.345 Sum_probs=143.1
Q ss_pred CCEEEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCccccCCCCCcEEEccCCCCCCCCcccccCCCCCCEEec
Q 042348 57 GQVFSLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQVLDL 136 (686)
Q Consensus 57 ~~~~~l~l~~n~l~g~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l 136 (686)
..++.|++++|.++. + +.+..+++|+.|+|++|.+++ + ..+.++++|++|+|++|.+++..+..|+.+++|++|+|
T Consensus 41 ~~L~~L~l~~~~i~~-~-~~l~~l~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 116 (272)
T 3rfs_A 41 NSIDQIIANNSDIKS-V-QGIQYLPNVRYLALGGNKLHD-I-SALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVL 116 (272)
T ss_dssp TTCCEEECTTSCCCC-C-TTGGGCTTCCEEECTTSCCCC-C-GGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEEC
T ss_pred cceeeeeeCCCCccc-c-cccccCCCCcEEECCCCCCCC-c-hhhcCCCCCCEEECCCCccCccChhHhcCCcCCCEEEC
Confidence 567888888888874 2 357888888899999888885 3 47888888999999999888777777888888999999
Q ss_pred cCCCCCCCCChhhhhccccccccccccccCCCCchhhhhcCcccceecccccccCCCCchhhhccccccccccccccccc
Q 042348 137 SQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSGLIPNDIANLSRLRLLAQRVYVDLT 216 (686)
Q Consensus 137 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~~~~~l~l~ 216 (686)
++|++++..|..+..+++|++|+|++|++++ +|...+..+++|+.|+|++|++++.+|..+..+++|+.| +++
T Consensus 117 ~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L------~L~ 189 (272)
T 3rfs_A 117 VENQLQSLPDGVFDKLTNLTYLNLAHNQLQS-LPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDL------RLY 189 (272)
T ss_dssp TTSCCCCCCTTTTTTCTTCCEEECCSSCCCC-CCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE------ECC
T ss_pred CCCcCCccCHHHhccCCCCCEEECCCCccCc-cCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEE------ECC
Confidence 9888887777778888889999999888885 444444578888999999998888877777777777655 888
Q ss_pred CCCCCCCccccc-ccccCCcccccCCCCCCCCC
Q 042348 217 YNNLSGLIPQNA-ALLSLGPTAFIGNPFLCGPP 248 (686)
Q Consensus 217 ~N~l~~~~p~~~-~~~~~~~~~~~~n~~~c~~p 248 (686)
+|++++.+|..+ .+.++..+.+.+|++.|.+|
T Consensus 190 ~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 222 (272)
T 3rfs_A 190 QNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCP 222 (272)
T ss_dssp SSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred CCcCCccCHHHHhCCcCCCEEEccCCCccccCc
Confidence 888888777643 45667777888888877543
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.83 E-value=5.1e-21 Score=214.21 Aligned_cols=161 Identities=19% Similarity=0.262 Sum_probs=146.1
Q ss_pred CcceeeeEecC-------------CCEEEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCccccCCCCCcEEEc
Q 042348 46 PCSWNGITCRE-------------GQVFSLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLIL 112 (686)
Q Consensus 46 ~c~w~gv~c~~-------------~~~~~l~l~~n~l~g~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L 112 (686)
+|.|.|+ |+. ..++.|+|++|++++..|..|..+++|++|+|++|++++..|..|.++++|++|+|
T Consensus 3 ~C~~~~~-c~~~~~~l~~ip~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L 81 (549)
T 2z81_A 3 SCDASGV-CDGRSRSFTSIPSGLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDL 81 (549)
T ss_dssp EECTTSE-EECTTSCCSSCCSCCCTTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEC
T ss_pred cCCCCce-EECCCCccccccccCCCCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEEC
Confidence 5899998 862 37999999999999999999999999999999999999888899999999999999
Q ss_pred cCCCCCCCCcccccCCCCCCEEeccCCCCCC-CCChhhhhccccccccccccccCCCCchhhhhcCcccceecccccccC
Q 042348 113 SGNSFSGPVPMQIGKLKYLQVLDLSQNSFSS-SIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLS 191 (686)
Q Consensus 113 ~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~ 191 (686)
++|++++..|..|+.+++|++|+|++|.+++ .+|..+..+++|++|+|++|++.+.+|...+.++++|++|+|++|+++
T Consensus 82 s~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~ 161 (549)
T 2z81_A 82 SDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLR 161 (549)
T ss_dssp TTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCC
T ss_pred CCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCccc
Confidence 9999998888889999999999999999996 367889999999999999999766787655568999999999999999
Q ss_pred CCCchhhhcccccccc
Q 042348 192 GLIPNDIANLSRLRLL 207 (686)
Q Consensus 192 ~~~p~~~~~l~~L~~l 207 (686)
+.+|..++++++|+.|
T Consensus 162 ~~~~~~l~~l~~L~~L 177 (549)
T 2z81_A 162 NYQSQSLKSIRDIHHL 177 (549)
T ss_dssp EECTTTTTTCSEEEEE
T ss_pred ccChhhhhccccCceE
Confidence 9999999988887655
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.83 E-value=1.1e-20 Score=222.08 Aligned_cols=190 Identities=25% Similarity=0.306 Sum_probs=109.2
Q ss_pred CEEEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCccccCCCCCcEEEccCCCCCCCCcccccCCCCCCEEecc
Q 042348 58 QVFSLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQVLDLS 137 (686)
Q Consensus 58 ~~~~l~l~~n~l~g~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls 137 (686)
.++.|+|++|++++..|..|..+++|+.|+|++|++++..|..|.++++|+.|+|++|.+++..+..|..+++|+.|+|+
T Consensus 291 ~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls 370 (844)
T 3j0a_A 291 DLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLR 370 (844)
T ss_dssp CCCEEEEESCCCCEECTTTTTTCSSCCEEEEESCCCSCCCSCSCSSCTTCCEEECCSCCCCCCCSSCSCSCCCCCEEEEE
T ss_pred CCCEEECCCCcCCCCChHHhcCCCCCCEEECCCCCCCccCHHHhcCCCCCCEEECCCCCCCccChhhhcCCCCCCEEECC
Confidence 45555666666665555556666666666666666655555566666666666666666655555556666666666666
Q ss_pred CCCCCCCC------------------C----------------------hhhhhccccccccccccccCCCCch------
Q 042348 138 QNSFSSSI------------------P----------------------SSIVQCKRLKTVVLNQNSFTGPLPD------ 171 (686)
Q Consensus 138 ~N~l~~~~------------------p----------------------~~~~~l~~L~~L~L~~N~l~~~~p~------ 171 (686)
+|.+++.. | ..+..+++|+.|+|++|++++..+.
T Consensus 371 ~N~l~~i~~~~~L~~L~l~~N~l~~l~~~~~~l~~L~ls~N~l~~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~ 450 (844)
T 3j0a_A 371 DNALTTIHFIPSIPDIFLSGNKLVTLPKINLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSEN 450 (844)
T ss_dssp TCCSCCCSSCCSCSEEEEESCCCCCCCCCCTTCCEEECCSCCCCSSTTHHHHTTCTTCCEEEEESCCCCCCCSSSSSCSC
T ss_pred CCCCCcccCCCCcchhccCCCCcccccccccccceeecccCccccCchhhhhhcCCccceeeCCCCcccccccccccccC
Confidence 66554310 0 0122344444455555544421111
Q ss_pred -----------------------hhhhcCcccceecccccccCCCCchhhhcccccccc----------------ccccc
Q 042348 172 -----------------------GFATNLTALQKLDLSFNNLSGLIPNDIANLSRLRLL----------------AQRVY 212 (686)
Q Consensus 172 -----------------------~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l----------------~~~~~ 212 (686)
..+.++++|+.|+|++|+|++.+|..+.++++|+.| +++..
T Consensus 451 ~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~~L~~ 530 (844)
T 3j0a_A 451 PSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLPANLEI 530 (844)
T ss_dssp TTCCBCEEESCCCSSSCCSCCCSSCSSCBCCEECCCCCHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCCSCCCE
T ss_pred CccccccCCCCccccccccccchhhhcCcccccEEECCCCcccccChhHccchhhhheeECCCCCCCccChhhhhccccE
Confidence 112355667777777777777777667666666544 12345
Q ss_pred ccccCCCCCCCcccccccccCCcccccCCCCCCCCCC
Q 042348 213 VDLTYNNLSGLIPQNAALLSLGPTAFIGNPFLCGPPL 249 (686)
Q Consensus 213 l~l~~N~l~~~~p~~~~~~~~~~~~~~~n~~~c~~p~ 249 (686)
|||++|+|++.+|..+ .++..+.+.+||+.|.++.
T Consensus 531 L~Ls~N~l~~~~~~~~--~~L~~l~l~~Np~~C~c~~ 565 (844)
T 3j0a_A 531 LDISRNQLLAPNPDVF--VSLSVLDITHNKFICECEL 565 (844)
T ss_dssp EEEEEECCCCCCSCCC--SSCCEEEEEEECCCCSSSC
T ss_pred EECCCCcCCCCChhHh--CCcCEEEecCCCccccccc
Confidence 5666666666666543 3566678899999997654
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.83 E-value=1.6e-20 Score=212.92 Aligned_cols=197 Identities=21% Similarity=0.243 Sum_probs=171.2
Q ss_pred CCCccee----eeEec-----------CCCEEEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCccccCCCCCc
Q 042348 44 EDPCSWN----GITCR-----------EGQVFSLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQ 108 (686)
Q Consensus 44 ~~~c~w~----gv~c~-----------~~~~~~l~l~~n~l~g~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~ 108 (686)
.+||.|. .|.|. ...++.|+|++|++++..+..|.++++|++|+|++|++++..|..|.++++|+
T Consensus 4 ~~~c~~~~~~~~~~c~~~~l~~ip~~~~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~ 83 (606)
T 3vq2_A 4 LNPCIEVVPNITYQCMDQKLSKVPDDIPSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLS 83 (606)
T ss_dssp --CCEEEETTTEEECTTSCCSSCCTTSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCC
T ss_pred CCCceecCCCCceEccCCCcccCCCCCCCCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcC
Confidence 3577663 57775 25789999999999999998999999999999999999988899999999999
Q ss_pred EEEccCCCCCCCCcccccCCCCCCEEeccCCCCCCCCChhhhhccccccccccccccCC-CCchhhhhcCcccceecccc
Q 042348 109 SLILSGNSFSGPVPMQIGKLKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTG-PLPDGFATNLTALQKLDLSF 187 (686)
Q Consensus 109 ~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~~l~~L~~L~Ls~ 187 (686)
+|+|++|.+++..|..|+++++|++|+|++|.+++..|..+..+++|++|+|++|++++ .+|..+ .++++|++|+|++
T Consensus 84 ~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~-~~l~~L~~L~Ls~ 162 (606)
T 3vq2_A 84 NLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYF-SNLTNLVHVDLSY 162 (606)
T ss_dssp EEECTTCCCCCCCTTSSTTCTTCCEEECTTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGG-GTCTTCCEEECCS
T ss_pred EeECCCCcccccChhhcCCcccCCEEEccCCccccccccccCCCCCCCEEeCCCCcccceechHhH-hhcCCCCEEEccC
Confidence 99999999998889999999999999999999998777889999999999999999986 578877 4899999999999
Q ss_pred cccCCCCchhhhcccccccccccccccccCCCCCCCcccccccccCCcccccCCCC
Q 042348 188 NNLSGLIPNDIANLSRLRLLAQRVYVDLTYNNLSGLIPQNAALLSLGPTAFIGNPF 243 (686)
Q Consensus 188 N~l~~~~p~~~~~l~~L~~l~~~~~l~l~~N~l~~~~p~~~~~~~~~~~~~~~n~~ 243 (686)
|++++..|..++.+.+|+.+ +..+++++|++++..+..+...++....+.+|..
T Consensus 163 n~l~~~~~~~~~~l~~L~~~--l~~L~l~~n~l~~~~~~~~~~~~L~~L~L~~n~~ 216 (606)
T 3vq2_A 163 NYIQTITVNDLQFLRENPQV--NLSLDMSLNPIDFIQDQAFQGIKLHELTLRGNFN 216 (606)
T ss_dssp SCCCEECTTTTHHHHHCTTC--CCEEECTTCCCCEECTTTTTTCEEEEEEEESCCS
T ss_pred CcceecChhhhhhhhccccc--cceeeccCCCcceeCcccccCceeeeeeccCCcc
Confidence 99999999989888887631 3467999999998877766655666667777754
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.83 E-value=1.2e-20 Score=184.42 Aligned_cols=155 Identities=21% Similarity=0.221 Sum_probs=135.1
Q ss_pred EEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCC-ccccCCCCCcEEEccCCCCCCCCcccccCCCCCCEEeccCC
Q 042348 61 SLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLP-VELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQVLDLSQN 139 (686)
Q Consensus 61 ~l~l~~n~l~g~~p~~l~~l~~L~~L~L~~N~l~g~~p-~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N 139 (686)
.+++++|.|+. +|..+. ..++.|+|++|+|++..| ..|.++++|++|+|++|+|++..+..|..+++|++|+|++|
T Consensus 15 ~l~~s~n~l~~-iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N 91 (220)
T 2v70_A 15 TVDCSNQKLNK-IPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSN 91 (220)
T ss_dssp EEECCSSCCSS-CCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred EeEeCCCCccc-CccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCC
Confidence 57778888885 677664 456899999999997755 45789999999999999999877789999999999999999
Q ss_pred CCCCCCChhhhhccccccccccccccCCCCchhhhhcCcccceecccccccCCCCchhhhcccccccccccccccccCCC
Q 042348 140 SFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSGLIPNDIANLSRLRLLAQRVYVDLTYNN 219 (686)
Q Consensus 140 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~~~~~l~l~~N~ 219 (686)
.+++..|..+..+++|++|+|++|++++..|..+ ..+++|+.|+|++|+|++.+|..+..+++|+.| ++++|.
T Consensus 92 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~-~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L------~L~~N~ 164 (220)
T 2v70_A 92 RLENVQHKMFKGLESLKTLMLRSNRITCVGNDSF-IGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTL------NLLANP 164 (220)
T ss_dssp CCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSS-TTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEE------ECCSCC
T ss_pred ccCccCHhHhcCCcCCCEEECCCCcCCeECHhHc-CCCccCCEEECCCCcCCEECHHHhcCCCCCCEE------EecCcC
Confidence 9998888889999999999999999997667666 589999999999999999999999988887765 999999
Q ss_pred CCCCcc
Q 042348 220 LSGLIP 225 (686)
Q Consensus 220 l~~~~p 225 (686)
+++..+
T Consensus 165 l~c~c~ 170 (220)
T 2v70_A 165 FNCNCY 170 (220)
T ss_dssp EECSGG
T ss_pred CcCCCc
Confidence 987655
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.83 E-value=4.6e-21 Score=197.77 Aligned_cols=183 Identities=21% Similarity=0.262 Sum_probs=127.3
Q ss_pred CCEEEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCC-ccccCCCCCcEEEccCCCCCCCCcccccCCCCCCEEe
Q 042348 57 GQVFSLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLP-VELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQVLD 135 (686)
Q Consensus 57 ~~~~~l~l~~n~l~g~~p~~l~~l~~L~~L~L~~N~l~g~~p-~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ 135 (686)
..++.|+|++|.+++ +|..+..+++|++|+|++|++++..+ ..+.++++|++|+|++|.+++..|..+..+++|++|+
T Consensus 78 ~~L~~L~Ls~n~i~~-l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 156 (306)
T 2z66_A 78 TSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLK 156 (306)
T ss_dssp SCCCEEECCSCSEEE-EEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEE
T ss_pred cccCEEECCCCcccc-ChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEE
Confidence 456667777777764 55567777777777777777775444 4667777777777777777777777777777777777
Q ss_pred ccCCCCCC-CCChhhhhccccccccccccccCCCCchhhhhcCcccceecccccccCCCCchhhhccccccccccccccc
Q 042348 136 LSQNSFSS-SIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSGLIPNDIANLSRLRLLAQRVYVD 214 (686)
Q Consensus 136 ls~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~~~~~l~ 214 (686)
|++|.+++ .+|..+..+++|++|+|++|++++..|..+ ..+++|+.|+|++|++++..+..+..+++|+.| |
T Consensus 157 l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~-~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L------~ 229 (306)
T 2z66_A 157 MAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAF-NSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVL------D 229 (306)
T ss_dssp CTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTT-TTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEE------E
T ss_pred CCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHh-cCCCCCCEEECCCCccCccChhhccCcccCCEe------E
Confidence 77777765 466777777777777777777775545544 467777777777777777666666666665544 7
Q ss_pred ccCCCCCCCcccccc-c-ccCCcccccCCCCCCCC
Q 042348 215 LTYNNLSGLIPQNAA-L-LSLGPTAFIGNPFLCGP 247 (686)
Q Consensus 215 l~~N~l~~~~p~~~~-~-~~~~~~~~~~n~~~c~~ 247 (686)
+++|++++.+|.... + .++..+.+.+|++.|.+
T Consensus 230 L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~~c 264 (306)
T 2z66_A 230 YSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTC 264 (306)
T ss_dssp CTTSCCCBCSSSSCCCCCTTCCEEECTTCCEECSG
T ss_pred CCCCCCcccCHHHHHhhhccCCEEEccCCCeeccc
Confidence 888888877765543 2 25566677777777643
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.82 E-value=2.4e-20 Score=212.43 Aligned_cols=183 Identities=25% Similarity=0.275 Sum_probs=156.7
Q ss_pred CCccee----eeEecC-----------CCEEEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCccccCCCCCcE
Q 042348 45 DPCSWN----GITCRE-----------GQVFSLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQS 109 (686)
Q Consensus 45 ~~c~w~----gv~c~~-----------~~~~~l~l~~n~l~g~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~ 109 (686)
+||.+. .|.|.. ..++.|+|++|+|++..|.+|.++++|++|+|++|+|++..|.+|.++++|++
T Consensus 25 ~~c~~~~~~~~~~c~~~~l~~vP~~lp~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~ 104 (635)
T 4g8a_A 25 EPCVEVVPNITYQCMELNFYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLST 104 (635)
T ss_dssp CCSEEEETTTEEECTTSCCSSCCSSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCE
T ss_pred CCccccCCCCEEECCCCCcCccCCCCCcCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCE
Confidence 467543 467862 46899999999999988889999999999999999999888888999999999
Q ss_pred EEccCCCCCCCCcccccCCCCCCEEeccCCCCCCCCChhhhhccccccccccccccCCC-CchhhhhcCcccceeccccc
Q 042348 110 LILSGNSFSGPVPMQIGKLKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGP-LPDGFATNLTALQKLDLSFN 188 (686)
Q Consensus 110 L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~-~p~~~~~~l~~L~~L~Ls~N 188 (686)
|+|++|+|++..+..|.++++|++|+|++|++++..+..|+++++|++|+|++|++++. +|..+ ..+++|++|+|++|
T Consensus 105 L~Ls~N~l~~l~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~-~~l~~L~~L~L~~N 183 (635)
T 4g8a_A 105 LILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYF-SNLTNLEHLDLSSN 183 (635)
T ss_dssp EECTTCCCCEECGGGGTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGG-GGCTTCCEEECCSS
T ss_pred EEccCCcCCCCCHHHhcCCCCCCEEECCCCcCCCCChhhhhcCcccCeeccccCccccCCCchhh-ccchhhhhhcccCc
Confidence 99999999977778899999999999999999987777899999999999999999864 45555 58999999999999
Q ss_pred ccCCCCchhhhcccccccccccccccccCCCCCCCccccccc
Q 042348 189 NLSGLIPNDIANLSRLRLLAQRVYVDLTYNNLSGLIPQNAAL 230 (686)
Q Consensus 189 ~l~~~~p~~~~~l~~L~~l~~~~~l~l~~N~l~~~~p~~~~~ 230 (686)
+|++..|..+..+.++..+ ...++++.|.++...+.....
T Consensus 184 ~l~~~~~~~l~~L~~l~~~--~~~~~ls~n~l~~i~~~~~~~ 223 (635)
T 4g8a_A 184 KIQSIYCTDLRVLHQMPLL--NLSLDLSLNPMNFIQPGAFKE 223 (635)
T ss_dssp CCCEECGGGGHHHHTCTTC--CCEEECTTCCCCEECTTTTTT
T ss_pred cccccccccccchhhhhhh--hhhhhcccCcccccCcccccc
Confidence 9999999998888776543 235689999998776655443
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.82 E-value=5.6e-20 Score=186.13 Aligned_cols=162 Identities=23% Similarity=0.240 Sum_probs=144.7
Q ss_pred CCCEEEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCccccCCCCCcEEEccCCCCCCCCcccccCCCCCCEEe
Q 042348 56 EGQVFSLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQVLD 135 (686)
Q Consensus 56 ~~~~~~l~l~~n~l~g~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ 135 (686)
...++.|+|++|.+++. +.+..+++|++|+|++|.+++..|..+.++++|++|+|++|++++..+..|+.+++|++|+
T Consensus 62 l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 139 (272)
T 3rfs_A 62 LPNVRYLALGGNKLHDI--SALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLN 139 (272)
T ss_dssp CTTCCEEECTTSCCCCC--GGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCCcEEECCCCCCCCc--hhhcCCCCCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEE
Confidence 36899999999999973 5899999999999999999987788889999999999999999988888899999999999
Q ss_pred ccCCCCCCCCChhhhhccccccccccccccCCCCchhhhhcCcccceecccccccCCCCchhhhcccccccccccccccc
Q 042348 136 LSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSGLIPNDIANLSRLRLLAQRVYVDL 215 (686)
Q Consensus 136 ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~~~~~l~l 215 (686)
|++|++++..|..+..+++|+.|+|++|++++. |...+..+++|++|+|++|++++.+|..+..+++|+.| ++
T Consensus 140 L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~-~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L------~l 212 (272)
T 3rfs_A 140 LAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSL-PEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYI------WL 212 (272)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCC-CTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEE------EC
T ss_pred CCCCccCccCHHHhccCccCCEEECCCCCcCcc-CHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEE------Ec
Confidence 999999987777889999999999999999964 44444689999999999999999988888888887765 89
Q ss_pred cCCCCCCCccc
Q 042348 216 TYNNLSGLIPQ 226 (686)
Q Consensus 216 ~~N~l~~~~p~ 226 (686)
++|.+.+..|.
T Consensus 213 ~~N~~~~~~~~ 223 (272)
T 3rfs_A 213 HDNPWDCTCPG 223 (272)
T ss_dssp CSSCBCCCTTT
T ss_pred cCCCccccCcH
Confidence 99999888774
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=99.82 E-value=1.5e-20 Score=205.30 Aligned_cols=158 Identities=21% Similarity=0.287 Sum_probs=140.9
Q ss_pred CCCcceee--eEecC----------CCEEEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccC-CccccCCCCCcEE
Q 042348 44 EDPCSWNG--ITCRE----------GQVFSLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSL-PVELFNASNLQSL 110 (686)
Q Consensus 44 ~~~c~w~g--v~c~~----------~~~~~l~l~~n~l~g~~p~~l~~l~~L~~L~L~~N~l~g~~-p~~~~~l~~L~~L 110 (686)
...|.|.+ |.|.. .++++|+|++|.+++..|..|+++++|++|+|++|.+.+.+ |..|.++++|++|
T Consensus 5 ~~~c~~~~~~~~c~~~~l~~lp~l~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L 84 (455)
T 3v47_A 5 TSECSVIGYNAICINRGLHQVPELPAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIIL 84 (455)
T ss_dssp --CCEEETTEEECCSSCCSSCCCCCTTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEE
T ss_pred cceeEEEccccCcCCCCcccCCCCCCccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEE
Confidence 34577766 88873 45899999999999999999999999999999999998666 5678999999999
Q ss_pred EccCCCCCCCCcccccCCCCCCEEeccCCCCCCCCChh--hhhccccccccccccccCCCCchhhhhcCcccceeccccc
Q 042348 111 ILSGNSFSGPVPMQIGKLKYLQVLDLSQNSFSSSIPSS--IVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFN 188 (686)
Q Consensus 111 ~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~~~~p~~--~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N 188 (686)
+|++|++++..|..|+++++|++|+|++|.+++.+|.. +..+++|++|+|++|++++..|..++.++++|++|+|++|
T Consensus 85 ~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n 164 (455)
T 3v47_A 85 KLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFN 164 (455)
T ss_dssp ECTTCTTCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTC
T ss_pred eCCCCccCccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCC
Confidence 99999999888999999999999999999999866655 8999999999999999998778875678999999999999
Q ss_pred ccCCCCchhhhcc
Q 042348 189 NLSGLIPNDIANL 201 (686)
Q Consensus 189 ~l~~~~p~~~~~l 201 (686)
++++..|..+..+
T Consensus 165 ~l~~~~~~~l~~l 177 (455)
T 3v47_A 165 KVKSICEEDLLNF 177 (455)
T ss_dssp CBSCCCTTTSGGG
T ss_pred cccccChhhhhcc
Confidence 9999999888776
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.82 E-value=1.1e-20 Score=214.18 Aligned_cols=185 Identities=18% Similarity=0.150 Sum_probs=151.8
Q ss_pred CCEEEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCC-ccccCCCCCcEEEccCCCCCCCCcccccCCCCCCEEe
Q 042348 57 GQVFSLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLP-VELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQVLD 135 (686)
Q Consensus 57 ~~~~~l~l~~n~l~g~~p~~l~~l~~L~~L~L~~N~l~g~~p-~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ 135 (686)
..++.|+|++|.+++ +|..+..+++|+.|+|++|++.+..| ..+.++++|++|+|++|.+++.+|..++.+++|++|+
T Consensus 376 ~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 454 (606)
T 3vq2_A 376 NSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLK 454 (606)
T ss_dssp SCCCEEECCSCSEEE-ECCCCTTCTTCCEEECTTSEEESTTTTTTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEE
T ss_pred CcccEeECCCCcccc-chhhccCCCCCCeeECCCCccCCccChhhhhccccCCEEECcCCCCCccchhhhcCCCCCCEEE
Confidence 466777777777775 56788888888888888888887777 6788889999999999999888888888999999999
Q ss_pred ccCCCCCC-CCChhhhhccccccccccccccCCCCchhhhhcCcccceecccccccCCCCchhhhccccccccccccccc
Q 042348 136 LSQNSFSS-SIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSGLIPNDIANLSRLRLLAQRVYVD 214 (686)
Q Consensus 136 ls~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~~~~~l~ 214 (686)
|++|.+++ .+|..+..+++|+.|+|++|++++..|..+ ..+++|+.|+|++|++++.+|..+.++++|+.| |
T Consensus 455 l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~-~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L------~ 527 (606)
T 3vq2_A 455 MAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVF-DTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTL------D 527 (606)
T ss_dssp CTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTT-TTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEE------E
T ss_pred CCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhh-cccccCCEEECCCCcCCCcCHHHccCCCcCCEE------E
Confidence 99999887 378888889999999999999987666666 578999999999999999888888888887765 9
Q ss_pred ccCCCCCCCcccccccc-cCCcccccCCCCCCCCCC
Q 042348 215 LTYNNLSGLIPQNAALL-SLGPTAFIGNPFLCGPPL 249 (686)
Q Consensus 215 l~~N~l~~~~p~~~~~~-~~~~~~~~~n~~~c~~p~ 249 (686)
+++|+++..++....+. ++..+.+.+||+.|+++.
T Consensus 528 l~~N~l~~~p~~~~~l~~~L~~l~l~~N~~~c~c~~ 563 (606)
T 3vq2_A 528 CSFNRIETSKGILQHFPKSLAFFNLTNNSVACICEH 563 (606)
T ss_dssp CTTSCCCCEESCGGGSCTTCCEEECCSCCCCCSSTT
T ss_pred CCCCcCcccCHhHhhhcccCcEEEccCCCcccCCcc
Confidence 99999996544433444 377788999999997664
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=99.82 E-value=2.2e-20 Score=203.91 Aligned_cols=120 Identities=26% Similarity=0.286 Sum_probs=68.1
Q ss_pred cccccCCCCCCEEeccCCCCCCCCChhhhhccccccccccccccCCCCchhhhhcCcccceecccccccCCCCchhhhcc
Q 042348 122 PMQIGKLKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSGLIPNDIANL 201 (686)
Q Consensus 122 p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 201 (686)
|..++.+++|+.|+|++|.+++..|..+..+++|++|+|++|++++..|..+ ..+++|+.|+|++|++++.+|..+.++
T Consensus 292 ~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~-~~l~~L~~L~Ls~N~l~~~~~~~~~~l 370 (455)
T 3v47_A 292 KSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMF-ENLDKLEVLDLSYNHIRALGDQSFLGL 370 (455)
T ss_dssp TTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGG-TTCTTCCEEECCSSCCCEECTTTTTTC
T ss_pred hhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHh-cCcccCCEEECCCCcccccChhhcccc
Confidence 3444455555555555555555555555555555555555555554333333 355555666666665555555555555
Q ss_pred cccccccccccccccCCCCCCCccccc-ccccCCcccccCCCCCCCCC
Q 042348 202 SRLRLLAQRVYVDLTYNNLSGLIPQNA-ALLSLGPTAFIGNPFLCGPP 248 (686)
Q Consensus 202 ~~L~~l~~~~~l~l~~N~l~~~~p~~~-~~~~~~~~~~~~n~~~c~~p 248 (686)
++|+. |++++|++++.++..+ .+.++..+.+.+|++.|.+|
T Consensus 371 ~~L~~------L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 412 (455)
T 3v47_A 371 PNLKE------LALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 412 (455)
T ss_dssp TTCCE------EECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred ccccE------EECCCCccccCCHhHhccCCcccEEEccCCCcccCCC
Confidence 55443 3777777777655543 35556666777777777544
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.82 E-value=4.3e-20 Score=180.53 Aligned_cols=151 Identities=25% Similarity=0.250 Sum_probs=122.8
Q ss_pred EEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCccccCCCCCcEEEccCCCCCCCCcccccCCCCCCEEeccCCCC
Q 042348 62 LIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQVLDLSQNSF 141 (686)
Q Consensus 62 l~l~~n~l~g~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l 141 (686)
+++++++|+ .+|..+. ++|+.|+|++|+|++..+..|.++++|+.|+|++|++++..|..|..+++|++|+|++|++
T Consensus 16 v~c~~~~l~-~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l 92 (220)
T 2v9t_B 16 VDCRGKGLT-EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKI 92 (220)
T ss_dssp EECTTSCCS-SCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSCC
T ss_pred EEcCCCCcC-cCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCcC
Confidence 334466666 3666654 6889999999999977777889999999999999999988888999999999999999999
Q ss_pred CCCCChhhhhccccccccccccccCCCCchhhhhcCcccceecccccccCCCCchhhhcccccccccccccccccCCCCC
Q 042348 142 SSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSGLIPNDIANLSRLRLLAQRVYVDLTYNNLS 221 (686)
Q Consensus 142 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~~~~~l~l~~N~l~ 221 (686)
++..+..|..+++|+.|+|++|++++..|..+ ..+++|+.|+|++|+|++..+..+..+++|+.| ++++|.+.
T Consensus 93 ~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~-~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L------~L~~N~~~ 165 (220)
T 2v9t_B 93 TELPKSLFEGLFSLQLLLLNANKINCLRVDAF-QDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTM------HLAQNPFI 165 (220)
T ss_dssp CCCCTTTTTTCTTCCEEECCSSCCCCCCTTTT-TTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEE------ECCSSCEE
T ss_pred CccCHhHccCCCCCCEEECCCCCCCEeCHHHc-CCCCCCCEEECCCCcCCEECHHHHhCCCCCCEE------EeCCCCcC
Confidence 96666667889999999999999987656555 588999999999999998888778877776654 67766665
Q ss_pred C
Q 042348 222 G 222 (686)
Q Consensus 222 ~ 222 (686)
.
T Consensus 166 c 166 (220)
T 2v9t_B 166 C 166 (220)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.82 E-value=1.6e-20 Score=193.79 Aligned_cols=189 Identities=22% Similarity=0.301 Sum_probs=133.6
Q ss_pred cceeeeEecC-----------CCEEEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcc--cCCccccCCCCCcEEEcc
Q 042348 47 CSWNGITCRE-----------GQVFSLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSG--SLPVELFNASNLQSLILS 113 (686)
Q Consensus 47 c~w~gv~c~~-----------~~~~~l~l~~n~l~g~~p~~l~~l~~L~~L~L~~N~l~g--~~p~~~~~l~~L~~L~L~ 113 (686)
|.|.+|.|.. ..++.|+|++|+++...+..|..+++|+.|+|++|.++. ..|..+..+++|++|+|+
T Consensus 7 C~~~~l~c~~~~l~~ip~~~~~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~Ls 86 (306)
T 2z66_A 7 CSGTEIRCNSKGLTSVPTGIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLS 86 (306)
T ss_dssp EETTEEECCSSCCSSCCSCCCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEECC
T ss_pred eCCCEEEcCCCCcccCCCCCCCCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEECC
Confidence 7899999973 368899999999996555568999999999999999973 336667778888888888
Q ss_pred CCCCCCCCcccccCCCCCCEEeccCCCCCCCCC-hhhhhccccccccccccccCCCCchhhhhcCcccceecccccccCC
Q 042348 114 GNSFSGPVPMQIGKLKYLQVLDLSQNSFSSSIP-SSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSG 192 (686)
Q Consensus 114 ~N~l~g~~p~~~~~l~~L~~L~ls~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~ 192 (686)
+|.++ .+|..+..+++|++|+|++|.+++..+ ..+..+++|++|+|++|++++..|..+ ..+++|++|+|++|.+++
T Consensus 87 ~n~i~-~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~-~~l~~L~~L~l~~n~l~~ 164 (306)
T 2z66_A 87 FNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIF-NGLSSLEVLKMAGNSFQE 164 (306)
T ss_dssp SCSEE-EEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTT-TTCTTCCEEECTTCEEGG
T ss_pred CCccc-cChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhc-ccCcCCCEEECCCCcccc
Confidence 88877 566667777778888887777775444 466777777777777777775555444 467777777777777765
Q ss_pred -CCchhhhcccccccccccccccccCCCCCCCccccc-ccccCCcccccCCCC
Q 042348 193 -LIPNDIANLSRLRLLAQRVYVDLTYNNLSGLIPQNA-ALLSLGPTAFIGNPF 243 (686)
Q Consensus 193 -~~p~~~~~l~~L~~l~~~~~l~l~~N~l~~~~p~~~-~~~~~~~~~~~~n~~ 243 (686)
.+|..+..+++|+.| ++++|++++.+|..+ .+.++..+.+.+|..
T Consensus 165 ~~~~~~~~~l~~L~~L------~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l 211 (306)
T 2z66_A 165 NFLPDIFTELRNLTFL------DLSQCQLEQLSPTAFNSLSSLQVLNMSHNNF 211 (306)
T ss_dssp GEECSCCTTCTTCCEE------ECTTSCCCEECTTTTTTCTTCCEEECTTSCC
T ss_pred ccchhHHhhCcCCCEE------ECCCCCcCCcCHHHhcCCCCCCEEECCCCcc
Confidence 456666666655544 666666666555433 233444455555543
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=99.81 E-value=4.3e-20 Score=209.34 Aligned_cols=184 Identities=21% Similarity=0.234 Sum_probs=143.6
Q ss_pred CCEEEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCcc-ccCCCCCcEEEccCCCCCCCCcccccCCCCCCEEe
Q 042348 57 GQVFSLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVE-LFNASNLQSLILSGNSFSGPVPMQIGKLKYLQVLD 135 (686)
Q Consensus 57 ~~~~~l~l~~n~l~g~~p~~l~~l~~L~~L~L~~N~l~g~~p~~-~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ 135 (686)
.+++.|+|++|.+++..|..+..+++|+.|+|++|++.+..|.. +.++++|++|+|++|.+++..|..++.+++|+.|+
T Consensus 376 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 455 (606)
T 3t6q_A 376 SHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLN 455 (606)
T ss_dssp TTCCEEECCSCSCEEECTTTTTTCTTCSEEECTTCCEECCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCTTCCEEE
T ss_pred CCCCEEECCCCcCCcCCHHHhcCCccCCeEECCCCcCCCcccchhhhCcccCCEEECCCCccCCcCHHHHhCCCCCCEEE
Confidence 46777888888888777778888888888888888887666544 77788888888888888877777788888888888
Q ss_pred ccCCCCCCC---CChhhhhccccccccccccccCCCCchhhhhcCcccceecccccccCCCCchhhhccccccccccccc
Q 042348 136 LSQNSFSSS---IPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSGLIPNDIANLSRLRLLAQRVY 212 (686)
Q Consensus 136 ls~N~l~~~---~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~~~~~ 212 (686)
|++|.+++. .+..+..+++|+.|+|++|++++..|..+ ..+++|+.|+|++|++++.+|..+.++++| .|
T Consensus 456 L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~-~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L-~L----- 528 (606)
T 3t6q_A 456 LQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAF-TSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YL----- 528 (606)
T ss_dssp CTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECTTTT-TTCTTCCEEECCSSCCCGGGGGGGTTCCSC-EE-----
T ss_pred CCCCCCCccccccchhhccCCCccEEECCCCccCccChhhh-ccccCCCEEECCCCccCcCChhHhCccccc-EE-----
Confidence 888888752 33567788888888888888886666655 478888888888888888888877777666 44
Q ss_pred ccccCCCCCCCccccc-ccccCCcccccCCCCCCCCC
Q 042348 213 VDLTYNNLSGLIPQNA-ALLSLGPTAFIGNPFLCGPP 248 (686)
Q Consensus 213 l~l~~N~l~~~~p~~~-~~~~~~~~~~~~n~~~c~~p 248 (686)
|+++|++++.+|..+ .+.++..+.+.+||+.|.++
T Consensus 529 -~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 564 (606)
T 3t6q_A 529 -NLASNHISIILPSLLPILSQQRTINLRQNPLDCTCS 564 (606)
T ss_dssp -ECCSSCCCCCCGGGHHHHHTSSEEECTTCCEECSGG
T ss_pred -ECcCCcccccCHhhcccCCCCCEEeCCCCCccccCC
Confidence 999999998888754 35677788899999998543
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.81 E-value=5.6e-20 Score=201.99 Aligned_cols=189 Identities=20% Similarity=0.229 Sum_probs=164.9
Q ss_pred eeeeEecC-----------CCEEEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCccccCCCCCcEEEccCCCC
Q 042348 49 WNGITCRE-----------GQVFSLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSF 117 (686)
Q Consensus 49 w~gv~c~~-----------~~~~~l~l~~n~l~g~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l 117 (686)
|..|.|.. ..++.|+|++|+|++..|..|.++++|+.|+|++|.+++..|..|.++++|++|+|++|++
T Consensus 13 ~~~v~c~~~~l~~ip~~~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l 92 (477)
T 2id5_A 13 DRAVLCHRKRFVAVPEGIPTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRL 92 (477)
T ss_dssp TTEEECCSCCCSSCCSCCCTTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCC
T ss_pred CCEEEeCCCCcCcCCCCCCCCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCcC
Confidence 67888863 3678999999999999999999999999999999999988899999999999999999999
Q ss_pred CCCCcccccCCCCCCEEeccCCCCCCCCChhhhhccccccccccccccCCCCchhhhhcCcccceecccccccCCCCchh
Q 042348 118 SGPVPMQIGKLKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSGLIPND 197 (686)
Q Consensus 118 ~g~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~ 197 (686)
++..+..|.++++|++|+|++|.+++..|..+..+++|+.|+|++|++++..|..+ .++++|+.|+|++|++++..+..
T Consensus 93 ~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~-~~l~~L~~L~l~~n~l~~~~~~~ 171 (477)
T 2id5_A 93 KLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAF-SGLNSLEQLTLEKCNLTSIPTEA 171 (477)
T ss_dssp CSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSS-TTCTTCCEEEEESCCCSSCCHHH
T ss_pred CccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCccceeChhhc-cCCCCCCEEECCCCcCcccChhH
Confidence 96666678999999999999999999889999999999999999999997666665 58999999999999999988888
Q ss_pred hhcccccccccccccccccCCCCCCCccccc-ccccCCcccccCCCCC
Q 042348 198 IANLSRLRLLAQRVYVDLTYNNLSGLIPQNA-ALLSLGPTAFIGNPFL 244 (686)
Q Consensus 198 ~~~l~~L~~l~~~~~l~l~~N~l~~~~p~~~-~~~~~~~~~~~~n~~~ 244 (686)
+.++++|+.| ++++|++++..+..+ .+.++..+.+.+|+.+
T Consensus 172 l~~l~~L~~L------~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~ 213 (477)
T 2id5_A 172 LSHLHGLIVL------RLRHLNINAIRDYSFKRLYRLKVLEISHWPYL 213 (477)
T ss_dssp HTTCTTCCEE------EEESCCCCEECTTCSCSCTTCCEEEEECCTTC
T ss_pred hcccCCCcEE------eCCCCcCcEeChhhcccCcccceeeCCCCccc
Confidence 9888888765 999999998766544 3445566666676554
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.81 E-value=1.1e-20 Score=195.46 Aligned_cols=178 Identities=22% Similarity=0.252 Sum_probs=135.1
Q ss_pred CCEEEEEeCCCCccccCCcCc--CCCCCCCEEEccCCCCcccCCccccCC-----CCCcEEEccCCCCCCCCcccccCCC
Q 042348 57 GQVFSLIIPNKKLTGFIPADL--GSLSAIGRVNLRNNNFSGSLPVELFNA-----SNLQSLILSGNSFSGPVPMQIGKLK 129 (686)
Q Consensus 57 ~~~~~l~l~~n~l~g~~p~~l--~~l~~L~~L~L~~N~l~g~~p~~~~~l-----~~L~~L~L~~N~l~g~~p~~~~~l~ 129 (686)
.+++.|+|++|++++.+|..+ ..+++|++|+|++|+|++. |..+.++ ++|++|+|++|++++..|..|+.++
T Consensus 95 ~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~ 173 (312)
T 1wwl_A 95 SGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFP 173 (312)
T ss_dssp SCCCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCS
T ss_pred CCccEEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCC
Confidence 578889999999998888876 8889999999999999876 7777766 8899999999999887778888999
Q ss_pred CCCEEeccCCCCCCC--CChhh--hhccccccccccccccCC--CCchhhhhcCcccceecccccccCCCCc-hhhhccc
Q 042348 130 YLQVLDLSQNSFSSS--IPSSI--VQCKRLKTVVLNQNSFTG--PLPDGFATNLTALQKLDLSFNNLSGLIP-NDIANLS 202 (686)
Q Consensus 130 ~L~~L~ls~N~l~~~--~p~~~--~~l~~L~~L~L~~N~l~~--~~p~~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~ 202 (686)
+|++|+|++|++.+. +|..+ ..+++|++|+|++|++++ .++..++.++++|+.|||++|++++.+| ..+..++
T Consensus 174 ~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~ 253 (312)
T 1wwl_A 174 ALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPS 253 (312)
T ss_dssp SCCEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCT
T ss_pred CCCEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcC
Confidence 999999999988765 34444 778889999999998873 3344555577889999999999988775 3444455
Q ss_pred ccccccccccccccCCCCCCCcccccccccCCcccccCCCC
Q 042348 203 RLRLLAQRVYVDLTYNNLSGLIPQNAALLSLGPTAFIGNPF 243 (686)
Q Consensus 203 ~L~~l~~~~~l~l~~N~l~~~~p~~~~~~~~~~~~~~~n~~ 243 (686)
+|+. |++++|+++ .+|.... .++..+++.+|..
T Consensus 254 ~L~~------L~Ls~N~l~-~ip~~~~-~~L~~L~Ls~N~l 286 (312)
T 1wwl_A 254 QLNS------LNLSFTGLK-QVPKGLP-AKLSVLDLSYNRL 286 (312)
T ss_dssp TCCE------EECTTSCCS-SCCSSCC-SEEEEEECCSSCC
T ss_pred CCCE------EECCCCccC-hhhhhcc-CCceEEECCCCCC
Confidence 5554 488888888 4444333 4455556666654
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.81 E-value=1.7e-20 Score=194.05 Aligned_cols=164 Identities=24% Similarity=0.341 Sum_probs=120.2
Q ss_pred CCEEEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCccccCCC-CCcEEEccCCCCCCCCcccccCCCCCCEEe
Q 042348 57 GQVFSLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNAS-NLQSLILSGNSFSGPVPMQIGKLKYLQVLD 135 (686)
Q Consensus 57 ~~~~~l~l~~n~l~g~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~~l~-~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ 135 (686)
..+++|+|++|.+++.+|..+..+++|++|+|++|+|+|.+|..+.+++ +|+.|+|++|++++.+|..+..+. |+.|+
T Consensus 125 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~ 203 (313)
T 1ogq_A 125 KTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVD 203 (313)
T ss_dssp TTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEE
T ss_pred CCCCEEeCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEEE
Confidence 5788888888888888888888888888888888888888888888887 888888888888877777777776 77777
Q ss_pred ccCCCCCCCCChhhhhccccccccccccccCCCCchhhhhcCcccceecccccccCCCCchhhhcccccccc--------
Q 042348 136 LSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSGLIPNDIANLSRLRLL-------- 207 (686)
Q Consensus 136 ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l-------- 207 (686)
|++|.+++.+|..+..+++|+.|+|++|++++.+|. + ..+++|++|+|++|++++.+|..+..+++|+.|
T Consensus 204 Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~-~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~ 281 (313)
T 1ogq_A 204 LSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-V-GLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLC 281 (313)
T ss_dssp CCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGG-C-CCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEE
T ss_pred CcCCcccCcCCHHHhcCCCCCEEECCCCceeeecCc-c-cccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCccc
Confidence 777777766676666677777777766666654444 2 356666666666666666666666666555433
Q ss_pred ---------cccccccccCCC-CCCC
Q 042348 208 ---------AQRVYVDLTYNN-LSGL 223 (686)
Q Consensus 208 ---------~~~~~l~l~~N~-l~~~ 223 (686)
+.+..+++++|. +.|.
T Consensus 282 ~~ip~~~~l~~L~~l~l~~N~~lc~~ 307 (313)
T 1ogq_A 282 GEIPQGGNLQRFDVSAYANNKCLCGS 307 (313)
T ss_dssp EECCCSTTGGGSCGGGTCSSSEEEST
T ss_pred ccCCCCccccccChHHhcCCCCccCC
Confidence 234567999997 6664
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.81 E-value=6.1e-20 Score=193.85 Aligned_cols=177 Identities=25% Similarity=0.256 Sum_probs=112.7
Q ss_pred EEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCcccc-CCCCCcEEEccCCCCCCCCcccccCCCCCCEEeccCC
Q 042348 61 SLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELF-NASNLQSLILSGNSFSGPVPMQIGKLKYLQVLDLSQN 139 (686)
Q Consensus 61 ~l~l~~n~l~g~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~-~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N 139 (686)
.+++++++|+. +|..+. ..++.|+|++|+|++..+..+. ++++|+.|+|++|+|++..+..|..+++|++|+|++|
T Consensus 22 ~l~c~~~~l~~-iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N 98 (361)
T 2xot_A 22 ILSCSKQQLPN-VPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSN 98 (361)
T ss_dssp EEECCSSCCSS-CCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred EEEeCCCCcCc-cCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCCC
Confidence 45556666664 555543 3467777777777765565565 7777777777777777666666777777777777777
Q ss_pred CCCCCCChhhhhccccccccccccccCCCCchhhhhcCcccceecccccccCCCCchhh---hccccccccccccccccc
Q 042348 140 SFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSGLIPNDI---ANLSRLRLLAQRVYVDLT 216 (686)
Q Consensus 140 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~---~~l~~L~~l~~~~~l~l~ 216 (686)
+|++..+..|..+++|+.|+|++|++++..|..+ ..+++|+.|+|++|+|++..+..+ ..+++|+ .|||+
T Consensus 99 ~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~-~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~------~L~L~ 171 (361)
T 2xot_A 99 HLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAF-EDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLM------LLDLS 171 (361)
T ss_dssp CCCEECTTTTTTCTTCCEEECCSSCCCEECTTTT-TTCTTCCEEECCSSCCCSCCGGGTC----CTTCC------EEECC
T ss_pred cCCcCCHHHhCCCcCCCEEECCCCcccEECHHHh-CCcccCCEEECCCCcCCeeCHHHhcCcccCCcCC------EEECC
Confidence 7776556667777777777777777775444444 467777777777777776554444 2344443 34777
Q ss_pred CCCCCCCccccccc-cc--CCcccccCCCCCCCC
Q 042348 217 YNNLSGLIPQNAAL-LS--LGPTAFIGNPFLCGP 247 (686)
Q Consensus 217 ~N~l~~~~p~~~~~-~~--~~~~~~~~n~~~c~~ 247 (686)
+|+|++.++..+.. .. +..+.+.+|||.|.+
T Consensus 172 ~N~l~~l~~~~~~~l~~~~l~~l~l~~N~~~C~C 205 (361)
T 2xot_A 172 SNKLKKLPLTDLQKLPAWVKNGLYLHNNPLECDC 205 (361)
T ss_dssp SSCCCCCCHHHHHHSCHHHHTTEECCSSCEECCH
T ss_pred CCCCCccCHHHhhhccHhhcceEEecCCCccCCc
Confidence 77777655443321 11 234567777777754
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.81 E-value=5.4e-20 Score=194.27 Aligned_cols=172 Identities=23% Similarity=0.234 Sum_probs=150.8
Q ss_pred cceeeeEecC-----------CCEEEEEeCCCCccccCCcCcC-CCCCCCEEEccCCCCcccCCccccCCCCCcEEEccC
Q 042348 47 CSWNGITCRE-----------GQVFSLIIPNKKLTGFIPADLG-SLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSG 114 (686)
Q Consensus 47 c~w~gv~c~~-----------~~~~~l~l~~n~l~g~~p~~l~-~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~ 114 (686)
|.|..|.|.. ..++.|+|++|+|++..+..+. .+++|+.|+|++|+|++..|..|.++++|++|+|++
T Consensus 18 C~~~~l~c~~~~l~~iP~~~~~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~ 97 (361)
T 2xot_A 18 CASNILSCSKQQLPNVPQSLPSYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSS 97 (361)
T ss_dssp EETTEEECCSSCCSSCCSSCCTTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred ECCCEEEeCCCCcCccCccCCCCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCC
Confidence 6788889973 3477899999999998888888 999999999999999988888899999999999999
Q ss_pred CCCCCCCcccccCCCCCCEEeccCCCCCCCCChhhhhccccccccccccccCCCCchhhh---hcCcccceecccccccC
Q 042348 115 NSFSGPVPMQIGKLKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFA---TNLTALQKLDLSFNNLS 191 (686)
Q Consensus 115 N~l~g~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~---~~l~~L~~L~Ls~N~l~ 191 (686)
|+|++..+..|..+++|+.|+|++|++++..|..|..+++|+.|+|++|+|+ .+|..++ ..+++|+.|||++|+|+
T Consensus 98 N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~-~l~~~~~~~~~~l~~L~~L~L~~N~l~ 176 (361)
T 2xot_A 98 NHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLK 176 (361)
T ss_dssp SCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCC-SCCGGGTC----CTTCCEEECCSSCCC
T ss_pred CcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCC-eeCHHHhcCcccCCcCCEEECCCCCCC
Confidence 9999777778999999999999999999888999999999999999999999 4777664 46999999999999999
Q ss_pred CCCchhhhcccccccccccccccccCCCCCCC
Q 042348 192 GLIPNDIANLSRLRLLAQRVYVDLTYNNLSGL 223 (686)
Q Consensus 192 ~~~p~~~~~l~~L~~l~~~~~l~l~~N~l~~~ 223 (686)
+..+..+..++.+. +..|+|++|.+...
T Consensus 177 ~l~~~~~~~l~~~~----l~~l~l~~N~~~C~ 204 (361)
T 2xot_A 177 KLPLTDLQKLPAWV----KNGLYLHNNPLECD 204 (361)
T ss_dssp CCCHHHHHHSCHHH----HTTEECCSSCEECC
T ss_pred ccCHHHhhhccHhh----cceEEecCCCccCC
Confidence 88888888887641 13459999999754
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=99.81 E-value=9.5e-20 Score=209.38 Aligned_cols=186 Identities=24% Similarity=0.261 Sum_probs=126.9
Q ss_pred CCEEEEEeCCCCccccCC-cCcCCCCCCCEEEccCCCCcc--------------------------cCCccccCCCCCcE
Q 042348 57 GQVFSLIIPNKKLTGFIP-ADLGSLSAIGRVNLRNNNFSG--------------------------SLPVELFNASNLQS 109 (686)
Q Consensus 57 ~~~~~l~l~~n~l~g~~p-~~l~~l~~L~~L~L~~N~l~g--------------------------~~p~~~~~l~~L~~ 109 (686)
..++.|+|++|.+++.+| ..+.++++|+.|+|++|++.+ .+|..+.++++|+.
T Consensus 405 ~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l~~L~~ 484 (680)
T 1ziw_A 405 GHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTI 484 (680)
T ss_dssp TTCCEEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTTTTCTTCCE
T ss_pred CCCCEEeCCCCcCccccCcccccCcccccEEecCCCCcceeChhhhhcCcccccchhccccccccccCCcccccCCCCCE
Confidence 456667777777766555 456666666666666666543 45555666666666
Q ss_pred EEccCCCCCCCCcccccCCCCCCEEeccCCCCCCCC--------ChhhhhccccccccccccccCCCCchhhhhcCcccc
Q 042348 110 LILSGNSFSGPVPMQIGKLKYLQVLDLSQNSFSSSI--------PSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQ 181 (686)
Q Consensus 110 L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~~~~--------p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~ 181 (686)
|+|++|++++..|..|..+++|+.|+|++|++++.. +..+..+++|+.|+|++|+++ .+|...+.++++|+
T Consensus 485 L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~-~i~~~~~~~l~~L~ 563 (680)
T 1ziw_A 485 LDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFD-EIPVEVFKDLFELK 563 (680)
T ss_dssp EECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCC
T ss_pred EECCCCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCC-CCCHHHcccccCcc
Confidence 666666666555555666666777777776666421 122566677777777777776 46655445777777
Q ss_pred eecccccccCCCCchhhhcccccccccccccccccCCCCCCCccccc--ccccCCcccccCCCCCCCCCC
Q 042348 182 KLDLSFNNLSGLIPNDIANLSRLRLLAQRVYVDLTYNNLSGLIPQNA--ALLSLGPTAFIGNPFLCGPPL 249 (686)
Q Consensus 182 ~L~Ls~N~l~~~~p~~~~~l~~L~~l~~~~~l~l~~N~l~~~~p~~~--~~~~~~~~~~~~n~~~c~~p~ 249 (686)
.|||++|++++.++..+.++++|+.| ++++|++++.+|..+ .+.++..+.+.+|||.|+++.
T Consensus 564 ~L~Ls~N~l~~l~~~~~~~l~~L~~L------~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~~c~c~~ 627 (680)
T 1ziw_A 564 IIDLGLNNLNTLPASVFNNQVSLKSL------NLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCES 627 (680)
T ss_dssp EEECCSSCCCCCCTTTTTTCTTCCEE------ECTTSCCCBCCHHHHHHHHTTCSEEECTTCCCCBCCCC
T ss_pred eeECCCCCCCcCCHhHhCCCCCCCEE------ECCCCcCCccChhHhcccccccCEEEccCCCcccCCcc
Confidence 77887777777666666676666654 999999999888755 366778889999999997653
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.80 E-value=1.4e-20 Score=194.53 Aligned_cols=178 Identities=24% Similarity=0.277 Sum_probs=148.5
Q ss_pred CCCEEEEEeCCCCccccCCcCcCCC-----CCCCEEEccCCCCcccCCccccCCCCCcEEEccCCCCCCC--Ccccc--c
Q 042348 56 EGQVFSLIIPNKKLTGFIPADLGSL-----SAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGP--VPMQI--G 126 (686)
Q Consensus 56 ~~~~~~l~l~~n~l~g~~p~~l~~l-----~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~--~p~~~--~ 126 (686)
...++.|+|++|++++. |..++.+ ++|++|+|++|+|++..|..|.++++|++|+|++|++.|. +|..+ +
T Consensus 120 l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~ 198 (312)
T 1wwl_A 120 GPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPL 198 (312)
T ss_dssp SCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHHHSCTT
T ss_pred CCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHHHHHhc
Confidence 46799999999999997 8888877 9999999999999988889999999999999999999876 34455 8
Q ss_pred CCCCCCEEeccCCCCCC--CCC-hhhhhccccccccccccccCCCCchhhhhcCcccceecccccccCCCCchhhhcccc
Q 042348 127 KLKYLQVLDLSQNSFSS--SIP-SSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSGLIPNDIANLSR 203 (686)
Q Consensus 127 ~l~~L~~L~ls~N~l~~--~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 203 (686)
.+++|++|+|++|++++ .++ ..+..+++|++|+|++|++++.+|...+..+++|++|+|++|+|+ .+|..+. ++
T Consensus 199 ~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~-~ip~~~~--~~ 275 (312)
T 1wwl_A 199 KFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLP--AK 275 (312)
T ss_dssp SCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS-SCCSSCC--SE
T ss_pred cCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccC-hhhhhcc--CC
Confidence 99999999999999984 222 334577999999999999998776554457899999999999999 6677665 55
Q ss_pred cccccccccccccCCCCCCCcccccccccCCcccccCCCCC
Q 042348 204 LRLLAQRVYVDLTYNNLSGLIPQNAALLSLGPTAFIGNPFL 244 (686)
Q Consensus 204 L~~l~~~~~l~l~~N~l~~~~p~~~~~~~~~~~~~~~n~~~ 244 (686)
|+ +||+++|+|++. |....+.++..+.+.+|++.
T Consensus 276 L~------~L~Ls~N~l~~~-p~~~~l~~L~~L~L~~N~l~ 309 (312)
T 1wwl_A 276 LS------VLDLSYNRLDRN-PSPDELPQVGNLSLKGNPFL 309 (312)
T ss_dssp EE------EEECCSSCCCSC-CCTTTSCEEEEEECTTCTTT
T ss_pred ce------EEECCCCCCCCC-hhHhhCCCCCEEeccCCCCC
Confidence 55 459999999988 55555666777788888764
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.80 E-value=1.9e-20 Score=205.54 Aligned_cols=177 Identities=19% Similarity=0.176 Sum_probs=110.4
Q ss_pred CEEEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCccccCCCCCcEEEccCCCCCCCCcc--------------
Q 042348 58 QVFSLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPM-------------- 123 (686)
Q Consensus 58 ~~~~l~l~~n~l~g~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~-------------- 123 (686)
+++.|+|++|.+++..|..|+.+++|+.|+|++|.|++..| +.++++|++|+|++|.|++..+.
T Consensus 35 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~~~~~L~~L~L~~N~l~ 112 (487)
T 3oja_A 35 NVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLVGPSIETLHAANNNIS 112 (487)
T ss_dssp GCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEEECTTCCEEECCSSCCC
T ss_pred CccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCCCCCCcCEEECcCCcCC
Confidence 46666666666666555666666666666666666665444 55555555555555554421110
Q ss_pred --cccCCCCCCEEeccCCCCCCCCChhhhhccccccccccccccCCCCchhhhhcCcccceecccccccCCCCchhhhcc
Q 042348 124 --QIGKLKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSGLIPNDIANL 201 (686)
Q Consensus 124 --~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 201 (686)
....+++|+.|+|++|.+++..|..+..+++|+.|+|++|.+++.+|..+...+++|+.|+|++|.|++..+ ...+
T Consensus 113 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~~~--~~~l 190 (487)
T 3oja_A 113 RVSCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVKG--QVVF 190 (487)
T ss_dssp CEEECCCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEEEC--CCCC
T ss_pred CCCccccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccccccc--cccC
Confidence 012356777777777777777777777778888888888888776666665567777777777777776522 2234
Q ss_pred cccccccccccccccCCCCCCCcccccccccCCcccccCCCCC
Q 042348 202 SRLRLLAQRVYVDLTYNNLSGLIPQNAALLSLGPTAFIGNPFL 244 (686)
Q Consensus 202 ~~L~~l~~~~~l~l~~N~l~~~~p~~~~~~~~~~~~~~~n~~~ 244 (686)
++|+ +|+|++|+|++.+|....+.++..+++.+|...
T Consensus 191 ~~L~------~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~ 227 (487)
T 3oja_A 191 AKLK------TLDLSSNKLAFMGPEFQSAAGVTWISLRNNKLV 227 (487)
T ss_dssp TTCC------EEECCSSCCCEECGGGGGGTTCSEEECTTSCCC
T ss_pred CCCC------EEECCCCCCCCCCHhHcCCCCccEEEecCCcCc
Confidence 4443 347777777776666545555666666666543
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.80 E-value=1.4e-20 Score=215.98 Aligned_cols=204 Identities=21% Similarity=0.219 Sum_probs=127.5
Q ss_pred ChhHHHHHHHHHHhccCCCCC--CCCCCCCCCCcceeeeEecCCCEEEEEeCCCCccc----------------------
Q 042348 16 ANDEGLALLSFKQAIRNFPEG--NNWNNSNEDPCSWNGITCREGQVFSLIIPNKKLTG---------------------- 71 (686)
Q Consensus 16 ~~~~~~~l~~~k~~~~~~~~~--~~w~~~~~~~c~w~gv~c~~~~~~~l~l~~n~l~g---------------------- 71 (686)
...+..+|+.+.+.+....+. ..|......++.|.++++...+++.|.|.+|.+..
T Consensus 130 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~~l~L~~n~~~~~~~~~l~~l~Ls~~~i~~~~~~ 209 (727)
T 4b8c_D 130 VDCTKQALMEMADTLTDSKTAKKQQPTGDSTPSGTATNSAVSTPLTPKIELFANGKDEANQALLQHKKLSQYSIDEDDDI 209 (727)
T ss_dssp --CCCHHHHHHHHHHHHHHTTC----------------------------------------------------------
T ss_pred cccchhhhhhhhhhcccccCcccCCCcCCCCccccCCCceecCCccceEEeeCCCCCcchhhHhhcCccCcccccCcccc
Confidence 345678999998877443333 45655444557899988887666666665444332
Q ss_pred -----cCCcCcCCCCCCCEEEccCCCCcccCCccccCCCCCcEEEccCCCCCCCCcccccCCCCCCEEeccCCCCCCCCC
Q 042348 72 -----FIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQVLDLSQNSFSSSIP 146 (686)
Q Consensus 72 -----~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~~~~p 146 (686)
..|..+..+..|+.|+|++|.|. .+|..++++++|++|+|++|.|+ .+|..|+.|++|++|+|++|.|+ .+|
T Consensus 210 ~n~~~~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp 286 (727)
T 4b8c_D 210 ENRMVMPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLP 286 (727)
T ss_dssp ------------CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCC
T ss_pred ccceecChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccC
Confidence 23566778888888888888887 78888888888888888888888 78888888888888888888888 678
Q ss_pred hhhhhccccccccccccccCCCCchhhhhcCcccceecccccccCCCCchhhhcccccccccccccccccCCCCCCCccc
Q 042348 147 SSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSGLIPNDIANLSRLRLLAQRVYVDLTYNNLSGLIPQ 226 (686)
Q Consensus 147 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~~~~~l~l~~N~l~~~~p~ 226 (686)
..+..|++|++|+|++|.|+ .+|..+ ..|++|+.|+|++|.|++.+|..+..+.... ..++|++|.++|.+|.
T Consensus 287 ~~~~~l~~L~~L~L~~N~l~-~lp~~~-~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~-----~~l~l~~N~l~~~~p~ 359 (727)
T 4b8c_D 287 AELGSCFQLKYFYFFDNMVT-TLPWEF-GNLCNLQFLGVEGNPLEKQFLKILTEKSVTG-----LIFYLRDNRPEIPLPH 359 (727)
T ss_dssp SSGGGGTTCSEEECCSSCCC-CCCSST-TSCTTCCCEECTTSCCCSHHHHHHHHHHHHH-----HHHHHHHCCCCCCCCC
T ss_pred hhhcCCCCCCEEECCCCCCC-ccChhh-hcCCCccEEeCCCCccCCCChHHHhhcchhh-----hHHhhccCcccCcCcc
Confidence 88888888888888888887 678775 4788888888888888888888776654321 1357888888888887
Q ss_pred ccc
Q 042348 227 NAA 229 (686)
Q Consensus 227 ~~~ 229 (686)
...
T Consensus 360 ~l~ 362 (727)
T 4b8c_D 360 ERR 362 (727)
T ss_dssp C--
T ss_pred ccc
Confidence 554
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.80 E-value=5.9e-20 Score=189.78 Aligned_cols=182 Identities=17% Similarity=0.197 Sum_probs=147.1
Q ss_pred CCEEEEEeCCCCccccCCcCc--CCCCCCCEEEccCCCCcccCC----ccccCCCCCcEEEccCCCCCCCCcccccCCCC
Q 042348 57 GQVFSLIIPNKKLTGFIPADL--GSLSAIGRVNLRNNNFSGSLP----VELFNASNLQSLILSGNSFSGPVPMQIGKLKY 130 (686)
Q Consensus 57 ~~~~~l~l~~n~l~g~~p~~l--~~l~~L~~L~L~~N~l~g~~p----~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~ 130 (686)
.+++.|+|++|.+++..|..+ ..+++|+.|+|++|.+++..| ..+..+++|++|+|++|++++..|..|+.+++
T Consensus 91 ~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~ 170 (310)
T 4glp_A 91 SRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPA 170 (310)
T ss_dssp SCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCTT
T ss_pred CceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCCC
Confidence 358999999999999999998 999999999999999998766 45568999999999999999888899999999
Q ss_pred CCEEeccCCCCCCC--C--ChhhhhccccccccccccccCCCCchh---hhhcCcccceecccccccCCCCchhhhcccc
Q 042348 131 LQVLDLSQNSFSSS--I--PSSIVQCKRLKTVVLNQNSFTGPLPDG---FATNLTALQKLDLSFNNLSGLIPNDIANLSR 203 (686)
Q Consensus 131 L~~L~ls~N~l~~~--~--p~~~~~l~~L~~L~L~~N~l~~~~p~~---~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 203 (686)
|++|+|++|++.+. + +..+..+++|++|+|++|+++ .++.. ++..+++|++|||++|++++.+|..+..+..
T Consensus 171 L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~ 249 (310)
T 4glp_A 171 LTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGME-TPTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRCMW 249 (310)
T ss_dssp CCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCC-CHHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSCCC
T ss_pred CCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCC-chHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhccC
Confidence 99999999998752 2 223468899999999999997 34442 4457899999999999999998888777642
Q ss_pred cccccccccccccCCCCCCCcccccccccCCcccccCCCCC
Q 042348 204 LRLLAQRVYVDLTYNNLSGLIPQNAALLSLGPTAFIGNPFL 244 (686)
Q Consensus 204 L~~l~~~~~l~l~~N~l~~~~p~~~~~~~~~~~~~~~n~~~ 244 (686)
+ +++.+|+|++|+|+. +|.... .++..+.+.+|...
T Consensus 250 ~---~~L~~L~Ls~N~l~~-lp~~~~-~~L~~L~Ls~N~l~ 285 (310)
T 4glp_A 250 S---SALNSLNLSFAGLEQ-VPKGLP-AKLRVLDLSSNRLN 285 (310)
T ss_dssp C---TTCCCEECCSSCCCS-CCSCCC-SCCSCEECCSCCCC
T ss_pred c---CcCCEEECCCCCCCc-hhhhhc-CCCCEEECCCCcCC
Confidence 2 223455999999994 454432 56666777777654
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=99.80 E-value=2.6e-20 Score=211.65 Aligned_cols=167 Identities=16% Similarity=0.296 Sum_probs=144.9
Q ss_pred CccccCCcCcCCCCCCCEEEccCCCCccc-----------------CCcccc--CCCCCcEEEccCCCCCCCCcccccCC
Q 042348 68 KLTGFIPADLGSLSAIGRVNLRNNNFSGS-----------------LPVELF--NASNLQSLILSGNSFSGPVPMQIGKL 128 (686)
Q Consensus 68 ~l~g~~p~~l~~l~~L~~L~L~~N~l~g~-----------------~p~~~~--~l~~L~~L~L~~N~l~g~~p~~~~~l 128 (686)
+|+| +|..|+++++|++|+|++|.|+|. +|..++ ++++|++|+|++|++.|.+|..|+++
T Consensus 194 ~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l 272 (636)
T 4eco_A 194 NITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKAL 272 (636)
T ss_dssp EEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTC
T ss_pred CCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHhcC
Confidence 4556 899999999999999999999986 999999 99999999999999999999999999
Q ss_pred CCCCEEeccCCC-CCC-CCChhhhhc------cccccccccccccCCCCch--hhhhcCcccceecccccccCCCCchhh
Q 042348 129 KYLQVLDLSQNS-FSS-SIPSSIVQC------KRLKTVVLNQNSFTGPLPD--GFATNLTALQKLDLSFNNLSGLIPNDI 198 (686)
Q Consensus 129 ~~L~~L~ls~N~-l~~-~~p~~~~~l------~~L~~L~L~~N~l~~~~p~--~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 198 (686)
++|++|+|++|+ ++| .+|..++.+ ++|++|+|++|+++ .+|. .+ .++++|++|+|++|+++|.+| .+
T Consensus 273 ~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l-~~l~~L~~L~L~~N~l~g~ip-~~ 349 (636)
T 4eco_A 273 PEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSL-QKMKKLGMLECLYNQLEGKLP-AF 349 (636)
T ss_dssp SSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHH-TTCTTCCEEECCSCCCEEECC-CC
T ss_pred CCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhh-ccCCCCCEEeCcCCcCccchh-hh
Confidence 999999999998 998 899999887 99999999999999 7888 66 589999999999999999999 88
Q ss_pred hcccccccccccccccccCCCCCCCccccccccc-CCcccccCCCCC
Q 042348 199 ANLSRLRLLAQRVYVDLTYNNLSGLIPQNAALLS-LGPTAFIGNPFL 244 (686)
Q Consensus 199 ~~l~~L~~l~~~~~l~l~~N~l~~~~p~~~~~~~-~~~~~~~~n~~~ 244 (686)
+++++|+.| ++++|+++..+.....+.+ +..+.+.+|...
T Consensus 350 ~~l~~L~~L------~L~~N~l~~lp~~l~~l~~~L~~L~Ls~N~l~ 390 (636)
T 4eco_A 350 GSEIKLASL------NLAYNQITEIPANFCGFTEQVENLSFAHNKLK 390 (636)
T ss_dssp EEEEEESEE------ECCSSEEEECCTTSEEECTTCCEEECCSSCCS
T ss_pred CCCCCCCEE------ECCCCccccccHhhhhhcccCcEEEccCCcCc
Confidence 888777655 8888888843333344555 666777777654
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.80 E-value=4.7e-19 Score=184.89 Aligned_cols=188 Identities=19% Similarity=0.254 Sum_probs=137.4
Q ss_pred cceeeeEecC-----------CCEEEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCccccCCCCCcEEEccCC
Q 042348 47 CSWNGITCRE-----------GQVFSLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGN 115 (686)
Q Consensus 47 c~w~gv~c~~-----------~~~~~l~l~~n~l~g~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N 115 (686)
|.|..+.|.. ..++.|+|++|.+++..|..|.++++|+.|+|++|++++..|..|.++++|++|+|++|
T Consensus 33 c~l~~l~~~~~~l~~ip~~~~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n 112 (332)
T 2ft3_A 33 CHLRVVQCSDLGLKAVPKEISPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKN 112 (332)
T ss_dssp EETTEEECCSSCCSSCCSCCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECCSS
T ss_pred ccCCEEECCCCCccccCCCCCCCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECCCC
Confidence 6899999972 36889999999999988889999999999999999999888999999999999999999
Q ss_pred CCCCCCcccccCCCCCCEEeccCCCCCCCCChhhhhccccccccccccccCC--CCchhhhhcC----------------
Q 042348 116 SFSGPVPMQIGKLKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTG--PLPDGFATNL---------------- 177 (686)
Q Consensus 116 ~l~g~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~--~~p~~~~~~l---------------- 177 (686)
+++ .+|..+. ++|++|++++|.+++..+..+..+++|+.|+|++|.++. ..|..+ ..+
T Consensus 113 ~l~-~l~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~-~~l~L~~L~l~~n~l~~l~ 188 (332)
T 2ft3_A 113 HLV-EIPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAF-DGLKLNYLRISEAKLTGIP 188 (332)
T ss_dssp CCC-SCCSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSS-CSCCCSCCBCCSSBCSSCC
T ss_pred cCC-ccCcccc--ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccc-cCCccCEEECcCCCCCccC
Confidence 998 6666554 677788888877776555567777777777777776642 223222 122
Q ss_pred ----cccceecccccccCCCCchhhhcccccccccccccccccCCCCCCCccccc-ccccCCcccccCCCCC
Q 042348 178 ----TALQKLDLSFNNLSGLIPNDIANLSRLRLLAQRVYVDLTYNNLSGLIPQNA-ALLSLGPTAFIGNPFL 244 (686)
Q Consensus 178 ----~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~~~~~l~l~~N~l~~~~p~~~-~~~~~~~~~~~~n~~~ 244 (686)
++|+.|+|++|++++..|..+..+++|+. |++++|++++..|..+ .+.++..+.+.+|...
T Consensus 189 ~~~~~~L~~L~l~~n~i~~~~~~~l~~l~~L~~------L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 254 (332)
T 2ft3_A 189 KDLPETLNELHLDHNKIQAIELEDLLRYSKLYR------LGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS 254 (332)
T ss_dssp SSSCSSCSCCBCCSSCCCCCCTTSSTTCTTCSC------CBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC
T ss_pred ccccCCCCEEECCCCcCCccCHHHhcCCCCCCE------EECCCCcCCcCChhHhhCCCCCCEEECCCCcCe
Confidence 35666666666666665566666655554 4777777777666433 3445555666666544
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.80 E-value=1.2e-19 Score=179.99 Aligned_cols=178 Identities=13% Similarity=0.159 Sum_probs=148.2
Q ss_pred CCEEEEEeCCCCccccCCcCcCCCCCCCEEEccCCC-CcccCCccccCCCCCcEEEccC-CCCCCCCcccccCCCCCCEE
Q 042348 57 GQVFSLIIPNKKLTGFIPADLGSLSAIGRVNLRNNN-FSGSLPVELFNASNLQSLILSG-NSFSGPVPMQIGKLKYLQVL 134 (686)
Q Consensus 57 ~~~~~l~l~~n~l~g~~p~~l~~l~~L~~L~L~~N~-l~g~~p~~~~~l~~L~~L~L~~-N~l~g~~p~~~~~l~~L~~L 134 (686)
..++.|+|++|++++..+..|..+++|+.|+|++|+ +++..+..|.++++|++|+|++ |++++..+..|..+++|++|
T Consensus 31 ~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L 110 (239)
T 2xwt_C 31 PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFL 110 (239)
T ss_dssp TTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEE
T ss_pred CcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEE
Confidence 578999999999999888899999999999999997 8866677899999999999999 99997777889999999999
Q ss_pred eccCCCCCCCCChhhhhccccc---ccccccc-ccCCCCchhhhhcCcccc-eecccccccCCCCchhhhcccccccccc
Q 042348 135 DLSQNSFSSSIPSSIVQCKRLK---TVVLNQN-SFTGPLPDGFATNLTALQ-KLDLSFNNLSGLIPNDIANLSRLRLLAQ 209 (686)
Q Consensus 135 ~ls~N~l~~~~p~~~~~l~~L~---~L~L~~N-~l~~~~p~~~~~~l~~L~-~L~Ls~N~l~~~~p~~~~~l~~L~~l~~ 209 (686)
+|++|.+++ +|. +..+++|+ +|+|++| ++++ +|...+..+++|+ .|+|++|+++...+..+.. ++|+.|
T Consensus 111 ~l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~-i~~~~~~~l~~L~~~L~l~~n~l~~i~~~~~~~-~~L~~L-- 184 (239)
T 2xwt_C 111 GIFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTS-IPVNAFQGLCNETLTLKLYNNGFTSVQGYAFNG-TKLDAV-- 184 (239)
T ss_dssp EEEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCE-ECTTTTTTTBSSEEEEECCSCCCCEECTTTTTT-CEEEEE--
T ss_pred eCCCCCCcc-ccc-cccccccccccEEECCCCcchhh-cCcccccchhcceeEEEcCCCCCcccCHhhcCC-CCCCEE--
Confidence 999999996 776 88888888 9999999 9984 5555446899999 9999999999544444444 666654
Q ss_pred cccccccCC-CCCCCcccccc-c-ccCCcccccCCCCC
Q 042348 210 RVYVDLTYN-NLSGLIPQNAA-L-LSLGPTAFIGNPFL 244 (686)
Q Consensus 210 ~~~l~l~~N-~l~~~~p~~~~-~-~~~~~~~~~~n~~~ 244 (686)
++++| ++++..+..+. + .++..+.+.+|+..
T Consensus 185 ----~L~~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~ 218 (239)
T 2xwt_C 185 ----YLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT 218 (239)
T ss_dssp ----ECTTCTTCCEECTTTTTTCSBCCSEEECTTCCCC
T ss_pred ----EcCCCCCcccCCHHHhhccccCCcEEECCCCccc
Confidence 99999 49977666554 3 46667777777654
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.80 E-value=3.8e-19 Score=179.79 Aligned_cols=162 Identities=22% Similarity=0.243 Sum_probs=143.5
Q ss_pred CCEEEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCccccCCCCCcEEEccCCCCCCCCcccccCCCCCCEEec
Q 042348 57 GQVFSLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQVLDL 136 (686)
Q Consensus 57 ~~~~~l~l~~n~l~g~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l 136 (686)
.+++.|+|++|.++...+..|..+++|++|+|++|++++..+..|.++++|++|+|++|++++..+..|..+++|++|+|
T Consensus 61 ~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L 140 (270)
T 2o6q_A 61 TKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSL 140 (270)
T ss_dssp TTCCEEECCSSCCSCCCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCCEEECCCCccCeeChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEEC
Confidence 57999999999999776677899999999999999999777777899999999999999999888888999999999999
Q ss_pred cCCCCCCCCChhhhhccccccccccccccCCCCchhhhhcCcccceecccccccCCCCchhhhccccccccccccccccc
Q 042348 137 SQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSGLIPNDIANLSRLRLLAQRVYVDLT 216 (686)
Q Consensus 137 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~~~~~l~l~ 216 (686)
++|.+++..+..+..+++|+.|+|++|++++ +|...+..+++|++|+|++|++++..+..+..+++|+.| +++
T Consensus 141 s~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L------~l~ 213 (270)
T 2o6q_A 141 GYNELQSLPKGVFDKLTSLKELRLYNNQLKR-VPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKML------QLQ 213 (270)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCSC-CCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEE------ECC
T ss_pred CCCcCCccCHhHccCCcccceeEecCCcCcE-eChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEE------Eec
Confidence 9999997777778999999999999999996 555444689999999999999998887778888877655 999
Q ss_pred CCCCCCCcc
Q 042348 217 YNNLSGLIP 225 (686)
Q Consensus 217 ~N~l~~~~p 225 (686)
+|.+....+
T Consensus 214 ~N~~~c~c~ 222 (270)
T 2o6q_A 214 ENPWDCTCN 222 (270)
T ss_dssp SSCBCCSSS
T ss_pred CCCeeCCCc
Confidence 999976544
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.80 E-value=1.9e-19 Score=175.98 Aligned_cols=148 Identities=20% Similarity=0.266 Sum_probs=134.4
Q ss_pred cceeeeEecC-----------CCEEEEEeCCCCccccCCc-CcCCCCCCCEEEccCCCCcccCCccccCCCCCcEEEccC
Q 042348 47 CSWNGITCRE-----------GQVFSLIIPNKKLTGFIPA-DLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSG 114 (686)
Q Consensus 47 c~w~gv~c~~-----------~~~~~l~l~~n~l~g~~p~-~l~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~ 114 (686)
|.|..+.|.. ..++.|+|++|+|++..|. .|..+++|+.|+|++|+|++..|..|.++++|++|+|++
T Consensus 11 C~~~~l~~s~n~l~~iP~~~~~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~ 90 (220)
T 2v70_A 11 CEGTTVDCSNQKLNKIPEHIPQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTS 90 (220)
T ss_dssp EETTEEECCSSCCSSCCSCCCTTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred ECCCEeEeCCCCcccCccCCCCCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCC
Confidence 6799999973 2467899999999998664 589999999999999999988888999999999999999
Q ss_pred CCCCCCCcccccCCCCCCEEeccCCCCCCCCChhhhhccccccccccccccCCCCchhhhhcCcccceecccccccCCCC
Q 042348 115 NSFSGPVPMQIGKLKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSGLI 194 (686)
Q Consensus 115 N~l~g~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~ 194 (686)
|++++..|..|..+++|++|+|++|++++..|..+..+++|+.|+|++|++++..|..+ ..+++|+.|+|++|.++...
T Consensus 91 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~-~~l~~L~~L~L~~N~l~c~c 169 (220)
T 2v70_A 91 NRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAF-DTLHSLSTLNLLANPFNCNC 169 (220)
T ss_dssp SCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTT-TTCTTCCEEECCSCCEECSG
T ss_pred CccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHh-cCCCCCCEEEecCcCCcCCC
Confidence 99998888889999999999999999999889999999999999999999998767766 58999999999999999754
Q ss_pred c
Q 042348 195 P 195 (686)
Q Consensus 195 p 195 (686)
+
T Consensus 170 ~ 170 (220)
T 2v70_A 170 Y 170 (220)
T ss_dssp G
T ss_pred c
Confidence 4
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=99.79 E-value=1.5e-19 Score=204.84 Aligned_cols=181 Identities=18% Similarity=0.135 Sum_probs=160.4
Q ss_pred CCEEEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCccccCCCCCcEEEccCCCCCCCCcccccCCCCCCEEec
Q 042348 57 GQVFSLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQVLDL 136 (686)
Q Consensus 57 ~~~~~l~l~~n~l~g~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l 136 (686)
..++.|+|++|.+++..|..|+++++|++|+|++|++++..|..|.++++|++|+|++|++++..|..|+++++|++|+|
T Consensus 33 ~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L 112 (606)
T 3t6q_A 33 NSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFF 112 (606)
T ss_dssp TTCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCSEECTTTTSSCTTCCEEEC
T ss_pred CcCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcccccChhhhcccccccEeec
Confidence 47899999999999999999999999999999999999989999999999999999999999888999999999999999
Q ss_pred cCCCCCCCCChhhhhccccccccccccccCCCCchhhhhcCcccceecccccccCCCCchhhhccccccccccccccccc
Q 042348 137 SQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSGLIPNDIANLSRLRLLAQRVYVDLT 216 (686)
Q Consensus 137 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~~~~~l~l~ 216 (686)
++|.+++..|..+..+++|++|+|++|++++..++.+. .+++|++|+|++|.+++..|..++.+++|+.+ .++++
T Consensus 113 ~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~-~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~l----~L~l~ 187 (606)
T 3t6q_A 113 IQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGF-PTEKLKVLDFQNNAIHYLSKEDMSSLQQATNL----SLNLN 187 (606)
T ss_dssp TTSCCSCGGGSCCTTCTTCCEEECCSSCCCCCCCCTTC-CCTTCCEEECCSSCCCEECHHHHHTTTTCCSE----EEECT
T ss_pred cccCcccCCcchhccCCcccEEECCCCcccccCccccc-CCcccCEEEcccCcccccChhhhhhhccccee----EEecC
Confidence 99999987688899999999999999999973333443 59999999999999999999999999888743 45999
Q ss_pred CCCCCCCcccccccccCCcccccCCC
Q 042348 217 YNNLSGLIPQNAALLSLGPTAFIGNP 242 (686)
Q Consensus 217 ~N~l~~~~p~~~~~~~~~~~~~~~n~ 242 (686)
+|++++.+|..+....+....+.+|.
T Consensus 188 ~n~l~~~~~~~~~~~~L~~L~l~~~~ 213 (606)
T 3t6q_A 188 GNDIAGIEPGAFDSAVFQSLNFGGTQ 213 (606)
T ss_dssp TCCCCEECTTTTTTCEEEEEECTTCS
T ss_pred CCccCccChhHhhhccccccccCCch
Confidence 99999998887765555555565554
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.79 E-value=1.8e-19 Score=180.72 Aligned_cols=132 Identities=18% Similarity=0.175 Sum_probs=103.7
Q ss_pred cccCccCceEEEEEEe-CCCce--EEEEEcCCCCcc------------------------chHHHHHHHHHHhccCCCCc
Q 042348 373 FLLGKSTIGIVYKVAL-NNEEA--VAVRRLGNGGWQ------------------------RFKEFQTEAEAIGKIRHPNI 425 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~-~~~~~--vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l~H~nI 425 (686)
..||+|+||.||+|.. .+|+. ||||.++..... ....+.+|++++.+++|++|
T Consensus 53 ~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 132 (258)
T 1zth_A 53 GVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAKEAGV 132 (258)
T ss_dssp EEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred CEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHHhCCC
Confidence 4699999999999998 67888 999987543111 01357899999999988864
Q ss_pred --ceeeEEEEecCceeEEEeccCC-C----CHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHH-ccCCCCceecC
Q 042348 426 --VSLRAYFWSVDEKLLIYDYIPN-G----SLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLH-EVSPKRYVHGD 497 (686)
Q Consensus 426 --v~l~~~~~~~~~~~lV~e~~~~-g----sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH-~~~~~~iiHrD 497 (686)
+..+++ +..++||||+.+ | +|.++... .++..+..++.|++.||+||| + .+|+|||
T Consensus 133 ~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---------~~~~~~~~i~~qi~~~l~~lH~~---~givHrD 196 (258)
T 1zth_A 133 SVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE---------LKELDVEGIFNDVVENVKRLYQE---AELVHAD 196 (258)
T ss_dssp CCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG---------GGGSCHHHHHHHHHHHHHHHHHT---SCEECSS
T ss_pred CCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc---------cChHHHHHHHHHHHHHHHHHHHH---CCEEeCC
Confidence 344432 367899999942 4 67766432 234567899999999999999 8 8999999
Q ss_pred CCCCCeeecCCCCeEEeecCccccc
Q 042348 498 LRPSNILLGKNMEPHISDFGLARLA 522 (686)
Q Consensus 498 lkp~NILl~~~~~~kl~DfGla~~~ 522 (686)
|||+|||+++ .++|+|||+|...
T Consensus 197 lkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 197 LSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp CSTTSEEESS--SEEECCCTTCEET
T ss_pred CCHHHEEEcC--cEEEEECcccccC
Confidence 9999999988 9999999999754
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.79 E-value=1.2e-19 Score=203.66 Aligned_cols=161 Identities=27% Similarity=0.332 Sum_probs=132.2
Q ss_pred CCCCCCCEEEccCCCCcccCCccccCCCCCcEEEccCCCCCC--CCcccccCCCCCCEEeccCCCCCCCCCh-hhhhccc
Q 042348 78 GSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSG--PVPMQIGKLKYLQVLDLSQNSFSSSIPS-SIVQCKR 154 (686)
Q Consensus 78 ~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g--~~p~~~~~l~~L~~L~ls~N~l~~~~p~-~~~~l~~ 154 (686)
..+++|+.|+|++|++++.+|..+.++++|+.|+|++|++++ .+|..++.+++|+.|+|++|.+++.+|. .+..+++
T Consensus 350 ~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~ 429 (562)
T 3a79_B 350 PSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAES 429 (562)
T ss_dssp SSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTT
T ss_pred cCCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCccc
Confidence 678899999999999998899999999999999999999986 3456788999999999999999975665 4778899
Q ss_pred cccccccccccCCCCchhhhhcCcccceecccccccCCCCchhhhcccccccccccccccccCCCCCCCccc-ccccccC
Q 042348 155 LKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSGLIPNDIANLSRLRLLAQRVYVDLTYNNLSGLIPQ-NAALLSL 233 (686)
Q Consensus 155 L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~~~~~l~l~~N~l~~~~p~-~~~~~~~ 233 (686)
|+.|+|++|++++.+|..+. ++|+.|+|++|+|+ .+|..+.++++|+.| ++++|++++.++. ...+..+
T Consensus 430 L~~L~l~~n~l~~~~~~~l~---~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L------~L~~N~l~~l~~~~~~~l~~L 499 (562)
T 3a79_B 430 ILVLNLSSNMLTGSVFRCLP---PKVKVLDLHNNRIM-SIPKDVTHLQALQEL------NVASNQLKSVPDGVFDRLTSL 499 (562)
T ss_dssp CCEEECCSSCCCGGGGSSCC---TTCSEEECCSSCCC-CCCTTTTSSCCCSEE------ECCSSCCCCCCTTSTTTCTTC
T ss_pred CCEEECCCCCCCcchhhhhc---CcCCEEECCCCcCc-ccChhhcCCCCCCEE------ECCCCCCCCCCHHHHhcCCCC
Confidence 99999999999876665431 68999999999999 567766677777655 9999999976555 3456677
Q ss_pred CcccccCCCCCCCCC
Q 042348 234 GPTAFIGNPFLCGPP 248 (686)
Q Consensus 234 ~~~~~~~n~~~c~~p 248 (686)
..+.+.+||+.|.++
T Consensus 500 ~~L~l~~N~~~c~c~ 514 (562)
T 3a79_B 500 QYIWLHDNPWDCTCP 514 (562)
T ss_dssp CCEECCSCCBCCCHH
T ss_pred CEEEecCCCcCCCcc
Confidence 778899999998654
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.79 E-value=9.3e-19 Score=182.50 Aligned_cols=189 Identities=21% Similarity=0.287 Sum_probs=128.1
Q ss_pred CcceeeeEecC-----------CCEEEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCccccCCCCCcEEEccC
Q 042348 46 PCSWNGITCRE-----------GQVFSLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSG 114 (686)
Q Consensus 46 ~c~w~gv~c~~-----------~~~~~l~l~~n~l~g~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~ 114 (686)
.|.|..+.|.. ..++.|+|++|++++..+..|+++++|++|+|++|++++..|..|.++++|++|+|++
T Consensus 30 ~c~l~~l~~~~~~l~~lp~~~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~ 109 (330)
T 1xku_A 30 QCHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSK 109 (330)
T ss_dssp EEETTEEECTTSCCCSCCCSCCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred cCCCeEEEecCCCccccCccCCCCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECCC
Confidence 36799999972 3678899999999998888999999999999999999988899999999999999999
Q ss_pred CCCCCCCcccccCCCCCCEEeccCCCCCCCCChhhhhccccccccccccccCC--CCchhhhhcCcc-------------
Q 042348 115 NSFSGPVPMQIGKLKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTG--PLPDGFATNLTA------------- 179 (686)
Q Consensus 115 N~l~g~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~--~~p~~~~~~l~~------------- 179 (686)
|+++ .+|..+. ++|+.|++++|.+++..+..+..+++|+.|+|++|+++. ..+..+ ..+++
T Consensus 110 n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~-~~l~~L~~L~l~~n~l~~ 185 (330)
T 1xku_A 110 NQLK-ELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAF-QGMKKLSYIRIADTNITT 185 (330)
T ss_dssp SCCS-BCCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGG-GGCTTCCEEECCSSCCCS
T ss_pred CcCC-ccChhhc--ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhc-cCCCCcCEEECCCCcccc
Confidence 9987 5665443 566666666666665555555555666666666555532 223333 24444
Q ss_pred --------cceecccccccCCCCchhhhcccccccccccccccccCCCCCCCccccc-ccccCCcccccCCCCC
Q 042348 180 --------LQKLDLSFNNLSGLIPNDIANLSRLRLLAQRVYVDLTYNNLSGLIPQNA-ALLSLGPTAFIGNPFL 244 (686)
Q Consensus 180 --------L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~~~~~l~l~~N~l~~~~p~~~-~~~~~~~~~~~~n~~~ 244 (686)
|+.|+|++|++++..|..+..+++|+ .|++++|++++..+..+ .+.++..+.+.+|...
T Consensus 186 l~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~------~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~ 253 (330)
T 1xku_A 186 IPQGLPPSLTELHLDGNKITKVDAASLKGLNNLA------KLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV 253 (330)
T ss_dssp CCSSCCTTCSEEECTTSCCCEECTGGGTTCTTCC------EEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS
T ss_pred CCccccccCCEEECCCCcCCccCHHHhcCCCCCC------EEECCCCcCceeChhhccCCCCCCEEECCCCcCc
Confidence 44455555555554455555554444 33777777776655332 3445555566666543
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.79 E-value=9.5e-20 Score=202.49 Aligned_cols=161 Identities=25% Similarity=0.315 Sum_probs=113.2
Q ss_pred CCCCCCCEEEccCCCCcccCCccccCCCCCcEEEccCCCCCC--CCcccccCCCCCCEEeccCCCCCCCCChh-hhhccc
Q 042348 78 GSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSG--PVPMQIGKLKYLQVLDLSQNSFSSSIPSS-IVQCKR 154 (686)
Q Consensus 78 ~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g--~~p~~~~~l~~L~~L~ls~N~l~~~~p~~-~~~l~~ 154 (686)
..+++|+.|+|++|++++.+|..+.++++|++|+|++|++++ .+|..++.+++|++|+|++|.+++.+|.. +..+++
T Consensus 321 ~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~ 400 (520)
T 2z7x_B 321 SKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKS 400 (520)
T ss_dssp SSCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTT
T ss_pred hhCCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCcc
Confidence 566777777777777777777777777777777777777775 45566777777777777777777655543 666777
Q ss_pred cccccccccccCCCCchhhhhcCcccceecccccccCCCCchhhhcccccccccccccccccCCCCCCCccc-ccccccC
Q 042348 155 LKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSGLIPNDIANLSRLRLLAQRVYVDLTYNNLSGLIPQ-NAALLSL 233 (686)
Q Consensus 155 L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~~~~~l~l~~N~l~~~~p~-~~~~~~~ 233 (686)
|+.|+|++|++++.+|..+. ++|+.|||++|+++ .+|..+..+++|+.| ++++|+++..++. ...+.++
T Consensus 401 L~~L~Ls~N~l~~~~~~~l~---~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L------~L~~N~l~~l~~~~~~~l~~L 470 (520)
T 2z7x_B 401 LLSLNMSSNILTDTIFRCLP---PRIKVLDLHSNKIK-SIPKQVVKLEALQEL------NVASNQLKSVPDGIFDRLTSL 470 (520)
T ss_dssp CCEEECCSSCCCGGGGGSCC---TTCCEEECCSSCCC-CCCGGGGGCTTCCEE------ECCSSCCCCCCTTTTTTCTTC
T ss_pred CCEEECcCCCCCcchhhhhc---ccCCEEECCCCccc-ccchhhhcCCCCCEE------ECCCCcCCccCHHHhccCCcc
Confidence 77777777777765554331 57788888888887 566666666666654 8888888865444 2345566
Q ss_pred CcccccCCCCCCCCC
Q 042348 234 GPTAFIGNPFLCGPP 248 (686)
Q Consensus 234 ~~~~~~~n~~~c~~p 248 (686)
..+.+.+|++.|.++
T Consensus 471 ~~L~l~~N~~~c~c~ 485 (520)
T 2z7x_B 471 QKIWLHTNPWDCSCP 485 (520)
T ss_dssp CEEECCSSCBCCCHH
T ss_pred cEEECcCCCCcccCC
Confidence 777788888887543
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.79 E-value=3.6e-19 Score=200.97 Aligned_cols=142 Identities=23% Similarity=0.208 Sum_probs=108.1
Q ss_pred CEEEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCccccCCCCCcEEEccCCCCCCCCcccccCCCCCCEEecc
Q 042348 58 QVFSLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQVLDLS 137 (686)
Q Consensus 58 ~~~~l~l~~n~l~g~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls 137 (686)
.+..|++++|.++...+..+..+++|+.|+|++|.|++..|..|.++++|++|+|++|.+++..|..|+.+++|++|+|+
T Consensus 52 ~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 131 (597)
T 3oja_B 52 NQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLE 131 (597)
T ss_dssp CCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEee
Confidence 45677888888877655667778888888888888887777788888888888888888887777777888888888888
Q ss_pred CCCCCCCCChhhhhccccccccccccccCCCCchhhhhcCcccceecccccccCCCCchhhhc
Q 042348 138 QNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSGLIPNDIAN 200 (686)
Q Consensus 138 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 200 (686)
+|.+++..+..|..+++|++|+|++|.+++..|..+ ..+++|++|+|++|.+++..+..+.+
T Consensus 132 ~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~-~~l~~L~~L~L~~N~l~~~~~~~l~~ 193 (597)
T 3oja_B 132 RNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTF-QATTSLQNLQLSSNRLTHVDLSLIPS 193 (597)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTT-TTCTTCCEEECTTSCCSBCCGGGCTT
T ss_pred CCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhh-hcCCcCcEEECcCCCCCCcChhhhhh
Confidence 888886555556788888888888888886555555 47888888888888888764444333
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.79 E-value=2.7e-19 Score=174.92 Aligned_cols=155 Identities=26% Similarity=0.379 Sum_probs=137.5
Q ss_pred CEEEccCCCCcccCCccccCCCCCcEEEccCCCCCCCCcccccCCCCCCEEeccCCCCCCCCChhhhhcccccccccccc
Q 042348 84 GRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQN 163 (686)
Q Consensus 84 ~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N 163 (686)
+.+++++|.++ .+|..+. ++|+.|+|++|+|++..+..|..+++|+.|+|++|.+++..|..|..+++|++|+|++|
T Consensus 14 ~~v~c~~~~l~-~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N 90 (220)
T 2v9t_B 14 NIVDCRGKGLT-EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGN 90 (220)
T ss_dssp TEEECTTSCCS-SCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSS
T ss_pred CEEEcCCCCcC-cCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCC
Confidence 47899999998 7887665 78999999999999777778999999999999999999888999999999999999999
Q ss_pred ccCCCCchhhhhcCcccceecccccccCCCCchhhhcccccccccccccccccCCCCCCCcccccc-cccCCcccccCCC
Q 042348 164 SFTGPLPDGFATNLTALQKLDLSFNNLSGLIPNDIANLSRLRLLAQRVYVDLTYNNLSGLIPQNAA-LLSLGPTAFIGNP 242 (686)
Q Consensus 164 ~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~~~~~l~l~~N~l~~~~p~~~~-~~~~~~~~~~~n~ 242 (686)
+|+ .+|...+..+++|+.|+|++|+|++..|..+.++++|+.| +|++|++++..+..+. +.++..+.+.+|+
T Consensus 91 ~l~-~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L------~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~ 163 (220)
T 2v9t_B 91 KIT-ELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLL------SLYDNKLQTIAKGTFSPLRAIQTMHLAQNP 163 (220)
T ss_dssp CCC-CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE------ECCSSCCSCCCTTTTTTCTTCCEEECCSSC
T ss_pred cCC-ccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEE------ECCCCcCCEECHHHHhCCCCCCEEEeCCCC
Confidence 999 5777766789999999999999999999999998888765 9999999998886543 5677788899999
Q ss_pred CCCCCC
Q 042348 243 FLCGPP 248 (686)
Q Consensus 243 ~~c~~p 248 (686)
+.|.+.
T Consensus 164 ~~c~c~ 169 (220)
T 2v9t_B 164 FICDCH 169 (220)
T ss_dssp EECSGG
T ss_pred cCCCCc
Confidence 998643
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.78 E-value=4.1e-19 Score=200.47 Aligned_cols=111 Identities=18% Similarity=0.146 Sum_probs=102.7
Q ss_pred CCEEEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCccccCCCCCcEEEccCCCCCCCCcccccCCCCCCEEec
Q 042348 57 GQVFSLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQVLDL 136 (686)
Q Consensus 57 ~~~~~l~l~~n~l~g~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l 136 (686)
..++.|+|++|.+++..|..|+.+++|+.|+|++|.|++..|..|.++++|++|+|++|.|++..+..|+.+++|++|+|
T Consensus 75 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L 154 (597)
T 3oja_B 75 RQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSM 154 (597)
T ss_dssp CCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCEEEe
Confidence 47889999999999988889999999999999999999888888999999999999999999665666799999999999
Q ss_pred cCCCCCCCCChhhhhccccccccccccccCC
Q 042348 137 SQNSFSSSIPSSIVQCKRLKTVVLNQNSFTG 167 (686)
Q Consensus 137 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 167 (686)
++|.+++..|..+..+++|+.|+|++|.+++
T Consensus 155 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 185 (597)
T 3oja_B 155 SNNNLERIEDDTFQATTSLQNLQLSSNRLTH 185 (597)
T ss_dssp CSSCCCBCCTTTTTTCTTCCEEECTTSCCSB
T ss_pred eCCcCCCCChhhhhcCCcCcEEECcCCCCCC
Confidence 9999998888899999999999999999985
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.78 E-value=3.9e-19 Score=208.78 Aligned_cols=175 Identities=17% Similarity=0.164 Sum_probs=153.9
Q ss_pred cceeeeEecCCCEEEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccC-CccccCCCCCcEEEccCCCCCCCCcccc
Q 042348 47 CSWNGITCREGQVFSLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSL-PVELFNASNLQSLILSGNSFSGPVPMQI 125 (686)
Q Consensus 47 c~w~gv~c~~~~~~~l~l~~n~l~g~~p~~l~~l~~L~~L~L~~N~l~g~~-p~~~~~l~~L~~L~L~~N~l~g~~p~~~ 125 (686)
|.|..|-+....++.|+|++|.+++..|..|.++++|+.|+|++|.+.+.+ |..|.++++|++|+|++|.+++..|..|
T Consensus 14 ~~L~~vP~lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~~ 93 (844)
T 3j0a_A 14 CNLTQVPQVLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAF 93 (844)
T ss_dssp CCSSCCCSSCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTSS
T ss_pred CCCCCCCCCCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhHc
Confidence 346666665678999999999999999999999999999999999777676 7889999999999999999998889999
Q ss_pred cCCCCCCEEeccCCCCCCCCChh--hhhccccccccccccccCCCCchhhhhcCcccceecccccccCCCCchhhhcc--
Q 042348 126 GKLKYLQVLDLSQNSFSSSIPSS--IVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSGLIPNDIANL-- 201 (686)
Q Consensus 126 ~~l~~L~~L~ls~N~l~~~~p~~--~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l-- 201 (686)
+++++|++|+|++|.+++.+|.. +..+++|++|+|++|.+++..+...+.++++|++|+|++|.+++..|..+..+
T Consensus 94 ~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l~~l~~ 173 (844)
T 3j0a_A 94 QGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQG 173 (844)
T ss_dssp CSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGGGHHHHH
T ss_pred cCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHHHcccccC
Confidence 99999999999999999877765 89999999999999999977665444699999999999999999999998887
Q ss_pred cccccccccccccccCCCCCCCcccc
Q 042348 202 SRLRLLAQRVYVDLTYNNLSGLIPQN 227 (686)
Q Consensus 202 ~~L~~l~~~~~l~l~~N~l~~~~p~~ 227 (686)
++|+ .|++++|.+++..|..
T Consensus 174 ~~L~------~L~L~~n~l~~~~~~~ 193 (844)
T 3j0a_A 174 KTLS------FFSLAANSLYSRVSVD 193 (844)
T ss_dssp CSSC------CCEECCSBSCCCCCCC
T ss_pred Cccc------eEECCCCccccccccc
Confidence 5555 4488888888876653
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.78 E-value=2.1e-19 Score=197.38 Aligned_cols=93 Identities=22% Similarity=0.274 Sum_probs=59.1
Q ss_pred ccccccccccCCCCchhhhhcCcccceecccccccCCCCchhhhcccccccc------------------cccccccccC
Q 042348 156 KTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSGLIPNDIANLSRLRLL------------------AQRVYVDLTY 217 (686)
Q Consensus 156 ~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l------------------~~~~~l~l~~ 217 (686)
+.|+|++|+++ .+|...+..+++|+.|+|++|.+++..+..+.++++|+.| +.+..|+|++
T Consensus 227 ~~L~l~~n~l~-~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~ 305 (477)
T 2id5_A 227 TSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSG 305 (477)
T ss_dssp SEEEEESSCCC-SCCHHHHTTCTTCCEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECCS
T ss_pred cEEECcCCccc-ccCHHHhcCccccCeeECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCcccCCEEECCC
Confidence 33333444444 3443334566777777777777776666666655555433 2345668999
Q ss_pred CCCCCCccccc-ccccCCcccccCCCCCCCCCC
Q 042348 218 NNLSGLIPQNA-ALLSLGPTAFIGNPFLCGPPL 249 (686)
Q Consensus 218 N~l~~~~p~~~-~~~~~~~~~~~~n~~~c~~p~ 249 (686)
|++++..+..+ .+.++..+.+.+|++.|.++.
T Consensus 306 N~l~~~~~~~~~~l~~L~~L~l~~N~l~c~c~~ 338 (477)
T 2id5_A 306 NQLTTLEESVFHSVGNLETLILDSNPLACDCRL 338 (477)
T ss_dssp SCCSCCCGGGBSCGGGCCEEECCSSCEECSGGG
T ss_pred CcCceeCHhHcCCCcccCEEEccCCCccCccch
Confidence 99988777654 356677788899999887543
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.78 E-value=6.2e-19 Score=180.00 Aligned_cols=175 Identities=25% Similarity=0.269 Sum_probs=150.5
Q ss_pred CCEEEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCccccCCCCCcEEEccCCCCCCCCcccccCCCCCCEEec
Q 042348 57 GQVFSLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQVLDL 136 (686)
Q Consensus 57 ~~~~~l~l~~n~l~g~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l 136 (686)
..++.+++++|+|+. +|..+. +.|+.|+|++|.|++..|..|.++++|+.|+|++|.+++ ++.. +.+++|++|+|
T Consensus 10 ~~l~~l~~~~~~l~~-ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~-~~l~~L~~L~L 84 (290)
T 1p9a_G 10 ASHLEVNCDKRNLTA-LPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK-LQVD-GTLPVLGTLDL 84 (290)
T ss_dssp TTCCEEECTTSCCSS-CCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCE-EECC-SCCTTCCEEEC
T ss_pred CCccEEECCCCCCCc-CCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCc-ccCC-CCCCcCCEEEC
Confidence 568899999999995 676664 789999999999998888999999999999999999985 4443 88999999999
Q ss_pred cCCCCCCCCChhhhhccccccccccccccCCCCchhhhhcCcccceecccccccCCCCchhhhccccccccccccccccc
Q 042348 137 SQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSGLIPNDIANLSRLRLLAQRVYVDLT 216 (686)
Q Consensus 137 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~~~~~l~l~ 216 (686)
++|.++ .+|..+..+++|++|+|++|++++..|..+ ..+++|++|+|++|+|++.++..+..+++|+.| +|+
T Consensus 85 s~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~-~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L------~L~ 156 (290)
T 1p9a_G 85 SHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGAL-RGLGELQELYLKGNELKTLPPGLLTPTPKLEKL------SLA 156 (290)
T ss_dssp CSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTT-TTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEE------ECT
T ss_pred CCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHH-cCCCCCCEEECCCCCCCccChhhcccccCCCEE------ECC
Confidence 999999 788899999999999999999996444444 689999999999999999888888888887765 999
Q ss_pred CCCCCCCcccccc-cccCCcccccCCCCC
Q 042348 217 YNNLSGLIPQNAA-LLSLGPTAFIGNPFL 244 (686)
Q Consensus 217 ~N~l~~~~p~~~~-~~~~~~~~~~~n~~~ 244 (686)
+|+|++.++..+. +.++..+.+.+|...
T Consensus 157 ~N~l~~l~~~~~~~l~~L~~L~L~~N~l~ 185 (290)
T 1p9a_G 157 NNNLTELPAGLLNGLENLDTLLLQENSLY 185 (290)
T ss_dssp TSCCSCCCTTTTTTCTTCCEEECCSSCCC
T ss_pred CCcCCccCHHHhcCcCCCCEEECCCCcCC
Confidence 9999987776543 667777788888764
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.77 E-value=3.3e-19 Score=197.52 Aligned_cols=153 Identities=25% Similarity=0.380 Sum_probs=115.6
Q ss_pred CCCCCCCCCc-----ceeee-EecCCCEEEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCccccCCCCCcEEE
Q 042348 38 NWNNSNEDPC-----SWNGI-TCREGQVFSLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLI 111 (686)
Q Consensus 38 ~w~~~~~~~c-----~w~gv-~c~~~~~~~l~l~~n~l~g~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ 111 (686)
+|.. +.+|| .|.|+ .|..++++.|+|++|+|++ +|..+. ++|+.|+|++|+|+ .+| ..+++|++|+
T Consensus 35 ~W~~-~~~~~~~~~~~~~~l~~C~~~~L~~L~Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~ 106 (571)
T 3cvr_A 35 KWEK-QALPGENRNEAVSLLKECLINQFSELQLNRLNLSS-LPDNLP--PQITVLEITQNALI-SLP---ELPASLEYLD 106 (571)
T ss_dssp HHHT-TCCTTCCHHHHHHHHHHHHHTTCSEEECCSSCCSC-CCSCCC--TTCSEEECCSSCCS-CCC---CCCTTCCEEE
T ss_pred HHhc-cCCccccccchhhhccccccCCccEEEeCCCCCCc-cCHhHc--CCCCEEECcCCCCc-ccc---cccCCCCEEE
Confidence 4654 35788 79999 7988899999999999998 787664 78999999999998 677 4578899999
Q ss_pred ccCCCCCCCCcccccCCCCCCEEeccCCCCCCCCChhhhhccccccccccccccCCCCchhhhhcCcccceecccccccC
Q 042348 112 LSGNSFSGPVPMQIGKLKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLS 191 (686)
Q Consensus 112 L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~ 191 (686)
|++|+|++ +|. +.. +|+.|+|++|+|++ +|. .+++|+.|+|++|+|++ +|. .+++|+.|+|++|+|+
T Consensus 107 Ls~N~l~~-ip~-l~~--~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~----~l~~L~~L~Ls~N~L~ 173 (571)
T 3cvr_A 107 ACDNRLST-LPE-LPA--SLKHLDVDNNQLTM-LPE---LPALLEYINADNNQLTM-LPE----LPTSLEVLSVRNNQLT 173 (571)
T ss_dssp CCSSCCSC-CCC-CCT--TCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC----CCTTCCEEECCSSCCS
T ss_pred ccCCCCCC-cch-hhc--CCCEEECCCCcCCC-CCC---cCccccEEeCCCCccCc-CCC----cCCCcCEEECCCCCCC
Confidence 99999986 776 655 88888888888886 665 57788888888888875 665 4667777777777777
Q ss_pred CCCchhhhcccccccccccccccccCCCCC
Q 042348 192 GLIPNDIANLSRLRLLAQRVYVDLTYNNLS 221 (686)
Q Consensus 192 ~~~p~~~~~l~~L~~l~~~~~l~l~~N~l~ 221 (686)
+ +|. +. ++|+. |+|++|+|+
T Consensus 174 ~-lp~-l~--~~L~~------L~Ls~N~L~ 193 (571)
T 3cvr_A 174 F-LPE-LP--ESLEA------LDVSTNLLE 193 (571)
T ss_dssp C-CCC-CC--TTCCE------EECCSSCCS
T ss_pred C-cch-hh--CCCCE------EECcCCCCC
Confidence 6 444 43 33332 355555555
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.77 E-value=3.3e-19 Score=176.81 Aligned_cols=171 Identities=19% Similarity=0.188 Sum_probs=146.4
Q ss_pred CCEEEEEeCCCC-ccccCCcCcCCCCCCCEEEccC-CCCcccCCccccCCCCCcEEEccCCCCCCCCcccccCCCCCC--
Q 042348 57 GQVFSLIIPNKK-LTGFIPADLGSLSAIGRVNLRN-NNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQ-- 132 (686)
Q Consensus 57 ~~~~~l~l~~n~-l~g~~p~~l~~l~~L~~L~L~~-N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~-- 132 (686)
.+++.|+|++|+ +++..+..|..+++|++|+|++ |+|++..+..|.++++|++|+|++|++++ +|. |..+++|+
T Consensus 55 ~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~l~~n~l~~-lp~-~~~l~~L~~L 132 (239)
T 2xwt_C 55 PNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKM-FPD-LTKVYSTDIF 132 (239)
T ss_dssp TTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEEEEEECCCS-CCC-CTTCCBCCSE
T ss_pred CCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEeCCCCCCcc-ccc-cccccccccc
Confidence 579999999997 8887777999999999999999 99997777889999999999999999996 776 89999999
Q ss_pred -EEeccCC-CCCCCCChhhhhccccc-cccccccccCCCCchhhhhcCcccceecccccc-cCCCCchhhhcc-cccccc
Q 042348 133 -VLDLSQN-SFSSSIPSSIVQCKRLK-TVVLNQNSFTGPLPDGFATNLTALQKLDLSFNN-LSGLIPNDIANL-SRLRLL 207 (686)
Q Consensus 133 -~L~ls~N-~l~~~~p~~~~~l~~L~-~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l-~~L~~l 207 (686)
.|++++| .+++..+..+..+++|+ .|+|++|+++ .+|...+.. ++|+.|+|++|+ +++..+..+.++ ++|+.|
T Consensus 133 ~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~-~i~~~~~~~-~~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L 210 (239)
T 2xwt_C 133 FILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNG-TKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLL 210 (239)
T ss_dssp EEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCC-EECTTTTTT-CEEEEEECTTCTTCCEECTTTTTTCSBCCSEE
T ss_pred cEEECCCCcchhhcCcccccchhcceeEEEcCCCCCc-ccCHhhcCC-CCCCEEEcCCCCCcccCCHHHhhccccCCcEE
Confidence 9999999 99977777899999999 9999999999 788776644 899999999995 998888888888 777755
Q ss_pred cccccccccCCCCCCCcccccccccCCccccc
Q 042348 208 AQRVYVDLTYNNLSGLIPQNAALLSLGPTAFI 239 (686)
Q Consensus 208 ~~~~~l~l~~N~l~~~~p~~~~~~~~~~~~~~ 239 (686)
|+++|++++.++. .+..+..+.+.
T Consensus 211 ------~l~~N~l~~l~~~--~~~~L~~L~l~ 234 (239)
T 2xwt_C 211 ------DVSQTSVTALPSK--GLEHLKELIAR 234 (239)
T ss_dssp ------ECTTCCCCCCCCT--TCTTCSEEECT
T ss_pred ------ECCCCccccCChh--HhccCceeecc
Confidence 9999999976554 33344434333
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.77 E-value=2.5e-19 Score=207.52 Aligned_cols=177 Identities=23% Similarity=0.320 Sum_probs=154.6
Q ss_pred CCCEEEEEeCCCCccc-----------------cCCcCcC--CCCCCCEEEccCCCCcccCCccccCCCCCcEEEccCCC
Q 042348 56 EGQVFSLIIPNKKLTG-----------------FIPADLG--SLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNS 116 (686)
Q Consensus 56 ~~~~~~l~l~~n~l~g-----------------~~p~~l~--~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~ 116 (686)
-..++.|+|++|+|+| .+|..++ +|++|+.|+|++|.+.|.+|..|.++++|+.|+|++|+
T Consensus 447 L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~ 526 (876)
T 4ecn_A 447 LTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNR 526 (876)
T ss_dssp CTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCT
T ss_pred CCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCC
Confidence 3689999999999999 4999988 99999999999999999999999999999999999998
Q ss_pred -CCC-CCcccccCCC-------CCCEEeccCCCCCCCCCh--hhhhccccccccccccccCCCCchhhhhcCcccceecc
Q 042348 117 -FSG-PVPMQIGKLK-------YLQVLDLSQNSFSSSIPS--SIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDL 185 (686)
Q Consensus 117 -l~g-~~p~~~~~l~-------~L~~L~ls~N~l~~~~p~--~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L 185 (686)
++| .+|..++.++ +|+.|+|++|.++ .+|. .+..+++|+.|+|++|+++ .+| .+ ..+++|+.|+|
T Consensus 527 ~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp-~~-~~L~~L~~L~L 602 (876)
T 4ecn_A 527 GISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKLGLLDCVHNKVR-HLE-AF-GTNVKLTDLKL 602 (876)
T ss_dssp TSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCTTCCEEECTTSCCC-BCC-CC-CTTSEESEEEC
T ss_pred CcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhcCCCCCEEECCCCCcc-cch-hh-cCCCcceEEEC
Confidence 998 8998777665 9999999999999 8998 9999999999999999999 899 55 58999999999
Q ss_pred cccccCCCCchhhhcccc-cccccccccccccCCCCCCCccccccccc---CCcccccCCCCC
Q 042348 186 SFNNLSGLIPNDIANLSR-LRLLAQRVYVDLTYNNLSGLIPQNAALLS---LGPTAFIGNPFL 244 (686)
Q Consensus 186 s~N~l~~~~p~~~~~l~~-L~~l~~~~~l~l~~N~l~~~~p~~~~~~~---~~~~~~~~n~~~ 244 (686)
++|+++ .+|..+.++++ |+.| +|++|+++ .+|....... +..+.+.+|...
T Consensus 603 s~N~l~-~lp~~l~~l~~~L~~L------~Ls~N~L~-~lp~~~~~~~~~~L~~L~Ls~N~l~ 657 (876)
T 4ecn_A 603 DYNQIE-EIPEDFCAFTDQVEGL------GFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIG 657 (876)
T ss_dssp CSSCCS-CCCTTSCEECTTCCEE------ECCSSCCC-SCCSCCCTTCSSCEEEEECCSSCTT
T ss_pred cCCccc-cchHHHhhccccCCEE------ECcCCCCC-cCchhhhccccCCCCEEECcCCcCC
Confidence 999999 78888888887 7765 99999999 5665543322 445566666543
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.77 E-value=3.3e-18 Score=165.73 Aligned_cols=157 Identities=24% Similarity=0.278 Sum_probs=135.1
Q ss_pred EEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCccccCCCCCcEEEccCCCCCCCCcccccCCCCCCEEeccCC
Q 042348 60 FSLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQVLDLSQN 139 (686)
Q Consensus 60 ~~l~l~~n~l~g~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N 139 (686)
+.++++++.++. +|..+ .++|++|+|++|++++..+..|.++++|++|+|++|++++..+..|..+++|++|+|++|
T Consensus 10 ~~v~c~~~~l~~-~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n 86 (208)
T 2o6s_A 10 TTVECYSQGRTS-VPTGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTN 86 (208)
T ss_dssp TEEECCSSCCSS-CCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEecCCCccC-CCCCC--CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCC
Confidence 467889999885 56554 468999999999999777777899999999999999999776677899999999999999
Q ss_pred CCCCCCChhhhhccccccccccccccCCCCchhhhhcCcccceecccccccCCCCchhhhcccccccccccccccccCCC
Q 042348 140 SFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSGLIPNDIANLSRLRLLAQRVYVDLTYNN 219 (686)
Q Consensus 140 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~~~~~l~l~~N~ 219 (686)
++++..+..+..+++|++|+|++|++++ +|...+..+++|++|+|++|++++..+..+..+++|+.| ++++|.
T Consensus 87 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L------~l~~N~ 159 (208)
T 2o6s_A 87 QLQSLPNGVFDKLTQLKELALNTNQLQS-LPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYI------WLHDNP 159 (208)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCCC-CCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEE------ECCSCC
T ss_pred cCCccCHhHhcCccCCCEEEcCCCcCcc-cCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEE------EecCCC
Confidence 9997777778999999999999999995 555544689999999999999998887778888877755 999999
Q ss_pred CCCCccc
Q 042348 220 LSGLIPQ 226 (686)
Q Consensus 220 l~~~~p~ 226 (686)
+.+..|.
T Consensus 160 ~~~~~~~ 166 (208)
T 2o6s_A 160 WDCTCPG 166 (208)
T ss_dssp BCCCTTT
T ss_pred eecCCCC
Confidence 9987764
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.77 E-value=1e-18 Score=196.35 Aligned_cols=182 Identities=24% Similarity=0.249 Sum_probs=159.2
Q ss_pred CCEEEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCccccCCCCCcEEEccCCCCCCCCcccccCCCCCCEEec
Q 042348 57 GQVFSLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQVLDL 136 (686)
Q Consensus 57 ~~~~~l~l~~n~l~g~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l 136 (686)
..++.|+|++|++++..+..|.++++|++|+|++|++++..|..|.++++|++|+|++|++++..|..|+.+++|++|+|
T Consensus 28 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 107 (570)
T 2z63_A 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA 107 (570)
T ss_dssp SSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEEC
T ss_pred ccccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcCccccccccc
Confidence 47899999999999998899999999999999999999888889999999999999999999888889999999999999
Q ss_pred cCCCCCCCCChhhhhccccccccccccccCC-CCchhhhhcCcccceecccccccCCCCchhhhcccccccccccccccc
Q 042348 137 SQNSFSSSIPSSIVQCKRLKTVVLNQNSFTG-PLPDGFATNLTALQKLDLSFNNLSGLIPNDIANLSRLRLLAQRVYVDL 215 (686)
Q Consensus 137 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~~~~~l~l 215 (686)
++|++++..+..+..+++|++|+|++|.+++ .+|..+ .++++|++|+|++|++++..|..++.+.+|..+ ...+++
T Consensus 108 ~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~-~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~~--~~~L~l 184 (570)
T 2z63_A 108 VETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYF-SNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLL--NLSLDL 184 (570)
T ss_dssp TTSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGG-GGCTTCCEEECTTSCCCEECGGGGHHHHTCTTC--CCEEEC
T ss_pred cccccccCCCccccccccccEEecCCCccceecChhhh-cccCCCCEEeCcCCccceecHHHccchhccchh--hhhccc
Confidence 9999997666679999999999999999987 478877 489999999999999999989889888877322 135699
Q ss_pred cCCCCCCCcccccccccCCcccccCC
Q 042348 216 TYNNLSGLIPQNAALLSLGPTAFIGN 241 (686)
Q Consensus 216 ~~N~l~~~~p~~~~~~~~~~~~~~~n 241 (686)
++|.+++..|..+...++..+.+.+|
T Consensus 185 ~~n~l~~~~~~~~~~~~L~~L~l~~n 210 (570)
T 2z63_A 185 SLNPMNFIQPGAFKEIRLHKLTLRNN 210 (570)
T ss_dssp TTCCCCEECTTTTTTCEEEEEEEESC
T ss_pred CCCCceecCHHHhccCcceeEecccc
Confidence 99999998887665545555555555
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.77 E-value=9.3e-19 Score=186.99 Aligned_cols=142 Identities=23% Similarity=0.207 Sum_probs=112.3
Q ss_pred CCEEEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCccccCCCCCcEEEccCCCCCCCCcccccCCCCCCEEec
Q 042348 57 GQVFSLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQVLDL 136 (686)
Q Consensus 57 ~~~~~l~l~~n~l~g~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l 136 (686)
..++.|++++|.++...+..+..+++|++|+|++|.+++..|..|.++++|++|+|++|.+++..|..|+.+++|++|+|
T Consensus 45 ~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 124 (390)
T 3o6n_A 45 NNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVL 124 (390)
T ss_dssp CCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCceEEEecCCchhhCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEEC
Confidence 45677888888888655555788888999999999888777778888889999999999988777778888899999999
Q ss_pred cCCCCCCCCChhhhhccccccccccccccCCCCchhhhhcCcccceecccccccCCCCchhhh
Q 042348 137 SQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSGLIPNDIA 199 (686)
Q Consensus 137 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 199 (686)
++|.++...+..+..+++|++|+|++|++++..|..+ ..+++|+.|+|++|++++.....+.
T Consensus 125 ~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~-~~l~~L~~L~l~~n~l~~~~~~~l~ 186 (390)
T 3o6n_A 125 ERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTF-QATTSLQNLQLSSNRLTHVDLSLIP 186 (390)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTT-SSCTTCCEEECCSSCCSBCCGGGCT
T ss_pred CCCccCcCCHHHhcCCCCCcEEECCCCccCccChhhc-cCCCCCCEEECCCCcCCcccccccc
Confidence 9998885444446888889999999998886545444 5788888888888888876443333
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.76 E-value=2e-18 Score=184.44 Aligned_cols=111 Identities=18% Similarity=0.146 Sum_probs=94.3
Q ss_pred CCEEEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCccccCCCCCcEEEccCCCCCCCCcccccCCCCCCEEec
Q 042348 57 GQVFSLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQVLDL 136 (686)
Q Consensus 57 ~~~~~l~l~~n~l~g~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l 136 (686)
.++++|+|++|.+++..+..|..+++|+.|+|++|.+++..|..|.++++|++|+|++|.++...+..|..+++|++|+|
T Consensus 69 ~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L 148 (390)
T 3o6n_A 69 RQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSM 148 (390)
T ss_dssp CCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred ccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccCcCCHHHhcCCCCCcEEEC
Confidence 57888999999998887788999999999999999998777888889999999999999998444444688899999999
Q ss_pred cCCCCCCCCChhhhhccccccccccccccCC
Q 042348 137 SQNSFSSSIPSSIVQCKRLKTVVLNQNSFTG 167 (686)
Q Consensus 137 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 167 (686)
++|.+++..|..+..+++|++|+|++|++++
T Consensus 149 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~ 179 (390)
T 3o6n_A 149 SNNNLERIEDDTFQATTSLQNLQLSSNRLTH 179 (390)
T ss_dssp CSSCCCBCCTTTTSSCTTCCEEECCSSCCSB
T ss_pred CCCccCccChhhccCCCCCCEEECCCCcCCc
Confidence 9999987777788888889999998888874
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.76 E-value=1.1e-19 Score=188.38 Aligned_cols=169 Identities=18% Similarity=0.172 Sum_probs=92.5
Q ss_pred CCEEEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCccccCCCCCcEEEccCCCCCCCCcccccCCCCCCEEec
Q 042348 57 GQVFSLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQVLDL 136 (686)
Q Consensus 57 ~~~~~l~l~~n~l~g~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l 136 (686)
.+++.|+|++|.+++..| +..+++|++|+|++|+|++.. ..++|++|+|++|++++..+. .+++|+.|+|
T Consensus 58 ~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~n~l~~l~-----~~~~L~~L~l~~n~l~~~~~~---~~~~L~~L~l 127 (317)
T 3o53_A 58 TKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELL-----VGPSIETLHAANNNISRVSCS---RGQGKKNIYL 127 (317)
T ss_dssp TTCCEEECTTSCCEEEEE--ETTCTTCCEEECCSSEEEEEE-----ECTTCCEEECCSSCCSEEEEC---CCSSCEEEEC
T ss_pred CcCCEEECCCCcCCcchh--hhhcCCCCEEECcCCcccccc-----CCCCcCEEECCCCccCCcCcc---ccCCCCEEEC
Confidence 466677777777766544 666777777777777666321 124444444444444432222 2455666666
Q ss_pred cCCCCCCCCChhhhhccccccccccccccCCCCchhhhhcCcccceecccccccCCCCchhhhccccccccccccccccc
Q 042348 137 SQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSGLIPNDIANLSRLRLLAQRVYVDLT 216 (686)
Q Consensus 137 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~~~~~l~l~ 216 (686)
++|++++..|..+..+++|++|+|++|++++..|..+...+++|++|+|++|++++. |.. ..+++|+ .|+++
T Consensus 128 ~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~~-~~l~~L~------~L~Ls 199 (317)
T 3o53_A 128 ANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-KGQ-VVFAKLK------TLDLS 199 (317)
T ss_dssp CSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-ECC-CCCTTCC------EEECC
T ss_pred CCCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCccc-ccc-cccccCC------EEECC
Confidence 666666555556666666666666666666544444444556666666666666644 211 1233333 33566
Q ss_pred CCCCCCCcccccccccCCcccccCCCC
Q 042348 217 YNNLSGLIPQNAALLSLGPTAFIGNPF 243 (686)
Q Consensus 217 ~N~l~~~~p~~~~~~~~~~~~~~~n~~ 243 (686)
+|++++.++....+.++..+.+.+|..
T Consensus 200 ~N~l~~l~~~~~~l~~L~~L~L~~N~l 226 (317)
T 3o53_A 200 SNKLAFMGPEFQSAAGVTWISLRNNKL 226 (317)
T ss_dssp SSCCCEECGGGGGGTTCSEEECTTSCC
T ss_pred CCcCCcchhhhcccCcccEEECcCCcc
Confidence 666655544433444444555555543
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.76 E-value=3.2e-18 Score=168.35 Aligned_cols=154 Identities=27% Similarity=0.325 Sum_probs=132.6
Q ss_pred CCEEEccCCCCcccCCccccCCCCCcEEEccCCCCCCCCcccccCCCCCCEEeccCCCCCCCCChhhhhccccccccccc
Q 042348 83 IGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQ 162 (686)
Q Consensus 83 L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~ 162 (686)
.+.++.++|.+. .+|..+. ++|+.|+|++|++++..|..|..+++|+.|+|++|++++..+..+..+++|+.|+|++
T Consensus 21 ~~~v~c~~~~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~ 97 (229)
T 3e6j_A 21 GTTVDCRSKRHA-SVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGT 97 (229)
T ss_dssp TTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEeEccCCCcC-ccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCC
Confidence 457899999997 7887664 8999999999999998899999999999999999999876667789999999999999
Q ss_pred cccCCCCchhhhhcCcccceecccccccCCCCchhhhcccccccccccccccccCCCCCCCccccc-ccccCCcccccCC
Q 042348 163 NSFTGPLPDGFATNLTALQKLDLSFNNLSGLIPNDIANLSRLRLLAQRVYVDLTYNNLSGLIPQNA-ALLSLGPTAFIGN 241 (686)
Q Consensus 163 N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~~~~~l~l~~N~l~~~~p~~~-~~~~~~~~~~~~n 241 (686)
|+|++ +|...+..+++|+.|+|++|+|+ .+|..+..+++|+.| +|++|+|++.++..+ .+.++..+.+.+|
T Consensus 98 N~l~~-l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L------~L~~N~l~~~~~~~~~~l~~L~~L~l~~N 169 (229)
T 3e6j_A 98 NQLTV-LPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHL------ALDQNQLKSIPHGAFDRLSSLTHAYLFGN 169 (229)
T ss_dssp SCCCC-CCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEE------ECCSSCCCCCCTTTTTTCTTCCEEECTTS
T ss_pred CcCCc-cChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEE------ECCCCcCCccCHHHHhCCCCCCEEEeeCC
Confidence 99995 55555568999999999999999 578888888877755 999999998877544 3567778889999
Q ss_pred CCCCCC
Q 042348 242 PFLCGP 247 (686)
Q Consensus 242 ~~~c~~ 247 (686)
++.|.+
T Consensus 170 ~~~c~c 175 (229)
T 3e6j_A 170 PWDCEC 175 (229)
T ss_dssp CBCTTB
T ss_pred CccCCc
Confidence 999854
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.76 E-value=2.2e-18 Score=174.75 Aligned_cols=165 Identities=19% Similarity=0.198 Sum_probs=109.7
Q ss_pred CCEEEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCccccCCCCCcEEEccCCCCCCCCcccccCCCCCCEEec
Q 042348 57 GQVFSLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQVLDL 136 (686)
Q Consensus 57 ~~~~~l~l~~n~l~g~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l 136 (686)
.+++.|+|++|.+++..+..|..+++|+.|+|++|.+++..|..|.++++|++|+|++|++++..+..++.+++|++|+|
T Consensus 52 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l 131 (276)
T 2z62_A 52 PELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNV 131 (276)
T ss_dssp TTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEEC
T ss_pred cCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECCCCCccccCchhcccCCCCCEEEC
Confidence 45667777777777666666777777777777777776666666666777777777777766555556666667777777
Q ss_pred cCCCCCCC-CChhhhhccccccccccccccCCCCchhhh--------------------------hcCcccceecccccc
Q 042348 137 SQNSFSSS-IPSSIVQCKRLKTVVLNQNSFTGPLPDGFA--------------------------TNLTALQKLDLSFNN 189 (686)
Q Consensus 137 s~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~--------------------------~~l~~L~~L~Ls~N~ 189 (686)
++|.+++. +|..+..+++|++|+|++|++++..+..+. ....+|+.|+|++|+
T Consensus 132 ~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls~n~l~~~~~~~~~~~~L~~L~L~~n~ 211 (276)
T 2z62_A 132 AHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLKELALDTNQ 211 (276)
T ss_dssp CSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCEEEECCSSCCCEECTTSSCSCCEEEEECCSSC
T ss_pred cCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhccccceeeecCCCcccccCccccCCCcccEEECCCCc
Confidence 77766642 466666666666666666666643332221 022367778888888
Q ss_pred cCCCCchhhhcccccccccccccccccCCCCCCCcccc
Q 042348 190 LSGLIPNDIANLSRLRLLAQRVYVDLTYNNLSGLIPQN 227 (686)
Q Consensus 190 l~~~~p~~~~~l~~L~~l~~~~~l~l~~N~l~~~~p~~ 227 (686)
+++.++..+..+++|+.| ++++|.+++..|..
T Consensus 212 l~~~~~~~~~~l~~L~~L------~l~~N~~~c~c~~l 243 (276)
T 2z62_A 212 LKSVPDGIFDRLTSLQKI------WLHTNPWDCSCPRI 243 (276)
T ss_dssp CSCCCTTTTTTCCSCCEE------ECCSSCBCCCTTTT
T ss_pred eeecCHhHhcccccccEE------EccCCcccccCCch
Confidence 887766666777666654 99999999877643
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.75 E-value=3.3e-19 Score=200.45 Aligned_cols=184 Identities=23% Similarity=0.228 Sum_probs=155.7
Q ss_pred CCEEEEEeCCCCccccC--CcCcCCCCCCCEEEccCCCCcccCCccccCCCCCcEEEccCCCCCCCCc-ccccCCCCCCE
Q 042348 57 GQVFSLIIPNKKLTGFI--PADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVP-MQIGKLKYLQV 133 (686)
Q Consensus 57 ~~~~~l~l~~n~l~g~~--p~~l~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p-~~~~~l~~L~~ 133 (686)
..++.|+|++|.+++.. |..+..+++|+.|+|++|.+.+. |..+.++++|+.|+|++|.+++..| ..+..+++|+.
T Consensus 347 ~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~-~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~ 425 (570)
T 2z63_A 347 PSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITM-SSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIY 425 (570)
T ss_dssp TTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEEE-EEEEETCTTCCEEECTTSEEESCTTSCTTTTCTTCCE
T ss_pred CCCCEEeCcCCccCccccccccccccCccCEEECCCCccccc-cccccccCCCCEEEccCCccccccchhhhhcCCCCCE
Confidence 56788888888888654 67788889999999999998854 4448899999999999999987666 56889999999
Q ss_pred EeccCCCCCCCCChhhhhccccccccccccccC-CCCchhhhhcCcccceecccccccCCCCchhhhccccccccccccc
Q 042348 134 LDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFT-GPLPDGFATNLTALQKLDLSFNNLSGLIPNDIANLSRLRLLAQRVY 212 (686)
Q Consensus 134 L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~-~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~~~~~ 212 (686)
|++++|.+++.+|..+..+++|+.|+|++|+++ +.+|..+ ..+++|+.|+|++|++++.+|..+.++++|+.|
T Consensus 426 L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~-~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L----- 499 (570)
T 2z63_A 426 LDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIF-TELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVL----- 499 (570)
T ss_dssp EECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCC-TTCTTCCEEECTTSCCCEECTTTTTTCTTCCEE-----
T ss_pred EeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhh-hcccCCCEEECCCCccccCChhhhhcccCCCEE-----
Confidence 999999999888999999999999999999997 5678666 589999999999999999989999888887765
Q ss_pred ccccCCCCCCCccccc-ccccCCcccccCCCCCCCCC
Q 042348 213 VDLTYNNLSGLIPQNA-ALLSLGPTAFIGNPFLCGPP 248 (686)
Q Consensus 213 l~l~~N~l~~~~p~~~-~~~~~~~~~~~~n~~~c~~p 248 (686)
++++|++++.+|..+ .+.++..+.+.+|++.|.+|
T Consensus 500 -~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 535 (570)
T 2z63_A 500 -NMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 535 (570)
T ss_dssp -ECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred -eCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCCc
Confidence 999999999888654 46677788899999988644
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=99.75 E-value=2.1e-18 Score=198.23 Aligned_cols=165 Identities=22% Similarity=0.211 Sum_probs=146.8
Q ss_pred CCEEEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCccccCCCCCcEEEccCCCCCCCCcccccCCCCCCEEec
Q 042348 57 GQVFSLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQVLDL 136 (686)
Q Consensus 57 ~~~~~l~l~~n~l~g~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l 136 (686)
.+++.|+|++|.+++..+..|+++++|++|+|++|.+++..|..|.++++|++|+|++|++++..+..|+.+++|++|+|
T Consensus 25 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L 104 (680)
T 1ziw_A 25 TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHL 104 (680)
T ss_dssp TTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEEC
T ss_pred CCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccCccChhhhccCCCCCEEEC
Confidence 47899999999999988888999999999999999999989999999999999999999999655567999999999999
Q ss_pred cCCCCCCCCChhhhhccccccccccccccCCCCchhhhhcCcccceecccccccCCCCchhhhc--cccccccccccccc
Q 042348 137 SQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSGLIPNDIAN--LSRLRLLAQRVYVD 214 (686)
Q Consensus 137 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~--l~~L~~l~~~~~l~ 214 (686)
++|.+++..|..+..+++|++|+|++|++++..|..+ .++++|++|+|++|.+++..|..+.. +++|+. |+
T Consensus 105 ~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~-~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~------L~ 177 (680)
T 1ziw_A 105 MSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQ-VQLENLQELLLSNNKIQALKSEELDIFANSSLKK------LE 177 (680)
T ss_dssp CSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSS-SCCTTCCEEECCSSCCCCBCHHHHGGGTTCEESE------EE
T ss_pred CCCccCccChhHccccCCCCEEECCCCcccccCchhh-cccccCCEEEccCCcccccCHHHhhccccccccE------EE
Confidence 9999998778899999999999999999998777666 58999999999999999988887653 355554 49
Q ss_pred ccCCCCCCCccccc
Q 042348 215 LTYNNLSGLIPQNA 228 (686)
Q Consensus 215 l~~N~l~~~~p~~~ 228 (686)
+++|++++..|..+
T Consensus 178 L~~n~l~~~~~~~~ 191 (680)
T 1ziw_A 178 LSSNQIKEFSPGCF 191 (680)
T ss_dssp CTTCCCCCBCTTGG
T ss_pred CCCCcccccChhhh
Confidence 99999998877643
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.75 E-value=3e-18 Score=178.68 Aligned_cols=152 Identities=20% Similarity=0.297 Sum_probs=81.6
Q ss_pred CCEEEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCccccCCCCCcEEEccCCCCCC--CCcccccCCCCCCEE
Q 042348 57 GQVFSLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSG--PVPMQIGKLKYLQVL 134 (686)
Q Consensus 57 ~~~~~l~l~~n~l~g~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g--~~p~~~~~l~~L~~L 134 (686)
.+++.|+|++|.++ .+|..+. ++|+.|++++|++++..+..+.++++|+.|+|++|.++. ..+..+..+++|+.|
T Consensus 100 ~~L~~L~Ls~n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L 176 (330)
T 1xku_A 100 VKLERLYLSKNQLK-ELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYI 176 (330)
T ss_dssp TTCCEEECCSSCCS-BCCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEE
T ss_pred CCCCEEECCCCcCC-ccChhhc--ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEE
Confidence 45666777777666 3454443 566666666666665555555666666666666666642 445555556566665
Q ss_pred eccCCCCCCCCChhhhhccccccccccccccCCCCchhhhhcCcccceecccccccCCCCchhhhccccccccccccccc
Q 042348 135 DLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSGLIPNDIANLSRLRLLAQRVYVD 214 (686)
Q Consensus 135 ~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~~~~~l~ 214 (686)
++++|.++ .+|..+. ++|++|+|++|++++..|..+ ..+++|+.|+|++|++++..+..+..+++|+.| +
T Consensus 177 ~l~~n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~-~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L------~ 246 (330)
T 1xku_A 177 RIADTNIT-TIPQGLP--PSLTELHLDGNKITKVDAASL-KGLNNLAKLGLSFNSISAVDNGSLANTPHLREL------H 246 (330)
T ss_dssp ECCSSCCC-SCCSSCC--TTCSEEECTTSCCCEECTGGG-TTCTTCCEEECCSSCCCEECTTTGGGSTTCCEE------E
T ss_pred ECCCCccc-cCCcccc--ccCCEEECCCCcCCccCHHHh-cCCCCCCEEECCCCcCceeChhhccCCCCCCEE------E
Confidence 55555555 2333322 455555555555554333333 345555555555555555544444444444333 4
Q ss_pred ccCCCCC
Q 042348 215 LTYNNLS 221 (686)
Q Consensus 215 l~~N~l~ 221 (686)
+++|+++
T Consensus 247 L~~N~l~ 253 (330)
T 1xku_A 247 LNNNKLV 253 (330)
T ss_dssp CCSSCCS
T ss_pred CCCCcCc
Confidence 5555544
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.75 E-value=2.2e-18 Score=196.12 Aligned_cols=175 Identities=20% Similarity=0.222 Sum_probs=144.5
Q ss_pred CCCcceeeeEecCCCEEEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCccccCCCCCcEEEccCCCCCCCCcc
Q 042348 44 EDPCSWNGITCREGQVFSLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPM 123 (686)
Q Consensus 44 ~~~c~w~gv~c~~~~~~~l~l~~n~l~g~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~ 123 (686)
.-|..|....|..... +.+-++.+|+ .+|..+. +++++|||++|+|++..|.+|.++++|++|+|++|+|++..|.
T Consensus 19 ~~p~~~~~c~~~~~~~-~~~c~~~~l~-~vP~~lp--~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~ 94 (635)
T 4g8a_A 19 SIPESWEPCVEVVPNI-TYQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDG 94 (635)
T ss_dssp ------CCSEEEETTT-EEECTTSCCS-SCCSSSC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTT
T ss_pred CCCCCCCCccccCCCC-EEECCCCCcC-ccCCCCC--cCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChh
Confidence 3577898877764433 3577888888 5787664 5799999999999987788999999999999999999987788
Q ss_pred cccCCCCCCEEeccCCCCCCCCChhhhhccccccccccccccCCCCchhhhhcCcccceecccccccCCC-Cchhhhccc
Q 042348 124 QIGKLKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSGL-IPNDIANLS 202 (686)
Q Consensus 124 ~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~-~p~~~~~l~ 202 (686)
.|.+|++|++|+|++|+|++..+..|.++++|++|+|++|++++ +|...+.++++|++|+|++|++++. +|..++.++
T Consensus 95 ~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~Ls~N~l~~-l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~ 173 (635)
T 4g8a_A 95 AYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLAS-LENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLT 173 (635)
T ss_dssp TTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEECTTSCCCC-STTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCT
T ss_pred HhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEECCCCcCCC-CChhhhhcCcccCeeccccCccccCCCchhhccch
Confidence 89999999999999999997777889999999999999999996 5554446899999999999999874 688888888
Q ss_pred ccccccccccccccCCCCCCCcccccc
Q 042348 203 RLRLLAQRVYVDLTYNNLSGLIPQNAA 229 (686)
Q Consensus 203 ~L~~l~~~~~l~l~~N~l~~~~p~~~~ 229 (686)
+|+.| ++++|++++..|..+.
T Consensus 174 ~L~~L------~L~~N~l~~~~~~~l~ 194 (635)
T 4g8a_A 174 NLEHL------DLSSNKIQSIYCTDLR 194 (635)
T ss_dssp TCCEE------ECCSSCCCEECGGGGH
T ss_pred hhhhh------cccCcccccccccccc
Confidence 88765 9999999998887653
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.75 E-value=5.3e-18 Score=161.91 Aligned_cols=131 Identities=21% Similarity=0.252 Sum_probs=115.2
Q ss_pred EEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCc-cccCCCCCcEEEccCCCCCCCCcccccCCCCCCEEeccCC
Q 042348 61 SLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPV-ELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQVLDLSQN 139 (686)
Q Consensus 61 ~l~l~~n~l~g~~p~~l~~l~~L~~L~L~~N~l~g~~p~-~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N 139 (686)
.|++++|+|+ .+|..+.. +|+.|+|++|+|++..+. .|.++++|++|+|++|+|++..|..|..+++|++|+|++|
T Consensus 12 ~l~~s~~~l~-~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N 88 (192)
T 1w8a_A 12 TVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGEN 88 (192)
T ss_dssp EEECTTSCCS-SCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSC
T ss_pred EEEcCCCCcC-cCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCCC
Confidence 4566788885 57776654 899999999999976664 4889999999999999999988999999999999999999
Q ss_pred CCCCCCChhhhhccccccccccccccCCCCchhhhhcCcccceecccccccCCCCc
Q 042348 140 SFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSGLIP 195 (686)
Q Consensus 140 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p 195 (686)
++++..|..+..+++|++|+|++|++++.+|..+ ..+++|++|+|++|.+++..+
T Consensus 89 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~-~~l~~L~~L~L~~N~l~c~c~ 143 (192)
T 1w8a_A 89 KIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSF-EHLNSLTSLNLASNPFNCNCH 143 (192)
T ss_dssp CCCEECSSSSTTCTTCCEEECCSSCCCEECTTSS-TTCTTCCEEECTTCCBCCSGG
T ss_pred cCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHh-hcCCCCCEEEeCCCCccCcCc
Confidence 9998888889999999999999999998777766 489999999999999998655
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.74 E-value=5.9e-18 Score=176.55 Aligned_cols=172 Identities=22% Similarity=0.288 Sum_probs=99.6
Q ss_pred CCEEEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCccccCCCCCcEEEccCCCCC--CCCcccccCCCCCCEE
Q 042348 57 GQVFSLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFS--GPVPMQIGKLKYLQVL 134 (686)
Q Consensus 57 ~~~~~l~l~~n~l~g~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~--g~~p~~~~~l~~L~~L 134 (686)
..++.|+|++|.++ .+|..+. ++|++|+|++|++++..+..|.++++|+.|+|++|.++ +..|..+..+ +|+.|
T Consensus 102 ~~L~~L~L~~n~l~-~l~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L 177 (332)
T 2ft3_A 102 RKLQKLYISKNHLV-EIPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYL 177 (332)
T ss_dssp TTCCEEECCSSCCC-SCCSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCC
T ss_pred CCCCEEECCCCcCC-ccCcccc--ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEE
Confidence 57788888888887 4666554 77888888888888655566778888888888888885 3566666666 56666
Q ss_pred eccCCCCCCCCChhhhhccccccccccccccCCCCchhhhhcCcccceecccccccCCCCchhhhccccccccccccccc
Q 042348 135 DLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSGLIPNDIANLSRLRLLAQRVYVD 214 (686)
Q Consensus 135 ~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~~~~~l~ 214 (686)
++++|.+++ +|..+. ++|++|+|++|++++..|..+ ..+++|+.|+|++|++++..|..+..+++|+.| +
T Consensus 178 ~l~~n~l~~-l~~~~~--~~L~~L~l~~n~i~~~~~~~l-~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L------~ 247 (332)
T 2ft3_A 178 RISEAKLTG-IPKDLP--ETLNELHLDHNKIQAIELEDL-LRYSKLYRLGLGHNQIRMIENGSLSFLPTLREL------H 247 (332)
T ss_dssp BCCSSBCSS-CCSSSC--SSCSCCBCCSSCCCCCCTTSS-TTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEE------E
T ss_pred ECcCCCCCc-cCcccc--CCCCEEECCCCcCCccCHHHh-cCCCCCCEEECCCCcCCcCChhHhhCCCCCCEE------E
Confidence 666655553 443332 455555555555554333333 345555555555555555544445444444433 4
Q ss_pred ccCCCCCCCcccccccccCCcccccCCC
Q 042348 215 LTYNNLSGLIPQNAALLSLGPTAFIGNP 242 (686)
Q Consensus 215 l~~N~l~~~~p~~~~~~~~~~~~~~~n~ 242 (686)
+++|+++..++....+.++..+.+.+|+
T Consensus 248 L~~N~l~~lp~~l~~l~~L~~L~l~~N~ 275 (332)
T 2ft3_A 248 LDNNKLSRVPAGLPDLKLLQVVYLHTNN 275 (332)
T ss_dssp CCSSCCCBCCTTGGGCTTCCEEECCSSC
T ss_pred CCCCcCeecChhhhcCccCCEEECCCCC
Confidence 5555554322222233334444444443
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.74 E-value=7e-18 Score=173.86 Aligned_cols=170 Identities=22% Similarity=0.330 Sum_probs=122.3
Q ss_pred CCCEEEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCccccCCCCCcEEEccCCCCCCCCcccccCCCCCCEEe
Q 042348 56 EGQVFSLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQVLD 135 (686)
Q Consensus 56 ~~~~~~l~l~~n~l~g~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ 135 (686)
..+++.|+|++|.+++..+ +..+++|+.|+|++|++++ +| .+.++++|+.|+|++|++++ ++. +..+++|+.|+
T Consensus 62 l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~l~~-~~-~~~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~ 135 (308)
T 1h6u_A 62 LNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKN-VS-AIAGLQSIKTLDLTSTQITD-VTP-LAGLSNLQVLY 135 (308)
T ss_dssp CTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSC-CG-GGTTCTTCCEEECTTSCCCC-CGG-GTTCTTCCEEE
T ss_pred cCCCCEEEccCCcCCCChh--HccCCCCCEEEccCCcCCC-ch-hhcCCCCCCEEECCCCCCCC-chh-hcCCCCCCEEE
Confidence 3567888888888876444 7888888888888888874 33 57788888888888888875 443 77888888888
Q ss_pred ccCCCCCCCCChhhhhccccccccccccccCCCCchhhhhcCcccceecccccccCCCCchhhhcccccccccccccccc
Q 042348 136 LSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSGLIPNDIANLSRLRLLAQRVYVDL 215 (686)
Q Consensus 136 ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~~~~~l~l 215 (686)
|++|.+++. +. +..+++|+.|+|++|++++ ++. + ..+++|+.|+|++|++++..+ +..+++|+ .|++
T Consensus 136 l~~n~l~~~-~~-l~~l~~L~~L~l~~n~l~~-~~~-l-~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~------~L~L 202 (308)
T 1h6u_A 136 LDLNQITNI-SP-LAGLTNLQYLSIGNAQVSD-LTP-L-ANLSKLTTLKADDNKISDISP--LASLPNLI------EVHL 202 (308)
T ss_dssp CCSSCCCCC-GG-GGGCTTCCEEECCSSCCCC-CGG-G-TTCTTCCEEECCSSCCCCCGG--GGGCTTCC------EEEC
T ss_pred CCCCccCcC-cc-ccCCCCccEEEccCCcCCC-Chh-h-cCCCCCCEEECCCCccCcChh--hcCCCCCC------EEEc
Confidence 888888754 33 7778888888888888874 444 3 478888888888888886543 55555554 4488
Q ss_pred cCCCCCCCcccccccccCCcccccCCCCCC
Q 042348 216 TYNNLSGLIPQNAALLSLGPTAFIGNPFLC 245 (686)
Q Consensus 216 ~~N~l~~~~p~~~~~~~~~~~~~~~n~~~c 245 (686)
++|++++..| ...+.++..+.+.+|++.+
T Consensus 203 ~~N~l~~~~~-l~~l~~L~~L~l~~N~i~~ 231 (308)
T 1h6u_A 203 KNNQISDVSP-LANTSNLFIVTLTNQTITN 231 (308)
T ss_dssp TTSCCCBCGG-GTTCTTCCEEEEEEEEEEC
T ss_pred cCCccCcccc-ccCCCCCCEEEccCCeeec
Confidence 8888887664 4445566666777777643
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.74 E-value=5.3e-18 Score=162.70 Aligned_cols=152 Identities=18% Similarity=0.260 Sum_probs=129.0
Q ss_pred CCEEEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCccccCCCCCcEEEccCCCCCCCCcccccCCCCCCEEec
Q 042348 57 GQVFSLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQVLDL 136 (686)
Q Consensus 57 ~~~~~l~l~~n~l~g~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l 136 (686)
.+++.|++++|.++ .+| .+..+++|+.|+|++|.++ .+..+.++++|++|+|++|++++..|..++.+++|++|+|
T Consensus 44 ~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~--~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L 119 (197)
T 4ezg_A 44 NSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHAT--NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDI 119 (197)
T ss_dssp HTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCS--CCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEEC
T ss_pred CCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCC--cchhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEEe
Confidence 46889999999999 566 6999999999999999775 3457899999999999999999888999999999999999
Q ss_pred cCCCCCCCCChhhhhccccccccccccccCCCCchhhhhcCcccceecccccccCCCCchhhhccccccccccccccccc
Q 042348 137 SQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSGLIPNDIANLSRLRLLAQRVYVDLT 216 (686)
Q Consensus 137 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~~~~~l~l~ 216 (686)
++|.+++..|..+..+++|++|+|++|++.+.+| .+ ..+++|+.|+|++|++++.. .+..+++|+.| +++
T Consensus 120 s~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~~~~-~l-~~l~~L~~L~l~~n~i~~~~--~l~~l~~L~~L------~l~ 189 (197)
T 4ezg_A 120 SHSAHDDSILTKINTLPKVNSIDLSYNGAITDIM-PL-KTLPELKSLNIQFDGVHDYR--GIEDFPKLNQL------YAF 189 (197)
T ss_dssp CSSBCBGGGHHHHTTCSSCCEEECCSCTBCCCCG-GG-GGCSSCCEEECTTBCCCCCT--TGGGCSSCCEE------EEC
T ss_pred cCCccCcHhHHHHhhCCCCCEEEccCCCCccccH-hh-cCCCCCCEEECCCCCCcChH--HhccCCCCCEE------Eee
Confidence 9999998889999999999999999998334676 34 58999999999999999743 56666666654 999
Q ss_pred CCCCCC
Q 042348 217 YNNLSG 222 (686)
Q Consensus 217 ~N~l~~ 222 (686)
+|++.+
T Consensus 190 ~N~i~~ 195 (197)
T 4ezg_A 190 SQTIGG 195 (197)
T ss_dssp BC----
T ss_pred CcccCC
Confidence 999864
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.73 E-value=7.5e-18 Score=160.88 Aligned_cols=127 Identities=22% Similarity=0.329 Sum_probs=116.4
Q ss_pred cceeeeEecC-----------CCEEEEEeCCCCccccCCc-CcCCCCCCCEEEccCCCCcccCCccccCCCCCcEEEccC
Q 042348 47 CSWNGITCRE-----------GQVFSLIIPNKKLTGFIPA-DLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSG 114 (686)
Q Consensus 47 c~w~gv~c~~-----------~~~~~l~l~~n~l~g~~p~-~l~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~ 114 (686)
|.|..+.|.. ..++.|+|++|+|++..+. .|+.+++|+.|+|++|+|++..|..|.++++|++|+|++
T Consensus 8 C~~~~l~~s~~~l~~ip~~~~~~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 87 (192)
T 1w8a_A 8 CEGTTVDCTGRGLKEIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp EETTEEECTTSCCSSCCSCCCTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred ECCCEEEcCCCCcCcCccCCCCCCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence 6799999973 3788999999999987765 489999999999999999999999999999999999999
Q ss_pred CCCCCCCcccccCCCCCCEEeccCCCCCCCCChhhhhccccccccccccccCCCCchhh
Q 042348 115 NSFSGPVPMQIGKLKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGF 173 (686)
Q Consensus 115 N~l~g~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~ 173 (686)
|+|++..|..|..+++|++|+|++|++++.+|..+..+++|++|+|++|.+++..+...
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l~~ 146 (192)
T 1w8a_A 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAW 146 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHH
T ss_pred CcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCcchH
Confidence 99998888889999999999999999999999999999999999999999998766443
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.72 E-value=1.5e-17 Score=169.82 Aligned_cols=169 Identities=27% Similarity=0.406 Sum_probs=138.1
Q ss_pred CCEEEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCccccCCCCCcEEEccCCCCCCCCcccccCCCCCCEEec
Q 042348 57 GQVFSLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQVLDL 136 (686)
Q Consensus 57 ~~~~~l~l~~n~l~g~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l 136 (686)
.+++.|++++|.++.. + .+..+++|+.|+|++|++++..| +.++++|+.|+|++|++++ +| .+..+++|++|+|
T Consensus 46 ~~L~~L~l~~~~i~~~-~-~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~-~~-~l~~l~~L~~L~L 119 (291)
T 1h6t_A 46 NSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSL 119 (291)
T ss_dssp HTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEEC
T ss_pred CcccEEEccCCCcccC-h-hHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCC-Ch-hhccCCCCCEEEC
Confidence 4688999999999864 3 48899999999999999986444 8999999999999999985 44 4899999999999
Q ss_pred cCCCCCCCCChhhhhccccccccccccccCCCCchhhhhcCcccceecccccccCCCCchhhhccccccccccccccccc
Q 042348 137 SQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSGLIPNDIANLSRLRLLAQRVYVDLT 216 (686)
Q Consensus 137 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~~~~~l~l~ 216 (686)
++|++++ + ..+..+++|+.|+|++|++++ + ..+ ..+++|+.|+|++|++++..| +..+++|+.| +++
T Consensus 120 ~~n~i~~-~-~~l~~l~~L~~L~l~~n~l~~-~-~~l-~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L------~L~ 186 (291)
T 1h6t_A 120 EHNGISD-I-NGLVHLPQLESLYLGNNKITD-I-TVL-SRLTKLDTLSLEDNQISDIVP--LAGLTKLQNL------YLS 186 (291)
T ss_dssp TTSCCCC-C-GGGGGCTTCCEEECCSSCCCC-C-GGG-GGCTTCSEEECCSSCCCCCGG--GTTCTTCCEE------ECC
T ss_pred CCCcCCC-C-hhhcCCCCCCEEEccCCcCCc-c-hhh-ccCCCCCEEEccCCccccchh--hcCCCccCEE------ECC
Confidence 9999986 4 468899999999999999986 4 344 589999999999999998755 6676666654 999
Q ss_pred CCCCCCCcccccccccCCcccccCCCCCC
Q 042348 217 YNNLSGLIPQNAALLSLGPTAFIGNPFLC 245 (686)
Q Consensus 217 ~N~l~~~~p~~~~~~~~~~~~~~~n~~~c 245 (686)
+|++++. |....+.++..+.+.+|+..+
T Consensus 187 ~N~i~~l-~~l~~l~~L~~L~l~~n~i~~ 214 (291)
T 1h6t_A 187 KNHISDL-RALAGLKNLDVLELFSQECLN 214 (291)
T ss_dssp SSCCCBC-GGGTTCTTCSEEEEEEEEEEC
T ss_pred CCcCCCC-hhhccCCCCCEEECcCCcccC
Confidence 9999875 445556667777788887543
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.72 E-value=1e-17 Score=176.39 Aligned_cols=180 Identities=23% Similarity=0.287 Sum_probs=148.4
Q ss_pred eeEecCCCEEEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCccccCCCCCcEEEccCCCCCCCCcccccCCCC
Q 042348 51 GITCREGQVFSLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGKLKY 130 (686)
Q Consensus 51 gv~c~~~~~~~l~l~~n~l~g~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~ 130 (686)
...|....+ .++++|+++. +|..+. ++|++|+|++|.+++..+..|.++++|++|+|++|++++..|..|..+++
T Consensus 27 ~~~C~~~~~--c~~~~~~l~~-iP~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~ 101 (353)
T 2z80_A 27 SLSCDRNGI--CKGSSGSLNS-IPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGS 101 (353)
T ss_dssp CCEECTTSE--EECCSTTCSS-CCTTCC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTT
T ss_pred CCCCCCCeE--eeCCCCCccc-cccccc--ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCC
Confidence 567876554 8999999995 677665 58999999999999777778999999999999999999888889999999
Q ss_pred CCEEeccCCCCCCCCChhhhhccccccccccccccCCCCch-hhhhcCcccceeccccc-ccCCCCchhhhccccccccc
Q 042348 131 LQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPD-GFATNLTALQKLDLSFN-NLSGLIPNDIANLSRLRLLA 208 (686)
Q Consensus 131 L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~-~~~~~l~~L~~L~Ls~N-~l~~~~p~~~~~l~~L~~l~ 208 (686)
|++|+|++|++++..+..+..+++|++|+|++|+++ .+|. ..+..+++|++|+|++| .+++..|..+.++++|+.|
T Consensus 102 L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L- 179 (353)
T 2z80_A 102 LEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEEL- 179 (353)
T ss_dssp CCEEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCS-SSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEE-
T ss_pred CCEEECCCCcCCcCCHhHhCCCccCCEEECCCCCCc-ccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEE-
Confidence 999999999999655555899999999999999999 5666 44468999999999999 5787778888888888765
Q ss_pred ccccccccCCCCCCCcccccc-cccCCcccccCCC
Q 042348 209 QRVYVDLTYNNLSGLIPQNAA-LLSLGPTAFIGNP 242 (686)
Q Consensus 209 ~~~~l~l~~N~l~~~~p~~~~-~~~~~~~~~~~n~ 242 (686)
++++|++++..|..+. +.++..+.+.+|.
T Consensus 180 -----~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~ 209 (353)
T 2z80_A 180 -----EIDASDLQSYEPKSLKSIQNVSHLILHMKQ 209 (353)
T ss_dssp -----EEEETTCCEECTTTTTTCSEEEEEEEECSC
T ss_pred -----ECCCCCcCccCHHHHhccccCCeecCCCCc
Confidence 8999999887665543 3334444455543
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.71 E-value=1.1e-17 Score=185.75 Aligned_cols=160 Identities=24% Similarity=0.258 Sum_probs=141.9
Q ss_pred CCCEEEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcc--cCCccccCCCCCcEEEccCCCCCCCCccc-ccCCCCCC
Q 042348 56 EGQVFSLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSG--SLPVELFNASNLQSLILSGNSFSGPVPMQ-IGKLKYLQ 132 (686)
Q Consensus 56 ~~~~~~l~l~~n~l~g~~p~~l~~l~~L~~L~L~~N~l~g--~~p~~~~~l~~L~~L~L~~N~l~g~~p~~-~~~l~~L~ 132 (686)
...++.|+|++|++++.+|..++.+++|+.|+|++|++++ .+|..+.++++|++|+|++|.+++.+|.. +..+++|+
T Consensus 323 l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~ 402 (520)
T 2z7x_B 323 ISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLL 402 (520)
T ss_dssp CCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCC
T ss_pred CCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCC
Confidence 3578999999999999999999999999999999999996 56788999999999999999999867765 88899999
Q ss_pred EEeccCCCCCCCCChhhhhccccccccccccccCCCCchhhhhcCcccceecccccccCCCCchhhhccccccccccccc
Q 042348 133 VLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSGLIPNDIANLSRLRLLAQRVY 212 (686)
Q Consensus 133 ~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~~~~~ 212 (686)
.|+|++|.+++.+|..+. ++|+.|+|++|+++ .+|..++ .+++|++|+|++|+|++..+..+..+++|+.|
T Consensus 403 ~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~-~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L----- 473 (520)
T 2z7x_B 403 SLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVV-KLEALQELNVASNQLKSVPDGIFDRLTSLQKI----- 473 (520)
T ss_dssp EEECCSSCCCGGGGGSCC--TTCCEEECCSSCCC-CCCGGGG-GCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE-----
T ss_pred EEECcCCCCCcchhhhhc--ccCCEEECCCCccc-ccchhhh-cCCCCCEEECCCCcCCccCHHHhccCCcccEE-----
Confidence 999999999988877654 79999999999999 7998886 89999999999999996544447777777655
Q ss_pred ccccCCCCCCCcc
Q 042348 213 VDLTYNNLSGLIP 225 (686)
Q Consensus 213 l~l~~N~l~~~~p 225 (686)
++++|.+++..+
T Consensus 474 -~l~~N~~~c~c~ 485 (520)
T 2z7x_B 474 -WLHTNPWDCSCP 485 (520)
T ss_dssp -ECCSSCBCCCHH
T ss_pred -ECcCCCCcccCC
Confidence 999999998755
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.71 E-value=1.5e-17 Score=186.45 Aligned_cols=161 Identities=21% Similarity=0.246 Sum_probs=140.6
Q ss_pred CCCEEEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcc--cCCccccCCCCCcEEEccCCCCCCCCcc-cccCCCCCC
Q 042348 56 EGQVFSLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSG--SLPVELFNASNLQSLILSGNSFSGPVPM-QIGKLKYLQ 132 (686)
Q Consensus 56 ~~~~~~l~l~~n~l~g~~p~~l~~l~~L~~L~L~~N~l~g--~~p~~~~~l~~L~~L~L~~N~l~g~~p~-~~~~l~~L~ 132 (686)
...++.|+|++|.+++.+|..++.+++|+.|+|++|++++ .+|..+.++++|+.|+|++|++++.+|. .+..+++|+
T Consensus 352 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~ 431 (562)
T 3a79_B 352 PSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESIL 431 (562)
T ss_dssp CCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTCC
T ss_pred CCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCcccCC
Confidence 4679999999999999999999999999999999999996 3456789999999999999999985665 488999999
Q ss_pred EEeccCCCCCCCCChhhhhccccccccccccccCCCCchhhhhcCcccceecccccccCCCCchhhhccccccccccccc
Q 042348 133 VLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSGLIPNDIANLSRLRLLAQRVY 212 (686)
Q Consensus 133 ~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~~~~~ 212 (686)
.|+|++|++++.+|..+. ++|+.|+|++|+++ .+|..++ .+++|+.|+|++|+|++..+..+..+++|+.|
T Consensus 432 ~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~-~ip~~~~-~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L----- 502 (562)
T 3a79_B 432 VLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVT-HLQALQELNVASNQLKSVPDGVFDRLTSLQYI----- 502 (562)
T ss_dssp EEECCSSCCCGGGGSSCC--TTCSEEECCSSCCC-CCCTTTT-SSCCCSEEECCSSCCCCCCTTSTTTCTTCCCE-----
T ss_pred EEECCCCCCCcchhhhhc--CcCCEEECCCCcCc-ccChhhc-CCCCCCEEECCCCCCCCCCHHHHhcCCCCCEE-----
Confidence 999999999987776554 78999999999999 7998886 89999999999999996544447777777654
Q ss_pred ccccCCCCCCCccc
Q 042348 213 VDLTYNNLSGLIPQ 226 (686)
Q Consensus 213 l~l~~N~l~~~~p~ 226 (686)
++++|.+++..|.
T Consensus 503 -~l~~N~~~c~c~~ 515 (562)
T 3a79_B 503 -WLHDNPWDCTCPG 515 (562)
T ss_dssp -ECCSCCBCCCHHH
T ss_pred -EecCCCcCCCcch
Confidence 9999999987663
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.71 E-value=4.6e-17 Score=153.24 Aligned_cols=135 Identities=29% Similarity=0.369 Sum_probs=113.1
Q ss_pred cceeeeEecCCCEEEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCccccCCCCCcEEEccCCCCCCCCccccc
Q 042348 47 CSWNGITCREGQVFSLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIG 126 (686)
Q Consensus 47 c~w~gv~c~~~~~~~l~l~~n~l~g~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~ 126 (686)
|+|.+|.|. +|+++. +|..+ .++|+.|+|++|++++..+..|.++++|++|+|++|++++..+..|.
T Consensus 7 C~~~~l~~~----------~~~l~~-~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~ 73 (177)
T 2o6r_A 7 CSGTEIRCN----------SKGLTS-VPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFD 73 (177)
T ss_dssp EETTEEECC----------SSCCSS-CCTTC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTT
T ss_pred eCCCEEEec----------CCCCcc-CCCCC--CCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHcc
Confidence 678887775 455653 55444 36899999999999977777789999999999999999977777789
Q ss_pred CCCCCCEEeccCCCCCCCCChhhhhccccccccccccccCCCCchhhhhcCcccceecccccccCCCCc
Q 042348 127 KLKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSGLIP 195 (686)
Q Consensus 127 ~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p 195 (686)
.+++|+.|+|++|++++..+..+..+++|+.|+|++|++++ +|...+..+++|++|+|++|.+++..|
T Consensus 74 ~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~-~~~~~~~~l~~L~~L~l~~N~~~~~~~ 141 (177)
T 2o6r_A 74 KLTKLTILYLHENKLQSLPNGVFDKLTQLKELALDTNQLKS-VPDGIFDRLTSLQKIWLHTNPWDCSCP 141 (177)
T ss_dssp TCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSC-CCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred CCCccCEEECCCCCccccCHHHhhCCcccCEEECcCCcceE-eCHHHhcCCcccCEEEecCCCeeccCc
Confidence 99999999999999998777778899999999999999984 666655679999999999999998654
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.70 E-value=6.2e-17 Score=166.76 Aligned_cols=169 Identities=27% Similarity=0.375 Sum_probs=142.2
Q ss_pred CCEEEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCccccCCCCCcEEEccCCCCCCCCcccccCCCCCCEEec
Q 042348 57 GQVFSLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQVLDL 136 (686)
Q Consensus 57 ~~~~~l~l~~n~l~g~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l 136 (686)
.+++.|++++|.++. +| .+..+++|+.|+|++|.+++ +|. +.++++|++|+|++|++++ ++ .+..+++|+.|+|
T Consensus 41 ~~L~~L~l~~~~i~~-l~-~~~~l~~L~~L~L~~n~i~~-~~~-~~~l~~L~~L~L~~n~l~~-~~-~~~~l~~L~~L~l 114 (308)
T 1h6u_A 41 DGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITD-LAP-LKNLTKITELELSGNPLKN-VS-AIAGLQSIKTLDL 114 (308)
T ss_dssp HTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCC-CGG-GTTCCSCCEEECCSCCCSC-CG-GGTTCTTCCEEEC
T ss_pred CCcCEEEeeCCCccC-ch-hhhccCCCCEEEccCCcCCC-Chh-HccCCCCCEEEccCCcCCC-ch-hhcCCCCCCEEEC
Confidence 578999999999986 45 68999999999999999985 444 9999999999999999985 44 6999999999999
Q ss_pred cCCCCCCCCChhhhhccccccccccccccCCCCchhhhhcCcccceecccccccCCCCchhhhccccccccccccccccc
Q 042348 137 SQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSGLIPNDIANLSRLRLLAQRVYVDLT 216 (686)
Q Consensus 137 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~~~~~l~l~ 216 (686)
++|.+++ +|. +..+++|++|+|++|++++ ++. + ..+++|+.|+|++|++++..+ +..+++|+.| +++
T Consensus 115 ~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~-~~~-l-~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L------~l~ 181 (308)
T 1h6u_A 115 TSTQITD-VTP-LAGLSNLQVLYLDLNQITN-ISP-L-AGLTNLQYLSIGNAQVSDLTP--LANLSKLTTL------KAD 181 (308)
T ss_dssp TTSCCCC-CGG-GTTCTTCCEEECCSSCCCC-CGG-G-GGCTTCCEEECCSSCCCCCGG--GTTCTTCCEE------ECC
T ss_pred CCCCCCC-chh-hcCCCCCCEEECCCCccCc-Ccc-c-cCCCCccEEEccCCcCCCChh--hcCCCCCCEE------ECC
Confidence 9999996 554 8999999999999999995 444 4 589999999999999998644 7777766654 999
Q ss_pred CCCCCCCcccccccccCCcccccCCCCCC
Q 042348 217 YNNLSGLIPQNAALLSLGPTAFIGNPFLC 245 (686)
Q Consensus 217 ~N~l~~~~p~~~~~~~~~~~~~~~n~~~c 245 (686)
+|++++..+ ...+.++..+.+.+|....
T Consensus 182 ~n~l~~~~~-l~~l~~L~~L~L~~N~l~~ 209 (308)
T 1h6u_A 182 DNKISDISP-LASLPNLIEVHLKNNQISD 209 (308)
T ss_dssp SSCCCCCGG-GGGCTTCCEEECTTSCCCB
T ss_pred CCccCcChh-hcCCCCCCEEEccCCccCc
Confidence 999998765 4556667777788886543
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.70 E-value=3.3e-17 Score=178.48 Aligned_cols=178 Identities=21% Similarity=0.286 Sum_probs=137.8
Q ss_pred EecCCCEEEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCccccCCCCCcEEEccCCCCCCCCcccccCCCCCC
Q 042348 53 TCREGQVFSLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQ 132 (686)
Q Consensus 53 ~c~~~~~~~l~l~~n~l~g~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~ 132 (686)
.|.. ....++.++++|+. +|..+. ++|+.|+|++|+|++..|..|.++++|+.|+|++|++++..|..|.++++|+
T Consensus 51 ~C~~-~~~~v~c~~~~l~~-iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~ 126 (452)
T 3zyi_A 51 SCSN-QFSKVVCTRRGLSE-VPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLN 126 (452)
T ss_dssp EECS-SSCEEECCSSCCSS-CCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCC
T ss_pred EECC-CCcEEEECCCCcCc-cCCCCC--CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCC
Confidence 4753 34568889999984 777665 6899999999999998899999999999999999999988889999999999
Q ss_pred EEeccCCCCCCCCChhhhhccccccccccccccCCCCchhhhhcCcccceecccc-cccCCCCchhhhcccccccccccc
Q 042348 133 VLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSF-NNLSGLIPNDIANLSRLRLLAQRV 211 (686)
Q Consensus 133 ~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~l~~~~ 211 (686)
+|+|++|++++..+..+..+++|++|+|++|+++ .+|...+.++++|+.|+|++ |.+....+..+.++++|+.|
T Consensus 127 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L---- 201 (452)
T 3zyi_A 127 TLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYL---- 201 (452)
T ss_dssp EEECCSSCCSBCCTTTSSSCTTCCEEECCSCCCC-EECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEE----
T ss_pred EEECCCCcCCccChhhhcccCCCCEEECCCCCcc-eeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEE----
Confidence 9999999999777777999999999999999998 45555556888888888888 45554444457776666544
Q ss_pred cccccCCCCCCCcccccccccCCcccccCCC
Q 042348 212 YVDLTYNNLSGLIPQNAALLSLGPTAFIGNP 242 (686)
Q Consensus 212 ~l~l~~N~l~~~~p~~~~~~~~~~~~~~~n~ 242 (686)
+|++|++++. |....+.++..+.+.+|.
T Consensus 202 --~L~~n~l~~~-~~~~~l~~L~~L~Ls~N~ 229 (452)
T 3zyi_A 202 --NLGMCNIKDM-PNLTPLVGLEELEMSGNH 229 (452)
T ss_dssp --ECTTSCCSSC-CCCTTCTTCCEEECTTSC
T ss_pred --ECCCCccccc-ccccccccccEEECcCCc
Confidence 5666666543 333333344444444443
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.70 E-value=8.4e-18 Score=173.56 Aligned_cols=177 Identities=22% Similarity=0.230 Sum_probs=144.8
Q ss_pred CCCEEEEEeCCCCccccCC----cCcCCCCCCCEEEccCCCCcccCCccccCCCCCcEEEccCCCCCCC--Cc--ccccC
Q 042348 56 EGQVFSLIIPNKKLTGFIP----ADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGP--VP--MQIGK 127 (686)
Q Consensus 56 ~~~~~~l~l~~n~l~g~~p----~~l~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~--~p--~~~~~ 127 (686)
...++.|+|++|.+++..+ ..+..+++|++|+|++|++.+..|..+.++++|++|+|++|++.+. ++ ..++.
T Consensus 116 ~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~ 195 (310)
T 4glp_A 116 GLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHK 195 (310)
T ss_dssp CBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTS
T ss_pred CCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhc
Confidence 3578999999999998766 4566899999999999999988889999999999999999998753 32 33478
Q ss_pred CCCCCEEeccCCCCCCCCCh----hhhhccccccccccccccCCCCchhhhhcC---cccceecccccccCCCCchhhhc
Q 042348 128 LKYLQVLDLSQNSFSSSIPS----SIVQCKRLKTVVLNQNSFTGPLPDGFATNL---TALQKLDLSFNNLSGLIPNDIAN 200 (686)
Q Consensus 128 l~~L~~L~ls~N~l~~~~p~----~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l---~~L~~L~Ls~N~l~~~~p~~~~~ 200 (686)
+++|++|+|++|+++ .+|. .+..+++|++|+|++|++++.+|..+. .+ ++|++|+|++|+|+ .+|..+.
T Consensus 196 l~~L~~L~Ls~N~l~-~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~-~~~~~~~L~~L~Ls~N~l~-~lp~~~~- 271 (310)
T 4glp_A 196 FPAIQNLALRNTGME-TPTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAP-RCMWSSALNSLNLSFAGLE-QVPKGLP- 271 (310)
T ss_dssp SCCCCSCBCCSSCCC-CHHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCS-SCCCCTTCCCEECCSSCCC-SCCSCCC-
T ss_pred CCCCCEEECCCCCCC-chHHHHHHHHhcCCCCCEEECCCCCCCccchhhHH-hccCcCcCCEEECCCCCCC-chhhhhc-
Confidence 999999999999998 3444 357889999999999999987787664 44 79999999999999 5566553
Q ss_pred ccccccccccccccccCCCCCCCcccccccccCCcccccCCCCC
Q 042348 201 LSRLRLLAQRVYVDLTYNNLSGLIPQNAALLSLGPTAFIGNPFL 244 (686)
Q Consensus 201 l~~L~~l~~~~~l~l~~N~l~~~~p~~~~~~~~~~~~~~~n~~~ 244 (686)
++|+ .|||++|++++. |....+.++..+.+.+|++.
T Consensus 272 -~~L~------~L~Ls~N~l~~~-~~~~~l~~L~~L~L~~N~l~ 307 (310)
T 4glp_A 272 -AKLR------VLDLSSNRLNRA-PQPDELPEVDNLTLDGNPFL 307 (310)
T ss_dssp -SCCS------CEECCSCCCCSC-CCTTSCCCCSCEECSSTTTS
T ss_pred -CCCC------EEECCCCcCCCC-chhhhCCCccEEECcCCCCC
Confidence 4554 459999999985 33445567778888999874
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.70 E-value=5e-17 Score=151.58 Aligned_cols=132 Identities=21% Similarity=0.202 Sum_probs=79.1
Q ss_pred CCCCEEEccCCCCc-ccCCccccCCCCCcEEEccCCCCCCCCcccccCCCCCCEEeccCCCCCCCCChhhhhcccccccc
Q 042348 81 SAIGRVNLRNNNFS-GSLPVELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVV 159 (686)
Q Consensus 81 ~~L~~L~L~~N~l~-g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~ 159 (686)
++|+.|+|++|.++ +.+|..+..+++|+.|+|++|.+++. ..++.+++|++|+|++|.+++.+|..+..+++|++|+
T Consensus 24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 101 (168)
T 2ell_A 24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLN 101 (168)
T ss_dssp TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEE
T ss_pred ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEe
Confidence 55666666666665 55666566666666666666666643 5566666666666666666655666665666666666
Q ss_pred ccccccCCCCc--hhhhhcCcccceecccccccCCCCc---hhhhcccccccccccccccccCCCCCC
Q 042348 160 LNQNSFTGPLP--DGFATNLTALQKLDLSFNNLSGLIP---NDIANLSRLRLLAQRVYVDLTYNNLSG 222 (686)
Q Consensus 160 L~~N~l~~~~p--~~~~~~l~~L~~L~Ls~N~l~~~~p---~~~~~l~~L~~l~~~~~l~l~~N~l~~ 222 (686)
|++|++++ +| ..+ ..+++|++|+|++|.+++..+ ..+..+++|+.| |+++|.+..
T Consensus 102 Ls~N~l~~-~~~~~~l-~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L------~l~~n~~~~ 161 (168)
T 2ell_A 102 LSGNKLKD-ISTLEPL-KKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYL------DGYDREDQE 161 (168)
T ss_dssp CBSSSCCS-SGGGGGG-SSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEE------TTEETTSCB
T ss_pred ccCCccCc-chhHHHH-hcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEe------cCCCCChhh
Confidence 66666663 32 233 456666666666666665544 345555554433 666666554
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.69 E-value=3.5e-17 Score=177.64 Aligned_cols=157 Identities=24% Similarity=0.268 Sum_probs=106.9
Q ss_pred CCEEEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCccccCCCCCcEEEcc-----------------------
Q 042348 57 GQVFSLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILS----------------------- 113 (686)
Q Consensus 57 ~~~~~l~l~~n~l~g~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~----------------------- 113 (686)
..++.|+|++|+|++..+..|..+++|+.|+|++|.|++..+..|.++++|+.|+|+
T Consensus 112 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~ 191 (440)
T 3zyj_A 112 ANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLN 191 (440)
T ss_dssp SSCCEEECCSSCCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEE
T ss_pred ccCCEEECCCCcCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeec
Confidence 578889999999987777778888889999998888875555455555555555554
Q ss_pred --CCCCCCCCcccccCCCCCCEEeccCCCCCCCCChhhhhccccccccccccccCCCCchhhhhcCcccceecccccccC
Q 042348 114 --GNSFSGPVPMQIGKLKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLS 191 (686)
Q Consensus 114 --~N~l~g~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~ 191 (686)
+|+++ .+| .+..+++|+.|+|++|++++..|..+..+++|+.|+|++|++++..+..+ .++++|+.|||++|+|+
T Consensus 192 L~~n~l~-~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~-~~l~~L~~L~L~~N~l~ 268 (440)
T 3zyj_A 192 LAMCNLR-EIP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAF-DNLQSLVEINLAHNNLT 268 (440)
T ss_dssp CTTSCCS-SCC-CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSS-TTCTTCCEEECTTSCCC
T ss_pred CCCCcCc-ccc-ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhh-cCCCCCCEEECCCCCCC
Confidence 44444 333 24555666666666666666556666667777777777777765444443 46777777777777777
Q ss_pred CCCchhhhcccccccccccccccccCCCCCC
Q 042348 192 GLIPNDIANLSRLRLLAQRVYVDLTYNNLSG 222 (686)
Q Consensus 192 ~~~p~~~~~l~~L~~l~~~~~l~l~~N~l~~ 222 (686)
+..+..+..+++|+. |+|++|.+.-
T Consensus 269 ~~~~~~~~~l~~L~~------L~L~~Np~~C 293 (440)
T 3zyj_A 269 LLPHDLFTPLHHLER------IHLHHNPWNC 293 (440)
T ss_dssp CCCTTTTSSCTTCCE------EECCSSCEEC
T ss_pred ccChhHhccccCCCE------EEcCCCCccC
Confidence 766666666666554 5999998864
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.69 E-value=3.5e-18 Score=187.50 Aligned_cols=174 Identities=20% Similarity=0.206 Sum_probs=147.9
Q ss_pred CCCEEEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCccccCCCCCcEEEccCCCCCCCCcccccCCCCCCEEe
Q 042348 56 EGQVFSLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQVLD 135 (686)
Q Consensus 56 ~~~~~~l~l~~n~l~g~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ 135 (686)
...++.|+|++|.|++..+ .++|+.|+|++|.|++..+. .+++|+.|+|++|.+++..|..++.+++|+.|+
T Consensus 79 l~~L~~L~Ls~N~l~~l~~-----~~~L~~L~L~~N~l~~~~~~---~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 150 (487)
T 3oja_A 79 LSTLRTLDLNNNYVQELLV-----GPSIETLHAANNNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLD 150 (487)
T ss_dssp CTTCCEEECCSSEEEEEEE-----CTTCCEEECCSSCCCCEEEC---CCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEE
T ss_pred CCCCCEEEecCCcCCCCCC-----CCCcCEEECcCCcCCCCCcc---ccCCCCEEECCCCCCCCCCchhhcCCCCCCEEE
Confidence 4689999999999997543 38999999999999976654 468899999999999998899999999999999
Q ss_pred ccCCCCCCCCChhhh-hccccccccccccccCCCCchhhhhcCcccceecccccccCCCCchhhhccccccccccccccc
Q 042348 136 LSQNSFSSSIPSSIV-QCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSGLIPNDIANLSRLRLLAQRVYVD 214 (686)
Q Consensus 136 ls~N~l~~~~p~~~~-~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~~~~~l~ 214 (686)
|++|.+++.+|..+. .+++|+.|+|++|.|++. |... .+++|+.|+|++|.|++.+|. +..+++|+.| |
T Consensus 151 Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~-~~~~--~l~~L~~L~Ls~N~l~~~~~~-~~~l~~L~~L------~ 220 (487)
T 3oja_A 151 LKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-KGQV--VFAKLKTLDLSSNKLAFMGPE-FQSAAGVTWI------S 220 (487)
T ss_dssp CTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-ECCC--CCTTCCEEECCSSCCCEECGG-GGGGTTCSEE------E
T ss_pred CCCCCCCCcChHHHhhhCCcccEEecCCCccccc-cccc--cCCCCCEEECCCCCCCCCCHh-HcCCCCccEE------E
Confidence 999999998888886 799999999999999964 4432 689999999999999986554 7777777655 9
Q ss_pred ccCCCCCCCcccccccccCCcccccCCCCCCCC
Q 042348 215 LTYNNLSGLIPQNAALLSLGPTAFIGNPFLCGP 247 (686)
Q Consensus 215 l~~N~l~~~~p~~~~~~~~~~~~~~~n~~~c~~ 247 (686)
|++|+|++.++....+.++..+.+.+|++.|+.
T Consensus 221 Ls~N~l~~lp~~l~~l~~L~~L~l~~N~l~c~~ 253 (487)
T 3oja_A 221 LRNNKLVLIEKALRFSQNLEHFDLRGNGFHCGT 253 (487)
T ss_dssp CTTSCCCEECTTCCCCTTCCEEECTTCCBCHHH
T ss_pred ecCCcCcccchhhccCCCCCEEEcCCCCCcCcc
Confidence 999999986555445667788889999999864
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.69 E-value=3.2e-17 Score=183.30 Aligned_cols=164 Identities=27% Similarity=0.249 Sum_probs=141.6
Q ss_pred EecCCCEEEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCccccCCCCCcEEEccCCCCCCCCcccccCCCCCC
Q 042348 53 TCREGQVFSLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQ 132 (686)
Q Consensus 53 ~c~~~~~~~l~l~~n~l~g~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~ 132 (686)
.|....+ .++++|+++ .+|..+. ++|++|+|++|++++..|..|.++++|++|+|++|++++..|..|+.+++|+
T Consensus 3 ~C~~~~~--c~~~~~~l~-~ip~~~~--~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~ 77 (549)
T 2z81_A 3 SCDASGV--CDGRSRSFT-SIPSGLT--AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLE 77 (549)
T ss_dssp EECTTSE--EECTTSCCS-SCCSCCC--TTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCC
T ss_pred cCCCCce--EECCCCccc-cccccCC--CCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCC
Confidence 5765555 789999999 5777665 7999999999999988899999999999999999999988889999999999
Q ss_pred EEeccCCCCCCCCChhhhhccccccccccccccCC-CCchhhhhcCcccceecccccccCCCC-chhhhccccccccccc
Q 042348 133 VLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTG-PLPDGFATNLTALQKLDLSFNNLSGLI-PNDIANLSRLRLLAQR 210 (686)
Q Consensus 133 ~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~l~~~ 210 (686)
+|+|++|.+++..|..+..+++|++|+|++|++++ .+|..+ .++++|++|+|++|++.+.+ +..+.++++|+.|
T Consensus 78 ~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~-~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L--- 153 (549)
T 2z81_A 78 HLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLF-PNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNEL--- 153 (549)
T ss_dssp EEECTTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSC-TTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEE---
T ss_pred EEECCCCccCccCHHHhccCCCCcEEECCCCcccccchhhhh-hccCCccEEECCCCccccccCHhhhhcccccCee---
Confidence 99999999998777789999999999999999986 345555 58999999999999955444 4678888887765
Q ss_pred ccccccCCCCCCCccccc
Q 042348 211 VYVDLTYNNLSGLIPQNA 228 (686)
Q Consensus 211 ~~l~l~~N~l~~~~p~~~ 228 (686)
++++|++++.+|...
T Consensus 154 ---~L~~n~l~~~~~~~l 168 (549)
T 2z81_A 154 ---EIKALSLRNYQSQSL 168 (549)
T ss_dssp ---EEEETTCCEECTTTT
T ss_pred ---eccCCcccccChhhh
Confidence 899999998777553
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.69 E-value=4.2e-17 Score=152.09 Aligned_cols=134 Identities=25% Similarity=0.190 Sum_probs=120.2
Q ss_pred CCEEEEEeCCCCcc-ccCCcCcCCCCCCCEEEccCCCCcccCCccccCCCCCcEEEccCCCCCCCCcccccCCCCCCEEe
Q 042348 57 GQVFSLIIPNKKLT-GFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQVLD 135 (686)
Q Consensus 57 ~~~~~l~l~~n~l~-g~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ 135 (686)
..++.|+|++|+++ +.+|..+..+++|+.|+|++|.|++. ..+..+++|++|+|++|++++.+|..+..+++|++|+
T Consensus 24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 101 (168)
T 2ell_A 24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLN 101 (168)
T ss_dssp TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEE
T ss_pred ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEe
Confidence 57899999999999 88999999999999999999999965 7899999999999999999988898888899999999
Q ss_pred ccCCCCCCCC-ChhhhhccccccccccccccCCCCch---hhhhcCcccceecccccccCCC
Q 042348 136 LSQNSFSSSI-PSSIVQCKRLKTVVLNQNSFTGPLPD---GFATNLTALQKLDLSFNNLSGL 193 (686)
Q Consensus 136 ls~N~l~~~~-p~~~~~l~~L~~L~L~~N~l~~~~p~---~~~~~l~~L~~L~Ls~N~l~~~ 193 (686)
|++|.+++.. +..+..+++|+.|+|++|++++ +|. ..+..+++|++||+++|.+...
T Consensus 102 Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~-~~~~~~~~~~~l~~L~~L~l~~n~~~~~ 162 (168)
T 2ell_A 102 LSGNKLKDISTLEPLKKLECLKSLDLFNCEVTN-LNDYRESVFKLLPQLTYLDGYDREDQEA 162 (168)
T ss_dssp CBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGT-STTHHHHHHTTCSSCCEETTEETTSCBC
T ss_pred ccCCccCcchhHHHHhcCCCCCEEEeeCCcCcc-hHHHHHHHHHhCccCcEecCCCCChhhc
Confidence 9999999642 2788999999999999999996 444 3446899999999999999854
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.68 E-value=6.6e-17 Score=181.02 Aligned_cols=125 Identities=30% Similarity=0.421 Sum_probs=60.8
Q ss_pred CCEEEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCccccCCCCCcEEEccCCCCCCCCcccccCCCCCCEEec
Q 042348 57 GQVFSLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQVLDL 136 (686)
Q Consensus 57 ~~~~~l~l~~n~l~g~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l 136 (686)
..++.|+|++|+|++..| +..|++|+.|+|++|+|++ +| .+.++++|+.|+|++|.|++ + +.+..|++|+.|+|
T Consensus 65 ~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~-l~-~l~~l~~L~~L~Ls~N~l~~-l-~~l~~l~~L~~L~L 138 (605)
T 1m9s_A 65 PNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIKD-LS-SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYL 138 (605)
T ss_dssp TTCCEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCC-CT-TSTTCTTCCEEECTTSCCCC-C-GGGGGCTTCSEEEC
T ss_pred CCCCEEEeeCCCCCCChh--hccCCCCCEEECcCCCCCC-Ch-hhccCCCCCEEEecCCCCCC-C-ccccCCCccCEEEC
Confidence 344555555555554333 4555555555555555542 22 34555555555555555543 2 23445555555555
Q ss_pred cCCCCCCCCChhhhhccccccccccccccCCCCchhhhhcCcccceecccccccCC
Q 042348 137 SQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSG 192 (686)
Q Consensus 137 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~ 192 (686)
++|.+++. ..+..+++|+.|+|++|+|++..| + ..+++|+.|+|++|+|++
T Consensus 139 s~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~--l-~~l~~L~~L~Ls~N~i~~ 189 (605)
T 1m9s_A 139 GNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--L-AGLTKLQNLYLSKNHISD 189 (605)
T ss_dssp CSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGG--G-TTCTTCCEEECCSSCCCB
T ss_pred CCCccCCc--hhhcccCCCCEEECcCCcCCCchh--h-ccCCCCCEEECcCCCCCC
Confidence 55555532 344455555555555555553322 2 345555555555555554
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.67 E-value=8.7e-17 Score=168.89 Aligned_cols=171 Identities=20% Similarity=0.225 Sum_probs=118.4
Q ss_pred cceeeeEecC-----------CCEEEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCc-cccCCCCCcE-EEcc
Q 042348 47 CSWNGITCRE-----------GQVFSLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPV-ELFNASNLQS-LILS 113 (686)
Q Consensus 47 c~w~gv~c~~-----------~~~~~l~l~~n~l~g~~p~~l~~l~~L~~L~L~~N~l~g~~p~-~~~~l~~L~~-L~L~ 113 (686)
|+|..|.|+. ..++.|+|++|+|+...+..|.+|++|++|+|++|++.+.+|. .|.++++|+. +.++
T Consensus 9 C~~~~v~C~~~~Lt~iP~~l~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~ 88 (350)
T 4ay9_X 9 CSNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 88 (350)
T ss_dssp EETTEEEEESTTCCSCCTTCCTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEE
T ss_pred eeCCEEEecCCCCCccCcCcCCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhccc
Confidence 6899999973 3578999999999976667899999999999999999777764 5788988765 6778
Q ss_pred CCCCCCCCcccccCCCCCCEEeccCCCCCCCCChhhhhcccccc--------------------------ccccccccCC
Q 042348 114 GNSFSGPVPMQIGKLKYLQVLDLSQNSFSSSIPSSIVQCKRLKT--------------------------VVLNQNSFTG 167 (686)
Q Consensus 114 ~N~l~g~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~--------------------------L~L~~N~l~~ 167 (686)
+|+++...|..|..+++|++|++++|++++..+..+....++.. |+|++|+|+
T Consensus 89 ~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~- 167 (350)
T 4ay9_X 89 ANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ- 167 (350)
T ss_dssp ETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCC-
T ss_pred CCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhcccccccc-
Confidence 89999777889999999999999999998665544444444444 445555554
Q ss_pred CCchhhhhcCcccceecccc-cccCCCCchhhhcccccccccccccccccCCCCCCCcc
Q 042348 168 PLPDGFATNLTALQKLDLSF-NNLSGLIPNDIANLSRLRLLAQRVYVDLTYNNLSGLIP 225 (686)
Q Consensus 168 ~~p~~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~l~~~~~l~l~~N~l~~~~p 225 (686)
.+|...+ ...+|+.|++++ |.++.+.++.|.++++|+.| ||++|+|+..++
T Consensus 168 ~i~~~~f-~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~L------dLs~N~l~~lp~ 219 (350)
T 4ay9_X 168 EIHNSAF-NGTQLDELNLSDNNNLEELPNDVFHGASGPVIL------DISRTRIHSLPS 219 (350)
T ss_dssp EECTTSS-TTEEEEEEECTTCTTCCCCCTTTTTTEECCSEE------ECTTSCCCCCCS
T ss_pred CCChhhc-cccchhHHhhccCCcccCCCHHHhccCcccchh------hcCCCCcCccCh
Confidence 2333332 334455555543 33433333344444444433 666666665444
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.67 E-value=6.1e-17 Score=147.74 Aligned_cols=124 Identities=23% Similarity=0.251 Sum_probs=70.3
Q ss_pred CCCCEEEccCCCCc-ccCCccccCCCCCcEEEccCCCCCCCCcccccCCCCCCEEeccCCCCCCCCChhhhhcccccccc
Q 042348 81 SAIGRVNLRNNNFS-GSLPVELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVV 159 (686)
Q Consensus 81 ~~L~~L~L~~N~l~-g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~ 159 (686)
++|+.|++++|.++ +.+|..+..+++|+.|+|++|.+++. ..++.+++|++|+|++|.+++.+|..+..+++|++|+
T Consensus 17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ 94 (149)
T 2je0_A 17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLN 94 (149)
T ss_dssp GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEE
T ss_pred ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEE
Confidence 44555666666665 55555555666666666666666543 4555566666666666666655555555566666666
Q ss_pred ccccccCCC-CchhhhhcCcccceecccccccCCCCc---hhhhcccccccc
Q 042348 160 LNQNSFTGP-LPDGFATNLTALQKLDLSFNNLSGLIP---NDIANLSRLRLL 207 (686)
Q Consensus 160 L~~N~l~~~-~p~~~~~~l~~L~~L~Ls~N~l~~~~p---~~~~~l~~L~~l 207 (686)
|++|++++. .+..+ ..+++|++|+|++|.+++..+ ..+..+++|+.|
T Consensus 95 ls~N~i~~~~~~~~~-~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L 145 (149)
T 2je0_A 95 LSGNKIKDLSTIEPL-KKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYL 145 (149)
T ss_dssp CTTSCCCSHHHHGGG-GGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEE
T ss_pred CCCCcCCChHHHHHH-hhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccc
Confidence 666666531 11333 356666666666666665544 345555555443
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.67 E-value=1.8e-16 Score=166.27 Aligned_cols=168 Identities=22% Similarity=0.332 Sum_probs=81.3
Q ss_pred CEEEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCc---------------------cccCCCCCcEEEccCCC
Q 042348 58 QVFSLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPV---------------------ELFNASNLQSLILSGNS 116 (686)
Q Consensus 58 ~~~~l~l~~n~l~g~~p~~l~~l~~L~~L~L~~N~l~g~~p~---------------------~~~~l~~L~~L~L~~N~ 116 (686)
.++.|++++|.+.+..+ +..+++|+.|++++|.+.+ ++. .+..+++|+.|+|++|.
T Consensus 156 ~L~~L~l~~~~~~~~~~--~~~l~~L~~L~l~~n~l~~-~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~L~~L~l~~n~ 232 (347)
T 4fmz_A 156 GLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIED-ISPLASLTSLHYFTAYVNQITDITPVANMTRLNSLKIGNNK 232 (347)
T ss_dssp TCCEEECCSSCCCCCGG--GGGCTTCSEEECTTSCCCC-CGGGGGCTTCCEEECCSSCCCCCGGGGGCTTCCEEECCSSC
T ss_pred CCcEEEecCCCcCCchh--hccCCCCCEEEccCCcccc-cccccCCCccceeecccCCCCCCchhhcCCcCCEEEccCCc
Confidence 45555555555554332 5555555555555555542 222 04444555555555555
Q ss_pred CCCCCcccccCCCCCCEEeccCCCCCCCCChhhhhccccccccccccccCCCCchhhhhcCcccceecccccccCCCCch
Q 042348 117 FSGPVPMQIGKLKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSGLIPN 196 (686)
Q Consensus 117 l~g~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~ 196 (686)
+++. +. +..+++|+.|++++|.+++ + ..+..+++|+.|+|++|++++ ++ .+ ..+++|+.|+|++|++++..|.
T Consensus 233 l~~~-~~-~~~l~~L~~L~l~~n~l~~-~-~~~~~l~~L~~L~l~~n~l~~-~~-~~-~~l~~L~~L~L~~n~l~~~~~~ 305 (347)
T 4fmz_A 233 ITDL-SP-LANLSQLTWLEIGTNQISD-I-NAVKDLTKLKMLNVGSNQISD-IS-VL-NNLSQLNSLFLNNNQLGNEDME 305 (347)
T ss_dssp CCCC-GG-GTTCTTCCEEECCSSCCCC-C-GGGTTCTTCCEEECCSSCCCC-CG-GG-GGCTTCSEEECCSSCCCGGGHH
T ss_pred cCCC-cc-hhcCCCCCEEECCCCccCC-C-hhHhcCCCcCEEEccCCccCC-Ch-hh-cCCCCCCEEECcCCcCCCcChh
Confidence 5422 22 4555555555555555543 2 234455555555555555553 22 12 3455555555555555555555
Q ss_pred hhhcccccccccccccccccCCCCCCCcccccccccCCcccccCCC
Q 042348 197 DIANLSRLRLLAQRVYVDLTYNNLSGLIPQNAALLSLGPTAFIGNP 242 (686)
Q Consensus 197 ~~~~l~~L~~l~~~~~l~l~~N~l~~~~p~~~~~~~~~~~~~~~n~ 242 (686)
.+..+++|+.| ++++|++++.+| ...+.++..+.+.+|+
T Consensus 306 ~l~~l~~L~~L------~L~~n~l~~~~~-~~~l~~L~~L~l~~N~ 344 (347)
T 4fmz_A 306 VIGGLTNLTTL------FLSQNHITDIRP-LASLSKMDSADFANQV 344 (347)
T ss_dssp HHHTCTTCSEE------ECCSSSCCCCGG-GGGCTTCSEESSSCC-
T ss_pred HhhccccCCEE------EccCCccccccC-hhhhhccceeehhhhc
Confidence 55555444433 555555555544 3334444444444443
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.67 E-value=1e-16 Score=146.23 Aligned_cols=129 Identities=21% Similarity=0.183 Sum_probs=115.1
Q ss_pred CCEEEEEeCCCCcc-ccCCcCcCCCCCCCEEEccCCCCcccCCccccCCCCCcEEEccCCCCCCCCcccccCCCCCCEEe
Q 042348 57 GQVFSLIIPNKKLT-GFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQVLD 135 (686)
Q Consensus 57 ~~~~~l~l~~n~l~-g~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ 135 (686)
.+++.|++++|.++ +.+|..+..+++|+.|+|++|.+++. ..+.++++|++|+|++|.+++.+|..++.+++|++|+
T Consensus 17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ 94 (149)
T 2je0_A 17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLN 94 (149)
T ss_dssp GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEE
T ss_pred ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEE
Confidence 56889999999999 88999999999999999999999965 7889999999999999999988999888999999999
Q ss_pred ccCCCCCCC-CChhhhhccccccccccccccCCCCc--hhhhhcCcccceecccc
Q 042348 136 LSQNSFSSS-IPSSIVQCKRLKTVVLNQNSFTGPLP--DGFATNLTALQKLDLSF 187 (686)
Q Consensus 136 ls~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~p--~~~~~~l~~L~~L~Ls~ 187 (686)
+++|.+++. .|..+..+++|++|+|++|++++..+ ...+..+++|+.||+++
T Consensus 95 ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~d 149 (149)
T 2je0_A 95 LSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGYD 149 (149)
T ss_dssp CTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTBC
T ss_pred CCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCCC
Confidence 999999963 34789999999999999999996444 14446899999999974
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.67 E-value=1.9e-16 Score=151.18 Aligned_cols=127 Identities=27% Similarity=0.347 Sum_probs=109.7
Q ss_pred EEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCccccCCCCCcEEEccCCCCCCCCcccccCCCCCCEEeccCCC
Q 042348 61 SLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQVLDLSQNS 140 (686)
Q Consensus 61 ~l~l~~n~l~g~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~ 140 (686)
.+++++|+|+ .+|..+. ++|+.|+|++|+|+ .+|..|.++++|+.|+|++|+|++..+..|..+++|+.|+|++|+
T Consensus 14 ~l~~~~~~l~-~ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~ 89 (193)
T 2wfh_A 14 VVRCSNKGLK-VLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNR 89 (193)
T ss_dssp EEECTTSCCS-SCCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred EEEcCCCCCC-cCCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCc
Confidence 4666788887 4676654 68999999999998 788899999999999999999998888889999999999999999
Q ss_pred CCCCCChhhhhccccccccccccccCCCCchhhhhcCcccceecccccccCC
Q 042348 141 FSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSG 192 (686)
Q Consensus 141 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~ 192 (686)
+++..|..|..+++|+.|+|++|+|+ .+|...+..+++|+.|+|++|.+..
T Consensus 90 l~~i~~~~f~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~L~~N~~~C 140 (193)
T 2wfh_A 90 LRCIPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSALSHLAIGANPLYC 140 (193)
T ss_dssp CCBCCTTTTTTCTTCCEEECCSSCCC-BCCTTTTTTCTTCCEEECCSSCEEC
T ss_pred cCEeCHHHhCCCCCCCEEECCCCCCC-eeChhhhhcCccccEEEeCCCCeec
Confidence 99888888999999999999999998 4666555688999999999998875
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.67 E-value=1.7e-16 Score=161.96 Aligned_cols=150 Identities=28% Similarity=0.350 Sum_probs=128.7
Q ss_pred CCCEEEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCccccCCCCCcEEEccCCCCCCCCcccccCCCCCCEEe
Q 042348 56 EGQVFSLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQVLD 135 (686)
Q Consensus 56 ~~~~~~l~l~~n~l~g~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ 135 (686)
..+++.|+|++|++++..+ +..+++|+.|+|++|++++ +| .+.++++|+.|+|++|++++ + ..+..+++|+.|+
T Consensus 67 l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~-~~-~l~~l~~L~~L~L~~n~i~~-~-~~l~~l~~L~~L~ 140 (291)
T 1h6t_A 67 LPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLY 140 (291)
T ss_dssp CTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEECTTSCCCC-C-GGGGGCTTCCEEE
T ss_pred CCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCC-Ch-hhccCCCCCEEECCCCcCCC-C-hhhcCCCCCCEEE
Confidence 3689999999999998655 9999999999999999985 44 48999999999999999986 4 4689999999999
Q ss_pred ccCCCCCCCCChhhhhccccccccccccccCCCCchhhhhcCcccceecccccccCCCCchhhhcccccccccccccccc
Q 042348 136 LSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSGLIPNDIANLSRLRLLAQRVYVDL 215 (686)
Q Consensus 136 ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~~~~~l~l 215 (686)
|++|.+++. ..+..+++|+.|+|++|++++. +. + ..+++|+.|+|++|.+++. | .+..+++|+ .|++
T Consensus 141 l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~-~~-l-~~l~~L~~L~L~~N~i~~l-~-~l~~l~~L~------~L~l 207 (291)
T 1h6t_A 141 LGNNKITDI--TVLSRLTKLDTLSLEDNQISDI-VP-L-AGLTKLQNLYLSKNHISDL-R-ALAGLKNLD------VLEL 207 (291)
T ss_dssp CCSSCCCCC--GGGGGCTTCSEEECCSSCCCCC-GG-G-TTCTTCCEEECCSSCCCBC-G-GGTTCTTCS------EEEE
T ss_pred ccCCcCCcc--hhhccCCCCCEEEccCCccccc-hh-h-cCCCccCEEECCCCcCCCC-h-hhccCCCCC------EEEC
Confidence 999999964 6789999999999999999964 44 4 5899999999999999974 4 366666665 4599
Q ss_pred cCCCCCCCc
Q 042348 216 TYNNLSGLI 224 (686)
Q Consensus 216 ~~N~l~~~~ 224 (686)
++|+++...
T Consensus 208 ~~n~i~~~~ 216 (291)
T 1h6t_A 208 FSQECLNKP 216 (291)
T ss_dssp EEEEEECCC
T ss_pred cCCcccCCc
Confidence 999998643
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=99.66 E-value=2.2e-16 Score=172.74 Aligned_cols=136 Identities=30% Similarity=0.480 Sum_probs=77.7
Q ss_pred CCEEEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCccccCCCCCcEEEccCCCCCCCCcccccCCCCCCEEec
Q 042348 57 GQVFSLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQVLDL 136 (686)
Q Consensus 57 ~~~~~l~l~~n~l~g~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l 136 (686)
..++.|++++|.+++..| ++.+++|+.|+|++|++++ + ..+..+++|+.|+|++|.+++..| +..+++|+.|++
T Consensus 199 ~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l 272 (466)
T 1o6v_A 199 TNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD-I-GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKL 272 (466)
T ss_dssp TTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCC-C-GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEEC
T ss_pred CCCCEEEecCCccccccc--ccccCCCCEEECCCCCccc-c-hhhhcCCCCCEEECCCCccccchh--hhcCCCCCEEEC
Confidence 456667777777666544 5556666666666666653 2 245566666666666666664433 556666666666
Q ss_pred cCCCCCCCCChhhhhccccccccccccccCCCCchhhhhcCcccceecccccccCCCCchhhhcccccc
Q 042348 137 SQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSGLIPNDIANLSRLR 205 (686)
Q Consensus 137 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 205 (686)
++|.+++..| +..+++|+.|+|++|++++. +. + ..+++|+.|+|++|++++..| +..+++|+
T Consensus 273 ~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~-~~-~-~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~ 334 (466)
T 1o6v_A 273 GANQISNISP--LAGLTALTNLELNENQLEDI-SP-I-SNLKNLTYLTLYFNNISDISP--VSSLTKLQ 334 (466)
T ss_dssp CSSCCCCCGG--GTTCTTCSEEECCSSCCSCC-GG-G-GGCTTCSEEECCSSCCSCCGG--GGGCTTCC
T ss_pred CCCccCcccc--ccCCCccCeEEcCCCcccCc-hh-h-cCCCCCCEEECcCCcCCCchh--hccCccCC
Confidence 6666664322 55566666666666666542 22 2 355666666666666665544 34444443
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.66 E-value=1.2e-16 Score=153.28 Aligned_cols=154 Identities=15% Similarity=0.215 Sum_probs=128.2
Q ss_pred cCCCCCCCEEEccCCCCcccCCccccCCCCCcEEEccCCCCCCCCcccccCCCCCCEEeccCCCCCCCCChhhhhccccc
Q 042348 77 LGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQVLDLSQNSFSSSIPSSIVQCKRLK 156 (686)
Q Consensus 77 l~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~ 156 (686)
.+.+++|+.|++++|.++ .+| .+..+++|++|+|++|.++ . +..+..+++|++|++++|.+++..|..+..+++|+
T Consensus 40 ~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~-~-~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~ 115 (197)
T 4ezg_A 40 EAQMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHAT-N-YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLT 115 (197)
T ss_dssp HHHHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCS-C-CGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCC
T ss_pred hhhcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCC-c-chhhhcCCCCCEEEeECCccCcccChhhcCCCCCC
Confidence 367789999999999998 777 6899999999999999876 3 34799999999999999999988889999999999
Q ss_pred cccccccccCCCCchhhhhcCcccceecccccccCCCCchhhhcccccccccccccccccCCCCCCCcccccccccCCcc
Q 042348 157 TVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSGLIPNDIANLSRLRLLAQRVYVDLTYNNLSGLIPQNAALLSLGPT 236 (686)
Q Consensus 157 ~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~~~~~l~l~~N~l~~~~p~~~~~~~~~~~ 236 (686)
+|+|++|++++..|..+ ..+++|++|+|++|.+.+.+| .+..+++|+.| ++++|++++.. ....+.++..+
T Consensus 116 ~L~Ls~n~i~~~~~~~l-~~l~~L~~L~L~~n~~i~~~~-~l~~l~~L~~L------~l~~n~i~~~~-~l~~l~~L~~L 186 (197)
T 4ezg_A 116 LLDISHSAHDDSILTKI-NTLPKVNSIDLSYNGAITDIM-PLKTLPELKSL------NIQFDGVHDYR-GIEDFPKLNQL 186 (197)
T ss_dssp EEECCSSBCBGGGHHHH-TTCSSCCEEECCSCTBCCCCG-GGGGCSSCCEE------ECTTBCCCCCT-TGGGCSSCCEE
T ss_pred EEEecCCccCcHhHHHH-hhCCCCCEEEccCCCCccccH-hhcCCCCCCEE------ECCCCCCcChH-HhccCCCCCEE
Confidence 99999999997777777 589999999999998333455 57777766654 99999999853 45556677777
Q ss_pred cccCCCC
Q 042348 237 AFIGNPF 243 (686)
Q Consensus 237 ~~~~n~~ 243 (686)
.+.+|+.
T Consensus 187 ~l~~N~i 193 (197)
T 4ezg_A 187 YAFSQTI 193 (197)
T ss_dssp EECBC--
T ss_pred EeeCccc
Confidence 7888864
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.66 E-value=7.7e-17 Score=161.93 Aligned_cols=147 Identities=18% Similarity=0.268 Sum_probs=107.9
Q ss_pred CCEEEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCccccCCCCCcEEEccCCCCCCCCcccccCCCCCCEEec
Q 042348 57 GQVFSLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQVLDL 136 (686)
Q Consensus 57 ~~~~~l~l~~n~l~g~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l 136 (686)
.+++.|++++|+++. +| .+..+++|+.|+|++|+|++. |. +.++++|+.|+|++|++++ +|... . ++|+.|+|
T Consensus 41 ~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~L~~N~i~~~-~~-l~~l~~L~~L~L~~N~l~~-l~~~~-~-~~L~~L~L 113 (263)
T 1xeu_A 41 SGVQNFNGDNSNIQS-LA-GMQFFTNLKELHLSHNQISDL-SP-LKDLTKLEELSVNRNRLKN-LNGIP-S-ACLSRLFL 113 (263)
T ss_dssp TTCSEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCC-GG-GTTCSSCCEEECCSSCCSC-CTTCC-C-SSCCEEEC
T ss_pred CcCcEEECcCCCccc-ch-HHhhCCCCCEEECCCCccCCC-hh-hccCCCCCEEECCCCccCC-cCccc-c-CcccEEEc
Confidence 567788888888875 44 677888888888888888754 33 7888888888888888874 44332 2 78888888
Q ss_pred cCCCCCCCCChhhhhccccccccccccccCCCCchhhhhcCcccceecccccccCCCCchhhhccccccccccccccccc
Q 042348 137 SQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSGLIPNDIANLSRLRLLAQRVYVDLT 216 (686)
Q Consensus 137 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~~~~~l~l~ 216 (686)
++|.+++ +| .+..+++|+.|+|++|++++ ++ .+ ..+++|+.|+|++|++++. ..+..+++|+ .|+++
T Consensus 114 ~~N~l~~-~~-~l~~l~~L~~L~Ls~N~i~~-~~-~l-~~l~~L~~L~L~~N~i~~~--~~l~~l~~L~------~L~l~ 180 (263)
T 1xeu_A 114 DNNELRD-TD-SLIHLKNLEILSIRNNKLKS-IV-ML-GFLSKLEVLDLHGNEITNT--GGLTRLKKVN------WIDLT 180 (263)
T ss_dssp CSSCCSB-SG-GGTTCTTCCEEECTTSCCCB-CG-GG-GGCTTCCEEECTTSCCCBC--TTSTTCCCCC------EEEEE
T ss_pred cCCccCC-Ch-hhcCcccccEEECCCCcCCC-Ch-HH-ccCCCCCEEECCCCcCcch--HHhccCCCCC------EEeCC
Confidence 8888875 33 57788888888888888874 44 33 4788888888888888876 4455555554 44888
Q ss_pred CCCCCCC
Q 042348 217 YNNLSGL 223 (686)
Q Consensus 217 ~N~l~~~ 223 (686)
+|.+++.
T Consensus 181 ~N~~~~~ 187 (263)
T 1xeu_A 181 GQKCVNE 187 (263)
T ss_dssp EEEEECC
T ss_pred CCcccCC
Confidence 8887765
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.66 E-value=2e-17 Score=171.33 Aligned_cols=170 Identities=22% Similarity=0.213 Sum_probs=141.0
Q ss_pred CCEEEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCccccCCCCCcEEEccCCCCCCCCcccccCCCCCCEEec
Q 042348 57 GQVFSLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQVLDL 136 (686)
Q Consensus 57 ~~~~~l~l~~n~l~g~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l 136 (686)
.+++.|+|++|++++..|..|..+++|+.|+|++|++++..| +..+++|++|+|++|++++ +| .+++|++|++
T Consensus 34 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~n~l~~-l~----~~~~L~~L~l 106 (317)
T 3o53_A 34 WNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQE-LL----VGPSIETLHA 106 (317)
T ss_dssp GGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEECCSSEEEE-EE----ECTTCCEEEC
T ss_pred CCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEECcCCcccc-cc----CCCCcCEEEC
Confidence 478999999999999888899999999999999999987655 8999999999999999984 33 3489999999
Q ss_pred cCCCCCCCCChhhhhccccccccccccccCCCCchhhhhcCcccceecccccccCCCCchhhh-cccccccccccccccc
Q 042348 137 SQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSGLIPNDIA-NLSRLRLLAQRVYVDL 215 (686)
Q Consensus 137 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~l~~~~~l~l 215 (686)
++|++++..+. .+++|+.|+|++|++++..|..+ ..+++|++|+|++|.+++..|..+. .+++|+.| ++
T Consensus 107 ~~n~l~~~~~~---~~~~L~~L~l~~N~l~~~~~~~~-~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L------~L 176 (317)
T 3o53_A 107 ANNNISRVSCS---RGQGKKNIYLANNKITMLRDLDE-GCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHL------NL 176 (317)
T ss_dssp CSSCCSEEEEC---CCSSCEEEECCSSCCCSGGGBCT-GGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEE------EC
T ss_pred CCCccCCcCcc---ccCCCCEEECCCCCCCCccchhh-hccCCCCEEECCCCCCCcccHHHHhhccCcCCEE------EC
Confidence 99999975544 36789999999999996545455 5899999999999999998777764 66666654 99
Q ss_pred cCCCCCCCcccccccccCCcccccCCCCC
Q 042348 216 TYNNLSGLIPQNAALLSLGPTAFIGNPFL 244 (686)
Q Consensus 216 ~~N~l~~~~p~~~~~~~~~~~~~~~n~~~ 244 (686)
++|++++. |....+.++..+.+.+|...
T Consensus 177 ~~N~l~~~-~~~~~l~~L~~L~Ls~N~l~ 204 (317)
T 3o53_A 177 QYNFIYDV-KGQVVFAKLKTLDLSSNKLA 204 (317)
T ss_dssp TTSCCCEE-ECCCCCTTCCEEECCSSCCC
T ss_pred CCCcCccc-ccccccccCCEEECCCCcCC
Confidence 99999976 43334666777778887654
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.65 E-value=2.1e-16 Score=175.07 Aligned_cols=164 Identities=21% Similarity=0.301 Sum_probs=120.2
Q ss_pred CCEEEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCccccCCCCCcEEEccCCCCCCCCcccccCCCCCCEEec
Q 042348 57 GQVFSLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQVLDL 136 (686)
Q Consensus 57 ~~~~~l~l~~n~l~g~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l 136 (686)
..++.|+|++|+|+ .+| ..+++|+.|+|++|+|++ +|. +.+ +|+.|+|++|+|++ +|. .+++|+.|+|
T Consensus 80 ~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls~N~l~~-lp~---~l~~L~~L~L 147 (571)
T 3cvr_A 80 PQITVLEITQNALI-SLP---ELPASLEYLDACDNRLST-LPE-LPA--SLKHLDVDNNQLTM-LPE---LPALLEYINA 147 (571)
T ss_dssp TTCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSC-CCC-CCT--TCCEEECCSSCCSC-CCC---CCTTCCEEEC
T ss_pred CCCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCCC-cch-hhc--CCCEEECCCCcCCC-CCC---cCccccEEeC
Confidence 46889999999998 567 457889999999999986 777 665 89999999999986 666 6788899999
Q ss_pred cCCCCCCCCChhhhhccccccccccccccCCCCchhhhhcCcccceecccccccCCCCchhhhccccc-ccccccccccc
Q 042348 137 SQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSGLIPNDIANLSRL-RLLAQRVYVDL 215 (686)
Q Consensus 137 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L-~~l~~~~~l~l 215 (686)
++|.|++ +|. .+++|+.|+|++|+|++ +|. +. ++|+.|+|++|+|+. +|. +.. +| ...+.+..|+|
T Consensus 148 s~N~l~~-lp~---~l~~L~~L~Ls~N~L~~-lp~-l~---~~L~~L~Ls~N~L~~-lp~-~~~--~L~~~~~~L~~L~L 214 (571)
T 3cvr_A 148 DNNQLTM-LPE---LPTSLEVLSVRNNQLTF-LPE-LP---ESLEALDVSTNLLES-LPA-VPV--RNHHSEETEIFFRC 214 (571)
T ss_dssp CSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC-CC---TTCCEEECCSSCCSS-CCC-CC----------CCEEEEC
T ss_pred CCCccCc-CCC---cCCCcCEEECCCCCCCC-cch-hh---CCCCEEECcCCCCCc-hhh-HHH--hhhcccccceEEec
Confidence 9998886 665 56788888888888885 776 42 788888888888884 454 443 34 00111245588
Q ss_pred cCCCCCCCcccccccccCCcccccCCCCCC
Q 042348 216 TYNNLSGLIPQNAALLSLGPTAFIGNPFLC 245 (686)
Q Consensus 216 ~~N~l~~~~p~~~~~~~~~~~~~~~n~~~c 245 (686)
++|+|+.+++....+.++..+.+.+|+..+
T Consensus 215 s~N~l~~lp~~l~~l~~L~~L~L~~N~l~~ 244 (571)
T 3cvr_A 215 RENRITHIPENILSLDPTCTIILEDNPLSS 244 (571)
T ss_dssp CSSCCCCCCGGGGGSCTTEEEECCSSSCCH
T ss_pred CCCcceecCHHHhcCCCCCEEEeeCCcCCC
Confidence 888888655545556666667777887654
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.65 E-value=4.7e-17 Score=186.85 Aligned_cols=141 Identities=20% Similarity=0.219 Sum_probs=124.9
Q ss_pred CCCEEEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCccccCCCCCcEEEccCCCCCCCCcccccCCCCCCEEe
Q 042348 56 EGQVFSLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQVLD 135 (686)
Q Consensus 56 ~~~~~~l~l~~n~l~g~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ 135 (686)
...++.|+|++|.+. .+|..+..|++|+.|+|++|.|+ .+|..|.+|++|++|+|++|+|+ .+|..|+.|++|++|+
T Consensus 223 l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~ 299 (727)
T 4b8c_D 223 DQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYFY 299 (727)
T ss_dssp CCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEEE
T ss_pred CCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEEE
Confidence 467899999999999 68888889999999999999999 89999999999999999999999 8899999999999999
Q ss_pred ccCCCCCCCCChhhhhccccccccccccccCCCCchhhhhcCcccceecccccccCCCCchhhhc
Q 042348 136 LSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSGLIPNDIAN 200 (686)
Q Consensus 136 ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 200 (686)
|++|.|+ .+|..|..+++|+.|+|++|+|++.+|..+...-..+..|+|++|.+++.+|..+..
T Consensus 300 L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~~l~~ 363 (727)
T 4b8c_D 300 FFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPHERRF 363 (727)
T ss_dssp CCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCCC---
T ss_pred CCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCccccce
Confidence 9999998 789889999999999999999999888776422223345899999999999876543
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.64 E-value=5.4e-17 Score=168.78 Aligned_cols=133 Identities=13% Similarity=0.091 Sum_probs=96.9
Q ss_pred hcccCccCceEEEEEEeCCCceEEEEEcCCCCcc--------------chH--------HHHHHHHHHhccCCCCcceee
Q 042348 372 AFLLGKSTIGIVYKVALNNEEAVAVRRLGNGGWQ--------------RFK--------EFQTEAEAIGKIRHPNIVSLR 429 (686)
Q Consensus 372 ~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--------------~~~--------~~~~E~~~l~~l~H~nIv~l~ 429 (686)
...||+|++|.||+|...+|+.||||.++..... ... ...+|...|.++.+.++....
T Consensus 100 ~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~vp~ 179 (397)
T 4gyi_A 100 GSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFPVPE 179 (397)
T ss_dssp EEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCSCCC
T ss_pred cCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCCCCe
Confidence 3469999999999999999999999987532100 001 123567777777555443222
Q ss_pred EEEEecCceeEEEeccCCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCC
Q 042348 430 AYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNM 509 (686)
Q Consensus 430 ~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~ 509 (686)
-+.. ...++||||+++++|.++.. ......++.|++.+|.|||+ .+||||||||.|||+++++
T Consensus 180 p~~~--~~~~LVME~i~G~~L~~l~~------------~~~~~~l~~qll~~l~~lH~---~gIVHrDLKp~NILl~~dg 242 (397)
T 4gyi_A 180 PIAQ--SRHTIVMSLVDALPMRQVSS------------VPDPASLYADLIALILRLAK---HGLIHGDFNEFNILIREEK 242 (397)
T ss_dssp EEEE--ETTEEEEECCSCEEGGGCCC------------CSCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEEEEE
T ss_pred eeec--cCceEEEEecCCccHhhhcc------------cHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHEEEeCCC
Confidence 2211 23479999999988876432 12346789999999999999 8999999999999998776
Q ss_pred C----------eEEeecCcccc
Q 042348 510 E----------PHISDFGLARL 521 (686)
Q Consensus 510 ~----------~kl~DfGla~~ 521 (686)
. +.|+||+-+-.
T Consensus 243 d~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 243 DAEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp CSSCTTSEEEEEEECCCTTCEE
T ss_pred CcccccccccceEEEEeCCccc
Confidence 3 89999997753
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.64 E-value=4.5e-16 Score=148.47 Aligned_cols=128 Identities=29% Similarity=0.379 Sum_probs=110.1
Q ss_pred CEEEccCCCCcccCCccccCCCCCcEEEccCCCCCCCCcccccCCCCCCEEeccCCCCCCCCChhhhhcccccccccccc
Q 042348 84 GRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQN 163 (686)
Q Consensus 84 ~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N 163 (686)
+.+++++|.|+ .+|..+. ++|+.|+|++|+|+ .+|..|..+++|+.|+|++|.+++..+..|..+++|++|+|++|
T Consensus 13 ~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N 88 (193)
T 2wfh_A 13 TVVRCSNKGLK-VLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYN 88 (193)
T ss_dssp TEEECTTSCCS-SCCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEcCCCCCC-cCCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCC
Confidence 57999999998 7887664 68999999999998 78899999999999999999999888888999999999999999
Q ss_pred ccCCCCchhhhhcCcccceecccccccCCCCchhhhcccccccccccccccccCCCCCC
Q 042348 164 SFTGPLPDGFATNLTALQKLDLSFNNLSGLIPNDIANLSRLRLLAQRVYVDLTYNNLSG 222 (686)
Q Consensus 164 ~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~~~~~l~l~~N~l~~ 222 (686)
+|++..|..+ ..+++|+.|+|++|+|++..+..+..+++|+.| ++++|.+..
T Consensus 89 ~l~~i~~~~f-~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L------~L~~N~~~C 140 (193)
T 2wfh_A 89 RLRCIPPRTF-DGLKSLRLLSLHGNDISVVPEGAFNDLSALSHL------AIGANPLYC 140 (193)
T ss_dssp CCCBCCTTTT-TTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEE------ECCSSCEEC
T ss_pred ccCEeCHHHh-CCCCCCCEEECCCCCCCeeChhhhhcCccccEE------EeCCCCeec
Confidence 9996555455 589999999999999998877778887777654 777776654
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.64 E-value=3.8e-16 Score=174.87 Aligned_cols=169 Identities=27% Similarity=0.408 Sum_probs=143.4
Q ss_pred CCEEEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCccccCCCCCcEEEccCCCCCCCCcccccCCCCCCEEec
Q 042348 57 GQVFSLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQVLDL 136 (686)
Q Consensus 57 ~~~~~l~l~~n~l~g~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l 136 (686)
..++.|+|++|.+... | .|..|++|+.|+|++|+|++..| +.++++|+.|+|++|+|++ +| .+..+++|+.|+|
T Consensus 43 ~~L~~L~l~~n~i~~l-~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~-l~-~l~~l~~L~~L~L 116 (605)
T 1m9s_A 43 NSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIKD-LS-SLKDLKKLKSLSL 116 (605)
T ss_dssp TTCCCCBCTTCCCCCC-T-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCC-CT-TSTTCTTCCEEEC
T ss_pred CCCCEEECcCCCCCCC-h-HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEECcCCCCCC-Ch-hhccCCCCCEEEe
Confidence 5788899999999864 4 69999999999999999996554 8999999999999999985 44 7999999999999
Q ss_pred cCCCCCCCCChhhhhccccccccccccccCCCCchhhhhcCcccceecccccccCCCCchhhhccccccccccccccccc
Q 042348 137 SQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSGLIPNDIANLSRLRLLAQRVYVDLT 216 (686)
Q Consensus 137 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~~~~~l~l~ 216 (686)
++|.+++ + ..+..+++|+.|+|++|++++ + ..+ ..+++|+.|+|++|+|++.+| +..|++|+.| +|+
T Consensus 117 s~N~l~~-l-~~l~~l~~L~~L~Ls~N~l~~-l-~~l-~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L------~Ls 183 (605)
T 1m9s_A 117 EHNGISD-I-NGLVHLPQLESLYLGNNKITD-I-TVL-SRLTKLDTLSLEDNQISDIVP--LAGLTKLQNL------YLS 183 (605)
T ss_dssp TTSCCCC-C-GGGGGCTTCSEEECCSSCCCC-C-GGG-GSCTTCSEEECCSSCCCCCGG--GTTCTTCCEE------ECC
T ss_pred cCCCCCC-C-ccccCCCccCEEECCCCccCC-c-hhh-cccCCCCEEECcCCcCCCchh--hccCCCCCEE------ECc
Confidence 9999996 4 468999999999999999996 4 344 589999999999999998876 7777777655 999
Q ss_pred CCCCCCCcccccccccCCcccccCCCCCC
Q 042348 217 YNNLSGLIPQNAALLSLGPTAFIGNPFLC 245 (686)
Q Consensus 217 ~N~l~~~~p~~~~~~~~~~~~~~~n~~~c 245 (686)
+|+|++. |....+.++..+.+.+|+...
T Consensus 184 ~N~i~~l-~~l~~l~~L~~L~L~~N~l~~ 211 (605)
T 1m9s_A 184 KNHISDL-RALAGLKNLDVLELFSQECLN 211 (605)
T ss_dssp SSCCCBC-GGGTTCTTCSEEECCSEEEEC
T ss_pred CCCCCCC-hHHccCCCCCEEEccCCcCcC
Confidence 9999985 555566777777788887543
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.64 E-value=7.3e-16 Score=144.96 Aligned_cols=135 Identities=24% Similarity=0.282 Sum_probs=115.8
Q ss_pred CCEEEccCCCCcccCCccccCCCCCcEEEccCCCCCCCCcccccCCCCCCEEeccCCCCCCCCChhhhhccccccccccc
Q 042348 83 IGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQ 162 (686)
Q Consensus 83 L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~ 162 (686)
.+.+++++|.++ .+|..+. ++|+.|+|++|++++..+..|+.+++|++|+|++|.+++..+..+..+++|++|+|++
T Consensus 9 ~~~l~~~~~~l~-~~p~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 85 (177)
T 2o6r_A 9 GTEIRCNSKGLT-SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHE 85 (177)
T ss_dssp TTEEECCSSCCS-SCCTTCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEEEecCCCCc-cCCCCCC--CCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCC
Confidence 468999999998 6776553 7999999999999977777789999999999999999977777789999999999999
Q ss_pred cccCCCCchhhhhcCcccceecccccccCCCCchhhhcccccccccccccccccCCCCCCCcccc
Q 042348 163 NSFTGPLPDGFATNLTALQKLDLSFNNLSGLIPNDIANLSRLRLLAQRVYVDLTYNNLSGLIPQN 227 (686)
Q Consensus 163 N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~~~~~l~l~~N~l~~~~p~~ 227 (686)
|++++ +|...+..+++|++|+|++|+|++.++..+..+++|+.| ++++|.+++..|..
T Consensus 86 N~l~~-~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L------~l~~N~~~~~~~~l 143 (177)
T 2o6r_A 86 NKLQS-LPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKI------WLHTNPWDCSCPRI 143 (177)
T ss_dssp SCCCC-CCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEE------ECCSSCBCCCHHHH
T ss_pred CCccc-cCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEE------EecCCCeeccCccH
Confidence 99996 555444689999999999999998877777878777655 99999999987743
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.64 E-value=4.3e-16 Score=156.45 Aligned_cols=167 Identities=22% Similarity=0.279 Sum_probs=137.1
Q ss_pred EEEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCccccCCCCCcEEEccCCCCCCCCcccccCCCCCCEEeccC
Q 042348 59 VFSLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQVLDLSQ 138 (686)
Q Consensus 59 ~~~l~l~~n~l~g~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~ 138 (686)
++.+++++|.+++.. .+..+++|+.|+|++|.|+ .+| .+..+++|+.|+|++|++++..+ +..+++|+.|+|++
T Consensus 21 l~~l~l~~~~i~~~~--~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~L~~ 94 (263)
T 1xeu_A 21 AVKQNLGKQSVTDLV--SQKELSGVQNFNGDNSNIQ-SLA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEELSVNR 94 (263)
T ss_dssp HHHHHHTCSCTTSEE--CHHHHTTCSEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEEECCS
T ss_pred HHHHHhcCCCccccc--chhhcCcCcEEECcCCCcc-cch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEEECCC
Confidence 445677888888654 6888999999999999998 567 78999999999999999996444 99999999999999
Q ss_pred CCCCCCCChhhhhccccccccccccccCCCCchhhhhcCcccceecccccccCCCCchhhhcccccccccccccccccCC
Q 042348 139 NSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSGLIPNDIANLSRLRLLAQRVYVDLTYN 218 (686)
Q Consensus 139 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~~~~~l~l~~N 218 (686)
|++++ +|.... .+|+.|+|++|++++ ++ .+ ..+++|+.|+|++|++++. | .+..+++|+. |++++|
T Consensus 95 N~l~~-l~~~~~--~~L~~L~L~~N~l~~-~~-~l-~~l~~L~~L~Ls~N~i~~~-~-~l~~l~~L~~------L~L~~N 160 (263)
T 1xeu_A 95 NRLKN-LNGIPS--ACLSRLFLDNNELRD-TD-SL-IHLKNLEILSIRNNKLKSI-V-MLGFLSKLEV------LDLHGN 160 (263)
T ss_dssp SCCSC-CTTCCC--SSCCEEECCSSCCSB-SG-GG-TTCTTCCEEECTTSCCCBC-G-GGGGCTTCCE------EECTTS
T ss_pred CccCC-cCcccc--CcccEEEccCCccCC-Ch-hh-cCcccccEEECCCCcCCCC-h-HHccCCCCCE------EECCCC
Confidence 99996 554333 899999999999995 54 34 5899999999999999985 3 5666666665 499999
Q ss_pred CCCCCcccccccccCCcccccCCCCCCC
Q 042348 219 NLSGLIPQNAALLSLGPTAFIGNPFLCG 246 (686)
Q Consensus 219 ~l~~~~p~~~~~~~~~~~~~~~n~~~c~ 246 (686)
++++. +....+.++..+.+.+|+..+.
T Consensus 161 ~i~~~-~~l~~l~~L~~L~l~~N~~~~~ 187 (263)
T 1xeu_A 161 EITNT-GGLTRLKKVNWIDLTGQKCVNE 187 (263)
T ss_dssp CCCBC-TTSTTCCCCCEEEEEEEEEECC
T ss_pred cCcch-HHhccCCCCCEEeCCCCcccCC
Confidence 99987 5455566777788889987665
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=99.63 E-value=9.1e-16 Score=167.79 Aligned_cols=168 Identities=30% Similarity=0.429 Sum_probs=125.5
Q ss_pred CCEEEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCccccCCCCCcEEEccCCCCCCCCcccccCCCCCCEEec
Q 042348 57 GQVFSLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQVLDL 136 (686)
Q Consensus 57 ~~~~~l~l~~n~l~g~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l 136 (686)
..++.|++++|.+++. +.+..+++|+.|++++|.+++..| +..+++|+.|+|++|++++ ++ .+..+++|+.|++
T Consensus 177 ~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~-~~-~l~~l~~L~~L~l 250 (466)
T 1o6v_A 177 TTLERLDISSNKVSDI--SVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD-IG-TLASLTNLTDLDL 250 (466)
T ss_dssp TTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCC-CG-GGGGCTTCSEEEC
T ss_pred CCCCEEECcCCcCCCC--hhhccCCCCCEEEecCCccccccc--ccccCCCCEEECCCCCccc-ch-hhhcCCCCCEEEC
Confidence 5688888888888764 347888888888888888886555 6778888888888888874 33 5778888888888
Q ss_pred cCCCCCCCCChhhhhccccccccccccccCCCCchhhhhcCcccceecccccccCCCCchhhhccccccccccccccccc
Q 042348 137 SQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSGLIPNDIANLSRLRLLAQRVYVDLT 216 (686)
Q Consensus 137 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~~~~~l~l~ 216 (686)
++|.+++..| +..+++|+.|+|++|++++ ++. + ..+++|+.|+|++|++++..| +..+++|+.| +++
T Consensus 251 ~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~-~~~-~-~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L------~L~ 317 (466)
T 1o6v_A 251 ANNQISNLAP--LSGLTKLTELKLGANQISN-ISP-L-AGLTALTNLELNENQLEDISP--ISNLKNLTYL------TLY 317 (466)
T ss_dssp CSSCCCCCGG--GTTCTTCSEEECCSSCCCC-CGG-G-TTCTTCSEEECCSSCCSCCGG--GGGCTTCSEE------ECC
T ss_pred CCCccccchh--hhcCCCCCEEECCCCccCc-ccc-c-cCCCccCeEEcCCCcccCchh--hcCCCCCCEE------ECc
Confidence 8888886544 7788888888888888885 443 3 478888888888888887654 5566655544 888
Q ss_pred CCCCCCCcccccccccCCcccccCCCCC
Q 042348 217 YNNLSGLIPQNAALLSLGPTAFIGNPFL 244 (686)
Q Consensus 217 ~N~l~~~~p~~~~~~~~~~~~~~~n~~~ 244 (686)
+|++++..| ...+.++..+.+.+|...
T Consensus 318 ~n~l~~~~~-~~~l~~L~~L~l~~n~l~ 344 (466)
T 1o6v_A 318 FNNISDISP-VSSLTKLQRLFFYNNKVS 344 (466)
T ss_dssp SSCCSCCGG-GGGCTTCCEEECCSSCCC
T ss_pred CCcCCCchh-hccCccCCEeECCCCccC
Confidence 888887766 344555666666666543
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.63 E-value=9.5e-16 Score=166.65 Aligned_cols=149 Identities=19% Similarity=0.175 Sum_probs=89.3
Q ss_pred CCEEEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCccccCCCCCcEEEccCCCCCCCCcccccCCCCCCEEec
Q 042348 57 GQVFSLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQVLDL 136 (686)
Q Consensus 57 ~~~~~l~l~~n~l~g~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l 136 (686)
..++.|++++|...+.+ .++.+++|+.|+|++|++++ +| +..+++|+.|+|++|++++. .++.+++|+.|+|
T Consensus 148 ~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~-l~--l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~L 219 (457)
T 3bz5_A 148 TQLTELDCHLNKKITKL--DVTPQTQLTTLDCSFNKITE-LD--VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDC 219 (457)
T ss_dssp TTCCEEECTTCSCCCCC--CCTTCTTCCEEECCSSCCCC-CC--CTTCTTCCEEECCSSCCSCC---CCTTCTTCSEEEC
T ss_pred CcCCEEECCCCCccccc--ccccCCcCCEEECCCCccce-ec--cccCCCCCEEECcCCcCCee---ccccCCCCCEEEC
Confidence 45667777777555555 36667777777777777764 44 66667777777777777643 3666677777777
Q ss_pred cCCCCCCCCChhhhhccccccccccccccCCCCchhhhhcCc-------ccceecccccccCCCCchhhhcccccccccc
Q 042348 137 SQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLT-------ALQKLDLSFNNLSGLIPNDIANLSRLRLLAQ 209 (686)
Q Consensus 137 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~-------~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~~ 209 (686)
++|++++ +| +..+++|+.|+|++|++++..+..+ .+|. +|+.|++++|.+.+.+| ++.+++|+.
T Consensus 220 s~N~l~~-ip--~~~l~~L~~L~l~~N~l~~~~~~~l-~~L~~L~l~~n~L~~L~l~~n~~~~~~~--~~~l~~L~~--- 290 (457)
T 3bz5_A 220 SSNKLTE-ID--VTPLTQLTYFDCSVNPLTELDVSTL-SKLTTLHCIQTDLLEIDLTHNTQLIYFQ--AEGCRKIKE--- 290 (457)
T ss_dssp CSSCCSC-CC--CTTCTTCSEEECCSSCCSCCCCTTC-TTCCEEECTTCCCSCCCCTTCTTCCEEE--CTTCTTCCC---
T ss_pred cCCcccc-cC--ccccCCCCEEEeeCCcCCCcCHHHC-CCCCEEeccCCCCCEEECCCCccCCccc--ccccccCCE---
Confidence 7777765 45 5666677777777777765332222 2333 34455555555555544 233444433
Q ss_pred cccccccCCCCCCCcc
Q 042348 210 RVYVDLTYNNLSGLIP 225 (686)
Q Consensus 210 ~~~l~l~~N~l~~~~p 225 (686)
|++++|.+.+.+|
T Consensus 291 ---L~Ls~n~~l~~l~ 303 (457)
T 3bz5_A 291 ---LDVTHNTQLYLLD 303 (457)
T ss_dssp ---CCCTTCTTCCEEE
T ss_pred ---EECCCCcccceec
Confidence 3566666555555
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.62 E-value=7.3e-18 Score=187.66 Aligned_cols=157 Identities=22% Similarity=0.252 Sum_probs=124.0
Q ss_pred CEEEEEeCCCCccccCCcCcCCCCCCCEEEccCCC-------------CcccCCccccCC--------------------
Q 042348 58 QVFSLIIPNKKLTGFIPADLGSLSAIGRVNLRNNN-------------FSGSLPVELFNA-------------------- 104 (686)
Q Consensus 58 ~~~~l~l~~n~l~g~~p~~l~~l~~L~~L~L~~N~-------------l~g~~p~~~~~l-------------------- 104 (686)
+++.|+|++|+|+ .+|..+++|++|+.|++++|. +.+.+|..+.++
T Consensus 350 ~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~L~~L~~l~~n~~~~L~~l 428 (567)
T 1dce_A 350 QLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLDDLRSK 428 (567)
T ss_dssp TSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHHHHHHCGGGHHHHHHHHHH
T ss_pred cceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHhcccCcchhhcccchhhhh
Confidence 3446778888887 678888888889888887775 444455433221
Q ss_pred ------------CCCcEEEccCCCCCCCCcccccCCCCCCEEeccCCCCCCCCChhhhhccccccccccccccCCCCchh
Q 042348 105 ------------SNLQSLILSGNSFSGPVPMQIGKLKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDG 172 (686)
Q Consensus 105 ------------~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~ 172 (686)
..|+.|+|++|+|++ +|. |+.+++|+.|+|++|.|+ .+|..++.+++|+.|+|++|+|++ +| .
T Consensus 429 ~l~~n~i~~l~~~~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~ 503 (567)
T 1dce_A 429 FLLENSVLKMEYADVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-G 503 (567)
T ss_dssp HHHHHHHHHHHHTTCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-G
T ss_pred hhhcccccccCccCceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-c
Confidence 247788899999985 676 888999999999999998 788889999999999999999986 77 5
Q ss_pred hhhcCcccceecccccccCCCC-chhhhcccccccccccccccccCCCCCCCcccc
Q 042348 173 FATNLTALQKLDLSFNNLSGLI-PNDIANLSRLRLLAQRVYVDLTYNNLSGLIPQN 227 (686)
Q Consensus 173 ~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~l~~~~~l~l~~N~l~~~~p~~ 227 (686)
+ ..+++|+.|+|++|+|++.+ |..++.|++|+.| +|++|+|++.+|..
T Consensus 504 l-~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L------~L~~N~l~~~~~~~ 552 (567)
T 1dce_A 504 V-ANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLL------NLQGNSLCQEEGIQ 552 (567)
T ss_dssp G-TTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEE------ECTTSGGGGSSSCT
T ss_pred c-CCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEE------EecCCcCCCCccHH
Confidence 5 57899999999999999887 8888888877755 89999998877654
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.61 E-value=3.1e-15 Score=162.60 Aligned_cols=146 Identities=22% Similarity=0.218 Sum_probs=112.8
Q ss_pred CCEEEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCccccCCCCCcEEEccCCCCCCCCcccccCCCCCCEEec
Q 042348 57 GQVFSLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQVLDL 136 (686)
Q Consensus 57 ~~~~~l~l~~n~l~g~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l 136 (686)
..++.|+|++|++++ +| ++.+++|+.|+|++|+|++ +| +.++++|++|+|++|...+.+ .++.+++|+.|++
T Consensus 106 ~~L~~L~L~~N~l~~-l~--~~~l~~L~~L~l~~N~l~~-l~--l~~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~l 177 (457)
T 3bz5_A 106 TKLTYLNCDTNKLTK-LD--VSQNPLLTYLNCARNTLTE-ID--VSHNTQLTELDCHLNKKITKL--DVTPQTQLTTLDC 177 (457)
T ss_dssp TTCCEEECCSSCCSC-CC--CTTCTTCCEEECTTSCCSC-CC--CTTCTTCCEEECTTCSCCCCC--CCTTCTTCCEEEC
T ss_pred CcCCEEECCCCcCCe-ec--CCCCCcCCEEECCCCccce-ec--cccCCcCCEEECCCCCccccc--ccccCCcCCEEEC
Confidence 578899999999998 44 8899999999999999986 43 778888888888888666666 4778888888888
Q ss_pred cCCCCCCCCChhhhhccccccccccccccCCCCchhhhhcCcccceecccccccCCCCchhhhccccccccccccccccc
Q 042348 137 SQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSGLIPNDIANLSRLRLLAQRVYVDLT 216 (686)
Q Consensus 137 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~~~~~l~l~ 216 (686)
++|++++ +| +..+++|+.|+|++|++++. + + ..+++|+.|+|++|++++ +| +..+++|+. |+++
T Consensus 178 s~n~l~~-l~--l~~l~~L~~L~l~~N~l~~~-~--l-~~l~~L~~L~Ls~N~l~~-ip--~~~l~~L~~------L~l~ 241 (457)
T 3bz5_A 178 SFNKITE-LD--VSQNKLLNRLNCDTNNITKL-D--L-NQNIQLTFLDCSSNKLTE-ID--VTPLTQLTY------FDCS 241 (457)
T ss_dssp CSSCCCC-CC--CTTCTTCCEEECCSSCCSCC-C--C-TTCTTCSEEECCSSCCSC-CC--CTTCTTCSE------EECC
T ss_pred CCCccce-ec--cccCCCCCEEECcCCcCCee-c--c-ccCCCCCEEECcCCcccc-cC--ccccCCCCE------EEee
Confidence 8888886 55 67778888888888888753 3 3 467888888888888887 44 555555554 4788
Q ss_pred CCCCCCCccc
Q 042348 217 YNNLSGLIPQ 226 (686)
Q Consensus 217 ~N~l~~~~p~ 226 (686)
+|++++.++.
T Consensus 242 ~N~l~~~~~~ 251 (457)
T 3bz5_A 242 VNPLTELDVS 251 (457)
T ss_dssp SSCCSCCCCT
T ss_pred CCcCCCcCHH
Confidence 8888776543
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.61 E-value=5.3e-17 Score=169.55 Aligned_cols=178 Identities=23% Similarity=0.211 Sum_probs=137.0
Q ss_pred CCEEEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCccc-CCccccCCCCCcEEEccCCCCCCCCcccccCCCCCCEEe
Q 042348 57 GQVFSLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGS-LPVELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQVLD 135 (686)
Q Consensus 57 ~~~~~l~l~~n~l~g~~p~~l~~l~~L~~L~L~~N~l~g~-~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ 135 (686)
..++.|++++|.+++..+. +..+++|+.|+|++|.+++. +|..+..+++|++|+|++|.+++..|..++.+++|++|+
T Consensus 70 ~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~ 148 (336)
T 2ast_B 70 QGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLN 148 (336)
T ss_dssp TTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEE
T ss_pred ccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEE
Confidence 5677888888888876655 56789999999999998865 788888899999999999998888888888899999999
Q ss_pred ccCC-CCCCC-CChhhhhcccccccccccc-ccCCC-CchhhhhcCc-ccceeccccc--ccC-CCCchhhhcccccccc
Q 042348 136 LSQN-SFSSS-IPSSIVQCKRLKTVVLNQN-SFTGP-LPDGFATNLT-ALQKLDLSFN--NLS-GLIPNDIANLSRLRLL 207 (686)
Q Consensus 136 ls~N-~l~~~-~p~~~~~l~~L~~L~L~~N-~l~~~-~p~~~~~~l~-~L~~L~Ls~N--~l~-~~~p~~~~~l~~L~~l 207 (686)
|++| .+++. +|..+..+++|++|+|++| .+++. ++..+ ..++ +|++|+|++| .++ +.+|..+..+++|+.|
T Consensus 149 L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~-~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L 227 (336)
T 2ast_B 149 LSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAV-AHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHL 227 (336)
T ss_dssp CTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHH-HHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEE
T ss_pred CCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHH-HhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEE
Confidence 9998 67753 6777888999999999999 88753 44444 5788 9999999999 555 4566677777776655
Q ss_pred cccccccccCCC-CCCCcc-cccccccCCcccccCCC
Q 042348 208 AQRVYVDLTYNN-LSGLIP-QNAALLSLGPTAFIGNP 242 (686)
Q Consensus 208 ~~~~~l~l~~N~-l~~~~p-~~~~~~~~~~~~~~~n~ 242 (686)
++++|. +++..+ ....+.++..+.+.+|.
T Consensus 228 ------~l~~~~~l~~~~~~~l~~l~~L~~L~l~~~~ 258 (336)
T 2ast_B 228 ------DLSDSVMLKNDCFQEFFQLNYLQHLSLSRCY 258 (336)
T ss_dssp ------ECTTCTTCCGGGGGGGGGCTTCCEEECTTCT
T ss_pred ------eCCCCCcCCHHHHHHHhCCCCCCEeeCCCCC
Confidence 899998 665444 33345556666666665
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.61 E-value=1.7e-15 Score=158.90 Aligned_cols=148 Identities=24% Similarity=0.359 Sum_probs=121.5
Q ss_pred CCEEEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCccccCCCCCcEEEccCCCCCCCCcccccCCCCCCEEec
Q 042348 57 GQVFSLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQVLDL 136 (686)
Q Consensus 57 ~~~~~l~l~~n~l~g~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l 136 (686)
..++.|++++|.+++..+ +..+++|+.|+|++|.+++ +|. +..+++|++|+|++|.+++ + +.+..+++|+.|++
T Consensus 199 ~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~-~~~-~~~l~~L~~L~l~~n~l~~-~-~~~~~l~~L~~L~l 272 (347)
T 4fmz_A 199 TSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITD-LSP-LANLSQLTWLEIGTNQISD-I-NAVKDLTKLKMLNV 272 (347)
T ss_dssp TTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCCC-C-GGGTTCTTCCEEEC
T ss_pred CccceeecccCCCCCCch--hhcCCcCCEEEccCCccCC-Ccc-hhcCCCCCEEECCCCccCC-C-hhHhcCCCcCEEEc
Confidence 455666666666665433 7888999999999999985 444 8999999999999999985 4 46899999999999
Q ss_pred cCCCCCCCCChhhhhccccccccccccccCCCCchhhhhcCcccceecccccccCCCCchhhhccccccccccccccccc
Q 042348 137 SQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSGLIPNDIANLSRLRLLAQRVYVDLT 216 (686)
Q Consensus 137 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~~~~~l~l~ 216 (686)
++|.+++ + ..+..+++|+.|+|++|++++..|..+ ..+++|+.|+|++|.+++.+| +..+++|+.| |++
T Consensus 273 ~~n~l~~-~-~~~~~l~~L~~L~L~~n~l~~~~~~~l-~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L------~l~ 341 (347)
T 4fmz_A 273 GSNQISD-I-SVLNNLSQLNSLFLNNNQLGNEDMEVI-GGLTNLTTLFLSQNHITDIRP--LASLSKMDSA------DFA 341 (347)
T ss_dssp CSSCCCC-C-GGGGGCTTCSEEECCSSCCCGGGHHHH-HTCTTCSEEECCSSSCCCCGG--GGGCTTCSEE------SSS
T ss_pred cCCccCC-C-hhhcCCCCCCEEECcCCcCCCcChhHh-hccccCCEEEccCCccccccC--hhhhhcccee------ehh
Confidence 9999996 4 458899999999999999997666666 589999999999999998776 7777776655 999
Q ss_pred CCCCC
Q 042348 217 YNNLS 221 (686)
Q Consensus 217 ~N~l~ 221 (686)
+|.++
T Consensus 342 ~N~i~ 346 (347)
T 4fmz_A 342 NQVIK 346 (347)
T ss_dssp CC---
T ss_pred hhccc
Confidence 99886
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.59 E-value=1.2e-16 Score=166.76 Aligned_cols=176 Identities=21% Similarity=0.231 Sum_probs=144.1
Q ss_pred CCEEEEEeCCCCcccc-CCcCcCCCCCCCEEEccCCCCcccCCccccCCCCCcEEEccCC-CCCC-CCcccccCCCCCCE
Q 042348 57 GQVFSLIIPNKKLTGF-IPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGN-SFSG-PVPMQIGKLKYLQV 133 (686)
Q Consensus 57 ~~~~~l~l~~n~l~g~-~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N-~l~g-~~p~~~~~l~~L~~ 133 (686)
.+++.|+|++|.+++. +|..+..+++|++|+|++|.+++..|..+..+++|++|+|++| .+++ .++..+..+++|+.
T Consensus 93 ~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~ 172 (336)
T 2ast_B 93 FRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDE 172 (336)
T ss_dssp BCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCE
T ss_pred CCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCE
Confidence 5789999999999977 8888999999999999999999888999999999999999999 7876 37777899999999
Q ss_pred EeccCC-CCCCC-CChhhhhcc-cccccccccc--ccC-CCCchhhhhcCcccceecccccc-cCCCCchhhhccccccc
Q 042348 134 LDLSQN-SFSSS-IPSSIVQCK-RLKTVVLNQN--SFT-GPLPDGFATNLTALQKLDLSFNN-LSGLIPNDIANLSRLRL 206 (686)
Q Consensus 134 L~ls~N-~l~~~-~p~~~~~l~-~L~~L~L~~N--~l~-~~~p~~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l~~L~~ 206 (686)
|+|++| .+++. ++..+..++ +|++|+|++| .++ +.+|..+ ..+++|+.|+|++|. +++..+..+..+++|+.
T Consensus 173 L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~-~~~~~L~~L~l~~~~~l~~~~~~~l~~l~~L~~ 251 (336)
T 2ast_B 173 LNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLV-RRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQH 251 (336)
T ss_dssp EECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHH-HHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCE
T ss_pred EcCCCCCCcChHHHHHHHHhcccCCCEEEeCCCcccCCHHHHHHHH-hhCCCCCEEeCCCCCcCCHHHHHHHhCCCCCCE
Confidence 999999 99864 678889999 9999999999 555 3456555 579999999999999 77777778887777765
Q ss_pred ccccccccccCCCCCCCccc----ccccccCCcccccCC
Q 042348 207 LAQRVYVDLTYNNLSGLIPQ----NAALLSLGPTAFIGN 241 (686)
Q Consensus 207 l~~~~~l~l~~N~l~~~~p~----~~~~~~~~~~~~~~n 241 (686)
| ++++|. +..+. ...+.++..+.+.+|
T Consensus 252 L------~l~~~~--~~~~~~~~~l~~~~~L~~L~l~~~ 282 (336)
T 2ast_B 252 L------SLSRCY--DIIPETLLELGEIPTLKTLQVFGI 282 (336)
T ss_dssp E------ECTTCT--TCCGGGGGGGGGCTTCCEEECTTS
T ss_pred e------eCCCCC--CCCHHHHHHHhcCCCCCEEeccCc
Confidence 5 999996 33333 223444555555555
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.58 E-value=4.1e-17 Score=173.92 Aligned_cols=159 Identities=23% Similarity=0.264 Sum_probs=80.7
Q ss_pred CCEEEEEeCCC---CccccCCcCc-------CCCCCCCEEEccCCCCcc----cCCccccCCCCCcEEEccCCCCCCCCc
Q 042348 57 GQVFSLIIPNK---KLTGFIPADL-------GSLSAIGRVNLRNNNFSG----SLPVELFNASNLQSLILSGNSFSGPVP 122 (686)
Q Consensus 57 ~~~~~l~l~~n---~l~g~~p~~l-------~~l~~L~~L~L~~N~l~g----~~p~~~~~l~~L~~L~L~~N~l~g~~p 122 (686)
..++.|+|++| ++++.+|..+ ..+++|++|+|++|.|++ .+|..+.++++|++|+|++|.+++..+
T Consensus 60 ~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~ 139 (386)
T 2ca6_A 60 KDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAG 139 (386)
T ss_dssp TTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHH
T ss_pred CCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECCCCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHH
Confidence 35556666553 4444445443 455666666666666654 345555556666666666666543222
Q ss_pred ccc----cCC---------CCCCEEeccCCCCC-CCCC---hhhhhccccccccccccccC--C---CCchhhhhcCccc
Q 042348 123 MQI----GKL---------KYLQVLDLSQNSFS-SSIP---SSIVQCKRLKTVVLNQNSFT--G---PLPDGFATNLTAL 180 (686)
Q Consensus 123 ~~~----~~l---------~~L~~L~ls~N~l~-~~~p---~~~~~l~~L~~L~L~~N~l~--~---~~p~~~~~~l~~L 180 (686)
..+ ..+ ++|++|+|++|+++ +.+| ..+..+++|+.|+|++|+++ | .+|..+ ..+++|
T Consensus 140 ~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l-~~~~~L 218 (386)
T 2ca6_A 140 AKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGL-AYCQEL 218 (386)
T ss_dssp HHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTG-GGCTTC
T ss_pred HHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHh-hcCCCc
Confidence 222 222 55666666666655 2333 24445555666666666554 1 111122 345556
Q ss_pred ceecccccccC----CCCchhhhcccccccccccccccccCCCCCC
Q 042348 181 QKLDLSFNNLS----GLIPNDIANLSRLRLLAQRVYVDLTYNNLSG 222 (686)
Q Consensus 181 ~~L~Ls~N~l~----~~~p~~~~~l~~L~~l~~~~~l~l~~N~l~~ 222 (686)
+.|+|++|.++ +.+|..+..+++|+.| +|++|++++
T Consensus 219 ~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L------~L~~n~i~~ 258 (386)
T 2ca6_A 219 KVLDLQDNTFTHLGSSALAIALKSWPNLREL------GLNDCLLSA 258 (386)
T ss_dssp CEEECCSSCCHHHHHHHHHHHGGGCTTCCEE------ECTTCCCCH
T ss_pred cEEECcCCCCCcHHHHHHHHHHccCCCcCEE------ECCCCCCch
Confidence 66666666554 3344444444444332 555555544
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.58 E-value=2.1e-15 Score=169.14 Aligned_cols=164 Identities=26% Similarity=0.353 Sum_probs=119.8
Q ss_pred CCCCCCCCCcceeee--------EecCCCEEEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCccccCCCCCcE
Q 042348 38 NWNNSNEDPCSWNGI--------TCREGQVFSLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQS 109 (686)
Q Consensus 38 ~w~~~~~~~c~w~gv--------~c~~~~~~~l~l~~n~l~g~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~ 109 (686)
.|.. +.+||.|.|. .|....++.|++++|+|+ .+|..+. ++|+.|+|++|+|+ .+|. .+++|++
T Consensus 14 ~W~~-~~~~~~~~~r~~~~~~~~~c~~~~l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~-~lp~---~l~~L~~ 85 (622)
T 3g06_A 14 AWRR-AAPAEESRGRAAVVQKMRACLNNGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA---LPPELRT 85 (622)
T ss_dssp HHHH-TCCGGGHHHHHHHHHHHHHHHHHCCCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCS-CCCC---CCTTCCE
T ss_pred HHHh-cCCcchhccccccCcccccccCCCCcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCC-CCCC---cCCCCCE
Confidence 3554 3567888654 344557889999999998 6787776 78999999999998 5776 5788999
Q ss_pred EEccCCCCCCCCcccccCCCCCCEEeccCCCCCCCCChhhhhccccccccccccccCCCCchhhhhcCcccceecccccc
Q 042348 110 LILSGNSFSGPVPMQIGKLKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNN 189 (686)
Q Consensus 110 L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~ 189 (686)
|+|++|+|+ .+|. .+++|++|+|++|++++ +|. .+.+|+.|+|++|++++ +|. .+++|++|+|++|+
T Consensus 86 L~Ls~N~l~-~lp~---~l~~L~~L~Ls~N~l~~-l~~---~l~~L~~L~L~~N~l~~-lp~----~l~~L~~L~Ls~N~ 152 (622)
T 3g06_A 86 LEVSGNQLT-SLPV---LPPGLLELSIFSNPLTH-LPA---LPSGLCKLWIFGNQLTS-LPV----LPPGLQELSVSDNQ 152 (622)
T ss_dssp EEECSCCCS-CCCC---CCTTCCEEEECSCCCCC-CCC---CCTTCCEEECCSSCCSC-CCC----CCTTCCEEECCSSC
T ss_pred EEcCCCcCC-cCCC---CCCCCCEEECcCCcCCC-CCC---CCCCcCEEECCCCCCCc-CCC----CCCCCCEEECcCCc
Confidence 999999998 5665 67889999999999885 555 56788888888888884 664 35788888888888
Q ss_pred cCCCCchhhhccccc-----------ccccccccccccCCCCCCC
Q 042348 190 LSGLIPNDIANLSRL-----------RLLAQRVYVDLTYNNLSGL 223 (686)
Q Consensus 190 l~~~~p~~~~~l~~L-----------~~l~~~~~l~l~~N~l~~~ 223 (686)
+++. |..+.+|..| ..++.+..|++++|++++.
T Consensus 153 l~~l-~~~~~~L~~L~L~~N~l~~l~~~~~~L~~L~Ls~N~l~~l 196 (622)
T 3g06_A 153 LASL-PALPSELCKLWAYNNQLTSLPMLPSGLQELSVSDNQLASL 196 (622)
T ss_dssp CSCC-CCCCTTCCEEECCSSCCSCCCCCCTTCCEEECCSSCCSCC
T ss_pred CCCc-CCccCCCCEEECCCCCCCCCcccCCCCcEEECCCCCCCCC
Confidence 8863 4333333332 0114455667777777763
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.57 E-value=2.9e-16 Score=165.69 Aligned_cols=186 Identities=24% Similarity=0.204 Sum_probs=128.5
Q ss_pred CCCEEEEEeCCCCccccCC----cCcCCCC-CCCEEEccCCCCcccCCccccCC-----CCCcEEEccCCCCCCCCcccc
Q 042348 56 EGQVFSLIIPNKKLTGFIP----ADLGSLS-AIGRVNLRNNNFSGSLPVELFNA-----SNLQSLILSGNSFSGPVPMQI 125 (686)
Q Consensus 56 ~~~~~~l~l~~n~l~g~~p----~~l~~l~-~L~~L~L~~N~l~g~~p~~~~~l-----~~L~~L~L~~N~l~g~~p~~~ 125 (686)
...++.|+|++|.+++..+ ..|..++ +|++|+|++|.|++..+..+..+ ++|++|+|++|.+++..+..+
T Consensus 21 ~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l 100 (362)
T 3goz_A 21 PHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDEL 100 (362)
T ss_dssp CTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHH
T ss_pred CCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCccEEECcCCcCChHHHHHH
Confidence 3458889999998887666 6777888 88999999998887777777664 889999999998887766654
Q ss_pred cC----C-CCCCEEeccCCCCCCCCChhhhh-----ccccccccccccccCCCCchhhh---hcCc-ccceecccccccC
Q 042348 126 GK----L-KYLQVLDLSQNSFSSSIPSSIVQ-----CKRLKTVVLNQNSFTGPLPDGFA---TNLT-ALQKLDLSFNNLS 191 (686)
Q Consensus 126 ~~----l-~~L~~L~ls~N~l~~~~p~~~~~-----l~~L~~L~L~~N~l~~~~p~~~~---~~l~-~L~~L~Ls~N~l~ 191 (686)
.. + ++|+.|+|++|.+++..+..+.. ..+|++|+|++|+++..-+..+. ..++ +|++|+|++|+++
T Consensus 101 ~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~ 180 (362)
T 3goz_A 101 VKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLA 180 (362)
T ss_dssp HHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGG
T ss_pred HHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHHHhcCCccccEeeecCCCCc
Confidence 43 3 78899999999888766655544 35888999999988853333221 2344 8889999999988
Q ss_pred CCCchhhhcccccccc-cccccccccCCCCCCC----cccccc--cccCCcccccCCCC
Q 042348 192 GLIPNDIANLSRLRLL-AQRVYVDLTYNNLSGL----IPQNAA--LLSLGPTAFIGNPF 243 (686)
Q Consensus 192 ~~~p~~~~~l~~L~~l-~~~~~l~l~~N~l~~~----~p~~~~--~~~~~~~~~~~n~~ 243 (686)
+..+..+... |... ..+..|||++|+++.. ++.... ..++..+++.+|..
T Consensus 181 ~~~~~~l~~~--l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l 237 (362)
T 3goz_A 181 SKNCAELAKF--LASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCL 237 (362)
T ss_dssp GSCHHHHHHH--HHTSCTTCCEEECTTSCGGGSCHHHHHHHHHHSCTTCCEEECCSSCC
T ss_pred hhhHHHHHHH--HHhCCCCCCEEECCCCCCChhHHHHHHHHHhcCCCCceEEECcCCCC
Confidence 8777666543 1111 1233458999988863 222221 12455566666643
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.57 E-value=2.9e-15 Score=140.67 Aligned_cols=132 Identities=18% Similarity=0.188 Sum_probs=79.1
Q ss_pred cCCCCCCCEEEccCCCCcccCCccccCC-CCCcEEEccCCCCCCCCcccccCCCCCCEEeccCCCCCCCCChhhhhcccc
Q 042348 77 LGSLSAIGRVNLRNNNFSGSLPVELFNA-SNLQSLILSGNSFSGPVPMQIGKLKYLQVLDLSQNSFSSSIPSSIVQCKRL 155 (686)
Q Consensus 77 l~~l~~L~~L~L~~N~l~g~~p~~~~~l-~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L 155 (686)
+.++.+|+.|+|++|+++ .+|. +..+ ++|++|+|++|.+++. ..++.+++|++|+|++|.+++..|..+..+++|
T Consensus 15 ~~~~~~L~~L~l~~n~l~-~i~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L 90 (176)
T 1a9n_A 15 YTNAVRDRELDLRGYKIP-VIEN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDL 90 (176)
T ss_dssp EECTTSCEEEECTTSCCC-SCCC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTC
T ss_pred cCCcCCceEEEeeCCCCc-hhHH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCC
Confidence 445566666666666666 3443 3333 3677777777766643 456666677777777777664434444666677
Q ss_pred ccccccccccCCCCch--hhhhcCcccceecccccccCCCCch----hhhcccccccccccccccccCCCCC
Q 042348 156 KTVVLNQNSFTGPLPD--GFATNLTALQKLDLSFNNLSGLIPN----DIANLSRLRLLAQRVYVDLTYNNLS 221 (686)
Q Consensus 156 ~~L~L~~N~l~~~~p~--~~~~~l~~L~~L~Ls~N~l~~~~p~----~~~~l~~L~~l~~~~~l~l~~N~l~ 221 (686)
++|+|++|+++ .+|. .+ ..+++|+.|+|++|.++.. |. .+..+++|+.| |++.|.+.
T Consensus 91 ~~L~L~~N~i~-~~~~~~~l-~~l~~L~~L~l~~N~i~~~-~~~~~~~~~~l~~L~~L------d~~~n~~~ 153 (176)
T 1a9n_A 91 TELILTNNSLV-ELGDLDPL-ASLKSLTYLCILRNPVTNK-KHYRLYVIYKVPQVRVL------DFQKVKLK 153 (176)
T ss_dssp CEEECCSCCCC-CGGGGGGG-GGCTTCCEEECCSSGGGGS-TTHHHHHHHHCTTCSEE------TTEECCHH
T ss_pred CEEECCCCcCC-cchhhHhh-hcCCCCCEEEecCCCCCCc-HhHHHHHHHHCCcccee------CCCcCCHH
Confidence 77777777665 4554 33 3566777777777777643 33 25555555433 66666554
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.57 E-value=4.5e-15 Score=139.41 Aligned_cols=131 Identities=17% Similarity=0.135 Sum_probs=112.3
Q ss_pred CCCEEEEEeCCCCccccCCcCcCCCC-CCCEEEccCCCCcccCCccccCCCCCcEEEccCCCCCCCCcccccCCCCCCEE
Q 042348 56 EGQVFSLIIPNKKLTGFIPADLGSLS-AIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQVL 134 (686)
Q Consensus 56 ~~~~~~l~l~~n~l~g~~p~~l~~l~-~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L 134 (686)
...++.|+|++|+++. +|. +..+. +|+.|+|++|.|++. ..+.++++|++|+|++|++++..+..+..+++|++|
T Consensus 18 ~~~L~~L~l~~n~l~~-i~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 93 (176)
T 1a9n_A 18 AVRDRELDLRGYKIPV-IEN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTEL 93 (176)
T ss_dssp TTSCEEEECTTSCCCS-CCC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEE
T ss_pred cCCceEEEeeCCCCch-hHH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCCCEE
Confidence 3578999999999995 454 55555 999999999999965 688999999999999999996544556999999999
Q ss_pred eccCCCCCCCCCh--hhhhccccccccccccccCCCCchh---hhhcCcccceecccccccCC
Q 042348 135 DLSQNSFSSSIPS--SIVQCKRLKTVVLNQNSFTGPLPDG---FATNLTALQKLDLSFNNLSG 192 (686)
Q Consensus 135 ~ls~N~l~~~~p~--~~~~l~~L~~L~L~~N~l~~~~p~~---~~~~l~~L~~L~Ls~N~l~~ 192 (686)
+|++|+++ .+|. .+..+++|+.|+|++|.++ .+|.. ....+++|+.||+++|.+..
T Consensus 94 ~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~-~~~~~~~~~~~~l~~L~~Ld~~~n~~~~ 154 (176)
T 1a9n_A 94 ILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLDFQKVKLKE 154 (176)
T ss_dssp ECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEETTEECCHHH
T ss_pred ECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCC-CcHhHHHHHHHHCCccceeCCCcCCHHH
Confidence 99999997 5776 8899999999999999998 56764 34589999999999998763
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.56 E-value=1.2e-14 Score=157.77 Aligned_cols=159 Identities=25% Similarity=0.303 Sum_probs=106.3
Q ss_pred CCEEEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCccccCCCCCcEEEccCCCCCCCCcccccCCCCCCEEec
Q 042348 57 GQVFSLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQVLDL 136 (686)
Q Consensus 57 ~~~~~l~l~~n~l~g~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l 136 (686)
..++.|++++|++++ +|.. .++|++|+|++|++++ +| ++.++++|++|+|++|++++ +|..+ .+|++|++
T Consensus 111 ~~L~~L~l~~n~l~~-l~~~---~~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l~~N~l~~-lp~~~---~~L~~L~L 180 (454)
T 1jl5_A 111 QSLKSLLVDNNNLKA-LSDL---PPLLEYLGVSNNQLEK-LP-ELQNSSFLKIIDVDNNSLKK-LPDLP---PSLEFIAA 180 (454)
T ss_dssp TTCCEEECCSSCCSC-CCSC---CTTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSC-CCCCC---TTCCEEEC
T ss_pred CCCcEEECCCCccCc-ccCC---CCCCCEEECcCCCCCC-Cc-ccCCCCCCCEEECCCCcCcc-cCCCc---ccccEEEC
Confidence 355666666666654 2221 1578888888888885 77 58888888888888888874 56543 47888888
Q ss_pred cCCCCCCCCChhhhhccccccccccccccCCCCchhhhhcCcccceecccccccCCCCchhhhccccccccccccccccc
Q 042348 137 SQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSGLIPNDIANLSRLRLLAQRVYVDLT 216 (686)
Q Consensus 137 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~~~~~l~l~ 216 (686)
++|++++ +| .+..+++|++|++++|++++ +|.. .++|+.|+|++|+++ .+|. ++.+++|+.| +++
T Consensus 181 ~~n~l~~-l~-~~~~l~~L~~L~l~~N~l~~-l~~~----~~~L~~L~l~~n~l~-~lp~-~~~l~~L~~L------~l~ 245 (454)
T 1jl5_A 181 GNNQLEE-LP-ELQNLPFLTAIYADNNSLKK-LPDL----PLSLESIVAGNNILE-ELPE-LQNLPFLTTI------YAD 245 (454)
T ss_dssp CSSCCSS-CC-CCTTCTTCCEEECCSSCCSS-CCCC----CTTCCEEECCSSCCS-SCCC-CTTCTTCCEE------ECC
T ss_pred cCCcCCc-Cc-cccCCCCCCEEECCCCcCCc-CCCC----cCcccEEECcCCcCC-cccc-cCCCCCCCEE------ECC
Confidence 8888885 56 57788888888888888875 5542 357888888888887 4553 6666665544 777
Q ss_pred CCCCCCCcccccccccCCcccccCCCC
Q 042348 217 YNNLSGLIPQNAALLSLGPTAFIGNPF 243 (686)
Q Consensus 217 ~N~l~~~~p~~~~~~~~~~~~~~~n~~ 243 (686)
+|++++. |.. ..++....+.+|..
T Consensus 246 ~N~l~~l-~~~--~~~L~~L~l~~N~l 269 (454)
T 1jl5_A 246 NNLLKTL-PDL--PPSLEALNVRDNYL 269 (454)
T ss_dssp SSCCSSC-CSC--CTTCCEEECCSSCC
T ss_pred CCcCCcc-ccc--ccccCEEECCCCcc
Confidence 7777763 322 13344455555543
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.56 E-value=1.5e-14 Score=156.97 Aligned_cols=161 Identities=22% Similarity=0.284 Sum_probs=126.8
Q ss_pred CCCEEEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCccccCCCCCcEEEccCCCCCCCCcccccCCCCCCEEe
Q 042348 56 EGQVFSLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQVLD 135 (686)
Q Consensus 56 ~~~~~~l~l~~n~l~g~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ 135 (686)
...++.|+|++|.+++ +|.. +++|+.|++++|++++ +|.. .++|++|+|++|++++ +| .|+.+++|++|+
T Consensus 90 ~~~L~~L~l~~n~l~~-lp~~---~~~L~~L~l~~n~l~~-l~~~---~~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~ 159 (454)
T 1jl5_A 90 PPHLESLVASCNSLTE-LPEL---PQSLKSLLVDNNNLKA-LSDL---PPLLEYLGVSNNQLEK-LP-ELQNSSFLKIID 159 (454)
T ss_dssp CTTCSEEECCSSCCSS-CCCC---CTTCCEEECCSSCCSC-CCSC---CTTCCEEECCSSCCSS-CC-CCTTCTTCCEEE
T ss_pred cCCCCEEEccCCcCCc-cccc---cCCCcEEECCCCccCc-ccCC---CCCCCEEECcCCCCCC-Cc-ccCCCCCCCEEE
Confidence 3578889999999887 6653 4788999999999884 4432 2689999999999996 78 699999999999
Q ss_pred ccCCCCCCCCChhhhhccccccccccccccCCCCchhhhhcCcccceecccccccCCCCchhhhcccccccccccccccc
Q 042348 136 LSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSGLIPNDIANLSRLRLLAQRVYVDL 215 (686)
Q Consensus 136 ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~~~~~l~l 215 (686)
+++|++++ +|..+ .+|++|+|++|++++ +| .+ .++++|+.|++++|++++ +|... ++|+ .|++
T Consensus 160 l~~N~l~~-lp~~~---~~L~~L~L~~n~l~~-l~-~~-~~l~~L~~L~l~~N~l~~-l~~~~---~~L~------~L~l 222 (454)
T 1jl5_A 160 VDNNSLKK-LPDLP---PSLEFIAAGNNQLEE-LP-EL-QNLPFLTAIYADNNSLKK-LPDLP---LSLE------SIVA 222 (454)
T ss_dssp CCSSCCSC-CCCCC---TTCCEEECCSSCCSS-CC-CC-TTCTTCCEEECCSSCCSS-CCCCC---TTCC------EEEC
T ss_pred CCCCcCcc-cCCCc---ccccEEECcCCcCCc-Cc-cc-cCCCCCCEEECCCCcCCc-CCCCc---Cccc------EEEC
Confidence 99999996 66543 589999999999996 77 44 589999999999999997 44433 2343 4599
Q ss_pred cCCCCCCCcccccccccCCcccccCCCCC
Q 042348 216 TYNNLSGLIPQNAALLSLGPTAFIGNPFL 244 (686)
Q Consensus 216 ~~N~l~~~~p~~~~~~~~~~~~~~~n~~~ 244 (686)
++|+++ .+|....+..+....+.+|...
T Consensus 223 ~~n~l~-~lp~~~~l~~L~~L~l~~N~l~ 250 (454)
T 1jl5_A 223 GNNILE-ELPELQNLPFLTTIYADNNLLK 250 (454)
T ss_dssp CSSCCS-SCCCCTTCTTCCEEECCSSCCS
T ss_pred cCCcCC-cccccCCCCCCCEEECCCCcCC
Confidence 999999 5666555666777778887654
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.56 E-value=1.3e-17 Score=160.11 Aligned_cols=134 Identities=24% Similarity=0.258 Sum_probs=101.1
Q ss_pred CCEEEEEeCCCCccccCCc------CcCCCCCCCEEEccCCCCcccCCccccCCCCCcEEEccCCCCCCCCcccccCCCC
Q 042348 57 GQVFSLIIPNKKLTGFIPA------DLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGKLKY 130 (686)
Q Consensus 57 ~~~~~l~l~~n~l~g~~p~------~l~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~ 130 (686)
..++.++++++.++|.+|. .+..+++|+.|+|++|.|++ +| .+.++++|++|+|++|.++ .+|..+..+++
T Consensus 18 ~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~ 94 (198)
T 1ds9_A 18 KSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADT 94 (198)
T ss_dssp TCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHH
T ss_pred ccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCCc
Confidence 4556666777777777766 78888888888888888875 66 7778888888888888887 67777777788
Q ss_pred CCEEeccCCCCCCCCChhhhhccccccccccccccCCCCch-hhhhcCcccceecccccccCCCCch
Q 042348 131 LQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPD-GFATNLTALQKLDLSFNNLSGLIPN 196 (686)
Q Consensus 131 L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~-~~~~~l~~L~~L~Ls~N~l~~~~p~ 196 (686)
|+.|+|++|++++ +| .+..+++|+.|+|++|++++ ++. .....+++|++|+|++|.+++.+|.
T Consensus 95 L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~-~~~~~~l~~l~~L~~L~l~~N~l~~~~~~ 158 (198)
T 1ds9_A 95 LEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITN-WGEIDKLAALDKLEDLLLAGNPLYNDYKE 158 (198)
T ss_dssp CSEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCC-HHHHHHHTTTTTCSEEEECSCHHHHHHHT
T ss_pred CCEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCc-hhHHHHHhcCCCCCEEEecCCcccccccc
Confidence 8888888888885 45 57788888888888888874 333 2335788888888888888776554
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.56 E-value=1e-15 Score=161.56 Aligned_cols=180 Identities=19% Similarity=0.186 Sum_probs=139.0
Q ss_pred EEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCC----ccccCCC-CCcEEEccCCCCCCCCcccccCC-----CC
Q 042348 61 SLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLP----VELFNAS-NLQSLILSGNSFSGPVPMQIGKL-----KY 130 (686)
Q Consensus 61 ~l~l~~n~l~g~~p~~l~~l~~L~~L~L~~N~l~g~~p----~~~~~l~-~L~~L~L~~N~l~g~~p~~~~~l-----~~ 130 (686)
.+.|++|+++|.+|..+...++|+.|+|++|.|++..+ ..+.+++ +|++|+|++|.+++..+..+..+ ++
T Consensus 2 ~~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~ 81 (362)
T 3goz_A 2 NYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPAN 81 (362)
T ss_dssp EEECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTT
T ss_pred ccccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCC
Confidence 46789999999999988888889999999999997666 6788898 99999999999998888888775 99
Q ss_pred CCEEeccCCCCCCCCChhhhhc-----cccccccccccccCCCCchhhhh---c-CcccceecccccccCCCCchhhhcc
Q 042348 131 LQVLDLSQNSFSSSIPSSIVQC-----KRLKTVVLNQNSFTGPLPDGFAT---N-LTALQKLDLSFNNLSGLIPNDIANL 201 (686)
Q Consensus 131 L~~L~ls~N~l~~~~p~~~~~l-----~~L~~L~L~~N~l~~~~p~~~~~---~-l~~L~~L~Ls~N~l~~~~p~~~~~l 201 (686)
|++|+|++|.+++..+..+... ++|++|+|++|++++..+..+.. . .++|++|+|++|++++..+..+...
T Consensus 82 L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~ 161 (362)
T 3goz_A 82 VTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQI 161 (362)
T ss_dssp CCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHH
T ss_pred ccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHH
Confidence 9999999999998777766554 89999999999998665554432 2 3699999999999997655444221
Q ss_pred ccccccc-ccccccccCCCCCCCcccccc-----c-ccCCcccccCCC
Q 042348 202 SRLRLLA-QRVYVDLTYNNLSGLIPQNAA-----L-LSLGPTAFIGNP 242 (686)
Q Consensus 202 ~~L~~l~-~~~~l~l~~N~l~~~~p~~~~-----~-~~~~~~~~~~n~ 242 (686)
+..++ .+..|+|++|++++..+.... . .++..+++.+|.
T Consensus 162 --l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~ 207 (362)
T 3goz_A 162 --LAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANL 207 (362)
T ss_dssp --HHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSC
T ss_pred --HhcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCC
Confidence 11111 334569999999987664322 1 245555566654
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.55 E-value=3.9e-16 Score=166.35 Aligned_cols=181 Identities=16% Similarity=0.284 Sum_probs=139.8
Q ss_pred CCEEEEEeCCCCcccc----CCcCcCCCCCCCEEEccCC---CCcccCCccc-------cCCCCCcEEEccCCCCCC---
Q 042348 57 GQVFSLIIPNKKLTGF----IPADLGSLSAIGRVNLRNN---NFSGSLPVEL-------FNASNLQSLILSGNSFSG--- 119 (686)
Q Consensus 57 ~~~~~l~l~~n~l~g~----~p~~l~~l~~L~~L~L~~N---~l~g~~p~~~-------~~l~~L~~L~L~~N~l~g--- 119 (686)
..++.|+|++|.+++. ++..|..+++|+.|+|++| ++++.+|..+ .++++|++|+|++|.+++
T Consensus 32 ~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~ 111 (386)
T 2ca6_A 32 DSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQ 111 (386)
T ss_dssp SCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCCTTTH
T ss_pred CCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECCCCcCCHHHH
Confidence 5789999999999987 4455889999999999995 5666777665 789999999999999997
Q ss_pred -CCcccccCCCCCCEEeccCCCCCCCCChhhh----hc---------cccccccccccccC-CCCch--hhhhcCcccce
Q 042348 120 -PVPMQIGKLKYLQVLDLSQNSFSSSIPSSIV----QC---------KRLKTVVLNQNSFT-GPLPD--GFATNLTALQK 182 (686)
Q Consensus 120 -~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~----~l---------~~L~~L~L~~N~l~-~~~p~--~~~~~l~~L~~ 182 (686)
.+|..+..+++|++|+|++|.+++..+..+. .+ ++|++|+|++|+++ +.+|. ..+..+++|++
T Consensus 112 ~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~ 191 (386)
T 2ca6_A 112 EPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHT 191 (386)
T ss_dssp HHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCE
T ss_pred HHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHHHHhCCCcCE
Confidence 4888899999999999999999754444443 44 89999999999998 44552 22247899999
Q ss_pred ecccccccC--C---CCchhhhcccccccccccccccccCCCCC----CCccccc-ccccCCcccccCCCC
Q 042348 183 LDLSFNNLS--G---LIPNDIANLSRLRLLAQRVYVDLTYNNLS----GLIPQNA-ALLSLGPTAFIGNPF 243 (686)
Q Consensus 183 L~Ls~N~l~--~---~~p~~~~~l~~L~~l~~~~~l~l~~N~l~----~~~p~~~-~~~~~~~~~~~~n~~ 243 (686)
|+|++|+++ | .+|..+..+++|+. |+|++|.++ +.+|... .+.++..+.+.+|..
T Consensus 192 L~L~~n~l~~~g~~~l~~~~l~~~~~L~~------L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i 256 (386)
T 2ca6_A 192 VKMVQNGIRPEGIEHLLLEGLAYCQELKV------LDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLL 256 (386)
T ss_dssp EECCSSCCCHHHHHHHHHTTGGGCTTCCE------EECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCC
T ss_pred EECcCCCCCHhHHHHHHHHHhhcCCCccE------EECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCC
Confidence 999999998 3 33435666666654 599999996 4555443 345566666777753
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.55 E-value=8.4e-15 Score=162.99 Aligned_cols=108 Identities=21% Similarity=0.264 Sum_probs=84.8
Q ss_pred CCCEEEccCCCCcccCCccccCCCCCcEEEccCCCCCCCCcccccCCCCCCEEeccCCCCCCCCChhhhhcccccccccc
Q 042348 82 AIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLN 161 (686)
Q Consensus 82 ~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~ 161 (686)
.|+.|+|++|+|++ +|. +.++++|+.|+|++|+|+ .+|..|+.+++|+.|+|++|+|++ +| .+..+++|+.|+|+
T Consensus 442 ~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls 516 (567)
T 1dce_A 442 DVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLC 516 (567)
T ss_dssp TCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECC
T ss_pred CceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECC
Confidence 37778888888874 665 788888888888888887 778888888888888888888885 66 77888888888888
Q ss_pred ccccCCCC-chhhhhcCcccceecccccccCCCCc
Q 042348 162 QNSFTGPL-PDGFATNLTALQKLDLSFNNLSGLIP 195 (686)
Q Consensus 162 ~N~l~~~~-p~~~~~~l~~L~~L~Ls~N~l~~~~p 195 (686)
+|+|++.+ |..+ ..+++|+.|+|++|.|++.+|
T Consensus 517 ~N~l~~~~~p~~l-~~l~~L~~L~L~~N~l~~~~~ 550 (567)
T 1dce_A 517 NNRLQQSAAIQPL-VSCPRLVLLNLQGNSLCQEEG 550 (567)
T ss_dssp SSCCCSSSTTGGG-GGCTTCCEEECTTSGGGGSSS
T ss_pred CCCCCCCCCcHHH-hcCCCCCEEEecCCcCCCCcc
Confidence 88888655 6666 378888888888888887655
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.53 E-value=4.1e-14 Score=158.65 Aligned_cols=54 Identities=22% Similarity=0.361 Sum_probs=31.5
Q ss_pred CCEEEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCccccCCCCCcEEEccCCCCC
Q 042348 57 GQVFSLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFS 118 (686)
Q Consensus 57 ~~~~~l~l~~n~l~g~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~ 118 (686)
..++.|+|++|+|++ +|. .+++|+.|+|++|+|++ +|. .+++|+.|+|++|+++
T Consensus 81 ~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-l~~---~l~~L~~L~L~~N~l~ 134 (622)
T 3g06_A 81 PELRTLEVSGNQLTS-LPV---LPPGLLELSIFSNPLTH-LPA---LPSGLCKLWIFGNQLT 134 (622)
T ss_dssp TTCCEEEECSCCCSC-CCC---CCTTCCEEEECSCCCCC-CCC---CCTTCCEEECCSSCCS
T ss_pred CCCCEEEcCCCcCCc-CCC---CCCCCCEEECcCCcCCC-CCC---CCCCcCEEECCCCCCC
Confidence 467778888888774 454 55666777777776663 333 2334444444444443
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.52 E-value=3.2e-14 Score=132.64 Aligned_cols=104 Identities=20% Similarity=0.213 Sum_probs=70.4
Q ss_pred EEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCccccCCCCCcEEEccCCCCCCCCcccccCCCCCCEEeccCCC
Q 042348 61 SLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQVLDLSQNS 140 (686)
Q Consensus 61 ~l~l~~n~l~g~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~ 140 (686)
.|++++|+|+. +|..+. ++|+.|+|++|+|++..|..|.++++|++|+|++|+|++..+..|..+++|++|+|++|+
T Consensus 13 ~l~~s~n~l~~-ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~ 89 (170)
T 3g39_A 13 TVDCSGKSLAS-VPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDNQ 89 (170)
T ss_dssp EEECTTSCCSS-CCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred EEEeCCCCcCc-cCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCCc
Confidence 45666777774 565553 677777777777776667777777777777777777775555556777777777777777
Q ss_pred CCCCCChhhhhccccccccccccccCC
Q 042348 141 FSSSIPSSIVQCKRLKTVVLNQNSFTG 167 (686)
Q Consensus 141 l~~~~p~~~~~l~~L~~L~L~~N~l~~ 167 (686)
|++..+..+..+++|+.|+|++|.++.
T Consensus 90 l~~~~~~~~~~l~~L~~L~L~~N~~~c 116 (170)
T 3g39_A 90 LKSIPRGAFDNLKSLTHIWLLNNPWDC 116 (170)
T ss_dssp CCCCCTTTTTTCTTCCEEECCSSCBCT
T ss_pred cCEeCHHHhcCCCCCCEEEeCCCCCCC
Confidence 775555556666666666666666553
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.51 E-value=6.4e-14 Score=130.60 Aligned_cols=108 Identities=23% Similarity=0.275 Sum_probs=96.3
Q ss_pred CCEEEccCCCCcccCCccccCCCCCcEEEccCCCCCCCCcccccCCCCCCEEeccCCCCCCCCChhhhhccccccccccc
Q 042348 83 IGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQ 162 (686)
Q Consensus 83 L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~ 162 (686)
.+.|++++|.|+ .+|..+. ++|++|+|++|+|++..|..|..+++|++|+|++|+|++..|..|..+++|++|+|++
T Consensus 11 ~~~l~~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~ 87 (170)
T 3g39_A 11 GTTVDCSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLND 87 (170)
T ss_dssp TTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEEEeCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCC
Confidence 468999999998 6887764 8999999999999988899999999999999999999987777789999999999999
Q ss_pred cccCCCCchhhhhcCcccceecccccccCCCC
Q 042348 163 NSFTGPLPDGFATNLTALQKLDLSFNNLSGLI 194 (686)
Q Consensus 163 N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~ 194 (686)
|+|++ +|...+..+++|+.|+|++|.++...
T Consensus 88 N~l~~-~~~~~~~~l~~L~~L~L~~N~~~c~c 118 (170)
T 3g39_A 88 NQLKS-IPRGAFDNLKSLTHIWLLNNPWDCAC 118 (170)
T ss_dssp SCCCC-CCTTTTTTCTTCCEEECCSSCBCTTB
T ss_pred CccCE-eCHHHhcCCCCCCEEEeCCCCCCCCc
Confidence 99995 55554468999999999999999754
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.50 E-value=6.1e-14 Score=131.18 Aligned_cols=104 Identities=25% Similarity=0.271 Sum_probs=68.5
Q ss_pred EEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCccccCCCCCcEEEccCCCCCCCCcccccCCCCCCEEeccCC
Q 042348 60 FSLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQVLDLSQN 139 (686)
Q Consensus 60 ~~l~l~~n~l~g~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N 139 (686)
+.+++++|+|+ .+|..+. ++|+.|+|++|+|++..|..|.++++|+.|+|++|+|++..+..|..+++|++|+|++|
T Consensus 15 ~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N 91 (174)
T 2r9u_A 15 TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN 91 (174)
T ss_dssp SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence 46777777775 4666554 67777777777777666777777777777777777777544445566777777777777
Q ss_pred CCCCCCChhhhhccccccccccccccC
Q 042348 140 SFSSSIPSSIVQCKRLKTVVLNQNSFT 166 (686)
Q Consensus 140 ~l~~~~p~~~~~l~~L~~L~L~~N~l~ 166 (686)
+|++..+..+..+++|++|+|++|.+.
T Consensus 92 ~l~~l~~~~~~~l~~L~~L~L~~N~~~ 118 (174)
T 2r9u_A 92 HLKSIPRGAFDNLKSLTHIYLYNNPWD 118 (174)
T ss_dssp CCCCCCTTTTTTCTTCSEEECCSSCBC
T ss_pred ccceeCHHHhccccCCCEEEeCCCCcc
Confidence 776544444555555555555555555
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.50 E-value=3e-14 Score=149.47 Aligned_cols=142 Identities=13% Similarity=0.098 Sum_probs=106.6
Q ss_pred eEecCCCEEEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCccccCCCCCcEEEccCCCCCCCCcc-cccCCCC
Q 042348 52 ITCREGQVFSLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPM-QIGKLKY 130 (686)
Q Consensus 52 v~c~~~~~~~l~l~~n~l~g~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~-~~~~l~~ 130 (686)
-+|... +++.++++|+ .+|..+ .+++++|+|++|+|+...+..|.++++|++|+|++|++.+.+|. .|.++++
T Consensus 7 C~C~~~---~v~C~~~~Lt-~iP~~l--~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~ 80 (350)
T 4ay9_X 7 CHCSNR---VFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPK 80 (350)
T ss_dssp SEEETT---EEEEESTTCC-SCCTTC--CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTT
T ss_pred cEeeCC---EEEecCCCCC-ccCcCc--CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchh
Confidence 357543 4678899999 578776 36899999999999955556799999999999999999876664 6788988
Q ss_pred CCE-EeccCCCCCCCCChhhhhccccccccccccccCCCCchhhhhcCcccceecccc-cccCCCCchhhhc
Q 042348 131 LQV-LDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSF-NNLSGLIPNDIAN 200 (686)
Q Consensus 131 L~~-L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~ 200 (686)
|+. ++++.|+++...|..|..+++|++|++++|++++..+..+ ....++..|++++ |++....+..+..
T Consensus 81 l~~~l~~~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~-~~~~~l~~l~l~~~~~i~~l~~~~f~~ 151 (350)
T 4ay9_X 81 LHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHK-IHSLQKVLLDIQDNINIHTIERNSFVG 151 (350)
T ss_dssp CCEEEEEEETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTT-CCBSSCEEEEEESCTTCCEECTTSSTT
T ss_pred hhhhhcccCCcccccCchhhhhccccccccccccccccCCchhh-cccchhhhhhhccccccccccccchhh
Confidence 875 6777899998888899999999999999999985433333 2444555555543 3444444444443
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.49 E-value=9.2e-14 Score=129.96 Aligned_cols=106 Identities=25% Similarity=0.283 Sum_probs=95.3
Q ss_pred CEEEccCCCCcccCCccccCCCCCcEEEccCCCCCCCCcccccCCCCCCEEeccCCCCCCCCChhhhhcccccccccccc
Q 042348 84 GRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQN 163 (686)
Q Consensus 84 ~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N 163 (686)
+.+++++|+++ .+|..+. ++|+.|+|++|+|++..|..|..+++|++|+|++|+|++..+..|..+++|+.|+|++|
T Consensus 15 ~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N 91 (174)
T 2r9u_A 15 TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN 91 (174)
T ss_dssp SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence 68999999997 7888775 89999999999999888999999999999999999999766667789999999999999
Q ss_pred ccCCCCchhhhhcCcccceecccccccCCC
Q 042348 164 SFTGPLPDGFATNLTALQKLDLSFNNLSGL 193 (686)
Q Consensus 164 ~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~ 193 (686)
+|++ +|...+..+++|++|+|++|.++..
T Consensus 92 ~l~~-l~~~~~~~l~~L~~L~L~~N~~~c~ 120 (174)
T 2r9u_A 92 HLKS-IPRGAFDNLKSLTHIYLYNNPWDCE 120 (174)
T ss_dssp CCCC-CCTTTTTTCTTCSEEECCSSCBCTT
T ss_pred ccce-eCHHHhccccCCCEEEeCCCCcccc
Confidence 9995 6665446899999999999999964
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.49 E-value=1.8e-16 Score=152.09 Aligned_cols=138 Identities=20% Similarity=0.269 Sum_probs=118.5
Q ss_pred cCCCCCCCEEEccCCCCcccCCc------cccCCCCCcEEEccCCCCCCCCcccccCCCCCCEEeccCCCCCCCCChhhh
Q 042348 77 LGSLSAIGRVNLRNNNFSGSLPV------ELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQVLDLSQNSFSSSIPSSIV 150 (686)
Q Consensus 77 l~~l~~L~~L~L~~N~l~g~~p~------~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~ 150 (686)
+.....++.++|+.|.++|.+|. .+.++++|++|+|++|.+++ +| .+..+++|+.|+|++|.++ .+|..+.
T Consensus 14 ~~~~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~ 90 (198)
T 1ds9_A 14 FEERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDA 90 (198)
T ss_dssp HHHTTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHH
T ss_pred HHhcccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhh
Confidence 44566788888999999988887 89999999999999999996 77 8999999999999999999 6898888
Q ss_pred hccccccccccccccCCCCchhhhhcCcccceecccccccCCCCc-hhhhcccccccccccccccccCCCCCCCccc
Q 042348 151 QCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSGLIP-NDIANLSRLRLLAQRVYVDLTYNNLSGLIPQ 226 (686)
Q Consensus 151 ~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~l~~~~~l~l~~N~l~~~~p~ 226 (686)
.+++|++|+|++|++++ +| .+ ..+++|++|+|++|++++..+ ..+..+++|+. |++++|.+++.+|.
T Consensus 91 ~~~~L~~L~L~~N~l~~-l~-~~-~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~------L~l~~N~l~~~~~~ 158 (198)
T 1ds9_A 91 VADTLEELWISYNQIAS-LS-GI-EKLVNLRVLYMSNNKITNWGEIDKLAALDKLED------LLLAGNPLYNDYKE 158 (198)
T ss_dssp HHHHCSEEEEEEEECCC-HH-HH-HHHHHSSEEEESEEECCCHHHHHHHTTTTTCSE------EEECSCHHHHHHHT
T ss_pred cCCcCCEEECcCCcCCc-CC-cc-ccCCCCCEEECCCCcCCchhHHHHHhcCCCCCE------EEecCCcccccccc
Confidence 99999999999999996 66 45 479999999999999997543 45666666654 49999999988775
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.45 E-value=1.2e-13 Score=144.77 Aligned_cols=108 Identities=18% Similarity=0.208 Sum_probs=89.8
Q ss_pred cceeeeEecCCCEEEEEeCCC-CccccCCcCcCCCCCCCEEEccC-CCCcccCCccccCCCCCcEEEccCCCCCCCCccc
Q 042348 47 CSWNGITCREGQVFSLIIPNK-KLTGFIPADLGSLSAIGRVNLRN-NNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQ 124 (686)
Q Consensus 47 c~w~gv~c~~~~~~~l~l~~n-~l~g~~p~~l~~l~~L~~L~L~~-N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~ 124 (686)
|.|.+|.|. ++ +|++ +|. |..+++|+.|+|++ |+|++..|..|.+|++|+.|+|++|+|++..|..
T Consensus 8 C~~~~v~~~----------~~n~l~~-ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~ 75 (347)
T 2ifg_A 8 HGSSGLRCT----------RDGALDS-LHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDA 75 (347)
T ss_dssp SSSSCEECC----------SSCCCTT-TTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTG
T ss_pred ccCCEEEcC----------CCCCCCc-cCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHH
Confidence 777777774 44 7875 777 99999999999996 9999877788999999999999999999888888
Q ss_pred ccCCCCCCEEeccCCCCCCCCChhhhhccccccccccccccCC
Q 042348 125 IGKLKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTG 167 (686)
Q Consensus 125 ~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 167 (686)
|.+|++|+.|+|++|+|++..+..+..+. |+.|+|++|.|..
T Consensus 76 ~~~l~~L~~L~l~~N~l~~~~~~~~~~~~-L~~l~l~~N~~~c 117 (347)
T 2ifg_A 76 FHFTPRLSRLNLSFNALESLSWKTVQGLS-LQELVLSGNPLHC 117 (347)
T ss_dssp GGSCSCCCEEECCSSCCSCCCSTTTCSCC-CCEEECCSSCCCC
T ss_pred hcCCcCCCEEeCCCCccceeCHHHcccCC-ceEEEeeCCCccC
Confidence 99999999999999999965555555554 8888888888764
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.39 E-value=1.3e-14 Score=158.43 Aligned_cols=161 Identities=15% Similarity=0.103 Sum_probs=95.4
Q ss_pred CCEEEEEeCCCCccccCCcCcC-----CCCCCCEEEccCCCCccc----CCccccCCCCCcEEEccCCCCCCCC-----c
Q 042348 57 GQVFSLIIPNKKLTGFIPADLG-----SLSAIGRVNLRNNNFSGS----LPVELFNASNLQSLILSGNSFSGPV-----P 122 (686)
Q Consensus 57 ~~~~~l~l~~n~l~g~~p~~l~-----~l~~L~~L~L~~N~l~g~----~p~~~~~l~~L~~L~L~~N~l~g~~-----p 122 (686)
..++.|+|++|.+++..+..+. .+++|+.|+|++|.+++. ++..+..+++|+.|+|++|.+++.- +
T Consensus 170 ~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~ 249 (461)
T 1z7x_W 170 PDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCP 249 (461)
T ss_dssp TTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHH
T ss_pred CCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCChHHHHHHHH
Confidence 4677777777777665444333 255777777777777643 4556666777777777777765421 2
Q ss_pred ccccCCCCCCEEeccCCCCCCC----CChhhhhccccccccccccccCCCCchhhh----hcCcccceecccccccCCC-
Q 042348 123 MQIGKLKYLQVLDLSQNSFSSS----IPSSIVQCKRLKTVVLNQNSFTGPLPDGFA----TNLTALQKLDLSFNNLSGL- 193 (686)
Q Consensus 123 ~~~~~l~~L~~L~ls~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~----~~l~~L~~L~Ls~N~l~~~- 193 (686)
..+..+++|+.|+|++|.+++. ++..+..+++|++|+|++|.+++..+..+. ...++|+.|+|++|.+++.
T Consensus 250 ~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~ 329 (461)
T 1z7x_W 250 GLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAAC 329 (461)
T ss_dssp HHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGG
T ss_pred HHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHH
Confidence 2223466777777777777643 455666677777777777776533222222 1224677777777776654
Q ss_pred ---CchhhhcccccccccccccccccCCCCCCC
Q 042348 194 ---IPNDIANLSRLRLLAQRVYVDLTYNNLSGL 223 (686)
Q Consensus 194 ---~p~~~~~l~~L~~l~~~~~l~l~~N~l~~~ 223 (686)
+|..+..+++|+.| |+++|++++.
T Consensus 330 ~~~l~~~l~~~~~L~~L------~Ls~n~i~~~ 356 (461)
T 1z7x_W 330 CSHFSSVLAQNRFLLEL------QISNNRLEDA 356 (461)
T ss_dssp HHHHHHHHHHCSSCCEE------ECCSSBCHHH
T ss_pred HHHHHHHHhhCCCccEE------EccCCccccc
Confidence 34444444444433 6666666543
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.34 E-value=3.3e-14 Score=155.09 Aligned_cols=181 Identities=18% Similarity=0.135 Sum_probs=138.5
Q ss_pred CCEEEEEeCCCCcccc----CCcCcCCCCCCCEEEccCCCCcccC-----CccccCCCCCcEEEccCCCCCCC----Ccc
Q 042348 57 GQVFSLIIPNKKLTGF----IPADLGSLSAIGRVNLRNNNFSGSL-----PVELFNASNLQSLILSGNSFSGP----VPM 123 (686)
Q Consensus 57 ~~~~~l~l~~n~l~g~----~p~~l~~l~~L~~L~L~~N~l~g~~-----p~~~~~l~~L~~L~L~~N~l~g~----~p~ 123 (686)
.+++.|+|++|.+++. ++..+..+++|+.|+|++|.+++.. +..+..+++|+.|+|++|.+++. ++.
T Consensus 199 ~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~ 278 (461)
T 1z7x_W 199 CQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCR 278 (461)
T ss_dssp CCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHH
T ss_pred CCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHH
Confidence 4899999999999974 6778888999999999999987532 22334689999999999999854 677
Q ss_pred cccCCCCCCEEeccCCCCCCCCChhhhhc-----cccccccccccccCCC----CchhhhhcCcccceecccccccCCCC
Q 042348 124 QIGKLKYLQVLDLSQNSFSSSIPSSIVQC-----KRLKTVVLNQNSFTGP----LPDGFATNLTALQKLDLSFNNLSGLI 194 (686)
Q Consensus 124 ~~~~l~~L~~L~ls~N~l~~~~p~~~~~l-----~~L~~L~L~~N~l~~~----~p~~~~~~l~~L~~L~Ls~N~l~~~~ 194 (686)
.+..+++|+.|+|++|.+++..+..+... ++|+.|+|++|.+++. ++..+ ..+++|+.|||++|.+++..
T Consensus 279 ~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l-~~~~~L~~L~Ls~n~i~~~~ 357 (461)
T 1z7x_W 279 VLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVL-AQNRFLLELQISNNRLEDAG 357 (461)
T ss_dssp HHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHH-HHCSSCCEEECCSSBCHHHH
T ss_pred HHhhCCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHHHHH-hhCCCccEEEccCCcccccc
Confidence 88889999999999999876555555543 6899999999999864 34444 46799999999999998765
Q ss_pred chhhhc-----ccccccccccccccccCCCCCC----Cccccc-ccccCCcccccCCCCC
Q 042348 195 PNDIAN-----LSRLRLLAQRVYVDLTYNNLSG----LIPQNA-ALLSLGPTAFIGNPFL 244 (686)
Q Consensus 195 p~~~~~-----l~~L~~l~~~~~l~l~~N~l~~----~~p~~~-~~~~~~~~~~~~n~~~ 244 (686)
+..+.. .++| ..|++++|++++ .+|... .+.++..+.+.+|+..
T Consensus 358 ~~~l~~~l~~~~~~L------~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~N~i~ 411 (461)
T 1z7x_W 358 VRELCQGLGQPGSVL------RVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLG 411 (461)
T ss_dssp HHHHHHHHTSTTCCC------CEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCC
T ss_pred HHHHHHHHcCCCCce------EEEECCCCCCChhhHHHHHHHHHhCCCccEEECCCCCCC
Confidence 555543 3344 455999999985 555443 3566777788888653
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.34 E-value=1.5e-12 Score=136.39 Aligned_cols=106 Identities=23% Similarity=0.210 Sum_probs=93.7
Q ss_pred CEEEccCC-CCcccCCccccCCCCCcEEEccC-CCCCCCCcccccCCCCCCEEeccCCCCCCCCChhhhhcccccccccc
Q 042348 84 GRVNLRNN-NFSGSLPVELFNASNLQSLILSG-NSFSGPVPMQIGKLKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLN 161 (686)
Q Consensus 84 ~~L~L~~N-~l~g~~p~~~~~l~~L~~L~L~~-N~l~g~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~ 161 (686)
..+++++| .|+ .+|. +..+++|+.|+|++ |+|++..+..|+.|++|+.|+|++|+|++..|..|.++++|+.|+|+
T Consensus 11 ~~v~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~ 88 (347)
T 2ifg_A 11 SGLRCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLS 88 (347)
T ss_dssp SCEECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECC
T ss_pred CEEEcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCC
Confidence 35799998 898 5888 99999999999996 99998888899999999999999999999889999999999999999
Q ss_pred ccccCCCCchhhhhcCcccceecccccccCCC
Q 042348 162 QNSFTGPLPDGFATNLTALQKLDLSFNNLSGL 193 (686)
Q Consensus 162 ~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~ 193 (686)
+|+|++ +|...+..++ |+.|+|++|.|...
T Consensus 89 ~N~l~~-~~~~~~~~~~-L~~l~l~~N~~~c~ 118 (347)
T 2ifg_A 89 FNALES-LSWKTVQGLS-LQELVLSGNPLHCS 118 (347)
T ss_dssp SSCCSC-CCSTTTCSCC-CCEEECCSSCCCCC
T ss_pred CCccce-eCHHHcccCC-ceEEEeeCCCccCC
Confidence 999995 6665554555 99999999999853
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.27 E-value=1.5e-11 Score=123.15 Aligned_cols=135 Identities=15% Similarity=0.107 Sum_probs=106.5
Q ss_pred ccCccCceEEEEEEeCCCceEEEEEcCCCCccchHHHHHHHHHHhccC-CCCcceeeEEEEecCceeEEEeccCCCCHHH
Q 042348 374 LLGKSTIGIVYKVALNNEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIR-HPNIVSLRAYFWSVDEKLLIYDYIPNGSLAT 452 (686)
Q Consensus 374 ~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lV~e~~~~gsL~~ 452 (686)
.++.|+.+.||++... +..+++|+...........+.+|+++++.+. |..+.++++++...+..++||||++|.+|.+
T Consensus 21 ~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~ 99 (263)
T 3tm0_A 21 DTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSE 99 (263)
T ss_dssp CCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHH
T ss_pred eccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecCCeehhh
Confidence 4677788999999865 6789999986532223356899999999984 6788899999998888999999999999987
Q ss_pred HhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccC-------------------------------------------
Q 042348 453 AIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVS------------------------------------------- 489 (686)
Q Consensus 453 ~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~------------------------------------------- 489 (686)
.+. +......++.+++++|+.||+..
T Consensus 100 ~~~-----------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (263)
T 3tm0_A 100 EYE-----------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPR 168 (263)
T ss_dssp HCC-----------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHH
T ss_pred ccC-----------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCHH
Confidence 632 11234578899999999999821
Q ss_pred -------------CCCceecCCCCCCeeecCCCCeEEeecCccc
Q 042348 490 -------------PKRYVHGDLRPSNILLGKNMEPHISDFGLAR 520 (686)
Q Consensus 490 -------------~~~iiHrDlkp~NILl~~~~~~kl~DfGla~ 520 (686)
+..++|+|++|.||+++++..+.|+||+.+.
T Consensus 169 ~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 169 ELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp HHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 1358999999999999876556799999875
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.18 E-value=6.2e-11 Score=118.46 Aligned_cols=128 Identities=16% Similarity=0.188 Sum_probs=98.3
Q ss_pred CccCceEEEEEEeCCCceEEEEEcCCCCccchHHHHHHHHHHhccCCCC--cceeeEEEEecCceeEEEeccCCCCHHHH
Q 042348 376 GKSTIGIVYKVALNNEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPN--IVSLRAYFWSVDEKLLIYDYIPNGSLATA 453 (686)
Q Consensus 376 G~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n--Iv~l~~~~~~~~~~~lV~e~~~~gsL~~~ 453 (686)
+.|..+.||++...+|..+++|..... ....+..|+++++.+.+.+ +.+++++....+..++||||++|.+|.
T Consensus 29 ~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~-- 103 (264)
T 1nd4_A 29 IGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL-- 103 (264)
T ss_dssp CTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT--
T ss_pred cCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC--
Confidence 355669999998877888999997654 2356889999999996544 566888888878889999999998884
Q ss_pred hhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccC--------------------------------------------
Q 042348 454 IHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVS-------------------------------------------- 489 (686)
Q Consensus 454 l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~-------------------------------------------- 489 (686)
... .+ ...++.++++.|+.||+..
T Consensus 104 ~~~---------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (264)
T 1nd4_A 104 SSH---------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELF 171 (264)
T ss_dssp TSC---------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHH
T ss_pred cCc---------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHH
Confidence 211 11 2357778888888888732
Q ss_pred -----------CCCceecCCCCCCeeecCCCCeEEeecCccc
Q 042348 490 -----------PKRYVHGDLRPSNILLGKNMEPHISDFGLAR 520 (686)
Q Consensus 490 -----------~~~iiHrDlkp~NILl~~~~~~kl~DfGla~ 520 (686)
+..++|+|++|.||+++++..+.|+||+.+.
T Consensus 172 ~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 172 ARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp HHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 1239999999999999877667799999875
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.16 E-value=1.9e-11 Score=126.92 Aligned_cols=89 Identities=19% Similarity=0.200 Sum_probs=56.2
Q ss_pred CCCCCEEeccCCCCCCCCChhhhhccccccccccccccCCCCchhhhhcCcccc-eecccccccCCCCchhhhccccccc
Q 042348 128 LKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQ-KLDLSFNNLSGLIPNDIANLSRLRL 206 (686)
Q Consensus 128 l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~-~L~Ls~N~l~~~~p~~~~~l~~L~~ 206 (686)
+++|+.|+|++|+++...+..|.+|.+|+.|+|.+| ++ .|+...+.++.+|+ .|+|.+ .++.+.+..|.+|++|+.
T Consensus 225 ~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~-~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~ 301 (329)
T 3sb4_A 225 MPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LK-TIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRY 301 (329)
T ss_dssp CTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CC-EECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEE
T ss_pred cCCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cc-eehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCE
Confidence 556677777766666544556666777777777666 54 45555556666676 777766 566555666666666665
Q ss_pred ccccccccccCCCCCCCcc
Q 042348 207 LAQRVYVDLTYNNLSGLIP 225 (686)
Q Consensus 207 l~~~~~l~l~~N~l~~~~p 225 (686)
+ ++++|+++...+
T Consensus 302 l------~l~~n~i~~I~~ 314 (329)
T 3sb4_A 302 V------LATGDKITTLGD 314 (329)
T ss_dssp E------EECSSCCCEECT
T ss_pred E------EeCCCccCccch
Confidence 4 666676665433
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.16 E-value=4.6e-13 Score=141.02 Aligned_cols=160 Identities=16% Similarity=0.181 Sum_probs=115.8
Q ss_pred CCEEEEEeCCCCccccCCcCcCC-----CCCCCEEEccCCCCcccCCcccc-CCCCCcEEEccCCCCCCCCcccc-----
Q 042348 57 GQVFSLIIPNKKLTGFIPADLGS-----LSAIGRVNLRNNNFSGSLPVELF-NASNLQSLILSGNSFSGPVPMQI----- 125 (686)
Q Consensus 57 ~~~~~l~l~~n~l~g~~p~~l~~-----l~~L~~L~L~~N~l~g~~p~~~~-~l~~L~~L~L~~N~l~g~~p~~~----- 125 (686)
..++.|+|++|.|+..-...|.. .++|+.|+|++|.|+..-...+. .+++|+.|+|++|.|+..-...+
T Consensus 72 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~ 151 (372)
T 3un9_A 72 SSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLL 151 (372)
T ss_dssp TTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHH
T ss_pred hhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHH
Confidence 57889999999998754433332 37999999999999754333333 45789999999999975433333
Q ss_pred cCCCCCCEEeccCCCCCCC----CChhhhhccccccccccccccCCC----CchhhhhcCcccceecccccccCCCC---
Q 042348 126 GKLKYLQVLDLSQNSFSSS----IPSSIVQCKRLKTVVLNQNSFTGP----LPDGFATNLTALQKLDLSFNNLSGLI--- 194 (686)
Q Consensus 126 ~~l~~L~~L~ls~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~~l~~L~~L~Ls~N~l~~~~--- 194 (686)
...++|+.|+|++|.++.. ++..+..+++|++|+|++|.++.. ++..+ ...++|+.|||++|.|+..-
T Consensus 152 ~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L-~~~~~L~~L~Ls~N~i~~~g~~~ 230 (372)
T 3un9_A 152 HDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQL-DRNRQLQELNVAYNGAGDTAALA 230 (372)
T ss_dssp STTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHG-GGCSCCCEEECCSSCCCHHHHHH
T ss_pred hcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHH-hcCCCcCeEECCCCCCCHHHHHH
Confidence 3468899999999998742 344557789999999999998742 22333 36789999999999998642
Q ss_pred -chhhhcccccccccccccccccCCCCCCC
Q 042348 195 -PNDIANLSRLRLLAQRVYVDLTYNNLSGL 223 (686)
Q Consensus 195 -p~~~~~l~~L~~l~~~~~l~l~~N~l~~~ 223 (686)
+..+...++|+ +|||++|.|+..
T Consensus 231 l~~~L~~~~~L~------~L~Ls~N~i~~~ 254 (372)
T 3un9_A 231 LARAAREHPSLE------LLHLYFNELSSE 254 (372)
T ss_dssp HHHHHHHCSSCC------EEECTTSSCCHH
T ss_pred HHHHHHhCCCCC------EEeccCCCCCHH
Confidence 23333344444 559999998753
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.05 E-value=4.2e-10 Score=118.20 Aligned_cols=140 Identities=16% Similarity=0.215 Sum_probs=105.8
Q ss_pred ccCccCceEEEEEEeCCCceEEEEEcC--CCC-ccchHHHHHHHHHHhccC--CCCcceeeEEEEec---CceeEEEecc
Q 042348 374 LLGKSTIGIVYKVALNNEEAVAVRRLG--NGG-WQRFKEFQTEAEAIGKIR--HPNIVSLRAYFWSV---DEKLLIYDYI 445 (686)
Q Consensus 374 ~iG~G~~g~Vy~~~~~~~~~vavK~~~--~~~-~~~~~~~~~E~~~l~~l~--H~nIv~l~~~~~~~---~~~~lV~e~~ 445 (686)
.++.|.++.||++...+ ..+++|+.. ... ......+.+|+++++.+. +..++++++++.+. +..++||||+
T Consensus 45 ~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~v 123 (359)
T 3dxp_A 45 QFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEFV 123 (359)
T ss_dssp ECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEECC
T ss_pred EcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEec
Confidence 47899999999998764 578888876 332 122357889999999996 45688899888766 4479999999
Q ss_pred CCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccC------------------------------------
Q 042348 446 PNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVS------------------------------------ 489 (686)
Q Consensus 446 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~------------------------------------ 489 (686)
+|..+.+... ..++..++..++.++++.|+.||+..
T Consensus 124 ~G~~l~~~~~--------~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (359)
T 3dxp_A 124 SGRVLWDQSL--------PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP 195 (359)
T ss_dssp CCBCCCCTTC--------TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred CCeecCCCcc--------ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence 9877754211 34778888999999999999999731
Q ss_pred -------------------CCCceecCCCCCCeeecCCCC--eEEeecCccccc
Q 042348 490 -------------------PKRYVHGDLRPSNILLGKNME--PHISDFGLARLA 522 (686)
Q Consensus 490 -------------------~~~iiHrDlkp~NILl~~~~~--~kl~DfGla~~~ 522 (686)
+..++|+|++|.||+++.++. +.|+||+.+...
T Consensus 196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g 249 (359)
T 3dxp_A 196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG 249 (359)
T ss_dssp HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence 246999999999999997753 689999988753
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.05 E-value=1.9e-10 Score=119.30 Aligned_cols=147 Identities=20% Similarity=0.208 Sum_probs=121.1
Q ss_pred CCEEEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCcccc----------------------------------
Q 042348 57 GQVFSLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELF---------------------------------- 102 (686)
Q Consensus 57 ~~~~~l~l~~n~l~g~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~---------------------------------- 102 (686)
..++.|+|++ +++..-+..|.++++|+.|+|++|.+....+..|.
T Consensus 101 ~~L~~l~L~~-~i~~I~~~aF~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~~~~~L~ 179 (329)
T 3sb4_A 101 QTLEKVILSE-KIKNIEDAAFKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFIEGEPLE 179 (329)
T ss_dssp TTCCC-CBCT-TCCEECTTTTTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEEESCCCE
T ss_pred CCCcEEECCc-cccchhHHHhhcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhccccccccccccccccc
Confidence 5788899988 88877777899999999999999976311111110
Q ss_pred --------------------------------------------CCCCCcEEEccCCCCCCCCcccccCCCCCCEEeccC
Q 042348 103 --------------------------------------------NASNLQSLILSGNSFSGPVPMQIGKLKYLQVLDLSQ 138 (686)
Q Consensus 103 --------------------------------------------~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~ 138 (686)
.+++|+.|+|++|+++...+..|.++.+|+.|+|++
T Consensus 180 ~~i~~~~~~~l~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~ 259 (329)
T 3sb4_A 180 TTIQVGAMGKLEDEIMKAGLQPRDINFLTIEGKLDNADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPH 259 (329)
T ss_dssp EEEEECTTCCHHHHHHHTTCCGGGCSEEEEEECCCHHHHHHHHHHCTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCT
T ss_pred eeEEecCCCcHHHHHhhcccCccccceEEEeeeecHHHHHHHHHhcCCCeEEECCCCCcceecHhhhhCCCCCCEEECCc
Confidence 267999999999999965566799999999999999
Q ss_pred CCCCCCCChhhhhccccc-cccccccccCCCCchhhhhcCcccceecccccccCCCCchhhhcccccccc
Q 042348 139 NSFSSSIPSSIVQCKRLK-TVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSGLIPNDIANLSRLRLL 207 (686)
Q Consensus 139 N~l~~~~p~~~~~l~~L~-~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l 207 (686)
| ++..-+..|.+|.+|+ .|+|.+ +++ .|+...+.++++|+.|+|+.|+++.+.+..|.++++|+.+
T Consensus 260 n-i~~I~~~aF~~~~~L~~~l~l~~-~l~-~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~~~~~L~~l 326 (329)
T 3sb4_A 260 N-LKTIGQRVFSNCGRLAGTLELPA-SVT-AIEFGAFMGCDNLRYVLATGDKITTLGDELFGNGVPSKLI 326 (329)
T ss_dssp T-CCEECTTTTTTCTTCCEEEEECT-TCC-EECTTTTTTCTTEEEEEECSSCCCEECTTTTCTTCCCCEE
T ss_pred c-cceehHHHhhCChhccEEEEEcc-cce-EEchhhhhCCccCCEEEeCCCccCccchhhhcCCcchhhh
Confidence 8 7766678899999999 999988 777 5776666799999999999999999888899999998865
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.99 E-value=1.1e-11 Score=130.44 Aligned_cols=143 Identities=15% Similarity=0.161 Sum_probs=108.4
Q ss_pred CCEEEEEeCCCCccccCCcCc-CCCCCCCEEEccCCCCcccCCccc-----cCCCCCcEEEccCCCCCC----CCccccc
Q 042348 57 GQVFSLIIPNKKLTGFIPADL-GSLSAIGRVNLRNNNFSGSLPVEL-----FNASNLQSLILSGNSFSG----PVPMQIG 126 (686)
Q Consensus 57 ~~~~~l~l~~n~l~g~~p~~l-~~l~~L~~L~L~~N~l~g~~p~~~-----~~l~~L~~L~L~~N~l~g----~~p~~~~ 126 (686)
..++.|+|++|.|+..-...+ ..+++|+.|+|++|.|+..-...+ ...++|++|+|++|.|+. .++..+.
T Consensus 101 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~ 180 (372)
T 3un9_A 101 HALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLA 180 (372)
T ss_dssp SCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHHH
T ss_pred CCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHHhcCCccceeeCCCCCCChHHHHHHHHHHh
Confidence 589999999999976433333 346789999999999975433333 356889999999999974 3555667
Q ss_pred CCCCCCEEeccCCCCCCC----CChhhhhccccccccccccccCCC----CchhhhhcCcccceecccccccCCCCchhh
Q 042348 127 KLKYLQVLDLSQNSFSSS----IPSSIVQCKRLKTVVLNQNSFTGP----LPDGFATNLTALQKLDLSFNNLSGLIPNDI 198 (686)
Q Consensus 127 ~l~~L~~L~ls~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 198 (686)
.+++|++|+|++|.++.. ++..+..+++|+.|+|++|.++.. ++..+ ...++|++|||++|.|+..-...+
T Consensus 181 ~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l~~~L-~~~~~L~~L~Ls~N~i~~~g~~~L 259 (372)
T 3un9_A 181 GNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAA-REHPSLELLHLYFNELSSEGRQVL 259 (372)
T ss_dssp TCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHHHHHH-HHCSSCCEEECTTSSCCHHHHHHH
T ss_pred cCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHHHHHH-HhCCCCCEEeccCCCCCHHHHHHH
Confidence 899999999999998742 245567788999999999999742 22222 256899999999999986544444
Q ss_pred hc
Q 042348 199 AN 200 (686)
Q Consensus 199 ~~ 200 (686)
..
T Consensus 260 ~~ 261 (372)
T 3un9_A 260 RD 261 (372)
T ss_dssp HH
T ss_pred HH
Confidence 44
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.99 E-value=1.6e-11 Score=121.57 Aligned_cols=157 Identities=17% Similarity=0.157 Sum_probs=85.9
Q ss_pred CcceeeeEecCC--CEEEEEeCC---CCccccCCc-CcCCCCCCCEEEccCCCCcccCCc-cccCCCCCcE--EEccCCC
Q 042348 46 PCSWNGITCREG--QVFSLIIPN---KKLTGFIPA-DLGSLSAIGRVNLRNNNFSGSLPV-ELFNASNLQS--LILSGNS 116 (686)
Q Consensus 46 ~c~w~gv~c~~~--~~~~l~l~~---n~l~g~~p~-~l~~l~~L~~L~L~~N~l~g~~p~-~~~~l~~L~~--L~L~~N~ 116 (686)
.|.|.|+.|... ++..+...+ ..+.|.+++ .+..|.. .|...+|..++.++- .|...+.|.. ++++.|+
T Consensus 77 l~~~~g~i~~~~~~ki~~~v~~~~~~~~~~~~l~~~~~~~Lk~--~l~~ryn~~~~~LdLs~l~~dp~L~~~~l~l~~N~ 154 (267)
T 3rw6_A 77 LKAVNYKILDRENRRISIIINSSAPPHTILNELKPEQVEQLKL--IMSKRYDGSQQALDLKGLRSDPDLVAQNIDVVLNR 154 (267)
T ss_dssp HHHTTSSCBCTTSCBCCCEEEECCCCHHHHTSCCHHHHHHHHH--HHHHTEETTTTEEECTTGGGCHHHHHTTCCCCTTS
T ss_pred HHhcCcEEECCCCCEEEEEEecCCCcccccccCCHHHHHHHHH--HHHhccchhccccCHHHcCCCcchhhcCccccCCH
Confidence 588999999854 665555544 233333331 2222221 122233333322221 1333344444 5666664
Q ss_pred CC---CCCcccccCCCCCCEEeccCCCCCC--CCChhhhhccccccccccccccCCCCchhhhhcCc--ccceecccccc
Q 042348 117 FS---GPVPMQIGKLKYLQVLDLSQNSFSS--SIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLT--ALQKLDLSFNN 189 (686)
Q Consensus 117 l~---g~~p~~~~~l~~L~~L~ls~N~l~~--~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~--~L~~L~Ls~N~ 189 (686)
.. +.++....++++|+.|+|++|+|++ .+|..+..+++|+.|+|++|+|++. ..+ ..+. +|+.|+|++|.
T Consensus 155 ~~~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l-~~l~~l~L~~L~L~~Np 231 (267)
T 3rw6_A 155 RSCMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--REL-DKIKGLKLEELWLDGNS 231 (267)
T ss_dssp HHHHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGG-GGGTTSCCSEEECTTST
T ss_pred HHHHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhh-hhcccCCcceEEccCCc
Confidence 33 1122222456777788888887776 4456667777888888888877753 122 2333 78888888888
Q ss_pred cCCCCch-------hhhcccccccc
Q 042348 190 LSGLIPN-------DIANLSRLRLL 207 (686)
Q Consensus 190 l~~~~p~-------~~~~l~~L~~l 207 (686)
+.+.+|. .+..+++|+.|
T Consensus 232 l~~~~~~~~~y~~~il~~~P~L~~L 256 (267)
T 3rw6_A 232 LCDTFRDQSTYISAIRERFPKLLRL 256 (267)
T ss_dssp TGGGCSSHHHHHHHHHHHCTTCCEE
T ss_pred CccccCcchhHHHHHHHHCcccCeE
Confidence 8876652 24555555543
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=98.95 E-value=2.5e-11 Score=136.69 Aligned_cols=180 Identities=15% Similarity=0.073 Sum_probs=125.0
Q ss_pred CCEEEEEeCCCCccccCCcCcCCCCCCCEEEcc-----------CCCCccc-CCccccCCCCCcEEEccCCCCCCCCccc
Q 042348 57 GQVFSLIIPNKKLTGFIPADLGSLSAIGRVNLR-----------NNNFSGS-LPVELFNASNLQSLILSGNSFSGPVPMQ 124 (686)
Q Consensus 57 ~~~~~l~l~~n~l~g~~p~~l~~l~~L~~L~L~-----------~N~l~g~-~p~~~~~l~~L~~L~L~~N~l~g~~p~~ 124 (686)
.+++.|+|+++-..+.++..+..+++|++|+|+ .|.+++. ++.-+.++++|++|+|+.|++++..+..
T Consensus 318 ~~L~~L~L~~~~~~~~l~~~~~~~~~L~~L~L~~g~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~L~l~~~~l~~~~~~~ 397 (592)
T 3ogk_B 318 PNLEVLETRNVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLES 397 (592)
T ss_dssp TTCCEEEEEGGGHHHHHHHHHHHCTTCCEEEEECCCCSSTTSSTTCCCCHHHHHHHHHHCTTCSEEEEEESCCCHHHHHH
T ss_pred cCCCEEeccCccCHHHHHHHHHhCCCCCEEEeecCccccccccccCccCHHHHHHHHhhCccCeEEEeecCCccHHHHHH
Confidence 578888888443334445555678889999999 3666643 2222446889999999999998877777
Q ss_pred ccC-CCCCCEEecc----CCCCCCC-----CChhhhhccccccccccc--cccCCCCchhhhhcCcccceecccccccCC
Q 042348 125 IGK-LKYLQVLDLS----QNSFSSS-----IPSSIVQCKRLKTVVLNQ--NSFTGPLPDGFATNLTALQKLDLSFNNLSG 192 (686)
Q Consensus 125 ~~~-l~~L~~L~ls----~N~l~~~-----~p~~~~~l~~L~~L~L~~--N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~ 192 (686)
++. +++|+.|+|+ .|.+++. ++..+..+++|+.|+|++ |.+++..+..+...+++|+.|+|++|++++
T Consensus 398 l~~~~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~ 477 (592)
T 3ogk_B 398 IGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESD 477 (592)
T ss_dssp HHHHCCSCCEEEEEECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSH
T ss_pred HHhhCCCCcEEEEeecCCCccccCchHHHHHHHHHHhCCCCCEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCCCH
Confidence 766 8899999996 6778763 344467788999999974 346655555565568889999999998876
Q ss_pred -CCchhhhcccccccccccccccccCCCCCCC-cccc-cccccCCcccccCCC
Q 042348 193 -LIPNDIANLSRLRLLAQRVYVDLTYNNLSGL-IPQN-AALLSLGPTAFIGNP 242 (686)
Q Consensus 193 -~~p~~~~~l~~L~~l~~~~~l~l~~N~l~~~-~p~~-~~~~~~~~~~~~~n~ 242 (686)
.++..+..+++|+.| ++++|.+++. ++.. ..+.++..+.+.+|.
T Consensus 478 ~~~~~~~~~~~~L~~L------~l~~n~l~~~~~~~~~~~l~~L~~L~ls~n~ 524 (592)
T 3ogk_B 478 EGLMEFSRGCPNLQKL------EMRGCCFSERAIAAAVTKLPSLRYLWVQGYR 524 (592)
T ss_dssp HHHHHHHTCCTTCCEE------EEESCCCBHHHHHHHHHHCSSCCEEEEESCB
T ss_pred HHHHHHHhcCcccCee------eccCCCCcHHHHHHHHHhcCccCeeECcCCc
Confidence 334445666666544 8888887643 2322 235566677777776
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=98.91 E-value=7.6e-11 Score=132.71 Aligned_cols=147 Identities=14% Similarity=0.102 Sum_probs=80.4
Q ss_pred EEEEEeCCCC-ccc-cCCcCcCCCCCCCEEEccCCCCccc----CCccccCCCCCcEEEccCCCCCC----CCcccccCC
Q 042348 59 VFSLIIPNKK-LTG-FIPADLGSLSAIGRVNLRNNNFSGS----LPVELFNASNLQSLILSGNSFSG----PVPMQIGKL 128 (686)
Q Consensus 59 ~~~l~l~~n~-l~g-~~p~~l~~l~~L~~L~L~~N~l~g~----~p~~~~~l~~L~~L~L~~N~l~g----~~p~~~~~l 128 (686)
++.|+|+++. ++. .++..+..+++|++|+|++|.+++. ++..+.++++|++|+|++|.+++ .++..+..+
T Consensus 140 L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~ 219 (592)
T 3ogk_B 140 LETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNC 219 (592)
T ss_dssp CCEEEEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHHC
T ss_pred CcEEECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhhC
Confidence 6666666654 111 1122223556666666666666543 22233455666666666666652 233344456
Q ss_pred CCCCEEeccCCCCCCCCChhhhhcccccccccccccc--------------------------CCCCchhhhhcCcccce
Q 042348 129 KYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSF--------------------------TGPLPDGFATNLTALQK 182 (686)
Q Consensus 129 ~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l--------------------------~~~~p~~~~~~l~~L~~ 182 (686)
++|+.|+|++|.+.+ +|..+..+++|+.|+++.+.. .+.+|..+ ..+++|++
T Consensus 220 ~~L~~L~L~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~~l~~~~-~~~~~L~~ 297 (592)
T 3ogk_B 220 RSLVSVKVGDFEILE-LVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPNEMPILF-PFAAQIRK 297 (592)
T ss_dssp TTCCEEECSSCBGGG-GHHHHHHCTTCCEEEECBCCCCTTCTTSSSCCCCCTTCCEEEETTCCTTTGGGGG-GGGGGCCE
T ss_pred CCCcEEeccCccHHH-HHHHHhhhhHHHhhcccccccccchHHHHHHhhccccccccCccccchhHHHHHH-hhcCCCcE
Confidence 666666666666653 455555555555555543211 12344433 46788899
Q ss_pred ecccccccCCCCc-hhhhcccccccc
Q 042348 183 LDLSFNNLSGLIP-NDIANLSRLRLL 207 (686)
Q Consensus 183 L~Ls~N~l~~~~p-~~~~~l~~L~~l 207 (686)
|+|++|.+++... ..+..+++|+.|
T Consensus 298 L~Ls~~~l~~~~~~~~~~~~~~L~~L 323 (592)
T 3ogk_B 298 LDLLYALLETEDHCTLIQKCPNLEVL 323 (592)
T ss_dssp EEETTCCCCHHHHHHHHTTCTTCCEE
T ss_pred EecCCCcCCHHHHHHHHHhCcCCCEE
Confidence 9999888765433 234556665544
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.88 E-value=1.1e-09 Score=112.20 Aligned_cols=197 Identities=15% Similarity=0.135 Sum_probs=122.8
Q ss_pred ccCccCceEEEEEEeCCCceEEEEEcCCCCccchHHHHHHHHHHhcc-CCCC--cceeeEEEEecC---ceeEEEeccCC
Q 042348 374 LLGKSTIGIVYKVALNNEEAVAVRRLGNGGWQRFKEFQTEAEAIGKI-RHPN--IVSLRAYFWSVD---EKLLIYDYIPN 447 (686)
Q Consensus 374 ~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~n--Iv~l~~~~~~~~---~~~lV~e~~~~ 447 (686)
.++.|....||++. ..+++|..... .....+.+|+++++.+ .+.. +.+.+......+ ..|+|||+++|
T Consensus 27 ~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G 100 (304)
T 3sg8_A 27 ISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKG 100 (304)
T ss_dssp EEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCC
T ss_pred ecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCC
Confidence 47889999999863 45888886542 2346789999999888 3333 345555443333 34899999999
Q ss_pred CCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccC--------------------------------------
Q 042348 448 GSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVS-------------------------------------- 489 (686)
Q Consensus 448 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~-------------------------------------- 489 (686)
.+|.+... ..++..++..++.++++.|+.||+..
T Consensus 101 ~~l~~~~~--------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (304)
T 3sg8_A 101 VPLTPLLL--------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKK 172 (304)
T ss_dssp EECCHHHH--------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHH
T ss_pred eECCcccc--------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHH
Confidence 88875432 23677788888889999888888611
Q ss_pred -----------------CCCceecCCCCCCeeecC--CCCeEEeecCcccccccccCCccccccccccCCCCCCCccccc
Q 042348 490 -----------------PKRYVHGDLRPSNILLGK--NMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFT 550 (686)
Q Consensus 490 -----------------~~~iiHrDlkp~NILl~~--~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~ 550 (686)
+..++|+|++|.||++++ ...+.|+||+.+....... +........ ....+.
T Consensus 173 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~---Dl~~~~~~~---~~~~~~--- 243 (304)
T 3sg8_A 173 VDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDN---DFISLMEDD---EEYGME--- 243 (304)
T ss_dssp HHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTH---HHHTTCCTT---TSCCHH---
T ss_pred HHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHH---HHHHHHhhc---cccCHH---
Confidence 134799999999999998 4567899999887543211 000000000 000000
Q ss_pred cccCCCCCccccC-cccccCCCCCCcchHHHHHHHHHHHHhCCCCc
Q 042348 551 ALNSTTSRSYYQA-PEASKVRKPTQKWDIYSYGVILLEMISGKLPM 595 (686)
Q Consensus 551 ~~~~~~gt~~y~a-PE~~~~~~~~~~sDVwSlGvvl~elltG~~P~ 595 (686)
........+++.. |+.... .....+.|++|.++|.+.+|..+|
T Consensus 244 ~~~~~l~~Y~~~~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 244 FVSKILNHYKHKDIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHHHHHHHTCSCHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHHHHHHHcCCCCcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHH
Confidence 0000000111222 232211 122368999999999999999887
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=98.73 E-value=3.9e-10 Score=126.92 Aligned_cols=127 Identities=18% Similarity=0.173 Sum_probs=81.1
Q ss_pred CCEEEEEeCCCCccccCCcCcC-CCCCCCEEEccCC-CCccc-CCccccCCCCCcEEEccCCCCCCCCccccc----CCC
Q 042348 57 GQVFSLIIPNKKLTGFIPADLG-SLSAIGRVNLRNN-NFSGS-LPVELFNASNLQSLILSGNSFSGPVPMQIG----KLK 129 (686)
Q Consensus 57 ~~~~~l~l~~n~l~g~~p~~l~-~l~~L~~L~L~~N-~l~g~-~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~----~l~ 129 (686)
.+++.|+|++|.+++..+..+. .+++|+.|+|++| .++.. ++..+.++++|++|+|++|.+++..+..+. .++
T Consensus 105 ~~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~ 184 (594)
T 2p1m_B 105 TWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYT 184 (594)
T ss_dssp TTCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCC
T ss_pred CCCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCC
Confidence 4677788888877776666665 5778888888877 44422 344444677888888888877654444333 566
Q ss_pred CCCEEeccCCCCCCCCC-h----hhhhcccccccccccc-ccCCCCchhhhhcCcccceecccc
Q 042348 130 YLQVLDLSQNSFSSSIP-S----SIVQCKRLKTVVLNQN-SFTGPLPDGFATNLTALQKLDLSF 187 (686)
Q Consensus 130 ~L~~L~ls~N~l~~~~p-~----~~~~l~~L~~L~L~~N-~l~~~~p~~~~~~l~~L~~L~Ls~ 187 (686)
+|+.|+|++|. . .++ . .+..+++|+.|+|++| .+++ +|..+ ..+++|+.|+++.
T Consensus 185 ~L~~L~l~~~~-~-~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~-l~~~~-~~~~~L~~L~l~~ 244 (594)
T 2p1m_B 185 SLVSLNISCLA-S-EVSFSALERLVTRCPNLKSLKLNRAVPLEK-LATLL-QRAPQLEELGTGG 244 (594)
T ss_dssp CCCEEECTTCC-S-CCCHHHHHHHHHHCTTCCEEECCTTSCHHH-HHHHH-HHCTTCSEEECSB
T ss_pred cCcEEEecccC-C-cCCHHHHHHHHHhCCCCcEEecCCCCcHHH-HHHHH-hcCCcceEccccc
Confidence 78888888776 1 222 2 2344578888888777 3433 44444 4677777777443
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=98.71 E-value=4.5e-10 Score=126.44 Aligned_cols=179 Identities=12% Similarity=0.149 Sum_probs=107.5
Q ss_pred CCEEEEEeCCCCcccc-CCcCcCCCCCCCEEEc---------cCCCCcccCCcccc-CCCCCcEEEccCCCCCCCCcccc
Q 042348 57 GQVFSLIIPNKKLTGF-IPADLGSLSAIGRVNL---------RNNNFSGSLPVELF-NASNLQSLILSGNSFSGPVPMQI 125 (686)
Q Consensus 57 ~~~~~l~l~~n~l~g~-~p~~l~~l~~L~~L~L---------~~N~l~g~~p~~~~-~l~~L~~L~L~~N~l~g~~p~~~ 125 (686)
.+++.|+|++| ++.. ++.-...+++|+.|+| +.|.+++.....+. ++++|+.|.++.|.+++..+..+
T Consensus 314 ~~L~~L~l~~~-~~~~~l~~l~~~~~~L~~L~L~~~~~~g~~~~~~l~~~~l~~l~~~~~~L~~L~~~~~~l~~~~~~~l 392 (594)
T 2p1m_B 314 PKLQRLWVLDY-IEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALITI 392 (594)
T ss_dssp TTCCEEEEEGG-GHHHHHHHHHHHCTTCCEEEEECSCTTCSSCSSCCCHHHHHHHHHHCTTCCEEEEEESCCCHHHHHHH
T ss_pred CCcCEEeCcCc-cCHHHHHHHHHhCCCCCEEEEecCcccccccCCCCCHHHHHHHHHhchhHHHHHHhcCCcCHHHHHHH
Confidence 57888888877 4432 2222335778888888 33555533222332 47788888888888876555555
Q ss_pred c-CCCCCCEEecc--C----CCCCCCC-----ChhhhhccccccccccccccCCCCchhhhhcCcccceecccccccCCC
Q 042348 126 G-KLKYLQVLDLS--Q----NSFSSSI-----PSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSGL 193 (686)
Q Consensus 126 ~-~l~~L~~L~ls--~----N~l~~~~-----p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~ 193 (686)
. .+++|+.|+|+ + |.+++.. +..+..+++|+.|+|++ .+++..+..+...+++|+.|+|++|.+++.
T Consensus 393 ~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~l~~~~~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~ 471 (594)
T 2p1m_B 393 ARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDL 471 (594)
T ss_dssp HHHCTTCCEEEEEESSTTCCCTTTCCCTHHHHHHHHHHCTTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHH
T ss_pred HhhCCCcceeEeecccCCCcccccCCchhhHHHHHHhhCCCccEEeecC-cccHHHHHHHHHhchhccEeeccCCCCcHH
Confidence 4 47888888888 4 5555321 12256677888888866 555444444443477788888888887654
Q ss_pred Cchhh-hcccccccccccccccccCCCCCCCccc-c-cccccCCcccccCCCC
Q 042348 194 IPNDI-ANLSRLRLLAQRVYVDLTYNNLSGLIPQ-N-AALLSLGPTAFIGNPF 243 (686)
Q Consensus 194 ~p~~~-~~l~~L~~l~~~~~l~l~~N~l~~~~p~-~-~~~~~~~~~~~~~n~~ 243 (686)
.+..+ ..+++|+. |++++|.+++.... . ..+.++..+.+.+|+.
T Consensus 472 ~~~~l~~~~~~L~~------L~L~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~ 518 (594)
T 2p1m_B 472 GMHHVLSGCDSLRK------LEIRDCPFGDKALLANASKLETMRSLWMSSCSV 518 (594)
T ss_dssp HHHHHHHHCTTCCE------EEEESCSCCHHHHHHTGGGGGGSSEEEEESSCC
T ss_pred HHHHHHhcCCCcCE------EECcCCCCcHHHHHHHHHhCCCCCEEeeeCCCC
Confidence 44433 44555544 47888877543222 1 1244555666666654
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=98.64 E-value=6.3e-08 Score=102.76 Aligned_cols=143 Identities=14% Similarity=0.185 Sum_probs=84.9
Q ss_pred CEEEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCccccCCCCCcEEEccCCCCCCCCcccccCCCCCCEEecc
Q 042348 58 QVFSLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQVLDLS 137 (686)
Q Consensus 58 ~~~~l~l~~n~l~g~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls 137 (686)
.++.+.|++ .++..-+..|.++++|+.++|++|+++ .+|...+..++|+.+.|.+| ++..-...|.++++|+.++|.
T Consensus 158 ~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l~~n~l~-~I~~~aF~~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~ 234 (401)
T 4fdw_A 158 TVQEIVFPS-TLEQLKEDIFYYCYNLKKADLSKTKIT-KLPASTFVYAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIP 234 (401)
T ss_dssp CCCEEECCT-TCCEECSSTTTTCTTCCEEECTTSCCS-EECTTTTTTCCCSEEECCTT-CCEECTTTTTTCTTCCCEECC
T ss_pred CceEEEeCC-CccEehHHHhhCcccCCeeecCCCcce-EechhhEeecccCEEEeCCc-hheehhhHhhCCCCCCEEecC
Confidence 466677764 666555667777888888888877777 44443334577777777644 553445566777777777776
Q ss_pred CCCCCCCCChhhhhccccccccccccccCCCCchhhhhcCcccceecccccccC-----CCCchhhhcccccccc
Q 042348 138 QNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLS-----GLIPNDIANLSRLRLL 207 (686)
Q Consensus 138 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~-----~~~p~~~~~l~~L~~l 207 (686)
.| ++..-...|.+ .+|+.+.| .|.++ .|+...+.++++|+.++|.+|.+. .+.+..|.+|++|+.+
T Consensus 235 ~~-l~~I~~~aF~~-~~L~~i~l-p~~i~-~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l 305 (401)
T 4fdw_A 235 EN-VSTIGQEAFRE-SGITTVKL-PNGVT-NIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARF 305 (401)
T ss_dssp TT-CCEECTTTTTT-CCCSEEEE-ETTCC-EECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEE
T ss_pred CC-ccCcccccccc-CCccEEEe-CCCcc-EEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeE
Confidence 54 34233334444 45555555 33344 344444456666666666666554 3344556666655544
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.63 E-value=7.4e-09 Score=107.99 Aligned_cols=161 Identities=16% Similarity=0.170 Sum_probs=100.0
Q ss_pred CCEEEEEeCCCCcc---------ccCCcCcCCCCCCCEEEccCCCCcccCCccccCCCCCcEEEccCCCCCCCCccccc-
Q 042348 57 GQVFSLIIPNKKLT---------GFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIG- 126 (686)
Q Consensus 57 ~~~~~l~l~~n~l~---------g~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~- 126 (686)
.+++.|.+..+... +.++..+..+++|+.|+|++|.-. .+|. + .+++|+.|+|..+.++......+.
T Consensus 139 ~~L~~L~l~~~~~e~~~is~~~~~~L~~ll~~~P~L~~L~L~g~~~l-~l~~-~-~~~~L~~L~L~~~~l~~~~l~~l~~ 215 (362)
T 2ra8_A 139 AHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNL-SIGK-K-PRPNLKSLEIISGGLPDSVVEDILG 215 (362)
T ss_dssp TTCSEEEECCCCTTTCCGGGCBCCBCHHHHHTCTTCCEEEEECCBTC-BCCS-C-BCTTCSEEEEECSBCCHHHHHHHHH
T ss_pred chhhheeecCcchhhcccccccccCHHHHHhcCCCCcEEEEeCCCCc-eecc-c-cCCCCcEEEEecCCCChHHHHHHHH
Confidence 47778888665431 124445567789999999887311 2343 3 378899999998887644333443
Q ss_pred -CCCCCCEEeccC--CCCCCCC-----Chhh--hhccccccccccccccCCCCchhhh--hcCcccceecccccccCCCC
Q 042348 127 -KLKYLQVLDLSQ--NSFSSSI-----PSSI--VQCKRLKTVVLNQNSFTGPLPDGFA--TNLTALQKLDLSFNNLSGLI 194 (686)
Q Consensus 127 -~l~~L~~L~ls~--N~l~~~~-----p~~~--~~l~~L~~L~L~~N~l~~~~p~~~~--~~l~~L~~L~Ls~N~l~~~~ 194 (686)
.+++|+.|+|+. |...+.. ...+ ..+++|++|+|.+|.++...+..++ ..+++|++|||+.|.|++.-
T Consensus 216 ~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G 295 (362)
T 2ra8_A 216 SDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEG 295 (362)
T ss_dssp SBCTTCCEEEEECBCGGGTCCSCGGGTGGGSCTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHH
T ss_pred ccCCCCcEEEEeccccccccchhHHHHHHHHhcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHH
Confidence 688999998863 3322211 1112 2468899999998888743333333 24788999999999988643
Q ss_pred chhhhcccccccccccccccccCCCCCC
Q 042348 195 PNDIANLSRLRLLAQRVYVDLTYNNLSG 222 (686)
Q Consensus 195 p~~~~~l~~L~~l~~~~~l~l~~N~l~~ 222 (686)
+..+.. .|..++.+..|+|++|.++.
T Consensus 296 ~~~L~~--~L~~l~~L~~L~L~~n~i~d 321 (362)
T 2ra8_A 296 ARLLLD--HVDKIKHLKFINMKYNYLSD 321 (362)
T ss_dssp HHHHHT--THHHHTTCSEEECCSBBCCH
T ss_pred HHHHHh--hcccCCcceEEECCCCcCCH
Confidence 222211 12223334456899888764
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.55 E-value=1.2e-08 Score=100.91 Aligned_cols=106 Identities=26% Similarity=0.310 Sum_probs=76.9
Q ss_pred cCCCCCCCE--EEccCCCCc---ccCCccccCCCCCcEEEccCCCCCC--CCcccccCCCCCCEEeccCCCCCCCCChhh
Q 042348 77 LGSLSAIGR--VNLRNNNFS---GSLPVELFNASNLQSLILSGNSFSG--PVPMQIGKLKYLQVLDLSQNSFSSSIPSSI 149 (686)
Q Consensus 77 l~~l~~L~~--L~L~~N~l~---g~~p~~~~~l~~L~~L~L~~N~l~g--~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~ 149 (686)
|...+.|.. ++++.|+.. +.++....++++|++|+|++|+|++ .+|..+..+++|+.|+|++|+|++. ..+
T Consensus 137 l~~dp~L~~~~l~l~~N~~~~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l 214 (267)
T 3rw6_A 137 LRSDPDLVAQNIDVVLNRRSCMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--REL 214 (267)
T ss_dssp GGGCHHHHHTTCCCCTTSHHHHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGG
T ss_pred cCCCcchhhcCccccCCHHHHHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhh
Confidence 444455554 677788543 2223223568899999999999987 4567778899999999999999864 345
Q ss_pred hhcc--ccccccccccccCCCCch------hhhhcCcccceec
Q 042348 150 VQCK--RLKTVVLNQNSFTGPLPD------GFATNLTALQKLD 184 (686)
Q Consensus 150 ~~l~--~L~~L~L~~N~l~~~~p~------~~~~~l~~L~~L~ 184 (686)
..+. +|++|+|++|.+++.+|. .+...+++|+.||
T Consensus 215 ~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~~il~~~P~L~~LD 257 (267)
T 3rw6_A 215 DKIKGLKLEELWLDGNSLCDTFRDQSTYISAIRERFPKLLRLD 257 (267)
T ss_dssp GGGTTSCCSEEECTTSTTGGGCSSHHHHHHHHHHHCTTCCEES
T ss_pred hhcccCCcceEEccCCcCccccCcchhHHHHHHHHCcccCeEC
Confidence 5555 899999999999877763 2345788999887
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=98.53 E-value=1.4e-07 Score=100.04 Aligned_cols=173 Identities=12% Similarity=0.121 Sum_probs=128.6
Q ss_pred CCEEEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCccccCCCCCcEEEccCCCCCCCCcccccCCCCCCEEec
Q 042348 57 GQVFSLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQVLDL 136 (686)
Q Consensus 57 ~~~~~l~l~~n~l~g~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l 136 (686)
..++.++|++|+++..-...|. .++|+.+.|.+| +...-..+|.++++|+.++|..| ++..-..+|.+ .+|+.+.|
T Consensus 180 ~~L~~l~l~~n~l~~I~~~aF~-~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~l 255 (401)
T 4fdw_A 180 YNLKKADLSKTKITKLPASTFV-YAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVKL 255 (401)
T ss_dssp TTCCEEECTTSCCSEECTTTTT-TCCCSEEECCTT-CCEECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEEEE
T ss_pred ccCCeeecCCCcceEechhhEe-ecccCEEEeCCc-hheehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccEEEe
Confidence 4788999999999976666666 689999999855 76566778899999999999876 55344455666 78999999
Q ss_pred cCCCCCCCCChhhhhccccccccccccccC----CCCchhhhhcCcccceecccccccCCCCchhhhccccccccccccc
Q 042348 137 SQNSFSSSIPSSIVQCKRLKTVVLNQNSFT----GPLPDGFATNLTALQKLDLSFNNLSGLIPNDIANLSRLRLLAQRVY 212 (686)
Q Consensus 137 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~----~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~~~~~ 212 (686)
.|.++..-+..|.+|.+|+.+.+.+|.+. ..|+...+.++++|+.++|. |.++.+-...|.+|.+|+.+
T Consensus 256 -p~~i~~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L~~l----- 328 (401)
T 4fdw_A 256 -PNGVTNIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGNRKVTQL----- 328 (401)
T ss_dssp -ETTCCEECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTCCSCCEE-----
T ss_pred -CCCccEEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCCCCccEE-----
Confidence 45677556788999999999999888764 13666667789999999998 55877777788888888766
Q ss_pred ccccCCCCCCCcccccccccCCcccccCCC
Q 042348 213 VDLTYNNLSGLIPQNAALLSLGPTAFIGNP 242 (686)
Q Consensus 213 l~l~~N~l~~~~p~~~~~~~~~~~~~~~n~ 242 (686)
+|..| ++..-+..+...++..+.+.+|.
T Consensus 329 -~lp~~-l~~I~~~aF~~~~L~~l~l~~n~ 356 (401)
T 4fdw_A 329 -TIPAN-VTQINFSAFNNTGIKEVKVEGTT 356 (401)
T ss_dssp -EECTT-CCEECTTSSSSSCCCEEEECCSS
T ss_pred -EECcc-ccEEcHHhCCCCCCCEEEEcCCC
Confidence 66443 55444444443356666666663
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.48 E-value=8.8e-07 Score=90.41 Aligned_cols=135 Identities=21% Similarity=0.145 Sum_probs=95.7
Q ss_pred ccCccCceEEEEEEeCCCceEEEEEcCCCCccchHHHHHHHHHHhccCCC---CcceeeEEEE-ecCceeEEEeccCCCC
Q 042348 374 LLGKSTIGIVYKVALNNEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHP---NIVSLRAYFW-SVDEKLLIYDYIPNGS 449 (686)
Q Consensus 374 ~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~---nIv~l~~~~~-~~~~~~lV~e~~~~gs 449 (686)
.++.|....||+. +..+++|.... ......+.+|.++|..+.+. .+.+.+.++. ..+..++||||++|.+
T Consensus 26 ~l~~G~~n~v~~v----g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~ 99 (306)
T 3tdw_A 26 SLGEGFRNYAILV----NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQI 99 (306)
T ss_dssp EEEECSSEEEEEE----TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEE
T ss_pred ecCCCcceeEEEE----CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeE
Confidence 4678888899988 46688888532 22346789999999999652 3566777764 3456789999999988
Q ss_pred HHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHcc-----------------------------------------
Q 042348 450 LATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEV----------------------------------------- 488 (686)
Q Consensus 450 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~----------------------------------------- 488 (686)
+.+..- ..++..++..++.++++.|+.||+.
T Consensus 100 l~~~~~--------~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~ 171 (306)
T 3tdw_A 100 LGEDGM--------AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDY 171 (306)
T ss_dssp CHHHHH--------TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHH
T ss_pred Cchhhh--------hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHH
Confidence 876322 1245555566666666666666642
Q ss_pred ----------------CCCCceecCCCCCCeeecC---CCCe-EEeecCccccc
Q 042348 489 ----------------SPKRYVHGDLRPSNILLGK---NMEP-HISDFGLARLA 522 (686)
Q Consensus 489 ----------------~~~~iiHrDlkp~NILl~~---~~~~-kl~DfGla~~~ 522 (686)
.+..++|+|++|.||+++. ++.+ .|+||+.+...
T Consensus 172 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 172 LTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS 225 (306)
T ss_dssp HHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred HHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence 1235699999999999987 4554 89999988643
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.46 E-value=7.9e-07 Score=88.98 Aligned_cols=133 Identities=14% Similarity=0.190 Sum_probs=96.7
Q ss_pred cCccCce-EEEEEEeC-CCceEEEEEcCCCCccchHHHHHHHHHHhccC-CCCcceeeEEEEecCceeEEEeccCCCCHH
Q 042348 375 LGKSTIG-IVYKVALN-NEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIR-HPNIVSLRAYFWSVDEKLLIYDYIPNGSLA 451 (686)
Q Consensus 375 iG~G~~g-~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lV~e~~~~gsL~ 451 (686)
+..|..| .||+.... ++..+++|+-... ....+.+|...|+.+. +--+.++++++.+.+..++|||+++|.++.
T Consensus 32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~ 108 (272)
T 4gkh_A 32 DNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAF 108 (272)
T ss_dssp EECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHH
T ss_pred ccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcccc
Confidence 3345444 68988765 4567888986543 3456888999998884 334778899999999999999999998887
Q ss_pred HHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHcc-------------------------------------------
Q 042348 452 TAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEV------------------------------------------- 488 (686)
Q Consensus 452 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~------------------------------------------- 488 (686)
+..... ......++.+++..|+-||..
T Consensus 109 ~~~~~~----------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 178 (272)
T 4gkh_A 109 QVLEEY----------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQ 178 (272)
T ss_dssp HHHHHC----------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHH
T ss_pred ccccCC----------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHH
Confidence 765321 223445666777777777751
Q ss_pred ------------CCCCceecCCCCCCeeecCCCCeEEeecCccc
Q 042348 489 ------------SPKRYVHGDLRPSNILLGKNMEPHISDFGLAR 520 (686)
Q Consensus 489 ------------~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~ 520 (686)
.+..++|+|+.+.||++++++.+-|+||+.+.
T Consensus 179 ~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 179 VWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp HHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 01237999999999999987777799999875
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.41 E-value=3.4e-08 Score=92.86 Aligned_cols=118 Identities=15% Similarity=0.198 Sum_probs=69.4
Q ss_pred CCcCcCCCCCCCEEEccCC-CCccc----CCccccCCCCCcEEEccCCCCCCC----CcccccCCCCCCEEeccCCCCCC
Q 042348 73 IPADLGSLSAIGRVNLRNN-NFSGS----LPVELFNASNLQSLILSGNSFSGP----VPMQIGKLKYLQVLDLSQNSFSS 143 (686)
Q Consensus 73 ~p~~l~~l~~L~~L~L~~N-~l~g~----~p~~~~~l~~L~~L~L~~N~l~g~----~p~~~~~l~~L~~L~ls~N~l~~ 143 (686)
+...+...+.|++|+|++| .|... +...+...++|++|+|++|.+... +...+...++|++|+|++|.++.
T Consensus 28 l~~~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~ 107 (185)
T 1io0_A 28 LKRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISG 107 (185)
T ss_dssp HHHHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCH
T ss_pred HHHHHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCH
Confidence 3344566677777777777 66522 334455667777777777777531 33445555677777777777763
Q ss_pred C----CChhhhhccccccccc--cccccCCC----CchhhhhcCcccceecccccccC
Q 042348 144 S----IPSSIVQCKRLKTVVL--NQNSFTGP----LPDGFATNLTALQKLDLSFNNLS 191 (686)
Q Consensus 144 ~----~p~~~~~l~~L~~L~L--~~N~l~~~----~p~~~~~~l~~L~~L~Ls~N~l~ 191 (686)
. +...+...++|++|+| ++|.++.. +...+ ...++|++|+|++|.+.
T Consensus 108 ~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L-~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 108 SGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANML-EKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp HHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHH-HHCSSCCEEECCCSSHH
T ss_pred HHHHHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHH-HhCCCcCEEeccCCCCC
Confidence 2 2334445566777777 66666521 11111 23456777777777664
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.36 E-value=5.4e-08 Score=101.41 Aligned_cols=161 Identities=14% Similarity=0.139 Sum_probs=105.7
Q ss_pred CCEEEEEeCCCCccc-c-------CCcCcCCCCCCCEEEccCCCCc---------ccCCccccCCCCCcEEEccCCCCCC
Q 042348 57 GQVFSLIIPNKKLTG-F-------IPADLGSLSAIGRVNLRNNNFS---------GSLPVELFNASNLQSLILSGNSFSG 119 (686)
Q Consensus 57 ~~~~~l~l~~n~l~g-~-------~p~~l~~l~~L~~L~L~~N~l~---------g~~p~~~~~l~~L~~L~L~~N~l~g 119 (686)
.+|+.|.+......| . +..++..+++|+.|.+..+... +.++..+..+|+|+.|+|++|.-.
T Consensus 107 ~~v~~L~lg~~~~~~~~~~~~~~~L~~s~~~l~~L~~L~l~~~~~e~~~is~~~~~~L~~ll~~~P~L~~L~L~g~~~l- 185 (362)
T 2ra8_A 107 PSLKQITIGXWGYEGEDCSDIADGIVENKEKFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNL- 185 (362)
T ss_dssp GGCSEEEECCCCSSSCCSHHHHHHHHTTHHHHTTCSEEEECCCCTTTCCGGGCBCCBCHHHHHTCTTCCEEEEECCBTC-
T ss_pred hhcceEEEcccccCCCcHHHHHHHHHHhhhhcchhhheeecCcchhhcccccccccCHHHHHhcCCCCcEEEEeCCCCc-
Confidence 467788887655543 1 2344567889999999776432 234455667899999999998411
Q ss_pred CCcccccCCCCCCEEeccCCCCCCCCChhhh--hccccccccccc--cccCCC-----Cchhhh-hcCcccceecccccc
Q 042348 120 PVPMQIGKLKYLQVLDLSQNSFSSSIPSSIV--QCKRLKTVVLNQ--NSFTGP-----LPDGFA-TNLTALQKLDLSFNN 189 (686)
Q Consensus 120 ~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~--~l~~L~~L~L~~--N~l~~~-----~p~~~~-~~l~~L~~L~Ls~N~ 189 (686)
.++. + .+++|+.|+|..+.++......+. .+++|+.|+|+. |...+. +...+. ..+++|++|+|++|.
T Consensus 186 ~l~~-~-~~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~~~~p~Lr~L~L~~~~ 263 (362)
T 2ra8_A 186 SIGK-K-PRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAE 263 (362)
T ss_dssp BCCS-C-BCTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTGGGSCTTTCTTCCEEEEESCT
T ss_pred eecc-c-cCCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHHHHHHHhcCCCCCcCEEeCCCCC
Confidence 2343 4 389999999999887644334444 689999999863 332221 111111 247899999999999
Q ss_pred cCCCCchhhhcccccccccccccccccCCCCCCC
Q 042348 190 LSGLIPNDIANLSRLRLLAQRVYVDLTYNNLSGL 223 (686)
Q Consensus 190 l~~~~p~~~~~l~~L~~l~~~~~l~l~~N~l~~~ 223 (686)
+.+..+..+...+ .++++..|||++|.++..
T Consensus 264 i~~~~~~~la~a~---~~~~L~~LdLs~n~L~d~ 294 (362)
T 2ra8_A 264 EQNVVVEMFLESD---ILPQLETMDISAGVLTDE 294 (362)
T ss_dssp THHHHHHHHHHCS---SGGGCSEEECCSSCCBHH
T ss_pred CchHHHHHHHhCc---cCCCCCEEECCCCCCChH
Confidence 9865555554322 223445669999999863
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.34 E-value=9.3e-07 Score=92.39 Aligned_cols=79 Identities=8% Similarity=-0.009 Sum_probs=56.3
Q ss_pred cc-CccCceEEEEEEeC-------CCceEEEEEcCCCC---ccchHHHHHHHHHHhccC-C--CCcceeeEEEEec---C
Q 042348 374 LL-GKSTIGIVYKVALN-------NEEAVAVRRLGNGG---WQRFKEFQTEAEAIGKIR-H--PNIVSLRAYFWSV---D 436 (686)
Q Consensus 374 ~i-G~G~~g~Vy~~~~~-------~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-H--~nIv~l~~~~~~~---~ 436 (686)
.| +.|....+|+.... ++..+++|+..... ......+.+|+.+++.+. + -.+.++++++.+. +
T Consensus 27 ~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~g 106 (357)
T 3ats_A 27 GVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVLG 106 (357)
T ss_dssp EECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTTS
T ss_pred ECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCccC
Confidence 46 78889999998765 25678888865432 112256788999999884 3 3577888887655 3
Q ss_pred ceeEEEeccCCCCHHH
Q 042348 437 EKLLIYDYIPNGSLAT 452 (686)
Q Consensus 437 ~~~lV~e~~~~gsL~~ 452 (686)
..++||||++|..+.+
T Consensus 107 ~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 107 TPFFLMDYVEGVVPPD 122 (357)
T ss_dssp SCEEEEECCCCBCCCB
T ss_pred CceEEEEecCCCChhh
Confidence 5689999999876653
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.27 E-value=1.1e-07 Score=89.44 Aligned_cols=111 Identities=13% Similarity=0.103 Sum_probs=88.9
Q ss_pred CCCEEEEEeCCC-Ccccc----CCcCcCCCCCCCEEEccCCCCccc----CCccccCCCCCcEEEccCCCCCCC----Cc
Q 042348 56 EGQVFSLIIPNK-KLTGF----IPADLGSLSAIGRVNLRNNNFSGS----LPVELFNASNLQSLILSGNSFSGP----VP 122 (686)
Q Consensus 56 ~~~~~~l~l~~n-~l~g~----~p~~l~~l~~L~~L~L~~N~l~g~----~p~~~~~l~~L~~L~L~~N~l~g~----~p 122 (686)
...++.|+|++| .+... +...+...++|++|+|++|.|... +...+...++|++|+|++|.|+.. +.
T Consensus 35 ~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~~~l~ 114 (185)
T 1io0_A 35 DPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALV 114 (185)
T ss_dssp CTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHH
T ss_pred CCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHHHHHH
Confidence 467999999999 88753 455677789999999999999742 344556668899999999999843 56
Q ss_pred ccccCCCCCCEEec--cCCCCCCC----CChhhhhccccccccccccccC
Q 042348 123 MQIGKLKYLQVLDL--SQNSFSSS----IPSSIVQCKRLKTVVLNQNSFT 166 (686)
Q Consensus 123 ~~~~~l~~L~~L~l--s~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~ 166 (686)
..+...++|+.|+| ++|.++.. +...+...++|++|+|++|.+.
T Consensus 115 ~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 115 EALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp HGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence 67788899999999 88999843 2344556689999999999986
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.02 E-value=3.2e-05 Score=79.95 Aligned_cols=142 Identities=17% Similarity=0.208 Sum_probs=80.9
Q ss_pred ccCccCceEEEEEEeCCCceEEEEEcCCCCccchHHHHHHHHHHhccC--CCCcceeeE------EEEecCceeEEEecc
Q 042348 374 LLGKSTIGIVYKVALNNEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIR--HPNIVSLRA------YFWSVDEKLLIYDYI 445 (686)
Q Consensus 374 ~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--H~nIv~l~~------~~~~~~~~~lV~e~~ 445 (686)
.|+.|..+.||++...++. +++|+.... ..++..|.+++..+. .-.+++++. +....+..++||||+
T Consensus 39 ~l~gG~~n~~~~v~~~~~~-~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~i 113 (346)
T 2q83_A 39 VIQGNQMALVWKVHTDSGA-VCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDWI 113 (346)
T ss_dssp ECC----CEEEEEEETTEE-EEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEECC
T ss_pred eccccccCcEEEEEeCCCC-EEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEee
Confidence 3666778999999887654 889988752 234445666665553 112333333 123456678999999
Q ss_pred CCCCHH--------------HHhhcCCCcc--c------cCCCCHHHH-------------------------------H
Q 042348 446 PNGSLA--------------TAIHGKAGII--S------YRPLSWSDR-------------------------------L 472 (686)
Q Consensus 446 ~~gsL~--------------~~l~~~~~~~--~------~~~l~~~~~-------------------------------~ 472 (686)
+|..+. ..+|...... . ...-.|... .
T Consensus 114 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 193 (346)
T 2q83_A 114 EGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEID 193 (346)
T ss_dssp CCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHHH
T ss_pred cCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHHH
Confidence 986542 1122111000 0 001123221 0
Q ss_pred HHHHHHHHHHHHHHc----------cCCCCceecCCCCCCeeecCCCCeEEeecCccc
Q 042348 473 RIIKGVAKGIAFLHE----------VSPKRYVHGDLRPSNILLGKNMEPHISDFGLAR 520 (686)
Q Consensus 473 ~i~~~ia~gL~~LH~----------~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~ 520 (686)
.+..++..++++|++ ..+..++|+|+++.||+++.++.+.|+||+.+.
T Consensus 194 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 194 GFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 111224445666653 123689999999999999888899999999775
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.99 E-value=2.3e-05 Score=82.99 Aligned_cols=73 Identities=8% Similarity=0.152 Sum_probs=49.0
Q ss_pred ccCccCceEEEEEEeC-CCceEEEEEcCCCCc-------cchHHHHHHHHHHhccCC--CC-cceeeEEEEecCceeEEE
Q 042348 374 LLGKSTIGIVYKVALN-NEEAVAVRRLGNGGW-------QRFKEFQTEAEAIGKIRH--PN-IVSLRAYFWSVDEKLLIY 442 (686)
Q Consensus 374 ~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~H--~n-Iv~l~~~~~~~~~~~lV~ 442 (686)
.||.|.++.||++... +++.++||....... ....++..|.++++.+.. +. +.+++.+ +.+..++||
T Consensus 37 ~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~lvm 114 (397)
T 2olc_A 37 EIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTVM 114 (397)
T ss_dssp ECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEEE
T ss_pred ECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEEEE
Confidence 5899999999999754 467899997643211 123567889999988742 33 4455543 455678999
Q ss_pred eccCCC
Q 042348 443 DYIPNG 448 (686)
Q Consensus 443 e~~~~g 448 (686)
||+++.
T Consensus 115 E~l~g~ 120 (397)
T 2olc_A 115 EDLSHL 120 (397)
T ss_dssp CCCTTS
T ss_pred EeCCCc
Confidence 999764
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.83 E-value=7.7e-05 Score=75.15 Aligned_cols=72 Identities=17% Similarity=0.246 Sum_probs=54.2
Q ss_pred ccCccCceEEEEEEeCCCceEEEEEcCCCCccchHHHHHHHHHHhccC-C--CCcceeeEEEEecCceeEEEeccCCCC
Q 042348 374 LLGKSTIGIVYKVALNNEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIR-H--PNIVSLRAYFWSVDEKLLIYDYIPNGS 449 (686)
Q Consensus 374 ~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H--~nIv~l~~~~~~~~~~~lV~e~~~~gs 449 (686)
.+|.|..+.||+.+..+|+.|++|+...........|..|++.|+.+. . --+++.+++ +..++||||++++.
T Consensus 22 ~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~----~~~~lv~e~l~~~~ 96 (288)
T 3f7w_A 22 ERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW----DDRTLAMEWVDERP 96 (288)
T ss_dssp EEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE----ETTEEEEECCCCCC
T ss_pred ecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec----cCceEEEEeecccC
Confidence 378999999999999999999999876554444456889999999884 2 234455544 24589999998764
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.70 E-value=0.00016 Score=73.42 Aligned_cols=139 Identities=14% Similarity=0.142 Sum_probs=90.8
Q ss_pred ccCccCceEEEEEEeCCCceEEEEEcCCCCccchHHHHHHHHHHhccC---CCCcceeeEEEEecCceeEEEeccCCCCH
Q 042348 374 LLGKSTIGIVYKVALNNEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIR---HPNIVSLRAYFWSVDEKLLIYDYIPNGSL 450 (686)
Q Consensus 374 ~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---H~nIv~l~~~~~~~~~~~lV~e~~~~gsL 450 (686)
.|+.|....+|+.... +..+++|+.... ....+..|.+.|+.+. ...+++.++++...+..++||||+++..+
T Consensus 43 ~l~gG~~n~~y~v~~~-~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~~ 118 (312)
T 3jr1_A 43 KLYSGEMNEIWLINDE-VQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSKN 118 (312)
T ss_dssp EECCSSSSEEEEEESS-SCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCCC
T ss_pred EeCCccceeeeEEEEC-CCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCCC
Confidence 4788999999999864 667888886542 2467889999998883 36688899988888889999999998764
Q ss_pred H-----------HHhhcCCC--ccc--------------cCCCCHHHHH---HHHH----------------HHHHHH-H
Q 042348 451 A-----------TAIHGKAG--IIS--------------YRPLSWSDRL---RIIK----------------GVAKGI-A 483 (686)
Q Consensus 451 ~-----------~~l~~~~~--~~~--------------~~~l~~~~~~---~i~~----------------~ia~gL-~ 483 (686)
. ..||.... ... ...-+|.+.. ++.. .++..+ .
T Consensus 119 ~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l~~ 198 (312)
T 3jr1_A 119 KQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIVAD 198 (312)
T ss_dssp CTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHHHH
T ss_pred CchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHHHH
Confidence 2 12333211 000 0012454321 1111 111111 2
Q ss_pred HHHc-cCCCCceecCCCCCCeeecCCCCeEEeecC
Q 042348 484 FLHE-VSPKRYVHGDLRPSNILLGKNMEPHISDFG 517 (686)
Q Consensus 484 ~LH~-~~~~~iiHrDlkp~NILl~~~~~~kl~DfG 517 (686)
.|.. ..+..++|+|+.+.|++++.++ +.|.|+.
T Consensus 199 ~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 199 TLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 3321 1235799999999999999887 8999984
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.63 E-value=0.00017 Score=76.89 Aligned_cols=71 Identities=10% Similarity=0.155 Sum_probs=44.2
Q ss_pred ccCccCceEEEEEEeCCCceEEEEEcCC------CC-c--cchHHHHHHHHHHh-ccCCCCcceeeEEEEecCceeEEEe
Q 042348 374 LLGKSTIGIVYKVALNNEEAVAVRRLGN------GG-W--QRFKEFQTEAEAIG-KIRHPNIVSLRAYFWSVDEKLLIYD 443 (686)
Q Consensus 374 ~iG~G~~g~Vy~~~~~~~~~vavK~~~~------~~-~--~~~~~~~~E~~~l~-~l~H~nIv~l~~~~~~~~~~~lV~e 443 (686)
.||.|..+.||++.. ++..++||.... .. . .....++.|+..+. ......+++++.+. .+..++|||
T Consensus 41 ~l~~G~~n~vyrv~~-~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~lv~e 117 (420)
T 2pyw_A 41 EVGDGNLNFVFIVVG-SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMALIGMR 117 (420)
T ss_dssp ECCCSSSCEEEEEEC-SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTEEEEC
T ss_pred EccCCCcEEEEEEEc-CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccEEEEe
Confidence 478999999999965 467899994321 11 0 12233444443332 22234566777665 567799999
Q ss_pred cc-CC
Q 042348 444 YI-PN 447 (686)
Q Consensus 444 ~~-~~ 447 (686)
|+ ++
T Consensus 118 ~l~~g 122 (420)
T 2pyw_A 118 YLEPP 122 (420)
T ss_dssp CCCTT
T ss_pred ecCCc
Confidence 99 76
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.48 E-value=0.00031 Score=71.13 Aligned_cols=69 Identities=13% Similarity=0.184 Sum_probs=44.1
Q ss_pred ccCccCceEEEEEEeCCCceEEEEEcCCCCccchHHHHHHHHHHhccCCCCc-ceeeEEEEecCceeEEEecc-CCCCH
Q 042348 374 LLGKSTIGIVYKVALNNEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNI-VSLRAYFWSVDEKLLIYDYI-PNGSL 450 (686)
Q Consensus 374 ~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nI-v~l~~~~~~~~~~~lV~e~~-~~gsL 450 (686)
.|+.|....+|++ ..+++|+....... .....+|+.+++.+....+ .+++++ +.+..++|+||+ ++.++
T Consensus 25 ~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~l 95 (301)
T 3dxq_A 25 ERLGGLTNLVFRA-----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQTM 95 (301)
T ss_dssp EEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEEC
T ss_pred EcCCcccccccee-----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCccC
Confidence 4788999999998 45888887654221 1234568888887743233 455544 344568999999 65444
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=97.39 E-value=0.00027 Score=74.65 Aligned_cols=113 Identities=16% Similarity=0.251 Sum_probs=76.5
Q ss_pred CCcCcCCCCCCCEEEccCCCCcccCCccccCCCCCcEEEccCCCCCCCCcccccCCCCCCEEeccCCCCCCCCChhhhhc
Q 042348 73 IPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQVLDLSQNSFSSSIPSSIVQC 152 (686)
Q Consensus 73 ~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l 152 (686)
-...|.++..|+.+.+.++..+ .-...|.++++|+.+.+. +.++..-...|.++.+|+.++|..| ++..-..+|.+|
T Consensus 257 ~~~aF~~c~~L~~i~lp~~~~~-I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C 333 (394)
T 4gt6_A 257 ETHAFDSCAYLASVKMPDSVVS-IGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGC 333 (394)
T ss_dssp CTTTTTTCSSCCEEECCTTCCE-ECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTC
T ss_pred ccceeeecccccEEecccccce-ecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCC
Confidence 3446777778888887766543 445667778888888875 3444344456777788888888654 554445677778
Q ss_pred cccccccccccccCCCCchhhhhcCcccceeccccccc
Q 042348 153 KRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNL 190 (686)
Q Consensus 153 ~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l 190 (686)
.+|+.+.|..+ ++ .|....+.++++|+.+++.+|..
T Consensus 334 ~~L~~i~ip~s-v~-~I~~~aF~~C~~L~~i~~~~~~~ 369 (394)
T 4gt6_A 334 EQLERIAIPSS-VT-KIPESAFSNCTALNNIEYSGSRS 369 (394)
T ss_dssp TTCCEEEECTT-CC-BCCGGGGTTCTTCCEEEESSCHH
T ss_pred CCCCEEEECcc-cC-EEhHhHhhCCCCCCEEEECCcee
Confidence 88888888644 55 56666666788888888777654
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.35 E-value=0.00048 Score=70.42 Aligned_cols=144 Identities=10% Similarity=0.055 Sum_probs=80.4
Q ss_pred ccCccCceEEEEEEeCCCceEEEEEcCCCCccchHHHHHHHHHHhccCCCC--cceeeEE------EEecCceeEEEecc
Q 042348 374 LLGKSTIGIVYKVALNNEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPN--IVSLRAY------FWSVDEKLLIYDYI 445 (686)
Q Consensus 374 ~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n--Iv~l~~~------~~~~~~~~lV~e~~ 445 (686)
.|+.|....+|++...++ .+++|...... ....+..|+.++..+.... +.+++.. ....+..+++|+|+
T Consensus 29 ~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~l 105 (322)
T 2ppq_A 29 GIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISFL 105 (322)
T ss_dssp EECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEECC
T ss_pred ccCCCcccceEEEEeCCc-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEeC
Confidence 367788899999987766 58889886531 2245667888887774212 3333321 12235568999999
Q ss_pred CCCCHHH--------------HhhcCCCcccc------CCCCHHHHHH------------HHHHHHHHHHHHHcc----C
Q 042348 446 PNGSLAT--------------AIHGKAGIISY------RPLSWSDRLR------------IIKGVAKGIAFLHEV----S 489 (686)
Q Consensus 446 ~~gsL~~--------------~l~~~~~~~~~------~~l~~~~~~~------------i~~~ia~gL~~LH~~----~ 489 (686)
+|..+.. .+|........ ....|..... +...+...++++++. .
T Consensus 106 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~~ 185 (322)
T 2ppq_A 106 EGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKDL 185 (322)
T ss_dssp CCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCSS
T ss_pred CCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCcccC
Confidence 8865321 12211100000 0011322110 011244455666532 2
Q ss_pred CCCceecCCCCCCeeecCCCCeEEeecCccc
Q 042348 490 PKRYVHGDLRPSNILLGKNMEPHISDFGLAR 520 (686)
Q Consensus 490 ~~~iiHrDlkp~NILl~~~~~~kl~DfGla~ 520 (686)
+..++|+|+.+.||+++++..+.|+||+.+.
T Consensus 186 ~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 186 PAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp CEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred CcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 3579999999999999887656899999775
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.32 E-value=0.00058 Score=72.81 Aligned_cols=71 Identities=15% Similarity=0.155 Sum_probs=48.6
Q ss_pred ccCccCceEEEEEEeCC--------CceEEEEEcCCCCccchHHHHHHHHHHhccCCCC-cceeeEEEEecCceeEEEec
Q 042348 374 LLGKSTIGIVYKVALNN--------EEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPN-IVSLRAYFWSVDEKLLIYDY 444 (686)
Q Consensus 374 ~iG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n-Iv~l~~~~~~~~~~~lV~e~ 444 (686)
.|+.|....||++...+ +..+++|+..... ....+..|..+++.+...+ .+++++.+.+ .+||||
T Consensus 80 ~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~--~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e~ 153 (429)
T 1nw1_A 80 RIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEY 153 (429)
T ss_dssp EECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECC
T ss_pred EeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC--cHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEEE
Confidence 47788889999998753 4678888874421 1145668999998884333 3667766532 389999
Q ss_pred cCCCCH
Q 042348 445 IPNGSL 450 (686)
Q Consensus 445 ~~~gsL 450 (686)
++|.++
T Consensus 154 l~G~~l 159 (429)
T 1nw1_A 154 IPSRPL 159 (429)
T ss_dssp CCEEEC
T ss_pred eCCccc
Confidence 986443
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.30 E-value=0.00066 Score=70.79 Aligned_cols=142 Identities=20% Similarity=0.273 Sum_probs=83.8
Q ss_pred ccCccCceEEEEEEeCC--------CceEEEEEcCCCCccchHHHHHHHHHHhccC-CCCcceeeEEEEecCceeEEEec
Q 042348 374 LLGKSTIGIVYKVALNN--------EEAVAVRRLGNGGWQRFKEFQTEAEAIGKIR-HPNIVSLRAYFWSVDEKLLIYDY 444 (686)
Q Consensus 374 ~iG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lV~e~ 444 (686)
.+..|-...+|++...+ ++.+++|+.... ........+|.++++.+. +.-..++++++.+ .+||||
T Consensus 57 ~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e~ 131 (379)
T 3feg_A 57 PVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQY 131 (379)
T ss_dssp EC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEEC
T ss_pred EcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEEE
Confidence 36677888899988752 467888886432 233456778999998884 3334667766543 299999
Q ss_pred cCCCCHHHH-----------------hhcCCCccccCCC-CHHHHHHHHHHHHH-------------------HHHHHHc
Q 042348 445 IPNGSLATA-----------------IHGKAGIISYRPL-SWSDRLRIIKGVAK-------------------GIAFLHE 487 (686)
Q Consensus 445 ~~~gsL~~~-----------------l~~~~~~~~~~~l-~~~~~~~i~~~ia~-------------------gL~~LH~ 487 (686)
++|.+|..- +|.........+. -|.++.++..++.. .++.|.+
T Consensus 132 i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~ 211 (379)
T 3feg_A 132 IPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRK 211 (379)
T ss_dssp CSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHH
T ss_pred ecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHH
Confidence 998654311 1221110010111 24555555544422 2333332
Q ss_pred -----cCCCCceecCCCCCCeeecCC----CCeEEeecCccc
Q 042348 488 -----VSPKRYVHGDLRPSNILLGKN----MEPHISDFGLAR 520 (686)
Q Consensus 488 -----~~~~~iiHrDlkp~NILl~~~----~~~kl~DfGla~ 520 (686)
..+..++|+|+.+.||+++.+ +.+.++||..+.
T Consensus 212 ~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 212 LLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 123468999999999999876 789999999886
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.29 E-value=0.0012 Score=70.62 Aligned_cols=72 Identities=15% Similarity=0.165 Sum_probs=47.3
Q ss_pred ccCccCceEEEEEEeCC-CceEEEEEcCCCCccchHHHHHHHHHHhccCCCCc-ceeeEEEEecCceeEEEeccCCCCH
Q 042348 374 LLGKSTIGIVYKVALNN-EEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNI-VSLRAYFWSVDEKLLIYDYIPNGSL 450 (686)
Q Consensus 374 ~iG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nI-v~l~~~~~~~~~~~lV~e~~~~gsL 450 (686)
.|+.|-...+|++...+ +..+++|+...... ..-+-.+|..++..+...++ .++++++. + .+||||++|.+|
T Consensus 115 ~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~-~~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~l 188 (458)
T 2qg7_A 115 IINGGITNILIKVKDMSKQAKYLIRLYGPKTD-EIINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYAL 188 (458)
T ss_dssp EECC--CEEEEEEEETTTTEEEEEEEECC-CC-SCSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEEC
T ss_pred EcCCCeEeEEEEEEECCCCceEEEEECCCChh-hhcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCccC
Confidence 47788889999998875 46788888754321 11223689999998865444 56777662 2 359999987544
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.22 E-value=0.0015 Score=67.10 Aligned_cols=142 Identities=13% Similarity=0.069 Sum_probs=74.0
Q ss_pred cCccCceE-EEEEEeCCCceEEEEEcCCCCccchHHHHHHHHHHhccCC--CCcceeeEEEEecCceeEEEeccCCCCHH
Q 042348 375 LGKSTIGI-VYKVALNNEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRH--PNIVSLRAYFWSVDEKLLIYDYIPNGSLA 451 (686)
Q Consensus 375 iG~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H--~nIv~l~~~~~~~~~~~lV~e~~~~gsL~ 451 (686)
|+.|.... +|+....++..+++|....... ..+..|+.++..+.. -.+.+++.+.. +.-++|||++.+..+.
T Consensus 26 l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~--~~g~ll~e~l~~~~l~ 100 (333)
T 3csv_A 26 LAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEH--ARGLLLIEDLGDALFT 100 (333)
T ss_dssp --------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEET--TTTEEEECCCCSCBHH
T ss_pred CCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecC--CCCEEEEeeCCCcchH
Confidence 44554444 6677654466777776544321 334567777777632 23556666532 2337899999877776
Q ss_pred HHhhcCCCc--------------------cccCCCCHHHHH-------HH-------------HHHHHHHHHHHH---cc
Q 042348 452 TAIHGKAGI--------------------ISYRPLSWSDRL-------RI-------------IKGVAKGIAFLH---EV 488 (686)
Q Consensus 452 ~~l~~~~~~--------------------~~~~~l~~~~~~-------~i-------------~~~ia~gL~~LH---~~ 488 (686)
+++...... .....++..... .+ ...+...++.+. ..
T Consensus 101 ~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~~~ 180 (333)
T 3csv_A 101 EVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQLE 180 (333)
T ss_dssp HHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHHCC
T ss_pred HHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhccc
Confidence 554321100 000111111100 00 011112222221 11
Q ss_pred CCCCceecCCCCCCeeecCC----CCeEEeecCcccc
Q 042348 489 SPKRYVHGDLRPSNILLGKN----MEPHISDFGLARL 521 (686)
Q Consensus 489 ~~~~iiHrDlkp~NILl~~~----~~~kl~DfGla~~ 521 (686)
.+..++|||+.+.||+++.+ ..+.|+||+.+..
T Consensus 181 ~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 181 GDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp SCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 23579999999999999874 6789999998864
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.22 E-value=0.0024 Score=65.35 Aligned_cols=142 Identities=16% Similarity=0.206 Sum_probs=81.0
Q ss_pred cCccCceEEEEEEeCCCceEEEEEcCCCCccchHHHHHHHHHHhccCCC--CcceeeEE-----EEecCceeEEEeccCC
Q 042348 375 LGKSTIGIVYKVALNNEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHP--NIVSLRAY-----FWSVDEKLLIYDYIPN 447 (686)
Q Consensus 375 iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~--nIv~l~~~-----~~~~~~~~lV~e~~~~ 447 (686)
++ |....||++...+|+.+++|....... ....+..|..++..+... .+++++.. ....+..++||||++|
T Consensus 34 l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~-~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i~G 111 (328)
T 1zyl_A 34 LN-SYENRVYQFQDEDRRRFVVKFYRPERW-TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGG 111 (328)
T ss_dssp EC-CSSSEEEEECCTTCCCEEEEEECTTTS-CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCC
T ss_pred ec-CcccceEEEEcCCCCEEEEEEcCCCCC-CHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEecCC
Confidence 55 777899998877777899999864321 235677788888877422 24444443 1224456789999987
Q ss_pred CCHH-----HH---------hhcCC---CccccCCCCHHHH----HH---------------HHHHHHHHHHHHHcc---
Q 042348 448 GSLA-----TA---------IHGKA---GIISYRPLSWSDR----LR---------------IIKGVAKGIAFLHEV--- 488 (686)
Q Consensus 448 gsL~-----~~---------l~~~~---~~~~~~~l~~~~~----~~---------------i~~~ia~gL~~LH~~--- 488 (686)
..+. .+ +|... .......+++... .. +...+...++.+.+.
T Consensus 112 ~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 191 (328)
T 1zyl_A 112 RQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWRE 191 (328)
T ss_dssp EECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCS
T ss_pred CCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHhhh
Confidence 5432 10 12110 0000011222111 00 111111223333221
Q ss_pred -CCCCceecCCCCCCeeecCCCCeEEeecCccc
Q 042348 489 -SPKRYVHGDLRPSNILLGKNMEPHISDFGLAR 520 (686)
Q Consensus 489 -~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~ 520 (686)
.+..++|+|+++.||+++ + .+.|+||+.+.
T Consensus 192 ~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~ 222 (328)
T 1zyl_A 192 DFTVLRLHGDCHAGNILWR-D-GPMFVDLDDAR 222 (328)
T ss_dssp CSCCEECCSSCSGGGEEES-S-SEEECCCTTCC
T ss_pred cCCeeeeeCCCCcccEeEc-C-CCEEEECCCCC
Confidence 235689999999999998 4 89999998775
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.16 E-value=0.00011 Score=67.18 Aligned_cols=34 Identities=6% Similarity=-0.029 Sum_probs=17.5
Q ss_pred CCCEEEccCCCCcccCCccccCCCCCcEEEccCC
Q 042348 82 AIGRVNLRNNNFSGSLPVELFNASNLQSLILSGN 115 (686)
Q Consensus 82 ~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N 115 (686)
.|+.|||+++.|+..-=..+.++++|+.|+|+++
T Consensus 62 ~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C 95 (176)
T 3e4g_A 62 KIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKC 95 (176)
T ss_dssp CEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESC
T ss_pred eEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCC
Confidence 4566666665554322223445555555555555
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=97.16 E-value=0.00072 Score=71.31 Aligned_cols=140 Identities=15% Similarity=0.183 Sum_probs=89.8
Q ss_pred EEEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCccccCCCCCcEEEccCCCCCCCCcccccCCCCCCEEeccC
Q 042348 59 VFSLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQVLDLSQ 138 (686)
Q Consensus 59 ~~~l~l~~n~l~g~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~ 138 (686)
++.+.+++ .++..-...+..+..|+.+.+..|... .....|.++..|+.+.+..+.+. ...|..+.+|+.+.+..
T Consensus 232 l~~i~ip~-~~~~i~~~~f~~~~~l~~~~~~~~~~~-i~~~~F~~~~~l~~~~~~~~~i~---~~~F~~~~~L~~i~l~~ 306 (394)
T 4fs7_A 232 VKNIIIPD-SFTELGKSVFYGCTDLESISIQNNKLR-IGGSLFYNCSGLKKVIYGSVIVP---EKTFYGCSSLTEVKLLD 306 (394)
T ss_dssp CCEEEECT-TCCEECSSTTTTCSSCCEEEECCTTCE-ECSCTTTTCTTCCEEEECSSEEC---TTTTTTCTTCCEEEECT
T ss_pred CceEEECC-CceecccccccccccceeEEcCCCcce-eeccccccccccceeccCceeec---ccccccccccccccccc
Confidence 44444432 233233345666677777777766543 44556667777777766655432 33566778888888865
Q ss_pred CCCCCCCChhhhhccccccccccccccCCCCchhhhhcCcccceecccccccCCCCchhhhcccccccc
Q 042348 139 NSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSGLIPNDIANLSRLRLL 207 (686)
Q Consensus 139 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l 207 (686)
+ ++..-...|.++.+|+.++|.++ ++ .|+...+.++.+|+.++|..| ++.+-...|.++.+|+.+
T Consensus 307 ~-i~~I~~~aF~~c~~L~~i~lp~~-v~-~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i 371 (394)
T 4fs7_A 307 S-VKFIGEEAFESCTSLVSIDLPYL-VE-EIGKRSFRGCTSLSNINFPLS-LRKIGANAFQGCINLKKV 371 (394)
T ss_dssp T-CCEECTTTTTTCTTCCEECCCTT-CC-EECTTTTTTCTTCCEECCCTT-CCEECTTTBTTCTTCCEE
T ss_pred c-cceechhhhcCCCCCCEEEeCCc-cc-EEhHHhccCCCCCCEEEECcc-ccEehHHHhhCCCCCCEE
Confidence 4 55444567778888888888644 55 566665667888888888766 665656677887777655
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=97.06 E-value=0.0011 Score=69.42 Aligned_cols=131 Identities=11% Similarity=0.149 Sum_probs=93.2
Q ss_pred cCCcCcCCCCCCCEEEccCCCCcccCCccccCCCCCcEEEccCCCCCCCCcccccCCCCCCEEeccCCCCCCCCChhhhh
Q 042348 72 FIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQVLDLSQNSFSSSIPSSIVQ 151 (686)
Q Consensus 72 ~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~ 151 (686)
.....+....+|+.+.+..+ +...-...+.++.+|+.+.+..+ ++..-...|..+.+|+.+.+..+ ++..-...|.+
T Consensus 208 i~~~~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~ 284 (379)
T 4h09_A 208 VTAYGFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSG 284 (379)
T ss_dssp ECTTTTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTT
T ss_pred Eeecccccccccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-ceecccccccc
Confidence 34456677788888888765 33345566778888888888766 44344556777888888888654 55344567788
Q ss_pred ccccccccccccccCCCCchhhhhcCcccceecccccccCCCCchhhhcccccccc
Q 042348 152 CKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSGLIPNDIANLSRLRLL 207 (686)
Q Consensus 152 l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l 207 (686)
+.+|+.+.+.+|.++ .|+...+.++.+|+.++|..| ++.+-...|.++.+|+.+
T Consensus 285 c~~L~~i~l~~~~i~-~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i 338 (379)
T 4h09_A 285 CSNLTKVVMDNSAIE-TLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALSTI 338 (379)
T ss_dssp CTTCCEEEECCTTCC-EECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCCC
T ss_pred ccccccccccccccc-eehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCEE
Confidence 888888888888777 566666678888888888654 665556678888887755
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=97.04 E-value=0.0014 Score=68.71 Aligned_cols=126 Identities=13% Similarity=0.141 Sum_probs=80.1
Q ss_pred cCCCCCCCEEEccCCCCcccCCccccCCCCCcEEEccCCCCCCCCcccccCCCCCCEEeccCCCCCCCCChhhhhccccc
Q 042348 77 LGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQVLDLSQNSFSSSIPSSIVQCKRLK 156 (686)
Q Consensus 77 l~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~ 156 (686)
+.....+..+.+..+.-. .....+....+|+.+.+..+- ...-...|..+.+|+.+.+..+ ++..-...+.++.+|+
T Consensus 190 ~~~~~~~~~~~~~~~~~~-i~~~~f~~~~~l~~i~~~~~~-~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~ 266 (379)
T 4h09_A 190 YPAAKTGTEFTIPSTVKT-VTAYGFSYGKNLKKITITSGV-TTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALK 266 (379)
T ss_dssp CCTTCCCSEEECCTTCCE-ECTTTTTTCSSCSEEECCTTC-CEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCC
T ss_pred ccccccccccccccceeE-Eeecccccccccceeeeccce-eEEccccccCCccceEEEcCCC-ccEeCccccceeehhc
Confidence 344455555555544332 445556667777777776553 3234455667778888877665 5534455677777788
Q ss_pred cccccccccCCCCchhhhhcCcccceecccccccCCCCchhhhcccccccc
Q 042348 157 TVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSGLIPNDIANLSRLRLL 207 (686)
Q Consensus 157 ~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l 207 (686)
.+.+..+ ++ .++...+.++.+|+.+++.+|.++.+-...|.++.+|+.+
T Consensus 267 ~i~l~~~-i~-~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i 315 (379)
T 4h09_A 267 TLNFYAK-VK-TVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSV 315 (379)
T ss_dssp EEEECCC-CS-EECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEE
T ss_pred ccccccc-ce-eccccccccccccccccccccccceehhhhhcCCCCCCEE
Confidence 7777544 44 4555555677888888887777776666777777777654
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.03 E-value=0.0016 Score=67.94 Aligned_cols=72 Identities=15% Similarity=0.151 Sum_probs=44.4
Q ss_pred ccCccCceEEEEEEeCC---------CceEEEEEcCCCCccchHHHHHHHHHHhccCCCC-cceeeEEEEecCceeEEEe
Q 042348 374 LLGKSTIGIVYKVALNN---------EEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPN-IVSLRAYFWSVDEKLLIYD 443 (686)
Q Consensus 374 ~iG~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n-Iv~l~~~~~~~~~~~lV~e 443 (686)
.++.|....+|++...+ +..+++|+..... ....+...|.++++.+...+ +.++++.. .-++|||
T Consensus 40 ~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~~~~E~~~l~~L~~~g~~P~~~~~~----~~~~v~e 114 (369)
T 3c5i_A 40 QILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV-DELYNTISEFEVYKTMSKYKIAPQLLNTF----NGGRIEE 114 (369)
T ss_dssp EC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG-GGTSCHHHHHHHHHHHHHTTSSCCEEEEE----TTEEEEE
T ss_pred EeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc-cceecHHHHHHHHHHHHhcCCCCceEEec----CCcEEEE
Confidence 36778888999998764 2678888875432 22223467888888884333 44666554 2378999
Q ss_pred ccCCCCH
Q 042348 444 YIPNGSL 450 (686)
Q Consensus 444 ~~~~gsL 450 (686)
|++|..+
T Consensus 115 ~i~G~~l 121 (369)
T 3c5i_A 115 WLYGDPL 121 (369)
T ss_dssp CCCSEEC
T ss_pred EecCCcC
Confidence 9987543
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=97.00 E-value=0.0011 Score=69.90 Aligned_cols=139 Identities=15% Similarity=0.130 Sum_probs=104.7
Q ss_pred CEEEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCccccCCCCCcEEEccCCCCCCCCcccccCCCCCCEEecc
Q 042348 58 QVFSLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQVLDLS 137 (686)
Q Consensus 58 ~~~~l~l~~n~l~g~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls 137 (686)
.++.+.+..+... .-...+..+..++.+.+..+.+. ...|.++.+|+.+.+.++ ++..-..+|.++.+|+.++|.
T Consensus 254 ~l~~~~~~~~~~~-i~~~~F~~~~~l~~~~~~~~~i~---~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp 328 (394)
T 4fs7_A 254 DLESISIQNNKLR-IGGSLFYNCSGLKKVIYGSVIVP---EKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLP 328 (394)
T ss_dssp SCCEEEECCTTCE-ECSCTTTTCTTCCEEEECSSEEC---TTTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCC
T ss_pred cceeEEcCCCcce-eeccccccccccceeccCceeec---cccccccccccccccccc-cceechhhhcCCCCCCEEEeC
Confidence 5666777766443 55667889999999998877543 356788999999999766 553445678899999999997
Q ss_pred CCCCCCCCChhhhhccccccccccccccCCCCchhhhhcCcccceecccccccCCCCchhhhccccccc
Q 042348 138 QNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSGLIPNDIANLSRLRL 206 (686)
Q Consensus 138 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 206 (686)
.+ ++..-..+|.+|.+|+.+.|..| ++ .|+...+.++.+|+.++|..| ++ .+...|.++++|+.
T Consensus 329 ~~-v~~I~~~aF~~c~~L~~i~lp~~-l~-~I~~~aF~~C~~L~~i~lp~~-~~-~~~~~F~~c~~L~~ 392 (394)
T 4fs7_A 329 YL-VEEIGKRSFRGCTSLSNINFPLS-LR-KIGANAFQGCINLKKVELPKR-LE-QYRYDFEDTTKFKW 392 (394)
T ss_dssp TT-CCEECTTTTTTCTTCCEECCCTT-CC-EECTTTBTTCTTCCEEEEEGG-GG-GGGGGBCTTCEEEE
T ss_pred Cc-ccEEhHHhccCCCCCCEEEECcc-cc-EehHHHhhCCCCCCEEEECCC-CE-EhhheecCCCCCcE
Confidence 54 76555678999999999999877 66 677777789999999999765 33 23456777776653
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.97 E-value=0.0029 Score=65.06 Aligned_cols=68 Identities=12% Similarity=0.040 Sum_probs=44.1
Q ss_pred CccCceEEEEEEeCCCceEEEEEcCCCCccchHHHHHHHHHHhccC---CCCcceeeEE------EEecCceeEEEeccC
Q 042348 376 GKSTIGIVYKVALNNEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIR---HPNIVSLRAY------FWSVDEKLLIYDYIP 446 (686)
Q Consensus 376 G~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---H~nIv~l~~~------~~~~~~~~lV~e~~~ 446 (686)
|.|....||++...+| .+++|+...... ..|+.++..+. -|++++.+.. ....+..++||+|++
T Consensus 32 G~g~~N~vy~v~~~~g-~~vLK~~~~~~~------~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~ 104 (339)
T 3i1a_A 32 GADTNAFAYQADSESK-SYFIKLKYGYHD------EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIH 104 (339)
T ss_dssp TSCSSCEEEEEECSSC-EEEEEEEECSSC------CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCC
T ss_pred cCccccceEEEEeCCC-CEEEEEecCccc------hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccC
Confidence 4555789999988777 899998755431 34666666552 2224454432 223466789999999
Q ss_pred CCCH
Q 042348 447 NGSL 450 (686)
Q Consensus 447 ~gsL 450 (686)
|..+
T Consensus 105 G~~~ 108 (339)
T 3i1a_A 105 APNG 108 (339)
T ss_dssp CCBT
T ss_pred CCcC
Confidence 8765
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=96.94 E-value=0.00034 Score=63.92 Aligned_cols=91 Identities=13% Similarity=0.094 Sum_probs=59.8
Q ss_pred CccccCCCCCcEEEccCCCCCCCCcccccCCCCCCEEeccCCC-CCCCCChhhhhc----cccccccccccc-cCCCCch
Q 042348 98 PVELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQVLDLSQNS-FSSSIPSSIVQC----KRLKTVVLNQNS-FTGPLPD 171 (686)
Q Consensus 98 p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~-l~~~~p~~~~~l----~~L~~L~L~~N~-l~~~~p~ 171 (686)
|.....--+|+.|||+++.++..--..+..+++|+.|+|+++. ++..-=..+..+ ++|++|+|+++. +|..=-.
T Consensus 54 P~~~~~~~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~ 133 (176)
T 3e4g_A 54 PTGPLDKYKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGII 133 (176)
T ss_dssp CCCSTTCCCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHH
T ss_pred CcccCCCceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHH
Confidence 4333233469999999999885544567889999999999985 653222234442 368888888864 5521111
Q ss_pred hhhhcCcccceecccccc
Q 042348 172 GFATNLTALQKLDLSFNN 189 (686)
Q Consensus 172 ~~~~~l~~L~~L~Ls~N~ 189 (686)
.+ ..+++|++|+|++..
T Consensus 134 ~L-~~~~~L~~L~L~~c~ 150 (176)
T 3e4g_A 134 AL-HHFRNLKYLFLSDLP 150 (176)
T ss_dssp HG-GGCTTCCEEEEESCT
T ss_pred HH-hcCCCCCEEECCCCC
Confidence 22 367888888888764
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.91 E-value=0.0016 Score=56.58 Aligned_cols=37 Identities=24% Similarity=0.430 Sum_probs=20.6
Q ss_pred CCcEEEccCCCCCCCCcccccCCCCCCEEeccCCCCC
Q 042348 106 NLQSLILSGNSFSGPVPMQIGKLKYLQVLDLSQNSFS 142 (686)
Q Consensus 106 ~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~ 142 (686)
+|+.|+|++|+|+...+..|..+++|+.|+|++|.+.
T Consensus 32 ~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 32 DTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp TCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred CCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence 3555555555555433444555666666666666554
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=96.84 E-value=0.0001 Score=68.70 Aligned_cols=87 Identities=16% Similarity=0.190 Sum_probs=48.6
Q ss_pred cCCCCCCCEEEccCC-CCccc----CCccccCCCCCcEEEccCCCCCC----CCcccccCCCCCCEEeccCCCCCCCCC-
Q 042348 77 LGSLSAIGRVNLRNN-NFSGS----LPVELFNASNLQSLILSGNSFSG----PVPMQIGKLKYLQVLDLSQNSFSSSIP- 146 (686)
Q Consensus 77 l~~l~~L~~L~L~~N-~l~g~----~p~~~~~l~~L~~L~L~~N~l~g----~~p~~~~~l~~L~~L~ls~N~l~~~~p- 146 (686)
+.+-+.|+.|+|++| .|... +-..+..-+.|+.|+|++|+|.. .+...+..=+.|+.|+|++|.++..--
T Consensus 37 l~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~ 116 (197)
T 1pgv_A 37 REDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLA 116 (197)
T ss_dssp HTTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHH
T ss_pred HhcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHH
Confidence 344566777777774 66421 23344445667777777777762 233344445677777777777763211
Q ss_pred ---hhhhhcccccccccccc
Q 042348 147 ---SSIVQCKRLKTVVLNQN 163 (686)
Q Consensus 147 ---~~~~~l~~L~~L~L~~N 163 (686)
..+..-+.|++|+|++|
T Consensus 117 ala~aL~~N~tL~~L~L~n~ 136 (197)
T 1pgv_A 117 RLLRSTLVTQSIVEFKADNQ 136 (197)
T ss_dssp HHHHHTTTTCCCSEEECCCC
T ss_pred HHHHHHhhCCceeEEECCCC
Confidence 12222345666666644
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.78 E-value=0.0021 Score=55.82 Aligned_cols=56 Identities=20% Similarity=0.207 Sum_probs=45.8
Q ss_pred EEEeCCCCcc-ccCCcCcCCCCCCCEEEccCCCCcccCCccccCCCCCcEEEccCCCCC
Q 042348 61 SLIIPNKKLT-GFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFS 118 (686)
Q Consensus 61 ~l~l~~n~l~-g~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~ 118 (686)
.++.++++|+ ..+|..+. .+|+.|+|++|+|+..-+..|..+++|+.|+|++|.+.
T Consensus 12 ~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp EEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred EEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence 6777888887 35676543 46999999999999666667889999999999999885
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=96.54 E-value=0.0051 Score=64.73 Aligned_cols=104 Identities=14% Similarity=0.177 Sum_probs=74.6
Q ss_pred ccccCCCCCcEEEccCCCCCCCCcccccCCCCCCEEeccCCCCCCCCChhhhhccccccccccccccCCCCchhhhhcCc
Q 042348 99 VELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLT 178 (686)
Q Consensus 99 ~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~ 178 (686)
.+|.++.+|+.+.+.++..+ .-...|.++.+|+.+.+. +.++..-...|.+|.+|+.+.|..| ++ .|....+.++.
T Consensus 259 ~aF~~c~~L~~i~lp~~~~~-I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~-~I~~~aF~~C~ 334 (394)
T 4gt6_A 259 HAFDSCAYLASVKMPDSVVS-IGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-IT-QILDDAFAGCE 334 (394)
T ss_dssp TTTTTCSSCCEEECCTTCCE-ECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CC-EECTTTTTTCT
T ss_pred ceeeecccccEEecccccce-ecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-cc-EehHhHhhCCC
Confidence 45667788888888766543 445567788888888885 4555445567888888888888754 55 56666667888
Q ss_pred ccceecccccccCCCCchhhhcccccccc
Q 042348 179 ALQKLDLSFNNLSGLIPNDIANLSRLRLL 207 (686)
Q Consensus 179 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l 207 (686)
+|+.+.|..| ++.+-...|.++.+|+.+
T Consensus 335 ~L~~i~ip~s-v~~I~~~aF~~C~~L~~i 362 (394)
T 4gt6_A 335 QLERIAIPSS-VTKIPESAFSNCTALNNI 362 (394)
T ss_dssp TCCEEEECTT-CCBCCGGGGTTCTTCCEE
T ss_pred CCCEEEECcc-cCEEhHhHhhCCCCCCEE
Confidence 8888888654 665666778888888765
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=96.44 E-value=0.00056 Score=63.78 Aligned_cols=87 Identities=13% Similarity=0.077 Sum_probs=64.5
Q ss_pred cCCCEEEEEeCCC-Ccccc----CCcCcCCCCCCCEEEccCCCCccc----CCccccCCCCCcEEEccCCCCCCC----C
Q 042348 55 REGQVFSLIIPNK-KLTGF----IPADLGSLSAIGRVNLRNNNFSGS----LPVELFNASNLQSLILSGNSFSGP----V 121 (686)
Q Consensus 55 ~~~~~~~l~l~~n-~l~g~----~p~~l~~l~~L~~L~L~~N~l~g~----~p~~~~~l~~L~~L~L~~N~l~g~----~ 121 (686)
.+..++.|+|++| +|... +-..+..-+.|+.|+|++|+|... +...+..=+.|++|+|++|.|+.. +
T Consensus 39 ~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~al 118 (197)
T 1pgv_A 39 DDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARL 118 (197)
T ss_dssp TCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHH
T ss_pred cCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHHH
Confidence 3568999999986 77642 445566778999999999999733 233344457899999999999842 4
Q ss_pred cccccCCCCCCEEeccCCCC
Q 042348 122 PMQIGKLKYLQVLDLSQNSF 141 (686)
Q Consensus 122 p~~~~~l~~L~~L~ls~N~l 141 (686)
-..+..-+.|+.|+|++|..
T Consensus 119 a~aL~~N~tL~~L~L~n~~~ 138 (197)
T 1pgv_A 119 LRSTLVTQSIVEFKADNQRQ 138 (197)
T ss_dssp HHHTTTTCCCSEEECCCCSS
T ss_pred HHHHhhCCceeEEECCCCcC
Confidence 44566667899999987643
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=96.27 E-value=0.0076 Score=63.66 Aligned_cols=142 Identities=16% Similarity=0.206 Sum_probs=84.8
Q ss_pred ccCccCceEEEEEEeCC--------CceEEEEEcCCCCccchHHHHHHHHHHhccC-CCCcceeeEEEEecCceeEEEec
Q 042348 374 LLGKSTIGIVYKVALNN--------EEAVAVRRLGNGGWQRFKEFQTEAEAIGKIR-HPNIVSLRAYFWSVDEKLLIYDY 444 (686)
Q Consensus 374 ~iG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lV~e~ 444 (686)
.+..|-...+|+....+ +..+++|+..... ....+..+|.++++.+. +.-..++++.+ .-+.||||
T Consensus 77 ~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~~~idR~~E~~~l~~L~~~gi~P~l~~~~----~~~~I~ef 151 (424)
T 3mes_A 77 QIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-GKFYDSKVELDVFRYLSNINIAPNIIADF----PEGRIEEF 151 (424)
T ss_dssp EECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEE----TTEEEEEC
T ss_pred EcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-chhcCHHHHHHHHHHHHhcCCCCCEEEEc----CCCEEEEE
Confidence 36678888999998763 5778888865432 22223467888888884 33345666543 23789999
Q ss_pred cCCCCHHH--------------H---hhcCCC----cc---ccCCCCHHHHHHHHHHH-------------------HHH
Q 042348 445 IPNGSLAT--------------A---IHGKAG----II---SYRPLSWSDRLRIIKGV-------------------AKG 481 (686)
Q Consensus 445 ~~~gsL~~--------------~---l~~~~~----~~---~~~~l~~~~~~~i~~~i-------------------a~g 481 (686)
++|..|.. . +|.... .. ...+.-|.++.++..++ ...
T Consensus 152 I~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~e 231 (424)
T 3mes_A 152 IDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKILEE 231 (424)
T ss_dssp CCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHHHH
T ss_pred eCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHHHH
Confidence 99865421 0 111000 00 01122345544444332 222
Q ss_pred HHHHHc---------------------cCCCCceecCCCCCCeeecCCCCeEEeecCcccc
Q 042348 482 IAFLHE---------------------VSPKRYVHGDLRPSNILLGKNMEPHISDFGLARL 521 (686)
Q Consensus 482 L~~LH~---------------------~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~ 521 (686)
+++|.+ ..+..++|+|+.+.||+ +.++.+.++||..|..
T Consensus 232 ~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 232 IDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp HHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred HHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 333321 11246899999999999 7888999999998863
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.21 E-value=0.039 Score=51.71 Aligned_cols=103 Identities=11% Similarity=0.027 Sum_probs=67.4
Q ss_pred CCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccC
Q 042348 448 GSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEE 527 (686)
Q Consensus 448 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 527 (686)
-||.++|...+ .++++.+++.++.|.+.+|.-+-.. +.-..+=+.|..|++..+|.+.+.+ +.+..
T Consensus 33 vSL~eIL~~~~-----~PlsEEqaWALc~Qc~~~L~~~~~~--~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~~------ 98 (229)
T 2yle_A 33 LSLEEILRLYN-----QPINEEQAWAVCYQCCGSLRAAARR--RQPRHRVRSAAQIRVWRDGAVTLAP-AADDA------ 98 (229)
T ss_dssp EEHHHHHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCCSGGGEEEETTSCEEECC-C----------
T ss_pred ccHHHHHHHcC-----CCcCHHHHHHHHHHHHHHHHhhhhc--ccCCceecCCcceEEecCCceeccc-ccccc------
Confidence 38999998776 6899999999999999998776210 1111223346889999999888775 22110
Q ss_pred CccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCC
Q 042348 528 TPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLP 594 (686)
Q Consensus 528 ~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P 594 (686)
....+.|||... ...+.+.=|||+|+++|.-+--..|
T Consensus 99 -----------------------------~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 99 -----------------------------GEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp -------------------------------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred -----------------------------cccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 001267888764 3446788899999999999875444
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=93.50 E-value=0.21 Score=52.37 Aligned_cols=29 Identities=28% Similarity=0.503 Sum_probs=24.8
Q ss_pred ceecCCCCCCeee------cCCCCeEEeecCcccc
Q 042348 493 YVHGDLRPSNILL------GKNMEPHISDFGLARL 521 (686)
Q Consensus 493 iiHrDlkp~NILl------~~~~~~kl~DfGla~~ 521 (686)
++|+|+.+.|||+ +++..++++||-.|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 5799999999999 4567799999998864
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=86.09 E-value=2.1 Score=39.89 Aligned_cols=84 Identities=15% Similarity=0.191 Sum_probs=61.1
Q ss_pred CCCCcceeeEEEEecCceeEEEeccCC-CCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCC
Q 042348 421 RHPNIVSLRAYFWSVDEKLLIYDYIPN-GSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLR 499 (686)
Q Consensus 421 ~H~nIv~l~~~~~~~~~~~lV~e~~~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk 499 (686)
.||+.+.. .+-.+.+...+.|+.-+. -++.. + +.++...+++++..|+..-.+++. =+|--+.
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-i---------k~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~ 106 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-I---------KSFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLA 106 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-G---------GGSCHHHHHHHHHHGGGGGGGGGS-----SEECCCS
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-H---------HhcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEe
Confidence 68888866 455556655555554432 23333 2 347788999999999988866665 4788899
Q ss_pred CCCeeecCCCCeEEeecCccc
Q 042348 500 PSNILLGKNMEPHISDFGLAR 520 (686)
Q Consensus 500 p~NILl~~~~~~kl~DfGla~ 520 (686)
|+||+++.++.+++.=.|+-.
T Consensus 107 P~NL~f~~~~~p~i~~RGik~ 127 (215)
T 4ann_A 107 PDELFFTRDGLPIAKTRGLQN 127 (215)
T ss_dssp GGGEEECTTSCEEESCCEETT
T ss_pred cceEEEcCCCCEEEEEccCcc
Confidence 999999999999999888643
|
| >2k1k_A Ephrin type-A receptor 1; EPHA1, receptor tyrosine kinase, dimeric transmembrane domain, ATP-binding, glycoprotein, nucleotide-binding; NMR {Homo sapiens} PDB: 2k1l_A | Back alignment and structure |
|---|
Probab=81.83 E-value=0.66 Score=29.95 Aligned_cols=28 Identities=18% Similarity=0.146 Sum_probs=17.3
Q ss_pred cccceeeehhHHHHHHHHHHHHhhhhhh
Q 042348 279 HSCAVITTVAVAVLLGICITGFLFYRQY 306 (686)
Q Consensus 279 ~~~~~i~~v~v~~~~~~~~~~~~~~~~~ 306 (686)
.+.+.+.+++++.++++++++.+.++.+
T Consensus 8 ls~GaIAGiVvG~v~gv~li~~l~~~~~ 35 (38)
T 2k1k_A 8 LTGGEIVAVIFGLLLGAALLLGILVFRS 35 (38)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred CCCCceeeeehHHHHHHHHHHHHHHHHe
Confidence 3456677888887777665555444333
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=81.65 E-value=3.1 Score=38.95 Aligned_cols=83 Identities=20% Similarity=0.247 Sum_probs=60.0
Q ss_pred CCCCcceeeEEEEecCceeEEEeccCCC-CHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHH-HHHccCCCCceecCC
Q 042348 421 RHPNIVSLRAYFWSVDEKLLIYDYIPNG-SLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIA-FLHEVSPKRYVHGDL 498 (686)
Q Consensus 421 ~H~nIv~l~~~~~~~~~~~lV~e~~~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~-~LH~~~~~~iiHrDl 498 (686)
.||++ -..+-.+.+...+.++.-+++ ++. .+ +.++...+++++..|+.... +++. -+|--+
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~-~i---------~~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l 110 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFA-AI---------RKTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIV 110 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHH-HH---------HTSCHHHHHHHHHHHHHHHSSCCSS-----SEECCC
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHH-HH---------HhcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEE
Confidence 68888 333445666666667665333 333 33 24678889999999988766 5555 578889
Q ss_pred CCCCeeecCCCCeEEeecCccc
Q 042348 499 RPSNILLGKNMEPHISDFGLAR 520 (686)
Q Consensus 499 kp~NILl~~~~~~kl~DfGla~ 520 (686)
.|+||+++.++.+++.-.|+-.
T Consensus 111 ~P~NL~f~~~~~p~i~hRGi~~ 132 (219)
T 4ano_A 111 CPENLMFNRALEPFFLHVGVKE 132 (219)
T ss_dssp CGGGEEECTTCCEEESCCEETT
T ss_pred eCceEEEeCCCcEEEEEcCCcc
Confidence 9999999999999999888753
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 686 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 1e-54 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 3e-49 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 4e-47 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 3e-46 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 9e-46 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-45 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 3e-45 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-44 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 4e-44 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 5e-44 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-43 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-43 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-43 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-43 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 4e-43 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 9e-43 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 3e-42 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 4e-42 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 6e-42 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 7e-42 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 7e-42 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 8e-42 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 9e-41 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 8e-40 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 3e-39 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 6e-39 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 3e-38 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 4e-38 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 5e-38 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-37 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 6e-37 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 3e-36 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 7e-36 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 8e-36 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 5e-35 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 7e-35 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-33 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 5e-33 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-32 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-31 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-31 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-31 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 8e-31 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 3e-30 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 4e-30 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-29 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 3e-29 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 4e-28 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 5e-28 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-27 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-27 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-27 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 1e-26 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 8e-26 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-25 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 8e-25 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-24 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-23 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 4e-23 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-21 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-18 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 3e-17 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 8e-16 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 3e-15 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-04 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 3e-04 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 0.001 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 0.002 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-14 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 3e-14 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 5e-12 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-12 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 9e-10 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-08 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 6e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.001 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 1e-09 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 3e-07 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 9e-06 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 2e-09 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 5e-09 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 2e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 1e-08 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 6e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 1e-04 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 1e-08 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 1e-08 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 4e-07 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 1e-05 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 1e-04 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 8e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 2e-05 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 4e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 8e-04 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 2e-05 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 6e-04 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 3e-05 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 4e-05 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 9e-04 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 0.001 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 0.001 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.002 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 0.003 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 0.003 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 0.003 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (473), Expect = 1e-54
Identities = 59/298 (19%), Positives = 124/298 (41%), Gaps = 45/298 (15%)
Query: 374 LLGKSTIGIVYKVALNNEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFW 433
+G + G VYK + + AV + + Q+ + F+ E + K RH NI+ Y
Sbjct: 15 RIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST 74
Query: 434 SVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRY 493
+ + ++ + SL +H + I + A+G+ +LH K
Sbjct: 75 A-PQLAIVTQWCEGSSLYHHLHIIET-----KFEMIKLIDIARQTAQGMDYLH---AKSI 125
Query: 494 VHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALN 553
+H DL+ +NI L +++ I DFGLA + + H + +G+
Sbjct: 126 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGS---HQFEQLSGSI------------ 170
Query: 554 STTSRSYYQAPEASKVRKP---TQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQWIQ 610
+ APE +++ + + D+Y++G++L E+++G+LP +N I
Sbjct: 171 ------LWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPY-----SNINNRDQII 219
Query: 611 LILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRV 668
++ D+ + + ++ ++ +C+ K D+RP + S++ +
Sbjct: 220 FMVGRGYLSPDLSKV-------RSNCPKAMKRLMAECLKKKRDERPLFPQILASIELL 270
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (435), Expect = 3e-49
Identities = 70/300 (23%), Positives = 123/300 (41%), Gaps = 47/300 (15%)
Query: 374 LLGKSTIGIVYKVALNNEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFW 433
LG G V+ N VAV+ L G F EA + +++H +V L A
Sbjct: 20 RLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLVRLYAVVT 78
Query: 434 SVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRY 493
+ +I +Y+ NGSL + +GI L+ + L + +A+G+AF+ E + Y
Sbjct: 79 Q-EPIYIITEYMENGSLVDFLKTPSGI----KLTINKLLDMAAQIAEGMAFIEE---RNY 130
Query: 494 VHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALN 553
+H DLR +NIL+ + I+DFGLARL E E +
Sbjct: 131 IHRDLRAANILVSDTLSCKIADFGLARLI----EDNEYTAREGAKFPI------------ 174
Query: 554 STTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQWIQLIL 613
+ APEA T K D++S+G++L E+++ + + IQ +
Sbjct: 175 ------KWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYP----GMTNPEVIQNLE 224
Query: 614 EDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRVNISTE 673
+ + ++ + ++ C + P+ RP+ ++ L+ +TE
Sbjct: 225 RGYRM------------VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATE 272
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (421), Expect = 4e-47
Identities = 60/313 (19%), Positives = 116/313 (37%), Gaps = 47/313 (15%)
Query: 375 LGKSTIGIVYKVALNNEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWS 434
+GK G V++ EE VAV+ + + + + E +RH NI+ A
Sbjct: 11 IGKGRFGEVWRGKWRGEE-VAVKIFSSREERSW-FREAEIYQTVMLRHENILGFIAADNK 68
Query: 435 VDEKL----LIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHE--- 487
+ L+ DY +GSL ++ ++ +++ A G+A LH
Sbjct: 69 DNGTWTQLWLVSDYHEHGSLFDYLNR-------YTVTVEGMIKLALSTASGLAHLHMEIV 121
Query: 488 --VSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSS 545
H DL+ NIL+ KN I+D GLA D A +T + GT +
Sbjct: 122 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTID-IAPNHRVGTKRYMA 180
Query: 546 PYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKL----------PM 595
P K + ++ DIY+ G++ E+ P
Sbjct: 181 P------------EVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY 228
Query: 596 IQIGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKR 655
+ + ++ + +++ E + L P + + + + + KI +C + + R
Sbjct: 229 YDLVPSDPSVEEMRKVVCEQK------LRPNIPNRWQSCEALRVMAKIMRECWYANGAAR 282
Query: 656 PSMRHVCDSLDRV 668
+ + +L ++
Sbjct: 283 LTALRIKKTLSQL 295
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 164 bits (415), Expect = 3e-46
Identities = 70/301 (23%), Positives = 128/301 (42%), Gaps = 49/301 (16%)
Query: 374 LLGKSTIGIVYKVAL----NNEEAVAVRRLGNGGWQRF-KEFQTEAEAIGKIRHPNIVSL 428
++G G V L E VA++ L +G ++ ++F +EA +G+ HPN++ L
Sbjct: 33 VIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHL 92
Query: 429 RAYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEV 488
++I +++ NGSL + + G + + +++G+A G+ +L
Sbjct: 93 EGVVTKSTPVMIITEFMENGSLDSFLRQNDG-----QFTVIQLVGMLRGIAAGMKYLA-- 145
Query: 489 SPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYE 548
YVH DL NIL+ N+ +SDFGL+R + P
Sbjct: 146 -DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPI------- 197
Query: 549 FTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQIGSMELNIVQ 607
+ APEA + RK T D++SYG+++ E++S G+ P ++
Sbjct: 198 -----------RWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPY-----WDMTNQD 241
Query: 608 WIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDR 667
I I +D + D ++ ++ LDC K + RP + ++LD+
Sbjct: 242 VINAIEQDYRLP------------PPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDK 289
Query: 668 V 668
+
Sbjct: 290 M 290
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (409), Expect = 9e-46
Identities = 52/294 (17%), Positives = 106/294 (36%), Gaps = 47/294 (15%)
Query: 375 LGKSTIGIVYKVALNNEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWS 434
+G G+V+ N++ VA++ + G ++F EAE + K+ HP +V L
Sbjct: 13 IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE-EDFIEEAEVMMKLSHPKLVQLYGVCLE 71
Query: 435 VDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYV 494
L+++++ +G L+ + + + L + V +G + + +
Sbjct: 72 QAPICLVFEFMEHGCLSDYLRTQ-----RGLFAAETLLGMCLDVCEG---MAYLEEACVI 123
Query: 495 HGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNS 554
H DL N L+G+N +SDFG+ R + T
Sbjct: 124 HRDLAARNCLVGENQVIKVSDFGMTRFV----LDDQYTSSTGTKFPV------------- 166
Query: 555 TTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQWIQLILE 614
+ +PE + + K D++S+GV++ E+ S + + ++ I
Sbjct: 167 -----KWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPY----ENRSNSEVVEDIST 217
Query: 615 DRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRV 668
+ V +I C + P+ RP+ + L +
Sbjct: 218 GFRLY------------KPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEI 259
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (406), Expect = 2e-45
Identities = 62/297 (20%), Positives = 117/297 (39%), Gaps = 55/297 (18%)
Query: 374 LLGKSTIGIVYKVALNNEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFW 433
+GK G V + VAV+ + N + F EA + ++RH N+V L
Sbjct: 14 TIGKGEFGDVMLGDYRGNK-VAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIV 70
Query: 434 SVDEKL-LIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKR 492
L ++ +Y+ GSL + + L L+ V + + +L
Sbjct: 71 EEKGGLYIVTEYMAKGSLVDYLRSR----GRSVLGGDCLLKFSLDVCEAMEYLEG---NN 123
Query: 493 YVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTAL 552
+VH DL N+L+ ++ +SDFGL + A ++T ++
Sbjct: 124 FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV------------------- 164
Query: 553 NSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQIGSMELNIVQWIQL 611
+ APEA + +K + K D++S+G++L E+ S G++P + + +
Sbjct: 165 -------KWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPY-----PRIPLKDVVPR 212
Query: 612 ILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRV 668
+ + K D D +V ++ +C H RPS + + L+ +
Sbjct: 213 VEKGYKM--DAPDGCPP----------AVYEVMKNCWHLDAAMRPSFLQLREQLEHI 257
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (407), Expect = 3e-45
Identities = 75/307 (24%), Positives = 129/307 (42%), Gaps = 47/307 (15%)
Query: 375 LGKSTIGIVYKVALNNEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWS 434
LG+ G V+ N VA++ L G + F EA+ + K+RH +V L A
Sbjct: 25 LGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS- 82
Query: 435 VDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYV 494
+ ++ +Y+ GSL + G+ G + L + + +A G+A++ YV
Sbjct: 83 EEPIYIVTEYMSKGSLLDFLKGETG----KYLRLPQLVDMAAQIASGMAYVE---RMNYV 135
Query: 495 HGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNS 554
H DLR +NIL+G+N+ ++DFGLARL E E Q
Sbjct: 136 HRDLRAANILVGENLVCKVADFGLARLI----EDNEYTARQGAKFPI------------- 178
Query: 555 TTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQWIQLILE 614
+ APEA+ + T K D++S+G++L E+ + G + ++ ++
Sbjct: 179 -----KWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYP-GMVNREVLDQVERGYR 232
Query: 615 DRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRVNISTEQ 674
P + S+ + C K P++RP+ ++ L+ STE
Sbjct: 233 MPCP---------------PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 277
Query: 675 QFMKGEE 681
Q+ GE
Sbjct: 278 QYQPGEN 284
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (402), Expect = 2e-44
Identities = 59/296 (19%), Positives = 109/296 (36%), Gaps = 51/296 (17%)
Query: 375 LGKSTIGIVYKV---ALNNEEAVAVRRLGNGGWQRF-KEFQTEAEAIGKIRHPNIVSLRA 430
LG G V + + VA++ L G + +E EA+ + ++ +P IV L
Sbjct: 17 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 76
Query: 431 YFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSP 490
+ + +L+ + G L + GK + S+ ++ V+ G+ +L
Sbjct: 77 VCQA-EALMLVMEMAGGGPLHKFLVGKRE-----EIPVSNVAELLHQVSMGMKYLE---E 127
Query: 491 KRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFT 550
K +VH DL N+LL ISDFGL++ + +
Sbjct: 128 KNFVHRDLAARNVLLVNRHYAKISDFGLSKALG--ADDSYYTARSAGKWPL--------- 176
Query: 551 ALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQIGSMELNIVQWI 609
+ APE RK + + D++SYGV + E +S G+ P ++ + +
Sbjct: 177 ---------KWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPY-----KKMKGPEVM 222
Query: 610 QLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSL 665
I + ++ + E + + DC + RP V +
Sbjct: 223 AFIEQGKR-------MECPPECPPE-----LYALMSDCWIYKWEDRPDFLTVEQRM 266
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 158 bits (401), Expect = 4e-44
Identities = 60/294 (20%), Positives = 110/294 (37%), Gaps = 59/294 (20%)
Query: 375 LGKSTIGIVYKV-ALNNEEAVAVRRL---GNGGWQRFKEFQTEAEAIGKIRHPNIVSLRA 430
+G + G VY + N E VA++++ G +++++ E + K+RHPN + R
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 431 YFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSP 490
+ L+ +Y + K +PL + + G +G+A+LH
Sbjct: 83 CYLREHTAWLVMEYCLGSASDLLEVHK------KPLQEVEIAAVTHGALQGLAYLHS--- 133
Query: 491 KRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFT 550
+H D++ NILL + + DFG A + + S GTP
Sbjct: 134 HNMIHRDVKAGNILLSEPGLVKLGDFGSASI---------MAPANSFVGTP--------- 175
Query: 551 ALNSTTSRSYYQAPE---ASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQ 607
Y+ APE A + K D++S G+ +E+ K P+ +N +
Sbjct: 176 ---------YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL-----FNMNAMS 221
Query: 608 WIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHV 661
+ I ++ P + + C+ K P RP+ +
Sbjct: 222 ALYHIAQNESP------ALQSGHWSEY-----FRNFVDSCLQKIPQDRPTSEVL 264
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (396), Expect = 5e-44
Identities = 59/292 (20%), Positives = 105/292 (35%), Gaps = 49/292 (16%)
Query: 375 LGKSTIGIVYKVALNNEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWS 434
LG G+V + VA++ + G EF EA+ + + H +V L
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLVQLYGVCTK 70
Query: 435 VDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYV 494
+I +Y+ NG L + L + K V + + +L K+++
Sbjct: 71 QRPIFIITEYMANGCLLNYLREMRH-----RFQTQQLLEMCKDVCEAMEYLE---SKQFL 122
Query: 495 HGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNS 554
H DL N L+ +SDFGL+R E +
Sbjct: 123 HRDLAARNCLVNDQGVVKVSDFGLSRYV----LDDEYTSSVGSKFPV------------- 165
Query: 555 TTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQIGSMELNIVQWIQLIL 613
+ PE K + K DI+++GV++ E+ S GK+P + + I
Sbjct: 166 -----RWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPY-----ERFTNSETAEHIA 215
Query: 614 EDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSL 665
+ L + H ++ V I C H+ D+RP+ + + ++
Sbjct: 216 QG-------LRLYRPHLASEK-----VYTIMYSCWHEKADERPTFKILLSNI 255
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (395), Expect = 1e-43
Identities = 67/300 (22%), Positives = 125/300 (41%), Gaps = 50/300 (16%)
Query: 374 LLGKSTIGIVYKVALNN-----EEAVAVRRLGNGGWQRFK-EFQTEAEAIGKIRHPNIVS 427
++G G VYK L E VA++ L G ++ + +F EA +G+ H NI+
Sbjct: 14 VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIR 73
Query: 428 LRAYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHE 487
L ++I +Y+ NG+L + K G S + +++G+A G+ +L
Sbjct: 74 LEGVISKYKPMMIITEYMENGALDKFLREKDG-----EFSVLQLVGMLRGIAAGMKYLAN 128
Query: 488 VSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPY 547
YVH DL NIL+ N+ +SDFGL+R+ + ++ +
Sbjct: 129 ---MNYVHRDLAARNILVNSNLVCKVSDFGLSRV--LEDDPEATYTTSGGKIPI------ 177
Query: 548 EFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQ 607
+ APEA RK T D++S+G+++ E+++ EL+ +
Sbjct: 178 ------------RWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERP----YWELSNHE 221
Query: 608 WIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDR 667
++ I + + T D ++ ++ + C + +RP + LD+
Sbjct: 222 VMKAINDGFRLPTP------------MDCPSAIYQLMMQCWQQERARRPKFADIVSILDK 269
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (395), Expect = 2e-43
Identities = 66/312 (21%), Positives = 118/312 (37%), Gaps = 47/312 (15%)
Query: 351 YEFVPLDSQVDFDLEQLLKASAFLLGKSTIGIVYKV-ALNNEEAVAVRRLGNGGWQRFKE 409
YE V D + D +++ LG G VYK A + + + ++
Sbjct: 1 YEHVTRDLNPE-DFWEIIG----ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELED 55
Query: 410 FQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWS 469
+ E + + HPNIV L F+ + ++ ++ G++ + RPL+ S
Sbjct: 56 YMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLEL-----ERPLTES 110
Query: 470 DRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETP 529
+ K + +LH+ + +H DL+ NIL + + ++DFG++ + T
Sbjct: 111 QIQVVCKQTLDALNYLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSA-----KNTR 162
Query: 530 EVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMI 589
+ S GTP +P E SK R K D++S G+ L+EM
Sbjct: 163 TIQRRDSFIGTPYWMAP-------------EVVMCETSKDRPYDYKADVWSLGITLIEMA 209
Query: 590 SGKLPMIQIGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVH 649
+ P ELN ++ + I + P + LK C+
Sbjct: 210 EIEPPH-----HELNPMRVLLKIAKSEPPTLAQPSRW-------SSNFKDFLK---KCLE 254
Query: 650 KSPDKRPSMRHV 661
K+ D R + +
Sbjct: 255 KNVDARWTTSQL 266
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 156 bits (394), Expect = 2e-43
Identities = 66/329 (20%), Positives = 130/329 (39%), Gaps = 58/329 (17%)
Query: 341 LDTMSENMEQYEFVPLDSQVDFDLEQLLKASAFLLGKSTIGIVYKVAL-NNEEAVAVRRL 399
+D S N +++E + D ++ L G G VY+ VAV+ L
Sbjct: 2 MDPSSPNYDKWE-MERT---DITMKHKL-------GGGQYGEVYEGVWKKYSLTVAVKTL 50
Query: 400 GNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLATAIHGKAG 459
+ +EF EA + +I+HPN+V L +I +++ G+L +
Sbjct: 51 KEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLREC-- 107
Query: 460 IISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLA 519
+ + +S L + ++ + +L + K ++H DL N L+G+N ++DFGL+
Sbjct: 108 --NRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLS 162
Query: 520 RLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIY 579
RL + +TA + APE+ K + K D++
Sbjct: 163 RLM----------------------TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVW 200
Query: 580 SYGVILLEMISGKLPMIQIGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVS 639
++GV+L E+ + + +++ Q +L+ +D + E
Sbjct: 201 AFGVLLWEIATYGMSP----YPGIDLSQVYELLEKDYRMERP------------EGCPEK 244
Query: 640 VLKIALDCVHKSPDKRPSMRHVCDSLDRV 668
V ++ C +P RPS + + + +
Sbjct: 245 VYELMRACWQWNPSDRPSFAEIHQAFETM 273
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (396), Expect = 2e-43
Identities = 65/301 (21%), Positives = 117/301 (38%), Gaps = 49/301 (16%)
Query: 374 LLGKSTIGIVYKVALNN----EEAVAVRRLGNGGWQRF-KEFQTEAEAIGKIRHPNIVSL 428
++G+ G VY L + + AV+ L +F TE + HPN++SL
Sbjct: 34 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 93
Query: 429 RAYFWSVDEK-LLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHE 487
+ L++ Y+ +G L I + + D + VAKG +
Sbjct: 94 LGICLRSEGSPLVVLPYMKHGDLRNFIRNET-----HNPTVKDLIGFGLQVAKG---MKF 145
Query: 488 VSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPY 547
++ K++VH DL N +L + ++DFGLAR +E VH +
Sbjct: 146 LASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY-DKEFDSVHNKTGAKLPV------ 198
Query: 548 EFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQ 607
+ A E+ + +K T K D++S+GV+L E+++ P ++N
Sbjct: 199 ------------KWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP----DVNTFD 242
Query: 608 WIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDR 667
+L+ R+ L E + ++ L C H + RPS + +
Sbjct: 243 ITVYLLQGRRL------------LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISA 290
Query: 668 V 668
+
Sbjct: 291 I 291
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (394), Expect = 4e-43
Identities = 72/341 (21%), Positives = 111/341 (32%), Gaps = 66/341 (19%)
Query: 355 PLDSQVDFDLE--QLLKASAFLLGKSTIGIVYKVAL------NNEEAVAVRRLGNGGWQR 406
P D + +F K LG G V + + VAV+ L
Sbjct: 13 PYDHKWEFPRNRLSFGK----TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLT 68
Query: 407 FKE-FQTEAEAIGKI-RHPNIVSLRAYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISY- 463
+E +E + + + H NIV+L L+I +Y G L + K
Sbjct: 69 EREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICS 128
Query: 464 -----------RPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPH 512
L D L VAKG+AFL K +H DL NILL
Sbjct: 129 KTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITK 185
Query: 513 ISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKP 572
I DFGLAR + + APE+
Sbjct: 186 ICDFGLARDIKNDSNYVVKGNARLPVK---------------------WMAPESIFNCVY 224
Query: 573 TQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLD 632
T + D++SYG+ L E+ S + + ++++ M L
Sbjct: 225 TFESDVWSYGIFLWELFSLGSSP----YPGMPVDSKFYKMIKEGFRM-----------LS 269
Query: 633 KEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDR-VNIST 672
E + I C P KRP+ + + +++ ++ ST
Sbjct: 270 PEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISEST 310
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (391), Expect = 9e-43
Identities = 65/325 (20%), Positives = 123/325 (37%), Gaps = 62/325 (19%)
Query: 359 QVDFDLEQLLKASAFLLGKSTIGIVYKVALNN---EEAVAVRRL-GNGGWQRFKEFQTEA 414
+D++ + ++G+ G V K + A++R+ ++F E
Sbjct: 6 VLDWNDIKFQD----VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGEL 61
Query: 415 EAIGKI-RHPNIVSLRAYFWSVDEKLLIYDYIPNGSLATAIHGKAGI----------ISY 463
E + K+ HPNI++L L +Y P+G+L + + +
Sbjct: 62 EVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTA 121
Query: 464 RPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLAD 523
LS L VA+G+ +L + K+++H DL NIL+G+N I+DFGL+R +
Sbjct: 122 STLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQE 178
Query: 524 IAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGV 583
+ + + A E+ T D++SYGV
Sbjct: 179 VYVKK------TMGRLPV------------------RWMAIESLNYSVYTTNSDVWSYGV 214
Query: 584 ILLEMISGKLPMIQIGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKI 643
+L E++S + + + + + + + + D E V +
Sbjct: 215 LLWEIVSLGGTP----YCGMTCAELYEKLPQGYRLEKPL-------NCDDE-----VYDL 258
Query: 644 ALDCVHKSPDKRPSMRHVCDSLDRV 668
C + P +RPS + SL+R+
Sbjct: 259 MRQCWREKPYERPSFAQILVSLNRM 283
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (388), Expect = 3e-42
Identities = 58/316 (18%), Positives = 111/316 (35%), Gaps = 61/316 (19%)
Query: 374 LLGKSTIGIVYKVA-LNNEEAVAVRRLGNGGWQRF-KEFQTEAEAIGKIRHPNIVSLRAY 431
LG G+V+KV+ + +A + + + E + + + P IV
Sbjct: 13 ELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 72
Query: 432 FWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPK 491
F+S E + +++ GSL + + ++ V KG+ +L E
Sbjct: 73 FYSDGEISICMEHMDGGSLDQVLK------KAGRIPEQILGKVSIAVIKGLTYLREK--H 124
Query: 492 RYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTA 551
+ +H D++PSNIL+ E + DFG++ + S GT
Sbjct: 125 KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN-------SFVGTR---------- 167
Query: 552 LNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQWIQL 611
Y +PE + + + DI+S G+ L+EM G+ P+ + EL ++ Q+
Sbjct: 168 --------SYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQV 219
Query: 612 ILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALD------------------------- 646
+ + P D + L
Sbjct: 220 EGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVN 279
Query: 647 -CVHKSPDKRPSMRHV 661
C+ K+P +R ++ +
Sbjct: 280 KCLIKNPAERADLKQL 295
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 152 bits (385), Expect = 4e-42
Identities = 68/318 (21%), Positives = 117/318 (36%), Gaps = 65/318 (20%)
Query: 375 LGKSTIGIVYKV------ALNNEEAVAVRRLGNGGWQRF-KEFQTEAEAIGKIRHPNIVS 427
+G+ G V++ VAV+ L +FQ EA + + +PNIV
Sbjct: 21 IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 80
Query: 428 LRAYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISY------------------RPLSWS 469
L L+++Y+ G L + + PLS +
Sbjct: 81 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCA 140
Query: 470 DRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETP 529
++L I + VA G+A+L E +++VH DL N L+G+NM I+DFGL+R A+
Sbjct: 141 EQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYY- 196
Query: 530 EVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMI 589
+ + + PE+ + T + D+++YGV+L E+
Sbjct: 197 --KADGNDAIPI------------------RWMPPESIFYNRYTTESDVWAYGVVLWEIF 236
Query: 590 SGKLPMIQIGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVH 649
S L + + I + + E+ + + + C
Sbjct: 237 SYGLQPYY----GMAHEEVIYYVRDGNILACP------------ENCPLELYNLMRLCWS 280
Query: 650 KSPDKRPSMRHVCDSLDR 667
K P RPS + L R
Sbjct: 281 KLPADRPSFCSIHRILQR 298
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (382), Expect = 6e-42
Identities = 55/297 (18%), Positives = 101/297 (34%), Gaps = 53/297 (17%)
Query: 375 LGKSTIGIVYKVALNNE---EAVAVRRLGNGGWQR--FKEFQTEAEAIGKIRHPNIVSLR 429
LG G V K + + VAV+ L N E EA + ++ +P IV +
Sbjct: 15 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 74
Query: 430 AYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVS 489
+ +L+ + G L + R + + + ++ V+ G+ +L
Sbjct: 75 GICE-AESWMLVMEMAELGPLNKYLQQN------RHVKDKNIIELVHQVSMGMKYLE--- 124
Query: 490 PKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEF 549
+VH DL N+LL ISDFGL++ + + +
Sbjct: 125 ESNFVHRDLAARNVLLVTQHYAKISDFGLSKA--LRADENYYKAQTHGKWPV-------- 174
Query: 550 TALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQIGSMELNIVQW 608
+ APE K + K D++S+GV++ E S G+ P + +
Sbjct: 175 ----------KWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPY-----RGMKGSEV 219
Query: 609 IQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSL 665
++ + + +E + + C + RP V L
Sbjct: 220 TAMLEKGER-------MGCPAGCPRE-----MYDLMNLCWTYDVENRPGFAAVELRL 264
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (385), Expect = 7e-42
Identities = 74/358 (20%), Positives = 115/358 (32%), Gaps = 75/358 (20%)
Query: 341 LDTMSENMEQYEFV-----PLDSQVDFDLE--QLLKASAFLLGKSTIGIVYKVALNN--- 390
+ + +Y +V D + +F E + K +LG G V
Sbjct: 8 VQVTGSSDNEYFYVDFREYEYDLKWEFPRENLEFGK----VLGSGAFGKVMNATAYGISK 63
Query: 391 ---EEAVAVRRLGNGGWQRFKE-FQTEAEAIGKI-RHPNIVSLRAYFWSVDEKLLIYDYI 445
VAV+ L +E +E + + ++ H NIV+L LI++Y
Sbjct: 64 TGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYC 123
Query: 446 PNGSLATAIHGKAGIIS-----------------YRPLSWSDRLRIIKGVAKGIAFLHEV 488
G L + K S L++ D L VAKG+ FL
Sbjct: 124 CYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF- 182
Query: 489 SPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYE 548
K VH DL N+L+ I DFGLAR +
Sbjct: 183 --KSCVHRDLAARNVLVTHGKVVKICDFGLARDIM---SDSNYVVRGNARLPV------- 230
Query: 549 FTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQW 608
+ APE+ T K D++SYG++L E+ S + ++ N +
Sbjct: 231 -----------KWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKL 279
Query: 609 IQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLD 666
IQ + +P + I C KRPS ++ L
Sbjct: 280 IQNGFKMDQP---------------FYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (381), Expect = 7e-42
Identities = 65/295 (22%), Positives = 117/295 (39%), Gaps = 56/295 (18%)
Query: 375 LGKSTIGIVYKVAL-NNEEAVAVRRLGNGGWQR--FKEFQTEAEAIGKIRHPNIVSLRAY 431
+G+ + VYK VA L + + + F+ EAE + ++HPNIV
Sbjct: 17 IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDS 76
Query: 432 FWSVDEK----LLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHE 487
+ S + +L+ + + +G+L T + ++ + + + KG+ FLH
Sbjct: 77 WESTVKGKKCIVLVTELMTSGTLKTYLK------RFKVMKIKVLRSWCRQILKGLQFLHT 130
Query: 488 VSPKRYVHGDLRPSNILL-GKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSP 546
+P +H DL+ NI + G I D GLA L + ++ GTP
Sbjct: 131 RTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATL-------KRASFAKAVIGTP----- 177
Query: 547 YEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIV 606
+ APE + K + D+Y++G+ +LEM + + P S N
Sbjct: 178 -------------EFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPY----SECQNAA 219
Query: 607 QWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHV 661
Q + + KP E V +I C+ ++ D+R S++ +
Sbjct: 220 QIYRRVTSGVKP------ASFDKVAIPE-----VKEIIEGCIRQNKDERYSIKDL 263
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (381), Expect = 8e-42
Identities = 57/295 (19%), Positives = 108/295 (36%), Gaps = 49/295 (16%)
Query: 374 LLGKSTIGIVYKVA-LNNEEAVAVRRL--GNGGWQRFKEFQTEAEAIGKIRHPNIVSLRA 430
+G + G K+ ++ + + + L G+ + +E + +++HPNIV
Sbjct: 11 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 70
Query: 431 YFWSVDEKLL--IYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEV 488
L + +Y G LA+ I G + L LR++ + + H
Sbjct: 71 RIIDRTNTTLYIVMEYCEGGDLASVITK--GTKERQYLDEEFVLRVMTQLTLALKECHRR 128
Query: 489 SP--KRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSP 546
S +H DL+P+N+ L + DFGLAR+ + + + ++ GTP
Sbjct: 129 SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILN-----HDTSFAKAFVGTP----- 178
Query: 547 YEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIV 606
YY +PE +K DI+S G +L E+ + P +
Sbjct: 179 -------------YYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPF-----TAFSQK 220
Query: 607 QWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHV 661
+ I E + + + E + +I ++ RPS+ +
Sbjct: 221 ELAGKIREGK-------FRRIPYRYSDE-----LNEIITRMLNLKDYHRPSVEEI 263
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (373), Expect = 9e-41
Identities = 65/299 (21%), Positives = 110/299 (36%), Gaps = 53/299 (17%)
Query: 375 LGKSTIGIVYKVALN----NEEAVAVRRL---GNGGWQRFKEFQTEAEAIGKIRHPNIVS 427
LG + G+V + + +VAV+ L + +F E A+ + H N++
Sbjct: 16 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 428 LRAYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHE 487
L + ++ + P GSL + G R VA+G+ +L
Sbjct: 76 LYGVVLT-PPMKMVTELAPLGSLLDRLRKHQG-----HFLLGTLSRYAVQVAEGMGYLES 129
Query: 488 VSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPY 547
KR++H DL N+LL I DFGL R + + + Q P
Sbjct: 130 ---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALP---QNDDHYVMQEHRKVPF----- 178
Query: 548 EFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQIGSMELNIV 606
+ APE+ K R + D + +GV L EM + G+ P + LN
Sbjct: 179 ------------AWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPW-----IGLNGS 221
Query: 607 QWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSL 665
Q + I ++ + + ED + + + C P+ RP+ + D L
Sbjct: 222 QILHKIDKEGERLPRP-----------EDCPQDIYNVMVQCWAHKPEDRPTFVALRDFL 269
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (366), Expect = 8e-40
Identities = 64/292 (21%), Positives = 105/292 (35%), Gaps = 56/292 (19%)
Query: 374 LLGKSTIGIVYKVAL-NNEEAVAVRRLGNGGWQR---FKEFQTEAEAIGKIRHPNIVSLR 429
LGK G VY ++ +A++ L ++ + + E E +RHPNI+ L
Sbjct: 13 PLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 72
Query: 430 AYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVS 489
YF LI +Y P G++ + I +A +++ H
Sbjct: 73 GYFHDATRVYLILEYAPLGTVYRELQ------KLSKFDEQRTATYITELANALSYCHS-- 124
Query: 490 PKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEF 549
KR +H D++P N+LLG E I+DFG + A + T GT
Sbjct: 125 -KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC-------GTL-------- 168
Query: 550 TALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQWI 609
Y PE + R +K D++S GV+ E + GK P +
Sbjct: 169 ----------DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF-----EANTYQETY 213
Query: 610 QLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHV 661
+ I D + + + + +P +RP +R V
Sbjct: 214 KRISRVEFTFPDFVTEGARDLISR-------------LLKHNPSQRPMLREV 252
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (364), Expect = 3e-39
Identities = 58/290 (20%), Positives = 119/290 (41%), Gaps = 51/290 (17%)
Query: 374 LLGKSTIGIVYKV-ALNNEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYF 432
+G+ G VY + + VA+R++ + + E + + ++PNIV+ +
Sbjct: 27 KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 433 WSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKR 492
DE ++ +Y+ GSL +++ + + + + + FLH +
Sbjct: 87 LVGDELWVVMEYLAGGSLTD-------VVTETCMDEGQIAAVCRECLQALEFLHS---NQ 136
Query: 493 YVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTAL 552
+H D++ NILLG + ++DFG ++ EQS T + +
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCA---------QITPEQSKRSTMVGT-------- 179
Query: 553 NSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQWIQLI 612
Y+ APE + K DI+S G++ +EMI G+ P + N ++ + LI
Sbjct: 180 ------PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPY-----LNENPLRALYLI 228
Query: 613 LEDRKPMTDILDPFLAHDLDKEDEIVSVLK-IALDCVHKSPDKRPSMRHV 661
+ P +L +++ ++ + C+ +KR S + +
Sbjct: 229 ATNGTP-----------ELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKEL 267
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 145 bits (366), Expect = 6e-39
Identities = 60/317 (18%), Positives = 118/317 (37%), Gaps = 55/317 (17%)
Query: 350 QYEFVPLDSQVDFDLE--QLLKASAFLLGKSTIGIVYKVA-LNNEEAVAVRRLGNGGWQR 406
QY P++ + D L+ + + LG G+V++V A + +
Sbjct: 11 QYYPQPVEIKHDHVLDHYDIHE----ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESD 66
Query: 407 FKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPL 466
+ + E + + +RHP +V+L F +E ++IY+++ G L + + +
Sbjct: 67 KETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHN-----KM 121
Query: 467 SWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHI--SDFGLARLADI 524
S + + ++ V KG+ +HE YVH DL+P NI+ + DFGL D
Sbjct: 122 SEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD- 177
Query: 525 AEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVI 584
++ TT + + APE ++ + D++S GV+
Sbjct: 178 -----------------------PKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVL 214
Query: 585 LLEMISGKLPMIQIGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIA 644
++SG P N + ++ + M D ++ D
Sbjct: 215 SYILLSGLSPF-----GGENDDETLRNVKSCDWNMDDSAFSGISEDG---------KDFI 260
Query: 645 LDCVHKSPDKRPSMRHV 661
+ P+ R ++
Sbjct: 261 RKLLLADPNTRMTIHQA 277
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (355), Expect = 3e-38
Identities = 59/302 (19%), Positives = 105/302 (34%), Gaps = 56/302 (18%)
Query: 374 LLGKSTIGIVYKVAL----NNEEAVAVRRLGNGGWQRFKE-FQTEAEAIGKIRHPNIVSL 428
+G+ G V++ N AVA++ N +E F EA + + HP+IV L
Sbjct: 14 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73
Query: 429 RAYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEV 488
+ +I + G L + + + L + + ++ +A+L
Sbjct: 74 IGVITE-NPVWIIMELCTLGELRSFLQVR-----KYSLDLASLILYAYQLSTALAYLES- 126
Query: 489 SPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYE 548
KR+VH D+ N+L+ N + DFGL+R E +
Sbjct: 127 --KRFVHRDIAARNVLVSSNDCVKLGDFGLSRY----MEDSTYYKASKGKLPI------- 173
Query: 549 FTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMI-SGKLPMIQIGSMELNIVQ 607
+ APE+ R+ T D++ +GV + E++ G P +
Sbjct: 174 -----------KWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF-----QGVKNND 217
Query: 608 WIQLILE-DRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLD 666
I I +R PM P ++ + C P +RP + L
Sbjct: 218 VIGRIENGERLPMPPNCPP-------------TLYSLMTKCWAYDPSRRPRFTELKAQLS 264
Query: 667 RV 668
+
Sbjct: 265 TI 266
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (357), Expect = 4e-38
Identities = 65/325 (20%), Positives = 123/325 (37%), Gaps = 57/325 (17%)
Query: 353 FVPLDSQVDFDLEQLLKASAFLLGKSTIGIVYKVALNN------EEAVAVRRLGNGGWQR 406
+VP + +V + + + LG+ + G+VY+ E VA++ + R
Sbjct: 10 YVPDEWEVAREKITMSR----ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMR 65
Query: 407 FK-EFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYR- 464
+ EF EA + + ++V L L+I + + G L + + ++
Sbjct: 66 ERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNP 125
Query: 465 ---PLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARL 521
P S S +++ +A G+A+L+ ++VH DL N ++ ++ I DFG+ R
Sbjct: 126 VLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRD 182
Query: 522 ADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSY 581
ET + +PE+ K T D++S+
Sbjct: 183 IY---ETDYYRKGGKGLLPV------------------RWMSPESLKDGVFTTYSDVWSF 221
Query: 582 GVILLEMISGKLPMIQIGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVL 641
GV+L E+ + Q L+ Q ++ ++E DK D +L
Sbjct: 222 GVVLWEIATLAEQPYQ----GLSNEQVLRFVMEGGLL-------------DKPDNCPDML 264
Query: 642 K-IALDCVHKSPDKRPSMRHVCDSL 665
+ C +P RPS + S+
Sbjct: 265 FELMRMCWQYNPKMRPSFLEIISSI 289
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 5e-38
Identities = 60/291 (20%), Positives = 99/291 (34%), Gaps = 48/291 (16%)
Query: 374 LLGKSTIGIVYKVA-LNNEEAVAVRRL-GNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAY 431
LG+ G V EEAVAV+ + + + E + H N+V +
Sbjct: 12 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 71
Query: 432 FWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPK 491
+ + L +Y G L I + D R + G+ +LH
Sbjct: 72 RREGNIQYLFLEYCSGGELFDRIEPD------IGMPEPDAQRFFHQLMAGVVYLHG---I 122
Query: 492 RYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTA 551
H D++P N+LL + ISDFGLA + ++ GT
Sbjct: 123 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN---KMCGTL---------- 169
Query: 552 LNSTTSRSYYQAPEASKVRKP-TQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQWIQ 610
Y APE K R+ + D++S G++L M++G+LP Q W +
Sbjct: 170 --------PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE 221
Query: 611 LILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHV 661
+D L K + ++P R ++ +
Sbjct: 222 KK--TYLNPWKKIDSAPLALLHK-------------ILVENPSARITIPDI 257
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (352), Expect = 2e-37
Identities = 64/313 (20%), Positives = 108/313 (34%), Gaps = 58/313 (18%)
Query: 366 QLLKASAF----LLGKSTIGIVYKVALNNE-----EAVAVRRLGNGGWQRF-KEFQTEAE 415
++LK + F +LG G VYK E VA++ L + KE EA
Sbjct: 4 RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 63
Query: 416 AIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRII 475
+ + +P++ L + LI +P G L + + L
Sbjct: 64 VMASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREH-----KDNIGSQYLLNWC 117
Query: 476 KGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQ 535
+AKG+ +L +R VH DL N+L+ I+DFGLA+L E+ + +
Sbjct: 118 VQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE---YHAE 171
Query: 536 STTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPM 595
+ A E+ R T + D++SYGV + E+++
Sbjct: 172 GGKVPI------------------KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 213
Query: 596 IQIGSMELNIVQWIQLILED-RKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDK 654
+ + ++ + R P I V I + C D
Sbjct: 214 YD----GIPASEISSILEKGERLPQPPICTI-------------DVYMIMVKCWMIDADS 256
Query: 655 RPSMRHVCDSLDR 667
RP R + +
Sbjct: 257 RPKFRELIIEFSK 269
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (347), Expect = 6e-37
Identities = 52/297 (17%), Positives = 95/297 (31%), Gaps = 52/297 (17%)
Query: 374 LLGKSTIGIVYKV-ALNNEEAVAVRRL---GNGGWQRFKEFQTEAEAIGKIRHPNIVSLR 429
+LG+ + V L A++ L + E + + ++ HP V L
Sbjct: 15 ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY 74
Query: 430 AYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVS 489
F ++ Y NG L I + + + +LH
Sbjct: 75 FTFQDDEKLYFGLSYAKNGELLKYIR------KIGSFDETCTRFYTAEIVSALEYLHG-- 126
Query: 490 PKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEF 549
K +H DL+P NILL ++M I+DFG A+ + S +
Sbjct: 127 -KGIIHRDLKPENILLNEDMHIQITDFGTAK---------------------VLSPESKQ 164
Query: 550 TALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQWI 609
NS + Y +PE + + D+++ G I+ ++++G P N
Sbjct: 165 ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF-----RAGNEYLIF 219
Query: 610 QLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLD 666
Q I++ + P ++K + KR +
Sbjct: 220 QKIIKLEYDFPEKFFPKARDLVEK-------------LLVLDATKRLGCEEMEGYGP 263
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (344), Expect = 3e-36
Identities = 50/291 (17%), Positives = 104/291 (35%), Gaps = 50/291 (17%)
Query: 374 LLGKSTIGIVYKV-ALNNEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYF 432
LG+ GIV++ ++++ + + G + + E + RH NI+ L F
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQ-VLVKKEISILNIARHRNILHLHESF 70
Query: 433 WSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKR 492
S++E ++I+++I + I+ A L+ + + + V + + FLH
Sbjct: 71 ESMEELVMIFEFISGLDIFERINTSAF-----ELNEREIVSYVHQVCEALQFLHS---HN 122
Query: 493 YVHGDLRPSNILLGKNMEPH--ISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFT 550
H D+RP NI+ I +FG AR + + P
Sbjct: 123 IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF------RLLFTAP--------- 167
Query: 551 ALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQWIQ 610
Y APE + + D++S G ++ ++SG P + + ++ I+
Sbjct: 168 ---------EYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQI-----IE 213
Query: 611 LILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHV 661
I+ + ++ + + + K R +
Sbjct: 214 NIMNAEYTFDEEAFKEISIEA---------MDFVDRLLVKERKSRMTASEA 255
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (339), Expect = 7e-36
Identities = 67/336 (19%), Positives = 121/336 (36%), Gaps = 66/336 (19%)
Query: 355 PLDSQVDFDLE--QLLKASAFLLGKSTIGIVYKV--------ALNNEEAVAVRRLGNGGW 404
P D + + + L K LG+ G V N VAV+ L +
Sbjct: 3 PEDPRWELPRDRLVLGK----PLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT 58
Query: 405 QR-FKEFQTEAEAIGKI-RHPNIVSLRAYFWSVDEKLLIYDYIPNGSLATAIHGK----- 457
++ + +E E + I +H NI++L +I +Y G+L + +
Sbjct: 59 EKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGL 118
Query: 458 -----AGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPH 512
LS D + VA+G+ +L K+ +H DL N+L+ ++
Sbjct: 119 EYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMK 175
Query: 513 ISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKP 572
I+DFGLAR + + APEA R
Sbjct: 176 IADFGLARDIH---HIDYYKKTTNGRLPV------------------KWMAPEALFDRIY 214
Query: 573 TQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLD 632
T + D++S+GV+L E+ + + + + +L+ E +
Sbjct: 215 THQSDVWSFGVLLWEIFTLGGSPYP----GVPVEELFKLLKEGHRMDKP----------- 259
Query: 633 KEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRV 668
+ + + DC H P +RP+ + + + LDR+
Sbjct: 260 -SNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 294
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 136 bits (343), Expect = 8e-36
Identities = 51/303 (16%), Positives = 104/303 (34%), Gaps = 53/303 (17%)
Query: 362 FDLEQLLKASAFLLGKSTIGIVYKVA-LNNEEAVAVRRLGNGGWQRFKEFQTEAEAIGKI 420
+D +L+ LG G+V++ + + + E + ++
Sbjct: 28 YDYYDILE----ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQL 83
Query: 421 RHPNIVSLRAYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAK 480
HP +++L F E +LI +++ G L I + +S ++ + ++ +
Sbjct: 84 HHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAE-----DYKMSEAEVINYMRQACE 138
Query: 481 GIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHI--SDFGLARLADIAEETPEVHWEQSTT 538
G+ +HE VH D++P NI+ + DFGLA + E + TT
Sbjct: 139 GLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIV------KVTT 189
Query: 539 GTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQI 598
T + APE D+++ GV+ ++SG P
Sbjct: 190 ATA------------------EFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGE 231
Query: 599 GSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSM 658
+E +Q + + ++ + + + K P KR ++
Sbjct: 232 DDLET-----LQNVKRCDWEFDEDAFSSVSPEA---------KDFIKNLLQKEPRKRLTV 277
Query: 659 RHV 661
Sbjct: 278 HDA 280
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 132 bits (332), Expect = 5e-35
Identities = 55/299 (18%), Positives = 108/299 (36%), Gaps = 52/299 (17%)
Query: 374 LLGKSTIGIVYKV-ALNNEEAVAVRRLGNGGWQRF---------KEFQTEAEAIGKIR-H 422
+LG+ +V + + AV+ + G F + E + + K+ H
Sbjct: 10 ILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGH 69
Query: 423 PNIVSLRAYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGI 482
PNI+ L+ + + L++D + G L + K LS + +I++ + + I
Sbjct: 70 PNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK------VTLSEKETRKIMRALLEVI 123
Query: 483 AFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPL 542
LH+ VH DL+P NILL +M ++DFG + D E+ + GTP
Sbjct: 124 CALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL------REVCGTPS 174
Query: 543 QSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSME 602
+P + ++ D++S GVI+ +++G P
Sbjct: 175 YLAPE------------IIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF-----WH 217
Query: 603 LNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHV 661
+ +++I+ + + + + P KR +
Sbjct: 218 RKQMLMLRMIMSGNYQFGSPEWDDYSDTV---------KDLVSRFLVVQPQKRYTAEEA 267
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 131 bits (330), Expect = 7e-35
Identities = 60/304 (19%), Positives = 115/304 (37%), Gaps = 52/304 (17%)
Query: 374 LLGKSTIGIVYKV-ALNNEEAVAVRRL---GNGGWQRFKEFQTEAEAIGKIRHPNIVSLR 429
+LG + V+ L VAV+ L + F+ EA+ + HP IV++
Sbjct: 14 ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 73
Query: 430 AYFWSVDEKL----LIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFL 485
+ ++ +Y+ +L +H + P++ + +I + + F
Sbjct: 74 DTGEAETPAGPLPYIVMEYVDGVTLRDIVH------TEGPMTPKRAIEVIADACQALNFS 127
Query: 486 HEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSS 545
H+ +H D++P+NI++ + DFG+AR IA+ V + GT
Sbjct: 128 HQ---NGIIHRDVKPANIMISATNAVKVMDFGIAR--AIADSGNSVTQTAAVIGTA---- 178
Query: 546 PYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNI 605
Y +PE ++ + D+YS G +L E+++G+ P +
Sbjct: 179 --------------QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPF-----TGDSP 219
Query: 606 VQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRP-SMRHVCDS 664
V + + L+ DLD + L + K+P+ R + +
Sbjct: 220 VSVAYQHVREDPIPPSARHEGLSADLD---------AVVLKALAKNPENRYQTAAEMRAD 270
Query: 665 LDRV 668
L RV
Sbjct: 271 LVRV 274
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (322), Expect = 2e-33
Identities = 65/314 (20%), Positives = 111/314 (35%), Gaps = 58/314 (18%)
Query: 374 LLGKSTIGIVYKV------ALNNEEAVAVRRLGNGGWQ-RFKEFQTEAEAIGKIRH-PNI 425
LG+ G V + VAV+ L G + +E + + I H N+
Sbjct: 20 PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 79
Query: 426 VSLRAYFWSVDEKLLI-YDYIPNGSLATAIHGKAG----------IISYRPLSWSDRLRI 474
V+L L++ ++ G+L+T + K + L+ +
Sbjct: 80 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 139
Query: 475 IKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWE 534
VAKG+ FL ++ +H DL NILL + I DFGLAR + P+ +
Sbjct: 140 SFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIY---KDPDYVRK 193
Query: 535 QSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLP 594
+ APE R T + D++S+GV+L E+ S
Sbjct: 194 GDARLPL------------------KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS 235
Query: 595 MIQIGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDK 654
+ I + L++ M + + + LDC H P +
Sbjct: 236 PYP----GVKIDEEFCRRLKEGTRMRAP-----------DYTTPEMYQTMLDCWHGEPSQ 280
Query: 655 RPSMRHVCDSLDRV 668
RP+ + + L +
Sbjct: 281 RPTFSELVEHLGNL 294
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 127 bits (319), Expect = 5e-33
Identities = 62/293 (21%), Positives = 105/293 (35%), Gaps = 52/293 (17%)
Query: 374 LLGKSTIGIVYKV-ALNNEEAVAVRRLGNGGWQRFKE-FQTEAEAIGKIRHPNIVSLRAY 431
+LG V ++ VA++ + + + + E + KI+HPNIV+L
Sbjct: 16 VLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDI 75
Query: 432 FWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPK 491
+ S LI + G L I K + D R+I V + +LH+
Sbjct: 76 YESGGHLYLIMQLVSGGELFDRIVEK------GFYTERDASRLIFQVLDAVKYLHD---L 126
Query: 492 RYVHGDLRPSNILL---GKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYE 548
VH DL+P N+L ++ + ISDFGL+++ D + GTP
Sbjct: 127 GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVL------STACGTP------- 173
Query: 549 FTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQW 608
Y APE + ++ D +S GVI ++ G P + N +
Sbjct: 174 -----------GYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPF-----YDENDAKL 217
Query: 609 IQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHV 661
+ IL+ ++ + K P+KR +
Sbjct: 218 FEQILKAEYEFDSPYWDDISDSA---------KDFIRHLMEKDPEKRFTCEQA 261
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 125 bits (314), Expect = 2e-32
Identities = 47/313 (15%), Positives = 97/313 (30%), Gaps = 48/313 (15%)
Query: 374 LLGKSTIGIVYKVA-LNNEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYF 432
+G + G +Y + E VA++ + + E++ ++ + +
Sbjct: 14 KIGSGSFGDIYLGTDIAAGEEVAIKLECVK--TKHPQLHIESKIYKMMQGGVGIPTIRWC 71
Query: 433 WSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKR 492
+ + ++ + SL + + R S L + + I ++H K
Sbjct: 72 GAEGDYNVMVMELLGPSLEDLFNFCS-----RKFSLKTVLLLADQMISRIEYIHS---KN 123
Query: 493 YVHGDLRPSNIL---LGKNMEPHISDFGLARLADIAEETPEVHWEQSTT--GTPLQSSPY 547
++H D++P N L K +I DFGLA+ A + + ++ GT
Sbjct: 124 FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTA------ 177
Query: 548 EFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQ 607
Y + + +++ D+ S G +L+ G LP + +
Sbjct: 178 ------------RYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATK---- 221
Query: 608 WIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLD- 666
Q + L E C D +P ++
Sbjct: 222 -RQKYERISEKKMSTPIEVLCKGYPSE-----FATYLNFCRSLRFDDKPDYSYLRQLFRN 275
Query: 667 ---RVNISTEQQF 676
R S + F
Sbjct: 276 LFHRQGFSYDYVF 288
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 122 bits (308), Expect = 1e-31
Identities = 45/315 (14%), Positives = 101/315 (32%), Gaps = 50/315 (15%)
Query: 374 LLGKSTIGIVYKV-ALNNEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYF 432
+G+ + G++++ L N + VA++ + + E + + YF
Sbjct: 12 RIGEGSFGVIFEGTNLLNNQQVAIKFEPRR--SDAPQLRDEYRTYKLLAGCTGIPNVYYF 69
Query: 433 WSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKR 492
++ + SL + R S K + + +HE K
Sbjct: 70 GQEGLHNVLVIDLLGPSLEDLLDLCG-----RKFSVKTVAMAAKQMLARVQSIHE---KS 121
Query: 493 YVHGDLRPSNILLGKNMEPH-----ISDFGLARLADIAEETPEVHWEQSTT--GTPLQSS 545
V+ D++P N L+G+ + + DFG+ + + + + GT
Sbjct: 122 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTA---- 177
Query: 546 PYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNI 605
Y + R+ +++ D+ + G + + + G + G
Sbjct: 178 --------------RYMSINTHLGREQSRRDDLEALGHVFMYFLRGS--LPWQGLKAATN 221
Query: 606 VQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSL 665
Q + I E ++ L +E K + + D P ++
Sbjct: 222 KQKYERIGEKKQSTP---LRELCAGFPEE-----FYKYMHYARNLAFDATPDYDYLQGLF 273
Query: 666 D----RVNISTEQQF 676
R+N + ++ F
Sbjct: 274 SKVLERLNTTEDENF 288
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (311), Expect = 1e-31
Identities = 46/294 (15%), Positives = 98/294 (33%), Gaps = 49/294 (16%)
Query: 374 LLGKSTIGIVYKV-ALNNEEAVAVRRLGNGGWQRFKEFQTEAEAIGKI-RHPNIVSLRAY 431
+LG G V ++ +E A++ L Q + + E E + + P+IV +
Sbjct: 19 VLGLGINGKVLQIFNKRTQEKFALKML-----QDCPKARREVELHWRASQCPHIVRIVDV 73
Query: 432 FWSVDEK----LLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHE 487
+ ++ L++ + + G L + I + + + + I+K + + I +LH
Sbjct: 74 YENLYAGRKCLLIVMECLDGGELFSRIQDRGD----QAFTEREASEIMKSIGEAIQYLHS 129
Query: 488 VSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPY 547
H D++P N+L I A + T
Sbjct: 130 ---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTP--------- 177
Query: 548 EFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQ 607
YY APE K + D++S GVI+ ++ G P + +
Sbjct: 178 ------------YYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI-SPG 224
Query: 608 WIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHV 661
I + + ++ ++ + + + P +R ++
Sbjct: 225 MKTRIRMGQYEFPNPEWSEVSEEV---------KMLIRNLLKTEPTQRMTITEF 269
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (311), Expect = 1e-31
Identities = 59/304 (19%), Positives = 115/304 (37%), Gaps = 42/304 (13%)
Query: 374 LLGKSTIGIVYKV-ALNNEEAVAVRRLGNGGWQRF-KEFQTEAEAIGKIRHPNIVSLRAY 431
+G+ G+V N+ VA++++ Q + + E + + + RH NI+ +
Sbjct: 15 YIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDI 74
Query: 432 FWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPK 491
+ + + Y+ + ++ ++ + LS + + +G+ ++H
Sbjct: 75 IRAPTIEQMKDVYLVTHLMGADLYK---LLKTQHLSNDHICYFLYQILRGLKYIHS---A 128
Query: 492 RYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTA 551
+H DL+PSN+LL + I DFGLAR+AD +
Sbjct: 129 NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT------------------ 170
Query: 552 LNSTTSRSYYQAPEASKVRKP-TQKWDIYSYGVILLEMISGKLP---------MIQIGSM 601
+ +Y+APE K T+ DI+S G IL EM+S + + I +
Sbjct: 171 --EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGI 228
Query: 602 ELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALD----CVHKSPDKRPS 657
+ Q + + K +L + + + ALD + +P KR
Sbjct: 229 LGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIE 288
Query: 658 MRHV 661
+
Sbjct: 289 VEQA 292
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (303), Expect = 8e-31
Identities = 63/304 (20%), Positives = 100/304 (32%), Gaps = 62/304 (20%)
Query: 361 DFDLEQLLKASAFLLGKSTIGIVYKV-ALNNEEAVAVRRLGNGGWQR---FKEFQTEAEA 416
DF L ++L GK + G V+ + A++ L + E
Sbjct: 3 DFILHKML-------GKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRV 55
Query: 417 IGK-IRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRII 475
+ HP + + F + + + +Y+ G L I S
Sbjct: 56 LSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSC------HKFDLSRATFYA 109
Query: 476 KGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQ 535
+ G+ FLH K V+ DL+ NILL K+ I+DFG+ + E
Sbjct: 110 AEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCK-----ENMLGDAKTN 161
Query: 536 STTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPM 595
+ GTP Y APE +K D +S+GV+L EM+ G+ P
Sbjct: 162 TFCGTP------------------DYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPF 203
Query: 596 IQIGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKR 655
+ + I D L+ L K + P+KR
Sbjct: 204 -----HGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVK-------------LFVREPEKR 245
Query: 656 PSMR 659
+R
Sbjct: 246 LGVR 249
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 120 bits (302), Expect = 3e-30
Identities = 54/307 (17%), Positives = 101/307 (32%), Gaps = 62/307 (20%)
Query: 361 DFDLEQLLKASAFLLGKSTIGIVYKV-ALNNEEAVAVRRL------GNGGWQRFKEFQTE 413
DF + +++ G+ G VY + + A++ L G +
Sbjct: 5 DFSVHRII-------GRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIM 57
Query: 414 AEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLR 473
+ P IV + F + D+ I D + G L + + S +D
Sbjct: 58 LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS------QHGVFSEADMRF 111
Query: 474 IIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHW 533
+ G+ +H + V+ DL+P+NILL ++ ISD GLA D +++ P
Sbjct: 112 YAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLAC--DFSKKKPHASV 166
Query: 534 EQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKL 593
+ Y K D +S G +L +++ G
Sbjct: 167 ----------------------GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHS 204
Query: 594 PMIQIGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPD 653
P Q + + + + + L + P D P L L+ + + +
Sbjct: 205 PFRQHKTKDKHEIDRMTLTMAVELP--DSFSPELRSLLEG-------------LLQRDVN 249
Query: 654 KRPSMRH 660
+R
Sbjct: 250 RRLGCLG 256
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (297), Expect = 4e-30
Identities = 61/305 (20%), Positives = 101/305 (33%), Gaps = 43/305 (14%)
Query: 375 LGKSTIGIVYKV--ALNNEEAVAVRRLGNGGWQRFKEFQTEAEA-----IGKIRHPNIVS 427
+G+ G V+K N VA++R+ + T E + HPN+V
Sbjct: 15 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 74
Query: 428 LRAYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHE 487
L + + + + + ++ + +G+ FLH
Sbjct: 75 LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS 134
Query: 488 VSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPY 547
R VH DL+P NIL+ + + ++DFGLAR+ S T
Sbjct: 135 ---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYS------FQMALTSVVVTL------ 179
Query: 548 EFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMEL--NI 605
+Y+APE D++S G I EM K ++ I
Sbjct: 180 ------------WYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKI 227
Query: 606 VQWIQLILEDRKPMTDILDPFLAHDLDK---EDEIVSVLKIALD----CVHKSPDKRPSM 658
+ I L E+ P L H E + + ++ D C+ +P KR S
Sbjct: 228 LDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISA 287
Query: 659 RHVCD 663
Sbjct: 288 YSALS 292
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 117 bits (294), Expect = 1e-29
Identities = 55/290 (18%), Positives = 101/290 (34%), Gaps = 57/290 (19%)
Query: 374 LLGKSTIGIVYKV-ALNNEEAVAVRRL---GNGGWQRFKEFQTEAEAIGKIRHPNIVSLR 429
LG + G V+ + + +N A++ L ++ + E + + HP I+ +
Sbjct: 11 TLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMW 70
Query: 430 AYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVS 489
F + +I DYI G L + + + V + +LH
Sbjct: 71 GTFQDAQQIFMIMDYIEGGELFSLLRKS------QRFPNPVAKFYAAEVCLALEYLHS-- 122
Query: 490 PKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEF 549
K ++ DL+P NILL KN I+DFG A+ + GTP
Sbjct: 123 -KDIIYRDLKPENILLDKNGHIKITDFGFAKYVP--------DVTYTLCGTP-------- 165
Query: 550 TALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQWI 609
Y APE + + D +S+G+++ EM++G P + N ++
Sbjct: 166 ----------DYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPF-----YDSNTMKTY 210
Query: 610 QLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMR 659
+ IL + + L + + + +R
Sbjct: 211 EKILNAELRFPPFFNEDVKDLLSR-------------LITRDLSQRLGNL 247
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (293), Expect = 3e-29
Identities = 59/309 (19%), Positives = 111/309 (35%), Gaps = 52/309 (16%)
Query: 374 LLGKSTIGIVYKVAL-NNEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYF 432
++G + G+VY+ L ++ E VA++++ Q + E + + K+ H NIV LR +F
Sbjct: 27 VIGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVRLRYFF 82
Query: 433 WSVDEK------LLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLH 486
+S EK L+ DY+P A H + + L + + + +A++H
Sbjct: 83 YSSGEKKDEVYLNLVLDYVPETVYRVARHY---SRAKQTLPVIYVKLYMYQLFRSLAYIH 139
Query: 487 EVSPKRYVHGDLRPSNILLGKNMEPH-ISDFGLARLADIAEETPEVHWEQSTTGTPLQSS 545
H D++P N+LL + + DFG A+ E
Sbjct: 140 S---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICS----------- 185
Query: 546 PYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMEL-- 603
R Y T D++S G +L E++ G+ ++
Sbjct: 186 ------------RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 233
Query: 604 NIVQWI-----QLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALD----CVHKSPDK 654
I++ + + I E T+ P + + A+ + +P
Sbjct: 234 EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTA 293
Query: 655 RPSMRHVCD 663
R + C
Sbjct: 294 RLTPLEACA 302
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (281), Expect = 4e-28
Identities = 57/299 (19%), Positives = 102/299 (34%), Gaps = 58/299 (19%)
Query: 374 LLGKSTIGIVYKV-ALNNEEAVAVRRL------GNGGWQRFKEFQTEAEAIGKIRHPNIV 426
LG +V K + A + + + ++ + E + +I+HPN++
Sbjct: 17 ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76
Query: 427 SLRAYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLH 486
+L + + + +LI + + G L + K L+ + +K + G+ +LH
Sbjct: 77 TLHEVYENKTDVILILELVAGGELFDFLAEK------ESLTEEEATEFLKQILNGVYYLH 130
Query: 487 EVSPKRYVHGDLRPSNILLGKNMEP----HISDFGLARLADIAEETPEVHWEQSTTGTPL 542
+ H DL+P NI+L P I DFGLA D E + GTP
Sbjct: 131 S---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF------GTP- 180
Query: 543 QSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSME 602
+ APE + D++S GVI ++SG P + E
Sbjct: 181 -----------------EFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE 223
Query: 603 LNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHV 661
+ + D + + K P KR +++
Sbjct: 224 T-----LANVSAVNYEFEDEYFSNTSALA---------KDFIRRLLVKDPKKRMTIQDS 268
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 111 bits (279), Expect = 5e-28
Identities = 57/302 (18%), Positives = 102/302 (33%), Gaps = 44/302 (14%)
Query: 375 LGKSTIGIVYKVALNNEEAVAVR--RLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYF 432
+G+ T G+VYK N E A++ RL E + +++H NIV L
Sbjct: 10 IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 433 WSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKR 492
+ +L+++++ + L + + GIA+ H+ +R
Sbjct: 70 HTKKRLVLVFEHLDQDLKKLLDVCE------GGLESVTAKSFLLQLLNGIAYCHD---RR 120
Query: 493 YVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTAL 552
+H DL+P N+L+ + E I+DFGLAR I
Sbjct: 121 VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVT----------------- 163
Query: 553 NSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMEL--NIVQWIQ 610
Y +K + DI+S G I EM++G + + I + +
Sbjct: 164 -----LWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILG 218
Query: 611 LILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALD---------CVHKSPDKRPSMRHV 661
P L + + E LD + P++R + +
Sbjct: 219 TPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278
Query: 662 CD 663
+
Sbjct: 279 LE 280
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (276), Expect = 1e-27
Identities = 55/318 (17%), Positives = 96/318 (30%), Gaps = 77/318 (24%)
Query: 355 PLDSQVDFDLEQLLKASAFLLGKSTIGIVYKV-ALNNEEAVAVRRL------GNGGWQRF 407
PL+SQ + + LL G G VY +++ VA++ + G
Sbjct: 1 PLESQ--YQVGPLL-------GSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNG 51
Query: 408 KEFQTEAEAIGKIR--HPNIVSLRAYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRP 465
E + K+ ++ L +F D +LI + I
Sbjct: 52 TRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDF-----ITERGA 106
Query: 466 LSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKN-MEPHISDFGLARLADI 524
L V + + H +H D++ NIL+ N E + DFG L
Sbjct: 107 LQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLK- 162
Query: 525 AEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPE-ASKVRKPTQKWDIYSYGV 583
GT Y PE R + ++S G+
Sbjct: 163 ------DTVYTDFDGTR------------------VYSPPEWIRYHRYHGRSAAVWSLGI 198
Query: 584 ILLEMISGKLPMIQIGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKI 643
+L +M+ G +P + I++ Q+ R E +++
Sbjct: 199 LLYDMVCGDIPF----EHDEEIIRG-QVFFRQRVS----------------SECQHLIR- 236
Query: 644 ALDCVHKSPDKRPSMRHV 661
C+ P RP+ +
Sbjct: 237 --WCLALRPSDRPTFEEI 252
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (279), Expect = 2e-27
Identities = 61/331 (18%), Positives = 110/331 (33%), Gaps = 48/331 (14%)
Query: 374 LLGKSTIGIVYKVA-LNNEEAVAVRRL--GNGGWQRFKEFQTEAEAIGKIRHPNIVSLRA 430
+G G V VA+++L K E + +RH N++ L
Sbjct: 25 PVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLD 84
Query: 431 YFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSP 490
F + D+ GK ++ + L ++ + KG+ ++H
Sbjct: 85 VFTPDETLDDFTDFYLVMPFMGTDLGK--LMKHEKLGEDRIQFLVYQMLKGLRYIHA--- 139
Query: 491 KRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFT 550
+H DL+P N+ + ++ E I DFGLAR AD + T
Sbjct: 140 AGIIHRDLKPGNLAVNEDCELKILDFGLARQAD----------SEMTG------------ 177
Query: 551 ALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLP-----------MIQIG 599
+R Y + TQ DI+S G I+ EMI+GK I
Sbjct: 178 ---YVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKV 234
Query: 600 SMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIAL--DCVHKSPDKRPS 657
+ +L ++ K L D S L + L + ++R +
Sbjct: 235 TGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVT 294
Query: 658 MRHVCDS--LDRVNISTEQQFMKGEEPKFDQ 686
+ ++ + ++ ++ + FD
Sbjct: 295 AGEALAHPYFESLHDTEDEPQVQKYDDSFDD 325
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (275), Expect = 2e-27
Identities = 52/302 (17%), Positives = 98/302 (32%), Gaps = 47/302 (15%)
Query: 374 LLGKSTIGIVYKV-ALNNEEAVAVRRLGNGGWQRFKE-----FQTEAEAIGKIRHPNIVS 427
LG+ VYK N + VA++++ G K+ E + + ++ HPNI+
Sbjct: 5 FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 64
Query: 428 LRAYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHE 487
L F L++D++ L+ S + +G+ +LH+
Sbjct: 65 LLDAFGHKSNISLVFDFMETDLEVIIKDNS------LVLTPSHIKAYMLMTLQGLEYLHQ 118
Query: 488 VSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPY 547
+H DL+P+N+LL +N ++DFGLA+ T
Sbjct: 119 ---HWILHRDLKPNNLLLDENGVLKLADFGLAK-----SFGSPNRAYTHQVVTRW----- 165
Query: 548 EFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLP------MIQIGSM 601
Y R D+++ G IL E++ + Q+ +
Sbjct: 166 ------------YRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRI 213
Query: 602 ELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALD----CVHKSPDKRPS 657
+ + D + D + + + LD +P R +
Sbjct: 214 FETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARIT 273
Query: 658 MR 659
Sbjct: 274 AT 275
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (271), Expect = 1e-26
Identities = 50/316 (15%), Positives = 114/316 (36%), Gaps = 56/316 (17%)
Query: 375 LGKSTIGIVYKV-ALNNEEAVAVRRL--GNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAY 431
+G+ T G V+K + VA++++ N E + + ++H N+V+L
Sbjct: 18 IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 77
Query: 432 FWSVDEK--------LLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIA 483
+ L++D+ + + + S+ R+++ + G+
Sbjct: 78 CRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVL------VKFTLSEIKRVMQMLLNGLY 131
Query: 484 FLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQ 543
++H + +H D++ +N+L+ ++ ++DFGLAR +A+ + + + T
Sbjct: 132 YIHR---NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRY-TNRVVTL-- 185
Query: 544 SSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMEL 603
Y R D++ G I+ EM + M G+ E
Sbjct: 186 ---------------WYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIM--QGNTEQ 228
Query: 604 NIVQWIQLIL----------EDRKPMTDILDPFLAHDLDKEDEIVSVLK--IALD----C 647
+ + I + D + + L+ +D + + ++ ALD
Sbjct: 229 HQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKL 288
Query: 648 VHKSPDKRPSMRHVCD 663
+ P +R +
Sbjct: 289 LVLDPAQRIDSDDALN 304
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (266), Expect = 8e-26
Identities = 59/290 (20%), Positives = 98/290 (33%), Gaps = 54/290 (18%)
Query: 374 LLGKSTIGIVYKV-ALNNEEAVAVRRL---GNGGWQRFKEFQTEAEAIGKIRHPNIVSLR 429
LLGK T G V V A++ L TE+ + RHP + +L+
Sbjct: 12 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 71
Query: 430 AYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVS 489
F + D + +Y G L + + R + + + +LH
Sbjct: 72 YAFQTHDRLCFVMEYANGGELFFHLSRE------RVFTEERARFYGAEIVSALEYLHS-- 123
Query: 490 PKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEF 549
+ V+ D++ N++L K+ I+DFGL + T + GTP
Sbjct: 124 -RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC-----GTP-------- 169
Query: 550 TALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQWI 609
Y APE + + D + GV++ EM+ G+LP + +
Sbjct: 170 ----------EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF-----YNQDHERLF 214
Query: 610 QLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMR 659
+LIL + L P L + K P +R
Sbjct: 215 ELILMEEIRFPRTLSPEAKSLLAG-------------LLKKDPKQRLGGG 251
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (262), Expect = 1e-25
Identities = 59/300 (19%), Positives = 102/300 (34%), Gaps = 44/300 (14%)
Query: 374 LLGKSTIGIVYKVA-LNNEEAVAVR--RLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRA 430
+G+ T G+VYK E VA++ RL E + ++ HPNIV L
Sbjct: 9 KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL- 67
Query: 431 YFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSP 490
+ KL + + L + + + + + +G+AF H
Sbjct: 68 DVIHTENKLYLVFEFLHQDLKKFMDAS----ALTGIPLPLIKSYLFQLLQGLAFCHS--- 120
Query: 491 KRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFT 550
R +H DL+P N+L+ ++DFGLAR V T
Sbjct: 121 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFG-----VPVRTYTHEVVTL--------- 166
Query: 551 ALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLP------MIQIGSMELN 604
Y + + DI+S G I EM++ + + Q+ +
Sbjct: 167 --------WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRT 218
Query: 605 IVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVL-KIALD----CVHKSPDKRPSMR 659
+ +++ M D F ++V L + +H P+KR S +
Sbjct: 219 LGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAK 278
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 104 bits (259), Expect = 8e-25
Identities = 50/324 (15%), Positives = 96/324 (29%), Gaps = 61/324 (18%)
Query: 337 TRNNLDTMSENMEQYEFVPLDSQVDFDLEQLLKASAFLLGKSTIGIVYKV-ALNNEEAVA 395
+ L E+ + P + D +K LG + G V V + A
Sbjct: 15 VKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIK----TLGTGSFGRVMLVKHKESGNHYA 70
Query: 396 VRRLGNG---GWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLAT 452
++ L ++ + E + + P +V L F ++ +Y+ G + +
Sbjct: 71 MKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFS 130
Query: 453 AIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPH 512
+ S + +LH ++ DL+P N+L+ +
Sbjct: 131 HLR------RIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQ 181
Query: 513 ISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKP 572
++DFG A+ + GTP APE +
Sbjct: 182 VTDFGFAK--------RVKGRTWTLCGTP------------------EALAPEIILSKGY 215
Query: 573 TQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLD 632
+ D ++ GV++ EM +G P +Q + I+ + L L
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPF-----FADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR 270
Query: 633 KEDEIVSVLKIALDCVHKSPDKRP 656
+ KR
Sbjct: 271 N-------------LLQVDLTKRF 281
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (253), Expect = 2e-24
Identities = 52/302 (17%), Positives = 101/302 (33%), Gaps = 46/302 (15%)
Query: 375 LGKSTIGIVYKV-ALNNEEAVAVR--RLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAY 431
+G+ T G V+K E VA++ RL + E + +++H NIV L
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 432 FWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPK 491
S + L++++ L + + KG+ F H +
Sbjct: 70 LHSDKKLTLVFEFCDQDLKKYFDSCN------GDLDPEIVKSFLFQLLKGLGFCH---SR 120
Query: 492 RYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTA 551
+H DL+P N+L+ +N E +++FGLAR + + +
Sbjct: 121 NVLHRDLKPQNLLINRNGELKLANFGLARAFG----------IPVRCYSAEVVTLW---- 166
Query: 552 LNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSME---LNIVQW 608
Y + + D++S G I E+ + P+ ++ I +
Sbjct: 167 --------YRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRL 218
Query: 609 IQLILEDRKPMTDIL-----DPFLAHDLDKEDEIVSVLKIALD----CVHKSPDKRPSMR 659
+ E++ P L P + + + D + +P +R S
Sbjct: 219 LGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAE 278
Query: 660 HV 661
Sbjct: 279 EA 280
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 99.5 bits (247), Expect = 2e-23
Identities = 50/296 (16%), Positives = 99/296 (33%), Gaps = 52/296 (17%)
Query: 374 LLGKSTIGIVYKV----ALNNEEAVAVRRL----GNGGWQRFKEFQTEAEAIGKIRH-PN 424
+LG G V+ V + + A++ L + + +TE + + IR P
Sbjct: 31 VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 90
Query: 425 IVSLRAYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAF 484
+V+L F + + LI DYI G L T + + + + + +
Sbjct: 91 LVTLHYAFQTETKLHLILDYINGGELFTHLS------QRERFTEHEVQIYVGEIVLALEH 144
Query: 485 LHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQS 544
LH+ ++ D++ NILL N ++DFGL++ E + +
Sbjct: 145 LHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTI------- 194
Query: 545 SPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELN 604
+ D +S GV++ E+++G P + + +
Sbjct: 195 -------------EYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPF-TVDGEKNS 240
Query: 605 IVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRH 660
+ + IL+ P + + + + K P KR
Sbjct: 241 QAEISRRILKSEPPYPQEMSALAKDLIQR-------------LLMKDPKKRLGCGP 283
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 98.8 bits (245), Expect = 4e-23
Identities = 52/331 (15%), Positives = 109/331 (32%), Gaps = 70/331 (21%)
Query: 354 VPLDSQVDFDLEQLLKASAFLLGKSTIGIVYKV-ALNNEEAVAVRRLGNGGWQRFKEFQT 412
V +Q D+ L + L G+ V++ + N E V V+ L + K+ +
Sbjct: 29 VEWGNQDDYQLVRKL-------GRGKYSEVFEAINITNNEKVVVKILKP---VKKKKIKR 78
Query: 413 EAEAIGKIR-HPNIVSLRAYFWSVDEKL--LIYDYIPNGSLATAIHGKAGIISYRPLSWS 469
E + + +R PNI++L + L+++++ N + L+
Sbjct: 79 EIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY---------QTLTDY 129
Query: 470 DRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLG-KNMEPHISDFGLARLADIAEET 528
D + + K + + H +H D++P N+++ ++ + + D+GLA +E
Sbjct: 130 DIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY 186
Query: 529 PEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEM 588
+ + + D++S G +L M
Sbjct: 187 ------NVRVASR-----------------YFKGPELLVDYQMYDYSLDMWSLGCMLASM 223
Query: 589 ISGKLP-------------MIQIGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKED 635
I K P + ++ E + +E DIL ++
Sbjct: 224 IFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFV 283
Query: 636 EIVSVLKI---ALD----CVHKSPDKRPSMR 659
+ + ALD + R + R
Sbjct: 284 HSENQHLVSPEALDFLDKLLRYDHQSRLTAR 314
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 95.0 bits (235), Expect = 1e-21
Identities = 54/302 (17%), Positives = 93/302 (30%), Gaps = 46/302 (15%)
Query: 374 LLGKSTIGIVYKV-ALNNEEAVAVRRL--GNGGWQRFKEFQTEAEAIGKIRHPNIVSLRA 430
+G G V VAV++L K E + ++H N++ L
Sbjct: 25 PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 84
Query: 431 YFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSP 490
F D L A I+ + L+ +I + +G+ ++H
Sbjct: 85 VFTPARSLEEFNDVYLVTHLMGADLNN--IVKCQKLTDDHVQFLIYQILRGLKYIHS--- 139
Query: 491 KRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFT 550
+H DL+PSN+ + ++ E I DFGLAR D
Sbjct: 140 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY--------------------- 178
Query: 551 ALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLP-----------MIQIG 599
+R Y Q DI+S G I+ E+++G+ +I
Sbjct: 179 ----VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL 234
Query: 600 SMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIAL--DCVHKSPDKRPS 657
++ E + L + + L + L + DKR +
Sbjct: 235 VGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 294
Query: 658 MR 659
Sbjct: 295 AA 296
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 85.8 bits (211), Expect = 1e-18
Identities = 61/319 (19%), Positives = 100/319 (31%), Gaps = 69/319 (21%)
Query: 374 LLGKSTIGIVYKV-ALNNEEAVAVRRL--GNGGWQRFKEFQTEAEAIGKIRHPNIVSLRA 430
+G GIV + VA+++L K E + + H NI+SL
Sbjct: 24 PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83
Query: 431 YFWS------VDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAF 484
F + L+ + + + L ++ + GI
Sbjct: 84 VFTPQKTLEEFQDVYLVMELMDANLCQ---------VIQMELDHERMSYLLYQMLCGIKH 134
Query: 485 LHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQS 544
LH +H DL+PSNI++ + I DFGLAR A + T
Sbjct: 135 LHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM------TPYVVTR--- 182
Query: 545 SPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMEL- 603
YY+APE + DI+S G I+ EM+ K+ ++
Sbjct: 183 ---------------YYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQW 227
Query: 604 ----------------NIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKI---A 644
+ ++ +E+R + P L D + A
Sbjct: 228 NKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQA 287
Query: 645 LD----CVHKSPDKRPSMR 659
D + P KR S+
Sbjct: 288 RDLLSKMLVIDPAKRISVD 306
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 81.0 bits (198), Expect = 3e-17
Identities = 65/309 (21%), Positives = 112/309 (36%), Gaps = 75/309 (24%)
Query: 18 DEGLALLSFKQAIRNFPEGNNWNNSNEDPC--SWNGITC----REGQVFSLIIPNKKLTG 71
+ ALL K+ + N ++W + D C +W G+ C + +V +L + L
Sbjct: 6 QDKQALLQIKKDLGNPTTLSSWLPTT-DCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPK 64
Query: 72 F--IPADLGSLSAIGRVNLRNN-NFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGKL 128
IP+ L +L + + + N G +P + + L L ++ + SG +P + ++
Sbjct: 65 PYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQI 124
Query: 129 KYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFN 188
K L LD S N+ S ++P SI L + + N +G +PD + + + +S N
Sbjct: 125 KTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRN 184
Query: 189 NLSGLIPNDIANLSRLRLLA---------------------------------------- 208
L+G IP ANL+ +
Sbjct: 185 RLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSK 244
Query: 209 QRVYVDLTYNNLSGLI------------------------PQNAALLSLGPTAFIGNPFL 244
+DL N + G + PQ L +A+ N L
Sbjct: 245 NLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCL 304
Query: 245 CGPPLKVSC 253
CG PL +C
Sbjct: 305 CGSPLP-AC 312
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 77.7 bits (190), Expect = 8e-16
Identities = 47/202 (23%), Positives = 67/202 (33%), Gaps = 41/202 (20%)
Query: 37 NNWNNSNEDPCSWNGITCREGQVFSLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGS 96
NN D +T + L + +L L SL+ + ++L NN S
Sbjct: 203 IATNNQISDITPLGILTNLD----ELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNL 256
Query: 97 LPVELFNASNLQSLILSGNSFSGPVP--------------------MQIGKLKYLQVLDL 136
P L + L L L N S P I LK L L L
Sbjct: 257 AP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTL 314
Query: 137 SQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSGLIPN 196
N+ S P + +L+ + N + A NLT + L N +S L P
Sbjct: 315 YFNNISDISP--VSSLTKLQRLFFANNKVSDV--SSLA-NLTNINWLSAGHNQISDLTP- 368
Query: 197 DIANLSRLRLLAQRVYVDLTYN 218
+ANL+R+ L L
Sbjct: 369 -LANLTRITQL------GLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 75.8 bits (185), Expect = 3e-15
Identities = 45/209 (21%), Positives = 77/209 (36%), Gaps = 37/209 (17%)
Query: 37 NNWNNSNEDPCSWNGITCREGQVFSLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGS 96
+ + + S + + + SLI N +++ P + + + ++L N
Sbjct: 177 LERLDISSNKVSDISVLAKLTNLESLIATNNQISDITPLGILT--NLDELSLNGNQLKD- 233
Query: 97 LPVELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQVLDLSQNSFSSSIP---------- 146
L + +NL L L+ N S P + L L L L N S+ P
Sbjct: 234 -IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNL 290
Query: 147 ----------SSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSGLIPN 196
S I K L + L N+ + P +LT LQ+L + N +S +
Sbjct: 291 ELNENQLEDISPISNLKNLTYLTLYFNNISDISPVS---SLTKLQRLFFANNKVSD--VS 345
Query: 197 DIANLSRLRLLAQRVYVDLTYNNLSGLIP 225
+ANL+ + L +N +S L P
Sbjct: 346 SLANLTNINWL------SAGHNQISDLTP 368
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 41.5 bits (96), Expect = 2e-04
Identities = 14/80 (17%), Positives = 34/80 (42%), Gaps = 7/80 (8%)
Query: 128 LKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSF 187
L L + + + ++ + ++ T+ ++ DG L L +++ S
Sbjct: 21 LAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKSI--DGVE-YLNNLTQINFSN 75
Query: 188 NNLSGLIPNDIANLSRLRLL 207
N L+ + P + NL++L +
Sbjct: 76 NQLTDITP--LKNLTKLVDI 93
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 41.1 bits (95), Expect = 3e-04
Identities = 11/67 (16%), Positives = 26/67 (38%), Gaps = 11/67 (16%)
Query: 159 VLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSGLIPNDIANLSRLRLLAQRVYVDLTYN 218
VL + + T + T+L + L + + + + L+ L + + + N
Sbjct: 28 VLGKTNVTDTVSQ---TDLDQVTTLQADRLGIKSI--DGVEYLNNLTQI------NFSNN 76
Query: 219 NLSGLIP 225
L+ + P
Sbjct: 77 QLTDITP 83
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 39.2 bits (90), Expect = 0.001
Identities = 12/82 (14%), Positives = 27/82 (32%), Gaps = 12/82 (14%)
Query: 79 SLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGN---SFSGPVPMQIGKLKYLQVLD 135
+L+ + L N + ++ + + +L S G + L L ++
Sbjct: 20 ALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKSIDG-----VEYLNNLTQIN 72
Query: 136 LSQNSFSSSIPSSIVQCKRLKT 157
S N + P + +L
Sbjct: 73 FSNNQLTDITP--LKNLTKLVD 92
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 38.8 bits (89), Expect = 0.002
Identities = 13/85 (15%), Positives = 25/85 (29%), Gaps = 7/85 (8%)
Query: 100 ELFNASNLQSLI---LSGNSFSGPVPMQIGKLKYLQVLDLSQNSFSSSIPSSIVQCKRLK 156
++F + L + L + + V L + L + S + L
Sbjct: 14 QIFTDTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS--IDGVEYLNNLT 69
Query: 157 TVVLNQNSFTGPLPDGFATNLTALQ 181
+ + N T P T L +
Sbjct: 70 QINFSNNQLTDITPLKNLTKLVDIL 94
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 73.9 bits (180), Expect = 1e-14
Identities = 50/331 (15%), Positives = 95/331 (28%), Gaps = 72/331 (21%)
Query: 374 LLGKSTIGIVYKV-ALNNEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYF 432
LG V+ + N VA++ + G + + E + + ++ + +
Sbjct: 20 KLGWGHFSTVWLAKDMVNNTHVAMKIV-RGDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 78
Query: 433 WSVDEKLLIY--DYIPNGSLATAIHGKAG--------IISYRPLSWSDRLRIIKGVAKGI 482
+ KLL + PNG + G +R + +I K + G+
Sbjct: 79 ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138
Query: 483 AFLHEVSPKRYVHGDLRPSNILLGKN-MEPHISDFGLARLADIAEETPEVHWEQSTTGTP 541
++H +H D++P N+L+ ++ +A L +
Sbjct: 139 DYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTN-------- 188
Query: 542 LQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMI-QIGS 600
+ Y++PE DI+S ++ E+I+G G
Sbjct: 189 -------------SIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGH 235
Query: 601 MELNIVQWIQLILE--------------------------------DRKPMTDILDPFLA 628
I I+E P+ D+L
Sbjct: 236 SYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYK 295
Query: 629 HDLDKEDEIVSVLKIALDCVHKSPDKRPSMR 659
D+ EI L + P KR
Sbjct: 296 FSKDEAKEISDFLS---PMLQLDPRKRADAG 323
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 72.0 bits (175), Expect = 3e-14
Identities = 38/197 (19%), Positives = 63/197 (31%), Gaps = 5/197 (2%)
Query: 37 NNWNNSNEDPCSWNGITCREGQVFSLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGS 96
N + V L K +G + + + + + N + +
Sbjct: 106 RVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-T 164
Query: 97 LPVELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQVLDLSQNSFSSSIPSSIVQCKRLK 156
+P L +L L L GN + + L L L LS NS S+ S+ L+
Sbjct: 165 IPQGLP--PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLR 222
Query: 157 TVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSGLIPNDIANLSRLRLLAQRVYVDLT 216
+ LN N + +Q + L NN+S + ND A V L
Sbjct: 223 ELHLNNNKLVKVPGGLA--DHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLF 280
Query: 217 YNNLSGLIPQNAALLSL 233
N + Q + +
Sbjct: 281 SNPVQYWEIQPSTFRCV 297
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 65.1 bits (157), Expect = 5e-12
Identities = 34/203 (16%), Positives = 61/203 (30%), Gaps = 46/203 (22%)
Query: 47 CSWNGITCREGQVFSLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASN 106
C + C + L +P DL ++L+NN + + N N
Sbjct: 10 CHLRVVQCS----------DLGLE-KVPKDLPP--DTALLDLQNNKITEIKDGDFKNLKN 56
Query: 107 LQSLILSGNSFSGPVPMQIGKLKYLQVLDLSQNSFSSSIPSSIVQCKRLKT--------- 157
L +LIL N S P L L+ L LS+N + L+
Sbjct: 57 LHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVR 116
Query: 158 --------------VVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSGLIPNDIANLSR 203
+ N +G F + L + ++ N++ + +L+
Sbjct: 117 KSVFNGLNQMIVVELGTNPLKSSGIENGAF-QGMKKLSYIRIADTNITTIPQGLPPSLTE 175
Query: 204 LRLLAQRVYVDLTYNNLSGLIPQ 226
L L N ++ +
Sbjct: 176 L---------HLDGNKITKVDAA 189
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 64.0 bits (155), Expect = 2e-12
Identities = 19/164 (11%), Positives = 46/164 (28%), Gaps = 31/164 (18%)
Query: 374 LLGKSTIGIVYKVALNNEEAVAV----------RRLGNGGWQRFKEFQTEAEAIGKIRHP 423
L+G+ V+ V +++ F A +
Sbjct: 7 LMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFR 66
Query: 424 NIVSLR----AYFWSVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVA 479
+ L+ ++ + ++ + I + + ++ +
Sbjct: 67 ALQKLQGLAVPKVYAWEGNAVLMELIDAKE-------------LYRVRVENPDEVLDMIL 113
Query: 480 KGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLAD 523
+ +A + + VHGDL N+L+ I DF +
Sbjct: 114 EEVAKFYH---RGIVHGDLSQYNVLVS-EEGIWIIDFPQSVEVG 153
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 59.2 bits (141), Expect = 9e-10
Identities = 19/93 (20%), Positives = 32/93 (34%), Gaps = 9/93 (9%)
Query: 106 NLQSLILSGNSFSGPVPMQI-GKLKYLQVLDLSQNSFS----SSIPSSIVQCKRLKTVVL 160
++QSL + S ++ L+ QV+ L + I S++ L + L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 161 NQNSFTG----PLPDGFATNLTALQKLDLSFNN 189
N + G T +QKL L
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCC 95
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 53.8 bits (127), Expect = 4e-08
Identities = 16/83 (19%), Positives = 34/83 (40%), Gaps = 8/83 (9%)
Query: 131 LQVLDLSQNSFS----SSIPSSIVQCKRLKTVVLNQNSFTGP----LPDGFATNLTALQK 182
L+VL L+ S SS+ ++++ L+ + L+ N L + L++
Sbjct: 371 LRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQ 430
Query: 183 LDLSFNNLSGLIPNDIANLSRLR 205
L L S + + + L + +
Sbjct: 431 LVLYDIYWSEEMEDRLQALEKDK 453
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.0 bits (117), Expect = 6e-07
Identities = 14/76 (18%), Positives = 30/76 (39%), Gaps = 6/76 (7%)
Query: 131 LQVLDLSQNSFSSSIPSSIV-QCKRLKTVVLNQNSFTG----PLPDGFATNLTALQKLDL 185
+Q LD+ S + + ++ ++ + V L+ T + N AL +L+L
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVN-PALAELNL 62
Query: 186 SFNNLSGLIPNDIANL 201
N L + + +
Sbjct: 63 RSNELGDVGVHCVLQG 78
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.6 bits (90), Expect = 0.001
Identities = 15/102 (14%), Positives = 38/102 (37%), Gaps = 9/102 (8%)
Query: 37 NNWNNSNEDPCSWNGITCREGQVFSLIIPNKKLTG----FIPADLGSLSAIGRVNLRNNN 92
NN G+ + L + + ++ + A L + ++ ++L NN
Sbjct: 349 NNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNC 408
Query: 93 FSGSLPVELFNA-----SNLQSLILSGNSFSGPVPMQIGKLK 129
+ ++L + L+ L+L +S + ++ L+
Sbjct: 409 LGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQALE 450
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 57.9 bits (138), Expect = 1e-09
Identities = 33/182 (18%), Positives = 56/182 (30%), Gaps = 11/182 (6%)
Query: 41 NSNEDPCSWNGITCREGQVFSLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVE 100
+ G+ + L + + L L + + L N S
Sbjct: 113 DRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERA 172
Query: 101 LFNASNLQSLILSGNSFSGPVPMQIGKLKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVL 160
+L L+L N + P L L L L N+ S+ ++ + L+ + L
Sbjct: 173 FRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRL 232
Query: 161 NQNSFTGPLPDGFATNLTALQKLDLSFNNLSGLIPNDIANLSRLRLLAQRVYVDLTYNNL 220
N N + LQK S + + +P L+ L L N+L
Sbjct: 233 NDNPWVCDCR--ARPLWAWLQKFRGSSSEVPCSLP---QRLAGRDLK------RLAANDL 281
Query: 221 SG 222
G
Sbjct: 282 QG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.6 bits (119), Expect = 3e-07
Identities = 27/156 (17%), Positives = 52/156 (33%), Gaps = 5/156 (3%)
Query: 37 NNWNNSNEDPCSWNGITCREGQVFSLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGS 96
+ N + G + L + +++ L ++ R+ L N +
Sbjct: 133 YLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHV 192
Query: 97 LPVELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQVLDLSQNSFSSSIPSSIVQCKRLK 156
P + L +L L N+ S + L+ LQ L L+ N + + + L+
Sbjct: 193 HPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPL-WAWLQ 251
Query: 157 TVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSG 192
+ + LP L L+ N+L G
Sbjct: 252 KFRGSSSEVPCSLPQ----RLAGRDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.6 bits (106), Expect = 9e-06
Identities = 28/141 (19%), Positives = 47/141 (33%), Gaps = 9/141 (6%)
Query: 85 RVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQVLDLSQNSFSSS 144
+ ++PV + + Q + L GN S + L +L L N +
Sbjct: 15 TTSCPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARI 71
Query: 145 IPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSGLIPNDIANLSRL 204
++ L+ + L+ N+ + L L L L L L P L+ L
Sbjct: 72 DAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAAL 131
Query: 205 RLLAQRVYVDLTYNNLSGLIP 225
+ Y+ L N L L
Sbjct: 132 Q------YLYLQDNALQALPD 146
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 57.0 bits (136), Expect = 2e-09
Identities = 20/111 (18%), Positives = 38/111 (34%), Gaps = 2/111 (1%)
Query: 108 QSLILSGNSFSGPVPMQIGKLKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTG 167
Q+L L+G + V ++ + ++ + R++ + L+ +
Sbjct: 3 QTLDLTGKNLHPDVTGRLLSQG-VIAFRCPRSFMDQPLAEHF-SPFRVQHMDLSNSVIEV 60
Query: 168 PLPDGFATNLTALQKLDLSFNNLSGLIPNDIANLSRLRLLAQRVYVDLTYN 218
G + + LQ L L LS I N +A S L L +
Sbjct: 61 STLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEF 111
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 55.9 bits (133), Expect = 5e-09
Identities = 17/101 (16%), Positives = 41/101 (40%), Gaps = 4/101 (3%)
Query: 85 RVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQVLDLSQNSFS-S 143
++L N + L + + + + P+ + +Q +DLS + S
Sbjct: 4 TLDLTGKNLHPDVTGRLL-SQGVIAFRCPRSFMDQPLAEHFSPFR-VQHMDLSNSVIEVS 61
Query: 144 SIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLD 184
++ + QC +L+ + L + P+ + A + L +L+
Sbjct: 62 TLHGILSQCSKLQNLSLEGLRLSDPIVNTLA-KNSNLVRLN 101
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.1 bits (105), Expect = 2e-05
Identities = 19/102 (18%), Positives = 40/102 (39%), Gaps = 10/102 (9%)
Query: 132 QVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLS 191
Q LDL+ + + ++ + + ++ PL + F+ +Q +DLS + +
Sbjct: 3 QTLDLTGKNLHPDVTGRLLS-QGVIAFRCPRSFMDQPLAEHFS--PFRVQHMDLSNSVIE 59
Query: 192 G-LIPNDIANLSRLRLLAQRVYVDLTYNNLSGLIPQNAALLS 232
+ ++ S+L+ L+ LS I A S
Sbjct: 60 VSTLHGILSQCSKLQNLSLE------GLRLSDPIVNTLAKNS 95
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 55.2 bits (131), Expect = 1e-08
Identities = 18/95 (18%), Positives = 39/95 (41%), Gaps = 10/95 (10%)
Query: 112 LSGNSFSGPVPMQIGKLKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPD 171
N+ S + L+ L++S N +P+ RL+ ++ + N +P+
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKL-IELPALP---PRLERLIASFNHLAE-VPE 321
Query: 172 GFATNLTALQKLDLSFNNLSGLIPNDIANLSRLRL 206
L++L + +N L P+ ++ LR+
Sbjct: 322 ----LPQNLKQLHVEYNPLREF-PDIPESVEDLRM 351
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 43.3 bits (100), Expect = 6e-05
Identities = 21/88 (23%), Positives = 34/88 (38%), Gaps = 15/88 (17%)
Query: 136 LSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSGLIP 195
N+ S+ I S L+ + ++ N LP L++L SFN+L+ +P
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPAL----PPRLERLIASFNHLAE-VP 320
Query: 196 NDIANLSRLRLLAQRVYVDLTYNNLSGL 223
NL +L + YN L
Sbjct: 321 ELPQNLKQL---------HVEYNPLREF 339
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 42.5 bits (98), Expect = 1e-04
Identities = 21/125 (16%), Positives = 36/125 (28%), Gaps = 9/125 (7%)
Query: 32 NFPEGNNWNNSNEDPCSWNGITCREGQVFSLIIPNKKLTGFIPADLGSLSAIGRVNLRNN 91
+ S I ++ + + I + ++ +N+ NN
Sbjct: 235 YLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNN 294
Query: 92 NFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQVLDLSQNSFSSSIPSSIVQ 151
LP L+ LI S N + VP LK L + N P
Sbjct: 295 KLI-ELPALP---PRLERLIASFNHLAE-VPELPQNLKQ---LHVEYNPL-REFPDIPES 345
Query: 152 CKRLK 156
+ L+
Sbjct: 346 VEDLR 350
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 51.6 bits (123), Expect = 1e-08
Identities = 21/118 (17%), Positives = 40/118 (33%), Gaps = 6/118 (5%)
Query: 87 NLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQVLDLSQNSFSSSIP 146
+L + + + L + L LS N P + L+ L+VL + +
Sbjct: 4 HLAHKDLTV--LCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQ--ASDNALENV 58
Query: 147 SSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSGLIPNDIANLSRL 204
+ RL+ ++L N + L L+L N+L L+ +
Sbjct: 59 DGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ-EEGIQERLAEM 115
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 51.3 bits (122), Expect = 1e-08
Identities = 26/130 (20%), Positives = 47/130 (36%), Gaps = 13/130 (10%)
Query: 108 QSLILSGNSFSGPVPMQIGKLKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTG 167
+ L L+ + + +L + LDLS N + P+ + + L+ + + N+
Sbjct: 1 RVLHLAHKDLTVLCH--LEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVLQASDNALEN 57
Query: 168 PLPDGFATNLTALQKLDLSFNNLSGL-IPNDIANLSRLRLLAQRVYVDLTYNNLSGLIPQ 226
L Q+L L N L + + RL LL +L N+L
Sbjct: 58 VDGVANLPRL---QELLLCNNRLQQSAAIQPLVSCPRLVLL------NLQGNSLCQEEGI 108
Query: 227 NAALLSLGPT 236
L + P+
Sbjct: 109 QERLAEMLPS 118
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.7 bits (117), Expect = 4e-07
Identities = 39/214 (18%), Positives = 66/214 (30%), Gaps = 53/214 (24%)
Query: 76 DLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQVLD 135
++ +++ VN N + +LP +L + L LS N + L L+
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 136 LSQNSFS--------------------------------------------SSIPSSIVQ 151
L + + +S+P ++
Sbjct: 62 LDRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALR 121
Query: 152 CKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSGLIPNDIANLSRLRLLAQRV 211
+ + + LP G T L+KL L+ NNL+ L + L L L
Sbjct: 122 GLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTL---- 177
Query: 212 YVDLTYNNLSGLIPQNAALLSLGPTAFIGNPFLC 245
L N+L + L GNP+LC
Sbjct: 178 --LLQENSLYTIPKGFFGSHLLPFAFLHGNPWLC 209
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.1 bits (105), Expect = 1e-05
Identities = 17/81 (20%), Positives = 30/81 (37%), Gaps = 1/81 (1%)
Query: 37 NNWNNSNEDPCSWNGITCREGQVFSLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGS 96
+ NE G+ ++ L + N LT L L + + L+ N+ +
Sbjct: 128 ELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-T 186
Query: 97 LPVELFNASNLQSLILSGNSF 117
+P F + L L GN +
Sbjct: 187 IPKGFFGSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.4 bits (98), Expect = 1e-04
Identities = 27/134 (20%), Positives = 46/134 (34%), Gaps = 1/134 (0%)
Query: 32 NFPEGNNWNNSNEDPCSWNGITCREGQVFSLIIPNKKLTGFIPADLGSLSAIGRVNLRNN 91
P + S+ S + + L + +LT L L + + L+ N
Sbjct: 75 TLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGN 134
Query: 92 NFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQVLDLSQNSFSSSIPSSIVQ 151
P L L+ L L+ N+ + + L+ L L L +NS +IP
Sbjct: 135 ELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSL-YTIPKGFFG 193
Query: 152 CKRLKTVVLNQNSF 165
L L+ N +
Sbjct: 194 SHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.7 bits (91), Expect = 8e-04
Identities = 31/187 (16%), Positives = 45/187 (24%), Gaps = 50/187 (26%)
Query: 66 NKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNS--------- 116
+ LT +P DL ++L N L + L L L
Sbjct: 19 KRNLT-ALPPDLPKD--TTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVDGT 75
Query: 117 ------------------------------------FSGPVPMQIGKLKYLQVLDLSQNS 140
+ + L LQ L L N
Sbjct: 76 LPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNE 135
Query: 141 FSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSGLIPNDIAN 200
+ P + +L+ + L N+ T L L L L N+L IP
Sbjct: 136 LKTLPPGLLTPTPKLEKLSLANNNLTELPAGLL-NGLENLDTLLLQENSLYT-IPKGFFG 193
Query: 201 LSRLRLL 207
L
Sbjct: 194 SHLLPFA 200
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.1 bits (102), Expect = 2e-05
Identities = 10/43 (23%), Positives = 16/43 (37%)
Query: 165 FTGPLPDGFATNLTALQKLDLSFNNLSGLIPNDIANLSRLRLL 207
LP+ + LD+S + L + NL +LR
Sbjct: 188 NLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRAR 230
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.3 bits (92), Expect = 4e-04
Identities = 8/60 (13%), Positives = 16/60 (26%), Gaps = 5/60 (8%)
Query: 146 PSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSGLIPNDIANLSRLR 205
I C + + ++ T +P N +L L + + L
Sbjct: 2 HHRICHC-SNRVFLCQESKVTE-IPSDLPRNAI---ELRFVLTKLRVIQKGAFSGFGDLE 56
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.1 bits (89), Expect = 8e-04
Identities = 13/59 (22%), Positives = 21/59 (35%), Gaps = 4/59 (6%)
Query: 90 NNNFSGSLPVELF-NASNLQSLILSGNSFSGPVPMQIGKLKYLQVLDLSQNSFSSSIPS 147
+NN LP ++F AS L +S + LK L+ +P+
Sbjct: 185 DNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNL---KKLPT 240
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.9 bits (99), Expect = 2e-05
Identities = 20/120 (16%), Positives = 39/120 (32%), Gaps = 7/120 (5%)
Query: 131 LQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNL 190
L +++ + + L + + L L L+ L + + L
Sbjct: 10 SSGLRCTRDGALD-SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGL 68
Query: 191 SGLIPNDIANLSRLRLLAQRVYVDLTYNNLSGLIPQNAALLSLGPTAFIGNPFLCGPPLK 250
+ P+ + ++L++N L L + LSL GNP C L+
Sbjct: 69 RFVAPDAFHFTP------RLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALR 122
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.6 bits (88), Expect = 6e-04
Identities = 23/157 (14%), Positives = 44/157 (28%), Gaps = 13/157 (8%)
Query: 46 PCSWNGITCREGQVFSLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELF-NA 104
P +G+ C L + + + N L +
Sbjct: 7 PHGSSGLRCTRDGALD-----------SLHHLPGAENLTELYIENQQHLQHLELRDLRGL 55
Query: 105 SNLQSLILSGNSFSGPVPMQIGKLKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNS 164
L++L + + P L L+LS N+ S+ VQ L+ +VL+ N
Sbjct: 56 GELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNAL-ESLSWKTVQGLSLQELVLSGNP 114
Query: 165 FTGPLPDGFATNLTALQKLDLSFNNLSGLIPNDIANL 201
+ + L +A++
Sbjct: 115 LHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHM 151
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 43.3 bits (100), Expect = 3e-05
Identities = 30/189 (15%), Positives = 60/189 (31%), Gaps = 30/189 (15%)
Query: 86 VNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQI-GKLKYLQVLDLSQNSFSSS 144
V+ +P ++ + L+L+ N + G+L +L L+L +N +
Sbjct: 13 VDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGI 69
Query: 145 IPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSGLIPNDIANLSRL 204
P++ ++ + L +N F L L+ L+L N +S ++P +L+ L
Sbjct: 70 EPNAFEGASHIQELQLGENKIKEISNKMFL-GLHQLKTLNLYDNQISCVMPGSFEHLNSL 128
Query: 205 R-----------------LLAQRVYVDLTYNNLSGLIP---QNAALLSLGPTAFIGNPFL 244
L P ++ + L + F
Sbjct: 129 TSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAPSKVRDVQIKDLPH-----SEFK 183
Query: 245 CGPPLKVSC 253
C C
Sbjct: 184 CSSENSEGC 192
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 43.1 bits (100), Expect = 4e-05
Identities = 16/71 (22%), Positives = 31/71 (43%), Gaps = 5/71 (7%)
Query: 137 SQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSGLIPN 196
S + S + + +L T+ + N + P +L L ++ L N +S + P
Sbjct: 157 SIGNAQVSDLTPLANLSKLTTLKADDNKISDISPLA---SLPNLIEVHLKNNQISDVSP- 212
Query: 197 DIANLSRLRLL 207
+AN S L ++
Sbjct: 213 -LANTSNLFIV 222
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 39.2 bits (90), Expect = 9e-04
Identities = 19/63 (30%), Positives = 23/63 (36%), Gaps = 5/63 (7%)
Query: 101 LFNASNLQSLILSGNSFSGPVPMQIGKLKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVL 160
L N S L +L N S P + L L + L N S P + L V L
Sbjct: 169 LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTL 224
Query: 161 -NQ 162
NQ
Sbjct: 225 TNQ 227
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 38.5 bits (88), Expect = 0.001
Identities = 12/48 (25%), Positives = 19/48 (39%), Gaps = 4/48 (8%)
Query: 90 NNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQVLDLS 137
+N S P L + NL + L N S P + L ++ L+
Sbjct: 182 DNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.5 bits (86), Expect = 0.001
Identities = 27/141 (19%), Positives = 46/141 (32%), Gaps = 35/141 (24%)
Query: 76 DLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSG--PVPMQIGKLKYLQV 133
DL + + +N R++ + +L + N L SL LS N + + K L++
Sbjct: 37 DLVAQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKI 95
Query: 134 LDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSGL 193
L+LS N S + L++L L N+LS
Sbjct: 96 LNLSGNELKS-------------------------ERELDKIKGLKLEELWLDGNSLSDT 130
Query: 194 IPND-------IANLSRLRLL 207
+ +L L
Sbjct: 131 FRDQSTYISAIRERFPKLLRL 151
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 38.7 bits (88), Expect = 0.002
Identities = 15/106 (14%), Positives = 27/106 (25%), Gaps = 28/106 (26%)
Query: 112 LSGNSFSGPVPMQIG------KLKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSF 165
L+ S + + LQ L L N +
Sbjct: 250 LNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRT----------------- 292
Query: 166 TGPLPDGFATNLTALQKLDLSFNNLS--GLIPNDIANLSRLRLLAQ 209
L + L L+L+ N S + ++I + R +
Sbjct: 293 ---LKTVIDEKMPDLLFLELNGNRFSEEDDVVDEIREVFSTRGRGE 335
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 36.8 bits (84), Expect = 0.003
Identities = 15/71 (21%), Positives = 23/71 (32%), Gaps = 3/71 (4%)
Query: 100 ELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVV 159
+ NA + L L G + L +D S N +RLKT++
Sbjct: 13 QYTNAVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIRKLDGFP--LLRRLKTLL 69
Query: 160 LNQNSFTGPLP 170
+N N
Sbjct: 70 VNNNRICRIGE 80
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 36.8 bits (84), Expect = 0.003
Identities = 19/124 (15%), Positives = 36/124 (29%), Gaps = 6/124 (4%)
Query: 87 NLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQVLDLSQNSFSSSIP 146
+LR + ++ S N L+ L+ L ++ N
Sbjct: 24 DLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKLDGF--PLLRRLKTLLVNNNRICRIGE 80
Query: 147 SSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLS---FNNLSGLIPNDIANLSR 203
L ++L NS +L +L L + N I + +
Sbjct: 81 GLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQ 140
Query: 204 LRLL 207
+R+L
Sbjct: 141 VRVL 144
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 37.3 bits (85), Expect = 0.003
Identities = 33/189 (17%), Positives = 59/189 (31%), Gaps = 47/189 (24%)
Query: 58 QVFSLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSF 117
+ + K +T + L++I ++ N++ ++ N+ L L+GN
Sbjct: 25 ETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSVQGIQ--YLPNVTKLFLNGNKL 80
Query: 118 SGPVPMQIGKLKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFA--- 174
+ + LK L L L +N ++ + ++ N S L
Sbjct: 81 TDI--KPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHLPQLES 138
Query: 175 ------------------------------------TNLTALQKLDLSFNNLSGLIPNDI 198
LT LQ L LS N++S L +
Sbjct: 139 LYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKNHISDL--RAL 196
Query: 199 ANLSRLRLL 207
A L L +L
Sbjct: 197 AGLKNLDVL 205
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 686 | |||
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.88 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.87 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.83 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.8 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.77 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.74 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.7 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.69 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.68 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.6 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.59 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.58 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.55 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.55 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.51 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.5 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.5 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.49 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.48 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.48 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.46 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.43 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.38 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.35 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.31 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.29 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.25 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.23 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 98.96 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 98.86 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 98.84 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 98.71 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 98.58 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 98.56 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.53 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.52 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.4 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 98.22 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 98.22 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.19 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.82 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.46 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.41 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.21 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.78 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 96.59 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 96.34 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.19 |
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-52 Score=416.69 Aligned_cols=251 Identities=23% Similarity=0.356 Sum_probs=197.5
Q ss_pred cccCccCceEEEEEEeCCCceEEEEEcCCCCccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCCHHH
Q 042348 373 FLLGKSTIGIVYKVALNNEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLAT 452 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL~~ 452 (686)
+.||+|+||.||+|.+.+++.||||+++... ...++|.+|++++++++|||||+++|+|...+..++|||||++|+|.+
T Consensus 11 ~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g~L~~ 89 (263)
T d1sm2a_ 11 QEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSD 89 (263)
T ss_dssp EEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHH
T ss_pred EEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCCCcHHH
Confidence 3699999999999999888899999997654 334789999999999999999999999999999999999999999999
Q ss_pred HhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCcccc
Q 042348 453 AIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVH 532 (686)
Q Consensus 453 ~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 532 (686)
++.... ..++|..+..|+.|||.||+|||+ ++|+||||||+|||+++++.+||+|||+|+.......
T Consensus 90 ~l~~~~-----~~~~~~~~~~i~~qia~gl~~lH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~----- 156 (263)
T d1sm2a_ 90 YLRTQR-----GLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY----- 156 (263)
T ss_dssp HHHTTT-----TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCTTCSGGGEEECGGGCEEECSCC---------------
T ss_pred Hhhccc-----cCCCHHHHHHHHHHHHHHHHhhhc---cceeecccchhheeecCCCCeEecccchheeccCCCc-----
Confidence 988654 468999999999999999999999 8999999999999999999999999999986643221
Q ss_pred ccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHHHHHH
Q 042348 533 WEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQWIQLI 612 (686)
Q Consensus 533 ~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~ 612 (686)
.......||..|+|||++.+..++.++|||||||++|||+|+..|+.... ...+.+..+
T Consensus 157 -----------------~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~----~~~~~~~~i 215 (263)
T d1sm2a_ 157 -----------------TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR----SNSEVVEDI 215 (263)
T ss_dssp -------------------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSC----CHHHHHHHH
T ss_pred -----------------eeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCC----CHHHHHHHH
Confidence 11123457888999999999999999999999999999999544442221 112223333
Q ss_pred HhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccc
Q 042348 613 LEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRVNI 670 (686)
Q Consensus 613 ~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~ 670 (686)
..+... ..|. .+..++.+++.+||+.||++||||+||+++|++|.+
T Consensus 216 ~~~~~~----~~p~--------~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 216 STGFRL----YKPR--------LASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp HHTCCC----CCCT--------TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HhcCCC----CCcc--------ccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 333221 1111 122467899999999999999999999999999864
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-52 Score=418.57 Aligned_cols=254 Identities=23% Similarity=0.413 Sum_probs=197.8
Q ss_pred cccCccCceEEEEEEeCCCceEEEEEcCCC--CccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCCH
Q 042348 373 FLLGKSTIGIVYKVALNNEEAVAVRRLGNG--GWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSL 450 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL 450 (686)
+.||+|+||.||+|++++ .||||+++.. .....+.|.+|++++++++|||||++++++. .+..++|||||++|+|
T Consensus 14 ~~lG~G~fg~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~~lv~Ey~~~g~L 90 (276)
T d1uwha_ 14 QRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIVTQWCEGSSL 90 (276)
T ss_dssp SEEEECSSCEEEEEESSS--EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEECCCEEEH
T ss_pred EEEeeCCCcEEEEEEECC--EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccEEEEEEecCCCCCH
Confidence 469999999999998753 5999998654 3445678999999999999999999999875 4568999999999999
Q ss_pred HHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCcc
Q 042348 451 ATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPE 530 (686)
Q Consensus 451 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 530 (686)
.++++... ..+++.++..|+.|||+||+|||+ ++||||||||+|||++.++.+||+|||+|+........
T Consensus 91 ~~~l~~~~-----~~~~~~~~~~i~~qi~~gl~yLH~---~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~-- 160 (276)
T d1uwha_ 91 YHHLHIIE-----TKFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGS-- 160 (276)
T ss_dssp HHHHHTSC-----CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTSSEEECCCCCSCC---------
T ss_pred HHHHhhcc-----CCCCHHHHHHHHHHHHHHHHHHhc---CCEeccccCHHHEEEcCCCCEEEccccceeeccccCCc--
Confidence 99998654 459999999999999999999999 89999999999999999999999999999865432211
Q ss_pred ccccccccCCCCCCCccccccccCCCCCccccCcccccC---CCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHH
Q 042348 531 VHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKV---RKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQ 607 (686)
Q Consensus 531 ~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~ 607 (686)
.......||+.|+|||++.+ ..|+.++|||||||++|||+||+.||.......
T Consensus 161 -------------------~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~----- 216 (276)
T d1uwha_ 161 -------------------HQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD----- 216 (276)
T ss_dssp ------------------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH-----
T ss_pred -------------------ccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHH-----
Confidence 12234567889999999864 358999999999999999999999996543322
Q ss_pred HHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccc
Q 042348 608 WIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRVNI 670 (686)
Q Consensus 608 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~ 670 (686)
.+..........+... ... .....++.+++.+||+.||++|||++||+++|+.+..
T Consensus 217 ~~~~~~~~~~~~p~~~--~~~-----~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~ 272 (276)
T d1uwha_ 217 QIIFMVGRGYLSPDLS--KVR-----SNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR 272 (276)
T ss_dssp HHHHHHHHTSCCCCGG--GSC-----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHhcCCCCCcch--hcc-----ccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 1222222221111110 000 1123468899999999999999999999999998764
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-51 Score=414.46 Aligned_cols=253 Identities=28% Similarity=0.406 Sum_probs=203.5
Q ss_pred cccCccCceEEEEEEeCCCceEEEEEcCCCCccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCCHHH
Q 042348 373 FLLGKSTIGIVYKVALNNEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLAT 452 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL~~ 452 (686)
+.||+|+||.||+|.+++++.||||+++... ...++|.+|++++++++|||||++++++. .+..++|||||++|+|.+
T Consensus 19 ~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~-~~~~~iv~Ey~~~g~L~~ 96 (272)
T d1qpca_ 19 ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYMENGSLVD 96 (272)
T ss_dssp EEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCTTCBHHH
T ss_pred EEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeec-cCCeEEEEEeCCCCcHHH
Confidence 4699999999999999988899999997654 34578999999999999999999999875 456799999999999999
Q ss_pred HhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCcccc
Q 042348 453 AIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVH 532 (686)
Q Consensus 453 ~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 532 (686)
++..... ..++|.++++|+.||++||+|||+ ++|+||||||+|||+++++.+||+|||+|+.......
T Consensus 97 ~~~~~~~----~~l~~~~~~~i~~qi~~gl~~lH~---~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~----- 164 (272)
T d1qpca_ 97 FLKTPSG----IKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY----- 164 (272)
T ss_dssp HTTSHHH----HTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE-----
T ss_pred HHhhcCC----CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCccchhheeeecccceeeccccceEEccCCcc-----
Confidence 8875432 359999999999999999999999 8999999999999999999999999999987643221
Q ss_pred ccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHHHHHH
Q 042348 533 WEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQWIQLI 612 (686)
Q Consensus 533 ~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~ 612 (686)
.......||..|+|||++.+..++.++|||||||++|||+||..|+...... .+..+.+
T Consensus 165 -----------------~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~----~~~~~~i 223 (272)
T d1qpca_ 165 -----------------TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN----PEVIQNL 223 (272)
T ss_dssp -----------------ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH----HHHHHHH
T ss_pred -----------------ccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCH----HHHHHHH
Confidence 1122346788899999999889999999999999999999976665332221 2223333
Q ss_pred HhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccccc
Q 042348 613 LEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRVNIST 672 (686)
Q Consensus 613 ~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~~~ 672 (686)
..+..+. .| .....++.+++.+||+.||++||||+||++.|+++-.++
T Consensus 224 ~~~~~~~----~p--------~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ftst 271 (272)
T d1qpca_ 224 ERGYRMV----RP--------DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT 271 (272)
T ss_dssp HTTCCCC----CC--------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred HhcCCCC----Cc--------ccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhcC
Confidence 3322111 01 112236789999999999999999999999999875443
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-51 Score=407.40 Aligned_cols=240 Identities=25% Similarity=0.380 Sum_probs=200.3
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCC---CccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCC
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNG---GWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNG 448 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~g 448 (686)
+.||+|+||.||+|+.. +++.||+|++... .....+.+.+|++++++++|||||++++++.+.+..++|||||++|
T Consensus 12 ~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmEy~~~g 91 (263)
T d2j4za1 12 RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLG 91 (263)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTC
T ss_pred EEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEeecCCC
Confidence 46999999999999975 5889999998643 2233567899999999999999999999999999999999999999
Q ss_pred CHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCC
Q 042348 449 SLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEET 528 (686)
Q Consensus 449 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 528 (686)
+|.+++... ..+++.++..|+.||+.||+|||+ ++||||||||+|||++.++.+||+|||+|+......
T Consensus 92 ~L~~~l~~~------~~l~e~~~~~i~~qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~-- 160 (263)
T d2j4za1 92 TVYRELQKL------SKFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR-- 160 (263)
T ss_dssp BHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC--
T ss_pred cHHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeeeeccccceecCCCCEeecccceeeecCCCc--
Confidence 999999864 469999999999999999999999 899999999999999999999999999997543211
Q ss_pred ccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHH
Q 042348 529 PEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQW 608 (686)
Q Consensus 529 ~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~ 608 (686)
.....||+.|+|||++.+..++.++|||||||++|||+||+.||.... ..+.
T Consensus 161 -----------------------~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~-----~~~~ 212 (263)
T d2j4za1 161 -----------------------RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT-----YQET 212 (263)
T ss_dssp -----------------------CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS-----HHHH
T ss_pred -----------------------ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCC-----HHHH
Confidence 123468889999999999999999999999999999999999995432 2223
Q ss_pred HHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 609 IQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 609 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
...+.......++. ...++.+++.+||+.||++|||++|++++
T Consensus 213 ~~~i~~~~~~~p~~-------------~s~~~~~li~~~L~~dp~~R~t~~eil~h 255 (263)
T d2j4za1 213 YKRISRVEFTFPDF-------------VTEGARDLISRLLKHNPSQRPMLREVLEH 255 (263)
T ss_dssp HHHHHTTCCCCCTT-------------SCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred HHHHHcCCCCCCcc-------------CCHHHHHHHHHHccCCHhHCcCHHHHHcC
Confidence 34444433322221 12357789999999999999999999864
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.7e-51 Score=416.37 Aligned_cols=255 Identities=27% Similarity=0.481 Sum_probs=196.0
Q ss_pred cccCccCceEEEEEEeCC-C---ceEEEEEcCCC-CccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCC
Q 042348 373 FLLGKSTIGIVYKVALNN-E---EAVAVRRLGNG-GWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPN 447 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~~-~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~ 447 (686)
+.||+|+||+||+|.+.. + ..||||.+... .....++|.+|+++|++++|||||+++|++...+..++|||||++
T Consensus 32 ~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv~Ey~~~ 111 (299)
T d1jpaa_ 32 QVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMEN 111 (299)
T ss_dssp EEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTT
T ss_pred eEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEecCC
Confidence 479999999999998753 2 36899998764 334457899999999999999999999999999999999999999
Q ss_pred CCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccC
Q 042348 448 GSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEE 527 (686)
Q Consensus 448 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 527 (686)
|+|.+++.... ..++|.++..|+.|||.||+|||+ ++|+||||||+|||++.++.+||+|||+|+.......
T Consensus 112 g~L~~~~~~~~-----~~l~~~~~~~i~~qia~gl~yLH~---~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~ 183 (299)
T d1jpaa_ 112 GSLDSFLRQND-----GQFTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS 183 (299)
T ss_dssp EEHHHHHHTTT-----TCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC-----------
T ss_pred Ccceeeecccc-----CCCCHHHHHHHHHHHHHHHHHHhh---CCCccCccccceEEECCCCcEEECCcccceEccCCCC
Confidence 99999988654 469999999999999999999999 8999999999999999999999999999987654322
Q ss_pred CccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCccccCccchhHH
Q 042348 528 TPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQIGSMELNIV 606 (686)
Q Consensus 528 ~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~~~~~ 606 (686)
... ........||..|+|||.+.+..++.++|||||||++|||+| |+.||......
T Consensus 184 ~~~------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~----- 240 (299)
T d1jpaa_ 184 DPT------------------YTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ----- 240 (299)
T ss_dssp ------------------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-----
T ss_pred cce------------------eeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHH-----
Confidence 110 011123456888999999999999999999999999999998 89999554322
Q ss_pred HHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccc
Q 042348 607 QWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRVNI 670 (686)
Q Consensus 607 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~ 670 (686)
+.+..+..+... +. .......+.+++.+||+.||++||||.||++.|+++..
T Consensus 241 ~~~~~i~~~~~~-~~-----------~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~ 292 (299)
T d1jpaa_ 241 DVINAIEQDYRL-PP-----------PMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292 (299)
T ss_dssp HHHHHHHTTCCC-CC-----------CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHcCCCC-CC-----------CccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 223333332211 10 01123467899999999999999999999999998753
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-50 Score=410.52 Aligned_cols=243 Identities=22% Similarity=0.390 Sum_probs=201.6
Q ss_pred ccCccCceEEEEEEeC-CCceEEEEEcCCCCccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCCHHH
Q 042348 374 LLGKSTIGIVYKVALN-NEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLAT 452 (686)
Q Consensus 374 ~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL~~ 452 (686)
.||+|+||+||+|... +|+.||||++........+.+.+|++++++++|||||++++++.+.+..++|||||++|+|.+
T Consensus 27 ~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~~ 106 (293)
T d1yhwa1 27 KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTD 106 (293)
T ss_dssp ECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHH
T ss_pred EEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEecCCCcHHH
Confidence 5999999999999864 689999999976655566789999999999999999999999999999999999999999999
Q ss_pred HhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCcccc
Q 042348 453 AIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVH 532 (686)
Q Consensus 453 ~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 532 (686)
++... .+++.++..|+.||+.||+|||+ ++||||||||+|||++.++++||+|||+|+.+.....
T Consensus 107 ~~~~~-------~l~~~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~----- 171 (293)
T d1yhwa1 107 VVTET-------CMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS----- 171 (293)
T ss_dssp HHHHS-------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-----
T ss_pred Hhhcc-------CCCHHHHHHHHHHHHHHHHHHHH---CCCcccCCcHHHeEECCCCcEeeccchhheeeccccc-----
Confidence 88653 58999999999999999999999 8999999999999999999999999999986543211
Q ss_pred ccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHHHHHH
Q 042348 533 WEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQWIQLI 612 (686)
Q Consensus 533 ~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~ 612 (686)
.....+||+.|+|||++.+..|+.++|||||||++|||+||+.||...... ..+...
T Consensus 172 ------------------~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~-----~~~~~~ 228 (293)
T d1yhwa1 172 ------------------KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL-----RALYLI 228 (293)
T ss_dssp ------------------CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-----HHHHHH
T ss_pred ------------------cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHH-----HHHHHH
Confidence 123456888999999999999999999999999999999999999543321 222333
Q ss_pred HhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 613 LEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 613 ~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
.....+... .+ ......+.+++.+||+.||++|||+.|+++|
T Consensus 229 ~~~~~~~~~--~~--------~~~s~~~~~li~~~L~~dP~~R~s~~eil~H 270 (293)
T d1yhwa1 229 ATNGTPELQ--NP--------EKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (293)
T ss_dssp HHHCSCCCS--SG--------GGSCHHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred HhCCCCCCC--Cc--------ccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 333221111 00 1122457799999999999999999999875
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-51 Score=411.67 Aligned_cols=247 Identities=24% Similarity=0.310 Sum_probs=196.8
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCC-ccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCCH
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGG-WQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSL 450 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL 450 (686)
+.||+|+||+||+|+.. +++.||||++.... ....+++.+|++++++++|||||++++++.+.+..++|||||++|+|
T Consensus 11 ~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L 90 (271)
T d1nvra_ 11 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL 90 (271)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEG
T ss_pred EEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEeccCCCcH
Confidence 46999999999999975 68899999986543 23346799999999999999999999999999999999999999999
Q ss_pred HHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCcc
Q 042348 451 ATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPE 530 (686)
Q Consensus 451 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 530 (686)
.+++... ..+++.++..|+.|++.||+|||+ ++|+||||||+|||+++++.+||+|||+|+........
T Consensus 91 ~~~l~~~------~~l~e~~~~~i~~qi~~al~ylH~---~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~-- 159 (271)
T d1nvra_ 91 FDRIEPD------IGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE-- 159 (271)
T ss_dssp GGGSBTT------TBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEE--
T ss_pred HHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHH---cCCccCcccHHHEEECCCCCEEEccchhheeeccCCcc--
Confidence 9999754 469999999999999999999999 89999999999999999999999999999876432210
Q ss_pred ccccccccCCCCCCCccccccccCCCCCccccCcccccCCCC-CCcchHHHHHHHHHHHHhCCCCccccCccchhHHHHH
Q 042348 531 VHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKP-TQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQWI 609 (686)
Q Consensus 531 ~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~ 609 (686)
......+||+.|+|||++.+..+ +.++|||||||++|||+||+.||..........
T Consensus 160 -------------------~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~---- 216 (271)
T d1nvra_ 160 -------------------RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY---- 216 (271)
T ss_dssp -------------------CCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHH----
T ss_pred -------------------ccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHH----
Confidence 11234678999999999988775 678999999999999999999996544332211
Q ss_pred HHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 610 QLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 610 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
...... ..... + ......++.+++.+||+.||++|||++|++++
T Consensus 217 ~~~~~~-~~~~~---~-------~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 260 (271)
T d1nvra_ 217 SDWKEK-KTYLN---P-------WKKIDSAPLALLHKILVENPSARITIPDIKKD 260 (271)
T ss_dssp HHHHTT-CTTST---T-------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred HHHhcC-CCCCC---c-------cccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 111111 11110 0 01112357789999999999999999999764
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-51 Score=412.59 Aligned_cols=246 Identities=22% Similarity=0.365 Sum_probs=202.8
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCCccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCCHH
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLA 451 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL~ 451 (686)
..||+|+||.||+|+.. +++.||||++........+.+.+|+++|++++|||||++++++.+.+..++|||||++|+|.
T Consensus 18 ~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~~g~L~ 97 (288)
T d2jfla1 18 GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVD 97 (288)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHH
T ss_pred EEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCCCCcHH
Confidence 35999999999999975 58899999998766667788999999999999999999999999999999999999999999
Q ss_pred HHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCccc
Q 042348 452 TAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEV 531 (686)
Q Consensus 452 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 531 (686)
+++.... ..+++.++..|+.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+|+......
T Consensus 98 ~~~~~~~-----~~l~e~~~~~i~~qi~~gL~ylH~---~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~----- 164 (288)
T d2jfla1 98 AVMLELE-----RPLTESQIQVVCKQTLDALNYLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI----- 164 (288)
T ss_dssp HHHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH-----
T ss_pred HHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHH---CCEEEeecChhheeECCCCCEEEEechhhhccCCCc-----
Confidence 9987543 469999999999999999999999 899999999999999999999999999997653221
Q ss_pred cccccccCCCCCCCccccccccCCCCCccccCccccc-----CCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHH
Q 042348 532 HWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASK-----VRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIV 606 (686)
Q Consensus 532 ~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~ 606 (686)
.......||+.|+|||++. ...|+.++|||||||++|||+||+.||......+
T Consensus 165 ------------------~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~---- 222 (288)
T d2jfla1 165 ------------------QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR---- 222 (288)
T ss_dssp ------------------HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG----
T ss_pred ------------------ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHH----
Confidence 1123456888999999873 4568999999999999999999999996544332
Q ss_pred HHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 607 QWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 607 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
.+..+.....+... .+ .....++.+++.+||+.||++|||+.|++++
T Consensus 223 -~~~~i~~~~~~~~~--~~--------~~~s~~~~~li~~~L~~dp~~R~t~~ell~h 269 (288)
T d2jfla1 223 -VLLKIAKSEPPTLA--QP--------SRWSSNFKDFLKKCLEKNVDARWTTSQLLQH 269 (288)
T ss_dssp -HHHHHHHSCCCCCS--SG--------GGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred -HHHHHHcCCCCCCC--cc--------ccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 12333333222111 11 1123467899999999999999999999875
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=6.6e-51 Score=413.35 Aligned_cols=252 Identities=25% Similarity=0.352 Sum_probs=205.1
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCCccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCCHH
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLA 451 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL~ 451 (686)
+.||+|+||+||+|.+. +++.||||+++... ...++|.+|+++|++++|||||+++++|.+.+..++|||||++|+|.
T Consensus 23 ~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~ 101 (287)
T d1opja_ 23 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLL 101 (287)
T ss_dssp EETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHH
T ss_pred eEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeecccCcchH
Confidence 46999999999999976 47889999997653 34578999999999999999999999999999999999999999999
Q ss_pred HHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCccc
Q 042348 452 TAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEV 531 (686)
Q Consensus 452 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 531 (686)
+++..... ..+++..+..|+.|||.||+|||+ ++|+||||||+|||+++++.+||+|||+|+.......
T Consensus 102 ~~l~~~~~----~~~~~~~~~~i~~qi~~gL~yLH~---~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~---- 170 (287)
T d1opja_ 102 DYLRECNR----QEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY---- 170 (287)
T ss_dssp HHHHHSCT----TTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSS----
T ss_pred HHhhhccc----cchHHHHHHHHHHHHHHHHHHHHH---CCcccCccccCeEEECCCCcEEEccccceeecCCCCc----
Confidence 99976543 468999999999999999999999 8999999999999999999999999999986543211
Q ss_pred cccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHHHHH
Q 042348 532 HWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQWIQL 611 (686)
Q Consensus 532 ~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~ 611 (686)
.......||..|+|||++.+..|+.++|||||||++|||++|..||..... .....+.
T Consensus 171 ------------------~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~----~~~~~~~ 228 (287)
T d1opja_ 171 ------------------TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID----LSQVYEL 228 (287)
T ss_dssp ------------------EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCC----HHHHHHH
T ss_pred ------------------eeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcch----HHHHHHH
Confidence 112234567889999999999999999999999999999998777643222 1122222
Q ss_pred HHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccc
Q 042348 612 ILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRVNI 670 (686)
Q Consensus 612 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~ 670 (686)
+..+ ... + .. .....++.+++.+||+.||++|||++||++.|+.+..
T Consensus 229 i~~~-~~~-~-----~~-----~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~ 275 (287)
T d1opja_ 229 LEKD-YRM-E-----RP-----EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275 (287)
T ss_dssp HHTT-CCC-C-----CC-----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred HhcC-CCC-C-----CC-----ccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 2222 111 1 00 1122468899999999999999999999999998754
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-50 Score=400.96 Aligned_cols=248 Identities=24% Similarity=0.371 Sum_probs=206.5
Q ss_pred cccCccCceEEEEEEeCCCceEEEEEcCCCCccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCCHHH
Q 042348 373 FLLGKSTIGIVYKVALNNEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLAT 452 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL~~ 452 (686)
+.||+|+||+||+|++++++.||||+++.... ..++|.+|+.++++++|||||+++|+|.+.+..++||||+++|+|.+
T Consensus 10 ~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g~l~~ 88 (258)
T d1k2pa_ 10 KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLN 88 (258)
T ss_dssp CCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTTEEHHH
T ss_pred EEEecCCCeEEEEEEECCCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCCCcHHH
Confidence 36999999999999998888999999976543 34789999999999999999999999999999999999999999999
Q ss_pred HhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCcccc
Q 042348 453 AIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVH 532 (686)
Q Consensus 453 ~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 532 (686)
++.... ..+++..+.+|+.|+++||+|||+ ++|+||||||+||++++++.+||+|||+++.......
T Consensus 89 ~~~~~~-----~~~~~~~~~~i~~qi~~gl~~LH~---~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~----- 155 (258)
T d1k2pa_ 89 YLREMR-----HRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY----- 155 (258)
T ss_dssp HHHSGG-----GCCCHHHHHHHHHHHHHHHHHHHH---TTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSC-----
T ss_pred hhhccc-----cCCcHHHHHHHHHHHHHHHHHHhh---cCcccccccceeEEEcCCCcEEECcchhheeccCCCc-----
Confidence 987654 468999999999999999999999 8999999999999999999999999999986543221
Q ss_pred ccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCccccCccchhHHHHHHH
Q 042348 533 WEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQIGSMELNIVQWIQL 611 (686)
Q Consensus 533 ~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~ 611 (686)
.......+|..|+|||.+.+..++.++|||||||++|||+| |+.||...... +....
T Consensus 156 -----------------~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~-----~~~~~ 213 (258)
T d1k2pa_ 156 -----------------TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS-----ETAEH 213 (258)
T ss_dssp -----------------CCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHH-----HHHHH
T ss_pred -----------------eeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHH-----HHHHH
Confidence 11223457888999999999999999999999999999998 89999654322 22333
Q ss_pred HHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 042348 612 ILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRV 668 (686)
Q Consensus 612 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i 668 (686)
+...... ..|. ....++.+++.+||+.||++|||++||+++|.+|
T Consensus 214 i~~~~~~----~~p~--------~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 214 IAQGLRL----YRPH--------LASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp HHTTCCC----CCCT--------TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred HHhCCCC----CCcc--------cccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 3332211 1111 1224688999999999999999999999999765
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-50 Score=410.18 Aligned_cols=251 Identities=25% Similarity=0.382 Sum_probs=202.6
Q ss_pred cCccCceEEEEEEeC---CCceEEEEEcCCCC-ccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCCH
Q 042348 375 LGKSTIGIVYKVALN---NEEAVAVRRLGNGG-WQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSL 450 (686)
Q Consensus 375 iG~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL 450 (686)
||+|+||.||+|.++ ++..||||+++... ....++|.+|+++|++++|||||+++|++.+ +..++|||||++|+|
T Consensus 17 iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvmE~~~~g~L 95 (285)
T d1u59a_ 17 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPL 95 (285)
T ss_dssp EECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTTEEH
T ss_pred EecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEEEEeCCCCcH
Confidence 899999999999764 34579999997643 3446789999999999999999999999865 568999999999999
Q ss_pred HHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCcc
Q 042348 451 ATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPE 530 (686)
Q Consensus 451 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 530 (686)
.+++.... ..+++.++.+|+.|||.||+|||+ ++|+||||||+|||++.++.+||+|||+|+.+......
T Consensus 96 ~~~l~~~~-----~~l~~~~~~~i~~qi~~gL~ylH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~-- 165 (285)
T d1u59a_ 96 HKFLVGKR-----EEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSY-- 165 (285)
T ss_dssp HHHHTTCT-----TTSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCE--
T ss_pred HHHhhccc-----cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCcCchhheeeccCCceeeccchhhhcccccccc--
Confidence 99987654 469999999999999999999999 89999999999999999999999999999876432210
Q ss_pred ccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCccccCccchhHHHHH
Q 042348 531 VHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQIGSMELNIVQWI 609 (686)
Q Consensus 531 ~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~~~~~~~~ 609 (686)
........||+.|+|||++.+..++.++|||||||++|||+| |+.||...... +..
T Consensus 166 ------------------~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~-----~~~ 222 (285)
T d1u59a_ 166 ------------------YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP-----EVM 222 (285)
T ss_dssp ------------------ECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH-----HHH
T ss_pred ------------------cccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH-----HHH
Confidence 011223457888999999998899999999999999999998 99999654322 222
Q ss_pred HHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccccc
Q 042348 610 QLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRVNIS 671 (686)
Q Consensus 610 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~~ 671 (686)
..+..+..+ +. . +....++.+++.+||+.||++|||+.+|++.|+.+-.+
T Consensus 223 ~~i~~~~~~--~~-p---------~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 223 AFIEQGKRM--EC-P---------PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp HHHHTTCCC--CC-C---------TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHcCCCC--CC-C---------CcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 333333211 10 0 11234678999999999999999999999999876543
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-50 Score=406.81 Aligned_cols=255 Identities=25% Similarity=0.397 Sum_probs=198.0
Q ss_pred cccCccCceEEEEEEeCCC-----ceEEEEEcCCCC-ccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccC
Q 042348 373 FLLGKSTIGIVYKVALNNE-----EAVAVRRLGNGG-WQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIP 446 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~~~-----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~ 446 (686)
++||+|+||.||+|.++.. ..||||++.... .....+|.+|++++++++|||||+++|++.+.+..++|||||.
T Consensus 13 ~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v~e~~~ 92 (283)
T d1mqba_ 13 KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYME 92 (283)
T ss_dssp EEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred eEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEEEEEecc
Confidence 5799999999999987642 479999997543 3344679999999999999999999999999999999999999
Q ss_pred CCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCccccccccc
Q 042348 447 NGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAE 526 (686)
Q Consensus 447 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~ 526 (686)
+|++.+++.... ..++|.++.+|+.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+|+......
T Consensus 93 ~~~l~~~~~~~~-----~~~~~~~~~~i~~~i~~gl~~lH~---~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~ 164 (283)
T d1mqba_ 93 NGALDKFLREKD-----GEFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 164 (283)
T ss_dssp TEEHHHHHHHTT-----TCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC--------
T ss_pred cCcchhhhhccc-----ccccHHHHHHHHHHHHHhhhhccc---cccccCccccceEEECCCCeEEEcccchhhcccCCC
Confidence 999999887654 469999999999999999999999 899999999999999999999999999998765322
Q ss_pred CCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHH
Q 042348 527 ETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIV 606 (686)
Q Consensus 527 ~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~ 606 (686)
... .......||..|+|||++.+..++.++|||||||++|||+||..|+...... .
T Consensus 165 ~~~--------------------~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~----~ 220 (283)
T d1mqba_ 165 EAT--------------------YTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN----H 220 (283)
T ss_dssp -----------------------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH----H
T ss_pred ccc--------------------eEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCH----H
Confidence 110 1122345788899999999999999999999999999999976666432221 2
Q ss_pred HHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccccc
Q 042348 607 QWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRVNIS 671 (686)
Q Consensus 607 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~~ 671 (686)
+....+..+..+ . . ......++.+++.+||+.||++||||.||++.|+++...
T Consensus 221 ~~~~~i~~~~~~-~------~-----~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 221 EVMKAINDGFRL-P------T-----PMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp HHHHHHHTTCCC-C------C-----CTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred HHHHHHhccCCC-C------C-----chhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence 222333222111 1 0 011234688999999999999999999999999987643
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-50 Score=404.16 Aligned_cols=250 Identities=21% Similarity=0.311 Sum_probs=188.4
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCC--ccchHHHHHHHHHHhccCCCCcceeeEEEEe--cCceeEEEeccCC
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGG--WQRFKEFQTEAEAIGKIRHPNIVSLRAYFWS--VDEKLLIYDYIPN 447 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~--~~~~~lV~e~~~~ 447 (686)
+.||+|+||.||+|+.. +|+.||||.+.... ....+.+.+|++++++++|||||++++++.+ .+..++|||||++
T Consensus 10 ~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivmEy~~~ 89 (269)
T d2java1 10 YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEG 89 (269)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEEECCTT
T ss_pred EEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEEecCCC
Confidence 36999999999999875 68899999987653 3345678999999999999999999999865 4567999999999
Q ss_pred CCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccC--CCCceecCCCCCCeeecCCCCeEEeecCcccccccc
Q 042348 448 GSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVS--PKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIA 525 (686)
Q Consensus 448 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~--~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~ 525 (686)
|+|.+++...... ...+++..++.|+.|++.||+|||+.. ..+||||||||+|||++.++.+||+|||+|+.....
T Consensus 90 g~L~~~i~~~~~~--~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~ 167 (269)
T d2java1 90 GDLASVITKGTKE--RQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD 167 (269)
T ss_dssp EEHHHHHHHHHHH--TCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHHC---
T ss_pred CcHHHHHHhcccc--CCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeecccC
Confidence 9999998753211 146999999999999999999999832 124999999999999999999999999999876432
Q ss_pred cCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhH
Q 042348 526 EETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNI 605 (686)
Q Consensus 526 ~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~ 605 (686)
.. ......||+.|+|||++.+..|+.++|||||||++|||+||+.||.....
T Consensus 168 ~~-----------------------~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~----- 219 (269)
T d2java1 168 TS-----------------------FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ----- 219 (269)
T ss_dssp -------------------------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH-----
T ss_pred CC-----------------------ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCH-----
Confidence 11 12245678889999999999999999999999999999999999954322
Q ss_pred HHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 606 VQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 606 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
.+....+.....+ .+ . .. ...++.+++.+||+.||++|||+.|++++
T Consensus 220 ~~~~~~i~~~~~~--~~-~----~~-----~s~~l~~li~~~L~~dp~~Rps~~ell~h 266 (269)
T d2java1 220 KELAGKIREGKFR--RI-P----YR-----YSDELNEIITRMLNLKDYHRPSVEEILEN 266 (269)
T ss_dssp HHHHHHHHHTCCC--CC-C----TT-----SCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHHcCCCC--CC-C----cc-----cCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 2223333333211 11 0 11 12357889999999999999999999864
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-50 Score=404.97 Aligned_cols=248 Identities=23% Similarity=0.320 Sum_probs=197.1
Q ss_pred ccCccCceEEEEEEeCC---CceEEEEEcCCCC--ccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCC
Q 042348 374 LLGKSTIGIVYKVALNN---EEAVAVRRLGNGG--WQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNG 448 (686)
Q Consensus 374 ~iG~G~~g~Vy~~~~~~---~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~g 448 (686)
.||+|+||.||+|.+++ ++.||||+++... ....++|.+|+++|++++|||||+++++|.. +..++|||||++|
T Consensus 14 ~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~g 92 (277)
T d1xbba_ 14 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAELG 92 (277)
T ss_dssp EEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTTE
T ss_pred CcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCCC
Confidence 59999999999998653 4679999996532 2335679999999999999999999999864 5678999999999
Q ss_pred CHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCC
Q 042348 449 SLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEET 528 (686)
Q Consensus 449 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 528 (686)
+|.++++.. ..+++.+++.|+.||+.||+|||+ ++||||||||+|||++.++.+||+|||+|+........
T Consensus 93 ~L~~~l~~~------~~l~~~~~~~i~~qi~~gl~ylH~---~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~ 163 (277)
T d1xbba_ 93 PLNKYLQQN------RHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 163 (277)
T ss_dssp EHHHHHHHC------TTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSE
T ss_pred cHHHHHhhc------cCCCHHHHHHHHHHHHHHHhhHHh---CCcccCCCcchhhcccccCcccccchhhhhhccccccc
Confidence 999999865 469999999999999999999999 89999999999999999999999999999866432210
Q ss_pred ccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCccccCccchhHHH
Q 042348 529 PEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQIGSMELNIVQ 607 (686)
Q Consensus 529 ~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~~~~~~ 607 (686)
........||+.|+|||.+.+..++.++|||||||++|||+| |+.||...... +
T Consensus 164 --------------------~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~-----~ 218 (277)
T d1xbba_ 164 --------------------YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS-----E 218 (277)
T ss_dssp --------------------EEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-----H
T ss_pred --------------------cccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHH-----H
Confidence 011223467888999999998999999999999999999998 89999653321 2
Q ss_pred HHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 042348 608 WIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRV 668 (686)
Q Consensus 608 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i 668 (686)
....+..+..+ +. . .....++.+++.+||+.||++|||++||++.|+..
T Consensus 219 ~~~~i~~~~~~--~~-p---------~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~ 267 (277)
T d1xbba_ 219 VTAMLEKGERM--GC-P---------AGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 267 (277)
T ss_dssp HHHHHHTTCCC--CC-C---------TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred HHHHHHcCCCC--CC-C---------cccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCH
Confidence 22233222211 00 0 11234678999999999999999999999988775
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-50 Score=404.02 Aligned_cols=261 Identities=28% Similarity=0.427 Sum_probs=205.9
Q ss_pred cccCccCceEEEEEEeCCCceEEEEEcCCCCccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCCHHH
Q 042348 373 FLLGKSTIGIVYKVALNNEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLAT 452 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL~~ 452 (686)
..||+|+||.||+|..++++.||||+++... ...++|.+|+.++++++|||||++++++. .+..++|||||++|+|.+
T Consensus 23 ~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~Ey~~~g~l~~ 100 (285)
T d1fmka3 23 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMSKGSLLD 100 (285)
T ss_dssp EEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEECCCTTCBHHH
T ss_pred eEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEEEecCCCchhh
Confidence 4699999999999999988889999997654 34578999999999999999999999985 466899999999999999
Q ss_pred HhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCcccc
Q 042348 453 AIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEVH 532 (686)
Q Consensus 453 ~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 532 (686)
++..... ..++|.+++.|+.||+.||+|||+ ++|+||||||+|||++.++++||+|||+|+.......
T Consensus 101 ~~~~~~~----~~l~~~~~~~i~~~i~~gl~~LH~---~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~----- 168 (285)
T d1fmka3 101 FLKGETG----KYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY----- 168 (285)
T ss_dssp HHSHHHH----TTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCTTC------------
T ss_pred hhhhccc----ccchHHHHHHHHHHHHHHHHHHhh---hheecccccceEEEECCCCcEEEcccchhhhccCCCc-----
Confidence 9876432 469999999999999999999999 8999999999999999999999999999986543221
Q ss_pred ccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHHHHHH
Q 042348 533 WEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQWIQLI 612 (686)
Q Consensus 533 ~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~ 612 (686)
.......||..|+|||++....++.++|||||||++|||+||..|+...... .+.+..+
T Consensus 169 -----------------~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~----~~~~~~i 227 (285)
T d1fmka3 169 -----------------TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN----REVLDQV 227 (285)
T ss_dssp ------------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH----HHHHHHH
T ss_pred -----------------eeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCH----HHHHHHH
Confidence 1122345788899999999999999999999999999999977776433221 2222333
Q ss_pred HhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccccchhhhhccC
Q 042348 613 LEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRVNISTEQQFMKGE 680 (686)
Q Consensus 613 ~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~~~~~~~~~~~ 680 (686)
..+... + ..+ ....++.+++.+||+.||++||||++|++.|++.-...+.++++++
T Consensus 228 ~~~~~~--~-~~~---------~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~p~~~p~~ 283 (285)
T d1fmka3 228 ERGYRM--P-CPP---------ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPGE 283 (285)
T ss_dssp HTTCCC--C-CCT---------TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCCCCCCSC
T ss_pred HhcCCC--C-CCc---------ccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCCCCCCCCC
Confidence 222111 0 111 1234678999999999999999999999999998877777766554
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-50 Score=406.05 Aligned_cols=244 Identities=19% Similarity=0.269 Sum_probs=199.3
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCC---CccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCC
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNG---GWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNG 448 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~g 448 (686)
+.||+|+||.||+|... +++.||||++... .....+.+.+|++++++++|||||++++++.+.+..++|||||++|
T Consensus 14 ~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy~~gg 93 (288)
T d1uu3a_ 14 KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNG 93 (288)
T ss_dssp EEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEECCCTTE
T ss_pred EEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEEccCCC
Confidence 46999999999999875 6889999998643 2234567999999999999999999999999999999999999999
Q ss_pred CHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCC
Q 042348 449 SLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEET 528 (686)
Q Consensus 449 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 528 (686)
+|.+++... ..+++..+..++.|++.||+|||+ ++||||||||+|||+++++.+||+|||+|+.+......
T Consensus 94 ~L~~~~~~~------~~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~ 164 (288)
T d1uu3a_ 94 ELLKYIRKI------GSFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ 164 (288)
T ss_dssp EHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred CHHHhhhcc------CCCCHHHHHHHHHHHHHHHHhhcc---ccEEcCcCCccccccCCCceEEecccccceecccCCcc
Confidence 999998765 469999999999999999999999 89999999999999999999999999999876432211
Q ss_pred ccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHH
Q 042348 529 PEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQW 608 (686)
Q Consensus 529 ~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~ 608 (686)
......+||+.|+|||++.+..|+.++|||||||++|||+||+.||.... ..+.
T Consensus 165 ---------------------~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-----~~~~ 218 (288)
T d1uu3a_ 165 ---------------------ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN-----EYLI 218 (288)
T ss_dssp --------------------------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHH
T ss_pred ---------------------cccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcC-----HHHH
Confidence 12234578999999999999999999999999999999999999995432 2223
Q ss_pred HHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 609 IQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 609 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
...+.......++. ...++.+++.+||+.||++|||++|++++
T Consensus 219 ~~~i~~~~~~~p~~-------------~s~~~~~li~~~L~~dP~~R~t~~e~~~~ 261 (288)
T d1uu3a_ 219 FQKIIKLEYDFPEK-------------FFPKARDLVEKLLVLDATKRLGCEEMEGY 261 (288)
T ss_dssp HHHHHTTCCCCCTT-------------CCHHHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred HHHHHcCCCCCCcc-------------CCHHHHHHHHHHccCCHhHCcCHHHHcCC
Confidence 34444443222211 12357799999999999999999997543
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-49 Score=396.98 Aligned_cols=241 Identities=24% Similarity=0.376 Sum_probs=192.3
Q ss_pred ccCccCceEEEEEEeC-CCceEEEEEcCCC--CccchHHHHHHHHHHhccCCCCcceeeEEEEe----cCceeEEEeccC
Q 042348 374 LLGKSTIGIVYKVALN-NEEAVAVRRLGNG--GWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWS----VDEKLLIYDYIP 446 (686)
Q Consensus 374 ~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~----~~~~~lV~e~~~ 446 (686)
.||+|+||+||+|... +++.||+|.+... .....+.|.+|+++|++++|||||++++++.+ ....++|||||+
T Consensus 16 ~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivmE~~~ 95 (270)
T d1t4ha_ 16 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMT 95 (270)
T ss_dssp EEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECCC
T ss_pred EEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEEeCCC
Confidence 5999999999999875 5789999998654 33345679999999999999999999999875 245789999999
Q ss_pred CCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCC--ceecCCCCCCeeec-CCCCeEEeecCcccccc
Q 042348 447 NGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKR--YVHGDLRPSNILLG-KNMEPHISDFGLARLAD 523 (686)
Q Consensus 447 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~--iiHrDlkp~NILl~-~~~~~kl~DfGla~~~~ 523 (686)
+|+|.+++... ..+++..+..|+.||+.||+|||+ ++ |+||||||+|||++ +++.+||+|||+|+...
T Consensus 96 ~g~L~~~l~~~------~~~~~~~~~~~~~qi~~gl~yLH~---~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~ 166 (270)
T d1t4ha_ 96 SGTLKTYLKRF------KVMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 166 (270)
T ss_dssp SCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred CCcHHHHHhcc------ccccHHHHHHHHHHHHHHHHHHHH---CCCCEEeCCcChhhceeeCCCCCEEEeecCcceecc
Confidence 99999999764 468999999999999999999999 66 99999999999996 57899999999997543
Q ss_pred cccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccch
Q 042348 524 IAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMEL 603 (686)
Q Consensus 524 ~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~ 603 (686)
.. .....+||+.|+|||++.+ .++.++|||||||++|||+||+.||......
T Consensus 167 ~~-------------------------~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~-- 218 (270)
T d1t4ha_ 167 AS-------------------------FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA-- 218 (270)
T ss_dssp TT-------------------------SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH--
T ss_pred CC-------------------------ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccH--
Confidence 11 1123567889999999875 6999999999999999999999999543322
Q ss_pred hHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 604 NIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 604 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
....+.+..+..+ ..++ .. ...++.+++.+||+.||++|||++|+++|
T Consensus 219 --~~~~~~i~~~~~~--~~~~----~~-----~~~~~~~li~~~l~~dp~~R~s~~ell~H 266 (270)
T d1t4ha_ 219 --AQIYRRVTSGVKP--ASFD----KV-----AIPEVKEIIEGCIRQNKDERYSIKDLLNH 266 (270)
T ss_dssp --HHHHHHHTTTCCC--GGGG----GC-----CCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred --HHHHHHHHcCCCC--cccC----cc-----CCHHHHHHHHHHccCCHhHCcCHHHHhCC
Confidence 2222222222111 1111 11 12357789999999999999999999864
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-50 Score=413.74 Aligned_cols=261 Identities=23% Similarity=0.314 Sum_probs=199.0
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCC-ccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCCH
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGG-WQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSL 450 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL 450 (686)
+.||+|+||+||+|... +++.||+|+++... ....+++.+|+.+|++++|||||+++++|.+.+..++|||||++|+|
T Consensus 12 ~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmEy~~gg~L 91 (322)
T d1s9ja_ 12 SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL 91 (322)
T ss_dssp EEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEECCTTEEH
T ss_pred EEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCcH
Confidence 36999999999999975 68899999986542 33356789999999999999999999999999999999999999999
Q ss_pred HHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCcc
Q 042348 451 ATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPE 530 (686)
Q Consensus 451 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 530 (686)
.+++... ..+++..+..++.|++.||+|||+. ++|+||||||+|||+++++.+||+|||+|+......
T Consensus 92 ~~~l~~~------~~l~~~~~~~~~~qil~aL~yLH~~--~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~---- 159 (322)
T d1s9ja_ 92 DQVLKKA------GRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM---- 159 (322)
T ss_dssp HHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHHH--HCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHT----
T ss_pred HHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHHh--CCEEccccCHHHeeECCCCCEEEeeCCCccccCCCc----
Confidence 9999765 3589999999999999999999971 389999999999999999999999999998654221
Q ss_pred ccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHHHH
Q 042348 531 VHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQWIQ 610 (686)
Q Consensus 531 ~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~ 610 (686)
....+||..|+|||++.+..|+.++||||+||++|||++|+.||............. .
T Consensus 160 ---------------------~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~-~ 217 (322)
T d1s9ja_ 160 ---------------------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFG-C 217 (322)
T ss_dssp ---------------------C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC---
T ss_pred ---------------------cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH-H
Confidence 124578899999999999999999999999999999999999996543322111000 0
Q ss_pred HHHhhc---------------------CCcc---cccCcccc---cCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042348 611 LILEDR---------------------KPMT---DILDPFLA---HDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCD 663 (686)
Q Consensus 611 ~~~~~~---------------------~~~~---~~~d~~l~---~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 663 (686)
...... .+.. +..+.... ..........++.+++.+||+.||++|||++|+++
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~ 297 (322)
T d1s9ja_ 218 QVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 297 (322)
T ss_dssp ----------------------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HhcCCcccCCcccccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 000000 0000 00000000 00000011246788999999999999999999998
Q ss_pred H--Hhc
Q 042348 664 S--LDR 667 (686)
Q Consensus 664 ~--L~~ 667 (686)
| +++
T Consensus 298 Hpf~~~ 303 (322)
T d1s9ja_ 298 HAFIKR 303 (322)
T ss_dssp SHHHHH
T ss_pred CHhhCc
Confidence 6 544
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-49 Score=411.22 Aligned_cols=255 Identities=26% Similarity=0.314 Sum_probs=200.2
Q ss_pred hcccCccCceEEEEEEeCC-C-----ceEEEEEcCCC-CccchHHHHHHHHHHhcc-CCCCcceeeEEEEecCceeEEEe
Q 042348 372 AFLLGKSTIGIVYKVALNN-E-----EAVAVRRLGNG-GWQRFKEFQTEAEAIGKI-RHPNIVSLRAYFWSVDEKLLIYD 443 (686)
Q Consensus 372 ~~~iG~G~~g~Vy~~~~~~-~-----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~e 443 (686)
.+.||+|+||+||+|+... + ..||||.+... .......+.+|+.++.++ +|||||++++++.+.+..++|||
T Consensus 42 ~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E 121 (325)
T d1rjba_ 42 GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFE 121 (325)
T ss_dssp EEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred eeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeEEEEEE
Confidence 3579999999999998643 2 36999998654 334456799999999998 89999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCCcc-----------------ccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeec
Q 042348 444 YIPNGSLATAIHGKAGII-----------------SYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLG 506 (686)
Q Consensus 444 ~~~~gsL~~~l~~~~~~~-----------------~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~ 506 (686)
||++|+|.++++...... ....+++..++.|+.||+.||+|||+ ++||||||||+|||++
T Consensus 122 y~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~---~~IiHRDlKp~Nill~ 198 (325)
T d1rjba_ 122 YCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVT 198 (325)
T ss_dssp CCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH---TTEEETTCSGGGEEEE
T ss_pred cCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCchhccccc
Confidence 999999999998754211 11358999999999999999999999 8999999999999999
Q ss_pred CCCCeEEeecCcccccccccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHH
Q 042348 507 KNMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILL 586 (686)
Q Consensus 507 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ 586 (686)
.++.+||+|||+|+........ .......||+.|+|||++.+..++.++|||||||++|
T Consensus 199 ~~~~~Kl~DFGla~~~~~~~~~---------------------~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~ 257 (325)
T d1rjba_ 199 HGKVVKICDFGLARDIMSDSNY---------------------VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLW 257 (325)
T ss_dssp TTTEEEECCCGGGSCGGGCTTS---------------------EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHH
T ss_pred cCCeEEEeeccccccccCCCce---------------------eeeccccCCCccCChHHHcCCCCCcceeccchhHHHH
Confidence 9999999999999865432210 1122345688899999999999999999999999999
Q ss_pred HHHh-CCCCccccCccchhHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 042348 587 EMIS-GKLPMIQIGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSL 665 (686)
Q Consensus 587 ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L 665 (686)
||+| |+.||....... . +..+........ .. .....++.+++.+||+.||++|||++||+++|
T Consensus 258 emlt~g~~Pf~~~~~~~-~----~~~~~~~~~~~~------~p-----~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L 321 (325)
T d1rjba_ 258 EIFSLGVNPYPGIPVDA-N----FYKLIQNGFKMD------QP-----FYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL 321 (325)
T ss_dssp HHTTTSCCSSTTCCCSH-H----HHHHHHTTCCCC------CC-----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHhCCCCCCCCCCHHH-H----HHHHHhcCCCCC------CC-----CcCCHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 9998 899996543322 1 222333322111 00 11224688999999999999999999999999
Q ss_pred h
Q 042348 666 D 666 (686)
Q Consensus 666 ~ 666 (686)
.
T Consensus 322 ~ 322 (325)
T d1rjba_ 322 G 322 (325)
T ss_dssp H
T ss_pred h
Confidence 5
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.8e-49 Score=403.77 Aligned_cols=245 Identities=25% Similarity=0.342 Sum_probs=186.9
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCCc-cchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCCH
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGGW-QRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSL 450 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL 450 (686)
+.||+|+||+||+|+.. +++.||||++..... ...+.+.+|+++|++++|||||++++++.+.+..++|||||++|+|
T Consensus 15 ~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~~~gg~L 94 (307)
T d1a06a_ 15 DVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGEL 94 (307)
T ss_dssp EESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred EEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcH
Confidence 46999999999999875 588999999865432 2345688999999999999999999999999999999999999999
Q ss_pred HHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeec---CCCCeEEeecCcccccccccC
Q 042348 451 ATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLG---KNMEPHISDFGLARLADIAEE 527 (686)
Q Consensus 451 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~---~~~~~kl~DfGla~~~~~~~~ 527 (686)
.+++... ..+++.++..++.||+.||+|||+ ++|+||||||+|||+. +++.+||+|||+|+......
T Consensus 95 ~~~l~~~------~~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~- 164 (307)
T d1a06a_ 95 FDRIVEK------GFYTERDASRLIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS- 164 (307)
T ss_dssp HHHHHTC------SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSTTCCEEECCC-----------
T ss_pred HHhhhcc------cCCCHHHHHHHHHHHHHHHHhhhh---ceeeeEEecccceeecccCCCceEEEeccceeEEccCCC-
Confidence 9999765 469999999999999999999999 9999999999999994 57899999999998654221
Q ss_pred CccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHH
Q 042348 528 TPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQ 607 (686)
Q Consensus 528 ~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~ 607 (686)
.....+||+.|+|||++.+..|+.++|||||||++|||+||+.||..... .+
T Consensus 165 -----------------------~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~-----~~ 216 (307)
T d1a06a_ 165 -----------------------VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEND-----AK 216 (307)
T ss_dssp -------------------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-----HH
T ss_pred -----------------------eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCH-----HH
Confidence 12235688899999999999999999999999999999999999954322 22
Q ss_pred HHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 608 WIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 608 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
....+............+ ....++.+++.+||+.||++|||++|++++
T Consensus 217 ~~~~i~~~~~~~~~~~~~---------~~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 217 LFEQILKAEYEFDSPYWD---------DISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp HHHHHHTTCCCCCTTTTT---------TSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred HHHHHhccCCCCCCcccc---------CCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 233444433222111111 122357899999999999999999999986
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.3e-49 Score=403.39 Aligned_cols=240 Identities=24% Similarity=0.418 Sum_probs=195.9
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCCc---cchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCC
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGGW---QRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNG 448 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~g 448 (686)
+.||+|+||.||+|+.. +++.||||++..... ...+++.+|+++|++++|||||++++++.+.+..++|||||++|
T Consensus 21 ~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g 100 (309)
T d1u5ra_ 21 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGS 100 (309)
T ss_dssp EEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSEE
T ss_pred EEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEEecCCC
Confidence 35999999999999865 688999999865432 23457899999999999999999999999999999999999999
Q ss_pred CHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCC
Q 042348 449 SLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEET 528 (686)
Q Consensus 449 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 528 (686)
+|..++... ..+++.++..|+.||+.||+|||+ ++||||||||+|||++.++.+||+|||+|+.....
T Consensus 101 ~l~~~~~~~------~~l~e~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~--- 168 (309)
T d1u5ra_ 101 ASDLLEVHK------KPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--- 168 (309)
T ss_dssp HHHHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB---
T ss_pred chHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHh---CCEeccCCCcceEEECCCCCEEEeecccccccCCC---
Confidence 998776654 469999999999999999999999 89999999999999999999999999999754311
Q ss_pred ccccccccccCCCCCCCccccccccCCCCCccccCcccccC---CCCCCcchHHHHHHHHHHHHhCCCCccccCccchhH
Q 042348 529 PEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKV---RKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNI 605 (686)
Q Consensus 529 ~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~ 605 (686)
....||+.|+|||++.+ ..|+.++|||||||++|||++|+.||.....
T Consensus 169 ------------------------~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~----- 219 (309)
T d1u5ra_ 169 ------------------------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA----- 219 (309)
T ss_dssp ------------------------CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-----
T ss_pred ------------------------CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCH-----
Confidence 23467889999999854 4589999999999999999999999954322
Q ss_pred HHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 606 VQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 606 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
.+.+..+.....+. ..+. .....+.+++.+||+.||++|||+.|+++|
T Consensus 220 ~~~~~~i~~~~~~~--~~~~---------~~s~~~~~li~~~L~~dP~~Rpt~~ell~H 267 (309)
T d1u5ra_ 220 MSALYHIAQNESPA--LQSG---------HWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (309)
T ss_dssp HHHHHHHHHSCCCC--CSCT---------TSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred HHHHHHHHhCCCCC--CCCC---------CCCHHHHHHHHHHCcCChhHCcCHHHHHhC
Confidence 22233333332221 1111 112367899999999999999999999864
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.1e-48 Score=407.31 Aligned_cols=246 Identities=22% Similarity=0.339 Sum_probs=204.0
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCCccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCCHH
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLA 451 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL~ 451 (686)
+.||+|+||.||+|+.. +|+.||||++........+.+.+|+++|++++|||||++++++.+.+..++|||||++|+|.
T Consensus 32 ~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~ 111 (350)
T d1koaa2 32 EELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELF 111 (350)
T ss_dssp EEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCCCSCBHH
T ss_pred EEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCCHH
Confidence 46999999999999875 68899999998776666778999999999999999999999999999999999999999999
Q ss_pred HHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeec--CCCCeEEeecCcccccccccCCc
Q 042348 452 TAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLG--KNMEPHISDFGLARLADIAEETP 529 (686)
Q Consensus 452 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~--~~~~~kl~DfGla~~~~~~~~~~ 529 (686)
+++.... ..+++.++..|+.||+.||+|||+ ++||||||||+|||++ .++.+||+|||+|+.+....
T Consensus 112 ~~l~~~~-----~~l~e~~~~~i~~qi~~aL~ylH~---~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~--- 180 (350)
T d1koaa2 112 EKVADEH-----NKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ--- 180 (350)
T ss_dssp HHHTCTT-----SCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS---
T ss_pred HHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHh---cCCeeeeechhHeeeccCCCCeEEEeecchheeccccc---
Confidence 9997553 459999999999999999999999 9999999999999995 46789999999998654321
Q ss_pred cccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHHH
Q 042348 530 EVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQWI 609 (686)
Q Consensus 530 ~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~ 609 (686)
......||+.|+|||++.+..++.++|||||||++|||+||+.||..... .+.+
T Consensus 181 ---------------------~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~-----~~~~ 234 (350)
T d1koaa2 181 ---------------------SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND-----DETL 234 (350)
T ss_dssp ---------------------CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHH
T ss_pred ---------------------ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCH-----HHHH
Confidence 11235678889999999999999999999999999999999999954322 2334
Q ss_pred HHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 610 QLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 610 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
..+............+ ....++.+++.+||+.||++|||++|++++
T Consensus 235 ~~i~~~~~~~~~~~~~---------~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 235 RNVKSCDWNMDDSAFS---------GISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp HHHHHTCCCSCCGGGG---------GCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred HHHHhCCCCCCccccc---------CCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 4444433222211111 112357789999999999999999999986
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-48 Score=398.43 Aligned_cols=258 Identities=25% Similarity=0.372 Sum_probs=205.4
Q ss_pred cccCccCceEEEEEEeCCC----ceEEEEEcCCC-CccchHHHHHHHHHHhccCCCCcceeeEEEEec-CceeEEEeccC
Q 042348 373 FLLGKSTIGIVYKVALNNE----EAVAVRRLGNG-GWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSV-DEKLLIYDYIP 446 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~~~----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~-~~~~lV~e~~~ 446 (686)
++||+|+||+||+|.+.++ ..||||+++.. .....++|.+|+++|++++|||||+++|++... +..++|||||+
T Consensus 33 ~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~~ 112 (311)
T d1r0pa_ 33 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMK 112 (311)
T ss_dssp EEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECCT
T ss_pred eEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEee
Confidence 4799999999999987542 36899999753 444567899999999999999999999998764 57899999999
Q ss_pred CCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCccccccccc
Q 042348 447 NGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAE 526 (686)
Q Consensus 447 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~ 526 (686)
+|+|.++++... ..+++..+++++.|++.||.|||+ ++|+||||||+|||+++++.+||+|||+++......
T Consensus 113 ~g~l~~~~~~~~-----~~~~~~~~~~i~~qia~gL~~lH~---~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~ 184 (311)
T d1r0pa_ 113 HGDLRNFIRNET-----HNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 184 (311)
T ss_dssp TCBHHHHHHCTT-----CCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTT
T ss_pred cCchhhhhcccc-----ccchHHHHHHHHHHHHHhhhhhcc---cCcccCCccHHhEeECCCCCEEEecccchhhccccc
Confidence 999999998764 457889999999999999999999 899999999999999999999999999998765332
Q ss_pred CCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHH
Q 042348 527 ETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIV 606 (686)
Q Consensus 527 ~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~ 606 (686)
... ........||..|+|||.+.+..++.++||||||+++|||+||+.||..... ..
T Consensus 185 ~~~-------------------~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~----~~ 241 (311)
T d1r0pa_ 185 FDS-------------------VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN----TF 241 (311)
T ss_dssp CCC-------------------TTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC---------
T ss_pred ccc-------------------ceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCC----HH
Confidence 210 0112335678899999999999999999999999999999998888754322 12
Q ss_pred HHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccccch
Q 042348 607 QWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRVNISTE 673 (686)
Q Consensus 607 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~~~~ 673 (686)
++...+..+..+. .| .....++.+++.+||+.||++||||.||+++|+++..+..
T Consensus 242 ~~~~~i~~g~~~~----~p--------~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~ 296 (311)
T d1r0pa_ 242 DITVYLLQGRRLL----QP--------EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 296 (311)
T ss_dssp -CHHHHHTTCCCC----CC--------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred HHHHHHHcCCCCC----Cc--------ccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhhh
Confidence 2233333333221 11 1122367899999999999999999999999999875543
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.9e-48 Score=405.80 Aligned_cols=246 Identities=20% Similarity=0.289 Sum_probs=203.5
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCCccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCCHH
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLA 451 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL~ 451 (686)
+.||+|+||.||+|... +|+.||||++........+.+.+|+++|++++|||||++++++.+.+..++|||||++|+|.
T Consensus 35 ~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~ 114 (352)
T d1koba_ 35 EELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELF 114 (352)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBHH
T ss_pred EEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCChHH
Confidence 46999999999999874 68999999997765555678899999999999999999999999999999999999999999
Q ss_pred HHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeec--CCCCeEEeecCcccccccccCCc
Q 042348 452 TAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLG--KNMEPHISDFGLARLADIAEETP 529 (686)
Q Consensus 452 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~--~~~~~kl~DfGla~~~~~~~~~~ 529 (686)
+++.... ..+++.++..|+.||+.||+|||+ ++||||||||+|||++ .++.+||+|||+|+......
T Consensus 115 ~~~~~~~-----~~l~e~~~~~i~~qi~~aL~ylH~---~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~--- 183 (352)
T d1koba_ 115 DRIAAED-----YKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE--- 183 (352)
T ss_dssp HHTTCTT-----CCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS---
T ss_pred HHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccccccccccccCCCeEEEeecccceecCCCC---
Confidence 9887653 469999999999999999999999 9999999999999998 67899999999998764321
Q ss_pred cccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHHH
Q 042348 530 EVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQWI 609 (686)
Q Consensus 530 ~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~ 609 (686)
......||+.|+|||++.+..++.++|||||||++|||+||+.||..... .+..
T Consensus 184 ---------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~-----~~~~ 237 (352)
T d1koba_ 184 ---------------------IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD-----LETL 237 (352)
T ss_dssp ---------------------CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH-----HHHH
T ss_pred ---------------------ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH-----HHHH
Confidence 11234578889999999999999999999999999999999999954322 2223
Q ss_pred HHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 610 QLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 610 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
..+............+ ....++.+++.+||+.||++|||+.|++++
T Consensus 238 ~~i~~~~~~~~~~~~~---------~~s~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 238 QNVKRCDWEFDEDAFS---------SVSPEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp HHHHHCCCCCCSSTTT---------TSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred HHHHhCCCCCCccccc---------CCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 4444433222211111 122357899999999999999999999886
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-48 Score=398.52 Aligned_cols=242 Identities=22% Similarity=0.335 Sum_probs=201.9
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCC---CccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCC
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNG---GWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNG 448 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~g 448 (686)
+.||+|+||.||+|+.. +++.||||++.+. .....+++.+|+.+|++++|||||++++++.+.+..++|||||++|
T Consensus 11 ~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ey~~gg 90 (337)
T d1o6la_ 11 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 90 (337)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECCTTC
T ss_pred EEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccceeccCCC
Confidence 46999999999999974 6899999998653 2234577899999999999999999999999999999999999999
Q ss_pred CHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCC
Q 042348 449 SLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEET 528 (686)
Q Consensus 449 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 528 (686)
+|.+++... ..+++..++.++.||+.||+|||+ ++||||||||+|||+++++.+||+|||+|+......
T Consensus 91 ~L~~~~~~~------~~~~e~~~~~~~~qil~al~ylH~---~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~-- 159 (337)
T d1o6la_ 91 ELFFHLSRE------RVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-- 159 (337)
T ss_dssp BHHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT--
T ss_pred chhhhhhcc------cCCcHHHHHHHHHHHhhhhhhhhh---cCccccccCHHHeEecCCCCEEEeecccccccccCC--
Confidence 999999865 458999999999999999999999 999999999999999999999999999998653221
Q ss_pred ccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHH
Q 042348 529 PEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQW 608 (686)
Q Consensus 529 ~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~ 608 (686)
......+||+.|+|||++.+..|+.++||||+||++|||++|+.||..... .+.
T Consensus 160 ---------------------~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~-----~~~ 213 (337)
T d1o6la_ 160 ---------------------ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-----ERL 213 (337)
T ss_dssp ---------------------CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH-----HHH
T ss_pred ---------------------cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCH-----HHH
Confidence 112345788999999999999999999999999999999999999965332 233
Q ss_pred HHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCC-----HHHHHHH
Q 042348 609 IQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPS-----MRHVCDS 664 (686)
Q Consensus 609 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~ev~~~ 664 (686)
.+.+.......+..+ ..++.+++.+||++||++||+ +.|+++|
T Consensus 214 ~~~i~~~~~~~p~~~-------------s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 214 FELILMEEIRFPRTL-------------SPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp HHHHHHCCCCCCTTS-------------CHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred HHHHhcCCCCCCccC-------------CHHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence 444444433332211 235778999999999999995 7888775
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-49 Score=395.90 Aligned_cols=251 Identities=21% Similarity=0.324 Sum_probs=193.5
Q ss_pred cccCccCceEEEEEEeCC----CceEEEEEcCCCC-ccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCC
Q 042348 373 FLLGKSTIGIVYKVALNN----EEAVAVRRLGNGG-WQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPN 447 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~ 447 (686)
+.||+|+||.||+|.+.. +..||||.++... ....+.|.+|++++++++|||||++++++. .+..++|||||++
T Consensus 13 ~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv~E~~~~ 91 (273)
T d1mp8a_ 13 RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTL 91 (273)
T ss_dssp EEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEEECCTT
T ss_pred EEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEEEEeccC
Confidence 469999999999998653 3578999986543 334567999999999999999999999985 5678999999999
Q ss_pred CCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccC
Q 042348 448 GSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEE 527 (686)
Q Consensus 448 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 527 (686)
|+|.+++.... ..+++..++.++.||+.||+|||+ ++||||||||+||++++++.+||+|||+|+.......
T Consensus 92 g~l~~~~~~~~-----~~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~~ 163 (273)
T d1mp8a_ 92 GELRSFLQVRK-----YSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY 163 (273)
T ss_dssp EEHHHHHHHTT-----TTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECC------------
T ss_pred CcHHhhhhccC-----CCCCHHHHHHHHHHHHHHhhhhcc---cCeeccccchhheeecCCCcEEEccchhheeccCCcc
Confidence 99999887654 468999999999999999999999 9999999999999999999999999999986543221
Q ss_pred CccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCccccCccchhHH
Q 042348 528 TPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQIGSMELNIV 606 (686)
Q Consensus 528 ~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~~~~~ 606 (686)
.......||+.|+|||++.+..++.++|||||||++|||+| |..||......+ +
T Consensus 164 ----------------------~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~--~- 218 (273)
T d1mp8a_ 164 ----------------------YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND--V- 218 (273)
T ss_dssp -----------------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--H-
T ss_pred ----------------------eeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHH--H-
Confidence 11223456888999999999999999999999999999998 899986544332 2
Q ss_pred HHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccccc
Q 042348 607 QWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRVNIS 671 (686)
Q Consensus 607 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~~ 671 (686)
...+..+... . ..+ ....++.+++.+||+.||++|||+.||+++|++|...
T Consensus 219 --~~~i~~~~~~--~-~~~---------~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 269 (273)
T d1mp8a_ 219 --IGRIENGERL--P-MPP---------NCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 269 (273)
T ss_dssp --HHHHHTTCCC--C-CCT---------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --HHHHHcCCCC--C-CCC---------CCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 2223332211 1 111 1234688999999999999999999999999988643
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-48 Score=394.06 Aligned_cols=245 Identities=21% Similarity=0.301 Sum_probs=199.7
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCC------ccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEecc
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGG------WQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYI 445 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~ 445 (686)
+.||+|+||+||+|+.. +|+.||||++.... ....+.+.+|+++|++++|||||++++++.+.+..++|||||
T Consensus 16 ~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~ 95 (293)
T d1jksa_ 16 EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELV 95 (293)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred EEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 46999999999999975 68899999985431 123567999999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCC----CeEEeecCcccc
Q 042348 446 PNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNM----EPHISDFGLARL 521 (686)
Q Consensus 446 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~----~~kl~DfGla~~ 521 (686)
++|+|.+++... ..+++..+..++.|++.||+|||+ ++|+||||||+|||++.++ .+|++|||+|+.
T Consensus 96 ~gg~L~~~i~~~------~~l~~~~~~~~~~qi~~al~yLH~---~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~ 166 (293)
T d1jksa_ 96 AGGELFDFLAEK------ESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK 166 (293)
T ss_dssp CSCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred CCccccchhccc------cccchhHHHHHHHHHHHHHHhhhh---cceeecccccceEEEecCCCcccceEecchhhhhh
Confidence 999999999765 369999999999999999999999 8999999999999998776 499999999986
Q ss_pred cccccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCcc
Q 042348 522 ADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSM 601 (686)
Q Consensus 522 ~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~ 601 (686)
..... ......||..|+|||++.+..++.++|||||||++|||+||+.||.....
T Consensus 167 ~~~~~------------------------~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~- 221 (293)
T d1jksa_ 167 IDFGN------------------------EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK- 221 (293)
T ss_dssp CTTSC------------------------BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-
T ss_pred cCCCc------------------------cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCH-
Confidence 54321 11234678889999999999999999999999999999999999964332
Q ss_pred chhHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 602 ELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 602 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
.+....+............ . .....+.+++.+||+.||++|||++|++++
T Consensus 222 ----~~~~~~i~~~~~~~~~~~~----~-----~~s~~~~~li~~~L~~dP~~R~s~~eil~h 271 (293)
T d1jksa_ 222 ----QETLANVSAVNYEFEDEYF----S-----NTSALAKDFIRRLLVKDPKKRMTIQDSLQH 271 (293)
T ss_dssp ----HHHHHHHHTTCCCCCHHHH----T-----TSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ----HHHHHHHHhcCCCCCchhc----C-----CCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 2223333333222111110 1 112357789999999999999999999875
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=9.1e-48 Score=395.13 Aligned_cols=243 Identities=22% Similarity=0.338 Sum_probs=202.7
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCC---CccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCC
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNG---GWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNG 448 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~g 448 (686)
+.||+|+||+||+|+.. +|+.||||+++.. .....+.+.+|+.++++++|||||++++++.+.+..++|||||++|
T Consensus 10 ~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg 89 (316)
T d1fota_ 10 RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGG 89 (316)
T ss_dssp EEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred EEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEeeecCCc
Confidence 46999999999999975 5899999998643 2234567999999999999999999999999999999999999999
Q ss_pred CHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCC
Q 042348 449 SLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEET 528 (686)
Q Consensus 449 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 528 (686)
+|..++... ..+++..+..++.||+.||+|||+ ++||||||||+|||++.++.+||+|||+|+.....
T Consensus 90 ~l~~~~~~~------~~~~~~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~--- 157 (316)
T d1fota_ 90 ELFSLLRKS------QRFPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV--- 157 (316)
T ss_dssp BHHHHHHHT------SSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC---
T ss_pred ccccccccc------ccccccHHHHHHHHHHHhhhhhcc---CcEEccccCchheeEcCCCCEEEecCccceEeccc---
Confidence 999999866 358899999999999999999999 99999999999999999999999999999865321
Q ss_pred ccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHH
Q 042348 529 PEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQW 608 (686)
Q Consensus 529 ~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~ 608 (686)
....+||+.|+|||++.+..|+.++|||||||++|||+||+.||.... ..+.
T Consensus 158 -----------------------~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~-----~~~~ 209 (316)
T d1fota_ 158 -----------------------TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN-----TMKT 209 (316)
T ss_dssp -----------------------BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS-----HHHH
T ss_pred -----------------------cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcC-----HHHH
Confidence 123567888999999999999999999999999999999999995432 2333
Q ss_pred HHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH--Hhcc
Q 042348 609 IQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRP-----SMRHVCDS--LDRV 668 (686)
Q Consensus 609 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~ev~~~--L~~i 668 (686)
...+.......+..+ ..++.+++.+||++||++|| |++|+++| ++++
T Consensus 210 ~~~i~~~~~~~p~~~-------------s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i 263 (316)
T d1fota_ 210 YEKILNAELRFPPFF-------------NEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEV 263 (316)
T ss_dssp HHHHHHCCCCCCTTS-------------CHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSC
T ss_pred HHHHHcCCCCCCCCC-------------CHHHHHHHHHHhhhCHHhccccchhhHHHHHcCcccccC
Confidence 444544433332211 13577899999999999996 89999876 4444
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-49 Score=392.03 Aligned_cols=245 Identities=25% Similarity=0.419 Sum_probs=192.7
Q ss_pred cccCccCceEEEEEEeCCCceEEEEEcCCCCccchHHHHHHHHHHhccCCCCcceeeEEEEe-cCceeEEEeccCCCCHH
Q 042348 373 FLLGKSTIGIVYKVALNNEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWS-VDEKLLIYDYIPNGSLA 451 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~-~~~~~lV~e~~~~gsL~ 451 (686)
+.||+|+||.||+|+++ |..||||+++... ..++|.+|++++++++|||||+++|+|.+ .+..++||||+++|+|.
T Consensus 13 ~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~g~L~ 89 (262)
T d1byga_ 13 QTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLV 89 (262)
T ss_dssp EEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHH
T ss_pred EEEecCCCeEEEEEEEC-CeEEEEEEECcHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccCCCCHH
Confidence 46999999999999985 6789999997643 34789999999999999999999999865 45689999999999999
Q ss_pred HHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCccc
Q 042348 452 TAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPEV 531 (686)
Q Consensus 452 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 531 (686)
+++..+.. ..++|..+++|+.||+.||+|||+ ++|+||||||+|||++.++.+|++|||+++......
T Consensus 90 ~~l~~~~~----~~l~~~~~~~i~~~i~~al~ylH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~----- 157 (262)
T d1byga_ 90 DYLRSRGR----SVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ----- 157 (262)
T ss_dssp HHHHHHHH----HHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC-------------
T ss_pred HHHHhcCC----CCCCHHHHHHHHHHHHhhcccccc---CceeccccchHhheecCCCCEeecccccceecCCCC-----
Confidence 99976432 358999999999999999999999 899999999999999999999999999998543211
Q ss_pred cccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCccccCccchhHHHHHH
Q 042348 532 HWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQIGSMELNIVQWIQ 610 (686)
Q Consensus 532 ~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~~~~~~~~~ 610 (686)
....+|..|+|||++.+..++.++|||||||++|||+| |+.||...... ++...
T Consensus 158 ---------------------~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~--~~~~~-- 212 (262)
T d1byga_ 158 ---------------------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--DVVPR-- 212 (262)
T ss_dssp -------------------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG--GHHHH--
T ss_pred ---------------------ccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHH--HHHHH--
Confidence 12345677999999998999999999999999999998 68777543322 22222
Q ss_pred HHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccc
Q 042348 611 LILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRVNI 670 (686)
Q Consensus 611 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~ 670 (686)
+..+..+ + ... ....++.+++.+||+.||++||||.||+++|++|+.
T Consensus 213 -i~~~~~~--~-----~~~-----~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~ 259 (262)
T d1byga_ 213 -VEKGYKM--D-----APD-----GCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259 (262)
T ss_dssp -HTTTCCC--C-----CCT-----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -HHcCCCC--C-----CCc-----cCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence 2222111 1 111 122367899999999999999999999999998863
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.2e-48 Score=396.39 Aligned_cols=256 Identities=27% Similarity=0.384 Sum_probs=203.4
Q ss_pred cccCccCceEEEEEEeC------CCceEEEEEcCCCCc-cchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEecc
Q 042348 373 FLLGKSTIGIVYKVALN------NEEAVAVRRLGNGGW-QRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYI 445 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~ 445 (686)
+.||+|+||.||+|+.. +++.||||+++.... ...++|.+|++++++++||||++++++|...+..++||||+
T Consensus 19 ~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~~v~e~~ 98 (301)
T d1lufa_ 19 RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYM 98 (301)
T ss_dssp EEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred EEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCceEEEEEec
Confidence 35999999999999864 357899999976533 33567999999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcCCCc------------------cccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecC
Q 042348 446 PNGSLATAIHGKAGI------------------ISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGK 507 (686)
Q Consensus 446 ~~gsL~~~l~~~~~~------------------~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~ 507 (686)
++|+|.++++..... .....+++..++.|+.|++.||+|||+ ++||||||||+|||+|.
T Consensus 99 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~---~~ivHrDlKp~NILld~ 175 (301)
T d1lufa_ 99 AYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGE 175 (301)
T ss_dssp TTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECG
T ss_pred CCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhccc---CCeEeeEEcccceEECC
Confidence 999999999754321 111358999999999999999999999 89999999999999999
Q ss_pred CCCeEEeecCcccccccccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHH
Q 042348 508 NMEPHISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLE 587 (686)
Q Consensus 508 ~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~e 587 (686)
++.+||+|||+|+........ .......+|..|+|||.+.+..|+.++|||||||++||
T Consensus 176 ~~~~Kl~DFGls~~~~~~~~~---------------------~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~e 234 (301)
T d1lufa_ 176 NMVVKIADFGLSRNIYSADYY---------------------KADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWE 234 (301)
T ss_dssp GGCEEECCCSCHHHHTGGGCB---------------------C----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHH
T ss_pred CCcEEEccchhheeccCCccc---------------------cccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHH
Confidence 999999999999866433211 11223457788999999999999999999999999999
Q ss_pred HHhCC-CCccccCccchhHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 042348 588 MISGK-LPMIQIGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLD 666 (686)
Q Consensus 588 lltG~-~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~ 666 (686)
|++|. .||..... .+....+..+.. .+. . ...+.++.+++.+||+.||++||||.||++.|+
T Consensus 235 ll~~~~~p~~~~~~-----~e~~~~v~~~~~--~~~-p---------~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~ 297 (301)
T d1lufa_ 235 IFSYGLQPYYGMAH-----EEVIYYVRDGNI--LAC-P---------ENCPLELYNLMRLCWSKLPADRPSFCSIHRILQ 297 (301)
T ss_dssp HHTTTCCTTTTSCH-----HHHHHHHHTTCC--CCC-C---------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHccCCCCCCCCCH-----HHHHHHHHcCCC--CCC-C---------ccchHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence 99986 56643322 222333333321 111 0 112246789999999999999999999999999
Q ss_pred ccc
Q 042348 667 RVN 669 (686)
Q Consensus 667 ~i~ 669 (686)
+|.
T Consensus 298 ~i~ 300 (301)
T d1lufa_ 298 RMC 300 (301)
T ss_dssp HTT
T ss_pred Hhc
Confidence 875
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-47 Score=395.72 Aligned_cols=252 Identities=25% Similarity=0.377 Sum_probs=197.6
Q ss_pred cccCccCceEEEEEEeC-CCc----eEEEEEcCCC-CccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccC
Q 042348 373 FLLGKSTIGIVYKVALN-NEE----AVAVRRLGNG-GWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIP 446 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~ 446 (686)
+.||+|+||+||+|.+. +|+ .||||+++.. .....++|.+|++++++++|||||+++|+|.+. ..+++|||+.
T Consensus 15 ~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~v~e~~~ 93 (317)
T d1xkka_ 15 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMP 93 (317)
T ss_dssp EEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEEECCT
T ss_pred eEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeEEEEecc
Confidence 47999999999999865 333 5899998654 334467899999999999999999999999864 5678899999
Q ss_pred CCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCccccccccc
Q 042348 447 NGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAE 526 (686)
Q Consensus 447 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~ 526 (686)
+|+|.+++.... ..+++..+++|+.|||.||+|||+ ++||||||||+|||++.++.+||+|||+|+......
T Consensus 94 ~~~l~~~~~~~~-----~~~~~~~~~~i~~qi~~gl~yLH~---~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~ 165 (317)
T d1xkka_ 94 FGCLLDYVREHK-----DNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 165 (317)
T ss_dssp TCBHHHHHHHTS-----SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTC
T ss_pred CCcccccccccc-----cCCCHHHHHHHHHHHHHHHHHHHH---cCcccCcchhhcceeCCCCCeEeeccccceeccccc
Confidence 999999888764 469999999999999999999999 899999999999999999999999999998765322
Q ss_pred CCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCccccCccchhH
Q 042348 527 ETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQIGSMELNI 605 (686)
Q Consensus 527 ~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~~~~ 605 (686)
.. .......||..|+|||++.+..++.++|||||||++|||+| |+.||......+ +
T Consensus 166 ~~---------------------~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~--~ 222 (317)
T d1xkka_ 166 KE---------------------YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--I 222 (317)
T ss_dssp C-----------------------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG--H
T ss_pred cc---------------------ccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHH--H
Confidence 11 11223457889999999999999999999999999999999 788885543322 2
Q ss_pred HHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccccc
Q 042348 606 VQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRVNIS 671 (686)
Q Consensus 606 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~~ 671 (686)
. ..+..+..+ .. | +.....+.+++.+||+.||++|||+.||+++|+++...
T Consensus 223 ~---~~i~~~~~~-~~---p--------~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~~ 273 (317)
T d1xkka_ 223 S---SILEKGERL-PQ---P--------PICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 273 (317)
T ss_dssp H---HHHHHTCCC-CC---C--------TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred H---HHHHcCCCC-CC---C--------cccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHhC
Confidence 2 222222211 10 0 11234678999999999999999999999999887543
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=3.5e-47 Score=385.00 Aligned_cols=254 Identities=20% Similarity=0.307 Sum_probs=198.2
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCC---ccchHHHHHHHHHHhccCCCCcceeeEEEEecCc----eeEEEec
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGG---WQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDE----KLLIYDY 444 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~----~~lV~e~ 444 (686)
+.||+|+||.||+|... +++.||||.++... ....++|.+|++++++++|||||++++++...+. .|+||||
T Consensus 13 ~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~lvmE~ 92 (277)
T d1o6ya_ 13 EILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEY 92 (277)
T ss_dssp EEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEEEEEEC
T ss_pred EEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceEEEEEEC
Confidence 46999999999999864 68899999997542 2334579999999999999999999999987653 7899999
Q ss_pred cCCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCccccccc
Q 042348 445 IPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADI 524 (686)
Q Consensus 445 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~ 524 (686)
|++|+|.+++... ..+++.++..|+.||+.||+|||+ ++|+||||||+|||++.++..+++|||.++....
T Consensus 93 ~~g~~L~~~~~~~------~~l~~~~~~~i~~qi~~al~~lH~---~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~ 163 (277)
T d1o6ya_ 93 VDGVTLRDIVHTE------GPMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIAD 163 (277)
T ss_dssp CCEEEHHHHHHHH------CSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTSCEEECCCTTCEECC-
T ss_pred CCCCEehhhhccc------CCCCHHHHHHHHHHHHHHHHHHHh---CCccCccccCcccccCccccceeehhhhhhhhcc
Confidence 9999999998765 469999999999999999999999 8999999999999999999999999999875542
Q ss_pred ccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchh
Q 042348 525 AEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELN 604 (686)
Q Consensus 525 ~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~ 604 (686)
.... ........||+.|+|||++.+..++.++|||||||++|||+||+.||.....
T Consensus 164 ~~~~--------------------~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~---- 219 (277)
T d1o6ya_ 164 SGNS--------------------VTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP---- 219 (277)
T ss_dssp -----------------------------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH----
T ss_pred cccc--------------------ccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCH----
Confidence 2210 0122345788999999999999999999999999999999999999954322
Q ss_pred HHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCC-CHHHHHHHHhccc
Q 042348 605 IVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRP-SMRHVCDSLDRVN 669 (686)
Q Consensus 605 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-s~~ev~~~L~~i~ 669 (686)
.+.................+. ...++.+++.+||++||++|| |++++.+.|.++.
T Consensus 220 -~~~~~~~~~~~~~~~~~~~~~---------~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 220 -VSVAYQHVREDPIPPSARHEG---------LSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp -HHHHHHHHHCCCCCGGGTSSS---------CCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred -HHHHHHHHhcCCCCCchhccC---------CCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 222333444332222111111 123677899999999999999 8999999998764
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-48 Score=395.60 Aligned_cols=265 Identities=23% Similarity=0.249 Sum_probs=197.4
Q ss_pred cccCccCceEEEEEEeCCCceEEEEEcCCCCccchHHHHHHHHHHhccCCCCcceeeEEEEecC----ceeEEEeccCCC
Q 042348 373 FLLGKSTIGIVYKVALNNEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVD----EKLLIYDYIPNG 448 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~----~~~lV~e~~~~g 448 (686)
+.||+|+||.||+|+++ |+.||||++...... ...++.|+..+.+++|||||++++++.+.+ ..++|||||++|
T Consensus 9 ~~iG~G~fg~Vy~~~~~-g~~vAvK~~~~~~~~-~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~~~g 86 (303)
T d1vjya_ 9 ESIGKGRFGEVWRGKWR-GEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHG 86 (303)
T ss_dssp EEEECCSSSEEEEEEET-TEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTC
T ss_pred EEEeeCCCeEEEEEEEC-CEEEEEEEECccchh-HHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEecccCC
Confidence 46999999999999974 789999999654221 122344555667889999999999998764 468999999999
Q ss_pred CHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccC-----CCCceecCCCCCCeeecCCCCeEEeecCcccccc
Q 042348 449 SLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVS-----PKRYVHGDLRPSNILLGKNMEPHISDFGLARLAD 523 (686)
Q Consensus 449 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~-----~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~ 523 (686)
+|.++++.. .++|.++.+++.|+|.||+|+|+.. .++||||||||+|||++.++.+||+|||+++...
T Consensus 87 ~L~~~l~~~-------~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~ 159 (303)
T d1vjya_ 87 SLFDYLNRY-------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHD 159 (303)
T ss_dssp BHHHHHHHC-------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEE
T ss_pred CHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcccccc
Confidence 999999753 4899999999999999999999731 2589999999999999999999999999998765
Q ss_pred cccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCC------CCCcchHHHHHHHHHHHHhCCCCccc
Q 042348 524 IAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRK------PTQKWDIYSYGVILLEMISGKLPMIQ 597 (686)
Q Consensus 524 ~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------~~~~sDVwSlGvvl~elltG~~P~~~ 597 (686)
...... ........||+.|+|||++.+.. ++.++|||||||++|||+||..||..
T Consensus 160 ~~~~~~-------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~ 220 (303)
T d1vjya_ 160 SATDTI-------------------DIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI 220 (303)
T ss_dssp TTTTEE-------------------CC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTB
T ss_pred CCCcce-------------------eccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCc
Confidence 332110 01223457899999999987542 57789999999999999999988743
Q ss_pred cCccch---------hHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 042348 598 IGSMEL---------NIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRV 668 (686)
Q Consensus 598 ~~~~~~---------~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i 668 (686)
...... ............. ..+|.+.......+....+.+++.+||+.||++|||+.||++.|+++
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i 295 (303)
T d1vjya_ 221 HEDYQLPYYDLVPSDPSVEEMRKVVCEQ-----KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 295 (303)
T ss_dssp CCCCCCTTTTTSCSSCCHHHHHHHHTTS-----CCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred ccccccchhhcccccchHHHHHHHHhcc-----ccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 221110 0111222222211 11222222222345667789999999999999999999999999988
Q ss_pred cc
Q 042348 669 NI 670 (686)
Q Consensus 669 ~~ 670 (686)
..
T Consensus 296 ~~ 297 (303)
T d1vjya_ 296 SQ 297 (303)
T ss_dssp HH
T ss_pred HH
Confidence 63
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-48 Score=388.84 Aligned_cols=250 Identities=24% Similarity=0.392 Sum_probs=191.5
Q ss_pred ccCccCceEEEEEEeCC----CceEEEEEcCCC---CccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccC
Q 042348 374 LLGKSTIGIVYKVALNN----EEAVAVRRLGNG---GWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIP 446 (686)
Q Consensus 374 ~iG~G~~g~Vy~~~~~~----~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~ 446 (686)
.||+|+||.||+|++.. ...||||++... .....++|.+|+++|++++|||||+++|++.+ +..++|||||+
T Consensus 15 ~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~lv~e~~~ 93 (273)
T d1u46a_ 15 KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMKMVTELAP 93 (273)
T ss_dssp ECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCT
T ss_pred EEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchheeeeeec
Confidence 59999999999998642 237899998653 23345689999999999999999999999965 46789999999
Q ss_pred CCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCccccccccc
Q 042348 447 NGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAE 526 (686)
Q Consensus 447 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~ 526 (686)
+|++.+++.... ..+++..++.++.|||.||+|||+ ++|+||||||+||+++.++.+||+|||+++......
T Consensus 94 ~~~l~~~~~~~~-----~~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~~ 165 (273)
T d1u46a_ 94 LGSLLDRLRKHQ-----GHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQND 165 (273)
T ss_dssp TCBHHHHHHHHG-----GGSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-C
T ss_pred Ccchhhhhhccc-----CCCCHHHHHHHHHHHHHHHHHhhh---CCEeeeeecHHHhccccccceeeccchhhhhcccCC
Confidence 999999887654 469999999999999999999999 899999999999999999999999999998764332
Q ss_pred CCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHh-CCCCccccCccchhH
Q 042348 527 ETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-GKLPMIQIGSMELNI 605 (686)
Q Consensus 527 ~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~~~~ 605 (686)
.. ........|+..|+|||.+.+..++.++|||||||++|||+| |+.||.....
T Consensus 166 ~~--------------------~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~----- 220 (273)
T d1u46a_ 166 DH--------------------YVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG----- 220 (273)
T ss_dssp CE--------------------EEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH-----
T ss_pred Cc--------------------ceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCH-----
Confidence 11 011223456788999999999999999999999999999998 8999954322
Q ss_pred HHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 042348 606 VQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRV 668 (686)
Q Consensus 606 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i 668 (686)
.+.+..+........ . . ......+.+++.+||+.||++|||+.||.+.|++.
T Consensus 221 ~~~~~~i~~~~~~~~-~-----~-----~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 221 SQILHKIDKEGERLP-R-----P-----EDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp HHHHHHHHTSCCCCC-C-----C-----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHHhCCCCCC-C-----c-----ccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 222334433322211 0 0 11223678999999999999999999999999875
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.1e-47 Score=394.92 Aligned_cols=239 Identities=17% Similarity=0.237 Sum_probs=199.7
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCC---CccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCC
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNG---GWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNG 448 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~g 448 (686)
+.||+|+||.||+|+.. +|+.||||++... .....+.+.+|+++|++++|||||++++++.+.+..++||||+.+|
T Consensus 47 ~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e~~~~g 126 (350)
T d1rdqe_ 47 KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGG 126 (350)
T ss_dssp EEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTC
T ss_pred EEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccccccccc
Confidence 36999999999999875 6899999998643 2233567899999999999999999999999999999999999999
Q ss_pred CHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCC
Q 042348 449 SLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEET 528 (686)
Q Consensus 449 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 528 (686)
+|.+++... ..+++.++..|+.||+.||+|||+ ++||||||||+|||++.++.+||+|||+|+.....
T Consensus 127 ~l~~~l~~~------~~l~e~~~~~i~~qi~~aL~yLH~---~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~--- 194 (350)
T d1rdqe_ 127 EMFSHLRRI------GRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--- 194 (350)
T ss_dssp BHHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC---
T ss_pred chhhhHhhc------CCCCHHHHHHHHHHHHHHHHHHHh---CCEecCcCCHHHcccCCCCCEEeeeceeeeecccc---
Confidence 999999765 358999999999999999999999 89999999999999999999999999999865421
Q ss_pred ccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHH
Q 042348 529 PEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQW 608 (686)
Q Consensus 529 ~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~ 608 (686)
.....||+.|+|||++.+..++.++|||||||++|||+||+.||.... ....
T Consensus 195 -----------------------~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~-----~~~~ 246 (350)
T d1rdqe_ 195 -----------------------TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ-----PIQI 246 (350)
T ss_dssp -----------------------BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHH
T ss_pred -----------------------cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcC-----HHHH
Confidence 123467888999999999999999999999999999999999995432 2333
Q ss_pred HHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 042348 609 IQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRP-----SMRHVCDS 664 (686)
Q Consensus 609 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~ev~~~ 664 (686)
...+.......+.. ...++.+++.+||+.||++|+ |++|+++|
T Consensus 247 ~~~i~~~~~~~p~~-------------~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~H 294 (350)
T d1rdqe_ 247 YEKIVSGKVRFPSH-------------FSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp HHHHHHCCCCCCTT-------------CCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred HHHHhcCCCCCCcc-------------CCHHHHHHHHHHhhhCHHhccccccccHHHHHcC
Confidence 44444443222211 123577999999999999994 89999875
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-47 Score=391.08 Aligned_cols=258 Identities=26% Similarity=0.326 Sum_probs=192.3
Q ss_pred cccCccCceEEEEEEeC------CCceEEEEEcCCC-CccchHHHHHHHHHHhcc-CCCCcceeeEEEEec-CceeEEEe
Q 042348 373 FLLGKSTIGIVYKVALN------NEEAVAVRRLGNG-GWQRFKEFQTEAEAIGKI-RHPNIVSLRAYFWSV-DEKLLIYD 443 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~-~~~~lV~e 443 (686)
+.||+|+||.||+|... +++.||||+++.. .....+.+.+|...+.++ +|+|||.+++++... +..++|||
T Consensus 19 ~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~~iv~E 98 (299)
T d1ywna1 19 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVE 98 (299)
T ss_dssp EEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEEEE
T ss_pred eEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCeEEEEEE
Confidence 46999999999999864 2468999999754 333456788899888887 689999999998765 46799999
Q ss_pred ccCCCCHHHHhhcCCCcc----------ccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEE
Q 042348 444 YIPNGSLATAIHGKAGII----------SYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHI 513 (686)
Q Consensus 444 ~~~~gsL~~~l~~~~~~~----------~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl 513 (686)
||++|+|.++++...... ....+++.+++.++.||+.||+|||+ ++||||||||+|||+++++.+||
T Consensus 99 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~---~~ivHrDlKp~NILl~~~~~~Kl 175 (299)
T d1ywna1 99 FCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKI 175 (299)
T ss_dssp CCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECGGGCEEE
T ss_pred ecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHh---CCCcCCcCCccceeECCCCcEEE
Confidence 999999999998653210 11358999999999999999999999 89999999999999999999999
Q ss_pred eecCcccccccccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCC-
Q 042348 514 SDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGK- 592 (686)
Q Consensus 514 ~DfGla~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~- 592 (686)
+|||+|+........ .......||+.|+|||++.+..++.++|||||||++|||+||.
T Consensus 176 ~DFGla~~~~~~~~~---------------------~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~ 234 (299)
T d1ywna1 176 CDFGLARDIYKDPDY---------------------VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA 234 (299)
T ss_dssp CC------CCSCTTS---------------------CCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred ccCcchhhccccccc---------------------cccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCC
Confidence 999999865432210 1223456889999999999999999999999999999999975
Q ss_pred CCccccCccchhHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccc
Q 042348 593 LPMIQIGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRVNI 670 (686)
Q Consensus 593 ~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~ 670 (686)
.||......+ . +.......... ...+ ....++.+++.+||+.||++|||+.||+++|+++-+
T Consensus 235 ~p~~~~~~~~-~----~~~~~~~~~~~-~~~~----------~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq 296 (299)
T d1ywna1 235 SPYPGVKIDE-E----FCRRLKEGTRM-RAPD----------YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 296 (299)
T ss_dssp CSSTTCCCSH-H----HHHHHHHTCCC-CCCT----------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCCHHH-H----HHHHHhcCCCC-CCCc----------cCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 5674432221 1 22222222111 1100 122357899999999999999999999999998753
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-47 Score=391.48 Aligned_cols=256 Identities=25% Similarity=0.364 Sum_probs=199.2
Q ss_pred cccCccCceEEEEEEeCC-Cc--eEEEEEcCCC-CccchHHHHHHHHHHhcc-CCCCcceeeEEEEecCceeEEEeccCC
Q 042348 373 FLLGKSTIGIVYKVALNN-EE--AVAVRRLGNG-GWQRFKEFQTEAEAIGKI-RHPNIVSLRAYFWSVDEKLLIYDYIPN 447 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~~-~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~e~~~~ 447 (686)
+.||+|+||.||+|.+.+ +. .||||++... .....++|.+|+++|+++ +|||||+++++|.+.+..++||||+++
T Consensus 16 ~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~ey~~~ 95 (309)
T d1fvra_ 16 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 95 (309)
T ss_dssp EEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCTT
T ss_pred EEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEEEEecCC
Confidence 469999999999998764 33 5788987543 334456799999999999 799999999999999999999999999
Q ss_pred CCHHHHhhcCCC----------ccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecC
Q 042348 448 GSLATAIHGKAG----------IISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFG 517 (686)
Q Consensus 448 gsL~~~l~~~~~----------~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfG 517 (686)
|+|.++++.... ......+++..+.+++.|||.||.|||+ ++|+||||||+|||++.++.+||+|||
T Consensus 96 g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~---~~iiHrDlkp~NIL~~~~~~~kl~DfG 172 (309)
T d1fvra_ 96 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFG 172 (309)
T ss_dssp CBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCEEECCTT
T ss_pred CcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhc---CCccccccccceEEEcCCCceEEcccc
Confidence 999999976521 0112569999999999999999999999 899999999999999999999999999
Q ss_pred cccccccccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCC-Ccc
Q 042348 518 LARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKL-PMI 596 (686)
Q Consensus 518 la~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~-P~~ 596 (686)
+|+....... .....||..|+|||.+.+..++.++|||||||++|||++|.. ||.
T Consensus 173 ~a~~~~~~~~------------------------~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~ 228 (309)
T d1fvra_ 173 LSRGQEVYVK------------------------KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYC 228 (309)
T ss_dssp CEESSCEECC------------------------C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred cccccccccc------------------------ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCC
Confidence 9985542211 123356788999999999999999999999999999999765 564
Q ss_pred ccCccchhHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccccc
Q 042348 597 QIGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRVNIST 672 (686)
Q Consensus 597 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~~~ 672 (686)
... ..+....+..+..+ + .. .....++.+++.+||+.||++||||+||+++|+++....
T Consensus 229 ~~~-----~~~~~~~i~~~~~~--~-----~~-----~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~ 287 (309)
T d1fvra_ 229 GMT-----CAELYEKLPQGYRL--E-----KP-----LNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 287 (309)
T ss_dssp TCC-----HHHHHHHGGGTCCC--C-----CC-----TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred CCC-----HHHHHHHHHhcCCC--C-----CC-----ccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence 322 22222332222111 0 00 112246889999999999999999999999999986433
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.3e-46 Score=378.93 Aligned_cols=245 Identities=24% Similarity=0.368 Sum_probs=197.8
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCCcc---------chHHHHHHHHHHhccC-CCCcceeeEEEEecCceeEE
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGGWQ---------RFKEFQTEAEAIGKIR-HPNIVSLRAYFWSVDEKLLI 441 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---------~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lV 441 (686)
+.||+|+||+||+|+.. +++.||||++...... ..+.+.+|+.++++++ |||||++++++.+++..++|
T Consensus 9 ~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~iv 88 (277)
T d1phka_ 9 EILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLV 88 (277)
T ss_dssp EEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred eEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccCcceEEE
Confidence 46999999999999874 6889999998653211 1246889999999997 99999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccc
Q 042348 442 YDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARL 521 (686)
Q Consensus 442 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~ 521 (686)
||||++|||.++++.. ..+++.++..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++.
T Consensus 89 mE~~~~g~L~~~l~~~------~~l~e~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~ 159 (277)
T d1phka_ 89 FDLMKKGELFDYLTEK------VTLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQ 159 (277)
T ss_dssp EECCTTCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEcCCCchHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---cCCcccccccceEEEcCCCCeEEccchheeE
Confidence 9999999999999765 469999999999999999999999 8999999999999999999999999999986
Q ss_pred cccccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccC------CCCCCcchHHHHHHHHHHHHhCCCCc
Q 042348 522 ADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKV------RKPTQKWDIYSYGVILLEMISGKLPM 595 (686)
Q Consensus 522 ~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~sDVwSlGvvl~elltG~~P~ 595 (686)
..... ......||..|+|||.+.+ ..++.++||||+||++|||+||+.||
T Consensus 160 ~~~~~------------------------~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf 215 (277)
T d1phka_ 160 LDPGE------------------------KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF 215 (277)
T ss_dssp CCTTC------------------------CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred ccCCC------------------------ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCC
Confidence 64321 1123567888999998752 35788999999999999999999999
Q ss_pred cccCccchhHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 596 IQIGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 596 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
..... ....+.+..+...... +.. .....++.+++.+||+.||++|||+.||+++
T Consensus 216 ~~~~~-----~~~~~~i~~~~~~~~~---~~~------~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 216 WHRKQ-----MLMLRMIMSGNYQFGS---PEW------DDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp CCSSH-----HHHHHHHHHTCCCCCT---TTG------GGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred CCCCH-----HHHHHHHHhCCCCCCC---ccc------ccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 64332 2223334443322111 100 1122468899999999999999999999765
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-46 Score=385.93 Aligned_cols=258 Identities=21% Similarity=0.263 Sum_probs=193.1
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCCcc-----chHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccC
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGGWQ-----RFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIP 446 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~ 446 (686)
++||+|+||+||+|+.. +++.||||+++..... ..+.+.+|+.++++++|||||++++++.+.+..++|||||.
T Consensus 4 ~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~~ 83 (299)
T d1ua2a_ 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFME 83 (299)
T ss_dssp EEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCS
T ss_pred eEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhhc
Confidence 46999999999999975 5889999998654322 13468899999999999999999999999999999999999
Q ss_pred CCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCccccccccc
Q 042348 447 NGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAE 526 (686)
Q Consensus 447 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~ 526 (686)
++++..+.... ..+++.++..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+|+......
T Consensus 84 ~~~~~~~~~~~------~~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~ 154 (299)
T d1ua2a_ 84 TDLEVIIKDNS------LVLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN 154 (299)
T ss_dssp EEHHHHHTTCC------SSCCSSHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC
T ss_pred chHHhhhhhcc------cCCCHHHHHHHHHHHHHHHHHhhc---cceecccCCcceEEecCCCccccccCccccccCCCc
Confidence 88777766543 468999999999999999999999 999999999999999999999999999997654221
Q ss_pred CCccccccccccCCCCCCCccccccccCCCCCccccCcccccC-CCCCCcchHHHHHHHHHHHHhCCCCccccCccchhH
Q 042348 527 ETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKV-RKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNI 605 (686)
Q Consensus 527 ~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~ 605 (686)
. .....+||..|+|||++.. ..|+.++|||||||++|||+||+.||..... .+.
T Consensus 155 ~-----------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~--~~~ 209 (299)
T d1ua2a_ 155 R-----------------------AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSD--LDQ 209 (299)
T ss_dssp C-----------------------CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH--HHH
T ss_pred c-----------------------cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCH--HHH
Confidence 1 1223467888999998865 4579999999999999999999999954332 222
Q ss_pred HHHHHHHHhhc--CCcccccCc----cccc--CCCc----HHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 606 VQWIQLILEDR--KPMTDILDP----FLAH--DLDK----EDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 606 ~~~~~~~~~~~--~~~~~~~d~----~l~~--~~~~----~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
...+....... ......... .... .... ......+.+++.+||+.||++|||++|+++|
T Consensus 210 l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H 280 (299)
T d1ua2a_ 210 LTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280 (299)
T ss_dssp HHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred HHHHHHhcCCCChhhccchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence 22222221110 000000000 0000 0000 0112468899999999999999999999875
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=2.2e-46 Score=392.22 Aligned_cols=243 Identities=21% Similarity=0.242 Sum_probs=191.7
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCC---ccchHHHH---HHHHHHhccCCCCcceeeEEEEecCceeEEEecc
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGG---WQRFKEFQ---TEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYI 445 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~---~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~ 445 (686)
+.||+|+||.||+|+.. +|+.||||++.... ......+. .|+++++.++|||||++++++.+.+..++|||||
T Consensus 10 ~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ivmE~~ 89 (364)
T d1omwa3 10 RIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLM 89 (364)
T ss_dssp EEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred eEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEEEEEEec
Confidence 46999999999999975 58999999985421 11122333 4577788889999999999999999999999999
Q ss_pred CCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccc
Q 042348 446 PNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIA 525 (686)
Q Consensus 446 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~ 525 (686)
++|+|.+++... ..+++.++..++.||+.||+|||+ ++||||||||+|||++.++.+||+|||+|+.....
T Consensus 90 ~gg~L~~~l~~~------~~~~e~~~~~~~~qi~~aL~ylH~---~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~ 160 (364)
T d1omwa3 90 NGGDLHYHLSQH------GVFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK 160 (364)
T ss_dssp CSCBHHHHHHHH------CSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECSSSCEEECCCTTCEECSSS
T ss_pred CCCcHHHHHHhc------ccccHHHHHHHHHHHHHHHHHHHH---CCccceeeccceeEEcCCCcEEEeeeceeeecCCC
Confidence 999999999765 458899999999999999999999 99999999999999999999999999999865422
Q ss_pred cCCccccccccccCCCCCCCccccccccCCCCCccccCcccccC-CCCCCcchHHHHHHHHHHHHhCCCCccccCccchh
Q 042348 526 EETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKV-RKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELN 604 (686)
Q Consensus 526 ~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~ 604 (686)
. .....||+.|+|||++.. ..|+.++|||||||++|||+||+.||......+.
T Consensus 161 ~-------------------------~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~- 214 (364)
T d1omwa3 161 K-------------------------PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK- 214 (364)
T ss_dssp C-------------------------CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCH-
T ss_pred c-------------------------ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHH-
Confidence 1 123468889999999864 5689999999999999999999999965433322
Q ss_pred HHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCC-----HHHHHHH
Q 042348 605 IVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPS-----MRHVCDS 664 (686)
Q Consensus 605 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~ev~~~ 664 (686)
..............+. . ...++.+++.+||+.||++||| ++|+++|
T Consensus 215 -~~~~~~~~~~~~~~~~--------~-----~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H 265 (364)
T d1omwa3 215 -HEIDRMTLTMAVELPD--------S-----FSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 265 (364)
T ss_dssp -HHHHHHSSSCCCCCCS--------S-----SCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred -HHHHHhcccCCCCCCC--------C-----CCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence 1111111111111111 1 1235789999999999999999 6888765
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-46 Score=387.61 Aligned_cols=241 Identities=22% Similarity=0.333 Sum_probs=196.9
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCC---CccchHHHHHHHHHHh-ccCCCCcceeeEEEEecCceeEEEeccCC
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNG---GWQRFKEFQTEAEAIG-KIRHPNIVSLRAYFWSVDEKLLIYDYIPN 447 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~-~l~H~nIv~l~~~~~~~~~~~lV~e~~~~ 447 (686)
+.||+|+||+||+|+.. +++.||||+++.. .....+.+..|+.++. .++|||||++++++.+++..|+|||||++
T Consensus 8 ~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivmEy~~~ 87 (320)
T d1xjda_ 8 KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNG 87 (320)
T ss_dssp EEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred eEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEEeecCC
Confidence 46999999999999875 6889999999643 1233456777888766 68999999999999999999999999999
Q ss_pred CCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccC
Q 042348 448 GSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEE 527 (686)
Q Consensus 448 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 527 (686)
|+|.++++.. ..+++.++..++.||+.||+|||+ ++|+||||||+|||+++++.+||+|||+|+......
T Consensus 88 g~L~~~i~~~------~~~~e~~~~~~~~qi~~al~ylH~---~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~- 157 (320)
T d1xjda_ 88 GDLMYHIQSC------HKFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD- 157 (320)
T ss_dssp CBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT-
T ss_pred CcHHHHhhcc------CCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCcccceeecCCCceeccccchhhhccccc-
Confidence 9999999865 358999999999999999999999 899999999999999999999999999998543221
Q ss_pred CccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHH
Q 042348 528 TPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQ 607 (686)
Q Consensus 528 ~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~ 607 (686)
.......||+.|+|||++.+..++.++|||||||++|||+||+.||..... .+
T Consensus 158 ----------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~-----~~ 210 (320)
T d1xjda_ 158 ----------------------AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE-----EE 210 (320)
T ss_dssp ----------------------CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HH
T ss_pred ----------------------ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCH-----HH
Confidence 112345688899999999999999999999999999999999999954322 22
Q ss_pred HHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHH-HHHH
Q 042348 608 WIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMR-HVCD 663 (686)
Q Consensus 608 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~-ev~~ 663 (686)
....+.......+.. ...++.+++.+||+.||++|||+. |+++
T Consensus 211 ~~~~i~~~~~~~p~~-------------~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 211 LFHSIRMDNPFYPRW-------------LEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp HHHHHHHCCCCCCTT-------------SCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred HHHHHHcCCCCCCcc-------------CCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 233343333222211 123577999999999999999996 7765
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-46 Score=387.30 Aligned_cols=245 Identities=20% Similarity=0.287 Sum_probs=200.1
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCCccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCCHH
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSLA 451 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL~ 451 (686)
+.||+|+||+||+|... +++.||||.++.... +...+.+|+++|++++|||||++++++.+.+..|+|||||++|+|.
T Consensus 11 ~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~gg~L~ 89 (321)
T d1tkia_ 11 EDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIF 89 (321)
T ss_dssp EEEEECSSEEEEEEEETTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBHH
T ss_pred EEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecCCCCcHH
Confidence 46999999999999875 688999999976543 3356889999999999999999999999999999999999999999
Q ss_pred HHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCC--CCeEEeecCcccccccccCCc
Q 042348 452 TAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKN--MEPHISDFGLARLADIAEETP 529 (686)
Q Consensus 452 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~--~~~kl~DfGla~~~~~~~~~~ 529 (686)
+++.... ..+++.++..|+.||+.||+|||+ ++|+||||||+|||++.+ ..+||+|||+++......
T Consensus 90 ~~i~~~~-----~~l~e~~~~~i~~qi~~al~yLH~---~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~--- 158 (321)
T d1tkia_ 90 ERINTSA-----FELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD--- 158 (321)
T ss_dssp HHHTSSS-----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC---
T ss_pred HHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHH---cCCCcccccccceeecCCCceEEEEcccchhhccccCC---
Confidence 9998654 358999999999999999999999 999999999999999854 589999999998654221
Q ss_pred cccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHHH
Q 042348 530 EVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQWI 609 (686)
Q Consensus 530 ~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~ 609 (686)
......+|+.|+|||...+..|+.++||||+||++|||++|+.||..... .+.+
T Consensus 159 ---------------------~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~-----~~~~ 212 (321)
T d1tkia_ 159 ---------------------NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN-----QQII 212 (321)
T ss_dssp ---------------------EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH-----HHHH
T ss_pred ---------------------cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCH-----HHHH
Confidence 11234567789999999999999999999999999999999999955332 2334
Q ss_pred HHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 610 QLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 610 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
..+............+ . ...++.+++.+||+.||++|||+.|++++
T Consensus 213 ~~i~~~~~~~~~~~~~----~-----~s~~~~~li~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 213 ENIMNAEYTFDEEAFK----E-----ISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp HHHHHTCCCCCHHHHT----T-----SCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred HHHHhCCCCCChhhcc----C-----CCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 4444443322211111 1 12357799999999999999999999985
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-46 Score=381.84 Aligned_cols=257 Identities=26% Similarity=0.372 Sum_probs=199.4
Q ss_pred cccCccCceEEEEEEeCC--------CceEEEEEcCCCCc-cchHHHHHHHHHHhcc-CCCCcceeeEEEEecCceeEEE
Q 042348 373 FLLGKSTIGIVYKVALNN--------EEAVAVRRLGNGGW-QRFKEFQTEAEAIGKI-RHPNIVSLRAYFWSVDEKLLIY 442 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~ 442 (686)
+.||+|+||.||+|+... +..||||+++.... ....++.+|...+.++ +|||||+++++|.+++..++||
T Consensus 19 ~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~~~~~v~ 98 (299)
T d1fgka_ 19 KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIV 98 (299)
T ss_dssp EECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred eEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCCeEEEEE
Confidence 469999999999998532 24799999976533 3457789999999998 8999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCCc----------cccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeE
Q 042348 443 DYIPNGSLATAIHGKAGI----------ISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPH 512 (686)
Q Consensus 443 e~~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~k 512 (686)
|||++|+|.+++...... .....+++.++++++.||+.||+|||+ ++||||||||+|||++.++.+|
T Consensus 99 e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~---~~ivHrDiKp~NiLl~~~~~~k 175 (299)
T d1fgka_ 99 EYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMK 175 (299)
T ss_dssp CCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEE
T ss_pred EccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhh---CCEEeeeecccceeecCCCCeE
Confidence 999999999999865421 112468999999999999999999999 9999999999999999999999
Q ss_pred EeecCcccccccccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHh-C
Q 042348 513 ISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMIS-G 591 (686)
Q Consensus 513 l~DfGla~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G 591 (686)
|+|||+++........ .......+|+.|+|||.+.++.|+.++||||||||+|||+| |
T Consensus 176 l~dfg~~~~~~~~~~~---------------------~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g 234 (299)
T d1fgka_ 176 IADFGLARDIHHIDYY---------------------KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLG 234 (299)
T ss_dssp ECSTTCCCCGGGCCTT---------------------CCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTS
T ss_pred eccchhhccccccccc---------------------cccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCC
Confidence 9999999876533211 11234567888999999999999999999999999999998 6
Q ss_pred CCCccccCccchhHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccc
Q 042348 592 KLPMIQIGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRVNI 670 (686)
Q Consensus 592 ~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~ 670 (686)
..||...... +....+..+ ... .. . . .....+.+++.+||+.||++|||+.||++.|++|.+
T Consensus 235 ~~p~~~~~~~-----~~~~~i~~~-~~~-~~-p----~-----~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 235 GSPYPGVPVE-----ELFKLLKEG-HRM-DK-P----S-----NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp CCSSTTCCHH-----HHHHHHHTT-CCC-CC-C----S-----SCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCCCHH-----HHHHHHHcC-CCC-CC-C----c-----cchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence 8888433221 122222222 111 10 1 1 122358899999999999999999999999998854
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-46 Score=389.44 Aligned_cols=246 Identities=20% Similarity=0.344 Sum_probs=192.1
Q ss_pred cccCccCceEEEEEEe-CCCceEEEEEcCCCCccchHHHHHHHHHHhcc-CCCCcceeeEEEEe----cCceeEEEeccC
Q 042348 373 FLLGKSTIGIVYKVAL-NNEEAVAVRRLGNGGWQRFKEFQTEAEAIGKI-RHPNIVSLRAYFWS----VDEKLLIYDYIP 446 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~----~~~~~lV~e~~~ 446 (686)
.+||+|+||.||+|.. .+++.||||+++. ...+.+|++++.++ +|||||+++++|.+ ....++|||||+
T Consensus 18 ~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~~ 92 (335)
T d2ozaa1 18 QVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLD 92 (335)
T ss_dssp EEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCC
T ss_pred EEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEECCC
Confidence 3699999999999986 4689999999854 25678899997665 89999999999976 356799999999
Q ss_pred CCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecC---CCCeEEeecCcccccc
Q 042348 447 NGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGK---NMEPHISDFGLARLAD 523 (686)
Q Consensus 447 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~---~~~~kl~DfGla~~~~ 523 (686)
+|+|.+++..... ..+++.++..|+.||+.||+|||+ ++|+||||||+|||+++ ++.+||+|||+|+...
T Consensus 93 gg~L~~~i~~~~~----~~l~e~~~~~i~~qi~~al~ylH~---~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~ 165 (335)
T d2ozaa1 93 GGELFSRIQDRGD----QAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT 165 (335)
T ss_dssp SEEHHHHHHSCSC----CCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSTTCCEEECCCTTCEECC
T ss_pred CCcHHHHHHhcCC----CCcCHHHHHHHHHHHHHHHHHHHH---cCCccccccccccccccccccccccccccceeeecc
Confidence 9999999986532 469999999999999999999999 99999999999999985 5679999999998654
Q ss_pred cccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccch
Q 042348 524 IAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMEL 603 (686)
Q Consensus 524 ~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~ 603 (686)
... ......||+.|+|||++.+..|+.++|||||||++|||+||+.||........
T Consensus 166 ~~~------------------------~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~ 221 (335)
T d2ozaa1 166 SHN------------------------SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI 221 (335)
T ss_dssp CCC------------------------CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--
T ss_pred CCC------------------------ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHH
Confidence 322 11235678899999999999999999999999999999999999965433221
Q ss_pred hHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 604 NIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 604 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
.. ...... .... .+ .. .........++.+++.+||+.||++|||+.|++++
T Consensus 222 --~~---~~~~~i-~~~~-~~--~~-~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 222 --SP---GMKTRI-RMGQ-YE--FP-NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp -----------CC-CSCS-SS--CC-TTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred --HH---HHHHHH-hcCC-CC--CC-CcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 00 000000 0000 00 00 00011234568899999999999999999999885
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-46 Score=386.85 Aligned_cols=259 Identities=21% Similarity=0.322 Sum_probs=205.9
Q ss_pred hcccCccCceEEEEEEeC------CCceEEEEEcCCC-CccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEec
Q 042348 372 AFLLGKSTIGIVYKVALN------NEEAVAVRRLGNG-GWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDY 444 (686)
Q Consensus 372 ~~~iG~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~ 444 (686)
.+.||+|+||.||+|.+. ++..||||+++.. .......|.+|++++++++|||||++++++...+..++||||
T Consensus 25 ~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~ 104 (308)
T d1p4oa_ 25 SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMEL 104 (308)
T ss_dssp EEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred eeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCceeEEEee
Confidence 356999999999999864 2578999999754 334445789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCc----cccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCccc
Q 042348 445 IPNGSLATAIHGKAGI----ISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLAR 520 (686)
Q Consensus 445 ~~~gsL~~~l~~~~~~----~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~ 520 (686)
|++|+|.++++..... .....+++..+.+++.|+|+||.|||+ ++|+||||||+|||+++++++||+|||+|+
T Consensus 105 ~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~---~~ivHrDlk~~NiLld~~~~~Kl~DFGla~ 181 (308)
T d1p4oa_ 105 MTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTR 181 (308)
T ss_dssp CTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCSGGGEEECTTCCEEECCTTCCC
T ss_pred cCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhh---CCeeeceEcCCceeecCCceEEEeecccce
Confidence 9999999998753211 111357899999999999999999999 899999999999999999999999999998
Q ss_pred ccccccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCC-CCccccC
Q 042348 521 LADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGK-LPMIQIG 599 (686)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~-~P~~~~~ 599 (686)
........ .......+|+.|+|||.+.+..++.++|||||||++|||+||. .||...
T Consensus 182 ~~~~~~~~---------------------~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~- 239 (308)
T d1p4oa_ 182 DIYETDYY---------------------RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL- 239 (308)
T ss_dssp GGGGGGCE---------------------EGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS-
T ss_pred eccCCcce---------------------eeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCC-
Confidence 76533211 1123345788899999999999999999999999999999985 666432
Q ss_pred ccchhHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccccc
Q 042348 600 SMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRVNIS 671 (686)
Q Consensus 600 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~~ 671 (686)
+..+....+..+.. .+.. ......+.+++.+||+.||++||||.||+++|++....
T Consensus 240 ----~~~~~~~~i~~~~~--~~~p----------~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~ 295 (308)
T d1p4oa_ 240 ----SNEQVLRFVMEGGL--LDKP----------DNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 295 (308)
T ss_dssp ----CHHHHHHHHHTTCC--CCCC----------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCT
T ss_pred ----CHHHHHHHHHhCCC--CCCc----------ccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCC
Confidence 22333444433321 1110 11224688999999999999999999999999887543
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.6e-47 Score=387.89 Aligned_cols=259 Identities=25% Similarity=0.299 Sum_probs=203.2
Q ss_pred hcccCccCceEEEEEEeC------CCceEEEEEcCCCC-ccchHHHHHHHHHHhcc-CCCCcceeeEEEEecCceeEEEe
Q 042348 372 AFLLGKSTIGIVYKVALN------NEEAVAVRRLGNGG-WQRFKEFQTEAEAIGKI-RHPNIVSLRAYFWSVDEKLLIYD 443 (686)
Q Consensus 372 ~~~iG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~e 443 (686)
.+.||+|+||.||+|++. +++.||||+++... .....+|.+|+.+++++ +|||||++++++.+.+..++|||
T Consensus 28 ~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~~lvmE 107 (311)
T d1t46a_ 28 GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITE 107 (311)
T ss_dssp EEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred eeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEEEEEEE
Confidence 347999999999999852 45689999997643 34456799999999999 69999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCCc------------cccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCe
Q 042348 444 YIPNGSLATAIHGKAGI------------ISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEP 511 (686)
Q Consensus 444 ~~~~gsL~~~l~~~~~~------------~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~ 511 (686)
||++|+|.++++..... .....+++..+.+++.||+.||+|||+ ++||||||||+||+++.++.+
T Consensus 108 ~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~---~~ivHrDLKp~NIl~~~~~~~ 184 (311)
T d1t46a_ 108 YCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRIT 184 (311)
T ss_dssp CCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEETTTEE
T ss_pred cCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccccccccccccCcc
Confidence 99999999999865321 112368999999999999999999999 899999999999999999999
Q ss_pred EEeecCcccccccccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhC
Q 042348 512 HISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISG 591 (686)
Q Consensus 512 kl~DfGla~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG 591 (686)
|++|||+++........ .......||+.|+|||++.+..++.++|||||||++|||+|+
T Consensus 185 ki~DfG~~~~~~~~~~~---------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~ 243 (311)
T d1t46a_ 185 KICDFGLARDIKNDSNY---------------------VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSL 243 (311)
T ss_dssp EECCCGGGSCTTSCTTS---------------------EECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred cccccchheeccCCCcc---------------------eEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhC
Confidence 99999999865432211 122345678899999999999999999999999999999995
Q ss_pred CCCccccCccchhHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 042348 592 KLPMIQIGSMELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRVN 669 (686)
Q Consensus 592 ~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~ 669 (686)
..|+......... +..+........ . + ......+.+|+.+||+.||++||||.||++.|+++-
T Consensus 244 g~p~~~~~~~~~~----~~~~i~~~~~~~--~-~--------~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i 306 (311)
T d1t46a_ 244 GSSPYPGMPVDSK----FYKMIKEGFRML--S-P--------EHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI 306 (311)
T ss_dssp TCCSSTTCCSSHH----HHHHHHHTCCCC--C-C--------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCCCCHHHH----HHHHHhcCCCCC--C-c--------ccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhh
Confidence 5454332222222 222222222111 0 0 112246889999999999999999999999998764
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-46 Score=379.01 Aligned_cols=260 Identities=22% Similarity=0.309 Sum_probs=194.0
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCCc--cchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCC
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGGW--QRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGS 449 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gs 449 (686)
+.||+|+||+||+|... +++.||||+++.... ...+++.+|+++|++++|||||++++++.+.+..++||||+.+ +
T Consensus 8 ~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~~~~-~ 86 (298)
T d1gz8a_ 8 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-D 86 (298)
T ss_dssp EEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSE-E
T ss_pred cEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEeecCC-c
Confidence 36999999999999974 689999999965432 2357899999999999999999999999999999999999975 4
Q ss_pred HHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCc
Q 042348 450 LATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETP 529 (686)
Q Consensus 450 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 529 (686)
+.+++..... ..+++..+..++.|++.||+|||+ ++||||||||+|||++.++.+||+|||+|+......
T Consensus 87 ~~~~~~~~~~----~~l~e~~~~~~~~qil~~L~yLH~---~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~--- 156 (298)
T d1gz8a_ 87 LKKFMDASAL----TGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV--- 156 (298)
T ss_dssp HHHHHHHTTT----TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS---
T ss_pred hhhhhhhhcc----cCCCHHHHHHHHHHHHHHHHHhhc---CCEEccccCchheeecccCcceeccCCcceeccCCc---
Confidence 4444433321 469999999999999999999999 899999999999999999999999999998654221
Q ss_pred cccccccccCCCCCCCccccccccCCCCCccccCcccccCCC-CCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHH
Q 042348 530 EVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRK-PTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQW 608 (686)
Q Consensus 530 ~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~ 608 (686)
.......||..|+|||.+.... ++.++||||+||++|||++|+.||......+ .
T Consensus 157 --------------------~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~--~--- 211 (298)
T d1gz8a_ 157 --------------------RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID--Q--- 211 (298)
T ss_dssp --------------------BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--H---
T ss_pred --------------------ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHH--H---
Confidence 1122346788899999876655 5889999999999999999999996443221 1
Q ss_pred HHHHHhhcCCcccccCccc------ccC----C--Cc----HHHHHHHHHHHHhccccCCCCCCCHHHHHHH--Hhcc
Q 042348 609 IQLILEDRKPMTDILDPFL------AHD----L--DK----EDEIVSVLKIALDCVHKSPDKRPSMRHVCDS--LDRV 668 (686)
Q Consensus 609 ~~~~~~~~~~~~~~~d~~l------~~~----~--~~----~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~--L~~i 668 (686)
...+........+...+.. ... . .. .....++.+++.+||+.||++|||++|++++ ++++
T Consensus 212 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~ 289 (298)
T d1gz8a_ 212 LFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 289 (298)
T ss_dssp HHHHHHHHCCCCTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTC
T ss_pred HHHHHHhcCCCchhhccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccC
Confidence 1122111111111000000 000 0 00 0112467899999999999999999999987 5554
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=8.1e-45 Score=369.66 Aligned_cols=257 Identities=22% Similarity=0.309 Sum_probs=193.7
Q ss_pred cccCccCceEEEEEEeCCCceEEEEEcCCCC--ccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCCH
Q 042348 373 FLLGKSTIGIVYKVALNNEEAVAVRRLGNGG--WQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGSL 450 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL 450 (686)
+.||+|+||+||+|+.++++.||||++.... ....+++.+|+.+|++++|||||++++++.+.+..+++|||+.++.+
T Consensus 8 ~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~~~~~~ 87 (286)
T d1ob3a_ 8 EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLK 87 (286)
T ss_dssp EEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSEEHH
T ss_pred cEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEeehhhhH
Confidence 3599999999999999999999999996643 23357899999999999999999999999999999999999988777
Q ss_pred HHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCcc
Q 042348 451 ATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETPE 530 (686)
Q Consensus 451 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 530 (686)
..+.... ..+++..+..|+.||+.||+|||+ ++||||||||+|||++.++.+|++|||.|........
T Consensus 88 ~~~~~~~------~~l~~~~~~~i~~qi~~~L~~LH~---~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~--- 155 (286)
T d1ob3a_ 88 KLLDVCE------GGLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR--- 155 (286)
T ss_dssp HHHHTST------TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred HHHHhhc------CCcchhhhHHHHHHHHHHHHHhcc---CcEEecCCCCceeeEcCCCCEEecccccceecccCcc---
Confidence 7766544 469999999999999999999999 8999999999999999999999999999986542211
Q ss_pred ccccccccCCCCCCCccccccccCCCCCccccCcccccC-CCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHHH
Q 042348 531 VHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKV-RKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQWI 609 (686)
Q Consensus 531 ~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~ 609 (686)
......++..|+|||.+.+ ..++.++|||||||++|||++|+.||...... +....+
T Consensus 156 --------------------~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~--~~~~~i 213 (286)
T d1ob3a_ 156 --------------------KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEA--DQLMRI 213 (286)
T ss_dssp --------------------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHH
T ss_pred --------------------ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHH--HHHHHH
Confidence 1123356778999999865 45699999999999999999999999654321 111111
Q ss_pred HHHHhhcCCccccc--------Cccccc-CC-----CcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 610 QLILEDRKPMTDIL--------DPFLAH-DL-----DKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 610 ~~~~~~~~~~~~~~--------d~~l~~-~~-----~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
...... ....... +..... .. ........+.+++.+||+.||++|||++|++++
T Consensus 214 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H 281 (286)
T d1ob3a_ 214 FRILGT-PNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (286)
T ss_dssp HHHHCC-CCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHhhCC-CChhhccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 111111 0000000 000000 00 001122467899999999999999999999864
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-45 Score=372.14 Aligned_cols=239 Identities=19% Similarity=0.272 Sum_probs=191.8
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCCc------cchHHHHHHHHHHhccC--CCCcceeeEEEEecCceeEEEe
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGGW------QRFKEFQTEAEAIGKIR--HPNIVSLRAYFWSVDEKLLIYD 443 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~--H~nIv~l~~~~~~~~~~~lV~e 443 (686)
+.||+|+||.||+|+.. +++.||||++..... ....++.+|+.++++++ |||||++++++.+.+..++|||
T Consensus 10 ~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~~~lv~e 89 (273)
T d1xwsa_ 10 PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILE 89 (273)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEEEE
T ss_pred EEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCeEEEEEE
Confidence 46999999999999875 689999999864321 12245778999999996 8999999999999999999999
Q ss_pred ccCC-CCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecC-CCCeEEeecCcccc
Q 042348 444 YIPN-GSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGK-NMEPHISDFGLARL 521 (686)
Q Consensus 444 ~~~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~-~~~~kl~DfGla~~ 521 (686)
|+.+ +++.+++... ..+++.++..++.|++.||+|||+ ++|+||||||+|||++. ++.+||+|||+|+.
T Consensus 90 ~~~~~~~l~~~~~~~------~~l~e~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~ 160 (273)
T d1xwsa_ 90 RPEPVQDLFDFITER------GALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGAL 160 (273)
T ss_dssp CCSSEEEHHHHHHHH------CSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred eccCcchHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHH---CCCccccCcccceEEecCCCeEEECcccccee
Confidence 9976 6888888754 469999999999999999999999 99999999999999985 47899999999975
Q ss_pred cccccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCC-CCcchHHHHHHHHHHHHhCCCCccccCc
Q 042348 522 ADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKP-TQKWDIYSYGVILLEMISGKLPMIQIGS 600 (686)
Q Consensus 522 ~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDVwSlGvvl~elltG~~P~~~~~~ 600 (686)
.... ..+...||+.|+|||++.+..+ +.++||||+||++|||+||+.||...
T Consensus 161 ~~~~-------------------------~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~-- 213 (273)
T d1xwsa_ 161 LKDT-------------------------VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD-- 213 (273)
T ss_dssp CCSS-------------------------CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH--
T ss_pred cccc-------------------------cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCc--
Confidence 4321 1124568889999999877665 67799999999999999999999431
Q ss_pred cchhHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH--Hhccc
Q 042348 601 MELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS--LDRVN 669 (686)
Q Consensus 601 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~--L~~i~ 669 (686)
..+.......... ...++.+++.+||+.||++|||++|++++ ++++.
T Consensus 214 ---------~~i~~~~~~~~~~-------------~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~~ 262 (273)
T d1xwsa_ 214 ---------EEIIRGQVFFRQR-------------VSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 262 (273)
T ss_dssp ---------HHHHHCCCCCSSC-------------CCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred ---------hHHhhcccCCCCC-------------CCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCCC
Confidence 1122222221111 12357789999999999999999999886 55543
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-44 Score=370.28 Aligned_cols=260 Identities=22% Similarity=0.263 Sum_probs=192.0
Q ss_pred ccCccCceEEEEEEeC-C-CceEEEEEcCCC--CccchHHHHHHHHHHhcc---CCCCcceeeEEEEe-----cCceeEE
Q 042348 374 LLGKSTIGIVYKVALN-N-EEAVAVRRLGNG--GWQRFKEFQTEAEAIGKI---RHPNIVSLRAYFWS-----VDEKLLI 441 (686)
Q Consensus 374 ~iG~G~~g~Vy~~~~~-~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l---~H~nIv~l~~~~~~-----~~~~~lV 441 (686)
.||+|+||+||+|+.. + ++.||||+++.. .......+.+|+.+++.+ +||||++++++|.. ....+++
T Consensus 14 ~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~~~~~~~ 93 (305)
T d1blxa_ 14 EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLV 93 (305)
T ss_dssp EEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEEEE
T ss_pred EEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccccCceEEEE
Confidence 5999999999999874 3 567999998543 222234577888887766 79999999999864 2457999
Q ss_pred EeccCCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccc
Q 042348 442 YDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARL 521 (686)
Q Consensus 442 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~ 521 (686)
|||++++++........ ..+++..+..++.|++.||+|||+ ++||||||||+|||+++++.+||+|||+++.
T Consensus 94 ~e~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~qi~~aL~yLH~---~~ivHrDiKp~NILi~~~~~~kl~dfg~~~~ 165 (305)
T d1blxa_ 94 FEHVDQDLTTYLDKVPE-----PGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARI 165 (305)
T ss_dssp EECCSCBHHHHHHHSCT-----TCSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECSCCSCCC
T ss_pred EEeccCCchhhhhhccC-----CCCCHHHHHHHHHHHHHHHHHHHh---CCEEecCCCccEEEEcCCCCeeecchhhhhh
Confidence 99999887766555443 468999999999999999999999 9999999999999999999999999999875
Q ss_pred cccccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCcc
Q 042348 522 ADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSM 601 (686)
Q Consensus 522 ~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~ 601 (686)
..... ......||+.|+|||++.+..|+.++||||+||++|||+||+.||.....
T Consensus 166 ~~~~~------------------------~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~- 220 (305)
T d1blxa_ 166 YSFQM------------------------ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD- 220 (305)
T ss_dssp CCGGG------------------------GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-
T ss_pred hcccc------------------------cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCH-
Confidence 43221 22345688899999999999999999999999999999999999964432
Q ss_pred chhHHHHHHHHHhhcCCcccccCc-------ccc-cCCC-----cHHHHHHHHHHHHhccccCCCCCCCHHHHHHH--Hh
Q 042348 602 ELNIVQWIQLILEDRKPMTDILDP-------FLA-HDLD-----KEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS--LD 666 (686)
Q Consensus 602 ~~~~~~~~~~~~~~~~~~~~~~d~-------~l~-~~~~-----~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~--L~ 666 (686)
.+....+...... +....... ... .... .......+.+++.+||++||++|||++|+++| ++
T Consensus 221 -~~~~~~i~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~ 297 (305)
T d1blxa_ 221 -VDQLGKILDVIGL--PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQ 297 (305)
T ss_dssp -HHHHHHHHHHHCC--CCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGT
T ss_pred -HHHHHHHHHhhCC--CchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhc
Confidence 2222212111111 00000000 000 0000 00122357789999999999999999999886 55
Q ss_pred ccc
Q 042348 667 RVN 669 (686)
Q Consensus 667 ~i~ 669 (686)
++.
T Consensus 298 ~i~ 300 (305)
T d1blxa_ 298 DLE 300 (305)
T ss_dssp TCC
T ss_pred Cch
Confidence 554
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-43 Score=365.43 Aligned_cols=257 Identities=21% Similarity=0.309 Sum_probs=188.3
Q ss_pred ccCccCceEEEEEEeC-CCceEEEEEcCCC--CccchHHHHHHHHHHhccCCCCcceeeEEEEecC------ceeEEEec
Q 042348 374 LLGKSTIGIVYKVALN-NEEAVAVRRLGNG--GWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVD------EKLLIYDY 444 (686)
Q Consensus 374 ~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~------~~~lV~e~ 444 (686)
.||+|+||+||+|... +|+.||||+++.. .....+.+.+|+++|++++|||||+++++|...+ +.++||||
T Consensus 25 ~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~ 104 (346)
T d1cm8a_ 25 PVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPF 104 (346)
T ss_dssp EC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEEC
T ss_pred EEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccceEEEEEec
Confidence 5999999999999865 5899999999754 2233567899999999999999999999998654 46999999
Q ss_pred cCCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCccccccc
Q 042348 445 IPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADI 524 (686)
Q Consensus 445 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~ 524 (686)
| +.+|..+++. ..+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+|++|||+|+....
T Consensus 105 ~-~~~l~~~~~~-------~~l~~~~~~~~~~qi~~aL~~LH~---~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~ 173 (346)
T d1cm8a_ 105 M-GTDLGKLMKH-------EKLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQADS 173 (346)
T ss_dssp C-SEEHHHHHHH-------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred c-cccHHHHHHh-------ccccHHHHHHHHHHHHHHHHHHHh---CCCcccccCcchhhcccccccccccccceeccCC
Confidence 9 6688887754 359999999999999999999999 9999999999999999999999999999985432
Q ss_pred ccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccC-CCCCCcchHHHHHHHHHHHHhCCCCccccCccch
Q 042348 525 AEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKV-RKPTQKWDIYSYGVILLEMISGKLPMIQIGSMEL 603 (686)
Q Consensus 525 ~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~ 603 (686)
. .+...||..|+|||++.+ ..++.++||||+||++|||++|+.||......
T Consensus 174 ~--------------------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~-- 225 (346)
T d1cm8a_ 174 E--------------------------MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHL-- 225 (346)
T ss_dssp S--------------------------CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH--
T ss_pred c--------------------------cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChH--
Confidence 1 134567888999999876 45789999999999999999999999554321
Q ss_pred hHHHHHHHHHhhc-----------------CCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH--
Q 042348 604 NIVQWIQLILEDR-----------------KPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS-- 664 (686)
Q Consensus 604 ~~~~~~~~~~~~~-----------------~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~-- 664 (686)
............. ....+.....+.... ......+.+++.+||+.||++|||++|+++|
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~ 303 (346)
T d1cm8a_ 226 DQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASIL--TNASPLAVNLLEKMLVLDAEQRVTAGEALAHPY 303 (346)
T ss_dssp HHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTC--TTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGG
T ss_pred HHHHHHHhccCCCcHHHHhhhcchhhhhhhccCCcccccchHHhc--cCCCHHHHHHHHHHCcCChhHCcCHHHHhcChh
Confidence 1111111110000 000000000000000 0112357789999999999999999999997
Q ss_pred Hhccccc
Q 042348 665 LDRVNIS 671 (686)
Q Consensus 665 L~~i~~~ 671 (686)
++.+...
T Consensus 304 f~~~~~~ 310 (346)
T d1cm8a_ 304 FESLHDT 310 (346)
T ss_dssp GTTTC--
T ss_pred hCcCCCc
Confidence 7776533
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-43 Score=360.83 Aligned_cols=261 Identities=18% Similarity=0.248 Sum_probs=190.4
Q ss_pred ccCccCceEEEEEEeC-CCceEEEEEcCCC--CccchHHHHHHHHHHhccCCCCcceeeEEEEe--------cCceeEEE
Q 042348 374 LLGKSTIGIVYKVALN-NEEAVAVRRLGNG--GWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWS--------VDEKLLIY 442 (686)
Q Consensus 374 ~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~--------~~~~~lV~ 442 (686)
.||+|+||+||+|+.. +|+.||||++... .....+++.+|+++|++++||||+++++++.. .+..++||
T Consensus 17 ~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~~~~~iv~ 96 (318)
T d3blha1 17 KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVF 96 (318)
T ss_dssp EEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC----------CEEEEE
T ss_pred EEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccCceEEEEE
Confidence 5999999999999974 6899999998653 22345678999999999999999999999865 34578999
Q ss_pred eccCCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCccccc
Q 042348 443 DYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLA 522 (686)
Q Consensus 443 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~ 522 (686)
||+.++.+....... ..++...++.|+.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++..
T Consensus 97 e~~~~~~~~~~~~~~------~~~~~~~~~~i~~qil~~l~~lH~---~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~ 167 (318)
T d3blha1 97 DFCEHDLAGLLSNVL------VKFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLARAF 167 (318)
T ss_dssp ECCCEEHHHHHTCTT------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred eccCCCccchhhhcc------cccccHHHHHHHHHHHHHHHHhcc---CCEEecCcCchheeecCCCcEEeeecceeeec
Confidence 999887766554433 468899999999999999999999 89999999999999999999999999999866
Q ss_pred ccccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCC-CCCCcchHHHHHHHHHHHHhCCCCccccCcc
Q 042348 523 DIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVR-KPTQKWDIYSYGVILLEMISGKLPMIQIGSM 601 (686)
Q Consensus 523 ~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlGvvl~elltG~~P~~~~~~~ 601 (686)
....... ........||..|+|||++.+. .+++++||||+||++|||++|+.||....
T Consensus 168 ~~~~~~~-------------------~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~-- 226 (318)
T d3blha1 168 SLAKNSQ-------------------PNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNT-- 226 (318)
T ss_dssp CC------------------------CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSS--
T ss_pred ccccccc-------------------cccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCC--
Confidence 4322110 0122345689999999998765 68999999999999999999999995432
Q ss_pred chhHHHHHHHHHhhcCC-c-ccccCccc-------cc-CCCcHH------HHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 602 ELNIVQWIQLILEDRKP-M-TDILDPFL-------AH-DLDKED------EIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 602 ~~~~~~~~~~~~~~~~~-~-~~~~d~~l-------~~-~~~~~~------~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
.......+........+ . ........ .. .....+ ....+.+++.+||+.||++|||++|+++|
T Consensus 227 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 227 EQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp HHHHHHHHHHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHHHHHhcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 22222222222221100 0 00000000 00 000011 12346789999999999999999999876
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.9e-43 Score=357.68 Aligned_cols=257 Identities=19% Similarity=0.226 Sum_probs=191.8
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCCccchHHHHHHHHHHhccCCCCcce-eeEEEEecCceeEEEeccCCCCH
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVS-LRAYFWSVDEKLLIYDYIPNGSL 450 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~-l~~~~~~~~~~~lV~e~~~~gsL 450 (686)
+.||+|+||.||+|... +++.||||.+..... .+++..|++++++++|+|++. +.+++.+.+..++||||+ +|++
T Consensus 13 ~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~-~~~l 89 (299)
T d1ckia_ 13 RKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSL 89 (299)
T ss_dssp EEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC-CCBH
T ss_pred EEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEc-CCch
Confidence 46999999999999864 588999998765432 246889999999998766554 555566777889999999 5677
Q ss_pred HHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeec---CCCCeEEeecCcccccccccC
Q 042348 451 ATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLG---KNMEPHISDFGLARLADIAEE 527 (686)
Q Consensus 451 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~---~~~~~kl~DfGla~~~~~~~~ 527 (686)
.+.+.... ..+++..+..++.|++.||+|||+ ++||||||||+|||++ .+..+||+|||+|+.+.....
T Consensus 90 ~~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~---~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~ 161 (299)
T d1ckia_ 90 EDLFNFCS-----RKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART 161 (299)
T ss_dssp HHHHHHTT-----TCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTT
T ss_pred hhhhhhcc-----CCCcHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHhhccccccCCCceeeeeccCcceecccccc
Confidence 77766543 469999999999999999999999 9999999999999975 456799999999997754332
Q ss_pred CccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhHHH
Q 042348 528 TPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQ 607 (686)
Q Consensus 528 ~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~ 607 (686)
.... .........||+.|+|||.+.+..++.++|||||||++|||+||+.||......... .
T Consensus 162 ~~~~----------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~--~ 223 (299)
T d1ckia_ 162 HQHI----------------PYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKR--Q 223 (299)
T ss_dssp CCBC----------------CCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC--------
T ss_pred ccce----------------eccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHH--H
Confidence 1110 011223567899999999999999999999999999999999999999654432221 1
Q ss_pred HHHHHHhh--cCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 042348 608 WIQLILED--RKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRV 668 (686)
Q Consensus 608 ~~~~~~~~--~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i 668 (686)
.+...... ..+... +.. ..+.++.+++.+||+.+|++||++.++.+.|+.+
T Consensus 224 ~~~~~~~~~~~~~~~~-----~~~-----~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~ 276 (299)
T d1ckia_ 224 KYERISEKKMSTPIEV-----LCK-----GYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 276 (299)
T ss_dssp -HHHHHHHHHHSCHHH-----HTT-----TSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHH
T ss_pred HHHHhhcccCCCChhH-----hcc-----CCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 11111111 011111 000 1224578899999999999999999998888775
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-42 Score=362.81 Aligned_cols=262 Identities=23% Similarity=0.329 Sum_probs=191.5
Q ss_pred cccCccCceEEEEEEe-CCCceEEEEEcCCCC-ccchHHHHHHHHHHhccCCCCcceeeEEEEecC----ceeEEEeccC
Q 042348 373 FLLGKSTIGIVYKVAL-NNEEAVAVRRLGNGG-WQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVD----EKLLIYDYIP 446 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~----~~~lV~e~~~ 446 (686)
..||+|+||+||+|.. .+++.||||++.... ....+++.+|+++|++++||||+++++++.... ..+++++|+.
T Consensus 14 ~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l~~~~~ 93 (345)
T d1pmea_ 14 SYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLM 93 (345)
T ss_dssp EECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEECC
T ss_pred EEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEEEEeec
Confidence 3699999999999986 478999999997543 334567899999999999999999999997653 2355566677
Q ss_pred CCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCccccccccc
Q 042348 447 NGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAE 526 (686)
Q Consensus 447 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~ 526 (686)
+|+|.+++... .+++..+..++.|++.||+|||+ ++||||||||+|||+++++.+||+|||+|+......
T Consensus 94 ~g~L~~~l~~~-------~l~~~~i~~i~~qil~al~yLH~---~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~ 163 (345)
T d1pmea_ 94 GADLYKLLKTQ-------HLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 163 (345)
T ss_dssp CEEHHHHHHHC-------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGG
T ss_pred CCchhhhhhcC-------CCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCcceEEECCCCCEEEcccCceeeccCCC
Confidence 99999999743 58999999999999999999999 899999999999999999999999999998664332
Q ss_pred CCccccccccccCCCCCCCccccccccCCCCCccccCcccccC-CCCCCcchHHHHHHHHHHHHhCCCCccccCccchhH
Q 042348 527 ETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKV-RKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNI 605 (686)
Q Consensus 527 ~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~ 605 (686)
... ......+||..|+|||.+.. ..++.++||||+||++|||++|+.||......+ .
T Consensus 164 ~~~--------------------~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~--~ 221 (345)
T d1pmea_ 164 DHT--------------------GFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD--Q 221 (345)
T ss_dssp CBC--------------------CTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--H
T ss_pred ccc--------------------eeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHH--H
Confidence 110 11234567889999999844 567899999999999999999999995543221 1
Q ss_pred HHHHHHHHhhcCCccccc--------------CcccccCCCcH----HHHHHHHHHHHhccccCCCCCCCHHHHHHH--H
Q 042348 606 VQWIQLILEDRKPMTDIL--------------DPFLAHDLDKE----DEIVSVLKIALDCVHKSPDKRPSMRHVCDS--L 665 (686)
Q Consensus 606 ~~~~~~~~~~~~~~~~~~--------------d~~l~~~~~~~----~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~--L 665 (686)
.......... +..... .+.. ...... ....++.+++.+||+.||++|||+.|++++ +
T Consensus 222 ~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~ 298 (345)
T d1pmea_ 222 LNHILGILGS--PSQEDLNCIINLKARNYLLSLPHK-NKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 298 (345)
T ss_dssp HHHHHHHHCS--CCHHHHHTCCCHHHHHHHHTSCCC-CCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGG
T ss_pred HHHHhhhccC--CChhhhhhhhhhhhhcccccCCcc-CCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhh
Confidence 1111111100 000000 0000 000000 011357899999999999999999999987 5
Q ss_pred hccc
Q 042348 666 DRVN 669 (686)
Q Consensus 666 ~~i~ 669 (686)
++..
T Consensus 299 ~~~~ 302 (345)
T d1pmea_ 299 EQYY 302 (345)
T ss_dssp TTTC
T ss_pred ccCC
Confidence 5443
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-43 Score=367.70 Aligned_cols=260 Identities=23% Similarity=0.333 Sum_probs=188.0
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCCccchHHHHHHHHHHhccCCCCcceeeEEEEec------CceeEEEecc
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSV------DEKLLIYDYI 445 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~------~~~~lV~e~~ 445 (686)
++||+|+||+||+|+.. +++.||||++.... ..+.+|+++|++++|||||+++++|... .+.++|||||
T Consensus 26 k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey~ 101 (350)
T d1q5ka_ 26 KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV 101 (350)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEECCS----SSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEECC
T ss_pred eEEeeCcCeEEEEEEECCCCCEEEEEEECccc----hHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEEecc
Confidence 46999999999999975 58999999996543 2235799999999999999999998643 2468999999
Q ss_pred CCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCC-CeEEeecCccccccc
Q 042348 446 PNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNM-EPHISDFGLARLADI 524 (686)
Q Consensus 446 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~-~~kl~DfGla~~~~~ 524 (686)
+++.+..+.+.... ...+++.+++.|+.||+.||+|||+ ++|+||||||+|||++.++ .+||+|||+++....
T Consensus 102 ~~~~~~~l~~~~~~---~~~l~~~~~~~i~~qil~aL~yLH~---~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~ 175 (350)
T d1q5ka_ 102 PETVYRVARHYSRA---KQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR 175 (350)
T ss_dssp SEEHHHHHHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTTCCEEECCCTTCEECCT
T ss_pred CCccHHHHHhhhhc---cCCCCHHHHHHHHHHHHHHHHHHHh---cCCcccCCCcceEEEecCCCceeEecccchhhccC
Confidence 87644444332111 1469999999999999999999999 9999999999999999775 899999999986543
Q ss_pred ccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccC-CCCCCcchHHHHHHHHHHHHhCCCCccccCccch
Q 042348 525 AEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKV-RKPTQKWDIYSYGVILLEMISGKLPMIQIGSMEL 603 (686)
Q Consensus 525 ~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~ 603 (686)
... .....||..|+|||.+.+ ..++.++||||+||++|||++|+.||......+
T Consensus 176 ~~~------------------------~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~- 230 (350)
T d1q5ka_ 176 GEP------------------------NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD- 230 (350)
T ss_dssp TSC------------------------CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHH-
T ss_pred Ccc------------------------cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHH-
Confidence 221 123467788999998765 568999999999999999999999995443221
Q ss_pred hHHHHHHHHHh---------hcC-----CcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH--Hhc
Q 042348 604 NIVQWIQLILE---------DRK-----PMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS--LDR 667 (686)
Q Consensus 604 ~~~~~~~~~~~---------~~~-----~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~--L~~ 667 (686)
.+...+ .... ... ........... .........++.+++.+||+.||++|||+.|++++ +++
T Consensus 231 ~l~~i~-~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~ 308 (350)
T d1q5ka_ 231 QLVEII-KVLGTPTREQIREMNPNYTEFKFPQIKAHPWT-KVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDE 308 (350)
T ss_dssp HHHHHH-HHHCCCCHHHHHHHCC---CCCCCCCCCCCGG-GTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGG
T ss_pred HHHHHH-HHhCCChHHhhhhhccchhhccccccccCchh-hhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcc
Confidence 111111 1100 000 00000000000 00011123457899999999999999999999976 555
Q ss_pred cc
Q 042348 668 VN 669 (686)
Q Consensus 668 i~ 669 (686)
+.
T Consensus 309 ~~ 310 (350)
T d1q5ka_ 309 LR 310 (350)
T ss_dssp GG
T ss_pred cc
Confidence 54
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=2e-42 Score=352.33 Aligned_cols=258 Identities=16% Similarity=0.218 Sum_probs=200.7
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCCccchHHHHHHHHHHhccCC-CCcceeeEEEEecCceeEEEeccCCCCH
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRH-PNIVSLRAYFWSVDEKLLIYDYIPNGSL 450 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H-~nIv~l~~~~~~~~~~~lV~e~~~~gsL 450 (686)
+.||+|+||+||+|+.. +++.||||.+.... ....+.+|++.++.++| +||+.+++++......++||||+ +|+|
T Consensus 11 ~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~-~~~l 87 (293)
T d1csna_ 11 RRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSL 87 (293)
T ss_dssp EEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CCBH
T ss_pred EEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec-CCCH
Confidence 46999999999999965 58899999885542 23467889999999965 89999999999999999999999 7899
Q ss_pred HHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecC-----CCCeEEeecCcccccccc
Q 042348 451 ATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGK-----NMEPHISDFGLARLADIA 525 (686)
Q Consensus 451 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~-----~~~~kl~DfGla~~~~~~ 525 (686)
.+++.... ..+++.++..++.|++.||+|||+ ++|+||||||+|||++. ++.+||+|||+|+.....
T Consensus 88 ~~~~~~~~-----~~~~~~~~~~i~~q~~~~l~~lH~---~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~ 159 (293)
T d1csna_ 88 EDLLDLCG-----RKFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDP 159 (293)
T ss_dssp HHHHHHTT-----TCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCT
T ss_pred HHHHHhhc-----cchhhHHHHHHHHHHHHHHHHHHH---CCceeccCCccceeecCcccccCCceEEcccceeEEcccC
Confidence 99987654 468999999999999999999999 99999999999999974 578999999999976543
Q ss_pred cCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccchhH
Q 042348 526 EETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNI 605 (686)
Q Consensus 526 ~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~ 605 (686)
...... .........||+.|+|||++.+..++.++|||||||++|||+||+.||........
T Consensus 160 ~~~~~~----------------~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~-- 221 (293)
T d1csna_ 160 VTKQHI----------------PYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATN-- 221 (293)
T ss_dssp TTCCBC----------------CCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCH--
T ss_pred ccccce----------------eecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhH--
Confidence 221100 00123346789999999999999999999999999999999999999965433221
Q ss_pred HHHHHHHHhhc--CCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 042348 606 VQWIQLILEDR--KPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDSLDRVN 669 (686)
Q Consensus 606 ~~~~~~~~~~~--~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~ 669 (686)
......+.... .+..+. ... .+.++.+++..|++.+|++||+++.+.+.|+++-
T Consensus 222 ~~~~~~i~~~~~~~~~~~l-----~~~-----~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~ 277 (293)
T d1csna_ 222 KQKYERIGEKKQSTPLREL-----CAG-----FPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVL 277 (293)
T ss_dssp HHHHHHHHHHHHHSCHHHH-----TTT-----SCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred HHHHHHHHhccCCCChHHh-----cCC-----CCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 11122221111 111111 111 1235778899999999999999999988887763
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-42 Score=358.12 Aligned_cols=251 Identities=22% Similarity=0.310 Sum_probs=197.0
Q ss_pred cccCccCceEEEEEEeC----CCceEEEEEcCCCC----ccchHHHHHHHHHHhccCC-CCcceeeEEEEecCceeEEEe
Q 042348 373 FLLGKSTIGIVYKVALN----NEEAVAVRRLGNGG----WQRFKEFQTEAEAIGKIRH-PNIVSLRAYFWSVDEKLLIYD 443 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~----~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~H-~nIv~l~~~~~~~~~~~lV~e 443 (686)
+.||+|+||+||+|... +|+.||||.++... ....+.+.+|++++++++| |||+++++++.+.+..++|||
T Consensus 30 ~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~~~v~e 109 (322)
T d1vzoa_ 30 KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILD 109 (322)
T ss_dssp EEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEEEEC
T ss_pred EEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCceeeeee
Confidence 46999999999999852 47899999986532 2234678899999999966 899999999999999999999
Q ss_pred ccCCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccc
Q 042348 444 YIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLAD 523 (686)
Q Consensus 444 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~ 523 (686)
|+.+|+|.+++... ..+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+|+...
T Consensus 110 ~~~~~~L~~~i~~~------~~~~e~~~~~~~~Qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~ 180 (322)
T d1vzoa_ 110 YINGGELFTHLSQR------ERFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFV 180 (322)
T ss_dssp CCCSCBHHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred cccccHHHHHHHhc------ccccHHHHHHHHHHHHHHHHHhhc---CCEEeccCCccceeecCCCCEEEeeccchhhhc
Confidence 99999999999865 357889999999999999999999 899999999999999999999999999998664
Q ss_pred cccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCC--CCCCcchHHHHHHHHHHHHhCCCCccccCcc
Q 042348 524 IAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVR--KPTQKWDIYSYGVILLEMISGKLPMIQIGSM 601 (686)
Q Consensus 524 ~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDVwSlGvvl~elltG~~P~~~~~~~ 601 (686)
.... .......|++.|+|||.+.+. .++.++|||||||++|||+||+.||......
T Consensus 181 ~~~~----------------------~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~ 238 (322)
T d1vzoa_ 181 ADET----------------------ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEK 238 (322)
T ss_dssp GGGG----------------------GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSC
T ss_pred cccc----------------------ccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHH
Confidence 3221 112234577789999998754 4688999999999999999999999655433
Q ss_pred chhHHHHHHHHHhhcCCcccccCcccccCCCcHHHHHHHHHHHHhccccCCCCCCC-----HHHHHHH--Hhcc
Q 042348 602 ELNIVQWIQLILEDRKPMTDILDPFLAHDLDKEDEIVSVLKIALDCVHKSPDKRPS-----MRHVCDS--LDRV 668 (686)
Q Consensus 602 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~ev~~~--L~~i 668 (686)
+. .............+.+. ....++.+++.+||++||++||| ++|+++| ++++
T Consensus 239 ~~-~~~i~~~~~~~~~~~~~-------------~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i 298 (322)
T d1vzoa_ 239 NS-QAEISRRILKSEPPYPQ-------------EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKI 298 (322)
T ss_dssp CC-HHHHHHHHHHCCCCCCT-------------TSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTC
T ss_pred HH-HHHHHHhcccCCCCCcc-------------cCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCC
Confidence 22 22222222222222111 12246788999999999999994 7888875 4444
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=3.5e-42 Score=357.30 Aligned_cols=252 Identities=20% Similarity=0.282 Sum_probs=189.8
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCCccchHHHHHHHHHHhccC-CCCcceeeEEEEec--CceeEEEeccCCC
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIR-HPNIVSLRAYFWSV--DEKLLIYDYIPNG 448 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~--~~~~lV~e~~~~g 448 (686)
..||+|+||+||+|+.. +++.||||+++.. ..+++.+|+++|++++ ||||+++++++... ...++|||||+++
T Consensus 41 ~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~~~~ 117 (328)
T d3bqca1 41 RKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNT 117 (328)
T ss_dssp EEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEECCCSC
T ss_pred EEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEeecCCC
Confidence 46999999999999874 6889999999764 3467899999999995 99999999999854 5689999999999
Q ss_pred CHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCC-CeEEeecCcccccccccC
Q 042348 449 SLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNM-EPHISDFGLARLADIAEE 527 (686)
Q Consensus 449 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~-~~kl~DfGla~~~~~~~~ 527 (686)
+|..+. +.+++.++..++.||+.||+|||+ ++|+||||||+|||++.++ .+||+|||+|+.......
T Consensus 118 ~L~~~~---------~~l~e~~i~~i~~qil~aL~~LH~---~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~~ 185 (328)
T d3bqca1 118 DFKQLY---------QTLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE 185 (328)
T ss_dssp BGGGTT---------TSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTCC
T ss_pred cHHHHh---------cCCCHHHHHHHHHHHHHHHHHHhh---cccccccccccceEEcCCCCeeeecccccceeccCCCc
Confidence 998764 358999999999999999999999 9999999999999998655 589999999986543221
Q ss_pred CccccccccccCCCCCCCccccccccCCCCCccccCcccccCC-CCCCcchHHHHHHHHHHHHhCCCCccccCccchhHH
Q 042348 528 TPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVR-KPTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIV 606 (686)
Q Consensus 528 ~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~ 606 (686)
.....+|..|+|||.+.+. .++.++||||+||++|||++|+.||..........
T Consensus 186 ------------------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~- 240 (328)
T d3bqca1 186 ------------------------YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQL- 240 (328)
T ss_dssp ------------------------CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHH-
T ss_pred ------------------------ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHH-
Confidence 1234567889999998765 47999999999999999999999996543322111
Q ss_pred HHHHHHHh----------hcCCcc----cccCc-------ccccCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 607 QWIQLILE----------DRKPMT----DILDP-------FLAHDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 607 ~~~~~~~~----------~~~~~~----~~~d~-------~l~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
..+..... ...... ..... .............++.+++.+||+.||++|||++|+++|
T Consensus 241 ~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~H 319 (328)
T d3bqca1 241 VRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 319 (328)
T ss_dssp HHHHHHHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHCCchhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11111110 000000 00000 000001111223467899999999999999999999874
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-42 Score=353.28 Aligned_cols=259 Identities=20% Similarity=0.268 Sum_probs=196.4
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCC--ccchHHHHHHHHHHhccCCCCcceeeEEEEecCceeEEEeccCCCC
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGG--WQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSVDEKLLIYDYIPNGS 449 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gs 449 (686)
+.||+|+||+||+|+.. +++.||||+++... ....+++.+|+.++++++|||||++++++.+.+..++|||++.+++
T Consensus 8 ~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~~~~~~ 87 (292)
T d1unla_ 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDL 87 (292)
T ss_dssp EEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSEEH
T ss_pred eEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEeeeccccc
Confidence 36999999999999975 68899999986432 2345789999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccccccCCc
Q 042348 450 LATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADIAEETP 529 (686)
Q Consensus 450 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 529 (686)
|..++... +.+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||.|+.......
T Consensus 88 l~~~~~~~------~~~~~~~~~~~~~q~~~aL~~lH~---~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~-- 156 (292)
T d1unla_ 88 KKYFDSCN------GDLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR-- 156 (292)
T ss_dssp HHHHHHTT------TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS--
T ss_pred cccccccc------cccchhHHHHHHHHHHHHHHHhhc---CCEeeecccCcccccccCCceeeeecchhhcccCCCc--
Confidence 99888755 468899999999999999999999 8999999999999999999999999999986543221
Q ss_pred cccccccccCCCCCCCccccccccCCCCCccccCcccccCCC-CCCcchHHHHHHHHHHHHhCCCCccccCccchhHHHH
Q 042348 530 EVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRK-PTQKWDIYSYGVILLEMISGKLPMIQIGSMELNIVQW 608 (686)
Q Consensus 530 ~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~ 608 (686)
......++..|+|||.+.... ++.++||||+||++|||++|+.||....+.. +....
T Consensus 157 ---------------------~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~-~~~~~ 214 (292)
T d1unla_ 157 ---------------------CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD-DQLKR 214 (292)
T ss_dssp ---------------------CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHH-HHHHH
T ss_pred ---------------------cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHH-HHHHH
Confidence 112234567799999887655 6899999999999999999999985433222 22222
Q ss_pred HHHHHhhcCC--cc---cccC----cccc----cCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042348 609 IQLILEDRKP--MT---DILD----PFLA----HDLDKEDEIVSVLKIALDCVHKSPDKRPSMRHVCDS 664 (686)
Q Consensus 609 ~~~~~~~~~~--~~---~~~d----~~l~----~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 664 (686)
+......... .. ...+ +... ...........+.+++.+||+.||.+|||++|++++
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 215 IFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp HHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred HHhhcCCCChhhhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 2222111000 00 0000 0000 000011123457789999999999999999999875
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-41 Score=352.13 Aligned_cols=254 Identities=23% Similarity=0.278 Sum_probs=183.9
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCC--CccchHHHHHHHHHHhccCCCCcceeeEEEEec------CceeEEEe
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNG--GWQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSV------DEKLLIYD 443 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~------~~~~lV~e 443 (686)
+.||+|+||+||+|... +|+.||||++... .....+++.+|+.++++++|||||+++++|... ...|+|||
T Consensus 23 ~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~~iv~E 102 (355)
T d2b1pa1 23 KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVME 102 (355)
T ss_dssp EECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEE
T ss_pred EEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCceeEEEEe
Confidence 36999999999999976 6899999999654 233446789999999999999999999999643 56799999
Q ss_pred ccCCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCcccccc
Q 042348 444 YIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLAD 523 (686)
Q Consensus 444 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~ 523 (686)
||.++ +.+.+. ..+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+|++|||+++...
T Consensus 103 y~~~~-l~~~~~--------~~~~~~~i~~~~~qil~gl~~LH~---~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~ 170 (355)
T d2b1pa1 103 LMDAN-LCQVIQ--------MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 170 (355)
T ss_dssp CCSEE-HHHHHT--------SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred ccchH-HHHhhh--------cCCCHHHHHHHHHHHHHHHHHhhh---cccccccCCccccccccccceeeechhhhhccc
Confidence 99765 444443 358999999999999999999999 999999999999999999999999999987544
Q ss_pred cccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhCCCCccccCccch
Q 042348 524 IAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISGKLPMIQIGSMEL 603 (686)
Q Consensus 524 ~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~ 603 (686)
... ......+|..|+|||++.+..+++++||||+||++|||++|+.||......
T Consensus 171 ~~~------------------------~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~-- 224 (355)
T d2b1pa1 171 TSF------------------------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYI-- 224 (355)
T ss_dssp ----------------------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH--
T ss_pred ccc------------------------ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHH--
Confidence 221 123446788899999999999999999999999999999999999543221
Q ss_pred hHHHHHH-------------------HHHhhcCCccc-----ccCcccccCCC--cHHHHHHHHHHHHhccccCCCCCCC
Q 042348 604 NIVQWIQ-------------------LILEDRKPMTD-----ILDPFLAHDLD--KEDEIVSVLKIALDCVHKSPDKRPS 657 (686)
Q Consensus 604 ~~~~~~~-------------------~~~~~~~~~~~-----~~d~~l~~~~~--~~~~~~~l~~l~~~cl~~dP~~RPs 657 (686)
.....+. ........... .+......... .......+.+++.+||+.||++|||
T Consensus 225 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t 304 (355)
T d2b1pa1 225 DQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRIS 304 (355)
T ss_dssp HHHHHHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCC
T ss_pred HHHHHHHHhccCCCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcC
Confidence 1111111 11111111000 01000000000 1234557889999999999999999
Q ss_pred HHHHHHH
Q 042348 658 MRHVCDS 664 (686)
Q Consensus 658 ~~ev~~~ 664 (686)
++|+++|
T Consensus 305 a~elL~H 311 (355)
T d2b1pa1 305 VDDALQH 311 (355)
T ss_dssp HHHHHTS
T ss_pred HHHHhcC
Confidence 9999987
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-41 Score=350.83 Aligned_cols=256 Identities=20% Similarity=0.301 Sum_probs=188.6
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCC--ccchHHHHHHHHHHhccCCCCcceeeEEEEec-----CceeEEEec
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGG--WQRFKEFQTEAEAIGKIRHPNIVSLRAYFWSV-----DEKLLIYDY 444 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~-----~~~~lV~e~ 444 (686)
..||+|+||+||+|+.. +|+.||||++.... ....+++.+|+++|++++|||||++++++... ...+++|+|
T Consensus 24 ~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~~i~~~ 103 (348)
T d2gfsa1 24 SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTH 103 (348)
T ss_dssp EECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCCEEEEE
T ss_pred EEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceEEEEEe
Confidence 36999999999999864 68999999997543 33456788999999999999999999998643 334677788
Q ss_pred cCCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEEeecCccccccc
Q 042348 445 IPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHISDFGLARLADI 524 (686)
Q Consensus 445 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~ 524 (686)
+.+|+|.+++.. +.+++.++..++.||+.||+|||+ ++|+||||||+|||++.++.+|++|||++.....
T Consensus 104 ~~gg~L~~~~~~-------~~l~e~~~~~i~~qil~aL~~LH~---~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~ 173 (348)
T d2gfsa1 104 LMGADLNNIVKC-------QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD 173 (348)
T ss_dssp CCSEEHHHHHTT-------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCC----CCTG
T ss_pred ecCCchhhhccc-------ccccHHHHHHHHHHHHHHHHHHHh---CCCcccccCCccccccccccccccccchhcccCc
Confidence 889999999964 359999999999999999999999 9999999999999999999999999999875432
Q ss_pred ccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCC-CCCCcchHHHHHHHHHHHHhCCCCccccCccch
Q 042348 525 AEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVR-KPTQKWDIYSYGVILLEMISGKLPMIQIGSMEL 603 (686)
Q Consensus 525 ~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~ 603 (686)
. .....||..|+|||...+. .++.++||||+||++|||++|+.||..... .
T Consensus 174 ~--------------------------~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~--~ 225 (348)
T d2gfsa1 174 E--------------------------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH--I 225 (348)
T ss_dssp G--------------------------GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSH--H
T ss_pred c--------------------------cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCH--H
Confidence 1 2234577889999987665 468999999999999999999999954322 1
Q ss_pred hHHHHHHHHHhhcCCcccccCc-----------cccc--CCCc----HHHHHHHHHHHHhccccCCCCCCCHHHHHHH--
Q 042348 604 NIVQWIQLILEDRKPMTDILDP-----------FLAH--DLDK----EDEIVSVLKIALDCVHKSPDKRPSMRHVCDS-- 664 (686)
Q Consensus 604 ~~~~~~~~~~~~~~~~~~~~d~-----------~l~~--~~~~----~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~-- 664 (686)
.....+...... +..+.... .+.. .... ......+.+++.+||+.||++|||++|+++|
T Consensus 226 ~~~~~i~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~ 303 (348)
T d2gfsa1 226 DQLKLILRLVGT--PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 303 (348)
T ss_dssp HHHHHHHHHHCC--CCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred HHHHHHHHhcCC--CChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHh
Confidence 111111111110 00000000 0000 0000 0112357789999999999999999999985
Q ss_pred Hhcc
Q 042348 665 LDRV 668 (686)
Q Consensus 665 L~~i 668 (686)
++++
T Consensus 304 f~~~ 307 (348)
T d2gfsa1 304 FAQY 307 (348)
T ss_dssp GTTT
T ss_pred hCCC
Confidence 4444
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=4.4e-36 Score=315.85 Aligned_cols=262 Identities=19% Similarity=0.201 Sum_probs=184.4
Q ss_pred cccCccCceEEEEEEeC-CCceEEEEEcCCCCccchHHHHHHHHHHhccC-----------CCCcceeeEEEEec--Cce
Q 042348 373 FLLGKSTIGIVYKVALN-NEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIR-----------HPNIVSLRAYFWSV--DEK 438 (686)
Q Consensus 373 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------H~nIv~l~~~~~~~--~~~ 438 (686)
..||+|+||+||+|+.. +|+.||||+++.... ..+.+.+|++++++++ |+|||++++++... ...
T Consensus 19 ~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~-~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~~~~~ 97 (362)
T d1q8ya_ 19 RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV-YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGV 97 (362)
T ss_dssp EEEEECSSEEEEEEEETTTTEEEEEEEECSCHH-HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEE
T ss_pred EEEeeCCCeEEEEEEECCCCCEEEEEEEecccc-chHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeeccccce
Confidence 46999999999999874 689999999976432 2367788999988875 57899999988654 456
Q ss_pred eEEEeccCCCCHHHH-hhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCC------e
Q 042348 439 LLIYDYIPNGSLATA-IHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNME------P 511 (686)
Q Consensus 439 ~lV~e~~~~gsL~~~-l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~------~ 511 (686)
+++|+++..+..... ...... ..+++..+..++.||+.||+|||+. .+|+||||||+|||++.++. +
T Consensus 98 ~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~i~~i~~qil~al~~lh~~--~~IvHrDlKp~NIll~~~~~~~~~~~~ 171 (362)
T d1q8ya_ 98 HVVMVFEVLGENLLALIKKYEH----RGIPLIYVKQISKQLLLGLDYMHRR--CGIIHTDIKPENVLMEIVDSPENLIQI 171 (362)
T ss_dssp EEEEEECCCCEEHHHHHHHTTT----SCCCHHHHHHHHHHHHHHHHHHHHT--TCEECSCCSGGGEEEEEEETTTTEEEE
T ss_pred eeeeeecccccccccccccccc----cCCcHHHHHHHHHHHHHHHHHHhhh--cCcccccCChhHeeeeccCccccccee
Confidence 677777655543322 222221 5688999999999999999999963 57999999999999986653 8
Q ss_pred EEeecCcccccccccCCccccccccccCCCCCCCccccccccCCCCCccccCcccccCCCCCCcchHHHHHHHHHHHHhC
Q 042348 512 HISDFGLARLADIAEETPEVHWEQSTTGTPLQSSPYEFTALNSTTSRSYYQAPEASKVRKPTQKWDIYSYGVILLEMISG 591 (686)
Q Consensus 512 kl~DfGla~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG 591 (686)
+++|||.|...... .....||..|+|||++....++.++||||+||+++||++|
T Consensus 172 kl~dfg~s~~~~~~--------------------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g 225 (362)
T d1q8ya_ 172 KIADLGNACWYDEH--------------------------YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITG 225 (362)
T ss_dssp EECCCTTCEETTBC--------------------------CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHS
T ss_pred eEeecccccccccc--------------------------cccccccccccChhhccccCCCccccccchHHHHHHHHHC
Confidence 99999998754311 1234678889999999999999999999999999999999
Q ss_pred CCCccccCccc----h-hHHHHHHHHHhh--------cCC---------cccccCcc--------c-ccCCCcHHHHHHH
Q 042348 592 KLPMIQIGSME----L-NIVQWIQLILED--------RKP---------MTDILDPF--------L-AHDLDKEDEIVSV 640 (686)
Q Consensus 592 ~~P~~~~~~~~----~-~~~~~~~~~~~~--------~~~---------~~~~~d~~--------l-~~~~~~~~~~~~l 640 (686)
+.||....... . .+...+ ..+.. ... ........ . ............+
T Consensus 226 ~~pF~~~~~~~~~~~~~~~~~~~-~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (362)
T d1q8ya_ 226 DFLFEPDEGHSYTKDDDHIAQII-ELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEI 304 (362)
T ss_dssp SCCC---------CHHHHHHHHH-HHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHH
T ss_pred CCCCCCCccccccchhHHHHHHH-HHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHH
Confidence 99995432211 0 111111 11100 000 00000000 0 0011123456779
Q ss_pred HHHHHhccccCCCCCCCHHHHHHH--Hhcc
Q 042348 641 LKIALDCVHKSPDKRPSMRHVCDS--LDRV 668 (686)
Q Consensus 641 ~~l~~~cl~~dP~~RPs~~ev~~~--L~~i 668 (686)
.+++.+||+.||++|||++|+++| +++.
T Consensus 305 ~dll~~mL~~dP~~Rpta~e~L~Hp~f~~~ 334 (362)
T d1q8ya_ 305 SDFLSPMLQLDPRKRADAGGLVNHPWLKDT 334 (362)
T ss_dssp HHHHGGGGCSSTTTCBCHHHHHTCGGGTTC
T ss_pred HHHHHHHCCCChhHCcCHHHHhcCcccCCC
Confidence 999999999999999999999987 5543
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=100.00 E-value=1.3e-35 Score=305.61 Aligned_cols=231 Identities=29% Similarity=0.544 Sum_probs=194.8
Q ss_pred CChhHHHHHHHHHHhccCCCCCCCCCCCCCCCc--ceeeeEecC----CCEEEEEeCCCCccc--cCCcCcCCCCCCCEE
Q 042348 15 SANDEGLALLSFKQAIRNFPEGNNWNNSNEDPC--SWNGITCRE----GQVFSLIIPNKKLTG--FIPADLGSLSAIGRV 86 (686)
Q Consensus 15 ~~~~~~~~l~~~k~~~~~~~~~~~w~~~~~~~c--~w~gv~c~~----~~~~~l~l~~n~l~g--~~p~~l~~l~~L~~L 86 (686)
+.++|++||++||+++.+++.-.+|+. +.||| +|.||+|+. .||+.|+|++|+++| .+|+.|++|++|++|
T Consensus 3 c~~~e~~aLl~~k~~~~~~~~l~sW~~-~~d~C~~~w~gv~C~~~~~~~~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L 81 (313)
T d1ogqa_ 3 CNPQDKQALLQIKKDLGNPTTLSSWLP-TTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFL 81 (313)
T ss_dssp SCHHHHHHHHHHHHHTTCCGGGTTCCT-TSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTCSEE
T ss_pred CCHHHHHHHHHHHHHCCCCCcCCCCCC-CCCCCCCcCCCeEEeCCCCcEEEEEEECCCCCCCCCCCCChHHhcCcccccc
Confidence 457899999999999965443378975 46999 599999974 379999999999998 589999999999999
Q ss_pred EccC-CCCcccCCccccCCCCCcEEEccCCCCCCCCcccccCCCCCCEEeccCCCCCCCCChhhhhcccccccccccccc
Q 042348 87 NLRN-NNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSF 165 (686)
Q Consensus 87 ~L~~-N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l 165 (686)
+|++ |+++|.+|.+|+++++|++|+|++|++.+..+..+..+..|+.++++.|.+.+.+|..+..+++|+.+++++|.+
T Consensus 82 ~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l 161 (313)
T d1ogqa_ 82 YIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRI 161 (313)
T ss_dssp EEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCC
T ss_pred ccccccccccccccccccccccchhhhccccccccccccccchhhhcccccccccccccCchhhccCcccceeecccccc
Confidence 9996 899999999999999999999999999988887777777888888887777777777777777777777777777
Q ss_pred CCCCchhhh----------------------------------------------------------------------h
Q 042348 166 TGPLPDGFA----------------------------------------------------------------------T 175 (686)
Q Consensus 166 ~~~~p~~~~----------------------------------------------------------------------~ 175 (686)
+|.+|..+. .
T Consensus 162 ~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~~~~ 241 (313)
T d1ogqa_ 162 SGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVG 241 (313)
T ss_dssp EEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGGCC
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 665554331 2
Q ss_pred cCcccceecccccccCCCCchhhhcccccccccccccccccCCCCCCCcccccccccCCcccccCCCCCCCCCCCCCC
Q 042348 176 NLTALQKLDLSFNNLSGLIPNDIANLSRLRLLAQRVYVDLTYNNLSGLIPQNAALLSLGPTAFIGNPFLCGPPLKVSC 253 (686)
Q Consensus 176 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~~~~~l~l~~N~l~~~~p~~~~~~~~~~~~~~~n~~~c~~p~~~~c 253 (686)
.+++|+.|||++|+|+|.+|..+++|++|+.| ||++|+|+|.+|+...+.++....+.+|+.+||.|+. +|
T Consensus 242 ~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L------~Ls~N~l~g~iP~~~~L~~L~~l~l~~N~~l~g~plp-~c 312 (313)
T d1ogqa_ 242 LSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSL------NVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSPLP-AC 312 (313)
T ss_dssp CCTTCCEEECCSSCCEECCCGGGGGCTTCCEE------ECCSSEEEEECCCSTTGGGSCGGGTCSSSEEESTTSS-CC
T ss_pred cccccccccCccCeecccCChHHhCCCCCCEE------ECcCCcccccCCCcccCCCCCHHHhCCCccccCCCCC-CC
Confidence 35678899999999999999999888887755 9999999999998877888888999999999998874 55
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.88 E-value=1.1e-23 Score=199.11 Aligned_cols=130 Identities=17% Similarity=0.210 Sum_probs=104.4
Q ss_pred hcccCccCceEEEEEEeCCCceEEEEEcCCCCc------------------cchHHHHHHHHHHhccCCCCcceeeEEEE
Q 042348 372 AFLLGKSTIGIVYKVALNNEEAVAVRRLGNGGW------------------QRFKEFQTEAEAIGKIRHPNIVSLRAYFW 433 (686)
Q Consensus 372 ~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~H~nIv~l~~~~~ 433 (686)
++.||+|+||+||+|...+|+.||||.++.... .....+..|...+.++.|.+++..+++.
T Consensus 5 g~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~- 83 (191)
T d1zara2 5 GKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWE- 83 (191)
T ss_dssp EEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEE-
T ss_pred CCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEec-
Confidence 467999999999999988899999998653210 0112355788999999999999987653
Q ss_pred ecCceeEEEeccCCCCHHHHhhcCCCccccCCCCHHHHHHHHHHHHHHHHHHHccCCCCceecCCCCCCeeecCCCCeEE
Q 042348 434 SVDEKLLIYDYIPNGSLATAIHGKAGIISYRPLSWSDRLRIIKGVAKGIAFLHEVSPKRYVHGDLRPSNILLGKNMEPHI 513 (686)
Q Consensus 434 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl 513 (686)
..++||||+++..+.+ ++......++.|++.||+|||+ ++|+||||||+|||++++ .++|
T Consensus 84 ---~~~lvme~~~~~~~~~-------------l~~~~~~~i~~ql~~~l~~lH~---~giiHrDiKP~NILv~~~-~~~l 143 (191)
T d1zara2 84 ---GNAVLMELIDAKELYR-------------VRVENPDEVLDMILEEVAKFYH---RGIVHGDLSQYNVLVSEE-GIWI 143 (191)
T ss_dssp ---TTEEEEECCCCEEGGG-------------CCCSCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEETT-EEEE
T ss_pred ---CCEEEEEeeccccccc-------------hhhHHHHHHHHHHHHHHHHHhh---CCEEEccCChhheeeeCC-CEEE
Confidence 3479999998755432 4455667899999999999999 899999999999999865 5899
Q ss_pred eecCccccc
Q 042348 514 SDFGLARLA 522 (686)
Q Consensus 514 ~DfGla~~~ 522 (686)
+|||+|+..
T Consensus 144 iDFG~a~~~ 152 (191)
T d1zara2 144 IDFPQSVEV 152 (191)
T ss_dssp CCCTTCEET
T ss_pred EECCCcccC
Confidence 999999754
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.87 E-value=1.5e-22 Score=202.01 Aligned_cols=181 Identities=27% Similarity=0.283 Sum_probs=160.4
Q ss_pred CCEEEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCccccCCCCCcEEEccCCCCCCCCcccccCCCCCCEEec
Q 042348 57 GQVFSLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQVLDL 136 (686)
Q Consensus 57 ~~~~~l~l~~n~l~g~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l 136 (686)
..++.|+|++|+|++..+..|.++++|+.|+|++|+|+ .+| .+..+++|+.|+|++|+++ .++..+..+++|+.|++
T Consensus 31 ~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~-~l~-~~~~l~~L~~L~Ls~N~l~-~~~~~~~~l~~L~~L~l 107 (266)
T d1p9ag_ 31 KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQ-VDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDV 107 (266)
T ss_dssp TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCC-EEE-CCSCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEEC
T ss_pred cCCCEEECcCCcCCCcCHHHhhcccccccccccccccc-ccc-ccccccccccccccccccc-ccccccccccccccccc
Confidence 46889999999999887789999999999999999998 455 3578999999999999998 56778999999999999
Q ss_pred cCCCCCCCCChhhhhccccccccccccccCCCCchhhhhcCcccceecccccccCCCCchhhhccccccccccccccccc
Q 042348 137 SQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSGLIPNDIANLSRLRLLAQRVYVDLT 216 (686)
Q Consensus 137 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~~~~~l~l~ 216 (686)
++|.+.+..+..+..+.+++.|++++|.++ .+|..++..+++|+.|++++|+|++.++..+..+++|+.| ||+
T Consensus 108 ~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~-~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L------~Ls 180 (266)
T d1p9ag_ 108 SFNRLTSLPLGALRGLGELQELYLKGNELK-TLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTL------LLQ 180 (266)
T ss_dssp CSSCCCCCCSSTTTTCTTCCEEECTTSCCC-CCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEE------ECC
T ss_pred cccccceeeccccccccccccccccccccc-eeccccccccccchhcccccccccccCcccccccccccee------ecc
Confidence 999999888888999999999999999999 5666666789999999999999999988889888888765 999
Q ss_pred CCCCCCCcccccccccCCcccccCCCCCCCC
Q 042348 217 YNNLSGLIPQNAALLSLGPTAFIGNPFLCGP 247 (686)
Q Consensus 217 ~N~l~~~~p~~~~~~~~~~~~~~~n~~~c~~ 247 (686)
+|+|+..++..+.+..+..+.+.||||.|++
T Consensus 181 ~N~L~~lp~~~~~~~~L~~L~L~~Np~~CdC 211 (266)
T d1p9ag_ 181 ENSLYTIPKGFFGSHLLPFAFLHGNPWLCNC 211 (266)
T ss_dssp SSCCCCCCTTTTTTCCCSEEECCSCCBCCSG
T ss_pred cCCCcccChhHCCCCCCCEEEecCCCCCCCc
Confidence 9999965555666777888899999999964
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.83 E-value=1e-20 Score=190.41 Aligned_cols=183 Identities=21% Similarity=0.272 Sum_probs=152.1
Q ss_pred CEEEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccC-------------------------CccccCCCCCcEEEc
Q 042348 58 QVFSLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSL-------------------------PVELFNASNLQSLIL 112 (686)
Q Consensus 58 ~~~~l~l~~n~l~g~~p~~l~~l~~L~~L~L~~N~l~g~~-------------------------p~~~~~l~~L~~L~L 112 (686)
.+++|+|++|+|++..+..|.++++|++|++++|+|.+.. |..|.++++|++|+|
T Consensus 33 ~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~l~~L~~L~l 112 (284)
T d1ozna_ 33 ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHL 112 (284)
T ss_dssp TCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCEEECcCCcCCCCCHHHhhccccccccccccccccccccccccccccccccccccccccccccchhhcccccCCEEec
Confidence 5678999999999877778999999999999999876322 445677888999999
Q ss_pred cCCCCCCCCcccccCCCCCCEEeccCCCCCCCCChhhhhccccccccccccccCCCCchhhhhcCcccceecccccccCC
Q 042348 113 SGNSFSGPVPMQIGKLKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSG 192 (686)
Q Consensus 113 ~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~ 192 (686)
++|.+....+..+..+.+|+.+++++|++++..+..+..+++|+.|+|++|++++ +|...+.++++|+.+++++|++++
T Consensus 113 ~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~-l~~~~f~~l~~L~~l~l~~N~l~~ 191 (284)
T d1ozna_ 113 DRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISS-VPERAFRGLHSLDRLLLHQNRVAH 191 (284)
T ss_dssp TTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCE-ECTTTTTTCTTCCEEECCSSCCCE
T ss_pred CCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccc-cchhhhccccccchhhhhhccccc
Confidence 9999887677778888899999999999987667788888899999999999985 444444688999999999999998
Q ss_pred CCchhhhcccccccccccccccccCCCCCCCccccc-ccccCCcccccCCCCCCCC
Q 042348 193 LIPNDIANLSRLRLLAQRVYVDLTYNNLSGLIPQNA-ALLSLGPTAFIGNPFLCGP 247 (686)
Q Consensus 193 ~~p~~~~~l~~L~~l~~~~~l~l~~N~l~~~~p~~~-~~~~~~~~~~~~n~~~c~~ 247 (686)
..|..|.++++|+.| |+++|++++.+|..+ ...++..+.+.+||+.|.+
T Consensus 192 i~~~~f~~l~~L~~L------~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C 241 (284)
T d1ozna_ 192 VHPHAFRDLGRLMTL------YLFANNLSALPTEALAPLRALQYLRLNDNPWVCDC 241 (284)
T ss_dssp ECTTTTTTCTTCCEE------ECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSG
T ss_pred cChhHhhhhhhcccc------cccccccccccccccccccccCEEEecCCCCCCCc
Confidence 888888888877655 999999999888765 4566778889999999854
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.80 E-value=1e-20 Score=193.40 Aligned_cols=159 Identities=33% Similarity=0.470 Sum_probs=129.3
Q ss_pred CCEEEEEeCC-CCccccCCcCcCCCCCCCEEEccCCCCcccCCccccCCCCCcEEEccCCCCCCCCcccccCCCCCCEEe
Q 042348 57 GQVFSLIIPN-KKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQVLD 135 (686)
Q Consensus 57 ~~~~~l~l~~-n~l~g~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ 135 (686)
..+++|+|++ |+++|.+|..|++|++|++|+|++|+|.+..|..+.++++|+.|++++|.+.+.+|..++.++.|+.++
T Consensus 76 ~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~ 155 (313)
T d1ogqa_ 76 PYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGIT 155 (313)
T ss_dssp TTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEE
T ss_pred ccccccccccccccccccccccccccccchhhhccccccccccccccchhhhcccccccccccccCchhhccCcccceee
Confidence 5788999986 899999999999999999999999999988887777777777777777777777777777777777777
Q ss_pred ccCCCCCCCCChhhh-----------------------------------------------------------------
Q 042348 136 LSQNSFSSSIPSSIV----------------------------------------------------------------- 150 (686)
Q Consensus 136 ls~N~l~~~~p~~~~----------------------------------------------------------------- 150 (686)
+++|.++|.+|..+.
T Consensus 156 l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~ 235 (313)
T d1ogqa_ 156 FDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAF 235 (313)
T ss_dssp CCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECC
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 777776665554322
Q ss_pred ------hccccccccccccccCCCCchhhhhcCcccceecccccccCCCCchhhhcccccccccccccccccCCC-CCCC
Q 042348 151 ------QCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSGLIPNDIANLSRLRLLAQRVYVDLTYNN-LSGL 223 (686)
Q Consensus 151 ------~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~~~~~l~l~~N~-l~~~ 223 (686)
.+++|+.|+|++|+|+|.+|..+. ++++|++|||++|+|+|.+|. +++|++|+. +++++|+ +.|.
T Consensus 236 ~~~~~~~~~~L~~L~Ls~N~l~g~iP~~l~-~L~~L~~L~Ls~N~l~g~iP~-~~~L~~L~~------l~l~~N~~l~g~ 307 (313)
T d1ogqa_ 236 DLGKVGLSKNLNGLDLRNNRIYGTLPQGLT-QLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDV------SAYANNKCLCGS 307 (313)
T ss_dssp BGGGCCCCTTCCEEECCSSCCEECCCGGGG-GCTTCCEEECCSSEEEEECCC-STTGGGSCG------GGTCSSSEEEST
T ss_pred cccccccccccccccCccCeecccCChHHh-CCCCCCEEECcCCcccccCCC-cccCCCCCH------HHhCCCccccCC
Confidence 234678899999999999999885 899999999999999999984 566666654 4899997 6765
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.77 E-value=5.2e-19 Score=166.64 Aligned_cols=174 Identities=19% Similarity=0.172 Sum_probs=134.3
Q ss_pred EEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccC-CccccCCCCCcEEEccCCCCCCCCcccccCCCCCCEEeccCCC
Q 042348 62 LIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSL-PVELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQVLDLSQNS 140 (686)
Q Consensus 62 l~l~~n~l~g~~p~~l~~l~~L~~L~L~~N~l~g~~-p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~ 140 (686)
++.++++|+ .+|..+. +++++|+|++|+|++.+ +..|.++++|+.|+|++|++.+..+..|..+++|+.|+|++|+
T Consensus 13 v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~ 89 (192)
T d1w8aa_ 13 VDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENK 89 (192)
T ss_dssp EECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCC
T ss_pred EEEeCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeecccc
Confidence 444577787 5787764 68999999999998755 5567899999999999999998899999999999999999999
Q ss_pred CCCCCChhhhhccccccccccccccCCCCchhhhhcCcccceecccccccCCCCchhhhcccccccccccccccccCCCC
Q 042348 141 FSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSGLIPNDIANLSRLRLLAQRVYVDLTYNNL 220 (686)
Q Consensus 141 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~~~~~l~l~~N~l 220 (686)
+++..|..|.++++|++|+|++|+|++ +|+..+..+++|++|+|++|.+....+..+. ...++ .+.+..|.+
T Consensus 90 l~~l~~~~F~~l~~L~~L~L~~N~l~~-i~~~~f~~l~~L~~l~L~~N~~~~~~~~~~~-~~~l~------~~~l~~~~~ 161 (192)
T d1w8aa_ 90 IKEISNKMFLGLHQLKTLNLYDNQISC-VMPGSFEHLNSLTSLNLASNPFNCNCHLAWF-AEWLR------KKSLNGGAA 161 (192)
T ss_dssp CCEECSSSSTTCTTCCEEECCSSCCCE-ECTTSSTTCTTCCEEECTTCCBCCSGGGHHH-HHHHH------HHCCSGGGC
T ss_pred ccccCHHHHhCCCcccccccCCccccc-cCHHHhcCCcccccccccccccccccchHHH-hhhhh------hhcccCCCe
Confidence 998788889999999999999999995 5555556899999999999999865432221 11233 236777787
Q ss_pred CCCcccccccccCCcccccCCCCCCCCC
Q 042348 221 SGLIPQNAALLSLGPTAFIGNPFLCGPP 248 (686)
Q Consensus 221 ~~~~p~~~~~~~~~~~~~~~n~~~c~~p 248 (686)
+...|.... ......+..|.+.|..+
T Consensus 162 ~c~~p~~l~--~~~l~~L~~n~l~C~~~ 187 (192)
T d1w8aa_ 162 RCGAPSKVR--DVQIKDLPHSEFKCSSE 187 (192)
T ss_dssp BBCSSTTTT--TSBGGGSCTTTCCCCCC
T ss_pred EeCCChhhc--CCEeeecCHhhCcCCCC
Confidence 766665433 23334566777777544
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.74 E-value=6.3e-18 Score=171.62 Aligned_cols=168 Identities=23% Similarity=0.330 Sum_probs=112.9
Q ss_pred cceeeeEecC-----------CCEEEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCccccCCCCCcEEEccCC
Q 042348 47 CSWNGITCRE-----------GQVFSLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGN 115 (686)
Q Consensus 47 c~w~gv~c~~-----------~~~~~l~l~~n~l~g~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N 115 (686)
|.|.+|.|.. ..++.|+|++|+|+...+..|.++++|+.|++++|.+....|..|.++++|+.|+|++|
T Consensus 10 c~~~~~~C~~~~L~~lP~~l~~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~~n 89 (305)
T d1xkua_ 10 CHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKN 89 (305)
T ss_dssp EETTEEECTTSCCCSCCCSCCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSS
T ss_pred ecCCEEEecCCCCCccCCCCCCCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEecccCC
Confidence 6799999973 45778999999999876678999999999999999999888889999999999999999
Q ss_pred CCCCCCcc------------------------------------------------cccCCCCCCEEeccCCCCC-----
Q 042348 116 SFSGPVPM------------------------------------------------QIGKLKYLQVLDLSQNSFS----- 142 (686)
Q Consensus 116 ~l~g~~p~------------------------------------------------~~~~l~~L~~L~ls~N~l~----- 142 (686)
+++ .+|. .+..+++|+.+++++|.++
T Consensus 90 ~l~-~l~~~~~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~~l~~~ 168 (305)
T d1xkua_ 90 QLK-ELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQG 168 (305)
T ss_dssp CCS-BCCSSCCTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCSCCSS
T ss_pred ccC-cCccchhhhhhhhhccccchhhhhhhhhhccccccccccccccccccCCCccccccccccCccccccCCccccCcc
Confidence 876 2321 1223344555555555544
Q ss_pred ----------------CCCChhhhhccccccccccccccCCCCchhhhhcCcccceecccccccCCCCchhhhccccccc
Q 042348 143 ----------------SSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSGLIPNDIANLSRLRL 206 (686)
Q Consensus 143 ----------------~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 206 (686)
+..+..+..++.++.|++++|.+++..+ ..+.++++|++|+|++|+|+. +|..+.++++|+.
T Consensus 169 ~~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~-~~~~~l~~L~~L~L~~N~L~~-lp~~l~~l~~L~~ 246 (305)
T d1xkua_ 169 LPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDN-GSLANTPHLRELHLNNNKLVK-VPGGLADHKYIQV 246 (305)
T ss_dssp CCTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECT-TTGGGSTTCCEEECCSSCCSS-CCTTTTTCSSCCE
T ss_pred cCCccCEEECCCCcCCCCChhHhhcccccccccccccccccccc-ccccccccceeeecccccccc-cccccccccCCCE
Confidence 3334444555555555555555553323 222455666666666666653 3555555555543
Q ss_pred ccccccccccCCCCCCC
Q 042348 207 LAQRVYVDLTYNNLSGL 223 (686)
Q Consensus 207 l~~~~~l~l~~N~l~~~ 223 (686)
| +|++|+|+..
T Consensus 247 L------~Ls~N~i~~i 257 (305)
T d1xkua_ 247 V------YLHNNNISAI 257 (305)
T ss_dssp E------ECCSSCCCCC
T ss_pred E------ECCCCccCcc
Confidence 3 6666666644
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.70 E-value=3.3e-17 Score=162.69 Aligned_cols=156 Identities=25% Similarity=0.256 Sum_probs=137.1
Q ss_pred CCCEEEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCccccCCCCCcEEEccCCCCCCCCcccccCCCCCCEEe
Q 042348 56 EGQVFSLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQVLD 135 (686)
Q Consensus 56 ~~~~~~l~l~~n~l~g~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ 135 (686)
-.+++.|+|++|+|+. +| .++.+++|++|+|++|+++ .+|..+.++++|+.|+|++|.+.+..+..+..+.+|+.|+
T Consensus 54 l~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~Ls~N~l~-~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~ 130 (266)
T d1p9ag_ 54 YTRLTQLNLDRAELTK-LQ-VDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELY 130 (266)
T ss_dssp CTTCCEEECTTSCCCE-EE-CCSCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEE
T ss_pred cccccccccccccccc-cc-ccccccccccccccccccc-ccccccccccccccccccccccceeecccccccccccccc
Confidence 4689999999999985 44 4688999999999999998 5677899999999999999999988888889999999999
Q ss_pred ccCCCCCCCCChhhhhccccccccccccccCCCCchhhhhcCcccceecccccccCCCCchhhhcccccccccccccccc
Q 042348 136 LSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSGLIPNDIANLSRLRLLAQRVYVDL 215 (686)
Q Consensus 136 ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~~~~~l~l 215 (686)
+++|.++...+..+..+++|+.|++++|++++. |...+..+++|++|||++|+|+ .+|..+..+++|+.| +|
T Consensus 131 l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~-~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L------~L 202 (266)
T d1p9ag_ 131 LKGNELKTLPPGLLTPTPKLEKLSLANNNLTEL-PAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFA------FL 202 (266)
T ss_dssp CTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCC-CTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEE------EC
T ss_pred ccccccceeccccccccccchhccccccccccc-CccccccccccceeecccCCCc-ccChhHCCCCCCCEE------Ee
Confidence 999999987778888999999999999999964 4444468999999999999999 678888887777655 99
Q ss_pred cCCCCCC
Q 042348 216 TYNNLSG 222 (686)
Q Consensus 216 ~~N~l~~ 222 (686)
++|.+.-
T Consensus 203 ~~Np~~C 209 (266)
T d1p9ag_ 203 HGNPWLC 209 (266)
T ss_dssp CSCCBCC
T ss_pred cCCCCCC
Confidence 9998864
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.69 E-value=2.2e-17 Score=155.27 Aligned_cols=166 Identities=20% Similarity=0.276 Sum_probs=141.1
Q ss_pred cceeeeEecC-----------CCEEEEEeCCCCccccC-CcCcCCCCCCCEEEccCCCCcccCCccccCCCCCcEEEccC
Q 042348 47 CSWNGITCRE-----------GQVFSLIIPNKKLTGFI-PADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSG 114 (686)
Q Consensus 47 c~w~gv~c~~-----------~~~~~l~l~~n~l~g~~-p~~l~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~ 114 (686)
|+|..|.|+. ..+++|+|++|+|++.+ +..|..+++|+.|+|++|.+.+..+..+..+++|++|+|++
T Consensus 8 C~~~~v~Cs~~~L~~iP~~lp~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~ 87 (192)
T d1w8aa_ 8 CEGTTVDCTGRGLKEIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp EETTEEECTTSCCSSCCSCCCTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred EcCCEEEEeCCCcCccCCCCCCCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeecc
Confidence 6799999972 36889999999998755 45789999999999999999999999999999999999999
Q ss_pred CCCCCCCcccccCCCCCCEEeccCCCCCCCCChhhhhccccccccccccccCCCCchhhhhcCcccceecccccccCCCC
Q 042348 115 NSFSGPVPMQIGKLKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSGLI 194 (686)
Q Consensus 115 N~l~g~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~ 194 (686)
|+|++..|..|.++++|++|+|++|+|++..|..|..+++|++|+|++|.+....+..++ ...++.+.+..|.++...
T Consensus 88 N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~~~~--~~~l~~~~l~~~~~~c~~ 165 (192)
T d1w8aa_ 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWF--AEWLRKKSLNGGAARCGA 165 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHH--HHHHHHHCCSGGGCBBCS
T ss_pred ccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccchHHH--hhhhhhhcccCCCeEeCC
Confidence 999987888899999999999999999988888899999999999999999865444432 345778889999998777
Q ss_pred chhhhcccccccccccccccccCCCCCCC
Q 042348 195 PNDIANLSRLRLLAQRVYVDLTYNNLSGL 223 (686)
Q Consensus 195 p~~~~~l~~L~~l~~~~~l~l~~N~l~~~ 223 (686)
|..+.++ + .+||+.|.|.-.
T Consensus 166 p~~l~~~---~------l~~L~~n~l~C~ 185 (192)
T d1w8aa_ 166 PSKVRDV---Q------IKDLPHSEFKCS 185 (192)
T ss_dssp STTTTTS---B------GGGSCTTTCCCC
T ss_pred ChhhcCC---E------eeecCHhhCcCC
Confidence 7655443 2 348999988743
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.68 E-value=2.9e-17 Score=164.83 Aligned_cols=154 Identities=26% Similarity=0.237 Sum_probs=137.2
Q ss_pred CCCCccccCCcCcCCCCCCCEEEccCCCCcccCCccccCCCCCcEEEccCCCCCCCCcccccCCCCCCEEeccCCCCCCC
Q 042348 65 PNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQVLDLSQNSFSSS 144 (686)
Q Consensus 65 ~~n~l~g~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~~~ 144 (686)
..|.++...|..|.++++|+.|+|++|.+....+..+..+++|+.+++++|+|++..+..|..+++|+.|+|++|++++.
T Consensus 89 ~~~~~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l 168 (284)
T d1ozna_ 89 DNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSV 168 (284)
T ss_dssp SCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEE
T ss_pred cccccccccchhhcccccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCccccc
Confidence 35556666677899999999999999999877777888999999999999999977778899999999999999999988
Q ss_pred CChhhhhccccccccccccccCCCCchhhhhcCcccceecccccccCCCCchhhhcccccccccccccccccCCCCCCCc
Q 042348 145 IPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSGLIPNDIANLSRLRLLAQRVYVDLTYNNLSGLI 224 (686)
Q Consensus 145 ~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~~~~~l~l~~N~l~~~~ 224 (686)
.|..+.++++|+.+++++|++++..|..+ .++++|++||+++|.+++.+|..+.++++|+.| ++++|.+...-
T Consensus 169 ~~~~f~~l~~L~~l~l~~N~l~~i~~~~f-~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L------~l~~N~l~C~C 241 (284)
T d1ozna_ 169 PERAFRGLHSLDRLLLHQNRVAHVHPHAF-RDLGRLMTLYLFANNLSALPTEALAPLRALQYL------RLNDNPWVCDC 241 (284)
T ss_dssp CTTTTTTCTTCCEEECCSSCCCEECTTTT-TTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEE------ECCSSCEECSG
T ss_pred chhhhccccccchhhhhhccccccChhHh-hhhhhcccccccccccccccccccccccccCEE------EecCCCCCCCc
Confidence 88899999999999999999997777766 589999999999999999999999998888755 99999998765
Q ss_pred c
Q 042348 225 P 225 (686)
Q Consensus 225 p 225 (686)
+
T Consensus 242 ~ 242 (284)
T d1ozna_ 242 R 242 (284)
T ss_dssp G
T ss_pred c
Confidence 4
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.60 E-value=2.3e-15 Score=142.12 Aligned_cols=148 Identities=25% Similarity=0.413 Sum_probs=123.7
Q ss_pred CCEEEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCccccCCCCCcEEEccCCCCCCCCcccccCCCCCCEEec
Q 042348 57 GQVFSLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQVLDL 136 (686)
Q Consensus 57 ~~~~~l~l~~n~l~g~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l 136 (686)
..++.|++++|+++. + +.+..+++|++|+|++|+|++. ++ +.++++|+.|++++|.+. .++ .+..+++|+.|++
T Consensus 40 ~~l~~L~l~~~~i~~-l-~~l~~l~nL~~L~Ls~N~l~~~-~~-l~~l~~L~~L~l~~n~~~-~~~-~l~~l~~L~~L~l 113 (199)
T d2omxa2 40 DQVTTLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLTDI-TP-LKNLTKLVDILMNNNQIA-DIT-PLANLTNLTGLTL 113 (199)
T ss_dssp TTCCEEECTTSCCCC-C-TTGGGCTTCCEEECCSSCCCCC-GG-GTTCTTCCEEECCSSCCC-CCG-GGTTCTTCSEEEC
T ss_pred cCCCEEECCCCCCCC-c-cccccCCCcCcCccccccccCc-cc-ccCCcccccccccccccc-ccc-ccccccccccccc
Confidence 578899999999985 3 3588999999999999999854 43 899999999999999997 455 4889999999999
Q ss_pred cCCCCCCCCChhhhhccccccccccccccCCCCchhhhhcCcccceecccccccCCCCchhhhccccccccccccccccc
Q 042348 137 SQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSGLIPNDIANLSRLRLLAQRVYVDLT 216 (686)
Q Consensus 137 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~~~~~l~l~ 216 (686)
++|.+.. + ..+..+++|+.|++++|++. .++ .+ ..+++|+.|++++|++++.. .++++++|+.| +++
T Consensus 114 ~~~~~~~-~-~~~~~l~~L~~L~l~~n~l~-~~~-~l-~~~~~L~~L~l~~n~l~~l~--~l~~l~~L~~L------~ls 180 (199)
T d2omxa2 114 FNNQITD-I-DPLKNLTNLNRLELSSNTIS-DIS-AL-SGLTSLQQLNFSSNQVTDLK--PLANLTTLERL------DIS 180 (199)
T ss_dssp CSSCCCC-C-GGGTTCTTCSEEECCSSCCC-CCG-GG-TTCTTCSEEECCSSCCCCCG--GGTTCTTCCEE------ECC
T ss_pred ccccccc-c-cccchhhhhHHhhhhhhhhc-ccc-cc-cccccccccccccccccCCc--cccCCCCCCEE------ECC
Confidence 9999885 3 34788999999999999998 455 34 47999999999999999753 36677776654 999
Q ss_pred CCCCCCC
Q 042348 217 YNNLSGL 223 (686)
Q Consensus 217 ~N~l~~~ 223 (686)
+|+++..
T Consensus 181 ~N~i~~i 187 (199)
T d2omxa2 181 SNKVSDI 187 (199)
T ss_dssp SSCCCCC
T ss_pred CCCCCCC
Confidence 9999874
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.59 E-value=3.2e-15 Score=142.34 Aligned_cols=159 Identities=27% Similarity=0.401 Sum_probs=127.3
Q ss_pred CCEEEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCccccCCCCCcEEEccCCCCCCCCcccccCCCCCCEEec
Q 042348 57 GQVFSLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQVLDL 136 (686)
Q Consensus 57 ~~~~~l~l~~n~l~g~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l 136 (686)
..++.|++++|.+++. + .+..+++|++|+|++|+|++ ++ .+.++++|+.|+|++|+++ .+| .+..+++|+.|++
T Consensus 46 ~~L~~L~l~~~~i~~l-~-~l~~l~~L~~L~L~~n~i~~-l~-~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l 119 (210)
T d1h6ta2 46 NSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTD-IK-PLANLKNLGWLFLDENKVK-DLS-SLKDLKKLKSLSL 119 (210)
T ss_dssp HTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCC-CGG-GGTTCTTCCEEEC
T ss_pred cCccEEECcCCCCCCc-h-hHhhCCCCCEEeCCCccccC-cc-ccccCcccccccccccccc-ccc-ccccccccccccc
Confidence 3688999999999864 3 48889999999999999985 44 3688999999999999998 456 5889999999999
Q ss_pred cCCCCCCCCChhhhhccccccccccccccCCCCchhhhhcCcccceecccccccCCCCchhhhccccccccccccccccc
Q 042348 137 SQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSGLIPNDIANLSRLRLLAQRVYVDLT 216 (686)
Q Consensus 137 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~~~~~l~l~ 216 (686)
++|.+.. + ..+..+++|+.++++.|.+++ ++ .+ ..+++|+.+++++|++++.. .++++++|+.| +|+
T Consensus 120 ~~~~~~~-~-~~l~~l~~l~~l~~~~n~l~~-~~-~~-~~l~~L~~l~l~~n~l~~i~--~l~~l~~L~~L------~Ls 186 (210)
T d1h6ta2 120 EHNGISD-I-NGLVHLPQLESLYLGNNKITD-IT-VL-SRLTKLDTLSLEDNQISDIV--PLAGLTKLQNL------YLS 186 (210)
T ss_dssp TTSCCCC-C-GGGGGCTTCCEEECCSSCCCC-CG-GG-GGCTTCSEEECCSSCCCCCG--GGTTCTTCCEE------ECC
T ss_pred ccccccc-c-ccccccccccccccccccccc-cc-cc-cccccccccccccccccccc--cccCCCCCCEE------ECC
Confidence 9999873 4 458889999999999999985 33 23 47999999999999999753 37777777655 999
Q ss_pred CCCCCCCcccccccccCCc
Q 042348 217 YNNLSGLIPQNAALLSLGP 235 (686)
Q Consensus 217 ~N~l~~~~p~~~~~~~~~~ 235 (686)
+|+++.. |....+.++..
T Consensus 187 ~N~i~~l-~~l~~l~~L~~ 204 (210)
T d1h6ta2 187 KNHISDL-RALAGLKNLDV 204 (210)
T ss_dssp SSCCCBC-GGGTTCTTCSE
T ss_pred CCCCCCC-hhhcCCCCCCE
Confidence 9999864 44333444433
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.58 E-value=3e-15 Score=129.12 Aligned_cols=101 Identities=23% Similarity=0.298 Sum_probs=44.6
Q ss_pred EEEccCCCCcccCCccccCCCCCcEEEccCCCCCCCCcccccCCCCCCEEeccCCCCCCCCChhhhhccccccccccccc
Q 042348 85 RVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNS 164 (686)
Q Consensus 85 ~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~ 164 (686)
.|+|++|+|+ .+| .+.++++|++|+|++|+|+ .+|+.++.+++|+.|++++|.+++ +| .+..+++|++|++++|+
T Consensus 2 ~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~N~ 76 (124)
T d1dcea3 2 VLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNR 76 (124)
T ss_dssp EEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSC
T ss_pred EEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhcccccccccccccc-cC-ccccccccCeEECCCCc
Confidence 3444444444 233 2444444444444444444 334444444444444444444442 22 24444444444444444
Q ss_pred cCCCCch-hhhhcCcccceecccccccC
Q 042348 165 FTGPLPD-GFATNLTALQKLDLSFNNLS 191 (686)
Q Consensus 165 l~~~~p~-~~~~~l~~L~~L~Ls~N~l~ 191 (686)
++. +|. .....+++|+.|+|++|.++
T Consensus 77 i~~-~~~~~~l~~~~~L~~L~l~~N~i~ 103 (124)
T d1dcea3 77 LQQ-SAAIQPLVSCPRLVLLNLQGNSLC 103 (124)
T ss_dssp CCS-SSTTGGGGGCTTCCEEECTTSGGG
T ss_pred cCC-CCCchhhcCCCCCCEEECCCCcCC
Confidence 442 221 11234555555555555554
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.55 E-value=3.8e-15 Score=135.10 Aligned_cols=128 Identities=16% Similarity=0.140 Sum_probs=97.8
Q ss_pred CcCCCCCCCEEEccCCCCcccCCccccCCCCCcEEEccCCCCCCCCcccccCCCCCCEEeccCCCCCCCCChhhhhcccc
Q 042348 76 DLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQVLDLSQNSFSSSIPSSIVQCKRL 155 (686)
Q Consensus 76 ~l~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L 155 (686)
.+.+...|+.|+|++|+|+ .+|..+..+++|+.|+|++|+++ .++ .|..+++|++|++++|+++...+..+..+++|
T Consensus 13 ~~~n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L 89 (162)
T d1a9na_ 13 QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDL 89 (162)
T ss_dssp EEECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTC
T ss_pred hccCcCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCC-ccC-CcccCcchhhhhcccccccCCCcccccccccc
Confidence 4567778889999999998 56766678889999999999988 454 58888999999999999986555666788999
Q ss_pred ccccccccccCCCCch-hhhhcCcccceecccccccCCCC---chhhhcccccccc
Q 042348 156 KTVVLNQNSFTGPLPD-GFATNLTALQKLDLSFNNLSGLI---PNDIANLSRLRLL 207 (686)
Q Consensus 156 ~~L~L~~N~l~~~~p~-~~~~~l~~L~~L~Ls~N~l~~~~---p~~~~~l~~L~~l 207 (686)
+.|+|++|+++. ++. .....+++|++|+|++|.++... +..+..+++|+.|
T Consensus 90 ~~L~L~~N~i~~-~~~l~~l~~l~~L~~L~l~~N~i~~~~~~r~~~i~~lp~L~~L 144 (162)
T d1a9na_ 90 TELILTNNSLVE-LGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVL 144 (162)
T ss_dssp CEEECCSCCCCC-GGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEE
T ss_pred ccceeccccccc-cccccccccccccchhhcCCCccccccchHHHHHHHCCCcCee
Confidence 999999999873 443 23357889999999999887543 2245666665543
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.55 E-value=1.4e-14 Score=124.95 Aligned_cols=118 Identities=27% Similarity=0.364 Sum_probs=98.9
Q ss_pred EEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCccccCCCCCcEEEccCCCCCCCCcccccCCCCCCEEeccCCC
Q 042348 61 SLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQVLDLSQNS 140 (686)
Q Consensus 61 ~l~l~~n~l~g~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~ 140 (686)
.|+|++|+|+. ++ .+..+++|++|+|++|+|+ .+|..+..+++|+.|+|++|+|+ .+| .++.+++|++|++++|+
T Consensus 2 ~L~Ls~n~l~~-l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~-~l~-~~~~l~~L~~L~l~~N~ 76 (124)
T d1dcea3 2 VLHLAHKDLTV-LC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNNR 76 (124)
T ss_dssp EEECTTSCCSS-CC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCG-GGTTCSSCCEEECCSSC
T ss_pred EEEcCCCCCCC-Cc-ccccCCCCCEEECCCCccC-cchhhhhhhhccccccccccccc-ccC-ccccccccCeEECCCCc
Confidence 68999999994 44 5999999999999999998 78889999999999999999998 455 59999999999999999
Q ss_pred CCCCC-ChhhhhccccccccccccccCCC--CchhhhhcCccccee
Q 042348 141 FSSSI-PSSIVQCKRLKTVVLNQNSFTGP--LPDGFATNLTALQKL 183 (686)
Q Consensus 141 l~~~~-p~~~~~l~~L~~L~L~~N~l~~~--~p~~~~~~l~~L~~L 183 (686)
++... ...+..+++|+.|+|++|+++.. ++..+...+++|+.|
T Consensus 77 i~~~~~~~~l~~~~~L~~L~l~~N~i~~~~~~~~~l~~~lp~L~~L 122 (124)
T d1dcea3 77 LQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSI 122 (124)
T ss_dssp CCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHCTTCSEE
T ss_pred cCCCCCchhhcCCCCCCEEECCCCcCCcCccHHHHHHHHCcCcceE
Confidence 98543 25788999999999999999742 234444456666654
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.51 E-value=3.9e-14 Score=133.44 Aligned_cols=138 Identities=28% Similarity=0.418 Sum_probs=116.5
Q ss_pred CCCEEEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCccccCCCCCcEEEccCCCCCCCCcccccCCCCCCEEe
Q 042348 56 EGQVFSLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQVLD 135 (686)
Q Consensus 56 ~~~~~~l~l~~n~l~g~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ 135 (686)
-..+++|+|++|++++..| ++++++|+.|++++|.+. .+| .+.++++|+.|++++|.+... ..+..+++|+.|+
T Consensus 61 l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~-~~~-~l~~l~~L~~L~l~~~~~~~~--~~~~~l~~L~~L~ 134 (199)
T d2omxa2 61 LNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIA-DIT-PLANLTNLTGLTLFNNQITDI--DPLKNLTNLNRLE 134 (199)
T ss_dssp CTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC-CCG-GGTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEE
T ss_pred CCCcCcCccccccccCccc--ccCCcccccccccccccc-ccc-ccccccccccccccccccccc--cccchhhhhHHhh
Confidence 3689999999999998543 999999999999999997 455 488999999999999999743 3588999999999
Q ss_pred ccCCCCCCCCChhhhhccccccccccccccCCCCchhhhhcCcccceecccccccCCCCchhhhccccccc
Q 042348 136 LSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSGLIPNDIANLSRLRL 206 (686)
Q Consensus 136 ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 206 (686)
+++|++.. +| .+..+++|+.|++++|++++ +++ + .++++|++|+|++|++++. | .++.|++|+.
T Consensus 135 l~~n~l~~-~~-~l~~~~~L~~L~l~~n~l~~-l~~-l-~~l~~L~~L~ls~N~i~~i-~-~l~~L~~L~~ 198 (199)
T d2omxa2 135 LSSNTISD-IS-ALSGLTSLQQLNFSSNQVTD-LKP-L-ANLTTLERLDISSNKVSDI-S-VLAKLTNLES 198 (199)
T ss_dssp CCSSCCCC-CG-GGTTCTTCSEEECCSSCCCC-CGG-G-TTCTTCCEEECCSSCCCCC-G-GGGGCTTCSE
T ss_pred hhhhhhcc-cc-cccccccccccccccccccC-Ccc-c-cCCCCCCEEECCCCCCCCC-c-cccCCCCCCc
Confidence 99999984 44 58899999999999999995 543 4 5899999999999999974 3 4667776654
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.50 E-value=3.5e-14 Score=134.99 Aligned_cols=138 Identities=29% Similarity=0.399 Sum_probs=117.2
Q ss_pred CCEEEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCccccCCCCCcEEEccCCCCCCCCcccccCCCCCCEEec
Q 042348 57 GQVFSLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQVLDL 136 (686)
Q Consensus 57 ~~~~~l~l~~n~l~g~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l 136 (686)
.++++|+|++|++++.. .++.+++|+.|++++|+|+ .+| .+.++++|+.|++++|.+. .++ .+..+++|+.+++
T Consensus 68 ~~L~~L~L~~n~i~~l~--~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~~~~~-~~~-~l~~l~~l~~l~~ 141 (210)
T d1h6ta2 68 PNVTKLFLNGNKLTDIK--PLANLKNLGWLFLDENKVK-DLS-SLKDLKKLKSLSLEHNGIS-DIN-GLVHLPQLESLYL 141 (210)
T ss_dssp TTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCC-CGG-GGTTCTTCCEEECTTSCCC-CCG-GGGGCTTCCEEEC
T ss_pred CCCCEEeCCCccccCcc--ccccCcccccccccccccc-ccc-ccccccccccccccccccc-ccc-ccccccccccccc
Confidence 57999999999999743 4789999999999999998 455 5889999999999999987 444 6889999999999
Q ss_pred cCCCCCCCCChhhhhccccccccccccccCCCCchhhhhcCcccceecccccccCCCCchhhhcccccccc
Q 042348 137 SQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSGLIPNDIANLSRLRLL 207 (686)
Q Consensus 137 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l 207 (686)
++|.+++ +..+..+++|+.+++++|++++ +++ + .++++|+.|+|++|+++. +| .+.+|++|+.|
T Consensus 142 ~~n~l~~--~~~~~~l~~L~~l~l~~n~l~~-i~~-l-~~l~~L~~L~Ls~N~i~~-l~-~l~~l~~L~~L 205 (210)
T d1h6ta2 142 GNNKITD--ITVLSRLTKLDTLSLEDNQISD-IVP-L-AGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVL 205 (210)
T ss_dssp CSSCCCC--CGGGGGCTTCSEEECCSSCCCC-CGG-G-TTCTTCCEEECCSSCCCB-CG-GGTTCTTCSEE
T ss_pred ccccccc--cccccccccccccccccccccc-ccc-c-cCCCCCCEEECCCCCCCC-Ch-hhcCCCCCCEE
Confidence 9999984 3457789999999999999985 554 4 589999999999999986 44 47777777655
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.50 E-value=4.8e-14 Score=142.49 Aligned_cols=158 Identities=22% Similarity=0.292 Sum_probs=129.2
Q ss_pred EEEEEeCCCC--ccccCCcCcCCCCCCCEEEccCCCCcccCCccccCCCCCcEEEccCCCCCCCCcccccCCCCCCEEec
Q 042348 59 VFSLIIPNKK--LTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQVLDL 136 (686)
Q Consensus 59 ~~~l~l~~n~--l~g~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l 136 (686)
...+....|. ..+..+..+..+++|+.+++++|.++ .+|..+ +++|+.|++++|..++..+..|..++.++.|++
T Consensus 126 ~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~-~l~~~~--~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~ 202 (305)
T d1xkua_ 126 MIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGL 202 (305)
T ss_dssp CCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC-SCCSSC--CTTCSEEECTTSCCCEECTGGGTTCTTCCEEEC
T ss_pred ccccccccccccccCCCccccccccccCccccccCCcc-ccCccc--CCccCEEECCCCcCCCCChhHhhcccccccccc
Confidence 3345555443 33345567888899999999999998 567654 689999999999999999999999999999999
Q ss_pred cCCCCCCCCChhhhhccccccccccccccCCCCchhhhhcCcccceecccccccCCCCchhhhccccccccccccccccc
Q 042348 137 SQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSGLIPNDIANLSRLRLLAQRVYVDLT 216 (686)
Q Consensus 137 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~~~~~l~l~ 216 (686)
++|.+++..+..+.++++|++|+|++|+|+ .+|..+ ..+++|++|+|++|+|+......|.....+..+.++..++|+
T Consensus 203 s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l-~~l~~L~~L~Ls~N~i~~i~~~~f~~~~~~~~~~~L~~L~L~ 280 (305)
T d1xkua_ 203 SFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGL-ADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLF 280 (305)
T ss_dssp CSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTT-TTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECC
T ss_pred ccccccccccccccccccceeeeccccccc-cccccc-ccccCCCEEECCCCccCccChhhccCcchhcccCCCCEEECC
Confidence 999999888999999999999999999998 688877 489999999999999997766566554444444555667898
Q ss_pred CCCCC
Q 042348 217 YNNLS 221 (686)
Q Consensus 217 ~N~l~ 221 (686)
+|.++
T Consensus 281 ~N~~~ 285 (305)
T d1xkua_ 281 SNPVQ 285 (305)
T ss_dssp SSSSC
T ss_pred CCcCc
Confidence 88875
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.49 E-value=7.1e-14 Score=134.68 Aligned_cols=151 Identities=25% Similarity=0.367 Sum_probs=94.4
Q ss_pred CCEEEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCccccCCCCCcEEEccCCCCCCCCcccccCCCCCCEEec
Q 042348 57 GQVFSLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQVLDL 136 (686)
Q Consensus 57 ~~~~~l~l~~n~l~g~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l 136 (686)
..++.|++.+|+++. ++ .+..+++|+.|+|++|++++..| +.++++|+.|++++|.++ .++ .+..+++|+.|++
T Consensus 41 ~~L~~L~l~~~~i~~-l~-~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~n~~~-~i~-~l~~l~~L~~l~l 114 (227)
T d1h6ua2 41 DGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLK-NVS-AIAGLQSIKTLDL 114 (227)
T ss_dssp HTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCS-CCG-GGTTCTTCCEEEC
T ss_pred CCcCEEECCCCCCCc-ch-hHhcCCCCcEeecCCceeecccc--cccccccccccccccccc-ccc-ccccccccccccc
Confidence 356777777777775 33 47777777777777777764333 677777777777777776 344 4667777777777
Q ss_pred cCCCCCCCCC--------------------hhhhhccccccccccccccCCCCchhhhhcCcccceecccccccCCCCch
Q 042348 137 SQNSFSSSIP--------------------SSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSGLIPN 196 (686)
Q Consensus 137 s~N~l~~~~p--------------------~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~ 196 (686)
++|...+..+ ..+..+++|+.|++++|.++. ++. + .++++|+.|||++|++++. |
T Consensus 115 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~~~~-~~~-l-~~l~~L~~L~Ls~n~l~~l-~- 189 (227)
T d1h6ua2 115 TSTQITDVTPLAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSD-LTP-L-ANLSKLTTLKADDNKISDI-S- 189 (227)
T ss_dssp TTSCCCCCGGGTTCTTCCEEECCSSCCCCCGGGGGCTTCCEEECCSSCCCC-CGG-G-TTCTTCCEEECCSSCCCCC-G-
T ss_pred ccccccccchhccccchhhhhchhhhhchhhhhcccccccccccccccccc-chh-h-cccccceecccCCCccCCC-h-
Confidence 7776654221 124455666677777666653 222 3 3567777777777777653 2
Q ss_pred hhhcccccccccccccccccCCCCCCCc
Q 042348 197 DIANLSRLRLLAQRVYVDLTYNNLSGLI 224 (686)
Q Consensus 197 ~~~~l~~L~~l~~~~~l~l~~N~l~~~~ 224 (686)
.++++++|+. |++++|+++...
T Consensus 190 ~l~~l~~L~~------L~Ls~N~lt~i~ 211 (227)
T d1h6ua2 190 PLASLPNLIE------VHLKNNQISDVS 211 (227)
T ss_dssp GGGGCTTCCE------EECTTSCCCBCG
T ss_pred hhcCCCCCCE------EECcCCcCCCCc
Confidence 2455554443 367777766543
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.48 E-value=7.7e-14 Score=145.58 Aligned_cols=164 Identities=27% Similarity=0.359 Sum_probs=94.3
Q ss_pred CEEEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCccccCCCCCcEEEccCCCCCCCCcccccCCCCCCEEecc
Q 042348 58 QVFSLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQVLDLS 137 (686)
Q Consensus 58 ~~~~l~l~~n~l~g~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls 137 (686)
.++.|++++|.++. .+.+..+++|+.|++++|.+++..| +..+++|+.|++++|++++.. .+..++.++.++++
T Consensus 220 ~L~~L~l~~n~l~~--~~~l~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~~~l~~~~--~~~~~~~l~~l~~~ 293 (384)
T d2omza2 220 NLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNIS--PLAGLTALTNLELN 293 (384)
T ss_dssp TCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCG--GGTTCTTCSEEECC
T ss_pred CCCEEECCCCCCCC--cchhhcccccchhccccCccCCCCc--ccccccCCEeeccCcccCCCC--cccccccccccccc
Confidence 44555555555553 1245555556666666665553222 455556666666666655322 24555556666666
Q ss_pred CCCCCCCCChhhhhccccccccccccccCCCCchhhhhcCcccceecccccccCCCCchhhhcccccccccccccccccC
Q 042348 138 QNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSGLIPNDIANLSRLRLLAQRVYVDLTY 217 (686)
Q Consensus 138 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~~~~~l~l~~ 217 (686)
.|.+++ +..+..+++++.|+|++|++++ +++ + ..+++|+.|+|++|+|++. | .++++++|+.| ++++
T Consensus 294 ~n~l~~--~~~~~~~~~l~~L~ls~n~l~~-l~~-l-~~l~~L~~L~L~~n~l~~l-~-~l~~l~~L~~L------~l~~ 360 (384)
T d2omza2 294 ENQLED--ISPISNLKNLTYLTLYFNNISD-ISP-V-SSLTKLQRLFFANNKVSDV-S-SLANLTNINWL------SAGH 360 (384)
T ss_dssp SSCCSC--CGGGGGCTTCSEEECCSSCCSC-CGG-G-GGCTTCCEEECCSSCCCCC-G-GGGGCTTCCEE------ECCS
T ss_pred cccccc--ccccchhcccCeEECCCCCCCC-Ccc-c-ccCCCCCEEECCCCCCCCC-h-hHcCCCCCCEE------ECCC
Confidence 666553 2346667777777777777775 332 3 4677788888888877752 3 46666655544 7888
Q ss_pred CCCCCCcccccccccCCcccccCC
Q 042348 218 NNLSGLIPQNAALLSLGPTAFIGN 241 (686)
Q Consensus 218 N~l~~~~p~~~~~~~~~~~~~~~n 241 (686)
|++++.+| ...+.++..+.+.+|
T Consensus 361 N~l~~l~~-l~~l~~L~~L~L~~N 383 (384)
T d2omza2 361 NQISDLTP-LANLTRITQLGLNDQ 383 (384)
T ss_dssp SCCCBCGG-GTTCTTCSEEECCCE
T ss_pred CcCCCChh-hccCCCCCEeeCCCC
Confidence 88777655 333344444444443
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.48 E-value=4.4e-14 Score=137.55 Aligned_cols=146 Identities=15% Similarity=0.165 Sum_probs=101.8
Q ss_pred cceeeeEecC-----------CCEEEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCC-ccccCCCCCcEEEcc-
Q 042348 47 CSWNGITCRE-----------GQVFSLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLP-VELFNASNLQSLILS- 113 (686)
Q Consensus 47 c~w~gv~c~~-----------~~~~~l~l~~n~l~g~~p~~l~~l~~L~~L~L~~N~l~g~~p-~~~~~l~~L~~L~L~- 113 (686)
|....|.|.. ..+++|+|++|+|+...+..|.++++|++|+|++|.+...+| ..|.++++++.|.+.
T Consensus 8 C~~~~i~c~~~~l~~iP~~l~~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~ 87 (242)
T d1xwdc1 8 CSNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 87 (242)
T ss_dssp ECSSEEEEESCSCSSCCSCSCSCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEEC
T ss_pred CcCCEEEEeCCCCCCcCCCCCCCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccccc
Confidence 5677888862 358899999999997666789999999999999999876554 467889999999876
Q ss_pred CCCCCCCCcccccCCCCCCEEeccCCCCCCCCCh-hhhhccccccccccccccCCCCchhhhhcC-cccceecccccccC
Q 042348 114 GNSFSGPVPMQIGKLKYLQVLDLSQNSFSSSIPS-SIVQCKRLKTVVLNQNSFTGPLPDGFATNL-TALQKLDLSFNNLS 191 (686)
Q Consensus 114 ~N~l~g~~p~~~~~l~~L~~L~ls~N~l~~~~p~-~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l-~~L~~L~Ls~N~l~ 191 (686)
.|++....+..|.++++|+.|++++|.+....+. .+..+..+..+..+++++. .++...+..+ ..++.|++++|+++
T Consensus 88 ~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~-~i~~~~~~~~~~~l~~L~l~~n~l~ 166 (242)
T d1xwdc1 88 ANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIH-TIERNSFVGLSFESVILWLNKNGIQ 166 (242)
T ss_dssp CTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCC-EECTTSSTTSBSSCEEEECCSSCCC
T ss_pred cccccccccccccccccccccccchhhhcccccccccccccccccccccccccc-cccccccccccccceeeeccccccc
Confidence 4788877788899999999999999998743332 2233444444444444544 2222222222 24555555555555
Q ss_pred CC
Q 042348 192 GL 193 (686)
Q Consensus 192 ~~ 193 (686)
..
T Consensus 167 ~i 168 (242)
T d1xwdc1 167 EI 168 (242)
T ss_dssp EE
T ss_pred cc
Confidence 43
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.46 E-value=4.3e-14 Score=128.00 Aligned_cols=124 Identities=17% Similarity=0.143 Sum_probs=104.0
Q ss_pred CCEEEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCccccCCCCCcEEEccCCCCCCCCcccccCCCCCCEEec
Q 042348 57 GQVFSLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQVLDL 136 (686)
Q Consensus 57 ~~~~~l~l~~n~l~g~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l 136 (686)
.++.+|+|++|+|+. +|..+..+++|+.|+|++|+|+ .++ .|..+++|++|+|++|+++...+..+..+++|+.|+|
T Consensus 18 ~~lr~L~L~~n~I~~-i~~~~~~l~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~L~L 94 (162)
T d1a9na_ 18 VRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELIL 94 (162)
T ss_dssp TSCEEEECTTSCCCS-CCCGGGGTTCCSEEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEEC
T ss_pred CcCcEEECCCCCCCc-cCccccccccCCEEECCCCCCC-ccC-CcccCcchhhhhcccccccCCCcccccccccccccee
Confidence 467899999999996 4766788999999999999998 554 5889999999999999999554555678999999999
Q ss_pred cCCCCCCCCC--hhhhhccccccccccccccCCCCch---hhhhcCcccceecc
Q 042348 137 SQNSFSSSIP--SSIVQCKRLKTVVLNQNSFTGPLPD---GFATNLTALQKLDL 185 (686)
Q Consensus 137 s~N~l~~~~p--~~~~~l~~L~~L~L~~N~l~~~~p~---~~~~~l~~L~~L~L 185 (686)
++|+++. ++ ..+..+++|++|++++|.++ ..|. .....+++|+.||-
T Consensus 95 ~~N~i~~-~~~l~~l~~l~~L~~L~l~~N~i~-~~~~~r~~~i~~lp~L~~LD~ 146 (162)
T d1a9na_ 95 TNNSLVE-LGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLDF 146 (162)
T ss_dssp CSCCCCC-GGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEETT
T ss_pred ccccccc-cccccccccccccchhhcCCCccc-cccchHHHHHHHCCCcCeeCC
Confidence 9999984 44 46788999999999999998 4553 23457999999984
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.43 E-value=1.5e-13 Score=143.34 Aligned_cols=143 Identities=26% Similarity=0.406 Sum_probs=122.2
Q ss_pred CCEEEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCccccCCCCCcEEEccCCCCCCCCcccccCCCCCCEEec
Q 042348 57 GQVFSLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQVLDL 136 (686)
Q Consensus 57 ~~~~~l~l~~n~l~g~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l 136 (686)
..++.|++++|.+++..+ ++.+++|+.|++++|.+++.. .+.+++.++.++++.|.+++ + ..+..+++++.|++
T Consensus 241 ~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~~~l~~~~--~~~~~~~l~~l~~~~n~l~~-~-~~~~~~~~l~~L~l 314 (384)
T d2omza2 241 TNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNIS--PLAGLTALTNLELNENQLED-I-SPISNLKNLTYLTL 314 (384)
T ss_dssp TTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCG--GGTTCTTCSEEECCSSCCSC-C-GGGGGCTTCSEEEC
T ss_pred cccchhccccCccCCCCc--ccccccCCEeeccCcccCCCC--cccccccccccccccccccc-c-cccchhcccCeEEC
Confidence 578899999999998543 889999999999999998543 37789999999999999985 3 35889999999999
Q ss_pred cCCCCCCCCChhhhhccccccccccccccCCCCchhhhhcCcccceecccccccCCCCchhhhccccccccccccccccc
Q 042348 137 SQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSGLIPNDIANLSRLRLLAQRVYVDLT 216 (686)
Q Consensus 137 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~~~~~l~l~ 216 (686)
++|++++. + .+..+++|+.|+|++|++++ ++ .+ .++++|++|+|++|+|++.+| +.+|++|+.| +|+
T Consensus 315 s~n~l~~l-~-~l~~l~~L~~L~L~~n~l~~-l~-~l-~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L------~L~ 381 (384)
T d2omza2 315 YFNNISDI-S-PVSSLTKLQRLFFANNKVSD-VS-SL-ANLTNINWLSAGHNQISDLTP--LANLTRITQL------GLN 381 (384)
T ss_dssp CSSCCSCC-G-GGGGCTTCCEEECCSSCCCC-CG-GG-GGCTTCCEEECCSSCCCBCGG--GTTCTTCSEE------ECC
T ss_pred CCCCCCCC-c-ccccCCCCCEEECCCCCCCC-Ch-hH-cCCCCCCEEECCCCcCCCChh--hccCCCCCEe------eCC
Confidence 99999964 3 38899999999999999984 55 45 589999999999999998765 7777777655 898
Q ss_pred CC
Q 042348 217 YN 218 (686)
Q Consensus 217 ~N 218 (686)
+|
T Consensus 382 ~N 383 (384)
T d2omza2 382 DQ 383 (384)
T ss_dssp CE
T ss_pred CC
Confidence 87
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.38 E-value=7e-13 Score=127.55 Aligned_cols=148 Identities=20% Similarity=0.376 Sum_probs=116.6
Q ss_pred ceeeeEecCCCEEEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCccccCCCCCcEEEccCCCCCCCCc-----
Q 042348 48 SWNGITCREGQVFSLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVP----- 122 (686)
Q Consensus 48 ~w~gv~c~~~~~~~l~l~~n~l~g~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p----- 122 (686)
++.|+ ..-..++.|+|++|.+++..| +..+++|+.|++++|.++ .++ .+.++++|+.|++++|...+..+
T Consensus 55 ~l~~l-~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~n~~~-~i~-~l~~l~~L~~l~l~~~~~~~~~~~~~~~ 129 (227)
T d1h6ua2 55 TIEGV-QYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLK-NVS-AIAGLQSIKTLDLTSTQITDVTPLAGLS 129 (227)
T ss_dssp CCTTG-GGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCS-CCG-GGTTCTTCCEEECTTSCCCCCGGGTTCT
T ss_pred cchhH-hcCCCCcEeecCCceeecccc--cccccccccccccccccc-ccc-cccccccccccccccccccccchhcccc
Confidence 34444 234689999999999997544 899999999999999987 454 57889999999999888764322
Q ss_pred ---------------ccccCCCCCCEEeccCCCCCCCCChhhhhccccccccccccccCCCCchhhhhcCcccceecccc
Q 042348 123 ---------------MQIGKLKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSF 187 (686)
Q Consensus 123 ---------------~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~ 187 (686)
..+..+++|+.|++++|.+++. + .+.++++|+.|+|++|++++ ++. + .++++|++|+|++
T Consensus 130 ~~~~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~~~~~-~-~l~~l~~L~~L~Ls~n~l~~-l~~-l-~~l~~L~~L~Ls~ 204 (227)
T d1h6ua2 130 NLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDL-T-PLANLSKLTTLKADDNKISD-ISP-L-ASLPNLIEVHLKN 204 (227)
T ss_dssp TCCEEECCSSCCCCCGGGGGCTTCCEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCCC-CGG-G-GGCTTCCEEECTT
T ss_pred chhhhhchhhhhchhhhhccccccccccccccccccc-h-hhcccccceecccCCCccCC-Chh-h-cCCCCCCEEECcC
Confidence 2356678899999999999843 3 38899999999999999985 554 4 5899999999999
Q ss_pred cccCCCCchhhhcccccccc
Q 042348 188 NNLSGLIPNDIANLSRLRLL 207 (686)
Q Consensus 188 N~l~~~~p~~~~~l~~L~~l 207 (686)
|++++..| ++++++|+.|
T Consensus 205 N~lt~i~~--l~~l~~L~~L 222 (227)
T d1h6ua2 205 NQISDVSP--LANTSNLFIV 222 (227)
T ss_dssp SCCCBCGG--GTTCTTCCEE
T ss_pred CcCCCCcc--cccCCCCCEE
Confidence 99997543 6666666544
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.35 E-value=8.6e-13 Score=118.44 Aligned_cols=100 Identities=18% Similarity=0.147 Sum_probs=76.3
Q ss_pred CCCCccccCCcCcCCCCCCCEEEccCC-CCcccCCccccCCCCCcEEEccCCCCCCCCcccccCCCCCCEEeccCCCCCC
Q 042348 65 PNKKLTGFIPADLGSLSAIGRVNLRNN-NFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQVLDLSQNSFSS 143 (686)
Q Consensus 65 ~~n~l~g~~p~~l~~l~~L~~L~L~~N-~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~~ 143 (686)
+++++. ..|..+..+++|+.|+|++| .|+..-+..|.++++|+.|+|++|+|+...|..|..+++|++|+|++|+|+
T Consensus 16 ~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~- 93 (156)
T d2ifga3 16 TRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALE- 93 (156)
T ss_dssp CSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCS-
T ss_pred cCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccCCCCc-
Confidence 345555 35777888899999999766 477555677888999999999999998766778888999999999999988
Q ss_pred CCChhhhhccccccccccccccC
Q 042348 144 SIPSSIVQCKRLKTVVLNQNSFT 166 (686)
Q Consensus 144 ~~p~~~~~l~~L~~L~L~~N~l~ 166 (686)
.+|.......+|+.|+|++|.+.
T Consensus 94 ~l~~~~~~~~~l~~L~L~~Np~~ 116 (156)
T d2ifga3 94 SLSWKTVQGLSLQELVLSGNPLH 116 (156)
T ss_dssp CCCSTTTCSCCCCEEECCSSCCC
T ss_pred ccChhhhccccccccccCCCccc
Confidence 45544444446778888888774
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.31 E-value=9.2e-15 Score=137.34 Aligned_cols=117 Identities=25% Similarity=0.249 Sum_probs=94.0
Q ss_pred CCcCcCCCCCCCEEEccCCCCcccCCccccCCCCCcEEEccCCCCCCCCcccccCCCCCCEEeccCCCCCCCCChhhhhc
Q 042348 73 IPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQVLDLSQNSFSSSIPSSIVQC 152 (686)
Q Consensus 73 ~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l 152 (686)
+|.++..|++|++|+|++|+|+ .++ .+.++++|+.|+|++|.++ .+|..+..+++|+.|++++|+++. + ..+..+
T Consensus 40 l~~sl~~L~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~-l-~~~~~l 114 (198)
T d1m9la_ 40 MDATLSTLKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-L-SGIEKL 114 (198)
T ss_dssp CHHHHHHTTTCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCC-H-HHHHHH
T ss_pred hhhHHhcccccceeECcccCCC-Ccc-cccCCccccChhhcccccc-cccccccccccccccccccccccc-c-cccccc
Confidence 4567888999999999999998 565 5888999999999999997 667666667789999999999984 4 357888
Q ss_pred cccccccccccccCCCCch-hhhhcCcccceecccccccCCCCc
Q 042348 153 KRLKTVVLNQNSFTGPLPD-GFATNLTALQKLDLSFNNLSGLIP 195 (686)
Q Consensus 153 ~~L~~L~L~~N~l~~~~p~-~~~~~l~~L~~L~Ls~N~l~~~~p 195 (686)
++|+.|+|++|+++. ++. ..+..+++|+.|+|++|.+....+
T Consensus 115 ~~L~~L~L~~N~i~~-~~~~~~l~~l~~L~~L~L~~N~l~~~~~ 157 (198)
T d1m9la_ 115 VNLRVLYMSNNKITN-WGEIDKLAALDKLEDLLLAGNPLYNDYK 157 (198)
T ss_dssp HHSSEEEESEEECCC-HHHHHHHTTTTTCSEEEECSSHHHHHHC
T ss_pred ccccccccccchhcc-ccccccccCCCccceeecCCCccccCcc
Confidence 999999999999974 443 334578999999999998875433
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.29 E-value=3.8e-12 Score=114.11 Aligned_cols=108 Identities=19% Similarity=0.138 Sum_probs=91.6
Q ss_pred CCCCEEEccCCCCcccCCccccCCCCCcEEEccCCC-CCCCCcccccCCCCCCEEeccCCCCCCCCChhhhhcccccccc
Q 042348 81 SAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNS-FSGPVPMQIGKLKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVV 159 (686)
Q Consensus 81 ~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~-l~g~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~ 159 (686)
...+.++.+++.+. .+|..+..+++|+.|+|++|+ ++..-+..|.++++|+.|+|++|+|+...|..|..+++|++|+
T Consensus 8 ~~~~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~ 86 (156)
T d2ifga3 8 HGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLN 86 (156)
T ss_dssp SSSSCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEE
T ss_pred CCCCeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCccccccccccccccee
Confidence 34456888998887 678889999999999998764 8866667899999999999999999987788899999999999
Q ss_pred ccccccCCCCchhhhhcCcccceecccccccC
Q 042348 160 LNQNSFTGPLPDGFATNLTALQKLDLSFNNLS 191 (686)
Q Consensus 160 L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~ 191 (686)
|++|+|+ .+|...+. ..+|+.|+|++|.+.
T Consensus 87 Ls~N~l~-~l~~~~~~-~~~l~~L~L~~Np~~ 116 (156)
T d2ifga3 87 LSFNALE-SLSWKTVQ-GLSLQELVLSGNPLH 116 (156)
T ss_dssp CCSSCCS-CCCSTTTC-SCCCCEEECCSSCCC
T ss_pred ccCCCCc-ccChhhhc-cccccccccCCCccc
Confidence 9999998 67777654 457999999999886
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.25 E-value=8.3e-12 Score=121.06 Aligned_cols=163 Identities=13% Similarity=0.079 Sum_probs=125.9
Q ss_pred EEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCccccCCCCCcEEEccCCCCCCCCc-ccccCCCCCCEEeccC-
Q 042348 61 SLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVP-MQIGKLKYLQVLDLSQ- 138 (686)
Q Consensus 61 ~l~l~~n~l~g~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p-~~~~~l~~L~~L~ls~- 138 (686)
.++.++++|+ .+|+.+. ++++.|+|++|+|+...+..|.++++|++|+|++|.+...++ ..|..+++++.|++..
T Consensus 12 ~i~c~~~~l~-~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~ 88 (242)
T d1xwdc1 12 VFLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKA 88 (242)
T ss_dssp EEEEESCSCS-SCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECC
T ss_pred EEEEeCCCCC-CcCCCCC--CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeecccccccccccccccccc
Confidence 5777888888 6787664 589999999999996556678999999999999999986554 4688999999999864
Q ss_pred CCCCCCCChhhhhccccccccccccccCCCCchhhhhcCcccceecccccccCCCCchhhhcccccccccccccccccCC
Q 042348 139 NSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSGLIPNDIANLSRLRLLAQRVYVDLTYN 218 (686)
Q Consensus 139 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~~~~~l~l~~N 218 (686)
|++....+..+..+++|++|++++|++....+......+..|..+..+++.+....+..+.+++. .+..+++++|
T Consensus 89 n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~-----~l~~L~l~~n 163 (242)
T d1xwdc1 89 NNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSF-----ESVILWLNKN 163 (242)
T ss_dssp TTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBS-----SCEEEECCSS
T ss_pred ccccccccccccccccccccccchhhhcccccccccccccccccccccccccccccccccccccc-----cceeeecccc
Confidence 78887788889999999999999999985444444456777777788888888776666665542 1234588888
Q ss_pred CCCCCcccccccc
Q 042348 219 NLSGLIPQNAALL 231 (686)
Q Consensus 219 ~l~~~~p~~~~~~ 231 (686)
+++...+..+...
T Consensus 164 ~l~~i~~~~~~~~ 176 (242)
T d1xwdc1 164 GIQEIHNCAFNGT 176 (242)
T ss_dssp CCCEECTTTTTTC
T ss_pred cccccccccccch
Confidence 8886655444333
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.23 E-value=1.3e-13 Score=129.38 Aligned_cols=130 Identities=21% Similarity=0.275 Sum_probs=100.8
Q ss_pred CCEEEccCC--CCcccCCccccCCCCCcEEEccCCCCCCCCcccccCCCCCCEEeccCCCCCCCCChhhhhccccccccc
Q 042348 83 IGRVNLRNN--NFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQVLDLSQNSFSSSIPSSIVQCKRLKTVVL 160 (686)
Q Consensus 83 L~~L~L~~N--~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L 160 (686)
++.++++++ .++ .+|..+..+++|+.|+|++|+|+ .++ .+..+++|+.|+|++|.++ .+|..+..+++|++|++
T Consensus 25 ~~~~~l~~~~~~i~-~l~~sl~~L~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l 100 (198)
T d1m9la_ 25 AEKVELHGMIPPIE-KMDATLSTLKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWI 100 (198)
T ss_dssp CSCEECCBCCTTCC-CCHHHHHHTTTCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEEC
T ss_pred cceeeeecccCchh-hhhhHHhcccccceeECcccCCC-Ccc-cccCCccccChhhcccccc-ccccccccccccccccc
Confidence 344555543 233 56678899999999999999998 565 5899999999999999998 67877777889999999
Q ss_pred cccccCCCCchhhhhcCcccceecccccccCCCCc-hhhhcccccccccccccccccCCCCCCCcc
Q 042348 161 NQNSFTGPLPDGFATNLTALQKLDLSFNNLSGLIP-NDIANLSRLRLLAQRVYVDLTYNNLSGLIP 225 (686)
Q Consensus 161 ~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~l~~~~~l~l~~N~l~~~~p 225 (686)
++|+++. ++ .+ ..+++|+.|+|++|+++.... ..+..+++|+ +|++++|.++...+
T Consensus 101 ~~N~i~~-l~-~~-~~l~~L~~L~L~~N~i~~~~~~~~l~~l~~L~------~L~L~~N~l~~~~~ 157 (198)
T d1m9la_ 101 SYNQIAS-LS-GI-EKLVNLRVLYMSNNKITNWGEIDKLAALDKLE------DLLLAGNPLYNDYK 157 (198)
T ss_dssp SEEECCC-HH-HH-HHHHHSSEEEESEEECCCHHHHHHHTTTTTCS------EEEECSSHHHHHHC
T ss_pred ccccccc-cc-cc-cccccccccccccchhccccccccccCCCccc------eeecCCCccccCcc
Confidence 9999984 54 34 478999999999999986422 3455555554 55999998875544
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=98.96 E-value=3.1e-09 Score=108.22 Aligned_cols=76 Identities=25% Similarity=0.381 Sum_probs=48.3
Q ss_pred CCEEEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCccccCCCCCcEEEccCCCCCCCCcccccCCCCCCEEec
Q 042348 57 GQVFSLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQVLDL 136 (686)
Q Consensus 57 ~~~~~l~l~~n~l~g~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l 136 (686)
.++++|+|++|+|+ .+|..+ .+|+.|++++|+++ .++. + .++|++|+|++|.++ .+|. ++.+++|+.|++
T Consensus 58 ~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~-~l~~-l--p~~L~~L~L~~n~l~-~lp~-~~~l~~L~~L~l 127 (353)
T d1jl5a_ 58 PHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLK-ALSD-L--PPLLEYLGVSNNQLE-KLPE-LQNSSFLKIIDV 127 (353)
T ss_dssp TTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCS-CCCS-C--CTTCCEEECCSSCCS-SCCC-CTTCTTCCEEEC
T ss_pred CCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccc-hhhh-h--ccccccccccccccc-cccc-hhhhccceeecc
Confidence 46777888888887 456543 35566666666665 3331 1 134777777777776 4553 566777777777
Q ss_pred cCCCCC
Q 042348 137 SQNSFS 142 (686)
Q Consensus 137 s~N~l~ 142 (686)
++|.++
T Consensus 128 ~~~~~~ 133 (353)
T d1jl5a_ 128 DNNSLK 133 (353)
T ss_dssp CSSCCS
T ss_pred cccccc
Confidence 777665
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.86 E-value=1.5e-10 Score=114.77 Aligned_cols=160 Identities=19% Similarity=0.193 Sum_probs=113.9
Q ss_pred CCEEEEEeCCCCcccc-CCcCcCCCCCCCEEEccCCCCcccCCccccCCCCCcEEEccCC-CCCCC-CcccccCCCCCCE
Q 042348 57 GQVFSLIIPNKKLTGF-IPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGN-SFSGP-VPMQIGKLKYLQV 133 (686)
Q Consensus 57 ~~~~~l~l~~n~l~g~-~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N-~l~g~-~p~~~~~l~~L~~ 133 (686)
.+++.|+|+++.+++. ++.-+..+++|++|+|+++.+++..+..+..+++|+.|+|+++ .++.. +..-+..+++|+.
T Consensus 46 ~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~ 125 (284)
T d2astb2 46 FRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDE 125 (284)
T ss_dssp BCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCE
T ss_pred CCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhccc
Confidence 4788999999988754 4455788999999999999998888888889999999999995 56521 2233457899999
Q ss_pred EeccCC-CCCCC-CChhhhh-cccccccccccc--ccCCCCchhhhhcCcccceeccccc-ccCCCCchhhhcccccccc
Q 042348 134 LDLSQN-SFSSS-IPSSIVQ-CKRLKTVVLNQN--SFTGPLPDGFATNLTALQKLDLSFN-NLSGLIPNDIANLSRLRLL 207 (686)
Q Consensus 134 L~ls~N-~l~~~-~p~~~~~-l~~L~~L~L~~N--~l~~~~p~~~~~~l~~L~~L~Ls~N-~l~~~~p~~~~~l~~L~~l 207 (686)
|+++++ .++.. +...+.. +++|+.|++++. .++..--..+..++++|++|+|++| .+++.....+.++++|+.
T Consensus 126 L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~- 204 (284)
T d2astb2 126 LNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQH- 204 (284)
T ss_dssp EECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCE-
T ss_pred cccccccccccccchhhhcccccccchhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccCcCCE-
Confidence 999985 45421 2223333 468999999864 3442222234457899999999986 577666666666666654
Q ss_pred cccccccccC-CCCCC
Q 042348 208 AQRVYVDLTY-NNLSG 222 (686)
Q Consensus 208 ~~~~~l~l~~-N~l~~ 222 (686)
|++++ ++++.
T Consensus 205 -----L~L~~C~~i~~ 215 (284)
T d2astb2 205 -----LSLSRCYDIIP 215 (284)
T ss_dssp -----EECTTCTTCCG
T ss_pred -----EECCCCCCCCh
Confidence 48888 46654
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=98.84 E-value=3.8e-09 Score=107.52 Aligned_cols=140 Identities=24% Similarity=0.320 Sum_probs=104.2
Q ss_pred CCEEEEEeCCCCccccCCcCcCCCCCCCEEEccCCCCcccCCccccCCCCCcEEEccCCCCCCCCcccccCCCCCCEEec
Q 042348 57 GQVFSLIIPNKKLTGFIPADLGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGPVPMQIGKLKYLQVLDL 136 (686)
Q Consensus 57 ~~~~~l~l~~n~l~g~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l 136 (686)
.+++.|+|++++|+. +|+. +++|++|+|++|+|+ .+|..+ .+|+.|++++|+++ .++.. .++|++|++
T Consensus 38 ~~l~~LdLs~~~L~~-lp~~---~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~-~l~~l---p~~L~~L~L 105 (353)
T d1jl5a_ 38 RQAHELELNNLGLSS-LPEL---PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLK-ALSDL---PPLLEYLGV 105 (353)
T ss_dssp HTCSEEECTTSCCSC-CCSC---CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCS-CCCSC---CTTCCEEEC
T ss_pred cCCCEEEeCCCCCCC-CCCC---CCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccc-hhhhh---ccccccccc
Confidence 467899999999985 7764 568999999999999 788654 57999999999998 55532 246999999
Q ss_pred cCCCCCCCCChhhhhccccccccccccccCCCCchhhhhcCcccceecccccccCCCCchhhhccccccccccccccccc
Q 042348 137 SQNSFSSSIPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSGLIPNDIANLSRLRLLAQRVYVDLT 216 (686)
Q Consensus 137 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~~~~~l~l~ 216 (686)
++|.++ .+|. +..+++|+.|++++|.++. .|. ....+..+++.++.... +..+..++.++ .++++
T Consensus 106 ~~n~l~-~lp~-~~~l~~L~~L~l~~~~~~~-~~~----~~~~l~~l~~~~~~~~~--~~~l~~l~~l~------~L~l~ 170 (353)
T d1jl5a_ 106 SNNQLE-KLPE-LQNSSFLKIIDVDNNSLKK-LPD----LPPSLEFIAAGNNQLEE--LPELQNLPFLT------AIYAD 170 (353)
T ss_dssp CSSCCS-SCCC-CTTCTTCCEEECCSSCCSC-CCC----CCTTCCEEECCSSCCSS--CCCCTTCTTCC------EEECC
T ss_pred cccccc-cccc-hhhhccceeeccccccccc-ccc----ccccccchhhccccccc--cccccccccce------ecccc
Confidence 999998 5665 5789999999999999984 333 24566777777766653 23344444444 34788
Q ss_pred CCCCCCC
Q 042348 217 YNNLSGL 223 (686)
Q Consensus 217 ~N~l~~~ 223 (686)
+|.+...
T Consensus 171 ~n~~~~~ 177 (353)
T d1jl5a_ 171 NNSLKKL 177 (353)
T ss_dssp SSCCSSC
T ss_pred ccccccc
Confidence 8877654
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.71 E-value=2.3e-09 Score=106.06 Aligned_cols=155 Identities=22% Similarity=0.259 Sum_probs=111.9
Q ss_pred CCEEEEEeCCCCccccCCcCcCCCCCCCEEEccCC-CCccc-CCccccCCCCCcEEEccCC-CCCCC-CcccccC-CCCC
Q 042348 57 GQVFSLIIPNKKLTGFIPADLGSLSAIGRVNLRNN-NFSGS-LPVELFNASNLQSLILSGN-SFSGP-VPMQIGK-LKYL 131 (686)
Q Consensus 57 ~~~~~l~l~~n~l~g~~p~~l~~l~~L~~L~L~~N-~l~g~-~p~~~~~l~~L~~L~L~~N-~l~g~-~p~~~~~-l~~L 131 (686)
.+++.|+|.++.+++..+..++.+++|+.|+|+++ .++.. +..-+.++++|++|+|+++ +++.. +...+.. .++|
T Consensus 71 ~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L~ls~c~~~~~~~~~~~~~~~~~~L 150 (284)
T d2astb2 71 SKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETI 150 (284)
T ss_dssp CCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTC
T ss_pred CCcccccccccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhccccccccccccccccchhhhccccccc
Confidence 57899999999999888889999999999999994 56521 2222457899999999985 55421 2233333 4789
Q ss_pred CEEeccCC--CCCCC-CChhhhhcccccccccccc-ccCCCCchhhhhcCcccceecccc-cccCCCCchhhhccccccc
Q 042348 132 QVLDLSQN--SFSSS-IPSSIVQCKRLKTVVLNQN-SFTGPLPDGFATNLTALQKLDLSF-NNLSGLIPNDIANLSRLRL 206 (686)
Q Consensus 132 ~~L~ls~N--~l~~~-~p~~~~~l~~L~~L~L~~N-~l~~~~p~~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~ 206 (686)
+.|++++. .++.. +......+++|++|+|++| .+++.....+ ..+++|++|+|++ +.+++.....++++++|+
T Consensus 151 ~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l-~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~- 228 (284)
T d2astb2 151 TQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEF-FQLNYLQHLSLSRCYDIIPETLLELGEIPTLK- 228 (284)
T ss_dssp CEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGG-GGCTTCCEEECTTCTTCCGGGGGGGGGCTTCC-
T ss_pred chhhhcccccccccccccccccccccccccccccccCCCchhhhhh-cccCcCCEEECCCCCCCChHHHHHHhcCCCCC-
Confidence 99999864 34422 3334567899999999986 5665555555 4789999999999 567765555555555555
Q ss_pred ccccccccccCC
Q 042348 207 LAQRVYVDLTYN 218 (686)
Q Consensus 207 l~~~~~l~l~~N 218 (686)
.|+++++
T Consensus 229 -----~L~l~~~ 235 (284)
T d2astb2 229 -----TLQVFGI 235 (284)
T ss_dssp -----EEECTTS
T ss_pred -----EEeeeCC
Confidence 4588776
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=98.58 E-value=1.3e-09 Score=111.09 Aligned_cols=41 Identities=27% Similarity=0.290 Sum_probs=20.3
Q ss_pred cCCCCCCCEEEccCCCCccc----CCccccCCCCCcEEEccCCCC
Q 042348 77 LGSLSAIGRVNLRNNNFSGS----LPVELFNASNLQSLILSGNSF 117 (686)
Q Consensus 77 l~~l~~L~~L~L~~N~l~g~----~p~~~~~l~~L~~L~L~~N~l 117 (686)
+...++|+.|+|++|.+... +...+...++|+.|+|++|.+
T Consensus 89 l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l 133 (344)
T d2ca6a1 89 LLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGL 133 (344)
T ss_dssp HTTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCC
T ss_pred HhhCCCcccccccccccccccccchhhhhcccccchheecccccc
Confidence 34445555556655555432 222233445555555555554
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=98.56 E-value=2.5e-09 Score=109.05 Aligned_cols=186 Identities=18% Similarity=0.212 Sum_probs=121.9
Q ss_pred CCCEEEEEeCCCCcccc----CCcCcCCCCCCCEEEccCCCCcccCC----c---------cccCCCCCcEEEccCCCCC
Q 042348 56 EGQVFSLIIPNKKLTGF----IPADLGSLSAIGRVNLRNNNFSGSLP----V---------ELFNASNLQSLILSGNSFS 118 (686)
Q Consensus 56 ~~~~~~l~l~~n~l~g~----~p~~l~~l~~L~~L~L~~N~l~g~~p----~---------~~~~l~~L~~L~L~~N~l~ 118 (686)
..+++.|+|++|.++.. +...+...++|++|+|++|.+...-. . .....+.|+.|.+++|.++
T Consensus 92 ~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~ 171 (344)
T d2ca6a1 92 CPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLE 171 (344)
T ss_dssp CTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCT
T ss_pred CCCcccccccccccccccccchhhhhcccccchheecccccccccccccccccccccccccccccCcccceeeccccccc
Confidence 35789999999998764 44566778899999999998752111 1 1135678999999999886
Q ss_pred CC----CcccccCCCCCCEEeccCCCCCCC-----CChhhhhccccccccccccccCCC----CchhhhhcCcccceecc
Q 042348 119 GP----VPMQIGKLKYLQVLDLSQNSFSSS-----IPSSIVQCKRLKTVVLNQNSFTGP----LPDGFATNLTALQKLDL 185 (686)
Q Consensus 119 g~----~p~~~~~l~~L~~L~ls~N~l~~~-----~p~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~~l~~L~~L~L 185 (686)
.. +...+...+.|+.|+|++|.++.. +...+..+++|+.|+|++|.++.. +...+ ..+++|++|+|
T Consensus 172 ~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l-~~~~~L~~L~L 250 (344)
T d2ca6a1 172 NGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIAL-KSWPNLRELGL 250 (344)
T ss_dssp GGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHG-GGCTTCCEEEC
T ss_pred ccccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccccc-cccccchhhhh
Confidence 32 344456778999999999988632 223456678899999999988632 22222 46788999999
Q ss_pred cccccCCCCchhhhcccccccc--cccccccccCCCCCCC----ccccc--ccccCCcccccCCCCC
Q 042348 186 SFNNLSGLIPNDIANLSRLRLL--AQRVYVDLTYNNLSGL----IPQNA--ALLSLGPTAFIGNPFL 244 (686)
Q Consensus 186 s~N~l~~~~p~~~~~l~~L~~l--~~~~~l~l~~N~l~~~----~p~~~--~~~~~~~~~~~~n~~~ 244 (686)
++|.|++.-...++. .|... ..+..||+++|+++.. +.... ....+..+.+.+|.+.
T Consensus 251 s~n~i~~~g~~~l~~--~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~ 315 (344)
T d2ca6a1 251 NDCLLSARGAAAVVD--AFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS 315 (344)
T ss_dssp TTCCCCHHHHHHHHH--HHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSC
T ss_pred hcCccCchhhHHHHH--HhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCC
Confidence 999988543233321 11111 2245669999988642 11111 1334556667777653
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.53 E-value=2.4e-09 Score=96.17 Aligned_cols=73 Identities=22% Similarity=0.158 Sum_probs=39.1
Q ss_pred cccccCCCCCCEEeccCCCCCCC--CChhhhhccccccccccccccCCCCchhhhhcCcccceecccccccCCCCc
Q 042348 122 PMQIGKLKYLQVLDLSQNSFSSS--IPSSIVQCKRLKTVVLNQNSFTGPLPDGFATNLTALQKLDLSFNNLSGLIP 195 (686)
Q Consensus 122 p~~~~~l~~L~~L~ls~N~l~~~--~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p 195 (686)
+..+..+++|++|+|++|+++.. ++..+..+++|+.|+|++|+++. +++-.......|+.|+|++|.++....
T Consensus 58 ~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~-l~~l~~l~~~~L~~L~L~~Npl~~~~~ 132 (162)
T d1koha1 58 RIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKS-ERELDKIKGLKLEELWLDGNSLSDTFR 132 (162)
T ss_dssp HHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCC-GGGHHHHTTCCCSSCCCTTSTTSSSSS
T ss_pred HHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCcccc-chhhhhhhccccceeecCCCCcCcCcc
Confidence 33334556666666666666532 12345556666666666666662 333211233456666666666665443
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.52 E-value=6e-09 Score=93.45 Aligned_cols=107 Identities=24% Similarity=0.248 Sum_probs=66.2
Q ss_pred cCCCCCCCEEEccCCCCcccCCccccCCCCCcEEEccCCCCCCC--CcccccCCCCCCEEeccCCCCCCCCChhhhhccc
Q 042348 77 LGSLSAIGRVNLRNNNFSGSLPVELFNASNLQSLILSGNSFSGP--VPMQIGKLKYLQVLDLSQNSFSSSIPSSIVQCKR 154 (686)
Q Consensus 77 l~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~--~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~ 154 (686)
+..+..+..+++.+|.+. .++..+.++++|++|+|++|+|+.. ++..+..+++|+.|+|++|.++...+-......+
T Consensus 38 l~~~~~~~~l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~ 116 (162)
T d1koha1 38 LVAQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLK 116 (162)
T ss_dssp TTTTTCCCCTTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCC
T ss_pred hhhccchhhcchhhhHhh-hhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccc
Confidence 444444444555554443 4444445678888888888888743 2345667888888888888887433334444556
Q ss_pred cccccccccccCCCCchh------hhhcCcccceec
Q 042348 155 LKTVVLNQNSFTGPLPDG------FATNLTALQKLD 184 (686)
Q Consensus 155 L~~L~L~~N~l~~~~p~~------~~~~l~~L~~L~ 184 (686)
|+.|+|++|.++...... +...+++|+.||
T Consensus 117 L~~L~L~~Npl~~~~~~~~~y~~~i~~~~P~L~~LD 152 (162)
T d1koha1 117 LEELWLDGNSLSDTFRDQSTYISAIRERFPKLLRLD 152 (162)
T ss_dssp CSSCCCTTSTTSSSSSSHHHHHHHHHTTSTTCCEET
T ss_pred cceeecCCCCcCcCcccchhHHHHHHHHCCCCCEEC
Confidence 788888888887544322 223566666665
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.40 E-value=5.8e-07 Score=87.07 Aligned_cols=130 Identities=15% Similarity=0.145 Sum_probs=92.5
Q ss_pred CceEEEEEEeCCCceEEEEEcCCCCccchHHHHHHHHHHhccC-CCCcceeeEEEEecCceeEEEeccCCCCHHHHhhcC
Q 042348 379 TIGIVYKVALNNEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIR-HPNIVSLRAYFWSVDEKLLIYDYIPNGSLATAIHGK 457 (686)
Q Consensus 379 ~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~ 457 (686)
+.+.||+.... ++.+++|+...........+.+|...+..+. +--+.+++++...++..++||+++++.++.+.....
T Consensus 26 s~~~v~rv~~~-~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~~~~ 104 (263)
T d1j7la_ 26 SPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYEDE 104 (263)
T ss_dssp SSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHTTTC
T ss_pred CCCcEEEEEeC-CCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEeccccccccccccc
Confidence 34689998754 5567888886654444556788999888774 434677888888888899999999998886654221
Q ss_pred CCccccCCCCHHHHHHHHHHHHHHHHHHHcc-------------------------------------------------
Q 042348 458 AGIISYRPLSWSDRLRIIKGVAKGIAFLHEV------------------------------------------------- 488 (686)
Q Consensus 458 ~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~------------------------------------------------- 488 (686)
.....++.++++.++.||+.
T Consensus 105 -----------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (263)
T d1j7la_ 105 -----------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDF 173 (263)
T ss_dssp -----------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHH
T ss_pred -----------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHH
Confidence 11233555666666666640
Q ss_pred -------CCCCceecCCCCCCeeecCCCCeEEeecCccc
Q 042348 489 -------SPKRYVHGDLRPSNILLGKNMEPHISDFGLAR 520 (686)
Q Consensus 489 -------~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~ 520 (686)
.+..++|+|+.|.||++++++.+.|+||+.+.
T Consensus 174 l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 174 LKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp HHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 01237899999999999987667799999876
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.22 E-value=5.3e-08 Score=102.52 Aligned_cols=160 Identities=21% Similarity=0.210 Sum_probs=103.1
Q ss_pred CCEEEEEeCCCCccc-----cCCcCcCCCCCCCEEEccCCCCccc----CCccccCCCCCcEEEccCCCCCCCCccc---
Q 042348 57 GQVFSLIIPNKKLTG-----FIPADLGSLSAIGRVNLRNNNFSGS----LPVELFNASNLQSLILSGNSFSGPVPMQ--- 124 (686)
Q Consensus 57 ~~~~~l~l~~n~l~g-----~~p~~l~~l~~L~~L~L~~N~l~g~----~p~~~~~l~~L~~L~L~~N~l~g~~p~~--- 124 (686)
..+..+.+.+|.+.. .++........|+.|++++|.+... ....+...+.++.+++++|.++......
T Consensus 226 ~~~~~l~~~~n~~~~~~~~~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~l~~ 305 (460)
T d1z7xw1 226 ASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCE 305 (460)
T ss_dssp TTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHH
T ss_pred ccccccchhhccccccccchhhcccccccccccccccccccccccccccccccccccccccccccccccccccccchhhc
Confidence 456778888877643 2334455667888899998887633 2233456788888999988886322211
Q ss_pred -c-cCCCCCCEEeccCCCCCCCCChh----hhhccccccccccccccCCC----CchhhhhcCcccceecccccccCCC-
Q 042348 125 -I-GKLKYLQVLDLSQNSFSSSIPSS----IVQCKRLKTVVLNQNSFTGP----LPDGFATNLTALQKLDLSFNNLSGL- 193 (686)
Q Consensus 125 -~-~~l~~L~~L~ls~N~l~~~~p~~----~~~l~~L~~L~L~~N~l~~~----~p~~~~~~l~~L~~L~Ls~N~l~~~- 193 (686)
+ .....|+.+++++|.++...... +....+|++|+|++|+++.. ++..+....+.|++|+|++|.|+..
T Consensus 306 ~l~~~~~~L~~l~l~~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~ 385 (460)
T d1z7xw1 306 TLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSS 385 (460)
T ss_dssp HHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHH
T ss_pred cccccccccccccccccchhhhhhhhcccccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCChHH
Confidence 1 23457889999988887543232 34456789999999888632 2333333456788999999988743
Q ss_pred ---CchhhhcccccccccccccccccCCCCCC
Q 042348 194 ---IPNDIANLSRLRLLAQRVYVDLTYNNLSG 222 (686)
Q Consensus 194 ---~p~~~~~l~~L~~l~~~~~l~l~~N~l~~ 222 (686)
++..+..+++|+ +|||++|+++.
T Consensus 386 ~~~l~~~l~~~~~L~------~L~Ls~N~i~~ 411 (460)
T d1z7xw1 386 CSSLAATLLANHSLR------ELDLSNNCLGD 411 (460)
T ss_dssp HHHHHHHHHHCCCCC------EEECCSSSCCH
T ss_pred HHHHHHHHhcCCCCC------EEECCCCcCCH
Confidence 233344444444 45899988874
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.22 E-value=4e-08 Score=103.55 Aligned_cols=166 Identities=17% Similarity=0.138 Sum_probs=112.3
Q ss_pred CCEEEEEeCCCCcccc----CCcCcCCCCCCCEEEccCCCCcccCCcc----c-cCCCCCcEEEccCCCCCCCCcc----
Q 042348 57 GQVFSLIIPNKKLTGF----IPADLGSLSAIGRVNLRNNNFSGSLPVE----L-FNASNLQSLILSGNSFSGPVPM---- 123 (686)
Q Consensus 57 ~~~~~l~l~~n~l~g~----~p~~l~~l~~L~~L~L~~N~l~g~~p~~----~-~~l~~L~~L~L~~N~l~g~~p~---- 123 (686)
..+..|++++|.+... ....+...+.+..+++++|.++...... + .....|+.+++++|.++..-..
T Consensus 255 ~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~l~~~l~~~~~~L~~l~l~~~~l~~~~~~~l~~ 334 (460)
T d1z7xw1 255 SRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSS 334 (460)
T ss_dssp CCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccchhhccccccccccccccccccchhhhhhhhccc
Confidence 4788999999998754 2334567889999999999986432221 1 2346899999999999854333
Q ss_pred cccCCCCCCEEeccCCCCCCC----CChhhh-hccccccccccccccCCC----CchhhhhcCcccceecccccccCCCC
Q 042348 124 QIGKLKYLQVLDLSQNSFSSS----IPSSIV-QCKRLKTVVLNQNSFTGP----LPDGFATNLTALQKLDLSFNNLSGLI 194 (686)
Q Consensus 124 ~~~~l~~L~~L~ls~N~l~~~----~p~~~~-~l~~L~~L~L~~N~l~~~----~p~~~~~~l~~L~~L~Ls~N~l~~~~ 194 (686)
.+...++|++|+|++|+++.. ++..+. ....|++|+|++|+|+.. ++..+ ..+++|++|||++|+|+...
T Consensus 335 ~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~l-~~~~~L~~L~Ls~N~i~~~g 413 (460)
T d1z7xw1 335 VLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATL-LANHSLRELDLSNNCLGDAG 413 (460)
T ss_dssp HHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHH-HHCCCCCEEECCSSSCCHHH
T ss_pred ccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCChHHHHHHHHHH-hcCCCCCEEECCCCcCCHHH
Confidence 344567899999999998742 223332 356799999999999742 33333 35789999999999998543
Q ss_pred chhhhccccccc-ccccccccccCCCCCCCcc
Q 042348 195 PNDIANLSRLRL-LAQRVYVDLTYNNLSGLIP 225 (686)
Q Consensus 195 p~~~~~l~~L~~-l~~~~~l~l~~N~l~~~~p 225 (686)
...+.. .++. ...+..+++++|.+.....
T Consensus 414 ~~~l~~--~l~~~~~~L~~l~l~~~~~~~~~~ 443 (460)
T d1z7xw1 414 ILQLVE--SVRQPGCLLEQLVLYDIYWSEEME 443 (460)
T ss_dssp HHHHHH--HHTSTTCCCCEEECTTCCCCHHHH
T ss_pred HHHHHH--HHHhCCCccCEEECCCCCCCHHHH
Confidence 333321 1110 1123456888888875433
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.19 E-value=1.9e-06 Score=82.84 Aligned_cols=73 Identities=14% Similarity=0.173 Sum_probs=54.0
Q ss_pred CccC-ceEEEEEEeCCCceEEEEEcCCCCccchHHHHHHHHHHhccCC--CCcceeeEEEEecCceeEEEeccCCCCHH
Q 042348 376 GKST-IGIVYKVALNNEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRH--PNIVSLRAYFWSVDEKLLIYDYIPNGSLA 451 (686)
Q Consensus 376 G~G~-~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H--~nIv~l~~~~~~~~~~~lV~e~~~~gsL~ 451 (686)
..|. -+.||+....++..+++|....... ..+..|...++.+.. --+.+++++..+.+..++||+|++|.++.
T Consensus 19 ~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~ 94 (255)
T d1nd4a_ 19 TIGCSDAAVFRLSAQGRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL 94 (255)
T ss_dssp SCTTSSCEEEEEECTTSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT
T ss_pred CCcccCCeEEEEEeCCCCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccccc
Confidence 3444 3679999988888889998765432 357788888887743 33667888888888899999999886553
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.82 E-value=7.8e-05 Score=76.09 Aligned_cols=74 Identities=8% Similarity=0.123 Sum_probs=48.3
Q ss_pred ccCccCceEEEEEEeCC-CceEEEEEcCC------CC-ccchHHHHHHHHHHhccC-C--CCcceeeEEEEecCceeEEE
Q 042348 374 LLGKSTIGIVYKVALNN-EEAVAVRRLGN------GG-WQRFKEFQTEAEAIGKIR-H--PNIVSLRAYFWSVDEKLLIY 442 (686)
Q Consensus 374 ~iG~G~~g~Vy~~~~~~-~~~vavK~~~~------~~-~~~~~~~~~E~~~l~~l~-H--~nIv~l~~~~~~~~~~~lV~ 442 (686)
-||.|....||++...+ ++.|+||.-.. .. .....+...|.+.|+.+. + ..+++++.+ +.+..++||
T Consensus 33 eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lvm 110 (392)
T d2pula1 33 EIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTVM 110 (392)
T ss_dssp ECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEEE
T ss_pred EeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEEE
Confidence 37999999999998764 67889986432 11 122345667888887662 3 345556544 556778999
Q ss_pred eccCCCC
Q 042348 443 DYIPNGS 449 (686)
Q Consensus 443 e~~~~gs 449 (686)
|++++..
T Consensus 111 E~L~~~~ 117 (392)
T d2pula1 111 EDLSHLK 117 (392)
T ss_dssp CCCTTSE
T ss_pred eccCCcc
Confidence 9997654
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.46 E-value=2.2e-05 Score=69.82 Aligned_cols=88 Identities=16% Similarity=0.195 Sum_probs=46.3
Q ss_pred CCCCCCEEEccCC-CCccc----CCccccCCCCCcEEEccCCCCCC----CCcccccCCCCCCEEeccCCCCCCCC----
Q 042348 79 SLSAIGRVNLRNN-NFSGS----LPVELFNASNLQSLILSGNSFSG----PVPMQIGKLKYLQVLDLSQNSFSSSI---- 145 (686)
Q Consensus 79 ~l~~L~~L~L~~N-~l~g~----~p~~~~~l~~L~~L~L~~N~l~g----~~p~~~~~l~~L~~L~ls~N~l~~~~---- 145 (686)
+.++|+.|+|+++ .++.. +-..+...++|+.|+|++|.+.. .+...+...+.|+.|+|++|.++..-
T Consensus 13 n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l 92 (167)
T d1pgva_ 13 DDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARL 92 (167)
T ss_dssp TCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHH
T ss_pred CCCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHH
Confidence 3456677777653 34321 22234455667777777776652 22233444566777777777665321
Q ss_pred ChhhhhccccccccccccccC
Q 042348 146 PSSIVQCKRLKTVVLNQNSFT 166 (686)
Q Consensus 146 p~~~~~l~~L~~L~L~~N~l~ 166 (686)
-..+...++|++|+|++|.+.
T Consensus 93 ~~aL~~n~sL~~L~l~~n~~~ 113 (167)
T d1pgva_ 93 LRSTLVTQSIVEFKADNQRQS 113 (167)
T ss_dssp HHHTTTTCCCSEEECCCCSSC
T ss_pred HHHHHhCCcCCEEECCCCcCC
Confidence 112333355666666665544
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.41 E-value=3.1e-05 Score=68.84 Aligned_cols=92 Identities=14% Similarity=0.134 Sum_probs=64.5
Q ss_pred cCCCCCcEEEccCC-CCCCC----CcccccCCCCCCEEeccCCCCCCC----CChhhhhccccccccccccccCCCCchh
Q 042348 102 FNASNLQSLILSGN-SFSGP----VPMQIGKLKYLQVLDLSQNSFSSS----IPSSIVQCKRLKTVVLNQNSFTGPLPDG 172 (686)
Q Consensus 102 ~~l~~L~~L~L~~N-~l~g~----~p~~~~~l~~L~~L~ls~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~p~~ 172 (686)
.+.++|++|+|+++ .++.. +-..+...++|+.|+|++|.+... +...+...++|++|+|++|.++..--..
T Consensus 12 ~n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~ 91 (167)
T d1pgva_ 12 EDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLAR 91 (167)
T ss_dssp TTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHH
T ss_pred hCCCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHH
Confidence 35688999999974 56521 334567788999999999998632 2234556788999999999987321111
Q ss_pred h---hhcCcccceecccccccCCC
Q 042348 173 F---ATNLTALQKLDLSFNNLSGL 193 (686)
Q Consensus 173 ~---~~~l~~L~~L~Ls~N~l~~~ 193 (686)
+ ...-++|++|+|++|.+...
T Consensus 92 l~~aL~~n~sL~~L~l~~n~~~~~ 115 (167)
T d1pgva_ 92 LLRSTLVTQSIVEFKADNQRQSVL 115 (167)
T ss_dssp HHHHTTTTCCCSEEECCCCSSCCC
T ss_pred HHHHHHhCCcCCEEECCCCcCCCc
Confidence 1 13446799999999987643
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.21 E-value=0.00037 Score=68.91 Aligned_cols=137 Identities=15% Similarity=0.175 Sum_probs=77.8
Q ss_pred eEEEEEEeCCCceEEEEEcCCCCccchHHHHHHHHHHhccCCCCcc--eee-----EEEEecCceeEEEeccCCCCHH--
Q 042348 381 GIVYKVALNNEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNIV--SLR-----AYFWSVDEKLLIYDYIPNGSLA-- 451 (686)
Q Consensus 381 g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv--~l~-----~~~~~~~~~~lV~e~~~~gsL~-- 451 (686)
-.||++..++|+.+++|..+.+.. ..+++..|...+..|....|. ..+ ..+...+..+.++++++|..+.
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~~~-s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~ 114 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPERW-TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEAD 114 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTTTS-CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSS
T ss_pred ceeEEEEcCCCCEEEEEEeCCCCC-CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCC
Confidence 479999999999999999865432 346788899888887422221 111 1123455678899999763221
Q ss_pred ---H---------HhhcC---CCccccCCCCH-------------------HHHHHHHHHHHHHHHHHHc----cCCCCc
Q 042348 452 ---T---------AIHGK---AGIISYRPLSW-------------------SDRLRIIKGVAKGIAFLHE----VSPKRY 493 (686)
Q Consensus 452 ---~---------~l~~~---~~~~~~~~l~~-------------------~~~~~i~~~ia~gL~~LH~----~~~~~i 493 (686)
. .+|.. ........+++ ..+..+...+...++.+.. ..+.++
T Consensus 115 ~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~l 194 (325)
T d1zyla1 115 NIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLR 194 (325)
T ss_dssp CHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEE
T ss_pred CHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCcee
Confidence 0 11110 00000011111 1111222222333333332 234579
Q ss_pred eecCCCCCCeeecCCCCeEEeecCccc
Q 042348 494 VHGDLRPSNILLGKNMEPHISDFGLAR 520 (686)
Q Consensus 494 iHrDlkp~NILl~~~~~~kl~DfGla~ 520 (686)
||+|+.+.|||++++ ..++||+-+.
T Consensus 195 iHgDlh~~NvL~~~~--~~~IDFdd~~ 219 (325)
T d1zyla1 195 LHGDCHAGNILWRDG--PMFVDLDDAR 219 (325)
T ss_dssp CCSSCSGGGEEESSS--EEECCCTTCC
T ss_pred ecCCCCcccEEEeCC--ceEEechhcc
Confidence 999999999999743 5689999775
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.78 E-value=0.0017 Score=65.84 Aligned_cols=71 Identities=14% Similarity=0.118 Sum_probs=47.8
Q ss_pred ccCccCceEEEEEEeCCC--------ceEEEEEcCCCCccchHHHHHHHHHHhccC-CCCcceeeEEEEecCceeEEEec
Q 042348 374 LLGKSTIGIVYKVALNNE--------EAVAVRRLGNGGWQRFKEFQTEAEAIGKIR-HPNIVSLRAYFWSVDEKLLIYDY 444 (686)
Q Consensus 374 ~iG~G~~g~Vy~~~~~~~--------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lV~e~ 444 (686)
.|+.|-.-.+|++...++ ..|.++... .. .......+|..+++.+. +.-..++++++. -.+||||
T Consensus 49 ~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~~-~~~idr~~E~~i~~~ls~~gl~Pkll~~~~----~g~I~ef 122 (395)
T d1nw1a_ 49 RIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-NP-ETESHLVAESVIFTLLSERHLGPKLYGIFS----GGRLEEY 122 (395)
T ss_dssp EECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-SC-CCHHHHHHHHHHHHHHHHTTSSSCEEEEET----TEEEECC
T ss_pred EcCCccccceEEEEeCCCCccccCCCCcEEEEecC-Cc-chhhHHHHHHHHHHHHHhCCCCCeEEEEcC----CceEEEE
Confidence 477888899999987543 346666554 22 22345668999999884 444457777763 2689999
Q ss_pred cCCCCH
Q 042348 445 IPNGSL 450 (686)
Q Consensus 445 ~~~gsL 450 (686)
+++..+
T Consensus 123 i~g~~l 128 (395)
T d1nw1a_ 123 IPSRPL 128 (395)
T ss_dssp CCEEEC
T ss_pred eccccC
Confidence 987543
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.59 E-value=0.00021 Score=63.10 Aligned_cols=111 Identities=16% Similarity=0.186 Sum_probs=55.6
Q ss_pred CCCCCCCEEEccC-CCCccc----CCccccCCCCCcEEEccCCCCCCC----CcccccCCCCCCEEeccCCCCCCCC---
Q 042348 78 GSLSAIGRVNLRN-NNFSGS----LPVELFNASNLQSLILSGNSFSGP----VPMQIGKLKYLQVLDLSQNSFSSSI--- 145 (686)
Q Consensus 78 ~~l~~L~~L~L~~-N~l~g~----~p~~~~~l~~L~~L~L~~N~l~g~----~p~~~~~l~~L~~L~ls~N~l~~~~--- 145 (686)
.+.+.|+.|+|++ |.++.. +-..+...++|+.|+|++|.++.. +-..+...++|+.|++++|.++..-
T Consensus 14 ~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~ 93 (166)
T d1io0a_ 14 NNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILA 93 (166)
T ss_dssp TTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHH
T ss_pred hcCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHH
Confidence 3456677777776 345311 223344566777777777776532 2233445567777777776665221
Q ss_pred -Chhhhhccccccc--cccccccCC----CCchhhhhcCcccceecccccc
Q 042348 146 -PSSIVQCKRLKTV--VLNQNSFTG----PLPDGFATNLTALQKLDLSFNN 189 (686)
Q Consensus 146 -p~~~~~l~~L~~L--~L~~N~l~~----~~p~~~~~~l~~L~~L~Ls~N~ 189 (686)
-..+...++|+.+ +++.|.+.. .+...+ ...++|+.|+|+.|.
T Consensus 94 l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L-~~n~~L~~L~l~~~~ 143 (166)
T d1io0a_ 94 LVEALQSNTSLIELRIDNQSQPLGNNVEMEIANML-EKNTTLLKFGYHFTQ 143 (166)
T ss_dssp HHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHH-HHCSSCCEEECCCSS
T ss_pred HHHHHHhCccccEEeeccCCCcCcHHHHHHHHHHH-HhCCCcCEEeCcCCC
Confidence 1223344555543 333444431 111112 234556666655544
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.34 E-value=0.00046 Score=60.80 Aligned_cols=91 Identities=14% Similarity=0.192 Sum_probs=61.6
Q ss_pred cCCCCCcEEEccC-CCCCCC----CcccccCCCCCCEEeccCCCCCCCCC----hhhhhccccccccccccccCCCCchh
Q 042348 102 FNASNLQSLILSG-NSFSGP----VPMQIGKLKYLQVLDLSQNSFSSSIP----SSIVQCKRLKTVVLNQNSFTGPLPDG 172 (686)
Q Consensus 102 ~~l~~L~~L~L~~-N~l~g~----~p~~~~~l~~L~~L~ls~N~l~~~~p----~~~~~l~~L~~L~L~~N~l~~~~p~~ 172 (686)
.+.++|+.|+|++ |.++.. +-..+...+.|+.|+|++|.++...- ..+....+++.|++++|.++..--..
T Consensus 14 ~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~ 93 (166)
T d1io0a_ 14 NNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILA 93 (166)
T ss_dssp TTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHH
T ss_pred hcCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHH
Confidence 4678999999998 557521 34456688999999999998874322 23456688999999999886321111
Q ss_pred hh---hcCcccce--ecccccccCC
Q 042348 173 FA---TNLTALQK--LDLSFNNLSG 192 (686)
Q Consensus 173 ~~---~~l~~L~~--L~Ls~N~l~~ 192 (686)
++ ...++|+. |++++|.+..
T Consensus 94 l~~~l~~~~~L~~l~L~l~~n~i~~ 118 (166)
T d1io0a_ 94 LVEALQSNTSLIELRIDNQSQPLGN 118 (166)
T ss_dssp HHHGGGGCSSCCEEECCCCSSCCCH
T ss_pred HHHHHHhCccccEEeeccCCCcCcH
Confidence 11 34567775 5556777764
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.19 E-value=0.0086 Score=58.31 Aligned_cols=143 Identities=9% Similarity=-0.020 Sum_probs=73.7
Q ss_pred cCccCceEEEEEEeCCCceEEEEEcCCCCccchHHHHHHHHHHhccCCCCc--ceeeE------EEEecCceeEEEeccC
Q 042348 375 LGKSTIGIVYKVALNNEEAVAVRRLGNGGWQRFKEFQTEAEAIGKIRHPNI--VSLRA------YFWSVDEKLLIYDYIP 446 (686)
Q Consensus 375 iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nI--v~l~~------~~~~~~~~~lV~e~~~ 446 (686)
|..|---+.|+....+|+ +++|+..... ..++...|++++..+...++ ...+. +.........++.++.
T Consensus 26 i~~G~~N~ny~v~t~~g~-yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~~~~~~~~~~~~~~ 102 (316)
T d2ppqa1 26 IAEGVENSNFLLHTTKDP-LILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISFLE 102 (316)
T ss_dssp ECC---EEEEEEEESSCC-EEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEECCC
T ss_pred CCCCcccCeEEEEECCCc-EEEEEcCCCC--CHHHHHHHHHHHHhhhhccccccccceecCCCcceeeecccceeeeecc
Confidence 566777889999988765 8889886532 22456667777777743222 11111 1112344566777776
Q ss_pred CCCHHH--------------HhhcC----CCccccCCC-----------------CHHHHHHHHHHHHHHHHHHHc-cCC
Q 042348 447 NGSLAT--------------AIHGK----AGIISYRPL-----------------SWSDRLRIIKGVAKGIAFLHE-VSP 490 (686)
Q Consensus 447 ~gsL~~--------------~l~~~----~~~~~~~~l-----------------~~~~~~~i~~~ia~gL~~LH~-~~~ 490 (686)
+..... .++.. ......... ........+..+...+.-.+. ..+
T Consensus 103 g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~L~ 182 (316)
T d2ppqa1 103 GMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKDLP 182 (316)
T ss_dssp CBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCSSC
T ss_pred cccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHHHHHHHHHHhhhccCccccc
Confidence 532211 11100 000000000 001111222222222332221 234
Q ss_pred CCceecCCCCCCeeecCCCCeEEeecCccc
Q 042348 491 KRYVHGDLRPSNILLGKNMEPHISDFGLAR 520 (686)
Q Consensus 491 ~~iiHrDlkp~NILl~~~~~~kl~DfGla~ 520 (686)
.++||+|+.+.||+++.+...-|.||+.+.
T Consensus 183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cccccCCcchhhhhcccccceeEecccccc
Confidence 689999999999999988777899999875
|